PGEN_.00g000010	Scaffold_01	2	4719	Q86IC9	CAMT1_DICDI	Probable caffeoyl-CoA O-methyltransferase 1 (EC 2.1.1.104) (O-methyltransferase 5)	GO:0032259; GO:0042409; GO:0046872	caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; methylation [GO:0032259]
PGEN_.00g000020	Scaffold_01	19808	36739	P04177	TY3H_RAT	Tyrosine 3-monooxygenase (EC 1.14.16.2) (Tyrosine 3-hydroxylase) (TH)	GO:0001666; GO:0001963; GO:0001975; GO:0004497; GO:0004511; GO:0005634; GO:0005737; GO:0005739; GO:0005790; GO:0005829; GO:0006585; GO:0006631; GO:0006665; GO:0007507; GO:0007601; GO:0007605; GO:0007612; GO:0007613; GO:0007617; GO:0007626; GO:0008016; GO:0008021; GO:0008198; GO:0008199; GO:0009414; GO:0009416; GO:0009635; GO:0009651; GO:0009887; GO:0009898; GO:0010038; GO:0010043; GO:0010259; GO:0014070; GO:0014823; GO:0015842; GO:0016137; GO:0016597; GO:0017085; GO:0018963; GO:0019825; GO:0019899; GO:0019904; GO:0021987; GO:0030424; GO:0030425; GO:0030659; GO:0031410; GO:0031667; GO:0032355; GO:0032496; GO:0033076; GO:0033162; GO:0034617; GO:0035094; GO:0035176; GO:0035240; GO:0035690; GO:0035900; GO:0035902; GO:0042136; GO:0042214; GO:0042416; GO:0042418; GO:0042421; GO:0042423; GO:0042462; GO:0042493; GO:0042745; GO:0042755; GO:0042802; GO:0043005; GO:0043025; GO:0043195; GO:0043204; GO:0043434; GO:0045471; GO:0045472; GO:0046684; GO:0048545; GO:0048596; GO:0050890; GO:0051412; GO:0051602; GO:0052314; GO:0070848; GO:0071287; GO:0071312; GO:0071316; GO:0071333; GO:0071363	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; melanosome membrane [GO:0033162]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; amino acid binding [GO:0016597]; dopamine binding [GO:0035240]; enzyme binding [GO:0019899]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; protein domain specific binding [GO:0019904]; tetrahydrobiopterin binding [GO:0034617]; tyrosine 3-monooxygenase activity [GO:0004511]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; animal organ morphogenesis [GO:0009887]; catecholamine biosynthetic process [GO:0042423]; cellular response to alkaloid [GO:0071312]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to manganese ion [GO:0071287]; cellular response to nicotine [GO:0071316]; cerebral cortex development [GO:0021987]; circadian sleep/wake cycle [GO:0042745]; cognition [GO:0050890]; dopamine biosynthetic process [GO:0042416]; dopamine biosynthetic process from tyrosine [GO:0006585]; eating behavior [GO:0042755]; embryonic camera-type eye morphogenesis [GO:0048596]; epinephrine biosynthetic process [GO:0042418]; eye photoreceptor cell development [GO:0042462]; fatty acid metabolic process [GO:0006631]; glycoside metabolic process [GO:0016137]; heart development [GO:0007507]; isoquinoline alkaloid metabolic process [GO:0033076]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; multicellular organism aging [GO:0010259]; neurotransmitter biosynthetic process [GO:0042136]; norepinephrine biosynthetic process [GO:0042421]; phthalate metabolic process [GO:0018963]; phytoalexin metabolic process [GO:0052314]; regulation of heart contraction [GO:0008016]; response to activity [GO:0014823]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to ether [GO:0045472]; response to growth factor [GO:0070848]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to insecticide [GO:0017085]; response to isolation stress [GO:0035900]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to metal ion [GO:0010038]; response to nicotine [GO:0035094]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to pyrethroid [GO:0046684]; response to salt stress [GO:0009651]; response to steroid hormone [GO:0048545]; response to water deprivation [GO:0009414]; response to zinc ion [GO:0010043]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; sphingolipid metabolic process [GO:0006665]; synaptic transmission, dopaminergic [GO:0001963]; terpene metabolic process [GO:0042214]; visual perception [GO:0007601]"
PGEN_.00g000030	Scaffold_01	49248	52578	NA	NA	NA	NA	NA
PGEN_.00g000040	Scaffold_01	55792	67546	NA	NA	NA	NA	NA
PGEN_.00g000050	Scaffold_01	67586	69113	Q8L840	RQL4A_ARATH	ATP-dependent DNA helicase Q-like 4A (EC 3.6.4.12) (RecQ-like protein 4A) (AtRecQ4A) (AtRecQl4A) (SGS1-like protein) (AtSGS1)	GO:0000724; GO:0003676; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0009378; GO:0009506; GO:0032508; GO:0043138; GO:0046872; GO:0051276; GO:0070417; GO:0071215	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasmodesma [GO:0009506]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cellular response to abscisic acid stimulus [GO:0071215]; cellular response to cold [GO:0070417]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]
PGEN_.00g000060	Scaffold_01	70713	81099	Q61043	NIN_MOUSE	Ninein	GO:0000242; GO:0000922; GO:0005509; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005886; GO:0008104; GO:0010457; GO:0019900; GO:0021540; GO:0021957; GO:0030424; GO:0030425; GO:0031116; GO:0034454; GO:0036449; GO:0044295; GO:0045177; GO:0048668; GO:0050772; GO:0051642; GO:0072686; GO:0090222; GO:0097431; GO:0097539; GO:0120103	apical part of cell [GO:0045177]; axon [GO:0030424]; axonal growth cone [GO:0044295]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule minus-end [GO:0036449]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; centriole-centriole cohesion [GO:0010457]; centrosome localization [GO:0051642]; centrosome-templated microtubule nucleation [GO:0090222]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of axonogenesis [GO:0050772]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104]
PGEN_.00g000070	Scaffold_01	183686	186073	NA	NA	NA	NA	NA
PGEN_.00g000080	Scaffold_01	187328	188353	A1E2V0	BIRC3_CANLF	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BIRC3)	GO:0005634; GO:0005737; GO:0031398; GO:0043027; GO:0043154; GO:0046872; GO:0060546; GO:0061630; GO:1990001	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; positive regulation of protein ubiquitination [GO:0031398]
PGEN_.00g000090	Scaffold_01	189849	190460	P34456	YMD2_CAEEL	Uncharacterized protein F54H12.2	GO:0004748; GO:0005829; GO:0009263	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]"
PGEN_.00g000100	Scaffold_01	191069	191410	NA	NA	NA	NA	NA
PGEN_.00g000110	Scaffold_01	191836	192282	NA	NA	NA	NA	NA
PGEN_.00g000120	Scaffold_01	192526	193324	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g000130	Scaffold_01	194601	195002	NA	NA	NA	NA	NA
PGEN_.00g000140	Scaffold_01	195061	196757	NA	NA	NA	NA	NA
PGEN_.00g000150	Scaffold_01	196813	197325	NA	NA	NA	NA	NA
PGEN_.00g000160	Scaffold_01	197831	198256	NA	NA	NA	NA	NA
PGEN_.00g000170	Scaffold_01	198658	198945	NA	NA	NA	NA	NA
PGEN_.00g000180	Scaffold_01	199108	207581	NA	NA	NA	NA	NA
PGEN_.00g000190	Scaffold_01	207756	208058	NA	NA	NA	NA	NA
PGEN_.00g000200	Scaffold_01	208188	210053	NA	NA	NA	NA	NA
PGEN_.00g000210	Scaffold_01	225369	238796	O00463	TRAF5_HUMAN	TNF receptor-associated factor 5 (RING finger protein 84)	GO:0005164; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0009898; GO:0031625; GO:0031996; GO:0032991; GO:0035631; GO:0042802; GO:0042981; GO:0043123; GO:0051091; GO:0051092	CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]
PGEN_.00g000220	Scaffold_01	295582	296213	NA	NA	NA	NA	NA
PGEN_.00g000230	Scaffold_01	311069	315793	Q00945	CONO_LYMST	Conopressin/neurophysin [Cleaved into: Lys-conopressin G; Neurophysin]	GO:0005185; GO:0005576	extracellular region [GO:0005576]; neurohypophyseal hormone activity [GO:0005185]
PGEN_.00g000240	Scaffold_01	326245	329049	Q5SWK7	RN145_MOUSE	RING finger protein 145 (EC 2.3.2.27)	GO:0005783; GO:0005789; GO:0008270; GO:0012505; GO:0016021; GO:0061630	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]
PGEN_.00g000250	Scaffold_01	343914	344213	NA	NA	NA	NA	NA
PGEN_.00g000260	Scaffold_01	344343	344645	NA	NA	NA	NA	NA
PGEN_.00g000270	Scaffold_01	344820	379444	NA	NA	NA	NA	NA
PGEN_.00g000280	Scaffold_01	402378	436712	Q8ZXT3	Y1111_PYRAE	Uncharacterized protein PAE1111		
PGEN_.00g000290	Scaffold_01	480810	495581	NA	NA	NA	NA	NA
PGEN_.00g000300	Scaffold_01	503707	557915	Q5REG4	DTX3_PONAB	Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3)	GO:0005737; GO:0007219; GO:0016567; GO:0016740; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g000310	Scaffold_01	563507	564382	NA	NA	NA	NA	NA
PGEN_.00g000320	Scaffold_01	571666	599482	NA	NA	NA	NA	NA
PGEN_.00g000330	Scaffold_01	610746	611273	NA	NA	NA	NA	NA
PGEN_.00g000340	Scaffold_01	612875	639118	NA	NA	NA	NA	NA
PGEN_.00g000350	Scaffold_01	651708	652814	NA	NA	NA	NA	NA
PGEN_.00g000360	Scaffold_01	664411	665104	NA	NA	NA	NA	NA
PGEN_.00g000370	Scaffold_01	668292	668636	NA	NA	NA	NA	NA
PGEN_.00g000380	Scaffold_01	691023	698310	Q8QG60	CRY2_CHICK	Cryptochrome-2	GO:0005634; GO:0005737; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0032922; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; FAD binding [GO:0071949]; photoreceptor activity [GO:0009881]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; response to light stimulus [GO:0009416]"
PGEN_.00g000390	Scaffold_01	717161	743048	NA	NA	NA	NA	NA
PGEN_.00g000400	Scaffold_01	772210	774393	NA	NA	NA	NA	NA
PGEN_.00g000410	Scaffold_01	781010	783193	NA	NA	NA	NA	NA
PGEN_.00g000420	Scaffold_01	812355	819404	NA	NA	NA	NA	NA
PGEN_.00g000430	Scaffold_01	838769	839182	NA	NA	NA	NA	NA
PGEN_.00g000440	Scaffold_01	868194	911401	Q9H583	HEAT1_HUMAN	"HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed]"	GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006364; GO:0016020; GO:0030686; GO:0032040; GO:0034455; GO:0045943; GO:2000234	"90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]"
PGEN_.00g000450	Scaffold_01	912369	922837	A0JMR6	MYSM1_XENLA	"Histone H2A deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)"	GO:0003677; GO:0003713; GO:0004843; GO:0005634; GO:0006338; GO:0008237; GO:0035522; GO:0036459; GO:0042393; GO:0045944; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g000460	Scaffold_01	936602	978401	O94910	AGRL1_HUMAN	Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) (Lectomedin-2)	GO:0004930; GO:0005886; GO:0005887; GO:0007157; GO:0007166; GO:0007186; GO:0007189; GO:0014069; GO:0016021; GO:0016524; GO:0030054; GO:0030246; GO:0030424; GO:0030426; GO:0035584; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0051965; GO:0090129	axon [GO:0030424]; cell junction [GO:0030054]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]
PGEN_.00g000470	Scaffold_01	1017150	1018252	NA	NA	NA	NA	NA
PGEN_.00g000480	Scaffold_01	1018280	1021447	NA	NA	NA	NA	NA
PGEN_.00g000490	Scaffold_01	1042400	1066675	Q7RX33	EGT1_NEUCR	Ergothioneine biosynthesis protein 1 [Includes: L-histidine N(alpha)-methyltransferase (EC 2.1.1.44); Hercynylcysteine S-oxide synthase (EC 1.14.99.51)]	GO:0005634; GO:0005737; GO:0016491; GO:0030745; GO:0032259; GO:0046872; GO:0052699	cytoplasm [GO:0005737]; nucleus [GO:0005634]; dimethylhistidine N-methyltransferase activity [GO:0030745]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ergothioneine biosynthetic process [GO:0052699]; methylation [GO:0032259]
PGEN_.00g000500	Scaffold_01	1071310	1071795	NA	NA	NA	NA	NA
PGEN_.00g000510	Scaffold_01	1094769	1105337	NA	NA	NA	NA	NA
PGEN_.00g000520	Scaffold_01	1105662	1112517	Q92968	PEX13_HUMAN	Peroxisomal membrane protein PEX13 (Peroxin-13)	GO:0001561; GO:0001764; GO:0001967; GO:0005777; GO:0005778; GO:0005779; GO:0006625; GO:0007626; GO:0016020; GO:0016560; GO:0016567; GO:0021795; GO:0043231; GO:0060152; GO:1990429	"integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; suckling behavior [GO:0001967]"
PGEN_.00g000530	Scaffold_01	1119467	1128894	P62081	RS7_HUMAN	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	GO:0000184; GO:0001843; GO:0003723; GO:0003730; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005815; GO:0005829; GO:0005840; GO:0005925; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0010628; GO:0016020; GO:0019083; GO:0019901; GO:0022627; GO:0030154; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1904667; GO:1990904; GO:1990948; GO:2000059	"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cell differentiation [GO:0030154]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
PGEN_.00g000540	Scaffold_01	1129780	1201223	Q14676	MDC1_HUMAN	Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1)	GO:0005634; GO:0005654; GO:0005694; GO:0005925; GO:0006303; GO:0008022; GO:0016604; GO:0031573; GO:0042802; GO:0070975	chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; FHA domain binding [GO:0070975]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; double-strand break repair via nonhomologous end joining [GO:0006303]; intra-S DNA damage checkpoint [GO:0031573]
PGEN_.00g000550	Scaffold_01	1207653	1208228	NA	NA	NA	NA	NA
PGEN_.00g000560	Scaffold_01	1209438	1218258	Q54W11	MCFL_DICDI	Mitochondrial substrate carrier family protein L	GO:0005743; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]
PGEN_.00g000570	Scaffold_01	1234081	1236648	NA	NA	NA	NA	NA
PGEN_.00g000580	Scaffold_01	1271727	1273334	NA	NA	NA	NA	NA
PGEN_.00g000590	Scaffold_01	1336335	1346264	NA	NA	NA	NA	NA
PGEN_.00g000600	Scaffold_01	1347939	1362339	Q9FKK7	XYLA_ARATH	Xylose isomerase (EC 5.3.1.5)	GO:0005773; GO:0005774; GO:0005783; GO:0005794; GO:0009045; GO:0009536; GO:0042732; GO:0046872; GO:0099503	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plastid [GO:0009536]; secretory vesicle [GO:0099503]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]; D-xylose metabolic process [GO:0042732]
PGEN_.00g000610	Scaffold_01	1362473	1362805	NA	NA	NA	NA	NA
PGEN_.00g000620	Scaffold_01	1363737	1364009	NA	NA	NA	NA	NA
PGEN_.00g000630	Scaffold_01	1364058	1364549	NA	NA	NA	NA	NA
PGEN_.00g000640	Scaffold_01	1364574	1364801	NA	NA	NA	NA	NA
PGEN_.00g000650	Scaffold_01	1365222	1368097	NA	NA	NA	NA	NA
PGEN_.00g000660	Scaffold_01	1373196	1385142	Q3ZCD7	TECR_BOVIN	"Very-long-chain enoyl-CoA reductase (EC 1.3.1.93) (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase) (TER)"	GO:0005783; GO:0006665; GO:0006694; GO:0016491; GO:0030176; GO:0030497; GO:0042761; GO:0102758	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; fatty acid elongation [GO:0030497]; sphingolipid metabolic process [GO:0006665]; steroid biosynthetic process [GO:0006694]; very long-chain fatty acid biosynthetic process [GO:0042761]
PGEN_.00g000670	Scaffold_01	1389639	1400328	Q9D180	CFA57_MOUSE	Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65)		
PGEN_.00g000680	Scaffold_01	1402133	1405997	Q9D6Z0	ALKB7_MOUSE	"Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7)"	GO:0005739; GO:0005759; GO:0006631; GO:0006974; GO:0010883; GO:0046872; GO:0051213; GO:1902445	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]
PGEN_.00g000690	Scaffold_01	1408223	1411348	NA	NA	NA	NA	NA
PGEN_.00g000700	Scaffold_01	1419037	1419480	NA	NA	NA	NA	NA
PGEN_.00g000710	Scaffold_01	1419795	1420178	NA	NA	NA	NA	NA
PGEN_.00g000720	Scaffold_01	1420774	1424799	NA	NA	NA	NA	NA
PGEN_.00g000730	Scaffold_01	1424920	1428363	O67987	CLCA_RHOOP	"Chlorocatechol 1,2-dioxygenase (EC 1.13.11.-)"	GO:0008199; GO:0009712; GO:0018575; GO:0018576; GO:0019439	"catechol 1,2-dioxygenase activity [GO:0018576]; chlorocatechol 1,2-dioxygenase activity [GO:0018575]; ferric iron binding [GO:0008199]; aromatic compound catabolic process [GO:0019439]; catechol-containing compound metabolic process [GO:0009712]"
PGEN_.00g000740	Scaffold_01	1428782	1429477	P86029	HQD2_CANAL	"Catechol 1,2-dioxygenase (EC 1.13.11.1)"	GO:0005506; GO:0008199; GO:0009712; GO:0016702; GO:0018576; GO:0019614; GO:0019615	"catechol 1,2-dioxygenase activity [GO:0018576]; ferric iron binding [GO:0008199]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; catechol catabolic process, ortho-cleavage [GO:0019615]; catechol-containing compound catabolic process [GO:0019614]; catechol-containing compound metabolic process [GO:0009712]"
PGEN_.00g000750	Scaffold_01	1436447	1448680	Q3B8M3	EI3EB_XENLA	Eukaryotic translation initiation factor 3 subunit E-B (eIF3e-B) (Eukaryotic translation initiation factor 3 subunit 6-B)	GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071540	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"
PGEN_.00g000760	Scaffold_01	1448744	1455770	Q8BKE9	IFT74_MOUSE	Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein) (CMG-1) (Coiled-coil domain-containing protein 2)	GO:0003334; GO:0003682; GO:0005634; GO:0005813; GO:0005929; GO:0007219; GO:0007368; GO:0007507; GO:0008544; GO:0030992; GO:0031410; GO:0033630; GO:0035735; GO:0042073; GO:0045944; GO:0048487; GO:0050680; GO:0060271; GO:1905515	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epidermis development [GO:0008544]; heart development [GO:0007507]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g000770	Scaffold_01	1533006	1537764	P35408	PE2R4_HUMAN	Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor)	GO:0004957; GO:0005623; GO:0005886; GO:0006954; GO:0006955; GO:0007186; GO:0007188; GO:0007189; GO:0007204; GO:0007254; GO:0009612; GO:0016021; GO:0030278; GO:0032496; GO:0033624; GO:0042093; GO:0050710; GO:0050715; GO:0050728; GO:0050729; GO:0051492; GO:0060348; GO:0070371; GO:0071260; GO:0071380; GO:2000420	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; prostaglandin E receptor activity [GO:0004957]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; cellular response to mechanical stimulus [GO:0071260]; cellular response to prostaglandin E stimulus [GO:0071380]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of eosinophil extravasation [GO:2000420]; negative regulation of inflammatory response [GO:0050728]; negative regulation of integrin activation [GO:0033624]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of inflammatory response [GO:0050729]; regulation of ossification [GO:0030278]; regulation of stress fiber assembly [GO:0051492]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; T-helper cell differentiation [GO:0042093]
PGEN_.00g000780	Scaffold_01	1542680	1545183	NA	NA	NA	NA	NA
PGEN_.00g000790	Scaffold_01	1558681	1570002	Q9GKL8	CATL1_CHLAE	Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]	GO:0004197; GO:0005764; GO:0046718	lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; viral entry into host cell [GO:0046718]
PGEN_.00g000800	Scaffold_01	1578826	1579798	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g000810	Scaffold_01	1590253	1596669	NA	NA	NA	NA	NA
PGEN_.00g000820	Scaffold_01	1600971	1604356	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g000830	Scaffold_01	1698522	1699625	NA	NA	NA	NA	NA
PGEN_.00g000840	Scaffold_01	1731735	1734670	NA	NA	NA	NA	NA
PGEN_.00g000850	Scaffold_01	1752562	1753387	NA	NA	NA	NA	NA
PGEN_.00g000860	Scaffold_01	1757122	1785762	NA	NA	NA	NA	NA
PGEN_.00g000870	Scaffold_01	1788447	1802950	NA	NA	NA	NA	NA
PGEN_.00g000880	Scaffold_01	1811502	1815627	NA	NA	NA	NA	NA
PGEN_.00g000890	Scaffold_01	1816902	1818659	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g000900	Scaffold_01	1831135	1831596	B1AWJ5	TMM8B_MOUSE	Transmembrane protein 8B (Protein NGX6)	GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0007160; GO:0009986; GO:0016021; GO:0040008	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell-matrix adhesion [GO:0007160]; regulation of growth [GO:0040008]
PGEN_.00g000910	Scaffold_01	1840209	1856918	Q9ESN3	TMM8A_MOUSE	Post-GPI attachment to proteins factor 6 (EC 3.1.1.4) (GPI processing phospholipase A2) (GPI-PLA2) (M83 protein) (Transmembrane protein 8) (Transmembrane protein 8A)	GO:0004623; GO:0005765; GO:0005886; GO:0005887; GO:0102567; GO:0102568	"integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]"
PGEN_.00g000920	Scaffold_01	1860046	1864547	Q9XVZ8	ELOF1_CAEEL	Transcription elongation factor 1 homolog	GO:0000993; GO:0005730; GO:0006368; GO:0008023; GO:0046872; GO:0048096	nucleolus [GO:0005730]; transcription elongation factor complex [GO:0008023]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; chromatin-mediated maintenance of transcription [GO:0048096]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g000930	Scaffold_01	1866428	1870555	Q9QYM7	XPF_CRIGR	DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4)	GO:0000110; GO:0000724; GO:0000784; GO:0001094; GO:0003684; GO:0003697; GO:0005634; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0033683; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1904357; GO:1905765; GO:1905768; GO:1990599; GO:1990841	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]; cellular response to UV [GO:0034644]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; response to UV [GO:0009411]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]"
PGEN_.00g000940	Scaffold_01	1873410	1873874	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g000950	Scaffold_01	1873971	1892032	Q9QYM7	XPF_CRIGR	DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4)	GO:0000110; GO:0000724; GO:0000784; GO:0001094; GO:0003684; GO:0003697; GO:0005634; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0033683; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1904357; GO:1905765; GO:1905768; GO:1990599; GO:1990841	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]; cellular response to UV [GO:0034644]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; response to UV [GO:0009411]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]"
PGEN_.00g000960	Scaffold_01	1948723	1963472	P06180	HIBN_XENLA	Histone-binding protein N1/N2	GO:0005634; GO:0061676	nucleus [GO:0005634]; importin-alpha family protein binding [GO:0061676]
PGEN_.00g000970	Scaffold_01	1970367	1991359	P55096	ABCD3_MOUSE	ATP-binding cassette sub-family D member 3 (68 kDa peroxisomal membrane protein) (PMP68) (70 kDa peroxisomal membrane protein) (PMP70)	GO:0005324; GO:0005524; GO:0005739; GO:0005743; GO:0005777; GO:0005778; GO:0005782; GO:0006633; GO:0006635; GO:0007031; GO:0014070; GO:0015910; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0043621	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; very long-chain fatty acid catabolic process [GO:0042760]
PGEN_.00g000980	Scaffold_01	2015518	2047143	Q9BQI6	SLF1_HUMAN	SMC5-SMC6 complex localization factor protein 1 (Ankyrin repeat domain-containing protein 32) (BRCT domain-containing protein 1) (Smc5/6 localization factor 1)	GO:0000786; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0031334; GO:0031625; GO:0034184; GO:0035861; GO:0042405; GO:0044877; GO:1990166; GO:2000781	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]
PGEN_.00g000990	Scaffold_01	2054038	2055057	NA	NA	NA	NA	NA
PGEN_.00g001000	Scaffold_01	2058418	2067040	Q2KIL7	R3HD4_BOVIN	R3H domain-containing protein 4	GO:0003676; GO:0005634	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]
PGEN_.00g001010	Scaffold_01	2071632	2079843	Q5R5C1	UROM_PONAB	"Uromodulin [Cleaved into: Uromodulin, secreted form]"	GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]
PGEN_.00g001020	Scaffold_01	2087620	2116638	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g001030	Scaffold_01	2129680	2143865	Q15831	STK11_HUMAN	Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19)	GO:0000287; GO:0001558; GO:0001894; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0006470; GO:0006914; GO:0006974; GO:0007050; GO:0007283; GO:0007409; GO:0008285; GO:0010212; GO:0010508; GO:0016020; GO:0030010; GO:0030275; GO:0030295; GO:0030308; GO:0030511; GO:0032147; GO:0042593; GO:0043276; GO:0045059; GO:0046777; GO:0048814; GO:0050772; GO:0050852; GO:0051645; GO:0051896; GO:0060070; GO:0060770; GO:0070062; GO:0071493; GO:0072332; GO:0090090; GO:0097484; GO:0120163; GO:1900182; GO:1901796; GO:1904262	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; LRR domain binding [GO:0030275]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; anoikis [GO:0043276]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV-B [GO:0071493]; dendrite extension [GO:0097484]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; Golgi localization [GO:0051645]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of dendrite morphogenesis [GO:0048814]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; tissue homeostasis [GO:0001894]; vasculature development [GO:0001944]
PGEN_.00g001040	Scaffold_01	2152425	2166737	Q5ZJN0	ASND1_CHICK	Asparagine synthetase domain-containing protein 1	GO:0004066; GO:0006529; GO:0006541	asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]
PGEN_.00g001050	Scaffold_01	2172493	2175806	NA	NA	NA	NA	NA
PGEN_.00g001060	Scaffold_01	2182708	2183085	NA	NA	NA	NA	NA
PGEN_.00g001070	Scaffold_01	2183111	2184127	NA	NA	NA	NA	NA
PGEN_.00g001080	Scaffold_01	2184093	2211336	Q3TAE8	ALG6_MOUSE	"Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.267) (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase)"	GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016021; GO:0042281; GO:0046527	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; glucosyltransferase activity [GO:0046527]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]"
PGEN_.00g001090	Scaffold_01	2216842	2217063	NA	NA	NA	NA	NA
PGEN_.00g001100	Scaffold_01	2220616	2222059	NA	NA	NA	NA	NA
PGEN_.00g001110	Scaffold_01	2230331	2230681	NA	NA	NA	NA	NA
PGEN_.00g001120	Scaffold_01	2230744	2237266	Q0EEE2	PTHD3_MOUSE	Patched domain-containing protein 3 (RND-type protein RNDEu-3)	GO:0016021; GO:0097225	integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]
PGEN_.00g001130	Scaffold_01	2244406	2252299	P29540	T2EB_XENLA	General transcription factor IIE subunit 2 (Transcription initiation factor IIE subunit beta) (TFIIE-beta)	GO:0003677; GO:0005673; GO:0006367	transcription factor TFIIE complex [GO:0005673]; DNA binding [GO:0003677]; transcription initiation from RNA polymerase II promoter [GO:0006367]
PGEN_.00g001140	Scaffold_01	2257307	2316262	Q6PDJ1	CAHD1_MOUSE	VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)	GO:0005245; GO:0005891	voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245]
PGEN_.00g001150	Scaffold_01	2329867	2330799	D4GU72	AGL12_HALVD	Low-salt glycan biosynthesis protein Agl12 (EC 4.2.1.-)	GO:0006486; GO:0008460; GO:0009225; GO:0045232	"dTDP-glucose 4,6-dehydratase activity [GO:0008460]; nucleotide-sugar metabolic process [GO:0009225]; protein glycosylation [GO:0006486]; S-layer organization [GO:0045232]"
PGEN_.00g001160	Scaffold_01	2332632	2333325	NA	NA	NA	NA	NA
PGEN_.00g001170	Scaffold_01	2366888	2417042	Q66HA5	C2D1A_RAT	Coiled-coil and C2 domain-containing protein 1A (Five prime repressor element under dual repression-binding protein 1) (FRE under dual repression-binding protein 1) (Freud-1)	GO:0000122; GO:0000978; GO:0001227; GO:0001650; GO:0005634; GO:0005815; GO:0005829; GO:0005886	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g001180	Scaffold_01	2421491	2424493	NA	NA	NA	NA	NA
PGEN_.00g001190	Scaffold_01	2496997	2532777	Q9HAR2	AGRL3_HUMAN	Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)	GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]
PGEN_.00g001200	Scaffold_01	2543753	2574931	Q07666	KHDR1_HUMAN	"KH domain-containing, RNA-binding, signal transduction-associated protein 1 (GAP-associated tyrosine phosphoprotein p62) (Src-associated in mitosis 68 kDa protein) (Sam68) (p21 Ras GTPase-activating protein-associated p62) (p68)"	GO:0000082; GO:0000086; GO:0000122; GO:0000381; GO:0003677; GO:0003723; GO:0005070; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0007166; GO:0007283; GO:0008143; GO:0008266; GO:0016020; GO:0017124; GO:0019904; GO:0042802; GO:0044877; GO:0045892; GO:0045948; GO:0046831; GO:0046833; GO:0048024; GO:0051259; GO:0070618	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Grb2-Sos complex [GO:0070618]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; cell surface receptor signaling pathway [GO:0007166]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of translational initiation [GO:0045948]; protein complex oligomerization [GO:0051259]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA export from nucleus [GO:0046831]; spermatogenesis [GO:0007283]"
PGEN_.00g001210	Scaffold_01	2577228	2600155	Q9WTK8	SPO11_MOUSE	Meiotic recombination protein SPO11 (EC 5.6.2.2)	GO:0000706; GO:0000737; GO:0000781; GO:0001541; GO:0003677; GO:0003918; GO:0005524; GO:0005623; GO:0005654; GO:0007129; GO:0007130; GO:0007131; GO:0007141; GO:0007286; GO:0016889; GO:0034502; GO:0042138; GO:0045141; GO:0046872; GO:0048477; GO:1990918	"cell [GO:0005623]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; endodeoxyribonuclease activity, producing 3'-phosphomonoesters [GO:0016889]; metal ion binding [GO:0046872]; DNA catabolic process, endonucleolytic [GO:0000737]; double-strand break repair involved in meiotic recombination [GO:1990918]; male meiosis I [GO:0007141]; meiotic DNA double-strand break formation [GO:0042138]; meiotic DNA double-strand break processing [GO:0000706]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; synapsis [GO:0007129]; synaptonemal complex assembly [GO:0007130]"
PGEN_.00g001220	Scaffold_01	2602068	2613333	NA	NA	NA	NA	NA
PGEN_.00g001230	Scaffold_01	2608118	2608462	NA	NA	NA	NA	NA
PGEN_.00g001240	Scaffold_01	2608860	2609144	NA	NA	NA	NA	NA
PGEN_.00g001250	Scaffold_01	2610179	2610481	NA	NA	NA	NA	NA
PGEN_.00g001260	Scaffold_01	2623830	2629857	NA	NA	NA	NA	NA
PGEN_.00g001270	Scaffold_01	2649074	2649781	NA	NA	NA	NA	NA
PGEN_.00g001280	Scaffold_01	2658794	2675442	NA	NA	NA	NA	NA
PGEN_.00g001290	Scaffold_01	2675965	2676771	NA	NA	NA	NA	NA
PGEN_.00g001300	Scaffold_01	2680968	2690580	NA	NA	NA	NA	NA
PGEN_.00g001310	Scaffold_01	2708387	2715800	NA	NA	NA	NA	NA
PGEN_.00g001320	Scaffold_01	2749387	2754762	NA	NA	NA	NA	NA
PGEN_.00g001330	Scaffold_01	2776080	2783518	NA	NA	NA	NA	NA
PGEN_.00g001340	Scaffold_01	2787417	2787668	NA	NA	NA	NA	NA
PGEN_.00g001350	Scaffold_01	2794647	2838542	Q9U943	APLP_LOCMI	Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]	GO:0005319; GO:0005576; GO:0008289; GO:0016055	extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]
PGEN_.00g001360	Scaffold_01	2844428	2852597	NA	NA	NA	NA	NA
PGEN_.00g001370	Scaffold_01	2852743	2868293	NA	NA	NA	NA	NA
PGEN_.00g001380	Scaffold_01	2878758	2888130	NA	NA	NA	NA	NA
PGEN_.00g001390	Scaffold_01	2888353	2905488	Q9D1E8	PLCE_MOUSE	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon)	GO:0002244; GO:0003841; GO:0005635; GO:0005739; GO:0005783; GO:0005789; GO:0006639; GO:0016021; GO:0016024; GO:0016746; GO:0036149	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidylinositol acyl-chain remodeling [GO:0036149]"
PGEN_.00g001400	Scaffold_01	2921976	2926097	NA	NA	NA	NA	NA
PGEN_.00g001410	Scaffold_01	2961919	2993436	Q96285	LRK55_ARATH	L-type lectin-domain containing receptor kinase V.5 (Arabidopsis thaliana lectin-receptor kinase a1) (Ath.lecRK1) (AthlecRK-a1) (LecRK-V.5) (EC 2.7.11.1)	GO:0002229; GO:0004674; GO:0004675; GO:0005524; GO:0005886; GO:0006952; GO:0016021; GO:0030246; GO:0042742; GO:0046777; GO:0090333; GO:1900425	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; protein serine/threonine kinase activity [GO:0004674]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to oomycetes [GO:0002229]; negative regulation of defense response to bacterium [GO:1900425]; protein autophosphorylation [GO:0046777]; regulation of stomatal closure [GO:0090333]
PGEN_.00g001420	Scaffold_01	3007503	3009654	NA	NA	NA	NA	NA
PGEN_.00g001430	Scaffold_01	3015853	3020987	NA	NA	NA	NA	NA
PGEN_.00g001440	Scaffold_01	3021809	3023329	O54750	CP2J6_MOUSE	Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)	GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g001450	Scaffold_01	3029248	3030768	P79761	CP1A5_CHICK	Cytochrome P450 1A5 (EC 1.14.14.1) (CYPIA5) (Cytochrome P450 TCDDAA)	GO:0004497; GO:0005506; GO:0005623; GO:0005789; GO:0017144; GO:0019825; GO:0020037; GO:0043231; GO:0043385; GO:0046677; GO:0070330; GO:0070989; GO:0071615	cell [GO:0005623]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; drug metabolic process [GO:0017144]; mycotoxin metabolic process [GO:0043385]; oxidative deethylation [GO:0071615]; oxidative demethylation [GO:0070989]; response to antibiotic [GO:0046677]
PGEN_.00g001460	Scaffold_01	3036425	3075067	NA	NA	NA	NA	NA
PGEN_.00g001470	Scaffold_01	3088535	3112660	NA	NA	NA	NA	NA
PGEN_.00g001480	Scaffold_01	3120104	3151510	Q3MHR0	LYPA1_BOVIN	Acyl-protein thioesterase 1 (APT-1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I)	GO:0002084; GO:0005737; GO:0006631; GO:0008474; GO:0052689	cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]
PGEN_.00g001490	Scaffold_01	3185022	3185805	NA	NA	NA	NA	NA
PGEN_.00g001500	Scaffold_01	3186149	3189920	Q86Y13	DZIP3_HUMAN	E3 ubiquitin-protein ligase DZIP3 (EC 2.3.2.27) (DAZ-interacting protein 3) (RING-type E3 ubiquitin transferase DZIP3) (RNA-binding ubiquitin ligase of 138 kDa) (hRUL138)	GO:0000209; GO:0003723; GO:0004842; GO:0005737; GO:0019902; GO:0031593; GO:0046872; GO:0061630	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]
PGEN_.00g001510	Scaffold_01	3189991	3191931	Q8BZ25	ANKK1_MOUSE	Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0010564; GO:0042995	cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; regulation of cell cycle process [GO:0010564]
PGEN_.00g001520	Scaffold_01	3194169	3208775	P27169	PON1_HUMAN	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]
PGEN_.00g001530	Scaffold_01	3208910	3209976	NA	NA	NA	NA	NA
PGEN_.00g001540	Scaffold_01	3211276	3226468	P27169	PON1_HUMAN	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]
PGEN_.00g001550	Scaffold_01	3241404	3243113	NA	NA	NA	NA	NA
PGEN_.00g001560	Scaffold_01	3250326	3263843	P27169	PON1_HUMAN	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]
PGEN_.00g001570	Scaffold_01	3272606	3274076	NA	NA	NA	NA	NA
PGEN_.00g001580	Scaffold_01	3299070	3299474	NA	NA	NA	NA	NA
PGEN_.00g001590	Scaffold_01	3313644	3322635	P27169	PON1_HUMAN	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]
PGEN_.00g001600	Scaffold_01	3339747	3341462	Q01484	ANK2_HUMAN	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	GO:0002027; GO:0003283; GO:0005200; GO:0005623; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]"
PGEN_.00g001610	Scaffold_01	3341637	3342098	Q9ERK0	RIPK4_MOUSE	Receptor-interacting serine/threonine-protein kinase 4 (EC 2.7.11.1) (Ankyrin repeat domain-containing protein 3) (PKC-associated protein kinase) (PKC-regulated protein kinase)	GO:0002009; GO:0004674; GO:0005524; GO:0005737; GO:0016020; GO:0051092	cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]
PGEN_.00g001620	Scaffold_01	3348636	3368451	P27169	PON1_HUMAN	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]
PGEN_.00g001630	Scaffold_01	3381741	3386453	P27169	PON1_HUMAN	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]
PGEN_.00g001640	Scaffold_01	3398865	3406292	P27169	PON1_HUMAN	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]
PGEN_.00g001650	Scaffold_01	3408026	3408436	NA	NA	NA	NA	NA
PGEN_.00g001660	Scaffold_01	3421229	3430343	P26150	3BHS3_MOUSE	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 3 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type III) (3-beta-HSD III) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (EC 5.3.3.1) (Delta-5-3-ketosteroid isomerase)]	GO:0003854; GO:0004769; GO:0005730; GO:0005743; GO:0005758; GO:0005783; GO:0005789; GO:0006694; GO:0008207; GO:0016021; GO:0016491; GO:0016616; GO:0021766; GO:0043231; GO:0045171; GO:0051412; GO:0102294	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; cholesterol dehydrogenase activity [GO:0102294]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid delta-isomerase activity [GO:0004769]; C21-steroid hormone metabolic process [GO:0008207]; hippocampus development [GO:0021766]; response to corticosterone [GO:0051412]; steroid biosynthetic process [GO:0006694]"
PGEN_.00g001670	Scaffold_01	3442458	3468503	Q14162	SREC_HUMAN	Scavenger receptor class F member 1 (Acetyl LDL receptor) (Scavenger receptor expressed by endothelial cells 1) (SREC-I)	GO:0004888; GO:0005044; GO:0005886; GO:0006707; GO:0006898; GO:0007155; GO:0010976; GO:0016021; GO:0016322; GO:0016358; GO:0030169; GO:0030666; GO:0048680	endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g001680	Scaffold_01	3470994	3473527	NA	NA	NA	NA	NA
PGEN_.00g001690	Scaffold_01	3481019	3530305	Q3U0J8	TBD2B_MOUSE	TBC1 domain family member 2B	GO:0005096; GO:0005829; GO:0006886; GO:0017137; GO:0090630	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]
PGEN_.00g001700	Scaffold_01	3530653	3562178	Q90511	EI2BB_TAKRU	Translation initiation factor eIF-2B subunit beta (S20I15) (eIF-2B GDP-GTP exchange factor subunit beta)	GO:0003743; GO:0005524; GO:0005525; GO:0005737; GO:0005851; GO:0006413; GO:0007417; GO:0014003; GO:0042552; GO:0050852	cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; central nervous system development [GO:0007417]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]
PGEN_.00g001710	Scaffold_01	3549016	3549950	NA	NA	NA	NA	NA
PGEN_.00g001720	Scaffold_01	3578879	3584684	Q567C6	ZN367_DANRE	Zinc finger protein 367	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g001730	Scaffold_01	3585240	3594053	Q8NC51	PAIRB_HUMAN	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016020; GO:0030578; GO:0032183; GO:0042981; GO:0043488; GO:0045296; GO:0048471; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; PML body organization [GO:0030578]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
PGEN_.00g001740	Scaffold_01	3599291	3603918	Q8NE22	SETD9_HUMAN	SET domain-containing protein 9 (EC 2.1.1.-)	GO:0005654; GO:0016278; GO:0032259; GO:1901796	nucleoplasm [GO:0005654]; lysine N-methyltransferase activity [GO:0016278]; methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796]
PGEN_.00g001750	Scaffold_01	3622826	3623443	Q66IC8	TC1D1_DANRE	Tctex1 domain-containing protein 1	GO:0060271	cilium assembly [GO:0060271]
PGEN_.00g001760	Scaffold_01	3640127	3640720	Q9D5I4	TC1D1_MOUSE	Tctex1 domain-containing protein 1		
PGEN_.00g001770	Scaffold_01	3653853	3659176	H9D1R1	TXD12_EPICO	Thioredoxin domain-containing protein 12 (EC 1.8.4.2)	GO:0005623; GO:0005788; GO:0009055; GO:0016032; GO:0019153; GO:0045454; GO:0051607; GO:0055114	cell [GO:0005623]; endoplasmic reticulum lumen [GO:0005788]; electron transfer activity [GO:0009055]; protein-disulfide reductase (glutathione) activity [GO:0019153]; cell redox homeostasis [GO:0045454]; defense response to virus [GO:0051607]; oxidation-reduction process [GO:0055114]; viral process [GO:0016032]
PGEN_.00g001780	Scaffold_01	3684779	3689770	P42285	MTREX_HUMAN	Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)	GO:0000398; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006401; GO:0016076; GO:0016607; GO:0031499; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"
PGEN_.00g001790	Scaffold_01	3695307	3702382	NA	NA	NA	NA	NA
PGEN_.00g001800	Scaffold_01	3708096	3713528	Q8N3J6	CADM2_HUMAN	Cell adhesion molecule 2 (Immunoglobulin superfamily member 4D) (IgSF4D) (Nectin-like protein 3) (NECL-3) (Synaptic cell adhesion molecule 2) (SynCAM 2)	GO:0005886; GO:0007155; GO:0016021; GO:0030054; GO:0030424; GO:0034332; GO:0045202	axon [GO:0030424]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; adherens junction organization [GO:0034332]; cell adhesion [GO:0007155]
PGEN_.00g001810	Scaffold_01	3719116	3720027	NA	NA	NA	NA	NA
PGEN_.00g001820	Scaffold_01	3725754	3743747	Q80V70	MEGF6_MOUSE	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	GO:0005509; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]
PGEN_.00g001830	Scaffold_01	3770648	3771127	NA	NA	NA	NA	NA
PGEN_.00g001840	Scaffold_01	3781338	3781808	NA	NA	NA	NA	NA
PGEN_.00g001850	Scaffold_01	3791937	3792386	NA	NA	NA	NA	NA
PGEN_.00g001860	Scaffold_01	3795132	3796060	NA	NA	NA	NA	NA
PGEN_.00g001870	Scaffold_01	3862382	3870889	Q7T3Q2	CRIM1_DANRE	Cysteine-rich motor neuron 1 protein (CRIM-1)	GO:0001568; GO:0001756; GO:0004867; GO:0005520; GO:0005576; GO:0016021; GO:0048570	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; insulin-like growth factor binding [GO:0005520]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood vessel development [GO:0001568]; notochord morphogenesis [GO:0048570]; somitogenesis [GO:0001756]
PGEN_.00g001880	Scaffold_01	3876762	3887904	Q8K3E5	AHI1_MOUSE	Jouberin (Abelson helper integration site 1 protein) (AHI-1)	GO:0001738; GO:0001750; GO:0001947; GO:0002092; GO:0005623; GO:0005737; GO:0005813; GO:0005814; GO:0005911; GO:0005912; GO:0005929; GO:0006903; GO:0007169; GO:0007417; GO:0010628; GO:0010842; GO:0010976; GO:0016192; GO:0030862; GO:0030902; GO:0033365; GO:0034613; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0039023; GO:0042462; GO:0042802; GO:0043066; GO:0045927; GO:0045944; GO:0046325; GO:0046548; GO:0046549; GO:0050708; GO:0050795; GO:0060041; GO:0060271; GO:0065001; GO:0070121; GO:0070986; GO:0071599; GO:0097730; GO:0120206; GO:1905515	adherens junction [GO:0005912]; cell [GO:0005623]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]; identical protein binding [GO:0042802]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; eye photoreceptor cell development [GO:0042462]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glucose import [GO:0046325]; non-motile cilium assembly [GO:1905515]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of neuron projection development [GO:0010976]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; protein localization to organelle [GO:0033365]; regulation of behavior [GO:0050795]; regulation of protein secretion [GO:0050708]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle targeting [GO:0006903]; vesicle-mediated transport [GO:0016192]
PGEN_.00g001890	Scaffold_01	3888367	3912024	Q6DTM3	AHI1_RAT	Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1)	GO:0001738; GO:0001750; GO:0001947; GO:0002092; GO:0005623; GO:0005737; GO:0005813; GO:0005814; GO:0005911; GO:0005912; GO:0005929; GO:0006903; GO:0007169; GO:0007417; GO:0010628; GO:0010842; GO:0010976; GO:0016192; GO:0021510; GO:0030862; GO:0030902; GO:0032094; GO:0033365; GO:0034613; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0039023; GO:0042462; GO:0042802; GO:0043066; GO:0045927; GO:0045944; GO:0046325; GO:0046548; GO:0046549; GO:0050708; GO:0050795; GO:0060041; GO:0060271; GO:0065001; GO:0070121; GO:0070986; GO:0071599; GO:0097730; GO:0120206; GO:1905515; GO:1990403	adherens junction [GO:0005912]; cell [GO:0005623]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]; identical protein binding [GO:0042802]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; embryonic brain development [GO:1990403]; eye photoreceptor cell development [GO:0042462]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glucose import [GO:0046325]; non-motile cilium assembly [GO:1905515]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of neuron projection development [GO:0010976]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; protein localization to organelle [GO:0033365]; regulation of behavior [GO:0050795]; regulation of protein secretion [GO:0050708]; response to food [GO:0032094]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; specification of axis polarity [GO:0065001]; spinal cord development [GO:0021510]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle targeting [GO:0006903]; vesicle-mediated transport [GO:0016192]
PGEN_.00g001900	Scaffold_01	3937971	3949536	D3ZYR1	FCHO2_RAT	F-BAR domain only protein 2	GO:0001786; GO:0005546; GO:0005737; GO:0005856; GO:0005886; GO:0005905; GO:0008092; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098835	"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]"
PGEN_.00g001910	Scaffold_01	3955686	3956024	Q9Y493	ZAN_HUMAN	Zonadhesin	GO:0005886; GO:0007339; GO:0016021; GO:0098609	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609]
PGEN_.00g001920	Scaffold_01	3956825	3992262	Q5R807	FCHO2_PONAB	F-BAR domain only protein 2	GO:0001786; GO:0005546; GO:0005886; GO:0005905; GO:0010324; GO:0035091; GO:0048268; GO:0072583; GO:0072659	"clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]"
PGEN_.00g001930	Scaffold_01	3993048	3995339	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g001940	Scaffold_01	4016042	4056415	Q9UPU5	UBP24_HUMAN	Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)	GO:0004197; GO:0004843; GO:0005654; GO:0006511; GO:0016579; GO:0036459	nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g001950	Scaffold_01	4057581	4060051	Q9UPU5	UBP24_HUMAN	Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)	GO:0004197; GO:0004843; GO:0005654; GO:0006511; GO:0016579; GO:0036459	nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g001960	Scaffold_01	4060276	4100419	Q9UPU5	UBP24_HUMAN	Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)	GO:0004197; GO:0004843; GO:0005654; GO:0006511; GO:0016579; GO:0036459	nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g001970	Scaffold_01	4085015	4087783	NA	NA	NA	NA	NA
PGEN_.00g001980	Scaffold_01	4088727	4092907	NA	NA	NA	NA	NA
PGEN_.00g001990	Scaffold_01	4109720	4172563	P12370	KAPC1_DROME	cAMP-dependent protein kinase catalytic subunit 1 (PKA C) (EC 2.7.11.11) (Protein kinase DC0)	GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006468; GO:0007186; GO:0007314; GO:0007317; GO:0007448; GO:0007476; GO:0007615; GO:0007622; GO:0008103; GO:0008355; GO:0008359; GO:0010628; GO:0010737; GO:0019933; GO:0030425; GO:0032436; GO:0034237; GO:0040040; GO:0042981; GO:0044297; GO:0045187; GO:0045879; GO:0045880; GO:0046823; GO:0048149; GO:0048477; GO:0048682; GO:0048749; GO:0050804; GO:0071361; GO:2000249	"cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine/threonine kinase activity [GO:0004674]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; behavioral response to ethanol [GO:0048149]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; compound eye development [GO:0048749]; G protein-coupled receptor signaling pathway [GO:0007186]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]"
PGEN_.00g002000	Scaffold_01	4271489	4271980	NA	NA	NA	NA	NA
PGEN_.00g002010	Scaffold_01	4297967	4302603	NA	NA	NA	NA	NA
PGEN_.00g002020	Scaffold_01	4302661	4303011	NA	NA	NA	NA	NA
PGEN_.00g002030	Scaffold_01	4303081	4303437	NA	NA	NA	NA	NA
PGEN_.00g002040	Scaffold_01	4322481	4323044	NA	NA	NA	NA	NA
PGEN_.00g002050	Scaffold_01	4323077	4323706	Q9XTR8	LIP1_CAEEL	Lipase ZK262.3 (EC 3.1.1.-)	GO:0005576; GO:0016042; GO:0016787	extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042]
PGEN_.00g002060	Scaffold_01	4339734	4341047	Q9XTR8	LIP1_CAEEL	Lipase ZK262.3 (EC 3.1.1.-)	GO:0005576; GO:0016042; GO:0016787	extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042]
PGEN_.00g002070	Scaffold_01	4351725	4352963	Q9XTR8	LIP1_CAEEL	Lipase ZK262.3 (EC 3.1.1.-)	GO:0005576; GO:0016042; GO:0016787	extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042]
PGEN_.00g002080	Scaffold_01	4422855	4423175	NA	NA	NA	NA	NA
PGEN_.00g002090	Scaffold_01	4521430	4547903	NA	NA	NA	NA	NA
PGEN_.00g002100	Scaffold_01	4556702	4574725	P38040	GBG1_DROME	Guanine nucleotide-binding protein subunit gamma-1	GO:0003015; GO:0003380; GO:0003924; GO:0005834; GO:0007186; GO:0007391; GO:0007637; GO:0010470; GO:0031680; GO:0031681; GO:0035050; GO:0043519; GO:0045176; GO:0048383; GO:0055059; GO:0060027; GO:0061343	G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]
PGEN_.00g002110	Scaffold_01	4592883	4594964	NA	NA	NA	NA	NA
PGEN_.00g002120	Scaffold_01	4600650	4612103	Q60519	SEM5B_MOUSE	Semaphorin-5B (Semaphorin-G) (Sema G)	GO:0016021; GO:0030215; GO:0048675; GO:0050908; GO:0097485; GO:1990138	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]
PGEN_.00g002130	Scaffold_01	4616177	4687745	Q96N67	DOCK7_HUMAN	Dedicator of cytokinesis protein 7	GO:0000226; GO:0005085; GO:0005925; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0030426; GO:0031175; GO:0033138; GO:0043005; GO:0045178; GO:0045200; GO:0048365; GO:0050767; GO:0090630; GO:0120163; GO:1904754	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g002140	Scaffold_01	4691713	4694790	E1BD59	TRI56_BOVIN	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0051607; GO:0070534	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
PGEN_.00g002150	Scaffold_01	4722842	4732333	Q07553	GCY3E_DROME	Guanylate cyclase 32E (EC 4.6.1.2)	GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0019934; GO:0038023	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; signaling receptor activity [GO:0038023]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g002160	Scaffold_01	4748453	4749691	Q9BI23	YELL_DROER	Protein yellow	GO:0005576; GO:0007275; GO:0042438; GO:0060179	extracellular region [GO:0005576]; male mating behavior [GO:0060179]; melanin biosynthetic process [GO:0042438]; multicellular organism development [GO:0007275]
PGEN_.00g002170	Scaffold_01	4750957	4752102	Q9BI23	YELL_DROER	Protein yellow	GO:0005576; GO:0007275; GO:0042438; GO:0060179	extracellular region [GO:0005576]; male mating behavior [GO:0060179]; melanin biosynthetic process [GO:0042438]; multicellular organism development [GO:0007275]
PGEN_.00g002180	Scaffold_01	4781323	4787454	P70031	CCKAR_XENLA	Cholecystokinin receptor (CCK-XLR)	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g002190	Scaffold_01	4794894	4811538	C3ZQF9	QRFPR_BRAFL	QRFP-like peptide receptor	GO:0004930; GO:0004983; GO:0005887; GO:1901653	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; cellular response to peptide [GO:1901653]
PGEN_.00g002200	Scaffold_01	4965028	4965414	P49146	NPY2R_HUMAN	Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor)	GO:0001601; GO:0001662; GO:0002793; GO:0003151; GO:0003214; GO:0004983; GO:0005246; GO:0005623; GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0007193; GO:0007204; GO:0007263; GO:0007568; GO:0007626; GO:0010811; GO:0033603; GO:0038023; GO:0043951; GO:0045987; GO:0046010; GO:0046903; GO:0051048; GO:0051930; GO:0051967; GO:0090394; GO:0097730; GO:2000252	"cell [GO:0005623]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aging [GO:0007568]; behavioral fear response [GO:0001662]; cardiac left ventricle morphogenesis [GO:0003214]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of feeding behavior [GO:2000252]; negative regulation of secretion [GO:0051048]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; nitric oxide mediated signal transduction [GO:0007263]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of peptide secretion [GO:0002793]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of sensory perception of pain [GO:0051930]; secretion [GO:0046903]"
PGEN_.00g002210	Scaffold_01	5056420	5069517	Q96PY6	NEK1_HUMAN	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)	GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0023014; GO:0032147; GO:0034451; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]"
PGEN_.00g002220	Scaffold_01	5070996	5076548	NA	NA	NA	NA	NA
PGEN_.00g002230	Scaffold_01	5087884	5120166	Q9NZI5	GRHL1_HUMAN	Grainyhead-like protein 1 homolog (Mammalian grainyhead) (NH32) (Transcription factor CP2-like 2) (Transcription factor LBP-32)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0002934; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008544; GO:0019216; GO:0031490; GO:0042803; GO:0043231; GO:0043565; GO:0044212; GO:0045616; GO:0045944; GO:0061436	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; desmosome organization [GO:0002934]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of keratinocyte differentiation [GO:0045616]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g002240	Scaffold_01	5163600	5192642	NA	NA	NA	NA	NA
PGEN_.00g002250	Scaffold_01	5321937	5322569	NA	NA	NA	NA	NA
PGEN_.00g002260	Scaffold_01	5409751	5412818	NA	NA	NA	NA	NA
PGEN_.00g002270	Scaffold_01	5448685	5453395	Q9VML9	TRISR_DROME	Trissin receptor	GO:0004930; GO:0005887; GO:0007186; GO:0008188; GO:0008528; GO:0016021; GO:0032870	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g002280	Scaffold_01	5493010	5493587	NA	NA	NA	NA	NA
PGEN_.00g002290	Scaffold_01	5501612	5520575	Q71R50	DHR11_CHICK	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703; GO:0072555; GO:0072582	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]
PGEN_.00g002300	Scaffold_01	5530784	5542999	Q71R50	DHR11_CHICK	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703; GO:0072555; GO:0072582	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]
PGEN_.00g002310	Scaffold_01	5552743	5561506	NA	NA	NA	NA	NA
PGEN_.00g002320	Scaffold_01	5561567	5564186	NA	NA	NA	NA	NA
PGEN_.00g002330	Scaffold_01	5566611	5567881	Q94521	DNAT_DROME	Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase)	GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066	"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]"
PGEN_.00g002340	Scaffold_01	5583490	5584407	NA	NA	NA	NA	NA
PGEN_.00g002350	Scaffold_01	5588429	5588737	NA	NA	NA	NA	NA
PGEN_.00g002360	Scaffold_01	5625779	5626636	Q9T0F4	IAN13_ARATH	Immune-associated nucleotide-binding protein 13 (AtIAN13) (AIG1-like protein)	GO:0005525	GTP binding [GO:0005525]
PGEN_.00g002370	Scaffold_01	5629182	5639239	NA	NA	NA	NA	NA
PGEN_.00g002380	Scaffold_01	5640237	5669831	NA	NA	NA	NA	NA
PGEN_.00g002390	Scaffold_01	5685845	5688709	NA	NA	NA	NA	NA
PGEN_.00g002400	Scaffold_01	5690716	5723136	Q3U487	HECD3_MOUSE	E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3)	GO:0004842; GO:0019905; GO:0043161; GO:0048471	perinuclear region of cytoplasm [GO:0048471]; syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]
PGEN_.00g002410	Scaffold_01	5726364	5728349	NA	NA	NA	NA	NA
PGEN_.00g002420	Scaffold_01	5732605	5754981	P56520	HDAC3_CHICK	Histone deacetylase 3 (HD3) (EC 3.5.1.98)	GO:0000118; GO:0000122; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005737; GO:0006325; GO:0008134; GO:0017053; GO:0032041; GO:0032922; GO:0042752; GO:0045944; GO:0070491; GO:0070932; GO:0070933	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]
PGEN_.00g002430	Scaffold_01	5761729	5830003	Q6AY22	SPAT1_RAT	Spermatogenesis-associated protein 1		
PGEN_.00g002440	Scaffold_01	5862129	5874005	P48416	CP10_LYMST	Cytochrome P450 10 (EC 1.14.-.-) (CYPX)	GO:0004497; GO:0005506; GO:0016705; GO:0020037	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g002450	Scaffold_01	5882254	5884580	NA	NA	NA	NA	NA
PGEN_.00g002460	Scaffold_01	5899281	5920633	Q9CR50	ZN363_MOUSE	RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)	GO:0000151; GO:0002039; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g002470	Scaffold_01	5922084	5927923	Q5ZM20	RMI2_CHICK	RecQ-mediated genome instability protein 2	GO:0003677; GO:0005829; GO:0006260; GO:0006281; GO:0016607; GO:0033045; GO:0043007; GO:2000042	cytosol [GO:0005829]; nuclear speck [GO:0016607]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; maintenance of rDNA [GO:0043007]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of sister chromatid segregation [GO:0033045]
PGEN_.00g002480	Scaffold_01	5933156	5984637	Q8BFY9	TNPO1_MOUSE	Transportin-1 (Importin beta-2) (Karyopherin beta-2)	GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0008536; GO:0061608	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]
PGEN_.00g002490	Scaffold_01	6021979	6027723	Q148G4	TATD1_BOVIN	Putative deoxyribonuclease TATDN1 (EC 3.1.21.-)	GO:0005654; GO:0008296; GO:0016888; GO:0046872	"nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"
PGEN_.00g002500	Scaffold_01	6032245	6046586	A0JMW6	T214A_XENLA	Transmembrane protein 214-A	GO:0005789; GO:0005881; GO:0006915; GO:0016021	cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]
PGEN_.00g002510	Scaffold_01	6053072	6090279	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g002520	Scaffold_01	6125349	6149160	Q6UPR8	ERMP1_RAT	Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina)	GO:0001541; GO:0005783; GO:0005789; GO:0006508; GO:0008237; GO:0016021; GO:0046872	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ovarian follicle development [GO:0001541]; proteolysis [GO:0006508]
PGEN_.00g002530	Scaffold_01	6149241	6149588	NA	NA	NA	NA	NA
PGEN_.00g002540	Scaffold_01	6178168	6178566	NA	NA	NA	NA	NA
PGEN_.00g002550	Scaffold_01	6178730	6179495	NA	NA	NA	NA	NA
PGEN_.00g002560	Scaffold_01	6182097	6195673	NA	NA	NA	NA	NA
PGEN_.00g002570	Scaffold_01	6188282	6190832	NA	NA	NA	NA	NA
PGEN_.00g002580	Scaffold_01	6245646	6316687	NA	NA	NA	NA	NA
PGEN_.00g002590	Scaffold_01	6336924	6377418	NA	NA	NA	NA	NA
PGEN_.00g002600	Scaffold_01	6379314	6379574	NA	NA	NA	NA	NA
PGEN_.00g002610	Scaffold_01	6398227	6398841	O14792	HS3S1_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1)	GO:0005796; GO:0006024; GO:0008146; GO:0008467	Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g002620	Scaffold_01	6414222	6414635	NA	NA	NA	NA	NA
PGEN_.00g002630	Scaffold_01	6433080	6433346	NA	NA	NA	NA	NA
PGEN_.00g002640	Scaffold_01	6441064	6446302	O15973	OPSD1_MIZYE	"Rhodopsin, GQ-coupled (GQ-rhodopsin)"	GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g002650	Scaffold_01	6485744	6494275	Q6IRT3	PARI_MOUSE	PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP)	GO:0000785; GO:0003677; GO:0005654; GO:0005737; GO:0006281; GO:2000042	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]
PGEN_.00g002660	Scaffold_01	6532409	6532651	NA	NA	NA	NA	NA
PGEN_.00g002670	Scaffold_01	6543889	6545109	NA	NA	NA	NA	NA
PGEN_.00g002680	Scaffold_01	6552422	6577753	P08289	PPBT_RAT	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme)"	GO:0001958; GO:0003006; GO:0004035; GO:0005615; GO:0005886; GO:0016311; GO:0016462; GO:0031012; GO:0031225; GO:0032496; GO:0033280; GO:0046677; GO:0046872; GO:0051384; GO:0065010; GO:0071407; GO:0071529	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]
PGEN_.00g002690	Scaffold_01	6583364	6597365	Q5R9H4	A1CF_PONAB	APOBEC1 complementation factor (APOBEC1-stimulating protein)	GO:0003727; GO:0005737; GO:0005783; GO:0006397; GO:0016556; GO:0030895; GO:0050821	apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; single-stranded RNA binding [GO:0003727]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; protein stabilization [GO:0050821]
PGEN_.00g002700	Scaffold_01	6604833	6621571	Q96EQ0	SGTB_HUMAN	Small glutamine-rich tetratricopeptide repeat-containing protein beta (Beta-SGT) (Small glutamine-rich protein with tetratricopeptide repeats 2)	GO:0005829; GO:0006620; GO:0016020; GO:0030433; GO:0072380; GO:1903646	cytosol [GO:0005829]; membrane [GO:0016020]; TRC complex [GO:0072380]; positive regulation of chaperone-mediated protein folding [GO:1903646]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g002710	Scaffold_01	6632680	6662250	O01159	RSP7_CAEEL	"Probable splicing factor, arginine/serine-rich 7 (p54)"	GO:0000398; GO:0003723; GO:0005654	"nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g002720	Scaffold_01	6668371	6676468	O59028	MDH_PYRHO	Malate dehydrogenase (EC 1.1.1.37)	GO:0005737; GO:0006099; GO:0030060	cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g002730	Scaffold_01	6688609	6709060	Q5E9N4	AADAT_BOVIN	"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Kynurenine aminotransferase II) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II)"	GO:0005739; GO:0006103; GO:0006536; GO:0008483; GO:0009058; GO:0016212; GO:0030170; GO:0033512; GO:0047536; GO:0070189; GO:1901605	mitochondrion [GO:0005739]; 2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]
PGEN_.00g002740	Scaffold_01	6714159	6715349	NA	NA	NA	NA	NA
PGEN_.00g002750	Scaffold_01	6722689	6757020	P49454	CENPF_HUMAN	Centromere protein F (CENP-F) (AH antigen) (Kinetochore protein CENPF) (Mitosin)	GO:0000278; GO:0000775; GO:0000776; GO:0000922; GO:0000940; GO:0001822; GO:0003682; GO:0005623; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005930; GO:0007059; GO:0007094; GO:0007517; GO:0008022; GO:0008134; GO:0010389; GO:0015031; GO:0016202; GO:0016363; GO:0021591; GO:0030154; GO:0030496; GO:0036064; GO:0042493; GO:0042803; GO:0045120; GO:0045892; GO:0048471; GO:0051301; GO:0051310; GO:0051382; GO:0051726; GO:0070840; GO:0071897; GO:0097539	"axoneme [GO:0005930]; cell [GO:0005623]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to drug [GO:0042493]; ventricular system development [GO:0021591]"
PGEN_.00g002760	Scaffold_01	6757096	6765594	Q96GM8	TOE1_HUMAN	Target of EGR1 protein 1	GO:0000175; GO:0004535; GO:0005654; GO:0005730; GO:0005737; GO:0015030; GO:0016604; GO:0016607; GO:0017069; GO:0034472; GO:0046872; GO:0090503	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; snRNA binding [GO:0017069]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]"
PGEN_.00g002770	Scaffold_01	6776093	6783646	Q5GH57	XKR6_RAT	XK-related protein 6	GO:0005886; GO:0016020; GO:0016021; GO:0043652; GO:0070782; GO:1902742	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]
PGEN_.00g002780	Scaffold_01	6784326	6784607	NA	NA	NA	NA	NA
PGEN_.00g002790	Scaffold_01	6787176	6788729	NA	NA	NA	NA	NA
PGEN_.00g002800	Scaffold_01	6805695	6809009	NA	NA	NA	NA	NA
PGEN_.00g002810	Scaffold_01	6805807	6816630	NA	NA	NA	NA	NA
PGEN_.00g002820	Scaffold_01	6816778	6817485	Q70KF4	CMYA5_MOUSE	Cardiomyopathy-associated protein 5 (Heart and skeletal muscle-specific and sprouty domain-containing) (Myospryn) (Stretch-response protein 553) (Stretch-responsive fibronectin protein type 3) (TRIM-like protein)	GO:0005634; GO:0014733; GO:0016529; GO:0031430; GO:0032515; GO:0042802; GO:0043034; GO:0048471; GO:0070885	costamere [GO:0043034]; M band [GO:0031430]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; identical protein binding [GO:0042802]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of skeletal muscle adaptation [GO:0014733]
PGEN_.00g002830	Scaffold_01	6817761	6843514	Q54YF2	AMPKA_DICDI	"5'-AMP-activated serine/threonine-protein kinase catalytic subunit alpha (AMPKA) (EC 2.7.11.1) (Protein kinase, AMP-activated, alpha subunit) (SNF1/AMP-activated kinase catalytic subunit) (Sucrose non-fermenting protein snfA)"	GO:0004674; GO:0004679; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006754; GO:0007005; GO:0010628; GO:0010629; GO:0019954; GO:0031285; GO:0035556; GO:0046956; GO:0060176; GO:1901261; GO:1903665	cytoplasm [GO:0005737]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; asexual reproduction [GO:0019954]; ATP biosynthetic process [GO:0006754]; intracellular signal transduction [GO:0035556]; mitochondrion organization [GO:0007005]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of gene expression [GO:0010629]; positive phototaxis [GO:0046956]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of aggregation involved in sorocarp development [GO:0060176]; regulation of sorocarp spore cell differentiation [GO:1901261]; regulation of sorocarp stalk cell differentiation [GO:0031285]
PGEN_.00g002840	Scaffold_01	6873325	6875154	NA	NA	NA	NA	NA
PGEN_.00g002850	Scaffold_01	7032317	7033844	Q7M6Y2	SOX11_MOUSE	Transcription factor SOX-11	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001158; GO:0001228; GO:0001501; GO:0001822; GO:0001841; GO:0002089; GO:0003151; GO:0003211; GO:0003357; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008284; GO:0010628; GO:0010629; GO:0014003; GO:0014009; GO:0014032; GO:0017015; GO:0021510; GO:0021782; GO:0030154; GO:0030182; GO:0030513; GO:0035332; GO:0035914; GO:0044798; GO:0045666; GO:0045669; GO:0045778; GO:0045893; GO:0045944; GO:0046887; GO:0048485; GO:0048557; GO:0048704; GO:0050672; GO:0050769; GO:0060022; GO:0060023; GO:0060174; GO:0060253; GO:0060412; GO:0060425; GO:0060548; GO:0060563; GO:0061029; GO:0061053; GO:0061303; GO:0061386; GO:0072395; GO:2000648; GO:2000678; GO:2001111	"cytoplasm [GO:0005737]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; closure of optic fissure [GO:0061386]; cornea development in camera-type eye [GO:0061303]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; hard palate development [GO:0060022]; kidney development [GO:0001822]; lens morphogenesis in camera-type eye [GO:0002089]; limb bud formation [GO:0060174]; lung morphogenesis [GO:0060425]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural crest cell development [GO:0014032]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; oligodendrocyte development [GO:0014003]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lens epithelial cell proliferation [GO:2001111]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; signal transduction involved in cell cycle checkpoint [GO:0072395]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]; somite development [GO:0061053]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; ventricular septum morphogenesis [GO:0060412]"
PGEN_.00g002860	Scaffold_01	7115090	7115326	NA	NA	NA	NA	NA
PGEN_.00g002870	Scaffold_01	7141954	7142229	NA	NA	NA	NA	NA
PGEN_.00g002880	Scaffold_01	7150706	7150909	NA	NA	NA	NA	NA
PGEN_.00g002890	Scaffold_01	7150967	7151185	NA	NA	NA	NA	NA
PGEN_.00g002900	Scaffold_01	7151244	7151681	NA	NA	NA	NA	NA
PGEN_.00g002910	Scaffold_01	7206069	7206452	NA	NA	NA	NA	NA
PGEN_.00g002920	Scaffold_01	7221425	7221757	NA	NA	NA	NA	NA
PGEN_.00g002930	Scaffold_01	7279750	7281039	NA	NA	NA	NA	NA
PGEN_.00g002940	Scaffold_01	7283378	7318437	Q8C0P7	ZN451_MOUSE	E3 SUMO-protein ligase ZNF451 (EC 2.3.2.-) (E3 SUMO-protein transferase ZNF451) (Zinc finger protein 451)	GO:0000979; GO:0003714; GO:0005634; GO:0010468; GO:0016605; GO:0016925; GO:0030512; GO:0046872; GO:0060633; GO:0061665; GO:2000616	nucleus [GO:0005634]; PML body [GO:0016605]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; SUMO ligase activity [GO:0061665]; transcription corepressor activity [GO:0003714]; negative regulation of histone H3-K9 acetylation [GO:2000616]; negative regulation of transcription initiation from RNA polymerase II promoter [GO:0060633]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468]
PGEN_.00g002950	Scaffold_01	7359877	7363556	NA	NA	NA	NA	NA
PGEN_.00g002960	Scaffold_01	7384415	7388950	NA	NA	NA	NA	NA
PGEN_.00g002970	Scaffold_01	7388994	7405154	NA	NA	NA	NA	NA
PGEN_.00g002980	Scaffold_01	7457938	7458231	NA	NA	NA	NA	NA
PGEN_.00g002990	Scaffold_01	7458304	7488684	NA	NA	NA	NA	NA
PGEN_.00g003000	Scaffold_01	7502536	7503836	NA	NA	NA	NA	NA
PGEN_.00g003010	Scaffold_01	7506282	7521583	Q86YT6	MIB1_HUMAN	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]
PGEN_.00g003020	Scaffold_01	7530262	7535212	NA	NA	NA	NA	NA
PGEN_.00g003030	Scaffold_01	7562643	7588941	Q86YT6	MIB1_HUMAN	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]
PGEN_.00g003040	Scaffold_01	7607112	7616724	Q6P3N9	ZNT7_XENTR	Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7)	GO:0005794; GO:0006829; GO:0008324; GO:0016021	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cation transmembrane transporter activity [GO:0008324]; zinc ion transport [GO:0006829]
PGEN_.00g003050	Scaffold_01	7617215	7666227	Q1HCL7	NAKD2_RAT	"NAD kinase 2, mitochondrial (EC 2.7.1.23) (Mitochondrial NAD kinase) (NAD kinase domain-containing protein 1, mitochondrial)"	GO:0003951; GO:0005524; GO:0005739; GO:0006741; GO:0019674; GO:0042803	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]
PGEN_.00g003060	Scaffold_01	7672313	7688062	Q6DCD1	FGGY_XENLA	FGGY carbohydrate kinase domain-containing protein (EC 2.7.1.-)	GO:0005975; GO:0016301; GO:0016773	"kinase activity [GO:0016301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; carbohydrate metabolic process [GO:0005975]"
PGEN_.00g003070	Scaffold_01	7689783	7713997	Q15569	TESK1_HUMAN	Dual specificity testis-specific protein kinase 1 (EC 2.7.12.1) (Testicular protein kinase 1)	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0008022; GO:0019901; GO:0030036; GO:0031410; GO:0031953; GO:0032880; GO:0046872; GO:0051496; GO:0071901	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of stress fiber assembly [GO:0051496]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]
PGEN_.00g003080	Scaffold_01	7696672	7713930	NA	NA	NA	NA	NA
PGEN_.00g003090	Scaffold_01	7724467	7746714	Q924U5	TESK2_RAT	Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2)	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006915; GO:0007283; GO:0016604; GO:0030036; GO:0035556; GO:0046872; GO:0048041	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]
PGEN_.00g003100	Scaffold_01	7779978	7780484	NA	NA	NA	NA	NA
PGEN_.00g003110	Scaffold_01	7781684	7782232	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g003120	Scaffold_01	7805957	7815163	Q2TAP8	CHCH7_XENLA	Coiled-coil-helix-coiled-coil-helix domain-containing protein 7	GO:0005758	mitochondrial intermembrane space [GO:0005758]
PGEN_.00g003130	Scaffold_01	7818094	7830646	Q5U2T6	PLAG1_RAT	Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein)	GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005813; GO:0005829; GO:0006355; GO:0010628; GO:0010629; GO:0016607; GO:0022612; GO:0035264; GO:0035265; GO:0045944; GO:0046872; GO:0060252; GO:0060736	"centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g003140	Scaffold_01	7841125	7887077	A7MB74	SGK1_BOVIN	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005789; GO:0005886; GO:0006915; GO:0015459; GO:0018105; GO:0035556; GO:0048812	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; potassium channel regulator activity [GO:0015459]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]
PGEN_.00g003150	Scaffold_01	7947825	7952415	Q7T0W5	TFB1M_XENLA	"Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)"	GO:0000179; GO:0003677; GO:0003723; GO:0005739	"mitochondrion [GO:0005739]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"
PGEN_.00g003160	Scaffold_01	7953792	7966400	Q49LS7	XKR8_TETNG	XK-related protein 8	GO:0005886; GO:0016021; GO:0043652; GO:0070782	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]
PGEN_.00g003170	Scaffold_01	7977509	7982122	Q6INU2	BSC1A_XENLA	BSD domain-containing protein 1-A		
PGEN_.00g003180	Scaffold_01	7982531	7986829	A7RM45	LMBD1_NEMVE	Probable lysosomal cobalamin transporter	GO:0005765; GO:0016021; GO:0031419	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; cobalamin binding [GO:0031419]
PGEN_.00g003190	Scaffold_01	8000690	8023490	Q80U95	UBE3C_MOUSE	Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C)	GO:0000209; GO:0004842; GO:0005634; GO:0006511; GO:0061631	nucleus [GO:0005634]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g003200	Scaffold_01	8023790	8027532	Q9CWQ0	DPH5_MOUSE	Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase)	GO:0004164; GO:0017183; GO:0032259	diphthine synthase activity [GO:0004164]; methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]
PGEN_.00g003210	Scaffold_01	8032273	8039078	A6QGC0	PRKC_STAAE	Serine/threonine-protein kinase PrkC (Ser/Thr-protein kinase PrkC) (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007165; GO:0009847; GO:0016021; GO:0042834; GO:0071224	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; peptidoglycan binding [GO:0042834]; protein serine/threonine kinase activity [GO:0004674]; cellular response to peptidoglycan [GO:0071224]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; spore germination [GO:0009847]
PGEN_.00g003220	Scaffold_01	8114943	8115404	NA	NA	NA	NA	NA
PGEN_.00g003230	Scaffold_01	8124012	8147550	A5HK05	APBP2_RAT	Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2)	GO:0005634; GO:0005874; GO:0006886; GO:0030659; GO:0046907	cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]
PGEN_.00g003240	Scaffold_01	8147720	8157455	Q2KHU4	CLPP_BOVIN	"ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Endopeptidase Clp)"	GO:0004176; GO:0004252; GO:0005759; GO:0006515; GO:0009368; GO:0051117; GO:0051603	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; serine-type endopeptidase activity [GO:0004252]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g003250	Scaffold_01	8168125	8169542	Q90655	AKR_CHICK	Homeobox protein AKR (Avian knotted-related protein)	GO:0003677; GO:0005634; GO:0045892	"nucleus [GO:0005634]; DNA binding [GO:0003677]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g003260	Scaffold_01	8173306	8173641	NA	NA	NA	NA	NA
PGEN_.00g003270	Scaffold_01	8177922	8199615	Q1RMJ7	TSAP1_BOVIN	tRNA selenocysteine 1-associated protein 1 (tRNA selenocysteine-associated protein 1)	GO:0001514; GO:0003723; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; selenocysteine incorporation [GO:0001514]
PGEN_.00g003280	Scaffold_01	8199982	8210256	Q6TNS2	PK1IP_DANRE	p21-activated protein kinase-interacting protein 1-like (PAK1-interacting protein 1-like)	GO:0005730; GO:0009968; GO:0042273	nucleolus [GO:0005730]; negative regulation of signal transduction [GO:0009968]; ribosomal large subunit biogenesis [GO:0042273]
PGEN_.00g003290	Scaffold_01	8210932	8214390	Q9P0S9	TM14C_HUMAN	Transmembrane protein 14C	GO:0005743; GO:0006783; GO:0006839; GO:0016021; GO:0030218; GO:0070453	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; regulation of heme biosynthetic process [GO:0070453]
PGEN_.00g003300	Scaffold_01	8216582	8237984	Q13029	PRDM2_HUMAN	PR domain zinc finger protein 2 (EC 2.1.1.355) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ)	GO:0000977; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0008270; GO:0008340; GO:0018024; GO:0031490; GO:0043565; GO:0045893; GO:0045944	"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; determination of adult lifespan [GO:0008340]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g003310	Scaffold_01	8250236	8250808	NA	NA	NA	NA	NA
PGEN_.00g003320	Scaffold_01	8256420	8256734	NA	NA	NA	NA	NA
PGEN_.00g003330	Scaffold_01	8257067	8258104	NA	NA	NA	NA	NA
PGEN_.00g003340	Scaffold_01	8264242	8310374	Q5XHH9	TT39B_XENLA	Tetratricopeptide repeat protein 39B (TPR repeat protein 39B)	GO:0006629	lipid metabolic process [GO:0006629]
PGEN_.00g003350	Scaffold_01	8332618	8335229	Q2T9T9	FBXW9_BOVIN	F-box/WD repeat-containing protein 9 (F-box and WD-40 domain-containing protein 9)	GO:0030687; GO:0070545	"PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]"
PGEN_.00g003360	Scaffold_01	8368517	8390872	Q60HG0	FKTN_MACFA	Fukutin (EC 2.4.2.-) (Fukuyama-type congenital muscular dystrophy protein) (Ribitol-5-phosphate transferase)	GO:0005634; GO:0005794; GO:0005801; GO:0006493; GO:0016740; GO:0030173; GO:0035269	cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; transferase activity [GO:0016740]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]
PGEN_.00g003370	Scaffold_01	8391260	8401072	Q9VR50	S35E1_DROME	Solute carrier family 35 member E1 homolog	GO:0005794; GO:0015297; GO:0016021; GO:0022857	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]
PGEN_.00g003380	Scaffold_01	8421578	8439080	NA	NA	NA	NA	NA
PGEN_.00g003390	Scaffold_01	8446216	8446725	NA	NA	NA	NA	NA
PGEN_.00g003400	Scaffold_01	8457648	8461578	Q8JIS3	DER_CHICK	D-erythrulose reductase (EC 1.1.1.162) (Probable L-xylulose reductase) (XR) (EC 1.1.1.10)	GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0047880; GO:0050038; GO:0051289	"cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g003410	Scaffold_01	8462534	8465536	NA	NA	NA	NA	NA
PGEN_.00g003420	Scaffold_01	8500632	8506815	Q498D9	GIPC2_RAT	PDZ domain-containing protein GIPC2	GO:0005737; GO:0042802	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]
PGEN_.00g003430	Scaffold_01	8518359	8522114	Q2V897	TLR2_BOSTR	Toll-like receptor 2 (CD antigen CD282)	GO:0002755; GO:0005794; GO:0006954; GO:0016021; GO:0030670; GO:0034134; GO:0045087; GO:0045121; GO:0050707; GO:0050729; GO:0071726; GO:0071727	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]
PGEN_.00g003440	Scaffold_01	8526493	8550506	Q54RB7	SHKA_DICDI	Dual specificity protein kinase shkA (EC 2.7.11.1) (SH2 domain-containing protein 1) (SH2 domain-containing protein A)	GO:0004674; GO:0004713; GO:0005524; GO:0005938; GO:0006909; GO:0006935; GO:0009968; GO:0016020; GO:0030036	cell cortex [GO:0005938]; membrane [GO:0016020]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; chemotaxis [GO:0006935]; negative regulation of signal transduction [GO:0009968]; phagocytosis [GO:0006909]
PGEN_.00g003450	Scaffold_01	8563936	8570912	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g003460	Scaffold_01	8581561	8592800	Q5UAK0	MIER1_MOUSE	Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1)	GO:0000122; GO:0001103; GO:0003677; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0016575; GO:0017053; GO:0031937; GO:0032991; GO:0042826	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin silencing [GO:0031937]
PGEN_.00g003470	Scaffold_01	8593161	8623276	Q5VTH9	WDR78_HUMAN	WD repeat-containing protein 78	GO:0002244; GO:0003341; GO:0005858; GO:0007018; GO:0045503; GO:0045504	axonemal dynein complex [GO:0005858]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018]
PGEN_.00g003480	Scaffold_01	8625768	8681145	Q9HAR2	AGRL3_HUMAN	Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)	GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]
PGEN_.00g003490	Scaffold_01	8701460	8715540	O42993	FKBP_SCHPO	Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (FK506-binding protein) (FKBP)	GO:0000413; GO:0000747; GO:0003755; GO:0005634; GO:0005737; GO:0005829; GO:0061077	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; conjugation with cellular fusion [GO:0000747]; protein peptidyl-prolyl isomerization [GO:0000413]
PGEN_.00g003500	Scaffold_01	8740870	8756032	P48375	FKB12_DROME	12 kDa FK506-binding protein (FKBP) (EC 5.2.1.8) (Macrolide-binding protein) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)	GO:0000413; GO:0003755; GO:0005737; GO:0005886; GO:0061077	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413]
PGEN_.00g003510	Scaffold_01	8762565	8766855	NA	NA	NA	NA	NA
PGEN_.00g003520	Scaffold_01	8767297	8783750	NA	NA	NA	NA	NA
PGEN_.00g003530	Scaffold_01	8792733	8804446	NA	NA	NA	NA	NA
PGEN_.00g003540	Scaffold_01	8808366	8817562	NA	NA	NA	NA	NA
PGEN_.00g003550	Scaffold_01	8821444	8824709	NA	NA	NA	NA	NA
PGEN_.00g003560	Scaffold_01	8832446	8833359	NA	NA	NA	NA	NA
PGEN_.00g003570	Scaffold_01	8865055	8881278	P18075	BMP7_HUMAN	Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1) (Eptotermin alfa)	GO:0001501; GO:0001503; GO:0001656; GO:0001657; GO:0001707; GO:0001823; GO:0001837; GO:0003272; GO:0003344; GO:0005125; GO:0005160; GO:0005576; GO:0005615; GO:0007411; GO:0008083; GO:0008201; GO:0009880; GO:0010628; GO:0010664; GO:0010718; GO:0010800; GO:0010862; GO:0016358; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030902; GO:0031982; GO:0032088; GO:0032355; GO:0033280; GO:0034116; GO:0034504; GO:0042326; GO:0042475; GO:0042981; GO:0043065; GO:0043401; GO:0043407; GO:0043408; GO:0043434; GO:0045665; GO:0045669; GO:0045746; GO:0045786; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048596; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0051216; GO:0060037; GO:0060272; GO:0060393; GO:0060395; GO:0060411; GO:0060445; GO:0060485; GO:0060548; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0062023; GO:0070487; GO:0071456; GO:0071773; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:1900006; GO:1900106; GO:1901223; GO:1905069; GO:1905312; GO:2000121	"collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; vesicle [GO:0031982]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; transforming growth factor beta receptor binding [GO:0005160]; allantois development [GO:1905069]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cellular response to BMP stimulus [GO:0071773]; cellular response to hypoxia [GO:0071456]; chorio-allantoic fusion [GO:0060710]; dendrite development [GO:0016358]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; epithelial to mesenchymal transition [GO:0001837]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; mesonephros development [GO:0001823]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; metanephros development [GO:0001656]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]; regulation of apoptotic process [GO:0042981]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of MAPK cascade [GO:0043408]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of removal of superoxide radicals [GO:2000121]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; steroid hormone mediated signaling pathway [GO:0043401]; ureteric bud development [GO:0001657]"
PGEN_.00g003580	Scaffold_01	9015114	9015705	NA	NA	NA	NA	NA
PGEN_.00g003590	Scaffold_01	9032805	9047702	Q8TAC1	RFESD_HUMAN	Rieske domain-containing protein	GO:0016491; GO:0046872; GO:0051537	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]"
PGEN_.00g003600	Scaffold_01	9047754	9049434	NA	NA	NA	NA	NA
PGEN_.00g003610	Scaffold_01	9049580	9053771	NA	NA	NA	NA	NA
PGEN_.00g003620	Scaffold_01	9065572	9091868	Q5RDY2	TM9S4_PONAB	Transmembrane 9 superfamily member 4	GO:0001666; GO:0005623; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:2000010	cell [GO:0005623]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]
PGEN_.00g003630	Scaffold_01	9094056	9114982	Q4R5D0	RS20_MACFA	40S ribosomal protein S20	GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0015935	cytoplasm [GO:0005737]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g003640	Scaffold_01	9119466	9135420	NA	NA	NA	NA	NA
PGEN_.00g003650	Scaffold_01	9145366	9176150	Q9V9S7	SYDE_DROME	Rho GTPase-activating protein 100F (RhoGAP-100F) (Synapse defective protein 1 homolog) (Protein syd-1 homolog)	GO:0005096; GO:0007266; GO:0007416; GO:0031594; GO:0045467; GO:0048786; GO:0048789; GO:0048790; GO:0048846; GO:0090630; GO:0097479; GO:0098831; GO:1990709	neuromuscular junction [GO:0031594]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; axon extension involved in axon guidance [GO:0048846]; cytoskeletal matrix organization at active zone [GO:0048789]; maintenance of presynaptic active zone structure [GO:0048790]; presynaptic active zone organization [GO:1990709]; R7 cell development [GO:0045467]; Rho protein signal transduction [GO:0007266]; synapse assembly [GO:0007416]; synaptic vesicle localization [GO:0097479]
PGEN_.00g003660	Scaffold_01	9210995	9212617	Q9V9S7	SYDE_DROME	Rho GTPase-activating protein 100F (RhoGAP-100F) (Synapse defective protein 1 homolog) (Protein syd-1 homolog)	GO:0005096; GO:0007266; GO:0007416; GO:0031594; GO:0045467; GO:0048786; GO:0048789; GO:0048790; GO:0048846; GO:0090630; GO:0097479; GO:0098831; GO:1990709	neuromuscular junction [GO:0031594]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; axon extension involved in axon guidance [GO:0048846]; cytoskeletal matrix organization at active zone [GO:0048789]; maintenance of presynaptic active zone structure [GO:0048790]; presynaptic active zone organization [GO:1990709]; R7 cell development [GO:0045467]; Rho protein signal transduction [GO:0007266]; synapse assembly [GO:0007416]; synaptic vesicle localization [GO:0097479]
PGEN_.00g003670	Scaffold_01	9304644	9309939	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g003680	Scaffold_01	9326867	9335186	C9JJ37	BTBDJ_HUMAN	BTB/POZ domain-containing protein 19		
PGEN_.00g003690	Scaffold_01	9336295	9337494	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g003700	Scaffold_01	9346004	9354016	Q9WTP7	KAD3_MOUSE	"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (AK 3) (Adenylate kinase 3 alpha-like 1)"	GO:0004017; GO:0005524; GO:0005525; GO:0005739; GO:0005758; GO:0005759; GO:0006172; GO:0006756; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046041; GO:0046051; GO:0046060; GO:0046899	mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; UTP metabolic process [GO:0046051]
PGEN_.00g003710	Scaffold_01	9354818	9374260	Q562C7	PUM3_RAT	Pumilio homolog 3	GO:0003677; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005783; GO:0010835	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835]
PGEN_.00g003720	Scaffold_01	9387153	9456089	NA	NA	NA	NA	NA
PGEN_.00g003730	Scaffold_01	9566757	9568313	NA	NA	NA	NA	NA
PGEN_.00g003740	Scaffold_01	9570212	9570547	Q96MB7	HARB1_HUMAN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g003750	Scaffold_01	9577948	9584498	NA	NA	NA	NA	NA
PGEN_.00g003760	Scaffold_01	9656116	9752521	Q5R4R7	PHF24_PONAB	PHD finger protein 24	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g003770	Scaffold_01	9767517	9768506	NA	NA	NA	NA	NA
PGEN_.00g003780	Scaffold_01	9791284	9791733	NA	NA	NA	NA	NA
PGEN_.00g003790	Scaffold_01	9795512	9822936	P59510	ATS20_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM-TS 20) (ADAM-TS20) (ADAMTS-20) (EC 3.4.24.-)	GO:0004222; GO:0005615; GO:0008270; GO:0009967; GO:0030198; GO:0043066; GO:0045636	extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]
PGEN_.00g003800	Scaffold_01	9843451	9844083	NA	NA	NA	NA	NA
PGEN_.00g003810	Scaffold_01	9846257	9860593	NA	NA	NA	NA	NA
PGEN_.00g003820	Scaffold_01	9868450	9868737	NA	NA	NA	NA	NA
PGEN_.00g003830	Scaffold_01	9880517	9888128	NA	NA	NA	NA	NA
PGEN_.00g003840	Scaffold_01	9890189	9890569	NA	NA	NA	NA	NA
PGEN_.00g003850	Scaffold_01	9920196	9921407	Q9GRC0	MOS_PATPE	Serine/threonine-protein kinase mos (EC 2.7.11.1) (Oocyte maturation factor mos)	GO:0004709; GO:0005524; GO:0007147; GO:0007292; GO:0045930	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; female gamete generation [GO:0007292]; female meiosis II [GO:0007147]; negative regulation of mitotic cell cycle [GO:0045930]
PGEN_.00g003860	Scaffold_01	9926127	9940155	NA	NA	NA	NA	NA
PGEN_.00g003870	Scaffold_01	9943665	9944865	NA	NA	NA	NA	NA
PGEN_.00g003880	Scaffold_01	9947054	9955879	P37193	ADXH1_DROME	"Adrenodoxin-like protein 1, mitochondrial (Ferredoxin-1)"	GO:0005739; GO:0005759; GO:0006694; GO:0009055; GO:0045998; GO:0046872; GO:0051537	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; positive regulation of ecdysteroid biosynthetic process [GO:0045998]; steroid biosynthetic process [GO:0006694]"
PGEN_.00g003890	Scaffold_01	9981218	10004414	Q90YB1	DNLI4_CHICK	DNA ligase 4 (EC 6.5.1.1) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4)	GO:0003677; GO:0003910; GO:0005524; GO:0005654; GO:0005958; GO:0006260; GO:0006297; GO:0006303; GO:0007049; GO:0032807; GO:0033152; GO:0046872; GO:0051103; GO:0051301; GO:0070419; GO:0071897	"DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; nucleotide-excision repair, DNA gap filling [GO:0006297]"
PGEN_.00g003900	Scaffold_01	10005225	10015950	Q14376	GALE_HUMAN	UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase)	GO:0003974; GO:0003978; GO:0005829; GO:0019388; GO:0033499; GO:0042802; GO:0042803	cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]
PGEN_.00g003910	Scaffold_01	10025899	10027125	NA	NA	NA	NA	NA
PGEN_.00g003920	Scaffold_01	10039762	10051652	Q9V477	TOLL8_DROME	Toll-like receptor Tollo (Toll-like receptor 8)	GO:0002227; GO:0003401; GO:0007165; GO:0016021; GO:0016324; GO:0048935; GO:0060026; GO:0060049	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response in mucosa [GO:0002227]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]
PGEN_.00g003930	Scaffold_01	10060410	10072957	Q6TLF6	RGN_DANRE	Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)	GO:0004341; GO:0005509; GO:0005623; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848	cell [GO:0005623]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]
PGEN_.00g003940	Scaffold_01	10078087	10084378	Q2PFX5	RGN_MACFA	Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30)	GO:0004341; GO:0005509; GO:0005623; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0030234; GO:0032781; GO:0050848	cell [GO:0005623]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]
PGEN_.00g003950	Scaffold_01	10084738	10097421	P57784	RU2A_MOUSE	U2 small nuclear ribonucleoprotein A' (U2 snRNP A')	GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0007283; GO:0016604; GO:0016607; GO:0030620; GO:0071005; GO:0071007; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2 snRNA binding [GO:0030620]; mRNA splicing, via spliceosome [GO:0000398]; spermatogenesis [GO:0007283]"
PGEN_.00g003960	Scaffold_01	10109301	10146767	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g003970	Scaffold_01	10161492	10162508	A4IF63	TRIM2_BOVIN	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g003980	Scaffold_01	10168173	10180181	Q0R4F1	PIF1_XENLA	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)	GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0043139	mitochondrion [GO:0005739]; nucleus [GO:0005634]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]
PGEN_.00g003990	Scaffold_01	10182063	10185419	Q6DI40	TTC33_DANRE	Tetratricopeptide repeat protein 33 (TPR repeat protein 33)		
PGEN_.00g004000	Scaffold_01	10187726	10188022	NA	NA	NA	NA	NA
PGEN_.00g004010	Scaffold_01	10195366	10218140	Q9NA75	T38B1_CAEEL	Trimeric intracellular cation channel type 1B.1 (TRIC-1B.1) (TRIC-B1)	GO:0005267; GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; potassium channel activity [GO:0005267]
PGEN_.00g004020	Scaffold_01	10345340	10378622	Q92481	AP2B_HUMAN	Transcription factor AP-2-beta (AP2-beta) (Activating enhancer-binding protein 2-beta)	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001158; GO:0001228; GO:0001822; GO:0003091; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005623; GO:0005634; GO:0005654; GO:0006006; GO:0006355; GO:0006357; GO:0006366; GO:0008284; GO:0008285; GO:0010842; GO:0010960; GO:0030510; GO:0035136; GO:0035137; GO:0035810; GO:0035909; GO:0042493; GO:0042593; GO:0042803; GO:0043027; GO:0043066; GO:0043154; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0046983; GO:0048485; GO:0050796; GO:0055062; GO:0055074; GO:0055075; GO:0055078; GO:0072017; GO:0072044; GO:0072210; GO:0097070; GO:0097275; GO:0097276; GO:0097277	"cell [GO:0005623]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; aorta morphogenesis [GO:0035909]; calcium ion homeostasis [GO:0055074]; cellular ammonia homeostasis [GO:0097275]; cellular creatinine homeostasis [GO:0097276]; cellular urea homeostasis [GO:0097277]; collecting duct development [GO:0072044]; distal tubule development [GO:0072017]; ductus arteriosus closure [GO:0097070]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hindlimb morphogenesis [GO:0035137]; kidney development [GO:0001822]; magnesium ion homeostasis [GO:0010960]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphate ion homeostasis [GO:0055062]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; potassium ion homeostasis [GO:0055075]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell differentiation [GO:0045595]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal water homeostasis [GO:0003091]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; skin development [GO:0043588]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g004030	Scaffold_01	10489571	10499231	NA	NA	NA	NA	NA
PGEN_.00g004040	Scaffold_01	10504516	10513254	Q92485	ASM3B_HUMAN	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
PGEN_.00g004050	Scaffold_01	10547793	10624191	NA	NA	NA	NA	NA
PGEN_.00g004060	Scaffold_01	10624382	10669247	NA	NA	NA	NA	NA
PGEN_.00g004070	Scaffold_01	10696884	10698565	NA	NA	NA	NA	NA
PGEN_.00g004080	Scaffold_01	10698858	10699187	O35437	TCF21_MOUSE	Transcription factor 21 (TCF-21) (Capsulin) (Epicardin) (Podocyte-expressed 1) (Pod-1)	GO:0000122; GO:0001227; GO:0001228; GO:0001657; GO:0001658; GO:0001763; GO:0001822; GO:0001944; GO:0005634; GO:0007530; GO:0007548; GO:0009887; GO:0014707; GO:0030855; GO:0031063; GO:0032835; GO:0042826; GO:0043425; GO:0045944; GO:0046983; GO:0048286; GO:0048536; GO:0048557; GO:0048608; GO:0048732; GO:0050681; GO:0060008; GO:0060021; GO:0060425; GO:0060426; GO:0060435; GO:0060539; GO:0060541; GO:0060766; GO:0070888; GO:0072162; GO:0072277	"nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; animal organ morphogenesis [GO:0009887]; branching involved in ureteric bud morphogenesis [GO:0001658]; branchiomeric skeletal muscle development [GO:0014707]; bronchiole development [GO:0060435]; diaphragm development [GO:0060539]; embryonic digestive tract morphogenesis [GO:0048557]; epithelial cell differentiation [GO:0030855]; gland development [GO:0048732]; glomerulus development [GO:0032835]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; metanephric glomerular capillary formation [GO:0072277]; metanephric mesenchymal cell differentiation [GO:0072162]; morphogenesis of a branching structure [GO:0001763]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone deacetylation [GO:0031063]; reproductive structure development [GO:0048608]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; ureteric bud development [GO:0001657]; vasculature development [GO:0001944]"
PGEN_.00g004090	Scaffold_01	10725334	10762013	P0C928	RTEL1_DANRE	Regulator of telomere elongation helicase 1 (EC 3.6.4.12)	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0032508; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1904430	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomeric loop disassembly [GO:0090657]"
PGEN_.00g004100	Scaffold_01	10763341	10767165	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g004110	Scaffold_01	10767250	10780399	P0C928	RTEL1_DANRE	Regulator of telomere elongation helicase 1 (EC 3.6.4.12)	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0032508; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1904430	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomeric loop disassembly [GO:0090657]"
PGEN_.00g004120	Scaffold_01	10780665	10782359	Q6E2N3	TRI33_DANRE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]
PGEN_.00g004130	Scaffold_01	10792378	10798672	NA	NA	NA	NA	NA
PGEN_.00g004140	Scaffold_01	10804462	10804698	NA	NA	NA	NA	NA
PGEN_.00g004150	Scaffold_01	10817320	10818331	NA	NA	NA	NA	NA
PGEN_.00g004160	Scaffold_01	10839310	10848439	Q16X92	RTEL1_AEDAE	Regulator of telomere elongation helicase 1 homolog (EC 3.6.4.12)	GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0010569; GO:0046872; GO:0051539	"nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]"
PGEN_.00g004170	Scaffold_01	10862517	10885272	P13668	STMN1_RAT	Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Pr22 protein) (Prosolin) (pp17)	GO:0000281; GO:0005737; GO:0005829; GO:0005874; GO:0007019; GO:0007052; GO:0007409; GO:0007420; GO:0009615; GO:0015631; GO:0016020; GO:0031110; GO:0031115; GO:0031175; GO:0035024; GO:0035556; GO:0043005; GO:0048012; GO:0051272; GO:0051493; GO:0051497; GO:0061436; GO:0070495; GO:1905098	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; axonogenesis [GO:0007409]; brain development [GO:0007420]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; positive regulation of cellular component movement [GO:0051272]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615]
PGEN_.00g004180	Scaffold_01	10891637	10912223	Q6P4Y0	CDKAL_XENTR	Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase)	GO:0005783; GO:0005789; GO:0016021; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]; tRNA methylthiolation [GO:0035600]"
PGEN_.00g004190	Scaffold_01	10914494	10922253	Q99LU8	CF062_MOUSE	Uncharacterized protein C6orf62 homolog		
PGEN_.00g004200	Scaffold_01	10915477	10915890	NA	NA	NA	NA	NA
PGEN_.00g004210	Scaffold_01	10930994	10940601	Q9GZR5	ELOV4_HUMAN	Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)	GO:0005783; GO:0006633; GO:0006636; GO:0008020; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"
PGEN_.00g004220	Scaffold_01	10958837	10980219	Q9NWZ5	UCKL1_HUMAN	Uridine-cytidine kinase-like 1 (EC 2.7.1.48)	GO:0004849; GO:0005524; GO:0005634; GO:0005829; GO:0016032; GO:0016301; GO:0043097; GO:0044206; GO:0044211	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032]
PGEN_.00g004230	Scaffold_01	11007096	11008193	Q28113	FUT2_BOVIN	"Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g004240	Scaffold_01	11012870	11013652	NA	NA	NA	NA	NA
PGEN_.00g004250	Scaffold_01	11013706	11014014	NA	NA	NA	NA	NA
PGEN_.00g004260	Scaffold_01	11020714	11077206	Q9H799	CPLN1_HUMAN	Ciliogenesis and planar polarity effector 1 (Protein JBTS17)	GO:0001736; GO:0001822; GO:0003281; GO:0016021; GO:0021549; GO:0035869; GO:0042733; GO:0060021; GO:0060271; GO:0060976; GO:1904491	ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; kidney development [GO:0001822]; protein localization to ciliary transition zone [GO:1904491]; roof of mouth development [GO:0060021]; ventricular septum development [GO:0003281]
PGEN_.00g004270	Scaffold_01	11082926	11088899	Q4KM95	LRC42_RAT	Leucine-rich repeat-containing protein 42		
PGEN_.00g004280	Scaffold_01	11098949	11126653	P17713	STK_HYDVU	Tyrosine-protein kinase STK (EC 2.7.10.2) (P57-STK)	GO:0004715; GO:0005524	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]
PGEN_.00g004290	Scaffold_01	11112652	11112984	NA	NA	NA	NA	NA
PGEN_.00g004300	Scaffold_01	11114982	11115230	NA	NA	NA	NA	NA
PGEN_.00g004310	Scaffold_01	11115508	11115972	NA	NA	NA	NA	NA
PGEN_.00g004320	Scaffold_01	11135658	11138403	NA	NA	NA	NA	NA
PGEN_.00g004330	Scaffold_01	11144131	11155307	Q64425	LIPP_MYOCO	Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) (Fragment)	GO:0004806; GO:0005576; GO:0016042; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]
PGEN_.00g004340	Scaffold_01	11157213	11163170	NA	NA	NA	NA	NA
PGEN_.00g004350	Scaffold_01	11164338	11165012	NA	NA	NA	NA	NA
PGEN_.00g004360	Scaffold_01	11165077	11166012	NA	NA	NA	NA	NA
PGEN_.00g004370	Scaffold_01	11168458	11175950	NA	NA	NA	NA	NA
PGEN_.00g004380	Scaffold_01	11185035	11200911	Q7ZYA0	LMBD2_XENLA	G-protein coupled receptor-associated protein LMBRD2 (LMBR1 domain-containing protein 2)	GO:0005886; GO:0016021; GO:0071875	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adrenergic receptor signaling pathway [GO:0071875]
PGEN_.00g004390	Scaffold_01	11227692	11282198	P35573	GDE_HUMAN	"Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)]"	GO:0004133; GO:0004134; GO:0004135; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005978; GO:0005980; GO:0007584; GO:0016234; GO:0016529; GO:0030247; GO:0031593; GO:0034774; GO:0043033; GO:0043312; GO:0051384; GO:0102500; GO:1904813	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]"
PGEN_.00g004400	Scaffold_01	11291051	11336417	Q6VH22	IF172_MOUSE	Intraflagellar transport protein 172 homolog (Protein wimple)	GO:0000122; GO:0001841; GO:0001843; GO:0001947; GO:0005634; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007368; GO:0007420; GO:0007507; GO:0008134; GO:0008544; GO:0008589; GO:0009953; GO:0016485; GO:0021522; GO:0021915; GO:0030992; GO:0031122; GO:0031514; GO:0036064; GO:0042073; GO:0045880; GO:0050680; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097598; GO:1905515	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; transcription factor binding [GO:0008134]; bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]
PGEN_.00g004410	Scaffold_01	11338279	11338602	NA	NA	NA	NA	NA
PGEN_.00g004420	Scaffold_01	11344911	11370484	NA	NA	NA	NA	NA
PGEN_.00g004430	Scaffold_01	11370525	11371234	NA	NA	NA	NA	NA
PGEN_.00g004440	Scaffold_01	11371563	11381025	NA	NA	NA	NA	NA
PGEN_.00g004450	Scaffold_01	11419209	11419550	NA	NA	NA	NA	NA
PGEN_.00g004460	Scaffold_01	11427039	11435852	NA	NA	NA	NA	NA
PGEN_.00g004470	Scaffold_01	11444160	11444504	NA	NA	NA	NA	NA
PGEN_.00g004480	Scaffold_01	11452224	11456827	Q3UHD1	AGRB1_MOUSE	Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-120 (Vstat120); Vasculostatin-40 (Vstat-40)]	GO:0001530; GO:0001786; GO:0001891; GO:0004888; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0006910; GO:0006911; GO:0007166; GO:0007189; GO:0007399; GO:0007517; GO:0010596; GO:0014069; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051963; GO:0051965; GO:0098974; GO:0098978; GO:0099055; GO:1901741; GO:1903428	"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]"
PGEN_.00g004490	Scaffold_01	11487533	11490199	C0HL12	AGRB1_RAT	Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-120 (Vstat120); Vasculostatin-40 (Vstat-40)]	GO:0001530; GO:0001786; GO:0001891; GO:0004888; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0006910; GO:0006911; GO:0007166; GO:0007189; GO:0007399; GO:0007517; GO:0010596; GO:0014069; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051963; GO:0051965; GO:0098974; GO:0098978; GO:0099055; GO:1901741; GO:1903428	"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]"
PGEN_.00g004500	Scaffold_01	11493436	11493711	NA	NA	NA	NA	NA
PGEN_.00g004510	Scaffold_01	11512219	11578082	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g004520	Scaffold_01	11579529	11580146	NA	NA	NA	NA	NA
PGEN_.00g004530	Scaffold_01	11599441	11603232	Q8CG65	SSPO_MOUSE	SCO-spondin	GO:0005615; GO:0005737; GO:0007155; GO:0007399; GO:0030154; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g004540	Scaffold_01	11642667	11643110	NA	NA	NA	NA	NA
PGEN_.00g004550	Scaffold_01	11654971	11659821	NA	NA	NA	NA	NA
PGEN_.00g004560	Scaffold_01	11669405	11673621	NA	NA	NA	NA	NA
PGEN_.00g004570	Scaffold_01	11688215	11688475	NA	NA	NA	NA	NA
PGEN_.00g004580	Scaffold_01	11688652	11692953	NA	NA	NA	NA	NA
PGEN_.00g004590	Scaffold_01	11693148	11693780	NA	NA	NA	NA	NA
PGEN_.00g004600	Scaffold_01	11708983	11709617	NA	NA	NA	NA	NA
PGEN_.00g004610	Scaffold_01	11713100	11720500	NA	NA	NA	NA	NA
PGEN_.00g004620	Scaffold_01	11738827	11776352	NA	NA	NA	NA	NA
PGEN_.00g004630	Scaffold_01	11776446	11776790	NA	NA	NA	NA	NA
PGEN_.00g004640	Scaffold_01	11780961	11781248	NA	NA	NA	NA	NA
PGEN_.00g004650	Scaffold_01	11781557	11781997	NA	NA	NA	NA	NA
PGEN_.00g004660	Scaffold_01	11787697	11831066	NA	NA	NA	NA	NA
PGEN_.00g004670	Scaffold_01	11858526	11923216	Q7TPD6	RAVR2_MOUSE	Ribonucleoprotein PTB-binding 2 (Protein raver-2)	GO:0003723; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]
PGEN_.00g004680	Scaffold_01	11933653	11952196	Q5XI28	RAVR1_RAT	Ribonucleoprotein PTB-binding 1 (Protein raver-1)	GO:0003723; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]
PGEN_.00g004690	Scaffold_01	11962630	12021181	Q9D7W5	MED8_MOUSE	Mediator of RNA polymerase II transcription subunit 8 (Activator-recruited cofactor 32 kDa component) (ARC32) (Mediator complex subunit 8)	GO:0000978; GO:0003712; GO:0005654; GO:0006357; GO:0016567; GO:0016592; GO:0070847	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g004700	Scaffold_01	12034424	12034657	NA	NA	NA	NA	NA
PGEN_.00g004710	Scaffold_01	12043551	12043928	NA	NA	NA	NA	NA
PGEN_.00g004720	Scaffold_01	12044750	12078289	P70353	NFYC_MOUSE	Nuclear transcription factor Y subunit gamma (CAAT box DNA-binding protein subunit C) (Nuclear transcription factor Y subunit C) (NF-YC)	GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0008134; GO:0016602; GO:0032993; GO:0045893; GO:0045944; GO:0046982; GO:0090575	"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g004730	Scaffold_01	12080351	12082350	NA	NA	NA	NA	NA
PGEN_.00g004740	Scaffold_01	12101639	12152348	Q13415	ORC1_HUMAN	Origin recognition complex subunit 1 (Replication control protein 1)	GO:0000082; GO:0000083; GO:0000278; GO:0000784; GO:0000808; GO:0003677; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270; GO:0033314; GO:0046872	"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"
PGEN_.00g004750	Scaffold_01	12184362	12185438	NA	NA	NA	NA	NA
PGEN_.00g004760	Scaffold_01	12194263	12194811	NA	NA	NA	NA	NA
PGEN_.00g004770	Scaffold_01	12220200	12220895	NA	NA	NA	NA	NA
PGEN_.00g004780	Scaffold_01	12234805	12236592	NA	NA	NA	NA	NA
PGEN_.00g004790	Scaffold_01	12309645	12310037	NA	NA	NA	NA	NA
PGEN_.00g004800	Scaffold_01	12310136	12310426	NA	NA	NA	NA	NA
PGEN_.00g004810	Scaffold_01	12310510	12310893	NA	NA	NA	NA	NA
PGEN_.00g004820	Scaffold_01	12331921	12360338	Q5RD00	AAPK2_PONAB	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)	GO:0003682; GO:0004679; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010508; GO:0016055; GO:0016241; GO:0031669; GO:0032007; GO:0035174; GO:0042149; GO:0042593; GO:0042752; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0097009	cytoplasm [GO:0005737]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g004830	Scaffold_01	12421414	12459019	Q8BRK8	AAPK2_MOUSE	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)	GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010468; GO:0010494; GO:0010508; GO:0010629; GO:0014823; GO:0014850; GO:0016055; GO:0016241; GO:0016324; GO:0016607; GO:0019216; GO:0030424; GO:0030425; GO:0030674; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0032991; GO:0034599; GO:0035174; GO:0035556; GO:0035690; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0044877; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0097009; GO:1903829; GO:1904428; GO:2000758	"apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of glycolytic process [GO:0045821]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of lipid metabolic process [GO:0019216]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g004840	Scaffold_01	12482981	12539247	P54646	AAPK2_HUMAN	5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)	GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0006633; GO:0006695; GO:0006853; GO:0007050; GO:0007165; GO:0008610; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016236; GO:0016239; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031669; GO:0032007; GO:0034599; GO:0035174; GO:0035556; GO:0035690; GO:0042149; GO:0042304; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0097009; GO:1901796; GO:1903829; GO:1904428; GO:2000758	axon [GO:0030424]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; carnitine shuttle [GO:0006853]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]
PGEN_.00g004850	Scaffold_01	12559748	12560907	NA	NA	NA	NA	NA
PGEN_.00g004860	Scaffold_01	12561934	12572343	NA	NA	NA	NA	NA
PGEN_.00g004870	Scaffold_01	12596888	12599594	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g004880	Scaffold_01	12599640	12603174	NA	NA	NA	NA	NA
PGEN_.00g004890	Scaffold_01	12608697	12655189	Q9D8H7	OMA1_MOUSE	"Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog)"	GO:0002024; GO:0004222; GO:0005739; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0007005; GO:0010637; GO:0016021; GO:0031966; GO:0034982; GO:0042407; GO:0046872; GO:0097009; GO:0120162	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]
PGEN_.00g004900	Scaffold_01	12655237	12655680	NA	NA	NA	NA	NA
PGEN_.00g004910	Scaffold_01	12655765	12656768	NA	NA	NA	NA	NA
PGEN_.00g004920	Scaffold_01	12656803	12657618	NA	NA	NA	NA	NA
PGEN_.00g004930	Scaffold_01	12658801	12659544	NA	NA	NA	NA	NA
PGEN_.00g004940	Scaffold_01	12666698	12696509	E9QBI7	OMA1_DANRE	"Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog)"	GO:0002024; GO:0004222; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0010637; GO:0016021; GO:0031966; GO:0034982; GO:0046872; GO:0097009	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; negative regulation of mitochondrial fusion [GO:0010637]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]
PGEN_.00g004950	Scaffold_01	12709157	12711543	NA	NA	NA	NA	NA
PGEN_.00g004960	Scaffold_01	12743265	12745796	A6ZM04	PIF1_YEAS7	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) (Petite integration frequency protein 1) (Telomere stability protein 1)	GO:0000002; GO:0000723; GO:0005524; GO:0005730; GO:0005743; GO:0006281; GO:0006310; GO:0010521; GO:0032211; GO:0043139; GO:0051880	mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; G-quadruplex DNA binding [GO:0051880]; telomerase inhibitor activity [GO:0010521]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomere maintenance via telomerase [GO:0032211]; telomere maintenance [GO:0000723]
PGEN_.00g004970	Scaffold_01	12746457	12746702	NA	NA	NA	NA	NA
PGEN_.00g004980	Scaffold_01	12766120	12787184	NA	NA	NA	NA	NA
PGEN_.00g004990	Scaffold_01	12811371	12812823	NA	NA	NA	NA	NA
PGEN_.00g005000	Scaffold_01	12812856	12813882	NA	NA	NA	NA	NA
PGEN_.00g005010	Scaffold_01	12820980	12822446	NA	NA	NA	NA	NA
PGEN_.00g005020	Scaffold_01	12844024	12845374	NA	NA	NA	NA	NA
PGEN_.00g005030	Scaffold_01	12857326	12892624	O44388	TBB_TRITR	Tubulin beta chain (Beta-tubulin)	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g005040	Scaffold_01	12894398	12894850	NA	NA	NA	NA	NA
PGEN_.00g005050	Scaffold_01	12895078	12895880	NA	NA	NA	NA	NA
PGEN_.00g005060	Scaffold_01	12904610	12911746	NA	NA	NA	NA	NA
PGEN_.00g005070	Scaffold_01	12929826	12930338	NA	NA	NA	NA	NA
PGEN_.00g005080	Scaffold_01	12930761	12932516	NA	NA	NA	NA	NA
PGEN_.00g005090	Scaffold_01	12933113	12933439	NA	NA	NA	NA	NA
PGEN_.00g005100	Scaffold_01	12933916	12934254	NA	NA	NA	NA	NA
PGEN_.00g005110	Scaffold_01	13027821	13031640	NA	NA	NA	NA	NA
PGEN_.00g005120	Scaffold_01	13109846	13110295	NA	NA	NA	NA	NA
PGEN_.00g005130	Scaffold_01	13136635	13139339	NA	NA	NA	NA	NA
PGEN_.00g005140	Scaffold_01	13140057	13148549	NA	NA	NA	NA	NA
PGEN_.00g005150	Scaffold_01	13160924	13194552	O60242	AGRB3_HUMAN	Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3)	GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007520; GO:0016021; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]; G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]
PGEN_.00g005160	Scaffold_01	13221822	13233369	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g005170	Scaffold_01	13233945	13234217	NA	NA	NA	NA	NA
PGEN_.00g005180	Scaffold_01	13240040	13244949	C0HL12	AGRB1_RAT	Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-120 (Vstat120); Vasculostatin-40 (Vstat-40)]	GO:0001530; GO:0001786; GO:0001891; GO:0004888; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0006910; GO:0006911; GO:0007166; GO:0007189; GO:0007399; GO:0007517; GO:0010596; GO:0014069; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051963; GO:0051965; GO:0098974; GO:0098978; GO:0099055; GO:1901741; GO:1903428	"dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; nervous system development [GO:0007399]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of synapse assembly [GO:0051963]; regulation of synaptic plasticity [GO:0048167]"
PGEN_.00g005190	Scaffold_01	13271288	13272229	NA	NA	NA	NA	NA
PGEN_.00g005200	Scaffold_01	13277774	13294046	NA	NA	NA	NA	NA
PGEN_.00g005210	Scaffold_01	13295969	13297277	NA	NA	NA	NA	NA
PGEN_.00g005220	Scaffold_01	13297838	13298104	NA	NA	NA	NA	NA
PGEN_.00g005230	Scaffold_01	13298913	13311409	P29451	THIO_MACMU	Thioredoxin (Trx)	GO:0005576; GO:0005623; GO:0005634; GO:0005737; GO:0006662; GO:0009314; GO:0015035; GO:0043388; GO:0045454; GO:0055114	cell [GO:0005623]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; oxidation-reduction process [GO:0055114]; positive regulation of DNA binding [GO:0043388]; response to radiation [GO:0009314]
PGEN_.00g005240	Scaffold_01	13312514	13312858	NA	NA	NA	NA	NA
PGEN_.00g005250	Scaffold_01	13336601	13339475	Q9BXM0	PRAX_HUMAN	Periaxin	GO:0005634; GO:0005737; GO:0005886; GO:0008366; GO:0030054; GO:0030315; GO:0043484	cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; axon ensheathment [GO:0008366]; regulation of RNA splicing [GO:0043484]
PGEN_.00g005260	Scaffold_01	13368110	13398858	Q20930	MIG17_CAEEL	Metalloprotease mig-17 (EC 3.4.24.-) (Abnormal cell migration protein 17)	GO:0004222; GO:0005604; GO:0005615; GO:0008104; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354	basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]
PGEN_.00g005270	Scaffold_01	13432827	13433126	NA	NA	NA	NA	NA
PGEN_.00g005280	Scaffold_01	13451900	13458859	P10394	POL4_DROME	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]
PGEN_.00g005290	Scaffold_01	13459035	13459469	NA	NA	NA	NA	NA
PGEN_.00g005300	Scaffold_01	13459775	13462154	NA	NA	NA	NA	NA
PGEN_.00g005310	Scaffold_01	13465944	13466309	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g005320	Scaffold_01	13466694	13468066	NA	NA	NA	NA	NA
PGEN_.00g005330	Scaffold_01	13485794	13514307	Q6PAF4	NSE1_XENLA	Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 2.3.2.27)	GO:0000781; GO:0004842; GO:0005634; GO:0006281; GO:0006310; GO:0030915; GO:0046872; GO:0046983; GO:2001022	"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022]"
PGEN_.00g005340	Scaffold_01	13527098	13533428	NA	NA	NA	NA	NA
PGEN_.00g005350	Scaffold_01	13555668	13556273	NA	NA	NA	NA	NA
PGEN_.00g005360	Scaffold_01	13556612	13556944	NA	NA	NA	NA	NA
PGEN_.00g005370	Scaffold_01	13557749	13558006	NA	NA	NA	NA	NA
PGEN_.00g005380	Scaffold_01	13602064	13607670	A5DPU0	MAK5_PICGU	ATP-dependent RNA helicase MAK5 (EC 3.6.4.13)	GO:0000463; GO:0000466; GO:0003723; GO:0003724; GO:0005524; GO:0005730	"nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"
PGEN_.00g005390	Scaffold_01	13612636	13613629	NA	NA	NA	NA	NA
PGEN_.00g005400	Scaffold_01	13618847	13648843	NA	NA	NA	NA	NA
PGEN_.00g005410	Scaffold_01	13650218	13650481	NA	NA	NA	NA	NA
PGEN_.00g005420	Scaffold_01	13651014	13651346	NA	NA	NA	NA	NA
PGEN_.00g005430	Scaffold_01	13651391	13658917	Q7TQN8	GP119_RAT	Glucose-dependent insulinotropic receptor (G-protein coupled receptor 119)	GO:0004930; GO:0005886; GO:0016021; GO:0030073; GO:0031210; GO:0043235	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210]; insulin secretion [GO:0030073]
PGEN_.00g005440	Scaffold_01	13663510	13665073	NA	NA	NA	NA	NA
PGEN_.00g005450	Scaffold_01	13665723	13666247	NA	NA	NA	NA	NA
PGEN_.00g005460	Scaffold_01	13668308	13668688	NA	NA	NA	NA	NA
PGEN_.00g005470	Scaffold_01	13699410	13699937	NA	NA	NA	NA	NA
PGEN_.00g005480	Scaffold_01	13725578	13827565	Q12857	NFIA_HUMAN	Nuclear factor 1 A-type (NF1-A) (Nuclear factor 1/A) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/A) (NF-I/A) (NFI-A) (TGGCA-binding protein)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006355; GO:0008134; GO:0019079; GO:0030054; GO:0045944; GO:0060074; GO:0072189	"cell junction [GO:0030054]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; synapse maturation [GO:0060074]; ureter development [GO:0072189]; viral genome replication [GO:0019079]"
PGEN_.00g005490	Scaffold_01	13753611	13753895	NA	NA	NA	NA	NA
PGEN_.00g005500	Scaffold_01	13825530	13825778	NA	NA	NA	NA	NA
PGEN_.00g005510	Scaffold_01	13899592	13899900	NA	NA	NA	NA	NA
PGEN_.00g005520	Scaffold_01	13929513	13929863	NA	NA	NA	NA	NA
PGEN_.00g005530	Scaffold_01	13937794	13947594	Q61361	PGCB_MOUSE	Brevican core protein	GO:0001501; GO:0005509; GO:0005540; GO:0005615; GO:0007160; GO:0007417; GO:0009986; GO:0021766; GO:0030246; GO:0030424; GO:0030425; GO:0031012; GO:0031225; GO:0033268; GO:0043194; GO:0045202; GO:0060074; GO:0072534; GO:0098966; GO:0098978; GO:0098982; GO:1990138	anchored component of membrane [GO:0031225]; axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; node of Ranvier [GO:0033268]; perineuronal net [GO:0072534]; perisynaptic extracellular matrix [GO:0098966]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell-matrix adhesion [GO:0007160]; central nervous system development [GO:0007417]; hippocampus development [GO:0021766]; neuron projection extension [GO:1990138]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]
PGEN_.00g005540	Scaffold_01	14044358	14044771	NA	NA	NA	NA	NA
PGEN_.00g005550	Scaffold_01	14067455	14092824	F1N9Y5	KSYK_CHICK	Tyrosine-protein kinase SYK (EC 2.7.10.2)	GO:0001945; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0004713; GO:0004715; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007159; GO:0007229; GO:0010543; GO:0018108; GO:0030593; GO:0032009; GO:0032928; GO:0033630; GO:0035556; GO:0042742; GO:0043306; GO:0043313; GO:0045087; GO:0045579; GO:0045780; GO:0046641; GO:0048514; GO:0050764; GO:0050853; GO:0070301; GO:0070372; GO:0071226; GO:0090237; GO:0090330	cytosol [GO:0005829]; early phagosome [GO:0032009]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to molecule of fungal origin [GO:0071226]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of mast cell degranulation [GO:0043306]; protein phosphorylation [GO:0006468]; regulation of arachidonic acid secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; serotonin secretion by platelet [GO:0002554]
PGEN_.00g005560	Scaffold_01	14082963	14084813	NA	NA	NA	NA	NA
PGEN_.00g005570	Scaffold_01	14132000	14132423	NA	NA	NA	NA	NA
PGEN_.00g005580	Scaffold_01	14183632	14187578	NA	NA	NA	NA	NA
PGEN_.00g005590	Scaffold_01	14200297	14200554	NA	NA	NA	NA	NA
PGEN_.00g005600	Scaffold_01	14201526	14202350	NA	NA	NA	NA	NA
PGEN_.00g005610	Scaffold_01	14206678	14207466	NA	NA	NA	NA	NA
PGEN_.00g005620	Scaffold_01	14207826	14208224	NA	NA	NA	NA	NA
PGEN_.00g005630	Scaffold_01	14219622	14223964	Q91ZU6	DYST_MOUSE	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	GO:0001725; GO:0003779; GO:0005509; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005882; GO:0005925; GO:0005938; GO:0007155; GO:0007409; GO:0008017; GO:0008090; GO:0009898; GO:0014069; GO:0014704; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030018; GO:0030056; GO:0030424; GO:0031110; GO:0031122; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042383; GO:0042803; GO:0045104; GO:0046907; GO:0048471; GO:0051010; GO:0060053; GO:0097038; GO:1904115	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; regulation of microtubule polymerization or depolymerization [GO:0031110]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]
PGEN_.00g005640	Scaffold_01	14238384	14238737	NA	NA	NA	NA	NA
PGEN_.00g005650	Scaffold_01	14260404	14262596	NA	NA	NA	NA	NA
PGEN_.00g005660	Scaffold_01	14272638	14385002	Q91ZU6	DYST_MOUSE	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	GO:0001725; GO:0003779; GO:0005509; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005882; GO:0005925; GO:0005938; GO:0007155; GO:0007409; GO:0008017; GO:0008090; GO:0009898; GO:0014069; GO:0014704; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030018; GO:0030056; GO:0030424; GO:0031110; GO:0031122; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042383; GO:0042803; GO:0045104; GO:0046907; GO:0048471; GO:0051010; GO:0060053; GO:0097038; GO:1904115	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; regulation of microtubule polymerization or depolymerization [GO:0031110]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]
PGEN_.00g005670	Scaffold_01	14385195	14420035	Q91ZU6	DYST_MOUSE	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	GO:0001725; GO:0003779; GO:0005509; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005882; GO:0005925; GO:0005938; GO:0007155; GO:0007409; GO:0008017; GO:0008090; GO:0009898; GO:0014069; GO:0014704; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030018; GO:0030056; GO:0030424; GO:0031110; GO:0031122; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042383; GO:0042803; GO:0045104; GO:0046907; GO:0048471; GO:0051010; GO:0060053; GO:0097038; GO:1904115	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; regulation of microtubule polymerization or depolymerization [GO:0031110]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]
PGEN_.00g005680	Scaffold_01	14479825	14499811	P9WN47	EGTD_MYCTU	Histidine N-alpha-methyltransferase (EC 2.1.1.44) (Histidine trimethyltransferase)	GO:0005886; GO:0008276; GO:0030745; GO:0052704; GO:0052707	"plasma membrane [GO:0005886]; dimethylhistidine N-methyltransferase activity [GO:0030745]; protein methyltransferase activity [GO:0008276]; ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]; N-alpha,N-alpha,N-alpha-trimethyl-L-histidine biosynthesis from histidine [GO:0052707]"
PGEN_.00g005690	Scaffold_01	14513047	14515210	NA	NA	NA	NA	NA
PGEN_.00g005700	Scaffold_01	14540212	14555269	NA	NA	NA	NA	NA
PGEN_.00g005710	Scaffold_01	14556788	14557147	NA	NA	NA	NA	NA
PGEN_.00g005720	Scaffold_01	14557302	14561451	NA	NA	NA	NA	NA
PGEN_.00g005730	Scaffold_01	14560020	14560322	NA	NA	NA	NA	NA
PGEN_.00g005740	Scaffold_01	14582730	14611094	Q8MSU3	FRRS1_DROME	Putative ferric-chelate reductase 1 homolog (DmSDR2) (EC 1.-.-.-)	GO:0000293; GO:0016021; GO:0055114	integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; oxidation-reduction process [GO:0055114]
PGEN_.00g005750	Scaffold_01	14665398	14666869	NA	NA	NA	NA	NA
PGEN_.00g005760	Scaffold_01	14667238	14667552	NA	NA	NA	NA	NA
PGEN_.00g005770	Scaffold_01	14789084	14818158	Q8IZU9	KIRR3_HUMAN	Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3]	GO:0001764; GO:0002121; GO:0005576; GO:0005886; GO:0007156; GO:0007416; GO:0016021; GO:0021740; GO:0021766; GO:0030097; GO:0030424; GO:0030425; GO:0043198; GO:0048812; GO:0072102	axon [GO:0030424]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416]
PGEN_.00g005780	Scaffold_01	14818778	14819617	NA	NA	NA	NA	NA
PGEN_.00g005790	Scaffold_01	14833339	14836553	NA	NA	NA	NA	NA
PGEN_.00g005800	Scaffold_01	14837023	14838535	NA	NA	NA	NA	NA
PGEN_.00g005810	Scaffold_01	14875041	14877289	NA	NA	NA	NA	NA
PGEN_.00g005820	Scaffold_01	14887745	14888671	NA	NA	NA	NA	NA
PGEN_.00g005830	Scaffold_01	14909167	14909757	NA	NA	NA	NA	NA
PGEN_.00g005840	Scaffold_01	14939229	14941822	NA	NA	NA	NA	NA
PGEN_.00g005850	Scaffold_01	14947685	14949424	NA	NA	NA	NA	NA
PGEN_.00g005860	Scaffold_01	14980863	14981754	NA	NA	NA	NA	NA
PGEN_.00g005870	Scaffold_01	14997406	14998080	NA	NA	NA	NA	NA
PGEN_.00g005880	Scaffold_01	15016151	15016888	NA	NA	NA	NA	NA
PGEN_.00g005890	Scaffold_01	15054734	15055105	NA	NA	NA	NA	NA
PGEN_.00g005900	Scaffold_01	15080888	15081112	NA	NA	NA	NA	NA
PGEN_.00g005910	Scaffold_01	15092373	15092606	NA	NA	NA	NA	NA
PGEN_.00g005920	Scaffold_01	15107408	15107701	NA	NA	NA	NA	NA
PGEN_.00g005930	Scaffold_01	15109420	15110797	NA	NA	NA	NA	NA
PGEN_.00g005940	Scaffold_01	15110830	15111060	NA	NA	NA	NA	NA
PGEN_.00g005950	Scaffold_01	15180442	15180885	NA	NA	NA	NA	NA
PGEN_.00g005960	Scaffold_01	15204792	15220625	P9WN47	EGTD_MYCTU	Histidine N-alpha-methyltransferase (EC 2.1.1.44) (Histidine trimethyltransferase)	GO:0005886; GO:0008276; GO:0030745; GO:0052704; GO:0052707	"plasma membrane [GO:0005886]; dimethylhistidine N-methyltransferase activity [GO:0030745]; protein methyltransferase activity [GO:0008276]; ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]; N-alpha,N-alpha,N-alpha-trimethyl-L-histidine biosynthesis from histidine [GO:0052707]"
PGEN_.00g005970	Scaffold_01	15226177	15226820	NA	NA	NA	NA	NA
PGEN_.00g005980	Scaffold_01	15227072	15227416	NA	NA	NA	NA	NA
PGEN_.00g005990	Scaffold_01	15228653	15230334	NA	NA	NA	NA	NA
PGEN_.00g006000	Scaffold_01	15235673	15236221	NA	NA	NA	NA	NA
PGEN_.00g006010	Scaffold_01	15278614	15286166	NA	NA	NA	NA	NA
PGEN_.00g006020	Scaffold_01	15309140	15312448	NA	NA	NA	NA	NA
PGEN_.00g006030	Scaffold_01	15332036	15340143	P04157	PTPRC_RAT	Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45)	GO:0000187; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002378; GO:0002711; GO:0002923; GO:0002925; GO:0004725; GO:0005001; GO:0005102; GO:0005623; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016021; GO:0016311; GO:0019887; GO:0019901; GO:0030183; GO:0030217; GO:0030506; GO:0030507; GO:0030890; GO:0031668; GO:0031953; GO:0032059; GO:0032677; GO:0032760; GO:0034113; GO:0035584; GO:0042098; GO:0042100; GO:0042102; GO:0043395; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045085; GO:0045086; GO:0045121; GO:0045582; GO:0045588; GO:0046425; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050731; GO:0050732; GO:0050764; GO:0050852; GO:0050853; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0061097; GO:0061099; GO:0070373; GO:0070374; GO:0071944; GO:0098857; GO:1903615; GO:1905451; GO:2000473; GO:2000648; GO:2001236; GO:2001238	bleb [GO:0032059]; cell [GO:0005623]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 biosynthetic process [GO:0045085]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of gene expression [GO:0010468]; regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002923]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]
PGEN_.00g006040	Scaffold_01	15345610	15346074	NA	NA	NA	NA	NA
PGEN_.00g006050	Scaffold_01	15360263	15361240	NA	NA	NA	NA	NA
PGEN_.00g006060	Scaffold_01	15373008	15374841	NA	NA	NA	NA	NA
PGEN_.00g006070	Scaffold_01	15389222	15389572	NA	NA	NA	NA	NA
PGEN_.00g006080	Scaffold_01	15389607	15395816	NA	NA	NA	NA	NA
PGEN_.00g006090	Scaffold_01	15407645	15408438	NA	NA	NA	NA	NA
PGEN_.00g006100	Scaffold_01	15409485	15413426	NA	NA	NA	NA	NA
PGEN_.00g006110	Scaffold_01	15419033	15424983	NA	NA	NA	NA	NA
PGEN_.00g006120	Scaffold_01	15441130	15455918	NA	NA	NA	NA	NA
PGEN_.00g006130	Scaffold_01	15456073	15473258	Q8BR07	BICD1_MOUSE	Protein bicaudal D homolog 1 (Bic-D 1)	GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005881; GO:0008093; GO:0016020; GO:0016032; GO:0017137; GO:0019901; GO:0031410; GO:0031871; GO:0033365; GO:0034063; GO:0034452; GO:0045505; GO:0048260; GO:0048471; GO:0070507; GO:0070840; GO:0072385; GO:0072393; GO:0072517; GO:1900275; GO:1900276; GO:1900737; GO:1904781	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; host cell viral assembly compartment [GO:0072517]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; cytoskeletal adaptor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; Rab GTPase binding [GO:0017137]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; stress granule assembly [GO:0034063]; viral process [GO:0016032]
PGEN_.00g006140	Scaffold_01	15487215	15500399	Q99J45	NRBP_MOUSE	Nuclear receptor-binding protein (HLS7-interacting protein kinase) (MLF1 adapter molecule)	GO:0004674; GO:0005737; GO:0005938; GO:0006888; GO:0012505; GO:0016020; GO:0030027; GO:0035556; GO:0042802; GO:0042803; GO:0048471	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular signal transduction [GO:0035556]
PGEN_.00g006150	Scaffold_01	15509663	15530516	Q1LZA0	PIGB_BOVIN	GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B)	GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016021	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g006160	Scaffold_01	15537320	15581341	Q96Q15	SMG1_HUMAN	Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (61E3.4) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein)	GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0018105; GO:0032204; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:2001020	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]"
PGEN_.00g006170	Scaffold_01	15589530	15621657	Q02763	TIE2_HUMAN	Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b)	GO:0000165; GO:0001525; GO:0001666; GO:0001934; GO:0001935; GO:0001938; GO:0001958; GO:0002040; GO:0004672; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007165; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0032878; GO:0034446; GO:0034451; GO:0038023; GO:0043066; GO:0043114; GO:0043235; GO:0043434; GO:0043552; GO:0043627; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0050728; GO:0050900; GO:0051259; GO:0051591; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000251; GO:2000351; GO:2000352	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endochondral ossification [GO:0001958]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; response to cAMP [GO:0051591]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g006180	Scaffold_01	15632994	15633263	NA	NA	NA	NA	NA
PGEN_.00g006190	Scaffold_01	15636493	15643496	NA	NA	NA	NA	NA
PGEN_.00g006200	Scaffold_01	15653480	15653740	NA	NA	NA	NA	NA
PGEN_.00g006210	Scaffold_01	15661263	15674447	Q86Y82	STX12_HUMAN	Syntaxin-12	GO:0000045; GO:0000139; GO:0000149; GO:0000407; GO:0005484; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0030285; GO:0031201; GO:0031901; GO:0031982; GO:0033344; GO:0045121; GO:0045335; GO:0048278; GO:0050821; GO:0055038; GO:0098837	early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]
PGEN_.00g006220	Scaffold_01	15679756	15684992	NA	NA	NA	NA	NA
PGEN_.00g006230	Scaffold_01	15702812	15730893	NA	NA	NA	NA	NA
PGEN_.00g006240	Scaffold_01	15731016	15731402	NA	NA	NA	NA	NA
PGEN_.00g006250	Scaffold_01	15737808	15744493	Q86WI3	NLRC5_HUMAN	Protein NLRC5 (Caterpiller protein 16.1) (CLR16.1) (Nucleotide-binding oligomerization domain protein 27) (Nucleotide-binding oligomerization domain protein 4)	GO:0000978; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0009617; GO:0032088; GO:0032480; GO:0035556; GO:0043549; GO:0045087; GO:0045345; GO:0045944; GO:0051607; GO:0060335; GO:0060339; GO:0060340	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon production [GO:0032480]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of kinase activity [GO:0043549]; response to bacterium [GO:0009617]
PGEN_.00g006260	Scaffold_01	15750591	15754832	Q8NA29	NLS1_HUMAN	Sodium-dependent lysophosphatidylcholine symporter 1 (NLS1) (Sodium-dependent LPC symporter 1) (Major facilitator superfamily domain-containing protein 2A)	GO:0005548; GO:0005789; GO:0005886; GO:0005887; GO:0006656; GO:0008643; GO:0015245; GO:0015293; GO:0015908; GO:0021766; GO:0045056; GO:0051977; GO:0051978; GO:0060856; GO:0071702; GO:0140348; GO:1990379	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; fatty acid transmembrane transporter activity [GO:0015245]; lysophosphatidylcholine flippase activity [GO:0140348]; lysophospholipid:sodium symporter activity [GO:0051978]; phospholipid transporter activity [GO:0005548]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; establishment of blood-brain barrier [GO:0060856]; fatty acid transport [GO:0015908]; hippocampus development [GO:0021766]; lipid transport across blood-brain barrier [GO:1990379]; lysophospholipid transport [GO:0051977]; organic substance transport [GO:0071702]; phosphatidylcholine biosynthetic process [GO:0006656]; transcytosis [GO:0045056]
PGEN_.00g006270	Scaffold_01	15795533	15799135	Q8N4L8	CCD24_HUMAN	Coiled-coil domain-containing protein 24	GO:0001835	blastocyst hatching [GO:0001835]
PGEN_.00g006280	Scaffold_01	15806701	15832625	Q9BYK8	HELZ2_HUMAN	"Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) (EC 3.6.4.-)"	GO:0000184; GO:0003677; GO:0003723; GO:0004386; GO:0004540; GO:0005524; GO:0005654; GO:0005737; GO:0016020; GO:0019216; GO:0030374; GO:0045944; GO:0046872	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216]"
PGEN_.00g006290	Scaffold_01	15846895	15878825	Q9BYK8	HELZ2_HUMAN	"Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) (EC 3.6.4.-)"	GO:0000184; GO:0003677; GO:0003723; GO:0004386; GO:0004540; GO:0005524; GO:0005654; GO:0005737; GO:0016020; GO:0019216; GO:0030374; GO:0045944; GO:0046872	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216]"
PGEN_.00g006300	Scaffold_01	15882832	15906560	Q5FVW6	SKAP2_XENTR	Src kinase-associated phosphoprotein 2	GO:0005737; GO:0005886; GO:0042113	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; B cell activation [GO:0042113]
PGEN_.00g006310	Scaffold_01	15915232	15917426	P18238	ADT3_YEAST	"ADP,ATP carrier protein 3 (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3)"	GO:0005471; GO:0005739; GO:0005743; GO:0009061; GO:0015886; GO:0016021; GO:0042802; GO:0055085	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP:ADP antiporter activity [GO:0005471]; identical protein binding [GO:0042802]; anaerobic respiration [GO:0009061]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]
PGEN_.00g006320	Scaffold_01	15946119	15956301	NA	NA	NA	NA	NA
PGEN_.00g006330	Scaffold_01	15986312	15987355	NA	NA	NA	NA	NA
PGEN_.00g006340	Scaffold_01	15992168	15996703	NA	NA	NA	NA	NA
PGEN_.00g006350	Scaffold_01	16020381	16021061	NA	NA	NA	NA	NA
PGEN_.00g006360	Scaffold_01	16023446	16024855	NA	NA	NA	NA	NA
PGEN_.00g006370	Scaffold_01	16026675	16029848	P60323	NANO3_HUMAN	Nanos homolog 3 (NOS-3)	GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0006417; GO:0007275; GO:0007281; GO:0007283; GO:0008270; GO:0010494; GO:0017148; GO:0048471; GO:0048477; GO:0051726; GO:1900153; GO:2001234	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulation of cell cycle [GO:0051726]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]"
PGEN_.00g006380	Scaffold_01	16037773	16062499	Q54TR1	CFAD_DICDI	Counting factor associated protein D	GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0030435; GO:0031288; GO:0031410; GO:0051603; GO:0072659; GO:1903665; GO:1903669	cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435]
PGEN_.00g006390	Scaffold_01	16065335	16078174	Q4WBR2	NEG1_ASPFU	"Endo-1,6-beta-D-glucanase neg1 (EC 3.2.1.75) (Beta-1,6-glucanase neg1) (Glucan endo-1,6-beta-glucosidase neg1)"	GO:0004348; GO:0005576; GO:0006665; GO:0016787; GO:0046557	"extracellular region [GO:0005576]; glucan endo-1,6-beta-glucosidase activity [GO:0046557]; glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; sphingolipid metabolic process [GO:0006665]"
PGEN_.00g006400	Scaffold_01	16083582	16091833	Q7M4T0	NEG1_NEUCR	"Endo-1,6-beta-D-glucanase (EC 3.2.1.75) (Beta-1,6-glucanase Neg1) (Glucan endo-1,6-beta-glucosidase)"	GO:0004348; GO:0005576; GO:0006665; GO:0016787; GO:0046557	"extracellular region [GO:0005576]; glucan endo-1,6-beta-glucosidase activity [GO:0046557]; glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; sphingolipid metabolic process [GO:0006665]"
PGEN_.00g006410	Scaffold_01	16099097	16127374	P43005	EAA3_HUMAN	Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Neuronal and epithelial glutamate transporter) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1)	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0010460; GO:0014047; GO:0015108; GO:0015501; GO:0015813; GO:0016020; GO:0016324; GO:0016595; GO:0030054; GO:0031901; GO:0031902; GO:0033229; GO:0042802; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0051260; GO:0051938; GO:0055038; GO:0070062; GO:0070779; GO:0098712; GO:0140009; GO:1902476	apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; identical protein binding [GO:0042802]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; positive regulation of heart rate [GO:0010460]; protein homooligomerization [GO:0051260]
PGEN_.00g006420	Scaffold_01	16148891	16165027	Q92794	KAT6A_HUMAN	"Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger protein) (Runt-related transcription factor-binding protein 2) (Zinc finger protein 220)"	GO:0000123; GO:0000786; GO:0000790; GO:0003677; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006323; GO:0006334; GO:0006473; GO:0008134; GO:0008270; GO:0016407; GO:0016573; GO:0016605; GO:0016607; GO:0030099; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0070776; GO:0090398; GO:1901796	"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cellular senescence [GO:0090398]; DNA packaging [GO:0006323]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]"
PGEN_.00g006430	Scaffold_01	16166669	16167103	NA	NA	NA	NA	NA
PGEN_.00g006440	Scaffold_01	16169040	16172757	A2ARS0	ANR63_MOUSE	Ankyrin repeat domain-containing protein 63		
PGEN_.00g006450	Scaffold_01	16175545	16177431	NA	NA	NA	NA	NA
PGEN_.00g006460	Scaffold_01	16246522	16297666	Q8VII6	CTL1_RAT	Choline transporter-like protein 1 (Solute carrier family 44 member 1) (CD antigen CD92)	GO:0015220; GO:0015871; GO:0016021	integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; choline transport [GO:0015871]
PGEN_.00g006470	Scaffold_01	16318035	16337963	O88281	MEGF6_RAT	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g006480	Scaffold_01	16355742	16356611	Q0V9X5	BHE22_XENTR	Class E basic helix-loop-helix protein 22 (bHLHe22) (Class B basic helix-loop-helix protein 5) (bHLHb5)	GO:0000981; GO:0005634; GO:0022008; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; neurogenesis [GO:0022008]"
PGEN_.00g006490	Scaffold_01	16376564	16379186	Q9HAY6	BCDO1_HUMAN	"Beta,beta-carotene 15,15'-dioxygenase (EC 1.13.11.63) (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1)"	GO:0001523; GO:0003834; GO:0004744; GO:0005829; GO:0010436; GO:0016121; GO:0035238; GO:0042572; GO:0042574; GO:0046872; GO:1901810	"cytosol [GO:0005829]; beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; retinal isomerase activity [GO:0004744]; beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; vitamin A biosynthetic process [GO:0035238]"
PGEN_.00g006500	Scaffold_01	16394002	16396947	Q9HAY6	BCDO1_HUMAN	"Beta,beta-carotene 15,15'-dioxygenase (EC 1.13.11.63) (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1)"	GO:0001523; GO:0003834; GO:0004744; GO:0005829; GO:0010436; GO:0016121; GO:0035238; GO:0042572; GO:0042574; GO:0046872; GO:1901810	"cytosol [GO:0005829]; beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; retinal isomerase activity [GO:0004744]; beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; vitamin A biosynthetic process [GO:0035238]"
PGEN_.00g006510	Scaffold_01	16426715	16427877	NA	NA	NA	NA	NA
PGEN_.00g006520	Scaffold_01	16435723	16435983	NA	NA	NA	NA	NA
PGEN_.00g006530	Scaffold_01	16455068	16455442	NA	NA	NA	NA	NA
PGEN_.00g006540	Scaffold_01	16466084	16466326	NA	NA	NA	NA	NA
PGEN_.00g006550	Scaffold_01	16467102	16467473	NA	NA	NA	NA	NA
PGEN_.00g006560	Scaffold_01	16467827	16476428	NA	NA	NA	NA	NA
PGEN_.00g006570	Scaffold_01	16487210	16489543	NA	NA	NA	NA	NA
PGEN_.00g006580	Scaffold_01	16489930	16490250	NA	NA	NA	NA	NA
PGEN_.00g006590	Scaffold_01	16507127	16508946	NA	NA	NA	NA	NA
PGEN_.00g006600	Scaffold_01	16530105	16530803	Q5PR73	DIRA2_MOUSE	GTP-binding protein Di-Ras2 (Distinct subgroup of the Ras family member 2)	GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0019003	plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]
PGEN_.00g006610	Scaffold_01	16606675	16619655	NA	NA	NA	NA	NA
PGEN_.00g006620	Scaffold_01	16678458	16679009	NA	NA	NA	NA	NA
PGEN_.00g006630	Scaffold_01	16691475	16691917	NA	NA	NA	NA	NA
PGEN_.00g006640	Scaffold_01	16696927	16697133	NA	NA	NA	NA	NA
PGEN_.00g006650	Scaffold_01	16697158	16697649	NA	NA	NA	NA	NA
PGEN_.00g006660	Scaffold_01	16697966	16698181	NA	NA	NA	NA	NA
PGEN_.00g006670	Scaffold_01	16701729	16703546	Q5BIM1	TRI45_BOVIN	Tripartite motif-containing protein 45	GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
PGEN_.00g006680	Scaffold_01	16717912	16733139	NA	NA	NA	NA	NA
PGEN_.00g006690	Scaffold_01	16722524	16722823	NA	NA	NA	NA	NA
PGEN_.00g006700	Scaffold_01	16755302	16760228	NA	NA	NA	NA	NA
PGEN_.00g006710	Scaffold_01	16765295	16765726	NA	NA	NA	NA	NA
PGEN_.00g006720	Scaffold_01	16778425	16811557	Q9H8E8	CSR2B_HUMAN	Cysteine-rich protein 2-binding protein (CSRP2-binding protein) (ADA2A-containing complex subunit 2) (ATAC2) (CRP2-binding partner) (CRP2BP) (Lysine acetyltransferase 14)	GO:0000086; GO:0004402; GO:0005634; GO:0005671; GO:0005737; GO:0016573; GO:0030274; GO:0043966	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; LIM domain binding [GO:0030274]; G2/M transition of mitotic cell cycle [GO:0000086]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]
PGEN_.00g006730	Scaffold_01	16815188	16816210	NA	NA	NA	NA	NA
PGEN_.00g006740	Scaffold_01	16816250	16823602	NA	NA	NA	NA	NA
PGEN_.00g006750	Scaffold_01	16836637	16837107	NA	NA	NA	NA	NA
PGEN_.00g006760	Scaffold_01	16844786	16845355	NA	NA	NA	NA	NA
PGEN_.00g006770	Scaffold_01	16849516	16855788	NA	NA	NA	NA	NA
PGEN_.00g006780	Scaffold_01	16855909	16856337	NA	NA	NA	NA	NA
PGEN_.00g006790	Scaffold_01	16860065	16860352	NA	NA	NA	NA	NA
PGEN_.00g006800	Scaffold_01	16877837	16886219	P12716	ACTC_PISOC	"Actin, cytoplasmic [Cleaved into: Actin, cytoplasmic, intermediate form]"	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g006810	Scaffold_01	16899442	16903015	NA	NA	NA	NA	NA
PGEN_.00g006820	Scaffold_01	16953377	16965383	NA	NA	NA	NA	NA
PGEN_.00g006830	Scaffold_01	16965423	16980220	A0JNC4	ELOV7_BOVIN	Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very long chain 3-ketoacyl-CoA synthase 7) (Very long chain 3-oxoacyl-CoA synthase 7)	GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"
PGEN_.00g006840	Scaffold_01	16995810	17033348	Q0EEE2	PTHD3_MOUSE	Patched domain-containing protein 3 (RND-type protein RNDEu-3)	GO:0016021; GO:0097225	integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]
PGEN_.00g006850	Scaffold_01	17033474	17035815	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g006860	Scaffold_01	17067371	17099392	NA	NA	NA	NA	NA
PGEN_.00g006870	Scaffold_01	17159079	17160511	NA	NA	NA	NA	NA
PGEN_.00g006880	Scaffold_01	17168482	17168988	NA	NA	NA	NA	NA
PGEN_.00g006890	Scaffold_01	17170891	17235289	Q18779	SQV7_CAEEL	UDP-sugar transporter sqv-7 (Squashed vulva protein 7)	GO:0000003; GO:0000139; GO:0002009; GO:0005459; GO:0005461; GO:0005462; GO:0005463; GO:0005737; GO:0005794; GO:0008643; GO:0009792; GO:0015014; GO:0015165; GO:0015297; GO:0015787; GO:0015789; GO:0016021; GO:0018991; GO:0022857; GO:0030206; GO:0035262; GO:0040025; GO:0072334; GO:1903354	"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643]; chondroitin sulfate biosynthetic process [GO:0030206]; embryo development ending in birth or egg hatching [GO:0009792]; gonad morphogenesis [GO:0035262]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; morphogenesis of an epithelium [GO:0002009]; oviposition [GO:0018991]; regulation of distal tip cell migration [GO:1903354]; reproduction [GO:0000003]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucuronic acid transmembrane transport [GO:0015787]; UDP-N-acetylgalactosamine transmembrane transport [GO:0015789]; vulval development [GO:0040025]"
PGEN_.00g006900	Scaffold_01	17251802	17269406	NA	NA	NA	NA	NA
PGEN_.00g006910	Scaffold_01	17277705	17278145	NA	NA	NA	NA	NA
PGEN_.00g006920	Scaffold_01	17296876	17304261	Q9VKM6	VPS72_DROME	Vacuolar protein sorting-associated protein 72 homolog (Protein YL-1)	GO:0003677; GO:0005634; GO:0006355; GO:0010629; GO:0016573; GO:0035267; GO:0043486	"NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; negative regulation of gene expression [GO:0010629]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g006930	Scaffold_01	17305262	17315688	A2A9C3	SZT2_MOUSE	KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR)	GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130	GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667]
PGEN_.00g006940	Scaffold_01	17319738	17322029	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g006950	Scaffold_01	17326135	17326416	NA	NA	NA	NA	NA
PGEN_.00g006960	Scaffold_01	17333815	17337533	P96576	YDAC_BACSU	Uncharacterized methyltransferase YdaC (EC 2.1.1.-)	GO:0008168; GO:0032259	methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g006970	Scaffold_01	17344669	17344947	NA	NA	NA	NA	NA
PGEN_.00g006980	Scaffold_01	17345286	17345843	NA	NA	NA	NA	NA
PGEN_.00g006990	Scaffold_01	17348402	17350812	P96576	YDAC_BACSU	Uncharacterized methyltransferase YdaC (EC 2.1.1.-)	GO:0008168; GO:0032259	methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g007000	Scaffold_01	17359343	17365519	P96576	YDAC_BACSU	Uncharacterized methyltransferase YdaC (EC 2.1.1.-)	GO:0008168; GO:0032259	methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g007010	Scaffold_01	17369564	17369887	NA	NA	NA	NA	NA
PGEN_.00g007020	Scaffold_01	17378484	17387022	P96576	YDAC_BACSU	Uncharacterized methyltransferase YdaC (EC 2.1.1.-)	GO:0008168; GO:0032259	methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g007030	Scaffold_01	17405249	17442922	A2A9C3	SZT2_MOUSE	KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR)	GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130	GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667]
PGEN_.00g007040	Scaffold_01	17443992	17447197	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g007050	Scaffold_01	17449070	17452908	A2A9C3	SZT2_MOUSE	KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR)	GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130	GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667]
PGEN_.00g007060	Scaffold_01	17454399	17459075	Q5T011	SZT2_HUMAN	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]
PGEN_.00g007070	Scaffold_01	17467961	17488697	A2A9C3	SZT2_MOUSE	KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR)	GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130	GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667]
PGEN_.00g007080	Scaffold_01	17494052	17529339	Q8R3N6	THOC1_MOUSE	THO complex subunit 1 (Tho1) (Nuclear matrix protein p84)	GO:0000018; GO:0000346; GO:0000347; GO:0000445; GO:0000784; GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607; GO:0031297; GO:0032784; GO:0032786; GO:0046784; GO:0048297; GO:2000002	"cytoplasm [GO:0005737]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]"
PGEN_.00g007090	Scaffold_01	17529642	17545221	Q29RL9	TCEA1_BOVIN	Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1)	GO:0003677; GO:0005634; GO:0006351; GO:0008270; GO:0045944	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g007100	Scaffold_01	17552714	17565704	Q7SYV0	SYFAB_XENLA	Phenylalanine--tRNA ligase alpha subunit B (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit B) (PheRS)	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0006432; GO:0009328; GO:0051290	cytoplasm [GO:0005737]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]
PGEN_.00g007110	Scaffold_01	17565992	17569498	Q8HXX8	GCDH_MACFA	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)"	GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0044466; GO:0050660	mitochondrial matrix [GO:0005759]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; glutaryl-CoA hydrolase activity [GO:0044466]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; tryptophan metabolic process [GO:0006568]
PGEN_.00g007120	Scaffold_01	17570490	17579123	P81140	GCDH_PIG	"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6) (Fragment)"	GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0044466; GO:0050660	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; glutaryl-CoA hydrolase activity [GO:0044466]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; tryptophan metabolic process [GO:0006568]
PGEN_.00g007130	Scaffold_01	17597787	17598287	P24585	DEG1_CAEEL	Degenerin deg-1 (Degeneration of certain neurons protein 1)	GO:0005272; GO:0010447; GO:0016021; GO:0043200	integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; response to acidic pH [GO:0010447]; response to amino acid [GO:0043200]
PGEN_.00g007140	Scaffold_01	17602841	17603179	P37091	SCNNG_RAT	Amiloride-sensitive sodium channel subunit gamma (Epithelial Na(+) channel subunit gamma) (Gamma-ENaC) (Gamma-NaCH) (Nonvoltage-gated sodium channel 1 subunit gamma) (SCNEG)	GO:0001666; GO:0005216; GO:0005887; GO:0006814; GO:0009897; GO:0009986; GO:0015280; GO:0016020; GO:0016021; GO:0016324; GO:0034706; GO:0035313; GO:0035725; GO:0050699; GO:0050891; GO:0050909; GO:0055078; GO:0070062	"apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; sodium channel complex [GO:0034706]; ion channel activity [GO:0005216]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]; multicellular organismal water homeostasis [GO:0050891]; response to hypoxia [GO:0001666]; sensory perception of taste [GO:0050909]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; wound healing, spreading of epidermal cells [GO:0035313]"
PGEN_.00g007150	Scaffold_01	17603234	17621999	Q09274	UN105_CAEEL	Degenerin-like protein unc-105 (Uncoordinated protein 105)	GO:0005216; GO:0005272; GO:0006816; GO:0007517; GO:0015693; GO:0016021; GO:0030154	integral component of membrane [GO:0016021]; ion channel activity [GO:0005216]; sodium channel activity [GO:0005272]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; magnesium ion transport [GO:0015693]; muscle organ development [GO:0007517]
PGEN_.00g007160	Scaffold_01	17623479	17640972	NA	NA	NA	NA	NA
PGEN_.00g007170	Scaffold_01	17650338	17652503	Q40593	VDE_TOBAC	"Violaxanthin de-epoxidase, chloroplastic (EC 1.23.5.1)"	GO:0009535; GO:0046422	chloroplast thylakoid membrane [GO:0009535]; violaxanthin de-epoxidase activity [GO:0046422]
PGEN_.00g007180	Scaffold_01	17656502	17663049	NA	NA	NA	NA	NA
PGEN_.00g007190	Scaffold_01	17689888	17697573	Q0VAA2	LR74A_HUMAN	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g007200	Scaffold_01	17714055	17716204	Q8CGF5	TLCD4_MOUSE	TLC domain-containing protein 4 (Transmembrane protein 56)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g007210	Scaffold_01	17732425	17733886	Q96F25	ALG14_HUMAN	UDP-N-acetylglucosamine transferase subunit ALG14 homolog	GO:0005789; GO:0006488; GO:0016021; GO:0031965; GO:0043541	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]
PGEN_.00g007220	Scaffold_01	17739519	17770571	NA	NA	NA	NA	NA
PGEN_.00g007230	Scaffold_01	17819325	17824493	NA	NA	NA	NA	NA
PGEN_.00g007240	Scaffold_01	17830000	17831256	NA	NA	NA	NA	NA
PGEN_.00g007250	Scaffold_01	17832941	17833747	NA	NA	NA	NA	NA
PGEN_.00g007260	Scaffold_01	17851563	17859163	O42123	FKB1A_XENLA	Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase)	GO:0000413; GO:0001933; GO:0003007; GO:0003755; GO:0005528; GO:0005623; GO:0005737; GO:0005829; GO:0006936; GO:0007183; GO:0008144; GO:0014802; GO:0016020; GO:0019221; GO:0019855; GO:0030018; GO:0031000; GO:0031312; GO:0031398; GO:0032092; GO:0032515; GO:0032880; GO:0032925; GO:0033017; GO:0042098; GO:0042803; GO:0043123; GO:0044325; GO:0046332; GO:0048185; GO:0050776; GO:0051209; GO:0051280; GO:0055010; GO:0060314; GO:0060315; GO:0060347; GO:0070062; GO:0097435; GO:0098562; GO:1902991; GO:1990000; GO:1990425	cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum membrane [GO:0033017]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; activin binding [GO:0048185]; calcium channel inhibitor activity [GO:0019855]; drug binding [GO:0008144]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; amyloid fibril formation [GO:1990000]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]
PGEN_.00g007270	Scaffold_01	17861068	17861337	NA	NA	NA	NA	NA
PGEN_.00g007280	Scaffold_01	17874308	17874511	NA	NA	NA	NA	NA
PGEN_.00g007290	Scaffold_01	17874613	17874954	NA	NA	NA	NA	NA
PGEN_.00g007300	Scaffold_01	17915518	18009266	B4F785	EGFLA_RAT	"Pikachurin (EGF-like, fibronectin type-III and laminin G-like domain-containing protein)"	GO:0005509; GO:0005539; GO:0005604; GO:0005614; GO:0008045; GO:0009887; GO:0009888; GO:0009986; GO:0010811; GO:0016358; GO:0019800; GO:0030054; GO:0030198; GO:0031012; GO:0042995; GO:0043083; GO:0048786	basement membrane [GO:0005604]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; interstitial matrix [GO:0005614]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; extracellular matrix organization [GO:0030198]; motor neuron axon guidance [GO:0008045]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; tissue development [GO:0009888]
PGEN_.00g007310	Scaffold_01	18025497	18047312	Q8MSU3	FRRS1_DROME	Putative ferric-chelate reductase 1 homolog (DmSDR2) (EC 1.-.-.-)	GO:0000293; GO:0016021; GO:0055114	integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; oxidation-reduction process [GO:0055114]
PGEN_.00g007320	Scaffold_01	18130645	18152291	NA	NA	NA	NA	NA
PGEN_.00g007330	Scaffold_01	18162626	18170649	Q08AN1	ZN616_HUMAN	Zinc finger protein 616	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g007340	Scaffold_01	18195064	18316661	Q08499	PDE4D_HUMAN	"cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43)"	GO:0002027; GO:0004114; GO:0004115; GO:0005813; GO:0005829; GO:0005886; GO:0005891; GO:0006198; GO:0006939; GO:0007186; GO:0007568; GO:0008144; GO:0010469; GO:0010880; GO:0016020; GO:0016324; GO:0019899; GO:0019933; GO:0030552; GO:0030593; GO:0031625; GO:0031698; GO:0032729; GO:0032743; GO:0032754; GO:0033137; GO:0034704; GO:0035264; GO:0043951; GO:0044325; GO:0045822; GO:0046872; GO:0050852; GO:0051117; GO:0060314; GO:0061028; GO:0071222; GO:0071320; GO:0071872; GO:0071875; GO:0086004; GO:0086024; GO:0097110; GO:1901844; GO:1901898	"apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate [GO:0086024]; adrenergic receptor signaling pathway [GO:0071875]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of signaling receptor activity [GO:0010469]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]"
PGEN_.00g007350	Scaffold_01	18323701	18323973	NA	NA	NA	NA	NA
PGEN_.00g007360	Scaffold_01	18324509	18324757	NA	NA	NA	NA	NA
PGEN_.00g007370	Scaffold_01	18360243	18360806	NA	NA	NA	NA	NA
PGEN_.00g007380	Scaffold_01	18395172	18398667	NA	NA	NA	NA	NA
PGEN_.00g007390	Scaffold_01	18422632	18444171	P12252	PDE4B_DROME	"cAMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.53) (Learning/memory process protein) (Protein dunce)"	GO:0000003; GO:0001661; GO:0004115; GO:0005634; GO:0006198; GO:0007268; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008306; GO:0008355; GO:0010738; GO:0019933; GO:0040040; GO:0043951; GO:0045202; GO:0045475; GO:0046872; GO:0046958; GO:0048149; GO:0048675	"nucleus [GO:0005634]; synapse [GO:0045202]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]; anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; behavioral response to ethanol [GO:0048149]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; mating behavior [GO:0007617]; memory [GO:0007613]; negative regulation of cAMP-mediated signaling [GO:0043951]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; regulation of protein kinase A signaling [GO:0010738]; reproduction [GO:0000003]; short-term memory [GO:0007614]; thermosensory behavior [GO:0040040]"
PGEN_.00g007400	Scaffold_01	18465944	18466495	NA	NA	NA	NA	NA
PGEN_.00g007410	Scaffold_01	18581688	18582507	NA	NA	NA	NA	NA
PGEN_.00g007420	Scaffold_01	18658234	18658476	NA	NA	NA	NA	NA
PGEN_.00g007430	Scaffold_01	18682089	18682295	NA	NA	NA	NA	NA
PGEN_.00g007440	Scaffold_01	18686833	18689991	NA	NA	NA	NA	NA
PGEN_.00g007450	Scaffold_01	18692678	18694634	NA	NA	NA	NA	NA
PGEN_.00g007460	Scaffold_01	18708290	18708550	NA	NA	NA	NA	NA
PGEN_.00g007470	Scaffold_01	18789018	18789347	NA	NA	NA	NA	NA
PGEN_.00g007480	Scaffold_01	18789628	18790465	NA	NA	NA	NA	NA
PGEN_.00g007490	Scaffold_01	18805750	18806181	NA	NA	NA	NA	NA
PGEN_.00g007500	Scaffold_01	18843807	18871688	NA	NA	NA	NA	NA
PGEN_.00g007510	Scaffold_01	18883468	18883668	NA	NA	NA	NA	NA
PGEN_.00g007520	Scaffold_01	18898111	18906973	Q9NYY3	PLK2_HUMAN	Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase)	GO:0000082; GO:0000278; GO:0000785; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006468; GO:0006977; GO:0007052; GO:0007093; GO:0007265; GO:0007613; GO:0010508; GO:0016525; GO:0018105; GO:0030425; GO:0032092; GO:0032436; GO:0032465; GO:0032486; GO:0043008; GO:0043066; GO:0043123; GO:0044877; GO:0045732; GO:0046599; GO:0048167; GO:0060291; GO:0060292; GO:0061000; GO:0071866; GO:0090050; GO:2000773	"centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; G1/S transition of mitotic cell cycle [GO:0000082]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitotic cell cycle [GO:0000278]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of cellular senescence [GO:2000773]; negative regulation of dendritic spine development [GO:0061000]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein phosphorylation [GO:0006468]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of centriole replication [GO:0046599]; regulation of cytokinesis [GO:0032465]; regulation of synaptic plasticity [GO:0048167]"
PGEN_.00g007530	Scaffold_01	18941748	18949260	NA	NA	NA	NA	NA
PGEN_.00g007540	Scaffold_01	18966509	18989939	Q5R9T5	SPTC1_PONAB	Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1)	GO:0004758; GO:0006665; GO:0009058; GO:0016021; GO:0030170; GO:0035339; GO:1904649	integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; biosynthetic process [GO:0009058]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g007550	Scaffold_01	18991546	18996710	NA	NA	NA	NA	NA
PGEN_.00g007560	Scaffold_01	18996968	18997330	NA	NA	NA	NA	NA
PGEN_.00g007570	Scaffold_01	18998749	19009246	NA	NA	NA	NA	NA
PGEN_.00g007580	Scaffold_01	19030057	19030347	NA	NA	NA	NA	NA
PGEN_.00g007590	Scaffold_01	19039719	19040111	NA	NA	NA	NA	NA
PGEN_.00g007600	Scaffold_01	19051496	19055456	NA	NA	NA	NA	NA
PGEN_.00g007610	Scaffold_01	19060027	19081148	Q7T0Q5	NOL10_XENLA	Nucleolar protein 10	GO:0005730	nucleolus [GO:0005730]
PGEN_.00g007620	Scaffold_01	19084484	19088307	Q5BK60	KLH38_RAT	Kelch-like protein 38		
PGEN_.00g007630	Scaffold_01	19091702	19128324	Q9BE72	GTR12_MACFA	"Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12) (GLUT-12)"	GO:0005886; GO:0008643; GO:0012505; GO:0016021; GO:0022857; GO:0048471	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]
PGEN_.00g007640	Scaffold_01	19139000	19144538	Q96DM1	PGBD4_HUMAN	PiggyBac transposable element-derived protein 4		
PGEN_.00g007650	Scaffold_01	19144866	19156475	NA	NA	NA	NA	NA
PGEN_.00g007660	Scaffold_01	19157345	19157560	NA	NA	NA	NA	NA
PGEN_.00g007670	Scaffold_01	19157819	19159854	NA	NA	NA	NA	NA
PGEN_.00g007680	Scaffold_01	19173101	19173948	NA	NA	NA	NA	NA
PGEN_.00g007690	Scaffold_01	19197648	19259844	NA	NA	NA	NA	NA
PGEN_.00g007700	Scaffold_01	19342019	19342408	NA	NA	NA	NA	NA
PGEN_.00g007710	Scaffold_01	19359370	19364384	NA	NA	NA	NA	NA
PGEN_.00g007720	Scaffold_01	19377169	19458888	P23727	P85A_BOVIN	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	GO:0001678; GO:0001784; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005168; GO:0005623; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0006606; GO:0008134; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0019903; GO:0030183; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0042307; GO:0042802; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0050821; GO:0051492; GO:0060396; GO:1900103; GO:1903078; GO:1990578	"cell [GO:0005623]; cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transcription factor binding [GO:0008134]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of glucose import [GO:0046326]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]"
PGEN_.00g007730	Scaffold_01	19469656	19470186	NA	NA	NA	NA	NA
PGEN_.00g007740	Scaffold_01	19473492	19510625	NA	NA	NA	NA	NA
PGEN_.00g007750	Scaffold_01	19511983	19516141	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g007760	Scaffold_01	19521443	19550452	NA	NA	NA	NA	NA
PGEN_.00g007770	Scaffold_01	19562652	19565183	Q0V9J0	TMM69_XENTR	Transmembrane protein 69	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g007780	Scaffold_01	19577249	19579818	Q13351	KLF1_HUMAN	Krueppel-like factor 1 (Erythroid krueppel-like transcription factor) (EKLF)	GO:0000790; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0030218; GO:0044212; GO:0045893; GO:0046872; GO:0060135; GO:1901653	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; transcription regulatory region DNA binding [GO:0044212]; cellular response to peptide [GO:1901653]; erythrocyte differentiation [GO:0030218]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g007790	Scaffold_01	19604664	19605038	NA	NA	NA	NA	NA
PGEN_.00g007800	Scaffold_01	19655691	19703939	NA	NA	NA	NA	NA
PGEN_.00g007810	Scaffold_01	19715761	19726497	NA	NA	NA	NA	NA
PGEN_.00g007820	Scaffold_01	19757567	19759314	NA	NA	NA	NA	NA
PGEN_.00g007830	Scaffold_01	19759640	19759888	NA	NA	NA	NA	NA
PGEN_.00g007840	Scaffold_01	19759980	19763356	NA	NA	NA	NA	NA
PGEN_.00g007850	Scaffold_01	19768667	19769968	NA	NA	NA	NA	NA
PGEN_.00g007860	Scaffold_01	19770707	19772944	P53478	ACT5_CHICK	"Actin, cytoplasmic type 5"	GO:0005524; GO:0005856; GO:0005884; GO:0005886; GO:0005925; GO:0048488; GO:0097433; GO:0098793; GO:0098973	actin filament [GO:0005884]; cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g007870	Scaffold_01	19789621	19794144	P41340	ACT3_LIMPO	Actin-3	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g007880	Scaffold_01	19800483	19804989	P12716	ACTC_PISOC	"Actin, cytoplasmic [Cleaved into: Actin, cytoplasmic, intermediate form]"	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g007890	Scaffold_01	19809892	19810485	NA	NA	NA	NA	NA
PGEN_.00g007900	Scaffold_01	19810530	19810841	NA	NA	NA	NA	NA
PGEN_.00g007910	Scaffold_01	19811041	19812492	NA	NA	NA	NA	NA
PGEN_.00g007920	Scaffold_01	19812530	19812871	NA	NA	NA	NA	NA
PGEN_.00g007930	Scaffold_01	19822841	19826861	Q0VE29	SAM12_MOUSE	Sterile alpha motif domain-containing protein 12 (SAM domain-containing protein 12)		
PGEN_.00g007940	Scaffold_01	19834488	19837966	Q7Z5L3	C1QL2_HUMAN	Complement C1q-like protein 2 (C1q and tumor necrosis factor-related protein 10) (C1q/TNF-related protein 10)	GO:0005576; GO:0005581; GO:0042802	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]
PGEN_.00g007950	Scaffold_01	19851438	19852799	NA	NA	NA	NA	NA
PGEN_.00g007960	Scaffold_01	19876232	19883492	NA	NA	NA	NA	NA
PGEN_.00g007970	Scaffold_01	19900518	19913600	Q9NQT5	EXOS3_HUMAN	Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10)	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0034427; GO:0034475; GO:0035327; GO:0043488; GO:0043928; GO:0045006; GO:0045190; GO:0045830; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"
PGEN_.00g007980	Scaffold_01	19917223	19928812	Q6DC04	CARM1_DANRE	Histone-arginine methyltransferase CARM1 (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4)	GO:0003713; GO:0005634; GO:0005829; GO:0008757; GO:0016274; GO:0030374; GO:0033146; GO:0034969; GO:0034971; GO:0035242; GO:0035642; GO:0042054; GO:0044212; GO:0045600; GO:0048742; GO:0070577	cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; histone arginine methylation [GO:0034969]; histone H3-R17 methylation [GO:0034971]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of skeletal muscle fiber development [GO:0048742]
PGEN_.00g007990	Scaffold_01	19955727	19959370	NA	NA	NA	NA	NA
PGEN_.00g008000	Scaffold_01	19968828	20014821	Q96MU7	YTDC1_HUMAN	YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B)	GO:0003723; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:1990247	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]"
PGEN_.00g008010	Scaffold_01	20016635	20031771	Q503V9	ENDUB_DANRE	Poly(U)-specific endoribonuclease-B (EC 3.1.-.-) (Protein endoU-B) (Uridylate-specific endoribonuclease-B)	GO:0003723; GO:0004521; GO:0046872	endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]
PGEN_.00g008020	Scaffold_01	20037000	20047698	Q6NYX8	PITH1_DANRE	PITH domain-containing protein 1	GO:0005634; GO:0005737; GO:0045654; GO:0045893	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g008030	Scaffold_01	20085937	20113770	Q07598	NLTP_CHICK	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X) (Fragment)	GO:0005739; GO:0005777; GO:0006869; GO:0008289; GO:0032385; GO:0033814; GO:0050632	mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; lipid transport [GO:0006869]; positive regulation of intracellular cholesterol transport [GO:0032385]
PGEN_.00g008040	Scaffold_01	20123365	20229166	Q6KCD5	NIPBL_MOUSE	Nipped-B-like protein (Delangin homolog) (SCC2 homolog)	GO:0000122; GO:0000228; GO:0000785; GO:0000790; GO:0003007; GO:0003151; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006357; GO:0006974; GO:0007064; GO:0007076; GO:0007420; GO:0007507; GO:0007605; GO:0008022; GO:0019827; GO:0031065; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0034613; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045892; GO:0045944; GO:0045995; GO:0047485; GO:0048557; GO:0048589; GO:0048592; GO:0048638; GO:0048701; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0070087; GO:0070550; GO:0071169; GO:0071481; GO:0071733; GO:0071921; GO:0090694; GO:1905406; GO:1990414; GO:2001224	"chromatin [GO:0000785]; cytosol [GO:0005829]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; double-strand break repair [GO:0006302]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of mitotic cohesin loading [GO:1905406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA condensation [GO:0070550]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transcriptional activation by promoter-enhancer looping [GO:0071733]; uterus morphogenesis [GO:0061038]"
PGEN_.00g008050	Scaffold_01	20235505	20235900	NA	NA	NA	NA	NA
PGEN_.00g008060	Scaffold_01	20237039	20254841	Q8CFF0	PAR11_MOUSE	Protein mono-ADP-ribosyltransferase PARP11 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 11) (ARTD11) (Poly [ADP-ribose] polymerase 11) (PARP-11)	GO:0003950; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006998; GO:0007283; GO:0015031; GO:0016604; GO:0030154; GO:0051028; GO:0070213; GO:0140289; GO:1990404	cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]
PGEN_.00g008070	Scaffold_01	20287090	20320408	Q8CFF0	PAR11_MOUSE	Protein mono-ADP-ribosyltransferase PARP11 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 11) (ARTD11) (Poly [ADP-ribose] polymerase 11) (PARP-11)	GO:0003950; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006998; GO:0007283; GO:0015031; GO:0016604; GO:0030154; GO:0051028; GO:0070213; GO:0140289; GO:1990404	cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]
PGEN_.00g008080	Scaffold_01	20329294	20354610	Q9NQI0	DDX4_HUMAN	Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog)	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007275; GO:0007276; GO:0007283; GO:0010529; GO:0016887; GO:0030154; GO:0030317; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:1990511	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; flagellated sperm motility [GO:0030317]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
PGEN_.00g008090	Scaffold_01	20356918	20368229	NA	NA	NA	NA	NA
PGEN_.00g008100	Scaffold_01	20435042	20435341	NA	NA	NA	NA	NA
PGEN_.00g008110	Scaffold_01	20446847	20482089	NA	NA	NA	NA	NA
PGEN_.00g008120	Scaffold_01	20499029	20505726	NA	NA	NA	NA	NA
PGEN_.00g008130	Scaffold_01	20558005	20744692	P16621	LAR_DROME	Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)	GO:0004725; GO:0005001; GO:0005925; GO:0006470; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0016021; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0035335; GO:0045467; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0120034; GO:1903386	axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; peptidyl-tyrosine dephosphorylation [GO:0035335]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; protein dephosphorylation [GO:0006470]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124]
PGEN_.00g008140	Scaffold_01	20640315	20640629	NA	NA	NA	NA	NA
PGEN_.00g008150	Scaffold_01	20712981	20713367	NA	NA	NA	NA	NA
PGEN_.00g008160	Scaffold_01	20789881	20790450	NA	NA	NA	NA	NA
PGEN_.00g008170	Scaffold_01	20821060	20821335	NA	NA	NA	NA	NA
PGEN_.00g008180	Scaffold_01	20870040	20871197	NA	NA	NA	NA	NA
PGEN_.00g008190	Scaffold_01	20886760	20887347	NA	NA	NA	NA	NA
PGEN_.00g008200	Scaffold_01	20888463	20889029	NA	NA	NA	NA	NA
PGEN_.00g008210	Scaffold_01	20894728	20895246	NA	NA	NA	NA	NA
PGEN_.00g008220	Scaffold_01	20917580	20917903	NA	NA	NA	NA	NA
PGEN_.00g008230	Scaffold_01	20928441	20928956	NA	NA	NA	NA	NA
PGEN_.00g008240	Scaffold_01	21016933	21017505	NA	NA	NA	NA	NA
PGEN_.00g008250	Scaffold_01	21024871	21025404	NA	NA	NA	NA	NA
PGEN_.00g008260	Scaffold_01	21044505	21045332	NA	NA	NA	NA	NA
PGEN_.00g008270	Scaffold_01	21051889	21127302	NA	NA	NA	NA	NA
PGEN_.00g008280	Scaffold_01	21140942	21141346	NA	NA	NA	NA	NA
PGEN_.00g008290	Scaffold_01	21141377	21141781	NA	NA	NA	NA	NA
PGEN_.00g008300	Scaffold_01	21170604	21203310	Q5M8U1	ELOV5_XENTR	Elongation of very long chain fatty acids protein 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase elovl5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5)	GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0043025; GO:0097447; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"dendrite [GO:0030425]; dendritic tree [GO:0097447]; integral component of endoplasmic reticulum membrane [GO:0030176]; neuronal cell body [GO:0043025]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"
PGEN_.00g008310	Scaffold_01	21208365	21209866	NA	NA	NA	NA	NA
PGEN_.00g008320	Scaffold_01	21212688	21264751	F6PTN1	TIKI1_XENTR	Metalloprotease TIKI1 (EC 3.4.-.-) (TRAB domain-containing protein 2A)	GO:0004222; GO:0005887; GO:0006508; GO:0016020; GO:0016055; GO:0017147; GO:0030178; GO:0031301; GO:0046872; GO:0060322	integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147]; head development [GO:0060322]; negative regulation of Wnt signaling pathway [GO:0030178]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055]
PGEN_.00g008330	Scaffold_01	21271581	21271967	NA	NA	NA	NA	NA
PGEN_.00g008340	Scaffold_01	21276591	21277843	NA	NA	NA	NA	NA
PGEN_.00g008350	Scaffold_01	21319948	21335950	Q9NXG6	P4HTM_HUMAN	Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)	GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0016706; GO:0018401; GO:0031418; GO:0045646	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646]
PGEN_.00g008360	Scaffold_01	21338425	21367366	Q9V6L0	KDM4B_DROME	Probable lysine-specific demethylase 4B (EC 1.14.11.-) (Probable JmjC domain-containing histone demethylation protein 3B)	GO:0005634; GO:0006338; GO:0016577; GO:0032452; GO:0032454; GO:0033169; GO:0035097; GO:0045892; GO:0046872; GO:0051864; GO:0070544	"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g008370	Scaffold_01	21376381	21389902	O75167	PHAR2_HUMAN	Phosphatase and actin regulator 2	GO:0002576; GO:0003779; GO:0004864; GO:0005886; GO:0031092	plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; actin binding [GO:0003779]; protein phosphatase inhibitor activity [GO:0004864]; platelet degranulation [GO:0002576]
PGEN_.00g008380	Scaffold_01	21395349	21424425	Q501J7	PHAR4_MOUSE	Phosphatase and actin regulator 4 (Protein Humpty dumpty) (Humdy)	GO:0001755; GO:0001843; GO:0003779; GO:0004864; GO:0005737; GO:0007266; GO:0008157; GO:0030027; GO:0030036; GO:0043085; GO:0048484; GO:0051726; GO:0061386; GO:0072542; GO:2001045	cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase activator activity [GO:0072542]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton organization [GO:0030036]; closure of optic fissure [GO:0061386]; enteric nervous system development [GO:0048484]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of catalytic activity [GO:0043085]; regulation of cell cycle [GO:0051726]; Rho protein signal transduction [GO:0007266]
PGEN_.00g008390	Scaffold_01	21470527	21476979	O08992	SDCB1_MOUSE	Syntenin-1 (Scaffold protein Pbp1) (Syndecan-binding protein 1)	GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005925; GO:0007265; GO:0007268; GO:0007346; GO:0008022; GO:0008284; GO:0010718; GO:0010862; GO:0019838; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0042043; GO:0042327; GO:0042470; GO:0042802; GO:0042803; GO:0044877; GO:0045121; GO:0045202; GO:0045545; GO:0046875; GO:0046982; GO:0047485; GO:0050839; GO:0070062; GO:0099054; GO:1903543; GO:1903553	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]"
PGEN_.00g008400	Scaffold_01	21496470	21532736	Q02977	YRK_CHICK	Proto-oncogene tyrosine-protein kinase Yrk (EC 2.7.10.2) (Yes-related kinase) (p60-Yrk)	GO:0001784; GO:0004715; GO:0005102; GO:0005524; GO:0007169; GO:0007229; GO:0008360; GO:0014068; GO:0015629; GO:0016235; GO:0019901; GO:0030154; GO:0030282; GO:0030335; GO:0031234; GO:0032587; GO:0032815; GO:0034988; GO:0038083; GO:0042127; GO:0043306; GO:0043552; GO:0045088; GO:0045859; GO:0048705; GO:0050715; GO:0050764; GO:0050830	actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; Fc-gamma receptor I complex binding [GO:0034988]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of natural killer cell activation [GO:0032815]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of innate immune response [GO:0045088]; regulation of phagocytosis [GO:0050764]; regulation of protein kinase activity [GO:0045859]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g008410	Scaffold_01	21534071	21535176	NA	NA	NA	NA	NA
PGEN_.00g008420	Scaffold_01	21557587	21557901	NA	NA	NA	NA	NA
PGEN_.00g008430	Scaffold_01	21564229	21578543	B5X186	CALUA_SALSA	Calumenin-A	GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]
PGEN_.00g008440	Scaffold_01	21585946	21604800	O60306	AQR_HUMAN	RNA helicase aquarius (EC 3.6.4.13) (Intron-binding protein of 160 kDa) (IBP160)	GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0006283; GO:0016020; GO:0071007; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283]"
PGEN_.00g008450	Scaffold_01	21612957	21613916	NA	NA	NA	NA	NA
PGEN_.00g008460	Scaffold_01	21618498	21631091	NA	NA	NA	NA	NA
PGEN_.00g008470	Scaffold_01	21643764	21647913	Q9VHI4	SF3B5_DROME	Splicing factor 3B subunit 5 (Pre-mRNA-splicing factor SF3b 10 kDa subunit)	GO:0000124; GO:0000398; GO:0005686; GO:0007283; GO:0010468; GO:0071011	"precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U2 snRNP [GO:0005686]; mRNA splicing, via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]"
PGEN_.00g008480	Scaffold_01	21653404	21657059	Q7KIN0	TOLL7_DROME	Toll-like receptor 7	GO:0002752; GO:0005030; GO:0005615; GO:0007411; GO:0008329; GO:0009897; GO:0010508; GO:0016021; GO:0031012; GO:0045087; GO:0046790; GO:0050688; GO:0051607	external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neurotrophin receptor activity [GO:0005030]; signaling pattern recognition receptor activity [GO:0008329]; virion binding [GO:0046790]; axon guidance [GO:0007411]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; regulation of defense response to virus [GO:0050688]
PGEN_.00g008490	Scaffold_01	21664439	21672533	P18754	RCC1_HUMAN	Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1)	GO:0000082; GO:0000785; GO:0000790; GO:0000794; GO:0003682; GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007059; GO:0007088; GO:0008536; GO:0016032; GO:0031491; GO:0031492; GO:0031965; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051290; GO:0051301	chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; protein heterotetramerization [GO:0051290]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032]
PGEN_.00g008500	Scaffold_01	21679058	21720103	NA	NA	NA	NA	NA
PGEN_.00g008510	Scaffold_01	21768232	21772648	NA	NA	NA	NA	NA
PGEN_.00g008520	Scaffold_01	21784289	21784537	NA	NA	NA	NA	NA
PGEN_.00g008530	Scaffold_01	21847568	21918435	Q9C0A0	CNTP4_HUMAN	Contactin-associated protein-like 4 (Cell recognition molecule Caspr4)	GO:0007155; GO:0016021; GO:0030054; GO:0032225; GO:0032228; GO:0042734; GO:0042995; GO:2000821	"cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]; cell adhesion [GO:0007155]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228]"
PGEN_.00g008540	Scaffold_01	21928303	21978649	Q2IA00	SPEF2_PIG	Sperm flagellar protein 2 (Protein KPL2)	GO:0005794; GO:0007283; GO:0030154	Golgi apparatus [GO:0005794]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]
PGEN_.00g008550	Scaffold_01	22013975	22038511	Q8K4R9	DLGP5_MOUSE	Disks large-associated protein 5 (DAP-5) (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein homolog) (HURP)	GO:0004721; GO:0005634; GO:0005739; GO:0005829; GO:0007049; GO:0023052; GO:0031616; GO:0034451	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; phosphoprotein phosphatase activity [GO:0004721]; cell cycle [GO:0007049]; signaling [GO:0023052]
PGEN_.00g008560	Scaffold_01	22040027	22128884	NA	NA	NA	NA	NA
PGEN_.00g008570	Scaffold_01	22135031	22140999	Q6DHN0	TMM53_DANRE	Transmembrane protein 53	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g008580	Scaffold_01	22141316	22146198	A7MBF6	ARMD1_BOVIN	Armadillo-like helical domain containing protein 1		
PGEN_.00g008590	Scaffold_01	22151998	22189133	Q8IWG1	WDR63_HUMAN	WD repeat-containing protein 63 (Testis development protein NYD-SP29)	GO:0007018; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0060294	inner dynein arm [GO:0036156]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]
PGEN_.00g008600	Scaffold_01	22192648	22204935	Q6DFK0	S38A9_XENLA	Sodium-coupled neutral amino acid transporter 9 (Solute carrier family 38 member 9)	GO:0003333; GO:0005764; GO:0005765; GO:0005770; GO:0015171; GO:0016021; GO:0031902; GO:0032008; GO:0046872; GO:0071230	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; amino acid transmembrane transporter activity [GO:0015171]; metal ion binding [GO:0046872]; amino acid transmembrane transport [GO:0003333]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]
PGEN_.00g008610	Scaffold_01	22208026	22209303	P26152	ACHA5_CHICK	Neuronal acetylcholine receptor subunit alpha-5	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g008620	Scaffold_01	22228863	22230221	Q9U298	ACH8_CAEEL	Neuronal acetylcholine receptor subunit eat-2 (Abnormal pharyngeal pumping eat-2)	GO:0001508; GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007274; GO:0008340; GO:0010628; GO:0010629; GO:0022848; GO:0030054; GO:0030536; GO:0031594; GO:0034220; GO:0040014; GO:0042391; GO:0043005; GO:0043050; GO:0043051; GO:0045202; GO:0045211; GO:0048609; GO:0050877; GO:0060378; GO:0061063; GO:1904000	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; action potential [GO:0001508]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; ion transmembrane transport [GO:0034220]; larval feeding behavior [GO:0030536]; multicellular organismal reproductive process [GO:0048609]; negative regulation of gene expression [GO:0010629]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; pharyngeal pumping [GO:0043050]; positive regulation of eating behavior [GO:1904000]; positive regulation of gene expression [GO:0010628]; positive regulation of nematode larval development [GO:0061063]; regulation of brood size [GO:0060378]; regulation of membrane potential [GO:0042391]; regulation of multicellular organism growth [GO:0040014]; regulation of pharyngeal pumping [GO:0043051]; signal transduction [GO:0007165]
PGEN_.00g008630	Scaffold_01	22236308	22252917	Q19425	S38A9_CAEEL	Sodium-coupled neutral amino acid transporter 9 homolog	GO:0003333; GO:0005765; GO:0015171; GO:0016021; GO:0031902; GO:0046872	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; amino acid transmembrane transporter activity [GO:0015171]; metal ion binding [GO:0046872]; amino acid transmembrane transport [GO:0003333]
PGEN_.00g008640	Scaffold_01	22264926	22276434	Q9D0F9	PGM1_MOUSE	Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1) (Phosphoglucomutase-2)	GO:0000287; GO:0004614; GO:0005737; GO:0005829; GO:0005978; GO:0006006; GO:0019388; GO:0030018	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Z disc [GO:0030018]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]
PGEN_.00g008650	Scaffold_01	22283134	22291704	NA	NA	NA	NA	NA
PGEN_.00g008660	Scaffold_01	22301034	22383392	Q60675	LAMA2_MOUSE	Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain)	GO:0005102; GO:0005576; GO:0005604; GO:0005615; GO:0007155; GO:0007411; GO:0009887; GO:0009888; GO:0014037; GO:0030155; GO:0030334; GO:0031594; GO:0032224; GO:0042383; GO:0043083; GO:0043197; GO:0045995; GO:0062023	"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]; tissue development [GO:0009888]"
PGEN_.00g008670	Scaffold_01	22411397	22419088	NA	NA	NA	NA	NA
PGEN_.00g008680	Scaffold_01	22454119	22454451	NA	NA	NA	NA	NA
PGEN_.00g008690	Scaffold_01	22454984	22455830	NA	NA	NA	NA	NA
PGEN_.00g008700	Scaffold_01	22510350	22512607	NA	NA	NA	NA	NA
PGEN_.00g008710	Scaffold_01	22579524	22581624	NA	NA	NA	NA	NA
PGEN_.00g008720	Scaffold_01	22583434	22584813	NA	NA	NA	NA	NA
PGEN_.00g008730	Scaffold_01	22608961	22692162	O43614	OX2R_HUMAN	Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2)	GO:0004930; GO:0005623; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007268; GO:0007631; GO:0008188; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0045202; GO:0051480	"cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; cellular response to hormone stimulus [GO:0032870]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]"
PGEN_.00g008740	Scaffold_01	22671497	22671724	NA	NA	NA	NA	NA
PGEN_.00g008750	Scaffold_01	22746165	22750793	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g008760	Scaffold_01	22750828	22752510	NA	NA	NA	NA	NA
PGEN_.00g008770	Scaffold_01	22752559	22757248	Q9H8W5	TRI45_HUMAN	Tripartite motif-containing protein 45 (RING finger protein 99)	GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
PGEN_.00g008780	Scaffold_01	22772037	22773542	NA	NA	NA	NA	NA
PGEN_.00g008790	Scaffold_01	22775791	22776084	NA	NA	NA	NA	NA
PGEN_.00g008800	Scaffold_01	22784357	22785311	NA	NA	NA	NA	NA
PGEN_.00g008810	Scaffold_01	22881318	22882611	NA	NA	NA	NA	NA
PGEN_.00g008820	Scaffold_01	22900413	22914121	A4QNP7	DMTA2_XENTR	Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5)	GO:0003700; GO:0005634; GO:0042803; GO:0043565; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]
PGEN_.00g008830	Scaffold_01	22916440	22917647	NA	NA	NA	NA	NA
PGEN_.00g008840	Scaffold_01	22934745	22935098	NA	NA	NA	NA	NA
PGEN_.00g008850	Scaffold_01	22942938	22960419	P27986	P85A_HUMAN	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	GO:0001678; GO:0001784; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005168; GO:0005623; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0006606; GO:0006661; GO:0007173; GO:0007186; GO:0007411; GO:0008134; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0014068; GO:0016020; GO:0016032; GO:0019221; GO:0019903; GO:0030168; GO:0030183; GO:0030335; GO:0031295; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0038095; GO:0038096; GO:0038128; GO:0042307; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048010; GO:0048015; GO:0050821; GO:0050852; GO:0050900; GO:0051492; GO:0051897; GO:0060396; GO:1900103; GO:1903078; GO:1990578	"cell [GO:0005623]; cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transcription factor binding [GO:0008134]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; axon guidance [GO:0007411]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone receptor signaling pathway [GO:0060396]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; leukocyte migration [GO:0050900]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of glucose import [GO:0046326]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]"
PGEN_.00g008860	Scaffold_01	22975557	23017189	F7E540	TTLL7_XENTR	Tubulin polyglutamylase TTLL7 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 7)	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007399; GO:0018095; GO:0030154; GO:0030425; GO:0043204; GO:0070740	cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; tubulin-glutamic acid ligase activity [GO:0070740]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; protein polyglutamylation [GO:0018095]
PGEN_.00g008870	Scaffold_01	23032384	23042499	O62742	NLTP_RABIT	Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)	GO:0005739; GO:0005777; GO:0006869; GO:0008289; GO:0033814; GO:0050632	mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; lipid transport [GO:0006869]
PGEN_.00g008880	Scaffold_01	23045562	23055678	Q6PAY8	HSDL2_XENLA	Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-)	GO:0005777; GO:0016491	peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491]
PGEN_.00g008890	Scaffold_01	23066022	23066414	NA	NA	NA	NA	NA
PGEN_.00g008900	Scaffold_01	23066987	23067367	NA	NA	NA	NA	NA
PGEN_.00g008910	Scaffold_01	23067438	23067779	NA	NA	NA	NA	NA
PGEN_.00g008920	Scaffold_01	23105343	23105546	NA	NA	NA	NA	NA
PGEN_.00g008930	Scaffold_01	23243862	23246394	NA	NA	NA	NA	NA
PGEN_.00g008940	Scaffold_01	23284999	23285604	NA	NA	NA	NA	NA
PGEN_.00g008950	Scaffold_01	23285880	23286314	NA	NA	NA	NA	NA
PGEN_.00g008960	Scaffold_01	23296481	23384286	Q58CY8	TSN18_BOVIN	Tetraspanin-18 (Tspan-18)	GO:0005887	integral component of plasma membrane [GO:0005887]
PGEN_.00g008970	Scaffold_01	23393225	23393806	NA	NA	NA	NA	NA
PGEN_.00g008980	Scaffold_01	23398419	23400436	NA	NA	NA	NA	NA
PGEN_.00g008990	Scaffold_01	23404530	23413975	NA	NA	NA	NA	NA
PGEN_.00g009000	Scaffold_01	23427687	23433162	NA	NA	NA	NA	NA
PGEN_.00g009010	Scaffold_01	23434409	23484204	Q99MV1	TDRD1_MOUSE	Tudor domain-containing protein 1	GO:0005737; GO:0005829; GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546; GO:1990904	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
PGEN_.00g009020	Scaffold_01	23496309	23520554	Q5RDX4	ATAD2_PONAB	ATPase family AAA domain-containing protein 2 (EC 3.6.1.3)	GO:0005524; GO:0005634; GO:0006325; GO:0006355; GO:0016887	"nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin organization [GO:0006325]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g009030	Scaffold_01	23521151	23526666	Q5VVB8	TM244_HUMAN	Transmembrane protein 244	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g009040	Scaffold_01	23532053	23532256	NA	NA	NA	NA	NA
PGEN_.00g009050	Scaffold_01	23532892	23533182	NA	NA	NA	NA	NA
PGEN_.00g009060	Scaffold_01	23537282	23538461	NA	NA	NA	NA	NA
PGEN_.00g009070	Scaffold_01	23552328	23558278	NA	NA	NA	NA	NA
PGEN_.00g009080	Scaffold_01	23563012	23564356	NA	NA	NA	NA	NA
PGEN_.00g009090	Scaffold_01	23564634	23564906	NA	NA	NA	NA	NA
PGEN_.00g009100	Scaffold_01	23585368	23609015	Q7Z020	TRPA1_DROME	Transient receptor potential cation channel subfamily A member 1 (dTRPA1) (Ankyrin-like with transmembrane domains protein 1) (dANKTM1)	GO:0001580; GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007602; GO:0007638; GO:0009408; GO:0009416; GO:0010378; GO:0015276; GO:0016021; GO:0023041; GO:0034605; GO:0034703; GO:0040040; GO:0043052; GO:0046957; GO:0050850; GO:0050960; GO:0050965; GO:0050968; GO:0097604	cation channel complex [GO:0034703]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ligand-gated ion channel activity [GO:0015276]; temperature-gated cation channel activity [GO:0097604]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; mechanosensory behavior [GO:0007638]; negative phototaxis [GO:0046957]; neuronal signal transduction [GO:0023041]; phototransduction [GO:0007602]; positive regulation of calcium-mediated signaling [GO:0050850]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]; temperature compensation of the circadian clock [GO:0010378]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]
PGEN_.00g009110	Scaffold_01	23619855	23623122	P0C2B8	RM55_BOVIN	"39S ribosomal protein L55, mitochondrial (L55mt) (MRP-L55)"	GO:0003735; GO:0005743; GO:0005762; GO:0006412	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g009120	Scaffold_01	23632272	23637760	NA	NA	NA	NA	NA
PGEN_.00g009130	Scaffold_01	23640484	23674950	Q7ZVT3	SAS6_DANRE	Spindle assembly abnormal protein 6 homolog	GO:0000280; GO:0005737; GO:0005813; GO:0005814; GO:0007052; GO:0007099; GO:0007283; GO:0040016; GO:0051298; GO:0098536	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; embryonic cleavage [GO:0040016]; mitotic spindle organization [GO:0007052]; nuclear division [GO:0000280]; spermatogenesis [GO:0007283]
PGEN_.00g009140	Scaffold_01	23712978	23748922	Q8BYM5	NLGN3_MOUSE	Neuroligin-3 (Gliotactin homolog)	GO:0002087; GO:0005887; GO:0006898; GO:0007158; GO:0007416; GO:0007612; GO:0008542; GO:0009986; GO:0030054; GO:0030139; GO:0030534; GO:0035176; GO:0038023; GO:0042043; GO:0043025; GO:0045202; GO:0048488; GO:0048675; GO:0048709; GO:0050804; GO:0050808; GO:0050839; GO:0051965; GO:0051966; GO:0051968; GO:0060024; GO:0060076; GO:0060077; GO:0060079; GO:0060080; GO:0060291; GO:0060999; GO:0061001; GO:0061002; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0097151; GO:0098698; GO:0098793; GO:0098978; GO:0098982; GO:0099055; GO:0099060; GO:1900271; GO:1902474; GO:2000310; GO:2000311; GO:2000331; GO:2000463; GO:2000809; GO:2000969	"cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon extension [GO:0048675]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; oligodendrocyte differentiation [GO:0048709]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of terminal button organization [GO:2000331]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; visual learning [GO:0008542]; vocalization behavior [GO:0071625]"
PGEN_.00g009150	Scaffold_01	23757922	23758227	NA	NA	NA	NA	NA
PGEN_.00g009160	Scaffold_01	23844184	23844483	NA	NA	NA	NA	NA
PGEN_.00g009170	Scaffold_01	23844551	23845192	NA	NA	NA	NA	NA
PGEN_.00g009180	Scaffold_01	23920149	23924456	NA	NA	NA	NA	NA
PGEN_.00g009190	Scaffold_01	23951294	23988378	NA	NA	NA	NA	NA
PGEN_.00g009200	Scaffold_01	23995529	23998653	NA	NA	NA	NA	NA
PGEN_.00g009210	Scaffold_01	23998908	23999234	NA	NA	NA	NA	NA
PGEN_.00g009220	Scaffold_01	24010433	24010702	NA	NA	NA	NA	NA
PGEN_.00g009230	Scaffold_01	24048829	24086525	NA	NA	NA	NA	NA
PGEN_.00g009240	Scaffold_01	24078076	24078999	NA	NA	NA	NA	NA
PGEN_.00g009250	Scaffold_01	24083569	24083910	NA	NA	NA	NA	NA
PGEN_.00g009260	Scaffold_01	24093264	24093572	NA	NA	NA	NA	NA
PGEN_.00g009270	Scaffold_01	24118614	24127098	NA	NA	NA	NA	NA
PGEN_.00g009280	Scaffold_01	24135710	24156957	Q805A1	SMC5_XENLA	Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5)	GO:0000722; GO:0000724; GO:0000781; GO:0005524; GO:0005634; GO:0007062; GO:0016605; GO:0030915; GO:0034184; GO:0051301; GO:0090398	"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; sister chromatid cohesion [GO:0007062]; telomere maintenance via recombination [GO:0000722]"
PGEN_.00g009290	Scaffold_01	24158956	24178469	Q8CG46	SMC5_MOUSE	Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (mSMC5) (Protein expressed in male leptotene and zygotene spermatocytes 453) (MLZ-453)	GO:0000722; GO:0000724; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0006974; GO:0007062; GO:0016605; GO:0016607; GO:0030054; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0051301; GO:0051984; GO:0090398	"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; sister chromatid cohesion [GO:0007062]; telomere maintenance via recombination [GO:0000722]"
PGEN_.00g009300	Scaffold_01	24181848	24192589	NA	NA	NA	NA	NA
PGEN_.00g009310	Scaffold_01	24192615	24221593	P48380	RFX3_HUMAN	Transcription factor RFX3 (Regulatory factor X 3)	GO:0000790; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005576; GO:0005634; GO:0005667; GO:0006351; GO:0006355; GO:0006357; GO:0031018; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0050796; GO:0060271; GO:0060285; GO:0060287; GO:0072560; GO:2000078	"extracellular region [GO:0005576]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; cell maturation [GO:0048469]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; type B pancreatic cell maturation [GO:0072560]"
PGEN_.00g009320	Scaffold_01	24301248	24318845	Q6INU7	FRRS1_XENLA	Putative ferric-chelate reductase 1 (EC 1.-.-.-)	GO:0016021; GO:0016491	integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]
PGEN_.00g009330	Scaffold_01	24363955	24386887	P55567	Y4MH_SINFN	Uncharacterized protein y4mH	GO:0016787	hydrolase activity [GO:0016787]
PGEN_.00g009340	Scaffold_01	24393095	24421422	P55203	GUC2D_BOVIN	"Retinal guanylyl cyclase 1 (RETGC-1) (EC 4.6.1.2) (Guanylate cyclase 2D, retinal) (Guanylate cyclase E) (GC-E) (Rod outer segment membrane guanylate cyclase) (ROS-GC)"	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005789; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0007601; GO:0016021; GO:0016941; GO:0017046; GO:0035556; GO:0042803; GO:0120200	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]; visual perception [GO:0007601]
PGEN_.00g009350	Scaffold_01	24482481	24508358	NA	NA	NA	NA	NA
PGEN_.00g009360	Scaffold_01	24509212	24509448	NA	NA	NA	NA	NA
PGEN_.00g009370	Scaffold_01	24514101	24564329	O35346	FAK1_RAT	Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)	GO:0000165; GO:0000226; GO:0001525; GO:0001568; GO:0001570; GO:0001725; GO:0001764; GO:0001932; GO:0001934; GO:0003779; GO:0004713; GO:0004715; GO:0005178; GO:0005524; GO:0005623; GO:0005634; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0007097; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007254; GO:0008284; GO:0008360; GO:0008432; GO:0009612; GO:0009749; GO:0010033; GO:0010243; GO:0010507; GO:0010613; GO:0010632; GO:0014068; GO:0014070; GO:0014704; GO:0014911; GO:0016323; GO:0016324; GO:0016604; GO:0018108; GO:0019901; GO:0019902; GO:0019903; GO:0021955; GO:0022408; GO:0030027; GO:0030155; GO:0030198; GO:0030307; GO:0030335; GO:0030336; GO:0030644; GO:0031625; GO:0032355; GO:0033628; GO:0038083; GO:0042127; GO:0042169; GO:0042383; GO:0042493; GO:0042802; GO:0043066; GO:0043197; GO:0043542; GO:0043548; GO:0044877; GO:0045444; GO:0045667; GO:0045785; GO:0045860; GO:0046621; GO:0046685; GO:0046777; GO:0048013; GO:0048471; GO:0048661; GO:0050766; GO:0050771; GO:0050806; GO:0051893; GO:0051897; GO:0051964; GO:0060252; GO:0060396; GO:0071560; GO:0097755; GO:0098794; GO:0098978; GO:1900024; GO:2000060; GO:2000811	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; ubiquitin protein ligase binding [GO:0031625]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cellular chloride ion homeostasis [GO:0030644]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system neuron axonogenesis [GO:0021955]; endothelial cell migration [GO:0043542]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; extracellular matrix organization [GO:0030198]; fat cell differentiation [GO:0045444]; growth hormone receptor signaling pathway [GO:0060396]; integrin-mediated signaling pathway [GO:0007229]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of organ growth [GO:0046621]; negative regulation of synapse assembly [GO:0051964]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]
PGEN_.00g009380	Scaffold_01	24523113	24524546	NA	NA	NA	NA	NA
PGEN_.00g009390	Scaffold_01	24571609	24606065	NA	NA	NA	NA	NA
PGEN_.00g009400	Scaffold_01	24613291	24615319	Q9ESK9	RBCC1_MOUSE	RB1-inducible coiled-coil protein 1 (Coiled-coil-forming protein 1) (FAK family kinase-interacting protein of 200 kDa) (FIP200) (LaXp180)	GO:0000045; GO:0000407; GO:0000422; GO:0001889; GO:0001934; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0006914; GO:0007049; GO:0007507; GO:0019898; GO:0019901; GO:0030242; GO:0031965; GO:0034045; GO:0034727; GO:0043066; GO:0045793; GO:0046330; GO:0061709; GO:0061723; GO:1990316; GO:2001237	Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; reticulophagy [GO:0061709]
PGEN_.00g009410	Scaffold_01	24615409	24652149	Q9ESK9	RBCC1_MOUSE	RB1-inducible coiled-coil protein 1 (Coiled-coil-forming protein 1) (FAK family kinase-interacting protein of 200 kDa) (FIP200) (LaXp180)	GO:0000045; GO:0000407; GO:0000422; GO:0001889; GO:0001934; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0006914; GO:0007049; GO:0007507; GO:0019898; GO:0019901; GO:0030242; GO:0031965; GO:0034045; GO:0034727; GO:0043066; GO:0045793; GO:0046330; GO:0061709; GO:0061723; GO:1990316; GO:2001237	Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; reticulophagy [GO:0061709]
PGEN_.00g009420	Scaffold_01	24660741	24669504	Q96T60	PNKP_HUMAN	Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase (EC 3.1.3.32) (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase (EC 2.7.1.78)]	GO:0000718; GO:0003684; GO:0003690; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006261; GO:0006281; GO:0006979; GO:0009314; GO:0010836; GO:0016020; GO:0016311; GO:0017076; GO:0032212; GO:0042769; GO:0046403; GO:0046404; GO:0046939; GO:0050145; GO:0051973; GO:0098504; GO:1904355	"membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; nucleoside monophosphate kinase activity [GO:0050145]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076]; dephosphorylation [GO:0016311]; DNA 3' dephosphorylation involved in DNA repair [GO:0098504]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair, DNA damage removal [GO:0000718]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]"
PGEN_.00g009430	Scaffold_01	24673153	24721159	Q9JL19	NCOA6_MOUSE	"Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (Thyroid hormone receptor-binding protein)"	GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006974; GO:0007420; GO:0007507; GO:0010468; GO:0030099; GO:0030374; GO:0035097; GO:0045893; GO:0045944; GO:0046966; GO:0060716; GO:0080182	"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; heart development [GO:0007507]; histone H3-K4 trimethylation [GO:0080182]; labyrinthine layer blood vessel development [GO:0060716]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]"
PGEN_.00g009440	Scaffold_01	24742532	24756523	Q4R5L5	ANXA7_MACFA	Annexin A7 (Annexin VII) (Annexin-7)	GO:0005509; GO:0005544	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]
PGEN_.00g009450	Scaffold_01	24786311	24787928	NA	NA	NA	NA	NA
PGEN_.00g009460	Scaffold_01	24801346	24812731	NA	NA	NA	NA	NA
PGEN_.00g009470	Scaffold_01	24813390	24815858	NA	NA	NA	NA	NA
PGEN_.00g009480	Scaffold_01	24817203	24821533	NA	NA	NA	NA	NA
PGEN_.00g009490	Scaffold_01	24844082	24878187	O43614	OX2R_HUMAN	Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2)	GO:0004930; GO:0005623; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007268; GO:0007631; GO:0008188; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0045202; GO:0051480	"cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; cellular response to hormone stimulus [GO:0032870]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]"
PGEN_.00g009500	Scaffold_01	24948938	24949246	NA	NA	NA	NA	NA
PGEN_.00g009510	Scaffold_01	24957377	24957745	Q8BZ39	NMUR2_MOUSE	Neuromedin-U receptor 2 (NMU-R2)	GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005623; GO:0005886; GO:0006816; GO:0007200; GO:0007204; GO:0007218; GO:0007417; GO:0007625; GO:0008188; GO:0016021; GO:0042924; GO:0043006; GO:0048016; GO:0048265; GO:0050482; GO:0051930	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; central nervous system development [GO:0007417]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265]
PGEN_.00g009520	Scaffold_01	25068614	25068865	NA	NA	NA	NA	NA
PGEN_.00g009530	Scaffold_01	25069236	25069604	NA	NA	NA	NA	NA
PGEN_.00g009540	Scaffold_01	25077514	25077912	NA	NA	NA	NA	NA
PGEN_.00g009550	Scaffold_01	25112576	25142107	Q28FY0	TILB_XENTR	Protein tilB homolog (Leucine-rich repeat-containing protein 6)	GO:0005737; GO:0005929	cilium [GO:0005929]; cytoplasm [GO:0005737]
PGEN_.00g009560	Scaffold_01	25145732	25146334	NA	NA	NA	NA	NA
PGEN_.00g009570	Scaffold_01	25154748	25155386	NA	NA	NA	NA	NA
PGEN_.00g009580	Scaffold_01	25156415	25157098	NA	NA	NA	NA	NA
PGEN_.00g009590	Scaffold_01	25171629	25173539	Q3ZMH1	SC5A8_DANRE	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (zSMCTe) (Sodium solute symporter family 5 member 8 protein) (Solute carrier family 5 member 8)	GO:0006814; GO:0015293; GO:0015355; GO:0016021	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g009600	Scaffold_01	25197588	25199744	NA	NA	NA	NA	NA
PGEN_.00g009610	Scaffold_01	25216421	25261807	Q6RG02	VIT_PENME	Vitellogenin [Cleaved into: Vitellin]	GO:0005319; GO:0008289; GO:0045735; GO:0048477	lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]; oogenesis [GO:0048477]
PGEN_.00g009620	Scaffold_01	25262656	25267459	NA	NA	NA	NA	NA
PGEN_.00g009630	Scaffold_01	25267959	25270942	NA	NA	NA	NA	NA
PGEN_.00g009640	Scaffold_01	25274891	25280213	A0KKE6	SELU_AERHH	tRNA 2-selenouridine synthase (EC 2.5.1.-)	GO:0002098; GO:0016765; GO:0043828; GO:0070329	"transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; tRNA 2-selenouridine synthase activity [GO:0043828]; tRNA seleno-modification [GO:0070329]; tRNA wobble uridine modification [GO:0002098]"
PGEN_.00g009650	Scaffold_01	25284750	25296448	Q3U034	METL4_MOUSE	N(6)-adenine-specific DNA methyltransferase METTL4 (EC 2.1.1.72) (Methyltransferase-like protein 4)	GO:0003676; GO:0005634; GO:0006325; GO:0009007; GO:0032775; GO:1902275	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]
PGEN_.00g009660	Scaffold_01	25306569	25400505	Q29099	PTBP1_PIG	Polypyrimidine tract-binding protein 1 (PTB) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I)	GO:0000381; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0048025; GO:0051148	"nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"
PGEN_.00g009670	Scaffold_01	25485678	25508446	Q9UKP5	ATS6_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)	GO:0003279; GO:0004222; GO:0005576; GO:0008237; GO:0035904; GO:0046872; GO:0060976	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]
PGEN_.00g009680	Scaffold_01	25508545	25509252	NA	NA	NA	NA	NA
PGEN_.00g009690	Scaffold_01	25509619	25510053	Q9UKP5	ATS6_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)	GO:0003279; GO:0004222; GO:0005576; GO:0008237; GO:0035904; GO:0046872; GO:0060976	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]
PGEN_.00g009700	Scaffold_01	25528923	25538650	Q5F359	TPPC5_CHICK	Trafficking protein particle complex subunit 5	GO:0005783; GO:0006888; GO:0030008; GO:1990070; GO:1990071; GO:1990072	endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]
PGEN_.00g009710	Scaffold_01	25555130	25564712	P02707	LECH_CHICK	Hepatic lectin	GO:0006897; GO:0016021; GO:0030246	integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; endocytosis [GO:0006897]
PGEN_.00g009720	Scaffold_01	25607545	25608825	Q5IS51	ACHA5_PANTR	Neuronal acetylcholine receptor subunit alpha-5	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g009730	Scaffold_01	25633255	25645249	B1AS42	NB5R5_MOUSE	NADH-cytochrome b5 reductase-like (EC 1.6.2.2)	GO:0004128; GO:0005654	"nucleoplasm [GO:0005654]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]"
PGEN_.00g009740	Scaffold_01	25645793	25651652	NA	NA	NA	NA	NA
PGEN_.00g009750	Scaffold_01	25652113	25675019	Q5M7W7	SYPM_RAT	"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)"	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]
PGEN_.00g009760	Scaffold_01	25788188	25788427	Q7SIG4	DFPA_LOLVU	Diisopropyl-fluorophosphatase (DFPase) (EC 3.1.8.2)	GO:0005509; GO:0047862	calcium ion binding [GO:0005509]; diisopropyl-fluorophosphatase activity [GO:0047862]
PGEN_.00g009770	Scaffold_01	25791545	25795100	Q9D3D9	ATPD_MOUSE	"ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)"	GO:0000275; GO:0005739; GO:0005740; GO:0005743; GO:0005753; GO:0009060; GO:0015078; GO:0015986; GO:0016887; GO:0033615; GO:0044877; GO:0045259; GO:0045261; GO:0046034; GO:0046933; GO:1902600	"mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATPase activity [GO:0016887]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; aerobic respiration [GO:0009060]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton transmembrane transport [GO:1902600]"
PGEN_.00g009780	Scaffold_01	25809384	25842969	P49790	NU153_HUMAN	Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153)	GO:0003677; GO:0005643; GO:0005654; GO:0005730; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0008139; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0034399; GO:0042405; GO:0042802; GO:0043495; GO:0043657; GO:0044613; GO:0044615; GO:0046718; GO:0046832; GO:0046872; GO:0051292; GO:0060964; GO:0075732; GO:0075733; GO:1900034	cytosol [GO:0005829]; host cell [GO:0043657]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclear localization sequence binding [GO:0008139]; protein membrane anchor [GO:0043495]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; negative regulation of RNA export from nucleus [GO:0046832]; nuclear pore complex assembly [GO:0051292]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732]; viral process [GO:0016032]; viral transcription [GO:0019083]
PGEN_.00g009790	Scaffold_01	25852451	25870391	NA	NA	NA	NA	NA
PGEN_.00g009800	Scaffold_01	25894354	25914609	NA	NA	NA	NA	NA
PGEN_.00g009810	Scaffold_01	25930418	25932195	NA	NA	NA	NA	NA
PGEN_.00g009820	Scaffold_01	25939409	25943618	NA	NA	NA	NA	NA
PGEN_.00g009830	Scaffold_01	25972403	25972714	NA	NA	NA	NA	NA
PGEN_.00g009840	Scaffold_01	25996632	25998644	NA	NA	NA	NA	NA
PGEN_.00g009850	Scaffold_01	26008987	26015546	Q9BSF4	TIM29_HUMAN	Mitochondrial import inner membrane translocase subunit Tim29 (TIM29)	GO:0005743; GO:0005758; GO:0016021; GO:0042721; GO:0045039	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; protein insertion into mitochondrial inner membrane [GO:0045039]
PGEN_.00g009860	Scaffold_01	26015696	26021552	Q5RBL0	YIPF1_PONAB	Protein YIPF1 (YIP1 family member 1)	GO:0000138; GO:0005797; GO:0005802; GO:0016021; GO:0016192; GO:0031902	Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; trans-Golgi network [GO:0005802]; vesicle-mediated transport [GO:0016192]
PGEN_.00g009870	Scaffold_01	26033012	26085862	O14522	PTPRT_HUMAN	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g009880	Scaffold_01	26124057	26180873	Q91584	ELAV3_XENLA	ELAV-like protein 3 (Protein ElrC)	GO:0003723; GO:0007399; GO:0030154; GO:1990904	ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g009890	Scaffold_01	26197690	26218250	NA	NA	NA	NA	NA
PGEN_.00g009900	Scaffold_01	26273502	26323434	Q13233	M3K1_HUMAN	Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1)	GO:0002755; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0008270; GO:0019901; GO:0023014; GO:0032147; GO:0038095; GO:0071260	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; activation of protein kinase activity [GO:0032147]; cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g009910	Scaffold_01	26346623	26370612	NA	NA	NA	NA	NA
PGEN_.00g009920	Scaffold_01	26378930	26383523	NA	NA	NA	NA	NA
PGEN_.00g009930	Scaffold_01	26395030	26401245	Q5G266	NETR_TRAPH	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424	axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]
PGEN_.00g009940	Scaffold_01	26415623	26443344	Q5PPX0	PPR42_XENLA	Protein phosphatase 1 regulatory subunit 42 (Leucine-rich repeat-containing protein 67)	GO:0002177; GO:0003779; GO:0005737; GO:0005813; GO:0005815; GO:0015630; GO:0015631; GO:0070840	centrosome [GO:0005813]; cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; actin binding [GO:0003779]; dynein complex binding [GO:0070840]; tubulin binding [GO:0015631]
PGEN_.00g009950	Scaffold_01	26451387	26457438	Q5G265	NETR_SAGLB	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424	axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]
PGEN_.00g009960	Scaffold_01	26462582	26463085	NA	NA	NA	NA	NA
PGEN_.00g009970	Scaffold_01	26472483	26502573	Q9BYK8	HELZ2_HUMAN	"Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) (EC 3.6.4.-)"	GO:0000184; GO:0003677; GO:0003723; GO:0004386; GO:0004540; GO:0005524; GO:0005654; GO:0005737; GO:0016020; GO:0019216; GO:0030374; GO:0045944; GO:0046872	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216]"
PGEN_.00g009980	Scaffold_01	26504994	26542884	Q9BYK8	HELZ2_HUMAN	"Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) (EC 3.6.4.-)"	GO:0000184; GO:0003677; GO:0003723; GO:0004386; GO:0004540; GO:0005524; GO:0005654; GO:0005737; GO:0016020; GO:0019216; GO:0030374; GO:0045944; GO:0046872	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216]"
PGEN_.00g009990	Scaffold_01	26562587	26568321	NA	NA	NA	NA	NA
PGEN_.00g010000	Scaffold_01	26586488	26586964	NA	NA	NA	NA	NA
PGEN_.00g010010	Scaffold_01	26599725	26606018	Q3S8M4	ELOV4_MACMU	Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)	GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"
PGEN_.00g010020	Scaffold_01	26624863	26632527	NA	NA	NA	NA	NA
PGEN_.00g010030	Scaffold_01	26648570	26708823	NA	NA	NA	NA	NA
PGEN_.00g010040	Scaffold_01	26716788	26721923	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g010050	Scaffold_01	26746067	26792660	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g010060	Scaffold_01	26799208	26811305	Q8GX78	ANTR2_ARATH	"Ascorbate transporter, chloroplastic (Phosphate transporter PHT4;4) (AtPHT4;4) (Probable anion transporter 2)"	GO:0005315; GO:0009507; GO:0009536; GO:0009706; GO:0009941; GO:0010028; GO:0015229; GO:0015882; GO:0016021	chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast inner membrane [GO:0009706]; integral component of membrane [GO:0016021]; plastid [GO:0009536]; inorganic phosphate transmembrane transporter activity [GO:0005315]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; L-ascorbic acid transmembrane transport [GO:0015882]; xanthophyll cycle [GO:0010028]
PGEN_.00g010070	Scaffold_01	26818982	26819443	NA	NA	NA	NA	NA
PGEN_.00g010080	Scaffold_01	26819505	26819945	NA	NA	NA	NA	NA
PGEN_.00g010090	Scaffold_01	26820088	26820399	NA	NA	NA	NA	NA
PGEN_.00g010100	Scaffold_01	26820954	26821325	NA	NA	NA	NA	NA
PGEN_.00g010110	Scaffold_01	26838335	26843740	Q8HXQ4	SODC_PONPY	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	GO:0000187; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0002262; GO:0004784; GO:0005507; GO:0005623; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006749; GO:0006801; GO:0006879; GO:0007283; GO:0007566; GO:0007569; GO:0007605; GO:0007626; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031410; GO:0032287; GO:0032839; GO:0032991; GO:0040014; GO:0042493; GO:0042542; GO:0043025; GO:0043085; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046716; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0072593	cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; protein phosphatase 2B binding [GO:0030346]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]
PGEN_.00g010120	Scaffold_01	26853283	26859572	NA	NA	NA	NA	NA
PGEN_.00g010130	Scaffold_01	26862589	26868426	Q5ZIT8	TAF2_CHICK	Transcription initiation factor TFIID subunit 2 (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)	GO:0003682; GO:0005669; GO:0006367; GO:0044212; GO:0045944	transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription initiation from RNA polymerase II promoter [GO:0006367]
PGEN_.00g010140	Scaffold_01	26871198	26879270	NA	NA	NA	NA	NA
PGEN_.00g010150	Scaffold_01	26881599	26959736	Q32PW3	TAF2_DANRE	Transcription initiation factor TFIID subunit 2 (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)	GO:0003682; GO:0005669; GO:0006367; GO:0044212; GO:0045944	transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription initiation from RNA polymerase II promoter [GO:0006367]
PGEN_.00g010160	Scaffold_01	26964291	26970839	P07632	SODC_RAT	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0019899; GO:0030141; GO:0030346; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0032991; GO:0034465; GO:0034599; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0050728; GO:0050766; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115	axon cytoplasm [GO:1904115]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]
PGEN_.00g010170	Scaffold_01	26978357	26978791	NA	NA	NA	NA	NA
PGEN_.00g010180	Scaffold_01	26979124	26979600	NA	NA	NA	NA	NA
PGEN_.00g010190	Scaffold_01	26979676	26979984	NA	NA	NA	NA	NA
PGEN_.00g010200	Scaffold_01	26980659	27012263	Q99JR5	TINAL_MOUSE	Tubulointerstitial nephritis antigen-like (Adrenocortical zonation factor 1) (AZ-1) (Androgen-regulated gene 1 protein) (Tubulointerstitial nephritis antigen-related protein) (TARP)	GO:0005615; GO:0005737; GO:0007155; GO:0008234; GO:0043236; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cysteine-type peptidase activity [GO:0008234]; laminin binding [GO:0043236]; cell adhesion [GO:0007155]
PGEN_.00g010210	Scaffold_01	27018947	27025090	NA	NA	NA	NA	NA
PGEN_.00g010220	Scaffold_01	27040980	27041450	NA	NA	NA	NA	NA
PGEN_.00g010230	Scaffold_01	27045394	27058750	Q19038	DEL1_CAEEL	Degenerin del-1	GO:0005272; GO:0016021	integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]
PGEN_.00g010240	Scaffold_01	27085674	27086357	NA	NA	NA	NA	NA
PGEN_.00g010250	Scaffold_01	27110555	27120190	Q5UR67	RIBX_MIMIV	N-glycosidase R617 (EC 3.2.2.-) (Riboflavin biosynthesis intermediates N-glycosidase)	GO:0008152; GO:0016798	"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152]"
PGEN_.00g010260	Scaffold_01	27155854	27156192	NA	NA	NA	NA	NA
PGEN_.00g010270	Scaffold_01	27162682	27163582	NA	NA	NA	NA	NA
PGEN_.00g010280	Scaffold_01	27163830	27164162	NA	NA	NA	NA	NA
PGEN_.00g010290	Scaffold_01	27167311	27168063	NA	NA	NA	NA	NA
PGEN_.00g010300	Scaffold_01	27168267	27168614	NA	NA	NA	NA	NA
PGEN_.00g010310	Scaffold_01	27183805	27184280	NA	NA	NA	NA	NA
PGEN_.00g010320	Scaffold_01	27184941	27185561	NA	NA	NA	NA	NA
PGEN_.00g010330	Scaffold_01	27199235	27202083	NA	NA	NA	NA	NA
PGEN_.00g010340	Scaffold_01	27216725	27260625	NA	NA	NA	NA	NA
PGEN_.00g010350	Scaffold_01	27263133	27266231	NA	NA	NA	NA	NA
PGEN_.00g010360	Scaffold_01	27267506	27267805	NA	NA	NA	NA	NA
PGEN_.00g010370	Scaffold_01	27279627	27279848	NA	NA	NA	NA	NA
PGEN_.00g010380	Scaffold_01	27282658	27283395	NA	NA	NA	NA	NA
PGEN_.00g010390	Scaffold_01	27284430	27285080	NA	NA	NA	NA	NA
PGEN_.00g010400	Scaffold_01	27287195	27319844	NA	NA	NA	NA	NA
PGEN_.00g010410	Scaffold_01	27313121	27314320	NA	NA	NA	NA	NA
PGEN_.00g010420	Scaffold_01	27332062	27360470	Q9UGU5	HMGX4_HUMAN	HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG)	GO:0003677; GO:0008333; GO:0016055; GO:0016589; GO:0030178	NURF complex [GO:0016589]; DNA binding [GO:0003677]; endosome to lysosome transport [GO:0008333]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]
PGEN_.00g010430	Scaffold_01	27370716	27445755	B3DK56	PTPRU_DANRE	Receptor-type tyrosine-protein phosphatase U (R-PTP-U) (EC 3.1.3.48) (Receptor-type protein-tyrosine phosphatase psi) (R-PTP-psi)	GO:0001757; GO:0004725; GO:0005886; GO:0006470; GO:0007155; GO:0016021; GO:0030054; GO:0030154	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; protein dephosphorylation [GO:0006470]; somite specification [GO:0001757]
PGEN_.00g010440	Scaffold_01	27487194	27547063	NA	NA	NA	NA	NA
PGEN_.00g010450	Scaffold_01	27614094	27617495	NA	NA	NA	NA	NA
PGEN_.00g010460	Scaffold_01	27664948	27687987	Q9ESM0	IP6K1_RAT	Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1)	GO:0000828; GO:0000832; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032958; GO:0046854; GO:0052723; GO:0052724; GO:0120163	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol phosphate biosynthetic process [GO:0032958]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphorylation [GO:0046854]
PGEN_.00g010470	Scaffold_01	27743075	27743554	NA	NA	NA	NA	NA
PGEN_.00g010480	Scaffold_01	27754512	27772825	Q502M6	ANR29_DANRE	Ankyrin repeat domain-containing protein 29		
PGEN_.00g010490	Scaffold_01	27804483	27823230	Q9H074	PAIP1_HUMAN	Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1)	GO:0003723; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0008494; GO:0048255	cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; mRNA stabilization [GO:0048255]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]
PGEN_.00g010500	Scaffold_01	27875031	27890847	NA	NA	NA	NA	NA
PGEN_.00g010510	Scaffold_01	27890876	27895358	NA	NA	NA	NA	NA
PGEN_.00g010520	Scaffold_01	27912510	27912890	NA	NA	NA	NA	NA
PGEN_.00g010530	Scaffold_01	27913351	27913578	NA	NA	NA	NA	NA
PGEN_.00g010540	Scaffold_01	27922789	27930911	NA	NA	NA	NA	NA
PGEN_.00g010550	Scaffold_01	27987061	27987294	NA	NA	NA	NA	NA
PGEN_.00g010560	Scaffold_01	27987494	27987715	NA	NA	NA	NA	NA
PGEN_.00g010570	Scaffold_01	27998152	27999416	NA	NA	NA	NA	NA
PGEN_.00g010580	Scaffold_01	28009230	28009655	NA	NA	NA	NA	NA
PGEN_.00g010590	Scaffold_01	28010652	28010990	NA	NA	NA	NA	NA
PGEN_.00g010600	Scaffold_01	28020738	28024963	NA	NA	NA	NA	NA
PGEN_.00g010610	Scaffold_01	28029819	28037595	O75581	LRP6_HUMAN	Low-density lipoprotein receptor-related protein 6 (LRP-6)	GO:0001702; GO:0001843; GO:0001933; GO:0003344; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005623; GO:0005783; GO:0005886; GO:0005901; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009952; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021987; GO:0030326; GO:0030901; GO:0030917; GO:0031410; GO:0031901; GO:0034185; GO:0034392; GO:0035261; GO:0042475; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0051091; GO:0060021; GO:0060026; GO:0060059; GO:0060070; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090090; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:1904886; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g010620	Scaffold_01	28057259	28084791	O75581	LRP6_HUMAN	Low-density lipoprotein receptor-related protein 6 (LRP-6)	GO:0001702; GO:0001843; GO:0001933; GO:0003344; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005623; GO:0005783; GO:0005886; GO:0005901; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009952; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021987; GO:0030326; GO:0030901; GO:0030917; GO:0031410; GO:0031901; GO:0034185; GO:0034392; GO:0035261; GO:0042475; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0051091; GO:0060021; GO:0060026; GO:0060059; GO:0060070; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090090; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:1904886; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g010630	Scaffold_01	28104499	28148907	P46530	NOTC1_DANRE	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0016021; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor-mediated endocytosis [GO:0048259]; regulation of transcription, DNA-templated [GO:0006355]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514]"
PGEN_.00g010640	Scaffold_01	28175173	28197727	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g010650	Scaffold_01	28220762	28229765	NA	NA	NA	NA	NA
PGEN_.00g010660	Scaffold_01	28249757	28273387	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g010670	Scaffold_01	28298302	28316912	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g010680	Scaffold_01	28317912	28323253	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g010690	Scaffold_01	28329707	28393083	E9Q555	RN213_MOUSE	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g010700	Scaffold_01	28402415	28402660	NA	NA	NA	NA	NA
PGEN_.00g010710	Scaffold_01	28402979	28403323	NA	NA	NA	NA	NA
PGEN_.00g010720	Scaffold_01	28405056	28407356	Q63HN8	RN213_HUMAN	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g010730	Scaffold_01	28412394	28412675	NA	NA	NA	NA	NA
PGEN_.00g010740	Scaffold_01	28412797	28413399	NA	NA	NA	NA	NA
PGEN_.00g010750	Scaffold_01	28419028	28436661	NA	NA	NA	NA	NA
PGEN_.00g010760	Scaffold_01	28438022	28438585	NA	NA	NA	NA	NA
PGEN_.00g010770	Scaffold_01	28455254	28456753	NA	NA	NA	NA	NA
PGEN_.00g010780	Scaffold_01	28461925	28480621	NA	NA	NA	NA	NA
PGEN_.00g010790	Scaffold_01	28480849	28497736	NA	NA	NA	NA	NA
PGEN_.00g010800	Scaffold_01	28516924	28517247	NA	NA	NA	NA	NA
PGEN_.00g010810	Scaffold_01	28540506	28540781	NA	NA	NA	NA	NA
PGEN_.00g010820	Scaffold_01	28566727	28579528	Q66JD1	ATPF1_XENTR	ATP synthase mitochondrial F1 complex assembly factor 1	GO:0005739; GO:0007602; GO:0033615	mitochondrion [GO:0005739]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; phototransduction [GO:0007602]
PGEN_.00g010830	Scaffold_01	28593865	28595373	P00184	CP1A1_MOUSE	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0001666; GO:0002933; GO:0003824; GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0006778; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0008395; GO:0009308; GO:0009404; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009636; GO:0009804; GO:0009812; GO:0010041; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0016829; GO:0017143; GO:0017144; GO:0019341; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0033189; GO:0035902; GO:0042493; GO:0042572; GO:0042904; GO:0043010; GO:0043231; GO:0046483; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0055114; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0101020; GO:0101021; GO:1900087	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; maternal process involved in parturition [GO:0060137]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]"
PGEN_.00g010840	Scaffold_01	28601638	28601886	NA	NA	NA	NA	NA
PGEN_.00g010850	Scaffold_01	28610795	28611199	NA	NA	NA	NA	NA
PGEN_.00g010860	Scaffold_01	28632099	28639535	Q4V8D1	CP2U1_RAT	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g010870	Scaffold_01	28667883	28669391	P00184	CP1A1_MOUSE	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0001666; GO:0002933; GO:0003824; GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0006778; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0008395; GO:0009308; GO:0009404; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009636; GO:0009804; GO:0009812; GO:0010041; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0016829; GO:0017143; GO:0017144; GO:0019341; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0033189; GO:0035902; GO:0042493; GO:0042572; GO:0042904; GO:0043010; GO:0043231; GO:0046483; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0055114; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0101020; GO:0101021; GO:1900087	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; maternal process involved in parturition [GO:0060137]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]"
PGEN_.00g010880	Scaffold_01	28684342	28684644	NA	NA	NA	NA	NA
PGEN_.00g010890	Scaffold_01	28693266	28716771	Q06367	CP1A1_CAVPO	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0002933; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0008391; GO:0009308; GO:0009404; GO:0009636; GO:0016829; GO:0020037; GO:0030544; GO:0042572; GO:0046483; GO:0050665; GO:0051879; GO:0070330; GO:0070576; GO:0071407; GO:0101020; GO:0101021	endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; vitamin D 24-hydroxylase activity [GO:0070576]; amine metabolic process [GO:0009308]; cellular response to organic cyclic compound [GO:0071407]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid hydroxylation [GO:0002933]; response to toxic substance [GO:0009636]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; toxin metabolic process [GO:0009404]
PGEN_.00g010900	Scaffold_01	28716929	28717240	NA	NA	NA	NA	NA
PGEN_.00g010910	Scaffold_01	28733679	28734907	NA	NA	NA	NA	NA
PGEN_.00g010920	Scaffold_01	28735294	28735758	NA	NA	NA	NA	NA
PGEN_.00g010930	Scaffold_01	28737254	28739064	NA	NA	NA	NA	NA
PGEN_.00g010940	Scaffold_01	28753761	28760005	O18809	CP2F3_CAPHI	Cytochrome P450 2F3 (EC 1.14.14.1) (CYPIIF3)	GO:0005506; GO:0005789; GO:0019825; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]
PGEN_.00g010950	Scaffold_01	28772062	28773391	NA	NA	NA	NA	NA
PGEN_.00g010960	Scaffold_01	28783129	28785714	NA	NA	NA	NA	NA
PGEN_.00g010970	Scaffold_01	28799007	28814917	NA	NA	NA	NA	NA
PGEN_.00g010980	Scaffold_01	28818521	28823315	NA	NA	NA	NA	NA
PGEN_.00g010990	Scaffold_01	28848053	28848391	NA	NA	NA	NA	NA
PGEN_.00g011000	Scaffold_01	28849081	28850710	NA	NA	NA	NA	NA
PGEN_.00g011010	Scaffold_01	28851145	28851459	NA	NA	NA	NA	NA
PGEN_.00g011020	Scaffold_01	28851715	28851987	NA	NA	NA	NA	NA
PGEN_.00g011030	Scaffold_01	28852023	28852262	NA	NA	NA	NA	NA
PGEN_.00g011040	Scaffold_01	28854304	28872970	P49355	FNTB_BOVIN	Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta)	GO:0004311; GO:0004660; GO:0005965; GO:0008270; GO:0008285; GO:0018342; GO:0018343; GO:0042060; GO:0048146	protein farnesyltransferase complex [GO:0005965]; farnesyltranstransferase activity [GO:0004311]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of fibroblast proliferation [GO:0048146]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; wound healing [GO:0042060]
PGEN_.00g011050	Scaffold_01	28898800	28906365	P61244	MAX_HUMAN	Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X)	GO:0000082; GO:0000122; GO:0000790; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006366; GO:0009267; GO:0016605; GO:0030425; GO:0032868; GO:0032993; GO:0042803; GO:0044877; GO:0045944; GO:0046982; GO:0048678; GO:0051402; GO:0060041; GO:0065003; GO:0070317; GO:0070888; GO:0071339; GO:0071375; GO:0090575	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g011060	Scaffold_01	28907113	28907517	NA	NA	NA	NA	NA
PGEN_.00g011070	Scaffold_01	28924862	28926052	Q02290	XYNB_NEOPA	"Endo-1,4-beta-xylanase B (Xylanase B) (EC 3.2.1.8) (1,4-beta-D-xylan xylanohydrolase B)"	GO:0005576; GO:0030248; GO:0031176; GO:0045493	"extracellular region [GO:0005576]; cellulose binding [GO:0030248]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g011080	Scaffold_01	28926261	28926494	NA	NA	NA	NA	NA
PGEN_.00g011090	Scaffold_01	28932007	28932519	NA	NA	NA	NA	NA
PGEN_.00g011100	Scaffold_01	28986407	28998071	Q6EV77	FUT8_PANTR	"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	GO:0006487; GO:0006491; GO:0007179; GO:0007229; GO:0007585; GO:0008424; GO:0010468; GO:0016021; GO:0016477; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0043112; GO:0046368; GO:0046921; GO:1900407	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; integrin-mediated signaling pathway [GO:0007229]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g011110	Scaffold_01	29012250	29036580	Q6EV77	FUT8_PANTR	"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	GO:0006487; GO:0006491; GO:0007179; GO:0007229; GO:0007585; GO:0008424; GO:0010468; GO:0016021; GO:0016477; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0043112; GO:0046368; GO:0046921; GO:1900407	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; integrin-mediated signaling pathway [GO:0007229]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g011120	Scaffold_01	29060886	29062103	Q8VHI3	OFUT2_MOUSE	GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2)	GO:0001707; GO:0005783; GO:0005794; GO:0006004; GO:0008417; GO:0010468; GO:0010717; GO:0036065; GO:0036066; GO:0046922; GO:0051046	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; mesoderm formation [GO:0001707]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046]
PGEN_.00g011130	Scaffold_01	29063007	29066561	Q8CAT8	FBX48_MOUSE	F-box only protein 48	GO:0005737; GO:0019005; GO:0031146	cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g011140	Scaffold_01	29068940	29073164	Q07326	PIGF_HUMAN	Phosphatidylinositol-glycan biosynthesis class F protein (PIG-F) (GPI11 homolog)	GO:0004307; GO:0005789; GO:0006506; GO:0016021; GO:0016254	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ethanolaminephosphotransferase activity [GO:0004307]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]
PGEN_.00g011150	Scaffold_01	29088964	29112389	Q96L93	KI16B_HUMAN	Kinesin-like protein KIF16B (Sorting nexin-23)	GO:0001704; GO:0001919; GO:0003777; GO:0005524; GO:0005547; GO:0005768; GO:0005769; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0017137; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0045335; GO:0071346; GO:0080025	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Rab GTPase binding [GO:0017137]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]"
PGEN_.00g011160	Scaffold_01	29118468	29156170	B1AVY7	KI16B_MOUSE	Kinesin-like protein KIF16B	GO:0001704; GO:0001919; GO:0003777; GO:0005524; GO:0005547; GO:0005768; GO:0005769; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0017137; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0045335; GO:0071346; GO:0080025	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Rab GTPase binding [GO:0017137]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]"
PGEN_.00g011170	Scaffold_01	29170652	29174761	Q9UGM3	DMBT1_HUMAN	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0007275; GO:0008329; GO:0009897; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]
PGEN_.00g011180	Scaffold_01	29239964	29246177	NA	NA	NA	NA	NA
PGEN_.00g011190	Scaffold_01	29285834	29307969	Q9Y3Q0	NALD2_HUMAN	N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)	GO:0004180; GO:0005886; GO:0006508; GO:0008236; GO:0008237; GO:0008239; GO:0008652; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]; cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]
PGEN_.00g011200	Scaffold_01	29307990	29308367	NA	NA	NA	NA	NA
PGEN_.00g011210	Scaffold_01	29317165	29317515	NA	NA	NA	NA	NA
PGEN_.00g011220	Scaffold_01	29318692	29319030	NA	NA	NA	NA	NA
PGEN_.00g011230	Scaffold_01	29320661	29329093	NA	NA	NA	NA	NA
PGEN_.00g011240	Scaffold_01	29345024	29350126	Q05557	CRYAB_ANAPL	Alpha-crystallin B chain (Alpha(B)-crystallin)	GO:0001540; GO:0001666; GO:0002088; GO:0005212; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0007021; GO:0007517; GO:0030018; GO:0031333; GO:0032387; GO:0032991; GO:0042542; GO:0042803; GO:0043154; GO:0044877; GO:0045892; GO:0046872; GO:0050821; GO:0051082; GO:0051260; GO:0060561; GO:0071480; GO:1905907	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; amyloid-beta binding [GO:0001540]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; structural constituent of eye lens [GO:0005212]; unfolded protein binding [GO:0051082]; apoptotic process involved in morphogenesis [GO:0060561]; cellular response to gamma radiation [GO:0071480]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intracellular transport [GO:0032387]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; protein stabilization [GO:0050821]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; tubulin complex assembly [GO:0007021]"
PGEN_.00g011250	Scaffold_01	29356290	29358950	Q9Y2I6	NINL_HUMAN	Ninein-like protein	GO:0000086; GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0010389; GO:0034454; GO:0045171; GO:0097711	centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; calcium ion binding [GO:0005509]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule anchoring at centrosome [GO:0034454]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]
PGEN_.00g011260	Scaffold_01	29365115	29366353	Q99999	G3ST1_HUMAN	Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)	GO:0000139; GO:0001733; GO:0005887; GO:0006487; GO:0006682; GO:0007283; GO:0008146; GO:0016020; GO:0042552	Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; galactosylceramide biosynthetic process [GO:0006682]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]
PGEN_.00g011270	Scaffold_01	29371938	29372966	Q0VCH4	G3ST3_BOVIN	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g011280	Scaffold_01	29383727	29454277	Q9Y2I6	NINL_HUMAN	Ninein-like protein	GO:0000086; GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0010389; GO:0034454; GO:0045171; GO:0097711	centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; calcium ion binding [GO:0005509]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule anchoring at centrosome [GO:0034454]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]
PGEN_.00g011290	Scaffold_01	29463050	29469978	NA	NA	NA	NA	NA
PGEN_.00g011300	Scaffold_01	29477149	29477382	NA	NA	NA	NA	NA
PGEN_.00g011310	Scaffold_01	29527232	29528704	NA	NA	NA	NA	NA
PGEN_.00g011320	Scaffold_01	29528735	29529364	NA	NA	NA	NA	NA
PGEN_.00g011330	Scaffold_01	29548168	29548993	NA	NA	NA	NA	NA
PGEN_.00g011340	Scaffold_01	29611085	29613743	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g011350	Scaffold_01	29621195	29630566	Q90660	BIR_CHICK	Inhibitor of apoptosis protein (IAP) (Inhibitor of T-cell apoptosis protein)	GO:0005634; GO:0005737; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0060546; GO:0061630; GO:1990001	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; positive regulation of protein ubiquitination [GO:0031398]
PGEN_.00g011360	Scaffold_01	29643957	29662566	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g011370	Scaffold_01	29668982	29675488	Q90660	BIR_CHICK	Inhibitor of apoptosis protein (IAP) (Inhibitor of T-cell apoptosis protein)	GO:0005634; GO:0005737; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0060546; GO:0061630; GO:1990001	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; positive regulation of protein ubiquitination [GO:0031398]
PGEN_.00g011380	Scaffold_01	29682835	29683095	NA	NA	NA	NA	NA
PGEN_.00g011390	Scaffold_01	29692281	29694815	NA	NA	NA	NA	NA
PGEN_.00g011400	Scaffold_01	29695986	29696672	NA	NA	NA	NA	NA
PGEN_.00g011410	Scaffold_01	29706645	29708230	NA	NA	NA	NA	NA
PGEN_.00g011420	Scaffold_01	29710274	29711033	NA	NA	NA	NA	NA
PGEN_.00g011430	Scaffold_01	29711131	29719182	Q9NJ15	PCSK5_BRACL	Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase PC6-like) (aPC6)	GO:0004252; GO:0005576; GO:0005886; GO:0016021	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g011440	Scaffold_01	29731972	29732361	NA	NA	NA	NA	NA
PGEN_.00g011450	Scaffold_01	29740888	29742776	NA	NA	NA	NA	NA
PGEN_.00g011460	Scaffold_01	29742800	29744390	NA	NA	NA	NA	NA
PGEN_.00g011470	Scaffold_01	29748169	29748711	NA	NA	NA	NA	NA
PGEN_.00g011480	Scaffold_01	29750146	29750634	NA	NA	NA	NA	NA
PGEN_.00g011490	Scaffold_01	29805852	29814291	A0PA85	DCE1_CANLF	Glutamate decarboxylase 1 (EC 4.1.1.15) (67 kDa glutamic acid decarboxylase) (GAD-67) (Glutamate decarboxylase 67 kDa isoform)	GO:0004351; GO:0019752; GO:0030170; GO:0042136	glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]; carboxylic acid metabolic process [GO:0019752]; neurotransmitter biosynthetic process [GO:0042136]
PGEN_.00g011500	Scaffold_01	29819576	29832192	P29121	PCSK4_MOUSE	Proprotein convertase subtilisin/kexin type 4 (EC 3.4.21.-) (KEX2-like endoprotease 3) (Neuroendocrine convertase 3) (NEC 3) (Prohormone convertase 3)	GO:0001669; GO:0002080; GO:0004252; GO:0005788; GO:0005802; GO:0007339; GO:0007340; GO:0009566; GO:0016020; GO:0016485; GO:0016486; GO:0022414; GO:0030173; GO:0048240	acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; endoplasmic reticulum lumen [GO:0005788]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240]
PGEN_.00g011510	Scaffold_01	29841546	29843237	NA	NA	NA	NA	NA
PGEN_.00g011520	Scaffold_01	29844959	29846425	NA	NA	NA	NA	NA
PGEN_.00g011530	Scaffold_01	29850703	29862591	P29119	FURI1_XENLA	Furin-1 (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE)	GO:0004252; GO:0005576; GO:0005794; GO:0005886; GO:0010008; GO:0016021; GO:0046872; GO:1901394	endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; positive regulation of transforming growth factor beta1 activation [GO:1901394]
PGEN_.00g011540	Scaffold_01	29875076	29887372	NA	NA	NA	NA	NA
PGEN_.00g011550	Scaffold_01	29890616	29890903	NA	NA	NA	NA	NA
PGEN_.00g011560	Scaffold_01	29896379	29921909	Q93235	AT1B1_CAEEL	Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1)	GO:0001671; GO:0005623; GO:0005890; GO:0006883; GO:0010248; GO:0030007; GO:0036376; GO:1990573	cell [GO:0005623]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]
PGEN_.00g011570	Scaffold_01	29940943	29991460	NA	NA	NA	NA	NA
PGEN_.00g011580	Scaffold_01	30017337	30059633	A8C752	THADA_CHLAE	Thyroid adenoma-associated protein homolog		
PGEN_.00g011590	Scaffold_01	30062073	30062864	NA	NA	NA	NA	NA
PGEN_.00g011600	Scaffold_01	30094762	30095037	NA	NA	NA	NA	NA
PGEN_.00g011610	Scaffold_01	30113088	30113861	NA	NA	NA	NA	NA
PGEN_.00g011620	Scaffold_01	30177164	30276892	P48037	ANXA6_RAT	Annexin A6 (Annexin VI) (Annexin-6) (Calcium-binding protein 65/67) (CBP 65/67)	GO:0001778; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005525; GO:0005544; GO:0005634; GO:0005737; GO:0005739; GO:0005765; GO:0005925; GO:0006816; GO:0006937; GO:0008289; GO:0014704; GO:0015276; GO:0015485; GO:0016020; GO:0016324; GO:0031902; GO:0032991; GO:0034220; GO:0035374; GO:0042383; GO:0042470; GO:0042803; GO:0044877; GO:0046903; GO:0048306; GO:0048471; GO:0051015; GO:0051260; GO:0051283; GO:0051560; GO:0097190	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; plasma membrane repair [GO:0001778]; protein homooligomerization [GO:0051260]; regulation of muscle contraction [GO:0006937]; secretion [GO:0046903]
PGEN_.00g011630	Scaffold_01	30278618	30297953	Q8N841	TTLL6_HUMAN	Tubulin polyglutamylase TTLL6 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 6)	GO:0001578; GO:0003353; GO:0005524; GO:0005829; GO:0005874; GO:0015631; GO:0018095; GO:0036064; GO:0051013; GO:0070739	ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]
PGEN_.00g011640	Scaffold_01	30300028	30301398	NA	NA	NA	NA	NA
PGEN_.00g011650	Scaffold_01	30303804	30320827	NA	NA	NA	NA	NA
PGEN_.00g011660	Scaffold_01	30349861	30358458	Q9GLR0	NEC2_BOVIN	Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (Prohormone convertase 2) (Proprotein convertase 2) (PC2)	GO:0004252; GO:0005615; GO:0005802; GO:0006508; GO:0007399; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0030133; GO:0030173	extracellular space [GO:0005615]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; serine-type endopeptidase activity [GO:0004252]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]
PGEN_.00g011670	Scaffold_01	30428666	30456357	Q9D565	WDR64_MOUSE	WD repeat-containing protein 64		
PGEN_.00g011680	Scaffold_01	30457893	30458957	Q96PF2	TSSK2_HUMAN	Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B)	GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0006468; GO:0007275; GO:0007286; GO:0018105; GO:0035556; GO:0044877; GO:0046777	acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]
PGEN_.00g011690	Scaffold_01	30459312	30462129	Q3SZW1	TSSK1_BOVIN	Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1)	GO:0001669; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007275; GO:0007286; GO:0031514; GO:0035556; GO:0046872	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]
PGEN_.00g011700	Scaffold_01	30467969	30477576	Q9UI42	CBPA4_HUMAN	Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3)	GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0016573	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; histone acetylation [GO:0016573]; proteolysis [GO:0006508]
PGEN_.00g011710	Scaffold_01	30496151	30524602	Q6PJG2	EMSA1_HUMAN	ELM2 and SANT domain-containing protein 1 (MIDEAS)	GO:0000118; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0008134; GO:0044212	"histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]"
PGEN_.00g011720	Scaffold_01	30524812	30536166	Q9H0D2	ZN541_HUMAN	Zinc finger protein 541	GO:0000118; GO:0000981; GO:0003700; GO:0005634; GO:0005667; GO:0007275; GO:0007283; GO:0008134; GO:0030154; GO:0044212; GO:0046872	"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]"
PGEN_.00g011730	Scaffold_01	30538958	30546317	NA	NA	NA	NA	NA
PGEN_.00g011740	Scaffold_01	30553302	30599610	O43374	RASL2_HUMAN	Ras GTPase-activating protein 4 (Calcium-promoted Ras inactivator) (Ras p21 protein activator 4) (RasGAP-activating-like protein 2)	GO:0000165; GO:0005096; GO:0005543; GO:0005829; GO:0005886; GO:0034260; GO:0046580; GO:0046872; GO:0071277	cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cellular response to calcium ion [GO:0071277]; MAPK cascade [GO:0000165]; negative regulation of GTPase activity [GO:0034260]; negative regulation of Ras protein signal transduction [GO:0046580]
PGEN_.00g011750	Scaffold_01	30612888	30613127	NA	NA	NA	NA	NA
PGEN_.00g011760	Scaffold_01	30623543	30636085	NA	NA	NA	NA	NA
PGEN_.00g011770	Scaffold_01	30648205	30661448	A1L2F3	NUSAP_DANRE	Nucleolar and spindle-associated protein 1 (NuSAP)	GO:0000281; GO:0001755; GO:0003677; GO:0005623; GO:0005730; GO:0005737; GO:0005874; GO:0007076; GO:0008017; GO:0040001; GO:0072686	cell [GO:0005623]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; neural crest cell migration [GO:0001755]
PGEN_.00g011780	Scaffold_01	30668457	30668789	NA	NA	NA	NA	NA
PGEN_.00g011790	Scaffold_01	30713938	30716121	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g011800	Scaffold_01	30742143	30749166	Q5E971	TMEDA_BOVIN	Transmembrane emp24 domain-containing protein 10 (21 kDa transmembrane-trafficking protein) (Transmembrane protein Tmp21) (p24 family protein delta-1) (p24delta1)	GO:0000139; GO:0005623; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0016021; GO:0019905; GO:0030134; GO:0030137; GO:0030140; GO:0030658; GO:0030667; GO:0033116; GO:0035964; GO:0042470; GO:0042589; GO:0045055; GO:0070765; GO:1902003	"cell [GO:0005623]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; syntaxin binding [GO:0019905]; COPI-coated vesicle budding [GO:0035964]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g011810	Scaffold_01	30761026	30761835	NA	NA	NA	NA	NA
PGEN_.00g011820	Scaffold_01	30813845	30816716	NA	NA	NA	NA	NA
PGEN_.00g011830	Scaffold_01	30824907	30825566	Q03400	SANT_PLAF7	S-antigen protein	GO:0020003	symbiont-containing vacuole [GO:0020003]
PGEN_.00g011840	Scaffold_01	30832756	30843486	NA	NA	NA	NA	NA
PGEN_.00g011850	Scaffold_01	30861663	30862432	NA	NA	NA	NA	NA
PGEN_.00g011860	Scaffold_01	30865809	30866989	NA	NA	NA	NA	NA
PGEN_.00g011870	Scaffold_01	30880431	30880637	NA	NA	NA	NA	NA
PGEN_.00g011880	Scaffold_01	30880698	30884579	NA	NA	NA	NA	NA
PGEN_.00g011890	Scaffold_01	30889633	30909169	P81282	CSPG2_BOVIN	Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M)	GO:0001501; GO:0001750; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0033165	extracellular matrix [GO:0031012]; interphotoreceptor matrix [GO:0033165]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g011900	Scaffold_01	30917545	30944228	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g011910	Scaffold_01	30947063	30948268	NA	NA	NA	NA	NA
PGEN_.00g011920	Scaffold_01	30951299	30952501	NA	NA	NA	NA	NA
PGEN_.00g011930	Scaffold_01	30983278	30983562	NA	NA	NA	NA	NA
PGEN_.00g011940	Scaffold_01	31018017	31023606	NA	NA	NA	NA	NA
PGEN_.00g011950	Scaffold_01	31031480	31031872	NA	NA	NA	NA	NA
PGEN_.00g011960	Scaffold_01	31042050	31043309	NA	NA	NA	NA	NA
PGEN_.00g011970	Scaffold_01	31059339	31061768	NA	NA	NA	NA	NA
PGEN_.00g011980	Scaffold_01	31088501	31096357	NA	NA	NA	NA	NA
PGEN_.00g011990	Scaffold_01	31105847	31123265	P45878	FKBP2_MOUSE	Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase)	GO:0003755; GO:0005789	endoplasmic reticulum membrane [GO:0005789]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
PGEN_.00g012000	Scaffold_01	31128418	31131520	NA	NA	NA	NA	NA
PGEN_.00g012010	Scaffold_01	31140228	31144599	NA	NA	NA	NA	NA
PGEN_.00g012020	Scaffold_01	31157616	31164852	NA	NA	NA	NA	NA
PGEN_.00g012030	Scaffold_01	31168183	31189817	NA	NA	NA	NA	NA
PGEN_.00g012040	Scaffold_01	31200517	31213725	P81491	SAA5_MESAU	Serum amyloid A-5 protein	GO:0006953; GO:0034364	high-density lipoprotein particle [GO:0034364]; acute-phase response [GO:0006953]
PGEN_.00g012050	Scaffold_01	31216523	31220986	NA	NA	NA	NA	NA
PGEN_.00g012060	Scaffold_01	31225498	31225947	NA	NA	NA	NA	NA
PGEN_.00g012070	Scaffold_01	31230201	31237352	P02740	SAA_ANAPL	Serum amyloid A protein (SAA)	GO:0006953; GO:0034364	high-density lipoprotein particle [GO:0034364]; acute-phase response [GO:0006953]
PGEN_.00g012080	Scaffold_01	31255062	31256914	NA	NA	NA	NA	NA
PGEN_.00g012090	Scaffold_01	31262507	31273491	NA	NA	NA	NA	NA
PGEN_.00g012100	Scaffold_01	31405275	31421399	NA	NA	NA	NA	NA
PGEN_.00g012110	Scaffold_01	31428058	31455655	NA	NA	NA	NA	NA
PGEN_.00g012120	Scaffold_01	31482254	31533907	Q96L93	KI16B_HUMAN	Kinesin-like protein KIF16B (Sorting nexin-23)	GO:0001704; GO:0001919; GO:0003777; GO:0005524; GO:0005547; GO:0005768; GO:0005769; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0017137; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0045335; GO:0071346; GO:0080025	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Rab GTPase binding [GO:0017137]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]"
PGEN_.00g012130	Scaffold_01	31541003	31551554	Q5U2R3	FRMD8_RAT	FERM domain-containing protein 8	GO:0005829; GO:0005856; GO:0005886; GO:1904469	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; positive regulation of tumor necrosis factor secretion [GO:1904469]
PGEN_.00g012140	Scaffold_01	31588684	31596690	Q9Y253	POLH_HUMAN	DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)	GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0019985; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]; translesion synthesis [GO:0019985]
PGEN_.00g012150	Scaffold_01	31597087	31598204	NA	NA	NA	NA	NA
PGEN_.00g012160	Scaffold_01	31616745	31657629	Q8IV61	GRP3_HUMAN	Ras guanyl-releasing protein 3 (Calcium and DAG-regulated guanine nucleotide exchange factor III) (Guanine nucleotide exchange factor for Rap1)	GO:0000165; GO:0005085; GO:0005088; GO:0005096; GO:0005509; GO:0005886; GO:0005887; GO:0007264; GO:0007265; GO:0019900; GO:0019992; GO:0032045; GO:0048471	guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; MAPK cascade [GO:0000165]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g012170	Scaffold_01	31629845	31630756	NA	NA	NA	NA	NA
PGEN_.00g012180	Scaffold_01	31723848	31756209	Q6P4F7	RHGBA_HUMAN	Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A)	GO:0005096; GO:0005829; GO:0007165; GO:0051056	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]
PGEN_.00g012190	Scaffold_01	31765073	31790958	P62743	AP2S1_MOUSE	AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma-adaptin 3b) (Sigma2-adaptin)	GO:0006886; GO:0016192; GO:0030122; GO:0035615; GO:0043231; GO:0072583	AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231]; clathrin adaptor activity [GO:0035615]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g012200	Scaffold_01	31793785	31795263	P00185	CP1A1_RAT	Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Cytochrome P450MT2) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B]	GO:0001666; GO:0001889; GO:0002933; GO:0003824; GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0006778; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0008395; GO:0009308; GO:0009404; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009636; GO:0009804; GO:0009812; GO:0010033; GO:0010041; GO:0014070; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0016829; GO:0017143; GO:0017144; GO:0018894; GO:0019341; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0032502; GO:0033189; GO:0035902; GO:0042493; GO:0042572; GO:0042904; GO:0043010; GO:0043231; GO:0046483; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0055114; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0101020; GO:0101021; GO:1900087	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; developmental process [GO:0032502]; dibenzo-p-dioxin catabolic process [GO:0019341]; dibenzo-p-dioxin metabolic process [GO:0018894]; digestive tract development [GO:0048565]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; liver development [GO:0001889]; maternal process involved in parturition [GO:0060137]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]"
PGEN_.00g012210	Scaffold_01	31795458	31809638	NA	NA	NA	NA	NA
PGEN_.00g012220	Scaffold_01	31809729	31810076	NA	NA	NA	NA	NA
PGEN_.00g012230	Scaffold_01	31810423	31810740	NA	NA	NA	NA	NA
PGEN_.00g012240	Scaffold_01	31811585	31814674	NA	NA	NA	NA	NA
PGEN_.00g012250	Scaffold_01	31825694	31836794	NA	NA	NA	NA	NA
PGEN_.00g012260	Scaffold_01	31839704	31840543	NA	NA	NA	NA	NA
PGEN_.00g012270	Scaffold_01	31849751	31851598	Q5EA79	GALM_BOVIN	Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase)	GO:0004034; GO:0005737; GO:0006006; GO:0030246; GO:0033499	cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]
PGEN_.00g012280	Scaffold_01	31852156	31859297	Q8K157	GALM_MOUSE	Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase)	GO:0004034; GO:0005737; GO:0005975; GO:0006006; GO:0006012; GO:0030246; GO:0033499	cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006]
PGEN_.00g012290	Scaffold_01	31861369	31878921	Q0V9M0	CRAC1_XENTR	Cartilage acidic protein 1 (ASPIC)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g012300	Scaffold_01	31879112	31879360	NA	NA	NA	NA	NA
PGEN_.00g012310	Scaffold_01	31882862	31896676	NA	NA	NA	NA	NA
PGEN_.00g012320	Scaffold_01	31900110	31914463	NA	NA	NA	NA	NA
PGEN_.00g012330	Scaffold_01	31917649	31949364	Q7QC84	MMSA_ANOGA	"Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)"	GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478	mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]
PGEN_.00g012340	Scaffold_01	31954439	31970687	Q8VDQ8	SIR2_MOUSE	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2)	GO:0000122; GO:0003682; GO:0003950; GO:0004407; GO:0005634; GO:0005694; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006471; GO:0006476; GO:0006914; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0010801; GO:0014065; GO:0016575; GO:0017136; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0035035; GO:0035729; GO:0035748; GO:0042177; GO:0042826; GO:0042903; GO:0043066; GO:0043130; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0043491; GO:0044224; GO:0044242; GO:0045598; GO:0045599; GO:0045836; GO:0045843; GO:0045892; GO:0045944; GO:0046970; GO:0048012; GO:0048471; GO:0048715; GO:0051301; GO:0051321; GO:0051726; GO:0051781; GO:0051987; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070932; GO:0070933; GO:0071219; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0097456; GO:0098978; GO:0099149; GO:1900119; GO:1900195; GO:1900226; GO:1900425; GO:2000378; GO:2000777	"centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; terminal loop [GO:0097456]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; regulation of cell cycle [GO:0051726]; regulation of fat cell differentiation [GO:0045598]; regulation of myelination [GO:0031641]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; tubulin deacetylation [GO:0090042]"
PGEN_.00g012350	Scaffold_01	31973614	31987686	Q8IXJ6	SIR2_HUMAN	NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)	GO:0000122; GO:0000183; GO:0000781; GO:0003682; GO:0003950; GO:0004407; GO:0005634; GO:0005677; GO:0005694; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006342; GO:0006348; GO:0006471; GO:0006476; GO:0006914; GO:0007096; GO:0008134; GO:0008270; GO:0008285; GO:0010507; GO:0010801; GO:0014065; GO:0016575; GO:0017136; GO:0021762; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0035035; GO:0035729; GO:0042177; GO:0042325; GO:0042826; GO:0042903; GO:0043130; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0043491; GO:0044224; GO:0044242; GO:0045087; GO:0045599; GO:0045836; GO:0045843; GO:0045892; GO:0045944; GO:0046970; GO:0048012; GO:0048471; GO:0051301; GO:0051321; GO:0051726; GO:0051775; GO:0051781; GO:0051987; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070932; GO:0070933; GO:0071219; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:1900119; GO:1900195; GO:1900226; GO:1900425; GO:2000378; GO:2000777	"centriole [GO:0005814]; centrosome [GO:0005813]; chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; protein deacetylase activity [GO:0033558]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; chromatin silencing [GO:0006342]; chromatin silencing at rDNA [GO:0000183]; chromatin silencing at telomere [GO:0006348]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; innate immune response [GO:0045087]; meiotic cell cycle [GO:0051321]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; regulation of cell cycle [GO:0051726]; regulation of exit from mitosis [GO:0007096]; regulation of myelination [GO:0031641]; regulation of phosphorylation [GO:0042325]; response to redox state [GO:0051775]; substantia nigra development [GO:0021762]; tubulin deacetylation [GO:0090042]"
PGEN_.00g012360	Scaffold_01	32072589	32094859	Q9DBM0	ABCG8_MOUSE	ATP-binding cassette sub-family G member 8 (EC 7.6.2.-) (Sterolin-2)	GO:0005524; GO:0005886; GO:0005887; GO:0007584; GO:0007588; GO:0010949; GO:0015914; GO:0015918; GO:0016324; GO:0016887; GO:0030299; GO:0033344; GO:0042493; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045796; GO:0046872; GO:0046982; GO:0055085; GO:0055092; GO:0120020	apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; phospholipid transport [GO:0015914]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; sterol homeostasis [GO:0055092]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]
PGEN_.00g012370	Scaffold_01	32097621	32107220	NA	NA	NA	NA	NA
PGEN_.00g012380	Scaffold_01	32119668	32124541	NA	NA	NA	NA	NA
PGEN_.00g012390	Scaffold_01	32124701	32128212	NA	NA	NA	NA	NA
PGEN_.00g012400	Scaffold_01	32128299	32151805	NA	NA	NA	NA	NA
PGEN_.00g012410	Scaffold_01	32156950	32169646	P28663	SNAB_MOUSE	Beta-soluble NSF attachment protein (SNAP-beta) (Brain protein I47) (N-ethylmaleimide-sensitive factor attachment protein beta)	GO:0000149; GO:0002090; GO:0005483; GO:0005774; GO:0006886; GO:0010807; GO:0019905; GO:0031201; GO:0032984; GO:0035249; GO:0035494; GO:0043209; GO:0043462; GO:0048488; GO:0070044; GO:0098793; GO:0098794; GO:0098978	"glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; postsynapse [GO:0098794]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; vacuolar membrane [GO:0005774]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; protein-containing complex disassembly [GO:0032984]; regulation of ATPase activity [GO:0043462]; regulation of receptor internalization [GO:0002090]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]"
PGEN_.00g012420	Scaffold_01	32179515	32197273	Q9QYE6	GOGA5_MOUSE	Golgin subfamily A member 5 (Golgin-84) (Protein Ret-II) (Protein Sumiko)	GO:0000137; GO:0000138; GO:0000139; GO:0000301; GO:0005794; GO:0005797; GO:0005801; GO:0007030; GO:0016021; GO:0017137; GO:0030663; GO:0030674; GO:0031985; GO:0042803; GO:0048193	"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna [GO:0031985]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; protein binding, bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"
PGEN_.00g012430	Scaffold_01	32201192	32224834	Q5M9F5	DPH6_RAT	Diphthine--ammonia ligase (EC 6.3.1.14) (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)	GO:0005524; GO:0017178; GO:0017183	ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]
PGEN_.00g012440	Scaffold_01	32228898	32229401	NA	NA	NA	NA	NA
PGEN_.00g012450	Scaffold_01	32246527	32254458	NA	NA	NA	NA	NA
PGEN_.00g012460	Scaffold_01	32257260	32263800	Q28G71	FOXN3_XENTR	Forkhead box protein N3	GO:0003700; GO:0005634; GO:0007049; GO:0043565; GO:0045892	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g012470	Scaffold_01	32289113	32309100	Q9Y394	DHRS7_HUMAN	Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)	GO:0016020; GO:0016491	membrane [GO:0016020]; oxidoreductase activity [GO:0016491]
PGEN_.00g012480	Scaffold_01	32346006	32360790	NA	NA	NA	NA	NA
PGEN_.00g012490	Scaffold_01	32360816	32365029	NA	NA	NA	NA	NA
PGEN_.00g012500	Scaffold_01	32383423	32398599	A4IIU3	TM196_XENTR	Transmembrane protein 196	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g012510	Scaffold_01	32401026	32401559	NA	NA	NA	NA	NA
PGEN_.00g012520	Scaffold_01	32405711	32406277	NA	NA	NA	NA	NA
PGEN_.00g012530	Scaffold_01	32424053	32427576	NA	NA	NA	NA	NA
PGEN_.00g012540	Scaffold_01	32433924	32435066	Q4V622	CCH2R_DROME	Neuropeptide CCHamide-2 receptor	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g012550	Scaffold_01	32442353	32458898	NA	NA	NA	NA	NA
PGEN_.00g012560	Scaffold_01	32458924	32473768	NA	NA	NA	NA	NA
PGEN_.00g012570	Scaffold_01	32476162	32482846	NA	NA	NA	NA	NA
PGEN_.00g012580	Scaffold_01	32483098	32487181	Q5U3N7	CHUR_DANRE	Protein Churchill	GO:0008270; GO:0030334; GO:0030336; GO:0040037; GO:0042074; GO:0042661; GO:0045893; GO:0090243	"zinc ion binding [GO:0008270]; cell migration involved in gastrulation [GO:0042074]; fibroblast growth factor receptor signaling pathway involved in somitogenesis [GO:0090243]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell migration [GO:0030334]; regulation of mesodermal cell fate specification [GO:0042661]"
PGEN_.00g012590	Scaffold_01	32494202	32497846	Q9DCX1	MD2BP_MOUSE	MAD2L1-binding protein	GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0007093; GO:0007094; GO:0007096; GO:0031965	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; regulation of exit from mitosis [GO:0007096]
PGEN_.00g012600	Scaffold_01	32498146	32498454	NA	NA	NA	NA	NA
PGEN_.00g012610	Scaffold_01	32504901	32505470	B3DL53	NDK6_XENTR	Nucleoside diphosphate kinase 6 (NDK 6) (NDP kinase 6) (EC 2.7.4.6)	GO:0004550; GO:0005524; GO:0006183; GO:0006228; GO:0006241; GO:0046872	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]
PGEN_.00g012620	Scaffold_01	32505578	32506930	NA	NA	NA	NA	NA
PGEN_.00g012630	Scaffold_01	32512080	32513363	NA	NA	NA	NA	NA
PGEN_.00g012640	Scaffold_01	32561207	32575393	Q53G44	IF44L_HUMAN	Interferon-induced protein 44-like	GO:0005525; GO:0005737; GO:0006955; GO:0051607	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]
PGEN_.00g012650	Scaffold_01	32598940	32604768	P27473	IFI44_PANTR	Interferon-induced protein 44 (Antigen p44) (Non-A non-B hepatitis-associated microtubular aggregates protein)	GO:0005737; GO:0006955; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]
PGEN_.00g012660	Scaffold_01	32664779	32667188	NA	NA	NA	NA	NA
PGEN_.00g012670	Scaffold_01	32741135	32741865	NA	NA	NA	NA	NA
PGEN_.00g012680	Scaffold_01	32766898	32769853	NA	NA	NA	NA	NA
PGEN_.00g012690	Scaffold_01	32799487	32799795	NA	NA	NA	NA	NA
PGEN_.00g012700	Scaffold_01	32799876	32800106	NA	NA	NA	NA	NA
PGEN_.00g012710	Scaffold_01	32919454	32920854	NA	NA	NA	NA	NA
PGEN_.00g012720	Scaffold_01	32948068	32952620	NA	NA	NA	NA	NA
PGEN_.00g012730	Scaffold_01	33076206	33077795	Q6UNA4	C5AR1_ONCMY	C5a anaphylatoxin chemotactic receptor 1 (C5a anaphylatoxin chemotactic receptor) (C5a-R) (C5aR)	GO:0001856; GO:0002690; GO:0004878; GO:0004930; GO:0006935; GO:0016021; GO:0016323; GO:0042789; GO:0045177; GO:0050679; GO:0070374; GO:0071624	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; complement component C5a binding [GO:0001856]; complement component C5a receptor activity [GO:0004878]; G protein-coupled receptor activity [GO:0004930]; chemotaxis [GO:0006935]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of granulocyte chemotaxis [GO:0071624]; positive regulation of leukocyte chemotaxis [GO:0002690]
PGEN_.00g012740	Scaffold_01	33146473	33151176	NA	NA	NA	NA	NA
PGEN_.00g012750	Scaffold_01	33170124	33182318	NA	NA	NA	NA	NA
PGEN_.00g012760	Scaffold_01	33225736	33226065	NA	NA	NA	NA	NA
PGEN_.00g012770	Scaffold_01	33256150	33257514	NA	NA	NA	NA	NA
PGEN_.00g012780	Scaffold_01	33296824	33414854	Q9UM73	ALK_HUMAN	ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246)	GO:0000187; GO:0004704; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0008283; GO:0016310; GO:0021766; GO:0030534; GO:0032991; GO:0036269; GO:0042127; GO:0042802; GO:0042981; GO:0043235; GO:0045664; GO:0046777; GO:0048666; GO:0051092; GO:0060159; GO:0070062; GO:0090648; GO:1900006	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; cell population proliferation [GO:0008283]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; phosphorylation [GO:0016310]; positive regulation of dendrite development [GO:1900006]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g012790	Scaffold_01	33321932	33323234	NA	NA	NA	NA	NA
PGEN_.00g012800	Scaffold_01	33411432	33411998	NA	NA	NA	NA	NA
PGEN_.00g012810	Scaffold_01	33424913	33427345	NA	NA	NA	NA	NA
PGEN_.00g012820	Scaffold_01	33441295	33442056	NA	NA	NA	NA	NA
PGEN_.00g012830	Scaffold_01	33450403	33450660	NA	NA	NA	NA	NA
PGEN_.00g012840	Scaffold_01	33456420	33476884	Q9NUC0	SRTD4_HUMAN	SERTA domain-containing protein 4	GO:0005634	nucleus [GO:0005634]
PGEN_.00g012850	Scaffold_01	33532692	33533843	NA	NA	NA	NA	NA
PGEN_.00g012860	Scaffold_01	33563836	33570561	Q03017	CACT_DROME	NF-kappa-B inhibitor cactus	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]
PGEN_.00g012870	Scaffold_01	33585915	33592988	Q5BL29	S39A9_DANRE	Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9)	GO:0005385; GO:0006829; GO:0016021	integral component of membrane [GO:0016021]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transport [GO:0006829]
PGEN_.00g012880	Scaffold_01	33594393	33597629	NA	NA	NA	NA	NA
PGEN_.00g012890	Scaffold_01	33602121	33620460	Q99M87	DNJA3_MOUSE	"DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (mTid-1) (Tumorous imaginal discs protein Tid56 homolog)"	GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005884; GO:0005886; GO:0006264; GO:0006457; GO:0006469; GO:0006915; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0007569; GO:0008134; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030054; GO:0030544; GO:0030695; GO:0030971; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0071340; GO:0106137	actin filament [GO:0005884]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]
PGEN_.00g012900	Scaffold_01	33619705	33619968	NA	NA	NA	NA	NA
PGEN_.00g012910	Scaffold_01	33633935	33685480	Q9H4F8	SMOC1_HUMAN	SPARC-related modular calcium-binding protein 1 (Secreted modular calcium-binding protein 1) (SMOC-1)	GO:0001654; GO:0005509; GO:0005604; GO:0030154; GO:0045667; GO:0050840; GO:0060173	basement membrane [GO:0005604]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; cell differentiation [GO:0030154]; eye development [GO:0001654]; limb development [GO:0060173]; regulation of osteoblast differentiation [GO:0045667]
PGEN_.00g012920	Scaffold_01	33694552	33697169	NA	NA	NA	NA	NA
PGEN_.00g012930	Scaffold_01	33697700	33698152	NA	NA	NA	NA	NA
PGEN_.00g012940	Scaffold_01	33698828	33700262	NA	NA	NA	NA	NA
PGEN_.00g012950	Scaffold_01	33700304	33702244	NA	NA	NA	NA	NA
PGEN_.00g012960	Scaffold_01	33706055	33714259	NA	NA	NA	NA	NA
PGEN_.00g012970	Scaffold_01	33716563	33717648	NA	NA	NA	NA	NA
PGEN_.00g012980	Scaffold_01	33730802	33738033	Q9NNZ3	DNJC4_HUMAN	DnaJ homolog subfamily C member 4 (DnaJ-like protein HSPF2) (Multiple endocrine neoplasia type 1 candidate protein number 18)	GO:0006457; GO:0006986; GO:0016020; GO:0016021; GO:0051082	integral component of membrane [GO:0016021]; membrane [GO:0016020]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986]
PGEN_.00g012990	Scaffold_01	33751881	33753341	NA	NA	NA	NA	NA
PGEN_.00g013000	Scaffold_01	33762293	33764125	NA	NA	NA	NA	NA
PGEN_.00g013010	Scaffold_01	33770805	33778623	Q8BMT9	HHAT_MOUSE	Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Skinny hedgehog protein)	GO:0005525; GO:0005783; GO:0005789; GO:0007224; GO:0007275; GO:0016021; GO:0016409; GO:0016746; GO:0018345	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525]; palmitoyltransferase activity [GO:0016409]; transferase activity, transferring acyl groups [GO:0016746]; multicellular organism development [GO:0007275]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224]"
PGEN_.00g013020	Scaffold_01	33857437	33868007	Q8NCM2	KCNH5_HUMAN	Potassium voltage-gated channel subfamily H member 5 (Ether-a-go-go potassium channel 2) (hEAG2) (Voltage-gated potassium channel subunit Kv10.2)	GO:0005249; GO:0005516; GO:0005886; GO:0005887; GO:0009986; GO:0010389; GO:0034765; GO:0042391; GO:0044325; GO:0046982; GO:0071805	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]
PGEN_.00g013030	Scaffold_01	33885988	33890644	O18965	KCNH1_BOVIN	Potassium voltage-gated channel subfamily H member 1 (Ether-a-go-go potassium channel 1) (EAG channel 1) (bEAG) (Voltage-gated potassium channel subunit Kv10.1)	GO:0005249; GO:0005251; GO:0005516; GO:0005637; GO:0005887; GO:0008076; GO:0030054; GO:0030424; GO:0030425; GO:0031901; GO:0034765; GO:0042127; GO:0042391; GO:0042734; GO:0043204; GO:0048015; GO:0071277; GO:0071805; GO:0098839; GO:1902936	axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; nuclear inner membrane [GO:0005637]; perikaryon [GO:0043204]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; phosphatidylinositol bisphosphate binding [GO:1902936]; voltage-gated potassium channel activity [GO:0005249]; cellular response to calcium ion [GO:0071277]; phosphatidylinositol-mediated signaling [GO:0048015]; potassium ion transmembrane transport [GO:0071805]; regulation of cell population proliferation [GO:0042127]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]
PGEN_.00g013040	Scaffold_01	33967909	33973330	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g013050	Scaffold_01	33986861	33987193	NA	NA	NA	NA	NA
PGEN_.00g013060	Scaffold_01	33987997	34002505	NA	NA	NA	NA	NA
PGEN_.00g013070	Scaffold_01	34060815	34075932	NA	NA	NA	NA	NA
PGEN_.00g013080	Scaffold_01	34106441	34158275	Q69ZR2	HECD1_MOUSE	E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1) (Protein open mind)	GO:0001779; GO:0001843; GO:0001892; GO:0003170; GO:0003281; GO:0035904; GO:0046872; GO:0051865; GO:0060707; GO:0060708; GO:0061630; GO:0070534; GO:1903077	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; aorta development [GO:0035904]; embryonic placenta development [GO:0001892]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]
PGEN_.00g013090	Scaffold_01	34158320	34170147	NA	NA	NA	NA	NA
PGEN_.00g013100	Scaffold_01	34172383	34176211	NA	NA	NA	NA	NA
PGEN_.00g013110	Scaffold_01	34178020	34178726	NA	NA	NA	NA	NA
PGEN_.00g013120	Scaffold_01	34178948	34201686	NA	NA	NA	NA	NA
PGEN_.00g013130	Scaffold_01	34214590	34224683	Q6DCX5	PCFT_XENLA	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)	GO:0005542; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]
PGEN_.00g013140	Scaffold_01	34230013	34234379	NA	NA	NA	NA	NA
PGEN_.00g013150	Scaffold_01	34253405	34263059	Q9BQ04	RBM4B_HUMAN	RNA-binding protein 4B (RNA-binding motif protein 30) (RNA-binding motif protein 4B) (RNA-binding protein 30)	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006417; GO:0007623; GO:0008270; GO:0010628; GO:0016607; GO:0032922; GO:0032991; GO:0043153; GO:0045292	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]"
PGEN_.00g013160	Scaffold_01	34269487	34272503	Q9DGJ3	NPC2_DANRE	NPC intracellular cholesterol transporter 2 (16.5 kDa secretory protein) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog)	GO:0005576; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0015918; GO:0032367; GO:0032934; GO:0033344	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]
PGEN_.00g013170	Scaffold_01	34278876	34282230	Q9DGJ3	NPC2_DANRE	NPC intracellular cholesterol transporter 2 (16.5 kDa secretory protein) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog)	GO:0005576; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0015918; GO:0032367; GO:0032934; GO:0033344	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]
PGEN_.00g013180	Scaffold_01	34284400	34293380	A6H791	TRM61_BOVIN	tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (EC 2.1.1.220) (mRNA methyladenosine-N(1)-methyltransferase catalytic subunit TRMT61A) (EC 2.1.1.-) (tRNA(m1A58)-methyltransferase subunit TRMT61A) (tRNA(m1A58)MTase subunit TRMT61A)	GO:0005634; GO:0016429; GO:0030488; GO:0031515; GO:0061953; GO:0080009	nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]
PGEN_.00g013190	Scaffold_01	34303021	34303389	NA	NA	NA	NA	NA
PGEN_.00g013200	Scaffold_01	34326215	34333186	Q7SXW3	LRC40_DANRE	Leucine-rich repeat-containing protein 40		
PGEN_.00g013210	Scaffold_01	34338748	34339089	NA	NA	NA	NA	NA
PGEN_.00g013220	Scaffold_01	34364182	34373220	NA	NA	NA	NA	NA
PGEN_.00g013230	Scaffold_01	34423517	34471593	Q63722	JAG1_RAT	Protein jagged-1 (Jagged1) (CD antigen CD339)	GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002456; GO:0003184; GO:0003215; GO:0005112; GO:0005509; GO:0005543; GO:0005886; GO:0005912; GO:0007219; GO:0009887; GO:0010628; GO:0016021; GO:0016324; GO:0022408; GO:0030336; GO:0031100; GO:0032495; GO:0035909; GO:0042060; GO:0042127; GO:0042491; GO:0043010; GO:0045177; GO:0045596; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045746; GO:0045747; GO:0045944; GO:0048018; GO:0048839; GO:0060411; GO:0061073; GO:0061156; GO:0061309; GO:0061314; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018]; animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; aorta morphogenesis [GO:0035909]; blood vessel remodeling [GO:0001974]; camera-type eye development [GO:0043010]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; glomerular visceral epithelial cell development [GO:0072015]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of gene expression [GO:0010628]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456]; wound healing [GO:0042060]
PGEN_.00g013240	Scaffold_01	34484859	34485185	NA	NA	NA	NA	NA
PGEN_.00g013250	Scaffold_01	34485218	34485466	NA	NA	NA	NA	NA
PGEN_.00g013260	Scaffold_01	34487315	34489738	Q10741	ADA10_BOVIN	Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (Myelin-associated metalloproteinase) (CD antigen CD156c)	GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034612; GO:0042117; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]
PGEN_.00g013270	Scaffold_01	34490077	34500606	Q6IQ49	SDE2_HUMAN	Replication stress response regulator SDE2	GO:0003684; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0006260; GO:0007049; GO:0016485; GO:0016567; GO:0016607; GO:0034644; GO:0051301; GO:0071156	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; damaged DNA binding [GO:0003684]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; protein processing [GO:0016485]; protein ubiquitination [GO:0016567]; regulation of cell cycle arrest [GO:0071156]
PGEN_.00g013280	Scaffold_01	34504685	34508784	NA	NA	NA	NA	NA
PGEN_.00g013290	Scaffold_01	34512421	34532313	A4IFB1	SRRT_BOVIN	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2)	GO:0003677; GO:0005654; GO:0005737; GO:0006355; GO:0006397; GO:0008283; GO:0031053; GO:0032991; GO:0050769; GO:0097150	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of neurogenesis [GO:0050769]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g013300	Scaffold_01	34548985	34559896	Q9CZ15	PSF1_MOUSE	DNA replication complex GINS protein PSF1 (GINS complex subunit 1)	GO:0000811; GO:0001833; GO:0005634; GO:0005737; GO:0006260; GO:0043138; GO:1902983	cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; DNA replication [GO:0006260]; DNA strand elongation involved in mitotic DNA replication [GO:1902983]; inner cell mass cell proliferation [GO:0001833]
PGEN_.00g013310	Scaffold_01	34565920	34574863	Q7ZY87	PURA2_XENLA	"Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2)"	GO:0000287; GO:0004019; GO:0005525; GO:0005739; GO:0044208	mitochondrion [GO:0005739]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; 'de novo' AMP biosynthetic process [GO:0044208]
PGEN_.00g013320	Scaffold_01	34575459	34582124	NA	NA	NA	NA	NA
PGEN_.00g013330	Scaffold_01	34585683	34594672	Q17G75	PURA_AEDAE	Adenylosuccinate synthetase (AMPSase) (AdSS) (EC 6.3.4.4) (IMP--aspartate ligase)	GO:0000287; GO:0004019; GO:0005525; GO:0005737; GO:0044208	cytoplasm [GO:0005737]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; 'de novo' AMP biosynthetic process [GO:0044208]
PGEN_.00g013340	Scaffold_01	34598904	34633046	P11179	ODO2_BOVIN	"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K)"	GO:0004149; GO:0005634; GO:0005739; GO:0005759; GO:0006099; GO:0006103; GO:0006104; GO:0033512; GO:0045252; GO:0106077	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; 2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g013350	Scaffold_01	34638594	34640742	Q9CQE2	TM223_MOUSE	Transmembrane protein 223	GO:0005739; GO:0007399; GO:0016021	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nervous system development [GO:0007399]
PGEN_.00g013360	Scaffold_01	34644410	34644727	NA	NA	NA	NA	NA
PGEN_.00g013370	Scaffold_01	34648322	34677390	A8K0R7	ZN839_HUMAN	Zinc finger protein 839 (Renal carcinoma antigen NY-REN-50)	GO:0003676; GO:0046872	metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]
PGEN_.00g013380	Scaffold_01	34687119	34738449	L7UZ85	ACTN_DERFA	Alpha-actinin (F-actin cross-linking protein) (allergen Der f 24)	GO:0005509; GO:0019863; GO:0051015; GO:0051017	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; IgE binding [GO:0019863]; actin filament bundle assembly [GO:0051017]
PGEN_.00g013390	Scaffold_01	34739708	34746512	NA	NA	NA	NA	NA
PGEN_.00g013400	Scaffold_01	34753053	34783471	Q8TBE0	BAHD1_HUMAN	Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1)	GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0031507; GO:0045892	"chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g013410	Scaffold_01	34787873	34791443	NA	NA	NA	NA	NA
PGEN_.00g013420	Scaffold_01	34795781	34815410	P97878	EXOC5_RAT	Exocyst complex component 5 (71 kDa component of rsec6/8 secretory complex) (Exocyst complex component Sec10) (p71)	GO:0000145; GO:0001736; GO:0005829; GO:0006887; GO:0006893; GO:0015031; GO:0017160; GO:0030496; GO:0047485; GO:0048278; GO:0072659; GO:1904019; GO:1905515	cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; non-motile cilium assembly [GO:1905515]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking [GO:0048278]
PGEN_.00g013430	Scaffold_01	34824086	34825210	Q7Z5L3	C1QL2_HUMAN	Complement C1q-like protein 2 (C1q and tumor necrosis factor-related protein 10) (C1q/TNF-related protein 10)	GO:0005576; GO:0005581; GO:0042802	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]
PGEN_.00g013440	Scaffold_01	34863001	34863941	NA	NA	NA	NA	NA
PGEN_.00g013450	Scaffold_01	34865397	34865801	NA	NA	NA	NA	NA
PGEN_.00g013460	Scaffold_01	34874389	34899508	P28841	NEC2_RAT	Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2) (PC2)	GO:0004175; GO:0004252; GO:0005615; GO:0005654; GO:0005802; GO:0006508; GO:0007399; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030173; GO:0030425; GO:0034230; GO:0034231; GO:0034774; GO:0043025; GO:0043204; GO:0044877	dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; endopeptidase activity [GO:0004175]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]
PGEN_.00g013470	Scaffold_01	34955552	34956052	NA	NA	NA	NA	NA
PGEN_.00g013480	Scaffold_01	34963477	34963935	NA	NA	NA	NA	NA
PGEN_.00g013490	Scaffold_01	34970557	34977571	P29147	BDH_RAT	"D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH)"	GO:0001889; GO:0003858; GO:0005543; GO:0005743; GO:0005759; GO:0007420; GO:0007584; GO:0009636; GO:0009725; GO:0032355; GO:0032868; GO:0042493; GO:0042594; GO:0045471; GO:0046686; GO:0051412; GO:0060416; GO:0060612; GO:0099617	matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; liver development [GO:0001889]; response to cadmium ion [GO:0046686]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]
PGEN_.00g013500	Scaffold_01	34979674	34979910	NA	NA	NA	NA	NA
PGEN_.00g013510	Scaffold_01	34980756	34981043	NA	NA	NA	NA	NA
PGEN_.00g013520	Scaffold_01	34994072	34997604	Q8NBN7	RDH13_HUMAN	Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3)	GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650	mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]
PGEN_.00g013530	Scaffold_01	35014550	35022391	Q66HG4	GALM_RAT	Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase)	GO:0004034; GO:0005737; GO:0006006; GO:0006012; GO:0030246; GO:0033499	cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006]
PGEN_.00g013540	Scaffold_01	35023679	35024881	NA	NA	NA	NA	NA
PGEN_.00g013550	Scaffold_01	35035013	35069368	Q4JIJ3	METH_BOVIN	Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS)	GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]
PGEN_.00g013560	Scaffold_01	35069483	35083866	Q08DB5	STX5_BOVIN	Syntaxin-5	GO:0000139; GO:0000149; GO:0005484; GO:0005829; GO:0006886; GO:0006888; GO:0006906; GO:0012505; GO:0016021; GO:0031201; GO:0031982; GO:0033116; GO:0034498; GO:0045732; GO:0047485; GO:0048278; GO:0090166; GO:1903358	cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; protein N-terminus binding [GO:0047485]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]
PGEN_.00g013570	Scaffold_01	35096095	35113817	A2BDA5	DCA15_XENLA	DDB1- and CUL4-associated factor 15	GO:0016567	protein ubiquitination [GO:0016567]
PGEN_.00g013580	Scaffold_01	35125653	35147046	Q99NB1	ACS2L_MOUSE	"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)"	GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]
PGEN_.00g013590	Scaffold_01	35151932	35152153	NA	NA	NA	NA	NA
PGEN_.00g013600	Scaffold_01	35156356	35156850	NA	NA	NA	NA	NA
PGEN_.00g013610	Scaffold_01	35160427	35160720	NA	NA	NA	NA	NA
PGEN_.00g013620	Scaffold_01	35162544	35162864	NA	NA	NA	NA	NA
PGEN_.00g013630	Scaffold_01	35163357	35163587	NA	NA	NA	NA	NA
PGEN_.00g013640	Scaffold_01	35166327	35170926	NA	NA	NA	NA	NA
PGEN_.00g013650	Scaffold_01	35178295	35178657	NA	NA	NA	NA	NA
PGEN_.00g013660	Scaffold_01	35184359	35191588	NA	NA	NA	NA	NA
PGEN_.00g013670	Scaffold_01	35200434	35200817	NA	NA	NA	NA	NA
PGEN_.00g013680	Scaffold_01	35289467	35327946	NA	NA	NA	NA	NA
PGEN_.00g013690	Scaffold_01	35343819	35344331	NA	NA	NA	NA	NA
PGEN_.00g013700	Scaffold_01	35348717	35349805	NA	NA	NA	NA	NA
PGEN_.00g013710	Scaffold_01	35363146	35363538	NA	NA	NA	NA	NA
PGEN_.00g013720	Scaffold_01	35369448	35438817	Q6S5H8	TPC1_HORVU	Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1) (HvTPC1)	GO:0005244; GO:0005262; GO:0005509; GO:0006952; GO:0016021; GO:0034765	integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; voltage-gated ion channel activity [GO:0005244]; defense response [GO:0006952]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g013730	Scaffold_01	35478681	35483447	NA	NA	NA	NA	NA
PGEN_.00g013740	Scaffold_01	35493516	35547693	Q05BC3	EMAL1_MOUSE	Echinoderm microtubule-associated protein-like 1 (EMAP-1)	GO:0000226; GO:0002244; GO:0005829; GO:0005874; GO:0007052; GO:0007405; GO:0007420; GO:0008017; GO:0015631; GO:0048471	cytosol [GO:0005829]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405]
PGEN_.00g013750	Scaffold_01	35552292	35553402	NA	NA	NA	NA	NA
PGEN_.00g013760	Scaffold_01	35561891	35570574	Q63ZM9	ZN830_XENLA	Zinc finger protein 830 (Coiled-coil domain-containing protein 16)	GO:0003676; GO:0005681; GO:0005694; GO:0007049; GO:0007275; GO:0008270; GO:0016607; GO:0051301	chromosome [GO:0005694]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; multicellular organism development [GO:0007275]
PGEN_.00g013770	Scaffold_01	35570839	35593417	Q9CXC3	MGME1_MOUSE	Mitochondrial genome maintenance exonuclease 1 (EC 3.1.-.-)	GO:0000002; GO:0005739; GO:0006264; GO:0008297; GO:0043504	mitochondrion [GO:0005739]; single-stranded DNA exodeoxyribonuclease activity [GO:0008297]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002]
PGEN_.00g013780	Scaffold_01	35600665	35603509	O93403	CHST3_TETCF	Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Nervous system involved sulfotransferase)	GO:0000139; GO:0005975; GO:0008459; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 6-sulfotransferase activity [GO:0008459]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g013790	Scaffold_01	35608488	35624792	Q8VEM9	KLDC3_MOUSE	Kelch domain-containing protein 3 (Protein Peas) (Testis intracellular mediator protein)	GO:0000790; GO:0003682; GO:0005654; GO:0005737; GO:0051321	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; meiotic cell cycle [GO:0051321]
PGEN_.00g013800	Scaffold_01	35641165	35641602	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g013810	Scaffold_01	35645129	35647911	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g013820	Scaffold_01	35652521	35660620	Q8CCG1	ZC21C_MOUSE	Zinc finger C2HC domain-containing protein 1C	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g013830	Scaffold_01	35669567	35694090	Q9UHC1	MLH3_HUMAN	DNA mismatch repair protein Mlh3 (MutL protein homolog 3)	GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300	chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696]; female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130]
PGEN_.00g013840	Scaffold_01	35704766	35719480	Q9MYP6	DHB14_BOVIN	17-beta-hydroxysteroid dehydrogenase 14 (17-beta-HSD 14) (EC 1.1.1.-) (17-beta-hydroxysteroid dehydrogenase DHRS10) (Dehydrogenase/reductase SDR family member 10) (Retinal short-chain dehydrogenase/reductase retSDR3)	GO:0004303; GO:0005829; GO:0006706; GO:0042802; GO:0047045	cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706]
PGEN_.00g013850	Scaffold_01	35739294	35751785	NA	NA	NA	NA	NA
PGEN_.00g013860	Scaffold_01	35771821	35794668	P33527	MRP1_HUMAN	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0006855; GO:0008559; GO:0009235; GO:0009925; GO:0009986; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1904646	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled vitamin B12 transmembrane transporter activity [GO:0015420]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cobalamin metabolic process [GO:0009235]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g013870	Scaffold_01	35798977	35801716	O88563	MRP3_RAT	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (MRP-like protein 2) (MLP-2) (Multidrug resistance-associated protein 3)	GO:0005524; GO:0005886; GO:0005887; GO:0010033; GO:0010243; GO:0014070; GO:0015722; GO:0016020; GO:0016323; GO:0016887; GO:0032355; GO:0032496; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0098656	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g013880	Scaffold_01	35806389	35815822	NA	NA	NA	NA	NA
PGEN_.00g013890	Scaffold_01	35816078	35816482	NA	NA	NA	NA	NA
PGEN_.00g013900	Scaffold_01	35824608	35872288	Q80TN7	NAV3_MOUSE	Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1)	GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0022008; GO:0030336; GO:0031116; GO:0032703; GO:1905929	nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of invadopodium disassembly [GO:1905929]; positive regulation of microtubule polymerization [GO:0031116]
PGEN_.00g013910	Scaffold_01	35882375	35888412	P17081	RHOQ_HUMAN	Rho-related GTP-binding protein RhoQ (Ras-like protein TC10) (Ras-like protein family member 7A)	GO:0003924; GO:0005522; GO:0005525; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007163; GO:0007266; GO:0008286; GO:0008360; GO:0019901; GO:0030031; GO:0030036; GO:0030660; GO:0030866; GO:0032427; GO:0032869; GO:0032956; GO:0042995; GO:0045121; GO:0045944; GO:0046039; GO:0046326; GO:0051056; GO:0051491; GO:0070062; GO:1903077	actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi-associated vesicle membrane [GO:0030660]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; profilin binding [GO:0005522]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; GTP metabolic process [GO:0046039]; insulin receptor signaling pathway [GO:0008286]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]
PGEN_.00g013920	Scaffold_01	35892788	35899921	F1NZI4	PGGHG_CHICK	Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1)	GO:0004553; GO:0005829; GO:0005975; GO:0047402	"cytosol [GO:0005829]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]"
PGEN_.00g013930	Scaffold_01	36003811	36042803	Q20930	MIG17_CAEEL	Metalloprotease mig-17 (EC 3.4.24.-) (Abnormal cell migration protein 17)	GO:0004222; GO:0005604; GO:0005615; GO:0008104; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354	basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]
PGEN_.00g013940	Scaffold_01	36072405	36072947	NA	NA	NA	NA	NA
PGEN_.00g013950	Scaffold_01	36084478	36119619	Q68CQ4	DIEXF_HUMAN	Digestive organ expansion factor homolog	GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0007275; GO:0019843; GO:0030163; GO:0031648; GO:0032040; GO:0034511; GO:0040019	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; rRNA processing [GO:0006364]"
PGEN_.00g013960	Scaffold_01	36121116	36155942	Q8C2Q3	RBM14_MOUSE	RNA-binding protein 14 (RNA-binding motif protein 14)	GO:0002218; GO:0003723; GO:0005634; GO:0005667; GO:0005730; GO:0005737; GO:0016575; GO:0016607; GO:0030374; GO:0045087; GO:0045944; GO:0046600; GO:0060395; GO:0098534	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; activation of innate immune response [GO:0002218]; centriole assembly [GO:0098534]; histone deacetylation [GO:0016575]; innate immune response [GO:0045087]; negative regulation of centriole replication [GO:0046600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; SMAD protein signal transduction [GO:0060395]
PGEN_.00g013970	Scaffold_01	36174503	36174919	NA	NA	NA	NA	NA
PGEN_.00g013980	Scaffold_01	36222821	36254721	Q575T0	CYGB1_ORYLA	Cytoglobin-1	GO:0005344; GO:0005506; GO:0005737; GO:0019825; GO:0020037	cytoplasm [GO:0005737]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g013990	Scaffold_01	36266074	36337869	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g014000	Scaffold_01	36324597	36325178	NA	NA	NA	NA	NA
PGEN_.00g014010	Scaffold_01	36380694	36401914	A6QLH6	SCYL1_BOVIN	N-terminal kinase-like protein (SCY1-like protein 1)	GO:0004672; GO:0005524; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0006890	"cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g014020	Scaffold_01	36401961	36409472	O95861	BPNT1_HUMAN	"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP)"	GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046872; GO:0050427	"cytosol [GO:0005829]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854]"
PGEN_.00g014030	Scaffold_01	36419203	36430761	NA	NA	NA	NA	NA
PGEN_.00g014040	Scaffold_01	36439382	36445736	NA	NA	NA	NA	NA
PGEN_.00g014050	Scaffold_01	36473531	36497701	Q7T1N4	ASIC1_OPSTA	"Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal)"	GO:0005887; GO:0035725; GO:0044736; GO:0070207; GO:0071467	integral component of plasma membrane [GO:0005887]; acid-sensing ion channel activity [GO:0044736]; cellular response to pH [GO:0071467]; protein homotrimerization [GO:0070207]; sodium ion transmembrane transport [GO:0035725]
PGEN_.00g014060	Scaffold_01	36563714	36569090	Q7TNS7	ASIC4_MOUSE	Acid-sensing ion channel 4 (ASIC4) (Amiloride-sensitive cation channel 4)	GO:0001662; GO:0005272; GO:0016021	integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; behavioral fear response [GO:0001662]
PGEN_.00g014070	Scaffold_01	36599238	36601821	NA	NA	NA	NA	NA
PGEN_.00g014080	Scaffold_01	36614879	36622592	P24329	THTR_RAT	Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese)	GO:0004792; GO:0005739; GO:0005759; GO:0008097; GO:0016226; GO:0016783; GO:0019346; GO:0030855; GO:0035928; GO:0051029	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; epithelial cell differentiation [GO:0030855]; iron-sulfur cluster assembly [GO:0016226]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029]; transsulfuration [GO:0019346]
PGEN_.00g014090	Scaffold_01	36626392	36643896	NA	NA	NA	NA	NA
PGEN_.00g014100	Scaffold_01	36647816	36652793	Q9DBT3	CCD97_MOUSE	Coiled-coil domain-containing protein 97		
PGEN_.00g014110	Scaffold_01	36654025	36663027	Q8BGF3	WDR92_MOUSE	WD repeat-containing protein 92 (WD repeat-containing protein Monad)	GO:0006915; GO:0043130	ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915]
PGEN_.00g014120	Scaffold_01	36667317	36678494	Q96M32	KAD7_HUMAN	Adenylate kinase 7 (AK 7) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 7)	GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005829; GO:0006165; GO:0009142; GO:0015949; GO:0030030; GO:0031514	cytosol [GO:0005829]; motile cilium [GO:0031514]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; cell projection organization [GO:0030030]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]
PGEN_.00g014130	Scaffold_01	36678752	36686488	Q566R4	LRA25_RAT	Leucine repeat adapter protein 25 (Mammary tumor virus receptor 2)	GO:0001222; GO:0005737; GO:0030010; GO:0030027; GO:0030335; GO:0030512; GO:0060392	cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; transcription corepressor binding [GO:0001222]; establishment of cell polarity [GO:0030010]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]
PGEN_.00g014140	Scaffold_01	36740606	36752297	O15040	TCPR2_HUMAN	Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297)	GO:0006914	autophagy [GO:0006914]
PGEN_.00g014150	Scaffold_01	36754829	36763653	Q6P7Q4	LGUL_RAT	Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)	GO:0004462; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g014160	Scaffold_01	36764738	36782224	P50748	KNTC1_HUMAN	Kinetochore-associated protein 1 (Rough deal homolog) (HsROD) (Rod) (hRod)	GO:0000777; GO:0000922; GO:0005634; GO:0005828; GO:0005829; GO:0005886; GO:0007093; GO:0007096; GO:0015629; GO:0051301; GO:0065003; GO:1990423	actin cytoskeleton [GO:0015629]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096]
PGEN_.00g014170	Scaffold_01	36811692	36823700	A4SG26	PNP_CHLPM	Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase)	GO:0000287; GO:0003723; GO:0004654; GO:0005737; GO:0006396; GO:0006402	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396]
PGEN_.00g014180	Scaffold_01	36880185	36893624	Q5RCW2	PNPT1_PONAB	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (Polynucleotide phosphorylase 1) (PNPase 1)"	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000964; GO:0000965; GO:0004654; GO:0005739; GO:0005758; GO:0005759; GO:0006401; GO:0006402; GO:0008266; GO:0016020; GO:0034046; GO:0034599; GO:0035198; GO:0035927; GO:0035928; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0071850; GO:0097222; GO:2000627; GO:2000772	membrane [GO:0016020]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; cellular response to oxidative stress [GO:0034599]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle arrest [GO:0071850]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]
PGEN_.00g014190	Scaffold_01	36901084	36902127	NA	NA	NA	NA	NA
PGEN_.00g014200	Scaffold_01	36907243	36914733	NA	NA	NA	NA	NA
PGEN_.00g014210	Scaffold_01	36914768	36929523	Q8CFC7	CLASR_MOUSE	"CLK4-associating serine/arginine rich protein (Clk4-associating SR-related protein) (Serine/arginine-rich splicing factor 16) (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2)"	GO:0005654; GO:0006397; GO:0008380	nucleoplasm [GO:0005654]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g014220	Scaffold_01	36931905	36932627	NA	NA	NA	NA	NA
PGEN_.00g014230	Scaffold_01	36950676	36951023	NA	NA	NA	NA	NA
PGEN_.00g014240	Scaffold_01	36956462	37080410	Q9H165	BC11A_HUMAN	B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856)	GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010628; GO:0010976; GO:0010977; GO:0014069; GO:0016925; GO:0019901; GO:0030517; GO:0032463; GO:0042803; GO:0043565; GO:0045944; GO:0046872; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:1903860; GO:1904800; GO:1905232; GO:2000171; GO:2000173	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g014250	Scaffold_01	37113966	37125047	Q8AVH4	PNO1_XENLA	RNA-binding protein PNO1	GO:0003723; GO:0005730	nucleolus [GO:0005730]; RNA binding [GO:0003723]
PGEN_.00g014260	Scaffold_01	37127314	37146168	Q8NA03	FSIP1_HUMAN	Fibrous sheath-interacting protein 1		
PGEN_.00g014270	Scaffold_01	37153628	37156987	NA	NA	NA	NA	NA
PGEN_.00g014280	Scaffold_01	37169896	37172334	Q3SYK4	VRTN_MOUSE	Vertnin	GO:0000122; GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g014290	Scaffold_01	37172527	37173036	NA	NA	NA	NA	NA
PGEN_.00g014300	Scaffold_01	37180342	37180623	NA	NA	NA	NA	NA
PGEN_.00g014310	Scaffold_01	37201434	37205082	NA	NA	NA	NA	NA
PGEN_.00g014320	Scaffold_01	37205159	37205641	NA	NA	NA	NA	NA
PGEN_.00g014330	Scaffold_01	37206481	37206828	NA	NA	NA	NA	NA
PGEN_.00g014340	Scaffold_01	37207956	37208861	NA	NA	NA	NA	NA
PGEN_.00g014350	Scaffold_01	37241872	37254688	P16537	SPC3_STRPU	Protein SPEC3	GO:0000139; GO:0005929; GO:0016021	cilium [GO:0005929]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]
PGEN_.00g014360	Scaffold_01	37262580	37268176	P13135	CPNS1_BOVIN	Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit)	GO:0004198; GO:0005509; GO:0005737; GO:0005886	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]
PGEN_.00g014370	Scaffold_01	37277926	37336883	Q11002	CANA_DROME	Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]
PGEN_.00g014380	Scaffold_01	37347571	37348689	P54923	ADPRH_MOUSE	[Protein ADP-ribosylarginine] hydrolase (ADP-ribosylarginine hydrolase) (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme)	GO:0000287; GO:0003875; GO:0005096; GO:0005615; GO:0005829; GO:0006464; GO:0006886; GO:0017137; GO:0030955; GO:0051725; GO:0090630	cytosol [GO:0005829]; extracellular space [GO:0005615]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725]
PGEN_.00g014390	Scaffold_01	37355150	37363287	NA	NA	NA	NA	NA
PGEN_.00g014400	Scaffold_01	37363331	37396179	Q9D805	CAN9_MOUSE	Calpain-9 (EC 3.4.22.-) (Digestive tract-specific calpain) (New calpain 4) (nCL-4)	GO:0004198; GO:0005509; GO:0005737; GO:0045214	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; sarcomere organization [GO:0045214]
PGEN_.00g014410	Scaffold_01	37410652	37412397	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g014420	Scaffold_01	37428943	37429829	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g014430	Scaffold_01	37434623	37436395	P18173	DHGL_DROME	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"
PGEN_.00g014440	Scaffold_01	37455208	37466097	Q95LC6	CD209_MACNE	CD209 antigen (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN1) (CD antigen CD209)	GO:0002250; GO:0005537; GO:0006897; GO:0007155; GO:0016021; GO:0045087; GO:0046872	integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; innate immune response [GO:0045087]
PGEN_.00g014450	Scaffold_01	37499470	37501296	P60953	CDC42_HUMAN	Cell division control protein 42 homolog (EC 3.6.5.2) (G25K GTP-binding protein)	GO:0000139; GO:0000322; GO:0002040; GO:0003161; GO:0003924; GO:0005525; GO:0005623; GO:0005737; GO:0005789; GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0006897; GO:0006911; GO:0007015; GO:0007030; GO:0007088; GO:0007097; GO:0007163; GO:0007229; GO:0007266; GO:0007596; GO:0008360; GO:0010591; GO:0010592; GO:0016020; GO:0017119; GO:0019901; GO:0021762; GO:0030031; GO:0030036; GO:0030141; GO:0030175; GO:0030225; GO:0030307; GO:0030496; GO:0030742; GO:0031256; GO:0031274; GO:0031295; GO:0031333; GO:0031435; GO:0031996; GO:0032427; GO:0032467; GO:0032488; GO:0032956; GO:0032991; GO:0034191; GO:0034329; GO:0034332; GO:0034613; GO:0035722; GO:0036336; GO:0036464; GO:0038096; GO:0038189; GO:0039694; GO:0042059; GO:0042802; GO:0042995; GO:0043005; GO:0043025; GO:0043197; GO:0043393; GO:0043525; GO:0043552; GO:0045177; GO:0045198; GO:0045335; GO:0045740; GO:0046330; GO:0046847; GO:0048010; GO:0048013; GO:0048664; GO:0051056; GO:0051149; GO:0051233; GO:0051489; GO:0051491; GO:0051492; GO:0051496; GO:0051683; GO:0051835; GO:0051988; GO:0060047; GO:0060071; GO:0060501; GO:0060661; GO:0060997; GO:0061630; GO:0070062; GO:0071346; GO:0072384; GO:0072686; GO:0090135; GO:0090316; GO:0098685; GO:0099159; GO:0099563; GO:1900026; GO:2000251	"apical part of cell [GO:0045177]; cell [GO:0005623]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]; apolipoprotein A-I receptor binding [GO:0034191]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; blood coagulation [GO:0007596]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; filopodium assembly [GO:0046847]; Golgi organization [GO:0007030]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; interleukin-12-mediated signaling pathway [GO:0035722]; macrophage differentiation [GO:0030225]; modification of synaptic structure [GO:0099563]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; organelle transport along microtubule [GO:0072384]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of synapse structural plasticity [GO:0051835]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; regulation of mitotic nuclear division [GO:0007088]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein binding [GO:0043393]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of stress fiber assembly [GO:0051492]; Rho protein signal transduction [GO:0007266]; sprouting angiogenesis [GO:0002040]; submandibular salivary gland formation [GO:0060661]; substantia nigra development [GO:0021762]; T cell costimulation [GO:0031295]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g014460	Scaffold_01	37507920	37509251	NA	NA	NA	NA	NA
PGEN_.00g014470	Scaffold_01	37523379	37531826	Q9UBV2	SE1L1_HUMAN	Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L)	GO:0000836; GO:0000839; GO:0005783; GO:0005789; GO:0006641; GO:0007219; GO:0009306; GO:0016021; GO:0016567; GO:0030433; GO:0030970; GO:0036503; GO:0036513; GO:0044322; GO:0050821; GO:0055085; GO:1904380	"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]; endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; transmembrane transport [GO:0055085]; triglyceride metabolic process [GO:0006641]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g014480	Scaffold_01	37542845	37543496	NA	NA	NA	NA	NA
PGEN_.00g014490	Scaffold_01	37547763	37548077	NA	NA	NA	NA	NA
PGEN_.00g014500	Scaffold_01	37601225	37601536	NA	NA	NA	NA	NA
PGEN_.00g014510	Scaffold_01	37635697	37636281	NA	NA	NA	NA	NA
PGEN_.00g014520	Scaffold_01	37736882	37738808	NA	NA	NA	NA	NA
PGEN_.00g014530	Scaffold_01	37797570	37798541	NA	NA	NA	NA	NA
PGEN_.00g014540	Scaffold_01	37833445	37833894	NA	NA	NA	NA	NA
PGEN_.00g014550	Scaffold_01	37838949	37839599	NA	NA	NA	NA	NA
PGEN_.00g014560	Scaffold_01	37861926	37873089	P58307	OX1R_MOUSE	Orexin receptor type 1 (Ox-1-R) (Ox1-R) (Ox1R) (Hypocretin receptor type 1)	GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007218; GO:0007631; GO:0016499; GO:0017046; GO:0032870; GO:0051480; GO:0070374	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; cellular response to hormone stimulus [GO:0032870]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]
PGEN_.00g014570	Scaffold_01	37926437	37926706	NA	NA	NA	NA	NA
PGEN_.00g014580	Scaffold_01	37964319	37965029	NA	NA	NA	NA	NA
PGEN_.00g014590	Scaffold_01	37994089	38001560	NA	NA	NA	NA	NA
PGEN_.00g014600	Scaffold_01	38025204	38032998	NA	NA	NA	NA	NA
PGEN_.00g014610	Scaffold_01	38034092	38048849	P26686	SRR55_DROME	Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)	GO:0000278; GO:0000381; GO:0000398; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0035327; GO:0044819; GO:0045292; GO:0048024; GO:0051607; GO:0071011; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; precatalytic spliceosome [GO:0071011]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint [GO:0044819]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]"
PGEN_.00g014620	Scaffold_01	38052107	38058186	Q9ULG1	INO80_HUMAN	Chromatin-remodeling ATPase INO80 (hINO80) (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80) (INO80 complex subunit A)	GO:0000070; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0006281; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016579; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0034644; GO:0042393; GO:0042766; GO:0043014; GO:0043044; GO:0043618; GO:0045944; GO:0051225; GO:0051301; GO:0070914; GO:0071479; GO:2000045	"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"
PGEN_.00g014630	Scaffold_01	38059667	38113107	Q6ZPV2	INO80_MOUSE	Chromatin-remodeling ATPase INO80 (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80)	GO:0000070; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0006281; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0034644; GO:0042393; GO:0042766; GO:0043014; GO:0043044; GO:0043618; GO:0045944; GO:0051225; GO:0051301; GO:0070914; GO:0071479; GO:2000045	"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"
PGEN_.00g014640	Scaffold_01	38184175	38189417	NA	NA	NA	NA	NA
PGEN_.00g014650	Scaffold_01	38252516	38271727	P97677	DLL1_RAT	Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1)	GO:0001709; GO:0001756; GO:0001757; GO:0001947; GO:0002315; GO:0003323; GO:0005112; GO:0005509; GO:0005886; GO:0005912; GO:0007219; GO:0007267; GO:0007368; GO:0007386; GO:0007399; GO:0008217; GO:0008284; GO:0008285; GO:0009912; GO:0009954; GO:0010628; GO:0014002; GO:0014807; GO:0016021; GO:0016324; GO:0021510; GO:0021688; GO:0021693; GO:0030155; GO:0030857; GO:0030957; GO:0031410; GO:0032693; GO:0034351; GO:0035265; GO:0040008; GO:0045121; GO:0045596; GO:0045605; GO:0045608; GO:0045638; GO:0045662; GO:0045665; GO:0045746; GO:0045747; GO:0045807; GO:0045944; GO:0046331; GO:0048630; GO:0048631; GO:0048633; GO:0048665; GO:0048839; GO:0050767; GO:0051302; GO:0060041; GO:0060042; GO:0060853; GO:0070986; GO:0072006; GO:0072014; GO:0072070; GO:0072583; GO:0097009; GO:0097102; GO:0097110; GO:0097150; GO:0098773; GO:1900746; GO:1903672; GO:2000726	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; scaffold protein binding [GO:0097110]; Tat protein binding [GO:0030957]; astrocyte development [GO:0014002]; auditory receptor cell fate commitment [GO:0009912]; cell fate determination [GO:0001709]; cell-cell signaling [GO:0007267]; cerebellar molecular layer formation [GO:0021688]; cerebellar Purkinje cell layer structural organization [GO:0021693]; clathrin-dependent endocytosis [GO:0072583]; compartment pattern specification [GO:0007386]; determination of left/right symmetry [GO:0007368]; endothelial tip cell fate specification [GO:0097102]; energy homeostasis [GO:0097009]; heart looping [GO:0001947]; inner ear development [GO:0048839]; lateral inhibition [GO:0046331]; left/right axis specification [GO:0070986]; loop of Henle development [GO:0072070]; marginal zone B cell differentiation [GO:0002315]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; organ growth [GO:0035265]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; proximal/distal pattern formation [GO:0009954]; regulation of blood pressure [GO:0008217]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of growth [GO:0040008]; regulation of neurogenesis [GO:0050767]; regulation of skeletal muscle tissue growth [GO:0048631]; regulation of somitogenesis [GO:0014807]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle tissue growth [GO:0048630]; skin epidermis development [GO:0098773]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; type B pancreatic cell development [GO:0003323]
PGEN_.00g014660	Scaffold_01	38329880	38330239	NA	NA	NA	NA	NA
PGEN_.00g014670	Scaffold_01	38344260	38344742	NA	NA	NA	NA	NA
PGEN_.00g014680	Scaffold_01	38435014	38435256	NA	NA	NA	NA	NA
PGEN_.00g014690	Scaffold_01	38459331	38489835	Q9W4V8	TI50C_DROME	Mitochondrial import inner membrane translocase subunit TIM50-C (Tiny tim 50)	GO:0004721; GO:0004722; GO:0004725; GO:0005739; GO:0005743; GO:0005744; GO:0006470; GO:0007005; GO:0007006; GO:0016021; GO:0030150	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150]
PGEN_.00g014700	Scaffold_01	38591691	38601820	Q6DHB1	DNAL1_DANRE	"Dynein light chain 1, axonemal"	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0036158; GO:0042995; GO:0043014; GO:0045504	cell projection [GO:0042995]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158]
PGEN_.00g014710	Scaffold_01	38602716	38614636	NA	NA	NA	NA	NA
PGEN_.00g014720	Scaffold_01	38617325	38627198	Q8T888	DNAL1_CIOIN	"Dynein light chain 1, axonemal (Leucine-rich repeat dynein light chain)"	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0036158; GO:0042995; GO:0043014; GO:0045504	cell projection [GO:0042995]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158]
PGEN_.00g014730	Scaffold_01	38638791	38641409	NA	NA	NA	NA	NA
PGEN_.00g014740	Scaffold_01	38651725	38659556	P61917	NPC2_PANTR	NPC intracellular cholesterol transporter 2 (EPI-1) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog)	GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0015918; GO:0030301; GO:0032367; GO:0032934; GO:0033344	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]
PGEN_.00g014750	Scaffold_01	38666841	38674966	NA	NA	NA	NA	NA
PGEN_.00g014760	Scaffold_01	38679425	38681062	Q9VCG3	OPA32_DROME	Putative OPA3-like protein CG13603	GO:0005739; GO:0019216	mitochondrion [GO:0005739]; regulation of lipid metabolic process [GO:0019216]
PGEN_.00g014770	Scaffold_01	38686009	38687270	NA	NA	NA	NA	NA
PGEN_.00g014780	Scaffold_01	38691826	38776991	Q8MQW8	SPRI_DROME	Protein sprint (SH2 poly-proline-containing Ras-interactor protein)	GO:0005085; GO:0005096; GO:0005938; GO:0007165; GO:0017016; GO:0017112; GO:0019901; GO:0030139; GO:0030971; GO:0032483; GO:0048260; GO:0048675; GO:1903688	cell cortex [GO:0005938]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Ras GTPase binding [GO:0017016]; receptor tyrosine kinase binding [GO:0030971]; axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]
PGEN_.00g014790	Scaffold_01	38845405	38846840	Q2TGI8	ZDH22_RAT	Palmitoyltransferase ZDHHC22 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 22) (DHHC-22) (zDHHC22)	GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]
PGEN_.00g014800	Scaffold_01	38853905	38869778	Q6IP50	UBX1A_XENLA	UBX domain-containing protein 1-A (SAPK substrate protein 1-A)	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g014810	Scaffold_01	38881958	38882938	E7FDW2	PZR3B_DANRE	E3 ubiquitin-protein ligase PDZRN3-B (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3-B)	GO:0005737; GO:0007528; GO:0016567; GO:0030054; GO:0045202; GO:0046872; GO:0061630	cell junction [GO:0030054]; cytoplasm [GO:0005737]; synapse [GO:0045202]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]
PGEN_.00g014820	Scaffold_01	38896514	38913958	Q8N806	UBR7_HUMAN	Putative E3 ubiquitin-protein ligase UBR7 (EC 2.3.2.27) (N-recognin-7) (RING-type E3 ubiquitin transferase UBR7)	GO:0005737; GO:0008270; GO:0061630	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]
PGEN_.00g014830	Scaffold_01	38944509	38958175	Q2JVA4	GLMU_SYNJA	Bifunctional protein GlmU [Includes: UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (N-acetylglucosamine-1-phosphate uridyltransferase); Glucosamine-1-phosphate N-acetyltransferase (EC 2.3.1.157)]	GO:0000287; GO:0000902; GO:0003977; GO:0005737; GO:0006048; GO:0008360; GO:0009103; GO:0009245; GO:0009252; GO:0019134; GO:0071555	cytoplasm [GO:0005737]; glucosamine-1-phosphate N-acetyltransferase activity [GO:0019134]; magnesium ion binding [GO:0000287]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; cell morphogenesis [GO:0000902]; cell wall organization [GO:0071555]; lipid A biosynthetic process [GO:0009245]; lipopolysaccharide biosynthetic process [GO:0009103]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]
PGEN_.00g014840	Scaffold_01	38958700	38959743	NA	NA	NA	NA	NA
PGEN_.00g014850	Scaffold_01	38965704	38973559	NA	NA	NA	NA	NA
PGEN_.00g014860	Scaffold_01	38975108	39000703	Q5RKZ7	MOCS1_MOUSE	"Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]"	GO:0005525; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799	"molybdopterin synthase complex [GO:0019008]; 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]"
PGEN_.00g014870	Scaffold_01	39009831	39012735	NA	NA	NA	NA	NA
PGEN_.00g014880	Scaffold_01	39021652	39021897	NA	NA	NA	NA	NA
PGEN_.00g014890	Scaffold_01	39027301	39027546	NA	NA	NA	NA	NA
PGEN_.00g014900	Scaffold_01	39030166	39030886	NA	NA	NA	NA	NA
PGEN_.00g014910	Scaffold_01	39031303	39033633	NA	NA	NA	NA	NA
PGEN_.00g014920	Scaffold_01	39038147	39038578	NA	NA	NA	NA	NA
PGEN_.00g014930	Scaffold_01	39040801	39041850	NA	NA	NA	NA	NA
PGEN_.00g014940	Scaffold_01	39125757	39141359	NA	NA	NA	NA	NA
PGEN_.00g014950	Scaffold_01	39150721	39155072	NA	NA	NA	NA	NA
PGEN_.00g014960	Scaffold_01	39160323	39164016	NA	NA	NA	NA	NA
PGEN_.00g014970	Scaffold_01	39218214	39229473	Q5U239	TM145_XENLA	Transmembrane protein 145	GO:0007186; GO:0016021; GO:0019236	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]
PGEN_.00g014980	Scaffold_01	39245401	39268488	Q92994	TF3B_HUMAN	"Transcription factor IIIB 90 kDa subunit (TFIIIB90) (hTFIIIB90) (B-related factor 1) (BRF-1) (hBRF) (TAF3B2) (TATA box-binding protein-associated factor, RNA polymerase III, subunit 2)"	GO:0000126; GO:0001006; GO:0005634; GO:0005654; GO:0006352; GO:0006383; GO:0006384; GO:0008134; GO:0009303; GO:0009304; GO:0017025; GO:0045945; GO:0046872; GO:0070898	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; RNA polymerase III preinitiation complex assembly [GO:0070898]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]"
PGEN_.00g014990	Scaffold_01	39268842	39271519	P58545	BTBD3_MOUSE	BTB/POZ domain-containing protein 3	GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813	cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]
PGEN_.00g015000	Scaffold_01	39272672	39285810	Q8CFK2	TF3B_MOUSE	Transcription factor IIIB 90 kDa subunit (TFIIIB90) (mTFIIIB90) (B-related factor 1) (BRF-1)	GO:0000126; GO:0001006; GO:0005634; GO:0006352; GO:0008134; GO:0017025; GO:0043488; GO:0045945; GO:0046872; GO:0070898	"nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of mRNA stability [GO:0043488]; RNA polymerase III preinitiation complex assembly [GO:0070898]"
PGEN_.00g015010	Scaffold_01	39289419	39293531	Q80TF4	KLH13_MOUSE	Kelch-like protein 13 (BTB and kelch domain-containing protein 2)	GO:0004842; GO:0007049; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0051301	Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]
PGEN_.00g015020	Scaffold_01	39333366	39334714	Q9NRK6	ABCBA_HUMAN	"ATP-binding cassette sub-family B member 10, mitochondrial (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2) (M-ABC2)"	GO:0005524; GO:0005743; GO:0006839; GO:0016021; GO:0016887; GO:0032592; GO:0042626; GO:0042803	integral component of membrane [GO:0016021]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein homodimerization activity [GO:0042803]; mitochondrial transport [GO:0006839]
PGEN_.00g015030	Scaffold_01	39335348	39379451	O55096	DPP3_RAT	Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III) (Enkephalinase B)	GO:0005829; GO:0006508; GO:0008237; GO:0008239; GO:0008270	cytosol [GO:0005829]; dipeptidyl-peptidase activity [GO:0008239]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g015040	Scaffold_01	39433830	39456346	Q8WPI2	BOOH2_RHIMP	Boophilin-H2	GO:0004867; GO:0005576	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g015050	Scaffold_01	39527747	39554285	Q7L622	G2E3_HUMAN	G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)	GO:0004842; GO:0005730; GO:0005794; GO:0005829; GO:0006915; GO:0007275; GO:0043231; GO:0046872	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; multicellular organism development [GO:0007275]
PGEN_.00g015060	Scaffold_01	39556995	39557339	NA	NA	NA	NA	NA
PGEN_.00g015070	Scaffold_01	39560104	39576024	O14618	CCS_HUMAN	Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone)	GO:0005507; GO:0005634; GO:0005737; GO:0005829; GO:0006801; GO:0015035; GO:0015680; GO:0016532; GO:0019430; GO:0030001; GO:0034599; GO:0045296; GO:0051353	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein disulfide oxidoreductase activity [GO:0015035]; superoxide dismutase copper chaperone activity [GO:0016532]; cellular response to oxidative stress [GO:0034599]; metal ion transport [GO:0030001]; positive regulation of oxidoreductase activity [GO:0051353]; protein maturation by copper ion transfer [GO:0015680]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801]
PGEN_.00g015080	Scaffold_01	39581265	39590232	Q9YGL1	SPD1B_XENLA	Speedy protein 1-B (Spy1-B) (Protein Ls27) (Rapid inducer of G2/M progression in oocytes B) (RINGO-B) (XSpy1-B) (p33 ringo-B) (xRINGO-B)	GO:0000187; GO:0001556; GO:0005634; GO:0006378; GO:0007275; GO:0008315; GO:0019901; GO:0030332; GO:0045737; GO:0051446	nucleus [GO:0005634]; cyclin binding [GO:0030332]; protein kinase binding [GO:0019901]; activation of MAPK activity [GO:0000187]; G2/MI transition of meiotic cell cycle [GO:0008315]; mRNA polyadenylation [GO:0006378]; multicellular organism development [GO:0007275]; oocyte maturation [GO:0001556]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of meiotic cell cycle [GO:0051446]
PGEN_.00g015090	Scaffold_01	39626799	39628095	NA	NA	NA	NA	NA
PGEN_.00g015100	Scaffold_01	39632483	39664718	NA	NA	NA	NA	NA
PGEN_.00g015110	Scaffold_01	39676276	39683202	NA	NA	NA	NA	NA
PGEN_.00g015120	Scaffold_01	39683533	39711106	Q5F3K0	TTC27_CHICK	Tetratricopeptide repeat protein 27 (TPR repeat protein 27)		
PGEN_.00g015130	Scaffold_01	39717982	39757377	Q99698	LYST_HUMAN	Lysosomal-trafficking regulator (Beige homolog)	GO:0005737; GO:0007040; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; pigmentation [GO:0043473]; protein transport [GO:0015031]
PGEN_.00g015140	Scaffold_01	39768072	39773474	Q9C005	DPY30_HUMAN	Protein dpy-30 homolog (Dpy-30-like protein) (Dpy-30L)	GO:0005634; GO:0005654; GO:0005794; GO:0005802; GO:0016197; GO:0035097; GO:0042802; GO:0042803; GO:0044666; GO:0045652; GO:0048188; GO:0051568	Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; endosomal transport [GO:0016197]; histone H3-K4 methylation [GO:0051568]; regulation of megakaryocyte differentiation [GO:0045652]
PGEN_.00g015150	Scaffold_01	39797010	39812236	Q2T9V5	TRM6_BOVIN	tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6) (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6)	GO:0005634; GO:0030488; GO:0031515; GO:0080009	nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]
PGEN_.00g015160	Scaffold_01	39812993	39815033	NA	NA	NA	NA	NA
PGEN_.00g015170	Scaffold_01	39817127	39829852	Q9Y2U9	KLDC2_HUMAN	Kelch domain-containing protein 2 (Hepatocellular carcinoma-associated antigen 33) (Host cell factor homolog LCP) (Host cell factor-like protein 1) (HCLP-1)	GO:0005634; GO:0005654; GO:0016604; GO:0031965	nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
PGEN_.00g015180	Scaffold_01	39885629	39897725	NA	NA	NA	NA	NA
PGEN_.00g015190	Scaffold_01	39942439	39991804	Q6INC8	VGLU1_XENLA	Vesicular glutamate transporter 1 (VGluT1) (Solute carrier family 17 member 7)	GO:0006814; GO:0006836; GO:0015293; GO:0016021; GO:0030054; GO:0030672; GO:0043005	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; symporter activity [GO:0015293]; neurotransmitter transport [GO:0006836]; sodium ion transport [GO:0006814]
PGEN_.00g015200	Scaffold_01	40000547	40028571	Q66H50	FACR1_RAT	Fatty acyl-CoA reductase 1 (EC 1.2.1.84)	GO:0005777; GO:0005779; GO:0008611; GO:0010025; GO:0035336; GO:0046474; GO:0080019; GO:0102965	integral component of peroxisomal membrane [GO:0005779]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid biosynthetic process [GO:0046474]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]
PGEN_.00g015210	Scaffold_01	40072571	40072912	NA	NA	NA	NA	NA
PGEN_.00g015220	Scaffold_01	40087293	40097368	Q0IID7	DUS10_BOVIN	Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48)	GO:0000188; GO:0002819; GO:0004725; GO:0005737; GO:0005794; GO:0005829; GO:0006470; GO:0008138; GO:0008330; GO:0008432; GO:0010633; GO:0016607; GO:0017017; GO:0032496; GO:0033549; GO:0035970; GO:0043508; GO:0044387; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0050680; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042; GO:1990264	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; inactivation of MAPK activity [GO:0000188]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein dephosphorylation [GO:0006470]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]
PGEN_.00g015230	Scaffold_01	40172585	40173364	NA	NA	NA	NA	NA
PGEN_.00g015240	Scaffold_01	40174925	40175335	NA	NA	NA	NA	NA
PGEN_.00g015250	Scaffold_01	40183448	40184050	NA	NA	NA	NA	NA
PGEN_.00g015260	Scaffold_01	40190770	40191183	NA	NA	NA	NA	NA
PGEN_.00g015270	Scaffold_01	40216119	40216775	NA	NA	NA	NA	NA
PGEN_.00g015280	Scaffold_01	40257995	40263483	NA	NA	NA	NA	NA
PGEN_.00g015290	Scaffold_01	40276171	40280597	Q9NPB0	SMDC1_HUMAN	SAYSvFN domain-containing protein 1	GO:0016021; GO:0030659; GO:0043231	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]
PGEN_.00g015300	Scaffold_01	40280881	40283877	Q7XR46	PAO4_ORYSJ	Polyamine oxidase 4 (OsPAO4) (EC 1.5.3.-)	GO:0005777; GO:0006598; GO:0016491; GO:0046208; GO:0046592; GO:0050660; GO:0052894; GO:0052901; GO:1903602	peroxisome [GO:0005777]; flavin adenine dinucleotide binding [GO:0050660]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602]
PGEN_.00g015310	Scaffold_01	40287575	40304036	Q14746	COG2_HUMAN	Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein)	GO:0000139; GO:0005795; GO:0005829; GO:0006888; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0044877	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; protein-containing complex binding [GO:0044877]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]
PGEN_.00g015320	Scaffold_01	40305072	40312256	A7SL20	RRP36_NEMVE	Ribosomal RNA processing protein 36 homolog	GO:0000462; GO:0000469; GO:0005730; GO:0030686	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"
PGEN_.00g015330	Scaffold_01	40312895	40320903	Q9VFJ2	RM11_DROME	"39S ribosomal protein L11, mitochondrial (L11mt) (MRP-L11)"	GO:0000027; GO:0003735; GO:0005762; GO:0006412; GO:0006417; GO:0015934; GO:0019843; GO:0031047; GO:0032543; GO:0070180	large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]
PGEN_.00g015340	Scaffold_01	40323606	40354579	O13046	WDHD1_XENLA	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	GO:0003677; GO:0005654; GO:0005737	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]
PGEN_.00g015350	Scaffold_01	40379195	40379794	P25110	ACHD_RAT	Acetylcholine receptor subunit delta	GO:0003009; GO:0004888; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005892; GO:0006812; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015276; GO:0022848; GO:0030054; GO:0031594; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0048630; GO:0050877; GO:0050881; GO:0099060; GO:1904315	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g015360	Scaffold_01	40392880	40397442	Q0VC91	SOCS4_BOVIN	Suppressor of cytokine signaling 4 (SOCS-4)	GO:0005942; GO:0007175; GO:0016567; GO:0032436; GO:0035556; GO:0040008; GO:0046854; GO:0046935	phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]
PGEN_.00g015370	Scaffold_01	40411133	40417025	Q9JHB5	TSNAX_RAT	Translin-associated protein X (Translin-associated factor X)	GO:0003697; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0007275; GO:0007283; GO:0030154; GO:0031687; GO:0043565; GO:0044877; GO:0046872; GO:0048471	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; A2A adenosine receptor binding [GO:0031687]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g015380	Scaffold_01	40420122	40426320	P16230	SRCH_RABIT	Sarcoplasmic reticulum histidine-rich calcium-binding protein	GO:0005509; GO:0033018	sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]
PGEN_.00g015390	Scaffold_01	40436532	40450735	NA	NA	NA	NA	NA
PGEN_.00g015400	Scaffold_01	40462731	40470814	Q9U6D3	CALM_MYXGL	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g015410	Scaffold_01	40476894	40487737	O97341	CALM_SUBDO	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g015420	Scaffold_01	40520658	40584154	Q5TYP8	STUM_DANRE	Protein stum homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g015430	Scaffold_01	40599157	40605494	P08842	STS_HUMAN	Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)	GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006687; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0016021; GO:0043231; GO:0046872	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706]
PGEN_.00g015440	Scaffold_01	40629574	40656385	P08842	STS_HUMAN	Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)	GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006687; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0016021; GO:0043231; GO:0046872	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; glycosphingolipid metabolic process [GO:0006687]; steroid catabolic process [GO:0006706]
PGEN_.00g015450	Scaffold_01	40662591	40665384	NA	NA	NA	NA	NA
PGEN_.00g015460	Scaffold_01	40673976	40676668	NA	NA	NA	NA	NA
PGEN_.00g015470	Scaffold_01	40692154	40692846	NA	NA	NA	NA	NA
PGEN_.00g015480	Scaffold_01	40708966	40713339	NA	NA	NA	NA	NA
PGEN_.00g015490	Scaffold_01	40717340	40724302	Q460N5	PAR14_HUMAN	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g015500	Scaffold_01	40727867	40729217	NA	NA	NA	NA	NA
PGEN_.00g015510	Scaffold_01	40733971	40734321	NA	NA	NA	NA	NA
PGEN_.00g015520	Scaffold_01	40748433	40748831	NA	NA	NA	NA	NA
PGEN_.00g015530	Scaffold_01	40749394	40768002	Q49B93	SC5AC_MOUSE	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g015540	Scaffold_01	40775727	40776141	NA	NA	NA	NA	NA
PGEN_.00g015550	Scaffold_01	40831307	40851102	Q9VFB2	RT10_DROME	"28S ribosomal protein S10, mitochondrial (MRP-S10) (S10mt)"	GO:0003735; GO:0005763; GO:0006412; GO:0032543	mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
PGEN_.00g015560	Scaffold_01	40855352	40855672	NA	NA	NA	NA	NA
PGEN_.00g015570	Scaffold_01	40889786	40896873	Q49B93	SC5AC_MOUSE	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g015580	Scaffold_01	40939395	40943675	NA	NA	NA	NA	NA
PGEN_.00g015590	Scaffold_01	40990612	40999533	A0A0F7YZI5	CTHB5_CONVC	Thyrostimulin beta-5 subunit	GO:0005179; GO:0005576; GO:0009405; GO:0090729	extracellular region [GO:0005576]; hormone activity [GO:0005179]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g015600	Scaffold_01	41060241	41080620	A0A0F7Z3J2	CTHA2_CONVC	Thyrostimulin alpha-2 subunit	GO:0005179; GO:0005576; GO:0009405; GO:0090729	extracellular region [GO:0005576]; hormone activity [GO:0005179]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g015610	Scaffold_01	41129511	41130233	NA	NA	NA	NA	NA
PGEN_.00g015620	Scaffold_01	41131371	41133003	NA	NA	NA	NA	NA
PGEN_.00g015630	Scaffold_01	41140009	41160663	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g015640	Scaffold_01	41162033	41169972	NA	NA	NA	NA	NA
PGEN_.00g015650	Scaffold_01	41328888	41329136	NA	NA	NA	NA	NA
PGEN_.00g015660	Scaffold_01	41365889	41370459	NA	NA	NA	NA	NA
PGEN_.00g015670	Scaffold_01	41377360	41381668	NA	NA	NA	NA	NA
PGEN_.00g015680	Scaffold_01	41457182	41482710	P24507	SY63_DIPOM	Synaptotagmin-C (Synaptic vesicle protein O-p65-C)	GO:0016021; GO:0017156; GO:0030054; GO:0030672; GO:0046872	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; metal ion binding [GO:0046872]; calcium-ion regulated exocytosis [GO:0017156]
PGEN_.00g015690	Scaffold_01	41525384	41527721	NA	NA	NA	NA	NA
PGEN_.00g015700	Scaffold_01	41527871	41528212	NA	NA	NA	NA	NA
PGEN_.00g015710	Scaffold_01	41537700	41538113	NA	NA	NA	NA	NA
PGEN_.00g015720	Scaffold_01	41561281	41562714	NA	NA	NA	NA	NA
PGEN_.00g015730	Scaffold_01	41600238	41642495	Q3V3N7	BBS1_MOUSE	Bardet-Biedl syndrome 1 protein homolog	GO:0000226; GO:0001103; GO:0001764; GO:0001895; GO:0005102; GO:0005113; GO:0005119; GO:0005813; GO:0005929; GO:0005930; GO:0007601; GO:0007608; GO:0008104; GO:0008594; GO:0009566; GO:0016358; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0034451; GO:0034464; GO:0035721; GO:0036064; GO:0042048; GO:0042445; GO:0043001; GO:0044255; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0051219; GO:0060170; GO:0060271; GO:0060296; GO:0061351; GO:0061512; GO:1905515	axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]
PGEN_.00g015740	Scaffold_01	41661734	41689565	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g015750	Scaffold_01	41776016	41808835	B3EWZ6	MLRP2_ACRMI	MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g015760	Scaffold_01	41815864	41834910	B3EWZ6	MLRP2_ACRMI	MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g015770	Scaffold_01	41839350	41859432	Q5RBN9	TAD2B_PONAB	Transcriptional adapter 2-beta	GO:0003677; GO:0003713; GO:0005634; GO:0006357; GO:0008270; GO:0035065	nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; regulation of histone acetylation [GO:0035065]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g015780	Scaffold_01	41876632	41922473	Q868Z9	PPN_DROME	Papilin	GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198	basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]
PGEN_.00g015790	Scaffold_01	41916150	41917104	NA	NA	NA	NA	NA
PGEN_.00g015800	Scaffold_01	42028001	42054472	O76840	PPN1_CAEEL	Papilin (Abnormal cell migration protein 6)	GO:0000902; GO:0002119; GO:0004867; GO:0005604; GO:0008233; GO:0009792; GO:0032504; GO:0048598	basement membrane [GO:0005604]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell morphogenesis [GO:0000902]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; multicellular organism reproduction [GO:0032504]; nematode larval development [GO:0002119]
PGEN_.00g015810	Scaffold_01	42058577	42063608	NA	NA	NA	NA	NA
PGEN_.00g015820	Scaffold_01	42068444	42073309	O76840	PPN1_CAEEL	Papilin (Abnormal cell migration protein 6)	GO:0000902; GO:0002119; GO:0004867; GO:0005604; GO:0008233; GO:0009792; GO:0032504; GO:0048598	basement membrane [GO:0005604]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell morphogenesis [GO:0000902]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; multicellular organism reproduction [GO:0032504]; nematode larval development [GO:0002119]
PGEN_.00g015830	Scaffold_01	42077152	42089600	Q4VC17	ATS18_MOUSE	A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-)	GO:0001654; GO:0004222; GO:0005576; GO:0046872; GO:0090331	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]
PGEN_.00g015840	Scaffold_01	42128189	42128407	NA	NA	NA	NA	NA
PGEN_.00g015850	Scaffold_01	42128639	42128956	NA	NA	NA	NA	NA
PGEN_.00g015860	Scaffold_01	42147306	42159796	P52655	TF2AA_HUMAN	Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) (TFIIAL) (Transcription initiation factor TFIIA 42 kDa subunit) (TFIIA-42) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p35 subunit); Transcription initiation factor IIA beta chain (TFIIA p19 subunit)]	GO:0001103; GO:0003677; GO:0003713; GO:0005654; GO:0005669; GO:0005672; GO:0005829; GO:0006366; GO:0006367; GO:0008134; GO:0016251; GO:0017025; GO:0042795; GO:0046982	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]
PGEN_.00g015870	Scaffold_01	42174022	42262223	Q00963	SPTCB_DROME	Spectrin beta chain	GO:0003779; GO:0005200; GO:0005516; GO:0005546; GO:0005886; GO:0007009; GO:0007026; GO:0007274; GO:0007399; GO:0007409; GO:0007411; GO:0008017; GO:0008091; GO:0016199; GO:0016327; GO:0016328; GO:0030424; GO:0030506; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0048790; GO:0050807; GO:0051693; GO:0072499	"apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807]"
PGEN_.00g015880	Scaffold_01	42262755	42327714	Q9NRC6	SPTN5_HUMAN	"Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)"	GO:0000165; GO:0003779; GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0007041; GO:0007411; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030507; GO:0032029; GO:0032391; GO:0034452; GO:0042802; GO:0043621; GO:0045505; GO:0051693; GO:0097381	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091]; actin binding [GO:0003779]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; protein self-association [GO:0043621]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]; MAPK cascade [GO:0000165]
PGEN_.00g015890	Scaffold_01	42350754	42354478	NA	NA	NA	NA	NA
PGEN_.00g015900	Scaffold_01	42357582	42360686	P43147	EMPA_VIBAN	Virulence metalloprotease (EC 3.4.24.-) (Vibriolysin)	GO:0004222; GO:0005576; GO:0009405; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; pathogenesis [GO:0009405]
PGEN_.00g015910	Scaffold_01	42440998	42457038	P24153	HAPT_VIBCH	Hemagglutinin/proteinase (HA/protease) (EC 3.4.24.-) (Vibriolysin)	GO:0004222; GO:0005576; GO:0006508; GO:0009405; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; pathogenesis [GO:0009405]; proteolysis [GO:0006508]
PGEN_.00g015920	Scaffold_01	42461897	42462226	P14756	ELAS_PSEAE	Elastase (EC 3.4.24.26) (Neutral metalloproteinase) (PAE) (Pseudolysin) [Cleaved into: Pro-elastase]	GO:0004222; GO:0005576; GO:0006508; GO:0009405; GO:0015628; GO:0043952; GO:0044010; GO:0046872; GO:0071978	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; bacterial-type flagellum-dependent swarming motility [GO:0071978]; pathogenesis [GO:0009405]; protein secretion by the type II secretion system [GO:0015628]; protein transport by the Sec complex [GO:0043952]; proteolysis [GO:0006508]; single-species biofilm formation [GO:0044010]
PGEN_.00g015930	Scaffold_01	42462405	42466721	NA	NA	NA	NA	NA
PGEN_.00g015940	Scaffold_01	42492476	42493201	Q9CWM2	CDCA4_MOUSE	Cell division cycle-associated protein 4 (Hematopoietic progenitor protein)	GO:0005634; GO:0005654; GO:0005829; GO:0005886	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
PGEN_.00g015950	Scaffold_01	42502735	42503247	NA	NA	NA	NA	NA
PGEN_.00g015960	Scaffold_01	42503463	42504053	NA	NA	NA	NA	NA
PGEN_.00g015970	Scaffold_01	42507480	42529398	Q08CA1	GDPP1_DANRE	GDP-D-glucose phosphorylase 1 (EC 2.7.7.78)	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]
PGEN_.00g015980	Scaffold_01	42535414	42549462	B6NXD5	BABA2_BRAFL	BRISC and BRCA1-A complex member 2 (BRCA1-A complex subunit BRE) (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein)	GO:0005634; GO:0005737; GO:0006302; GO:0006325; GO:0006915; GO:0007049; GO:0010212; GO:0031593; GO:0045739; GO:0051301; GO:0070531; GO:0070552; GO:0072425	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; polyubiquitin modification-dependent protein binding [GO:0031593]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]
PGEN_.00g015990	Scaffold_01	42549736	42561056	Q2NKS2	COX16_BOVIN	"Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial"	GO:0031305; GO:0033617	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial respiratory chain complex IV assembly [GO:0033617]
PGEN_.00g016000	Scaffold_01	42572870	42588465	NA	NA	NA	NA	NA
PGEN_.00g016010	Scaffold_01	42596603	42599882	Q66J05	SPTSB_XENLA	Serine palmitoyltransferase small subunit B (Protein ADMP) (Small subunit of serine palmitoyltransferase B) (ssSPTb)	GO:0007029; GO:0016021; GO:0017059; GO:0030148; GO:0046513; GO:1904220	integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; ceramide biosynthetic process [GO:0046513]; endoplasmic reticulum organization [GO:0007029]; regulation of serine C-palmitoyltransferase activity [GO:1904220]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g016020	Scaffold_01	42622473	42630175	Q6AZD1	T179A_DANRE	Transmembrane protein 179	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g016030	Scaffold_01	42630443	42655469	Q4KLU2	PRP39_XENLA	Pre-mRNA-processing factor 39 (PRP39 homolog)	GO:0005634; GO:0006397; GO:0008380	nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g016040	Scaffold_01	42656653	42687913	Q8IX04	UEVLD_HUMAN	Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein)	GO:0005975; GO:0006464; GO:0015031; GO:0016616; GO:0019752; GO:0070062	"extracellular exosome [GO:0070062]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; carbohydrate metabolic process [GO:0005975]; carboxylic acid metabolic process [GO:0019752]; cellular protein modification process [GO:0006464]; protein transport [GO:0015031]"
PGEN_.00g016050	Scaffold_01	42774616	42796347	NA	NA	NA	NA	NA
PGEN_.00g016060	Scaffold_01	42784240	42793662	Q17QR8	HARB1_BOVIN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g016070	Scaffold_01	42798438	42805711	NA	NA	NA	NA	NA
PGEN_.00g016080	Scaffold_01	42826781	42829152	NA	NA	NA	NA	NA
PGEN_.00g016090	Scaffold_01	42846325	42850225	NA	NA	NA	NA	NA
PGEN_.00g016100	Scaffold_01	42867776	42868129	NA	NA	NA	NA	NA
PGEN_.00g016110	Scaffold_01	42878026	42879497	NA	NA	NA	NA	NA
PGEN_.00g016120	Scaffold_01	42968236	42968628	NA	NA	NA	NA	NA
PGEN_.00g016130	Scaffold_01	43017630	43037713	P27473	IFI44_PANTR	Interferon-induced protein 44 (Antigen p44) (Non-A non-B hepatitis-associated microtubular aggregates protein)	GO:0005737; GO:0006955; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]
PGEN_.00g016140	Scaffold_01	43046657	43048063	NA	NA	NA	NA	NA
PGEN_.00g016150	Scaffold_01	43109771	43110616	NA	NA	NA	NA	NA
PGEN_.00g016160	Scaffold_01	43178140	43179264	NA	NA	NA	NA	NA
PGEN_.00g016170	Scaffold_01	43180985	43194410	Q9H0D6	XRN2_HUMAN	5'-3' exoribonuclease 2 (EC 3.1.13.-) (DHM1-like protein) (DHP protein)	GO:0000175; GO:0000738; GO:0001147; GO:0003723; GO:0004518; GO:0004534; GO:0005634; GO:0005654; GO:0005730; GO:0006353; GO:0006364; GO:0006396; GO:0006397; GO:0006401; GO:0007283; GO:0008409; GO:0016020; GO:0016070; GO:0016235; GO:0021766; GO:0030182; GO:0046872; GO:0060041	"aggresome [GO:0016235]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA-templated transcription, termination [GO:0006353]; hippocampus development [GO:0021766]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]"
PGEN_.00g016180	Scaffold_01	43210615	43211769	NA	NA	NA	NA	NA
PGEN_.00g016190	Scaffold_01	43212061	43212372	NA	NA	NA	NA	NA
PGEN_.00g016200	Scaffold_01	43218934	43230729	NA	NA	NA	NA	NA
PGEN_.00g016210	Scaffold_01	43244721	43245718	NA	NA	NA	NA	NA
PGEN_.00g016220	Scaffold_01	43276507	43277295	NA	NA	NA	NA	NA
PGEN_.00g016230	Scaffold_01	43285754	43290603	NA	NA	NA	NA	NA
PGEN_.00g016240	Scaffold_01	43304740	43306573	NA	NA	NA	NA	NA
PGEN_.00g016250	Scaffold_01	43306677	43307126	NA	NA	NA	NA	NA
PGEN_.00g016260	Scaffold_01	43401669	43409258	P43699	NKX21_HUMAN	Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1) (TTF-1) (Thyroid-specific enhancer-binding protein) (T/EBP)	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001012; GO:0001161; GO:0001764; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006644; GO:0007411; GO:0007420; GO:0007492; GO:0007626; GO:0009725; GO:0010628; GO:0010719; GO:0019899; GO:0021759; GO:0021766; GO:0021795; GO:0021798; GO:0021877; GO:0021892; GO:0021983; GO:0030154; GO:0030324; GO:0030336; GO:0030512; GO:0030878; GO:0030900; GO:0031128; GO:0033327; GO:0042753; GO:0043565; GO:0044212; GO:0044213; GO:0045892; GO:0045893; GO:0045944; GO:0048511; GO:0048646; GO:0048709; GO:0060430; GO:0060441; GO:0060486; GO:0060510	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; intronic transcription regulatory region DNA binding [GO:0044213]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region DNA binding [GO:0001012]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; anatomical structure formation involved in morphogenesis [GO:0048646]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cerebral cortex cell migration [GO:0021795]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; club cell differentiation [GO:0060486]; developmental induction [GO:0031128]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain neuron fate commitment [GO:0021877]; globus pallidus development [GO:0021759]; hippocampus development [GO:0021766]; Leydig cell differentiation [GO:0033327]; locomotory behavior [GO:0007626]; lung development [GO:0030324]; lung saccule development [GO:0060430]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron migration [GO:0001764]; oligodendrocyte differentiation [GO:0048709]; phospholipid metabolic process [GO:0006644]; pituitary gland development [GO:0021983]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to hormone [GO:0009725]; rhythmic process [GO:0048511]; thyroid gland development [GO:0030878]; type II pneumocyte differentiation [GO:0060510]"
PGEN_.00g016270	Scaffold_01	43488765	43497192	Q95NI4	CALM_HALOK	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g016280	Scaffold_01	43499000	43509873	NA	NA	NA	NA	NA
PGEN_.00g016290	Scaffold_01	43515632	43587080	Q96L34	MARK4_HUMAN	MAP/microtubule affinity-regulating kinase 4 (EC 2.7.11.1) (MAP/microtubule affinity-regulating kinase-like 1)	GO:0000226; GO:0000930; GO:0001578; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0007049; GO:0007399; GO:0008017; GO:0015630; GO:0030425; GO:0030496; GO:0035556; GO:0036064; GO:0043005; GO:0043015; GO:0043068; GO:0043130; GO:0044782; GO:0045724; GO:0046605; GO:0048156; GO:0050321; GO:0051301; GO:0097711; GO:1904781	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; gamma-tubulin complex [GO:0000930]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; neuron projection [GO:0043005]; ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium organization [GO:0044782]; intracellular signal transduction [GO:0035556]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]; positive regulation of cilium assembly [GO:0045724]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein localization to centrosome [GO:1904781]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]
PGEN_.00g016300	Scaffold_01	43662888	43732517	P49816	TSC2_RAT	Tuberin (Tuberous sclerosis 2 protein homolog)	GO:0001666; GO:0001843; GO:0001933; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0005856; GO:0005901; GO:0006469; GO:0006606; GO:0007165; GO:0007507; GO:0007568; GO:0008104; GO:0008285; GO:0010508; GO:0010719; GO:0010763; GO:0010976; GO:0014065; GO:0014067; GO:0014069; GO:0016020; GO:0016239; GO:0016242; GO:0019902; GO:0030010; GO:0030030; GO:0030100; GO:0030178; GO:0030425; GO:0030426; GO:0031267; GO:0032007; GO:0032869; GO:0032991; GO:0033596; GO:0034394; GO:0035176; GO:0042803; GO:0042995; GO:0043005; GO:0043025; GO:0043231; GO:0043276; GO:0043407; GO:0043491; GO:0044861; GO:0044877; GO:0045121; GO:0045184; GO:0045202; GO:0045785; GO:0045792; GO:0045944; GO:0046323; GO:0046626; GO:0046627; GO:0047485; GO:0048009; GO:0048147; GO:0048471; GO:0048550; GO:0050680; GO:0050771; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:0060999; GO:0071889; GO:0098978; GO:0099175; GO:1904262; GO:1905563	caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; TSC1-TSC2 complex [GO:0033596]; 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; aging [GO:0007568]; anoikis [GO:0043276]; cell projection organization [GO:0030030]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; glucose import [GO:0046323]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive chemotaxis [GO:0050918]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macroautophagy [GO:0016239]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein transport into plasma membrane raft [GO:0044861]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; social behavior [GO:0035176]
PGEN_.00g016310	Scaffold_01	43735987	43737424	NA	NA	NA	NA	NA
PGEN_.00g016320	Scaffold_01	43737611	43738916	NA	NA	NA	NA	NA
PGEN_.00g016330	Scaffold_01	43751058	43764779	Q7SXM7	PRP31_DANRE	U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31)	GO:0000244; GO:0000398; GO:0005634; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030622; GO:0046540; GO:0060041; GO:0071005; GO:0071339	"Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244]"
PGEN_.00g016340	Scaffold_01	43770409	43782863	Q99LC9	PEX6_MOUSE	Peroxisome assembly factor 2 (PAF-2) (Peroxin-6) (Peroxisomal biogenesis factor 6) (Peroxisomal-type ATPase 1)	GO:0001750; GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016561; GO:0016887; GO:0042623; GO:0044877; GO:0050821; GO:0097733	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]"
PGEN_.00g016350	Scaffold_01	43784320	43791216	NA	NA	NA	NA	NA
PGEN_.00g016360	Scaffold_01	43791364	43814547	Q5U508	TBCE_XENLA	Tubulin-specific chaperone E (Tubulin-folding cofactor E)	GO:0005737; GO:0005856; GO:0007023	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; post-chaperonin tubulin folding pathway [GO:0007023]
PGEN_.00g016370	Scaffold_01	43824782	43825198	NA	NA	NA	NA	NA
PGEN_.00g016380	Scaffold_01	43825479	43826195	NA	NA	NA	NA	NA
PGEN_.00g016390	Scaffold_01	43826408	43827194	NA	NA	NA	NA	NA
PGEN_.00g016400	Scaffold_01	43845979	43852186	NA	NA	NA	NA	NA
PGEN_.00g016410	Scaffold_01	43852979	43863088	P55862	MCM5A_XENLA	DNA replication licensing factor mcm5-A (xMCM5-A) (EC 3.6.4.12) (CDC46 homolog A) (xCDC46-A) (CDC46p) (p92)	GO:0000785; GO:0003678; GO:0003688; GO:0005524; GO:0005634; GO:0005829; GO:0006268; GO:0006270; GO:0007049; GO:0030174; GO:0042555	chromatin [GO:0000785]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174]
PGEN_.00g016420	Scaffold_01	43870325	43874225	NA	NA	NA	NA	NA
PGEN_.00g016430	Scaffold_01	43907762	43908346	NA	NA	NA	NA	NA
PGEN_.00g016440	Scaffold_01	43921745	43922479	P33300	SUR1_YEAST	Mannosyl phosphorylinositol ceramide synthase SUR1 (EC 2.4.-.-)	GO:0000030; GO:0000324; GO:0000329; GO:0006675; GO:0006688; GO:0016021; GO:0030148; GO:0051999	fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; glycosphingolipid biosynthetic process [GO:0006688]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]; mannosyl-inositol phosphorylceramide metabolic process [GO:0006675]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g016450	Scaffold_01	43932208	43932957	P38287	CSH1_YEAST	Mannosyl phosphorylinositol ceramide synthase CSH1 (EC 2.-.-.-) (CSG1/SUR1 homolog 1)	GO:0000030; GO:0000324; GO:0005774; GO:0006688; GO:0016021; GO:0030148; GO:0051999	fungal-type vacuole [GO:0000324]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; mannosyltransferase activity [GO:0000030]; glycosphingolipid biosynthetic process [GO:0006688]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g016460	Scaffold_01	43934796	43935047	NA	NA	NA	NA	NA
PGEN_.00g016470	Scaffold_01	43958616	43964750	NA	NA	NA	NA	NA
PGEN_.00g016480	Scaffold_01	43965411	43975563	P60206	CALM_AJECG	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g016490	Scaffold_01	43977850	43986414	P79881	GUC1B_CHICK	Guanylyl cyclase-activating protein 2 (GCAP 2) (Guanylate cyclase activator 1B)	GO:0005509; GO:0007601; GO:0050896	calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g016500	Scaffold_01	43992638	44091407	Q9ULB1	NRX1A_HUMAN	Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha)	GO:0005246; GO:0005509; GO:0005730; GO:0005783; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030054; GO:0030534; GO:0031965; GO:0031982; GO:0032991; GO:0033130; GO:0035176; GO:0038023; GO:0042297; GO:0042734; GO:0042995; GO:0043025; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0060134; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:0098685; GO:0098693; GO:0098978; GO:0098982; GO:0099059; GO:0099151; GO:0099542; GO:0099560; GO:1905606; GO:2000463; GO:2000821	"cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; prepulse inhibition [GO:0060134]; regulation of grooming behavior [GO:2000821]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle cycle [GO:0098693]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by endocannabinoid [GO:0099542]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]"
PGEN_.00g016510	Scaffold_01	44105835	44106086	NA	NA	NA	NA	NA
PGEN_.00g016520	Scaffold_01	44184633	44185058	NA	NA	NA	NA	NA
PGEN_.00g016530	Scaffold_01	44201148	44201927	Q63374	NRX2A_RAT	Neurexin-2 (Neurexin II-alpha) (Neurexin-2-alpha)	GO:0004888; GO:0005246; GO:0005886; GO:0007155; GO:0007165; GO:0007268; GO:0007269; GO:0007416; GO:0016021; GO:0030534; GO:0032991; GO:0035176; GO:0042297; GO:0046872; GO:0050839; GO:0071625; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:0098793	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888]; adult behavior [GO:0030534]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neurotransmitter secretion [GO:0007269]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]
PGEN_.00g016540	Scaffold_01	44219819	44225827	NA	NA	NA	NA	NA
PGEN_.00g016550	Scaffold_01	44233330	44234460	NA	NA	NA	NA	NA
PGEN_.00g016560	Scaffold_01	44234635	44238950	NA	NA	NA	NA	NA
PGEN_.00g016570	Scaffold_01	44257157	44308758	Q5VT25	MRCKA_HUMAN	Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha)	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005911; GO:0006468; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031532; GO:0035556; GO:0042641; GO:0042802; GO:0070062	actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; intracellular signal transduction [GO:0035556]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]
PGEN_.00g016580	Scaffold_01	44309775	44330213	O54874	MRCKA_RAT	Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha)	GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005911; GO:0006468; GO:0007010; GO:0007097; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031532; GO:0035556; GO:0042641; GO:0042802; GO:0051056	actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; nuclear migration [GO:0007097]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g016590	Scaffold_01	44345210	44369080	P0DP23	CALM1_HUMAN	Calmodulin-1	GO:0000165; GO:0000922; GO:0002027; GO:0002576; GO:0005509; GO:0005513; GO:0005576; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0005980; GO:0006936; GO:0007186; GO:0007223; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0019722; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0022400; GO:0030017; GO:0031432; GO:0031954; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0038095; GO:0043539; GO:0043647; GO:0044325; GO:0050999; GO:0051186; GO:0051343; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0097718; GO:1901844; GO:1902494	"calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; vesicle [GO:0031982]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; calcium-mediated signaling [GO:0019722]; cofactor metabolic process [GO:0051186]; detection of calcium ion [GO:0005513]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; glycogen catabolic process [GO:0005980]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; muscle contraction [GO:0006936]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to calcium ion [GO:0051592]; substantia nigra development [GO:0021762]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"
PGEN_.00g016600	Scaffold_01	44392476	44392877	NA	NA	NA	NA	NA
PGEN_.00g016610	Scaffold_01	44401562	44411020	NA	NA	NA	NA	NA
PGEN_.00g016620	Scaffold_01	44414859	44428661	Q96BY7	ATG2B_HUMAN	Autophagy-related protein 2 homolog B	GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005811; GO:0019898; GO:0034045	extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]
PGEN_.00g016630	Scaffold_01	44429135	44445989	Q28997	ADRB2_PIG	Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)	GO:0002025; GO:0002032; GO:0004935; GO:0004941; GO:0005769; GO:0005887; GO:0006898; GO:0007188; GO:0007190; GO:0042803; GO:0043235; GO:0043410; GO:0045986; GO:0051379; GO:0051380; GO:0071880; GO:1901098; GO:1904504	early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; adrenergic receptor activity [GO:0004935]; beta2-adrenergic receptor activity [GO:0004941]; epinephrine binding [GO:0051379]; norepinephrine binding [GO:0051380]; protein homodimerization activity [GO:0042803]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g016640	Scaffold_01	44488250	44490820	A0N0X6	LRRN1_BOVIN	Leucine-rich repeat neuronal protein 1 (Neuronal leucine-rich repeat protein 1) (NLRR-1)	GO:0005615; GO:0016021; GO:0031012; GO:0051965	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]
PGEN_.00g016650	Scaffold_01	44507176	44521129	P35858	ALS_HUMAN	Insulin-like growth factor-binding protein complex acid labile subunit (ALS)	GO:0005520; GO:0005576; GO:0005615; GO:0007155; GO:0007165; GO:0031012; GO:0042567; GO:0044267; GO:0070062	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567]; insulin-like growth factor binding [GO:0005520]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; signal transduction [GO:0007165]
PGEN_.00g016660	Scaffold_01	44521379	44521693	NA	NA	NA	NA	NA
PGEN_.00g016670	Scaffold_01	44522145	44568799	Q2TAZ0	ATG2A_HUMAN	Autophagy-related protein 2 homolog A	GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005811; GO:0005829; GO:0019898; GO:0034045; GO:0043231	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]
PGEN_.00g016680	Scaffold_01	44579430	44579831	NA	NA	NA	NA	NA
PGEN_.00g016690	Scaffold_01	44607152	44608252	Q9ES74	NEK7_MOUSE	Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7)	GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0006468; GO:0032212; GO:0046872; GO:0051973; GO:1904355	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]
PGEN_.00g016700	Scaffold_01	44608626	44664955	Q6AZT2	SPAST_XENLA	Spastin (EC 5.6.1.1)	GO:0000281; GO:0001578; GO:0005524; GO:0005813; GO:0005819; GO:0005874; GO:0006888; GO:0007409; GO:0008017; GO:0008089; GO:0008568; GO:0010458; GO:0016021; GO:0016853; GO:0019896; GO:0030496; GO:0031117; GO:0031468; GO:0031965; GO:0032506; GO:0034214; GO:0043014; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0090148; GO:1904115	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]
PGEN_.00g016710	Scaffold_01	44683821	44685445	NA	NA	NA	NA	NA
PGEN_.00g016720	Scaffold_01	44692042	44692725	NA	NA	NA	NA	NA
PGEN_.00g016730	Scaffold_01	44692803	44693030	NA	NA	NA	NA	NA
PGEN_.00g016740	Scaffold_01	44696116	44724466	Q75J93	CPAS1_DICDI	Circularly permutated Ras protein 1 (DdiCPRas1)	GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0006888; GO:0007265; GO:0008270; GO:0019003; GO:0030127	COPII vesicle coat [GO:0030127]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; Ras protein signal transduction [GO:0007265]
PGEN_.00g016750	Scaffold_01	44735407	44772791	Q8IWY9	CDAN1_HUMAN	Codanin-1	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0008104; GO:0008156; GO:0012505; GO:0016021; GO:0031497	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; protein localization [GO:0008104]
PGEN_.00g016760	Scaffold_01	44775600	44793686	P61011	SRP54_HUMAN	Signal recognition particle 54 kDa protein (SRP54)	GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005786; GO:0005829; GO:0006614; GO:0006616; GO:0006617; GO:0008144; GO:0008312; GO:0016607; GO:0019003; GO:0030942; GO:0042493; GO:0043021; GO:0045047	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; protein targeting to ER [GO:0045047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"
PGEN_.00g016770	Scaffold_01	44799583	44833098	Q9Y597	KCTD3_HUMAN	BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45)	GO:0005886; GO:0051260	plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]
PGEN_.00g016780	Scaffold_01	44833682	44855105	NA	NA	NA	NA	NA
PGEN_.00g016790	Scaffold_01	44856991	44857197	NA	NA	NA	NA	NA
PGEN_.00g016800	Scaffold_01	44876930	44907887	Q92673	SORL_HUMAN	Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA)	GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005041; GO:0005615; GO:0005623; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0010008; GO:0010897; GO:0014910; GO:0016020; GO:0016021; GO:0030169; GO:0030306; GO:0030514; GO:0030658; GO:0031901; GO:0031985; GO:0032091; GO:0032460; GO:0032585; GO:0034067; GO:0038020; GO:0043407; GO:0044267; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0051604; GO:0055037; GO:0055038; GO:0070062; GO:0070863; GO:1900168; GO:1901215; GO:1902430; GO:1902771; GO:1902948; GO:1902953; GO:1902955; GO:1902960; GO:1902963; GO:1902966; GO:1902997; GO:1904179; GO:1990845; GO:2001137	cell [GO:0005623]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; ADP-ribosylation factor binding [GO:0030306]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; transmembrane signaling receptor activity [GO:0004888]; adaptive thermogenesis [GO:1990845]; cellular protein metabolic process [GO:0044267]; diet induced thermogenesis [GO:0002024]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor secretion [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]
PGEN_.00g016810	Scaffold_01	44966506	44992438	NA	NA	NA	NA	NA
PGEN_.00g016820	Scaffold_01	45064958	45106456	A2ARS0	ANR63_MOUSE	Ankyrin repeat domain-containing protein 63		
PGEN_.00g016830	Scaffold_01	45116189	45121017	P37383	RAD51_CHICK	DNA repair protein RAD51 homolog 1	GO:0000150; GO:0000228; GO:0000722; GO:0000724; GO:0000730; GO:0000784; GO:0000790; GO:0000793; GO:0000794; GO:0000800; GO:0001932; GO:0003682; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006268; GO:0006281; GO:0006312; GO:0006974; GO:0007131; GO:0008022; GO:0008094; GO:0010569; GO:0010833; GO:0016605; GO:0017116; GO:0032991; GO:0035861; GO:0036297; GO:0042148; GO:0042802; GO:0048471; GO:0051106; GO:0051260; GO:0051321; GO:0070182; GO:0070192; GO:0071479; GO:0072711; GO:0072757; GO:1990414; GO:1990426	"condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; protein homooligomerization [GO:0051260]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]"
PGEN_.00g016840	Scaffold_01	45149237	45165565	Q91917	RA51B_XENLA	DNA repair protein RAD51 homolog B (xRAD51.2)	GO:0000150; GO:0000228; GO:0000724; GO:0000730; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005737; GO:0006974; GO:0017116; GO:1990426	cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombinase assembly [GO:0000730]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination-dependent replication fork processing [GO:1990426]
PGEN_.00g016850	Scaffold_01	45172016	45201549	P33611	DPOA2_MOUSE	DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit)	GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005658; GO:0005829; GO:0006260; GO:0006270; GO:0006606; GO:0046982	alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; protein import into nucleus [GO:0006606]
PGEN_.00g016860	Scaffold_01	45201848	45213053	NA	NA	NA	NA	NA
PGEN_.00g016870	Scaffold_01	45329925	45330404	P10981	ACT5_DROME	Actin-87E	GO:0000281; GO:0005524; GO:0005737; GO:0015629; GO:0016573; GO:0035267; GO:0043486	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; NuA4 histone acetyltransferase complex [GO:0035267]; ATP binding [GO:0005524]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; mitotic cytokinesis [GO:0000281]
PGEN_.00g016880	Scaffold_01	45330445	45330894	P02576	ACTA_PHYPO	"Actin, plasmodial isoform"	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g016890	Scaffold_01	45331218	45335407	NA	NA	NA	NA	NA
PGEN_.00g016900	Scaffold_01	45348270	45359965	NA	NA	NA	NA	NA
PGEN_.00g016910	Scaffold_01	45422622	45424045	Q07352	TISB_HUMAN	"mRNA decay activator protein ZFP36L1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (TPA-induced sequence 11b) (Zinc finger protein 36, C3H1 type-like 1) (ZFP36-like 1)"	GO:0000165; GO:0000288; GO:0000932; GO:0000981; GO:0001570; GO:0003342; GO:0003677; GO:0003700; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006915; GO:0007507; GO:0008283; GO:0009611; GO:0010468; GO:0010837; GO:0014065; GO:0021915; GO:0031086; GO:0031440; GO:0032869; GO:0033077; GO:0035264; GO:0035925; GO:0038066; GO:0043488; GO:0043491; GO:0044344; GO:0045577; GO:0045600; GO:0045616; GO:0045647; GO:0045657; GO:0045661; GO:0046872; GO:0048382; GO:0051028; GO:0060710; GO:0060712; GO:0061158; GO:0070371; GO:0071320; GO:0071356; GO:0071364; GO:0071375; GO:0071385; GO:0071456; GO:0071472; GO:0071560; GO:0071889; GO:0072091; GO:0097403; GO:1900153; GO:1901991; GO:1902172; GO:1904582; GO:1990904	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; 14-3-3 protein binding [GO:0071889]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to raffinose [GO:0097403]; cellular response to salt stress [GO:0071472]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chorio-allantoic fusion [GO:0060710]; ERK1 and ERK2 cascade [GO:0070371]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mesendoderm development [GO:0048382]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; neural tube development [GO:0021915]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; p38MAPK cascade [GO:0038066]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; proepicardium development [GO:0003342]; protein kinase B signaling [GO:0043491]; regulation of B cell differentiation [GO:0045577]; regulation of gene expression [GO:0010468]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA stability [GO:0043488]; regulation of myoblast differentiation [GO:0045661]; regulation of stem cell proliferation [GO:0072091]; response to wounding [GO:0009611]; spongiotrophoblast layer development [GO:0060712]; T cell differentiation in thymus [GO:0033077]; vasculogenesis [GO:0001570]"
PGEN_.00g016920	Scaffold_01	45453004	45453534	NA	NA	NA	NA	NA
PGEN_.00g016930	Scaffold_01	45483122	45499350	S3D9F1	GLOL_GLAL2	Highly reducing polyketide synthase gloL (HR-PKS gloL) (EC 2.3.1.-) (Pneumocandin acyl side chain synthase) (Pneumocandin biosynthesis cluster protein L)	GO:0008168; GO:0016491; GO:0016746; GO:0031177; GO:0032259	"methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]; methylation [GO:0032259]"
PGEN_.00g016940	Scaffold_01	45519530	45519808	NA	NA	NA	NA	NA
PGEN_.00g016950	Scaffold_01	45671868	45672938	O14792	HS3S1_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1)	GO:0005796; GO:0006024; GO:0008146; GO:0008467	Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g016960	Scaffold_01	45735845	45740041	NA	NA	NA	NA	NA
PGEN_.00g016970	Scaffold_01	45797128	45797370	NA	NA	NA	NA	NA
PGEN_.00g016980	Scaffold_01	45797452	45797670	NA	NA	NA	NA	NA
PGEN_.00g016990	Scaffold_01	45821453	45821959	NA	NA	NA	NA	NA
PGEN_.00g017000	Scaffold_01	45882833	45896255	Q6PB93	GALT2_MOUSE	Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]	GO:0002378; GO:0004653; GO:0005615; GO:0005794; GO:0005795; GO:0005796; GO:0006493; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471	extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g017010	Scaffold_01	45935267	45945468	Q91250	ESR1_TAEGU	Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)	GO:0003700; GO:0005496; GO:0005634; GO:0008270; GO:0010628; GO:0030284; GO:0043565; GO:0048747	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; estrogen receptor activity [GO:0030284]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]; muscle fiber development [GO:0048747]; positive regulation of gene expression [GO:0010628]
PGEN_.00g017020	Scaffold_01	46016105	46036814	Q2YDI5	RM48_BOVIN	"39S ribosomal protein L48, mitochondrial (L48mt) (MRP-L48)"	GO:0005743; GO:0005761; GO:0005762	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]
PGEN_.00g017030	Scaffold_01	46025747	46026112	NA	NA	NA	NA	NA
PGEN_.00g017040	Scaffold_01	46037948	46042499	NA	NA	NA	NA	NA
PGEN_.00g017050	Scaffold_01	46060422	46140759	Q5RDQ2	MPP5_PONAB	MAGUK p55 subfamily member 5	GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0030424; GO:0043204; GO:0070830; GO:0090162	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162]
PGEN_.00g017060	Scaffold_01	46182213	46188802	Q8C547	HTR5B_MOUSE	HEAT repeat-containing protein 5B	GO:0005829; GO:0006897; GO:0008104; GO:0030139; GO:0042147	"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g017070	Scaffold_01	46195246	46202441	NA	NA	NA	NA	NA
PGEN_.00g017080	Scaffold_01	46217717	46218121	NA	NA	NA	NA	NA
PGEN_.00g017090	Scaffold_01	46253513	46281945	NA	NA	NA	NA	NA
PGEN_.00g017100	Scaffold_01	46291260	46293001	NA	NA	NA	NA	NA
PGEN_.00g017110	Scaffold_01	46318655	46348387	P97481	EPAS1_MOUSE	Endothelial PAS domain-containing protein 1 (EPAS-1) (HIF-1-alpha-like factor) (HLF) (mHLF) (HIF-related factor) (HRF) (Hypoxia-inducible factor 2-alpha) (HIF-2-alpha) (HIF2-alpha)	GO:0000122; GO:0000981; GO:0000987; GO:0001228; GO:0001525; GO:0001666; GO:0001892; GO:0001974; GO:0002027; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006979; GO:0007005; GO:0007601; GO:0008134; GO:0016607; GO:0030097; GO:0030154; GO:0030218; GO:0030324; GO:0035035; GO:0042415; GO:0042421; GO:0043129; GO:0043565; GO:0043619; GO:0045944; GO:0046982; GO:0048469; GO:0048625; GO:0050897; GO:0055072; GO:0071456; GO:0120162; GO:1903181	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; protein heterodimerization activity [GO:0046982]; proximal promoter sequence-specific DNA binding [GO:0000987]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; cellular response to hypoxia [GO:0071456]; embryonic placenta development [GO:0001892]; erythrocyte differentiation [GO:0030218]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; myoblast fate commitment [GO:0048625]; negative regulation of transcription by RNA polymerase II [GO:0000122]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; surfactant homeostasis [GO:0043129]; visual perception [GO:0007601]"
PGEN_.00g017120	Scaffold_01	46365528	46373771	NA	NA	NA	NA	NA
PGEN_.00g017130	Scaffold_01	46402563	46428205	Q3U1U7	AHRR_MOUSE	Aryl hydrocarbon receptor repressor (AhR repressor) (AhRR)	GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006805; GO:0009410; GO:0033235; GO:0045892; GO:0045944; GO:0046983	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g017140	Scaffold_01	46431026	46431337	NA	NA	NA	NA	NA
PGEN_.00g017150	Scaffold_01	46434018	46434647	NA	NA	NA	NA	NA
PGEN_.00g017160	Scaffold_01	46461867	46468806	Q98SW2	HIF1A_ONCMY	Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha)	GO:0003677; GO:0005623; GO:0005634; GO:0005737; GO:0016607; GO:0046983	cell [GO:0005623]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]
PGEN_.00g017170	Scaffold_01	46502223	46579566	E1BLZ4	ZFY26_BOVIN	Zinc finger FYVE domain-containing protein 26	GO:0000281; GO:0000724; GO:0005737; GO:0005813; GO:0030496; GO:0032266; GO:0032465; GO:0046872	centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]
PGEN_.00g017180	Scaffold_01	46580329	46602088	P51955	NEK2_HUMAN	Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1)	GO:0000070; GO:0000086; GO:0000278; GO:0000776; GO:0000777; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0006468; GO:0007059; GO:0007088; GO:0010389; GO:0019903; GO:0030496; GO:0032212; GO:0032991; GO:0043392; GO:0046602; GO:0046777; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051973; GO:0051988; GO:0090307; GO:0097711; GO:1903126; GO:1904355	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; negative regulation of DNA binding [GO:0043392]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]
PGEN_.00g017190	Scaffold_01	46610954	46629296	NA	NA	NA	NA	NA
PGEN_.00g017200	Scaffold_01	46654023	46658707	A0A1B0GWB2	PRT1B_HUMAN	Proline rich transmembrane protein 1B	GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]
PGEN_.00g017210	Scaffold_01	46670015	46678058	NA	NA	NA	NA	NA
PGEN_.00g017220	Scaffold_01	46691929	46692641	NA	NA	NA	NA	NA
PGEN_.00g017230	Scaffold_01	46693992	46694739	NA	NA	NA	NA	NA
PGEN_.00g017240	Scaffold_01	46694890	46696553	NA	NA	NA	NA	NA
PGEN_.00g017250	Scaffold_01	46717358	46719976	NA	NA	NA	NA	NA
PGEN_.00g017260	Scaffold_01	46723271	46738924	P56597	NDK5_HUMAN	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	GO:0003351; GO:0004550; GO:0005576; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0060271; GO:1902176	extracellular region [GO:0005576]; sperm flagellum [GO:0036126]; nucleoside diphosphate kinase activity [GO:0004550]; cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]
PGEN_.00g017270	Scaffold_01	46743870	46744094	NA	NA	NA	NA	NA
PGEN_.00g017280	Scaffold_01	46744784	46747680	NA	NA	NA	NA	NA
PGEN_.00g017290	Scaffold_01	46747748	46748681	NA	NA	NA	NA	NA
PGEN_.00g017300	Scaffold_01	46748834	46757007	NA	NA	NA	NA	NA
PGEN_.00g017310	Scaffold_01	46757099	46776661	NA	NA	NA	NA	NA
PGEN_.00g017320	Scaffold_01	46778649	46781301	NA	NA	NA	NA	NA
PGEN_.00g017330	Scaffold_01	46781408	46781914	NA	NA	NA	NA	NA
PGEN_.00g017340	Scaffold_01	46802416	46804832	NA	NA	NA	NA	NA
PGEN_.00g017350	Scaffold_01	46819679	46820326	P41894	DEI_DROME	Helix-loop-helix protein delilah (Protein taxi)	GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007474; GO:0007498; GO:0007525; GO:0016203; GO:0033627; GO:0043425; GO:0046982	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; regulation of transcription, DNA-templated [GO:0006355]; somatic muscle development [GO:0007525]"
PGEN_.00g017360	Scaffold_01	46824352	46824585	NA	NA	NA	NA	NA
PGEN_.00g017370	Scaffold_01	46840060	46858760	Q9H0R1	AP5M1_HUMAN	AP-5 complex subunit mu-1 (Adaptor-related protein complex 5 subunit mu-1) (Mu5) (Mu-2-related death-inducing protein) (MuD) (Putative HIV-1 infection-related protein)	GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016020; GO:0016197; GO:0030119; GO:0031902	AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; endosomal transport [GO:0016197]; protein transport [GO:0015031]
PGEN_.00g017380	Scaffold_01	46866640	46866963	NA	NA	NA	NA	NA
PGEN_.00g017390	Scaffold_01	46867450	46868793	NA	NA	NA	NA	NA
PGEN_.00g017400	Scaffold_01	46892067	46892654	NA	NA	NA	NA	NA
PGEN_.00g017410	Scaffold_01	46907751	46911774	NA	NA	NA	NA	NA
PGEN_.00g017420	Scaffold_01	46921333	46932660	NA	NA	NA	NA	NA
PGEN_.00g017430	Scaffold_01	46936058	46942315	NA	NA	NA	NA	NA
PGEN_.00g017440	Scaffold_01	46952299	46981025	NA	NA	NA	NA	NA
PGEN_.00g017450	Scaffold_01	46981101	46981466	NA	NA	NA	NA	NA
PGEN_.00g017460	Scaffold_01	46987555	46989435	NA	NA	NA	NA	NA
PGEN_.00g017470	Scaffold_01	46992388	46992735	NA	NA	NA	NA	NA
PGEN_.00g017480	Scaffold_01	47000712	47001619	NA	NA	NA	NA	NA
PGEN_.00g017490	Scaffold_01	47002002	47002580	NA	NA	NA	NA	NA
PGEN_.00g017500	Scaffold_01	47145605	47167411	Q90481	NX22A_DANRE	Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A)	GO:0000978; GO:0003700; GO:0005634; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0043565; GO:0045944	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514]
PGEN_.00g017510	Scaffold_01	47199919	47200977	NA	NA	NA	NA	NA
PGEN_.00g017520	Scaffold_01	47201100	47202611	NA	NA	NA	NA	NA
PGEN_.00g017530	Scaffold_01	47207814	47222315	Q58EM4	ARMT1_DANRE	Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1)	GO:0008757; GO:0016791; GO:0032259; GO:0046872; GO:0051998; GO:2001020	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020]
PGEN_.00g017540	Scaffold_01	47222452	47229786	Q93015	NAA80_HUMAN	N-alpha-acetyltransferase 80 (HsNAAA80) (EC 2.3.1.-) (N-acetyltransferase 6) (Protein fusion-2) (Protein fus-2)	GO:0004596; GO:0005737; GO:0005829; GO:0006473; GO:0008064; GO:0008080; GO:0017190; GO:0018002; GO:0030047; GO:1905502	cytoplasm [GO:0005737]; cytosol [GO:0005829]; acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; actin modification [GO:0030047]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]; regulation of actin polymerization or depolymerization [GO:0008064]
PGEN_.00g017550	Scaffold_01	47241498	47252077	Q5PPV4	CHAC2_XENLA	Putative glutathione-specific gamma-glutamylcyclotransferase 2 (Gamma-GCG 2) (EC 4.3.2.7) (Cation transport regulator-like protein 2)	GO:0003839; GO:0006751; GO:0061928	gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; glutathione catabolic process [GO:0006751]
PGEN_.00g017560	Scaffold_01	47257372	47260960	Q5VWW1	C1QL3_HUMAN	Complement C1q-like protein 3 (C1q and tumor necrosis factor-related protein 13) (C1q/TNF-related protein 13)	GO:0005576; GO:0005581; GO:0042802; GO:0050807	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]; regulation of synapse organization [GO:0050807]
PGEN_.00g017570	Scaffold_01	47272704	47275427	NA	NA	NA	NA	NA
PGEN_.00g017580	Scaffold_01	47335732	47338427	Q86Z23	C1QL4_HUMAN	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g017590	Scaffold_01	47343133	47352615	P86881	NGB_DISMA	Neuroglobin	GO:0005344; GO:0005737; GO:0019825; GO:0020037; GO:0043204; GO:0046872	cytoplasm [GO:0005737]; perikaryon [GO:0043204]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g017600	Scaffold_01	47364258	47376401	Q6UWX4	HIPL2_HUMAN	HHIP-like protein 2	GO:0003824; GO:0005576	extracellular region [GO:0005576]; catalytic activity [GO:0003824]
PGEN_.00g017610	Scaffold_01	47381416	47392973	Q9CYL5	GAPR1_MOUSE	Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)	GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070374	extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]
PGEN_.00g017620	Scaffold_01	47393170	47393424	NA	NA	NA	NA	NA
PGEN_.00g017630	Scaffold_01	47396356	47405349	Q96G97	BSCL2_HUMAN	Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein)	GO:0016042; GO:0019915; GO:0030176; GO:0034389; GO:0045444; GO:0050995; GO:0120162	integral component of endoplasmic reticulum membrane [GO:0030176]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of cold-induced thermogenesis [GO:0120162]
PGEN_.00g017640	Scaffold_01	47411111	47455188	Q6PCL9	PAPOG_MOUSE	Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme)	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016604; GO:0043631; GO:0046872	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]
PGEN_.00g017650	Scaffold_01	47481381	47499839	NA	NA	NA	NA	NA
PGEN_.00g017660	Scaffold_01	47590140	47592461	NA	NA	NA	NA	NA
PGEN_.00g017670	Scaffold_01	47594074	47595131	NA	NA	NA	NA	NA
PGEN_.00g017680	Scaffold_01	47621980	47635502	NA	NA	NA	NA	NA
PGEN_.00g017690	Scaffold_01	47637792	47653654	Q640Z9	LRC14_XENLA	Leucine-rich repeat-containing protein 14	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g017700	Scaffold_01	47660507	47661619	Q5EB73	TM246_RAT	Transmembrane protein 246	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g017710	Scaffold_01	47668207	47668515	NA	NA	NA	NA	NA
PGEN_.00g017720	Scaffold_01	47675304	47767008	Q12955	ANK3_HUMAN	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]"
PGEN_.00g017730	Scaffold_01	47785060	47789679	O60232	ZNRD2_HUMAN	Protein ZNRD2 (Autoantigen p27) (Sjoegren syndrome/scleroderma autoantigen 1) (Zinc ribbon domain-containing protein 2)	GO:0000278; GO:0051301	cell division [GO:0051301]; mitotic cell cycle [GO:0000278]
PGEN_.00g017740	Scaffold_01	47807579	47817893	NA	NA	NA	NA	NA
PGEN_.00g017750	Scaffold_01	47917586	47944595	M9NDE3	BARK_DROME	Protein bark beetle (Protein anakonda)	GO:0005044; GO:0005886; GO:0005912; GO:0005918; GO:0005923; GO:0016021; GO:0030246; GO:0034976; GO:0035002; GO:0035159; GO:0045217; GO:0061689; GO:0090557; GO:1904274	"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]; carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]; cell-cell junction maintenance [GO:0045217]; establishment of endothelial intestinal barrier [GO:0090557]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]"
PGEN_.00g017760	Scaffold_01	47972375	47972890	NA	NA	NA	NA	NA
PGEN_.00g017770	Scaffold_01	47998484	48001788	NA	NA	NA	NA	NA
PGEN_.00g017780	Scaffold_01	48020909	48021337	NA	NA	NA	NA	NA
PGEN_.00g017790	Scaffold_01	48025578	48030440	Q6FMI5	LYS2_CANGA	L-2-aminoadipate reductase large subunit (EC 1.2.1.31) (EC 1.2.1.95) (Alpha-aminoadipate reductase) (Alpha-AR) (L-aminoadipate-semialdehyde dehydrogenase)	GO:0004043; GO:0019878; GO:0031177	L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; phosphopantetheine binding [GO:0031177]; lysine biosynthetic process via aminoadipic acid [GO:0019878]
PGEN_.00g017800	Scaffold_01	48030886	48032431	NA	NA	NA	NA	NA
PGEN_.00g017810	Scaffold_01	48042364	48057390	Q86U28	ISCA2_HUMAN	"Iron-sulfur cluster assembly 2 homolog, mitochondrial (HESB-like domain-containing protein 1)"	GO:0005198; GO:0005506; GO:0005739; GO:0005759; GO:0016226; GO:0044281; GO:0051537; GO:0051539; GO:0051604; GO:0106035	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; structural molecule activity [GO:0005198]; iron-sulfur cluster assembly [GO:0016226]; protein maturation [GO:0051604]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; small molecule metabolic process [GO:0044281]"
PGEN_.00g017820	Scaffold_01	48057504	48065544	Q8BIG4	FBX28_MOUSE	F-box only protein 28	GO:0000776; GO:0000777	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]
PGEN_.00g017830	Scaffold_01	48088590	48094792	Q16975	KPC2_APLCA	Calcium-independent protein kinase C (EC 2.7.11.13) (APL II)	GO:0004697; GO:0005524; GO:0016020; GO:0035556; GO:0046872	membrane [GO:0016020]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; intracellular signal transduction [GO:0035556]
PGEN_.00g017840	Scaffold_01	48122780	48123466	Q16975	KPC2_APLCA	Calcium-independent protein kinase C (EC 2.7.11.13) (APL II)	GO:0004697; GO:0005524; GO:0016020; GO:0035556; GO:0046872	membrane [GO:0016020]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; intracellular signal transduction [GO:0035556]
PGEN_.00g017850	Scaffold_01	48128906	48130207	NA	NA	NA	NA	NA
PGEN_.00g017860	Scaffold_01	48136795	48272553	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g017870	Scaffold_01	48273528	48275249	O13076	AA2BR_CHICK	Adenosine receptor A2b (Adenosine receptor 2b)	GO:0001609; GO:0002882; GO:0005886; GO:0007189; GO:0010575; GO:0010753; GO:0016021; GO:0031284; GO:0031668; GO:0032722; GO:0032755; GO:0043306; GO:0060087; GO:0098685; GO:0098978; GO:2000300	glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled adenosine receptor activity [GO:0001609]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to extracellular stimulus [GO:0031668]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of synaptic vesicle exocytosis [GO:2000300]; relaxation of vascular smooth muscle [GO:0060087]
PGEN_.00g017880	Scaffold_01	48282510	48284356	O70528	5HT4R_CAVPO	5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)	GO:0004993; GO:0005768; GO:0005887; GO:0007268; GO:0032098; GO:0045202	endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; chemical synaptic transmission [GO:0007268]; regulation of appetite [GO:0032098]
PGEN_.00g017890	Scaffold_01	48295222	48296991	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g017900	Scaffold_01	48314580	48336920	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g017910	Scaffold_01	48342303	48348049	NA	NA	NA	NA	NA
PGEN_.00g017920	Scaffold_01	48349326	48370449	Q8IYT3	CC170_HUMAN	Coiled-coil domain-containing protein 170		
PGEN_.00g017930	Scaffold_01	48389852	48414339	Q6P2K6	P4R3A_MOUSE	Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1)	GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0006470; GO:0016607; GO:0030289; GO:0045722	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]
PGEN_.00g017940	Scaffold_01	48427740	48429429	NA	NA	NA	NA	NA
PGEN_.00g017950	Scaffold_01	48430588	48431529	NA	NA	NA	NA	NA
PGEN_.00g017960	Scaffold_01	48435044	48435514	NA	NA	NA	NA	NA
PGEN_.00g017970	Scaffold_01	48445794	48453145	Q6GM07	CINP_XENLA	Cyclin-dependent kinase 2-interacting protein	GO:0005634; GO:0006260; GO:0006281; GO:0007049; GO:0051301	nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; DNA replication [GO:0006260]
PGEN_.00g017980	Scaffold_01	48453276	48465628	Q9H477	RBSK_HUMAN	Ribokinase (RK) (EC 2.7.1.15)	GO:0004747; GO:0005524; GO:0005634; GO:0005829; GO:0006098; GO:0019303; GO:0046872	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]
PGEN_.00g017990	Scaffold_01	48476500	48507483	Q9YIB9	HIF1A_CHICK	Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha)	GO:0000981; GO:0001666; GO:0003677; GO:0005634; GO:0005737; GO:0006357; GO:0016607; GO:0035035; GO:0045893; GO:0045944; GO:0046983	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; protein dimerization activity [GO:0046983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]"
PGEN_.00g018000	Scaffold_01	48558582	48587007	B2RY56	RBM25_MOUSE	RNA-binding protein 25 (RNA-binding motif protein 25)	GO:0000381; GO:0003729; GO:0005737; GO:0006397; GO:0006915; GO:0008380; GO:0016607; GO:0042981	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"
PGEN_.00g018010	Scaffold_01	48596642	48611029	Q9BQT8	ODC_HUMAN	Mitochondrial 2-oxodicarboxylate carrier (Solute carrier family 25 member 21)	GO:0005743; GO:0006554; GO:0015139; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; lysine catabolic process [GO:0006554]
PGEN_.00g018020	Scaffold_01	48615038	48616849	O35680	RT12_MOUSE	"28S ribosomal protein S12, mitochondrial (MRP-S12) (S12mt) (MT-RPS12)"	GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0032543	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
PGEN_.00g018030	Scaffold_01	48702636	48702932	NA	NA	NA	NA	NA
PGEN_.00g018040	Scaffold_01	48712202	48713636	NA	NA	NA	NA	NA
PGEN_.00g018050	Scaffold_01	48715178	48721301	NA	NA	NA	NA	NA
PGEN_.00g018060	Scaffold_01	48822855	48839806	Q866F4	ADCYA_RABIT	Adenylate cyclase type 10 (EC 4.6.1.1) (Germ cell soluble adenylyl cyclase) (sAC) (Testicular soluble adenylyl cyclase)	GO:0000287; GO:0003351; GO:0004016; GO:0005524; GO:0005576; GO:0005634; GO:0005856; GO:0005886; GO:0005929; GO:0006171; GO:0007283; GO:0035556; GO:0048471; GO:0071241; GO:0071890	cilium [GO:0005929]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; cAMP biosynthetic process [GO:0006171]; cellular response to inorganic substance [GO:0071241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intracellular signal transduction [GO:0035556]; spermatogenesis [GO:0007283]
PGEN_.00g018070	Scaffold_01	48841477	48856905	B2RYG6	OTUB1_RAT	Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (Ubiquitin-specific-processing protease OTUB1)	GO:0002250; GO:0004843; GO:0005634; GO:0005737; GO:0006281; GO:0006974; GO:0019784; GO:0031625; GO:0043130; GO:0071108; GO:0071347; GO:1901315; GO:2000780	cytoplasm [GO:0005737]; nucleus [GO:0005634]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein K48-linked deubiquitination [GO:0071108]
PGEN_.00g018080	Scaffold_01	48861199	48922414	G5EFX6	SLIT1_CAEEL	Slit homolog 1 protein (Slt-1)	GO:0001764; GO:0005102; GO:0005509; GO:0005576; GO:0008201; GO:0016199; GO:0033563; GO:0048495; GO:0048843; GO:0097374; GO:1905489	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; signaling receptor binding [GO:0005102]; axon midline choice point recognition [GO:0016199]; dorsal/ventral axon guidance [GO:0033563]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; sensory neuron axon guidance [GO:0097374]
PGEN_.00g018090	Scaffold_01	48922532	48923107	NA	NA	NA	NA	NA
PGEN_.00g018100	Scaffold_01	48923323	48959908	P35447	SPON1_XENLA	Spondin-1 (F-spondin)	GO:0005576; GO:0007155; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]
PGEN_.00g018110	Scaffold_01	48967499	48970010	NA	NA	NA	NA	NA
PGEN_.00g018120	Scaffold_01	48993531	48996827	NA	NA	NA	NA	NA
PGEN_.00g018130	Scaffold_01	49084777	49108427	O42406	SIX3_CHICK	Homeobox protein SIX3 (CSIX3) (Sine oculis homeobox homolog 3)	GO:0000976; GO:0000981; GO:0001222; GO:0001228; GO:0001654; GO:0002070; GO:0002088; GO:0003404; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005667; GO:0006606; GO:0007420; GO:0009946; GO:0014016; GO:0021537; GO:0021797; GO:0021798; GO:0021846; GO:0021978; GO:0021983; GO:0030178; GO:0042127; GO:0042826; GO:0045665; GO:0045892; GO:0048512; GO:0048856; GO:0060235; GO:0061074; GO:0070306; GO:0097402; GO:1901987; GO:1902692; GO:1902742; GO:1990086; GO:2000177	"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; transcription coactivator activity [GO:0003713]; transcription corepressor binding [GO:0001222]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; apoptotic process involved in development [GO:1902742]; brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; circadian behavior [GO:0048512]; epithelial cell maturation [GO:0002070]; eye development [GO:0001654]; forebrain anterior/posterior pattern specification [GO:0021797]; forebrain dorsal/ventral pattern formation [GO:0021798]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lens fiber cell differentiation [GO:0070306]; lens induction in camera-type eye [GO:0060235]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; neuroblast differentiation [GO:0014016]; neuroblast migration [GO:0097402]; optic vesicle morphogenesis [GO:0003404]; pituitary gland development [GO:0021983]; protein import into nucleus [GO:0006606]; proximal/distal axis specification [GO:0009946]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell population proliferation [GO:0042127]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neural retina development [GO:0061074]; regulation of neuroblast proliferation [GO:1902692]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]"
PGEN_.00g018140	Scaffold_01	49153660	49162615	Q6ZQY2	LR74B_HUMAN	Leucine-rich repeat-containing protein 74B		
PGEN_.00g018150	Scaffold_01	49166497	49171322	NA	NA	NA	NA	NA
PGEN_.00g018160	Scaffold_01	49183247	49188772	Q5TZE1	BTB6B_DANRE	BTB/POZ domain-containing protein 6-B	GO:0005634; GO:0005829; GO:0022008	cytosol [GO:0005829]; nucleus [GO:0005634]; neurogenesis [GO:0022008]
PGEN_.00g018170	Scaffold_01	49216763	49217212	NA	NA	NA	NA	NA
PGEN_.00g018180	Scaffold_01	49218121	49219104	NA	NA	NA	NA	NA
PGEN_.00g018190	Scaffold_01	49219774	49223234	NA	NA	NA	NA	NA
PGEN_.00g018200	Scaffold_01	49223319	49224266	NA	NA	NA	NA	NA
PGEN_.00g018210	Scaffold_01	49226948	49227163	NA	NA	NA	NA	NA
PGEN_.00g018220	Scaffold_01	49227251	49228205	NA	NA	NA	NA	NA
PGEN_.00g018230	Scaffold_01	49233103	49245067	NA	NA	NA	NA	NA
PGEN_.00g018240	Scaffold_01	49260226	49285562	NA	NA	NA	NA	NA
PGEN_.00g018250	Scaffold_01	49403531	49403812	NA	NA	NA	NA	NA
PGEN_.00g018260	Scaffold_01	49403844	49410690	NA	NA	NA	NA	NA
PGEN_.00g018270	Scaffold_01	49420265	49420531	NA	NA	NA	NA	NA
PGEN_.00g018280	Scaffold_01	49426797	49442685	NA	NA	NA	NA	NA
PGEN_.00g018290	Scaffold_01	49444038	49446318	NA	NA	NA	NA	NA
PGEN_.00g018300	Scaffold_01	49449433	49449939	Q17QR8	HARB1_BOVIN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g018310	Scaffold_01	49450969	49487609	NA	NA	NA	NA	NA
PGEN_.00g018320	Scaffold_01	49544420	49552544	Q6R653	UN5CL_MOUSE	UNC5C-like protein (Protein unc-5 homolog C-like) (ZU5 and death domain-containing protein)	GO:0005042; GO:0005737; GO:0008233; GO:0016020; GO:0016021; GO:0043123; GO:0046330	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; netrin receptor activity [GO:0005042]; peptidase activity [GO:0008233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]
PGEN_.00g018330	Scaffold_01	49556609	49591107	Q96BD0	SO4A1_HUMAN	Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)	GO:0005886; GO:0005887; GO:0015347; GO:0015349; GO:0043252	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; sodium-independent organic anion transport [GO:0043252]
PGEN_.00g018340	Scaffold_01	49593319	49605976	Q8BGD4	SO4C1_MOUSE	Solute carrier organic anion transporter family member 4C1 (Oatp-R) (Solute carrier family 21 member 20)	GO:0005887; GO:0007275; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016021; GO:0016323; GO:0030154; GO:0043252	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]
PGEN_.00g018350	Scaffold_01	49627759	49628181	NA	NA	NA	NA	NA
PGEN_.00g018360	Scaffold_01	49645823	49647055	NA	NA	NA	NA	NA
PGEN_.00g018370	Scaffold_01	49649265	49651007	NA	NA	NA	NA	NA
PGEN_.00g018380	Scaffold_01	49667268	49690794	Q6DF46	COQ6_XENTR	"Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial (EC 1.14.13.-) (Coenzyme Q10 monooxygenase 6)"	GO:0005739; GO:0005794; GO:0006744; GO:0016491; GO:0016709; GO:0016712; GO:0031314; GO:0042995; GO:0071949	"cell projection [GO:0042995]; extrinsic component of mitochondrial inner membrane [GO:0031314]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; ubiquinone biosynthetic process [GO:0006744]"
PGEN_.00g018390	Scaffold_01	49708297	49715095	Q66KE9	F161A_XENLA	Protein FAM161A	GO:0005737; GO:0005856; GO:0005929; GO:0030030	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cell projection organization [GO:0030030]
PGEN_.00g018400	Scaffold_01	49724335	49731311	Q9JLJ5	ELOV1_MOUSE	Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very long chain 3-ketoacyl-CoA synthase 1) (Very long chain 3-oxoacyl-CoA synthase 1)	GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0046513; GO:0061436; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"
PGEN_.00g018410	Scaffold_01	49762445	49763524	NA	NA	NA	NA	NA
PGEN_.00g018420	Scaffold_01	49773043	49773429	Q07981	FAR1_CORAP	FMRFamide-related peptides type HF-4 (HeptaFaRP) [Cleaved into: NDPFLRFGKKSDPFLRF-amide; FMRFamide-like; ENNNGYIRF-amide; NDPFLRF-amide; QDPFLRI-amide; QDPFLRF-amide; KQDPFLRI-amide; SEPYLRF-amide; NDPYLRF-amide]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g018430	Scaffold_01	49846884	49849270	NA	NA	NA	NA	NA
PGEN_.00g018440	Scaffold_01	49849274	49849955	A6NE01	F186A_HUMAN	Protein FAM186A		
PGEN_.00g018450	Scaffold_01	49854656	49864522	Q05062	CDC42_CAEEL	Cell division control protein 42 homolog (CDC42Ce)	GO:0000132; GO:0003924; GO:0005525; GO:0005623; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0016021; GO:0019901; GO:0030031; GO:0030036; GO:0032488; GO:0032956; GO:0032970; GO:0040001; GO:0042995; GO:0048471; GO:0051301; GO:0055037; GO:0060562; GO:0110039; GO:1903358; GO:2000370	cell [GO:0005623]; cell cortex [GO:0005938]; cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell division [GO:0051301]; cell projection assembly [GO:0030031]; endocytosis [GO:0006897]; epithelial tube morphogenesis [GO:0060562]; establishment of mitotic spindle localization [GO:0040001]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of cell shape [GO:0008360]; regulation of Golgi organization [GO:1903358]; Rho protein signal transduction [GO:0007266]
PGEN_.00g018460	Scaffold_01	49874958	49883439	E3VWI4	PNTH_STRAE	1-deoxypentalenic acid 11-beta-hydroxylase (EC 1.14.11.35) (Pentalenolactone biosynthesis protein H)	GO:0017000; GO:0031418; GO:0046872; GO:0051213	dioxygenase activity [GO:0051213]; L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; antibiotic biosynthetic process [GO:0017000]
PGEN_.00g018470	Scaffold_01	49895275	49897847	NA	NA	NA	NA	NA
PGEN_.00g018480	Scaffold_01	49912797	49924949	Q8K1J6	TRNT1_MOUSE	"CCA tRNA nucleotidyltransferase 1, mitochondrial (EC 2.7.7.72) (mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase)"	GO:0000049; GO:0001680; GO:0005524; GO:0005739; GO:0008033; GO:0009022; GO:0052927; GO:0052928; GO:0052929; GO:1990180	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA binding [GO:0000049]; tRNA nucleotidyltransferase activity [GO:0009022]; mitochondrial tRNA 3'-end processing [GO:1990180]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033]
PGEN_.00g018490	Scaffold_01	49932323	49932643	NA	NA	NA	NA	NA
PGEN_.00g018500	Scaffold_01	49936419	50002165	P47990	XDH_CHICK	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949	"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]"
PGEN_.00g018510	Scaffold_01	50002502	50010839	Q5ZIH3	ZNT6_CHICK	Zinc transporter 6 (ZnT-6) (Solute carrier family 30 member 6)	GO:0005794; GO:0006829; GO:0008324; GO:0016021	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cation transmembrane transporter activity [GO:0008324]; zinc ion transport [GO:0006829]
PGEN_.00g018520	Scaffold_01	50069481	50078247	NA	NA	NA	NA	NA
PGEN_.00g018530	Scaffold_01	50078270	50079559	P41224	TEF_RAT	Thyrotroph embryonic factor	GO:0000977; GO:0000978; GO:0001228; GO:0003690; GO:0005634; GO:0042802; GO:0043565; GO:0044877; GO:0045944; GO:0048511	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]"
PGEN_.00g018540	Scaffold_01	50130028	50160320	Q6P158	DHX57_HUMAN	Putative ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57)	GO:0003723; GO:0003724; GO:0005524; GO:0046872	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]
PGEN_.00g018550	Scaffold_01	50161300	50177431	Q9BQ69	MACD1_HUMAN	ADP-ribose glycohydrolase MACROD1 (MACRO domain-containing protein 1) (O-acetyl-ADP-ribose deacetylase MACROD1) (EC 3.1.1.106) (Protein LRP16) ([Protein ADP-ribosylaspartate] hydrolase MACROD1) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD1) (EC 3.2.2.-)	GO:0005634; GO:0005654; GO:0006974; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]"
PGEN_.00g018560	Scaffold_01	50212945	50213981	NA	NA	NA	NA	NA
PGEN_.00g018570	Scaffold_01	50214521	50217485	Q5XII0	EPDR1_RAT	Mammalian ependymin-related protein 1 (MERP-1)	GO:0005509; GO:0005576; GO:0005764; GO:0007160; GO:0008289; GO:0043202	extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; cell-matrix adhesion [GO:0007160]
PGEN_.00g018580	Scaffold_01	50227754	50228688	NA	NA	NA	NA	NA
PGEN_.00g018590	Scaffold_01	50242529	50265764	Q8TD19	NEK9_HUMAN	Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8)	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0007077; GO:0019901; GO:0046872; GO:0051301	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic nuclear envelope disassembly [GO:0007077]
PGEN_.00g018600	Scaffold_01	50293208	50296125	NA	NA	NA	NA	NA
PGEN_.00g018610	Scaffold_01	50353659	50357397	NA	NA	NA	NA	NA
PGEN_.00g018620	Scaffold_01	50496834	50497109	NA	NA	NA	NA	NA
PGEN_.00g018630	Scaffold_01	50497499	50497759	NA	NA	NA	NA	NA
PGEN_.00g018640	Scaffold_01	50498056	50498376	NA	NA	NA	NA	NA
PGEN_.00g018650	Scaffold_01	50518601	50521816	NA	NA	NA	NA	NA
PGEN_.00g018660	Scaffold_01	50534081	50537913	NA	NA	NA	NA	NA
PGEN_.00g018670	Scaffold_01	50550035	50564751	NA	NA	NA	NA	NA
PGEN_.00g018680	Scaffold_01	50568605	50573036	P02826	HSP7A_DROSI	Heat shock 70 kDa protein cognate 1 (Heat shock 70 kDa protein 70C) (Fragments)	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g018690	Scaffold_01	50588051	50590424	P29176	FOSX_MSVFR	Transforming protein v-Fos/v-Fox	GO:0003677; GO:0003700; GO:0005667; GO:0006357; GO:0042025	host cell nucleus [GO:0042025]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g018700	Scaffold_01	50601491	50601835	NA	NA	NA	NA	NA
PGEN_.00g018710	Scaffold_01	50606828	50610212	NA	NA	NA	NA	NA
PGEN_.00g018720	Scaffold_01	50617719	50628977	NA	NA	NA	NA	NA
PGEN_.00g018730	Scaffold_01	50642400	50644051	NA	NA	NA	NA	NA
PGEN_.00g018740	Scaffold_01	50664191	50683506	NA	NA	NA	NA	NA
PGEN_.00g018750	Scaffold_01	50696065	50743858	O75582	KS6A5_HUMAN	Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL)	GO:0000287; GO:0001818; GO:0002223; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007173; GO:0007411; GO:0016572; GO:0032793; GO:0033129; GO:0035066; GO:0035556; GO:0043987; GO:0043988; GO:0043990; GO:0045892; GO:0045944; GO:0051092; GO:0070498	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon guidance [GO:0007411]; epidermal growth factor receptor signaling pathway [GO:0007173]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
PGEN_.00g018760	Scaffold_01	50764893	50780298	NA	NA	NA	NA	NA
PGEN_.00g018770	Scaffold_01	50784512	50787956	Q5HWE7	UBIE_CAMJR	"Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE (EC 2.1.1.163) (EC 2.1.1.201) (2-methoxy-6-polyprenyl-1,4-benzoquinol methylase) (Demethylmenaquinone methyltransferase)"	GO:0006744; GO:0009060; GO:0009234; GO:0032259; GO:0043333; GO:0102955	"2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; aerobic respiration [GO:0009060]; menaquinone biosynthetic process [GO:0009234]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"
PGEN_.00g018780	Scaffold_01	50804627	50828735	A1A4Q2	PRXD1_BOVIN	Prolyl-tRNA synthetase associated domain-containing protein 1 (PrdX deacylase domain-containing protein 1)	GO:0002161	aminoacyl-tRNA editing activity [GO:0002161]
PGEN_.00g018790	Scaffold_01	50829517	50833022	C4YDI6	CDC42_CANAW	Cell division control protein 42 homolog	GO:0003924; GO:0005525; GO:0005886; GO:0007049; GO:0007264; GO:0009405; GO:0051301	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell cycle [GO:0007049]; cell division [GO:0051301]; pathogenesis [GO:0009405]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g018800	Scaffold_01	50839429	50848777	A8I1Q0	CALM_HETTR	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g018810	Scaffold_01	50851195	50860604	NA	NA	NA	NA	NA
PGEN_.00g018820	Scaffold_01	50867877	50893810	Q803I8	SYVN1_DANRE	E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1)	GO:0000836; GO:0006511; GO:0012505; GO:0016021; GO:0018279; GO:0030433; GO:0046872; GO:0061630	endomembrane system [GO:0012505]; Hrd1p ubiquitin ligase complex [GO:0000836]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein N-linked glycosylation via asparagine [GO:0018279]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g018830	Scaffold_01	50894340	50897744	NA	NA	NA	NA	NA
PGEN_.00g018840	Scaffold_01	50897966	50898229	NA	NA	NA	NA	NA
PGEN_.00g018850	Scaffold_01	50901781	50923366	Q86TW2	ADCK1_HUMAN	AarF domain-containing protein kinase 1 (EC 2.7.-.-)	GO:0004674; GO:0005524; GO:0005576; GO:0010637; GO:1903852	extracellular region [GO:0005576]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cristae formation [GO:1903852]
PGEN_.00g018860	Scaffold_01	50925808	50942879	Q1JQE0	SNW1_BOVIN	SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein)	GO:0000122; GO:0000398; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0016363; GO:0030511; GO:0035257; GO:0042771; GO:0042809; GO:0042974; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050769; GO:0051571; GO:0070562; GO:0071007	"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]"
PGEN_.00g018870	Scaffold_01	51012724	51028488	Q9P2K8	E2AK4_HUMAN	eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein)	GO:0000049; GO:0000077; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005634; GO:0005844; GO:0006446; GO:0006468; GO:0007050; GO:0007612; GO:0007616; GO:0010998; GO:0019081; GO:0022626; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0036492; GO:0039520; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0060733; GO:0070417; GO:0071264; GO:1900273; GO:1990138; GO:1990253	cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049]; adaptive immune response [GO:0002250]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; induction by virus of host autophagy [GO:0039520]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of eIF2 alpha phosphorylation by amino acid starvation [GO:0060733]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081]
PGEN_.00g018880	Scaffold_01	51039219	51040316	NA	NA	NA	NA	NA
PGEN_.00g018890	Scaffold_01	51040846	51043347	NA	NA	NA	NA	NA
PGEN_.00g018900	Scaffold_01	51044227	51044595	NA	NA	NA	NA	NA
PGEN_.00g018910	Scaffold_01	51050083	51052536	O08590	AOC3_RAT	Membrane primary amine oxidase (EC 1.4.3.21) (Copper amine oxidase) (Semicarbazide-sensitive amine oxidase) (SSAO) (VP97) (Vascular adhesion protein 1) (VAP-1)	GO:0002523; GO:0002675; GO:0002687; GO:0005507; GO:0005509; GO:0005615; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005902; GO:0007155; GO:0007568; GO:0008131; GO:0008217; GO:0009308; GO:0009986; GO:0010828; GO:0016021; GO:0035902; GO:0042755; GO:0042802; GO:0043231; GO:0046677; GO:0046982; GO:0048038; GO:0052593; GO:0052594; GO:0052595; GO:0052596; GO:1902283	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; aging [GO:0007568]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; eating behavior [GO:0042755]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of primary amine oxidase activity [GO:1902283]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of leukocyte migration [GO:0002687]; regulation of blood pressure [GO:0008217]; response to antibiotic [GO:0046677]; response to immobilization stress [GO:0035902]
PGEN_.00g018920	Scaffold_01	51069199	51069411	NA	NA	NA	NA	NA
PGEN_.00g018930	Scaffold_01	51078648	51078869	NA	NA	NA	NA	NA
PGEN_.00g018940	Scaffold_01	51079044	51079409	NA	NA	NA	NA	NA
PGEN_.00g018950	Scaffold_01	51125351	51134114	NA	NA	NA	NA	NA
PGEN_.00g018960	Scaffold_01	51134206	51140042	NA	NA	NA	NA	NA
PGEN_.00g018970	Scaffold_01	51303024	51415241	Q9WTQ1	KPCD1_RAT	Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)	GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007265; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0045087; GO:0045669; GO:0045766; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0050829; GO:0051092; GO:0051279; GO:0060548; GO:0071447; GO:0089700; GO:1901727; GO:2001028	autophagosome membrane [GO:0000421]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]
PGEN_.00g018980	Scaffold_01	51415754	51416950	NA	NA	NA	NA	NA
PGEN_.00g018990	Scaffold_01	51435662	51437632	NA	NA	NA	NA	NA
PGEN_.00g019000	Scaffold_01	51438141	51439035	NA	NA	NA	NA	NA
PGEN_.00g019010	Scaffold_01	51454482	51480344	Q8CGQ8	NCKX4_MOUSE	Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4)	GO:0005262; GO:0005432; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006874; GO:0007608; GO:0008273; GO:0015293; GO:0016020; GO:0050896; GO:0070588; GO:0097186	"cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium:sodium antiporter activity [GO:0005432]; symporter activity [GO:0015293]; amelogenesis [GO:0097186]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]"
PGEN_.00g019020	Scaffold_01	51505819	51516303	NA	NA	NA	NA	NA
PGEN_.00g019030	Scaffold_01	51630175	51667895	Q5DRC7	PCDB7_PANTR	Protocadherin beta-7 (PCDH-beta-7)	GO:0005509; GO:0005887; GO:0007155; GO:0007156	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g019040	Scaffold_01	51677724	51679511	NA	NA	NA	NA	NA
PGEN_.00g019050	Scaffold_01	51696417	51703003	Q9Y394	DHRS7_HUMAN	Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1)	GO:0016020; GO:0016491	membrane [GO:0016020]; oxidoreductase activity [GO:0016491]
PGEN_.00g019060	Scaffold_01	51713481	51717153	NA	NA	NA	NA	NA
PGEN_.00g019070	Scaffold_01	51725344	51742133	Q9BZJ0	CRNL1_HUMAN	Crooked neck-like protein 1 (Crooked neck homolog) (hCrn)	GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"
PGEN_.00g019080	Scaffold_01	51742585	51756409	Q8IWZ3	ANKH1_HUMAN	Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)	GO:0003723; GO:0005737; GO:0045087	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]
PGEN_.00g019090	Scaffold_01	51770271	51781000	Q9UJA2	CRLS1_HUMAN	Cardiolipin synthase (CMP-forming) (CLS) (EC 2.7.8.41) (Protein GCD10 homolog)	GO:0003841; GO:0005739; GO:0005743; GO:0008808; GO:0016021; GO:0032049; GO:0036148; GO:0043337; GO:0046474; GO:0047144; GO:0097068; GO:1905711	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; cardiolipin synthase activity [GO:0008808]; CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity [GO:0043337]; cardiolipin biosynthetic process [GO:0032049]; glycerophospholipid biosynthetic process [GO:0046474]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; response to phosphatidylethanolamine [GO:1905711]; response to thyroxine [GO:0097068]
PGEN_.00g019100	Scaffold_01	51781505	51792856	Q5RAL9	GNA1_PONAB	Glucosamine 6-phosphate N-acetyltransferase (EC 2.3.1.4) (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase)	GO:0000139; GO:0004343; GO:0005770; GO:0005793; GO:0006048; GO:0010008; GO:0042802; GO:1990830	endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; identical protein binding [GO:0042802]; cellular response to leukemia inhibitory factor [GO:1990830]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]
PGEN_.00g019110	Scaffold_01	51811339	51817894	NA	NA	NA	NA	NA
PGEN_.00g019120	Scaffold_01	51820978	51824660	NA	NA	NA	NA	NA
PGEN_.00g019130	Scaffold_01	51825301	51825792	NA	NA	NA	NA	NA
PGEN_.00g019140	Scaffold_01	51835723	51846250	NA	NA	NA	NA	NA
PGEN_.00g019150	Scaffold_01	51866081	51912115	P27008	PARP1_RAT	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)	GO:0000723; GO:0000977; GO:0001228; GO:0003682; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0006259; GO:0006284; GO:0006302; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016540; GO:0016604; GO:0016763; GO:0018312; GO:0018424; GO:0019899; GO:0019901; GO:0023019; GO:0030331; GO:0030592; GO:0032042; GO:0032869; GO:0032991; GO:0032993; GO:0033148; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0040009; GO:0042769; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0046332; GO:0047485; GO:0048148; GO:0050790; GO:0050882; GO:0051287; GO:0051901; GO:0060391; GO:0070212; GO:0070213; GO:0070412; GO:0071294; GO:0071451; GO:0071560; GO:0090734; GO:0140294; GO:1900182; GO:1901216; GO:1903376; GO:1903516; GO:1903518; GO:1903827; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1905077; GO:1905168; GO:1990404; GO:1990966; GO:2000679; GO:2001170	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; transferase activity, transferring pentosyl groups [GO:0016763]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair [GO:0006284]; behavioral response to cocaine [GO:0048148]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to superoxide [GO:0071451]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA metabolic process [GO:0006259]; double-strand break repair [GO:0006302]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of interleukin-17 secretion [GO:1905077]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of growth rate [GO:0040009]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of single strand break repair [GO:1903516]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]"
PGEN_.00g019160	Scaffold_01	51936631	51936986	NA	NA	NA	NA	NA
PGEN_.00g019170	Scaffold_01	51937027	51938709	NA	NA	NA	NA	NA
PGEN_.00g019180	Scaffold_01	51946901	51990189	Q5ND34	WDR81_MOUSE	WD repeat-containing protein 81	GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0010923; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0043551; GO:0045022; GO:0050821; GO:0070530	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; negative regulation of phosphatase activity [GO:0010923]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g019190	Scaffold_01	51995201	51997118	NA	NA	NA	NA	NA
PGEN_.00g019200	Scaffold_01	52008632	52058486	Q2PFW9	NOVA1_MACFA	RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Ventral neuron-specific protein 1)	GO:0000398; GO:0003723; GO:0005634	"nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g019210	Scaffold_01	52083156	52099886	P60901	PSA6_RAT	Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)	GO:0000502; GO:0000932; GO:0003723; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005839; GO:0005844; GO:0010498; GO:0010499; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0043161; GO:0051059; GO:0051092; GO:0051603	"cytoplasm [GO:0005737]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603]"
PGEN_.00g019220	Scaffold_01	52104740	52111493	Q91ZN5	S35B2_MOUSE	Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Solute carrier family 35 member B2)	GO:0005794; GO:0016020; GO:0022857; GO:0030173; GO:0030176; GO:0046963; GO:0046964	Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]
PGEN_.00g019230	Scaffold_01	52130408	52133102	NA	NA	NA	NA	NA
PGEN_.00g019240	Scaffold_01	52136654	52145770	NA	NA	NA	NA	NA
PGEN_.00g019250	Scaffold_01	52153660	52163767	B8A5G9	TRM5_DANRE	tRNA (guanine(37)-N1)-methyltransferase (EC 2.1.1.228) (M1G-methyltransferase) (tRNA [GM37] methyltransferase) (tRNA methyltransferase 5 homolog)	GO:0002939; GO:0005634; GO:0005737; GO:0005759; GO:0008175; GO:0009019; GO:0030488; GO:0052906; GO:0070901	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175]; mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939]
PGEN_.00g019260	Scaffold_01	52173999	52192311	NA	NA	NA	NA	NA
PGEN_.00g019270	Scaffold_01	52262796	52269595	NA	NA	NA	NA	NA
PGEN_.00g019280	Scaffold_01	52274219	52275235	Q6DJM2	TAM41_XENLA	"Phosphatidate cytidylyltransferase, mitochondrial (EC 2.7.7.41) (CDP-diacylglycerol synthase) (CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 homolog) (TAM41)"	GO:0004605; GO:0016024; GO:0031314; GO:0032049	extrinsic component of mitochondrial inner membrane [GO:0031314]; phosphatidate cytidylyltransferase activity [GO:0004605]; cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024]
PGEN_.00g019290	Scaffold_01	52275452	52275703	A8PU71	SDHF1_BOVIN	"Succinate dehydrogenase assembly factor 1, mitochondrial (SDH assembly factor 1) (SDHAF1) (LYR motif-containing protein 8)"	GO:0005739; GO:0005759; GO:0034553	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex II assembly [GO:0034553]
PGEN_.00g019300	Scaffold_01	52277739	52304414	Q7ZUH1	RTRAF_DANRE	"RNA transcription, translation and transport factor protein"	GO:0000993; GO:0003723; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006388; GO:0006469; GO:0045944; GO:0048471; GO:0072669; GO:0072686	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
PGEN_.00g019310	Scaffold_01	52340535	52340975	NA	NA	NA	NA	NA
PGEN_.00g019320	Scaffold_01	52345461	52353263	Q6BWX4	COFI_DEBHA	Cofilin (Actin-depolymerizing factor 1)	GO:0006897; GO:0007049; GO:0016363; GO:0030042; GO:0030479; GO:0043001; GO:0051014; GO:0051015; GO:0051301	actin cortical patch [GO:0030479]; nuclear matrix [GO:0016363]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament severing [GO:0051014]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]
PGEN_.00g019330	Scaffold_01	52365138	52399513	Q4I963	COFI_GIBZE	Cofilin (Actin-depolymerizing factor 1)	GO:0003779; GO:0005737; GO:0007049; GO:0015629; GO:0016363; GO:0030042; GO:0051301	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g019340	Scaffold_01	52442422	52469543	P23913	LBR_CHICK	Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (Lamin-B receptor) (Sterol C14-reductase)	GO:0003677; GO:0005634; GO:0005637; GO:0005737; GO:0005789; GO:0006695; GO:0016021; GO:0016126; GO:0030223; GO:0050613; GO:0070402	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; NADPH binding [GO:0070402]; cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126]
PGEN_.00g019350	Scaffold_01	52479390	52487471	Q6NXP6	NXRD1_HUMAN	NADP-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-) (Pyrroline-5-carboxylate reductase-like protein C14orf148)	GO:0004735; GO:0055129	pyrroline-5-carboxylate reductase activity [GO:0004735]; L-proline biosynthetic process [GO:0055129]
PGEN_.00g019360	Scaffold_01	52487523	52505345	Q2VPH1	F50AA_XENLA	Protein FAM50A-A	GO:0005634	nucleus [GO:0005634]
PGEN_.00g019370	Scaffold_01	52513637	52521972	NA	NA	NA	NA	NA
PGEN_.00g019380	Scaffold_01	52530207	52574703	P31836	NCAM1_BOVIN	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)	GO:0005886; GO:0007155; GO:0016021; GO:0030017	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; cell adhesion [GO:0007155]
PGEN_.00g019390	Scaffold_01	52608142	52636938	Q96LQ0	PPR36_HUMAN	Protein phosphatase 1 regulatory subunit 36	GO:0004864; GO:0010923; GO:0019902	phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g019400	Scaffold_01	52646081	52675177	Q92797	SYMPK_HUMAN	Symplekin	GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006369; GO:0006378; GO:0006406; GO:0007155; GO:0031124; GO:0032091; GO:0035307; GO:0097165	"bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369]"
PGEN_.00g019410	Scaffold_01	52746686	52756944	NA	NA	NA	NA	NA
PGEN_.00g019420	Scaffold_01	52768826	52770368	NA	NA	NA	NA	NA
PGEN_.00g019430	Scaffold_01	52814507	52868788	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g019440	Scaffold_01	52879001	52892700	P98170	XIAP_HUMAN	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0016055; GO:0030510; GO:0031398; GO:0042127; GO:0042802; GO:0043027; GO:0043066; GO:0043154; GO:0045088; GO:0046872; GO:0050727; GO:0051402; GO:0055070; GO:0061630; GO:0070424; GO:0090263; GO:1902530; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055]
PGEN_.00g019450	Scaffold_01	52926769	52935427	Q9DGJ3	NPC2_DANRE	NPC intracellular cholesterol transporter 2 (16.5 kDa secretory protein) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog)	GO:0005576; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0015918; GO:0032367; GO:0032934; GO:0033344	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]
PGEN_.00g019460	Scaffold_01	52946581	52947477	NA	NA	NA	NA	NA
PGEN_.00g019470	Scaffold_01	52962492	52963868	NA	NA	NA	NA	NA
PGEN_.00g019480	Scaffold_01	53012008	53012724	NA	NA	NA	NA	NA
PGEN_.00g019490	Scaffold_01	53080171	53143939	Q62232	SIX2_MOUSE	Homeobox protein SIX2 (Sine oculis homeobox homolog 2)	GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001656; GO:0001822; GO:0002062; GO:0003337; GO:0003700; GO:0005634; GO:0005667; GO:0006606; GO:0007501; GO:0008134; GO:0008283; GO:0009948; GO:0016477; GO:0030278; GO:0032330; GO:0042474; GO:0043565; GO:0044877; GO:0045596; GO:0045892; GO:0045944; GO:0048557; GO:0048701; GO:0048704; GO:0048856; GO:0072006; GO:0072028; GO:0072038; GO:0072137; GO:0072161; GO:0090189; GO:0097168; GO:1902732	"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; anterior/posterior axis specification [GO:0009948]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; condensed mesenchymal cell proliferation [GO:0072137]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; kidney development [GO:0001822]; mesenchymal cell differentiation involved in kidney development [GO:0072161]; mesenchymal stem cell maintenance involved in nephron morphogenesis [GO:0072038]; mesenchymal stem cell proliferation [GO:0097168]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron development [GO:0072006]; nephron morphogenesis [GO:0072028]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; regulation of branching involved in ureteric bud morphogenesis [GO:0090189]; regulation of chondrocyte differentiation [GO:0032330]; regulation of ossification [GO:0030278]"
PGEN_.00g019500	Scaffold_01	53197353	53203256	NA	NA	NA	NA	NA
PGEN_.00g019510	Scaffold_01	53207874	53208227	NA	NA	NA	NA	NA
PGEN_.00g019520	Scaffold_01	53322337	53329005	Q9Y3Q0	NALD2_HUMAN	N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)	GO:0004180; GO:0005886; GO:0006508; GO:0008236; GO:0008237; GO:0008239; GO:0008652; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]; cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]
PGEN_.00g019530	Scaffold_01	53351205	53374441	Q70E20	SNED1_MOUSE	"Sushi, nidogen and EGF-like domain-containing protein 1 (Secreted protein SST-3) (Stromal nidogen extracellular matrix protein)"	GO:0005112; GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160]
PGEN_.00g019540	Scaffold_01	53375737	53377134	NA	NA	NA	NA	NA
PGEN_.00g019550	Scaffold_01	53378406	53411787	Q07954	LRP1_HUMAN	Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]	GO:0001523; GO:0001540; GO:0002020; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005623; GO:0005634; GO:0005765; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0007568; GO:0008283; GO:0010715; GO:0010875; GO:0010942; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030226; GO:0030425; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038023; GO:0038024; GO:0042157; GO:0042953; GO:0043025; GO:0043235; GO:0043277; GO:0043395; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045056; GO:0045177; GO:0045202; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051481; GO:0051895; GO:0061642; GO:0070325; GO:0070374; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905049; GO:1905167; GO:2000587	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; synapse [GO:0045202]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]
PGEN_.00g019560	Scaffold_01	53414795	53416666	NA	NA	NA	NA	NA
PGEN_.00g019570	Scaffold_01	53434104	53446541	Q6NRW5	CO041_XENLA	Protein C15orf41 homolog	GO:0005634; GO:0005737; GO:0030218	cytoplasm [GO:0005737]; nucleus [GO:0005634]; erythrocyte differentiation [GO:0030218]
PGEN_.00g019580	Scaffold_01	53446603	53447061	NA	NA	NA	NA	NA
PGEN_.00g019590	Scaffold_01	53448576	53466006	NA	NA	NA	NA	NA
PGEN_.00g019600	Scaffold_01	53477001	53477779	NA	NA	NA	NA	NA
PGEN_.00g019610	Scaffold_01	53478418	53505636	Q6DEL2	CLPT1_DANRE	Cleft lip and palate transmembrane protein 1 homolog	GO:0007275; GO:0016021; GO:0030154	integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]
PGEN_.00g019620	Scaffold_01	53505852	53517821	Q0P5I0	MEN1_BOVIN	Menin	GO:0000122; GO:0000165; GO:0000400; GO:0000403; GO:0000785; GO:0000790; GO:0002076; GO:0003682; GO:0003690; GO:0005829; GO:0006974; GO:0008285; GO:0009411; GO:0010332; GO:0016363; GO:0018024; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0035097; GO:0043433; GO:0044212; GO:0045668; GO:0045736; GO:0045786; GO:0046329; GO:0047485; GO:0051974; GO:0070412	"chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; histone-lysine N-methyltransferase activity [GO:0018024]; protein binding, bridging [GO:0030674]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; transcription regulatory region DNA binding [GO:0044212]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; MAPK cascade [GO:0000165]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to gamma radiation [GO:0010332]; response to UV [GO:0009411]"
PGEN_.00g019630	Scaffold_01	53555838	53581056	P00489	PYGM_RABIT	"Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase)"	GO:0000166; GO:0005977; GO:0008184; GO:0030170; GO:0098723; GO:0102250; GO:0102499	skeletal muscle myofibril [GO:0098723]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen metabolic process [GO:0005977]
PGEN_.00g019640	Scaffold_01	53617269	53647483	Q03701	CEBPZ_HUMAN	CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)	GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003723; GO:0005634; GO:0006366; GO:0042254; GO:0045944	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ribosome biogenesis [GO:0042254]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g019650	Scaffold_01	53663477	53666397	NA	NA	NA	NA	NA
PGEN_.00g019660	Scaffold_01	53667213	53668419	NA	NA	NA	NA	NA
PGEN_.00g019670	Scaffold_01	53671479	53685879	Q9D6N5	NC2A_MOUSE	Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha)	GO:0000122; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0008134; GO:0042802; GO:0046982	nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g019680	Scaffold_01	53693160	53709635	Q8CEQ0	CDKL1_MOUSE	Cyclin-dependent kinase-like 1 (EC 2.7.11.22)	GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007507; GO:0035869; GO:0043231; GO:1902017	ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; heart development [GO:0007507]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]
PGEN_.00g019690	Scaffold_01	53718491	53718847	NA	NA	NA	NA	NA
PGEN_.00g019700	Scaffold_01	53783249	53826388	Q8IVH8	M4K3_HUMAN	Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3)	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007254; GO:0008349; GO:0009411; GO:0023014; GO:0032147; GO:0034612; GO:0035556	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g019710	Scaffold_01	53837425	53842449	Q575S8	CYGB2_DANRE	Cytoglobin-2	GO:0005344; GO:0005506; GO:0005737; GO:0019825; GO:0020037; GO:0098809	cytoplasm [GO:0005737]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; nitrite reductase activity [GO:0098809]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g019720	Scaffold_01	53852350	53871835	P12694	ODBA_HUMAN	"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha)"	GO:0003826; GO:0003863; GO:0005739; GO:0005759; GO:0005947; GO:0009083; GO:0016831; GO:0046872	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; carboxy-lyase activity [GO:0016831]; metal ion binding [GO:0046872]; branched-chain amino acid catabolic process [GO:0009083]
PGEN_.00g019730	Scaffold_01	53965977	54013801	Q9UIU6	SIX4_HUMAN	Homeobox protein SIX4 (Sine oculis homeobox homolog 4)	GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0005737; GO:0007519; GO:0008582; GO:0008584; GO:0009653; GO:0030238; GO:0030910; GO:0032880; GO:0034504; GO:0042472; GO:0043066; GO:0043524; GO:0043586; GO:0045214; GO:0045892; GO:0045893; GO:0046661; GO:0048538; GO:0048699; GO:0048701; GO:0048856; GO:0050678; GO:0051451; GO:0060037; GO:0061055; GO:0061197; GO:0061551; GO:0072075; GO:0072095; GO:0072107; GO:0090190; GO:0098528; GO:1902725	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; embryonic cranial skeleton morphogenesis [GO:0048701]; fungiform papilla morphogenesis [GO:0061197]; generation of neurons [GO:0048699]; inner ear morphogenesis [GO:0042472]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; metanephric mesenchyme development [GO:0072075]; myoblast migration [GO:0051451]; myotome development [GO:0061055]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory placode formation [GO:0030910]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of protein localization [GO:0032880]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; sarcomere organization [GO:0045214]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; tongue development [GO:0043586]; trigeminal ganglion development [GO:0061551]"
PGEN_.00g019740	Scaffold_01	54052124	54083568	Q96S38	KS6C1_HUMAN	Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein)	GO:0004674; GO:0005524; GO:0005769; GO:0007165; GO:0016020; GO:0035091	early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165]
PGEN_.00g019750	Scaffold_01	54083826	54085725	NA	NA	NA	NA	NA
PGEN_.00g019760	Scaffold_01	54091458	54107147	P36404	ARL2_HUMAN	ADP-ribosylation factor-like protein 2	GO:0003924; GO:0005095; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005758; GO:0005759; GO:0005794; GO:0005813; GO:0005829; GO:0005925; GO:0007021; GO:0007098; GO:0010811; GO:0015630; GO:0016328; GO:0019003; GO:0031113; GO:0031116; GO:0034260; GO:0050796; GO:0051457; GO:0070830	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021]
PGEN_.00g019770	Scaffold_01	54117521	54127937	NA	NA	NA	NA	NA
PGEN_.00g019780	Scaffold_01	54161400	54186929	P25788	PSA3_HUMAN	Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0006521; GO:0010498; GO:0010499; GO:0010972; GO:0016032; GO:0016579; GO:0019773; GO:0031145; GO:0031146; GO:0031625; GO:0033209; GO:0038061; GO:0038095; GO:0043161; GO:0043488; GO:0043687; GO:0045202; GO:0050852; GO:0052548; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of endopeptidase activity [GO:0052548]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g019790	Scaffold_01	54197227	54211052	A0LMC0	PHNW_SYNFM	2-aminoethylphosphonate--pyruvate transaminase (EC 2.6.1.37) (2-aminoethylphosphonate aminotransferase) (AEP transaminase) (AEPT)	GO:0019700; GO:0047304	2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]; organic phosphonate catabolic process [GO:0019700]
PGEN_.00g019800	Scaffold_01	54216790	54320318	NA	NA	NA	NA	NA
PGEN_.00g019810	Scaffold_01	54331577	54357137	NA	NA	NA	NA	NA
PGEN_.00g019820	Scaffold_01	54371463	54437375	NA	NA	NA	NA	NA
PGEN_.00g019830	Scaffold_01	54446962	54459077	P15330	DORS_DROME	Embryonic polarity protein dorsal	GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0002225; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008063; GO:0009950; GO:0009953; GO:0031594; GO:0034097; GO:0035006; GO:0035206; GO:0035208; GO:0038061; GO:0042802; GO:0043565; GO:0045612; GO:0045944; GO:0048935; GO:0070379; GO:0070491; GO:0071212	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte differentiation [GO:0045612]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hemocyte proliferation [GO:0035206]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]"
PGEN_.00g019840	Scaffold_01	54463400	54467212	NA	NA	NA	NA	NA
PGEN_.00g019850	Scaffold_01	54472157	54486298	Q96NE9	FRMD6_HUMAN	FERM domain-containing protein 6 (Willin)	GO:0003383; GO:0005737; GO:0005856; GO:0005886; GO:0031032; GO:0032970; GO:0034613; GO:0043296	apical junction complex [GO:0043296]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; cellular protein localization [GO:0034613]; regulation of actin filament-based process [GO:0032970]
PGEN_.00g019860	Scaffold_01	54502121	54504885	Q6INL2	KLH30_XENLA	Kelch-like protein 30		
PGEN_.00g019870	Scaffold_01	54532183	54551497	F4KD71	DUR3_ARATH	Urea-proton symporter DUR3 (AtDUR3) (High-affinity urea active transporter DUR3)	GO:0005886; GO:0006995; GO:0015204; GO:0015293; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918]
PGEN_.00g019880	Scaffold_01	54572981	54573337	NA	NA	NA	NA	NA
PGEN_.00g019890	Scaffold_01	54600457	54600912	NA	NA	NA	NA	NA
PGEN_.00g019900	Scaffold_01	54611380	54622091	NA	NA	NA	NA	NA
PGEN_.00g019910	Scaffold_01	54632361	54632720	P10072	ZN875_HUMAN	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g019920	Scaffold_01	54675295	54675555	NA	NA	NA	NA	NA
PGEN_.00g019930	Scaffold_01	54679465	54679899	NA	NA	NA	NA	NA
PGEN_.00g019940	Scaffold_01	54708725	54729622	NA	NA	NA	NA	NA
PGEN_.00g019950	Scaffold_01	54754372	54768199	Q3UJK4	GTPB2_MOUSE	GTP-binding protein 2 (GTP-binding-like protein 2)	GO:0003746; GO:0003924; GO:0005525; GO:0006414; GO:0043231; GO:0070966; GO:0072344	"intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]"
PGEN_.00g019960	Scaffold_01	54779745	54781645	NA	NA	NA	NA	NA
PGEN_.00g019970	Scaffold_01	54790810	54799541	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g019980	Scaffold_01	54805361	54820943	Q8WPJ2	MANA_MYTED	"Mannan endo-1,4-beta-mannosidase (EC 3.2.1.78) (Beta-mannanase) (Endo-beta-1,4-mannanase) (Man5A) (ManA)"	GO:0016985; GO:0046355	"mannan endo-1,4-beta-mannosidase activity [GO:0016985]; mannan catabolic process [GO:0046355]"
PGEN_.00g019990	Scaffold_01	54823680	54828243	O43704	ST1B1_HUMAN	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (Sulfotransferase 1B2) (ST1B2) (Thyroid hormone sulfotransferase)	GO:0004062; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cellular biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g020000	Scaffold_01	54830577	54834401	P0DMN0	ST1A4_HUMAN	Sulfotransferase 1A4 (ST1A4) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Sulfotransferase 1A3/1A4)	GO:0004062; GO:0005829; GO:0006584; GO:0008202; GO:0050427	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]
PGEN_.00g020010	Scaffold_01	54848833	54850869	NA	NA	NA	NA	NA
PGEN_.00g020020	Scaffold_01	54851215	54851889	NA	NA	NA	NA	NA
PGEN_.00g020030	Scaffold_01	54851954	54852265	NA	NA	NA	NA	NA
PGEN_.00g020040	Scaffold_01	54852299	54865165	Q8JG30	ST1B1_CHICK	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-)	GO:0005737; GO:0008146; GO:0008202	cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]
PGEN_.00g020050	Scaffold_01	54923939	54967529	Q8C5K5	CX038_MOUSE	Uncharacterized protein CXorf38 homolog		
PGEN_.00g020060	Scaffold_01	54956637	54956999	NA	NA	NA	NA	NA
PGEN_.00g020070	Scaffold_01	54977408	54985143	Q56R14	TRI33_XENLA	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g020080	Scaffold_01	54993901	54995116	NA	NA	NA	NA	NA
PGEN_.00g020090	Scaffold_01	55000711	55016913	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g020100	Scaffold_01	55062114	55247891	Q9U1M8	MYOI_DICDI	Myosin-I heavy chain (Class VII unconventional myosin) (DdMVII) (DdM7)	GO:0000902; GO:0001891; GO:0003774; GO:0003779; GO:0005524; GO:0005829; GO:0006909; GO:0008017; GO:0009847; GO:0016020; GO:0016459; GO:0030048; GO:0030175; GO:0030898; GO:0031252; GO:0031589; GO:0032433; GO:0043621; GO:0046847; GO:0051015	cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; membrane [GO:0016020]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein self-association [GO:0043621]; actin filament-based movement [GO:0030048]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847]
PGEN_.00g020110	Scaffold_01	55249348	55269301	Q99PP2	ZN318_MOUSE	Zinc finger protein 318 (Testicular zinc finger protein)	GO:0003676; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0042803; GO:0045892; GO:0045893; GO:0046982; GO:0051321	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; meiotic cell cycle [GO:0051321]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g020120	Scaffold_01	55279476	55280975	NA	NA	NA	NA	NA
PGEN_.00g020130	Scaffold_01	55281714	55283582	NA	NA	NA	NA	NA
PGEN_.00g020140	Scaffold_01	55289677	55303717	Q4R6D9	MEMO1_MACFA	Protein MEMO1 (Mediator of ErbB2-driven cell motility 1) (Memo-1)	GO:0032886	regulation of microtubule-based process [GO:0032886]
PGEN_.00g020150	Scaffold_01	55305530	55307794	NA	NA	NA	NA	NA
PGEN_.00g020160	Scaffold_01	55309345	55319925	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g020170	Scaffold_01	55321243	55333418	NA	NA	NA	NA	NA
PGEN_.00g020180	Scaffold_01	55334153	55357462	NA	NA	NA	NA	NA
PGEN_.00g020190	Scaffold_01	55359470	55362445	Q15751	HERC1_HUMAN	Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)	GO:0004842; GO:0005086; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]
PGEN_.00g020200	Scaffold_01	55365811	55410603	Q6ZU80	CE128_HUMAN	Centrosomal protein of 128 kDa (Cep128)	GO:0000922; GO:0005737; GO:0005814; GO:0008104; GO:0120103	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; protein localization [GO:0008104]
PGEN_.00g020210	Scaffold_01	55425315	55470237	NA	NA	NA	NA	NA
PGEN_.00g020220	Scaffold_01	55470283	55499666	Q8VC31	CCDC9_MOUSE	Coiled-coil domain-containing protein 9		
PGEN_.00g020230	Scaffold_01	55508532	55508891	NA	NA	NA	NA	NA
PGEN_.00g020240	Scaffold_01	55509824	55517078	NA	NA	NA	NA	NA
PGEN_.00g020250	Scaffold_01	55524127	55525429	NA	NA	NA	NA	NA
PGEN_.00g020260	Scaffold_01	55537516	55538539	NA	NA	NA	NA	NA
PGEN_.00g020270	Scaffold_01	55569066	55577711	Q4R2Y2	HYLS1_MACFA	Hydrolethalus syndrome protein 1 homolog	GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0060271	centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]
PGEN_.00g020280	Scaffold_01	55613832	55622358	P60952	CDC42_CANLF	Cell division control protein 42 homolog (EC 3.6.5.2) (G25K GTP-binding protein)	GO:0003924; GO:0005525; GO:0005737; GO:0005815; GO:0005886; GO:0005938; GO:0006897; GO:0006911; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0016020; GO:0019901; GO:0030031; GO:0030036; GO:0030496; GO:0031258; GO:0032467; GO:0032488; GO:0032956; GO:0034329; GO:0042995; GO:0043005; GO:0043197; GO:0045198; GO:0051233; GO:0051489; GO:0051491; GO:0051988; GO:0060997; GO:0072686; GO:0099563; GO:1900026	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; modification of synaptic structure [GO:0099563]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; Rho protein signal transduction [GO:0007266]"
PGEN_.00g020290	Scaffold_01	55651288	55663371	Q17031	CDC42_ANOGA	Cdc42 homolog (25 kDa GTP-binding protein)	GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0005912; GO:0005938; GO:0006897; GO:0007015; GO:0007163; GO:0007266; GO:0007275; GO:0008360; GO:0019901; GO:0030031; GO:0030036; GO:0032488; GO:0032956; GO:0042995	adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell projection assembly [GO:0030031]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; multicellular organism development [GO:0007275]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]
PGEN_.00g020300	Scaffold_01	55665638	55667580	P34727	ARF_AJECA	ADP-ribosylation factor	GO:0005525; GO:0005794; GO:0015031; GO:0016192	Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g020310	Scaffold_01	55673748	55676400	P91924	ARF_DUGJA	ADP-ribosylation factor	GO:0005525; GO:0005794; GO:0015031; GO:0016192	Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g020320	Scaffold_01	55676929	55678708	P34727	ARF_AJECA	ADP-ribosylation factor	GO:0005525; GO:0005794; GO:0015031; GO:0016192	Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g020330	Scaffold_01	55680748	55688107	P41696	AZF1_YEAST	Asparagine-rich zinc finger protein AZF1	GO:0000978; GO:0001228; GO:0005634; GO:0005829; GO:0006357; GO:0043565; GO:0046872; GO:0060237; GO:0071322	"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to carbohydrate stimulus [GO:0071322]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g020340	Scaffold_01	55694265	55720845	Q54KD0	Y7407_DICDI	TPR repeat-containing protein DDB_G0287407		
PGEN_.00g020350	Scaffold_01	55740709	55750592	NA	NA	NA	NA	NA
PGEN_.00g020360	Scaffold_01	55771950	55775220	NA	NA	NA	NA	NA
PGEN_.00g020370	Scaffold_01	55776438	55790869	Q497V5	SRBD1_MOUSE	S1 RNA-binding domain-containing protein 1	GO:0003729; GO:0003735; GO:0006139; GO:0006412	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412]
PGEN_.00g020380	Scaffold_01	55791018	55792299	Q75WS4	CRYD_XENLA	Cryptochrome DASH	GO:0003913; GO:0006281; GO:0018298	DNA photolyase activity [GO:0003913]; DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298]
PGEN_.00g020390	Scaffold_01	55798334	55802071	A0PK84	ZDH22_MOUSE	Palmitoyltransferase ZDHHC22 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 22) (DHHC-22) (zDHHC22)	GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]
PGEN_.00g020400	Scaffold_01	55806239	55813935	Q4KML2	CRYD_DANRE	Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH)	GO:0000719; GO:0003684; GO:0003904; GO:0018298; GO:0050660	damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; flavin adenine dinucleotide binding [GO:0050660]; photoreactive repair [GO:0000719]; protein-chromophore linkage [GO:0018298]
PGEN_.00g020410	Scaffold_01	55870601	55891064	Q9UPU9	SMAG1_HUMAN	Protein Smaug homolog 1 (Smaug 1) (hSmaug1) (Sterile alpha motif domain-containing protein 4A) (SAM domain-containing protein 4A)	GO:0000289; GO:0000932; GO:0001650; GO:0003723; GO:0003729; GO:0005829; GO:0017148; GO:0030054; GO:0030371; GO:0030425; GO:0043488; GO:0045202; GO:0045727	cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; P-body [GO:0000932]; synapse [GO:0045202]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488]
PGEN_.00g020420	Scaffold_01	55925168	55954577	Q9DGJ3	NPC2_DANRE	NPC intracellular cholesterol transporter 2 (16.5 kDa secretory protein) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog)	GO:0005576; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0015918; GO:0032367; GO:0032934; GO:0033344	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]
PGEN_.00g020430	Scaffold_01	55945752	55945994	NA	NA	NA	NA	NA
PGEN_.00g020440	Scaffold_01	55985925	56005311	P58283	RN216_MOUSE	E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (UbcM4-interacting protein 83) (Ubiquitin-conjugating enzyme 7-interacting protein 1)	GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0032648; GO:0043161; GO:0046872; GO:0050691; GO:0061630; GO:0070936; GO:0098685; GO:0098843; GO:0098978; GO:0099546	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]"
PGEN_.00g020450	Scaffold_01	56008906	56011429	NA	NA	NA	NA	NA
PGEN_.00g020460	Scaffold_01	56014179	56014550	NA	NA	NA	NA	NA
PGEN_.00g020470	Scaffold_01	56019956	56020405	NA	NA	NA	NA	NA
PGEN_.00g020480	Scaffold_01	56020866	56021126	NA	NA	NA	NA	NA
PGEN_.00g020490	Scaffold_01	56022041	56022451	NA	NA	NA	NA	NA
PGEN_.00g020500	Scaffold_01	56023439	56023714	NA	NA	NA	NA	NA
PGEN_.00g020510	Scaffold_01	56029696	56030010	NA	NA	NA	NA	NA
PGEN_.00g020520	Scaffold_01	56034709	56039359	NA	NA	NA	NA	NA
PGEN_.00g020530	Scaffold_01	56041565	56042053	NA	NA	NA	NA	NA
PGEN_.00g020540	Scaffold_01	56042240	56043500	A0A1B0GUU1	CQ113_HUMAN	Transmembrane protein C17orf113	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g020550	Scaffold_01	56043573	56045338	NA	NA	NA	NA	NA
PGEN_.00g020560	Scaffold_01	56045843	56048303	NA	NA	NA	NA	NA
PGEN_.00g020570	Scaffold_01	56048564	56048968	NA	NA	NA	NA	NA
PGEN_.00g020580	Scaffold_01	56050584	56050880	NA	NA	NA	NA	NA
PGEN_.00g020590	Scaffold_01	56051771	56052064	NA	NA	NA	NA	NA
PGEN_.00g020600	Scaffold_01	56058988	56065720	NA	NA	NA	NA	NA
PGEN_.00g020610	Scaffold_01	56187426	56187797	NA	NA	NA	NA	NA
PGEN_.00g020620	Scaffold_01	56258703	56259356	NA	NA	NA	NA	NA
PGEN_.00g020630	Scaffold_01	56269949	56273814	NA	NA	NA	NA	NA
PGEN_.00g020640	Scaffold_01	56292598	56295837	Q8BRK9	MA2A2_MOUSE	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016799; GO:0030246; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"
PGEN_.00g020650	Scaffold_01	56307957	56323362	Q9QZB7	ARP10_MOUSE	Actin-related protein 10 (Actin-related protein 11)	GO:0000132; GO:0005623; GO:0005813; GO:0005869; GO:0007018; GO:0030473; GO:0098958; GO:0099738; GO:1904115	axon cytoplasm [GO:1904115]; cell [GO:0005623]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; dynactin complex [GO:0005869]; establishment of mitotic spindle orientation [GO:0000132]; microtubule-based movement [GO:0007018]; nuclear migration along microtubule [GO:0030473]; retrograde axonal transport of mitochondrion [GO:0098958]
PGEN_.00g020660	Scaffold_01	56339912	56358598	NA	NA	NA	NA	NA
PGEN_.00g020670	Scaffold_01	56368505	56372615	Q8K3A2	TRPT1_MOUSE	tRNA 2'-phosphotransferase 1 (mTPT1) (EC 2.7.1.160)	GO:0000215; GO:0006388; GO:0045859	"tRNA 2'-phosphotransferase activity [GO:0000215]; regulation of protein kinase activity [GO:0045859]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
PGEN_.00g020680	Scaffold_01	56375349	56377323	Q6ZFH6	RCN11_ORYSJ	"Beta-1,2-xylosyltransferase RCN11 (OsXylT) (EC 2.4.2.-) (Protein REDUCED CULM NUMBER 11)"	GO:0000139; GO:0005797; GO:0006487; GO:0016021; GO:0031204; GO:0035252; GO:0048367; GO:0050513	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein 2-beta-D-xylosyltransferase activity [GO:0050513]; UDP-xylosyltransferase activity [GO:0035252]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein N-linked glycosylation [GO:0006487]; shoot system development [GO:0048367]"
PGEN_.00g020690	Scaffold_01	56379304	56389887	NA	NA	NA	NA	NA
PGEN_.00g020700	Scaffold_01	56397856	56406232	Q99020	ROAA_MOUSE	Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (CArG-binding factor-A) (CBF-A)	GO:0000122; GO:0001837; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0043565; GO:0045893; GO:0090575; GO:0099523; GO:1990837; GO:1990904	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g020710	Scaffold_01	56406454	56420844	Q13686	ALKB1_HUMAN	Nucleic acid dioxygenase ALKBH1 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 1) (Alpha-ketoglutarate-dependent dioxygenase ABH1) (DNA 6mA demethylase) (DNA N6-methyl adenine demethylase ALKBH1) (EC 1.14.11.51) (DNA lyase ABH1) (EC 4.2.99.18) (DNA oxidative demethylase ALKBH1) (EC 1.14.11.33) (mRNA N(3)-methylcytidine demethylase) (EC 1.14.11.-)	GO:0000049; GO:0001701; GO:0001764; GO:0001890; GO:0002101; GO:0005654; GO:0005719; GO:0005739; GO:0005783; GO:0006281; GO:0006307; GO:0006446; GO:0006448; GO:0008198; GO:0016706; GO:0031175; GO:0035513; GO:0035515; GO:0035516; GO:0042056; GO:0042245; GO:0043524; GO:0048589; GO:0070129; GO:0070579; GO:0070989; GO:0080111; GO:0103053; GO:0140078; GO:1990983; GO:1990984	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; 1-ethyladenine demethylase activity [GO:0103053]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chemoattractant activity [GO:0042056]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; oxidative DNA demethylase activity [GO:0035516]; oxidative RNA demethylase activity [GO:0035515]; tRNA binding [GO:0000049]; tRNA demethylase activity [GO:1990984]; developmental growth [GO:0048589]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oxidative demethylation [GO:0070989]; oxidative RNA demethylation [GO:0035513]; placenta development [GO:0001890]; regulation of mitochondrial translation [GO:0070129]; regulation of translational elongation [GO:0006448]; regulation of translational initiation [GO:0006446]; RNA repair [GO:0042245]; tRNA demethylation [GO:1990983]; tRNA wobble cytosine modification [GO:0002101]
PGEN_.00g020720	Scaffold_01	56507659	56518851	Q5BJI6	POP5_DANRE	Ribonuclease P/MRP protein subunit POP5 (EC 3.1.26.5)	GO:0000172; GO:0001682; GO:0004526; GO:0005655; GO:0005730; GO:0006364; GO:0008033; GO:0030681; GO:0033204	multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]
PGEN_.00g020730	Scaffold_01	56519204	56528399	Q9D7K5	DMAC2_MOUSE	Distal membrane-arm assembly complex protein 2 (ATP synthase subunit s-like protein)	GO:0005739; GO:0005747; GO:0006511; GO:0016567; GO:0019005; GO:0031146; GO:0032981	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; SCF ubiquitin ligase complex [GO:0019005]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g020740	Scaffold_01	56533887	56550303	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g020750	Scaffold_01	56561977	56583796	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g020760	Scaffold_01	56584715	56585020	NA	NA	NA	NA	NA
PGEN_.00g020770	Scaffold_01	56598718	56600534	P87061	TEA1_SCHPO	Tip elongation aberrant protein 1 (Altered polarity protein 8) (Cell polarity protein tea1)	GO:0000935; GO:0008360; GO:0015630; GO:0031115; GO:0031500; GO:0032153; GO:0034613; GO:0035838; GO:0035839; GO:0035840; GO:0051285; GO:0051286; GO:0061246; GO:0099070; GO:1904511; GO:1904758; GO:1990752; GO:1990896; GO:2000771	cell cortex of cell tip [GO:0051285]; cell division site [GO:0032153]; cell tip [GO:0051286]; cytoplasmic microtubule plus-end [GO:1904511]; division septum [GO:0000935]; growing cell tip [GO:0035838]; microtubule cytoskeleton [GO:0015630]; microtubule end [GO:1990752]; non-growing cell tip [GO:0035839]; old growing cell tip [GO:0035840]; static microtubule bundle [GO:0099070]; Tea1 cell-end complex [GO:0031500]; cellular protein localization [GO:0034613]; establishment or maintenance of bipolar cell polarity regulating cell shape [GO:0061246]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000771]; protein localization to cell cortex of cell tip [GO:1990896]; protein localization to new growing cell tip [GO:1904758]; regulation of cell shape [GO:0008360]
PGEN_.00g020780	Scaffold_01	56676772	56678886	Q9H321	VCX3B_HUMAN	Variable charge X-linked protein 3B (Variably charged protein X-C) (VCX-C)	GO:0005634; GO:0005730; GO:0007420	nucleolus [GO:0005730]; nucleus [GO:0005634]; brain development [GO:0007420]
PGEN_.00g020790	Scaffold_01	56676982	56683819	NA	NA	NA	NA	NA
PGEN_.00g020800	Scaffold_01	56693668	56693868	NA	NA	NA	NA	NA
PGEN_.00g020810	Scaffold_01	56696627	56726661	NA	NA	NA	NA	NA
PGEN_.00g020820	Scaffold_01	56728616	56737167	NA	NA	NA	NA	NA
PGEN_.00g020830	Scaffold_01	56737420	56739383	O13774	GCH1_SCHPO	GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I)	GO:0003934; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0006729; GO:0008270; GO:0035998; GO:0046654; GO:0046656	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; folic acid biosynthetic process [GO:0046656]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"
PGEN_.00g020840	Scaffold_01	56753406	56753681	NA	NA	NA	NA	NA
PGEN_.00g020850	Scaffold_01	56768029	56768941	P22288	GCH1_RAT	GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I)	GO:0003924; GO:0003934; GO:0005509; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006729; GO:0008217; GO:0008270; GO:0010460; GO:0014916; GO:0030742; GO:0031369; GO:0031410; GO:0031965; GO:0032496; GO:0032991; GO:0034341; GO:0034612; GO:0035998; GO:0042311; GO:0042416; GO:0042559; GO:0042802; GO:0042803; GO:0044877; GO:0045776; GO:0046654; GO:0048265; GO:0050662; GO:0050884; GO:0051000; GO:0051019; GO:0051066; GO:0051260; GO:0065003; GO:2000121	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; coenzyme binding [GO:0050662]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dihydrobiopterin metabolic process [GO:0051066]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein homooligomerization [GO:0051260]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]"
PGEN_.00g020860	Scaffold_01	56781648	56796396	P46507	PRS6B_MANSE	26S proteasome regulatory subunit 6B (ATPase MS73)	GO:0000502; GO:0005524; GO:0005634; GO:0005737; GO:0030163; GO:0036402	cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; protein catabolic process [GO:0030163]
PGEN_.00g020870	Scaffold_01	56804388	56818101	NA	NA	NA	NA	NA
PGEN_.00g020880	Scaffold_01	56836304	56836841	NA	NA	NA	NA	NA
PGEN_.00g020890	Scaffold_01	56848577	56849330	NA	NA	NA	NA	NA
PGEN_.00g020900	Scaffold_01	56856676	56857765	NA	NA	NA	NA	NA
PGEN_.00g020910	Scaffold_01	56859888	56869773	NA	NA	NA	NA	NA
PGEN_.00g020920	Scaffold_01	56880252	56892615	NA	NA	NA	NA	NA
PGEN_.00g020930	Scaffold_01	56893363	56894022	NA	NA	NA	NA	NA
PGEN_.00g020940	Scaffold_01	56894180	56894434	NA	NA	NA	NA	NA
PGEN_.00g020950	Scaffold_01	56896946	56897392	NA	NA	NA	NA	NA
PGEN_.00g020960	Scaffold_01	56898670	56898906	NA	NA	NA	NA	NA
PGEN_.00g020970	Scaffold_01	56898953	56900464	NA	NA	NA	NA	NA
PGEN_.00g020980	Scaffold_01	56903756	56904178	NA	NA	NA	NA	NA
PGEN_.00g020990	Scaffold_01	56909321	56910062	NA	NA	NA	NA	NA
PGEN_.00g021000	Scaffold_01	56921864	56930526	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g021010	Scaffold_01	56933299	56933649	NA	NA	NA	NA	NA
PGEN_.00g021020	Scaffold_01	56933848	56935332	Q9Z0E8	S22A5_MOUSE	Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2)	GO:0005524; GO:0006814; GO:0007005; GO:0007512; GO:0007626; GO:0009437; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0030165; GO:0031526; GO:0048608; GO:0052106; GO:0060731; GO:0070715	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; adult heart development [GO:0007512]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; reproductive structure development [GO:0048608]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]
PGEN_.00g021030	Scaffold_01	56936883	56942488	NA	NA	NA	NA	NA
PGEN_.00g021040	Scaffold_01	56945449	56957966	NA	NA	NA	NA	NA
PGEN_.00g021050	Scaffold_01	56982275	56982475	NA	NA	NA	NA	NA
PGEN_.00g021060	Scaffold_01	57009689	57017198	NA	NA	NA	NA	NA
PGEN_.00g021070	Scaffold_01	57073678	57079425	NA	NA	NA	NA	NA
PGEN_.00g021080	Scaffold_01	57084834	57085046	NA	NA	NA	NA	NA
PGEN_.00g021090	Scaffold_01	57115068	57124894	NA	NA	NA	NA	NA
PGEN_.00g021100	Scaffold_01	57137612	57142588	Q3UES3	TNKS2_MOUSE	Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2)	GO:0000139; GO:0000209; GO:0000242; GO:0000723; GO:0000781; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0006471; GO:0016055; GO:0019899; GO:0035264; GO:0040014; GO:0046872; GO:0047485; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g021110	Scaffold_01	57142681	57147748	NA	NA	NA	NA	NA
PGEN_.00g021120	Scaffold_01	57189678	57190445	NA	NA	NA	NA	NA
PGEN_.00g021130	Scaffold_01	57204744	57207383	NA	NA	NA	NA	NA
PGEN_.00g021140	Scaffold_01	57216181	57216429	NA	NA	NA	NA	NA
PGEN_.00g021150	Scaffold_01	57229123	57233935	NA	NA	NA	NA	NA
PGEN_.00g021160	Scaffold_01	57244995	57245717	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g021170	Scaffold_01	57270958	57313441	P46825	KLC_DORPE	Kinesin light chain (KLC)	GO:0003777; GO:0005737; GO:0005871; GO:0005874	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule motor activity [GO:0003777]
PGEN_.00g021180	Scaffold_01	57330236	57339403	P55010	IF5_HUMAN	Eukaryotic translation initiation factor 5 (eIF-5)	GO:0001731; GO:0001732; GO:0003723; GO:0003743; GO:0003924; GO:0005092; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0006413; GO:0006446; GO:0008135; GO:0045296; GO:0071074	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; eukaryotic initiation factor eIF2 binding [GO:0071074]; GDP-dissociation inhibitor activity [GO:0005092]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"
PGEN_.00g021190	Scaffold_01	57347148	57356481	NA	NA	NA	NA	NA
PGEN_.00g021200	Scaffold_01	57360193	57362211	Q5REP9	KLHL3_PONAB	Kelch-like protein 3	GO:0003779; GO:0005829; GO:0005856; GO:0006511; GO:0016567; GO:0031463; GO:0050801; GO:0070294; GO:0070936; GO:0072156	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; distal tubule morphogenesis [GO:0072156]; ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g021210	Scaffold_01	57373663	57379868	Q8K386	RAB15_MOUSE	Ras-related protein Rab-15	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006886; GO:0006904; GO:0008021; GO:0009306; GO:0017157; GO:0032482; GO:0072659	endosome [GO:0005768]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]
PGEN_.00g021220	Scaffold_01	57385002	57403240	NA	NA	NA	NA	NA
PGEN_.00g021230	Scaffold_01	57407262	57448191	Q8R5L3	VPS39_MOUSE	Vam6/Vps39-like protein	GO:0005765; GO:0006886; GO:0006914; GO:0008333; GO:0016192; GO:0030897; GO:0031902; GO:0034058; GO:1902774; GO:1990126	"HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g021240	Scaffold_01	57457594	57495883	Q96JC1	VPS39_HUMAN	Vam6/Vps39-like protein (TRAP1-like protein) (hVam6p)	GO:0005765; GO:0006886; GO:0006914; GO:0008333; GO:0016192; GO:0030123; GO:0030897; GO:0031902; GO:0034058; GO:1902774; GO:1990126	"AP-3 adaptor complex [GO:0030123]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g021250	Scaffold_01	57498689	57501412	NA	NA	NA	NA	NA
PGEN_.00g021260	Scaffold_01	57523829	57538394	Q9UQ07	MOK_HUMAN	MAPK/MAK/MRK overlapping kinase (EC 2.7.11.22) (MOK protein kinase) (Renal tumor antigen 1) (RAGE-1)	GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0006468; GO:0007165; GO:0010468; GO:0035556; GO:0046872; GO:0097546	ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]
PGEN_.00g021270	Scaffold_01	57548214	57570567	Q9UQ07	MOK_HUMAN	MAPK/MAK/MRK overlapping kinase (EC 2.7.11.22) (MOK protein kinase) (Renal tumor antigen 1) (RAGE-1)	GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0006468; GO:0007165; GO:0010468; GO:0035556; GO:0046872; GO:0097546	ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]
PGEN_.00g021280	Scaffold_01	57587827	57588147	NA	NA	NA	NA	NA
PGEN_.00g021290	Scaffold_01	57591985	57593090	NA	NA	NA	NA	NA
PGEN_.00g021300	Scaffold_01	57629070	57629426	NA	NA	NA	NA	NA
PGEN_.00g021310	Scaffold_01	57647506	57647793	NA	NA	NA	NA	NA
PGEN_.00g021320	Scaffold_01	57647981	57648388	NA	NA	NA	NA	NA
PGEN_.00g021330	Scaffold_01	57654773	57674949	Q9D2J7	ANKE1_MOUSE	Ankyrin repeat and EF-hand domain-containing protein 1 (Ankyrin repeat domain-containing protein 5)		
PGEN_.00g021340	Scaffold_01	57683645	57689390	Q6INV3	LRC57_XENLA	Leucine-rich repeat-containing protein 57		
PGEN_.00g021350	Scaffold_01	57689561	57696724	Q9BSD7	NTPCR_HUMAN	Cancer-related nucleoside-triphosphatase (NTPase) (EC 3.6.1.15) (Nucleoside triphosphate phosphohydrolase)	GO:0003723; GO:0005524; GO:0016020; GO:0017111; GO:0098519	"membrane [GO:0016020]; ATP binding [GO:0005524]; nucleoside-triphosphatase activity [GO:0017111]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; RNA binding [GO:0003723]"
PGEN_.00g021360	Scaffold_01	57732450	57732728	NA	NA	NA	NA	NA
PGEN_.00g021370	Scaffold_01	57826741	57836919	Q91994	OTX1B_DANRE	Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B)	GO:0003406; GO:0003700; GO:0005634; GO:0042472; GO:0043565; GO:0060875	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; inner ear morphogenesis [GO:0042472]; lateral semicircular canal development [GO:0060875]; retinal pigment epithelium development [GO:0003406]
PGEN_.00g021380	Scaffold_01	57906723	57908009	NA	NA	NA	NA	NA
PGEN_.00g021390	Scaffold_01	57908993	57912833	NA	NA	NA	NA	NA
PGEN_.00g021400	Scaffold_01	57926918	57928192	NA	NA	NA	NA	NA
PGEN_.00g021410	Scaffold_01	57933294	57934694	NA	NA	NA	NA	NA
PGEN_.00g021420	Scaffold_01	57943383	57959612	Q6GPU3	DTLB_XENLA	Denticleless protein homolog B	GO:0000209; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0009411; GO:0019985; GO:0031464; GO:0031465; GO:0048511; GO:0051726; GO:0072425	centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g021430	Scaffold_01	57967952	57986745	P80315	TCPD_MOUSE	T-complex protein 1 subunit delta (TCP-1-delta) (A45) (CCT-delta)	GO:0002199; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0005929; GO:0006457; GO:0007339; GO:0032212; GO:0042470; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytosol [GO:0005829]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]
PGEN_.00g021440	Scaffold_01	58007962	58035884	Q9BX95	SGPP1_HUMAN	Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1) (Sphingosine-1-phosphate phosphohydrolase 1) (SPP-1)	GO:0005654; GO:0005789; GO:0005886; GO:0006668; GO:0006670; GO:0016021; GO:0030148; GO:0035621; GO:0042392; GO:0045616; GO:0045682; GO:0097191; GO:0097193	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; ER to Golgi ceramide transport [GO:0035621]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]; sphinganine-1-phosphate metabolic process [GO:0006668]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]
PGEN_.00g021450	Scaffold_01	58147626	58152468	NA	NA	NA	NA	NA
PGEN_.00g021460	Scaffold_01	58153825	58207160	Q6PB66	LPPRC_MOUSE	"Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein) (LRP 130) (mLRP130)"	GO:0000794; GO:0000961; GO:0003697; GO:0003723; GO:0005634; GO:0005637; GO:0005640; GO:0005654; GO:0005737; GO:0005739; GO:0005856; GO:0005874; GO:0031625; GO:0042645; GO:0048471; GO:0048487; GO:0051028; GO:0070129; GO:1990904	condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; beta-tubulin binding [GO:0048487]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129]
PGEN_.00g021470	Scaffold_01	58220196	58231783	D3Z5L6	S18B1_MOUSE	MFS-type transporter SLC18B1 (Solute carrier family 18 member B1)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g021480	Scaffold_01	58253659	58268764	NA	NA	NA	NA	NA
PGEN_.00g021490	Scaffold_01	58279168	58279506	NA	NA	NA	NA	NA
PGEN_.00g021500	Scaffold_01	58327907	58342073	NA	NA	NA	NA	NA
PGEN_.00g021510	Scaffold_01	58374994	58387611	Q9Y2R4	DDX52_HUMAN	Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)	GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0030490	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]
PGEN_.00g021520	Scaffold_01	58419014	58429644	Q9Y2R4	DDX52_HUMAN	Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)	GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0030490	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]
PGEN_.00g021530	Scaffold_01	58432804	58456922	Q9NVP4	DZAN1_HUMAN	Double zinc ribbon and ankyrin repeat-containing protein 1	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g021540	Scaffold_01	58498698	58520960	Q8C419	GP158_MOUSE	Probable G-protein coupled receptor 158	GO:0004930; GO:0005886; GO:0007186; GO:0016020; GO:0016021; GO:0072659	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; protein localization to plasma membrane [GO:0072659]
PGEN_.00g021550	Scaffold_01	58545152	58545897	NA	NA	NA	NA	NA
PGEN_.00g021560	Scaffold_01	58546228	58546449	NA	NA	NA	NA	NA
PGEN_.00g021570	Scaffold_01	58546646	58548831	NA	NA	NA	NA	NA
PGEN_.00g021580	Scaffold_01	58579875	58602004	P16395	ACM1_DROME	Muscarinic acetylcholine receptor DM1	GO:0004930; GO:0004993; GO:0005887; GO:0007187; GO:0007197; GO:0007200; GO:0007213; GO:0007268; GO:0008227; GO:0016021; GO:0016907; GO:0030054; GO:0030425; GO:0030594; GO:0045211	"cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]"
PGEN_.00g021590	Scaffold_01	58672031	58672636	NA	NA	NA	NA	NA
PGEN_.00g021600	Scaffold_01	58775055	58775711	Q8VDM6	HNRL1_MOUSE	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396]
PGEN_.00g021610	Scaffold_01	58811753	58826840	Q7ZW41	RPB7_DANRE	DNA-directed RNA polymerase II subunit RPB7 (RNA polymerase II subunit B7)	GO:0000291; GO:0000932; GO:0003697; GO:0003727; GO:0003899; GO:0005634; GO:0005665; GO:0006366; GO:0006367; GO:0031369; GO:0045948; GO:0060213	"nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g021620	Scaffold_01	58827166	58843983	Q9BYD3	RM04_HUMAN	"39S ribosomal protein L4, mitochondrial (L4mt) (MRP-L4) (Mitochondrial large ribosomal subunit protein uL4m)"	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]
PGEN_.00g021630	Scaffold_01	58852055	58855956	Q9UK22	FBX2_HUMAN	F-box only protein 2	GO:0000209; GO:0001540; GO:0004842; GO:0005737; GO:0005783; GO:0005829; GO:0006464; GO:0006508; GO:0006516; GO:0008285; GO:0016567; GO:0019005; GO:0030246; GO:0030433; GO:0031090; GO:0031146; GO:0031396; GO:0043197; GO:0043687	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; SCF ubiquitin ligase complex [GO:0019005]; amyloid-beta binding [GO:0001540]; carbohydrate binding [GO:0030246]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; negative regulation of cell population proliferation [GO:0008285]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of protein ubiquitination [GO:0031396]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g021640	Scaffold_01	58889631	58895423	NA	NA	NA	NA	NA
PGEN_.00g021650	Scaffold_01	58919288	58949732	NA	NA	NA	NA	NA
PGEN_.00g021660	Scaffold_01	58948784	58970913	NA	NA	NA	NA	NA
PGEN_.00g021670	Scaffold_01	58987887	58999362	Q4R642	DRC5_MACFA	Dynein regulatory complex subunit 5 (T-complex-associated testis-expressed protein 1) (Tcte-1)	GO:0005737; GO:0005856; GO:0030317; GO:0036126	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; flagellated sperm motility [GO:0030317]
PGEN_.00g021680	Scaffold_01	59002882	59023419	Q9BWH6	RPAP1_HUMAN	RNA polymerase II-associated protein 1	GO:0003677; GO:0003899; GO:0005634; GO:0006366	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g021690	Scaffold_01	59026780	59042587	P59046	NAL12_HUMAN	"NACHT, LRR and PYD domains-containing protein 12 (Monarch-1) (PYRIN-containing APAF1-like protein 7) (Regulated by nitric oxide)"	GO:0005524; GO:0005737; GO:0006919; GO:0007165; GO:0008656; GO:0009968; GO:0031953; GO:0032088; GO:0036336; GO:0043122; GO:0043124; GO:0043281; GO:0045345; GO:0045381; GO:0045409; GO:0045751; GO:0050710; GO:0050711; GO:0050718; GO:0050728; GO:0050729; GO:0070373; GO:0071345; GO:1901223; GO:1901224	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell migration [GO:0036336]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 secretion [GO:0050711]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of signal transduction [GO:0009968]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interleukin-18 biosynthetic process [GO:0045381]; signal transduction [GO:0007165]
PGEN_.00g021700	Scaffold_01	59053697	59054068	NA	NA	NA	NA	NA
PGEN_.00g021710	Scaffold_01	59074776	59113683	A0JN53	RPAP1_BOVIN	RNA polymerase II-associated protein 1	GO:0003677; GO:0003899; GO:0005634; GO:0006366	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g021720	Scaffold_01	59121767	59139860	Q792Q4	CRIPT_RAT	Cysteine-rich PDZ-binding protein (Cysteine-rich interactor of PDZ three) (Cysteine-rich interactor of PDZ3)	GO:0005737; GO:0008017; GO:0014069; GO:0030054; GO:0030165; GO:0030425; GO:0031122; GO:0035372; GO:0043025; GO:0043197; GO:0043198; GO:0044877; GO:0045184; GO:0097110; GO:1902897	cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; cytoplasmic microtubule organization [GO:0031122]; establishment of protein localization [GO:0045184]; protein localization to microtubule [GO:0035372]; regulation of postsynaptic density protein 95 clustering [GO:1902897]
PGEN_.00g021730	Scaffold_01	59144393	59149173	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g021740	Scaffold_01	59160632	59162635	NA	NA	NA	NA	NA
PGEN_.00g021750	Scaffold_01	59175992	59189638	NA	NA	NA	NA	NA
PGEN_.00g021760	Scaffold_01	59200596	59201264	NA	NA	NA	NA	NA
PGEN_.00g021770	Scaffold_01	59215071	59219930	NA	NA	NA	NA	NA
PGEN_.00g021780	Scaffold_01	59246959	59250935	NA	NA	NA	NA	NA
PGEN_.00g021790	Scaffold_01	59251721	59277719	F1LQ48	HNRPL_RAT	Heterogeneous nuclear ribonucleoprotein L (hnRNP L)	GO:0000381; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0007623; GO:0034198; GO:0035770; GO:0044212; GO:0045120; GO:0045727; GO:0048025; GO:0048471; GO:0097157; GO:1901652; GO:1902416; GO:1990715; GO:1990904	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to peptide [GO:1901652]"
PGEN_.00g021800	Scaffold_01	59284470	59293821	Q9CQ46	DRC8_MOUSE	Dynein regulatory complex protein 8 (EF-hand calcium-binding domain-containing protein 2)	GO:0005509; GO:0005737; GO:0005856; GO:0031514	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]
PGEN_.00g021810	Scaffold_01	59294909	59303165	Q5R6P6	GMFB_PONAB	Glia maturation factor beta (GMF-beta)	GO:0003779; GO:0008083; GO:0034316; GO:0071933	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]
PGEN_.00g021820	Scaffold_01	59303473	59331935	Q5TYV4	SPE39_DANRE	Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction)	GO:0005737; GO:0005769; GO:0005770; GO:0006886; GO:0007283; GO:0030154; GO:0055037; GO:0061008	cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]
PGEN_.00g021830	Scaffold_01	59331981	59377667	Q8CGC7	SYEP_MOUSE	Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)]	GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006424; GO:0006433; GO:0008270; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042802; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]
PGEN_.00g021840	Scaffold_01	59380416	59381972	Q868Z9	PPN_DROME	Papilin	GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198	basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]
PGEN_.00g021850	Scaffold_01	59385961	59393858	O15442	MPPD1_HUMAN	Metallophosphoesterase domain-containing protein 1 (EC 3.1.-.-) (Adult brain protein 239) (239AB)	GO:0016787	hydrolase activity [GO:0016787]
PGEN_.00g021860	Scaffold_01	59399497	59450700	P62200	CALM1_DAUCA	Calmodulin-1/11/16 (CaM-1/11/16)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g021870	Scaffold_01	59455442	59485985	P13868	CALM1_SOLTU	Calmodulin-1 (CaM-1)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g021880	Scaffold_01	59491953	59492207	NA	NA	NA	NA	NA
PGEN_.00g021890	Scaffold_01	59495087	59501985	O96081	CALMB_HALRO	Calmodulin-B (CaM B)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g021900	Scaffold_01	59509753	59518678	Q58ED9	NAA20_DANRE	N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit)	GO:0004596; GO:0005634; GO:0005737; GO:0017196; GO:0031416	cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]
PGEN_.00g021910	Scaffold_01	59522758	59527778	NA	NA	NA	NA	NA
PGEN_.00g021920	Scaffold_01	59584628	59609586	E1BB03	ZRAB3_BOVIN	DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)]	GO:0004386; GO:0004520; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008094; GO:0009411; GO:0031297; GO:0032508; GO:0036292; GO:0036310; GO:0043596; GO:0045910; GO:0046872; GO:0048478; GO:0070530	nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; endodeoxyribonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to UV [GO:0009411]
PGEN_.00g021930	Scaffold_01	59622613	59623626	NA	NA	NA	NA	NA
PGEN_.00g021940	Scaffold_01	59628564	59664565	Q8K4B0	MTA1_MOUSE	Metastasis-associated protein MTA1	GO:0000122; GO:0000978; GO:0001103; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0008270; GO:0010212; GO:0016575; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0040029; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:1902499	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]"
PGEN_.00g021950	Scaffold_01	59673353	59725680	Q5ZL91	INT7_CHICK	Integrator complex subunit 7 (Int7)	GO:0005694; GO:0006974; GO:0032039; GO:0034472	chromosome [GO:0005694]; integrator complex [GO:0032039]; cellular response to DNA damage stimulus [GO:0006974]; snRNA 3'-end processing [GO:0034472]
PGEN_.00g021960	Scaffold_01	59729424	59745373	Q5REJ1	RT05_PONAB	"28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt)"	GO:0003723; GO:0003735; GO:0005763; GO:0006412	mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g021970	Scaffold_01	59750371	59779779	P23819	GRIA2_MOUSE	"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"	GO:0000149; GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005234; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007268; GO:0008021; GO:0008066; GO:0008092; GO:0009986; GO:0014069; GO:0015277; GO:0016020; GO:0019865; GO:0019901; GO:0030054; GO:0030165; GO:0030425; GO:0030426; GO:0030672; GO:0031623; GO:0032279; GO:0032281; GO:0032839; GO:0032991; GO:0035235; GO:0035249; GO:0036477; GO:0038023; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0045184; GO:0045202; GO:0045211; GO:0050804; GO:0050806; GO:0051117; GO:0051262; GO:0051966; GO:0097060; GO:0098685; GO:0098839; GO:0098978; GO:0099055; GO:0099056; GO:0099061; GO:1904315	"AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]; SNARE binding [GO:0000149]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; establishment of protein localization [GO:0045184]; ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic transmission [GO:0050806]; protein tetramerization [GO:0051262]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g021980	Scaffold_01	59803789	59835926	Q7XBS0	DUR3_ORYSJ	Urea-proton symporter DUR3 (OsDUR3) (High-affinity urea active transporter DUR3)	GO:0005886; GO:0015204; GO:0015293; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; urea transmembrane transport [GO:0071918]
PGEN_.00g021990	Scaffold_01	59840476	59847763	F4KD71	DUR3_ARATH	Urea-proton symporter DUR3 (AtDUR3) (High-affinity urea active transporter DUR3)	GO:0005886; GO:0006995; GO:0015204; GO:0015293; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918]
PGEN_.00g022000	Scaffold_01	59916988	59917248	NA	NA	NA	NA	NA
PGEN_.00g022010	Scaffold_01	59928768	59935042	Q9YH85	TECTA_CHICK	Alpha-tectorin	GO:0005201; GO:0005886; GO:0007160; GO:0007605; GO:0031225; GO:0062023	anchored component of membrane [GO:0031225]; collagen-containing extracellular matrix [GO:0062023]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]
PGEN_.00g022020	Scaffold_01	59935719	59954296	Q8BGD4	SO4C1_MOUSE	Solute carrier organic anion transporter family member 4C1 (Oatp-R) (Solute carrier family 21 member 20)	GO:0005887; GO:0007275; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016021; GO:0016323; GO:0030154; GO:0043252	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]
PGEN_.00g022030	Scaffold_01	59960837	59976059	Q8K078	SO4A1_MOUSE	Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)	GO:0005887; GO:0008514; GO:0015347; GO:0015349; GO:0015711; GO:0042403; GO:0043252	integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]
PGEN_.00g022040	Scaffold_01	59982420	59991965	NA	NA	NA	NA	NA
PGEN_.00g022050	Scaffold_01	60042872	60043129	NA	NA	NA	NA	NA
PGEN_.00g022060	Scaffold_01	60054826	60074938	NA	NA	NA	NA	NA
PGEN_.00g022070	Scaffold_01	60085212	60099150	Q9U1H8	FACE2_DROME	CAAX prenyl protease 2 (EC 3.4.22.-) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (Protein severas)	GO:0004197; GO:0004222; GO:0030176; GO:0071586	integral component of endoplasmic reticulum membrane [GO:0030176]; cysteine-type endopeptidase activity [GO:0004197]; metalloendopeptidase activity [GO:0004222]; CAAX-box protein processing [GO:0071586]
PGEN_.00g022080	Scaffold_01	60106671	60119965	NA	NA	NA	NA	NA
PGEN_.00g022090	Scaffold_01	60121536	60122309	NA	NA	NA	NA	NA
PGEN_.00g022100	Scaffold_01	60122943	60123392	NA	NA	NA	NA	NA
PGEN_.00g022110	Scaffold_01	60127935	60128479	NA	NA	NA	NA	NA
PGEN_.00g022120	Scaffold_01	60196758	60213212	NA	NA	NA	NA	NA
PGEN_.00g022130	Scaffold_01	60238838	60256130	O88874	CCNK_MOUSE	Cyclin-K	GO:0001701; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006357; GO:0006974; GO:0007049; GO:0008024; GO:0008353; GO:0016538; GO:0019901; GO:0032786; GO:0044828; GO:0051301; GO:0061575; GO:0071157; GO:2000737; GO:2001165	"cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; in utero embryonic development [GO:0001701]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g022140	Scaffold_01	60256177	60257372	Q9JHG0	CBLN3_MOUSE	Cerebellin-3	GO:0005615; GO:0005783; GO:0005794; GO:0030054; GO:0045202	cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202]
PGEN_.00g022150	Scaffold_01	60263708	60267661	NA	NA	NA	NA	NA
PGEN_.00g022160	Scaffold_01	60272561	60276154	NA	NA	NA	NA	NA
PGEN_.00g022170	Scaffold_01	60282934	60308826	Q8R4P9	MRP7_MOUSE	Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10)	GO:0005524; GO:0005886; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g022180	Scaffold_01	60331059	60341165	Q6GNV7	DIRC2_XENLA	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	GO:0005765; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]
PGEN_.00g022190	Scaffold_01	60420240	60422841	NA	NA	NA	NA	NA
PGEN_.00g022200	Scaffold_01	60424208	60425608	NA	NA	NA	NA	NA
PGEN_.00g022210	Scaffold_01	60425707	60426096	NA	NA	NA	NA	NA
PGEN_.00g022220	Scaffold_01	60479244	60482164	NA	NA	NA	NA	NA
PGEN_.00g022230	Scaffold_01	60507031	60512194	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g022240	Scaffold_01	60540592	60559620	NA	NA	NA	NA	NA
PGEN_.00g022250	Scaffold_01	60562083	60563104	NA	NA	NA	NA	NA
PGEN_.00g022260	Scaffold_01	60604079	60604420	NA	NA	NA	NA	NA
PGEN_.00g022270	Scaffold_01	60613322	60613600	NA	NA	NA	NA	NA
PGEN_.00g022280	Scaffold_01	60642681	60642998	NA	NA	NA	NA	NA
PGEN_.00g022290	Scaffold_01	60672637	60680782	P53440	CALMF_NAEGR	"Calmodulin, flagellar (CAM-1)"	GO:0005509; GO:0019722; GO:0031514	motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g022300	Scaffold_01	60691934	60714119	Q9D6P8	CALL3_MOUSE	Calmodulin-like protein 3	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g022310	Scaffold_01	60719633	60752438	P02599	CALM_DICDI	Calmodulin (CaM)	GO:0000281; GO:0000331; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0017024; GO:0019722; GO:0019900; GO:0019901; GO:0031012; GO:0031013; GO:0031285; GO:0032781; GO:0043549; GO:0045861; GO:0050839; GO:0051284; GO:0051343; GO:0061122; GO:0072666; GO:1903665	contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]
PGEN_.00g022320	Scaffold_01	60757226	60768237	P47948	TNNC2_DROME	"Troponin C, isoform 2"	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g022330	Scaffold_01	60770333	60777183	P24044	CALM_PLAFA	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g022340	Scaffold_01	60944778	60947314	Q12729	LAC1_PLEOS	Laccase-1 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 1) (Diphenol oxidase 1) (Urishiol oxidase 1)	GO:0005507; GO:0005576; GO:0046274; GO:0052716	extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]
PGEN_.00g022350	Scaffold_01	60950048	60954653	NA	NA	NA	NA	NA
PGEN_.00g022360	Scaffold_01	60966436	60982783	A2AKK5	ACNT1_MOUSE	Acyl-coenzyme A amino acid N-acyltransferase 1 (EC 2.3.1.-)	GO:0005777; GO:0006631; GO:0006637; GO:0016410; GO:0047617	peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]
PGEN_.00g022370	Scaffold_01	60988138	61000508	A2AKK5	ACNT1_MOUSE	Acyl-coenzyme A amino acid N-acyltransferase 1 (EC 2.3.1.-)	GO:0005777; GO:0006631; GO:0006637; GO:0016410; GO:0047617	peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]
PGEN_.00g022380	Scaffold_01	61004563	61019211	Q9P2K9	DISP3_HUMAN	Protein dispatched homolog 3 (Patched domain-containing protein 2)	GO:0005737; GO:0005783; GO:0005789; GO:0007224; GO:0008203; GO:0016021; GO:0030659; GO:0031965; GO:0032368; GO:0042632; GO:0045665; GO:0045834; GO:2000179	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of lipid transport [GO:0032368]; smoothened signaling pathway [GO:0007224]
PGEN_.00g022390	Scaffold_01	61022230	61033798	Q9NW75	GPTC2_HUMAN	G patch domain-containing protein 2	GO:0003676; GO:0005730; GO:0010923; GO:0016607	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g022400	Scaffold_01	61060233	61060883	D3ZTX0	TMED7_RAT	Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27)	GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0012507; GO:0016021; GO:0030134; GO:0030663; GO:0033116	COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]
PGEN_.00g022410	Scaffold_01	61069594	61082691	Q5CAZ6	B3GA2_CANLF	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 2) (GlcAT-D) (UDP-glucuronosyltransferase S) (GlcAT-S) (Glucuronosyltransferase S)"	GO:0000139; GO:0006486; GO:0015018; GO:0016021; GO:0046872; GO:0050650	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; protein glycosylation [GO:0006486]
PGEN_.00g022420	Scaffold_01	61131166	61211539	Q00963	SPTCB_DROME	Spectrin beta chain	GO:0003779; GO:0005200; GO:0005516; GO:0005546; GO:0005886; GO:0007009; GO:0007026; GO:0007274; GO:0007399; GO:0007409; GO:0007411; GO:0008017; GO:0008091; GO:0016199; GO:0016327; GO:0016328; GO:0030424; GO:0030506; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0048790; GO:0050807; GO:0051693; GO:0072499	"apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807]"
PGEN_.00g022430	Scaffold_01	61290499	61293602	NA	NA	NA	NA	NA
PGEN_.00g022440	Scaffold_01	61294288	61294785	NA	NA	NA	NA	NA
PGEN_.00g022450	Scaffold_01	61304961	61313742	Q9MYP6	DHB14_BOVIN	17-beta-hydroxysteroid dehydrogenase 14 (17-beta-HSD 14) (EC 1.1.1.-) (17-beta-hydroxysteroid dehydrogenase DHRS10) (Dehydrogenase/reductase SDR family member 10) (Retinal short-chain dehydrogenase/reductase retSDR3)	GO:0004303; GO:0005829; GO:0006706; GO:0042802; GO:0047045	cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706]
PGEN_.00g022460	Scaffold_01	61331722	61341078	Q9MYP6	DHB14_BOVIN	17-beta-hydroxysteroid dehydrogenase 14 (17-beta-HSD 14) (EC 1.1.1.-) (17-beta-hydroxysteroid dehydrogenase DHRS10) (Dehydrogenase/reductase SDR family member 10) (Retinal short-chain dehydrogenase/reductase retSDR3)	GO:0004303; GO:0005829; GO:0006706; GO:0042802; GO:0047045	cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706]
PGEN_.00g022470	Scaffold_01	61345924	61354620	Q9MYP6	DHB14_BOVIN	17-beta-hydroxysteroid dehydrogenase 14 (17-beta-HSD 14) (EC 1.1.1.-) (17-beta-hydroxysteroid dehydrogenase DHRS10) (Dehydrogenase/reductase SDR family member 10) (Retinal short-chain dehydrogenase/reductase retSDR3)	GO:0004303; GO:0005829; GO:0006706; GO:0042802; GO:0047045	cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706]
PGEN_.00g022480	Scaffold_01	61364499	61372012	NA	NA	NA	NA	NA
PGEN_.00g022490	Scaffold_01	61409541	61410393	NA	NA	NA	NA	NA
PGEN_.00g022500	Scaffold_01	61413818	61424009	NA	NA	NA	NA	NA
PGEN_.00g022510	Scaffold_01	61436611	61440771	NA	NA	NA	NA	NA
PGEN_.00g022520	Scaffold_01	61445168	61446774	NA	NA	NA	NA	NA
PGEN_.00g022530	Scaffold_01	61451334	61456193	NA	NA	NA	NA	NA
PGEN_.00g022540	Scaffold_01	61456817	61457110	NA	NA	NA	NA	NA
PGEN_.00g022550	Scaffold_01	61459642	61460193	NA	NA	NA	NA	NA
PGEN_.00g022560	Scaffold_01	61464916	61470837	Q6PEM8	PCFT_MOUSE	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)	GO:0005542; GO:0005737; GO:0005886; GO:0008517; GO:0015078; GO:0015232; GO:0015350; GO:0015884; GO:0015886; GO:0016021; GO:0016324; GO:0031526; GO:0051958; GO:1902600; GO:1904447	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; heme transporter activity [GO:0015232]; methotrexate transmembrane transporter activity [GO:0015350]; proton transmembrane transporter activity [GO:0015078]; folate import across plasma membrane [GO:1904447]; folic acid transport [GO:0015884]; heme transport [GO:0015886]; methotrexate transport [GO:0051958]; proton transmembrane transport [GO:1902600]
PGEN_.00g022570	Scaffold_01	61472527	61476927	Q5F4B8	S46A3_CHICK	Solute carrier family 46 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g022580	Scaffold_01	61477970	61487289	Q5F4B8	S46A3_CHICK	Solute carrier family 46 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g022590	Scaffold_01	61491280	61498059	Q5F4B8	S46A3_CHICK	Solute carrier family 46 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g022600	Scaffold_01	61498441	61507491	P11118	CALM_EUGGR	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g022610	Scaffold_01	61513087	61516168	P02599	CALM_DICDI	Calmodulin (CaM)	GO:0000281; GO:0000331; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0017024; GO:0019722; GO:0019900; GO:0019901; GO:0031012; GO:0031013; GO:0031285; GO:0032781; GO:0043549; GO:0045861; GO:0050839; GO:0051284; GO:0051343; GO:0061122; GO:0072666; GO:1903665	contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; kinase binding [GO:0019900]; myosin I binding [GO:0017024]; protein kinase binding [GO:0019901]; troponin I binding [GO:0031013]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to vacuole [GO:0072666]; mitotic cytokinesis [GO:0000281]; negative regulation of asexual reproduction [GO:1903665]; negative regulation of proteolysis [GO:0045861]; positive regulation of ATPase activity [GO:0032781]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of positive chemotaxis to cAMP [GO:0061122]; positive regulation of sequestering of calcium ion [GO:0051284]; regulation of kinase activity [GO:0043549]; regulation of sorocarp stalk cell differentiation [GO:0031285]
PGEN_.00g022620	Scaffold_01	61516805	61518657	P24044	CALM_PLAFA	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g022630	Scaffold_01	61563119	61567763	Q682T9	CALM5_ARATH	Calmodulin-5 (CaM-5)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g022640	Scaffold_01	61570364	61760544	NA	NA	NA	NA	NA
PGEN_.00g022650	Scaffold_01	61805223	61820503	P48637	GSHB_HUMAN	Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)	GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0006520; GO:0006750; GO:0006979; GO:0007399; GO:0007568; GO:0009410; GO:0016594; GO:0031667; GO:0034612; GO:0042802; GO:0042803; GO:0043200; GO:0043295; GO:0046686; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; glutathione biosynthetic process [GO:0006750]; nervous system development [GO:0007399]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]
PGEN_.00g022660	Scaffold_01	61822122	61833338	Q80XN0	BDH_MOUSE	"D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH)"	GO:0003858; GO:0005543; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0099617	matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543]
PGEN_.00g022670	Scaffold_01	61836983	61846750	Q02338	BDH_HUMAN	"D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) (Short chain dehydrogenase/reductase family 9C member 1)"	GO:0003858; GO:0005654; GO:0005739; GO:0005759; GO:0046951; GO:0046952; GO:0099617	matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]
PGEN_.00g022680	Scaffold_01	61849006	61849350	NA	NA	NA	NA	NA
PGEN_.00g022690	Scaffold_01	61850697	61906610	Q8IWV8	UBR2_HUMAN	E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)	GO:0000151; GO:0000209; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0006342; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]
PGEN_.00g022700	Scaffold_01	61915344	61915580	NA	NA	NA	NA	NA
PGEN_.00g022710	Scaffold_01	61916324	61917019	NA	NA	NA	NA	NA
PGEN_.00g022720	Scaffold_01	61928638	61930088	NA	NA	NA	NA	NA
PGEN_.00g022730	Scaffold_01	61932500	61932952	NA	NA	NA	NA	NA
PGEN_.00g022740	Scaffold_01	61936930	61964564	NA	NA	NA	NA	NA
PGEN_.00g022750	Scaffold_01	61969703	62002275	Q0V9S9	DRC7_XENTR	Dynein regulatory complex subunit 7 (Coiled-coil domain-containing protein 135) (Coiled-coil domain-containing protein lobo homolog)	GO:0005737; GO:0005856; GO:0030317; GO:0031514; GO:0048870	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]
PGEN_.00g022760	Scaffold_01	62012492	62017548	NA	NA	NA	NA	NA
PGEN_.00g022770	Scaffold_01	62043174	62326239	Q52KG5	KI26A_MOUSE	Kinesin-like protein KIF26A	GO:0001560; GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0008017; GO:0008574; GO:0009968; GO:0048484	"cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]"
PGEN_.00g022780	Scaffold_01	62331274	62334760	NA	NA	NA	NA	NA
PGEN_.00g022790	Scaffold_01	62358386	62361559	NA	NA	NA	NA	NA
PGEN_.00g022800	Scaffold_01	62365235	62372821	NA	NA	NA	NA	NA
PGEN_.00g022810	Scaffold_01	62390812	62420307	Q9H2Y7	ZN106_HUMAN	Zinc finger protein 106 (Zfp-106) (Zinc finger protein 474)	GO:0003723; GO:0005730; GO:0005829; GO:0008286; GO:0016020; GO:0016607; GO:0017124; GO:0046872	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; insulin receptor signaling pathway [GO:0008286]
PGEN_.00g022820	Scaffold_01	62452960	62491055	P36975	SNP25_DROME	Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein)	GO:0000149; GO:0005484; GO:0005623; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489	cell [GO:0005623]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]
PGEN_.00g022830	Scaffold_01	62499877	62501962	NA	NA	NA	NA	NA
PGEN_.00g022840	Scaffold_01	62507037	62527780	Q1EHB4	SC5AC_HUMAN	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	GO:0005343; GO:0005886; GO:0006811; GO:0015129; GO:0016021; GO:0016324; GO:0070062	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; organic acid:sodium symporter activity [GO:0005343]; ion transport [GO:0006811]
PGEN_.00g022850	Scaffold_01	62533045	62533659	NA	NA	NA	NA	NA
PGEN_.00g022860	Scaffold_01	62535528	62538953	NA	NA	NA	NA	NA
PGEN_.00g022870	Scaffold_01	62563665	62604162	Q86UA1	PRP39_HUMAN	Pre-mRNA-processing factor 39 (PRP39 homolog)	GO:0000243; GO:0000395; GO:0005685; GO:0071004	commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395]
PGEN_.00g022880	Scaffold_01	62613043	62643430	Q9NTG1	PKDRE_HUMAN	Polycystic kidney disease and receptor for egg jelly-related protein (PKD and REJ homolog)	GO:0005262; GO:0005509; GO:0007340; GO:0016020; GO:0016021; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g022890	Scaffold_01	62643864	62691354	NA	NA	NA	NA	NA
PGEN_.00g022900	Scaffold_01	62703121	62710330	NA	NA	NA	NA	NA
PGEN_.00g022910	Scaffold_01	62725672	62726073	NA	NA	NA	NA	NA
PGEN_.00g022920	Scaffold_01	62808435	62831050	Q502K2	SAMH1_DANRE	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]
PGEN_.00g022930	Scaffold_01	62833825	62839257	Q0VCA5	SAMH1_BOVIN	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0004540; GO:0005525; GO:0005634; GO:0005654; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0042802; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0097197; GO:0110025	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]
PGEN_.00g022940	Scaffold_01	62864553	62913934	Q69ZN6	GNPTA_MOUSE	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0009306; GO:0016021; GO:0016256; GO:0033299; GO:0046835	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; protein secretion [GO:0009306]; secretion of lysosomal enzymes [GO:0033299]
PGEN_.00g022950	Scaffold_01	62913986	62918142	NA	NA	NA	NA	NA
PGEN_.00g022960	Scaffold_01	62933068	62933418	NA	NA	NA	NA	NA
PGEN_.00g022970	Scaffold_01	62947085	62950492	NA	NA	NA	NA	NA
PGEN_.00g022980	Scaffold_01	62950773	62951445	NA	NA	NA	NA	NA
PGEN_.00g022990	Scaffold_01	62951452	62953970	NA	NA	NA	NA	NA
PGEN_.00g023000	Scaffold_01	63022943	63030705	A0A1B0GWB2	PRT1B_HUMAN	Proline rich transmembrane protein 1B	GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]
PGEN_.00g023010	Scaffold_01	63142761	63147374	NA	NA	NA	NA	NA
PGEN_.00g023020	Scaffold_01	63166683	63167978	O42097	FOXA2_ORYLA	Hepatocyte nuclear factor 3-beta (HNF-3-beta) (HNF-3B) (Forkhead box protein A2) (Me-HNF3B)	GO:0000981; GO:0005634; GO:0006357; GO:0008134; GO:0009653; GO:0019904; GO:0030154; GO:0043565	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g023030	Scaffold_01	63217420	63217785	NA	NA	NA	NA	NA
PGEN_.00g023040	Scaffold_01	63263585	63314677	Q8TD10	MIPO1_HUMAN	Mirror-image polydactyly gene 1 protein	GO:0005634; GO:0042802	nucleus [GO:0005634]; identical protein binding [GO:0042802]
PGEN_.00g023050	Scaffold_01	63319454	63324649	NA	NA	NA	NA	NA
PGEN_.00g023060	Scaffold_01	63330967	63332640	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g023070	Scaffold_01	63341822	63355909	Q8BK64	AHSA1_MOUSE	Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1)	GO:0001671; GO:0005737; GO:0005783; GO:0005829; GO:0006457; GO:0032781; GO:0051087; GO:0051879	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]
PGEN_.00g023080	Scaffold_01	63366426	63383374	O54926	SIVA_MOUSE	Apoptosis regulatory protein Siva (CD27-binding protein) (CD27BP)	GO:0001618; GO:0005164; GO:0005175; GO:0005654; GO:0005737; GO:0005739; GO:0006924; GO:0008270; GO:0032088; GO:0097191; GO:1901030	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; CD27 receptor binding [GO:0005175]; tumor necrosis factor receptor binding [GO:0005164]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]
PGEN_.00g023090	Scaffold_01	63393468	63463330	NA	NA	NA	NA	NA
PGEN_.00g023100	Scaffold_01	63492925	63528511	Q9Y4F5	C170B_HUMAN	Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B)	GO:0005737; GO:0005874	cytoplasm [GO:0005737]; microtubule [GO:0005874]
PGEN_.00g023110	Scaffold_01	63538620	63567496	B8JK76	SDCG8_DANRE	Serologically defined colon cancer antigen 8 homolog	GO:0001764; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0030010; GO:0030030; GO:0030054; GO:0031023; GO:0035148; GO:0042995; GO:0043009	cell junction [GO:0030054]; cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cell projection organization [GO:0030030]; centrosome cycle [GO:0007098]; chordate embryonic development [GO:0043009]; establishment of cell polarity [GO:0030010]; microtubule organizing center organization [GO:0031023]; neuron migration [GO:0001764]; tube formation [GO:0035148]
PGEN_.00g023120	Scaffold_01	63570502	63571386	NA	NA	NA	NA	NA
PGEN_.00g023130	Scaffold_01	63625267	63694110	Q8AWW5	CRIM1_CHICK	Cysteine-rich motor neuron 1 protein (CRIM-1)	GO:0004867; GO:0005520; GO:0005576; GO:0016021	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; insulin-like growth factor binding [GO:0005520]; serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g023140	Scaffold_01	63734181	63734525	A6QQ14	DPOE4_BOVIN	DNA polymerase epsilon subunit 4 (DNA polymerase II subunit 4)	GO:0003677; GO:0003700; GO:0005671; GO:0008622; GO:0043966; GO:0046982	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; histone H3 acetylation [GO:0043966]
PGEN_.00g023150	Scaffold_01	63742324	63743263	NA	NA	NA	NA	NA
PGEN_.00g023160	Scaffold_01	63745447	63768459	G5ECD6	CHS1_CAEEL	Chitin synthase chs-1 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-1)	GO:0004100; GO:0005886; GO:0005938; GO:0006031; GO:0006038; GO:0016021; GO:0030428; GO:0030703; GO:1904778	cell cortex [GO:0005938]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; eggshell formation [GO:0030703]; positive regulation of protein localization to cell cortex [GO:1904778]
PGEN_.00g023170	Scaffold_01	63832997	63836957	NA	NA	NA	NA	NA
PGEN_.00g023180	Scaffold_01	63837250	63838924	NA	NA	NA	NA	NA
PGEN_.00g023190	Scaffold_01	63861844	63896573	Q9Z2H2	RGS6_MOUSE	Regulator of G-protein signaling 6 (RGS6)	GO:0005096; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007186; GO:0009968; GO:0019898; GO:0019904; GO:0032991; GO:0035556; GO:0043547; GO:0045666	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron differentiation [GO:0045666]
PGEN_.00g023200	Scaffold_01	63936073	63991256	P49803	RGS7_RAT	Regulator of G-protein signaling 7 (RGS7)	GO:0001965; GO:0001975; GO:0005096; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007420; GO:0008277; GO:0009409; GO:0009968; GO:0031681; GO:0032991; GO:0035556; GO:0043547; GO:0044292; GO:0045121; GO:0045211; GO:0045471; GO:0060078; GO:0098793; GO:0098978; GO:1901381	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite terminus [GO:0044292]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; brain development [GO:0007420]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of postsynaptic membrane potential [GO:0060078]; response to amphetamine [GO:0001975]; response to cold [GO:0009409]; response to ethanol [GO:0045471]
PGEN_.00g023210	Scaffold_01	64002771	64003175	NA	NA	NA	NA	NA
PGEN_.00g023220	Scaffold_01	64029372	64031994	NA	NA	NA	NA	NA
PGEN_.00g023230	Scaffold_01	64039560	64042629	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g023240	Scaffold_01	64043334	64062816	Q86V25	VASH2_HUMAN	Tubulinyl-Tyr carboxypeptidase 2 (EC 3.4.17.17) (Vasohibin-2) (Vasohibin-like protein)	GO:0000768; GO:0001938; GO:0003779; GO:0004181; GO:0005576; GO:0005737; GO:0006508; GO:0045766; GO:0060716; GO:0140253	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; syncytium formation by plasma membrane fusion [GO:0000768]
PGEN_.00g023250	Scaffold_01	64066839	64069907	P51910	APOD_MOUSE	Apolipoprotein D (Apo-D) (ApoD)	GO:0000302; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]
PGEN_.00g023260	Scaffold_01	64081163	64083568	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g023270	Scaffold_01	64091085	64097487	A6H7I3	ANGE2_BOVIN	Protein angel homolog 2	GO:0000175; GO:0003730; GO:0005737; GO:0015030; GO:0045930; GO:0070935	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; 3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR binding [GO:0003730]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; negative regulation of mitotic cell cycle [GO:0045930]
PGEN_.00g023280	Scaffold_01	64106439	64145354	Q8R1B8	RORB_MOUSE	Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta)	GO:0000978; GO:0001228; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0007601; GO:0008134; GO:0008270; GO:0008502; GO:0035881; GO:0042462; GO:0042752; GO:0043565; GO:0045668; GO:0045892; GO:0045893; GO:0045944; GO:0046548; GO:0046549; GO:0048511; GO:0060041; GO:0071300	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; melatonin receptor activity [GO:0008502]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; amacrine cell differentiation [GO:0035881]; cellular response to retinoic acid [GO:0071300]; eye photoreceptor cell development [GO:0042462]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; rhythmic process [GO:0048511]; visual perception [GO:0007601]"
PGEN_.00g023290	Scaffold_01	64163810	64164757	NA	NA	NA	NA	NA
PGEN_.00g023300	Scaffold_01	64170082	64175858	NA	NA	NA	NA	NA
PGEN_.00g023310	Scaffold_01	64179844	64180065	NA	NA	NA	NA	NA
PGEN_.00g023320	Scaffold_01	64215978	64252168	A2AJ88	PLPL7_MOUSE	Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (Neuropathy target esterase-related esterase) (NRE) (NTE-related esterase)	GO:0004622; GO:0005765; GO:0005783; GO:0005789; GO:0016021; GO:0016042; GO:0031965; GO:0031966; GO:0052689	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; nuclear membrane [GO:0031965]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042]
PGEN_.00g023330	Scaffold_01	64259292	64259597	NA	NA	NA	NA	NA
PGEN_.00g023340	Scaffold_01	64261485	64277705	Q99946	PRRT1_HUMAN	Proline-rich transmembrane protein 1 (Dispanin subfamily D member 1) (DSPD1)	GO:0016020; GO:0030054; GO:0098978; GO:0099055	cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]
PGEN_.00g023350	Scaffold_01	64289936	64290247	NA	NA	NA	NA	NA
PGEN_.00g023360	Scaffold_01	64301389	64304676	NA	NA	NA	NA	NA
PGEN_.00g023370	Scaffold_01	64325442	64363166	Q5RGJ8	GNPTA_DANRE	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein gnptab) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	GO:0000139; GO:0002063; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0046835; GO:0048701; GO:0048703; GO:0051216; GO:0060348	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; bone development [GO:0060348]; carbohydrate phosphorylation [GO:0046835]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]
PGEN_.00g023380	Scaffold_01	64363242	64364251	P23435	CBLN1_HUMAN	Cerebellin-1 (Precerebellin) [Cleaved into: Cerebellin (CER); [des-Ser1]-cerebellin]	GO:0007157; GO:0007268; GO:0007399; GO:0009306; GO:0021707; GO:0030054; GO:0042803; GO:0043083; GO:0045211; GO:0051965; GO:0062023; GO:0090394; GO:0098688; GO:0098978; GO:0099151; GO:1900454; GO:1905606	cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; synaptic cleft [GO:0043083]; protein homodimerization activity [GO:0042803]; cerebellar granule cell differentiation [GO:0021707]; chemical synaptic transmission [GO:0007268]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of excitatory postsynaptic potential [GO:0090394]; nervous system development [GO:0007399]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein secretion [GO:0009306]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]
PGEN_.00g023390	Scaffold_01	64364962	64374341	NA	NA	NA	NA	NA
PGEN_.00g023400	Scaffold_01	64407381	64453770	Q9NZ56	FMN2_HUMAN	Formin-2	GO:0003779; GO:0005623; GO:0005634; GO:0005730; GO:0005737; GO:0005789; GO:0005819; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0007275; GO:0015031; GO:0016192; GO:0030659; GO:0035556; GO:0040038; GO:0042177; GO:0043066; GO:0046907; GO:0048471; GO:0048477; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781	cell [GO:0005623]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole involved in homologous chromosome segregation [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g023410	Scaffold_01	64477357	64480673	NA	NA	NA	NA	NA
PGEN_.00g023420	Scaffold_01	64492121	64492936	NA	NA	NA	NA	NA
PGEN_.00g023430	Scaffold_01	64505774	64506412	Q9H772	GREM2_HUMAN	"Gremlin-2 (Cysteine knot superfamily 1, BMP antagonist 2) (DAN domain family member 3) (Protein related to DAN and cerberus)"	GO:0005125; GO:0005576; GO:0005615; GO:0008201; GO:0010172; GO:0019221; GO:0030509; GO:0036122; GO:0038098; GO:0042803; GO:0048263; GO:0060300	extracellular region [GO:0005576]; extracellular space [GO:0005615]; BMP binding [GO:0036122]; cytokine activity [GO:0005125]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; BMP signaling pathway [GO:0030509]; cytokine-mediated signaling pathway [GO:0019221]; determination of dorsal identity [GO:0048263]; embryonic body morphogenesis [GO:0010172]; regulation of cytokine activity [GO:0060300]; sequestering of BMP from receptor via BMP binding [GO:0038098]
PGEN_.00g023440	Scaffold_01	64520719	64522512	NA	NA	NA	NA	NA
PGEN_.00g023450	Scaffold_01	64560988	64561230	NA	NA	NA	NA	NA
PGEN_.00g023460	Scaffold_01	64572048	64588145	Q9EQT3	RHOU_MOUSE	Rho-related GTP-binding protein RhoU (Rho GTPase-like protein ARHU) (Wnt-1 responsive Cdc42 homolog 1) (WRCH-1)	GO:0000082; GO:0000139; GO:0002102; GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0005925; GO:0005938; GO:0006897; GO:0007010; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0016601; GO:0019901; GO:0030031; GO:0030036; GO:0032488; GO:0032956; GO:0042995; GO:0046872	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell projection assembly [GO:0030031]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; G1/S transition of mitotic cell cycle [GO:0000082]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]
PGEN_.00g023470	Scaffold_01	64635317	64635619	NA	NA	NA	NA	NA
PGEN_.00g023480	Scaffold_01	64717880	64740210	Q91ZX7	LRP1_MOUSE	Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]	GO:0002020; GO:0002265; GO:0003279; GO:0005509; GO:0005623; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005856; GO:0005887; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0008203; GO:0008283; GO:0010812; GO:0010875; GO:0010942; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0030054; GO:0030136; GO:0030178; GO:0030425; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045177; GO:0045202; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060548; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0150093; GO:0150094; GO:1900149; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905167; GO:2000587	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; receptor complex [GO:0043235]; synapse [GO:0045202]; alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]
PGEN_.00g023490	Scaffold_01	64744168	64748221	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g023500	Scaffold_01	64760928	64766155	NA	NA	NA	NA	NA
PGEN_.00g023510	Scaffold_01	64779945	64796926	NA	NA	NA	NA	NA
PGEN_.00g023520	Scaffold_01	64816776	64852168	NA	NA	NA	NA	NA
PGEN_.00g023530	Scaffold_01	64856117	64857613	NA	NA	NA	NA	NA
PGEN_.00g023540	Scaffold_01	64861723	64863921	NA	NA	NA	NA	NA
PGEN_.00g023550	Scaffold_01	64877220	64882542	NA	NA	NA	NA	NA
PGEN_.00g023560	Scaffold_01	64883013	64883450	NA	NA	NA	NA	NA
PGEN_.00g023570	Scaffold_01	64888667	64910184	NA	NA	NA	NA	NA
PGEN_.00g023580	Scaffold_01	64920771	64923822	Q03650	CRAM_TRYBB	"Cysteine-rich, acidic integral membrane protein"	GO:0005886; GO:0006897; GO:0016021; GO:0020016	ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]
PGEN_.00g023590	Scaffold_01	64932652	64946158	Q567G6	NEPRO_DANRE	Nucleolus and neural progenitor protein	GO:0005634; GO:0005730; GO:0045665; GO:0045747	nucleolus [GO:0005730]; nucleus [GO:0005634]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Notch signaling pathway [GO:0045747]
PGEN_.00g023600	Scaffold_01	64951660	64952037	NA	NA	NA	NA	NA
PGEN_.00g023610	Scaffold_01	64962469	65039125	Q5F480	ITPK1_CHICK	"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)"	GO:0000287; GO:0000825; GO:0005524; GO:0005737; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]"
PGEN_.00g023620	Scaffold_01	65047129	65049522	Q6DRC5	USPL1_DANRE	SUMO-specific isopeptidase USPL1 (EC 3.4.22.-) (Ubiquitin-specific peptidase-like protein 1)	GO:0008283; GO:0015030; GO:0016926; GO:0030576; GO:0032183; GO:0070140	Cajal body [GO:0015030]; SUMO binding [GO:0032183]; SUMO-specific isopeptidase activity [GO:0070140]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; protein desumoylation [GO:0016926]
PGEN_.00g023630	Scaffold_01	65053382	65062022	NA	NA	NA	NA	NA
PGEN_.00g023640	Scaffold_01	65062138	65072993	A0JPQ7	CS047_RAT	Uncharacterized protein C19orf47 homolog		
PGEN_.00g023650	Scaffold_01	65084220	65094324	Q3T0C9	SYJ2B_BOVIN	Synaptojanin-2-binding protein (Activin receptor-interacting protein 2) (Mitochondrial outer membrane protein 25)	GO:0001937; GO:0005741; GO:0006897; GO:0007268; GO:0008593; GO:0010596; GO:0016021; GO:0016323; GO:0016525; GO:0030054; GO:0031594; GO:0043005; GO:0043113; GO:0045197; GO:0048471; GO:0070373; GO:0097120; GO:0098609; GO:0098839; GO:1903671	basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density membrane [GO:0098839]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of Notch signaling pathway [GO:0008593]
PGEN_.00g023660	Scaffold_01	65100354	65112559	NA	NA	NA	NA	NA
PGEN_.00g023670	Scaffold_01	65143629	65228341	D2IYS2	TORSO_BOMMO	Tyrosine-protein kinase receptor torso (EC 2.7.10.1)	GO:0004714; GO:0005524; GO:0005886; GO:0007275; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]
PGEN_.00g023680	Scaffold_01	65241419	65244335	NA	NA	NA	NA	NA
PGEN_.00g023690	Scaffold_01	65255139	65258219	Q90751	BMP2_CHICK	Bone morphogenetic protein 2 (BMP-2) (Fragment)	GO:0000122; GO:0001503; GO:0005125; GO:0005160; GO:0005615; GO:0008083; GO:0010718; GO:0010862; GO:0030509; GO:0042981; GO:0043408; GO:0048468; GO:0051216; GO:0060317; GO:0060395; GO:0070700	extracellular space [GO:0005615]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cartilage development [GO:0051216]; cell development [GO:0048468]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; SMAD protein signal transduction [GO:0060395]
PGEN_.00g023700	Scaffold_01	65258293	65281783	NA	NA	NA	NA	NA
PGEN_.00g023710	Scaffold_01	65322764	65325719	P9WI28	PPE16_MYCTO	Uncharacterized PPE family protein PPE16		
PGEN_.00g023720	Scaffold_01	65342352	65345468	Q69Z37	SAM9L_MOUSE	Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like)	GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536	cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]
PGEN_.00g023730	Scaffold_01	65345622	65347133	NA	NA	NA	NA	NA
PGEN_.00g023740	Scaffold_01	65348979	65351774	P25067	CO8A2_HUMAN	Collagen alpha-2(VIII) chain (Endothelial collagen)	GO:0001525; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0030674; GO:0031012; GO:0048593; GO:0050673; GO:0062023; GO:0098609	"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein binding, bridging [GO:0030674]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]"
PGEN_.00g023750	Scaffold_01	65362699	65384156	P90648	MHCKB_DICDI	Myosin heavy chain kinase B (MHCK-B) (EC 2.7.11.7)	GO:0000281; GO:0004674; GO:0005524; GO:0005737; GO:0005826; GO:0016905; GO:0018107; GO:0031037; GO:0045159; GO:0046777; GO:1903013	actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; myosin heavy chain kinase activity [GO:0016905]; myosin II binding [GO:0045159]; protein serine/threonine kinase activity [GO:0004674]; mitotic cytokinesis [GO:0000281]; myosin II filament disassembly [GO:0031037]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; response to differentiation-inducing factor 1 [GO:1903013]
PGEN_.00g023760	Scaffold_01	65370893	65372345	NA	NA	NA	NA	NA
PGEN_.00g023770	Scaffold_01	65404557	65444498	D4AM37	SCONB_ARTBC	Probable E3 ubiquitin ligase complex SCF subunit sconB (Sulfur controller B) (Sulfur metabolite repression control protein B)	GO:0016567	protein ubiquitination [GO:0016567]
PGEN_.00g023780	Scaffold_01	65447509	65460962	Q16667	CDKN3_HUMAN	Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Cyclin-dependent kinase interactor 1) (Cyclin-dependent kinase-interacting protein 2) (Kinase-associated phosphatase)	GO:0000079; GO:0000082; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0007050; GO:0008138; GO:0008285; GO:0048471; GO:0060271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell cycle arrest [GO:0007050]; cilium assembly [GO:0060271]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell population proliferation [GO:0008285]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]
PGEN_.00g023790	Scaffold_01	65545079	65552046	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g023800	Scaffold_01	65554790	65555185	NA	NA	NA	NA	NA
PGEN_.00g023810	Scaffold_01	65559907	65560275	NA	NA	NA	NA	NA
PGEN_.00g023820	Scaffold_01	65560852	65570141	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g023830	Scaffold_01	65646628	65647643	NA	NA	NA	NA	NA
PGEN_.00g023840	Scaffold_01	65656579	65659613	P98087	CBLN2_RAT	Cerebellin-2 (Cerebellin-like protein)	GO:0005615; GO:0051965; GO:0098978; GO:1905606	extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]
PGEN_.00g023850	Scaffold_01	65719827	65724680	NA	NA	NA	NA	NA
PGEN_.00g023860	Scaffold_01	65727405	65727629	NA	NA	NA	NA	NA
PGEN_.00g023870	Scaffold_01	65788582	65788983	NA	NA	NA	NA	NA
PGEN_.00g023880	Scaffold_01	65805363	65806800	NA	NA	NA	NA	NA
PGEN_.00g023890	Scaffold_01	65877394	65879016	NA	NA	NA	NA	NA
PGEN_.00g023900	Scaffold_01	65915575	65915880	NA	NA	NA	NA	NA
PGEN_.00g023910	Scaffold_01	65947002	66036701	Q70CQ2	UBP34_HUMAN	Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34)	GO:0004197; GO:0004843; GO:0005737; GO:0005829; GO:0006511; GO:0016055; GO:0016579; GO:0036459; GO:0071108; GO:0090263	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g023920	Scaffold_01	66056885	66058085	NA	NA	NA	NA	NA
PGEN_.00g023930	Scaffold_01	66063758	66065428	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g023940	Scaffold_01	66081438	66101104	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g023950	Scaffold_01	66125180	66196704	Q9TXQ1	TNKS1_CAEEL	Poly [ADP-ribose] polymerase tankyrase (EC 2.4.2.30) (Poly ADP-ribose metabolism enzyme 5) (Protein poly-ADP-ribosyltransferase tankyrase) (EC 2.4.2.-)	GO:0003950; GO:0005634; GO:0005694; GO:0005730; GO:0006302; GO:0006974; GO:0008630; GO:0010332; GO:0043069; GO:0070212; GO:1990404	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of programmed cell death [GO:0043069]; protein poly-ADP-ribosylation [GO:0070212]; response to gamma radiation [GO:0010332]
PGEN_.00g023960	Scaffold_01	66207273	66207494	NA	NA	NA	NA	NA
PGEN_.00g023970	Scaffold_01	66208505	66208762	NA	NA	NA	NA	NA
PGEN_.00g023980	Scaffold_01	66208895	66209930	NA	NA	NA	NA	NA
PGEN_.00g023990	Scaffold_01	66219310	66228413	Q05974	RAB1A_LYMST	Ras-related protein Rab-1A	GO:0003924; GO:0005525; GO:0005783; GO:0005794; GO:0015031; GO:0016192	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g024000	Scaffold_01	66238317	66250135	P22125	RAB1_DIPOM	Ras-related protein ORAB-1	GO:0003924; GO:0005525; GO:0005886; GO:0015031	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]
PGEN_.00g024010	Scaffold_01	66262566	66271306	NA	NA	NA	NA	NA
PGEN_.00g024020	Scaffold_01	66271406	66285728	O46606	DDHD1_BOVIN	Phospholipase DDHD1 (EC 3.1.1.-) (DDHD domain-containing protein 1) (Phosphatidic acid-preferring phospholipase A1) (PA-PLA1)	GO:0004620; GO:0005737; GO:0016042; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]
PGEN_.00g024030	Scaffold_01	66287987	66288265	A1L2P2	SI12A_XENLA	Small integral membrane protein 12-A	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g024040	Scaffold_01	66298464	66310095	NA	NA	NA	NA	NA
PGEN_.00g024050	Scaffold_01	66325200	66332077	A5D6U8	ACP7_DANRE	Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)	GO:0003993; GO:0005576; GO:0046872	extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]
PGEN_.00g024060	Scaffold_01	66362674	66366846	NA	NA	NA	NA	NA
PGEN_.00g024070	Scaffold_01	66368434	66368802	NA	NA	NA	NA	NA
PGEN_.00g024080	Scaffold_01	66370692	66371110	NA	NA	NA	NA	NA
PGEN_.00g024090	Scaffold_01	66374524	66374784	NA	NA	NA	NA	NA
PGEN_.00g024100	Scaffold_01	66381608	66392984	NA	NA	NA	NA	NA
PGEN_.00g024110	Scaffold_01	66418689	66427957	NA	NA	NA	NA	NA
PGEN_.00g024120	Scaffold_01	66440118	66460574	Q8N357	S35F6_HUMAN	Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog)	GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016021; GO:0022857; GO:0043231; GO:0070062; GO:1901029	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]
PGEN_.00g024130	Scaffold_01	66461028	66473303	Q5R613	SNX6_PONAB	"Sorting nexin-6 [Cleaved into: Sorting nexin-6, N-terminally processed]"	GO:0005634; GO:0005829; GO:0006886; GO:0030904; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0097422	"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; retromer complex [GO:0030904]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g024140	Scaffold_01	66479477	66501345	NA	NA	NA	NA	NA
PGEN_.00g024150	Scaffold_01	66517475	66520758	A4IFW2	PTPRF_DANRE	Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48)	GO:0004725; GO:0006470; GO:0008201; GO:0016021; GO:0035335; GO:0097374; GO:0099560	integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; sensory neuron axon guidance [GO:0097374]; synaptic membrane adhesion [GO:0099560]
PGEN_.00g024160	Scaffold_01	66544323	66576858	NA	NA	NA	NA	NA
PGEN_.00g024170	Scaffold_01	66579294	66603552	E9PVB3	CC175_MOUSE	Coiled-coil domain-containing protein 175		
PGEN_.00g024180	Scaffold_01	66645045	66645503	NA	NA	NA	NA	NA
PGEN_.00g024190	Scaffold_01	66708821	66709663	NA	NA	NA	NA	NA
PGEN_.00g024200	Scaffold_01	66715656	66716069	NA	NA	NA	NA	NA
PGEN_.00g024210	Scaffold_01	66762714	66763076	NA	NA	NA	NA	NA
PGEN_.00g024220	Scaffold_01	66767960	66854869	Q07553	GCY3E_DROME	Guanylate cyclase 32E (EC 4.6.1.2)	GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0019934; GO:0038023	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; signaling receptor activity [GO:0038023]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g024230	Scaffold_01	66863567	66867949	NA	NA	NA	NA	NA
PGEN_.00g024240	Scaffold_01	66874295	66876345	NA	NA	NA	NA	NA
PGEN_.00g024250	Scaffold_01	66877163	66883616	A3KMW7	MAP10_BOVIN	Microtubule-associated protein 10 (Microtubule regulator of 120 KDa)	GO:0005813; GO:0005881; GO:0008017; GO:0030496; GO:0031122; GO:0032467; GO:0032886; GO:0051256; GO:0051301; GO:0097431; GO:1990023	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; microtubule binding [GO:0008017]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467]; regulation of microtubule-based process [GO:0032886]
PGEN_.00g024260	Scaffold_01	66894446	66896090	NA	NA	NA	NA	NA
PGEN_.00g024270	Scaffold_01	66901394	66927757	Q8IYD8	FANCM_HUMAN	Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog)	GO:0000712; GO:0003677; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0031297; GO:0036297; GO:0043240; GO:0071821; GO:1902527	FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]
PGEN_.00g024280	Scaffold_01	66940314	66943580	NA	NA	NA	NA	NA
PGEN_.00g024290	Scaffold_01	66947885	66949797	NA	NA	NA	NA	NA
PGEN_.00g024300	Scaffold_01	66956616	66965113	G5EDR5	FUTA_CAEEL	"Alpha-(1,3)-fucosyltransferase fut-1 (EC 2.4.1.214) (Fucosyltransferase fut-1)"	GO:0000139; GO:0006486; GO:0008417; GO:0016021; GO:0016051; GO:0017060; GO:0018392; GO:0032580; GO:0036065; GO:0046872; GO:0046920	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872]; carbohydrate biosynthetic process [GO:0016051]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g024310	Scaffold_01	66970368	66972221	NA	NA	NA	NA	NA
PGEN_.00g024320	Scaffold_01	66981175	67019974	NA	NA	NA	NA	NA
PGEN_.00g024330	Scaffold_01	67046996	67049938	NA	NA	NA	NA	NA
PGEN_.00g024340	Scaffold_01	67059662	67062823	NA	NA	NA	NA	NA
PGEN_.00g024350	Scaffold_01	67155048	67196579	Q8NBP0	TTC13_HUMAN	Tetratricopeptide repeat protein 13 (TPR repeat protein 13)		
PGEN_.00g024360	Scaffold_01	67198570	67207513	O42282	RDS2_CHICK	Photoreceptor outer segment membrane glycoprotein 2 (CRDS2)	GO:0005887; GO:0007601	integral component of plasma membrane [GO:0005887]; visual perception [GO:0007601]
PGEN_.00g024370	Scaffold_01	67223489	67231215	Q14774	HLX_HUMAN	H2.0-like homeobox protein (Homeobox protein HB24) (Homeobox protein HLX1)	GO:0000790; GO:0000981; GO:0001889; GO:0007275; GO:0007519; GO:0008284; GO:0030154; GO:0043565; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557	"nuclear chromatin [GO:0000790]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; liver development [GO:0001889]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]"
PGEN_.00g024380	Scaffold_01	67253377	67296854	P49750	YLPM1_HUMAN	YLP motif-containing protein 1 (Nuclear protein ZAP3) (ZAP113)	GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016607; GO:0032204	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; regulation of telomere maintenance [GO:0032204]
PGEN_.00g024390	Scaffold_01	67378549	67391428	Q2VL56	PAX9_SAGOE	Paired box protein Pax-9	GO:0003677; GO:0003700; GO:0005634; GO:0009887	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; animal organ morphogenesis [GO:0009887]
PGEN_.00g024400	Scaffold_01	67421880	67427239	NA	NA	NA	NA	NA
PGEN_.00g024410	Scaffold_01	67427299	67432382	NA	NA	NA	NA	NA
PGEN_.00g024420	Scaffold_01	67445548	67470260	O00189	AP4M1_HUMAN	AP-4 complex subunit mu-1 (AP-4 adaptor complex mu subunit) (Adaptor-related protein complex 4 subunit mu-1) (Mu subunit of AP-4) (Mu-adaptin-related protein 2) (mu-ARP2) (Mu4-adaptin) (mu4)	GO:0005769; GO:0005802; GO:0005829; GO:0006605; GO:0006622; GO:0006886; GO:0006895; GO:0008104; GO:0019904; GO:0030124; GO:0030131; GO:0031904; GO:0032588; GO:0070062; GO:0090160; GO:1903361	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome lumen [GO:0031904]; extracellular exosome [GO:0070062]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; protein domain specific binding [GO:0019904]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; intracellular protein transport [GO:0006886]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]
PGEN_.00g024430	Scaffold_01	67473867	67503943	P31748	AKT_MLVAT	AKT kinase-transforming protein (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0016032; GO:0043491; GO:0060416; GO:1990418	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein kinase B signaling [GO:0043491]; response to growth hormone [GO:0060416]; response to insulin-like growth factor stimulus [GO:1990418]; viral process [GO:0016032]
PGEN_.00g024440	Scaffold_01	67519316	67522224	Q6P9U1	NUD22_RAT	Uridine diphosphate glucose pyrophosphatase NUDT22 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 22) (Nudix motif 22)	GO:0005654; GO:0008768; GO:0046872; GO:0052751	nucleoplasm [GO:0005654]; GDP-mannose hydrolase activity [GO:0052751]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]
PGEN_.00g024450	Scaffold_01	67531314	67535874	Q2KIU7	RSPH9_BOVIN	Radial spoke head protein 9 homolog	GO:0001534; GO:0005930; GO:0035082; GO:0044458; GO:0060294; GO:0097729	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]
PGEN_.00g024460	Scaffold_01	67542177	67546745	Q99N85	RT18A_MOUSE	"28S ribosomal protein S18a, mitochondrial (MRP-S18-a) (Mrps18a) (S18mt-a) (28S ribosomal protein S18-3, mitochondrial) (MRP-S18-3)"	GO:0003735; GO:0005739; GO:0005762; GO:0005763; GO:0032543; GO:0070181	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g024470	Scaffold_01	67547218	67566490	A0JPP8	CCD61_RAT	Coiled-coil domain-containing protein 61	GO:0005813	centrosome [GO:0005813]
PGEN_.00g024480	Scaffold_01	67569680	67571873	NA	NA	NA	NA	NA
PGEN_.00g024490	Scaffold_01	67591513	67604014	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g024500	Scaffold_01	67619819	67668239	Q28653	2A5D_RABIT	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)	GO:0000159; GO:0005634; GO:0007165; GO:0019888	nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; signal transduction [GO:0007165]
PGEN_.00g024510	Scaffold_01	67694245	67726371	Q6PA06	ATLA2_MOUSE	Atlastin-2 (EC 3.6.5.-) (ADP-ribosylation factor-like protein 6-interacting protein 2) (ARL-6-interacting protein 2) (Aip-2)	GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0007029; GO:0007030; GO:0016021; GO:0042802; GO:0051260; GO:0098826; GO:1990809	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260]
PGEN_.00g024520	Scaffold_01	67734635	67748271	Q9P203	BTBD7_HUMAN	BTB/POZ domain-containing protein 7	GO:0005634; GO:0007275; GO:0060693; GO:0061138	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; multicellular organism development [GO:0007275]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]
PGEN_.00g024530	Scaffold_01	67766140	67767894	NA	NA	NA	NA	NA
PGEN_.00g024540	Scaffold_01	67767963	67786196	Q28D01	WDR26_XENTR	WD repeat-containing protein 26	GO:0005634; GO:0005739	mitochondrion [GO:0005739]; nucleus [GO:0005634]
PGEN_.00g024550	Scaffold_01	67911456	67911743	NA	NA	NA	NA	NA
PGEN_.00g024560	Scaffold_01	67984265	67991575	Q91WL8	WWOX_MOUSE	WW domain-containing oxidoreductase (EC 1.1.1.-)	GO:0001649; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001238; GO:2001241	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription factor complex [GO:0090575]; enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]; cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055]
PGEN_.00g024570	Scaffold_01	67995902	67997281	Q8WZ60	KLHL6_HUMAN	Kelch-like protein 6	GO:0002467; GO:0009617; GO:0050853	B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617]
PGEN_.00g024580	Scaffold_01	68009505	68050714	Q8TAM2	TTC8_HUMAN	Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein)	GO:0001103; GO:0005813; GO:0005829; GO:0005929; GO:0015031; GO:0034464; GO:0036064; GO:0048560; GO:0050893; GO:0060170; GO:0060271; GO:0097730; GO:1905515	BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; non-motile cilium [GO:0097730]; RNA polymerase II repressing transcription factor binding [GO:0001103]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; non-motile cilium assembly [GO:1905515]; protein transport [GO:0015031]; sensory processing [GO:0050893]
PGEN_.00g024590	Scaffold_01	68050810	68125116	Q9VZI3	UN112_DROME	Unc-112-related protein (Fermitin-1)	GO:0005737; GO:0007160; GO:0007229; GO:0048738; GO:0050829; GO:0050839	cytoplasm [GO:0005737]; cell adhesion molecule binding [GO:0050839]; cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229]
PGEN_.00g024600	Scaffold_01	68135960	68163277	Q6P286	DHTK1_XENLA	"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1)"	GO:0004591; GO:0005739; GO:0006096; GO:0006099; GO:0030976	mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g024610	Scaffold_01	68174984	68225542	Q86X10	RLGPB_HUMAN	Ral GTPase-activating protein subunit beta (p170)	GO:0005096; GO:0046982; GO:0051056; GO:0090630	GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g024620	Scaffold_01	68239257	68268096	Q4R6I5	CLHC1_MACFA	Clathrin heavy chain linker domain-containing protein 1		
PGEN_.00g024630	Scaffold_01	68274868	68282247	P17081	RHOQ_HUMAN	Rho-related GTP-binding protein RhoQ (Ras-like protein TC10) (Ras-like protein family member 7A)	GO:0003924; GO:0005522; GO:0005525; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007163; GO:0007266; GO:0008286; GO:0008360; GO:0019901; GO:0030031; GO:0030036; GO:0030660; GO:0030866; GO:0032427; GO:0032869; GO:0032956; GO:0042995; GO:0045121; GO:0045944; GO:0046039; GO:0046326; GO:0051056; GO:0051491; GO:0070062; GO:1903077	actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi-associated vesicle membrane [GO:0030660]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; profilin binding [GO:0005522]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; GTP metabolic process [GO:0046039]; insulin receptor signaling pathway [GO:0008286]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]
PGEN_.00g024640	Scaffold_01	68287200	68287478	NA	NA	NA	NA	NA
PGEN_.00g024650	Scaffold_01	68309810	68310373	NA	NA	NA	NA	NA
PGEN_.00g024660	Scaffold_01	68315021	68326366	Q60864	STIP1_MOUSE	Stress-induced-phosphoprotein 1 (STI1) (mSTI1) (Hsc70/Hsp90-organizing protein) (Hop)	GO:0005634; GO:0005829; GO:0008022; GO:0030544; GO:0032991; GO:0043209; GO:0051087; GO:0051879; GO:0098761; GO:0101031	chaperone complex [GO:0101031]; cytosol [GO:0005829]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; cellular response to interleukin-7 [GO:0098761]
PGEN_.00g024670	Scaffold_01	68330548	68330844	NA	NA	NA	NA	NA
PGEN_.00g024680	Scaffold_01	68342336	68345785	NA	NA	NA	NA	NA
PGEN_.00g024690	Scaffold_01	68347759	68362176	Q04592	PCSK5_MOUSE	Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (Subtilisin-like proprotein convertase 6) (SPC6) (Subtilisin/kexin-like protease PC5)	GO:0001822; GO:0002001; GO:0003279; GO:0004175; GO:0004252; GO:0005615; GO:0005788; GO:0005794; GO:0005797; GO:0005802; GO:0005886; GO:0006465; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030141; GO:0030173; GO:0030323; GO:0033625; GO:0035108; GO:0042089; GO:0042277; GO:0043043; GO:0043204; GO:0048566; GO:0048706; GO:0060976; GO:1904754; GO:1905609; GO:1990635; GO:2001046	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]
PGEN_.00g024700	Scaffold_01	68371838	68374012	O75339	CILP1_HUMAN	Cartilage intermediate layer protein 1 (CILP-1) (Cartilage intermediate-layer protein) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2]	GO:0005615; GO:0010629; GO:0016311; GO:0043569; GO:0060392; GO:0062023; GO:0070062; GO:0071560	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]
PGEN_.00g024710	Scaffold_01	68404016	68412133	NA	NA	NA	NA	NA
PGEN_.00g024720	Scaffold_01	68417370	68429159	Q8IUL8	CILP2_HUMAN	Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2]	GO:0016311; GO:0070062	extracellular exosome [GO:0070062]; dephosphorylation [GO:0016311]
PGEN_.00g024730	Scaffold_01	68433798	68445572	P29119	FURI1_XENLA	Furin-1 (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE)	GO:0004252; GO:0005576; GO:0005794; GO:0005886; GO:0010008; GO:0016021; GO:0046872; GO:1901394	endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; positive regulation of transforming growth factor beta1 activation [GO:1901394]
PGEN_.00g024740	Scaffold_01	68465001	68468778	Q91X17	UROM_MOUSE	"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]"	GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]
PGEN_.00g024750	Scaffold_01	68563872	68593941	NA	NA	NA	NA	NA
PGEN_.00g024760	Scaffold_01	68638204	68659974	Q68EK7	RAB4B_DANRE	Ras-related protein Rab-4B	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006886; GO:0030100; GO:0032482; GO:0032593	endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]
PGEN_.00g024770	Scaffold_01	68674954	68675561	NA	NA	NA	NA	NA
PGEN_.00g024780	Scaffold_01	68675827	68682022	NA	NA	NA	NA	NA
PGEN_.00g024790	Scaffold_01	68702337	68721210	NA	NA	NA	NA	NA
PGEN_.00g024800	Scaffold_01	68732597	68732941	NA	NA	NA	NA	NA
PGEN_.00g024810	Scaffold_01	68755368	68761722	NA	NA	NA	NA	NA
PGEN_.00g024820	Scaffold_01	68859922	68899720	Q13395	TARB1_HUMAN	Probable methyltransferase TARBP1 (EC 2.1.1.-) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185)	GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488	nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]
PGEN_.00g024830	Scaffold_01	68901755	68902024	NA	NA	NA	NA	NA
PGEN_.00g024840	Scaffold_01	68902083	68902763	NA	NA	NA	NA	NA
PGEN_.00g024850	Scaffold_01	68902946	68903428	NA	NA	NA	NA	NA
PGEN_.00g024860	Scaffold_01	68956918	68973766	Q9BXW4	MLP3C_HUMAN	Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C) (MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma)	GO:0000045; GO:0000421; GO:0000422; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0035973; GO:0036464; GO:0097352	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]
PGEN_.00g024870	Scaffold_01	68984699	69041883	Q1G7G9	TALD3_CHICK	TALPID3 protein	GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0044458; GO:0051642; GO:0060271; GO:0070201	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; regulation of establishment of protein localization [GO:0070201]; smoothened signaling pathway [GO:0007224]
PGEN_.00g024880	Scaffold_01	69067434	69068600	NA	NA	NA	NA	NA
PGEN_.00g024890	Scaffold_01	69089214	69090998	Q8K3X4	I2BPL_MOUSE	Probable E3 ubiquitin-protein ligase IRF2BPL (EC 2.3.2.27) (Enhanced at puberty protein 1) (Interferon regulatory factor 2-binding protein-like)	GO:0000122; GO:0000977; GO:0001228; GO:0005634; GO:0005654; GO:0007399; GO:0045944; GO:0046543; GO:0046872; GO:0061630	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g024900	Scaffold_01	69132186	69146407	NA	NA	NA	NA	NA
PGEN_.00g024910	Scaffold_01	69189710	69213901	Q9WVJ3	CBPQ_MOUSE	Carboxypeptidase Q (EC 3.4.17.-) (Hematopoietic lineage switch 2) (Plasma glutamate carboxypeptidase)	GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0006590; GO:0042246; GO:0042803; GO:0043171; GO:0043231; GO:0046872; GO:0070573	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246]
PGEN_.00g024920	Scaffold_01	69223580	69224346	NA	NA	NA	NA	NA
PGEN_.00g024930	Scaffold_01	69235527	69237950	P08953	TOLL_DROME	Protein toll	GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]
PGEN_.00g024940	Scaffold_01	69258419	69260299	NA	NA	NA	NA	NA
PGEN_.00g024950	Scaffold_01	69259485	69276406	Q17QK3	CBPQ_BOVIN	Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase)	GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0006590; GO:0042246; GO:0042803; GO:0043171; GO:0046872; GO:0070573	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246]
PGEN_.00g024960	Scaffold_01	69278011	69280314	Q6BK42	DDI1_DEBHA	DNA damage-inducible protein 1 (EC 3.4.23.-)	GO:0000149; GO:0004190; GO:0005737; GO:0005886; GO:0009306; GO:0043130; GO:0043328; GO:0045740; GO:0072710	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type endopeptidase activity [GO:0004190]; SNARE binding [GO:0000149]; ubiquitin binding [GO:0043130]; positive regulation of DNA replication [GO:0045740]; protein secretion [GO:0009306]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; response to hydroxyurea [GO:0072710]
PGEN_.00g024970	Scaffold_01	69285540	69289889	NA	NA	NA	NA	NA
PGEN_.00g024980	Scaffold_01	69290613	69295366	NA	NA	NA	NA	NA
PGEN_.00g024990	Scaffold_01	69298309	69300190	Q96KE9	BTBD6_HUMAN	BTB/POZ domain-containing protein 6 (Lens BTB domain protein)	GO:0005829; GO:0022008; GO:0043687	cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]
PGEN_.00g025000	Scaffold_01	69300223	69312901	NA	NA	NA	NA	NA
PGEN_.00g025010	Scaffold_01	69303890	69312961	NA	NA	NA	NA	NA
PGEN_.00g025020	Scaffold_01	69329022	69373103	NA	NA	NA	NA	NA
PGEN_.00g025030	Scaffold_01	69375893	69492472	Q8VHS2	CRUM1_MOUSE	Protein crumbs homolog 1	GO:0001917; GO:0005509; GO:0005886; GO:0005902; GO:0005913; GO:0007009; GO:0007157; GO:0016021; GO:0032991; GO:0042462; GO:0045197; GO:0061024	cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]
PGEN_.00g025040	Scaffold_01	69502178	69525759	Q0KK59	UNC79_MOUSE	Protein unc-79 homolog	GO:0016021; GO:0030534; GO:0035264; GO:0048149	integral component of membrane [GO:0016021]; adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]
PGEN_.00g025050	Scaffold_01	69528266	69580789	Q0KK59	UNC79_MOUSE	Protein unc-79 homolog	GO:0016021; GO:0030534; GO:0035264; GO:0048149	integral component of membrane [GO:0016021]; adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]
PGEN_.00g025060	Scaffold_01	69587602	69597834	Q6GLJ1	BTBDH_XENLA	BTB/POZ domain-containing protein 17	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g025070	Scaffold_01	69598315	69610312	Q9JJL8	SYSM_MOUSE	"Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	GO:0000049; GO:0004828; GO:0005524; GO:0005739; GO:0005759; GO:0006434; GO:0070158; GO:0097056	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]
PGEN_.00g025080	Scaffold_01	69614858	69622317	Q91981	OTX2_DANRE	Homeobox protein OTX2 (zOTX2) (Orthodenticle homolog 2)	GO:0003406; GO:0003700; GO:0005634; GO:0021549; GO:0030901; GO:0030902; GO:0030917; GO:0043565; GO:0097306	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cellular response to alcohol [GO:0097306]; cerebellum development [GO:0021549]; hindbrain development [GO:0030902]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; retinal pigment epithelium development [GO:0003406]
PGEN_.00g025090	Scaffold_01	69654982	69655332	NA	NA	NA	NA	NA
PGEN_.00g025100	Scaffold_01	69691912	69771035	Q8NDI1	EHBP1_HUMAN	EH domain-binding protein 1	GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006897; GO:0015031; GO:0030036; GO:0031941	cytosol [GO:0005829]; endosome [GO:0005768]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031]
PGEN_.00g025110	Scaffold_01	69812801	69825876	Q9UC07	ZNF69_HUMAN	Zinc finger protein 69 (hZNF3)	GO:0003700; GO:0005634; GO:0043565; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]
PGEN_.00g025120	Scaffold_01	69833817	69834089	NA	NA	NA	NA	NA
PGEN_.00g025130	Scaffold_01	69837562	69862202	NA	NA	NA	NA	NA
PGEN_.00g025140	Scaffold_01	69873331	69874600	NA	NA	NA	NA	NA
PGEN_.00g025150	Scaffold_01	69899430	69912456	NA	NA	NA	NA	NA
PGEN_.00g025160	Scaffold_01	69913484	69913783	NA	NA	NA	NA	NA
PGEN_.00g025170	Scaffold_01	69920006	69943084	Q1RM35	CFA36_DANRE	Cilia- and flagella-associated protein 36 (Coiled-coil domain-containing protein 104)	GO:0005634; GO:0005737; GO:0031514	cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]
PGEN_.00g025180	Scaffold_01	69958910	69959923	NA	NA	NA	NA	NA
PGEN_.00g025190	Scaffold_01	70000230	70000538	NA	NA	NA	NA	NA
PGEN_.00g025200	Scaffold_01	70000579	70000941	NA	NA	NA	NA	NA
PGEN_.00g025210	Scaffold_01	70001035	70001808	NA	NA	NA	NA	NA
PGEN_.00g025220	Scaffold_01	70001903	70002256	NA	NA	NA	NA	NA
PGEN_.00g025230	Scaffold_01	70008057	70008464	NA	NA	NA	NA	NA
PGEN_.00g025240	Scaffold_01	70008708	70009385	NA	NA	NA	NA	NA
PGEN_.00g025250	Scaffold_01	70009440	70009718	NA	NA	NA	NA	NA
PGEN_.00g025260	Scaffold_01	70009765	70010097	NA	NA	NA	NA	NA
PGEN_.00g025270	Scaffold_01	70010503	70010757	NA	NA	NA	NA	NA
PGEN_.00g025280	Scaffold_01	70025141	70025705	NA	NA	NA	NA	NA
PGEN_.00g025290	Scaffold_01	70027070	70034205	Q9QZH4	AAKB2_RAT	5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2)	GO:0004679; GO:0005634; GO:0005654; GO:0005737; GO:0005952; GO:0006633; GO:0016324; GO:0019899; GO:0019901; GO:0031588; GO:0042802; GO:0050790; GO:0120162	apical plasma membrane [GO:0016324]; cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of catalytic activity [GO:0050790]
PGEN_.00g025300	Scaffold_01	70035035	70044714	NA	NA	NA	NA	NA
PGEN_.00g025310	Scaffold_01	70054458	70078720	NA	NA	NA	NA	NA
PGEN_.00g025320	Scaffold_01	70188221	70203219	NA	NA	NA	NA	NA
PGEN_.00g025330	Scaffold_01	70203671	70222268	P52432	RPAC1_MOUSE	DNA-directed RNA polymerases I and III subunit RPAC1 (DNA-directed RNA polymerase I subunit C) (RNA polymerases I and III subunit AC1) (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide) (RPA40) (RPC40)	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005736; GO:0006360; GO:0006366; GO:0006383; GO:0046983	nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g025340	Scaffold_01	70245399	70245656	NA	NA	NA	NA	NA
PGEN_.00g025350	Scaffold_01	70261320	70274046	Q91048	PTK7_CHICK	Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7)	GO:0001736; GO:0003401; GO:0004713; GO:0005524; GO:0005911; GO:0007155; GO:0016021; GO:0016055	cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; cell adhesion [GO:0007155]; establishment of planar polarity [GO:0001736]; Wnt signaling pathway [GO:0016055]
PGEN_.00g025360	Scaffold_01	70286424	70286744	NA	NA	NA	NA	NA
PGEN_.00g025370	Scaffold_01	70297794	70300066	NA	NA	NA	NA	NA
PGEN_.00g025380	Scaffold_01	70329405	70404003	Q8BKG3	PTK7_MOUSE	Inactive tyrosine-protein kinase 7 (Protein chuzhoi) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7)	GO:0001736; GO:0001843; GO:0003281; GO:0003401; GO:0005886; GO:0005911; GO:0007155; GO:0007507; GO:0010976; GO:0016020; GO:0016021; GO:0016477; GO:0018108; GO:0031532; GO:0042060; GO:0045198; GO:0060026; GO:0060484; GO:0060976; GO:0071300; GO:0090103; GO:0090179; GO:0090263	cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin cytoskeleton reorganization [GO:0031532]; axis elongation [GO:0003401]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; convergent extension [GO:0060026]; coronary vasculature development [GO:0060976]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; lung-associated mesenchyme development [GO:0060484]; neural tube closure [GO:0001843]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuron projection development [GO:0010976]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]
PGEN_.00g025390	Scaffold_01	70407541	70407849	NA	NA	NA	NA	NA
PGEN_.00g025400	Scaffold_01	70408357	70410384	NA	NA	NA	NA	NA
PGEN_.00g025410	Scaffold_01	70414573	70435587	Q6R5J2	DISP1_DANRE	Protein dispatched homolog 1 (Protein chameleon)	GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016021; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839	integral component of membrane [GO:0016021]; adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224]
PGEN_.00g025420	Scaffold_01	70435632	70442030	NA	NA	NA	NA	NA
PGEN_.00g025430	Scaffold_01	70449572	70456768	O42282	RDS2_CHICK	Photoreceptor outer segment membrane glycoprotein 2 (CRDS2)	GO:0005887; GO:0007601	integral component of plasma membrane [GO:0005887]; visual perception [GO:0007601]
PGEN_.00g025440	Scaffold_01	70462602	70463090	NA	NA	NA	NA	NA
PGEN_.00g025450	Scaffold_01	70466293	70467306	Q3SZE9	TBCC_BOVIN	Tubulin-specific chaperone C (Tubulin-folding cofactor C) (CFC)	GO:0000902; GO:0003924; GO:0005737; GO:0005829; GO:0006457; GO:0007021; GO:0007023; GO:0015631; GO:0032391	cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]; cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]
PGEN_.00g025460	Scaffold_01	70472843	70502350	O95714	HERC2_HUMAN	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g025470	Scaffold_01	70503722	70508593	NA	NA	NA	NA	NA
PGEN_.00g025480	Scaffold_01	70564683	70591797	NA	NA	NA	NA	NA
PGEN_.00g025490	Scaffold_01	70591831	70606908	Q967D7	TUTL_DROME	Protein turtle	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0007414; GO:0007629; GO:0007638; GO:0008039; GO:0008344; GO:0016199; GO:0030424; GO:0030537; GO:0045467; GO:0048814; GO:0070593; GO:0098632	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal defasciculation [GO:0007414]; dendrite self-avoidance [GO:0070593]; flight behavior [GO:0007629]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; larval behavior [GO:0030537]; mechanosensory behavior [GO:0007638]; R7 cell development [GO:0045467]; regulation of dendrite morphogenesis [GO:0048814]; synaptic target recognition [GO:0008039]
PGEN_.00g025500	Scaffold_01	70627625	70633984	Q6ZWR6	SYNE1_MOUSE	Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1)	GO:0000932; GO:0002053; GO:0003779; GO:0005102; GO:0005521; GO:0005623; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005819; GO:0007030; GO:0007097; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0030496; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0043197; GO:0044327; GO:0045211; GO:0048260; GO:0048471; GO:0048814; GO:0051015; GO:0051642; GO:0061886; GO:0090286; GO:0090292; GO:0099149; GO:1902017; GO:1903353; GO:2001054	cell [GO:0005623]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; spindle [GO:0005819]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; centrosome localization [GO:0051642]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of cilium assembly [GO:1902017]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; spermatogenesis [GO:0007283]
PGEN_.00g025510	Scaffold_01	70634316	70712415	Q8NF91	SYNE1_HUMAN	Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1)	GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005623; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090286; GO:0090292	cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]
PGEN_.00g025520	Scaffold_01	70724715	70735910	NA	NA	NA	NA	NA
PGEN_.00g025530	Scaffold_01	70738879	70863837	Q8NF91	SYNE1_HUMAN	Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1)	GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005623; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090286; GO:0090292	cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]
PGEN_.00g025540	Scaffold_01	70863959	70869317	NA	NA	NA	NA	NA
PGEN_.00g025550	Scaffold_01	70878688	70882665	Q9H3P7	GCP60_HUMAN	"Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7) [Cleaved into: Golgi resident protein GCP60, N-terminally processed]"	GO:0000062; GO:0000139; GO:0005739; GO:0005794; GO:0006694; GO:0016020; GO:0016032; GO:0034237	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694]; viral process [GO:0016032]
PGEN_.00g025560	Scaffold_01	70908729	70912268	Q8BMP6	GCP60_MOUSE	Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7)	GO:0000062; GO:0000139; GO:0005739; GO:0005794; GO:0006694; GO:0034237	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694]
PGEN_.00g025570	Scaffold_01	70918268	70918585	NA	NA	NA	NA	NA
PGEN_.00g025580	Scaffold_01	70921106	70921411	NA	NA	NA	NA	NA
PGEN_.00g025590	Scaffold_01	70963391	70987958	Q13114	TRAF3_HUMAN	TNF receptor-associated factor 3 (EC 2.3.2.27) (CAP-1) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (LMP1-associated protein 1) (LAP1) (RING-type E3 ubiquitin transferase TRAF3)	GO:0001817; GO:0002224; GO:0004842; GO:0005164; GO:0005739; GO:0005768; GO:0005829; GO:0006915; GO:0007165; GO:0008063; GO:0008270; GO:0009898; GO:0016579; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032648; GO:0032991; GO:0033209; GO:0035631; GO:0035666; GO:0042981; GO:0045087; GO:0050688	CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]
PGEN_.00g025600	Scaffold_01	71001407	71092671	Q3V6T2	GRDN_HUMAN	Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1)	GO:0001932; GO:0001965; GO:0003779; GO:0005085; GO:0005154; GO:0005623; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0006260; GO:0006275; GO:0007264; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030142; GO:0030705; GO:0031122; GO:0031410; GO:0031682; GO:0031929; GO:0032148; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042803; GO:0043422; GO:0045724; GO:0045742; GO:0051959; GO:0061024; GO:0072660; GO:1903566	cell [GO:0005623]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; COPI-coated Golgi to ER transport vesicle [GO:0030142]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; epidermal growth factor receptor binding [GO:0005154]; G-protein alpha-subunit binding [GO:0001965]; G-protein gamma-subunit binding [GO:0031682]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; maintenance of protein location in plasma membrane [GO:0072660]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929]
PGEN_.00g025610	Scaffold_01	71113868	71134556	Q9US38	YFZ3_SCHPO	AB hydrolase superfamily protein C1039.03 (EC 3.-.-.-)	GO:0005634; GO:0005829; GO:0009056; GO:0016787	cytosol [GO:0005829]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; catabolic process [GO:0009056]
PGEN_.00g025620	Scaffold_01	71177087	71177629	NA	NA	NA	NA	NA
PGEN_.00g025630	Scaffold_01	71181779	71182688	NA	NA	NA	NA	NA
PGEN_.00g025640	Scaffold_01	71182830	71198502	NA	NA	NA	NA	NA
PGEN_.00g025650	Scaffold_01	71213144	71246848	Q95M12	LGMN_BOVIN	"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)"	GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0006624; GO:0032801; GO:0051603; GO:1901185	lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624]
PGEN_.00g025660	Scaffold_01	71247482	71255429	Q3TUU5	TEX30_MOUSE	Testis-expressed protein 30	GO:0005634; GO:0016787	nucleus [GO:0005634]; hydrolase activity [GO:0016787]
PGEN_.00g025670	Scaffold_01	71257826	71266025	Q56P03	EAPP_HUMAN	E2F-associated phosphoprotein (EAPP)	GO:0005634; GO:0005737; GO:0008284; GO:0032968; GO:0034244	cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]
PGEN_.00g025680	Scaffold_01	71271127	71288491	Q568K5	NAA40_DANRE	N-alpha-acetyltransferase 40 (EC 2.3.1.257) (N-acetyltransferase 11) (N-alpha-acetyltransferase D) (NatD)	GO:0005634; GO:0005737; GO:0006474; GO:0010485; GO:0043967; GO:0043968; GO:0043998; GO:0061187; GO:1990189	cytoplasm [GO:0005737]; nucleus [GO:0005634]; H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of chromatin silencing at rDNA [GO:0061187]
PGEN_.00g025690	Scaffold_01	71305305	71332434	Q9QW07	PLCB4_RAT	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4) (PLC-beta-4)"	GO:0004435; GO:0005509; GO:0005623; GO:0005634; GO:0005737; GO:0005790; GO:0007602; GO:0014069; GO:0016042; GO:0030425; GO:0032959; GO:0043267; GO:0048015; GO:0050804; GO:0051019; GO:0051209; GO:0098688; GO:0098794; GO:0098978	cell [GO:0005623]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; mitogen-activated protein kinase binding [GO:0051019]; phosphatidylinositol phospholipase C activity [GO:0004435]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of potassium ion transport [GO:0043267]; phosphatidylinositol-mediated signaling [GO:0048015]; phototransduction [GO:0007602]; release of sequestered calcium ion into cytosol [GO:0051209]
PGEN_.00g025700	Scaffold_01	71342833	71346067	NA	NA	NA	NA	NA
PGEN_.00g025710	Scaffold_01	71400875	71410075	Q9QW07	PLCB4_RAT	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4) (PLC-beta-4)"	GO:0004435; GO:0005509; GO:0005623; GO:0005634; GO:0005737; GO:0005790; GO:0007602; GO:0014069; GO:0016042; GO:0030425; GO:0032959; GO:0043267; GO:0048015; GO:0050804; GO:0051019; GO:0051209; GO:0098688; GO:0098794; GO:0098978	cell [GO:0005623]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; mitogen-activated protein kinase binding [GO:0051019]; phosphatidylinositol phospholipase C activity [GO:0004435]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of potassium ion transport [GO:0043267]; phosphatidylinositol-mediated signaling [GO:0048015]; phototransduction [GO:0007602]; release of sequestered calcium ion into cytosol [GO:0051209]
PGEN_.00g025720	Scaffold_01	71430827	71431213	NA	NA	NA	NA	NA
PGEN_.00g025730	Scaffold_01	71431863	71473039	Q9QW07	PLCB4_RAT	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4) (PLC-beta-4)"	GO:0004435; GO:0005509; GO:0005623; GO:0005634; GO:0005737; GO:0005790; GO:0007602; GO:0014069; GO:0016042; GO:0030425; GO:0032959; GO:0043267; GO:0048015; GO:0050804; GO:0051019; GO:0051209; GO:0098688; GO:0098794; GO:0098978	cell [GO:0005623]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; mitogen-activated protein kinase binding [GO:0051019]; phosphatidylinositol phospholipase C activity [GO:0004435]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of potassium ion transport [GO:0043267]; phosphatidylinositol-mediated signaling [GO:0048015]; phototransduction [GO:0007602]; release of sequestered calcium ion into cytosol [GO:0051209]
PGEN_.00g025740	Scaffold_01	71473286	71474391	NA	NA	NA	NA	NA
PGEN_.00g025750	Scaffold_01	71474910	71476315	NA	NA	NA	NA	NA
PGEN_.00g025760	Scaffold_01	71496771	71504935	Q9BPU9	B9D2_HUMAN	B9 domain-containing protein 2 (MKS1-related protein 2)	GO:0005634; GO:0005813; GO:0005829; GO:0016020; GO:0036038; GO:0036064; GO:0043015; GO:0060271; GO:0097711	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; gamma-tubulin binding [GO:0043015]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]
PGEN_.00g025770	Scaffold_01	71558656	71569386	Q5BKM6	NDUF7_XENTR	"Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)"	GO:0005739; GO:0019918; GO:0032981; GO:0035243	"mitochondrion [GO:0005739]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]"
PGEN_.00g025780	Scaffold_01	71569777	71604440	Q8R4A1	ERO1A_RAT	ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductase alpha) (Endoplasmic reticulum oxidoreductin-1-like protein) (Global ischemia-induced protein 11) (Oxidoreductin-1-L-alpha)	GO:0003756; GO:0005623; GO:0005783; GO:0005789; GO:0006457; GO:0010260; GO:0015035; GO:0016491; GO:0016671; GO:0018401; GO:0019471; GO:0022417; GO:0030198; GO:0030425; GO:0030968; GO:0034975; GO:0034976; GO:0045454; GO:0050873; GO:0051085; GO:0051209; GO:0055114; GO:0070059; GO:0071456	"cell [GO:0005623]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; 4-hydroxyproline metabolic process [GO:0019471]; animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]"
PGEN_.00g025790	Scaffold_01	71622107	71636800	O60478	G137B_HUMAN	Integral membrane protein GPR137B (Transmembrane 7 superfamily member 1 protein)	GO:0005765; GO:0005887; GO:0016020	integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]
PGEN_.00g025800	Scaffold_01	71646347	71657620	NA	NA	NA	NA	NA
PGEN_.00g025810	Scaffold_01	71669731	71669982	NA	NA	NA	NA	NA
PGEN_.00g025820	Scaffold_01	71670204	71670677	NA	NA	NA	NA	NA
PGEN_.00g025830	Scaffold_01	71671386	71674087	NA	NA	NA	NA	NA
PGEN_.00g025840	Scaffold_01	71686299	71691322	NA	NA	NA	NA	NA
PGEN_.00g025850	Scaffold_01	71696353	71701935	Q7ZWG6	PCFT_DANRE	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)	GO:0005542; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]
PGEN_.00g025860	Scaffold_01	71734285	71744252	A0JMD4	TPC2_DANRE	Two pore calcium channel protein 2 (Voltage-dependent calcium channel protein TPC2)	GO:0005245; GO:0005623; GO:0005764; GO:0005765; GO:0006939; GO:0014866; GO:0016021; GO:0019722; GO:0034765; GO:0072345; GO:2000290	cell [GO:0005623]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; regulation of ion transmembrane transport [GO:0034765]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939]
PGEN_.00g025870	Scaffold_01	71749520	71849558	A3KGS3	RGPA2_MOUSE	Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (P220)	GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0032484; GO:0032880; GO:0046982; GO:0051056; GO:0060178; GO:0090630	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; Ral protein signal transduction [GO:0032484]; regulation of exocyst localization [GO:0060178]; regulation of protein localization [GO:0032880]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g025880	Scaffold_01	71860206	71867010	Q8N5M4	TTC9C_HUMAN	Tetratricopeptide repeat protein 9C (TPR repeat protein 9C)		
PGEN_.00g025890	Scaffold_01	71867325	71877075	Q9UBQ5	EIF3K_HUMAN	Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28)	GO:0001732; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]
PGEN_.00g025900	Scaffold_01	71888568	71890151	NA	NA	NA	NA	NA
PGEN_.00g025910	Scaffold_01	71904732	71905025	NA	NA	NA	NA	NA
PGEN_.00g025920	Scaffold_01	71905221	71905856	NA	NA	NA	NA	NA
PGEN_.00g025930	Scaffold_01	71909149	71959304	Q8N8S7	ENAH_HUMAN	Protein enabled homolog	GO:0003779; GO:0005522; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007411; GO:0008154; GO:0017124; GO:0030027; GO:0030054; GO:0030175; GO:0045202; GO:0050699; GO:0070358	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]
PGEN_.00g025940	Scaffold_01	71965825	71967023	NA	NA	NA	NA	NA
PGEN_.00g025950	Scaffold_01	71967860	71968156	NA	NA	NA	NA	NA
PGEN_.00g025960	Scaffold_01	71968409	71968690	NA	NA	NA	NA	NA
PGEN_.00g025970	Scaffold_01	71968796	71969113	NA	NA	NA	NA	NA
PGEN_.00g025980	Scaffold_01	71970879	71971891	NA	NA	NA	NA	NA
PGEN_.00g025990	Scaffold_01	71979526	71994528	Q5U3G6	YIF1B_DANRE	Protein YIF1B (YIP1-interacting factor homolog B)	GO:0005789; GO:0005793; GO:0006888; GO:0030134; GO:0030173	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]
PGEN_.00g026000	Scaffold_01	72007606	72008304	NA	NA	NA	NA	NA
PGEN_.00g026010	Scaffold_01	72014236	72014739	NA	NA	NA	NA	NA
PGEN_.00g026020	Scaffold_01	72014794	72016239	NA	NA	NA	NA	NA
PGEN_.00g026030	Scaffold_01	72018567	72024369	Q24817	RACD_ENTHI	Rho-related protein racD (Fragment)	GO:0003924; GO:0005525; GO:0005886; GO:0007264	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g026040	Scaffold_01	72030312	72030599	NA	NA	NA	NA	NA
PGEN_.00g026050	Scaffold_01	72048678	72057170	NA	NA	NA	NA	NA
PGEN_.00g026060	Scaffold_01	72063992	72067527	NA	NA	NA	NA	NA
PGEN_.00g026070	Scaffold_01	72067867	72069403	NA	NA	NA	NA	NA
PGEN_.00g026080	Scaffold_01	72085046	72090154	Q53G44	IF44L_HUMAN	Interferon-induced protein 44-like	GO:0005525; GO:0005737; GO:0006955; GO:0051607	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]
PGEN_.00g026090	Scaffold_01	72094088	72096960	NA	NA	NA	NA	NA
PGEN_.00g026100	Scaffold_01	72098723	72107825	NA	NA	NA	NA	NA
PGEN_.00g026110	Scaffold_01	72135969	72145158	P27473	IFI44_PANTR	Interferon-induced protein 44 (Antigen p44) (Non-A non-B hepatitis-associated microtubular aggregates protein)	GO:0005737; GO:0006955; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]
PGEN_.00g026120	Scaffold_01	72195819	72196836	NA	NA	NA	NA	NA
PGEN_.00g026130	Scaffold_01	72206715	72207281	NA	NA	NA	NA	NA
PGEN_.00g026140	Scaffold_01	72207449	72207787	NA	NA	NA	NA	NA
PGEN_.00g026150	Scaffold_01	72221981	72223603	NA	NA	NA	NA	NA
PGEN_.00g026160	Scaffold_01	72227770	72232999	NA	NA	NA	NA	NA
PGEN_.00g026170	Scaffold_01	72237853	72282890	Q8MV48	GALT7_DROME	N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) (pp-GaNTase 7) (dGalNAc-T2)	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0012505; GO:0016021; GO:0030246; GO:0046872	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]
PGEN_.00g026180	Scaffold_01	72292116	72340617	P29119	FURI1_XENLA	Furin-1 (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE)	GO:0004252; GO:0005576; GO:0005794; GO:0005886; GO:0010008; GO:0016021; GO:0046872; GO:1901394	endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; positive regulation of transforming growth factor beta1 activation [GO:1901394]
PGEN_.00g026190	Scaffold_01	72370017	72466177	Q15643	TRIPB_HUMAN	Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230)	GO:0000139; GO:0002079; GO:0002081; GO:0003281; GO:0003413; GO:0003713; GO:0005623; GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0005929; GO:0006366; GO:0006486; GO:0016607; GO:0030133; GO:0033116; GO:0035735; GO:0051216; GO:0060122; GO:0090161; GO:0099041	cell [GO:0005623]; cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; transcription coactivator activity [GO:0003713]; cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport involved in cilium assembly [GO:0035735]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041]
PGEN_.00g026200	Scaffold_01	72490303	72537442	O77237	PELI_DROME	Protein pellino	GO:0000209; GO:0002225; GO:0004842; GO:0005829; GO:0008063; GO:0009898; GO:0019207; GO:0045087; GO:0045751; GO:0045752; GO:0061630; GO:0070936; GO:1900425; GO:1905035	cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; kinase regulator activity [GO:0019207]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; innate immune response [GO:0045087]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of Toll signaling pathway [GO:0045752]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; Toll signaling pathway [GO:0008063]
PGEN_.00g026210	Scaffold_01	72548577	72563277	NA	NA	NA	NA	NA
PGEN_.00g026220	Scaffold_01	72563420	72568517	Q8WV16	DCAF4_HUMAN	DDB1- and CUL4-associated factor 4 (WD repeat-containing protein 21A)	GO:0005654; GO:0016567; GO:0043687; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]
PGEN_.00g026230	Scaffold_01	72576374	72619305	B3EWZ3	CADN_ACRMI	Coadhesin (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g026240	Scaffold_01	72620758	72635006	G5ECS8	ADT1_CAEEL	A disintegrin and metalloproteinase with thrombospondin motifs adt-1 (ADAMTS adt-1) (EC 3.4.24.-)	GO:0004222; GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]
PGEN_.00g026250	Scaffold_01	72635466	72647248	Q0V9M0	CRAC1_XENTR	Cartilage acidic protein 1 (ASPIC)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g026260	Scaffold_01	72653637	72655938	Q8UCM8	UNG_AGRFC	Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)	GO:0004844; GO:0005737; GO:0006284	cytoplasm [GO:0005737]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]
PGEN_.00g026270	Scaffold_01	72684061	72687754	NA	NA	NA	NA	NA
PGEN_.00g026280	Scaffold_01	72689416	72708897	NA	NA	NA	NA	NA
PGEN_.00g026290	Scaffold_01	72719953	72735100	NA	NA	NA	NA	NA
PGEN_.00g026300	Scaffold_01	72736583	72759726	Q16706	MA2A1_HUMAN	"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062	"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]"
PGEN_.00g026310	Scaffold_01	72791082	72802302	P62861	RS30_HUMAN	40S ribosomal protein S30 (Small ribosomal subunit protein eS30)	GO:0000184; GO:0002227; GO:0003723; GO:0003735; GO:0005615; GO:0005654; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0015935; GO:0019083; GO:0019731; GO:0022627; GO:0050830; GO:0061844	"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
PGEN_.00g026320	Scaffold_01	72804598	72817969	Q2HJ46	RNF8_BOVIN	E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8)	GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0007049; GO:0007286; GO:0008270; GO:0010212; GO:0016567; GO:0030496; GO:0033522; GO:0033523; GO:0034244; GO:0035093; GO:0035861; GO:0042393; GO:0042803; GO:0043130; GO:0043486; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070535; GO:0070936	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g026330	Scaffold_01	72823271	72831654	NA	NA	NA	NA	NA
PGEN_.00g026340	Scaffold_01	72831689	72834040	NA	NA	NA	NA	NA
PGEN_.00g026350	Scaffold_01	72834876	72839730	NA	NA	NA	NA	NA
PGEN_.00g026360	Scaffold_01	72849181	72862637	Q9CWT6	DDX28_MOUSE	Probable ATP-dependent RNA helicase DDX28 (EC 3.6.4.13) (Mitochondrial DEAD box protein 28)	GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0019843; GO:0035770; GO:0042645; GO:1902775	cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; mitochondrial large ribosomal subunit assembly [GO:1902775]
PGEN_.00g026370	Scaffold_01	72873566	72885354	Q17R31	TATD3_HUMAN	Putative deoxyribonuclease TATDN3 (EC 3.1.21.-)	GO:0004518; GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g026380	Scaffold_01	72888061	72967811	F1MKX4	PSME4_BOVIN	Proteasome activator complex subunit 4 (Proteasome activator PA200)	GO:0005634; GO:0005829; GO:0006281; GO:0006974; GO:0007275; GO:0010499; GO:0016504; GO:0016607; GO:0035093; GO:0070577; GO:0070628; GO:1990111	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; multicellular organism development [GO:0007275]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"
PGEN_.00g026390	Scaffold_01	72980147	73044811	NA	NA	NA	NA	NA
PGEN_.00g026400	Scaffold_01	73061774	73062421	NA	NA	NA	NA	NA
PGEN_.00g026410	Scaffold_01	73068187	73068498	NA	NA	NA	NA	NA
PGEN_.00g026420	Scaffold_01	73068552	73069040	NA	NA	NA	NA	NA
PGEN_.00g026430	Scaffold_01	73069083	73069310	NA	NA	NA	NA	NA
PGEN_.00g026440	Scaffold_01	73069503	73069835	NA	NA	NA	NA	NA
PGEN_.00g026450	Scaffold_01	73140411	73140617	NA	NA	NA	NA	NA
PGEN_.00g026460	Scaffold_01	73165159	73195666	Q5UE96	KCNK1_RABIT	Potassium channel subfamily K member 1	GO:0005242; GO:0005267; GO:0005272; GO:0005887; GO:0016021; GO:0016324; GO:0022841; GO:0030054; GO:0030425; GO:0034705; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0045202; GO:0055037; GO:0060075; GO:0071805; GO:1902937	apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; perikaryon [GO:0043204]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synapse [GO:0045202]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]
PGEN_.00g026470	Scaffold_01	73201214	73201849	NA	NA	NA	NA	NA
PGEN_.00g026480	Scaffold_01	73209510	73233845	Q55E31	RB32B_DICDI	Ras-related protein Rab-32B	GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0016192; GO:0032482; GO:0042470	melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192]
PGEN_.00g026490	Scaffold_01	73247249	73247608	NA	NA	NA	NA	NA
PGEN_.00g026500	Scaffold_01	73264574	73273306	F4J0A8	P4H6_ARATH	Probable prolyl 4-hydroxylase 6 (AtP4H6) (EC 1.14.11.2)	GO:0004656; GO:0005506; GO:0005783; GO:0005789; GO:0016021; GO:0018401; GO:0031418	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]
PGEN_.00g026510	Scaffold_01	73286664	73287884	NA	NA	NA	NA	NA
PGEN_.00g026520	Scaffold_01	73300886	73307187	P35442	TSP2_HUMAN	Thrombospondin-2	GO:0005509; GO:0005576; GO:0005604; GO:0007155; GO:0008201; GO:0016525; GO:0031091; GO:0051965; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965]
PGEN_.00g026530	Scaffold_01	73316200	73325674	NA	NA	NA	NA	NA
PGEN_.00g026540	Scaffold_01	73425582	73430461	NA	NA	NA	NA	NA
PGEN_.00g026550	Scaffold_01	73442561	73452136	NA	NA	NA	NA	NA
PGEN_.00g026560	Scaffold_01	73468005	73469273	NA	NA	NA	NA	NA
PGEN_.00g026570	Scaffold_01	73472584	73483107	O45782	ARD17_CAEEL	Arrestin domain-containing protein 17 (Calcineurin-interacting protein 1)	GO:0007610; GO:0030346	protein phosphatase 2B binding [GO:0030346]; behavior [GO:0007610]
PGEN_.00g026580	Scaffold_01	73503355	73503872	NA	NA	NA	NA	NA
PGEN_.00g026590	Scaffold_01	73513407	73517236	NA	NA	NA	NA	NA
PGEN_.00g026600	Scaffold_01	73520175	73523840	P0C862	C1T9A_HUMAN	Complement C1q and tumor necrosis factor-related protein 9A (Complement C1q and tumor necrosis factor-related protein 9)	GO:0005179; GO:0005576; GO:0005581; GO:0042802	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]
PGEN_.00g026610	Scaffold_01	73561277	73570584	C0JB50	B1R2_LOXSN	Dermonecrotic toxin LspiSicTox-betaIE1ii (EC 4.6.1.-) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D) (Fragment)	GO:0005576; GO:0008081; GO:0009405; GO:0016042; GO:0016829; GO:0044179; GO:0046872; GO:0090729	extracellular region [GO:0005576]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]
PGEN_.00g026620	Scaffold_01	73570771	73573575	NA	NA	NA	NA	NA
PGEN_.00g026630	Scaffold_01	73582141	73583052	C0JB51	B1R_LOXAS	Dermonecrotic toxin LafSicTox-betaIE1 (EC 4.6.1.-) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D) (Fragment)	GO:0005576; GO:0008081; GO:0009405; GO:0016042; GO:0016829; GO:0044179; GO:0046872; GO:0090729	extracellular region [GO:0005576]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]
PGEN_.00g026640	Scaffold_01	73614255	73621934	Q9ESN4	C1QL3_MOUSE	Complement C1q-like protein 3 (C1q and tumor necrosis factor-related protein 13) (C1q/TNF-related protein 13) (CTRP13) (Gliacolin)	GO:0005576; GO:0005581; GO:0042802; GO:0050807	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]; regulation of synapse organization [GO:0050807]
PGEN_.00g026650	Scaffold_01	73623233	73677477	F8WLE0	KIF28_RAT	Kinesin-like protein KIF28P (Kinesin-like protein 6)	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0030705; GO:0031966; GO:0072384	kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]
PGEN_.00g026660	Scaffold_01	73687859	73697150	Q5VWZ2	LYPL1_HUMAN	Lysophospholipase-like protein 1 (EC 3.1.2.-)	GO:0002084; GO:0004622; GO:0005737; GO:0005829; GO:0008474; GO:0052689	cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084]
PGEN_.00g026670	Scaffold_01	73699254	73705010	Q8CHB8	TTLL5_MOUSE	Tubulin polyglutamylase TTLL5 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 5)	GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0016874; GO:0018095; GO:0030317; GO:0060041	centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]
PGEN_.00g026680	Scaffold_01	73708100	73758883	Q6EEF3	TTLL5_CHLAE	Tubulin polyglutamylase TTLL5 (EC 6.-.-.-) (SRC1 and TIF2-associated modulatory protein) (Tubulin--tyrosine ligase-like protein 5)	GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0005929; GO:0006464; GO:0016874	cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; cellular protein modification process [GO:0006464]
PGEN_.00g026690	Scaffold_01	73770754	73787865	Q69YW2	STUM_HUMAN	Protein stum homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g026700	Scaffold_01	73797188	73799948	Q8AXZ4	CNT1A_DANRE	Contactin-1a (F3/F11/contactin) (Neural cell recognition molecule F11)	GO:0005886; GO:0007155; GO:0031175; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; neuron projection development [GO:0031175]
PGEN_.00g026710	Scaffold_01	73816951	73817280	NA	NA	NA	NA	NA
PGEN_.00g026720	Scaffold_01	73824577	73841060	NA	NA	NA	NA	NA
PGEN_.00g026730	Scaffold_01	73919505	73925782	NA	NA	NA	NA	NA
PGEN_.00g026740	Scaffold_01	74013017	74018554	NA	NA	NA	NA	NA
PGEN_.00g026750	Scaffold_01	74042499	74048205	NA	NA	NA	NA	NA
PGEN_.00g026760	Scaffold_01	74067197	74068358	NA	NA	NA	NA	NA
PGEN_.00g026770	Scaffold_01	74076194	74098828	D4AR77	A6907_ARTBC	Uncharacterized secreted protein ARB_06907	GO:0005576; GO:0008236	extracellular region [GO:0005576]; serine-type peptidase activity [GO:0008236]
PGEN_.00g026780	Scaffold_01	74099254	74119591	A4IF87	GNPAT_BOVIN	Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)	GO:0005778; GO:0006631; GO:0006650; GO:0008611; GO:0008654; GO:0016287; GO:0031966	mitochondrial membrane [GO:0031966]; peroxisomal membrane [GO:0005778]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; phospholipid biosynthetic process [GO:0008654]
PGEN_.00g026790	Scaffold_01	74126407	74132654	P84339	CALM_AGABI	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g026800	Scaffold_01	74143072	74158843	P41041	CALM_PNECA	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g026810	Scaffold_01	74169832	74177632	P84339	CALM_AGABI	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g026820	Scaffold_01	74181283	74189590	Q9GRJ1	CALM_LUMRU	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g026830	Scaffold_01	74207923	74208351	NA	NA	NA	NA	NA
PGEN_.00g026840	Scaffold_01	74227898	74278041	NA	NA	NA	NA	NA
PGEN_.00g026850	Scaffold_01	74289783	74291414	NA	NA	NA	NA	NA
PGEN_.00g026860	Scaffold_01	74291479	74296846	Q95SX7	RTBS_DROME	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	GO:0003964; GO:0006313	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g026870	Scaffold_01	74298336	74298593	NA	NA	NA	NA	NA
PGEN_.00g026880	Scaffold_01	74303804	74304187	NA	NA	NA	NA	NA
PGEN_.00g026890	Scaffold_01	74304271	74304660	NA	NA	NA	NA	NA
PGEN_.00g026900	Scaffold_01	74312907	74313910	NA	NA	NA	NA	NA
PGEN_.00g026910	Scaffold_01	74354188	74366788	NA	NA	NA	NA	NA
PGEN_.00g026920	Scaffold_01	74369832	74453692	M9MRI4	TRIM9_DROME	E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (Anomalies in sensory axon patterning protein) (asap) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif containing protein 9)	GO:0004842; GO:0007409; GO:0007411; GO:0008270; GO:0016199; GO:0038007; GO:0043161; GO:0043204; GO:0044295; GO:0048749; GO:0048936; GO:0050770; GO:0090325	axonal growth cone [GO:0044295]; perikaryon [GO:0043204]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; netrin-activated signaling pathway [GO:0038007]; peripheral nervous system neuron axonogenesis [GO:0048936]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of axonogenesis [GO:0050770]; regulation of locomotion involved in locomotory behavior [GO:0090325]
PGEN_.00g026930	Scaffold_01	74460411	74467608	Q8CDR2	RSH6A_MOUSE	Radial spoke head protein 6 homolog A (Radial spoke head-like protein 1)	GO:0001534; GO:0005929; GO:0060271; GO:0060294	cilium [GO:0005929]; radial spoke [GO:0001534]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]
PGEN_.00g026940	Scaffold_01	74470022	74485461	Q8VEB2	SAV1_MOUSE	Protein salvador homolog 1 (45 kDa WW domain protein) (mWW45)	GO:0001942; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007165; GO:0030216; GO:0035329; GO:0042802; GO:0043065; GO:0045600; GO:0046620; GO:0050680; GO:0050821; GO:0051091; GO:0060044; GO:0060090; GO:0060412; GO:0060487; GO:0060575; GO:2000036	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; protein stabilization [GO:0050821]; regulation of organ growth [GO:0046620]; regulation of stem cell population maintenance [GO:2000036]; signal transduction [GO:0007165]; ventricular septum morphogenesis [GO:0060412]
PGEN_.00g026950	Scaffold_01	74491815	74492961	NA	NA	NA	NA	NA
PGEN_.00g026960	Scaffold_01	74493924	74498298	NA	NA	NA	NA	NA
PGEN_.00g026970	Scaffold_01	74527988	74535828	Q86IV5	CTNA_DICDI	Countin-1	GO:0005576; GO:0006110; GO:0007162; GO:0007275; GO:0010225; GO:0010754; GO:0030041; GO:0031157; GO:0032114; GO:0042593; GO:0043950; GO:0048870; GO:0098727	extracellular region [GO:0005576]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; glucose homeostasis [GO:0042593]; maintenance of cell number [GO:0098727]; multicellular organism development [GO:0007275]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cGMP-mediated signaling [GO:0010754]; positive regulation of cAMP-mediated signaling [GO:0043950]; regulation of aggregate size involved in sorocarp development [GO:0031157]; regulation of glucose-6-phosphatase activity [GO:0032114]; regulation of glycolytic process [GO:0006110]; response to UV-C [GO:0010225]
PGEN_.00g026980	Scaffold_01	74541793	74591327	Q8VCD5	MED17_MOUSE	Mediator of RNA polymerase II transcription subunit 17 (Cofactor required for Sp1 transcriptional activation subunit 6) (CRSP complex subunit 6) (Mediator complex subunit 17) (Thyroid hormone receptor-associated protein complex 80 kDa component)	GO:0000151; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006367; GO:0016567; GO:0016592; GO:0019827; GO:0030374; GO:0045893; GO:0045944; GO:0046966; GO:0061630; GO:0070847	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ubiquitin ligase complex [GO:0000151]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g026990	Scaffold_01	74615632	74645227	Q5HZQ9	PCX4_XENLA	Pecanex-like protein 4 (Pecanex homolog protein 4)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g027000	Scaffold_01	74667351	74685689	Q10471	GALT2_HUMAN	Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]	GO:0000139; GO:0002378; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030173; GO:0030246; GO:0032580; GO:0048471	endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g027010	Scaffold_01	74707666	74707917	NA	NA	NA	NA	NA
PGEN_.00g027020	Scaffold_01	74710371	74710628	NA	NA	NA	NA	NA
PGEN_.00g027030	Scaffold_01	74723234	74726805	P35846	FOLR1_MOUSE	Folate receptor alpha (FR-alpha) (Folate receptor 1) (Folate-binding protein 1)	GO:0001947; GO:0003147; GO:0003253; GO:0005542; GO:0005576; GO:0005634; GO:0005768; GO:0005903; GO:0006620; GO:0008144; GO:0015884; GO:0016020; GO:0016323; GO:0016324; GO:0017015; GO:0030136; GO:0031103; GO:0031362; GO:0031526; GO:0038023; GO:0046655; GO:0046658; GO:0048678; GO:0051870; GO:0060828; GO:0061626; GO:0061713; GO:0061714; GO:0071231; GO:1904447	anchored component of external side of plasma membrane [GO:0031362]; anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; folic acid receptor activity [GO:0061714]; methotrexate binding [GO:0051870]; signaling receptor activity [GO:0038023]; anterior neural tube closure [GO:0061713]; axon regeneration [GO:0031103]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cellular response to folic acid [GO:0071231]; folate import across plasma membrane [GO:1904447]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; heart looping [GO:0001947]; neural crest cell migration involved in heart formation [GO:0003147]; pharyngeal arch artery morphogenesis [GO:0061626]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to axon injury [GO:0048678]
PGEN_.00g027040	Scaffold_01	74729400	74729714	NA	NA	NA	NA	NA
PGEN_.00g027050	Scaffold_01	74850026	74850247	NA	NA	NA	NA	NA
PGEN_.00g027060	Scaffold_01	74866940	74887584	O95198	KLHL2_HUMAN	Kelch-like protein 2 (Actin-binding protein Mayven)	GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802; GO:0043687	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]
PGEN_.00g027070	Scaffold_01	74890149	74941234	Q8NHU2	CFA61_HUMAN	Cilia- and flagella-associated protein 61	GO:0003341; GO:0005930; GO:0031514; GO:0044782	axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341]; cilium organization [GO:0044782]
PGEN_.00g027080	Scaffold_01	74947331	74954656	Q5UQN4	YL432_MIMIV	Uncharacterized protein L432	GO:0016787	hydrolase activity [GO:0016787]
PGEN_.00g027090	Scaffold_01	75086166	75088944	NA	NA	NA	NA	NA
PGEN_.00g027100	Scaffold_01	75165411	75165683	NA	NA	NA	NA	NA
PGEN_.00g027110	Scaffold_01	75185234	75185602	NA	NA	NA	NA	NA
PGEN_.00g027120	Scaffold_01	75185901	75205081	P79937	MEIS1_XENLA	Homeobox protein Meis1 (XMeis1)	GO:0005634; GO:0005667; GO:0005737; GO:0014036; GO:0043565; GO:0045893; GO:0045944	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; sequence-specific DNA binding [GO:0043565]; neural crest cell fate specification [GO:0014036]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g027130	Scaffold_01	75205050	75205334	NA	NA	NA	NA	NA
PGEN_.00g027140	Scaffold_01	75237200	75336773	O14770	MEIS2_HUMAN	Homeobox protein Meis2 (Meis1-related protein 1)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003677; GO:0003700; GO:0003712; GO:0003714; GO:0006366; GO:0008134; GO:0008542; GO:0009612; GO:0031016; GO:0043565; GO:0045638; GO:0045931; GO:0045944; GO:0048471; GO:0070848; GO:0110024	"nuclear chromatin [GO:0000790]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542]"
PGEN_.00g027150	Scaffold_01	75369030	75383369	Q9H501	ESF1_HUMAN	ESF1 homolog (ABT1-associated protein)	GO:0003723; GO:0005615; GO:0005654; GO:0005730; GO:0006364	extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]
PGEN_.00g027160	Scaffold_01	75408287	75409222	NA	NA	NA	NA	NA
PGEN_.00g027170	Scaffold_01	75422362	75424270	Q505D1	ANR28_MOUSE	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK)	GO:0005654	nucleoplasm [GO:0005654]
PGEN_.00g027180	Scaffold_01	75431581	75442463	Q9CVD2	ATX3_MOUSE	Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1 homolog)	GO:0000226; GO:0001012; GO:0004407; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006511; GO:0006515; GO:0010810; GO:0016579; GO:0030036; GO:0031625; GO:0031966; GO:0034605; GO:0035520; GO:0035640; GO:0036459; GO:0042405; GO:0042802; GO:0043161; GO:0045104; GO:0051117; GO:0061578; GO:0070536; GO:0070932; GO:0071108; GO:0071218; GO:1904294; GO:1904379; GO:1990380	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; histone deacetylase activity [GO:0004407]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; RNA polymerase II regulatory region DNA binding [GO:0001012]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; exploration behavior [GO:0035640]; histone H3 deacetylation [GO:0070932]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g027190	Scaffold_01	75448478	75454743	NA	NA	NA	NA	NA
PGEN_.00g027200	Scaffold_01	75467772	75468314	NA	NA	NA	NA	NA
PGEN_.00g027210	Scaffold_01	75524711	75525265	NA	NA	NA	NA	NA
PGEN_.00g027220	Scaffold_01	75547165	75561519	Q4JIM4	PSN1_CHICK	Presenilin-1 (PS-1) (EC 3.4.23.-) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit]	GO:0000139; GO:0004175; GO:0005634; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005789; GO:0005790; GO:0005794; GO:0005886; GO:0005887; GO:0006509; GO:0006816; GO:0006915; GO:0007155; GO:0007219; GO:0007220; GO:0008013; GO:0009986; GO:0016021; GO:0016324; GO:0016485; GO:0030018; GO:0030054; GO:0030424; GO:0030426; GO:0031594; GO:0034205; GO:0035253; GO:0035556; GO:0042325; GO:0042500; GO:0042982; GO:0042987; GO:0043025; GO:0043066; GO:0043085; GO:0043198; GO:0045121; GO:0045296; GO:0048471; GO:0050435; GO:0051563; GO:0060828; GO:0070765	"apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; ciliary rootlet [GO:0035253]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; endopeptidase activity [GO:0004175]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; apoptotic process [GO:0006915]; calcium ion transport [GO:0006816]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of apoptotic process [GO:0043066]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of phosphorylation [GO:0042325]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]"
PGEN_.00g027230	Scaffold_01	75566900	75567528	Q9CZR2	NALD2_MOUSE	N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)	GO:0004180; GO:0005886; GO:0006508; GO:0008233; GO:0008237; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; peptidase activity [GO:0008233]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]
PGEN_.00g027240	Scaffold_01	75571967	75580536	NA	NA	NA	NA	NA
PGEN_.00g027250	Scaffold_01	75593307	75593636	NA	NA	NA	NA	NA
PGEN_.00g027260	Scaffold_01	75594388	75627708	Q5ZKA2	SYIM_CHICK	"Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)"	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005739; GO:0005759; GO:0006428; GO:0032543	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]
PGEN_.00g027270	Scaffold_01	75657109	75689952	O14686	KMT2D_HUMAN	Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.354) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)	GO:0000981; GO:0001555; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006342; GO:0006355; GO:0008284; GO:0033148; GO:0035097; GO:0042393; GO:0042800; GO:0043627; GO:0044212; GO:0044666; GO:0045652; GO:0045944; GO:0046872; GO:0048477; GO:0051568; GO:1904837	"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; beta-catenin-TCF complex assembly [GO:1904837]; chromatin silencing [GO:0006342]; histone H3-K4 methylation [GO:0051568]; oocyte growth [GO:0001555]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription, DNA-templated [GO:0006355]; response to estrogen [GO:0043627]"
PGEN_.00g027280	Scaffold_01	75690095	75695530	Q32M78	ZN699_HUMAN	Zinc finger protein 699 (Hangover homolog)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g027290	Scaffold_01	75735774	75750279	Q05481	ZNF91_HUMAN	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]"
PGEN_.00g027300	Scaffold_01	75756656	75782001	Q4V8F4	RABEK_RAT	Rab9 effector protein with kelch motifs	GO:0010008	endosome membrane [GO:0010008]
PGEN_.00g027310	Scaffold_01	75789796	75797103	NA	NA	NA	NA	NA
PGEN_.00g027320	Scaffold_01	75797981	75803999	NA	NA	NA	NA	NA
PGEN_.00g027330	Scaffold_01	75815754	75870728	Q6ZRR7	LRRC9_HUMAN	Leucine-rich repeat-containing protein 9		
PGEN_.00g027340	Scaffold_01	75880684	75887061	Q9Y276	BCS1_HUMAN	Mitochondrial chaperone BCS1 (h-BCS1) (BCS1-like protein)	GO:0005524; GO:0005739; GO:0005750; GO:0007005; GO:0016021; GO:0032981; GO:0033617; GO:0034551	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; mitochondrion organization [GO:0007005]
PGEN_.00g027350	Scaffold_01	75891742	75904899	Q32PI1	VRK1_BOVIN	Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005795; GO:0005819; GO:0006468; GO:0007049; GO:0018105; GO:0046777; GO:0051301; GO:0090166	cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]
PGEN_.00g027360	Scaffold_01	75907469	75943080	Q1L994	PPR37_DANRE	Protein phosphatase 1 regulatory subunit 37 (Leucine-rich repeat-containing protein 68)	GO:0004864; GO:0010923	protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g027370	Scaffold_01	75959485	75970568	Q6NUP7	PP4R4_HUMAN	Serine/threonine-protein phosphatase 4 regulatory subunit 4	GO:0001835; GO:0005737; GO:0005829; GO:0008287; GO:0019888; GO:0032515; GO:0080163	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287]; protein phosphatase regulator activity [GO:0019888]; blastocyst hatching [GO:0001835]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of protein serine/threonine phosphatase activity [GO:0080163]
PGEN_.00g027380	Scaffold_01	75979106	76045024	Q6NUP7	PP4R4_HUMAN	Serine/threonine-protein phosphatase 4 regulatory subunit 4	GO:0001835; GO:0005737; GO:0005829; GO:0008287; GO:0019888; GO:0032515; GO:0080163	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287]; protein phosphatase regulator activity [GO:0019888]; blastocyst hatching [GO:0001835]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of protein serine/threonine phosphatase activity [GO:0080163]
PGEN_.00g027390	Scaffold_01	76055218	76061012	NA	NA	NA	NA	NA
PGEN_.00g027400	Scaffold_01	76072824	76082678	NA	NA	NA	NA	NA
PGEN_.00g027410	Scaffold_01	76092655	76101147	P47173	YJ9J_YEAST	Uncharacterized protein YJR142W	GO:0044715	8-oxo-dGDP phosphatase activity [GO:0044715]
PGEN_.00g027420	Scaffold_01	76110993	76115709	NA	NA	NA	NA	NA
PGEN_.00g027430	Scaffold_01	76120878	76141998	Q8VEH8	ERLEC_MOUSE	Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin)	GO:0005788; GO:0030433; GO:0030970; GO:0051082; GO:1904153	"endoplasmic reticulum lumen [GO:0005788]; unfolded protein binding [GO:0051082]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g027440	Scaffold_01	76142297	76175107	Q28EW0	TM87A_XENTR	Transmembrane protein 87A	GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]
PGEN_.00g027450	Scaffold_01	76225756	76271808	Q9QZQ0	NPAS3_MOUSE	Neuronal PAS domain-containing protein 3 (Neuronal PAS3) (Basic-helix-loop-helix-PAS protein MOP6) (Member of PAS protein 6)	GO:0000981; GO:0001964; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007626; GO:0042711; GO:0045893; GO:0045944; GO:0046982	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; startle response [GO:0001964]"
PGEN_.00g027460	Scaffold_01	76280789	76290167	NA	NA	NA	NA	NA
PGEN_.00g027470	Scaffold_01	76306983	76307291	NA	NA	NA	NA	NA
PGEN_.00g027480	Scaffold_01	76313965	76316220	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g027490	Scaffold_01	76317533	76319058	NA	NA	NA	NA	NA
PGEN_.00g027500	Scaffold_01	76321420	76321632	NA	NA	NA	NA	NA
PGEN_.00g027510	Scaffold_01	76322083	76323378	NA	NA	NA	NA	NA
PGEN_.00g027520	Scaffold_01	76355401	76357077	NA	NA	NA	NA	NA
PGEN_.00g027530	Scaffold_01	76374378	76382260	NA	NA	NA	NA	NA
PGEN_.00g027540	Scaffold_01	76391977	76395748	NA	NA	NA	NA	NA
PGEN_.00g027550	Scaffold_01	76405950	76406243	NA	NA	NA	NA	NA
PGEN_.00g027560	Scaffold_01	76406295	76406693	NA	NA	NA	NA	NA
PGEN_.00g027570	Scaffold_01	76429912	76430178	NA	NA	NA	NA	NA
PGEN_.00g027580	Scaffold_01	76454100	76454360	NA	NA	NA	NA	NA
PGEN_.00g027590	Scaffold_01	76459510	76478571	Q08C93	ABD12_DANRE	Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-)	GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0010842; GO:0016021; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269]
PGEN_.00g027600	Scaffold_01	76487019	76491075	NA	NA	NA	NA	NA
PGEN_.00g027610	Scaffold_01	76497655	76503367	Q1LWJ6	ARPIN_DANRE	Arpin	GO:0030027; GO:0030336; GO:0033058; GO:0051126	lamellipodium [GO:0030027]; directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336]
PGEN_.00g027620	Scaffold_01	76508334	76515059	Q5RCS8	VATD_PONAB	V-type proton ATPase subunit D (V-ATPase subunit D) (Vacuolar proton pump subunit D)	GO:0005813; GO:0005929; GO:0006811; GO:0033176; GO:0042626; GO:0060271; GO:0061512	centrosome [GO:0005813]; cilium [GO:0005929]; proton-transporting V-type ATPase complex [GO:0033176]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cilium assembly [GO:0060271]; ion transport [GO:0006811]; protein localization to cilium [GO:0061512]
PGEN_.00g027630	Scaffold_01	76516383	76528791	Q60HF9	FUMH_MACFA	"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)"	GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0045239; GO:2001034	chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]
PGEN_.00g027640	Scaffold_01	76538209	76564135	Q9NX78	TM260_HUMAN	Transmembrane protein 260	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g027650	Scaffold_01	76572458	76576165	Q14697	GANAB_HUMAN	Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha)	GO:0003723; GO:0005788; GO:0005794; GO:0005975; GO:0006457; GO:0006491; GO:0016020; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0043231; GO:0070062; GO:0090599	"endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,3-alpha-glucosidase activity [GO:0033919]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein folding [GO:0006457]"
PGEN_.00g027660	Scaffold_01	76594482	76614824	P79403	GANAB_PIG	Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha)	GO:0005794; GO:0005975; GO:0006491; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0043231; GO:0090599	"glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,3-alpha-glucosidase activity [GO:0033919]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]"
PGEN_.00g027670	Scaffold_01	76627459	76634615	NA	NA	NA	NA	NA
PGEN_.00g027680	Scaffold_01	76674932	76675306	NA	NA	NA	NA	NA
PGEN_.00g027690	Scaffold_01	76675600	76675809	NA	NA	NA	NA	NA
PGEN_.00g027700	Scaffold_01	76717323	76731372	NA	NA	NA	NA	NA
PGEN_.00g027710	Scaffold_01	76774175	76776460	NA	NA	NA	NA	NA
PGEN_.00g027720	Scaffold_01	76776501	76781784	NA	NA	NA	NA	NA
PGEN_.00g027730	Scaffold_01	76800226	76807818	NA	NA	NA	NA	NA
PGEN_.00g027740	Scaffold_01	76821908	76830381	Q7TT28	REXO1_MOUSE	RNA exonuclease 1 homolog (EC 3.1.-.-) (Transcription elongation factor B polypeptide 3-binding protein 1)	GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]
PGEN_.00g027750	Scaffold_01	76847393	76849279	NA	NA	NA	NA	NA
PGEN_.00g027760	Scaffold_01	76857894	76873259	NA	NA	NA	NA	NA
PGEN_.00g027770	Scaffold_01	76887028	76892149	NA	NA	NA	NA	NA
PGEN_.00g027780	Scaffold_01	76896840	76899125	NA	NA	NA	NA	NA
PGEN_.00g027790	Scaffold_01	76908264	76916102	Q8IX06	GOR_HUMAN	Putative exonuclease GOR (EC 3.1.-.-) (Antigen GOR homolog) (RNA exonuclease 1 homolog-like 1)	GO:0003676; GO:0004527; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]
PGEN_.00g027800	Scaffold_01	76918151	76921900	NA	NA	NA	NA	NA
PGEN_.00g027810	Scaffold_01	76931860	76936118	NA	NA	NA	NA	NA
PGEN_.00g027820	Scaffold_01	76949322	76956895	Q0P4P2	FBCD1_XENTR	Fibrinogen C domain-containing protein 1	GO:0008061; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g027830	Scaffold_01	76961005	76968502	Q6IQE9	ALKB6_DANRE	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)	GO:0005634; GO:0005737; GO:0046872; GO:0051213	cytoplasm [GO:0005737]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]
PGEN_.00g027840	Scaffold_01	76968781	76992428	Q25BN1	DICER_CHICK	Endoribonuclease Dicer (EC 3.1.26.3)	GO:0003677; GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0016442; GO:0030422; GO:0030423; GO:0031054; GO:0046872; GO:0070578	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; apoptotic DNA fragmentation [GO:0006309]; pre-miRNA processing [GO:0031054]; production of siRNA involved in RNA interference [GO:0030422]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]
PGEN_.00g027850	Scaffold_01	77002052	77026390	P07307	ASGR2_HUMAN	Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2)	GO:0004873; GO:0005886; GO:0007166; GO:0016021; GO:0016032; GO:0018279; GO:0030246; GO:0030282; GO:0031647; GO:0044322; GO:0048471; GO:0055088	endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; bone mineralization [GO:0030282]; cell surface receptor signaling pathway [GO:0007166]; lipid homeostasis [GO:0055088]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; viral process [GO:0016032]
PGEN_.00g027860	Scaffold_01	77032225	77032611	NA	NA	NA	NA	NA
PGEN_.00g027870	Scaffold_01	77033026	77035682	NA	NA	NA	NA	NA
PGEN_.00g027880	Scaffold_01	77036422	77036736	NA	NA	NA	NA	NA
PGEN_.00g027890	Scaffold_01	77036786	77037763	NA	NA	NA	NA	NA
PGEN_.00g027900	Scaffold_01	77037829	77039946	NA	NA	NA	NA	NA
PGEN_.00g027910	Scaffold_01	77055545	77063151	Q9HCD6	TANC2_HUMAN	"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)"	GO:0001701; GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0098978; GO:0099092; GO:0099519	"axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; dense core granule cytoskeletal transport [GO:0099519]; in utero embryonic development [GO:0001701]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]"
PGEN_.00g027920	Scaffold_01	77076672	77082366	Q0IHH1	NAA30_XENLA	N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit)	GO:0004596; GO:0005634; GO:0005737; GO:0031417	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]
PGEN_.00g027930	Scaffold_01	77082491	77086798	Q2M2S5	COA6_BOVIN	Cytochrome c oxidase assembly factor 6 homolog	GO:0005507; GO:0005739; GO:0005758; GO:0005886; GO:0008535; GO:0042774; GO:0072492	host cell mitochondrial intermembrane space [GO:0072492]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; plasma membrane ATP synthesis coupled electron transport [GO:0042774]; respiratory chain complex IV assembly [GO:0008535]
PGEN_.00g027940	Scaffold_01	77096985	77097577	NA	NA	NA	NA	NA
PGEN_.00g027950	Scaffold_01	77097770	77126380	Q4V8V1	BM1LA_DANRE	Breast cancer metastasis-suppressor 1-like protein-A	GO:0000122; GO:0016575; GO:0042826; GO:0070822	Sin3-type complex [GO:0070822]; histone deacetylase binding [GO:0042826]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g027960	Scaffold_01	77126692	77139780	Q9VMU8	SENJU_DROME	UDP-galactose transporter senju	GO:0002225; GO:0005459; GO:0005794; GO:0005797; GO:0008643; GO:0030173; GO:0045751; GO:0045824; GO:0060050; GO:0072334	Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]; negative regulation of innate immune response [GO:0045824]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of protein glycosylation [GO:0060050]; UDP-galactose transmembrane transport [GO:0072334]
PGEN_.00g027970	Scaffold_01	77146170	77155265	NA	NA	NA	NA	NA
PGEN_.00g027980	Scaffold_01	77156656	77178851	NA	NA	NA	NA	NA
PGEN_.00g027990	Scaffold_01	77179183	77187672	NA	NA	NA	NA	NA
PGEN_.00g028000	Scaffold_01	77241338	77245019	Q94126	CES2_CAEEL	Cell death specification protein 2	GO:0000977; GO:0001012; GO:0003700; GO:0005634; GO:0006357; GO:0006915; GO:0043068; GO:1990837	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region DNA binding [GO:0001012]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; apoptotic process [GO:0006915]; positive regulation of programmed cell death [GO:0043068]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g028010	Scaffold_01	77247899	77249130	Q1LZH1	MARC2_BOVIN	Mitochondrial amidoxime reducing component 2 (mARC2) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2) (MOSC domain-containing protein 2) (Moco sulfurase C-terminal domain-containing protein 2)	GO:0005741; GO:0005777; GO:0008940; GO:0030151; GO:0030170; GO:0042126; GO:0043546	mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; nitrate metabolic process [GO:0042126]
PGEN_.00g028020	Scaffold_01	77251038	77260024	Q1LZH1	MARC2_BOVIN	Mitochondrial amidoxime reducing component 2 (mARC2) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2) (MOSC domain-containing protein 2) (Moco sulfurase C-terminal domain-containing protein 2)	GO:0005741; GO:0005777; GO:0008940; GO:0030151; GO:0030170; GO:0042126; GO:0043546	mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; nitrate metabolic process [GO:0042126]
PGEN_.00g028030	Scaffold_01	77385647	77411500	Q61830	MRC1_MOUSE	Macrophage mannose receptor 1 (MMR) (CD antigen CD206)	GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g028040	Scaffold_01	77412760	77429687	P41500	ACYP1_BOVIN	"Acylphosphatase-1 (EC 3.6.1.7) (Acylphosphatase, erythrocyte/testis isozyme) (Acylphosphatase, organ-common type isozyme) (Acylphosphate phosphohydrolase 1)"	GO:0003998	acylphosphatase activity [GO:0003998]
PGEN_.00g028050	Scaffold_01	77431949	77449601	P62193	PRS4_RAT	26S proteasome regulatory subunit 4 (P26s4) (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1)	GO:0000502; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008540; GO:0016020; GO:0016887; GO:0017025; GO:0022624; GO:0030163; GO:0036402; GO:1901215	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; negative regulation of neuron death [GO:1901215]; protein catabolic process [GO:0030163]"
PGEN_.00g028060	Scaffold_01	77460909	77481463	Q0VD27	ENOPH_BOVIN	"Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)"	GO:0000287; GO:0005634; GO:0005737; GO:0019284; GO:0019509; GO:0043715; GO:0043716; GO:0043874	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]"
PGEN_.00g028070	Scaffold_01	77482942	77521727	Q28298	RRBP1_CANLF	Ribosome-binding protein 1 (180 kDa ribosome receptor) (RRp)	GO:0007165; GO:0015031; GO:0030176	integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165]
PGEN_.00g028080	Scaffold_01	77528944	77531031	NA	NA	NA	NA	NA
PGEN_.00g028090	Scaffold_01	77537350	77574666	Q5R5C9	SCPDL_PONAB	Saccharopine dehydrogenase-like oxidoreductase (EC 1.-.-.-)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g028100	Scaffold_01	77582916	77640348	Q96JK4	HIPL1_HUMAN	HHIP-like protein 1	GO:0003824; GO:0005044; GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]; catalytic activity [GO:0003824]; scavenger receptor activity [GO:0005044]
PGEN_.00g028110	Scaffold_01	77668637	77673851	Q6PT52	CLCA1_MACMU	Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1)	GO:0005229; GO:0005615; GO:0005887; GO:0006816; GO:0008237; GO:0046872	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]
PGEN_.00g028120	Scaffold_01	77777285	77789891	Q14CN2	CLCA4_HUMAN	"Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form]"	GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0008237; GO:0016324; GO:0034220; GO:0046872	apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ion transmembrane transport [GO:0034220]
PGEN_.00g028130	Scaffold_01	77808360	77808689	NA	NA	NA	NA	NA
PGEN_.00g028140	Scaffold_01	77835921	77836829	Q9TUB5	CLCA1_PIG	Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (pCLCA1)	GO:0005229; GO:0005615; GO:0005887; GO:0006816; GO:0008237; GO:0046872	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]
PGEN_.00g028150	Scaffold_01	77837873	77841390	NA	NA	NA	NA	NA
PGEN_.00g028160	Scaffold_01	77851496	77855571	Q6Q473	CLA4A_MOUSE	"Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form]"	GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0006821; GO:0008237; GO:0015276; GO:0016324; GO:0046872	apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; chloride transport [GO:0006821]
PGEN_.00g028170	Scaffold_01	77866058	77872368	Q6PT52	CLCA1_MACMU	Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1)	GO:0005229; GO:0005615; GO:0005887; GO:0006816; GO:0008237; GO:0046872	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]
PGEN_.00g028180	Scaffold_01	77877467	77878744	NA	NA	NA	NA	NA
PGEN_.00g028190	Scaffold_01	77890225	77895934	NA	NA	NA	NA	NA
PGEN_.00g028200	Scaffold_01	77926340	77929661	NA	NA	NA	NA	NA
PGEN_.00g028210	Scaffold_01	77931326	77935330	NA	NA	NA	NA	NA
PGEN_.00g028220	Scaffold_01	77943392	77984064	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g028230	Scaffold_01	78049722	78085939	Q9H1A4	APC1_HUMAN	Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein)	GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007091; GO:0031145; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g028240	Scaffold_01	78087929	78092709	Q4KMC9	CA198_DANRE	Uncharacterized protein C1orf198 homolog		
PGEN_.00g028250	Scaffold_01	78107192	78123692	Q6PBN2	AIDA_DANRE	"Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist)"	GO:0009953; GO:0016020; GO:0035091; GO:0043496; GO:0043508; GO:0046329; GO:0048264; GO:2000016	membrane [GO:0016020]; phosphatidylinositol binding [GO:0035091]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; regulation of protein homodimerization activity [GO:0043496]
PGEN_.00g028260	Scaffold_01	78124254	78142945	Q07890	SOS2_HUMAN	Son of sevenless homolog 2 (SOS-2)	GO:0000786; GO:0003677; GO:0005085; GO:0005829; GO:0007186; GO:0007264; GO:0043065; GO:0046982; GO:0051056; GO:0051057	cytosol [GO:0005829]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g028270	Scaffold_01	78143629	78155092	Q62245	SOS1_MOUSE	Son of sevenless homolog 1 (SOS-1) (mSOS-1)	GO:0000786; GO:0001782; GO:0001942; GO:0002260; GO:0003007; GO:0003209; GO:0003344; GO:0003677; GO:0005085; GO:0005088; GO:0005737; GO:0005829; GO:0005886; GO:0007173; GO:0007264; GO:0007265; GO:0007296; GO:0014069; GO:0017124; GO:0033081; GO:0035264; GO:0042129; GO:0043025; GO:0045742; GO:0046579; GO:0046982; GO:0048011; GO:0048514; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:1904693; GO:2000973	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleosome [GO:0000786]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; SH3 domain binding [GO:0017124]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; heart trabecula morphogenesis [GO:0061384]; lymphocyte homeostasis [GO:0002260]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; roof of mouth development [GO:0060021]; small GTPase mediated signal transduction [GO:0007264]; vitellogenesis [GO:0007296]
PGEN_.00g028280	Scaffold_01	78164630	78265700	Q9JHU4	DYHC1_MOUSE	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	GO:0000278; GO:0002177; GO:0003341; GO:0005524; GO:0005623; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832	"axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell [GO:0005623]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]"
PGEN_.00g028290	Scaffold_01	78269282	78288943	Q09675	HSP32_SCHPO	Glutathione-independent glyoxalase hsp3102 (EC 4.2.1.130) (Glyoxalase 3 homolog 2) (Heat shock protein 31 homolog 2)	GO:0005634; GO:0005737; GO:0005829; GO:0019172; GO:1990748	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; glyoxalase III activity [GO:0019172]; cellular detoxification [GO:1990748]
PGEN_.00g028300	Scaffold_01	78297178	78309141	Q6AXQ2	EFC11_RAT	EF-hand calcium-binding domain-containing protein 11	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g028310	Scaffold_01	78309410	78335352	Q7TSL3	FBX11_RAT	F-box only protein 11	GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0007605; GO:0008270; GO:0016274; GO:0016567; GO:0042981	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g028320	Scaffold_01	78346822	78363990	B5XBI1	IF43A_SALSA	Intraflagellar transport protein 43 homolog A	GO:0005929; GO:0030991; GO:0035721; GO:0060271	cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]
PGEN_.00g028330	Scaffold_01	78368455	78385123	Q96L03	SPT17_HUMAN	Spermatogenesis-associated protein 17	GO:0005516; GO:0005737	cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]
PGEN_.00g028340	Scaffold_01	78385390	78389930	A6QQL5	CB073_BOVIN	Uncharacterized protein C2orf73 homolog		
PGEN_.00g028350	Scaffold_01	78391006	78391389	NA	NA	NA	NA	NA
PGEN_.00g028360	Scaffold_01	78397789	78413040	O43264	ZW10_HUMAN	Centromere/kinetochore protein zw10 homolog	GO:0000070; GO:0000132; GO:0000776; GO:0000777; GO:0000922; GO:0005623; GO:0005634; GO:0005783; GO:0005789; GO:0005828; GO:0005829; GO:0006888; GO:0006890; GO:0007030; GO:0007080; GO:0007093; GO:0007094; GO:0007096; GO:0015031; GO:0016020; GO:0019237; GO:0034501; GO:0051301; GO:0051321; GO:0065003; GO:0070939; GO:1990423	"cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; centromeric DNA binding [GO:0019237]; cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; mitotic cell cycle checkpoint [GO:0007093]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g028370	Scaffold_01	78491839	78492726	Q8X119	ACT_EXODE	Actin	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g028380	Scaffold_01	78493731	78493991	NA	NA	NA	NA	NA
PGEN_.00g028390	Scaffold_01	78496122	78508138	P49632	RL40_CAEEL	Ubiquitin-60S ribosomal protein L40 (CEP52) [Cleaved into: Ubiquitin; 60S ribosomal protein L40]	GO:0003735; GO:0005634; GO:0005737; GO:0006412; GO:0009949; GO:0016567; GO:0019941; GO:0022627; GO:0031386; GO:0031625	cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; modification-dependent protein catabolic process [GO:0019941]; polarity specification of anterior/posterior axis [GO:0009949]; protein ubiquitination [GO:0016567]; translation [GO:0006412]
PGEN_.00g028400	Scaffold_01	78524343	78533735	O35790	PIGL_RAT	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase (EC 3.5.1.89) (Phosphatidylinositol-glycan biosynthesis class L protein) (PIG-L)	GO:0000225; GO:0005783; GO:0005789; GO:0006506; GO:0016021	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; N-acetylglucosaminylphosphatidylinositol deacetylase activity [GO:0000225]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g028410	Scaffold_01	78545472	78546089	NA	NA	NA	NA	NA
PGEN_.00g028420	Scaffold_01	78548097	78578328	Q62130	PTN14_MOUSE	Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase PTP36)	GO:0001946; GO:0003712; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0008285; GO:0030971; GO:0046825	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; transcription coregulator activity [GO:0003712]; lymphangiogenesis [GO:0001946]; negative regulation of cell population proliferation [GO:0008285]; regulation of protein export from nucleus [GO:0046825]
PGEN_.00g028430	Scaffold_01	78580762	78596833	P62334	PRS10_MOUSE	26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42)	GO:0000502; GO:0005524; GO:0005634; GO:0008540; GO:0016234; GO:0016887; GO:0022624; GO:0030433; GO:0031597; GO:0042802; GO:0045899; GO:0090261	"cytosolic proteasome complex [GO:0031597]; inclusion body [GO:0016234]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g028440	Scaffold_01	78607903	78630407	Q6P116	RCOR2_DANRE	REST corepressor 2	GO:0003700; GO:0003714; GO:0005634; GO:0005667; GO:0008134; GO:0017053; GO:0044212	nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]
PGEN_.00g028450	Scaffold_01	78642041	78664651	Q80WT5	AFTIN_MOUSE	Aftiphilin	GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015031; GO:0030121; GO:0030276; GO:0032588; GO:0043231; GO:0046907	AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; intracellular transport [GO:0046907]; protein transport [GO:0015031]
PGEN_.00g028460	Scaffold_01	78693745	78695686	Q196V4	VF030_IIV3	Uncharacterized protein 106R	GO:0000723; GO:0003678; GO:0006281	DNA helicase activity [GO:0003678]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723]
PGEN_.00g028470	Scaffold_01	78761827	78762120	NA	NA	NA	NA	NA
PGEN_.00g028480	Scaffold_01	78768934	78800274	Q575T0	CYGB1_ORYLA	Cytoglobin-1	GO:0005344; GO:0005506; GO:0005737; GO:0019825; GO:0020037	cytoplasm [GO:0005737]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g028490	Scaffold_01	78862969	78871886	NA	NA	NA	NA	NA
PGEN_.00g028500	Scaffold_01	78966679	78971094	P58797	NXF1_COTJA	Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP)	GO:0003723; GO:0005634; GO:0005737; GO:0006406; GO:0016607	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]
PGEN_.00g028510	Scaffold_01	78971190	78972416	NA	NA	NA	NA	NA
PGEN_.00g028520	Scaffold_01	78986588	78989446	NA	NA	NA	NA	NA
PGEN_.00g028530	Scaffold_01	78989963	79005953	B1WB06	MET24_XENTR	Methyltransferase-like protein 24 (EC 2.1.1.-)	GO:0005576; GO:0008168; GO:0032259	extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g028540	Scaffold_01	78998286	78998750	NA	NA	NA	NA	NA
PGEN_.00g028550	Scaffold_01	79012876	79013166	NA	NA	NA	NA	NA
PGEN_.00g028560	Scaffold_01	79104014	79104310	NA	NA	NA	NA	NA
PGEN_.00g028570	Scaffold_01	79104394	79104777	NA	NA	NA	NA	NA
PGEN_.00g028580	Scaffold_01	79151844	79152056	NA	NA	NA	NA	NA
PGEN_.00g028590	Scaffold_01	79167499	79167990	NA	NA	NA	NA	NA
PGEN_.00g028600	Scaffold_01	79179498	79180690	NA	NA	NA	NA	NA
PGEN_.00g028610	Scaffold_01	79181568	79182008	NA	NA	NA	NA	NA
PGEN_.00g028620	Scaffold_01	79189384	79189932	NA	NA	NA	NA	NA
PGEN_.00g028630	Scaffold_01	79190071	79190382	NA	NA	NA	NA	NA
PGEN_.00g028640	Scaffold_01	79194580	79196164	NA	NA	NA	NA	NA
PGEN_.00g028650	Scaffold_01	79209613	79209822	NA	NA	NA	NA	NA
PGEN_.00g028660	Scaffold_01	79226535	79226951	NA	NA	NA	NA	NA
PGEN_.00g028670	Scaffold_01	79245437	79246467	NA	NA	NA	NA	NA
PGEN_.00g028680	Scaffold_01	79278085	79278372	NA	NA	NA	NA	NA
PGEN_.00g028690	Scaffold_01	79293467	79294787	NA	NA	NA	NA	NA
PGEN_.00g028700	Scaffold_01	79297333	79297920	NA	NA	NA	NA	NA
PGEN_.00g028710	Scaffold_01	79367016	79367309	NA	NA	NA	NA	NA
PGEN_.00g028720	Scaffold_01	79488506	79489573	Q8CIQ6	MTR1B_MOUSE	Melatonin receptor type 1B (Mel-1B-R) (Mel1b receptor)	GO:0004930; GO:0005623; GO:0005886; GO:0005887; GO:0007623; GO:0008502; GO:0010754; GO:0042593; GO:0042753; GO:0043524; GO:0046010; GO:0046676; GO:0050796; GO:0051481; GO:0051970; GO:0051971; GO:0097755; GO:0098908; GO:1902260	"cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502]; circadian rhythm [GO:0007623]; glucose homeostasis [GO:0042593]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908]"
PGEN_.00g028730	Scaffold_01	79500149	79501452	NA	NA	NA	NA	NA
PGEN_.00g028740	Scaffold_01	79541896	79542297	NA	NA	NA	NA	NA
PGEN_.00g028750	Scaffold_01	79601729	79602391	NA	NA	NA	NA	NA
PGEN_.00g028760	Scaffold_01	79662708	79662911	NA	NA	NA	NA	NA
PGEN_.00g028770	Scaffold_01	79663013	79663354	NA	NA	NA	NA	NA
PGEN_.00g028780	Scaffold_01	79706329	79707728	NA	NA	NA	NA	NA
PGEN_.00g028790	Scaffold_01	79723819	79735543	NA	NA	NA	NA	NA
PGEN_.00g028800	Scaffold_01	79736802	79737590	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g028810	Scaffold_01	79737693	79738073	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g028820	Scaffold_01	79751461	79752258	NA	NA	NA	NA	NA
PGEN_.00g028830	Scaffold_01	79759697	79760209	NA	NA	NA	NA	NA
PGEN_.00g028840	Scaffold_01	79767730	79768281	NA	NA	NA	NA	NA
PGEN_.00g028850	Scaffold_01	79768505	79771106	NA	NA	NA	NA	NA
PGEN_.00g028860	Scaffold_01	79771501	79772740	NA	NA	NA	NA	NA
PGEN_.00g028870	Scaffold_01	79772829	79773290	NA	NA	NA	NA	NA
PGEN_.00g028880	Scaffold_01	79773484	79774086	NA	NA	NA	NA	NA
PGEN_.00g028890	Scaffold_01	79774215	79774526	NA	NA	NA	NA	NA
PGEN_.00g028900	Scaffold_01	79774627	79775277	NA	NA	NA	NA	NA
PGEN_.00g028910	Scaffold_01	79775320	79776381	NA	NA	NA	NA	NA
PGEN_.00g028920	Scaffold_01	79776624	79777529	NA	NA	NA	NA	NA
PGEN_.00g028930	Scaffold_01	79777581	79778354	NA	NA	NA	NA	NA
PGEN_.00g028940	Scaffold_01	79778424	79778717	NA	NA	NA	NA	NA
PGEN_.00g028950	Scaffold_01	79778781	79779608	NA	NA	NA	NA	NA
PGEN_.00g028960	Scaffold_01	79779641	79780141	NA	NA	NA	NA	NA
PGEN_.00g028970	Scaffold_01	79780166	79780900	NA	NA	NA	NA	NA
PGEN_.00g028980	Scaffold_01	79780928	79781527	NA	NA	NA	NA	NA
PGEN_.00g028990	Scaffold_01	79781750	79782319	NA	NA	NA	NA	NA
PGEN_.00g029000	Scaffold_01	79796560	79798215	NA	NA	NA	NA	NA
PGEN_.00g029010	Scaffold_01	79840776	79844142	NA	NA	NA	NA	NA
PGEN_.00g029020	Scaffold_01	79856974	79857336	NA	NA	NA	NA	NA
PGEN_.00g029030	Scaffold_01	79861897	79862367	NA	NA	NA	NA	NA
PGEN_.00g029040	Scaffold_01	79862577	79863242	NA	NA	NA	NA	NA
PGEN_.00g029050	Scaffold_01	79870481	79875012	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g029060	Scaffold_01	79878898	79888782	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g029070	Scaffold_01	79898643	79906885	P0DP23	CALM1_HUMAN	Calmodulin-1	GO:0000165; GO:0000922; GO:0002027; GO:0002576; GO:0005509; GO:0005513; GO:0005576; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0005980; GO:0006936; GO:0007186; GO:0007223; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0019722; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0022400; GO:0030017; GO:0031432; GO:0031954; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0038095; GO:0043539; GO:0043647; GO:0044325; GO:0050999; GO:0051186; GO:0051343; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0097718; GO:1901844; GO:1902494	"calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; vesicle [GO:0031982]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; calcium-mediated signaling [GO:0019722]; cofactor metabolic process [GO:0051186]; detection of calcium ion [GO:0005513]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; glycogen catabolic process [GO:0005980]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; muscle contraction [GO:0006936]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to calcium ion [GO:0051592]; substantia nigra development [GO:0021762]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"
PGEN_.00g029080	Scaffold_01	79911574	79911816	NA	NA	NA	NA	NA
PGEN_.00g029090	Scaffold_01	79922839	79925607	NA	NA	NA	NA	NA
PGEN_.00g029100	Scaffold_01	79925949	79926257	NA	NA	NA	NA	NA
PGEN_.00g029110	Scaffold_01	79930399	79933573	NA	NA	NA	NA	NA
PGEN_.00g029120	Scaffold_01	79938646	79942197	NA	NA	NA	NA	NA
PGEN_.00g029130	Scaffold_01	79981242	79983243	NA	NA	NA	NA	NA
PGEN_.00g029140	Scaffold_01	80004954	80020185	Q501I9	DIRC2_XENTR	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	GO:0005765; GO:0016021; GO:0043231; GO:0055085	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]
PGEN_.00g029150	Scaffold_01	80029135	80029830	NA	NA	NA	NA	NA
PGEN_.00g029160	Scaffold_01	80083278	80084441	NA	NA	NA	NA	NA
PGEN_.00g029170	Scaffold_01	80107633	80108081	NA	NA	NA	NA	NA
PGEN_.00g029180	Scaffold_01	80150482	80150823	NA	NA	NA	NA	NA
PGEN_.00g029190	Scaffold_01	80164327	80168372	NA	NA	NA	NA	NA
PGEN_.00g029200	Scaffold_01	80173097	80177868	NA	NA	NA	NA	NA
PGEN_.00g029210	Scaffold_01	80197837	80223917	NA	NA	NA	NA	NA
PGEN_.00g029220	Scaffold_01	80232312	80238661	Q3TDN0	DISP1_MOUSE	Protein dispatched homolog 1 (Mdispa)	GO:0007225; GO:0007368; GO:0009880; GO:0009953; GO:0015833; GO:0016021; GO:0060539; GO:1904680	integral component of membrane [GO:0016021]; peptide transmembrane transporter activity [GO:1904680]; determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]
PGEN_.00g029230	Scaffold_01	80283358	80335940	Q8TAE6	PP14C_HUMAN	Protein phosphatase 1 regulatory subunit 14C (Kinase-enhanced PP1 inhibitor) (PKC-potentiated PP1 inhibitory protein) (Serologically defined breast cancer antigen NY-BR-81)	GO:0004865; GO:0005737; GO:0016020; GO:0042325	cytoplasm [GO:0005737]; membrane [GO:0016020]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; regulation of phosphorylation [GO:0042325]
PGEN_.00g029240	Scaffold_01	80336882	80352069	Q86VZ4	LRP11_HUMAN	Low-density lipoprotein receptor-related protein 11 (LRP-11)	GO:0005886; GO:0009408; GO:0009409; GO:0009414; GO:0009612; GO:0016021; GO:0033555; GO:0035902; GO:0042594; GO:0051219	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414]
PGEN_.00g029250	Scaffold_01	80362384	80362815	NA	NA	NA	NA	NA
PGEN_.00g029260	Scaffold_01	80363182	80374408	P22061	PIMT_HUMAN	Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)	GO:0004719; GO:0005737; GO:0005829; GO:0006479; GO:0030091; GO:0045296; GO:0070062; GO:1903561	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; cadherin binding [GO:0045296]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]; protein methylation [GO:0006479]; protein repair [GO:0030091]
PGEN_.00g029270	Scaffold_01	80402053	80409290	NA	NA	NA	NA	NA
PGEN_.00g029280	Scaffold_01	80464128	80502888	Q9ULL1	PKHG1_HUMAN	Pleckstrin homology domain-containing family G member 1	GO:0005085; GO:0005654	nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]
PGEN_.00g029290	Scaffold_01	80510262	80514226	L7YAI7	B4GA1_DANRE	"Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)"	GO:0000139; GO:0005794; GO:0006486; GO:0015020; GO:0016021; GO:0035269; GO:0046872; GO:0048747	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; muscle fiber development [GO:0048747]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]
PGEN_.00g029300	Scaffold_01	80520203	80522461	NA	NA	NA	NA	NA
PGEN_.00g029310	Scaffold_01	80526688	80531776	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g029320	Scaffold_01	80534309	80535601	NA	NA	NA	NA	NA
PGEN_.00g029330	Scaffold_01	80550308	80553987	NA	NA	NA	NA	NA
PGEN_.00g029340	Scaffold_01	80563308	80570075	NA	NA	NA	NA	NA
PGEN_.00g029350	Scaffold_01	80584261	80584869	NA	NA	NA	NA	NA
PGEN_.00g029360	Scaffold_01	80586477	80587058	NA	NA	NA	NA	NA
PGEN_.00g029370	Scaffold_01	80591397	80628284	NA	NA	NA	NA	NA
PGEN_.00g029380	Scaffold_01	80638142	80652504	Q96M20	CNBD2_HUMAN	Cyclic nucleotide-binding domain-containing protein 2	GO:0005829; GO:0007283; GO:0030552	cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
PGEN_.00g029390	Scaffold_01	80736142	80739441	NA	NA	NA	NA	NA
PGEN_.00g029400	Scaffold_01	80761192	80833763	P35546	RET_MOUSE	Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]	GO:0000165; GO:0000187; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0005887; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042493; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241	"axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]"
PGEN_.00g029410	Scaffold_01	80842242	80842526	NA	NA	NA	NA	NA
PGEN_.00g029420	Scaffold_01	80854706	80886177	O88508	DNM3A_MOUSE	DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (DNA methyltransferase MmuIIIA) (DNA MTase MmuIIIA) (M.MmuIIIA)	GO:0000122; GO:0000278; GO:0000775; GO:0000791; GO:0000792; GO:0000978; GO:0001741; GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0005654; GO:0005720; GO:0005737; GO:0006306; GO:0006346; GO:0006349; GO:0007283; GO:0007568; GO:0008134; GO:0008168; GO:0010212; GO:0010216; GO:0010288; GO:0010942; GO:0016363; GO:0030182; GO:0032355; GO:0032776; GO:0033189; GO:0042220; GO:0042802; GO:0043045; GO:0043046; GO:0044027; GO:0046872; GO:0051719; GO:0071230; GO:0071361; GO:0071456; GO:0097284	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear heterochromatin [GO:0005720]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; XY body [GO:0001741]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA (cytosine-5-)-methyltransferase activity, acting on CpN substrates [GO:0051719]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; aging [GO:0007568]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; DNA methylation on cytosine [GO:0032776]; hepatocyte apoptotic process [GO:0097284]; hypermethylation of CpG island [GO:0044027]; maintenance of DNA methylation [GO:0010216]; methylation-dependent chromatin silencing [GO:0006346]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of cell death [GO:0010942]; regulation of gene expression by genetic imprinting [GO:0006349]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to vitamin A [GO:0033189]; spermatogenesis [GO:0007283]"
PGEN_.00g029430	Scaffold_01	80898880	80901911	P0DPH8	TBA3D_HUMAN	Tubulin alpha-3D chain (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g029440	Scaffold_01	80902424	80905529	NA	NA	NA	NA	NA
PGEN_.00g029450	Scaffold_01	80905591	80906299	NA	NA	NA	NA	NA
PGEN_.00g029460	Scaffold_01	80906399	80932632	B2GV47	RADX_RAT	RPA-related protein RADX	GO:0003697; GO:0005657; GO:2000042	replication fork [GO:0005657]; single-stranded DNA binding [GO:0003697]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]
PGEN_.00g029470	Scaffold_01	80960786	80961145	NA	NA	NA	NA	NA
PGEN_.00g029480	Scaffold_01	80961552	81044457	Q2PZL6	FAT4_MOUSE	Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
PGEN_.00g029490	Scaffold_01	81060043	81073988	Q80V70	MEGF6_MOUSE	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	GO:0005509; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]
PGEN_.00g029500	Scaffold_01	81097492	81104346	Q3T001	H17B6_BOVIN	17-beta-hydroxysteroid dehydrogenase type 6 (17-beta-HSD 6) (17-beta-HSD6) (EC 1.1.1.105) (EC 1.1.1.239) (EC 1.1.1.62) (3-alpha->beta-hydroxysteroid epimerase) (3-alpha->beta-HSE) (Oxidative 3-alpha hydroxysteroid dehydrogenase)	GO:0004303; GO:0004745; GO:0005789; GO:0008202; GO:0047035	endoplasmic reticulum membrane [GO:0005789]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; steroid metabolic process [GO:0008202]
PGEN_.00g029510	Scaffold_01	81125612	81140996	P55083	MFAP4_HUMAN	Microfibril-associated glycoprotein 4	GO:0001527; GO:0005576; GO:0007155; GO:0009650; GO:0010712; GO:0048251; GO:0062023; GO:0071493; GO:0071953; GO:0097435	collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular region [GO:0005576]; microfibril [GO:0001527]; cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; supramolecular fiber organization [GO:0097435]; UV protection [GO:0009650]
PGEN_.00g029520	Scaffold_01	81150254	81163624	O75897	ST1C4_HUMAN	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]
PGEN_.00g029530	Scaffold_01	81170064	81170852	NA	NA	NA	NA	NA
PGEN_.00g029540	Scaffold_01	81185702	81187789	NA	NA	NA	NA	NA
PGEN_.00g029550	Scaffold_01	81204803	81207979	NA	NA	NA	NA	NA
PGEN_.00g029560	Scaffold_01	81211671	81215067	NA	NA	NA	NA	NA
PGEN_.00g029570	Scaffold_01	81224876	81259362	Q9VMA7	TGO1_DROME	Transport and Golgi organization protein 1	GO:0000137; GO:0000139; GO:0005794; GO:0006887; GO:0007030; GO:0009306; GO:0012505; GO:0016021; GO:0033363; GO:0051047; GO:0070971	endomembrane system [GO:0012505]; endoplasmic reticulum exit site [GO:0070971]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; positive regulation of secretion [GO:0051047]; protein secretion [GO:0009306]; secretory granule organization [GO:0033363]
PGEN_.00g029580	Scaffold_01	81278528	81295998	Q6DIZ0	3HAO_XENTR	"3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6) (3-hydroxyanthranilate oxygenase) (3-HAO) (3-hydroxyanthranilic acid dioxygenase) (HAD)"	GO:0000334; GO:0005737; GO:0005829; GO:0006569; GO:0008198; GO:0009435; GO:0019805; GO:0034354; GO:0043420; GO:0046874	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3-hydroxyanthranilate 3,4-dioxygenase activity [GO:0000334]; ferrous iron binding [GO:0008198]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; NAD biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; tryptophan catabolic process [GO:0006569]"
PGEN_.00g029590	Scaffold_01	81312974	81328624	Q9GKX6	GALM_PIG	Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase)	GO:0004034; GO:0005737; GO:0006006; GO:0030246; GO:0033499	cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]
PGEN_.00g029600	Scaffold_01	81330835	81335291	NA	NA	NA	NA	NA
PGEN_.00g029610	Scaffold_01	81381905	81382333	NA	NA	NA	NA	NA
PGEN_.00g029620	Scaffold_01	81394788	81406123	NA	NA	NA	NA	NA
PGEN_.00g029630	Scaffold_01	81409021	81422954	Q61412	VSX2_MOUSE	Visual system homeobox 2 (Ceh-10 homeodomain-containing homolog) (Homeobox protein CHX10)	GO:0005634; GO:0005737; GO:0007601; GO:0008284; GO:0008285; GO:0043010; GO:0043565; GO:0045165; GO:0045944; GO:0050896; GO:0060040; GO:0060042	cytoplasm [GO:0005737]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; camera-type eye development [GO:0043010]; cell fate commitment [GO:0045165]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to stimulus [GO:0050896]; retina morphogenesis in camera-type eye [GO:0060042]; retinal bipolar neuron differentiation [GO:0060040]; visual perception [GO:0007601]
PGEN_.00g029640	Scaffold_01	81442251	81447723	NA	NA	NA	NA	NA
PGEN_.00g029650	Scaffold_01	81504280	81507743	NA	NA	NA	NA	NA
PGEN_.00g029660	Scaffold_01	81520449	81525771	NA	NA	NA	NA	NA
PGEN_.00g029670	Scaffold_01	81527053	81537557	NA	NA	NA	NA	NA
PGEN_.00g029680	Scaffold_01	81542186	81555839	NA	NA	NA	NA	NA
PGEN_.00g029690	Scaffold_01	81558272	81575243	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g029700	Scaffold_01	81588639	81618414	NA	NA	NA	NA	NA
PGEN_.00g029710	Scaffold_01	81646816	81650780	NA	NA	NA	NA	NA
PGEN_.00g029720	Scaffold_01	81654415	81662635	Q91X17	UROM_MOUSE	"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]"	GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]
PGEN_.00g029730	Scaffold_01	81668820	81688390	Q70E20	SNED1_MOUSE	"Sushi, nidogen and EGF-like domain-containing protein 1 (Secreted protein SST-3) (Stromal nidogen extracellular matrix protein)"	GO:0005112; GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160]
PGEN_.00g029740	Scaffold_01	81698327	81709108	NA	NA	NA	NA	NA
PGEN_.00g029750	Scaffold_01	81711485	81735619	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g029760	Scaffold_01	81740361	81752084	Q91X17	UROM_MOUSE	"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]"	GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]
PGEN_.00g029770	Scaffold_01	81762966	81770704	NA	NA	NA	NA	NA
PGEN_.00g029780	Scaffold_01	81774871	81775833	NA	NA	NA	NA	NA
PGEN_.00g029790	Scaffold_01	81806669	81808051	NA	NA	NA	NA	NA
PGEN_.00g029800	Scaffold_01	81817994	81820856	NA	NA	NA	NA	NA
PGEN_.00g029810	Scaffold_01	81823025	81823294	Q2TL60	ZN667_MOUSE	Zinc finger protein 667 (Myocardial ischemic preconditioning up-regulated protein 1)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g029820	Scaffold_01	81823810	81825038	NA	NA	NA	NA	NA
PGEN_.00g029830	Scaffold_01	81844213	81864228	Q9P109	GCNT4_HUMAN	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102) (Core 2-branching enzyme 3) (Core2-GlcNAc-transferase 3) (C2GnT3)"	GO:0000139; GO:0002121; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0016021; GO:0016266; GO:0042403; GO:0048729; GO:0048872; GO:0060993	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]"
PGEN_.00g029840	Scaffold_01	81876207	81876662	NA	NA	NA	NA	NA
PGEN_.00g029850	Scaffold_01	81876726	81877058	NA	NA	NA	NA	NA
PGEN_.00g029860	Scaffold_01	81877805	81878092	NA	NA	NA	NA	NA
PGEN_.00g029870	Scaffold_01	81904148	81915297	NA	NA	NA	NA	NA
PGEN_.00g029880	Scaffold_01	81929005	81937124	P56282	DPOE2_HUMAN	DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)	GO:0000082; GO:0003677; GO:0003887; GO:0005654; GO:0006260; GO:0006261; GO:0006270; GO:0006281; GO:0008622; GO:0016604; GO:0032201; GO:0042276; GO:0043231	epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]
PGEN_.00g029890	Scaffold_01	81942695	81944527	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g029900	Scaffold_01	81949458	81962312	A7YWS7	DPOE2_BOVIN	DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)	GO:0003677; GO:0003887; GO:0006261; GO:0008622; GO:0042276	epsilon DNA polymerase complex [GO:0008622]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]
PGEN_.00g029910	Scaffold_01	81968659	81981008	Q9JI19	FIBP_MOUSE	Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein)	GO:0005634; GO:0012505; GO:0016020; GO:0016607; GO:0017134	endomembrane system [GO:0012505]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]
PGEN_.00g029920	Scaffold_01	81992897	81993265	NA	NA	NA	NA	NA
PGEN_.00g029930	Scaffold_01	81993504	81993791	NA	NA	NA	NA	NA
PGEN_.00g029940	Scaffold_01	81999150	81999958	NA	NA	NA	NA	NA
PGEN_.00g029950	Scaffold_01	82011344	82017882	NA	NA	NA	NA	NA
PGEN_.00g029960	Scaffold_01	82017945	82018469	NA	NA	NA	NA	NA
PGEN_.00g029970	Scaffold_01	82018705	82019487	NA	NA	NA	NA	NA
PGEN_.00g029980	Scaffold_01	82024587	82024910	NA	NA	NA	NA	NA
PGEN_.00g029990	Scaffold_01	82025268	82025501	NA	NA	NA	NA	NA
PGEN_.00g030000	Scaffold_01	82025837	82026205	NA	NA	NA	NA	NA
PGEN_.00g030010	Scaffold_01	82035651	82050664	P29617	PROS_DROME	Homeobox protein prospero	GO:0000122; GO:0001227; GO:0001708; GO:0001754; GO:0002052; GO:0003677; GO:0003700; GO:0005634; GO:0005886; GO:0005938; GO:0006355; GO:0007399; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007409; GO:0007411; GO:0007416; GO:0007417; GO:0007419; GO:0007420; GO:0007422; GO:0007423; GO:0007465; GO:0007619; GO:0008049; GO:0008104; GO:0008285; GO:0008356; GO:0010001; GO:0010468; GO:0010628; GO:0010629; GO:0014016; GO:0042673; GO:0042676; GO:0043565; GO:0043697; GO:0045165; GO:0045178; GO:0045179; GO:0045180; GO:0045664; GO:0045676; GO:0045944; GO:0048813; GO:0050771; GO:0050909; GO:0051090; GO:0055059; GO:0055060; GO:0060385; GO:0061564; GO:0070314; GO:0070983; GO:1900180; GO:1902692	"apical cortex [GO:0045179]; basal cortex [GO:0045180]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division [GO:0055059]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; brain development [GO:0007420]; cell dedifferentiation [GO:0043697]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; compound eye cone cell fate commitment [GO:0042676]; courtship behavior [GO:0007619]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; eye photoreceptor cell differentiation [GO:0001754]; G1 to G0 transition [GO:0070314]; ganglion mother cell fate determination [GO:0007402]; glial cell differentiation [GO:0010001]; male courtship behavior [GO:0008049]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; R7 cell fate commitment [GO:0007465]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron differentiation [GO:0045664]; regulation of protein localization to nucleus [GO:1900180]; regulation of R7 cell differentiation [GO:0045676]; regulation of retinal cone cell fate specification [GO:0042673]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sensory perception of taste [GO:0050909]; synapse assembly [GO:0007416]; ventral cord development [GO:0007419]"
PGEN_.00g030020	Scaffold_01	82132702	82134585	NA	NA	NA	NA	NA
PGEN_.00g030030	Scaffold_01	82146002	82146319	NA	NA	NA	NA	NA
PGEN_.00g030040	Scaffold_01	82146758	82147177	NA	NA	NA	NA	NA
PGEN_.00g030050	Scaffold_01	82168491	82174582	Q91994	OTX1B_DANRE	Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B)	GO:0003406; GO:0003700; GO:0005634; GO:0042472; GO:0043565; GO:0060875	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; inner ear morphogenesis [GO:0042472]; lateral semicircular canal development [GO:0060875]; retinal pigment epithelium development [GO:0003406]
PGEN_.00g030060	Scaffold_01	82195785	82214455	Q17CA7	MOCS3_AEDAE	Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)]	GO:0002143; GO:0004792; GO:0005524; GO:0005829; GO:0006777; GO:0008641; GO:0018192; GO:0046872; GO:0061604; GO:0061605	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; thiosulfate sulfurtransferase activity [GO:0004792]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; tRNA wobble position uridine thiolation [GO:0002143]
PGEN_.00g030070	Scaffold_01	82242993	82262928	NA	NA	NA	NA	NA
PGEN_.00g030080	Scaffold_01	82273126	82282950	P41827	HSP74_ANOAL	Heat shock protein 70 B2	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g030090	Scaffold_01	82293006	82338304	Q6NS57	MABP1_MOUSE	Mitogen-activated protein kinase-binding protein 1 (JNK-binding protein 1) (JNKBP-1)	GO:0005654; GO:0005730; GO:0005737; GO:0007256; GO:0043124; GO:0097431; GO:1900425; GO:2000483	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; activation of JNKK activity [GO:0007256]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 secretion [GO:2000483]
PGEN_.00g030100	Scaffold_01	82365430	82390012	NA	NA	NA	NA	NA
PGEN_.00g030110	Scaffold_01	82404440	82411579	NA	NA	NA	NA	NA
PGEN_.00g030120	Scaffold_01	82417559	82426502	P06734	FCER2_HUMAN	Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form]	GO:0002925; GO:0005178; GO:0005886; GO:0005887; GO:0007219; GO:0009897; GO:0019221; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770; GO:0070062	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cytokine-mediated signaling pathway [GO:0019221]; Notch signaling pathway [GO:0007219]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]
PGEN_.00g030130	Scaffold_01	82432374	82435094	Q0VFV7	KCTD7_DANRE	BTB/POZ domain-containing protein KCTD7	GO:0005829; GO:0005886; GO:0051260	cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]
PGEN_.00g030140	Scaffold_01	82504804	82505433	NA	NA	NA	NA	NA
PGEN_.00g030150	Scaffold_01	82512277	82523905	Q9GKX6	GALM_PIG	Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase)	GO:0004034; GO:0005737; GO:0006006; GO:0030246; GO:0033499	cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006]
PGEN_.00g030160	Scaffold_01	82528529	82528906	NA	NA	NA	NA	NA
PGEN_.00g030170	Scaffold_01	82531382	82531780	NA	NA	NA	NA	NA
PGEN_.00g030180	Scaffold_01	82538165	82553259	Q7RTX9	MOT14_HUMAN	Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g030190	Scaffold_01	82576370	82591504	Q24212	STNB_DROME	Protein stoned-B (Stn-B) (StonedB)	GO:0005623; GO:0007268; GO:0008021; GO:0030054; GO:0030100; GO:0030139; GO:0048488; GO:0048489; GO:0048786; GO:0097110; GO:0099504; GO:1900242	cell [GO:0005623]; cell junction [GO:0030054]; endocytic vesicle [GO:0030139]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; scaffold protein binding [GO:0097110]; chemical synaptic transmission [GO:0007268]; regulation of endocytosis [GO:0030100]; regulation of synaptic vesicle endocytosis [GO:1900242]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]
PGEN_.00g030200	Scaffold_01	82619176	82619472	NA	NA	NA	NA	NA
PGEN_.00g030210	Scaffold_01	82672964	82680980	NA	NA	NA	NA	NA
PGEN_.00g030220	Scaffold_01	82689861	82690673	NA	NA	NA	NA	NA
PGEN_.00g030230	Scaffold_01	82715780	82716322	NA	NA	NA	NA	NA
PGEN_.00g030240	Scaffold_01	82737102	82739920	NA	NA	NA	NA	NA
PGEN_.00g030250	Scaffold_01	82744790	82748854	NA	NA	NA	NA	NA
PGEN_.00g030260	Scaffold_01	82751449	82777376	P42262	GRIA2_HUMAN	"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"	GO:0001540; GO:0004970; GO:0004971; GO:0005789; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0008066; GO:0009897; GO:0014069; GO:0030054; GO:0030425; GO:0030666; GO:0032281; GO:0035235; GO:0035249; GO:0043197; GO:0045211; GO:0050804; GO:0060076; GO:0098794; GO:0098839; GO:0098843; GO:1904315; GO:2000310	"AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g030270	Scaffold_01	82787134	82811786	Q9Z2W9	GRIA3_MOUSE	"Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3) (GluA3)"	GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005886; GO:0008066; GO:0014069; GO:0016020; GO:0030054; GO:0030165; GO:0030425; GO:0032279; GO:0032281; GO:0032991; GO:0035249; GO:0043025; GO:0043083; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0050804; GO:0098688; GO:0098839; GO:0098978; GO:0099055; GO:0099056; GO:0099061; GO:1904315	"AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; PDZ domain binding [GO:0030165]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; regulation of receptor recycling [GO:0001919]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g030280	Scaffold_01	82820079	82828207	P70338	GFI1_MOUSE	Zinc finger protein Gfi-1 (Growth factor independent protein 1)	GO:0000122; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0007638; GO:0009996; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0032088; GO:0034121; GO:0042472; GO:0042491; GO:0042660; GO:0044212; GO:0045165; GO:0045892; GO:0045944; GO:0046872; GO:0051569; GO:0070105; GO:0071222	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cell fate commitment [GO:0045165]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; mechanosensory behavior [GO:0007638]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell fate specification [GO:0009996]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell fate specification [GO:0042660]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]"
PGEN_.00g030290	Scaffold_01	82840230	82857329	Q95NI4	CALM_HALOK	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g030300	Scaffold_01	82861008	82861304	NA	NA	NA	NA	NA
PGEN_.00g030310	Scaffold_01	82898549	82941392	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g030320	Scaffold_01	82945874	82958561	Q8TB03	CX038_HUMAN	Uncharacterized protein CXorf38		
PGEN_.00g030330	Scaffold_01	82958754	82959365	NA	NA	NA	NA	NA
PGEN_.00g030340	Scaffold_01	82974778	82981738	Q0D9C7	CCB22_ORYSJ	Cyclin-B2-2 (CycB2-Os2) (G2/mitotic-specific cyclin-B2-2) (CycB2;2)	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0006468; GO:0016538; GO:0019901; GO:0044772; GO:0051301	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]
PGEN_.00g030350	Scaffold_01	82992304	83004583	Q5F3X0	LCLT1_CHICK	Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1)	GO:0003841; GO:0005783; GO:0005789; GO:0007275; GO:0016021; GO:0016024; GO:0016746; GO:0036149	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; multicellular organism development [GO:0007275]; phosphatidylinositol acyl-chain remodeling [GO:0036149]"
PGEN_.00g030360	Scaffold_01	83008670	83008969	NA	NA	NA	NA	NA
PGEN_.00g030370	Scaffold_01	83021948	83024195	Q504Y2	PKDCC_HUMAN	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g030380	Scaffold_01	83051636	83054528	Q504Y2	PKDCC_HUMAN	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g030390	Scaffold_01	83088095	83088361	NA	NA	NA	NA	NA
PGEN_.00g030400	Scaffold_01	83097601	83117384	Q9VZF4	FBXW7_DROME	F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago)	GO:0005634; GO:0007088; GO:0007096; GO:0007411; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1903146; GO:1990381	"nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381]; axon guidance [GO:0007411]; branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]"
PGEN_.00g030410	Scaffold_01	83119803	83125578	P58200	VTI1B_RAT	Vesicle transport through interaction with t-SNAREs homolog 1B (Vesicle transport v-SNARE protein Vti1-like 1) (Vti1-rp1)	GO:0000149; GO:0005484; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006623; GO:0006888; GO:0006891; GO:0006896; GO:0008021; GO:0012507; GO:0016021; GO:0019869; GO:0031201; GO:0031901; GO:0031902; GO:0031982; GO:0042147; GO:0043025; GO:0048280; GO:0048471; GO:0055037; GO:0055038; GO:1903076	"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]"
PGEN_.00g030420	Scaffold_01	83143691	83159388	Q9HBF4	ZFYV1_HUMAN	Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1)	GO:0000407; GO:0005545; GO:0005547; GO:0005776; GO:0005783; GO:0005795; GO:0008270; GO:0009267; GO:0010923; GO:0016236; GO:0043325; GO:0044233; GO:0048471; GO:0097629; GO:1990462	"autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; extrinsic component of omegasome membrane [GO:0097629]; Golgi stack [GO:0005795]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923]"
PGEN_.00g030430	Scaffold_01	83159682	83181475	A2AQ19	RTF1_MOUSE	RNA polymerase-associated protein RTF1 homolog	GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0005730; GO:0016055; GO:0016593; GO:0019827; GO:0032968; GO:0045944; GO:0051571; GO:0080182; GO:1990269	Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; Wnt signaling pathway [GO:0016055]
PGEN_.00g030440	Scaffold_01	83192228	83197699	Q9VLU0	BAF_DROME	Barrier-to-autointegration factor	GO:0003677; GO:0005635; GO:0005654; GO:0005694; GO:0005737; GO:0007059; GO:0030261; GO:0030717	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; oocyte karyosome formation [GO:0030717]
PGEN_.00g030450	Scaffold_01	83210005	83212101	Q6P026	BAF_DANRE	Barrier-to-autointegration factor	GO:0003677; GO:0005654; GO:0005694; GO:0007059; GO:0030261	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]
PGEN_.00g030460	Scaffold_01	83224172	83261758	A6NEE1	PLHD1_HUMAN	Pleckstrin homology domain-containing family D member 1 (PH domain-containing family D member 1)		
PGEN_.00g030470	Scaffold_01	83262884	83263621	NA	NA	NA	NA	NA
PGEN_.00g030480	Scaffold_01	83263736	83263984	NA	NA	NA	NA	NA
PGEN_.00g030490	Scaffold_01	83264049	83264459	NA	NA	NA	NA	NA
PGEN_.00g030500	Scaffold_01	83265828	83276524	B1WBU8	PLHD1_RAT	Pleckstrin homology domain-containing family D member 1 (PH domain-containing family D member 1)		
PGEN_.00g030510	Scaffold_01	83287856	83288185	P0DMQ5	INAM2_HUMAN	Putative transmembrane protein INAFM2 (InaF-motif-containing protein 2) (Osteogenesis up-regulated transcript 1)	GO:0005246; GO:0016021	integral component of membrane [GO:0016021]; calcium channel regulator activity [GO:0005246]
PGEN_.00g030520	Scaffold_01	83298159	83301045	Q68FF9	S5A1_MOUSE	3-oxo-5-alpha-steroid 4-dehydrogenase 1 (EC 1.3.1.22) (SR type 1) (Steroid 5-alpha-reductase 1) (S5AR 1)	GO:0003865; GO:0005737; GO:0005789; GO:0006694; GO:0006702; GO:0006710; GO:0007548; GO:0008209; GO:0016021; GO:0016491; GO:0030154; GO:0033218; GO:0042448; GO:0042493; GO:0043025; GO:0043209; GO:0043231; GO:0047751; GO:0048471; GO:0070402; GO:0070852	cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; amide binding [GO:0033218]; cholestenone 5-alpha-reductase activity [GO:0047751]; NADPH binding [GO:0070402]; oxidoreductase activity [GO:0016491]; androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; androgen metabolic process [GO:0008209]; cell differentiation [GO:0030154]; progesterone metabolic process [GO:0042448]; response to drug [GO:0042493]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]
PGEN_.00g030530	Scaffold_01	83307037	83308035	Q99L04	DHRS1_MOUSE	Dehydrogenase/reductase SDR family member 1 (EC 1.1.-.-)	GO:0005739; GO:0005743; GO:0005783; GO:0016491	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]
PGEN_.00g030540	Scaffold_01	83313902	83318221	Q68FF9	S5A1_MOUSE	3-oxo-5-alpha-steroid 4-dehydrogenase 1 (EC 1.3.1.22) (SR type 1) (Steroid 5-alpha-reductase 1) (S5AR 1)	GO:0003865; GO:0005737; GO:0005789; GO:0006694; GO:0006702; GO:0006710; GO:0007548; GO:0008209; GO:0016021; GO:0016491; GO:0030154; GO:0033218; GO:0042448; GO:0042493; GO:0043025; GO:0043209; GO:0043231; GO:0047751; GO:0048471; GO:0070402; GO:0070852	cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; amide binding [GO:0033218]; cholestenone 5-alpha-reductase activity [GO:0047751]; NADPH binding [GO:0070402]; oxidoreductase activity [GO:0016491]; androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; androgen metabolic process [GO:0008209]; cell differentiation [GO:0030154]; progesterone metabolic process [GO:0042448]; response to drug [GO:0042493]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]
PGEN_.00g030550	Scaffold_01	83322491	83334787	P62147	CALM1_BRAFL	Calmodulin-1 (CaM 1)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g030560	Scaffold_01	83352466	83407643	P02588	TNNC2_CHICK	"Troponin C, skeletal muscle"	GO:0003009; GO:0005509; GO:0005861; GO:0006937; GO:0048306; GO:0051015	troponin complex [GO:0005861]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009]
PGEN_.00g030570	Scaffold_01	83425191	83428061	NA	NA	NA	NA	NA
PGEN_.00g030580	Scaffold_01	83489118	83493445	Q03509	CALM6_ARATH	Calmodulin-6 (CaM-6)	GO:0005509; GO:0005829; GO:0009536; GO:0019722	cytosol [GO:0005829]; plastid [GO:0009536]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g030590	Scaffold_01	83551294	83569674	Q23551	UNC22_CAEEL	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	GO:0004674; GO:0005516; GO:0005524; GO:0005865; GO:0006936; GO:0008307; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0030017; GO:0030018; GO:0031430; GO:0031672; GO:0035095; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051015; GO:0051371; GO:0051782; GO:0060298; GO:0071688	A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]
PGEN_.00g030600	Scaffold_01	83578778	83582829	Q8BV66	IFI44_MOUSE	Interferon-induced protein 44 (Microtubule-associated protein 44)	GO:0005737; GO:0006955; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]
PGEN_.00g030610	Scaffold_01	83585564	83624868	NA	NA	NA	NA	NA
PGEN_.00g030620	Scaffold_01	83625335	83628649	NA	NA	NA	NA	NA
PGEN_.00g030630	Scaffold_01	83651649	83652200	Q9Y7S2	YQO3_SCHPO	UPF0612 protein C569.003	GO:0005829	cytosol [GO:0005829]
PGEN_.00g030640	Scaffold_01	83652260	83652463	NA	NA	NA	NA	NA
PGEN_.00g030650	Scaffold_01	83664030	83666884	Q96MB7	HARB1_HUMAN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g030660	Scaffold_01	83667058	83671275	NA	NA	NA	NA	NA
PGEN_.00g030670	Scaffold_01	83775474	83794949	Q8IUM7	NPAS4_HUMAN	Neuronal PAS domain-containing protein 4 (Neuronal PAS4) (Class E basic helix-loop-helix protein 79) (bHLHe79) (HLH-PAS transcription factor NXF) (PAS domain-containing protein 10)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0007612; GO:0007614; GO:0007616; GO:0030154; GO:0032228; GO:0035176; GO:0045944; GO:0046982; GO:0048167; GO:0060079; GO:0060080; GO:0071386; GO:0098794; GO:1904862	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]"
PGEN_.00g030680	Scaffold_01	83799243	83801360	NA	NA	NA	NA	NA
PGEN_.00g030690	Scaffold_01	83824670	83825554	NA	NA	NA	NA	NA
PGEN_.00g030700	Scaffold_01	83825963	83827872	NA	NA	NA	NA	NA
PGEN_.00g030710	Scaffold_01	83829452	83829685	NA	NA	NA	NA	NA
PGEN_.00g030720	Scaffold_01	83851755	83852108	NA	NA	NA	NA	NA
PGEN_.00g030730	Scaffold_01	83861265	83870355	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g030740	Scaffold_01	83870460	83969308	Q9UGM3	DMBT1_HUMAN	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0007275; GO:0008329; GO:0009897; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]
PGEN_.00g030750	Scaffold_01	83983515	83983919	NA	NA	NA	NA	NA
PGEN_.00g030760	Scaffold_01	83990971	83991651	NA	NA	NA	NA	NA
PGEN_.00g030770	Scaffold_01	84016703	84018099	NA	NA	NA	NA	NA
PGEN_.00g030780	Scaffold_01	84021459	84022070	NA	NA	NA	NA	NA
PGEN_.00g030790	Scaffold_01	84033854	84034778	NA	NA	NA	NA	NA
PGEN_.00g030800	Scaffold_01	84037596	84039027	NA	NA	NA	NA	NA
PGEN_.00g030810	Scaffold_01	84072458	84082706	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g030820	Scaffold_01	84090729	84092216	NA	NA	NA	NA	NA
PGEN_.00g030830	Scaffold_01	84108161	84115058	P9WK87	NLHH_MYCTU	Carboxylesterase NlhH (EC 3.1.1.1)	GO:0009056; GO:0016787; GO:0034338; GO:0080030	hydrolase activity [GO:0016787]; methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056]
PGEN_.00g030840	Scaffold_01	84126860	84132032	Q5RDY3	KBTB2_PONAB	Kelch repeat and BTB domain-containing protein 2		
PGEN_.00g030850	Scaffold_01	84134240	84144502	Q5M7T4	YIPF4_RAT	Protein YIPF4 (YIP1 family member 4)	GO:0005783; GO:0005794; GO:0005886; GO:0016021	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g030860	Scaffold_01	84149115	84152918	NA	NA	NA	NA	NA
PGEN_.00g030870	Scaffold_01	84152987	84153373	NA	NA	NA	NA	NA
PGEN_.00g030880	Scaffold_01	84153750	84187329	Q803U7	EXO1_DANRE	Exonuclease 1 (EC 3.1.-.-) (Exonuclease I)	GO:0003677; GO:0005634; GO:0006298; GO:0006310; GO:0017108; GO:0035312; GO:0045145; GO:0046872; GO:0048256	nucleus [GO:0005634]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; DNA recombination [GO:0006310]; mismatch repair [GO:0006298]
PGEN_.00g030890	Scaffold_01	84188480	84192687	P22309	UD11_HUMAN	UDP-glucuronosyltransferase 1-1 (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-A) (UGT-1A) (UGT1A) (UDP-glucuronosyltransferase 1A1)	GO:0001889; GO:0001972; GO:0004857; GO:0005496; GO:0005783; GO:0005789; GO:0005887; GO:0006789; GO:0006953; GO:0007584; GO:0008202; GO:0008210; GO:0015020; GO:0017144; GO:0019899; GO:0031100; GO:0032496; GO:0034663; GO:0042167; GO:0042573; GO:0042594; GO:0042803; GO:0045922; GO:0045939; GO:0046483; GO:0046982; GO:0051552; GO:0052695; GO:0052696; GO:0052697; GO:0070069; GO:0070980; GO:0071361; GO:0071385; GO:0071392; GO:1904224; GO:2001030	cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]; acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; bilirubin conjugation [GO:0006789]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; heme catabolic process [GO:0042167]; heterocycle metabolic process [GO:0046483]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]
PGEN_.00g030900	Scaffold_01	84194164	84198029	NA	NA	NA	NA	NA
PGEN_.00g030910	Scaffold_01	84206614	84212137	NA	NA	NA	NA	NA
PGEN_.00g030920	Scaffold_01	84235009	84253459	Q9VXE5	PAKM_DROME	Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein)	GO:0000187; GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0005913; GO:0006468; GO:0007010; GO:0007030; GO:0016319; GO:0017048; GO:0018105; GO:0023014; GO:0032147; GO:0045315; GO:0045792; GO:0048749; GO:2000047	adherens junction [GO:0005912]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of compound eye photoreceptor development [GO:0045315]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g030930	Scaffold_01	84265697	84286226	Q6UWR7	ENPP6_HUMAN	Glycerophosphocholine cholinephosphodiesterase ENPP6 (GPC-Cpde) (EC 3.1.4.-) (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6) (E-NPP 6) (NPP-6)	GO:0005576; GO:0005886; GO:0006629; GO:0008081; GO:0008889; GO:0019695; GO:0031225; GO:0046475; GO:0046872; GO:0047390; GO:0070062	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; choline metabolic process [GO:0019695]; glycerophospholipid catabolic process [GO:0046475]; lipid metabolic process [GO:0006629]
PGEN_.00g030940	Scaffold_01	84301143	84303629	Q9R186	TRPV6_RAT	Transient receptor potential cation channel subfamily V member 6 (TrpV6) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2)	GO:0005216; GO:0005227; GO:0005262; GO:0005516; GO:0005623; GO:0005886; GO:0005887; GO:0006816; GO:0016324; GO:0035898; GO:0042802; GO:0046872; GO:0051289; GO:0051592; GO:0055074; GO:0070509; GO:0070588; GO:0098703	apical plasma membrane [GO:0016324]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592]
PGEN_.00g030950	Scaffold_01	84306907	84307152	NA	NA	NA	NA	NA
PGEN_.00g030960	Scaffold_01	84307355	84325101	P42696	RBM34_HUMAN	RNA-binding protein 34 (RNA-binding motif protein 34)	GO:0003723; GO:0005654; GO:0005730	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]
PGEN_.00g030970	Scaffold_01	84331466	84334518	Q9H7Z3	NRDE2_HUMAN	Nuclear exosome regulator NRDE2 (Protein NRDE2 homolog)	GO:0005654; GO:0005730; GO:0016246; GO:0016607; GO:0031048; GO:0046833; GO:1902369	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin silencing by small RNA [GO:0031048]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; RNA interference [GO:0016246]
PGEN_.00g030980	Scaffold_01	84350490	84367996	Q6ZNE5	BAKOR_HUMAN	Beclin 1-associated autophagy-related key regulator (Barkor) (Autophagy-related protein 14-like protein) (Atg14L)	GO:0000045; GO:0000421; GO:0000423; GO:0001932; GO:0001933; GO:0001934; GO:0005776; GO:0005789; GO:0005829; GO:0005930; GO:0008333; GO:0009267; GO:0010608; GO:0016236; GO:0016240; GO:0034045; GO:0035032; GO:0042149; GO:0043552; GO:0044233; GO:0045335; GO:0051020; GO:0061635; GO:0090207; GO:0097629; GO:0097632; GO:0098780	"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle [GO:0045335]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; GTPase binding [GO:0051020]; autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; endosome to lysosome transport [GO:0008333]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of protein complex stability [GO:0061635]; regulation of protein phosphorylation [GO:0001932]; regulation of triglyceride metabolic process [GO:0090207]; response to mitochondrial depolarisation [GO:0098780]"
PGEN_.00g030990	Scaffold_01	84373689	84413443	O88379	BAZ1A_MOUSE	Bromodomain adjacent to zinc finger domain protein 1A (Cbp146)	GO:0000228; GO:0006261; GO:0006338; GO:0008623; GO:0046872	CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]
PGEN_.00g031000	Scaffold_01	84416238	84416978	NA	NA	NA	NA	NA
PGEN_.00g031010	Scaffold_01	84427521	84436167	NA	NA	NA	NA	NA
PGEN_.00g031020	Scaffold_01	84436359	84440138	A3KQV2	BROX_DANRE	BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)	GO:0016020	membrane [GO:0016020]
PGEN_.00g031030	Scaffold_01	84441852	84452127	A4IIL4	BROX_XENTR	BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)	GO:0016020	membrane [GO:0016020]
PGEN_.00g031040	Scaffold_01	84471643	84472275	Q9CQ66	TC1D2_MOUSE	Tctex1 domain-containing protein 2	GO:0005868; GO:0045505; GO:0060271; GO:1902017; GO:1905799	cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; cilium assembly [GO:0060271]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799]
PGEN_.00g031050	Scaffold_01	84476186	84496170	NA	NA	NA	NA	NA
PGEN_.00g031060	Scaffold_01	84507849	84514768	NA	NA	NA	NA	NA
PGEN_.00g031070	Scaffold_01	84536971	84543257	Q86TV6	TTC7B_HUMAN	Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1)	GO:0005829; GO:0005886; GO:0046854; GO:0072659	cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]
PGEN_.00g031080	Scaffold_01	84549096	84562126	E9Q6P5	TTC7B_MOUSE	Tetratricopeptide repeat protein 7B (TPR repeat protein 7B)	GO:0005829; GO:0005886; GO:0046854; GO:0072659	cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]
PGEN_.00g031090	Scaffold_01	84597268	84609641	NA	NA	NA	NA	NA
PGEN_.00g031100	Scaffold_01	84676863	84677120	NA	NA	NA	NA	NA
PGEN_.00g031110	Scaffold_01	84677163	84677576	NA	NA	NA	NA	NA
PGEN_.00g031120	Scaffold_01	84758079	84826339	A0A0F7YYX3	CPROH_CONVC	Neuropeptide prohormone-4	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g031130	Scaffold_01	85062849	85072966	Q60989	XIAP_MOUSE	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP homolog A) (Inhibitor of apoptosis protein 3) (IAP-3) (mIAP-3) (mIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	GO:0002020; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006974; GO:0016055; GO:0031398; GO:0032991; GO:0042802; GO:0043027; GO:0043066; GO:0043154; GO:0043524; GO:0046872; GO:0048471; GO:0051402; GO:0061630; GO:0090263; GO:0097110; GO:1902530; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; Wnt signaling pathway [GO:0016055]
PGEN_.00g031140	Scaffold_01	85074131	85074964	NA	NA	NA	NA	NA
PGEN_.00g031150	Scaffold_01	85093615	85094241	NA	NA	NA	NA	NA
PGEN_.00g031160	Scaffold_01	85094625	85097051	NA	NA	NA	NA	NA
PGEN_.00g031170	Scaffold_01	85097082	85097363	NA	NA	NA	NA	NA
PGEN_.00g031180	Scaffold_01	85097425	85097826	NA	NA	NA	NA	NA
PGEN_.00g031190	Scaffold_01	85115545	85147121	P12261	EF1G_ARTSA	Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)	GO:0003746	translation elongation factor activity [GO:0003746]
PGEN_.00g031200	Scaffold_01	85147250	85185071	Q63810	CANB1_MOUSE	Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1)	GO:0001569; GO:0001837; GO:0004721; GO:0005509; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0007507; GO:0014044; GO:0016018; GO:0019899; GO:0019902; GO:0019904; GO:0022011; GO:0033173; GO:0034504; GO:0042383; GO:0045202; GO:0045944; GO:0060487; GO:0098685; GO:0098688; GO:0098794; GO:0098978; GO:0099149; GO:0099170	calcineurin complex [GO:0005955]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; protein domain specific binding [GO:0019904]; branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; epithelial to mesenchymal transition [GO:0001837]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; myelination in peripheral nervous system [GO:0022011]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; Schwann cell development [GO:0014044]
PGEN_.00g031210	Scaffold_01	85205525	85212440	Q8VDL4	ADPGK_MOUSE	ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147)	GO:0005576; GO:0005783; GO:0006006; GO:0006096; GO:0043843; GO:0046872	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]
PGEN_.00g031220	Scaffold_01	85217765	85256662	P40925	MDHC_HUMAN	"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase) (Diiodophenylpyruvate reductase) (EC 1.1.1.96)"	GO:0004470; GO:0005615; GO:0005829; GO:0006094; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0019674; GO:0030060; GO:0047860; GO:0051287; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; diiodophenylpyruvate reductase activity [GO:0047860]; L-malate dehydrogenase activity [GO:0030060]; malic enzyme activity [GO:0004470]; NAD binding [GO:0051287]; gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; NAD metabolic process [GO:0019674]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g031230	Scaffold_01	85264140	85278068	Q3UK37	TEDC1_MOUSE	Tubulin epsilon and delta complex protein 1 (Uncharacterized protein C14orf80 homolog)	GO:0005737; GO:0005814; GO:0005929; GO:0045880	centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; positive regulation of smoothened signaling pathway [GO:0045880]
PGEN_.00g031240	Scaffold_01	85300605	85314625	NA	NA	NA	NA	NA
PGEN_.00g031250	Scaffold_01	85337856	85338245	NA	NA	NA	NA	NA
PGEN_.00g031260	Scaffold_01	85343537	85350904	Q9P1V8	SAM15_HUMAN	Sterile alpha motif domain-containing protein 15 (SAM domain-containing protein 15)		
PGEN_.00g031270	Scaffold_01	85442002	85523966	A2APX8	SCN1A_MOUSE	Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1)	GO:0001508; GO:0001518; GO:0005244; GO:0005248; GO:0005654; GO:0005886; GO:0006814; GO:0007628; GO:0014704; GO:0016020; GO:0016604; GO:0019227; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0031402; GO:0033268; GO:0034706; GO:0034765; GO:0035725; GO:0042391; GO:0043025; GO:0043194; GO:0050884; GO:0050966; GO:0086002; GO:0086010; GO:0099056	axon [GO:0030424]; axon initial segment [GO:0043194]; integral component of presynaptic membrane [GO:0099056]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; sodium ion binding [GO:0031402]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cardiac muscle cell action potential involved in contraction [GO:0086002]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane depolarization during action potential [GO:0086010]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]
PGEN_.00g031280	Scaffold_01	85538502	85552937	P13688	CEAM1_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (CD antigen CD66a)	GO:0001525; GO:0001558; GO:0001568; GO:0001915; GO:0002859; GO:0003779; GO:0005516; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006469; GO:0007155; GO:0007156; GO:0007229; GO:0009925; GO:0009986; GO:0010594; GO:0014066; GO:0015125; GO:0015721; GO:0016020; GO:0016021; GO:0016324; GO:0016328; GO:0016477; GO:0019900; GO:0019903; GO:0030054; GO:0030334; GO:0030658; GO:0030853; GO:0031005; GO:0031528; GO:0032692; GO:0032869; GO:0035579; GO:0035726; GO:0038016; GO:0038158; GO:0042058; GO:0042802; GO:0042803; GO:0043116; GO:0043312; GO:0043318; GO:0044319; GO:0045601; GO:0045717; GO:0046983; GO:0050860; GO:0050900; GO:0051055; GO:0060312; GO:0070062; GO:0070372; GO:0070821; GO:0090331; GO:0098742; GO:1901143; GO:1903385; GO:1903670; GO:1990782; GO:2000346; GO:2001214	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle membrane [GO:0030658]; actin binding [GO:0003779]; bile acid transmembrane transporter activity [GO:0015125]; calmodulin binding [GO:0005516]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; angiogenesis [GO:0001525]; bile acid and bile salt transport [GO:0015721]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to insulin stimulus [GO:0032869]; common myeloid progenitor cell proliferation [GO:0035726]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insulin catabolic process [GO:1901143]; insulin receptor internalization [GO:0038016]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; neutrophil degranulation [GO:0043312]; positive regulation of vasculogenesis [GO:2001214]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of endothelial cell differentiation [GO:0045601]; regulation of endothelial cell migration [GO:0010594]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of homophilic cell adhesion [GO:1903385]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of sprouting angiogenesis [GO:1903670]; wound healing, spreading of cells [GO:0044319]"
PGEN_.00g031290	Scaffold_01	85583995	85589916	NA	NA	NA	NA	NA
PGEN_.00g031300	Scaffold_01	85593090	85600428	P86982	IMSP1_RUDPH	Insoluble matrix shell protein 1 (IMSP1) (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g031310	Scaffold_01	85603481	85611691	Q6A152	CP4X1_MOUSE	Cytochrome P450 4X1 (EC 1.14.14.1) (CYPIVX1)	GO:0005506; GO:0005789; GO:0016021; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g031320	Scaffold_01	85611791	85612999	NA	NA	NA	NA	NA
PGEN_.00g031330	Scaffold_01	85618530	85637494	P49109	FMO5_CAVPO	Dimethylaniline monooxygenase [N-oxide-forming] 5 (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (FMO 5)	GO:0004499; GO:0005789; GO:0005829; GO:0016021; GO:0050660; GO:0050661	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
PGEN_.00g031340	Scaffold_01	85649192	85702953	Q3U1V8	M3K9_MOUSE	Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25)	GO:0004674; GO:0004706; GO:0005524; GO:0006468; GO:0006915; GO:0007257; GO:0008219; GO:0043065; GO:0046777	ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; apoptotic process [GO:0006915]; cell death [GO:0008219]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]
PGEN_.00g031350	Scaffold_01	85718989	85735833	Q9D361	SNR48_MOUSE	U11/U12 small nuclear ribonucleoprotein 48 kDa protein (U11/U12 snRNP 48 kDa protein)	GO:0005654; GO:0005689; GO:0005829; GO:0006397; GO:0008380; GO:0046872	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689]; metal ion binding [GO:0046872]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g031360	Scaffold_01	85736202	85748755	NA	NA	NA	NA	NA
PGEN_.00g031370	Scaffold_01	85757247	85771457	Q9BQ24	ZFY21_HUMAN	Zinc finger FYVE domain-containing protein 21 (ZF21)	GO:0005768; GO:0005925; GO:0046872	endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872]
PGEN_.00g031380	Scaffold_01	85858160	85872070	Q9MYU4	ENTP1_PIG	Ectonucleoside triphosphate diphosphohydrolase 1 (NTPDase 1) (EC 3.6.1.5) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (CD antigen CD39) [Cleaved into: Ectonucleoside triphosphate diphosphohydrolase 1 27 kDa subunit; Ectonucleoside triphosphate diphosphohydrolase 1 54 kDa subunit]	GO:0005524; GO:0005975; GO:0016021; GO:0016616; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491	"integral component of membrane [GO:0016021]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; carbohydrate metabolic process [GO:0005975]"
PGEN_.00g031390	Scaffold_01	85880535	85890855	Q9DA42	CT085_MOUSE	Uncharacterized protein C20orf85 homolog		
PGEN_.00g031400	Scaffold_01	85905540	85910368	NA	NA	NA	NA	NA
PGEN_.00g031410	Scaffold_01	85917679	85923388	NA	NA	NA	NA	NA
PGEN_.00g031420	Scaffold_01	85923465	85924820	NA	NA	NA	NA	NA
PGEN_.00g031430	Scaffold_01	85931180	85936443	Q7SY07	EIF1A_DANRE	Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein)	GO:0003743; GO:0005634	nucleus [GO:0005634]; translation initiation factor activity [GO:0003743]
PGEN_.00g031440	Scaffold_01	85940181	85944537	NA	NA	NA	NA	NA
PGEN_.00g031450	Scaffold_01	85948096	85948713	NA	NA	NA	NA	NA
PGEN_.00g031460	Scaffold_01	85953578	85955096	Q5VV17	OTUD1_HUMAN	OTU domain-containing protein 1 (EC 3.4.19.12) (DUBA-7)	GO:0004843; GO:0070536	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K63-linked deubiquitination [GO:0070536]
PGEN_.00g031470	Scaffold_01	85955468	85967411	NA	NA	NA	NA	NA
PGEN_.00g031480	Scaffold_01	85970969	85983208	NA	NA	NA	NA	NA
PGEN_.00g031490	Scaffold_01	85996838	86018310	NA	NA	NA	NA	NA
PGEN_.00g031500	Scaffold_01	86019349	86035420	Q9WVL1	AP4S1_MOUSE	AP-4 complex subunit sigma-1 (AP-4 adaptor complex subunit sigma-1) (Adaptor-related protein complex 4 subunit sigma-1) (Sigma-1 subunit of AP-4) (Sigma-4-adaptin) (Sigma4-adaptin)	GO:0005802; GO:0006886; GO:0016192; GO:0030124; GO:0043231	AP-4 adaptor complex [GO:0030124]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g031510	Scaffold_01	86039880	86075028	A5D7H2	STRN3_BOVIN	Striatin-3	GO:0000122; GO:0003700; GO:0005516; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0017048; GO:0030425; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; Rho GTPase binding [GO:0017048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g031520	Scaffold_01	86084955	86113448	Q95216	HLTF_RABIT	Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase HLTF) (RUSH-1) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3)	GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0006325; GO:0008270; GO:0016567; GO:0016740	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; protein ubiquitination [GO:0016567]
PGEN_.00g031530	Scaffold_01	86115227	86131675	Q95216	HLTF_RABIT	Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase HLTF) (RUSH-1) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3)	GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0006325; GO:0008270; GO:0016567; GO:0016740	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; protein ubiquitination [GO:0016567]
PGEN_.00g031540	Scaffold_01	86190254	86191759	NA	NA	NA	NA	NA
PGEN_.00g031550	Scaffold_01	86202542	86202760	NA	NA	NA	NA	NA
PGEN_.00g031560	Scaffold_01	86203017	86223056	Q95LU3	FBCD1_MACFA	Fibrinogen C domain-containing protein 1	GO:0008061; GO:0016020; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g031570	Scaffold_01	86254616	86260309	Q80Y14	GLRX5_MOUSE	"Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)"	GO:0005623; GO:0005634; GO:0005739; GO:0005759; GO:0009055; GO:0009249; GO:0015035; GO:0030097; GO:0030425; GO:0043025; GO:0045454; GO:0046872; GO:0051537	"cell [GO:0005623]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249]"
PGEN_.00g031580	Scaffold_01	86264259	86265515	NA	NA	NA	NA	NA
PGEN_.00g031590	Scaffold_01	86266570	86270117	Q80TC5	POGK_MOUSE	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g031600	Scaffold_01	86271741	86287523	Q9H2K2	TNKS2_HUMAN	Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2) (Tankyrase-like protein) (Tankyrase-related protein)	GO:0000139; GO:0000209; GO:0000242; GO:0000784; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006471; GO:0016055; GO:0019899; GO:0032212; GO:0035264; GO:0040014; GO:0046872; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g031610	Scaffold_01	86288217	86294614	NA	NA	NA	NA	NA
PGEN_.00g031620	Scaffold_01	86298778	86323412	NA	NA	NA	NA	NA
PGEN_.00g031630	Scaffold_01	86326937	86340606	Q8VCX6	KPTN_MOUSE	KICSTOR complex protein kaptin	GO:0005765; GO:0007015; GO:0030027; GO:0032420; GO:0034198; GO:0042149; GO:0051015; GO:0061462; GO:0098871; GO:0140007; GO:1904262	KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]
PGEN_.00g031640	Scaffold_01	86346752	86348554	NA	NA	NA	NA	NA
PGEN_.00g031650	Scaffold_01	86355100	86362707	P15105	GLNA_MOUSE	Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)	GO:0000287; GO:0001525; GO:0004356; GO:0005524; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005886; GO:0006536; GO:0006542; GO:0008283; GO:0009267; GO:0009749; GO:0010594; GO:0016595; GO:0018345; GO:0019676; GO:0019706; GO:0030145; GO:0032024; GO:0032991; GO:0042254; GO:0042802; GO:0042995; GO:0043005; GO:0043204; GO:0043209; GO:0043231; GO:0043679; GO:0044297; GO:0045503; GO:0050679; GO:0051260; GO:0051968; GO:0097386; GO:1903670; GO:1904749	"axon terminus [GO:0043679]; cell body [GO:0044297]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate binding [GO:0016595]; glutamate-ammonia ligase activity [GO:0004356]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; glutamate metabolic process [GO:0006536]; glutamine biosynthetic process [GO:0006542]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein homooligomerization [GO:0051260]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]"
PGEN_.00g031660	Scaffold_01	86425264	86426205	NA	NA	NA	NA	NA
PGEN_.00g031670	Scaffold_01	86439437	86447512	Q4LE39	ARI4B_HUMAN	AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1)	GO:0005634; GO:0005654; GO:0005737; GO:0006349; GO:0006357; GO:0007283; GO:0034773; GO:0036124; GO:0044212; GO:0045944; GO:0097368	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulatory region DNA binding [GO:0044212]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]
PGEN_.00g031680	Scaffold_01	86448506	86469121	Q9JKB5	ARI4B_RAT	AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1)	GO:0005634; GO:0006349; GO:0006357; GO:0007283; GO:0034773; GO:0036124; GO:0044212; GO:0045944; GO:0097368	nucleus [GO:0005634]; transcription regulatory region DNA binding [GO:0044212]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]
PGEN_.00g031690	Scaffold_01	86472181	86475050	Q80TC5	POGK_MOUSE	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g031700	Scaffold_01	86475081	86479781	Q80TC5	POGK_MOUSE	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g031710	Scaffold_01	86485360	86493219	Q9H1D9	RPC6_HUMAN	DNA-directed RNA polymerase III subunit RPC6 (RNA polymerase III subunit C6) (DNA-directed RNA polymerase III subunit F) (RNA polymerase III 39 kDa subunit) (RPC39)	GO:0003690; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0032481; GO:0032728; GO:0045087; GO:0045089; GO:0051607	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g031720	Scaffold_01	86493483	86512294	Q5RBG4	KAT5_PONAB	Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5)	GO:0000812; GO:0003713; GO:0004402; GO:0005730; GO:0006978; GO:0010508; GO:0018394; GO:0032777; GO:0035267; GO:0040008; GO:0045893; GO:0046872; GO:0048471; GO:0061733	"NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]"
PGEN_.00g031730	Scaffold_01	86522316	86579359	P97742	CPT1A_MOUSE	"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)"	GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0005743; GO:0006006; GO:0006635; GO:0006641; GO:0009437; GO:0014070; GO:0016021; GO:0030855; GO:0031307; GO:0032000; GO:0042493; GO:0042755; GO:0042802; GO:0043231; GO:0046320; GO:0050796; GO:0051260; GO:0071398; GO:1990698	integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; glucose metabolic process [GO:0006006]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; protein homooligomerization [GO:0051260]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; triglyceride metabolic process [GO:0006641]
PGEN_.00g031740	Scaffold_01	86599457	86600077	NA	NA	NA	NA	NA
PGEN_.00g031750	Scaffold_01	86603985	86612859	P24329	THTR_RAT	Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese)	GO:0004792; GO:0005739; GO:0005759; GO:0008097; GO:0016226; GO:0016783; GO:0019346; GO:0030855; GO:0035928; GO:0051029	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; epithelial cell differentiation [GO:0030855]; iron-sulfur cluster assembly [GO:0016226]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029]; transsulfuration [GO:0019346]
PGEN_.00g031760	Scaffold_01	86630701	86643607	P24329	THTR_RAT	Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese)	GO:0004792; GO:0005739; GO:0005759; GO:0008097; GO:0016226; GO:0016783; GO:0019346; GO:0030855; GO:0035928; GO:0051029	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; epithelial cell differentiation [GO:0030855]; iron-sulfur cluster assembly [GO:0016226]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029]; transsulfuration [GO:0019346]
PGEN_.00g031770	Scaffold_01	86660547	86663079	Q5J6M8	RTN3A_XENLA	Reticulon-3-A (RTN3.1)	GO:0000139; GO:0005789; GO:0016021; GO:0016192	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle-mediated transport [GO:0016192]
PGEN_.00g031780	Scaffold_01	86663887	86665056	NA	NA	NA	NA	NA
PGEN_.00g031790	Scaffold_01	86676579	86706041	NA	NA	NA	NA	NA
PGEN_.00g031800	Scaffold_01	86708579	86708806	NA	NA	NA	NA	NA
PGEN_.00g031810	Scaffold_01	86719659	86721637	NA	NA	NA	NA	NA
PGEN_.00g031820	Scaffold_01	86723962	86724297	NA	NA	NA	NA	NA
PGEN_.00g031830	Scaffold_01	86738494	86738997	NA	NA	NA	NA	NA
PGEN_.00g031840	Scaffold_01	86746166	86777233	P97363	SPTC2_MOUSE	Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)	GO:0004758; GO:0005739; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]
PGEN_.00g031850	Scaffold_01	86789919	86838858	P97363	SPTC2_MOUSE	Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)	GO:0004758; GO:0005739; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]
PGEN_.00g031860	Scaffold_01	86862033	86873378	NA	NA	NA	NA	NA
PGEN_.00g031870	Scaffold_01	86876327	86889828	NA	NA	NA	NA	NA
PGEN_.00g031880	Scaffold_01	86897644	86928309	B4J4Y2	KTU_DROGR	"Protein kintoun (Dynein assembly factor 2, axonemal homolog) (PP1-interacting protein 20)"	GO:0005737; GO:0008157; GO:0060285; GO:0070286	cytoplasm [GO:0005737]; protein phosphatase 1 binding [GO:0008157]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]
PGEN_.00g031890	Scaffold_01	86938366	86957473	NA	NA	NA	NA	NA
PGEN_.00g031900	Scaffold_01	86946929	86948558	NA	NA	NA	NA	NA
PGEN_.00g031910	Scaffold_01	86962814	86964717	Q9H6A9	PCX3_HUMAN	Pecanex-like protein 3 (Pecanex homolog protein 3)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g031920	Scaffold_01	86981109	87023773	Q96RV3	PCX1_HUMAN	Pecanex-like protein 1 (Pecanex homolog protein 1)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g031930	Scaffold_01	87054198	87055800	NA	NA	NA	NA	NA
PGEN_.00g031940	Scaffold_01	87072002	87075320	NA	NA	NA	NA	NA
PGEN_.00g031950	Scaffold_01	87081709	87101548	NA	NA	NA	NA	NA
PGEN_.00g031960	Scaffold_01	87136890	87137874	NA	NA	NA	NA	NA
PGEN_.00g031970	Scaffold_01	87138062	87138511	NA	NA	NA	NA	NA
PGEN_.00g031980	Scaffold_01	87142567	87152041	Q7ZUH5	RM14_DANRE	"39S ribosomal protein L14, mitochondrial (L14mt) (MRP-L14)"	GO:0003735; GO:0005739; GO:0005762; GO:0006412	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g031990	Scaffold_01	87157906	87158361	NA	NA	NA	NA	NA
PGEN_.00g032000	Scaffold_01	87159031	87169869	NA	NA	NA	NA	NA
PGEN_.00g032010	Scaffold_01	87173329	87174277	NA	NA	NA	NA	NA
PGEN_.00g032020	Scaffold_01	87184546	87190158	NA	NA	NA	NA	NA
PGEN_.00g032030	Scaffold_01	87194584	87211126	A0JNH9	APLF_BOVIN	Aprataxin and PNK-like factor (EC 4.2.99.18) (Apurinic-apyrimidinic endonuclease APLF)	GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005829; GO:0006302; GO:0006974; GO:0008408; GO:0035861; GO:0046872; GO:0140078	cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]
PGEN_.00g032040	Scaffold_01	87233649	87239969	Q8BI36	JKAMP_MOUSE	JNK1/MAPK8-associated membrane protein (JKAMP) (JNK1-associated membrane protein) (JAMP) (Medulloblastoma antigen MU-MB-50.4 homolog)	GO:0005789; GO:0006986; GO:0016021; GO:0030433; GO:0031625	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g032050	Scaffold_01	87240227	87284231	Q0P6H9	TMM62_HUMAN	Transmembrane protein 62	GO:0016021; GO:0016787	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]
PGEN_.00g032060	Scaffold_01	87322358	87327233	Q920B6	KCNK2_RAT	Potassium channel subfamily K member 2 (Outward rectifying potassium channel protein TREK-1) (Stretch-activated potassium channel TREK-1) (TREK-1 K(+) channel subunit) (Two pore domain potassium channel TREK-1) (Two pore potassium channel TPKC1)	GO:0003231; GO:0005249; GO:0005634; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006813; GO:0007186; GO:0007613; GO:0008076; GO:0009612; GO:0009986; GO:0010942; GO:0015271; GO:0016324; GO:0019870; GO:0022841; GO:0030322; GO:0030424; GO:0042391; GO:0043005; GO:0043025; GO:0043679; GO:0044305; GO:0048678; GO:0060044; GO:0071456; GO:0071805; GO:0090102; GO:0097449; GO:1900039; GO:2000279	apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; axon [GO:0030424]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; outward rectifier potassium channel activity [GO:0015271]; potassium channel inhibitor activity [GO:0019870]; potassium ion leak channel activity [GO:0022841]; voltage-gated potassium channel activity [GO:0005249]; cardiac ventricle development [GO:0003231]; cellular response to hypoxia [GO:0071456]; cochlea development [GO:0090102]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of cell death [GO:0010942]; positive regulation of cellular response to hypoxia [GO:1900039]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391]; response to axon injury [GO:0048678]; response to mechanical stimulus [GO:0009612]; stabilization of membrane potential [GO:0030322]
PGEN_.00g032070	Scaffold_01	87343668	87344876	P07550	ADRB2_HUMAN	Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)	GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0002032; GO:0004935; GO:0004941; GO:0005634; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0005887; GO:0006898; GO:0007166; GO:0007171; GO:0007186; GO:0007188; GO:0007190; GO:0008179; GO:0008333; GO:0009409; GO:0010008; GO:0010739; GO:0015459; GO:0016020; GO:0016324; GO:0016579; GO:0030501; GO:0030665; GO:0031398; GO:0031649; GO:0040015; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045453; GO:0045944; GO:0045986; GO:0050873; GO:0051379; GO:0051380; GO:0061024; GO:0061885; GO:0071875; GO:0071880; GO:0071902; GO:0120162; GO:1901098; GO:1904504; GO:1904646; GO:1990911; GO:2000481; GO:2000969	apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; adenylate cyclase binding [GO:0008179]; adrenergic receptor activity [GO:0004935]; amyloid-beta binding [GO:0001540]; beta2-adrenergic receptor activity [GO:0004941]; epinephrine binding [GO:0051379]; identical protein binding [GO:0042802]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; activation of adenylate cyclase activity [GO:0007190]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenergic receptor signaling pathway [GO:0071875]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; diet induced thermogenesis [GO:0002024]; endosome to lysosome transport [GO:0008333]; G protein-coupled receptor signaling pathway [GO:0007186]; heat generation [GO:0031649]; membrane organization [GO:0061024]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; response to psychosocial stress [GO:1990911]
PGEN_.00g032080	Scaffold_01	87350238	87352175	A4IF63	TRIM2_BOVIN	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g032090	Scaffold_01	87358934	87359311	NA	NA	NA	NA	NA
PGEN_.00g032100	Scaffold_01	87361465	87376708	P53041	PPP5_HUMAN	Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT)	GO:0000165; GO:0000278; GO:0001933; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006351; GO:0006470; GO:0008017; GO:0008289; GO:0010288; GO:0016576; GO:0016791; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043204; GO:0043231; GO:0043278; GO:0043531; GO:0046872; GO:0048156; GO:0051291; GO:0051879; GO:0070262; GO:0070301; GO:0071276; GO:0101031; GO:1901215; GO:1904550; GO:1990635; GO:2000324	"chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g032110	Scaffold_01	87381507	87391585	Q96FN9	DTD2_HUMAN	D-aminoacyl-tRNA deacylase 2 (EC 3.1.1.96) (Animalia-specific tRNA deacylase) (ATD) (D-tyrosyl-tRNA(Tyr) deacylase 2) (L-alanyl-tRNA deacylase) (EC 3.1.1.-)	GO:0000049; GO:0002161; GO:0005737; GO:0006399; GO:0051500; GO:0106074; GO:0106105	cytoplasm [GO:0005737]; Ala-tRNA(Thr) hydrolase activity [GO:0106105]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049]; aminoacyl-tRNA metabolism involved in translational fidelity [GO:0106074]; tRNA metabolic process [GO:0006399]
PGEN_.00g032120	Scaffold_01	87397813	87428498	P35815	PPM1B_RAT	Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)	GO:0000287; GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]
PGEN_.00g032130	Scaffold_01	87434951	87441668	O94766	B3GA3_HUMAN	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I)"	GO:0000139; GO:0005794; GO:0005801; GO:0006024; GO:0006486; GO:0015012; GO:0015018; GO:0015020; GO:0016020; GO:0016021; GO:0030203; GO:0043085; GO:0046872; GO:0050650; GO:0050651; GO:0070062; GO:0072542; GO:0090316	cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein phosphatase activator activity [GO:0072542]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of catalytic activity [GO:0043085]; positive regulation of intracellular protein transport [GO:0090316]; protein glycosylation [GO:0006486]
PGEN_.00g032140	Scaffold_01	87446766	87456098	Q5E951	TBCB_BOVIN	Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B)	GO:0005737; GO:0005829; GO:0005874; GO:0007399; GO:0030154	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g032150	Scaffold_01	87459945	87516368	O88738	BIRC6_MOUSE	Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)	GO:0000922; GO:0001890; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0006511; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; placenta development [GO:0001890]; positive regulation of cell population proliferation [GO:0008284]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g032160	Scaffold_01	87517014	87526727	Q9NR09	BIRC6_HUMAN	Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)	GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0006468; GO:0006511; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g032170	Scaffold_01	87534576	87538917	NA	NA	NA	NA	NA
PGEN_.00g032180	Scaffold_01	87552464	87563486	Q5R5M4	MOT9_PONAB	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]
PGEN_.00g032190	Scaffold_01	87563574	87569465	NA	NA	NA	NA	NA
PGEN_.00g032200	Scaffold_01	87586560	87601639	Q8TBZ3	WDR20_HUMAN	WD repeat-containing protein 20 (Protein DMR)	GO:0005654; GO:0016579	nucleoplasm [GO:0005654]; protein deubiquitination [GO:0016579]
PGEN_.00g032210	Scaffold_01	87607475	87607756	NA	NA	NA	NA	NA
PGEN_.00g032220	Scaffold_01	87624196	87624507	Q9D5R2	WDR20_MOUSE	WD repeat-containing protein 20		
PGEN_.00g032230	Scaffold_01	87626445	87627469	NA	NA	NA	NA	NA
PGEN_.00g032240	Scaffold_01	87656189	87667346	Q6ETN3	4CL3_ORYSJ	Probable 4-coumarate--CoA ligase 3 (4CL 3) (Os4CL3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3)	GO:0005524; GO:0009698; GO:0016207	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]
PGEN_.00g032250	Scaffold_01	87697650	87700319	NA	NA	NA	NA	NA
PGEN_.00g032260	Scaffold_01	87704462	87708958	NA	NA	NA	NA	NA
PGEN_.00g032270	Scaffold_01	87725574	87728051	NA	NA	NA	NA	NA
PGEN_.00g032280	Scaffold_01	87740561	87741052	NA	NA	NA	NA	NA
PGEN_.00g032290	Scaffold_01	87742032	87742885	NA	NA	NA	NA	NA
PGEN_.00g032300	Scaffold_01	87763239	87771513	P08478	AMDA_XENLA	Peptidyl-glycine alpha-amidating monooxygenase A (PAM-A) (Peptide C-terminal alpha-amidating enzyme I) (AE-I) (Peptidyl-glycine alpha-amidating monooxygenase I) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase A (PHM-A) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase A (EC 4.3.2.5) (Peptidylamidoglycolate lyase-A) (PAL-A)]	GO:0004504; GO:0004598; GO:0005507; GO:0006518; GO:0016021; GO:0030658	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; peptide metabolic process [GO:0006518]
PGEN_.00g032310	Scaffold_01	87775685	87777037	NA	NA	NA	NA	NA
PGEN_.00g032320	Scaffold_01	87778822	87779355	NA	NA	NA	NA	NA
PGEN_.00g032330	Scaffold_01	87779669	87780338	NA	NA	NA	NA	NA
PGEN_.00g032340	Scaffold_01	87841011	87841493	NA	NA	NA	NA	NA
PGEN_.00g032350	Scaffold_01	87843935	87844228	NA	NA	NA	NA	NA
PGEN_.00g032360	Scaffold_01	87844631	87844921	NA	NA	NA	NA	NA
PGEN_.00g032370	Scaffold_01	87846891	87847160	NA	NA	NA	NA	NA
PGEN_.00g032380	Scaffold_01	87853568	87866536	Q9S725	4CL2_ARATH	4-coumarate--CoA ligase 2 (4CL 2) (EC 6.2.1.12) (4-coumarate--CoA ligase isoform 2) (At4CL2) (4-coumaroyl-CoA synthase 2)	GO:0005524; GO:0009698; GO:0016207	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]
PGEN_.00g032390	Scaffold_01	87873846	87875862	NA	NA	NA	NA	NA
PGEN_.00g032400	Scaffold_01	87875993	87876382	NA	NA	NA	NA	NA
PGEN_.00g032410	Scaffold_01	87878322	87888596	Q6ETN3	4CL3_ORYSJ	Probable 4-coumarate--CoA ligase 3 (4CL 3) (Os4CL3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3)	GO:0005524; GO:0009698; GO:0016207	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]
PGEN_.00g032420	Scaffold_01	87893456	87916915	Q6ZMI0	PPR21_HUMAN	Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (KLRAQ motif-containing protein 1)	GO:0005769; GO:0016020	early endosome [GO:0005769]; membrane [GO:0016020]
PGEN_.00g032430	Scaffold_01	87924706	87926833	NA	NA	NA	NA	NA
PGEN_.00g032440	Scaffold_01	87929847	87954455	Q13435	SF3B2_HUMAN	Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (Spliceosome-associated protein 145) (SAP 145)	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005689; GO:0006397; GO:0008380; GO:0016032; GO:0016607; GO:0071005; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; viral process [GO:0016032]"
PGEN_.00g032450	Scaffold_01	87963370	87995917	D3Z5L6	S18B1_MOUSE	MFS-type transporter SLC18B1 (Solute carrier family 18 member B1)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g032460	Scaffold_01	88009618	88019715	Q15907	RB11B_HUMAN	Ras-related protein Rab-11B (GTP-binding protein YPT3)	GO:0001881; GO:0003924; GO:0005525; GO:0005623; GO:0005768; GO:0005829; GO:0006886; GO:0006887; GO:0008021; GO:0019003; GO:0030054; GO:0030670; GO:0031489; GO:0032402; GO:0032482; GO:0033572; GO:0035773; GO:0043687; GO:0044070; GO:0045054; GO:0045055; GO:0045296; GO:0045335; GO:0055037; GO:0055038; GO:0070062; GO:0071468; GO:0090150; GO:0098993; GO:0150093; GO:1990126; GO:2000008; GO:2001135	"anchored component of synaptic vesicle membrane [GO:0098993]; cell [GO:0005623]; cell junction [GO:0030054]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; cadherin binding [GO:0045296]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; amyloid-beta clearance by transcytosis [GO:0150093]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; establishment of protein localization to membrane [GO:0090150]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; post-translational protein modification [GO:0043687]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"
PGEN_.00g032470	Scaffold_01	88039144	88058022	Q9QXM0	ABHD2_MOUSE	Monoacylglycerol lipase ABHD2 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Acetylesterase) (EC 3.1.1.6) (Lung alpha/beta hydrolase 2) (MmLABH2) (Triacylglycerol lipase) (EC 3.1.1.79)	GO:0001669; GO:0002080; GO:0003707; GO:0007340; GO:0008126; GO:0009611; GO:0016021; GO:0016298; GO:0030336; GO:0032570; GO:0033878; GO:0036126; GO:0042562; GO:0043401; GO:0044255; GO:0046464; GO:0047372; GO:0048240; GO:0097524	acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; hormone binding [GO:0042562]; hormone-sensitive lipase activity [GO:0033878]; lipase activity [GO:0016298]; steroid hormone receptor activity [GO:0003707]; acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; negative regulation of cell migration [GO:0030336]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401]
PGEN_.00g032480	Scaffold_01	88084553	88090315	Q9WVL0	MAAI_MOUSE	Maleylacetoacetate isomerase (MAAI) (EC 5.2.1.2) (GSTZ1-1) (Glutathione S-transferase zeta 1) (EC 2.5.1.18)	GO:0004364; GO:0005739; GO:0006559; GO:0006572; GO:0006749; GO:0016034; GO:0042802; GO:0042803	mitochondrion [GO:0005739]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; maleylacetoacetate isomerase activity [GO:0016034]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]
PGEN_.00g032490	Scaffold_01	88093229	88112538	F1Q8R9	POMT2_DANRE	Protein O-mannosyl-transferase 2 (EC 2.4.1.109)	GO:0004169; GO:0005789; GO:0016021; GO:0035269; GO:0071712	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; ER-associated misfolded protein catabolic process [GO:0071712]; protein O-linked mannosylation [GO:0035269]
PGEN_.00g032500	Scaffold_01	88118979	88121037	NA	NA	NA	NA	NA
PGEN_.00g032510	Scaffold_01	88121224	88138544	D3Z5L6	S18B1_MOUSE	MFS-type transporter SLC18B1 (Solute carrier family 18 member B1)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g032520	Scaffold_01	88158389	88159285	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g032530	Scaffold_01	88163619	88164778	NA	NA	NA	NA	NA
PGEN_.00g032540	Scaffold_01	88188637	88189209	Q02290	XYNB_NEOPA	"Endo-1,4-beta-xylanase B (Xylanase B) (EC 3.2.1.8) (1,4-beta-D-xylan xylanohydrolase B)"	GO:0005576; GO:0030248; GO:0031176; GO:0045493	"extracellular region [GO:0005576]; cellulose binding [GO:0030248]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g032550	Scaffold_01	88232167	88236442	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g032560	Scaffold_01	88247945	88261676	P69201	RL40_LEIMA	Ubiquitin-60S ribosomal protein L40 [Cleaved into: Ubiquitin; 60S ribosomal protein L40 (CEP52)]	GO:0003735; GO:0005634; GO:0005737; GO:0005840; GO:0006412; GO:0016567; GO:0019941; GO:0031386; GO:0031625	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribosome [GO:0005840]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]
PGEN_.00g032570	Scaffold_01	88264995	88265429	NA	NA	NA	NA	NA
PGEN_.00g032580	Scaffold_01	88265504	88266094	NA	NA	NA	NA	NA
PGEN_.00g032590	Scaffold_01	88266379	88267323	NA	NA	NA	NA	NA
PGEN_.00g032600	Scaffold_01	88280011	88281404	NA	NA	NA	NA	NA
PGEN_.00g032610	Scaffold_01	88290489	88336044	NA	NA	NA	NA	NA
PGEN_.00g032620	Scaffold_01	88337949	88339472	NA	NA	NA	NA	NA
PGEN_.00g032630	Scaffold_01	88349645	88350031	NA	NA	NA	NA	NA
PGEN_.00g032640	Scaffold_01	88350365	88350820	NA	NA	NA	NA	NA
PGEN_.00g032650	Scaffold_01	88351115	88352266	NA	NA	NA	NA	NA
PGEN_.00g032660	Scaffold_01	88352306	88353025	D3ZEN0	MILK2_RAT	MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2)	GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0031941; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]
PGEN_.00g032670	Scaffold_01	88357420	88371915	NA	NA	NA	NA	NA
PGEN_.00g032680	Scaffold_01	88387127	88390975	NA	NA	NA	NA	NA
PGEN_.00g032690	Scaffold_01	88404594	88406437	NA	NA	NA	NA	NA
PGEN_.00g032700	Scaffold_01	88430831	88432429	NA	NA	NA	NA	NA
PGEN_.00g032710	Scaffold_01	88432687	88433025	NA	NA	NA	NA	NA
PGEN_.00g032720	Scaffold_01	88433062	88433472	NA	NA	NA	NA	NA
PGEN_.00g032730	Scaffold_01	88433511	88434919	Q552Z2	FNKE_DICDI	Probable serine/threonine-protein kinase fnkE (EC 2.7.11.1) (FNIP repeat-containing protein E)	GO:0004674; GO:0005524; GO:0046872	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g032740	Scaffold_01	88473419	88475944	NA	NA	NA	NA	NA
PGEN_.00g032750	Scaffold_01	88479537	88480148	NA	NA	NA	NA	NA
PGEN_.00g032760	Scaffold_01	88482240	88485477	NA	NA	NA	NA	NA
PGEN_.00g032770	Scaffold_01	88490387	88490788	NA	NA	NA	NA	NA
PGEN_.00g032780	Scaffold_01	88530189	88530893	NA	NA	NA	NA	NA
PGEN_.00g032790	Scaffold_01	88530944	88531318	NA	NA	NA	NA	NA
PGEN_.00g032800	Scaffold_01	88531706	88531921	NA	NA	NA	NA	NA
PGEN_.00g032810	Scaffold_01	88532144	88532521	NA	NA	NA	NA	NA
PGEN_.00g032820	Scaffold_01	88532690	88533571	NA	NA	NA	NA	NA
PGEN_.00g032830	Scaffold_01	88564522	88564878	Q8JIS3	DER_CHICK	D-erythrulose reductase (EC 1.1.1.162) (Probable L-xylulose reductase) (XR) (EC 1.1.1.10)	GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0047880; GO:0050038; GO:0051289	"cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g032840	Scaffold_01	88567352	88567720	NA	NA	NA	NA	NA
PGEN_.00g032850	Scaffold_01	88567920	88569633	NA	NA	NA	NA	NA
PGEN_.00g032860	Scaffold_01	88570058	88577459	NA	NA	NA	NA	NA
PGEN_.00g032870	Scaffold_01	88595674	88598566	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g032880	Scaffold_01	88636687	88658038	Q99M80	PTPRT_MOUSE	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0050807; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:0098978; GO:0099061; GO:1904893; GO:1990264	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g032890	Scaffold_01	88658193	88679544	Q99M80	PTPRT_MOUSE	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0050807; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:0098978; GO:0099061; GO:1904893; GO:1990264	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g032900	Scaffold_01	88717665	88746173	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g032910	Scaffold_01	88746598	88748311	NA	NA	NA	NA	NA
PGEN_.00g032920	Scaffold_01	88748511	88748879	NA	NA	NA	NA	NA
PGEN_.00g032930	Scaffold_01	88758124	88758726	NA	NA	NA	NA	NA
PGEN_.00g032940	Scaffold_01	88785859	88786917	NA	NA	NA	NA	NA
PGEN_.00g032950	Scaffold_01	88831616	88833180	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g032960	Scaffold_01	88842768	88856665	Q6DD19	GPBP1_XENLA	Vasculin (GC-rich promoter-binding protein 1)	GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0045893	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g032970	Scaffold_01	88857232	88864444	NA	NA	NA	NA	NA
PGEN_.00g032980	Scaffold_01	88870279	88870806	NA	NA	NA	NA	NA
PGEN_.00g032990	Scaffold_01	88871532	88872542	NA	NA	NA	NA	NA
PGEN_.00g033000	Scaffold_01	88873034	88873972	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g033010	Scaffold_01	88901037	88901549	NA	NA	NA	NA	NA
PGEN_.00g033020	Scaffold_01	88905669	88914105	Q02224	CENPE_HUMAN	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin-7) (Kinesin-related protein CENPE)	GO:0000278; GO:0000775; GO:0000776; GO:0000777; GO:0000779; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007275; GO:0008017; GO:0015630; GO:0016020; GO:0016887; GO:0019886; GO:0030071; GO:0030496; GO:0043515; GO:0045860; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0099606; GO:0099607; GO:1990023	"cell [GO:0005623]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g033030	Scaffold_01	88915247	88948631	Q6RT24	CENPE_MOUSE	Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)	GO:0000278; GO:0000775; GO:0000776; GO:0000778; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005694; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0007275; GO:0008017; GO:0008608; GO:0015630; GO:0016887; GO:0019901; GO:0030071; GO:0030496; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0099606; GO:0099607; GO:1990023	"cell [GO:0005623]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome outer kinetochore [GO:0000940]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle organization [GO:0007052]; multicellular organism development [GO:0007275]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]"
PGEN_.00g033040	Scaffold_01	88954764	89011700	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g033050	Scaffold_01	89032325	89038602	Q9QYG6	CP2DR_MESAU	Cytochrome P450 2D27 (EC 1.14.14.-) (CYPIID27)	GO:0005506; GO:0005789; GO:0016712; GO:0020037	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]"
PGEN_.00g033060	Scaffold_01	89052975	89055368	NA	NA	NA	NA	NA
PGEN_.00g033070	Scaffold_01	89057103	89059168	O18809	CP2F3_CAPHI	Cytochrome P450 2F3 (EC 1.14.14.1) (CYPIIF3)	GO:0005506; GO:0005789; GO:0019825; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]
PGEN_.00g033080	Scaffold_01	89062529	89065700	NA	NA	NA	NA	NA
PGEN_.00g033090	Scaffold_01	89094243	89098105	Q6R7M4	C15A1_DIPPU	Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1)	GO:0005506; GO:0006718; GO:0016709; GO:0020037	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]"
PGEN_.00g033100	Scaffold_01	89100681	89108076	Q53G44	IF44L_HUMAN	Interferon-induced protein 44-like	GO:0005525; GO:0005737; GO:0006955; GO:0051607	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]
PGEN_.00g033110	Scaffold_01	89124420	89124698	NA	NA	NA	NA	NA
PGEN_.00g033120	Scaffold_01	89161900	89167035	Q53G44	IF44L_HUMAN	Interferon-induced protein 44-like	GO:0005525; GO:0005737; GO:0006955; GO:0051607	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]
PGEN_.00g033130	Scaffold_01	89181240	89194852	P97355	SPSY_MOUSE	Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase)	GO:0006597; GO:0008215; GO:0016768	spermine synthase activity [GO:0016768]; spermine biosynthetic process [GO:0006597]; spermine metabolic process [GO:0008215]
PGEN_.00g033140	Scaffold_01	89200432	89203189	NA	NA	NA	NA	NA
PGEN_.00g033150	Scaffold_01	89204335	89213565	P27473	IFI44_PANTR	Interferon-induced protein 44 (Antigen p44) (Non-A non-B hepatitis-associated microtubular aggregates protein)	GO:0005737; GO:0006955; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]
PGEN_.00g033160	Scaffold_01	89230968	89234030	NA	NA	NA	NA	NA
PGEN_.00g033170	Scaffold_01	89236495	89240677	NA	NA	NA	NA	NA
PGEN_.00g033180	Scaffold_01	89240703	89258042	NA	NA	NA	NA	NA
PGEN_.00g033190	Scaffold_01	89262424	89272142	NA	NA	NA	NA	NA
PGEN_.00g033200	Scaffold_01	89305315	89313122	Q9BDB7	IF44L_MOUSE	Interferon-induced protein 44-like [Cleaved into: Minor histocompatibility antigen HA-28 (HLA-HA28) (IFL8)]	GO:0005737; GO:0006955; GO:0051607	cytoplasm [GO:0005737]; defense response to virus [GO:0051607]; immune response [GO:0006955]
PGEN_.00g033210	Scaffold_01	89349086	89358493	NA	NA	NA	NA	NA
PGEN_.00g033220	Scaffold_01	89374690	89375022	NA	NA	NA	NA	NA
PGEN_.00g033230	Scaffold_01	89389742	89390866	NA	NA	NA	NA	NA
PGEN_.00g033240	Scaffold_01	89426178	89428526	P0DP23	CALM1_HUMAN	Calmodulin-1	GO:0000165; GO:0000922; GO:0002027; GO:0002576; GO:0005509; GO:0005513; GO:0005576; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0005980; GO:0006936; GO:0007186; GO:0007223; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0019722; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0022400; GO:0030017; GO:0031432; GO:0031954; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0038095; GO:0043539; GO:0043647; GO:0044325; GO:0050999; GO:0051186; GO:0051343; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0097718; GO:1901844; GO:1902494	"calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; vesicle [GO:0031982]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; calcium-mediated signaling [GO:0019722]; cofactor metabolic process [GO:0051186]; detection of calcium ion [GO:0005513]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; glycogen catabolic process [GO:0005980]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; muscle contraction [GO:0006936]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to calcium ion [GO:0051592]; substantia nigra development [GO:0021762]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"
PGEN_.00g033250	Scaffold_01	89451311	89455462	P02594	CALM_ELEEL	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g033260	Scaffold_01	89477440	89493698	P62148	CALM1_BRALA	Calmodulin-1 (CaM 1)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g033270	Scaffold_01	89509716	89543234	P62153	CALMA_HALRO	Calmodulin-A (CaM A)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g033280	Scaffold_01	89556182	89562340	Q9UWF0	CALM_MAGO7	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g033290	Scaffold_01	89587337	89595215	P0DP23	CALM1_HUMAN	Calmodulin-1	GO:0000165; GO:0000922; GO:0002027; GO:0002576; GO:0005509; GO:0005513; GO:0005576; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0005980; GO:0006936; GO:0007186; GO:0007223; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0019722; GO:0019855; GO:0019901; GO:0019904; GO:0021762; GO:0022400; GO:0030017; GO:0031432; GO:0031954; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0038095; GO:0043539; GO:0043647; GO:0044325; GO:0050999; GO:0051186; GO:0051343; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0097718; GO:1901844; GO:1902494	"calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; vesicle [GO:0031982]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; disordered domain specific binding [GO:0097718]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; calcium-mediated signaling [GO:0019722]; cofactor metabolic process [GO:0051186]; detection of calcium ion [GO:0005513]; Fc-epsilon receptor signaling pathway [GO:0038095]; G protein-coupled receptor signaling pathway [GO:0007186]; glycogen catabolic process [GO:0005980]; inositol phosphate metabolic process [GO:0043647]; MAPK cascade [GO:0000165]; muscle contraction [GO:0006936]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; platelet degranulation [GO:0002576]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to calcium ion [GO:0051592]; substantia nigra development [GO:0021762]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"
PGEN_.00g033300	Scaffold_01	89601769	89638524	Q8CCP0	NEMF_MOUSE	Nuclear export mediator factor Nemf (Serologically defined colon cancer antigen 1 homolog)	GO:0000049; GO:0005634; GO:0043023; GO:0051168; GO:0072344; GO:1990112; GO:1990116	nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]
PGEN_.00g033310	Scaffold_02	642	56377	Q5DTT2	PSD1_MOUSE	PH and SEC7 domain-containing protein 1 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6) (Exchange factor for ARF6) (Exchange factor for ARF6 A) (Pleckstrin homology and SEC7 domain-containing protein 1)	GO:0005086; GO:0005543; GO:0014069; GO:0016021; GO:0031175; GO:0032012; GO:0032154; GO:0032587; GO:0043197; GO:0098999; GO:0099092	"cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phospholipid binding [GO:0005543]; neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]"
PGEN_.00g033320	Scaffold_02	77047	111398	Q5R4G0	SGPL1_PONAB	Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL) (SPL 1) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)	GO:0005783; GO:0005789; GO:0006631; GO:0006915; GO:0008117; GO:0016021; GO:0016831; GO:0030149; GO:0030170	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; apoptotic process [GO:0006915]; fatty acid metabolic process [GO:0006631]; sphingolipid catabolic process [GO:0030149]
PGEN_.00g033330	Scaffold_02	135111	164310	Q5U2Z7	RHG24_RAT	Rho GTPase-activating protein 24 (Down-regulated in nephrectomized rat kidney #2) (Rho-type GTPase-activating protein 24)	GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:0090630; GO:1900028	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]"
PGEN_.00g033340	Scaffold_02	169133	204814	P92208	JNK_DROME	Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket)	GO:0000165; GO:0001736; GO:0004672; GO:0004674; GO:0004705; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0007391; GO:0007395; GO:0007411; GO:0007616; GO:0009408; GO:0010468; GO:0010508; GO:0010628; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0035556; GO:0042060; GO:0043508; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048010; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0071243; GO:0071276; GO:0071907; GO:1903688; GO:1904801	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"
PGEN_.00g033350	Scaffold_02	215510	217695	NA	NA	NA	NA	NA
PGEN_.00g033360	Scaffold_02	222092	230078	Q5VNW5	IMCL2_ORYSJ	Probable isoprenylcysteine alpha-carbonyl methylesterase ICMEL2 (EC 3.1.1.n2) (Isoprenylcysteine methylesterase-like protein 2)	GO:0000139; GO:0005789; GO:0009056; GO:0010296; GO:0016021; GO:0016787	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; prenylcysteine methylesterase activity [GO:0010296]; catabolic process [GO:0009056]
PGEN_.00g033370	Scaffold_02	231941	240053	Q9WTN0	GGPPS_MOUSE	"Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10)"	GO:0004161; GO:0004311; GO:0004337; GO:0005737; GO:0006720; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0046872	cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid metabolic process [GO:0006720]
PGEN_.00g033380	Scaffold_02	271748	272035	NA	NA	NA	NA	NA
PGEN_.00g033390	Scaffold_02	289485	290345	NA	NA	NA	NA	NA
PGEN_.00g033400	Scaffold_02	293345	298899	NA	NA	NA	NA	NA
PGEN_.00g033410	Scaffold_02	304153	309037	NA	NA	NA	NA	NA
PGEN_.00g033420	Scaffold_02	317251	317900	NA	NA	NA	NA	NA
PGEN_.00g033430	Scaffold_02	343397	343663	NA	NA	NA	NA	NA
PGEN_.00g033440	Scaffold_02	358113	391472	O57685	PAX2A_XENLA	Paired box protein Pax-2-A (xPax-2a)	GO:0000122; GO:0003677; GO:0005634; GO:0007367; GO:0045944	nucleus [GO:0005634]; DNA binding [GO:0003677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]
PGEN_.00g033450	Scaffold_02	439726	453690	NA	NA	NA	NA	NA
PGEN_.00g033460	Scaffold_02	462698	477169	NA	NA	NA	NA	NA
PGEN_.00g033470	Scaffold_02	487956	493661	NA	NA	NA	NA	NA
PGEN_.00g033480	Scaffold_02	502828	522319	NA	NA	NA	NA	NA
PGEN_.00g033490	Scaffold_02	534478	556223	O00534	VMA5A_HUMAN	von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein)	GO:0005654	nucleoplasm [GO:0005654]
PGEN_.00g033500	Scaffold_02	569509	570606	Q93127	GPR18_AMPAM	Probable G-protein coupled receptor No18	GO:0004989; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]
PGEN_.00g033510	Scaffold_02	597508	602728	Q09324	GCNT1_MOUSE	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT)"	GO:0000139; GO:0003829; GO:0005615; GO:0005802; GO:0006486; GO:0009101; GO:0016021; GO:0031985; GO:0032868; GO:0048729; GO:0050901; GO:0060352; GO:0060993	"extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; protein glycosylation [GO:0006486]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]"
PGEN_.00g033520	Scaffold_02	615608	628973	NA	NA	NA	NA	NA
PGEN_.00g033530	Scaffold_02	687342	792503	Q9VJ79	PDE11_DROME	"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11)"	GO:0004115; GO:0005829; GO:0007165; GO:0046058; GO:0046068; GO:0046872; GO:0047555	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]"
PGEN_.00g033540	Scaffold_02	802008	828796	P42942	YG4I_YEAST	Uncharacterized GTP-binding protein YGR210C	GO:0005525; GO:0005737; GO:0016887	cytoplasm [GO:0005737]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]
PGEN_.00g033550	Scaffold_02	828896	910839	Q6Q0C0	TRAF7_HUMAN	E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7)	GO:0000151; GO:0000185; GO:0004842; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0043231; GO:0043410; GO:0070372; GO:2001235	cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]
PGEN_.00g033560	Scaffold_02	941000	997104	Q922B6	TRAF7_MOUSE	E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7)	GO:0000122; GO:0000151; GO:0000185; GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0032880; GO:0033235; GO:0043231; GO:0043410; GO:0048471; GO:0070372; GO:0071354; GO:2001235	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; cellular response to interleukin-6 [GO:0071354]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein sumoylation [GO:0033235]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein localization [GO:0032880]
PGEN_.00g033570	Scaffold_02	1018258	1020771	Q9UJU3	ZN112_HUMAN	Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g033580	Scaffold_02	1055519	1055977	NA	NA	NA	NA	NA
PGEN_.00g033590	Scaffold_02	1056711	1067043	NA	NA	NA	NA	NA
PGEN_.00g033600	Scaffold_02	1076765	1078003	NA	NA	NA	NA	NA
PGEN_.00g033610	Scaffold_02	1105645	1105908	NA	NA	NA	NA	NA
PGEN_.00g033620	Scaffold_02	1134621	1135958	P02711	ACHA_TORMA	Acetylcholine receptor subunit alpha	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g033630	Scaffold_02	1143517	1150895	NA	NA	NA	NA	NA
PGEN_.00g033640	Scaffold_02	1160024	1165781	P03952	KLKB1_HUMAN	Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) (PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]	GO:0002542; GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007597; GO:0022617; GO:0031638; GO:0031639; GO:0042730; GO:0051919; GO:0070062	"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]"
PGEN_.00g033650	Scaffold_02	1188579	1191287	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g033660	Scaffold_02	1196986	1198128	NA	NA	NA	NA	NA
PGEN_.00g033670	Scaffold_02	1199764	1200132	NA	NA	NA	NA	NA
PGEN_.00g033680	Scaffold_02	1209305	1238574	Q8K4K5	L2GL1_RAT	Lethal(2) giant larvae protein homolog 1 (LLGL) (Rgl-1)	GO:0000137; GO:0005096; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0006887; GO:0006893; GO:0007409; GO:0008593; GO:0016323; GO:0017137; GO:0019901; GO:0030424; GO:0030864; GO:0030866; GO:0031901; GO:0032588; GO:0032878; GO:0035090; GO:0035748; GO:0045159; GO:0051294; GO:0065003	axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; myelin sheath abaxonal region [GO:0035748]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; maintenance of apical/basal cell polarity [GO:0035090]; protein-containing complex assembly [GO:0065003]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]
PGEN_.00g033690	Scaffold_02	1260582	1271475	Q05481	ZNF91_HUMAN	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]"
PGEN_.00g033700	Scaffold_02	1291116	1310529	P42664	UVS2_XENLA	Embryonic protein UVS.2 (EC 3.4.24.-)	GO:0004222; GO:0008270	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g033710	Scaffold_02	1334679	1359922	B3EWZ6	MLRP2_ACRMI	MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g033720	Scaffold_02	1362244	1372506	P30975	TLR2_DROME	Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR)	GO:0004995; GO:0005886; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0042048; GO:0050805; GO:0050911; GO:1904058	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]
PGEN_.00g033730	Scaffold_02	1379620	1385022	NA	NA	NA	NA	NA
PGEN_.00g033740	Scaffold_02	1392310	1400398	P86734	EPDR1_HALAI	Ependymin-related protein 1	GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g033750	Scaffold_02	1409941	1419074	NA	NA	NA	NA	NA
PGEN_.00g033760	Scaffold_02	1427111	1428637	NA	NA	NA	NA	NA
PGEN_.00g033770	Scaffold_02	1430692	1466110	P22770	ACHA7_CHICK	Neuronal acetylcholine receptor subunit alpha-7	GO:0000187; GO:0001540; GO:0001666; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890	"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g033780	Scaffold_02	1507844	1508101	NA	NA	NA	NA	NA
PGEN_.00g033790	Scaffold_02	1508884	1509141	NA	NA	NA	NA	NA
PGEN_.00g033800	Scaffold_02	1562800	1563054	NA	NA	NA	NA	NA
PGEN_.00g033810	Scaffold_02	1581092	1586427	NA	NA	NA	NA	NA
PGEN_.00g033820	Scaffold_02	1597297	1606444	NA	NA	NA	NA	NA
PGEN_.00g033830	Scaffold_02	1675660	1675908	NA	NA	NA	NA	NA
PGEN_.00g033840	Scaffold_02	1676094	1676486	NA	NA	NA	NA	NA
PGEN_.00g033850	Scaffold_02	1699470	1700087	NA	NA	NA	NA	NA
PGEN_.00g033860	Scaffold_02	1700603	1701250	NA	NA	NA	NA	NA
PGEN_.00g033870	Scaffold_02	1745518	1758357	Q9JKQ2	S26A5_MERUN	Prestin (Solute carrier family 26 member 5)	GO:0007605; GO:0008271; GO:0008360; GO:0016021; GO:0016323	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; secondary active sulfate transmembrane transporter activity [GO:0008271]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]
PGEN_.00g033880	Scaffold_02	1769388	1770427	NA	NA	NA	NA	NA
PGEN_.00g033890	Scaffold_02	1788782	1819250	Q14692	BMS1_HUMAN	Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog)	GO:0000462; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0006364; GO:0030686; GO:0034511	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]"
PGEN_.00g033900	Scaffold_02	1825008	1893348	A8Y5H7	S14L1_MOUSE	SEC14-like protein 1	GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039536; GO:0039552; GO:0045087; GO:0098772	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; molecular function regulator [GO:0098772]; RIG-I binding [GO:0039552]; choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]
PGEN_.00g033910	Scaffold_02	1897684	1900047	NA	NA	NA	NA	NA
PGEN_.00g033920	Scaffold_02	1954424	1967213	P30551	CCKAR_RAT	Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R)	GO:0001659; GO:0001696; GO:0001764; GO:0002023; GO:0004930; GO:0004951; GO:0005623; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0005887; GO:0007186; GO:0007204; GO:0007409; GO:0007584; GO:0007631; GO:0009314; GO:0009408; GO:0016020; GO:0017046; GO:0030073; GO:0030157; GO:0030900; GO:0031016; GO:0031100; GO:0031532; GO:0032496; GO:0032870; GO:0038188; GO:0042594; GO:0042755; GO:0043195; GO:0043266; GO:0046883; GO:0048545; GO:0051384; GO:0051924; GO:0090274	cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; actin cytoskeleton reorganization [GO:0031532]; animal organ regeneration [GO:0031100]; axonogenesis [GO:0007409]; cellular response to hormone stimulus [GO:0032870]; cholecystokinin signaling pathway [GO:0038188]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric acid secretion [GO:0001696]; insulin secretion [GO:0030073]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; pancreatic juice secretion [GO:0030157]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of somatostatin secretion [GO:0090274]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of calcium ion transport [GO:0051924]; regulation of hormone secretion [GO:0046883]; regulation of potassium ion transport [GO:0043266]; response to glucocorticoid [GO:0051384]; response to heat [GO:0009408]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to radiation [GO:0009314]; response to starvation [GO:0042594]; response to steroid hormone [GO:0048545]; temperature homeostasis [GO:0001659]
PGEN_.00g033930	Scaffold_02	2006354	2016916	NA	NA	NA	NA	NA
PGEN_.00g033940	Scaffold_02	2024773	2071489	O75112	LDB3_HUMAN	LIM domain-binding protein 3 (Protein cypher) (Z-band alternatively spliced PDZ-motif protein)	GO:0001725; GO:0003779; GO:0005080; GO:0005856; GO:0005913; GO:0007507; GO:0008092; GO:0030018; GO:0030036; GO:0031143; GO:0031941; GO:0045214; GO:0046872; GO:0048471; GO:0051371; GO:0061061	cell-cell adherens junction [GO:0005913]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]; sarcomere organization [GO:0045214]
PGEN_.00g033950	Scaffold_02	2079138	2101489	NA	NA	NA	NA	NA
PGEN_.00g033960	Scaffold_02	2130611	2131741	Q96A11	G3ST3_HUMAN	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal3ST3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0005996; GO:0006790; GO:0009247; GO:0009311; GO:0016021; GO:0030166; GO:0030246; GO:0030309; GO:0032580; GO:0050656; GO:0050694; GO:0050698	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; carbohydrate binding [GO:0030246]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; glycolipid biosynthetic process [GO:0009247]; monosaccharide metabolic process [GO:0005996]; oligosaccharide metabolic process [GO:0009311]; poly-N-acetyllactosamine metabolic process [GO:0030309]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g033970	Scaffold_02	2168076	2187460	Q0P595	SIR7_BOVIN	NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7)	GO:0000122; GO:0003682; GO:0004407; GO:0005634; GO:0005724; GO:0005730; GO:0005731; GO:0005737; GO:0007072; GO:0009303; GO:0016740; GO:0046872; GO:0070403; GO:0070932; GO:0097372	cytoplasm [GO:0005737]; nuclear telomeric heterochromatin [GO:0005724]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; transferase activity [GO:0016740]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; rRNA transcription [GO:0009303]
PGEN_.00g033980	Scaffold_02	2250307	2314472	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g033990	Scaffold_02	2329998	2438724	P07207	NOTCH_DROME	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	GO:0001708; GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0005915; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007455; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035003; GO:0035153; GO:0035162; GO:0035165; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043525; GO:0043697; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048	"adherens junction [GO:0005912]; cell [GO:0005623]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
PGEN_.00g034000	Scaffold_02	2472657	2499140	A6NMZ7	CO6A6_HUMAN	Collagen alpha-6(VI) chain	GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g034010	Scaffold_02	2542580	2543652	NA	NA	NA	NA	NA
PGEN_.00g034020	Scaffold_02	2545960	2554354	Q60847	COCA1_MOUSE	Collagen alpha-1(XII) chain	GO:0003429; GO:0005595; GO:0005615; GO:0007155; GO:0031012; GO:0035987; GO:0062023	collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g034030	Scaffold_02	2558451	2558867	NA	NA	NA	NA	NA
PGEN_.00g034040	Scaffold_02	2559286	2698429	O89029	MATN4_MOUSE	Matrilin-4 (MAT-4)	GO:0003429; GO:0005509; GO:0005615; GO:0031012; GO:0048678; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; response to axon injury [GO:0048678]
PGEN_.00g034050	Scaffold_02	2735046	2735336	NA	NA	NA	NA	NA
PGEN_.00g034060	Scaffold_02	2735499	2742341	NA	NA	NA	NA	NA
PGEN_.00g034070	Scaffold_02	2768453	2783314	A2AL36	CNTRL_MOUSE	Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110)	GO:0003279; GO:0003281; GO:0005813; GO:0005815; GO:0005829; GO:0007049; GO:0008092; GO:0035904; GO:0048471; GO:0051301; GO:0051493; GO:0060976; GO:0090543; GO:0097431; GO:0120103	centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; cytoskeletal protein binding [GO:0008092]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell cycle [GO:0007049]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281]
PGEN_.00g034080	Scaffold_02	2783435	2797321	NA	NA	NA	NA	NA
PGEN_.00g034090	Scaffold_02	2797989	2799295	A4D2P6	GRD2I_HUMAN	"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)"	GO:0030054; GO:0045211; GO:0060292	cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; long-term synaptic depression [GO:0060292]
PGEN_.00g034100	Scaffold_02	2823919	2824743	NA	NA	NA	NA	NA
PGEN_.00g034110	Scaffold_02	2832777	2853575	A4D2P6	GRD2I_HUMAN	"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)"	GO:0030054; GO:0045211; GO:0060292	cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; long-term synaptic depression [GO:0060292]
PGEN_.00g034120	Scaffold_02	2873283	2894631	Q6ZM86	GRD2I_DANRE	"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)"	GO:0030054; GO:0045211	cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]
PGEN_.00g034130	Scaffold_02	2910136	2920182	NA	NA	NA	NA	NA
PGEN_.00g034140	Scaffold_02	2920446	2930956	Q90596	MAFK_CHICK	Transcription factor MafK	GO:0000122; GO:0000976; GO:0000978; GO:0003700; GO:0005634; GO:0005654; GO:0043565	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g034150	Scaffold_02	2958789	2959271	NA	NA	NA	NA	NA
PGEN_.00g034160	Scaffold_02	2969725	2973601	NA	NA	NA	NA	NA
PGEN_.00g034170	Scaffold_02	2987232	2987567	NA	NA	NA	NA	NA
PGEN_.00g034180	Scaffold_02	3092065	3098013	C5IAW9	UN5BB_XENLA	Netrin receptor UNC5B-b (Protein unc-5 homolog-b) (Unc-5-like protein B)	GO:0005042; GO:0005886; GO:0007275; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; multicellular organism development [GO:0007275]
PGEN_.00g034190	Scaffold_02	3100626	3127071	Q8K1S4	UNC5A_MOUSE	Netrin receptor UNC5A (Protein unc-5 homolog 1) (Protein unc-5 homolog A)	GO:0005042; GO:0005829; GO:0005886; GO:0006915; GO:0007411; GO:0016021; GO:0031175; GO:0031226; GO:0032589; GO:0032809; GO:0033564; GO:0038007; GO:0045121	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; neuron projection membrane [GO:0032589]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; netrin-activated signaling pathway [GO:0038007]; neuron projection development [GO:0031175]
PGEN_.00g034200	Scaffold_02	3176795	3177061	NA	NA	NA	NA	NA
PGEN_.00g034210	Scaffold_02	3191073	3191375	NA	NA	NA	NA	NA
PGEN_.00g034220	Scaffold_02	3254017	3255242	NA	NA	NA	NA	NA
PGEN_.00g034230	Scaffold_02	3270822	3271806	NA	NA	NA	NA	NA
PGEN_.00g034240	Scaffold_02	3271834	3272760	NA	NA	NA	NA	NA
PGEN_.00g034250	Scaffold_02	3281256	3330740	Q08BC4	STPG2_DANRE	Sperm-tail PG-rich repeat-containing protein 2		
PGEN_.00g034260	Scaffold_02	3348419	3361733	NA	NA	NA	NA	NA
PGEN_.00g034270	Scaffold_02	3381945	3382214	NA	NA	NA	NA	NA
PGEN_.00g034280	Scaffold_02	3387465	3416902	Q08BC4	STPG2_DANRE	Sperm-tail PG-rich repeat-containing protein 2		
PGEN_.00g034290	Scaffold_02	3422059	3428494	A6NKP2	D42E2_HUMAN	Putative short-chain dehydrogenase/reductase family 42E member 2 (EC 1.1.1.-)	GO:0003854; GO:0006694; GO:0016491; GO:0016616	"3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid biosynthetic process [GO:0006694]"
PGEN_.00g034300	Scaffold_02	3498899	3509858	NA	NA	NA	NA	NA
PGEN_.00g034310	Scaffold_02	3529017	3536782	NA	NA	NA	NA	NA
PGEN_.00g034320	Scaffold_02	3539806	3541046	NA	NA	NA	NA	NA
PGEN_.00g034330	Scaffold_02	3560711	3561571	NA	NA	NA	NA	NA
PGEN_.00g034340	Scaffold_02	3574122	3709463	Q00168	KCC2A_DROME	Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17)	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0005954; GO:0006468; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0043005; GO:0045211; GO:0048786; GO:0050710; GO:0051489; GO:0060278; GO:1990443	axon [GO:0030424]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; peptidyl-threonine autophosphorylation [GO:1990443]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic growth at neuromuscular junction [GO:0008582]
PGEN_.00g034350	Scaffold_02	3709956	3711979	NA	NA	NA	NA	NA
PGEN_.00g034360	Scaffold_02	3729155	3729526	NA	NA	NA	NA	NA
PGEN_.00g034370	Scaffold_02	3729880	3730221	NA	NA	NA	NA	NA
PGEN_.00g034380	Scaffold_02	3733174	3733878	NA	NA	NA	NA	NA
PGEN_.00g034390	Scaffold_02	3738142	3740403	NA	NA	NA	NA	NA
PGEN_.00g034400	Scaffold_02	3758256	3760472	NA	NA	NA	NA	NA
PGEN_.00g034410	Scaffold_02	3770302	3771288	NA	NA	NA	NA	NA
PGEN_.00g034420	Scaffold_02	3772782	3773360	NA	NA	NA	NA	NA
PGEN_.00g034430	Scaffold_02	3809421	3813435	NA	NA	NA	NA	NA
PGEN_.00g034440	Scaffold_02	3818042	3819871	NA	NA	NA	NA	NA
PGEN_.00g034450	Scaffold_02	3838197	3848657	Q76JQ2	FLCN_RAT	Folliculin (Birt-Hogg-Dube syndrome protein homolog)	GO:0000122; GO:0001701; GO:0001932; GO:0001934; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007043; GO:0010508; GO:0010629; GO:0010823; GO:0030097; GO:0030308; GO:0030336; GO:0030496; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032465; GO:0035024; GO:0035065; GO:0043065; GO:0043547; GO:0044291; GO:0044877; GO:0045785; GO:0045892; GO:0045944; GO:0051898; GO:0070373; GO:0097009; GO:0120163; GO:1900181; GO:1901723; GO:1901856; GO:1901859; GO:1901862; GO:1901874; GO:1904263; GO:2000973; GO:2001170; GO:2001244	"cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; cell-cell junction assembly [GO:0007043]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]"
PGEN_.00g034460	Scaffold_02	3851212	3890706	Q7TSH4	CP110_MOUSE	Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa) (Cep110) (Cp110)	GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0005929; GO:0007099; GO:0032053; GO:0032465; GO:0032991; GO:0045724; GO:0051298; GO:1902018	centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; protein-containing complex [GO:0032991]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body organization [GO:0032053]; negative regulation of cilium assembly [GO:1902018]; positive regulation of cilium assembly [GO:0045724]; regulation of cytokinesis [GO:0032465]
PGEN_.00g034470	Scaffold_02	3899615	3946186	Q8CF82	ABCA5_RAT	ATP-binding cassette sub-family A member 5	GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0006869; GO:0010745; GO:0015918; GO:0016021; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0043231	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; sterol transport [GO:0015918]
PGEN_.00g034480	Scaffold_02	3988897	4039276	Q8K448	ABCA5_MOUSE	ATP-binding cassette sub-family A member 5	GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0006869; GO:0010745; GO:0016021; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0043231; GO:0043691	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; reverse cholesterol transport [GO:0043691]
PGEN_.00g034490	Scaffold_02	4046072	4047903	NA	NA	NA	NA	NA
PGEN_.00g034500	Scaffold_02	4049426	4050256	NA	NA	NA	NA	NA
PGEN_.00g034510	Scaffold_02	4052138	4053809	NA	NA	NA	NA	NA
PGEN_.00g034520	Scaffold_02	4059338	4061470	NA	NA	NA	NA	NA
PGEN_.00g034530	Scaffold_02	4089478	4089753	NA	NA	NA	NA	NA
PGEN_.00g034540	Scaffold_02	4089836	4090681	NA	NA	NA	NA	NA
PGEN_.00g034550	Scaffold_02	4116010	4116348	NA	NA	NA	NA	NA
PGEN_.00g034560	Scaffold_02	4141506	4210665	P56974	NRG2_MOUSE	"Pro-neuregulin-2, membrane-bound isoform (Pro-NRG2) [Cleaved into: Neuregulin-2 (NRG-2) (Divergent of neuregulin 1) (DON-1)]"	GO:0005006; GO:0005102; GO:0005154; GO:0005615; GO:0005886; GO:0007173; GO:0007399; GO:0008083; GO:0016021; GO:0035556; GO:0043125; GO:0051963; GO:0090128; GO:0098978; GO:0098982	extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; epidermal growth factor-activated receptor activity [GO:0005006]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; regulation of synapse assembly [GO:0051963]; regulation of synapse maturation [GO:0090128]
PGEN_.00g034570	Scaffold_02	4219610	4222705	NA	NA	NA	NA	NA
PGEN_.00g034580	Scaffold_02	4222743	4239692	NA	NA	NA	NA	NA
PGEN_.00g034590	Scaffold_02	4240057	4273748	Q13472	TOP3A_HUMAN	DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha)	GO:0003677; GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005694; GO:0005759; GO:0006260; GO:0006265; GO:0008270; GO:0016605; GO:0032042; GO:0051304; GO:0051321; GO:1901796	"chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; regulation of signal transduction by p53 class mediator [GO:1901796]"
PGEN_.00g034600	Scaffold_02	4275841	4283151	Q91XV4	DCXR_MESAU	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g034610	Scaffold_02	4286910	4289376	NA	NA	NA	NA	NA
PGEN_.00g034620	Scaffold_02	4298650	4356564	Q9TZM3	LRK1_CAEEL	"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) (Leucine-rich repeats, ras-like domain, kinase protein 1) (PARK8-related kinase)"	GO:0004674; GO:0005524; GO:0005525; GO:0005623; GO:0005737; GO:0005794; GO:0006979; GO:0034613; GO:0034976; GO:0043025; GO:0046872; GO:0048489; GO:0048846; GO:1901215	cell [GO:0005623]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; axon extension involved in axon guidance [GO:0048846]; cellular protein localization [GO:0034613]; negative regulation of neuron death [GO:1901215]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; synaptic vesicle transport [GO:0048489]
PGEN_.00g034630	Scaffold_02	4358667	4366312	Q5R454	AR6P1_PONAB	ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2)	GO:0002038; GO:0005783; GO:0005784; GO:0005789; GO:0005829; GO:0006613; GO:0006915; GO:0030176; GO:0043066; GO:0043154; GO:0071787; GO:1990809	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Sec61 translocon complex [GO:0005784]; apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]
PGEN_.00g034640	Scaffold_02	4378527	4379720	NA	NA	NA	NA	NA
PGEN_.00g034650	Scaffold_02	4380243	4381811	NA	NA	NA	NA	NA
PGEN_.00g034660	Scaffold_02	4381858	4390985	NA	NA	NA	NA	NA
PGEN_.00g034670	Scaffold_02	4400805	4406599	NA	NA	NA	NA	NA
PGEN_.00g034680	Scaffold_02	4410755	4411786	NA	NA	NA	NA	NA
PGEN_.00g034690	Scaffold_02	4439494	4443302	NA	NA	NA	NA	NA
PGEN_.00g034700	Scaffold_02	4494445	4504301	Q6P8Y1	CAPSL_MOUSE	Calcyphosin-like protein	GO:0005509; GO:0005737	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]
PGEN_.00g034710	Scaffold_02	4511137	4514047	Q6P8Y1	CAPSL_MOUSE	Calcyphosin-like protein	GO:0005509; GO:0005737	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]
PGEN_.00g034720	Scaffold_02	4530023	4537387	Q3LIE5	ADPRM_HUMAN	Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase (EC 3.6.1.13) (EC 3.6.1.16) (EC 3.6.1.53) (ADPRibase-Mn) (CDP-choline phosphohydrolase)	GO:0005829; GO:0034656; GO:0046872; GO:0047631; GO:0047734	cytosol [GO:0005829]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; metal ion binding [GO:0046872]; nucleobase-containing small molecule catabolic process [GO:0034656]
PGEN_.00g034730	Scaffold_02	4543362	4543577	NA	NA	NA	NA	NA
PGEN_.00g034740	Scaffold_02	4553491	4571323	Q9V3L1	NDST_DROME	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)]	GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008146; GO:0008543; GO:0008587; GO:0015012; GO:0015014; GO:0015016; GO:0016021; GO:0016055; GO:0019213; GO:0030210; GO:0042328; GO:0045570	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; sulfotransferase activity [GO:0008146]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g034750	Scaffold_02	4588945	4613943	Q9JID6	ACSL1_CAVPO	Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)	GO:0000038; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0102391	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]
PGEN_.00g034760	Scaffold_02	4622705	4639242	NA	NA	NA	NA	NA
PGEN_.00g034770	Scaffold_02	4655169	4656177	NA	NA	NA	NA	NA
PGEN_.00g034780	Scaffold_02	4672279	4675794	NA	NA	NA	NA	NA
PGEN_.00g034790	Scaffold_02	4676479	4678375	NA	NA	NA	NA	NA
PGEN_.00g034800	Scaffold_02	4680920	4702385	Q14894	CRYM_HUMAN	Ketimine reductase mu-crystallin (EC 1.5.1.25) (NADP-regulated thyroid-hormone-binding protein)	GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0006554; GO:0007605; GO:0042403; GO:0042562; GO:0042803; GO:0047127; GO:0050661; GO:0070062; GO:0070324; GO:0070327	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]; lysine catabolic process [GO:0006554]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327]
PGEN_.00g034810	Scaffold_02	4710391	4744045	NA	NA	NA	NA	NA
PGEN_.00g034820	Scaffold_02	4744063	4788992	NA	NA	NA	NA	NA
PGEN_.00g034830	Scaffold_02	4747898	4748509	NA	NA	NA	NA	NA
PGEN_.00g034840	Scaffold_02	4839738	4840592	P07898	PGCA_CHICK	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g034850	Scaffold_02	4840848	4841474	P07898	PGCA_CHICK	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g034860	Scaffold_02	4841624	4842034	NA	NA	NA	NA	NA
PGEN_.00g034870	Scaffold_02	4842075	4842344	NA	NA	NA	NA	NA
PGEN_.00g034880	Scaffold_02	4842436	4843044	P07898	PGCA_CHICK	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g034890	Scaffold_02	4843094	4843462	NA	NA	NA	NA	NA
PGEN_.00g034900	Scaffold_02	4869394	4869720	NA	NA	NA	NA	NA
PGEN_.00g034910	Scaffold_02	4893375	4918200	Q08DX6	GDF10_BOVIN	Growth/differentiation factor 10 (GDF-10) (Bone morphogenetic protein 3B) (BMP-3B)	GO:0001649; GO:0005125; GO:0005160; GO:0005615; GO:0008083; GO:0010862; GO:0030509; GO:0042981; GO:0043408; GO:0045444; GO:0045668; GO:0048468; GO:0060395	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; BMP signaling pathway [GO:0030509]; cell development [GO:0048468]; fat cell differentiation [GO:0045444]; negative regulation of osteoblast differentiation [GO:0045668]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; SMAD protein signal transduction [GO:0060395]
PGEN_.00g034920	Scaffold_02	4934462	4934767	NA	NA	NA	NA	NA
PGEN_.00g034930	Scaffold_02	4943786	4994016	NA	NA	NA	NA	NA
PGEN_.00g034940	Scaffold_02	5012208	5021363	Q5PQ44	CF299_XENLA	Cilia- and flagella-associated protein 299	GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g034950	Scaffold_02	5027208	5027654	NA	NA	NA	NA	NA
PGEN_.00g034960	Scaffold_02	5027890	5060492	P82094	TMF1_HUMAN	TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa)	GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003712; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006355; GO:0006366; GO:0007289; GO:0010629; GO:0030317; GO:0032275; GO:0033327; GO:0042742; GO:0043066; GO:0061136; GO:0071407; GO:2000845	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; acrosome assembly [GO:0001675]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription, DNA-templated [GO:0006355]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g034970	Scaffold_02	5071433	5074822	NA	NA	NA	NA	NA
PGEN_.00g034980	Scaffold_02	5079864	5085291	NA	NA	NA	NA	NA
PGEN_.00g034990	Scaffold_02	5090999	5093054	NA	NA	NA	NA	NA
PGEN_.00g035000	Scaffold_02	5104180	5104935	NA	NA	NA	NA	NA
PGEN_.00g035010	Scaffold_02	5105997	5116673	NA	NA	NA	NA	NA
PGEN_.00g035020	Scaffold_02	5116709	5116921	NA	NA	NA	NA	NA
PGEN_.00g035030	Scaffold_02	5116990	5117244	NA	NA	NA	NA	NA
PGEN_.00g035040	Scaffold_02	5132794	5136934	NA	NA	NA	NA	NA
PGEN_.00g035050	Scaffold_02	5145459	5164768	NA	NA	NA	NA	NA
PGEN_.00g035060	Scaffold_02	5216622	5258633	Q9ULI1	NWD2_HUMAN	NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)		
PGEN_.00g035070	Scaffold_02	5274572	5275072	NA	NA	NA	NA	NA
PGEN_.00g035080	Scaffold_02	5299978	5302086	NA	NA	NA	NA	NA
PGEN_.00g035090	Scaffold_02	5302330	5302536	NA	NA	NA	NA	NA
PGEN_.00g035100	Scaffold_02	5366733	5414673	Q99PF4	CAD23_MOUSE	Cadherin-23 (Otocadherin)	GO:0000902; GO:0001917; GO:0005509; GO:0005623; GO:0005813; GO:0005886; GO:0005913; GO:0006816; GO:0007043; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008092; GO:0009986; GO:0016021; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0034332; GO:0042472; GO:0042491; GO:0042803; GO:0044331; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0047485; GO:0048563; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0098609; GO:0098683; GO:0098684	apical part of cell [GO:0045177]; catenin complex [GO:0016342]; cell [GO:0005623]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; integral component of membrane [GO:0016021]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; adherens junction organization [GO:0034332]; auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]
PGEN_.00g035110	Scaffold_02	5442970	5457582	Q96AJ9	VTI1A_HUMAN	Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2)	GO:0000139; GO:0000149; GO:0005484; GO:0005768; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006623; GO:0006888; GO:0006891; GO:0006896; GO:0006914; GO:0008021; GO:0012507; GO:0016021; GO:0030136; GO:0031201; GO:0031902; GO:0032588; GO:0042147; GO:0043025; GO:0043231; GO:0044306; GO:0048280; GO:0048471; GO:0050882; GO:0090161	"autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagy [GO:0006914]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi ribbon formation [GO:0090161]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882]"
PGEN_.00g035120	Scaffold_02	5464063	5477585	P12001	RL18_RAT	60S ribosomal protein L18	GO:0002181; GO:0003735; GO:0005791; GO:0022625; GO:0042788; GO:0045202; GO:0097421	cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; liver regeneration [GO:0097421]
PGEN_.00g035130	Scaffold_02	5471221	5472197	Q80TC5	POGK_MOUSE	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g035140	Scaffold_02	5485566	5530549	Q8CI15	SPHK1_MOUSE	Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-)	GO:0000287; GO:0001568; GO:0001934; GO:0001956; GO:0003677; GO:0003951; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006473; GO:0006670; GO:0006954; GO:0007420; GO:0008021; GO:0008284; GO:0008289; GO:0008481; GO:0010800; GO:0010803; GO:0010976; GO:0016310; GO:0016407; GO:0017050; GO:0019371; GO:0019722; GO:0030054; GO:0030100; GO:0030139; GO:0030307; GO:0030335; GO:0030424; GO:0031398; GO:0031901; GO:0032651; GO:0032740; GO:0034612; GO:0035924; GO:0038036; GO:0043005; GO:0043066; GO:0045766; GO:0045840; GO:0045931; GO:0045987; GO:0046512; GO:0048146; GO:0050764; GO:0051092; GO:0051721; GO:0070301; GO:0071897; GO:0090520; GO:0098793; GO:0150077; GO:1900060; GO:1900745; GO:1901224; GO:1903978; GO:1905364	axon [GO:0030424]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cyclooxygenase pathway [GO:0019371]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingolipid mediated signaling pathway [GO:0090520]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]
PGEN_.00g035150	Scaffold_02	5549194	5550033	Q9NYA1	SPHK1_HUMAN	Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-)	GO:0000287; GO:0003677; GO:0003951; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006457; GO:0006473; GO:0006670; GO:0008289; GO:0008481; GO:0010800; GO:0010803; GO:0016407; GO:0017050; GO:0019722; GO:0030054; GO:0030100; GO:0030139; GO:0030148; GO:0030307; GO:0030335; GO:0031398; GO:0031901; GO:0032740; GO:0034612; GO:0035556; GO:0035924; GO:0038036; GO:0043066; GO:0045766; GO:0045931; GO:0045987; GO:0046512; GO:0046521; GO:0048146; GO:0050764; GO:0051092; GO:0051721; GO:0098793; GO:0150077; GO:1900060; GO:1900745; GO:1901224; GO:1903978; GO:1905364	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; calcium-mediated signaling [GO:0019722]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; protein folding [GO:0006457]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]
PGEN_.00g035160	Scaffold_02	5568757	5591590	Q5ZIB2	FBF1_CHICK	Fas-binding factor 1 homolog (FBF-1)	GO:0000922; GO:0005737; GO:0005814; GO:0030054; GO:0036064; GO:0043297; GO:0060271; GO:0090162; GO:0097539	cell junction [GO:0030054]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; apical junction assembly [GO:0043297]; cilium assembly [GO:0060271]; establishment of epithelial cell polarity [GO:0090162]
PGEN_.00g035170	Scaffold_02	5593345	5614757	NA	NA	NA	NA	NA
PGEN_.00g035180	Scaffold_02	5614989	5621767	P56597	NDK5_HUMAN	Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)	GO:0003351; GO:0004550; GO:0005576; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0060271; GO:1902176	extracellular region [GO:0005576]; sperm flagellum [GO:0036126]; nucleoside diphosphate kinase activity [GO:0004550]; cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591]
PGEN_.00g035190	Scaffold_02	5623388	5626805	NA	NA	NA	NA	NA
PGEN_.00g035200	Scaffold_02	5636361	5636762	NA	NA	NA	NA	NA
PGEN_.00g035210	Scaffold_02	5643330	5689956	O15381	NVL_HUMAN	Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)	GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]
PGEN_.00g035220	Scaffold_02	5705181	5705558	NA	NA	NA	NA	NA
PGEN_.00g035230	Scaffold_02	5721226	5728300	Q47944	SDH_GLUOY	L-sorbose 1-dehydrogenase (SDH) (EC 1.1.99.32)	GO:0016614; GO:0050660	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g035240	Scaffold_02	5769882	5771651	NA	NA	NA	NA	NA
PGEN_.00g035250	Scaffold_02	5783151	5788198	P30975	TLR2_DROME	Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR)	GO:0004995; GO:0005886; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0042048; GO:0050805; GO:0050911; GO:1904058	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]
PGEN_.00g035260	Scaffold_02	5837246	5837599	NA	NA	NA	NA	NA
PGEN_.00g035270	Scaffold_02	5838101	5838340	NA	NA	NA	NA	NA
PGEN_.00g035280	Scaffold_02	5854376	5854849	P30975	TLR2_DROME	Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR)	GO:0004995; GO:0005886; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0042048; GO:0050805; GO:0050911; GO:1904058	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]
PGEN_.00g035290	Scaffold_02	5937737	5938219	NA	NA	NA	NA	NA
PGEN_.00g035300	Scaffold_02	5957929	5958201	NA	NA	NA	NA	NA
PGEN_.00g035310	Scaffold_02	6028832	6029209	NA	NA	NA	NA	NA
PGEN_.00g035320	Scaffold_02	6082647	6092968	O69060	HTXA_PSEST	Probable alpha-ketoglutarate-dependent hypophosphite dioxygenase (EC 1.-.-.-)	GO:0051213	dioxygenase activity [GO:0051213]
PGEN_.00g035330	Scaffold_02	6096349	6102963	NA	NA	NA	NA	NA
PGEN_.00g035340	Scaffold_02	6107157	6109984	O42446	DNAS1_OREMO	Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I)	GO:0000737; GO:0002283; GO:0002673; GO:0004530; GO:0005576; GO:0005635; GO:0070948	"extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; deoxyribonuclease I activity [GO:0004530]; DNA catabolic process, endonucleolytic [GO:0000737]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]"
PGEN_.00g035350	Scaffold_02	6117772	6136163	NA	NA	NA	NA	NA
PGEN_.00g035360	Scaffold_02	6151533	6163366	Q08BA6	ALKB5_DANRE	RNA demethylase ALKBH5 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5)	GO:0001666; GO:0005634; GO:0006397; GO:0006406; GO:0007283; GO:0016607; GO:0016706; GO:0035515; GO:0035553; GO:0046872; GO:1990931	nuclear speck [GO:0016607]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; oxidative RNA demethylase activity [GO:0035515]; RNA N6-methyladenosine dioxygenase activity [GO:1990931]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; oxidative single-stranded RNA demethylation [GO:0035553]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283]
PGEN_.00g035370	Scaffold_02	6193184	6196620	Q69ZS0	PZRN3_MOUSE	E3 ubiquitin-protein ligase PDZRN3 (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3) (RING-type E3 ubiquitin transferase PDZRN3) (Semaphorin cytoplasmic domain-associated protein 3) (Protein SEMACAP3)	GO:0004842; GO:0005737; GO:0007528; GO:0008270; GO:0016567; GO:0030054; GO:0031594; GO:0061630	cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]
PGEN_.00g035380	Scaffold_02	6208476	6241978	B2ZGJ1	CLAT_DANRE	Choline O-acetyltransferase (CHOACTase) (ChAT) (Choline acetylase) (EC 2.3.1.6)	GO:0004102; GO:0005737; GO:0007274; GO:0007626; GO:0008292; GO:0043005; GO:0045202	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; synapse [GO:0045202]; choline O-acetyltransferase activity [GO:0004102]; acetylcholine biosynthetic process [GO:0008292]; locomotory behavior [GO:0007626]; neuromuscular synaptic transmission [GO:0007274]
PGEN_.00g035390	Scaffold_02	6287214	6287573	NA	NA	NA	NA	NA
PGEN_.00g035400	Scaffold_02	6289661	6291364	O17444	VACHT_DROME	Vesicular acetylcholine transporter (VAChT)	GO:0005277; GO:0016021; GO:0030121; GO:0030122; GO:0042910; GO:0043195	AP-1 adaptor complex [GO:0030121]; AP-2 adaptor complex [GO:0030122]; integral component of membrane [GO:0016021]; terminal bouton [GO:0043195]; acetylcholine transmembrane transporter activity [GO:0005277]; xenobiotic transmembrane transporter activity [GO:0042910]
PGEN_.00g035410	Scaffold_02	6303520	6303864	NA	NA	NA	NA	NA
PGEN_.00g035420	Scaffold_02	6399092	6400159	NA	NA	NA	NA	NA
PGEN_.00g035430	Scaffold_02	6447750	6465717	NA	NA	NA	NA	NA
PGEN_.00g035440	Scaffold_02	6469216	6497638	O75112	LDB3_HUMAN	LIM domain-binding protein 3 (Protein cypher) (Z-band alternatively spliced PDZ-motif protein)	GO:0001725; GO:0003779; GO:0005080; GO:0005856; GO:0005913; GO:0007507; GO:0008092; GO:0030018; GO:0030036; GO:0031143; GO:0031941; GO:0045214; GO:0046872; GO:0048471; GO:0051371; GO:0061061	cell-cell adherens junction [GO:0005913]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]; sarcomere organization [GO:0045214]
PGEN_.00g035450	Scaffold_02	6537877	6549834	NA	NA	NA	NA	NA
PGEN_.00g035460	Scaffold_02	6554439	6554705	NA	NA	NA	NA	NA
PGEN_.00g035470	Scaffold_02	6554847	6555248	NA	NA	NA	NA	NA
PGEN_.00g035480	Scaffold_02	6556045	6560999	NA	NA	NA	NA	NA
PGEN_.00g035490	Scaffold_02	6570178	6586178	P17644	ACH2_DROME	Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2)	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g035500	Scaffold_02	6602873	6603526	NA	NA	NA	NA	NA
PGEN_.00g035510	Scaffold_02	6607679	6627139	P18845	ACHA3_CARAU	Neuronal acetylcholine receptor subunit alpha-3 (GF-alpha-3)	GO:0005892; GO:0007165; GO:0007399; GO:0015464; GO:0022848; GO:0030054; GO:0035095; GO:0045211; GO:0060084	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; behavioral response to nicotine [GO:0035095]; nervous system development [GO:0007399]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]
PGEN_.00g035520	Scaffold_02	6630867	6631076	NA	NA	NA	NA	NA
PGEN_.00g035530	Scaffold_02	6649930	6651684	NA	NA	NA	NA	NA
PGEN_.00g035540	Scaffold_02	6652464	6655785	NA	NA	NA	NA	NA
PGEN_.00g035550	Scaffold_02	6665996	6666286	NA	NA	NA	NA	NA
PGEN_.00g035560	Scaffold_02	6672958	6673269	NA	NA	NA	NA	NA
PGEN_.00g035570	Scaffold_02	6673460	6673858	NA	NA	NA	NA	NA
PGEN_.00g035580	Scaffold_02	6679322	6689926	NA	NA	NA	NA	NA
PGEN_.00g035590	Scaffold_02	6690381	6690869	NA	NA	NA	NA	NA
PGEN_.00g035600	Scaffold_02	6693472	6694284	NA	NA	NA	NA	NA
PGEN_.00g035610	Scaffold_02	6698251	6707107	P54797	TNG2_MOUSE	Transport and Golgi organization 2 homolog (Ser/Thr-rich protein T10 in DGCR region)	GO:0005739; GO:0005794; GO:0007030; GO:0009306	Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; Golgi organization [GO:0007030]; protein secretion [GO:0009306]
PGEN_.00g035620	Scaffold_02	6711864	6712910	NA	NA	NA	NA	NA
PGEN_.00g035630	Scaffold_02	6731747	6737998	Q8WVQ1	CANT1_HUMAN	Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107)	GO:0004382; GO:0005509; GO:0005576; GO:0005789; GO:0005886; GO:0016020; GO:0016021; GO:0030166; GO:0032580; GO:0035580; GO:0042803; GO:0043123; GO:0043262; GO:0043312; GO:0045134; GO:0070062; GO:1904724; GO:1904813	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134]; neutrophil degranulation [GO:0043312]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteoglycan biosynthetic process [GO:0030166]
PGEN_.00g035640	Scaffold_02	6745101	6757691	Q554E7	ZDHC5_DICDI	Putative ZDHHC-type palmitoyltransferase 5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5)	GO:0016021; GO:0019706	integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]
PGEN_.00g035650	Scaffold_02	6759246	6759527	Q3ZCU0	GVQW3_HUMAN	Protein GVQW3 (GVQW motif-containing protein 3)		
PGEN_.00g035660	Scaffold_02	6772698	6772988	NA	NA	NA	NA	NA
PGEN_.00g035670	Scaffold_02	6773357	6773827	NA	NA	NA	NA	NA
PGEN_.00g035680	Scaffold_02	6774376	6774723	NA	NA	NA	NA	NA
PGEN_.00g035690	Scaffold_02	6796082	6811743	Q02742	GCNT1_HUMAN	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT) (Core 2 GNT)"	GO:0000139; GO:0003829; GO:0005615; GO:0005802; GO:0009101; GO:0016021; GO:0016266; GO:0031985; GO:0032868; GO:0048729; GO:0050901; GO:0060352; GO:0060993	"extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; O-glycan processing [GO:0016266]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]"
PGEN_.00g035700	Scaffold_02	6832384	6836971	Q4QR86	DEPD7_RAT	DEP domain-containing protein 7	GO:0035556	intracellular signal transduction [GO:0035556]
PGEN_.00g035710	Scaffold_02	6844734	6849605	Q4QR86	DEPD7_RAT	DEP domain-containing protein 7	GO:0035556	intracellular signal transduction [GO:0035556]
PGEN_.00g035720	Scaffold_02	6872186	6873566	NA	NA	NA	NA	NA
PGEN_.00g035730	Scaffold_02	6881422	6883518	Q5IS76	ACHA6_PANTR	Neuronal acetylcholine receptor subunit alpha-6	GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007399; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060084	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g035740	Scaffold_02	6907187	6912690	NA	NA	NA	NA	NA
PGEN_.00g035750	Scaffold_02	6919574	6920908	P48181	ACH2_CAEEL	Acetylcholine receptor subunit beta-type unc-29 (Uncoordinated protein 29)	GO:0004888; GO:0005887; GO:0006937; GO:0007165; GO:0007268; GO:0007274; GO:0014057; GO:0022848; GO:0030054; GO:0034220; GO:0040011; GO:0042391; GO:0043005; GO:0043025; GO:0043051; GO:0045202; GO:0045211; GO:0046662; GO:0050877	"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; locomotion [GO:0040011]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]; signal transduction [GO:0007165]"
PGEN_.00g035760	Scaffold_02	6933686	6957520	Q13976	KGP1_HUMAN	cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)	GO:0001764; GO:0004672; GO:0004692; GO:0005246; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0016358; GO:0019934; GO:0030036; GO:0030553; GO:0030900; GO:0042802; GO:0043087; GO:0060087; GO:0090331; GO:1904706; GO:1904753	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; actin cytoskeleton organization [GO:0030036]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; relaxation of vascular smooth muscle [GO:0060087]; signal transduction [GO:0007165]
PGEN_.00g035770	Scaffold_02	6970612	6989549	P0C605	KGP1_MOUSE	cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)	GO:0001669; GO:0001764; GO:0004672; GO:0004674; GO:0004692; GO:0005246; GO:0005524; GO:0005623; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007204; GO:0010920; GO:0014050; GO:0014912; GO:0016020; GO:0016358; GO:0019934; GO:0030553; GO:0030900; GO:0042753; GO:0042802; GO:0043087; GO:0045822; GO:0045986; GO:0048273; GO:0060087; GO:0061049; GO:0090331; GO:0097755; GO:1902608; GO:1904706; GO:1904753; GO:2000224	acrosomal vesicle [GO:0001669]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell growth involved in cardiac muscle cell development [GO:0061049]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of heart contraction [GO:0045822]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; regulation of testosterone biosynthetic process [GO:2000224]; relaxation of vascular smooth muscle [GO:0060087]; signal transduction [GO:0007165]
PGEN_.00g035780	Scaffold_02	7017402	7017716	NA	NA	NA	NA	NA
PGEN_.00g035790	Scaffold_02	7058934	7066349	Q13976	KGP1_HUMAN	cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)	GO:0001764; GO:0004672; GO:0004692; GO:0005246; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0016358; GO:0019934; GO:0030036; GO:0030553; GO:0030900; GO:0042802; GO:0043087; GO:0060087; GO:0090331; GO:1904706; GO:1904753	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; actin cytoskeleton organization [GO:0030036]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; relaxation of vascular smooth muscle [GO:0060087]; signal transduction [GO:0007165]
PGEN_.00g035800	Scaffold_02	7066632	7069595	NA	NA	NA	NA	NA
PGEN_.00g035810	Scaffold_02	7071602	7079144	P07602	SAP_HUMAN	Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]	GO:0001664; GO:0002020; GO:0002576; GO:0003335; GO:0004565; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006683; GO:0006687; GO:0006869; GO:0007041; GO:0007186; GO:0007193; GO:0007605; GO:0008047; GO:0008289; GO:0010506; GO:0019216; GO:0035577; GO:0042552; GO:0042802; GO:0042803; GO:0043202; GO:0043231; GO:0043312; GO:0043410; GO:0050885; GO:0051345; GO:0060073; GO:0060736; GO:0060742; GO:0062023; GO:0070062; GO:0071310; GO:0090102; GO:0090659; GO:1903206; GO:1903575; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577	azurophil granule membrane [GO:0035577]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-galactosidase activity [GO:0004565]; enzyme activator activity [GO:0008047]; G protein-coupled receptor binding [GO:0001664]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to organic substance [GO:0071310]; cochlea development [GO:0090102]; corneocyte development [GO:0003335]; cornified envelope assembly [GO:1903575]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; G protein-coupled receptor signaling pathway [GO:0007186]; galactosylceramide catabolic process [GO:0006683]; ganglioside GM1 transport to membrane [GO:1905572]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; micturition [GO:0060073]; myelination [GO:0042552]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of MAPK cascade [GO:0043410]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sensory perception of sound [GO:0007605]; walking behavior [GO:0090659]
PGEN_.00g035820	Scaffold_02	7093558	7131622	P26779	SAP_BOVIN	Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]	GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0019216; GO:0060736; GO:0060742	extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g035830	Scaffold_02	7131767	7141784	Q1JQA4	TSN15_BOVIN	Tetraspanin-15 (Tspan-15)	GO:0005887; GO:0031902; GO:0051604; GO:0072659	integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]
PGEN_.00g035840	Scaffold_02	7154853	7199289	Q8TBG4	AT2L1_HUMAN	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	GO:0005759; GO:0006646; GO:0008483; GO:0030170; GO:0050459	mitochondrial matrix [GO:0005759]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; phosphatidylethanolamine biosynthetic process [GO:0006646]
PGEN_.00g035850	Scaffold_02	7216640	7233756	NA	NA	NA	NA	NA
PGEN_.00g035860	Scaffold_02	7233816	7234523	NA	NA	NA	NA	NA
PGEN_.00g035870	Scaffold_02	7234720	7236960	NA	NA	NA	NA	NA
PGEN_.00g035880	Scaffold_02	7237151	7237432	NA	NA	NA	NA	NA
PGEN_.00g035890	Scaffold_02	7237596	7243225	Q8CG19	LTBP1_MOUSE	Latent-transforming growth factor beta-binding protein 1 (LTBP-1) (Transforming growth factor beta-1-binding protein 1) (TGF-beta1-BP-1)	GO:0001527; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005739; GO:0007179; GO:0030425; GO:0031012; GO:0032967; GO:0032991; GO:0035583; GO:0035904; GO:0038045; GO:0043025; GO:0048471; GO:0050431; GO:0050436; GO:0060976; GO:0062023; GO:1901388	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; large latent transforming growth factor-beta complex [GO:0038045]; microfibril [GO:0001527]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; positive regulation of collagen biosynthetic process [GO:0032967]; regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum development [GO:0003281]
PGEN_.00g035900	Scaffold_02	7269337	7326994	Q7Z442	PK1L2_HUMAN	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g035910	Scaffold_02	7332467	7347158	Q9ULJ6	ZMIZ1_HUMAN	Zinc finger MIZ domain-containing protein 1 (PIAS-like protein Zimp10) (Retinoic acid-induced protein 17)	GO:0001085; GO:0001570; GO:0001701; GO:0003007; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007296; GO:0007569; GO:0008270; GO:0016607; GO:0016925; GO:0030374; GO:0043231; GO:0045582; GO:0045747; GO:0045944; GO:0048096; GO:0048146; GO:0048589; GO:0048844; GO:0061665	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; chromatin-mediated maintenance of transcription [GO:0048096]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]
PGEN_.00g035920	Scaffold_02	7348787	7391892	NA	NA	NA	NA	NA
PGEN_.00g035930	Scaffold_02	7362193	7375869	NA	NA	NA	NA	NA
PGEN_.00g035940	Scaffold_02	7376036	7376290	NA	NA	NA	NA	NA
PGEN_.00g035950	Scaffold_02	7397368	7397754	NA	NA	NA	NA	NA
PGEN_.00g035960	Scaffold_02	7408631	7409691	NA	NA	NA	NA	NA
PGEN_.00g035970	Scaffold_02	7430609	7430833	NA	NA	NA	NA	NA
PGEN_.00g035980	Scaffold_02	7499202	7499450	NA	NA	NA	NA	NA
PGEN_.00g035990	Scaffold_02	7499525	7500169	NA	NA	NA	NA	NA
PGEN_.00g036000	Scaffold_02	7500194	7500430	NA	NA	NA	NA	NA
PGEN_.00g036010	Scaffold_02	7659945	7660271	NA	NA	NA	NA	NA
PGEN_.00g036020	Scaffold_02	7664873	7665755	NA	NA	NA	NA	NA
PGEN_.00g036030	Scaffold_02	7665918	7666145	NA	NA	NA	NA	NA
PGEN_.00g036040	Scaffold_02	7781567	7803022	P70280	VAMP7_MOUSE	Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1)	GO:0000149; GO:0005484; GO:0005623; GO:0005737; GO:0005765; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008021; GO:0008333; GO:0009986; GO:0016020; GO:0016192; GO:0017156; GO:0019905; GO:0030027; GO:0030054; GO:0030133; GO:0030141; GO:0030175; GO:0030285; GO:0030667; GO:0030670; GO:0031091; GO:0031143; GO:0031201; GO:0031902; GO:0034197; GO:0035493; GO:0035577; GO:0043001; GO:0043005; GO:0043231; GO:0043308; GO:0043312; GO:0043320; GO:0045177; GO:0045335; GO:0047496; GO:0048280; GO:0048471; GO:0050775; GO:0098686; GO:1900483; GO:1903595	"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g036050	Scaffold_02	7805561	7805767	NA	NA	NA	NA	NA
PGEN_.00g036060	Scaffold_02	7808988	7850766	Q3UPL0	SC31A_MOUSE	Protein transport protein Sec31A (SEC31-like protein 1) (SEC31-related protein A)	GO:0000139; GO:0005198; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0007029; GO:0030120; GO:0030127; GO:0030134; GO:0043231; GO:0048306; GO:0048471; GO:0051592; GO:0070971; GO:0090110; GO:0090114	COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; vesicle coat [GO:0030120]; calcium-dependent protein binding [GO:0048306]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; response to calcium ion [GO:0051592]
PGEN_.00g036070	Scaffold_02	7862355	7870492	Q9BZE7	EVG1_HUMAN	UPF0193 protein EVG1		
PGEN_.00g036080	Scaffold_02	7879209	7915056	D3ZEN0	MILK2_RAT	MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2)	GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0031941; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]
PGEN_.00g036090	Scaffold_02	7947090	7955400	Q5TTP0	WDY_ANOGA	WD repeat-containing protein on Y chromosome (WD40 Y)		
PGEN_.00g036100	Scaffold_02	7956587	7987803	Q8R0H9	GGA1_MOUSE	"ADP-ribosylation factor-binding protein GGA1 (Gamma-adaptin-related protein 1) (Golgi-localized, gamma ear-containing, ARF-binding protein 1)"	GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0006893; GO:0008104; GO:0030306; GO:0031901; GO:0032991; GO:0034394; GO:0042147; GO:0043001; GO:0043231; GO:0045732; GO:0046982; GO:1901998; GO:1903441	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ADP-ribosylation factor binding [GO:0030306]; protein heterodimerization activity [GO:0046982]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]; toxin transport [GO:1901998]"
PGEN_.00g036110	Scaffold_02	7999185	8000267	NA	NA	NA	NA	NA
PGEN_.00g036120	Scaffold_02	8005915	8034080	Q3U829	AP5Z1_MOUSE	AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit) (Zeta5)	GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0015031; GO:0016197; GO:0016607; GO:0044599	AP-5 adaptor complex [GO:0044599]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]
PGEN_.00g036130	Scaffold_02	8036268	8046019	Q16960	DYI3_HELCR	"Dynein intermediate chain 3, ciliary"	GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]
PGEN_.00g036140	Scaffold_02	8074635	8078685	O17320	ACT_CRAGI	Actin	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g036150	Scaffold_02	8083871	8085067	NA	NA	NA	NA	NA
PGEN_.00g036160	Scaffold_02	8085234	8085902	NA	NA	NA	NA	NA
PGEN_.00g036170	Scaffold_02	8087565	8094547	NA	NA	NA	NA	NA
PGEN_.00g036180	Scaffold_02	8096301	8123886	NA	NA	NA	NA	NA
PGEN_.00g036190	Scaffold_02	8133868	8144243	Q8VIM6	STRC_MOUSE	Stereocilin	GO:0007160; GO:0007605; GO:0009986; GO:0032426; GO:0050910; GO:0060088; GO:0060091	cell surface [GO:0009986]; kinocilium [GO:0060091]; stereocilium tip [GO:0032426]; auditory receptor cell stereocilium organization [GO:0060088]; cell-matrix adhesion [GO:0007160]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; sensory perception of sound [GO:0007605]
PGEN_.00g036200	Scaffold_02	8145263	8146069	NA	NA	NA	NA	NA
PGEN_.00g036210	Scaffold_02	8146298	8180276	NA	NA	NA	NA	NA
PGEN_.00g036220	Scaffold_02	8198299	8198850	NA	NA	NA	NA	NA
PGEN_.00g036230	Scaffold_02	8210312	8210590	NA	NA	NA	NA	NA
PGEN_.00g036240	Scaffold_02	8213393	8213734	NA	NA	NA	NA	NA
PGEN_.00g036250	Scaffold_02	8218831	8254250	Q5EA75	PCY2_BOVIN	Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)	GO:0004306; GO:0006646	ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]
PGEN_.00g036260	Scaffold_02	8262171	8272107	Q2TBW2	COQ7_BOVIN	"5-demethoxyubiquinone hydroxylase, mitochondrial (DMQ hydroxylase) (EC 1.14.13.-) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)"	GO:0005634; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0016709; GO:0031314; GO:0046872; GO:2000377	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; 2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity [GO:0008682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; determination of adult lifespan [GO:0008340]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]"
PGEN_.00g036270	Scaffold_02	8292364	8293009	NA	NA	NA	NA	NA
PGEN_.00g036280	Scaffold_02	8327747	8331304	NA	NA	NA	NA	NA
PGEN_.00g036290	Scaffold_02	8343585	8358432	NA	NA	NA	NA	NA
PGEN_.00g036300	Scaffold_02	8384250	8385485	P17644	ACH2_DROME	Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2)	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g036310	Scaffold_02	8398001	8398243	NA	NA	NA	NA	NA
PGEN_.00g036320	Scaffold_02	8406839	8420667	Q0IHQ9	PXYP1_XENTR	2-phosphoxylose phosphatase 1 (EC 3.1.3.-) (Acid phosphatase-like protein 2)	GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016021; GO:0016791; GO:0050650	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]
PGEN_.00g036330	Scaffold_02	8431952	8444583	Q09003	COIL_XENLA	Coilin (Sphere organelles protein SPH-1) (Sphere protein 1)	GO:0071601	sphere organelle [GO:0071601]
PGEN_.00g036340	Scaffold_02	8445150	8445620	NA	NA	NA	NA	NA
PGEN_.00g036350	Scaffold_02	8447853	8448509	NA	NA	NA	NA	NA
PGEN_.00g036360	Scaffold_02	8452452	8452961	NA	NA	NA	NA	NA
PGEN_.00g036370	Scaffold_02	8455859	8456155	NA	NA	NA	NA	NA
PGEN_.00g036380	Scaffold_02	8465347	8486845	A5PKG7	KCTD5_BOVIN	BTB/POZ domain-containing protein KCTD5	GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0043161; GO:0051260; GO:0097602	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]
PGEN_.00g036390	Scaffold_02	8487346	8500880	Q24251	ATP5H_DROME	"ATP synthase subunit d, mitochondrial (ATPase subunit d)"	GO:0000274; GO:0000276; GO:0005739; GO:0006979; GO:0008340; GO:0015078; GO:0015986; GO:0032007; GO:0046034; GO:0051881; GO:0070373; GO:1902600	"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of TOR signaling [GO:0032007]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979]"
PGEN_.00g036400	Scaffold_02	8512711	8513726	NA	NA	NA	NA	NA
PGEN_.00g036410	Scaffold_02	8514979	8546824	Q9D4J7	PHF6_MOUSE	PHD finger protein 6	GO:0000122; GO:0000777; GO:0001227; GO:0001835; GO:0005634; GO:0005654; GO:0005730; GO:0015631; GO:0019899; GO:0042393; GO:0042826; GO:0043021; GO:0043565; GO:0046872; GO:0051219; GO:0097110	"condensed chromosome kinetochore [GO:0000777]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; ribonucleoprotein complex binding [GO:0043021]; scaffold protein binding [GO:0097110]; sequence-specific DNA binding [GO:0043565]; tubulin binding [GO:0015631]; blastocyst hatching [GO:0001835]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g036420	Scaffold_02	8559253	8559573	NA	NA	NA	NA	NA
PGEN_.00g036430	Scaffold_02	8597482	8597943	NA	NA	NA	NA	NA
PGEN_.00g036440	Scaffold_02	8627064	8627750	NA	NA	NA	NA	NA
PGEN_.00g036450	Scaffold_02	8668972	8670627	Q8N6G5	CGAT2_HUMAN	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2 (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2) (Beta4GalNAcT-2) (GalNAcT-2)"	GO:0000139; GO:0008376; GO:0016020; GO:0030166; GO:0030173; GO:0030206; GO:0032580; GO:0046872; GO:0047237; GO:0050650; GO:0050651; GO:0050652; GO:0050653	"Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]"
PGEN_.00g036460	Scaffold_02	8704673	8705449	NA	NA	NA	NA	NA
PGEN_.00g036470	Scaffold_02	8707214	8723507	NA	NA	NA	NA	NA
PGEN_.00g036480	Scaffold_02	8723538	8723792	NA	NA	NA	NA	NA
PGEN_.00g036490	Scaffold_02	8822120	8822494	NA	NA	NA	NA	NA
PGEN_.00g036500	Scaffold_02	8822793	8823134	NA	NA	NA	NA	NA
PGEN_.00g036510	Scaffold_02	8857537	8858614	NA	NA	NA	NA	NA
PGEN_.00g036520	Scaffold_02	8886948	8887232	NA	NA	NA	NA	NA
PGEN_.00g036530	Scaffold_02	8887342	8887656	NA	NA	NA	NA	NA
PGEN_.00g036540	Scaffold_02	8894608	8894808	NA	NA	NA	NA	NA
PGEN_.00g036550	Scaffold_02	8951590	8956741	P62955	CCG7_HUMAN	Voltage-dependent calcium channel gamma-7 subunit (Neuronal voltage-gated calcium channel gamma-7 subunit) (Transmembrane AMPAR regulatory protein gamma-7) (TARP gamma-7)	GO:0005245; GO:0005246; GO:0005769; GO:0005886; GO:0005891; GO:0006816; GO:0032281; GO:0043025; GO:0043488; GO:0044300; GO:0061337; GO:0098978; GO:0099061; GO:0099645; GO:1903861; GO:1990454; GO:2000311	AMPA glutamate receptor complex [GO:0032281]; cerebellar mossy fiber [GO:0044300]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; L-type voltage-gated calcium channel complex [GO:1990454]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; cardiac conduction [GO:0061337]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of dendrite extension [GO:1903861]; regulation of AMPA receptor activity [GO:2000311]; regulation of mRNA stability [GO:0043488]
PGEN_.00g036560	Scaffold_02	8983145	8984630	NA	NA	NA	NA	NA
PGEN_.00g036570	Scaffold_02	8988988	8989386	NA	NA	NA	NA	NA
PGEN_.00g036580	Scaffold_02	8990986	8991231	NA	NA	NA	NA	NA
PGEN_.00g036590	Scaffold_02	8997406	8998348	NA	NA	NA	NA	NA
PGEN_.00g036600	Scaffold_02	9041541	9041999	NA	NA	NA	NA	NA
PGEN_.00g036610	Scaffold_02	9042072	9048055	NA	NA	NA	NA	NA
PGEN_.00g036620	Scaffold_02	9062321	9065575	NA	NA	NA	NA	NA
PGEN_.00g036630	Scaffold_02	9085407	9085715	NA	NA	NA	NA	NA
PGEN_.00g036640	Scaffold_02	9106126	9107221	NA	NA	NA	NA	NA
PGEN_.00g036650	Scaffold_02	9136677	9137543	NA	NA	NA	NA	NA
PGEN_.00g036660	Scaffold_02	9149561	9150328	NA	NA	NA	NA	NA
PGEN_.00g036670	Scaffold_02	9165266	9170617	NA	NA	NA	NA	NA
PGEN_.00g036680	Scaffold_02	9183933	9184821	NA	NA	NA	NA	NA
PGEN_.00g036690	Scaffold_02	9203274	9205705	NA	NA	NA	NA	NA
PGEN_.00g036700	Scaffold_02	9206038	9206439	NA	NA	NA	NA	NA
PGEN_.00g036710	Scaffold_02	9210806	9216803	NA	NA	NA	NA	NA
PGEN_.00g036720	Scaffold_02	9233008	9267458	NA	NA	NA	NA	NA
PGEN_.00g036730	Scaffold_02	9271987	9273487	NA	NA	NA	NA	NA
PGEN_.00g036740	Scaffold_02	9279184	9316411	NA	NA	NA	NA	NA
PGEN_.00g036750	Scaffold_02	9289984	9290256	NA	NA	NA	NA	NA
PGEN_.00g036760	Scaffold_02	9334967	9337725	NA	NA	NA	NA	NA
PGEN_.00g036770	Scaffold_02	9338705	9339049	NA	NA	NA	NA	NA
PGEN_.00g036780	Scaffold_02	9343469	9345199	Q9ESN6	TRIM2_MOUSE	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (Neural activity-related RING finger protein) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017022; GO:0043161; GO:0043523; GO:0061630; GO:1990830	cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g036790	Scaffold_02	9357486	9446434	Q08BI9	MCU_DANRE	"Calcium uniporter protein, mitochondrial"	GO:0005262; GO:0005743; GO:0006851; GO:0007015; GO:0008016; GO:0015292; GO:0019722; GO:0031305; GO:0032024; GO:0034704; GO:0036444; GO:0042593; GO:0042802; GO:0043009; GO:0051259; GO:0051560; GO:0051561; GO:0060027; GO:1990246	calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292]; actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016]
PGEN_.00g036800	Scaffold_02	9399585	9400407	NA	NA	NA	NA	NA
PGEN_.00g036810	Scaffold_02	9446557	9480171	P56079	CDS_DROME	"Phosphatidate cytidylyltransferase, photoreceptor-specific (EC 2.7.7.41) (CDP-DAG synthase) (CDP-DG synthase) (CDP-diacylglycerol synthase) (CDS) (CDP-diglyceride pyrophosphorylase) (CDP-diglyceride synthase) (CTP:phosphatidate cytidylyltransferase)"	GO:0004605; GO:0005789; GO:0007291; GO:0007430; GO:0007601; GO:0007602; GO:0008610; GO:0010513; GO:0010868; GO:0010883; GO:0016021; GO:0016024; GO:0016056; GO:0043052	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid biosynthetic process [GO:0008610]; negative regulation of triglyceride biosynthetic process [GO:0010868]; phototransduction [GO:0007602]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of lipid storage [GO:0010883]; rhodopsin mediated signaling pathway [GO:0016056]; sperm individualization [GO:0007291]; terminal branching, open tracheal system [GO:0007430]; thermotaxis [GO:0043052]; visual perception [GO:0007601]"
PGEN_.00g036820	Scaffold_02	9496532	9501582	Q9CQM2	ERD22_MOUSE	ER lumen protein-retaining receptor 2 (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2)	GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005794; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030663	"cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g036830	Scaffold_02	9508980	9532123	Q9W6G7	DPOG2_XENLA	"DNA polymerase subunit gamma-2, mitochondrial (Mitochondrial DNA polymerase accessory subunit) (MtPolB) (PolG-beta)"	GO:0003677; GO:0005739; GO:0006260; GO:0006281	mitochondrion [GO:0005739]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260]
PGEN_.00g036840	Scaffold_02	9532697	9658973	Q28EC1	RGF1B_XENTR	Ras-GEF domain-containing family member 1B	GO:0005088; GO:0007264	Ras guanyl-nucleotide exchange factor activity [GO:0005088]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g036850	Scaffold_02	9568672	9570744	NA	NA	NA	NA	NA
PGEN_.00g036860	Scaffold_02	9661889	9662518	NA	NA	NA	NA	NA
PGEN_.00g036870	Scaffold_02	9691165	9704989	Q8CF89	TAB1_MOUSE	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1)	GO:0000185; GO:0001701; GO:0003007; GO:0003279; GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:0007179; GO:0016607; GO:0019209; GO:0030324; GO:0032991; GO:0035904; GO:0043406; GO:0044877; GO:0048273; GO:0060976	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; kinase activator activity [GO:0019209]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; positive regulation of MAP kinase activity [GO:0043406]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g036880	Scaffold_02	9717263	9781629	Q68CJ6	SLIP_HUMAN	Nuclear GTPase SLIP-GC (EC 3.6.1.-) (Speckled-like pattern in the germinal center)	GO:0003924; GO:0005525; GO:0016607; GO:0033262; GO:0043066; GO:0071222	nuclear speck [GO:0016607]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of apoptotic process [GO:0043066]; regulation of nuclear cell cycle DNA replication [GO:0033262]
PGEN_.00g036890	Scaffold_02	9726226	9726849	NA	NA	NA	NA	NA
PGEN_.00g036900	Scaffold_02	9809232	9810175	NA	NA	NA	NA	NA
PGEN_.00g036910	Scaffold_02	9823455	9830124	Q9FT73	MED34_ARATH	Mediator of RNA polymerase II transcription subunit 34 (ATP-dependent DNA helicase Q-like 2) (EC 3.6.4.12) (RecQ-like protein 2) (AtRecQ2) (AtRecQl2)	GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016592; GO:0032508; GO:0043138; GO:0046872	chromosome [GO:0005694]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]
PGEN_.00g036920	Scaffold_02	9832005	9834239	NA	NA	NA	NA	NA
PGEN_.00g036930	Scaffold_02	9851902	9861969	Q8BJW7	EME1_MOUSE	Crossover junction endonuclease EME1 (EC 3.1.22.-)	GO:0000712; GO:0000790; GO:0003677; GO:0004519; GO:0005720; GO:0005730; GO:0006302; GO:0031297; GO:0031573; GO:0046872; GO:0048476; GO:0072429	Holliday junction resolvase complex [GO:0048476]; nuclear chromatin [GO:0000790]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; double-strand break repair [GO:0006302]; intra-S DNA damage checkpoint [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]
PGEN_.00g036940	Scaffold_02	9868409	9870330	NA	NA	NA	NA	NA
PGEN_.00g036950	Scaffold_02	9871817	9872191	NA	NA	NA	NA	NA
PGEN_.00g036960	Scaffold_02	9884849	9897416	O94673	GPC1_SCHPO	Glycerophosphocholine acyltransferase 1 (GPCAT) (EC 2.3.1.-)	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006656; GO:0016021; GO:0106158	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycero-3-phosphocholine acyltransferase activity [GO:0106158]; phosphatidylcholine biosynthetic process [GO:0006656]
PGEN_.00g036970	Scaffold_02	9916049	9925382	NA	NA	NA	NA	NA
PGEN_.00g036980	Scaffold_02	9960799	9962127	NA	NA	NA	NA	NA
PGEN_.00g036990	Scaffold_02	9980316	10004366	Q6P1E8	EFCB6_MOUSE	EF-hand calcium-binding domain-containing protein 6 (DJ-1-binding protein) (DJBP)	GO:0005509; GO:0005654	nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]
PGEN_.00g037000	Scaffold_02	10042686	10056067	Q9UMX1	SUFU_HUMAN	Suppressor of fused homolog (SUFUH)	GO:0000122; GO:0001501; GO:0001843; GO:0001947; GO:0003281; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006508; GO:0007165; GO:0007275; GO:0008013; GO:0008134; GO:0019901; GO:0021775; GO:0021776; GO:0035904; GO:0042308; GO:0042994; GO:0043433; GO:0043588; GO:0045668; GO:0045879; GO:0060976; GO:0097542; GO:0097546; GO:1901621; GO:2000059	"ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; cytoplasmic sequestering of transcription factor [GO:0042994]; heart looping [GO:0001947]; multicellular organism development [GO:0007275]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; proteolysis [GO:0006508]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; ventricular septum development [GO:0003281]"
PGEN_.00g037010	Scaffold_02	10072739	10121187	Q8K4Q0	RPTOR_MOUSE	Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein)	GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0001558; GO:0001932; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0008361; GO:0009267; GO:0010494; GO:0010800; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0038202; GO:0042325; GO:0044877; GO:0045945; GO:0046676; GO:0071230; GO:0071233; GO:0071889; GO:0071902; GO:1900087	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein binding, bridging [GO:0030674]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]"
PGEN_.00g037020	Scaffold_02	10142166	10178401	A6N7Y9	PIWL1_CHICK	Piwi-like protein 1 (EC 3.1.26.-)	GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007275; GO:0007283; GO:0007286; GO:0010529; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0035093; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:1905538	"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; single-stranded RNA binding [GO:0003727]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"
PGEN_.00g037030	Scaffold_02	10178830	10200280	Q8CH18	CCAR1_MOUSE	Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1)	GO:0000978; GO:0003713; GO:0003714; GO:0005634; GO:0005641; GO:0006355; GO:0006915; GO:0007049; GO:0008284; GO:0030335; GO:0030374; GO:0043065; GO:0048471	"nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g037040	Scaffold_02	10203397	10208515	Q8IX12	CCAR1_HUMAN	Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain)	GO:0000398; GO:0000978; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0006915; GO:0007049; GO:0008284; GO:0030335; GO:0030374; GO:0048471	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g037050	Scaffold_02	10212699	10248770	Q5EAD0	BAIP2_BOVIN	Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2)	GO:0001726; GO:0005654; GO:0005829; GO:0007009; GO:0008093; GO:0008360; GO:0009617; GO:0015629; GO:0016020; GO:0030175; GO:0030838; GO:0032956; GO:0051017; GO:0051764; GO:0070064; GO:2000251	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ruffle [GO:0001726]; cytoskeletal adaptor activity [GO:0008093]; proline-rich region binding [GO:0070064]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; response to bacterium [GO:0009617]
PGEN_.00g037060	Scaffold_02	10280105	10281178	NA	NA	NA	NA	NA
PGEN_.00g037070	Scaffold_02	10282815	10306474	Q5ZIE8	MCAF1_CHICK	Activating transcription factor 7-interacting protein 1 (MBD1-containing chromatin-associated factor 1)	GO:0005634; GO:0031647; GO:0050821; GO:0090309	nucleus [GO:0005634]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]
PGEN_.00g037080	Scaffold_02	10334641	10348858	Q9QYT7	PIGQ_MOUSE	Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q (EC 2.4.1.198) (MGpi1p) (N-acetylglucosamyl transferase component GPI1) (Phosphatidylinositol-glycan biosynthesis class Q protein) (PIG-Q)	GO:0000506; GO:0006506; GO:0016021; GO:0017176	glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g037090	Scaffold_02	10364671	10367628	Q94B65	UTR7_ARATH	UDP-galactose/UDP-glucose transporter 7 (AtUTr7)	GO:0000139; GO:0005459; GO:0005460; GO:0005794; GO:0008643; GO:0015297; GO:0015786; GO:0016021; GO:0022857; GO:0048527; GO:0072334; GO:0080147	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; carbohydrate transport [GO:0008643]; lateral root development [GO:0048527]; root hair cell development [GO:0080147]; UDP-galactose transmembrane transport [GO:0072334]; UDP-glucose transmembrane transport [GO:0015786]
PGEN_.00g037100	Scaffold_02	10390233	10425974	Q09499	IRE1_CAEEL	Serine/threonine-protein kinase/endoribonuclease ire-1 (Inositol-requiring protein 2) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	GO:0001666; GO:0002119; GO:0004521; GO:0004672; GO:0004674; GO:0005524; GO:0005789; GO:0006397; GO:0006468; GO:0006990; GO:0030176; GO:0030968; GO:0035966; GO:0036498; GO:0051082; GO:0070059; GO:0090305; GO:1902255; GO:1904576; GO:1990440; GO:1990604	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; nematode larval development [GO:0002119]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; protein phosphorylation [GO:0006468]; response to hypoxia [GO:0001666]; response to topologically incorrect protein [GO:0035966]; response to tunicamycin [GO:1904576]
PGEN_.00g037110	Scaffold_02	10455163	10465338	Q8IWB9	TEX2_HUMAN	Testis-expressed protein 2 (Transmembrane protein 96)	GO:0005783; GO:0006665; GO:0006869; GO:0007165; GO:0008289; GO:0016021	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g037120	Scaffold_02	10480498	10481265	NA	NA	NA	NA	NA
PGEN_.00g037130	Scaffold_02	10489769	10507414	P10111	PPIA_RAT	"Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) (p1B15) (p31) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]"	GO:0000413; GO:0003755; GO:0005576; GO:0005634; GO:0005829; GO:0016018; GO:0030182; GO:0032515; GO:0032991; GO:0034389; GO:0042026; GO:0045069; GO:0045070; GO:0050714; GO:0051082	cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; lipid droplet organization [GO:0034389]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; neuron differentiation [GO:0030182]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of viral genome replication [GO:0045069]
PGEN_.00g037140	Scaffold_02	10515357	10595607	Q12767	TMM94_HUMAN	Transmembrane protein 94	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g037150	Scaffold_02	10608223	10617853	NA	NA	NA	NA	NA
PGEN_.00g037160	Scaffold_02	10629910	10669970	Q3KQF0	NUP1A_XENLA	Cytosolic Fe-S cluster assembly factor nubp1-A (Nucleotide-binding protein 1-A) (NBP 1-A)	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"
PGEN_.00g037170	Scaffold_02	10670343	10682914	A6H782	TEKT3_BOVIN	Tektin-3	GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378	acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]
PGEN_.00g037180	Scaffold_02	10689510	10733866	Q7TN88	PK1L2_MOUSE	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g037190	Scaffold_02	10735342	10743726	NA	NA	NA	NA	NA
PGEN_.00g037200	Scaffold_02	10795504	10801951	Q5QQ53	XYLT_DROPS	Xylosyltransferase oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase)	GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030206; GO:0042732; GO:0046872; GO:0050650	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]
PGEN_.00g037210	Scaffold_02	10812347	10815333	NA	NA	NA	NA	NA
PGEN_.00g037220	Scaffold_02	10818986	10834438	Q5F2N3	FUT10_DANRE	"Alpha-(1,3)-fucosyltransferase 10 (EC 2.4.1.-) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10)"	GO:0006486; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g037230	Scaffold_02	10842784	10865417	Q91YU8	SSF1_MOUSE	Suppressor of SWI4 1 homolog (Ssf-1) (Peter Pan homolog)	GO:0000027; GO:0001560; GO:0005634; GO:0005730; GO:0030687	"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; regulation of cell growth by extracellular stimulus [GO:0001560]; ribosomal large subunit assembly [GO:0000027]"
PGEN_.00g037240	Scaffold_02	10867271	10867591	NA	NA	NA	NA	NA
PGEN_.00g037250	Scaffold_02	10868048	10868530	NA	NA	NA	NA	NA
PGEN_.00g037260	Scaffold_02	10871652	10872767	NA	NA	NA	NA	NA
PGEN_.00g037270	Scaffold_02	11056700	11058049	Q10018	SPP11_CAEEL	Saposin-like protein 11		
PGEN_.00g037280	Scaffold_02	11104951	11152793	NA	NA	NA	NA	NA
PGEN_.00g037290	Scaffold_02	11154303	11158007	NA	NA	NA	NA	NA
PGEN_.00g037300	Scaffold_02	11194720	11206264	Q9MYM4	LYAG_BOVIN	Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase)	GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005623; GO:0005765; GO:0005980; GO:0007040; GO:0007626; GO:0009888; GO:0030246; GO:0032450; GO:0043181; GO:0046716; GO:0050884; GO:0050885; GO:0060048	"cell [GO:0005623]; lysosomal membrane [GO:0005765]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]"
PGEN_.00g037310	Scaffold_02	11235386	11271987	Q12830	BPTF_HUMAN	Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen)	GO:0000122; GO:0000790; GO:0001892; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006357; GO:0007420; GO:0007492; GO:0008134; GO:0009952; GO:0016589; GO:0043565; GO:0045944; GO:0046872; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic placenta development [GO:0001892]; endoderm development [GO:0007492]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g037320	Scaffold_02	11289940	11290335	NA	NA	NA	NA	NA
PGEN_.00g037330	Scaffold_02	11290700	11291881	NA	NA	NA	NA	NA
PGEN_.00g037340	Scaffold_02	11313547	11313771	NA	NA	NA	NA	NA
PGEN_.00g037350	Scaffold_02	11321662	11338493	Q13257	MD2L1_HUMAN	Mitotic spindle assembly checkpoint protein MAD2A (HsMAD2) (Mitotic arrest deficient 2-like protein 1) (MAD2-like protein 1)	GO:0000070; GO:0000132; GO:0000776; GO:0000777; GO:0000922; GO:0005623; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006511; GO:0007093; GO:0007094; GO:0008022; GO:0031145; GO:0042177; GO:0042802; GO:0042803; GO:0043066; GO:0044615; GO:0045930; GO:0048471; GO:0051301; GO:0051660; GO:0072686; GO:0090267; GO:1901990; GO:1904667	cell [GO:0005623]; chromosome [GO:0005694]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g037360	Scaffold_02	11343512	11356539	NA	NA	NA	NA	NA
PGEN_.00g037370	Scaffold_02	11357569	11447291	B2RX12	MRP3_MOUSE	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multidrug resistance-associated protein 3)	GO:0005524; GO:0005886; GO:0005887; GO:0015722; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0098656	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g037380	Scaffold_02	11483451	11500720	Q8NCG7	DGLB_HUMAN	Sn1-specific diacylglycerol lipase beta (DGL-beta) (EC 3.1.1.-) (KCCR13L)	GO:0005654; GO:0005765; GO:0005886; GO:0007216; GO:0007405; GO:0016021; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]
PGEN_.00g037390	Scaffold_02	11501882	11504834	NA	NA	NA	NA	NA
PGEN_.00g037400	Scaffold_02	11504904	11506361	NA	NA	NA	NA	NA
PGEN_.00g037410	Scaffold_02	11558936	11577351	Q5YCC5	TMC7_CHICK	Transmembrane channel-like protein 7	GO:0005216; GO:0005887; GO:0008381	integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]
PGEN_.00g037420	Scaffold_02	11581263	11600992	NA	NA	NA	NA	NA
PGEN_.00g037430	Scaffold_02	11603338	11604006	NA	NA	NA	NA	NA
PGEN_.00g037440	Scaffold_02	11604121	11604582	NA	NA	NA	NA	NA
PGEN_.00g037450	Scaffold_02	11649605	11669177	NA	NA	NA	NA	NA
PGEN_.00g037460	Scaffold_02	11675270	11684268	NA	NA	NA	NA	NA
PGEN_.00g037470	Scaffold_02	11700597	11711888	NA	NA	NA	NA	NA
PGEN_.00g037480	Scaffold_02	11711922	11718480	Q8I7P9	POL5_DROME	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g037490	Scaffold_02	11720003	11754913	B0JZG0	S23A2_XENTR	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	GO:0016021; GO:0019852; GO:0070890	integral component of membrane [GO:0016021]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]
PGEN_.00g037500	Scaffold_02	11762942	11774009	P08873	PA2B2_NOTSC	Basic phospholipase A2 notechis 11'2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase)	GO:0004623; GO:0005509; GO:0005576; GO:0006644; GO:0016042; GO:0050482; GO:0102567; GO:0102568	"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]"
PGEN_.00g037510	Scaffold_02	11819007	11819354	NA	NA	NA	NA	NA
PGEN_.00g037520	Scaffold_02	11820212	11821817	NA	NA	NA	NA	NA
PGEN_.00g037530	Scaffold_02	11823337	11823705	NA	NA	NA	NA	NA
PGEN_.00g037540	Scaffold_02	11836287	11839926	NA	NA	NA	NA	NA
PGEN_.00g037550	Scaffold_02	11847832	11852560	NA	NA	NA	NA	NA
PGEN_.00g037560	Scaffold_02	11873969	11918107	P25931	RYAR_DROME	RYamide receptor (Neuropeptide Y-like receptor) (NPY-R)	GO:0001653; GO:0004983; GO:0005886; GO:0007166; GO:0007186; GO:0008188; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; peptide receptor activity [GO:0001653]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g037570	Scaffold_02	12024245	12035003	NA	NA	NA	NA	NA
PGEN_.00g037580	Scaffold_02	12129202	12132872	NA	NA	NA	NA	NA
PGEN_.00g037590	Scaffold_02	12159560	12159988	NA	NA	NA	NA	NA
PGEN_.00g037600	Scaffold_02	12173242	12174414	NA	NA	NA	NA	NA
PGEN_.00g037610	Scaffold_02	12177548	12179130	Q64425	LIPP_MYOCO	Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) (Fragment)	GO:0004806; GO:0005576; GO:0016042; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]
PGEN_.00g037620	Scaffold_02	12183979	12185491	P06857	LIPR1_CANLF	Inactive pancreatic lipase-related protein 1 (PL-RP1)	GO:0005509; GO:0005576; GO:0016042; GO:0052689	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carboxylic ester hydrolase activity [GO:0052689]; lipid catabolic process [GO:0016042]
PGEN_.00g037630	Scaffold_02	12325283	12326320	Q90ZY4	SBK1_DANRE	Serine/threonine-protein kinase SBK1 (EC 2.7.11.1) (Brain-specific protein kinase BSK146) (SH3-binding kinase 1)	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]
PGEN_.00g037640	Scaffold_02	12339410	12339715	NA	NA	NA	NA	NA
PGEN_.00g037650	Scaffold_02	12354300	12371010	P07228	ITB1_CHICK	Integrin beta-1 (CSAT antigen) (JG22 antigen) (RGD-receptor)	GO:0001968; GO:0005178; GO:0005623; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0008305; GO:0009986; GO:0016477; GO:0030027; GO:0032587; GO:0033627; GO:0038023; GO:0042470; GO:0046872; GO:0071438; GO:0098639; GO:1990782	cell [GO:0005623]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; collagen binding involved in cell-matrix adhesion [GO:0098639]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]
PGEN_.00g037660	Scaffold_02	12420956	12421195	NA	NA	NA	NA	NA
PGEN_.00g037670	Scaffold_02	12425017	12447926	Q5M9B3	ITGBL_XENLA	Integrin beta-like protein 1	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g037680	Scaffold_02	12451336	12454993	NA	NA	NA	NA	NA
PGEN_.00g037690	Scaffold_02	12457379	12460137	NA	NA	NA	NA	NA
PGEN_.00g037700	Scaffold_02	12481587	12484503	NA	NA	NA	NA	NA
PGEN_.00g037710	Scaffold_02	12493030	12496430	NA	NA	NA	NA	NA
PGEN_.00g037720	Scaffold_02	12499884	12500225	NA	NA	NA	NA	NA
PGEN_.00g037730	Scaffold_02	12518881	12552040	A6H8I2	SGSM3_XENLA	Small G protein signaling modulator 3 homolog (RUN and TBC1 domain-containing protein 3)		
PGEN_.00g037740	Scaffold_02	12553069	12608511	NA	NA	NA	NA	NA
PGEN_.00g037750	Scaffold_02	12608807	12609487	NA	NA	NA	NA	NA
PGEN_.00g037760	Scaffold_02	12609521	12609862	NA	NA	NA	NA	NA
PGEN_.00g037770	Scaffold_02	12643239	12651518	Q5M7W4	TMC5_RAT	Transmembrane channel-like protein 5	GO:0005216; GO:0005887; GO:0008381	integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]
PGEN_.00g037780	Scaffold_02	12654360	12661421	Q9D1C2	CBY1_MOUSE	"Protein chibby homolog 1 (Cytosolic leucine-rich protein) (PIGEA-14) (PKD2 interactor, Golgi and endoplasmic reticulum-associated 1)"	GO:0005634; GO:0005802; GO:0005814; GO:0008013; GO:0008104; GO:0016607; GO:0030178; GO:0033504; GO:0036064; GO:0042802; GO:0042803; GO:0045444; GO:0045892; GO:0051289; GO:0055007; GO:0060271; GO:0090090; GO:1905349	"centriole [GO:0005814]; ciliary basal body [GO:0036064]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; beta-catenin binding [GO:0008013]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cardiac muscle cell differentiation [GO:0055007]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; floor plate development [GO:0033504]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; protein homotetramerization [GO:0051289]; protein localization [GO:0008104]"
PGEN_.00g037790	Scaffold_02	12667055	12668346	Q5E9F8	H33_BOVIN	Histone H3.3	GO:0000784; GO:0000788; GO:0000979; GO:0001649; GO:0001740; GO:0005634; GO:0006336; GO:0006997; GO:0007286; GO:0007338; GO:0007566; GO:0008283; GO:0008584; GO:0030307; GO:0031492; GO:0031508; GO:0031509; GO:0035264; GO:0042692; GO:0046982; GO:0048477; GO:0090230; GO:1902340	"Barr body [GO:0001740]; nuclear chromosome, telomeric region [GO:0000784]; nuclear nucleosome [GO:0000788]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; cell population proliferation [GO:0008283]; DNA replication-independent nucleosome assembly [GO:0006336]; embryo implantation [GO:0007566]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle cell differentiation [GO:0042692]; negative regulation of chromosome condensation [GO:1902340]; nucleus organization [GO:0006997]; oogenesis [GO:0048477]; osteoblast differentiation [GO:0001649]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cell growth [GO:0030307]; regulation of centromere complex assembly [GO:0090230]; single fertilization [GO:0007338]; spermatid development [GO:0007286]; telomeric heterochromatin assembly [GO:0031509]"
PGEN_.00g037800	Scaffold_02	12680202	12692068	Q58CU3	HBAP1_BOVIN	HSPB1-associated protein 1 (27 kDa heat shock protein-associated protein 1)	GO:0005737; GO:0016706	cytoplasm [GO:0005737]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]
PGEN_.00g037810	Scaffold_02	12694347	12729306	A7RJI7	CCZ1_NEMVE	Vacuolar fusion protein CCZ1 homolog	GO:0016192; GO:0035658; GO:0043231	intracellular membrane-bounded organelle [GO:0043231]; Mon1-Ccz1 complex [GO:0035658]; vesicle-mediated transport [GO:0016192]
PGEN_.00g037820	Scaffold_02	12741760	12750041	Q5XII0	EPDR1_RAT	Mammalian ependymin-related protein 1 (MERP-1)	GO:0005509; GO:0005576; GO:0005764; GO:0007160; GO:0008289; GO:0043202	extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; cell-matrix adhesion [GO:0007160]
PGEN_.00g037830	Scaffold_02	12750628	12750936	NA	NA	NA	NA	NA
PGEN_.00g037840	Scaffold_02	12752169	12760001	P51028	WNT8A_DANRE	Protein Wnt-8a	GO:0001654; GO:0001707; GO:0001710; GO:0001756; GO:0003676; GO:0005109; GO:0005615; GO:0007398; GO:0007417; GO:0007492; GO:0007498; GO:0009952; GO:0009953; GO:0010628; GO:0016055; GO:0021512; GO:0021999; GO:0030182; GO:0030902; GO:0030903; GO:0035284; GO:0036342; GO:0039015; GO:0042074; GO:0044332; GO:0045165; GO:0045743; GO:0048263; GO:0060061; GO:0060070; GO:0060823; GO:0060896; GO:0090090; GO:2000742	extracellular space [GO:0005615]; frizzled binding [GO:0005109]; nucleic acid binding [GO:0003676]; anterior/posterior pattern specification [GO:0009952]; brain segmentation [GO:0035284]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060823]; cell fate commitment [GO:0045165]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in pronephros development [GO:0039015]; central nervous system development [GO:0007417]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; endoderm development [GO:0007492]; eye development [GO:0001654]; hindbrain development [GO:0030902]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mesodermal cell fate commitment [GO:0001710]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural plate anterior/posterior regionalization [GO:0021999]; neural plate pattern specification [GO:0060896]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; post-anal tail morphogenesis [GO:0036342]; regulation of anterior head development [GO:2000742]; somitogenesis [GO:0001756]; Spemann organizer formation [GO:0060061]; spinal cord anterior/posterior patterning [GO:0021512]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in dorsal/ventral axis specification [GO:0044332]
PGEN_.00g037850	Scaffold_02	12769926	12787685	Q95334	AMPE_PIG	Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249)	GO:0003081; GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0008283; GO:0016021; GO:0016477; GO:0042277; GO:0043171; GO:0070006	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]
PGEN_.00g037860	Scaffold_02	12792623	12794836	NA	NA	NA	NA	NA
PGEN_.00g037870	Scaffold_02	12796326	12798268	P50123	AMPE_RAT	Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249)	GO:0001525; GO:0003081; GO:0004177; GO:0005737; GO:0005886; GO:0005903; GO:0006508; GO:0008233; GO:0008270; GO:0008283; GO:0009897; GO:0016021; GO:0016324; GO:0016477; GO:0031410; GO:0031526; GO:0032835; GO:0042277; GO:0043171; GO:0045177; GO:0070006	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; glomerulus development [GO:0032835]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]
PGEN_.00g037880	Scaffold_02	12802896	12804364	NA	NA	NA	NA	NA
PGEN_.00g037890	Scaffold_02	12806281	12806815	NA	NA	NA	NA	NA
PGEN_.00g037900	Scaffold_02	12813155	12839163	Q32LQ0	AMPE_BOVIN	Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249)	GO:0003081; GO:0004177; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0008283; GO:0016021; GO:0016477; GO:0042277; GO:0043171; GO:0070006	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]
PGEN_.00g037910	Scaffold_02	12865912	12866169	NA	NA	NA	NA	NA
PGEN_.00g037920	Scaffold_02	12886302	12886553	NA	NA	NA	NA	NA
PGEN_.00g037930	Scaffold_02	12895069	12909286	Q9U637	PITX_BRABE	Pituitary homeobox x (Bicoid type transcription factor Pitx) (BbPtx) (Homeobox protein Ptx) (Paired-like homeodomain transcription factor x)	GO:0003700; GO:0005634; GO:0007275; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]
PGEN_.00g037940	Scaffold_02	12959316	12966603	Q8JI10	DMX1A_DANRE	Diencephalon/mesencephalon homeobox protein 1-A (Paired homeobox protein 1)	GO:0001654; GO:0005634; GO:0007346; GO:0007420; GO:0030901; GO:0043010; GO:0043565; GO:0045892; GO:0050767; GO:0051726; GO:0060041; GO:0061074	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; eye development [GO:0001654]; midbrain development [GO:0030901]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; retina development in camera-type eye [GO:0060041]"
PGEN_.00g037950	Scaffold_02	13076330	13077622	NA	NA	NA	NA	NA
PGEN_.00g037960	Scaffold_02	13077820	13092358	Q8BUM9	UBP43_MOUSE	Ubiquitin carboxyl-terminal hydrolase 43 (EC 3.4.19.12) (Deubiquitinating enzyme 43) (Ubiquitin thioesterase 43) (Ubiquitin-specific-processing protease 43)	GO:0006511; GO:0016579; GO:0036459	thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g037970	Scaffold_02	13106115	13114102	NA	NA	NA	NA	NA
PGEN_.00g037980	Scaffold_02	13117434	13118958	NA	NA	NA	NA	NA
PGEN_.00g037990	Scaffold_02	13129566	13138239	NA	NA	NA	NA	NA
PGEN_.00g038000	Scaffold_02	13130316	13133773	NA	NA	NA	NA	NA
PGEN_.00g038010	Scaffold_02	13155548	13165099	NA	NA	NA	NA	NA
PGEN_.00g038020	Scaffold_02	13179741	13191452	NA	NA	NA	NA	NA
PGEN_.00g038030	Scaffold_02	13201482	13204102	NA	NA	NA	NA	NA
PGEN_.00g038040	Scaffold_02	13204430	13204699	NA	NA	NA	NA	NA
PGEN_.00g038050	Scaffold_02	13204728	13205228	NA	NA	NA	NA	NA
PGEN_.00g038060	Scaffold_02	13205277	13205717	Q01133	FMRA_CALPA	Antho-RFamide neuropeptides [Cleaved into: Antho-RFamide]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g038070	Scaffold_02	13205876	13206307	NA	NA	NA	NA	NA
PGEN_.00g038080	Scaffold_02	13206351	13206782	NA	NA	NA	NA	NA
PGEN_.00g038090	Scaffold_02	13207229	13248916	Q3B7N2	ACTN1_BOVIN	Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)	GO:0001725; GO:0001726; GO:0005509; GO:0005523; GO:0005915; GO:0005923; GO:0005925; GO:0012506; GO:0016328; GO:0017166; GO:0030018; GO:0030027; GO:0030486; GO:0031252; GO:0042383; GO:0042803; GO:0043462; GO:0043495; GO:0045214; GO:0046928; GO:0048741; GO:0051015; GO:0051017; GO:0051234; GO:0051393; GO:0051764; GO:0090636; GO:0090637; GO:0097433; GO:1990357	bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; dense body [GO:0097433]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; outer dense plaque of desmosome [GO:0090636]; ruffle [GO:0001726]; sarcolemma [GO:0042383]; smooth muscle dense body [GO:0030486]; stress fiber [GO:0001725]; terminal web [GO:1990357]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]; tropomyosin binding [GO:0005523]; vinculin binding [GO:0017166]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; establishment of localization [GO:0051234]; regulation of ATPase activity [GO:0043462]; regulation of neurotransmitter secretion [GO:0046928]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]
PGEN_.00g038100	Scaffold_02	13249008	13262583	F1LZF0	KLHL2_RAT	Kelch-like protein 2 (Mayven)	GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein ubiquitination [GO:0016567]
PGEN_.00g038110	Scaffold_02	13276963	13368146	Q5R754	CDKL2_PONAB	Cyclin-dependent kinase-like 2 (EC 2.7.11.22)	GO:0004693; GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]
PGEN_.00g038120	Scaffold_02	13392015	13392821	Q4V8B2	DCNL3_RAT	DCN1-like protein 3 (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3)	GO:0000151; GO:0005886; GO:0010225; GO:0010332; GO:0030308; GO:0031624; GO:0032182; GO:0043065; GO:0045116; GO:0048471; GO:0051443; GO:0097602; GO:2000134	perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]
PGEN_.00g038130	Scaffold_02	13401814	13412710	Q9DBY5	CBX6_MOUSE	Chromobox protein homolog 6	GO:0000122; GO:0000792; GO:0003727; GO:0005634; GO:0006325; GO:0031519	heterochromatin [GO:0000792]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; single-stranded RNA binding [GO:0003727]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g038140	Scaffold_02	13432997	13433356	P30975	TLR2_DROME	Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR)	GO:0004995; GO:0005886; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0042048; GO:0050805; GO:0050911; GO:1904058	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]
PGEN_.00g038150	Scaffold_02	13449327	13452096	NA	NA	NA	NA	NA
PGEN_.00g038160	Scaffold_02	13461131	13467962	NA	NA	NA	NA	NA
PGEN_.00g038170	Scaffold_02	13497711	13504151	NA	NA	NA	NA	NA
PGEN_.00g038180	Scaffold_02	13510019	13510285	NA	NA	NA	NA	NA
PGEN_.00g038190	Scaffold_02	13510435	13512448	NA	NA	NA	NA	NA
PGEN_.00g038200	Scaffold_02	13513547	13513957	NA	NA	NA	NA	NA
PGEN_.00g038210	Scaffold_02	13514429	13517298	NA	NA	NA	NA	NA
PGEN_.00g038220	Scaffold_02	13521242	13523616	P55213	CASP3_RAT	Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	GO:0001554; GO:0001666; GO:0001782; GO:0002020; GO:0004190; GO:0004197; GO:0004861; GO:0005123; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007413; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0008627; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010038; GO:0010165; GO:0014070; GO:0016005; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0031647; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0035556; GO:0042060; GO:0042493; GO:0042542; GO:0043025; GO:0043029; GO:0043065; GO:0043066; GO:0043200; GO:0043525; GO:0044877; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051146; GO:0051384; GO:0051402; GO:0061713; GO:0071310; GO:0071407; GO:0071887; GO:0072734; GO:0097153; GO:0097194; GO:0097199; GO:0097200; GO:1902004	cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to metal ion [GO:0010038]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]
PGEN_.00g038230	Scaffold_02	13533630	13538477	NA	NA	NA	NA	NA
PGEN_.00g038240	Scaffold_02	13554771	13583753	NA	NA	NA	NA	NA
PGEN_.00g038250	Scaffold_02	13595180	13686048	O97394	SDK_DROME	Protein sidekick	GO:0005887; GO:0007156; GO:0042675; GO:0045177; GO:0046533; GO:0050931; GO:0098595	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; perivitelline space [GO:0098595]; compound eye cone cell differentiation [GO:0042675]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of photoreceptor cell differentiation [GO:0046533]; pigment cell differentiation [GO:0050931]
PGEN_.00g038260	Scaffold_02	13711841	13715006	NA	NA	NA	NA	NA
PGEN_.00g038270	Scaffold_02	13736605	13740078	NA	NA	NA	NA	NA
PGEN_.00g038280	Scaffold_02	13742783	13746560	NA	NA	NA	NA	NA
PGEN_.00g038290	Scaffold_02	13787182	13788927	NA	NA	NA	NA	NA
PGEN_.00g038300	Scaffold_02	13789483	13792794	NA	NA	NA	NA	NA
PGEN_.00g038310	Scaffold_02	13867565	13868488	NA	NA	NA	NA	NA
PGEN_.00g038320	Scaffold_02	13913781	13945342	Q0VGT4	ZGRF1_MOUSE	Protein ZGRF1 (GRF-type zinc finger domain-containing protein 1)	GO:0003723; GO:0008270; GO:0016021	integral component of membrane [GO:0016021]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]
PGEN_.00g038330	Scaffold_02	13945452	13963617	NA	NA	NA	NA	NA
PGEN_.00g038340	Scaffold_02	14018719	14025178	Q3MHW6	MOT1_BOVIN	Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1)	GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0035879	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]
PGEN_.00g038350	Scaffold_02	14095606	14110132	NA	NA	NA	NA	NA
PGEN_.00g038360	Scaffold_02	14117087	14131665	Q803V5	LST8_DANRE	"Target of rapamycin complex subunit lst8 (TORC subunit lst8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (MTOR associated protein, LST8 homolog)"	GO:0005737; GO:0031929; GO:0031931; GO:0031932; GO:0032956	cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929]
PGEN_.00g038370	Scaffold_02	14151950	14160280	Q9NQV8	PRDM8_HUMAN	PR domain zinc finger protein 8 (EC 2.1.1.-) (PR domain-containing protein 8)	GO:0003677; GO:0005634; GO:0008168; GO:0014003; GO:0032259; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; oligodendrocyte development [GO:0014003]
PGEN_.00g038380	Scaffold_02	14201615	14225545	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g038390	Scaffold_02	14246184	14246486	NA	NA	NA	NA	NA
PGEN_.00g038400	Scaffold_02	14247328	14256496	P80009	PLMN_CANLF	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Plasmin light chain B] (Fragment)	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
PGEN_.00g038410	Scaffold_02	14261631	14278657	NA	NA	NA	NA	NA
PGEN_.00g038420	Scaffold_02	14306864	14309199	NA	NA	NA	NA	NA
PGEN_.00g038430	Scaffold_02	14309993	14371078	Q6V0I7	FAT4_HUMAN	Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
PGEN_.00g038440	Scaffold_02	14376791	14377111	NA	NA	NA	NA	NA
PGEN_.00g038450	Scaffold_02	14379201	14380930	Q9CX98	CP2U1_MOUSE	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g038460	Scaffold_02	14395345	14468652	NA	NA	NA	NA	NA
PGEN_.00g038470	Scaffold_02	14509227	14511033	NA	NA	NA	NA	NA
PGEN_.00g038480	Scaffold_02	14511854	14522777	NA	NA	NA	NA	NA
PGEN_.00g038490	Scaffold_02	14524677	14529651	P20478	GLNA2_DROME	Glutamine synthetase 2 cytoplasmic (EC 6.3.1.2) (Glutamate--ammonia ligase 2)	GO:0004356; GO:0005524; GO:0005737; GO:0006538; GO:0006542; GO:0007416; GO:0045213	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416]
PGEN_.00g038500	Scaffold_02	14536595	14537125	NA	NA	NA	NA	NA
PGEN_.00g038510	Scaffold_02	14539443	14543204	A9KET6	TDH_COXBN	L-threonine 3-dehydrogenase (TDH) (EC 1.1.1.103)	GO:0005737; GO:0008270; GO:0008743; GO:0019518	cytoplasm [GO:0005737]; L-threonine 3-dehydrogenase activity [GO:0008743]; zinc ion binding [GO:0008270]; L-threonine catabolic process to glycine [GO:0019518]
PGEN_.00g038520	Scaffold_02	14550904	14552022	NA	NA	NA	NA	NA
PGEN_.00g038530	Scaffold_02	14566949	14573064	P28338	GSTT1_MUSDO	Glutathione S-transferase 1 (EC 2.5.1.18) (GST class-theta)	GO:0004364	glutathione transferase activity [GO:0004364]
PGEN_.00g038540	Scaffold_02	14581834	14591396	Q63ZM7	STABP_XENLA	STAM-binding protein-like (EC 3.4.19.-)	GO:0008237; GO:0046872	metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]
PGEN_.00g038550	Scaffold_02	14623201	14639883	O94988	FA13A_HUMAN	Protein FAM13A	GO:0005096; GO:0005829; GO:0007165; GO:0051056	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]
PGEN_.00g038560	Scaffold_02	14640873	14663925	Q8BGI4	FA13A_MOUSE	Protein FAM13A (Precm1 protein)		
PGEN_.00g038570	Scaffold_02	14706020	14716890	NA	NA	NA	NA	NA
PGEN_.00g038580	Scaffold_02	14748906	14749289	NA	NA	NA	NA	NA
PGEN_.00g038590	Scaffold_02	14797121	14797432	NA	NA	NA	NA	NA
PGEN_.00g038600	Scaffold_02	14799901	14801083	NA	NA	NA	NA	NA
PGEN_.00g038610	Scaffold_02	14873487	14874097	NA	NA	NA	NA	NA
PGEN_.00g038620	Scaffold_02	14885889	14886164	NA	NA	NA	NA	NA
PGEN_.00g038630	Scaffold_02	14908214	14908879	Q96D21	RHES_HUMAN	GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2)	GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031397; GO:0031624; GO:0031681; GO:0033235; GO:0043548; GO:0043949; GO:0045202; GO:0051897	"plasma membrane [GO:0005886]; synapse [GO:0045202]; G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]; locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]"
PGEN_.00g038640	Scaffold_02	14913982	14914200	NA	NA	NA	NA	NA
PGEN_.00g038650	Scaffold_02	14930154	14941717	Q2KIR0	CD045_BOVIN	Uncharacterized protein C4orf45 homolog		
PGEN_.00g038660	Scaffold_02	14944317	14952357	Q9D9T0	DYDC1_MOUSE	DPY30 domain-containing protein 1	GO:0044666; GO:0048188; GO:0051568	MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568]
PGEN_.00g038670	Scaffold_02	14965656	14966402	Q96D21	RHES_HUMAN	GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2)	GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031397; GO:0031624; GO:0031681; GO:0033235; GO:0043548; GO:0043949; GO:0045202; GO:0051897	"plasma membrane [GO:0005886]; synapse [GO:0045202]; G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]; locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]"
PGEN_.00g038680	Scaffold_02	14974404	14974736	NA	NA	NA	NA	NA
PGEN_.00g038690	Scaffold_02	15108431	15108730	NA	NA	NA	NA	NA
PGEN_.00g038700	Scaffold_02	15147005	15147304	NA	NA	NA	NA	NA
PGEN_.00g038710	Scaffold_02	15177540	15227148	P97819	PLPL9_MOUSE	85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)	GO:0001934; GO:0005516; GO:0005615; GO:0005623; GO:0005739; GO:0005829; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016020; GO:0016042; GO:0017171; GO:0019731; GO:0019901; GO:0032049; GO:0034451; GO:0034976; GO:0035774; GO:0043008; GO:0045921; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0097755; GO:0102567; GO:0102568; GO:1901339; GO:2000304	"cell [GO:0005623]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]"
PGEN_.00g038720	Scaffold_02	15233660	15246340	Q9BLG0	TNNC_TODPA	Troponin C (TN-C)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g038730	Scaffold_02	15254684	15276177	NA	NA	NA	NA	NA
PGEN_.00g038740	Scaffold_02	15351329	15352693	O95395	GCNT3_HUMAN	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (EC 2.4.1.102) (EC 2.4.1.148) (EC 2.4.1.150) (C2GnT-mucin type) (C2GnT-M) (hC2GnT-M) (Core 2/core 4 beta-1,6-N-acetylglucosaminyltransferase) (C2/4GnT)"	GO:0000139; GO:0002426; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0016020; GO:0016021; GO:0016266; GO:0047225; GO:0048729; GO:0050892; GO:0060993; GO:0070062	"extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0047225]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; immunoglobulin production in mucosal tissue [GO:0002426]; intestinal absorption [GO:0050892]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; tissue morphogenesis [GO:0048729]"
PGEN_.00g038750	Scaffold_02	15366188	15366832	NA	NA	NA	NA	NA
PGEN_.00g038760	Scaffold_02	15384760	15409546	Q9DC40	TELO2_MOUSE	Telomere length regulation protein TEL2 homolog	GO:0000784; GO:0005634; GO:0005737; GO:0005829; GO:0007004; GO:0016020; GO:0016604; GO:0019901; GO:0031931; GO:0031932; GO:0032006; GO:0034399; GO:0042162; GO:0044877; GO:0050821; GO:0051879; GO:0060090; GO:0070209; GO:0071902; GO:1904263; GO:1904515	"ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; Hsp90 protein binding [GO:0051879]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006]; telomere maintenance via telomerase [GO:0007004]"
PGEN_.00g038770	Scaffold_02	15413938	15417454	A4F4L4	DNAL4_PIG	"Dynein light chain 4, axonemal"	GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0007017; GO:0030286; GO:0045505; GO:0051959; GO:2000582	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"
PGEN_.00g038780	Scaffold_02	15427722	15435897	O75832	PSD10_HUMAN	26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK))	GO:0000122; GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006521; GO:0006915; GO:0007253; GO:0008134; GO:0010972; GO:0016579; GO:0030307; GO:0031145; GO:0031146; GO:0031398; GO:0032088; GO:0032436; GO:0033209; GO:0038061; GO:0038095; GO:0043066; GO:0043161; GO:0043409; GO:0043488; GO:0043518; GO:0043687; GO:0045111; GO:0045737; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0061629; GO:0070498; GO:0070682; GO:0090090; GO:0090201; GO:0090263; GO:1901990; GO:1902036	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription factor binding [GO:0008134]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g038790	Scaffold_02	15444409	15448382	NA	NA	NA	NA	NA
PGEN_.00g038800	Scaffold_02	15453483	15456011	NA	NA	NA	NA	NA
PGEN_.00g038810	Scaffold_02	15467714	15492699	P20397	NUCL_XENLA	Nucleolin (Protein C23)	GO:0003677; GO:0003723; GO:0005730	nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723]
PGEN_.00g038820	Scaffold_02	15506852	15515346	Q13542	4EBP2_HUMAN	Eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2) (eIF4E-binding protein 2)	GO:0005737; GO:0006412; GO:0007613; GO:0008190; GO:0008286; GO:0019933; GO:0030371; GO:0031929; GO:0035176; GO:0045947; GO:0048167; GO:0050804; GO:0098794	cytoplasm [GO:0005737]; postsynapse [GO:0098794]; eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371]; cAMP-mediated signaling [GO:0019933]; insulin receptor signaling pathway [GO:0008286]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of translational initiation [GO:0045947]; regulation of synaptic plasticity [GO:0048167]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; translation [GO:0006412]
PGEN_.00g038830	Scaffold_02	15526507	15530784	NA	NA	NA	NA	NA
PGEN_.00g038840	Scaffold_02	15537633	15542946	NA	NA	NA	NA	NA
PGEN_.00g038850	Scaffold_02	15552970	15706961	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g038860	Scaffold_02	15718269	15718715	NA	NA	NA	NA	NA
PGEN_.00g038870	Scaffold_02	15724064	15731139	NA	NA	NA	NA	NA
PGEN_.00g038880	Scaffold_02	15761631	15776086	NA	NA	NA	NA	NA
PGEN_.00g038890	Scaffold_02	15782194	15802816	Q96IK5	GMCL1_HUMAN	Germ cell-less protein-like 1	GO:0007275; GO:0007283; GO:0016363; GO:0030154; GO:0042802	nuclear matrix [GO:0016363]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g038900	Scaffold_02	15804415	15818421	NA	NA	NA	NA	NA
PGEN_.00g038910	Scaffold_02	15843428	15854375	Q9Z1T5	DEAF1_MOUSE	Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR)	GO:0000122; GO:0000977; GO:0001227; GO:0001650; GO:0001662; GO:0001843; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006366; GO:0008542; GO:0033599; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048706	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; behavioral fear response [GO:0001662]; embryonic skeletal system development [GO:0048706]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542]"
PGEN_.00g038920	Scaffold_02	15861911	15897553	P16924	P4HA1_CHICK	"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)"	GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"
PGEN_.00g038930	Scaffold_02	15952110	15956021	NA	NA	NA	NA	NA
PGEN_.00g038940	Scaffold_02	15961323	15962936	NA	NA	NA	NA	NA
PGEN_.00g038950	Scaffold_02	16001662	16003257	NA	NA	NA	NA	NA
PGEN_.00g038960	Scaffold_02	16010716	16014496	NA	NA	NA	NA	NA
PGEN_.00g038970	Scaffold_02	16018216	16018515	NA	NA	NA	NA	NA
PGEN_.00g038980	Scaffold_02	16018743	16022518	NA	NA	NA	NA	NA
PGEN_.00g038990	Scaffold_02	16024941	16025807	NA	NA	NA	NA	NA
PGEN_.00g039000	Scaffold_02	16034376	16037105	NA	NA	NA	NA	NA
PGEN_.00g039010	Scaffold_02	16048734	16049465	NA	NA	NA	NA	NA
PGEN_.00g039020	Scaffold_02	16062800	16080816	Q2KHY5	FAP24_BOVIN	Fanconi anemia core complex-associated protein 24 (Fanconi anemia-associated protein of 24 kDa)	GO:0003677; GO:0003682; GO:0036297; GO:0043240	Fanconi anaemia nuclear complex [GO:0043240]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; interstrand cross-link repair [GO:0036297]
PGEN_.00g039030	Scaffold_02	16081137	16094576	A7SLC8	NAT9_NEMVE	N-acetyltransferase 9-like protein (EC 2.3.1.-)	GO:0006473; GO:0008080	N-acetyltransferase activity [GO:0008080]; protein acetylation [GO:0006473]
PGEN_.00g039040	Scaffold_02	16097353	16098465	NA	NA	NA	NA	NA
PGEN_.00g039050	Scaffold_02	16105610	16112691	Q9N2D1	TRYT_PIG	Tryptase (EC 3.4.21.59)	GO:0004252; GO:0005615; GO:0006508	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]
PGEN_.00g039060	Scaffold_02	16120294	16125070	NA	NA	NA	NA	NA
PGEN_.00g039070	Scaffold_02	16133048	16133869	NA	NA	NA	NA	NA
PGEN_.00g039080	Scaffold_02	16147802	16154798	NA	NA	NA	NA	NA
PGEN_.00g039090	Scaffold_02	16159560	16163933	P56405	AQP8_RAT	Aquaporin-8 (AQP-8)	GO:0005886; GO:0006833; GO:0015250; GO:0015722; GO:0016021; GO:0043231; GO:0045177; GO:0046691; GO:0071320	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; intracellular canaliculus [GO:0046691]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; water channel activity [GO:0015250]; canalicular bile acid transport [GO:0015722]; cellular response to cAMP [GO:0071320]; water transport [GO:0006833]
PGEN_.00g039100	Scaffold_02	16176445	16184669	O94778	AQP8_HUMAN	Aquaporin-8 (AQP-8)	GO:0005886; GO:0005887; GO:0006833; GO:0015250; GO:0031966; GO:0045177; GO:0071320	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; water channel activity [GO:0015250]; cellular response to cAMP [GO:0071320]; water transport [GO:0006833]
PGEN_.00g039110	Scaffold_02	16189165	16189536	NA	NA	NA	NA	NA
PGEN_.00g039120	Scaffold_02	16194719	16196204	P83425	HIP_MYTED	Heavy metal-binding protein HIP	GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]
PGEN_.00g039130	Scaffold_02	16202148	16220079	Q9FPH3	THA2_ARATH	Probable low-specificity L-threonine aldolase 2 (EC 4.1.2.48) (Threonine aldolase 2)	GO:0004793; GO:0005829; GO:0006545; GO:0006567; GO:0008732	cytosol [GO:0005829]; L-allo-threonine aldolase activity [GO:0008732]; threonine aldolase activity [GO:0004793]; glycine biosynthetic process [GO:0006545]; threonine catabolic process [GO:0006567]
PGEN_.00g039140	Scaffold_02	16230735	16324235	Q2KHT3	CL16A_HUMAN	Protein CLEC16A (C-type lectin domain family 16 member A)	GO:0005794; GO:0005829; GO:0006914; GO:0008333; GO:0009267; GO:0016021; GO:0016197; GO:0017137; GO:0031982; GO:0032435; GO:0036020; GO:1901097; GO:1901098; GO:1901525; GO:1904263; GO:1904766	cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263]
PGEN_.00g039150	Scaffold_02	16359702	16360439	O14508	SOCS2_HUMAN	Suppressor of cytokine signaling 2 (SOCS-2) (Cytokine-inducible SH2 protein 2) (CIS-2) (STAT-induced STAT inhibitor 2) (SSI-2)	GO:0001558; GO:0005070; GO:0005131; GO:0005159; GO:0005737; GO:0005829; GO:0005942; GO:0007259; GO:0007595; GO:0008269; GO:0009966; GO:0016567; GO:0032355; GO:0032870; GO:0035556; GO:0038111; GO:0040015; GO:0043066; GO:0043687; GO:0045666; GO:0046426; GO:0046854; GO:0046935; GO:0060396; GO:0060749	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]; SH3/SH2 adaptor activity [GO:0005070]; cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; interleukin-7-mediated signaling pathway [GO:0038111]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355]
PGEN_.00g039160	Scaffold_02	16368816	16370721	NA	NA	NA	NA	NA
PGEN_.00g039170	Scaffold_02	16379190	16396775	Q5SUV1	RSAD1_MOUSE	"Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Putative heme chaperone)"	GO:0004109; GO:0005739; GO:0006779; GO:0046872; GO:0051539	"mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]; porphyrin-containing compound biosynthetic process [GO:0006779]"
PGEN_.00g039180	Scaffold_02	16434495	16436747	P54131	ACHA7_BOVIN	Neuronal acetylcholine receptor subunit alpha-7	GO:0000187; GO:0001540; GO:0001666; GO:0005623; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890	"acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g039190	Scaffold_02	16438005	16441788	NA	NA	NA	NA	NA
PGEN_.00g039200	Scaffold_02	16445860	16454586	Q2NKU0	CENPX_BOVIN	Centromere protein X (CENP-X) (FANCM-interacting histone fold protein 2) (Fanconi anemia-associated polypeptide of 10 kDa) (Stimulated by retinoic acid gene 13 protein homolog)	GO:0000712; GO:0000777; GO:0003690; GO:0006281; GO:0031297; GO:0043240; GO:0051301; GO:0051382; GO:0071821	condensed chromosome kinetochore [GO:0000777]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; double-stranded DNA binding [GO:0003690]; cell division [GO:0051301]; DNA repair [GO:0006281]; kinetochore assembly [GO:0051382]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]
PGEN_.00g039210	Scaffold_02	16457560	16457814	NA	NA	NA	NA	NA
PGEN_.00g039220	Scaffold_02	16458412	16464052	Q6DF57	GPT11_XENTR	G patch domain-containing protein 11 (Coiled-coil domain-containing protein 75)	GO:0000776; GO:0000777; GO:0003676	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleic acid binding [GO:0003676]
PGEN_.00g039230	Scaffold_02	16524507	16550347	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g039240	Scaffold_02	16615626	16616675	A8WQK3	ACH1_CAEBR	Acetylcholine receptor subunit alpha-type acr-16	GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g039250	Scaffold_02	16624967	16630032	Q8BMN3	ACHB3_MOUSE	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0016020; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0051291; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g039260	Scaffold_02	16635952	16637130	P43679	ACHB3_CHICK	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g039270	Scaffold_02	16640795	16642033	Q15822	ACHA2_HUMAN	Neuronal acetylcholine receptor subunit alpha-2	GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015464; GO:0016021; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051291	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g039280	Scaffold_02	16679852	16685217	Q9W141	ATPK_DROME	"Putative ATP synthase subunit f, mitochondrial"	GO:0000276; GO:0005739; GO:0006754; GO:1902600	"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600]"
PGEN_.00g039290	Scaffold_02	16689669	16696956	Q91XV4	DCXR_MESAU	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g039300	Scaffold_02	16703395	16722042	Q0V8S0	HGS_BOVIN	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0005764; GO:0005829; GO:0006622; GO:0010324; GO:0010628; GO:0010642; GO:0016525; GO:0019904; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0072657; GO:1903543	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-like protein ligase binding [GO:0044389]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]
PGEN_.00g039310	Scaffold_02	16723841	16724137	NA	NA	NA	NA	NA
PGEN_.00g039320	Scaffold_02	16729454	16737734	P56213	ALR_MOUSE	FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration)	GO:0005615; GO:0005739; GO:0005758; GO:0005829; GO:0008083; GO:0015035; GO:0016971; GO:0043066; GO:0045953; GO:0050660; GO:0097421; GO:1903204; GO:2000573	cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein disulfide oxidoreductase activity [GO:0015035]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of DNA biosynthetic process [GO:2000573]
PGEN_.00g039330	Scaffold_02	16737874	16739539	NA	NA	NA	NA	NA
PGEN_.00g039340	Scaffold_02	16744651	16749709	Q5VUR7	A20A3_HUMAN	Ankyrin repeat domain-containing protein 20A3		
PGEN_.00g039350	Scaffold_02	16762226	16861833	Q6VNB8	WDFY3_MOUSE	"WD repeat and FYVE domain-containing protein 3 (Beach domain, WD repeat and FYVE domain-containing protein 1) (BWF1)"	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0034274; GO:0035973; GO:0043204; GO:0046872; GO:0097635	"Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]"
PGEN_.00g039360	Scaffold_02	16873765	16880495	Q962X9	BUD31_BRABE	Protein BUD31 homolog (Protein G10 homolog)	GO:0005634	nucleus [GO:0005634]
PGEN_.00g039370	Scaffold_02	16880979	16890403	NA	NA	NA	NA	NA
PGEN_.00g039380	Scaffold_02	16910376	16955951	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g039390	Scaffold_02	16959071	16960682	P86982	IMSP1_RUDPH	Insoluble matrix shell protein 1 (IMSP1) (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g039400	Scaffold_02	16978287	17008521	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g039410	Scaffold_02	17010731	17024004	NA	NA	NA	NA	NA
PGEN_.00g039420	Scaffold_02	17055502	17083633	Q9TU53	CUBN_CANLF	Cubilin	GO:0005509; GO:0005765; GO:0005768; GO:0005905; GO:0008144; GO:0008203; GO:0015031; GO:0016324; GO:0031419; GO:0031526	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; lysosomal membrane [GO:0005765]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]
PGEN_.00g039430	Scaffold_02	17091237	17092112	NA	NA	NA	NA	NA
PGEN_.00g039440	Scaffold_02	17098190	17111160	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g039450	Scaffold_02	17117104	17117883	NA	NA	NA	NA	NA
PGEN_.00g039460	Scaffold_02	17124628	17328460	Q8VHK2	CSKI1_RAT	Caskin-1 (CASK-interacting protein 1)	GO:0005737; GO:0007165; GO:0016020; GO:0019904; GO:0042802	cytoplasm [GO:0005737]; membrane [GO:0016020]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; signal transduction [GO:0007165]
PGEN_.00g039470	Scaffold_02	17340252	17346893	A2ARS0	ANR63_MOUSE	Ankyrin repeat domain-containing protein 63		
PGEN_.00g039480	Scaffold_02	17350731	17376844	NA	NA	NA	NA	NA
PGEN_.00g039490	Scaffold_02	17359126	17359291	NA	NA	NA	NA	NA
PGEN_.00g039500	Scaffold_02	17401161	17414654	Q3T0P5	CASP6_BOVIN	Caspase-6 (CASP-6) (EC 3.4.22.59) [Cleaved into: Caspase-6 subunit p18; Caspase-6 subunit p11]	GO:0005737; GO:0006915; GO:0097153; GO:0097200	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]
PGEN_.00g039510	Scaffold_02	17420275	17446794	Q924Z6	XPO6_MOUSE	Exportin-6 (Exp6) (Ran-binding protein 20)	GO:0005049; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006611; GO:0008536; GO:0032991	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]
PGEN_.00g039520	Scaffold_02	17462387	17464914	NA	NA	NA	NA	NA
PGEN_.00g039530	Scaffold_02	17485334	17485804	NA	NA	NA	NA	NA
PGEN_.00g039540	Scaffold_02	17486150	17486524	NA	NA	NA	NA	NA
PGEN_.00g039550	Scaffold_02	17486598	17486927	NA	NA	NA	NA	NA
PGEN_.00g039560	Scaffold_02	17487086	17487385	NA	NA	NA	NA	NA
PGEN_.00g039570	Scaffold_02	17488554	17490794	NA	NA	NA	NA	NA
PGEN_.00g039580	Scaffold_02	17499365	17503740	NA	NA	NA	NA	NA
PGEN_.00g039590	Scaffold_02	17506003	17509429	NA	NA	NA	NA	NA
PGEN_.00g039600	Scaffold_02	17520785	17521138	NA	NA	NA	NA	NA
PGEN_.00g039610	Scaffold_02	17581704	17585380	NA	NA	NA	NA	NA
PGEN_.00g039620	Scaffold_02	17596710	17607651	NA	NA	NA	NA	NA
PGEN_.00g039630	Scaffold_02	17615382	17616386	NA	NA	NA	NA	NA
PGEN_.00g039640	Scaffold_02	17638128	17639522	Q61471	TOB1_MOUSE	Protein Tob1 (Transducer of erbB-2 1)	GO:0003714; GO:0005634; GO:0005737; GO:0008285; GO:0010468; GO:0017148; GO:0030014; GO:0030514; GO:0030971; GO:0045668; GO:0046332; GO:0060212; GO:0060213; GO:0060390; GO:1900153	"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; receptor tyrosine kinase binding [GO:0030971]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of gene expression [GO:0010468]; regulation of SMAD protein signal transduction [GO:0060390]"
PGEN_.00g039650	Scaffold_02	17663776	17664045	NA	NA	NA	NA	NA
PGEN_.00g039660	Scaffold_02	17666437	17670045	NA	NA	NA	NA	NA
PGEN_.00g039670	Scaffold_02	17670307	17670677	NA	NA	NA	NA	NA
PGEN_.00g039680	Scaffold_02	17693453	17696893	NA	NA	NA	NA	NA
PGEN_.00g039690	Scaffold_02	17775651	17776016	NA	NA	NA	NA	NA
PGEN_.00g039700	Scaffold_02	17789735	17790235	NA	NA	NA	NA	NA
PGEN_.00g039710	Scaffold_02	17790935	17791597	NA	NA	NA	NA	NA
PGEN_.00g039720	Scaffold_02	17897600	17901702	NA	NA	NA	NA	NA
PGEN_.00g039730	Scaffold_02	17915194	17915814	P13908	ACHN2_CARAU	Neuronal acetylcholine receptor subunit non-alpha-2 (GFN-alpha-2)	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g039740	Scaffold_02	17915856	17916482	Q5IS75	ACHB3_PANTR	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g039750	Scaffold_02	17953338	17971708	NA	NA	NA	NA	NA
PGEN_.00g039760	Scaffold_02	18084308	18135755	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g039770	Scaffold_02	18142779	18143636	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g039780	Scaffold_02	18215417	18215845	NA	NA	NA	NA	NA
PGEN_.00g039790	Scaffold_02	18232836	18265772	O16796	NPL11_CAEEL	Neprilysin-11 (EC 3.4.24.-)	GO:0004222; GO:0005886; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]
PGEN_.00g039800	Scaffold_02	18356630	18360133	NA	NA	NA	NA	NA
PGEN_.00g039810	Scaffold_02	18391634	18399751	NA	NA	NA	NA	NA
PGEN_.00g039820	Scaffold_02	18415672	18426473	A4VCL2	FA20C_DROME	Extracellular serine/threonine protein CG31145 (EC 2.7.11.1) (Golgi casein kinase) (Golgi-enriched fraction casein kinase) (GEF-CK)	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005794; GO:0006468; GO:0016021; GO:0016773; GO:0046872	"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]"
PGEN_.00g039830	Scaffold_02	18427610	18452185	Q7T2P6	TIM23_DANRE	Mitochondrial import inner membrane translocase subunit Tim23	GO:0005744; GO:0006886; GO:0007275; GO:0008320; GO:0015450; GO:0016021; GO:0030150; GO:0031305; GO:0042719; GO:0045039	integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; intracellular protein transport [GO:0006886]; multicellular organism development [GO:0007275]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]
PGEN_.00g039840	Scaffold_02	18457739	18468270	Q52KK4	NAF1_RAT	H/ACA ribonucleoprotein complex non-core subunit NAF1	GO:0000493; GO:0001522; GO:0003723; GO:0005634; GO:0005732; GO:0005737; GO:0006364; GO:0042254; GO:0043489; GO:0051973; GO:0070034; GO:0090669; GO:1904358; GO:1905323	cytoplasm [GO:0005737]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; rRNA processing [GO:0006364]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669]
PGEN_.00g039850	Scaffold_02	18476259	18493901	Q6ZWL3	CP4V2_HUMAN	Cytochrome P450 4V2 (EC 1.14.14.-) (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79)	GO:0001523; GO:0004497; GO:0005506; GO:0005789; GO:0007601; GO:0010430; GO:0016021; GO:0016125; GO:0016705; GO:0020037; GO:0050896	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; fatty acid omega-oxidation [GO:0010430]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; sterol metabolic process [GO:0016125]; visual perception [GO:0007601]"
PGEN_.00g039860	Scaffold_02	18544791	18549959	P0C6F1	DYH2_MOUSE	"Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2)"	GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036156; GO:0045505; GO:0051959	"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g039870	Scaffold_02	18574076	18574357	NA	NA	NA	NA	NA
PGEN_.00g039880	Scaffold_02	18575444	18575686	NA	NA	NA	NA	NA
PGEN_.00g039890	Scaffold_02	18645886	18650983	Q80YV3	TRRAP_MOUSE	Transformation/transcription domain-associated protein (Tra1 homolog)	GO:0000123; GO:0000124; GO:0000812; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0006281; GO:0006355; GO:0007093; GO:0016578; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968	"Golgi apparatus [GO:0005794]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor complex [GO:0005667]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle checkpoint [GO:0007093]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g039900	Scaffold_02	18670765	18681530	C3YWU0	FUCO_BRAFL	Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)	GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139	extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]
PGEN_.00g039910	Scaffold_02	18692227	18717405	O75179	ANR17_HUMAN	Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0016032; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]
PGEN_.00g039920	Scaffold_02	18739053	18753806	P06766	DPOLB_RAT	DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-)	GO:0001701; GO:0003677; GO:0003684; GO:0003887; GO:0005634; GO:0005737; GO:0005874; GO:0005876; GO:0006260; GO:0006284; GO:0006287; GO:0006290; GO:0006303; GO:0006915; GO:0006954; GO:0006974; GO:0007435; GO:0007568; GO:0008017; GO:0008630; GO:0010332; GO:0016445; GO:0016446; GO:0016829; GO:0019899; GO:0032991; GO:0045471; GO:0046872; GO:0048535; GO:0048536; GO:0048872; GO:0051402; GO:0055093; GO:0071707	"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; aging [GO:0007568]; apoptotic process [GO:0006915]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]"
PGEN_.00g039930	Scaffold_02	18754537	18830195	P82808	GFPT1_RAT	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1)	GO:0004360; GO:0006002; GO:0006042; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0009744; GO:0016597; GO:0030246; GO:0032868; GO:0032869; GO:0032922; GO:0042802; GO:0045719; GO:0097367	amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; identical protein binding [GO:0042802]; cellular response to insulin stimulus [GO:0032869]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein N-linked glycosylation [GO:0006487]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]
PGEN_.00g039940	Scaffold_02	18768391	18771180	NA	NA	NA	NA	NA
PGEN_.00g039950	Scaffold_02	18852347	18885354	Q5E9S4	AT2L1_BOVIN	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	GO:0005739; GO:0008483; GO:0030170; GO:0050459	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]
PGEN_.00g039960	Scaffold_02	18899035	18939530	E9PY46	IF140_MOUSE	Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2)	GO:0001750; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0048705; GO:0060041; GO:0060271; GO:0061512; GO:0072001; GO:0097730; GO:1902017; GO:1905515; GO:1990403	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]; renal system development [GO:0072001]; retina development in camera-type eye [GO:0060041]; skeletal system morphogenesis [GO:0048705]
PGEN_.00g039970	Scaffold_02	18944702	18978914	NA	NA	NA	NA	NA
PGEN_.00g039980	Scaffold_02	18992830	18994410	NA	NA	NA	NA	NA
PGEN_.00g039990	Scaffold_02	18996637	19001314	O15973	OPSD1_MIZYE	"Rhodopsin, GQ-coupled (GQ-rhodopsin)"	GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g040000	Scaffold_02	19012370	19013406	NA	NA	NA	NA	NA
PGEN_.00g040010	Scaffold_02	19032724	19056339	Q5G271	NETR_PANTR	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; zymogen activation [GO:0031638]
PGEN_.00g040020	Scaffold_02	19062096	19062365	NA	NA	NA	NA	NA
PGEN_.00g040030	Scaffold_02	19062583	19063143	NA	NA	NA	NA	NA
PGEN_.00g040040	Scaffold_02	19065215	19066870	Q56A24	KLH24_RAT	Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1)	GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312	adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]
PGEN_.00g040050	Scaffold_02	19074079	19078594	P83369	LSM11_HUMAN	U7 snRNA-associated Sm-like protein LSm11	GO:0005634; GO:0005654; GO:0005683; GO:0005697; GO:0006369; GO:0006398; GO:0008334; GO:0016604; GO:0071204; GO:0071209; GO:1900087	histone pre-mRNA 3'end processing complex [GO:0071204]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; U7 snRNP [GO:0005683]; U7 snRNA binding [GO:0071209]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; termination of RNA polymerase II transcription [GO:0006369]
PGEN_.00g040060	Scaffold_02	19078943	19087124	P0CW27	CC166_HUMAN	Coiled-coil domain-containing protein 166		
PGEN_.00g040070	Scaffold_02	19101520	19139641	Q6IPM2	IQCE_HUMAN	IQ domain-containing protein E	GO:0005929; GO:0035108; GO:0060170	ciliary membrane [GO:0060170]; cilium [GO:0005929]; limb morphogenesis [GO:0035108]
PGEN_.00g040080	Scaffold_02	19140783	19151784	Q8CFD4	SNX8_MOUSE	Sorting nexin-8	GO:0005829; GO:0006886; GO:0030904; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]
PGEN_.00g040090	Scaffold_02	19151919	19165977	Q9Y5X2	SNX8_HUMAN	Sorting nexin-8	GO:0005829; GO:0006886; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]
PGEN_.00g040100	Scaffold_02	19194238	19207953	NA	NA	NA	NA	NA
PGEN_.00g040110	Scaffold_02	19216275	19216871	NA	NA	NA	NA	NA
PGEN_.00g040120	Scaffold_02	19222136	19227319	NA	NA	NA	NA	NA
PGEN_.00g040130	Scaffold_02	19246649	19247632	Q61618	AA3R_MOUSE	Adenosine receptor A3 (A3AR)	GO:0001609; GO:0001973; GO:0002553; GO:0002687; GO:0005886; GO:0005887; GO:0008285; GO:0014068; GO:0030336; GO:0031594; GO:0032088; GO:0042629; GO:0043306; GO:0045202; GO:0050729; GO:0050850; GO:0070257	integral component of plasma membrane [GO:0005887]; mast cell granule [GO:0042629]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled adenosine receptor activity [GO:0001609]; adenosine receptor signaling pathway [GO:0001973]; histamine secretion by mast cell [GO:0002553]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of mucus secretion [GO:0070257]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]
PGEN_.00g040140	Scaffold_02	19256132	19269967	Q9UJU3	ZN112_HUMAN	Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g040150	Scaffold_02	19277062	19281162	P08991	H2AV_STRPU	Histone H2A.V (H2A.F/Z) (Fragment)	GO:0000786; GO:0000790; GO:0003677; GO:0006325; GO:0046982	nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]
PGEN_.00g040160	Scaffold_02	19290177	19291246	NA	NA	NA	NA	NA
PGEN_.00g040170	Scaffold_02	19292914	19293330	NA	NA	NA	NA	NA
PGEN_.00g040180	Scaffold_02	19294128	19294409	NA	NA	NA	NA	NA
PGEN_.00g040190	Scaffold_02	19350990	19369410	NA	NA	NA	NA	NA
PGEN_.00g040200	Scaffold_02	19378657	19397915	O14562	UBFD1_HUMAN	Ubiquitin domain-containing protein UBFD1 (Ubiquitin-binding protein homolog)	GO:0003723; GO:0045296	cadherin binding [GO:0045296]; RNA binding [GO:0003723]
PGEN_.00g040210	Scaffold_02	19401069	19401350	NA	NA	NA	NA	NA
PGEN_.00g040220	Scaffold_02	19406927	19408475	Q8WXD5	GEMI6_HUMAN	Gem-associated protein 6 (Gemin-6) (SIP2)	GO:0000245; GO:0000387; GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0051170; GO:0097504	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]"
PGEN_.00g040230	Scaffold_02	19408775	19410467	Q4V7L5	MED9_XENLA	Mediator of RNA polymerase II transcription subunit 9 (Mediator complex subunit 9)	GO:0003712; GO:0006357; GO:0016592	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g040240	Scaffold_02	19416357	19453702	O35920	CAN9_RAT	Calpain-9 (EC 3.4.22.-) (Digestive tract-specific calpain) (New calpain 4) (nCL-4)	GO:0004198; GO:0005509; GO:0005737; GO:0045214	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; sarcomere organization [GO:0045214]
PGEN_.00g040250	Scaffold_02	19472218	19474005	Q924H0	NPFF2_MOUSE	Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408; GO:0045761; GO:2000479	actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]
PGEN_.00g040260	Scaffold_02	19521407	19522081	NA	NA	NA	NA	NA
PGEN_.00g040270	Scaffold_02	19616989	19620180	Q4EW11	PRLHR_BOVIN	Prolactin-releasing peptide receptor (PrRP receptor) (PrRPR) (G-protein coupled receptor 10)	GO:0004983; GO:0005886; GO:0005929; GO:0007631; GO:0016021; GO:0042445	cilium [GO:0005929]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]; feeding behavior [GO:0007631]; hormone metabolic process [GO:0042445]
PGEN_.00g040280	Scaffold_02	19795031	19799001	NA	NA	NA	NA	NA
PGEN_.00g040290	Scaffold_02	19804754	19808390	NA	NA	NA	NA	NA
PGEN_.00g040300	Scaffold_02	19808594	19814342	NA	NA	NA	NA	NA
PGEN_.00g040310	Scaffold_02	19833619	19852765	NA	NA	NA	NA	NA
PGEN_.00g040320	Scaffold_02	19856565	19871958	NA	NA	NA	NA	NA
PGEN_.00g040330	Scaffold_02	19899297	19899863	NA	NA	NA	NA	NA
PGEN_.00g040340	Scaffold_02	19900738	19901358	NA	NA	NA	NA	NA
PGEN_.00g040350	Scaffold_02	19901992	19902970	NA	NA	NA	NA	NA
PGEN_.00g040360	Scaffold_02	19971552	19982361	Q8I8U7	TRA1_DROME	Transcription-associated protein 1 (dTRA1)	GO:0000123; GO:0000124; GO:0000281; GO:0003712; GO:0005634; GO:0005700; GO:0005703; GO:0005737; GO:0006281; GO:0006351; GO:0006355; GO:0016573; GO:0035222; GO:0035267; GO:0043486; GO:0043966	"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222]"
PGEN_.00g040370	Scaffold_02	19982497	19983774	NA	NA	NA	NA	NA
PGEN_.00g040380	Scaffold_02	19983839	19991945	NA	NA	NA	NA	NA
PGEN_.00g040390	Scaffold_02	19999232	20001094	NA	NA	NA	NA	NA
PGEN_.00g040400	Scaffold_02	20009481	20010039	NA	NA	NA	NA	NA
PGEN_.00g040410	Scaffold_02	20010904	20012338	NA	NA	NA	NA	NA
PGEN_.00g040420	Scaffold_02	20106530	20108896	F1P963	8ODP_CANLF	"7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55) (2-hydroxy-dATP diphosphatase) (EC 3.6.1.56) (8-oxo-dGTPase) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1)"	GO:0001669; GO:0003723; GO:0006281; GO:0008413; GO:0031965; GO:0046872	"acrosomal vesicle [GO:0001669]; nuclear membrane [GO:0031965]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA repair [GO:0006281]"
PGEN_.00g040430	Scaffold_02	20108962	20124505	Q5F3I6	TM104_CHICK	Transmembrane protein 104	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g040440	Scaffold_02	20127622	20139448	Q5F3I6	TM104_CHICK	Transmembrane protein 104	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g040450	Scaffold_02	20145841	20167109	G5E8K5	ANK3_MOUSE	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g040460	Scaffold_02	20209683	20210093	NA	NA	NA	NA	NA
PGEN_.00g040470	Scaffold_02	20216758	20232848	Q03468	ERCC6_HUMAN	DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)	GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006362; GO:0006366; GO:0006979; GO:0007256; GO:0007257; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032508; GO:0032784; GO:0032786; GO:0035264; GO:0043044; GO:0044877; GO:0045494; GO:0045739; GO:0045815; GO:0047485; GO:0060261; GO:0070063; GO:0090734; GO:0097680; GO:1905168; GO:2001033	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]; activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; ATP-dependent chromatin remodeling [GO:0043044]; base-excision repair [GO:0006284]; DNA damage checkpoint [GO:0000077]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]"
PGEN_.00g040480	Scaffold_02	20233415	20236164	P0DP91	ERPG3_HUMAN	Chimeric ERCC6-PGBD3 protein (Chimeric CSB-PGBD3 protein)	GO:0002230; GO:0005654; GO:0010628; GO:0016604; GO:0033141; GO:0043565; GO:0045739	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; sequence-specific DNA binding [GO:0043565]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]
PGEN_.00g040490	Scaffold_02	20242124	20243620	NA	NA	NA	NA	NA
PGEN_.00g040500	Scaffold_02	20247784	20253472	NA	NA	NA	NA	NA
PGEN_.00g040510	Scaffold_02	20253531	20283815	Q4V348	Z658B_HUMAN	Zinc finger protein 658B	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g040520	Scaffold_02	20309797	20310096	NA	NA	NA	NA	NA
PGEN_.00g040530	Scaffold_02	20312049	20312546	NA	NA	NA	NA	NA
PGEN_.00g040540	Scaffold_02	20319881	20324018	A2A9R3	MAGB4_MOUSE	Melanoma-associated antigen B4	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g040550	Scaffold_02	20460974	20564514	P0C605	KGP1_MOUSE	cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)	GO:0001669; GO:0001764; GO:0004672; GO:0004674; GO:0004692; GO:0005246; GO:0005524; GO:0005623; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007204; GO:0010920; GO:0014050; GO:0014912; GO:0016020; GO:0016358; GO:0019934; GO:0030553; GO:0030900; GO:0042753; GO:0042802; GO:0043087; GO:0045822; GO:0045986; GO:0048273; GO:0060087; GO:0061049; GO:0090331; GO:0097755; GO:1902608; GO:1904706; GO:1904753; GO:2000224	acrosomal vesicle [GO:0001669]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell growth involved in cardiac muscle cell development [GO:0061049]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of heart contraction [GO:0045822]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; regulation of testosterone biosynthetic process [GO:2000224]; relaxation of vascular smooth muscle [GO:0060087]; signal transduction [GO:0007165]
PGEN_.00g040560	Scaffold_02	20590272	20594175	NA	NA	NA	NA	NA
PGEN_.00g040570	Scaffold_02	20595342	20597344	NA	NA	NA	NA	NA
PGEN_.00g040580	Scaffold_02	20598664	20601573	NA	NA	NA	NA	NA
PGEN_.00g040590	Scaffold_02	20602141	20602431	NA	NA	NA	NA	NA
PGEN_.00g040600	Scaffold_02	20611092	20611346	NA	NA	NA	NA	NA
PGEN_.00g040610	Scaffold_02	20611415	20613092	NA	NA	NA	NA	NA
PGEN_.00g040620	Scaffold_02	20613196	20613810	NA	NA	NA	NA	NA
PGEN_.00g040630	Scaffold_02	20623166	20628296	Q1HG43	DOXA1_HUMAN	Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein)	GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016021; GO:0019899; GO:0031252; GO:0034613; GO:0042743; GO:0045666; GO:0050727; GO:2000609	cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609]
PGEN_.00g040640	Scaffold_02	20629250	20634210	Q0P4G7	DOXA1_XENTR	Dual oxidase maturation factor 1 (Dual oxidase activator 1)	GO:0005789; GO:0015031; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]
PGEN_.00g040650	Scaffold_02	20679768	20697333	NA	NA	NA	NA	NA
PGEN_.00g040660	Scaffold_02	20697586	20707308	NA	NA	NA	NA	NA
PGEN_.00g040670	Scaffold_02	20750440	20752429	Q9C6W5	AB14G_ARATH	ABC transporter G family member 14 (ABC transporter ABCG.14) (AtABCG14) (White-brown complex homolog protein 14) (AtWBC14)	GO:0005524; GO:0005886; GO:0010222; GO:0010588; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cotyledon vascular tissue pattern formation [GO:0010588]; stem vascular tissue pattern formation [GO:0010222]; transmembrane transport [GO:0055085]
PGEN_.00g040680	Scaffold_02	20762280	20778772	Q9BY77	PDIP3_HUMAN	Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein) (p46) (S6K1 Aly/REF-like target) (SKAR)	GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006406; GO:0016607; GO:0016973; GO:0031124; GO:0036464; GO:0044877; GO:0045727	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727]; RNA export from nucleus [GO:0006405]
PGEN_.00g040690	Scaffold_02	20789058	20792969	Q920P0	DCXR_RAT	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase)	GO:0004090; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016614; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289; GO:0055114	"brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g040700	Scaffold_02	20797154	20803424	P24721	ASGR2_MOUSE	Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (Hepatic lectin 2) (HL-2) (mHL-2)	GO:0006897; GO:0009100; GO:0016021; GO:0030246; GO:0030282; GO:0031647; GO:0044322; GO:0048471; GO:0055088	endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; bone mineralization [GO:0030282]; endocytosis [GO:0006897]; glycoprotein metabolic process [GO:0009100]; lipid homeostasis [GO:0055088]; regulation of protein stability [GO:0031647]
PGEN_.00g040710	Scaffold_02	20807755	20815183	P20693	FCER2_MOUSE	Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23)	GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]
PGEN_.00g040720	Scaffold_02	20934670	20937777	Q8IN35	SIFAR_DROME	Neuropeptide SIFamide receptor	GO:0004930; GO:0004983; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016021; GO:0032870; GO:0048047	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g040730	Scaffold_02	20969637	20972572	NA	NA	NA	NA	NA
PGEN_.00g040740	Scaffold_02	21025111	21032243	NA	NA	NA	NA	NA
PGEN_.00g040750	Scaffold_02	21042132	21047006	NA	NA	NA	NA	NA
PGEN_.00g040760	Scaffold_02	21052555	21052956	NA	NA	NA	NA	NA
PGEN_.00g040770	Scaffold_02	21060023	21060364	NA	NA	NA	NA	NA
PGEN_.00g040780	Scaffold_02	21061020	21062457	NA	NA	NA	NA	NA
PGEN_.00g040790	Scaffold_02	21075334	21077562	Q689D1	TLR2_CANLF	Toll-like receptor 2 (CD antigen CD282)	GO:0002224; GO:0002755; GO:0005794; GO:0005887; GO:0006954; GO:0030670; GO:0031226; GO:0034134; GO:0045087; GO:0045121; GO:0050707; GO:0050729; GO:0071726; GO:0071727	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g040800	Scaffold_02	21113578	21114987	A0A0P0XM10	PAO6_ORYSJ	Polyamine oxidase 6 (OsPAO6) (EC 1.5.3.-) (Polyamine oxidase B)	GO:0016491; GO:0046208; GO:0048046	apoplast [GO:0048046]; oxidoreductase activity [GO:0016491]; spermine catabolic process [GO:0046208]
PGEN_.00g040810	Scaffold_02	21123622	21124482	NA	NA	NA	NA	NA
PGEN_.00g040820	Scaffold_02	21144729	21145679	NA	NA	NA	NA	NA
PGEN_.00g040830	Scaffold_02	21156193	21158851	NA	NA	NA	NA	NA
PGEN_.00g040840	Scaffold_02	21230620	21247868	A2A6T1	CDR2L_MOUSE	Cerebellar degeneration-related protein 2-like		
PGEN_.00g040850	Scaffold_02	21256512	21257450	NA	NA	NA	NA	NA
PGEN_.00g040860	Scaffold_02	21270019	21271330	O97578	CATC_CANLF	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain 1 (Dipeptidyl peptidase I heavy chain 1); Dipeptidyl peptidase 1 heavy chain 2 (Dipeptidyl peptidase I heavy chain 2); Dipeptidyl peptidase 1 heavy chain 3 (Dipeptidyl peptidase I heavy chain 3); Dipeptidyl peptidase 1 heavy chain 4 (Dipeptidyl peptidase I heavy chain 4); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)] (Fragment)	GO:0004197; GO:0005615; GO:0005764; GO:0051603	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g040870	Scaffold_02	21278921	21279610	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g040880	Scaffold_02	21286640	21286888	NA	NA	NA	NA	NA
PGEN_.00g040890	Scaffold_02	21288360	21289199	NA	NA	NA	NA	NA
PGEN_.00g040900	Scaffold_02	21305249	21306226	NA	NA	NA	NA	NA
PGEN_.00g040910	Scaffold_02	21313839	21314531	NA	NA	NA	NA	NA
PGEN_.00g040920	Scaffold_02	21329608	21330558	NA	NA	NA	NA	NA
PGEN_.00g040930	Scaffold_02	21381773	21382843	Q7T3S3	CHSTB_DANRE	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)	GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]
PGEN_.00g040940	Scaffold_02	21388587	21391640	Q7T3S3	CHSTB_DANRE	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)	GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]
PGEN_.00g040950	Scaffold_02	21392515	21403754	P82596	PLC_HALLA	Perlucin	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g040960	Scaffold_02	21406462	21418940	Q2LK54	COL12_CHICK	Collectin-12 (Collectin-3) (CL-3) (cCL-3)	GO:0004888; GO:0005581; GO:0016021; GO:0030246; GO:0046872	collagen trimer [GO:0005581]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g040970	Scaffold_02	21430627	21438303	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g040980	Scaffold_02	21444046	21454801	NA	NA	NA	NA	NA
PGEN_.00g040990	Scaffold_02	21464217	21468512	P16112	PGCA_HUMAN	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2]	GO:0001501; GO:0001502; GO:0002063; GO:0005201; GO:0005540; GO:0005576; GO:0005604; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0007507; GO:0018146; GO:0030166; GO:0030198; GO:0030199; GO:0030246; GO:0031012; GO:0042340; GO:0043202; GO:0046872; GO:0062023; GO:0098966; GO:0098978; GO:0098982	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perisynaptic extracellular matrix [GO:0098966]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate catabolic process [GO:0042340]; proteoglycan biosynthetic process [GO:0030166]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]
PGEN_.00g041000	Scaffold_02	21471270	21474335	NA	NA	NA	NA	NA
PGEN_.00g041010	Scaffold_02	21476423	21481106	P0CM86	COX19_CRYNJ	Cytochrome c oxidase assembly protein COX19	GO:0005507; GO:0005758; GO:0005829; GO:0030001; GO:0033617	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; copper ion binding [GO:0005507]; metal ion transport [GO:0030001]; mitochondrial respiratory chain complex IV assembly [GO:0033617]
PGEN_.00g041020	Scaffold_02	21491400	21535075	Q4VSI4	UBP7_RAT	Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (rHAUSP) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7)	GO:0001741; GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006283; GO:0006511; GO:0007275; GO:0008022; GO:0008134; GO:0010216; GO:0016579; GO:0016605; GO:0031625; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0035616; GO:0036459; GO:0042752; GO:0042802; GO:0043065; GO:0048511; GO:0050821; GO:0051090; GO:0101005; GO:1901537; GO:1990380	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; XY body [GO:0001741]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g041030	Scaffold_02	21539292	21540914	NA	NA	NA	NA	NA
PGEN_.00g041040	Scaffold_02	21547540	21552331	NA	NA	NA	NA	NA
PGEN_.00g041050	Scaffold_02	21562594	21617712	Q9ULM6	CNOT6_HUMAN	CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (CCR4 carbon catabolite repression 4-like) (Carbon catabolite repressor protein 4 homolog) (Cytoplasmic deadenylase)	GO:0000175; GO:0000289; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0006977; GO:0008284; GO:0010606; GO:0016020; GO:0030014; GO:0035195; GO:0043928; GO:0046872; GO:0070966; GO:2000327	"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of translation [GO:0006417]"
PGEN_.00g041060	Scaffold_02	21617879	21618277	NA	NA	NA	NA	NA
PGEN_.00g041070	Scaffold_02	21626750	21628336	NA	NA	NA	NA	NA
PGEN_.00g041080	Scaffold_02	21653641	21659545	Q8VEG6	CNO6L_MOUSE	CCR4-NOT transcription complex subunit 6-like (EC 3.1.13.4)	GO:0000175; GO:0000288; GO:0000289; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0046872; GO:0061157	"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]"
PGEN_.00g041090	Scaffold_02	21664247	21683674	A6QPQ5	RM01_BOVIN	"39S ribosomal protein L1, mitochondrial (L1mt) (MRP-L1)"	GO:0000470; GO:0003723; GO:0003735; GO:0005743; GO:0006412; GO:0015934; GO:0030686	90S preribosome [GO:0030686]; large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]
PGEN_.00g041100	Scaffold_02	21689322	21706505	P26443	DHE3_MOUSE	"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)"	GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006537; GO:0006538; GO:0006541; GO:0007616; GO:0010044; GO:0019899; GO:0021549; GO:0032024; GO:0043531; GO:0070403; GO:0070728; GO:0072350	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; cerebellum development [GO:0021549]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; long-term memory [GO:0007616]; positive regulation of insulin secretion [GO:0032024]; response to aluminum ion [GO:0010044]; tricarboxylic acid metabolic process [GO:0072350]
PGEN_.00g041110	Scaffold_02	21717405	21731572	Q9NQ29	LUC7L_HUMAN	Putative RNA-binding protein Luc7-like 1 (Putative SR protein LUC7B1) (SR+89)	GO:0003729; GO:0005685; GO:0006376; GO:0042802; GO:0045843; GO:0050733; GO:0071004	U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]; mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]
PGEN_.00g041120	Scaffold_02	21735078	21741559	Q02366	NDUA6_BOVIN	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (NADH-ubiquinone oxidoreductase B14 subunit)	GO:0005747; GO:0006979; GO:0032981; GO:0055114	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]
PGEN_.00g041130	Scaffold_02	21766516	21769682	NA	NA	NA	NA	NA
PGEN_.00g041140	Scaffold_02	21774163	21775119	Q9N294	B3GT5_PANPA	"Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5) (Fragment)"	GO:0000139; GO:0006486; GO:0008378; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; protein glycosylation [GO:0006486]
PGEN_.00g041150	Scaffold_02	21900473	21907191	NA	NA	NA	NA	NA
PGEN_.00g041160	Scaffold_02	21916386	21916895	NA	NA	NA	NA	NA
PGEN_.00g041170	Scaffold_02	21917369	21917779	NA	NA	NA	NA	NA
PGEN_.00g041180	Scaffold_02	21937305	21937817	NA	NA	NA	NA	NA
PGEN_.00g041190	Scaffold_02	22009054	22009884	NA	NA	NA	NA	NA
PGEN_.00g041200	Scaffold_02	22026119	22026508	NA	NA	NA	NA	NA
PGEN_.00g041210	Scaffold_02	22058258	22115901	Q8N201	INT1_HUMAN	Integrator complex subunit 1 (Int1)	GO:0005654; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034474; GO:0042795	integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]; U2 snRNA 3'-end processing [GO:0034474]
PGEN_.00g041220	Scaffold_02	22120532	22125227	B4PEU8	RS9_DROYA	40S ribosomal protein S9	GO:0000228; GO:0003735; GO:0005730; GO:0005737; GO:0006412; GO:0015935; GO:0019843	cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g041230	Scaffold_02	22137946	22156380	Q69Z89	RADIL_MOUSE	Ras-associating and dilute domain-containing protein	GO:0005874; GO:0007165; GO:0007275; GO:0032991; GO:0034446	microtubule [GO:0005874]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]
PGEN_.00g041240	Scaffold_02	22165597	22166067	NA	NA	NA	NA	NA
PGEN_.00g041250	Scaffold_02	22237864	22261755	O32164	SUFS_BACSU	Cysteine desulfurase SufS (EC 2.8.1.7)	GO:0006534; GO:0030170; GO:0031071	cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170]; cysteine metabolic process [GO:0006534]
PGEN_.00g041260	Scaffold_02	22316347	22316610	NA	NA	NA	NA	NA
PGEN_.00g041270	Scaffold_02	22317410	22319388	NA	NA	NA	NA	NA
PGEN_.00g041280	Scaffold_02	22365555	22365773	NA	NA	NA	NA	NA
PGEN_.00g041290	Scaffold_02	22365827	22366102	NA	NA	NA	NA	NA
PGEN_.00g041300	Scaffold_02	22373706	22375777	NA	NA	NA	NA	NA
PGEN_.00g041310	Scaffold_02	22561340	22563432	NA	NA	NA	NA	NA
PGEN_.00g041320	Scaffold_02	22627941	22628483	NA	NA	NA	NA	NA
PGEN_.00g041330	Scaffold_02	22785790	22787160	Q49LX5	SSR1_CANLF	Somatostatin receptor type 1 (SS-1-R) (SS1-R) (SS1R)	GO:0004930; GO:0004994; GO:0005887; GO:0007215; GO:0007218; GO:0042277; GO:0042923; GO:0071392; GO:1990830	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; glutamate receptor signaling pathway [GO:0007215]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g041340	Scaffold_02	22803064	22803364	NA	NA	NA	NA	NA
PGEN_.00g041350	Scaffold_02	22803410	22803769	NA	NA	NA	NA	NA
PGEN_.00g041360	Scaffold_02	22869641	22869958	NA	NA	NA	NA	NA
PGEN_.00g041370	Scaffold_02	22923956	22929573	NA	NA	NA	NA	NA
PGEN_.00g041380	Scaffold_02	22937283	22941869	P15880	RS2_HUMAN	40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)	GO:0000184; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0017134; GO:0019083; GO:0019899; GO:0022627; GO:0045202; GO:0045296; GO:0051443; GO:0070062; GO:0071353	"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
PGEN_.00g041390	Scaffold_02	22949479	23020749	NA	NA	NA	NA	NA
PGEN_.00g041400	Scaffold_02	23024773	23049889	Q66KD0	BTBDH_XENTR	BTB/POZ domain-containing protein 17	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g041410	Scaffold_02	23127170	23130591	NA	NA	NA	NA	NA
PGEN_.00g041420	Scaffold_02	23155200	23191616	O00124	UBXN8_HUMAN	UBX domain-containing protein 8 (Reproduction 8 protein) (Rep-8 protein) (UBX domain-containing protein 6)	GO:0005654; GO:0005730; GO:0005783; GO:0007338; GO:0030176; GO:0030433	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; single fertilization [GO:0007338]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g041430	Scaffold_02	23191981	23200970	P18298	METK2_RAT	S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II)	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0007623; GO:0009416; GO:0009725; GO:0016597; GO:0034214; GO:0042493; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0051591; GO:1990830	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; amino acid binding [GO:0016597]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; circadian rhythm [GO:0007623]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to light stimulus [GO:0009416]; S-adenosylmethionine biosynthetic process [GO:0006556]
PGEN_.00g041440	Scaffold_02	23204079	23226413	Q9CYU6	DPH7_MOUSE	Diphthine methyltransferase (EC 3.1.1.97) (Diphthamide biosynthesis protein 7) (DPH7) (WD repeat-containing protein 85)	GO:0017183; GO:0061685	diphthine methylesterase activity [GO:0061685]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]
PGEN_.00g041450	Scaffold_02	23235048	23244088	NA	NA	NA	NA	NA
PGEN_.00g041460	Scaffold_02	23245229	23257814	NA	NA	NA	NA	NA
PGEN_.00g041470	Scaffold_02	23262852	23274998	Q5ZL16	WIPI3_CHICK	WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45B)	GO:0000045; GO:0000407; GO:0000422; GO:0005764; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0034045; GO:0034497; GO:0062078; GO:0080025	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"
PGEN_.00g041480	Scaffold_02	23275280	23291072	Q8BH95	ECHM_MOUSE	"Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)"	GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0016853	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; fatty acid beta-oxidation [GO:0006635]
PGEN_.00g041490	Scaffold_02	23304633	23343725	Q8BYI8	F234B_MOUSE	Protein FAM234B	GO:0005794; GO:0005856; GO:0016021; GO:0030054; GO:0045202	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; synapse [GO:0045202]
PGEN_.00g041500	Scaffold_02	23358523	23415473	Q9ULD0	OGDHL_HUMAN	"2-oxoglutarate dehydrogenase-like, mitochondrial (EC 1.2.4.-) (2-oxoglutarate dehydrogenase complex component E1-like) (OGDC-E1-like) (Alpha-ketoglutarate dehydrogenase-like)"	GO:0004591; GO:0005739; GO:0005759; GO:0006096; GO:0006099; GO:0030976; GO:0045252; GO:0046872	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g041510	Scaffold_02	23418507	23438100	G3V7W1	PDCD6_RAT	Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2)	GO:0000139; GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0006919; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043280; GO:0043495; GO:0045766; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:0051898; GO:0060090; GO:0070971; GO:1902527; GO:1990756	"COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; protein binding, bridging [GO:0030674]; protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]"
PGEN_.00g041520	Scaffold_02	23446030	23473702	Q60997	DMBT1_MOUSE	Deleted in malignant brain tumors 1 protein (Apactin) (CRP-ductin) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80)	GO:0001530; GO:0001824; GO:0001833; GO:0003677; GO:0005044; GO:0005615; GO:0005737; GO:0006898; GO:0009617; GO:0009897; GO:0015031; GO:0016021; GO:0019898; GO:0030154; GO:0030658; GO:0030670; GO:0030858; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0050829; GO:0050830; GO:0061844; GO:0062023; GO:0070891; GO:1904399	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; induction of bacterial agglutination [GO:0043152]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]
PGEN_.00g041530	Scaffold_02	23479801	23489942	Q8N8Q8	COX18_HUMAN	"Cytochrome c oxidase assembly protein COX18, mitochondrial (COX18Hs) (Cytochrome c oxidase assembly protein 18)"	GO:0008535; GO:0031305; GO:0032977; GO:0032979; GO:0033617; GO:0051204; GO:0051205	integral component of mitochondrial inner membrane [GO:0031305]; membrane insertase activity [GO:0032977]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]; respiratory chain complex IV assembly [GO:0008535]
PGEN_.00g041540	Scaffold_02	23497257	23498366	NA	NA	NA	NA	NA
PGEN_.00g041550	Scaffold_02	23502447	23518151	NA	NA	NA	NA	NA
PGEN_.00g041560	Scaffold_02	23530430	23547032	Q5XHC1	CD047_XENLA	UPF0602 protein C4orf47 homolog	GO:0005737; GO:0005813	centrosome [GO:0005813]; cytoplasm [GO:0005737]
PGEN_.00g041570	Scaffold_02	23547282	23561723	Q9JIM0	MRE11_RAT	Double-strand break repair protein MRE11 (EC 3.1.-.-) (Double-strand break repair protein MRE11A) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A)	GO:0000014; GO:0000723; GO:0000724; GO:0000784; GO:0000790; GO:0000794; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006302; GO:0006303; GO:0006974; GO:0007062; GO:0007095; GO:0007129; GO:0007507; GO:0008022; GO:0008283; GO:0008408; GO:0008409; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0046597; GO:0048471; GO:0051276; GO:0097552; GO:0110025	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; heart development [GO:0007507]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; synapsis [GO:0007129]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]"
PGEN_.00g041580	Scaffold_02	23569576	23593455	Q4R627	LARP7_MACFA	La-related protein 7 (La ribonucleoprotein domain family member 7)	GO:0003723; GO:0005654; GO:0006396; GO:1990904	nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; RNA processing [GO:0006396]
PGEN_.00g041590	Scaffold_02	23599536	23656123	Q80T14	FRAS1_MOUSE	Extracellular matrix protein FRAS1	GO:0002009; GO:0003338; GO:0005604; GO:0005886; GO:0007154; GO:0015031; GO:0016021; GO:0030326; GO:0043588; GO:0046872; GO:0060021; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588]
PGEN_.00g041600	Scaffold_02	23704834	23705187	NA	NA	NA	NA	NA
PGEN_.00g041610	Scaffold_02	23705366	23735091	NA	NA	NA	NA	NA
PGEN_.00g041620	Scaffold_02	23746750	23746980	NA	NA	NA	NA	NA
PGEN_.00g041630	Scaffold_02	23747062	23748512	NA	NA	NA	NA	NA
PGEN_.00g041640	Scaffold_02	23748850	23750306	NA	NA	NA	NA	NA
PGEN_.00g041650	Scaffold_02	23756803	23757384	NA	NA	NA	NA	NA
PGEN_.00g041660	Scaffold_02	23793943	23795403	P08953	TOLL_DROME	Protein toll	GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]
PGEN_.00g041670	Scaffold_02	23821075	23827216	A4QNE0	GET4_XENTR	Golgi to ER traffic protein 4 homolog	GO:0005829; GO:0071816; GO:0071818	BAT3 complex [GO:0071818]; cytosol [GO:0005829]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]
PGEN_.00g041680	Scaffold_02	23841099	23846787	NA	NA	NA	NA	NA
PGEN_.00g041690	Scaffold_02	23847509	23877735	Q99758	ABCA3_HUMAN	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]
PGEN_.00g041700	Scaffold_02	23890034	23927659	Q4G3H4	IKKA_DANRE	Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA)	GO:0001757; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007249; GO:0007252; GO:0007417; GO:0008385; GO:0018105; GO:0033209; GO:0042803; GO:0043066; GO:0043124; GO:0045944; GO:0046982; GO:0051092; GO:0055113; GO:0071356	cytoplasm [GO:0005737]; IkappaB kinase complex [GO:0008385]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; negative regulation of apoptotic process [GO:0043066]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; somite specification [GO:0001757]; tumor necrosis factor-mediated signaling pathway [GO:0033209]
PGEN_.00g041710	Scaffold_02	23932119	23937868	NA	NA	NA	NA	NA
PGEN_.00g041720	Scaffold_02	23942451	23943227	NA	NA	NA	NA	NA
PGEN_.00g041730	Scaffold_02	23946801	23959700	Q8FTH8	THIED_COREF	Thiamine biosynthesis multifunctional protein ThiED [Includes: Thiamine-phosphate synthase (TMP-PPase) (TP synthase) (TPS) (EC 2.5.1.3) (Thiamine-phosphate pyrophosphorylase) (TMP pyrophosphorylase); Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase (EC 2.7.1.49) (EC 2.7.4.7) (Hydroxymethylpyrimidine kinase) (HMP kinase) (Hydroxymethylpyrimidine phosphate kinase) (HMP-P kinase) (HMP-phosphate kinase) (HMPP kinase)]	GO:0000287; GO:0004789; GO:0005524; GO:0008902; GO:0008972; GO:0009228; GO:0009229	ATP binding [GO:0005524]; hydroxymethylpyrimidine kinase activity [GO:0008902]; magnesium ion binding [GO:0000287]; phosphomethylpyrimidine kinase activity [GO:0008972]; thiamine-phosphate diphosphorylase activity [GO:0004789]; thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229]
PGEN_.00g041740	Scaffold_02	24001566	24082760	Q5SSH7	ZZEF1_MOUSE	Zinc finger ZZ-type and EF-hand domain-containing protein 1	GO:0005509; GO:0008270	calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270]
PGEN_.00g041750	Scaffold_02	24055826	24058404	NA	NA	NA	NA	NA
PGEN_.00g041760	Scaffold_02	24089573	24095139	NA	NA	NA	NA	NA
PGEN_.00g041770	Scaffold_02	24122037	24133277	NA	NA	NA	NA	NA
PGEN_.00g041780	Scaffold_02	24149767	24156186	NA	NA	NA	NA	NA
PGEN_.00g041790	Scaffold_02	24156659	24158758	NA	NA	NA	NA	NA
PGEN_.00g041800	Scaffold_02	24158809	24161183	NA	NA	NA	NA	NA
PGEN_.00g041810	Scaffold_02	24162164	24163294	NA	NA	NA	NA	NA
PGEN_.00g041820	Scaffold_02	24170681	24180808	Q14AM7	CP072_MOUSE	UPF0472 protein C16orf72 homolog		
PGEN_.00g041830	Scaffold_02	24230043	24241733	NA	NA	NA	NA	NA
PGEN_.00g041840	Scaffold_02	24242299	24270715	Q8JHF2	LFNG_DANRE	"Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)"	GO:0007219; GO:0007389; GO:0008593; GO:0030173; GO:0031101; GO:0033829; GO:0036066; GO:0045665; GO:0046872; GO:0055016	integral component of Golgi membrane [GO:0030173]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]; fin regeneration [GO:0031101]; hypochord development [GO:0055016]; negative regulation of neuron differentiation [GO:0045665]; Notch signaling pathway [GO:0007219]; pattern specification process [GO:0007389]; protein O-linked fucosylation [GO:0036066]; regulation of Notch signaling pathway [GO:0008593]
PGEN_.00g041850	Scaffold_02	24290905	24295994	O94469	DUR31_SCHPO	Probable urea active transporter 1	GO:0005886; GO:0015204; GO:0015489; GO:0015606; GO:0015840; GO:0015847; GO:0015848; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; putrescine transmembrane transporter activity [GO:0015489]; spermidine transmembrane transporter activity [GO:0015606]; urea transmembrane transporter activity [GO:0015204]; putrescine transport [GO:0015847]; spermidine transport [GO:0015848]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]
PGEN_.00g041860	Scaffold_02	24312673	24312999	NA	NA	NA	NA	NA
PGEN_.00g041870	Scaffold_02	24325285	24326894	Q8K3P0	DR9C7_MOUSE	Short-chain dehydrogenase/reductase family 9C member 7 (EC 1.1.1.-) (Orphan short-chain dehydrogenase/reductase) (SDR-O) (RDH-S)	GO:0004745; GO:0005737; GO:0055114	cytoplasm [GO:0005737]; retinol dehydrogenase activity [GO:0004745]; oxidation-reduction process [GO:0055114]
PGEN_.00g041880	Scaffold_02	24340749	24353721	O94469	DUR31_SCHPO	Probable urea active transporter 1	GO:0005886; GO:0015204; GO:0015489; GO:0015606; GO:0015840; GO:0015847; GO:0015848; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; putrescine transmembrane transporter activity [GO:0015489]; spermidine transmembrane transporter activity [GO:0015606]; urea transmembrane transporter activity [GO:0015204]; putrescine transport [GO:0015847]; spermidine transport [GO:0015848]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]
PGEN_.00g041890	Scaffold_02	24360067	24366093	NA	NA	NA	NA	NA
PGEN_.00g041900	Scaffold_02	24367181	24377135	NA	NA	NA	NA	NA
PGEN_.00g041910	Scaffold_02	24381088	24381910	NA	NA	NA	NA	NA
PGEN_.00g041920	Scaffold_02	24394100	24403762	NA	NA	NA	NA	NA
PGEN_.00g041930	Scaffold_02	24418190	24425993	F1QYJ6	ST6B1_DANRE	Sulfotransferase 6B1 (EC 2.8.2.-) (Thyroxine sulfotransferase) (EC 2.8.2.n2)	GO:0008146; GO:0071466	sulfotransferase activity [GO:0008146]; cellular response to xenobiotic stimulus [GO:0071466]
PGEN_.00g041940	Scaffold_02	24435750	24450184	Q9VEU1	CAD89_DROME	Cadherin-89D	GO:0005509; GO:0005887; GO:0007156; GO:0016339; GO:0017022; GO:0044331; GO:0098609	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g041950	Scaffold_02	24455940	24471132	NA	NA	NA	NA	NA
PGEN_.00g041960	Scaffold_02	24484977	24485207	NA	NA	NA	NA	NA
PGEN_.00g041970	Scaffold_02	24582543	24595733	O95393	BMP10_HUMAN	Bone morphogenetic protein 10 (BMP-10)	GO:0005125; GO:0005160; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0007512; GO:0008083; GO:0009986; GO:0010596; GO:0010613; GO:0010614; GO:0010862; GO:0030018; GO:0030308; GO:0030336; GO:0030509; GO:0031433; GO:0032924; GO:0033612; GO:0042981; GO:0043408; GO:0045214; GO:0045893; GO:0048468; GO:0055009; GO:0055010; GO:0055015; GO:0055117; GO:0060038; GO:0060045; GO:0060298; GO:0060347; GO:0060389; GO:0060395; GO:0061036; GO:1903242; GO:2000138	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433]; transforming growth factor beta receptor binding [GO:0005160]; activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; cell development [GO:0048468]; heart trabecula formation [GO:0060347]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; regulation of MAPK cascade [GO:0043408]; sarcomere organization [GO:0045214]; SMAD protein signal transduction [GO:0060395]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]"
PGEN_.00g041980	Scaffold_02	24624338	24624973	NA	NA	NA	NA	NA
PGEN_.00g041990	Scaffold_02	24627488	24628852	Q93149	ACR3_CAEEL	Acetylcholine receptor subunit beta-type acr-3	GO:0004888; GO:0005230; GO:0005623; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098662; GO:0098703	cell [GO:0005623]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; calcium ion import across plasma membrane [GO:0098703]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g042000	Scaffold_02	24661710	24686899	Q4QY64	ATAD5_MOUSE	ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein)	GO:0002377; GO:0003677; GO:0005524; GO:0005634; GO:0006974; GO:0008630; GO:0030890; GO:0031391; GO:0033260; GO:0042100; GO:0042770; GO:0042771; GO:0045190; GO:0045740; GO:0048304; GO:0061860; GO:0090305; GO:0090618; GO:1901990; GO:1902166; GO:1902230; GO:1902751	Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]; B cell proliferation [GO:0042100]; cellular response to DNA damage stimulus [GO:0006974]; DNA clamp unloading [GO:0090618]; immunoglobulin production [GO:0002377]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]
PGEN_.00g042010	Scaffold_02	24687869	24692874	NA	NA	NA	NA	NA
PGEN_.00g042020	Scaffold_02	24703191	24725744	P53992	SC24C_HUMAN	Protein transport protein Sec24C (SEC24-related protein C)	GO:0000139; GO:0000149; GO:0001701; GO:0002474; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0030127; GO:0048208; GO:0090110	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]
PGEN_.00g042030	Scaffold_02	24741509	24757937	Q1HG43	DOXA1_HUMAN	Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein)	GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016021; GO:0019899; GO:0031252; GO:0034613; GO:0042743; GO:0045666; GO:0050727; GO:2000609	cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609]
PGEN_.00g042040	Scaffold_02	24804757	24805606	NA	NA	NA	NA	NA
PGEN_.00g042050	Scaffold_02	24832276	24836703	Q7RTX9	MOT14_HUMAN	Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g042060	Scaffold_02	24866494	24888516	P51049	MR1BB_DANRE	Melatonin receptor type 1B-B (Mel-1B-R-B) (Mel1b receptor B) (Melatonin receptor Mel1b Z2.6-4) (zMel1b-1)	GO:0004930; GO:0005886; GO:0008502; GO:0016021; GO:0048511	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502]; rhythmic process [GO:0048511]
PGEN_.00g042070	Scaffold_02	24892237	24903648	NA	NA	NA	NA	NA
PGEN_.00g042080	Scaffold_02	24903735	24903980	NA	NA	NA	NA	NA
PGEN_.00g042090	Scaffold_02	24904364	24904756	NA	NA	NA	NA	NA
PGEN_.00g042100	Scaffold_02	24904810	24905268	NA	NA	NA	NA	NA
PGEN_.00g042110	Scaffold_02	24905459	24905737	NA	NA	NA	NA	NA
PGEN_.00g042120	Scaffold_02	24905865	24906248	NA	NA	NA	NA	NA
PGEN_.00g042130	Scaffold_02	24906946	24907344	NA	NA	NA	NA	NA
PGEN_.00g042140	Scaffold_02	24909990	24918934	NA	NA	NA	NA	NA
PGEN_.00g042150	Scaffold_02	24923432	24937605	P25867	UBCD1_DROME	Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	GO:0000151; GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061630; GO:0061631; GO:0097039	cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g042160	Scaffold_02	24943771	24951526	P62838	UB2D2_MOUSE	Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-conjugating enzyme E2(17)KB 2) (Ubiquitin-conjugating enzyme E2-17 kDa 2) (Ubiquitin-protein ligase D2)	GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0006511; GO:0016567; GO:0031625; GO:0032991; GO:0051865; GO:0061631; GO:0070936	protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g042170	Scaffold_02	24974319	24977678	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g042180	Scaffold_02	24977922	24985160	NA	NA	NA	NA	NA
PGEN_.00g042190	Scaffold_02	24992066	25116776	Q6V0I7	FAT4_HUMAN	Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
PGEN_.00g042200	Scaffold_02	25193028	25197013	O54863	TSSK2_MOUSE	Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (Serine/threonine-protein kinase 22B)	GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0006468; GO:0007275; GO:0007286; GO:0018105; GO:0035556; GO:0044877; GO:0046777	acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]
PGEN_.00g042210	Scaffold_02	25254730	25262061	NA	NA	NA	NA	NA
PGEN_.00g042220	Scaffold_02	25267209	25280513	NA	NA	NA	NA	NA
PGEN_.00g042230	Scaffold_02	25287259	25291016	P35348	ADA1A_HUMAN	Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c)	GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0003084; GO:0004935; GO:0004937; GO:0005623; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0006915; GO:0006939; GO:0007165; GO:0007186; GO:0007188; GO:0007200; GO:0007202; GO:0007204; GO:0007267; GO:0007512; GO:0007568; GO:0008285; GO:0009725; GO:0010507; GO:0010613; GO:0030018; GO:0030315; GO:0031965; GO:0032230; GO:0035024; GO:0035556; GO:0042493; GO:0043410; GO:0045760; GO:0045907; GO:0045987; GO:0046982; GO:0060073; GO:0060402; GO:0060452; GO:0061049; GO:0070374; GO:0071880; GO:0090037; GO:0097195; GO:0098691; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0150099; GO:1903997; GO:2000300	"caveola [GO:0005901]; cell [GO:0005623]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; adrenergic receptor activity [GO:0004935]; alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adult heart development [GO:0007512]; aging [GO:0007568]; apoptotic process [GO:0006915]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; micturition [GO:0060073]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to drug [GO:0042493]; response to hormone [GO:0009725]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]"
PGEN_.00g042240	Scaffold_02	25301703	25305616	NA	NA	NA	NA	NA
PGEN_.00g042250	Scaffold_02	25328938	25354652	P79896	ADHX_SPAAU	Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]
PGEN_.00g042260	Scaffold_02	25388689	25400146	NA	NA	NA	NA	NA
PGEN_.00g042270	Scaffold_02	25406979	25420498	Q9HCD6	TANC2_HUMAN	"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)"	GO:0001701; GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0098978; GO:0099092; GO:0099519	"axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; dense core granule cytoskeletal transport [GO:0099519]; in utero embryonic development [GO:0001701]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]"
PGEN_.00g042280	Scaffold_02	25464387	25570669	Q9VEN1	FLNA_DROME	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"
PGEN_.00g042290	Scaffold_02	25581567	25581797	NA	NA	NA	NA	NA
PGEN_.00g042300	Scaffold_02	25585875	25586171	NA	NA	NA	NA	NA
PGEN_.00g042310	Scaffold_02	25586953	25588607	NA	NA	NA	NA	NA
PGEN_.00g042320	Scaffold_02	25588937	25589248	NA	NA	NA	NA	NA
PGEN_.00g042330	Scaffold_02	25610580	25640913	O13035	SAP_CHICK	Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A; Saposin-B; Saposin-C; Saposin-D]	GO:0005615; GO:0005764; GO:0006665; GO:0007193; GO:0019216; GO:0060736; GO:0060742	extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g042340	Scaffold_02	25644660	25647493	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g042350	Scaffold_02	25663917	25677250	P26779	SAP_BOVIN	Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]	GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0019216; GO:0060736; GO:0060742	extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g042360	Scaffold_02	25693909	25694460	NA	NA	NA	NA	NA
PGEN_.00g042370	Scaffold_02	25694576	25703178	NA	NA	NA	NA	NA
PGEN_.00g042380	Scaffold_02	25736161	25736532	NA	NA	NA	NA	NA
PGEN_.00g042390	Scaffold_02	25749539	25750648	O42606	NGN1_DANRE	Neurogenin-1 (NGN-1) (Neurogenic differentiation factor 3) (NeuroD3) (Neurogenin-related protein 1)	GO:0003682; GO:0005634; GO:0007399; GO:0007413; GO:0007422; GO:0021516; GO:0021575; GO:0021772; GO:0021884; GO:0021986; GO:0031103; GO:0045666; GO:0045944; GO:0046983; GO:0048699; GO:0048884; GO:0048909; GO:0048918; GO:0048935; GO:0050768; GO:0051091; GO:0070888; GO:0071698	nucleus [GO:0005634]; chromatin binding [GO:0003682]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; anterior lateral line nerve development [GO:0048909]; axon regeneration [GO:0031103]; axonal fasciculation [GO:0007413]; dorsal spinal cord development [GO:0021516]; forebrain neuron development [GO:0021884]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hindbrain morphogenesis [GO:0021575]; negative regulation of neurogenesis [GO:0050768]; nervous system development [GO:0007399]; neuromast development [GO:0048884]; olfactory bulb development [GO:0021772]; olfactory placode development [GO:0071698]; peripheral nervous system development [GO:0007422]; peripheral nervous system neuron development [GO:0048935]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior lateral line nerve development [GO:0048918]
PGEN_.00g042400	Scaffold_02	25775163	25775456	NA	NA	NA	NA	NA
PGEN_.00g042410	Scaffold_02	25815444	25816137	NA	NA	NA	NA	NA
PGEN_.00g042420	Scaffold_02	25819639	25820427	Q60867	NDF1_MOUSE	Neurogenic differentiation factor 1 (NeuroD1) (Beta-cell E-box transcriptional activator 2) (Beta2)	GO:0000978; GO:0000981; GO:0001102; GO:0001228; GO:0003326; GO:0003329; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003713; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0006913; GO:0007263; GO:0008134; GO:0009749; GO:0009952; GO:0021542; GO:0021549; GO:0023019; GO:0030073; GO:0030902; GO:0031018; GO:0035881; GO:0035883; GO:0042493; GO:0042593; GO:0043010; GO:0043065; GO:0043565; GO:0045165; GO:0045597; GO:0045664; GO:0045666; GO:0045893; GO:0045944; GO:0046426; GO:0046982; GO:0048562; GO:0048666; GO:0048839; GO:0051091; GO:0060730; GO:0070888; GO:0071156; GO:0071333; GO:0090575; GO:2000675; GO:2000679	"cell [GO:0005623]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; amacrine cell differentiation [GO:0035881]; anterior/posterior pattern specification [GO:0009952]; camera-type eye development [GO:0043010]; cell fate commitment [GO:0045165]; cellular response to glucose stimulus [GO:0071333]; cerebellum development [GO:0021549]; dentate gyrus development [GO:0021542]; embryonic organ morphogenesis [GO:0048562]; endocrine pancreas development [GO:0031018]; enteroendocrine cell differentiation [GO:0035883]; glucose homeostasis [GO:0042593]; hindbrain development [GO:0030902]; inner ear development [GO:0048839]; insulin secretion [GO:0030073]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neuron development [GO:0048666]; nitric oxide mediated signal transduction [GO:0007263]; nucleocytoplasmic transport [GO:0006913]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle arrest [GO:0071156]; regulation of intestinal epithelial structure maintenance [GO:0060730]; regulation of neuron differentiation [GO:0045664]; response to drug [GO:0042493]; response to glucose [GO:0009749]; signal transduction involved in regulation of gene expression [GO:0023019]"
PGEN_.00g042430	Scaffold_02	25824807	25870861	Q8BW94	DYH3_MOUSE	"Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)"	GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959	"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]"
PGEN_.00g042440	Scaffold_02	25871380	25912768	Q8TD57	DYH3_HUMAN	"Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)"	GO:0003341; GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959; GO:0060285	"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]"
PGEN_.00g042450	Scaffold_02	25913699	25931570	Q8TD57	DYH3_HUMAN	"Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)"	GO:0003341; GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959; GO:0060285	"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]"
PGEN_.00g042460	Scaffold_02	25937903	25942175	NA	NA	NA	NA	NA
PGEN_.00g042470	Scaffold_02	25949804	25956570	NA	NA	NA	NA	NA
PGEN_.00g042480	Scaffold_02	25967883	25969434	NA	NA	NA	NA	NA
PGEN_.00g042490	Scaffold_02	25988229	25997971	Q8NBI5	S43A3_HUMAN	Solute carrier family 43 member 3 (Protein FOAP-13)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g042500	Scaffold_02	26028250	26060078	Q3USW5	FXRD2_MOUSE	FAD-dependent oxidoreductase domain-containing protein 2	GO:0005788; GO:0016491; GO:0030433; GO:0050660	endoplasmic reticulum lumen [GO:0005788]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g042510	Scaffold_02	26109863	26110543	NA	NA	NA	NA	NA
PGEN_.00g042520	Scaffold_02	26112035	26113003	NA	NA	NA	NA	NA
PGEN_.00g042530	Scaffold_02	26201302	26246856	NA	NA	NA	NA	NA
PGEN_.00g042540	Scaffold_02	26271096	26289469	Q99NH7	S26A5_MOUSE	Prestin (Solute carrier family 26 member 5)	GO:0002931; GO:0005737; GO:0005886; GO:0005887; GO:0007605; GO:0008134; GO:0008271; GO:0008360; GO:0009751; GO:0010996; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015755; GO:0016323; GO:0016328; GO:0019531; GO:0030507; GO:0034220; GO:0034766; GO:0035864; GO:0042391; GO:0042802; GO:0042803; GO:0045793; GO:0051262; GO:0090102; GO:0097066; GO:0098656; GO:1902074; GO:1902476; GO:2000147	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; identical protein binding [GO:0042802]; oxalate transmembrane transporter activity [GO:0019531]; protein homodimerization activity [GO:0042803]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]; transcription factor binding [GO:0008134]; anion transmembrane transport [GO:0098656]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; ion transmembrane transport [GO:0034220]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; protein tetramerization [GO:0051262]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605]
PGEN_.00g042550	Scaffold_02	26318080	26321180	Q8CIW6	S26A6_MOUSE	Solute carrier family 26 member 6 (Anion exchange transporter) (Chloride-formate exchanger) (Pendrin-L1) (Pendrin-like protein 1) (Putative anion transporter-1) (Pat-1)	GO:0005254; GO:0005623; GO:0005783; GO:0005886; GO:0005887; GO:0006821; GO:0008271; GO:0008272; GO:0012506; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015499; GO:0015562; GO:0015660; GO:0015701; GO:0015724; GO:0015797; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019531; GO:0019532; GO:0030165; GO:0030321; GO:0030659; GO:0031526; GO:0031982; GO:0034707; GO:0038166; GO:0042045; GO:0046724; GO:0048240; GO:0050892; GO:0051453; GO:0051454; GO:0070528; GO:0070633; GO:0071320; GO:0071332; GO:0071346; GO:0097225; GO:2001150	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell [GO:0005623]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; efflux transmembrane transporter activity [GO:0015562]; formate efflux transmembrane transporter activity [GO:0015660]; formate transmembrane transporter activity [GO:0015499]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to interferon-gamma [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; mannitol transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633]
PGEN_.00g042560	Scaffold_02	26331684	26339687	NA	NA	NA	NA	NA
PGEN_.00g042570	Scaffold_02	26340707	26343850	NA	NA	NA	NA	NA
PGEN_.00g042580	Scaffold_02	26360315	26364454	NA	NA	NA	NA	NA
PGEN_.00g042590	Scaffold_02	26368973	26369854	NA	NA	NA	NA	NA
PGEN_.00g042600	Scaffold_02	26413312	26427863	Q03206	RAC1_CAEEL	Ras-related protein ced-10 (CErac1) (Cell death protein 10) (Cell-corpse engulfment protein ced-10) (Ras-related protein rac-1)	GO:0000132; GO:0001764; GO:0002119; GO:0003924; GO:0005525; GO:0005623; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006915; GO:0007015; GO:0007163; GO:0007264; GO:0007266; GO:0007369; GO:0008045; GO:0008360; GO:0009898; GO:0010171; GO:0010172; GO:0016021; GO:0016477; GO:0019901; GO:0030036; GO:0030334; GO:0030950; GO:0031103; GO:0031115; GO:0031410; GO:0032228; GO:0032956; GO:0033563; GO:0038007; GO:0042995; GO:0043025; GO:0043652; GO:0045138; GO:0048598; GO:0048812; GO:0048846; GO:0050764; GO:0061643; GO:0070986; GO:0097628; GO:1901076; GO:1903356; GO:1905815	"cell [GO:0005623]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon regeneration [GO:0031103]; body morphogenesis [GO:0010171]; cell migration [GO:0016477]; chemorepulsion of axon [GO:0061643]; distal tip cell migration [GO:0097628]; dorsal/ventral axon guidance [GO:0033563]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; engulfment of apoptotic cell [GO:0043652]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation [GO:0007369]; left/right axis specification [GO:0070986]; motor neuron axon guidance [GO:0008045]; negative regulation of microtubule polymerization [GO:0031115]; nematode larval development [GO:0002119]; nematode male tail tip morphogenesis [GO:0045138]; netrin-activated signaling pathway [GO:0038007]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dorsal/ventral axon guidance [GO:1905815]; regulation of phagocytosis [GO:0050764]; regulation of synaptic transmission, GABAergic [GO:0032228]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]"
PGEN_.00g042610	Scaffold_02	26456596	26458231	Q9TU25	RAC2_BOVIN	Ras-related C3 botulinum toxin substrate 2 (p21-Rac2)	GO:0003924; GO:0005525; GO:0005635; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007186; GO:0007266; GO:0008045; GO:0008284; GO:0008360; GO:0010592; GO:0010810; GO:0016601; GO:0019887; GO:0019901; GO:0030027; GO:0030031; GO:0030036; GO:0032956; GO:0042129; GO:0042995; GO:0043304; GO:0043652; GO:0060263; GO:0060753; GO:0071593; GO:0090023; GO:1902622	actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of cell-substrate adhesion [GO:0010810]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of T cell proliferation [GO:0042129]; Rho protein signal transduction [GO:0007266]
PGEN_.00g042620	Scaffold_02	26468144	26470881	NA	NA	NA	NA	NA
PGEN_.00g042630	Scaffold_02	26489302	26491236	Q5XGZ9	MF6LB_XENLA	Major facilitator superfamily domain-containing protein 6-like protein B	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g042640	Scaffold_02	26492915	26533714	Q66HY8	PDXD1_DANRE	Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-)	GO:0001667; GO:0005783; GO:0006665; GO:0008117; GO:0016831; GO:0019752; GO:0030149; GO:0030170	endoplasmic reticulum [GO:0005783]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g042650	Scaffold_02	26540833	26565383	Q8NCG7	DGLB_HUMAN	Sn1-specific diacylglycerol lipase beta (DGL-beta) (EC 3.1.1.-) (KCCR13L)	GO:0005654; GO:0005765; GO:0005886; GO:0007216; GO:0007405; GO:0016021; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]
PGEN_.00g042660	Scaffold_02	26601619	26642718	O08586	PTEN_MOUSE	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"	GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005161; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006470; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007568; GO:0007611; GO:0007613; GO:0007626; GO:0008138; GO:0008284; GO:0008285; GO:0009749; GO:0009898; GO:0010043; GO:0010628; GO:0010666; GO:0010719; GO:0010975; GO:0010977; GO:0010997; GO:0014823; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0031175; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0032869; GO:0033032; GO:0033198; GO:0033555; GO:0035176; GO:0035255; GO:0035749; GO:0036294; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043065; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0044320; GO:0045211; GO:0045475; GO:0045666; GO:0045736; GO:0045792; GO:0046621; GO:0046685; GO:0046855; GO:0046856; GO:0048008; GO:0048679; GO:0048681; GO:0048738; GO:0048853; GO:0048854; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0051091; GO:0051548; GO:0051717; GO:0051726; GO:0051800; GO:0051895; GO:0051898; GO:0060024; GO:0060044; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060341; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071257; GO:0071361; GO:0071456; GO:0090071; GO:0090344; GO:0090394; GO:0097105; GO:0097107; GO:0099524; GO:1901017; GO:1903690; GO:1903984; GO:1904668; GO:1904706; GO:1990090; GO:1990314; GO:1990381; GO:1990782; GO:2000060; GO:2000134; GO:2000272; GO:2000463; GO:2000808; GO:2001235	"apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; mitochondrion [GO:0005739]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron projection development [GO:0031175]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cell cycle [GO:0051726]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]"
PGEN_.00g042670	Scaffold_02	26678785	26681488	Q964E1	ACTC_BIOOB	"Actin, cytoplasmic [Cleaved into: Actin, cytoplasmic, intermediate form]"	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g042680	Scaffold_02	26690168	26691879	P30162	ACT1_ONCVO	Actin-1	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g042690	Scaffold_02	26693661	26698404	Q9P4C8	SAR1_KOMPG	Small COPII coat GTPase SAR1 (EC 3.6.5.-)	GO:0000139; GO:0000266; GO:0003400; GO:0003924; GO:0005525; GO:0005739; GO:0005789; GO:0006886; GO:0006998; GO:0007006; GO:0016050; GO:0016192; GO:0030127; GO:0044233; GO:0070971	COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; mitochondrial fission [GO:0000266]; mitochondrial membrane organization [GO:0007006]; nuclear envelope organization [GO:0006998]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]; vesicle-mediated transport [GO:0016192]
PGEN_.00g042700	Scaffold_02	26700167	26747288	P52429	DGKE_HUMAN	Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon)	GO:0003951; GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007205; GO:0008654; GO:0016020; GO:0016021; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050804; GO:0098978	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phospholipid biosynthetic process [GO:0008654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]
PGEN_.00g042710	Scaffold_02	26868689	26880501	Q641Q3	METRL_HUMAN	Meteorin-like protein (Subfatin)	GO:0005179; GO:0005615; GO:0009409; GO:0014850; GO:0045444; GO:0050728; GO:0050873; GO:0070062; GO:0090336; GO:0097009	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; brown fat cell differentiation [GO:0050873]; energy homeostasis [GO:0097009]; fat cell differentiation [GO:0045444]; negative regulation of inflammatory response [GO:0050728]; positive regulation of brown fat cell differentiation [GO:0090336]; response to cold [GO:0009409]; response to muscle activity [GO:0014850]
PGEN_.00g042720	Scaffold_02	26898944	26921254	Q3U129	B3GNL_MOUSE	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) (EC 2.4.1.-)"	GO:0016757	"transferase activity, transferring glycosyl groups [GO:0016757]"
PGEN_.00g042730	Scaffold_02	26962275	26988772	Q9Y4F3	MARF1_HUMAN	Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1)	GO:0003723; GO:0005777; GO:0005794; GO:0006302; GO:0007143; GO:0010468; GO:0010923; GO:0016020; GO:0043231; GO:0048477	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]; RNA binding [GO:0003723]; double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; negative regulation of phosphatase activity [GO:0010923]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]
PGEN_.00g042740	Scaffold_02	26988817	27012444	Q9UJW0	DCTN4_HUMAN	Dynactin subunit 4 (Dyn4) (Dynactin subunit p62)	GO:0000776; GO:0000922; GO:0001725; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0005925; GO:0005938; GO:0006888; GO:0019886; GO:0030017; GO:0047485	cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]
PGEN_.00g042750	Scaffold_02	27029786	27030088	NA	NA	NA	NA	NA
PGEN_.00g042760	Scaffold_02	27036010	27036360	NA	NA	NA	NA	NA
PGEN_.00g042770	Scaffold_02	27049272	27066644	NA	NA	NA	NA	NA
PGEN_.00g042780	Scaffold_02	27073360	27074667	NA	NA	NA	NA	NA
PGEN_.00g042790	Scaffold_02	27078900	27080117	Q03400	SANT_PLAF7	S-antigen protein	GO:0020003	symbiont-containing vacuole [GO:0020003]
PGEN_.00g042800	Scaffold_02	27082080	27087332	NA	NA	NA	NA	NA
PGEN_.00g042810	Scaffold_02	27087543	27095229	NA	NA	NA	NA	NA
PGEN_.00g042820	Scaffold_02	27101184	27101498	NA	NA	NA	NA	NA
PGEN_.00g042830	Scaffold_02	27102167	27119339	NA	NA	NA	NA	NA
PGEN_.00g042840	Scaffold_02	27141184	27171338	Q6NVC5	MIRO1_DANRE	Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A)	GO:0003924; GO:0005509; GO:0005525; GO:0005623; GO:0005739; GO:0007005; GO:0007266; GO:0010821; GO:0019725; GO:0031307; GO:0047497; GO:0097345	cell [GO:0005623]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; Rho protein signal transduction [GO:0007266]
PGEN_.00g042850	Scaffold_02	27180120	27196448	Q54IT3	AOFA_DICDI	Probable flavin-containing monoamine oxidase A (EC 1.4.3.4)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g042860	Scaffold_02	27199763	27206013	Q54IT3	AOFA_DICDI	Probable flavin-containing monoamine oxidase A (EC 1.4.3.4)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g042870	Scaffold_02	27277452	27282422	Q9Y278	HS3S2_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 2 (EC 2.8.2.29) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 2) (3-OST-2) (Heparan sulfate 3-O-sulfotransferase 2) (h3-OST-2)	GO:0000139; GO:0006024; GO:0007623; GO:0008146; GO:0008467; GO:0016021; GO:0033871	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 2 activity [GO:0033871]; sulfotransferase activity [GO:0008146]; circadian rhythm [GO:0007623]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g042880	Scaffold_02	27314186	27314563	NA	NA	NA	NA	NA
PGEN_.00g042890	Scaffold_02	27343481	27344713	NA	NA	NA	NA	NA
PGEN_.00g042900	Scaffold_02	27354124	27354896	NA	NA	NA	NA	NA
PGEN_.00g042910	Scaffold_02	27361438	27381160	O75897	ST1C4_HUMAN	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]
PGEN_.00g042920	Scaffold_02	27383689	27387920	P25067	CO8A2_HUMAN	Collagen alpha-2(VIII) chain (Endothelial collagen)	GO:0001525; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0030674; GO:0031012; GO:0048593; GO:0050673; GO:0062023; GO:0098609	"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein binding, bridging [GO:0030674]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]"
PGEN_.00g042930	Scaffold_02	27396704	27397162	NA	NA	NA	NA	NA
PGEN_.00g042940	Scaffold_02	27397753	27398070	NA	NA	NA	NA	NA
PGEN_.00g042950	Scaffold_02	27400405	27405327	Q9VUL9	FUCTA_DROME	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920	"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]"
PGEN_.00g042960	Scaffold_02	27415096	27416013	NA	NA	NA	NA	NA
PGEN_.00g042970	Scaffold_02	27419337	27423856	NA	NA	NA	NA	NA
PGEN_.00g042980	Scaffold_02	27426074	27426469	NA	NA	NA	NA	NA
PGEN_.00g042990	Scaffold_02	27431918	27432160	NA	NA	NA	NA	NA
PGEN_.00g043000	Scaffold_02	27445989	27489043	NA	NA	NA	NA	NA
PGEN_.00g043010	Scaffold_02	27543442	27581179	P27600	GNA12_MOUSE	Guanine nucleotide-binding protein subunit alpha-12 (G alpha-12) (G-protein subunit alpha-12)	GO:0001664; GO:0001701; GO:0003924; GO:0005525; GO:0005737; GO:0005834; GO:0007186; GO:0007188; GO:0007266; GO:0008360; GO:0010762; GO:0016328; GO:0030154; GO:0031526; GO:0031683; GO:0031752; GO:0032006; GO:0032434; GO:0035556; GO:0042493; GO:0042733; GO:0046872	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to drug [GO:0042493]; Rho protein signal transduction [GO:0007266]
PGEN_.00g043020	Scaffold_02	27581334	27610325	Q949P2	COPDA_ARATH	Probable cytosolic oligopeptidase A (EC 3.4.24.70) (Thimet metalloendopeptidase 2) (Zincin-like metalloproteases family protein 2)	GO:0004222; GO:0005829; GO:0005886; GO:0006508; GO:0006518; GO:0009507; GO:0046686; GO:0046872; GO:0048046	apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; response to cadmium ion [GO:0046686]
PGEN_.00g043030	Scaffold_02	27618258	27699921	Q27421	OSP_DROME	Protein outspread		
PGEN_.00g043040	Scaffold_02	27701429	27702406	NA	NA	NA	NA	NA
PGEN_.00g043050	Scaffold_02	27707890	27734201	NA	NA	NA	NA	NA
PGEN_.00g043060	Scaffold_02	27749279	27765477	P23610	HAP40_HUMAN	40-kDa huntingtin-associated protein (HAP40) (CpG island protein) (Factor VIII intron 22 protein)	GO:0005623; GO:0005634; GO:0005769; GO:0016604; GO:0099518; GO:1901799	cell [GO:0005623]; early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634]; negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518]
PGEN_.00g043070	Scaffold_02	27768013	27774344	Q9W107	SYYM_DROME	"Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Mitochondrial tyrosyl-tRNA synthetase) (Tyrosyl-tRNA synthetase) (TyrRS)"	GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006437; GO:0043039; GO:0070184	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437]
PGEN_.00g043080	Scaffold_02	27779028	27780152	NA	NA	NA	NA	NA
PGEN_.00g043090	Scaffold_02	27780300	27780716	NA	NA	NA	NA	NA
PGEN_.00g043100	Scaffold_02	27827347	27843983	NA	NA	NA	NA	NA
PGEN_.00g043110	Scaffold_02	27850717	27863455	Q9NWT6	HIF1N_HUMAN	Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase)	GO:0005112; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0016706; GO:0019826; GO:0031406; GO:0036138; GO:0036139; GO:0036140; GO:0042264; GO:0042265; GO:0042803; GO:0045663; GO:0045746; GO:0048037; GO:0048471; GO:0051059; GO:0055114; GO:0061418; GO:0061428; GO:0071532; GO:0102113; GO:2001214	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; iron ion binding [GO:0005506]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]
PGEN_.00g043120	Scaffold_02	27874468	27909283	A8DYE2	TRPCG_DROME	"Transient receptor potential cation channel trpm (Transient receptor potential cation channel, subfamily M ortholog)"	GO:0005385; GO:0010960; GO:0034703; GO:0051262; GO:0055069; GO:0070838; GO:0072509; GO:0097682; GO:0098655	"cation channel complex [GO:0034703]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069]"
PGEN_.00g043130	Scaffold_02	27906132	27930533	Q9HCF6	TRPM3_HUMAN	Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3) (LTrpC-3) (LTrpC3) (Melastatin-2) (MLSN2)	GO:0005227; GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0016021; GO:0016048; GO:0050951; GO:0051262; GO:0070588	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951]
PGEN_.00g043140	Scaffold_02	27943762	27955249	Q5RBN8	LIN54_PONAB	Protein lin-54 homolog	GO:0003677; GO:0005634; GO:0007049; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]
PGEN_.00g043150	Scaffold_02	27958035	27972034	Q6MZP7	LIN54_HUMAN	Protein lin-54 homolog (CXC domain-containing protein 1)	GO:0000977; GO:0005634; GO:0005654; GO:0006355; GO:0007049; GO:0046872; GO:0051726	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g043160	Scaffold_02	27977321	27998891	O88544	CSN4_MOUSE	COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4) (JAB1-containing signalosome subunit 4)	GO:0000338; GO:0005829; GO:0008021; GO:0008180; GO:0016607; GO:0030054	cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338]
PGEN_.00g043170	Scaffold_02	28003684	28027413	Q2TAC2	CCD57_HUMAN	Coiled-coil domain-containing protein 57		
PGEN_.00g043180	Scaffold_02	28032600	28045181	B0W6M9	SUR8_CULQU	Leucine-rich repeat protein soc-2 homolog (Protein Sur-8 homolog) (Protein soc-2 homolog)		
PGEN_.00g043190	Scaffold_02	28072858	28089443	P24733	MYS_ARGIR	"Myosin heavy chain, striated muscle"	GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0030016; GO:0032982; GO:0051015	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]
PGEN_.00g043200	Scaffold_02	28098829	28099149	NA	NA	NA	NA	NA
PGEN_.00g043210	Scaffold_02	28113051	28114913	NA	NA	NA	NA	NA
PGEN_.00g043220	Scaffold_02	28115269	28146802	P24733	MYS_ARGIR	"Myosin heavy chain, striated muscle"	GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0030016; GO:0032982; GO:0051015	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]
PGEN_.00g043230	Scaffold_02	28163794	28217702	Q9D4I2	MEII1_MOUSE	Meiosis inhibitor protein 1 (Meiosis defective protein 1)	GO:0005623; GO:0007141; GO:0007276; GO:0007286; GO:0045141; GO:0051321	cell [GO:0005623]; gamete generation [GO:0007276]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic telomere clustering [GO:0045141]; spermatid development [GO:0007286]
PGEN_.00g043240	Scaffold_02	28220764	28249453	O95487	SC24B_HUMAN	Protein transport protein Sec24B (SEC24-related protein B)	GO:0000139; GO:0001843; GO:0002474; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0021747; GO:0030127; GO:0035909; GO:0048208; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0090110; GO:0090178; GO:1901301	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178]
PGEN_.00g043250	Scaffold_02	28249938	28250693	NA	NA	NA	NA	NA
PGEN_.00g043260	Scaffold_02	28258627	28296907	Q63HQ0	AP1AR_HUMAN	AP-1 complex-associated regulatory protein (2c18) (Adaptor-related protein complex 1-associated regulatory protein) (Gamma-1-adaptin brefeldin A resistance protein) (GBAR) (Gamma-BAR) (Gamma-A1-adaptin and kinesin interactor) (Gadkin)	GO:0001920; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0015031; GO:0019894; GO:0030133; GO:0034315; GO:0034613; GO:0035650; GO:0048203; GO:1900025; GO:2000146	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]; AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894]; cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting, trans-Golgi to endosome [GO:0048203]"
PGEN_.00g043270	Scaffold_02	28407634	28409016	NA	NA	NA	NA	NA
PGEN_.00g043280	Scaffold_02	28487243	28487664	NA	NA	NA	NA	NA
PGEN_.00g043290	Scaffold_02	28500327	28504673	B6VQA1	DIMM_DROME	Protein dimmed	GO:0002793; GO:0003677; GO:0005634; GO:0005737; GO:0006355; GO:0007419; GO:0045944; GO:0046887; GO:0046983; GO:0061101	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; neuroendocrine cell differentiation [GO:0061101]; positive regulation of hormone secretion [GO:0046887]; positive regulation of peptide secretion [GO:0002793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; ventral cord development [GO:0007419]"
PGEN_.00g043300	Scaffold_02	28520130	28523424	Q07076	ANXA7_MOUSE	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	GO:0005178; GO:0005509; GO:0005544; GO:0005623; GO:0005634; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014070; GO:0030855; GO:0031982; GO:0042584; GO:0042802; GO:0048306; GO:0051592; GO:0061025; GO:0062023	cell [GO:0005623]; chromaffin granule membrane [GO:0042584]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]
PGEN_.00g043310	Scaffold_02	28526296	28555401	Q8VCY6	UTP6_MOUSE	U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein)	GO:0000462; GO:0005730; GO:0030515; GO:0032040; GO:0034388	"nucleolus [GO:0005730]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"
PGEN_.00g043320	Scaffold_02	28556809	28559037	NA	NA	NA	NA	NA
PGEN_.00g043330	Scaffold_02	28607987	28609372	NA	NA	NA	NA	NA
PGEN_.00g043340	Scaffold_02	28615153	28615470	NA	NA	NA	NA	NA
PGEN_.00g043350	Scaffold_02	28651297	28655567	Q9NYH9	UTP6_HUMAN	U3 small nucleolar RNA-associated protein 6 homolog (Hepatocellular carcinoma-associated antigen 66) (Multiple hat domains protein)	GO:0000462; GO:0005654; GO:0005730; GO:0006364; GO:0030515; GO:0032040; GO:0034388	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]"
PGEN_.00g043360	Scaffold_02	28694545	28729634	A1ZA47	ZASP_DROME	PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)	GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061	actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]
PGEN_.00g043370	Scaffold_02	28742172	28774849	A1ZA47	ZASP_DROME	PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)	GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061	actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]
PGEN_.00g043380	Scaffold_02	28783053	28793201	NA	NA	NA	NA	NA
PGEN_.00g043390	Scaffold_02	28802233	28802805	NA	NA	NA	NA	NA
PGEN_.00g043400	Scaffold_02	28814504	28816135	Q08890	IDS_MOUSE	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase)	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484	lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]
PGEN_.00g043410	Scaffold_02	28882418	28920398	Q29451	MA2B1_BOVIN	Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide]	GO:0004559; GO:0005764; GO:0005774; GO:0006013; GO:0006517; GO:0007611; GO:0030246; GO:0046872	lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]
PGEN_.00g043420	Scaffold_02	28925848	28945324	Q6GQ71	NUF2B_XENLA	Kinetochore protein Nuf2-B (Cell division cycle-associated protein 1-B)	GO:0000777; GO:0005634; GO:0007049; GO:0031262; GO:0051301	condensed chromosome kinetochore [GO:0000777]; Ndc80 complex [GO:0031262]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g043430	Scaffold_02	28949483	28950886	B2RYG8	ELP6_RAT	Elongator complex protein 6	GO:0002098; GO:0005634; GO:0005829; GO:0030335; GO:0033588	cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g043440	Scaffold_02	28967897	28977252	NA	NA	NA	NA	NA
PGEN_.00g043450	Scaffold_02	28979845	28981446	NA	NA	NA	NA	NA
PGEN_.00g043460	Scaffold_02	28995799	28996645	NA	NA	NA	NA	NA
PGEN_.00g043470	Scaffold_02	29003289	29015431	Q9Y6L6	SO1B1_HUMAN	Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6)	GO:0005886; GO:0005887; GO:0015125; GO:0015347; GO:0015711; GO:0015721; GO:0016020; GO:0016323; GO:0043252	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; bile acid and bile salt transport [GO:0015721]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]
PGEN_.00g043480	Scaffold_02	29028534	29028827	NA	NA	NA	NA	NA
PGEN_.00g043490	Scaffold_02	29034420	29034731	NA	NA	NA	NA	NA
PGEN_.00g043500	Scaffold_02	29037314	29038190	NA	NA	NA	NA	NA
PGEN_.00g043510	Scaffold_02	29101469	29119404	G5EBQ8	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063	cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]
PGEN_.00g043520	Scaffold_02	29137919	29140894	NA	NA	NA	NA	NA
PGEN_.00g043530	Scaffold_02	29141836	29153323	G5EBQ8	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063	cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]
PGEN_.00g043540	Scaffold_02	29160274	29161715	NA	NA	NA	NA	NA
PGEN_.00g043550	Scaffold_02	29253816	29254229	NA	NA	NA	NA	NA
PGEN_.00g043560	Scaffold_02	29254703	29298837	Q8BQP8	RFIP4_MOUSE	Rab11 family-interacting protein 4 (FIP4-Rab11) (Rab11-FIP4) (mRab11-FIP4A)	GO:0003407; GO:0005509; GO:0005768; GO:0007049; GO:0017137; GO:0030139; GO:0030306; GO:0030496; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048471; GO:0051301; GO:0055038; GO:1903452	cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; neural retina development [GO:0003407]; positive regulation of G1 to G0 transition [GO:1903452]; regulation of cytokinesis [GO:0032465]
PGEN_.00g043570	Scaffold_02	29320247	29320603	NA	NA	NA	NA	NA
PGEN_.00g043580	Scaffold_02	29321061	29321504	NA	NA	NA	NA	NA
PGEN_.00g043590	Scaffold_02	29329011	29412259	O35600	ABCA4_MOUSE	Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter)	GO:0001750; GO:0005319; GO:0005524; GO:0005548; GO:0005783; GO:0005887; GO:0006649; GO:0006869; GO:0007601; GO:0016887; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0050896; GO:0090555; GO:0140326; GO:0140327; GO:0140347	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g043600	Scaffold_02	29415023	29416830	P35903	ACHC_ACHFU	Achacin	GO:0016491; GO:0042742	oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]
PGEN_.00g043610	Scaffold_02	29419186	29437059	O14084	IMT1_SCHPO	Inositol phosphoceramide mannosyltransferase 1 (EC 2.4.-.-) (IPC mannosyltransferase 1)	GO:0000030; GO:0005537; GO:0005794; GO:0016021; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; mannose binding [GO:0005537]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g043620	Scaffold_02	29448705	29469645	Q1JP75	DCXR_BOVIN	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase)	GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016020; GO:0042732; GO:0044105; GO:0050038	cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; carbonyl reductase (NADPH) activity [GO:0004090]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; xylulose metabolic process [GO:0005997]
PGEN_.00g043630	Scaffold_02	29469881	29472632	NA	NA	NA	NA	NA
PGEN_.00g043640	Scaffold_02	29473026	29477160	NA	NA	NA	NA	NA
PGEN_.00g043650	Scaffold_02	29544921	29551136	Q9EQG7	ENPP5_MOUSE	Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-)	GO:0004551; GO:0005576; GO:0005886; GO:0005887; GO:0007154; GO:0009166; GO:0016020; GO:0046872	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nucleotide diphosphatase activity [GO:0004551]; cell communication [GO:0007154]; nucleotide catabolic process [GO:0009166]
PGEN_.00g043660	Scaffold_02	29569347	29605985	O95631	NET1_HUMAN	Netrin-1 (Epididymis tissue protein Li 131P)	GO:0001764; GO:0005576; GO:0005604; GO:0005737; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0008045; GO:0008284; GO:0009887; GO:0009888; GO:0016358; GO:0030334; GO:0030517; GO:0032488; GO:0033564; GO:0042472; GO:0045773; GO:0051963; GO:0060603; GO:0061643; GO:0098609; GO:1902842; GO:2000147	"basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of netrin-activated signaling pathway [GO:1902842]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]"
PGEN_.00g043670	Scaffold_02	29631313	29632350	O09118	NET1_MOUSE	Netrin-1	GO:0001764; GO:0002456; GO:0005125; GO:0005576; GO:0005604; GO:0005737; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0007409; GO:0007411; GO:0008045; GO:0008284; GO:0009887; GO:0009888; GO:0016358; GO:0019724; GO:0030334; GO:0030517; GO:0030879; GO:0031012; GO:0032488; GO:0033564; GO:0042100; GO:0042472; GO:0045773; GO:0051963; GO:0060603; GO:0061643; GO:0062023; GO:0071944; GO:0098609; GO:2000147	"basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cytokine activity [GO:0005125]; animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell mediated immunity [GO:0002456]; tissue development [GO:0009888]"
PGEN_.00g043680	Scaffold_02	29647359	29647658	NA	NA	NA	NA	NA
PGEN_.00g043690	Scaffold_02	29667456	29698676	Q6DDU8	FIGL1_XENLA	Fidgetin-like protein 1 (EC 3.6.4.-)	GO:0000228; GO:0000287; GO:0005524; GO:0016787; GO:0046034; GO:0048471	nuclear chromosome [GO:0000228]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; ATP metabolic process [GO:0046034]
PGEN_.00g043700	Scaffold_02	29705241	29716480	Q5REI6	ZN791_PONAB	Zinc finger protein 791	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g043710	Scaffold_02	29733303	29788656	A9JRZ0	SMUF2_DANRE	E3 ubiquitin-protein ligase SMURF2 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2)	GO:0000209; GO:0005634; GO:0005737; GO:0005886; GO:0006511; GO:0016567; GO:0030514; GO:0030579; GO:0043161; GO:0045121; GO:0045732; GO:0061630	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]
PGEN_.00g043720	Scaffold_02	29791126	29804963	A9JRZ0	SMUF2_DANRE	E3 ubiquitin-protein ligase SMURF2 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2)	GO:0000209; GO:0005634; GO:0005737; GO:0005886; GO:0006511; GO:0016567; GO:0030514; GO:0030579; GO:0043161; GO:0045121; GO:0045732; GO:0061630	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]
PGEN_.00g043730	Scaffold_02	29820152	29834460	Q6EV77	FUT8_PANTR	"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	GO:0006487; GO:0006491; GO:0007179; GO:0007229; GO:0007585; GO:0008424; GO:0010468; GO:0016021; GO:0016477; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0043112; GO:0046368; GO:0046921; GO:1900407	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; integrin-mediated signaling pathway [GO:0007229]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g043740	Scaffold_02	29844606	29848374	Q24K03	THUM1_BOVIN	THUMP domain-containing protein 1	GO:0003723; GO:0006400	RNA binding [GO:0003723]; tRNA modification [GO:0006400]
PGEN_.00g043750	Scaffold_02	29854734	29860090	NA	NA	NA	NA	NA
PGEN_.00g043760	Scaffold_02	29859564	29859827	NA	NA	NA	NA	NA
PGEN_.00g043770	Scaffold_02	29866343	29866756	NA	NA	NA	NA	NA
PGEN_.00g043780	Scaffold_02	29880139	29892842	P16260	GDC_HUMAN	Graves disease carrier protein (GDC) (Graves disease autoantigen) (GDA) (Mitochondrial solute carrier protein homolog) (Solute carrier family 25 member 16)	GO:0005739; GO:0005743; GO:0006839; GO:0009108; GO:0015291; GO:0015297; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; secondary active transmembrane transporter activity [GO:0015291]; coenzyme biosynthetic process [GO:0009108]; mitochondrial transport [GO:0006839]
PGEN_.00g043790	Scaffold_02	29899614	29910977	P97346	NXN_MOUSE	Nucleoredoxin (EC 1.8.1.8) (Protein Red-1)	GO:0001701; GO:0004791; GO:0005623; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0045454; GO:0047134; GO:0072358	cell [GO:0005623]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; in utero embryonic development [GO:0001701]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]
PGEN_.00g043800	Scaffold_02	29915119	29924081	O77404	TYPX_TRYBB	Tryparedoxin (TryX)	GO:0005623; GO:0045454; GO:0055114	cell [GO:0005623]; cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114]
PGEN_.00g043810	Scaffold_02	29930096	29930644	NA	NA	NA	NA	NA
PGEN_.00g043820	Scaffold_02	29943582	30045819	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g043830	Scaffold_02	30064343	30064618	NA	NA	NA	NA	NA
PGEN_.00g043840	Scaffold_02	30068621	30089677	P31695	NOTC4_MOUSE	Neurogenic locus notch homolog protein 4 (Notch 4) [Cleaved into: Transforming protein Int-3; Notch 4 extracellular truncation; Notch 4 intracellular domain]	GO:0001569; GO:0001763; GO:0001886; GO:0001944; GO:0005112; GO:0005509; GO:0005654; GO:0005783; GO:0005829; GO:0005886; GO:0006355; GO:0007219; GO:0008593; GO:0009986; GO:0016021; GO:0030879; GO:0031410; GO:0032880; GO:0038023; GO:0045446; GO:0045602; GO:0045746; GO:0045766; GO:0048845; GO:0070613; GO:1903849	"cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023]; branching involved in blood vessel morphogenesis [GO:0001569]; endothelial cell differentiation [GO:0045446]; endothelial cell morphogenesis [GO:0001886]; mammary gland development [GO:0030879]; morphogenesis of a branching structure [GO:0001763]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aorta morphogenesis [GO:1903849]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein localization [GO:0032880]; regulation of protein processing [GO:0070613]; regulation of transcription, DNA-templated [GO:0006355]; vasculature development [GO:0001944]; venous blood vessel morphogenesis [GO:0048845]"
PGEN_.00g043850	Scaffold_02	30116898	30157527	NA	NA	NA	NA	NA
PGEN_.00g043860	Scaffold_02	30172524	30282050	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g043870	Scaffold_02	30371045	30388394	Q80ZD3	S2611_MOUSE	Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11)	GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]
PGEN_.00g043880	Scaffold_02	30425965	30426261	NA	NA	NA	NA	NA
PGEN_.00g043890	Scaffold_02	30426876	30427271	NA	NA	NA	NA	NA
PGEN_.00g043900	Scaffold_02	30428863	30431669	P51688	SPHM_HUMAN	N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase)	GO:0005539; GO:0005764; GO:0006027; GO:0008449; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0070062	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]
PGEN_.00g043910	Scaffold_02	30432354	30439570	Q96CN5	LRC45_HUMAN	Leucine-rich repeat-containing protein 45	GO:0005654; GO:0005813; GO:0005829; GO:0005886	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
PGEN_.00g043920	Scaffold_02	30447300	30452604	Q8TCA0	LRC20_HUMAN	Leucine-rich repeat-containing protein 20		
PGEN_.00g043930	Scaffold_02	30457209	30484298	NA	NA	NA	NA	NA
PGEN_.00g043940	Scaffold_02	30488842	30491355	NA	NA	NA	NA	NA
PGEN_.00g043950	Scaffold_02	30494104	30496185	NA	NA	NA	NA	NA
PGEN_.00g043960	Scaffold_02	30511487	30514489	NA	NA	NA	NA	NA
PGEN_.00g043970	Scaffold_02	30521321	30523477	NA	NA	NA	NA	NA
PGEN_.00g043980	Scaffold_02	30532792	30533388	NA	NA	NA	NA	NA
PGEN_.00g043990	Scaffold_02	30536707	30538839	NA	NA	NA	NA	NA
PGEN_.00g044000	Scaffold_02	30545746	30548835	NA	NA	NA	NA	NA
PGEN_.00g044010	Scaffold_02	30562849	30566363	NA	NA	NA	NA	NA
PGEN_.00g044020	Scaffold_02	30569087	30571600	NA	NA	NA	NA	NA
PGEN_.00g044030	Scaffold_02	30576322	30600466	NA	NA	NA	NA	NA
PGEN_.00g044040	Scaffold_02	30605056	30610360	Q8TCA0	LRC20_HUMAN	Leucine-rich repeat-containing protein 20		
PGEN_.00g044050	Scaffold_02	30618113	30625164	Q96CN5	LRC45_HUMAN	Leucine-rich repeat-containing protein 45	GO:0005654; GO:0005813; GO:0005829; GO:0005886	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
PGEN_.00g044060	Scaffold_02	30625849	30628590	P51688	SPHM_HUMAN	N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase)	GO:0005539; GO:0005764; GO:0006027; GO:0008449; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0070062	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]
PGEN_.00g044070	Scaffold_02	30630182	30630439	NA	NA	NA	NA	NA
PGEN_.00g044080	Scaffold_02	30630550	30630876	NA	NA	NA	NA	NA
PGEN_.00g044090	Scaffold_02	30668202	30685749	Q80ZD3	S2611_MOUSE	Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11)	GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate transport [GO:0008272]
PGEN_.00g044100	Scaffold_02	30776181	30776405	NA	NA	NA	NA	NA
PGEN_.00g044110	Scaffold_02	30837962	30859536	A6NNA5	DRGX_HUMAN	Dorsal root ganglia homeobox protein (Paired-related homeobox protein-like 1)	GO:0000790; GO:0000977; GO:0000981; GO:0001764; GO:0005634; GO:0007411; GO:0009593; GO:0016048; GO:0021516; GO:0021559; GO:0050954	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; axon guidance [GO:0007411]; detection of chemical stimulus [GO:0009593]; detection of temperature stimulus [GO:0016048]; dorsal spinal cord development [GO:0021516]; neuron migration [GO:0001764]; sensory perception of mechanical stimulus [GO:0050954]; trigeminal nerve development [GO:0021559]"
PGEN_.00g044120	Scaffold_02	30908720	30909196	NA	NA	NA	NA	NA
PGEN_.00g044130	Scaffold_02	30926081	30961123	Q6NU40	CTF18_XENLA	Chromosome transmission fidelity protein 18 homolog	GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006260; GO:0007049	DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; cell cycle [GO:0007049]; DNA replication [GO:0006260]
PGEN_.00g044140	Scaffold_02	30964271	30967259	NA	NA	NA	NA	NA
PGEN_.00g044150	Scaffold_02	30972002	30972349	NA	NA	NA	NA	NA
PGEN_.00g044160	Scaffold_02	30979361	30983752	NA	NA	NA	NA	NA
PGEN_.00g044170	Scaffold_02	30986085	30999342	NA	NA	NA	NA	NA
PGEN_.00g044180	Scaffold_02	31000702	31012806	Q68FD7	FNIP1_MOUSE	Folliculin-interacting protein 1	GO:0000122; GO:0001932; GO:0001934; GO:0002327; GO:0002904; GO:0005085; GO:0005737; GO:0009267; GO:0010823; GO:0031334; GO:0031929; GO:0032007; GO:0033138; GO:0042030; GO:0043154; GO:0051087; GO:1904262; GO:2000973	cytoplasm [GO:0005737]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]
PGEN_.00g044190	Scaffold_02	31025709	31058588	Q9C0B0	UNK_HUMAN	RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5)	GO:0001701; GO:0001764; GO:0003723; GO:0005737; GO:0005844; GO:0046872; GO:0048667; GO:1905538; GO:1990715; GO:2000766	cytoplasm [GO:0005737]; polysome [GO:0005844]; metal ion binding [GO:0046872]; mRNA CDS binding [GO:1990715]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764]
PGEN_.00g044200	Scaffold_02	31077666	31125273	B1WB06	MET24_XENTR	Methyltransferase-like protein 24 (EC 2.1.1.-)	GO:0005576; GO:0008168; GO:0032259	extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g044210	Scaffold_02	31132061	31137252	A0A0K0MJN3	FABP4_PYGPA	"Fatty acid-binding protein, adipocyte (Adipocyte lipid-binding protein) (ALBP) (Adipocyte-type fatty acid-binding protein) (AFABP) (Fatty acid-binding protein 4)"	GO:0005324; GO:0005634; GO:0005737; GO:0015909; GO:0050727; GO:0070538; GO:0070539; GO:0070540; GO:0071399	cytoplasm [GO:0005737]; nucleus [GO:0005634]; linoleic acid binding [GO:0070539]; long-chain fatty acid transporter activity [GO:0005324]; oleic acid binding [GO:0070538]; stearic acid binding [GO:0070540]; cellular response to linoleic acid [GO:0071399]; long-chain fatty acid transport [GO:0015909]; regulation of inflammatory response [GO:0050727]
PGEN_.00g044220	Scaffold_02	31140164	31146548	Q3B8H3	TM11B_XENLA	"Transmembrane protein 11-B, mitochondrial"	GO:0007005; GO:0031305	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion organization [GO:0007005]
PGEN_.00g044230	Scaffold_02	31148257	31161206	Q5R6U1	DRS7B_PONAB	Dehydrogenase/reductase SDR family member 7B (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 32C member 1)	GO:0005789; GO:0016021; GO:0016491	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]
PGEN_.00g044240	Scaffold_02	31162154	31185425	Q9UPT9	UBP22_HUMAN	Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22)	GO:0000124; GO:0003713; GO:0004843; GO:0005654; GO:0006511; GO:0007049; GO:0008270; GO:0009792; GO:0016574; GO:0016578; GO:0016579; GO:0019899; GO:0030374; GO:0043967; GO:0045893; GO:0045931	"nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; enzyme binding [GO:0019899]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; embryo development ending in birth or egg hatching [GO:0009792]; histone deubiquitination [GO:0016578]; histone H4 acetylation [GO:0043967]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g044250	Scaffold_02	31201113	31206249	Q5M9B1	SPSB3_XENLA	SPRY domain-containing SOCS box protein 3 (SSB-3)	GO:0016567	protein ubiquitination [GO:0016567]
PGEN_.00g044260	Scaffold_02	31227115	31230000	NA	NA	NA	NA	NA
PGEN_.00g044270	Scaffold_02	31235138	31236322	NA	NA	NA	NA	NA
PGEN_.00g044280	Scaffold_02	31246383	31254175	Q6ZUK4	TMM26_HUMAN	Transmembrane protein 26	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g044290	Scaffold_02	31258014	31274786	O43670	ZN207_HUMAN	BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (hBuGZ) (Zinc finger protein 207)	GO:0000070; GO:0000776; GO:0000777; GO:0001578; GO:0003677; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006355; GO:0007094; GO:0008017; GO:0008201; GO:0008270; GO:0008608; GO:0046785; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047	"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heparin binding [GO:0008201]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g044300	Scaffold_02	31282531	31305041	Q3UDW8	HGNAT_MOUSE	Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)	GO:0005765; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0051259	"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]"
PGEN_.00g044310	Scaffold_02	31305224	31327672	Q3UDW8	HGNAT_MOUSE	Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)	GO:0005765; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0051259	"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]"
PGEN_.00g044320	Scaffold_02	31335417	31352689	O43670	ZN207_HUMAN	BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (hBuGZ) (Zinc finger protein 207)	GO:0000070; GO:0000776; GO:0000777; GO:0001578; GO:0003677; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0006355; GO:0007094; GO:0008017; GO:0008201; GO:0008270; GO:0008608; GO:0046785; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047	"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heparin binding [GO:0008201]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g044330	Scaffold_02	31356546	31364350	Q6ZUK4	TMM26_HUMAN	Transmembrane protein 26	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g044340	Scaffold_02	31374385	31375569	NA	NA	NA	NA	NA
PGEN_.00g044350	Scaffold_02	31381055	31383805	NA	NA	NA	NA	NA
PGEN_.00g044360	Scaffold_02	31404760	31409824	Q5M9B1	SPSB3_XENLA	SPRY domain-containing SOCS box protein 3 (SSB-3)	GO:0016567	protein ubiquitination [GO:0016567]
PGEN_.00g044370	Scaffold_02	31425120	31448694	Q9UPT9	UBP22_HUMAN	Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22)	GO:0000124; GO:0003713; GO:0004843; GO:0005654; GO:0006511; GO:0007049; GO:0008270; GO:0009792; GO:0016574; GO:0016578; GO:0016579; GO:0019899; GO:0030374; GO:0043967; GO:0045893; GO:0045931	"nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; enzyme binding [GO:0019899]; nuclear receptor transcription coactivator activity [GO:0030374]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; embryo development ending in birth or egg hatching [GO:0009792]; histone deubiquitination [GO:0016578]; histone H4 acetylation [GO:0043967]; histone ubiquitination [GO:0016574]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g044380	Scaffold_02	31449643	31457836	Q9Y140	DHRS7_DROME	Dehydrogenase/reductase SDR family protein 7-like (EC 1.1.-.-)	GO:0005778; GO:0016021; GO:0016491	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; oxidoreductase activity [GO:0016491]
PGEN_.00g044390	Scaffold_02	31465483	31471988	Q3B8H3	TM11B_XENLA	"Transmembrane protein 11-B, mitochondrial"	GO:0007005; GO:0031305	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion organization [GO:0007005]
PGEN_.00g044400	Scaffold_02	31474601	31479729	A0A0K0MJN3	FABP4_PYGPA	"Fatty acid-binding protein, adipocyte (Adipocyte lipid-binding protein) (ALBP) (Adipocyte-type fatty acid-binding protein) (AFABP) (Fatty acid-binding protein 4)"	GO:0005324; GO:0005634; GO:0005737; GO:0015909; GO:0050727; GO:0070538; GO:0070539; GO:0070540; GO:0071399	cytoplasm [GO:0005737]; nucleus [GO:0005634]; linoleic acid binding [GO:0070539]; long-chain fatty acid transporter activity [GO:0005324]; oleic acid binding [GO:0070538]; stearic acid binding [GO:0070540]; cellular response to linoleic acid [GO:0071399]; long-chain fatty acid transport [GO:0015909]; regulation of inflammatory response [GO:0050727]
PGEN_.00g044410	Scaffold_02	31486770	31534371	B1WB06	MET24_XENTR	Methyltransferase-like protein 24 (EC 2.1.1.-)	GO:0005576; GO:0008168; GO:0032259	extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g044420	Scaffold_02	31553474	31585601	Q9C0B0	UNK_HUMAN	RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5)	GO:0001701; GO:0001764; GO:0003723; GO:0005737; GO:0005844; GO:0046872; GO:0048667; GO:1905538; GO:1990715; GO:2000766	cytoplasm [GO:0005737]; polysome [GO:0005844]; metal ion binding [GO:0046872]; mRNA CDS binding [GO:1990715]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764]
PGEN_.00g044430	Scaffold_02	31598676	31625319	Q5W4S4	FNIP1_CHICK	Folliculin-interacting protein 1	GO:0005737; GO:0042030; GO:0051087	cytoplasm [GO:0005737]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]
PGEN_.00g044440	Scaffold_02	31628732	31629382	NA	NA	NA	NA	NA
PGEN_.00g044450	Scaffold_02	31629573	31635823	NA	NA	NA	NA	NA
PGEN_.00g044460	Scaffold_02	31639721	31640068	NA	NA	NA	NA	NA
PGEN_.00g044470	Scaffold_02	31644826	31647832	NA	NA	NA	NA	NA
PGEN_.00g044480	Scaffold_02	31650980	31685287	Q6NU40	CTF18_XENLA	Chromosome transmission fidelity protein 18 homolog	GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006260; GO:0007049	DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; cell cycle [GO:0007049]; DNA replication [GO:0006260]
PGEN_.00g044490	Scaffold_02	31702330	31702629	NA	NA	NA	NA	NA
PGEN_.00g044500	Scaffold_02	31752823	31774941	A6NNA5	DRGX_HUMAN	Dorsal root ganglia homeobox protein (Paired-related homeobox protein-like 1)	GO:0000790; GO:0000977; GO:0000981; GO:0001764; GO:0005634; GO:0007411; GO:0009593; GO:0016048; GO:0021516; GO:0021559; GO:0050954	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; axon guidance [GO:0007411]; detection of chemical stimulus [GO:0009593]; detection of temperature stimulus [GO:0016048]; dorsal spinal cord development [GO:0021516]; neuron migration [GO:0001764]; sensory perception of mechanical stimulus [GO:0050954]; trigeminal nerve development [GO:0021559]"
PGEN_.00g044510	Scaffold_02	31834305	31834811	NA	NA	NA	NA	NA
PGEN_.00g044520	Scaffold_02	31835108	31835398	NA	NA	NA	NA	NA
PGEN_.00g044530	Scaffold_02	31845751	31850039	Q68CP4	HGNAT_HUMAN	Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)	GO:0005765; GO:0005886; GO:0006027; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0035579; GO:0043312; GO:0051259; GO:0070821	"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; glycosaminoglycan catabolic process [GO:0006027]; lysosomal transport [GO:0007041]; neutrophil degranulation [GO:0043312]; protein complex oligomerization [GO:0051259]"
PGEN_.00g044540	Scaffold_02	31857113	31863827	Q8R0M8	MOT5_MOUSE	Monocarboxylate transporter 5 (MCT 5)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g044550	Scaffold_02	31874535	31879781	NA	NA	NA	NA	NA
PGEN_.00g044560	Scaffold_02	31884038	31909028	C3YWU0	FUCO_BRAFL	Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)	GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139	extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]
PGEN_.00g044570	Scaffold_02	31917218	31917460	NA	NA	NA	NA	NA
PGEN_.00g044580	Scaffold_02	31933353	31934177	NA	NA	NA	NA	NA
PGEN_.00g044590	Scaffold_02	31934442	31936817	NA	NA	NA	NA	NA
PGEN_.00g044600	Scaffold_02	31949707	31975984	Q9H694	BICC1_HUMAN	Protein bicaudal C homolog 1 (Bic-C)	GO:0003723; GO:0005737; GO:0007368; GO:0007507; GO:0090090	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]
PGEN_.00g044610	Scaffold_02	31978728	31979312	NA	NA	NA	NA	NA
PGEN_.00g044620	Scaffold_02	31985064	31997882	Q9IA00	BIC1A_XENLA	Protein bicaudal C homolog 1-A (Bic-C-A)	GO:0003723; GO:0007275	RNA binding [GO:0003723]; multicellular organism development [GO:0007275]
PGEN_.00g044630	Scaffold_02	32008188	32016183	NA	NA	NA	NA	NA
PGEN_.00g044640	Scaffold_02	32031421	32040117	Q8N5R6	CCD33_HUMAN	Coiled-coil domain-containing protein 33 (Cancer/testis antigen 61) (CT61)		
PGEN_.00g044650	Scaffold_02	32055846	32073551	Q5XIR4	CCD33_RAT	Coiled-coil domain-containing protein 33	GO:0005777	peroxisome [GO:0005777]
PGEN_.00g044660	Scaffold_02	32076911	32093388	Q8N5R6	CCD33_HUMAN	Coiled-coil domain-containing protein 33 (Cancer/testis antigen 61) (CT61)		
PGEN_.00g044670	Scaffold_02	32103359	32137165	Q6P7A9	LYAG_RAT	Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase)	GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005623; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0043181; GO:0046716; GO:0050884; GO:0050885; GO:0060048	"cell [GO:0005623]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]"
PGEN_.00g044680	Scaffold_02	32169528	32181405	Q96DW6	S2538_HUMAN	Mitochondrial glycine transporter (Mitochondrial glycine transporter GlyC) (Solute carrier family 25 member 38)	GO:0005739; GO:0005743; GO:0006783; GO:0015187; GO:0016021; GO:0030218; GO:1904983	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; glycine transmembrane transporter activity [GO:0015187]; erythrocyte differentiation [GO:0030218]; glycine import into mitochondrion [GO:1904983]; heme biosynthetic process [GO:0006783]
PGEN_.00g044690	Scaffold_02	32205766	32226484	Q8N957	ANKF1_HUMAN	Ankyrin repeat and fibronectin type-III domain-containing protein 1		
PGEN_.00g044700	Scaffold_02	32253894	32254328	NA	NA	NA	NA	NA
PGEN_.00g044710	Scaffold_02	32308203	32308448	NA	NA	NA	NA	NA
PGEN_.00g044720	Scaffold_02	32308576	32309052	NA	NA	NA	NA	NA
PGEN_.00g044730	Scaffold_02	32311869	32327589	NA	NA	NA	NA	NA
PGEN_.00g044740	Scaffold_02	32331200	32332168	NA	NA	NA	NA	NA
PGEN_.00g044750	Scaffold_02	32335013	32335847	NA	NA	NA	NA	NA
PGEN_.00g044760	Scaffold_02	32392480	32392731	NA	NA	NA	NA	NA
PGEN_.00g044770	Scaffold_02	32458651	32472479	NA	NA	NA	NA	NA
PGEN_.00g044780	Scaffold_02	32474413	32488428	Q9NZS9	BFAR_HUMAN	Bifunctional apoptosis regulator (RING finger protein 47)	GO:0000209; GO:0005783; GO:0005887; GO:0006511; GO:0006915; GO:0016020; GO:0030176; GO:0030674; GO:0043066; GO:0043161; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1903895	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g044790	Scaffold_02	32488603	32495641	Q90ZA1	PARN_XENLA	Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease) (parn-A)	GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0006402; GO:0043169; GO:0046872; GO:0051321	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; meiotic cell cycle [GO:0051321]; mRNA catabolic process [GO:0006402]
PGEN_.00g044800	Scaffold_02	32521179	32555892	Q7ZU92	PARN_DANRE	Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Polyadenylate-specific ribonuclease)	GO:0000175; GO:0000289; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0030097; GO:0043169; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; hemopoiesis [GO:0030097]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]
PGEN_.00g044810	Scaffold_02	32624950	32626080	NA	NA	NA	NA	NA
PGEN_.00g044820	Scaffold_02	32657432	32657938	NA	NA	NA	NA	NA
PGEN_.00g044830	Scaffold_02	32663714	32668515	NA	NA	NA	NA	NA
PGEN_.00g044840	Scaffold_02	32677859	32683631	NA	NA	NA	NA	NA
PGEN_.00g044850	Scaffold_02	32725666	32727642	Q61704	ITIH3_MOUSE	Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3)	GO:0004867; GO:0030212; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]
PGEN_.00g044860	Scaffold_02	32753941	32783025	Q6NXT1	ANR54_HUMAN	Ankyrin repeat domain-containing protein 54 (Lyn-interacting ankyrin repeat protein)	GO:0005634; GO:0005737; GO:0006913; GO:0019887; GO:0030496; GO:0044877; GO:0045648; GO:0045859; GO:1902531	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859]
PGEN_.00g044870	Scaffold_02	32783402	32805896	Q9BT22	ALG1_HUMAN	"Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1)"	GO:0000030; GO:0004578; GO:0005783; GO:0005789; GO:0006486; GO:0006488; GO:0016020; GO:0016021	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]
PGEN_.00g044880	Scaffold_02	32838069	32842095	Q6XIM8	RS15A_DROYA	40S ribosomal protein S15a	GO:0003735; GO:0005840; GO:0006412	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g044890	Scaffold_02	32842174	32889382	A2RTY3	HEAT9_HUMAN	Protein HEATR9 (HEAT repeat-containing protein 9)	GO:0002244	hematopoietic progenitor cell differentiation [GO:0002244]
PGEN_.00g044900	Scaffold_02	32896639	32907740	O05218	YWRD_BACSU	Glutathione hydrolase-like YwrD proenzyme (EC 2.3.2.2) (Putative gamma-glutamyltransferase YwrD) (EC 3.4.19.13) [Cleaved into: Glutathione hydrolase-like YwrD large chain; Glutathione hydrolase-like YwrD small chain]	GO:0006751; GO:0036374; GO:0102953; GO:0103068	glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione catabolic process [GO:0006751]
PGEN_.00g044910	Scaffold_02	32913531	32948700	Q9GL59	VKGC_SHEEP	Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase)	GO:0005789; GO:0008488; GO:0016021; GO:0017187	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; gamma-glutamyl carboxylase activity [GO:0008488]; peptidyl-glutamic acid carboxylation [GO:0017187]
PGEN_.00g044920	Scaffold_02	32961385	32962754	NA	NA	NA	NA	NA
PGEN_.00g044930	Scaffold_02	32962547	32995871	Q32KL8	TBATA_BOVIN	"Protein TBATA (Protein SPATIAL) (Stromal protein associated with thymii and lymph node homolog) (Thymus, brain and testes-associated protein)"	GO:0005829; GO:0007275; GO:0007283; GO:0030154	cytosol [GO:0005829]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g044940	Scaffold_02	33002943	33003299	NA	NA	NA	NA	NA
PGEN_.00g044950	Scaffold_02	33007987	33022391	B2RVL6	ZCH24_MOUSE	Zinc finger CCHC domain-containing protein 24	GO:0003676; GO:0008270	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]
PGEN_.00g044960	Scaffold_02	33039297	33066634	A0A0R4IVV0	MTP_DANRE	Microsomal triglyceride transfer protein large subunit	GO:0001579; GO:0002040; GO:0005319; GO:0005548; GO:0005783; GO:0005794; GO:0006629; GO:0006869; GO:0007586; GO:0008289; GO:0015909; GO:0016323; GO:0042157; GO:0042158; GO:0042632	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phospholipid transporter activity [GO:0005548]; cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; sprouting angiogenesis [GO:0002040]
PGEN_.00g044970	Scaffold_02	33067594	33074798	Q8C1Z8	TM10A_MOUSE	tRNA methyltransferase 10 homolog A (EC 2.1.1.221) (RNA (guanine-9-)-methyltransferase domain-containing protein 2) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10A)	GO:0000049; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0009019; GO:0010960; GO:0015629; GO:0030488; GO:0052905; GO:0090646	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; magnesium ion homeostasis [GO:0010960]; mitochondrial tRNA processing [GO:0090646]; tRNA methylation [GO:0030488]
PGEN_.00g044980	Scaffold_02	33080473	33099949	P37892	CBPE_LOPAM	Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase)	GO:0004181; GO:0005576; GO:0008270; GO:0030658	extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]
PGEN_.00g044990	Scaffold_02	33110236	33134205	Q9Y6D9	MD1L1_HUMAN	Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181)	GO:0000776; GO:0000777; GO:0000922; GO:0005623; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0007093; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051301; GO:0051315; GO:0072686; GO:0090235	cell [GO:0005623]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]
PGEN_.00g045000	Scaffold_02	33139813	33174882	Q9EPQ8	TCF20_MOUSE	Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein)	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0016604; GO:0044212; GO:0045944; GO:0046872	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g045010	Scaffold_02	33175150	33175590	NA	NA	NA	NA	NA
PGEN_.00g045020	Scaffold_02	33188614	33268700	P35580	MYH10_HUMAN	"Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)"	GO:0000146; GO:0000281; GO:0001701; GO:0001725; GO:0001764; GO:0001778; GO:0003279; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005844; GO:0005903; GO:0005938; GO:0006887; GO:0006930; GO:0007097; GO:0007155; GO:0007411; GO:0007512; GO:0008283; GO:0008360; GO:0016459; GO:0016460; GO:0016887; GO:0021592; GO:0021670; GO:0021678; GO:0021680; GO:0030027; GO:0030048; GO:0030426; GO:0030496; GO:0030898; GO:0031032; GO:0031594; GO:0032154; GO:0035613; GO:0035904; GO:0042641; GO:0043025; GO:0043197; GO:0043531; GO:0048027; GO:0050714; GO:0050885; GO:0051015; GO:0055003; GO:0055015; GO:0060041; GO:0060976; GO:0070062; GO:0097513; GO:0098885; GO:0098974; GO:0098978	"actomyosin [GO:0042641]; brush border [GO:0005903]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; spindle [GO:0005819]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; modification of postsynaptic actin cytoskeleton [GO:0098885]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; positive regulation of protein secretion [GO:0050714]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of cell shape [GO:0008360]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration, cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015]"
PGEN_.00g045030	Scaffold_02	33275123	33293847	Q6A4L0	S22AD_MOUSE	Solute carrier family 22 member 13 (Organic cation transporter-like 3) (ORCTL-3)	GO:0015747; GO:0016021; GO:0016324; GO:0090416; GO:2001142	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; nicotinate transmembrane transporter activity [GO:0090416]; nicotinate transport [GO:2001142]; urate transport [GO:0015747]
PGEN_.00g045040	Scaffold_02	33316632	33318856	NA	NA	NA	NA	NA
PGEN_.00g045050	Scaffold_02	33370419	33370766	NA	NA	NA	NA	NA
PGEN_.00g045060	Scaffold_02	33371155	33371637	NA	NA	NA	NA	NA
PGEN_.00g045070	Scaffold_02	33372306	33372716	NA	NA	NA	NA	NA
PGEN_.00g045080	Scaffold_02	33375682	33393044	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g045090	Scaffold_02	33401463	33428266	O75689	ADAP1_HUMAN	Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25)	GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0043087; GO:0043533; GO:0046872; GO:1902936	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087]"
PGEN_.00g045100	Scaffold_02	33440678	33449532	P0C7A1	ENASE_CHICK	Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96)	GO:0005615; GO:0005764; GO:0005829; GO:0006517; GO:0016231; GO:0016787; GO:0033925; GO:0051672	cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-N-acetylglucosaminidase activity [GO:0016231]; hydrolase activity [GO:0016787]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; catabolism by organism of cell wall peptidoglycan in other organism [GO:0051672]; protein deglycosylation [GO:0006517]
PGEN_.00g045110	Scaffold_02	33485286	33487777	Q8IYN6	UBAD2_HUMAN	UBA-like domain-containing protein 2		
PGEN_.00g045120	Scaffold_02	33488291	33516073	Q96PX1	RN157_HUMAN	E3 ubiquitin ligase RNF157 (EC 2.3.2.27) (RING finger protein 157) (RING-type E3 ubiquitin transferase RNF157)	GO:0005737; GO:0016567; GO:0043066; GO:0044297; GO:0046872; GO:0051865; GO:0061630; GO:1903861	cell body [GO:0044297]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite extension [GO:1903861]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]
PGEN_.00g045130	Scaffold_02	33524499	33525221	NA	NA	NA	NA	NA
PGEN_.00g045140	Scaffold_02	33686124	33686429	NA	NA	NA	NA	NA
PGEN_.00g045150	Scaffold_02	33695944	33696330	NA	NA	NA	NA	NA
PGEN_.00g045160	Scaffold_02	33715424	33716527	NA	NA	NA	NA	NA
PGEN_.00g045170	Scaffold_02	33724097	33725092	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g045180	Scaffold_02	33736759	33737877	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g045190	Scaffold_02	33941628	33942659	Q9Y2C9	TLR6_HUMAN	Toll-like receptor 6 (CD antigen CD286)	GO:0001540; GO:0001774; GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005102; GO:0005623; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0007250; GO:0010628; GO:0030670; GO:0034136; GO:0034150; GO:0035355; GO:0035663; GO:0035666; GO:0038023; GO:0038124; GO:0042496; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043507; GO:0045087; GO:0045121; GO:0045410; GO:0045429; GO:0046209; GO:0046982; GO:0050702; GO:0051092; GO:0071723; GO:0071726; GO:0140052; GO:1900017; GO:1900227; GO:1903223; GO:1903428; GO:1904646; GO:2000483	cell [GO:0005623]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; nitric oxide metabolic process [GO:0046209]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]
PGEN_.00g045200	Scaffold_02	34014727	34024076	NA	NA	NA	NA	NA
PGEN_.00g045210	Scaffold_02	34037739	34038427	NA	NA	NA	NA	NA
PGEN_.00g045220	Scaffold_02	34076470	34082117	P0DPH8	TBA3D_HUMAN	Tubulin alpha-3D chain (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g045230	Scaffold_02	34101476	34109587	Q7Z7L7	ZER1_HUMAN	Protein zer-1 homolog (Hzyg) (Zyg-11 homolog B-like protein) (Zyg11b-like protein)	GO:0006515; GO:0031462; GO:0032436	Cul2-RING ubiquitin ligase complex [GO:0031462]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]
PGEN_.00g045240	Scaffold_02	34116430	34118262	Q3UDW8	HGNAT_MOUSE	Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)	GO:0005765; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0051259	"integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; transferase activity, transferring acyl groups [GO:0016746]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]"
PGEN_.00g045250	Scaffold_02	34135790	34151666	NA	NA	NA	NA	NA
PGEN_.00g045260	Scaffold_02	34159390	34169468	Q9DAK4	FBP12_MOUSE	Fatty acid-binding protein 12	GO:0008289	lipid binding [GO:0008289]
PGEN_.00g045270	Scaffold_02	34180757	34181149	Q8IN35	SIFAR_DROME	Neuropeptide SIFamide receptor	GO:0004930; GO:0004983; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016021; GO:0032870; GO:0048047	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g045280	Scaffold_02	34199795	34201176	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g045290	Scaffold_02	34201323	34203055	NA	NA	NA	NA	NA
PGEN_.00g045300	Scaffold_02	34296616	34305674	Q96P65	QRFPR_HUMAN	Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)	GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g045310	Scaffold_02	34336035	34339500	NA	NA	NA	NA	NA
PGEN_.00g045320	Scaffold_02	34342425	34342871	NA	NA	NA	NA	NA
PGEN_.00g045330	Scaffold_02	34343987	34344355	NA	NA	NA	NA	NA
PGEN_.00g045340	Scaffold_02	34348590	34358901	Q9Y661	HS3S4_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 4 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 4) (3-OST-4) (Heparan sulfate 3-O-sulfotransferase 4) (h3-OST-4)	GO:0000139; GO:0008467; GO:0016021; GO:0030201	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate proteoglycan metabolic process [GO:0030201]
PGEN_.00g045350	Scaffold_02	34368131	34371521	NA	NA	NA	NA	NA
PGEN_.00g045360	Scaffold_02	34389047	34389646	NA	NA	NA	NA	NA
PGEN_.00g045370	Scaffold_02	34389943	34390290	NA	NA	NA	NA	NA
PGEN_.00g045380	Scaffold_02	34395369	34411286	Q59E83	NPR22_CAEEL	Neuropeptide receptor 22	GO:0005886; GO:0007218; GO:0008188; GO:0008340; GO:0016021; GO:0040013; GO:1901046; GO:2000252	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; determination of adult lifespan [GO:0008340]; negative regulation of feeding behavior [GO:2000252]; negative regulation of locomotion [GO:0040013]; neuropeptide signaling pathway [GO:0007218]; positive regulation of oviposition [GO:1901046]
PGEN_.00g045390	Scaffold_02	34421558	34451342	Q8HY87	RNZ2_MACFA	Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2)	GO:0004519; GO:0005634; GO:0005739; GO:0046872; GO:0072684	"mitochondrion [GO:0005739]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic [GO:0072684]"
PGEN_.00g045400	Scaffold_02	34451552	34482259	NA	NA	NA	NA	NA
PGEN_.00g045410	Scaffold_02	34487484	34490166	NA	NA	NA	NA	NA
PGEN_.00g045420	Scaffold_02	34498991	34534017	U3JAG9	CP131_DANRE	Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1)	GO:0000775; GO:0005576; GO:0005623; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317	"cell [GO:0005623]; centriolar satellite [GO:0034451]; chromosome, centromeric region [GO:0000775]; cilium [GO:0005929]; extracellular region [GO:0005576]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]"
PGEN_.00g045430	Scaffold_02	34534413	34569746	Q8K0V4	CNOT3_MOUSE	CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3)	GO:0000932; GO:0001829; GO:0005634; GO:0006355; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0120162; GO:2000036	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; trophectodermal cell differentiation [GO:0001829]"
PGEN_.00g045440	Scaffold_02	34588148	34588498	NA	NA	NA	NA	NA
PGEN_.00g045450	Scaffold_02	34596652	34596936	NA	NA	NA	NA	NA
PGEN_.00g045460	Scaffold_02	34636434	34668873	NA	NA	NA	NA	NA
PGEN_.00g045470	Scaffold_02	34726538	34733422	NA	NA	NA	NA	NA
PGEN_.00g045480	Scaffold_02	34755832	34758568	NA	NA	NA	NA	NA
PGEN_.00g045490	Scaffold_02	34759004	34775375	NA	NA	NA	NA	NA
PGEN_.00g045500	Scaffold_02	34775420	34810078	NA	NA	NA	NA	NA
PGEN_.00g045510	Scaffold_02	34817206	34858146	Q12955	ANK3_HUMAN	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]"
PGEN_.00g045520	Scaffold_02	34884688	34933951	G5E8K5	ANK3_MOUSE	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g045530	Scaffold_02	34958186	34958680	NA	NA	NA	NA	NA
PGEN_.00g045540	Scaffold_02	34992171	34992608	NA	NA	NA	NA	NA
PGEN_.00g045550	Scaffold_02	34996533	35011078	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g045560	Scaffold_02	35011116	35022656	NA	NA	NA	NA	NA
PGEN_.00g045570	Scaffold_02	35100446	35110504	Q9BG91	SOX9_CALJA	Transcription factor SOX-9	GO:0000978; GO:0000981; GO:0001158; GO:0001228; GO:0001501; GO:0001502; GO:0001708; GO:0001837; GO:0001894; GO:0001934; GO:0001942; GO:0002053; GO:0002062; GO:0002683; GO:0003170; GO:0003179; GO:0003203; GO:0003413; GO:0003415; GO:0003682; GO:0005634; GO:0006334; GO:0006338; GO:0007165; GO:0007173; GO:0007283; GO:0008284; GO:0010564; GO:0010628; GO:0010634; GO:0014036; GO:0014068; GO:0019100; GO:0019933; GO:0030279; GO:0030858; GO:0030916; GO:0032331; GO:0032332; GO:0032991; GO:0035019; GO:0035326; GO:0042127; GO:0042981; GO:0043066; GO:0043491; GO:0045662; GO:0045892; GO:0045944; GO:0046533; GO:0050679; GO:0050680; GO:0051216; GO:0060008; GO:0060041; GO:0060221; GO:0060517; GO:0060729; GO:0060784; GO:0061035; GO:0061138; GO:0065003; GO:0070168; GO:0070371; GO:0071260; GO:0071364; GO:0071504; GO:0071773; GO:0072034; GO:0072289; GO:0090090; GO:0090103; GO:0090184; GO:0090190; GO:2000020; GO:2000741	"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer binding [GO:0035326]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cAMP-mediated signaling [GO:0019933]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cellular response to BMP stimulus [GO:0071773]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to heparin [GO:0071504]; cellular response to mechanical stimulus [GO:0071260]; chondrocyte differentiation [GO:0002062]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte hypertrophy [GO:0003415]; chromatin remodeling [GO:0006338]; cochlea morphogenesis [GO:0090103]; endocardial cushion morphogenesis [GO:0003203]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in prostatic bud elongation [GO:0060517]; epithelial to mesenchymal transition [GO:0001837]; ERK1 and ERK2 cascade [GO:0070371]; hair follicle development [GO:0001942]; heart valve development [GO:0003170]; heart valve morphogenesis [GO:0003179]; intestinal epithelial structure maintenance [GO:0060729]; male germ-line sex determination [GO:0019100]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of immune system process [GO:0002683]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of ossification [GO:0030279]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell fate specification [GO:0014036]; nucleosome assembly [GO:0006334]; otic vesicle formation [GO:0030916]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of kidney development [GO:0090184]; positive regulation of male gonad development [GO:2000020]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of cartilage development [GO:0061035]; regulation of cell cycle process [GO:0010564]; regulation of cell population proliferation [GO:0042127]; regulation of cell proliferation involved in tissue homeostasis [GO:0060784]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell differentiation [GO:0060008]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; tissue homeostasis [GO:0001894]"
PGEN_.00g045580	Scaffold_02	35131697	35132323	NA	NA	NA	NA	NA
PGEN_.00g045590	Scaffold_02	35183019	35183306	NA	NA	NA	NA	NA
PGEN_.00g045600	Scaffold_02	35201985	35220339	NA	NA	NA	NA	NA
PGEN_.00g045610	Scaffold_02	35221547	35222182	P0C6X2	R1AB_CVHN1	Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Papain-like proteinase (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.69) (Non-structural protein 3) (nsp3) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); RNA-directed RNA polymerase (Pol) (RdRp) (EC 2.7.7.48) (nsp12) (p100); Helicase (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (nsp13) (p67); Guanine-N7 methyltransferase (ExoN) (EC 2.1.1.-) (EC 3.1.13.-) (nsp14); Uridylate-specific endoribonuclease (EC 3.1.-.-) (NendoU) (nsp15) (p35); 2'-O-methyltransferase (EC 2.1.1.-) (nsp16)]	GO:0003678; GO:0003723; GO:0003724; GO:0003968; GO:0004197; GO:0004519; GO:0005524; GO:0006351; GO:0008168; GO:0008242; GO:0008270; GO:0016021; GO:0016896; GO:0019079; GO:0019082; GO:0032259; GO:0033644; GO:0036459; GO:0039502; GO:0039520; GO:0039579; GO:0039595; GO:0039644; GO:0039648; GO:0044172; GO:0044220	"host cell endoplasmic reticulum-Golgi intermediate compartment [GO:0044172]; host cell membrane [GO:0033644]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; cysteine-type endopeptidase activity [GO:0004197]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; methyltransferase activity [GO:0008168]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; induction by virus of catabolism of host mRNA [GO:0039595]; induction by virus of host autophagy [GO:0039520]; methylation [GO:0032259]; modulation by virus of host protein ubiquitination [GO:0039648]; suppression by virus of host ISG15 activity [GO:0039579]; suppression by virus of host NF-kappaB transcription factor activity [GO:0039644]; suppression by virus of host type I interferon-mediated signaling pathway [GO:0039502]; transcription, DNA-templated [GO:0006351]; viral genome replication [GO:0019079]; viral protein processing [GO:0019082]"
PGEN_.00g045620	Scaffold_02	35257413	35257700	NA	NA	NA	NA	NA
PGEN_.00g045630	Scaffold_02	35257891	35258244	NA	NA	NA	NA	NA
PGEN_.00g045640	Scaffold_02	35281358	35281819	NA	NA	NA	NA	NA
PGEN_.00g045650	Scaffold_02	35357157	35366483	NA	NA	NA	NA	NA
PGEN_.00g045660	Scaffold_02	35377636	35379650	NA	NA	NA	NA	NA
PGEN_.00g045670	Scaffold_02	35414265	35414474	NA	NA	NA	NA	NA
PGEN_.00g045680	Scaffold_02	35414500	35435568	NA	NA	NA	NA	NA
PGEN_.00g045690	Scaffold_02	35451234	35451521	NA	NA	NA	NA	NA
PGEN_.00g045700	Scaffold_02	35451732	35452004	NA	NA	NA	NA	NA
PGEN_.00g045710	Scaffold_02	35454871	35455293	NA	NA	NA	NA	NA
PGEN_.00g045720	Scaffold_02	35455332	35455661	NA	NA	NA	NA	NA
PGEN_.00g045730	Scaffold_02	35505959	35517640	Q2YDD4	S39AB_BOVIN	Zinc transporter ZIP11 (Solute carrier family 39 member 11) (Zrt- and Irt-like protein 11) (ZIP-11)	GO:0005385; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0016021; GO:0071577	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]
PGEN_.00g045740	Scaffold_02	35518603	35564669	Q18PE1	DOK7_HUMAN	Protein Dok-7 (Downstream of tyrosine kinase 7)	GO:0005654; GO:0005739; GO:0005886; GO:0008289; GO:0019901; GO:0030054; GO:0045202; GO:0061098	cell junction [GO:0030054]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; positive regulation of protein tyrosine kinase activity [GO:0061098]
PGEN_.00g045750	Scaffold_02	35578086	35591205	Q6TCG8	PAQR3_MOUSE	Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG)	GO:0000139; GO:0001933; GO:0005794; GO:0010977; GO:0016021; GO:0033137; GO:0034067; GO:0038023; GO:0043407	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein phosphorylation [GO:0001933]; protein localization to Golgi apparatus [GO:0034067]
PGEN_.00g045760	Scaffold_02	35599732	35624307	P12276	FAS_CHICK	Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	GO:0003697; GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005623; GO:0006089; GO:0006633; GO:0008659; GO:0008693; GO:0016295; GO:0016296; GO:0031177; GO:0032100; GO:0047117; GO:0047451; GO:0102131; GO:0102132	"cell [GO:0005623]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; single-stranded DNA binding [GO:0003697]; fatty acid biosynthetic process [GO:0006633]; lactate metabolic process [GO:0006089]; positive regulation of appetite [GO:0032100]"
PGEN_.00g045770	Scaffold_02	35634861	35637649	O43761	SNG3_HUMAN	Synaptogyrin-3	GO:0001504; GO:0008021; GO:0016021; GO:0021762; GO:0030054; GO:0030672; GO:0031594; GO:0032411; GO:0042169; GO:0045055; GO:0047485	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; protein N-terminus binding [GO:0047485]; SH2 domain binding [GO:0042169]; neurotransmitter uptake [GO:0001504]; positive regulation of transporter activity [GO:0032411]; regulated exocytosis [GO:0045055]; substantia nigra development [GO:0021762]
PGEN_.00g045780	Scaffold_02	35671822	35681045	Q80YR4	ZN598_MOUSE	E3 ubiquitin-protein ligase ZNF598 (EC 2.3.2.27) (Zinc finger protein 598)	GO:0003676; GO:0006513; GO:0016567; GO:0043022; GO:0046872; GO:0061630; GO:0072344	metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]
PGEN_.00g045790	Scaffold_02	35683991	35686876	NA	NA	NA	NA	NA
PGEN_.00g045800	Scaffold_02	35694317	35694730	NA	NA	NA	NA	NA
PGEN_.00g045810	Scaffold_02	35699988	35719717	Q13507	TRPC3_HUMAN	Short transient receptor potential channel 3 (TrpC3) (Transient receptor protein 3) (TRP-3) (hTrp-3) (hTrp3)	GO:0005262; GO:0005623; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007338; GO:0007602; GO:0010524; GO:0015279; GO:0030168; GO:0033198; GO:0034703; GO:0051480; GO:0051592; GO:0070588; GO:0070679; GO:1903244	"cation channel complex [GO:0034703]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; platelet activation [GO:0030168]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]"
PGEN_.00g045820	Scaffold_02	35726887	35728865	NA	NA	NA	NA	NA
PGEN_.00g045830	Scaffold_02	35746886	35747781	NA	NA	NA	NA	NA
PGEN_.00g045840	Scaffold_02	35847362	35875262	Q9XZV3	GNAO_GEOCY	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g045850	Scaffold_02	35968575	35977721	Q9R088	KITM_MOUSE	"Thymidine kinase 2, mitochondrial (EC 2.7.1.21) (Mt-TK)"	GO:0004137; GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0006264; GO:0009262; GO:0019136; GO:0032042; GO:0046092; GO:0046104; GO:0071897	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; deoxynucleoside kinase activity [GO:0019136]; thymidine kinase activity [GO:0004797]; deoxycytidine metabolic process [GO:0046092]; deoxyribonucleotide metabolic process [GO:0009262]; DNA biosynthetic process [GO:0071897]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA replication [GO:0006264]; thymidine metabolic process [GO:0046104]
PGEN_.00g045860	Scaffold_02	35985527	36039563	Q8CIS0	CAR11_MOUSE	Caspase recruitment domain-containing protein 11	GO:0001772; GO:0001819; GO:0002377; GO:0005737; GO:0005886; GO:0007165; GO:0007249; GO:0030183; GO:0030890; GO:0031295; GO:0032449; GO:0038202; GO:0042100; GO:0042102; GO:0042110; GO:0042981; GO:0043123; GO:0045061; GO:0045086; GO:0045121; GO:0045577; GO:0045580; GO:0046649; GO:0048872; GO:0050700; GO:0050776; GO:0050870; GO:0051092; GO:0070970	CBM complex [GO:0032449]; cytoplasm [GO:0005737]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; CARD domain binding [GO:0050700]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; homeostasis of number of cells [GO:0048872]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin production [GO:0002377]; interleukin-2 secretion [GO:0070970]; lymphocyte activation [GO:0046649]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of immune response [GO:0050776]; regulation of T cell differentiation [GO:0045580]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; thymic T cell selection [GO:0045061]; TORC1 signaling [GO:0038202]
PGEN_.00g045870	Scaffold_02	36058289	36064599	Q9CXL3	CG050_MOUSE	Uncharacterized protein C7orf50 homolog		
PGEN_.00g045880	Scaffold_02	36083531	36090789	Q7A5L8	TDCB_STAAN	L-threonine dehydratase catabolic TdcB (EC 4.3.1.19) (Threonine deaminase)	GO:0000166; GO:0004794; GO:0030170; GO:0070689	L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; L-threonine catabolic process to propionate [GO:0070689]
PGEN_.00g045890	Scaffold_02	36096994	36112628	NA	NA	NA	NA	NA
PGEN_.00g045900	Scaffold_02	36124825	36127634	NA	NA	NA	NA	NA
PGEN_.00g045910	Scaffold_02	36230226	36231380	P12391	ACHB3_RAT	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0016020; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g045920	Scaffold_02	36247755	36251635	NA	NA	NA	NA	NA
PGEN_.00g045930	Scaffold_02	36264017	36264256	NA	NA	NA	NA	NA
PGEN_.00g045940	Scaffold_02	36266405	36267364	NA	NA	NA	NA	NA
PGEN_.00g045950	Scaffold_02	36274377	36274829	NA	NA	NA	NA	NA
PGEN_.00g045960	Scaffold_02	36278083	36280704	P12391	ACHB3_RAT	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0016020; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g045970	Scaffold_02	36293280	36294623	NA	NA	NA	NA	NA
PGEN_.00g045980	Scaffold_02	36302145	36308700	NA	NA	NA	NA	NA
PGEN_.00g045990	Scaffold_02	36356429	36356830	NA	NA	NA	NA	NA
PGEN_.00g046000	Scaffold_02	36356898	36357614	NA	NA	NA	NA	NA
PGEN_.00g046010	Scaffold_02	36363631	36371254	NA	NA	NA	NA	NA
PGEN_.00g046020	Scaffold_02	36380595	36390572	P86729	EPDR2_HALAI	Ependymin-related protein 2	GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g046030	Scaffold_02	36447992	36457445	NA	NA	NA	NA	NA
PGEN_.00g046040	Scaffold_02	36466212	36475913	B8D0W1	ALR_HALOH	Alanine racemase (EC 5.1.1.1)	GO:0008784; GO:0030170; GO:0030632	alanine racemase activity [GO:0008784]; pyridoxal phosphate binding [GO:0030170]; D-alanine biosynthetic process [GO:0030632]
PGEN_.00g046050	Scaffold_02	36480390	36485969	NA	NA	NA	NA	NA
PGEN_.00g046060	Scaffold_02	36489104	36503048	NA	NA	NA	NA	NA
PGEN_.00g046070	Scaffold_02	36515380	36540295	O95170	CDRT1_HUMAN	CMT1A duplicated region transcript 1 protein		
PGEN_.00g046080	Scaffold_02	36579524	36587576	Q5SUS0	FBW10_MOUSE	F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10)		
PGEN_.00g046090	Scaffold_02	36591958	36599876	NA	NA	NA	NA	NA
PGEN_.00g046100	Scaffold_02	36721426	36727925	NA	NA	NA	NA	NA
PGEN_.00g046110	Scaffold_02	36742333	36750296	G4WMX4	RYAR_TRICA	RYamide receptor	GO:0004983; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]
PGEN_.00g046120	Scaffold_02	36757029	36758338	NA	NA	NA	NA	NA
PGEN_.00g046130	Scaffold_02	36857422	36858356	NA	NA	NA	NA	NA
PGEN_.00g046140	Scaffold_02	36861767	36889447	Q8BZ36	RINT1_MOUSE	RAD50-interacting protein 1 (RAD50 interactor 1) (RINT-1)	GO:0005783; GO:0005789; GO:0006890; GO:0007049; GO:0015031; GO:0060628; GO:0070939; GO:1902504	"Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; cell cycle [GO:0007049]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g046150	Scaffold_02	36895001	36900291	NA	NA	NA	NA	NA
PGEN_.00g046160	Scaffold_02	36908337	36908543	NA	NA	NA	NA	NA
PGEN_.00g046170	Scaffold_02	36910200	36912021	NA	NA	NA	NA	NA
PGEN_.00g046180	Scaffold_02	36912210	36912521	NA	NA	NA	NA	NA
PGEN_.00g046190	Scaffold_02	36913475	36924894	Q9NYT6	ZN226_HUMAN	Zinc finger protein 226	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g046200	Scaffold_02	36930584	36948567	NA	NA	NA	NA	NA
PGEN_.00g046210	Scaffold_02	36945595	36946080	NA	NA	NA	NA	NA
PGEN_.00g046220	Scaffold_02	36967796	36992472	Q8QGX4	PRKDC_CHICK	DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1)	GO:0000723; GO:0000724; GO:0003677; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0006974; GO:0008630; GO:0033152; GO:0070419; GO:0072431	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]; telomere maintenance [GO:0000723]
PGEN_.00g046230	Scaffold_02	37033992	37081692	Q8QGX4	PRKDC_CHICK	DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1)	GO:0000723; GO:0000724; GO:0003677; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0006974; GO:0008630; GO:0033152; GO:0070419; GO:0072431	nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]; telomere maintenance [GO:0000723]
PGEN_.00g046240	Scaffold_02	37081876	37091807	P07992	ERCC1_HUMAN	DNA excision repair protein ERCC-1	GO:0000014; GO:0000109; GO:0000110; GO:0000710; GO:0000720; GO:0000784; GO:0001094; GO:0001302; GO:0003684; GO:0003697; GO:0005654; GO:0005737; GO:0006281; GO:0006283; GO:0006289; GO:0006293; GO:0006295; GO:0006296; GO:0006303; GO:0006310; GO:0006312; GO:0006949; GO:0006979; GO:0007283; GO:0007584; GO:0008022; GO:0008283; GO:0008584; GO:0009650; GO:0009744; GO:0010165; GO:0010259; GO:0019904; GO:0032205; GO:0033683; GO:0035166; GO:0035264; GO:0035902; GO:0036297; GO:0045190; GO:0046686; GO:0048477; GO:0048568; GO:0060261; GO:0061819; GO:0070522; GO:0070911; GO:0070914; GO:0090656; GO:1904431; GO:1905765; GO:1990841	"cytoplasm [GO:0005737]; ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]; cell population proliferation [GO:0008283]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative cell aging [GO:0001302]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]"
PGEN_.00g046250	Scaffold_02	37102456	37103226	NA	NA	NA	NA	NA
PGEN_.00g046260	Scaffold_02	37103491	37105197	NA	NA	NA	NA	NA
PGEN_.00g046270	Scaffold_02	37118056	37122446	NA	NA	NA	NA	NA
PGEN_.00g046280	Scaffold_02	37171163	37173649	NA	NA	NA	NA	NA
PGEN_.00g046290	Scaffold_02	37177584	37179077	P17666	CP2CE_RABIT	Cytochrome P450 2C14 (EC 1.14.14.1) (CYPIIC14) (Cytochrome P450 PHP3)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g046300	Scaffold_02	37199633	37203247	NA	NA	NA	NA	NA
PGEN_.00g046310	Scaffold_02	37204053	37208359	NA	NA	NA	NA	NA
PGEN_.00g046320	Scaffold_02	37211498	37211836	NA	NA	NA	NA	NA
PGEN_.00g046330	Scaffold_02	37250567	37310319	Q6P5U7	NWD2_MOUSE	NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)		
PGEN_.00g046340	Scaffold_02	37320769	37321062	NA	NA	NA	NA	NA
PGEN_.00g046350	Scaffold_02	37321314	37321655	NA	NA	NA	NA	NA
PGEN_.00g046360	Scaffold_02	37325215	37348539	Q6INU8	TT30A_XENLA	Tetratricopeptide repeat protein 30A (TPR repeat protein 30A)	GO:0005879; GO:0005929; GO:0018095; GO:0042073	axonemal microtubule [GO:0005879]; cilium [GO:0005929]; intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095]
PGEN_.00g046370	Scaffold_02	37358552	37360384	Q9C040	TRIM2_HUMAN	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g046380	Scaffold_02	37369152	37369412	NA	NA	NA	NA	NA
PGEN_.00g046390	Scaffold_02	37381185	37387063	P63000	RAC1_HUMAN	Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	GO:0000139; GO:0001764; GO:0001934; GO:0002551; GO:0003924; GO:0005525; GO:0005737; GO:0005789; GO:0005802; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006954; GO:0007015; GO:0007155; GO:0007160; GO:0007163; GO:0007266; GO:0007596; GO:0008045; GO:0008283; GO:0008360; GO:0008361; GO:0009611; GO:0009653; GO:0010310; GO:0010591; GO:0010592; GO:0010811; GO:0016020; GO:0016601; GO:0017137; GO:0019899; GO:0019901; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030667; GO:0031116; GO:0031295; GO:0031529; GO:0031996; GO:0032587; GO:0032707; GO:0032956; GO:0034446; GO:0035025; GO:0035556; GO:0035774; GO:0036464; GO:0038095; GO:0038096; GO:0042470; GO:0042826; GO:0042995; GO:0043197; GO:0043312; GO:0043652; GO:0044877; GO:0045428; GO:0045453; GO:0045740; GO:0048010; GO:0048012; GO:0048013; GO:0048261; GO:0048870; GO:0050690; GO:0051022; GO:0051056; GO:0051117; GO:0051492; GO:0051496; GO:0051668; GO:0051894; GO:0051897; GO:0055038; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0090023; GO:0097178; GO:0098794; GO:0098978; GO:0101003; GO:1900026; GO:1902622	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure morphogenesis [GO:0009653]; blood coagulation [GO:0007596]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; engulfment of apoptotic cell [GO:0043652]; ephrin receptor signaling pathway [GO:0048013]; establishment or maintenance of cell polarity [GO:0007163]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; negative regulation of receptor-mediated endocytosis [GO:0048261]; neuron migration [GO:0001764]; neutrophil degranulation [GO:0043312]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of defense response to virus by virus [GO:0050690]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of lamellipodium assembly [GO:0010591]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of stress fiber assembly [GO:0051492]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; ruffle organization [GO:0031529]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g046400	Scaffold_02	37401034	37409606	P62263	RS14_HUMAN	40S ribosomal protein S14 (Small ribosomal subunit protein uS11)	GO:0000028; GO:0000122; GO:0000184; GO:0000462; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0014069; GO:0016020; GO:0019083; GO:0022627; GO:0030218; GO:0030490; GO:0045182; GO:0048027; GO:0070062; GO:0070181	"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
PGEN_.00g046410	Scaffold_02	37425710	37446701	A7E305	ZSWM8_BOVIN	Zinc finger SWIM domain-containing protein 8	GO:0008270; GO:0031462; GO:1902667	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]
PGEN_.00g046420	Scaffold_02	37468737	37473877	Q96S16	JMJD8_HUMAN	JmjC domain-containing protein 8 (Jumonji domain-containing protein 8)	GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006110; GO:0043123; GO:1903302; GO:1903672	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302]
PGEN_.00g046430	Scaffold_02	37474552	37494568	Q6PCF9	S38AA_XENLA	Putative sodium-coupled neutral amino acid transporter 10 (Solute carrier family 38 member 10)	GO:0006814; GO:0006865; GO:0016021	integral component of membrane [GO:0016021]; amino acid transport [GO:0006865]; sodium ion transport [GO:0006814]
PGEN_.00g046440	Scaffold_02	37508187	37511779	NA	NA	NA	NA	NA
PGEN_.00g046450	Scaffold_02	37513734	37515101	NA	NA	NA	NA	NA
PGEN_.00g046460	Scaffold_02	37542612	37626764	Q99PF4	CAD23_MOUSE	Cadherin-23 (Otocadherin)	GO:0000902; GO:0001917; GO:0005509; GO:0005623; GO:0005813; GO:0005886; GO:0005913; GO:0006816; GO:0007043; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008092; GO:0009986; GO:0016021; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0034332; GO:0042472; GO:0042491; GO:0042803; GO:0044331; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0047485; GO:0048563; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0098609; GO:0098683; GO:0098684	apical part of cell [GO:0045177]; catenin complex [GO:0016342]; cell [GO:0005623]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; integral component of membrane [GO:0016021]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; adherens junction organization [GO:0034332]; auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]
PGEN_.00g046470	Scaffold_02	37632520	37637012	O14718	OPSX_HUMAN	Visual pigment-like receptor peropsin	GO:0001750; GO:0004930; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0018298; GO:0071482	integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g046480	Scaffold_02	37649229	37649510	NA	NA	NA	NA	NA
PGEN_.00g046490	Scaffold_02	37682137	37686082	NA	NA	NA	NA	NA
PGEN_.00g046500	Scaffold_02	37688345	37698145	Q969T9	WBP2_HUMAN	WW domain-binding protein 2 (WBP-2)	GO:0000790; GO:0000978; GO:0003713; GO:0005634; GO:0005737; GO:0030331; GO:0031490; GO:0032570; GO:0033148; GO:0043627; GO:0045184; GO:0045815; GO:0045944; GO:0050847; GO:0071391; GO:0071442	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]"
PGEN_.00g046510	Scaffold_02	37710158	37728518	NA	NA	NA	NA	NA
PGEN_.00g046520	Scaffold_02	37731260	37731961	NA	NA	NA	NA	NA
PGEN_.00g046530	Scaffold_02	37747990	37759290	Q3UHK8	TNR6A_MOUSE	Trinucleotide repeat-containing gene 6A protein	GO:0000932; GO:0003723; GO:0005623; GO:0005654; GO:0005794; GO:0009267; GO:0016442; GO:0031047; GO:0032507; GO:0035195; GO:0035278; GO:0043231; GO:0048471; GO:0060090; GO:0060213; GO:1900153	"cell [GO:0005623]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; cellular response to starvation [GO:0009267]; gene silencing by miRNA [GO:0035195]; gene silencing by RNA [GO:0031047]; maintenance of protein location in cell [GO:0032507]; miRNA mediated inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"
PGEN_.00g046540	Scaffold_02	37759316	37773307	NA	NA	NA	NA	NA
PGEN_.00g046550	Scaffold_02	37824117	37832016	Q9EP80	PICK1_RAT	PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein)	GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005484; GO:0005543; GO:0005737; GO:0005739; GO:0005794; GO:0005856; GO:0005886; GO:0006468; GO:0006605; GO:0006886; GO:0007205; GO:0008021; GO:0008022; GO:0008092; GO:0010629; GO:0014069; GO:0015844; GO:0015872; GO:0019899; GO:0019904; GO:0021782; GO:0030054; GO:0030425; GO:0030971; GO:0032588; GO:0032991; GO:0034316; GO:0035255; GO:0035256; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043113; GO:0045202; GO:0046872; GO:0046875; GO:0048471; GO:0051015; GO:0051020; GO:0060292; GO:0060548; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0098843; GO:0098978; GO:0099149	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; postsynaptic endocytic zone [GO:0098843]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; G protein-coupled glutamate receptor binding [GO:0035256]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; SNAP receptor activity [GO:0005484]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; dopamine transport [GO:0015872]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; receptor clustering [GO:0043113]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]
PGEN_.00g046560	Scaffold_02	37835960	37844595	Q86KD0	Y7416_DICDI	BolA-like protein DDB_G0274169	GO:0005739; GO:0006351	"mitochondrion [GO:0005739]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g046570	Scaffold_02	37846714	37866726	Q6P1R4	DUS1L_HUMAN	tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 1-like)	GO:0017150; GO:0050660	flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]
PGEN_.00g046580	Scaffold_02	37873672	37938635	Q9HBG4	VPP4_HUMAN	V-type proton ATPase 116 kDa subunit a isoform 4 (V-ATPase 116 kDa isoform a4) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4) (Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoform)	GO:0000220; GO:0001503; GO:0005623; GO:0005765; GO:0005768; GO:0005886; GO:0006885; GO:0007035; GO:0007588; GO:0007605; GO:0008286; GO:0010008; GO:0016021; GO:0016324; GO:0016471; GO:0030670; GO:0031526; GO:0033572; GO:0034220; GO:0045177; GO:0046961; GO:0051117; GO:0070062; GO:0090383; GO:1902600	"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell [GO:0005623]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; excretion [GO:0007588]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; ossification [GO:0001503]; phagosome acidification [GO:0090383]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; sensory perception of sound [GO:0007605]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]"
PGEN_.00g046590	Scaffold_02	37965135	37984259	Q99LD4	CSN1_MOUSE	COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1)	GO:0000338; GO:0005654; GO:0005829; GO:0008180	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338]
PGEN_.00g046600	Scaffold_02	37984508	37984783	NA	NA	NA	NA	NA
PGEN_.00g046610	Scaffold_02	37993231	37995224	NA	NA	NA	NA	NA
PGEN_.00g046620	Scaffold_02	37997674	37998273	NA	NA	NA	NA	NA
PGEN_.00g046630	Scaffold_02	38004759	38006072	A0KDV2	RHMD_BURCH	L-rhamnonate dehydratase (RhamD) (EC 4.2.1.90)	GO:0000287; GO:0009063; GO:0050032	L-rhamnonate dehydratase activity [GO:0050032]; magnesium ion binding [GO:0000287]; cellular amino acid catabolic process [GO:0009063]
PGEN_.00g046640	Scaffold_02	38018559	38019011	NA	NA	NA	NA	NA
PGEN_.00g046650	Scaffold_02	38041003	38050015	P22444	BMP3_BOVIN	Bone morphogenetic protein 3 (BMP-3) (Osteogenin)	GO:0001649; GO:0005125; GO:0005160; GO:0005615; GO:0008083; GO:0010862; GO:0030509; GO:0042981; GO:0043408; GO:0048468; GO:0051216; GO:0060395; GO:0070700	extracellular space [GO:0005615]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cell development [GO:0048468]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; SMAD protein signal transduction [GO:0060395]
PGEN_.00g046660	Scaffold_02	38065711	38083657	Q9CQA6	CHCH1_MOUSE	"Coiled-coil-helix-coiled-coil-helix domain-containing protein 1 (28S ribosomal protein S37, mitochondrial) (MRP-S37)"	GO:0001650; GO:0005654; GO:0005739; GO:0005761; GO:0005829; GO:0032543	cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; mitochondrial translation [GO:0032543]
PGEN_.00g046670	Scaffold_02	38090158	38114312	Q3UIK4	MET14_MOUSE	N6-adenosine-methyltransferase non-catalytic subunit (Methyltransferase-like protein 14)	GO:0000398; GO:0001510; GO:0003729; GO:0005634; GO:0005654; GO:0006402; GO:0007283; GO:0016422; GO:0019827; GO:0021861; GO:0036396; GO:0042063; GO:0061157; GO:0080009	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"
PGEN_.00g046680	Scaffold_02	38114954	38130738	P23004	QCR2_BOVIN	"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)"	GO:0004222; GO:0005739; GO:0005743; GO:0006627; GO:0017087; GO:0046872; GO:0055114; GO:0070469	mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; oxidation-reduction process [GO:0055114]; protein processing involved in protein targeting to mitochondrion [GO:0006627]
PGEN_.00g046690	Scaffold_02	38139317	38142000	NA	NA	NA	NA	NA
PGEN_.00g046700	Scaffold_02	38156539	38164416	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g046710	Scaffold_02	38179605	38199311	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g046720	Scaffold_02	38207577	38238113	NA	NA	NA	NA	NA
PGEN_.00g046730	Scaffold_02	38248844	38279774	Q9Y272	RASD1_HUMAN	Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1)	GO:0003924; GO:0005525; GO:0005634; GO:0005886; GO:0007165; GO:0007186; GO:0007263; GO:0016529; GO:0045892; GO:0048471	"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165]"
PGEN_.00g046740	Scaffold_02	38388308	38389742	NA	NA	NA	NA	NA
PGEN_.00g046750	Scaffold_02	38392785	38393156	NA	NA	NA	NA	NA
PGEN_.00g046760	Scaffold_02	38414735	38415037	NA	NA	NA	NA	NA
PGEN_.00g046770	Scaffold_02	38438457	38439359	Q9IR51	MREP_MDV1	Master replication protein (M-Rep) (EC 2.7.7.-) (EC 3.1.21.-) (EC 3.6.1.3)	GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0006260; GO:0016779; GO:0016888; GO:0018142; GO:0042025; GO:0046872	"host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA replication [GO:0006260]; protein-DNA covalent cross-linking [GO:0018142]"
PGEN_.00g046780	Scaffold_02	38439374	38439919	NA	NA	NA	NA	NA
PGEN_.00g046790	Scaffold_02	38477197	38492185	Q55G11	NCSEB_DICDI	Neutral ceramidase B (N-CDase B) (NCDase B) (EC 3.5.1.23) (Acylsphingosine deacylase 2B) (N-acylsphingosine amidohydrolase 2B)	GO:0005576; GO:0006672; GO:0017040; GO:0042759; GO:0046512; GO:0046514; GO:0102121	extracellular region [GO:0005576]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512]
PGEN_.00g046800	Scaffold_02	38522022	38525535	NA	NA	NA	NA	NA
PGEN_.00g046810	Scaffold_02	38526844	38537198	NA	NA	NA	NA	NA
PGEN_.00g046820	Scaffold_02	38537766	38538053	NA	NA	NA	NA	NA
PGEN_.00g046830	Scaffold_02	38538108	38538488	NA	NA	NA	NA	NA
PGEN_.00g046840	Scaffold_02	38538550	38539020	NA	NA	NA	NA	NA
PGEN_.00g046850	Scaffold_02	38539870	38555222	P04813	CTR2_CANLF	Chymotrypsinogen 2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin 2 chain A; Chymotrypsin 2 chain B; Chymotrypsin 2 chain C]	GO:0004252; GO:0005615; GO:0007586	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]
PGEN_.00g046860	Scaffold_02	38558519	38570916	NA	NA	NA	NA	NA
PGEN_.00g046870	Scaffold_02	38572633	38575175	NA	NA	NA	NA	NA
PGEN_.00g046880	Scaffold_02	38578445	38579558	NA	NA	NA	NA	NA
PGEN_.00g046890	Scaffold_02	38581517	38581837	NA	NA	NA	NA	NA
PGEN_.00g046900	Scaffold_02	38583456	38585630	NA	NA	NA	NA	NA
PGEN_.00g046910	Scaffold_02	38587886	38590508	NA	NA	NA	NA	NA
PGEN_.00g046920	Scaffold_02	38596073	38598285	NA	NA	NA	NA	NA
PGEN_.00g046930	Scaffold_02	38628287	38629898	NA	NA	NA	NA	NA
PGEN_.00g046940	Scaffold_02	38634037	38634279	NA	NA	NA	NA	NA
PGEN_.00g046950	Scaffold_02	38714534	38727742	Q8VHW8	CCG5_RAT	Voltage-dependent calcium channel gamma-5 subunit (Neuronal voltage-gated calcium channel gamma-5 subunit) (Transmembrane AMPAR regulatory protein gamma-5) (TARP gamma-5)	GO:0005244; GO:0005262; GO:0014069; GO:0030054; GO:0032281; GO:0098839; GO:0098962; GO:0098978; GO:0099055; GO:2000311	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; calcium channel activity [GO:0005262]; voltage-gated ion channel activity [GO:0005244]; regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]
PGEN_.00g046960	Scaffold_02	38734077	38737297	Q8NBH2	KY_HUMAN	Kyphoscoliosis peptidase (EC 3.4.-.-)	GO:0005856; GO:0008233; GO:0030018	cytoskeleton [GO:0005856]; Z disc [GO:0030018]; peptidase activity [GO:0008233]
PGEN_.00g046970	Scaffold_02	38758175	38775058	Q8C8H8	KY_MOUSE	Kyphoscoliosis peptidase (EC 3.4.-.-)	GO:0005856; GO:0007517; GO:0007528; GO:0008233; GO:0030018	cytoskeleton [GO:0005856]; Z disc [GO:0030018]; peptidase activity [GO:0008233]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]
PGEN_.00g046980	Scaffold_02	38781335	38782040	NA	NA	NA	NA	NA
PGEN_.00g046990	Scaffold_02	38782065	38782598	NA	NA	NA	NA	NA
PGEN_.00g047000	Scaffold_02	38782637	38783221	NA	NA	NA	NA	NA
PGEN_.00g047010	Scaffold_02	38783302	38783733	NA	NA	NA	NA	NA
PGEN_.00g047020	Scaffold_02	38783760	38784176	NA	NA	NA	NA	NA
PGEN_.00g047030	Scaffold_02	38784226	38784840	NA	NA	NA	NA	NA
PGEN_.00g047040	Scaffold_02	38824858	38830618	NA	NA	NA	NA	NA
PGEN_.00g047050	Scaffold_02	38846115	38854132	NA	NA	NA	NA	NA
PGEN_.00g047060	Scaffold_02	38857852	38909616	A1L253	F149B_DANRE	Protein FAM149B1		
PGEN_.00g047070	Scaffold_02	38920755	38950321	Q5PQR3	BTBD9_RAT	BTB/POZ domain-containing protein 9	GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050951; GO:0060586; GO:1900242	"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]"
PGEN_.00g047080	Scaffold_02	38959072	38969166	NA	NA	NA	NA	NA
PGEN_.00g047090	Scaffold_02	38970094	38972349	NA	NA	NA	NA	NA
PGEN_.00g047100	Scaffold_02	38979995	38980309	NA	NA	NA	NA	NA
PGEN_.00g047110	Scaffold_02	38980533	38982122	P48236	GPC1_YEAST	Glycerophosphocholine acyltransferase 1 (GPCAT) (EC 2.3.1.-)	GO:0005783; GO:0006656; GO:0016021; GO:0071944; GO:0106158	cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; glycero-3-phosphocholine acyltransferase activity [GO:0106158]; phosphatidylcholine biosynthetic process [GO:0006656]
PGEN_.00g047120	Scaffold_02	38980612	38983540	NA	NA	NA	NA	NA
PGEN_.00g047130	Scaffold_02	38995789	38999199	P0C920	CJ053_BOVIN	UPF0728 protein C10orf53 homolog		
PGEN_.00g047140	Scaffold_02	39013337	39036393	D3YZG8	MTD2L_MOUSE	Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2 (NADP-dependent methylenetetrahydrofolate dehydrogenase 2-like protein) (MTHFD2-like) [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]	GO:0000105; GO:0004477; GO:0004487; GO:0004488; GO:0005743; GO:0005759; GO:0006164; GO:0009086; GO:0009256; GO:0035999	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; 10-formyltetrahydrofolate metabolic process [GO:0009256]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]
PGEN_.00g047150	Scaffold_02	39066192	39087411	Q7L099	RUFY3_HUMAN	Protein RUFY3 (RUN and FYVE domain-containing protein 3) (Rap2-interacting protein x) (RIPx) (Single axon-regulated protein) (Singar)	GO:0005737; GO:0005829; GO:0007015; GO:0012505; GO:0016020; GO:0030027; GO:0030054; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0043025; GO:0043204; GO:0045773; GO:0050770; GO:0050771; GO:0071437; GO:0090316; GO:2000114	axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; growth cone [GO:0030426]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; actin filament organization [GO:0007015]; negative regulation of axonogenesis [GO:0050771]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; regulation of axonogenesis [GO:0050770]; regulation of establishment of cell polarity [GO:2000114]
PGEN_.00g047160	Scaffold_02	39098032	39100887	A0A0A7DNP6	GRHLP_RUDPH	Prepro-gonadotropin-releasing hormone-like protein (rp-GnRH) [Cleaved into: GnRH dodecapeptide; GnRH-associated peptide (GAP)]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g047170	Scaffold_02	39120934	39134899	Q5R5R4	RUFY2_PONAB	RUN and FYVE domain-containing protein 2	GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]
PGEN_.00g047180	Scaffold_02	39153554	39163985	C0HKA4	Y0031_DROME	Trypsin delta/gamma-like protein CG30031 (EC 3.4.21.4)	GO:0004252; GO:0005615; GO:0006508	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]
PGEN_.00g047190	Scaffold_02	39167608	39180242	Q8VHJ4	TM11D_RAT	Transmembrane protease serine 11D (EC 3.4.21.-) (Adrenal secretory serine protease) (AsP) (Airway trypsin-like protease) (AT) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain]	GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0008236; GO:0009986; GO:0040008	cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]; regulation of growth [GO:0040008]
PGEN_.00g047200	Scaffold_02	39182554	39212577	P54625	TRYB_DROER	Trypsin beta (EC 3.4.21.4)	GO:0004252; GO:0005615	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g047210	Scaffold_02	39222229	39231342	NA	NA	NA	NA	NA
PGEN_.00g047220	Scaffold_02	39235463	39240948	O94581	COX12_SCHPO	Cytochrome c oxidase subunit 6B (Cytochrome c oxidase polypeptide VIb)	GO:0005751; GO:0033617	mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrial respiratory chain complex IV assembly [GO:0033617]
PGEN_.00g047230	Scaffold_02	39267034	39343898	A7XY94	NMDE2_XENLA	"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B)"	GO:0004972; GO:0005887; GO:0010043; GO:0017146; GO:0030054; GO:0032026; GO:0045211; GO:0046872; GO:0051290	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic membrane [GO:0045211]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; protein heterotetramerization [GO:0051290]; response to magnesium ion [GO:0032026]; response to zinc ion [GO:0010043]
PGEN_.00g047240	Scaffold_02	39474871	39475512	NA	NA	NA	NA	NA
PGEN_.00g047250	Scaffold_02	39578038	39580680	NA	NA	NA	NA	NA
PGEN_.00g047260	Scaffold_02	39598485	39598958	NA	NA	NA	NA	NA
PGEN_.00g047270	Scaffold_02	39673208	39689072	A4FUW8	TXD11_BOVIN	Thioredoxin domain-containing protein 11	GO:0005623; GO:0005789; GO:0016021; GO:0045454	cell [GO:0005623]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cell redox homeostasis [GO:0045454]
PGEN_.00g047280	Scaffold_02	39689284	39696329	Q5PPK1	BRI3_RAT	Brain protein I3	GO:0005765; GO:0016021; GO:0042802	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; identical protein binding [GO:0042802]
PGEN_.00g047290	Scaffold_02	39703579	39715954	Q71R50	DHR11_CHICK	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703; GO:0072555; GO:0072582	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]
PGEN_.00g047300	Scaffold_02	39718709	39724218	A7SE07	NUBP2_NEMVE	Cytosolic Fe-S cluster assembly factor NUBP2 homolog	GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"
PGEN_.00g047310	Scaffold_02	39729919	39755509	F5H4B4	F227A_HUMAN	Protein FAM227A		
PGEN_.00g047320	Scaffold_02	39758276	39782636	Q62288	TICN1_MOUSE	Testican-1 (Protein SPOCK)	GO:0001764; GO:0004869; GO:0005509; GO:0005518; GO:0005615; GO:0005737; GO:0008191; GO:0010812; GO:0010951; GO:0010977; GO:0016528; GO:0021953; GO:0022008; GO:0031594; GO:0033268; GO:0050840	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; sarcoplasm [GO:0016528]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; extracellular matrix binding [GO:0050840]; metalloendopeptidase inhibitor activity [GO:0008191]; central nervous system neuron differentiation [GO:0021953]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of neuron projection development [GO:0010977]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]
PGEN_.00g047330	Scaffold_02	39788721	39835394	P40792	RAC1_DROME	Ras-related protein Rac1	GO:0000902; GO:0001726; GO:0001954; GO:0002433; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007254; GO:0007266; GO:0007298; GO:0007390; GO:0007391; GO:0007394; GO:0007395; GO:0007411; GO:0007413; GO:0007419; GO:0007422; GO:0007424; GO:0007426; GO:0007435; GO:0007516; GO:0007520; GO:0007613; GO:0008045; GO:0008078; GO:0008258; GO:0008283; GO:0008347; GO:0008360; GO:0009611; GO:0010593; GO:0016028; GO:0016199; GO:0016203; GO:0016358; GO:0019897; GO:0019901; GO:0030032; GO:0030036; GO:0030707; GO:0030866; GO:0031175; GO:0031532; GO:0032147; GO:0032794; GO:0032956; GO:0034334; GO:0035010; GO:0035011; GO:0035099; GO:0035212; GO:0035320; GO:0042052; GO:0042995; GO:0043652; GO:0045773; GO:0046330; GO:0046664; GO:0046843; GO:0048010; GO:0048615; GO:0048675; GO:0048747; GO:0048812; GO:0048813; GO:0048814; GO:0050770; GO:0050807; GO:0050975; GO:0051017; GO:0051450; GO:0051491; GO:0051963; GO:0071902; GO:0071907; GO:0090303; GO:0097206; GO:1902669; GO:1903688; GO:1904059	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; ruffle [GO:0001726]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; adherens junction maintenance [GO:0034334]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal fasciculation [GO:0007413]; border follicle cell migration [GO:0007298]; cell competition in a multicellular organism [GO:0035212]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cortical actin cytoskeleton organization [GO:0030866]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; encapsulation of foreign target [GO:0035010]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; germ-band shortening [GO:0007390]; glial cell migration [GO:0008347]; head involution [GO:0008258]; hemocyte development [GO:0007516]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair site selection [GO:0035320]; immune response-regulating cell surface receptor signaling pathway involved in phagocytosis [GO:0002433]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; mesodermal cell migration [GO:0008078]; motor neuron axon guidance [GO:0008045]; muscle attachment [GO:0016203]; muscle fiber development [GO:0048747]; myoblast fusion [GO:0007520]; myoblast proliferation [GO:0051450]; negative regulation of lamellipodium assembly [GO:0010593]; nephrocyte filtration [GO:0097206]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; peripheral nervous system development [GO:0007422]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of locomotor rhythm [GO:1904059]; regulation of synapse assembly [GO:0051963]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; rhabdomere development [GO:0042052]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; sensory perception of touch [GO:0050975]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; ventral cord development [GO:0007419]"
PGEN_.00g047340	Scaffold_02	39841305	39876840	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g047350	Scaffold_02	39876967	39877323	NA	NA	NA	NA	NA
PGEN_.00g047360	Scaffold_02	39877402	39877632	NA	NA	NA	NA	NA
PGEN_.00g047370	Scaffold_02	39886101	39916155	Q01177	PLMN_RAT	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004175; GO:0004252; GO:0005102; GO:0005615; GO:0005623; GO:0005886; GO:0006508; GO:0007596; GO:0009986; GO:0010812; GO:0019897; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0031232; GO:0034185; GO:0042246; GO:0042730; GO:0043231; GO:0043536; GO:0044218; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051603; GO:0051702; GO:0051918; GO:0051919; GO:0052213; GO:0060707; GO:0060716; GO:0071674; GO:0098685; GO:0098978; GO:0099183; GO:1904854; GO:1990405	"cell [GO:0005623]; cell surface [GO:0009986]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; other organism cell membrane [GO:0044218]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; proteasome core complex binding [GO:1904854]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; interaction with symbiont [GO:0051702]; interaction with symbiont via secreted substance [GO:0052213]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]"
PGEN_.00g047380	Scaffold_02	39923234	39929476	Q99496	RING2_HUMAN	E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (Huntingtin-interacting protein 2-interacting protein 3) (HIP2-interacting protein 3) (Protein DinG) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING finger protein BAP-1) (RING-type E3 ubiquitin transferase RING2)	GO:0000122; GO:0000151; GO:0000278; GO:0000791; GO:0001702; GO:0001739; GO:0003682; GO:0005634; GO:0005654; GO:0007281; GO:0008270; GO:0009948; GO:0010467; GO:0016604; GO:0031519; GO:0035102; GO:0035518; GO:0036353; GO:0043433; GO:0061630; GO:0070317; GO:0071339; GO:0071535	euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; anterior/posterior axis specification [GO:0009948]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g047390	Scaffold_02	39963478	40000168	Q9D5U8	CNBD2_MOUSE	Cyclic nucleotide-binding domain-containing protein 2 (Cyclic nucleotide receptor involved in sperm function)	GO:0005829; GO:0007283; GO:0030552	cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
PGEN_.00g047400	Scaffold_02	40000197	40001885	NA	NA	NA	NA	NA
PGEN_.00g047410	Scaffold_02	40005848	40016048	Q8N0W5	IQCK_HUMAN	IQ domain-containing protein K		
PGEN_.00g047420	Scaffold_02	40016503	40024601	Q7T0T2	LTR3B_XENLA	Ragulator complex protein LAMTOR3-B (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3-B) (Mitogen-activated protein kinase scaffold protein 1)	GO:0032008; GO:0034613; GO:0071230; GO:0071986	Ragulator complex [GO:0071986]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]
PGEN_.00g047430	Scaffold_02	40030003	40039122	NA	NA	NA	NA	NA
PGEN_.00g047440	Scaffold_02	40045080	40080606	P58269	DPF3_MOUSE	Zinc finger protein DPF3 (BRG1-associated factor 45C) (BAF45C) (Zinc finger protein cer-d4)	GO:0000123; GO:0000790; GO:0003676; GO:0004402; GO:0005634; GO:0005654; GO:0007399; GO:0008270; GO:0042393; GO:0045892; GO:0045944; GO:0071565	"histone acetyltransferase complex [GO:0000123]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g047450	Scaffold_02	40081376	40089726	Q5ZHY5	CHIP_CHICK	STIP1 homology and U box-containing protein 1 (EC 2.3.2.27) (E3 ubiquitin-protein ligase CHIP) (RING-type E3 ubiquitin transferase CHIP)	GO:0000151; GO:0000209; GO:0001664; GO:0004842; GO:0005654; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030911; GO:0030968; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0042405; GO:0042803; GO:0043161; GO:0046332; GO:0051087; GO:0051443; GO:0051787; GO:0051865; GO:0051879; GO:0070534; GO:0071218; GO:0090035; GO:0101031	chaperone complex [GO:0101031]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]
PGEN_.00g047460	Scaffold_02	40102537	40117241	NA	NA	NA	NA	NA
PGEN_.00g047470	Scaffold_02	40142917	40163701	NA	NA	NA	NA	NA
PGEN_.00g047480	Scaffold_02	40177161	40177613	NA	NA	NA	NA	NA
PGEN_.00g047490	Scaffold_02	40180526	40181056	P48987	ATO_DROME	Protein atonal	GO:0001746; GO:0001748; GO:0003677; GO:0005634; GO:0007399; GO:0007420; GO:0007423; GO:0007438; GO:0007455; GO:0007460; GO:0007605; GO:0008038; GO:0010608; GO:0016360; GO:0045165; GO:0045433; GO:0045944; GO:0046982; GO:0048800; GO:0048801	"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; antennal joint morphogenesis [GO:0048801]; antennal morphogenesis [GO:0048800]; Bolwig's organ morphogenesis [GO:0001746]; brain development [GO:0007420]; cell fate commitment [GO:0045165]; eye-antennal disc morphogenesis [GO:0007455]; male courtship behavior, veined wing generated song production [GO:0045433]; nervous system development [GO:0007399]; neuron recognition [GO:0008038]; oenocyte development [GO:0007438]; optic lobe placode development [GO:0001748]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posttranscriptional regulation of gene expression [GO:0010608]; R8 cell fate commitment [GO:0007460]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of sound [GO:0007605]"
PGEN_.00g047500	Scaffold_02	40193214	40194368	NA	NA	NA	NA	NA
PGEN_.00g047510	Scaffold_02	40213603	40224717	O09159	MA2B1_MOUSE	Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B)	GO:0004559; GO:0005537; GO:0005615; GO:0005764; GO:0005774; GO:0006013; GO:0006464; GO:0006517; GO:0007611; GO:0046872	extracellular space [GO:0005615]; lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; cellular protein modification process [GO:0006464]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]
PGEN_.00g047520	Scaffold_02	40264291	40278245	Q7TN88	PK1L2_MOUSE	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g047530	Scaffold_02	40278994	40296190	NA	NA	NA	NA	NA
PGEN_.00g047540	Scaffold_02	40333769	40345052	Q9GMS6	MPPE1_MACFA	Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5)	GO:0005793; GO:0005801; GO:0006506; GO:0006888; GO:0008081; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0070971	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; GPI anchor binding [GO:0034235]; manganese ion binding [GO:0030145]; phosphoric diester hydrolase activity [GO:0008081]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g047550	Scaffold_02	40361564	40376264	Q3UP23	TMM26_MOUSE	Transmembrane protein 26	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g047560	Scaffold_02	40380030	40380665	NA	NA	NA	NA	NA
PGEN_.00g047570	Scaffold_02	40386963	40387298	NA	NA	NA	NA	NA
PGEN_.00g047580	Scaffold_02	40387337	40388254	NA	NA	NA	NA	NA
PGEN_.00g047590	Scaffold_02	40393481	40393780	NA	NA	NA	NA	NA
PGEN_.00g047600	Scaffold_02	40393964	40394749	NA	NA	NA	NA	NA
PGEN_.00g047610	Scaffold_02	40394919	40395593	NA	NA	NA	NA	NA
PGEN_.00g047620	Scaffold_02	40395643	40395885	NA	NA	NA	NA	NA
PGEN_.00g047630	Scaffold_02	40396167	40396685	NA	NA	NA	NA	NA
PGEN_.00g047640	Scaffold_02	40397040	40397477	NA	NA	NA	NA	NA
PGEN_.00g047650	Scaffold_02	40425482	40452833	P70549	NAC3_RAT	Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3)	GO:0002244; GO:0005432; GO:0005516; GO:0005623; GO:0005739; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006851; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0030054; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0060402; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0099055; GO:0099580; GO:1905060; GO:1990034	cell [GO:0005623]; cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity [GO:0015368]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]
PGEN_.00g047660	Scaffold_02	40458087	40461217	NA	NA	NA	NA	NA
PGEN_.00g047670	Scaffold_02	40468822	40479212	NA	NA	NA	NA	NA
PGEN_.00g047680	Scaffold_02	40493925	40522093	Q5ZHN3	WIPI2_CHICK	WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2)	GO:0000045; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0061739; GO:0080025; GO:0098792	"autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]"
PGEN_.00g047690	Scaffold_02	40522437	40535835	Q8CFY5	COX10_MOUSE	"Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase)"	GO:0000266; GO:0004129; GO:0004311; GO:0005730; GO:0005739; GO:0005829; GO:0006784; GO:0007005; GO:0008495; GO:0008535; GO:0009060; GO:0016021; GO:0017004; GO:0018343; GO:0031966; GO:0045333; GO:0048034; GO:0070069	cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; cytochrome-c oxidase activity [GO:0004129]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; cytochrome complex assembly [GO:0017004]; heme a biosynthetic process [GO:0006784]; heme O biosynthetic process [GO:0048034]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; protein farnesylation [GO:0018343]; respiratory chain complex IV assembly [GO:0008535]
PGEN_.00g047700	Scaffold_02	40543880	40545357	Q9GPH3	ATFC_BOMMO	Activating transcription factor of chaperone	GO:0003677; GO:0003700; GO:0005634; GO:0006986	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; response to unfolded protein [GO:0006986]
PGEN_.00g047710	Scaffold_02	40545403	40552253	NA	NA	NA	NA	NA
PGEN_.00g047720	Scaffold_02	40552305	40562280	A9VFD6	MTNK_BACMK	Methylthioribose kinase (MTR kinase) (EC 2.7.1.100)	GO:0005524; GO:0019284; GO:0019509; GO:0046522	ATP binding [GO:0005524]; S-methyl-5-thioribose kinase activity [GO:0046522]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]
PGEN_.00g047730	Scaffold_02	40572477	40606711	O95905	ECD_HUMAN	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006110; GO:0006366; GO:0006397; GO:0008283; GO:0008380; GO:0035035; GO:0045944; GO:2000045	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g047740	Scaffold_02	40606885	40611131	B5FYY5	LTOR2_TAEGU	Ragulator complex protein LAMTOR2 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2)	GO:0001558; GO:0005085; GO:0005765; GO:0005770; GO:0032008; GO:0034613; GO:0060090; GO:0071230; GO:0071986	late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]
PGEN_.00g047750	Scaffold_02	40617141	40625988	Q6AXX6	PXL2A_RAT	Peroxiredoxin-like 2A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM) (Redox-regulatory protein FAM213A) (Sperm head protein 1)	GO:0005576; GO:0005737; GO:0016209; GO:0045670; GO:0055114	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; antioxidant activity [GO:0016209]; oxidation-reduction process [GO:0055114]; regulation of osteoclast differentiation [GO:0045670]
PGEN_.00g047760	Scaffold_02	40629478	40669688	Q8WYB5	KAT6B_HUMAN	"Histone acetyltransferase KAT6B (EC 2.3.1.48) (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Monocytic leukemia zinc finger protein-related factor)"	GO:0000123; GO:0000786; GO:0000790; GO:0003677; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006355; GO:0008134; GO:0016407; GO:0016573; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0070776; GO:1990830	"histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; cellular response to leukemia inhibitory factor [GO:1990830]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g047770	Scaffold_02	40700055	40714887	P42694	HELZ_HUMAN	Probable helicase with zinc finger domain (EC 3.6.4.-) (Down-regulated in human cancers protein)	GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016020; GO:0035194; GO:0043186; GO:0046872	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; posttranscriptional gene silencing by RNA [GO:0035194]
PGEN_.00g047780	Scaffold_02	40719972	40724778	NA	NA	NA	NA	NA
PGEN_.00g047790	Scaffold_02	40732694	40734677	NA	NA	NA	NA	NA
PGEN_.00g047800	Scaffold_02	40734847	40763486	Q58DN3	TSN17_BOVIN	Tetraspanin-17 (Tspan-17)	GO:0005887; GO:0051604; GO:0072659	integral component of plasma membrane [GO:0005887]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]
PGEN_.00g047810	Scaffold_02	40785870	40793955	P97615	THIOM_RAT	"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)"	GO:0001666; GO:0005623; GO:0005730; GO:0005739; GO:0006662; GO:0006979; GO:0009725; GO:0009749; GO:0014070; GO:0015035; GO:0030425; GO:0031669; GO:0042493; GO:0043025; GO:0044877; GO:0045454; GO:0048678	cell [GO:0005623]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; protein disulfide oxidoreductase activity [GO:0015035]; protein-containing complex binding [GO:0044877]; cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; glycerol ether metabolic process [GO:0006662]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]
PGEN_.00g047820	Scaffold_02	40797195	40804627	NA	NA	NA	NA	NA
PGEN_.00g047830	Scaffold_02	40807041	40821968	Q2KIH4	RRS1_BOVIN	Ribosome biogenesis regulatory protein homolog	GO:0000027; GO:0000055; GO:0000447; GO:0000794; GO:0005623; GO:0005730; GO:0007080; GO:0008097; GO:0030687; GO:0042273; GO:1901796; GO:1902570	"cell [GO:0005623]; condensed nuclear chromosome [GO:0000794]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; 5S rRNA binding [GO:0008097]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]"
PGEN_.00g047840	Scaffold_02	40822200	40836800	Q5SSM3	RHG44_MOUSE	Rho GTPase-activating protein 44 (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2)	GO:0005096; GO:0005543; GO:0007165; GO:0014069; GO:0030054; GO:0030425; GO:0031256; GO:0032956; GO:0035021; GO:0043087; GO:0043197; GO:0048365; GO:0048786; GO:0051490; GO:0055037; GO:0061001; GO:0098886; GO:0098887; GO:0098978; GO:0099010; GO:0099152	"cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; Rac GTPase binding [GO:0048365]; modification of dendritic spine [GO:0098886]; modification of postsynaptic structure [GO:0099010]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]"
PGEN_.00g047850	Scaffold_02	40838006	40873020	Q3UIA2	RHG17_MOUSE	Rho GTPase-activating protein 17 (Neuron-associated developmentally-regulated protein) (Nadrin) (Rho-type GTPase-activating protein 17)	GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0007015; GO:0007165; GO:0017124; GO:0017156; GO:0032956; GO:0048365	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; signal transduction [GO:0007165]
PGEN_.00g047860	Scaffold_02	40881334	40881906	Q9NQT4	EXOS5_HUMAN	Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B)	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0016075; GO:0034427; GO:0034475; GO:0035327; GO:0043488; GO:0043928; GO:0045006; GO:0051607; GO:0071028; GO:0071051	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"
PGEN_.00g047870	Scaffold_02	40886981	40904092	Q501J6	DDX17_MOUSE	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17)	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0010586; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:0061614; GO:1990904; GO:2001014	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rRNA processing [GO:0006364]"
PGEN_.00g047880	Scaffold_02	40918035	40953160	P57103	NAC3_HUMAN	Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3)	GO:0002244; GO:0005432; GO:0005516; GO:0005623; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006811; GO:0006851; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0016528; GO:0021537; GO:0030054; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0099055; GO:0099580; GO:1903779; GO:1905060; GO:1990034	cell [GO:0005623]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]
PGEN_.00g047890	Scaffold_02	40985336	41041606	Q99MT2	MSH4_MOUSE	MutS protein homolog 4 (mMsh4)	GO:0000228; GO:0000712; GO:0000793; GO:0000794; GO:0000795; GO:0001541; GO:0005524; GO:0005634; GO:0005654; GO:0005713; GO:0006298; GO:0007129; GO:0007131; GO:0007283; GO:0007292; GO:0008094; GO:0030983; GO:0051321	condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; mismatched DNA binding [GO:0030983]; female gamete generation [GO:0007292]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]
PGEN_.00g047900	Scaffold_02	41045595	41057864	Q5IS35	TPC_MACFA	Mitochondrial thiamine pyrophosphate carrier (Solute carrier family 25 member 19)	GO:0005743; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]
PGEN_.00g047910	Scaffold_02	41057963	41060375	NA	NA	NA	NA	NA
PGEN_.00g047920	Scaffold_02	41137351	41145168	NA	NA	NA	NA	NA
PGEN_.00g047930	Scaffold_02	41172591	41183228	NA	NA	NA	NA	NA
PGEN_.00g047940	Scaffold_02	41199232	41221191	NA	NA	NA	NA	NA
PGEN_.00g047950	Scaffold_02	41253573	41278450	Q9QXV1	CBX8_MOUSE	Chromobox protein homolog 8 (Polycomb 3 homolog) (Pc3) (mPc3)	GO:0000122; GO:0000151; GO:0000790; GO:0000792; GO:0003727; GO:0005634; GO:0005654; GO:0006342; GO:0008284; GO:0016574; GO:0031519; GO:0032967; GO:0035064; GO:0035102; GO:0045739; GO:0070301; GO:0097027	heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]; ubiquitin-protein transferase activator activity [GO:0097027]; cellular response to hydrogen peroxide [GO:0070301]; chromatin silencing [GO:0006342]; histone ubiquitination [GO:0016574]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA repair [GO:0045739]
PGEN_.00g047960	Scaffold_02	41291208	41313407	Q0DXS3	RDR1_ORYSJ	Probable RNA-dependent RNA polymerase 1 (OsRDR1) (EC 2.7.7.48)	GO:0003723; GO:0003968; GO:0005634; GO:0009615; GO:0009751; GO:0010025; GO:0030422; GO:0031380; GO:0060148; GO:0070919	nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; positive regulation of posttranscriptional gene silencing [GO:0060148]; production of siRNA involved in chromatin silencing by small RNA [GO:0070919]; production of siRNA involved in RNA interference [GO:0030422]; response to salicylic acid [GO:0009751]; response to virus [GO:0009615]; wax biosynthetic process [GO:0010025]
PGEN_.00g047970	Scaffold_02	41358888	41380355	P70549	NAC3_RAT	Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3)	GO:0002244; GO:0005432; GO:0005516; GO:0005623; GO:0005739; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006851; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0030054; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0060402; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0099055; GO:0099580; GO:1905060; GO:1990034	cell [GO:0005623]; cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity [GO:0015368]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]
PGEN_.00g047980	Scaffold_02	41399392	41406224	Q4R5C6	NH2L1_MACFA	"NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) [Cleaved into: NHP2-like protein 1, N-terminally processed]"	GO:0000398; GO:0005634; GO:0005690; GO:0005730; GO:0030622; GO:0042254; GO:0046540; GO:0071005	"nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribosome biogenesis [GO:0042254]"
PGEN_.00g047990	Scaffold_02	41412956	41437617	Q14565	DMC1_HUMAN	Meiotic recombination protein DMC1/LIM15 homolog	GO:0000150; GO:0000730; GO:0000781; GO:0000794; GO:0001541; GO:0001556; GO:0003677; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006312; GO:0007129; GO:0007131; GO:0007141; GO:0007283; GO:0007286; GO:0007292; GO:0008094; GO:0042148; GO:0051321	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; DNA recombinase assembly [GO:0000730]; female gamete generation [GO:0007292]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; strand invasion [GO:0042148]; synapsis [GO:0007129]"
PGEN_.00g048000	Scaffold_02	41452369	41482654	Q9JID6	ACSL1_CAVPO	Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)	GO:0000038; GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0102391	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]
PGEN_.00g048010	Scaffold_02	41487558	41499916	Q01177	PLMN_RAT	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004175; GO:0004252; GO:0005102; GO:0005615; GO:0005623; GO:0005886; GO:0006508; GO:0007596; GO:0009986; GO:0010812; GO:0019897; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0031232; GO:0034185; GO:0042246; GO:0042730; GO:0043231; GO:0043536; GO:0044218; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051603; GO:0051702; GO:0051918; GO:0051919; GO:0052213; GO:0060707; GO:0060716; GO:0071674; GO:0098685; GO:0098978; GO:0099183; GO:1904854; GO:1990405	"cell [GO:0005623]; cell surface [GO:0009986]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; other organism cell membrane [GO:0044218]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; proteasome core complex binding [GO:1904854]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; interaction with symbiont [GO:0051702]; interaction with symbiont via secreted substance [GO:0052213]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]"
PGEN_.00g048020	Scaffold_02	41508496	41522399	NA	NA	NA	NA	NA
PGEN_.00g048030	Scaffold_02	41529029	41529598	NA	NA	NA	NA	NA
PGEN_.00g048040	Scaffold_02	41546871	41547209	NA	NA	NA	NA	NA
PGEN_.00g048050	Scaffold_02	41629444	41630196	Q01338	ADA2A_MOUSE	Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR)	GO:0001819; GO:0002526; GO:0004935; GO:0004938; GO:0005737; GO:0005886; GO:0005887; GO:0006260; GO:0007186; GO:0007188; GO:0007565; GO:0019229; GO:0019901; GO:0030168; GO:0030335; GO:0031696; GO:0031996; GO:0032147; GO:0032148; GO:0032795; GO:0032870; GO:0035624; GO:0042593; GO:0042596; GO:0042802; GO:0042803; GO:0043025; GO:0043235; GO:0043406; GO:0043410; GO:0043679; GO:0045202; GO:0045741; GO:0045955; GO:0046676; GO:0046982; GO:0050955; GO:0050995; GO:0051044; GO:0051379; GO:0051380; GO:0061179; GO:0070473; GO:0071875; GO:0071880; GO:0071881; GO:0071882; GO:0090303; GO:0097755; GO:0098691; GO:0098978; GO:0098982; GO:0099055; GO:0099059; GO:0099061; GO:2000300	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; adrenergic receptor activity [GO:0004935]; alpha-2C adrenergic receptor binding [GO:0031696]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; heterotrimeric G-protein binding [GO:0032795]; identical protein binding [GO:0042802]; norepinephrine binding [GO:0051380]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenergic receptor signaling pathway [GO:0071875]; cellular response to hormone stimulus [GO:0032870]; DNA replication [GO:0006260]; fear response [GO:0042596]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of uterine smooth muscle contraction [GO:0070473]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; platelet activation [GO:0030168]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production [GO:0001819]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of wound healing [GO:0090303]; receptor transactivation [GO:0035624]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vasoconstriction [GO:0019229]; thermoception [GO:0050955]
PGEN_.00g048060	Scaffold_02	41643922	41644524	NA	NA	NA	NA	NA
PGEN_.00g048070	Scaffold_02	41652121	41663543	Q2KJ25	PSD12_BOVIN	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5)	GO:0005737; GO:0008541; GO:0022624; GO:0031595; GO:0043161	"cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"
PGEN_.00g048080	Scaffold_02	41663910	41704905	Q28CA0	PITC1_XENTR	Cytoplasmic phosphatidylinositol transfer protein 1 (Retinal degeneration B homolog beta) (RdgBbeta)	GO:0005737; GO:0007165; GO:0008526; GO:0035091	cytoplasm [GO:0005737]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; signal transduction [GO:0007165]
PGEN_.00g048090	Scaffold_02	41714206	41714910	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g048100	Scaffold_02	41722453	41722752	O22286	BPM3_ARATH	BTB/POZ and MATH domain-containing protein 3 (Protein BTB-POZ AND MATH DOMAIN 3) (AtBPM3)	GO:0005634; GO:0005829; GO:0006970; GO:0016567; GO:0031396; GO:0042802; GO:0071472	cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; cellular response to salt stress [GO:0071472]; protein ubiquitination [GO:0016567]; regulation of protein ubiquitination [GO:0031396]; response to osmotic stress [GO:0006970]
PGEN_.00g048110	Scaffold_02	41736535	41773654	Q4R7U0	TMC7_MACFA	Transmembrane channel-like protein 7	GO:0005887; GO:0006811	integral component of plasma membrane [GO:0005887]; ion transport [GO:0006811]
PGEN_.00g048120	Scaffold_02	41771262	41771522	NA	NA	NA	NA	NA
PGEN_.00g048130	Scaffold_02	41789847	41838373	Q9BW27	NUP85_HUMAN	Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (FROUNT) (Nucleoporin Nup75) (Nucleoporin Nup85) (Pericentrin-1)	GO:0000777; GO:0005635; GO:0005654; GO:0005819; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0030032; GO:0031080; GO:0031965; GO:0043657; GO:0045893; GO:0048246; GO:0060964; GO:0072006; GO:0075733; GO:1900034	"condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]"
PGEN_.00g048140	Scaffold_02	41841476	41852332	NA	NA	NA	NA	NA
PGEN_.00g048150	Scaffold_02	41859312	41870926	B9EJR8	DAAF5_MOUSE	"Dynein assembly factor 5, axonemal (HEAT repeat-containing protein 2)"	GO:0003341; GO:0005737; GO:0036158; GO:0036159; GO:0045505	cytoplasm [GO:0005737]; dynein intermediate chain binding [GO:0045505]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]
PGEN_.00g048160	Scaffold_02	41871142	41872652	NA	NA	NA	NA	NA
PGEN_.00g048170	Scaffold_02	41913624	41926589	O15973	OPSD1_MIZYE	"Rhodopsin, GQ-coupled (GQ-rhodopsin)"	GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g048180	Scaffold_02	41928164	41928517	NA	NA	NA	NA	NA
PGEN_.00g048190	Scaffold_02	41939281	41939511	NA	NA	NA	NA	NA
PGEN_.00g048200	Scaffold_02	41956931	41984696	Q96EB6	SIR1_HUMAN	NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]	GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000790; GO:0001228; GO:0001525; GO:0001542; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003714; GO:0004407; GO:0005623; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005719; GO:0005720; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006325; GO:0006343; GO:0006344; GO:0006346; GO:0006476; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007569; GO:0008022; GO:0008134; GO:0008284; GO:0009267; GO:0010629; GO:0010875; GO:0010883; GO:0010906; GO:0010934; GO:0014068; GO:0016032; GO:0016239; GO:0016567; GO:0016575; GO:0016605; GO:0016740; GO:0017136; GO:0018394; GO:0019213; GO:0019899; GO:0030225; GO:0030308; GO:0030512; GO:0031393; GO:0031648; GO:0031937; GO:0032007; GO:0032071; GO:0032088; GO:0032868; GO:0032922; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0034983; GO:0035257; GO:0035356; GO:0035358; GO:0042127; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043280; GO:0043398; GO:0043425; GO:0043433; GO:0043518; GO:0043536; GO:0044321; GO:0045348; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045892; GO:0045944; GO:0046628; GO:0046872; GO:0046969; GO:0050872; GO:0051019; GO:0051097; GO:0051152; GO:0051574; GO:0051898; GO:0055089; GO:0060766; GO:0070301; GO:0070403; GO:0070857; GO:0070914; GO:0070932; GO:0071356; GO:0071441; GO:0071456; GO:0071479; GO:0071900; GO:0090335; GO:0090400; GO:1900034; GO:1900113; GO:1901215; GO:1901984; GO:1902166; GO:1902176; GO:1902237; GO:1904179; GO:1990254; GO:1990830; GO:2000111; GO:2000480; GO:2000481; GO:2000619; GO:2000655; GO:2000757; GO:2000773; GO:2000774	"cell [GO:0005623]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transferase activity [GO:0016740]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cell aging [GO:0007569]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; circadian regulation of gene expression [GO:0032922]; DNA synthesis involved in DNA repair [GO:0000731]; establishment of chromatin silencing [GO:0006343]; fatty acid homeostasis [GO:0055089]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage cytokine production [GO:0010934]; macrophage differentiation [GO:0030225]; maintenance of chromatin silencing [GO:0006344]; methylation-dependent chromatin silencing [GO:0006346]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; viral process [GO:0016032]; white fat cell differentiation [GO:0050872]"
PGEN_.00g048210	Scaffold_02	41984954	41991255	Q9R022	DJC12_MOUSE	DnaJ homolog subfamily C member 12 (J domain-containing protein 1)	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g048220	Scaffold_02	41997350	42003032	NA	NA	NA	NA	NA
PGEN_.00g048230	Scaffold_02	42007142	42008323	O14792	HS3S1_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1)	GO:0005796; GO:0006024; GO:0008146; GO:0008467	Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g048240	Scaffold_02	42033907	42034551	NA	NA	NA	NA	NA
PGEN_.00g048250	Scaffold_02	42036486	42036911	NA	NA	NA	NA	NA
PGEN_.00g048260	Scaffold_02	42076615	42077859	Q9R0W9	ACHA6_MOUSE	Neuronal acetylcholine receptor subunit alpha-6	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0014059; GO:0016020; GO:0022848; GO:0030054; GO:0033603; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0050877; GO:0051899; GO:0098691; GO:0099055; GO:0099056; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g048270	Scaffold_02	42083211	42083531	NA	NA	NA	NA	NA
PGEN_.00g048280	Scaffold_02	42088113	42088412	NA	NA	NA	NA	NA
PGEN_.00g048290	Scaffold_02	42088498	42089103	NA	NA	NA	NA	NA
PGEN_.00g048300	Scaffold_02	42168974	42172791	NA	NA	NA	NA	NA
PGEN_.00g048310	Scaffold_02	42304904	42305203	NA	NA	NA	NA	NA
PGEN_.00g048320	Scaffold_02	42343702	42356633	NA	NA	NA	NA	NA
PGEN_.00g048330	Scaffold_02	42361206	42361517	NA	NA	NA	NA	NA
PGEN_.00g048340	Scaffold_02	42364088	42365410	Q9VQB7	EOGT_DROME	EGF domain-specific O-linked N-acetylglucosamine transferase (EC 2.4.1.255) (Extracellular O-linked N-acetylglucosamine transferase)	GO:0005788; GO:0006493; GO:0008363; GO:0016262; GO:0097363; GO:0097370	endoplasmic reticulum lumen [GO:0005788]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; larval chitin-based cuticle development [GO:0008363]; protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493]
PGEN_.00g048350	Scaffold_02	42388402	42389283	NA	NA	NA	NA	NA
PGEN_.00g048360	Scaffold_02	42389383	42389721	NA	NA	NA	NA	NA
PGEN_.00g048370	Scaffold_02	42396798	42397478	NA	NA	NA	NA	NA
PGEN_.00g048380	Scaffold_02	42404430	42404855	NA	NA	NA	NA	NA
PGEN_.00g048390	Scaffold_02	42416382	42417155	NA	NA	NA	NA	NA
PGEN_.00g048400	Scaffold_02	42424862	42459974	NA	NA	NA	NA	NA
PGEN_.00g048410	Scaffold_02	42472977	42501093	NA	NA	NA	NA	NA
PGEN_.00g048420	Scaffold_02	42512397	42514465	NA	NA	NA	NA	NA
PGEN_.00g048430	Scaffold_02	42515510	42544334	Q8K561	OTOAN_MOUSE	Otoancorin	GO:0005576; GO:0007160; GO:0007605; GO:0009986; GO:0016324; GO:0019226; GO:0031225	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular region [GO:0005576]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]
PGEN_.00g048440	Scaffold_02	42557002	42568455	NA	NA	NA	NA	NA
PGEN_.00g048450	Scaffold_02	42631685	42631975	NA	NA	NA	NA	NA
PGEN_.00g048460	Scaffold_02	42640462	42685884	NA	NA	NA	NA	NA
PGEN_.00g048470	Scaffold_02	42722929	42723643	NA	NA	NA	NA	NA
PGEN_.00g048480	Scaffold_02	42724642	42725013	NA	NA	NA	NA	NA
PGEN_.00g048490	Scaffold_02	42725140	42725463	NA	NA	NA	NA	NA
PGEN_.00g048500	Scaffold_02	42772682	42775940	NA	NA	NA	NA	NA
PGEN_.00g048510	Scaffold_02	42826683	42831821	NA	NA	NA	NA	NA
PGEN_.00g048520	Scaffold_02	42880708	42890697	D2XV59	GTPB1_RAT	GTP-binding protein 1	GO:0000177; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]
PGEN_.00g048530	Scaffold_02	42898292	42914144	P61922	GABT_MOUSE	"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)"	GO:0001666; GO:0003867; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042220; GO:0042493; GO:0042803; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0048148; GO:0051536; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]
PGEN_.00g048540	Scaffold_02	42926206	43090431	O94812	BAIP3_HUMAN	BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3)	GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0055038; GO:0098793; GO:1905413; GO:1990502	"cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g048550	Scaffold_02	43078030	43078326	NA	NA	NA	NA	NA
PGEN_.00g048560	Scaffold_02	43190346	43208963	P04634	LIPG_RAT	Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) (Lingual lipase)	GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0007586; GO:0016042; GO:0016298; GO:0016615; GO:0043231	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; lipase activity [GO:0016298]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]
PGEN_.00g048570	Scaffold_02	43214485	43232478	P38571	LICH_HUMAN	Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)	GO:0000902; GO:0001650; GO:0001816; GO:0004771; GO:0005764; GO:0006954; GO:0008283; GO:0016042; GO:0016125; GO:0016298; GO:0030324; GO:0034383; GO:0043202; GO:0043231; GO:0048771; GO:0048873	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]
PGEN_.00g048580	Scaffold_02	43235481	43247802	Q8K2A6	LIPM_MOUSE	Lipase member M (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 3)	GO:0005576; GO:0016042; GO:0016788	"extracellular region [GO:0005576]; hydrolase activity, acting on ester bonds [GO:0016788]; lipid catabolic process [GO:0016042]"
PGEN_.00g048590	Scaffold_02	43258407	43268245	Q8BPB0	MOB1B_MOUSE	MOB kinase activator 1B (Mob1 homolog 1A) (Mps one binder kinase activator-like 1A)	GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0019209; GO:0019900; GO:0031952; GO:0035329; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinase activator activity [GO:0019209]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; hippo signaling [GO:0035329]; regulation of protein autophosphorylation [GO:0031952]
PGEN_.00g048600	Scaffold_02	43272636	43272968	NA	NA	NA	NA	NA
PGEN_.00g048610	Scaffold_02	43273388	43290537	Q6AY09	HNRH2_RAT	"Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]"	GO:0003723; GO:0005654; GO:0005829; GO:0014069; GO:1990904	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]
PGEN_.00g048620	Scaffold_02	43301678	43309080	Q12955	ANK3_HUMAN	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]"
PGEN_.00g048630	Scaffold_02	43317788	43318270	NA	NA	NA	NA	NA
PGEN_.00g048640	Scaffold_02	43322664	43328725	Q9D0M5	DYL2_MOUSE	"Dynein light chain 2, cytoplasmic (8 kDa dynein light chain b) (DLC8) (DLC8b) (Dynein light chain LC8-type 2)"	GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0030286; GO:0031475; GO:0042802; GO:0042803; GO:0044877; GO:0045505; GO:0046982; GO:0051959; GO:0097110; GO:0098794; GO:0098978; GO:2000582	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"
PGEN_.00g048650	Scaffold_02	43337096	43337365	Q9D0M5	DYL2_MOUSE	"Dynein light chain 2, cytoplasmic (8 kDa dynein light chain b) (DLC8) (DLC8b) (Dynein light chain LC8-type 2)"	GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0030286; GO:0031475; GO:0042802; GO:0042803; GO:0044877; GO:0045505; GO:0046982; GO:0051959; GO:0097110; GO:0098794; GO:0098978; GO:2000582	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"
PGEN_.00g048660	Scaffold_02	43348499	43348768	Q24117	DYL1_DROME	"Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein)"	GO:0000132; GO:0003774; GO:0005623; GO:0005737; GO:0005814; GO:0005868; GO:0005874; GO:0006914; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035071; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0097718; GO:1904801; GO:2000582	"cell [GO:0005623]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]"
PGEN_.00g048670	Scaffold_02	43366809	43372000	NA	NA	NA	NA	NA
PGEN_.00g048680	Scaffold_02	43382243	43382512	Q24117	DYL1_DROME	"Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein)"	GO:0000132; GO:0003774; GO:0005623; GO:0005737; GO:0005814; GO:0005868; GO:0005874; GO:0006914; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035071; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0097718; GO:1904801; GO:2000582	"cell [GO:0005623]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]"
PGEN_.00g048690	Scaffold_02	43388370	43388639	O02414	DYL1_HELCR	"Dynein light chain LC6, flagellar outer arm"	GO:0003774; GO:0005737; GO:0005874; GO:0007017; GO:0030286; GO:0031514	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]
PGEN_.00g048700	Scaffold_02	43395821	43396090	Q24117	DYL1_DROME	"Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein)"	GO:0000132; GO:0003774; GO:0005623; GO:0005737; GO:0005814; GO:0005868; GO:0005874; GO:0006914; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035071; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0097718; GO:1904801; GO:2000582	"cell [GO:0005623]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]"
PGEN_.00g048710	Scaffold_02	43397802	43398176	NA	NA	NA	NA	NA
PGEN_.00g048720	Scaffold_02	43410947	43417430	Q9D0M5	DYL2_MOUSE	"Dynein light chain 2, cytoplasmic (8 kDa dynein light chain b) (DLC8) (DLC8b) (Dynein light chain LC8-type 2)"	GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0030286; GO:0031475; GO:0042802; GO:0042803; GO:0044877; GO:0045505; GO:0046982; GO:0051959; GO:0097110; GO:0098794; GO:0098978; GO:2000582	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"
PGEN_.00g048730	Scaffold_02	43417459	43417692	Q24117	DYL1_DROME	"Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein)"	GO:0000132; GO:0003774; GO:0005623; GO:0005737; GO:0005814; GO:0005868; GO:0005874; GO:0006914; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035071; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0097718; GO:1904801; GO:2000582	"cell [GO:0005623]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]"
PGEN_.00g048740	Scaffold_02	43425913	43435322	Q24117	DYL1_DROME	"Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (Cut up protein)"	GO:0000132; GO:0003774; GO:0005623; GO:0005737; GO:0005814; GO:0005868; GO:0005874; GO:0006914; GO:0007283; GO:0007290; GO:0007291; GO:0007476; GO:0008407; GO:0022416; GO:0030286; GO:0032991; GO:0034454; GO:0035071; GO:0035220; GO:0042803; GO:0045505; GO:0048477; GO:0051017; GO:0051959; GO:0097718; GO:1904801; GO:2000582	"cell [GO:0005623]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; actin filament bundle assembly [GO:0051017]; autophagy [GO:0006914]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; establishment of mitotic spindle orientation [GO:0000132]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule anchoring at centrosome [GO:0034454]; oogenesis [GO:0048477]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; positive regulation of neuron remodeling [GO:1904801]; salivary gland cell autophagic cell death [GO:0035071]; sperm individualization [GO:0007291]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]; wing disc development [GO:0035220]"
PGEN_.00g048750	Scaffold_02	43435351	43435584	O96860	DYL2_DROME	"Dynein light chain 2, cytoplasmic (8 kDa dynein light chain)"	GO:0003774; GO:0005737; GO:0005874; GO:0007017; GO:0030286; GO:0045505; GO:0051959; GO:2000582	"cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"
PGEN_.00g048760	Scaffold_02	43446604	43447349	Q6DIR8	PALD_XENTR	Paladin	GO:0004725; GO:0005737; GO:0005829	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein tyrosine phosphatase activity [GO:0004725]
PGEN_.00g048770	Scaffold_02	43477254	43481196	NA	NA	NA	NA	NA
PGEN_.00g048780	Scaffold_02	43483726	43505114	Q803E0	PALD_DANRE	Paladin	GO:0001525; GO:0004725; GO:0005737; GO:0005829	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]
PGEN_.00g048790	Scaffold_02	43573790	43578195	NA	NA	NA	NA	NA
PGEN_.00g048800	Scaffold_02	43705970	43706173	NA	NA	NA	NA	NA
PGEN_.00g048810	Scaffold_02	43709432	43716483	NA	NA	NA	NA	NA
PGEN_.00g048820	Scaffold_02	43716542	43723474	Q9H3K2	GHITM_HUMAN	Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5)	GO:0005739; GO:0005743; GO:0006915; GO:0016021; GO:0070062	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]
PGEN_.00g048830	Scaffold_02	43749815	43754971	Q9HZ00	Y3240_PSEAE	"Putative quercetin 2,3-dioxygenase PA3240 (Putative quercetinase) (EC 1.13.11.24) (Pirin-like protein PA3240)"	GO:0008127; GO:0046872	"metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]"
PGEN_.00g048840	Scaffold_02	43761531	43764476	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g048850	Scaffold_02	43771932	43773464	P83425	HIP_MYTED	Heavy metal-binding protein HIP	GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]
PGEN_.00g048860	Scaffold_02	43774905	43785765	NA	NA	NA	NA	NA
PGEN_.00g048870	Scaffold_02	43790920	43801248	NA	NA	NA	NA	NA
PGEN_.00g048880	Scaffold_02	43841127	43851584	Q96S21	RB40C_HUMAN	Ras-related protein Rab-40C (Rar-like protein) (Ras-like protein family member 8C) (SOCS box-containing protein RAR3)	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006886; GO:0008021; GO:0016567; GO:0019003; GO:0032482; GO:0048471; GO:0072659	endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]; Rab protein signal transduction [GO:0032482]
PGEN_.00g048890	Scaffold_02	43853868	43868738	NA	NA	NA	NA	NA
PGEN_.00g048900	Scaffold_02	43872054	43873536	NA	NA	NA	NA	NA
PGEN_.00g048910	Scaffold_02	43879728	43891914	Q9P275	UBP36_HUMAN	Ubiquitin carboxyl-terminal hydrolase 36 (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36)	GO:0003723; GO:0004197; GO:0004843; GO:0005654; GO:0005730; GO:0005737; GO:0006511; GO:0007000; GO:0016242; GO:0016578; GO:0016579; GO:0016607; GO:0031647; GO:0042981; GO:0050821; GO:1903146; GO:1903955; GO:2000232	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g048920	Scaffold_02	43901516	43964892	Q15438	CYH1_HUMAN	"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1) (SEC7 homolog B2-1)"	GO:0000139; GO:0005086; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0008289; GO:0016192; GO:0030155; GO:0031234; GO:0032012; GO:0090162	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192]
PGEN_.00g048930	Scaffold_02	43968614	43990644	P79896	ADHX_SPAAU	Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)	GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0051903	cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]
PGEN_.00g048940	Scaffold_02	43991932	43992921	NA	NA	NA	NA	NA
PGEN_.00g048950	Scaffold_02	44026670	44036072	P51570	GALK1_HUMAN	Galactokinase (EC 2.7.1.6) (Galactose kinase)	GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019388; GO:0019402; GO:0033499; GO:0061623; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]
PGEN_.00g048960	Scaffold_02	44044960	44054044	Q5VYX0	RNLS_HUMAN	Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C)	GO:0002931; GO:0005576; GO:0005615; GO:0010459; GO:0016651; GO:0034356; GO:0045776; GO:0051379; GO:0055114; GO:0070404; GO:0071871; GO:0097621; GO:1902074	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]"
PGEN_.00g048970	Scaffold_02	44058970	44064565	Q9D8I1	MZB1_MOUSE	Marginal zone B- and B1-cell-specific protein (Plasma cell-induced resident endoplasmic reticulum protein) (Plasma cell-induced resident ER protein) (pERp1) (Proapoptotic caspase adapter protein)	GO:0002642; GO:0005576; GO:0005737; GO:0005788; GO:0008284; GO:0030888; GO:0033622; GO:0034663; GO:0042127; GO:0046626	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin biosynthetic process [GO:0002642]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626]
PGEN_.00g048980	Scaffold_02	44067651	44112075	Q6ZVD7	STOX1_HUMAN	Storkhead-box protein 1 (Winged-helix domain-containing protein)	GO:0000977; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007049; GO:0008284; GO:0010468; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0048839; GO:0050679; GO:0051301; GO:0051881; GO:0051897; GO:0061418; GO:0071500; GO:1901858; GO:1902882; GO:1904031; GO:1904120	cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]
PGEN_.00g048990	Scaffold_02	44124664	44137772	P55214	CASP7_MESAU	Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (ICE-like apoptotic protease 3) (ICE-LAP3) (SREBP cleavage activity 2) (SCA-2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]	GO:0004197; GO:0005737; GO:0006915	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]
PGEN_.00g049000	Scaffold_02	44134044	44155391	Q9U6M0	ECSIT_DROME	"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial"	GO:0005634; GO:0005737; GO:0005739; GO:0016651; GO:0045087; GO:0051341	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341]"
PGEN_.00g049010	Scaffold_02	44164365	44172519	NA	NA	NA	NA	NA
PGEN_.00g049020	Scaffold_02	44175572	44177720	NA	NA	NA	NA	NA
PGEN_.00g049030	Scaffold_02	44187540	44193525	Q6AI12	ANR40_HUMAN	Ankyrin repeat domain-containing protein 40		
PGEN_.00g049040	Scaffold_02	44193986	44214981	Q8C4J7	TBL3_MOUSE	Transducin beta-like protein 3	GO:0000462; GO:0005654; GO:0005730; GO:0032040; GO:0034388	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"
PGEN_.00g049050	Scaffold_02	44221113	44236265	P63279	UBC9_HUMAN	SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I) (p18)	GO:0000122; GO:0000795; GO:0001650; GO:0003723; GO:0004842; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0007049; GO:0007059; GO:0008022; GO:0008134; GO:0010469; GO:0016032; GO:0016605; GO:0016925; GO:0019789; GO:0019899; GO:0030425; GO:0033145; GO:0043123; GO:0043161; GO:0043398; GO:0043425; GO:0044388; GO:0045202; GO:0045892; GO:0051091; GO:0051301; GO:0061656; GO:0071535; GO:1903755; GO:1990234; GO:1990356	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sumoylated E2 ligase complex [GO:1990356]; synapse [GO:0045202]; synaptonemal complex [GO:0000795]; transferase complex [GO:1990234]; ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; enzyme binding [GO:0019899]; HLH domain binding [GO:0043398]; protein C-terminus binding [GO:0008022]; RING-like zinc finger domain binding [GO:0071535]; RNA binding [GO:0003723]; small protein activating enzyme binding [GO:0044388]; SUMO conjugating enzyme activity [GO:0061656]; SUMO transferase activity [GO:0019789]; transcription factor binding [GO:0008134]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein modification process [GO:0006464]; chromosome segregation [GO:0007059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular steroid hormone receptor signaling pathway [GO:0033145]; positive regulation of SUMO transferase activity [GO:1903755]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein sumoylation [GO:0016925]; regulation of signaling receptor activity [GO:0010469]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"
PGEN_.00g049060	Scaffold_02	44242084	44262933	Q6NV34	DECR2_DANRE	"Peroxisomal 2,4-dienoyl-CoA reductase (EC 1.3.1.34) (2,4-dienoyl-CoA reductase 2)"	GO:0005777; GO:0006631; GO:0008670	"peroxisome [GO:0005777]; 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; fatty acid metabolic process [GO:0006631]"
PGEN_.00g049070	Scaffold_02	44279031	44279495	NA	NA	NA	NA	NA
PGEN_.00g049080	Scaffold_02	44279574	44279840	NA	NA	NA	NA	NA
PGEN_.00g049090	Scaffold_02	44297681	44304424	NA	NA	NA	NA	NA
PGEN_.00g049100	Scaffold_02	44311089	44316483	NA	NA	NA	NA	NA
PGEN_.00g049110	Scaffold_02	44317127	44328516	O70594	S22A5_RAT	Solute carrier family 22 member 5 (CT1) (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2) (UST2r)	GO:0005524; GO:0006814; GO:0007005; GO:0007512; GO:0007626; GO:0009437; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016021; GO:0016323; GO:0016324; GO:0030165; GO:0031526; GO:0048608; GO:0052106; GO:0060731; GO:0070715	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; adult heart development [GO:0007512]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; reproductive structure development [GO:0048608]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]
PGEN_.00g049120	Scaffold_02	44334174	44343634	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g049130	Scaffold_02	44354375	44357445	P10394	POL4_DROME	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]
PGEN_.00g049140	Scaffold_02	44360086	44366594	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g049150	Scaffold_02	44379082	44381437	NA	NA	NA	NA	NA
PGEN_.00g049160	Scaffold_02	44569330	44624493	NA	NA	NA	NA	NA
PGEN_.00g049170	Scaffold_02	44634012	44636350	NA	NA	NA	NA	NA
PGEN_.00g049180	Scaffold_02	44649243	44661386	Q6DKC0	ERL2B_XENLA	Erlin-2-B (Endoplasmic reticulum lipid raft-associated protein 2-B) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2-B) (SPFH domain-containing protein 2-B)	GO:0005789; GO:0008203; GO:0016021; GO:0031625	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]
PGEN_.00g049190	Scaffold_02	44671605	44688697	Q03923	ZNF85_HUMAN	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0046872	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]
PGEN_.00g049200	Scaffold_02	44693628	44699545	Q8TD23	ZN675_HUMAN	Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein)	GO:0000122; GO:0003677; GO:0005634; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]
PGEN_.00g049210	Scaffold_02	44705194	44708118	NA	NA	NA	NA	NA
PGEN_.00g049220	Scaffold_02	44782138	44782464	NA	NA	NA	NA	NA
PGEN_.00g049230	Scaffold_02	44783604	44801307	NA	NA	NA	NA	NA
PGEN_.00g049240	Scaffold_02	44819493	44823613	Q9Y2V2	CHSP1_HUMAN	Calcium-regulated heat-stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24)	GO:0000177; GO:0000932; GO:0000981; GO:0003730; GO:0005737; GO:0005829; GO:0019902; GO:0035556; GO:0043186; GO:0043488	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA 3'-UTR binding [GO:0003730]; phosphatase binding [GO:0019902]; intracellular signal transduction [GO:0035556]; regulation of mRNA stability [GO:0043488]"
PGEN_.00g049250	Scaffold_02	44848749	44849300	NA	NA	NA	NA	NA
PGEN_.00g049260	Scaffold_02	44871515	44880257	NA	NA	NA	NA	NA
PGEN_.00g049270	Scaffold_02	44883068	44898319	Q6AXP4	CB081_RAT	Uncharacterized protein C2orf81 homolog		
PGEN_.00g049280	Scaffold_02	44899064	44906120	Q9H0I2	ENKD1_HUMAN	Enkurin domain-containing protein 1	GO:0005881; GO:0015630	cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630]
PGEN_.00g049290	Scaffold_02	44916588	44928173	NA	NA	NA	NA	NA
PGEN_.00g049300	Scaffold_02	44928300	44943121	Q3T106	SRSF7_BOVIN	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"
PGEN_.00g049310	Scaffold_02	44943523	44949650	Q4R3C7	TOM22_MACFA	Mitochondrial import receptor subunit TOM22 homolog (Translocase of outer membrane 22 kDa subunit homolog)	GO:0005741; GO:0006626; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; protein targeting to mitochondrion [GO:0006626]
PGEN_.00g049320	Scaffold_02	44954868	44972612	Q5T197	DCST1_HUMAN	E3 ubiquitin-protein ligase DCST1 (EC 2.3.2.27) (DC-STAMP domain-containing protein 1) (RING-type E3 ubiquitin transferase)	GO:0005886; GO:0006511; GO:0016021; GO:0045087; GO:0046872; GO:0060339; GO:0061630	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g049330	Scaffold_02	44977996	45000494	Q5T1A1	DCST2_HUMAN	DC-STAMP domain-containing protein 2	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g049340	Scaffold_02	45001617	45001838	NA	NA	NA	NA	NA
PGEN_.00g049350	Scaffold_02	45002174	45008023	O75715	GPX5_HUMAN	Epididymal secretory glutathione peroxidase (EC 1.11.1.9) (Epididymis-specific glutathione peroxidase-like protein) (EGLP) (Glutathione peroxidase 5) (GPx-5) (GSHPx-5)	GO:0004601; GO:0004602; GO:0005576; GO:0005615; GO:0006629; GO:0008430; GO:0034599; GO:0042744	extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; cellular response to oxidative stress [GO:0034599]; hydrogen peroxide catabolic process [GO:0042744]; lipid metabolic process [GO:0006629]
PGEN_.00g049360	Scaffold_02	45013336	45016514	Q4AEH3	GPX3_SAPAP	Glutathione peroxidase 3 (GPx-3) (GSHPx-3) (EC 1.11.1.9) (Plasma glutathione peroxidase) (GPx-P) (GSHPx-P)	GO:0004602; GO:0005615; GO:0006979; GO:0008430; GO:0051289	extracellular space [GO:0005615]; glutathione peroxidase activity [GO:0004602]; selenium binding [GO:0008430]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]
PGEN_.00g049370	Scaffold_02	45017072	45017434	NA	NA	NA	NA	NA
PGEN_.00g049380	Scaffold_02	45026750	45053451	Q6ZPJ3	UBE2O_MOUSE	(E3-independent) E2 ubiquitin-conjugating enzyme UBE2O (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O)	GO:0004842; GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0043066; GO:0061630; GO:0061631; GO:0070534	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g049390	Scaffold_02	45067015	45073583	Q9R0C0	BL1S6_MOUSE	Biogenesis of lysosome-related organelles complex 1 subunit 6 (BLOC-1 subunit 6) (Pallid protein) (Pallidin) (Syntaxin 13-interacting protein)	GO:0005623; GO:0005737; GO:0005768; GO:0006904; GO:0006906; GO:0007596; GO:0008089; GO:0019898; GO:0030133; GO:0030318; GO:0031083; GO:0031175; GO:0032402; GO:0032816; GO:0033299; GO:0035646; GO:0042802; GO:0042803; GO:0043473; GO:0048490; GO:0050942; GO:0051015; GO:0061025; GO:1904115	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell [GO:0005623]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; transport vesicle [GO:0030133]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; endosome to melanosome transport [GO:0035646]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; membrane fusion [GO:0061025]; neuron projection development [GO:0031175]; pigmentation [GO:0043473]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of pigment cell differentiation [GO:0050942]; secretion of lysosomal enzymes [GO:0033299]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]
PGEN_.00g049400	Scaffold_02	45076065	45076694	NA	NA	NA	NA	NA
PGEN_.00g049410	Scaffold_02	45086741	45097819	NA	NA	NA	NA	NA
PGEN_.00g049420	Scaffold_02	45111656	45111910	NA	NA	NA	NA	NA
PGEN_.00g049430	Scaffold_02	45201139	45220914	NA	NA	NA	NA	NA
PGEN_.00g049440	Scaffold_02	45221005	45230685	NA	NA	NA	NA	NA
PGEN_.00g049450	Scaffold_02	45240105	45240542	NA	NA	NA	NA	NA
PGEN_.00g049460	Scaffold_02	45246401	45247591	O88335	KCNJ1_MOUSE	"ATP-sensitive inward rectifier potassium channel 1 (ATP-regulated potassium channel ROM-K) (Inward rectifier K(+) channel Kir1.1) (Potassium channel, inwardly rectifying subfamily J member 1)"	GO:0001822; GO:0001894; GO:0005242; GO:0005524; GO:0005546; GO:0005886; GO:0006813; GO:0009791; GO:0015272; GO:0016021; GO:0030955; GO:0042277; GO:0043066; GO:0070294; GO:0071286; GO:0072358; GO:1900128; GO:1990573	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; peptide binding [GO:0042277]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium ion binding [GO:0030955]; cardiovascular system development [GO:0072358]; cellular response to magnesium ion [GO:0071286]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; post-embryonic development [GO:0009791]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of G-protein activated inward rectifier potassium channel activity [GO:1900128]; renal sodium ion absorption [GO:0070294]; tissue homeostasis [GO:0001894]"
PGEN_.00g049470	Scaffold_02	45249516	45251096	P48542	KCNJ6_MOUSE	"G protein-activated inward rectifier potassium channel 2 (GIRK-2) (Inward rectifier K(+) channel Kir3.2) (Potassium channel, inwardly rectifying subfamily J member 6)"	GO:0001965; GO:0005242; GO:0005737; GO:0009986; GO:0015467; GO:0030424; GO:0030425; GO:0032809; GO:0034765; GO:0098688; GO:0099056; GO:1990573	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; G-protein alpha-subunit binding [GO:0001965]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g049480	Scaffold_02	45266488	45269322	NA	NA	NA	NA	NA
PGEN_.00g049490	Scaffold_02	45287691	45295094	P29117	PPIF_RAT	"Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Rotamase F)"	GO:0000413; GO:0002931; GO:0003755; GO:0005739; GO:0005743; GO:0005757; GO:0005759; GO:0006979; GO:0008637; GO:0010849; GO:0010939; GO:0016018; GO:0032780; GO:0042026; GO:0042277; GO:0042981; GO:0043066; GO:0046902; GO:0051082; GO:0070266; GO:0070301; GO:0071243; GO:0071277; GO:0090200; GO:0090201; GO:0090324; GO:1902445; GO:1902686; GO:2000276; GO:2001243	"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; cyclosporin A binding [GO:0016018]; peptide binding [GO:0042277]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; apoptotic mitochondrial changes [GO:0008637]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATPase activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of necrotic cell death [GO:0010939]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]"
PGEN_.00g049500	Scaffold_02	45313512	45315024	NA	NA	NA	NA	NA
PGEN_.00g049510	Scaffold_02	45350315	45373894	Q8TDM6	DLG5_HUMAN	Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG)	GO:0001837; GO:0005737; GO:0005886; GO:0005913; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609	cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; receptor signaling complex adaptor activity [GO:0030159]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]
PGEN_.00g049520	Scaffold_02	45375425	45418379	E9Q9R9	DLG5_MOUSE	Disks large homolog 5	GO:0001837; GO:0005737; GO:0005886; GO:0005913; GO:0008013; GO:0008092; GO:0014069; GO:0030011; GO:0030054; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205	cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]
PGEN_.00g049530	Scaffold_02	45424429	45428986	NA	NA	NA	NA	NA
PGEN_.00g049540	Scaffold_02	45439462	45482043	Q923U0	TM1L1_MOUSE	TOM1-like protein 1 (Src-activating and signaling molecule protein) (Target of Myb-like protein 1)	GO:0005737; GO:0005768; GO:0005795; GO:0005829; GO:0006886; GO:0007165; GO:0007169; GO:0010008; GO:0017124; GO:0019901; GO:0030276; GO:0030295; GO:0031954; GO:0032147; GO:0045839	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi stack [GO:0005795]; clathrin binding [GO:0030276]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; positive regulation of protein autophosphorylation [GO:0031954]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g049550	Scaffold_02	45482205	45493679	Q9D5E4	DRC3_MOUSE	Dynein regulatory complex subunit 3 (Leucine-rich repeat-containing protein 48)	GO:0005737; GO:0005930; GO:0031514	axoneme [GO:0005930]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]
PGEN_.00g049560	Scaffold_02	45498443	45508611	Q1LZ96	ATPF2_BOVIN	ATP synthase mitochondrial F1 complex assembly factor 2	GO:0005739; GO:0005829; GO:0016607; GO:0043461	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; proton-transporting ATP synthase complex assembly [GO:0043461]
PGEN_.00g049570	Scaffold_02	45509699	45510088	NA	NA	NA	NA	NA
PGEN_.00g049580	Scaffold_02	45510909	45516862	Q9CPY6	GID4_MOUSE	Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog)	GO:0000151; GO:0043161; GO:0061630	ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]
PGEN_.00g049590	Scaffold_02	45533055	45554563	A1ZA47	ZASP_DROME	PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)	GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061	actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]
PGEN_.00g049600	Scaffold_02	45535009	45535479	NA	NA	NA	NA	NA
PGEN_.00g049610	Scaffold_02	45569094	45575986	Q9D5T0	ATAD1_MOUSE	ATPase family AAA domain-containing protein 1 (EC 3.6.1.3) (Thorase)	GO:0002092; GO:0005524; GO:0005739; GO:0005777; GO:0007612; GO:0007613; GO:0016887; GO:0030054; GO:0045211; GO:0051967; GO:0098794; GO:0098978; GO:0099149	"cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]"
PGEN_.00g049620	Scaffold_02	45585326	45614426	Q96LW4	PRIPO_HUMAN	DNA-directed primase/polymerase protein (hPrimpol1) (EC 2.7.7.-) (Coiled-coil domain-containing protein 111)	GO:0003682; GO:0003887; GO:0003896; GO:0005634; GO:0005759; GO:0006264; GO:0009411; GO:0019985; GO:0030145; GO:0031297	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; manganese ion binding [GO:0030145]; mitochondrial DNA replication [GO:0006264]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]
PGEN_.00g049630	Scaffold_02	45678982	45686285	Q5BJT4	TXD15_RAT	Thioredoxin domain-containing protein 15	GO:0005623; GO:0005929; GO:0016021; GO:0045454; GO:0045880; GO:0060170; GO:0060271	cell [GO:0005623]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; cell redox homeostasis [GO:0045454]; cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880]
PGEN_.00g049640	Scaffold_02	45686481	45687299	Q6PC64	ELOV6_DANRE	Elongation of very long chain fatty acids protein 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase elovl6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6)	GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"
PGEN_.00g049650	Scaffold_02	45708090	45709191	NA	NA	NA	NA	NA
PGEN_.00g049660	Scaffold_02	45720272	45720595	NA	NA	NA	NA	NA
PGEN_.00g049670	Scaffold_02	45723342	45745082	Q460N5	PAR14_HUMAN	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g049680	Scaffold_02	45747550	45783679	Q460N5	PAR14_HUMAN	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g049690	Scaffold_02	45796818	45797162	NA	NA	NA	NA	NA
PGEN_.00g049700	Scaffold_02	45797403	45823001	Q9Z1Z3	EPN2_RAT	Epsin-2 (EPS-15-interacting protein 2)	GO:0001701; GO:0006897; GO:0007219; GO:0008289; GO:0030100; GO:0030128; GO:0030948; GO:0045747; GO:0048568; GO:1903671	clathrin coat of endocytic vesicle [GO:0030128]; lipid binding [GO:0008289]; embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100]
PGEN_.00g049710	Scaffold_02	45825554	45849143	NA	NA	NA	NA	NA
PGEN_.00g049720	Scaffold_02	45862404	45933327	O14981	BTAF1_HUMAN	TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172)	GO:0003677; GO:0003700; GO:0004386; GO:0005524; GO:0005654; GO:0035562; GO:0043231; GO:0045892	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g049730	Scaffold_02	45865190	45866446	NA	NA	NA	NA	NA
PGEN_.00g049740	Scaffold_02	45946217	45949020	NA	NA	NA	NA	NA
PGEN_.00g049750	Scaffold_02	45949215	45952572	Q99020	ROAA_MOUSE	Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (CArG-binding factor-A) (CBF-A)	GO:0000122; GO:0001837; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0043565; GO:0045893; GO:0090575; GO:0099523; GO:1990837; GO:1990904	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g049760	Scaffold_02	45956721	45972454	NA	NA	NA	NA	NA
PGEN_.00g049770	Scaffold_02	45976253	45976657	NA	NA	NA	NA	NA
PGEN_.00g049780	Scaffold_02	45977209	45977718	NA	NA	NA	NA	NA
PGEN_.00g049790	Scaffold_02	45977891	45978523	NA	NA	NA	NA	NA
PGEN_.00g049800	Scaffold_02	45986363	45997068	NA	NA	NA	NA	NA
PGEN_.00g049810	Scaffold_02	46008275	46125740	Q7JQ32	GC76C_DROME	Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1)	GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0019934; GO:0030198; GO:0030215; GO:0030510; GO:0038023; GO:0046872	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]"
PGEN_.00g049820	Scaffold_02	46198436	46200678	NA	NA	NA	NA	NA
PGEN_.00g049830	Scaffold_02	46298851	46348611	NA	NA	NA	NA	NA
PGEN_.00g049840	Scaffold_02	46357485	46375893	Q64230	MEP1A_RAT	Meprin A subunit alpha (EC 3.4.24.18) (Endopeptidase-2) (Endopeptidase-24.18 subunit alpha) (E-24.18) (MEP-1)	GO:0004222; GO:0006508; GO:0008270; GO:0016020; GO:0017090	membrane [GO:0016020]; meprin A complex [GO:0017090]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g049850	Scaffold_02	46423666	46431893	Q65AC2	S26A2_HORSE	Sulfate transporter (Solute carrier family 26 member 2)	GO:0001503; GO:0005887; GO:0008271; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0019531; GO:1902358	integral component of plasma membrane [GO:0005887]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; ossification [GO:0001503]; sulfate transmembrane transport [GO:1902358]
PGEN_.00g049860	Scaffold_02	46474702	46490793	O95232	LC7L3_HUMAN	Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1) (CRE-associated protein 1) (CREAP-1)	GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]
PGEN_.00g049870	Scaffold_02	46493969	46514362	Q5R4B3	ERF3B_PONAB	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B (Eukaryotic peptide chain release factor subunit 3b) (eRF3b) (G1 to S phase transition protein 2 homolog)	GO:0000184; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0007049	"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell cycle [GO:0007049]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translation [GO:0006412]"
PGEN_.00g049880	Scaffold_02	46528687	46534277	NA	NA	NA	NA	NA
PGEN_.00g049890	Scaffold_02	46543571	46553497	Q64512	PTN13_MOUSE	Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (PTP36) (Protein tyrosine phosphatase DPZPTP) (Protein tyrosine phosphatase PTP-BL) (Protein-tyrosine phosphatase RIP)	GO:0001650; GO:0001933; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0014066; GO:0030027; GO:0030496; GO:0035335; GO:0036312; GO:0043005; GO:0044297	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]
PGEN_.00g049900	Scaffold_02	46572582	46591080	Q64512	PTN13_MOUSE	Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (PTP36) (Protein tyrosine phosphatase DPZPTP) (Protein tyrosine phosphatase PTP-BL) (Protein-tyrosine phosphatase RIP)	GO:0001650; GO:0001933; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0014066; GO:0030027; GO:0030496; GO:0035335; GO:0036312; GO:0043005; GO:0044297	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]
PGEN_.00g049910	Scaffold_02	46596707	46597072	NA	NA	NA	NA	NA
PGEN_.00g049920	Scaffold_02	46597969	46601660	NA	NA	NA	NA	NA
PGEN_.00g049930	Scaffold_02	46603801	46606070	E1BJS7	LIN41_BOVIN	E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)	GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0021915; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177	P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]
PGEN_.00g049940	Scaffold_02	46612862	46613260	NA	NA	NA	NA	NA
PGEN_.00g049950	Scaffold_02	46625003	46631377	Q8NET6	CHSTD_HUMAN	Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3)	GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]
PGEN_.00g049960	Scaffold_02	46665259	46666905	NA	NA	NA	NA	NA
PGEN_.00g049970	Scaffold_02	46688280	46688525	NA	NA	NA	NA	NA
PGEN_.00g049980	Scaffold_02	46698397	46710179	NA	NA	NA	NA	NA
PGEN_.00g049990	Scaffold_02	46702097	46702390	NA	NA	NA	NA	NA
PGEN_.00g050000	Scaffold_02	46702584	46704262	NA	NA	NA	NA	NA
PGEN_.00g050010	Scaffold_02	46724694	46724948	NA	NA	NA	NA	NA
PGEN_.00g050020	Scaffold_02	46748852	46763803	Q6MZM0	HPHL1_HUMAN	Ferroxidase HEPHL1 (EC 1.16.3.1) (Hephaestin-like protein 1)	GO:0004322; GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016021; GO:0055072; GO:0055114	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; oxidation-reduction process [GO:0055114]
PGEN_.00g050030	Scaffold_02	46753221	46753448	NA	NA	NA	NA	NA
PGEN_.00g050040	Scaffold_02	46779025	46779927	B3EWZ9	HEPHL_ACRMI	Hephaestin-like protein (EC 1.-.-.-)	GO:0005507; GO:0006825; GO:0016021; GO:0016491	integral component of membrane [GO:0016021]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; copper ion transport [GO:0006825]
PGEN_.00g050050	Scaffold_02	46784501	46807474	Q9JL26	FMNL1_MOUSE	Formin-like protein 1 (Formin-related protein)	GO:0005522; GO:0005829; GO:0005886; GO:0006929; GO:0008360; GO:0009987; GO:0030866; GO:0032794; GO:0045335; GO:0048365; GO:0051014; GO:0051015	cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; profilin binding [GO:0005522]; Rac GTPase binding [GO:0048365]; actin filament severing [GO:0051014]; cellular process [GO:0009987]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360]; substrate-dependent cell migration [GO:0006929]
PGEN_.00g050060	Scaffold_02	46855447	46869894	NA	NA	NA	NA	NA
PGEN_.00g050070	Scaffold_02	46873644	46895076	NA	NA	NA	NA	NA
PGEN_.00g050080	Scaffold_02	46956242	46959053	Q2VPM4	Z703B_XENLA	Zinc finger protein 703-B	GO:0003676; GO:0005634; GO:0005737; GO:0016363; GO:0017015; GO:0030335; GO:0034111; GO:0034333; GO:0045892; GO:0046872; GO:0051726; GO:0060828	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; adherens junction assembly [GO:0034333]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell migration [GO:0030335]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g050090	Scaffold_02	47048880	47051938	Q24423	NOC_DROME	Zinc finger protein Noc (Zinc finger protein NocA)	GO:0001752; GO:0003677; GO:0007219; GO:0007420; GO:0007424; GO:0007430; GO:0008056; GO:0008283; GO:0010629; GO:0035214; GO:0035218; GO:0035220; GO:0046872	"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; compound eye photoreceptor fate commitment [GO:0001752]; eye-antennal disc development [GO:0035214]; leg disc development [GO:0035218]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; ocellus development [GO:0008056]; open tracheal system development [GO:0007424]; terminal branching, open tracheal system [GO:0007430]; wing disc development [GO:0035220]"
PGEN_.00g050100	Scaffold_02	47085534	47085737	NA	NA	NA	NA	NA
PGEN_.00g050110	Scaffold_02	47085839	47086180	NA	NA	NA	NA	NA
PGEN_.00g050120	Scaffold_02	47110992	47115427	NA	NA	NA	NA	NA
PGEN_.00g050130	Scaffold_02	47137238	47139733	NA	NA	NA	NA	NA
PGEN_.00g050140	Scaffold_02	47155600	47158507	NA	NA	NA	NA	NA
PGEN_.00g050150	Scaffold_02	47207466	47254248	Q7Z5K2	WAPL_HUMAN	Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor)	GO:0000278; GO:0000775; GO:0000785; GO:0000795; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0009636; GO:0016032; GO:0035562; GO:0045132; GO:0045875; GO:0048146; GO:0051301; GO:0060623; GO:0071168; GO:0071922	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; meiotic chromosome segregation [GO:0045132]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]; viral process [GO:0016032]"
PGEN_.00g050160	Scaffold_02	47261500	47262690	NA	NA	NA	NA	NA
PGEN_.00g050170	Scaffold_02	47298190	47299423	NA	NA	NA	NA	NA
PGEN_.00g050180	Scaffold_02	47299859	47303590	NA	NA	NA	NA	NA
PGEN_.00g050190	Scaffold_02	47312228	47312500	NA	NA	NA	NA	NA
PGEN_.00g050200	Scaffold_02	47316596	47317150	NA	NA	NA	NA	NA
PGEN_.00g050210	Scaffold_02	47351094	47351651	NA	NA	NA	NA	NA
PGEN_.00g050220	Scaffold_02	47371212	47375677	Q61361	PGCB_MOUSE	Brevican core protein	GO:0001501; GO:0005509; GO:0005540; GO:0005615; GO:0007160; GO:0007417; GO:0009986; GO:0021766; GO:0030246; GO:0030424; GO:0030425; GO:0031012; GO:0031225; GO:0033268; GO:0043194; GO:0045202; GO:0060074; GO:0072534; GO:0098966; GO:0098978; GO:0098982; GO:1990138	anchored component of membrane [GO:0031225]; axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; node of Ranvier [GO:0033268]; perineuronal net [GO:0072534]; perisynaptic extracellular matrix [GO:0098966]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell-matrix adhesion [GO:0007160]; central nervous system development [GO:0007417]; hippocampus development [GO:0021766]; neuron projection extension [GO:1990138]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]
PGEN_.00g050230	Scaffold_02	47387834	47389469	NA	NA	NA	NA	NA
PGEN_.00g050240	Scaffold_02	47397523	47400244	NA	NA	NA	NA	NA
PGEN_.00g050250	Scaffold_02	47407061	47425582	G3V8Y7	AP4AT_RAT	AP-4 complex accessory subunit Tepsin (ENTH domain-containing protein 2) (Tetra-epsin)	GO:0005737; GO:0005829; GO:0016607; GO:0030662; GO:0031312; GO:0031965; GO:0032588	coated vesicle membrane [GO:0030662]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; trans-Golgi network membrane [GO:0032588]
PGEN_.00g050260	Scaffold_02	47428031	47444780	O75897	ST1C4_HUMAN	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]
PGEN_.00g050270	Scaffold_02	47462804	47517164	P59759	MRTFB_MOUSE	Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2)	GO:0001701; GO:0001764; GO:0001889; GO:0003007; GO:0003700; GO:0003713; GO:0003779; GO:0005634; GO:0005737; GO:0007507; GO:0007517; GO:0010467; GO:0010468; GO:0030036; GO:0030900; GO:0031175; GO:0045844; GO:0045893; GO:0045944; GO:0048514; GO:0048568; GO:0048738; GO:0051145	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; actin binding [GO:0003779]; DNA-binding transcription factor activity [GO:0003700]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; blood vessel morphogenesis [GO:0048514]; cardiac muscle tissue development [GO:0048738]; embryonic organ development [GO:0048568]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; muscle organ development [GO:0007517]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; smooth muscle cell differentiation [GO:0051145]"
PGEN_.00g050280	Scaffold_02	47545034	47546714	NA	NA	NA	NA	NA
PGEN_.00g050290	Scaffold_02	47586951	47587247	NA	NA	NA	NA	NA
PGEN_.00g050300	Scaffold_02	47593255	47616293	O55173	PDPK1_RAT	3-phosphoinositide-dependent protein kinase 1 (EC 2.7.11.1) (Protein kinase B kinase) (PkB kinase)	GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006469; GO:0006972; GO:0007173; GO:0010518; GO:0010594; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0018105; GO:0018107; GO:0019722; GO:0019901; GO:0030512; GO:0031410; GO:0032148; GO:0032869; GO:0034122; GO:0035556; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043524; GO:0043536; GO:0045766; GO:0048041; GO:0051281; GO:0071364; GO:0097191; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352	cell [GO:0005623]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein phosphorylation [GO:0006468]; regulation of endothelial cell migration [GO:0010594]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323]
PGEN_.00g050310	Scaffold_02	47622544	47626095	NA	NA	NA	NA	NA
PGEN_.00g050320	Scaffold_02	47649283	47669584	Q8UVJ7	CDHR1_CHICK	Cadherin-related family member 1 (Photoreceptor cadherin) (prCAD) (Protocadherin-21)	GO:0000902; GO:0005509; GO:0005886; GO:0005913; GO:0007043; GO:0007156; GO:0008092; GO:0009986; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0042803; GO:0044331; GO:0045296; GO:0098609	catenin complex [GO:0016342]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; protein homodimerization activity [GO:0042803]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g050330	Scaffold_02	47681210	47681455	NA	NA	NA	NA	NA
PGEN_.00g050340	Scaffold_02	47692152	47730974	P09405	NUCL_MOUSE	Nucleolin (Protein C23)	GO:0001525; GO:0001650; GO:0001651; GO:0003697; GO:0003723; GO:0005102; GO:0005509; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0005938; GO:0006897; GO:0008022; GO:0009986; GO:0017148; GO:0032760; GO:0035368; GO:0036464; GO:0042134; GO:0042162; GO:0042393; GO:0042802; GO:0043066; GO:0043236; GO:0043565; GO:0044547; GO:0045944; GO:0048026; GO:0048027; GO:0071222; GO:0071364; GO:1901838; GO:1990631; GO:1990830; GO:1990904; GO:2000232; GO:2000778	"cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; calcium ion binding [GO:0005509]; DNA topoisomerase binding [GO:0044547]; ErbB-4 class receptor binding [GO:1990631]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; mRNA 5'-UTR binding [GO:0048027]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134]; selenocysteine insertion sequence binding [GO:0035368]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162]; angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; endocytosis [GO:0006897]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of rRNA processing [GO:2000232]"
PGEN_.00g050350	Scaffold_02	47744305	47756841	Q3T0T7	SAR1B_BOVIN	GTP-binding protein SAR1b	GO:0003400; GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0032580; GO:0046872; GO:0061024; GO:0070863; GO:0070971	COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050]
PGEN_.00g050360	Scaffold_02	47764040	47775444	Q9VCC3	RT24_DROME	"28S ribosomal protein S24, mitochondrial (MRP-S24) (S24mt)"	GO:0003735; GO:0005763; GO:0006412; GO:0032543	mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
PGEN_.00g050370	Scaffold_02	47781663	47782946	C3ZQF9	QRFPR_BRAFL	QRFP-like peptide receptor	GO:0004930; GO:0004983; GO:0005887; GO:1901653	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; cellular response to peptide [GO:1901653]
PGEN_.00g050380	Scaffold_02	47784065	47785237	C3ZQF9	QRFPR_BRAFL	QRFP-like peptide receptor	GO:0004930; GO:0004983; GO:0005887; GO:1901653	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; cellular response to peptide [GO:1901653]
PGEN_.00g050390	Scaffold_02	47796390	47800783	Q5YKK9	OPN4_FELCA	Melanopsin (Opsin-4)	GO:0005502; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0016021; GO:0018298; GO:0042752; GO:0048511; GO:0071482	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601]
PGEN_.00g050400	Scaffold_02	47816105	47826770	NA	NA	NA	NA	NA
PGEN_.00g050410	Scaffold_02	47837440	47909756	O18023	IGDB2_CAEEL	Ig-like and fibronectin type-III domain-containing protein 2	GO:0005886; GO:0016021; GO:0030017	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]
PGEN_.00g050420	Scaffold_02	47917477	47917779	NA	NA	NA	NA	NA
PGEN_.00g050430	Scaffold_02	47917814	47920900	NA	NA	NA	NA	NA
PGEN_.00g050440	Scaffold_02	47939733	47952088	Q8BGA7	CG026_MOUSE	Uncharacterized protein C7orf26 homolog		
PGEN_.00g050450	Scaffold_02	48029054	48078115	Q9Y620	RA54B_HUMAN	DNA repair and recombination protein RAD54B (EC 3.6.4.-) (RAD54 homolog B)	GO:0000724; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005634; GO:0006312; GO:0007131; GO:0015616	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; RNA helicase activity [GO:0003724]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination [GO:0006312]; reciprocal meiotic recombination [GO:0007131]
PGEN_.00g050460	Scaffold_02	48107839	48316483	Q6V0I7	FAT4_HUMAN	Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
PGEN_.00g050470	Scaffold_02	48316483	48321151	NA	NA	NA	NA	NA
PGEN_.00g050480	Scaffold_02	48322311	48322919	NA	NA	NA	NA	NA
PGEN_.00g050490	Scaffold_02	48322986	48325153	NA	NA	NA	NA	NA
PGEN_.00g050500	Scaffold_02	48325526	48332325	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g050510	Scaffold_02	48344545	48349166	Q9NZV6	MSRB1_HUMAN	Methionine-R-sulfoxide reductase B1 (MsrB1) (EC 1.8.4.12) (EC 1.8.4.14) (Selenoprotein X) (SelX)	GO:0003779; GO:0005634; GO:0005829; GO:0008270; GO:0015629; GO:0030041; GO:0030091; GO:0033743; GO:0033745; GO:0045087; GO:0070191	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleus [GO:0005634]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; methionine-R-sulfoxide reductase activity [GO:0070191]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091]
PGEN_.00g050520	Scaffold_02	48356640	48358476	NA	NA	NA	NA	NA
PGEN_.00g050530	Scaffold_02	48362951	48374931	Q9H633	RPP21_HUMAN	Ribonuclease P protein subunit p21 (RNaseP protein p21) (EC 3.1.26.5) (Ribonuclease P/MRP 21 kDa subunit) (Ribonucleoprotein V)	GO:0001682; GO:0004526; GO:0005654; GO:0005655; GO:0008033; GO:0030681; GO:0033204; GO:0042493; GO:0046872	multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; response to drug [GO:0042493]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]
PGEN_.00g050540	Scaffold_02	48378406	48383417	NA	NA	NA	NA	NA
PGEN_.00g050550	Scaffold_02	48401783	48402283	P29294	MYLK_RABIT	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]
PGEN_.00g050560	Scaffold_02	48411086	48412096	NA	NA	NA	NA	NA
PGEN_.00g050570	Scaffold_02	48431041	48557150	Q96Q15	SMG1_HUMAN	Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (61E3.4) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein)	GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0018105; GO:0032204; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:2001020	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]"
PGEN_.00g050580	Scaffold_02	48575780	48579090	NA	NA	NA	NA	NA
PGEN_.00g050590	Scaffold_02	48579194	48609621	O15169	AXIN1_HUMAN	Axin-1 (Axis inhibition protein 1) (hAxin)	GO:0001934; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007275; GO:0008013; GO:0010800; GO:0016055; GO:0016328; GO:0019899; GO:0019901; GO:0030111; GO:0030877; GO:0031398; GO:0031410; GO:0031625; GO:0032147; GO:0033138; GO:0033146; GO:0034622; GO:0035591; GO:0042802; GO:0042803; GO:0045732; GO:0045893; GO:0046330; GO:0046332; GO:0048471; GO:0051443; GO:0060090; GO:0070016; GO:0070411; GO:0071944; GO:0090090; GO:0090263; GO:1904885; GO:1904886; GO:2000060	"beta-catenin destruction complex [GO:0030877]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cellular protein-containing complex assembly [GO:0034622]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of JNK cascade [GO:0046330]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of Wnt signaling pathway [GO:0030111]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g050600	Scaffold_02	48656711	48717285	O70496	CLCN7_MOUSE	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	GO:0005247; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016021; GO:0022857; GO:0031410; GO:0043231	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; response to pH [GO:0009268]
PGEN_.00g050610	Scaffold_02	48721951	48729822	Q17QK9	NAA60_BOVIN	N-alpha-acetyltransferase 60 (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF)	GO:0000139; GO:0004596; GO:0006334; GO:0006474; GO:0007059; GO:0008283; GO:0010485; GO:0017196; GO:0042803; GO:0043966; GO:0043967	Golgi membrane [GO:0000139]; H4 histone acetyltransferase activity [GO:0010485]; peptide alpha-N-acetyltransferase activity [GO:0004596]; protein homodimerization activity [GO:0042803]; cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334]
PGEN_.00g050620	Scaffold_02	48736015	48737814	Q17QK9	NAA60_BOVIN	N-alpha-acetyltransferase 60 (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF)	GO:0000139; GO:0004596; GO:0006334; GO:0006474; GO:0007059; GO:0008283; GO:0010485; GO:0017196; GO:0042803; GO:0043966; GO:0043967	Golgi membrane [GO:0000139]; H4 histone acetyltransferase activity [GO:0010485]; peptide alpha-N-acetyltransferase activity [GO:0004596]; protein homodimerization activity [GO:0042803]; cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334]
PGEN_.00g050630	Scaffold_02	48738918	48739445	NA	NA	NA	NA	NA
PGEN_.00g050640	Scaffold_02	48766123	48766419	NA	NA	NA	NA	NA
PGEN_.00g050650	Scaffold_02	48785345	48802729	P51537	MYG_HALMK	Myoglobin	GO:0005344; GO:0019441; GO:0020037; GO:0046872	heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen carrier activity [GO:0005344]; tryptophan catabolic process to kynurenine [GO:0019441]
PGEN_.00g050660	Scaffold_02	48802860	48826600	F1MH24	AAK1_BOVIN	AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1)	GO:0004674; GO:0005112; GO:0005524; GO:0005634; GO:0005905; GO:0006468; GO:0006897; GO:0019897; GO:0030054; GO:0030136; GO:0031252; GO:0032880; GO:0035612; GO:0043195; GO:0045747; GO:0046777; GO:0050821; GO:2000369	cell junction [GO:0030054]; cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of plasma membrane [GO:0019897]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880]
PGEN_.00g050670	Scaffold_02	48836237	48859066	NA	NA	NA	NA	NA
PGEN_.00g050680	Scaffold_02	48884823	48886949	NA	NA	NA	NA	NA
PGEN_.00g050690	Scaffold_02	48917141	48923734	NA	NA	NA	NA	NA
PGEN_.00g050700	Scaffold_02	48931822	48935529	NA	NA	NA	NA	NA
PGEN_.00g050710	Scaffold_02	48942711	48943930	NA	NA	NA	NA	NA
PGEN_.00g050720	Scaffold_02	48957625	48958359	Q9YHV3	NOGG3_DANRE	Noggin-3	GO:0001649; GO:0005615; GO:0007368; GO:0009953; GO:0030514; GO:0035844; GO:0045596; GO:0048703; GO:0048793; GO:0051216	extracellular space [GO:0005615]; cartilage development [GO:0051216]; cloaca development [GO:0035844]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; osteoblast differentiation [GO:0001649]; pronephros development [GO:0048793]
PGEN_.00g050730	Scaffold_02	48967663	48968127	NA	NA	NA	NA	NA
PGEN_.00g050740	Scaffold_02	48968416	48972199	NA	NA	NA	NA	NA
PGEN_.00g050750	Scaffold_02	48972734	49017150	O60303	K0556_HUMAN	Protein KIAA0556	GO:0005615; GO:0005737; GO:0005856; GO:0042995; GO:0090660	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; cerebrospinal fluid circulation [GO:0090660]
PGEN_.00g050760	Scaffold_02	49028648	49048650	Q5XK85	K0556_XENLA	Protein KIAA0556 homolog	GO:0005737; GO:0005856; GO:0042995	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]
PGEN_.00g050770	Scaffold_02	49049601	49055812	Q7Z6J9	SEN54_HUMAN	tRNA-splicing endonuclease subunit Sen54 (SEN54 homolog) (HsSEN54) (tRNA-intron endonuclease Sen54)	GO:0000214; GO:0000379; GO:0005654; GO:0005730; GO:0006388; GO:0006397; GO:0090502	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]; mRNA processing [GO:0006397]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]"
PGEN_.00g050780	Scaffold_02	49093276	49194745	Q60674	NR1D2_MOUSE	Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear receptor RVR) (Rev-erb-beta)	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007275; GO:0008134; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030374; GO:0033993; GO:0038023; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0090575; GO:0097009; GO:2001014	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; multicellular organism development [GO:0007275]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]; response to lipid [GO:0033993]"
PGEN_.00g050790	Scaffold_02	49127313	49132360	NA	NA	NA	NA	NA
PGEN_.00g050800	Scaffold_02	49196944	49206558	D4A770	CL004_RAT	Protein C12orf4 homolog	GO:0005737; GO:0043304	cytoplasm [GO:0005737]; regulation of mast cell degranulation [GO:0043304]
PGEN_.00g050810	Scaffold_02	49275049	49280076	Q3UN21	MF4B3_MOUSE	Deleted.		
PGEN_.00g050820	Scaffold_02	49286976	49291637	Q7SXB7	MFD4A_DANRE	Major facilitator superfamily domain-containing protein 4A	GO:0005355; GO:0016021	integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]
PGEN_.00g050830	Scaffold_02	49304499	49304798	NA	NA	NA	NA	NA
PGEN_.00g050840	Scaffold_02	49305105	49305452	NA	NA	NA	NA	NA
PGEN_.00g050850	Scaffold_02	49313686	49314618	NA	NA	NA	NA	NA
PGEN_.00g050860	Scaffold_02	49349659	49352723	NA	NA	NA	NA	NA
PGEN_.00g050870	Scaffold_02	49373237	49405221	NA	NA	NA	NA	NA
PGEN_.00g050880	Scaffold_02	49461279	49471643	Q7TN88	PK1L2_MOUSE	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g050890	Scaffold_02	49493216	49497077	NA	NA	NA	NA	NA
PGEN_.00g050900	Scaffold_02	49516356	49516772	NA	NA	NA	NA	NA
PGEN_.00g050910	Scaffold_02	49517237	49517674	NA	NA	NA	NA	NA
PGEN_.00g050920	Scaffold_02	49537905	49560388	NA	NA	NA	NA	NA
PGEN_.00g050930	Scaffold_02	49567891	49588743	NA	NA	NA	NA	NA
PGEN_.00g050940	Scaffold_02	49605641	49605844	NA	NA	NA	NA	NA
PGEN_.00g050950	Scaffold_02	49633073	49633474	NA	NA	NA	NA	NA
PGEN_.00g050960	Scaffold_02	49652981	49696670	NA	NA	NA	NA	NA
PGEN_.00g050970	Scaffold_02	49696979	49731700	Q7TN88	PK1L2_MOUSE	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g050980	Scaffold_02	49783171	49783527	NA	NA	NA	NA	NA
PGEN_.00g050990	Scaffold_02	49785826	49787574	NA	NA	NA	NA	NA
PGEN_.00g051000	Scaffold_02	49787601	49787876	NA	NA	NA	NA	NA
PGEN_.00g051010	Scaffold_02	49790481	49814024	Q3T077	TPPP2_BOVIN	Tubulin polymerization-promoting protein family member 2	GO:0001578; GO:0005829; GO:0007283; GO:0015631; GO:0030154; GO:0032273; GO:0036126; GO:0046785; GO:1901317	cytosol [GO:0005829]; sperm flagellum [GO:0036126]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]; regulation of flagellated sperm motility [GO:1901317]; spermatogenesis [GO:0007283]
PGEN_.00g051020	Scaffold_02	49816554	49819235	NA	NA	NA	NA	NA
PGEN_.00g051030	Scaffold_02	49819594	49820490	NA	NA	NA	NA	NA
PGEN_.00g051040	Scaffold_02	49822716	49840874	NA	NA	NA	NA	NA
PGEN_.00g051050	Scaffold_02	49847750	49852062	NA	NA	NA	NA	NA
PGEN_.00g051060	Scaffold_02	49852129	49852566	NA	NA	NA	NA	NA
PGEN_.00g051070	Scaffold_02	49876342	49876803	NA	NA	NA	NA	NA
PGEN_.00g051080	Scaffold_02	49878957	49893435	NA	NA	NA	NA	NA
PGEN_.00g051090	Scaffold_02	49903622	49904467	NA	NA	NA	NA	NA
PGEN_.00g051100	Scaffold_02	49910827	49911141	NA	NA	NA	NA	NA
PGEN_.00g051110	Scaffold_02	49913998	49977689	Q6P616	RBM22_XENTR	Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22)	GO:0000974; GO:0005634; GO:0005737; GO:0007275; GO:0017070; GO:0033120; GO:0036002; GO:0045292; GO:0046872; GO:0071006; GO:0071007	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]; mRNA cis splicing, via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of RNA splicing [GO:0033120]"
PGEN_.00g051120	Scaffold_02	49962784	49967975	NA	NA	NA	NA	NA
PGEN_.00g051130	Scaffold_02	49978900	49979876	NA	NA	NA	NA	NA
PGEN_.00g051140	Scaffold_02	49986906	50040437	Q9Y484	WIPI4_HUMAN	WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45)	GO:0000045; GO:0000407; GO:0000422; GO:0005829; GO:0006497; GO:0006914; GO:0009267; GO:0019898; GO:0019901; GO:0032266; GO:0034045; GO:0034497; GO:0080025; GO:1901981	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"
PGEN_.00g051150	Scaffold_02	50041391	50042473	NA	NA	NA	NA	NA
PGEN_.00g051160	Scaffold_02	50053357	50091755	Q9QYI4	DJB12_MOUSE	DnaJ homolog subfamily B member 12 (mDj10)	GO:0005783; GO:0005789; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0034622; GO:0036503; GO:0051085; GO:0071218	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g051170	Scaffold_02	50119280	50178813	Q24562	U2AF2_DROME	Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)	GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701	"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"
PGEN_.00g051180	Scaffold_02	50189409	50192062	NA	NA	NA	NA	NA
PGEN_.00g051190	Scaffold_02	50195622	50235490	Q24562	U2AF2_DROME	Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)	GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701	"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"
PGEN_.00g051200	Scaffold_02	50280250	50283620	NA	NA	NA	NA	NA
PGEN_.00g051210	Scaffold_02	50287285	50315444	O95847	UCP4_HUMAN	Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27)	GO:0005623; GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0016021; GO:0031966; GO:0035356; GO:0043025; GO:0043066; GO:0045177; GO:0046324; GO:0048839; GO:0051562; GO:0070997; GO:1902600	apical part of cell [GO:0045177]; cell [GO:0005623]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; cellular triglyceride homeostasis [GO:0035356]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; proton transmembrane transport [GO:1902600]; regulation of glucose import [GO:0046324]; response to cold [GO:0009409]
PGEN_.00g051220	Scaffold_02	50335585	50336028	NA	NA	NA	NA	NA
PGEN_.00g051230	Scaffold_02	50339928	50340554	NA	NA	NA	NA	NA
PGEN_.00g051240	Scaffold_02	50348448	50400042	Q6YKA8	DRK_DROSI	Protein E(sev)2B (Downstream of receptor kinase) (Protein enhancer of sevenless 2B) (SH2-SH3 adapter protein drk)	GO:0001784; GO:0005070; GO:0005118; GO:0005154; GO:0005654; GO:0005886; GO:0007173; GO:0007265; GO:0007426; GO:0007427; GO:0007476; GO:0007605; GO:0007614; GO:0008293; GO:0008355; GO:0008543; GO:0030707; GO:0032991; GO:0045500; GO:0045793; GO:0048010; GO:0048260; GO:0070374; GO:0098793; GO:1904263	"nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; sevenless binding [GO:0005118]; SH3/SH2 adaptor activity [GO:0005070]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; olfactory learning [GO:0008355]; ovarian follicle cell development [GO:0030707]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of TORC1 signaling [GO:1904263]; Ras protein signal transduction [GO:0007265]; sensory perception of sound [GO:0007605]; sevenless signaling pathway [GO:0045500]; short-term memory [GO:0007614]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"
PGEN_.00g051250	Scaffold_02	50411031	50412617	NA	NA	NA	NA	NA
PGEN_.00g051260	Scaffold_02	50412756	50415156	NA	NA	NA	NA	NA
PGEN_.00g051270	Scaffold_02	50415341	50415775	NA	NA	NA	NA	NA
PGEN_.00g051280	Scaffold_02	50417364	50417684	NA	NA	NA	NA	NA
PGEN_.00g051290	Scaffold_02	50417823	50418188	NA	NA	NA	NA	NA
PGEN_.00g051300	Scaffold_02	50421771	50452679	Q6YKA8	DRK_DROSI	Protein E(sev)2B (Downstream of receptor kinase) (Protein enhancer of sevenless 2B) (SH2-SH3 adapter protein drk)	GO:0001784; GO:0005070; GO:0005118; GO:0005154; GO:0005654; GO:0005886; GO:0007173; GO:0007265; GO:0007426; GO:0007427; GO:0007476; GO:0007605; GO:0007614; GO:0008293; GO:0008355; GO:0008543; GO:0030707; GO:0032991; GO:0045500; GO:0045793; GO:0048010; GO:0048260; GO:0070374; GO:0098793; GO:1904263	"nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; sevenless binding [GO:0005118]; SH3/SH2 adaptor activity [GO:0005070]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; olfactory learning [GO:0008355]; ovarian follicle cell development [GO:0030707]; positive regulation of cell size [GO:0045793]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of TORC1 signaling [GO:1904263]; Ras protein signal transduction [GO:0007265]; sensory perception of sound [GO:0007605]; sevenless signaling pathway [GO:0045500]; short-term memory [GO:0007614]; torso signaling pathway [GO:0008293]; tracheal outgrowth, open tracheal system [GO:0007426]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"
PGEN_.00g051310	Scaffold_02	50473194	50509724	Q5D1Z3	NOL12_RAT	Nucleolar protein 12 (25 kDa nucleolar protein)	GO:0003697; GO:0003723; GO:0005634; GO:0005730; GO:0019843	nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; single-stranded DNA binding [GO:0003697]
PGEN_.00g051320	Scaffold_02	50525112	50525393	NA	NA	NA	NA	NA
PGEN_.00g051330	Scaffold_02	50535742	50536432	NA	NA	NA	NA	NA
PGEN_.00g051340	Scaffold_02	50537898	50542646	NA	NA	NA	NA	NA
PGEN_.00g051350	Scaffold_02	50543931	50544152	NA	NA	NA	NA	NA
PGEN_.00g051360	Scaffold_02	50563306	50592779	NA	NA	NA	NA	NA
PGEN_.00g051370	Scaffold_02	50593074	50631203	D3YZP9	CCDC6_MOUSE	Coiled-coil domain-containing protein 6	GO:0005829; GO:0005856; GO:0017124	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; SH3 domain binding [GO:0017124]
PGEN_.00g051380	Scaffold_02	50647776	50682267	Q5RDY1	NPL_PONAB	N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase)	GO:0005737; GO:0005975; GO:0008747; GO:0019262	cytoplasm [GO:0005737]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262]
PGEN_.00g051390	Scaffold_02	50703113	50703718	NA	NA	NA	NA	NA
PGEN_.00g051400	Scaffold_02	50720351	50723096	NA	NA	NA	NA	NA
PGEN_.00g051410	Scaffold_02	50737403	50741672	NA	NA	NA	NA	NA
PGEN_.00g051420	Scaffold_02	50769264	50772866	NA	NA	NA	NA	NA
PGEN_.00g051430	Scaffold_02	50797608	50888432	Q2HJF4	PBLD_BOVIN	Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-)	GO:0005737; GO:0009058; GO:0010633; GO:0010719; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0050680; GO:0060392; GO:0060394	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]
PGEN_.00g051440	Scaffold_02	50907732	50916840	NA	NA	NA	NA	NA
PGEN_.00g051450	Scaffold_02	50929718	50930026	NA	NA	NA	NA	NA
PGEN_.00g051460	Scaffold_02	50958741	50959055	NA	NA	NA	NA	NA
PGEN_.00g051470	Scaffold_02	50982023	50982718	NA	NA	NA	NA	NA
PGEN_.00g051480	Scaffold_02	50983863	51005219	P20651	PP2BB_RAT	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta)	GO:0001915; GO:0001946; GO:0001975; GO:0004722; GO:0004723; GO:0005509; GO:0005516; GO:0005737; GO:0005829; GO:0005886; GO:0005955; GO:0006468; GO:0006470; GO:0007420; GO:0007507; GO:0008144; GO:0010468; GO:0017156; GO:0019899; GO:0030018; GO:0030217; GO:0030315; GO:0030346; GO:0031987; GO:0032991; GO:0033173; GO:0033192; GO:0034097; GO:0035690; GO:0035774; GO:0043029; GO:0044877; GO:0045202; GO:0045944; GO:0046716; GO:0046983; GO:0050796; GO:0097720; GO:0098978; GO:1900242	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to drug [GO:0035690]; heart development [GO:0007507]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to amphetamine [GO:0001975]; response to cytokine [GO:0034097]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]
PGEN_.00g051490	Scaffold_02	51005310	51005879	NA	NA	NA	NA	NA
PGEN_.00g051500	Scaffold_02	51009813	51133441	Q9VXF1	PP2B3_DROME	Serine/threonine-protein phosphatase 2B catalytic subunit 3 (EC 3.1.3.16) (Calmodulin-dependent calcineurin A3 subunit)	GO:0004722; GO:0005516; GO:0005737; GO:0005955; GO:0030431; GO:0033192; GO:0046872; GO:0097720	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; calcineurin-mediated signaling [GO:0097720]; sleep [GO:0030431]
PGEN_.00g051510	Scaffold_02	51168769	51169020	NA	NA	NA	NA	NA
PGEN_.00g051520	Scaffold_02	51170520	51170885	NA	NA	NA	NA	NA
PGEN_.00g051530	Scaffold_02	51215632	51376571	Q6C5Y8	VAC8_YARLI	Vacuolar protein 8	GO:0000011; GO:0000329; GO:0016236; GO:0042144; GO:0043495; GO:0071255; GO:0071561; GO:0071562; GO:0071563	"fungal-type vacuole membrane [GO:0000329]; Myo2p-Vac17p-Vac8p transport complex [GO:0071563]; nucleus-vacuole junction [GO:0071561]; protein membrane anchor [GO:0043495]; Cvt vesicle assembly [GO:0071255]; macroautophagy [GO:0016236]; nucleus-vacuole junction assembly [GO:0071562]; vacuole fusion, non-autophagic [GO:0042144]; vacuole inheritance [GO:0000011]"
PGEN_.00g051540	Scaffold_02	51396321	51427416	Q6IE24	UBP54_RAT	Inactive ubiquitin carboxyl-terminal hydrolase 54 (Inactive ubiquitin-specific peptidase 54)	GO:0016579; GO:0036459	thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]
PGEN_.00g051550	Scaffold_02	51438995	51439255	NA	NA	NA	NA	NA
PGEN_.00g051560	Scaffold_02	51439518	51440300	NA	NA	NA	NA	NA
PGEN_.00g051570	Scaffold_02	51493840	51494454	NA	NA	NA	NA	NA
PGEN_.00g051580	Scaffold_02	51536448	51606107	Q6IPR3	TYW3_HUMAN	tRNA wybutosine-synthesizing protein 3 homolog (tRNA-yW-synthesizing protein 3) (EC 2.1.1.282) (tRNA(Phe) 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase)	GO:0005737; GO:0008175; GO:0030488; GO:0031591	cytoplasm [GO:0005737]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591]
PGEN_.00g051590	Scaffold_02	51672663	51673644	NA	NA	NA	NA	NA
PGEN_.00g051600	Scaffold_02	51677042	51677996	NA	NA	NA	NA	NA
PGEN_.00g051610	Scaffold_02	51763833	51768161	Q8IN35	SIFAR_DROME	Neuropeptide SIFamide receptor	GO:0004930; GO:0004983; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016021; GO:0032870; GO:0048047	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g051620	Scaffold_02	51769619	51772024	NA	NA	NA	NA	NA
PGEN_.00g051630	Scaffold_02	51777111	51777557	NA	NA	NA	NA	NA
PGEN_.00g051640	Scaffold_02	51777681	51778040	NA	NA	NA	NA	NA
PGEN_.00g051650	Scaffold_02	51797856	51799276	NA	NA	NA	NA	NA
PGEN_.00g051660	Scaffold_02	51816200	51816448	NA	NA	NA	NA	NA
PGEN_.00g051670	Scaffold_02	51894704	51895388	NA	NA	NA	NA	NA
PGEN_.00g051680	Scaffold_02	51895571	51898691	NA	NA	NA	NA	NA
PGEN_.00g051690	Scaffold_02	51948537	51948764	NA	NA	NA	NA	NA
PGEN_.00g051700	Scaffold_02	51964269	51964631	Q8IN35	SIFAR_DROME	Neuropeptide SIFamide receptor	GO:0004930; GO:0004983; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016021; GO:0032870; GO:0048047	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g051710	Scaffold_02	52016552	52016770	NA	NA	NA	NA	NA
PGEN_.00g051720	Scaffold_02	52080363	52094907	Q1JQA3	AP3S2_BOVIN	AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adaptor-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b)	GO:0005794; GO:0006886; GO:0008089; GO:0016192; GO:0030123; GO:0030659; GO:0043231; GO:0048490; GO:1904115	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g051730	Scaffold_02	52086314	52090390	NA	NA	NA	NA	NA
PGEN_.00g051740	Scaffold_02	52100637	52138746	Q9DCR2	AP3S1_MOUSE	AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a)	GO:0005802; GO:0006886; GO:0008089; GO:0016020; GO:0016192; GO:0030123; GO:0030659; GO:0043231; GO:0048490; GO:1904115	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g051750	Scaffold_02	52117766	52125098	NA	NA	NA	NA	NA
PGEN_.00g051760	Scaffold_02	52162303	52164998	NA	NA	NA	NA	NA
PGEN_.00g051770	Scaffold_02	52170490	52170936	NA	NA	NA	NA	NA
PGEN_.00g051780	Scaffold_02	52171203	52172546	NA	NA	NA	NA	NA
PGEN_.00g051790	Scaffold_02	52172867	52173433	NA	NA	NA	NA	NA
PGEN_.00g051800	Scaffold_02	52173457	52174137	NA	NA	NA	NA	NA
PGEN_.00g051810	Scaffold_02	52175427	52178306	NA	NA	NA	NA	NA
PGEN_.00g051820	Scaffold_02	52204447	52204839	NA	NA	NA	NA	NA
PGEN_.00g051830	Scaffold_02	52204895	52206102	NA	NA	NA	NA	NA
PGEN_.00g051840	Scaffold_02	52212028	52214123	NA	NA	NA	NA	NA
PGEN_.00g051850	Scaffold_02	52271915	52273012	NA	NA	NA	NA	NA
PGEN_.00g051860	Scaffold_02	52286199	52289462	A6NE01	F186A_HUMAN	Protein FAM186A		
PGEN_.00g051870	Scaffold_02	52289526	52290630	NA	NA	NA	NA	NA
PGEN_.00g051880	Scaffold_02	52325581	52367978	Q9D9B4	LRMDA_MOUSE	Leucine-rich melanocyte differentiation-associated protein	GO:0030318	melanocyte differentiation [GO:0030318]
PGEN_.00g051890	Scaffold_02	52373502	52373936	NA	NA	NA	NA	NA
PGEN_.00g051900	Scaffold_02	52395350	52529488	NA	NA	NA	NA	NA
PGEN_.00g051910	Scaffold_02	52542921	52543208	NA	NA	NA	NA	NA
PGEN_.00g051920	Scaffold_02	52543413	52544093	NA	NA	NA	NA	NA
PGEN_.00g051930	Scaffold_02	52553539	52555587	NA	NA	NA	NA	NA
PGEN_.00g051940	Scaffold_02	52556887	52557114	NA	NA	NA	NA	NA
PGEN_.00g051950	Scaffold_02	52576783	52610741	C8YR32	LOXH1_MOUSE	Lipoxygenase homology domain-containing protein 1	GO:0004096; GO:0007605; GO:0020037; GO:0032420	stereocilium [GO:0032420]; catalase activity [GO:0004096]; heme binding [GO:0020037]; sensory perception of sound [GO:0007605]
PGEN_.00g051960	Scaffold_02	52634630	52635085	NA	NA	NA	NA	NA
PGEN_.00g051970	Scaffold_02	52755822	52756115	NA	NA	NA	NA	NA
PGEN_.00g051980	Scaffold_02	52824661	52840323	Q9VE46	SC5A7_DROME	High-affinity choline transporter 1	GO:0003333; GO:0005307; GO:0008292; GO:0015171; GO:0015220; GO:0015871; GO:0016021; GO:0033265	integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]
PGEN_.00g051990	Scaffold_02	52853398	52855984	NA	NA	NA	NA	NA
PGEN_.00g052000	Scaffold_02	52860825	52861880	NA	NA	NA	NA	NA
PGEN_.00g052010	Scaffold_02	52862006	52862440	NA	NA	NA	NA	NA
PGEN_.00g052020	Scaffold_02	52876108	52901269	Q8N0N3	BGBP_PENMO	"Beta-1,3-glucan-binding protein (GBP)"	GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087	"extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]"
PGEN_.00g052030	Scaffold_02	52903681	52904178	O64411	PAO1_MAIZE	Polyamine oxidase 1 (EC 1.5.3.14) (EC 1.5.3.15)	GO:0006598; GO:0009505; GO:0016491; GO:0046208; GO:0046592; GO:0048046; GO:0050660; GO:0052893; GO:0052896; GO:0052897; GO:0052898; GO:0052900	"apoplast [GO:0048046]; plant-type cell wall [GO:0009505]; flavin adenine dinucleotide binding [GO:0050660]; N1-acetylspermidine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity [GO:0052898]; N1-acetylspermine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity [GO:0052893]; N8-acetylspermidine:oxygen oxidoreductase (propane-1,3-diamine-forming) activity [GO:0052897]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine oxidase (propane-1,3-diamine-forming) activity [GO:0052896]; spermine oxidase (propane-1,3-diamine-forming) activity [GO:0052900]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]"
PGEN_.00g052040	Scaffold_02	52914877	52915218	NA	NA	NA	NA	NA
PGEN_.00g052050	Scaffold_02	52921442	52921846	NA	NA	NA	NA	NA
PGEN_.00g052060	Scaffold_02	52921906	52922250	NA	NA	NA	NA	NA
PGEN_.00g052070	Scaffold_02	52941164	53083123	Q3T8J9	GON4L_HUMAN	GON-4-like protein (GON-4 homolog)	GO:0000981; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0016604; GO:0030183; GO:0045892	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription corepressor activity [GO:0003714]; B cell differentiation [GO:0030183]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g052080	Scaffold_02	53026517	53041597	NA	NA	NA	NA	NA
PGEN_.00g052090	Scaffold_02	53096281	53111384	NA	NA	NA	NA	NA
PGEN_.00g052100	Scaffold_02	53125251	53164093	Q5R9L3	G3BP2_PONAB	Ras GTPase-activating protein-binding protein 2 (G3BP-2) (GAP SH3 domain-binding protein 2)	GO:0003723; GO:0005829; GO:0010494; GO:0034063; GO:0045087; GO:0051028; GO:0051260; GO:0062029	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; RNA binding [GO:0003723]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of stress granule assembly [GO:0062029]; protein homooligomerization [GO:0051260]; stress granule assembly [GO:0034063]
PGEN_.00g052110	Scaffold_02	53219098	53219790	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g052120	Scaffold_02	53219883	53220392	P46272	TBP_ACEPE	TATA-box-binding protein (TATA sequence-binding protein) (TBP) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit)	GO:0003677; GO:0005634; GO:0006352	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-templated transcription, initiation [GO:0006352]"
PGEN_.00g052130	Scaffold_02	53221214	53221537	NA	NA	NA	NA	NA
PGEN_.00g052140	Scaffold_02	53221564	53222268	NA	NA	NA	NA	NA
PGEN_.00g052150	Scaffold_02	53222334	53222867	P34456	YMD2_CAEEL	Uncharacterized protein F54H12.2	GO:0004748; GO:0005829; GO:0009263	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]"
PGEN_.00g052160	Scaffold_02	53223362	53306284	Q9UI32	GLSL_HUMAN	"Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase)"	GO:0004359; GO:0005739; GO:0005759; GO:0006520; GO:0006537; GO:0006543; GO:0008652; GO:0014047; GO:0042981; GO:0072593	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]
PGEN_.00g052170	Scaffold_02	53311126	53313334	Q5R890	MINP1_PONAB	"Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase)"	GO:0005788; GO:0034417; GO:0052826	endoplasmic reticulum lumen [GO:0005788]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]
PGEN_.00g052180	Scaffold_02	53318344	53329284	Q9Y535	RPC8_HUMAN	DNA-directed RNA polymerase III subunit RPC8 (RNA polymerase III subunit C8) (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit 22.9 kDa subunit) (RPC22.9)	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0005829; GO:0006139; GO:0006383; GO:0006384; GO:0032481; GO:0043231; GO:0045087; GO:0051607	centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of type I interferon production [GO:0032481]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]
PGEN_.00g052190	Scaffold_02	53376178	53377260	NA	NA	NA	NA	NA
PGEN_.00g052200	Scaffold_02	53399165	53401195	Q5MJ12	FXL16_RAT	F-box/LRR-repeat protein 16 (F-box and leucine-rich repeat protein 16) (Spinal cord injury and regeneration-related protein 1)	GO:0005737; GO:0006511; GO:0016567; GO:0019005; GO:0031146	cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g052210	Scaffold_02	53405045	53406910	NA	NA	NA	NA	NA
PGEN_.00g052220	Scaffold_02	53415742	53416221	NA	NA	NA	NA	NA
PGEN_.00g052230	Scaffold_02	53416446	53421196	NA	NA	NA	NA	NA
PGEN_.00g052240	Scaffold_02	53421413	53431385	NA	NA	NA	NA	NA
PGEN_.00g052250	Scaffold_02	53434453	53440599	NA	NA	NA	NA	NA
PGEN_.00g052260	Scaffold_02	53440818	53441672	NA	NA	NA	NA	NA
PGEN_.00g052270	Scaffold_02	53444933	53450980	NA	NA	NA	NA	NA
PGEN_.00g052280	Scaffold_02	53454621	53455472	NA	NA	NA	NA	NA
PGEN_.00g052290	Scaffold_02	53463770	53464840	NA	NA	NA	NA	NA
PGEN_.00g052300	Scaffold_02	53464894	53465631	NA	NA	NA	NA	NA
PGEN_.00g052310	Scaffold_02	53468491	53476185	NA	NA	NA	NA	NA
PGEN_.00g052320	Scaffold_02	53478232	53478594	NA	NA	NA	NA	NA
PGEN_.00g052330	Scaffold_02	53479680	53480732	NA	NA	NA	NA	NA
PGEN_.00g052340	Scaffold_02	53484723	53487104	NA	NA	NA	NA	NA
PGEN_.00g052350	Scaffold_02	53495097	53500530	NA	NA	NA	NA	NA
PGEN_.00g052360	Scaffold_02	53514996	53515781	Q5E9P3	S1PR1_BOVIN	Sphingosine 1-phosphate receptor 1 (S1P receptor 1) (S1P1) (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1) (S1P receptor Edg-1) (CD antigen CD363)	GO:0001525; GO:0001664; GO:0001955; GO:0003245; GO:0003376; GO:0005654; GO:0005768; GO:0006935; GO:0007193; GO:0007420; GO:0008284; GO:0009897; GO:0016021; GO:0016477; GO:0030032; GO:0030155; GO:0030500; GO:0030595; GO:0031226; GO:0031532; GO:0038036; GO:0045121; GO:0045124; GO:0061384; GO:0072678	endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; G protein-coupled receptor binding [GO:0001664]; sphingosine-1-phosphate receptor activity [GO:0038036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; positive regulation of cell population proliferation [GO:0008284]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678]
PGEN_.00g052370	Scaffold_02	53519511	53519888	NA	NA	NA	NA	NA
PGEN_.00g052380	Scaffold_02	53524602	53526086	P67775	PP2AA_HUMAN	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16) (Replication protein C) (RP-C)	GO:0000159; GO:0000184; GO:0000188; GO:0000775; GO:0000922; GO:0001932; GO:0004721; GO:0004722; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007084; GO:0007498; GO:0008022; GO:0008380; GO:0010033; GO:0010288; GO:0010719; GO:0015630; GO:0016020; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0035970; GO:0040008; GO:0042532; GO:0045121; GO:0045202; GO:0045595; GO:0046872; GO:0046982; GO:0048156; GO:0050811; GO:0051321; GO:0070062; GO:0070262; GO:0071902; GO:1904526; GO:1904528	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; tau protein binding [GO:0048156]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; inactivation of MAPK activity [GO:0000188]; meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of microtubule binding [GO:1904528]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of microtubule binding [GO:1904526]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to lead ion [GO:0010288]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]"
PGEN_.00g052390	Scaffold_02	53558643	53577485	P48463	PP2AA_CHICK	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16)	GO:0000159; GO:0000775; GO:0000922; GO:0004722; GO:0005634; GO:0005737; GO:0008637; GO:0010468; GO:0034976; GO:0042542; GO:0043161; GO:0046872; GO:0046982	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic mitochondrial changes [GO:0008637]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542]"
PGEN_.00g052400	Scaffold_02	53577995	53584774	P63247	RACK1_CHICK	Receptor of activated protein C kinase 1 (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Receptor for activated C kinase) (Receptor of activated protein kinase C 1) (RACK1)	GO:0001891; GO:0001934; GO:0005080; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0008200; GO:0008656; GO:0010629; GO:0016567; GO:0019899; GO:0019903; GO:0022627; GO:0030178; GO:0030292; GO:0030308; GO:0030332; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0032436; GO:0032464; GO:0032880; GO:0033137; GO:0035591; GO:0042169; GO:0042803; GO:0042998; GO:0043022; GO:0043025; GO:0043204; GO:0043473; GO:0043547; GO:0048471; GO:0050765; GO:0051302; GO:0051343; GO:0051726; GO:0051898; GO:0051901; GO:0071333; GO:0071363; GO:0072344; GO:1903208; GO:1990630; GO:2000114; GO:2000543; GO:2001244	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; IRE1-RACK1-PP2A complex [GO:1990630]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; cyclin binding [GO:0030332]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Wnt signaling pathway [GO:0030178]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]; signal transduction [GO:0007165]
PGEN_.00g052410	Scaffold_02	53600264	53612786	NA	NA	NA	NA	NA
PGEN_.00g052420	Scaffold_02	53616002	53616439	NA	NA	NA	NA	NA
PGEN_.00g052430	Scaffold_02	53643281	53659302	NA	NA	NA	NA	NA
PGEN_.00g052440	Scaffold_02	53670769	53680070	Q3T001	H17B6_BOVIN	17-beta-hydroxysteroid dehydrogenase type 6 (17-beta-HSD 6) (17-beta-HSD6) (EC 1.1.1.105) (EC 1.1.1.239) (EC 1.1.1.62) (3-alpha->beta-hydroxysteroid epimerase) (3-alpha->beta-HSE) (Oxidative 3-alpha hydroxysteroid dehydrogenase)	GO:0004303; GO:0004745; GO:0005789; GO:0008202; GO:0047035	endoplasmic reticulum membrane [GO:0005789]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; steroid metabolic process [GO:0008202]
PGEN_.00g052450	Scaffold_02	53690109	53704963	O94901	SUN1_HUMAN	SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1)	GO:0001503; GO:0005521; GO:0005623; GO:0005635; GO:0005639; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0009612; GO:0021817; GO:0031965; GO:0034993; GO:0043231; GO:0043495; GO:0051642; GO:0070197; GO:0090286; GO:0090292	cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; lamin binding [GO:0005521]; protein membrane anchor [GO:0043495]; centrosome localization [GO:0051642]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; ossification [GO:0001503]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]
PGEN_.00g052460	Scaffold_02	53705439	53706095	NA	NA	NA	NA	NA
PGEN_.00g052470	Scaffold_02	53706175	53707705	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g052480	Scaffold_02	53708640	53726472	NA	NA	NA	NA	NA
PGEN_.00g052490	Scaffold_02	53731835	53735804	NA	NA	NA	NA	NA
PGEN_.00g052500	Scaffold_02	53752605	53752973	NA	NA	NA	NA	NA
PGEN_.00g052510	Scaffold_02	53756874	53763001	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g052520	Scaffold_02	53766533	53771258	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g052530	Scaffold_02	53771460	53774935	Q9BXX0	EMIL2_HUMAN	EMILIN-2 (Elastin microfibril interface-located protein 2) (Elastin microfibril interfacer 2) (Protein FOAP-10)	GO:0005576; GO:0005581; GO:0007155; GO:0030023; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix constituent conferring elasticity [GO:0030023]; cell adhesion [GO:0007155]
PGEN_.00g052540	Scaffold_02	53781134	53781421	NA	NA	NA	NA	NA
PGEN_.00g052550	Scaffold_02	53783387	53783989	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g052560	Scaffold_02	53790931	53801106	Q9YIC0	EF1A_ORYLA	Elongation factor 1-alpha (EF-1-alpha)	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]
PGEN_.00g052570	Scaffold_02	53824134	53837518	NA	NA	NA	NA	NA
PGEN_.00g052580	Scaffold_02	53837853	53839441	Q6P5C7	ZN728_MOUSE	Zinc finger protein 728	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g052590	Scaffold_02	53839520	53840332	NA	NA	NA	NA	NA
PGEN_.00g052600	Scaffold_02	53840562	53842418	NA	NA	NA	NA	NA
PGEN_.00g052610	Scaffold_02	53854555	53855124	NA	NA	NA	NA	NA
PGEN_.00g052620	Scaffold_02	53858168	53859150	Q9YIC0	EF1A_ORYLA	Elongation factor 1-alpha (EF-1-alpha)	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]
PGEN_.00g052630	Scaffold_02	53878870	53918080	P79098	AMPN_BOVIN	Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13)	GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]
PGEN_.00g052640	Scaffold_02	53918904	53954492	O57579	AMPN_CHICK	Aminopeptidase Ey (EC 3.4.11.20) (Aminopeptidase N)	GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0016021; GO:0042277; GO:0043171; GO:0070006; GO:0070062	cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]
PGEN_.00g052650	Scaffold_02	53969949	53975987	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g052660	Scaffold_02	53980590	53982559	P82861	ADRO_SALFO	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	GO:0005739; GO:0005743; GO:0008203; GO:0015039	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NADPH-adrenodoxin reductase activity [GO:0015039]; cholesterol metabolic process [GO:0008203]
PGEN_.00g052670	Scaffold_02	53982592	53998481	P22570	ADRO_HUMAN	"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)"	GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006700; GO:0006744; GO:0008203; GO:0015039; GO:0016125; GO:0055114	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; oxidation-reduction process [GO:0055114]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; ubiquinone biosynthetic process [GO:0006744]
PGEN_.00g052680	Scaffold_02	54008892	54053093	Q20496	GDIR_CAEEL	Probable rho GDP-dissociation inhibitor (Rho GDI)	GO:0005094; GO:0005096; GO:0005829; GO:0007266; GO:0016020; GO:0048365	cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; Rho protein signal transduction [GO:0007266]
PGEN_.00g052690	Scaffold_02	54069121	54069612	A2VDL9	T184B_BOVIN	Transmembrane protein 184B	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g052700	Scaffold_02	54084846	54100799	Q3UFJ6	T184A_MOUSE	Transmembrane protein 184A (Sexually dimorphic expressed in male gonads 1)	GO:0005768; GO:0005886; GO:0008201; GO:0016021; GO:0018992; GO:0030658; GO:0030659; GO:0030667; GO:0031901; GO:0032880; GO:0048471; GO:0051046	cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; heparin binding [GO:0008201]; germ-line sex determination [GO:0018992]; regulation of protein localization [GO:0032880]; regulation of secretion [GO:0051046]
PGEN_.00g052710	Scaffold_02	54159978	54176683	NA	NA	NA	NA	NA
PGEN_.00g052720	Scaffold_02	54192274	54195451	A6NHN0	OTOL1_HUMAN	Otolin-1	GO:0005201; GO:0005509; GO:0005576; GO:0005581; GO:0005615; GO:0030198; GO:0031012; GO:0045299; GO:0051260	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; otolith mineralization [GO:0045299]; protein homooligomerization [GO:0051260]
PGEN_.00g052730	Scaffold_02	54230854	54271385	P51892	DNLI1_XENLA	DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)	GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0006260; GO:0006310; GO:0007049; GO:0046872; GO:0051103; GO:0051301; GO:0071897	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]
PGEN_.00g052740	Scaffold_02	54279991	54280416	NA	NA	NA	NA	NA
PGEN_.00g052750	Scaffold_02	54282743	54357674	Q96AX2	RAB37_HUMAN	Ras-related protein Rab-37	GO:0003924; GO:0005525; GO:0005793; GO:0005886; GO:0006886; GO:0032482; GO:0035577; GO:0035579; GO:0043312	azurophil granule membrane [GO:0035577]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; Rab protein signal transduction [GO:0032482]
PGEN_.00g052760	Scaffold_02	54385172	54385390	NA	NA	NA	NA	NA
PGEN_.00g052770	Scaffold_02	54407522	54407929	NA	NA	NA	NA	NA
PGEN_.00g052780	Scaffold_02	54427261	54429341	NA	NA	NA	NA	NA
PGEN_.00g052790	Scaffold_02	54510641	54528577	Q6ICB0	DESI1_HUMAN	Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2) (Polyubiquitinated substrate transporter) (POST)	GO:0005634; GO:0005737; GO:0008233; GO:0042802	cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]
PGEN_.00g052800	Scaffold_02	54541681	54543095	P20420	ACHA5_RAT	Neuronal acetylcholine receptor subunit alpha-5	GO:0005886; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015464; GO:0022848; GO:0030054; GO:0030425; GO:0034220; GO:0035094; GO:0035095; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; protein-containing complex binding [GO:0044877]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g052810	Scaffold_02	54543219	54543677	NA	NA	NA	NA	NA
PGEN_.00g052820	Scaffold_02	54543772	54544293	NA	NA	NA	NA	NA
PGEN_.00g052830	Scaffold_02	54549681	54551467	P02709	ACHA_BOVIN	Acetylcholine receptor subunit alpha	GO:0003009; GO:0005623; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007528; GO:0009986; GO:0015464; GO:0019228; GO:0022848; GO:0030054; GO:0031594; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0046716; GO:0048630; GO:0050877; GO:0050905; GO:0070050; GO:0099060	"acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell cellular homeostasis [GO:0046716]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neuronal action potential [GO:0019228]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g052840	Scaffold_02	54553118	54574835	A2ASQ1	AGRIN_MOUSE	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007416; GO:0007528; GO:0008045; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0016358; GO:0030054; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051290; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]
PGEN_.00g052850	Scaffold_02	54581341	54597971	NA	NA	NA	NA	NA
PGEN_.00g052860	Scaffold_02	54656838	54687836	Q8BMS9	RASF2_MOUSE	Ras association domain-containing protein 2	GO:0000776; GO:0000777; GO:0001501; GO:0001503; GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007049; GO:0031954; GO:0032991; GO:0033137; GO:0038168; GO:0043065; GO:0045667; GO:0045670; GO:0045860; GO:0046330; GO:0046849; GO:0048872; GO:0050821; GO:1901222; GO:1901223	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase activity [GO:0004672]; bone remodeling [GO:0046849]; cell cycle [GO:0007049]; epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade [GO:0038168]; homeostasis of number of cells [GO:0048872]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase activity [GO:0045860]; protein stabilization [GO:0050821]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; skeletal system development [GO:0001501]
PGEN_.00g052870	Scaffold_02	54732199	54738909	Q9UPT5	EXOC7_HUMAN	Exocyst complex component 7 (Exocyst complex component Exo70)	GO:0000145; GO:0005815; GO:0005829; GO:0005886; GO:0006887; GO:0015031; GO:0016020; GO:0016241; GO:0032584; GO:0034451; GO:0090543; GO:2000535	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of macroautophagy [GO:0016241]
PGEN_.00g052880	Scaffold_02	54738942	54768253	O35250	EXOC7_MOUSE	Exocyst complex component 7 (Exocyst complex component Exo70)	GO:0000145; GO:0005815; GO:0005829; GO:0005886; GO:0006887; GO:0015031; GO:0032584; GO:0034451; GO:0090543; GO:2000535	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]
PGEN_.00g052890	Scaffold_02	54768676	54785765	Q923D5	WBP11_MOUSE	WW domain-binding protein 11 (WBP-11) (Splicing factor that interacts with PQBP-1 and PP1)	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006364; GO:0008380; GO:0016607; GO:0019888; GO:0043231; GO:0045292; GO:0050699	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase regulator activity [GO:0019888]; WW domain binding [GO:0050699]; mRNA cis splicing, via spliceosome [GO:0045292]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]"
PGEN_.00g052900	Scaffold_02	54840034	54840973	NA	NA	NA	NA	NA
PGEN_.00g052910	Scaffold_02	54859039	54859589	NA	NA	NA	NA	NA
PGEN_.00g052920	Scaffold_02	54884996	54887291	Q708W2	FXJ1A_XENLA	Forkhead box protein J1-A (FoxJ1-A) (FoxJ1a) (xFoxJ1) (Forkhead protein 5) (xFKH5)	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0043565; GO:0060271	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cilium assembly [GO:0060271]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g052930	Scaffold_02	54901352	54952370	O60341	KDM1A_HUMAN	Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2)	GO:0000122; GO:0000380; GO:0000784; GO:0000790; GO:0001085; GO:0002039; GO:0002052; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006482; GO:0007596; GO:0008134; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034648; GO:0034720; GO:0035563; GO:0042162; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0044212; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0051572; GO:0051573; GO:0055001; GO:0060992; GO:0061752; GO:0071320; GO:0071480; GO:0120162; GO:1902166; GO:1903827; GO:1990391; GO:2000179; GO:2000648	"DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric DNA binding [GO:0042162]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]"
PGEN_.00g052940	Scaffold_02	54956253	54956741	NA	NA	NA	NA	NA
PGEN_.00g052950	Scaffold_02	54962849	55014252	O43490	PROM1_HUMAN	Prominin-1 (Antigen AC133) (Prominin-like protein 1) (CD antigen CD133)	GO:0001750; GO:0005615; GO:0005783; GO:0005793; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0010842; GO:0015485; GO:0016324; GO:0031528; GO:0031982; GO:0042622; GO:0042805; GO:0045296; GO:0045494; GO:0060042; GO:0060219; GO:0070062; GO:0071914; GO:0072112; GO:0072139; GO:2000768	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; vesicle [GO:0031982]; actinin binding [GO:0042805]; cadherin binding [GO:0045296]; cholesterol binding [GO:0015485]; camera-type eye photoreceptor cell differentiation [GO:0060219]; glomerular parietal epithelial cell differentiation [GO:0072139]; glomerular visceral epithelial cell differentiation [GO:0072112]; photoreceptor cell maintenance [GO:0045494]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; retina layer formation [GO:0010842]; retina morphogenesis in camera-type eye [GO:0060042]
PGEN_.00g052960	Scaffold_02	55023219	55023845	NA	NA	NA	NA	NA
PGEN_.00g052970	Scaffold_02	55023886	55024206	NA	NA	NA	NA	NA
PGEN_.00g052980	Scaffold_02	55024814	55025377	NA	NA	NA	NA	NA
PGEN_.00g052990	Scaffold_02	55027853	55034901	NA	NA	NA	NA	NA
PGEN_.00g053000	Scaffold_02	55035159	55035809	NA	NA	NA	NA	NA
PGEN_.00g053010	Scaffold_02	55040645	55041527	Q3URU2	PEG3_MOUSE	Paternally-expressed gene 3 protein (ASF-1)	GO:0000122; GO:0003676; GO:0005634; GO:0005776; GO:0006915; GO:0010468; GO:0045944; GO:0046872	autophagosome [GO:0005776]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]
PGEN_.00g053020	Scaffold_02	55041883	55069989	NA	NA	NA	NA	NA
PGEN_.00g053030	Scaffold_02	55075721	55099587	P47809	MP2K4_MOUSE	Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (C-JUN N-terminal kinase kinase 1) (JNK kinase 1) (JNKK 1) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1)	GO:0000165; GO:0000187; GO:0001934; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007254; GO:0007257; GO:0008545; GO:0009611; GO:0023014; GO:0030424; GO:0031435; GO:0032147; GO:0032839; GO:0034393; GO:0043065; GO:0043204; GO:0043525; GO:0045740; GO:0051770; GO:0061049; GO:0071260; GO:0072709; GO:2000672	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; protein phosphorylation [GO:0006468]; response to wounding [GO:0009611]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g053040	Scaffold_02	55117405	55128555	Q5HZT0	DXO_XENLA	Decapping and exoribonuclease protein (DXO) (EC 3.1.13.-) (EC 3.6.1.-) (Dom-3 homolog Z)	GO:0000166; GO:0000287; GO:0003729; GO:0005634; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090305; GO:0110152; GO:0110155	nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD-cap (NAD-forming) hydrolase activity [GO:0110152]; RNA pyrophosphohydrolase activity [GO:0034353]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779]
PGEN_.00g053050	Scaffold_02	55134838	55137810	NA	NA	NA	NA	NA
PGEN_.00g053060	Scaffold_02	55150822	55152447	Q13371	PHLP_HUMAN	Phosducin-like protein (PHLP)	GO:0005737; GO:0005829; GO:0005929; GO:0006457; GO:0007165; GO:0007601; GO:0008277; GO:0030030; GO:0044877; GO:0045880; GO:0061084; GO:1902605	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex binding [GO:0044877]; cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; negative regulation of protein refolding [GO:0061084]; positive regulation of smoothened signaling pathway [GO:0045880]; protein folding [GO:0006457]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601]
PGEN_.00g053070	Scaffold_02	55154414	55166122	Q5PR68	CE112_MOUSE	Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46)	GO:0005737; GO:0005813; GO:0005886; GO:0060077; GO:0097120	centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; receptor localization to synapse [GO:0097120]
PGEN_.00g053080	Scaffold_02	55172885	55184654	Q5PR68	CE112_MOUSE	Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46)	GO:0005737; GO:0005813; GO:0005886; GO:0060077; GO:0097120	centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; receptor localization to synapse [GO:0097120]
PGEN_.00g053090	Scaffold_02	55184749	55189248	Q8N8E3	CE112_HUMAN	Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46)	GO:0005737; GO:0005813; GO:0005886; GO:0060077; GO:0097120	centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; receptor localization to synapse [GO:0097120]
PGEN_.00g053100	Scaffold_02	55198837	55211850	Q94545	ASH2_DROME	"Set1/Ash2 histone methyltransferase complex subunit ASH2 (Absent, small, or homeotic discs protein 2)"	GO:0002168; GO:0003677; GO:0005634; GO:0005700; GO:0005703; GO:0006357; GO:0007420; GO:0007444; GO:0007474; GO:0007476; GO:0010628; GO:0010629; GO:0019899; GO:0033128; GO:0035075; GO:0035209; GO:0044212; GO:0044665; GO:0044666; GO:0046872; GO:0048096; GO:0048188; GO:0048813; GO:0051568; GO:0051571	MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; Set1C/COMPASS complex [GO:0048188]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; chromatin-mediated maintenance of transcription [GO:0048096]; dendrite morphogenesis [GO:0048813]; histone H3-K4 methylation [GO:0051568]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; negative regulation of gene expression [GO:0010629]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; pupal development [GO:0035209]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ecdysone [GO:0035075]
PGEN_.00g053110	Scaffold_02	55229915	55247178	NA	NA	NA	NA	NA
PGEN_.00g053120	Scaffold_02	55256190	55291263	Q91X20	ASH2L_MOUSE	Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein)	GO:0005634; GO:0005654; GO:0005719; GO:0006974; GO:0008013; GO:0008284; GO:0035097; GO:0042800; GO:0043627; GO:0044212; GO:0044666; GO:0045944; GO:0046872; GO:0048096; GO:0048188; GO:0051568; GO:0071339; GO:1990188	histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; euchromatin binding [GO:1990188]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cellular response to DNA damage stimulus [GO:0006974]; chromatin-mediated maintenance of transcription [GO:0048096]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627]
PGEN_.00g053130	Scaffold_02	55329927	55337015	NA	NA	NA	NA	NA
PGEN_.00g053140	Scaffold_02	55337250	55338215	NA	NA	NA	NA	NA
PGEN_.00g053150	Scaffold_02	55338246	55345155	NA	NA	NA	NA	NA
PGEN_.00g053160	Scaffold_02	55350315	55361871	O95639	CPSF4_HUMAN	Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit) (CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1) (Neb-1) (No arches homolog)	GO:0000398; GO:0003723; GO:0005654; GO:0005847; GO:0006369; GO:0006388; GO:0006406; GO:0008270; GO:0031124; GO:0043231; GO:0046778; GO:0098789	"intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; modification by virus of host mRNA processing [GO:0046778]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
PGEN_.00g053170	Scaffold_02	55381667	55443330	Q8N695	SC5A8_HUMAN	Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)	GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]
PGEN_.00g053180	Scaffold_02	55454311	55454574	NA	NA	NA	NA	NA
PGEN_.00g053190	Scaffold_02	55470486	55470746	NA	NA	NA	NA	NA
PGEN_.00g053200	Scaffold_02	55483844	55488826	Q32L83	BRI3_BOVIN	Brain protein I3	GO:0005765; GO:0016021	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]
PGEN_.00g053210	Scaffold_02	55495396	55495617	NA	NA	NA	NA	NA
PGEN_.00g053220	Scaffold_02	55526844	55529509	NA	NA	NA	NA	NA
PGEN_.00g053230	Scaffold_02	55544607	55558441	NA	NA	NA	NA	NA
PGEN_.00g053240	Scaffold_02	55566015	55571660	P83425	HIP_MYTED	Heavy metal-binding protein HIP	GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]
PGEN_.00g053250	Scaffold_02	55582354	55582575	NA	NA	NA	NA	NA
PGEN_.00g053260	Scaffold_02	55637633	55645279	NA	NA	NA	NA	NA
PGEN_.00g053270	Scaffold_02	55645766	55646269	NA	NA	NA	NA	NA
PGEN_.00g053280	Scaffold_02	55646523	55646957	NA	NA	NA	NA	NA
PGEN_.00g053290	Scaffold_02	55680684	55680971	NA	NA	NA	NA	NA
PGEN_.00g053300	Scaffold_02	55719171	55719410	NA	NA	NA	NA	NA
PGEN_.00g053310	Scaffold_02	55721498	55724533	NA	NA	NA	NA	NA
PGEN_.00g053320	Scaffold_02	55735741	55743677	P30975	TLR2_DROME	Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR)	GO:0004995; GO:0005886; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0042048; GO:0050805; GO:0050911; GO:1904058	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]
PGEN_.00g053330	Scaffold_02	55778921	55779706	P14600	NK1R_RAT	Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)	GO:0002118; GO:0002526; GO:0002687; GO:0003051; GO:0004995; GO:0005623; GO:0005737; GO:0005886; GO:0007204; GO:0007217; GO:0007218; GO:0007611; GO:0007616; GO:0008217; GO:0008306; GO:0009408; GO:0009725; GO:0009986; GO:0010193; GO:0010634; GO:0010996; GO:0014070; GO:0014910; GO:0016021; GO:0016496; GO:0019233; GO:0030425; GO:0032224; GO:0032230; GO:0032355; GO:0032570; GO:0035094; GO:0035106; GO:0035815; GO:0036126; GO:0042713; GO:0042755; GO:0043117; GO:0043278; GO:0044297; GO:0045471; GO:0045760; GO:0045777; GO:0045778; GO:0045907; GO:0046878; GO:0046887; GO:0048265; GO:0048266; GO:0048660; GO:0050671; GO:0050679; GO:0051496; GO:0051602; GO:0060083; GO:0061827; GO:0070472; GO:0070474; GO:0071944; GO:0097225; GO:1902093	"cell [GO:0005623]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; substance P receptor activity [GO:0016496]; tachykinin receptor activity [GO:0004995]; acute inflammatory response [GO:0002526]; aggressive behavior [GO:0002118]; angiotensin-mediated drinking behavior [GO:0003051]; associative learning [GO:0008306]; behavioral response to pain [GO:0048266]; eating behavior [GO:0042755]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; neuropeptide signaling pathway [GO:0007218]; operant conditioning [GO:0035106]; positive regulation of action potential [GO:0045760]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of hormone secretion [GO:0046887]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of ossification [GO:0045778]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of saliva secretion [GO:0046878]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of uterine smooth muscle contraction [GO:0070472]; response to auditory stimulus [GO:0010996]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to ozone [GO:0010193]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; sensory perception of pain [GO:0019233]; smooth muscle contraction involved in micturition [GO:0060083]; sperm ejaculation [GO:0042713]; tachykinin receptor signaling pathway [GO:0007217]"
PGEN_.00g053340	Scaffold_02	55793551	55795535	NA	NA	NA	NA	NA
PGEN_.00g053350	Scaffold_02	55821457	55821750	NA	NA	NA	NA	NA
PGEN_.00g053360	Scaffold_02	55840865	55847916	NA	NA	NA	NA	NA
PGEN_.00g053370	Scaffold_02	55951265	55956330	NA	NA	NA	NA	NA
PGEN_.00g053380	Scaffold_02	55957987	55964042	Q2LE78	BTBD6_XENLA	BTB/POZ domain-containing protein 6	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g053390	Scaffold_02	55975075	55982332	NA	NA	NA	NA	NA
PGEN_.00g053400	Scaffold_02	56001128	56023246	Q6P2U9	CSN3_DANRE	COP9 signalosome complex subunit 3 (Signalosome subunit 3)	GO:0005737; GO:0006511; GO:0008180	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g053410	Scaffold_02	56043204	56046894	Q8TCD5	NT5C_HUMAN	"5'(3')-deoxyribonucleotidase, cytosolic type (EC 3.1.3.-) (Cytosolic 5',3'-pyrimidine nucleotidase) (Deoxy-5'-nucleotidase 1) (dNT-1)"	GO:0005634; GO:0005737; GO:0005829; GO:0006195; GO:0008252; GO:0008253; GO:0009223; GO:0016311; GO:0019103; GO:0046135; GO:0046872; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; pyrimidine nucleotide binding [GO:0019103]; dephosphorylation [GO:0016311]; purine nucleotide catabolic process [GO:0006195]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]; pyrimidine nucleoside catabolic process [GO:0046135]
PGEN_.00g053420	Scaffold_02	56053353	56082704	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g053430	Scaffold_02	56093501	56099284	NA	NA	NA	NA	NA
PGEN_.00g053440	Scaffold_02	56099392	56117933	Q15637	SF01_HUMAN	Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162)	GO:0000245; GO:0000389; GO:0000398; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005840; GO:0008270; GO:0016604; GO:0030238; GO:0030575; GO:0033327; GO:0042802; GO:0045131; GO:0048662; GO:0050810	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245]"
PGEN_.00g053450	Scaffold_02	56138168	56167766	Q5ZL98	RPC1_CHICK	DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)	GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0046872	RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g053460	Scaffold_02	56167830	56168571	NA	NA	NA	NA	NA
PGEN_.00g053470	Scaffold_02	56181084	56212145	B9E8C3	ALR_MACCJ	Alanine racemase (EC 5.1.1.1)	GO:0008784; GO:0030170; GO:0030632	alanine racemase activity [GO:0008784]; pyridoxal phosphate binding [GO:0030170]; D-alanine biosynthetic process [GO:0030632]
PGEN_.00g053480	Scaffold_02	56218240	56218806	NA	NA	NA	NA	NA
PGEN_.00g053490	Scaffold_02	56220678	56221406	NA	NA	NA	NA	NA
PGEN_.00g053500	Scaffold_02	56228283	56229228	NA	NA	NA	NA	NA
PGEN_.00g053510	Scaffold_02	56241093	56241347	NA	NA	NA	NA	NA
PGEN_.00g053520	Scaffold_02	56243444	56243722	B7GYG5	BETA_ACIB3	Oxygen-dependent choline dehydrogenase (CDH) (CHD) (EC 1.1.99.1) (Betaine aldehyde dehydrogenase) (BADH) (EC 1.2.1.8)	GO:0008802; GO:0008812; GO:0019285; GO:0050660	betaine-aldehyde dehydrogenase activity [GO:0008802]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]
PGEN_.00g053530	Scaffold_02	56243754	56244419	P18173	DHGL_DROME	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"
PGEN_.00g053540	Scaffold_02	56244896	56245237	Q8NE62	CHDH_HUMAN	"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)"	GO:0005743; GO:0008812; GO:0019285; GO:0042426; GO:0050660	mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]
PGEN_.00g053550	Scaffold_02	56268205	56270191	B8D0W1	ALR_HALOH	Alanine racemase (EC 5.1.1.1)	GO:0008784; GO:0030170; GO:0030632	alanine racemase activity [GO:0008784]; pyridoxal phosphate binding [GO:0030170]; D-alanine biosynthetic process [GO:0030632]
PGEN_.00g053560	Scaffold_02	56272394	56274205	P18173	DHGL_DROME	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"
PGEN_.00g053570	Scaffold_02	56296097	56296405	NA	NA	NA	NA	NA
PGEN_.00g053580	Scaffold_02	56296535	56297014	NA	NA	NA	NA	NA
PGEN_.00g053590	Scaffold_02	56300714	56307002	NA	NA	NA	NA	NA
PGEN_.00g053600	Scaffold_02	56334054	56358065	Q95M71	BIRC8_GORGO	Baculoviral IAP repeat-containing protein 8 (Inhibitor of apoptosis-like protein 2) (IAP-like protein 2) (ILP-2)	GO:0005634; GO:0005737; GO:0031398; GO:0043027; GO:0043154; GO:0046872; GO:0061630; GO:0090263; GO:1990001	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]
PGEN_.00g053610	Scaffold_02	56378245	56389160	Q29S14	TV23B_BOVIN	Golgi apparatus membrane protein TVP23 homolog B	GO:0009306; GO:0016192; GO:0030173	integral component of Golgi membrane [GO:0030173]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]
PGEN_.00g053620	Scaffold_02	56389803	56391878	A8IW99	PLD6_CHLRE	Mitochondrial cardiolipin hydrolase (EC 3.1.-.-) (Phospholipase D6 homolog) (PLD 6)	GO:0004519; GO:0005741; GO:0016021; GO:0016042; GO:0046872; GO:0051321	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; lipid catabolic process [GO:0016042]; meiotic cell cycle [GO:0051321]
PGEN_.00g053630	Scaffold_02	56403698	56420355	Q9UGM3	DMBT1_HUMAN	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0007275; GO:0008329; GO:0009897; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]
PGEN_.00g053640	Scaffold_02	56420783	56421808	NA	NA	NA	NA	NA
PGEN_.00g053650	Scaffold_02	56421881	56427434	NA	NA	NA	NA	NA
PGEN_.00g053660	Scaffold_02	56431422	56435352	Q9UGM3	DMBT1_HUMAN	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0007275; GO:0008329; GO:0009897; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]
PGEN_.00g053670	Scaffold_02	56436280	56447952	P80010	PLMN_HORSE	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Plasmin light chain B] (Fragment)	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
PGEN_.00g053680	Scaffold_02	56452504	56453073	Q2V897	TLR2_BOSTR	Toll-like receptor 2 (CD antigen CD282)	GO:0002755; GO:0005794; GO:0006954; GO:0016021; GO:0030670; GO:0034134; GO:0045087; GO:0045121; GO:0050707; GO:0050729; GO:0071726; GO:0071727	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]
PGEN_.00g053690	Scaffold_02	56453812	56454666	NA	NA	NA	NA	NA
PGEN_.00g053700	Scaffold_02	56464980	56465868	NA	NA	NA	NA	NA
PGEN_.00g053710	Scaffold_02	56480281	56481093	NA	NA	NA	NA	NA
PGEN_.00g053720	Scaffold_02	56483542	56494802	P49842	STK19_HUMAN	Serine/threonine-protein kinase 19 (EC 2.7.11.1) (Protein G11) (Protein RP1)	GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0016607; GO:0017016; GO:0046579	nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Ras GTPase binding [GO:0017016]; positive regulation of Ras protein signal transduction [GO:0046579]; protein phosphorylation [GO:0006468]
PGEN_.00g053730	Scaffold_02	56494966	56498420	Q9NPF2	CHSTB_HUMAN	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)	GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]
PGEN_.00g053740	Scaffold_02	56508733	56509429	NA	NA	NA	NA	NA
PGEN_.00g053750	Scaffold_02	56551710	56563290	NA	NA	NA	NA	NA
PGEN_.00g053760	Scaffold_02	56565190	56597460	NA	NA	NA	NA	NA
PGEN_.00g053770	Scaffold_02	56597915	56603800	NA	NA	NA	NA	NA
PGEN_.00g053780	Scaffold_02	56649155	56650039	O18728	FSCN2_BOVIN	Fascin-2 (Retinal fascin)	GO:0003779; GO:0005737; GO:0007163; GO:0015629; GO:0016477; GO:0030036; GO:0030674; GO:0032420; GO:0042462; GO:0051015; GO:0051017	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein binding, bridging [GO:0030674]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; eye photoreceptor cell development [GO:0042462]"
PGEN_.00g053790	Scaffold_02	56670249	56671459	Q24524	SING_DROME	Protein singed	GO:0003779; GO:0005737; GO:0007163; GO:0008407; GO:0009913; GO:0015629; GO:0016358; GO:0016477; GO:0030034; GO:0030036; GO:0030674; GO:0035017; GO:0035099; GO:0035317; GO:0042060; GO:0043005; GO:0043025; GO:0046847; GO:0048477; GO:0048800; GO:0048812; GO:0051015; GO:0051017	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein binding, bridging [GO:0030674]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060]"
PGEN_.00g053800	Scaffold_02	56688145	56735343	Q6P8I6	COX11_MOUSE	"Cytochrome c oxidase assembly protein COX11, mitochondrial"	GO:0005507; GO:0005739; GO:0031305; GO:0032991; GO:0033132; GO:0055065	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; copper ion binding [GO:0005507]; metal ion homeostasis [GO:0055065]; negative regulation of glucokinase activity [GO:0033132]
PGEN_.00g053810	Scaffold_02	56736892	56760815	P55039	DRG2_HUMAN	Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-)	GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0043231; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165]
PGEN_.00g053820	Scaffold_02	56766857	56783931	Q8VIJ8	NPRL3_MOUSE	GATOR complex protein NPRL3 (Nitrogen permease regulator 3-like protein)	GO:0003281; GO:0005096; GO:0005765; GO:0032007; GO:0034198; GO:0035909; GO:0038202; GO:0048738; GO:0060021; GO:1990130; GO:2000785	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; GTPase activator activity [GO:0005096]; aorta morphogenesis [GO:0035909]; cardiac muscle tissue development [GO:0048738]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TOR signaling [GO:0032007]; regulation of autophagosome assembly [GO:2000785]; roof of mouth development [GO:0060021]; TORC1 signaling [GO:0038202]; ventricular septum development [GO:0003281]
PGEN_.00g053830	Scaffold_02	56784189	56788517	NA	NA	NA	NA	NA
PGEN_.00g053840	Scaffold_02	56788710	56825805	Q9NR30	DDX21_HUMAN	Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)	GO:0001649; GO:0002735; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006364; GO:0006366; GO:0016020; GO:0019843; GO:0030515; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045815; GO:0051607; GO:0097322	"cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g053850	Scaffold_02	56812238	56815115	NA	NA	NA	NA	NA
PGEN_.00g053860	Scaffold_02	56826605	56842806	P14316	IRF2_HUMAN	Interferon regulatory factor 2 (IRF-2)	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006355; GO:0007596; GO:0008283; GO:0045944; GO:0051607; GO:0060333; GO:0060337	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; blood coagulation [GO:0007596]; cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; type I interferon signaling pathway [GO:0060337]"
PGEN_.00g053870	Scaffold_02	56876835	56877164	NA	NA	NA	NA	NA
PGEN_.00g053880	Scaffold_02	56906898	56916000	Q98925	IRF2_CHICK	Interferon regulatory factor 2 (IRF-2)	GO:0000981; GO:0002376; GO:0005634; GO:0008283; GO:0044212	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region DNA binding [GO:0044212]; cell population proliferation [GO:0008283]; immune system process [GO:0002376]"
PGEN_.00g053890	Scaffold_02	56929382	56934430	NA	NA	NA	NA	NA
PGEN_.00g053900	Scaffold_02	57001072	57002882	NA	NA	NA	NA	NA
PGEN_.00g053910	Scaffold_02	57007854	57016678	NA	NA	NA	NA	NA
PGEN_.00g053920	Scaffold_02	57038283	57056712	Q8TBP0	TBC16_HUMAN	TBC1 domain family member 16	GO:0001919; GO:0005096; GO:0005769; GO:0005829; GO:0006886; GO:0017137; GO:0090630	cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919]
PGEN_.00g053930	Scaffold_02	57062991	57071151	NA	NA	NA	NA	NA
PGEN_.00g053940	Scaffold_02	57072276	57082622	Q8TBP0	TBC16_HUMAN	TBC1 domain family member 16	GO:0001919; GO:0005096; GO:0005769; GO:0005829; GO:0006886; GO:0017137; GO:0090630	cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919]
PGEN_.00g053950	Scaffold_02	57085922	57110274	Q4G0X9	CCD40_HUMAN	Coiled-coil domain-containing protein 40	GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0035469; GO:0036159; GO:0044458; GO:0060271; GO:0060287; GO:0070286; GO:0071907; GO:0071910	axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; regulation of cilium beat frequency [GO:0003356]
PGEN_.00g053960	Scaffold_02	57118708	57126541	Q7T0L6	CCNF_XENLA	Cyclin-F	GO:0005634; GO:0005737; GO:0005814; GO:0007049; GO:0010826; GO:0016567; GO:0019005; GO:0031146; GO:0051301	centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of centrosome duplication [GO:0010826]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g053970	Scaffold_02	57178282	57294577	Q7JQ32	GC76C_DROME	Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1)	GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0019934; GO:0030198; GO:0030215; GO:0030510; GO:0038023; GO:0046872	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; extracellular matrix organization [GO:0030198]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]"
PGEN_.00g053980	Scaffold_02	57317248	57318224	NA	NA	NA	NA	NA
PGEN_.00g053990	Scaffold_02	57336361	57338394	NA	NA	NA	NA	NA
PGEN_.00g054000	Scaffold_02	57372270	57372638	NA	NA	NA	NA	NA
PGEN_.00g054010	Scaffold_02	57401757	57402520	NA	NA	NA	NA	NA
PGEN_.00g054020	Scaffold_02	57438922	57439467	NA	NA	NA	NA	NA
PGEN_.00g054030	Scaffold_02	57439874	57441015	NA	NA	NA	NA	NA
PGEN_.00g054040	Scaffold_02	57509422	57514196	NA	NA	NA	NA	NA
PGEN_.00g054050	Scaffold_02	57532227	57542334	Q5HZL1	ERI2_XENLA	ERI1 exoribonuclease 2 (EC 3.1.-.-) (Exonuclease domain-containing protein 1)	GO:0003676; GO:0004527; GO:0008270	exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]
PGEN_.00g054060	Scaffold_02	57542626	57543303	A8K979	ERI2_HUMAN	ERI1 exoribonuclease 2 (EC 3.1.-.-) (Exonuclease domain-containing protein 1)	GO:0000175; GO:0003676; GO:0008270; GO:0008310	3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]
PGEN_.00g054070	Scaffold_02	57556327	57564003	NA	NA	NA	NA	NA
PGEN_.00g054080	Scaffold_02	57574019	57582335	B6CJY5	TRAF6_MACMU	TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)	GO:0000122; GO:0001503; GO:0001701; GO:0001843; GO:0002726; GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005829; GO:0005938; GO:0006974; GO:0007249; GO:0007250; GO:0008270; GO:0009898; GO:0019886; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032743; GO:0032991; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043123; GO:0043422; GO:0043507; GO:0045084; GO:0045410; GO:0045453; GO:0045672; GO:0045944; GO:0047485; GO:0048468; GO:0048471; GO:0050852; GO:0051023; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0071222; GO:1904996; GO:2000679	CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase B binding [GO:0043422]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 biosynthetic process [GO:0045084]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]
PGEN_.00g054090	Scaffold_02	57591241	57621421	A0JP70	WDR90_XENTR	WD repeat-containing protein 90	GO:0005737; GO:0005814; GO:0008017; GO:0060271	centriole [GO:0005814]; cytoplasm [GO:0005737]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]
PGEN_.00g054100	Scaffold_02	57627737	57629407	NA	NA	NA	NA	NA
PGEN_.00g054110	Scaffold_02	57631597	57633590	A1X158	FP1V1_PERVI	Foot protein 1 variant 1	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g054120	Scaffold_02	57646871	57687325	P20072	ANXA7_BOVIN	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	GO:0005178; GO:0005509; GO:0005544; GO:0005623; GO:0005634; GO:0006874; GO:0030855; GO:0042584; GO:0042802; GO:0048306; GO:0051592	cell [GO:0005623]; chromaffin granule membrane [GO:0042584]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; cellular calcium ion homeostasis [GO:0006874]; epithelial cell differentiation [GO:0030855]; response to calcium ion [GO:0051592]
PGEN_.00g054130	Scaffold_02	57707373	57707696	NA	NA	NA	NA	NA
PGEN_.00g054140	Scaffold_02	57725100	57763013	Q9R0W9	ACHA6_MOUSE	Neuronal acetylcholine receptor subunit alpha-6	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0014059; GO:0016020; GO:0022848; GO:0030054; GO:0033603; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0050877; GO:0051899; GO:0098691; GO:0099055; GO:0099056; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g054150	Scaffold_02	57782954	57783439	NA	NA	NA	NA	NA
PGEN_.00g054160	Scaffold_02	58005712	58010019	NA	NA	NA	NA	NA
PGEN_.00g054170	Scaffold_02	58032561	58038382	NA	NA	NA	NA	NA
PGEN_.00g054180	Scaffold_02	58045177	58054376	NA	NA	NA	NA	NA
PGEN_.00g054190	Scaffold_02	58062116	58062433	NA	NA	NA	NA	NA
PGEN_.00g054200	Scaffold_02	58111702	58114614	NA	NA	NA	NA	NA
PGEN_.00g054210	Scaffold_02	58115036	58182768	Q4TVV3	DDX46_DANRE	Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46)	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0007420; GO:0015030; GO:0016607; GO:0031017; GO:0045621; GO:0045648; GO:0048546; GO:0060216; GO:0072576; GO:1902038	"Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; digestive tract morphogenesis [GO:0048546]; exocrine pancreas development [GO:0031017]; liver morphogenesis [GO:0072576]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of lymphocyte differentiation [GO:0045621]"
PGEN_.00g054220	Scaffold_02	58148187	58148729	NA	NA	NA	NA	NA
PGEN_.00g054230	Scaffold_02	58190109	58199727	Q9CY66	GAR1_MOUSE	H/ACA ribonucleoprotein complex subunit 1 (Nucleolar protein family A member 1) (snoRNP protein GAR1)	GO:0000454; GO:0000784; GO:0001650; GO:0001651; GO:0005697; GO:0007004; GO:0015030; GO:0030515; GO:0031429; GO:0034513; GO:0070034; GO:0090661	"box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; nuclear chromosome, telomeric region [GO:0000784]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; snoRNA binding [GO:0030515]; telomerase RNA binding [GO:0070034]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomere maintenance via telomerase [GO:0007004]"
PGEN_.00g054240	Scaffold_02	58213672	58222969	NA	NA	NA	NA	NA
PGEN_.00g054250	Scaffold_02	58260794	58502688	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g054260	Scaffold_02	58511872	58538848	NA	NA	NA	NA	NA
PGEN_.00g054270	Scaffold_02	58542995	58567107	Q5RBD5	IVD_PONAB	"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4)"	GO:0005759; GO:0006552; GO:0008470; GO:0050660	mitochondrial matrix [GO:0005759]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; leucine catabolic process [GO:0006552]
PGEN_.00g054280	Scaffold_02	58572161	58579710	Q6GR34	CP52A_XENLA	Uncharacterized protein C16orf52 homolog A		
PGEN_.00g054290	Scaffold_02	58580204	58593548	O43808	PM34_HUMAN	Peroxisomal membrane protein PMP34 (34 kDa peroxisomal membrane protein) (Solute carrier family 25 member 17)	GO:0000295; GO:0001561; GO:0005347; GO:0005777; GO:0005778; GO:0005779; GO:0006635; GO:0015217; GO:0015228; GO:0015230; GO:0015867; GO:0015908; GO:0016020; GO:0044610; GO:0051087; GO:0051724; GO:0080122	integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; chaperone binding [GO:0051087]; coenzyme A transmembrane transporter activity [GO:0015228]; FAD transmembrane transporter activity [GO:0015230]; FMN transmembrane transporter activity [GO:0044610]; NAD transmembrane transporter activity [GO:0051724]; ATP transport [GO:0015867]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]
PGEN_.00g054300	Scaffold_02	58638147	58674559	O77460	IPYR_DROME	Inorganic pyrophosphatase (EC 3.6.1.1) (Nucleosome-remodeling factor 38 kDa subunit) (Pyrophosphate phospho-hydrolase) (PPase)	GO:0000287; GO:0004427; GO:0005634; GO:0005737; GO:0006338; GO:0006351; GO:0006796; GO:0016589; GO:0035076; GO:0035206; GO:0042766	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; NURF complex [GO:0016589]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; regulation of hemocyte proliferation [GO:0035206]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g054310	Scaffold_02	58694098	58696267	NA	NA	NA	NA	NA
PGEN_.00g054320	Scaffold_02	58700936	58701550	NA	NA	NA	NA	NA
PGEN_.00g054330	Scaffold_02	58701594	58736201	P91943	PANG1_DROME	"Protein pangolin, isoforms A/H/I/S (dTCF)"	GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007367; GO:0007435; GO:0007476; GO:0007500; GO:0007507; GO:0008013; GO:0009880; GO:0010628; GO:0016055; GO:0019900; GO:0035277; GO:0043565; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0060070; GO:0070491; GO:0072091	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; canonical Wnt signaling pathway [GO:0060070]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g054340	Scaffold_02	58737793	58738026	NA	NA	NA	NA	NA
PGEN_.00g054350	Scaffold_02	58755452	58756807	NA	NA	NA	NA	NA
PGEN_.00g054360	Scaffold_02	58757827	58797672	NA	NA	NA	NA	NA
PGEN_.00g054370	Scaffold_02	58800743	58801486	NA	NA	NA	NA	NA
PGEN_.00g054380	Scaffold_02	58808672	58817919	NA	NA	NA	NA	NA
PGEN_.00g054390	Scaffold_02	58829694	58859212	Q149M9	NWD1_HUMAN	NACHT domain- and WD repeat-containing protein 1	GO:0005524; GO:0005829; GO:0010628; GO:0032088	cytosol [GO:0005829]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]
PGEN_.00g054400	Scaffold_02	58860855	58861900	NA	NA	NA	NA	NA
PGEN_.00g054410	Scaffold_02	58864580	58876374	Q9QZD8	DIC_MOUSE	Mitochondrial dicarboxylate carrier (Solute carrier family 25 member 10)	GO:0005654; GO:0005739; GO:0005743; GO:0006817; GO:0006839; GO:0008272; GO:0015114; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015291; GO:0015297; GO:0015709; GO:0015729; GO:0015743; GO:0015744; GO:0016021; GO:0035435; GO:0071422; GO:0071423	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; phosphate ion transmembrane transporter activity [GO:0015114]; secondary active transmembrane transporter activity [GO:0015291]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; malate transmembrane transport [GO:0071423]; malate transport [GO:0015743]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; succinate transmembrane transport [GO:0071422]; succinate transport [GO:0015744]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]
PGEN_.00g054420	Scaffold_02	58898655	58985673	Q7Z442	PK1L2_HUMAN	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g054430	Scaffold_02	59015316	59015855	NA	NA	NA	NA	NA
PGEN_.00g054440	Scaffold_02	59016164	59016790	NA	NA	NA	NA	NA
PGEN_.00g054450	Scaffold_02	59016848	59017473	NA	NA	NA	NA	NA
PGEN_.00g054460	Scaffold_02	59017731	59018039	NA	NA	NA	NA	NA
PGEN_.00g054470	Scaffold_02	59018166	59018534	NA	NA	NA	NA	NA
PGEN_.00g054480	Scaffold_02	59020676	59056687	NA	NA	NA	NA	NA
PGEN_.00g054490	Scaffold_02	59041035	59044851	NA	NA	NA	NA	NA
PGEN_.00g054500	Scaffold_02	59060638	59062106	NA	NA	NA	NA	NA
PGEN_.00g054510	Scaffold_02	59127372	59128352	NA	NA	NA	NA	NA
PGEN_.00g054520	Scaffold_02	59211701	59249301	Q8BFR2	FSTL5_MOUSE	Follistatin-related protein 5 (Follistatin-like protein 5) (m-D/Bsp120I 1-2)	GO:0005509; GO:0005576; GO:0007275; GO:0030154	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]
PGEN_.00g054530	Scaffold_02	59250690	59253085	NA	NA	NA	NA	NA
PGEN_.00g054540	Scaffold_02	59259890	59264237	Q8IX30	SCUB3_HUMAN	"Signal peptide, CUB and EGF-like domain-containing protein 3"	GO:0005509; GO:0005615; GO:0005886; GO:0009986; GO:0022617; GO:0045880; GO:0051260; GO:0051291	cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; extracellular matrix disassembly [GO:0022617]; positive regulation of smoothened signaling pathway [GO:0045880]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]
PGEN_.00g054550	Scaffold_02	59326382	59335695	NA	NA	NA	NA	NA
PGEN_.00g054560	Scaffold_02	59335967	59337139	NA	NA	NA	NA	NA
PGEN_.00g054570	Scaffold_02	59337216	59338955	NA	NA	NA	NA	NA
PGEN_.00g054580	Scaffold_02	59342522	59380777	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g054590	Scaffold_02	59391836	59417484	NA	NA	NA	NA	NA
PGEN_.00g054600	Scaffold_02	59423183	59427731	Q6TFL4	KLH24_HUMAN	Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1)	GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312	adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]
PGEN_.00g054610	Scaffold_02	59429787	59435895	Q0P5N6	ARL16_HUMAN	ADP-ribosylation factor-like protein 16	GO:0005525	GTP binding [GO:0005525]
PGEN_.00g054620	Scaffold_02	59443952	59456981	Q95LS7	CCD96_MACFA	Coiled-coil domain-containing protein 96	GO:0005737; GO:0005815	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]
PGEN_.00g054630	Scaffold_02	59462152	59514345	Q54HX8	CDIP1_DICDI	Cell death-inducing p53-target protein 1 homolog (Protein LITAF homolog)	GO:0005765; GO:0031902; GO:0046872	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]
PGEN_.00g054640	Scaffold_02	59528046	59533154	Q804H7	BI52B_XENLA	Baculoviral IAP repeat-containing protein 5.2-B (Survivin in Xenopus) (SIX) (Survivin2-B) (XSurvivin2B)	GO:0000777; GO:0001944; GO:0005634; GO:0005737; GO:0005819; GO:0006468; GO:0007049; GO:0007059; GO:0030496; GO:0032133; GO:0043066; GO:0045892; GO:0046872; GO:0046965; GO:0051301	"chromosome passenger complex [GO:0032133]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; retinoid X receptor binding [GO:0046965]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; vasculature development [GO:0001944]"
PGEN_.00g054650	Scaffold_02	59539175	59574371	Q9ES39	NDE1_RAT	Nuclear distribution protein nudE homolog 1 (NudE) (rNudE)	GO:0000132; GO:0000776; GO:0000777; GO:0001764; GO:0005623; GO:0005737; GO:0005813; GO:0005815; GO:0005819; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0007405; GO:0008017; GO:0016477; GO:0019904; GO:0021987; GO:0030900; GO:0031023; GO:0031616; GO:0032154; GO:0042802; GO:0045202; GO:0047496; GO:0051298; GO:0051301; GO:0051303; GO:0051642; GO:2000574	cell [GO:0005623]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; forebrain development [GO:0030900]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496]
PGEN_.00g054660	Scaffold_02	59599198	59637019	Q27128	PAPSS_URECA	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]	GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779	adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; sulfate assimilation [GO:0000103]
PGEN_.00g054670	Scaffold_02	59640421	59658427	Q27128	PAPSS_URECA	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]	GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779	adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; sulfate assimilation [GO:0000103]
PGEN_.00g054680	Scaffold_02	59664903	59665178	NA	NA	NA	NA	NA
PGEN_.00g054690	Scaffold_02	59680887	59692701	NA	NA	NA	NA	NA
PGEN_.00g054700	Scaffold_02	59694904	59709521	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g054710	Scaffold_02	59718011	59726390	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g054720	Scaffold_02	59745517	59760391	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g054730	Scaffold_02	59770468	59770782	NA	NA	NA	NA	NA
PGEN_.00g054740	Scaffold_02	59776691	59786892	Q58CS8	GNPTG_BOVIN	N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma)	GO:0005576; GO:0005794; GO:0042803; GO:0046835	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; protein homodimerization activity [GO:0042803]; carbohydrate phosphorylation [GO:0046835]
PGEN_.00g054750	Scaffold_02	59787984	59799513	Q9UJK0	TSR3_HUMAN	Ribosome biogenesis protein TSR3 homolog	GO:0000154; GO:0005829; GO:0016740; GO:0030490	cytosol [GO:0005829]; transferase activity [GO:0016740]; maturation of SSU-rRNA [GO:0030490]; rRNA modification [GO:0000154]
PGEN_.00g054760	Scaffold_02	59806769	59811012	NA	NA	NA	NA	NA
PGEN_.00g054770	Scaffold_02	59808965	59809258	NA	NA	NA	NA	NA
PGEN_.00g054780	Scaffold_02	59854049	59854351	NA	NA	NA	NA	NA
PGEN_.00g054790	Scaffold_02	59855784	59856305	NA	NA	NA	NA	NA
PGEN_.00g054800	Scaffold_02	59856497	59857300	NA	NA	NA	NA	NA
PGEN_.00g054810	Scaffold_02	59904752	59905774	NA	NA	NA	NA	NA
PGEN_.00g054820	Scaffold_02	59966906	59967682	NA	NA	NA	NA	NA
PGEN_.00g054830	Scaffold_02	59968446	59972214	NA	NA	NA	NA	NA
PGEN_.00g054840	Scaffold_02	59991087	60033408	NA	NA	NA	NA	NA
PGEN_.00g054850	Scaffold_02	60034281	60073269	O18783	PLMN_MACEU	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
PGEN_.00g054860	Scaffold_02	60119388	60145193	Q9BZE9	ASPC1_HUMAN	Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein) (Alveolar soft part sarcoma locus) (Renal papillary cell carcinoma protein 17) (UBX domain-containing protein 9)	GO:0005654; GO:0005829; GO:0005886; GO:0006886; GO:0009898; GO:0012505; GO:0012506; GO:0019898; GO:0031401; GO:0033116; GO:0042593; GO:0043231; GO:0046324; GO:0048471	cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324]
PGEN_.00g054870	Scaffold_02	60153473	60153694	NA	NA	NA	NA	NA
PGEN_.00g054880	Scaffold_02	60157927	60167373	Q0P4F7	ACSF2_DANRE	"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)"	GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]
PGEN_.00g054890	Scaffold_02	60182931	60188505	Q8N6F8	MET27_HUMAN	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)		
PGEN_.00g054900	Scaffold_02	60196589	60197619	NA	NA	NA	NA	NA
PGEN_.00g054910	Scaffold_02	60211470	60212297	A7YVI8	OXLD1_BOVIN	Oxidoreductase-like domain-containing protein 1		
PGEN_.00g054920	Scaffold_02	60213381	60222381	Q8R0K4	CC137_MOUSE	Coiled-coil domain-containing protein 137	GO:0001650; GO:0005694; GO:0005730	chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]
PGEN_.00g054930	Scaffold_02	60229678	60232781	P02257	H1_ECHCR	"Histone H1, gonadal (Fragment)"	GO:0000786; GO:0003677; GO:0005634; GO:0006334	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome assembly [GO:0006334]
PGEN_.00g054940	Scaffold_02	60236606	60248225	Q8R035	ICT1_MOUSE	"Peptidyl-tRNA hydrolase ICT1, mitochondrial (EC 3.1.1.29) (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Immature colon carcinoma transcript 1 protein homolog)"	GO:0004045; GO:0005739; GO:0005762; GO:0016150; GO:0070126	"mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]; mitochondrial translational termination [GO:0070126]"
PGEN_.00g054950	Scaffold_02	60254924	60266682	P51958	CDK1_CARAU	Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)	GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0007049; GO:0008353; GO:0051301	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g054960	Scaffold_02	60273126	60318990	Q13045	FLII_HUMAN	Protein flightless-1 homolog	GO:0003779; GO:0005654; GO:0005829; GO:0005903; GO:0005925; GO:0007275; GO:0030036; GO:0034451; GO:0051014; GO:0051015	brush border [GO:0005903]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament severing [GO:0051014]; multicellular organism development [GO:0007275]
PGEN_.00g054970	Scaffold_02	60326241	60352529	NA	NA	NA	NA	NA
PGEN_.00g054980	Scaffold_02	60387788	60395770	Q9NWF9	RN216_HUMAN	E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (Ubiquitin-conjugating enzyme 7-interacting protein 1) (Zinc finger protein inhibiting NF-kappa-B)	GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0016032; GO:0032480; GO:0032648; GO:0043161; GO:0046872; GO:0050691; GO:0061630; GO:0070936; GO:0098685; GO:0098843; GO:0098978; GO:0099546	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]; viral process [GO:0016032]"
PGEN_.00g054990	Scaffold_02	60420409	60466283	Q91YE8	SYNP2_MOUSE	Synaptopodin-2 (Myopodin)	GO:0000045; GO:0001725; GO:0003779; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0015629; GO:0030018; GO:0030335; GO:0030674; GO:0031005; GO:0032233; GO:0043231; GO:0051371; GO:0051393; GO:0061684; GO:0071889; GO:2000298	"actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; protein binding, bridging [GO:0030674]; autophagosome assembly [GO:0000045]; chaperone-mediated autophagy [GO:0061684]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298]"
PGEN_.00g055000	Scaffold_02	60491809	60519663	Q62417	SRBS1_MOUSE	Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)	GO:0001725; GO:0005070; GO:0005158; GO:0005634; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005899; GO:0005913; GO:0005924; GO:0005925; GO:0008134; GO:0008286; GO:0016020; GO:0016363; GO:0019901; GO:0031625; GO:0032869; GO:0043149; GO:0045121; GO:0045202; GO:0045725; GO:0046326; GO:0046628; GO:0046889; GO:0048041; GO:0095500; GO:1903078; GO:1904393	cell-cell adherens junction [GO:0005913]; cell-substrate adherens junction [GO:0005924]; centrosome [GO:0005813]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; insulin receptor complex [GO:0005899]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; synapse [GO:0045202]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; SH3/SH2 adaptor activity [GO:0005070]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; acetylcholine receptor signaling pathway [GO:0095500]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; stress fiber assembly [GO:0043149]
PGEN_.00g055010	Scaffold_02	60508862	60509173	NA	NA	NA	NA	NA
PGEN_.00g055020	Scaffold_02	60521489	60529681	NA	NA	NA	NA	NA
PGEN_.00g055030	Scaffold_02	60545355	60640948	NA	NA	NA	NA	NA
PGEN_.00g055040	Scaffold_02	60642143	60642634	NA	NA	NA	NA	NA
PGEN_.00g055050	Scaffold_02	60644414	60710631	Q9PU47	PDLI3_CHICK	PDZ and LIM domain protein 3 (Alpha-actinin-associated LIM protein)	GO:0001725; GO:0003779; GO:0005623; GO:0005913; GO:0005925; GO:0007507; GO:0015629; GO:0030018; GO:0030027; GO:0030036; GO:0031941; GO:0046872; GO:0051371; GO:0051393; GO:0061061	actin cytoskeleton [GO:0015629]; cell [GO:0005623]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]
PGEN_.00g055060	Scaffold_02	60711015	60826611	Q5PPZ9	GDS1B_XENLA	Rap1 GTPase-GDP dissociation stimulator 1-B (Rap1gds1-B protein) (RalB-binding protein B) (XsmgGDS-B) (smgGDS-B)	GO:0005096; GO:0005737; GO:0005856; GO:0007264; GO:0017160; GO:0043547	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g055070	Scaffold_02	60826611	60826946	NA	NA	NA	NA	NA
PGEN_.00g055080	Scaffold_02	60851737	60853080	NA	NA	NA	NA	NA
PGEN_.00g055090	Scaffold_02	60866219	60870080	Q8VBX0	ASB13_MOUSE	Ankyrin repeat and SOCS box protein 13 (ASB-13)	GO:0016567; GO:0035556	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]
PGEN_.00g055100	Scaffold_02	60880025	60891370	P81004	VDAC2_XENLA	Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin)	GO:0000166; GO:0005741; GO:0008308; GO:0015288; GO:0046930	mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]
PGEN_.00g055110	Scaffold_02	60892219	60897358	NA	NA	NA	NA	NA
PGEN_.00g055120	Scaffold_02	60897414	60904698	Q96LT4	SAMD8_HUMAN	Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8)	GO:0002950; GO:0005783; GO:0005789; GO:0005829; GO:0005887; GO:0006686; GO:0016021; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:1905373; GO:2000303	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]
PGEN_.00g055130	Scaffold_02	60930311	60930883	NA	NA	NA	NA	NA
PGEN_.00g055140	Scaffold_02	60938751	60974193	Q6IVV8	PKD2_DANRE	Polycystin-2 (Curly up) (Cup) (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2)	GO:0001822; GO:0001946; GO:0001947; GO:0003143; GO:0003146; GO:0003171; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005623; GO:0005783; GO:0005856; GO:0005887; GO:0005929; GO:0007368; GO:0007507; GO:0009953; GO:0010882; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0016324; GO:0016328; GO:0030017; GO:0030659; GO:0032965; GO:0033017; GO:0034703; GO:0034765; GO:0042383; GO:0048793; GO:0050982; GO:0051209; GO:0051262; GO:0051284; GO:0051290; GO:0051371; GO:0061371; GO:0070121; GO:0070588; GO:0071277; GO:0071805; GO:0072019; GO:0072114; GO:0097704; GO:0098662; GO:0198738	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cell [GO:0005623]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]
PGEN_.00g055150	Scaffold_02	60984730	60984990	NA	NA	NA	NA	NA
PGEN_.00g055160	Scaffold_02	60992247	60992552	NA	NA	NA	NA	NA
PGEN_.00g055170	Scaffold_02	60995549	61046149	Q68F72	S15A4_XENLA	Solute carrier family 15 member 4 (Peptide transporter 4)	GO:0006857; GO:0015031; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031]
PGEN_.00g055180	Scaffold_02	61062175	61064834	NA	NA	NA	NA	NA
PGEN_.00g055190	Scaffold_02	61076032	61087769	F1MJR8	TEX14_BOVIN	Inactive serine/threonine-protein kinase TEX14 (Testis-expressed sequence 14) (Testis-expressed sequence 14 protein)	GO:0000776; GO:0000777; GO:0004672; GO:0005524; GO:0005623; GO:0005737; GO:0007094; GO:0007140; GO:0008608; GO:0019901; GO:0030496; GO:0032091; GO:0032466; GO:0043063; GO:0045171; GO:0051301; GO:0051306; GO:1990830	cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]
PGEN_.00g055200	Scaffold_02	61090296	61090799	NA	NA	NA	NA	NA
PGEN_.00g055210	Scaffold_02	61097741	61129199	Q20065	P4HA2_CAEEL	"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)"	GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"
PGEN_.00g055220	Scaffold_02	61143308	61156249	NA	NA	NA	NA	NA
PGEN_.00g055230	Scaffold_02	61169165	61208199	Q5PQN1	HERC4_RAT	Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)	GO:0001650; GO:0004842; GO:0005829; GO:0007283; GO:0030154	cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]
PGEN_.00g055240	Scaffold_02	61216421	61229852	NA	NA	NA	NA	NA
PGEN_.00g055250	Scaffold_02	61262951	61269589	P29506	UNC4_CAEEL	Homeobox protein unc-4 (Homeobox protein ceh-4) (Uncoordinated protein 4)	GO:0000977; GO:0000981; GO:0003700; GO:0005623; GO:0005634; GO:0006355; GO:0007400; GO:0007416; GO:0008039; GO:0030424; GO:0040011; GO:0048489; GO:0050770; GO:0050803	"axon [GO:0030424]; cell [GO:0005623]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; locomotion [GO:0040011]; neuroblast fate determination [GO:0007400]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; regulation of transcription, DNA-templated [GO:0006355]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039]; synaptic vesicle transport [GO:0048489]"
PGEN_.00g055260	Scaffold_02	61338977	61349459	O08934	UNC4_MOUSE	Homeobox protein unc-4 homolog (Homeobox protein Uncx4.1)	GO:0001502; GO:0005634; GO:0006355; GO:0007389; GO:0010468; GO:0021516; GO:0021889; GO:0035726; GO:0043565; GO:0045595	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; cartilage condensation [GO:0001502]; common myeloid progenitor cell proliferation [GO:0035726]; dorsal spinal cord development [GO:0021516]; olfactory bulb interneuron differentiation [GO:0021889]; pattern specification process [GO:0007389]; regulation of cell differentiation [GO:0045595]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g055270	Scaffold_02	61358710	61370877	Q14114	LRP8_HUMAN	Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2)	GO:0001523; GO:0004888; GO:0005041; GO:0005509; GO:0005576; GO:0005875; GO:0005886; GO:0005901; GO:0006508; GO:0006629; GO:0006897; GO:0007165; GO:0008035; GO:0014069; GO:0016020; GO:0016021; GO:0019221; GO:0019894; GO:0021541; GO:0021987; GO:0030229; GO:0030424; GO:0030425; GO:0032793; GO:0034185; GO:0038024; GO:0038025; GO:0038026; GO:0042493; GO:0042981; GO:0043025; GO:0043235; GO:0045088; GO:0050731; GO:0050804; GO:0061003; GO:0061098; GO:0071363; GO:0071397; GO:1900006	axon [GO:0030424]; caveola [GO:0005901]; dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; high-density lipoprotein particle binding [GO:0008035]; kinesin binding [GO:0019894]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; transmembrane signaling receptor activity [GO:0004888]; very-low-density lipoprotein particle receptor activity [GO:0030229]; ammon gyrus development [GO:0021541]; cellular response to cholesterol [GO:0071397]; cellular response to growth factor stimulus [GO:0071363]; cerebral cortex development [GO:0021987]; cytokine-mediated signaling pathway [GO:0019221]; endocytosis [GO:0006897]; lipid metabolic process [GO:0006629]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein tyrosine kinase activity [GO:0061098]; proteolysis [GO:0006508]; reelin-mediated signaling pathway [GO:0038026]; regulation of apoptotic process [GO:0042981]; regulation of innate immune response [GO:0045088]; response to drug [GO:0042493]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]
PGEN_.00g055280	Scaffold_02	61373025	61382128	NA	NA	NA	NA	NA
PGEN_.00g055290	Scaffold_02	61389753	61399338	NA	NA	NA	NA	NA
PGEN_.00g055300	Scaffold_02	61402725	61418258	P51028	WNT8A_DANRE	Protein Wnt-8a	GO:0001654; GO:0001707; GO:0001710; GO:0001756; GO:0003676; GO:0005109; GO:0005615; GO:0007398; GO:0007417; GO:0007492; GO:0007498; GO:0009952; GO:0009953; GO:0010628; GO:0016055; GO:0021512; GO:0021999; GO:0030182; GO:0030902; GO:0030903; GO:0035284; GO:0036342; GO:0039015; GO:0042074; GO:0044332; GO:0045165; GO:0045743; GO:0048263; GO:0060061; GO:0060070; GO:0060823; GO:0060896; GO:0090090; GO:2000742	extracellular space [GO:0005615]; frizzled binding [GO:0005109]; nucleic acid binding [GO:0003676]; anterior/posterior pattern specification [GO:0009952]; brain segmentation [GO:0035284]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060823]; cell fate commitment [GO:0045165]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in pronephros development [GO:0039015]; central nervous system development [GO:0007417]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; endoderm development [GO:0007492]; eye development [GO:0001654]; hindbrain development [GO:0030902]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mesodermal cell fate commitment [GO:0001710]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural plate anterior/posterior regionalization [GO:0021999]; neural plate pattern specification [GO:0060896]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; post-anal tail morphogenesis [GO:0036342]; regulation of anterior head development [GO:2000742]; somitogenesis [GO:0001756]; Spemann organizer formation [GO:0060061]; spinal cord anterior/posterior patterning [GO:0021512]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in dorsal/ventral axis specification [GO:0044332]
PGEN_.00g055310	Scaffold_02	61427959	61463441	Q5BP74	KC1D_XENLA	Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016055	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Wnt signaling pathway [GO:0016055]
PGEN_.00g055320	Scaffold_02	61475277	61477774	Q3UNX5	ACSM3_MOUSE	"Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog)"	GO:0003996; GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0018729; GO:0046872; GO:0047760; GO:0050218	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]
PGEN_.00g055330	Scaffold_02	61489695	61491433	G5EFC3	KCNAG_CAEEL	Potassium voltage-gated channel protein egl-36 (Egg-laying defective protein 36)	GO:0005244; GO:0005249; GO:0005251; GO:0008076; GO:0016021; GO:0030424; GO:0032590; GO:0032809; GO:0034220; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g055340	Scaffold_02	61493306	61495952	G5EFC3	KCNAG_CAEEL	Potassium voltage-gated channel protein egl-36 (Egg-laying defective protein 36)	GO:0005244; GO:0005249; GO:0005251; GO:0008076; GO:0016021; GO:0030424; GO:0032590; GO:0032809; GO:0034220; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g055350	Scaffold_02	61504697	61515461	C0SPB0	YTCI_BACSU	Uncharacterized acyl--CoA ligase YtcI (EC 6.2.1.-)	GO:0003996; GO:0004321; GO:0005524; GO:0006633; GO:0006637; GO:0015645	acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]
PGEN_.00g055360	Scaffold_02	61560843	61569140	NA	NA	NA	NA	NA
PGEN_.00g055370	Scaffold_02	61585196	61610087	P99177	CSD_STAAN	Probable cysteine desulfurase (EC 2.8.1.7)	GO:0006534; GO:0030170; GO:0031071	cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170]; cysteine metabolic process [GO:0006534]
PGEN_.00g055380	Scaffold_02	61614880	61624426	Q6TFL4	KLH24_HUMAN	Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1)	GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312	adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]
PGEN_.00g055390	Scaffold_02	61664010	61677504	Q6NUZ2	TTY2L_DANRE	Protein tweety homolog 2-like	GO:0005229; GO:0005886; GO:0034707; GO:0072320	chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; volume-sensitive chloride channel activity [GO:0072320]
PGEN_.00g055400	Scaffold_02	61678240	61719313	Q5E9X2	MP2K6_BOVIN	Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6)	GO:0000187; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006915; GO:0019901; GO:0023014; GO:0032147; GO:0060048; GO:0120163	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; negative regulation of cold-induced thermogenesis [GO:0120163]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g055410	Scaffold_02	61742945	61751113	P86982	IMSP1_RUDPH	Insoluble matrix shell protein 1 (IMSP1) (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g055420	Scaffold_02	61755488	61758591	NA	NA	NA	NA	NA
PGEN_.00g055430	Scaffold_02	61758678	61775565	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g055440	Scaffold_02	61784231	61792899	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g055450	Scaffold_02	61860293	61877204	Q0P5N1	CNPY3_BOVIN	Protein canopy homolog 3	GO:0005102; GO:0005783; GO:0045087	endoplasmic reticulum [GO:0005783]; signaling receptor binding [GO:0005102]; innate immune response [GO:0045087]
PGEN_.00g055460	Scaffold_02	61880036	61893606	A0A1L8EXB5	AR1AB_XENLA	Actin-related protein 2/3 complex subunit 1A-B	GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0034314; GO:0035861	Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; Arp2/3 complex-mediated actin nucleation [GO:0034314]
PGEN_.00g055470	Scaffold_02	61911170	61943276	O00418	EF2K_HUMAN	Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)	GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:1990416; GO:1990637	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]"
PGEN_.00g055480	Scaffold_02	61960275	61960586	NA	NA	NA	NA	NA
PGEN_.00g055490	Scaffold_02	61961352	61961621	NA	NA	NA	NA	NA
PGEN_.00g055500	Scaffold_02	62052060	62085065	NA	NA	NA	NA	NA
PGEN_.00g055510	Scaffold_02	62095497	62095772	NA	NA	NA	NA	NA
PGEN_.00g055520	Scaffold_02	62139835	62151385	B2RS91	RRN3_MOUSE	RNA polymerase I-specific transcription initiation factor RRN3	GO:0001042; GO:0001164; GO:0001181; GO:0001701; GO:0005634; GO:0005730; GO:0006352; GO:0006361; GO:0007000; GO:0007028; GO:0008283; GO:0010976; GO:0042254; GO:0045893; GO:0048872; GO:0070063; GO:1902254; GO:2000142	"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase binding [GO:0070063]; RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; DNA-templated transcription, initiation [GO:0006352]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]"
PGEN_.00g055530	Scaffold_02	62151627	62151947	NA	NA	NA	NA	NA
PGEN_.00g055540	Scaffold_02	62190716	62219044	P22770	ACHA7_CHICK	Neuronal acetylcholine receptor subunit alpha-7	GO:0000187; GO:0001540; GO:0001666; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890	"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g055550	Scaffold_02	62250764	62251063	NA	NA	NA	NA	NA
PGEN_.00g055560	Scaffold_02	62252082	62253185	NA	NA	NA	NA	NA
PGEN_.00g055570	Scaffold_02	62341848	62342595	NA	NA	NA	NA	NA
PGEN_.00g055580	Scaffold_02	62350267	62350569	NA	NA	NA	NA	NA
PGEN_.00g055590	Scaffold_02	62471235	62473595	NA	NA	NA	NA	NA
PGEN_.00g055600	Scaffold_02	62484535	62496827	NA	NA	NA	NA	NA
PGEN_.00g055610	Scaffold_02	62525472	62562130	Q4R495	MFS11_MACFA	UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g055620	Scaffold_02	62591387	62610230	Q5R452	SAFB1_PONAB	Scaffold attachment factor B1 (SAF-B1)	GO:0000978; GO:0003682; GO:0003723; GO:0005634; GO:0006355; GO:0050684	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g055630	Scaffold_02	62619658	62620248	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g055640	Scaffold_02	62620453	62620860	NA	NA	NA	NA	NA
PGEN_.00g055650	Scaffold_02	62620919	62621359	NA	NA	NA	NA	NA
PGEN_.00g055660	Scaffold_02	62621543	62625489	NA	NA	NA	NA	NA
PGEN_.00g055670	Scaffold_02	62628094	62649949	Q9NWH9	SLTM_HUMAN	SAFB-like transcription modulator (Modulator of estrogen-induced transcription)	GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0006915; GO:0016604; GO:0043565; GO:0050684	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g055680	Scaffold_02	62655793	62660629	P30352	SRSF2_CHICK	"Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)"	GO:0000381; GO:0003723; GO:0005634; GO:0005681; GO:0016607; GO:0036002; GO:0045292	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"
PGEN_.00g055690	Scaffold_02	62665095	62684043	NA	NA	NA	NA	NA
PGEN_.00g055700	Scaffold_02	62690514	62695656	Q2TA38	TEKT4_BOVIN	Tektin-4	GO:0015630; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0097225; GO:0097228	microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; regulation of brood size [GO:0060378]
PGEN_.00g055710	Scaffold_02	62703846	62704658	NA	NA	NA	NA	NA
PGEN_.00g055720	Scaffold_02	62712111	62725288	Q7ZX03	FOXK2_XENLA	Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1)	GO:0000287; GO:0000976; GO:0001227; GO:0001678; GO:0003677; GO:0003700; GO:0005623; GO:0005634; GO:0005737; GO:0006355; GO:0010507; GO:0010906; GO:0035947; GO:0042594; GO:0043565; GO:0045892; GO:0045893; GO:0061621	"cell [GO:0005623]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; magnesium ion binding [GO:0000287]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter [GO:0035947]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription, DNA-templated [GO:0006355]; response to starvation [GO:0042594]"
PGEN_.00g055730	Scaffold_02	62726091	62728299	Q3UCQ1	FOXK2_MOUSE	Forkhead box protein K2 (Cellular transcription factor ILF-1) (Interleukin enhancer-binding factor 1)	GO:0000287; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0001678; GO:0003700; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0010507; GO:0010906; GO:0035947; GO:0042594; GO:0043231; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0061621	"cell [GO:0005623]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; magnesium ion binding [GO:0000287]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter [GO:0035947]; regulation of glucose metabolic process [GO:0010906]; response to starvation [GO:0042594]"
PGEN_.00g055740	Scaffold_02	62729559	62729828	NA	NA	NA	NA	NA
PGEN_.00g055750	Scaffold_02	62733010	62751097	Q8N1V2	CFA52_HUMAN	Cilia- and flagella-associated protein 52 (WD repeat-containing protein 16) (WD40-repeat protein up-regulated in HCC)	GO:0005737; GO:0031514	cytoplasm [GO:0005737]; motile cilium [GO:0031514]
PGEN_.00g055760	Scaffold_02	62763905	62775358	Q6GMA4	CHM6A_XENLA	Charged multivesicular body protein 6-A (Chromatin-modifying protein 6-A)	GO:0007034; GO:0015031; GO:0031902	late endosome membrane [GO:0031902]; protein transport [GO:0015031]; vacuolar transport [GO:0007034]
PGEN_.00g055770	Scaffold_02	62775666	62781396	NA	NA	NA	NA	NA
PGEN_.00g055780	Scaffold_02	62796328	62797080	NA	NA	NA	NA	NA
PGEN_.00g055790	Scaffold_02	62810822	62811733	NA	NA	NA	NA	NA
PGEN_.00g055800	Scaffold_02	62826844	62867504	Q9UNQ0	ABCG2_HUMAN	Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)	GO:0005524; GO:0005623; GO:0005654; GO:0005886; GO:0006879; GO:0008559; GO:0009986; GO:0015143; GO:0015225; GO:0015562; GO:0015878; GO:0016021; GO:0016324; GO:0016887; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0042802; GO:0042803; GO:0042910; GO:0045121; GO:0046415; GO:0055085; GO:0070633; GO:0097744; GO:0098591; GO:0140115; GO:1990748; GO:1990962	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910]; biotin transport [GO:0015878]; cellular detoxification [GO:1990748]; cellular iron ion homeostasis [GO:0006879]; export across plasma membrane [GO:0140115]; riboflavin transport [GO:0032218]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; urate metabolic process [GO:0046415]; urate salt excretion [GO:0097744]; xenobiotic transport across blood-brain barrier [GO:1990962]
PGEN_.00g055810	Scaffold_02	62877376	62888495	A7M7B9	NTH_CHICK	Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase)	GO:0000703; GO:0003690; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006296; GO:0046872; GO:0051539; GO:0140078	"mitochondrion [GO:0005739]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]"
PGEN_.00g055820	Scaffold_02	62888819	62901330	Q5RBA8	KPRB_PONAB	Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2)	GO:0000287; GO:0004749; GO:0009116; GO:0009165	magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]
PGEN_.00g055830	Scaffold_02	62909645	62912221	Q6W3F4	AA2BR_CANLF	Adenosine receptor A2b	GO:0001609; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled adenosine receptor activity [GO:0001609]
PGEN_.00g055840	Scaffold_02	62916122	62917069	P29276	AA2BR_RAT	Adenosine receptor A2b	GO:0001609; GO:0001938; GO:0002882; GO:0004930; GO:0005886; GO:0007189; GO:0008284; GO:0008285; GO:0009986; GO:0010575; GO:0010595; GO:0010701; GO:0010753; GO:0010893; GO:0016021; GO:0031284; GO:0031668; GO:0032722; GO:0032755; GO:0032966; GO:0033605; GO:0043306; GO:0043950; GO:0045202; GO:0060087; GO:0097755; GO:0098685; GO:0098978; GO:2000300	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to extracellular stimulus [GO:0031668]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen biosynthetic process [GO:0032966]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of synaptic vesicle exocytosis [GO:2000300]; relaxation of vascular smooth muscle [GO:0060087]
PGEN_.00g055850	Scaffold_02	62919361	62928317	Q0VC81	AA3R_BOVIN	Adenosine receptor A3	GO:0001609; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled adenosine receptor activity [GO:0001609]
PGEN_.00g055860	Scaffold_02	62932072	62933052	Q32ZE2	AA2BR_RABIT	Adenosine receptor A2b	GO:0001609; GO:0002882; GO:0005886; GO:0007189; GO:0010575; GO:0010753; GO:0016021; GO:0031284; GO:0031668; GO:0032722; GO:0032755; GO:0043306; GO:0060087; GO:0098685; GO:0098978; GO:2000300	glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled adenosine receptor activity [GO:0001609]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to extracellular stimulus [GO:0031668]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of synaptic vesicle exocytosis [GO:2000300]; relaxation of vascular smooth muscle [GO:0060087]
PGEN_.00g055870	Scaffold_02	62951603	62956826	A9CB25	S22A4_PAPAN	Solute carrier family 22 member 4 (Organic cation/carnitine transporter 1)	GO:0005524; GO:0005739; GO:0006641; GO:0006814; GO:0009437; GO:0015226; GO:0015293; GO:0015491; GO:0016021; GO:0016324; GO:0030165	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; PDZ domain binding [GO:0030165]; symporter activity [GO:0015293]; carnitine metabolic process [GO:0009437]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]
PGEN_.00g055880	Scaffold_02	62969075	62985265	Q9H015	S22A4_HUMAN	Solute carrier family 22 member 4 (Ergothioneine transporter) (ET transporter) (Organic cation/carnitine transporter 1)	GO:0000166; GO:0005524; GO:0005739; GO:0005886; GO:0005887; GO:0006641; GO:0006814; GO:0007589; GO:0008513; GO:0009437; GO:0015226; GO:0015293; GO:0015491; GO:0015651; GO:0015695; GO:0015697; GO:0015879; GO:0016324; GO:0030165	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; nucleotide binding [GO:0000166]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; symporter activity [GO:0015293]; body fluid secretion [GO:0007589]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]
PGEN_.00g055890	Scaffold_02	62995336	62999861	NA	NA	NA	NA	NA
PGEN_.00g055900	Scaffold_02	63047040	63047378	NA	NA	NA	NA	NA
PGEN_.00g055910	Scaffold_02	63056128	63062970	Q8IZD6	S22AF_HUMAN	Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1)	GO:0006811; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]
PGEN_.00g055920	Scaffold_02	63069547	63093527	NA	NA	NA	NA	NA
PGEN_.00g055930	Scaffold_02	63118288	63118971	NA	NA	NA	NA	NA
PGEN_.00g055940	Scaffold_02	63137101	63144233	Q9Z0E8	S22A5_MOUSE	Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2)	GO:0005524; GO:0006814; GO:0007005; GO:0007512; GO:0007626; GO:0009437; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0030165; GO:0031526; GO:0048608; GO:0052106; GO:0060731; GO:0070715	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; adult heart development [GO:0007512]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; reproductive structure development [GO:0048608]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]
PGEN_.00g055950	Scaffold_02	63159405	63170067	E7FDW2	PZR3B_DANRE	E3 ubiquitin-protein ligase PDZRN3-B (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3-B)	GO:0005737; GO:0007528; GO:0016567; GO:0030054; GO:0045202; GO:0046872; GO:0061630	cell junction [GO:0030054]; cytoplasm [GO:0005737]; synapse [GO:0045202]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]
PGEN_.00g055960	Scaffold_02	63182253	63185570	Q6A1G3	FUT10_XENTR	"Alpha-(1,3)-fucosyltransferase 10 (EC 2.4.1.-) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10)"	GO:0006486; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g055970	Scaffold_02	63201754	63212193	P63000	RAC1_HUMAN	Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	GO:0000139; GO:0001764; GO:0001934; GO:0002551; GO:0003924; GO:0005525; GO:0005737; GO:0005789; GO:0005802; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006954; GO:0007015; GO:0007155; GO:0007160; GO:0007163; GO:0007266; GO:0007596; GO:0008045; GO:0008283; GO:0008360; GO:0008361; GO:0009611; GO:0009653; GO:0010310; GO:0010591; GO:0010592; GO:0010811; GO:0016020; GO:0016601; GO:0017137; GO:0019899; GO:0019901; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030667; GO:0031116; GO:0031295; GO:0031529; GO:0031996; GO:0032587; GO:0032707; GO:0032956; GO:0034446; GO:0035025; GO:0035556; GO:0035774; GO:0036464; GO:0038095; GO:0038096; GO:0042470; GO:0042826; GO:0042995; GO:0043197; GO:0043312; GO:0043652; GO:0044877; GO:0045428; GO:0045453; GO:0045740; GO:0048010; GO:0048012; GO:0048013; GO:0048261; GO:0048870; GO:0050690; GO:0051022; GO:0051056; GO:0051117; GO:0051492; GO:0051496; GO:0051668; GO:0051894; GO:0051897; GO:0055038; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0090023; GO:0097178; GO:0098794; GO:0098978; GO:0101003; GO:1900026; GO:1902622	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure morphogenesis [GO:0009653]; blood coagulation [GO:0007596]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; engulfment of apoptotic cell [GO:0043652]; ephrin receptor signaling pathway [GO:0048013]; establishment or maintenance of cell polarity [GO:0007163]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; negative regulation of receptor-mediated endocytosis [GO:0048261]; neuron migration [GO:0001764]; neutrophil degranulation [GO:0043312]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of defense response to virus by virus [GO:0050690]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of lamellipodium assembly [GO:0010591]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of stress fiber assembly [GO:0051492]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; ruffle organization [GO:0031529]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g055980	Scaffold_02	63259244	63385709	Q9EQ60	CAC1H_RAT	Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2)	GO:0001518; GO:0005244; GO:0005248; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016021; GO:0019228; GO:0019233; GO:0030425; GO:0032342; GO:0032870; GO:0034651; GO:0034765; GO:0035865; GO:0042383; GO:0042391; GO:0043204; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0099055; GO:0099059; GO:0106134; GO:2000344	caveola [GO:0005901]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; sensory perception of pain [GO:0019233]
PGEN_.00g055990	Scaffold_02	63390198	63431170	NA	NA	NA	NA	NA
PGEN_.00g056000	Scaffold_02	63416963	63417398	NA	NA	NA	NA	NA
PGEN_.00g056010	Scaffold_02	63442601	63477293	Q13231	CHIT1_HUMAN	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]"
PGEN_.00g056020	Scaffold_02	63507332	63523863	Q91XA9	CHIA_MOUSE	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (YNL)	GO:0000272; GO:0001878; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0006955; GO:0008061; GO:0019900; GO:0052356; GO:0090197	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; kinase binding [GO:0019900]; apoptotic process [GO:0006915]; catabolism by host of symbiont cell wall chitin [GO:0052356]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]; response to yeast [GO:0001878]
PGEN_.00g056030	Scaffold_02	63528341	63529252	NA	NA	NA	NA	NA
PGEN_.00g056040	Scaffold_02	63543850	63544413	NA	NA	NA	NA	NA
PGEN_.00g056050	Scaffold_02	63546516	63547196	NA	NA	NA	NA	NA
PGEN_.00g056060	Scaffold_02	63551818	63552690	NA	NA	NA	NA	NA
PGEN_.00g056070	Scaffold_02	63614397	63615026	NA	NA	NA	NA	NA
PGEN_.00g056080	Scaffold_02	63658793	63661176	NA	NA	NA	NA	NA
PGEN_.00g056090	Scaffold_02	63767582	63768799	Q8WPA2	AR_BOMMO	Allatostatin-A receptor (BAR)	GO:0004930; GO:0005886; GO:0016021; GO:0042562; GO:0042923	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; neuropeptide binding [GO:0042923]
PGEN_.00g056100	Scaffold_02	63847961	63848518	NA	NA	NA	NA	NA
PGEN_.00g056110	Scaffold_02	63882579	63882860	NA	NA	NA	NA	NA
PGEN_.00g056120	Scaffold_02	64005942	64006283	NA	NA	NA	NA	NA
PGEN_.00g056130	Scaffold_02	64094158	64094409	NA	NA	NA	NA	NA
PGEN_.00g056140	Scaffold_02	64138387	64149830	Q9UPM9	B9D1_HUMAN	B9 domain-containing protein 1 (MKS1-related protein 1)	GO:0001701; GO:0001944; GO:0005813; GO:0005829; GO:0007224; GO:0008158; GO:0016020; GO:0032880; GO:0035869; GO:0036038; GO:0036064; GO:0042733; GO:0043010; GO:0060271; GO:0060563; GO:0097711	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; hedgehog receptor activity [GO:0008158]; camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944]
PGEN_.00g056150	Scaffold_02	64238538	64252414	Q99PL7	SCD3_MOUSE	Acyl-CoA desaturase 3 (EC 1.14.19.-) (Delta(9)-desaturase 3) (Delta-9 desaturase 3) (Fatty acid desaturase 3) (Palmitoyl-CoA desaturase) (Stearoyl-CoA desaturase 3)	GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016021; GO:0030176; GO:0032896; GO:0070542; GO:1903966	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768]; monounsaturated fatty acid biosynthetic process [GO:1903966]; response to fatty acid [GO:0070542]; unsaturated fatty acid biosynthetic process [GO:0006636]
PGEN_.00g056160	Scaffold_02	64260859	64273671	Q92038	ACOD_CYPCA	Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase)	GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016021; GO:0016491	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768]; unsaturated fatty acid biosynthetic process [GO:0006636]
PGEN_.00g056170	Scaffold_02	64274512	64275321	NA	NA	NA	NA	NA
PGEN_.00g056180	Scaffold_02	64288967	64298239	Q149G0	CB068_MOUSE	UPF0561 protein C2orf68 homolog		
PGEN_.00g056190	Scaffold_02	64299708	64322478	Q3TIX9	SNUT2_MOUSE	U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39)	GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0007049; GO:0008270; GO:0016579; GO:0036459; GO:0046540; GO:0051301	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245]"
PGEN_.00g056200	Scaffold_02	64326400	64366395	Q7TT16	IPMK_MOUSE	"Inositol polyphosphate multikinase (EC 2.7.1.140) (EC 2.7.1.151) (EC 2.7.1.153) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase)"	GO:0000823; GO:0000824; GO:0000825; GO:0001841; GO:0005524; GO:0005634; GO:0005654; GO:0008440; GO:0032957; GO:0032958; GO:0046872; GO:0046934; GO:0047326; GO:0052812; GO:0070266; GO:0097243; GO:0102732	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate 3-kinase activity [GO:0000824]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube formation [GO:0001841]"
PGEN_.00g056210	Scaffold_02	64399312	64422666	O08901	BUB1_MOUSE	Mitotic checkpoint serine/threonine-protein kinase BUB1 (mBUB1) (EC 2.7.11.1) (BUB1A)	GO:0000775; GO:0000776; GO:0000777; GO:0000778; GO:0000780; GO:0000942; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006915; GO:0007059; GO:0007063; GO:0007094; GO:0051301; GO:0051754; GO:0051983; GO:2001244	"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]"
PGEN_.00g056220	Scaffold_02	64424876	64436672	NA	NA	NA	NA	NA
PGEN_.00g056230	Scaffold_02	64446535	64469808	NA	NA	NA	NA	NA
PGEN_.00g056240	Scaffold_02	64477769	64487646	NA	NA	NA	NA	NA
PGEN_.00g056250	Scaffold_02	64497598	64521014	E9Q735	UBE4A_MOUSE	Ubiquitin conjugation factor E4 A (EC 2.3.2.-)	GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0030433; GO:0034450; GO:0061630	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g056260	Scaffold_02	64525365	64536932	Q9NVX0	HAUS2_HUMAN	HAUS augmin-like complex subunit 2 (Centrosomal protein of 27 kDa) (Cep27)	GO:0000086; GO:0005813; GO:0005829; GO:0005876; GO:0007098; GO:0010389; GO:0051225; GO:0051301; GO:0070652; GO:0097711	centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; spindle microtubule [GO:0005876]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]
PGEN_.00g056270	Scaffold_02	64540759	64542675	NA	NA	NA	NA	NA
PGEN_.00g056280	Scaffold_02	64543711	64546485	NA	NA	NA	NA	NA
PGEN_.00g056290	Scaffold_02	64554647	64574822	Q28GW8	MELK_XENTR	Maternal embryonic leucine zipper kinase (EC 2.7.11.1)	GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005938; GO:0006468; GO:0006915; GO:0007049; GO:0008283; GO:0008289; GO:0030097; GO:0035556; GO:0043065; GO:0046777; GO:0061351	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]
PGEN_.00g056300	Scaffold_02	64577365	64612295	NA	NA	NA	NA	NA
PGEN_.00g056310	Scaffold_02	64642846	64643181	NA	NA	NA	NA	NA
PGEN_.00g056320	Scaffold_02	64650646	64677168	Q920M7	SYT17_MOUSE	Synaptotagmin-17 (Protein B/K) (Synaptotagmin XVII) (SytXVII)	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005802; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0070382; GO:0071277; GO:1903861	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]
PGEN_.00g056330	Scaffold_02	64693492	64713984	O88204	LRP3_RAT	Low-density lipoprotein receptor-related protein 3 (LRP-3) (105 kDa low-density lipoprotein receptor-related protein) (rLRp105)	GO:0005905; GO:0006897; GO:0016021	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; endocytosis [GO:0006897]
PGEN_.00g056340	Scaffold_02	64718863	64749484	P80010	PLMN_HORSE	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Plasmin light chain B] (Fragment)	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
PGEN_.00g056350	Scaffold_02	64772938	64774194	NA	NA	NA	NA	NA
PGEN_.00g056360	Scaffold_02	64909960	64910274	NA	NA	NA	NA	NA
PGEN_.00g056370	Scaffold_02	64942276	65066162	Q9BQS2	SYT15_HUMAN	Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV) (SytXV)	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0070382; GO:0071277	exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]
PGEN_.00g056380	Scaffold_02	65144099	65178970	Q8C428	TMC7_MOUSE	Transmembrane channel-like protein 7	GO:0005216; GO:0005887; GO:0008381	integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]
PGEN_.00g056390	Scaffold_02	65186921	65187508	NA	NA	NA	NA	NA
PGEN_.00g056400	Scaffold_02	65190403	65195472	NA	NA	NA	NA	NA
PGEN_.00g056410	Scaffold_02	65199922	65235013	Q4R7U0	TMC7_MACFA	Transmembrane channel-like protein 7	GO:0005887; GO:0006811	integral component of plasma membrane [GO:0005887]; ion transport [GO:0006811]
PGEN_.00g056420	Scaffold_02	65244590	65266505	NA	NA	NA	NA	NA
PGEN_.00g056430	Scaffold_02	65266807	65323416	P25867	UBCD1_DROME	Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	GO:0000151; GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061630; GO:0061631; GO:0097039	cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g056440	Scaffold_02	65341033	65351491	Q6GLW1	THO4B_XENLA	THO complex subunit 4-B (Tho4-B) (Aly/REF export factor-B)	GO:0005634; GO:0005737; GO:0006397; GO:0006405; GO:0008380; GO:0016607; GO:0051028; GO:0062153	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]
PGEN_.00g056450	Scaffold_02	65361288	65368477	P52740	ZN132_HUMAN	Zinc finger protein 132	GO:0003677; GO:0003700; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]
PGEN_.00g056460	Scaffold_02	65387785	65420526	Q9BXU1	STK31_HUMAN	Serine/threonine-protein kinase 31 (EC 2.7.11.1) (Serine/threonine-protein kinase NYD-SPK) (Sugen kinase 396) (SgK396)	GO:0001669; GO:0003723; GO:0004518; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006401	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nuclease activity [GO:0004518]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA catabolic process [GO:0006401]
PGEN_.00g056470	Scaffold_02	65461147	65489642	P54822	PUR8_MOUSE	Adenylosuccinate lyase (ASL) (EC 4.3.2.2) (Adenylosuccinase) (ASase)	GO:0001666; GO:0004018; GO:0005739; GO:0005829; GO:0006163; GO:0006167; GO:0006189; GO:0007584; GO:0009060; GO:0009156; GO:0014850; GO:0042594; GO:0042802; GO:0044208; GO:0051262; GO:0070626	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; identical protein binding [GO:0042802]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; aerobic respiration [GO:0009060]; AMP biosynthetic process [GO:0006167]; protein tetramerization [GO:0051262]; purine nucleotide metabolic process [GO:0006163]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; ribonucleoside monophosphate biosynthetic process [GO:0009156]"
PGEN_.00g056480	Scaffold_02	65484637	65490257	NA	NA	NA	NA	NA
PGEN_.00g056490	Scaffold_02	65496336	65508818	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g056500	Scaffold_02	65517037	65538431	O94925	GLSK_HUMAN	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0008652; GO:0014047; GO:0045202; GO:0051289; GO:0090461	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]
PGEN_.00g056510	Scaffold_02	65539748	65552125	O94925	GLSK_HUMAN	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0008652; GO:0014047; GO:0045202; GO:0051289; GO:0090461	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]
PGEN_.00g056520	Scaffold_02	65553719	65557585	O94925	GLSK_HUMAN	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0008652; GO:0014047; GO:0045202; GO:0051289; GO:0090461	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]
PGEN_.00g056530	Scaffold_02	65574521	65589746	NA	NA	NA	NA	NA
PGEN_.00g056540	Scaffold_02	65594481	65609751	NA	NA	NA	NA	NA
PGEN_.00g056550	Scaffold_02	65614188	65655396	Q9Z319	CORIN_MOUSE	"Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Low density lipoprotein receptor-related protein 4) (Pro-ANP-converting enzyme) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment]"	GO:0003050; GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0005887; GO:0007565; GO:0008217; GO:0009986; GO:0015629; GO:0016486; GO:0016604; GO:0030182; GO:0031410; GO:0035813	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; female pregnancy [GO:0007565]; neuron differentiation [GO:0030182]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]
PGEN_.00g056560	Scaffold_02	65669717	65698915	NA	NA	NA	NA	NA
PGEN_.00g056570	Scaffold_02	65830836	65848859	P36894	BMR1A_HUMAN	Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292)	GO:0000981; GO:0001701; GO:0001707; GO:0001756; GO:0001880; GO:0002053; GO:0002062; GO:0003148; GO:0003151; GO:0003161; GO:0003183; GO:0003186; GO:0003203; GO:0003215; GO:0003222; GO:0003223; GO:0003272; GO:0004674; GO:0004675; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0006955; GO:0007179; GO:0007398; GO:0009897; GO:0009950; GO:0009953; GO:0010862; GO:0014032; GO:0014912; GO:0016021; GO:0019827; GO:0021983; GO:0021998; GO:0030324; GO:0030425; GO:0030501; GO:0030509; GO:0035137; GO:0035912; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043235; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048352; GO:0048368; GO:0048378; GO:0048382; GO:0048568; GO:0048589; GO:0050679; GO:0050768; GO:0060021; GO:0060043; GO:0060045; GO:0060391; GO:0060914; GO:0061312; GO:0061626; GO:0071363; GO:0071773; GO:0098821; GO:1902895; GO:1904414; GO:1904707; GO:1905285; GO:1990712; GO:2000772	"dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; fibrous ring of heart morphogenesis [GO:1905285]; heart formation [GO:0060914]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm structural organization [GO:0048352]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somitogenesis [GO:0001756]; stem cell population maintenance [GO:0019827]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
PGEN_.00g056580	Scaffold_02	65880340	65880816	Q16974	KPC1_APLCA	Calcium-dependent protein kinase C (EC 2.7.11.13) (APL I)	GO:0004697; GO:0005524; GO:0005737; GO:0008270; GO:0035556	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]
PGEN_.00g056590	Scaffold_02	66057246	66093261	Q16974	KPC1_APLCA	Calcium-dependent protein kinase C (EC 2.7.11.13) (APL I)	GO:0004697; GO:0005524; GO:0005737; GO:0008270; GO:0035556	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]
PGEN_.00g056600	Scaffold_02	66096098	66108282	NA	NA	NA	NA	NA
PGEN_.00g056610	Scaffold_02	66141081	66148440	NA	NA	NA	NA	NA
PGEN_.00g056620	Scaffold_02	66157255	66164744	Q17RW2	COOA1_HUMAN	Collagen alpha-1(XXIV) chain	GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030198; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]
PGEN_.00g056630	Scaffold_02	66183723	66184058	NA	NA	NA	NA	NA
PGEN_.00g056640	Scaffold_02	66185800	66206455	P58873	RHBL3_MOUSE	Rhomboid-related protein 3 (EC 3.4.21.105) (Ventrhoid transmembrane protein)	GO:0004252; GO:0005509; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g056650	Scaffold_02	66214901	66220658	NA	NA	NA	NA	NA
PGEN_.00g056660	Scaffold_02	66235771	66238522	NA	NA	NA	NA	NA
PGEN_.00g056670	Scaffold_02	66262118	66271312	Q9Y5Z4	HEBP2_HUMAN	Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL)	GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]
PGEN_.00g056680	Scaffold_02	66278417	66302705	Q06732	ZN33B_HUMAN	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g056690	Scaffold_02	66310490	66312150	NA	NA	NA	NA	NA
PGEN_.00g056700	Scaffold_02	66317111	66325201	NA	NA	NA	NA	NA
PGEN_.00g056710	Scaffold_02	66327244	66344564	NA	NA	NA	NA	NA
PGEN_.00g056720	Scaffold_02	66353039	66353875	NA	NA	NA	NA	NA
PGEN_.00g056730	Scaffold_02	66386784	66389783	Q92847	GHSR_HUMAN	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032869; GO:0036321; GO:0040018; GO:0042536; GO:0042802; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045409; GO:0045923; GO:0046676; GO:0046697; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0099699; GO:0120058; GO:1903672; GO:1904000; GO:1904008; GO:1904349; GO:1904468; GO:1905333; GO:1905564; GO:1990314; GO:2000110	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; negative regulation of tumor necrosis factor secretion [GO:1904468]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]
PGEN_.00g056740	Scaffold_02	66412343	66418969	NA	NA	NA	NA	NA
PGEN_.00g056750	Scaffold_02	66441027	66442151	Q9GZQ4	NMUR2_HUMAN	Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1)	GO:0001607; GO:0002023; GO:0004930; GO:0005229; GO:0005525; GO:0005623; GO:0005886; GO:0006816; GO:0006940; GO:0007186; GO:0007200; GO:0007204; GO:0007218; GO:0007267; GO:0007417; GO:0007625; GO:0007631; GO:0016021; GO:0019722; GO:0042924; GO:0043006; GO:0048016; GO:0048265; GO:0050482; GO:0051930	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; regulation of smooth muscle contraction [GO:0006940]; response to pain [GO:0048265]
PGEN_.00g056760	Scaffold_02	66466538	66473919	NA	NA	NA	NA	NA
PGEN_.00g056770	Scaffold_02	66482038	66486450	A0NLY7	ISAHY_LABAI	Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b)	GO:0004061; GO:0016812; GO:0019441; GO:0030145	"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]; tryptophan catabolic process to kynurenine [GO:0019441]"
PGEN_.00g056780	Scaffold_02	66505955	66519317	Q8IWU2	LMTK2_HUMAN	Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2)	GO:0001881; GO:0004674; GO:0004714; GO:0004864; GO:0005524; GO:0005769; GO:0005794; GO:0005829; GO:0005887; GO:0006468; GO:0007169; GO:0016021; GO:0018105; GO:0018107; GO:0030426; GO:0032456; GO:0033572; GO:0043025; GO:0043235; GO:0045022; GO:0046777; GO:0048471; GO:0055037; GO:0070853	cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine kinase activity [GO:0004674]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g056790	Scaffold_02	66522462	66526649	Q5RF24	WDR13_PONAB	WD repeat-containing protein 13	GO:0005634	nucleus [GO:0005634]
PGEN_.00g056800	Scaffold_02	66569932	66571878	Q9P0M9	RM27_HUMAN	"39S ribosomal protein L27, mitochondrial (L27mt) (MRP-L27) (Mitochondrial large ribosomal subunit protein bL27m)"	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]
PGEN_.00g056810	Scaffold_02	66604490	66606514	NA	NA	NA	NA	NA
PGEN_.00g056820	Scaffold_02	66638432	66649886	Q8C8R3	ANK2_MOUSE	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin)	GO:0002027; GO:0005623; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259	"A band [GO:0031672]; cell [GO:0005623]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]"
PGEN_.00g056830	Scaffold_02	66667517	66679752	P86729	EPDR2_HALAI	Ependymin-related protein 2	GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g056840	Scaffold_02	66685457	66702541	NA	NA	NA	NA	NA
PGEN_.00g056850	Scaffold_02	66714899	66720935	NA	NA	NA	NA	NA
PGEN_.00g056860	Scaffold_02	66727166	66727387	NA	NA	NA	NA	NA
PGEN_.00g056870	Scaffold_02	66741982	66768668	Q3UST5	CP089_MOUSE	UPF0764 protein C16orf89 homolog	GO:0005576; GO:0005829; GO:0016020; GO:0042803	cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; protein homodimerization activity [GO:0042803]
PGEN_.00g056880	Scaffold_02	66784628	66788274	Q0VD05	CCG3_BOVIN	Voltage-dependent calcium channel gamma-3 subunit (Neuronal voltage-gated calcium channel gamma-3 subunit) (Transmembrane AMPAR regulatory protein gamma-3) (TARP gamma-3)	GO:0005245; GO:0006605; GO:0008104; GO:0019226; GO:0032281; GO:0036477; GO:0098685; GO:0098839; GO:0098943; GO:0098970; GO:0098978; GO:0099061; GO:0099590; GO:2000311	"AMPA glutamate receptor complex [GO:0032281]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; somatodendritic compartment [GO:0036477]; voltage-gated calcium channel activity [GO:0005245]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]"
PGEN_.00g056890	Scaffold_02	66892615	66902646	Q8BS45	IFT56_MOUSE	Intraflagellar transport protein 56 (Protein hop-sterile) (Tetratricopeptide repeat protein 26) (TPR repeat protein 26)	GO:0005813; GO:0005929; GO:0007224; GO:0007286; GO:0008594; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0046530; GO:0060271; GO:0061512; GO:0097546; GO:0120170; GO:1905198	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]
PGEN_.00g056900	Scaffold_02	66909137	66909625	NA	NA	NA	NA	NA
PGEN_.00g056910	Scaffold_02	66914384	66916560	G5E8K6	MOT6_MOUSE	Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5)	GO:0005887; GO:0008028; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g056920	Scaffold_02	66918145	66918414	NA	NA	NA	NA	NA
PGEN_.00g056930	Scaffold_02	66926909	66927385	NA	NA	NA	NA	NA
PGEN_.00g056940	Scaffold_02	66928545	66929396	Q503M4	MT12B_DANRE	Monocarboxylate transporter 12-B (MCT 12-B) (Solute carrier family 16 member 12-B)	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g056950	Scaffold_02	66933410	66935880	NA	NA	NA	NA	NA
PGEN_.00g056960	Scaffold_02	66939190	66941487	NA	NA	NA	NA	NA
PGEN_.00g056970	Scaffold_02	66942382	66959033	Q8BZP8	NPSR1_MOUSE	Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14)	GO:0005000; GO:0005623; GO:0005737; GO:0005887; GO:0007218; GO:0008188; GO:0042755; GO:0051281; GO:0060013; GO:0070374; GO:1903999; GO:2000293	cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; eating behavior [GO:0042755]; negative regulation of defecation [GO:2000293]; negative regulation of eating behavior [GO:1903999]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; righting reflex [GO:0060013]
PGEN_.00g056980	Scaffold_02	66988104	67007858	Q6GMF8	RHDF1_DANRE	Inactive rhomboid protein 1 (iRhom1) (Rhomboid family member 1)	GO:0000139; GO:0005789; GO:0006508; GO:0008283; GO:0015031; GO:0016021; GO:0016477; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0061136	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; growth factor binding [GO:0019838]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708]
PGEN_.00g056990	Scaffold_02	67037626	67041201	NA	NA	NA	NA	NA
PGEN_.00g057000	Scaffold_02	67041294	67041587	NA	NA	NA	NA	NA
PGEN_.00g057010	Scaffold_02	67145598	67145834	NA	NA	NA	NA	NA
PGEN_.00g057020	Scaffold_02	67145951	67146730	NA	NA	NA	NA	NA
PGEN_.00g057030	Scaffold_02	67146785	67147054	NA	NA	NA	NA	NA
PGEN_.00g057040	Scaffold_02	67155149	67160680	NA	NA	NA	NA	NA
PGEN_.00g057050	Scaffold_02	67173816	67174028	NA	NA	NA	NA	NA
PGEN_.00g057060	Scaffold_02	67189765	67190785	NA	NA	NA	NA	NA
PGEN_.00g057070	Scaffold_02	67195896	67202198	P61315	G3ST3_MOUSE	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g057080	Scaffold_02	67260260	67260583	NA	NA	NA	NA	NA
PGEN_.00g057090	Scaffold_02	67347213	67347824	Q9Y662	HS3SB_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 (EC 2.8.2.30) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3B1) (3-OST-3B) (Heparan sulfate 3-O-sulfotransferase 3B1) (h3-OST-3B)	GO:0000139; GO:0005887; GO:0006024; GO:0006477; GO:0008467; GO:0015012; GO:0015015; GO:0033872	"Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [GO:0033872]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; protein sulfation [GO:0006477]"
PGEN_.00g057100	Scaffold_02	67375070	67378261	Q9Y663	HS3SA_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 (EC 2.8.2.30) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1) (3-OST-3A) (Heparan sulfate 3-O-sulfotransferase 3A1) (h3-OST-3A)	GO:0000139; GO:0006024; GO:0008146; GO:0008467; GO:0016021; GO:0033872	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [GO:0033872]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g057110	Scaffold_02	67391724	67395173	P07898	PGCA_CHICK	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g057120	Scaffold_02	67416599	67430712	Q13231	CHIT1_HUMAN	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]"
PGEN_.00g057130	Scaffold_02	67432625	67442739	Q95M17	CHIA_BOVIN	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)	GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]
PGEN_.00g057140	Scaffold_02	67446785	67480025	Q13231	CHIT1_HUMAN	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]"
PGEN_.00g057150	Scaffold_02	67480141	67516413	Q91XA9	CHIA_MOUSE	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (YNL)	GO:0000272; GO:0001878; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0006955; GO:0008061; GO:0019900; GO:0052356; GO:0090197	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; kinase binding [GO:0019900]; apoptotic process [GO:0006915]; catabolism by host of symbiont cell wall chitin [GO:0052356]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]; response to yeast [GO:0001878]
PGEN_.00g057160	Scaffold_02	67516735	67524156	Q13231	CHIT1_HUMAN	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]"
PGEN_.00g057170	Scaffold_02	67525854	67540360	P14272	KLKB1_RAT	Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]	GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0051919; GO:0097421	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; liver regeneration [GO:0097421]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]
PGEN_.00g057180	Scaffold_02	67543968	67558608	P03952	KLKB1_HUMAN	Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) (PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]	GO:0002542; GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007597; GO:0022617; GO:0031638; GO:0031639; GO:0042730; GO:0051919; GO:0070062	"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]"
PGEN_.00g057190	Scaffold_02	67570554	67582586	P03952	KLKB1_HUMAN	Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) (PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]	GO:0002542; GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007597; GO:0022617; GO:0031638; GO:0031639; GO:0042730; GO:0051919; GO:0070062	"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; blood coagulation, intrinsic pathway [GO:0007597]; extracellular matrix disassembly [GO:0022617]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]"
PGEN_.00g057200	Scaffold_02	67590397	67595123	NA	NA	NA	NA	NA
PGEN_.00g057210	Scaffold_02	67691903	67692223	NA	NA	NA	NA	NA
PGEN_.00g057220	Scaffold_02	67705348	67706806	NA	NA	NA	NA	NA
PGEN_.00g057230	Scaffold_02	67729100	67729345	NA	NA	NA	NA	NA
PGEN_.00g057240	Scaffold_02	67738884	67741065	P31319	KAPR_APLCA	cAMP-dependent protein kinase regulatory subunit (N4 subunit of protein kinase A)	GO:0005952; GO:0008603; GO:0030552	cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]
PGEN_.00g057250	Scaffold_02	67749971	67751209	NA	NA	NA	NA	NA
PGEN_.00g057260	Scaffold_02	67752794	67768862	Q5ZIM5	MAP1_CHICK	Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1)	GO:0005737; GO:0046872; GO:0070006; GO:0070084	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]
PGEN_.00g057270	Scaffold_02	67768915	67770108	NA	NA	NA	NA	NA
PGEN_.00g057280	Scaffold_02	67770134	67779594	NA	NA	NA	NA	NA
PGEN_.00g057290	Scaffold_02	67780222	67801371	Q04786	HEX_VIBVL	Beta-hexosaminidase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Chitobiase) (N-acetyl-beta-glucosaminidase)	GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0102148	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]
PGEN_.00g057300	Scaffold_02	67801702	67815891	Q54468	CHB_SERMA	Chitobiase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (N-acetyl-beta-glucosaminidase)	GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0042597; GO:0102148	periplasmic space [GO:0042597]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]
PGEN_.00g057310	Scaffold_02	67822559	67834523	P82968	MCPI_MELCP	Four-domain proteases inhibitor (McaPI)	GO:0004867	serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g057320	Scaffold_02	67838520	67842365	P82968	MCPI_MELCP	Four-domain proteases inhibitor (McaPI)	GO:0004867	serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g057330	Scaffold_02	67851740	67852066	NA	NA	NA	NA	NA
PGEN_.00g057340	Scaffold_02	67856441	67856794	NA	NA	NA	NA	NA
PGEN_.00g057350	Scaffold_02	67859718	67860062	NA	NA	NA	NA	NA
PGEN_.00g057360	Scaffold_02	67863342	67863788	NA	NA	NA	NA	NA
PGEN_.00g057370	Scaffold_02	67876181	67885461	Q8N6F8	MET27_HUMAN	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)		
PGEN_.00g057380	Scaffold_02	67898208	67904591	Q9ESD1	PRSS8_MOUSE	Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]	GO:0004252; GO:0005615; GO:0005886; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0045121; GO:0046658; GO:0070633; GO:1902307	anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; transepithelial transport [GO:0070633]
PGEN_.00g057390	Scaffold_02	67930907	67946451	Q9ES54	NPL4_RAT	Nuclear protein localization protein 4 homolog (Protein NPL4)	GO:0005634; GO:0005829; GO:0006511; GO:0007030; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036501; GO:0039536; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0051117	"cytosol [GO:0005829]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g057400	Scaffold_02	67954166	67976643	Q4V8R6	E4F1_DANRE	Transcription factor E4F1 (EC 2.3.2.27) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F)	GO:0003677; GO:0005654; GO:0005737; GO:0007049; GO:0016567; GO:0016740; GO:0040008; GO:0046872; GO:0051301	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]
PGEN_.00g057410	Scaffold_02	67978188	67992090	P13908	ACHN2_CARAU	Neuronal acetylcholine receptor subunit non-alpha-2 (GFN-alpha-2)	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g057420	Scaffold_02	67995343	68004121	O75897	ST1C4_HUMAN	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]
PGEN_.00g057430	Scaffold_02	68010895	68017174	P30532	ACHA5_HUMAN	Neuronal acetylcholine receptor subunit alpha-5	GO:0005886; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015276; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g057440	Scaffold_02	68022115	68024991	NA	NA	NA	NA	NA
PGEN_.00g057450	Scaffold_02	68066745	68074886	Q62674	S28A1_RAT	Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1) (CNT 1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1)	GO:0005337; GO:0005350; GO:0005415; GO:0005887; GO:0015212; GO:0015213; GO:0015389; GO:0015855; GO:0015861; GO:0015862; GO:0016020; GO:0016324; GO:1901642	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cytidine transmembrane transporter activity [GO:0015212]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; uridine transmembrane transporter activity [GO:0015213]; cytidine transport [GO:0015861]; nucleoside transmembrane transport [GO:1901642]; pyrimidine nucleobase transport [GO:0015855]; uridine transport [GO:0015862]
PGEN_.00g057460	Scaffold_02	68095505	68097644	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g057470	Scaffold_02	68097936	68098301	NA	NA	NA	NA	NA
PGEN_.00g057480	Scaffold_02	68103155	68103699	NA	NA	NA	NA	NA
PGEN_.00g057490	Scaffold_02	68119066	68119650	NA	NA	NA	NA	NA
PGEN_.00g057500	Scaffold_02	68126176	68144725	NA	NA	NA	NA	NA
PGEN_.00g057510	Scaffold_02	68191219	68192488	NA	NA	NA	NA	NA
PGEN_.00g057520	Scaffold_02	68192593	68192868	NA	NA	NA	NA	NA
PGEN_.00g057530	Scaffold_02	68193005	68194370	NA	NA	NA	NA	NA
PGEN_.00g057540	Scaffold_02	68196377	68196799	NA	NA	NA	NA	NA
PGEN_.00g057550	Scaffold_02	68257367	68265528	Q09221	CPNA2_CAEEL	Copine family protein 2		
PGEN_.00g057560	Scaffold_02	68269181	68275469	NA	NA	NA	NA	NA
PGEN_.00g057570	Scaffold_02	68281599	68282222	NA	NA	NA	NA	NA
PGEN_.00g057580	Scaffold_02	68282355	68282642	NA	NA	NA	NA	NA
PGEN_.00g057590	Scaffold_02	68282894	68285223	NA	NA	NA	NA	NA
PGEN_.00g057600	Scaffold_02	68286948	68375610	O75127	PTCD1_HUMAN	"Pentatricopeptide repeat-containing protein 1, mitochondrial"	GO:0000049; GO:0003723; GO:0005739; GO:0005759; GO:0042780	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tRNA 3'-end processing [GO:0042780]
PGEN_.00g057610	Scaffold_02	68297519	68300094	NA	NA	NA	NA	NA
PGEN_.00g057620	Scaffold_02	68383830	68387785	Q9W0Y2	YS11_DROME	Putative gamma-glutamylcyclotransferase CG2811 (EC 2.3.2.-)	GO:0005829; GO:0016746; GO:0061929	"cytosol [GO:0005829]; gamma-glutamylaminecyclotransferase activity [GO:0061929]; transferase activity, transferring acyl groups [GO:0016746]"
PGEN_.00g057630	Scaffold_02	68464201	68496778	Q1RNF8	SAM11_MOUSE	Sterile alpha motif domain-containing protein 11 (SAM domain-containing protein 11) (Major retinal SAM domain-containing protein) (Mr-s)	GO:0000122; GO:0005634; GO:0032093; GO:0042731; GO:0043621	nucleus [GO:0005634]; PH domain binding [GO:0042731]; protein self-association [GO:0043621]; SAM domain binding [GO:0032093]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g057640	Scaffold_02	68497671	68517500	Q92538	GBF1_HUMAN	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1)	GO:0000139; GO:0002263; GO:0005085; GO:0005086; GO:0005547; GO:0005739; GO:0005777; GO:0005788; GO:0005793; GO:0005794; GO:0005795; GO:0005801; GO:0005802; GO:0005811; GO:0005829; GO:0006888; GO:0006890; GO:0006892; GO:0006895; GO:0007030; GO:0007346; GO:0015031; GO:0016020; GO:0016032; GO:0030593; GO:0031252; GO:0032012; GO:0034067; GO:0042147; GO:0048205; GO:0061162; GO:0070973; GO:0080025; GO:0090166; GO:0097111; GO:0098586; GO:1903409; GO:1903420; GO:2000008	"cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; viral process [GO:0016032]"
PGEN_.00g057650	Scaffold_02	68547910	68600615	Q28205	TBCD_BOVIN	Tubulin-specific chaperone D (Beta-tubulin cofactor D) (Tubulin-folding cofactor D)	GO:0000226; GO:0000278; GO:0005096; GO:0005813; GO:0005829; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0070830	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; beta-tubulin binding [GO:0048487]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]
PGEN_.00g057660	Scaffold_02	68600989	68609761	Q61425	HCDH_MOUSE	"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)"	GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0014823; GO:0032868; GO:0042493; GO:0046676; GO:0070403; GO:0120162	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868]
PGEN_.00g057670	Scaffold_02	68618856	68630490	Q5QQ57	XYLT1_PANTR	Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I)	GO:0000137; GO:0000139; GO:0005615; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030166; GO:0030206; GO:0043931; GO:0046872; GO:0048706; GO:0050650	extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166]
PGEN_.00g057680	Scaffold_02	68632347	68656620	Q5QQ53	XYLT_DROPS	Xylosyltransferase oxt (EC 2.4.2.26) (Peptide O-xylosyltransferase)	GO:0000139; GO:0005789; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030206; GO:0042732; GO:0046872; GO:0050650	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]
PGEN_.00g057690	Scaffold_02	68673107	68697372	A7Y2W8	SC6A9_XENLA	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9)	GO:0005283; GO:0005328; GO:0005887	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g057700	Scaffold_02	68719952	68737125	Q9BUT9	MCRI2_HUMAN	MAPK regulated corepressor interacting protein 2 (Protein FAM195A)	GO:0005634; GO:0005737; GO:0010494	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]
PGEN_.00g057710	Scaffold_02	68748907	68796593	NA	NA	NA	NA	NA
PGEN_.00g057720	Scaffold_02	68818177	68818401	NA	NA	NA	NA	NA
PGEN_.00g057730	Scaffold_02	68845432	68846046	NA	NA	NA	NA	NA
PGEN_.00g057740	Scaffold_02	68866593	68866910	NA	NA	NA	NA	NA
PGEN_.00g057750	Scaffold_02	68867593	68867952	NA	NA	NA	NA	NA
PGEN_.00g057760	Scaffold_02	68901156	68934815	Q96PV6	LENG8_HUMAN	Leukocyte receptor cluster member 8	GO:0005634	nucleus [GO:0005634]
PGEN_.00g057770	Scaffold_02	68937830	68938399	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g057780	Scaffold_02	68942204	68942959	Q5REU3	ARL4D_PONAB	ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L)	GO:0005525; GO:0005730; GO:0005737; GO:0005886	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]
PGEN_.00g057790	Scaffold_02	68969876	68974330	Q9JIK9	RT34_MOUSE	"28S ribosomal protein S34, mitochondrial (MRP-S34) (S34mt) (T-complex expressed gene 2 protein)"	GO:0003735; GO:0005739; GO:0005763; GO:0032543	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g057800	Scaffold_02	68988811	68989179	NA	NA	NA	NA	NA
PGEN_.00g057810	Scaffold_02	68992989	69025898	Q2KJ63	KLKB1_BOVIN	Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]	GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0042803; GO:0051919	extracellular space [GO:0005615]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]
PGEN_.00g057820	Scaffold_02	69055523	69055855	NA	NA	NA	NA	NA
PGEN_.00g057830	Scaffold_02	69056035	69056421	NA	NA	NA	NA	NA
PGEN_.00g057840	Scaffold_02	69066381	69081865	F8J2D3	PLB_DRYCN	Phospholipase-B 81 (PLB) (EC 3.1.1.-)	GO:0004620; GO:0005576; GO:0009405; GO:0016042; GO:0044179; GO:0090729	extracellular region [GO:0005576]; phospholipase activity [GO:0004620]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]
PGEN_.00g057850	Scaffold_02	69090128	69109769	NA	NA	NA	NA	NA
PGEN_.00g057860	Scaffold_02	69114327	69116735	Q54KA7	SECG_DICDI	"Ankyrin repeat, PH and SEC7 domain containing protein secG"	GO:0005086; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327	cytosol [GO:0005829]; lysosome [GO:0005764]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012]
PGEN_.00g057870	Scaffold_02	69132785	69134361	NA	NA	NA	NA	NA
PGEN_.00g057880	Scaffold_02	69134391	69134648	NA	NA	NA	NA	NA
PGEN_.00g057890	Scaffold_02	69141366	69142766	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g057900	Scaffold_02	69150188	69151435	P57788	MOT4_CHICK	Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3)	GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g057910	Scaffold_02	69161042	69167982	P86734	EPDR1_HALAI	Ependymin-related protein 1	GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g057920	Scaffold_02	69219361	69253394	P48060	GLIP1_HUMAN	Glioma pathogenesis-related protein 1 (GliPR 1) (Protein RTVP-1)	GO:0005615; GO:0005886; GO:0016020; GO:0016021; GO:0019216; GO:0035577; GO:0043312	azurophil granule membrane [GO:0035577]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; neutrophil degranulation [GO:0043312]; regulation of lipid metabolic process [GO:0019216]
PGEN_.00g057930	Scaffold_02	69265205	69266209	Q8HY00	CD209_PONPY	CD209 antigen (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN1) (CD antigen CD209)	GO:0002250; GO:0005537; GO:0006897; GO:0007155; GO:0016021; GO:0045087; GO:0046872	integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; innate immune response [GO:0045087]
PGEN_.00g057940	Scaffold_02	69270879	69272481	NA	NA	NA	NA	NA
PGEN_.00g057950	Scaffold_02	69279328	69280080	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g057960	Scaffold_02	69288667	69294340	NA	NA	NA	NA	NA
PGEN_.00g057970	Scaffold_02	69297086	69349795	A6NI56	CC154_HUMAN	Coiled-coil domain-containing protein 154	GO:0005769; GO:0035630; GO:0042475; GO:0044691; GO:0045453	early endosome [GO:0005769]; bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; odontogenesis of dentin-containing tooth [GO:0042475]; tooth eruption [GO:0044691]
PGEN_.00g057980	Scaffold_02	69349851	69362236	Q1JQD2	GRWD1_BOVIN	Glutamate-rich WD repeat-containing protein 1	GO:0003682; GO:0003688; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006260; GO:0006334; GO:0006337; GO:0032991; GO:0042393	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]
PGEN_.00g057990	Scaffold_02	69372066	69379241	P97864	CASP7_MOUSE	Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]	GO:0004190; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0007507; GO:0007568; GO:0008233; GO:0008234; GO:0009411; GO:0016485; GO:0043231; GO:0051146; GO:0051402; GO:0071887; GO:0072734; GO:0097153; GO:0097194; GO:0097200	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146]
PGEN_.00g058000	Scaffold_02	69391828	69414592	O02776	PARG_BOVIN	Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143)	GO:0004649; GO:0005634; GO:0005737; GO:0005975; GO:0006282; GO:0006974; GO:0009225; GO:1990966	cytoplasm [GO:0005737]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; cellular response to DNA damage stimulus [GO:0006974]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]
PGEN_.00g058010	Scaffold_02	69395560	69395946	NA	NA	NA	NA	NA
PGEN_.00g058020	Scaffold_02	69422019	69449611	O46043	PARG_DROME	Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143)	GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005975; GO:0006282; GO:0006342; GO:0009225; GO:0009408; GO:0030576; GO:0035065; GO:0036099; GO:0043484; GO:0051457; GO:1990966	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; Cajal body organization [GO:0030576]; carbohydrate metabolic process [GO:0005975]; chromatin silencing [GO:0006342]; female germ-line stem cell population maintenance [GO:0036099]; maintenance of protein location in nucleus [GO:0051457]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone acetylation [GO:0035065]; regulation of RNA splicing [GO:0043484]; response to heat [GO:0009408]
PGEN_.00g058030	Scaffold_02	69449874	69464333	Q962Q6	RS24_SPOFR	40S ribosomal protein S24	GO:0003735; GO:0005840; GO:0006412	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g058040	Scaffold_02	69479876	69480565	Q9Z2L6	MINP1_MOUSE	"Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase)"	GO:0003993; GO:0005788; GO:0005886; GO:0030351; GO:0030352; GO:0034417; GO:0052745; GO:0052826	"endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity [GO:0030352]"
PGEN_.00g058050	Scaffold_02	69488751	69489344	NA	NA	NA	NA	NA
PGEN_.00g058060	Scaffold_02	69489392	69497103	F1NPQ2	MINP1_CHICK	"Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Band 17) (Histidine phosphatase of the endoplasmic reticulum 1) (HiPER1)"	GO:0003993; GO:0005788; GO:0034417; GO:0052745; GO:0052826	endoplasmic reticulum lumen [GO:0005788]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]
PGEN_.00g058070	Scaffold_02	69507709	69507921	NA	NA	NA	NA	NA
PGEN_.00g058080	Scaffold_02	69554507	69560427	NA	NA	NA	NA	NA
PGEN_.00g058090	Scaffold_02	69581839	69582453	NA	NA	NA	NA	NA
PGEN_.00g058100	Scaffold_02	69592978	69593538	NA	NA	NA	NA	NA
PGEN_.00g058110	Scaffold_03	490	847	NA	NA	NA	NA	NA
PGEN_.00g058120	Scaffold_03	2349	5074	NA	NA	NA	NA	NA
PGEN_.00g058130	Scaffold_03	12946	15265	NA	NA	NA	NA	NA
PGEN_.00g058140	Scaffold_03	27023	28840	NA	NA	NA	NA	NA
PGEN_.00g058150	Scaffold_03	40371	41859	NA	NA	NA	NA	NA
PGEN_.00g058160	Scaffold_03	42689	43891	NA	NA	NA	NA	NA
PGEN_.00g058170	Scaffold_03	51932	53704	NA	NA	NA	NA	NA
PGEN_.00g058180	Scaffold_03	53748	54020	NA	NA	NA	NA	NA
PGEN_.00g058190	Scaffold_03	54334	54651	NA	NA	NA	NA	NA
PGEN_.00g058200	Scaffold_03	55818	56608	NA	NA	NA	NA	NA
PGEN_.00g058210	Scaffold_03	58198	59040	NA	NA	NA	NA	NA
PGEN_.00g058220	Scaffold_03	59582	59947	NA	NA	NA	NA	NA
PGEN_.00g058230	Scaffold_03	71254	72264	NA	NA	NA	NA	NA
PGEN_.00g058240	Scaffold_03	81848	99546	A9JTP3	BIRC7_XENTR	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7)	GO:0005634; GO:0005737; GO:0007275; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865; GO:0061630; GO:1990001	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]
PGEN_.00g058250	Scaffold_03	109864	154008	Q93092	TALDO_MOUSE	Transaldolase (EC 2.2.1.2)	GO:0004801; GO:0005829; GO:0005975; GO:0006002; GO:0006098; GO:0009052; GO:0019682; GO:0030246; GO:0043231; GO:0048029	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; carbohydrate binding [GO:0030246]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"
PGEN_.00g058260	Scaffold_03	154467	155705	NA	NA	NA	NA	NA
PGEN_.00g058270	Scaffold_03	163889	191296	Q6QDP7	CR3L2_RAT	Cyclic AMP-responsive element-binding protein 3-like protein 2 (cAMP-responsive element-binding protein 3-like protein 2) (SCI-related protein Ra69) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2]	GO:0000785; GO:0000978; GO:0001228; GO:0002062; GO:0005634; GO:0005654; GO:0005783; GO:0005789; GO:0006888; GO:0009611; GO:0010628; GO:0010976; GO:0016021; GO:0030968; GO:0034976; GO:0035497; GO:0044212; GO:0045893; GO:0045944; GO:0051216; GO:0097038	"chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to endoplasmic reticulum stress [GO:0034976]; response to wounding [GO:0009611]"
PGEN_.00g058280	Scaffold_03	205030	313977	E9Q8T7	DYH1_MOUSE	"Dynein heavy chain 1, axonemal (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7)"	GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294	"axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288]"
PGEN_.00g058290	Scaffold_03	316017	334206	Q9SX38	DRL4_ARATH	Putative disease resistance protein At1g50180	GO:0005524; GO:0006952; GO:0009506; GO:0043531	plasmodesma [GO:0009506]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; defense response [GO:0006952]
PGEN_.00g058300	Scaffold_03	411594	412381	NA	NA	NA	NA	NA
PGEN_.00g058310	Scaffold_03	418614	476537	Q8C5H1	ANO4_MOUSE	Anoctamin-4 (Transmembrane protein 16D)	GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0061589; GO:0061590; GO:0061591; GO:1902476	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]
PGEN_.00g058320	Scaffold_03	488393	497859	Q9H467	CUED2_HUMAN	CUE domain-containing protein 2	GO:0005654; GO:0005829; GO:0010936; GO:0031965; GO:1900016	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of macrophage cytokine production [GO:0010936]
PGEN_.00g058330	Scaffold_03	502464	509299	NA	NA	NA	NA	NA
PGEN_.00g058340	Scaffold_03	514640	523058	NA	NA	NA	NA	NA
PGEN_.00g058350	Scaffold_03	541764	542729	NA	NA	NA	NA	NA
PGEN_.00g058360	Scaffold_03	552060	554398	NA	NA	NA	NA	NA
PGEN_.00g058370	Scaffold_03	555199	557379	NA	NA	NA	NA	NA
PGEN_.00g058380	Scaffold_03	557496	558128	NA	NA	NA	NA	NA
PGEN_.00g058390	Scaffold_03	560501	560854	Q14191	WRN_HUMAN	"Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2)"	GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0001302; GO:0003677; GO:0003678; GO:0003682; GO:0004386; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006284; GO:0006302; GO:0006310; GO:0006974; GO:0006979; GO:0007420; GO:0007568; GO:0007569; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0010259; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0042981; GO:0043005; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090656; GO:0098530; GO:1901796; GO:1902570; GO:1905773	"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replicative cell aging [GO:0001302]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"
PGEN_.00g058400	Scaffold_03	580600	621429	NA	NA	NA	NA	NA
PGEN_.00g058410	Scaffold_03	674803	690798	NA	NA	NA	NA	NA
PGEN_.00g058420	Scaffold_03	803396	803791	NA	NA	NA	NA	NA
PGEN_.00g058430	Scaffold_03	817536	851042	Q9QYP2	CELR2_RAT	Cadherin EGF LAG seven-pass G-type receptor 2 (Multiple epidermal growth factor-like domains protein 3) (Multiple EGF-like domains protein 3) (Fragment)	GO:0001764; GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0007283; GO:0016021; GO:0016055; GO:0021591; GO:0021999; GO:0022407; GO:0032880; GO:0033326; GO:0048813; GO:0060271; GO:0098609	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural plate anterior/posterior regionalization [GO:0021999]; neuron migration [GO:0001764]; regulation of cell-cell adhesion [GO:0022407]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g058440	Scaffold_03	871921	911286	O14514	AGRB1_HUMAN	Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)]	GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016021; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428	"cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]"
PGEN_.00g058450	Scaffold_03	918034	918987	NA	NA	NA	NA	NA
PGEN_.00g058460	Scaffold_03	965271	980410	Q96A58	RERG_HUMAN	Ras-related and estrogen-regulated growth inhibitor	GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0007264; GO:0007265; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; estrogen receptor binding [GO:0030331]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g058470	Scaffold_03	1010003	1010602	NA	NA	NA	NA	NA
PGEN_.00g058480	Scaffold_03	1011190	1011939	Q6R2W3	SCND3_HUMAN	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	GO:0003676; GO:0003700; GO:0005654; GO:0015074	nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g058490	Scaffold_03	1012846	1021530	P98133	FBN1_BOVIN	Fibrillin-1 (MP340) [Cleaved into: Asprosin]	GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0010737; GO:0031012; GO:0034199; GO:0042593	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]
PGEN_.00g058500	Scaffold_03	1022118	1022717	NA	NA	NA	NA	NA
PGEN_.00g058510	Scaffold_03	1051845	1067004	Q96A58	RERG_HUMAN	Ras-related and estrogen-regulated growth inhibitor	GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0007264; GO:0007265; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; estrogen receptor binding [GO:0030331]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g058520	Scaffold_03	1113291	1114243	NA	NA	NA	NA	NA
PGEN_.00g058530	Scaffold_03	1121051	1160472	O14514	AGRB1_HUMAN	Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)]	GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016021; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428	"cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]"
PGEN_.00g058540	Scaffold_03	1184515	1213717	Q9ESC1	AGRL4_RAT	"Adhesion G protein-coupled receptor L4 (EGF,latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)"	GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0007166; GO:0007189; GO:0031410; GO:0065003	cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; protein-containing complex assembly [GO:0065003]
PGEN_.00g058550	Scaffold_03	1227422	1227817	NA	NA	NA	NA	NA
PGEN_.00g058560	Scaffold_03	1343717	1355023	Q9BRP4	PAAF1_HUMAN	Proteasomal ATPase-associated factor 1 (Protein G-16) (WD repeat-containing protein 71)	GO:0000502; GO:0016032	proteasome complex [GO:0000502]; viral process [GO:0016032]
PGEN_.00g058570	Scaffold_03	1366374	1402055	Q7RTP6	MICA3_HUMAN	[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3)	GO:0003779; GO:0005634; GO:0005654; GO:0005815; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0007049; GO:0016709; GO:0017137; GO:0030036; GO:0030042; GO:0031941; GO:0042995; GO:0045171; GO:0046872; GO:0051301; GO:0055114; GO:0071949; GO:0090543	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]; actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]"
PGEN_.00g058580	Scaffold_03	1407509	1409891	NA	NA	NA	NA	NA
PGEN_.00g058590	Scaffold_03	1454146	1467312	P84169	PSD13_CHICK	26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5)	GO:0005198; GO:0005634; GO:0005829; GO:0006511; GO:0007127; GO:0008541; GO:0022624; GO:0043248	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; meiosis I [GO:0007127]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g058600	Scaffold_03	1492911	1498147	NA	NA	NA	NA	NA
PGEN_.00g058610	Scaffold_03	1505639	1505980	Q16587	ZNF74_HUMAN	Zinc finger protein 74 (Zinc finger protein 520) (hZNF7)	GO:0003677; GO:0003723; GO:0005654; GO:0006355; GO:0007275; GO:0015629; GO:0046872	"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g058620	Scaffold_03	1511221	1511520	P18715	ZG26_XENLA	Gastrula zinc finger protein XlCGF26.1 (Fragment)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g058630	Scaffold_03	1518117	1527771	Q6ZS27	ZN662_HUMAN	Zinc finger protein 662	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g058640	Scaffold_03	1532223	1550839	NA	NA	NA	NA	NA
PGEN_.00g058650	Scaffold_03	1550308	1550842	NA	NA	NA	NA	NA
PGEN_.00g058660	Scaffold_03	1560429	1565122	NA	NA	NA	NA	NA
PGEN_.00g058670	Scaffold_03	1578288	1621805	NA	NA	NA	NA	NA
PGEN_.00g058680	Scaffold_03	1631440	1639434	Q8BMF3	MAON_MOUSE	"NADP-dependent malic enzyme, mitochondrial (NADP-ME) (EC 1.1.1.40) (Malic enzyme 3)"	GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006108; GO:0008948; GO:0046872; GO:0051287; GO:0055114	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; oxidation-reduction process [GO:0055114]; pyruvate metabolic process [GO:0006090]
PGEN_.00g058690	Scaffold_03	1644308	1645856	P40927	MAOX_COLLI	NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40)	GO:0004471; GO:0004473; GO:0005737; GO:0008948; GO:0046872; GO:0051287	cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]
PGEN_.00g058700	Scaffold_03	1649927	1650250	NA	NA	NA	NA	NA
PGEN_.00g058710	Scaffold_03	1660093	1662773	NA	NA	NA	NA	NA
PGEN_.00g058720	Scaffold_03	1664613	1744031	NA	NA	NA	NA	NA
PGEN_.00g058730	Scaffold_03	1755861	1769549	NA	NA	NA	NA	NA
PGEN_.00g058740	Scaffold_03	1773810	1783828	NA	NA	NA	NA	NA
PGEN_.00g058750	Scaffold_03	1784458	1799112	A2VDK6	WASF2_BOVIN	Wiskott-Aldrich syndrome protein family member 2 (WASP family protein member 2)	GO:0003779; GO:0005737; GO:0005856; GO:0030027; GO:0030036	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]
PGEN_.00g058760	Scaffold_03	1799189	1814400	NA	NA	NA	NA	NA
PGEN_.00g058770	Scaffold_03	1828569	1833796	P35398	RORA_HUMAN	Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha)	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001525; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0006355; GO:0006367; GO:0006805; GO:0006809; GO:0008013; GO:0008134; GO:0008142; GO:0008270; GO:0008589; GO:0010575; GO:0010906; GO:0019218; GO:0019221; GO:0021702; GO:0021930; GO:0030522; GO:0032922; GO:0036315; GO:0042632; GO:0042692; GO:0042753; GO:0043030; GO:0043124; GO:0043565; GO:0045599; GO:0045893; GO:0045944; GO:0046068; GO:0050728; GO:0060850; GO:0070328; GO:0071347; GO:0071356; GO:0071456; GO:0072539; GO:0098531	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; ligand-activated transcription factor activity [GO:0098531]; nuclear receptor activity [GO:0004879]; oxysterol binding [GO:0008142]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to sterol [GO:0036315]; cellular response to tumor necrosis factor [GO:0071356]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell differentiation [GO:0021702]; cGMP metabolic process [GO:0046068]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; cytokine-mediated signaling pathway [GO:0019221]; intracellular receptor signaling pathway [GO:0030522]; muscle cell differentiation [GO:0042692]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of glucose metabolic process [GO:0010906]; regulation of macrophage activation [GO:0043030]; regulation of smoothened signaling pathway [GO:0008589]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription involved in cell fate commitment [GO:0060850]; regulation of transcription, DNA-templated [GO:0006355]; T-helper 17 cell differentiation [GO:0072539]; transcription initiation from RNA polymerase II promoter [GO:0006367]; triglyceride homeostasis [GO:0070328]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g058780	Scaffold_03	1854386	1880131	Q5XXB5	MSH2_CHLAE	DNA mismatch repair protein Msh2 (MutS protein homolog 2)	GO:0005524; GO:0005694; GO:0006298; GO:0007049; GO:0030983; GO:0032301	chromosome [GO:0005694]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; mismatched DNA binding [GO:0030983]; cell cycle [GO:0007049]; mismatch repair [GO:0006298]
PGEN_.00g058790	Scaffold_03	1881220	1881850	NA	NA	NA	NA	NA
PGEN_.00g058800	Scaffold_03	1892976	1894706	NA	NA	NA	NA	NA
PGEN_.00g058810	Scaffold_03	1920361	1930076	NA	NA	NA	NA	NA
PGEN_.00g058820	Scaffold_03	1936725	1954165	Q1EHB4	SC5AC_HUMAN	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	GO:0005343; GO:0005886; GO:0006811; GO:0015129; GO:0016021; GO:0016324; GO:0070062	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; organic acid:sodium symporter activity [GO:0005343]; ion transport [GO:0006811]
PGEN_.00g058830	Scaffold_03	1967200	2015849	P42700	RO60_XENLA	60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (Ro60) (RoRNP) (TROVE domain family member 2)	GO:0005737; GO:0030030; GO:0034336; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; misfolded RNA binding [GO:0034336]; cell projection organization [GO:0030030]
PGEN_.00g058840	Scaffold_03	2019560	2020740	NA	NA	NA	NA	NA
PGEN_.00g058850	Scaffold_03	2029308	2061547	Q9P2F6	RHG20_HUMAN	Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20)	GO:0005096; GO:0005829; GO:0007165; GO:0051056	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]
PGEN_.00g058860	Scaffold_03	2075833	2090441	NA	NA	NA	NA	NA
PGEN_.00g058870	Scaffold_03	2119434	2120102	NA	NA	NA	NA	NA
PGEN_.00g058880	Scaffold_03	2144294	2146772	NA	NA	NA	NA	NA
PGEN_.00g058890	Scaffold_03	2149900	2150259	NA	NA	NA	NA	NA
PGEN_.00g058900	Scaffold_03	2226692	2231914	NA	NA	NA	NA	NA
PGEN_.00g058910	Scaffold_03	2290688	2292034	Q17237	SGF3_BOMMO	Silk gland factor 3 (SGF-3) (POU domain protein M1)	GO:0003700; GO:0005634; GO:0006357; GO:0007420; GO:0030154; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g058920	Scaffold_03	2382624	2393513	Q9UKU7	ACAD8_HUMAN	"Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)"	GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0009083; GO:0050660	mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]
PGEN_.00g058930	Scaffold_03	2402008	2415336	Q6DCD5	TMTC2_XENLA	Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 2)	GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0035269	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]
PGEN_.00g058940	Scaffold_03	2470469	2483113	O14777	NDC80_HUMAN	Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1) (HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC)	GO:0000070; GO:0000132; GO:0000278; GO:0000775; GO:0000776; GO:0000777; GO:0000778; GO:0000942; GO:0005623; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007052; GO:0007059; GO:0008608; GO:0016020; GO:0031262; GO:0042802; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:1905342	"cell [GO:0005623]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; kinetochore organization [GO:0051383]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein localization to kinetochore [GO:1905342]"
PGEN_.00g058950	Scaffold_03	2484195	2495514	Q5U303	TAB2_RAT	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TGF-beta-activated kinase 1-binding protein 2)	GO:0005634; GO:0005829; GO:0007507; GO:0032496; GO:0043123; GO:0045860; GO:0046872; GO:0070530	cytosol [GO:0005829]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; heart development [GO:0007507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; response to lipopolysaccharide [GO:0032496]
PGEN_.00g058960	Scaffold_03	2537164	2538402	Q2KI97	GPR84_BOVIN	G-protein coupled receptor 84	GO:0001604; GO:0005887; GO:0007218; GO:0008528	integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; urotensin II receptor activity [GO:0001604]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g058970	Scaffold_03	2548141	2549328	NA	NA	NA	NA	NA
PGEN_.00g058980	Scaffold_03	2638870	2639676	Q90XB3	OLIG2_CHICK	Oligodendrocyte transcription factor 2 (Oligo2)	GO:0000122; GO:0000981; GO:0003677; GO:0005634; GO:0005737; GO:0021522; GO:0021530; GO:0021794; GO:0042552; GO:0042803; GO:0045665; GO:0048663; GO:0048714; GO:0071837	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; protein homodimerization activity [GO:0042803]; myelination [GO:0042552]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; positive regulation of oligodendrocyte differentiation [GO:0048714]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; thalamus development [GO:0021794]"
PGEN_.00g058990	Scaffold_03	2684758	2685084	NA	NA	NA	NA	NA
PGEN_.00g059000	Scaffold_03	2707746	2708333	NA	NA	NA	NA	NA
PGEN_.00g059010	Scaffold_03	2730615	2730935	NA	NA	NA	NA	NA
PGEN_.00g059020	Scaffold_03	2742934	2767827	A0A0B5A7M7	INS1_CONIM	Con-Ins Im1 (Insulin 1) [Cleaved into: Con-Ins I1 B chain; Con-Ins I1 A chain]	GO:0005179; GO:0005576; GO:0006006; GO:0009405; GO:0090729	extracellular region [GO:0005576]; hormone activity [GO:0005179]; toxin activity [GO:0090729]; glucose metabolic process [GO:0006006]; pathogenesis [GO:0009405]
PGEN_.00g059030	Scaffold_03	2804162	2839320	Q9NDE7	INS_APLCA	Insulin [Cleaved into: Insulin B chain; Insulin B chain'; Insulin A chain]	GO:0005179; GO:0005576; GO:0007218	extracellular region [GO:0005576]; hormone activity [GO:0005179]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g059040	Scaffold_03	2850069	2853539	NA	NA	NA	NA	NA
PGEN_.00g059050	Scaffold_03	2856341	2865273	O45870	NSMA_CAEEL	Putative neutral sphingomyelinase (EC 3.1.4.12)	GO:0004767; GO:0005901; GO:0006684; GO:0016021; GO:0046872	caveola [GO:0005901]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin metabolic process [GO:0006684]
PGEN_.00g059060	Scaffold_03	2879509	2891058	NA	NA	NA	NA	NA
PGEN_.00g059070	Scaffold_03	2892820	2896287	NA	NA	NA	NA	NA
PGEN_.00g059080	Scaffold_03	2900163	2901098	NA	NA	NA	NA	NA
PGEN_.00g059090	Scaffold_03	2925047	2932802	Q4V8S3	TM242_DANRE	Transmembrane protein 242	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g059100	Scaffold_03	2933167	2987522	Q8IZN3	ZDH14_HUMAN	Probable palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14) (DHHC-14)	GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]
PGEN_.00g059110	Scaffold_03	3000830	3021399	Q9N1T2	RPGR_CANLF	X-linked retinitis pigmentosa GTPase regulator	GO:0005085; GO:0005794; GO:0005813; GO:0007601; GO:0036064; GO:0036126; GO:0042073; GO:0050896; GO:0060271	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g059120	Scaffold_03	3031951	3033234	O97967	BRS3_SHEEP	Bombesin receptor subtype-3 (BRS-3)	GO:0004946; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bombesin receptor activity [GO:0004946]
PGEN_.00g059130	Scaffold_03	3040622	3041908	D4A7K7	GP183_RAT	G-protein coupled receptor 183 (Epstein-Barr virus-induced G-protein coupled receptor 2) (EBI2) (EBV-induced G-protein coupled receptor 2)	GO:0002250; GO:0002313; GO:0002407; GO:0004930; GO:0005886; GO:0006959; GO:0007186; GO:0008142; GO:0010818; GO:0016021; GO:0030316; GO:0030595; GO:0030890; GO:0036145; GO:0060326; GO:0061470; GO:0070374; GO:2000458	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142]; adaptive immune response [GO:0002250]; cell chemotaxis [GO:0060326]; dendritic cell chemotaxis [GO:0002407]; dendritic cell homeostasis [GO:0036145]; G protein-coupled receptor signaling pathway [GO:0007186]; humoral immune response [GO:0006959]; leukocyte chemotaxis [GO:0030595]; mature B cell differentiation involved in immune response [GO:0002313]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of astrocyte chemotaxis [GO:2000458]; T cell chemotaxis [GO:0010818]; T follicular helper cell differentiation [GO:0061470]
PGEN_.00g059140	Scaffold_03	3048088	3048291	NA	NA	NA	NA	NA
PGEN_.00g059150	Scaffold_03	3112034	3121217	Q3T0V9	DEOC_BOVIN	Deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase)	GO:0004139; GO:0005654; GO:0005737; GO:0009264; GO:0016052; GO:0046121; GO:0046386	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; deoxyribose-phosphate aldolase activity [GO:0004139]; carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]
PGEN_.00g059160	Scaffold_03	3144839	3259367	C6KFA3	AGRG6_DANRE	Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	GO:0001503; GO:0004930; GO:0005518; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0007507; GO:0014037; GO:0019933; GO:0022011; GO:0032290; GO:0042552; GO:0043236; GO:0043583; GO:0048932; GO:0050840; GO:0060347; GO:0060879; GO:1903670	integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879]
PGEN_.00g059170	Scaffold_03	3269930	3271723	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g059180	Scaffold_03	3279817	3297208	Q9LJN4	BXL5_ARATH	Probable beta-D-xylosidase 5 (AtBXL5) (EC 3.2.1.-)	GO:0005576; GO:0005618; GO:0009044; GO:0009505; GO:0031222; GO:0045493; GO:0046556	"cell wall [GO:0005618]; extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]; alpha-L-arabinofuranosidase activity [GO:0046556]; xylan 1,4-beta-xylosidase activity [GO:0009044]; arabinan catabolic process [GO:0031222]; xylan catabolic process [GO:0045493]"
PGEN_.00g059190	Scaffold_03	3298566	3298910	NA	NA	NA	NA	NA
PGEN_.00g059200	Scaffold_03	3302197	3307236	P82450	SIAE_RAT	Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase) (Yolk sac protein 2) [Cleaved into: Sialate O-acetylesterase small subunit; Sialate O-acetylesterase large subunit]	GO:0001681; GO:0002682; GO:0005764; GO:0005975	lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]
PGEN_.00g059210	Scaffold_03	3307976	3311751	P82450	SIAE_RAT	Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase) (Yolk sac protein 2) [Cleaved into: Sialate O-acetylesterase small subunit; Sialate O-acetylesterase large subunit]	GO:0001681; GO:0002682; GO:0005764; GO:0005975	lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]
PGEN_.00g059220	Scaffold_03	3315059	3325045	P70665	SIAE_MOUSE	Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase) (Yolk sac protein 2) [Cleaved into: Sialate O-acetylesterase small subunit; Sialate O-acetylesterase large subunit]	GO:0001681; GO:0002682; GO:0005764; GO:0005975	lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]
PGEN_.00g059230	Scaffold_03	3335951	3352492	NA	NA	NA	NA	NA
PGEN_.00g059240	Scaffold_03	3359563	3364232	NA	NA	NA	NA	NA
PGEN_.00g059250	Scaffold_03	3370920	3391427	Q9UBI4	STML1_HUMAN	Stomatin-like protein 1 (SLP-1) (EPB72-like protein 1) (Protein unc-24 homolog) (Stomatin-related protein) (STORP)	GO:0005886; GO:0006869; GO:0016021; GO:0031902; GO:0045121	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; lipid transport [GO:0006869]
PGEN_.00g059260	Scaffold_03	3395777	3399471	Q9GUM2	BRE4_CAEEL	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	"integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"
PGEN_.00g059270	Scaffold_03	3419608	3434922	Q9GUM2	BRE4_CAEEL	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	"integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"
PGEN_.00g059280	Scaffold_03	3440959	3460786	Q9GUM2	BRE4_CAEEL	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	"integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"
PGEN_.00g059290	Scaffold_03	3545332	3555252	Q8C0T7	MFSD9_MOUSE	Major facilitator superfamily domain-containing protein 9	GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]
PGEN_.00g059300	Scaffold_03	3565423	3593572	NA	NA	NA	NA	NA
PGEN_.00g059310	Scaffold_03	3593922	3600743	O00628	PEX7_HUMAN	Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7)	GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803]; endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g059320	Scaffold_03	3628224	3630670	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g059330	Scaffold_03	3631547	3636943	NA	NA	NA	NA	NA
PGEN_.00g059340	Scaffold_03	3664420	3667575	P17900	SAP3_HUMAN	Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short]	GO:0005319; GO:0005576; GO:0006687; GO:0006689; GO:0007611; GO:0009313; GO:0009898; GO:0016004; GO:0016323; GO:0016324; GO:0019915; GO:0030290; GO:0032428; GO:0035578; GO:0043202; GO:0043312; GO:0050885; GO:0051345; GO:0070062	apical plasma membrane [GO:0016324]; azurophil granule lumen [GO:0035578]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; beta-N-acetylgalactosaminidase activity [GO:0032428]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; sphingolipid activator protein activity [GO:0030290]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]
PGEN_.00g059350	Scaffold_03	3671740	3676531	Q60648	SAP3_MOUSE	Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3)	GO:0004563; GO:0005319; GO:0005739; GO:0005764; GO:0006689; GO:0007611; GO:0008047; GO:0009313; GO:0009898; GO:0016004; GO:0016323; GO:0016324; GO:0019915; GO:0032428; GO:0050877; GO:0050885; GO:0051345	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]
PGEN_.00g059360	Scaffold_03	3679891	3686885	NA	NA	NA	NA	NA
PGEN_.00g059370	Scaffold_03	3701025	3711665	NA	NA	NA	NA	NA
PGEN_.00g059380	Scaffold_03	3731046	3731399	NA	NA	NA	NA	NA
PGEN_.00g059390	Scaffold_03	3749187	3757012	Q8IV01	SYT12_HUMAN	Synaptotagmin-12 (Synaptotagmin XII) (SytXII)	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030672; GO:0046928; GO:0048792; GO:0060291; GO:0070382; GO:0071277; GO:0098686	cell junction [GO:0030054]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; long-term synaptic potentiation [GO:0060291]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neurotransmitter secretion [GO:0046928]; spontaneous exocytosis of neurotransmitter [GO:0048792]; vesicle-mediated transport [GO:0016192]
PGEN_.00g059400	Scaffold_03	3772503	3773717	P09478	ACH1_DROME	Acetylcholine receptor subunit alpha-like 1 (Nicotinic acetylcholine receptor alpha 1)	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g059410	Scaffold_03	3778448	3787768	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g059420	Scaffold_03	3817120	3817503	NA	NA	NA	NA	NA
PGEN_.00g059430	Scaffold_03	3848145	3861407	NA	NA	NA	NA	NA
PGEN_.00g059440	Scaffold_03	3873370	3892877	Q7PYI7	CRY1_ANOGA	Cryptochrome-1 (agCRY1)	GO:0005634; GO:0005641; GO:0005737; GO:0009882; GO:0018298; GO:0042752; GO:0045892; GO:0048471; GO:0048511; GO:0050660	"cytoplasm [GO:0005737]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; blue light photoreceptor activity [GO:0009882]; flavin adenine dinucleotide binding [GO:0050660]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]"
PGEN_.00g059450	Scaffold_03	3929228	3929512	Q6P988	NOTUM_HUMAN	Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (hNOTUM)	GO:0004629; GO:0005576; GO:0005788; GO:0016055; GO:0030178; GO:0043687; GO:0044267; GO:0090090; GO:1990697; GO:1990699	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; phospholipase C activity [GO:0004629]; cellular protein metabolic process [GO:0044267]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; post-translational protein modification [GO:0043687]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]
PGEN_.00g059460	Scaffold_03	3946922	3966573	Q8R116	NOTUM_MOUSE	Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98)	GO:0005576; GO:0016055; GO:0030178; GO:0090090; GO:1990697; GO:1990699	extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055]
PGEN_.00g059470	Scaffold_03	4043996	4053497	P15555	DAC_STRSR	D-alanyl-D-alanine carboxypeptidase (DD-carboxypeptidase) (DD-peptidase) (EC 3.4.16.4)	GO:0005576; GO:0008360; GO:0009002; GO:0009252; GO:0071555	extracellular region [GO:0005576]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]
PGEN_.00g059480	Scaffold_03	4061842	4062180	NA	NA	NA	NA	NA
PGEN_.00g059490	Scaffold_03	4238071	4255486	A6QLU6	AGRD1_BOVIN	Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)	GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g059500	Scaffold_03	4274022	4274270	NA	NA	NA	NA	NA
PGEN_.00g059510	Scaffold_03	4274345	4304117	A7T167	GDAP2_NEMVE	Protein GDAP2 homolog		
PGEN_.00g059520	Scaffold_03	4323432	4353107	NA	NA	NA	NA	NA
PGEN_.00g059530	Scaffold_03	4334362	4335483	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g059540	Scaffold_03	4362376	4371423	P0C6R2	ARMC2_BOVIN	Armadillo repeat-containing protein 2	GO:0007288	sperm axoneme assembly [GO:0007288]
PGEN_.00g059550	Scaffold_03	4428341	4457085	NA	NA	NA	NA	NA
PGEN_.00g059560	Scaffold_03	4457195	4471937	NA	NA	NA	NA	NA
PGEN_.00g059570	Scaffold_03	4479636	4479950	NA	NA	NA	NA	NA
PGEN_.00g059580	Scaffold_03	4495377	4499836	Q9CWU9	NUP37_MOUSE	Nucleoporin Nup37 (Nup107-160 subcomplex subunit Nup37)	GO:0000777; GO:0005654; GO:0007049; GO:0007059; GO:0015031; GO:0031080; GO:0051028; GO:0051301	condensed chromosome kinetochore [GO:0000777]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]
PGEN_.00g059590	Scaffold_03	4525430	4526221	NA	NA	NA	NA	NA
PGEN_.00g059600	Scaffold_03	4528645	4613607	O95490	AGRL2_HUMAN	Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1)	GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007420; GO:0016021; GO:0016524; GO:0030246; GO:0043005	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g059610	Scaffold_03	4614556	4632213	O43390	HNRPR_HUMAN	Heterogeneous nuclear ribonucleoprotein R (hnRNP R)	GO:0000398; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0007623; GO:0016070; GO:0030425; GO:0030426; GO:0043086; GO:0043679; GO:0061157; GO:0071013; GO:1990904	"axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070]"
PGEN_.00g059620	Scaffold_03	4649525	4657952	Q9VZD5	RT06_DROME	"Probable 28S ribosomal protein S6, mitochondrial (MRP-S6) (S6mt)"	GO:0003735; GO:0005763; GO:0006412; GO:0032543; GO:0070181	mitochondrial small ribosomal subunit [GO:0005763]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
PGEN_.00g059630	Scaffold_03	4661874	4662107	NA	NA	NA	NA	NA
PGEN_.00g059640	Scaffold_03	4662154	4688430	O73872	SODC_DANRE	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005623; GO:0005634; GO:0005739; GO:0005777; GO:0005829; GO:0009410; GO:0010038; GO:0019430; GO:0051597; GO:0070050	cell [GO:0005623]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; neuron cellular homeostasis [GO:0070050]; removal of superoxide radicals [GO:0019430]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to xenobiotic stimulus [GO:0009410]
PGEN_.00g059650	Scaffold_03	4756943	4757314	NA	NA	NA	NA	NA
PGEN_.00g059660	Scaffold_03	4763302	4774843	NA	NA	NA	NA	NA
PGEN_.00g059670	Scaffold_03	4784812	4785207	NA	NA	NA	NA	NA
PGEN_.00g059680	Scaffold_03	4810601	4817373	NA	NA	NA	NA	NA
PGEN_.00g059690	Scaffold_03	4824661	4834387	Q52KD8	EAF6_XENLA	Chromatin modification-related protein MEAF6 (MYST/Esa1-associated factor 6) (Esa1-associated factor 6 homolog) (Protein EAF6 homolog)	GO:0000776; GO:0000777; GO:0005730; GO:0035267; GO:0043968; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0070776	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]
PGEN_.00g059700	Scaffold_03	4834518	4841248	NA	NA	NA	NA	NA
PGEN_.00g059710	Scaffold_03	4844271	4859579	Q5ZMJ9	SRRM1_CHICK	Serine/arginine repetitive matrix protein 1	GO:0005634; GO:0006397; GO:0008380	nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g059720	Scaffold_03	4867923	4880093	Q8IXU6	S35F2_HUMAN	Solute carrier family 35 member F2	GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]
PGEN_.00g059730	Scaffold_03	4884251	4885952	Q96DA2	RB39B_HUMAN	Ras-related protein Rab-39B	GO:0003924; GO:0005525; GO:0005622; GO:0005794; GO:0005886; GO:0006886; GO:0006914; GO:0010506; GO:0016192; GO:0030659; GO:0031489; GO:0031982; GO:0032482; GO:0043005; GO:0050808	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192]
PGEN_.00g059740	Scaffold_03	4893946	4894290	NA	NA	NA	NA	NA
PGEN_.00g059750	Scaffold_03	4907219	4914592	Q26636	CATL_SARPE	Cathepsin L (EC 3.4.22.15) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]	GO:0005764; GO:0007275; GO:0008234; GO:0030154	lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]
PGEN_.00g059760	Scaffold_03	4938560	4994077	Q6IRN2	QKIB_XENLA	Protein quaking-B	GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006417; GO:0007275; GO:0008380; GO:0030154; GO:0051028	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]
PGEN_.00g059770	Scaffold_03	5097538	5097951	NA	NA	NA	NA	NA
PGEN_.00g059780	Scaffold_03	5102969	5144002	Q8K363	DDX18_MOUSE	ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18)	GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0071392	"chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"
PGEN_.00g059790	Scaffold_03	5147136	5152242	NA	NA	NA	NA	NA
PGEN_.00g059800	Scaffold_03	5156649	5156996	NA	NA	NA	NA	NA
PGEN_.00g059810	Scaffold_03	5163568	5174705	Q652Q8	URH2_ORYSJ	Probable uridine nucleosidase 2 (EC 3.2.2.3) (Uridine ribohydrolase 2)	GO:0005829; GO:0006152; GO:0008477; GO:0045437	cytosol [GO:0005829]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437]; purine nucleoside catabolic process [GO:0006152]
PGEN_.00g059820	Scaffold_03	5177156	5180656	NA	NA	NA	NA	NA
PGEN_.00g059830	Scaffold_03	5184036	5195309	Q27546	IUNH_CRIFA	Inosine-uridine preferring nucleoside hydrolase (IU-NH) (IU-nucleoside hydrolase) (EC 3.2.2.2) (EC 3.2.2.3) (Non-specific nucleoside hydrolase)	GO:0009117; GO:0045437; GO:0046872; GO:0047724	inosine nucleosidase activity [GO:0047724]; metal ion binding [GO:0046872]; uridine nucleosidase activity [GO:0045437]; nucleotide metabolic process [GO:0009117]
PGEN_.00g059840	Scaffold_03	5197677	5198003	NA	NA	NA	NA	NA
PGEN_.00g059850	Scaffold_03	5200218	5200463	NA	NA	NA	NA	NA
PGEN_.00g059860	Scaffold_03	5207798	5219815	B6I8L3	RIHB_ECOSE	Pyrimidine-specific ribonucleoside hydrolase RihB (EC 3.2.2.8) (Cytidine/uridine-specific hydrolase)	GO:0005509; GO:0006206; GO:0046133; GO:0050263	calcium ion binding [GO:0005509]; ribosylpyrimidine nucleosidase activity [GO:0050263]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine ribonucleoside catabolic process [GO:0046133]
PGEN_.00g059870	Scaffold_03	5225291	5230957	Q27546	IUNH_CRIFA	Inosine-uridine preferring nucleoside hydrolase (IU-NH) (IU-nucleoside hydrolase) (EC 3.2.2.2) (EC 3.2.2.3) (Non-specific nucleoside hydrolase)	GO:0009117; GO:0045437; GO:0046872; GO:0047724	inosine nucleosidase activity [GO:0047724]; metal ion binding [GO:0046872]; uridine nucleosidase activity [GO:0045437]; nucleotide metabolic process [GO:0009117]
PGEN_.00g059880	Scaffold_03	5238106	5260462	NA	NA	NA	NA	NA
PGEN_.00g059890	Scaffold_03	5286235	5286438	NA	NA	NA	NA	NA
PGEN_.00g059900	Scaffold_03	5294258	5296104	NA	NA	NA	NA	NA
PGEN_.00g059910	Scaffold_03	5295454	5296594	NA	NA	NA	NA	NA
PGEN_.00g059920	Scaffold_03	5298850	5336006	NA	NA	NA	NA	NA
PGEN_.00g059930	Scaffold_03	5379498	5404611	O88923	AGRL2_RAT	Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin-2)	GO:0004930; GO:0005887; GO:0007166; GO:0007189; GO:0007420; GO:0009617; GO:0030165; GO:0030246; GO:0043005; GO:0050808; GO:0051965; GO:0098978; GO:0099055	glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of synapse assembly [GO:0051965]; response to bacterium [GO:0009617]; synapse organization [GO:0050808]
PGEN_.00g059940	Scaffold_03	5431408	5431833	NA	NA	NA	NA	NA
PGEN_.00g059950	Scaffold_03	5582860	5587016	NA	NA	NA	NA	NA
PGEN_.00g059960	Scaffold_03	5704962	5712130	NA	NA	NA	NA	NA
PGEN_.00g059970	Scaffold_03	5724343	5725661	NA	NA	NA	NA	NA
PGEN_.00g059980	Scaffold_03	5730587	5744420	NA	NA	NA	NA	NA
PGEN_.00g059990	Scaffold_03	5766973	5776359	Q9UBG0	MRC2_HUMAN	C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280)	GO:0001649; GO:0004888; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0016021; GO:0030246; GO:0030574	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]
PGEN_.00g060000	Scaffold_03	5819608	5820162	NA	NA	NA	NA	NA
PGEN_.00g060010	Scaffold_03	5862298	5864151	Q9Y289	SC5A6_HUMAN	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	GO:0005886; GO:0005887; GO:0006768; GO:0008523; GO:0012506; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0031526; GO:0055085	brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; transmembrane transport [GO:0055085]
PGEN_.00g060020	Scaffold_03	5874101	5874625	NA	NA	NA	NA	NA
PGEN_.00g060030	Scaffold_03	5885325	5887465	NA	NA	NA	NA	NA
PGEN_.00g060040	Scaffold_03	5898291	5905659	NA	NA	NA	NA	NA
PGEN_.00g060050	Scaffold_03	5945174	5948049	NA	NA	NA	NA	NA
PGEN_.00g060060	Scaffold_03	5973028	5977860	E1BD59	TRI56_BOVIN	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0051607; GO:0070534	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
PGEN_.00g060070	Scaffold_03	6049356	6049784	NA	NA	NA	NA	NA
PGEN_.00g060080	Scaffold_03	6075652	6085423	NA	NA	NA	NA	NA
PGEN_.00g060090	Scaffold_03	6125605	6133295	NA	NA	NA	NA	NA
PGEN_.00g060100	Scaffold_03	6156865	6208421	Q6TXF1	ARRD3_RAT	Arrestin domain-containing protein 3 (Liver regeneration-related protein LRRG00048)	GO:0001659; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0031651; GO:0031699; GO:0043588; GO:0051443; GO:0060613; GO:0071878; GO:0090327; GO:0120163	early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]
PGEN_.00g060110	Scaffold_03	6351134	6377099	D4A734	MOT12_RAT	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g060120	Scaffold_03	6387581	6394252	H1AFJ5	SCNNA_NEOFS	Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA)	GO:0001669; GO:0005737; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; sodium channel complex [GO:0034706]; ligand-gated sodium channel activity [GO:0015280]; sodium ion transmembrane transport [GO:0035725]
PGEN_.00g060130	Scaffold_03	6394337	6435030	O88422	GALT5_RAT	Polypeptide N-acetylgalactosaminyltransferase 5 (EC 2.4.1.41) (Polypeptide GalNAc transferase 5) (GalNAc-T5) (pp-GaNTase 5) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]
PGEN_.00g060140	Scaffold_03	6455442	6516005	Q9Y6R4	M3K4_HUMAN	Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)	GO:0000186; GO:0001890; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0023014; GO:0032147; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:1900745; GO:1904355	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g060150	Scaffold_03	6516287	6516562	NA	NA	NA	NA	NA
PGEN_.00g060160	Scaffold_03	6535523	6547593	Q9Y385	UB2J1_HUMAN	Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e)	GO:0005524; GO:0005789; GO:0007286; GO:0016021; GO:0018279; GO:0030433; GO:0031625; GO:0042534; GO:0061631; GO:1904153	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of tumor necrosis factor biosynthetic process [GO:0042534]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g060170	Scaffold_03	6550125	6575239	Q93034	CUL5_HUMAN	Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1)	GO:0000082; GO:0004842; GO:0005262; GO:0005829; GO:0006511; GO:0016032; GO:0019005; GO:0031146; GO:0031461; GO:0031466; GO:0031625; GO:0038023; GO:0038128; GO:0043161; GO:0043687; GO:0090734; GO:0097193	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734]; calcium channel activity [GO:0005262]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]
PGEN_.00g060180	Scaffold_03	6584214	6592981	Q32PE0	RPAB2_BOVIN	"DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog)"	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0006366	"nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g060190	Scaffold_03	6596809	6657704	Q15418	KS6A1_HUMAN	Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1)	GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007049; GO:0007165; GO:0030307; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944; GO:0072574; GO:2000491	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]
PGEN_.00g060200	Scaffold_03	6688200	6694596	NA	NA	NA	NA	NA
PGEN_.00g060210	Scaffold_03	6696719	6707475	P0CJ79	ZN888_HUMAN	Zinc finger protein 888	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g060220	Scaffold_03	6709059	6713056	P0DPH8	TBA3D_HUMAN	Tubulin alpha-3D chain (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g060230	Scaffold_03	6723656	6728537	NA	NA	NA	NA	NA
PGEN_.00g060240	Scaffold_03	6741503	6741790	NA	NA	NA	NA	NA
PGEN_.00g060250	Scaffold_03	6789753	6790190	NA	NA	NA	NA	NA
PGEN_.00g060260	Scaffold_03	6792770	6796473	Q90260	ASL1B_DANRE	Achaete-scute homolog 1b (Zash-1b)	GO:0000977; GO:0003700; GO:0005634; GO:0006357; GO:0007420; GO:0007423; GO:0008134; GO:0021575; GO:0030182; GO:0031018; GO:0043009; GO:0045666; GO:0045944; GO:0046983; GO:0050767; GO:0090575	nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; endocrine pancreas development [GO:0031018]; hindbrain morphogenesis [GO:0021575]; neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]
PGEN_.00g060270	Scaffold_03	6799786	6800082	NA	NA	NA	NA	NA
PGEN_.00g060280	Scaffold_03	6815509	6817330	A1ADJ6	NEUO_ECOK1	Polysialic acid O-acetyltransferase (EC 2.3.1.136) (Capsule O-acetyl transferase)	GO:0050208; GO:0070207	polysialic-acid O-acetyltransferase activity [GO:0050208]; protein homotrimerization [GO:0070207]
PGEN_.00g060290	Scaffold_03	6817494	6817955	Q90259	ASL1A_DANRE	Achaete-scute homolog 1a (Zash-1a) (Pituitary-absent protein)	GO:0000977; GO:0002070; GO:0005634; GO:0006357; GO:0007399; GO:0007423; GO:0008134; GO:0010629; GO:0021575; GO:0021984; GO:0030182; GO:0031099; GO:0031103; GO:0043565; GO:0043697; GO:0045666; GO:0045893; GO:0045944; GO:0046983; GO:0048566; GO:0050767; GO:0060575; GO:0061195; GO:0061549; GO:0070654; GO:0090575	"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; adenohypophysis development [GO:0021984]; axon regeneration [GO:0031103]; cell dedifferentiation [GO:0043697]; embryonic digestive tract development [GO:0048566]; epithelial cell maturation [GO:0002070]; hindbrain morphogenesis [GO:0021575]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regeneration [GO:0031099]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory epithelium regeneration [GO:0070654]; sensory organ development [GO:0007423]; sympathetic ganglion development [GO:0061549]; taste bud formation [GO:0061195]"
PGEN_.00g060300	Scaffold_03	6828628	6828861	NA	NA	NA	NA	NA
PGEN_.00g060310	Scaffold_03	6884916	6885473	P50553	ASCL1_HUMAN	Achaete-scute homolog 1 (ASH-1) (hASH1) (Class A basic helix-loop-helix protein 46) (bHLHa46)	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001764; GO:0003358; GO:0003359; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0007219; GO:0007346; GO:0007400; GO:0007405; GO:0007423; GO:0007507; GO:0008134; GO:0010226; GO:0010468; GO:0014003; GO:0021527; GO:0021530; GO:0021750; GO:0021892; GO:0021902; GO:0021954; GO:0021987; GO:0022008; GO:0030182; GO:0030856; GO:0032526; GO:0042803; GO:0043025; GO:0043066; GO:0043425; GO:0043525; GO:0045665; GO:0045666; GO:0045747; GO:0045787; GO:0045892; GO:0045944; GO:0048469; GO:0048485; GO:0048663; GO:0048665; GO:0048666; GO:0050767; GO:0050883; GO:0051593; GO:0060163; GO:0060165; GO:0060166; GO:0060487; GO:0060579; GO:0061100; GO:0061102; GO:0061103; GO:0061104; GO:0061549; GO:0070849; GO:0070888; GO:0071259; GO:0090575; GO:2000179	"neuronal cell body [GO:0043025]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; regulation of transcription by RNA polymerase II [GO:0006357]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to lithium ion [GO:0010226]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]"
PGEN_.00g060320	Scaffold_03	6898525	6898791	NA	NA	NA	NA	NA
PGEN_.00g060330	Scaffold_03	6927719	6953657	NA	NA	NA	NA	NA
PGEN_.00g060340	Scaffold_03	6956867	7033739	Q7SXV2	AEBP2_DANRE	Zinc finger protein AEBP2 (Adipocyte enhancer-binding protein 2 homolog) (AE-binding protein 2 homolog)	GO:0003677; GO:0006325; GO:0035098; GO:0046872	ESC/E(Z) complex [GO:0035098]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]
PGEN_.00g060350	Scaffold_03	7069091	7077510	Q8IUR5	TMTC1_HUMAN	Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 1)	GO:0000030; GO:0004169; GO:0005783; GO:0006396; GO:0016021; GO:0035269	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]
PGEN_.00g060360	Scaffold_03	7078276	7110962	Q3UV71	TMTC1_MOUSE	Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 1)	GO:0000030; GO:0004169; GO:0005739; GO:0005783; GO:0006396; GO:0016021; GO:0035269	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]
PGEN_.00g060370	Scaffold_03	7113299	7113622	NA	NA	NA	NA	NA
PGEN_.00g060380	Scaffold_03	7115807	7121584	Q3UES3	TNKS2_MOUSE	Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2)	GO:0000139; GO:0000209; GO:0000242; GO:0000723; GO:0000781; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0006471; GO:0016055; GO:0019899; GO:0035264; GO:0040014; GO:0046872; GO:0047485; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g060390	Scaffold_03	7126735	7135728	Q9D6J3	YJU2_MOUSE	Splicing factor YJU2 (Coiled-coil domain-containing protein 94)	GO:0006397; GO:0008380; GO:0043518; GO:0046872; GO:0071006	"U2-type catalytic step 1 spliceosome [GO:0071006]; metal ion binding [GO:0046872]; mRNA processing [GO:0006397]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]"
PGEN_.00g060400	Scaffold_03	7144218	7178145	Q93099	HGD_HUMAN	"Homogentisate 1,2-dioxygenase (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)"	GO:0004411; GO:0005829; GO:0006520; GO:0006559; GO:0006572; GO:0042802; GO:0046872; GO:0070062	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]"
PGEN_.00g060410	Scaffold_03	7185345	7265335	Q6ZN16	M3K15_HUMAN	Mitogen-activated protein kinase kinase kinase 15 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 3) (MAPK/ERK kinase kinase 15) (MEK kinase 15) (MEKK 15)	GO:0000186; GO:0004672; GO:0004709; GO:0005524; GO:0046872	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186]
PGEN_.00g060420	Scaffold_03	7280554	7282518	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g060430	Scaffold_03	7291043	7306666	Q7SXL7	FL2D_DANRE	Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein)	GO:0000381; GO:0005634; GO:0005737; GO:0006397; GO:0007049; GO:0007275; GO:0008380; GO:0016607; GO:0036396; GO:0042981; GO:0080009	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"
PGEN_.00g060440	Scaffold_03	7414090	7419610	Q99MV1	TDRD1_MOUSE	Tudor domain-containing protein 1	GO:0005737; GO:0005829; GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546; GO:1990904	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
PGEN_.00g060450	Scaffold_03	7428822	7449636	P08941	ROS1_CHICK	Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase)	GO:0001558; GO:0002066; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0006468; GO:0007169; GO:0008283; GO:0030154; GO:0032006; GO:0043235; GO:0070372	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; columnar/cuboidal epithelial cell development [GO:0002066]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of TOR signaling [GO:0032006]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g060460	Scaffold_03	7450372	7475802	P08922	ROS1_HUMAN	Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase)	GO:0001558; GO:0002066; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0006468; GO:0007169; GO:0007283; GO:0008283; GO:0009986; GO:0010629; GO:0010966; GO:0016020; GO:0019903; GO:0023014; GO:0030154; GO:0032006; GO:0038083; GO:0043235; GO:0048471; GO:0070372	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; columnar/cuboidal epithelial cell development [GO:0002066]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of phosphate transport [GO:0010966]; regulation of TOR signaling [GO:0032006]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g060470	Scaffold_03	7539143	7555194	Q63132	ROS1_RAT	Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase)	GO:0001558; GO:0002066; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0006468; GO:0007169; GO:0007283; GO:0008283; GO:0009986; GO:0010629; GO:0010966; GO:0019903; GO:0023014; GO:0030154; GO:0032006; GO:0038083; GO:0043235; GO:0048471; GO:0070372	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; columnar/cuboidal epithelial cell development [GO:0002066]; negative regulation of gene expression [GO:0010629]; peptidyl-tyrosine autophosphorylation [GO:0038083]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of phosphate transport [GO:0010966]; regulation of TOR signaling [GO:0032006]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g060480	Scaffold_03	7588062	7601843	Q8BH60	GOPC_MOUSE	Golgi-associated PDZ and coiled-coil motif-containing protein (PDZ protein interacting specifically with TC10) (PIST)	GO:0000139; GO:0005109; GO:0005737; GO:0005794; GO:0005886; GO:0006914; GO:0007289; GO:0008022; GO:0010360; GO:0014069; GO:0015031; GO:0016020; GO:0019905; GO:0030054; GO:0030140; GO:0030425; GO:0030695; GO:0032991; GO:0042803; GO:0043004; GO:0044325; GO:0045202; GO:0051260; GO:2000009	cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; frizzled binding [GO:0005109]; GTPase regulator activity [GO:0030695]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; cytoplasmic sequestering of CFTR protein [GO:0043004]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289]
PGEN_.00g060490	Scaffold_03	7602589	7602858	NA	NA	NA	NA	NA
PGEN_.00g060500	Scaffold_03	7606233	7606679	NA	NA	NA	NA	NA
PGEN_.00g060510	Scaffold_03	7622811	7625393	O75106	AOC2_HUMAN	Retina-specific copper amine oxidase (RAO) (EC 1.4.3.21) (Amine oxidase [copper-containing]) (Semicarbazide-sensitive amine oxidase) (SSAO)	GO:0005507; GO:0005737; GO:0005886; GO:0006584; GO:0006805; GO:0007601; GO:0008131; GO:0009055; GO:0009308; GO:0048038; GO:0052593; GO:0052594; GO:0052595; GO:0052596	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g060520	Scaffold_03	7626763	7629175	NA	NA	NA	NA	NA
PGEN_.00g060530	Scaffold_03	7632192	7634420	NA	NA	NA	NA	NA
PGEN_.00g060540	Scaffold_03	7645656	7645952	NA	NA	NA	NA	NA
PGEN_.00g060550	Scaffold_03	7647565	7653417	NA	NA	NA	NA	NA
PGEN_.00g060560	Scaffold_03	7663600	7678762	Q99J09	MEP50_MOUSE	Methylosome protein 50 (MEP-50) (WD repeat-containing protein 77)	GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006357; GO:0008284; GO:0008285; GO:0008327; GO:0030374; GO:0034709; GO:0060528; GO:0060770	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; nuclear receptor transcription coactivator activity [GO:0030374]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]
PGEN_.00g060570	Scaffold_03	7685981	7691910	Q5ZI57	TPPC3_CHICK	Trafficking protein particle complex subunit 3	GO:0005783; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106	cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]
PGEN_.00g060580	Scaffold_03	7691961	7702155	Q6GN98	EFMT1_XENLA	EEF1A lysine methyltransferase 1 (EC 2.1.1.-) (N(6)-adenine-specific DNA methyltransferase 2) (Protein-lysine N-methyltransferase n6amt2)	GO:0003676; GO:0005737; GO:0008168; GO:0016279; GO:0018022	cytoplasm [GO:0005737]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]
PGEN_.00g060590	Scaffold_03	7711154	7727098	Q3TLI0	TPC10_MOUSE	Trafficking protein particle complex subunit 10 (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1)	GO:0005829; GO:0006891; GO:0030008; GO:0034498; GO:0051259; GO:1990071	cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein complex oligomerization [GO:0051259]
PGEN_.00g060600	Scaffold_03	7728285	7736132	P48553	TPC10_HUMAN	Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein) (EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1)	GO:0000139; GO:0005829; GO:0006891; GO:0030008; GO:0034498; GO:0048208; GO:0051259; GO:1990071	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; COPII vesicle coating [GO:0048208]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein complex oligomerization [GO:0051259]
PGEN_.00g060610	Scaffold_03	7740752	7742461	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g060620	Scaffold_03	7748661	7753424	Q3TLI0	TPC10_MOUSE	Trafficking protein particle complex subunit 10 (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1)	GO:0005829; GO:0006891; GO:0030008; GO:0034498; GO:0051259; GO:1990071	cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein complex oligomerization [GO:0051259]
PGEN_.00g060630	Scaffold_03	7758775	7762751	Q2T9Y1	CC026_BOVIN	Uncharacterized protein C3orf26 homolog		
PGEN_.00g060640	Scaffold_03	7762805	7782318	Q9UNX4	WDR3_HUMAN	WD repeat-containing protein 3	GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0031965; GO:0032040; GO:0034388	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]
PGEN_.00g060650	Scaffold_03	7784226	7844346	Q5THR3	EFCB6_HUMAN	EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP)	GO:0005509; GO:0005654	nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]
PGEN_.00g060660	Scaffold_03	7852800	7860755	NA	NA	NA	NA	NA
PGEN_.00g060670	Scaffold_03	7873132	7879723	NA	NA	NA	NA	NA
PGEN_.00g060680	Scaffold_03	7879931	7902837	O70306	TBX15_MOUSE	T-box transcription factor TBX15 (T-box protein 15) (MmTBx8) (T-box transcription factor TBX14) (T-box protein 14)	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0001102; GO:0001227; GO:0001228; GO:0001708; GO:0005634; GO:0042803; GO:0045944; GO:0046982; GO:0048701; GO:0048704	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell fate specification [GO:0001708]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g060690	Scaffold_03	7913037	7917719	P23654	NRT_DROME	Neurotactin	GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007409; GO:0007411; GO:0007413; GO:0007417; GO:0016021; GO:0016323; GO:0052689	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]
PGEN_.00g060700	Scaffold_03	7970362	7988420	NA	NA	NA	NA	NA
PGEN_.00g060710	Scaffold_03	7989049	7989351	NA	NA	NA	NA	NA
PGEN_.00g060720	Scaffold_03	8035696	8040100	NA	NA	NA	NA	NA
PGEN_.00g060730	Scaffold_03	8059242	8060076	NA	NA	NA	NA	NA
PGEN_.00g060740	Scaffold_03	8067104	8075371	NA	NA	NA	NA	NA
PGEN_.00g060750	Scaffold_03	8086808	8087311	NA	NA	NA	NA	NA
PGEN_.00g060760	Scaffold_03	8087435	8095126	Q75FL1	MENG_LEPIC	Demethylmenaquinone methyltransferase (EC 2.1.1.163)	GO:0009234; GO:0032259; GO:0102955	S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; menaquinone biosynthetic process [GO:0009234]; methylation [GO:0032259]
PGEN_.00g060770	Scaffold_03	8100543	8100773	NA	NA	NA	NA	NA
PGEN_.00g060780	Scaffold_03	8101654	8101878	NA	NA	NA	NA	NA
PGEN_.00g060790	Scaffold_03	8102232	8103023	NA	NA	NA	NA	NA
PGEN_.00g060800	Scaffold_03	8114609	8114959	NA	NA	NA	NA	NA
PGEN_.00g060810	Scaffold_03	8132497	8139981	P25169	AT1B1_ARTSF	Sodium/potassium-transporting ATPase subunit beta (Sodium/potassium-dependent ATPase beta subunit)	GO:0005890; GO:0006813; GO:0006814	sodium:potassium-exchanging ATPase complex [GO:0005890]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]
PGEN_.00g060820	Scaffold_03	8156240	8171107	Q9DC48	PRP17_MOUSE	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog)	GO:0000398; GO:0005654; GO:0016607; GO:0071007; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g060830	Scaffold_03	8185237	8187111	NA	NA	NA	NA	NA
PGEN_.00g060840	Scaffold_03	8219845	8223899	Q9ESQ4	NMUR2_RAT	Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor TGR-1) (G-protein-coupled receptor FM-4)	GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005623; GO:0005886; GO:0006816; GO:0007200; GO:0007204; GO:0007218; GO:0007417; GO:0007625; GO:0008188; GO:0016021; GO:0042924; GO:0043006; GO:0048016; GO:0048265; GO:0050482; GO:0051930	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; central nervous system development [GO:0007417]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265]
PGEN_.00g060850	Scaffold_03	8274609	8274845	NA	NA	NA	NA	NA
PGEN_.00g060860	Scaffold_03	8274978	8275247	NA	NA	NA	NA	NA
PGEN_.00g060870	Scaffold_03	8275936	8276265	Q8ITC9	PK1R_DROME	Pyrokinin-1 receptor	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0036401; GO:0070328; GO:0090278	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]
PGEN_.00g060880	Scaffold_03	8402705	8410081	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g060890	Scaffold_03	8420619	8432141	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g060900	Scaffold_03	8449633	8453177	O16025	AOSL_PLEHO	Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (EC 4.2.1.92) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]	GO:0004096; GO:0005506; GO:0005737; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0047677; GO:0047987	cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408]
PGEN_.00g060910	Scaffold_03	8460002	8461099	NA	NA	NA	NA	NA
PGEN_.00g060920	Scaffold_03	8470368	8484172	G5E8K5	ANK3_MOUSE	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g060930	Scaffold_03	8492210	8519826	Q80Y44	DDX10_MOUSE	Probable ATP-dependent RNA helicase DDX10 (EC 3.6.4.13) (DEAD box protein 10)	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364; GO:0097065	nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; anterior head development [GO:0097065]; rRNA processing [GO:0006364]
PGEN_.00g060940	Scaffold_03	8557703	8586041	NA	NA	NA	NA	NA
PGEN_.00g060950	Scaffold_03	8603247	8626556	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g060960	Scaffold_03	8636168	8641262	NA	NA	NA	NA	NA
PGEN_.00g060970	Scaffold_03	8645643	8646155	NA	NA	NA	NA	NA
PGEN_.00g060980	Scaffold_03	8651948	8652982	NA	NA	NA	NA	NA
PGEN_.00g060990	Scaffold_03	8658717	8658929	NA	NA	NA	NA	NA
PGEN_.00g061000	Scaffold_03	8659689	8700183	A3KMI0	DHX29_XENLA	ATP-dependent RNA helicase dhx29 (EC 3.6.4.13) (DEAH box protein 29)	GO:0003724; GO:0003743; GO:0005524; GO:0016282; GO:0043024; GO:0045948	eukaryotic 43S preinitiation complex [GO:0016282]; ATP binding [GO:0005524]; ribosomal small subunit binding [GO:0043024]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; positive regulation of translational initiation [GO:0045948]
PGEN_.00g061010	Scaffold_03	8704679	8730730	Q9UL36	ZN236_HUMAN	Zinc finger protein 236	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g061020	Scaffold_03	8757293	8779559	Q6ZMW2	ZN782_HUMAN	Zinc finger protein 782	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g061030	Scaffold_03	8764299	8764607	Q0VCJ6	ZBT8A_BOVIN	Zinc finger and BTB domain-containing protein 8A	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g061040	Scaffold_03	8819221	8820329	NA	NA	NA	NA	NA
PGEN_.00g061050	Scaffold_03	8852707	8855548	NA	NA	NA	NA	NA
PGEN_.00g061060	Scaffold_03	8856733	8913809	O14514	AGRB1_HUMAN	Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)]	GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016021; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428	"cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]"
PGEN_.00g061070	Scaffold_03	8964164	8964490	NA	NA	NA	NA	NA
PGEN_.00g061080	Scaffold_03	8969653	9016569	P50416	CPT1A_HUMAN	"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)"	GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006635; GO:0006641; GO:0006853; GO:0007623; GO:0009437; GO:0014070; GO:0016020; GO:0019216; GO:0030855; GO:0031307; GO:0032000; GO:0042493; GO:0042755; GO:0042802; GO:0050796; GO:0051260; GO:0071398; GO:1990698	integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; glucose metabolic process [GO:0006006]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; protein homooligomerization [GO:0051260]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; triglyceride metabolic process [GO:0006641]
PGEN_.00g061090	Scaffold_03	9124277	9125761	NA	NA	NA	NA	NA
PGEN_.00g061100	Scaffold_03	9156101	9156865	Q3HXY4	NGFV_PSEPO	Venom nerve growth factor (v-NGF) (vNGF)	GO:0005576; GO:0008083; GO:0008191; GO:0008289; GO:0009405; GO:0090729	extracellular region [GO:0005576]; growth factor activity [GO:0008083]; lipid binding [GO:0008289]; metalloendopeptidase inhibitor activity [GO:0008191]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g061110	Scaffold_03	9162357	9165614	NA	NA	NA	NA	NA
PGEN_.00g061120	Scaffold_03	9170302	9170568	NA	NA	NA	NA	NA
PGEN_.00g061130	Scaffold_03	9170698	9172861	NA	NA	NA	NA	NA
PGEN_.00g061140	Scaffold_03	9178290	9179652	Q3HXY4	NGFV_PSEPO	Venom nerve growth factor (v-NGF) (vNGF)	GO:0005576; GO:0008083; GO:0008191; GO:0008289; GO:0009405; GO:0090729	extracellular region [GO:0005576]; growth factor activity [GO:0008083]; lipid binding [GO:0008289]; metalloendopeptidase inhibitor activity [GO:0008191]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g061150	Scaffold_03	9215400	9234743	P11217	PYGM_HUMAN	"Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase)"	GO:0000166; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0008184; GO:0030170; GO:0070062; GO:0102250; GO:0102499	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]
PGEN_.00g061160	Scaffold_03	9242082	9250645	NA	NA	NA	NA	NA
PGEN_.00g061170	Scaffold_03	9257545	9289218	P21953	ODBB_HUMAN	"2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDE1B) (BCKDH E1-beta)"	GO:0003826; GO:0003863; GO:0005730; GO:0005739; GO:0005759; GO:0005947; GO:0007584; GO:0009083	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; branched-chain amino acid catabolic process [GO:0009083]; response to nutrient [GO:0007584]
PGEN_.00g061180	Scaffold_03	9292689	9301737	NA	NA	NA	NA	NA
PGEN_.00g061190	Scaffold_03	9337066	9367156	Q60972	RBBP4_MOUSE	Histone-binding protein RBBP4 (Chromatin assembly factor 1 subunit C) (CAF-1 subunit C) (Chromatin assembly factor I p48 subunit) (CAF-I 48 kDa subunit) (CAF-I p48) (Nucleosome-remodeling factor subunit RBAP48) (Retinoblastoma-binding protein 4) (RBBP-4) (Retinoblastoma-binding protein p48)	GO:0000790; GO:0000978; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006335; GO:0006336; GO:0006338; GO:0007049; GO:0008094; GO:0016581; GO:0016589; GO:0031497; GO:0032991; GO:0033186; GO:0035098; GO:0042826; GO:0060416	CAF-1 complex [GO:0033186]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; protein-containing complex [GO:0032991]; DNA-dependent ATPase activity [GO:0008094]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; response to growth hormone [GO:0060416]
PGEN_.00g061200	Scaffold_03	9368612	9394872	B4GF83	NMDA1_DROPE	Glutamate [NMDA] receptor subunit 1	GO:0004970; GO:0004972; GO:0007268; GO:0007616; GO:0008355; GO:0014069; GO:0017146; GO:0030054; GO:0035235; GO:0042331; GO:0042391; GO:0045211; GO:0048149; GO:0050975; GO:0055074; GO:0072375	cell junction [GO:0030054]; NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]; NMDA glutamate receptor activity [GO:0004972]; behavioral response to ethanol [GO:0048149]; calcium ion homeostasis [GO:0055074]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term memory [GO:0007616]; medium-term memory [GO:0072375]; olfactory learning [GO:0008355]; phototaxis [GO:0042331]; regulation of membrane potential [GO:0042391]; sensory perception of touch [GO:0050975]
PGEN_.00g061210	Scaffold_03	9394998	9395783	NA	NA	NA	NA	NA
PGEN_.00g061220	Scaffold_03	9395936	9396148	NA	NA	NA	NA	NA
PGEN_.00g061230	Scaffold_03	9402327	9405769	NA	NA	NA	NA	NA
PGEN_.00g061240	Scaffold_03	9405845	9411678	NA	NA	NA	NA	NA
PGEN_.00g061250	Scaffold_03	9417001	9418835	NA	NA	NA	NA	NA
PGEN_.00g061260	Scaffold_03	9426183	9426590	NA	NA	NA	NA	NA
PGEN_.00g061270	Scaffold_03	9440227	9462156	P97772	GRM1_MOUSE	Metabotropic glutamate receptor 1 (mGluR1)	GO:0000186; GO:0000187; GO:0001639; GO:0005623; GO:0005634; GO:0005887; GO:0007186; GO:0007216; GO:0007626; GO:0008066; GO:0014069; GO:0019233; GO:0019722; GO:0030331; GO:0030424; GO:0030425; GO:0038037; GO:0038038; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043408; GO:0045211; GO:0051482; GO:0051930; GO:0051966; GO:0071257; GO:0098685; GO:0098839; GO:0098872; GO:0098978; GO:0099055; GO:0099061; GO:0099530; GO:0099583	"axon [GO:0030424]; cell [GO:0005623]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor homodimeric complex [GO:0038038]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; estrogen receptor binding [GO:0030331]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0098872]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PLC activating G protein-coupled glutamate receptor activity [GO:0001639]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; calcium-mediated signaling [GO:0019722]; cellular response to electrical stimulus [GO:0071257]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of MAPK cascade [GO:0043408]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]"
PGEN_.00g061280	Scaffold_03	9536180	9536482	NA	NA	NA	NA	NA
PGEN_.00g061290	Scaffold_03	9572283	9572945	Q13255	GRM1_HUMAN	Metabotropic glutamate receptor 1 (mGluR1)	GO:0000186; GO:0000187; GO:0004930; GO:0005623; GO:0005634; GO:0005886; GO:0005887; GO:0007186; GO:0007216; GO:0007268; GO:0007626; GO:0008066; GO:0019233; GO:0030425; GO:0038037; GO:0038038; GO:0042802; GO:0051482; GO:0051930; GO:0051966; GO:0071257; GO:0098685; GO:0098839; GO:0098872; GO:0098978; GO:0099530; GO:0099583	"cell [GO:0005623]; dendrite [GO:0030425]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor homodimeric complex [GO:0038038]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0098872]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]"
PGEN_.00g061300	Scaffold_03	9593721	9594491	NA	NA	NA	NA	NA
PGEN_.00g061310	Scaffold_03	9594764	9601465	NA	NA	NA	NA	NA
PGEN_.00g061320	Scaffold_03	9658369	9660126	NA	NA	NA	NA	NA
PGEN_.00g061330	Scaffold_03	9675419	9731665	Q64449	MRC2_MOUSE	C-type mannose receptor 2 (Lectin lambda) (Macrophage mannose receptor 2) (CD antigen CD280)	GO:0004888; GO:0005518; GO:0005886; GO:0006897; GO:0009986; GO:0016021; GO:0030246; GO:0030574	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]
PGEN_.00g061340	Scaffold_03	9735141	9771666	Q9DGQ7	CDC37_TETFL	Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37)	GO:0005737; GO:0019901	cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]
PGEN_.00g061350	Scaffold_03	9746636	9750222	NA	NA	NA	NA	NA
PGEN_.00g061360	Scaffold_03	9787562	9803167	NA	NA	NA	NA	NA
PGEN_.00g061370	Scaffold_03	9794525	9795958	NA	NA	NA	NA	NA
PGEN_.00g061380	Scaffold_03	9798477	9798863	NA	NA	NA	NA	NA
PGEN_.00g061390	Scaffold_03	9847248	9886204	O43900	PRIC3_HUMAN	Prickle planar cell polarity protein 3 (LIM domain only protein 6) (LMO-6) (Prickle-like protein 3) (Pk3) (Triple LIM domain protein 6)	GO:0005737; GO:0005886; GO:0007275; GO:0008270; GO:0030030	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; cell projection organization [GO:0030030]; multicellular organism development [GO:0007275]
PGEN_.00g061400	Scaffold_03	9920058	9941963	O35115	FHL2_RAT	Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3)	GO:0000122; GO:0001649; GO:0005634; GO:0006357; GO:0008134; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0045892; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885	"M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]"
PGEN_.00g061410	Scaffold_03	9949790	9962339	Q24799	MYPH_ECHGR	Myophilin		
PGEN_.00g061420	Scaffold_03	9966945	9973080	NA	NA	NA	NA	NA
PGEN_.00g061430	Scaffold_03	9973321	9973668	NA	NA	NA	NA	NA
PGEN_.00g061440	Scaffold_03	9986558	9995606	Q24799	MYPH_ECHGR	Myophilin		
PGEN_.00g061450	Scaffold_03	9999787	10001144	NA	NA	NA	NA	NA
PGEN_.00g061460	Scaffold_03	10001473	10001814	NA	NA	NA	NA	NA
PGEN_.00g061470	Scaffold_03	10027178	10040462	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g061480	Scaffold_03	10058845	10069764	NA	NA	NA	NA	NA
PGEN_.00g061490	Scaffold_03	10076947	10095391	Q99549	MPP8_HUMAN	M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3)	GO:0000788; GO:0000792; GO:0003682; GO:0005634; GO:0005654; GO:0005720; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0035064; GO:0044030; GO:0045814; GO:0045869; GO:0045892; GO:0090309	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear heterochromatin [GO:0005720]; nuclear nucleosome [GO:0000788]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; regulation of DNA methylation [GO:0044030]"
PGEN_.00g061500	Scaffold_03	10107529	10107942	NA	NA	NA	NA	NA
PGEN_.00g061510	Scaffold_03	10108219	10108461	NA	NA	NA	NA	NA
PGEN_.00g061520	Scaffold_03	10115228	10117105	NA	NA	NA	NA	NA
PGEN_.00g061530	Scaffold_03	10179754	10180883	O70131	NINJ1_MOUSE	Ninjurin-1 (Nerve injury-induced protein 1)	GO:0001954; GO:0007155; GO:0016021; GO:0042246; GO:1990384	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]
PGEN_.00g061540	Scaffold_03	10188656	10188964	NA	NA	NA	NA	NA
PGEN_.00g061550	Scaffold_03	10219079	10219966	NA	NA	NA	NA	NA
PGEN_.00g061560	Scaffold_03	10220076	10220426	NA	NA	NA	NA	NA
PGEN_.00g061570	Scaffold_03	10251085	10252965	NA	NA	NA	NA	NA
PGEN_.00g061580	Scaffold_03	10253110	10253373	NA	NA	NA	NA	NA
PGEN_.00g061590	Scaffold_03	10288362	10372491	NA	NA	NA	NA	NA
PGEN_.00g061600	Scaffold_03	10435144	10445048	P48181	ACH2_CAEEL	Acetylcholine receptor subunit beta-type unc-29 (Uncoordinated protein 29)	GO:0004888; GO:0005887; GO:0006937; GO:0007165; GO:0007268; GO:0007274; GO:0014057; GO:0022848; GO:0030054; GO:0034220; GO:0040011; GO:0042391; GO:0043005; GO:0043025; GO:0043051; GO:0045202; GO:0045211; GO:0046662; GO:0050877	"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; locomotion [GO:0040011]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]; signal transduction [GO:0007165]"
PGEN_.00g061610	Scaffold_03	10448606	10449879	Q92982	NINJ1_HUMAN	Ninjurin-1 (Nerve injury-induced protein 1)	GO:0001954; GO:0007155; GO:0007399; GO:0016021; GO:0042246; GO:1990384	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; nervous system development [GO:0007399]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]
PGEN_.00g061620	Scaffold_03	10482957	10484189	NA	NA	NA	NA	NA
PGEN_.00g061630	Scaffold_03	10493347	10515146	P23415	GLRA1_HUMAN	Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit)	GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005783; GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016021; GO:0016594; GO:0016934; GO:0030054; GO:0030425; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0044305; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051260; GO:0051291; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099056; GO:0099060; GO:1902476; GO:1904315; GO:2000344	"calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]"
PGEN_.00g061640	Scaffold_03	10515410	10515700	NA	NA	NA	NA	NA
PGEN_.00g061650	Scaffold_03	10528020	10583047	Q9HAR2	AGRL3_HUMAN	Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)	GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]
PGEN_.00g061660	Scaffold_03	10530623	10530832	NA	NA	NA	NA	NA
PGEN_.00g061670	Scaffold_03	10541781	10542694	NA	NA	NA	NA	NA
PGEN_.00g061680	Scaffold_03	10543672	10543929	NA	NA	NA	NA	NA
PGEN_.00g061690	Scaffold_03	10586427	10596430	NA	NA	NA	NA	NA
PGEN_.00g061700	Scaffold_03	10603044	10607914	A7S2N8	UFL1_NEMVE	E3 UFM1-protein ligase 1 homolog (EC 2.3.2.-) (E3 UFM1-protein transferase 1 homolog)	GO:0005789; GO:0032434; GO:0034976; GO:0071568; GO:1990592	endoplasmic reticulum membrane [GO:0005789]; UFM1 transferase activity [GO:0071568]; protein K69-linked ufmylation [GO:1990592]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g061710	Scaffold_03	10709504	10723081	Q641X7	FBX25_RAT	F-box only protein 25	GO:0005634; GO:0016567; GO:0019005	nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]
PGEN_.00g061720	Scaffold_03	10726862	10727287	NA	NA	NA	NA	NA
PGEN_.00g061730	Scaffold_03	10727648	10734225	Q5VVH5	IKBP1_HUMAN	Interleukin-1 receptor-associated kinase 1-binding protein 1 (IRAK1-binding protein 1)	GO:0005634; GO:0005737; GO:0006955; GO:0007249	cytoplasm [GO:0005737]; nucleus [GO:0005634]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]
PGEN_.00g061740	Scaffold_03	10734742	10738471	Q2NKY9	JAGN1_BOVIN	Protein jagunal homolog 1	GO:0002446; GO:0005783; GO:0005789; GO:0007029; GO:0015031; GO:0016021; GO:0016192; GO:0030223; GO:0038158; GO:0050832; GO:1990266	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g061750	Scaffold_03	10747354	10757688	NA	NA	NA	NA	NA
PGEN_.00g061760	Scaffold_03	10758474	10764601	NA	NA	NA	NA	NA
PGEN_.00g061770	Scaffold_03	10777571	10781112	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g061780	Scaffold_03	10790052	10827327	NA	NA	NA	NA	NA
PGEN_.00g061790	Scaffold_03	10903316	10904010	NA	NA	NA	NA	NA
PGEN_.00g061800	Scaffold_03	10904089	10904421	NA	NA	NA	NA	NA
PGEN_.00g061810	Scaffold_03	10918176	10969924	Q4KLH6	CE162_RAT	Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog)	GO:0005634; GO:0005813; GO:0005814; GO:0005819; GO:0005879; GO:0060271	axonemal microtubule [GO:0005879]; centriole [GO:0005814]; centrosome [GO:0005813]; nucleus [GO:0005634]; spindle [GO:0005819]; cilium assembly [GO:0060271]
PGEN_.00g061820	Scaffold_03	10977213	10981920	NA	NA	NA	NA	NA
PGEN_.00g061830	Scaffold_03	10984308	10988170	NA	NA	NA	NA	NA
PGEN_.00g061840	Scaffold_03	10996573	11000199	NA	NA	NA	NA	NA
PGEN_.00g061850	Scaffold_03	11006140	11044477	P21783	NOTC1_XENLA	Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]
PGEN_.00g061860	Scaffold_03	11048598	11056910	NA	NA	NA	NA	NA
PGEN_.00g061870	Scaffold_03	11066707	11070315	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g061880	Scaffold_03	11076651	11079565	NA	NA	NA	NA	NA
PGEN_.00g061890	Scaffold_03	11084429	11099168	Q9UPI3	FLVC2_HUMAN	Feline leukemia virus subgroup C receptor-related protein 2 (Calcium-chelate transporter) (CCT)	GO:0005886; GO:0015232; GO:0016021; GO:0020037; GO:0097037	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme transporter activity [GO:0015232]; heme export [GO:0097037]
PGEN_.00g061900	Scaffold_03	11133093	11186984	NA	NA	NA	NA	NA
PGEN_.00g061910	Scaffold_03	11191365	11191856	Q9N1F2	FLVC1_FELCA	Feline leukemia virus subgroup C receptor-related protein 1	GO:0001568; GO:0001618; GO:0001701; GO:0005739; GO:0005886; GO:0006839; GO:0015232; GO:0016021; GO:0020037; GO:0030218; GO:0035264; GO:0042733; GO:0043249; GO:0046620; GO:0048536; GO:0048704; GO:0060323; GO:0097037	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme transporter activity [GO:0015232]; virus receptor activity [GO:0001618]; blood vessel development [GO:0001568]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system morphogenesis [GO:0048704]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; head morphogenesis [GO:0060323]; heme export [GO:0097037]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839]; multicellular organism growth [GO:0035264]; regulation of organ growth [GO:0046620]; spleen development [GO:0048536]
PGEN_.00g061920	Scaffold_03	11212638	11217922	NA	NA	NA	NA	NA
PGEN_.00g061930	Scaffold_03	11217993	11232391	Q9Y5Y0	FLVC1_HUMAN	Feline leukemia virus subgroup C receptor-related protein 1 (Feline leukemia virus subgroup C receptor) (hFLVCR)	GO:0001568; GO:0001701; GO:0005215; GO:0005623; GO:0005739; GO:0005886; GO:0005887; GO:0006839; GO:0006879; GO:0007275; GO:0015232; GO:0015886; GO:0020037; GO:0030218; GO:0031966; GO:0035264; GO:0042733; GO:0043249; GO:0046620; GO:0048536; GO:0048704; GO:0060323; GO:0097037	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme transporter activity [GO:0015232]; transporter activity [GO:0005215]; blood vessel development [GO:0001568]; cellular iron ion homeostasis [GO:0006879]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system morphogenesis [GO:0048704]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; head morphogenesis [GO:0060323]; heme export [GO:0097037]; heme transport [GO:0015886]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; regulation of organ growth [GO:0046620]; spleen development [GO:0048536]
PGEN_.00g061940	Scaffold_03	11244039	11249798	NA	NA	NA	NA	NA
PGEN_.00g061950	Scaffold_03	11260053	11261976	NA	NA	NA	NA	NA
PGEN_.00g061960	Scaffold_03	11278708	11280428	NA	NA	NA	NA	NA
PGEN_.00g061970	Scaffold_03	11287202	11295004	NA	NA	NA	NA	NA
PGEN_.00g061980	Scaffold_03	11300074	11320906	Q9N285	MTCH2_BOVIN	Mitochondrial carrier homolog 2	GO:0005739; GO:0005743; GO:0016021; GO:0043065	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; positive regulation of apoptotic process [GO:0043065]
PGEN_.00g061990	Scaffold_03	11327105	11327398	NA	NA	NA	NA	NA
PGEN_.00g062000	Scaffold_03	11333314	11335749	Q9TRC7	AOC1_PIG	Amiloride-sensitive amine oxidase [copper-containing] (DAO) (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase)	GO:0005507; GO:0005509; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008144; GO:0008201; GO:0008270; GO:0009308; GO:0035874; GO:0042493; GO:0042803; GO:0044877; GO:0046677; GO:0048038; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0055114; GO:0070062; GO:0071280; GO:0071420; GO:0097185	"bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; drug binding [GO:0008144]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]; amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to histamine [GO:0071420]; oxidation-reduction process [GO:0055114]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]"
PGEN_.00g062010	Scaffold_03	11338801	11348967	P11862	GAS2_MOUSE	Growth arrest-specific protein 2 (GAS-2)	GO:0001544; GO:0001547; GO:0005737; GO:0005856; GO:0006915; GO:0007050; GO:0008017; GO:0008360; GO:0008593; GO:0016020; GO:0030728; GO:0071711	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; microtubule binding [GO:0008017]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; cell cycle arrest [GO:0007050]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593]
PGEN_.00g062020	Scaffold_03	11417321	11417689	NA	NA	NA	NA	NA
PGEN_.00g062030	Scaffold_03	11452052	11452384	NA	NA	NA	NA	NA
PGEN_.00g062040	Scaffold_03	11454031	11545175	Q8N7X0	ADGB_HUMAN	Androglobin (Calpain-7-like protein)	GO:0004198; GO:0019825; GO:0020037	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825]
PGEN_.00g062050	Scaffold_03	11556096	11566030	Q8WW12	PCNP_HUMAN	PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein)	GO:0005634; GO:0005654; GO:0007049; GO:0016567; GO:0016604; GO:0043161	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]
PGEN_.00g062060	Scaffold_03	11569678	11589860	NA	NA	NA	NA	NA
PGEN_.00g062070	Scaffold_03	11592124	11592324	NA	NA	NA	NA	NA
PGEN_.00g062080	Scaffold_03	11610370	11618436	O97827	AGRL3_BOVIN	Adhesion G protein-coupled receptor L3 (Latrophilin-3)	GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007189; GO:0007416; GO:0007420; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]
PGEN_.00g062090	Scaffold_03	11724100	11737177	P98110	LYAM2_PIG	E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E)	GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0046872; GO:1903238	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; positive regulation of leukocyte tethering or rolling [GO:1903238]
PGEN_.00g062100	Scaffold_03	11737287	11739900	NA	NA	NA	NA	NA
PGEN_.00g062110	Scaffold_03	11752392	11763720	Q9HAR2	AGRL3_HUMAN	Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)	GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]
PGEN_.00g062120	Scaffold_03	11827502	11846618	NA	NA	NA	NA	NA
PGEN_.00g062130	Scaffold_03	11853377	11853934	NA	NA	NA	NA	NA
PGEN_.00g062140	Scaffold_03	11854395	11860350	NA	NA	NA	NA	NA
PGEN_.00g062150	Scaffold_03	11904487	11908856	NA	NA	NA	NA	NA
PGEN_.00g062160	Scaffold_03	11937084	11954625	Q6IRE4	TS101_RAT	Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)	GO:0000813; GO:0001558; GO:0003714; GO:0005634; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007050; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0030154; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0044877; GO:0045892; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0070062; GO:0090543; GO:1902188; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]"
PGEN_.00g062170	Scaffold_03	11961639	11968624	P24539	AT5F1_HUMAN	"ATP synthase F(0) complex subunit B1, mitochondrial (ATP synthase peripheral stalk-membrane subunit b) (ATP synthase proton-transporting mitochondrial F(0) complex subunit B1) (ATP synthase subunit b) (ATPase subunit b)"	GO:0000276; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0006754; GO:0015078; GO:0015986; GO:0016020; GO:0021762; GO:0022857; GO:0042407; GO:0042776	"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762]"
PGEN_.00g062180	Scaffold_03	12010502	12015952	P15305	DYHC_ONCMY	Dynein heavy chain (DYHC) (Fragment)	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0031514	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; motor activity [GO:0003774]
PGEN_.00g062190	Scaffold_03	12016403	12024633	Q5E9R0	PRR5L_BOVIN	Proline-rich protein 5-like (Protein observed with Rictor-2) (Protor-2)	GO:0001933; GO:0009968; GO:0010762; GO:0031932; GO:0034599; GO:0038203; GO:0061014; GO:0090316	TORC2 complex [GO:0031932]; cellular response to oxidative stress [GO:0034599]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signal transduction [GO:0009968]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of fibroblast migration [GO:0010762]; TORC2 signaling [GO:0038203]
PGEN_.00g062200	Scaffold_03	12024662	12025066	NA	NA	NA	NA	NA
PGEN_.00g062210	Scaffold_03	12025166	12025576	NA	NA	NA	NA	NA
PGEN_.00g062220	Scaffold_03	12025608	12033253	Q5FVG6	PRR5_RAT	Proline-rich protein 5 (Protein observed with Rictor-1) (Protor-1)	GO:0001934; GO:0007049; GO:0014068; GO:0031932; GO:0038203	TORC2 complex [GO:0031932]; cell cycle [GO:0007049]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; TORC2 signaling [GO:0038203]
PGEN_.00g062230	Scaffold_03	12051767	12064610	Q96B97	SH3K1_HUMAN	SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1)	GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0007411; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0042059; GO:0043005; GO:0045202; GO:0050871; GO:0061024	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360]
PGEN_.00g062240	Scaffold_03	12069727	12080263	NA	NA	NA	NA	NA
PGEN_.00g062250	Scaffold_03	12096118	12098015	Q925Q9	SH3K1_RAT	"SH3 domain-containing kinase-binding protein 1 (Regulator of ubiquitous kinase) (Ruk) (SH3-containing, expressed in tumorigenic astrocytes)"	GO:0005737; GO:0005856; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0042981; GO:0043005; GO:0045202; GO:0050871	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of apoptotic process [GO:0042981]; regulation of cell shape [GO:0008360]
PGEN_.00g062260	Scaffold_03	12102981	12123917	Q96B97	SH3K1_HUMAN	SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1)	GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0007411; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0042059; GO:0043005; GO:0045202; GO:0050871; GO:0061024	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360]
PGEN_.00g062270	Scaffold_03	12127401	12127625	NA	NA	NA	NA	NA
PGEN_.00g062280	Scaffold_03	12132383	12149743	Q8VDH1	FBX21_MOUSE	F-box only protein 21	GO:0003677	DNA binding [GO:0003677]
PGEN_.00g062290	Scaffold_03	12166623	12167065	NA	NA	NA	NA	NA
PGEN_.00g062300	Scaffold_03	12167089	12202815	Q18297	TRPA1_CAEEL	Transient receptor potential cation channel subfamily A member 1 homolog	GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730	integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]
PGEN_.00g062310	Scaffold_03	12213877	12219108	Q7ZVC9	SMAP_DANRE	Small acidic protein		
PGEN_.00g062320	Scaffold_03	12225641	12244706	Q924X7	STK33_MOUSE	Serine/threonine-protein kinase 33 (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0042770; GO:0044773; GO:0046777; GO:0048471	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; mitotic DNA damage checkpoint [GO:0044773]; protein autophosphorylation [GO:0046777]; signal transduction in response to DNA damage [GO:0042770]
PGEN_.00g062330	Scaffold_03	12276822	12286577	Q5R4R9	NDUF4_PONAB	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 (Hormone-regulated proliferation-associated protein of 20 kDa homolog) (Protein HRPAP20)	GO:0005516; GO:0005739; GO:0016020; GO:0032981	membrane [GO:0016020]; mitochondrion [GO:0005739]; calmodulin binding [GO:0005516]; mitochondrial respiratory chain complex I assembly [GO:0032981]
PGEN_.00g062340	Scaffold_03	12299420	12357686	Q9VI75	PICAL_DROME	Phosphatidylinositol-binding clathrin assembly protein LAP (Like-AP180)	GO:0000149; GO:0005545; GO:0005546; GO:0005623; GO:0005794; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0006900; GO:0007268; GO:0007270; GO:0008021; GO:0016185; GO:0030136; GO:0030276; GO:0032050; GO:0042331; GO:0042734; GO:0048268; GO:0048488; GO:0048489; GO:0072583; GO:0098894; GO:0150007; GO:2000370	"cell [GO:0005623]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; chemical synaptic transmission [GO:0007268]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; neuron-neuron synaptic transmission [GO:0007270]; phototaxis [GO:0042331]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; vesicle budding from membrane [GO:0006900]"
PGEN_.00g062350	Scaffold_03	12365348	12373777	E7EYQ9	TM216_DANRE	Transmembrane protein 216	GO:0005737; GO:0005856; GO:0016021; GO:0035869; GO:0060271; GO:1905515	ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]
PGEN_.00g062360	Scaffold_03	12374209	12389725	Q7KZF4	SND1_HUMAN	Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator)	GO:0001649; GO:0003712; GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006401; GO:0010564; GO:0010587; GO:0016020; GO:0016032; GO:0016442; GO:0031047; GO:0042470; GO:0045296; GO:0070062; GO:0097433; GO:1905172	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442]; cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]; viral process [GO:0016032]
PGEN_.00g062370	Scaffold_03	12394558	12406019	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g062380	Scaffold_03	12415303	12428966	P58005	SESN3_HUMAN	Sestrin-3	GO:0005634; GO:0005737; GO:0016239; GO:0016684; GO:0031932; GO:0032868; GO:0034198; GO:0038203; GO:0042149; GO:0042593; GO:0046626; GO:0051896; GO:0070728; GO:0071230; GO:0071233; GO:1901031; GO:1904262; GO:1990253	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glucose homeostasis [GO:0042593]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031]; response to insulin [GO:0032868]; TORC2 signaling [GO:0038203]"
PGEN_.00g062390	Scaffold_03	12475874	12513181	NA	NA	NA	NA	NA
PGEN_.00g062400	Scaffold_03	12518552	12520750	NA	NA	NA	NA	NA
PGEN_.00g062410	Scaffold_03	12530307	12561386	E1C7T6	TYW5_CHICK	tRNA wybutosine-synthesizing protein 5 (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase)	GO:0000049; GO:0005506; GO:0016706; GO:0031591; GO:0042803; GO:0102524	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524]; wybutosine biosynthetic process [GO:0031591]
PGEN_.00g062420	Scaffold_03	12563724	12594209	Q92562	FIG4_HUMAN	"Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3)"	GO:0000139; GO:0004438; GO:0005783; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0048666; GO:0055037	"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]"
PGEN_.00g062430	Scaffold_03	12608178	12609098	NA	NA	NA	NA	NA
PGEN_.00g062440	Scaffold_03	12620491	12622344	Q8N695	SC5A8_HUMAN	Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)	GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]
PGEN_.00g062450	Scaffold_03	12634766	12636062	Q8HXP7	SODM_PANTR	"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)"	GO:0004784; GO:0005739; GO:0005759; GO:0030145; GO:0046872	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]
PGEN_.00g062460	Scaffold_03	12647339	12648319	NA	NA	NA	NA	NA
PGEN_.00g062470	Scaffold_03	12665989	12678397	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g062480	Scaffold_03	12684140	12788087	E9Q555	RN213_MOUSE	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g062490	Scaffold_03	12789012	12789837	Q6UPE0	CHDH_RAT	"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)"	GO:0005743; GO:0008812; GO:0019285; GO:0050660	mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]
PGEN_.00g062500	Scaffold_03	12803123	12803455	NA	NA	NA	NA	NA
PGEN_.00g062510	Scaffold_03	12837201	12842852	NA	NA	NA	NA	NA
PGEN_.00g062520	Scaffold_03	12852358	12859253	NA	NA	NA	NA	NA
PGEN_.00g062530	Scaffold_03	12868710	12868913	NA	NA	NA	NA	NA
PGEN_.00g062540	Scaffold_03	12875770	12898369	Q4R367	UFL1_MACFA	E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Regulator of C53/LZAP and DDRGK1)	GO:0005737; GO:0005783; GO:0005829; GO:0031397; GO:0032088; GO:0033146; GO:0061666; GO:0071569; GO:1990592	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; UFM1 ligase activity [GO:0061666]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]
PGEN_.00g062550	Scaffold_03	12933499	12968827	Q5RJY2	G2E3_MOUSE	G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)	GO:0000209; GO:0001824; GO:0005730; GO:0005794; GO:0005829; GO:0006915; GO:0043231; GO:0046872; GO:0061630; GO:2001243	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209]
PGEN_.00g062560	Scaffold_03	12978682	12981708	F1NTD6	ASCC3_CHICK	Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12)	GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0008283; GO:0016607; GO:0032508; GO:0043138; GO:0099053	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]
PGEN_.00g062570	Scaffold_03	12999443	13009957	Q8K385	FRRS1_MOUSE	Ferric-chelate reductase 1 (EC 1.-.-.-) (Stromal cell-derived receptor 2) (SDR-2)	GO:0000293; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872]
PGEN_.00g062580	Scaffold_03	13012773	13014245	NA	NA	NA	NA	NA
PGEN_.00g062590	Scaffold_03	13014931	13015194	NA	NA	NA	NA	NA
PGEN_.00g062600	Scaffold_03	13020620	13023322	NA	NA	NA	NA	NA
PGEN_.00g062610	Scaffold_03	13030880	13036749	NA	NA	NA	NA	NA
PGEN_.00g062620	Scaffold_03	13039816	13088425	Q92621	NU205_HUMAN	Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205)	GO:0005635; GO:0005643; GO:0006110; GO:0006406; GO:0006409; GO:0006913; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0034399; GO:0043657; GO:0051292; GO:0060964; GO:0075733; GO:1900034	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]
PGEN_.00g062630	Scaffold_03	13089701	13121485	A0JMD4	TPC2_DANRE	Two pore calcium channel protein 2 (Voltage-dependent calcium channel protein TPC2)	GO:0005245; GO:0005623; GO:0005764; GO:0005765; GO:0006939; GO:0014866; GO:0016021; GO:0019722; GO:0034765; GO:0072345; GO:2000290	cell [GO:0005623]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; regulation of ion transmembrane transport [GO:0034765]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939]
PGEN_.00g062640	Scaffold_03	13133832	13135412	NA	NA	NA	NA	NA
PGEN_.00g062650	Scaffold_03	13135544	13135846	NA	NA	NA	NA	NA
PGEN_.00g062660	Scaffold_03	13148174	13149331	NA	NA	NA	NA	NA
PGEN_.00g062670	Scaffold_03	13205759	13245852	O42091	TY3H_ANGAN	Tyrosine 3-monooxygenase (EC 1.14.16.2) (Tyrosine 3-hydroxylase) (TH)	GO:0004511; GO:0005506; GO:0009072; GO:0042136; GO:0042416	iron ion binding [GO:0005506]; tyrosine 3-monooxygenase activity [GO:0004511]; aromatic amino acid family metabolic process [GO:0009072]; dopamine biosynthetic process [GO:0042416]; neurotransmitter biosynthetic process [GO:0042136]
PGEN_.00g062680	Scaffold_03	13254259	13260103	Q9ESG5	HS3S1_RAT	Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (Heparan sulfate 3-O-sulfotransferase 1)	GO:0005796; GO:0008467	Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]
PGEN_.00g062690	Scaffold_03	13326281	13333991	NA	NA	NA	NA	NA
PGEN_.00g062700	Scaffold_03	13358965	13366727	NA	NA	NA	NA	NA
PGEN_.00g062710	Scaffold_03	13379192	13382324	NA	NA	NA	NA	NA
PGEN_.00g062720	Scaffold_03	13389233	13398468	NA	NA	NA	NA	NA
PGEN_.00g062730	Scaffold_03	13405264	13406142	Q6NS09	TM45B_XENLA	Transmembrane protein 45B	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g062740	Scaffold_03	13433037	13433918	Q6NS09	TM45B_XENLA	Transmembrane protein 45B	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g062750	Scaffold_03	13464440	13499892	Q18297	TRPA1_CAEEL	Transient receptor potential cation channel subfamily A member 1 homolog	GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730	integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]
PGEN_.00g062760	Scaffold_03	13511704	13524785	Q3HNM7	INSC_MOUSE	Protein inscuteable homolog (Minsc)	GO:0005886; GO:0005938; GO:0007399; GO:0008356; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991	"cell cortex [GO:0005938]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of protein stability [GO:0031647]"
PGEN_.00g062770	Scaffold_03	13526339	13528234	NA	NA	NA	NA	NA
PGEN_.00g062780	Scaffold_03	13547460	13561713	NA	NA	NA	NA	NA
PGEN_.00g062790	Scaffold_03	13577494	13581142	Q3MQ24	ATG5_BOVIN	Autophagy protein 5	GO:0000045; GO:0000422; GO:0001974; GO:0002739; GO:0005623; GO:0005776; GO:0005930; GO:0006501; GO:0006914; GO:0006915; GO:0006995; GO:0009620; GO:0019725; GO:0019883; GO:0031397; GO:0034045; GO:0034274; GO:0035973; GO:0039689; GO:0042311; GO:0042493; GO:0043066; GO:0044233; GO:0045060; GO:0048840; GO:0050765; GO:0051279; GO:0055015; GO:0060047; GO:0061739; GO:0070257; GO:0071500; GO:0075044; GO:1902017; GO:2000378; GO:2000619	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axoneme [GO:0005930]; cell [GO:0005623]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagophore assembly site membrane [GO:0034045]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cellular homeostasis [GO:0019725]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; heart contraction [GO:0060047]; negative regulation of apoptotic process [GO:0043066]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of mucus secretion [GO:0070257]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine secretion involved in immune response [GO:0002739]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]
PGEN_.00g062800	Scaffold_03	13593452	13615421	Q92738	US6NL_HUMAN	USP6 N-terminal-like protein (Related to the N-terminus of tre) (RN-tre)	GO:0005096; GO:0005829; GO:0005886; GO:0006886; GO:0007030; GO:0017137; GO:0019068; GO:0031410; GO:0032588; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"
PGEN_.00g062810	Scaffold_03	13628618	13633946	NA	NA	NA	NA	NA
PGEN_.00g062820	Scaffold_03	13647076	13680568	F1NTD6	ASCC3_CHICK	Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12)	GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0008283; GO:0016607; GO:0032508; GO:0043138; GO:0099053	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]
PGEN_.00g062830	Scaffold_03	13708259	13708570	NA	NA	NA	NA	NA
PGEN_.00g062840	Scaffold_03	13708625	13709707	NA	NA	NA	NA	NA
PGEN_.00g062850	Scaffold_03	13737603	13761886	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g062860	Scaffold_03	13788788	13803610	E1BNG3	ASCC3_BOVIN	Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12)	GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0008283; GO:0016607; GO:0032508; GO:0043138; GO:0099053	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]
PGEN_.00g062870	Scaffold_03	13810613	13821930	Q20176	NAS39_CAEEL	Zinc metalloproteinase nas-39 (EC 3.4.24.-) (Nematode astacin 39)	GO:0004222; GO:0005509; GO:0005576; GO:0008270	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g062880	Scaffold_03	13872519	13873853	NA	NA	NA	NA	NA
PGEN_.00g062890	Scaffold_03	13884477	13894453	F1NTD6	ASCC3_CHICK	Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12)	GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0008283; GO:0016607; GO:0032508; GO:0043138; GO:0099053	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]
PGEN_.00g062900	Scaffold_03	13950277	13996316	NA	NA	NA	NA	NA
PGEN_.00g062910	Scaffold_03	14002741	14022168	NA	NA	NA	NA	NA
PGEN_.00g062920	Scaffold_03	14022198	14070793	Q29122	MYO6_PIG	Unconventional myosin-VI (Unconventional myosin-6)	GO:0001726; GO:0003774; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005884; GO:0005902; GO:0005938; GO:0006886; GO:0006897; GO:0007605; GO:0016459; GO:0016591; GO:0030048; GO:0030136; GO:0030175; GO:0030330; GO:0031410; GO:0031941; GO:0031965; GO:0032587; GO:0043531; GO:0045944; GO:0048471; GO:0051015; GO:0051046	"actin filament [GO:0005884]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]"
PGEN_.00g062930	Scaffold_03	14084750	14085118	NA	NA	NA	NA	NA
PGEN_.00g062940	Scaffold_03	14103621	14103890	NA	NA	NA	NA	NA
PGEN_.00g062950	Scaffold_03	14109676	14121209	A8Y1P7	BRE4_CAEBR	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	GO:0005975; GO:0006486; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	"integral component of membrane [GO:0016021]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"
PGEN_.00g062960	Scaffold_03	14126973	14127398	NA	NA	NA	NA	NA
PGEN_.00g062970	Scaffold_03	14131740	14137369	P04058	ACES_TETCF	Acetylcholinesterase (AChE) (EC 3.1.1.7)	GO:0001507; GO:0003990; GO:0005886; GO:0030054; GO:0031225; GO:0043083	anchored component of membrane [GO:0031225]; cell junction [GO:0030054]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; acetylcholinesterase activity [GO:0003990]; acetylcholine catabolic process in synaptic cleft [GO:0001507]
PGEN_.00g062980	Scaffold_03	14138214	14142059	Q27459	ACE1_CAEBR	Acetylcholinesterase 1 (AChE 1) (EC 3.1.1.7)	GO:0003990; GO:0005615; GO:0005886; GO:0006581; GO:0030054; GO:0040012; GO:0042802; GO:0045202	cell junction [GO:0030054]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; identical protein binding [GO:0042802]; acetylcholine catabolic process [GO:0006581]; regulation of locomotion [GO:0040012]
PGEN_.00g062990	Scaffold_03	14147257	14148288	NA	NA	NA	NA	NA
PGEN_.00g063000	Scaffold_03	14148730	14149173	NA	NA	NA	NA	NA
PGEN_.00g063010	Scaffold_03	14151473	14156836	NA	NA	NA	NA	NA
PGEN_.00g063020	Scaffold_03	14157919	14160035	NA	NA	NA	NA	NA
PGEN_.00g063030	Scaffold_03	14162911	14180649	Q5ZIH9	CC174_CHICK	Coiled-coil domain-containing protein 174	GO:0005634	nucleus [GO:0005634]
PGEN_.00g063040	Scaffold_03	14223786	14239221	Q69ZU8	ANKR6_MOUSE	Ankyrin repeat domain-containing protein 6 (Diversin)	GO:0005634; GO:0005737; GO:0043231; GO:0046330; GO:0090090; GO:2000096	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]"
PGEN_.00g063050	Scaffold_03	14250938	14251705	NA	NA	NA	NA	NA
PGEN_.00g063060	Scaffold_03	14251833	14255160	NA	NA	NA	NA	NA
PGEN_.00g063070	Scaffold_03	14307387	14410294	E9Q555	RN213_MOUSE	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g063080	Scaffold_03	14417313	14418302	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g063090	Scaffold_03	14418405	14419064	P18173	DHGL_DROME	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"
PGEN_.00g063100	Scaffold_03	14423163	14441758	Q94KD8	BXL2_ARATH	Probable beta-D-xylosidase 2 (AtBXL2) (EC 3.2.1.-)	GO:0005576; GO:0009044; GO:0009505; GO:0031222; GO:0045493; GO:0046556	"extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]; alpha-L-arabinofuranosidase activity [GO:0046556]; xylan 1,4-beta-xylosidase activity [GO:0009044]; arabinan catabolic process [GO:0031222]; xylan catabolic process [GO:0045493]"
PGEN_.00g063110	Scaffold_03	14455943	14456266	NA	NA	NA	NA	NA
PGEN_.00g063120	Scaffold_03	14456307	14456900	NA	NA	NA	NA	NA
PGEN_.00g063130	Scaffold_03	14527212	14530870	NA	NA	NA	NA	NA
PGEN_.00g063140	Scaffold_03	14539650	14590198	P11029	ACAC_CHICK	Acetyl-CoA carboxylase (ACC) (EC 6.4.1.2) [Includes: Biotin carboxylase (EC 6.3.4.14)]	GO:0003989; GO:0004075; GO:0005102; GO:0005524; GO:0005623; GO:0005737; GO:0006633; GO:0006810; GO:0009374; GO:0009743; GO:0010628; GO:0032810; GO:0040029; GO:0045893; GO:0046872; GO:0046966; GO:0050692; GO:0065008; GO:0070542; GO:0097066; GO:2001295	"cell [GO:0005623]; cytoplasm [GO:0005737]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DBD domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression, epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810]"
PGEN_.00g063150	Scaffold_03	14602150	14615492	NA	NA	NA	NA	NA
PGEN_.00g063160	Scaffold_03	14630204	14650683	NA	NA	NA	NA	NA
PGEN_.00g063170	Scaffold_03	14666354	14689165	Q496A3	SPAS1_HUMAN	Spermatogenesis-associated serine-rich protein 1		
PGEN_.00g063180	Scaffold_03	14724888	14761956	F1NTD6	ASCC3_CHICK	Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12)	GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0008283; GO:0016607; GO:0032508; GO:0043138; GO:0099053	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]
PGEN_.00g063190	Scaffold_03	14775608	14807081	O95490	AGRL2_HUMAN	Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1)	GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007420; GO:0016021; GO:0016524; GO:0030246; GO:0043005	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g063200	Scaffold_03	14809423	14815868	Q9R0I6	XIAP_RAT	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP homolog A) (Inhibitor of apoptosis protein 3) (IAP-3) (rIAP-3) (rIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	GO:0002020; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006974; GO:0016055; GO:0031398; GO:0032991; GO:0042802; GO:0043027; GO:0043066; GO:0043154; GO:0043524; GO:0046872; GO:0048471; GO:0051402; GO:0061630; GO:0090263; GO:0097110; GO:1902530; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; Wnt signaling pathway [GO:0016055]
PGEN_.00g063210	Scaffold_03	14823823	14848360	Q6L8Q7	PDE12_HUMAN	"2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)"	GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0005829; GO:0006397; GO:0034611; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0051607; GO:0060548; GO:0071346; GO:0071359; GO:0090305; GO:0090324; GO:0090503	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; oligoribonucleotidase activity [GO:0034611]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; defense response to virus [GO:0051607]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"
PGEN_.00g063220	Scaffold_03	14878424	14897166	NA	NA	NA	NA	NA
PGEN_.00g063230	Scaffold_03	14911503	14912715	NA	NA	NA	NA	NA
PGEN_.00g063240	Scaffold_03	14923905	14927025	NA	NA	NA	NA	NA
PGEN_.00g063250	Scaffold_03	14931370	14959124	Q8AYG3	TTK_DANRE	Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap)	GO:0000776; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005819; GO:0007059; GO:0007060; GO:0007093; GO:0007094; GO:0016321; GO:0018105; GO:0031101; GO:0033316; GO:0034501; GO:0042246; GO:0046872; GO:0051301; GO:0051304; GO:0060249	kinetochore [GO:0000776]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; anatomical structure homeostasis [GO:0060249]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; fin regeneration [GO:0031101]; male meiosis chromosome segregation [GO:0007060]; meiotic spindle assembly checkpoint [GO:0033316]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; peptidyl-serine phosphorylation [GO:0018105]; protein localization to kinetochore [GO:0034501]; tissue regeneration [GO:0042246]
PGEN_.00g063260	Scaffold_03	14974125	14988793	NA	NA	NA	NA	NA
PGEN_.00g063270	Scaffold_03	14999170	15001816	P70665	SIAE_MOUSE	Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase) (Yolk sac protein 2) [Cleaved into: Sialate O-acetylesterase small subunit; Sialate O-acetylesterase large subunit]	GO:0001681; GO:0002682; GO:0005764; GO:0005975	lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]
PGEN_.00g063280	Scaffold_03	15003170	15010344	NA	NA	NA	NA	NA
PGEN_.00g063290	Scaffold_03	15018541	15021739	O15375	MOT6_HUMAN	Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5)	GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g063300	Scaffold_03	15029708	15053631	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g063310	Scaffold_03	15077866	15084584	P29274	AA2AR_HUMAN	Adenosine receptor A2a	GO:0000139; GO:0001609; GO:0001963; GO:0001975; GO:0005882; GO:0005886; GO:0005887; GO:0006355; GO:0006469; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007186; GO:0007188; GO:0007189; GO:0007205; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0014049; GO:0014057; GO:0014061; GO:0014069; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0035249; GO:0035810; GO:0035815; GO:0040013; GO:0042311; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043154; GO:0043524; GO:0044267; GO:0045938; GO:0046636; GO:0046982; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0098978; GO:0099055; GO:0099056; GO:1900273; GO:2000300; GO:2001235	"axolemma [GO:0030673]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; alpha-actinin binding [GO:0051393]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; type 5 metabotropic glutamate receptor binding [GO:0031802]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular protein metabolic process [GO:0044267]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inflammatory response [GO:0050728]; negative regulation of locomotion [GO:0040013]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription, DNA-templated [GO:0006355]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]"
PGEN_.00g063320	Scaffold_03	15094354	15096672	NA	NA	NA	NA	NA
PGEN_.00g063330	Scaffold_03	15108488	15141655	NA	NA	NA	NA	NA
PGEN_.00g063340	Scaffold_03	15155567	15158185	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g063350	Scaffold_03	15161082	15175446	NA	NA	NA	NA	NA
PGEN_.00g063360	Scaffold_03	15191071	15191544	NA	NA	NA	NA	NA
PGEN_.00g063370	Scaffold_03	15193897	15196311	NA	NA	NA	NA	NA
PGEN_.00g063380	Scaffold_03	15200233	15205928	Q6DFS6	CHM2A_XENTR	Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a)	GO:0000815; GO:0005635; GO:0005771; GO:0010458; GO:0015031; GO:0031468; GO:0031902; GO:0032509; GO:0045324	ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]
PGEN_.00g063390	Scaffold_03	15209918	15211997	NA	NA	NA	NA	NA
PGEN_.00g063400	Scaffold_03	15212027	15234502	Q91W50	CSDE1_MOUSE	Cold shock domain-containing protein E1	GO:0003723; GO:0005743; GO:0005794; GO:0005829; GO:0005886; GO:0070937; GO:0070966	"CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]"
PGEN_.00g063410	Scaffold_03	15240413	15247648	NA	NA	NA	NA	NA
PGEN_.00g063420	Scaffold_03	15247958	15248236	NA	NA	NA	NA	NA
PGEN_.00g063430	Scaffold_03	15248259	15248678	NA	NA	NA	NA	NA
PGEN_.00g063440	Scaffold_03	15250824	15252876	NA	NA	NA	NA	NA
PGEN_.00g063450	Scaffold_03	15254199	15255683	NA	NA	NA	NA	NA
PGEN_.00g063460	Scaffold_03	15269032	15274803	A3KG59	P20D2_MOUSE	Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2)	GO:0005654; GO:0006508; GO:0016805; GO:0032268	nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]
PGEN_.00g063470	Scaffold_03	15280058	15280321	NA	NA	NA	NA	NA
PGEN_.00g063480	Scaffold_03	15295961	15299302	NA	NA	NA	NA	NA
PGEN_.00g063490	Scaffold_03	15302111	15305973	Q09575	YRD6_CAEEL	Uncharacterized protein K02A2.6	GO:0003676; GO:0008270; GO:0015074	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]
PGEN_.00g063500	Scaffold_03	15306863	15308865	NA	NA	NA	NA	NA
PGEN_.00g063510	Scaffold_03	15343758	15348768	Q460N5	PAR14_HUMAN	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g063520	Scaffold_03	15352661	15355163	NA	NA	NA	NA	NA
PGEN_.00g063530	Scaffold_03	15356070	15360568	NA	NA	NA	NA	NA
PGEN_.00g063540	Scaffold_03	15360705	15368663	NA	NA	NA	NA	NA
PGEN_.00g063550	Scaffold_03	15369210	15371280	NA	NA	NA	NA	NA
PGEN_.00g063560	Scaffold_03	15423491	15437111	A0A1D3PCM3	SST_EMEND	Serine O-succinyltransferase (SST) (EC 2.3.1.-)	GO:0005739; GO:0016747; GO:0019344	"mitochondrion [GO:0005739]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; cysteine biosynthetic process [GO:0019344]"
PGEN_.00g063570	Scaffold_03	15441524	15442054	NA	NA	NA	NA	NA
PGEN_.00g063580	Scaffold_03	15444790	15464619	Q9EQX4	AIF1L_MOUSE	Allograft inflammatory factor 1-like (Ionized calcium-binding adapter molecule 2)	GO:0005509; GO:0005737; GO:0005884; GO:0005925; GO:0015629; GO:0032587; GO:0032991; GO:0042995; GO:0051015; GO:0051017; GO:0097178	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; ruffle assembly [GO:0097178]
PGEN_.00g063590	Scaffold_03	15474854	15489699	NA	NA	NA	NA	NA
PGEN_.00g063600	Scaffold_03	15494451	15497323	NA	NA	NA	NA	NA
PGEN_.00g063610	Scaffold_03	15511079	15511690	NA	NA	NA	NA	NA
PGEN_.00g063620	Scaffold_03	15527497	15529029	Q28037	VDR_BOVIN	"Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1)"	GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0003707; GO:0004879; GO:0005499; GO:0005634; GO:0005737; GO:0006629; GO:0007275; GO:0008134; GO:0008270; GO:0009887; GO:0030154; GO:0030374; GO:0038023; GO:0042632; GO:0045944; GO:0055088; GO:0070561; GO:0071222; GO:0090575; GO:1902098	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; calcitriol binding [GO:1902098]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; vitamin D receptor signaling pathway [GO:0070561]"
PGEN_.00g063630	Scaffold_03	15539311	15618935	Q3V1H9	SAMD5_MOUSE	Sterile alpha motif domain-containing protein 5 (SAM domain-containing protein 5)	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g063640	Scaffold_03	15659918	15670343	A0JN71	SASH3_BOVIN	SAM and SH3 domain-containing protein 3	GO:0002639; GO:0002726; GO:0002821; GO:0005634; GO:0005737; GO:0030890; GO:0032729; GO:0032733; GO:0032743; GO:0032753; GO:0032760; GO:0042102; GO:0043372; GO:0046622; GO:0048873	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]"
PGEN_.00g063650	Scaffold_03	15691371	15711900	Q7L1T6	NB5R4_HUMAN	Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R)	GO:0003032; GO:0004128; GO:0005783; GO:0005789; GO:0006091; GO:0006801; GO:0015701; GO:0016174; GO:0016653; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0055114	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; oxidation-reduction process [GO:0055114]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]"
PGEN_.00g063660	Scaffold_03	15743806	15767582	Q5ZMA6	NADE_CHICK	Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase)	GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0009435	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]
PGEN_.00g063670	Scaffold_03	15775431	15782590	O77792	UCP3_BOVIN	Mitochondrial uncoupling protein 3 (UCP 3) (Solute carrier family 25 member 9)	GO:0000303; GO:0005743; GO:0006631; GO:0009409; GO:0016021; GO:0017077; GO:1990542; GO:1990845	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; oxidative phosphorylation uncoupler activity [GO:0017077]; adaptive thermogenesis [GO:1990845]; fatty acid metabolic process [GO:0006631]; mitochondrial transmembrane transport [GO:1990542]; response to cold [GO:0009409]; response to superoxide [GO:0000303]
PGEN_.00g063680	Scaffold_03	15798272	15815921	Q9GUM2	BRE4_CAEEL	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	"integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"
PGEN_.00g063690	Scaffold_03	15823659	15824804	Q9EQQ3	GPR63_MOUSE	Probable G-protein coupled receptor 63 (PSP24-2) (PSP24-beta)	GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0016021; GO:0043235	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g063700	Scaffold_03	15838981	15869994	P59470	RPC2_MOUSE	DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)	GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g063710	Scaffold_03	15878495	15879985	NA	NA	NA	NA	NA
PGEN_.00g063720	Scaffold_03	15883953	15888678	NA	NA	NA	NA	NA
PGEN_.00g063730	Scaffold_03	15890252	15894572	NA	NA	NA	NA	NA
PGEN_.00g063740	Scaffold_03	15899580	15911594	NA	NA	NA	NA	NA
PGEN_.00g063750	Scaffold_03	15920925	15922888	NA	NA	NA	NA	NA
PGEN_.00g063760	Scaffold_03	15946129	15951887	NA	NA	NA	NA	NA
PGEN_.00g063770	Scaffold_03	15956519	15962661	NA	NA	NA	NA	NA
PGEN_.00g063780	Scaffold_03	15970546	15979673	Q2KJC1	CDC5L_BOVIN	Cell division cycle 5-like protein (Cdc5-like protein)	GO:0000398; GO:0000974; GO:0000977; GO:0001228; GO:0003723; GO:0005634; GO:0005662; GO:0005737; GO:0006281; GO:0007049; GO:0016607; GO:0071007; GO:0071987; GO:0072422	"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; signal transduction involved in DNA damage checkpoint [GO:0072422]"
PGEN_.00g063790	Scaffold_03	15979720	15998650	Q2KJC1	CDC5L_BOVIN	Cell division cycle 5-like protein (Cdc5-like protein)	GO:0000398; GO:0000974; GO:0000977; GO:0001228; GO:0003723; GO:0005634; GO:0005662; GO:0005737; GO:0006281; GO:0007049; GO:0016607; GO:0071007; GO:0071987; GO:0072422	"cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]; cell cycle [GO:0007049]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; signal transduction involved in DNA damage checkpoint [GO:0072422]"
PGEN_.00g063800	Scaffold_03	16004590	16007654	NA	NA	NA	NA	NA
PGEN_.00g063810	Scaffold_03	16011589	16012935	NA	NA	NA	NA	NA
PGEN_.00g063820	Scaffold_03	16013731	16019591	NA	NA	NA	NA	NA
PGEN_.00g063830	Scaffold_03	16024944	16049113	Q9NQW7	XPP1_HUMAN	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]
PGEN_.00g063840	Scaffold_03	16072599	16096192	P16641	KTRC_SCHMA	Taurocyamine kinase (EC 2.7.3.4) (ATP:guanidino kinase Smc74) (ATP:guanidino phosphotransferase) (SmGK)	GO:0004111; GO:0005524; GO:0016491; GO:0046314; GO:0046872; GO:0050324	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; taurocyamine kinase activity [GO:0050324]; phosphocreatine biosynthetic process [GO:0046314]
PGEN_.00g063850	Scaffold_03	16104607	16112423	NA	NA	NA	NA	NA
PGEN_.00g063860	Scaffold_03	16121565	16194929	P9WKC0	Y1425_MYCTO	Putative diacyglycerol O-acyltransferase MT1468 (EC 2.3.1.20) (Putative triacylglycerol synthase MT1468)	GO:0004144; GO:0006071; GO:0019432	diacylglycerol O-acyltransferase activity [GO:0004144]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]
PGEN_.00g063870	Scaffold_03	16209490	16211616	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g063880	Scaffold_03	16217563	16218141	NA	NA	NA	NA	NA
PGEN_.00g063890	Scaffold_03	16218971	16227771	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g063900	Scaffold_03	16239794	16265894	P11717	MPRI_HUMAN	Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222)	GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030665; GO:0030667; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0043312; GO:0044794; GO:0048471; GO:0051219; GO:0061024; GO:0070062	cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor-activated receptor activity [GO:0005010]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]
PGEN_.00g063910	Scaffold_03	16272125	16273237	NA	NA	NA	NA	NA
PGEN_.00g063920	Scaffold_03	16274649	16315113	P08169	MPRI_BOVIN	Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (CD antigen CD222)	GO:0005520; GO:0005537; GO:0005765; GO:0005768; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0007041; GO:0009986; GO:0016021; GO:0030139; GO:0036143; GO:0038023; GO:0051219	cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; insulin-like growth factor binding [GO:0005520]; kringle domain binding [GO:0036143]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; signaling receptor activity [GO:0038023]; lysosomal transport [GO:0007041]
PGEN_.00g063930	Scaffold_03	16332110	16340645	NA	NA	NA	NA	NA
PGEN_.00g063940	Scaffold_03	16361344	16385895	F1QFU0	TMC1_DANRE	Transmembrane channel-like protein 1	GO:0005216; GO:0005887; GO:0008381; GO:0032421; GO:0050910	integral component of plasma membrane [GO:0005887]; stereocilium bundle [GO:0032421]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]
PGEN_.00g063950	Scaffold_03	16394042	16417365	O60260	PRKN_HUMAN	E3 ubiquitin-protein ligase parkin (Parkin) (EC 2.3.2.31) (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2) (Parkinson disease protein 2)	GO:0000122; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0000976; GO:0001227; GO:0001664; GO:0001933; GO:0001964; GO:0003779; GO:0004842; GO:0005623; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007417; GO:0007612; GO:0008013; GO:0008270; GO:0008344; GO:0010498; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010906; GO:0010994; GO:0014059; GO:0015631; GO:0016235; GO:0016236; GO:0016567; GO:0016579; GO:0016607; GO:0017124; GO:0019899; GO:0019900; GO:0019901; GO:0030165; GO:0030544; GO:0031072; GO:0031396; GO:0031624; GO:0031625; GO:0031647; GO:0031648; GO:0032092; GO:0032232; GO:0032368; GO:0032436; GO:0033132; GO:0034620; GO:0034976; GO:0035249; GO:0035519; GO:0036503; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043123; GO:0043130; GO:0043161; GO:0043274; GO:0043388; GO:0043524; GO:0044257; GO:0044267; GO:0044314; GO:0044828; GO:0044877; GO:0045732; GO:0045944; GO:0046329; GO:0046676; GO:0048471; GO:0050821; GO:0051087; GO:0051582; GO:0051583; GO:0051865; GO:0051881; GO:0055069; GO:0060548; GO:0060828; GO:0061630; GO:0061734; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0071287; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0097237; GO:0097413; GO:0097602; GO:0098779; GO:0098793; GO:0099074; GO:1900407; GO:1901215; GO:1901800; GO:1902236; GO:1902254; GO:1902283; GO:1902530; GO:1902803; GO:1903202; GO:1903214; GO:1903265; GO:1903351; GO:1903377; GO:1903382; GO:1903542; GO:1903599; GO:1903861; GO:1904049; GO:1905281; GO:1905366; GO:1905477; GO:1990381; GO:1990444; GO:1990452; GO:2000377; GO:2000378	"aggresome [GO:0016235]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular protein metabolic process [GO:0044267]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; cellular response to unfolded protein [GO:0034620]; central nervous system development [GO:0007417]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; ERAD pathway [GO:0036503]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid transport [GO:0032368]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]"
PGEN_.00g063960	Scaffold_03	16422046	16430423	Q9H1K1	ISCU_HUMAN	"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein)"	GO:0005506; GO:0005623; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006879; GO:0008198; GO:0016226; GO:0044281; GO:0051537; GO:0051539; GO:0060090; GO:1902958; GO:1904234; GO:1904439	"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; molecular adaptor activity [GO:0060090]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; small molecule metabolic process [GO:0044281]"
PGEN_.00g063970	Scaffold_03	16436390	16451097	Q6INE3	TOIPB_XENLA	Toll-interacting protein B	GO:0005737; GO:0006914; GO:0006954; GO:0016310; GO:0045087	cytoplasm [GO:0005737]; autophagy [GO:0006914]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]
PGEN_.00g063980	Scaffold_03	16456831	16457061	NA	NA	NA	NA	NA
PGEN_.00g063990	Scaffold_03	16478253	16478546	NA	NA	NA	NA	NA
PGEN_.00g064000	Scaffold_03	16496940	16498530	NA	NA	NA	NA	NA
PGEN_.00g064010	Scaffold_03	16500456	16502909	NA	NA	NA	NA	NA
PGEN_.00g064020	Scaffold_03	16505871	16507927	NA	NA	NA	NA	NA
PGEN_.00g064030	Scaffold_03	16519797	16520594	NA	NA	NA	NA	NA
PGEN_.00g064040	Scaffold_03	16520633	16520962	NA	NA	NA	NA	NA
PGEN_.00g064050	Scaffold_03	16520992	16521375	NA	NA	NA	NA	NA
PGEN_.00g064060	Scaffold_03	16522288	16527634	NA	NA	NA	NA	NA
PGEN_.00g064070	Scaffold_03	16533073	16549962	P82925	RT31_BOVIN	"28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt)"	GO:0003735; GO:0005743; GO:0005763	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]
PGEN_.00g064080	Scaffold_03	16550132	16555652	Q86WC4	OSTM1_HUMAN	Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit)	GO:0005765; GO:0005829; GO:0016021; GO:0030316; GO:0034220	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; ion transmembrane transport [GO:0034220]; osteoclast differentiation [GO:0030316]
PGEN_.00g064090	Scaffold_03	16556739	16559181	NA	NA	NA	NA	NA
PGEN_.00g064100	Scaffold_03	16559224	16559799	NA	NA	NA	NA	NA
PGEN_.00g064110	Scaffold_03	16562283	16562603	NA	NA	NA	NA	NA
PGEN_.00g064120	Scaffold_03	16564828	16565781	Q8E245	ISPE_STRA5	Putative 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (CMK) (EC 2.7.1.148) (4-(cytidine-5'-diphospho)-2-C-methyl-D-erythritol kinase)	GO:0005524; GO:0016114; GO:0050515	4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase activity [GO:0050515]; ATP binding [GO:0005524]; terpenoid biosynthetic process [GO:0016114]
PGEN_.00g064130	Scaffold_03	16568729	16570756	Q8IYB1	M21D2_HUMAN	Protein MB21D2 (Mab-21 domain-containing protein 2)	GO:0044877; GO:0045296	cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]
PGEN_.00g064140	Scaffold_03	16571091	16579994	NA	NA	NA	NA	NA
PGEN_.00g064150	Scaffold_03	16667837	16699624	Q9W770	SPON1_CHICK	Spondin-1 (F-spondin)	GO:0007155; GO:0031012; GO:0046872	extracellular matrix [GO:0031012]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]
PGEN_.00g064160	Scaffold_03	16713273	16744787	Q8NCR3	CK065_HUMAN	Uncharacterized protein C11orf65		
PGEN_.00g064170	Scaffold_03	16773016	16775438	Q9D328	TM35A_MOUSE	Transmembrane protein 35A (Peroxisomal membrane protein 52) (PMP52)	GO:0005778; GO:0016021; GO:0031410	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]
PGEN_.00g064180	Scaffold_03	16775799	16782580	Q8CD19	LANC3_MOUSE	LanC-like protein 3	GO:0003824; GO:0005886	plasma membrane [GO:0005886]; catalytic activity [GO:0003824]
PGEN_.00g064190	Scaffold_03	16794179	16831297	Q8N5G2	MACOI_HUMAN	Macoilin (Macoilin-1) (Transmembrane protein 57)	GO:0005634; GO:0006935; GO:0007420; GO:0008017; GO:0016021; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0044306; GO:0045202; GO:0051015	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202]; actin filament binding [GO:0051015]; microtubule binding [GO:0008017]; brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]
PGEN_.00g064200	Scaffold_03	16831532	16842807	Q6EE31	TCPQ_CHICK	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta)	GO:0005524; GO:0005815; GO:0005832; GO:0006457; GO:0042995; GO:0051082	cell projection [GO:0042995]; chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]
PGEN_.00g064210	Scaffold_03	16857353	16879028	E1BBQ2	GP158_BOVIN	Probable G-protein coupled receptor 158	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g064220	Scaffold_03	16893772	16898807	Q6P9Y7	ZFP82_MOUSE	Zinc finger protein 82 (Zfp-82) (Zinc finger protein 545)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g064230	Scaffold_03	16903428	16927737	Q32PJ3	ORC3_BOVIN	Origin recognition complex subunit 3	GO:0000785; GO:0003688; GO:0005656; GO:0005664; GO:0006267; GO:0006270; GO:0006275; GO:0031261	chromatin [GO:0000785]; DNA replication preinitiation complex [GO:0031261]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; DNA replication origin binding [GO:0003688]; DNA replication initiation [GO:0006270]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA replication [GO:0006275]
PGEN_.00g064240	Scaffold_03	16963029	16963628	NA	NA	NA	NA	NA
PGEN_.00g064250	Scaffold_03	16963953	16964201	NA	NA	NA	NA	NA
PGEN_.00g064260	Scaffold_03	17003824	17004075	NA	NA	NA	NA	NA
PGEN_.00g064270	Scaffold_03	17004278	17004853	NA	NA	NA	NA	NA
PGEN_.00g064280	Scaffold_03	17008600	17011820	NA	NA	NA	NA	NA
PGEN_.00g064290	Scaffold_03	17035235	17041978	NA	NA	NA	NA	NA
PGEN_.00g064300	Scaffold_03	17044867	17045277	NA	NA	NA	NA	NA
PGEN_.00g064310	Scaffold_03	17045341	17046710	NA	NA	NA	NA	NA
PGEN_.00g064320	Scaffold_03	17047647	17050026	NA	NA	NA	NA	NA
PGEN_.00g064330	Scaffold_03	17148955	17149191	NA	NA	NA	NA	NA
PGEN_.00g064340	Scaffold_03	17172397	17179420	NA	NA	NA	NA	NA
PGEN_.00g064350	Scaffold_03	17191223	17191611	NA	NA	NA	NA	NA
PGEN_.00g064360	Scaffold_03	17191696	17192198	NA	NA	NA	NA	NA
PGEN_.00g064370	Scaffold_03	17230121	17233758	NA	NA	NA	NA	NA
PGEN_.00g064380	Scaffold_03	17237518	17244683	P98170	XIAP_HUMAN	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0016055; GO:0030510; GO:0031398; GO:0042127; GO:0042802; GO:0043027; GO:0043066; GO:0043154; GO:0045088; GO:0046872; GO:0050727; GO:0051402; GO:0055070; GO:0061630; GO:0070424; GO:0090263; GO:1902530; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055]
PGEN_.00g064390	Scaffold_03	17275379	17279909	Q0Q029	DFP1_ANTMY	Putative defense protein 1 (DFP-1)	GO:0005576; GO:0042742; GO:0042832; GO:0045087	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]
PGEN_.00g064400	Scaffold_03	17291257	17296846	Q0Q029	DFP1_ANTMY	Putative defense protein 1 (DFP-1)	GO:0005576; GO:0042742; GO:0042832; GO:0045087	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]
PGEN_.00g064410	Scaffold_03	17301124	17304954	NA	NA	NA	NA	NA
PGEN_.00g064420	Scaffold_03	17311333	17317787	NA	NA	NA	NA	NA
PGEN_.00g064430	Scaffold_03	17325865	17356809	NA	NA	NA	NA	NA
PGEN_.00g064440	Scaffold_03	17383290	17394965	NA	NA	NA	NA	NA
PGEN_.00g064450	Scaffold_03	17398739	17417199	Q24799	MYPH_ECHGR	Myophilin		
PGEN_.00g064460	Scaffold_03	17421605	17435166	Q9UKN5	PRDM4_HUMAN	PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4)	GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006366; GO:0008168; GO:0031490; GO:0035097; GO:0043565; GO:0043985; GO:0045893; GO:0046872; GO:1990226	"cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; histone H4-R3 methylation [GO:0043985]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g064470	Scaffold_03	17445927	17465850	P00432	CATA_BOVIN	Catalase (EC 1.11.1.6)	GO:0004096; GO:0005777; GO:0019899; GO:0020037; GO:0042542; GO:0042744; GO:0046872; GO:0051781; GO:0055114	peroxisome [GO:0005777]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; positive regulation of cell division [GO:0051781]; response to hydrogen peroxide [GO:0042542]
PGEN_.00g064480	Scaffold_03	17470239	17476538	Q6NRS1	IBTK_XENLA	Inhibitor of Bruton tyrosine kinase (IBtk)	GO:0005737; GO:0016020	cytoplasm [GO:0005737]; membrane [GO:0016020]
PGEN_.00g064490	Scaffold_03	17476983	17488884	Q6ZPR6	IBTK_MOUSE	Inhibitor of Bruton tyrosine kinase (IBtk)	GO:0001933; GO:0005623; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209	cell [GO:0005623]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]
PGEN_.00g064500	Scaffold_03	17490914	17497425	NA	NA	NA	NA	NA
PGEN_.00g064510	Scaffold_03	17509935	17510449	NA	NA	NA	NA	NA
PGEN_.00g064520	Scaffold_03	17651094	17727859	P91621	SIF1_DROME	"Protein still life, isoform SIF type 1"	GO:0001654; GO:0007601; GO:0030036; GO:0030054; GO:0030676; GO:0035556; GO:0043087; GO:0045202; GO:0050770; GO:0050803; GO:0051491	cell junction [GO:0030054]; synapse [GO:0045202]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; actin cytoskeleton organization [GO:0030036]; eye development [GO:0001654]; intracellular signal transduction [GO:0035556]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of synapse structure or activity [GO:0050803]; visual perception [GO:0007601]
PGEN_.00g064530	Scaffold_03	17728312	17739744	P91620	SIF2_DROME	"Protein still life, isoforms C/SIF type 2"	GO:0030036; GO:0030054; GO:0030676; GO:0035556; GO:0043087; GO:0045202; GO:0050770; GO:0050803; GO:0051491	cell junction [GO:0030054]; synapse [GO:0045202]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; actin cytoskeleton organization [GO:0030036]; intracellular signal transduction [GO:0035556]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of synapse structure or activity [GO:0050803]
PGEN_.00g064540	Scaffold_03	17749575	17752210	P25110	ACHD_RAT	Acetylcholine receptor subunit delta	GO:0003009; GO:0004888; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005892; GO:0006812; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015276; GO:0022848; GO:0030054; GO:0031594; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0048630; GO:0050877; GO:0050881; GO:0099060; GO:1904315	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g064550	Scaffold_03	17898867	17919345	Q64104	NR2E1_MOUSE	Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll) (mTll)	GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0001662; GO:0002118; GO:0003700; GO:0003707; GO:0005634; GO:0005654; GO:0006357; GO:0007420; GO:0007601; GO:0008270; GO:0008284; GO:0008347; GO:0019899; GO:0021542; GO:0021764; GO:0021772; GO:0021819; GO:0021872; GO:0021895; GO:0021960; GO:0021987; GO:0030154; GO:0030198; GO:0035019; GO:0035176; GO:0042826; GO:0043010; GO:0043066; GO:0045165; GO:0045665; GO:0045766; GO:0045787; GO:0048712; GO:0048814; GO:0048856; GO:0051128; GO:0060041; GO:0060164; GO:0060291; GO:0090049; GO:2000178; GO:2000179; GO:2000648	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; aggressive behavior [GO:0002118]; amygdala development [GO:0021764]; anatomical structure development [GO:0048856]; anterior commissure morphogenesis [GO:0021960]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; dentate gyrus development [GO:0021542]; extracellular matrix organization [GO:0030198]; forebrain generation of neurons [GO:0021872]; glial cell migration [GO:0008347]; layer formation in cerebral cortex [GO:0021819]; long-term synaptic potentiation [GO:0060291]; negative regulation of apoptotic process [GO:0043066]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of cellular component organization [GO:0051128]; regulation of dendrite morphogenesis [GO:0048814]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic stem cell population maintenance [GO:0035019]; visual perception [GO:0007601]"
PGEN_.00g064560	Scaffold_03	17940882	17941109	NA	NA	NA	NA	NA
PGEN_.00g064570	Scaffold_03	17976165	18017246	E9Q555	RN213_MOUSE	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g064580	Scaffold_03	18023478	18094214	E9Q555	RN213_MOUSE	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g064590	Scaffold_03	18104049	18135133	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g064600	Scaffold_03	18159130	18245404	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g064610	Scaffold_03	18257621	18320268	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g064620	Scaffold_03	18345710	18548969	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g064630	Scaffold_03	18560597	18562333	NA	NA	NA	NA	NA
PGEN_.00g064640	Scaffold_03	18563206	18573769	NA	NA	NA	NA	NA
PGEN_.00g064650	Scaffold_03	18578843	18579196	NA	NA	NA	NA	NA
PGEN_.00g064660	Scaffold_03	18598447	18632064	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g064670	Scaffold_03	18637031	18656062	NA	NA	NA	NA	NA
PGEN_.00g064680	Scaffold_03	18667520	18689208	P53618	COPB_HUMAN	Coatomer subunit beta (Beta-coat protein) (Beta-COP)	GO:0000139; GO:0005198; GO:0005789; GO:0005793; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0016032; GO:0030126; GO:0030133; GO:0030667; GO:0043231; GO:0043312; GO:0070821; GO:0101003	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; viral process [GO:0016032]"
PGEN_.00g064690	Scaffold_03	18697111	18704704	NA	NA	NA	NA	NA
PGEN_.00g064700	Scaffold_03	18705945	18711158	Q9CX00	IST1_MOUSE	IST1 homolog	GO:0000785; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0031410; GO:0042802; GO:0043231; GO:0044877; GO:0045184; GO:0045862; GO:0046745; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; establishment of protein localization [GO:0045184]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076]
PGEN_.00g064710	Scaffold_03	18719717	18739969	NA	NA	NA	NA	NA
PGEN_.00g064720	Scaffold_03	18757479	18774045	Q8N5D0	WDTC1_HUMAN	WD and tetratricopeptide repeats protein 1	GO:0000122; GO:0001701; GO:0004857; GO:0005623; GO:0005654; GO:0005829; GO:0006006; GO:0008361; GO:0016567; GO:0032869; GO:0035264; GO:0042393; GO:0042826; GO:0043687; GO:0045717; GO:0055082	cell [GO:0005623]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; cellular chemical homeostasis [GO:0055082]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361]
PGEN_.00g064730	Scaffold_03	18778215	18792180	Q642C0	DNJC8_RAT	DnaJ homolog subfamily C member 8	GO:0005634; GO:0030544	nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]
PGEN_.00g064740	Scaffold_03	18809878	18851487	Q5F471	PP6R3_CHICK	Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3)	GO:0019903; GO:0043666	protein phosphatase binding [GO:0019903]; regulation of phosphoprotein phosphatase activity [GO:0043666]
PGEN_.00g064750	Scaffold_03	18858106	18897343	Q8C8M1	SHCAF_MOUSE	SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein)	GO:0008284; GO:0016580; GO:0030336; GO:0045596	Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]
PGEN_.00g064760	Scaffold_03	18945957	18946313	NA	NA	NA	NA	NA
PGEN_.00g064770	Scaffold_03	18946447	18947085	NA	NA	NA	NA	NA
PGEN_.00g064780	Scaffold_03	18983850	19068403	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g064790	Scaffold_03	19072219	19072726	NA	NA	NA	NA	NA
PGEN_.00g064800	Scaffold_03	19085859	19123135	Q642P2	DOP2_XENLA	Protein dopey-2	GO:0000139; GO:0005829; GO:0006895; GO:0015031	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]
PGEN_.00g064810	Scaffold_03	19134534	19144309	Q5JWR5	DOP1_HUMAN	Protein dopey-1	GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]
PGEN_.00g064820	Scaffold_03	19144989	19147993	NA	NA	NA	NA	NA
PGEN_.00g064830	Scaffold_03	19161662	19186851	Q99LL5	PWP1_MOUSE	Periodic tryptophan protein 1 homolog	GO:0005634; GO:0005694; GO:0005730; GO:0005794; GO:0033140; GO:0034773; GO:0042254; GO:1901838; GO:1990889; GO:2000738	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; H4K20me3 modified histone binding [GO:1990889]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; ribosome biogenesis [GO:0042254]
PGEN_.00g064840	Scaffold_03	19191648	19192070	NA	NA	NA	NA	NA
PGEN_.00g064850	Scaffold_03	19197036	19251325	E9Q7E2	ARID2_MOUSE	AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200)	GO:0003007; GO:0003677; GO:0005654; GO:0005667; GO:0005886; GO:0006337; GO:0008134; GO:0008285; GO:0030336; GO:0042592; GO:0045944; GO:0046872; GO:0048568; GO:0060038; GO:0060982; GO:0072358	nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; cardiac muscle cell proliferation [GO:0060038]; cardiovascular system development [GO:0072358]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g064860	Scaffold_03	19263575	19263829	NA	NA	NA	NA	NA
PGEN_.00g064870	Scaffold_03	19283190	19298099	Q61102	ABCB7_MOUSE	"ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein)"	GO:0005524; GO:0005623; GO:0005739; GO:0005743; GO:0006879; GO:0016021; GO:0016887; GO:0042626	cell [GO:0005623]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cellular iron ion homeostasis [GO:0006879]
PGEN_.00g064880	Scaffold_03	19301262	19311701	B1AVZ0	UPP_MOUSE	Uracil phosphoribosyltransferase homolog	GO:0005525; GO:0005654; GO:0005829; GO:0006222; GO:0007565; GO:0007595; GO:0009116; GO:0016301; GO:0032868; GO:0043231	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; kinase activity [GO:0016301]; female pregnancy [GO:0007565]; lactation [GO:0007595]; nucleoside metabolic process [GO:0009116]; response to insulin [GO:0032868]; UMP biosynthetic process [GO:0006222]
PGEN_.00g064890	Scaffold_03	19328222	19330910	Q008S8	ECT2L_HUMAN	Epithelial cell-transforming sequence 2 oncogene-like (Lung-specific F-box and DH domain-containing protein) (Putative guanine nucleotide exchange factor LFDH)	GO:0005085	guanyl-nucleotide exchange factor activity [GO:0005085]
PGEN_.00g064900	Scaffold_03	19331467	19342228	Q008S8	ECT2L_HUMAN	Epithelial cell-transforming sequence 2 oncogene-like (Lung-specific F-box and DH domain-containing protein) (Putative guanine nucleotide exchange factor LFDH)	GO:0005085	guanyl-nucleotide exchange factor activity [GO:0005085]
PGEN_.00g064910	Scaffold_03	19352618	19379658	Q921E6	EED_MOUSE	Polycomb protein EED	GO:0000122; GO:0000978; GO:0001739; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006342; GO:0006349; GO:0016571; GO:0021510; GO:0035098; GO:0042054; GO:0042802; GO:0045120; GO:0046976; GO:0048709; GO:0061087; GO:1990830; GO:2000011	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]; chromatin binding [GO:0003682]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oligodendrocyte differentiation [GO:0048709]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]; spinal cord development [GO:0021510]
PGEN_.00g064920	Scaffold_03	19390386	19394493	Q3SZ25	EED_BOVIN	Polycomb protein EED	GO:0000122; GO:0000978; GO:0001739; GO:0003682; GO:0005829; GO:0006342; GO:0006349; GO:0035098; GO:0042802; GO:0045120; GO:0046976; GO:0048709; GO:0061087; GO:1990830; GO:2000011	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oligodendrocyte differentiation [GO:0048709]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]
PGEN_.00g064930	Scaffold_03	19394669	19399284	NA	NA	NA	NA	NA
PGEN_.00g064940	Scaffold_03	19409207	19419899	Q9X248	FABG_THEMA	3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)	GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132	3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]
PGEN_.00g064950	Scaffold_03	19521110	19522225	Q5XHI9	HUNKA_XENLA	Hormonally up-regulated neu tumor-associated kinase homolog A (EC 2.7.11.1) (Serine/threonine-protein kinase MAK-V A) (xMAK-V A)	GO:0004674; GO:0005524	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g064960	Scaffold_03	19530921	19535667	NA	NA	NA	NA	NA
PGEN_.00g064970	Scaffold_03	19547205	19570923	A6QLU6	AGRD1_BOVIN	Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)	GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g064980	Scaffold_03	19596836	19605600	Q8ITC7	CAPAR_DROME	Neuropeptides capa receptor (Cap2b receptor) (Capability receptor)	GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]
PGEN_.00g064990	Scaffold_03	19663300	19663836	NA	NA	NA	NA	NA
PGEN_.00g065000	Scaffold_03	19684194	19684490	NA	NA	NA	NA	NA
PGEN_.00g065010	Scaffold_03	19741710	19743666	NA	NA	NA	NA	NA
PGEN_.00g065020	Scaffold_03	19802569	19835352	NA	NA	NA	NA	NA
PGEN_.00g065030	Scaffold_03	19844940	19849328	Q5RAC8	MBTP2_PONAB	Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P)	GO:0004222; GO:0005737; GO:0008203; GO:0016021; GO:0046872; GO:0070977	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]
PGEN_.00g065040	Scaffold_03	19852197	19882112	Q9HB97	PARVA_RAT	Alpha-parvin (Actopaxin)	GO:0002040; GO:0003148; GO:0003779; GO:0005634; GO:0005737; GO:0005886; GO:0005925; GO:0007155; GO:0007163; GO:0008360; GO:0015629; GO:0019904; GO:0030018; GO:0030027; GO:0030031; GO:0030036; GO:0031532; GO:0032991; GO:0034113; GO:0034446; GO:0044877; GO:0060271; GO:0070252; GO:0071670	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; actin binding [GO:0003779]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell adhesion [GO:0007155]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]
PGEN_.00g065050	Scaffold_03	19920344	19948798	P28347	TEAD1_HUMAN	Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13)	GO:0000790; GO:0000981; GO:0000987; GO:0001085; GO:0001134; GO:0001223; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006367; GO:0035329; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0046982; GO:0065003; GO:0071148; GO:1902895	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-1-YAP complex [GO:0071148]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription regulator recruiting activity [GO:0001134]; transcription regulatory region DNA binding [GO:0044212]; hippo signaling [GO:0035329]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g065060	Scaffold_03	19967108	19972247	Q9GV41	PGFS_TRYBB	"9,11-endoperoxide prostaglandin H2 reductase (EC 1.1.1.-) (Prostaglandin F2-alpha synthase)"	GO:0000166; GO:0001516; GO:0004033; GO:0005737; GO:0019571; GO:0045290	cytoplasm [GO:0005737]; aldo-keto reductase (NADP) activity [GO:0004033]; D-arabinose 1-dehydrogenase [NAD(P)+] activity [GO:0045290]; nucleotide binding [GO:0000166]; D-arabinose catabolic process [GO:0019571]; prostaglandin biosynthetic process [GO:0001516]
PGEN_.00g065070	Scaffold_03	19973986	20015777	Q0VCJ7	RERG_BOVIN	Ras-related and estrogen-regulated growth inhibitor	GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0007265; GO:0008285; GO:0009725; GO:0019003; GO:0030308	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]
PGEN_.00g065080	Scaffold_03	19979017	19981432	NA	NA	NA	NA	NA
PGEN_.00g065090	Scaffold_03	20051216	20067427	NA	NA	NA	NA	NA
PGEN_.00g065100	Scaffold_03	20072500	20102998	NA	NA	NA	NA	NA
PGEN_.00g065110	Scaffold_03	20185767	20186296	NA	NA	NA	NA	NA
PGEN_.00g065120	Scaffold_03	20186480	20186785	NA	NA	NA	NA	NA
PGEN_.00g065130	Scaffold_03	20189470	20197864	NA	NA	NA	NA	NA
PGEN_.00g065140	Scaffold_03	20208457	20208767	NA	NA	NA	NA	NA
PGEN_.00g065150	Scaffold_03	20224611	20228795	NA	NA	NA	NA	NA
PGEN_.00g065160	Scaffold_03	20236562	20237053	NA	NA	NA	NA	NA
PGEN_.00g065170	Scaffold_03	20237275	20238033	NA	NA	NA	NA	NA
PGEN_.00g065180	Scaffold_03	20362903	20366574	NA	NA	NA	NA	NA
PGEN_.00g065190	Scaffold_03	20368527	20373184	NA	NA	NA	NA	NA
PGEN_.00g065200	Scaffold_03	20394298	20445541	NA	NA	NA	NA	NA
PGEN_.00g065210	Scaffold_03	20446152	20451136	P61165	TM258_HUMAN	Transmembrane protein 258 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258) (Oligosaccharyl transferase subunit TMEM258)	GO:0005783; GO:0006487; GO:0016021; GO:0034998	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oligosaccharyltransferase I complex [GO:0034998]; protein N-linked glycosylation [GO:0006487]
PGEN_.00g065220	Scaffold_03	20462726	20486046	Q9NZC7	WWOX_HUMAN	WW domain-containing oxidoreductase (EC 1.1.1.-) (Fragile site FRA16D oxidoreductase) (Short chain dehydrogenase/reductase family 41C member 1)	GO:0000122; GO:0001649; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0008202; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0046983; GO:0048037; GO:0048705; GO:0050662; GO:0055114; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001238; GO:2001241	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; coenzyme binding [GO:0050662]; cofactor binding [GO:0048037]; enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]; protein dimerization activity [GO:0046983]; transcription coactivator activity [GO:0003713]; cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; oxidation-reduction process [GO:0055114]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; steroid metabolic process [GO:0008202]; Wnt signaling pathway [GO:0016055]
PGEN_.00g065230	Scaffold_03	20500923	20502899	NA	NA	NA	NA	NA
PGEN_.00g065240	Scaffold_03	20511199	20511681	NA	NA	NA	NA	NA
PGEN_.00g065250	Scaffold_03	20513986	20587499	Q80YA9	CNKR2_MOUSE	Connector enhancer of kinase suppressor of ras 2 (Connector enhancer of KSR 2) (CNK homolog protein 2) (CNK2)	GO:0005737; GO:0005886; GO:0009966; GO:0014069; GO:0019901; GO:0035556; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0098978; GO:0099147; GO:0099173	cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; regulation of signal transduction [GO:0009966]
PGEN_.00g065260	Scaffold_03	20592304	20592573	NA	NA	NA	NA	NA
PGEN_.00g065270	Scaffold_03	20596655	20605916	Q9NZN8	CNOT2_HUMAN	CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2)	GO:0000122; GO:0000289; GO:0000932; GO:0001226; GO:0001829; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006977; GO:0010606; GO:0016020; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0090503; GO:2000036	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]"
PGEN_.00g065280	Scaffold_03	20642211	20684453	Q8BUG5	CAYP2_MOUSE	Calcyphosin-2 (Calcyphosine-2)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g065290	Scaffold_03	20694612	20694815	NA	NA	NA	NA	NA
PGEN_.00g065300	Scaffold_03	20696266	20713486	Q75J93	CPAS1_DICDI	Circularly permutated Ras protein 1 (DdiCPRas1)	GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0006888; GO:0007265; GO:0008270; GO:0019003; GO:0030127	COPII vesicle coat [GO:0030127]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; Ras protein signal transduction [GO:0007265]
PGEN_.00g065310	Scaffold_03	20715733	20716023	NA	NA	NA	NA	NA
PGEN_.00g065320	Scaffold_03	20719813	20720070	NA	NA	NA	NA	NA
PGEN_.00g065330	Scaffold_03	20720165	20723492	NA	NA	NA	NA	NA
PGEN_.00g065340	Scaffold_03	20759562	20760437	NA	NA	NA	NA	NA
PGEN_.00g065350	Scaffold_03	20781092	20781526	NA	NA	NA	NA	NA
PGEN_.00g065360	Scaffold_03	20781881	20782315	NA	NA	NA	NA	NA
PGEN_.00g065370	Scaffold_03	20787716	20789818	NA	NA	NA	NA	NA
PGEN_.00g065380	Scaffold_03	20799008	20799754	Q90XB3	OLIG2_CHICK	Oligodendrocyte transcription factor 2 (Oligo2)	GO:0000122; GO:0000981; GO:0003677; GO:0005634; GO:0005737; GO:0021522; GO:0021530; GO:0021794; GO:0042552; GO:0042803; GO:0045665; GO:0048663; GO:0048714; GO:0071837	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; protein homodimerization activity [GO:0042803]; myelination [GO:0042552]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; positive regulation of oligodendrocyte differentiation [GO:0048714]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; thalamus development [GO:0021794]"
PGEN_.00g065390	Scaffold_03	20815602	20822477	Q9DAK2	PACRG_MOUSE	Parkin coregulated gene protein homolog (Hypertension-related protein 1-like protein) (PARK2 coregulated gene protein)	GO:0001664; GO:0003779; GO:0005739; GO:0005829; GO:0005929; GO:0007286; GO:0030544; GO:0031072; GO:0031625; GO:0031982; GO:0034620; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051087; GO:0051879; GO:0060548; GO:0097225	cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286]
PGEN_.00g065400	Scaffold_03	20822753	20840910	Q9DC71	RT15_MOUSE	"28S ribosomal protein S15, mitochondrial (MRP-S15) (S15mt)"	GO:0003735; GO:0005654; GO:0005730; GO:0005739; GO:0005761; GO:0005763; GO:0032543	mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g065410	Scaffold_03	20846964	20856734	A1ZAY1	DLISH_DROME	SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)	GO:0001736; GO:0005737; GO:0016327; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251	apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cadherin binding [GO:0045296]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; protein localization involved in establishment of planar polarity [GO:0090251]
PGEN_.00g065420	Scaffold_03	20857374	20858339	NA	NA	NA	NA	NA
PGEN_.00g065430	Scaffold_03	20892656	20897279	NA	NA	NA	NA	NA
PGEN_.00g065440	Scaffold_03	20897309	20900285	NA	NA	NA	NA	NA
PGEN_.00g065450	Scaffold_03	20906009	20921499	Q9C0D5	TANC1_HUMAN	"Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)"	GO:0007520; GO:0008542; GO:0014069; GO:0030054; GO:0030425; GO:0043025; GO:0043679; GO:0097062	axon terminus [GO:0043679]; cell junction [GO:0030054]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; visual learning [GO:0008542]
PGEN_.00g065460	Scaffold_03	20933781	20938970	NA	NA	NA	NA	NA
PGEN_.00g065470	Scaffold_03	20962384	20973115	NA	NA	NA	NA	NA
PGEN_.00g065480	Scaffold_03	20993260	20993786	NA	NA	NA	NA	NA
PGEN_.00g065490	Scaffold_03	20994540	20995518	NA	NA	NA	NA	NA
PGEN_.00g065500	Scaffold_03	20999218	20999463	A1WFL2	RHMD_VEREI	L-rhamnonate dehydratase (RhamD) (EC 4.2.1.90)	GO:0000287; GO:0009063; GO:0050032	L-rhamnonate dehydratase activity [GO:0050032]; magnesium ion binding [GO:0000287]; cellular amino acid catabolic process [GO:0009063]
PGEN_.00g065510	Scaffold_03	20999792	21000022	NA	NA	NA	NA	NA
PGEN_.00g065520	Scaffold_03	21059160	21133011	Q0IH22	PPD1B_XENLA	Blood vessel epicardial substance-B (Popeye domain-containing protein 1-B) (Popeye protein 1-B) (Xpop-1-B)	GO:0001921; GO:0005198; GO:0005886; GO:0005923; GO:0007275; GO:0008360; GO:0016021; GO:0016192; GO:0016328; GO:0034446; GO:0040017; GO:0043087; GO:0090136	bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; epithelial cell-cell adhesion [GO:0090136]; multicellular organism development [GO:0007275]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle-mediated transport [GO:0016192]
PGEN_.00g065530	Scaffold_03	21147070	21152809	NA	NA	NA	NA	NA
PGEN_.00g065540	Scaffold_03	21157127	21157546	NA	NA	NA	NA	NA
PGEN_.00g065550	Scaffold_03	21192011	21199422	O96790	DPGN_DIPMA	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)	GO:0004867; GO:0005576; GO:0050819	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]
PGEN_.00g065560	Scaffold_03	21223326	21223793	NA	NA	NA	NA	NA
PGEN_.00g065570	Scaffold_03	21229900	21234659	Q6AW46	EST5A_MOUSE	Carboxylesterase 5A (EC 3.1.1.1) (Carboxylesterase-like urinary excreted protein homolog) (Cauxin)	GO:0004771; GO:0004806; GO:0005615; GO:0016042; GO:0052689; GO:0080030	extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]
PGEN_.00g065580	Scaffold_03	21236385	21236618	NA	NA	NA	NA	NA
PGEN_.00g065590	Scaffold_03	21241595	21274462	P43679	ACHB3_CHICK	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g065600	Scaffold_03	21288399	21310383	NA	NA	NA	NA	NA
PGEN_.00g065610	Scaffold_03	21333575	21334232	NA	NA	NA	NA	NA
PGEN_.00g065620	Scaffold_03	21334389	21334838	NA	NA	NA	NA	NA
PGEN_.00g065630	Scaffold_03	21334938	21335240	NA	NA	NA	NA	NA
PGEN_.00g065640	Scaffold_03	21335367	21335612	NA	NA	NA	NA	NA
PGEN_.00g065650	Scaffold_03	21355948	21357941	NA	NA	NA	NA	NA
PGEN_.00g065660	Scaffold_03	21359281	21360873	NA	NA	NA	NA	NA
PGEN_.00g065670	Scaffold_03	21370790	21373548	NA	NA	NA	NA	NA
PGEN_.00g065680	Scaffold_03	21375243	21375626	NA	NA	NA	NA	NA
PGEN_.00g065690	Scaffold_03	21375869	21378653	NA	NA	NA	NA	NA
PGEN_.00g065700	Scaffold_03	21395485	21421405	P80174	SODC_CARCR	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	GO:0004784; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]
PGEN_.00g065710	Scaffold_03	21401588	21401923	NA	NA	NA	NA	NA
PGEN_.00g065720	Scaffold_03	21429637	21434202	NA	NA	NA	NA	NA
PGEN_.00g065730	Scaffold_03	21438304	21438558	NA	NA	NA	NA	NA
PGEN_.00g065740	Scaffold_03	21453123	21560542	Q92832	NELL1_HUMAN	Protein kinase C-binding protein NELL1 (NEL-like protein 1) (Nel-related protein 1)	GO:0005080; GO:0005509; GO:0005576; GO:0005635; GO:0005737; GO:0007399; GO:0008201; GO:0010468; GO:0030154; GO:0030501; GO:0033689; GO:0045669; GO:0048471; GO:1903363	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080]; cell differentiation [GO:0030154]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of osteoblast proliferation [GO:0033689]; nervous system development [GO:0007399]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]
PGEN_.00g065750	Scaffold_03	21604971	21605279	NA	NA	NA	NA	NA
PGEN_.00g065760	Scaffold_03	21606716	21610472	NA	NA	NA	NA	NA
PGEN_.00g065770	Scaffold_03	21610554	21615688	NA	NA	NA	NA	NA
PGEN_.00g065780	Scaffold_03	21665130	21665489	NA	NA	NA	NA	NA
PGEN_.00g065790	Scaffold_03	21666680	21667033	NA	NA	NA	NA	NA
PGEN_.00g065800	Scaffold_03	21691236	21692030	NA	NA	NA	NA	NA
PGEN_.00g065810	Scaffold_03	21694162	21695921	NA	NA	NA	NA	NA
PGEN_.00g065820	Scaffold_03	21698023	21699069	NA	NA	NA	NA	NA
PGEN_.00g065830	Scaffold_03	21728812	21807530	Q8WUA2	PPIL4_HUMAN	Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4)	GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005829; GO:1901407	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]
PGEN_.00g065840	Scaffold_03	21811453	21811719	NA	NA	NA	NA	NA
PGEN_.00g065850	Scaffold_03	21811828	21812436	NA	NA	NA	NA	NA
PGEN_.00g065860	Scaffold_03	21885711	21916507	O75691	UTP20_HUMAN	Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6)	GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040	"90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]"
PGEN_.00g065870	Scaffold_03	21923906	22118212	O75691	UTP20_HUMAN	Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6)	GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040	"90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]"
PGEN_.00g065880	Scaffold_03	22152050	22215172	Q1LWH4	FAN1_DANRE	Fanconi-associated nuclease 1 (EC 3.1.21.-) (EC 3.1.4.1) (FANCD2/FANCI-associated nuclease 1) (Myotubularin-related protein 15)	GO:0000724; GO:0004528; GO:0005634; GO:0006281; GO:0006289; GO:0008409; GO:0017108; GO:0033683; GO:0036297; GO:0046872; GO:0070336; GO:0140036	"nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; metal ion binding [GO:0046872]; phosphodiesterase I activity [GO:0004528]; ubiquitin-dependent protein binding [GO:0140036]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]"
PGEN_.00g065890	Scaffold_03	22221836	22224127	NA	NA	NA	NA	NA
PGEN_.00g065900	Scaffold_03	22233624	22237326	NA	NA	NA	NA	NA
PGEN_.00g065910	Scaffold_03	22237588	22238535	Q9UUA2	PIF1_SCHPO	ATP-dependent DNA helicase pfh1 (EC 3.6.4.12) (DNA repair and recombination helicase pfh1) (PIF1 helicase homolog) (RRM3/PIF1 homolog 1)	GO:0000262; GO:0000723; GO:0000790; GO:0003723; GO:0005524; GO:0005634; GO:0005657; GO:0005724; GO:0005730; GO:0005739; GO:0006260; GO:0006310; GO:0016887; GO:0017116; GO:0031297; GO:0032508; GO:0033678; GO:0035861; GO:0043139; GO:0043504; GO:0043601; GO:0044806; GO:0045911; GO:0051880; GO:0061995; GO:0070336; GO:1902377; GO:1902983; GO:1903469; GO:1905467; GO:1990518; GO:1990814	mitochondrial chromosome [GO:0000262]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear rDNA heterochromatin [GO:1902377]; nuclear replisome [GO:0043601]; nuclear telomeric heterochromatin [GO:0005724]; nucleolus [GO:0005730]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; ATP-dependent protein-DNA complex displacement activity [GO:0061995]; ATPase activity [GO:0016887]; DNA/DNA annealing activity [GO:1990814]; flap-structured DNA binding [GO:0070336]; G-quadruplex DNA binding [GO:0051880]; RNA binding [GO:0003723]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA helicase activity [GO:0017116]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]; DNA strand elongation involved in mitotic DNA replication [GO:1902983]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial DNA repair [GO:0043504]; positive regulation of DNA recombination [GO:0045911]; positive regulation of G-quadruplex DNA unwinding [GO:1905467]; removal of RNA primer involved in mitotic DNA replication [GO:1903469]; replication fork processing [GO:0031297]; telomere maintenance [GO:0000723]
PGEN_.00g065920	Scaffold_03	22238561	22239031	NA	NA	NA	NA	NA
PGEN_.00g065930	Scaffold_03	22258230	22259135	NA	NA	NA	NA	NA
PGEN_.00g065940	Scaffold_03	22269277	22271087	NA	NA	NA	NA	NA
PGEN_.00g065950	Scaffold_03	22305616	22370797	O73925	KCNQ1_SQUAC	Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1)	GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0086009	"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]"
PGEN_.00g065960	Scaffold_03	22428835	22429131	NA	NA	NA	NA	NA
PGEN_.00g065970	Scaffold_03	22429322	22429675	NA	NA	NA	NA	NA
PGEN_.00g065980	Scaffold_03	22429945	22430295	NA	NA	NA	NA	NA
PGEN_.00g065990	Scaffold_03	22430338	22431105	NA	NA	NA	NA	NA
PGEN_.00g066000	Scaffold_03	22432058	22444786	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g066010	Scaffold_03	22524666	22597346	Q8AV57	SDK2_CHICK	Protein sidekick-2	GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0030054; GO:0042802; GO:0045202; GO:0060219	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]
PGEN_.00g066020	Scaffold_03	22586033	22586284	NA	NA	NA	NA	NA
PGEN_.00g066030	Scaffold_03	22641170	22653227	NA	NA	NA	NA	NA
PGEN_.00g066040	Scaffold_03	22657618	22660402	NA	NA	NA	NA	NA
PGEN_.00g066050	Scaffold_03	22678625	22682588	NA	NA	NA	NA	NA
PGEN_.00g066060	Scaffold_03	22685972	22783531	NA	NA	NA	NA	NA
PGEN_.00g066070	Scaffold_03	22794358	22795098	NA	NA	NA	NA	NA
PGEN_.00g066080	Scaffold_03	22807478	22807891	NA	NA	NA	NA	NA
PGEN_.00g066090	Scaffold_03	22852997	22870761	P02751	FINC_HUMAN	Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3]	GO:0001525; GO:0001932; GO:0002020; GO:0002576; GO:0005102; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005577; GO:0005604; GO:0005615; GO:0005788; GO:0005793; GO:0006953; GO:0007044; GO:0007155; GO:0007161; GO:0008022; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010628; GO:0016324; GO:0016504; GO:0018149; GO:0019221; GO:0019899; GO:0030198; GO:0031012; GO:0031093; GO:0033622; GO:0034446; GO:0035987; GO:0042060; GO:0042802; GO:0043394; GO:0043687; GO:0044267; GO:0045773; GO:0048146; GO:0050900; GO:0051087; GO:0051702; GO:0052047; GO:0062023; GO:0070062; GO:0070372; GO:0072562; GO:0097718; GO:1901166; GO:1904237; GO:2001202	"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule lumen [GO:0031093]; chaperone binding [GO:0051087]; collagen binding [GO:0005518]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-substrate junction assembly [GO:0007044]; cellular protein metabolic process [GO:0044267]; cytokine-mediated signaling pathway [GO:0019221]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; integrin activation [GO:0033622]; interaction with symbiont [GO:0051702]; leukocyte migration [GO:0050900]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet degranulation [GO:0002576]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; post-translational protein modification [GO:0043687]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; response to wounding [GO:0009611]; substrate adhesion-dependent cell spreading [GO:0034446]; symbiotic process mediated by secreted substance [GO:0052047]; wound healing [GO:0042060]"
PGEN_.00g066100	Scaffold_03	22889026	22921371	Q9TV36	FBN1_PIG	Fibrillin-1 [Cleaved into: Asprosin]	GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0010737; GO:0031012; GO:0034199; GO:0042593	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]
PGEN_.00g066110	Scaffold_03	22934357	22966925	NA	NA	NA	NA	NA
PGEN_.00g066120	Scaffold_03	22968771	22969034	NA	NA	NA	NA	NA
PGEN_.00g066130	Scaffold_03	22970218	22986887	NA	NA	NA	NA	NA
PGEN_.00g066140	Scaffold_03	22997486	22998329	NA	NA	NA	NA	NA
PGEN_.00g066150	Scaffold_03	23147109	23205800	NA	NA	NA	NA	NA
PGEN_.00g066160	Scaffold_03	23225496	23246197	NA	NA	NA	NA	NA
PGEN_.00g066170	Scaffold_03	23288001	23288363	NA	NA	NA	NA	NA
PGEN_.00g066180	Scaffold_03	23289310	23333372	NA	NA	NA	NA	NA
PGEN_.00g066190	Scaffold_03	23339740	23340021	NA	NA	NA	NA	NA
PGEN_.00g066200	Scaffold_03	23345122	23347681	NA	NA	NA	NA	NA
PGEN_.00g066210	Scaffold_03	23348367	23349956	NA	NA	NA	NA	NA
PGEN_.00g066220	Scaffold_03	23350020	23351543	NA	NA	NA	NA	NA
PGEN_.00g066230	Scaffold_03	23358507	23377048	NA	NA	NA	NA	NA
PGEN_.00g066240	Scaffold_03	23388881	23392157	NA	NA	NA	NA	NA
PGEN_.00g066250	Scaffold_03	23434368	23434796	NA	NA	NA	NA	NA
PGEN_.00g066260	Scaffold_03	23436104	23436451	NA	NA	NA	NA	NA
PGEN_.00g066270	Scaffold_03	23450002	23499044	NA	NA	NA	NA	NA
PGEN_.00g066280	Scaffold_03	23513469	23515655	NA	NA	NA	NA	NA
PGEN_.00g066290	Scaffold_03	23524783	23547733	NA	NA	NA	NA	NA
PGEN_.00g066300	Scaffold_03	23547825	23548178	NA	NA	NA	NA	NA
PGEN_.00g066310	Scaffold_03	23548322	23548534	NA	NA	NA	NA	NA
PGEN_.00g066320	Scaffold_03	23549233	23549745	NA	NA	NA	NA	NA
PGEN_.00g066330	Scaffold_03	23553269	23574903	NA	NA	NA	NA	NA
PGEN_.00g066340	Scaffold_03	23576108	23642329	A2ASS6	TITIN_MOUSE	Titin (EC 2.7.11.1) (Connectin)	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]
PGEN_.00g066350	Scaffold_03	23642454	23642747	NA	NA	NA	NA	NA
PGEN_.00g066360	Scaffold_03	23642808	23643167	NA	NA	NA	NA	NA
PGEN_.00g066370	Scaffold_03	23643364	23644775	NA	NA	NA	NA	NA
PGEN_.00g066380	Scaffold_03	23707387	23719126	NA	NA	NA	NA	NA
PGEN_.00g066390	Scaffold_03	23736090	23737913	NA	NA	NA	NA	NA
PGEN_.00g066400	Scaffold_03	23751032	23772585	NA	NA	NA	NA	NA
PGEN_.00g066410	Scaffold_03	23825069	23827008	NA	NA	NA	NA	NA
PGEN_.00g066420	Scaffold_03	23830962	23834616	NA	NA	NA	NA	NA
PGEN_.00g066430	Scaffold_03	23845600	23858563	NA	NA	NA	NA	NA
PGEN_.00g066440	Scaffold_03	23859945	23867839	NA	NA	NA	NA	NA
PGEN_.00g066450	Scaffold_03	23931878	23932891	Q2TBS9	SMU1_BOVIN	"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]"	GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"
PGEN_.00g066460	Scaffold_03	23968070	23971876	Q8N6Q8	MET25_HUMAN	Methyltransferase-like protein 25 (EC 2.1.1.-)	GO:0008168; GO:0032259	methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g066470	Scaffold_03	23985577	23986380	O09053	WRN_MOUSE	Werner syndrome ATP-dependent helicase homolog (EC 3.6.4.12) (Exonuclease WRN) (EC 3.1.-.-)	GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0001302; GO:0003677; GO:0003678; GO:0003682; GO:0004386; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006284; GO:0006302; GO:0006310; GO:0006974; GO:0006979; GO:0007420; GO:0007569; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0010259; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0042981; GO:0043005; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0070337; GO:0071480; GO:0098530; GO:1902570; GO:1905773	"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; Y-form DNA binding [GO:0000403]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative cell aging [GO:0001302]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"
PGEN_.00g066480	Scaffold_03	24149638	24150200	NA	NA	NA	NA	NA
PGEN_.00g066490	Scaffold_03	24153122	24153400	NA	NA	NA	NA	NA
PGEN_.00g066500	Scaffold_03	24153652	24154527	NA	NA	NA	NA	NA
PGEN_.00g066510	Scaffold_03	24157265	24157810	NA	NA	NA	NA	NA
PGEN_.00g066520	Scaffold_03	24198608	24198922	NA	NA	NA	NA	NA
PGEN_.00g066530	Scaffold_03	24223254	24223850	NA	NA	NA	NA	NA
PGEN_.00g066540	Scaffold_03	24298026	24299138	NA	NA	NA	NA	NA
PGEN_.00g066550	Scaffold_03	24345283	24346863	NA	NA	NA	NA	NA
PGEN_.00g066560	Scaffold_03	24348010	24349772	Q86VQ3	TXND2_HUMAN	Thioredoxin domain-containing protein 2 (Spermatid-specific thioredoxin-1) (Sptrx-1)	GO:0004791; GO:0005623; GO:0005737; GO:0007275; GO:0007283; GO:0030154; GO:0045454	cell [GO:0005623]; cytoplasm [GO:0005737]; thioredoxin-disulfide reductase activity [GO:0004791]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g066570	Scaffold_03	24352370	24356428	NA	NA	NA	NA	NA
PGEN_.00g066580	Scaffold_03	24385564	24387562	NA	NA	NA	NA	NA
PGEN_.00g066590	Scaffold_03	24391308	24391649	NA	NA	NA	NA	NA
PGEN_.00g066600	Scaffold_03	24395224	24402262	NA	NA	NA	NA	NA
PGEN_.00g066610	Scaffold_03	24406405	24424012	Q9X248	FABG_THEMA	3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)	GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132	3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]
PGEN_.00g066620	Scaffold_03	24481864	24491321	NA	NA	NA	NA	NA
PGEN_.00g066630	Scaffold_03	24496128	24498495	NA	NA	NA	NA	NA
PGEN_.00g066640	Scaffold_03	24498538	24498864	NA	NA	NA	NA	NA
PGEN_.00g066650	Scaffold_03	24499090	24499440	NA	NA	NA	NA	NA
PGEN_.00g066660	Scaffold_03	24526838	24560019	NA	NA	NA	NA	NA
PGEN_.00g066670	Scaffold_03	24565715	24579220	Q5T7P8	SYT6_HUMAN	Synaptotagmin-6 (Synaptotagmin VI) (SytVI)	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030054; GO:0030276; GO:0030672; GO:0042803; GO:0048306; GO:0060478; GO:0070382; GO:0071277; GO:0097038; GO:0098978; GO:0099525; GO:0099699	cell junction [GO:0030054]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of synaptic membrane [GO:0099699]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; acrosomal vesicle exocytosis [GO:0060478]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]
PGEN_.00g066680	Scaffold_03	24572923	24573366	NA	NA	NA	NA	NA
PGEN_.00g066690	Scaffold_03	24573409	24574050	NA	NA	NA	NA	NA
PGEN_.00g066700	Scaffold_03	24594703	24595122	NA	NA	NA	NA	NA
PGEN_.00g066710	Scaffold_03	24596327	24596899	NA	NA	NA	NA	NA
PGEN_.00g066720	Scaffold_03	24597242	24597529	NA	NA	NA	NA	NA
PGEN_.00g066730	Scaffold_03	24625546	24625860	NA	NA	NA	NA	NA
PGEN_.00g066740	Scaffold_03	24627948	24628274	NA	NA	NA	NA	NA
PGEN_.00g066750	Scaffold_03	24643694	24644170	Q9CWW7	CXXC1_MOUSE	CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1)	GO:0000987; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008270; GO:0016363; GO:0016607; GO:0035064; GO:0035097; GO:0042800; GO:0045322; GO:0045893; GO:0048188; GO:0051568	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; methylated histone binding [GO:0035064]; proximal promoter sequence-specific DNA binding [GO:0000987]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; histone H3-K4 methylation [GO:0051568]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g066760	Scaffold_03	24688030	24740133	Q9CZP0	UFSP1_MOUSE	Ufm1-specific protease 1 (UfSP1) (EC 3.4.22.-)	GO:0016790; GO:0071567	thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]
PGEN_.00g066770	Scaffold_03	24762456	24764892	NA	NA	NA	NA	NA
PGEN_.00g066780	Scaffold_03	24784419	24801240	Q9Z336	DYLT1_RAT	Dynein light chain Tctex-type 1 (Activator of G-protein signaling 2) (AGS2) (T-complex testis-specific protein 1 homolog)	GO:0000132; GO:0003774; GO:0005623; GO:0005739; GO:0005794; GO:0005819; GO:0005868; GO:0005881; GO:0006886; GO:0008022; GO:0008277; GO:0010976; GO:0016358; GO:0019060; GO:0030027; GO:0035022; GO:0035795; GO:0042802; GO:0043025; GO:0043087; GO:0043657; GO:0044295; GO:0048812; GO:0050768; GO:0051301; GO:0051493; GO:0060548; GO:0061564; GO:0099503	axonal growth cone [GO:0044295]; cell [GO:0005623]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]; axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087]
PGEN_.00g066790	Scaffold_03	24855425	24920614	P39087	GRIK2_MOUSE	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Glutamate receptor beta-2) (GluR beta-2)"	GO:0001662; GO:0004970; GO:0005234; GO:0005623; GO:0005886; GO:0005887; GO:0006874; GO:0006886; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0016020; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060079; GO:0060080; GO:0098686; GO:0098794; GO:0098839; GO:0098978; GO:0099507; GO:1904315	"axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g066800	Scaffold_03	24871575	24872555	NA	NA	NA	NA	NA
PGEN_.00g066810	Scaffold_03	24921436	24921723	NA	NA	NA	NA	NA
PGEN_.00g066820	Scaffold_03	24921941	24922222	NA	NA	NA	NA	NA
PGEN_.00g066830	Scaffold_03	24922508	24922892	NA	NA	NA	NA	NA
PGEN_.00g066840	Scaffold_03	24923165	24923566	NA	NA	NA	NA	NA
PGEN_.00g066850	Scaffold_03	24923593	24923979	NA	NA	NA	NA	NA
PGEN_.00g066860	Scaffold_03	24925921	24926193	NA	NA	NA	NA	NA
PGEN_.00g066870	Scaffold_03	24927039	24927494	NA	NA	NA	NA	NA
PGEN_.00g066880	Scaffold_03	24927642	24944243	Q13003	GRIK3_HUMAN	"Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7)"	GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015277; GO:0030054; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0098839; GO:0098978; GO:0099507; GO:1904315	"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g066890	Scaffold_03	24945478	24946764	NA	NA	NA	NA	NA
PGEN_.00g066900	Scaffold_03	24946793	24950570	NA	NA	NA	NA	NA
PGEN_.00g066910	Scaffold_03	24955030	24967490	Q13003	GRIK3_HUMAN	"Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7)"	GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015277; GO:0030054; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0098839; GO:0098978; GO:0099507; GO:1904315	"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g066920	Scaffold_03	25025176	25025517	NA	NA	NA	NA	NA
PGEN_.00g066930	Scaffold_03	25045891	25046160	NA	NA	NA	NA	NA
PGEN_.00g066940	Scaffold_03	25077924	25078802	NA	NA	NA	NA	NA
PGEN_.00g066950	Scaffold_03	25110777	25115601	NA	NA	NA	NA	NA
PGEN_.00g066960	Scaffold_03	25134234	25195450	NA	NA	NA	NA	NA
PGEN_.00g066970	Scaffold_03	25212428	25212781	NA	NA	NA	NA	NA
PGEN_.00g066980	Scaffold_03	25220329	25225041	NA	NA	NA	NA	NA
PGEN_.00g066990	Scaffold_03	25273647	25274135	NA	NA	NA	NA	NA
PGEN_.00g067000	Scaffold_03	25276766	25286022	NA	NA	NA	NA	NA
PGEN_.00g067010	Scaffold_03	25301594	25336986	Q8AVY1	ODF3A_XENLA	Outer dense fiber protein 3 (Outer dense fiber of sperm tails protein 3)	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g067020	Scaffold_03	25338692	25345530	NA	NA	NA	NA	NA
PGEN_.00g067030	Scaffold_03	25345630	25345863	NA	NA	NA	NA	NA
PGEN_.00g067040	Scaffold_03	25346906	25349431	NA	NA	NA	NA	NA
PGEN_.00g067050	Scaffold_03	25375310	25378375	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g067060	Scaffold_03	25396203	25396436	NA	NA	NA	NA	NA
PGEN_.00g067070	Scaffold_03	25398209	25508018	Q9Y345	SC6A5_HUMAN	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g067080	Scaffold_03	25561889	25562488	NA	NA	NA	NA	NA
PGEN_.00g067090	Scaffold_03	25562696	25562938	NA	NA	NA	NA	NA
PGEN_.00g067100	Scaffold_03	25563259	25563516	NA	NA	NA	NA	NA
PGEN_.00g067110	Scaffold_03	25563658	25564128	NA	NA	NA	NA	NA
PGEN_.00g067120	Scaffold_03	25592348	25636368	O60287	NPA1P_HUMAN	Nucleolar pre-ribosomal-associated protein 1 (Nucleolar protein 254 kDa) (URB1 ribosome biogenesis 1 homolog)	GO:0000463; GO:0000466; GO:0001650; GO:0003723; GO:0005730	"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"
PGEN_.00g067130	Scaffold_03	25636644	25649175	Q5ZKX1	CHM1B_CHICK	Charged multivesicular body protein 1b (Chromatin-modifying protein 1b) (CHMP1b)	GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]
PGEN_.00g067140	Scaffold_03	25681748	25709830	P17276	PH4H_DROME	Protein henna (EC 1.14.16.1) (EC 1.14.16.4) (Phe-4-monooxygenase) (Phenylalanine-4-hydroxylase) (PAH) (Tryptophan 5-hydroxylase) (TRH) (Tryptophan 5-monooxygenase)	GO:0004505; GO:0004510; GO:0005506; GO:0006559; GO:0006571; GO:0006726; GO:0007616; GO:0042427	iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571]
PGEN_.00g067150	Scaffold_03	25717544	25725775	Q6DGP2	SYF2_DANRE	Pre-mRNA-splicing factor syf2	GO:0000398; GO:0000974; GO:0005634; GO:0071007; GO:0071013; GO:0071014	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g067160	Scaffold_03	25740404	25746778	NA	NA	NA	NA	NA
PGEN_.00g067170	Scaffold_03	25772798	25789531	NA	NA	NA	NA	NA
PGEN_.00g067180	Scaffold_03	25851257	25868237	Q9Z2A5	ATE1_MOUSE	Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1)	GO:0004057; GO:0005634; GO:0005737; GO:0010498; GO:0016598	cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]
PGEN_.00g067190	Scaffold_03	25868298	25868840	NA	NA	NA	NA	NA
PGEN_.00g067200	Scaffold_03	25869195	25869494	NA	NA	NA	NA	NA
PGEN_.00g067210	Scaffold_03	25869555	25887704	Q2PFX0	ATE1_MACFA	Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1)	GO:0004057; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]
PGEN_.00g067220	Scaffold_03	25869619	25870363	NA	NA	NA	NA	NA
PGEN_.00g067230	Scaffold_03	25895378	25938457	NA	NA	NA	NA	NA
PGEN_.00g067240	Scaffold_03	25938530	25940805	NA	NA	NA	NA	NA
PGEN_.00g067250	Scaffold_03	25941067	25943921	NA	NA	NA	NA	NA
PGEN_.00g067260	Scaffold_03	25946357	25959196	Q9QX82	MUC24_RAT	Sialomucin core protein 24 (MUC-24) (Endolyn) (Multi-glycosylated core protein 24) (MGC-24) (MGC-24v)	GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0007155; GO:0007157; GO:0007517; GO:0010008; GO:0016021; GO:0031410	cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; muscle organ development [GO:0007517]
PGEN_.00g067270	Scaffold_03	25965133	25966134	NA	NA	NA	NA	NA
PGEN_.00g067280	Scaffold_03	25969909	25975337	NA	NA	NA	NA	NA
PGEN_.00g067290	Scaffold_03	25980316	25982417	NA	NA	NA	NA	NA
PGEN_.00g067300	Scaffold_03	25996083	26025415	Q8TCG1	CIP2A_HUMAN	Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen)	GO:0005737; GO:0005829; GO:0005886; GO:0007283; GO:0016021; GO:0042803; GO:0045296; GO:2000179	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; positive regulation of neural precursor cell proliferation [GO:2000179]; spermatogenesis [GO:0007283]
PGEN_.00g067310	Scaffold_03	26040982	26053634	O77783	EXT2_BOVIN	Exostosin-2 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (HS-polymerase) (HS-POL) (Multiple exostoses protein 2 homolog)	GO:0000139; GO:0005615; GO:0005789; GO:0005794; GO:0006024; GO:0006044; GO:0006486; GO:0008375; GO:0015012; GO:0015020; GO:0016021; GO:0016757; GO:0046872; GO:0050508; GO:0050509	"endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]"
PGEN_.00g067320	Scaffold_03	26053771	26066445	NA	NA	NA	NA	NA
PGEN_.00g067330	Scaffold_03	26080696	26139433	Q8TDW5	SYTL5_HUMAN	Synaptotagmin-like protein 5	GO:0005543; GO:0006886; GO:0006887; GO:0016020; GO:0017137; GO:0046872; GO:0070382	exocytic vesicle [GO:0070382]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]
PGEN_.00g067340	Scaffold_03	26143558	26145138	NA	NA	NA	NA	NA
PGEN_.00g067350	Scaffold_03	26151946	26158599	NA	NA	NA	NA	NA
PGEN_.00g067360	Scaffold_03	26177934	26197526	Q8TDW5	SYTL5_HUMAN	Synaptotagmin-like protein 5	GO:0005543; GO:0006886; GO:0006887; GO:0016020; GO:0017137; GO:0046872; GO:0070382	exocytic vesicle [GO:0070382]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; Rab GTPase binding [GO:0017137]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]
PGEN_.00g067370	Scaffold_03	26207858	26209828	NA	NA	NA	NA	NA
PGEN_.00g067380	Scaffold_03	26243885	26263423	Q9VRN5	LIN28_DROME	Protein lin-28 homolog	GO:0003729; GO:0005829; GO:0008270; GO:0046628; GO:0048477; GO:0098724; GO:2000632; GO:2000648	cytosol [GO:0005829]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; negative regulation of pre-miRNA processing [GO:2000632]; oogenesis [GO:0048477]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of stem cell proliferation [GO:2000648]; symmetric stem cell division [GO:0098724]
PGEN_.00g067390	Scaffold_03	26302988	26306069	Q96A58	RERG_HUMAN	Ras-related and estrogen-regulated growth inhibitor	GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0007264; GO:0007265; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; estrogen receptor binding [GO:0030331]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g067400	Scaffold_03	26327578	26327871	NA	NA	NA	NA	NA
PGEN_.00g067410	Scaffold_03	26346980	26347741	P02717	ACHD_CHICK	Acetylcholine receptor subunit delta	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g067420	Scaffold_03	26354148	26367288	Q05941	ACHA7_RAT	Neuronal acetylcholine receptor subunit alpha-7	GO:0000187; GO:0001540; GO:0001666; GO:0001933; GO:0001934; GO:0001988; GO:0005216; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007268; GO:0007271; GO:0007611; GO:0007613; GO:0008144; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0014061; GO:0014069; GO:0015464; GO:0015643; GO:0016020; GO:0016324; GO:0017081; GO:0019228; GO:0019901; GO:0022848; GO:0030054; GO:0030317; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0032094; GO:0032225; GO:0032279; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042416; GO:0042698; GO:0042734; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0044853; GO:0045121; GO:0045202; GO:0045471; GO:0045766; GO:0048149; GO:0050727; GO:0050728; GO:0050804; GO:0050808; GO:0050877; GO:0050890; GO:0050893; GO:0051117; GO:0051247; GO:0060112; GO:0070373; GO:0070374; GO:0095500; GO:0097061; GO:0097110; GO:0098690; GO:0098815; GO:0098981; GO:0099055; GO:0099056; GO:0099060; GO:0099065; GO:0140059; GO:1900273; GO:1901214; GO:1902004; GO:1902430; GO:1902991; GO:1904315; GO:1904645; GO:1905144; GO:1905906; GO:1905920; GO:2000300; GO:2000463	"acetylcholine-gated channel complex [GO:0005892]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; integral component of spine apparatus membrane [GO:0099065]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; chloride channel regulator activity [GO:0017081]; drug binding [GO:0008144]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; toxic substance binding [GO:0015643]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; activation of MAPK activity [GO:0000187]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; dopamine biosynthetic process [GO:0042416]; endocytosis [GO:0006897]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; regulation of norepinephrine secretion [GO:0014061]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]"
PGEN_.00g067430	Scaffold_03	26381531	26383993	NA	NA	NA	NA	NA
PGEN_.00g067440	Scaffold_03	26385508	26386394	NA	NA	NA	NA	NA
PGEN_.00g067450	Scaffold_03	26386675	26387621	NA	NA	NA	NA	NA
PGEN_.00g067460	Scaffold_03	26388863	26389213	NA	NA	NA	NA	NA
PGEN_.00g067470	Scaffold_03	26420509	26432357	Q2HJF9	RSAD2_BOVIN	"Radical S-adenosyl methionine domain-containing protein 2 (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible)"	GO:0001650; GO:0003824; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005811; GO:0009615; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0043621; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0051539; GO:0051607; GO:2000553	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; 4 iron, 4 sulfur cluster binding [GO:0051539]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]"
PGEN_.00g067480	Scaffold_03	26506521	26507535	NA	NA	NA	NA	NA
PGEN_.00g067490	Scaffold_03	26509084	26509320	NA	NA	NA	NA	NA
PGEN_.00g067500	Scaffold_03	26551615	26560102	NA	NA	NA	NA	NA
PGEN_.00g067510	Scaffold_03	26571538	26573725	NA	NA	NA	NA	NA
PGEN_.00g067520	Scaffold_03	26808181	26808468	NA	NA	NA	NA	NA
PGEN_.00g067530	Scaffold_03	26847371	26851170	Q9BY27	DGC6L_HUMAN	Protein DGCR6L (DiGeorge syndrome critical region 6-like protein)	GO:0005634	nucleus [GO:0005634]
PGEN_.00g067540	Scaffold_03	26857116	26896204	Q5THR3	EFCB6_HUMAN	EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP)	GO:0005509; GO:0005654	nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]
PGEN_.00g067550	Scaffold_03	26908516	26915192	Q4R5P3	RL10A_MACFA	60S ribosomal protein L10a	GO:0003723; GO:0003735; GO:0006412; GO:0015934	large ribosomal subunit [GO:0015934]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g067560	Scaffold_03	26915284	26950146	Q5U252	UBP47_XENLA	Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47)	GO:0004843; GO:0005737; GO:0006284; GO:0006511; GO:0006974; GO:0035520	cytoplasm [GO:0005737]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; monoubiquitinated protein deubiquitination [GO:0035520]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g067570	Scaffold_03	26958363	26970264	NA	NA	NA	NA	NA
PGEN_.00g067580	Scaffold_03	26977777	26982820	NA	NA	NA	NA	NA
PGEN_.00g067590	Scaffold_03	26982912	26985845	Q25434	FP1_MYTCO	Adhesive plaque matrix protein (Foot protein 1) (MCFP1)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g067600	Scaffold_03	26986498	26990674	NA	NA	NA	NA	NA
PGEN_.00g067610	Scaffold_03	26996254	27006074	NA	NA	NA	NA	NA
PGEN_.00g067620	Scaffold_03	27034782	27041015	Q9R1N2	SCNNA_CAVPO	Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA)	GO:0001669; GO:0005737; GO:0005887; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725; GO:0050891; GO:0050896; GO:0050909; GO:0055078; GO:0060170; GO:0097228	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; motile cilium [GO:0031514]; sodium channel complex [GO:0034706]; sperm principal piece [GO:0097228]; ligand-gated sodium channel activity [GO:0015280]; multicellular organismal water homeostasis [GO:0050891]; response to stimulus [GO:0050896]; sensory perception of taste [GO:0050909]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]
PGEN_.00g067630	Scaffold_03	27052370	27060773	NA	NA	NA	NA	NA
PGEN_.00g067640	Scaffold_03	27062782	27063312	NA	NA	NA	NA	NA
PGEN_.00g067650	Scaffold_03	27063399	27063754	NA	NA	NA	NA	NA
PGEN_.00g067660	Scaffold_03	27063869	27072496	P12027	PSGP_ONCMY	Polysialoglycoprotein (PSGP) (Apopolysialoglycoprotein) (apoPSGP)		
PGEN_.00g067670	Scaffold_03	27074281	27081160	NA	NA	NA	NA	NA
PGEN_.00g067680	Scaffold_03	27101958	27117373	NA	NA	NA	NA	NA
PGEN_.00g067690	Scaffold_03	27132553	27139063	Q86KC7	Y4171_DICDI	Uncharacterized protein DDB_G0274171	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g067700	Scaffold_03	27141425	27146142	NA	NA	NA	NA	NA
PGEN_.00g067710	Scaffold_03	27146766	27147227	NA	NA	NA	NA	NA
PGEN_.00g067720	Scaffold_03	27162020	27162268	NA	NA	NA	NA	NA
PGEN_.00g067730	Scaffold_03	27162317	27162580	NA	NA	NA	NA	NA
PGEN_.00g067740	Scaffold_03	27178731	27180039	NA	NA	NA	NA	NA
PGEN_.00g067750	Scaffold_03	27184181	27203187	Q8N7Z5	ANR31_HUMAN	Ankyrin repeat domain-containing protein 31	GO:0000785; GO:0005634; GO:0007129; GO:0010780; GO:1903343	chromatin [GO:0000785]; nucleus [GO:0005634]; meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:0010780]; positive regulation of meiotic DNA double-strand break formation [GO:1903343]; synapsis [GO:0007129]
PGEN_.00g067760	Scaffold_03	27224499	27234394	Q9Y600	CSAD_HUMAN	Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Aspartate 1-decarboxylase) (EC 4.1.1.11) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)	GO:0004068; GO:0004782; GO:0005737; GO:0019449; GO:0019452; GO:0030170; GO:0042412	cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412]
PGEN_.00g067770	Scaffold_03	27240121	27245386	Q4PRC2	DCE2_CANLF	Glutamate decarboxylase 2 (EC 4.1.1.15) (65 kDa glutamic acid decarboxylase) (GAD-65) (Glutamate decarboxylase 65 kDa isoform)	GO:0000139; GO:0004351; GO:0005829; GO:0019752; GO:0030054; GO:0030170; GO:0031410; GO:0042136; GO:0042734; GO:0042995	cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; presynaptic membrane [GO:0042734]; glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]; carboxylic acid metabolic process [GO:0019752]; neurotransmitter biosynthetic process [GO:0042136]
PGEN_.00g067780	Scaffold_03	27250926	27276438	Q9UQF2	JIP1_HUMAN	C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1)	GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0006898; GO:0007258; GO:0008432; GO:0016192; GO:0019894; GO:0031434; GO:0031435; GO:0031966; GO:0043508; GO:0044294; GO:0044295; GO:0044297; GO:0044302; GO:0045202; GO:0045807; GO:0046328; GO:0046330; GO:0048471; GO:0090090; GO:2000564; GO:2001243	"axonal growth cone [GO:0044295]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase inhibitor activity [GO:0004860]; JUN phosphorylation [GO:0007258]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of endocytosis [GO:0045807]; positive regulation of JNK cascade [GO:0046330]; receptor-mediated endocytosis [GO:0006898]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of JNK cascade [GO:0046328]; regulation of transcription, DNA-templated [GO:0006355]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g067790	Scaffold_03	27281413	27291330	Q9CR23	TMEM9_MOUSE	Transmembrane protein 9	GO:0005764; GO:0005765; GO:0005770; GO:0016021; GO:0031902	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]
PGEN_.00g067800	Scaffold_03	27300508	27334830	Q9UBC3	DNM3B_HUMAN	DNA (cytosine-5)-methyltransferase 3B (Dnmt3b) (EC 2.1.1.37) (DNA methyltransferase HsaIIIB) (DNA MTase HsaIIIB) (M.HsaIIIB)	GO:0000122; GO:0001666; GO:0003677; GO:0003682; GO:0003714; GO:0003886; GO:0005634; GO:0005654; GO:0006306; GO:0009008; GO:0009636; GO:0010212; GO:0010628; GO:0014823; GO:0031000; GO:0032355; GO:0033189; GO:0042220; GO:0042826; GO:0045666; GO:0045814; GO:0046872; GO:0051571; GO:0051573; GO:0071455; GO:0071549	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hyperoxia [GO:0071455]; DNA methylation [GO:0006306]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of neuron differentiation [GO:0045666]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]"
PGEN_.00g067810	Scaffold_03	27346270	27351549	NA	NA	NA	NA	NA
PGEN_.00g067820	Scaffold_03	27363243	27364399	NA	NA	NA	NA	NA
PGEN_.00g067830	Scaffold_03	27364435	27376641	NA	NA	NA	NA	NA
PGEN_.00g067840	Scaffold_03	27377459	27379942	NA	NA	NA	NA	NA
PGEN_.00g067850	Scaffold_03	27379999	27381163	NA	NA	NA	NA	NA
PGEN_.00g067860	Scaffold_03	27382342	27389374	NA	NA	NA	NA	NA
PGEN_.00g067870	Scaffold_03	27396051	27426616	Q9C0C7	AMRA1_HUMAN	Activating molecule in BECN1-regulated autophagy protein 1	GO:0000045; GO:0000422; GO:0000423; GO:0005737; GO:0005739; GO:0005741; GO:0005776; GO:0005829; GO:0005930; GO:0006914; GO:0008285; GO:0009267; GO:0010508; GO:0010667; GO:0016236; GO:0021915; GO:0030154; GO:0031625; GO:0043524; GO:0043552; GO:0045335; GO:0048471; GO:0051020; GO:0098780	autophagosome [GO:0005776]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; GTPase binding [GO:0051020]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; neural tube development [GO:0021915]; positive regulation of autophagy [GO:0010508]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to mitochondrial depolarisation [GO:0098780]
PGEN_.00g067880	Scaffold_03	27436769	27443303	NA	NA	NA	NA	NA
PGEN_.00g067890	Scaffold_03	27460007	27498034	NA	NA	NA	NA	NA
PGEN_.00g067900	Scaffold_03	27526421	27552852	Q9JJR6	CK016_MOUSE	Uncharacterized protein C11orf16 homolog		
PGEN_.00g067910	Scaffold_03	27560738	27561508	NA	NA	NA	NA	NA
PGEN_.00g067920	Scaffold_03	27561533	27562198	NA	NA	NA	NA	NA
PGEN_.00g067930	Scaffold_03	27562591	27563019	NA	NA	NA	NA	NA
PGEN_.00g067940	Scaffold_03	27573013	27579956	NA	NA	NA	NA	NA
PGEN_.00g067950	Scaffold_03	27673652	27675022	NA	NA	NA	NA	NA
PGEN_.00g067960	Scaffold_03	27677053	27689342	Q9NUJ3	T11L1_HUMAN	T-complex protein 11-like protein 1	GO:0005874	microtubule [GO:0005874]
PGEN_.00g067970	Scaffold_03	27734894	27739767	Q9EQC0	CHST1_MOUSE	Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST)	GO:0000139; GO:0001517; GO:0005802; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0042339; GO:0045130	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g067980	Scaffold_03	27744223	27762875	NA	NA	NA	NA	NA
PGEN_.00g067990	Scaffold_03	27769180	27772889	NA	NA	NA	NA	NA
PGEN_.00g068000	Scaffold_03	27780007	27780306	NA	NA	NA	NA	NA
PGEN_.00g068010	Scaffold_03	27780435	27781470	NA	NA	NA	NA	NA
PGEN_.00g068020	Scaffold_03	27782031	27782330	NA	NA	NA	NA	NA
PGEN_.00g068030	Scaffold_03	27786052	27803552	Q7Z407	CSMD3_HUMAN	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g068040	Scaffold_03	27813533	27813787	NA	NA	NA	NA	NA
PGEN_.00g068050	Scaffold_03	27823179	27929908	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g068060	Scaffold_03	27932682	27933026	NA	NA	NA	NA	NA
PGEN_.00g068070	Scaffold_03	27936655	27937523	NA	NA	NA	NA	NA
PGEN_.00g068080	Scaffold_03	27939852	27971331	Q80T79	CSMD3_MOUSE	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g068090	Scaffold_03	27978350	27979001	NA	NA	NA	NA	NA
PGEN_.00g068100	Scaffold_03	28014423	28033377	Q5ZK88	PSPC1_CHICK	Paraspeckle component 1	GO:0000976; GO:0001650; GO:0002218; GO:0003723; GO:0005634; GO:0005737; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0045892; GO:0048511; GO:0070888	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; E-box binding [GO:0070888]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]"
PGEN_.00g068110	Scaffold_03	28043733	28051399	Q99417	MYCBP_HUMAN	c-Myc-binding protein (Associate of Myc 1) (AMY-1)	GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006355; GO:0007283	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"
PGEN_.00g068120	Scaffold_03	28053437	28117180	Q13315	ATM_HUMAN	Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated)	GO:0000077; GO:0000723; GO:0000724; GO:0000729; GO:0001541; GO:0001666; GO:0001756; GO:0002331; GO:0002377; GO:0003677; GO:0004674; GO:0004677; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005730; GO:0005819; GO:0006260; GO:0006303; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0007050; GO:0007094; GO:0007131; GO:0007140; GO:0007143; GO:0007165; GO:0007420; GO:0007507; GO:0008340; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0010628; GO:0016303; GO:0016572; GO:0018105; GO:0030335; GO:0030889; GO:0031410; GO:0032210; GO:0032212; GO:0033129; GO:0033151; GO:0035264; GO:0036289; GO:0042159; GO:0042802; GO:0042981; GO:0043065; GO:0043231; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0045785; GO:0045944; GO:0046777; GO:0047485; GO:0048538; GO:0048599; GO:0051402; GO:0071044; GO:0071300; GO:0071480; GO:0071481; GO:0071500; GO:0072434; GO:0090399; GO:0097694; GO:0097695; GO:1900034; GO:1901796; GO:1903626; GO:1903978; GO:1904262; GO:1904354; GO:1904358; GO:1904884; GO:1905843; GO:1990391	"cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; DNA repair complex [GO:1990391]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; immunoglobulin production [GO:0002377]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic spindle assembly checkpoint [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to gamma radiation [GO:1905843]; regulation of cellular response to heat [GO:1900034]; regulation of microglial cell activation [GO:1903978]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; signal transduction involved in mitotic G2 DNA damage checkpoint [GO:0072434]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]"
PGEN_.00g068130	Scaffold_03	28129187	28154238	Q6PQD5	ATM_PIG	Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated homolog) (A-T mutated homolog)	GO:0000077; GO:0000723; GO:0002331; GO:0003677; GO:0003735; GO:0004674; GO:0005524; GO:0005634; GO:0005840; GO:0006281; GO:0006412; GO:0006468; GO:0006974; GO:0006975; GO:0007094; GO:0008630; GO:0010212; GO:0016303; GO:0016572; GO:0031410; GO:0046777; GO:0047485; GO:0071044; GO:1904262	cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; ribosome [GO:0005840]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of ribosome [GO:0003735]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA repair [GO:0006281]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of TORC1 signaling [GO:1904262]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]; translation [GO:0006412]
PGEN_.00g068140	Scaffold_03	28231802	28232407	NA	NA	NA	NA	NA
PGEN_.00g068150	Scaffold_03	28283731	28284640	NA	NA	NA	NA	NA
PGEN_.00g068160	Scaffold_03	28336827	28356661	Q9R0N4	SYT10_MOUSE	Synaptotagmin-10 (Synaptotagmin X) (SytX)	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030658; GO:0042802; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0071277; GO:0098793	"exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g068170	Scaffold_03	28436736	28441558	NA	NA	NA	NA	NA
PGEN_.00g068180	Scaffold_03	28449604	28450488	NA	NA	NA	NA	NA
PGEN_.00g068190	Scaffold_03	28463731	28464609	NA	NA	NA	NA	NA
PGEN_.00g068200	Scaffold_03	28470690	28471280	NA	NA	NA	NA	NA
PGEN_.00g068210	Scaffold_03	28478898	28479173	NA	NA	NA	NA	NA
PGEN_.00g068220	Scaffold_03	28481516	28483999	NA	NA	NA	NA	NA
PGEN_.00g068230	Scaffold_03	28491795	28495375	NA	NA	NA	NA	NA
PGEN_.00g068240	Scaffold_03	28497078	28519056	NA	NA	NA	NA	NA
PGEN_.00g068250	Scaffold_03	28525736	28528201	NA	NA	NA	NA	NA
PGEN_.00g068260	Scaffold_03	28565980	28579500	C1C4R8	BDH2_LITCT	3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase)	GO:0003858; GO:0005737; GO:0016628; GO:0019290; GO:0042168; GO:0055072	"cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]"
PGEN_.00g068270	Scaffold_03	28583959	28588977	Q5RD64	CNTP2_PONAB	Contactin-associated protein-like 2	GO:0007155; GO:0016021; GO:0033010; GO:0044224; GO:0048812; GO:0071205	integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; paranodal junction [GO:0033010]; cell adhesion [GO:0007155]; neuron projection morphogenesis [GO:0048812]; protein localization to juxtaparanode region of axon [GO:0071205]
PGEN_.00g068280	Scaffold_03	28594794	28620373	Q802D3	XPO4_DANRE	Exportin-4	GO:0005049; GO:0005643; GO:0005737; GO:0006611	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nuclear export signal receptor activity [GO:0005049]; protein export from nucleus [GO:0006611]
PGEN_.00g068290	Scaffold_03	28626145	28634105	Q8NER1	TRPV1_HUMAN	Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1)	GO:0000122; GO:0001660; GO:0001774; GO:0002024; GO:0002790; GO:0003085; GO:0004888; GO:0005216; GO:0005230; GO:0005231; GO:0005262; GO:0005516; GO:0005524; GO:0005623; GO:0005739; GO:0005829; GO:0005886; GO:0005887; GO:0006629; GO:0007166; GO:0007635; GO:0009897; GO:0010459; GO:0010917; GO:0014047; GO:0015278; GO:0016021; GO:0017081; GO:0030054; GO:0031226; GO:0032591; GO:0034605; GO:0035091; GO:0042802; GO:0043025; GO:0043065; GO:0043434; GO:0045211; GO:0045429; GO:0046872; GO:0048266; GO:0050954; GO:0050955; GO:0050960; GO:0050965; GO:0050968; GO:0051219; GO:0051289; GO:0060083; GO:0060454; GO:0070588; GO:0071312; GO:0071318; GO:0071356; GO:0071468; GO:0071502; GO:0090212; GO:0097603; GO:0098703; GO:1901594; GO:1990090	cell [GO:0005623]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendritic spine membrane [GO:0032591]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; chloride channel regulator activity [GO:0017081]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular ligand-gated ion channel activity [GO:0005230]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphoprotein binding [GO:0051219]; temperature-gated ion channel activity [GO:0097603]; transmembrane signaling receptor activity [GO:0004888]; behavioral response to pain [GO:0048266]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to acidic pH [GO:0071468]; cellular response to alkaloid [GO:0071312]; cellular response to ATP [GO:0071318]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to temperature stimulus [GO:0071502]; cellular response to tumor necrosis factor [GO:0071356]; chemosensory behavior [GO:0007635]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; diet induced thermogenesis [GO:0002024]; fever generation [GO:0001660]; glutamate secretion [GO:0014047]; lipid metabolic process [GO:0006629]; microglial cell activation [GO:0001774]; negative regulation of establishment of blood-brain barrier [GO:0090212]; negative regulation of heart rate [GO:0010459]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptide secretion [GO:0002790]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein homotetramerization [GO:0051289]; response to capsazepine [GO:1901594]; response to peptide hormone [GO:0043434]; sensory perception of mechanical stimulus [GO:0050954]; smooth muscle contraction involved in micturition [GO:0060083]; thermoception [GO:0050955]
PGEN_.00g068300	Scaffold_03	28680579	28695709	Q95LD9	AHR_DELLE	Aryl hydrocarbon receptor (Ah receptor) (AhR)	GO:0003700; GO:0005634; GO:0005737; GO:0006805; GO:0007049; GO:0032922; GO:0034751; GO:0045892; GO:0045893; GO:0046983; GO:0070888	"aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; cell cycle [GO:0007049]; circadian regulation of gene expression [GO:0032922]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g068310	Scaffold_03	28731630	28731899	NA	NA	NA	NA	NA
PGEN_.00g068320	Scaffold_03	28739886	28740161	NA	NA	NA	NA	NA
PGEN_.00g068330	Scaffold_03	28799267	28823650	Q92734	TFG_HUMAN	Protein TFG (TRK-fused gene protein)	GO:0000139; GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0043231; GO:0048208; GO:0070971	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]
PGEN_.00g068340	Scaffold_03	28835212	28838614	Q8K2J9	BTBD6_MOUSE	BTB/POZ domain-containing protein 6	GO:0005829; GO:0022008	cytosol [GO:0005829]; neurogenesis [GO:0022008]
PGEN_.00g068350	Scaffold_03	28842802	28854648	A1L1W9	MOT10_DANRE	Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)	GO:0005887; GO:0008028; GO:0015173; GO:0015349	integral component of plasma membrane [GO:0005887]; aromatic amino acid transmembrane transporter activity [GO:0015173]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; thyroid hormone transmembrane transporter activity [GO:0015349]
PGEN_.00g068360	Scaffold_03	28862969	28863253	NA	NA	NA	NA	NA
PGEN_.00g068370	Scaffold_03	28866259	28866531	NA	NA	NA	NA	NA
PGEN_.00g068380	Scaffold_03	28892219	28900572	P23654	NRT_DROME	Neurotactin	GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007409; GO:0007411; GO:0007413; GO:0007417; GO:0016021; GO:0016323; GO:0052689	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]
PGEN_.00g068390	Scaffold_03	28908300	28908857	NA	NA	NA	NA	NA
PGEN_.00g068400	Scaffold_03	28919270	28920148	NA	NA	NA	NA	NA
PGEN_.00g068410	Scaffold_03	28945791	28953929	NA	NA	NA	NA	NA
PGEN_.00g068420	Scaffold_03	28960627	28966225	Q8GUQ8	XDH1_ARATH	Xanthine dehydrogenase 1 (AtXDH1) (EC 1.17.1.4)	GO:0000302; GO:0004854; GO:0005506; GO:0005829; GO:0005886; GO:0006145; GO:0009055; GO:0009414; GO:0042554; GO:0046110; GO:0051537; GO:0071949	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; xanthine dehydrogenase activity [GO:0004854]; purine nucleobase catabolic process [GO:0006145]; response to reactive oxygen species [GO:0000302]; response to water deprivation [GO:0009414]; superoxide anion generation [GO:0042554]; xanthine metabolic process [GO:0046110]"
PGEN_.00g068430	Scaffold_03	29010755	29049122	F4JLI5	XDH2_ARATH	Xanthine dehydrogenase 2 (AtXDH2) (EC 1.17.1.4)	GO:0004854; GO:0005506; GO:0005886; GO:0009055; GO:0046110; GO:0051537; GO:0071949	"plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; xanthine dehydrogenase activity [GO:0004854]; xanthine metabolic process [GO:0046110]"
PGEN_.00g068440	Scaffold_03	29065724	29111157	NA	NA	NA	NA	NA
PGEN_.00g068450	Scaffold_03	29116573	29119045	NA	NA	NA	NA	NA
PGEN_.00g068460	Scaffold_03	29119126	29133511	Q9P2F9	ZN319_HUMAN	Zinc finger protein 319	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g068470	Scaffold_03	29156474	29200643	Q9VN14	CONT_DROME	Contactin	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]
PGEN_.00g068480	Scaffold_03	29201293	29216174	O35490	BHMT1_MOUSE	Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)	GO:0005829; GO:0006479; GO:0006577; GO:0006579; GO:0008168; GO:0008270; GO:0009086; GO:0032991; GO:0044877; GO:0047150; GO:0070062; GO:0071267	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]
PGEN_.00g068490	Scaffold_03	29232843	29248691	Q9BTX7	TTPAL_HUMAN	Alpha-tocopherol transfer protein-like	GO:0016020	membrane [GO:0016020]
PGEN_.00g068500	Scaffold_03	29255176	29264841	Q03567	SL172_CAEEL	Uncharacterized transporter slc-17.2	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g068510	Scaffold_03	29272677	29283768	P52899	ODPA_CAEEL	"Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)"	GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]
PGEN_.00g068520	Scaffold_03	29300884	29301393	NA	NA	NA	NA	NA
PGEN_.00g068530	Scaffold_03	29301470	29303072	NA	NA	NA	NA	NA
PGEN_.00g068540	Scaffold_03	29304721	29305074	NA	NA	NA	NA	NA
PGEN_.00g068550	Scaffold_03	29306267	29306695	NA	NA	NA	NA	NA
PGEN_.00g068560	Scaffold_03	29307187	29308115	NA	NA	NA	NA	NA
PGEN_.00g068570	Scaffold_03	29308550	29309230	NA	NA	NA	NA	NA
PGEN_.00g068580	Scaffold_03	29333052	29340137	P52899	ODPA_CAEEL	"Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)"	GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]
PGEN_.00g068590	Scaffold_03	29340526	29342996	P52902	ODPA_PEA	"Pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)"	GO:0004739; GO:0005759; GO:0006086; GO:0006096	mitochondrial matrix [GO:0005759]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]
PGEN_.00g068600	Scaffold_03	29362295	29388815	NA	NA	NA	NA	NA
PGEN_.00g068610	Scaffold_03	29395970	29405706	Q8BGC0	HTSF1_MOUSE	HIV Tat-specific factor 1 homolog	GO:0000398; GO:0003723; GO:0005654; GO:0005684; GO:0005686	"nucleoplasm [GO:0005654]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g068620	Scaffold_03	29408882	29411338	Q9UGM6	SYWM_HUMAN	"Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS)"	GO:0001570; GO:0004830; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006418; GO:0006436; GO:0070183	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]; mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]; vasculogenesis [GO:0001570]
PGEN_.00g068630	Scaffold_03	29411867	29412712	NA	NA	NA	NA	NA
PGEN_.00g068640	Scaffold_03	29429491	29434690	Q874B9	EF2_PICPA	Elongation factor 2 (EF-2)	GO:0003746; GO:0003924; GO:0005525; GO:0005737	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]
PGEN_.00g068650	Scaffold_03	29439382	29439642	NA	NA	NA	NA	NA
PGEN_.00g068660	Scaffold_03	29439674	29442375	NA	NA	NA	NA	NA
PGEN_.00g068670	Scaffold_03	29454775	29455158	NA	NA	NA	NA	NA
PGEN_.00g068680	Scaffold_03	29458858	29464104	NA	NA	NA	NA	NA
PGEN_.00g068690	Scaffold_03	29471452	29474462	NA	NA	NA	NA	NA
PGEN_.00g068700	Scaffold_03	29478495	29512506	Q149N8	SHPRH_HUMAN	"E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)"	GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0031625; GO:0046872; GO:0061630	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]
PGEN_.00g068710	Scaffold_03	29523699	29524618	NA	NA	NA	NA	NA
PGEN_.00g068720	Scaffold_03	29524834	29525839	NA	NA	NA	NA	NA
PGEN_.00g068730	Scaffold_03	29532069	29536009	Q53H80	AKIR2_HUMAN	Akirin-2	GO:0000122; GO:0005634; GO:0005654; GO:0008284; GO:0009792; GO:0010950; GO:0017053; GO:0019899; GO:0032496; GO:0032755; GO:0045087; GO:0045944	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; enzyme binding [GO:0019899]; embryo development ending in birth or egg hatching [GO:0009792]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]
PGEN_.00g068740	Scaffold_03	29546183	29566176	NA	NA	NA	NA	NA
PGEN_.00g068750	Scaffold_03	29577214	29601422	Q640N2	AR13B_MOUSE	ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein hennin)	GO:0001947; GO:0005525; GO:0005929; GO:0005930; GO:0007224; GO:0007368; GO:0009953; GO:0010226; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0060170; GO:0060271; GO:0070986; GO:0097500; GO:0097730; GO:1905515	axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; GTP binding [GO:0005525]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224]
PGEN_.00g068760	Scaffold_03	29608103	29608503	NA	NA	NA	NA	NA
PGEN_.00g068770	Scaffold_03	29610135	29640260	NA	NA	NA	NA	NA
PGEN_.00g068780	Scaffold_03	29659552	29667868	NA	NA	NA	NA	NA
PGEN_.00g068790	Scaffold_03	29668378	29678333	NA	NA	NA	NA	NA
PGEN_.00g068800	Scaffold_03	29678384	29679199	NA	NA	NA	NA	NA
PGEN_.00g068810	Scaffold_03	29779241	29814809	Q9NTJ4	MA2C1_HUMAN	Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)	GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]
PGEN_.00g068820	Scaffold_03	29867296	29893309	Q91W89	MA2C1_MOUSE	Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1) (Neutral/cytosolic alpha-mannosidase)	GO:0004559; GO:0005654; GO:0005737; GO:0006013; GO:0009313; GO:0030246; GO:0046872	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]
PGEN_.00g068830	Scaffold_03	29927288	29928741	Q8IY51	TIGD4_HUMAN	Tigger transposable element-derived protein 4	GO:0003677; GO:0005634	nucleus [GO:0005634]; DNA binding [GO:0003677]
PGEN_.00g068840	Scaffold_03	29961163	29962029	NA	NA	NA	NA	NA
PGEN_.00g068850	Scaffold_03	30008119	30008721	NA	NA	NA	NA	NA
PGEN_.00g068860	Scaffold_03	30035360	30096671	Q8ITC7	CAPAR_DROME	Neuropeptides capa receptor (Cap2b receptor) (Capability receptor)	GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]
PGEN_.00g068870	Scaffold_03	30103586	30134629	Q80T79	CSMD3_MOUSE	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g068880	Scaffold_03	30156236	30160000	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g068890	Scaffold_03	30262310	30304421	P41823	SY65_APLCA	Synaptotagmin-1 (Synaptotagmin I) (p65)	GO:0000149; GO:0005509; GO:0005544; GO:0016079; GO:0030054; GO:0030285; GO:0045955	cell junction [GO:0030054]; integral component of synaptic vesicle membrane [GO:0030285]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; synaptic vesicle exocytosis [GO:0016079]
PGEN_.00g068900	Scaffold_03	30271948	30279744	NA	NA	NA	NA	NA
PGEN_.00g068910	Scaffold_03	30388990	30422785	Q28BK1	HACE1_XENTR	E3 ubiquitin-protein ligase HACE1 (EC 2.3.2.26) (HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1) (HECT-type E3 ubiquitin transferase HACE1)	GO:0000139; GO:0000209; GO:0004842; GO:0005737; GO:0005783; GO:0006511; GO:0007030; GO:0007049; GO:0016567; GO:0017137; GO:0030334; GO:0032580; GO:0043161; GO:0045732; GO:0061025; GO:0061630; GO:0070936	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g068920	Scaffold_03	30478522	30480216	Q9ULV1	FZD4_HUMAN	Frizzled-4 (Fz-4) (hFz4) (FzE4) (CD antigen CD344)	GO:0001540; GO:0001570; GO:0004896; GO:0004930; GO:0005886; GO:0005887; GO:0005911; GO:0007223; GO:0007605; GO:0009986; GO:0010812; GO:0016055; GO:0017147; GO:0019955; GO:0030165; GO:0030182; GO:0030425; GO:0030665; GO:0030669; GO:0030947; GO:0031625; GO:0031987; GO:0034446; GO:0035426; GO:0035567; GO:0038023; GO:0042701; GO:0042803; GO:0042813; GO:0043507; GO:0044877; GO:0045893; GO:0046982; GO:0051091; GO:0060070; GO:0060071; GO:0061024; GO:0061299; GO:0061301; GO:0061304; GO:0071300; GO:0098978; GO:0110135; GO:0150012; GO:1990830	"cell surface [GO:0009986]; cell-cell junction [GO:0005911]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to retinoic acid [GO:0071300]; cerebellum vasculature morphogenesis [GO:0061301]; extracellular matrix-cell signaling [GO:0035426]; locomotion involved in locomotory behavior [GO:0031987]; membrane organization [GO:0061024]; negative regulation of cell-substrate adhesion [GO:0010812]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; Norrin signaling pathway [GO:0110135]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone secretion [GO:0042701]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g068930	Scaffold_03	30497328	30497675	NA	NA	NA	NA	NA
PGEN_.00g068940	Scaffold_03	30558088	30559203	NA	NA	NA	NA	NA
PGEN_.00g068950	Scaffold_03	30577439	30718554	Q86UB9	TM135_HUMAN	Transmembrane protein 135 (Peroxisomal membrane protein 52) (PMP52)	GO:0005777; GO:0005778; GO:0005811; GO:0007031; GO:0009409; GO:0016021; GO:0031966; GO:0032094; GO:0090140	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; peroxisome organization [GO:0007031]; regulation of mitochondrial fission [GO:0090140]; response to cold [GO:0009409]; response to food [GO:0032094]
PGEN_.00g068960	Scaffold_03	30729923	30749501	NA	NA	NA	NA	NA
PGEN_.00g068970	Scaffold_03	30763489	30779371	Q9D6I3	PROF4_MOUSE	Profilin-4 (Profilin IV)	GO:0003785; GO:0005623; GO:0005856; GO:0005938; GO:0008289; GO:0042989	cell [GO:0005623]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; actin monomer binding [GO:0003785]; lipid binding [GO:0008289]; sequestering of actin monomers [GO:0042989]
PGEN_.00g068980	Scaffold_03	30786130	30792913	Q8BXK9	CLIC5_MOUSE	Chloride intracellular channel protein 5	GO:0002021; GO:0002024; GO:0005244; GO:0005254; GO:0005634; GO:0005794; GO:0005815; GO:0005938; GO:0006821; GO:0007601; GO:0007605; GO:0008104; GO:0015629; GO:0016324; GO:0032420; GO:0032421; GO:0034707; GO:0034765; GO:0050885; GO:0060088	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; chloride channel complex [GO:0034707]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; auditory receptor cell stereocilium organization [GO:0060088]; chloride transport [GO:0006821]; diet induced thermogenesis [GO:0002024]; neuromuscular process controlling balance [GO:0050885]; protein localization [GO:0008104]; regulation of ion transmembrane transport [GO:0034765]; response to dietary excess [GO:0002021]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g068990	Scaffold_03	30799245	30801106	NA	NA	NA	NA	NA
PGEN_.00g069000	Scaffold_03	30810611	30841514	P36021	MOT8_HUMAN	Monocarboxylate transporter 8 (MCT 8) (Monocarboxylate transporter 7) (MCT 7) (Solute carrier family 16 member 2) (X-linked PEST-containing transporter)	GO:0005215; GO:0005886; GO:0005887; GO:0006590; GO:0008028; GO:0015293; GO:0015349; GO:0015718; GO:0043252; GO:0070327; GO:0070460	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; thyroid hormone transmembrane transporter activity [GO:0015349]; transporter activity [GO:0005215]; monocarboxylic acid transport [GO:0015718]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone generation [GO:0006590]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460]
PGEN_.00g069010	Scaffold_03	30881386	30887115	NA	NA	NA	NA	NA
PGEN_.00g069020	Scaffold_03	30888413	30894768	NA	NA	NA	NA	NA
PGEN_.00g069030	Scaffold_03	30897478	30932588	NA	NA	NA	NA	NA
PGEN_.00g069040	Scaffold_03	30937657	30947012	Q921W4	QORL1_MOUSE	Quinone oxidoreductase-like protein 1 (EC 1.-.-.-) (Quinone oxidoreductase homolog 1) (QOH-1) (Zeta-crystallin homolog)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g069050	Scaffold_03	30951077	30987421	Q9Z0R4	ITSN1_MOUSE	Intersectin-1 (EH and SH3 domains protein 1)	GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0007264; GO:0007420; GO:0015031; GO:0019209; GO:0030027; GO:0030054; GO:0030139; GO:0034613; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0045202; GO:0048488; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098871; GO:0098978; GO:1905274; GO:2001288	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g069060	Scaffold_03	31011364	31024704	Q15811	ITSN1_HUMAN	Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17)	GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0007186; GO:0007264; GO:0007420; GO:0015031; GO:0016032; GO:0019209; GO:0030027; GO:0030054; GO:0030139; GO:0034613; GO:0043025; GO:0043065; GO:0043197; GO:0043524; GO:0044305; GO:0048013; GO:0048488; GO:0051056; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0061024; GO:0070064; GO:0097440; GO:0098833; GO:0098871; GO:0098978; GO:1905274; GO:2001288	apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic endocytic zone [GO:0098833]; recycling endosome [GO:0055037]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; ephrin receptor signaling pathway [GO:0048013]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; membrane organization [GO:0061024]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of apoptotic process [GO:0043065]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]; viral process [GO:0016032]
PGEN_.00g069070	Scaffold_03	31063574	31071031	Q1JQB2	BUB3_BOVIN	Mitotic checkpoint protein BUB3	GO:0000070; GO:0000776; GO:0000777; GO:0005654; GO:0007094; GO:0008608; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:0051983; GO:1990298	bub1-bub3 complex [GO:1990298]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; ubiquitin binding [GO:0043130]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983]
PGEN_.00g069080	Scaffold_03	31081517	31100074	Q5H9S7	DCA17_HUMAN	DDB1- and CUL4-associated factor 17	GO:0005654; GO:0005730; GO:0005829; GO:0016021; GO:0016567; GO:0043687; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]
PGEN_.00g069090	Scaffold_03	31116387	31124757	O15990	KARG_LIOJA	Arginine kinase (AK) (EC 2.7.3.3)	GO:0004054; GO:0004111; GO:0005524; GO:0046314	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]
PGEN_.00g069100	Scaffold_03	31151529	31152680	Q8N695	SC5A8_HUMAN	Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)	GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]
PGEN_.00g069110	Scaffold_03	31217397	31309686	P39060	COIA1_HUMAN	Collagen alpha-1(XVIII) chain [Cleaved into: Endostatin; Non-collagenous domain 1 (NC1)]	GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0007601; GO:0008284; GO:0008285; GO:0009887; GO:0030198; GO:0030335; GO:0031012; GO:0042493; GO:0042802; GO:0046872; GO:0051599; GO:0062023; GO:0070062; GO:2000353	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; response to drug [GO:0042493]; response to hydrostatic pressure [GO:0051599]; visual perception [GO:0007601]
PGEN_.00g069120	Scaffold_03	31321339	31331259	Q01714	SP1_RAT	Transcription factor Sp1	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001103; GO:0001228; GO:0001503; GO:0001701; GO:0001829; GO:0001889; GO:0001892; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008022; GO:0008134; GO:0010628; GO:0017053; GO:0030219; GO:0030324; GO:0032869; GO:0032993; GO:0033194; GO:0035035; GO:0035326; GO:0042789; GO:0042803; GO:0042826; GO:0043353; GO:0043425; GO:0043536; GO:0043565; GO:0043923; GO:0044212; GO:0045766; GO:0045893; GO:0045944; GO:0046872; GO:0048511; GO:0048596; GO:0048706; GO:0060136; GO:0060216; GO:0070491; GO:0071837; GO:1904828; GO:1905564	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcriptional repressor complex [GO:0017053]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; enhancer binding [GO:0035326]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cellular response to insulin stimulus [GO:0032869]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; mRNA transcription by RNA polymerase II [GO:0042789]; ossification [GO:0001503]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]; trophectodermal cell differentiation [GO:0001829]"
PGEN_.00g069130	Scaffold_03	31335935	31350223	NA	NA	NA	NA	NA
PGEN_.00g069140	Scaffold_03	31366411	31369017	NA	NA	NA	NA	NA
PGEN_.00g069150	Scaffold_03	31383022	31418831	Q9UPV9	TRAK1_HUMAN	Trafficking kinesin-binding protein 1 (106 kDa O-GlcNAc transferase-interacting protein) (Protein Milton)	GO:0005102; GO:0005623; GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005938; GO:0006357; GO:0006493; GO:0006605; GO:0008089; GO:0008104; GO:0008333; GO:0017022; GO:0022008; GO:0030425; GO:0030911; GO:0031410; GO:0031966; GO:0044295; GO:0047496; GO:0048311; GO:0048471; GO:0048813; GO:0050772; GO:0050811; GO:0098957; GO:1904115	axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; cell [GO:0005623]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; TPR domain binding [GO:0030911]; anterograde axonal transport [GO:0008089]; anterograde axonal transport of mitochondrion [GO:0098957]; dendrite morphogenesis [GO:0048813]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; positive regulation of axonogenesis [GO:0050772]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; protein targeting [GO:0006605]; regulation of transcription by RNA polymerase II [GO:0006357]; vesicle transport along microtubule [GO:0047496]
PGEN_.00g069160	Scaffold_03	31442932	31443757	NA	NA	NA	NA	NA
PGEN_.00g069170	Scaffold_03	31444005	31444679	NA	NA	NA	NA	NA
PGEN_.00g069180	Scaffold_03	31453096	31485480	Q6NYL3	ECHP_DANRE	"Peroxisomal bifunctional enzyme (PBE) (PBFE) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]"	GO:0003857; GO:0004165; GO:0004300; GO:0005777; GO:0006635	peroxisome [GO:0005777]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]
PGEN_.00g069190	Scaffold_03	31505174	31509895	B0CMA4	INSI2_CALJA	Insulin-induced gene 2 protein (INSIG-2)	GO:0005789; GO:0008203; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cholesterol metabolic process [GO:0008203]
PGEN_.00g069200	Scaffold_03	31521134	31538670	P46336	IOLS_BACSU	Aldo-keto reductase IolS (EC 1.1.1.-) (AKR11A) (Vegetative protein 147) (VEG147)	GO:0005829; GO:0016491	cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]
PGEN_.00g069210	Scaffold_03	31546607	31552450	F1LMZ8	PSD11_RAT	26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6)	GO:0000502; GO:0005198; GO:0005634; GO:0005829; GO:0005838; GO:0006511; GO:0008541; GO:0022624; GO:0043248; GO:0048863	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; proteasome assembly [GO:0043248]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g069220	Scaffold_03	31559792	31560298	NA	NA	NA	NA	NA
PGEN_.00g069230	Scaffold_03	31562364	31563656	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g069240	Scaffold_03	31573217	31573759	Q28199	CD5R1_BOVIN	"Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)]"	GO:0001764; GO:0002020; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0007158; GO:0007213; GO:0007411; GO:0007413; GO:0007420; GO:0009792; GO:0014069; GO:0016020; GO:0016301; GO:0016533; GO:0018107; GO:0019901; GO:0021549; GO:0021722; GO:0021766; GO:0021819; GO:0030182; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0031116; GO:0031175; GO:0031594; GO:0032956; GO:0035235; GO:0035255; GO:0042501; GO:0043005; GO:0043014; GO:0043025; GO:0043197; GO:0043204; GO:0043292; GO:0043525; GO:0043539; GO:0045296; GO:0045892; GO:0048013; GO:0048471; GO:0048487; GO:0048511; GO:0051015; GO:0061001; GO:0061575; GO:0071158; GO:0090314	"axon [GO:0030424]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein kinase 5 complex [GO:0016533]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; negative regulation of axon extension [GO:0030517]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; rhythmic process [GO:0048511]; serine phosphorylation of STAT protein [GO:0042501]; superior olivary nucleus maturation [GO:0021722]"
PGEN_.00g069250	Scaffold_03	31599884	31604038	L0R8F8	MIDUO_HUMAN	MIEF1 upstream open reading frame protein (Alternative MIEF1 protein) (AltMIEF1) (MIEF1 microprotein) (MIEF1-MP)	GO:0005739; GO:0005759; GO:0042254; GO:0070131	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; positive regulation of mitochondrial translation [GO:0070131]; ribosome biogenesis [GO:0042254]
PGEN_.00g069260	Scaffold_03	31605271	31606098	Q502K3	ANR52_DANRE	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C)		
PGEN_.00g069270	Scaffold_03	31695480	31696307	Q502K3	ANR52_DANRE	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C)		
PGEN_.00g069280	Scaffold_03	31697540	31701721	L0R8F8	MIDUO_HUMAN	MIEF1 upstream open reading frame protein (Alternative MIEF1 protein) (AltMIEF1) (MIEF1 microprotein) (MIEF1-MP)	GO:0005739; GO:0005759; GO:0042254; GO:0070131	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; positive regulation of mitochondrial translation [GO:0070131]; ribosome biogenesis [GO:0042254]
PGEN_.00g069290	Scaffold_03	31730296	31730838	Q28199	CD5R1_BOVIN	"Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)]"	GO:0001764; GO:0002020; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0007158; GO:0007213; GO:0007411; GO:0007413; GO:0007420; GO:0009792; GO:0014069; GO:0016020; GO:0016301; GO:0016533; GO:0018107; GO:0019901; GO:0021549; GO:0021722; GO:0021766; GO:0021819; GO:0030182; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0031116; GO:0031175; GO:0031594; GO:0032956; GO:0035235; GO:0035255; GO:0042501; GO:0043005; GO:0043014; GO:0043025; GO:0043197; GO:0043204; GO:0043292; GO:0043525; GO:0043539; GO:0045296; GO:0045892; GO:0048013; GO:0048471; GO:0048487; GO:0048511; GO:0051015; GO:0061001; GO:0061575; GO:0071158; GO:0090314	"axon [GO:0030424]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein kinase 5 complex [GO:0016533]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; negative regulation of axon extension [GO:0030517]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; rhythmic process [GO:0048511]; serine phosphorylation of STAT protein [GO:0042501]; superior olivary nucleus maturation [GO:0021722]"
PGEN_.00g069300	Scaffold_03	31740282	31741574	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g069310	Scaffold_03	31751690	31757533	F1LMZ8	PSD11_RAT	26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6)	GO:0000502; GO:0005198; GO:0005634; GO:0005829; GO:0005838; GO:0006511; GO:0008541; GO:0022624; GO:0043248; GO:0048863	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; proteasome assembly [GO:0043248]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g069320	Scaffold_03	31765587	31782893	P46336	IOLS_BACSU	Aldo-keto reductase IolS (EC 1.1.1.-) (AKR11A) (Vegetative protein 147) (VEG147)	GO:0005829; GO:0016491	cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]
PGEN_.00g069330	Scaffold_03	31794227	31798912	B0CMA4	INSI2_CALJA	Insulin-induced gene 2 protein (INSIG-2)	GO:0005789; GO:0008203; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cholesterol metabolic process [GO:0008203]
PGEN_.00g069340	Scaffold_03	31818849	31850775	Q9DBM2	ECHP_MOUSE	"Peroxisomal bifunctional enzyme (PBE) (PBFE) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]"	GO:0003857; GO:0004165; GO:0004300; GO:0005739; GO:0005777; GO:0005829; GO:0006475; GO:0006635; GO:0006637; GO:0019899	cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; enzyme binding [GO:0019899]; acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation [GO:0006635]; internal protein amino acid acetylation [GO:0006475]
PGEN_.00g069350	Scaffold_03	31882326	31884048	NA	NA	NA	NA	NA
PGEN_.00g069360	Scaffold_03	31886878	31929932	NA	NA	NA	NA	NA
PGEN_.00g069370	Scaffold_03	31931388	31959587	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g069380	Scaffold_03	31971418	31979972	NA	NA	NA	NA	NA
PGEN_.00g069390	Scaffold_03	31989712	31991379	NA	NA	NA	NA	NA
PGEN_.00g069400	Scaffold_03	31997336	32000950	NA	NA	NA	NA	NA
PGEN_.00g069410	Scaffold_03	32101826	32107773	NA	NA	NA	NA	NA
PGEN_.00g069420	Scaffold_03	32107830	32108576	NA	NA	NA	NA	NA
PGEN_.00g069430	Scaffold_03	32112793	32113095	NA	NA	NA	NA	NA
PGEN_.00g069440	Scaffold_03	32157205	32158730	NA	NA	NA	NA	NA
PGEN_.00g069450	Scaffold_03	32158794	32161618	Q7Z5P9	MUC19_HUMAN	Mucin-19 (MUC-19)	GO:0002223; GO:0005576; GO:0005796; GO:0005886; GO:0016266	extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]
PGEN_.00g069460	Scaffold_03	32185233	32186680	Q54TM7	DRKD_DICDI	Probable serine/threonine-protein kinase drkD (EC 2.7.11.1) (Receptor-like kinase D)	GO:0004674; GO:0005524	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g069470	Scaffold_03	32193835	32195755	Q02241	KIF23_HUMAN	Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1)	GO:0000022; GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0006890; GO:0007018; GO:0008017; GO:0016887; GO:0019886; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149	"cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g069480	Scaffold_03	32204560	32204832	NA	NA	NA	NA	NA
PGEN_.00g069490	Scaffold_03	32229001	32231743	P16373	ZFP59_MOUSE	Zinc finger protein 59 (Zfp-59) (Zinc finger protein Mfg-2)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g069500	Scaffold_03	32234120	32234518	NA	NA	NA	NA	NA
PGEN_.00g069510	Scaffold_03	32240381	32240734	NA	NA	NA	NA	NA
PGEN_.00g069520	Scaffold_03	32243097	32250432	NA	NA	NA	NA	NA
PGEN_.00g069530	Scaffold_03	32255249	32255677	NA	NA	NA	NA	NA
PGEN_.00g069540	Scaffold_03	32260597	32260908	NA	NA	NA	NA	NA
PGEN_.00g069550	Scaffold_03	32277176	32277451	NA	NA	NA	NA	NA
PGEN_.00g069560	Scaffold_03	32288684	32301375	NA	NA	NA	NA	NA
PGEN_.00g069570	Scaffold_03	32324323	32324583	NA	NA	NA	NA	NA
PGEN_.00g069580	Scaffold_03	32330021	32330485	NA	NA	NA	NA	NA
PGEN_.00g069590	Scaffold_03	32333181	32346251	Q5U2R1	DLP1_RAT	Decaprenyl-diphosphate synthase subunit 2 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 2) (Decaprenyl pyrophosphate synthase subunit 2)	GO:0000010; GO:0005739; GO:0005829; GO:0006744; GO:0008299; GO:0046982; GO:0050347; GO:0050878; GO:0051290; GO:1990234	cytosol [GO:0005829]; mitochondrion [GO:0005739]; transferase complex [GO:1990234]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]
PGEN_.00g069600	Scaffold_03	32346644	32372356	Q920F5	DCMC_RAT	"Malonyl-CoA decarboxylase, mitochondrial (MCD) (EC 4.1.1.9)"	GO:0002931; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006085; GO:0006633; GO:0010906; GO:0019395; GO:0031998; GO:0042802; GO:0046320; GO:0046321; GO:0050080; GO:2001294	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; acetyl-CoA biosynthetic process [GO:0006085]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]
PGEN_.00g069610	Scaffold_03	32387002	32406962	NA	NA	NA	NA	NA
PGEN_.00g069620	Scaffold_03	32460680	32477054	Q5FVR2	TYPH_RAT	Thymidine phosphorylase (TP) (EC 2.4.2.4) (TdRPase)	GO:0000002; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0009032; GO:0016154; GO:0031641; GO:0042803; GO:0051969; GO:1905333	cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]
PGEN_.00g069630	Scaffold_03	32498902	32500610	NA	NA	NA	NA	NA
PGEN_.00g069640	Scaffold_03	32515913	32542975	NA	NA	NA	NA	NA
PGEN_.00g069650	Scaffold_03	32565337	32573600	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g069660	Scaffold_03	32594585	32616020	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g069670	Scaffold_03	32627500	32629523	NA	NA	NA	NA	NA
PGEN_.00g069680	Scaffold_03	32630238	32633357	NA	NA	NA	NA	NA
PGEN_.00g069690	Scaffold_03	32634144	32636798	NA	NA	NA	NA	NA
PGEN_.00g069700	Scaffold_03	32641953	32642258	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g069710	Scaffold_03	32649287	32660418	Q8R422	CD109_MOUSE	CD109 antigen (GPI-anchored alpha-2 macroglobulin-related protein) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0004867; GO:0005615; GO:0005829; GO:0005886; GO:0010839; GO:0030512; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g069720	Scaffold_03	32661022	32663072	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g069730	Scaffold_03	32663140	32671900	NA	NA	NA	NA	NA
PGEN_.00g069740	Scaffold_03	32680715	32697311	Q5BJS7	CPNE9_RAT	Copine-9 (Copine IX)	GO:0005544; GO:0005886; GO:0071277; GO:1903861	plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]
PGEN_.00g069750	Scaffold_03	32725099	32725401	NA	NA	NA	NA	NA
PGEN_.00g069760	Scaffold_03	32725609	32743283	E7FA21	SMR8A_DANRE	Guanine nucleotide exchange protein smcr8a (Smith-Magenis syndrome chromosomal region candidate gene 8 protein homolog A)	GO:0005085; GO:0005634; GO:0005737; GO:0006914; GO:0032045	cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; autophagy [GO:0006914]
PGEN_.00g069770	Scaffold_03	32758542	32763934	Q3E6S9	CNIF3_ARATH	"Probable L-cysteine desulfhydrase, chloroplastic (EC 4.4.1.-) (Chloroplastic cysteine desulfurase-like protein 3) (NIFS-like protein 3) (CpNifS3)"	GO:0009507; GO:0016829	chloroplast [GO:0009507]; lyase activity [GO:0016829]
PGEN_.00g069780	Scaffold_03	32777421	32785699	B0FPE9	NLRP3_MACMU	"NACHT, LRR and PYD domains-containing protein 3"	GO:0002830; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0006954; GO:0008134; GO:0032753; GO:0043280; GO:0043565; GO:0045087; GO:0045630; GO:0045944; GO:0050718; GO:0072559; GO:1901223; GO:2000553	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; ATP binding [GO:0005524]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]
PGEN_.00g069790	Scaffold_03	32795767	32796790	NA	NA	NA	NA	NA
PGEN_.00g069800	Scaffold_03	32808944	32813094	P0DMN0	ST1A4_HUMAN	Sulfotransferase 1A4 (ST1A4) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Sulfotransferase 1A3/1A4)	GO:0004062; GO:0005829; GO:0006584; GO:0008202; GO:0050427	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]
PGEN_.00g069810	Scaffold_03	32828975	32841806	D5FM38	NAS36_BRUMA	Zinc metalloproteinase nas-36 (EC 3.4.24.-) (Nematode astacin 36)	GO:0004222; GO:0005576; GO:0008270; GO:0018996	"extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle, collagen and cuticulin-based cuticle [GO:0018996]"
PGEN_.00g069820	Scaffold_03	32853412	32856342	NA	NA	NA	NA	NA
PGEN_.00g069830	Scaffold_03	32866465	32866914	NA	NA	NA	NA	NA
PGEN_.00g069840	Scaffold_03	32872130	32888396	NA	NA	NA	NA	NA
PGEN_.00g069850	Scaffold_03	32894482	32895615	B2GV91	LYRM2_RAT	LYR motif-containing protein 2		
PGEN_.00g069860	Scaffold_03	32899283	32901091	NA	NA	NA	NA	NA
PGEN_.00g069870	Scaffold_03	32918963	32934808	NA	NA	NA	NA	NA
PGEN_.00g069880	Scaffold_03	32957686	32964133	NA	NA	NA	NA	NA
PGEN_.00g069890	Scaffold_03	32970289	32970807	NA	NA	NA	NA	NA
PGEN_.00g069900	Scaffold_03	32984350	32990463	NA	NA	NA	NA	NA
PGEN_.00g069910	Scaffold_03	33003978	33010278	NA	NA	NA	NA	NA
PGEN_.00g069920	Scaffold_03	33016683	33054809	B4F7A7	CEP57_RAT	Centrosomal protein of 57 kDa (Cep57) (Translokin)	GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034453; GO:0042803; GO:0043015; GO:0051260	centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; fibroblast growth factor receptor signaling pathway [GO:0008543]; microtubule anchoring [GO:0034453]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286]
PGEN_.00g069930	Scaffold_03	33068146	33084437	P55745	RAB21_CANLF	Ras-related protein Rab-21	GO:0000139; GO:0003924; GO:0005525; GO:0005769; GO:0005789; GO:0006886; GO:0019003; GO:0030659; GO:0031901; GO:0032154; GO:0032482; GO:0043005	cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g069940	Scaffold_03	33084804	33103175	Q9CXF4	TBC15_MOUSE	TBC1 domain family member 15 (GTPase-activating protein RAB7) (GAP for RAB7) (Rab7-GAP)	GO:0005096; GO:0005576; GO:0005737; GO:0005739; GO:0006886; GO:0017137; GO:0043087; GO:0090630	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]
PGEN_.00g069950	Scaffold_03	33121469	33164706	Q9JKK0	RCAN3_MOUSE	Calcipressin-3 (Down syndrome candidate region 1-like protein 2) (Myocyte-enriched calcineurin-interacting protein 3) (MCIP3) (Regulator of calcineurin 3)	GO:0003676; GO:0005737; GO:0008597; GO:0019722; GO:0019902; GO:0031013; GO:0070884	cytoplasm [GO:0005737]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; nucleic acid binding [GO:0003676]; phosphatase binding [GO:0019902]; troponin I binding [GO:0031013]; calcium-mediated signaling [GO:0019722]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]
PGEN_.00g069960	Scaffold_03	33188495	33191971	NA	NA	NA	NA	NA
PGEN_.00g069970	Scaffold_03	33210078	33211910	NA	NA	NA	NA	NA
PGEN_.00g069980	Scaffold_03	33229571	33240435	NA	NA	NA	NA	NA
PGEN_.00g069990	Scaffold_03	33253948	33302796	Q9V5N8	STAN_DROME	Protocadherin-like wing polarity protein stan (Protein flamingo) (Protein starry night)	GO:0001736; GO:0001738; GO:0004888; GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007367; GO:0007409; GO:0007411; GO:0007464; GO:0016021; GO:0016318; GO:0016319; GO:0016324; GO:0016339; GO:0016358; GO:0035159; GO:0042067; GO:0045773; GO:0048057; GO:0048813; GO:0050770; GO:0050839; GO:0051963; GO:0060071; GO:0070593; GO:0090175; GO:0098609; GO:1902669	"apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of a polarized epithelium [GO:0001738]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; R3/R4 cell fate commitment [GO:0007464]; R3/R4 development [GO:0048057]; regulation of axonogenesis [GO:0050770]; regulation of establishment of planar polarity [GO:0090175]; regulation of synapse assembly [GO:0051963]; regulation of tube length, open tracheal system [GO:0035159]; segment polarity determination [GO:0007367]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g070000	Scaffold_03	33355559	33356461	NA	NA	NA	NA	NA
PGEN_.00g070010	Scaffold_03	33364059	33380715	NA	NA	NA	NA	NA
PGEN_.00g070020	Scaffold_03	33379400	33380368	NA	NA	NA	NA	NA
PGEN_.00g070030	Scaffold_03	33442729	33444331	NA	NA	NA	NA	NA
PGEN_.00g070040	Scaffold_03	33449408	33481486	Q9U943	APLP_LOCMI	Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]	GO:0005319; GO:0005576; GO:0008289; GO:0016055	extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]
PGEN_.00g070050	Scaffold_03	33507742	33522314	NA	NA	NA	NA	NA
PGEN_.00g070060	Scaffold_03	33536081	33558998	Q10741	ADA10_BOVIN	Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (Myelin-associated metalloproteinase) (CD antigen CD156c)	GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034612; GO:0042117; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]
PGEN_.00g070070	Scaffold_03	33571851	33595441	P53352	INCE_CHICK	Inner centromere protein	GO:0000070; GO:0000281; GO:0000775; GO:0000777; GO:0005634; GO:0005721; GO:0005737; GO:0005819; GO:0005874; GO:0007059; GO:0030496; GO:0032991; GO:1902412	"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412]"
PGEN_.00g070080	Scaffold_03	33599005	33599229	NA	NA	NA	NA	NA
PGEN_.00g070090	Scaffold_03	33600666	33617396	P62071	RRAS2_MOUSE	Ras-related protein R-Ras2	GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0009987; GO:0019003; GO:0030335; GO:1901214	plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular process [GO:0009987]; positive regulation of cell migration [GO:0030335]; Ras protein signal transduction [GO:0007265]; regulation of neuron death [GO:1901214]
PGEN_.00g070100	Scaffold_03	33638530	33644035	NA	NA	NA	NA	NA
PGEN_.00g070110	Scaffold_03	33651551	33653170	NA	NA	NA	NA	NA
PGEN_.00g070120	Scaffold_03	33668573	33670312	Q8IYB1	M21D2_HUMAN	Protein MB21D2 (Mab-21 domain-containing protein 2)	GO:0044877; GO:0045296	cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]
PGEN_.00g070130	Scaffold_03	33678845	33680596	NA	NA	NA	NA	NA
PGEN_.00g070140	Scaffold_03	33691232	33735876	Q0VCJ7	RERG_BOVIN	Ras-related and estrogen-regulated growth inhibitor	GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0007265; GO:0008285; GO:0009725; GO:0019003; GO:0030308	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]
PGEN_.00g070150	Scaffold_03	33742276	33756789	Q05927	5NTD_BOVIN	5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73)	GO:0000166; GO:0005886; GO:0006196; GO:0008253; GO:0031225; GO:0046872	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; AMP catabolic process [GO:0006196]
PGEN_.00g070160	Scaffold_03	33759683	33760222	NA	NA	NA	NA	NA
PGEN_.00g070170	Scaffold_03	33781977	33801856	NA	NA	NA	NA	NA
PGEN_.00g070180	Scaffold_03	33811168	33816007	P29240	5NTD_DIPOM	5'-nucleotidase (EC 3.1.3.5) (Ecto-nucleotidase)	GO:0000166; GO:0005886; GO:0008253; GO:0009166; GO:0031225; GO:0046872	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]
PGEN_.00g070190	Scaffold_03	33820048	33834337	NA	NA	NA	NA	NA
PGEN_.00g070200	Scaffold_03	33840216	33846026	NA	NA	NA	NA	NA
PGEN_.00g070210	Scaffold_03	33851462	33851695	NA	NA	NA	NA	NA
PGEN_.00g070220	Scaffold_03	33858544	33858867	NA	NA	NA	NA	NA
PGEN_.00g070230	Scaffold_03	33866881	33867246	NA	NA	NA	NA	NA
PGEN_.00g070240	Scaffold_03	33880557	33880946	NA	NA	NA	NA	NA
PGEN_.00g070250	Scaffold_03	33881972	33882368	NA	NA	NA	NA	NA
PGEN_.00g070260	Scaffold_03	33904430	33904738	NA	NA	NA	NA	NA
PGEN_.00g070270	Scaffold_03	33913974	33981185	O88808	TUB_RAT	Tubby protein homolog	GO:0001664; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0006910; GO:0007605; GO:0008277; GO:0009725; GO:0042073; GO:0044877; GO:0045494; GO:0050766; GO:0060041; GO:0061512; GO:0097500; GO:0120160; GO:1903546	"cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; intraciliary transport particle A binding [GO:0120160]; protein-containing complex binding [GO:0044877]; intraciliary transport [GO:0042073]; phagocytosis, recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; receptor localization to non-motile cilium [GO:0097500]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to hormone [GO:0009725]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605]"
PGEN_.00g070280	Scaffold_03	33921574	33922353	NA	NA	NA	NA	NA
PGEN_.00g070290	Scaffold_03	34054160	34054855	NA	NA	NA	NA	NA
PGEN_.00g070300	Scaffold_03	34059732	34063598	NA	NA	NA	NA	NA
PGEN_.00g070310	Scaffold_03	34064162	34172814	Q6P5C7	ZN728_MOUSE	Zinc finger protein 728	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g070320	Scaffold_03	34176604	34182405	NA	NA	NA	NA	NA
PGEN_.00g070330	Scaffold_03	34234324	34234572	NA	NA	NA	NA	NA
PGEN_.00g070340	Scaffold_03	34288816	34289124	NA	NA	NA	NA	NA
PGEN_.00g070350	Scaffold_03	34295740	34304467	P30279	CCND2_HUMAN	G1/S-specific cyclin-D2	GO:0000079; GO:0000307; GO:0000785; GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0016538; GO:0019901; GO:0031965; GO:0043066; GO:0044772; GO:0045737; GO:0051301; GO:1900087	chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]
PGEN_.00g070360	Scaffold_03	34390175	34390864	NA	NA	NA	NA	NA
PGEN_.00g070370	Scaffold_03	34398934	34400752	NA	NA	NA	NA	NA
PGEN_.00g070380	Scaffold_03	34404109	34411503	Q5ZJA9	BORC5_CHICK	BLOC-1-related complex subunit 5	GO:0030672; GO:0031224; GO:0032418; GO:0072384; GO:0098574; GO:0099078; GO:1903744	BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; intrinsic component of membrane [GO:0031224]; synaptic vesicle membrane [GO:0030672]; lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]
PGEN_.00g070390	Scaffold_03	34445216	34452734	NA	NA	NA	NA	NA
PGEN_.00g070400	Scaffold_03	34457400	34469586	Q4R918	KIF25_MACFA	Kinesin-like protein KIF25	GO:0005524; GO:0005623; GO:0005737; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647	"cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; microtubule binding [GO:0008017]; establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289]"
PGEN_.00g070410	Scaffold_03	34521825	34522112	NA	NA	NA	NA	NA
PGEN_.00g070420	Scaffold_03	34536775	34537654	NA	NA	NA	NA	NA
PGEN_.00g070430	Scaffold_03	34597116	34597659	NA	NA	NA	NA	NA
PGEN_.00g070440	Scaffold_03	34597700	34602663	NA	NA	NA	NA	NA
PGEN_.00g070450	Scaffold_03	34684075	34711243	A1L1W9	MOT10_DANRE	Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)	GO:0005887; GO:0008028; GO:0015173; GO:0015349	integral component of plasma membrane [GO:0005887]; aromatic amino acid transmembrane transporter activity [GO:0015173]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; thyroid hormone transmembrane transporter activity [GO:0015349]
PGEN_.00g070460	Scaffold_03	34737645	34757828	Q96GD3	SCMH1_HUMAN	Polycomb protein SCMH1 (Sex comb on midleg homolog 1)	GO:0005654; GO:0006338; GO:0007283; GO:0009952; GO:0010369; GO:0016458; GO:0045892	"chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]"
PGEN_.00g070470	Scaffold_03	34760198	34764698	NA	NA	NA	NA	NA
PGEN_.00g070480	Scaffold_03	34771613	34776773	Q9Z1T5	DEAF1_MOUSE	Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR)	GO:0000122; GO:0000977; GO:0001227; GO:0001650; GO:0001662; GO:0001843; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006366; GO:0008542; GO:0033599; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048706	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; behavioral fear response [GO:0001662]; embryonic skeletal system development [GO:0048706]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542]"
PGEN_.00g070490	Scaffold_03	34777197	34800549	A2RRV3	PATL1_DANRE	Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b)	GO:0000290; GO:0000932; GO:0003723; GO:0016605; GO:0016607; GO:0033962	nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]
PGEN_.00g070500	Scaffold_03	34805331	34808621	NA	NA	NA	NA	NA
PGEN_.00g070510	Scaffold_03	34814082	34865787	Q32LP2	RADI_BOVIN	Radixin	GO:0001726; GO:0003779; GO:0005902; GO:0005925; GO:0008360; GO:0010628; GO:0016324; GO:0019904; GO:0030027; GO:0030033; GO:0030175; GO:0030335; GO:0030864; GO:0032154; GO:0032231; GO:0032420; GO:0034111; GO:0034260; GO:0042803; GO:0045176; GO:0045184; GO:0045792; GO:0051117; GO:0051693; GO:0061028; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903364; GO:1903392; GO:2000643	apical plasma membrane [GO:0016324]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; apical protein localization [GO:0045176]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027]
PGEN_.00g070520	Scaffold_03	34871501	34902711	NA	NA	NA	NA	NA
PGEN_.00g070530	Scaffold_03	34911543	34916026	Q8ISQ3	RL24_BRABE	60S ribosomal protein L24	GO:0005840	ribosome [GO:0005840]
PGEN_.00g070540	Scaffold_03	34920306	34922833	NA	NA	NA	NA	NA
PGEN_.00g070550	Scaffold_03	34930040	35036210	Q9CZ62	CEP97_MOUSE	Centrosomal protein of 97 kDa (Cep97) (Leucine-rich repeat and IQ domain-containing protein 2)	GO:0005813; GO:0005829; GO:0030030; GO:0032991; GO:0034451; GO:1901673; GO:1902018	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673]
PGEN_.00g070560	Scaffold_03	35044306	35048499	Q9VHN6	RM19_DROME	"39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19)"	GO:0003735; GO:0005762; GO:0006412; GO:0032543	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
PGEN_.00g070570	Scaffold_03	35054371	35056605	NA	NA	NA	NA	NA
PGEN_.00g070580	Scaffold_03	35063888	35134077	P58659	EVA1C_MOUSE	Protein eva-1 homolog C (Protein FAM176C)	GO:0005576; GO:0005886; GO:0008201; GO:0016021; GO:0030246	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]
PGEN_.00g070590	Scaffold_03	35153871	35160580	NA	NA	NA	NA	NA
PGEN_.00g070600	Scaffold_03	35207424	35213201	Q8NFZ3	NLGNY_HUMAN	"Neuroligin-4, Y-linked (Neuroligin Y)"	GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0030054; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"
PGEN_.00g070610	Scaffold_03	35222912	35228654	Q9BGI2	PRDX4_BOVIN	Peroxiredoxin-4 (EC 1.11.1.15) (Peroxiredoxin IV) (Prx-IV)	GO:0005623; GO:0005783; GO:0005829; GO:0006979; GO:0008379; GO:0042744; GO:0045454	cell [GO:0005623]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]
PGEN_.00g070620	Scaffold_03	35233150	35250484	O96790	DPGN_DIPMA	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)	GO:0004867; GO:0005576; GO:0050819	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]
PGEN_.00g070630	Scaffold_03	35313437	35320513	Q2TBS9	SMU1_BOVIN	"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]"	GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"
PGEN_.00g070640	Scaffold_03	35322882	35324243	NA	NA	NA	NA	NA
PGEN_.00g070650	Scaffold_03	35330422	35331981	A8WGA3	LFN1L_DANRE	Leucine-rich repeat and fibronectin type III domain-containing protein 1-like protein	GO:0016021; GO:0030054; GO:0045202	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; synapse [GO:0045202]
PGEN_.00g070660	Scaffold_03	35342308	35343333	Q9UT27	PVG1_SCHPO	"Pyruvyl transferase 1 (EC 2.-.-.-) (Pyruvylated Gal-beta-1,3-epitope synthesis protein 1) (PvGal synthesis protein 1)"	GO:0005737; GO:0005794; GO:0009272; GO:0046919; GO:0051072; GO:0071555	"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; pyruvyltransferase activity [GO:0046919]; 4,6-pyruvylated galactose residue biosynthetic process [GO:0051072]; cell wall organization [GO:0071555]; fungal-type cell wall biogenesis [GO:0009272]"
PGEN_.00g070670	Scaffold_03	35388295	35395264	Q9UT27	PVG1_SCHPO	"Pyruvyl transferase 1 (EC 2.-.-.-) (Pyruvylated Gal-beta-1,3-epitope synthesis protein 1) (PvGal synthesis protein 1)"	GO:0005737; GO:0005794; GO:0009272; GO:0046919; GO:0051072; GO:0071555	"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; pyruvyltransferase activity [GO:0046919]; 4,6-pyruvylated galactose residue biosynthetic process [GO:0051072]; cell wall organization [GO:0071555]; fungal-type cell wall biogenesis [GO:0009272]"
PGEN_.00g070680	Scaffold_03	35450058	35453748	NA	NA	NA	NA	NA
PGEN_.00g070690	Scaffold_03	35466925	35471251	Q9UT27	PVG1_SCHPO	"Pyruvyl transferase 1 (EC 2.-.-.-) (Pyruvylated Gal-beta-1,3-epitope synthesis protein 1) (PvGal synthesis protein 1)"	GO:0005737; GO:0005794; GO:0009272; GO:0046919; GO:0051072; GO:0071555	"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; pyruvyltransferase activity [GO:0046919]; 4,6-pyruvylated galactose residue biosynthetic process [GO:0051072]; cell wall organization [GO:0071555]; fungal-type cell wall biogenesis [GO:0009272]"
PGEN_.00g070700	Scaffold_03	35484035	35487881	Q8WXS8	ATS14_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 14 (ADAM-TS 14) (ADAM-TS14) (ADAMTS-14) (EC 3.4.24.-)	GO:0004222; GO:0005576; GO:0030199; GO:0030574; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]
PGEN_.00g070710	Scaffold_03	35487941	35488708	NA	NA	NA	NA	NA
PGEN_.00g070720	Scaffold_03	35516898	35517485	NA	NA	NA	NA	NA
PGEN_.00g070730	Scaffold_03	35535848	35548436	NA	NA	NA	NA	NA
PGEN_.00g070740	Scaffold_03	35549349	35571880	NA	NA	NA	NA	NA
PGEN_.00g070750	Scaffold_03	35578777	35678307	Q8VHE6	DYH5_MOUSE	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (mDNAH5) (Ciliary dynein heavy chain 5)"	GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	"9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"
PGEN_.00g070760	Scaffold_03	35712761	35770822	Q921C3	BRWD1_MOUSE	Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9)	GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0007010; GO:0008360	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g070770	Scaffold_03	35771723	35794393	Q86SQ9	DHDDS_HUMAN	Dehydrodolichyl diphosphate synthase complex subunit DHDDS (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m)	GO:0002094; GO:0005783; GO:0005789; GO:0006489; GO:0016094; GO:0045547; GO:1904423	dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; dehydrodolichyl diphosphate synthase activity [GO:0045547]; polyprenyltransferase activity [GO:0002094]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094]
PGEN_.00g070780	Scaffold_03	35803007	35838929	NA	NA	NA	NA	NA
PGEN_.00g070790	Scaffold_03	35840354	35843350	NA	NA	NA	NA	NA
PGEN_.00g070800	Scaffold_03	35846607	35854732	NA	NA	NA	NA	NA
PGEN_.00g070810	Scaffold_03	35869364	35869696	NA	NA	NA	NA	NA
PGEN_.00g070820	Scaffold_03	35870435	35870689	NA	NA	NA	NA	NA
PGEN_.00g070830	Scaffold_03	35976162	35980023	NA	NA	NA	NA	NA
PGEN_.00g070840	Scaffold_03	35990543	35991658	Q8BKN6	HS3SA_MOUSE	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1) (Heparan sulfate 3-O-sulfotransferase 3A1)	GO:0000139; GO:0008467; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]
PGEN_.00g070850	Scaffold_03	35999238	36013928	A2RU49	HYKK_HUMAN	Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1)	GO:0005759; GO:0006554; GO:0016301; GO:0047992	mitochondrial matrix [GO:0005759]; hydroxylysine kinase activity [GO:0047992]; kinase activity [GO:0016301]; lysine catabolic process [GO:0006554]
PGEN_.00g070860	Scaffold_03	36024834	36025586	Q6PFG8	OLIG3_MOUSE	Oligodendrocyte transcription factor 3 (Oligo3) (Class B basic helix-loop-helix protein 7) (bHLHb7) (Oligodendrocyte-specific bHLH transcription factor 3)	GO:0000122; GO:0003677; GO:0003714; GO:0005634; GO:0010468; GO:0021520; GO:0021522; GO:0046983; GO:0097476	nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord motor neuron migration [GO:0097476]
PGEN_.00g070870	Scaffold_03	36030562	36046095	A9CAZ8	TM50B_PAPAN	Transmembrane protein 50B	GO:0000139; GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]
PGEN_.00g070880	Scaffold_03	36049178	36049438	NA	NA	NA	NA	NA
PGEN_.00g070890	Scaffold_03	36111600	36114678	NA	NA	NA	NA	NA
PGEN_.00g070900	Scaffold_03	36124394	36125608	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g070910	Scaffold_03	36130963	36171188	Q14202	ZMYM3_HUMAN	Zinc finger MYM-type protein 3 (Zinc finger protein 261)	GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0007010; GO:0007275; GO:0008270; GO:0022604	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g070920	Scaffold_03	36179824	36187053	Q5U2S3	ZUP1_RAT	Zinc finger-containing ubiquitin peptidase 1 (EC 3.4.19.12) (Lys-63-specific deubiquitinase ZUFSP) (DUB) (Zinc finger with UFM1-specific peptidase domain protein)	GO:0003676; GO:0005634; GO:0005737; GO:0036459; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]
PGEN_.00g070930	Scaffold_03	36187143	36194112	Q5R504	F162A_PONAB	Protein FAM162A (E2-induced gene 5 protein homolog)	GO:0005739; GO:0005829; GO:0006919; GO:0016021; GO:0043065; GO:0051402; GO:0071456; GO:0090200	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to hypoxia [GO:0071456]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]
PGEN_.00g070940	Scaffold_03	36205129	36226487	Q16611	BAK_HUMAN	Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK) (Bcl-2-like protein 7) (Bcl2-L-7)	GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005623; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0006915; GO:0007420; GO:0007568; GO:0008053; GO:0008283; GO:0008285; GO:0008630; GO:0008635; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0014070; GO:0031018; GO:0031072; GO:0031100; GO:0031307; GO:0032469; GO:0032471; GO:0033137; GO:0034620; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0043496; GO:0043497; GO:0044325; GO:0044346; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0051087; GO:0051400; GO:0051726; GO:0051881; GO:0060068; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0097136; GO:0097145; GO:0097190; GO:0097192; GO:0097202; GO:1900103; GO:1901030; GO:1902262; GO:1903896	BAK complex [GO:0097145]; Bcl-2 family protein complex [GO:0097136]; cell [GO:0005623]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; BH domain binding [GO:0051400]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to UV-C [GO:0010225]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]
PGEN_.00g070950	Scaffold_03	36232786	36239838	NA	NA	NA	NA	NA
PGEN_.00g070960	Scaffold_03	36257149	36362873	P35992	PTP10_DROME	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0042059; GO:0045177; GO:0060446	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]
PGEN_.00g070970	Scaffold_03	36433553	36443147	Q96PZ7	CSMD1_HUMAN	CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)	GO:0001964; GO:0016021; GO:0042593	integral component of membrane [GO:0016021]; glucose homeostasis [GO:0042593]; startle response [GO:0001964]
PGEN_.00g070980	Scaffold_03	36464485	36478312	Q9W6V5	PTPRJ_CHICK	Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (Supporting-cell antigen)	GO:0004725; GO:0005886; GO:0005911; GO:0006470; GO:0016021; GO:0016791; GO:0032587; GO:0042059; GO:0043407; GO:0045785; GO:0048008; GO:0050860; GO:0051894; GO:0051898	cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell adhesion [GO:0045785]; positive regulation of focal adhesion assembly [GO:0051894]; protein dephosphorylation [GO:0006470]
PGEN_.00g070990	Scaffold_03	36480540	36484048	NA	NA	NA	NA	NA
PGEN_.00g071000	Scaffold_03	36488147	36531929	A2A8L5	PTPRF_MOUSE	Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)	GO:0001960; GO:0004721; GO:0004725; GO:0005001; GO:0005158; GO:0005768; GO:0005886; GO:0006470; GO:0007156; GO:0007399; GO:0008201; GO:0008285; GO:0010975; GO:0016020; GO:0016477; GO:0030426; GO:0030971; GO:0031102; GO:0031345; GO:0035335; GO:0035373; GO:0042059; GO:0042301; GO:0043005; GO:0043025; GO:0043065; GO:0043231; GO:0043525; GO:0044877; GO:0046627; GO:0048679; GO:0050775; GO:0050803; GO:0050839; GO:0051387; GO:0060076; GO:0099061; GO:0099175; GO:0099560; GO:1900121	endosome [GO:0005768]; excitatory synapse [GO:0060076]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; insulin receptor binding [GO:0005158]; phosphate ion binding [GO:0042301]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell migration [GO:0016477]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of receptor binding [GO:1900121]; nervous system development [GO:0007399]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron apoptotic process [GO:0043525]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of synapse structure or activity [GO:0050803]; synaptic membrane adhesion [GO:0099560]
PGEN_.00g071010	Scaffold_03	36571116	36576239	NA	NA	NA	NA	NA
PGEN_.00g071020	Scaffold_03	36624684	36654486	P35992	PTP10_DROME	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0042059; GO:0045177; GO:0060446	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]
PGEN_.00g071030	Scaffold_03	36657489	36657767	NA	NA	NA	NA	NA
PGEN_.00g071040	Scaffold_03	36658068	36664120	NA	NA	NA	NA	NA
PGEN_.00g071050	Scaffold_03	36677721	36685680	NA	NA	NA	NA	NA
PGEN_.00g071060	Scaffold_03	36687864	36708436	NA	NA	NA	NA	NA
PGEN_.00g071070	Scaffold_03	36719900	36745362	Q9UMZ3	PTPRQ_HUMAN	Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)	GO:0004725; GO:0016021; GO:0045598	integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; regulation of fat cell differentiation [GO:0045598]
PGEN_.00g071080	Scaffold_03	36781609	36782249	NA	NA	NA	NA	NA
PGEN_.00g071090	Scaffold_03	36859164	36859898	NA	NA	NA	NA	NA
PGEN_.00g071100	Scaffold_03	36880273	36946609	B2RU80	PTPRB_MOUSE	Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP)	GO:0001525; GO:0004725; GO:0016021; GO:0016311; GO:0043235; GO:0045296	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]
PGEN_.00g071110	Scaffold_03	36952453	36952818	NA	NA	NA	NA	NA
PGEN_.00g071120	Scaffold_03	36970695	36973157	NA	NA	NA	NA	NA
PGEN_.00g071130	Scaffold_03	37086107	37096353	D3Z6H8	DCAM2_MOUSE	S-adenosylmethionine decarboxylase proenzyme 2 (AdoMetDC 2) (SAMDC 2) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase 2 alpha chain; S-adenosylmethionine decarboxylase 2 beta chain]	GO:0004014; GO:0005829; GO:0006557; GO:0006597; GO:0008295; GO:0019810	cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; putrescine binding [GO:0019810]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]
PGEN_.00g071140	Scaffold_03	37128633	37130910	NA	NA	NA	NA	NA
PGEN_.00g071150	Scaffold_03	37141106	37142506	Q7KVW5	KCNN_DROME	Small conductance calcium-activated potassium channel protein (Protein SK) (dSK)	GO:0005516; GO:0005886; GO:0006813; GO:0009881; GO:0016021; GO:0016057; GO:0016286; GO:0043005; GO:0043025; GO:0071805	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057]
PGEN_.00g071160	Scaffold_03	37262609	37281373	NA	NA	NA	NA	NA
PGEN_.00g071170	Scaffold_03	37319271	37319633	NA	NA	NA	NA	NA
PGEN_.00g071180	Scaffold_03	37319788	37320588	NA	NA	NA	NA	NA
PGEN_.00g071190	Scaffold_03	37320728	37323289	NA	NA	NA	NA	NA
PGEN_.00g071200	Scaffold_03	37323307	37323888	NA	NA	NA	NA	NA
PGEN_.00g071210	Scaffold_03	37324856	37325227	NA	NA	NA	NA	NA
PGEN_.00g071220	Scaffold_03	37328885	37329229	NA	NA	NA	NA	NA
PGEN_.00g071230	Scaffold_03	37330177	37330521	NA	NA	NA	NA	NA
PGEN_.00g071240	Scaffold_03	37330958	37331290	NA	NA	NA	NA	NA
PGEN_.00g071250	Scaffold_03	37331844	37332371	NA	NA	NA	NA	NA
PGEN_.00g071260	Scaffold_03	37333853	37334320	NA	NA	NA	NA	NA
PGEN_.00g071270	Scaffold_03	37371250	37371753	A2VDD2	TC1DB_XENLA	Tctex1 domain-containing protein 1-B (Fragment)		
PGEN_.00g071280	Scaffold_03	37425953	37448896	Q6PAM1	TXLNA_MOUSE	Alpha-taxilin	GO:0005737; GO:0006887; GO:0019905; GO:0042113	cytoplasm [GO:0005737]; syntaxin binding [GO:0019905]; B cell activation [GO:0042113]; exocytosis [GO:0006887]
PGEN_.00g071290	Scaffold_03	37484580	37486109	Q9N2M8	HDC_DROME	Headcase protein [Cleaved into: Headcase short protein]	GO:0002165; GO:0005737; GO:0007430; GO:0016246; GO:0030424; GO:0030425; GO:0035071; GO:0048471; GO:0048675; GO:0050768; GO:1904799	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; axon extension [GO:0048675]; instar larval or pupal development [GO:0002165]; negative regulation of neurogenesis [GO:0050768]; regulation of neuron remodeling [GO:1904799]; RNA interference [GO:0016246]; salivary gland cell autophagic cell death [GO:0035071]; terminal branching, open tracheal system [GO:0007430]"
PGEN_.00g071300	Scaffold_03	37486995	37499449	NA	NA	NA	NA	NA
PGEN_.00g071310	Scaffold_03	37519221	37526876	A6H7H7	FBX3_BOVIN	F-box only protein 3	GO:0005654; GO:0005829	cytosol [GO:0005829]; nucleoplasm [GO:0005654]
PGEN_.00g071320	Scaffold_03	37588371	37589462	G3M4F8	OCTB2_CHISP	Octopamine receptor beta-2R (CsOA2B2)	GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016021; GO:0071418; GO:0071927; GO:0071928	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; tyramine signaling pathway [GO:0071928]
PGEN_.00g071330	Scaffold_03	37613469	37623412	P18173	DHGL_DROME	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"
PGEN_.00g071340	Scaffold_03	37625226	37629114	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g071350	Scaffold_03	37642495	37646549	NA	NA	NA	NA	NA
PGEN_.00g071360	Scaffold_03	37673888	37787513	Q9JIL5	TULP4_MOUSE	Tubby-related protein 4 (Tubby superfamily protein) (Tubby-like protein 4)	GO:0005737; GO:0016567	cytoplasm [GO:0005737]; protein ubiquitination [GO:0016567]
PGEN_.00g071370	Scaffold_03	37803100	37827769	Q9D0N7	CAF1B_MOUSE	Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60)	GO:0000790; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186; GO:0042393	CAF-1 complex [GO:0033186]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]
PGEN_.00g071380	Scaffold_03	37833644	37834018	NA	NA	NA	NA	NA
PGEN_.00g071390	Scaffold_03	37840637	37840959	NA	NA	NA	NA	NA
PGEN_.00g071400	Scaffold_03	37845100	37851751	Q8SPX7	CRYL1_BOVIN	Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH)	GO:0003857; GO:0005829; GO:0006631; GO:0050104; GO:0070403	cytosol [GO:0005829]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; fatty acid metabolic process [GO:0006631]
PGEN_.00g071410	Scaffold_03	37860354	37861286	NA	NA	NA	NA	NA
PGEN_.00g071420	Scaffold_03	37868240	37885956	NA	NA	NA	NA	NA
PGEN_.00g071430	Scaffold_03	37894924	37910862	O46522	CY24B_BOVIN	Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (Neutrophil cytochrome b 91 kDa polypeptide) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)	GO:0005244; GO:0005764; GO:0005886; GO:0006801; GO:0006952; GO:0006954; GO:0016175; GO:0034765; GO:0042554; GO:0043020; GO:0045087; GO:0045121; GO:0046872; GO:0055114	lysosome [GO:0005764]; membrane raft [GO:0045121]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; superoxide-generating NADPH oxidase activity [GO:0016175]; voltage-gated ion channel activity [GO:0005244]; defense response [GO:0006952]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; oxidation-reduction process [GO:0055114]; regulation of ion transmembrane transport [GO:0034765]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]
PGEN_.00g071440	Scaffold_03	37964145	37987092	Q9P2F6	RHG20_HUMAN	Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20)	GO:0005096; GO:0005829; GO:0007165; GO:0051056	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]
PGEN_.00g071450	Scaffold_03	38002939	38041396	Q6ZPD9	D19L3_HUMAN	Probable C-mannosyltransferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3)	GO:0000030; GO:0005637; GO:0016021; GO:0018406	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]
PGEN_.00g071460	Scaffold_03	38050553	38059901	Q71B07	D19L3_MOUSE	Probable C-mannosyltransferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3)	GO:0000030; GO:0005637; GO:0016021; GO:0018406	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]
PGEN_.00g071470	Scaffold_03	38073067	38091964	Q17134	TBXT1_BRAFL	T-box transcription factor T homolog 1 (AmBra-1) (Brachyury protein homolog 1)	GO:0003677; GO:0003700; GO:0005634; GO:0007275	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; multicellular organism development [GO:0007275]
PGEN_.00g071480	Scaffold_03	38112013	38113699	NA	NA	NA	NA	NA
PGEN_.00g071490	Scaffold_03	38119034	38133176	NA	NA	NA	NA	NA
PGEN_.00g071500	Scaffold_03	38140113	38145754	O35474	EDIL3_MOUSE	EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)	GO:0005178; GO:0005509; GO:0005576; GO:0007155; GO:0007275; GO:0010811	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811]
PGEN_.00g071510	Scaffold_03	38176976	38183118	A2RUV9	AEBP1_RAT	Adipocyte enhancer-binding protein 1 (AE-binding protein 1) (Aortic carboxypeptidase-like protein)	GO:0000122; GO:0000977; GO:0001227; GO:0003714; GO:0004180; GO:0004181; GO:0005516; GO:0005518; GO:0005615; GO:0006355; GO:0006518; GO:0008270; GO:0016485; GO:1904026	"extracellular space [GO:0005615]; calmodulin binding [GO:0005516]; carboxypeptidase activity [GO:0004180]; collagen binding [GO:0005518]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metallocarboxypeptidase activity [GO:0004181]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; regulation of collagen fibril organization [GO:1904026]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g071520	Scaffold_03	38208525	38208956	NA	NA	NA	NA	NA
PGEN_.00g071530	Scaffold_03	38209759	38210094	NA	NA	NA	NA	NA
PGEN_.00g071540	Scaffold_03	38210134	38211435	NA	NA	NA	NA	NA
PGEN_.00g071550	Scaffold_03	38260126	38264000	Q6TNS7	RABL3_DANRE	Rab-like protein 3	GO:0003924; GO:0005525; GO:0006886; GO:0032482	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g071560	Scaffold_03	38269478	38272601	NA	NA	NA	NA	NA
PGEN_.00g071570	Scaffold_03	38282566	38288447	NA	NA	NA	NA	NA
PGEN_.00g071580	Scaffold_03	38321326	38323799	Q13489	BIRC3_HUMAN	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Apoptosis inhibitor 2) (API2) (Cellular inhibitor of apoptosis 2) (C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1) (hIAP-1) (hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1)	GO:0002756; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0007283; GO:0010803; GO:0016579; GO:0016740; GO:0031398; GO:0032991; GO:0033209; GO:0034121; GO:0035666; GO:0038061; GO:0039535; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043154; GO:0045088; GO:0045121; GO:0046872; GO:0050727; GO:0051291; GO:0060544; GO:0060546; GO:0061630; GO:0070424; GO:1990001; GO:2000116	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; regulation of apoptotic process [GO:0042981]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; spermatogenesis [GO:0007283]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]
PGEN_.00g071590	Scaffold_03	38336633	38342777	Q24306	DIAP1_DROME	Death-associated inhibitor of apoptosis 1 (EC 2.3.2.27) (Apoptosis 1 inhibitor) (E3 ubiquitin-protein ligase th) (Inhibitor of apoptosis 1) (Protein thread) (RING-type E3 ubiquitin transferase Diap1)	GO:0000209; GO:0004842; GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0007275; GO:0007283; GO:0007289; GO:0007298; GO:0008270; GO:0008354; GO:0016055; GO:0022416; GO:0031398; GO:0031624; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0044390; GO:0045035; GO:0045116; GO:0046673; GO:0048800; GO:0051865; GO:0061630; GO:0061663; GO:0070936; GO:0089720; GO:0090263; GO:0097340; GO:1903688; GO:1990001; GO:1990381; GO:2001271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; NEDD8 ligase activity [GO:0061663]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; germ cell migration [GO:0008354]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g071600	Scaffold_03	38385833	38390060	Q24306	DIAP1_DROME	Death-associated inhibitor of apoptosis 1 (EC 2.3.2.27) (Apoptosis 1 inhibitor) (E3 ubiquitin-protein ligase th) (Inhibitor of apoptosis 1) (Protein thread) (RING-type E3 ubiquitin transferase Diap1)	GO:0000209; GO:0004842; GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0007275; GO:0007283; GO:0007289; GO:0007298; GO:0008270; GO:0008354; GO:0016055; GO:0022416; GO:0031398; GO:0031624; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0044390; GO:0045035; GO:0045116; GO:0046673; GO:0048800; GO:0051865; GO:0061630; GO:0061663; GO:0070936; GO:0089720; GO:0090263; GO:0097340; GO:1903688; GO:1990001; GO:1990381; GO:2001271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; NEDD8 ligase activity [GO:0061663]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; germ cell migration [GO:0008354]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g071610	Scaffold_03	38395259	38409135	Q24306	DIAP1_DROME	Death-associated inhibitor of apoptosis 1 (EC 2.3.2.27) (Apoptosis 1 inhibitor) (E3 ubiquitin-protein ligase th) (Inhibitor of apoptosis 1) (Protein thread) (RING-type E3 ubiquitin transferase Diap1)	GO:0000209; GO:0004842; GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0007275; GO:0007283; GO:0007289; GO:0007298; GO:0008270; GO:0008354; GO:0016055; GO:0022416; GO:0031398; GO:0031624; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0044390; GO:0045035; GO:0045116; GO:0046673; GO:0048800; GO:0051865; GO:0061630; GO:0061663; GO:0070936; GO:0089720; GO:0090263; GO:0097340; GO:1903688; GO:1990001; GO:1990381; GO:2001271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; NEDD8 ligase activity [GO:0061663]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; germ cell migration [GO:0008354]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g071620	Scaffold_03	38410715	38411606	NA	NA	NA	NA	NA
PGEN_.00g071630	Scaffold_03	38422952	38423332	NA	NA	NA	NA	NA
PGEN_.00g071640	Scaffold_03	38423483	38423761	NA	NA	NA	NA	NA
PGEN_.00g071650	Scaffold_03	38424951	38425208	NA	NA	NA	NA	NA
PGEN_.00g071660	Scaffold_03	38435675	38439663	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g071670	Scaffold_03	38444915	38456277	NA	NA	NA	NA	NA
PGEN_.00g071680	Scaffold_03	38456379	38459853	A9JTP3	BIRC7_XENTR	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7)	GO:0005634; GO:0005737; GO:0007275; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865; GO:0061630; GO:1990001	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]
PGEN_.00g071690	Scaffold_03	38469437	38472235	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g071700	Scaffold_03	38476519	38476884	NA	NA	NA	NA	NA
PGEN_.00g071710	Scaffold_03	38481398	38483120	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g071720	Scaffold_03	38491120	38497102	NA	NA	NA	NA	NA
PGEN_.00g071730	Scaffold_03	38500952	38505663	NA	NA	NA	NA	NA
PGEN_.00g071740	Scaffold_03	38508168	38511984	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g071750	Scaffold_03	38518095	38518961	NA	NA	NA	NA	NA
PGEN_.00g071760	Scaffold_03	38528414	38529802	P98170	XIAP_HUMAN	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0016055; GO:0030510; GO:0031398; GO:0042127; GO:0042802; GO:0043027; GO:0043066; GO:0043154; GO:0045088; GO:0046872; GO:0050727; GO:0051402; GO:0055070; GO:0061630; GO:0070424; GO:0090263; GO:1902530; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055]
PGEN_.00g071770	Scaffold_03	38540631	38543148	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g071780	Scaffold_03	38550248	38552641	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g071790	Scaffold_03	38656933	38658318	P37288	V1AR_HUMAN	Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor)	GO:0001992; GO:0002125; GO:0003084; GO:0004930; GO:0005000; GO:0005080; GO:0005623; GO:0005768; GO:0005886; GO:0005887; GO:0006091; GO:0007186; GO:0007202; GO:0007204; GO:0007621; GO:0007625; GO:0008015; GO:0008284; GO:0010460; GO:0014049; GO:0014902; GO:0017046; GO:0019722; GO:0021537; GO:0030139; GO:0030307; GO:0031394; GO:0031894; GO:0032849; GO:0032870; GO:0035176; GO:0035815; GO:0042631; GO:0042711; GO:0042713; GO:0043084; GO:0045907; GO:0051412; GO:0051970	cell [GO:0005623]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; protein kinase C binding [GO:0005080]; V1A vasopressin receptor binding [GO:0031894]; vasopressin receptor activity [GO:0005000]; activation of phospholipase C activity [GO:0007202]; blood circulation [GO:0008015]; calcium-mediated signaling [GO:0019722]; cellular response to hormone stimulus [GO:0032870]; cellular response to water deprivation [GO:0042631]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of precursor metabolites and energy [GO:0006091]; grooming behavior [GO:0007625]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; myotube differentiation [GO:0014902]; negative regulation of female receptivity [GO:0007621]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of heart rate [GO:0010460]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to corticosterone [GO:0051412]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; telencephalon development [GO:0021537]
PGEN_.00g071800	Scaffold_03	38710978	38717909	A9JTP3	BIRC7_XENTR	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7)	GO:0005634; GO:0005737; GO:0007275; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865; GO:0061630; GO:1990001	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]
PGEN_.00g071810	Scaffold_03	38740919	38741146	NA	NA	NA	NA	NA
PGEN_.00g071820	Scaffold_03	38742854	38757459	A9ULZ2	BIR7B_XENLA	Baculoviral IAP repeat-containing protein 7-B (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-B) (Embryonic/Egg IAP-B) (EIAP/XLX-B) (RING-type E3 ubiquitin transferase EIAP-B)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g071830	Scaffold_03	38762132	38762422	NA	NA	NA	NA	NA
PGEN_.00g071840	Scaffold_03	38808622	38815469	A9ULZ2	BIR7B_XENLA	Baculoviral IAP repeat-containing protein 7-B (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-B) (Embryonic/Egg IAP-B) (EIAP/XLX-B) (RING-type E3 ubiquitin transferase EIAP-B)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g071850	Scaffold_03	38880642	38899773	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g071860	Scaffold_03	38905277	38931675	NA	NA	NA	NA	NA
PGEN_.00g071870	Scaffold_03	38942937	38945885	NA	NA	NA	NA	NA
PGEN_.00g071880	Scaffold_03	38946152	38946592	NA	NA	NA	NA	NA
PGEN_.00g071890	Scaffold_03	38958594	38958806	NA	NA	NA	NA	NA
PGEN_.00g071900	Scaffold_03	38991988	38992930	NA	NA	NA	NA	NA
PGEN_.00g071910	Scaffold_03	38995760	39006071	NA	NA	NA	NA	NA
PGEN_.00g071920	Scaffold_03	39022793	39023314	NA	NA	NA	NA	NA
PGEN_.00g071930	Scaffold_03	39033325	39045793	O95562	SFT2B_HUMAN	Vesicle transport protein SFT2B (SFT2 domain-containing protein 2)	GO:0015031; GO:0016021; GO:0016192; GO:0070062	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g071940	Scaffold_03	39048142	39053220	Q28062	PGCB_BOVIN	Brevican core protein	GO:0001501; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g071950	Scaffold_03	39057147	39074258	Q5FVR2	TYPH_RAT	Thymidine phosphorylase (TP) (EC 2.4.2.4) (TdRPase)	GO:0000002; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0009032; GO:0016154; GO:0031641; GO:0042803; GO:0051969; GO:1905333	cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]
PGEN_.00g071960	Scaffold_03	39119294	39126886	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g071970	Scaffold_03	39200675	39214004	Q75FL1	MENG_LEPIC	Demethylmenaquinone methyltransferase (EC 2.1.1.163)	GO:0009234; GO:0032259; GO:0102955	S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; menaquinone biosynthetic process [GO:0009234]; methylation [GO:0032259]
PGEN_.00g071980	Scaffold_03	39264509	39267512	Q1GC56	UBIE_RUEST	"Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE (EC 2.1.1.163) (EC 2.1.1.201) (2-methoxy-6-polyprenyl-1,4-benzoquinol methylase) (Demethylmenaquinone methyltransferase)"	GO:0006744; GO:0009060; GO:0009234; GO:0032259; GO:0043333; GO:0102955	"2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; aerobic respiration [GO:0009060]; menaquinone biosynthetic process [GO:0009234]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"
PGEN_.00g071990	Scaffold_03	39291423	39291701	NA	NA	NA	NA	NA
PGEN_.00g072000	Scaffold_03	39292370	39295631	NA	NA	NA	NA	NA
PGEN_.00g072010	Scaffold_03	39361988	39370134	Q95JD5	ST1B1_CANLF	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (cSULT1B1) (EC 2.8.2.-)	GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008202; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g072020	Scaffold_03	39391600	39445644	Q5TCS8	KAD9_HUMAN	Adenylate kinase 9 (AK 9) (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2)	GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006174; GO:0006186; GO:0006756; GO:0006757; GO:0015949; GO:0031965; GO:0050145; GO:0061508; GO:0061565; GO:0061566; GO:0061567; GO:0061568; GO:0061569; GO:0061570; GO:0061571	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569]
PGEN_.00g072030	Scaffold_03	39446312	39466538	P84039	ENPP5_RAT	Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-)	GO:0005886; GO:0007154; GO:0016020; GO:0016021; GO:0016787; GO:0046872	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; cell communication [GO:0007154]
PGEN_.00g072040	Scaffold_03	39472952	39487422	NA	NA	NA	NA	NA
PGEN_.00g072050	Scaffold_03	39501941	39503837	NA	NA	NA	NA	NA
PGEN_.00g072060	Scaffold_03	39504019	39507459	NA	NA	NA	NA	NA
PGEN_.00g072070	Scaffold_03	39572105	39572524	NA	NA	NA	NA	NA
PGEN_.00g072080	Scaffold_03	39633625	39633963	NA	NA	NA	NA	NA
PGEN_.00g072090	Scaffold_03	39684111	39704411	A9JTP3	BIRC7_XENTR	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7)	GO:0005634; GO:0005737; GO:0007275; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865; GO:0061630; GO:1990001	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]
PGEN_.00g072100	Scaffold_03	39715353	39744074	P63239	NEC1_MOUSE	Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Furin homolog) (PC3) (Prohormone convertase 1) (Propeptide-processing protease) (Proprotein convertase 1) (PC1)	GO:0004175; GO:0004252; GO:0005615; GO:0005788; GO:0016020; GO:0016485; GO:0016486; GO:0030133; GO:0034774; GO:0042802; GO:0043005; GO:0043043	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]
PGEN_.00g072110	Scaffold_03	39751425	39754156	Q5S003	SPG17_MOUSE	Sperm-associated antigen 17 (Projection protein PF6 homolog)	GO:0003351; GO:0005576; GO:0005874; GO:0031514; GO:1904158; GO:1990716	axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]
PGEN_.00g072120	Scaffold_03	39756652	39814551	Q5S003	SPG17_MOUSE	Sperm-associated antigen 17 (Projection protein PF6 homolog)	GO:0003351; GO:0005576; GO:0005874; GO:0031514; GO:1904158; GO:1990716	axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]
PGEN_.00g072130	Scaffold_03	39828385	39841187	Q8TF01	PNISR_HUMAN	"Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130) (SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18)"	GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016607; GO:0048786	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; RNA binding [GO:0003723]
PGEN_.00g072140	Scaffold_03	39844729	39852935	Q8BMS4	COQ3_MOUSE	"Ubiquinone biosynthesis O-methyltransferase, mitochondrial (3-demethylubiquinol 3-O-methyltransferase) (EC 2.1.1.64) (Polyprenyldihydroxybenzoate methyltransferase) (EC 2.1.1.114)"	GO:0004395; GO:0005739; GO:0006071; GO:0006744; GO:0008171; GO:0008425; GO:0008689; GO:0010795; GO:0031314; GO:0032259	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrion [GO:0005739]; 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; hexaprenyldihydroxybenzoate methyltransferase activity [GO:0004395]; O-methyltransferase activity [GO:0008171]; glycerol metabolic process [GO:0006071]; methylation [GO:0032259]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744]"
PGEN_.00g072150	Scaffold_03	39866466	39872105	Q4V7A9	K895L_RAT	Uncharacterized protein KIAA0895-like		
PGEN_.00g072160	Scaffold_03	39889948	39894364	Q9H446	RWDD1_HUMAN	RWD domain-containing protein 1 (DRG family-regulatory protein 2)	GO:0002181; GO:0005737; GO:0005844; GO:0007569; GO:0030521; GO:0034599; GO:0071394; GO:2000825	cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]
PGEN_.00g072170	Scaffold_03	39894532	39894915	NA	NA	NA	NA	NA
PGEN_.00g072180	Scaffold_03	39894952	39895323	NA	NA	NA	NA	NA
PGEN_.00g072190	Scaffold_03	39895372	39901715	Q9CQK7	RWDD1_MOUSE	RWD domain-containing protein 1 (DRG family-regulatory protein 2) (IH1)	GO:0002181; GO:0005737; GO:0005844; GO:0007569; GO:0030521; GO:0034599; GO:0071394; GO:2000825	cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825]
PGEN_.00g072200	Scaffold_03	39958997	39962113	NA	NA	NA	NA	NA
PGEN_.00g072210	Scaffold_03	39962166	39965590	B6SFA4	MAA3_ARATH	Probable helicase MAGATAMA 3 (EC 3.6.4.-) (SEN1-like protein)	GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0009553; GO:0009875; GO:0010183	nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; embryo sac development [GO:0009553]; pollen tube guidance [GO:0010183]; pollen-pistil interaction [GO:0009875]
PGEN_.00g072220	Scaffold_03	40068976	40077420	Q54V41	ARFK_DICDI	ADP-ribosylation factor K	GO:0005525; GO:0005737; GO:0005794; GO:0005886; GO:0006886; GO:0016192	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g072230	Scaffold_03	40078822	40084358	NA	NA	NA	NA	NA
PGEN_.00g072240	Scaffold_03	40084412	40085128	NA	NA	NA	NA	NA
PGEN_.00g072250	Scaffold_03	40122015	40148532	Q66J74	TFP11_XENLA	Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1)	GO:0003676; GO:0005681; GO:0006397; GO:0008380	spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g072260	Scaffold_03	40153408	40163087	Q5XXP2	OPN4_PHOSU	Melanopsin (Opsin-4)	GO:0005502; GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0016021; GO:0018298; GO:0042752; GO:0048511	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601]
PGEN_.00g072270	Scaffold_03	40170902	40171144	NA	NA	NA	NA	NA
PGEN_.00g072280	Scaffold_03	40178079	40246896	Q8R512	UBX11_RAT	UBX domain-containing protein 11 (Socius) (UBX domain-containing protein 5)	GO:0005737; GO:0005856; GO:0043130; GO:0043161	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ubiquitin binding [GO:0043130]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]
PGEN_.00g072290	Scaffold_03	40262544	40275671	Q9BWV7	TTLL2_HUMAN	Probable tubulin polyglutamylase TTLL2 (EC 6.-.-.-) (Testis-specific protein NYD-TSPG) (Tubulin--tyrosine ligase-like protein 2)	GO:0005524; GO:0006464; GO:0016874	ATP binding [GO:0005524]; ligase activity [GO:0016874]; cellular protein modification process [GO:0006464]
PGEN_.00g072300	Scaffold_03	40288888	40311184	Q9BVJ6	UT14A_HUMAN	U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16)	GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0032040	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]
PGEN_.00g072310	Scaffold_03	40311290	40330281	Q2T9T0	PPR32_BOVIN	Protein phosphatase 1 regulatory subunit 32	GO:0019902	phosphatase binding [GO:0019902]
PGEN_.00g072320	Scaffold_03	40339235	40357551	Q5YLM1	DGLA_RAT	Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator)	GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055	integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]
PGEN_.00g072330	Scaffold_03	40388303	40389165	NA	NA	NA	NA	NA
PGEN_.00g072340	Scaffold_03	40395179	40450690	Q9Y4D2	DGLA_HUMAN	Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator)	GO:0005886; GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055	integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]
PGEN_.00g072350	Scaffold_03	40469088	40477301	Q5YLM1	DGLA_RAT	Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator)	GO:0007216; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0071926; GO:0098921; GO:0099055	integral component of postsynaptic membrane [GO:0099055]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]
PGEN_.00g072360	Scaffold_03	40480075	40502230	Q9QX47	SON_MOUSE	Protein SON (Negative regulatory element-binding protein) (NRE-binding protein)	GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726	"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"
PGEN_.00g072370	Scaffold_03	40503384	40514631	Q9JJ80	RPF2_MOUSE	Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog)	GO:0000027; GO:0000463; GO:0000981; GO:0005654; GO:0005730; GO:0008097; GO:0019843; GO:0042273; GO:1901796; GO:1902570	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5S rRNA binding [GO:0008097]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]"
PGEN_.00g072380	Scaffold_03	40516561	40544272	Q14166	TTL12_HUMAN	Tubulin--tyrosine ligase-like protein 12 (Inactive tubulin--tyrosine ligase-like protein 12)	GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0007346; GO:0015631; GO:0030496; GO:0034968; GO:0045087; GO:0060339; GO:1990889	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; H4K20me3 modified histone binding [GO:1990889]; tubulin binding [GO:0015631]; histone lysine methylation [GO:0034968]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of mitotic cell cycle [GO:0007346]
PGEN_.00g072390	Scaffold_03	40552195	40564647	NA	NA	NA	NA	NA
PGEN_.00g072400	Scaffold_03	40568971	40581774	Q80XP8	FA76B_MOUSE	Protein FAM76B	GO:0016607	nuclear speck [GO:0016607]
PGEN_.00g072410	Scaffold_03	40586148	40597655	Q7T3C7	RT4I1_DANRE	"Reticulon-4-interacting protein 1 homolog, mitochondrial"	GO:0005739; GO:0005741; GO:0010842; GO:0016491; GO:0042462; GO:0050773	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; eye photoreceptor cell development [GO:0042462]; regulation of dendrite development [GO:0050773]; retina layer formation [GO:0010842]
PGEN_.00g072420	Scaffold_03	40655067	40660204	Q9U3W6	MAB21_DROME	Protein mab-21		
PGEN_.00g072430	Scaffold_03	40681512	40686568	NA	NA	NA	NA	NA
PGEN_.00g072440	Scaffold_03	40692016	40692762	Q8JIS3	DER_CHICK	D-erythrulose reductase (EC 1.1.1.162) (Probable L-xylulose reductase) (XR) (EC 1.1.1.10)	GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0047880; GO:0050038; GO:0051289	"cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g072450	Scaffold_03	40698741	40699713	NA	NA	NA	NA	NA
PGEN_.00g072460	Scaffold_03	40701262	40702011	NA	NA	NA	NA	NA
PGEN_.00g072470	Scaffold_03	40718230	40718976	Q8JIS3	DER_CHICK	D-erythrulose reductase (EC 1.1.1.162) (Probable L-xylulose reductase) (XR) (EC 1.1.1.10)	GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0047880; GO:0050038; GO:0051289	"cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g072480	Scaffold_03	40727235	40732837	Q8VCV9	MF4B1_MOUSE	Sodium-dependent glucose transporter 1A (Major facilitator superfamily domain-containing protein 4B1)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g072490	Scaffold_03	40739162	40740681	NA	NA	NA	NA	NA
PGEN_.00g072500	Scaffold_03	40756756	40761670	NA	NA	NA	NA	NA
PGEN_.00g072510	Scaffold_03	40771067	40771552	NA	NA	NA	NA	NA
PGEN_.00g072520	Scaffold_03	40773845	40793203	NA	NA	NA	NA	NA
PGEN_.00g072530	Scaffold_03	40807305	40807694	NA	NA	NA	NA	NA
PGEN_.00g072540	Scaffold_03	40810256	40821055	NA	NA	NA	NA	NA
PGEN_.00g072550	Scaffold_03	40826332	40864069	Q17IE8	CDK8_AEDAE	Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit Cdk8) (Mediator of RNA polymerase II transcription subunit Cdk8)	GO:0000082; GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0008353	nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; G1/S transition of mitotic cell cycle [GO:0000082]; protein phosphorylation [GO:0006468]
PGEN_.00g072560	Scaffold_03	40865036	40872879	NA	NA	NA	NA	NA
PGEN_.00g072570	Scaffold_03	40880605	40920244	O95835	LATS1_HUMAN	Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)	GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005815; GO:0005829; GO:0006468; GO:0009755; GO:0018105; GO:0019901; GO:0030216; GO:0030331; GO:0030833; GO:0033138; GO:0033146; GO:0034613; GO:0035329; GO:0035556; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051220; GO:0051301; GO:0060644; GO:0090090; GO:2000058	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein complex assembly [GO:0043254]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]
PGEN_.00g072580	Scaffold_03	40932919	40951183	Q5RHB5	LRMP_DANRE	Lymphoid-restricted membrane protein	GO:0000785; GO:0005789; GO:0005813; GO:0007052; GO:0007344; GO:0016021; GO:0031965; GO:0035046; GO:0051028; GO:0051984; GO:0072686; GO:0097431	centrosome [GO:0005813]; chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear membrane [GO:0031965]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; positive regulation of chromosome segregation [GO:0051984]; pronuclear fusion [GO:0007344]; pronuclear migration [GO:0035046]
PGEN_.00g072590	Scaffold_03	40980376	40982480	NA	NA	NA	NA	NA
PGEN_.00g072600	Scaffold_03	40982508	40982765	NA	NA	NA	NA	NA
PGEN_.00g072610	Scaffold_03	40988496	41031343	NA	NA	NA	NA	NA
PGEN_.00g072620	Scaffold_03	41101215	41172321	Q9WUX5	MRVI1_MOUSE	"Protein MRVI1 (Inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate) (JAW1-related protein MRVI1) (Murine retrovirus integration site 1 protein)"	GO:0016021; GO:0016529; GO:0019934; GO:0045986; GO:0048471; GO:0060087	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; cGMP-mediated signaling [GO:0019934]; negative regulation of smooth muscle contraction [GO:0045986]; relaxation of vascular smooth muscle [GO:0060087]
PGEN_.00g072630	Scaffold_03	41218179	41226061	Q63802	WEE1_RAT	Wee1-like protein kinase (EC 2.7.10.2) (Wee1A kinase)	GO:0000226; GO:0000287; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0006468; GO:0007093; GO:0018108; GO:0030010; GO:0048812; GO:0051301	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle checkpoint [GO:0007093]; neuron projection morphogenesis [GO:0048812]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein phosphorylation [GO:0006468]
PGEN_.00g072640	Scaffold_03	41247062	41247277	NA	NA	NA	NA	NA
PGEN_.00g072650	Scaffold_03	41248939	41261540	NA	NA	NA	NA	NA
PGEN_.00g072660	Scaffold_03	41267256	41268244	NA	NA	NA	NA	NA
PGEN_.00g072670	Scaffold_03	41268809	41275720	Q92179	CHST3_CHICK	Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0016021; GO:0030206	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g072680	Scaffold_03	41302196	41310765	Q9CR27	WASC3_MOUSE	WASH complex subunit 3 (Coiled-coil domain-containing protein 53)	GO:0005769; GO:0006887; GO:0015031; GO:0030041; GO:0071203	early endosome [GO:0005769]; WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; exocytosis [GO:0006887]; protein transport [GO:0015031]
PGEN_.00g072690	Scaffold_03	41311134	41344192	Q6P2B1	TNPO3_MOUSE	Transportin-3	GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0008536; GO:0042802; GO:0043231	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]
PGEN_.00g072700	Scaffold_03	41357348	41366498	NA	NA	NA	NA	NA
PGEN_.00g072710	Scaffold_03	41380843	41402559	B0BLT0	ZN593_XENTR	Zinc finger protein 593	GO:0000055; GO:0003676; GO:0008270; GO:0030687; GO:0043023	"preribosome, large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; ribosomal large subunit binding [GO:0043023]; zinc ion binding [GO:0008270]; ribosomal large subunit export from nucleus [GO:0000055]"
PGEN_.00g072720	Scaffold_03	41436078	41451776	Q6DH69	FAH2A_DANRE	Fatty-acid amide hydrolase 2-A (EC 3.5.1.99)	GO:0016021; GO:0102077; GO:0103073	integral component of membrane [GO:0016021]; anandamide amidohydrolase activity [GO:0103073]; oleamide hydrolase activity [GO:0102077]
PGEN_.00g072730	Scaffold_03	41457330	41465311	Q60769	TNAP3_MOUSE	Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 2.3.2.-) (EC 3.4.19.12) (Putative DNA-binding protein A20) (Zinc finger protein A20)	GO:0001922; GO:0002020; GO:0002237; GO:0002315; GO:0002632; GO:0002634; GO:0002637; GO:0002677; GO:0003677; GO:0004842; GO:0004843; GO:0005634; GO:0005737; GO:0005764; GO:0006915; GO:0006954; GO:0007010; GO:0008270; GO:0009611; GO:0010507; GO:0016477; GO:0016579; GO:0019900; GO:0030177; GO:0031397; GO:0032088; GO:0032495; GO:0032691; GO:0032703; GO:0032715; GO:0032720; GO:0034115; GO:0034140; GO:0034148; GO:0035523; GO:0035871; GO:0036459; GO:0042802; GO:0043124; GO:0043130; GO:0043231; GO:0043621; GO:0045088; GO:0045732; GO:0045736; GO:0045824; GO:0048662; GO:0050713; GO:0050728; GO:0050869; GO:0060548; GO:0061578; GO:0070301; GO:0070429; GO:0070433; GO:0070530; GO:0070536; GO:0070936; GO:0071108; GO:0071222; GO:0071947; GO:0072573; GO:0072666; GO:1902042; GO:1903364; GO:1990168; GO:2000347; GO:2000349; GO:2000352	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; kinase binding [GO:0019900]; Lys63-specific deubiquitinase activity [GO:0061578]; protease binding [GO:0002020]; protein self-association [GO:0043621]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B-1 B cell homeostasis [GO:0001922]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytoskeleton organization [GO:0007010]; establishment of protein localization to vacuole [GO:0072666]; inflammatory response [GO:0006954]; marginal zone B cell differentiation [GO:0002315]; negative regulation of autophagy [GO:0010507]; negative regulation of B cell activation [GO:0050869]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of cell death [GO:0060548]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of granuloma formation [GO:0002632]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070429]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of toll-like receptor 5 signaling pathway [GO:0034148]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked deubiquitination [GO:0070536]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of innate immune response [GO:0045088]; response to molecule of bacterial origin [GO:0002237]; response to muramyl dipeptide [GO:0032495]; response to wounding [GO:0009611]; tolerance induction to lipopolysaccharide [GO:0072573]
PGEN_.00g072740	Scaffold_03	41481269	41491104	NA	NA	NA	NA	NA
PGEN_.00g072750	Scaffold_03	41497959	41509673	Q02083	NAAA_HUMAN	N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.60) (Acid ceramidase-like protein) (N-acylsphingosine amidohydrolase-like) (ASAH-like protein) [Cleaved into: N-acylethanolamine-hydrolyzing acid amidase subunit alpha; N-acylethanolamine-hydrolyzing acid amidase subunit beta]	GO:0005737; GO:0005764; GO:0006631; GO:0007269; GO:0008134; GO:0016042; GO:0016810; GO:0017064; GO:0019898; GO:0043202; GO:0047412; GO:0070062; GO:0070291; GO:0098793	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; presynapse [GO:0098793]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-(long-chain-acyl)ethanolamine deacylase activity [GO:0047412]; transcription factor binding [GO:0008134]; fatty acid metabolic process [GO:0006631]; lipid catabolic process [GO:0016042]; N-acylethanolamine metabolic process [GO:0070291]; neurotransmitter secretion [GO:0007269]"
PGEN_.00g072760	Scaffold_03	41498314	41498697	NA	NA	NA	NA	NA
PGEN_.00g072770	Scaffold_03	41511255	41557003	E1C2Z0	MMS22_CHICK	Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like)	GO:0000724; GO:0031297; GO:0043596	nuclear replication fork [GO:0043596]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]
PGEN_.00g072780	Scaffold_03	41560798	41561067	NA	NA	NA	NA	NA
PGEN_.00g072790	Scaffold_03	41566923	41585327	Q99MZ3	MLXPL_MOUSE	Carbohydrate-responsive element-binding protein (ChREBP) (MLX interactor) (MLX-interacting protein-like) (Williams-Beuren syndrome chromosomal region 14 protein homolog)	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0003700; GO:0005623; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006110; GO:0006357; GO:0008134; GO:0008284; GO:0009749; GO:0010255; GO:0019901; GO:0033137; GO:0035538; GO:0042593; GO:0043565; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0071157; GO:0071333; GO:0090324; GO:0097009	"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; cellular response to glucose stimulus [GO:0071333]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]"
PGEN_.00g072800	Scaffold_03	41593049	41593435	NA	NA	NA	NA	NA
PGEN_.00g072810	Scaffold_03	41594641	41598424	Q875Z2	EF2_NAUCC	Elongation factor 2 (EF-2)	GO:0003746; GO:0003924; GO:0005525; GO:0005737	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]
PGEN_.00g072820	Scaffold_03	41599348	41614586	P42322	CANB1_NAEGR	Calcineurin subunit B (Calcineurin regulatory subunit) (Protein phosphatase 2B regulatory subunit)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g072830	Scaffold_03	41617448	41620910	NA	NA	NA	NA	NA
PGEN_.00g072840	Scaffold_03	41621056	41621346	NA	NA	NA	NA	NA
PGEN_.00g072850	Scaffold_03	41621374	41622344	NA	NA	NA	NA	NA
PGEN_.00g072860	Scaffold_03	41631139	41644641	Q80X66	BTBDA_MOUSE	BTB/POZ domain-containing protein 10 (Glucose metabolism-related protein 1)	GO:0001650; GO:0005654; GO:0005737; GO:0042327; GO:0044342; GO:1901215	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342]
PGEN_.00g072870	Scaffold_03	41658960	41669303	B8Q0B2	POPD1_PIG	Blood vessel epicardial substance (Popeye domain-containing protein 1) (Popeye protein 1)	GO:0001921; GO:0002931; GO:0005198; GO:0005886; GO:0005901; GO:0005923; GO:0007507; GO:0007519; GO:0008360; GO:0016020; GO:0016021; GO:0016192; GO:0016328; GO:0030552; GO:0034446; GO:0040017; GO:0042383; GO:0042391; GO:0043087; GO:0051146; GO:0090136	bicellular tight junction [GO:0005923]; caveola [GO:0005901]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cAMP binding [GO:0030552]; structural molecule activity [GO:0005198]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle-mediated transport [GO:0016192]
PGEN_.00g072880	Scaffold_03	41675627	41679714	O15990	KARG_LIOJA	Arginine kinase (AK) (EC 2.7.3.3)	GO:0004054; GO:0004111; GO:0005524; GO:0046314	arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; phosphocreatine biosynthetic process [GO:0046314]
PGEN_.00g072890	Scaffold_03	41706436	41711254	NA	NA	NA	NA	NA
PGEN_.00g072900	Scaffold_03	41722677	41723984	NA	NA	NA	NA	NA
PGEN_.00g072910	Scaffold_03	41738220	41746236	NA	NA	NA	NA	NA
PGEN_.00g072920	Scaffold_03	41753065	41757813	NA	NA	NA	NA	NA
PGEN_.00g072930	Scaffold_03	41772270	41778466	NA	NA	NA	NA	NA
PGEN_.00g072940	Scaffold_03	41778872	41795856	NA	NA	NA	NA	NA
PGEN_.00g072950	Scaffold_03	41799998	41804312	NA	NA	NA	NA	NA
PGEN_.00g072960	Scaffold_03	41807938	41824332	NA	NA	NA	NA	NA
PGEN_.00g072970	Scaffold_03	41836842	41837234	NA	NA	NA	NA	NA
PGEN_.00g072980	Scaffold_03	41859992	41866314	O95563	MPC2_HUMAN	Mitochondrial pyruvate carrier 2 (Brain protein 44)	GO:0005634; GO:0005739; GO:0006850; GO:0031305; GO:0035774; GO:0050833; GO:0061732	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pyruvate transmembrane transporter activity [GO:0050833]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial pyruvate transmembrane transport [GO:0006850]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]
PGEN_.00g072990	Scaffold_03	41877704	41891512	O75486	SUPT3_HUMAN	Transcription initiation protein SPT3 homolog (SPT3-like protein)	GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006355; GO:0006357; GO:0006366; GO:0016578; GO:0030914; GO:0033276; GO:0043966; GO:0045893; GO:0046982	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g073000	Scaffold_03	41896125	41897072	NA	NA	NA	NA	NA
PGEN_.00g073010	Scaffold_03	41900248	41904095	NA	NA	NA	NA	NA
PGEN_.00g073020	Scaffold_03	41930831	41931244	NA	NA	NA	NA	NA
PGEN_.00g073030	Scaffold_03	41963005	41963430	NA	NA	NA	NA	NA
PGEN_.00g073040	Scaffold_03	42004842	42063386	Q63046	RUNX1_RAT	Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B)	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001701; GO:0001889; GO:0002062; GO:0002318; GO:0002667; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005604; GO:0005634; GO:0006355; GO:0007417; GO:0008134; GO:0008285; GO:0009966; GO:0014894; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030728; GO:0030853; GO:0030854; GO:0031069; GO:0032526; GO:0032729; GO:0032743; GO:0035162; GO:0042803; GO:0043371; GO:0043378; GO:0044212; GO:0045766; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0048266; GO:0048663; GO:0048666; GO:0060216; GO:0070491; GO:0071336; GO:0071560; GO:1903431; GO:1990837; GO:1990841; GO:2000872	"basement membrane [GO:0005604]; core-binding factor complex [GO:0016513]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; behavioral response to pain [GO:0048266]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; hair follicle morphogenesis [GO:0031069]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; myeloid cell differentiation [GO:0030099]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; ovulation [GO:0030728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell maturation [GO:1903431]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hair follicle cell proliferation [GO:0071336]; regulation of signal transduction [GO:0009966]; regulation of T cell anergy [GO:0002667]; regulation of transcription, DNA-templated [GO:0006355]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to retinoic acid [GO:0032526]; skeletal system development [GO:0001501]"
PGEN_.00g073050	Scaffold_03	42072835	42074282	NA	NA	NA	NA	NA
PGEN_.00g073060	Scaffold_03	42099846	42101004	NA	NA	NA	NA	NA
PGEN_.00g073070	Scaffold_03	42130106	42131336	NA	NA	NA	NA	NA
PGEN_.00g073080	Scaffold_03	42138074	42220170	NA	NA	NA	NA	NA
PGEN_.00g073090	Scaffold_03	42329557	42347245	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g073100	Scaffold_03	42353196	42353909	NA	NA	NA	NA	NA
PGEN_.00g073110	Scaffold_03	42354011	42357398	NA	NA	NA	NA	NA
PGEN_.00g073120	Scaffold_03	42385029	42386255	NA	NA	NA	NA	NA
PGEN_.00g073130	Scaffold_03	42442061	42456637	NA	NA	NA	NA	NA
PGEN_.00g073140	Scaffold_03	42491163	42491459	NA	NA	NA	NA	NA
PGEN_.00g073150	Scaffold_03	42494566	42494880	NA	NA	NA	NA	NA
PGEN_.00g073160	Scaffold_03	42502195	42502428	NA	NA	NA	NA	NA
PGEN_.00g073170	Scaffold_03	42507242	42507586	NA	NA	NA	NA	NA
PGEN_.00g073180	Scaffold_03	42527912	42544893	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g073190	Scaffold_03	42548762	42557371	Q9U943	APLP_LOCMI	Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]	GO:0005319; GO:0005576; GO:0008289; GO:0016055	extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]
PGEN_.00g073200	Scaffold_03	42594655	42594990	NA	NA	NA	NA	NA
PGEN_.00g073210	Scaffold_03	42606249	42620721	Q7TNT2	FACR2_MOUSE	Fatty acyl-CoA reductase 2 (EC 1.2.1.84)	GO:0005777; GO:0005779; GO:0006629; GO:0010025; GO:0035336; GO:0080019; GO:0102965	integral component of peroxisomal membrane [GO:0005779]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; lipid metabolic process [GO:0006629]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]
PGEN_.00g073220	Scaffold_03	42633060	42649889	Q66H50	FACR1_RAT	Fatty acyl-CoA reductase 1 (EC 1.2.1.84)	GO:0005777; GO:0005779; GO:0008611; GO:0010025; GO:0035336; GO:0046474; GO:0080019; GO:0102965	integral component of peroxisomal membrane [GO:0005779]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid biosynthetic process [GO:0046474]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]
PGEN_.00g073230	Scaffold_03	42667012	42667992	NA	NA	NA	NA	NA
PGEN_.00g073240	Scaffold_03	42668679	42669173	NA	NA	NA	NA	NA
PGEN_.00g073250	Scaffold_03	42710669	42723442	Q922J9	FACR1_MOUSE	Fatty acyl-CoA reductase 1 (EC 1.2.1.84)	GO:0005777; GO:0005779; GO:0008611; GO:0010025; GO:0035336; GO:0046474; GO:0080019; GO:0102965	integral component of peroxisomal membrane [GO:0005779]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid biosynthetic process [GO:0046474]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]
PGEN_.00g073260	Scaffold_03	42759213	42760904	NA	NA	NA	NA	NA
PGEN_.00g073270	Scaffold_03	42763047	42766853	P42620	YQJG_ECOLI	Glutathionyl-hydroquinone reductase YqjG (GS-HQR) (EC 1.8.5.7)	GO:0004364; GO:0005737; GO:0016672	"cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor [GO:0016672]"
PGEN_.00g073280	Scaffold_03	42776758	42790057	Q5TFE4	NT5D1_HUMAN	5'-nucleotidase domain-containing protein 1 (EC 3.1.3.-)	GO:0008253; GO:0046872	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]
PGEN_.00g073290	Scaffold_03	42816908	42860420	Q07954	LRP1_HUMAN	Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]	GO:0001523; GO:0001540; GO:0002020; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005623; GO:0005634; GO:0005765; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0007568; GO:0008283; GO:0010715; GO:0010875; GO:0010942; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030226; GO:0030425; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038023; GO:0038024; GO:0042157; GO:0042953; GO:0043025; GO:0043235; GO:0043277; GO:0043395; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045056; GO:0045177; GO:0045202; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051481; GO:0051895; GO:0061642; GO:0070325; GO:0070374; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905049; GO:1905167; GO:2000587	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; synapse [GO:0045202]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]
PGEN_.00g073300	Scaffold_03	42862748	42863095	NA	NA	NA	NA	NA
PGEN_.00g073310	Scaffold_03	42863191	42875431	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g073320	Scaffold_03	42875487	42876377	Q47944	SDH_GLUOY	L-sorbose 1-dehydrogenase (SDH) (EC 1.1.99.32)	GO:0016614; GO:0050660	"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g073330	Scaffold_03	42880380	42882466	NA	NA	NA	NA	NA
PGEN_.00g073340	Scaffold_03	42883240	42911735	P82933	RT09_HUMAN	"28S ribosomal protein S9, mitochondrial (MRP-S9) (S9mt) (Mitochondrial small ribosomal subunit protein uS9m)"	GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0042769; GO:0070125; GO:0070126	"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; DNA damage response, detection of DNA damage [GO:0042769]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]"
PGEN_.00g073350	Scaffold_03	42904338	42906119	Q15399	TLR1_HUMAN	Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281)	GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0034130; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0038123; GO:0042116; GO:0042495; GO:0042535; GO:0042802; GO:0045087; GO:0045121; GO:0045410; GO:0046982; GO:0071723; GO:0071727; GO:2000484	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; cell activation [GO:0001775]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR1:TLR2 signaling pathway [GO:0038123]
PGEN_.00g073360	Scaffold_03	42917422	42950017	Q9Y3A2	UTP11_HUMAN	Probable U3 small nucleolar RNA-associated protein 11 (U3 snoRNA-associated protein 11) (UTP11-like protein)	GO:0003723; GO:0005615; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0007399; GO:0032040; GO:0043065	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; rRNA processing [GO:0006364]
PGEN_.00g073370	Scaffold_03	42951664	42991962	A2ASS6	TITIN_MOUSE	Titin (EC 2.7.11.1) (Connectin)	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]
PGEN_.00g073380	Scaffold_03	43001579	43011311	Q91WL8	WWOX_MOUSE	WW domain-containing oxidoreductase (EC 1.1.1.-)	GO:0001649; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001238; GO:2001241	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription factor complex [GO:0090575]; enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]; cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055]
PGEN_.00g073390	Scaffold_03	43015832	43017370	Q8BYM5	NLGN3_MOUSE	Neuroligin-3 (Gliotactin homolog)	GO:0002087; GO:0005887; GO:0006898; GO:0007158; GO:0007416; GO:0007612; GO:0008542; GO:0009986; GO:0030054; GO:0030139; GO:0030534; GO:0035176; GO:0038023; GO:0042043; GO:0043025; GO:0045202; GO:0048488; GO:0048675; GO:0048709; GO:0050804; GO:0050808; GO:0050839; GO:0051965; GO:0051966; GO:0051968; GO:0060024; GO:0060076; GO:0060077; GO:0060079; GO:0060080; GO:0060291; GO:0060999; GO:0061001; GO:0061002; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0097151; GO:0098698; GO:0098793; GO:0098978; GO:0098982; GO:0099055; GO:0099060; GO:1900271; GO:1902474; GO:2000310; GO:2000311; GO:2000331; GO:2000463; GO:2000809; GO:2000969	"cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon extension [GO:0048675]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; oligodendrocyte differentiation [GO:0048709]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of terminal button organization [GO:2000331]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; visual learning [GO:0008542]; vocalization behavior [GO:0071625]"
PGEN_.00g073400	Scaffold_03	43030551	43030931	NA	NA	NA	NA	NA
PGEN_.00g073410	Scaffold_03	43031005	43124997	NA	NA	NA	NA	NA
PGEN_.00g073420	Scaffold_03	43104752	43105075	NA	NA	NA	NA	NA
PGEN_.00g073430	Scaffold_03	43199895	43201954	Q8MSU3	FRRS1_DROME	Putative ferric-chelate reductase 1 homolog (DmSDR2) (EC 1.-.-.-)	GO:0000293; GO:0016021; GO:0055114	integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; oxidation-reduction process [GO:0055114]
PGEN_.00g073440	Scaffold_03	43207669	43227959	Q8MSU3	FRRS1_DROME	Putative ferric-chelate reductase 1 homolog (DmSDR2) (EC 1.-.-.-)	GO:0000293; GO:0016021; GO:0055114	integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; oxidation-reduction process [GO:0055114]
PGEN_.00g073450	Scaffold_03	43237145	43251118	Q6INU7	FRRS1_XENLA	Putative ferric-chelate reductase 1 (EC 1.-.-.-)	GO:0016021; GO:0016491	integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]
PGEN_.00g073460	Scaffold_03	43255080	43257285	NA	NA	NA	NA	NA
PGEN_.00g073470	Scaffold_03	43261873	43271459	Q95K40	CCD83_MACFA	Coiled-coil domain-containing protein 83		
PGEN_.00g073480	Scaffold_03	43383311	43408535	Q63HN8	RN213_HUMAN	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g073490	Scaffold_03	43409504	43411979	NA	NA	NA	NA	NA
PGEN_.00g073500	Scaffold_03	43413818	43579766	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g073510	Scaffold_03	43627692	43633329	NA	NA	NA	NA	NA
PGEN_.00g073520	Scaffold_03	43636760	43637782	Q9TTR7	COT2_BOVIN	COUP transcription factor 2 (COUP-TF2) (COUP transcription factor II) (COUP-TF II) (Nuclear receptor subfamily 2 group F member 2)	GO:0000122; GO:0000977; GO:0001764; GO:0001893; GO:0001937; GO:0001972; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007519; GO:0008270; GO:0009566; GO:0009952; GO:0009956; GO:0010596; GO:0030154; GO:0030900; GO:0042803; GO:0045736; GO:0045893; GO:0048514; GO:0048856; GO:0060173; GO:0060674; GO:0060707; GO:0060849	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; fertilization [GO:0009566]; forebrain development [GO:0030900]; limb development [GO:0060173]; maternal placenta development [GO:0001893]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; placenta blood vessel development [GO:0060674]; positive regulation of transcription, DNA-templated [GO:0045893]; radial pattern formation [GO:0009956]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in lymphatic endothelial cell fate commitment [GO:0060849]; skeletal muscle tissue development [GO:0007519]; trophoblast giant cell differentiation [GO:0060707]"
PGEN_.00g073530	Scaffold_03	43653374	43658173	Q7KSC4	MPC1_DROME	Mitochondrial pyruvate carrier 1 (MPC1)	GO:0005739; GO:0006090; GO:0006850; GO:0031305; GO:0050833	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; pyruvate transmembrane transporter activity [GO:0050833]; mitochondrial pyruvate transmembrane transport [GO:0006850]; pyruvate metabolic process [GO:0006090]
PGEN_.00g073540	Scaffold_03	43668251	43680098	Q8HXM1	CSTF2_BOVIN	Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64)	GO:0003723; GO:0003729; GO:0005847; GO:0006378; GO:0071920; GO:0098789	cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]
PGEN_.00g073550	Scaffold_03	43685587	43704156	Q3V384	AFG1L_MOUSE	AFG1-like ATPase (EC 3.6.-.-) (Lactation elevated protein 1)	GO:0005524; GO:0005737; GO:0005739; GO:0006123; GO:0007005; GO:0016887; GO:0031966; GO:0035694	"cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]"
PGEN_.00g073560	Scaffold_03	43728060	43743506	Q07243	MTF1_MOUSE	Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1)	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0006979; GO:0007417; GO:0035035; GO:0045893; GO:0045944; GO:0046686; GO:0046872	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; central nervous system development [GO:0007417]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]"
PGEN_.00g073570	Scaffold_03	43749155	43757896	Q4PMB3	RS4_IXOSC	40S ribosomal protein S4	GO:0003735; GO:0005840; GO:0006412; GO:0019843	ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g073580	Scaffold_03	43761204	43771849	NA	NA	NA	NA	NA
PGEN_.00g073590	Scaffold_03	43777549	43780847	Q964E0	ACTC_BIOTE	"Actin, cytoplasmic [Cleaved into: Actin, cytoplasmic, intermediate form]"	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g073600	Scaffold_03	43808587	43812366	Q5BIM1	TRI45_BOVIN	Tripartite motif-containing protein 45	GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
PGEN_.00g073610	Scaffold_03	43814549	43821235	Q8N0W4	NLGNX_HUMAN	"Neuroligin-4, X-linked (Neuroligin X) (HNLX)"	GO:0003360; GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0016021; GO:0021549; GO:0030054; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0071625; GO:0089717; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"
PGEN_.00g073620	Scaffold_03	43824762	43830356	Q8N0W4	NLGNX_HUMAN	"Neuroligin-4, X-linked (Neuroligin X) (HNLX)"	GO:0003360; GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0016021; GO:0021549; GO:0030054; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0071625; GO:0089717; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"
PGEN_.00g073630	Scaffold_03	43832217	43845968	O60678	ANM3_HUMAN	Protein arginine N-methyltransferase 3 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3)	GO:0003676; GO:0005634; GO:0005737; GO:0005829; GO:0006479; GO:0008168; GO:0016274; GO:0031397; GO:0043022; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-arginine N-methyltransferase activity [GO:0016274]; ribosome binding [GO:0043022]; negative regulation of protein ubiquitination [GO:0031397]; protein methylation [GO:0006479]
PGEN_.00g073640	Scaffold_03	43886160	43898730	Q2TBS2	RM21_BOVIN	"39S ribosomal protein L21, mitochondrial (L21mt) (MRP-L21)"	GO:0003735; GO:0005743; GO:0005762	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]
PGEN_.00g073650	Scaffold_03	43913493	43929762	NA	NA	NA	NA	NA
PGEN_.00g073660	Scaffold_03	43940041	43940364	NA	NA	NA	NA	NA
PGEN_.00g073670	Scaffold_03	44073862	44109805	Q8BQH6	CDCP2_MOUSE	CUB domain-containing protein 2	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g073680	Scaffold_03	44125128	44156638	P47990	XDH_CHICK	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949	"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]"
PGEN_.00g073690	Scaffold_03	44167439	44178459	NA	NA	NA	NA	NA
PGEN_.00g073700	Scaffold_03	44204798	44236229	NA	NA	NA	NA	NA
PGEN_.00g073710	Scaffold_03	44255793	44362253	O35889	AFAD_RAT	Afadin (Afadin adherens junction formation factor) (Protein Af-6)	GO:0005737; GO:0005829; GO:0005911; GO:0005912; GO:0005913; GO:0007165; GO:0010628; GO:0017016; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0043547; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0140059; GO:1902414; GO:1903861; GO:2000049	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pore complex [GO:0046930]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; Ras GTPase binding [GO:0017016]; adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]
PGEN_.00g073720	Scaffold_03	44369125	44398583	Q61371	IFT88_MOUSE	Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10) (TgN(Imorpk)737Rpw)	GO:0001654; GO:0001822; GO:0001886; GO:0001889; GO:0002080; GO:0002081; GO:0005737; GO:0005802; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007288; GO:0007290; GO:0007368; GO:0007399; GO:0007420; GO:0007507; GO:0008104; GO:0008544; GO:0009887; GO:0009952; GO:0009953; GO:0019894; GO:0021513; GO:0021537; GO:0030324; GO:0030992; GO:0031016; GO:0031122; GO:0031514; GO:0032391; GO:0034405; GO:0036064; GO:0036126; GO:0036334; GO:0042073; GO:0042487; GO:0042733; GO:0043568; GO:0045598; GO:0048853; GO:0050680; GO:0055007; GO:0060091; GO:0060122; GO:0060173; GO:0060259; GO:0060271; GO:0060411; GO:0060426; GO:0060914; GO:0061351; GO:0070613; GO:0090102; GO:0097541; GO:0097542; GO:0097546; GO:0097730; GO:1902017; GO:1903929; GO:1905515; GO:2000785	acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]; kinesin binding [GO:0019894]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; sperm axoneme assembly [GO:0007288]; spermatid nucleus elongation [GO:0007290]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537]
PGEN_.00g073730	Scaffold_03	44400808	44402193	NA	NA	NA	NA	NA
PGEN_.00g073740	Scaffold_03	44449619	44449858	NA	NA	NA	NA	NA
PGEN_.00g073750	Scaffold_03	44462454	44488124	B4PTD3	FOXO_DROYA	Forkhead box protein O	GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0007049; GO:0008285; GO:0010259; GO:0019216; GO:0030154; GO:0030308; GO:0042593; GO:0043565; GO:0046627	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g073760	Scaffold_03	44538545	44542749	Q24307	DIAP2_DROME	Death-associated inhibitor of apoptosis 2 (Apoptosis 2 inhibitor) (IAP homolog A) (IAP-like protein) (ILP) (dILP) (Inhibitor of apoptosis 2)	GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006964; GO:0008270; GO:0016567; GO:0022416; GO:0031398; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0043281; GO:0045087; GO:0048471; GO:0050829; GO:0061057; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chaeta development [GO:0022416]; defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g073770	Scaffold_03	44549102	44549467	NA	NA	NA	NA	NA
PGEN_.00g073780	Scaffold_03	44556966	44598968	Q96D71	REPS1_HUMAN	RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1)	GO:0005509; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0017124; GO:0061024	clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]; membrane organization [GO:0061024]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g073790	Scaffold_03	44652122	44655937	Q9NBX4	RTXE_DROME	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	GO:0003964; GO:0006313	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g073800	Scaffold_03	44661440	44678560	NA	NA	NA	NA	NA
PGEN_.00g073810	Scaffold_03	44694542	44718447	NA	NA	NA	NA	NA
PGEN_.00g073820	Scaffold_03	44718564	44726254	NA	NA	NA	NA	NA
PGEN_.00g073830	Scaffold_03	44760794	44761750	NA	NA	NA	NA	NA
PGEN_.00g073840	Scaffold_03	44764314	44796662	NA	NA	NA	NA	NA
PGEN_.00g073850	Scaffold_03	44799521	44815692	NA	NA	NA	NA	NA
PGEN_.00g073860	Scaffold_03	44828961	44832855	NA	NA	NA	NA	NA
PGEN_.00g073870	Scaffold_03	44836747	44838261	Q10038	VHP1_CAEEL	Tyrosine-protein phosphatase vhp-1 (EC 3.1.3.48) (Vh1 dual specificity phosphatase family protein 1)	GO:0000187; GO:0000188; GO:0001933; GO:0002119; GO:0004725; GO:0005634; GO:0005737; GO:0006470; GO:0006986; GO:0008138; GO:0008340; GO:0008579; GO:0017017; GO:0046329; GO:0046686; GO:0046688; GO:0048692; GO:0051019; GO:1900180; GO:1900181; GO:1900182; GO:1900425; GO:1900426; GO:1903854	cytoplasm [GO:0005737]; nucleus [GO:0005634]; JUN kinase phosphatase activity [GO:0008579]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; activation of MAPK activity [GO:0000187]; determination of adult lifespan [GO:0008340]; inactivation of MAPK activity [GO:0000188]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress response to copper ion [GO:1903854]; nematode larval development [GO:0002119]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of protein localization to nucleus [GO:1900182]; protein dephosphorylation [GO:0006470]; regulation of protein localization to nucleus [GO:1900180]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to unfolded protein [GO:0006986]
PGEN_.00g073880	Scaffold_03	44866610	44867078	NA	NA	NA	NA	NA
PGEN_.00g073890	Scaffold_03	44869292	44903250	Q9NFT7	HXK2_DROME	Hexokinase type 2 (EC 2.7.1.1)	GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005623; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158	cell [GO:0005623]; cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]
PGEN_.00g073900	Scaffold_03	44906288	44906871	NA	NA	NA	NA	NA
PGEN_.00g073910	Scaffold_03	44922549	44964976	P22334	ILP_BRACL	Insulin-like peptide [Cleaved into: Insulin-like peptide B chain; Insulin-like peptide A chain]	GO:0005179; GO:0005576; GO:0006006	extracellular region [GO:0005576]; hormone activity [GO:0005179]; glucose metabolic process [GO:0006006]
PGEN_.00g073920	Scaffold_03	44976777	44977607	NA	NA	NA	NA	NA
PGEN_.00g073930	Scaffold_03	45051297	45060720	NA	NA	NA	NA	NA
PGEN_.00g073940	Scaffold_03	45086571	45105694	NA	NA	NA	NA	NA
PGEN_.00g073950	Scaffold_03	45106839	45110083	NA	NA	NA	NA	NA
PGEN_.00g073960	Scaffold_03	45134410	45189950	Q9Z0H4	CELF2_MOUSE	CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (mETR-3) (Neuroblastoma apoptosis-related RNA-binding protein) (mNapor) (RNA-binding protein BRUNOL-3)	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0036002; GO:1990904	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"
PGEN_.00g073970	Scaffold_03	45171374	45172532	NA	NA	NA	NA	NA
PGEN_.00g073980	Scaffold_03	45179614	45179886	NA	NA	NA	NA	NA
PGEN_.00g073990	Scaffold_03	45193872	45218103	Q7T2T1	CELF2_CHICK	CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (RNA-binding protein BRUNOL-3)	GO:0000166; GO:0000380; GO:0000381; GO:0000900; GO:0003676; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0042835; GO:1990904	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; BRE binding [GO:0042835]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"
PGEN_.00g074000	Scaffold_03	45237664	45238692	NA	NA	NA	NA	NA
PGEN_.00g074010	Scaffold_03	45242612	45242914	NA	NA	NA	NA	NA
PGEN_.00g074020	Scaffold_03	45243635	45244255	NA	NA	NA	NA	NA
PGEN_.00g074030	Scaffold_03	45262658	45266297	NA	NA	NA	NA	NA
PGEN_.00g074040	Scaffold_03	45266573	45266980	NA	NA	NA	NA	NA
PGEN_.00g074050	Scaffold_03	45267103	45271581	NA	NA	NA	NA	NA
PGEN_.00g074060	Scaffold_03	45277612	45278205	NA	NA	NA	NA	NA
PGEN_.00g074070	Scaffold_03	45280701	45281804	NA	NA	NA	NA	NA
PGEN_.00g074080	Scaffold_03	45282021	45286253	P70665	SIAE_MOUSE	Sialate O-acetylesterase (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase) (Yolk sac protein 2) [Cleaved into: Sialate O-acetylesterase small subunit; Sialate O-acetylesterase large subunit]	GO:0001681; GO:0002682; GO:0005764; GO:0005975	lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]
PGEN_.00g074090	Scaffold_03	45295815	45296450	NA	NA	NA	NA	NA
PGEN_.00g074100	Scaffold_03	45305230	45330035	O15078	CE290_HUMAN	Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87) (CT87) (Nephrocystin-6) (Tumor antigen se2-2)	GO:0000086; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010389; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043312; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711	"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; G2/M transition of mitotic cell cycle [GO:0000086]; hindbrain development [GO:0030902]; neutrophil degranulation [GO:0043312]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]"
PGEN_.00g074110	Scaffold_03	45344699	45352267	O15078	CE290_HUMAN	Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87) (CT87) (Nephrocystin-6) (Tumor antigen se2-2)	GO:0000086; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010389; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043312; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711	"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; G2/M transition of mitotic cell cycle [GO:0000086]; hindbrain development [GO:0030902]; neutrophil degranulation [GO:0043312]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]"
PGEN_.00g074120	Scaffold_03	45360442	45372541	Q3ZBH0	TCPB_BOVIN	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0007339; GO:0031625; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]
PGEN_.00g074130	Scaffold_03	45449887	45452288	NA	NA	NA	NA	NA
PGEN_.00g074140	Scaffold_03	45516580	45517989	NA	NA	NA	NA	NA
PGEN_.00g074150	Scaffold_03	45533364	45567730	Q9JLB4	CUBN_MOUSE	Cubilin (Intrinsic factor-cobalamin receptor)	GO:0001701; GO:0005509; GO:0005623; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0045177; GO:0070062	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]
PGEN_.00g074160	Scaffold_03	45588861	45602147	NA	NA	NA	NA	NA
PGEN_.00g074170	Scaffold_03	45609977	45610237	NA	NA	NA	NA	NA
PGEN_.00g074180	Scaffold_03	45610302	45652962	NA	NA	NA	NA	NA
PGEN_.00g074190	Scaffold_03	45646934	45648841	NA	NA	NA	NA	NA
PGEN_.00g074200	Scaffold_03	45662545	45773486	Q9JLB4	CUBN_MOUSE	Cubilin (Intrinsic factor-cobalamin receptor)	GO:0001701; GO:0005509; GO:0005623; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0045177; GO:0070062	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]
PGEN_.00g074210	Scaffold_03	45782932	45794184	B0VXW0	OXLA_SISCA	L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2)	GO:0001716; GO:0005576; GO:0006915; GO:0009405; GO:0042742; GO:0044179; GO:0090729	extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; toxin activity [GO:0090729]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; hemolysis in other organism [GO:0044179]; pathogenesis [GO:0009405]
PGEN_.00g074220	Scaffold_03	45798598	45813570	A8QL52	OXLA_BUNFA	L-amino-acid oxidase (Bf-LAAO) (LAO) (EC 1.4.3.2)	GO:0001716; GO:0005576; GO:0006915; GO:0009405; GO:0042742; GO:0044179; GO:0090729	extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; toxin activity [GO:0090729]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; hemolysis in other organism [GO:0044179]; pathogenesis [GO:0009405]
PGEN_.00g074230	Scaffold_03	45819125	45828423	O34363	YOBN_BACSU	Putative L-amino-acid oxidase YobN (EC 1.4.3.2)	GO:0001716; GO:0009063; GO:0016491	L-amino-acid oxidase activity [GO:0001716]; oxidoreductase activity [GO:0016491]; cellular amino acid catabolic process [GO:0009063]
PGEN_.00g074240	Scaffold_03	45833451	45849260	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g074250	Scaffold_03	45858620	45875804	O08966	S22A1_MOUSE	Solute carrier family 22 member 1 (Organic cation transporter 1) (mOCT1)	GO:0005277; GO:0005330; GO:0005334; GO:0005887; GO:0006812; GO:0006855; GO:0008504; GO:0008513; GO:0010248; GO:0015101; GO:0015651; GO:0015695; GO:0015697; GO:0015844; GO:0015872; GO:0015874; GO:0016323; GO:0042802; GO:0042803; GO:0048241; GO:0051260; GO:0098655	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; protein homodimerization activity [GO:0042803]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; dopamine transport [GO:0015872]; drug transmembrane transport [GO:0006855]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; monoamine transport [GO:0015844]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; protein homooligomerization [GO:0051260]; quaternary ammonium group transport [GO:0015697]
PGEN_.00g074260	Scaffold_03	45880857	45913208	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g074270	Scaffold_03	45924666	45936322	Q5ZL33	STRAP_CHICK	Serine-threonine kinase receptor-associated protein	GO:0000122; GO:0000387; GO:0005102; GO:0005634; GO:0005829; GO:0010633; GO:0010719; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:0050680; GO:0060394	cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387]
PGEN_.00g074280	Scaffold_03	45943542	45953048	Q0MQE6	NDUB8_GORGO	"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)"	GO:0005747; GO:0005783; GO:0006120; GO:0008137; GO:0016021; GO:0032981	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"
PGEN_.00g074290	Scaffold_03	46034996	46040856	NA	NA	NA	NA	NA
PGEN_.00g074300	Scaffold_03	46180532	46180744	NA	NA	NA	NA	NA
PGEN_.00g074310	Scaffold_03	46199397	46208715	NA	NA	NA	NA	NA
PGEN_.00g074320	Scaffold_03	46475788	46477067	O14084	IMT1_SCHPO	Inositol phosphoceramide mannosyltransferase 1 (EC 2.4.-.-) (IPC mannosyltransferase 1)	GO:0000030; GO:0005537; GO:0005794; GO:0016021; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; mannose binding [GO:0005537]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g074330	Scaffold_03	46486981	46495965	P52809	RL44_CYBJA	60S ribosomal protein L44 (60S ribosomal protein L41)	GO:0003735; GO:0005840; GO:0006412; GO:0046898	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; response to cycloheximide [GO:0046898]; translation [GO:0006412]
PGEN_.00g074340	Scaffold_03	46506096	46524659	A2ASQ1	AGRIN_MOUSE	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007416; GO:0007528; GO:0008045; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0016358; GO:0030054; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051290; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]
PGEN_.00g074350	Scaffold_03	46527541	46531204	NA	NA	NA	NA	NA
PGEN_.00g074360	Scaffold_03	46639012	46649206	P98170	XIAP_HUMAN	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0016055; GO:0030510; GO:0031398; GO:0042127; GO:0042802; GO:0043027; GO:0043066; GO:0043154; GO:0045088; GO:0046872; GO:0050727; GO:0051402; GO:0055070; GO:0061630; GO:0070424; GO:0090263; GO:1902530; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055]
PGEN_.00g074370	Scaffold_03	46743061	46743951	NA	NA	NA	NA	NA
PGEN_.00g074380	Scaffold_03	46744866	46760952	Q13702	RAPSN_HUMAN	43 kDa receptor-associated protein of the synapse (RAPsyn) (43 kDa postsynaptic protein) (Acetylcholine receptor-associated 43 kDa protein) (RING finger protein 205)	GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0007268; GO:0007271; GO:0030054; GO:0031594; GO:0033130; GO:0035255; GO:0043495; GO:0043525; GO:0046872; GO:0099634; GO:1900075; GO:1901626; GO:1903540	"cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; acetylcholine receptor binding [GO:0033130]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; protein membrane anchor [GO:0043495]; chemical synaptic transmission [GO:0007268]; establishment of protein localization to postsynaptic membrane [GO:1903540]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of postsynaptic membrane organization [GO:1901626]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g074390	Scaffold_03	46869821	46870670	NA	NA	NA	NA	NA
PGEN_.00g074400	Scaffold_03	46898688	46907669	Q9GPR3	TM2D1_DICDI	TM2 domain-containing protein DDB_G0277895	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g074410	Scaffold_03	46967990	46971736	Q9V477	TOLL8_DROME	Toll-like receptor Tollo (Toll-like receptor 8)	GO:0002227; GO:0003401; GO:0007165; GO:0016021; GO:0016324; GO:0048935; GO:0060026; GO:0060049	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response in mucosa [GO:0002227]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]
PGEN_.00g074420	Scaffold_03	46981260	46988614	NA	NA	NA	NA	NA
PGEN_.00g074430	Scaffold_03	47069707	47070891	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g074440	Scaffold_03	47077314	47105855	NA	NA	NA	NA	NA
PGEN_.00g074450	Scaffold_03	47118667	47120609	NA	NA	NA	NA	NA
PGEN_.00g074460	Scaffold_03	47126297	47133344	A2RUV0	NOTC1_XENTR	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g074470	Scaffold_03	47146639	47148856	NA	NA	NA	NA	NA
PGEN_.00g074480	Scaffold_03	47151604	47197008	P98068	SPAN_STRPU	Protein SpAN (EC 3.4.24.-)	GO:0004222; GO:0007275; GO:0008270	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]
PGEN_.00g074490	Scaffold_03	47206860	47213670	Q8WZ60	KLHL6_HUMAN	Kelch-like protein 6	GO:0002467; GO:0009617; GO:0050853	B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617]
PGEN_.00g074500	Scaffold_03	47221778	47243082	NA	NA	NA	NA	NA
PGEN_.00g074510	Scaffold_03	47251221	47258593	Q7ZUG0	RUXE_DANRE	Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE)	GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007	"cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"
PGEN_.00g074520	Scaffold_03	47268949	47271238	Q9Y530	OARD1_HUMAN	ADP-ribose glycohydrolase OARD1 (O-acetyl-ADP-ribose deacetylase 1) (EC 3.5.1.-) (Terminal ADP-ribose protein glycohydrolase 1) ([Protein ADP-ribosylglutamate] hydrolase OARD1) (EC 3.2.2.-)	GO:0001883; GO:0005654; GO:0005730; GO:0006974; GO:0042278; GO:0051725; GO:0061463; GO:0090734; GO:0140291; GO:0140293	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]
PGEN_.00g074530	Scaffold_03	47335480	47337148	NA	NA	NA	NA	NA
PGEN_.00g074540	Scaffold_03	47362042	47362401	NA	NA	NA	NA	NA
PGEN_.00g074550	Scaffold_03	47362543	47362812	NA	NA	NA	NA	NA
PGEN_.00g074560	Scaffold_03	47362904	47366453	NA	NA	NA	NA	NA
PGEN_.00g074570	Scaffold_03	47421574	47422815	Q96IP4	TET5A_HUMAN	Terminal nucleotidyltransferase 5A (EC 2.7.7.-) (HBV X-transactivated gene 11 protein) (HBV XAg-transactivated protein 11)	GO:0003723; GO:0009617; GO:1990817	RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; response to bacterium [GO:0009617]
PGEN_.00g074580	Scaffold_03	47422900	47426213	NA	NA	NA	NA	NA
PGEN_.00g074590	Scaffold_03	47427323	47435595	NA	NA	NA	NA	NA
PGEN_.00g074600	Scaffold_03	47507183	47507551	NA	NA	NA	NA	NA
PGEN_.00g074610	Scaffold_03	47558470	47574131	Q5R8X9	AMN1_PONAB	Protein AMN1 homolog		
PGEN_.00g074620	Scaffold_03	47575040	47575958	NA	NA	NA	NA	NA
PGEN_.00g074630	Scaffold_03	47582013	47585146	Q3MID3	ARFG2_RAT	ADP-ribosylation factor GTPase-activating protein 2 (ARF GAP 2) (GTPase-activating protein ZNF289) (Zinc finger protein 289)	GO:0000139; GO:0005096; GO:0005829; GO:0005886; GO:0015031; GO:0046872; GO:0048205	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; protein transport [GO:0015031]
PGEN_.00g074640	Scaffold_03	47608530	47608922	NA	NA	NA	NA	NA
PGEN_.00g074650	Scaffold_03	47637455	47638281	NA	NA	NA	NA	NA
PGEN_.00g074660	Scaffold_03	47642696	47649403	NA	NA	NA	NA	NA
PGEN_.00g074670	Scaffold_03	47649600	47650679	NA	NA	NA	NA	NA
PGEN_.00g074680	Scaffold_03	47650861	47651178	NA	NA	NA	NA	NA
PGEN_.00g074690	Scaffold_03	47663971	47664339	NA	NA	NA	NA	NA
PGEN_.00g074700	Scaffold_03	47665183	47665545	NA	NA	NA	NA	NA
PGEN_.00g074710	Scaffold_03	47673710	47678691	Q9R0N7	SYT7_MOUSE	Synaptotagmin-7 (Synaptotagmin VII) (SytVII)	GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006909; GO:0008021; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030425; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0043025; GO:0043679; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070092; GO:0070382; GO:0071277; GO:0090119; GO:0090385; GO:0098686; GO:0098978; GO:0098982; GO:0099056; GO:0099502; GO:1900242; GO:1990926; GO:1990927	"axon terminus [GO:0043679]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g074720	Scaffold_03	47688448	47689089	NA	NA	NA	NA	NA
PGEN_.00g074730	Scaffold_03	47794565	47808423	P41437	IAP3_NPVOP	E3 ubiquitin-protein ligase IAP-3 (EC 2.3.2.27) (IAP-3) (RING-type E3 ubiquitin transferase IAP-3)	GO:0016740; GO:0039648; GO:0046872	metal ion binding [GO:0046872]; transferase activity [GO:0016740]; modulation by virus of host protein ubiquitination [GO:0039648]
PGEN_.00g074740	Scaffold_03	47831151	47836596	NA	NA	NA	NA	NA
PGEN_.00g074750	Scaffold_03	47867910	47868293	NA	NA	NA	NA	NA
PGEN_.00g074760	Scaffold_03	47887139	47888239	NA	NA	NA	NA	NA
PGEN_.00g074770	Scaffold_03	47894275	47903471	NA	NA	NA	NA	NA
PGEN_.00g074780	Scaffold_03	47906607	47906957	NA	NA	NA	NA	NA
PGEN_.00g074790	Scaffold_03	48065462	48065803	NA	NA	NA	NA	NA
PGEN_.00g074800	Scaffold_03	48201164	48242027	P42260	GRIK2_RAT	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6)"	GO:0001662; GO:0004970; GO:0005234; GO:0005623; GO:0005886; GO:0005887; GO:0006874; GO:0006886; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0016020; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0042802; GO:0043025; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060079; GO:0060080; GO:0098686; GO:0098839; GO:0098978; GO:0099507; GO:1904315	"axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g074810	Scaffold_03	48262904	48305803	P39086	GRIK1_HUMAN	"Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5)"	GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0007399; GO:0007417; GO:0008066; GO:0015277; GO:0030054; GO:0032983; GO:0035249; GO:0042734; GO:0045211; GO:0050804; GO:0051966; GO:0098839; GO:1904315	"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; nervous system development [GO:0007399]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g074820	Scaffold_03	48326443	48326697	NA	NA	NA	NA	NA
PGEN_.00g074830	Scaffold_03	48378398	48378616	NA	NA	NA	NA	NA
PGEN_.00g074840	Scaffold_03	48471333	48474363	NA	NA	NA	NA	NA
PGEN_.00g074850	Scaffold_03	48483814	48495055	NA	NA	NA	NA	NA
PGEN_.00g074860	Scaffold_03	48510705	48511070	NA	NA	NA	NA	NA
PGEN_.00g074870	Scaffold_03	48519672	48521291	Q5ZEQ8	FJX1_XIPMA	Four-jointed box protein 1 (Four-jointed protein homolog)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g074880	Scaffold_03	48521365	48524899	NA	NA	NA	NA	NA
PGEN_.00g074890	Scaffold_03	48582469	48590277	Q9UTA8	YL8A_SCHPO	Uncharacterized methyltransferase-like C25B8.10 (EC 2.1.1.-)	GO:0005634; GO:0005829; GO:0032259; GO:0046547; GO:1990748	cytosol [GO:0005829]; nucleus [GO:0005634]; trans-aconitate 3-methyltransferase activity [GO:0046547]; cellular detoxification [GO:1990748]; methylation [GO:0032259]
PGEN_.00g074900	Scaffold_03	48593907	48604449	NA	NA	NA	NA	NA
PGEN_.00g074910	Scaffold_03	48615976	48640138	Q5FWK3	RHG01_MOUSE	Rho GTPase-activating protein 1 (Rho-type GTPase-activating protein 1)	GO:0001726; GO:0005096; GO:0005737; GO:0005886; GO:0007264; GO:0010008; GO:0016197; GO:0017124; GO:0017137; GO:0031252; GO:0033572; GO:0043087; GO:0048471; GO:2001136	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; SH3 domain binding [GO:0017124]; endosomal transport [GO:0016197]; negative regulation of endocytic recycling [GO:2001136]; regulation of GTPase activity [GO:0043087]; small GTPase mediated signal transduction [GO:0007264]; transferrin transport [GO:0033572]
PGEN_.00g074920	Scaffold_03	48671014	48682951	Q14432	PDE3A_HUMAN	"cGMP-inhibited 3',5'-cyclic phosphodiesterase A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A)"	GO:0001556; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0016021; GO:0019933; GO:0019934; GO:0040020; GO:0042493; GO:0043066; GO:0043116; GO:0043117; GO:0043951; GO:0046872; GO:0060282; GO:0071321; GO:0071560	"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493]"
PGEN_.00g074930	Scaffold_03	48693602	48711879	Q14432	PDE3A_HUMAN	"cGMP-inhibited 3',5'-cyclic phosphodiesterase A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A)"	GO:0001556; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0016021; GO:0019933; GO:0019934; GO:0040020; GO:0042493; GO:0043066; GO:0043116; GO:0043117; GO:0043951; GO:0046872; GO:0060282; GO:0071321; GO:0071560	"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493]"
PGEN_.00g074940	Scaffold_03	48731713	48731937	NA	NA	NA	NA	NA
PGEN_.00g074950	Scaffold_03	48782614	48782913	NA	NA	NA	NA	NA
PGEN_.00g074960	Scaffold_03	48827583	48828473	Q14432	PDE3A_HUMAN	"cGMP-inhibited 3',5'-cyclic phosphodiesterase A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A)"	GO:0001556; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0016021; GO:0019933; GO:0019934; GO:0040020; GO:0042493; GO:0043066; GO:0043116; GO:0043117; GO:0043951; GO:0046872; GO:0060282; GO:0071321; GO:0071560	"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493]"
PGEN_.00g074970	Scaffold_03	48845140	48845472	NA	NA	NA	NA	NA
PGEN_.00g074980	Scaffold_03	48896497	48896865	NA	NA	NA	NA	NA
PGEN_.00g074990	Scaffold_03	48898444	48900101	NA	NA	NA	NA	NA
PGEN_.00g075000	Scaffold_03	48918085	48919936	NA	NA	NA	NA	NA
PGEN_.00g075010	Scaffold_03	48920204	48920632	NA	NA	NA	NA	NA
PGEN_.00g075020	Scaffold_03	48929121	48938729	Q63663	GBP2_RAT	Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2) (p67)	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005794; GO:0009617; GO:0020005; GO:0031410; GO:0034504; GO:0035458; GO:0042803; GO:0042832; GO:0044406; GO:0048471; GO:0050830; GO:0071222; GO:0071346; GO:0071347; GO:0071356	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; protein localization to nucleus [GO:0034504]; response to bacterium [GO:0009617]
PGEN_.00g075030	Scaffold_03	48958764	48964770	P61216	TAF13_MOUSE	Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18)	GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0005669; GO:0005730; GO:0006357; GO:0006366; GO:0008022; GO:0046982	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g075040	Scaffold_03	48971136	49074974	Q13393	PLD1_HUMAN	Phospholipase D1 (PLD 1) (hPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1)	GO:0000139; GO:0004630; GO:0005765; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006654; GO:0006935; GO:0007264; GO:0007265; GO:0016020; GO:0016042; GO:0016324; GO:0030139; GO:0031902; GO:0032534; GO:0035091; GO:0035579; GO:0043312; GO:0048017; GO:0048471; GO:0048870; GO:0070290; GO:0070821; GO:0098693; GO:0098981	apical plasma membrane [GO:0016324]; cholinergic synapse [GO:0098981]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; cell motility [GO:0048870]; chemotaxis [GO:0006935]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; neutrophil degranulation [GO:0043312]; phosphatidic acid biosynthetic process [GO:0006654]; Ras protein signal transduction [GO:0007265]; regulation of microvillus assembly [GO:0032534]; regulation of synaptic vesicle cycle [GO:0098693]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g075050	Scaffold_03	49105114	49122162	Q6P7W0	SENP6_MOUSE	Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6)	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016925; GO:0016926; GO:0070139; GO:0070646; GO:0090169; GO:0090234	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]
PGEN_.00g075060	Scaffold_03	49136295	49150622	Q8CH62	LTO1_MOUSE	Protein LTO1 homolog (Oral cancer-overexpressed protein 1 homolog)	GO:0000723; GO:0005634; GO:0006413; GO:0042273; GO:0106035	nucleus [GO:0005634]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; ribosomal large subunit biogenesis [GO:0042273]; telomere maintenance [GO:0000723]; translational initiation [GO:0006413]
PGEN_.00g075070	Scaffold_03	49164157	49176153	Q8MP06	SNO1_TYRJA	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	GO:0004499; GO:0005576; GO:0009820; GO:0033784; GO:0050660; GO:0050661; GO:0051289; GO:0055114	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
PGEN_.00g075080	Scaffold_03	49191462	49191764	NA	NA	NA	NA	NA
PGEN_.00g075090	Scaffold_03	49205521	49207266	Q5ZEQ8	FJX1_XIPMA	Four-jointed box protein 1 (Four-jointed protein homolog)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g075100	Scaffold_03	49229882	49232024	NA	NA	NA	NA	NA
PGEN_.00g075110	Scaffold_03	49233821	49253797	NA	NA	NA	NA	NA
PGEN_.00g075120	Scaffold_03	49256670	49271253	Q9R1P4	PSA1_MOUSE	Proteasome subunit alpha type-1 (EC 3.4.25.1) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain)	GO:0000502; GO:0001530; GO:0002376; GO:0002862; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]; immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"
PGEN_.00g075130	Scaffold_03	49271480	49320899	A0JM49	LTN1_XENTR	E3 ubiquitin-protein ligase listerin (EC 2.3.2.27) (RING finger protein 160) (Zfp-294) (RING-type E3 ubiquitin transferase listerin)	GO:0005829; GO:0008270; GO:0043023; GO:0043161; GO:0061630; GO:0072344; GO:1990112; GO:1990116	cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]
PGEN_.00g075140	Scaffold_03	49326739	49348458	P0C8E4	M3K7_RAT	Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25)	GO:0000165; GO:0000186; GO:0000187; GO:0000287; GO:0001525; GO:0001841; GO:0002726; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005524; GO:0005671; GO:0005737; GO:0005886; GO:0006468; GO:0007179; GO:0007250; GO:0007252; GO:0007254; GO:0014069; GO:0016239; GO:0018107; GO:0030971; GO:0032743; GO:0042802; GO:0043123; GO:0043276; GO:0043507; GO:0043966; GO:0046330; GO:0051403; GO:0060546; GO:0097110; GO:1902443; GO:2000377; GO:2000378; GO:2001234	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; histone H3 acetylation [GO:0043966]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of T cell cytokine production [GO:0002726]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377]; stress-activated MAPK cascade [GO:0051403]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g075150	Scaffold_03	49387212	49423506	O35134	RPA1_MOUSE	DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194)	GO:0001054; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005736; GO:0008270; GO:0009303; GO:1904750	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]; negative regulation of protein localization to nucleolus [GO:1904750]; rRNA transcription [GO:0009303]
PGEN_.00g075160	Scaffold_03	49427813	49428900	NA	NA	NA	NA	NA
PGEN_.00g075170	Scaffold_03	49428992	49458157	NA	NA	NA	NA	NA
PGEN_.00g075180	Scaffold_03	49460241	49465992	NA	NA	NA	NA	NA
PGEN_.00g075190	Scaffold_03	49475460	49476739	NA	NA	NA	NA	NA
PGEN_.00g075200	Scaffold_03	49476954	49477334	NA	NA	NA	NA	NA
PGEN_.00g075210	Scaffold_03	49519568	49520095	NA	NA	NA	NA	NA
PGEN_.00g075220	Scaffold_03	49538694	49541089	NA	NA	NA	NA	NA
PGEN_.00g075230	Scaffold_03	49564064	49571374	NA	NA	NA	NA	NA
PGEN_.00g075240	Scaffold_03	49576376	49577452	NA	NA	NA	NA	NA
PGEN_.00g075250	Scaffold_03	49577693	49594994	Q62210	BIRC2_MOUSE	Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (Inhibitor of apoptosis protein 2) (mIAP2) (RING-type E3 ubiquitin transferase BIRC2)	GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0032991; GO:0035631; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043154; GO:0043161; GO:0044877; GO:0045121; GO:0045471; GO:0047485; GO:0051087; GO:0051291; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0071356; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:1902916; GO:1990001; GO:2000377	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein heterooligomerization [GO:0051291]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]
PGEN_.00g075260	Scaffold_03	49611137	49616728	NA	NA	NA	NA	NA
PGEN_.00g075270	Scaffold_03	49635636	49653961	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g075280	Scaffold_03	49660714	49661538	NA	NA	NA	NA	NA
PGEN_.00g075290	Scaffold_03	49680541	49681721	NA	NA	NA	NA	NA
PGEN_.00g075300	Scaffold_03	49719107	49732176	P33269	CP4D1_DROME	Cytochrome P450 4d1 (EC 1.14.-.-) (CYPIVD1)	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g075310	Scaffold_03	49738438	49749539	NA	NA	NA	NA	NA
PGEN_.00g075320	Scaffold_03	49787075	49796031	Q6DRJ7	NDC80_DANRE	Kinetochore protein NDC80 homolog (Kinetochore protein Hec1) (Kinetochore-associated protein 2-like)	GO:0000776; GO:0000777; GO:0000778; GO:0005623; GO:0007052; GO:0007059; GO:0031262; GO:0051301; GO:0051310; GO:0051315; GO:0090267	cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; metaphase plate congression [GO:0051310]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]
PGEN_.00g075330	Scaffold_03	49798482	49814887	A7YVH9	PYRD1_BOVIN	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (EC 1.8.1.-)	GO:0005634; GO:0005737; GO:0016491; GO:0030017; GO:0034599	cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]; oxidoreductase activity [GO:0016491]; cellular response to oxidative stress [GO:0034599]
PGEN_.00g075340	Scaffold_03	49819266	49826326	Q8N394	TMTC2_HUMAN	Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 2)	GO:0000030; GO:0004169; GO:0005783; GO:0005789; GO:0016021; GO:0035269; GO:0055074	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269]
PGEN_.00g075350	Scaffold_03	49882456	49898330	Q96A58	RERG_HUMAN	Ras-related and estrogen-regulated growth inhibitor	GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0007264; GO:0007265; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; estrogen receptor binding [GO:0030331]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g075360	Scaffold_03	49906526	49907041	NA	NA	NA	NA	NA
PGEN_.00g075370	Scaffold_03	49907980	49909656	A2VDP6	NXPE3_BOVIN	NXPE family member 3 (Protein FAM55C)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g075380	Scaffold_03	49935378	49954531	NA	NA	NA	NA	NA
PGEN_.00g075390	Scaffold_03	50035775	50037121	NA	NA	NA	NA	NA
PGEN_.00g075400	Scaffold_03	50046020	50046514	NA	NA	NA	NA	NA
PGEN_.00g075410	Scaffold_03	50058337	50065634	NA	NA	NA	NA	NA
PGEN_.00g075420	Scaffold_03	50101399	50104531	NA	NA	NA	NA	NA
PGEN_.00g075430	Scaffold_03	50111415	50117136	NA	NA	NA	NA	NA
PGEN_.00g075440	Scaffold_03	50120087	50120623	NA	NA	NA	NA	NA
PGEN_.00g075450	Scaffold_03	50145811	50146152	NA	NA	NA	NA	NA
PGEN_.00g075460	Scaffold_03	50207227	50213174	NA	NA	NA	NA	NA
PGEN_.00g075470	Scaffold_03	50231273	50231635	NA	NA	NA	NA	NA
PGEN_.00g075480	Scaffold_03	50290115	50294934	F7E235	FAXC_XENTR	Failed axon connections homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g075490	Scaffold_03	50295461	50298209	NA	NA	NA	NA	NA
PGEN_.00g075500	Scaffold_03	50318753	50324527	NA	NA	NA	NA	NA
PGEN_.00g075510	Scaffold_03	50365014	50367263	NA	NA	NA	NA	NA
PGEN_.00g075520	Scaffold_03	50394416	50394766	NA	NA	NA	NA	NA
PGEN_.00g075530	Scaffold_03	50397646	50402090	NA	NA	NA	NA	NA
PGEN_.00g075540	Scaffold_03	50409834	50411147	NA	NA	NA	NA	NA
PGEN_.00g075550	Scaffold_03	50446220	50448701	NA	NA	NA	NA	NA
PGEN_.00g075560	Scaffold_03	50451971	50456543	H1AFJ5	SCNNA_NEOFS	Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA)	GO:0001669; GO:0005737; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; sodium channel complex [GO:0034706]; ligand-gated sodium channel activity [GO:0015280]; sodium ion transmembrane transport [GO:0035725]
PGEN_.00g075570	Scaffold_03	50463805	50467605	Q95R48	OCTL_DROME	Organic cation transporter-like protein	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]
PGEN_.00g075580	Scaffold_03	50473470	50481149	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g075590	Scaffold_03	50498541	50501200	NA	NA	NA	NA	NA
PGEN_.00g075600	Scaffold_03	50549977	50560403	NA	NA	NA	NA	NA
PGEN_.00g075610	Scaffold_03	50563097	50566963	NA	NA	NA	NA	NA
PGEN_.00g075620	Scaffold_03	50571073	50595604	NA	NA	NA	NA	NA
PGEN_.00g075630	Scaffold_03	50598717	50603296	NA	NA	NA	NA	NA
PGEN_.00g075640	Scaffold_03	50617044	50673183	O60476	MA1A2_HUMAN	"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)"	GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0016021; GO:0048286; GO:0070062; GO:1904381	"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]"
PGEN_.00g075650	Scaffold_03	50680828	50681130	NA	NA	NA	NA	NA
PGEN_.00g075660	Scaffold_03	50687538	50702317	NA	NA	NA	NA	NA
PGEN_.00g075670	Scaffold_03	50698808	50699155	NA	NA	NA	NA	NA
PGEN_.00g075680	Scaffold_03	50706177	50707268	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g075690	Scaffold_03	50710744	50717258	A0MTA1	APEX1_DANRE	DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (zAP1)	GO:0001947; GO:0003677; GO:0003723; GO:0003906; GO:0004519; GO:0004528; GO:0005634; GO:0005730; GO:0005739; GO:0005783; GO:0006284; GO:0008311; GO:0010628; GO:0016607; GO:0043066; GO:0046872; GO:0055114; GO:0060047; GO:0080111; GO:0140078	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; phosphodiesterase I activity [GO:0004528]; RNA binding [GO:0003723]; base-excision repair [GO:0006284]; DNA demethylation [GO:0080111]; heart contraction [GO:0060047]; heart looping [GO:0001947]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; positive regulation of gene expression [GO:0010628]
PGEN_.00g075700	Scaffold_03	50726782	50795337	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g075710	Scaffold_03	50802882	50806529	NA	NA	NA	NA	NA
PGEN_.00g075720	Scaffold_03	50821317	50832369	Q9UQP3	TENN_HUMAN	Tenascin-N (TN-N) (Tenascin-W) (TN-W)	GO:0002076; GO:0005178; GO:0007160; GO:0007409; GO:0009986; GO:0031012; GO:0033689; GO:0042802; GO:0043025; GO:0045668; GO:0070593; GO:0097442; GO:1905240; GO:1990026; GO:2001223	CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; hippocampal mossy fiber expansion [GO:1990026]; neuronal cell body [GO:0043025]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; osteoblast development [GO:0002076]
PGEN_.00g075730	Scaffold_03	50837621	50838187	NA	NA	NA	NA	NA
PGEN_.00g075740	Scaffold_03	50844513	50852955	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g075750	Scaffold_03	50860629	50860883	NA	NA	NA	NA	NA
PGEN_.00g075760	Scaffold_03	50862089	50887817	Q67FQ3	ARHB_XENLA	Low density lipoprotein receptor adapter protein 1-B (Autosomal recessive hypercholesterolemia protein homolog beta) (ARH beta) (xARH beta)	GO:0005737; GO:0006897; GO:0008203	cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]
PGEN_.00g075770	Scaffold_03	50903153	50906607	Q5R8H5	T2EA_PONAB	General transcription factor IIE subunit 1 (Transcription initiation factor IIE subunit alpha) (TFIIE-alpha)	GO:0005669; GO:0005829; GO:0006367; GO:0016251; GO:0046872; GO:0097550	cytosol [GO:0005829]; transcription factor TFIID complex [GO:0005669]; transcriptional preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription initiation from RNA polymerase II promoter [GO:0006367]
PGEN_.00g075780	Scaffold_03	50912473	50923596	Q5F3A2	CHM2B_CHICK	Charged multivesicular body protein 2b (Chromatin-modifying protein 2b) (CHMP2b)	GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]
PGEN_.00g075790	Scaffold_03	50961464	50973419	NA	NA	NA	NA	NA
PGEN_.00g075800	Scaffold_03	50978634	51016030	O60293	ZC3H1_HUMAN	Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2)	GO:0000178; GO:0003723; GO:0005615; GO:0005634; GO:0006396; GO:0046872	exosome (RNase complex) [GO:0000178]; extracellular space [GO:0005615]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA processing [GO:0006396]
PGEN_.00g075810	Scaffold_03	51026827	51030235	NA	NA	NA	NA	NA
PGEN_.00g075820	Scaffold_03	51104794	51105039	NA	NA	NA	NA	NA
PGEN_.00g075830	Scaffold_03	51108499	51151025	Q9Y4W2	LAS1L_HUMAN	Ribosomal biogenesis protein LAS1L (Protein LAS1 homolog)	GO:0000460; GO:0000470; GO:0003723; GO:0004519; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0030687; GO:0071339; GO:0090730	"Las1 complex [GO:0090730]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; endonuclease activity [GO:0004519]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]"
PGEN_.00g075840	Scaffold_03	51177119	51214873	Q5DTV4	ZC12C_MOUSE	Probable ribonuclease ZC3H12C (EC 3.1.-.-) (Zinc finger CCCH domain-containing protein 12C)	GO:0004519; GO:0046872	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]
PGEN_.00g075850	Scaffold_03	51226508	51226942	NA	NA	NA	NA	NA
PGEN_.00g075860	Scaffold_03	51227350	51228663	NA	NA	NA	NA	NA
PGEN_.00g075870	Scaffold_03	51229072	51229353	NA	NA	NA	NA	NA
PGEN_.00g075880	Scaffold_03	51231439	51231903	NA	NA	NA	NA	NA
PGEN_.00g075890	Scaffold_03	51255907	51256647	NA	NA	NA	NA	NA
PGEN_.00g075900	Scaffold_03	51258920	51261212	NA	NA	NA	NA	NA
PGEN_.00g075910	Scaffold_03	51264461	51265168	NA	NA	NA	NA	NA
PGEN_.00g075920	Scaffold_03	51267300	51290468	Q8K2I2	CCHCR_MOUSE	Coiled-coil alpha-helical rod protein 1 (Alpha-helical coiled-coil rod protein)	GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0006611; GO:0007275; GO:0030154; GO:0042802	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein export from nucleus [GO:0006611]
PGEN_.00g075930	Scaffold_03	51351812	51352303	NA	NA	NA	NA	NA
PGEN_.00g075940	Scaffold_03	51352347	51352940	NA	NA	NA	NA	NA
PGEN_.00g075950	Scaffold_03	51353031	51353318	NA	NA	NA	NA	NA
PGEN_.00g075960	Scaffold_03	51360181	51392967	Q0KI50	DMDD_DROME	"Dystrophin, isoform D (Protein detached)"	GO:0003779; GO:0005623; GO:0005737; GO:0005856; GO:0005938; GO:0007274; GO:0007474; GO:0007517; GO:0008270; GO:0008307; GO:0008586; GO:0016010; GO:0030010; GO:0042383; GO:0045202; GO:0046716; GO:0046928; GO:0048172; GO:0050699	cell [GO:0005623]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]
PGEN_.00g075970	Scaffold_03	51414535	51418925	P11532	DMD_HUMAN	Dystrophin	GO:0002027; GO:0002162; GO:0003779; GO:0005200; GO:0005623; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007517; GO:0008270; GO:0008307; GO:0009986; GO:0010880; GO:0010881; GO:0010976; GO:0014809; GO:0014819; GO:0016010; GO:0016013; GO:0017022; GO:0017166; GO:0030018; GO:0030049; GO:0030055; GO:0030175; GO:0031527; GO:0032991; GO:0033137; GO:0034613; GO:0034622; GO:0035994; GO:0042383; GO:0043034; GO:0043043; GO:0044306; GO:0044458; GO:0045121; GO:0045202; GO:0045211; GO:0045666; GO:0046716; GO:0048747; GO:0050998; GO:0060048; GO:0060314; GO:0086001; GO:0090287; GO:1901385; GO:1902083; GO:2000651	cell [GO:0005623]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; Z disc [GO:0030018]; actin binding [GO:0003779]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cellular protein localization [GO:0034613]; cellular protein-containing complex assembly [GO:0034622]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle fiber development [GO:0048747]; muscle filament sliding [GO:0030049]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]
PGEN_.00g075980	Scaffold_03	51478727	51479050	NA	NA	NA	NA	NA
PGEN_.00g075990	Scaffold_03	51492694	51495913	NA	NA	NA	NA	NA
PGEN_.00g076000	Scaffold_03	51502491	51576145	Q5GN48	DMD_PIG	Dystrophin	GO:0003779; GO:0005737; GO:0005856; GO:0008270; GO:0030054; GO:0042383; GO:0045211	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; zinc ion binding [GO:0008270]
PGEN_.00g076010	Scaffold_03	51579531	51581474	Q64127	TIF1A_MOUSE	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005737; GO:0006468; GO:0008270; GO:0008285; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043565; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]"
PGEN_.00g076020	Scaffold_03	51600535	51635458	O97592	DMD_CANLF	Dystrophin	GO:0003779; GO:0005737; GO:0005856; GO:0008270; GO:0030054; GO:0042383; GO:0045211	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; zinc ion binding [GO:0008270]
PGEN_.00g076030	Scaffold_03	51638845	51639493	NA	NA	NA	NA	NA
PGEN_.00g076040	Scaffold_03	51656904	51701204	P46939	UTRO_HUMAN	Utrophin (Dystrophin-related protein 1) (DRP-1)	GO:0001954; GO:0003779; GO:0005178; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0006936; GO:0007517; GO:0007528; GO:0008270; GO:0014894; GO:0016010; GO:0016020; GO:0017166; GO:0019901; GO:0030054; GO:0030175; GO:0030426; GO:0030864; GO:0031527; GO:0031594; GO:0032991; GO:0042383; GO:0045211; GO:0051015; GO:0070062; GO:2000649	cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; growth cone [GO:0030426]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; response to denervation involved in regulation of muscle adaptation [GO:0014894]
PGEN_.00g076050	Scaffold_03	51730460	51740609	NA	NA	NA	NA	NA
PGEN_.00g076060	Scaffold_03	51740690	51744346	NA	NA	NA	NA	NA
PGEN_.00g076070	Scaffold_03	51794589	51795815	NA	NA	NA	NA	NA
PGEN_.00g076080	Scaffold_03	51809615	51837420	Q8N187	CARTF_HUMAN	Calcium-responsive transcription factor (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein) (Calcium-response factor) (CaRF) (Testis development protein NYD-SP24)	GO:0000978; GO:0001228; GO:0001652; GO:0003677; GO:0003700; GO:0005634; GO:0035865; GO:0051090; GO:0061400; GO:0071277	"granular component [GO:0001652]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to calcium ion [GO:0071277]; cellular response to potassium ion [GO:0035865]; positive regulation of transcription from RNA polymerase II promoter in response to calcium ion [GO:0061400]; regulation of DNA-binding transcription factor activity [GO:0051090]"
PGEN_.00g076090	Scaffold_03	51842516	51843344	NA	NA	NA	NA	NA
PGEN_.00g076100	Scaffold_03	51845129	51846665	NA	NA	NA	NA	NA
PGEN_.00g076110	Scaffold_03	51862576	51866972	Q6DHR8	NGBR_DANRE	"Dehydrodolichyl diphosphate synthase complex subunit nus1 (EC 2.5.1.87) (Di-trans,poly-cis-decaprenylcistransferase) (Nogo-B receptor) (NgBR) (Nuclear undecaprenyl pyrophosphate synthase 1 homolog)"	GO:0002040; GO:0005789; GO:0006486; GO:0016021; GO:0016765; GO:0019408; GO:1904423	"dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; dolichol biosynthetic process [GO:0019408]; protein glycosylation [GO:0006486]; sprouting angiogenesis [GO:0002040]"
PGEN_.00g076120	Scaffold_03	51878469	51910252	Q921G8	GCP2_MOUSE	Gamma-tubulin complex component 2 (GCP-2)	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005654; GO:0005737; GO:0005813; GO:0005874; GO:0008275; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415	centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]
PGEN_.00g076130	Scaffold_03	51910605	51917494	NA	NA	NA	NA	NA
PGEN_.00g076140	Scaffold_03	51917542	51924065	B1WBM3	TM138_RAT	Transmembrane protein 138	GO:0005774; GO:0005929; GO:0016021; GO:0060271	cilium [GO:0005929]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; cilium assembly [GO:0060271]
PGEN_.00g076150	Scaffold_03	51931201	51937877	Q5RA42	IF1AX_PONAB	"Eukaryotic translation initiation factor 1A, X-chromosomal (eIF-1A X isoform) (Eukaryotic translation initiation factor 4C) (eIF-4C)"	GO:0003743	translation initiation factor activity [GO:0003743]
PGEN_.00g076160	Scaffold_03	51943477	51945882	NA	NA	NA	NA	NA
PGEN_.00g076170	Scaffold_03	51957820	51959293	NA	NA	NA	NA	NA
PGEN_.00g076180	Scaffold_03	51960428	51967440	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g076190	Scaffold_03	51977800	51990307	NA	NA	NA	NA	NA
PGEN_.00g076200	Scaffold_03	52091806	52092264	NA	NA	NA	NA	NA
PGEN_.00g076210	Scaffold_03	52107396	52114715	NA	NA	NA	NA	NA
PGEN_.00g076220	Scaffold_03	52124795	52126579	NA	NA	NA	NA	NA
PGEN_.00g076230	Scaffold_03	52144916	52145350	NA	NA	NA	NA	NA
PGEN_.00g076240	Scaffold_03	52152325	52203760	O43895	XPP2_HUMAN	Xaa-Pro aminopeptidase 2 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (Membrane-bound AmP) (mAmP) (X-Pro aminopeptidase 2)	GO:0004177; GO:0005576; GO:0005737; GO:0005886; GO:0016020; GO:0031225; GO:0046872; GO:0070006; GO:0070062	anchored component of membrane [GO:0031225]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]
PGEN_.00g076250	Scaffold_03	52244003	52249825	NA	NA	NA	NA	NA
PGEN_.00g076260	Scaffold_03	52249850	52256052	Q8CEG5	CC28B_MOUSE	Coiled-coil domain-containing protein 28B	GO:0005737; GO:0005813; GO:0060271	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]
PGEN_.00g076270	Scaffold_03	52294444	52298896	NA	NA	NA	NA	NA
PGEN_.00g076280	Scaffold_03	52299037	52299840	NA	NA	NA	NA	NA
PGEN_.00g076290	Scaffold_03	52300739	52326893	O75844	FACE1_HUMAN	CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog)	GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004222; GO:0005637; GO:0006281; GO:0006508; GO:0006925; GO:0006998; GO:0007628; GO:0008235; GO:0008340; GO:0008360; GO:0010506; GO:0010906; GO:0016020; GO:0019216; GO:0030176; GO:0030282; GO:0030327; GO:0030500; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0043007; GO:0043516; GO:0043979; GO:0044029; GO:0044255; GO:0046872; GO:0048145; GO:0048538; GO:0048739; GO:0050688; GO:0050905; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070062; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903025; GO:1903463; GO:1903799; GO:1990036; GO:1990164; GO:2000618; GO:2000730; GO:2000772	"extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235]; adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to gamma radiation [GO:0071480]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; prenylated protein catabolic process [GO:0030327]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]"
PGEN_.00g076300	Scaffold_03	52372546	52398977	NA	NA	NA	NA	NA
PGEN_.00g076310	Scaffold_03	52420527	52432487	NA	NA	NA	NA	NA
PGEN_.00g076320	Scaffold_03	52435466	52441991	NA	NA	NA	NA	NA
PGEN_.00g076330	Scaffold_03	52443146	52462475	Q6ZMT9	DTHD1_HUMAN	Death domain-containing protein 1	GO:0007165	signal transduction [GO:0007165]
PGEN_.00g076340	Scaffold_03	52496346	52532678	O14514	AGRB1_HUMAN	Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)]	GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016021; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428	"cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]"
PGEN_.00g076350	Scaffold_03	52534390	52535340	NA	NA	NA	NA	NA
PGEN_.00g076360	Scaffold_03	52537498	52572251	Q6V0I7	FAT4_HUMAN	Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
PGEN_.00g076370	Scaffold_03	52572438	52573247	NA	NA	NA	NA	NA
PGEN_.00g076380	Scaffold_03	52580400	52603990	P0DMQ6	DHSO_CHICK	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase)	GO:0003939; GO:0006000; GO:0006061; GO:0006062; GO:0006116; GO:0006735; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0032991; GO:0042802; GO:0046370; GO:0051160; GO:0051287; GO:0070062	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]
PGEN_.00g076390	Scaffold_03	52607909	52608382	NA	NA	NA	NA	NA
PGEN_.00g076400	Scaffold_03	52612750	52614345	NA	NA	NA	NA	NA
PGEN_.00g076410	Scaffold_03	52646062	52715313	Q60636	PRDM1_MOUSE	PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1)	GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001701; GO:0001763; GO:0001892; GO:0001893; GO:0002250; GO:0003170; GO:0003279; GO:0003281; GO:0003700; GO:0005634; GO:0005737; GO:0007281; GO:0008168; GO:0009791; GO:0010628; GO:0010629; GO:0030889; GO:0031490; GO:0031665; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0045579; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990841	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]"
PGEN_.00g076420	Scaffold_03	52795238	52796595	P20075	LEAD8_DAUCA	Embryonic protein DC-8	GO:0005576; GO:0005618; GO:0005737	cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]
PGEN_.00g076430	Scaffold_03	52799988	52804506	O00338	ST1C2_HUMAN	Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.-) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)	GO:0005737; GO:0005829; GO:0008146; GO:0009308; GO:0050427; GO:0051923	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]
PGEN_.00g076440	Scaffold_03	52809278	52809808	NA	NA	NA	NA	NA
PGEN_.00g076450	Scaffold_03	52817813	52818457	NA	NA	NA	NA	NA
PGEN_.00g076460	Scaffold_03	52827209	52835693	Q96CB9	NSUN4_HUMAN	5-methylcytosine rRNA methyltransferase NSUN4 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4)	GO:0005759; GO:0005762; GO:0008168; GO:0009383; GO:0031167; GO:0042256; GO:0070131; GO:0070181	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; small ribosomal subunit rRNA binding [GO:0070181]; mature ribosome assembly [GO:0042256]; positive regulation of mitochondrial translation [GO:0070131]; rRNA methylation [GO:0031167]
PGEN_.00g076470	Scaffold_03	52840652	52847446	P61759	PFD3_MOUSE	Prefoldin subunit 3 (von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1)	GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0043231	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]; tubulin binding [GO:0015631]; microtubule-based process [GO:0007017]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]
PGEN_.00g076480	Scaffold_03	52852972	52859676	P58545	BTBD3_MOUSE	BTB/POZ domain-containing protein 3	GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813	cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]
PGEN_.00g076490	Scaffold_03	52863806	52914568	Q5ZKI7	WDCP_CHICK	WD repeat and coiled-coil-containing protein		
PGEN_.00g076500	Scaffold_03	52924554	52945335	Q9UPN6	SCAF8_HUMAN	SR-related and CTD-associated factor 8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16)	GO:0000993; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005849; GO:0006369; GO:0006378; GO:0016363; GO:0032786; GO:0043175; GO:1990269; GO:2000805	"cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]"
PGEN_.00g076510	Scaffold_03	52977500	53005968	Q9H251	CAD23_HUMAN	Cadherin-23 (Otocadherin)	GO:0000902; GO:0005509; GO:0005623; GO:0005886; GO:0005913; GO:0006816; GO:0007043; GO:0007156; GO:0007601; GO:0007605; GO:0007626; GO:0008092; GO:0009986; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0032420; GO:0034332; GO:0042803; GO:0044331; GO:0045296; GO:0045494; GO:0050896; GO:0050953; GO:0050957; GO:0051480; GO:0060122; GO:0098609	catenin complex [GO:0016342]; cell [GO:0005623]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; protein homodimerization activity [GO:0042803]; adherens junction organization [GO:0034332]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g076520	Scaffold_03	53006729	53007148	NA	NA	NA	NA	NA
PGEN_.00g076530	Scaffold_03	53007331	53007621	NA	NA	NA	NA	NA
PGEN_.00g076540	Scaffold_03	53020097	53031536	NA	NA	NA	NA	NA
PGEN_.00g076550	Scaffold_03	53032223	53034107	NA	NA	NA	NA	NA
PGEN_.00g076560	Scaffold_03	53034201	53035290	NA	NA	NA	NA	NA
PGEN_.00g076570	Scaffold_03	53036182	53036553	P09815	ICEN_PSEFL	Ice nucleation protein	GO:0009279; GO:0050825	cell outer membrane [GO:0009279]; ice binding [GO:0050825]
PGEN_.00g076580	Scaffold_03	53103710	53114868	NA	NA	NA	NA	NA
PGEN_.00g076590	Scaffold_03	53117074	53122255	NA	NA	NA	NA	NA
PGEN_.00g076600	Scaffold_03	53133168	53194172	P35992	PTP10_DROME	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0042059; GO:0045177; GO:0060446	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]
PGEN_.00g076610	Scaffold_03	53194495	53209691	P53004	BIEA_HUMAN	Biliverdin reductase A (BVR A) (EC 1.3.1.24) (Biliverdin-IX alpha-reductase)	GO:0004074; GO:0005829; GO:0008270; GO:0042167; GO:0055114; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; biliverdin reductase activity [GO:0004074]; zinc ion binding [GO:0008270]; heme catabolic process [GO:0042167]; oxidation-reduction process [GO:0055114]
PGEN_.00g076620	Scaffold_03	53221493	53222050	NA	NA	NA	NA	NA
PGEN_.00g076630	Scaffold_03	53222682	53223044	NA	NA	NA	NA	NA
PGEN_.00g076640	Scaffold_03	53223200	53242143	NA	NA	NA	NA	NA
PGEN_.00g076650	Scaffold_03	53246851	53271154	NA	NA	NA	NA	NA
PGEN_.00g076660	Scaffold_03	53278061	53305395	Q5ZIN1	NUDC_CHICK	Nuclear migration protein nudC (Nuclear distribution protein C homolog)	GO:0005737; GO:0005874; GO:0006457; GO:0007049; GO:0032502; GO:0051082; GO:0051301	cytoplasm [GO:0005737]; microtubule [GO:0005874]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; cell division [GO:0051301]; developmental process [GO:0032502]; protein folding [GO:0006457]
PGEN_.00g076670	Scaffold_03	53308913	53316565	NA	NA	NA	NA	NA
PGEN_.00g076680	Scaffold_03	53329778	53337361	Q8BGW8	VGLL2_MOUSE	Transcription cofactor vestigial-like protein 2 (Vgl-2) (Protein VITO1)	GO:0003713; GO:0005634; GO:0005737; GO:0007519; GO:0008022; GO:0045944	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein C-terminus binding [GO:0008022]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g076690	Scaffold_03	53387734	53414101	Q6TGS6	SYYC_DANRE	"Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS)"	GO:0000049; GO:0004831; GO:0005524; GO:0005737; GO:0006437; GO:0006974	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; cellular response to DNA damage stimulus [GO:0006974]; tyrosyl-tRNA aminoacylation [GO:0006437]
PGEN_.00g076700	Scaffold_03	53416225	53426545	Q9NRZ7	PLCC_HUMAN	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 3) (1-AGP acyltransferase 3) (1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma) (LPAAT-gamma)	GO:0000139; GO:0003841; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006654; GO:0008654; GO:0016020; GO:0016021; GO:0016024; GO:0016746	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]"
PGEN_.00g076710	Scaffold_03	53435381	53441667	Q8BH58	TIPRL_MOUSE	TIP41-like protein	GO:0000077; GO:0005829; GO:0007165; GO:0032515	cytosol [GO:0005829]; DNA damage checkpoint [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; signal transduction [GO:0007165]
PGEN_.00g076720	Scaffold_03	53473550	53484913	Q8BH58	TIPRL_MOUSE	TIP41-like protein	GO:0000077; GO:0005829; GO:0007165; GO:0032515	cytosol [GO:0005829]; DNA damage checkpoint [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; signal transduction [GO:0007165]
PGEN_.00g076730	Scaffold_03	53485040	53510204	Q99973	TEP1_HUMAN	Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog)	GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]"
PGEN_.00g076740	Scaffold_03	53516231	53522446	P14755	CRYL1_RABIT	Lambda-crystallin (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH)	GO:0003857; GO:0005212; GO:0005829; GO:0006631; GO:0042803; GO:0050104; GO:0070403	cytosol [GO:0005829]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; fatty acid metabolic process [GO:0006631]
PGEN_.00g076750	Scaffold_03	53533673	53555807	Q9V3D2	HEM6_DROME	Oxygen-dependent coproporphyrinogen-III oxidase (COX) (Coprogen oxidase) (Coproporphyrinogenase) (EC 1.3.3.3)	GO:0004109; GO:0005737; GO:0005739; GO:0005758; GO:0006782; GO:0006783; GO:0042803	cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]
PGEN_.00g076760	Scaffold_03	53561766	53577753	Q5T5C0	STXB5_HUMAN	Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1)	GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0008021; GO:0015031; GO:0017075; GO:0017137; GO:0017157; GO:0019905; GO:0030054; GO:0030659; GO:0031201; GO:0031594; GO:0045159; GO:0045921; GO:0098685; GO:0098888; GO:0099504; GO:0099523	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of presynaptic membrane [GO:0098888]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; synaptic vesicle cycle [GO:0099504]
PGEN_.00g076770	Scaffold_03	53610095	53641731	Q8K400	STXB5_MOUSE	Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1)	GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0007409; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017137; GO:0017157; GO:0019905; GO:0030141; GO:0031201; GO:0031594; GO:0045159; GO:0045921; GO:0098674; GO:0098685; GO:0098686; GO:0098793; GO:0098888; GO:0099504; GO:0099523; GO:2000300	acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; extrinsic component of presynaptic membrane [GO:0098888]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; axonogenesis [GO:0007409]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle cycle [GO:0099504]
PGEN_.00g076780	Scaffold_03	53649513	53660879	Q5T5C0	STXB5_HUMAN	Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1)	GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0008021; GO:0015031; GO:0017075; GO:0017137; GO:0017157; GO:0019905; GO:0030054; GO:0030659; GO:0031201; GO:0031594; GO:0045159; GO:0045921; GO:0098685; GO:0098888; GO:0099504; GO:0099523	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of presynaptic membrane [GO:0098888]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; synaptic vesicle cycle [GO:0099504]
PGEN_.00g076790	Scaffold_03	53665755	53666907	NA	NA	NA	NA	NA
PGEN_.00g076800	Scaffold_03	53702816	53705100	Q5DQR4	STB5L_MOUSE	Syntaxin-binding protein 5-like (Lethal(2) giant larvae protein homolog 4) (Tomosyn-2)	GO:0005096; GO:0005737; GO:0005886; GO:0006887; GO:0015031; GO:0017137; GO:0017157; GO:0019905; GO:0031201; GO:0031594; GO:0042593; GO:0045159; GO:0046676; GO:0050714; GO:0098992; GO:2000300	cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; neuronal dense core vesicle [GO:0098992]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; negative regulation of insulin secretion [GO:0046676]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]
PGEN_.00g076810	Scaffold_03	53761237	53767685	NA	NA	NA	NA	NA
PGEN_.00g076820	Scaffold_03	53778370	53779356	O70528	5HT4R_CAVPO	5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)	GO:0004993; GO:0005768; GO:0005887; GO:0007268; GO:0032098; GO:0045202	endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; chemical synaptic transmission [GO:0007268]; regulation of appetite [GO:0032098]
PGEN_.00g076830	Scaffold_03	53811028	53817199	Q962U0	RL13A_SPOFR	60S ribosomal protein L13a	GO:0003735; GO:0006412; GO:0015934	large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g076840	Scaffold_03	53833356	53871945	Q9HAR2	AGRL3_HUMAN	Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)	GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]
PGEN_.00g076850	Scaffold_03	53878270	53878545	NA	NA	NA	NA	NA
PGEN_.00g076860	Scaffold_03	53901038	53902837	Q9PWH2	FZD10_CHICK	Frizzled-10 (Fz-10) (cFz-10)	GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0017147; GO:0035567; GO:0042813; GO:0060070	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; non-canonical Wnt signaling pathway [GO:0035567]
PGEN_.00g076870	Scaffold_03	54062770	54107693	P11678	PERE_HUMAN	Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain]	GO:0002215; GO:0004601; GO:0005576; GO:0005615; GO:0005737; GO:0006979; GO:0020037; GO:0032693; GO:0032714; GO:0032753; GO:0034774; GO:0042742; GO:0042744; GO:0043312; GO:0046872; GO:0070062; GO:0072677	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979]
PGEN_.00g076880	Scaffold_03	54131670	54133797	NA	NA	NA	NA	NA
PGEN_.00g076890	Scaffold_03	54170257	54170613	Q9MYS6	KCNQ1_RABIT	Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1)	GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005769; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0086009	"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]"
PGEN_.00g076900	Scaffold_03	54266076	54266570	NA	NA	NA	NA	NA
PGEN_.00g076910	Scaffold_03	54270231	54272439	NA	NA	NA	NA	NA
PGEN_.00g076920	Scaffold_03	54291574	54292842	NA	NA	NA	NA	NA
PGEN_.00g076930	Scaffold_03	54292802	54310793	P70057	KCNQ1_XENLA	Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha xKvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1)	GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005783; GO:0005886; GO:0008076; GO:0015271; GO:0016323; GO:0030659; GO:0034702; GO:0034765; GO:0045121; GO:0048839; GO:0050892; GO:0060453; GO:0070293; GO:0086009	"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; ion channel complex [GO:0034702]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity [GO:0005249]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; regulation of gastric acid secretion [GO:0060453]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]"
PGEN_.00g076940	Scaffold_03	54320324	54329682	P97414	KCNQ1_MOUSE	Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1)	GO:0005249; GO:0005251; GO:0005267; GO:0005516; GO:0005546; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005783; GO:0005886; GO:0005887; GO:0006349; GO:0006813; GO:0008076; GO:0008157; GO:0010460; GO:0015271; GO:0016021; GO:0016323; GO:0016458; GO:0030659; GO:0034236; GO:0034237; GO:0034702; GO:0035690; GO:0042383; GO:0042391; GO:0042589; GO:0042802; GO:0044325; GO:0045121; GO:0046676; GO:0048839; GO:0050892; GO:0060048; GO:0060306; GO:0060307; GO:0060372; GO:0060452; GO:0060453; GO:0060454; GO:0070293; GO:0071320; GO:0071805; GO:0072347; GO:0072358; GO:0086005; GO:0086008; GO:0086009; GO:0086011; GO:0086013; GO:0086014; GO:0086089; GO:0086091; GO:0097110; GO:0097623; GO:0098914; GO:0098915; GO:1901381; GO:1902260; GO:1902282; GO:1903817	"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; zymogen granule membrane [GO:0042589]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium channel activity [GO:0005267]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157]; scaffold protein binding [GO:0097110]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; atrial cardiac muscle cell action potential [GO:0086014]; cardiac muscle contraction [GO:0060048]; cardiovascular system development [GO:0072358]; cellular response to cAMP [GO:0071320]; cellular response to drug [GO:0035690]; gene silencing [GO:0016458]; inner ear development [GO:0048839]; intestinal absorption [GO:0050892]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of insulin secretion [GO:0046676]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of gastric acid secretion [GO:0060453]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; renal absorption [GO:0070293]; response to anesthetic [GO:0072347]; ventricular cardiac muscle cell action potential [GO:0086005]"
PGEN_.00g076950	Scaffold_03	54393332	54397252	Q5F364	MRP1_CHICK	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	GO:0005524; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g076960	Scaffold_03	54412359	54413633	Q9QZS6	HS3SB_MOUSE	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 (EC 2.8.2.30) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3B1) (3-OST-3B) (Heparan sulfate 3-O-sulfotransferase 3B1) (m3-OST-3B)	GO:0000139; GO:0005887; GO:0006477; GO:0008467; GO:0033872	Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [GO:0033872]; protein sulfation [GO:0006477]
PGEN_.00g076970	Scaffold_03	54418144	54419430	Q96QI5	HS3S6_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 6 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 6) (3-OST-6) (Heparan sulfate 3-O-sulfotransferase 6) (h3-OST-6)	GO:0000139; GO:0001835; GO:0006024; GO:0008467; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; blastocyst hatching [GO:0001835]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g076980	Scaffold_03	54423971	54424976	NA	NA	NA	NA	NA
PGEN_.00g076990	Scaffold_03	54425600	54426850	Q9Y662	HS3SB_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 (EC 2.8.2.30) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3B1) (3-OST-3B) (Heparan sulfate 3-O-sulfotransferase 3B1) (h3-OST-3B)	GO:0000139; GO:0005887; GO:0006024; GO:0006477; GO:0008467; GO:0015012; GO:0015015; GO:0033872	"Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [GO:0033872]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; protein sulfation [GO:0006477]"
PGEN_.00g077000	Scaffold_03	54475117	54505087	Q5RGJ8	GNPTA_DANRE	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein gnptab) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	GO:0000139; GO:0002063; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0046835; GO:0048701; GO:0048703; GO:0051216; GO:0060348	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; bone development [GO:0060348]; carbohydrate phosphorylation [GO:0046835]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]
PGEN_.00g077010	Scaffold_03	54507943	54510904	P83425	HIP_MYTED	Heavy metal-binding protein HIP	GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]
PGEN_.00g077020	Scaffold_03	54516703	54517059	NA	NA	NA	NA	NA
PGEN_.00g077030	Scaffold_03	54539769	54540382	NA	NA	NA	NA	NA
PGEN_.00g077040	Scaffold_03	54566244	54566516	NA	NA	NA	NA	NA
PGEN_.00g077050	Scaffold_03	54568922	54578483	NA	NA	NA	NA	NA
PGEN_.00g077060	Scaffold_03	54582970	54585308	NA	NA	NA	NA	NA
PGEN_.00g077070	Scaffold_03	54609767	54610342	NA	NA	NA	NA	NA
PGEN_.00g077080	Scaffold_03	54614278	54616368	NA	NA	NA	NA	NA
PGEN_.00g077090	Scaffold_03	54617089	54633618	NA	NA	NA	NA	NA
PGEN_.00g077100	Scaffold_03	54633685	54634569	NA	NA	NA	NA	NA
PGEN_.00g077110	Scaffold_03	54637257	54642620	NA	NA	NA	NA	NA
PGEN_.00g077120	Scaffold_03	54642645	54642881	NA	NA	NA	NA	NA
PGEN_.00g077130	Scaffold_03	54651458	54651748	NA	NA	NA	NA	NA
PGEN_.00g077140	Scaffold_03	54674250	54692884	NA	NA	NA	NA	NA
PGEN_.00g077150	Scaffold_03	54697846	54701680	NA	NA	NA	NA	NA
PGEN_.00g077160	Scaffold_03	54705353	54710847	NA	NA	NA	NA	NA
PGEN_.00g077170	Scaffold_03	54721428	54726455	NA	NA	NA	NA	NA
PGEN_.00g077180	Scaffold_03	54726594	54727260	NA	NA	NA	NA	NA
PGEN_.00g077190	Scaffold_03	54728730	54732827	NA	NA	NA	NA	NA
PGEN_.00g077200	Scaffold_03	54734019	54734606	NA	NA	NA	NA	NA
PGEN_.00g077210	Scaffold_03	54735069	54735599	NA	NA	NA	NA	NA
PGEN_.00g077220	Scaffold_03	54735830	54736507	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g077230	Scaffold_03	54737566	54738474	NA	NA	NA	NA	NA
PGEN_.00g077240	Scaffold_03	54739929	54740267	O08863	BIRC3_MOUSE	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 2) (C-IAP2) (Inhibitor of apoptosis protein 1) (mIAP1) (RING-type E3 ubiquitin transferase BIRC3)	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016740; GO:0031398; GO:0032991; GO:0042326; GO:0042981; GO:0043027; GO:0043154; GO:0044877; GO:0045121; GO:0046872; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0071356; GO:1901222; GO:1902916; GO:1990001; GO:2000378	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of phosphorylation [GO:0042326]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]
PGEN_.00g077250	Scaffold_03	54740352	54741040	NA	NA	NA	NA	NA
PGEN_.00g077260	Scaffold_03	54772154	54786834	Q70EX6	SOAT_RAT	Solute carrier family 10 member 6 (Sodium-dependent organic anion transporter)	GO:0005886; GO:0008508; GO:0015721; GO:0016021; GO:0043250; GO:0043251	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]; bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]
PGEN_.00g077270	Scaffold_03	54806636	54807404	NA	NA	NA	NA	NA
PGEN_.00g077280	Scaffold_03	54814710	54815390	NA	NA	NA	NA	NA
PGEN_.00g077290	Scaffold_03	54816186	54831063	NA	NA	NA	NA	NA
PGEN_.00g077300	Scaffold_03	54831599	54840304	NA	NA	NA	NA	NA
PGEN_.00g077310	Scaffold_03	54853728	54865488	Q0II59	PDXK_BOVIN	Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase)	GO:0000287; GO:0005524; GO:0005654; GO:0005829; GO:0008270; GO:0008283; GO:0008478; GO:0009443; GO:0030170; GO:0030955; GO:0031402; GO:0031403; GO:0042803	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; pyridoxal kinase activity [GO:0008478]; pyridoxal phosphate binding [GO:0030170]; sodium ion binding [GO:0031402]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; pyridoxal 5'-phosphate salvage [GO:0009443]
PGEN_.00g077320	Scaffold_03	54892273	54908430	D5EY15	XYL3A_PRER2	"Xylan 1,4-beta-xylosidase (EC 3.2.1.37) (1,4-beta-D-xylan xylohydrolase) (Alpha-L-arabinofuranosidase) (Arabinosidase) (EC 3.2.1.55) (Beta-D-xylosidase) (Exo-1,4-beta-xylosidase)"	GO:0009044; GO:0045493; GO:0046556	"alpha-L-arabinofuranosidase activity [GO:0046556]; xylan 1,4-beta-xylosidase activity [GO:0009044]; xylan catabolic process [GO:0045493]"
PGEN_.00g077330	Scaffold_03	54909107	55002095	Q8C5H1	ANO4_MOUSE	Anoctamin-4 (Transmembrane protein 16D)	GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0061589; GO:0061590; GO:0061591; GO:1902476	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]
PGEN_.00g077340	Scaffold_03	55041225	55065015	Q00492	SUM1_LYTVA	Transcription factor SUM-1 (Sea urchin myogenic factor 1)	GO:0003677; GO:0005634; GO:0006355; GO:0007517; GO:0046983	"nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; muscle organ development [GO:0007517]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g077350	Scaffold_03	55078480	55078908	NA	NA	NA	NA	NA
PGEN_.00g077360	Scaffold_03	55123413	55125903	NA	NA	NA	NA	NA
PGEN_.00g077370	Scaffold_03	55133628	55134701	NA	NA	NA	NA	NA
PGEN_.00g077380	Scaffold_03	55147361	55147756	NA	NA	NA	NA	NA
PGEN_.00g077390	Scaffold_03	55177388	55183268	NA	NA	NA	NA	NA
PGEN_.00g077400	Scaffold_03	55183878	55187935	NA	NA	NA	NA	NA
PGEN_.00g077410	Scaffold_03	55209910	55218307	NA	NA	NA	NA	NA
PGEN_.00g077420	Scaffold_03	55228439	55229737	NA	NA	NA	NA	NA
PGEN_.00g077430	Scaffold_03	55230051	55230323	NA	NA	NA	NA	NA
PGEN_.00g077440	Scaffold_03	55230532	55230795	NA	NA	NA	NA	NA
PGEN_.00g077450	Scaffold_03	55232465	55232836	NA	NA	NA	NA	NA
PGEN_.00g077460	Scaffold_03	55232943	55233236	NA	NA	NA	NA	NA
PGEN_.00g077470	Scaffold_03	55274593	55283849	Q9BWD1	THIC_HUMAN	"Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase)"	GO:0003985; GO:0003988; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0006635; GO:0006695; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629]
PGEN_.00g077480	Scaffold_03	55296757	55431045	Q13574	DGKZ_HUMAN	Diacylglycerol kinase zeta (DAG kinase zeta) (EC 2.7.1.107) (Diglyceride kinase zeta) (DGK-zeta)	GO:0001727; GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006654; GO:0007205; GO:0008022; GO:0014069; GO:0016301; GO:0016477; GO:0016607; GO:0030027; GO:0030168; GO:0031571; GO:0035556; GO:0045930; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0051966; GO:0090216; GO:0098978	"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid kinase activity [GO:0001727]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein C-terminus binding [GO:0008022]; cell migration [GO:0016477]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of mitotic cell cycle [GO:0045930]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]"
PGEN_.00g077490	Scaffold_03	55475176	55489738	NA	NA	NA	NA	NA
PGEN_.00g077500	Scaffold_03	55495279	55495521	NA	NA	NA	NA	NA
PGEN_.00g077510	Scaffold_03	55570158	55585644	Q5U4U4	DONS_XENLA	Protein downstream neighbor of son homolog	GO:0000077; GO:0005634; GO:0005657; GO:0006260; GO:0007095; GO:0007275; GO:0030894; GO:0048478; GO:0051301	nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894]; cell division [GO:0051301]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint [GO:0007095]; multicellular organism development [GO:0007275]; replication fork protection [GO:0048478]
PGEN_.00g077520	Scaffold_03	55585758	55593077	Q3T100	MGST3_BOVIN	Microsomal glutathione S-transferase 3 (Microsomal GST-3) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (Microsomal glutathione S-transferase III) (Microsomal GST-III)	GO:0004364; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0016021	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]
PGEN_.00g077530	Scaffold_03	55605254	55606562	NA	NA	NA	NA	NA
PGEN_.00g077540	Scaffold_03	55653926	55654306	NA	NA	NA	NA	NA
PGEN_.00g077550	Scaffold_03	55657373	55657948	NA	NA	NA	NA	NA
PGEN_.00g077560	Scaffold_03	55665539	55666714	Q13641	TPBG_HUMAN	Trophoblast glycoprotein (5T4 oncofetal antigen) (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (M6P1) (Wnt-activated inhibitory factor 1) (WAIF1)	GO:0005783; GO:0005887; GO:0007155; GO:0009986; GO:0051965	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; cell adhesion [GO:0007155]; positive regulation of synapse assembly [GO:0051965]
PGEN_.00g077570	Scaffold_03	55673044	55685293	NA	NA	NA	NA	NA
PGEN_.00g077580	Scaffold_03	55689392	55698688	Q9CX80	CYGB_MOUSE	Cytoglobin (Histoglobin) (HGb)	GO:0001666; GO:0004096; GO:0004601; GO:0005344; GO:0005506; GO:0005737; GO:0006979; GO:0010764; GO:0019395; GO:0019825; GO:0020037; GO:0032966; GO:0043005; GO:0043025; GO:0047888; GO:2000490	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; catalase activity [GO:0004096]; fatty acid peroxidase activity [GO:0047888]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; peroxidase activity [GO:0004601]; fatty acid oxidation [GO:0019395]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of hepatic stellate cell activation [GO:2000490]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]
PGEN_.00g077590	Scaffold_03	55713366	55713692	NA	NA	NA	NA	NA
PGEN_.00g077600	Scaffold_03	55738741	55739256	NA	NA	NA	NA	NA
PGEN_.00g077610	Scaffold_03	55746982	55748648	NA	NA	NA	NA	NA
PGEN_.00g077620	Scaffold_03	55774670	55774918	NA	NA	NA	NA	NA
PGEN_.00g077630	Scaffold_03	55783891	55784262	NA	NA	NA	NA	NA
PGEN_.00g077640	Scaffold_03	55784297	55784563	NA	NA	NA	NA	NA
PGEN_.00g077650	Scaffold_03	55799060	55845117	Q9QUK4	BIR1B_MOUSE	Baculoviral IAP repeat-containing protein 1b (Neuronal apoptosis inhibitory protein 2)	GO:0005524; GO:0006954; GO:0016045; GO:0042742; GO:0043027; GO:0043154; GO:0045087; GO:0046872; GO:0070269; GO:0071391; GO:0072557	IPAF inflammasome complex [GO:0072557]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; cellular response to estrogen stimulus [GO:0071391]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; pyroptosis [GO:0070269]
PGEN_.00g077660	Scaffold_03	55885563	55902320	Q80VY9	DHX33_MOUSE	ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)	GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0032481; GO:0033613; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:1900227	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]
PGEN_.00g077670	Scaffold_03	55902360	55915229	Q8BKN6	HS3SA_MOUSE	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1) (Heparan sulfate 3-O-sulfotransferase 3A1)	GO:0000139; GO:0008467; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]
PGEN_.00g077680	Scaffold_03	55928686	55934625	NA	NA	NA	NA	NA
PGEN_.00g077690	Scaffold_03	55935845	55936201	NA	NA	NA	NA	NA
PGEN_.00g077700	Scaffold_03	55967562	55977160	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g077710	Scaffold_03	55996714	56004381	NA	NA	NA	NA	NA
PGEN_.00g077720	Scaffold_03	56004681	56005223	NA	NA	NA	NA	NA
PGEN_.00g077730	Scaffold_03	56061379	56062014	NA	NA	NA	NA	NA
PGEN_.00g077740	Scaffold_03	56062046	56062402	NA	NA	NA	NA	NA
PGEN_.00g077750	Scaffold_03	56065838	56066137	NA	NA	NA	NA	NA
PGEN_.00g077760	Scaffold_03	56066358	56067894	NA	NA	NA	NA	NA
PGEN_.00g077770	Scaffold_03	56084401	56107489	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g077780	Scaffold_03	56107649	56109652	NA	NA	NA	NA	NA
PGEN_.00g077790	Scaffold_03	56113692	56124060	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g077800	Scaffold_03	56129104	56140254	NA	NA	NA	NA	NA
PGEN_.00g077810	Scaffold_03	56151240	56152301	Q95254	GHSR_PIG	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0016021; GO:0016520; GO:0030252; GO:0032094; GO:0032100; GO:0032691; GO:0032869; GO:0040018; GO:0042536; GO:0043005; GO:0043568; GO:0045121; GO:0045409; GO:0046697; GO:0050728; GO:0051963	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of appetite [GO:0032100]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of synapse assembly [GO:0051963]; response to food [GO:0032094]; response to hormone [GO:0009725]
PGEN_.00g077820	Scaffold_03	56155769	56156986	P09481	ACHA3_CHICK	Neuronal acetylcholine receptor subunit alpha-3	GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007399; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060084	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g077830	Scaffold_03	56224876	56228931	Q96DM1	PGBD4_HUMAN	PiggyBac transposable element-derived protein 4		
PGEN_.00g077840	Scaffold_03	56239751	56262503	Q99LI7	CSTF3_MOUSE	Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit) (CSTF 77 kDa subunit) (CstF-77)	GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0031123	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123]
PGEN_.00g077850	Scaffold_03	56277500	56310720	Q6ZZY0	CRY1_SYLBO	Cryptochrome-1	GO:0000166; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0042622; GO:0045721; GO:0097381	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]
PGEN_.00g077860	Scaffold_03	56318369	56325308	Q9UMY4	SNX12_HUMAN	Sorting nexin-12	GO:0005769; GO:0010629; GO:0010955; GO:0015031; GO:0016020; GO:0019899; GO:0030100; GO:0035091; GO:0042177; GO:0051224; GO:2000642	early endosome [GO:0005769]; membrane [GO:0016020]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]
PGEN_.00g077870	Scaffold_03	56325773	56328346	NA	NA	NA	NA	NA
PGEN_.00g077880	Scaffold_03	56344028	56360630	Q6PEI7	PYRG1_DANRE	CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1)	GO:0003883; GO:0005524; GO:0005737; GO:0006241; GO:0006541; GO:0019856; GO:0030903; GO:0042802; GO:0044210; GO:0097268	cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; notochord development [GO:0030903]; pyrimidine nucleobase biosynthetic process [GO:0019856]
PGEN_.00g077890	Scaffold_03	56369898	56390135	Q9BY41	HDAC8_HUMAN	Histone deacetylase 8 (HD8) (EC 3.5.1.98)	GO:0000118; GO:0000122; GO:0000228; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006325; GO:0006333; GO:0007062; GO:0008134; GO:0030544; GO:0031397; GO:0031647; GO:0032041; GO:0032204; GO:0045944; GO:0046872; GO:0051879; GO:0070932; GO:0070933; GO:0071922	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; histone deacetylase activity [GO:0004407]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]; chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cohesin loading [GO:0071922]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; sister chromatid cohesion [GO:0007062]
PGEN_.00g077900	Scaffold_03	56395209	56401936	NA	NA	NA	NA	NA
PGEN_.00g077910	Scaffold_03	56401456	56401758	NA	NA	NA	NA	NA
PGEN_.00g077920	Scaffold_03	56401975	56405232	NA	NA	NA	NA	NA
PGEN_.00g077930	Scaffold_03	56413615	56441340	Q940M4	OCT7_ARATH	Organic cation/carnitine transporter 7 (AtOCT7)	GO:0005524; GO:0005886; GO:0016021; GO:0090416; GO:0090417; GO:2001142; GO:2001143	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; N-methylnicotinate transmembrane transporter activity [GO:0090417]; nicotinate transmembrane transporter activity [GO:0090416]; N-methylnicotinate transport [GO:2001143]; nicotinate transport [GO:2001142]
PGEN_.00g077940	Scaffold_03	56460510	56481631	Q8NFH3	NUP43_HUMAN	Nucleoporin Nup43 (Nup107-160 subcomplex subunit Nup43) (p42)	GO:0000777; GO:0005635; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0007049; GO:0007059; GO:0016032; GO:0016925; GO:0019083; GO:0031080; GO:0043657; GO:0051301; GO:0060964; GO:0075733; GO:1900034	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]
PGEN_.00g077950	Scaffold_03	56483758	56484192	NA	NA	NA	NA	NA
PGEN_.00g077960	Scaffold_03	56489743	56500703	NA	NA	NA	NA	NA
PGEN_.00g077970	Scaffold_03	56505560	56508609	Q17QM8	DUS14_BOVIN	Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48)	GO:0004725; GO:0017017	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]
PGEN_.00g077980	Scaffold_03	56555174	56572171	O95147	DUS14_HUMAN	Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48) (MKP-1-like protein tyrosine phosphatase) (MKP-L) (Mitogen-activated protein kinase phosphatase 6) (MAP kinase phosphatase 6) (MKP-6)	GO:0003723; GO:0004725; GO:0017017	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]
PGEN_.00g077990	Scaffold_03	56568260	56569806	NA	NA	NA	NA	NA
PGEN_.00g078000	Scaffold_03	56575323	56597664	Q2YDF6	RT35_BOVIN	"28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt) (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt)"	GO:0003735; GO:0005743; GO:0005763; GO:0032543	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g078010	Scaffold_03	56600104	56606366	Q02724	ULP1_YEAST	Ubiquitin-like-specific protease 1 (EC 3.4.22.68)	GO:0000086; GO:0005634; GO:0005635; GO:0005730; GO:0008234; GO:0016926; GO:0044877; GO:0070140	nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; protein-containing complex binding [GO:0044877]; SUMO-specific isopeptidase activity [GO:0070140]; G2/M transition of mitotic cell cycle [GO:0000086]; protein desumoylation [GO:0016926]
PGEN_.00g078020	Scaffold_03	56607679	56608122	NA	NA	NA	NA	NA
PGEN_.00g078030	Scaffold_03	56611697	56612641	NA	NA	NA	NA	NA
PGEN_.00g078040	Scaffold_03	56726784	56787647	Q9DBR7	MYPT1_MOUSE	Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1)	GO:0000278; GO:0000776; GO:0004857; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006470; GO:0007098; GO:0007165; GO:0015629; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0035507; GO:0035508; GO:0035690; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0071889; GO:0072357	A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; cellular response to drug [GO:0035690]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165]
PGEN_.00g078050	Scaffold_03	56800275	56801399	O88799	ZAN_MOUSE	Zonadhesin	GO:0005886; GO:0007155; GO:0007339; GO:0016021; GO:0050840; GO:2000359	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix binding [GO:0050840]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; regulation of binding of sperm to zona pellucida [GO:2000359]
PGEN_.00g078060	Scaffold_03	56811092	56829452	Q6DRG7	MYPT1_DANRE	Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit)	GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0031672; GO:0035507; GO:0046982; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357	A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; signal transduction [GO:0007165]
PGEN_.00g078070	Scaffold_03	56839653	56841404	NA	NA	NA	NA	NA
PGEN_.00g078080	Scaffold_03	56844035	56845138	NA	NA	NA	NA	NA
PGEN_.00g078090	Scaffold_03	56845274	56865545	P50747	BPL1_HUMAN	Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)]	GO:0000785; GO:0004077; GO:0004078; GO:0004079; GO:0004080; GO:0005524; GO:0005652; GO:0005739; GO:0005829; GO:0006768; GO:0009305; GO:0009374; GO:0016363; GO:0016570; GO:0018271; GO:0019899; GO:0042803; GO:0070781; GO:0071110	chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; biotin metabolic process [GO:0006768]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781]
PGEN_.00g078100	Scaffold_03	56935928	56972768	Q98SJ5	SIM1A_DANRE	Single-minded homolog 1-A	GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0007411; GO:0021536; GO:0021979; GO:0035776; GO:0045944; GO:0046983; GO:0048793; GO:0071542; GO:0072020	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; axon guidance [GO:0007411]; diencephalon development [GO:0021536]; dopaminergic neuron differentiation [GO:0071542]; hypothalamus cell differentiation [GO:0021979]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric proximal tubule development [GO:0035776]; pronephros development [GO:0048793]; proximal straight tubule development [GO:0072020]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g078110	Scaffold_03	56972827	56986317	NA	NA	NA	NA	NA
PGEN_.00g078120	Scaffold_03	57000349	57000621	NA	NA	NA	NA	NA
PGEN_.00g078130	Scaffold_03	57000693	57003276	NA	NA	NA	NA	NA
PGEN_.00g078140	Scaffold_03	57025528	57031650	P52292	IMA1_HUMAN	Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha)	GO:0000018; GO:0003723; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0016020; GO:0019054; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:0098892; GO:0098978; GO:0099527; GO:1903902	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; modulation by virus of host cellular process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]
PGEN_.00g078150	Scaffold_03	57036582	57046450	NA	NA	NA	NA	NA
PGEN_.00g078160	Scaffold_03	57059626	57060840	NA	NA	NA	NA	NA
PGEN_.00g078170	Scaffold_03	57060893	57063357	NA	NA	NA	NA	NA
PGEN_.00g078180	Scaffold_03	57063493	57089952	NA	NA	NA	NA	NA
PGEN_.00g078190	Scaffold_03	57092247	57093831	NA	NA	NA	NA	NA
PGEN_.00g078200	Scaffold_03	57094011	57094571	NA	NA	NA	NA	NA
PGEN_.00g078210	Scaffold_03	57094595	57094912	NA	NA	NA	NA	NA
PGEN_.00g078220	Scaffold_03	57097954	57098604	NA	NA	NA	NA	NA
PGEN_.00g078230	Scaffold_03	57105446	57111001	C0JB27	A423_LOXLA	Dermonecrotic toxin LlSicTox-alphaIV2iii (EC 4.6.1.-) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D) (Fragment)	GO:0005576; GO:0008081; GO:0009405; GO:0016042; GO:0016829; GO:0044179; GO:0046872; GO:0090729	extracellular region [GO:0005576]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405]
PGEN_.00g078240	Scaffold_03	57114747	57129716	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g078250	Scaffold_03	57137008	57137814	NA	NA	NA	NA	NA
PGEN_.00g078260	Scaffold_03	57158707	57167971	Q8VHE0	SEC63_MOUSE	Translocation protein SEC63 homolog	GO:0001889; GO:0005783; GO:0006614; GO:0006620; GO:0006807; GO:0010259; GO:0016020; GO:0016021; GO:0031204; GO:0031207	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]; liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"
PGEN_.00g078270	Scaffold_03	57168237	57170482	Q8VHE0	SEC63_MOUSE	Translocation protein SEC63 homolog	GO:0001889; GO:0005783; GO:0006614; GO:0006620; GO:0006807; GO:0010259; GO:0016020; GO:0016021; GO:0031204; GO:0031207	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]; liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"
PGEN_.00g078280	Scaffold_03	57175303	57180916	NA	NA	NA	NA	NA
PGEN_.00g078290	Scaffold_03	57203580	57207817	Q9UT27	PVG1_SCHPO	"Pyruvyl transferase 1 (EC 2.-.-.-) (Pyruvylated Gal-beta-1,3-epitope synthesis protein 1) (PvGal synthesis protein 1)"	GO:0005737; GO:0005794; GO:0009272; GO:0046919; GO:0051072; GO:0071555	"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; pyruvyltransferase activity [GO:0046919]; 4,6-pyruvylated galactose residue biosynthetic process [GO:0051072]; cell wall organization [GO:0071555]; fungal-type cell wall biogenesis [GO:0009272]"
PGEN_.00g078300	Scaffold_03	57231680	57345173	Q7Z407	CSMD3_HUMAN	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g078310	Scaffold_03	57399874	57483677	P35992	PTP10_DROME	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0042059; GO:0045177; GO:0060446	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]
PGEN_.00g078320	Scaffold_03	57494523	57508116	P35992	PTP10_DROME	Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D)	GO:0004725; GO:0005001; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0042059; GO:0045177; GO:0060446	apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]
PGEN_.00g078330	Scaffold_03	57512245	57512844	NA	NA	NA	NA	NA
PGEN_.00g078340	Scaffold_03	57683430	57690947	NA	NA	NA	NA	NA
PGEN_.00g078350	Scaffold_03	57712487	57736761	NA	NA	NA	NA	NA
PGEN_.00g078360	Scaffold_04	563	3115	NA	NA	NA	NA	NA
PGEN_.00g078370	Scaffold_04	23767	23997	NA	NA	NA	NA	NA
PGEN_.00g078380	Scaffold_04	60919	80354	P21519	MAM_DROME	Neurogenic protein mastermind	GO:0000775; GO:0000785; GO:0003007; GO:0003713; GO:0005634; GO:0005700; GO:0005703; GO:0007059; GO:0007219; GO:0007398; GO:0007418; GO:0007475; GO:0007476; GO:0007500; GO:0008356; GO:0008587; GO:0016607; GO:0030707; GO:0030718; GO:0034080; GO:0035019; GO:0045944; GO:0046331; GO:0048664; GO:1990433	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; transcription coactivator activity [GO:0003713]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; asymmetric cell division [GO:0008356]; CENP-A containing nucleosome assembly [GO:0034080]; chromosome segregation [GO:0007059]; ectoderm development [GO:0007398]; germ-line stem cell population maintenance [GO:0030718]; heart morphogenesis [GO:0003007]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; lateral inhibition [GO:0046331]; mesodermal cell fate determination [GO:0007500]; neuron fate determination [GO:0048664]; Notch signaling pathway [GO:0007219]; ovarian follicle cell development [GO:0030707]; positive regulation of transcription by RNA polymerase II [GO:0045944]; somatic stem cell population maintenance [GO:0035019]; ventral midline development [GO:0007418]"
PGEN_.00g078390	Scaffold_04	127328	127786	NA	NA	NA	NA	NA
PGEN_.00g078400	Scaffold_04	198761	199402	NA	NA	NA	NA	NA
PGEN_.00g078410	Scaffold_04	228108	238643	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g078420	Scaffold_04	239967	244303	NA	NA	NA	NA	NA
PGEN_.00g078430	Scaffold_04	246102	260619	P51589	CP2J2_HUMAN	Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070062; GO:0071614	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g078440	Scaffold_04	262171	262623	NA	NA	NA	NA	NA
PGEN_.00g078450	Scaffold_04	263035	263370	NA	NA	NA	NA	NA
PGEN_.00g078460	Scaffold_04	303045	309706	P57101	HAND2_XENLA	"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)"	GO:0003677; GO:0005634; GO:0007275; GO:0046983	nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; multicellular organism development [GO:0007275]
PGEN_.00g078470	Scaffold_04	364032	376191	P61295	HAND2_RAT	"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)"	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0001525; GO:0001701; GO:0001947; GO:0001967; GO:0003007; GO:0003219; GO:0003253; GO:0003266; GO:0003278; GO:0003680; GO:0005634; GO:0005667; GO:0006355; GO:0007507; GO:0007512; GO:0008134; GO:0010463; GO:0010613; GO:0010628; GO:0010629; GO:0010667; GO:0014032; GO:0032991; GO:0033613; GO:0034103; GO:0042475; GO:0042733; GO:0042803; GO:0043066; GO:0043392; GO:0043433; GO:0043565; GO:0043586; GO:0045668; GO:0045893; GO:0045944; GO:0046982; GO:0048485; GO:0048538; GO:0048935; GO:0060021; GO:0060485; GO:0060536; GO:0060982; GO:0061032; GO:0061309; GO:0061325; GO:0061371; GO:0070374; GO:0070888; GO:0071300; GO:0071407; GO:1900745; GO:1903929; GO:2000679; GO:2000763; GO:2000764	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; AT DNA binding [GO:0003680]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; adult heart development [GO:0007512]; angiogenesis [GO:0001525]; apoptotic process involved in heart morphogenesis [GO:0003278]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cardiac right ventricle formation [GO:0003219]; cartilage morphogenesis [GO:0060536]; cell proliferation involved in outflow tract morphogenesis [GO:0061325]; cellular response to organic cyclic compound [GO:0071407]; cellular response to retinoic acid [GO:0071300]; coronary artery morphogenesis [GO:0060982]; determination of heart left/right asymmetry [GO:0061371]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; mesenchymal cell proliferation [GO:0010463]; mesenchyme development [GO:0060485]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; neural crest cell development [GO:0014032]; odontogenesis of dentin-containing tooth [GO:0042475]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [GO:2000764]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [GO:2000763]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; primary palate development [GO:1903929]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of tissue remodeling [GO:0034103]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; suckling behavior [GO:0001967]; sympathetic nervous system development [GO:0048485]; thymus development [GO:0048538]; tongue development [GO:0043586]; visceral serous pericardium development [GO:0061032]"
PGEN_.00g078480	Scaffold_04	376588	411129	Q6DJH2	ADPPT_XENLA	L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC 2.7.8.7) (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT)	GO:0000287; GO:0005737; GO:0006633; GO:0008897	cytoplasm [GO:0005737]; holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]; fatty acid biosynthetic process [GO:0006633]
PGEN_.00g078490	Scaffold_04	420122	429884	Q8TBK6	ZCH10_HUMAN	Zinc finger CCHC domain-containing protein 10	GO:0003676; GO:0008270	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]
PGEN_.00g078500	Scaffold_04	434085	438184	NA	NA	NA	NA	NA
PGEN_.00g078510	Scaffold_04	438517	438852	NA	NA	NA	NA	NA
PGEN_.00g078520	Scaffold_04	444597	461699	A6H584	CO6A5_MOUSE	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)	GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g078530	Scaffold_04	468999	476598	Q99715	COCA1_HUMAN	Collagen alpha-1(XII) chain	GO:0003429; GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0062023; GO:0070062; GO:1903561	collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g078540	Scaffold_04	477244	488745	A6H584	CO6A5_MOUSE	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)	GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g078550	Scaffold_04	497171	507633	A6NMZ7	CO6A6_HUMAN	Collagen alpha-6(VI) chain	GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g078560	Scaffold_04	536886	537185	NA	NA	NA	NA	NA
PGEN_.00g078570	Scaffold_04	537425	537883	NA	NA	NA	NA	NA
PGEN_.00g078580	Scaffold_04	562497	563402	NA	NA	NA	NA	NA
PGEN_.00g078590	Scaffold_04	567439	568200	NA	NA	NA	NA	NA
PGEN_.00g078600	Scaffold_04	568239	568568	NA	NA	NA	NA	NA
PGEN_.00g078610	Scaffold_04	575867	680954	Q14CM0	FRPD4_HUMAN	FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis) (Preso)	GO:0005546; GO:0005856; GO:0014069; GO:0030054; GO:0032991; GO:0043197; GO:0051835; GO:0098974; GO:0098978	"cell junction [GO:0030054]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; positive regulation of synapse structural plasticity [GO:0051835]; postsynaptic actin cytoskeleton organization [GO:0098974]"
PGEN_.00g078620	Scaffold_04	761594	774985	Q9UIL1	SCOC_HUMAN	Short coiled-coil protein	GO:0000139; GO:0005654; GO:0005794; GO:0005829; GO:0016239; GO:0061635	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; positive regulation of macroautophagy [GO:0016239]; regulation of protein complex stability [GO:0061635]
PGEN_.00g078630	Scaffold_04	785764	808066	Q61316	HSP74_MOUSE	Heat shock 70 kDa protein 4 (Heat shock 70-related protein APG-2)	GO:0001085; GO:0001933; GO:0005524; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0009408; GO:0010628; GO:0010629; GO:0032092; GO:0033613; GO:0043066; GO:0043392; GO:0044877; GO:0045040; GO:0051131; GO:0060548; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor binding [GO:0001085]; chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to heat [GO:0009408]
PGEN_.00g078640	Scaffold_04	814205	814492	NA	NA	NA	NA	NA
PGEN_.00g078650	Scaffold_04	814606	814926	NA	NA	NA	NA	NA
PGEN_.00g078660	Scaffold_04	814963	815623	NA	NA	NA	NA	NA
PGEN_.00g078670	Scaffold_04	825411	826019	NA	NA	NA	NA	NA
PGEN_.00g078680	Scaffold_04	841127	841800	NA	NA	NA	NA	NA
PGEN_.00g078690	Scaffold_04	844925	849993	Q8L0X4	MEGL_FUSNP	L-methionine gamma-lyase (MGL) (EC 4.4.1.11) (Homocysteine desulfhydrase) (EC 4.4.1.2) (L-methionine-alpha-deamino-gamma-mercaptomethane-lyase) (METase)	GO:0018826; GO:0019346; GO:0030170; GO:0046677; GO:0047982	homocysteine desulfhydrase activity [GO:0047982]; methionine gamma-lyase activity [GO:0018826]; pyridoxal phosphate binding [GO:0030170]; response to antibiotic [GO:0046677]; transsulfuration [GO:0019346]
PGEN_.00g078700	Scaffold_04	851927	856480	P26714	GBRB_LYMST	Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor)	GO:0004890; GO:0005230; GO:0005254; GO:0030054; GO:0034707; GO:0045211	cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]
PGEN_.00g078710	Scaffold_04	870388	872160	P26714	GBRB_LYMST	Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor)	GO:0004890; GO:0005230; GO:0005254; GO:0030054; GO:0034707; GO:0045211	cell junction [GO:0030054]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]
PGEN_.00g078720	Scaffold_04	899893	915973	NA	NA	NA	NA	NA
PGEN_.00g078730	Scaffold_04	927567	927878	NA	NA	NA	NA	NA
PGEN_.00g078740	Scaffold_04	947462	952560	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g078750	Scaffold_04	990419	1004542	Q08E50	GBRA5_BOVIN	Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5)	GO:0001662; GO:0004890; GO:0005237; GO:0005254; GO:0005654; GO:0005829; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007605; GO:0008306; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043524; GO:0044297; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0060119; GO:0060384; GO:0090102; GO:0098794; GO:1902476; GO:1902711; GO:1904315	"cell body [GO:0044297]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"
PGEN_.00g078760	Scaffold_04	1012652	1013950	P09480	ACHA2_CHICK	Neuronal acetylcholine receptor subunit alpha-2	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g078770	Scaffold_04	1022417	1022758	NA	NA	NA	NA	NA
PGEN_.00g078780	Scaffold_04	1081762	1086686	A0A159BP93	CITB_MONRU	2-oxoglutarate-dependent dioxygenase citB (EC 1.14.-.-) (Citrinin synthesis protein B)	GO:0046872; GO:0051213	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]
PGEN_.00g078790	Scaffold_04	1087271	1088269	P10621	IPNS_STRC2	Isopenicillin N synthase (IPNS) (EC 1.21.3.1)	GO:0005506; GO:0016216; GO:0017000; GO:0031418	iron ion binding [GO:0005506]; isopenicillin-N synthase activity [GO:0016216]; L-ascorbic acid binding [GO:0031418]; antibiotic biosynthetic process [GO:0017000]
PGEN_.00g078800	Scaffold_04	1100838	1146596	P46100	ATRX_HUMAN	Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX)	GO:0000212; GO:0000780; GO:0000784; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005720; GO:0005721; GO:0006281; GO:0006306; GO:0006334; GO:0006336; GO:0006338; GO:0006355; GO:0007283; GO:0010571; GO:0015616; GO:0016604; GO:0016605; GO:0030330; GO:0030900; GO:0031297; GO:0031618; GO:0031933; GO:0032206; GO:0035064; GO:0035128; GO:0035264; GO:0042393; GO:0045944; GO:0046872; GO:0060009; GO:0070087; GO:0070192; GO:0070198; GO:0072520; GO:0072711; GO:1900112; GO:1901581; GO:1901582; GO:1904908; GO:1990707	"condensed nuclear chromosome, centromeric region [GO:0000780]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nuclear pericentric heterochromatin [GO:0031618]; nuclear subtelomeric heterochromatin [GO:1990707]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; telomeric heterochromatin [GO:0031933]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]"
PGEN_.00g078810	Scaffold_04	1159641	1166492	NA	NA	NA	NA	NA
PGEN_.00g078820	Scaffold_04	1179568	1184506	NA	NA	NA	NA	NA
PGEN_.00g078830	Scaffold_04	1184650	1187223	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g078840	Scaffold_04	1187575	1204203	P35377	OPRX_MOUSE	Nociceptin receptor (K3 opiate receptor) (Kappa-type 3 opioid receptor) (KOR-3) (ORGC) (Orphanin FQ receptor)	GO:0001626; GO:0004930; GO:0005623; GO:0005887; GO:0007193; GO:0007218; GO:0008022; GO:0016020; GO:0019233; GO:0031410; GO:0032355; GO:0035810; GO:0038003; GO:0042277; GO:0042755; GO:0042923; GO:0043951; GO:0044849; GO:0045776; GO:0051482; GO:0051930; GO:0060454; GO:0106072; GO:1901386; GO:1904058; GO:1904059; GO:1990708	cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; nociceptin receptor activity [GO:0001626]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; conditioned place preference [GO:1990708]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of blood pressure [GO:0045776]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; neuropeptide signaling pathway [GO:0007218]; opioid receptor signaling pathway [GO:0038003]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of urine volume [GO:0035810]; regulation of locomotor rhythm [GO:1904059]; regulation of sensory perception of pain [GO:0051930]; response to estradiol [GO:0032355]; sensory perception of pain [GO:0019233]
PGEN_.00g078850	Scaffold_04	1210773	1224426	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g078860	Scaffold_04	1224811	1251355	NA	NA	NA	NA	NA
PGEN_.00g078870	Scaffold_04	1255652	1264569	NA	NA	NA	NA	NA
PGEN_.00g078880	Scaffold_04	1320843	1321091	NA	NA	NA	NA	NA
PGEN_.00g078890	Scaffold_04	1343175	1370876	NA	NA	NA	NA	NA
PGEN_.00g078900	Scaffold_04	1377121	1383221	NA	NA	NA	NA	NA
PGEN_.00g078910	Scaffold_04	1394460	1394834	NA	NA	NA	NA	NA
PGEN_.00g078920	Scaffold_04	1397111	1411812	NA	NA	NA	NA	NA
PGEN_.00g078930	Scaffold_04	1420863	1425646	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g078940	Scaffold_04	1425720	1428821	NA	NA	NA	NA	NA
PGEN_.00g078950	Scaffold_04	1457893	1474952	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g078960	Scaffold_04	1478916	1483122	NA	NA	NA	NA	NA
PGEN_.00g078970	Scaffold_04	1509468	1513563	NA	NA	NA	NA	NA
PGEN_.00g078980	Scaffold_04	1532535	1545184	P46692	HMD1_CHICK	Homeobox protein CHOX-CAD	GO:0000977; GO:0003700; GO:0005634; GO:0006357; GO:0009948; GO:0030154	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior axis specification [GO:0009948]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g078990	Scaffold_04	1570924	1581009	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g079000	Scaffold_04	1581082	1581594	NA	NA	NA	NA	NA
PGEN_.00g079010	Scaffold_04	1581633	1582199	NA	NA	NA	NA	NA
PGEN_.00g079020	Scaffold_04	1620597	1663422	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g079030	Scaffold_04	1698183	1700162	E1BD59	TRI56_BOVIN	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0051607; GO:0070534	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
PGEN_.00g079040	Scaffold_04	1703742	1704287	NA	NA	NA	NA	NA
PGEN_.00g079050	Scaffold_04	1730233	1731255	NA	NA	NA	NA	NA
PGEN_.00g079060	Scaffold_04	1731358	1731843	NA	NA	NA	NA	NA
PGEN_.00g079070	Scaffold_04	1731879	1732355	NA	NA	NA	NA	NA
PGEN_.00g079080	Scaffold_04	1777608	1778012	NA	NA	NA	NA	NA
PGEN_.00g079090	Scaffold_04	1778141	1778488	NA	NA	NA	NA	NA
PGEN_.00g079100	Scaffold_04	1778901	1779482	NA	NA	NA	NA	NA
PGEN_.00g079110	Scaffold_04	1802917	1804694	NA	NA	NA	NA	NA
PGEN_.00g079120	Scaffold_04	1805108	1805503	NA	NA	NA	NA	NA
PGEN_.00g079130	Scaffold_04	1871129	1878313	NA	NA	NA	NA	NA
PGEN_.00g079140	Scaffold_04	1883280	1944403	Q9VJJ7	TRPG_DROME	Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma)	GO:0005261; GO:0005262; GO:0005623; GO:0005887; GO:0006812; GO:0006816; GO:0006828; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635	"cation channel complex [GO:0034703]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive ion channel activity [GO:0008381]; store-operated calcium channel activity [GO:0015279]; adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; manganese ion transport [GO:0006828]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416]"
PGEN_.00g079150	Scaffold_04	1944427	1945035	NA	NA	NA	NA	NA
PGEN_.00g079160	Scaffold_04	1953660	1963506	Q4R6U7	RM30_MACFA	"39S ribosomal protein L30, mitochondrial (L30mt) (MRP-L30)"	GO:0003735; GO:0005762; GO:0006412	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g079170	Scaffold_04	1969028	1989528	O96064	MYSP_MYTGA	Paramyosin	GO:0003774; GO:0016459; GO:0030016; GO:0032982	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; motor activity [GO:0003774]
PGEN_.00g079180	Scaffold_04	1994651	2013306	Q95JR6	CNBD2_MACFA	Cyclic nucleotide-binding domain-containing protein 2	GO:0005829; GO:0030552	cytosol [GO:0005829]; cAMP binding [GO:0030552]
PGEN_.00g079190	Scaffold_04	2013418	2013636	Q3SZ93	TIM8B_BOVIN	Mitochondrial import inner membrane translocase subunit Tim8 B	GO:0005743; GO:0005758; GO:0046872; GO:0072321	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; chaperone-mediated protein transport [GO:0072321]
PGEN_.00g079200	Scaffold_04	2049235	2053231	NA	NA	NA	NA	NA
PGEN_.00g079210	Scaffold_04	2057264	2061530	NA	NA	NA	NA	NA
PGEN_.00g079220	Scaffold_04	2068401	2074263	NA	NA	NA	NA	NA
PGEN_.00g079230	Scaffold_04	2076100	2076735	NA	NA	NA	NA	NA
PGEN_.00g079240	Scaffold_04	2078253	2084027	NA	NA	NA	NA	NA
PGEN_.00g079250	Scaffold_04	2085595	2086110	Q7TQN8	GP119_RAT	Glucose-dependent insulinotropic receptor (G-protein coupled receptor 119)	GO:0004930; GO:0005886; GO:0016021; GO:0030073; GO:0031210; GO:0043235	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210]; insulin secretion [GO:0030073]
PGEN_.00g079260	Scaffold_04	2185749	2187725	NA	NA	NA	NA	NA
PGEN_.00g079270	Scaffold_04	2191058	2197637	NA	NA	NA	NA	NA
PGEN_.00g079280	Scaffold_04	2220045	2220482	Q9BXJ3	C1QT4_HUMAN	Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4)	GO:0005125; GO:0005615; GO:0032755; GO:0070105; GO:1901224; GO:1904469; GO:2000778	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469]
PGEN_.00g079290	Scaffold_04	2223437	2224018	NA	NA	NA	NA	NA
PGEN_.00g079300	Scaffold_04	2238748	2268153	Q9GLR1	NEC1_BOVIN	Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Prohormone convertase 1) (Proprotein convertase 1) (PC1)	GO:0004252; GO:0005615; GO:0016020; GO:0016485; GO:0016486; GO:0030133; GO:0043005	extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]
PGEN_.00g079310	Scaffold_04	2281131	2285401	Q29RU2	OIT3_BOVIN	Oncoprotein-induced transcript 3 protein	GO:0005509; GO:0005635; GO:0007339; GO:0032190; GO:0035803; GO:2000344	nuclear envelope [GO:0005635]; acrosin binding [GO:0032190]; calcium ion binding [GO:0005509]; binding of sperm to zona pellucida [GO:0007339]; egg coat formation [GO:0035803]; positive regulation of acrosome reaction [GO:2000344]
PGEN_.00g079320	Scaffold_04	2291189	2295568	NA	NA	NA	NA	NA
PGEN_.00g079330	Scaffold_04	2298534	2315219	O75339	CILP1_HUMAN	Cartilage intermediate layer protein 1 (CILP-1) (Cartilage intermediate-layer protein) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2]	GO:0005615; GO:0010629; GO:0016311; GO:0043569; GO:0060392; GO:0062023; GO:0070062; GO:0071560	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]
PGEN_.00g079340	Scaffold_04	2318506	2325020	NA	NA	NA	NA	NA
PGEN_.00g079350	Scaffold_04	2328486	2335255	Q6V0K7	OIT3_RAT	Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein)	GO:0005509; GO:0005635; GO:1903118	nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; urate homeostasis [GO:1903118]
PGEN_.00g079360	Scaffold_04	2336864	2357841	Q66K08	CILP1_MOUSE	Cartilage intermediate layer protein 1 (CILP-1) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2]	GO:0005615; GO:0010629; GO:0043569; GO:0060392; GO:0062023; GO:0071560	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]
PGEN_.00g079370	Scaffold_04	2364949	2365209	NA	NA	NA	NA	NA
PGEN_.00g079380	Scaffold_04	2374115	2379597	NA	NA	NA	NA	NA
PGEN_.00g079390	Scaffold_04	2381411	2383365	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g079400	Scaffold_04	2392278	2415478	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g079410	Scaffold_04	2427242	2427547	NA	NA	NA	NA	NA
PGEN_.00g079420	Scaffold_04	2428662	2462493	Q923L3	CSMD1_MOUSE	CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)	GO:0001964; GO:0016021; GO:0042593	integral component of membrane [GO:0016021]; glucose homeostasis [GO:0042593]; startle response [GO:0001964]
PGEN_.00g079430	Scaffold_04	2469189	2470342	NA	NA	NA	NA	NA
PGEN_.00g079440	Scaffold_04	2475562	2492155	Q7Z407	CSMD3_HUMAN	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g079450	Scaffold_04	2510387	2523161	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g079460	Scaffold_04	2530420	2539397	NA	NA	NA	NA	NA
PGEN_.00g079470	Scaffold_04	2549784	2586103	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g079480	Scaffold_04	2590473	2607992	Q7Z408	CSMD2_HUMAN	CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2)	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g079490	Scaffold_04	2609732	2635438	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g079500	Scaffold_04	2639944	2648017	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g079510	Scaffold_04	2663220	2674320	Q6WYY1	PC11X_PANPA	Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X)	GO:0005509; GO:0005886; GO:0007156; GO:0010923; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g079520	Scaffold_04	2709509	2737345	Q54RF3	EI2BE_DICDI	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	GO:0003743; GO:0005085; GO:0005851; GO:0016779; GO:0031369	eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]
PGEN_.00g079530	Scaffold_04	2747237	2750703	NA	NA	NA	NA	NA
PGEN_.00g079540	Scaffold_04	2750880	2805055	NA	NA	NA	NA	NA
PGEN_.00g079550	Scaffold_04	2809782	2858495	Q700K0	SSPO_RAT	SCO-spondin	GO:0005615; GO:0005737; GO:0007155; GO:0007399; GO:0030154	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g079560	Scaffold_04	2914673	2916942	NA	NA	NA	NA	NA
PGEN_.00g079570	Scaffold_04	2973103	2974673	NA	NA	NA	NA	NA
PGEN_.00g079580	Scaffold_04	2978046	2985309	NA	NA	NA	NA	NA
PGEN_.00g079590	Scaffold_04	2995607	3035690	NA	NA	NA	NA	NA
PGEN_.00g079600	Scaffold_04	3059112	3060731	NA	NA	NA	NA	NA
PGEN_.00g079610	Scaffold_04	3079689	3081278	NA	NA	NA	NA	NA
PGEN_.00g079620	Scaffold_04	3107459	3108810	NA	NA	NA	NA	NA
PGEN_.00g079630	Scaffold_04	3118916	3119997	Q5VUY0	ADCL3_HUMAN	Arylacetamide deacetylase-like 3 (EC 3.1.1.-)	GO:0009056; GO:0016021; GO:0016787; GO:0034338	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056]
PGEN_.00g079640	Scaffold_04	3121022	3124541	Q99PG0	AAAD_MOUSE	Arylacetamide deacetylase (EC 3.1.1.3)	GO:0004806; GO:0005789; GO:0009056; GO:0010898; GO:0016021; GO:0016298; GO:0016787; GO:0017171; GO:0019213; GO:0034338	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; deacetylase activity [GO:0019213]; hydrolase activity [GO:0016787]; lipase activity [GO:0016298]; serine hydrolase activity [GO:0017171]; short-chain carboxylesterase activity [GO:0034338]; triglyceride lipase activity [GO:0004806]; catabolic process [GO:0009056]; positive regulation of triglyceride catabolic process [GO:0010898]
PGEN_.00g079650	Scaffold_04	3138682	3158733	Q5JRC9	FA47A_HUMAN	Protein FAM47A		
PGEN_.00g079660	Scaffold_04	3159841	3161217	NA	NA	NA	NA	NA
PGEN_.00g079670	Scaffold_04	3173219	3174823	NA	NA	NA	NA	NA
PGEN_.00g079680	Scaffold_04	3179003	3179878	Q8HY02	CD209_SYMSY	CD209 antigen (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN1) (CD antigen CD209)	GO:0002250; GO:0005537; GO:0006897; GO:0007155; GO:0016021; GO:0045087; GO:0046872	integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; innate immune response [GO:0045087]
PGEN_.00g079690	Scaffold_04	3191489	3213638	Q6TH15	EIF3D_DANRE	Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7)	GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0098808	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]
PGEN_.00g079700	Scaffold_04	3216987	3217262	NA	NA	NA	NA	NA
PGEN_.00g079710	Scaffold_04	3218193	3218462	NA	NA	NA	NA	NA
PGEN_.00g079720	Scaffold_04	3219897	3232126	NA	NA	NA	NA	NA
PGEN_.00g079730	Scaffold_04	3273719	3283339	NA	NA	NA	NA	NA
PGEN_.00g079740	Scaffold_04	3319368	3323906	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g079750	Scaffold_04	3333801	3334142	NA	NA	NA	NA	NA
PGEN_.00g079760	Scaffold_04	3366474	3380308	P23780	BGAL_MOUSE	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005773; GO:0005794; GO:0016787; GO:0016936; GO:0019388; GO:0042803; GO:0043231; GO:0044262; GO:0051413; GO:1904016	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016]
PGEN_.00g079770	Scaffold_04	3385678	3388733	NA	NA	NA	NA	NA
PGEN_.00g079780	Scaffold_04	3411760	3415776	NA	NA	NA	NA	NA
PGEN_.00g079790	Scaffold_04	3415921	3417089	NA	NA	NA	NA	NA
PGEN_.00g079800	Scaffold_04	3460945	3461241	NA	NA	NA	NA	NA
PGEN_.00g079810	Scaffold_04	3468535	3468852	NA	NA	NA	NA	NA
PGEN_.00g079820	Scaffold_04	3495759	3499311	NA	NA	NA	NA	NA
PGEN_.00g079830	Scaffold_04	3499575	3500244	NA	NA	NA	NA	NA
PGEN_.00g079840	Scaffold_04	3643432	3643878	NA	NA	NA	NA	NA
PGEN_.00g079850	Scaffold_04	3661587	3663932	Q1ZXD6	ROCO5_DICDI	Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5)	GO:0004674; GO:0005085; GO:0005524; GO:0005525; GO:0030587	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; sorocarp development [GO:0030587]
PGEN_.00g079860	Scaffold_04	3681279	3682697	NA	NA	NA	NA	NA
PGEN_.00g079870	Scaffold_04	3763004	3763363	NA	NA	NA	NA	NA
PGEN_.00g079880	Scaffold_04	3772752	3773102	NA	NA	NA	NA	NA
PGEN_.00g079890	Scaffold_04	3775944	3797771	Q58D55	BGAL_BOVIN	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GO:0004565; GO:0005764; GO:0005773; GO:0005975	lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g079900	Scaffold_04	3800434	3811328	P60924	DELE1_RAT	DAP3-binding cell death enhancer 1 (Death ligand signal enhancer)	GO:0005739; GO:0008625; GO:0043281	mitochondrion [GO:0005739]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]
PGEN_.00g079910	Scaffold_04	3817602	3827617	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g079920	Scaffold_04	3838892	3848130	NA	NA	NA	NA	NA
PGEN_.00g079930	Scaffold_04	3851203	3859156	NA	NA	NA	NA	NA
PGEN_.00g079940	Scaffold_04	3872000	3882156	NA	NA	NA	NA	NA
PGEN_.00g079950	Scaffold_04	3885298	3885636	NA	NA	NA	NA	NA
PGEN_.00g079960	Scaffold_04	3916988	3917275	NA	NA	NA	NA	NA
PGEN_.00g079970	Scaffold_04	3917313	3919466	NA	NA	NA	NA	NA
PGEN_.00g079980	Scaffold_04	3920219	3920551	NA	NA	NA	NA	NA
PGEN_.00g079990	Scaffold_04	3939490	3939741	NA	NA	NA	NA	NA
PGEN_.00g080000	Scaffold_04	3949677	3954710	Q6PFX9	TNKS1_MOUSE	Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1)	GO:0000139; GO:0000209; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005815; GO:0005829; GO:0006471; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g080010	Scaffold_04	3955571	3957338	NA	NA	NA	NA	NA
PGEN_.00g080020	Scaffold_04	3957391	3962737	Q2KJG2	UFM1_BOVIN	Ubiquitin-fold modifier 1	GO:0005634; GO:0005737; GO:0005783; GO:0007420; GO:0033146; GO:0034976; GO:0071569; GO:1990592	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; brain development [GO:0007420]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g080030	Scaffold_04	3970448	4027395	O35828	CORO7_RAT	Coronin-7 (Crn7) (70 kDa WD repeat tumor rejection antigen)	GO:0000139; GO:0003779; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0007015; GO:0007030; GO:0015031; GO:0016021; GO:0016477; GO:0030010; GO:0030041; GO:0031410; GO:0051015	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]
PGEN_.00g080040	Scaffold_04	4027445	4050229	Q24331	TID_DROVI	"Protein tumorous imaginal discs, mitochondrial (Protein lethal(2)tumorous imaginal discs) (TID58)"	GO:0005524; GO:0005741; GO:0006457; GO:0007275; GO:0009408; GO:0031072; GO:0046872; GO:0051082	mitochondrial outer membrane [GO:0005741]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; response to heat [GO:0009408]
PGEN_.00g080050	Scaffold_04	4055393	4085292	A0JMU5	ANM9_XENLA	Protein arginine N-methyltransferase 9 (Protein arginine N-methyltransferase 10) (EC 2.1.1.320)	GO:0005737; GO:0006397; GO:0016274; GO:0035243	cytoplasm [GO:0005737]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; mRNA processing [GO:0006397]
PGEN_.00g080060	Scaffold_04	4085739	4090416	NA	NA	NA	NA	NA
PGEN_.00g080070	Scaffold_04	4095950	4120484	Q460N5	PAR14_HUMAN	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g080080	Scaffold_04	4126016	4127294	NA	NA	NA	NA	NA
PGEN_.00g080090	Scaffold_04	4127356	4127607	NA	NA	NA	NA	NA
PGEN_.00g080100	Scaffold_04	4127685	4127930	NA	NA	NA	NA	NA
PGEN_.00g080110	Scaffold_04	4130296	4158918	Q8C5S7	REC8_MOUSE	Meiotic recombination protein REC8 homolog (Cohesin Rec8p)	GO:0000724; GO:0000778; GO:0000780; GO:0000793; GO:0000794; GO:0000795; GO:0000800; GO:0001556; GO:0001673; GO:0003682; GO:0005634; GO:0005654; GO:0006302; GO:0007062; GO:0007129; GO:0007130; GO:0007141; GO:0007286; GO:0009566; GO:0030893; GO:0034991; GO:0051321; GO:0072520	"condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome, centromeric region [GO:0000780]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; oocyte maturation [GO:0001556]; seminiferous tubule development [GO:0072520]; sister chromatid cohesion [GO:0007062]; spermatid development [GO:0007286]; synapsis [GO:0007129]; synaptonemal complex assembly [GO:0007130]"
PGEN_.00g080120	Scaffold_04	4214862	4220716	NA	NA	NA	NA	NA
PGEN_.00g080130	Scaffold_04	4233008	4234746	Q4HVS2	GNT1_GIBZE	Glucose N-acetyltransferase 1 (EC 2.4.1.-) (N-acetylglucosaminyltransferase)	GO:0000139; GO:0005774; GO:0006487; GO:0008375; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; acetylglucosaminyltransferase activity [GO:0008375]; protein N-linked glycosylation [GO:0006487]
PGEN_.00g080140	Scaffold_04	4243619	4245517	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g080150	Scaffold_04	4251852	4252709	NA	NA	NA	NA	NA
PGEN_.00g080160	Scaffold_04	4253346	4253693	Q6E2N3	TRI33_DANRE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]
PGEN_.00g080170	Scaffold_04	4254322	4256358	NA	NA	NA	NA	NA
PGEN_.00g080180	Scaffold_04	4294989	4322158	Q14108	SCRB2_HUMAN	Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36)	GO:0000139; GO:0001618; GO:0001786; GO:0004888; GO:0005044; GO:0005548; GO:0005765; GO:0005789; GO:0005886; GO:0005925; GO:0006622; GO:0006898; GO:0010008; GO:0010976; GO:0015485; GO:0015917; GO:0016020; GO:0016021; GO:0019899; GO:0030665; GO:0030666; GO:0031210; GO:0031902; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:0061024; GO:0070062; GO:1904978; GO:1905123; GO:1905671	clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; aminophospholipid transport [GO:0015917]; membrane organization [GO:0061024]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]
PGEN_.00g080190	Scaffold_04	4331208	4355068	Q5RFQ3	PWP2_PONAB	Periodic tryptophan protein 2 homolog	GO:0005730	nucleolus [GO:0005730]
PGEN_.00g080200	Scaffold_04	4356663	4367937	Q03105	VATL_TORMA	V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (15 kDa mediatophore protein) (Vacuolar proton pump 16 kDa proteolipid subunit)	GO:0005774; GO:0015078; GO:0016021; GO:0033179	"integral component of membrane [GO:0016021]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar membrane [GO:0005774]; proton transmembrane transporter activity [GO:0015078]"
PGEN_.00g080210	Scaffold_04	4378335	4411462	Q9CQN1	TRAP1_MOUSE	"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)"	GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0019901; GO:0051082; GO:1901856; GO:1903751	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]
PGEN_.00g080220	Scaffold_04	4411637	4411939	NA	NA	NA	NA	NA
PGEN_.00g080230	Scaffold_04	4412069	4412368	NA	NA	NA	NA	NA
PGEN_.00g080240	Scaffold_04	4448428	4481295	O42287	ITSN1_XENLA	Intersectin-1	GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0015031; GO:0030027; GO:0030054; GO:0035556; GO:0043005; GO:0045202; GO:0055037	cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]
PGEN_.00g080250	Scaffold_04	4493102	4502837	NA	NA	NA	NA	NA
PGEN_.00g080260	Scaffold_04	4585646	4587843	NA	NA	NA	NA	NA
PGEN_.00g080270	Scaffold_04	4588202	4588693	NA	NA	NA	NA	NA
PGEN_.00g080280	Scaffold_04	4594329	4598379	NA	NA	NA	NA	NA
PGEN_.00g080290	Scaffold_04	4598514	4602529	NA	NA	NA	NA	NA
PGEN_.00g080300	Scaffold_04	4607596	4608396	NA	NA	NA	NA	NA
PGEN_.00g080310	Scaffold_04	4610535	4613802	NA	NA	NA	NA	NA
PGEN_.00g080320	Scaffold_04	4613830	4614372	NA	NA	NA	NA	NA
PGEN_.00g080330	Scaffold_04	4624776	4625249	NA	NA	NA	NA	NA
PGEN_.00g080340	Scaffold_04	4628753	4631126	NA	NA	NA	NA	NA
PGEN_.00g080350	Scaffold_04	4638630	4642208	NA	NA	NA	NA	NA
PGEN_.00g080360	Scaffold_04	4733674	4761427	NA	NA	NA	NA	NA
PGEN_.00g080370	Scaffold_04	4780178	4780543	NA	NA	NA	NA	NA
PGEN_.00g080380	Scaffold_04	4802831	4812762	NA	NA	NA	NA	NA
PGEN_.00g080390	Scaffold_04	4813032	4813712	O18883	TXND9_BOVIN	Thioredoxin domain-containing protein 9 (Protein 1-4)	GO:0005623; GO:0005634; GO:0005737; GO:0005815; GO:0030496; GO:0045454	cell [GO:0005623]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; cell redox homeostasis [GO:0045454]
PGEN_.00g080400	Scaffold_04	4821388	4848290	Q5RAA7	FIP1_PONAB	Pre-mRNA 3'-end-processing factor FIP1 (FIP1-like 1 protein)	GO:0003723; GO:0005847; GO:0098789	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; pre-mRNA cleavage required for polyadenylation [GO:0098789]
PGEN_.00g080410	Scaffold_04	4850203	4852037	NA	NA	NA	NA	NA
PGEN_.00g080420	Scaffold_04	4882859	4923096	P42680	TEC_HUMAN	Tyrosine-protein kinase Tec (EC 2.7.10.2)	GO:0002250; GO:0004715; GO:0005524; GO:0005543; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0007229; GO:0010543; GO:0018108; GO:0019221; GO:0035556; GO:0038083; GO:0038095; GO:0042246; GO:0046872; GO:0050731; GO:0050852; GO:0050853	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cytokine-mediated signaling pathway [GO:0019221]; Fc-epsilon receptor signaling pathway [GO:0038095]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246]
PGEN_.00g080430	Scaffold_04	4963277	4974262	NA	NA	NA	NA	NA
PGEN_.00g080440	Scaffold_04	5007049	5007285	NA	NA	NA	NA	NA
PGEN_.00g080450	Scaffold_04	5019253	5025013	P51521	OVO_DROME	Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)]	GO:0000122; GO:0001227; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0007010; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0019099; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048067; GO:0048477; GO:0070896	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; female germ-line sex determination [GO:0019099]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]"
PGEN_.00g080460	Scaffold_04	5045175	5046938	NA	NA	NA	NA	NA
PGEN_.00g080470	Scaffold_04	5058424	5058831	NA	NA	NA	NA	NA
PGEN_.00g080480	Scaffold_04	5097751	5124347	P51521	OVO_DROME	Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)]	GO:0000122; GO:0001227; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0007010; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0019099; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048067; GO:0048477; GO:0070896	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; female germ-line sex determination [GO:0019099]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]"
PGEN_.00g080490	Scaffold_04	5134443	5134784	NA	NA	NA	NA	NA
PGEN_.00g080500	Scaffold_04	5135091	5135423	NA	NA	NA	NA	NA
PGEN_.00g080510	Scaffold_04	5145802	5174006	P51521	OVO_DROME	Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)]	GO:0000122; GO:0001227; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0007010; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0019099; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048067; GO:0048477; GO:0070896	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; female germ-line sex determination [GO:0019099]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transposon integration [GO:0070896]; regulation of cell shape [GO:0008360]"
PGEN_.00g080520	Scaffold_04	5194013	5195002	P10621	IPNS_STRC2	Isopenicillin N synthase (IPNS) (EC 1.21.3.1)	GO:0005506; GO:0016216; GO:0017000; GO:0031418	iron ion binding [GO:0005506]; isopenicillin-N synthase activity [GO:0016216]; L-ascorbic acid binding [GO:0031418]; antibiotic biosynthetic process [GO:0017000]
PGEN_.00g080530	Scaffold_04	5209601	5210203	NA	NA	NA	NA	NA
PGEN_.00g080540	Scaffold_04	5215615	5216947	NA	NA	NA	NA	NA
PGEN_.00g080550	Scaffold_04	5220253	5228840	NA	NA	NA	NA	NA
PGEN_.00g080560	Scaffold_04	5228995	5232749	NA	NA	NA	NA	NA
PGEN_.00g080570	Scaffold_04	5249318	5267233	Q8CA95	PDE10_MOUSE	"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) (EC 3.1.4.35)"	GO:0004112; GO:0004114; GO:0004118; GO:0005737; GO:0006198; GO:0007165; GO:0010738; GO:0010754; GO:0016020; GO:0030552; GO:0030553; GO:0043025; GO:0043204; GO:0043949; GO:0043951; GO:0046069; GO:0046872; GO:0047555	"cytoplasm [GO:0005737]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165]"
PGEN_.00g080580	Scaffold_04	5332429	5332770	NA	NA	NA	NA	NA
PGEN_.00g080590	Scaffold_04	5333150	5333413	NA	NA	NA	NA	NA
PGEN_.00g080600	Scaffold_04	5417102	5420826	O15973	OPSD1_MIZYE	"Rhodopsin, GQ-coupled (GQ-rhodopsin)"	GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g080610	Scaffold_04	5468160	5474112	NA	NA	NA	NA	NA
PGEN_.00g080620	Scaffold_04	5488175	5498063	NA	NA	NA	NA	NA
PGEN_.00g080630	Scaffold_04	5513375	5517125	NA	NA	NA	NA	NA
PGEN_.00g080640	Scaffold_04	5552343	5556067	NA	NA	NA	NA	NA
PGEN_.00g080650	Scaffold_04	5578791	5583887	NA	NA	NA	NA	NA
PGEN_.00g080660	Scaffold_04	5594057	5606348	NA	NA	NA	NA	NA
PGEN_.00g080670	Scaffold_04	5613849	5625424	A4IH75	ATGA1_XENTR	Autophagy-related protein 101	GO:0000045; GO:0000407	phagophore assembly site [GO:0000407]; autophagosome assembly [GO:0000045]
PGEN_.00g080680	Scaffold_04	5625865	5639987	Q9JMD3	STA10_MOUSE	START domain-containing protein 10 (StARD10) (PCTP-like protein) (PCTP-L) (Serologically defined colon cancer antigen 28 homolog) (StAR-related lipid transfer protein 10)	GO:0005829; GO:0005902; GO:0006869; GO:0008289; GO:0016020; GO:0031514; GO:0032782; GO:0035360; GO:0046581	cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; lipid binding [GO:0008289]; bile acid secretion [GO:0032782]; lipid transport [GO:0006869]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]
PGEN_.00g080690	Scaffold_04	5670425	5730456	O18894	CLCN3_RABIT	H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3)	GO:0005247; GO:0005524; GO:0005769; GO:0005770; GO:0005794; GO:0012506; GO:0015297; GO:0016021; GO:0030165; GO:0030658; GO:0031901; GO:0031902	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; transport vesicle membrane [GO:0030658]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]
PGEN_.00g080700	Scaffold_04	5730516	5769291	NA	NA	NA	NA	NA
PGEN_.00g080710	Scaffold_04	5774976	5795595	P86789	GIGA6_CRAGI	Gigasin-6	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g080720	Scaffold_04	5805659	5810324	B9EJ80	PDZD8_MOUSE	PDZ domain-containing protein 8	GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008289; GO:0016021; GO:0022604; GO:0035556; GO:0044233; GO:0046872; GO:0051560; GO:1990456	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604]
PGEN_.00g080730	Scaffold_04	5825594	5830161	NA	NA	NA	NA	NA
PGEN_.00g080740	Scaffold_04	5861385	5889506	Q6NRD3	SH3R1_XENLA	E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (xPOSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1)	GO:0001764; GO:0005078; GO:0005794; GO:0006915; GO:0030027; GO:0043370; GO:0046330; GO:0046872; GO:0048471; GO:0051865; GO:0061630; GO:2000564	"Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]"
PGEN_.00g080750	Scaffold_04	5909975	5928337	P19492	GRIA3_RAT	"Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3) (GluA3)"	GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005886; GO:0008066; GO:0008328; GO:0010226; GO:0014069; GO:0016020; GO:0030054; GO:0030165; GO:0030425; GO:0032279; GO:0032281; GO:0032991; GO:0035249; GO:0043025; GO:0043083; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0050804; GO:0060992; GO:0098688; GO:0098839; GO:0098978; GO:0099055; GO:0099056; GO:0099061; GO:1904315	"AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; PDZ domain binding [GO:0030165]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; regulation of receptor recycling [GO:0001919]; response to fungicide [GO:0060992]; response to lithium ion [GO:0010226]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g080760	Scaffold_04	5932089	5932451	NA	NA	NA	NA	NA
PGEN_.00g080770	Scaffold_04	6013921	6016204	P26591	GLRK_LYMST	Glutamate receptor	GO:0004970; GO:0016021; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]
PGEN_.00g080780	Scaffold_04	6058636	6064943	NA	NA	NA	NA	NA
PGEN_.00g080790	Scaffold_04	6130749	6135119	P82596	PLC_HALLA	Perlucin	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g080800	Scaffold_04	6136322	6136663	NA	NA	NA	NA	NA
PGEN_.00g080810	Scaffold_04	6136872	6139144	P82596	PLC_HALLA	Perlucin	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g080820	Scaffold_04	6144837	6145127	NA	NA	NA	NA	NA
PGEN_.00g080830	Scaffold_04	6145221	6145520	NA	NA	NA	NA	NA
PGEN_.00g080840	Scaffold_04	6146955	6160277	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g080850	Scaffold_04	6164340	6188728	NA	NA	NA	NA	NA
PGEN_.00g080860	Scaffold_04	6286617	6293607	Q9WVD5	ORNT1_MOUSE	Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15)	GO:0000064; GO:0005739; GO:0005743; GO:0016021; GO:1990575	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; L-ornithine transmembrane transporter activity [GO:0000064]; mitochondrial L-ornithine transmembrane transport [GO:1990575]
PGEN_.00g080870	Scaffold_04	6303439	6316236	NA	NA	NA	NA	NA
PGEN_.00g080880	Scaffold_04	6351843	6367619	NA	NA	NA	NA	NA
PGEN_.00g080890	Scaffold_04	6369870	6381909	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g080900	Scaffold_04	6396396	6397205	NA	NA	NA	NA	NA
PGEN_.00g080910	Scaffold_04	6404219	6409104	NA	NA	NA	NA	NA
PGEN_.00g080920	Scaffold_04	6409641	6414059	NA	NA	NA	NA	NA
PGEN_.00g080930	Scaffold_04	6417565	6421535	NA	NA	NA	NA	NA
PGEN_.00g080940	Scaffold_04	6436685	6454810	NA	NA	NA	NA	NA
PGEN_.00g080950	Scaffold_04	6458184	6464465	NA	NA	NA	NA	NA
PGEN_.00g080960	Scaffold_04	6469130	6469885	NA	NA	NA	NA	NA
PGEN_.00g080970	Scaffold_04	6491128	6496426	NA	NA	NA	NA	NA
PGEN_.00g080980	Scaffold_04	6499421	6499942	NA	NA	NA	NA	NA
PGEN_.00g080990	Scaffold_04	6525658	6556643	Q27802	DYHC2_TRIGR	Cytoplasmic dynein 2 heavy chain 1 (Dynein heavy chain isotype 1B)	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0007275; GO:0030030; GO:0030286	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275]
PGEN_.00g081000	Scaffold_04	6562308	6600640	Q27802	DYHC2_TRIGR	Cytoplasmic dynein 2 heavy chain 1 (Dynein heavy chain isotype 1B)	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0007275; GO:0030030; GO:0030286	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275]
PGEN_.00g081010	Scaffold_04	6604091	6609307	Q5RHX6	DCNL4_DANRE	DCN1-like protein 4 (DCUN1 domain-containing protein 4) (Defective in cullin neddylation protein 1-like protein 4)	GO:0000151; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602	ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]
PGEN_.00g081020	Scaffold_04	6639083	6641622	NA	NA	NA	NA	NA
PGEN_.00g081030	Scaffold_04	6649719	6656618	NA	NA	NA	NA	NA
PGEN_.00g081040	Scaffold_04	6660897	6674484	NA	NA	NA	NA	NA
PGEN_.00g081050	Scaffold_04	6679833	6697014	Q5I2E5	FCN2_BOVIN	Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin)	GO:0001867; GO:0005576; GO:0005581; GO:0030246; GO:0046872	"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; complement activation, lectin pathway [GO:0001867]"
PGEN_.00g081060	Scaffold_04	6702687	6709788	O70165	FCN1_MOUSE	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	GO:0001867; GO:0002752; GO:0005576; GO:0005581; GO:0007186; GO:0008329; GO:0030246; GO:0031232; GO:0045087; GO:0046872; GO:0097367; GO:2000484	"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; positive regulation of interleukin-8 secretion [GO:2000484]"
PGEN_.00g081070	Scaffold_04	6736174	6744208	Q6AX44	FBCDA_XENLA	Fibrinogen C domain-containing protein 1-A	GO:0008061; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g081080	Scaffold_04	6750169	6758376	Q9BVJ7	DUS23_HUMAN	Dual specificity protein phosphatase 23 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular mass dual specificity phosphatase 3) (LDP-3) (VH1-like phosphatase Z)	GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0016311; GO:0016791	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]
PGEN_.00g081090	Scaffold_04	6765853	6773444	NA	NA	NA	NA	NA
PGEN_.00g081100	Scaffold_04	6786019	6788710	NA	NA	NA	NA	NA
PGEN_.00g081110	Scaffold_04	6798992	6799830	NA	NA	NA	NA	NA
PGEN_.00g081120	Scaffold_04	6803653	6817714	Q8IZJ3	CPMD8_HUMAN	C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8	GO:0001654; GO:0004867; GO:0005615; GO:0005886	extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; eye development [GO:0001654]
PGEN_.00g081130	Scaffold_04	6817743	6821506	NA	NA	NA	NA	NA
PGEN_.00g081140	Scaffold_04	6823689	6850427	Q9CWP6	MSPD2_MOUSE	Motile sperm domain-containing protein 2	GO:0005887; GO:0006935; GO:0090023; GO:0090026	integral component of plasma membrane [GO:0005887]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]
PGEN_.00g081150	Scaffold_04	6859137	6861830	Q10323	IMT3_SCHPO	Inositol phosphoceramide mannosyltransferase 3 (EC 2.4.-.-) (IPC mannosyltransferase 3)	GO:0000030; GO:0005783; GO:0005789; GO:0005794; GO:0016021; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g081160	Scaffold_04	6934294	6937789	Q15319	PO4F3_HUMAN	"POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C)"	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0007601; GO:0007605; GO:0021562; GO:0031290; GO:0042472; GO:0042491; GO:0045944; GO:0048675; GO:0050885; GO:0051402	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601]"
PGEN_.00g081170	Scaffold_04	6991924	7011883	Q6ZQY2	LR74B_HUMAN	Leucine-rich repeat-containing protein 74B		
PGEN_.00g081180	Scaffold_04	7024115	7035455	NA	NA	NA	NA	NA
PGEN_.00g081190	Scaffold_04	7041798	7042397	NA	NA	NA	NA	NA
PGEN_.00g081200	Scaffold_04	7059879	7115721	Q460N5	PAR14_HUMAN	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g081210	Scaffold_04	7131575	7131913	NA	NA	NA	NA	NA
PGEN_.00g081220	Scaffold_04	7143516	7144930	NA	NA	NA	NA	NA
PGEN_.00g081230	Scaffold_04	7184355	7190776	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g081240	Scaffold_04	7194682	7198305	NA	NA	NA	NA	NA
PGEN_.00g081250	Scaffold_04	7211470	7223551	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g081260	Scaffold_04	7242061	7246823	NA	NA	NA	NA	NA
PGEN_.00g081270	Scaffold_04	7259424	7269530	D8VNS8	FCNV2_CERRY	Ryncolin-2	GO:0005576; GO:0009405; GO:0090729	extracellular region [GO:0005576]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g081280	Scaffold_04	7292267	7305711	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g081290	Scaffold_04	7352038	7352802	NA	NA	NA	NA	NA
PGEN_.00g081300	Scaffold_04	7357131	7365913	NA	NA	NA	NA	NA
PGEN_.00g081310	Scaffold_04	7383463	7383756	NA	NA	NA	NA	NA
PGEN_.00g081320	Scaffold_04	7415383	7432045	P57088	TMM33_HUMAN	Transmembrane protein 33 (Protein DB83) (SHINC-3)	GO:0005635; GO:0005783; GO:0005789; GO:0030176; GO:0034976; GO:0042470; GO:1903371; GO:1903896; GO:1903899	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g081330	Scaffold_04	7433367	7433762	NA	NA	NA	NA	NA
PGEN_.00g081340	Scaffold_04	7433900	7434229	NA	NA	NA	NA	NA
PGEN_.00g081350	Scaffold_04	7464519	7467079	P03360	POL_AVIRE	Gag-Pol polyprotein [Cleaved into: Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)] (Fragment)	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0046872; GO:0075713	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]
PGEN_.00g081360	Scaffold_04	7485185	7485481	NA	NA	NA	NA	NA
PGEN_.00g081370	Scaffold_04	7486071	7486589	NA	NA	NA	NA	NA
PGEN_.00g081380	Scaffold_04	7509157	7510464	NA	NA	NA	NA	NA
PGEN_.00g081390	Scaffold_04	7529937	7531642	NA	NA	NA	NA	NA
PGEN_.00g081400	Scaffold_04	7536326	7539353	NA	NA	NA	NA	NA
PGEN_.00g081410	Scaffold_04	7565533	7565997	NA	NA	NA	NA	NA
PGEN_.00g081420	Scaffold_04	7566051	7566431	NA	NA	NA	NA	NA
PGEN_.00g081430	Scaffold_04	7566473	7566994	NA	NA	NA	NA	NA
PGEN_.00g081440	Scaffold_04	7567247	7570314	NA	NA	NA	NA	NA
PGEN_.00g081450	Scaffold_04	7581741	7605534	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g081460	Scaffold_04	7632780	7644932	NA	NA	NA	NA	NA
PGEN_.00g081470	Scaffold_04	7709840	7724988	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g081480	Scaffold_04	7732784	7733431	NA	NA	NA	NA	NA
PGEN_.00g081490	Scaffold_04	7746687	7750857	NA	NA	NA	NA	NA
PGEN_.00g081500	Scaffold_04	7756900	7757793	NA	NA	NA	NA	NA
PGEN_.00g081510	Scaffold_04	7757819	7758334	NA	NA	NA	NA	NA
PGEN_.00g081520	Scaffold_04	7766742	7773293	NA	NA	NA	NA	NA
PGEN_.00g081530	Scaffold_04	7807812	7808057	NA	NA	NA	NA	NA
PGEN_.00g081540	Scaffold_04	7810003	7812175	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g081550	Scaffold_04	7812569	7812880	NA	NA	NA	NA	NA
PGEN_.00g081560	Scaffold_04	7840705	7842207	NA	NA	NA	NA	NA
PGEN_.00g081570	Scaffold_04	7842604	7843005	NA	NA	NA	NA	NA
PGEN_.00g081580	Scaffold_04	7843190	7844696	NA	NA	NA	NA	NA
PGEN_.00g081590	Scaffold_04	7847335	7849550	NA	NA	NA	NA	NA
PGEN_.00g081600	Scaffold_04	7852859	7859696	Q8K4Q8	COL12_MOUSE	Collectin-12 (Collectin placenta protein 1) (CL-P1) (Scavenger receptor with C-type lectin)	GO:0004888; GO:0005581; GO:0006910; GO:0006955; GO:0008329; GO:0016021; GO:0030169; GO:0030246; GO:0034138; GO:0046872; GO:0060355; GO:0062023; GO:0071360	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; transmembrane signaling receptor activity [GO:0004888]; cellular response to exogenous dsRNA [GO:0071360]; immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]"
PGEN_.00g081610	Scaffold_04	7886078	7898761	Q2TU62	CLCA1_HORSE	Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (eCLCA1)	GO:0005229; GO:0005615; GO:0005887; GO:0005902; GO:0006816; GO:0008237; GO:0030141; GO:0046872	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]
PGEN_.00g081620	Scaffold_04	7962272	7967851	P07996	TSP1_HUMAN	Thrombospondin-1 (Glycoprotein G)	GO:0000187; GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002040; GO:0002544; GO:0002576; GO:0002581; GO:0002605; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006954; GO:0006955; GO:0006986; GO:0007050; GO:0007155; GO:0008201; GO:0008284; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030198; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032695; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0040037; GO:0042327; GO:0042493; GO:0042535; GO:0042802; GO:0043032; GO:0043066; GO:0043154; GO:0043236; GO:0043394; GO:0043536; GO:0043537; GO:0043652; GO:0045652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431]; activation of MAPK activity [GO:0000187]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; platelet degranulation [GO:0002576]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of megakaryocyte differentiation [GO:0045652]; response to calcium ion [GO:0051592]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; sprouting angiogenesis [GO:0002040]
PGEN_.00g081630	Scaffold_04	7986628	7988682	Q9BXX0	EMIL2_HUMAN	EMILIN-2 (Elastin microfibril interface-located protein 2) (Elastin microfibril interfacer 2) (Protein FOAP-10)	GO:0005576; GO:0005581; GO:0007155; GO:0030023; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix constituent conferring elasticity [GO:0030023]; cell adhesion [GO:0007155]
PGEN_.00g081640	Scaffold_04	8021331	8043610	P23606	TGM1_RAT	Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)	GO:0003810; GO:0005913; GO:0009887; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031224; GO:0031424; GO:0045787; GO:0046872	cell-cell adherens junction [GO:0005913]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; animal organ morphogenesis [GO:0009887]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]
PGEN_.00g081650	Scaffold_04	8052612	8052905	NA	NA	NA	NA	NA
PGEN_.00g081660	Scaffold_04	8061849	8062448	NA	NA	NA	NA	NA
PGEN_.00g081670	Scaffold_04	8062849	8064532	NA	NA	NA	NA	NA
PGEN_.00g081680	Scaffold_04	8066756	8067130	NA	NA	NA	NA	NA
PGEN_.00g081690	Scaffold_04	8167493	8169896	NA	NA	NA	NA	NA
PGEN_.00g081700	Scaffold_04	8186171	8186638	NA	NA	NA	NA	NA
PGEN_.00g081710	Scaffold_04	8200628	8215743	NA	NA	NA	NA	NA
PGEN_.00g081720	Scaffold_04	8222740	8223462	NA	NA	NA	NA	NA
PGEN_.00g081730	Scaffold_04	8223788	8224375	NA	NA	NA	NA	NA
PGEN_.00g081740	Scaffold_04	8236910	8237119	NA	NA	NA	NA	NA
PGEN_.00g081750	Scaffold_04	8312400	8312804	NA	NA	NA	NA	NA
PGEN_.00g081760	Scaffold_04	8315256	8316350	Q9ESQ4	NMUR2_RAT	Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor TGR-1) (G-protein-coupled receptor FM-4)	GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005623; GO:0005886; GO:0006816; GO:0007200; GO:0007204; GO:0007218; GO:0007417; GO:0007625; GO:0008188; GO:0016021; GO:0042924; GO:0043006; GO:0048016; GO:0048265; GO:0050482; GO:0051930	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; central nervous system development [GO:0007417]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265]
PGEN_.00g081770	Scaffold_04	8331074	8382217	Q04656	ATP7A_HUMAN	Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein)	GO:0001568; GO:0001701; GO:0001889; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005623; GO:0005634; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006568; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007595; GO:0007626; GO:0010041; GO:0010042; GO:0010043; GO:0010273; GO:0010468; GO:0010592; GO:0015677; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016532; GO:0018205; GO:0019430; GO:0019730; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030141; GO:0030198; GO:0030199; GO:0030670; GO:0031069; GO:0031252; GO:0031526; GO:0032767; GO:0034220; GO:0034760; GO:0036120; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042428; GO:0043005; GO:0043025; GO:0043085; GO:0043086; GO:0043204; GO:0043473; GO:0043588; GO:0043682; GO:0045121; GO:0045793; GO:0048251; GO:0048286; GO:0048365; GO:0048471; GO:0048812; GO:0050679; GO:0051087; GO:0051216; GO:0051353; GO:0051542; GO:0060003; GO:0071230; GO:0071236; GO:0071276; GO:0071279; GO:0071280; GO:0071281; GO:0071284; GO:0071456; GO:1903036; GO:1903136; GO:1904754; GO:1904959	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper transmembrane transporter activity, phosphorylative mechanism [GO:0043682]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]; antimicrobial humoral response [GO:0019730]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; ion transmembrane transport [GO:0034220]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catalytic activity [GO:0043086]; negative regulation of iron ion transmembrane transport [GO:0034760]; neuron projection morphogenesis [GO:0048812]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; removal of superoxide radicals [GO:0019430]; response to iron(III) ion [GO:0010041]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]"
PGEN_.00g081780	Scaffold_04	8391708	8400829	Q3TZM9	ALG11_MOUSE	"GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase (EC 2.4.1.131) (Asparagine-linked glycosylation protein 11 homolog) (Glycolipid 2-alpha-mannosyltransferase)"	GO:0004377; GO:0005789; GO:0006487; GO:0006490; GO:0016021	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]"
PGEN_.00g081790	Scaffold_04	8406372	8406962	NA	NA	NA	NA	NA
PGEN_.00g081800	Scaffold_04	8434200	8470280	Q92793	CBP_HUMAN	CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-)	GO:0000122; GO:0000123; GO:0000790; GO:0000987; GO:0001085; GO:0001102; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006367; GO:0006473; GO:0007165; GO:0007219; GO:0007221; GO:0008134; GO:0008270; GO:0008589; GO:0016032; GO:0016407; GO:0016573; GO:0016604; GO:0018076; GO:0019216; GO:0030511; GO:0031648; GO:0032481; GO:0034644; GO:0042592; GO:0042733; GO:0042981; GO:0043426; GO:0045637; GO:0045747; GO:0045893; GO:0045944; GO:0048511; GO:0061418; GO:0065003; GO:1900034; GO:1904837	"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of type I interferon production [GO:0032481]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of cellular response to heat [GO:1900034]; regulation of lipid metabolic process [GO:0019216]; regulation of myeloid cell differentiation [GO:0045637]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]"
PGEN_.00g081810	Scaffold_04	8509721	8514682	P10986	ACT4_CAEEL	Actin-4	GO:0000281; GO:0005200; GO:0005524; GO:0005856; GO:0005865; GO:0015629; GO:0030036; GO:0045121	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; membrane raft [GO:0045121]; striated muscle thin filament [GO:0005865]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; mitotic cytokinesis [GO:0000281]
PGEN_.00g081820	Scaffold_04	8526490	8537505	Q9DGG6	ADCY9_CHICK	Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9)	GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]
PGEN_.00g081830	Scaffold_04	8537442	8541634	NA	NA	NA	NA	NA
PGEN_.00g081840	Scaffold_04	8537707	8541791	Q8NCB2	CAMKV_HUMAN	CaM kinase-like vesicle-associated protein	GO:0004683; GO:0005516; GO:0005524; GO:0005886; GO:0030659; GO:0098978; GO:0099159	cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; regulation of modification of postsynaptic structure [GO:0099159]
PGEN_.00g081850	Scaffold_04	8543344	8605176	Q9DGG6	ADCY9_CHICK	Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9)	GO:0004016; GO:0005524; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0046872; GO:0071880	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]
PGEN_.00g081860	Scaffold_04	8607584	8607883	NA	NA	NA	NA	NA
PGEN_.00g081870	Scaffold_04	8650581	8679174	E9PSK7	JIP3_RAT	C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3)	GO:0000139; GO:0001701; GO:0005078; GO:0005737; GO:0005790; GO:0005886; GO:0007254; GO:0007257; GO:0007411; GO:0007585; GO:0008104; GO:0008432; GO:0009791; GO:0010468; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0030900; GO:0031103; GO:0031175; GO:0031410; GO:0031434; GO:0031435; GO:0043005; GO:0043507; GO:0044297; GO:0045666; GO:0046328; GO:0048286; GO:0048471; GO:0060425; GO:0061564; GO:0099641; GO:1904115; GO:2001224	axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; receptor signaling complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; JNK cascade [GO:0007254]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; neuron projection development [GO:0031175]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; regulation of JNK cascade [GO:0046328]; respiratory gaseous exchange by respiratory system [GO:0007585]; vesicle-mediated transport [GO:0016192]
PGEN_.00g081880	Scaffold_04	8754091	8791238	Q9GQF1	JIP3_DROME	JNK-interacting protein 3 (Protein sunday driver)	GO:0000139; GO:0005078; GO:0005737; GO:0007257; GO:0008088; GO:0008432; GO:0016020; GO:0016192; GO:0019894; GO:0030140; GO:0030159; GO:0043005; GO:0046328	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuron projection [GO:0043005]; trans-Golgi network transport vesicle [GO:0030140]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; receptor signaling complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; axo-dendritic transport [GO:0008088]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]
PGEN_.00g081890	Scaffold_04	8791430	8809930	NA	NA	NA	NA	NA
PGEN_.00g081900	Scaffold_04	8817826	8819701	NA	NA	NA	NA	NA
PGEN_.00g081910	Scaffold_04	8837223	8848736	NA	NA	NA	NA	NA
PGEN_.00g081920	Scaffold_04	8857106	8862107	NA	NA	NA	NA	NA
PGEN_.00g081930	Scaffold_04	8871315	8871743	NA	NA	NA	NA	NA
PGEN_.00g081940	Scaffold_04	8875333	8897558	Q9D7G0	PRPS1_MOUSE	Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase I) (PRS-I)	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006144; GO:0006164; GO:0006167; GO:0007399; GO:0009116; GO:0009165; GO:0016208; GO:0016301; GO:0019003; GO:0019693; GO:0030246; GO:0032991; GO:0034418; GO:0042802; GO:0042803; GO:0043531; GO:0046101	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; hypoxanthine biosynthetic process [GO:0046101]; nervous system development [GO:0007399]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleobase metabolic process [GO:0006144]; purine nucleotide biosynthetic process [GO:0006164]; ribose phosphate metabolic process [GO:0019693]; urate biosynthetic process [GO:0034418]
PGEN_.00g081950	Scaffold_04	8897952	8908290	P52486	UBCD4_DROME	Ubiquitin-conjugating enzyme E2-22 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 4) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0031625; GO:0061631; GO:0070628	nucleus [GO:0005634]; ATP binding [GO:0005524]; proteasome binding [GO:0070628]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]
PGEN_.00g081960	Scaffold_04	8970629	8972672	NA	NA	NA	NA	NA
PGEN_.00g081970	Scaffold_04	8982060	8990581	NA	NA	NA	NA	NA
PGEN_.00g081980	Scaffold_04	9007561	9010245	A0A0P0XM10	PAO6_ORYSJ	Polyamine oxidase 6 (OsPAO6) (EC 1.5.3.-) (Polyamine oxidase B)	GO:0016491; GO:0046208; GO:0048046	apoplast [GO:0048046]; oxidoreductase activity [GO:0016491]; spermine catabolic process [GO:0046208]
PGEN_.00g081990	Scaffold_04	9018383	9020640	NA	NA	NA	NA	NA
PGEN_.00g082000	Scaffold_04	9038959	9062333	Q0P4F7	ACSF2_DANRE	"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)"	GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]
PGEN_.00g082010	Scaffold_04	9071805	9127557	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g082020	Scaffold_04	9137858	9138067	NA	NA	NA	NA	NA
PGEN_.00g082030	Scaffold_04	9138110	9138373	NA	NA	NA	NA	NA
PGEN_.00g082040	Scaffold_04	9138581	9138892	NA	NA	NA	NA	NA
PGEN_.00g082050	Scaffold_04	9140555	9156293	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g082060	Scaffold_04	9158546	9158857	NA	NA	NA	NA	NA
PGEN_.00g082070	Scaffold_04	9161441	9165834	NA	NA	NA	NA	NA
PGEN_.00g082080	Scaffold_04	9173584	9173850	NA	NA	NA	NA	NA
PGEN_.00g082090	Scaffold_04	9174378	9174785	NA	NA	NA	NA	NA
PGEN_.00g082100	Scaffold_04	9175060	9175533	NA	NA	NA	NA	NA
PGEN_.00g082110	Scaffold_04	9176760	9177086	NA	NA	NA	NA	NA
PGEN_.00g082120	Scaffold_04	9181287	9202989	Q7JQD3	GELS1_LUMTE	Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1)	GO:0003779; GO:0005509; GO:0005737; GO:0005856; GO:0007275; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275]
PGEN_.00g082130	Scaffold_04	9209804	9214425	NA	NA	NA	NA	NA
PGEN_.00g082140	Scaffold_04	9215109	9215330	NA	NA	NA	NA	NA
PGEN_.00g082150	Scaffold_04	9230412	9234862	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g082160	Scaffold_04	9243613	9248131	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g082170	Scaffold_04	9257724	9258374	NA	NA	NA	NA	NA
PGEN_.00g082180	Scaffold_04	9258553	9260675	NA	NA	NA	NA	NA
PGEN_.00g082190	Scaffold_04	9277241	9283496	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g082200	Scaffold_04	9284471	9331380	NA	NA	NA	NA	NA
PGEN_.00g082210	Scaffold_04	9333481	9333756	NA	NA	NA	NA	NA
PGEN_.00g082220	Scaffold_04	9339997	9342830	NA	NA	NA	NA	NA
PGEN_.00g082230	Scaffold_04	9353627	9371524	Q5RFR0	TTPAL_PONAB	Alpha-tocopherol transfer protein-like		
PGEN_.00g082240	Scaffold_04	9376638	9393367	P51569	AGAL_MOUSE	Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase)	GO:0003824; GO:0004557; GO:0005102; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0009311; GO:0016139; GO:0016787; GO:0016936; GO:0042803; GO:0045019; GO:0046477; GO:0051001; GO:0052692	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; signaling receptor binding [GO:0005102]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; oligosaccharide metabolic process [GO:0009311]
PGEN_.00g082250	Scaffold_04	9403149	9412378	Q90744	NAGAB_CHICK	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]
PGEN_.00g082260	Scaffold_04	9414399	9419889	NA	NA	NA	NA	NA
PGEN_.00g082270	Scaffold_04	9433943	9454553	NA	NA	NA	NA	NA
PGEN_.00g082280	Scaffold_04	9488063	9488806	NA	NA	NA	NA	NA
PGEN_.00g082290	Scaffold_04	9491574	9492140	NA	NA	NA	NA	NA
PGEN_.00g082300	Scaffold_04	9504403	9562558	P26591	GLRK_LYMST	Glutamate receptor	GO:0004970; GO:0016021; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]
PGEN_.00g082310	Scaffold_04	9613913	9674522	P42262	GRIA2_HUMAN	"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"	GO:0001540; GO:0004970; GO:0004971; GO:0005789; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0008066; GO:0009897; GO:0014069; GO:0030054; GO:0030425; GO:0030666; GO:0032281; GO:0035235; GO:0035249; GO:0043197; GO:0045211; GO:0050804; GO:0060076; GO:0098794; GO:0098839; GO:0098843; GO:1904315; GO:2000310	"AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g082320	Scaffold_04	9681312	9713169	NA	NA	NA	NA	NA
PGEN_.00g082330	Scaffold_04	9733380	9756345	Q96G03	PGM2_HUMAN	Phosphoglucomutase-2 (PGM 2) (EC 5.4.2.2) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphopentomutase) (EC 5.4.2.7)	GO:0000287; GO:0004614; GO:0005576; GO:0005829; GO:0005978; GO:0005980; GO:0006006; GO:0006098; GO:0008973; GO:0019388; GO:0034774; GO:0043312; GO:0046386; GO:0070062; GO:1904813	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098]
PGEN_.00g082340	Scaffold_04	9772529	9775178	NA	NA	NA	NA	NA
PGEN_.00g082350	Scaffold_04	9792947	9794149	Q03017	CACT_DROME	NF-kappa-B inhibitor cactus	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]
PGEN_.00g082360	Scaffold_04	9808973	9810187	Q03017	CACT_DROME	NF-kappa-B inhibitor cactus	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]
PGEN_.00g082370	Scaffold_04	9834005	9835240	Q03017	CACT_DROME	NF-kappa-B inhibitor cactus	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]
PGEN_.00g082380	Scaffold_04	9846252	9852039	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g082390	Scaffold_04	9894020	9900405	Q8BR93	HARB1_MOUSE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g082400	Scaffold_04	9902872	9904319	NA	NA	NA	NA	NA
PGEN_.00g082410	Scaffold_04	9959688	9969085	NA	NA	NA	NA	NA
PGEN_.00g082420	Scaffold_04	9986146	9988884	NA	NA	NA	NA	NA
PGEN_.00g082430	Scaffold_04	9997653	9998528	NA	NA	NA	NA	NA
PGEN_.00g082440	Scaffold_04	10001932	10002159	NA	NA	NA	NA	NA
PGEN_.00g082450	Scaffold_04	10007375	10009655	NA	NA	NA	NA	NA
PGEN_.00g082460	Scaffold_04	10029553	10030584	NA	NA	NA	NA	NA
PGEN_.00g082470	Scaffold_04	10033283	10033627	NA	NA	NA	NA	NA
PGEN_.00g082480	Scaffold_04	10070871	10072546	NA	NA	NA	NA	NA
PGEN_.00g082490	Scaffold_04	10073622	10075401	NA	NA	NA	NA	NA
PGEN_.00g082500	Scaffold_04	10087797	10098405	NA	NA	NA	NA	NA
PGEN_.00g082510	Scaffold_04	10144068	10147218	NA	NA	NA	NA	NA
PGEN_.00g082520	Scaffold_04	10150770	10154053	NA	NA	NA	NA	NA
PGEN_.00g082530	Scaffold_04	10176182	10177377	NA	NA	NA	NA	NA
PGEN_.00g082540	Scaffold_04	10179181	10185756	Q9JHS6	ASIC4_RAT	Acid-sensing ion channel 4 (ASIC4) (Amiloride-sensitive cation channel 4) (Spinal chord ASIC)	GO:0001662; GO:0005272; GO:0016021	integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]; behavioral fear response [GO:0001662]
PGEN_.00g082550	Scaffold_04	10208222	10210749	NA	NA	NA	NA	NA
PGEN_.00g082560	Scaffold_04	10220217	10221299	O54905	B3GT2_MOUSE	"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-II)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g082570	Scaffold_04	10235870	10238646	Q24537	HMG2_DROME	High mobility group protein DSP1 (Protein dorsal switch 1)	GO:0000122; GO:0000790; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0005737; GO:0006268; GO:0006310; GO:0006338; GO:0006357; GO:0007379; GO:0008134; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0043388; GO:0045089; GO:0045892; GO:0045944	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]"
PGEN_.00g082580	Scaffold_04	10248755	10253555	Q3BSE3	SELO_XANC5	Protein adenylyltransferase SelO (EC 2.7.7.-) (EC 2.7.7.n1)	GO:0000287; GO:0005524; GO:0016779	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]
PGEN_.00g082590	Scaffold_04	10258198	10284908	O00303	EIF3F_HUMAN	Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47)	GO:0001732; GO:0003743; GO:0004843; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0016579; GO:0031369; GO:0033290; GO:0071541; GO:0075522	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413]"
PGEN_.00g082600	Scaffold_04	10289427	10323766	Q6P4R8	NFRKB_HUMAN	Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G)	GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006366; GO:0006954; GO:0016579; GO:0031011	Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein deubiquitination [GO:0016579]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g082610	Scaffold_04	10329324	10335111	NA	NA	NA	NA	NA
PGEN_.00g082620	Scaffold_04	10343382	10346256	B0BLZ5	THEM6_XENTR	Protein THEM6	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g082630	Scaffold_04	10355416	10356402	NA	NA	NA	NA	NA
PGEN_.00g082640	Scaffold_04	10378366	10392555	O94864	ST65G_HUMAN	STAGA complex 65 subunit gamma (Adenocarcinoma antigen ART1) (SPTF-associated factor 65 gamma) (STAF65gamma) (Suppressor of Ty 7-like)	GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0030914; GO:0043966; GO:0046982; GO:0051457	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; histone acetyltransferase activity [GO:0004402]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; histone H3 acetylation [GO:0043966]; maintenance of protein location in nucleus [GO:0051457]
PGEN_.00g082650	Scaffold_04	10392719	10404977	Q32NR4	TTC29_XENLA	Tetratricopeptide repeat protein 29 (TPR repeat protein 29)		
PGEN_.00g082660	Scaffold_04	10412164	10416779	O08623	SQSTM_RAT	Sequestosome-1 (Protein kinase C-zeta-interacting protein) (PKC-zeta-interacting protein) (Ubiquitin-binding protein p62)	GO:0000122; GO:0000407; GO:0000423; GO:0000932; GO:0001934; GO:0002376; GO:0002931; GO:0005080; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006914; GO:0006915; GO:0007005; GO:0007032; GO:0008270; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0031397; GO:0031625; GO:0035255; GO:0035973; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0044753; GO:0044754; GO:0044877; GO:0061635; GO:0061912; GO:0070530; GO:0097225; GO:0097413; GO:0098780; GO:1900273; GO:1903078; GO:1905719	aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]
PGEN_.00g082670	Scaffold_04	10422560	10422865	NA	NA	NA	NA	NA
PGEN_.00g082680	Scaffold_04	10427808	10433845	O08623	SQSTM_RAT	Sequestosome-1 (Protein kinase C-zeta-interacting protein) (PKC-zeta-interacting protein) (Ubiquitin-binding protein p62)	GO:0000122; GO:0000407; GO:0000423; GO:0000932; GO:0001934; GO:0002376; GO:0002931; GO:0005080; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006914; GO:0006915; GO:0007005; GO:0007032; GO:0008270; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0031397; GO:0031625; GO:0035255; GO:0035973; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0044753; GO:0044754; GO:0044877; GO:0061635; GO:0061912; GO:0070530; GO:0097225; GO:0097413; GO:0098780; GO:1900273; GO:1903078; GO:1905719	aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]
PGEN_.00g082690	Scaffold_04	10434223	10451849	P36956	SRBP1_HUMAN	Sterol regulatory element-binding protein 1 (SREBP-1) (Class D basic helix-loop-helix protein 1) (bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1]	GO:0000122; GO:0000139; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006629; GO:0007568; GO:0007623; GO:0008203; GO:0008286; GO:0008610; GO:0009267; GO:0009749; GO:0010867; GO:0012507; GO:0016021; GO:0019217; GO:0019901; GO:0030324; GO:0031065; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0032991; GO:0033762; GO:0033993; GO:0042789; GO:0044877; GO:0045444; GO:0045540; GO:0045542; GO:0045944; GO:0046676; GO:0046983; GO:0051591; GO:0071398; GO:1902895; GO:1903146; GO:1903214	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sterol response element binding [GO:0032810]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]"
PGEN_.00g082700	Scaffold_04	10486837	10494719	NA	NA	NA	NA	NA
PGEN_.00g082710	Scaffold_04	10497168	10501340	NA	NA	NA	NA	NA
PGEN_.00g082720	Scaffold_04	10511799	10512083	NA	NA	NA	NA	NA
PGEN_.00g082730	Scaffold_04	10514413	10527348	Q3V1H1	CKAP2_MOUSE	Cytoskeleton-associated protein 2	GO:0000281; GO:0000922; GO:0005813; GO:0005829; GO:0005881; GO:0006915; GO:0007026; GO:0015630; GO:0045944	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; spindle pole [GO:0000922]; apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g082740	Scaffold_04	10532037	10554499	E7FCN8	INTU_DANRE	Protein inturned (Inturned planar cell polarity effector homolog)	GO:0001736; GO:0005737; GO:0005856; GO:0007399; GO:0008589; GO:0009986; GO:0042995; GO:0060173; GO:0060271	cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; establishment of planar polarity [GO:0001736]; limb development [GO:0060173]; nervous system development [GO:0007399]; regulation of smoothened signaling pathway [GO:0008589]
PGEN_.00g082750	Scaffold_04	10572257	10581538	NA	NA	NA	NA	NA
PGEN_.00g082760	Scaffold_04	10619153	10637557	Q4KL91	S36A4_XENLA	Proton-coupled amino acid transporter 4 (Proton/amino acid transporter 4) (Solute carrier family 36 member 4)	GO:0006865; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]
PGEN_.00g082770	Scaffold_04	10661891	10662412	NA	NA	NA	NA	NA
PGEN_.00g082780	Scaffold_04	10662537	10662854	NA	NA	NA	NA	NA
PGEN_.00g082790	Scaffold_04	10688379	10690022	NA	NA	NA	NA	NA
PGEN_.00g082800	Scaffold_04	10690260	10690523	NA	NA	NA	NA	NA
PGEN_.00g082810	Scaffold_04	10712026	10727860	NA	NA	NA	NA	NA
PGEN_.00g082820	Scaffold_04	10743953	10752726	Q9UGT4	SUSD2_HUMAN	Sushi domain-containing protein 2	GO:0005886; GO:0016021; GO:0051782; GO:0070062; GO:1902807	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782]
PGEN_.00g082830	Scaffold_04	10753717	10758913	NA	NA	NA	NA	NA
PGEN_.00g082840	Scaffold_04	10800764	10804946	NA	NA	NA	NA	NA
PGEN_.00g082850	Scaffold_04	10807774	10808373	NA	NA	NA	NA	NA
PGEN_.00g082860	Scaffold_04	10855581	10855901	NA	NA	NA	NA	NA
PGEN_.00g082870	Scaffold_04	10881096	10882011	NA	NA	NA	NA	NA
PGEN_.00g082880	Scaffold_04	10891729	10904784	Q01664	TFAP4_HUMAN	Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41)	GO:0000790; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0006978; GO:0008285; GO:0017053; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0044212; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071157; GO:0071549; GO:1901990; GO:2001269	"mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g082890	Scaffold_04	10912184	10915038	NA	NA	NA	NA	NA
PGEN_.00g082900	Scaffold_04	10915100	10916706	A8Y236	GLT10_CAEBR	Putative polypeptide N-acetylgalactosaminyltransferase 10 (pp-GaNTase 10) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)	GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]
PGEN_.00g082910	Scaffold_04	10950138	10955799	A8Y236	GLT10_CAEBR	Putative polypeptide N-acetylgalactosaminyltransferase 10 (pp-GaNTase 10) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)	GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]
PGEN_.00g082920	Scaffold_04	10973576	10975258	NA	NA	NA	NA	NA
PGEN_.00g082930	Scaffold_04	10976376	10996820	Q3SWY2	ILK_BOVIN	Integrin-linked protein kinase (EC 2.7.11.1)	GO:0001658; GO:0001934; GO:0003151; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0008284; GO:0010761; GO:0018105; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030030; GO:0030513; GO:0033209; GO:0034446; GO:0043491; GO:0045197; GO:0045669; GO:0045893; GO:0090263; GO:1901224; GO:2000178	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"
PGEN_.00g082940	Scaffold_04	10996964	11003943	O44410	RRP8_CAEEL	Ribosomal RNA-processing protein 8 (EC 2.1.1.-)	GO:0000183; GO:0005677; GO:0005730; GO:0006364; GO:0008168; GO:0032259; GO:0033553; GO:0035064; GO:0042149; GO:0046015	chromatin silencing complex [GO:0005677]; nucleolus [GO:0005730]; rDNA heterochromatin [GO:0033553]; methylated histone binding [GO:0035064]; methyltransferase activity [GO:0008168]; cellular response to glucose starvation [GO:0042149]; chromatin silencing at rDNA [GO:0000183]; methylation [GO:0032259]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]
PGEN_.00g082950	Scaffold_04	11008820	11052279	Q9VF87	CYFIP_DROME	Cytoplasmic FMR1-interacting protein (Specifically Rac1-associated protein 1) (DSra-1)	GO:0000340; GO:0000902; GO:0001745; GO:0005737; GO:0006417; GO:0007411; GO:0008360; GO:0022416; GO:0030031; GO:0030866; GO:0031209; GO:0033627; GO:0043005; GO:0045177; GO:0045202; GO:0050807; GO:0051491; GO:0060269	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417]
PGEN_.00g082960	Scaffold_04	11059086	11070611	Q5XK67	RPAC2_XENLA	DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (AC19) (DNA-directed RNA polymerase I subunit D)	GO:0003677; GO:0003899; GO:0005634; GO:0006351; GO:0046983	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g082970	Scaffold_04	11073993	11092645	Q5ZL74	VAMP7_CHICK	Vesicle-associated membrane protein 7 (Synaptobrevin-like protein 1)	GO:0000149; GO:0005484; GO:0005765; GO:0005789; GO:0005802; GO:0005886; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008333; GO:0009986; GO:0016021; GO:0016192; GO:0017156; GO:0030027; GO:0030054; GO:0030658; GO:0030670; GO:0031091; GO:0031143; GO:0031201; GO:0031902; GO:0035493; GO:0035577; GO:0043001; GO:0043005; GO:0043308; GO:0043312; GO:0043320; GO:0045177; GO:0045202; GO:0045335; GO:0048471; GO:0050775; GO:1900483; GO:1903595	"apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g082980	Scaffold_04	11095967	11097562	NA	NA	NA	NA	NA
PGEN_.00g082990	Scaffold_04	11114082	11123714	NA	NA	NA	NA	NA
PGEN_.00g083000	Scaffold_04	11153462	11153812	NA	NA	NA	NA	NA
PGEN_.00g083010	Scaffold_04	11162155	11189009	O17389	TYB_CAEEL	Thymosin beta (Tetrathymosin beta)	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]
PGEN_.00g083020	Scaffold_04	11195299	11198096	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g083030	Scaffold_04	11206833	11207660	NA	NA	NA	NA	NA
PGEN_.00g083040	Scaffold_04	11220127	11221035	NA	NA	NA	NA	NA
PGEN_.00g083050	Scaffold_04	11234362	11243155	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g083060	Scaffold_04	11307620	11307976	NA	NA	NA	NA	NA
PGEN_.00g083070	Scaffold_04	11308069	11308922	NA	NA	NA	NA	NA
PGEN_.00g083080	Scaffold_04	11310851	11319988	Q2TU62	CLCA1_HORSE	Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (eCLCA1)	GO:0005229; GO:0005615; GO:0005887; GO:0005902; GO:0006816; GO:0008237; GO:0030141; GO:0046872	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]
PGEN_.00g083090	Scaffold_04	11325001	11326397	NA	NA	NA	NA	NA
PGEN_.00g083100	Scaffold_04	11326762	11326977	NA	NA	NA	NA	NA
PGEN_.00g083110	Scaffold_04	11327093	11327299	NA	NA	NA	NA	NA
PGEN_.00g083120	Scaffold_04	11356764	11356997	NA	NA	NA	NA	NA
PGEN_.00g083130	Scaffold_04	11361583	11372213	Q61035	SYHC_MOUSE	"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)"	GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006427; GO:0032543; GO:0042802	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]
PGEN_.00g083140	Scaffold_04	11372354	11377437	NA	NA	NA	NA	NA
PGEN_.00g083150	Scaffold_04	11386277	11388000	NA	NA	NA	NA	NA
PGEN_.00g083160	Scaffold_04	11404237	11404569	NA	NA	NA	NA	NA
PGEN_.00g083170	Scaffold_04	11409344	11418228	Q7TPH6	MYCB2_MOUSE	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.-) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein Magellan) (Protein associated with Myc)	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0008045; GO:0008270; GO:0008536; GO:0015630; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042803; GO:0043231; GO:0048667; GO:0050905; GO:0051493; GO:0061630; GO:1902667	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; cell morphogenesis involved in neuron differentiation [GO:0048667]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; motor neuron axon guidance [GO:0008045]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]
PGEN_.00g083180	Scaffold_04	11409407	11409676	NA	NA	NA	NA	NA
PGEN_.00g083190	Scaffold_04	11430963	11457566	NA	NA	NA	NA	NA
PGEN_.00g083200	Scaffold_04	11524723	11537403	NA	NA	NA	NA	NA
PGEN_.00g083210	Scaffold_04	11540687	11541283	NA	NA	NA	NA	NA
PGEN_.00g083220	Scaffold_04	11563177	11574793	Q8N6F8	MET27_HUMAN	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)		
PGEN_.00g083230	Scaffold_04	11594165	11603856	O00625	PIR_HUMAN	"Pirin (EC 1.13.11.24) (Probable quercetin 2,3-dioxygenase PIR) (Probable quercetinase)"	GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0007586; GO:0008127; GO:0030224; GO:0046872	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g083240	Scaffold_04	11642454	11646921	NA	NA	NA	NA	NA
PGEN_.00g083250	Scaffold_04	11648708	11651414	NA	NA	NA	NA	NA
PGEN_.00g083260	Scaffold_04	11669529	11678303	Q8CBW7	CHIC1_MOUSE	Cysteine-rich hydrophobic domain-containing protein 1 (Brain X-linked protein)	GO:0005886; GO:0031410	cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]
PGEN_.00g083270	Scaffold_04	11691455	11696186	Q6E2N3	TRI33_DANRE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]
PGEN_.00g083280	Scaffold_04	11700329	11710452	P47957	APT_MUSSI	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	GO:0002055; GO:0003999; GO:0005737; GO:0006166; GO:0006168; GO:0007625; GO:0044209	cytoplasm [GO:0005737]; adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; grooming behavior [GO:0007625]; purine ribonucleoside salvage [GO:0006166]
PGEN_.00g083290	Scaffold_04	11716815	11717321	NA	NA	NA	NA	NA
PGEN_.00g083300	Scaffold_04	11719605	11730134	P54363	APT_DROPS	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	GO:0003999; GO:0005737; GO:0006166; GO:0006168; GO:0044209	cytoplasm [GO:0005737]; adenine phosphoribosyltransferase activity [GO:0003999]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166]
PGEN_.00g083310	Scaffold_04	11731455	11748698	P68372	TBB4B_MOUSE	Tubulin beta-4B chain (Tubulin beta-2C chain)	GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0043209; GO:0045298	cytoplasm [GO:0005737]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; tubulin complex [GO:0045298]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]
PGEN_.00g083320	Scaffold_04	11772802	11795974	Q8K203	NEIL3_MOUSE	Endonuclease 8-like 3 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase FPG2) (DNA glycosylase/AP lyase Neil3) (Endonuclease VIII-like 3) (Nei-like protein 3)	GO:0000405; GO:0003684; GO:0003690; GO:0003697; GO:0003906; GO:0005634; GO:0005654; GO:0006284; GO:0006289; GO:0008270; GO:0019104; GO:0140078	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; nucleotide-excision repair [GO:0006289]
PGEN_.00g083330	Scaffold_04	11802093	11812764	Q17QF9	CBLN3_BOVIN	Cerebellin-3	GO:0005576; GO:0005783; GO:0005794; GO:0030054; GO:0045202	cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; synapse [GO:0045202]
PGEN_.00g083340	Scaffold_04	11826039	11828260	NA	NA	NA	NA	NA
PGEN_.00g083350	Scaffold_04	11834123	11834998	NA	NA	NA	NA	NA
PGEN_.00g083360	Scaffold_04	11910117	11911473	NA	NA	NA	NA	NA
PGEN_.00g083370	Scaffold_04	11917110	11917472	NA	NA	NA	NA	NA
PGEN_.00g083380	Scaffold_04	11918703	11927190	NA	NA	NA	NA	NA
PGEN_.00g083390	Scaffold_04	11938467	11938730	NA	NA	NA	NA	NA
PGEN_.00g083400	Scaffold_04	11938923	11940549	NA	NA	NA	NA	NA
PGEN_.00g083410	Scaffold_04	11940608	11954391	NA	NA	NA	NA	NA
PGEN_.00g083420	Scaffold_04	11954453	11956441	NA	NA	NA	NA	NA
PGEN_.00g083430	Scaffold_04	11972047	11972703	Q9YGN5	SLA_GLOBR	Snaclec salmorin subunit A	GO:0005576; GO:0009405; GO:0046872; GO:0090729	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g083440	Scaffold_04	11982570	11983226	Q9YGN5	SLA_GLOBR	Snaclec salmorin subunit A	GO:0005576; GO:0009405; GO:0046872; GO:0090729	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g083450	Scaffold_04	12011474	12020681	NA	NA	NA	NA	NA
PGEN_.00g083460	Scaffold_04	12028825	12029406	NA	NA	NA	NA	NA
PGEN_.00g083470	Scaffold_04	12039462	12040220	Q08731	LIT2_MOUSE	Lithostathine-2 (Islet of Langerhans regenerating protein 2) (REG-2) (Pancreatic stone protein 2) (PSP) (Pancreatic thread protein 2) (PTP)	GO:0001967; GO:0004888; GO:0005615; GO:0008284; GO:0042552; GO:0042834; GO:0043434; GO:0044278; GO:0061844; GO:0062023; GO:0070492	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; oligosaccharide binding [GO:0070492]; peptidoglycan binding [GO:0042834]; transmembrane signaling receptor activity [GO:0004888]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell wall disruption in other organism [GO:0044278]; myelination [GO:0042552]; positive regulation of cell population proliferation [GO:0008284]; response to peptide hormone [GO:0043434]; suckling behavior [GO:0001967]
PGEN_.00g083480	Scaffold_04	12067696	12077569	NA	NA	NA	NA	NA
PGEN_.00g083490	Scaffold_04	12078799	12079642	NA	NA	NA	NA	NA
PGEN_.00g083500	Scaffold_04	12080399	12083132	Q91DM0	POLG_PVCV1	Genome polyprotein [Includes: Aspartic protease (PR) (EC 3.4.23.-); Reverse transcriptase (RT) (EC 2.7.7.49) (EC 2.7.7.7)]	GO:0003677; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0008270; GO:0046740	"aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]; zinc ion binding [GO:0008270]; transport of virus in host, cell to cell [GO:0046740]"
PGEN_.00g083510	Scaffold_04	12087506	12110665	Q06S87	HIUH_DANRE	5-hydroxyisourate hydrolase (HIU hydrolase) (HIUHase) (EC 3.5.2.17) (Transthyretin-related protein)	GO:0005777; GO:0006144; GO:0016811; GO:0019628; GO:0033971	"peroxisome [GO:0005777]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; hydroxyisourate hydrolase activity [GO:0033971]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]"
PGEN_.00g083520	Scaffold_04	12144971	12146890	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g083530	Scaffold_04	12165047	12167037	NA	NA	NA	NA	NA
PGEN_.00g083540	Scaffold_04	12191919	12203648	Q7TNU6	ZN250_MOUSE	Zinc finger protein 250 (Zinc finger protein 647)	GO:0003677; GO:0005634; GO:0006355; GO:0042802; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g083550	Scaffold_04	12213934	12214185	NA	NA	NA	NA	NA
PGEN_.00g083560	Scaffold_04	12226250	12264950	NA	NA	NA	NA	NA
PGEN_.00g083570	Scaffold_04	12277941	12315161	Q5F3U9	PDS5B_CHICK	Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor)	GO:0000785; GO:0005634; GO:0006281; GO:0007064; GO:0008285; GO:0051301	chromatin [GO:0000785]; nucleus [GO:0005634]; cell division [GO:0051301]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]
PGEN_.00g083580	Scaffold_04	12331462	12331713	NA	NA	NA	NA	NA
PGEN_.00g083590	Scaffold_04	12358017	12358262	NA	NA	NA	NA	NA
PGEN_.00g083600	Scaffold_04	12423079	12439225	Q9HC56	PCDH9_HUMAN	Protocadherin-9	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291	cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g083610	Scaffold_04	12443918	12452920	P22304	IDS_HUMAN	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain]	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484; GO:0030207; GO:0043202	lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]
PGEN_.00g083620	Scaffold_04	12455765	12463263	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g083630	Scaffold_04	12505260	12541035	O15067	PUR4_HUMAN	Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase)	GO:0004642; GO:0005524; GO:0005737; GO:0005829; GO:0006189; GO:0006541; GO:0009168; GO:0042493; GO:0046872; GO:0070062; GO:0097065	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493]
PGEN_.00g083640	Scaffold_04	12560752	12564727	Q13887	KLF5_HUMAN	Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0006366; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0046872; GO:0060576; GO:0061586; GO:0071407; GO:0099156; GO:1901653; GO:1902895; GO:1990830	"Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g083650	Scaffold_04	12594468	12594722	NA	NA	NA	NA	NA
PGEN_.00g083660	Scaffold_04	12602774	12647466	O01391	UCHL_APLCA	Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12) (Ubiquitin thioesterase)	GO:0004843; GO:0005737; GO:0006511	cytoplasm [GO:0005737]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g083670	Scaffold_04	12647946	12648485	NA	NA	NA	NA	NA
PGEN_.00g083680	Scaffold_04	12650838	12651203	NA	NA	NA	NA	NA
PGEN_.00g083690	Scaffold_04	12651381	12652634	NA	NA	NA	NA	NA
PGEN_.00g083700	Scaffold_04	12671390	12671731	NA	NA	NA	NA	NA
PGEN_.00g083710	Scaffold_04	12672511	12673272	NA	NA	NA	NA	NA
PGEN_.00g083720	Scaffold_04	12680281	12726317	Q60949	TBCD1_MOUSE	TBC1 domain family member 1	GO:0005096; GO:0005634; GO:0005829; GO:0006886; GO:0017137; GO:0032880; GO:0090630	cytosol [GO:0005829]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]
PGEN_.00g083730	Scaffold_04	12753119	12765142	NA	NA	NA	NA	NA
PGEN_.00g083740	Scaffold_04	12771404	12809849	NA	NA	NA	NA	NA
PGEN_.00g083750	Scaffold_04	12826079	12840296	Q6QGW5	SRA1_RAT	Steroid receptor RNA activator 1 (Steroid receptor RNA activator protein) (SRAP)	GO:0002153; GO:0003677; GO:0003713; GO:0005634; GO:0005667; GO:0005737; GO:0006915; GO:0008283; GO:0016922; GO:0030154; GO:0030374; GO:0030375; GO:0031252; GO:0042981; GO:0045662; GO:0045944; GO:0071391; GO:1990904	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; steroid receptor RNA activator RNA binding [GO:0002153]; thyroid hormone receptor coactivator activity [GO:0030375]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]
PGEN_.00g083760	Scaffold_04	12840808	12951136	P83093	STIM2_MOUSE	Stromal interaction molecule 2	GO:0002115; GO:0005246; GO:0005509; GO:0005623; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0015279; GO:0016021; GO:0032237; GO:0051928	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of calcium ion transport [GO:0051928]; store-operated calcium entry [GO:0002115]
PGEN_.00g083770	Scaffold_04	12971682	12993737	Q32N90	MBTD1_XENLA	MBT domain-containing protein 1	GO:0005634; GO:0006325; GO:0006355; GO:0008270	"nucleus [GO:0005634]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g083780	Scaffold_04	12994085	13010474	Q5F457	WBP4_CHICK	WW domain-binding protein 4 (WBP-4)	GO:0000398; GO:0003676; GO:0005634; GO:0008270; GO:0016607; GO:0071005	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g083790	Scaffold_04	13017295	13026265	Q04671	P_HUMAN	P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog)	GO:0005215; GO:0005302; GO:0005737; GO:0005765; GO:0005789; GO:0006726; GO:0007286; GO:0008283; GO:0010008; GO:0016021; GO:0030318; GO:0033162; GO:0042438	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; L-tyrosine transmembrane transporter activity [GO:0005302]; transporter activity [GO:0005215]; cell population proliferation [GO:0008283]; eye pigment biosynthetic process [GO:0006726]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286]
PGEN_.00g083800	Scaffold_04	13047212	13089144	Q8MIQ9	P_PIG	P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog)	GO:0016021; GO:0033162; GO:0055085	integral component of membrane [GO:0016021]; melanosome membrane [GO:0033162]; transmembrane transport [GO:0055085]
PGEN_.00g083810	Scaffold_04	13088596	13088898	NA	NA	NA	NA	NA
PGEN_.00g083820	Scaffold_04	13090041	13092554	NA	NA	NA	NA	NA
PGEN_.00g083830	Scaffold_04	13109857	13119321	Q5ZLF0	F10A1_CHICK	Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog)	GO:0005737; GO:0046983; GO:0051085	cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983]; chaperone cofactor-dependent protein refolding [GO:0051085]
PGEN_.00g083840	Scaffold_04	13119362	13120135	NA	NA	NA	NA	NA
PGEN_.00g083850	Scaffold_04	13121647	13123167	NA	NA	NA	NA	NA
PGEN_.00g083860	Scaffold_04	13123359	13124024	NA	NA	NA	NA	NA
PGEN_.00g083870	Scaffold_04	13124282	13124524	NA	NA	NA	NA	NA
PGEN_.00g083880	Scaffold_04	13134629	13158712	P50502	F10A1_HUMAN	Hsc70-interacting protein (Hip) (Aging-associated protein 2) (Progesterone receptor-associated p48 protein) (Protein FAM10A1) (Putative tumor suppressor ST13) (Renal carcinoma antigen NY-REN-33) (Suppression of tumorigenicity 13 protein)	GO:0005737; GO:0005829; GO:0006457; GO:0009617; GO:0019904; GO:0030544; GO:0030674; GO:0032564; GO:0032991; GO:0042802; GO:0044877; GO:0046983; GO:0051082; GO:0051085; GO:0051087; GO:0051289; GO:0061084; GO:0070062	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; dATP binding [GO:0032564]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of protein refolding [GO:0061084]; protein folding [GO:0006457]; protein homotetramerization [GO:0051289]; response to bacterium [GO:0009617]"
PGEN_.00g083890	Scaffold_04	13159718	13168197	Q9NQH7	XPP3_HUMAN	Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3)	GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508]
PGEN_.00g083900	Scaffold_04	13169345	13169815	NA	NA	NA	NA	NA
PGEN_.00g083910	Scaffold_04	13169956	13170213	NA	NA	NA	NA	NA
PGEN_.00g083920	Scaffold_04	13178114	13178386	NA	NA	NA	NA	NA
PGEN_.00g083930	Scaffold_04	13178478	13179330	NA	NA	NA	NA	NA
PGEN_.00g083940	Scaffold_04	13191645	13191995	NA	NA	NA	NA	NA
PGEN_.00g083950	Scaffold_04	13192545	13208544	P28173	PUR1_CHICK	Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT)	GO:0004044; GO:0005829; GO:0006189; GO:0006541; GO:0009113; GO:0009116; GO:0046872; GO:0051539	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]"
PGEN_.00g083960	Scaffold_04	13234221	13253651	P38024	PUR6_CHICK	Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]	GO:0004638; GO:0004639; GO:0005524; GO:0005829; GO:0006189; GO:0043727	cytosol [GO:0005829]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189]
PGEN_.00g083970	Scaffold_04	13272148	13286654	Q1ZXD6	ROCO5_DICDI	Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5)	GO:0004674; GO:0005085; GO:0005524; GO:0005525; GO:0030587	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; sorocarp development [GO:0030587]
PGEN_.00g083980	Scaffold_04	13356805	13391045	NA	NA	NA	NA	NA
PGEN_.00g083990	Scaffold_04	13397949	13398218	NA	NA	NA	NA	NA
PGEN_.00g084000	Scaffold_04	13398479	13398799	NA	NA	NA	NA	NA
PGEN_.00g084010	Scaffold_04	13411377	13466204	Q14AT5	ANO7_MOUSE	Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)	GO:0005229; GO:0005634; GO:0005783; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0061589; GO:0061590; GO:0061591	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transport [GO:0006821]
PGEN_.00g084020	Scaffold_04	13499417	13509361	NA	NA	NA	NA	NA
PGEN_.00g084030	Scaffold_04	13514480	13515668	NA	NA	NA	NA	NA
PGEN_.00g084040	Scaffold_04	13531555	13545778	Q03311	CHLE_MOUSE	Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase)	GO:0003990; GO:0004104; GO:0005615; GO:0005641; GO:0005783; GO:0005788; GO:0007584; GO:0007612; GO:0008285; GO:0014016; GO:0016020; GO:0019695; GO:0033265; GO:0042493; GO:0042802; GO:0043279; GO:0050805; GO:0051384; GO:0051593	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; acetylcholinesterase activity [GO:0003990]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; identical protein binding [GO:0042802]; choline metabolic process [GO:0019695]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; response to alkaloid [GO:0043279]; response to drug [GO:0042493]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]
PGEN_.00g084050	Scaffold_04	13615723	13649795	B6ELU0	TTCA_ALISL	tRNA-cytidine(32) 2-sulfurtransferase (EC 2.8.1.-) (Two-thiocytidine biosynthesis protein A) (tRNA 2-thiocytidine biosynthesis protein TtcA)	GO:0000049; GO:0000287; GO:0005524; GO:0005737; GO:0016783; GO:0034227; GO:0051539	"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; tRNA thio-modification [GO:0034227]"
PGEN_.00g084060	Scaffold_04	13662152	13683046	NA	NA	NA	NA	NA
PGEN_.00g084070	Scaffold_04	13693267	13695125	NA	NA	NA	NA	NA
PGEN_.00g084080	Scaffold_04	13697991	13698239	NA	NA	NA	NA	NA
PGEN_.00g084090	Scaffold_04	13703677	13705804	P03010	TRAC9_MAIZE	Putative AC9 transposase	GO:0003677; GO:0006310; GO:0032196; GO:0046983	DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; DNA recombination [GO:0006310]; transposition [GO:0032196]
PGEN_.00g084100	Scaffold_04	13706726	13707073	NA	NA	NA	NA	NA
PGEN_.00g084110	Scaffold_04	13707146	13707406	NA	NA	NA	NA	NA
PGEN_.00g084120	Scaffold_04	13708821	13710292	NA	NA	NA	NA	NA
PGEN_.00g084130	Scaffold_04	13712341	13712907	NA	NA	NA	NA	NA
PGEN_.00g084140	Scaffold_04	13713588	13715854	NA	NA	NA	NA	NA
PGEN_.00g084150	Scaffold_04	13715889	13718782	NA	NA	NA	NA	NA
PGEN_.00g084160	Scaffold_04	13720410	13723876	NA	NA	NA	NA	NA
PGEN_.00g084170	Scaffold_04	13739510	13805184	Q811B3	ATS12_MOUSE	A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAM-TS 12) (ADAM-TS12) (ADAMTS-12) (EC 3.4.24.-)	GO:0004222; GO:0005576; GO:0007160; GO:0016477; GO:0030167; GO:0032331; GO:0046872; GO:0050727; GO:0051603; GO:0071347; GO:0071356; GO:0071773; GO:1901509; GO:1902203; GO:1902548; GO:2001113	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; proteoglycan catabolic process [GO:0030167]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727]
PGEN_.00g084180	Scaffold_04	13812150	13812797	NA	NA	NA	NA	NA
PGEN_.00g084190	Scaffold_04	13819493	13893733	Q8IV35	WDR49_HUMAN	WD repeat-containing protein 49		
PGEN_.00g084200	Scaffold_04	13894051	13896192	NA	NA	NA	NA	NA
PGEN_.00g084210	Scaffold_04	13912672	13924186	Q9UMR7	CLC4A_HUMAN	C-type lectin domain family 4 member A (C-type lectin DDB27) (C-type lectin superfamily member 6) (Dendritic cell immunoreceptor) (Lectin-like immunoreceptor) (CD antigen CD367)	GO:0001818; GO:0002223; GO:0002250; GO:0002470; GO:0004888; GO:0005509; GO:0005537; GO:0005886; GO:0005887; GO:0007155; GO:0007166; GO:0030246; GO:0032720; GO:0036037; GO:0042590; GO:0045087	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of tumor necrosis factor production [GO:0032720]; plasmacytoid dendritic cell antigen processing and presentation [GO:0002470]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
PGEN_.00g084220	Scaffold_04	13956000	13959491	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g084230	Scaffold_04	13959666	13983646	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g084240	Scaffold_04	13992102	14037567	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g084250	Scaffold_04	14048300	14083865	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g084260	Scaffold_04	14108820	14109101	NA	NA	NA	NA	NA
PGEN_.00g084270	Scaffold_04	14109327	14112486	NA	NA	NA	NA	NA
PGEN_.00g084280	Scaffold_04	14114374	14137794	P49596	PP2C2_CAEEL	Probable protein phosphatase 2C T23F11.1 (PP2C) (EC 3.1.3.16)	GO:0004722; GO:0004724; GO:0030517; GO:0031625; GO:0046872; GO:0048786; GO:0051965	presynaptic active zone [GO:0048786]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of axon extension [GO:0030517]; positive regulation of synapse assembly [GO:0051965]
PGEN_.00g084290	Scaffold_04	14155132	14164381	Q0D4Z6	GH38_ORYSJ	Probable indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8)	GO:0005737; GO:0016881	cytoplasm [GO:0005737]; acid-amino acid ligase activity [GO:0016881]
PGEN_.00g084300	Scaffold_04	14194582	14222009	P09481	ACHA3_CHICK	Neuronal acetylcholine receptor subunit alpha-3	GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007399; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060084	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g084310	Scaffold_04	14224862	14267880	B2GV87	PTPRE_RAT	Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48)	GO:0004725; GO:0005634; GO:0005737; GO:0005886; GO:0006470; GO:0007185; GO:0016021; GO:0033003; GO:0042803; GO:0046627	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]
PGEN_.00g084320	Scaffold_04	14251389	14251991	NA	NA	NA	NA	NA
PGEN_.00g084330	Scaffold_04	14253428	14253697	NA	NA	NA	NA	NA
PGEN_.00g084340	Scaffold_04	14304379	14335635	Q80T91	MEG11_MOUSE	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	GO:0010842; GO:0016021; GO:0016323; GO:0034109	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
PGEN_.00g084350	Scaffold_04	14350168	14369780	Q96KG7	MEG10_HUMAN	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g084360	Scaffold_04	14377569	14380356	NA	NA	NA	NA	NA
PGEN_.00g084370	Scaffold_04	14380422	14385327	NA	NA	NA	NA	NA
PGEN_.00g084380	Scaffold_04	14447241	14462900	Q2ABP2	PGAP2_CRIGR	Post-GPI attachment to proteins factor 2 (FGF receptor-activating protein 1)	GO:0000139; GO:0005789; GO:0006506; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g084390	Scaffold_04	14487283	14493829	NA	NA	NA	NA	NA
PGEN_.00g084400	Scaffold_04	14498301	14526332	NA	NA	NA	NA	NA
PGEN_.00g084410	Scaffold_04	14526575	14541789	NA	NA	NA	NA	NA
PGEN_.00g084420	Scaffold_04	14641908	14715543	NA	NA	NA	NA	NA
PGEN_.00g084430	Scaffold_04	14732261	14738409	NA	NA	NA	NA	NA
PGEN_.00g084440	Scaffold_04	14758340	14765132	NA	NA	NA	NA	NA
PGEN_.00g084450	Scaffold_04	14782370	14785799	Q9NQM4	PIHD3_HUMAN	Protein PIH1D3 (PIH1 domain-containing protein 3) (Sarcoma antigen NY-SAR-97)	GO:0003341; GO:0005737; GO:0030317; GO:0051087; GO:0070286	cytoplasm [GO:0005737]; chaperone binding [GO:0051087]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]
PGEN_.00g084460	Scaffold_04	14791041	14807054	NA	NA	NA	NA	NA
PGEN_.00g084470	Scaffold_04	14812181	14826324	NA	NA	NA	NA	NA
PGEN_.00g084480	Scaffold_04	14883941	14904428	O13066	RAGP1_XENLA	Ran GTPase-activating protein 1 (RanGAP1)	GO:0000777; GO:0005096; GO:0005635; GO:0005654; GO:0005737; GO:0005819; GO:0007165	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; GTPase activator activity [GO:0005096]; signal transduction [GO:0007165]
PGEN_.00g084490	Scaffold_04	14932248	14947776	Q80T91	MEG11_MOUSE	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	GO:0010842; GO:0016021; GO:0016323; GO:0034109	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
PGEN_.00g084500	Scaffold_04	14955623	14967953	A6BM72	MEG11_HUMAN	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	GO:0010842; GO:0016021; GO:0016323; GO:0034109	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
PGEN_.00g084510	Scaffold_04	14978205	15010079	A6BM72	MEG11_HUMAN	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	GO:0010842; GO:0016021; GO:0016323; GO:0034109	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
PGEN_.00g084520	Scaffold_04	15010202	15010441	NA	NA	NA	NA	NA
PGEN_.00g084530	Scaffold_04	15019760	15023405	Q08BN9	NXPE3_DANRE	NXPE family member 3 (Protein FAM55C)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g084540	Scaffold_04	15026641	15028805	Q52KP5	NXPE4_MOUSE	NXPE family member 4 (Protein FAM55D)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g084550	Scaffold_04	15031759	15061573	P23470	PTPRG_HUMAN	Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48)	GO:0004725; GO:0005001; GO:0005887; GO:0006470; GO:0007169; GO:0007420; GO:0010633; GO:0010977; GO:0042802; GO:0070062	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g084560	Scaffold_04	15114123	15130529	O14522	PTPRT_HUMAN	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g084570	Scaffold_04	15137991	15150163	Q6DIB5	MEG10_MOUSE	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g084580	Scaffold_04	15153370	15154996	NA	NA	NA	NA	NA
PGEN_.00g084590	Scaffold_04	15155960	15156208	NA	NA	NA	NA	NA
PGEN_.00g084600	Scaffold_04	15156411	15157016	NA	NA	NA	NA	NA
PGEN_.00g084610	Scaffold_04	15158905	15159339	NA	NA	NA	NA	NA
PGEN_.00g084620	Scaffold_04	15159577	15159942	NA	NA	NA	NA	NA
PGEN_.00g084630	Scaffold_04	15168915	15174053	NA	NA	NA	NA	NA
PGEN_.00g084640	Scaffold_04	15208703	15209929	NA	NA	NA	NA	NA
PGEN_.00g084650	Scaffold_04	15211065	15214368	NA	NA	NA	NA	NA
PGEN_.00g084660	Scaffold_04	15214403	15215750	NA	NA	NA	NA	NA
PGEN_.00g084670	Scaffold_04	15216485	15217003	NA	NA	NA	NA	NA
PGEN_.00g084680	Scaffold_04	15217873	15218235	NA	NA	NA	NA	NA
PGEN_.00g084690	Scaffold_04	15218939	15219628	NA	NA	NA	NA	NA
PGEN_.00g084700	Scaffold_04	15233224	15239424	P28824	NRP1_XENLA	Neuropilin-1 (A5 antigen) (A5 protein)	GO:0001525; GO:0005021; GO:0005886; GO:0007411; GO:0008201; GO:0009887; GO:0016021; GO:0017154; GO:0019838; GO:0031966; GO:0035767; GO:0046872; GO:0048010	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; endothelial cell chemotaxis [GO:0035767]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]
PGEN_.00g084710	Scaffold_04	15255406	15263263	NA	NA	NA	NA	NA
PGEN_.00g084720	Scaffold_04	15270510	15279066	NA	NA	NA	NA	NA
PGEN_.00g084730	Scaffold_04	15285402	15294471	NA	NA	NA	NA	NA
PGEN_.00g084740	Scaffold_04	15302788	15307711	Q2KJG4	MGST2_BOVIN	Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18)	GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006750; GO:0008047; GO:0016021; GO:0019370; GO:0046466	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; membrane lipid catabolic process [GO:0046466]
PGEN_.00g084750	Scaffold_04	15328988	15333111	P10716	CLC4F_RAT	C-type lectin domain family 4 member F (C-type lectin superfamily member 13) (C-type lectin 13) (Kupffer cell receptor)	GO:0005534; GO:0005886; GO:0006897; GO:0016021; GO:0030246; GO:0038023; GO:0051132; GO:0051861	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; galactose binding [GO:0005534]; glycolipid binding [GO:0051861]; signaling receptor activity [GO:0038023]; endocytosis [GO:0006897]; NK T cell activation [GO:0051132]
PGEN_.00g084760	Scaffold_04	15337442	15354981	Q69Z28	ATS16_MOUSE	A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-)	GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0046872; GO:0048232; GO:1902017	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]
PGEN_.00g084770	Scaffold_04	15355019	15369770	NA	NA	NA	NA	NA
PGEN_.00g084780	Scaffold_04	15376787	15390485	Q2KJG4	MGST2_BOVIN	Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18)	GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006750; GO:0008047; GO:0016021; GO:0019370; GO:0046466	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; membrane lipid catabolic process [GO:0046466]
PGEN_.00g084790	Scaffold_04	15411064	15411390	NA	NA	NA	NA	NA
PGEN_.00g084800	Scaffold_04	15412612	15413631	NA	NA	NA	NA	NA
PGEN_.00g084810	Scaffold_04	15425688	15426290	NA	NA	NA	NA	NA
PGEN_.00g084820	Scaffold_04	15426314	15437280	Q8TE57	ATS16_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-)	GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0046872; GO:0048232; GO:1902017	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]
PGEN_.00g084830	Scaffold_04	15455355	15455696	NA	NA	NA	NA	NA
PGEN_.00g084840	Scaffold_04	15463761	15477285	NA	NA	NA	NA	NA
PGEN_.00g084850	Scaffold_04	15479559	15497002	NA	NA	NA	NA	NA
PGEN_.00g084860	Scaffold_04	15526576	15526923	NA	NA	NA	NA	NA
PGEN_.00g084870	Scaffold_04	15545020	15559173	Q9UK39	NOCT_HUMAN	Nocturnin (EC 3.1.3.-) (Carbon catabolite repression 4-like protein)	GO:0000175; GO:0000290; GO:0000932; GO:0003729; GO:0004535; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006366; GO:0006739; GO:0007623; GO:0009991; GO:0010629; GO:0019178; GO:0032496; GO:0032922; GO:0033962; GO:0042752; GO:0045600; GO:0045668; GO:0045995; GO:0046872; GO:0048255; GO:0048471; GO:0102757	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g084880	Scaffold_04	15620328	15627535	Q6WYY1	PC11X_PANPA	Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X)	GO:0005509; GO:0005886; GO:0007156; GO:0010923; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g084890	Scaffold_04	15640136	15650588	Q6X862	PC11X_GORGO	Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome)	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0010923	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g084900	Scaffold_04	15668436	15672716	NA	NA	NA	NA	NA
PGEN_.00g084910	Scaffold_04	15790649	15811890	E2QUI9	NNRD_CANLF	ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) (NAD(P)HX dehydratase)	GO:0005524; GO:0005739; GO:0046496; GO:0047453; GO:0052855; GO:0052856; GO:0052857	mitochondrion [GO:0005739]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nicotinamide nucleotide metabolic process [GO:0046496]
PGEN_.00g084920	Scaffold_04	15818835	15819071	NA	NA	NA	NA	NA
PGEN_.00g084930	Scaffold_04	15843759	15844703	Q866F1	FUT1_SAISC	"Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]
PGEN_.00g084940	Scaffold_04	15847045	15849472	NA	NA	NA	NA	NA
PGEN_.00g084950	Scaffold_04	15871480	15871917	NA	NA	NA	NA	NA
PGEN_.00g084960	Scaffold_04	15892187	15901469	P0C6Y7	PRDM9_RAT	Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.-) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-)	GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0031490; GO:0034968; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044212; GO:0044648; GO:0045893; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	"chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]"
PGEN_.00g084970	Scaffold_04	15955925	15962512	NA	NA	NA	NA	NA
PGEN_.00g084980	Scaffold_04	15963544	15964661	NA	NA	NA	NA	NA
PGEN_.00g084990	Scaffold_04	15965334	15965624	NA	NA	NA	NA	NA
PGEN_.00g085000	Scaffold_04	15966117	15966419	NA	NA	NA	NA	NA
PGEN_.00g085010	Scaffold_04	15977474	15993429	Q96M89	CC138_HUMAN	Coiled-coil domain-containing protein 138		
PGEN_.00g085020	Scaffold_04	15997782	16010915	NA	NA	NA	NA	NA
PGEN_.00g085030	Scaffold_04	16017489	16041743	NA	NA	NA	NA	NA
PGEN_.00g085040	Scaffold_04	16043494	16047305	F1R345	DDX11_DANRE	ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (DEAD/H-box protein 11)	GO:0000922; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005815; GO:0006260; GO:0006281; GO:0007275; GO:0009303; GO:0030496; GO:0032508; GO:0034085; GO:0046872; GO:0051539; GO:1901836; GO:1990700	"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; multicellular organism development [GO:0007275]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]"
PGEN_.00g085050	Scaffold_04	16049150	16113802	F1R345	DDX11_DANRE	ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (DEAD/H-box protein 11)	GO:0000922; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005815; GO:0006260; GO:0006281; GO:0007275; GO:0009303; GO:0030496; GO:0032508; GO:0034085; GO:0046872; GO:0051539; GO:1901836; GO:1990700	"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; multicellular organism development [GO:0007275]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]"
PGEN_.00g085060	Scaffold_04	16118613	16132007	Q6NZG4	DDIAS_MOUSE	DNA damage-induced apoptosis suppressor protein (Nitric oxide-inducible gene protein)	GO:0005634; GO:0005737; GO:0006915; GO:0006974; GO:0007286; GO:0030097; GO:0034644; GO:0071345; GO:0071447; GO:0071480; GO:0071850; GO:0097752; GO:1902230; GO:2000270	cytoplasm [GO:0005737]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; hemopoiesis [GO:0030097]; mitotic cell cycle arrest [GO:0071850]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; regulation of DNA stability [GO:0097752]; spermatid development [GO:0007286]
PGEN_.00g085070	Scaffold_04	16222743	16267211	NA	NA	NA	NA	NA
PGEN_.00g085080	Scaffold_04	16277998	16281135	Q5M9G0	DCTD_RAT	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	GO:0004132; GO:0005737; GO:0006226; GO:0006231; GO:0008270; GO:0042802	cytoplasm [GO:0005737]; dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]
PGEN_.00g085090	Scaffold_04	16282955	16283281	NA	NA	NA	NA	NA
PGEN_.00g085100	Scaffold_04	16284758	16284988	NA	NA	NA	NA	NA
PGEN_.00g085110	Scaffold_04	16302182	16327531	Q5RC69	DCTD_PONAB	Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)	GO:0004132; GO:0006220; GO:0008270; GO:0009165; GO:0042802	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220]
PGEN_.00g085120	Scaffold_04	16334031	16343390	NA	NA	NA	NA	NA
PGEN_.00g085130	Scaffold_04	16345830	16346174	NA	NA	NA	NA	NA
PGEN_.00g085140	Scaffold_04	16346580	16347203	NA	NA	NA	NA	NA
PGEN_.00g085150	Scaffold_04	16347519	16347830	NA	NA	NA	NA	NA
PGEN_.00g085160	Scaffold_04	16353977	16360613	Q06527	ANKH_ALLVD	Ankyrin homolog		
PGEN_.00g085170	Scaffold_04	16368215	16371216	NA	NA	NA	NA	NA
PGEN_.00g085180	Scaffold_04	16391086	16391463	NA	NA	NA	NA	NA
PGEN_.00g085190	Scaffold_04	16393106	16405734	NA	NA	NA	NA	NA
PGEN_.00g085200	Scaffold_04	16423496	16426404	NA	NA	NA	NA	NA
PGEN_.00g085210	Scaffold_04	16432137	16439539	O46162	SGP1_SCHGR	Serine protease inhibitor I/II [Cleaved into: Protease inhibitor SGPI-1 (Schistocerca gregaria trypsin inhibitor) (SGTI); Protease inhibitor SGPI-2 (Schistocerca gregaria chymotrypsin inhibitor) (SGCI)]	GO:0004867; GO:0005576	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g085220	Scaffold_04	16443385	16457022	P82349	SGCB_MOUSE	Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG)	GO:0005737; GO:0005856; GO:0005886; GO:0005887; GO:0007517; GO:0016010; GO:0016011; GO:0016012; GO:0042383; GO:0048747; GO:0055013; GO:0061024; GO:0097084	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; cardiac muscle cell development [GO:0055013]; membrane organization [GO:0061024]; muscle fiber development [GO:0048747]; muscle organ development [GO:0007517]; vascular smooth muscle cell development [GO:0097084]
PGEN_.00g085230	Scaffold_04	16464927	16471317	NA	NA	NA	NA	NA
PGEN_.00g085240	Scaffold_04	16471917	16474420	NA	NA	NA	NA	NA
PGEN_.00g085250	Scaffold_04	16482795	16496335	Q3ZBM5	SNX5_BOVIN	Sorting nexin-5	GO:0001726; GO:0001891; GO:0005768; GO:0005829; GO:0006886; GO:0006907; GO:0030659; GO:0031234; GO:0031313; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0070685	"cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; macropinocytic cup [GO:0070685]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]; pinocytosis [GO:0006907]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g085260	Scaffold_04	16508160	16508534	NA	NA	NA	NA	NA
PGEN_.00g085270	Scaffold_04	16512893	16516749	Q5ENY9	CRYAB_SHEEP	Alpha-crystallin B chain (Alpha(B)-crystallin)	GO:0005212; GO:0005634; GO:0005737; GO:0032991; GO:0042803; GO:0045892; GO:0046872	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g085280	Scaffold_04	16527835	16544287	P13866	SC5A1_HUMAN	Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1)	GO:0005412; GO:0005886; GO:0005887; GO:0005911; GO:0006814; GO:0016021; GO:0016324; GO:0031526; GO:0070062; GO:0106001; GO:1904659	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; glucose transmembrane transport [GO:1904659]; intestinal hexose absorption [GO:0106001]; sodium ion transport [GO:0006814]
PGEN_.00g085290	Scaffold_04	16548226	16567569	Q2M3M2	SC5A9_HUMAN	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (hSGLT4) (Solute carrier family 5 member 9)	GO:0005362; GO:0005412; GO:0005886; GO:0008645; GO:0016021; GO:0070062	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; low-affinity glucose:sodium symporter activity [GO:0005362]; hexose transmembrane transport [GO:0008645]
PGEN_.00g085300	Scaffold_04	16598506	16615367	Q99056	LAC5_TRAVI	Laccase-5 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 5) (Diphenol oxidase 5) (Urishiol oxidase 5)	GO:0005507; GO:0005576; GO:0046274; GO:0052716	extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]
PGEN_.00g085310	Scaffold_04	16629125	16643637	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g085320	Scaffold_04	16651819	16654092	NA	NA	NA	NA	NA
PGEN_.00g085330	Scaffold_04	16671012	16671344	NA	NA	NA	NA	NA
PGEN_.00g085340	Scaffold_04	16677287	16677946	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g085350	Scaffold_04	16677983	16682605	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g085360	Scaffold_04	16682643	16706148	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g085370	Scaffold_04	16713921	16714625	NA	NA	NA	NA	NA
PGEN_.00g085380	Scaffold_04	16730303	16742295	NA	NA	NA	NA	NA
PGEN_.00g085390	Scaffold_04	16802048	16826745	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g085400	Scaffold_04	16828049	16830327	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g085410	Scaffold_04	16839697	16848256	Q8BGF6	ELMD2_MOUSE	ELMO domain-containing protein 2	GO:0005096; GO:0050688	GTPase activator activity [GO:0005096]; regulation of defense response to virus [GO:0050688]
PGEN_.00g085420	Scaffold_04	16868515	16964019	Q92545	TM131_HUMAN	Transmembrane protein 131 (Protein RW1)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g085430	Scaffold_04	16967067	16975711	Q1KSC7	RL31_MARMO	60S ribosomal protein L31	GO:0003735; GO:0005840; GO:0006412	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g085440	Scaffold_04	16993031	16996215	O70131	NINJ1_MOUSE	Ninjurin-1 (Nerve injury-induced protein 1)	GO:0001954; GO:0007155; GO:0016021; GO:0042246; GO:1990384	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]
PGEN_.00g085450	Scaffold_04	17035410	17075714	NA	NA	NA	NA	NA
PGEN_.00g085460	Scaffold_04	17083941	17093771	Q8BXN7	PPM1K_MOUSE	"Protein phosphatase 1K, mitochondrial (EC 3.1.3.16) (Protein phosphatase 2C isoform kappa) (PP2C-kappa)"	GO:0004722; GO:0004724; GO:0005739; GO:0005759; GO:0046872	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]
PGEN_.00g085470	Scaffold_04	17151925	17154051	Q6NWX7	NTM1A_DANRE	N-terminal Xaa-Pro-Lys N-methyltransferase 1 (EC 2.1.1.244) (Alpha N-terminal protein methyltransferase 1A) (Methyltransferase-like protein 11A) (X-Pro-Lys N-terminal protein methyltransferase 1A) (NTM1A)	GO:0005634; GO:0005737; GO:0007051; GO:0007059; GO:0008276; GO:0016571; GO:0018013; GO:0018016; GO:0035572; GO:0035573; GO:0042054; GO:0071885	cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]; chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine trimethylation [GO:0035573]; spindle organization [GO:0007051]
PGEN_.00g085480	Scaffold_04	17167060	17179709	O31826	YNGI_BACSU	Putative acyl-CoA synthetase YngI (EC 6.2.1.-)	GO:0005524; GO:0016874	ATP binding [GO:0005524]; ligase activity [GO:0016874]
PGEN_.00g085490	Scaffold_04	17258362	17260527	NA	NA	NA	NA	NA
PGEN_.00g085500	Scaffold_04	17284132	17286947	O31826	YNGI_BACSU	Putative acyl-CoA synthetase YngI (EC 6.2.1.-)	GO:0005524; GO:0016874	ATP binding [GO:0005524]; ligase activity [GO:0016874]
PGEN_.00g085510	Scaffold_04	17338906	17342639	NA	NA	NA	NA	NA
PGEN_.00g085520	Scaffold_04	17356841	17365611	NA	NA	NA	NA	NA
PGEN_.00g085530	Scaffold_04	17366358	17367086	NA	NA	NA	NA	NA
PGEN_.00g085540	Scaffold_04	17439538	17443942	Q5F478	ANR44_CHICK	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)		
PGEN_.00g085550	Scaffold_04	17446791	17451099	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g085560	Scaffold_04	17461012	17462667	Q62192	CD180_MOUSE	CD180 antigen (Lymphocyte antigen 78) (Ly-78) (Radioprotective 105 kDa protein) (CD antigen CD180)	GO:0002322; GO:0005615; GO:0005886; GO:0006954; GO:0016021; GO:0031012; GO:0031666; GO:0045087; GO:0071222	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; B cell proliferation involved in immune response [GO:0002322]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]
PGEN_.00g085570	Scaffold_04	17540574	17541540	NA	NA	NA	NA	NA
PGEN_.00g085580	Scaffold_04	17553317	17561888	P40313	CTRL_HUMAN	Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-)	GO:0004252; GO:0005615; GO:0008236; GO:0030163	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]
PGEN_.00g085590	Scaffold_04	17604194	17605208	NA	NA	NA	NA	NA
PGEN_.00g085600	Scaffold_04	17611696	17613676	Q00546	TENR_CHICK	Tenascin-R (TN-R) (Restrictin)	GO:0007155; GO:0050767; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; cell adhesion [GO:0007155]; regulation of neurogenesis [GO:0050767]
PGEN_.00g085610	Scaffold_04	17617206	17618077	Q00546	TENR_CHICK	Tenascin-R (TN-R) (Restrictin)	GO:0007155; GO:0050767; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; cell adhesion [GO:0007155]; regulation of neurogenesis [GO:0050767]
PGEN_.00g085620	Scaffold_04	17619787	17629771	Q8MP06	SNO1_TYRJA	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	GO:0004499; GO:0005576; GO:0009820; GO:0033784; GO:0050660; GO:0050661; GO:0051289; GO:0055114	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
PGEN_.00g085630	Scaffold_04	17635137	17638125	NA	NA	NA	NA	NA
PGEN_.00g085640	Scaffold_04	17658821	17663688	Q94BV5	GSXL4_ARATH	Flavin-containing monooxygenase FMO GS-OX-like 4 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 4)	GO:0004499; GO:0005773; GO:0050660; GO:0050661	"vacuole [GO:0005773]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
PGEN_.00g085650	Scaffold_04	17684188	17704572	Q62381	TLL1_MOUSE	Tolloid-like protein 1 (mTll) (EC 3.4.24.-)	GO:0004222; GO:0005509; GO:0005518; GO:0005576; GO:0007275; GO:0008270; GO:0030154	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]
PGEN_.00g085660	Scaffold_04	17726500	17726841	NA	NA	NA	NA	NA
PGEN_.00g085670	Scaffold_04	17753861	17756663	NA	NA	NA	NA	NA
PGEN_.00g085680	Scaffold_04	17783728	17797672	O00548	DLL1_HUMAN	Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1) (H-Delta-1)	GO:0001709; GO:0001756; GO:0001757; GO:0001947; GO:0002315; GO:0003323; GO:0005112; GO:0005509; GO:0005576; GO:0005886; GO:0005887; GO:0005912; GO:0007219; GO:0007368; GO:0007386; GO:0008217; GO:0008284; GO:0008285; GO:0009954; GO:0014002; GO:0014807; GO:0016324; GO:0021510; GO:0021688; GO:0021693; GO:0030097; GO:0030154; GO:0030155; GO:0030857; GO:0030957; GO:0031410; GO:0032693; GO:0034351; GO:0035265; GO:0040008; GO:0045121; GO:0045596; GO:0045605; GO:0045608; GO:0045638; GO:0045662; GO:0045665; GO:0045746; GO:0045747; GO:0045807; GO:0045944; GO:0046331; GO:0048630; GO:0048631; GO:0048633; GO:0048665; GO:0048839; GO:0050767; GO:0051302; GO:0060041; GO:0060042; GO:0060853; GO:0070986; GO:0072006; GO:0072014; GO:0072070; GO:0072583; GO:0097009; GO:0097102; GO:0097110; GO:0097150; GO:0098773; GO:1900746; GO:1903672; GO:2000726	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; scaffold protein binding [GO:0097110]; Tat protein binding [GO:0030957]; astrocyte development [GO:0014002]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cerebellar molecular layer formation [GO:0021688]; cerebellar Purkinje cell layer structural organization [GO:0021693]; clathrin-dependent endocytosis [GO:0072583]; compartment pattern specification [GO:0007386]; determination of left/right symmetry [GO:0007368]; endothelial tip cell fate specification [GO:0097102]; energy homeostasis [GO:0097009]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; lateral inhibition [GO:0046331]; left/right axis specification [GO:0070986]; loop of Henle development [GO:0072070]; marginal zone B cell differentiation [GO:0002315]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; nephron development [GO:0072006]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; organ growth [GO:0035265]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; proximal/distal pattern formation [GO:0009954]; regulation of blood pressure [GO:0008217]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of growth [GO:0040008]; regulation of neurogenesis [GO:0050767]; regulation of skeletal muscle tissue growth [GO:0048631]; regulation of somitogenesis [GO:0014807]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle tissue growth [GO:0048630]; skin epidermis development [GO:0098773]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; type B pancreatic cell development [GO:0003323]
PGEN_.00g085690	Scaffold_04	17872364	17919202	Q60544	TAF1_MESAU	Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250)	GO:0003677; GO:0004402; GO:0004674; GO:0005524; GO:0005669; GO:0006352; GO:0007049; GO:0045944; GO:0071339	"MLL1 complex [GO:0071339]; transcription factor TFIID complex [GO:0005669]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g085700	Scaffold_04	17919331	17919996	Q6DJF8	MET23_XENLA	Methyltransferase-like protein 23 (EC 2.1.1.-)	GO:0005737; GO:0008168; GO:0016021; GO:0032259	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g085710	Scaffold_04	17931631	17941693	NA	NA	NA	NA	NA
PGEN_.00g085720	Scaffold_04	17948419	17960393	Q8RA32	DPO3_CALS4	DNA polymerase III PolC-type (PolIII) (EC 2.7.7.7)	GO:0003677; GO:0003887; GO:0005737; GO:0006261; GO:0008408	cytoplasm [GO:0005737]; 3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261]
PGEN_.00g085730	Scaffold_04	18002183	18002797	NA	NA	NA	NA	NA
PGEN_.00g085740	Scaffold_04	18025281	18038237	NA	NA	NA	NA	NA
PGEN_.00g085750	Scaffold_04	18039686	18053760	NA	NA	NA	NA	NA
PGEN_.00g085760	Scaffold_04	18065944	18071668	Q15582	BGH3_HUMAN	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP)	GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0044267; GO:0050839; GO:0050840; GO:0050896; GO:0062023; GO:0070062	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular protein metabolic process [GO:0044267]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g085770	Scaffold_04	18077342	18086286	O11780	BGH3_PIG	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP)	GO:0005178; GO:0005518; GO:0005615; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; extracellular matrix organization [GO:0030198]
PGEN_.00g085780	Scaffold_04	18093888	18101824	Q15582	BGH3_HUMAN	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP)	GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0044267; GO:0050839; GO:0050840; GO:0050896; GO:0062023; GO:0070062	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular protein metabolic process [GO:0044267]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g085790	Scaffold_04	18109128	18118165	P55906	BGH3_BOVIN	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (MP70) (MP78)	GO:0001525; GO:0005178; GO:0005518; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; extracellular matrix organization [GO:0030198]
PGEN_.00g085800	Scaffold_04	18126168	18139205	P74615	Y1483_SYNY3	Uncharacterized protein sll1483	GO:0005615; GO:0030288	extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]
PGEN_.00g085810	Scaffold_04	18174179	18174697	NA	NA	NA	NA	NA
PGEN_.00g085820	Scaffold_04	18182803	18206321	NA	NA	NA	NA	NA
PGEN_.00g085830	Scaffold_04	18214259	18222213	Q80WC9	ACSF4_MOUSE	Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4) (Protein LYS2 homolog)	GO:0005524; GO:0006631; GO:0016878; GO:0019482; GO:0043041	acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631]
PGEN_.00g085840	Scaffold_04	18227227	18227529	NA	NA	NA	NA	NA
PGEN_.00g085850	Scaffold_04	18231760	18234289	NA	NA	NA	NA	NA
PGEN_.00g085860	Scaffold_04	18239126	18242994	NA	NA	NA	NA	NA
PGEN_.00g085870	Scaffold_04	18245631	18264039	Q5RG49	ACSF4_DANRE	Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4)	GO:0005524; GO:0006631; GO:0016878	acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]
PGEN_.00g085880	Scaffold_04	18270715	18273881	Q9UM13	APC10_HUMAN	Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10)	GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007049; GO:0031145; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g085890	Scaffold_04	18280349	18291656	P33587	PROC_MOUSE	Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide]	GO:0001889; GO:0004252; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0007596; GO:0008233; GO:0030195; GO:0043066; GO:0043621; GO:0044537; GO:0050728; GO:0050819; GO:0070012; GO:1903142	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; oligopeptidase activity [GO:0070012]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]; proteolysis [GO:0006508]; regulation of circulating fibrinogen levels [GO:0044537]
PGEN_.00g085900	Scaffold_04	18294456	18297452	Q9ESN4	C1QL3_MOUSE	Complement C1q-like protein 3 (C1q and tumor necrosis factor-related protein 13) (C1q/TNF-related protein 13) (CTRP13) (Gliacolin)	GO:0005576; GO:0005581; GO:0042802; GO:0050807	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]; regulation of synapse organization [GO:0050807]
PGEN_.00g085910	Scaffold_04	18305928	18320365	P24524	GLRA3_RAT	Glycine receptor subunit alpha-3	GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0097688; GO:0098690; GO:0098978; GO:0098982; GO:0099060; GO:1902476; GO:2000300	"cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g085920	Scaffold_04	18338676	18434557	O75311	GLRA3_HUMAN	Glycine receptor subunit alpha-3	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:1902476	"cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g085930	Scaffold_04	18465234	18473309	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g085940	Scaffold_04	18552537	18574154	P79784	ENTP2_CHICK	Ectonucleoside triphosphate diphosphohydrolase 2 (NTPDase 2) (EC 3.6.1.-) (CD39 antigen-like 1) (Ecto-ATP diphosphohydrolase 2) (Ecto-ATPDase 2) (Ecto-ATPase 2)	GO:0005524; GO:0016020; GO:0016021; GO:0016887	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]
PGEN_.00g085950	Scaffold_04	18584293	18605886	NA	NA	NA	NA	NA
PGEN_.00g085960	Scaffold_04	18608728	18610091	NA	NA	NA	NA	NA
PGEN_.00g085970	Scaffold_04	18613651	18617878	NA	NA	NA	NA	NA
PGEN_.00g085980	Scaffold_04	18623841	18624173	NA	NA	NA	NA	NA
PGEN_.00g085990	Scaffold_04	18631304	18642705	NA	NA	NA	NA	NA
PGEN_.00g086000	Scaffold_04	18685119	18693454	NA	NA	NA	NA	NA
PGEN_.00g086010	Scaffold_04	18709945	18714863	NA	NA	NA	NA	NA
PGEN_.00g086020	Scaffold_04	18717706	18730665	NA	NA	NA	NA	NA
PGEN_.00g086030	Scaffold_04	18737907	18762048	NA	NA	NA	NA	NA
PGEN_.00g086040	Scaffold_04	18766407	18773968	Q38PU8	GRIA1_MACFA	"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)"	GO:0004971; GO:0005789; GO:0014069; GO:0030054; GO:0030425; GO:0031901; GO:0032281; GO:0043197; GO:0055038; GO:0098839	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; AMPA glutamate receptor activity [GO:0004971]
PGEN_.00g086050	Scaffold_04	18775551	18797295	P26591	GLRK_LYMST	Glutamate receptor	GO:0004970; GO:0016021; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970]
PGEN_.00g086060	Scaffold_04	18806765	18807166	NA	NA	NA	NA	NA
PGEN_.00g086070	Scaffold_04	18983022	19006232	Q175F8	GLYR1_AEDAE	Putative oxidoreductase GLYR1 homolog (EC 1.-.-.-) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60 homolog)	GO:0016491; GO:0050661; GO:0051287	NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]
PGEN_.00g086080	Scaffold_04	19022565	19025498	P34595	IGLR2_CAEEL	Immunoglobulin domain and leucine-rich repeat-containing protein 2	GO:0003735; GO:0005763; GO:0016021; GO:0070181	integral component of membrane [GO:0016021]; mitochondrial small ribosomal subunit [GO:0005763]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]
PGEN_.00g086090	Scaffold_04	19050646	19060239	Q5RKN4	GLYR1_DANRE	Putative oxidoreductase GLYR1 (EC 1.-.-.-) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60)	GO:0016491; GO:0016607; GO:0035064; GO:0050661; GO:0051287	nuclear speck [GO:0016607]; methylated histone binding [GO:0035064]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]
PGEN_.00g086100	Scaffold_04	19066690	19088580	Q08D69	MED16_XENTR	Mediator of RNA polymerase II transcription subunit 16 (Mediator complex subunit 16)	GO:0016592; GO:0045893	"mediator complex [GO:0016592]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g086110	Scaffold_04	19111716	19131784	NA	NA	NA	NA	NA
PGEN_.00g086120	Scaffold_04	19139020	19142192	P10394	POL4_DROME	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]
PGEN_.00g086130	Scaffold_04	19142266	19143123	NA	NA	NA	NA	NA
PGEN_.00g086140	Scaffold_04	19146083	19153166	NA	NA	NA	NA	NA
PGEN_.00g086150	Scaffold_04	19163985	19166511	NA	NA	NA	NA	NA
PGEN_.00g086160	Scaffold_04	19175373	19186177	Q14094	CCNI_HUMAN	Cyclin-I	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0006468; GO:0007283; GO:0016538; GO:0019901; GO:0044772	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; mitotic cell cycle phase transition [GO:0044772]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; spermatogenesis [GO:0007283]
PGEN_.00g086170	Scaffold_04	19186583	19193079	P51945	CCNG1_MOUSE	Cyclin-G1 (Cyclin-G)	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0006468; GO:0006949; GO:0007095; GO:0016538; GO:0019901; GO:0030425; GO:0043025; GO:0043066; GO:0044772; GO:0048471; GO:0051301	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; syncytium formation [GO:0006949]
PGEN_.00g086180	Scaffold_04	19220280	19240990	Q6PFD9	NUP98_MOUSE	Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)]	GO:0000973; GO:0003713; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0006405; GO:0006606; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034398; GO:0034399; GO:0042277; GO:0042405; GO:0043231; GO:0044614; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:1990841; GO:1990904	"intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]"
PGEN_.00g086190	Scaffold_04	19262458	19264105	P73392	Y1735_SYNY3	Uncharacterized protein sll1735	GO:0005615	extracellular space [GO:0005615]
PGEN_.00g086200	Scaffold_04	19272708	19412670	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g086210	Scaffold_04	19447571	19447912	NA	NA	NA	NA	NA
PGEN_.00g086220	Scaffold_04	19469232	19472161	NA	NA	NA	NA	NA
PGEN_.00g086230	Scaffold_04	19521084	19521596	NA	NA	NA	NA	NA
PGEN_.00g086240	Scaffold_04	19558627	19571547	Q9JI35	HRH3_CAVPO	Histamine H3 receptor (H3R) (HH3R)	GO:0001505; GO:0004969; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; histamine receptor activity [GO:0004969]; regulation of neurotransmitter levels [GO:0001505]
PGEN_.00g086250	Scaffold_04	19579276	19590228	NA	NA	NA	NA	NA
PGEN_.00g086260	Scaffold_04	19605301	19605507	NA	NA	NA	NA	NA
PGEN_.00g086270	Scaffold_04	19608727	19610623	Q9H3N8	HRH4_HUMAN	Histamine H4 receptor (H4R) (HH4R) (AXOR35) (G-protein coupled receptor 105) (GPRv53) (Pfi-013) (SP9144)	GO:0004930; GO:0004969; GO:0004993; GO:0005623; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007187; GO:0007197; GO:0007204; GO:0007268; GO:0016907; GO:0030425; GO:0030594; GO:0043408; GO:0045202	"cell [GO:0005623]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of MAPK cascade [GO:0043408]"
PGEN_.00g086280	Scaffold_04	19619625	19632915	P26153	ACHB4_CHICK	Neuronal acetylcholine receptor subunit beta-4 (Neuronal acetylcholine receptor non-alpha-3 chain) (N-alpha 3) (Fragment)	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g086290	Scaffold_04	19681658	19682728	NA	NA	NA	NA	NA
PGEN_.00g086300	Scaffold_04	19734379	19740253	Q24352	GBRAL_DROME	Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD)	GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1902476; GO:1904456	"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g086310	Scaffold_04	19751927	19765660	Q24352	GBRAL_DROME	Gamma-aminobutyric acid receptor alpha-like (GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila) (GRD)	GO:0004890; GO:0005261; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007268; GO:0015276; GO:0016021; GO:0016933; GO:0022851; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0042752; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:1902476; GO:1904456	"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; cation channel activity [GO:0005261]; extracellularly glycine-gated ion channel activity [GO:0016933]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; glycine-gated chloride ion channel activity [GO:0022852]; ligand-gated ion channel activity [GO:0015276]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; negative regulation of neuronal action potential [GO:1904456]; nervous system process [GO:0050877]; regulation of circadian rhythm [GO:0042752]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g086320	Scaffold_04	19818652	19830245	Q08DH3	TRM9B_BOVIN	Probable tRNA methyltransferase 9B (Probable tRNA methyltransferase 9-like protein) (EC 2.1.1.-)	GO:0002098; GO:0005634; GO:0005737; GO:0016300	cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g086330	Scaffold_04	19839382	19849203	Q86TX2	ACOT1_HUMAN	Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (EC 3.1.2.-) (CTE-I) (CTE-Ib) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2)	GO:0000038; GO:0001676; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0047617; GO:0052689; GO:0102991	cytosol [GO:0005829]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]
PGEN_.00g086340	Scaffold_04	19852541	19858973	Q63276	BAAT_RAT	Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Kan-1) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2)	GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016290; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817; GO:0102991	cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; glycine N-choloyltransferase activity [GO:0047963]; long-chain acyl-CoA hydrolase activity [GO:0052816]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; very long chain acyl-CoA hydrolase activity [GO:0052817]; acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530]
PGEN_.00g086350	Scaffold_04	19883526	19883828	NA	NA	NA	NA	NA
PGEN_.00g086360	Scaffold_04	19896533	19896805	NA	NA	NA	NA	NA
PGEN_.00g086370	Scaffold_04	19901144	19910244	A2AKK5	ACNT1_MOUSE	Acyl-coenzyme A amino acid N-acyltransferase 1 (EC 2.3.1.-)	GO:0005777; GO:0006631; GO:0006637; GO:0016410; GO:0047617	peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]
PGEN_.00g086380	Scaffold_04	19910688	19911982	NA	NA	NA	NA	NA
PGEN_.00g086390	Scaffold_04	19963027	19980648	Q91X34	BAAT_MOUSE	Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2)	GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016290; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817; GO:0102991	cytosol [GO:0005829]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; glycine N-choloyltransferase activity [GO:0047963]; long-chain acyl-CoA hydrolase activity [GO:0052816]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; very long chain acyl-CoA hydrolase activity [GO:0052817]; acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530]
PGEN_.00g086400	Scaffold_04	19980742	19999126	A2AKK5	ACNT1_MOUSE	Acyl-coenzyme A amino acid N-acyltransferase 1 (EC 2.3.1.-)	GO:0005777; GO:0006631; GO:0006637; GO:0016410; GO:0047617	peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]
PGEN_.00g086410	Scaffold_04	20023160	20023579	NA	NA	NA	NA	NA
PGEN_.00g086420	Scaffold_04	20026973	20033676	Q3UHD3	MTUS2_MOUSE	Microtubule-associated tumor suppressor candidate 2 homolog (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150) (Tracking protein of 150 kDa)	GO:0005634; GO:0005737; GO:0005874; GO:0008017; GO:0042803; GO:0045171	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]
PGEN_.00g086430	Scaffold_04	20042259	20046429	NA	NA	NA	NA	NA
PGEN_.00g086440	Scaffold_04	20051745	20073739	NA	NA	NA	NA	NA
PGEN_.00g086450	Scaffold_04	20083254	20136598	O42184	CLIP1_CHICK	CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 170) (CLIP-170) (Restin)	GO:0001578; GO:0001726; GO:0005635; GO:0005813; GO:0005881; GO:0008017; GO:0008270; GO:0030659; GO:0031116; GO:0035371; GO:0044354; GO:0044861; GO:0051010	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; macropinosome [GO:0044354]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; ruffle [GO:0001726]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; zinc ion binding [GO:0008270]; microtubule bundle formation [GO:0001578]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861]
PGEN_.00g086460	Scaffold_04	20160197	20160640	NA	NA	NA	NA	NA
PGEN_.00g086470	Scaffold_04	20166262	20166591	NA	NA	NA	NA	NA
PGEN_.00g086480	Scaffold_04	20181256	20185591	NA	NA	NA	NA	NA
PGEN_.00g086490	Scaffold_04	20190638	20191340	NA	NA	NA	NA	NA
PGEN_.00g086500	Scaffold_04	20191398	20191691	NA	NA	NA	NA	NA
PGEN_.00g086510	Scaffold_04	20191734	20196464	NA	NA	NA	NA	NA
PGEN_.00g086520	Scaffold_04	20199766	20237494	Q6AWC2	WWC2_HUMAN	Protein WWC2 (BH-3-only member B) (WW domain-containing protein 2)	GO:0000122; GO:0005829; GO:0019900; GO:0035331; GO:0046621; GO:0060090	cytosol [GO:0005829]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g086530	Scaffold_04	20248221	20253961	NA	NA	NA	NA	NA
PGEN_.00g086540	Scaffold_04	20260871	20268259	P49666	RL21_PIG	60S ribosomal protein L21	GO:0003735; GO:0005783; GO:0006412; GO:0022625	cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g086550	Scaffold_04	20271893	20286241	A5D9H7	UBP12_BOVIN	Ubiquitin carboxyl-terminal hydrolase 12 (EC 3.4.19.12) (Deubiquitinating enzyme 12) (Ubiquitin thioesterase 12) (Ubiquitin-specific-processing protease 12)	GO:0004197; GO:0004843; GO:0006511; GO:0016579; GO:0036459; GO:0046872	cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g086560	Scaffold_04	20314169	20327614	NA	NA	NA	NA	NA
PGEN_.00g086570	Scaffold_04	20363266	20369713	Q9UI36	DACH1_HUMAN	Dachshund homolog 1 (Dach1)	GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001967; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0007585; GO:0008283; GO:0010944; GO:0030336; GO:0033262; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell population proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]"
PGEN_.00g086580	Scaffold_04	20484091	20484405	NA	NA	NA	NA	NA
PGEN_.00g086590	Scaffold_04	20500336	20522354	NA	NA	NA	NA	NA
PGEN_.00g086600	Scaffold_04	20529903	20534682	NA	NA	NA	NA	NA
PGEN_.00g086610	Scaffold_04	20539997	20578425	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g086620	Scaffold_04	20593265	20594477	Q54R58	YTYK2_DICDI	Probable tyrosine-protein kinase DDB_G0283397 (EC 2.7.10.2)	GO:0004715; GO:0005524	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]
PGEN_.00g086630	Scaffold_04	20610072	20611263	NA	NA	NA	NA	NA
PGEN_.00g086640	Scaffold_04	20613271	20617948	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g086650	Scaffold_04	20619512	20619988	NA	NA	NA	NA	NA
PGEN_.00g086660	Scaffold_04	20620170	20660193	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g086670	Scaffold_04	20665550	20666140	NA	NA	NA	NA	NA
PGEN_.00g086680	Scaffold_04	20774265	20774765	NA	NA	NA	NA	NA
PGEN_.00g086690	Scaffold_04	20774865	20775269	NA	NA	NA	NA	NA
PGEN_.00g086700	Scaffold_04	20775349	20775660	NA	NA	NA	NA	NA
PGEN_.00g086710	Scaffold_04	20780837	20781808	NA	NA	NA	NA	NA
PGEN_.00g086720	Scaffold_04	20785669	20785962	NA	NA	NA	NA	NA
PGEN_.00g086730	Scaffold_04	20786012	20786962	NA	NA	NA	NA	NA
PGEN_.00g086740	Scaffold_04	20787692	20787988	NA	NA	NA	NA	NA
PGEN_.00g086750	Scaffold_04	20788128	20788430	NA	NA	NA	NA	NA
PGEN_.00g086760	Scaffold_04	20788814	20789611	NA	NA	NA	NA	NA
PGEN_.00g086770	Scaffold_04	20792736	20793308	NA	NA	NA	NA	NA
PGEN_.00g086780	Scaffold_04	20793591	20793998	NA	NA	NA	NA	NA
PGEN_.00g086790	Scaffold_04	20794374	20795730	Q6SJ95	TBPL2_MOUSE	TATA box-binding protein-like protein 2 (TBP-like protein 2) (TATA box-binding protein-related factor 3) (TBP-related factor 3)	GO:0000126; GO:0000978; GO:0000979; GO:0001016; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005669; GO:0005737; GO:0006366; GO:0007275; GO:0008134; GO:0045892; GO:0070898	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIIB complex [GO:0000126]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase III regulatory region DNA binding [GO:0001016]; transcription factor binding [GO:0008134]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA polymerase III preinitiation complex assembly [GO:0070898]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g086800	Scaffold_04	20839169	20849731	Q8TCB0	IFI44_HUMAN	Interferon-induced protein 44 (p44) (Microtubule-associated protein 44)	GO:0005737; GO:0006955; GO:0009615; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]
PGEN_.00g086810	Scaffold_04	20881894	20892746	NA	NA	NA	NA	NA
PGEN_.00g086820	Scaffold_04	20914352	20914801	NA	NA	NA	NA	NA
PGEN_.00g086830	Scaffold_04	20925269	20925808	NA	NA	NA	NA	NA
PGEN_.00g086840	Scaffold_04	20937894	20960498	P61222	ABCE1_MOUSE	ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006415; GO:0016887; GO:0043024; GO:0060698; GO:0060702	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]
PGEN_.00g086850	Scaffold_04	20977230	20981489	P61222	ABCE1_MOUSE	ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006415; GO:0016887; GO:0043024; GO:0060698; GO:0060702	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]
PGEN_.00g086860	Scaffold_04	21004196	21010452	NA	NA	NA	NA	NA
PGEN_.00g086870	Scaffold_04	21010762	21013132	NA	NA	NA	NA	NA
PGEN_.00g086880	Scaffold_04	21149045	21156446	NA	NA	NA	NA	NA
PGEN_.00g086890	Scaffold_04	21167709	21167984	NA	NA	NA	NA	NA
PGEN_.00g086900	Scaffold_04	21173628	21173969	NA	NA	NA	NA	NA
PGEN_.00g086910	Scaffold_04	21191304	21192269	NA	NA	NA	NA	NA
PGEN_.00g086920	Scaffold_04	21192431	21201177	NA	NA	NA	NA	NA
PGEN_.00g086930	Scaffold_04	21295954	21296205	NA	NA	NA	NA	NA
PGEN_.00g086940	Scaffold_04	21340327	21341278	NA	NA	NA	NA	NA
PGEN_.00g086950	Scaffold_04	21447763	21502526	Q62398	CNGA2_MOUSE	Cyclic nucleotide-gated olfactory channel (Cyclic nucleotide-gated cation channel 2) (Cyclic nucleotide-gated channel alpha-2) (CNG channel alpha-2) (CNG-2) (CNG2)	GO:0005216; GO:0005222; GO:0005223; GO:0005249; GO:0005516; GO:0005886; GO:0007608; GO:0017071; GO:0030552; GO:0030553; GO:0042802; GO:0043204; GO:0044877; GO:0050896; GO:0051899	intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ion channel activity [GO:0005216]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]; membrane depolarization [GO:0051899]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]
PGEN_.00g086960	Scaffold_04	21541234	21541980	NA	NA	NA	NA	NA
PGEN_.00g086970	Scaffold_04	21543897	21544861	NA	NA	NA	NA	NA
PGEN_.00g086980	Scaffold_04	21544897	21545553	NA	NA	NA	NA	NA
PGEN_.00g086990	Scaffold_04	21545688	21546053	NA	NA	NA	NA	NA
PGEN_.00g087000	Scaffold_04	21546234	21546614	NA	NA	NA	NA	NA
PGEN_.00g087010	Scaffold_04	21546782	21547876	NA	NA	NA	NA	NA
PGEN_.00g087020	Scaffold_04	21561606	21561944	NA	NA	NA	NA	NA
PGEN_.00g087030	Scaffold_04	21570957	21594056	Q68CJ6	SLIP_HUMAN	Nuclear GTPase SLIP-GC (EC 3.6.1.-) (Speckled-like pattern in the germinal center)	GO:0003924; GO:0005525; GO:0016607; GO:0033262; GO:0043066; GO:0071222	nuclear speck [GO:0016607]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of apoptotic process [GO:0043066]; regulation of nuclear cell cycle DNA replication [GO:0033262]
PGEN_.00g087040	Scaffold_04	21620506	21641986	NA	NA	NA	NA	NA
PGEN_.00g087050	Scaffold_04	21659137	21660356	NA	NA	NA	NA	NA
PGEN_.00g087060	Scaffold_04	21662824	21678701	NA	NA	NA	NA	NA
PGEN_.00g087070	Scaffold_04	21678776	21679126	NA	NA	NA	NA	NA
PGEN_.00g087080	Scaffold_04	21679768	21680412	NA	NA	NA	NA	NA
PGEN_.00g087090	Scaffold_04	21680476	21686457	A4QN56	MFS4B_DANRE	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g087100	Scaffold_04	21696951	21698382	NA	NA	NA	NA	NA
PGEN_.00g087110	Scaffold_04	21792758	21793552	NA	NA	NA	NA	NA
PGEN_.00g087120	Scaffold_04	21794442	21800858	NA	NA	NA	NA	NA
PGEN_.00g087130	Scaffold_04	21803194	21807068	NA	NA	NA	NA	NA
PGEN_.00g087140	Scaffold_04	21811296	21811670	Q08B72	MYPOP_XENLA	"Myb-related transcription factor, partner of profilin (Myb-related protein p42POP)"	GO:0003677; GO:0005634	nucleus [GO:0005634]; DNA binding [GO:0003677]
PGEN_.00g087150	Scaffold_04	21864610	21872626	NA	NA	NA	NA	NA
PGEN_.00g087160	Scaffold_04	21888689	21897944	NA	NA	NA	NA	NA
PGEN_.00g087170	Scaffold_04	21908341	21920436	NA	NA	NA	NA	NA
PGEN_.00g087180	Scaffold_04	21924916	21961231	P40694	SMBP2_MOUSE	DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Cardiac transcription factor 1) (CATF1) (Immunoglobulin mu-binding protein 2)	GO:0000049; GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006412; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0021522; GO:0030424; GO:0030426; GO:0032574; GO:0042802; GO:0043022; GO:0043025; GO:0043139; GO:0043621; GO:0048471; GO:0050905; GO:1990904; GO:1990955	"axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; DNA-dependent ATPase activity [GO:0008094]; G-rich single-stranded DNA binding [GO:1990955]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA-dependent ATPase activity [GO:0008186]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process [GO:0050905]; spinal cord motor neuron differentiation [GO:0021522]; translation [GO:0006412]"
PGEN_.00g087190	Scaffold_04	21975367	22078490	O75592	MYCB2_HUMAN	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.-) (Myc-binding protein 2) (Protein associated with Myc)	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008536; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042803; GO:0043231; GO:0050905; GO:0051493; GO:0061630; GO:1902667	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]
PGEN_.00g087200	Scaffold_04	22078517	22096921	F1RD40	MYCB2_DANRE	E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.-) (Myc-binding protein 2) (Protein Esrom)	GO:0004842; GO:0005085; GO:0005634; GO:0005737; GO:0005856; GO:0007411; GO:0008536; GO:0016198; GO:0021952; GO:0021986; GO:0030424; GO:0031290; GO:0032922; GO:0042068; GO:0046872; GO:0048066; GO:0050905; GO:0061630; GO:1902667	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290]
PGEN_.00g087210	Scaffold_04	22101996	22104650	Q90YI5	TIM8A_TAKRU	Mitochondrial import inner membrane translocase subunit Tim8 A	GO:0005743; GO:0005758; GO:0046872; GO:0072321	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; chaperone-mediated protein transport [GO:0072321]
PGEN_.00g087220	Scaffold_04	22109613	22110467	NA	NA	NA	NA	NA
PGEN_.00g087230	Scaffold_04	22112653	22119775	NA	NA	NA	NA	NA
PGEN_.00g087240	Scaffold_04	22124512	22133060	NA	NA	NA	NA	NA
PGEN_.00g087250	Scaffold_04	22133863	22135507	NA	NA	NA	NA	NA
PGEN_.00g087260	Scaffold_04	22136453	22145843	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g087270	Scaffold_04	22149395	22149802	NA	NA	NA	NA	NA
PGEN_.00g087280	Scaffold_04	22150288	22150578	NA	NA	NA	NA	NA
PGEN_.00g087290	Scaffold_04	22152595	22160997	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g087300	Scaffold_04	22166024	22174866	NA	NA	NA	NA	NA
PGEN_.00g087310	Scaffold_04	22179186	22194544	F7J220	SRCR1_PATPE	Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1)	GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]
PGEN_.00g087320	Scaffold_04	22195388	22217291	Q3B8N0	UFSP2_XENLA	Ufm1-specific protease 2 (UfSP2) (EC 3.4.22.-)	GO:0005634; GO:0005737; GO:0005783; GO:0006508; GO:0016790; GO:0071567	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]; proteolysis [GO:0006508]
PGEN_.00g087330	Scaffold_04	22219118	22244721	Q5RGB8	KLH26_DANRE	Kelch-like protein 26		
PGEN_.00g087340	Scaffold_04	22251164	22253272	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g087350	Scaffold_04	22267762	22268067	NA	NA	NA	NA	NA
PGEN_.00g087360	Scaffold_04	22274690	22275037	NA	NA	NA	NA	NA
PGEN_.00g087370	Scaffold_04	22279263	22302648	Q53G44	IF44L_HUMAN	Interferon-induced protein 44-like	GO:0005525; GO:0005737; GO:0006955; GO:0051607	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]
PGEN_.00g087380	Scaffold_04	22320906	22332753	NA	NA	NA	NA	NA
PGEN_.00g087390	Scaffold_04	22373884	22376035	NA	NA	NA	NA	NA
PGEN_.00g087400	Scaffold_04	22393681	22394142	NA	NA	NA	NA	NA
PGEN_.00g087410	Scaffold_04	22409806	22410424	NA	NA	NA	NA	NA
PGEN_.00g087420	Scaffold_04	22412202	22412528	NA	NA	NA	NA	NA
PGEN_.00g087430	Scaffold_04	22423508	22438757	Q90744	NAGAB_CHICK	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]
PGEN_.00g087440	Scaffold_04	22463226	22464440	NA	NA	NA	NA	NA
PGEN_.00g087450	Scaffold_04	22471320	22488830	O77475	CPESY_DROME	Ceramide phosphoethanolamine synthase (CPE synthase) (EC 2.7.8.n3)	GO:0000139; GO:0005886; GO:0006665; GO:0016021; GO:0016740	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity [GO:0016740]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g087460	Scaffold_04	22496781	22512247	Q8NFZ3	NLGNY_HUMAN	"Neuroligin-4, Y-linked (Neuroligin Y)"	GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0030054; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"
PGEN_.00g087470	Scaffold_04	22516742	22535205	NA	NA	NA	NA	NA
PGEN_.00g087480	Scaffold_04	22551141	22556464	Q8BGC3	MOT12_MOUSE	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g087490	Scaffold_04	22565292	22572587	NA	NA	NA	NA	NA
PGEN_.00g087500	Scaffold_04	22586725	22648537	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g087510	Scaffold_04	22651661	22691839	Q69Z28	ATS16_MOUSE	A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-)	GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0046872; GO:0048232; GO:1902017	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]
PGEN_.00g087520	Scaffold_04	22699410	22728829	NA	NA	NA	NA	NA
PGEN_.00g087530	Scaffold_04	22744556	22784419	F7J220	SRCR1_PATPE	Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1)	GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]
PGEN_.00g087540	Scaffold_04	22789990	22794536	Q8CIZ5	DMBT1_RAT	Deleted in malignant brain tumors 1 protein (Ebnerin) (Hensin) (Pancrin)	GO:0001530; GO:0001824; GO:0001833; GO:0003677; GO:0005044; GO:0005615; GO:0005737; GO:0006898; GO:0009611; GO:0009617; GO:0009897; GO:0010033; GO:0015031; GO:0016021; GO:0019898; GO:0030154; GO:0030658; GO:0030670; GO:0030858; GO:0031012; GO:0035375; GO:0038187; GO:0042246; GO:0042589; GO:0043152; GO:0043627; GO:0050829; GO:0050830; GO:0061844; GO:0062023; GO:0070891; GO:1904399	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; induction of bacterial agglutination [GO:0043152]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to estrogen [GO:0043627]; response to organic substance [GO:0010033]; response to wounding [GO:0009611]; tissue regeneration [GO:0042246]
PGEN_.00g087550	Scaffold_04	22805215	22841848	NA	NA	NA	NA	NA
PGEN_.00g087560	Scaffold_04	22880001	22888677	NA	NA	NA	NA	NA
PGEN_.00g087570	Scaffold_04	22946087	22951242	NA	NA	NA	NA	NA
PGEN_.00g087580	Scaffold_04	22951331	22951861	NA	NA	NA	NA	NA
PGEN_.00g087590	Scaffold_04	22961924	22963814	NA	NA	NA	NA	NA
PGEN_.00g087600	Scaffold_04	22964929	22972317	NA	NA	NA	NA	NA
PGEN_.00g087610	Scaffold_04	22988064	22988513	NA	NA	NA	NA	NA
PGEN_.00g087620	Scaffold_04	22994690	23018843	NA	NA	NA	NA	NA
PGEN_.00g087630	Scaffold_04	23081926	23084416	NA	NA	NA	NA	NA
PGEN_.00g087640	Scaffold_04	23090003	23102414	NA	NA	NA	NA	NA
PGEN_.00g087650	Scaffold_04	23121408	23124663	NA	NA	NA	NA	NA
PGEN_.00g087660	Scaffold_04	23135637	23137409	NA	NA	NA	NA	NA
PGEN_.00g087670	Scaffold_04	23158974	23159477	NA	NA	NA	NA	NA
PGEN_.00g087680	Scaffold_04	23168676	23207446	Q6P7D4	CP20A_RAT	Cytochrome P450 20A1 (EC 1.14.-.-)	GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037	"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g087690	Scaffold_04	23209560	23230699	NA	NA	NA	NA	NA
PGEN_.00g087700	Scaffold_04	23231121	23265281	Q6UW02	CP20A_HUMAN	Cytochrome P450 20A1 (EC 1.14.-.-)	GO:0004497; GO:0005506; GO:0016020; GO:0016021; GO:0016705; GO:0020037	"integral component of membrane [GO:0016021]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g087710	Scaffold_04	23310022	23319244	Q6P7D4	CP20A_RAT	Cytochrome P450 20A1 (EC 1.14.-.-)	GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037	"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g087720	Scaffold_04	23324359	23354815	NA	NA	NA	NA	NA
PGEN_.00g087730	Scaffold_04	23388259	23399825	Q9I9M5	FZD1_XENLA	Frizzled-1 (Fz-1) (Xfz1)	GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0042813	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275]
PGEN_.00g087740	Scaffold_04	23484681	23484971	NA	NA	NA	NA	NA
PGEN_.00g087750	Scaffold_04	23484997	23485239	NA	NA	NA	NA	NA
PGEN_.00g087760	Scaffold_04	23485299	23485616	NA	NA	NA	NA	NA
PGEN_.00g087770	Scaffold_04	23485648	23486106	NA	NA	NA	NA	NA
PGEN_.00g087780	Scaffold_04	23487748	23505941	O35316	SC6A6_MOUSE	Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6)	GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0005887; GO:0015734; GO:0030977; GO:0042165; GO:0043005; GO:0050804; GO:0098982; GO:0099055	GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; taurine binding [GO:0030977]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369]; modulation of chemical synaptic transmission [GO:0050804]; taurine transport [GO:0015734]
PGEN_.00g087790	Scaffold_04	23517213	23520442	NA	NA	NA	NA	NA
PGEN_.00g087800	Scaffold_04	23525621	23525872	NA	NA	NA	NA	NA
PGEN_.00g087810	Scaffold_04	23549766	23560994	Q9IBG7	KCP_XENLA	Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g087820	Scaffold_04	23565044	23577513	NA	NA	NA	NA	NA
PGEN_.00g087830	Scaffold_04	23582697	23592809	NA	NA	NA	NA	NA
PGEN_.00g087840	Scaffold_04	23595110	23604024	NA	NA	NA	NA	NA
PGEN_.00g087850	Scaffold_04	23621710	23634551	Q9ULI3	HEG1_HUMAN	Protein HEG homolog 1	GO:0001570; GO:0001701; GO:0001886; GO:0001945; GO:0003017; GO:0003209; GO:0003222; GO:0003281; GO:0005509; GO:0005576; GO:0005911; GO:0007043; GO:0007507; GO:0009791; GO:0009897; GO:0016021; GO:0030324; GO:0035024; GO:0035264; GO:0048845; GO:0050878; GO:0055017; GO:0060039; GO:0090271; GO:1902414; GO:1905709; GO:2000299	cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction assembly [GO:0007043]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222]
PGEN_.00g087860	Scaffold_04	23665579	23667354	P0CJ79	ZN888_HUMAN	Zinc finger protein 888	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g087870	Scaffold_04	23671069	23672907	NA	NA	NA	NA	NA
PGEN_.00g087880	Scaffold_04	23691106	23697000	NA	NA	NA	NA	NA
PGEN_.00g087890	Scaffold_04	23699115	23700122	NA	NA	NA	NA	NA
PGEN_.00g087900	Scaffold_04	23700261	23700904	NA	NA	NA	NA	NA
PGEN_.00g087910	Scaffold_04	23715879	23731852	NA	NA	NA	NA	NA
PGEN_.00g087920	Scaffold_04	23733979	23736323	NA	NA	NA	NA	NA
PGEN_.00g087930	Scaffold_04	23748499	23774449	NA	NA	NA	NA	NA
PGEN_.00g087940	Scaffold_04	23768145	23769978	NA	NA	NA	NA	NA
PGEN_.00g087950	Scaffold_04	23781402	23781914	NA	NA	NA	NA	NA
PGEN_.00g087960	Scaffold_04	23803473	23810027	Q8NI99	ANGL6_HUMAN	Angiopoietin-related protein 6 (Angiopoietin-like protein 6) (Angiopoietin-related growth factor) (Angiopoietin-related protein 5)	GO:0001525; GO:0030141; GO:0030154; GO:0062023; GO:0070062	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; secretory granule [GO:0030141]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]
PGEN_.00g087970	Scaffold_04	23819705	23819980	NA	NA	NA	NA	NA
PGEN_.00g087980	Scaffold_04	23820215	23821621	NA	NA	NA	NA	NA
PGEN_.00g087990	Scaffold_04	23823148	23823405	NA	NA	NA	NA	NA
PGEN_.00g088000	Scaffold_04	23831937	23834169	NA	NA	NA	NA	NA
PGEN_.00g088010	Scaffold_04	23835307	23835753	NA	NA	NA	NA	NA
PGEN_.00g088020	Scaffold_04	23835802	23837394	NA	NA	NA	NA	NA
PGEN_.00g088030	Scaffold_04	23869390	23900240	Q9WTS8	FCN1_RAT	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	GO:0001867; GO:0002752; GO:0003823; GO:0005576; GO:0005581; GO:0006956; GO:0007186; GO:0008329; GO:0030246; GO:0031232; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0097367; GO:1902679; GO:2000484	"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of RNA biosynthetic process [GO:1902679]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 secretion [GO:2000484]; recognition of apoptotic cell [GO:0043654]"
PGEN_.00g088040	Scaffold_04	23963967	23964248	NA	NA	NA	NA	NA
PGEN_.00g088050	Scaffold_04	23980684	23988300	NA	NA	NA	NA	NA
PGEN_.00g088060	Scaffold_04	23994325	23994837	NA	NA	NA	NA	NA
PGEN_.00g088070	Scaffold_04	24037708	24038163	NA	NA	NA	NA	NA
PGEN_.00g088080	Scaffold_04	24046311	24048200	NA	NA	NA	NA	NA
PGEN_.00g088090	Scaffold_04	24048269	24076715	NA	NA	NA	NA	NA
PGEN_.00g088100	Scaffold_04	24105908	24134306	B3EWZ3	CADN_ACRMI	Coadhesin (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g088110	Scaffold_04	24166393	24166680	NA	NA	NA	NA	NA
PGEN_.00g088120	Scaffold_04	24171797	24175814	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g088130	Scaffold_04	24189080	24201788	NA	NA	NA	NA	NA
PGEN_.00g088140	Scaffold_04	24215470	24220639	NA	NA	NA	NA	NA
PGEN_.00g088150	Scaffold_04	24254915	24263035	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g088160	Scaffold_04	24266265	24282466	NA	NA	NA	NA	NA
PGEN_.00g088170	Scaffold_04	24287801	24309482	NA	NA	NA	NA	NA
PGEN_.00g088180	Scaffold_04	24322053	24332918	NA	NA	NA	NA	NA
PGEN_.00g088190	Scaffold_04	24365134	24373598	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g088200	Scaffold_04	24379386	24386270	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g088210	Scaffold_04	24391694	24399183	NA	NA	NA	NA	NA
PGEN_.00g088220	Scaffold_04	24434908	24474351	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g088230	Scaffold_04	24488415	24540380	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g088240	Scaffold_04	24544030	24578138	P20740	OVOS_CHICK	Ovostatin (Ovomacroglobulin)	GO:0004867; GO:0005615	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g088250	Scaffold_04	24580296	24589750	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g088260	Scaffold_04	24601572	24609932	Q8R0W6	NFIP1_MOUSE	NEDD4 family-interacting protein 1 (NEDD4 WW domain-binding protein 5)	GO:0002761; GO:0002829; GO:0005576; GO:0005623; GO:0005783; GO:0005794; GO:0005938; GO:0006511; GO:0006879; GO:0007034; GO:0010008; GO:0010629; GO:0016021; GO:0030001; GO:0030054; GO:0030173; GO:0030425; GO:0031398; GO:0032410; GO:0032713; GO:0042130; GO:0045202; GO:0045619; GO:0045732; GO:0048294; GO:0048302; GO:0048471; GO:0050699; GO:0050728; GO:0051224	cell [GO:0005623]; cell cortex [GO:0005938]; cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; WW domain binding [GO:0050699]; cellular iron ion homeostasis [GO:0006879]; metal ion transport [GO:0030001]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of protein transport [GO:0051224]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transporter activity [GO:0032410]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of lymphocyte differentiation [GO:0045619]; regulation of myeloid leukocyte differentiation [GO:0002761]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034]
PGEN_.00g088270	Scaffold_04	24619547	24621627	NA	NA	NA	NA	NA
PGEN_.00g088280	Scaffold_04	24637444	24637797	NA	NA	NA	NA	NA
PGEN_.00g088290	Scaffold_04	24639811	24640221	NA	NA	NA	NA	NA
PGEN_.00g088300	Scaffold_04	24646217	24648755	NA	NA	NA	NA	NA
PGEN_.00g088310	Scaffold_04	24649131	24649448	NA	NA	NA	NA	NA
PGEN_.00g088320	Scaffold_04	24649644	24649958	NA	NA	NA	NA	NA
PGEN_.00g088330	Scaffold_04	24650229	24650516	NA	NA	NA	NA	NA
PGEN_.00g088340	Scaffold_04	24650723	24652526	NA	NA	NA	NA	NA
PGEN_.00g088350	Scaffold_04	24668134	24668409	NA	NA	NA	NA	NA
PGEN_.00g088360	Scaffold_04	24725603	24732780	NA	NA	NA	NA	NA
PGEN_.00g088370	Scaffold_04	24766920	24776047	Q9PTL2	SPY2_CHICK	Protein sprouty homolog 2 (Spry-2)	GO:0005829; GO:0007275; GO:0016020; GO:0040037; GO:0042127; GO:0043407; GO:0045595; GO:0046580; GO:0070373	cytosol [GO:0005829]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]
PGEN_.00g088380	Scaffold_04	24806739	24831831	O60841	IF2P_HUMAN	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)	GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006446; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]
PGEN_.00g088390	Scaffold_04	24865678	24876694	Q05D44	IF2P_MOUSE	Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)	GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0006446; GO:0046872	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]
PGEN_.00g088400	Scaffold_04	24903510	24907486	NA	NA	NA	NA	NA
PGEN_.00g088410	Scaffold_04	24908548	24915013	NA	NA	NA	NA	NA
PGEN_.00g088420	Scaffold_04	24916232	24922238	NA	NA	NA	NA	NA
PGEN_.00g088430	Scaffold_04	24959899	25006130	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g088440	Scaffold_04	25032467	25041468	NA	NA	NA	NA	NA
PGEN_.00g088450	Scaffold_04	25048699	25070536	P86789	GIGA6_CRAGI	Gigasin-6	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g088460	Scaffold_04	25070720	25082216	B9EJ80	PDZD8_MOUSE	PDZ domain-containing protein 8	GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008289; GO:0016021; GO:0022604; GO:0035556; GO:0044233; GO:0046872; GO:0051560; GO:1990456	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604]
PGEN_.00g088470	Scaffold_04	25089416	25090369	Q9QUN7	TLR2_MOUSE	Toll-like receptor 2 (CD antigen CD282)	GO:0001530; GO:0001540; GO:0001774; GO:0001775; GO:0002224; GO:0002238; GO:0002374; GO:0002687; GO:0002730; GO:0002752; GO:0002755; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0006691; GO:0006952; GO:0006954; GO:0007252; GO:0007612; GO:0008285; GO:0008329; GO:0009617; GO:0009897; GO:0009986; GO:0010628; GO:0014005; GO:0030177; GO:0030670; GO:0030837; GO:0031226; GO:0032289; GO:0032493; GO:0032494; GO:0032613; GO:0032640; GO:0032695; GO:0032700; GO:0032722; GO:0032728; GO:0032733; GO:0032735; GO:0032741; GO:0032755; GO:0032757; GO:0032760; GO:0034123; GO:0034134; GO:0035325; GO:0035354; GO:0035355; GO:0042495; GO:0042496; GO:0042497; GO:0042498; GO:0042535; GO:0042802; GO:0042834; GO:0042995; GO:0044297; GO:0044877; GO:0045087; GO:0045121; GO:0045429; GO:0045944; GO:0046209; GO:0046982; GO:0048714; GO:0050715; GO:0050718; GO:0050729; GO:0050765; GO:0050830; GO:0051092; GO:0051770; GO:0051964; GO:0052063; GO:0060907; GO:0070374; GO:0070542; GO:0070891; GO:0071221; GO:0071223; GO:0071224; GO:0071346; GO:0071723; GO:0071726; GO:0071727; GO:1901224; GO:1903974; GO:1904417; GO:1904466; GO:1904469; GO:2000484; GO:2000778	cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; diacyl lipopeptide binding [GO:0042498]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; peptidoglycan binding [GO:0042834]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; signaling pattern recognition receptor activity [GO:0008329]; Toll-like receptor binding [GO:0035325]; triacyl lipopeptide binding [GO:0042497]; cell activation [GO:0001775]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to peptidoglycan [GO:0071224]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; central nervous system myelin formation [GO:0032289]; cytokine secretion involved in immune response [GO:0002374]; defense response [GO:0006952]; defense response to Gram-positive bacterium [GO:0050830]; detection of diacyl bacterial lipopeptide [GO:0042496]; detection of triacyl bacterial lipopeptide [GO:0042495]; I-kappaB phosphorylation [GO:0007252]; induction by symbiont of defense-related host nitric oxide production [GO:0052063]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-10 production [GO:0032613]; learning [GO:0007612]; leukotriene metabolic process [GO:0006691]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of phagocytosis [GO:0050765]; negative regulation of synapse assembly [GO:0051964]; nitric oxide metabolic process [GO:0046209]; positive regulation of cellular response to macrophage colony-stimulating factor stimulus [GO:1903974]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of xenophagy [GO:1904417]; regulation of dendritic cell cytokine production [GO:0002730]; response to bacterial lipoprotein [GO:0032493]; response to bacterium [GO:0009617]; response to fatty acid [GO:0070542]; response to molecule of fungal origin [GO:0002238]; response to peptidoglycan [GO:0032494]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor production [GO:0032640]
PGEN_.00g088480	Scaffold_04	25090552	25091772	NA	NA	NA	NA	NA
PGEN_.00g088490	Scaffold_04	25092033	25117623	Q8NEN9	PDZD8_HUMAN	PDZ domain-containing protein 8 (Sarcoma antigen NY-SAR-84/NY-SAR-104)	GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008289; GO:0016020; GO:0016021; GO:0016032; GO:0022604; GO:0035556; GO:0044233; GO:0046872; GO:0051560; GO:1990456	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604]; viral process [GO:0016032]
PGEN_.00g088500	Scaffold_04	25150891	25178247	O70511	ANK3_RAT	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045838; GO:0050808; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g088510	Scaffold_04	25197117	25204953	O08997	ATOX1_MOUSE	Copper transport protein ATOX1 (Metal transport protein ATX1)	GO:0005507; GO:0005623; GO:0005829; GO:0006825; GO:0006878; GO:0006979; GO:0016531; GO:0032767; GO:0043066; GO:0051117; GO:0060003	cell [GO:0005623]; cytosol [GO:0005829]; ATPase binding [GO:0051117]; copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; copper-dependent protein binding [GO:0032767]; cellular copper ion homeostasis [GO:0006878]; copper ion export [GO:0060003]; copper ion transport [GO:0006825]; negative regulation of apoptotic process [GO:0043066]; response to oxidative stress [GO:0006979]
PGEN_.00g088520	Scaffold_04	25215619	25237596	A5A6P2	ASAH1_PANTR	Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta]	GO:0005615; GO:0005764; GO:0016810; GO:0017040; GO:0030216; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356; GO:0102121	"extracellular space [GO:0005615]; lysosome [GO:0005764]; ceramidase activity [GO:0102121]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-acylsphingosine amidohydrolase activity [GO:0017040]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]"
PGEN_.00g088530	Scaffold_04	25241131	25259397	A5A6P2	ASAH1_PANTR	Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta]	GO:0005615; GO:0005764; GO:0016810; GO:0017040; GO:0030216; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356; GO:0102121	"extracellular space [GO:0005615]; lysosome [GO:0005764]; ceramidase activity [GO:0102121]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-acylsphingosine amidohydrolase activity [GO:0017040]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]"
PGEN_.00g088540	Scaffold_04	25260388	25288187	Q96M20	CNBD2_HUMAN	Cyclic nucleotide-binding domain-containing protein 2	GO:0005829; GO:0007283; GO:0030552	cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
PGEN_.00g088550	Scaffold_04	25395523	25405925	NA	NA	NA	NA	NA
PGEN_.00g088560	Scaffold_04	25425485	25432617	NA	NA	NA	NA	NA
PGEN_.00g088570	Scaffold_04	25437562	25441408	NA	NA	NA	NA	NA
PGEN_.00g088580	Scaffold_04	25450200	25452171	NA	NA	NA	NA	NA
PGEN_.00g088590	Scaffold_04	25456447	25477609	Q9WVS9	CLOCK_RAT	Circadian locomoter output cycles protein kaput (rCLOCK) (EC 2.3.1.48)	GO:0000077; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0004402; GO:0005634; GO:0005667; GO:0005694; GO:0005726; GO:0005730; GO:0005737; GO:0005791; GO:0005829; GO:0006355; GO:0006473; GO:0007283; GO:0007565; GO:0007623; GO:0009416; GO:0009649; GO:0031490; GO:0032922; GO:0033391; GO:0042634; GO:0042752; GO:0043161; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050729; GO:0050796; GO:0051092; GO:0051775; GO:0070888; GO:0071479; GO:2000074; GO:2000323	"chromatoid body [GO:0033391]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; rough endoplasmic reticulum [GO:0005791]; transcription factor complex [GO:0005667]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone acetyltransferase activity [GO:0004402]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to ionizing radiation [GO:0071479]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage checkpoint [GO:0000077]; entrainment of circadian clock [GO:0009649]; female pregnancy [GO:0007565]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein acetylation [GO:0006473]; regulation of circadian rhythm [GO:0042752]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to light stimulus [GO:0009416]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]"
PGEN_.00g088600	Scaffold_04	25492697	25508037	Q9NYB0	TE2IP_HUMAN	Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Dopamine receptor-interacting protein 5) (Repressor/activator protein 1 homolog) (RAP1 homolog) (hRap1)	GO:0000228; GO:0000723; GO:0000781; GO:0000783; GO:0000784; GO:0001933; GO:0003677; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0007004; GO:0010569; GO:0010833; GO:0016233; GO:0016604; GO:0019902; GO:0031848; GO:0032204; GO:0032205; GO:0033138; GO:0042162; GO:0043123; GO:0048239; GO:0051092; GO:0070187; GO:0070198; GO:0098505; GO:1901224; GO:1901985	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; DNA binding [GO:0003677]; G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; telomeric DNA binding [GO:0042162]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of telomere maintenance [GO:0032204]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomere maintenance via telomere lengthening [GO:0010833]"
PGEN_.00g088610	Scaffold_04	25513515	25602757	Q9Y2Q0	AT8A1_HUMAN	Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1)	GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006869; GO:0007612; GO:0016020; GO:0016021; GO:0016887; GO:0019829; GO:0022857; GO:0030335; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0043231; GO:0043312; GO:0045332; GO:0055085; GO:0061092; GO:0070062; GO:0140327	azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; flippase activity [GO:0140327]; magnesium ion binding [GO:0000287]; transmembrane transporter activity [GO:0022857]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; lipid transport [GO:0006869]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; transmembrane transport [GO:0055085]
PGEN_.00g088620	Scaffold_04	25614910	25621214	Q9R9I9	MYCC_BACIU	Mycosubtilin synthase subunit C (EC 2.3.1.-) [Includes: ATP-dependent serine adenylase (SerA) (Serine activase); ATP-dependent asparagine adenylase 3 (AsnA 3) (Asparagine activase 3)]	GO:0016740; GO:0016788; GO:0017000	"hydrolase activity, acting on ester bonds [GO:0016788]; transferase activity [GO:0016740]; antibiotic biosynthetic process [GO:0017000]"
PGEN_.00g088630	Scaffold_04	25621879	25635541	Q6GDV6	Y2567_STAAR	Uncharacterized oxidoreductase SAR2567 (EC 1.-.-.-)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g088640	Scaffold_04	25660594	25667296	Q49WS9	Y1627_STAS1	Uncharacterized oxidoreductase SSP1627 (EC 1.-.-.-)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g088650	Scaffold_04	25667935	25674933	NA	NA	NA	NA	NA
PGEN_.00g088660	Scaffold_04	25674990	25688791	Q8BYM8	SYCM_MOUSE	"Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	GO:0004817; GO:0005524; GO:0005737; GO:0005759; GO:0006423; GO:0046872	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]
PGEN_.00g088670	Scaffold_04	25698913	25764936	Q6IFT6	ANO7_RAT	Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)	GO:0005229; GO:0005634; GO:0005783; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0061589; GO:0061590; GO:0061591	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transport [GO:0006821]
PGEN_.00g088680	Scaffold_04	25747105	25747425	NA	NA	NA	NA	NA
PGEN_.00g088690	Scaffold_04	25774124	25818276	A0JM13	C2CD3_XENTR	C2 domain-containing protein 3	GO:0005737; GO:0005814; GO:0005929; GO:0034451; GO:0061511; GO:0071539; GO:1905515	centriolar satellite [GO:0034451]; centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; centriole elongation [GO:0061511]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]
PGEN_.00g088700	Scaffold_04	25833248	25838606	NA	NA	NA	NA	NA
PGEN_.00g088710	Scaffold_04	25851960	25886978	Q7T163	KDISB_DANRE	Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B)	GO:0005770; GO:0007399; GO:0016021; GO:0019887; GO:0030165; GO:0031902	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; nervous system development [GO:0007399]
PGEN_.00g088720	Scaffold_04	25896734	25907562	Q8VDL9	GLIS2_MOUSE	Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein) (Zinc finger protein GLI5)	GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007417; GO:0016607; GO:0043433; GO:0044212; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0060994; GO:0061005; GO:0097730; GO:1900182	"cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; cell differentiation involved in kidney development [GO:0061005]; central nervous system development [GO:0007417]; kidney development [GO:0001822]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in kidney development [GO:0060994]"
PGEN_.00g088730	Scaffold_04	25938922	25977800	Q8R4D5	TRPM8_MOUSE	Transient receptor potential cation channel subfamily M member 8 (Long transient receptor potential channel 6) (LTrpC-6) (LTrpC6) (Transient receptor potential p8) (Trp-p8)	GO:0005216; GO:0005262; GO:0005623; GO:0005886; GO:0006816; GO:0006874; GO:0009266; GO:0009409; GO:0009897; GO:0016020; GO:0016021; GO:0016048; GO:0042802; GO:0045121; GO:0050955; GO:0120162	cell [GO:0005623]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; detection of temperature stimulus [GO:0016048]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266]; thermoception [GO:0050955]
PGEN_.00g088740	Scaffold_04	25985576	25991882	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g088750	Scaffold_04	26010349	26014085	NA	NA	NA	NA	NA
PGEN_.00g088760	Scaffold_04	26029067	26052003	NA	NA	NA	NA	NA
PGEN_.00g088770	Scaffold_04	26062074	26073005	NA	NA	NA	NA	NA
PGEN_.00g088780	Scaffold_04	26084054	26111428	P18173	DHGL_DROME	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"
PGEN_.00g088790	Scaffold_04	26130289	26130570	NA	NA	NA	NA	NA
PGEN_.00g088800	Scaffold_04	26135143	26142806	Q08BN9	NXPE3_DANRE	NXPE family member 3 (Protein FAM55C)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g088810	Scaffold_04	26150148	26153469	NA	NA	NA	NA	NA
PGEN_.00g088820	Scaffold_04	26167364	26180728	P24524	GLRA3_RAT	Glycine receptor subunit alpha-3	GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0097688; GO:0098690; GO:0098978; GO:0098982; GO:0099060; GO:1902476; GO:2000300	"cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g088830	Scaffold_04	26203106	26241657	Q91XP5	GLRA3_MOUSE	Glycine receptor subunit alpha-3	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0097688; GO:0098690; GO:0098978; GO:0098982; GO:0099060; GO:1902476; GO:2000300	"cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g088840	Scaffold_04	26292792	26299292	NA	NA	NA	NA	NA
PGEN_.00g088850	Scaffold_04	26297842	26303854	NA	NA	NA	NA	NA
PGEN_.00g088860	Scaffold_04	26324786	26332554	NA	NA	NA	NA	NA
PGEN_.00g088870	Scaffold_04	26348143	26349968	NA	NA	NA	NA	NA
PGEN_.00g088880	Scaffold_04	26356592	26359261	NA	NA	NA	NA	NA
PGEN_.00g088890	Scaffold_04	26465615	26518672	Q38PU8	GRIA1_MACFA	"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)"	GO:0004971; GO:0005789; GO:0014069; GO:0030054; GO:0030425; GO:0031901; GO:0032281; GO:0043197; GO:0055038; GO:0098839	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; AMPA glutamate receptor activity [GO:0004971]
PGEN_.00g088900	Scaffold_04	26529182	26536736	NA	NA	NA	NA	NA
PGEN_.00g088910	Scaffold_04	26573434	26656444	P39087	GRIK2_MOUSE	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Glutamate receptor beta-2) (GluR beta-2)"	GO:0001662; GO:0004970; GO:0005234; GO:0005623; GO:0005886; GO:0005887; GO:0006874; GO:0006886; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0016020; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060079; GO:0060080; GO:0098686; GO:0098794; GO:0098839; GO:0098978; GO:0099507; GO:1904315	"axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g088920	Scaffold_04	26693083	26694006	NA	NA	NA	NA	NA
PGEN_.00g088930	Scaffold_04	26694211	26694576	NA	NA	NA	NA	NA
PGEN_.00g088940	Scaffold_04	26705671	26707143	NA	NA	NA	NA	NA
PGEN_.00g088950	Scaffold_04	26738897	26768370	Q502W6	VWA3B_HUMAN	von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B)	GO:0005654; GO:0005829	cytosol [GO:0005829]; nucleoplasm [GO:0005654]
PGEN_.00g088960	Scaffold_04	26777528	26803413	NA	NA	NA	NA	NA
PGEN_.00g088970	Scaffold_04	26804792	26805124	NA	NA	NA	NA	NA
PGEN_.00g088980	Scaffold_04	26812676	26834428	F1QXD3	ZDH15_DANRE	Palmitoyltransferase ZDHHC15B (EC 2.3.1.225)	GO:0005783; GO:0005794; GO:0006612; GO:0008270; GO:0018230; GO:0019706; GO:0030173; GO:0030900; GO:0045234; GO:0071542	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; zinc ion binding [GO:0008270]; dopaminergic neuron differentiation [GO:0071542]; forebrain development [GO:0030900]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoleylation [GO:0045234]; protein targeting to membrane [GO:0006612]
PGEN_.00g088990	Scaffold_04	26850398	26866768	Q6GQI7	MGT4A_XENLA	"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa) (GlcNAc-T IVa) (GnT-IVa) (N-acetylglucosaminyltransferase IVa) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVa)"	GO:0000139; GO:0006486; GO:0008454; GO:0016021; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486]"
PGEN_.00g089000	Scaffold_04	26876994	26882501	NA	NA	NA	NA	NA
PGEN_.00g089010	Scaffold_04	26907773	26908411	NA	NA	NA	NA	NA
PGEN_.00g089020	Scaffold_04	26915316	26936414	O94762	RECQ5_HUMAN	"ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5)"	GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0032508; GO:0034244; GO:0042802; GO:0051301; GO:0051304; GO:0072757; GO:1990414; GO:2000042	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]"
PGEN_.00g089030	Scaffold_04	26940691	26953216	P49446	PTPRE_MOUSE	Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48)	GO:0004725; GO:0005634; GO:0005737; GO:0005886; GO:0006470; GO:0007185; GO:0016021; GO:0033003; GO:0042803; GO:0046627	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]
PGEN_.00g089040	Scaffold_04	26960361	26980818	Q6DIB5	MEG10_MOUSE	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g089050	Scaffold_04	27041933	27053417	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g089060	Scaffold_04	27059966	27081032	NA	NA	NA	NA	NA
PGEN_.00g089070	Scaffold_04	27083560	27096166	NA	NA	NA	NA	NA
PGEN_.00g089080	Scaffold_04	27123229	27126021	NA	NA	NA	NA	NA
PGEN_.00g089090	Scaffold_04	27147778	27158838	NA	NA	NA	NA	NA
PGEN_.00g089100	Scaffold_04	27160898	27161200	NA	NA	NA	NA	NA
PGEN_.00g089110	Scaffold_04	27167998	27168459	NA	NA	NA	NA	NA
PGEN_.00g089120	Scaffold_04	27168531	27169163	NA	NA	NA	NA	NA
PGEN_.00g089130	Scaffold_04	27205188	27219842	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g089140	Scaffold_04	27222580	27222891	NA	NA	NA	NA	NA
PGEN_.00g089150	Scaffold_04	27232095	27233849	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g089160	Scaffold_04	27250647	27328950	O54834	RHG06_MOUSE	Rho GTPase-activating protein 6 (Rho-type GTPase-activating protein 6) (Rho-type GTPase-activating protein RhoGAPX-1)	GO:0005096; GO:0005737; GO:0005829; GO:0007015; GO:0007165; GO:0007202; GO:0010518; GO:0015629; GO:0016004; GO:0017124; GO:0043087; GO:0043274; GO:0043547; GO:0048041; GO:0051497; GO:0051895	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]
PGEN_.00g089170	Scaffold_04	27351326	27352309	NA	NA	NA	NA	NA
PGEN_.00g089180	Scaffold_04	27379068	27396545	NA	NA	NA	NA	NA
PGEN_.00g089190	Scaffold_04	27413479	27415196	NA	NA	NA	NA	NA
PGEN_.00g089200	Scaffold_04	27415506	27416987	A0RQR9	HLDE_CAMFF	Bifunctional protein HldE [Includes: D-beta-D-heptose 7-phosphate kinase (EC 2.7.1.167) (D-beta-D-heptose 7-phosphotransferase) (D-glycero-beta-D-manno-heptose-7-phosphate kinase); D-beta-D-heptose 1-phosphate adenylyltransferase (EC 2.7.7.70) (D-glycero-beta-D-manno-heptose 1-phosphate adenylyltransferase)]	GO:0005524; GO:0016773; GO:0033785; GO:0033786; GO:0097171	"ATP binding [GO:0005524]; heptose 7-phosphate kinase activity [GO:0033785]; heptose-1-phosphate adenylyltransferase activity [GO:0033786]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; ADP-L-glycero-beta-D-manno-heptose biosynthetic process [GO:0097171]"
PGEN_.00g089210	Scaffold_04	27419074	27420549	A0RQR9	HLDE_CAMFF	Bifunctional protein HldE [Includes: D-beta-D-heptose 7-phosphate kinase (EC 2.7.1.167) (D-beta-D-heptose 7-phosphotransferase) (D-glycero-beta-D-manno-heptose-7-phosphate kinase); D-beta-D-heptose 1-phosphate adenylyltransferase (EC 2.7.7.70) (D-glycero-beta-D-manno-heptose 1-phosphate adenylyltransferase)]	GO:0005524; GO:0016773; GO:0033785; GO:0033786; GO:0097171	"ATP binding [GO:0005524]; heptose 7-phosphate kinase activity [GO:0033785]; heptose-1-phosphate adenylyltransferase activity [GO:0033786]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; ADP-L-glycero-beta-D-manno-heptose biosynthetic process [GO:0097171]"
PGEN_.00g089220	Scaffold_04	27539960	27550720	O60494	CUBN_HUMAN	Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]
PGEN_.00g089230	Scaffold_04	27581928	27593894	Q7Z408	CSMD2_HUMAN	CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2)	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g089240	Scaffold_04	27606317	27606823	NA	NA	NA	NA	NA
PGEN_.00g089250	Scaffold_04	27606877	27607230	NA	NA	NA	NA	NA
PGEN_.00g089260	Scaffold_04	27607268	27607651	NA	NA	NA	NA	NA
PGEN_.00g089270	Scaffold_04	27619086	27629623	Q4A3R3	DMBT1_PIG	Deleted in malignant brain tumors 1 protein (Hensin)	GO:0005044; GO:0007275; GO:0009897; GO:0015031; GO:0016021; GO:0019898; GO:0030154; GO:0030658; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830	external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]
PGEN_.00g089280	Scaffold_04	27645911	27665240	B7Z0W9	OTOP_DROME	Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)	GO:0005886; GO:0015252; GO:0016021; GO:1902600	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]
PGEN_.00g089290	Scaffold_04	27672606	27679772	Q4KLI9	FBXW5_RAT	F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5)	GO:0005737; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; protein kinase binding [GO:0019901]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g089300	Scaffold_04	27684513	27687434	Q3ZCK8	COA5_BOVIN	Cytochrome c oxidase assembly factor 5	GO:0005739; GO:0033617	mitochondrion [GO:0005739]; mitochondrial respiratory chain complex IV assembly [GO:0033617]
PGEN_.00g089310	Scaffold_04	27687672	27711036	Q4R628	KIF3A_MACFA	Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)	GO:0003777; GO:0005524; GO:0005737; GO:0005814; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0010457; GO:0034454; GO:0060271	centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]
PGEN_.00g089320	Scaffold_04	27718217	27737367	B3DL84	PLK4_XENTR	Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase Sak)	GO:0000278; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0032465; GO:0046601; GO:0098535; GO:0098536	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; mitotic cell cycle [GO:0000278]; positive regulation of centriole replication [GO:0046601]; regulation of cytokinesis [GO:0032465]
PGEN_.00g089330	Scaffold_04	27747155	27789565	Q8AV28	PCM1_CHICK	Pericentriolar material 1 protein (PCM-1)	GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0034451; GO:0034454; GO:0035735; GO:0036064; GO:0060271; GO:0071539; GO:0090316	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]
PGEN_.00g089340	Scaffold_04	27796825	27801673	Q9CQP2	TPPC2_MOUSE	Trafficking protein particle complex subunit 2 (Sedlin)	GO:0001501; GO:0005634; GO:0005654; GO:0005783; GO:0005793; GO:0006355; GO:0006888; GO:0008134; GO:0030008; GO:0043231; GO:0044325; GO:0048471	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; ion channel binding [GO:0044325]; transcription factor binding [GO:0008134]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]"
PGEN_.00g089350	Scaffold_04	27810037	27824312	Q2LD37	K1109_HUMAN	Transmembrane protein KIAA1109 (Fragile site-associated protein)	GO:0001558; GO:0005634; GO:0016020; GO:0016021; GO:0030856; GO:0048488; GO:0098793	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g089360	Scaffold_04	27868089	27871274	O75973	C1QRF_HUMAN	C1q-related factor (C1q and tumor necrosis factor-related protein 14) (C1q/TNF-related protein 14) (Complement component 1 Q subcomponent-like 1)	GO:0005102; GO:0005581; GO:0005737; GO:0007626; GO:0016322; GO:0043083; GO:0044301; GO:0061743; GO:0098793; GO:0099558	climbing fiber [GO:0044301]; collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; presynapse [GO:0098793]; synaptic cleft [GO:0043083]; signaling receptor binding [GO:0005102]; locomotory behavior [GO:0007626]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; neuron remodeling [GO:0016322]
PGEN_.00g089370	Scaffold_04	27874757	27930228	A2AAE1	K1109_MOUSE	Transmembrane protein KIAA1109 (Fragile site-associated protein homolog)	GO:0001558; GO:0005634; GO:0006629; GO:0007283; GO:0016021; GO:0019915; GO:0045444; GO:0048488; GO:0051647; GO:0060612; GO:0098793	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; presynapse [GO:0098793]; adipose tissue development [GO:0060612]; fat cell differentiation [GO:0045444]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; nucleus localization [GO:0051647]; regulation of cell growth [GO:0001558]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g089380	Scaffold_04	27939292	27946483	Q14BP6	LR74B_MOUSE	Leucine-rich repeat-containing protein 74B		
PGEN_.00g089390	Scaffold_04	27990063	28003451	NA	NA	NA	NA	NA
PGEN_.00g089400	Scaffold_04	28006085	28015538	NA	NA	NA	NA	NA
PGEN_.00g089410	Scaffold_04	28015671	28017012	NA	NA	NA	NA	NA
PGEN_.00g089420	Scaffold_04	28024954	28041614	NA	NA	NA	NA	NA
PGEN_.00g089430	Scaffold_04	28051332	28065676	NA	NA	NA	NA	NA
PGEN_.00g089440	Scaffold_04	28068601	28091255	NA	NA	NA	NA	NA
PGEN_.00g089450	Scaffold_04	28096741	28104371	NA	NA	NA	NA	NA
PGEN_.00g089460	Scaffold_04	28111649	28114870	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g089470	Scaffold_04	28132850	28136375	NA	NA	NA	NA	NA
PGEN_.00g089480	Scaffold_04	28140021	28151728	R9UTQ8	PROHY_STRGD	L-proline trans-4-hydroxylase (P4H) (EC 1.14.11.57)	GO:0005506; GO:0016706; GO:0016999; GO:0017000	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]
PGEN_.00g089490	Scaffold_04	28152847	28153332	NA	NA	NA	NA	NA
PGEN_.00g089500	Scaffold_04	28158801	28159190	NA	NA	NA	NA	NA
PGEN_.00g089510	Scaffold_04	28159483	28159716	NA	NA	NA	NA	NA
PGEN_.00g089520	Scaffold_04	28177946	28208935	NA	NA	NA	NA	NA
PGEN_.00g089530	Scaffold_04	28215475	28217567	P55918	MFAP4_BOVIN	Microfibril-associated glycoprotein 4 (36 kDa microfibril-associated glycoprotein) (36 kDa MAP)	GO:0001527; GO:0007155; GO:0009650; GO:0010712; GO:0048251; GO:0062023; GO:0071493; GO:0071953	collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; microfibril [GO:0001527]; cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; UV protection [GO:0009650]
PGEN_.00g089540	Scaffold_04	28221186	28237644	NA	NA	NA	NA	NA
PGEN_.00g089550	Scaffold_04	28265075	28265779	NA	NA	NA	NA	NA
PGEN_.00g089560	Scaffold_04	28271352	28272431	NA	NA	NA	NA	NA
PGEN_.00g089570	Scaffold_04	28286224	28295530	Q9HC56	PCDH9_HUMAN	Protocadherin-9	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291	cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g089580	Scaffold_04	28398462	28418982	Q9HC56	PCDH9_HUMAN	Protocadherin-9	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291	cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g089590	Scaffold_04	28515691	28521483	NA	NA	NA	NA	NA
PGEN_.00g089600	Scaffold_04	28744932	28770517	Q6X862	PC11X_GORGO	Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome)	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0010923	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g089610	Scaffold_04	28819850	28840371	Q9HC56	PCDH9_HUMAN	Protocadherin-9	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291	cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g089620	Scaffold_04	28913451	28918128	NA	NA	NA	NA	NA
PGEN_.00g089630	Scaffold_04	28928444	28935135	Q9GKT2	FXDC2_MACFA	Fatty acid hydroxylase domain-containing protein 2	GO:0001934; GO:0005506; GO:0005737; GO:0008610; GO:0016021; GO:0016491; GO:0045654	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; lipid biosynthetic process [GO:0008610]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]
PGEN_.00g089640	Scaffold_04	28942422	28952725	Q9GKT2	FXDC2_MACFA	Fatty acid hydroxylase domain-containing protein 2	GO:0001934; GO:0005506; GO:0005737; GO:0008610; GO:0016021; GO:0016491; GO:0045654	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; lipid biosynthetic process [GO:0008610]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]
PGEN_.00g089650	Scaffold_04	28967624	28971665	NA	NA	NA	NA	NA
PGEN_.00g089660	Scaffold_04	28980143	28983360	NA	NA	NA	NA	NA
PGEN_.00g089670	Scaffold_04	29047295	29076366	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g089680	Scaffold_04	29132781	29133185	NA	NA	NA	NA	NA
PGEN_.00g089690	Scaffold_04	29301129	29328594	P23416	GLRA2_HUMAN	Glycine receptor subunit alpha-2	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315	"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g089700	Scaffold_04	29336924	29339774	P35440	TSP2_CHICK	Thrombospondin-2	GO:0005509; GO:0007155; GO:0008201; GO:0016525; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]
PGEN_.00g089710	Scaffold_04	29344552	29345430	NA	NA	NA	NA	NA
PGEN_.00g089720	Scaffold_04	29346529	29351834	P35442	TSP2_HUMAN	Thrombospondin-2	GO:0005509; GO:0005576; GO:0005604; GO:0007155; GO:0008201; GO:0016525; GO:0031091; GO:0051965; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965]
PGEN_.00g089730	Scaffold_04	29358661	29358933	NA	NA	NA	NA	NA
PGEN_.00g089740	Scaffold_04	29366099	29367283	B3EWZ3	CADN_ACRMI	Coadhesin (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g089750	Scaffold_04	29371225	29380281	NA	NA	NA	NA	NA
PGEN_.00g089760	Scaffold_04	29381168	29385982	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g089770	Scaffold_04	29395700	29402973	Q645M6	FADD_BOVIN	FAS-associated death domain protein (FAS-associating death domain-containing protein) (Protein FADD)	GO:0001916; GO:0002821; GO:0005123; GO:0005737; GO:0006915; GO:0031265; GO:0032729; GO:0032757; GO:0032760; GO:0033077; GO:0035877; GO:0036462; GO:0042104; GO:0042802; GO:0043029; GO:0043123; GO:0045087; GO:0045651; GO:0045944; GO:0048535; GO:0048536; GO:0048538; GO:0051607; GO:0060340; GO:0060546; GO:0070236; GO:0071260; GO:0089720; GO:0097049; GO:0097192; GO:0097202; GO:0097342; GO:0097527; GO:2000454; GO:2001238	"CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; ripoptosome [GO:0097342]; caspase binding [GO:0089720]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; innate immune response [GO:0045087]; lymph node development [GO:0048535]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of activation-induced cell death of T cells [GO:0070236]; negative regulation of necroptotic process [GO:0060546]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation [GO:2000454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"
PGEN_.00g089780	Scaffold_04	29421201	29428672	NA	NA	NA	NA	NA
PGEN_.00g089790	Scaffold_04	29438015	29441585	Q9QZN3	FBX8_MOUSE	F-box only protein 8	GO:0000151; GO:0005086; GO:0006511; GO:0032012	ubiquitin ligase complex [GO:0000151]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; regulation of ARF protein signal transduction [GO:0032012]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g089800	Scaffold_04	29448250	29448711	NA	NA	NA	NA	NA
PGEN_.00g089810	Scaffold_04	29459039	29463759	Q02040	AK17A_HUMAN	"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)"	GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]"
PGEN_.00g089820	Scaffold_04	29465352	29481415	Q5ZM11	SYRC_CHICK	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	GO:0004814; GO:0005524; GO:0005829; GO:0006420; GO:0017101	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]
PGEN_.00g089830	Scaffold_04	29528916	29530787	NA	NA	NA	NA	NA
PGEN_.00g089840	Scaffold_04	29578776	29591859	Q6P1S4	SYRC_XENTR	"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	GO:0004814; GO:0005524; GO:0005829; GO:0006420; GO:0017101	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]
PGEN_.00g089850	Scaffold_04	29640609	29643308	NA	NA	NA	NA	NA
PGEN_.00g089860	Scaffold_04	29647412	29672260	Q9P2G9	KLHL8_HUMAN	Kelch-like protein 8	GO:0005654; GO:0006511; GO:0016567; GO:0031463	Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g089870	Scaffold_04	29680024	29687411	O95671	ASML_HUMAN	Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)]	GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0035529; GO:0047429	cytosol [GO:0005829]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]
PGEN_.00g089880	Scaffold_04	29742897	29750793	NA	NA	NA	NA	NA
PGEN_.00g089890	Scaffold_04	29755354	29760190	NA	NA	NA	NA	NA
PGEN_.00g089900	Scaffold_04	29773838	29815968	Q86XS8	GOLI_HUMAN	E3 ubiquitin-protein ligase RNF130 (EC 2.3.2.27) (Goliath homolog) (H-Goliath) (RING finger protein 130) (RING-type E3 ubiquitin transferase RNF130)	GO:0004842; GO:0005737; GO:0006511; GO:0006915; GO:0012501; GO:0016021; GO:0046872; GO:0061630	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; programmed cell death [GO:0012501]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g089910	Scaffold_04	29822764	29836549	NA	NA	NA	NA	NA
PGEN_.00g089920	Scaffold_04	29840902	29843750	O70277	TRIM3_RAT	Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22)	GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0043161; GO:0061630; GO:0098794; GO:0098978	cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]
PGEN_.00g089930	Scaffold_04	29852376	29865020	Q9Y2Z0	SGT1_HUMAN	Protein SGT1 homolog (Protein 40-6-3) (Sgt1) (Suppressor of G2 allele of SKP1 homolog)	GO:0000151; GO:0000278; GO:0000776; GO:0005634; GO:0005829; GO:0031647; GO:0032991; GO:0043947; GO:0050821	cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; mitotic cell cycle [GO:0000278]; positive regulation by host of symbiont catalytic activity [GO:0043947]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]
PGEN_.00g089940	Scaffold_04	29873720	29878201	Q9VXN2	SUN_DROME	Protein stunted	GO:0000275; GO:0001664; GO:0005615; GO:0005743; GO:0006979; GO:0008340; GO:0015986; GO:0045745; GO:0046933; GO:1902600	"extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; G protein-coupled receptor binding [GO:0001664]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proton transmembrane transport [GO:1902600]; response to oxidative stress [GO:0006979]"
PGEN_.00g089950	Scaffold_04	29879098	29887046	Q96IZ5	RBM41_HUMAN	RNA-binding protein 41 (RNA-binding motif protein 41)	GO:0003723	RNA binding [GO:0003723]
PGEN_.00g089960	Scaffold_04	29889069	29907327	Q3LSS0	C19L2_DANRE	CWF19-like protein 2	GO:0000398; GO:0071014	"post-mRNA release spliceosomal complex [GO:0071014]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g089970	Scaffold_04	29907513	29922155	Q3SWZ4	EXOS9_BOVIN	Exosome complex component RRP45 (Exosome component 9)	GO:0000176; GO:0000177; GO:0000178; GO:0000228; GO:0000467; GO:0003723; GO:0005654; GO:0005730; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"
PGEN_.00g089980	Scaffold_04	29928266	29935562	P04962	CCNA_SPISO	G2/mitotic-specific cyclin-A	GO:0005634; GO:0007049; GO:0051301	nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g089990	Scaffold_04	29946039	29946820	NA	NA	NA	NA	NA
PGEN_.00g090000	Scaffold_04	29967158	29978331	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g090010	Scaffold_04	29986484	29998842	P24524	GLRA3_RAT	Glycine receptor subunit alpha-3	GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030054; GO:0030425; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0097688; GO:0098690; GO:0098978; GO:0098982; GO:0099060; GO:1902476; GO:2000300	"cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g090020	Scaffold_04	30004000	30004848	NA	NA	NA	NA	NA
PGEN_.00g090030	Scaffold_04	30013000	30015729	NA	NA	NA	NA	NA
PGEN_.00g090040	Scaffold_04	30017151	30017750	NA	NA	NA	NA	NA
PGEN_.00g090050	Scaffold_04	30019780	30046609	Q7TNC8	GLRA2_MOUSE	Glycine receptor subunit alpha-2	GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315	"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g090060	Scaffold_04	30053634	30054632	Q501J6	DDX17_MOUSE	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17)	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006364; GO:0010586; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:0061614; GO:1990904; GO:2001014	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rRNA processing [GO:0006364]"
PGEN_.00g090070	Scaffold_04	30056829	30062850	NA	NA	NA	NA	NA
PGEN_.00g090080	Scaffold_04	30066811	30070431	NA	NA	NA	NA	NA
PGEN_.00g090090	Scaffold_04	30072998	30074348	NA	NA	NA	NA	NA
PGEN_.00g090100	Scaffold_04	30086854	30113817	O88917	AGRL1_RAT	Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1)	GO:0004930; GO:0005886; GO:0005887; GO:0007157; GO:0007166; GO:0007189; GO:0007420; GO:0014069; GO:0015643; GO:0016524; GO:0030054; GO:0030246; GO:0030424; GO:0030426; GO:0035584; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0051965; GO:0090129; GO:0098978; GO:0099056	axon [GO:0030424]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; toxic substance binding [GO:0015643]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]
PGEN_.00g090110	Scaffold_04	30132791	30138026	NA	NA	NA	NA	NA
PGEN_.00g090120	Scaffold_04	30202146	30202733	NA	NA	NA	NA	NA
PGEN_.00g090130	Scaffold_04	30202842	30203285	NA	NA	NA	NA	NA
PGEN_.00g090140	Scaffold_04	30285246	30286714	NA	NA	NA	NA	NA
PGEN_.00g090150	Scaffold_04	30305768	30313293	Q7RTY1	MOT9_HUMAN	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g090160	Scaffold_04	30321645	30327523	NA	NA	NA	NA	NA
PGEN_.00g090170	Scaffold_04	30327926	30346527	Q8K482	EMIL2_MOUSE	EMILIN-2 (Basilin) (Elastin microfibril interface-located protein 2) (Elastin microfibril interfacer 2)	GO:0005576; GO:0005581; GO:0005615; GO:0007155; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]
PGEN_.00g090180	Scaffold_04	30349946	30351036	NA	NA	NA	NA	NA
PGEN_.00g090190	Scaffold_04	30351084	30351392	NA	NA	NA	NA	NA
PGEN_.00g090200	Scaffold_04	30351504	30364895	NA	NA	NA	NA	NA
PGEN_.00g090210	Scaffold_04	30365281	30368185	NA	NA	NA	NA	NA
PGEN_.00g090220	Scaffold_04	30377421	30380180	NA	NA	NA	NA	NA
PGEN_.00g090230	Scaffold_04	30404333	30417979	NA	NA	NA	NA	NA
PGEN_.00g090240	Scaffold_04	30458355	30458648	NA	NA	NA	NA	NA
PGEN_.00g090250	Scaffold_04	30458733	30458972	NA	NA	NA	NA	NA
PGEN_.00g090260	Scaffold_04	30459084	30459797	NA	NA	NA	NA	NA
PGEN_.00g090270	Scaffold_04	30460245	30460604	NA	NA	NA	NA	NA
PGEN_.00g090280	Scaffold_04	30461411	30461722	NA	NA	NA	NA	NA
PGEN_.00g090290	Scaffold_04	30461941	30462414	NA	NA	NA	NA	NA
PGEN_.00g090300	Scaffold_04	30462647	30462850	NA	NA	NA	NA	NA
PGEN_.00g090310	Scaffold_04	30465602	30468653	NA	NA	NA	NA	NA
PGEN_.00g090320	Scaffold_04	30484023	30488951	NA	NA	NA	NA	NA
PGEN_.00g090330	Scaffold_04	30533517	30534910	NA	NA	NA	NA	NA
PGEN_.00g090340	Scaffold_04	30548844	30549149	NA	NA	NA	NA	NA
PGEN_.00g090350	Scaffold_04	30602281	30602550	NA	NA	NA	NA	NA
PGEN_.00g090360	Scaffold_04	30641384	30641854	NA	NA	NA	NA	NA
PGEN_.00g090370	Scaffold_04	30703145	30703774	NA	NA	NA	NA	NA
PGEN_.00g090380	Scaffold_04	30772609	30773025	NA	NA	NA	NA	NA
PGEN_.00g090390	Scaffold_04	30776474	30777112	NA	NA	NA	NA	NA
PGEN_.00g090400	Scaffold_04	30808836	30809126	NA	NA	NA	NA	NA
PGEN_.00g090410	Scaffold_04	30809241	30809987	NA	NA	NA	NA	NA
PGEN_.00g090420	Scaffold_04	30810101	30833680	Q18932	CAH2_CAEEL	Putative carbonic anhydrase-like protein 2	GO:0004089; GO:0005576; GO:0008270	extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
PGEN_.00g090430	Scaffold_04	30836144	30836422	NA	NA	NA	NA	NA
PGEN_.00g090440	Scaffold_04	30848604	30848990	NA	NA	NA	NA	NA
PGEN_.00g090450	Scaffold_04	30850325	30863196	NA	NA	NA	NA	NA
PGEN_.00g090460	Scaffold_04	30882676	30882993	NA	NA	NA	NA	NA
PGEN_.00g090470	Scaffold_04	30893639	30894868	NA	NA	NA	NA	NA
PGEN_.00g090480	Scaffold_04	30896941	30899025	O95625	ZBT11_HUMAN	Zinc finger and BTB domain-containing protein 11	GO:0003677; GO:0005654; GO:0005730; GO:0046872	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g090490	Scaffold_04	30904829	30992100	NA	NA	NA	NA	NA
PGEN_.00g090500	Scaffold_04	31013749	31053682	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g090510	Scaffold_04	31068503	31070297	NA	NA	NA	NA	NA
PGEN_.00g090520	Scaffold_04	31076321	31117621	P86789	GIGA6_CRAGI	Gigasin-6	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g090530	Scaffold_04	31129344	31129586	NA	NA	NA	NA	NA
PGEN_.00g090540	Scaffold_04	31129810	31133688	NA	NA	NA	NA	NA
PGEN_.00g090550	Scaffold_04	31138675	31139823	NA	NA	NA	NA	NA
PGEN_.00g090560	Scaffold_04	31139976	31140648	NA	NA	NA	NA	NA
PGEN_.00g090570	Scaffold_04	31141684	31141986	NA	NA	NA	NA	NA
PGEN_.00g090580	Scaffold_04	31178176	31178589	NA	NA	NA	NA	NA
PGEN_.00g090590	Scaffold_04	31207356	31221440	Q96PY6	NEK1_HUMAN	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)	GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0023014; GO:0032147; GO:0034451; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]"
PGEN_.00g090600	Scaffold_04	31222008	31222883	NA	NA	NA	NA	NA
PGEN_.00g090610	Scaffold_04	31228343	31230033	NA	NA	NA	NA	NA
PGEN_.00g090620	Scaffold_04	31230949	31232727	NA	NA	NA	NA	NA
PGEN_.00g090630	Scaffold_04	31264014	31274249	NA	NA	NA	NA	NA
PGEN_.00g090640	Scaffold_04	31285967	31288684	NA	NA	NA	NA	NA
PGEN_.00g090650	Scaffold_04	31288902	31289426	NA	NA	NA	NA	NA
PGEN_.00g090660	Scaffold_04	31291486	31299640	Q96PY6	NEK1_HUMAN	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)	GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0023014; GO:0032147; GO:0034451; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]"
PGEN_.00g090670	Scaffold_04	31321934	31322293	NA	NA	NA	NA	NA
PGEN_.00g090680	Scaffold_04	31322882	31327985	NA	NA	NA	NA	NA
PGEN_.00g090690	Scaffold_04	31328037	31328351	NA	NA	NA	NA	NA
PGEN_.00g090700	Scaffold_04	31329161	31329415	NA	NA	NA	NA	NA
PGEN_.00g090710	Scaffold_04	31343206	31344876	NA	NA	NA	NA	NA
PGEN_.00g090720	Scaffold_04	31344922	31345356	NA	NA	NA	NA	NA
PGEN_.00g090730	Scaffold_04	31345961	31346794	NA	NA	NA	NA	NA
PGEN_.00g090740	Scaffold_04	31377025	31377297	NA	NA	NA	NA	NA
PGEN_.00g090750	Scaffold_04	31377718	31378203	NA	NA	NA	NA	NA
PGEN_.00g090760	Scaffold_04	31378237	31378668	NA	NA	NA	NA	NA
PGEN_.00g090770	Scaffold_04	31379962	31417765	Q8NUZ4	FLP_STAAW	Protein flp (FmtA-like protein)	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g090780	Scaffold_04	31424417	31427896	NA	NA	NA	NA	NA
PGEN_.00g090790	Scaffold_04	31464838	31468795	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g090800	Scaffold_04	31485493	31486311	NA	NA	NA	NA	NA
PGEN_.00g090810	Scaffold_04	31530275	31563259	NA	NA	NA	NA	NA
PGEN_.00g090820	Scaffold_04	31568712	31569809	NA	NA	NA	NA	NA
PGEN_.00g090830	Scaffold_04	31580096	31586638	NA	NA	NA	NA	NA
PGEN_.00g090840	Scaffold_04	31639519	31710147	P61215	CAH10_MOUSE	Carbonic anhydrase-related protein 10 (Carbonic anhydrase-related protein X) (CA-RP X) (CARP X)	GO:0004089; GO:0008270	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
PGEN_.00g090850	Scaffold_04	31718323	31752182	NA	NA	NA	NA	NA
PGEN_.00g090860	Scaffold_04	31752389	31805657	NA	NA	NA	NA	NA
PGEN_.00g090870	Scaffold_04	31837953	31838249	NA	NA	NA	NA	NA
PGEN_.00g090880	Scaffold_04	31840193	31859142	NA	NA	NA	NA	NA
PGEN_.00g090890	Scaffold_04	31852673	31859413	NA	NA	NA	NA	NA
PGEN_.00g090900	Scaffold_04	31864032	31873022	A8I1Q0	CALM_HETTR	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g090910	Scaffold_04	31876380	31876721	NA	NA	NA	NA	NA
PGEN_.00g090920	Scaffold_04	31884305	31889100	NA	NA	NA	NA	NA
PGEN_.00g090930	Scaffold_04	31905014	31923347	Q8K2Y0	OBI1_MOUSE	ORC ubiquitin ligase 1 (OBI1) (EC 2.3.2.27) (RING finger protein 219)	GO:0000785; GO:0003682; GO:0004842; GO:0006275; GO:0006513; GO:0046872; GO:0048026; GO:0051865	"chromatin [GO:0000785]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; regulation of DNA replication [GO:0006275]"
PGEN_.00g090940	Scaffold_04	31923667	31941183	Q7T0V6	NTP7A_XENLA	Sodium/bile acid cotransporter 7-A (Na(+)/bile acid cotransporter 7-A) (Solute carrier family 10 member 7-A)	GO:0000139; GO:0005789; GO:0005886; GO:0006814; GO:0015293; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g090950	Scaffold_04	31953531	31965940	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g090960	Scaffold_04	31965998	31966669	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g090970	Scaffold_04	31976536	31980536	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g090980	Scaffold_04	31990836	32023885	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g090990	Scaffold_04	32140006	32145451	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g091000	Scaffold_04	32167071	32171452	NA	NA	NA	NA	NA
PGEN_.00g091010	Scaffold_04	32172735	32195637	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g091020	Scaffold_04	32202543	32208694	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g091030	Scaffold_04	32211451	32211702	NA	NA	NA	NA	NA
PGEN_.00g091040	Scaffold_04	32227587	32228147	NA	NA	NA	NA	NA
PGEN_.00g091050	Scaffold_04	32231272	32242825	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g091060	Scaffold_04	32250122	32255087	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g091070	Scaffold_04	32257432	32267625	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g091080	Scaffold_04	32269424	32269633	NA	NA	NA	NA	NA
PGEN_.00g091090	Scaffold_04	32286156	32290860	NA	NA	NA	NA	NA
PGEN_.00g091100	Scaffold_04	32302338	32307961	NA	NA	NA	NA	NA
PGEN_.00g091110	Scaffold_04	32317578	32329383	NA	NA	NA	NA	NA
PGEN_.00g091120	Scaffold_04	32338518	32366100	O94469	DUR31_SCHPO	Probable urea active transporter 1	GO:0005886; GO:0015204; GO:0015489; GO:0015606; GO:0015840; GO:0015847; GO:0015848; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; putrescine transmembrane transporter activity [GO:0015489]; spermidine transmembrane transporter activity [GO:0015606]; urea transmembrane transporter activity [GO:0015204]; putrescine transport [GO:0015847]; spermidine transport [GO:0015848]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]
PGEN_.00g091130	Scaffold_04	32372493	32394857	NA	NA	NA	NA	NA
PGEN_.00g091140	Scaffold_04	32404155	32434025	O95239	KIF4A_HUMAN	Chromosome-associated kinesin KIF4A (Chromokinesin-A)	GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005876; GO:0006890; GO:0006996; GO:0007018; GO:0007052; GO:0008017; GO:0008089; GO:0016020; GO:0016363; GO:0016887; GO:0019886; GO:0030496; GO:0051256; GO:1904115	"axon cytoplasm [GO:1904115]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; organelle organization [GO:0006996]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g091150	Scaffold_04	32443952	32462697	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g091160	Scaffold_04	32465926	32475988	Q8R323	RFC3_MOUSE	Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38)	GO:0003689; GO:0005634; GO:0005663; GO:0006260; GO:0006261; GO:0017116; GO:0031390; GO:0046683; GO:1900264	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]
PGEN_.00g091170	Scaffold_04	32479818	32480438	NA	NA	NA	NA	NA
PGEN_.00g091180	Scaffold_04	32480497	32496173	Q6P1D7	SLX4_MOUSE	Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12)	GO:0000706; GO:0000712; GO:0000724; GO:0000781; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006289; GO:0008047; GO:0010792; GO:0017108; GO:0030054; GO:0033557; GO:0036297; GO:0046872; GO:0061820; GO:0072429; GO:0090656; GO:1904357; GO:1904431	"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; 5'-flap endonuclease activity [GO:0017108]; enzyme activator activity [GO:0008047]; metal ion binding [GO:0046872]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]"
PGEN_.00g091190	Scaffold_04	32496862	32500333	NA	NA	NA	NA	NA
PGEN_.00g091200	Scaffold_04	32500371	32503147	NA	NA	NA	NA	NA
PGEN_.00g091210	Scaffold_04	32505438	32513922	P62878	RBX1_MOUSE	"E3 ubiquitin-protein ligase RBX1 (EC 2.3.2.27) (EC 2.3.2.32) (E3 ubiquitin-protein transferase RBX1) (RING finger protein 75) (RING-box protein 1) (Rbx1) [Cleaved into: E3 ubiquitin-protein ligase RBX1, N-terminally processed]"	GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0006281; GO:0006511; GO:0006513; GO:0008134; GO:0008190; GO:0008270; GO:0016567; GO:0019005; GO:0019788; GO:0030163; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031463; GO:0031464; GO:0031465; GO:0031466; GO:0031467; GO:0031625; GO:0032436; GO:0034450; GO:0043161; GO:0043224; GO:0044877; GO:0045116; GO:0061630; GO:0061663; GO:0080008; GO:0097602	anaphase-promoting complex [GO:0005680]; Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; VCB complex [GO:0030891]; cullin family protein binding [GO:0097602]; eukaryotic initiation factor 4E binding [GO:0008190]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g091220	Scaffold_04	32530396	32551376	Q0VBL6	HIF3A_MOUSE	Hypoxia-inducible factor 3-alpha (HIF-3-alpha) (HIF3-alpha) (Basic-helix-loop-helix-PAS protein MOP7) (HIF3-alpha-1) (Inhibitory PAS domain protein) (IPAS) (Member of PAS protein 7) (Neonatal and embryonic PAS protein)	GO:0000981; GO:0001525; GO:0001666; GO:0003677; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006357; GO:0006366; GO:0006915; GO:0016607; GO:0045944; GO:0046983	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g091230	Scaffold_04	32586641	32594443	Q8NHS3	MFSD8_HUMAN	Major facilitator superfamily domain-containing protein 8 (Ceroid-lipofuscinosis neuronal protein 7)	GO:0005654; GO:0005765; GO:0007040; GO:0010506; GO:0016021; GO:0043231; GO:0048666; GO:0055085	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; lysosome organization [GO:0007040]; neuron development [GO:0048666]; regulation of autophagy [GO:0010506]; transmembrane transport [GO:0055085]
PGEN_.00g091240	Scaffold_04	32597240	32613355	P07190	MAL1_DROME	Maltase A1 (EC 3.2.1.20) (Larval visceral protein H)	GO:0032450	maltose alpha-glucosidase activity [GO:0032450]
PGEN_.00g091250	Scaffold_04	32626713	32670456	NA	NA	NA	NA	NA
PGEN_.00g091260	Scaffold_04	32686602	32698268	NA	NA	NA	NA	NA
PGEN_.00g091270	Scaffold_04	32711348	32736745	Q60648	SAP3_MOUSE	Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3)	GO:0004563; GO:0005319; GO:0005739; GO:0005764; GO:0006689; GO:0007611; GO:0008047; GO:0009313; GO:0009898; GO:0016004; GO:0016323; GO:0016324; GO:0019915; GO:0032428; GO:0050877; GO:0050885; GO:0051345	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]
PGEN_.00g091280	Scaffold_04	32754049	32761922	P86789	GIGA6_CRAGI	Gigasin-6	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g091290	Scaffold_04	32762911	32763805	P05364	AMPC_ENTCL	Beta-lactamase (EC 3.5.2.6) (Cephalosporinase)	GO:0008800; GO:0017001; GO:0030288; GO:0046677	outer membrane-bounded periplasmic space [GO:0030288]; beta-lactamase activity [GO:0008800]; antibiotic catabolic process [GO:0017001]; response to antibiotic [GO:0046677]
PGEN_.00g091300	Scaffold_04	32766523	32783071	P86789	GIGA6_CRAGI	Gigasin-6	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g091310	Scaffold_04	32802841	32803544	NA	NA	NA	NA	NA
PGEN_.00g091320	Scaffold_04	32805659	32810957	Q66S03	LECG_THANI	Galactose-specific lectin nattectin (CTL)	GO:0005576; GO:0006954; GO:0009405; GO:0030246; GO:0046872; GO:0090729	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954]; pathogenesis [GO:0009405]
PGEN_.00g091330	Scaffold_04	32815024	32825564	O75095	MEGF6_HUMAN	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g091340	Scaffold_04	32832579	32835878	Q5KU26	COL12_HUMAN	Collectin-12 (Collectin placenta protein 1) (CL-P1) (hCL-P1) (Nurse cell scavenger receptor 2) (Scavenger receptor class A member 4) (Scavenger receptor with C-type lectin)	GO:0005044; GO:0005534; GO:0005581; GO:0005615; GO:0005886; GO:0006898; GO:0006910; GO:0006952; GO:0008329; GO:0009756; GO:0016021; GO:0030169; GO:0030666; GO:0031012; GO:0034138; GO:0045087; GO:0046872; GO:0050776; GO:0051260; GO:0060355; GO:0071360	"collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; galactose binding [GO:0005534]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; carbohydrate mediated signaling [GO:0009756]; cellular response to exogenous dsRNA [GO:0071360]; defense response [GO:0006952]; innate immune response [GO:0045087]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; protein homooligomerization [GO:0051260]; receptor-mediated endocytosis [GO:0006898]; regulation of immune response [GO:0050776]; toll-like receptor 3 signaling pathway [GO:0034138]"
PGEN_.00g091350	Scaffold_04	32836332	32851355	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g091360	Scaffold_04	32854232	32854441	NA	NA	NA	NA	NA
PGEN_.00g091370	Scaffold_04	32854246	32885227	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g091380	Scaffold_04	32897529	32916054	NA	NA	NA	NA	NA
PGEN_.00g091390	Scaffold_04	32919144	32938477	O94469	DUR31_SCHPO	Probable urea active transporter 1	GO:0005886; GO:0015204; GO:0015489; GO:0015606; GO:0015840; GO:0015847; GO:0015848; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; putrescine transmembrane transporter activity [GO:0015489]; spermidine transmembrane transporter activity [GO:0015606]; urea transmembrane transporter activity [GO:0015204]; putrescine transport [GO:0015847]; spermidine transport [GO:0015848]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]
PGEN_.00g091400	Scaffold_04	32948565	32974648	NA	NA	NA	NA	NA
PGEN_.00g091410	Scaffold_04	32977608	32985821	B6CZ61	LRC51_RAT	Leucine-rich repeat-containing protein 51 (Protein LRTOMT1)	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g091420	Scaffold_04	32998764	33011383	O35738	KLF12_MOUSE	Krueppel-like factor 12 (Transcriptional repressor AP-2rep)	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0045944; GO:0046872	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g091430	Scaffold_04	33012487	33012807	NA	NA	NA	NA	NA
PGEN_.00g091440	Scaffold_04	33030513	33057244	NA	NA	NA	NA	NA
PGEN_.00g091450	Scaffold_04	33060503	33060739	NA	NA	NA	NA	NA
PGEN_.00g091460	Scaffold_04	33068181	33076740	Q8DET7	ANMK_VIBVU	Anhydro-N-acetylmuramic acid kinase (EC 2.7.1.170) (AnhMurNAc kinase)	GO:0005524; GO:0005975; GO:0006040; GO:0009254; GO:0016301; GO:0016773; GO:0097175	"ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; 1,6-anhydro-N-acetyl-beta-muramic acid catabolic process [GO:0097175]; amino sugar metabolic process [GO:0006040]; carbohydrate metabolic process [GO:0005975]; peptidoglycan turnover [GO:0009254]"
PGEN_.00g091470	Scaffold_04	33084217	33095584	Q4R7I0	CEP44_MACFA	Centrosomal protein of 44 kDa (Cep44)	GO:0000922; GO:0005737; GO:0005813; GO:0030496	centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922]
PGEN_.00g091480	Scaffold_04	33125883	33127829	NA	NA	NA	NA	NA
PGEN_.00g091490	Scaffold_04	33131426	33158434	Q3UTQ8	CDKL5_MOUSE	Cyclin-dependent kinase-like 5 (EC 2.7.11.22)	GO:0001764; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005813; GO:0006468; GO:0016301; GO:0032587; GO:0032839; GO:0036064; GO:0043547; GO:0044294; GO:0045202; GO:0045773; GO:0046777; GO:0048365; GO:0048471; GO:0050773; GO:0050775; GO:0060999; GO:0097542; GO:0098978; GO:0099092; GO:0099175; GO:1902017	"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; Rac GTPase binding [GO:0048365]; neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of GTPase activity [GO:0043547]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]; regulation of postsynapse organization [GO:0099175]"
PGEN_.00g091500	Scaffold_04	33172509	33216190	Q659C4	LAR1B_HUMAN	La-related protein 1B (La ribonucleoprotein domain family member 1B) (La ribonucleoprotein domain family member 2) (La-related protein 2)	GO:0003723; GO:0005634	nucleus [GO:0005634]; RNA binding [GO:0003723]
PGEN_.00g091510	Scaffold_04	33245893	33249898	P34611	NCL1_CAEEL	B-box type zinc finger protein ncl-1	GO:0000209; GO:0005737; GO:0008270; GO:0016479; GO:0016480; GO:0017126; GO:0030371; GO:0042254; GO:0043161; GO:0061630; GO:0072697; GO:0090071; GO:2000114	cytoplasm [GO:0005737]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]; nucleologenesis [GO:0017126]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell cortex [GO:0072697]; protein polyubiquitination [GO:0000209]; regulation of establishment of cell polarity [GO:2000114]; ribosome biogenesis [GO:0042254]
PGEN_.00g091520	Scaffold_04	33291922	33296115	NA	NA	NA	NA	NA
PGEN_.00g091530	Scaffold_04	33296907	33305624	NA	NA	NA	NA	NA
PGEN_.00g091540	Scaffold_04	33334254	33366329	Q96PQ7	KLHL5_HUMAN	Kelch-like protein 5	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0043687	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; post-translational protein modification [GO:0043687]
PGEN_.00g091550	Scaffold_04	33373318	33395845	NA	NA	NA	NA	NA
PGEN_.00g091560	Scaffold_04	33397008	33410001	NA	NA	NA	NA	NA
PGEN_.00g091570	Scaffold_04	33411570	33414171	NA	NA	NA	NA	NA
PGEN_.00g091580	Scaffold_04	33415840	33423699	Q68EV6	RM28_XENLA	"39S ribosomal protein L28, mitochondrial (L28mt) (MRP-L28)"	GO:0003735; GO:0005762	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]
PGEN_.00g091590	Scaffold_04	33428050	33433524	NA	NA	NA	NA	NA
PGEN_.00g091600	Scaffold_04	33495843	33498619	NA	NA	NA	NA	NA
PGEN_.00g091610	Scaffold_04	33503436	33505711	Q8BMN3	ACHB3_MOUSE	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0016020; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0051291; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g091620	Scaffold_04	33508086	33511705	Q5IS76	ACHA6_PANTR	Neuronal acetylcholine receptor subunit alpha-6	GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007399; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060084	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g091630	Scaffold_04	33517414	33521170	P02709	ACHA_BOVIN	Acetylcholine receptor subunit alpha	GO:0003009; GO:0005623; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007528; GO:0009986; GO:0015464; GO:0019228; GO:0022848; GO:0030054; GO:0031594; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0046716; GO:0048630; GO:0050877; GO:0050905; GO:0070050; GO:0099060	"acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell cellular homeostasis [GO:0046716]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neuronal action potential [GO:0019228]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g091640	Scaffold_04	33536327	33568843	O14813	PHX2A_HUMAN	Paired mesoderm homeobox protein 2A (ARIX1 homeodomain protein) (Aristaless homeobox protein homolog) (Paired-like homeobox 2A)	GO:0000790; GO:0000977; GO:0000981; GO:0003357; GO:0003700; GO:0005634; GO:0007399; GO:0021523; GO:0021623; GO:0021642; GO:0021703; GO:0030901; GO:0043576; GO:0045944; GO:0048483; GO:0048484; GO:0048485; GO:0071542	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autonomic nervous system development [GO:0048483]; dopaminergic neuron differentiation [GO:0071542]; enteric nervous system development [GO:0048484]; locus ceruleus development [GO:0021703]; midbrain development [GO:0030901]; nervous system development [GO:0007399]; noradrenergic neuron differentiation [GO:0003357]; oculomotor nerve formation [GO:0021623]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of respiratory gaseous exchange [GO:0043576]; somatic motor neuron differentiation [GO:0021523]; sympathetic nervous system development [GO:0048485]; trochlear nerve formation [GO:0021642]"
PGEN_.00g091650	Scaffold_04	33579884	33581892	NA	NA	NA	NA	NA
PGEN_.00g091660	Scaffold_04	33581926	33582204	NA	NA	NA	NA	NA
PGEN_.00g091670	Scaffold_04	33582280	33582744	NA	NA	NA	NA	NA
PGEN_.00g091680	Scaffold_04	33582826	33583534	NA	NA	NA	NA	NA
PGEN_.00g091690	Scaffold_04	33592505	33592933	NA	NA	NA	NA	NA
PGEN_.00g091700	Scaffold_04	33619339	33626480	O15294	OGT1_HUMAN	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	GO:0000123; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016032; GO:0016262; GO:0016485; GO:0016579; GO:0017122; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0061087; GO:0080182; GO:0097363; GO:0120162	"cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; viral process [GO:0016032]"
PGEN_.00g091710	Scaffold_04	33627358	33629637	A0A1B0GUU1	CQ113_HUMAN	Transmembrane protein C17orf113	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g091720	Scaffold_04	33630587	33647134	Q27HV0	OGT1_PIG	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)	GO:0000123; GO:0005547; GO:0005634; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006493; GO:0006915; GO:0016262; GO:0016485; GO:0016757; GO:0031397; GO:0031966; GO:0032922; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0045862; GO:0045944; GO:0048015; GO:0061087; GO:0080182; GO:0097363	"cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transferase activity, transferring glycosyl groups [GO:0016757]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]"
PGEN_.00g091730	Scaffold_04	33667252	33670239	NA	NA	NA	NA	NA
PGEN_.00g091740	Scaffold_04	33670507	33670824	NA	NA	NA	NA	NA
PGEN_.00g091750	Scaffold_04	33683314	33705251	Q8VHT6	AS3MT_RAT	Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase)	GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0030792; GO:0032259; GO:0046685	cytosol [GO:0005829]; arsenite methyltransferase activity [GO:0030791]; methylarsonite methyltransferase activity [GO:0030792]; protein methyltransferase activity [GO:0008276]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404]
PGEN_.00g091760	Scaffold_04	33707930	33708647	NA	NA	NA	NA	NA
PGEN_.00g091770	Scaffold_04	33721909	33743942	Q9HBK9	AS3MT_HUMAN	Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase)	GO:0005829; GO:0009404; GO:0018872; GO:0030791; GO:0030792; GO:0032259	cytosol [GO:0005829]; arsenite methyltransferase activity [GO:0030791]; methylarsonite methyltransferase activity [GO:0030792]; arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; toxin metabolic process [GO:0009404]
PGEN_.00g091780	Scaffold_04	33752225	33752902	NA	NA	NA	NA	NA
PGEN_.00g091790	Scaffold_04	33753862	33754257	Q8I335	GUF1_PLAF7	"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)"	GO:0003924; GO:0005525; GO:0005743; GO:0006412	mitochondrial inner membrane [GO:0005743]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation [GO:0006412]
PGEN_.00g091800	Scaffold_04	33754628	33754894	NA	NA	NA	NA	NA
PGEN_.00g091810	Scaffold_04	33754963	33755451	Q8I335	GUF1_PLAF7	"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)"	GO:0003924; GO:0005525; GO:0005743; GO:0006412	mitochondrial inner membrane [GO:0005743]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation [GO:0006412]
PGEN_.00g091820	Scaffold_04	33772992	33797204	Q9SVG0	AVT3C_ARATH	Amino acid transporter AVT3C (AtAvt3C) (Aromatic and neutral amino acid transporter-like protein 2)	GO:0003333; GO:0005774; GO:0015171; GO:0015175; GO:0015804; GO:0016021	integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; amino acid transmembrane transporter activity [GO:0015171]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transmembrane transport [GO:0003333]; neutral amino acid transport [GO:0015804]
PGEN_.00g091830	Scaffold_04	33812806	33836915	Q0VAA2	LR74A_HUMAN	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g091840	Scaffold_04	33836956	33850261	Q9VPT7	PGAP2_DROME	Post-GPI attachment to proteins factor 2	GO:0000139; GO:0005789; GO:0006506; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g091850	Scaffold_04	33860074	33868992	P35441	TSP1_MOUSE	Thrombospondin-1 (Glycoprotein G)	GO:0000187; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002040; GO:0002581; GO:0002605; GO:0003151; GO:0003197; GO:0003417; GO:0005178; GO:0005509; GO:0005577; GO:0005615; GO:0005737; GO:0005783; GO:0006954; GO:0006986; GO:0007050; GO:0007155; GO:0008201; GO:0008284; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0010811; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0032026; GO:0032695; GO:0034976; GO:0040037; GO:0042327; GO:0042535; GO:0043032; GO:0043066; GO:0043154; GO:0043236; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048514; GO:0048661; GO:0050431; GO:0050840; GO:0050921; GO:0051592; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0071636; GO:0071732; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; transforming growth factor beta binding [GO:0050431]; activation of MAPK activity [GO:0000187]; behavioral response to pain [GO:0048266]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to nitric oxide [GO:0071732]; endocardial cushion development [GO:0003197]; engulfment of apoptotic cell [GO:0043652]; growth plate cartilage development [GO:0003417]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; outflow tract morphogenesis [GO:0003151]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to unfolded protein [GO:0006986]; sprouting angiogenesis [GO:0002040]
PGEN_.00g091860	Scaffold_04	33878265	33888335	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g091870	Scaffold_04	33893397	33898928	P35448	TSP1_XENLA	Thrombospondin-1 (Glycoprotein G)	GO:0005509; GO:0005615; GO:0005783; GO:0006954; GO:0006986; GO:0007155; GO:0008201; GO:0009986; GO:0016525; GO:0016529; GO:0031012; GO:0050840	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986]
PGEN_.00g091880	Scaffold_04	33951736	33951990	NA	NA	NA	NA	NA
PGEN_.00g091890	Scaffold_04	34106274	34112398	P30551	CCKAR_RAT	Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R)	GO:0001659; GO:0001696; GO:0001764; GO:0002023; GO:0004930; GO:0004951; GO:0005623; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0005887; GO:0007186; GO:0007204; GO:0007409; GO:0007584; GO:0007631; GO:0009314; GO:0009408; GO:0016020; GO:0017046; GO:0030073; GO:0030157; GO:0030900; GO:0031016; GO:0031100; GO:0031532; GO:0032496; GO:0032870; GO:0038188; GO:0042594; GO:0042755; GO:0043195; GO:0043266; GO:0046883; GO:0048545; GO:0051384; GO:0051924; GO:0090274	cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; actin cytoskeleton reorganization [GO:0031532]; animal organ regeneration [GO:0031100]; axonogenesis [GO:0007409]; cellular response to hormone stimulus [GO:0032870]; cholecystokinin signaling pathway [GO:0038188]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric acid secretion [GO:0001696]; insulin secretion [GO:0030073]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; pancreatic juice secretion [GO:0030157]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of somatostatin secretion [GO:0090274]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of calcium ion transport [GO:0051924]; regulation of hormone secretion [GO:0046883]; regulation of potassium ion transport [GO:0043266]; response to glucocorticoid [GO:0051384]; response to heat [GO:0009408]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to radiation [GO:0009314]; response to starvation [GO:0042594]; response to steroid hormone [GO:0048545]; temperature homeostasis [GO:0001659]
PGEN_.00g091900	Scaffold_04	34196766	34202130	Q09575	YRD6_CAEEL	Uncharacterized protein K02A2.6	GO:0003676; GO:0008270; GO:0015074	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]
PGEN_.00g091910	Scaffold_04	34202153	34208648	NA	NA	NA	NA	NA
PGEN_.00g091920	Scaffold_04	34209199	34215466	NA	NA	NA	NA	NA
PGEN_.00g091930	Scaffold_04	34215870	34218611	NA	NA	NA	NA	NA
PGEN_.00g091940	Scaffold_04	34227577	34230563	NA	NA	NA	NA	NA
PGEN_.00g091950	Scaffold_04	34236294	34245804	NA	NA	NA	NA	NA
PGEN_.00g091960	Scaffold_04	34249737	34254596	Q9JHE4	G3ST1_MOUSE	Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)	GO:0000139; GO:0001733; GO:0006682; GO:0007283; GO:0009247; GO:0016021; GO:0042552	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; galactosylceramide biosynthetic process [GO:0006682]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]
PGEN_.00g091970	Scaffold_04	34266750	34268165	NA	NA	NA	NA	NA
PGEN_.00g091980	Scaffold_04	34286531	34287628	NA	NA	NA	NA	NA
PGEN_.00g091990	Scaffold_04	34338080	34408890	NA	NA	NA	NA	NA
PGEN_.00g092000	Scaffold_04	34410411	34411607	NA	NA	NA	NA	NA
PGEN_.00g092010	Scaffold_04	34431632	34477799	P51816	AFF2_HUMAN	AF4/FMR2 family member 2 (Fragile X E mental retardation syndrome protein) (Fragile X mental retardation 2 protein) (FMR2P) (Protein FMR-2) (Protein Ox19)	GO:0002151; GO:0005634; GO:0006355; GO:0006397; GO:0007420; GO:0007611; GO:0008380; GO:0010468; GO:0010629; GO:0016607; GO:0035063; GO:0043484	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; G-quadruplex RNA binding [GO:0002151]; brain development [GO:0007420]; learning or memory [GO:0007611]; mRNA processing [GO:0006397]; negative regulation of gene expression [GO:0010629]; nuclear speck organization [GO:0035063]; regulation of gene expression [GO:0010468]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"
PGEN_.00g092020	Scaffold_04	34491253	34498710	Q62210	BIRC2_MOUSE	Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (Inhibitor of apoptosis protein 2) (mIAP2) (RING-type E3 ubiquitin transferase BIRC2)	GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0032991; GO:0035631; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043154; GO:0043161; GO:0044877; GO:0045121; GO:0045471; GO:0047485; GO:0051087; GO:0051291; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0071356; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:1902916; GO:1990001; GO:2000377	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein heterooligomerization [GO:0051291]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]
PGEN_.00g092030	Scaffold_04	34499118	34500791	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g092040	Scaffold_04	34513750	34529134	Q8JHV9	BIR7A_XENLA	Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g092050	Scaffold_04	34564687	34589533	Q8N5T2	TBC19_HUMAN	TBC1 domain family member 19	GO:0005096	GTPase activator activity [GO:0005096]
PGEN_.00g092060	Scaffold_04	34729179	34741618	A1L1C7	PAN3_XENTR	PAN2-PAN3 deadenylation complex subunit pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3)	GO:0000289; GO:0000290; GO:0000932; GO:0003723; GO:0004672; GO:0005524; GO:0006397; GO:0010606; GO:0031251; GO:0046872; GO:0090503	"P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"
PGEN_.00g092070	Scaffold_04	34758411	34768381	Q90744	NAGAB_CHICK	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]
PGEN_.00g092080	Scaffold_04	34773183	34778511	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g092090	Scaffold_04	34789185	34794833	Q9UBS8	RNF14_HUMAN	E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) (Triad2 protein)	GO:0000151; GO:0000209; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0016567; GO:0019787; GO:0030521; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g092100	Scaffold_04	34811371	34828363	NA	NA	NA	NA	NA
PGEN_.00g092110	Scaffold_04	34836695	34844467	Q3ZBG6	UNC50_BOVIN	Protein unc-50 homolog	GO:0003723; GO:0005637; GO:0015031; GO:0030173	integral component of Golgi membrane [GO:0030173]; nuclear inner membrane [GO:0005637]; RNA binding [GO:0003723]; protein transport [GO:0015031]
PGEN_.00g092120	Scaffold_04	34886864	34890317	NA	NA	NA	NA	NA
PGEN_.00g092130	Scaffold_04	34893988	34896811	NA	NA	NA	NA	NA
PGEN_.00g092140	Scaffold_04	34901812	34905191	NA	NA	NA	NA	NA
PGEN_.00g092150	Scaffold_04	34909570	34913060	P17972	KCNAW_DROME	Potassium voltage-gated channel protein Shaw (Shaw2)	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]
PGEN_.00g092160	Scaffold_04	34932688	34938587	NA	NA	NA	NA	NA
PGEN_.00g092170	Scaffold_04	34943965	34964172	Q96M20	CNBD2_HUMAN	Cyclic nucleotide-binding domain-containing protein 2	GO:0005829; GO:0007283; GO:0030552	cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
PGEN_.00g092180	Scaffold_04	34970884	34974497	NA	NA	NA	NA	NA
PGEN_.00g092190	Scaffold_04	34982687	34991910	Q9NX08	COMD8_HUMAN	COMM domain-containing protein 8	GO:0005654; GO:0005829	cytosol [GO:0005829]; nucleoplasm [GO:0005654]
PGEN_.00g092200	Scaffold_04	34992731	35039567	O54827	AT10A_MOUSE	Probable phospholipid-transporting ATPase VA (EC 7.6.2.1) (ATPase class V type 10A) (P-locus fat-associated ATPase) (P4-ATPase flippase complex alpha subunit ATP10A)	GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0016021; GO:0045332; GO:0140326	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phospholipid translocation [GO:0045332]
PGEN_.00g092210	Scaffold_04	35053998	35057949	Q9CQ69	QCR8_MOUSE	Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C)	GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0021539; GO:0021548; GO:0021680; GO:0021766; GO:0021794; GO:0021854; GO:0021860; GO:0030901	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]"
PGEN_.00g092220	Scaffold_04	35058081	35111977	Q9W391	KPBA_DROME	Probable phosphorylase b kinase regulatory subunit alpha (Phosphorylase kinase subunit alpha)	GO:0003824; GO:0005516; GO:0005886; GO:0005964; GO:0005977; GO:0006468	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468]
PGEN_.00g092230	Scaffold_04	35121878	35152341	Q3EC11	ZDHC2_ARATH	Probable protein S-acyltransferase 23 (EC 2.3.1.225) (Probable palmitoyltransferase At2g14255) (Zinc finger DHHC domain-containing protein At2g14255)	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]
PGEN_.00g092240	Scaffold_04	35152658	35161882	O14657	TOR1B_HUMAN	Torsin-1B (Torsin ATPase-1B) (EC 3.6.4.-) (Torsin family 1 member B)	GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0006986; GO:0007029; GO:0016887; GO:0019894; GO:0031965; GO:0034504; GO:0042802; GO:0051085; GO:0070062; GO:0071763	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum organization [GO:0007029]; nuclear membrane organization [GO:0071763]; protein localization to nucleus [GO:0034504]; response to unfolded protein [GO:0006986]
PGEN_.00g092250	Scaffold_04	35162622	35164569	NA	NA	NA	NA	NA
PGEN_.00g092260	Scaffold_04	35182554	35220655	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g092270	Scaffold_04	35245149	35300084	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g092280	Scaffold_04	35300135	35318236	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g092290	Scaffold_04	35326066	35329738	NA	NA	NA	NA	NA
PGEN_.00g092300	Scaffold_04	35329861	35338444	Q6IE52	MUG2_RAT	Murinoglobulin-2	GO:0001654; GO:0002020; GO:0004866; GO:0004867; GO:0005615	extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; eye development [GO:0001654]
PGEN_.00g092310	Scaffold_04	35342406	35373427	Q3KPT0	CC169_XENLA	Coiled-coil domain-containing protein 169		
PGEN_.00g092320	Scaffold_04	35375909	35384277	P82198	BGH3_MOUSE	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3)	GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]
PGEN_.00g092330	Scaffold_04	35387898	35395700	Q62009	POSTN_MOUSE	Periostin (PN) (Osteoblast-specific factor 2) (OSF-2)	GO:0001666; GO:0001953; GO:0003073; GO:0005615; GO:0005737; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009612; GO:0009888; GO:0014850; GO:0014911; GO:0030198; GO:0031012; GO:0031594; GO:0032355; GO:0044344; GO:0046872; GO:0050839; GO:0062023; GO:0071307; GO:0071356; GO:0071560; GO:1900025; GO:1904209; GO:1990138; GO:1990523	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]
PGEN_.00g092340	Scaffold_04	35399610	35404334	Q62009	POSTN_MOUSE	Periostin (PN) (Osteoblast-specific factor 2) (OSF-2)	GO:0001666; GO:0001953; GO:0003073; GO:0005615; GO:0005737; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009612; GO:0009888; GO:0014850; GO:0014911; GO:0030198; GO:0031012; GO:0031594; GO:0032355; GO:0044344; GO:0046872; GO:0050839; GO:0062023; GO:0071307; GO:0071356; GO:0071560; GO:1900025; GO:1904209; GO:1990138; GO:1990523	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]
PGEN_.00g092350	Scaffold_04	35418509	35421287	NA	NA	NA	NA	NA
PGEN_.00g092360	Scaffold_04	35424515	35424901	NA	NA	NA	NA	NA
PGEN_.00g092370	Scaffold_04	35451947	35461943	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g092380	Scaffold_04	35465852	35470200	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g092390	Scaffold_04	35475235	35483702	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g092400	Scaffold_04	35483727	35484122	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g092410	Scaffold_04	35509118	35513440	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g092420	Scaffold_04	35523889	35531402	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g092430	Scaffold_04	35537636	35575979	Q6P5D4	CP135_MOUSE	Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4)	GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0008022; GO:0010457; GO:1902857; GO:1904951	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein C-terminus binding [GO:0008022]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]
PGEN_.00g092440	Scaffold_04	35581677	35584334	Q4VBD9	GZF1_MOUSE	GDNF-inducible zinc finger protein 1 (Zinc finger protein 336)	GO:0000122; GO:0000978; GO:0001227; GO:0001658; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g092450	Scaffold_04	35599842	35605710	D3ZUU2	GZF1_RAT	GDNF-inducible zinc finger protein 1 (Zinc finger protein 336)	GO:0000122; GO:0000978; GO:0001227; GO:0001658; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0043565; GO:0045892; GO:0046872	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g092460	Scaffold_04	35611402	35618375	Q4VBD9	GZF1_MOUSE	GDNF-inducible zinc finger protein 1 (Zinc finger protein 336)	GO:0000122; GO:0000978; GO:0001227; GO:0001658; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g092470	Scaffold_04	35622952	35626734	Q4VBD9	GZF1_MOUSE	GDNF-inducible zinc finger protein 1 (Zinc finger protein 336)	GO:0000122; GO:0000978; GO:0001227; GO:0001658; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g092480	Scaffold_04	35634506	35637424	P17035	ZNF28_HUMAN	Zinc finger protein 28 (Zinc finger protein KOX24)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g092490	Scaffold_04	35646983	35656413	Q95K79	ALKB8_MACFA	Alkylated DNA repair protein alkB homolog 8 (EC 1.14.11.-) (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8) (EC 2.1.1.-) (EC 2.1.1.229)	GO:0000049; GO:0002098; GO:0005506; GO:0005634; GO:0005829; GO:0006974; GO:0008270; GO:0016300; GO:0016706; GO:0030488; GO:0055114	cytosol [GO:0005829]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g092500	Scaffold_04	35656826	35657338	NA	NA	NA	NA	NA
PGEN_.00g092510	Scaffold_04	35658267	35707440	Q8NI27	THOC2_HUMAN	THO complex subunit 2 (Tho2) (hTREX120)	GO:0000346; GO:0000347; GO:0000445; GO:0003729; GO:0005654; GO:0006405; GO:0006406; GO:0008380; GO:0016607; GO:0016973; GO:0031124; GO:0046784; GO:0048666; GO:0048699	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; mRNA binding [GO:0003729]; generation of neurons [GO:0048699]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]
PGEN_.00g092520	Scaffold_04	35719217	35729803	Q96AG4	LRC59_HUMAN	"Leucine-rich repeat-containing protein 59 (Ribosome-binding protein p34) (p34) [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]"	GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0042645; GO:0045296	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]
PGEN_.00g092530	Scaffold_04	35730150	35734075	Q9CQV1	TIM16_MOUSE	Mitochondrial import inner membrane translocase subunit TIM16 (Mitochondria-associated granulocyte macrophage CSF-signaling molecule) (Presequence translocated-associated motor subunit PAM16)	GO:0001405; GO:0001503; GO:0005737; GO:0005739; GO:0005743; GO:0005744; GO:0005759; GO:0030150; GO:0031314; GO:0032780; GO:0032991; GO:0043066; GO:0071897; GO:0090201; GO:1902511; GO:2001234	"cytoplasm [GO:0005737]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; PAM complex, Tim23 associated import motor [GO:0001405]; protein-containing complex [GO:0032991]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; DNA biosynthetic process [GO:0071897]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of ATPase activity [GO:0032780]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; ossification [GO:0001503]; protein import into mitochondrial matrix [GO:0030150]"
PGEN_.00g092540	Scaffold_04	35737805	35740358	Q28960	CBR1_PIG	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)	GO:0004090; GO:0005737; GO:0017144; GO:0042373; GO:0047021; GO:0050221	cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373]
PGEN_.00g092550	Scaffold_04	35750105	35770564	NA	NA	NA	NA	NA
PGEN_.00g092560	Scaffold_04	35796871	35812123	NA	NA	NA	NA	NA
PGEN_.00g092570	Scaffold_04	35813092	35816473	NA	NA	NA	NA	NA
PGEN_.00g092580	Scaffold_04	35824536	35835553	Q9VW71	FAT2_DROME	Fat-like cadherin-related tumor suppressor homolog (Protein kugelei)	GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463	actin-based cell projection [GO:0098858]; basal plasma membrane [GO:0009925]; cell trailing edge [GO:0031254]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein-containing complex binding [GO:0044877]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]
PGEN_.00g092590	Scaffold_04	35865239	35990829	Q14517	FAT1_HUMAN	"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]"	GO:0003382; GO:0005509; GO:0005634; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0045197; GO:0048471; GO:0048593; GO:0070062; GO:0098609	apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g092600	Scaffold_04	35998349	36003289	Q9Y3B3	TMED7_HUMAN	Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27)	GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0016021; GO:0030126; GO:0030127; GO:0030133; GO:0030134; GO:0033116	"COPI vesicle coat [GO:0030126]; COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g092610	Scaffold_04	36004039	36015714	NA	NA	NA	NA	NA
PGEN_.00g092620	Scaffold_04	36021100	36026421	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g092630	Scaffold_04	36095573	36102594	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g092640	Scaffold_04	36113937	36114212	Q9VQB7	EOGT_DROME	EGF domain-specific O-linked N-acetylglucosamine transferase (EC 2.4.1.255) (Extracellular O-linked N-acetylglucosamine transferase)	GO:0005788; GO:0006493; GO:0008363; GO:0016262; GO:0097363; GO:0097370	endoplasmic reticulum lumen [GO:0005788]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; larval chitin-based cuticle development [GO:0008363]; protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493]
PGEN_.00g092650	Scaffold_04	36114321	36115286	Q6ZFH6	RCN11_ORYSJ	"Beta-1,2-xylosyltransferase RCN11 (OsXylT) (EC 2.4.2.-) (Protein REDUCED CULM NUMBER 11)"	GO:0000139; GO:0005797; GO:0006487; GO:0016021; GO:0031204; GO:0035252; GO:0048367; GO:0050513	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein 2-beta-D-xylosyltransferase activity [GO:0050513]; UDP-xylosyltransferase activity [GO:0035252]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein N-linked glycosylation [GO:0006487]; shoot system development [GO:0048367]"
PGEN_.00g092660	Scaffold_04	36118155	36119171	NA	NA	NA	NA	NA
PGEN_.00g092670	Scaffold_04	36119293	36119583	NA	NA	NA	NA	NA
PGEN_.00g092680	Scaffold_04	36135201	36136580	Q9LDH0	XYLT_ARATH	"Beta-1,2-xylosyltransferase (AtXYLT) (EC 2.4.2.38)"	GO:0000138; GO:0000139; GO:0005794; GO:0005797; GO:0006487; GO:0016021; GO:0031204; GO:0042285; GO:0048367; GO:0050513	"Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; glycoprotein 2-beta-D-xylosyltransferase activity [GO:0050513]; xylosyltransferase activity [GO:0042285]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein N-linked glycosylation [GO:0006487]; shoot system development [GO:0048367]"
PGEN_.00g092690	Scaffold_04	36217779	36244610	Q6NTV6	INF2_XENLA	Inverted formin-2	GO:0003779; GO:0017048; GO:0030036	actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]
PGEN_.00g092700	Scaffold_04	36265071	36285621	Q6NTV6	INF2_XENLA	Inverted formin-2	GO:0003779; GO:0017048; GO:0030036	actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]
PGEN_.00g092710	Scaffold_04	36346650	36348449	NA	NA	NA	NA	NA
PGEN_.00g092720	Scaffold_04	36356472	36371528	NA	NA	NA	NA	NA
PGEN_.00g092730	Scaffold_04	36371906	36388647	P07742	RIR1_MOUSE	Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)	GO:0000278; GO:0004748; GO:0005524; GO:0005635; GO:0005737; GO:0005829; GO:0005971; GO:0006206; GO:0006260; GO:0008584; GO:0009263; GO:0010212; GO:0017076; GO:0021846; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0060041; GO:0097718	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041]"
PGEN_.00g092740	Scaffold_04	36394491	36397194	P91924	ARF_DUGJA	ADP-ribosylation factor	GO:0005525; GO:0005794; GO:0015031; GO:0016192	Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g092750	Scaffold_04	36402550	36411305	O74549	UBC12_SCHPO	NEDD8-conjugating enzyme ubc12 (EC 2.3.2.-) (RUB1-conjugating enzyme) (Ubiquitin carrier protein 12)	GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; protein neddylation [GO:0045116]
PGEN_.00g092760	Scaffold_04	36415477	36434083	Q28E45	MCM10_XENTR	Protein MCM10 homolog	GO:0003688; GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0031298; GO:0046872	nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]
PGEN_.00g092770	Scaffold_04	36459308	36459754	NA	NA	NA	NA	NA
PGEN_.00g092780	Scaffold_04	36543279	36548175	NA	NA	NA	NA	NA
PGEN_.00g092790	Scaffold_04	36550651	36562015	NA	NA	NA	NA	NA
PGEN_.00g092800	Scaffold_04	36562550	36575224	NA	NA	NA	NA	NA
PGEN_.00g092810	Scaffold_04	36567943	36568434	NA	NA	NA	NA	NA
PGEN_.00g092820	Scaffold_04	36576275	36588735	NA	NA	NA	NA	NA
PGEN_.00g092830	Scaffold_04	36588796	36602837	NA	NA	NA	NA	NA
PGEN_.00g092840	Scaffold_04	36608665	36626228	NA	NA	NA	NA	NA
PGEN_.00g092850	Scaffold_04	36628981	36631951	NA	NA	NA	NA	NA
PGEN_.00g092860	Scaffold_04	36636751	36648714	NA	NA	NA	NA	NA
PGEN_.00g092870	Scaffold_04	36652765	36658496	NA	NA	NA	NA	NA
PGEN_.00g092880	Scaffold_04	36664679	36676304	NA	NA	NA	NA	NA
PGEN_.00g092890	Scaffold_04	36680477	36690515	NA	NA	NA	NA	NA
PGEN_.00g092900	Scaffold_04	36719790	36720491	NA	NA	NA	NA	NA
PGEN_.00g092910	Scaffold_04	36754086	36768801	O75899	GABR2_HUMAN	Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)	GO:0004965; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007194; GO:0007214; GO:0007268; GO:0030054; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0150099; GO:1902710	cell junction [GO:0030054]; cytoplasm [GO:0005737]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]
PGEN_.00g092920	Scaffold_04	36806841	36807071	NA	NA	NA	NA	NA
PGEN_.00g092930	Scaffold_04	36813312	36814142	NA	NA	NA	NA	NA
PGEN_.00g092940	Scaffold_04	36814617	36815096	NA	NA	NA	NA	NA
PGEN_.00g092950	Scaffold_04	36821036	36828235	NA	NA	NA	NA	NA
PGEN_.00g092960	Scaffold_04	36907212	36915109	NA	NA	NA	NA	NA
PGEN_.00g092970	Scaffold_04	36915333	36944681	G5EBX9	PPE_CAEEL	Serine/threonine-protein phosphatase with EF-hands pef-1 (CePPEF) (EC 3.1.3.16) (Phosphatase with EF hands 1)	GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0030145; GO:0030424; GO:0030425; GO:0043025; GO:0043204; GO:0050906	axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; detection of stimulus involved in sensory perception [GO:0050906]
PGEN_.00g092980	Scaffold_04	36992904	37034784	Q8NBS3	S4A11_HUMAN	Sodium bicarbonate transporter-like protein 11 (Bicarbonate transporter-related protein 1) (Sodium borate cotransporter 1) (NaBC1) (Solute carrier family 4 member 11)	GO:0005272; GO:0005452; GO:0005623; GO:0006814; GO:0015106; GO:0015252; GO:0015293; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0030003; GO:0042044; GO:0046713; GO:0046715; GO:0046983; GO:0051453; GO:1902600	basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; integral component of membrane [GO:0016021]; active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]; bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; fluid transport [GO:0042044]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814]
PGEN_.00g092990	Scaffold_04	37035854	37036105	NA	NA	NA	NA	NA
PGEN_.00g093000	Scaffold_04	37036320	37040530	NA	NA	NA	NA	NA
PGEN_.00g093010	Scaffold_04	37096759	37110246	P50430	ARSB_RAT	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]
PGEN_.00g093020	Scaffold_04	37114066	37115592	G5E8K5	ANK3_MOUSE	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g093030	Scaffold_04	37121157	37122875	Q9V3H8	NXT1_DROME	NTF2-related export protein (p15)	GO:0005635; GO:0005654; GO:0005737; GO:0006606; GO:0006913; GO:0016973; GO:0044613; GO:0045824; GO:0050829	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of innate immune response [GO:0045824]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]
PGEN_.00g093040	Scaffold_04	37132475	37142077	Q9HC07	TM165_HUMAN	Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL)	GO:0005623; GO:0005765; GO:0005794; GO:0006487; GO:0006874; GO:0010008; GO:0016021; GO:0031901; GO:0031902; GO:0032472; GO:0032588; GO:0035751; GO:0043231	cell [GO:0005623]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751]
PGEN_.00g093050	Scaffold_04	37152086	37175009	P91427	PGK_CAEEL	Probable phosphoglycerate kinase (EC 2.7.2.3)	GO:0004618; GO:0005524; GO:0005829; GO:0006094; GO:0006096; GO:0016310; GO:0043531; GO:1903862	cytosol [GO:0005829]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310]; positive regulation of oxidative phosphorylation [GO:1903862]
PGEN_.00g093060	Scaffold_04	37178758	37179234	NA	NA	NA	NA	NA
PGEN_.00g093070	Scaffold_04	37206854	37221219	NA	NA	NA	NA	NA
PGEN_.00g093080	Scaffold_04	37321371	37321841	NA	NA	NA	NA	NA
PGEN_.00g093090	Scaffold_04	37381249	37394147	P61215	CAH10_MOUSE	Carbonic anhydrase-related protein 10 (Carbonic anhydrase-related protein X) (CA-RP X) (CARP X)	GO:0004089; GO:0008270	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
PGEN_.00g093100	Scaffold_04	37401910	37406808	NA	NA	NA	NA	NA
PGEN_.00g093110	Scaffold_04	37430045	37456510	Q14162	SREC_HUMAN	Scavenger receptor class F member 1 (Acetyl LDL receptor) (Scavenger receptor expressed by endothelial cells 1) (SREC-I)	GO:0004888; GO:0005044; GO:0005886; GO:0006707; GO:0006898; GO:0007155; GO:0010976; GO:0016021; GO:0016322; GO:0016358; GO:0030169; GO:0030666; GO:0048680	endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g093120	Scaffold_04	37470699	37470977	NA	NA	NA	NA	NA
PGEN_.00g093130	Scaffold_04	37479771	37491272	Q06805	TIE1_BOVIN	Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)	GO:0001525; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0043235; GO:0045766	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g093140	Scaffold_04	37520492	37535514	Q14162	SREC_HUMAN	Scavenger receptor class F member 1 (Acetyl LDL receptor) (Scavenger receptor expressed by endothelial cells 1) (SREC-I)	GO:0004888; GO:0005044; GO:0005886; GO:0006707; GO:0006898; GO:0007155; GO:0010976; GO:0016021; GO:0016322; GO:0016358; GO:0030169; GO:0030666; GO:0048680	endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g093150	Scaffold_04	37668125	37693320	Q14162	SREC_HUMAN	Scavenger receptor class F member 1 (Acetyl LDL receptor) (Scavenger receptor expressed by endothelial cells 1) (SREC-I)	GO:0004888; GO:0005044; GO:0005886; GO:0006707; GO:0006898; GO:0007155; GO:0010976; GO:0016021; GO:0016322; GO:0016358; GO:0030169; GO:0030666; GO:0048680	endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g093160	Scaffold_04	37699031	37699513	NA	NA	NA	NA	NA
PGEN_.00g093170	Scaffold_04	37700283	37707896	NA	NA	NA	NA	NA
PGEN_.00g093180	Scaffold_04	37722474	37754936	A0JM12	MEG10_XENTR	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0005112; GO:0005886; GO:0007155; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0043277	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Notch binding [GO:0005112]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g093190	Scaffold_04	37790874	37807671	Q96KG7	MEG10_HUMAN	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g093200	Scaffold_04	37816559	37817544	NA	NA	NA	NA	NA
PGEN_.00g093210	Scaffold_04	37817701	37838239	O75095	MEGF6_HUMAN	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g093220	Scaffold_04	37854256	37854652	NA	NA	NA	NA	NA
PGEN_.00g093230	Scaffold_04	37855746	37856024	NA	NA	NA	NA	NA
PGEN_.00g093240	Scaffold_04	37856126	37856787	NA	NA	NA	NA	NA
PGEN_.00g093250	Scaffold_04	37870436	37883362	O75095	MEGF6_HUMAN	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g093260	Scaffold_04	38019978	38031221	O68007	BACB_BACLI	Bacitracin synthase 2 (BA2) [Includes: ATP-dependent lysine adenylase (LysA) (Lysine activase); ATP-dependent D-ornithine adenylase (D-OrnA) (D-ornithine activase); Ornithine racemase (EC 5.1.1.12)]	GO:0016874; GO:0017000; GO:0050157	ligase activity [GO:0016874]; ornithine racemase activity [GO:0050157]; antibiotic biosynthetic process [GO:0017000]
PGEN_.00g093270	Scaffold_04	38034990	38051960	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g093280	Scaffold_04	38100018	38169915	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g093290	Scaffold_04	38171409	38205162	Q5ND28	SREC_MOUSE	Scavenger receptor class F member 1 (Acetyl LDL receptor) (Scavenger receptor expressed by endothelial cells 1 protein) (SREC-I)	GO:0005044; GO:0005886; GO:0006898; GO:0007155; GO:0010976; GO:0016021; GO:0016322; GO:0016358; GO:0030169; GO:0048680	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g093300	Scaffold_04	38210094	38264358	Q6DIB5	MEG10_MOUSE	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g093310	Scaffold_04	38295241	38303665	Q96KG7	MEG10_HUMAN	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g093320	Scaffold_04	38328332	38354155	Q80T91	MEG11_MOUSE	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	GO:0010842; GO:0016021; GO:0016323; GO:0034109	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
PGEN_.00g093330	Scaffold_04	38358435	38359682	P34456	YMD2_CAEEL	Uncharacterized protein F54H12.2	GO:0004748; GO:0005829; GO:0009263	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]"
PGEN_.00g093340	Scaffold_04	38413903	38430779	D9IQ16	GXN_ACRMI	Galaxin	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g093350	Scaffold_04	38444208	38463113	Q29IK4	RM22_DROPS	"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)"	GO:0003735; GO:0005739; GO:0005762; GO:0006412	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g093360	Scaffold_04	38479542	38528741	Q14832	GRM3_HUMAN	Metabotropic glutamate receptor 3 (mGluR3)	GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0005887; GO:0007186; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0014069; GO:0030424; GO:0043197; GO:0051966; GO:0098978; GO:0099055; GO:0099056	"axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission, glutamatergic [GO:0051966]"
PGEN_.00g093370	Scaffold_04	38532393	38534680	NA	NA	NA	NA	NA
PGEN_.00g093380	Scaffold_04	38552312	38552656	NA	NA	NA	NA	NA
PGEN_.00g093390	Scaffold_04	38590400	38610321	P58743	S26A5_HUMAN	Prestin (Solute carrier family 26 member 5)	GO:0002931; GO:0005737; GO:0005887; GO:0007605; GO:0008134; GO:0008271; GO:0008360; GO:0009751; GO:0010996; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015755; GO:0016323; GO:0016328; GO:0019531; GO:0030507; GO:0034766; GO:0035864; GO:0042391; GO:0042803; GO:0045793; GO:0051262; GO:0090102; GO:0097066; GO:1902074; GO:2000147	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; protein homodimerization activity [GO:0042803]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]; transcription factor binding [GO:0008134]; cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; protein tetramerization [GO:0051262]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605]
PGEN_.00g093400	Scaffold_04	38628644	38628919	NA	NA	NA	NA	NA
PGEN_.00g093410	Scaffold_04	38638562	38657791	O43511	S26A4_HUMAN	Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4)	GO:0005886; GO:0005887; GO:0006811; GO:0006885; GO:0007605; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015111; GO:0015116; GO:0015301; GO:0015698; GO:0016021; GO:0016324; GO:0019531; GO:0031526; GO:0032880; GO:0070062	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; iodide transmembrane transporter activity [GO:0015111]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; inorganic anion transport [GO:0015698]; ion transport [GO:0006811]; regulation of pH [GO:0006885]; regulation of protein localization [GO:0032880]; sensory perception of sound [GO:0007605]; sulfate transport [GO:0008272]
PGEN_.00g093420	Scaffold_04	38699465	38700520	Q8IN35	SIFAR_DROME	Neuropeptide SIFamide receptor	GO:0004930; GO:0004983; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016021; GO:0032870; GO:0048047	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g093430	Scaffold_04	38731520	38752820	Q91502	SC6A8_TORMA	Creatine transporter	GO:0005328; GO:0016021	integral component of membrane [GO:0016021]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g093440	Scaffold_04	38759146	38760417	NA	NA	NA	NA	NA
PGEN_.00g093450	Scaffold_04	38760419	38760844	NA	NA	NA	NA	NA
PGEN_.00g093460	Scaffold_04	38760914	38761375	NA	NA	NA	NA	NA
PGEN_.00g093470	Scaffold_04	38761800	38762492	NA	NA	NA	NA	NA
PGEN_.00g093480	Scaffold_04	38775103	38793840	O00339	MATN2_HUMAN	Matrilin-2	GO:0001764; GO:0003429; GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007411; GO:0008347; GO:0031012; GO:0031104; GO:0048678; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; glial cell migration [GO:0008347]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]
PGEN_.00g093490	Scaffold_04	38806831	38841316	O18875	SC6A8_BOVIN	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	GO:0005309; GO:0005332; GO:0005886; GO:0005887; GO:0015881; GO:0042165; GO:0043005	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; creatine:sodium symporter activity [GO:0005309]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; creatine transmembrane transport [GO:0015881]
PGEN_.00g093500	Scaffold_04	38845510	38873774	O18875	SC6A8_BOVIN	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	GO:0005309; GO:0005332; GO:0005886; GO:0005887; GO:0015881; GO:0042165; GO:0043005	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; creatine:sodium symporter activity [GO:0005309]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; creatine transmembrane transport [GO:0015881]
PGEN_.00g093510	Scaffold_04	38882860	38893393	Q8N1A6	CD033_HUMAN	UPF0462 protein C4orf33		
PGEN_.00g093520	Scaffold_04	38895065	38897901	NA	NA	NA	NA	NA
PGEN_.00g093530	Scaffold_04	38905061	38914019	NA	NA	NA	NA	NA
PGEN_.00g093540	Scaffold_04	38914969	38915499	NA	NA	NA	NA	NA
PGEN_.00g093550	Scaffold_04	38928186	38930116	Q7TM99	MOT9_MOUSE	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g093560	Scaffold_04	38944398	38970628	Q9VNL4	GRCR1_DROME	Glutaredoxin domain-containing cysteine-rich protein CG31559	GO:0005623; GO:0009055; GO:0015035; GO:0045454	cell [GO:0005623]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]
PGEN_.00g093570	Scaffold_04	38988879	39037303	NA	NA	NA	NA	NA
PGEN_.00g093580	Scaffold_04	39037678	39078358	O95239	KIF4A_HUMAN	Chromosome-associated kinesin KIF4A (Chromokinesin-A)	GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005876; GO:0006890; GO:0006996; GO:0007018; GO:0007052; GO:0008017; GO:0008089; GO:0016020; GO:0016363; GO:0016887; GO:0019886; GO:0030496; GO:0051256; GO:1904115	"axon cytoplasm [GO:1904115]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; organelle organization [GO:0006996]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g093590	Scaffold_04	39078705	39085390	Q9NWY4	HPF1_HUMAN	Histone PARylation factor 1	GO:0005634; GO:0006974; GO:0008270; GO:0010835; GO:0018312; GO:0042393; GO:0072572	nucleus [GO:0005634]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]
PGEN_.00g093600	Scaffold_04	39106519	39117179	Q24799	MYPH_ECHGR	Myophilin		
PGEN_.00g093610	Scaffold_04	39120797	39122646	NA	NA	NA	NA	NA
PGEN_.00g093620	Scaffold_04	39131850	39133931	NA	NA	NA	NA	NA
PGEN_.00g093630	Scaffold_04	39139376	39145674	NA	NA	NA	NA	NA
PGEN_.00g093640	Scaffold_04	39182079	39184075	NA	NA	NA	NA	NA
PGEN_.00g093650	Scaffold_04	39217316	39255121	Q9Y345	SC6A5_HUMAN	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g093660	Scaffold_04	39259758	39260105	NA	NA	NA	NA	NA
PGEN_.00g093670	Scaffold_04	39276980	39278029	NA	NA	NA	NA	NA
PGEN_.00g093680	Scaffold_04	39280873	39284959	NA	NA	NA	NA	NA
PGEN_.00g093690	Scaffold_04	39301391	39360344	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g093700	Scaffold_04	39361019	39361324	NA	NA	NA	NA	NA
PGEN_.00g093710	Scaffold_04	39362114	39362437	NA	NA	NA	NA	NA
PGEN_.00g093720	Scaffold_04	39362798	39363157	NA	NA	NA	NA	NA
PGEN_.00g093730	Scaffold_04	39363188	39364067	NA	NA	NA	NA	NA
PGEN_.00g093740	Scaffold_04	39364308	39364652	NA	NA	NA	NA	NA
PGEN_.00g093750	Scaffold_04	39365607	39365876	NA	NA	NA	NA	NA
PGEN_.00g093760	Scaffold_04	39366132	39366455	NA	NA	NA	NA	NA
PGEN_.00g093770	Scaffold_04	39366947	39367252	NA	NA	NA	NA	NA
PGEN_.00g093780	Scaffold_04	39367442	39367681	NA	NA	NA	NA	NA
PGEN_.00g093790	Scaffold_04	39367977	39368264	NA	NA	NA	NA	NA
PGEN_.00g093800	Scaffold_04	39368559	39377616	Q8R422	CD109_MOUSE	CD109 antigen (GPI-anchored alpha-2 macroglobulin-related protein) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0004867; GO:0005615; GO:0005829; GO:0005886; GO:0010839; GO:0030512; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g093810	Scaffold_04	39382663	39390114	NA	NA	NA	NA	NA
PGEN_.00g093820	Scaffold_04	39399995	39419266	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g093830	Scaffold_04	39425901	39427936	NA	NA	NA	NA	NA
PGEN_.00g093840	Scaffold_04	39432580	39440358	A8K2U0	A2ML1_HUMAN	Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9)	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0030414; GO:0052548; GO:0070062	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of endopeptidase activity [GO:0052548]
PGEN_.00g093850	Scaffold_04	39444984	39445331	NA	NA	NA	NA	NA
PGEN_.00g093860	Scaffold_04	39494077	39562291	Q761V0	SC6A5_MOUSE	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0001504; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g093870	Scaffold_04	39570316	39578717	O75382	TRIM3_HUMAN	Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97)	GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008022; GO:0008270; GO:0015031; GO:0030425; GO:0043161; GO:0061630	cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]
PGEN_.00g093880	Scaffold_04	39588223	39590083	Q6UW01	CBLN3_HUMAN	Cerebellin-3	GO:0005615; GO:0005783; GO:0005794; GO:0030054; GO:0045202	cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202]
PGEN_.00g093890	Scaffold_04	39601789	39604064	NA	NA	NA	NA	NA
PGEN_.00g093900	Scaffold_04	39698012	39698528	NA	NA	NA	NA	NA
PGEN_.00g093910	Scaffold_04	39698739	39701008	NA	NA	NA	NA	NA
PGEN_.00g093920	Scaffold_04	39941303	39942297	NA	NA	NA	NA	NA
PGEN_.00g093930	Scaffold_04	39944692	39949920	NA	NA	NA	NA	NA
PGEN_.00g093940	Scaffold_04	39951959	39954340	NA	NA	NA	NA	NA
PGEN_.00g093950	Scaffold_04	40028380	40028640	Q9NZJ4	SACS_HUMAN	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]
PGEN_.00g093960	Scaffold_04	40035794	40046635	NA	NA	NA	NA	NA
PGEN_.00g093970	Scaffold_04	40049141	40064452	Q8VIF2	PRS42_MOUSE	Serine protease 42 (EC 3.4.21.-) (Testis serine protease 2)	GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0007281; GO:0007283; GO:0046658	anchored component of plasma membrane [GO:0046658]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; germ cell development [GO:0007281]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]
PGEN_.00g093980	Scaffold_04	40088019	40098762	Q9DBI0	TMPS6_MOUSE	Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2)	GO:0000122; GO:0004252; GO:0005615; GO:0005623; GO:0005886; GO:0006508; GO:0006879; GO:0016021; GO:0030514; GO:0033619; GO:0042730; GO:0045892; GO:0045944; GO:0055072; GO:0097264	"cell [GO:0005623]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; cellular iron ion homeostasis [GO:0006879]; fibrinolysis [GO:0042730]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]"
PGEN_.00g093990	Scaffold_04	40113741	40124683	Q9VWK6	PGP2L_DROME	Post-GPI attachment to proteins factor 2-like	GO:0000139; GO:0005789; GO:0006506; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g094000	Scaffold_04	40124929	40162087	Q8K2G4	BBS7_MOUSE	Bardet-Biedl syndrome 7 protein homolog (BBS2-like protein 1)	GO:0001103; GO:0001654; GO:0001750; GO:0005634; GO:0005813; GO:0005930; GO:0006357; GO:0007224; GO:0007420; GO:0007507; GO:0008104; GO:0015031; GO:0016020; GO:0032436; GO:0034464; GO:0036064; GO:0043005; GO:0045444; GO:0046907; GO:0060170; GO:0060173; GO:0060271; GO:1903929; GO:1905515	axoneme [GO:0005930]; BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; RNA polymerase II repressing transcription factor binding [GO:0001103]; brain development [GO:0007420]; cilium assembly [GO:0060271]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; intracellular transport [GO:0046907]; limb development [GO:0060173]; non-motile cilium assembly [GO:1905515]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]
PGEN_.00g094010	Scaffold_04	40177786	40251498	O94868	FCSD2_HUMAN	F-BAR and double SH3 domains protein 2 (Carom) (Protein nervous wreck 1) (NWK1) (SH3 multiple domains protein 3)	GO:0005547; GO:0005886; GO:0005905; GO:0007274; GO:0015031; GO:0030054; GO:0030833; GO:0030838; GO:0031594; GO:0043325; GO:0044803; GO:0055037; GO:0072583; GO:0120043; GO:2000601	"cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stereocilium shaft [GO:0120043]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; clathrin-dependent endocytosis [GO:0072583]; multi-organism membrane organization [GO:0044803]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833]"
PGEN_.00g094020	Scaffold_04	40225989	40226429	NA	NA	NA	NA	NA
PGEN_.00g094030	Scaffold_04	40257406	40281241	Q5RED7	AGK_PONAB	"Acylglycerol kinase, mitochondrial (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) (MuLK) (Multi-substrate lipid kinase)"	GO:0001729; GO:0003951; GO:0004143; GO:0005524; GO:0005743; GO:0005758; GO:0031305; GO:0031966; GO:0042721; GO:0045039; GO:0046486; GO:0046513; GO:0047620; GO:0102773	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; diacylglycerol kinase activity [GO:0004143]; dihydroceramide kinase activity [GO:0102773]; NAD+ kinase activity [GO:0003951]; ceramide biosynthetic process [GO:0046513]; glycerolipid metabolic process [GO:0046486]; protein insertion into mitochondrial inner membrane [GO:0045039]
PGEN_.00g094040	Scaffold_04	40283159	40283539	NA	NA	NA	NA	NA
PGEN_.00g094050	Scaffold_04	40285364	40285714	NA	NA	NA	NA	NA
PGEN_.00g094060	Scaffold_04	40290168	40296527	Q56R14	TRI33_XENLA	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g094070	Scaffold_04	40302735	40307694	NA	NA	NA	NA	NA
PGEN_.00g094080	Scaffold_04	40310365	40318148	NA	NA	NA	NA	NA
PGEN_.00g094090	Scaffold_04	40323174	40328737	NA	NA	NA	NA	NA
PGEN_.00g094100	Scaffold_04	40330323	40338518	NA	NA	NA	NA	NA
PGEN_.00g094110	Scaffold_04	40345894	40346379	NA	NA	NA	NA	NA
PGEN_.00g094120	Scaffold_04	40346510	40346926	NA	NA	NA	NA	NA
PGEN_.00g094130	Scaffold_04	40359195	40366858	NA	NA	NA	NA	NA
PGEN_.00g094140	Scaffold_04	40375302	40375589	NA	NA	NA	NA	NA
PGEN_.00g094150	Scaffold_04	40381180	40433767	P82198	BGH3_MOUSE	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3)	GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]
PGEN_.00g094160	Scaffold_04	40463553	40467081	NA	NA	NA	NA	NA
PGEN_.00g094170	Scaffold_04	40477346	40477612	NA	NA	NA	NA	NA
PGEN_.00g094180	Scaffold_04	40478252	40481372	NA	NA	NA	NA	NA
PGEN_.00g094190	Scaffold_04	40482768	40483572	NA	NA	NA	NA	NA
PGEN_.00g094200	Scaffold_04	40483601	40483957	NA	NA	NA	NA	NA
PGEN_.00g094210	Scaffold_04	40489286	40490170	Q15063	POSTN_HUMAN	Periostin (PN) (Osteoblast-specific factor 2) (OSF-2)	GO:0001666; GO:0001953; GO:0003073; GO:0005615; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009612; GO:0014850; GO:0014911; GO:0030198; GO:0031012; GO:0031594; GO:0032355; GO:0044344; GO:0046872; GO:0050839; GO:0062023; GO:0071307; GO:0071356; GO:0071560; GO:1900025; GO:1904209; GO:1990138; GO:1990523	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]
PGEN_.00g094220	Scaffold_04	40557609	40557980	NA	NA	NA	NA	NA
PGEN_.00g094230	Scaffold_04	40560714	40564936	NA	NA	NA	NA	NA
PGEN_.00g094240	Scaffold_04	40566053	40571315	NA	NA	NA	NA	NA
PGEN_.00g094250	Scaffold_04	40626916	40632604	NA	NA	NA	NA	NA
PGEN_.00g094260	Scaffold_04	40636488	40653674	NA	NA	NA	NA	NA
PGEN_.00g094270	Scaffold_04	40657214	40657555	NA	NA	NA	NA	NA
PGEN_.00g094280	Scaffold_04	40660920	40664755	Q6P5I8	YIPF5_DANRE	Protein YIPF5 (YIP1 family member 5)	GO:0005789; GO:0005794; GO:0015031; GO:0016021; GO:0016192	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g094290	Scaffold_04	40671401	40671787	NA	NA	NA	NA	NA
PGEN_.00g094300	Scaffold_04	40672071	40679007	NA	NA	NA	NA	NA
PGEN_.00g094310	Scaffold_04	40716918	40720970	NA	NA	NA	NA	NA
PGEN_.00g094320	Scaffold_04	40724354	40726330	Q3URE9	LIGO2_MOUSE	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 6C)	GO:0005615; GO:0016021; GO:0031012; GO:0051965	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]
PGEN_.00g094330	Scaffold_04	40738437	40745750	Q6P5I8	YIPF5_DANRE	Protein YIPF5 (YIP1 family member 5)	GO:0005789; GO:0005794; GO:0015031; GO:0016021; GO:0016192	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g094340	Scaffold_04	40754813	40759161	Q963B7	RL9_SPOFR	60S ribosomal protein L9	GO:0003735; GO:0005840; GO:0006412; GO:0019843	ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g094350	Scaffold_04	40770204	40777458	Q28CH8	YIPF6_XENTR	Protein YIPF6 (YIP1 family member 6)	GO:0000138; GO:0000139; GO:0005797; GO:0005802; GO:0016021	Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]
PGEN_.00g094360	Scaffold_04	40779810	40794468	Q28F39	CC134_XENTR	Coiled-coil domain-containing protein 134	GO:0005576; GO:0005634; GO:0005783	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]
PGEN_.00g094370	Scaffold_04	40801468	40804708	NA	NA	NA	NA	NA
PGEN_.00g094380	Scaffold_04	40813930	40816613	NA	NA	NA	NA	NA
PGEN_.00g094390	Scaffold_04	40823633	40825156	Q4V348	Z658B_HUMAN	Zinc finger protein 658B	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g094400	Scaffold_04	40826254	40827453	NA	NA	NA	NA	NA
PGEN_.00g094410	Scaffold_04	40827638	40832389	NA	NA	NA	NA	NA
PGEN_.00g094420	Scaffold_04	40852643	40888962	B7Z0W9	OTOP_DROME	Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)	GO:0005886; GO:0015252; GO:0016021; GO:1902600	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]
PGEN_.00g094430	Scaffold_04	40897474	40901721	Q9UT67	IMT2_SCHPO	Inositol phosphoceramide mannosyltransferase 2 (EC 2.4.-.-) (IPC mannosyltransferase 2)	GO:0000030; GO:0005794; GO:0016021; GO:0031501; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g094440	Scaffold_04	40927599	40943357	NA	NA	NA	NA	NA
PGEN_.00g094450	Scaffold_04	41049613	41062906	NA	NA	NA	NA	NA
PGEN_.00g094460	Scaffold_04	41088098	41095157	NA	NA	NA	NA	NA
PGEN_.00g094470	Scaffold_04	41110726	41122899	F4KD71	DUR3_ARATH	Urea-proton symporter DUR3 (AtDUR3) (High-affinity urea active transporter DUR3)	GO:0005886; GO:0006995; GO:0015204; GO:0015293; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918]
PGEN_.00g094480	Scaffold_04	41126626	41127111	NA	NA	NA	NA	NA
PGEN_.00g094490	Scaffold_04	41141400	41149846	Q9URY6	DUR33_SCHPO	Probable urea active transporter 3	GO:0000139; GO:0005737; GO:0005794; GO:0005886; GO:0015204; GO:0015489; GO:0015606; GO:0015840; GO:0015847; GO:0015848; GO:0016021; GO:0071918	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; putrescine transmembrane transporter activity [GO:0015489]; spermidine transmembrane transporter activity [GO:0015606]; urea transmembrane transporter activity [GO:0015204]; putrescine transport [GO:0015847]; spermidine transport [GO:0015848]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]
PGEN_.00g094500	Scaffold_04	41236872	41248845	Q7XBS0	DUR3_ORYSJ	Urea-proton symporter DUR3 (OsDUR3) (High-affinity urea active transporter DUR3)	GO:0005886; GO:0015204; GO:0015293; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; urea transmembrane transport [GO:0071918]
PGEN_.00g094510	Scaffold_04	41275574	41285207	F4KD71	DUR3_ARATH	Urea-proton symporter DUR3 (AtDUR3) (High-affinity urea active transporter DUR3)	GO:0005886; GO:0006995; GO:0015204; GO:0015293; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918]
PGEN_.00g094520	Scaffold_04	41293035	41330986	Q9TU53	CUBN_CANLF	Cubilin	GO:0005509; GO:0005765; GO:0005768; GO:0005905; GO:0008144; GO:0008203; GO:0015031; GO:0016324; GO:0031419; GO:0031526	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; lysosomal membrane [GO:0005765]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]
PGEN_.00g094530	Scaffold_04	41347333	41371111	P42839	VNX1_YEAST	Low affinity vacuolar monovalent cation/H(+) antiporter (Vacuolar Na(+)/H(+) exchanger)	GO:0000324; GO:0000329; GO:0005623; GO:0005789; GO:0006813; GO:0006814; GO:0006874; GO:0015369; GO:0015385; GO:0015386; GO:0016021; GO:0070588; GO:1902600; GO:1990816	cell [GO:0005623]; endoplasmic reticulum membrane [GO:0005789]; fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; vacuole-mitochondrion membrane contact site [GO:1990816]; calcium:proton antiporter activity [GO:0015369]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; sodium ion transport [GO:0006814]
PGEN_.00g094540	Scaffold_04	41375965	41392254	Q5ZM71	SP20H_CHICK	Transcription factor SPT20 homolog	GO:0000124; GO:0003712; GO:0006357; GO:0007369	SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; gastrulation [GO:0007369]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g094550	Scaffold_04	41443869	41449289	Q9NP73	ALG13_HUMAN	Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 (EC 2.4.1.141) (EC 3.4.19.12) (Asparagine-linked glycosylation 13 homolog) (Glycosyltransferase 28 domain-containing protein 1) (UDP-N-acetylglucosamine transferase subunit ALG13 homolog)	GO:0003723; GO:0004577; GO:0005789; GO:0006488; GO:0036459	endoplasmic reticulum membrane [GO:0005789]; N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]; RNA binding [GO:0003723]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]
PGEN_.00g094560	Scaffold_04	41453895	41456174	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g094570	Scaffold_04	41466638	41475990	NA	NA	NA	NA	NA
PGEN_.00g094580	Scaffold_04	41608062	41608430	NA	NA	NA	NA	NA
PGEN_.00g094590	Scaffold_04	41707473	41708467	NA	NA	NA	NA	NA
PGEN_.00g094600	Scaffold_04	41734418	41757628	NA	NA	NA	NA	NA
PGEN_.00g094610	Scaffold_04	41801112	41807808	Q7XUW4	KOR2_ORYSJ	Potassium channel KOR2 (K(+) outward-rectifying channel 2)	GO:0005249; GO:0016021; GO:0034765	integral component of membrane [GO:0016021]; voltage-gated potassium channel activity [GO:0005249]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g094620	Scaffold_04	41921690	41922313	O08786	CCKAR_MOUSE	Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R)	GO:0001659; GO:0001696; GO:0001764; GO:0002023; GO:0004930; GO:0004951; GO:0005623; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0005887; GO:0007186; GO:0007204; GO:0007409; GO:0007631; GO:0009408; GO:0016020; GO:0017046; GO:0030073; GO:0030157; GO:0030900; GO:0031532; GO:0032870; GO:0038188; GO:0042594; GO:0042755; GO:0043195; GO:0043266; GO:0046883; GO:0051924; GO:0090274	cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cellular response to hormone stimulus [GO:0032870]; cholecystokinin signaling pathway [GO:0038188]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric acid secretion [GO:0001696]; insulin secretion [GO:0030073]; neuron migration [GO:0001764]; pancreatic juice secretion [GO:0030157]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of somatostatin secretion [GO:0090274]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of calcium ion transport [GO:0051924]; regulation of hormone secretion [GO:0046883]; regulation of potassium ion transport [GO:0043266]; response to heat [GO:0009408]; response to starvation [GO:0042594]; temperature homeostasis [GO:0001659]
PGEN_.00g094630	Scaffold_04	42059795	42060538	NA	NA	NA	NA	NA
PGEN_.00g094640	Scaffold_04	42127065	42135704	Q7Z5L3	C1QL2_HUMAN	Complement C1q-like protein 2 (C1q and tumor necrosis factor-related protein 10) (C1q/TNF-related protein 10)	GO:0005576; GO:0005581; GO:0042802	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]
PGEN_.00g094650	Scaffold_04	42140914	42147961	P23435	CBLN1_HUMAN	Cerebellin-1 (Precerebellin) [Cleaved into: Cerebellin (CER); [des-Ser1]-cerebellin]	GO:0007157; GO:0007268; GO:0007399; GO:0009306; GO:0021707; GO:0030054; GO:0042803; GO:0043083; GO:0045211; GO:0051965; GO:0062023; GO:0090394; GO:0098688; GO:0098978; GO:0099151; GO:1900454; GO:1905606	cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; synaptic cleft [GO:0043083]; protein homodimerization activity [GO:0042803]; cerebellar granule cell differentiation [GO:0021707]; chemical synaptic transmission [GO:0007268]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of excitatory postsynaptic potential [GO:0090394]; nervous system development [GO:0007399]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein secretion [GO:0009306]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]
PGEN_.00g094660	Scaffold_04	42172656	42177207	P31315	GSX1_MOUSE	GS homeobox 1 (Homeobox protein GSH-1)	GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0007417; GO:0021527; GO:0021854; GO:0021984; GO:0030182; GO:0043565; GO:0045944; GO:0048663	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; adenohypophysis development [GO:0021984]; central nervous system development [GO:0007417]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]"
PGEN_.00g094670	Scaffold_04	42221390	42221590	NA	NA	NA	NA	NA
PGEN_.00g094680	Scaffold_04	42267931	42296750	P70118	PDX1_MESAU	Pancreas/duodenum homeobox protein 1 (Homeodomain protein PDX1) (Insulin promoter factor 1) (IPF-1)	GO:0003700; GO:0005634; GO:0005829; GO:0043565	cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]
PGEN_.00g094690	Scaffold_04	42318560	42318796	NA	NA	NA	NA	NA
PGEN_.00g094700	Scaffold_04	42337928	42384343	NA	NA	NA	NA	NA
PGEN_.00g094710	Scaffold_04	42392281	42394460	P25067	CO8A2_HUMAN	Collagen alpha-2(VIII) chain (Endothelial collagen)	GO:0001525; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0030674; GO:0031012; GO:0048593; GO:0050673; GO:0062023; GO:0098609	"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein binding, bridging [GO:0030674]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]"
PGEN_.00g094720	Scaffold_04	42465928	42469752	NA	NA	NA	NA	NA
PGEN_.00g094730	Scaffold_04	42473758	42476042	NA	NA	NA	NA	NA
PGEN_.00g094740	Scaffold_04	42488934	42489311	NA	NA	NA	NA	NA
PGEN_.00g094750	Scaffold_04	42581810	42616136	Q7TNC8	GLRA2_MOUSE	Glycine receptor subunit alpha-2	GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315	"cell junction [GO:0030054]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g094760	Scaffold_04	42625756	42637297	NA	NA	NA	NA	NA
PGEN_.00g094770	Scaffold_04	42639994	42644709	Q5RA17	RRP7A_PONAB	Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14 homolog)	GO:0003723	RNA binding [GO:0003723]
PGEN_.00g094780	Scaffold_04	42645698	42649952	Q9D1C9	RRP7A_MOUSE	Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14 homolog)	GO:0000028; GO:0001825; GO:0003723; GO:0005737; GO:0006364; GO:0032545; GO:0034456	CURI complex [GO:0032545]; cytoplasm [GO:0005737]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]
PGEN_.00g094790	Scaffold_04	42655203	42663944	Q9NWZ8	GEMI8_HUMAN	Gem-associated protein 8 (Gemin-8) (Protein FAM51A1)	GO:0000387; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032797; GO:0034719; GO:0051170; GO:0097504	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; import into nucleus [GO:0051170]; spliceosomal snRNP assembly [GO:0000387]
PGEN_.00g094800	Scaffold_04	42668643	42680129	Q8IZU2	WDR17_HUMAN	WD repeat-containing protein 17		
PGEN_.00g094810	Scaffold_04	42680835	42695699	Q8IZU2	WDR17_HUMAN	WD repeat-containing protein 17		
PGEN_.00g094820	Scaffold_04	42710638	42717909	O14772	FPGT_HUMAN	Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30) (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase)	GO:0003824; GO:0005525; GO:0005737; GO:0005829; GO:0006004; GO:0047341	cytoplasm [GO:0005737]; cytosol [GO:0005829]; catalytic activity [GO:0003824]; fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525]; fucose metabolic process [GO:0006004]
PGEN_.00g094830	Scaffold_04	42723824	42743932	F4KD71	DUR3_ARATH	Urea-proton symporter DUR3 (AtDUR3) (High-affinity urea active transporter DUR3)	GO:0005886; GO:0006995; GO:0015204; GO:0015293; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918]
PGEN_.00g094840	Scaffold_04	42745844	42746590	NA	NA	NA	NA	NA
PGEN_.00g094850	Scaffold_04	42750716	42777414	NA	NA	NA	NA	NA
PGEN_.00g094860	Scaffold_04	42777641	42778066	NA	NA	NA	NA	NA
PGEN_.00g094870	Scaffold_04	42797271	42802163	Q55EX9	Y8948_DICDI	Putative methyltransferase DDB_G0268948 (EC 2.1.1.-)	GO:0008168; GO:0032259; GO:0045335	phagocytic vesicle [GO:0045335]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g094880	Scaffold_04	42806108	42808515	NA	NA	NA	NA	NA
PGEN_.00g094890	Scaffold_04	42828617	42830035	O01346	EGH_DROME	"Beta-1,4-mannosyltransferase egh (EC 2.4.1.-) (Protein egghead) (Protein zeste-white 4)"	GO:0001744; GO:0005737; GO:0006688; GO:0007281; GO:0007293; GO:0007298; GO:0007299; GO:0007411; GO:0008049; GO:0016021; GO:0016325; GO:0016333; GO:0019187; GO:0030707; GO:0030720; GO:0033227; GO:0042248; GO:0045165; GO:0045434; GO:0046662; GO:0048935	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; beta-1,4-mannosyltransferase activity [GO:0019187]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell fate commitment [GO:0045165]; dsRNA transport [GO:0033227]; germ cell development [GO:0007281]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; male courtship behavior [GO:0008049]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of female receptivity, post-mating [GO:0045434]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; optic lobe placode formation [GO:0001744]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell-cell adhesion [GO:0007299]; peripheral nervous system neuron development [GO:0048935]; regulation of oviposition [GO:0046662]"
PGEN_.00g094900	Scaffold_04	42918006	42931548	NA	NA	NA	NA	NA
PGEN_.00g094910	Scaffold_04	42954484	42954918	NA	NA	NA	NA	NA
PGEN_.00g094920	Scaffold_04	42980420	42996677	NA	NA	NA	NA	NA
PGEN_.00g094930	Scaffold_04	43001046	43024423	Q8BTS4	NUP54_MOUSE	Nuclear pore complex protein Nup54 (54 kDa nucleoporin) (Nucleoporin Nup54)	GO:0005635; GO:0005643; GO:0006605; GO:0006607; GO:0006913; GO:0006999; GO:0017056; GO:0031965; GO:0032991; GO:0036228; GO:0042306; GO:0042802; GO:0044613; GO:0044877; GO:0051028; GO:0051260; GO:0051290; GO:0070208	nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein localization to nuclear inner membrane [GO:0036228]; protein targeting [GO:0006605]; regulation of protein import into nucleus [GO:0042306]
PGEN_.00g094940	Scaffold_04	43078861	43099747	Q9HC56	PCDH9_HUMAN	Protocadherin-9	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291	cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g094950	Scaffold_04	43113659	43137408	NA	NA	NA	NA	NA
PGEN_.00g094960	Scaffold_04	43137987	43157761	NA	NA	NA	NA	NA
PGEN_.00g094970	Scaffold_04	43164794	43171034	Q6XQH0	G3ST2_MOUSE	"Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2)"	GO:0001733; GO:0008146; GO:0009101; GO:0009247; GO:0016020; GO:0016021; GO:0032580; GO:0050694; GO:0051923	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; sulfation [GO:0051923]
PGEN_.00g094980	Scaffold_04	43182135	43209127	Q8BLF1	NCEH1_MOUSE	Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Arylacetamide deacetylase-like 1) (Chlorpyrifos oxon-binding protein) (CPO-BP)	GO:0005783; GO:0006470; GO:0006805; GO:0009056; GO:0016020; GO:0016021; GO:0016042; GO:0016787; GO:0017171; GO:0034338; GO:0042301; GO:0060395	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; hydrolase activity [GO:0016787]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056]; lipid catabolic process [GO:0016042]; protein dephosphorylation [GO:0006470]; SMAD protein signal transduction [GO:0060395]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g094990	Scaffold_04	43216392	43222705	Q9BXX0	EMIL2_HUMAN	EMILIN-2 (Elastin microfibril interface-located protein 2) (Elastin microfibril interfacer 2) (Protein FOAP-10)	GO:0005576; GO:0005581; GO:0007155; GO:0030023; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix constituent conferring elasticity [GO:0030023]; cell adhesion [GO:0007155]
PGEN_.00g095000	Scaffold_04	43234400	43236758	NA	NA	NA	NA	NA
PGEN_.00g095010	Scaffold_04	43239716	43240039	NA	NA	NA	NA	NA
PGEN_.00g095020	Scaffold_04	43240234	43240524	NA	NA	NA	NA	NA
PGEN_.00g095030	Scaffold_04	43241393	43273018	Q9D5U8	CNBD2_MOUSE	Cyclic nucleotide-binding domain-containing protein 2 (Cyclic nucleotide receptor involved in sperm function)	GO:0005829; GO:0007283; GO:0030552	cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
PGEN_.00g095040	Scaffold_04	43279562	43303220	Q9NVU7	SDA1_HUMAN	Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1) (hSDA)	GO:0000055; GO:0005634; GO:0005654; GO:0005730; GO:0030036; GO:0042273	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]
PGEN_.00g095050	Scaffold_04	43303524	43307866	A9JSB3	APC15_XENTR	Anaphase-promoting complex subunit 15 (APC15)	GO:0005680; GO:0007049; GO:0051301; GO:0090266	anaphase-promoting complex [GO:0005680]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]
PGEN_.00g095060	Scaffold_04	43317838	43362449	NA	NA	NA	NA	NA
PGEN_.00g095070	Scaffold_04	43368159	43372397	NA	NA	NA	NA	NA
PGEN_.00g095080	Scaffold_04	43372735	43373472	NA	NA	NA	NA	NA
PGEN_.00g095090	Scaffold_04	43381376	43382087	NA	NA	NA	NA	NA
PGEN_.00g095100	Scaffold_04	43387551	43400722	NA	NA	NA	NA	NA
PGEN_.00g095110	Scaffold_04	43403854	43404947	NA	NA	NA	NA	NA
PGEN_.00g095120	Scaffold_04	43415098	43419051	NA	NA	NA	NA	NA
PGEN_.00g095130	Scaffold_04	43453926	43455996	NA	NA	NA	NA	NA
PGEN_.00g095140	Scaffold_04	43591233	43592357	NA	NA	NA	NA	NA
PGEN_.00g095150	Scaffold_04	43592380	43601893	NA	NA	NA	NA	NA
PGEN_.00g095160	Scaffold_04	43615250	43627022	Q95RI5	FAXC_DROME	Failed axon connections	GO:0005737; GO:0005886; GO:0007409; GO:0036099	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]
PGEN_.00g095170	Scaffold_04	43668725	43691326	P35822	PTPRK_MOUSE	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005886; GO:0005911; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g095180	Scaffold_04	43698344	43700948	NA	NA	NA	NA	NA
PGEN_.00g095190	Scaffold_04	43701224	43701979	NA	NA	NA	NA	NA
PGEN_.00g095200	Scaffold_04	43704057	43704398	NA	NA	NA	NA	NA
PGEN_.00g095210	Scaffold_04	43704693	43705328	P34456	YMD2_CAEEL	Uncharacterized protein F54H12.2	GO:0004748; GO:0005829; GO:0009263	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]"
PGEN_.00g095220	Scaffold_04	43705601	43706017	NA	NA	NA	NA	NA
PGEN_.00g095230	Scaffold_04	43706853	43707467	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g095240	Scaffold_04	43724500	43727903	NA	NA	NA	NA	NA
PGEN_.00g095250	Scaffold_04	43733727	43737350	NA	NA	NA	NA	NA
PGEN_.00g095260	Scaffold_04	43745896	43749327	Q54WS5	ROCO6_DICDI	Probable serine/threonine-protein kinase roco6 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 6)	GO:0004674; GO:0005524; GO:0005525; GO:0016021	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g095270	Scaffold_04	43750080	43769779	NA	NA	NA	NA	NA
PGEN_.00g095280	Scaffold_04	43771980	43773745	NA	NA	NA	NA	NA
PGEN_.00g095290	Scaffold_04	43778406	43785872	Q5ZKN2	PGRC1_CHICK	Membrane-associated progesterone receptor component 1 (mPR)	GO:0005496; GO:0016021; GO:0030868	integral component of membrane [GO:0016021]; smooth endoplasmic reticulum membrane [GO:0030868]; steroid binding [GO:0005496]
PGEN_.00g095300	Scaffold_04	43799544	43819140	Q2KIG0	ETFD_BOVIN	"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)"	GO:0004174; GO:0009055; GO:0022904; GO:0031305; GO:0046872; GO:0048039; GO:0051539	"integral component of mitochondrial inner membrane [GO:0031305]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; ubiquinone binding [GO:0048039]; respiratory electron transport chain [GO:0022904]"
PGEN_.00g095310	Scaffold_04	43831575	43832609	Q7Z2Y8	GVIN1_HUMAN	Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g095320	Scaffold_04	43832692	43843422	Q80SU7	GVIN1_MOUSE	Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g095330	Scaffold_04	43898763	43899107	NA	NA	NA	NA	NA
PGEN_.00g095340	Scaffold_04	43899167	43899571	NA	NA	NA	NA	NA
PGEN_.00g095350	Scaffold_04	43899894	43912124	Q7ZV35	MED7_DANRE	Mediator of RNA polymerase II transcription subunit 7 (Cofactor required for Sp1 transcriptional activation subunit 9) (CRSP complex subunit 9) (Mediator complex subunit 7)	GO:0003712; GO:0006357; GO:0016592	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g095360	Scaffold_04	43917581	43933391	Q86XL3	ANKL2_HUMAN	Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4)	GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0016020; GO:0019888; GO:0030176; GO:0035307; GO:0042326; GO:0043066; GO:0050790; GO:0051301; GO:0051721	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of catalytic activity [GO:0050790]
PGEN_.00g095370	Scaffold_04	43941414	43942877	NA	NA	NA	NA	NA
PGEN_.00g095380	Scaffold_04	43944555	43948940	Q15582	BGH3_HUMAN	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP)	GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0044267; GO:0050839; GO:0050840; GO:0050896; GO:0062023; GO:0070062	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular protein metabolic process [GO:0044267]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g095390	Scaffold_04	43949421	43955988	P82198	BGH3_MOUSE	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3)	GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]
PGEN_.00g095400	Scaffold_04	43971678	43995849	Q6XPS3	TPTE2_HUMAN	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)"	GO:0000139; GO:0004725; GO:0005737; GO:0005789; GO:0006661; GO:0008138; GO:0016021; GO:0016314	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; phosphatidylinositol biosynthetic process [GO:0006661]"
PGEN_.00g095410	Scaffold_04	44037119	44042860	Q1PRL4	LIN41_CHICK	E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)	GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177	P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]
PGEN_.00g095420	Scaffold_04	44046422	44046742	NA	NA	NA	NA	NA
PGEN_.00g095430	Scaffold_04	44050510	44068536	Q6XPS3	TPTE2_HUMAN	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)"	GO:0000139; GO:0004725; GO:0005737; GO:0005789; GO:0006661; GO:0008138; GO:0016021; GO:0016314	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; phosphatidylinositol biosynthetic process [GO:0006661]"
PGEN_.00g095440	Scaffold_04	44070446	44076017	NA	NA	NA	NA	NA
PGEN_.00g095450	Scaffold_04	44076125	44082542	Q7TP65	ANKL2_RAT	Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4) (Liver regeneration-related protein LRRG057)	GO:0005783; GO:0007084; GO:0007417; GO:0030176; GO:0035307; GO:0042326; GO:0043066; GO:0051301; GO:0051721	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; protein phosphatase 2A binding [GO:0051721]; cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]
PGEN_.00g095460	Scaffold_04	44093642	44111358	Q9I8S4	AZIN2_XENLA	Antizyme inhibitor 2 (AzI2) (Ornithine decarboxylase 2) (ODC 2) (xODC2) (Ornithine decarboxylase-like protein) (ODC-like protein) (ornithine decarboxylase paralog) (ODC-p)	GO:0003824; GO:0005634; GO:0005737; GO:0005801; GO:0005802; GO:0006596; GO:0030133; GO:0030424; GO:0030425; GO:0031410; GO:0033116; GO:0042978; GO:0043085; GO:0043204; GO:0048471; GO:0098629; GO:1902269; GO:1990005	axon [GO:0030424]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; granular vesicle [GO:1990005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; catalytic activity [GO:0003824]; ornithine decarboxylase activator activity [GO:0042978]; polyamine biosynthetic process [GO:0006596]; positive regulation of catalytic activity [GO:0043085]; positive regulation of polyamine transmembrane transport [GO:1902269]; trans-Golgi network membrane organization [GO:0098629]
PGEN_.00g095470	Scaffold_04	44128899	44129216	NA	NA	NA	NA	NA
PGEN_.00g095480	Scaffold_04	44149164	44157414	Q76EC5	CHST9_MOUSE	Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)	GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g095490	Scaffold_04	44218171	44227870	P69478	CHSTB_RAT	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)	GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]
PGEN_.00g095500	Scaffold_04	44249252	44258300	Q8R395	COMD5_MOUSE	COMM domain-containing protein 5	GO:0005634; GO:0005654; GO:0005829	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
PGEN_.00g095510	Scaffold_04	44268308	44283904	Q1L5Z9	LONF2_HUMAN	LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192)	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g095520	Scaffold_04	44292666	44311185	Q8C7H1	MMAA_MOUSE	"Methylmalonic aciduria type A homolog, mitochondrial (EC 3.6.-.-)"	GO:0003924; GO:0005525; GO:0005739; GO:0009236; GO:0042802; GO:0042803	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cobalamin biosynthetic process [GO:0009236]
PGEN_.00g095530	Scaffold_04	44316582	44332928	Q9CR16	PPID_MOUSE	Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D)	GO:0000122; GO:0000413; GO:0003755; GO:0005528; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0006915; GO:0008134; GO:0015031; GO:0016018; GO:0019899; GO:0030331; GO:0030544; GO:0031072; GO:0034389; GO:0042026; GO:0043065; GO:0045070; GO:0050714; GO:0051082; GO:0051879; GO:0061077; GO:0065003; GO:0071492	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]
PGEN_.00g095540	Scaffold_04	44344270	44345187	Q03017	CACT_DROME	NF-kappa-B inhibitor cactus	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]
PGEN_.00g095550	Scaffold_04	44345283	44400123	P47990	XDH_CHICK	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949	"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]"
PGEN_.00g095560	Scaffold_04	44434561	44439294	P49219	MTR1C_XENLA	Melatonin receptor type 1C (Mel-1C-R) (Mel1c (alpha) receptor) (Mel1c receptor)	GO:0005886; GO:0008502; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; melatonin receptor activity [GO:0008502]
PGEN_.00g095570	Scaffold_04	44464175	44465263	Q03017	CACT_DROME	NF-kappa-B inhibitor cactus	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]
PGEN_.00g095580	Scaffold_04	44482254	44489207	Q03017	CACT_DROME	NF-kappa-B inhibitor cactus	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]
PGEN_.00g095590	Scaffold_04	44495199	44496245	Q91974	IKBA_CHICK	NF-kappa-B inhibitor alpha (I-kappa-B-alpha) (IkB-alpha) (IkappaBalpha) (REL-associated protein pp40)	GO:0005737; GO:0048145	cytoplasm [GO:0005737]; regulation of fibroblast proliferation [GO:0048145]
PGEN_.00g095600	Scaffold_04	44505500	44507807	Q03017	CACT_DROME	NF-kappa-B inhibitor cactus	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]
PGEN_.00g095610	Scaffold_04	44524622	44529838	P83757	CACT_DROYA	NF-kappa-B inhibitor cactus	GO:0005737; GO:0007275; GO:0046843	cytoplasm [GO:0005737]; dorsal appendage formation [GO:0046843]; multicellular organism development [GO:0007275]
PGEN_.00g095620	Scaffold_04	44569651	44576518	NA	NA	NA	NA	NA
PGEN_.00g095630	Scaffold_04	44598314	44612156	Q9BZA8	PC11Y_HUMAN	Protocadherin-11 Y-linked (Protocadherin-11) (Protocadherin on the Y chromosome) (PCDH-Y) (Protocadherin prostate cancer) (Protocadherin-PC) (Protocadherin-22)	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007283; GO:0030177; GO:0061827; GO:0097225	integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283]
PGEN_.00g095640	Scaffold_04	44688365	44688580	NA	NA	NA	NA	NA
PGEN_.00g095650	Scaffold_04	44793518	44794396	P83425	HIP_MYTED	Heavy metal-binding protein HIP	GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]
PGEN_.00g095660	Scaffold_04	44808223	44814844	Q9HC56	PCDH9_HUMAN	Protocadherin-9	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291	cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g095670	Scaffold_04	44892676	44893086	NA	NA	NA	NA	NA
PGEN_.00g095680	Scaffold_04	44903666	44908288	Q9HC56	PCDH9_HUMAN	Protocadherin-9	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291	cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g095690	Scaffold_04	45008929	45009543	NA	NA	NA	NA	NA
PGEN_.00g095700	Scaffold_04	45012782	45014813	NA	NA	NA	NA	NA
PGEN_.00g095710	Scaffold_04	45020441	45021286	NA	NA	NA	NA	NA
PGEN_.00g095720	Scaffold_04	45021663	45029452	NA	NA	NA	NA	NA
PGEN_.00g095730	Scaffold_04	45035567	45046275	Q9QZ85	IIGP1_MOUSE	Interferon-inducible GTPase 1 (EC 3.6.5.-)	GO:0003924; GO:0005525; GO:0005789; GO:0006952; GO:0009617; GO:0010506; GO:0019003; GO:0019221; GO:0020005; GO:0031965; GO:0032580; GO:0035458; GO:0042802; GO:0042832; GO:0045087; GO:0050829	endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]
PGEN_.00g095740	Scaffold_04	45059179	45065321	NA	NA	NA	NA	NA
PGEN_.00g095750	Scaffold_04	45072891	45079516	Q9BYX4	IFIH1_HUMAN	Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116)	GO:0003677; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016032; GO:0016579; GO:0016925; GO:0032480; GO:0032727; GO:0032728; GO:0034344; GO:0035549; GO:0039528; GO:0039530; GO:0042802; GO:0043021; GO:0045087; GO:0051607; GO:0060760; GO:0071360; GO:1902741; GO:1904469; GO:2000778	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of type I interferon production [GO:0032480]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; viral process [GO:0016032]
PGEN_.00g095760	Scaffold_04	45088336	45121698	NA	NA	NA	NA	NA
PGEN_.00g095770	Scaffold_04	45135889	45143748	NA	NA	NA	NA	NA
PGEN_.00g095780	Scaffold_04	45167731	45183182	Q3ZT31	SNX25_MOUSE	Sorting nexin-25	GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091; GO:0043231; GO:0060394	endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]
PGEN_.00g095790	Scaffold_04	45185487	45206234	Q5ZLC6	ANR10_CHICK	Ankyrin repeat domain-containing protein 10		
PGEN_.00g095800	Scaffold_04	45214217	45227489	Q9UUY8	NDK_NEUCR	Nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6)	GO:0004550; GO:0005524; GO:0006163; GO:0006183; GO:0006220; GO:0006228; GO:0006241; GO:0046872	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; purine nucleotide metabolic process [GO:0006163]; pyrimidine nucleotide metabolic process [GO:0006220]; UTP biosynthetic process [GO:0006228]
PGEN_.00g095810	Scaffold_04	45232455	45243372	NA	NA	NA	NA	NA
PGEN_.00g095820	Scaffold_04	45258669	45289910	NA	NA	NA	NA	NA
PGEN_.00g095830	Scaffold_04	45335992	45352891	NA	NA	NA	NA	NA
PGEN_.00g095840	Scaffold_04	45383011	45383274	NA	NA	NA	NA	NA
PGEN_.00g095850	Scaffold_04	45451226	45457391	P16273	PRPX_HORVU	Pathogen-related protein	GO:0006952; GO:0009607	defense response [GO:0006952]; response to biotic stimulus [GO:0009607]
PGEN_.00g095860	Scaffold_04	45466970	45467657	NA	NA	NA	NA	NA
PGEN_.00g095870	Scaffold_04	45474756	45483491	Q53G44	IF44L_HUMAN	Interferon-induced protein 44-like	GO:0005525; GO:0005737; GO:0006955; GO:0051607	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]
PGEN_.00g095880	Scaffold_04	45488401	45491916	NA	NA	NA	NA	NA
PGEN_.00g095890	Scaffold_04	45509173	45513558	NA	NA	NA	NA	NA
PGEN_.00g095900	Scaffold_04	45513581	45514510	NA	NA	NA	NA	NA
PGEN_.00g095910	Scaffold_04	45532038	45556769	Q60997	DMBT1_MOUSE	Deleted in malignant brain tumors 1 protein (Apactin) (CRP-ductin) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80)	GO:0001530; GO:0001824; GO:0001833; GO:0003677; GO:0005044; GO:0005615; GO:0005737; GO:0006898; GO:0009617; GO:0009897; GO:0015031; GO:0016021; GO:0019898; GO:0030154; GO:0030658; GO:0030670; GO:0030858; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0050829; GO:0050830; GO:0061844; GO:0062023; GO:0070891; GO:1904399	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; induction of bacterial agglutination [GO:0043152]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]
PGEN_.00g095920	Scaffold_04	45562817	45581473	P46098	5HT3A_HUMAN	5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)	GO:0004888; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0022850; GO:0030054; GO:0030424; GO:0032154; GO:0032414; GO:0034220; GO:0042220; GO:0042391; GO:0043005; GO:0043025; GO:0045202; GO:0045471; GO:0050877; GO:0051378; GO:0071363; GO:0098978; GO:0099055; GO:0099056; GO:1904602	axon [GO:0030424]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]; serotonin binding [GO:0051378]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; cellular response to growth factor stimulus [GO:0071363]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; positive regulation of ion transmembrane transporter activity [GO:0032414]; regulation of membrane potential [GO:0042391]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; signal transduction [GO:0007165]
PGEN_.00g095930	Scaffold_04	45589838	45601632	Q9I8C7	ACH10_CHICK	Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10)	GO:0004888; GO:0005262; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g095940	Scaffold_04	45607604	45615534	NA	NA	NA	NA	NA
PGEN_.00g095950	Scaffold_04	45624608	45630247	Q7RTY7	OVCH1_HUMAN	Ovochymase-1 (EC 3.4.21.-)	GO:0004252; GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g095960	Scaffold_04	45634870	45641474	Q7TMR0	PCP_MOUSE	Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP)	GO:0002155; GO:0002353; GO:0003085; GO:0004180; GO:0005764; GO:0006508; GO:0008236; GO:0008239; GO:0042593; GO:0043231; GO:0043535; GO:0045178; GO:0060055; GO:0097009; GO:2000377	basal part of cell [GO:0045178]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; angiogenesis involved in wound healing [GO:0060055]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]
PGEN_.00g095970	Scaffold_04	45641786	45647890	Q9VCA9	SPCS3_DROME	Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22 kDa subunit) (SPC22) (SPase 22 kDa subunit)	GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0019089; GO:0045047	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]; transmission of virus [GO:0019089]
PGEN_.00g095980	Scaffold_04	45656798	45770085	P33450	FAT_DROME	Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]	GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016021; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0017022; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045198; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090176; GO:0090251; GO:0098609	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g095990	Scaffold_04	45796674	45797216	Q8BHH2	RAB9B_MOUSE	Ras-related protein Rab-9B	GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005829; GO:0005886; GO:0006886; GO:0019003; GO:0030670; GO:0032482; GO:0042147; GO:0042802; GO:0045335	"cytosol [GO:0005829]; late endosome [GO:0005770]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g096000	Scaffold_04	45833009	45834066	NA	NA	NA	NA	NA
PGEN_.00g096010	Scaffold_04	45847048	45857560	NA	NA	NA	NA	NA
PGEN_.00g096020	Scaffold_04	45865723	45866022	NA	NA	NA	NA	NA
PGEN_.00g096030	Scaffold_04	45890233	45891742	NA	NA	NA	NA	NA
PGEN_.00g096040	Scaffold_04	45891875	45892493	NA	NA	NA	NA	NA
PGEN_.00g096050	Scaffold_04	45938285	45939878	NA	NA	NA	NA	NA
PGEN_.00g096060	Scaffold_04	45949618	45956239	Q8TCB0	IFI44_HUMAN	Interferon-induced protein 44 (p44) (Microtubule-associated protein 44)	GO:0005737; GO:0006955; GO:0009615; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]
PGEN_.00g096070	Scaffold_04	45956644	45958021	NA	NA	NA	NA	NA
PGEN_.00g096080	Scaffold_04	46001596	46014054	NA	NA	NA	NA	NA
PGEN_.00g096090	Scaffold_04	46001872	46002447	NA	NA	NA	NA	NA
PGEN_.00g096100	Scaffold_04	46018858	46029334	Q8TCB0	IFI44_HUMAN	Interferon-induced protein 44 (p44) (Microtubule-associated protein 44)	GO:0005737; GO:0006955; GO:0009615; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]
PGEN_.00g096110	Scaffold_04	46071565	46080594	Q8TCB0	IFI44_HUMAN	Interferon-induced protein 44 (p44) (Microtubule-associated protein 44)	GO:0005737; GO:0006955; GO:0009615; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615]
PGEN_.00g096120	Scaffold_04	46086855	46092237	NA	NA	NA	NA	NA
PGEN_.00g096130	Scaffold_04	46097973	46099228	NA	NA	NA	NA	NA
PGEN_.00g096140	Scaffold_04	46111705	46117724	NA	NA	NA	NA	NA
PGEN_.00g096150	Scaffold_04	46168374	46174302	Q6WYY1	PC11X_PANPA	Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X)	GO:0005509; GO:0005886; GO:0007156; GO:0010923; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g096160	Scaffold_04	46192993	46211871	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g096170	Scaffold_04	46219482	46219814	NA	NA	NA	NA	NA
PGEN_.00g096180	Scaffold_04	46220341	46220787	NA	NA	NA	NA	NA
PGEN_.00g096190	Scaffold_04	46220846	46227639	Q687X5	STEA4_HUMAN	"Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9)"	GO:0000139; GO:0005654; GO:0005768; GO:0005886; GO:0008823; GO:0009055; GO:0015677; GO:0016021; GO:0020037; GO:0031901; GO:0045444; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0070062; GO:0070207; GO:0071949; GO:0098706	early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]
PGEN_.00g096200	Scaffold_04	46244792	46246531	NA	NA	NA	NA	NA
PGEN_.00g096210	Scaffold_04	46288824	46289222	NA	NA	NA	NA	NA
PGEN_.00g096220	Scaffold_04	46289438	46289737	NA	NA	NA	NA	NA
PGEN_.00g096230	Scaffold_04	46322021	46334683	NA	NA	NA	NA	NA
PGEN_.00g096240	Scaffold_04	46334589	46336034	Q687X5	STEA4_HUMAN	"Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9)"	GO:0000139; GO:0005654; GO:0005768; GO:0005886; GO:0008823; GO:0009055; GO:0015677; GO:0016021; GO:0020037; GO:0031901; GO:0045444; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0070062; GO:0070207; GO:0071949; GO:0098706	early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]
PGEN_.00g096250	Scaffold_04	46337129	46339700	Q687X5	STEA4_HUMAN	"Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9)"	GO:0000139; GO:0005654; GO:0005768; GO:0005886; GO:0008823; GO:0009055; GO:0015677; GO:0016021; GO:0020037; GO:0031901; GO:0045444; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0070062; GO:0070207; GO:0071949; GO:0098706	early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]
PGEN_.00g096260	Scaffold_04	46343921	46351248	NA	NA	NA	NA	NA
PGEN_.00g096270	Scaffold_04	46351883	46381147	Q2KJ63	KLKB1_BOVIN	Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]	GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0042803; GO:0051919	extracellular space [GO:0005615]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]
PGEN_.00g096280	Scaffold_04	46387235	46387840	NA	NA	NA	NA	NA
PGEN_.00g096290	Scaffold_04	46387927	46388541	NA	NA	NA	NA	NA
PGEN_.00g096300	Scaffold_04	46390175	46390939	NA	NA	NA	NA	NA
PGEN_.00g096310	Scaffold_04	46393109	46395166	Q64127	TIF1A_MOUSE	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005737; GO:0006468; GO:0008270; GO:0008285; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043565; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]"
PGEN_.00g096320	Scaffold_04	46403158	46405167	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g096330	Scaffold_04	46415925	46423615	Q08DY8	ATG13_BOVIN	Autophagy-related protein 13	GO:0000045; GO:0000407; GO:0000422; GO:0000423; GO:0005739; GO:0005829; GO:0016236; GO:0019887; GO:0019898; GO:0019901; GO:0032147; GO:0034497; GO:0034727; GO:0098780; GO:1990316	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; activation of protein kinase activity [GO:0032147]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; protein localization to phagophore assembly site [GO:0034497]; response to mitochondrial depolarisation [GO:0098780]
PGEN_.00g096340	Scaffold_04	46488905	46499764	A4IF63	TRIM2_BOVIN	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g096350	Scaffold_04	46509735	46512964	NA	NA	NA	NA	NA
PGEN_.00g096360	Scaffold_04	46519614	46520216	NA	NA	NA	NA	NA
PGEN_.00g096370	Scaffold_04	46520760	46522016	NA	NA	NA	NA	NA
PGEN_.00g096380	Scaffold_04	46535720	46552760	Q91XQ5	CHSTF_MOUSE	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; hexose biosynthetic process [GO:0019319]
PGEN_.00g096390	Scaffold_04	46552987	46572525	NA	NA	NA	NA	NA
PGEN_.00g096400	Scaffold_04	46590546	46611111	Q7LFX5	CHSTF_HUMAN	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]
PGEN_.00g096410	Scaffold_04	46620767	46621830	P15305	DYHC_ONCMY	Dynein heavy chain (DYHC) (Fragment)	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0031514	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; motor activity [GO:0003774]
PGEN_.00g096420	Scaffold_04	46632924	46633472	NA	NA	NA	NA	NA
PGEN_.00g096430	Scaffold_04	46633665	46633925	NA	NA	NA	NA	NA
PGEN_.00g096440	Scaffold_04	46644697	46649230	Q7LFX5	CHSTF_HUMAN	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]
PGEN_.00g096450	Scaffold_04	46663431	46663868	NA	NA	NA	NA	NA
PGEN_.00g096460	Scaffold_04	46672226	46694012	NA	NA	NA	NA	NA
PGEN_.00g096470	Scaffold_04	46699969	46746483	NA	NA	NA	NA	NA
PGEN_.00g096480	Scaffold_04	46747499	46763843	NA	NA	NA	NA	NA
PGEN_.00g096490	Scaffold_04	46767959	46772889	NA	NA	NA	NA	NA
PGEN_.00g096500	Scaffold_04	46773636	46881425	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g096510	Scaffold_04	46904217	46908313	NA	NA	NA	NA	NA
PGEN_.00g096520	Scaffold_04	46917332	46917565	NA	NA	NA	NA	NA
PGEN_.00g096530	Scaffold_04	46950623	46957602	NA	NA	NA	NA	NA
PGEN_.00g096540	Scaffold_04	46963525	46992995	A0JM12	MEG10_XENTR	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0005112; GO:0005886; GO:0007155; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0043277	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Notch binding [GO:0005112]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g096550	Scaffold_04	46999717	47001448	NA	NA	NA	NA	NA
PGEN_.00g096560	Scaffold_04	47002819	47024613	Q53G44	IF44L_HUMAN	Interferon-induced protein 44-like	GO:0005525; GO:0005737; GO:0006955; GO:0051607	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955]
PGEN_.00g096570	Scaffold_04	47028045	47031689	NA	NA	NA	NA	NA
PGEN_.00g096580	Scaffold_04	47040049	47047600	NA	NA	NA	NA	NA
PGEN_.00g096590	Scaffold_04	47124938	47128172	Q01514	GBP1_MOUSE	Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 1) (GBP-1) (mGBP-1) (mGBP1) (Guanine nucleotide-binding protein 1) (Interferon-gamma-inducible protein MAG-1) (Interferon-induced guanylate-binding protein 1)	GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0019002; GO:0020005; GO:0031410; GO:0035458; GO:0042803; GO:0042832; GO:0044406; GO:0050830; GO:0051607; GO:0071346	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; symbiont-containing vacuole membrane [GO:0020005]; GMP binding [GO:0019002]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]
PGEN_.00g096600	Scaffold_04	47183199	47183489	NA	NA	NA	NA	NA
PGEN_.00g096610	Scaffold_04	47192183	47196631	P27473	IFI44_PANTR	Interferon-induced protein 44 (Antigen p44) (Non-A non-B hepatitis-associated microtubular aggregates protein)	GO:0005737; GO:0006955; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]
PGEN_.00g096620	Scaffold_04	47200752	47204363	NA	NA	NA	NA	NA
PGEN_.00g096630	Scaffold_04	47237221	47240063	Q9H0R5	GBP3_HUMAN	Guanylate-binding protein 3 (EC 3.6.5.-) (GTP-binding protein 3) (GBP-3) (Guanine nucleotide-binding protein 3)	GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0031410; GO:0042803; GO:0048471; GO:0051607; GO:0071346; GO:0071347; GO:0071356	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]
PGEN_.00g096640	Scaffold_04	47259922	47262286	NA	NA	NA	NA	NA
PGEN_.00g096650	Scaffold_04	47309344	47312677	NA	NA	NA	NA	NA
PGEN_.00g096660	Scaffold_04	47344692	47377474	Q6DIB5	MEG10_MOUSE	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g096670	Scaffold_04	47390111	47397155	Q9W0A0	DRPR_DROME	Protein draper	GO:0001786; GO:0001891; GO:0005737; GO:0005886; GO:0005938; GO:0006909; GO:0006911; GO:0008345; GO:0016021; GO:0016322; GO:0030054; GO:0030424; GO:0031224; GO:0035071; GO:0035212; GO:0042742; GO:0043277; GO:0043652; GO:0045211; GO:0045335; GO:0048190; GO:0048678; GO:0060100; GO:0098794; GO:1904396	"axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; positive regulation of phagocytosis, engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190]"
PGEN_.00g096680	Scaffold_04	47419799	47435005	NA	NA	NA	NA	NA
PGEN_.00g096690	Scaffold_04	47445839	47451583	NA	NA	NA	NA	NA
PGEN_.00g096700	Scaffold_04	47466207	47482210	Q96GP6	SREC2_HUMAN	Scavenger receptor class F member 2 (SRECRP-1) (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II)	GO:0005044; GO:0005925; GO:0007157; GO:0016021	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]
PGEN_.00g096710	Scaffold_04	47497745	47524143	Q6DIB5	MEG10_MOUSE	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g096720	Scaffold_04	47524440	47540237	NA	NA	NA	NA	NA
PGEN_.00g096730	Scaffold_04	47540548	47541162	NA	NA	NA	NA	NA
PGEN_.00g096740	Scaffold_04	47541215	47542439	NA	NA	NA	NA	NA
PGEN_.00g096750	Scaffold_04	47551792	47554748	NA	NA	NA	NA	NA
PGEN_.00g096760	Scaffold_04	47555713	47556183	NA	NA	NA	NA	NA
PGEN_.00g096770	Scaffold_04	47556682	47557614	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g096780	Scaffold_04	47559542	47575070	Q96KG7	MEG10_HUMAN	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g096790	Scaffold_04	47641374	47644044	NA	NA	NA	NA	NA
PGEN_.00g096800	Scaffold_04	47644429	47644884	NA	NA	NA	NA	NA
PGEN_.00g096810	Scaffold_04	47645360	47645794	NA	NA	NA	NA	NA
PGEN_.00g096820	Scaffold_04	47645846	47646217	NA	NA	NA	NA	NA
PGEN_.00g096830	Scaffold_04	47646411	47646908	NA	NA	NA	NA	NA
PGEN_.00g096840	Scaffold_04	47678043	47683922	NA	NA	NA	NA	NA
PGEN_.00g096850	Scaffold_04	47698689	47726926	Q9W0A0	DRPR_DROME	Protein draper	GO:0001786; GO:0001891; GO:0005737; GO:0005886; GO:0005938; GO:0006909; GO:0006911; GO:0008345; GO:0016021; GO:0016322; GO:0030054; GO:0030424; GO:0031224; GO:0035071; GO:0035212; GO:0042742; GO:0043277; GO:0043652; GO:0045211; GO:0045335; GO:0048190; GO:0048678; GO:0060100; GO:0098794; GO:1904396	"axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; positive regulation of phagocytosis, engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190]"
PGEN_.00g096860	Scaffold_04	47878688	47881088	NA	NA	NA	NA	NA
PGEN_.00g096870	Scaffold_04	47896182	47896433	NA	NA	NA	NA	NA
PGEN_.00g096880	Scaffold_04	47935037	47980686	O88281	MEGF6_RAT	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g096890	Scaffold_04	48025127	48045404	A6BM72	MEG11_HUMAN	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	GO:0010842; GO:0016021; GO:0016323; GO:0034109	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
PGEN_.00g096900	Scaffold_04	48051376	48087307	Q6DIB5	MEG10_MOUSE	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g096910	Scaffold_04	48120823	48127398	P59222	SREC2_MOUSE	Scavenger receptor class F member 2 (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II)	GO:0005044; GO:0007157; GO:0016021	integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]
PGEN_.00g096920	Scaffold_04	48134544	48134795	NA	NA	NA	NA	NA
PGEN_.00g096930	Scaffold_04	48137208	48141713	Q9W0A0	DRPR_DROME	Protein draper	GO:0001786; GO:0001891; GO:0005737; GO:0005886; GO:0005938; GO:0006909; GO:0006911; GO:0008345; GO:0016021; GO:0016322; GO:0030054; GO:0030424; GO:0031224; GO:0035071; GO:0035212; GO:0042742; GO:0043277; GO:0043652; GO:0045211; GO:0045335; GO:0048190; GO:0048678; GO:0060100; GO:0098794; GO:1904396	"axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; positive regulation of phagocytosis, engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190]"
PGEN_.00g096940	Scaffold_04	48153518	48163754	Q9W0A0	DRPR_DROME	Protein draper	GO:0001786; GO:0001891; GO:0005737; GO:0005886; GO:0005938; GO:0006909; GO:0006911; GO:0008345; GO:0016021; GO:0016322; GO:0030054; GO:0030424; GO:0031224; GO:0035071; GO:0035212; GO:0042742; GO:0043277; GO:0043652; GO:0045211; GO:0045335; GO:0048190; GO:0048678; GO:0060100; GO:0098794; GO:1904396	"axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; positive regulation of phagocytosis, engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190]"
PGEN_.00g096950	Scaffold_04	48173035	48173349	NA	NA	NA	NA	NA
PGEN_.00g096960	Scaffold_04	48192747	48218591	Q80T91	MEG11_MOUSE	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	GO:0010842; GO:0016021; GO:0016323; GO:0034109	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
PGEN_.00g096970	Scaffold_04	48236685	48247418	O14522	PTPRT_HUMAN	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g096980	Scaffold_04	48250310	48283094	NA	NA	NA	NA	NA
PGEN_.00g096990	Scaffold_04	48305464	48305826	NA	NA	NA	NA	NA
PGEN_.00g097000	Scaffold_04	48312426	48319860	NA	NA	NA	NA	NA
PGEN_.00g097010	Scaffold_04	48333074	48333307	NA	NA	NA	NA	NA
PGEN_.00g097020	Scaffold_04	48349088	48369248	NA	NA	NA	NA	NA
PGEN_.00g097030	Scaffold_04	48384662	48385612	NA	NA	NA	NA	NA
PGEN_.00g097040	Scaffold_04	48427705	48448324	NA	NA	NA	NA	NA
PGEN_.00g097050	Scaffold_04	48448477	48450880	NA	NA	NA	NA	NA
PGEN_.00g097060	Scaffold_04	48483024	48493924	Q2ABP2	PGAP2_CRIGR	Post-GPI attachment to proteins factor 2 (FGF receptor-activating protein 1)	GO:0000139; GO:0005789; GO:0006506; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g097070	Scaffold_04	48501941	48505956	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g097080	Scaffold_04	48520586	48549491	O95164	UBL3_HUMAN	Ubiquitin-like protein 3 (Membrane-anchored ubiquitin-fold protein) (HsMUB) (MUB) (Protein HCG-1)	GO:0005622; GO:0005886; GO:0070062	extracellular exosome [GO:0070062]; intracellular [GO:0005622]; plasma membrane [GO:0005886]
PGEN_.00g097090	Scaffold_04	48553623	48566226	Q9NUP9	LIN7C_HUMAN	Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3)	GO:0002011; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008092; GO:0015031; GO:0016323; GO:0019904; GO:0030165; GO:0045199; GO:0045202; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:0098978; GO:1903361	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]; cytoskeletal protein binding [GO:0008092]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; morphogenesis of an epithelial sheet [GO:0002011]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]
PGEN_.00g097100	Scaffold_04	48628235	48628612	NA	NA	NA	NA	NA
PGEN_.00g097110	Scaffold_04	48629009	48629266	NA	NA	NA	NA	NA
PGEN_.00g097120	Scaffold_04	48633449	48635649	NA	NA	NA	NA	NA
PGEN_.00g097130	Scaffold_04	48653534	48656799	NA	NA	NA	NA	NA
PGEN_.00g097140	Scaffold_04	48677228	48677602	NA	NA	NA	NA	NA
PGEN_.00g097150	Scaffold_04	48678572	48681527	NA	NA	NA	NA	NA
PGEN_.00g097160	Scaffold_04	48695932	48701163	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g097170	Scaffold_04	48804494	48848655	C3ZQF9	QRFPR_BRAFL	QRFP-like peptide receptor	GO:0004930; GO:0004983; GO:0005887; GO:1901653	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; cellular response to peptide [GO:1901653]
PGEN_.00g097180	Scaffold_04	48934553	48961862	Q60997	DMBT1_MOUSE	Deleted in malignant brain tumors 1 protein (Apactin) (CRP-ductin) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80)	GO:0001530; GO:0001824; GO:0001833; GO:0003677; GO:0005044; GO:0005615; GO:0005737; GO:0006898; GO:0009617; GO:0009897; GO:0015031; GO:0016021; GO:0019898; GO:0030154; GO:0030658; GO:0030670; GO:0030858; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0050829; GO:0050830; GO:0061844; GO:0062023; GO:0070891; GO:1904399	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; induction of bacterial agglutination [GO:0043152]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]
PGEN_.00g097190	Scaffold_04	49015060	49081695	NA	NA	NA	NA	NA
PGEN_.00g097200	Scaffold_04	49083488	49087853	NA	NA	NA	NA	NA
PGEN_.00g097210	Scaffold_04	49098813	49102433	NA	NA	NA	NA	NA
PGEN_.00g097220	Scaffold_04	49115448	49122863	Q923S9	RAB30_MOUSE	Ras-related protein Rab-30	GO:0003924; GO:0005525; GO:0005801; GO:0005802; GO:0006886; GO:0007030; GO:0016020; GO:0031985; GO:0032482; GO:0043231	cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g097230	Scaffold_04	49124196	49233907	Q9BXJ9	NAA15_HUMAN	"N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100)"	GO:0001525; GO:0003723; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0006474; GO:0016020; GO:0017196; GO:0030154; GO:0031415; GO:0043022; GO:0043066; GO:0045893; GO:0050821	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]"
PGEN_.00g097240	Scaffold_04	49240756	49268450	P95329	MASY_MYXXD	Malate synthase (EC 2.3.3.9)	GO:0004474; GO:0005737; GO:0006097; GO:0006099	cytoplasm [GO:0005737]; malate synthase activity [GO:0004474]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g097250	Scaffold_04	49276584	49289588	NA	NA	NA	NA	NA
PGEN_.00g097260	Scaffold_04	49290512	49298997	NA	NA	NA	NA	NA
PGEN_.00g097270	Scaffold_04	49304626	49317299	O77475	CPESY_DROME	Ceramide phosphoethanolamine synthase (CPE synthase) (EC 2.7.8.n3)	GO:0000139; GO:0005886; GO:0006665; GO:0016021; GO:0016740	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity [GO:0016740]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g097280	Scaffold_04	49321389	49321619	NA	NA	NA	NA	NA
PGEN_.00g097290	Scaffold_04	49345113	49345613	Q9UGN5	PARP2_HUMAN	Poly [ADP-ribose] polymerase 2 (PARP-2) (hPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-)	GO:0003677; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0006471; GO:0018312; GO:0030592; GO:0061051; GO:0070212; GO:0097191; GO:0140294; GO:1901215; GO:1990404	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g097300	Scaffold_04	49350670	49369134	O75581	LRP6_HUMAN	Low-density lipoprotein receptor-related protein 6 (LRP-6)	GO:0001702; GO:0001843; GO:0001933; GO:0003344; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005623; GO:0005783; GO:0005886; GO:0005901; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009952; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021987; GO:0030326; GO:0030901; GO:0030917; GO:0031410; GO:0031901; GO:0034185; GO:0034392; GO:0035261; GO:0042475; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0051091; GO:0060021; GO:0060026; GO:0060059; GO:0060070; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090090; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:1904886; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g097310	Scaffold_04	49371035	49371271	NA	NA	NA	NA	NA
PGEN_.00g097320	Scaffold_04	49374412	49374777	NA	NA	NA	NA	NA
PGEN_.00g097330	Scaffold_04	49379150	49379737	NA	NA	NA	NA	NA
PGEN_.00g097340	Scaffold_04	49379820	49380767	NA	NA	NA	NA	NA
PGEN_.00g097350	Scaffold_04	49380787	49381573	NA	NA	NA	NA	NA
PGEN_.00g097360	Scaffold_04	49415636	49416424	NA	NA	NA	NA	NA
PGEN_.00g097370	Scaffold_04	49471660	49472398	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g097380	Scaffold_04	49476017	49476355	NA	NA	NA	NA	NA
PGEN_.00g097390	Scaffold_04	49493599	49493949	NA	NA	NA	NA	NA
PGEN_.00g097400	Scaffold_04	49495767	49496330	NA	NA	NA	NA	NA
PGEN_.00g097410	Scaffold_04	49496432	49496722	NA	NA	NA	NA	NA
PGEN_.00g097420	Scaffold_04	49496871	49497431	NA	NA	NA	NA	NA
PGEN_.00g097430	Scaffold_04	49497580	49497816	NA	NA	NA	NA	NA
PGEN_.00g097440	Scaffold_04	49520205	49520981	NA	NA	NA	NA	NA
PGEN_.00g097450	Scaffold_04	49521111	49521662	NA	NA	NA	NA	NA
PGEN_.00g097460	Scaffold_04	49527647	49528045	NA	NA	NA	NA	NA
PGEN_.00g097470	Scaffold_04	49529894	49530127	NA	NA	NA	NA	NA
PGEN_.00g097480	Scaffold_04	49534232	49534510	NA	NA	NA	NA	NA
PGEN_.00g097490	Scaffold_04	49552048	49567388	NA	NA	NA	NA	NA
PGEN_.00g097500	Scaffold_04	49573630	49574076	NA	NA	NA	NA	NA
PGEN_.00g097510	Scaffold_04	49728228	49731008	NA	NA	NA	NA	NA
PGEN_.00g097520	Scaffold_04	49737942	49740011	NA	NA	NA	NA	NA
PGEN_.00g097530	Scaffold_04	49741599	49745114	NA	NA	NA	NA	NA
PGEN_.00g097540	Scaffold_04	49755913	49757776	NA	NA	NA	NA	NA
PGEN_.00g097550	Scaffold_04	49794445	49794803	NA	NA	NA	NA	NA
PGEN_.00g097560	Scaffold_04	49797857	49798222	NA	NA	NA	NA	NA
PGEN_.00g097570	Scaffold_04	49823815	49824378	NA	NA	NA	NA	NA
PGEN_.00g097580	Scaffold_04	49824531	49824824	NA	NA	NA	NA	NA
PGEN_.00g097590	Scaffold_04	49824946	49825441	NA	NA	NA	NA	NA
PGEN_.00g097600	Scaffold_04	49831385	49836877	Q6SR69	OTP_HELER	Homeobox protein orthopedia	GO:0005634; GO:0006355; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g097610	Scaffold_04	49865780	49866076	NA	NA	NA	NA	NA
PGEN_.00g097620	Scaffold_04	49867412	49867750	NA	NA	NA	NA	NA
PGEN_.00g097630	Scaffold_04	49867796	49868182	NA	NA	NA	NA	NA
PGEN_.00g097640	Scaffold_04	49878486	49879031	NA	NA	NA	NA	NA
PGEN_.00g097650	Scaffold_04	49879121	49881170	NA	NA	NA	NA	NA
PGEN_.00g097660	Scaffold_04	49901403	49908786	NA	NA	NA	NA	NA
PGEN_.00g097670	Scaffold_04	49925357	49947077	NA	NA	NA	NA	NA
PGEN_.00g097680	Scaffold_04	49966210	49973061	NA	NA	NA	NA	NA
PGEN_.00g097690	Scaffold_04	49991247	50014951	NA	NA	NA	NA	NA
PGEN_.00g097700	Scaffold_04	50029601	50032204	NA	NA	NA	NA	NA
PGEN_.00g097710	Scaffold_04	50077633	50096648	NA	NA	NA	NA	NA
PGEN_.00g097720	Scaffold_04	50100317	50102949	NA	NA	NA	NA	NA
PGEN_.00g097730	Scaffold_04	50104803	50105309	NA	NA	NA	NA	NA
PGEN_.00g097740	Scaffold_04	50109845	50110449	NA	NA	NA	NA	NA
PGEN_.00g097750	Scaffold_04	50115740	50128846	NA	NA	NA	NA	NA
PGEN_.00g097760	Scaffold_04	50135318	50148191	NA	NA	NA	NA	NA
PGEN_.00g097770	Scaffold_04	50152473	50152970	NA	NA	NA	NA	NA
PGEN_.00g097780	Scaffold_04	50155481	50156464	NA	NA	NA	NA	NA
PGEN_.00g097790	Scaffold_04	50163995	50167542	NA	NA	NA	NA	NA
PGEN_.00g097800	Scaffold_04	50179229	50180955	NA	NA	NA	NA	NA
PGEN_.00g097810	Scaffold_04	50228618	50230462	NA	NA	NA	NA	NA
PGEN_.00g097820	Scaffold_04	50240293	50245841	NA	NA	NA	NA	NA
PGEN_.00g097830	Scaffold_04	50300728	50301759	NA	NA	NA	NA	NA
PGEN_.00g097840	Scaffold_04	50315620	50316868	NA	NA	NA	NA	NA
PGEN_.00g097850	Scaffold_04	50367719	50368837	NA	NA	NA	NA	NA
PGEN_.00g097860	Scaffold_04	50368862	50383821	NA	NA	NA	NA	NA
PGEN_.00g097870	Scaffold_04	50389031	50431939	Q5W041	ARMC3_HUMAN	Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1)	GO:0070062	extracellular exosome [GO:0070062]
PGEN_.00g097880	Scaffold_04	50437636	50438136	NA	NA	NA	NA	NA
PGEN_.00g097890	Scaffold_04	50452281	50460063	NA	NA	NA	NA	NA
PGEN_.00g097900	Scaffold_04	50508740	50515410	NA	NA	NA	NA	NA
PGEN_.00g097910	Scaffold_04	50517885	50519940	NA	NA	NA	NA	NA
PGEN_.00g097920	Scaffold_04	50523015	50523269	NA	NA	NA	NA	NA
PGEN_.00g097930	Scaffold_04	50531866	50532150	NA	NA	NA	NA	NA
PGEN_.00g097940	Scaffold_04	50541475	50541843	NA	NA	NA	NA	NA
PGEN_.00g097950	Scaffold_04	50543734	50544429	NA	NA	NA	NA	NA
PGEN_.00g097960	Scaffold_04	50562118	50562384	NA	NA	NA	NA	NA
PGEN_.00g097970	Scaffold_04	50566182	50566472	NA	NA	NA	NA	NA
PGEN_.00g097980	Scaffold_04	50579166	50580767	NA	NA	NA	NA	NA
PGEN_.00g097990	Scaffold_04	50584686	50585009	NA	NA	NA	NA	NA
PGEN_.00g098000	Scaffold_04	50601245	50601760	NA	NA	NA	NA	NA
PGEN_.00g098010	Scaffold_04	50602370	50603065	NA	NA	NA	NA	NA
PGEN_.00g098020	Scaffold_04	50604958	50605326	NA	NA	NA	NA	NA
PGEN_.00g098030	Scaffold_04	50608501	50611647	NA	NA	NA	NA	NA
PGEN_.00g098040	Scaffold_04	50620077	50620331	NA	NA	NA	NA	NA
PGEN_.00g098050	Scaffold_04	50623464	50625497	NA	NA	NA	NA	NA
PGEN_.00g098060	Scaffold_04	50627980	50643514	NA	NA	NA	NA	NA
PGEN_.00g098070	Scaffold_04	50683460	50691242	NA	NA	NA	NA	NA
PGEN_.00g098080	Scaffold_04	50705423	50705923	NA	NA	NA	NA	NA
PGEN_.00g098090	Scaffold_04	50711620	50758249	Q5W041	ARMC3_HUMAN	Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1)	GO:0070062	extracellular exosome [GO:0070062]
PGEN_.00g098100	Scaffold_04	50763459	50778418	NA	NA	NA	NA	NA
PGEN_.00g098110	Scaffold_04	50778443	50779561	NA	NA	NA	NA	NA
PGEN_.00g098120	Scaffold_04	50810320	50815960	NA	NA	NA	NA	NA
PGEN_.00g098130	Scaffold_04	50819482	50820902	NA	NA	NA	NA	NA
PGEN_.00g098140	Scaffold_04	50823742	50830048	NA	NA	NA	NA	NA
PGEN_.00g098150	Scaffold_04	50831592	50831984	NA	NA	NA	NA	NA
PGEN_.00g098160	Scaffold_04	50838193	50851326	NA	NA	NA	NA	NA
PGEN_.00g098170	Scaffold_04	50853114	50859825	NA	NA	NA	NA	NA
PGEN_.00g098180	Scaffold_04	50865635	50868094	NA	NA	NA	NA	NA
PGEN_.00g098190	Scaffold_04	50878277	50880763	NA	NA	NA	NA	NA
PGEN_.00g098200	Scaffold_04	50887197	50892238	NA	NA	NA	NA	NA
PGEN_.00g098210	Scaffold_04	50897167	50903486	NA	NA	NA	NA	NA
PGEN_.00g098220	Scaffold_04	50905963	50914707	NA	NA	NA	NA	NA
PGEN_.00g098230	Scaffold_04	50948466	50948918	NA	NA	NA	NA	NA
PGEN_.00g098240	Scaffold_04	50974665	50985773	Q9VZZ9	DOS_DROME	Protein daughter of sevenless	GO:0005737; GO:0005886; GO:0007465; GO:0008293; GO:0008595; GO:0042169; GO:0042461; GO:0045500; GO:0046578	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; anterior/posterior axis specification, embryo [GO:0008595]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of Ras protein signal transduction [GO:0046578]; sevenless signaling pathway [GO:0045500]; torso signaling pathway [GO:0008293]"
PGEN_.00g098250	Scaffold_04	51037096	51066764	P27398	CAND_DROME	Calpain-D (EC 3.4.22.-) (Calcium-activated neutral proteinase D) (CANP D) (Small optic lobes protein)	GO:0004198; GO:0005737; GO:0006508; GO:0007399; GO:0007601; GO:0046872; GO:0050896	cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g098260	Scaffold_04	51072599	51075045	NA	NA	NA	NA	NA
PGEN_.00g098270	Scaffold_04	51112554	51139374	Q9VT28	FRY_DROME	Protein furry	GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0070593	"apical part of cell [GO:0045177]; axon [GO:0030424]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]"
PGEN_.00g098280	Scaffold_04	51149620	51181830	O94915	FRYL_HUMAN	Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein)	GO:0000902; GO:0005938; GO:0031175	cell cortex [GO:0005938]; cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175]
PGEN_.00g098290	Scaffold_04	51185848	51217775	Q3UGF1	WDR19_MOUSE	WD repeat-containing protein 19 (Intraflagellar transport 144 homolog)	GO:0000902; GO:0001701; GO:0001750; GO:0005737; GO:0005856; GO:0005929; GO:0007224; GO:0008406; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0060830; GO:0060831; GO:0061055; GO:0061512; GO:0065003; GO:0097730; GO:1903441	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; protein-containing complex assembly [GO:0065003]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]
PGEN_.00g098300	Scaffold_04	51248916	51249143	NA	NA	NA	NA	NA
PGEN_.00g098310	Scaffold_04	51250407	51282373	Q5SQX6	CYFP2_MOUSE	Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121)	GO:0000902; GO:0005634; GO:0005737; GO:0006915; GO:0007411; GO:0030031; GO:0030054; GO:0031175; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0097202; GO:0097484; GO:0098609	cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]
PGEN_.00g098320	Scaffold_04	51317193	51318578	C8YR32	LOXH1_MOUSE	Lipoxygenase homology domain-containing protein 1	GO:0004096; GO:0007605; GO:0020037; GO:0032420	stereocilium [GO:0032420]; catalase activity [GO:0004096]; heme binding [GO:0020037]; sensory perception of sound [GO:0007605]
PGEN_.00g098330	Scaffold_04	51325611	51328690	O16025	AOSL_PLEHO	Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (EC 4.2.1.92) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]	GO:0004096; GO:0005506; GO:0005737; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0047677; GO:0047987	cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408]
PGEN_.00g098340	Scaffold_04	51340143	51340628	C8YR32	LOXH1_MOUSE	Lipoxygenase homology domain-containing protein 1	GO:0004096; GO:0007605; GO:0020037; GO:0032420	stereocilium [GO:0032420]; catalase activity [GO:0004096]; heme binding [GO:0020037]; sensory perception of sound [GO:0007605]
PGEN_.00g098350	Scaffold_04	51346898	51347416	O16025	AOSL_PLEHO	Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (EC 4.2.1.92) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]	GO:0004096; GO:0005506; GO:0005737; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0047677; GO:0047987	cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408]
PGEN_.00g098360	Scaffold_04	51367360	51370415	O70582	LX12B_MOUSE	"Arachidonate 12-lipoxygenase, 12R-type (12R-LOX) (12R-lipoxygenase) (EC 1.13.11.-) (Epidermis-type lipoxygenase 12) (Epidermis-type lipoxygenase 2) (e-LOX 2)"	GO:0003824; GO:0004052; GO:0005506; GO:0006497; GO:0006665; GO:0010628; GO:0016702; GO:0019369; GO:0019372; GO:0043410; GO:0043651; GO:0046513; GO:0047677; GO:0048471; GO:0051122; GO:0055114; GO:0061436; GO:0070257; GO:1990136	"perinuclear region of cytoplasm [GO:0048471]; arachidonate 12-lipoxygenase activity [GO:0004052]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalytic activity [GO:0003824]; iron ion binding [GO:0005506]; linoleate 9S-lipoxygenase activity [GO:1990136]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; oxidation-reduction process [GO:0055114]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; protein lipidation [GO:0006497]; sphingolipid metabolic process [GO:0006665]"
PGEN_.00g098370	Scaffold_04	51401855	51428926	F1MDL2	INTU_BOVIN	Protein inturned (Inturned planar cell polarity effector homolog) (PDZ domain-containing protein 6)	GO:0001736; GO:0005737; GO:0007399; GO:0008589; GO:0009986; GO:0010839; GO:0021513; GO:0021915; GO:0030216; GO:0030278; GO:0031069; GO:0031514; GO:0036064; GO:0042733; GO:0044458; GO:0045880; GO:0051782; GO:0060173; GO:0060271; GO:1905515	cell surface [GO:0009986]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; spinal cord dorsal/ventral patterning [GO:0021513]
PGEN_.00g098380	Scaffold_04	51791795	51792586	NA	NA	NA	NA	NA
PGEN_.00g098390	Scaffold_04	51797232	51888099	O61307	TENM_DROME	Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)	GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0030054; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]
PGEN_.00g098400	Scaffold_04	51987194	51999800	Q9R1C0	TAF7_MOUSE	Transcription initiation factor TFIID subunit 7 (RNA polymerase II TBP-associated factor subunit F) (Transcription initiation factor TFIID 55 kDa subunit) (TAF(II)55) (TAFII-55) (TAFII55)	GO:0000122; GO:0001097; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005669; GO:0005737; GO:0005794; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0006469; GO:0008134; GO:0030520; GO:0033276; GO:0035035; GO:0035067; GO:0042809; GO:0044212; GO:0045892; GO:0045944; GO:0046966; GO:0046982; GO:0051123; GO:0061628; GO:0071339; GO:0106140	"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA-binding transcription factor activity [GO:0003700]; H3K27me3 modified histone binding [GO:0061628]; histone acetyltransferase binding [GO:0035035]; P-TEFb complex binding [GO:0106140]; protein heterodimerization activity [GO:0046982]; TFIIH-class transcription factor complex binding [GO:0001097]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; vitamin D receptor binding [GO:0042809]; DNA-templated transcription, initiation [GO:0006352]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of histone acetylation [GO:0035067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g098410	Scaffold_04	52005499	52032614	Q3SWX0	NIPA2_BOVIN	Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2 homolog)	GO:0005769; GO:0005886; GO:0015095; GO:0015693; GO:0016021	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]
PGEN_.00g098420	Scaffold_04	52051223	52073370	NA	NA	NA	NA	NA
PGEN_.00g098430	Scaffold_04	52073404	52079242	Q5R7Q3	NIPA2_PONAB	Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2 homolog)	GO:0005769; GO:0005886; GO:0015095; GO:0016021	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]
PGEN_.00g098440	Scaffold_04	52117438	52125761	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g098450	Scaffold_04	52133063	52139692	Q1ZXD6	ROCO5_DICDI	Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5)	GO:0004674; GO:0005085; GO:0005524; GO:0005525; GO:0030587	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; sorocarp development [GO:0030587]
PGEN_.00g098460	Scaffold_04	52176624	52183861	NA	NA	NA	NA	NA
PGEN_.00g098470	Scaffold_04	52189662	52191994	NA	NA	NA	NA	NA
PGEN_.00g098480	Scaffold_04	52219907	52221775	NA	NA	NA	NA	NA
PGEN_.00g098490	Scaffold_04	52345156	52349532	NA	NA	NA	NA	NA
PGEN_.00g098500	Scaffold_04	52380145	52398174	Q923Q2	STA13_MOUSE	StAR-related lipid transfer protein 13 (START domain-containing protein 13) (StARD13)	GO:0005096; GO:0005811; GO:0007049; GO:0007165; GO:0008289; GO:0031966; GO:0043542; GO:0090051; GO:0097498; GO:1903671	lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; signal transduction [GO:0007165]
PGEN_.00g098510	Scaffold_04	52405914	52550295	B9VTT2	RHG07_CANLF	Rho GTPase-activating protein 7 (Deleted in liver cancer 1 protein homolog) (DLC-1) (Rho-type GTPase-activating protein 7) (START domain-containing protein 12) (StARD12) (StAR-related lipid transfer protein 12)	GO:0005096; GO:0005737; GO:0005925; GO:0007165; GO:0008289; GO:0016020; GO:0035023	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165]
PGEN_.00g098520	Scaffold_04	52550352	52569178	NA	NA	NA	NA	NA
PGEN_.00g098530	Scaffold_04	52656024	52658010	NA	NA	NA	NA	NA
PGEN_.00g098540	Scaffold_04	52658558	52660134	NA	NA	NA	NA	NA
PGEN_.00g098550	Scaffold_04	52660828	52663397	NA	NA	NA	NA	NA
PGEN_.00g098560	Scaffold_04	52666689	52677035	NA	NA	NA	NA	NA
PGEN_.00g098570	Scaffold_04	52682352	52685448	NA	NA	NA	NA	NA
PGEN_.00g098580	Scaffold_04	52693841	52694750	NA	NA	NA	NA	NA
PGEN_.00g098590	Scaffold_04	52694862	52695158	NA	NA	NA	NA	NA
PGEN_.00g098600	Scaffold_04	52770425	52772460	NA	NA	NA	NA	NA
PGEN_.00g098610	Scaffold_04	52851013	52852320	NA	NA	NA	NA	NA
PGEN_.00g098620	Scaffold_04	52873567	52890346	Q8N5Y2	MS3L1_HUMAN	Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1) (MSL3-like 1)	GO:0000123; GO:0003677; GO:0005654; GO:0006342; GO:0016573; GO:0016575; GO:0035064; GO:0035267; GO:0043967; GO:0043968; GO:0043984; GO:0072487	histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; chromatin silencing [GO:0006342]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]
PGEN_.00g098630	Scaffold_04	52898312	52905556	P49395	RS3A_APLCA	40S ribosomal protein S3a (Lysine-rich protein KRP-A)	GO:0003735; GO:0006412; GO:0022627	cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g098640	Scaffold_04	52919423	52928195	Q5TYV0	EMC7_DANRE	ER membrane protein complex subunit 7	GO:0016021; GO:0030246; GO:0072546	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]
PGEN_.00g098650	Scaffold_04	52934614	52936494	NA	NA	NA	NA	NA
PGEN_.00g098660	Scaffold_04	52940576	52941397	NA	NA	NA	NA	NA
PGEN_.00g098670	Scaffold_04	52941426	52946556	NA	NA	NA	NA	NA
PGEN_.00g098680	Scaffold_04	52947947	52964648	F1QYJ6	ST6B1_DANRE	Sulfotransferase 6B1 (EC 2.8.2.-) (Thyroxine sulfotransferase) (EC 2.8.2.n2)	GO:0008146; GO:0071466	sulfotransferase activity [GO:0008146]; cellular response to xenobiotic stimulus [GO:0071466]
PGEN_.00g098690	Scaffold_04	52965369	52965830	NA	NA	NA	NA	NA
PGEN_.00g098700	Scaffold_04	52967166	52972115	F1QYJ6	ST6B1_DANRE	Sulfotransferase 6B1 (EC 2.8.2.-) (Thyroxine sulfotransferase) (EC 2.8.2.n2)	GO:0008146; GO:0071466	sulfotransferase activity [GO:0008146]; cellular response to xenobiotic stimulus [GO:0071466]
PGEN_.00g098710	Scaffold_04	52986371	52986730	NA	NA	NA	NA	NA
PGEN_.00g098720	Scaffold_04	52986796	52987218	NA	NA	NA	NA	NA
PGEN_.00g098730	Scaffold_04	52995212	53003862	O43704	ST1B1_HUMAN	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (Sulfotransferase 1B2) (ST1B2) (Thyroid hormone sulfotransferase)	GO:0004062; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cellular biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g098740	Scaffold_04	53009794	53010108	NA	NA	NA	NA	NA
PGEN_.00g098750	Scaffold_04	53087053	53103719	G3V9R3	ST1D1_RAT	Sulfotransferase 1 family member D1 (ST1D1) (EC 2.8.2.-) (Dopamine sulfotransferase Sult1d1) (Tyrosine-ester sulfotransferase)	GO:0005737; GO:0006584; GO:0006629; GO:0008146	cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; catecholamine metabolic process [GO:0006584]; lipid metabolic process [GO:0006629]
PGEN_.00g098760	Scaffold_04	53121040	53121297	NA	NA	NA	NA	NA
PGEN_.00g098770	Scaffold_04	53121474	53121758	NA	NA	NA	NA	NA
PGEN_.00g098780	Scaffold_04	53233978	53238515	O43704	ST1B1_HUMAN	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (Sulfotransferase 1B2) (ST1B2) (Thyroid hormone sulfotransferase)	GO:0004062; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cellular biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g098790	Scaffold_04	53251491	53254268	NA	NA	NA	NA	NA
PGEN_.00g098800	Scaffold_04	53262952	53265700	Q9UBQ7	GRHPR_HUMAN	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	GO:0005737; GO:0005782; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0034641; GO:0042803; GO:0043648; GO:0046487; GO:0051259; GO:0051287; GO:0055114; GO:0070062; GO:0070402	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]"
PGEN_.00g098810	Scaffold_04	53265791	53289801	Q6ZPI0	JADE1_MOUSE	Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17)	GO:0000123; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0016607; GO:0036064; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0046872; GO:0090090; GO:2000134	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]
PGEN_.00g098820	Scaffold_04	53296156	53299933	Q5M823	NUDC2_RAT	NudC domain-containing protein 2	GO:0000777; GO:0000922; GO:0005737; GO:0005815; GO:0005829; GO:0006457; GO:0032502; GO:0045171; GO:0051082; GO:0072686	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; unfolded protein binding [GO:0051082]; developmental process [GO:0032502]; protein folding [GO:0006457]
PGEN_.00g098830	Scaffold_04	53303192	53338945	Q9P2J5	SYLC_HUMAN	"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0006622; GO:0008361; GO:0010507; GO:0012505; GO:0016604; GO:0017101; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; negative regulation of autophagy [GO:0010507]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; protein targeting to lysosome [GO:0006622]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]
PGEN_.00g098840	Scaffold_04	53352822	53361040	NA	NA	NA	NA	NA
PGEN_.00g098850	Scaffold_04	53383095	53385623	NA	NA	NA	NA	NA
PGEN_.00g098860	Scaffold_04	53394538	53435605	Q55GU0	Y9955_DICDI	Probable serine/threonine-protein kinase DDB_G0267514 (EC 2.7.11.1)	GO:0004674; GO:0005524	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g098870	Scaffold_04	53435648	53435965	NA	NA	NA	NA	NA
PGEN_.00g098880	Scaffold_04	53438274	53448905	O75596	CLC3A_HUMAN	C-type lectin domain family 3 member A (C-type lectin superfamily member 1) (Cartilage-derived C-type lectin)	GO:0001501; GO:0001503; GO:0005615; GO:0030246	extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; ossification [GO:0001503]; skeletal system development [GO:0001501]
PGEN_.00g098890	Scaffold_04	53463805	53464197	NA	NA	NA	NA	NA
PGEN_.00g098900	Scaffold_04	53465236	53465595	NA	NA	NA	NA	NA
PGEN_.00g098910	Scaffold_04	53466543	53466989	NA	NA	NA	NA	NA
PGEN_.00g098920	Scaffold_04	53474231	53485852	NA	NA	NA	NA	NA
PGEN_.00g098930	Scaffold_04	53485903	53497860	NA	NA	NA	NA	NA
PGEN_.00g098940	Scaffold_04	53500406	53502572	NA	NA	NA	NA	NA
PGEN_.00g098950	Scaffold_04	53503416	53503757	NA	NA	NA	NA	NA
PGEN_.00g098960	Scaffold_04	53578237	53595371	NA	NA	NA	NA	NA
PGEN_.00g098970	Scaffold_04	53600490	53619747	NA	NA	NA	NA	NA
PGEN_.00g098980	Scaffold_04	53619851	53629069	P42519	STAR_DROME	Protein Star	GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]
PGEN_.00g098990	Scaffold_04	53630017	53631429	NA	NA	NA	NA	NA
PGEN_.00g099000	Scaffold_04	53643128	53646966	NA	NA	NA	NA	NA
PGEN_.00g099010	Scaffold_04	53649555	53658025	NA	NA	NA	NA	NA
PGEN_.00g099020	Scaffold_04	53669492	53670094	NA	NA	NA	NA	NA
PGEN_.00g099030	Scaffold_04	53684588	53690991	NA	NA	NA	NA	NA
PGEN_.00g099040	Scaffold_04	53708712	53709143	NA	NA	NA	NA	NA
PGEN_.00g099050	Scaffold_04	53815380	53815748	NA	NA	NA	NA	NA
PGEN_.00g099060	Scaffold_04	53815882	53816511	NA	NA	NA	NA	NA
PGEN_.00g099070	Scaffold_04	53816616	53817059	NA	NA	NA	NA	NA
PGEN_.00g099080	Scaffold_04	53831132	53833059	NA	NA	NA	NA	NA
PGEN_.00g099090	Scaffold_04	53849362	53852930	NA	NA	NA	NA	NA
PGEN_.00g099100	Scaffold_04	53859133	53873383	P29786	TRY3_AEDAE	Trypsin 3A1 (EC 3.4.21.4)	GO:0004252; GO:0005615; GO:0007586	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]
PGEN_.00g099110	Scaffold_04	53877643	53897124	Q8BYI9	TENR_MOUSE	Tenascin-R (TN-R) (Janusin) (Neural recognition molecule J1-160/180) (Restrictin)	GO:0005178; GO:0007158; GO:0007162; GO:0008306; GO:0009986; GO:0010977; GO:0022029; GO:0022408; GO:0030198; GO:0030517; GO:0031012; GO:0035641; GO:0045121; GO:0046625; GO:0048692; GO:0050804; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0072534; GO:0098685; GO:0098686; GO:0098966; GO:0098978	"cell surface [GO:0009986]; extracellular matrix [GO:0031012]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; perisynaptic extracellular matrix [GO:0098966]; Schaffer collateral - CA1 synapse [GO:0098685]; integrin binding [GO:0005178]; sphingolipid binding [GO:0046625]; associative learning [GO:0008306]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic transmission [GO:0050805]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; synapse organization [GO:0050808]; telencephalon cell migration [GO:0022029]"
PGEN_.00g099120	Scaffold_04	53938791	53947872	NA	NA	NA	NA	NA
PGEN_.00g099130	Scaffold_04	53949332	53958877	Q6P791	LTOR1_RAT	Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18)	GO:0001558; GO:0001919; GO:0005085; GO:0005764; GO:0005765; GO:0005886; GO:0007032; GO:0007040; GO:0010872; GO:0010874; GO:0016197; GO:0031902; GO:0032008; GO:0032418; GO:0034613; GO:0042632; GO:0043410; GO:0045121; GO:0051020; GO:0060090; GO:0060620; GO:0071230; GO:0071986	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919]
PGEN_.00g099140	Scaffold_04	53959150	53976885	Q96I59	SYNM_HUMAN	"Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS)"	GO:0003676; GO:0004816; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006421	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421]
PGEN_.00g099150	Scaffold_04	53999027	54043343	NA	NA	NA	NA	NA
PGEN_.00g099160	Scaffold_04	54043700	54044236	NA	NA	NA	NA	NA
PGEN_.00g099170	Scaffold_04	54044260	54044595	NA	NA	NA	NA	NA
PGEN_.00g099180	Scaffold_04	54044661	54044990	NA	NA	NA	NA	NA
PGEN_.00g099190	Scaffold_04	54048861	54075322	NA	NA	NA	NA	NA
PGEN_.00g099200	Scaffold_04	54099214	54102201	P18052	PTPRA_MOUSE	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28)	GO:0004725; GO:0005886; GO:0006468; GO:0006470; GO:0008286; GO:0043231; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0098685; GO:0099699	integral component of synaptic membrane [GO:0099699]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; insulin receptor signaling pathway [GO:0008286]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]
PGEN_.00g099210	Scaffold_04	54119598	54167793	Q9W0A0	DRPR_DROME	Protein draper	GO:0001786; GO:0001891; GO:0005737; GO:0005886; GO:0005938; GO:0006909; GO:0006911; GO:0008345; GO:0016021; GO:0016322; GO:0030054; GO:0030424; GO:0031224; GO:0035071; GO:0035212; GO:0042742; GO:0043277; GO:0043652; GO:0045211; GO:0045335; GO:0048190; GO:0048678; GO:0060100; GO:0098794; GO:1904396	"axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; positive regulation of phagocytosis, engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190]"
PGEN_.00g099220	Scaffold_04	54174097	54174852	NA	NA	NA	NA	NA
PGEN_.00g099230	Scaffold_04	54174944	54175231	NA	NA	NA	NA	NA
PGEN_.00g099240	Scaffold_04	54189024	54191742	NA	NA	NA	NA	NA
PGEN_.00g099250	Scaffold_04	54232414	54247618	NA	NA	NA	NA	NA
PGEN_.00g099260	Scaffold_04	54250759	54251319	NA	NA	NA	NA	NA
PGEN_.00g099270	Scaffold_04	54257709	54260703	NA	NA	NA	NA	NA
PGEN_.00g099280	Scaffold_04	54260754	54261218	NA	NA	NA	NA	NA
PGEN_.00g099290	Scaffold_04	54261620	54262321	NA	NA	NA	NA	NA
PGEN_.00g099300	Scaffold_04	54271602	54279044	NA	NA	NA	NA	NA
PGEN_.00g099310	Scaffold_04	54295629	54296111	P9WI29	PPE16_MYCTU	Uncharacterized PPE family protein PPE16		
PGEN_.00g099320	Scaffold_04	54301551	54301763	NA	NA	NA	NA	NA
PGEN_.00g099330	Scaffold_04	54311070	54323407	Q17QV3	SUMO3_BOVIN	Small ubiquitin-related modifier 3 (SUMO-3)	GO:0005737; GO:0016605; GO:0016925; GO:0019899; GO:0043392	cytoplasm [GO:0005737]; PML body [GO:0016605]; enzyme binding [GO:0019899]; negative regulation of DNA binding [GO:0043392]; protein sumoylation [GO:0016925]
PGEN_.00g099340	Scaffold_04	54326585	54337736	Q91YL7	PG2IP_MOUSE	PGAP2-interacting protein (Cell wall biogenesis protein 43 C-terminal homolog)	GO:0005783; GO:0006506; GO:0016021	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g099350	Scaffold_04	54352693	54380035	Q9H720	PG2IP_HUMAN	PGAP2-interacting protein (Cell wall biogenesis protein 43 C-terminal homolog)	GO:0005783; GO:0006506; GO:0016021	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g099360	Scaffold_04	54391610	54391891	NA	NA	NA	NA	NA
PGEN_.00g099370	Scaffold_04	54406648	54414016	NA	NA	NA	NA	NA
PGEN_.00g099380	Scaffold_04	54449834	54458195	Q80VF6	F181B_MOUSE	Protein FAM181B		
PGEN_.00g099390	Scaffold_04	54458223	54463950	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g099400	Scaffold_04	54485380	54494099	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g099410	Scaffold_04	54497915	54501136	NA	NA	NA	NA	NA
PGEN_.00g099420	Scaffold_04	54521412	54544394	NA	NA	NA	NA	NA
PGEN_.00g099430	Scaffold_04	54553041	54553445	NA	NA	NA	NA	NA
PGEN_.00g099440	Scaffold_04	54625054	54633347	Q71R50	DHR11_CHICK	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703; GO:0072555; GO:0072582	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]
PGEN_.00g099450	Scaffold_04	54638464	54640118	NA	NA	NA	NA	NA
PGEN_.00g099460	Scaffold_04	54656024	54665722	Q71R50	DHR11_CHICK	Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006703; GO:0072555; GO:0072582	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]
PGEN_.00g099470	Scaffold_04	54671942	54673590	NA	NA	NA	NA	NA
PGEN_.00g099480	Scaffold_04	54681481	54682158	NA	NA	NA	NA	NA
PGEN_.00g099490	Scaffold_04	54698981	54707639	NA	NA	NA	NA	NA
PGEN_.00g099500	Scaffold_04	54720373	54720780	NA	NA	NA	NA	NA
PGEN_.00g099510	Scaffold_04	54721059	54764033	O60879	DIAP2_HUMAN	Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2)	GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0007015; GO:0007275; GO:0007292; GO:0017048; GO:0043231; GO:0048477	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; female gamete generation [GO:0007292]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]
PGEN_.00g099520	Scaffold_04	54786154	54786717	NA	NA	NA	NA	NA
PGEN_.00g099530	Scaffold_04	54792918	54794728	NA	NA	NA	NA	NA
PGEN_.00g099540	Scaffold_04	54802683	54828038	Q5ZMS6	TDRD3_CHICK	Tudor domain-containing protein 3	GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005737; GO:0006325; GO:0006397; GO:0035064	cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397]
PGEN_.00g099550	Scaffold_04	54842103	54866315	Q6PG95	CRML_MOUSE	Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein)	GO:0003677; GO:0003682; GO:0005634	nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]
PGEN_.00g099560	Scaffold_04	54867816	54889243	NA	NA	NA	NA	NA
PGEN_.00g099570	Scaffold_04	54899150	54899979	NA	NA	NA	NA	NA
PGEN_.00g099580	Scaffold_04	54900032	54900376	NA	NA	NA	NA	NA
PGEN_.00g099590	Scaffold_04	54900609	54902008	NA	NA	NA	NA	NA
PGEN_.00g099600	Scaffold_04	54916197	54978159	Q9C0D6	FHDC1_HUMAN	FH2 domain-containing protein 1 (Inverted formin-1)	GO:0003779; GO:0005794; GO:0005874; GO:0005881; GO:0005929; GO:0008017; GO:0043149; GO:0060271; GO:0090161	cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149]
PGEN_.00g099610	Scaffold_04	54990312	54990641	NA	NA	NA	NA	NA
PGEN_.00g099620	Scaffold_04	54990690	54990932	NA	NA	NA	NA	NA
PGEN_.00g099630	Scaffold_04	54995489	54995719	NA	NA	NA	NA	NA
PGEN_.00g099640	Scaffold_04	55052850	55056576	NA	NA	NA	NA	NA
PGEN_.00g099650	Scaffold_04	55058777	55064675	Q6VUC1	DPH3_CRIGR	DPH3 homolog (CSL-type zinc finger-containing protein 2) (Diphtheria toxin and Pseudomonas exotoxin A sensitivity-required protein 1)	GO:0005634; GO:0005737; GO:0017183; GO:0046872; GO:0050709; GO:0051099	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of protein secretion [GO:0050709]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]; positive regulation of binding [GO:0051099]
PGEN_.00g099660	Scaffold_04	55068746	55073655	NA	NA	NA	NA	NA
PGEN_.00g099670	Scaffold_04	55089615	55131416	Q8MQJ9	BRAT_DROME	Brain tumor protein	GO:0000209; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007411; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0043161; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0061630; GO:0099738; GO:1900242; GO:1902692	apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex region [GO:0099738]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon guidance [GO:0007411]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]
PGEN_.00g099680	Scaffold_04	55136221	55136445	NA	NA	NA	NA	NA
PGEN_.00g099690	Scaffold_04	55152048	55159892	Q0IJ01	ZWILC_XENTR	Protein zwilch homolog	GO:0000777; GO:0007093; GO:0051301; GO:1990423	condensed chromosome kinetochore [GO:0000777]; RZZ complex [GO:1990423]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]
PGEN_.00g099700	Scaffold_04	55162400	55176716	Q96B26	EXOS8_HUMAN	Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2) (OIP-2) (Ribosomal RNA-processing protein 43) (p9)	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006364; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043488; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"
PGEN_.00g099710	Scaffold_04	55176977	55181367	Q9D753	EXOS8_MOUSE	Exosome complex component RRP43 (Exosome component 8) (Ribosomal RNA-processing protein 43)	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"
PGEN_.00g099720	Scaffold_04	55190812	55199336	NA	NA	NA	NA	NA
PGEN_.00g099730	Scaffold_04	55289930	55352398	NA	NA	NA	NA	NA
PGEN_.00g099740	Scaffold_04	55353503	55360691	NA	NA	NA	NA	NA
PGEN_.00g099750	Scaffold_04	55384834	55393020	A4FV08	GNPI1_BOVIN	Glucosamine-6-phosphate isomerase 1 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 1) (GNPDA 1) (GlcN6P deaminase 1) (Oscillin)	GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0006091; GO:0019262; GO:0042802	cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]
PGEN_.00g099760	Scaffold_04	55405362	55439708	Q80SU7	GVIN1_MOUSE	Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g099770	Scaffold_04	55456151	55458697	NA	NA	NA	NA	NA
PGEN_.00g099780	Scaffold_04	55461459	55461731	NA	NA	NA	NA	NA
PGEN_.00g099790	Scaffold_04	55506600	55509398	NA	NA	NA	NA	NA
PGEN_.00g099800	Scaffold_04	55531006	55531314	NA	NA	NA	NA	NA
PGEN_.00g099810	Scaffold_04	55538428	55538958	NA	NA	NA	NA	NA
PGEN_.00g099820	Scaffold_04	55538993	55539352	NA	NA	NA	NA	NA
PGEN_.00g099830	Scaffold_04	55548145	55554241	NA	NA	NA	NA	NA
PGEN_.00g099840	Scaffold_04	55567957	55578184	Q60649	CLPB_MOUSE	Caseinolytic peptidase B protein homolog (EC 3.6.1.3) (Suppressor of potassium transport defect 3)	GO:0005524; GO:0005739; GO:0016887; GO:0034605	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cellular response to heat [GO:0034605]
PGEN_.00g099850	Scaffold_04	55605496	55619623	NA	NA	NA	NA	NA
PGEN_.00g099860	Scaffold_04	55624886	55625143	NA	NA	NA	NA	NA
PGEN_.00g099870	Scaffold_04	55629024	55629826	NA	NA	NA	NA	NA
PGEN_.00g099880	Scaffold_04	55630371	55630754	NA	NA	NA	NA	NA
PGEN_.00g099890	Scaffold_04	55631069	55646276	NA	NA	NA	NA	NA
PGEN_.00g099900	Scaffold_04	55649115	55649354	NA	NA	NA	NA	NA
PGEN_.00g099910	Scaffold_04	55671813	55677636	NA	NA	NA	NA	NA
PGEN_.00g099920	Scaffold_04	55687862	55689011	NA	NA	NA	NA	NA
PGEN_.00g099930	Scaffold_04	55713570	55714802	A1ZAI5	FACR1_DROME	Putative fatty acyl-CoA reductase CG5065 (EC 1.2.1.84)	GO:0005777; GO:0005778; GO:0005779; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965	integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]
PGEN_.00g099940	Scaffold_04	55721524	55722455	NA	NA	NA	NA	NA
PGEN_.00g099950	Scaffold_04	55738088	55761145	Q8BW70	UBP38_MOUSE	Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38)	GO:0004197; GO:0004843; GO:0006511; GO:0016579	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g099960	Scaffold_04	55761405	55770226	Q8NB14	UBP38_HUMAN	Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (HP43.8KD) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38)	GO:0004197; GO:0004843; GO:0006511; GO:0016579	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g099970	Scaffold_04	55785029	55785229	NA	NA	NA	NA	NA
PGEN_.00g099980	Scaffold_04	55785416	55785811	NA	NA	NA	NA	NA
PGEN_.00g099990	Scaffold_04	55786543	55786818	NA	NA	NA	NA	NA
PGEN_.00g100000	Scaffold_04	55787213	55788386	NA	NA	NA	NA	NA
PGEN_.00g100010	Scaffold_04	55788537	55788821	NA	NA	NA	NA	NA
PGEN_.00g100020	Scaffold_04	55808779	55824096	Q66HG8	RED_RAT	Protein Red (Cytokine IK) (IK factor)	GO:0000278; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0034501; GO:0042802; GO:0071005	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]"
PGEN_.00g100030	Scaffold_04	55829959	55850309	Q1RLY6	KMO_DANRE	Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase)	GO:0001878; GO:0004502; GO:0005739; GO:0005741; GO:0006569; GO:0016021; GO:0016174; GO:0019674; GO:0019805; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071949; GO:0072015	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; glomerular visceral epithelial cell development [GO:0072015]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; response to yeast [GO:0001878]; tryptophan catabolic process [GO:0006569]
PGEN_.00g100040	Scaffold_04	55852766	55853200	NA	NA	NA	NA	NA
PGEN_.00g100050	Scaffold_04	55854061	55872919	NA	NA	NA	NA	NA
PGEN_.00g100060	Scaffold_04	55882074	55895308	NA	NA	NA	NA	NA
PGEN_.00g100070	Scaffold_04	55896795	55909064	Q4U2R1	HERC2_MOUSE	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g100080	Scaffold_04	55954667	55963628	NA	NA	NA	NA	NA
PGEN_.00g100090	Scaffold_04	55966528	55986366	Q4G0Z9	MCMD2_HUMAN	Minichromosome maintenance domain-containing protein 2 (MCM domain-containing protein 2)	GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0007130; GO:0007283; GO:0042140; GO:0042555; GO:0048477; GO:1990918	MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; double-strand break repair involved in meiotic recombination [GO:1990918]; late meiotic recombination nodule assembly [GO:0042140]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]
PGEN_.00g100100	Scaffold_04	55990340	56005472	Q2KID6	PLRG1_BOVIN	Pleiotropic regulator 1	GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005662; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:0080008; GO:1900087	"catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"
PGEN_.00g100110	Scaffold_04	56010005	56026354	Q9NVA2	SEP11_HUMAN	Septin-11	GO:0001725; GO:0003924; GO:0005525; GO:0005940; GO:0015630; GO:0030054; GO:0030424; GO:0031105; GO:0043197; GO:0050807; GO:0051291; GO:0060271; GO:0061640; GO:0098978; GO:0098982; GO:0099629	axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; postsynaptic specialization of symmetric synapse [GO:0099629]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein heterooligomerization [GO:0051291]; regulation of synapse organization [GO:0050807]
PGEN_.00g100120	Scaffold_04	56029434	56082091	Q8NFP9	NBEA_HUMAN	Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B)	GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0019901	cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; protein kinase binding [GO:0019901]; protein localization [GO:0008104]
PGEN_.00g100130	Scaffold_04	56085402	56086337	NA	NA	NA	NA	NA
PGEN_.00g100140	Scaffold_04	56086576	56119382	Q9W4E2	NBEA_DROME	Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550)	GO:0005737; GO:0007528; GO:0007614; GO:0008355; GO:0016021; GO:0016319; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614]
PGEN_.00g100150	Scaffold_04	56159484	56160005	NA	NA	NA	NA	NA
PGEN_.00g100160	Scaffold_04	56166401	56167507	Q6NYB4	MB211_DANRE	Putative nucleotidyltransferase MAB21L1 (EC 2.7.7.-) (Protein mab-21-like 1)	GO:0000166; GO:0005634; GO:0007275; GO:0016779; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; multicellular organism development [GO:0007275]
PGEN_.00g100170	Scaffold_04	56187628	56190125	NA	NA	NA	NA	NA
PGEN_.00g100180	Scaffold_04	56218424	56249536	Q9W4E2	NBEA_DROME	Neurobeachin (A-kinase anchor protein 550) (AKAP 550) (Protein rugose) (dAKAP550)	GO:0005737; GO:0007528; GO:0007614; GO:0008355; GO:0016021; GO:0016319; GO:0042462; GO:0042675; GO:0043025; GO:0043204; GO:0051018	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614]
PGEN_.00g100190	Scaffold_04	56259402	56259905	NA	NA	NA	NA	NA
PGEN_.00g100200	Scaffold_04	56265618	56283542	Q14590	ZN235_HUMAN	Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g100210	Scaffold_04	56299786	56323141	NA	NA	NA	NA	NA
PGEN_.00g100220	Scaffold_04	56323194	56328305	NA	NA	NA	NA	NA
PGEN_.00g100230	Scaffold_04	56328345	56330008	NA	NA	NA	NA	NA
PGEN_.00g100240	Scaffold_04	56339127	56339378	NA	NA	NA	NA	NA
PGEN_.00g100250	Scaffold_04	56344943	56378635	Q86UW6	N4BP2_HUMAN	NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)	GO:0004519; GO:0005524; GO:0005829; GO:0046404	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]
PGEN_.00g100260	Scaffold_04	56383596	56388608	NA	NA	NA	NA	NA
PGEN_.00g100270	Scaffold_04	56399323	56419123	NA	NA	NA	NA	NA
PGEN_.00g100280	Scaffold_04	56424607	56432432	NA	NA	NA	NA	NA
PGEN_.00g100290	Scaffold_04	56470283	56519588	Q7YQL6	OPHN1_PANTR	Oligophrenin-1	GO:0005096; GO:0005737; GO:0007165; GO:0007399; GO:0015629; GO:0030036; GO:0030054; GO:0030100; GO:0034329; GO:0043195; GO:0043197; GO:0045198; GO:0048488; GO:0051966; GO:1901799	"actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; actin cytoskeleton organization [GO:0030036]; cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; negative regulation of proteasomal protein catabolic process [GO:1901799]; nervous system development [GO:0007399]; regulation of endocytosis [GO:0030100]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]; synaptic vesicle endocytosis [GO:0048488]"
PGEN_.00g100300	Scaffold_04	56532591	56534008	NA	NA	NA	NA	NA
PGEN_.00g100310	Scaffold_04	56548628	56548915	NA	NA	NA	NA	NA
PGEN_.00g100320	Scaffold_04	56549751	56562426	Q6Y5D8	RHG10_MOUSE	Rho GTPase-activating protein 10 (PH and SH3 domain-containing rhoGAP protein) (PS-GAP) (PSGAP) (Rho-type GTPase-activating protein 10)	GO:0005096; GO:0005829; GO:0005886; GO:0007010; GO:0007165; GO:0043066; GO:0048471	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]
PGEN_.00g100330	Scaffold_04	56562646	56571283	Q9Y3S2	ZN330_HUMAN	Zinc finger protein 330 (Nucleolar autoantigen 36) (Nucleolar cysteine-rich protein)	GO:0000775; GO:0005730; GO:0008270; GO:0030496; GO:0046872	"chromosome, centromeric region [GO:0000775]; midbody [GO:0030496]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]"
PGEN_.00g100340	Scaffold_04	56576274	56586433	NA	NA	NA	NA	NA
PGEN_.00g100350	Scaffold_04	56586886	56589468	NA	NA	NA	NA	NA
PGEN_.00g100360	Scaffold_04	56591040	56594874	NA	NA	NA	NA	NA
PGEN_.00g100370	Scaffold_04	56601629	56602833	P34586	TRPL_CAEEL	Transient-receptor-potential-like protein (TRP homologous cation channel protein 1)	GO:0005623; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679	"cation channel complex [GO:0034703]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]"
PGEN_.00g100380	Scaffold_04	56633624	56633851	NA	NA	NA	NA	NA
PGEN_.00g100390	Scaffold_04	56659122	56659803	O62852	TRPC5_RABIT	Short transient receptor potential channel 5 (Rtrp5) (TrpC5) (Capacitative calcium entry channel 2) (CCE2)	GO:0005262; GO:0005886; GO:0034704; GO:0070679	"calcium channel complex [GO:0034704]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]"
PGEN_.00g100400	Scaffold_04	56661974	56671851	P34586	TRPL_CAEEL	Transient-receptor-potential-like protein (TRP homologous cation channel protein 1)	GO:0005623; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679	"cation channel complex [GO:0034703]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]"
PGEN_.00g100410	Scaffold_04	56746170	56746415	NA	NA	NA	NA	NA
PGEN_.00g100420	Scaffold_04	56758419	56758865	NA	NA	NA	NA	NA
PGEN_.00g100430	Scaffold_04	56759263	56760171	NA	NA	NA	NA	NA
PGEN_.00g100440	Scaffold_04	56764750	56765406	NA	NA	NA	NA	NA
PGEN_.00g100450	Scaffold_04	56769782	56863588	O95714	HERC2_HUMAN	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g100460	Scaffold_04	56871526	56893058	Q5HYK7	SH319_HUMAN	SH3 domain-containing protein 19 (ADAM-binding protein Eve-1) (EEN-binding protein) (EBP)	GO:0005654; GO:0005829; GO:0005886; GO:0007010; GO:0022604; GO:0051044; GO:0070064	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proline-rich region binding [GO:0070064]; cytoskeleton organization [GO:0007010]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of cell morphogenesis [GO:0022604]
PGEN_.00g100470	Scaffold_04	56907773	56909096	NA	NA	NA	NA	NA
PGEN_.00g100480	Scaffold_04	56909499	56909813	NA	NA	NA	NA	NA
PGEN_.00g100490	Scaffold_04	56914280	56914669	NA	NA	NA	NA	NA
PGEN_.00g100500	Scaffold_04	56916848	56921453	NA	NA	NA	NA	NA
PGEN_.00g100510	Scaffold_04	56933990	56943251	NA	NA	NA	NA	NA
PGEN_.00g100520	Scaffold_04	56980526	56983215	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g100530	Scaffold_04	56995724	57004905	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g100540	Scaffold_04	57008019	57012960	NA	NA	NA	NA	NA
PGEN_.00g100550	Scaffold_04	57013581	57015468	NA	NA	NA	NA	NA
PGEN_.00g100560	Scaffold_04	57025573	57065888	Q62784	INP4A_RAT	"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)"	GO:0005634; GO:0005737; GO:0005886; GO:0014069; GO:0016316; GO:0030054; GO:0031901; GO:0034597; GO:0055038	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]"
PGEN_.00g100570	Scaffold_04	57089858	57101940	Q62784	INP4A_RAT	"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)"	GO:0005634; GO:0005737; GO:0005886; GO:0014069; GO:0016316; GO:0030054; GO:0031901; GO:0034597; GO:0055038	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]"
PGEN_.00g100580	Scaffold_04	57102010	57109418	Q96PE3	INP4A_HUMAN	"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)"	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0007165; GO:0014069; GO:0016316; GO:0030054; GO:0031901; GO:0034597; GO:0043647; GO:0055038	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165]"
PGEN_.00g100590	Scaffold_04	57109866	57133932	Q96PE3	INP4A_HUMAN	"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)"	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0007165; GO:0014069; GO:0016316; GO:0030054; GO:0031901; GO:0034597; GO:0043647; GO:0055038	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165]"
PGEN_.00g100600	Scaffold_04	57144035	57145914	NA	NA	NA	NA	NA
PGEN_.00g100610	Scaffold_04	57146535	57151478	NA	NA	NA	NA	NA
PGEN_.00g100620	Scaffold_04	57154592	57163766	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g100630	Scaffold_04	57175927	57178943	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g100640	Scaffold_04	57216228	57225466	NA	NA	NA	NA	NA
PGEN_.00g100650	Scaffold_04	57238042	57242647	NA	NA	NA	NA	NA
PGEN_.00g100660	Scaffold_04	57244826	57245269	NA	NA	NA	NA	NA
PGEN_.00g100670	Scaffold_04	57249120	57249434	NA	NA	NA	NA	NA
PGEN_.00g100680	Scaffold_04	57249837	57250094	NA	NA	NA	NA	NA
PGEN_.00g100690	Scaffold_04	57265884	57287517	Q5HYK7	SH319_HUMAN	SH3 domain-containing protein 19 (ADAM-binding protein Eve-1) (EEN-binding protein) (EBP)	GO:0005654; GO:0005829; GO:0005886; GO:0007010; GO:0022604; GO:0051044; GO:0070064	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proline-rich region binding [GO:0070064]; cytoskeleton organization [GO:0007010]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of cell morphogenesis [GO:0022604]
PGEN_.00g100700	Scaffold_04	57295454	57389996	O95714	HERC2_HUMAN	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g100710	Scaffold_04	57400287	57401195	NA	NA	NA	NA	NA
PGEN_.00g100720	Scaffold_04	57401593	57402039	NA	NA	NA	NA	NA
PGEN_.00g100730	Scaffold_04	57413732	57413977	NA	NA	NA	NA	NA
PGEN_.00g100740	Scaffold_04	57488149	57500279	P34586	TRPL_CAEEL	Transient-receptor-potential-like protein (TRP homologous cation channel protein 1)	GO:0005623; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679	"cation channel complex [GO:0034703]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]"
PGEN_.00g100750	Scaffold_04	57500321	57500969	O62852	TRPC5_RABIT	Short transient receptor potential channel 5 (Rtrp5) (TrpC5) (Capacitative calcium entry channel 2) (CCE2)	GO:0005262; GO:0005886; GO:0034704; GO:0070679	"calcium channel complex [GO:0034704]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]"
PGEN_.00g100760	Scaffold_04	57525787	57526020	NA	NA	NA	NA	NA
PGEN_.00g100770	Scaffold_04	57543275	57543514	NA	NA	NA	NA	NA
PGEN_.00g100780	Scaffold_04	57557939	57559145	P34586	TRPL_CAEEL	Transient-receptor-potential-like protein (TRP homologous cation channel protein 1)	GO:0005623; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679	"cation channel complex [GO:0034703]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]"
PGEN_.00g100790	Scaffold_04	57565737	57569522	NA	NA	NA	NA	NA
PGEN_.00g100800	Scaffold_04	57571127	57573709	NA	NA	NA	NA	NA
PGEN_.00g100810	Scaffold_04	57574162	57585786	NA	NA	NA	NA	NA
PGEN_.00g100820	Scaffold_04	57588661	57598552	Q32LC9	ZN330_BOVIN	Zinc finger protein 330 (Nucleolar autoantigen 36)	GO:0000775; GO:0005730; GO:0008270	"chromosome, centromeric region [GO:0000775]; nucleolus [GO:0005730]; zinc ion binding [GO:0008270]"
PGEN_.00g100830	Scaffold_04	57598772	57611439	Q6Y5D8	RHG10_MOUSE	Rho GTPase-activating protein 10 (PH and SH3 domain-containing rhoGAP protein) (PS-GAP) (PSGAP) (Rho-type GTPase-activating protein 10)	GO:0005096; GO:0005829; GO:0005886; GO:0007010; GO:0007165; GO:0043066; GO:0048471	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]
PGEN_.00g100840	Scaffold_04	57612274	57612675	NA	NA	NA	NA	NA
PGEN_.00g100850	Scaffold_04	57627959	57691817	Q6Y5D8	RHG10_MOUSE	Rho GTPase-activating protein 10 (PH and SH3 domain-containing rhoGAP protein) (PS-GAP) (PSGAP) (Rho-type GTPase-activating protein 10)	GO:0005096; GO:0005829; GO:0005886; GO:0007010; GO:0007165; GO:0043066; GO:0048471	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]
PGEN_.00g100860	Scaffold_04	57706212	57709811	Q9VLQ1	ALG5_DROME	Dolichyl-phosphate beta-glucosyltransferase (EC 2.4.1.117) (Wollknaeuel)	GO:0004581; GO:0005783; GO:0005789; GO:0006487; GO:0006493; GO:0007009; GO:0007029; GO:0007030; GO:0007379; GO:0007509; GO:0009953; GO:0010004; GO:0016021; GO:0019991; GO:0040003	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; chitin-based cuticle development [GO:0040003]; dorsal/ventral pattern formation [GO:0009953]; endoplasmic reticulum organization [GO:0007029]; gastrulation involving germ band extension [GO:0010004]; Golgi organization [GO:0007030]; mesoderm migration involved in gastrulation [GO:0007509]; plasma membrane organization [GO:0007009]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; segment specification [GO:0007379]; septate junction assembly [GO:0019991]
PGEN_.00g100870	Scaffold_04	57729572	57737396	NA	NA	NA	NA	NA
PGEN_.00g100880	Scaffold_04	57743680	57762377	NA	NA	NA	NA	NA
PGEN_.00g100890	Scaffold_04	57775785	57783790	Q6Y5D8	RHG10_MOUSE	Rho GTPase-activating protein 10 (PH and SH3 domain-containing rhoGAP protein) (PS-GAP) (PSGAP) (Rho-type GTPase-activating protein 10)	GO:0005096; GO:0005829; GO:0005886; GO:0007010; GO:0007165; GO:0043066; GO:0048471	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]
PGEN_.00g100900	Scaffold_04	57802292	57802771	NA	NA	NA	NA	NA
PGEN_.00g100910	Scaffold_04	57802870	57803127	NA	NA	NA	NA	NA
PGEN_.00g100920	Scaffold_04	57827470	57827838	NA	NA	NA	NA	NA
PGEN_.00g100930	Scaffold_04	57828553	57828807	NA	NA	NA	NA	NA
PGEN_.00g100940	Scaffold_04	57837090	57847202	P27473	IFI44_PANTR	Interferon-induced protein 44 (Antigen p44) (Non-A non-B hepatitis-associated microtubular aggregates protein)	GO:0005737; GO:0006955; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]
PGEN_.00g100950	Scaffold_04	57885900	57886430	NA	NA	NA	NA	NA
PGEN_.00g100960	Scaffold_04	57887272	57888653	NA	NA	NA	NA	NA
PGEN_.00g100970	Scaffold_04	57896078	57910749	Q869W9	PKS16_DICDI	Probable polyketide synthase 16 (dipks16) (EC 2.3.1.-)	GO:0016491; GO:0016740; GO:0019953	oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740]; sexual reproduction [GO:0019953]
PGEN_.00g100980	Scaffold_04	57912165	57912392	NA	NA	NA	NA	NA
PGEN_.00g100990	Scaffold_04	57912512	57914668	NA	NA	NA	NA	NA
PGEN_.00g101000	Scaffold_04	57918317	57918526	Q05470	PKSL_BACSU	Polyketide synthase PksL (PKS)	GO:0005737; GO:0016491; GO:0016746; GO:0017000; GO:0031177	"cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]; antibiotic biosynthetic process [GO:0017000]"
PGEN_.00g101010	Scaffold_04	57933508	57939549	NA	NA	NA	NA	NA
PGEN_.00g101020	Scaffold_04	57942638	57943782	NA	NA	NA	NA	NA
PGEN_.00g101030	Scaffold_04	57953649	57955140	NA	NA	NA	NA	NA
PGEN_.00g101040	Scaffold_04	57971694	57974218	NA	NA	NA	NA	NA
PGEN_.00g101050	Scaffold_04	57974245	57974985	NA	NA	NA	NA	NA
PGEN_.00g101060	Scaffold_04	57976223	57976669	NA	NA	NA	NA	NA
PGEN_.00g101070	Scaffold_04	57982609	57989420	NA	NA	NA	NA	NA
PGEN_.00g101080	Scaffold_04	57995311	57995745	NA	NA	NA	NA	NA
PGEN_.00g101090	Scaffold_04	57996209	57996553	NA	NA	NA	NA	NA
PGEN_.00g101100	Scaffold_04	58022909	58026717	NA	NA	NA	NA	NA
PGEN_.00g101110	Scaffold_04	58040155	58063437	NA	NA	NA	NA	NA
PGEN_.00g101120	Scaffold_04	58079942	58080880	NA	NA	NA	NA	NA
PGEN_.00g101130	Scaffold_04	58082015	58083424	NA	NA	NA	NA	NA
PGEN_.00g101140	Scaffold_04	58095911	58106639	Q58D31	DHSO_BOVIN	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)	GO:0003939; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0046526	mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; D-xylulose reductase activity [GO:0046526]; L-iditol 2-dehydrogenase activity [GO:0003939]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]
PGEN_.00g101150	Scaffold_04	58108646	58122507	P0DMQ6	DHSO_CHICK	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase)	GO:0003939; GO:0006000; GO:0006061; GO:0006062; GO:0006116; GO:0006735; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0032991; GO:0042802; GO:0046370; GO:0051160; GO:0051287; GO:0070062	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]
PGEN_.00g101160	Scaffold_04	58131292	58131726	NA	NA	NA	NA	NA
PGEN_.00g101170	Scaffold_04	58135279	58276214	Q8WZ64	ARAP2_HUMAN	"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 (Centaurin-delta-1) (Cnt-d1) (Protein PARX)"	GO:0005096; GO:0005547; GO:0005829; GO:0007165; GO:0046872; GO:0051056	"cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]"
PGEN_.00g101180	Scaffold_04	58305200	58308704	NA	NA	NA	NA	NA
PGEN_.00g101190	Scaffold_04	58319912	58320454	Q93075	TATD2_HUMAN	Putative deoxyribonuclease TATDN2 (EC 3.1.21.-)	GO:0005634; GO:0005654; GO:0016888; GO:0036498; GO:0046872	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]"
PGEN_.00g101200	Scaffold_04	58331526	58335042	NA	NA	NA	NA	NA
PGEN_.00g101210	Scaffold_04	58339181	58375268	C9JQI7	TM232_HUMAN	Transmembrane protein 232	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g101220	Scaffold_04	58377612	58393487	B4F7A1	LYRM7_RAT	Complex III assembly factor LYRM7 (LYR motif-containing protein 7)	GO:0005759; GO:0031966; GO:0034551; GO:0045333	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; cellular respiration [GO:0045333]; mitochondrial respiratory chain complex III assembly [GO:0034551]
PGEN_.00g101230	Scaffold_04	58430207	58431619	NA	NA	NA	NA	NA
PGEN_.00g101240	Scaffold_04	58453902	58454414	NA	NA	NA	NA	NA
PGEN_.00g101250	Scaffold_04	58457075	58471283	NA	NA	NA	NA	NA
PGEN_.00g101260	Scaffold_04	58471860	58472237	NA	NA	NA	NA	NA
PGEN_.00g101270	Scaffold_04	58472463	58474403	NA	NA	NA	NA	NA
PGEN_.00g101280	Scaffold_04	58524265	58589123	NA	NA	NA	NA	NA
PGEN_.00g101290	Scaffold_04	58641457	58697440	P14099	PDE2A_BOVIN	"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)"	GO:0000122; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0008144; GO:0010628; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030553; GO:0035690; GO:0036006; GO:0042734; GO:0042803; GO:0043116; GO:0043117; GO:0043951; GO:0046038; GO:0046069; GO:0046872; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071321; GO:0097011	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; drug binding [GO:0008144]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to drug [GO:0035690]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]"
PGEN_.00g101300	Scaffold_04	58720505	58742690	Q01062	PDE2A_RAT	"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)"	GO:0000122; GO:0000287; GO:0003170; GO:0003279; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0007507; GO:0008144; GO:0008270; GO:0010628; GO:0010749; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030224; GO:0030424; GO:0030425; GO:0030552; GO:0030553; GO:0030911; GO:0035690; GO:0035904; GO:0036004; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0043951; GO:0045121; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0060548; GO:0060976; GO:0061028; GO:0071222; GO:0071260; GO:0071320; GO:0071321; GO:0071560; GO:0090324; GO:0097011; GO:0097060; GO:0097457; GO:1904613; GO:1904880	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber [GO:0097457]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; drug binding [GO:0008144]; GAF domain binding [GO:0036004]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cardiac septum development [GO:0003279]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to drug [GO:0035690]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; coronary vasculature development [GO:0060976]; establishment of endothelial barrier [GO:0061028]; heart development [GO:0007507]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell death [GO:0060548]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to hydrogen sulfide [GO:1904880]; ventricular septum development [GO:0003281]"
PGEN_.00g101310	Scaffold_04	58753058	58758323	NA	NA	NA	NA	NA
PGEN_.00g101320	Scaffold_04	58761154	58776297	Q91X58	ZFN2B_MOUSE	AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein)	GO:0000502; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0031225; GO:0031593; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047	"anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"
PGEN_.00g101330	Scaffold_04	58779842	58780828	NA	NA	NA	NA	NA
PGEN_.00g101340	Scaffold_04	58879387	58894813	Q8R3S6	EXOC1_MOUSE	Exocyst complex component 1 (Exocyst complex component Sec3)	GO:0000145; GO:0005546; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0015031; GO:0017049; GO:0048015; GO:0050714; GO:0051601; GO:0090543; GO:0098592	"cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; exocyst [GO:0000145]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; GTP-Rho binding [GO:0017049]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]"
PGEN_.00g101350	Scaffold_04	58925931	58927246	NA	NA	NA	NA	NA
PGEN_.00g101360	Scaffold_04	58939743	58963551	Q9C0D6	FHDC1_HUMAN	FH2 domain-containing protein 1 (Inverted formin-1)	GO:0003779; GO:0005794; GO:0005874; GO:0005881; GO:0005929; GO:0008017; GO:0043149; GO:0060271; GO:0090161	cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149]
PGEN_.00g101370	Scaffold_04	58964036	58964740	NA	NA	NA	NA	NA
PGEN_.00g101380	Scaffold_04	58964767	58965435	Q3UHC2	LRRK1_MOUSE	Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0050731; GO:0050732; GO:0090263; GO:1902533	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; bone resorption [GO:0045453]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]
PGEN_.00g101390	Scaffold_04	58965464	58966429	NA	NA	NA	NA	NA
PGEN_.00g101400	Scaffold_04	58969226	58969462	NA	NA	NA	NA	NA
PGEN_.00g101410	Scaffold_04	58983345	58990872	NA	NA	NA	NA	NA
PGEN_.00g101420	Scaffold_04	58992584	58997220	NA	NA	NA	NA	NA
PGEN_.00g101430	Scaffold_04	59002741	59009346	NA	NA	NA	NA	NA
PGEN_.00g101440	Scaffold_04	59021694	59028141	Q99684	GFI1_HUMAN	Zinc finger protein Gfi-1 (Growth factor independent protein 1) (Zinc finger protein 163)	GO:0000083; GO:0000122; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0010956; GO:0010957; GO:0010977; GO:0016032; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0032088; GO:0034121; GO:0044212; GO:0045892; GO:0045944; GO:0046872; GO:0051569; GO:0070105; GO:0071222	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]"
PGEN_.00g101450	Scaffold_04	59042312	59043849	NA	NA	NA	NA	NA
PGEN_.00g101460	Scaffold_04	59043874	59046182	NA	NA	NA	NA	NA
PGEN_.00g101470	Scaffold_04	59083402	59083668	NA	NA	NA	NA	NA
PGEN_.00g101480	Scaffold_04	59176941	59185599	Q8AVI9	PORED_XENLA	Polyprenol reductase (EC 1.3.1.94) (3-oxo-5-alpha-steroid 4-dehydrogenase 3) (EC 1.3.1.22) (Steroid 5-alpha-reductase 3) (S5AR 3) (SR type 3)	GO:0003865; GO:0005783; GO:0005789; GO:0006488; GO:0016021; GO:0016095; GO:0016628; GO:0019348; GO:0047751; GO:0102389	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; cholestenone 5-alpha-reductase activity [GO:0047751]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; polyprenol reductase activity [GO:0102389]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; polyprenol catabolic process [GO:0016095]"
PGEN_.00g101490	Scaffold_04	59187047	59195906	Q8BTV1	TUSC3_MOUSE	Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)	GO:0005739; GO:0008250; GO:0015095; GO:0015693; GO:0016021; GO:0018279; GO:0050890; GO:0062062	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; magnesium ion transmembrane transporter activity [GO:0015095]; oligosaccharyltransferase complex binding [GO:0062062]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279]
PGEN_.00g101500	Scaffold_04	59216983	59219728	Q8SQ72	SGCG_CANLF	Gamma-sarcoglycan (Gamma-SG)	GO:0005737; GO:0005856; GO:0016012; GO:0016021; GO:0042383; GO:0048738; GO:0060047	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]
PGEN_.00g101510	Scaffold_04	59227602	59230415	Q9DB72	BTBDH_MOUSE	BTB/POZ domain-containing protein 17 (Galectin-3-binding protein-like)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g101520	Scaffold_04	59250564	59250812	NA	NA	NA	NA	NA
PGEN_.00g101530	Scaffold_04	59250952	59253761	NA	NA	NA	NA	NA
PGEN_.00g101540	Scaffold_04	59254795	59267973	O73747	FRG1_TAKRU	Protein FRG1	GO:0003723; GO:0003779; GO:0005730; GO:0006364; GO:0007517; GO:0015030; GO:0030018	Cajal body [GO:0015030]; nucleolus [GO:0005730]; Z disc [GO:0030018]; actin binding [GO:0003779]; RNA binding [GO:0003723]; muscle organ development [GO:0007517]; rRNA processing [GO:0006364]
PGEN_.00g101550	Scaffold_04	59270313	59274432	NA	NA	NA	NA	NA
PGEN_.00g101560	Scaffold_04	59275505	59276908	Q96MB7	HARB1_HUMAN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g101570	Scaffold_04	59287028	59292186	NA	NA	NA	NA	NA
PGEN_.00g101580	Scaffold_04	59292328	59308953	NA	NA	NA	NA	NA
PGEN_.00g101590	Scaffold_04	59309098	59310338	NA	NA	NA	NA	NA
PGEN_.00g101600	Scaffold_04	59416428	59419215	NA	NA	NA	NA	NA
PGEN_.00g101610	Scaffold_04	59429976	59556560	Q5SZK8	FREM2_HUMAN	FRAS1-related extracellular matrix protein 2 (ECM3 homolog)	GO:0001654; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0016021; GO:0042733; GO:0046872; GO:0048839; GO:0070062	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; morphogenesis of an epithelium [GO:0002009]
PGEN_.00g101620	Scaffold_04	59596475	59602575	Q8CHS8	VP37A_MOUSE	Vacuolar protein sorting-associated protein 37A (Vps37A) (ESCRT-I complex subunit VPS37A)	GO:0000813; GO:0005654; GO:0005813; GO:0005829; GO:0006612; GO:0006623; GO:0031902; GO:0032509; GO:0043162; GO:0043231	centrosome [GO:0005813]; cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; endosome transport via multivesicular body sorting pathway [GO:0032509]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]
PGEN_.00g101630	Scaffold_04	59604218	59620963	Q3ZC01	CNOT7_BOVIN	CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1)	GO:0000122; GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0003723; GO:0004532; GO:0004535; GO:0008134; GO:0008284; GO:0008285; GO:0016607; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0042509; GO:0043928; GO:0045070; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0075341; GO:1900153	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; host cell PML body [GO:0075341]; nuclear speck [GO:0016607]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]"
PGEN_.00g101640	Scaffold_04	59627843	59628268	NA	NA	NA	NA	NA
PGEN_.00g101650	Scaffold_04	59631727	59634415	O95271	TNKS1_HUMAN	Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1)	GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g101660	Scaffold_04	59663442	59710226	NA	NA	NA	NA	NA
PGEN_.00g101670	Scaffold_04	59695202	59695501	NA	NA	NA	NA	NA
PGEN_.00g101680	Scaffold_04	59714278	59714811	NA	NA	NA	NA	NA
PGEN_.00g101690	Scaffold_04	59717243	59718948	NA	NA	NA	NA	NA
PGEN_.00g101700	Scaffold_04	59727372	59734565	NA	NA	NA	NA	NA
PGEN_.00g101710	Scaffold_04	59738112	59796848	Q86XE3	MICU3_HUMAN	"Calcium uptake protein 3, mitochondrial (EF-hand domain-containing family member A2)"	GO:0005509; GO:0005743; GO:0006851; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; mitochondrial calcium ion transmembrane transport [GO:0006851]
PGEN_.00g101720	Scaffold_04	59792246	59792545	NA	NA	NA	NA	NA
PGEN_.00g101730	Scaffold_04	59899179	59902463	NA	NA	NA	NA	NA
PGEN_.00g101740	Scaffold_04	59904624	59908472	NA	NA	NA	NA	NA
PGEN_.00g101750	Scaffold_04	59931012	59931716	NA	NA	NA	NA	NA
PGEN_.00g101760	Scaffold_04	59946365	59948391	Q9P6I3	YHG7_SCHPO	"Putative mannan endo-1,6-alpha-mannosidase C1198.07c (EC 3.2.1.101) (Endo-alpha-1->6-D-mannanase C1198.07c)"	GO:0005783; GO:0005789; GO:0008496; GO:0009272; GO:0016021; GO:0031362; GO:0051692	"anchored component of external side of plasma membrane [GO:0031362]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannan endo-1,6-alpha-mannosidase activity [GO:0008496]; cellular oligosaccharide catabolic process [GO:0051692]; fungal-type cell wall biogenesis [GO:0009272]"
PGEN_.00g101770	Scaffold_04	59953665	59954276	NA	NA	NA	NA	NA
PGEN_.00g101780	Scaffold_04	59954440	59954808	NA	NA	NA	NA	NA
PGEN_.00g101790	Scaffold_04	59980174	59980641	NA	NA	NA	NA	NA
PGEN_.00g101800	Scaffold_04	59986460	59986813	P53370	NUDT6_HUMAN	Nucleoside diphosphate-linked moiety X motif 6 (Nudix motif 6) (EC 3.6.1.-) (Antisense basic fibroblast growth factor) (Protein GFG)	GO:0005634; GO:0005737; GO:0005739; GO:0008285; GO:0035529; GO:0045786; GO:0047631; GO:0051287	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ADP-ribose diphosphatase activity [GO:0047631]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]
PGEN_.00g101810	Scaffold_04	60006953	60008150	NA	NA	NA	NA	NA
PGEN_.00g101820	Scaffold_04	60008313	60009308	NA	NA	NA	NA	NA
PGEN_.00g101830	Scaffold_04	60015206	60031655	P53370	NUDT6_HUMAN	Nucleoside diphosphate-linked moiety X motif 6 (Nudix motif 6) (EC 3.6.1.-) (Antisense basic fibroblast growth factor) (Protein GFG)	GO:0005634; GO:0005737; GO:0005739; GO:0008285; GO:0035529; GO:0045786; GO:0047631; GO:0051287	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ADP-ribose diphosphatase activity [GO:0047631]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]
PGEN_.00g101840	Scaffold_04	60033809	60065559	Q8R197	SAST_MOUSE	"S-acyl fatty acid synthase thioesterase, medium chain (EC 3.1.2.14) (Oleoyl-ACP hydrolase) (Thioesterase II) (Thioesterase domain-containing protein 1)"	GO:0004320; GO:0005829; GO:0008610; GO:0016295; GO:0016296; GO:0016297; GO:0047381; GO:0051792	cytosol [GO:0005829]; acyl-[acyl-carrier-protein] hydrolase activity [GO:0016297]; dodecanoyl-[acyl-carrier-protein] hydrolase activity [GO:0047381]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; lipid biosynthetic process [GO:0008610]; medium-chain fatty acid biosynthetic process [GO:0051792]
PGEN_.00g101850	Scaffold_04	60096439	60115754	Q6AX44	FBCDA_XENLA	Fibrinogen C domain-containing protein 1-A	GO:0008061; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g101860	Scaffold_04	60129178	60129561	NA	NA	NA	NA	NA
PGEN_.00g101870	Scaffold_04	60138008	60148453	P20678	CP2H2_CHICK	Cytochrome P450 2H2 (EC 1.14.14.1) (CYPIIH2) (Cytochrome P450 PCHP7)	GO:0005506; GO:0005623; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0016712; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g101880	Scaffold_04	60211125	60227639	Q7Z449	CP2U1_HUMAN	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330; GO:0097267	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g101890	Scaffold_04	60237416	60238294	NA	NA	NA	NA	NA
PGEN_.00g101900	Scaffold_04	60310826	60324749	P35822	PTPRK_MOUSE	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005886; GO:0005911; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g101910	Scaffold_04	60331195	60331542	NA	NA	NA	NA	NA
PGEN_.00g101920	Scaffold_04	60340675	60342053	NA	NA	NA	NA	NA
PGEN_.00g101930	Scaffold_04	60395563	60418361	NA	NA	NA	NA	NA
PGEN_.00g101940	Scaffold_04	60425818	60439462	Q9H251	CAD23_HUMAN	Cadherin-23 (Otocadherin)	GO:0000902; GO:0005509; GO:0005623; GO:0005886; GO:0005913; GO:0006816; GO:0007043; GO:0007156; GO:0007601; GO:0007605; GO:0007626; GO:0008092; GO:0009986; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0032420; GO:0034332; GO:0042803; GO:0044331; GO:0045296; GO:0045494; GO:0050896; GO:0050953; GO:0050957; GO:0051480; GO:0060122; GO:0098609	catenin complex [GO:0016342]; cell [GO:0005623]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; protein homodimerization activity [GO:0042803]; adherens junction organization [GO:0034332]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g101950	Scaffold_04	60457122	60461044	NA	NA	NA	NA	NA
PGEN_.00g101960	Scaffold_04	60465451	60486735	Q2KI24	MTHSD_BOVIN	Methenyltetrahydrofolate synthase domain-containing protein	GO:0003723; GO:0005737	cytoplasm [GO:0005737]; RNA binding [GO:0003723]
PGEN_.00g101970	Scaffold_04	60493253	60507068	Q5BLF0	NMD3_DANRE	60S ribosomal export protein NMD3	GO:0000055; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0043023	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosomal large subunit binding [GO:0043023]; ribosomal large subunit export from nucleus [GO:0000055]
PGEN_.00g101980	Scaffold_04	60512695	60543561	P28828	PTPRM_MOUSE	Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)	GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005913; GO:0006470; GO:0007156; GO:0007165; GO:0010596; GO:0010842; GO:0016021; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042493; GO:0042802; GO:0045296; GO:0048471; GO:0097755	cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]
PGEN_.00g101990	Scaffold_04	60544962	60550985	NA	NA	NA	NA	NA
PGEN_.00g102000	Scaffold_04	60550590	60612677	Q96KG7	MEG10_HUMAN	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g102010	Scaffold_04	60619229	60619513	NA	NA	NA	NA	NA
PGEN_.00g102020	Scaffold_04	60625068	60629365	O75179	ANR17_HUMAN	Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)	GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0016032; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]
PGEN_.00g102030	Scaffold_04	60639826	60663859	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g102040	Scaffold_04	60670177	60680844	Q8C1A9	ABD18_MOUSE	Protein ABHD18 (Alpha/beta hydrolase domain-containing protein 18) (Abhydrolase domain-containing protein 18)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g102050	Scaffold_04	60681536	60685666	Q4V7A8	ABD18_RAT	Protein ABHD18 (Alpha/beta hydrolase domain-containing protein 18) (Abhydrolase domain-containing protein 18)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g102060	Scaffold_04	60704369	60718479	O54865	GCYB1_MOUSE	Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit)	GO:0004016; GO:0004383; GO:0005525; GO:0005737; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0032991; GO:0038060; GO:0043167; GO:0044877; GO:0046872; GO:0046982; GO:0047805; GO:0048786; GO:0051879; GO:0071732; GO:0098831; GO:0098978; GO:0099555	"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; protein-containing complex [GO:0032991]; adenylate cyclase activity [GO:0004016]; cytidylate cyclase activity [GO:0047805]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; ion binding [GO:0043167]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; trans-synaptic signaling by nitric oxide, modulating synaptic transmission [GO:0099555]"
PGEN_.00g102070	Scaffold_04	60712773	60714354	NA	NA	NA	NA	NA
PGEN_.00g102080	Scaffold_04	60802969	60848505	O54865	GCYB1_MOUSE	Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit)	GO:0004016; GO:0004383; GO:0005525; GO:0005737; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0032991; GO:0038060; GO:0043167; GO:0044877; GO:0046872; GO:0046982; GO:0047805; GO:0048786; GO:0051879; GO:0071732; GO:0098831; GO:0098978; GO:0099555	"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; protein-containing complex [GO:0032991]; adenylate cyclase activity [GO:0004016]; cytidylate cyclase activity [GO:0047805]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; ion binding [GO:0043167]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; trans-synaptic signaling by nitric oxide, modulating synaptic transmission [GO:0099555]"
PGEN_.00g102090	Scaffold_04	60868945	60869334	NA	NA	NA	NA	NA
PGEN_.00g102100	Scaffold_04	60876549	60877585	P0C6X4	R1AB_CVHN5	Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Papain-like proteinase (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.69) (Non-structural protein 3) (nsp3) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); RNA-directed RNA polymerase (Pol) (RdRp) (EC 2.7.7.48) (nsp12) (p100); Helicase (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (nsp13) (p67); Guanine-N7 methyltransferase (ExoN) (EC 2.1.1.-) (EC 3.1.13.-) (nsp14); Uridylate-specific endoribonuclease (EC 3.1.-.-) (NendoU) (nsp15) (p35); 2'-O-methyltransferase (EC 2.1.1.-) (nsp16)]	GO:0003678; GO:0003723; GO:0003724; GO:0003968; GO:0004197; GO:0004519; GO:0005524; GO:0006351; GO:0008168; GO:0008242; GO:0008270; GO:0016021; GO:0016896; GO:0019079; GO:0019082; GO:0032259; GO:0033644; GO:0036459; GO:0039502; GO:0039520; GO:0039579; GO:0039595; GO:0039644; GO:0039648; GO:0044172; GO:0044220	"host cell endoplasmic reticulum-Golgi intermediate compartment [GO:0044172]; host cell membrane [GO:0033644]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; cysteine-type endopeptidase activity [GO:0004197]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; methyltransferase activity [GO:0008168]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; induction by virus of catabolism of host mRNA [GO:0039595]; induction by virus of host autophagy [GO:0039520]; methylation [GO:0032259]; modulation by virus of host protein ubiquitination [GO:0039648]; suppression by virus of host ISG15 activity [GO:0039579]; suppression by virus of host NF-kappaB transcription factor activity [GO:0039644]; suppression by virus of host type I interferon-mediated signaling pathway [GO:0039502]; transcription, DNA-templated [GO:0006351]; viral genome replication [GO:0019079]; viral protein processing [GO:0019082]"
PGEN_.00g102110	Scaffold_04	60884931	60885503	NA	NA	NA	NA	NA
PGEN_.00g102120	Scaffold_04	60924649	60926205	NA	NA	NA	NA	NA
PGEN_.00g102130	Scaffold_04	60935630	60935863	NA	NA	NA	NA	NA
PGEN_.00g102140	Scaffold_04	60938778	60961998	Q9BVK2	ALG8_HUMAN	"Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)"	GO:0000033; GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016021; GO:0018279; GO:0042281; GO:0042283	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,3-mannosyltransferase activity [GO:0000033]; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"
PGEN_.00g102150	Scaffold_04	60979971	61024432	Q8IIG1	YK213_PLAF7	Uncharacterized protein PF11_0213	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g102160	Scaffold_04	61025562	61027045	NA	NA	NA	NA	NA
PGEN_.00g102170	Scaffold_04	61031430	61032340	NA	NA	NA	NA	NA
PGEN_.00g102180	Scaffold_04	61053558	61054166	NA	NA	NA	NA	NA
PGEN_.00g102190	Scaffold_04	61134912	61153138	Q8BX17	GEMI5_MOUSE	Gem-associated protein 5 (Gemin5)	GO:0000340; GO:0000387; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0097504	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]
PGEN_.00g102200	Scaffold_04	61159092	61159568	NA	NA	NA	NA	NA
PGEN_.00g102210	Scaffold_04	61163605	61164054	NA	NA	NA	NA	NA
PGEN_.00g102220	Scaffold_04	61167904	61170531	NA	NA	NA	NA	NA
PGEN_.00g102230	Scaffold_04	61170576	61178433	Q9R1K9	CETN2_MOUSE	Centrin-2 (Caltractin isoform 1)	GO:0000278; GO:0005509; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0006289; GO:0007099; GO:0007283; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0032465; GO:0032795; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390; GO:0071942	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]
PGEN_.00g102240	Scaffold_04	61185801	61194813	O75503	CLN5_HUMAN	"Ceroid-lipofuscinosis neuronal protein 5 (Protein CLN5) [Cleaved into: Ceroid-lipofuscinosis neuronal protein 5, secreted form]"	GO:0005537; GO:0005623; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0006465; GO:0007042; GO:0007420; GO:0016021; GO:0022008; GO:0030163; GO:0042147; GO:0042551; GO:0048471; GO:0070062; GO:0070085; GO:1904426	"cell [GO:0005623]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; mannose binding [GO:0005537]; brain development [GO:0007420]; glycosylation [GO:0070085]; lysosomal lumen acidification [GO:0007042]; neurogenesis [GO:0022008]; neuron maturation [GO:0042551]; positive regulation of GTP binding [GO:1904426]; protein catabolic process [GO:0030163]; retrograde transport, endosome to Golgi [GO:0042147]; signal peptide processing [GO:0006465]"
PGEN_.00g102250	Scaffold_04	61194940	61197111	NA	NA	NA	NA	NA
PGEN_.00g102260	Scaffold_04	61264176	61273975	Q9BZA8	PC11Y_HUMAN	Protocadherin-11 Y-linked (Protocadherin-11) (Protocadherin on the Y chromosome) (PCDH-Y) (Protocadherin prostate cancer) (Protocadherin-PC) (Protocadherin-22)	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007283; GO:0030177; GO:0061827; GO:0097225	integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283]
PGEN_.00g102270	Scaffold_04	61322119	61322388	NA	NA	NA	NA	NA
PGEN_.00g102280	Scaffold_04	61384495	61389878	NA	NA	NA	NA	NA
PGEN_.00g102290	Scaffold_04	61420761	61421991	NA	NA	NA	NA	NA
PGEN_.00g102300	Scaffold_04	61423645	61423992	NA	NA	NA	NA	NA
PGEN_.00g102310	Scaffold_04	61444204	61492574	A7Y2W8	SC6A9_XENLA	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9)	GO:0005283; GO:0005328; GO:0005887	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g102320	Scaffold_04	61571896	61635821	A7Y2W8	SC6A9_XENLA	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9)	GO:0005283; GO:0005328; GO:0005887	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g102330	Scaffold_04	61635978	61636334	NA	NA	NA	NA	NA
PGEN_.00g102340	Scaffold_04	61656530	61659192	NA	NA	NA	NA	NA
PGEN_.00g102350	Scaffold_04	61663924	61677507	Q5R9Q3	GPM6A_PONAB	Neuronal membrane glycoprotein M6-a (M6a)	GO:0001764; GO:0003407; GO:0005886; GO:0007416; GO:0016021; GO:0030054; GO:0030175; GO:0043005; GO:0043025; GO:0043197; GO:0044295; GO:0048812; GO:0048863; GO:0051491	axonal growth cone [GO:0044295]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; neural retina development [GO:0003407]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of filopodium assembly [GO:0051491]; stem cell differentiation [GO:0048863]; synapse assembly [GO:0007416]
PGEN_.00g102360	Scaffold_04	61697897	61700687	Q6ZSS7	MFSD6_HUMAN	Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog)	GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]
PGEN_.00g102370	Scaffold_04	61717593	61720337	P19540	FA9_CANLF	Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain]	GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0007596; GO:0031638	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]
PGEN_.00g102380	Scaffold_04	61731127	61732721	NA	NA	NA	NA	NA
PGEN_.00g102390	Scaffold_04	61732763	61733613	NA	NA	NA	NA	NA
PGEN_.00g102400	Scaffold_04	61789770	61795766	Q6GR66	T10B_XENLA	Mitochondrial import inner membrane translocase subunit Tim10 B (Mitochondrial import inner membrane translocase subunit Tim9 B)	GO:0015031; GO:0042721; GO:0046872	TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; metal ion binding [GO:0046872]; protein transport [GO:0015031]
PGEN_.00g102410	Scaffold_04	61795838	61812521	P53367	ARFP1_HUMAN	Arfaptin-1 (ADP-ribosylation factor-interacting protein 1)	GO:0000139; GO:0005543; GO:0005737; GO:0005829; GO:0006886; GO:0019904; GO:0032588; GO:0050708; GO:0070273	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network membrane [GO:0032588]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; intracellular protein transport [GO:0006886]; regulation of protein secretion [GO:0050708]
PGEN_.00g102420	Scaffold_04	61822600	61823583	NA	NA	NA	NA	NA
PGEN_.00g102430	Scaffold_04	61823747	61835688	NA	NA	NA	NA	NA
PGEN_.00g102440	Scaffold_04	61843341	61846540	NA	NA	NA	NA	NA
PGEN_.00g102450	Scaffold_04	61858352	61859651	NA	NA	NA	NA	NA
PGEN_.00g102460	Scaffold_04	61936211	61942107	NA	NA	NA	NA	NA
PGEN_.00g102470	Scaffold_04	61953588	61957367	NA	NA	NA	NA	NA
PGEN_.00g102480	Scaffold_04	61962816	61975438	Q6DMN8	SPAT4_PANTR	Spermatogenesis-associated protein 4	GO:0005634; GO:0005930; GO:0008017; GO:0051493	axoneme [GO:0005930]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; regulation of cytoskeleton organization [GO:0051493]
PGEN_.00g102490	Scaffold_04	61977335	61996643	Q8WV92	MITD1_HUMAN	MIT domain-containing protein 1	GO:0000281; GO:0019898; GO:0019904; GO:0030496; GO:0031902; GO:0032091; GO:0035091; GO:0042803; GO:0043231; GO:0061952; GO:0070062	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; negative regulation of protein binding [GO:0032091]
PGEN_.00g102500	Scaffold_04	61996667	61999033	NA	NA	NA	NA	NA
PGEN_.00g102510	Scaffold_04	62000886	62006780	Q90744	NAGAB_CHICK	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]
PGEN_.00g102520	Scaffold_04	62006852	62014753	Q90744	NAGAB_CHICK	Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)	GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477	cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]
PGEN_.00g102530	Scaffold_04	62021177	62021470	NA	NA	NA	NA	NA
PGEN_.00g102540	Scaffold_04	62031022	62040335	P11833	TBB_PARLI	Tubulin beta chain (Beta-tubulin)	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g102550	Scaffold_04	62045121	62045777	NA	NA	NA	NA	NA
PGEN_.00g102560	Scaffold_04	62054545	62062036	Q9EQC0	CHST1_MOUSE	Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST)	GO:0000139; GO:0001517; GO:0005802; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0042339; GO:0045130	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g102570	Scaffold_04	62150751	62151131	NA	NA	NA	NA	NA
PGEN_.00g102580	Scaffold_04	62161026	62207750	NA	NA	NA	NA	NA
PGEN_.00g102590	Scaffold_04	62210687	62214432	Q8NFZ3	NLGNY_HUMAN	"Neuroligin-4, Y-linked (Neuroligin Y)"	GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0030054; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"
PGEN_.00g102600	Scaffold_04	62231987	62254192	Q9HC56	PCDH9_HUMAN	Protocadherin-9	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291	cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g102610	Scaffold_04	62259180	62264680	NA	NA	NA	NA	NA
PGEN_.00g102620	Scaffold_04	62281589	62282185	NA	NA	NA	NA	NA
PGEN_.00g102630	Scaffold_04	62293025	62299558	Q8HXX6	SAP3_MACFA	Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3)	GO:0005764; GO:0006689; GO:0008047; GO:0016787	lysosome [GO:0005764]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; ganglioside catabolic process [GO:0006689]
PGEN_.00g102640	Scaffold_04	62305439	62307795	P17900	SAP3_HUMAN	Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short]	GO:0005319; GO:0005576; GO:0006687; GO:0006689; GO:0007611; GO:0009313; GO:0009898; GO:0016004; GO:0016323; GO:0016324; GO:0019915; GO:0030290; GO:0032428; GO:0035578; GO:0043202; GO:0043312; GO:0050885; GO:0051345; GO:0070062	apical plasma membrane [GO:0016324]; azurophil granule lumen [GO:0035578]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; beta-N-acetylgalactosaminidase activity [GO:0032428]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; sphingolipid activator protein activity [GO:0030290]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]
PGEN_.00g102650	Scaffold_04	62320052	62320516	NA	NA	NA	NA	NA
PGEN_.00g102660	Scaffold_04	62322364	62326771	Q8HXX6	SAP3_MACFA	Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3)	GO:0005764; GO:0006689; GO:0008047; GO:0016787	lysosome [GO:0005764]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; ganglioside catabolic process [GO:0006689]
PGEN_.00g102670	Scaffold_04	62330121	62350452	P27164	CALM3_PETHY	Calmodulin-related protein	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g102680	Scaffold_04	62359108	62365232	P04630	CALL_CAEEL	Calmodulin-like protein	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g102690	Scaffold_04	62380662	62381006	NA	NA	NA	NA	NA
PGEN_.00g102700	Scaffold_04	62381260	62393521	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g102710	Scaffold_04	62395185	62399370	NA	NA	NA	NA	NA
PGEN_.00g102720	Scaffold_04	62403527	62404051	NA	NA	NA	NA	NA
PGEN_.00g102730	Scaffold_04	62413895	62417646	NA	NA	NA	NA	NA
PGEN_.00g102740	Scaffold_04	62432522	62456864	Q7ZV34	MCTS1_DANRE	Malignant T-cell-amplified sequence 1 (MCT-1)	GO:0001731; GO:0002188; GO:0003723; GO:0007049; GO:0022627; GO:0040008	cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; formation of translation preinitiation complex [GO:0001731]; regulation of growth [GO:0040008]; translation reinitiation [GO:0002188]
PGEN_.00g102750	Scaffold_04	62464596	62468336	NA	NA	NA	NA	NA
PGEN_.00g102760	Scaffold_04	62475491	62476639	NA	NA	NA	NA	NA
PGEN_.00g102770	Scaffold_04	62483505	62502117	Q6NTV6	INF2_XENLA	Inverted formin-2	GO:0003779; GO:0017048; GO:0030036	actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]
PGEN_.00g102780	Scaffold_04	62505409	62505630	NA	NA	NA	NA	NA
PGEN_.00g102790	Scaffold_04	62550436	62554042	NA	NA	NA	NA	NA
PGEN_.00g102800	Scaffold_04	62595408	62595908	NA	NA	NA	NA	NA
PGEN_.00g102810	Scaffold_04	62596264	62599136	P04323	POL3_DROME	Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]
PGEN_.00g102820	Scaffold_04	62599553	62600692	P10394	POL4_DROME	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]
PGEN_.00g102830	Scaffold_04	62603569	62613876	NA	NA	NA	NA	NA
PGEN_.00g102840	Scaffold_04	62620117	62624955	Q9JI60	LRAT_MOUSE	Lecithin retinol acyltransferase (EC 2.3.1.135) (Phosphatidylcholine--retinol O-acyltransferase) (Phosphatidylcholine-retinol-O-acyltransferase)	GO:0001972; GO:0005771; GO:0005789; GO:0005791; GO:0006653; GO:0006776; GO:0007601; GO:0008374; GO:0009617; GO:0016021; GO:0019841; GO:0032370; GO:0032526; GO:0033189; GO:0042572; GO:0043231; GO:0047173; GO:0048471; GO:0102279; GO:1990830	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; lecithin:11-cis retinol acyltransferase activity [GO:0102279]; O-acyltransferase activity [GO:0008374]; phosphatidylcholine-retinol O-acyltransferase activity [GO:0047173]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; 1,2-diacyl-sn-glycero-3-phosphocholine metabolic process [GO:0006653]; cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of lipid transport [GO:0032370]; response to bacterium [GO:0009617]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776]"
PGEN_.00g102850	Scaffold_04	62735152	62738383	NA	NA	NA	NA	NA
PGEN_.00g102860	Scaffold_04	62746441	62746740	NA	NA	NA	NA	NA
PGEN_.00g102870	Scaffold_04	62778502	62779614	NA	NA	NA	NA	NA
PGEN_.00g102880	Scaffold_04	62791852	62799902	NA	NA	NA	NA	NA
PGEN_.00g102890	Scaffold_04	62800005	62800304	NA	NA	NA	NA	NA
PGEN_.00g102900	Scaffold_04	62823167	62852234	NA	NA	NA	NA	NA
PGEN_.00g102910	Scaffold_04	62863792	62883681	Q5R1M5	CELA1_FELCA	Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1)	GO:0004252; GO:0005615; GO:0006508; GO:0046872	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]
PGEN_.00g102920	Scaffold_04	62885464	62886315	NA	NA	NA	NA	NA
PGEN_.00g102930	Scaffold_04	62888661	62912400	Q16832	DDR2_HUMAN	"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)"	GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030198; GO:0030199; GO:0030500; GO:0031214; GO:0034103; GO:0035988; GO:0038062; GO:0038063; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0090091	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g102940	Scaffold_04	62918338	62964773	Q5M9N0	CD158_HUMAN	Coiled-coil domain-containing protein 158		
PGEN_.00g102950	Scaffold_04	62983900	62991447	NA	NA	NA	NA	NA
PGEN_.00g102960	Scaffold_04	62995038	62996144	NA	NA	NA	NA	NA
PGEN_.00g102970	Scaffold_04	62996362	62996937	NA	NA	NA	NA	NA
PGEN_.00g102980	Scaffold_04	63011866	63012715	NA	NA	NA	NA	NA
PGEN_.00g102990	Scaffold_04	63012756	63013001	NA	NA	NA	NA	NA
PGEN_.00g103000	Scaffold_04	63013341	63013667	NA	NA	NA	NA	NA
PGEN_.00g103010	Scaffold_04	63022778	63023398	NA	NA	NA	NA	NA
PGEN_.00g103020	Scaffold_04	63030405	63040365	NA	NA	NA	NA	NA
PGEN_.00g103030	Scaffold_04	63091470	63091949	NA	NA	NA	NA	NA
PGEN_.00g103040	Scaffold_04	63092055	63092273	NA	NA	NA	NA	NA
PGEN_.00g103050	Scaffold_04	63094735	63095697	NA	NA	NA	NA	NA
PGEN_.00g103060	Scaffold_04	63112734	63113018	NA	NA	NA	NA	NA
PGEN_.00g103070	Scaffold_04	63113528	63113815	NA	NA	NA	NA	NA
PGEN_.00g103080	Scaffold_04	63135317	63138983	NA	NA	NA	NA	NA
PGEN_.00g103090	Scaffold_04	63141982	63142930	NA	NA	NA	NA	NA
PGEN_.00g103100	Scaffold_04	63144119	63144598	NA	NA	NA	NA	NA
PGEN_.00g103110	Scaffold_04	63166324	63167373	NA	NA	NA	NA	NA
PGEN_.00g103120	Scaffold_04	63243188	63243469	NA	NA	NA	NA	NA
PGEN_.00g103130	Scaffold_04	63273309	63276773	NA	NA	NA	NA	NA
PGEN_.00g103140	Scaffold_04	63358330	63358677	NA	NA	NA	NA	NA
PGEN_.00g103150	Scaffold_04	63377472	63378272	Q68DU8	KCD16_HUMAN	BTB/POZ domain-containing protein KCTD16 (Potassium channel tetramerization domain-containing protein 16)	GO:0008277; GO:0030054; GO:0042734; GO:0042995; GO:0043235; GO:0045211; GO:0051260	cell junction [GO:0030054]; cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]
PGEN_.00g103160	Scaffold_04	63496371	63499331	NA	NA	NA	NA	NA
PGEN_.00g103170	Scaffold_04	63499471	63499986	NA	NA	NA	NA	NA
PGEN_.00g103180	Scaffold_04	63585803	63586093	NA	NA	NA	NA	NA
PGEN_.00g103190	Scaffold_04	63662872	63663420	NA	NA	NA	NA	NA
PGEN_.00g103200	Scaffold_04	63667757	63668971	NA	NA	NA	NA	NA
PGEN_.00g103210	Scaffold_04	63669292	63673024	NA	NA	NA	NA	NA
PGEN_.00g103220	Scaffold_04	63677593	63687613	P02671	FIBA_HUMAN	Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]	GO:0002224; GO:0002250; GO:0002576; GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005577; GO:0005615; GO:0005788; GO:0005886; GO:0005938; GO:0007160; GO:0007596; GO:0009897; GO:0009986; GO:0030198; GO:0031091; GO:0031093; GO:0031639; GO:0034116; GO:0034622; GO:0042730; GO:0043152; GO:0043687; GO:0044267; GO:0045087; GO:0045202; GO:0045907; GO:0045921; GO:0046872; GO:0050714; GO:0051258; GO:0051592; GO:0062023; GO:0065003; GO:0070062; GO:0070374; GO:0070527; GO:0072377; GO:0072378; GO:0072562; GO:0090277; GO:1900026; GO:1902042; GO:1903561; GO:2000261; GO:2000352	"blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; synapse [GO:0045202]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; cellular protein metabolic process [GO:0044267]; cellular protein-containing complex assembly [GO:0034622]; extracellular matrix organization [GO:0030198]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of blood coagulation, common pathway [GO:2000261]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; post-translational protein modification [GO:0043687]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]; toll-like receptor signaling pathway [GO:0002224]"
PGEN_.00g103230	Scaffold_04	63704105	63723098	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g103240	Scaffold_04	63743483	63746175	NA	NA	NA	NA	NA
PGEN_.00g103250	Scaffold_04	63750785	63751087	NA	NA	NA	NA	NA
PGEN_.00g103260	Scaffold_04	63762216	63762509	NA	NA	NA	NA	NA
PGEN_.00g103270	Scaffold_04	63767666	63771566	Q8R0Z6	ANGL6_MOUSE	Angiopoietin-related protein 6 (Angiopoietin-like protein 6) (Angiopoietin-related growth factor)	GO:0001525; GO:0005576; GO:0030141; GO:0030154	extracellular region [GO:0005576]; secretory granule [GO:0030141]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]
PGEN_.00g103280	Scaffold_04	63800942	63821932	P12804	FGL2_MOUSE	Fibroleukin (Cytotoxic T-lymphocyte-specific protein) (Fibrinogen-like protein 2) (Prothrombinase)	GO:0002291; GO:0002381; GO:0002605; GO:0002617; GO:0005576; GO:0008233; GO:0019835; GO:0043381; GO:0050687	extracellular region [GO:0005576]; peptidase activity [GO:0008233]; cytolysis [GO:0019835]; immunoglobulin production involved in immunoglobulin mediated immune response [GO:0002381]; negative regulation of defense response to virus [GO:0050687]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of macrophage antigen processing and presentation [GO:0002617]; negative regulation of memory T cell differentiation [GO:0043381]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]
PGEN_.00g103290	Scaffold_04	63848505	63861875	NA	NA	NA	NA	NA
PGEN_.00g103300	Scaffold_04	63868378	63871459	NA	NA	NA	NA	NA
PGEN_.00g103310	Scaffold_04	63871814	63874098	NA	NA	NA	NA	NA
PGEN_.00g103320	Scaffold_04	63950992	63956601	NA	NA	NA	NA	NA
PGEN_.00g103330	Scaffold_04	64020205	64020549	NA	NA	NA	NA	NA
PGEN_.00g103340	Scaffold_04	64021508	64046836	Q95NN1	T23O_TRICA	"Tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase) (TO) (TRPO) (Tryptophan pyrrolase) (Tryptophanase)"	GO:0004833; GO:0006727; GO:0019441; GO:0020037; GO:0046872	"heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; ommochrome biosynthetic process [GO:0006727]; tryptophan catabolic process to kynurenine [GO:0019441]"
PGEN_.00g103350	Scaffold_04	64051823	64104715	F4KD71	DUR3_ARATH	Urea-proton symporter DUR3 (AtDUR3) (High-affinity urea active transporter DUR3)	GO:0005886; GO:0006995; GO:0015204; GO:0015293; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; urea transmembrane transporter activity [GO:0015204]; cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918]
PGEN_.00g103360	Scaffold_04	64126993	64127760	NA	NA	NA	NA	NA
PGEN_.00g103370	Scaffold_04	64150258	64152844	Q05A80	CAPR2_MOUSE	Caprin-2 (C1q domain-containing protein 1) (Cytoplasmic activation/proliferation-associated protein 2) (RNA granule protein 140)	GO:0003723; GO:0005102; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0017148; GO:0030308; GO:0032092; GO:0033138; GO:0043235; GO:0045944; GO:0046872; GO:0050775; GO:0061003; GO:0090263	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; negative regulation of cell growth [GO:0030308]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g103380	Scaffold_04	64173568	64221546	B0V207	F16A2_DANRE	FTS and Hook-interacting protein homolog (FHIP) (Protein FAM160A2)	GO:0005829; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0045022; GO:0070695	cytosol [GO:0005829]; FHF complex [GO:0070695]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein transport [GO:0015031]
PGEN_.00g103390	Scaffold_04	64227097	64234633	NA	NA	NA	NA	NA
PGEN_.00g103400	Scaffold_04	64276610	64280124	NA	NA	NA	NA	NA
PGEN_.00g103410	Scaffold_04	64297021	64338702	Q969H0	FBXW7_HUMAN	F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4)	GO:0000209; GO:0001570; GO:0001944; GO:0005623; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016032; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0043687; GO:0045741; GO:0045746; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0051443; GO:0055088; GO:0070374; GO:0090049; GO:0097027; GO:1901800; GO:1902806; GO:1903026; GO:1903146; GO:1903378; GO:1903955; GO:1990452; GO:2000060; GO:2000346; GO:2000639; GO:2001205	"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein binding, bridging [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; lipid homeostasis [GO:0055088]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; viral process [GO:0016032]"
PGEN_.00g103420	Scaffold_04	64351855	64352946	NA	NA	NA	NA	NA
PGEN_.00g103430	Scaffold_04	64364989	64451146	Q8WWI1	LMO7_HUMAN	LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP)	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0043687; GO:0045944; GO:0046872	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051]
PGEN_.00g103440	Scaffold_04	64445877	64455279	NA	NA	NA	NA	NA
PGEN_.00g103450	Scaffold_04	64466002	64466487	NA	NA	NA	NA	NA
PGEN_.00g103460	Scaffold_04	64480600	64533036	Q3KQW7	LIMC1_XENLA	LIM and calponin homology domains-containing protein 1	GO:0001725; GO:0001934; GO:0003779; GO:0005737; GO:0030336; GO:0031032; GO:0046872; GO:0051496; GO:0051893	cytoplasm [GO:0005737]; stress fiber [GO:0001725]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; actomyosin structure organization [GO:0031032]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893]
PGEN_.00g103470	Scaffold_04	64559608	64560352	NA	NA	NA	NA	NA
PGEN_.00g103480	Scaffold_04	64561395	64562673	NA	NA	NA	NA	NA
PGEN_.00g103490	Scaffold_04	64568788	64573093	Q9VU41	ZMY10_DROME	Zinc finger MYND domain-containing protein 10 homolog	GO:0005737; GO:0005929; GO:0007605; GO:0008270; GO:0019230; GO:0030317; GO:0034451; GO:0035082; GO:0036158; GO:0036159; GO:0043025; GO:0044458	centriolar satellite [GO:0034451]; cilium [GO:0005929]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; zinc ion binding [GO:0008270]; axoneme assembly [GO:0035082]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; proprioception [GO:0019230]; sensory perception of sound [GO:0007605]
PGEN_.00g103500	Scaffold_04	64581863	64591794	Q00194	CNGA1_BOVIN	"cGMP-gated cation channel alpha-1 (Cyclic nucleotide-gated cation channel 1) (Cyclic nucleotide-gated channel alpha-1) (CNG channel alpha-1) (CNG-1) (CNG1) (Cyclic nucleotide-gated channel, photoreceptor) (Rod photoreceptor cGMP-gated channel subunit alpha)"	GO:0001750; GO:0005222; GO:0005223; GO:0006812; GO:0007601; GO:0030553; GO:0042622; GO:0050896; GO:1902495	photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; transmembrane transporter complex [GO:1902495]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; cation transport [GO:0006812]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g103510	Scaffold_04	64594246	64603703	NA	NA	NA	NA	NA
PGEN_.00g103520	Scaffold_04	64607430	64629475	Q8BM88	CATO_MOUSE	Cathepsin O (EC 3.4.22.42)	GO:0004197; GO:0005615; GO:0005764; GO:0051603	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g103530	Scaffold_04	64633352	64645834	Q3T169	RS3_BOVIN	40S ribosomal protein S3 (EC 4.2.99.18)	GO:0000977; GO:0003684; GO:0003729; GO:0003735; GO:0003906; GO:0004520; GO:0005634; GO:0005730; GO:0005743; GO:0005759; GO:0005783; GO:0005844; GO:0006281; GO:0006412; GO:0006915; GO:0007059; GO:0008017; GO:0008134; GO:0008534; GO:0010628; GO:0014069; GO:0017148; GO:0019901; GO:0022627; GO:0030544; GO:0031116; GO:0031397; GO:0032079; GO:0032357; GO:0032358; GO:0032587; GO:0032743; GO:0042104; GO:0042769; GO:0043507; GO:0044390; GO:0044877; GO:0045738; GO:0045739; GO:0050862; GO:0051018; GO:0051092; GO:0051225; GO:0051301; GO:0051879; GO:0061481; GO:0070181; GO:0070301; GO:0071159; GO:0071356; GO:0072686; GO:0097100; GO:0140078; GO:1901224; GO:1902231; GO:1902546; GO:1905053; GO:1990904; GO:2001235; GO:2001272	"cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; transcription factor binding [GO:0008134]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell receptor signaling pathway [GO:0050862]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]"
PGEN_.00g103540	Scaffold_04	64651128	64679733	Q96PE2	ARHGH_HUMAN	Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4)	GO:0005085; GO:0005089; GO:0005829; GO:0007186; GO:0030036; GO:0043065; GO:0051056	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g103550	Scaffold_04	64679825	64682581	NA	NA	NA	NA	NA
PGEN_.00g103560	Scaffold_04	64682624	64682995	NA	NA	NA	NA	NA
PGEN_.00g103570	Scaffold_04	64683530	64731658	Q96PE2	ARHGH_HUMAN	Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4)	GO:0005085; GO:0005089; GO:0005829; GO:0007186; GO:0030036; GO:0043065; GO:0051056	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g103580	Scaffold_04	64731715	64745287	NA	NA	NA	NA	NA
PGEN_.00g103590	Scaffold_04	64746021	64753853	NA	NA	NA	NA	NA
PGEN_.00g103600	Scaffold_04	64769518	64785079	Q3MHV6	SLAI2_BOVIN	SLAIN motif-containing protein 2	GO:0005737; GO:0007020; GO:0015630; GO:0031116; GO:0031122	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116]
PGEN_.00g103610	Scaffold_04	64796079	64810815	G5E8K5	ANK3_MOUSE	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g103620	Scaffold_04	64810849	64816404	NA	NA	NA	NA	NA
PGEN_.00g103630	Scaffold_04	64820675	64848551	P53792	SC5A2_RAT	Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2)	GO:0005412; GO:0005886; GO:0006814; GO:0016021; GO:0031526; GO:0035811; GO:0036359; GO:1904659	brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; glucose transmembrane transport [GO:1904659]; negative regulation of urine volume [GO:0035811]; renal potassium excretion [GO:0036359]; sodium ion transport [GO:0006814]
PGEN_.00g103640	Scaffold_04	64853269	64854039	NA	NA	NA	NA	NA
PGEN_.00g103650	Scaffold_04	64871493	64895986	NA	NA	NA	NA	NA
PGEN_.00g103660	Scaffold_04	64899716	64912531	Q7T3S3	CHSTB_DANRE	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)	GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]
PGEN_.00g103670	Scaffold_04	64912885	64913853	NA	NA	NA	NA	NA
PGEN_.00g103680	Scaffold_04	64914555	64945058	E1BLK7	MIEAP_BOVIN	Mitochondria-eating protein (Spermatogenesis-associated protein 18)	GO:0005737; GO:0005741; GO:0006974; GO:0035694; GO:0035695; GO:0043231	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695]
PGEN_.00g103690	Scaffold_04	64951359	64951661	NA	NA	NA	NA	NA
PGEN_.00g103700	Scaffold_04	64969659	64977582	Q5ZMD4	TRI59_CHICK	Tripartite motif-containing protein 59	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]
PGEN_.00g103710	Scaffold_04	64995298	65003188	P21369	PNCA_ECOLI	Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-)	GO:0008936; GO:0019365; GO:0046872	metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]
PGEN_.00g103720	Scaffold_04	65058204	65077948	NA	NA	NA	NA	NA
PGEN_.00g103730	Scaffold_04	65098815	65142995	P11536	E74EB_DROME	Ecdysone-induced protein 74EF isoform B (ETS-related protein E74B)	GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0008219; GO:0030154; GO:0035071; GO:0040034; GO:0043565; GO:0045944; GO:0048477	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; autophagy [GO:0006914]; cell death [GO:0008219]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland cell autophagic cell death [GO:0035071]"
PGEN_.00g103740	Scaffold_04	65156181	65156945	NA	NA	NA	NA	NA
PGEN_.00g103750	Scaffold_04	65165063	65165380	NA	NA	NA	NA	NA
PGEN_.00g103760	Scaffold_04	65165403	65165942	NA	NA	NA	NA	NA
PGEN_.00g103770	Scaffold_04	65175204	65175488	NA	NA	NA	NA	NA
PGEN_.00g103780	Scaffold_04	65217792	65223603	Q9JLC8	SACS_MOUSE	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	GO:0005737; GO:0050750	cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750]
PGEN_.00g103790	Scaffold_04	65243393	65245288	NA	NA	NA	NA	NA
PGEN_.00g103800	Scaffold_04	65258250	65261009	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g103810	Scaffold_05	8665	65122	P34416	LASP1_CAEEL	LIM and SH3 domain protein F42H10.3	GO:0005925; GO:0030054; GO:0046872; GO:0051015; GO:0055120	cell junction [GO:0030054]; focal adhesion [GO:0005925]; striated muscle dense body [GO:0055120]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]
PGEN_.00g103820	Scaffold_05	78044	80635	Q96BD6	SPSB1_HUMAN	SPRY domain-containing SOCS box protein 1 (SSB-1)	GO:0000209; GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0043161; GO:0043687; GO:1990756	"cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g103830	Scaffold_05	107037	109643	Q96BD6	SPSB1_HUMAN	SPRY domain-containing SOCS box protein 1 (SSB-1)	GO:0000209; GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0043161; GO:0043687; GO:1990756	"cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g103840	Scaffold_05	122771	178904	P34416	LASP1_CAEEL	LIM and SH3 domain protein F42H10.3	GO:0005925; GO:0030054; GO:0046872; GO:0051015; GO:0055120	cell junction [GO:0030054]; focal adhesion [GO:0005925]; striated muscle dense body [GO:0055120]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]
PGEN_.00g103850	Scaffold_05	194715	208463	NA	NA	NA	NA	NA
PGEN_.00g103860	Scaffold_05	223213	240482	Q9Z2F6	BCL3_MOUSE	B-cell lymphoma 3 protein homolog (BCL-3)	GO:0000978; GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006351; GO:0006974; GO:0007249; GO:0008134; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0032729; GO:0032991; GO:0032996; GO:0033257; GO:0042088; GO:0042536; GO:0042742; GO:0042771; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0045064; GO:0045082; GO:0045415; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:1901222	"Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g103870	Scaffold_05	252550	282204	Q9XWZ2	ACD11_CAEEL	Acyl-CoA dehydrogenase family member 11 (EC 1.3.99.-)	GO:0000166; GO:0006631; GO:0016627	"nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; fatty acid metabolic process [GO:0006631]"
PGEN_.00g103880	Scaffold_05	286000	291056	Q8IW92	GLBL2_HUMAN	Beta-galactosidase-1-like protein 2 (EC 3.2.1.-)	GO:0004565; GO:0005576; GO:0005773; GO:0005975	extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g103890	Scaffold_05	354853	356199	P02709	ACHA_BOVIN	Acetylcholine receptor subunit alpha	GO:0003009; GO:0005623; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007528; GO:0009986; GO:0015464; GO:0019228; GO:0022848; GO:0030054; GO:0031594; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0046716; GO:0048630; GO:0050877; GO:0050905; GO:0070050; GO:0099060	"acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell cellular homeostasis [GO:0046716]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neuronal action potential [GO:0019228]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g103900	Scaffold_05	363736	364875	P09479	ACHA_CHICK	Acetylcholine receptor subunit alpha	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g103910	Scaffold_05	368316	369162	NA	NA	NA	NA	NA
PGEN_.00g103920	Scaffold_05	380211	388037	O00462	MANBA_HUMAN	Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)	GO:0004567; GO:0005537; GO:0005764; GO:0005886; GO:0006464; GO:0006516; GO:0009313; GO:0035577; GO:0043202; GO:0043231; GO:0043312	azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]
PGEN_.00g103930	Scaffold_05	421629	426237	NA	NA	NA	NA	NA
PGEN_.00g103940	Scaffold_05	430719	469557	NA	NA	NA	NA	NA
PGEN_.00g103950	Scaffold_05	474721	512050	A0A1D5PUP4	RECK_CHICK	Reversion-inducing cysteine-rich protein with Kazal motifs	GO:0001955; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0017147; GO:0030198; GO:0030336; GO:0031225; GO:0035115; GO:0045765; GO:0090210; GO:0090263; GO:1904684; GO:1904928; GO:1990909	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867]; Wnt-protein binding [GO:0017147]; blood vessel maturation [GO:0001955]; embryonic forelimb morphogenesis [GO:0035115]; extracellular matrix organization [GO:0030198]; negative regulation of cell migration [GO:0030336]; negative regulation of metalloendopeptidase activity [GO:1904684]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of angiogenesis [GO:0045765]; regulation of establishment of blood-brain barrier [GO:0090210]
PGEN_.00g103960	Scaffold_05	516301	520397	NA	NA	NA	NA	NA
PGEN_.00g103970	Scaffold_05	543536	563973	Q8K2I4	MANBA_MOUSE	Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)	GO:0004567; GO:0005537; GO:0005615; GO:0005764; GO:0005975; GO:0006516; GO:0016787; GO:0043231	extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; beta-mannosidase activity [GO:0004567]; hydrolase activity [GO:0016787]; mannose binding [GO:0005537]; carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]
PGEN_.00g103980	Scaffold_05	571748	572594	NA	NA	NA	NA	NA
PGEN_.00g103990	Scaffold_05	576036	577175	P02711	ACHA_TORMA	Acetylcholine receptor subunit alpha	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g104000	Scaffold_05	584717	588426	P02709	ACHA_BOVIN	Acetylcholine receptor subunit alpha	GO:0003009; GO:0005623; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007528; GO:0009986; GO:0015464; GO:0019228; GO:0022848; GO:0030054; GO:0031594; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0046716; GO:0048630; GO:0050877; GO:0050905; GO:0070050; GO:0099060	"acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell cellular homeostasis [GO:0046716]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neuronal action potential [GO:0019228]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g104010	Scaffold_05	650644	654982	Q8IW92	GLBL2_HUMAN	Beta-galactosidase-1-like protein 2 (EC 3.2.1.-)	GO:0004565; GO:0005576; GO:0005773; GO:0005975	extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g104020	Scaffold_05	659258	689357	Q9XWZ2	ACD11_CAEEL	Acyl-CoA dehydrogenase family member 11 (EC 1.3.99.-)	GO:0000166; GO:0006631; GO:0016627	"nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; fatty acid metabolic process [GO:0006631]"
PGEN_.00g104030	Scaffold_05	701433	718753	P20749	BCL3_HUMAN	B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3)	GO:0000978; GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006351; GO:0006974; GO:0007249; GO:0008134; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032729; GO:0032991; GO:0032996; GO:0033257; GO:0042088; GO:0042536; GO:0042742; GO:0042771; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0045064; GO:0045082; GO:0045415; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0051457; GO:1901222	"Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; protein binding, bridging [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g104040	Scaffold_05	733490	747099	NA	NA	NA	NA	NA
PGEN_.00g104050	Scaffold_05	750445	757418	NA	NA	NA	NA	NA
PGEN_.00g104060	Scaffold_05	787377	805098	P16951	ATF2_MOUSE	Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (EC 2.3.1.48) (Activating transcription factor 2) (MXBP protein) (cAMP response element-binding protein CRE-BP1)	GO:0000122; GO:0000977; GO:0001102; GO:0001158; GO:0001228; GO:0003151; GO:0003677; GO:0003682; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006970; GO:0006974; GO:0008134; GO:0008140; GO:0009414; GO:0010628; GO:0016020; GO:0016525; GO:0019901; GO:0031573; GO:0032915; GO:0035497; GO:0035861; GO:0043525; GO:0043565; GO:0044877; GO:0045444; GO:0045944; GO:0046872; GO:0046982; GO:0050680; GO:0051091; GO:0060612; GO:0097186; GO:0110024; GO:1902110	"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; cellular response to DNA damage stimulus [GO:0006974]; fat cell differentiation [GO:0045444]; intra-S DNA damage checkpoint [GO:0031573]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]"
PGEN_.00g104070	Scaffold_05	823575	827201	NA	NA	NA	NA	NA
PGEN_.00g104080	Scaffold_05	839584	915993	Q9UIF8	BAZ2B_HUMAN	Bromodomain adjacent to zinc finger domain protein 2B (hWALp4)	GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g104090	Scaffold_05	923469	925837	NA	NA	NA	NA	NA
PGEN_.00g104100	Scaffold_05	932639	976316	Q07553	GCY3E_DROME	Guanylate cyclase 32E (EC 4.6.1.2)	GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0019934; GO:0038023	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; signaling receptor activity [GO:0038023]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g104110	Scaffold_05	1004253	1005021	NA	NA	NA	NA	NA
PGEN_.00g104120	Scaffold_05	1006304	1007069	NA	NA	NA	NA	NA
PGEN_.00g104130	Scaffold_05	1035332	1046051	NA	NA	NA	NA	NA
PGEN_.00g104140	Scaffold_05	1049642	1058609	NA	NA	NA	NA	NA
PGEN_.00g104150	Scaffold_05	1058695	1077436	P55202	ANPRB_ANGJA	Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)	GO:0001503; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0007168; GO:0016941; GO:0035556	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; protein kinase activity [GO:0004672]; intracellular signal transduction [GO:0035556]; ossification [GO:0001503]; receptor guanylyl cyclase signaling pathway [GO:0007168]
PGEN_.00g104160	Scaffold_05	1084706	1087094	NA	NA	NA	NA	NA
PGEN_.00g104170	Scaffold_05	1094419	1173170	Q9UIF8	BAZ2B_HUMAN	Bromodomain adjacent to zinc finger domain protein 2B (hWALp4)	GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g104180	Scaffold_05	1184785	1189307	NA	NA	NA	NA	NA
PGEN_.00g104190	Scaffold_05	1207847	1225558	P16951	ATF2_MOUSE	Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (EC 2.3.1.48) (Activating transcription factor 2) (MXBP protein) (cAMP response element-binding protein CRE-BP1)	GO:0000122; GO:0000977; GO:0001102; GO:0001158; GO:0001228; GO:0003151; GO:0003677; GO:0003682; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006970; GO:0006974; GO:0008134; GO:0008140; GO:0009414; GO:0010628; GO:0016020; GO:0016525; GO:0019901; GO:0031573; GO:0032915; GO:0035497; GO:0035861; GO:0043525; GO:0043565; GO:0044877; GO:0045444; GO:0045944; GO:0046872; GO:0046982; GO:0050680; GO:0051091; GO:0060612; GO:0097186; GO:0110024; GO:1902110	"cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; cellular response to DNA damage stimulus [GO:0006974]; fat cell differentiation [GO:0045444]; intra-S DNA damage checkpoint [GO:0031573]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]"
PGEN_.00g104200	Scaffold_05	1255506	1258066	NA	NA	NA	NA	NA
PGEN_.00g104210	Scaffold_05	1280431	1280853	NA	NA	NA	NA	NA
PGEN_.00g104220	Scaffold_05	1299867	1309565	Q96MB7	HARB1_HUMAN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g104230	Scaffold_05	1310993	1314979	NA	NA	NA	NA	NA
PGEN_.00g104240	Scaffold_05	1325666	1345503	NA	NA	NA	NA	NA
PGEN_.00g104250	Scaffold_05	1351846	1395865	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g104260	Scaffold_05	1479118	1482064	NA	NA	NA	NA	NA
PGEN_.00g104270	Scaffold_05	1486047	1504909	Q8I335	GUF1_PLAF7	"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)"	GO:0003924; GO:0005525; GO:0005743; GO:0006412	mitochondrial inner membrane [GO:0005743]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation [GO:0006412]
PGEN_.00g104280	Scaffold_05	1544433	1545769	NA	NA	NA	NA	NA
PGEN_.00g104290	Scaffold_05	1557114	1586705	Q8NBI5	S43A3_HUMAN	Solute carrier family 43 member 3 (Protein FOAP-13)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g104300	Scaffold_05	1591524	1612291	Q68CR1	SE1L3_HUMAN	Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3) (Sel-1L3)	GO:0005654; GO:0016021	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]
PGEN_.00g104310	Scaffold_05	1613856	1645554	Q68CR1	SE1L3_HUMAN	Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3) (Sel-1L3)	GO:0005654; GO:0016021	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]
PGEN_.00g104320	Scaffold_05	1659640	1696458	P47989	XDH_HUMAN	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006195; GO:0006919; GO:0007595; GO:0009055; GO:0009115; GO:0010629; GO:0016529; GO:0042803; GO:0043546; GO:0045602; GO:0050660; GO:0051537; GO:0051898; GO:0071949; GO:1900745; GO:1900747; GO:2000379; GO:2001213	"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115]"
PGEN_.00g104330	Scaffold_05	1703672	1704853	P61315	G3ST3_MOUSE	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g104340	Scaffold_05	1725281	1727936	NA	NA	NA	NA	NA
PGEN_.00g104350	Scaffold_05	1734571	1742219	NA	NA	NA	NA	NA
PGEN_.00g104360	Scaffold_05	1761283	1762383	Q504Y2	PKDCC_HUMAN	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g104370	Scaffold_05	1776486	1785960	Q9QZS7	NPHN_MOUSE	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0000165; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015	cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g104380	Scaffold_05	1806683	1807249	NA	NA	NA	NA	NA
PGEN_.00g104390	Scaffold_05	1810495	1811425	NA	NA	NA	NA	NA
PGEN_.00g104400	Scaffold_05	1829136	1834293	NA	NA	NA	NA	NA
PGEN_.00g104410	Scaffold_05	1857571	1865405	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g104420	Scaffold_05	1878651	1887662	NA	NA	NA	NA	NA
PGEN_.00g104430	Scaffold_05	1888947	1889276	NA	NA	NA	NA	NA
PGEN_.00g104440	Scaffold_05	1889784	1890017	NA	NA	NA	NA	NA
PGEN_.00g104450	Scaffold_05	1890203	1893844	Q6PAQ4	REXO4_MOUSE	RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog)	GO:0000726; GO:0000737; GO:0000738; GO:0003697; GO:0003713; GO:0004519; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0008408; GO:0016607; GO:0045944	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364]"
PGEN_.00g104460	Scaffold_05	1902769	1955487	Q9UJS0	CMC2_HUMAN	Calcium-binding mitochondrial carrier protein Aralar2 (Citrin) (Mitochondrial aspartate glutamate carrier 2) (Solute carrier family 25 member 13)	GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0005887; GO:0006094; GO:0006754; GO:0006839; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490; GO:0045333; GO:0051592	integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; response to calcium ion [GO:0051592]
PGEN_.00g104470	Scaffold_05	1971351	1997347	P28828	PTPRM_MOUSE	Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)	GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005913; GO:0006470; GO:0007156; GO:0007165; GO:0010596; GO:0010842; GO:0016021; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042493; GO:0042802; GO:0045296; GO:0048471; GO:0097755	cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]
PGEN_.00g104480	Scaffold_05	2009757	2010857	Q504Y2	PKDCC_HUMAN	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g104490	Scaffold_05	2022110	2035091	Q9R044	NPHN_RAT	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0000165; GO:0003094; GO:0005886; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015	cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g104500	Scaffold_05	2038633	2054870	Q9QZS7	NPHN_MOUSE	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0000165; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015	cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g104510	Scaffold_05	2059423	2085693	NA	NA	NA	NA	NA
PGEN_.00g104520	Scaffold_05	2120644	2129405	Q01484	ANK2_HUMAN	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	GO:0002027; GO:0003283; GO:0005200; GO:0005623; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]"
PGEN_.00g104530	Scaffold_05	2152781	2153362	E7FDB3	NANO1_DANRE	Nanos homolog 1	GO:0003723; GO:0005737; GO:0007281; GO:0008270; GO:0008354; GO:0030371; GO:0048471; GO:0060293	cytoplasm [GO:0005737]; germ plasm [GO:0060293]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]
PGEN_.00g104540	Scaffold_05	2170857	2172731	Q8TBZ5	ZN502_HUMAN	Zinc finger protein 502	GO:0003677; GO:0005634; GO:0044791; GO:0044794; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791]
PGEN_.00g104550	Scaffold_05	2247286	2248050	NA	NA	NA	NA	NA
PGEN_.00g104560	Scaffold_05	2252379	2261161	NA	NA	NA	NA	NA
PGEN_.00g104570	Scaffold_05	2278711	2279004	NA	NA	NA	NA	NA
PGEN_.00g104580	Scaffold_05	2294569	2302678	NA	NA	NA	NA	NA
PGEN_.00g104590	Scaffold_05	2306990	2309089	NA	NA	NA	NA	NA
PGEN_.00g104600	Scaffold_05	2307331	2307702	NA	NA	NA	NA	NA
PGEN_.00g104610	Scaffold_05	2307791	2308279	NA	NA	NA	NA	NA
PGEN_.00g104620	Scaffold_05	2309922	2310227	NA	NA	NA	NA	NA
PGEN_.00g104630	Scaffold_05	2362919	2368680	NA	NA	NA	NA	NA
PGEN_.00g104640	Scaffold_05	2373139	2378948	NA	NA	NA	NA	NA
PGEN_.00g104650	Scaffold_05	2385032	2390256	NA	NA	NA	NA	NA
PGEN_.00g104660	Scaffold_05	2420712	2434561	Q7ZXX1	CADM3_XENLA	Cell adhesion molecule 3 (Immunoglobulin superfamily member 4B) (IgSF4B)	GO:0005886; GO:0007155; GO:0016021; GO:0030054	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g104670	Scaffold_05	2439552	2440088	NA	NA	NA	NA	NA
PGEN_.00g104680	Scaffold_05	2441843	2445085	NA	NA	NA	NA	NA
PGEN_.00g104690	Scaffold_05	2463203	2467714	NA	NA	NA	NA	NA
PGEN_.00g104700	Scaffold_05	2481225	2485857	NA	NA	NA	NA	NA
PGEN_.00g104710	Scaffold_05	2512056	2512262	NA	NA	NA	NA	NA
PGEN_.00g104720	Scaffold_05	2514820	2515143	NA	NA	NA	NA	NA
PGEN_.00g104730	Scaffold_05	2521223	2525989	NA	NA	NA	NA	NA
PGEN_.00g104740	Scaffold_05	2526062	2541648	NA	NA	NA	NA	NA
PGEN_.00g104750	Scaffold_05	2555295	2555624	NA	NA	NA	NA	NA
PGEN_.00g104760	Scaffold_05	2585322	2585879	NA	NA	NA	NA	NA
PGEN_.00g104770	Scaffold_05	2587108	2589568	NA	NA	NA	NA	NA
PGEN_.00g104780	Scaffold_05	2589719	2590078	NA	NA	NA	NA	NA
PGEN_.00g104790	Scaffold_05	2610105	2656507	Q9TUZ0	STA5B_PIG	Signal transducer and activator of transcription 5B	GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019915; GO:0030155; GO:0030856; GO:0040018; GO:0042104; GO:0042127; GO:0042448; GO:0043029; GO:0043066; GO:0043434; GO:0045086; GO:0045579; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0046543; GO:0046544; GO:0046983; GO:0050729; GO:0060397; GO:0071363; GO:0071364	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; response to peptide hormone [GO:0043434]; T cell homeostasis [GO:0043029]"
PGEN_.00g104800	Scaffold_05	2658752	2659738	NA	NA	NA	NA	NA
PGEN_.00g104810	Scaffold_05	2659778	2673791	Q9TUZ1	STA5A_PIG	Signal transducer and activator of transcription 5A	GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019915; GO:0030155; GO:0030856; GO:0030879; GO:0040018; GO:0042104; GO:0042127; GO:0043029; GO:0043066; GO:0043434; GO:0045086; GO:0045579; GO:0045647; GO:0045931; GO:0045944; GO:0046543; GO:0050729; GO:0060397	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland development [GO:0030879]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; response to peptide hormone [GO:0043434]; T cell homeostasis [GO:0043029]"
PGEN_.00g104820	Scaffold_05	2676039	2676449	NA	NA	NA	NA	NA
PGEN_.00g104830	Scaffold_05	2690688	2691903	NA	NA	NA	NA	NA
PGEN_.00g104840	Scaffold_05	2702542	2709942	D2GXS7	TRIM2_AILME	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	GO:0004842; GO:0005737; GO:0008270; GO:0043523	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g104850	Scaffold_05	2770758	2776148	NA	NA	NA	NA	NA
PGEN_.00g104860	Scaffold_05	2780617	2796764	Q5RA77	COPD_PONAB	Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP)	GO:0000139; GO:0006890; GO:0015031; GO:0030126	"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g104870	Scaffold_05	2803479	2816715	Q26474	LACH_SCHAM	Lachesin	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g104880	Scaffold_05	2817183	2825882	P15364	AMAL_DROME	Protein amalgam	GO:0005886; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]
PGEN_.00g104890	Scaffold_05	2839312	2839599	NA	NA	NA	NA	NA
PGEN_.00g104900	Scaffold_05	2840896	2852694	Q7TNK1	RFX4_MOUSE	Transcription factor RFX4 (Regulatory factor X 4)	GO:0000978; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0021516; GO:0021537; GO:0021696; GO:0021914; GO:0030900; GO:0030901; GO:0045944; GO:0060271; GO:0070613	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cerebellar cortex morphogenesis [GO:0021696]; cilium assembly [GO:0060271]; dorsal spinal cord development [GO:0021516]; forebrain development [GO:0030900]; midbrain development [GO:0030901]; negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021914]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537]"
PGEN_.00g104910	Scaffold_05	2908672	2918740	P70097	C560_CRIGR	"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1) (QPs1)"	GO:0000104; GO:0005743; GO:0005749; GO:0006099; GO:0009055; GO:0016021; GO:0020037; GO:0046872	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]; tricarboxylic acid cycle [GO:0006099]"
PGEN_.00g104920	Scaffold_05	2924850	2935126	Q9Y7Y3	YGR4_SCHPO	Uncharacterized RNA-binding protein C365.04c	GO:0003723; GO:0005634; GO:0005730; GO:0042254	nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]
PGEN_.00g104930	Scaffold_05	2955313	2998718	NA	NA	NA	NA	NA
PGEN_.00g104940	Scaffold_05	3001016	3003099	NA	NA	NA	NA	NA
PGEN_.00g104950	Scaffold_05	3003202	3014286	NA	NA	NA	NA	NA
PGEN_.00g104960	Scaffold_05	3027420	3066125	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g104970	Scaffold_05	3093170	3093514	NA	NA	NA	NA	NA
PGEN_.00g104980	Scaffold_05	3124867	3159547	NA	NA	NA	NA	NA
PGEN_.00g104990	Scaffold_05	3165386	3165928	NA	NA	NA	NA	NA
PGEN_.00g105000	Scaffold_05	3166819	3167328	P17871	TBP_SCHPO	TATA-box-binding protein (TATA sequence-binding protein) (TBP) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit)	GO:0000120; GO:0000126; GO:0000978; GO:0000979; GO:0000995; GO:0001006; GO:0001016; GO:0001181; GO:0003700; GO:0005634; GO:0005667; GO:0005669; GO:0006361; GO:0006366; GO:0006367; GO:0006384; GO:0008134; GO:0016251; GO:0070898	nucleus [GO:0005634]; RNA polymerase I transcription factor complex [GO:0000120]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIIB complex [GO:0000126]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III regulatory region DNA binding [GO:0001016]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; transcription factor binding [GO:0008134]; RNA polymerase III preinitiation complex assembly [GO:0070898]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase III promoter [GO:0006384]
PGEN_.00g105010	Scaffold_05	3197945	3198412	NA	NA	NA	NA	NA
PGEN_.00g105020	Scaffold_05	3201104	3298592	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g105030	Scaffold_05	3308602	3308928	NA	NA	NA	NA	NA
PGEN_.00g105040	Scaffold_05	3370791	3396920	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g105050	Scaffold_05	3425768	3426331	NA	NA	NA	NA	NA
PGEN_.00g105060	Scaffold_05	3430689	3445267	NA	NA	NA	NA	NA
PGEN_.00g105070	Scaffold_05	3454061	3458736	NA	NA	NA	NA	NA
PGEN_.00g105080	Scaffold_05	3476110	3476397	NA	NA	NA	NA	NA
PGEN_.00g105090	Scaffold_05	3504124	3506375	NA	NA	NA	NA	NA
PGEN_.00g105100	Scaffold_05	3513810	3610827	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g105110	Scaffold_05	3650423	3659572	P14730	WFD18_RAT	WAP four-disulfide core domain protein 18 (Extracellular peptidase inhibitor) (Protein WDNM1) (Fragment)	GO:0005576; GO:0030414	extracellular region [GO:0005576]; peptidase inhibitor activity [GO:0030414]
PGEN_.00g105120	Scaffold_05	3664206	3680547	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g105130	Scaffold_05	3751054	3751632	NA	NA	NA	NA	NA
PGEN_.00g105140	Scaffold_05	3751896	3752264	NA	NA	NA	NA	NA
PGEN_.00g105150	Scaffold_05	3753778	3754074	NA	NA	NA	NA	NA
PGEN_.00g105160	Scaffold_05	3754682	3781425	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g105170	Scaffold_05	3831923	3863031	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g105180	Scaffold_05	3894540	3898304	NA	NA	NA	NA	NA
PGEN_.00g105190	Scaffold_05	3911749	3913253	NA	NA	NA	NA	NA
PGEN_.00g105200	Scaffold_05	3937383	3971315	NA	NA	NA	NA	NA
PGEN_.00g105210	Scaffold_05	3974327	3975116	NA	NA	NA	NA	NA
PGEN_.00g105220	Scaffold_05	3977691	3978119	NA	NA	NA	NA	NA
PGEN_.00g105230	Scaffold_05	3978186	3978485	NA	NA	NA	NA	NA
PGEN_.00g105240	Scaffold_05	3990936	3991538	NA	NA	NA	NA	NA
PGEN_.00g105250	Scaffold_05	3994182	3994562	NA	NA	NA	NA	NA
PGEN_.00g105260	Scaffold_05	4005199	4021104	NA	NA	NA	NA	NA
PGEN_.00g105270	Scaffold_05	4023612	4090310	NA	NA	NA	NA	NA
PGEN_.00g105280	Scaffold_05	4152468	4192674	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g105290	Scaffold_05	4220265	4233956	NA	NA	NA	NA	NA
PGEN_.00g105300	Scaffold_05	4328719	4354602	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g105310	Scaffold_05	4394606	4403242	P14730	WFD18_RAT	WAP four-disulfide core domain protein 18 (Extracellular peptidase inhibitor) (Protein WDNM1) (Fragment)	GO:0005576; GO:0030414	extracellular region [GO:0005576]; peptidase inhibitor activity [GO:0030414]
PGEN_.00g105320	Scaffold_05	4413890	4418076	NA	NA	NA	NA	NA
PGEN_.00g105330	Scaffold_05	4419489	4450285	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g105340	Scaffold_05	4468130	4468474	NA	NA	NA	NA	NA
PGEN_.00g105350	Scaffold_05	4471254	4474374	NA	NA	NA	NA	NA
PGEN_.00g105360	Scaffold_05	4482707	4483183	NA	NA	NA	NA	NA
PGEN_.00g105370	Scaffold_05	4528180	4533136	NA	NA	NA	NA	NA
PGEN_.00g105380	Scaffold_05	4554538	4557158	NA	NA	NA	NA	NA
PGEN_.00g105390	Scaffold_05	4574463	4582926	NA	NA	NA	NA	NA
PGEN_.00g105400	Scaffold_05	4615002	4643207	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g105410	Scaffold_05	4650475	4650783	NA	NA	NA	NA	NA
PGEN_.00g105420	Scaffold_05	4706994	4718403	P20273	CD22_HUMAN	B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)	GO:0001791; GO:0005102; GO:0005737; GO:0005769; GO:0005886; GO:0007155; GO:0009986; GO:0016021; GO:0019903; GO:0030100; GO:0030246; GO:0030888; GO:0032809; GO:0033691; GO:0042113; GO:0042609; GO:0050776; GO:0050849; GO:0050859; GO:0051025; GO:0055037; GO:0070062	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776]
PGEN_.00g105430	Scaffold_05	4732795	4740873	Q8NDA2	HMCN2_HUMAN	Hemicentin-2	GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g105440	Scaffold_05	4742278	4743118	NA	NA	NA	NA	NA
PGEN_.00g105450	Scaffold_05	4772498	4777142	NA	NA	NA	NA	NA
PGEN_.00g105460	Scaffold_05	4783727	4790416	NA	NA	NA	NA	NA
PGEN_.00g105470	Scaffold_05	4813720	4816173	NA	NA	NA	NA	NA
PGEN_.00g105480	Scaffold_05	4839491	4890965	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g105490	Scaffold_05	4932127	4954941	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g105500	Scaffold_05	4955276	4988736	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g105510	Scaffold_05	5034612	5115898	NA	NA	NA	NA	NA
PGEN_.00g105520	Scaffold_05	5132874	5133236	NA	NA	NA	NA	NA
PGEN_.00g105530	Scaffold_05	5142410	5152571	NA	NA	NA	NA	NA
PGEN_.00g105540	Scaffold_05	5162186	5163031	NA	NA	NA	NA	NA
PGEN_.00g105550	Scaffold_05	5249943	5264820	P28828	PTPRM_MOUSE	Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)	GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005913; GO:0006470; GO:0007156; GO:0007165; GO:0010596; GO:0010842; GO:0016021; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042493; GO:0042802; GO:0045296; GO:0048471; GO:0097755	cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]
PGEN_.00g105560	Scaffold_05	5266218	5267093	NA	NA	NA	NA	NA
PGEN_.00g105570	Scaffold_05	5273694	5304001	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g105580	Scaffold_05	5308098	5341497	NA	NA	NA	NA	NA
PGEN_.00g105590	Scaffold_05	5325409	5334523	NA	NA	NA	NA	NA
PGEN_.00g105600	Scaffold_05	5347284	5352781	NA	NA	NA	NA	NA
PGEN_.00g105610	Scaffold_05	5357618	5381267	NA	NA	NA	NA	NA
PGEN_.00g105620	Scaffold_05	5377972	5378971	NA	NA	NA	NA	NA
PGEN_.00g105630	Scaffold_05	5407321	5437903	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g105640	Scaffold_05	5446707	5461253	NA	NA	NA	NA	NA
PGEN_.00g105650	Scaffold_05	5462765	5465588	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g105660	Scaffold_05	5472937	5485395	O08836	IGBP1_RAT	Immunoglobulin-binding protein 1 (Alpha4 phosphoprotein) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit)	GO:0000122; GO:0005737; GO:0005829; GO:0005874; GO:0019888; GO:0019904; GO:0031434; GO:0032873; GO:0034612; GO:0035306; GO:0035308; GO:0042113; GO:0043154; GO:0044877; GO:0045944; GO:0051721; GO:0060632; GO:0070555; GO:2001234	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein domain specific binding [GO:0019904]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein-containing complex binding [GO:0044877]; B cell activation [GO:0042113]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]
PGEN_.00g105670	Scaffold_05	5485482	5489844	Q3SZA2	FMC1_BOVIN	Protein FMC1 homolog	GO:0005739; GO:0033615; GO:0050995; GO:0061469	mitochondrion [GO:0005739]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; negative regulation of lipid catabolic process [GO:0050995]; regulation of type B pancreatic cell proliferation [GO:0061469]
PGEN_.00g105680	Scaffold_05	5513186	5548360	P08793	XDH_CALVI	Xanthine dehydrogenase (XD) (EC 1.17.1.4)	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0009055; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949	"peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; xanthine catabolic process [GO:0009115]"
PGEN_.00g105690	Scaffold_05	5573345	5580001	Q80X72	LRC15_MOUSE	Leucine-rich repeat-containing protein 15	GO:0001968; GO:0005518; GO:0005615; GO:0009986; GO:0016021; GO:0030335; GO:0031012; GO:0043236; GO:0046813; GO:0062023; GO:1903077	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]
PGEN_.00g105700	Scaffold_05	5580165	5580458	NA	NA	NA	NA	NA
PGEN_.00g105710	Scaffold_05	5580519	5581094	NA	NA	NA	NA	NA
PGEN_.00g105720	Scaffold_05	5581328	5581801	NA	NA	NA	NA	NA
PGEN_.00g105730	Scaffold_05	5585792	5610903	Q9Z2J0	S23A1_MOUSE	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)	GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016021; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g105740	Scaffold_05	5636536	5636949	Q9SMT7	4CLLA_ARATH	Oxalate--CoA ligase (EC 6.2.1.8) (4-coumarate--CoA ligase isoform 8) (At4CL8) (4-coumarate--CoA ligase-like 10) (Acyl-activating enzyme 3) (Adenosine monophosphate binding protein 3) (AtMPBP3) (Oxalyl-CoA synthetase)	GO:0005524; GO:0005737; GO:0005829; GO:0009506; GO:0009507; GO:0009570; GO:0010030; GO:0010214; GO:0033611; GO:0046686; GO:0048046; GO:0050203; GO:0050832	apoplast [GO:0048046]; chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; oxalate-CoA ligase activity [GO:0050203]; defense response to fungus [GO:0050832]; oxalate catabolic process [GO:0033611]; positive regulation of seed germination [GO:0010030]; response to cadmium ion [GO:0046686]; seed coat development [GO:0010214]
PGEN_.00g105750	Scaffold_05	5638995	5639792	NA	NA	NA	NA	NA
PGEN_.00g105760	Scaffold_05	5649842	5650460	NA	NA	NA	NA	NA
PGEN_.00g105770	Scaffold_05	5713226	5714894	Q9EPR4	S23A2_MOUSE	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2)	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g105780	Scaffold_05	5737898	5738203	NA	NA	NA	NA	NA
PGEN_.00g105790	Scaffold_05	5748049	5765944	NA	NA	NA	NA	NA
PGEN_.00g105800	Scaffold_05	5767440	5768399	NA	NA	NA	NA	NA
PGEN_.00g105810	Scaffold_05	5768535	5768963	NA	NA	NA	NA	NA
PGEN_.00g105820	Scaffold_05	5794166	5794567	NA	NA	NA	NA	NA
PGEN_.00g105830	Scaffold_05	5794593	5794937	NA	NA	NA	NA	NA
PGEN_.00g105840	Scaffold_05	5798385	5798786	NA	NA	NA	NA	NA
PGEN_.00g105850	Scaffold_05	5800700	5802196	NA	NA	NA	NA	NA
PGEN_.00g105860	Scaffold_05	5802221	5802499	NA	NA	NA	NA	NA
PGEN_.00g105870	Scaffold_05	5802776	5803420	NA	NA	NA	NA	NA
PGEN_.00g105880	Scaffold_05	5803447	5803722	NA	NA	NA	NA	NA
PGEN_.00g105890	Scaffold_05	5818011	5849744	P28828	PTPRM_MOUSE	Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)	GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005913; GO:0006470; GO:0007156; GO:0007165; GO:0010596; GO:0010842; GO:0016021; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042493; GO:0042802; GO:0045296; GO:0048471; GO:0097755	cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]
PGEN_.00g105900	Scaffold_05	5854021	5868623	NA	NA	NA	NA	NA
PGEN_.00g105910	Scaffold_05	5856259	5856585	NA	NA	NA	NA	NA
PGEN_.00g105920	Scaffold_05	5856863	5857249	NA	NA	NA	NA	NA
PGEN_.00g105930	Scaffold_05	5881835	5882383	NA	NA	NA	NA	NA
PGEN_.00g105940	Scaffold_05	5882423	5882728	NA	NA	NA	NA	NA
PGEN_.00g105950	Scaffold_05	5883274	5883525	NA	NA	NA	NA	NA
PGEN_.00g105960	Scaffold_05	5884661	5884984	NA	NA	NA	NA	NA
PGEN_.00g105970	Scaffold_05	5894085	5894573	NA	NA	NA	NA	NA
PGEN_.00g105980	Scaffold_05	5894620	5894883	NA	NA	NA	NA	NA
PGEN_.00g105990	Scaffold_05	5925587	5925841	NA	NA	NA	NA	NA
PGEN_.00g106000	Scaffold_05	5929155	5956766	O14522	PTPRT_HUMAN	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g106010	Scaffold_05	5957624	5959829	P18052	PTPRA_MOUSE	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28)	GO:0004725; GO:0005886; GO:0006468; GO:0006470; GO:0008286; GO:0043231; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0098685; GO:0099699	integral component of synaptic membrane [GO:0099699]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; insulin receptor signaling pathway [GO:0008286]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]
PGEN_.00g106020	Scaffold_05	5973609	5973854	NA	NA	NA	NA	NA
PGEN_.00g106030	Scaffold_05	5973939	5974187	NA	NA	NA	NA	NA
PGEN_.00g106040	Scaffold_05	5975812	5978087	NA	NA	NA	NA	NA
PGEN_.00g106050	Scaffold_05	5979615	5980001	NA	NA	NA	NA	NA
PGEN_.00g106060	Scaffold_05	6157016	6159052	NA	NA	NA	NA	NA
PGEN_.00g106070	Scaffold_05	6280238	6280786	NA	NA	NA	NA	NA
PGEN_.00g106080	Scaffold_05	6281332	6281871	NA	NA	NA	NA	NA
PGEN_.00g106090	Scaffold_05	6283047	6286574	NA	NA	NA	NA	NA
PGEN_.00g106100	Scaffold_05	6288816	6305938	E9PZ19	TUTLB_MOUSE	Protein turtle homolog B (Immunoglobulin superfamily member 9B)	GO:0007156; GO:0007399; GO:0014069; GO:0016021; GO:0019900; GO:0030054; GO:0030425; GO:0043025; GO:0045211; GO:0060077; GO:0097151; GO:0098982; GO:0099560; GO:0099629	cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]; kinase binding [GO:0019900]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; synaptic membrane adhesion [GO:0099560]
PGEN_.00g106110	Scaffold_05	6326936	6332103	NA	NA	NA	NA	NA
PGEN_.00g106120	Scaffold_05	6345544	6355297	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g106130	Scaffold_05	6380308	6380553	NA	NA	NA	NA	NA
PGEN_.00g106140	Scaffold_05	6393726	6393983	NA	NA	NA	NA	NA
PGEN_.00g106150	Scaffold_05	6400923	6401321	NA	NA	NA	NA	NA
PGEN_.00g106160	Scaffold_05	6401438	6403436	NA	NA	NA	NA	NA
PGEN_.00g106170	Scaffold_05	6415213	6415755	NA	NA	NA	NA	NA
PGEN_.00g106180	Scaffold_05	6416048	6417166	NA	NA	NA	NA	NA
PGEN_.00g106190	Scaffold_05	6420974	6421570	NA	NA	NA	NA	NA
PGEN_.00g106200	Scaffold_05	6422596	6427033	NA	NA	NA	NA	NA
PGEN_.00g106210	Scaffold_05	6488264	6497730	NA	NA	NA	NA	NA
PGEN_.00g106220	Scaffold_05	6501222	6501647	NA	NA	NA	NA	NA
PGEN_.00g106230	Scaffold_05	6512156	6512557	NA	NA	NA	NA	NA
PGEN_.00g106240	Scaffold_05	6512822	6513379	NA	NA	NA	NA	NA
PGEN_.00g106250	Scaffold_05	6551204	6551887	NA	NA	NA	NA	NA
PGEN_.00g106260	Scaffold_05	6551948	6552229	NA	NA	NA	NA	NA
PGEN_.00g106270	Scaffold_05	6552283	6556358	NA	NA	NA	NA	NA
PGEN_.00g106280	Scaffold_05	6566463	6566759	NA	NA	NA	NA	NA
PGEN_.00g106290	Scaffold_05	6566971	6570457	NA	NA	NA	NA	NA
PGEN_.00g106300	Scaffold_05	6573539	6573841	NA	NA	NA	NA	NA
PGEN_.00g106310	Scaffold_05	6573972	6574454	NA	NA	NA	NA	NA
PGEN_.00g106320	Scaffold_05	6642001	6644210	NA	NA	NA	NA	NA
PGEN_.00g106330	Scaffold_05	6644416	6649740	NA	NA	NA	NA	NA
PGEN_.00g106340	Scaffold_05	6686456	6686779	NA	NA	NA	NA	NA
PGEN_.00g106350	Scaffold_05	6687172	6687558	NA	NA	NA	NA	NA
PGEN_.00g106360	Scaffold_05	6687590	6688006	NA	NA	NA	NA	NA
PGEN_.00g106370	Scaffold_05	6695512	6705027	NA	NA	NA	NA	NA
PGEN_.00g106380	Scaffold_05	6752975	6753262	NA	NA	NA	NA	NA
PGEN_.00g106390	Scaffold_05	6753456	6753677	NA	NA	NA	NA	NA
PGEN_.00g106400	Scaffold_05	6753707	6754618	NA	NA	NA	NA	NA
PGEN_.00g106410	Scaffold_05	6754729	6755298	NA	NA	NA	NA	NA
PGEN_.00g106420	Scaffold_05	6755329	6755706	NA	NA	NA	NA	NA
PGEN_.00g106430	Scaffold_05	6759269	6759915	NA	NA	NA	NA	NA
PGEN_.00g106440	Scaffold_05	6797711	6797986	NA	NA	NA	NA	NA
PGEN_.00g106450	Scaffold_05	6801643	6812086	NA	NA	NA	NA	NA
PGEN_.00g106460	Scaffold_05	6862885	6866100	NA	NA	NA	NA	NA
PGEN_.00g106470	Scaffold_05	6883806	6884243	NA	NA	NA	NA	NA
PGEN_.00g106480	Scaffold_05	6975405	7003778	NA	NA	NA	NA	NA
PGEN_.00g106490	Scaffold_05	7015750	7017234	NA	NA	NA	NA	NA
PGEN_.00g106500	Scaffold_05	7017516	7017905	NA	NA	NA	NA	NA
PGEN_.00g106510	Scaffold_05	7027649	7030250	NA	NA	NA	NA	NA
PGEN_.00g106520	Scaffold_05	7055868	7060307	NA	NA	NA	NA	NA
PGEN_.00g106530	Scaffold_05	7062139	7093217	NA	NA	NA	NA	NA
PGEN_.00g106540	Scaffold_05	7093391	7104729	NA	NA	NA	NA	NA
PGEN_.00g106550	Scaffold_05	7107522	7139798	NA	NA	NA	NA	NA
PGEN_.00g106560	Scaffold_05	7147381	7153905	NA	NA	NA	NA	NA
PGEN_.00g106570	Scaffold_05	7166065	7166517	NA	NA	NA	NA	NA
PGEN_.00g106580	Scaffold_05	7184474	7191579	NA	NA	NA	NA	NA
PGEN_.00g106590	Scaffold_05	7203152	7211688	NA	NA	NA	NA	NA
PGEN_.00g106600	Scaffold_05	7217085	7217765	NA	NA	NA	NA	NA
PGEN_.00g106610	Scaffold_05	7218386	7218685	NA	NA	NA	NA	NA
PGEN_.00g106620	Scaffold_05	7227503	7263534	NA	NA	NA	NA	NA
PGEN_.00g106630	Scaffold_05	7299206	7305519	Q8CDF7	EXD1_MOUSE	piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1) (mExd1)	GO:0003723; GO:0031047; GO:0034587; GO:0042803; GO:0043186; GO:0051321; GO:0090305; GO:1990923	P granule [GO:0043186]; PET complex [GO:1990923]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; piRNA metabolic process [GO:0034587]
PGEN_.00g106640	Scaffold_05	7309868	7315678	NA	NA	NA	NA	NA
PGEN_.00g106650	Scaffold_05	7322639	7357482	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g106660	Scaffold_05	7403797	7404039	NA	NA	NA	NA	NA
PGEN_.00g106670	Scaffold_05	7429638	7475313	Q86VB7	C163A_HUMAN	Scavenger receptor cysteine-rich type 1 protein M130 (Hemoglobin scavenger receptor) (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)]	GO:0005044; GO:0005576; GO:0005886; GO:0005887; GO:0006898; GO:0006953; GO:0009897; GO:0030666	endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g106680	Scaffold_05	7479654	7486416	NA	NA	NA	NA	NA
PGEN_.00g106690	Scaffold_05	7485077	7485542	NA	NA	NA	NA	NA
PGEN_.00g106700	Scaffold_05	7490327	7507877	NA	NA	NA	NA	NA
PGEN_.00g106710	Scaffold_05	7514095	7518977	NA	NA	NA	NA	NA
PGEN_.00g106720	Scaffold_05	7564105	7565097	NA	NA	NA	NA	NA
PGEN_.00g106730	Scaffold_05	7567220	7568461	NA	NA	NA	NA	NA
PGEN_.00g106740	Scaffold_05	7568749	7575744	NA	NA	NA	NA	NA
PGEN_.00g106750	Scaffold_05	7577086	7580819	NA	NA	NA	NA	NA
PGEN_.00g106760	Scaffold_05	7587776	7614832	Q7Z3B3	KANL1_HUMAN	KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog)	GO:0000123; GO:0000777; GO:0005634; GO:0005654; GO:0035035; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0071339	condensed chromosome kinetochore [GO:0000777]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]
PGEN_.00g106770	Scaffold_05	7627307	7628957	NA	NA	NA	NA	NA
PGEN_.00g106780	Scaffold_05	7646186	7662038	NA	NA	NA	NA	NA
PGEN_.00g106790	Scaffold_05	7665265	7668079	Q9DBB9	CPN2_MOUSE	Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit)	GO:0005615; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]
PGEN_.00g106800	Scaffold_05	7674623	7675174	NA	NA	NA	NA	NA
PGEN_.00g106810	Scaffold_05	7681610	7684674	NA	NA	NA	NA	NA
PGEN_.00g106820	Scaffold_05	7690637	7691143	Q8NCG5	CHST4_HUMAN	Carbohydrate sulfotransferase 4 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3) (GST-3) (High endothelial cells N-acetylglucosamine 6-O-sulfotransferase) (HEC-GlcNAc6ST) (L-selectin ligand sulfotransferase) (LSST) (N-acetylglucosamine 6-O-sulfotransferase 2) (GlcNAc6ST-2) (Gn6st-2)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006477; GO:0006790; GO:0006954; GO:0006955; GO:0007155; GO:0007267; GO:0008146; GO:0016021; GO:0016266; GO:0018146; GO:0031228	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; O-glycan processing [GO:0016266]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g106830	Scaffold_05	7715791	7733096	NA	NA	NA	NA	NA
PGEN_.00g106840	Scaffold_05	7765408	7766404	NA	NA	NA	NA	NA
PGEN_.00g106850	Scaffold_05	7774530	7785141	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g106860	Scaffold_05	7800673	7813661	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g106870	Scaffold_05	7815331	7854632	NA	NA	NA	NA	NA
PGEN_.00g106880	Scaffold_05	7861944	7875553	NA	NA	NA	NA	NA
PGEN_.00g106890	Scaffold_05	7885788	7906748	E9PZ19	TUTLB_MOUSE	Protein turtle homolog B (Immunoglobulin superfamily member 9B)	GO:0007156; GO:0007399; GO:0014069; GO:0016021; GO:0019900; GO:0030054; GO:0030425; GO:0043025; GO:0045211; GO:0060077; GO:0097151; GO:0098982; GO:0099560; GO:0099629	cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]; kinase binding [GO:0019900]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; synaptic membrane adhesion [GO:0099560]
PGEN_.00g106900	Scaffold_05	7912818	7917915	NA	NA	NA	NA	NA
PGEN_.00g106910	Scaffold_05	7917960	7954084	NA	NA	NA	NA	NA
PGEN_.00g106920	Scaffold_05	7964739	7965272	NA	NA	NA	NA	NA
PGEN_.00g106930	Scaffold_05	7968321	7968623	NA	NA	NA	NA	NA
PGEN_.00g106940	Scaffold_05	7968687	7969406	NA	NA	NA	NA	NA
PGEN_.00g106950	Scaffold_05	7976181	7976459	NA	NA	NA	NA	NA
PGEN_.00g106960	Scaffold_05	7979822	7986460	NA	NA	NA	NA	NA
PGEN_.00g106970	Scaffold_05	8039956	8041742	NA	NA	NA	NA	NA
PGEN_.00g106980	Scaffold_05	8052151	8066334	NA	NA	NA	NA	NA
PGEN_.00g106990	Scaffold_05	8066501	8066932	NA	NA	NA	NA	NA
PGEN_.00g107000	Scaffold_05	8067031	8067743	NA	NA	NA	NA	NA
PGEN_.00g107010	Scaffold_05	8067817	8068176	NA	NA	NA	NA	NA
PGEN_.00g107020	Scaffold_05	8113687	8118082	NA	NA	NA	NA	NA
PGEN_.00g107030	Scaffold_05	8147558	8148906	NA	NA	NA	NA	NA
PGEN_.00g107040	Scaffold_05	8149199	8150284	NA	NA	NA	NA	NA
PGEN_.00g107050	Scaffold_05	8150595	8152461	NA	NA	NA	NA	NA
PGEN_.00g107060	Scaffold_05	8168913	8169688	NA	NA	NA	NA	NA
PGEN_.00g107070	Scaffold_05	8224414	8253005	NA	NA	NA	NA	NA
PGEN_.00g107080	Scaffold_05	8329024	8329350	NA	NA	NA	NA	NA
PGEN_.00g107090	Scaffold_05	8435510	8441646	NA	NA	NA	NA	NA
PGEN_.00g107100	Scaffold_05	8444065	8445530	NA	NA	NA	NA	NA
PGEN_.00g107110	Scaffold_05	8455497	8455850	NA	NA	NA	NA	NA
PGEN_.00g107120	Scaffold_05	8456490	8456807	NA	NA	NA	NA	NA
PGEN_.00g107130	Scaffold_05	8463661	8463981	NA	NA	NA	NA	NA
PGEN_.00g107140	Scaffold_05	8507363	8512352	NA	NA	NA	NA	NA
PGEN_.00g107150	Scaffold_05	8529022	8530480	NA	NA	NA	NA	NA
PGEN_.00g107160	Scaffold_05	8536463	8537293	NA	NA	NA	NA	NA
PGEN_.00g107170	Scaffold_05	8537378	8537815	NA	NA	NA	NA	NA
PGEN_.00g107180	Scaffold_05	8552725	8553168	NA	NA	NA	NA	NA
PGEN_.00g107190	Scaffold_05	8553320	8553793	NA	NA	NA	NA	NA
PGEN_.00g107200	Scaffold_05	8554870	8558978	NA	NA	NA	NA	NA
PGEN_.00g107210	Scaffold_05	8560610	8584694	P06800	PTPRC_MOUSE	Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (Lymphocyte antigen 5) (Ly-5) (T200) (CD antigen CD45)	GO:0000187; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002378; GO:0002711; GO:0002923; GO:0002925; GO:0004725; GO:0005102; GO:0005623; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016021; GO:0016311; GO:0019901; GO:0030183; GO:0030217; GO:0030506; GO:0030507; GO:0030890; GO:0031668; GO:0031953; GO:0032059; GO:0032677; GO:0032760; GO:0034113; GO:0035584; GO:0042098; GO:0042100; GO:0042102; GO:0043395; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045085; GO:0045086; GO:0045121; GO:0045582; GO:0045588; GO:0046425; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050731; GO:0050732; GO:0050764; GO:0050852; GO:0050853; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0061097; GO:0061099; GO:0070373; GO:0070374; GO:0071944; GO:0098857; GO:1903615; GO:1905451; GO:2000473; GO:2000648; GO:2001236; GO:2001238	bleb [GO:0032059]; cell [GO:0005623]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 biosynthetic process [GO:0045085]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of gene expression [GO:0010468]; regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002923]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]
PGEN_.00g107220	Scaffold_05	8608765	8612983	NA	NA	NA	NA	NA
PGEN_.00g107230	Scaffold_05	8623870	8647327	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g107240	Scaffold_05	8720091	8720381	NA	NA	NA	NA	NA
PGEN_.00g107250	Scaffold_05	8728207	8728674	NA	NA	NA	NA	NA
PGEN_.00g107260	Scaffold_05	8728896	8729282	NA	NA	NA	NA	NA
PGEN_.00g107270	Scaffold_05	8729358	8731446	NA	NA	NA	NA	NA
PGEN_.00g107280	Scaffold_05	8731606	8732007	NA	NA	NA	NA	NA
PGEN_.00g107290	Scaffold_05	8732125	8732442	NA	NA	NA	NA	NA
PGEN_.00g107300	Scaffold_05	8734286	8736318	NA	NA	NA	NA	NA
PGEN_.00g107310	Scaffold_05	8751932	8753379	NA	NA	NA	NA	NA
PGEN_.00g107320	Scaffold_05	8753531	8753827	NA	NA	NA	NA	NA
PGEN_.00g107330	Scaffold_05	8793488	8793865	Q5BLK4	TUT7_MOUSE	Terminal uridylyltransferase 7 (TUTase 7) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 6)	GO:0001556; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010526; GO:0010586; GO:0031054; GO:0031123; GO:0035198; GO:0050265; GO:0070569; GO:0071076; GO:1990074	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]"
PGEN_.00g107340	Scaffold_05	8794264	8796343	NA	NA	NA	NA	NA
PGEN_.00g107350	Scaffold_05	8796423	8798468	NA	NA	NA	NA	NA
PGEN_.00g107360	Scaffold_05	8798493	8798804	NA	NA	NA	NA	NA
PGEN_.00g107370	Scaffold_05	8808212	8848396	NA	NA	NA	NA	NA
PGEN_.00g107380	Scaffold_05	8849038	8852522	NA	NA	NA	NA	NA
PGEN_.00g107390	Scaffold_05	8852631	8853071	NA	NA	NA	NA	NA
PGEN_.00g107400	Scaffold_05	8859633	8860129	NA	NA	NA	NA	NA
PGEN_.00g107410	Scaffold_05	8862802	8865840	NA	NA	NA	NA	NA
PGEN_.00g107420	Scaffold_05	8882855	8883448	NA	NA	NA	NA	NA
PGEN_.00g107430	Scaffold_05	9106170	9106787	NA	NA	NA	NA	NA
PGEN_.00g107440	Scaffold_05	9141907	9142981	NA	NA	NA	NA	NA
PGEN_.00g107450	Scaffold_05	9143132	9143374	NA	NA	NA	NA	NA
PGEN_.00g107460	Scaffold_05	9143522	9143725	NA	NA	NA	NA	NA
PGEN_.00g107470	Scaffold_05	9173076	9207666	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g107480	Scaffold_05	9208330	9208794	NA	NA	NA	NA	NA
PGEN_.00g107490	Scaffold_05	9209493	9212458	NA	NA	NA	NA	NA
PGEN_.00g107500	Scaffold_05	9212567	9221096	NA	NA	NA	NA	NA
PGEN_.00g107510	Scaffold_05	9223635	9235435	NA	NA	NA	NA	NA
PGEN_.00g107520	Scaffold_05	9249523	9250128	NA	NA	NA	NA	NA
PGEN_.00g107530	Scaffold_05	9254151	9254720	NA	NA	NA	NA	NA
PGEN_.00g107540	Scaffold_05	9271018	9274216	O14522	PTPRT_HUMAN	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g107550	Scaffold_05	9314634	9317781	B0BN95	HARB1_RAT	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g107560	Scaffold_05	9326892	9327242	NA	NA	NA	NA	NA
PGEN_.00g107570	Scaffold_05	9327373	9330671	NA	NA	NA	NA	NA
PGEN_.00g107580	Scaffold_05	9360907	9361598	NA	NA	NA	NA	NA
PGEN_.00g107590	Scaffold_05	9361693	9361986	NA	NA	NA	NA	NA
PGEN_.00g107600	Scaffold_05	9448911	9451752	NA	NA	NA	NA	NA
PGEN_.00g107610	Scaffold_05	9453534	9454481	NA	NA	NA	NA	NA
PGEN_.00g107620	Scaffold_05	9454686	9455505	NA	NA	NA	NA	NA
PGEN_.00g107630	Scaffold_05	9455537	9456920	NA	NA	NA	NA	NA
PGEN_.00g107640	Scaffold_05	9511023	9511427	NA	NA	NA	NA	NA
PGEN_.00g107650	Scaffold_05	9557731	9590081	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g107660	Scaffold_05	9616685	9623547	NA	NA	NA	NA	NA
PGEN_.00g107670	Scaffold_05	9662423	9684707	E9PZ19	TUTLB_MOUSE	Protein turtle homolog B (Immunoglobulin superfamily member 9B)	GO:0007156; GO:0007399; GO:0014069; GO:0016021; GO:0019900; GO:0030054; GO:0030425; GO:0043025; GO:0045211; GO:0060077; GO:0097151; GO:0098982; GO:0099560; GO:0099629	cell junction [GO:0030054]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]; kinase binding [GO:0019900]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; synaptic membrane adhesion [GO:0099560]
PGEN_.00g107680	Scaffold_05	9678301	9678627	NA	NA	NA	NA	NA
PGEN_.00g107690	Scaffold_05	9688426	9694651	NA	NA	NA	NA	NA
PGEN_.00g107700	Scaffold_05	9701728	9702078	NA	NA	NA	NA	NA
PGEN_.00g107710	Scaffold_05	9749799	9750674	NA	NA	NA	NA	NA
PGEN_.00g107720	Scaffold_05	9750953	9752735	NA	NA	NA	NA	NA
PGEN_.00g107730	Scaffold_05	9771490	9771921	NA	NA	NA	NA	NA
PGEN_.00g107740	Scaffold_05	9819301	9819864	NA	NA	NA	NA	NA
PGEN_.00g107750	Scaffold_05	9819941	9820474	NA	NA	NA	NA	NA
PGEN_.00g107760	Scaffold_05	9849374	9850727	NA	NA	NA	NA	NA
PGEN_.00g107770	Scaffold_05	9851066	9853398	NA	NA	NA	NA	NA
PGEN_.00g107780	Scaffold_05	9853489	9858591	NA	NA	NA	NA	NA
PGEN_.00g107790	Scaffold_05	9875942	9876367	NA	NA	NA	NA	NA
PGEN_.00g107800	Scaffold_05	9877253	9877468	NA	NA	NA	NA	NA
PGEN_.00g107810	Scaffold_05	9877792	9878097	NA	NA	NA	NA	NA
PGEN_.00g107820	Scaffold_05	9879425	9879715	NA	NA	NA	NA	NA
PGEN_.00g107830	Scaffold_05	9880637	9882205	NA	NA	NA	NA	NA
PGEN_.00g107840	Scaffold_05	9885713	9891145	NA	NA	NA	NA	NA
PGEN_.00g107850	Scaffold_05	9891275	9894805	NA	NA	NA	NA	NA
PGEN_.00g107860	Scaffold_05	9975494	9975982	NA	NA	NA	NA	NA
PGEN_.00g107870	Scaffold_05	9976064	9976732	NA	NA	NA	NA	NA
PGEN_.00g107880	Scaffold_05	9976909	9977217	NA	NA	NA	NA	NA
PGEN_.00g107890	Scaffold_05	10003944	10014149	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g107900	Scaffold_05	10100188	10101035	NA	NA	NA	NA	NA
PGEN_.00g107910	Scaffold_05	10101072	10124725	Q03348	PTPRA_RAT	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0004725; GO:0005886; GO:0006468; GO:0006470; GO:0008286; GO:0043231; GO:0043235; GO:0044877; GO:0048709; GO:0048714; GO:0050804; GO:0098685; GO:0099699	integral component of synaptic membrane [GO:0099699]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; insulin receptor signaling pathway [GO:0008286]; modulation of chemical synaptic transmission [GO:0050804]; oligodendrocyte differentiation [GO:0048709]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]
PGEN_.00g107920	Scaffold_05	10127060	10131757	NA	NA	NA	NA	NA
PGEN_.00g107930	Scaffold_05	10148098	10149044	NA	NA	NA	NA	NA
PGEN_.00g107940	Scaffold_05	10155033	10157047	NA	NA	NA	NA	NA
PGEN_.00g107950	Scaffold_05	10192711	10193025	NA	NA	NA	NA	NA
PGEN_.00g107960	Scaffold_05	10210214	10210501	NA	NA	NA	NA	NA
PGEN_.00g107970	Scaffold_05	10210733	10211655	NA	NA	NA	NA	NA
PGEN_.00g107980	Scaffold_05	10216451	10217440	NA	NA	NA	NA	NA
PGEN_.00g107990	Scaffold_05	10222383	10226382	NA	NA	NA	NA	NA
PGEN_.00g108000	Scaffold_05	10226513	10229497	NA	NA	NA	NA	NA
PGEN_.00g108010	Scaffold_05	10245471	10245857	NA	NA	NA	NA	NA
PGEN_.00g108020	Scaffold_05	10246256	10246528	NA	NA	NA	NA	NA
PGEN_.00g108030	Scaffold_05	10246561	10248051	NA	NA	NA	NA	NA
PGEN_.00g108040	Scaffold_05	10257032	10275518	P18052	PTPRA_MOUSE	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28)	GO:0004725; GO:0005886; GO:0006468; GO:0006470; GO:0008286; GO:0043231; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0098685; GO:0099699	integral component of synaptic membrane [GO:0099699]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; insulin receptor signaling pathway [GO:0008286]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]
PGEN_.00g108050	Scaffold_05	10282756	10290367	NA	NA	NA	NA	NA
PGEN_.00g108060	Scaffold_05	10290415	10290720	NA	NA	NA	NA	NA
PGEN_.00g108070	Scaffold_05	10308536	10308814	NA	NA	NA	NA	NA
PGEN_.00g108080	Scaffold_05	10311126	10330615	NA	NA	NA	NA	NA
PGEN_.00g108090	Scaffold_05	10408889	10409770	NA	NA	NA	NA	NA
PGEN_.00g108100	Scaffold_05	10427219	10427680	NA	NA	NA	NA	NA
PGEN_.00g108110	Scaffold_05	10441284	10441601	NA	NA	NA	NA	NA
PGEN_.00g108120	Scaffold_05	10442068	10442322	NA	NA	NA	NA	NA
PGEN_.00g108130	Scaffold_05	10454402	10488672	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g108140	Scaffold_05	10505321	10505689	NA	NA	NA	NA	NA
PGEN_.00g108150	Scaffold_05	10505741	10506049	NA	NA	NA	NA	NA
PGEN_.00g108160	Scaffold_05	10533875	10543220	Q76MJ5	ERN2_HUMAN	Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (hIRE2p) (Ire1-beta) (IRE1b) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	GO:0000287; GO:0004519; GO:0004521; GO:0004672; GO:0004674; GO:0005524; GO:0005789; GO:0006397; GO:0006468; GO:0007050; GO:0007257; GO:0016021; GO:0016075; GO:0030263; GO:0030968; GO:0034976; GO:0036498; GO:0045892; GO:0051082; GO:0070059; GO:1990604	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; apoptotic chromosome condensation [GO:0030263]; cell cycle arrest [GO:0007050]; endoplasmic reticulum unfolded protein response [GO:0030968]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]"
PGEN_.00g108170	Scaffold_05	10565860	10567417	NA	NA	NA	NA	NA
PGEN_.00g108180	Scaffold_05	10572604	10573143	NA	NA	NA	NA	NA
PGEN_.00g108190	Scaffold_05	10573291	10573908	NA	NA	NA	NA	NA
PGEN_.00g108200	Scaffold_05	10578260	10578490	NA	NA	NA	NA	NA
PGEN_.00g108210	Scaffold_05	10607562	10610506	NA	NA	NA	NA	NA
PGEN_.00g108220	Scaffold_05	10611821	10664075	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g108230	Scaffold_05	10674794	10675240	NA	NA	NA	NA	NA
PGEN_.00g108240	Scaffold_05	10687643	10701868	P28828	PTPRM_MOUSE	Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)	GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005913; GO:0006470; GO:0007156; GO:0007165; GO:0010596; GO:0010842; GO:0016021; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042493; GO:0042802; GO:0045296; GO:0048471; GO:0097755	cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]
PGEN_.00g108250	Scaffold_05	10708105	10708929	NA	NA	NA	NA	NA
PGEN_.00g108260	Scaffold_05	10711149	10719052	NA	NA	NA	NA	NA
PGEN_.00g108270	Scaffold_05	10722436	10727076	NA	NA	NA	NA	NA
PGEN_.00g108280	Scaffold_05	10814836	10815156	NA	NA	NA	NA	NA
PGEN_.00g108290	Scaffold_05	10839155	10839463	NA	NA	NA	NA	NA
PGEN_.00g108300	Scaffold_05	10868950	10883529	NA	NA	NA	NA	NA
PGEN_.00g108310	Scaffold_05	10891070	10892724	NA	NA	NA	NA	NA
PGEN_.00g108320	Scaffold_05	10895523	10916294	NA	NA	NA	NA	NA
PGEN_.00g108330	Scaffold_05	10927588	10934937	NA	NA	NA	NA	NA
PGEN_.00g108340	Scaffold_05	10975106	10992584	NA	NA	NA	NA	NA
PGEN_.00g108350	Scaffold_05	11022207	11031655	NA	NA	NA	NA	NA
PGEN_.00g108360	Scaffold_05	11044903	11045181	NA	NA	NA	NA	NA
PGEN_.00g108370	Scaffold_05	11054504	11054875	NA	NA	NA	NA	NA
PGEN_.00g108380	Scaffold_05	11121995	11124551	NA	NA	NA	NA	NA
PGEN_.00g108390	Scaffold_05	11125053	11125616	NA	NA	NA	NA	NA
PGEN_.00g108400	Scaffold_05	11126815	11127180	NA	NA	NA	NA	NA
PGEN_.00g108410	Scaffold_05	11127363	11128358	NA	NA	NA	NA	NA
PGEN_.00g108420	Scaffold_05	11148101	11156745	P18052	PTPRA_MOUSE	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28)	GO:0004725; GO:0005886; GO:0006468; GO:0006470; GO:0008286; GO:0043231; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0098685; GO:0099699	integral component of synaptic membrane [GO:0099699]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; insulin receptor signaling pathway [GO:0008286]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]
PGEN_.00g108430	Scaffold_05	11170347	11170742	NA	NA	NA	NA	NA
PGEN_.00g108440	Scaffold_05	11215195	11219068	NA	NA	NA	NA	NA
PGEN_.00g108450	Scaffold_05	11245157	11261508	O57429	UBP2_CHICK	Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2)	GO:0004843; GO:0005737; GO:0006511; GO:0016579; GO:0046872; GO:0048471; GO:0048511	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g108460	Scaffold_05	11278244	11301889	NA	NA	NA	NA	NA
PGEN_.00g108470	Scaffold_05	11310915	11311118	NA	NA	NA	NA	NA
PGEN_.00g108480	Scaffold_05	11317691	11318131	NA	NA	NA	NA	NA
PGEN_.00g108490	Scaffold_05	11321164	11322981	NA	NA	NA	NA	NA
PGEN_.00g108500	Scaffold_05	11323054	11324960	NA	NA	NA	NA	NA
PGEN_.00g108510	Scaffold_05	11325835	11347220	B0KTX4	UBIG_PSEPG	Ubiquinone biosynthesis O-methyltransferase (2-polyprenyl-6-hydroxyphenol methylase) (EC 2.1.1.222) (3-demethylubiquinone 3-O-methyltransferase) (EC 2.1.1.64)	GO:0006744; GO:0008425; GO:0008689; GO:0032259	"2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"
PGEN_.00g108520	Scaffold_05	11355215	11357736	Q66KU2	SC61G_XENLA	Protein transport protein Sec61 subunit gamma	GO:0005789; GO:0008320; GO:0015450; GO:0016021; GO:0045047	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein transmembrane transporter activity [GO:0008320]; protein targeting to ER [GO:0045047]
PGEN_.00g108530	Scaffold_05	11375988	11376206	NA	NA	NA	NA	NA
PGEN_.00g108540	Scaffold_05	11381156	11381479	NA	NA	NA	NA	NA
PGEN_.00g108550	Scaffold_05	11392531	11408537	NA	NA	NA	NA	NA
PGEN_.00g108560	Scaffold_05	11414483	11453724	G5EBQ8	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063	cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]
PGEN_.00g108570	Scaffold_05	11477545	11485025	NA	NA	NA	NA	NA
PGEN_.00g108580	Scaffold_05	11488766	11496449	Q9UGM1	ACHA9_HUMAN	Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9)	GO:0004888; GO:0005262; GO:0005623; GO:0005886; GO:0005887; GO:0005892; GO:0007165; GO:0007204; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0042472; GO:0043005; GO:0045202; GO:0050877; GO:0050910; GO:0070373; GO:0098981; GO:0099060	acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g108590	Scaffold_05	11535092	11537090	Q7KRY7	LAP4_DROME	Protein lap4 (Protein scribble) (Protein smell-impaired)	GO:0000122; GO:0000902; GO:0001708; GO:0001737; GO:0001738; GO:0005911; GO:0005913; GO:0005918; GO:0005923; GO:0005938; GO:0007318; GO:0007391; GO:0007464; GO:0007472; GO:0007608; GO:0007613; GO:0008283; GO:0008285; GO:0008593; GO:0014069; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016332; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019991; GO:0030054; GO:0030100; GO:0030707; GO:0030714; GO:0031594; GO:0035088; GO:0042048; GO:0042058; GO:0042067; GO:0043113; GO:0045169; GO:0045175; GO:0045186; GO:0045197; GO:0045198; GO:0045202; GO:0045571; GO:0046425; GO:0048749; GO:0048863; GO:0050680; GO:0050803; GO:0051726; GO:0060581; GO:0072002; GO:0072089; GO:0097120; GO:0098609; GO:0098887; GO:0098968; GO:1990794	"apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]"
PGEN_.00g108600	Scaffold_05	11543830	11547129	NA	NA	NA	NA	NA
PGEN_.00g108610	Scaffold_05	11550637	11559353	A2TF48	MYD88_PIG	Myeloid differentiation primary response protein MyD88	GO:0002755; GO:0005634; GO:0005737; GO:0005886; GO:0006954; GO:0008063; GO:0035325; GO:0043123; GO:0045087; GO:0050830; GO:0070976	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; TIR domain binding [GO:0070976]; Toll-like receptor binding [GO:0035325]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; Toll signaling pathway [GO:0008063]
PGEN_.00g108620	Scaffold_05	11589878	11595064	NA	NA	NA	NA	NA
PGEN_.00g108630	Scaffold_05	11609124	11629435	Q5ZL67	NF2L1_CHICK	"Endoplasmic reticulum membrane sensor NFE2L1 (Nuclear factor erythroid 2-related factor 1) (NF-E2-related factor 1) (NFE2-related factor 1) (Nuclear factor, erythroid derived 2, like 1) [Cleaved into: Transcription factor NRF1]"	GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0003700; GO:0005623; GO:0005634; GO:0005737; GO:0005789; GO:0008203; GO:0008289; GO:0015485; GO:0016021; GO:0030176; GO:0034599; GO:0036003; GO:0042632; GO:0045454; GO:0045893; GO:0055088; GO:0071397; GO:0097201; GO:1901329	"cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cholesterol binding [GO:0015485]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; lipid binding [GO:0008289]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell redox homeostasis [GO:0045454]; cellular response to cholesterol [GO:0071397]; cellular response to oxidative stress [GO:0034599]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; lipid homeostasis [GO:0055088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of odontoblast differentiation [GO:1901329]"
PGEN_.00g108640	Scaffold_05	11684677	11692097	Q63699	CDK2_RAT	Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2)	GO:0000082; GO:0000122; GO:0000287; GO:0000307; GO:0000781; GO:0000793; GO:0000805; GO:0000806; GO:0002088; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005667; GO:0005737; GO:0005768; GO:0005815; GO:0005829; GO:0006281; GO:0006468; GO:0006813; GO:0007099; GO:0007265; GO:0008284; GO:0009636; GO:0010389; GO:0015030; GO:0016301; GO:0016572; GO:0018105; GO:0019904; GO:0030332; GO:0031100; GO:0032298; GO:0032355; GO:0032869; GO:0042493; GO:0043231; GO:0044877; GO:0045471; GO:0045893; GO:0046686; GO:0051301; GO:0051321; GO:0051591; GO:0051602; GO:0060968; GO:0097123; GO:0097124; GO:0097134; GO:0097135; GO:0097472	"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cyclin A1-CDK2 complex [GO:0097123]; cyclin A2-CDK2 complex [GO:0097124]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; X chromosome [GO:0000805]; Y chromosome [GO:0000806]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; animal organ regeneration [GO:0031100]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; centriole replication [GO:0007099]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; histone phosphorylation [GO:0016572]; lens development in camera-type eye [GO:0002088]; meiotic cell cycle [GO:0051321]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-dependent DNA replication initiation [GO:0032298]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion transport [GO:0006813]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene silencing [GO:0060968]; response to cadmium ion [GO:0046686]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to toxic substance [GO:0009636]"
PGEN_.00g108650	Scaffold_05	11695845	11702691	NA	NA	NA	NA	NA
PGEN_.00g108660	Scaffold_05	11702763	11731872	Q9QXL7	NDK7_RAT	Nucleoside diphosphate kinase 7 (NDK 7) (NDP kinase 7) (EC 2.7.4.6) (nm23-R7)	GO:0003351; GO:0004550; GO:0005524; GO:0005576; GO:0005813; GO:0006183; GO:0006228; GO:0006241; GO:0007368; GO:0007420; GO:0036064; GO:0042073; GO:0046872; GO:0060830; GO:0060972; GO:1990830	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; brain development [GO:0007420]; cellular response to leukemia inhibitory factor [GO:1990830]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; CTP biosynthetic process [GO:0006241]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; UTP biosynthetic process [GO:0006228]
PGEN_.00g108670	Scaffold_05	11788432	11828492	NA	NA	NA	NA	NA
PGEN_.00g108680	Scaffold_05	11838730	11862665	NA	NA	NA	NA	NA
PGEN_.00g108690	Scaffold_05	11866610	11866960	NA	NA	NA	NA	NA
PGEN_.00g108700	Scaffold_05	11889536	11890080	NA	NA	NA	NA	NA
PGEN_.00g108710	Scaffold_05	11893400	11897730	NA	NA	NA	NA	NA
PGEN_.00g108720	Scaffold_05	11905756	11905965	NA	NA	NA	NA	NA
PGEN_.00g108730	Scaffold_05	11906140	11906535	NA	NA	NA	NA	NA
PGEN_.00g108740	Scaffold_05	11906898	11907326	NA	NA	NA	NA	NA
PGEN_.00g108750	Scaffold_05	11907397	11907639	NA	NA	NA	NA	NA
PGEN_.00g108760	Scaffold_05	11907801	11908184	NA	NA	NA	NA	NA
PGEN_.00g108770	Scaffold_05	11972974	11982072	Q9P959	AOX_EMENI	"Alternative oxidase, mitochondrial (EC 1.-.-.-)"	GO:0005739; GO:0005743; GO:0009916; GO:0010230; GO:0016021; GO:0046872; GO:0070469	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; alternative oxidase activity [GO:0009916]; metal ion binding [GO:0046872]; alternative respiration [GO:0010230]
PGEN_.00g108780	Scaffold_05	11995293	12034570	Q8C761	WDR60_MOUSE	WD repeat-containing protein 60	GO:0000242; GO:0000922; GO:0005868; GO:0005929; GO:0007018; GO:0031021; GO:0045503; GO:0045504; GO:0048704; GO:0060271; GO:0097546; GO:2000582	"ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; interphase microtubule organizing center [GO:0031021]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; microtubule-based movement [GO:0007018]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"
PGEN_.00g108790	Scaffold_05	12040667	12089918	Q3TZZ7	ESYT2_MOUSE	Extended synaptotagmin-2 (E-Syt2)	GO:0005509; GO:0005544; GO:0005887; GO:0006869; GO:0006897; GO:0008429; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0061817; GO:0140268	endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]
PGEN_.00g108800	Scaffold_05	12126721	12185082	Q10751	ACE_CHICK	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)	GO:0003081; GO:0003084; GO:0004180; GO:0005615; GO:0005886; GO:0008237; GO:0008238; GO:0008239; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0045777; GO:0060319	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidyl-peptidase activity [GO:0008239]; exopeptidase activity [GO:0008238]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]
PGEN_.00g108810	Scaffold_05	12186155	12186457	P12821	ACE_HUMAN	"Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]"	GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0008144; GO:0008217; GO:0008237; GO:0008238; GO:0008239; GO:0008240; GO:0008241; GO:0008270; GO:0009897; GO:0010608; GO:0010629; GO:0014910; GO:0016021; GO:0019229; GO:0031404; GO:0031434; GO:0031711; GO:0032091; GO:0032092; GO:0032943; GO:0042447; GO:0043171; GO:0045777; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0061098; GO:0070062; GO:0070573; GO:0071838; GO:0097746; GO:1900086; GO:1902033; GO:1903597; GO:2000170	endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; dipeptidyl-peptidase activity [GO:0008239]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel remodeling [GO:0001974]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; mononuclear cell proliferation [GO:0032943]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of blood pressure [GO:0045777]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; spermatogenesis [GO:0007283]
PGEN_.00g108820	Scaffold_05	12203072	12215120	NA	NA	NA	NA	NA
PGEN_.00g108830	Scaffold_05	12215495	12247533	P02460	CO2A1_CHICK	Collagen alpha-1(II) chain (Alpha-1 type II collagen) (Fragment)	GO:0001501; GO:0005201; GO:0005581; GO:0005585; GO:0005615; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0046872	collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; notochord development [GO:0030903]; skeletal system development [GO:0001501]
PGEN_.00g108840	Scaffold_05	12249150	12267910	Q28D99	GADL1_XENTR	Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase) (ADC) (EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase) (CSADC) (EC 4.1.1.29) (Glutamate decarboxylase-like protein 1) (Fragment)	GO:0004068; GO:0004782; GO:0019752; GO:0030170	aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]
PGEN_.00g108850	Scaffold_05	12270886	12271678	NA	NA	NA	NA	NA
PGEN_.00g108860	Scaffold_05	12277392	12323701	P12107	COBA1_HUMAN	Collagen alpha-1(XI) chain	GO:0001502; GO:0001503; GO:0002063; GO:0005201; GO:0005576; GO:0005592; GO:0005615; GO:0005788; GO:0006029; GO:0007601; GO:0007605; GO:0008201; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0035987; GO:0035989; GO:0042472; GO:0046872; GO:0048704; GO:0050840; GO:0050910; GO:0055010; GO:0062023; GO:1904399	"collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; cartilage condensation [GO:0001502]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601]"
PGEN_.00g108870	Scaffold_05	12332988	12333347	NA	NA	NA	NA	NA
PGEN_.00g108880	Scaffold_05	12388511	12388804	NA	NA	NA	NA	NA
PGEN_.00g108890	Scaffold_05	12442850	12451272	Q54I71	AARA_DICDI	Protein aardvark (Suppressor of amiB protein 16)	GO:0003382; GO:0005737; GO:0005813; GO:0005911; GO:0005912; GO:0007155; GO:0007275; GO:0009306; GO:0010468; GO:0031150; GO:0031154; GO:0034613; GO:0036360; GO:0044671; GO:0045180; GO:0045294; GO:0048870; GO:0051495; GO:0051642; GO:0051645; GO:0061245	adherens junction [GO:0005912]; basal cortex [GO:0045180]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; alpha-catenin binding [GO:0045294]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; culmination involved in sorocarp development [GO:0031154]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of bipolar cell polarity [GO:0061245]; Golgi localization [GO:0051645]; multicellular organism development [GO:0007275]; positive regulation of cytoskeleton organization [GO:0051495]; protein secretion [GO:0009306]; regulation of gene expression [GO:0010468]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk development [GO:0031150]; sorocarp stalk morphogenesis [GO:0036360]
PGEN_.00g108900	Scaffold_05	12453496	12458037	NA	NA	NA	NA	NA
PGEN_.00g108910	Scaffold_05	12461919	12475087	Q923P0	COKA1_MOUSE	Collagen alpha-1(XX) chain	GO:0003429; GO:0005581; GO:0005615; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g108920	Scaffold_05	12481944	12493520	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g108930	Scaffold_05	12498838	12518028	NA	NA	NA	NA	NA
PGEN_.00g108940	Scaffold_05	12521817	12528440	NA	NA	NA	NA	NA
PGEN_.00g108950	Scaffold_05	12535006	12545182	NA	NA	NA	NA	NA
PGEN_.00g108960	Scaffold_05	12588311	12589605	NA	NA	NA	NA	NA
PGEN_.00g108970	Scaffold_05	12608343	12635965	NA	NA	NA	NA	NA
PGEN_.00g108980	Scaffold_05	12649858	12669220	Q6RWA9	AT1A_TAESO	Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha) (TNaK1-alpha)	GO:0005391; GO:0005524; GO:0005886; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391]
PGEN_.00g108990	Scaffold_05	12700433	12717251	Q6PFM4	LNPB_DANRE	Endoplasmic reticulum junction formation protein lunapark-B (ER junction formation factor lunapark)	GO:0030176; GO:0042802; GO:0046872; GO:0071782; GO:0071786; GO:0071788; GO:0098826; GO:1903373	endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]
PGEN_.00g109000	Scaffold_05	12728889	12731711	NA	NA	NA	NA	NA
PGEN_.00g109010	Scaffold_05	12749457	12749852	NA	NA	NA	NA	NA
PGEN_.00g109020	Scaffold_05	12757549	12758391	Q4WBL2	GNT1_ASPFU	Glucose N-acetyltransferase 1 (EC 2.4.1.-) (N-acetylglucosaminyltransferase)	GO:0000139; GO:0005774; GO:0006487; GO:0008375; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; acetylglucosaminyltransferase activity [GO:0008375]; protein N-linked glycosylation [GO:0006487]
PGEN_.00g109030	Scaffold_05	12767124	12767345	NA	NA	NA	NA	NA
PGEN_.00g109040	Scaffold_05	12775105	12775989	Q4HVS2	GNT1_GIBZE	Glucose N-acetyltransferase 1 (EC 2.4.1.-) (N-acetylglucosaminyltransferase)	GO:0000139; GO:0005774; GO:0006487; GO:0008375; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; acetylglucosaminyltransferase activity [GO:0008375]; protein N-linked glycosylation [GO:0006487]
PGEN_.00g109050	Scaffold_05	12791442	12799818	NA	NA	NA	NA	NA
PGEN_.00g109060	Scaffold_05	12807657	12847179	Q7Z407	CSMD3_HUMAN	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g109070	Scaffold_05	12900656	12925371	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g109080	Scaffold_05	12925421	12965069	Q7Z407	CSMD3_HUMAN	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g109090	Scaffold_05	13002729	13008836	P18142	D2_DICDI	cAMP-regulated D2 protein	GO:0005938; GO:0033118; GO:0052689	cell cortex [GO:0005938]; esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689]
PGEN_.00g109100	Scaffold_05	13012216	13033629	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g109110	Scaffold_05	13088067	13099316	P36633	AOC1_RAT	Amiloride-sensitive amine oxidase [copper-containing] (DAO) (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase)	GO:0005507; GO:0005509; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008144; GO:0008201; GO:0008270; GO:0009308; GO:0035874; GO:0042493; GO:0042803; GO:0044877; GO:0046677; GO:0048038; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0055114; GO:0070062; GO:0071280; GO:0071420; GO:0097185	"bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; drug binding [GO:0008144]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]; amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to histamine [GO:0071420]; oxidation-reduction process [GO:0055114]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]"
PGEN_.00g109120	Scaffold_05	13103629	13104207	P19801	AOC1_HUMAN	Amiloride-sensitive amine oxidase [copper-containing] (DAO) (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase) (Kidney amine oxidase) (KAO)	GO:0005507; GO:0005509; GO:0005576; GO:0005615; GO:0005777; GO:0005886; GO:0005923; GO:0006805; GO:0008131; GO:0008144; GO:0008201; GO:0008270; GO:0009308; GO:0035580; GO:0035874; GO:0042493; GO:0042803; GO:0043312; GO:0044877; GO:0046677; GO:0048038; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0055114; GO:0070062; GO:0071280; GO:0071420; GO:0071504; GO:0097185	"bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; drug binding [GO:0008144]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]; amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to heparin [GO:0071504]; cellular response to histamine [GO:0071420]; neutrophil degranulation [GO:0043312]; oxidation-reduction process [GO:0055114]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g109130	Scaffold_05	13114060	13121554	P48159	RL23_DROME	60S ribosomal protein L23 (L17A)	GO:0002181; GO:0003735; GO:0017022; GO:0022625; GO:0070180	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]
PGEN_.00g109140	Scaffold_05	13172818	13195398	NA	NA	NA	NA	NA
PGEN_.00g109150	Scaffold_05	13234393	13259495	Q8BTI9	PK3CB_MOUSE	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta)"	GO:0001935; GO:0001952; GO:0005524; GO:0005623; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006874; GO:0006897; GO:0006914; GO:0007156; GO:0009611; GO:0010628; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0030168; GO:0030496; GO:0031526; GO:0033031; GO:0035005; GO:0036092; GO:0040016; GO:0043231; GO:0043560; GO:0046854; GO:0046934; GO:0048015; GO:0052812; GO:0060055	"brush border membrane [GO:0031526]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; regulation of cell-matrix adhesion [GO:0001952]; response to wounding [GO:0009611]"
PGEN_.00g109160	Scaffold_05	13290318	13296586	Q9VBW3	CAD96_DROME	Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)	GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005887; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303	apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]
PGEN_.00g109170	Scaffold_05	13317306	13318685	NA	NA	NA	NA	NA
PGEN_.00g109180	Scaffold_05	13318816	13319826	NA	NA	NA	NA	NA
PGEN_.00g109190	Scaffold_05	13319884	13334825	NA	NA	NA	NA	NA
PGEN_.00g109200	Scaffold_05	13339760	13340901	NA	NA	NA	NA	NA
PGEN_.00g109210	Scaffold_05	13348834	13361128	NA	NA	NA	NA	NA
PGEN_.00g109220	Scaffold_05	13369986	13375031	Q0IIV2	RHBG_XENTR	Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein) (Rh family type B glycoprotein) (Rh type B glycoprotein)	GO:0005887; GO:0008519; GO:0016323; GO:0030659; GO:0072488	basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]
PGEN_.00g109230	Scaffold_05	13377571	13409304	Q95JD3	RHCG_RABIT	Ammonium transporter Rh type C (Rhesus blood group family type C glycoprotein) (Rh family type C glycoprotein) (Rh type C glycoprotein)	GO:0008519; GO:0015696; GO:0016021; GO:0016324; GO:0031410	apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transport [GO:0015696]
PGEN_.00g109240	Scaffold_05	13423415	13423711	NA	NA	NA	NA	NA
PGEN_.00g109250	Scaffold_05	13511531	13520155	Q92110	CP1A1_ONCMY	Cytochrome P450 1A1 (EC 1.14.14.1) (CYP1A2) (CYPIA1)	GO:0005506; GO:0005623; GO:0005720; GO:0005737; GO:0005789; GO:0005790; GO:0005791; GO:0009925; GO:0020037; GO:0031528; GO:0031965; GO:0048471; GO:0070330; GO:0071615	basal plasma membrane [GO:0009925]; cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; microvillus membrane [GO:0031528]; nuclear heterochromatin [GO:0005720]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidative deethylation [GO:0071615]
PGEN_.00g109260	Scaffold_05	13526713	13577068	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g109270	Scaffold_05	13577841	13578248	NA	NA	NA	NA	NA
PGEN_.00g109280	Scaffold_05	13579083	13579304	NA	NA	NA	NA	NA
PGEN_.00g109290	Scaffold_05	13635088	13637128	NA	NA	NA	NA	NA
PGEN_.00g109300	Scaffold_05	13654469	13669260	Q0IIV2	RHBG_XENTR	Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein) (Rh family type B glycoprotein) (Rh type B glycoprotein)	GO:0005887; GO:0008519; GO:0016323; GO:0030659; GO:0072488	basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]
PGEN_.00g109310	Scaffold_05	13712425	13715285	NA	NA	NA	NA	NA
PGEN_.00g109320	Scaffold_05	13716955	13718049	Q20681	BAT38_CAEEL	BTB and MATH domain-containing protein 38		
PGEN_.00g109330	Scaffold_05	13746974	13794800	Q96IG2	FXL20_HUMAN	F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like)	GO:0000209; GO:0001662; GO:0005829; GO:0006511; GO:0019005; GO:0031146; GO:0043687; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g109340	Scaffold_05	13809750	13825979	Q9Y575	ASB3_HUMAN	Ankyrin repeat and SOCS box protein 3 (ASB-3)	GO:0005829; GO:0016567; GO:0035556; GO:0043687	cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]
PGEN_.00g109350	Scaffold_05	13826018	13831490	NA	NA	NA	NA	NA
PGEN_.00g109360	Scaffold_05	13832630	13844743	NA	NA	NA	NA	NA
PGEN_.00g109370	Scaffold_05	13857812	13859110	NA	NA	NA	NA	NA
PGEN_.00g109380	Scaffold_05	13865203	13871467	Q7Z449	CP2U1_HUMAN	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330; GO:0097267	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g109390	Scaffold_05	13871493	13872233	NA	NA	NA	NA	NA
PGEN_.00g109400	Scaffold_05	13872258	13872899	NA	NA	NA	NA	NA
PGEN_.00g109410	Scaffold_05	13877618	13877956	NA	NA	NA	NA	NA
PGEN_.00g109420	Scaffold_05	13883051	13883389	NA	NA	NA	NA	NA
PGEN_.00g109430	Scaffold_05	13885581	13896929	NA	NA	NA	NA	NA
PGEN_.00g109440	Scaffold_05	13902387	13903480	NA	NA	NA	NA	NA
PGEN_.00g109450	Scaffold_05	13905666	13906856	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g109460	Scaffold_05	13906902	13907570	NA	NA	NA	NA	NA
PGEN_.00g109470	Scaffold_05	13918203	13930784	NA	NA	NA	NA	NA
PGEN_.00g109480	Scaffold_05	13932777	13939973	NA	NA	NA	NA	NA
PGEN_.00g109490	Scaffold_05	13984881	13986575	NA	NA	NA	NA	NA
PGEN_.00g109500	Scaffold_05	13987170	13987592	NA	NA	NA	NA	NA
PGEN_.00g109510	Scaffold_05	13988126	14003310	NA	NA	NA	NA	NA
PGEN_.00g109520	Scaffold_05	14014353	14019370	NA	NA	NA	NA	NA
PGEN_.00g109530	Scaffold_05	14029643	14040010	NA	NA	NA	NA	NA
PGEN_.00g109540	Scaffold_05	14043851	14065973	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g109550	Scaffold_05	14068287	14087824	P13596	NCAM1_RAT	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	GO:0001928; GO:0005104; GO:0005886; GO:0005911; GO:0007155; GO:0007166; GO:0007413; GO:0007568; GO:0007611; GO:0008092; GO:0008201; GO:0009897; GO:0009986; GO:0010035; GO:0010288; GO:0014012; GO:0014823; GO:0016338; GO:0019902; GO:0021794; GO:0030275; GO:0030424; GO:0030426; GO:0031100; GO:0031175; GO:0033555; GO:0034109; GO:0042220; GO:0042493; GO:0042802; GO:0043025; GO:0048666; GO:0050804; GO:0050850; GO:0051930; GO:0060045; GO:0060548; GO:0071219; GO:0071241; GO:0071679; GO:0098685; GO:0098978; GO:0099055; GO:0099056; GO:2001260	axon [GO:0030424]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cytoskeletal protein binding [GO:0008092]; fibroblast growth factor receptor binding [GO:0005104]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; phosphatase binding [GO:0019902]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; axonal fasciculation [GO:0007413]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; commissural neuron axon guidance [GO:0071679]; homotypic cell-cell adhesion [GO:0034109]; learning or memory [GO:0007611]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of exocyst assembly [GO:0001928]; regulation of semaphorin-plexin signaling pathway [GO:2001260]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]
PGEN_.00g109560	Scaffold_05	14090592	14092019	NA	NA	NA	NA	NA
PGEN_.00g109570	Scaffold_05	14092187	14092759	NA	NA	NA	NA	NA
PGEN_.00g109580	Scaffold_05	14093618	14114563	NA	NA	NA	NA	NA
PGEN_.00g109590	Scaffold_05	14130722	14132693	NA	NA	NA	NA	NA
PGEN_.00g109600	Scaffold_05	14133950	14136809	NA	NA	NA	NA	NA
PGEN_.00g109610	Scaffold_05	14141720	14145445	NA	NA	NA	NA	NA
PGEN_.00g109620	Scaffold_05	14156666	14156950	NA	NA	NA	NA	NA
PGEN_.00g109630	Scaffold_05	14157944	14162831	NA	NA	NA	NA	NA
PGEN_.00g109640	Scaffold_05	14194492	14201153	NA	NA	NA	NA	NA
PGEN_.00g109650	Scaffold_05	14201280	14228561	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g109660	Scaffold_05	14240768	14241745	NA	NA	NA	NA	NA
PGEN_.00g109670	Scaffold_05	14250337	14261542	NA	NA	NA	NA	NA
PGEN_.00g109680	Scaffold_05	14296993	14319029	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g109690	Scaffold_05	14341880	14349038	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g109700	Scaffold_05	14370079	14370384	NA	NA	NA	NA	NA
PGEN_.00g109710	Scaffold_05	14381790	14383679	NA	NA	NA	NA	NA
PGEN_.00g109720	Scaffold_05	14384117	14384551	NA	NA	NA	NA	NA
PGEN_.00g109730	Scaffold_05	14386194	14390487	NA	NA	NA	NA	NA
PGEN_.00g109740	Scaffold_05	14391271	14396373	NA	NA	NA	NA	NA
PGEN_.00g109750	Scaffold_05	14422195	14434330	NA	NA	NA	NA	NA
PGEN_.00g109760	Scaffold_05	14434357	14457964	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g109770	Scaffold_05	14491629	14491898	NA	NA	NA	NA	NA
PGEN_.00g109780	Scaffold_05	14503609	14503998	NA	NA	NA	NA	NA
PGEN_.00g109790	Scaffold_05	14504303	14505284	NA	NA	NA	NA	NA
PGEN_.00g109800	Scaffold_05	14522799	14533883	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g109810	Scaffold_05	14535433	14536250	NA	NA	NA	NA	NA
PGEN_.00g109820	Scaffold_05	14544381	14576826	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g109830	Scaffold_05	14591587	14598456	NA	NA	NA	NA	NA
PGEN_.00g109840	Scaffold_05	14629824	14630159	NA	NA	NA	NA	NA
PGEN_.00g109850	Scaffold_05	14642610	14673692	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g109860	Scaffold_05	14693901	14712086	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g109870	Scaffold_05	14716046	14716357	NA	NA	NA	NA	NA
PGEN_.00g109880	Scaffold_05	14732887	14743159	NA	NA	NA	NA	NA
PGEN_.00g109890	Scaffold_05	14745600	14746286	NA	NA	NA	NA	NA
PGEN_.00g109900	Scaffold_05	14755398	14756764	NA	NA	NA	NA	NA
PGEN_.00g109910	Scaffold_05	14845924	14882716	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g109920	Scaffold_05	14898965	14912316	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g109930	Scaffold_05	14915245	14917828	NA	NA	NA	NA	NA
PGEN_.00g109940	Scaffold_05	14934121	14951318	NA	NA	NA	NA	NA
PGEN_.00g109950	Scaffold_05	14974785	14975132	NA	NA	NA	NA	NA
PGEN_.00g109960	Scaffold_05	14975217	14975657	NA	NA	NA	NA	NA
PGEN_.00g109970	Scaffold_05	15002740	15028475	NA	NA	NA	NA	NA
PGEN_.00g109980	Scaffold_05	15062311	15062670	NA	NA	NA	NA	NA
PGEN_.00g109990	Scaffold_05	15074577	15081813	NA	NA	NA	NA	NA
PGEN_.00g110000	Scaffold_05	15100227	15101091	NA	NA	NA	NA	NA
PGEN_.00g110010	Scaffold_05	15142627	15179609	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g110020	Scaffold_05	15190536	15191441	NA	NA	NA	NA	NA
PGEN_.00g110030	Scaffold_05	15196819	15237385	NA	NA	NA	NA	NA
PGEN_.00g110040	Scaffold_05	15239795	15283665	NA	NA	NA	NA	NA
PGEN_.00g110050	Scaffold_05	15290927	15308478	Q60528	MUC1_MESAU	Mucin-1 (MUC-1) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]	GO:0005634; GO:0005737; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]
PGEN_.00g110060	Scaffold_05	15354549	15361961	A7RWD2	CIAO1_NEMVE	Probable cytosolic iron-sulfur protein assembly protein CIAO1 homolog	GO:0016226; GO:0097361	CIA complex [GO:0097361]; iron-sulfur cluster assembly [GO:0016226]
PGEN_.00g110070	Scaffold_05	15362057	15370123	Q5E9C0	RSU1_BOVIN	Ras suppressor protein 1 (Rsu-1)		
PGEN_.00g110080	Scaffold_05	15371923	15372687	NA	NA	NA	NA	NA
PGEN_.00g110090	Scaffold_05	15372913	15373464	NA	NA	NA	NA	NA
PGEN_.00g110100	Scaffold_05	15401409	15416501	NA	NA	NA	NA	NA
PGEN_.00g110110	Scaffold_05	15457372	15458116	NA	NA	NA	NA	NA
PGEN_.00g110120	Scaffold_05	15466924	15468021	NA	NA	NA	NA	NA
PGEN_.00g110130	Scaffold_05	15485271	15490307	Q8N9F8	ZN454_HUMAN	Zinc finger protein 454	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g110140	Scaffold_05	15503344	15508363	P51523	ZNF84_HUMAN	Zinc finger protein 84 (Zinc finger protein HPF2)	GO:0003677; GO:0005634; GO:0006355; GO:0008270	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g110150	Scaffold_05	15521281	15528273	NA	NA	NA	NA	NA
PGEN_.00g110160	Scaffold_05	15528541	15534741	NA	NA	NA	NA	NA
PGEN_.00g110170	Scaffold_05	15537431	15562692	NA	NA	NA	NA	NA
PGEN_.00g110180	Scaffold_05	15565244	15565681	NA	NA	NA	NA	NA
PGEN_.00g110190	Scaffold_05	15565735	15566052	NA	NA	NA	NA	NA
PGEN_.00g110200	Scaffold_05	15568641	15571748	NA	NA	NA	NA	NA
PGEN_.00g110210	Scaffold_05	15578740	15586662	O43822	CF410_HUMAN	Cilia- and flagella-associated protein 410 (C21orf-HUMF09G8.5) (Leucine-rich repeat-containing protein 76) (YF5/A2)	GO:0001750; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0007010; GO:0008360; GO:0032391; GO:0036064; GO:0042769; GO:0043231; GO:0060271	"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response, detection of DNA damage [GO:0042769]; regulation of cell shape [GO:0008360]"
PGEN_.00g110220	Scaffold_05	15597226	15608400	Q4R5T4	RNF32_MACFA	RING finger protein 32	GO:0005737; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]
PGEN_.00g110230	Scaffold_05	15608588	15638177	P79769	TSN_CHICK	Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO)	GO:0003697; GO:0003723; GO:0004521; GO:0005634; GO:0005737; GO:0043565	cytoplasm [GO:0005737]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]
PGEN_.00g110240	Scaffold_05	15645817	15656463	A8MXY4	ZNF99_HUMAN	Zinc finger protein 99	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g110250	Scaffold_05	15656818	15665071	Q6DGL7	TM147_DANRE	Transmembrane protein 147	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g110260	Scaffold_05	15669855	15764255	Q39565	DYHB_CHLRE	"Dynein beta chain, flagellar outer arm"	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]
PGEN_.00g110270	Scaffold_05	15780747	15781457	Q9EQC0	CHST1_MOUSE	Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST)	GO:0000139; GO:0001517; GO:0005802; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0042339; GO:0045130	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g110280	Scaffold_05	15809001	15817485	Q6DBY2	NAA50_DANRE	N-alpha-acetyltransferase 50 (EC 2.3.1.258) (N-acetyltransferase NAT13) (N-epsilon-acetyltransferase 50) (EC 2.3.1.-) (NatE catalytic subunit)	GO:0001756; GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0010485; GO:0016573; GO:0031415; GO:0034087; GO:0052858; GO:0071962	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]; somitogenesis [GO:0001756]"
PGEN_.00g110290	Scaffold_05	15820167	15820508	NA	NA	NA	NA	NA
PGEN_.00g110300	Scaffold_05	15830838	15831958	NA	NA	NA	NA	NA
PGEN_.00g110310	Scaffold_05	15834035	15835736	NA	NA	NA	NA	NA
PGEN_.00g110320	Scaffold_05	15837450	15843198	NA	NA	NA	NA	NA
PGEN_.00g110330	Scaffold_05	15843293	15851726	Q4KMG0	CDON_HUMAN	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0001708; GO:0002088; GO:0005886; GO:0005887; GO:0007155; GO:0007224; GO:0007520; GO:0009952; GO:0010172; GO:0014816; GO:0021987; GO:0043393; GO:0043410; GO:0045663; GO:0045666; GO:0045944; GO:0048643; GO:0051057; GO:0051149; GO:0060059; GO:2000179	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anterior/posterior pattern specification [GO:0009952]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cerebral cortex development [GO:0021987]; embryonic body morphogenesis [GO:0010172]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; lens development in camera-type eye [GO:0002088]; myoblast fusion [GO:0007520]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein binding [GO:0043393]; skeletal muscle satellite cell differentiation [GO:0014816]; smoothened signaling pathway [GO:0007224]
PGEN_.00g110340	Scaffold_05	15960532	15963175	NA	NA	NA	NA	NA
PGEN_.00g110350	Scaffold_05	15963487	15963858	NA	NA	NA	NA	NA
PGEN_.00g110360	Scaffold_05	16056809	16075853	P60330	ESPL1_MOUSE	Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)	GO:0000070; GO:0000212; GO:0000278; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0007059; GO:0007127; GO:0008233; GO:0008234; GO:0045143; GO:0051307; GO:0072686	centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; chromosome segregation [GO:0007059]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]
PGEN_.00g110370	Scaffold_05	16081237	16094954	A1L209	AT7L3_DANRE	Ataxin-7-like protein 3 (SAGA-associated factor 11 homolog)	GO:0000124; GO:0003713; GO:0008270; GO:0016578; GO:0045893; GO:0071819	"DUBm complex [GO:0071819]; SAGA complex [GO:0000124]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; histone deubiquitination [GO:0016578]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g110380	Scaffold_05	16095747	16123754	Q16534	HLF_HUMAN	Hepatic leukemia factor	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0006366; GO:0007275; GO:0035914; GO:0043565; GO:0045944; GO:0048511	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g110390	Scaffold_05	16144484	16144696	NA	NA	NA	NA	NA
PGEN_.00g110400	Scaffold_05	16144959	16158627	NA	NA	NA	NA	NA
PGEN_.00g110410	Scaffold_05	16185116	16185430	NA	NA	NA	NA	NA
PGEN_.00g110420	Scaffold_05	16196117	16196446	NA	NA	NA	NA	NA
PGEN_.00g110430	Scaffold_05	16229234	16250661	A4GFB7	PROCA_OLEEU	Profilin-2 (Pollen allergen Ole e 2) (allergen Ole e 2)	GO:0003779; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]
PGEN_.00g110440	Scaffold_05	16259343	16286377	P34897	GLYM_HUMAN	"Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)"	GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006544; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0015630; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0046653; GO:0046655; GO:0050897; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715; GO:1904482	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]
PGEN_.00g110450	Scaffold_05	16307711	16308288	NA	NA	NA	NA	NA
PGEN_.00g110460	Scaffold_05	16312028	16326092	NA	NA	NA	NA	NA
PGEN_.00g110470	Scaffold_05	16329439	16340451	Q8BGD4	SO4C1_MOUSE	Solute carrier organic anion transporter family member 4C1 (Oatp-R) (Solute carrier family 21 member 20)	GO:0005887; GO:0007275; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016021; GO:0016323; GO:0030154; GO:0043252	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]
PGEN_.00g110480	Scaffold_05	16345638	16346180	NA	NA	NA	NA	NA
PGEN_.00g110490	Scaffold_05	16361928	16391494	Q90632	MOT3_CHICK	Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8)	GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g110500	Scaffold_05	16403020	16430797	Q8K1C7	MOT14_MOUSE	Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g110510	Scaffold_05	16526975	16540381	Q5ZI69	RM37_CHICK	"39S ribosomal protein L37, mitochondrial (L37mt) (MRP-L37)"	GO:0003735; GO:0005739; GO:0005762; GO:0006412	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g110520	Scaffold_05	16545003	16545923	Q7Z6M4	MTEF4_HUMAN	"Transcription termination factor 4, mitochondrial (Mitochondrial transcription termination factor 4) (mTERF domain-containing protein 2) [Cleaved into: mTERF domain-containing protein 2 processed]"	GO:0003690; GO:0005739; GO:0005759; GO:0005762; GO:0005829; GO:0006355; GO:0006390; GO:0006626; GO:0007507; GO:0019843; GO:0031167; GO:0032543; GO:0043010; GO:0061668	"cytosol [GO:0005829]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; double-stranded DNA binding [GO:0003690]; rRNA binding [GO:0019843]; camera-type eye development [GO:0043010]; heart development [GO:0007507]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial transcription [GO:0006390]; mitochondrial translation [GO:0032543]; protein targeting to mitochondrion [GO:0006626]; regulation of transcription, DNA-templated [GO:0006355]; rRNA methylation [GO:0031167]"
PGEN_.00g110530	Scaffold_05	16572533	16576250	Q8NHV1	GIMA7_HUMAN	GTPase IMAP family member 7 (Immunity-associated nucleotide 7 protein) (IAN-7)	GO:0003924; GO:0005525; GO:0005783; GO:0005794; GO:0005811; GO:0005829; GO:0042802; GO:0042803; GO:0043231; GO:0046039	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; GTP metabolic process [GO:0046039]
PGEN_.00g110540	Scaffold_05	16585033	16585284	NA	NA	NA	NA	NA
PGEN_.00g110550	Scaffold_05	16587224	16639593	Q967D7	TUTL_DROME	Protein turtle	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0007414; GO:0007629; GO:0007638; GO:0008039; GO:0008344; GO:0016199; GO:0030424; GO:0030537; GO:0045467; GO:0048814; GO:0070593; GO:0098632	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal defasciculation [GO:0007414]; dendrite self-avoidance [GO:0070593]; flight behavior [GO:0007629]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; larval behavior [GO:0030537]; mechanosensory behavior [GO:0007638]; R7 cell development [GO:0045467]; regulation of dendrite morphogenesis [GO:0048814]; synaptic target recognition [GO:0008039]
PGEN_.00g110560	Scaffold_05	16687751	16692852	Q967D7	TUTL_DROME	Protein turtle	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0007414; GO:0007629; GO:0007638; GO:0008039; GO:0008344; GO:0016199; GO:0030424; GO:0030537; GO:0045467; GO:0048814; GO:0070593; GO:0098632	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonal defasciculation [GO:0007414]; dendrite self-avoidance [GO:0070593]; flight behavior [GO:0007629]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; larval behavior [GO:0030537]; mechanosensory behavior [GO:0007638]; R7 cell development [GO:0045467]; regulation of dendrite morphogenesis [GO:0048814]; synaptic target recognition [GO:0008039]
PGEN_.00g110570	Scaffold_05	16765702	16766052	NA	NA	NA	NA	NA
PGEN_.00g110580	Scaffold_05	16845633	16850667	P18101	RL40_DROME	Ubiquitin-60S ribosomal protein L40 (CEP52) [Cleaved into: Ubiquitin; 60S ribosomal protein L40]	GO:0002181; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006464; GO:0006511; GO:0016567; GO:0019941; GO:0022625; GO:0022627; GO:0031386; GO:0031625	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; cellular protein modification process [GO:0006464]; cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g110590	Scaffold_05	16855273	16856370	Q8N8K9	K1958_HUMAN	Uncharacterized protein KIAA1958		
PGEN_.00g110600	Scaffold_05	16856442	16856936	NA	NA	NA	NA	NA
PGEN_.00g110610	Scaffold_05	16884224	16903770	Q5ZLT7	BZW1_CHICK	Basic leucine zipper and W2 domain-containing protein 1	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g110620	Scaffold_05	16910961	16916234	NA	NA	NA	NA	NA
PGEN_.00g110630	Scaffold_05	16923868	16924260	NA	NA	NA	NA	NA
PGEN_.00g110640	Scaffold_05	16931361	16979731	Q9R044	NPHN_RAT	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0000165; GO:0003094; GO:0005886; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015	cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g110650	Scaffold_05	16988115	17013752	NA	NA	NA	NA	NA
PGEN_.00g110660	Scaffold_05	17037796	17039882	NA	NA	NA	NA	NA
PGEN_.00g110670	Scaffold_05	17079909	17084826	NA	NA	NA	NA	NA
PGEN_.00g110680	Scaffold_05	17124009	17124419	NA	NA	NA	NA	NA
PGEN_.00g110690	Scaffold_05	17135737	17136837	Q1L673	VDRB_DANRE	"Vitamin D3 receptor B (VDR-B) (1,25-dihydroxyvitamin D3 receptor B) (Nuclear receptor subfamily 1 group I member 1-B)"	GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0001947; GO:0003146; GO:0003707; GO:0004879; GO:0005499; GO:0005634; GO:0005737; GO:0006629; GO:0007275; GO:0008134; GO:0008270; GO:0030154; GO:0030374; GO:0038023; GO:0042632; GO:0045944; GO:0055088; GO:0060119; GO:0071222; GO:0071599; GO:0090575; GO:1902098	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; calcitriol binding [GO:1902098]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner ear receptor cell development [GO:0060119]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; otic vesicle development [GO:0071599]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g110700	Scaffold_05	17149148	17195094	G5EFF5	DAF12_CAEEL	Nuclear hormone receptor family member daf-12 (Abnormal dauer formation protein 12)	GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0003700; GO:0004879; GO:0005634; GO:0006629; GO:0006935; GO:0007275; GO:0008134; GO:0008270; GO:0008340; GO:0009593; GO:0010035; GO:0010286; GO:0030154; GO:0030374; GO:0038023; GO:0040024; GO:0040034; GO:0042632; GO:0043051; GO:0043327; GO:0043565; GO:0045944; GO:0055088; GO:0060179; GO:0061065; GO:0061066; GO:0070781; GO:0071222; GO:0090575; GO:1902051; GO:1902052	"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; (25S)-Delta(4)-dafachronate binding [GO:1902051]; (25S)-Delta(7)-dafachronate binding [GO:1902052]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; cholesterol homeostasis [GO:0042632]; dauer larval development [GO:0040024]; detection of chemical stimulus [GO:0009593]; determination of adult lifespan [GO:0008340]; heat acclimation [GO:0010286]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; male mating behavior [GO:0060179]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dauer larval development [GO:0061066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of dauer larval development [GO:0061065]; regulation of development, heterochronic [GO:0040034]; regulation of pharyngeal pumping [GO:0043051]; response to biotin [GO:0070781]; response to inorganic substance [GO:0010035]"
PGEN_.00g110710	Scaffold_05	17207314	17207613	NA	NA	NA	NA	NA
PGEN_.00g110720	Scaffold_05	17212145	17212534	NA	NA	NA	NA	NA
PGEN_.00g110730	Scaffold_05	17213533	17213970	NA	NA	NA	NA	NA
PGEN_.00g110740	Scaffold_05	17215036	17299542	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g110750	Scaffold_05	17299684	17300190	NA	NA	NA	NA	NA
PGEN_.00g110760	Scaffold_05	17300246	17327460	Q923L3	CSMD1_MOUSE	CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)	GO:0001964; GO:0016021; GO:0042593	integral component of membrane [GO:0016021]; glucose homeostasis [GO:0042593]; startle response [GO:0001964]
PGEN_.00g110770	Scaffold_05	17328166	17349754	Q9BVL4	SELO_HUMAN	"Protein adenylyltransferase SelO, mitochondrial (EC 2.7.7.-) (EC 2.7.7.n1) (Selenoprotein O) (SelO)"	GO:0005524; GO:0005739; GO:0018117; GO:0046872; GO:0070733	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein adenylyltransferase activity [GO:0070733]; protein adenylylation [GO:0018117]
PGEN_.00g110780	Scaffold_05	17362243	17365185	NA	NA	NA	NA	NA
PGEN_.00g110790	Scaffold_05	17367083	17378940	Q1LVN8	SELO1_DANRE	"Protein adenylyltransferase SelO-1, mitochondrial (EC 2.7.7.-) (EC 2.7.7.n1) (Selenoprotein O) (SelO)"	GO:0005524; GO:0005739; GO:0016779; GO:0046872	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]
PGEN_.00g110800	Scaffold_05	17449840	17457288	P49749	EVX2_MOUSE	Homeobox even-skipped homolog protein 2 (EVX-2)	GO:0005634; GO:0006355; GO:0035108; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; limb morphogenesis [GO:0035108]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g110810	Scaffold_05	17471294	17471509	NA	NA	NA	NA	NA
PGEN_.00g110820	Scaffold_05	17475376	17504215	P53621	COPA_HUMAN	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463	"COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]; hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g110830	Scaffold_05	17631082	17664702	NA	NA	NA	NA	NA
PGEN_.00g110840	Scaffold_05	17689748	17783738	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g110850	Scaffold_05	17814795	17817892	P23253	TCNA_TRYCR	Sialidase (EC 3.2.1.18) (Major surface antigen) (Neuraminidase) (NA)	GO:0005886; GO:0008152; GO:0009405; GO:0031225; GO:0052794; GO:0052795; GO:0052796	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; metabolic process [GO:0008152]; pathogenesis [GO:0009405]
PGEN_.00g110860	Scaffold_05	17891154	17892110	NA	NA	NA	NA	NA
PGEN_.00g110870	Scaffold_05	17904624	17935486	Q90385	SHH_CYNPY	Sonic hedgehog protein (SHH) [Cleaved into: Sonic hedgehog protein N-product; Sonic hedgehog protein C-product]	GO:0005615; GO:0005886; GO:0007267; GO:0007275; GO:0008233; GO:0016539; GO:0046872	extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; multicellular organism development [GO:0007275]
PGEN_.00g110880	Scaffold_05	17961878	17964357	Q8BIV7	S45A1_MOUSE	Proton-associated sugar transporter A (PAST-A) (Deleted in neuroblastoma 5 protein homolog) (DNb-5 homolog) (Solute carrier family 45 member 1)	GO:0005355; GO:0008506; GO:0016020; GO:0016021; GO:1904659	integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose transmembrane transporter activity [GO:0005355]; sucrose:proton symporter activity [GO:0008506]; glucose transmembrane transport [GO:1904659]
PGEN_.00g110890	Scaffold_05	18028218	18033266	Q58D55	BGAL_BOVIN	Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)	GO:0004565; GO:0005764; GO:0005773; GO:0005975	lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g110900	Scaffold_05	18034817	18076980	Q9NZN5	ARHGC_HUMAN	Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF)	GO:0001664; GO:0005089; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0043065; GO:0051056; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]
PGEN_.00g110910	Scaffold_05	18049851	18050081	NA	NA	NA	NA	NA
PGEN_.00g110920	Scaffold_05	18086424	18129495	NA	NA	NA	NA	NA
PGEN_.00g110930	Scaffold_05	18133542	18179093	Q9NZN5	ARHGC_HUMAN	Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF)	GO:0001664; GO:0005089; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0043065; GO:0051056; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]
PGEN_.00g110940	Scaffold_05	18197893	18209417	Q06546	GABPA_HUMAN	GA-binding protein alpha chain (GABP subunit alpha) (Nuclear respiratory factor 2 subunit alpha) (Transcription factor E4TF1-60)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001825; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0007005; GO:0010628; GO:0030154; GO:0033613; GO:0044212; GO:0045653; GO:0045944; GO:0046982; GO:1903351	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; mitochondrion organization [GO:0007005]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g110950	Scaffold_05	18237160	18237633	NA	NA	NA	NA	NA
PGEN_.00g110960	Scaffold_05	18254038	18254421	Q02575	HEN1_HUMAN	Helix-loop-helix protein 1 (HEN-1) (Class A basic helix-loop-helix protein 35) (bHLHa35) (Nescient helix loop helix 1) (NSCL-1)	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007417; GO:0030154; GO:0045944; GO:0046983	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g110970	Scaffold_05	18269347	18294252	O88967	YMEL1_MOUSE	ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (ATP-dependent metalloprotease FtsH1) (YME1-like protein 1)	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006508; GO:0006515; GO:0007005; GO:0008283; GO:0016021; GO:0016604; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell population proliferation [GO:0008283]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]
PGEN_.00g110980	Scaffold_05	18301760	18347139	NA	NA	NA	NA	NA
PGEN_.00g110990	Scaffold_05	18355632	18355874	NA	NA	NA	NA	NA
PGEN_.00g111000	Scaffold_05	18364605	18364904	NA	NA	NA	NA	NA
PGEN_.00g111010	Scaffold_05	18365255	18382188	P61222	ABCE1_MOUSE	ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)	GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006415; GO:0016887; GO:0043024; GO:0060698; GO:0060702	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]
PGEN_.00g111020	Scaffold_05	18390848	18392766	NA	NA	NA	NA	NA
PGEN_.00g111030	Scaffold_05	18409470	18436972	NA	NA	NA	NA	NA
PGEN_.00g111040	Scaffold_05	18442129	18452499	NA	NA	NA	NA	NA
PGEN_.00g111050	Scaffold_05	18463316	18474694	NA	NA	NA	NA	NA
PGEN_.00g111060	Scaffold_05	18487005	18496384	NA	NA	NA	NA	NA
PGEN_.00g111070	Scaffold_05	18496442	18497138	NA	NA	NA	NA	NA
PGEN_.00g111080	Scaffold_05	18527857	18528606	NA	NA	NA	NA	NA
PGEN_.00g111090	Scaffold_05	18546679	18563721	NA	NA	NA	NA	NA
PGEN_.00g111100	Scaffold_05	18566855	18567628	NA	NA	NA	NA	NA
PGEN_.00g111110	Scaffold_05	18567710	18568632	NA	NA	NA	NA	NA
PGEN_.00g111120	Scaffold_05	18568740	18569063	NA	NA	NA	NA	NA
PGEN_.00g111130	Scaffold_05	18583072	18583581	NA	NA	NA	NA	NA
PGEN_.00g111140	Scaffold_05	18591333	18591803	NA	NA	NA	NA	NA
PGEN_.00g111150	Scaffold_05	18605139	18646958	Q9UJT9	FBXL7_HUMAN	F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7) (F-box protein FBL6/FBL7)	GO:0000086; GO:0000151; GO:0000209; GO:0000278; GO:0005813; GO:0005829; GO:0006511; GO:0008283; GO:0010265; GO:0010972; GO:0016567; GO:0019005; GO:0031146; GO:0043687; GO:0051301	centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g111160	Scaffold_05	18627301	18627684	NA	NA	NA	NA	NA
PGEN_.00g111170	Scaffold_05	18655107	18660170	NA	NA	NA	NA	NA
PGEN_.00g111180	Scaffold_05	18663627	18667030	NA	NA	NA	NA	NA
PGEN_.00g111190	Scaffold_05	18667684	18673518	NA	NA	NA	NA	NA
PGEN_.00g111200	Scaffold_05	18679712	18699586	O61577	KTNA1_STRPU	Katanin p60 ATPase-containing subunit A1 (Katanin p60 subunit A1) (EC 5.6.1.1) (p60 katanin)	GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007049; GO:0008017; GO:0008568; GO:0016853; GO:0016887; GO:0030496; GO:0031122; GO:0051301; GO:0097431	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]
PGEN_.00g111210	Scaffold_05	18702975	18705776	NA	NA	NA	NA	NA
PGEN_.00g111220	Scaffold_05	18712501	18739500	Q9D0D3	PAPD1_MOUSE	"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase)"	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005739; GO:0006378; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]
PGEN_.00g111230	Scaffold_05	18745636	18746042	NA	NA	NA	NA	NA
PGEN_.00g111240	Scaffold_05	18793297	18797299	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g111250	Scaffold_05	18804384	18813752	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g111260	Scaffold_05	18830488	18831102	NA	NA	NA	NA	NA
PGEN_.00g111270	Scaffold_05	18841693	18853928	Q5R4G2	PA1B2_PONAB	Platelet-activating factor acetylhydrolase IB subunit beta (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta)	GO:0003847; GO:0005737; GO:0016042	cytoplasm [GO:0005737]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; lipid catabolic process [GO:0016042]
PGEN_.00g111280	Scaffold_05	18865158	18868232	Q8N6F8	MET27_HUMAN	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)		
PGEN_.00g111290	Scaffold_05	18868710	18869048	NA	NA	NA	NA	NA
PGEN_.00g111300	Scaffold_05	18888084	18888593	NA	NA	NA	NA	NA
PGEN_.00g111310	Scaffold_05	18955728	18999372	Q9UBL0	ARP21_HUMAN	cAMP-regulated phosphoprotein 21 (ARPP-21) (Thymocyte cAMP-regulated phosphoprotein)	GO:0003676; GO:0005516; GO:0005737; GO:0034605	cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; nucleic acid binding [GO:0003676]; cellular response to heat [GO:0034605]
PGEN_.00g111320	Scaffold_05	19015761	19016240	NA	NA	NA	NA	NA
PGEN_.00g111330	Scaffold_05	19016266	19016610	Q07981	FAR1_CORAP	FMRFamide-related peptides type HF-4 (HeptaFaRP) [Cleaved into: NDPFLRFGKKSDPFLRF-amide; FMRFamide-like; ENNNGYIRF-amide; NDPFLRF-amide; QDPFLRI-amide; QDPFLRF-amide; KQDPFLRI-amide; SEPYLRF-amide; NDPYLRF-amide]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g111340	Scaffold_05	19017266	19023735	NA	NA	NA	NA	NA
PGEN_.00g111350	Scaffold_05	19028962	19031528	NA	NA	NA	NA	NA
PGEN_.00g111360	Scaffold_05	19035858	19042949	NA	NA	NA	NA	NA
PGEN_.00g111370	Scaffold_05	19043251	19044337	NA	NA	NA	NA	NA
PGEN_.00g111380	Scaffold_05	19049052	19049950	NA	NA	NA	NA	NA
PGEN_.00g111390	Scaffold_05	19061015	19096419	Q9BRI3	ZNT2_HUMAN	Zinc transporter 2 (ZnT-2) (Solute carrier family 30 member 2)	GO:0005385; GO:0005737; GO:0005765; GO:0005770; GO:0005886; GO:0010043; GO:0016021; GO:0042802; GO:0043231; GO:0061088; GO:0061090; GO:0071577	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385]; positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]
PGEN_.00g111400	Scaffold_05	19174693	19177295	NA	NA	NA	NA	NA
PGEN_.00g111410	Scaffold_05	19180434	19180877	NA	NA	NA	NA	NA
PGEN_.00g111420	Scaffold_05	19201441	19202625	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g111430	Scaffold_05	19233175	19233576	NA	NA	NA	NA	NA
PGEN_.00g111440	Scaffold_05	19236337	19238447	NA	NA	NA	NA	NA
PGEN_.00g111450	Scaffold_05	19541086	19541364	NA	NA	NA	NA	NA
PGEN_.00g111460	Scaffold_05	19637039	19637602	P10547	LSTP_STASI	Lysostaphin (EC 3.4.24.75) (Glycyl-glycine endopeptidase)	GO:0005576; GO:0008237; GO:0046872; GO:0071555	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cell wall organization [GO:0071555]
PGEN_.00g111470	Scaffold_05	19656040	19658598	NA	NA	NA	NA	NA
PGEN_.00g111480	Scaffold_05	19694871	19710945	O14929	HAT1_HUMAN	Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1)	GO:0000784; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0006323; GO:0006335; GO:0006336; GO:0006348; GO:0006475; GO:0007584; GO:0010485; GO:0016363; GO:0032991; GO:0042393; GO:0043967	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584]"
PGEN_.00g111490	Scaffold_05	19718687	19728721	NA	NA	NA	NA	NA
PGEN_.00g111500	Scaffold_05	19737309	19739240	NA	NA	NA	NA	NA
PGEN_.00g111510	Scaffold_05	19759480	19759818	NA	NA	NA	NA	NA
PGEN_.00g111520	Scaffold_05	19760633	19764943	Q6DFF7	KLH25_XENLA	Kelch-like protein 25 (Ectoderm-neural cortex protein 2) (ENC-2)	GO:0006446; GO:0006511; GO:0016567; GO:0031463	Cul3-RING ubiquitin ligase complex [GO:0031463]; protein ubiquitination [GO:0016567]; regulation of translational initiation [GO:0006446]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g111530	Scaffold_05	19778514	19779672	NA	NA	NA	NA	NA
PGEN_.00g111540	Scaffold_05	19807798	19835966	Q6GPD0	RHG32_XENLA	Rho GTPase-activating protein 32 (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS)	GO:0005096; GO:0005737; GO:0005886; GO:0007165; GO:0014069; GO:1901981	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981]; signal transduction [GO:0007165]
PGEN_.00g111550	Scaffold_05	19854504	19855004	NA	NA	NA	NA	NA
PGEN_.00g111560	Scaffold_05	19857215	19874795	Q90Z05	VNG2B_XENLA	Vang-like protein 2-B (Protein strabismus-B) (Van Gogh-like protein 2-B) (Xstrabismus-B) (Xstbm-B)	GO:0001736; GO:0005886; GO:0007399; GO:0016021; GO:0016055; GO:0060027; GO:0090090	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; convergent extension involved in gastrulation [GO:0060027]; establishment of planar polarity [GO:0001736]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; nervous system development [GO:0007399]; Wnt signaling pathway [GO:0016055]
PGEN_.00g111570	Scaffold_05	19884596	19893603	NA	NA	NA	NA	NA
PGEN_.00g111580	Scaffold_05	19893751	19913832	Q5ZIJ0	BUD13_CHICK	BUD13 homolog	GO:0000398; GO:0005634; GO:0005684; GO:0070274; GO:0071005	"nucleus [GO:0005634]; RES complex [GO:0070274]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g111590	Scaffold_05	19917161	19918520	Q9BXJ3	C1QT4_HUMAN	Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4)	GO:0005125; GO:0005615; GO:0032755; GO:0070105; GO:1901224; GO:1904469; GO:2000778	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469]
PGEN_.00g111600	Scaffold_05	19920349	19921581	Q86Z23	C1QL4_HUMAN	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g111610	Scaffold_05	19922464	19942605	Q91WR3	ASCC2_MOUSE	Activating signal cointegrator 1 complex subunit 2 (ASC-1 complex subunit p100) (Trip4 complex subunit p100)	GO:0005634; GO:0006281; GO:0006355; GO:0016607; GO:0043130; GO:0099053	"activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin binding [GO:0043130]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g111620	Scaffold_05	19999530	19999874	NA	NA	NA	NA	NA
PGEN_.00g111630	Scaffold_05	20012712	20013389	NA	NA	NA	NA	NA
PGEN_.00g111640	Scaffold_05	20023573	20027106	Q4VBD9	GZF1_MOUSE	GDNF-inducible zinc finger protein 1 (Zinc finger protein 336)	GO:0000122; GO:0000978; GO:0001227; GO:0001658; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g111650	Scaffold_05	20030246	20030500	NA	NA	NA	NA	NA
PGEN_.00g111660	Scaffold_05	20030604	20030888	NA	NA	NA	NA	NA
PGEN_.00g111670	Scaffold_05	20031909	20049836	Q9H892	TTC12_HUMAN	Tetratricopeptide repeat protein 12 (TPR repeat protein 12)	GO:0005813	centrosome [GO:0005813]
PGEN_.00g111680	Scaffold_05	20051934	20067424	Q5EA95	IFT57_BOVIN	Intraflagellar transport protein 57 homolog	GO:0003677; GO:0005794; GO:0005813; GO:0005929; GO:0006915; GO:0006919; GO:0030992; GO:0036064; GO:0042073; GO:0042981; GO:1905515	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; DNA binding [GO:0003677]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; intraciliary transport [GO:0042073]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]
PGEN_.00g111690	Scaffold_05	20069571	20075773	Q9VUJ0	RM39_DROME	"39S ribosomal protein L39, mitochondrial (MRP-L39) (MRP-L5)"	GO:0000166; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0006417; GO:0031047; GO:0032543	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; translation [GO:0006412]
PGEN_.00g111700	Scaffold_05	20080793	20081158	NA	NA	NA	NA	NA
PGEN_.00g111710	Scaffold_05	20086885	20090154	Q9JKF7	RM39_MOUSE	"39S ribosomal protein L39, mitochondrial (L39mt) (MRP-L39)"	GO:0000002; GO:0000166; GO:0003735; GO:0005739; GO:0005762; GO:0006412	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]; mitochondrial genome maintenance [GO:0000002]; translation [GO:0006412]
PGEN_.00g111720	Scaffold_05	20090382	20101999	Q9UL16	CFA45_HUMAN	Cilia- and flagella-associated protein 45 (Coiled-coil domain-containing protein 19) (Nasopharyngeal epithelium-specific protein 1)	GO:0005634; GO:0005654; GO:0005929	cilium [GO:0005929]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
PGEN_.00g111730	Scaffold_05	20109553	20121186	P31404	VATA_BOVIN	V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)	GO:0005524; GO:0005623; GO:0005774; GO:0005829; GO:0005886; GO:0006879; GO:0033180; GO:0036295; GO:0046034; GO:0046961	"cell [GO:0005623]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]"
PGEN_.00g111740	Scaffold_05	20129832	20130158	P24389	IOD1_RAT	Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)	GO:0004800; GO:0005789; GO:0006091; GO:0008430; GO:0016021; GO:0042403; GO:0042446	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; selenium binding [GO:0008430]; thyroxine 5'-deiodinase activity [GO:0004800]; generation of precursor metabolites and energy [GO:0006091]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]
PGEN_.00g111750	Scaffold_05	20130216	20130581	Q6U6H1	IOD_HALRO	Thyroxine 5'-deiodinase (EC 1.21.99.4) (Iodothyronine deiodinase)	GO:0004800; GO:0005634; GO:0016020; GO:0042446	membrane [GO:0016020]; nucleus [GO:0005634]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]
PGEN_.00g111760	Scaffold_05	20143500	20147790	Q9UJW8	ZN180_HUMAN	Zinc finger protein 180 (HHZ168)	GO:0003700; GO:0005634; GO:0043565; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]
PGEN_.00g111770	Scaffold_05	20149430	20178142	NA	NA	NA	NA	NA
PGEN_.00g111780	Scaffold_05	20188150	20191767	NA	NA	NA	NA	NA
PGEN_.00g111790	Scaffold_05	20198511	20199299	NA	NA	NA	NA	NA
PGEN_.00g111800	Scaffold_05	20205477	20225017	Q9DBG7	SRPRA_MOUSE	Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha)	GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006614; GO:0016020; GO:0045047	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]
PGEN_.00g111810	Scaffold_05	20236181	20259856	Q2KIN5	HEM3_BOVIN	Porphobilinogen deaminase (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS)	GO:0004418; GO:0005737; GO:0006782; GO:0006783; GO:0018160	cytoplasm [GO:0005737]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]
PGEN_.00g111820	Scaffold_05	20260530	20262131	Q8BT51	COA4_MOUSE	"Cytochrome c oxidase assembly factor 4 homolog, mitochondrial (Coiled-coil-helix-coiled-coil-helix domain-containing protein 8)"	GO:0005739; GO:0005758; GO:0033617	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex IV assembly [GO:0033617]
PGEN_.00g111830	Scaffold_05	20262394	20262609	Q5ZKH0	TF2H5_CHICK	General transcription factor IIH subunit 5 (General transcription factor IIH polypeptide 5) (TFB5 ortholog) (TFIIH basal transcription factor complex TTD-A subunit)	GO:0000439; GO:0000462; GO:0005654; GO:0005669; GO:0005675; GO:0005730; GO:0006281; GO:0006289; GO:0006294; GO:0006362; GO:0006366; GO:0070816; GO:0071480	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; cellular response to gamma radiation [GO:0071480]; DNA repair [GO:0006281]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]"
PGEN_.00g111840	Scaffold_05	20262829	20267444	Q7ZZ00	ZN511_DANRE	Zinc finger protein 511	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g111850	Scaffold_05	20274869	20290897	P56182	RRP1_HUMAN	Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein)	GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0030687; GO:0030688	"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]"
PGEN_.00g111860	Scaffold_05	20292784	20296105	O18638	OAF_DROVI	Out at first protein	GO:0007275	multicellular organism development [GO:0007275]
PGEN_.00g111870	Scaffold_05	20301540	20309654	NA	NA	NA	NA	NA
PGEN_.00g111880	Scaffold_05	20383375	20386499	NA	NA	NA	NA	NA
PGEN_.00g111890	Scaffold_05	20577079	20577912	NA	NA	NA	NA	NA
PGEN_.00g111900	Scaffold_05	20595619	20596928	NA	NA	NA	NA	NA
PGEN_.00g111910	Scaffold_05	20669042	20669683	NA	NA	NA	NA	NA
PGEN_.00g111920	Scaffold_05	20669912	20670451	NA	NA	NA	NA	NA
PGEN_.00g111930	Scaffold_05	20670813	20671046	NA	NA	NA	NA	NA
PGEN_.00g111940	Scaffold_05	20673220	20673468	NA	NA	NA	NA	NA
PGEN_.00g111950	Scaffold_05	20693023	20773328	P24628	DRD2A_XENLA	D(2) dopamine receptor A (D2R-A) (D2R 1)	GO:0004930; GO:0004952; GO:0005886; GO:0007195; GO:0016021; GO:0045202	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; dopamine neurotransmitter receptor activity [GO:0004952]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]
PGEN_.00g111960	Scaffold_05	20797846	20798295	NA	NA	NA	NA	NA
PGEN_.00g111970	Scaffold_05	20834351	20931219	Q8NEZ4	KMT2C_HUMAN	Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.354) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)	GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0016746; GO:0035097; GO:0042054; GO:0042393; GO:0042800; GO:0044666; GO:0045652; GO:0045944; GO:0046872	"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity, transferring acyl groups [GO:0016746]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]"
PGEN_.00g111980	Scaffold_05	20949549	20958946	NA	NA	NA	NA	NA
PGEN_.00g111990	Scaffold_05	20965310	20973730	P83565	RM40_RAT	"39S ribosomal protein L40, mitochondrial (L40mt) (MRP-L40)"	GO:0005730; GO:0005739; GO:0005761; GO:0005762	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]
PGEN_.00g112000	Scaffold_05	20974109	21047756	Q9WVF7	DPOE1_MOUSE	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)	GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539; GO:0071897	"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"
PGEN_.00g112010	Scaffold_05	21072343	21079638	NA	NA	NA	NA	NA
PGEN_.00g112020	Scaffold_05	21083587	21086998	NA	NA	NA	NA	NA
PGEN_.00g112030	Scaffold_05	21091284	21107426	Q9Y6R7	FCGBP_HUMAN	IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP)	GO:0070062	extracellular exosome [GO:0070062]
PGEN_.00g112040	Scaffold_05	21163677	21164699	NA	NA	NA	NA	NA
PGEN_.00g112050	Scaffold_05	21182432	21189698	NA	NA	NA	NA	NA
PGEN_.00g112060	Scaffold_05	21198248	21204621	Q9DGB6	TLR22_CHICK	Toll-like receptor 2 type-2	GO:0002224; GO:0002755; GO:0005887; GO:0006954; GO:0031226; GO:0034134; GO:0042494; GO:0045087; GO:0050707; GO:0050729	integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; detection of bacterial lipoprotein [GO:0042494]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g112070	Scaffold_05	21239149	21248579	O75899	GABR2_HUMAN	Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)	GO:0004965; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007194; GO:0007214; GO:0007268; GO:0030054; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0150099; GO:1902710	cell junction [GO:0030054]; cytoplasm [GO:0005737]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]
PGEN_.00g112080	Scaffold_05	21257387	21278572	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g112090	Scaffold_05	21294539	21295003	NA	NA	NA	NA	NA
PGEN_.00g112100	Scaffold_05	21359668	21368839	P53988	MOT2_MESAU	Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7)	GO:0005887; GO:0015129; GO:0015293; GO:0035873; GO:0050833; GO:1901475	integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]; lactate transmembrane transport [GO:0035873]; pyruvate transmembrane transport [GO:1901475]
PGEN_.00g112110	Scaffold_05	21389125	21392589	Q14201	BTG3_HUMAN	Protein BTG3 (Abundant in neuroepithelium area protein) (BTG family member 3) (Protein Tob5)	GO:0005634; GO:0005737; GO:0008285; GO:0045930	cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]
PGEN_.00g112120	Scaffold_05	21399156	21399762	NA	NA	NA	NA	NA
PGEN_.00g112130	Scaffold_05	21399886	21401034	NA	NA	NA	NA	NA
PGEN_.00g112140	Scaffold_05	21469329	21473057	Q5BJJ5	HDHD2_DANRE	Haloacid dehalogenase-like hydrolase domain-containing protein 2	GO:0016311; GO:0016791; GO:0046872	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]
PGEN_.00g112150	Scaffold_05	21493637	21495520	P17141	ZFP37_MOUSE	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	GO:0003700; GO:0005634; GO:0007275; GO:0007281; GO:0007283; GO:0008270; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g112160	Scaffold_05	21503497	21507597	Q08C99	VRTN_DANRE	Vertnin	GO:0000122; GO:0000785; GO:0001227	"chromatin [GO:0000785]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g112170	Scaffold_05	21507634	21508461	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g112180	Scaffold_05	21508507	21509175	NA	NA	NA	NA	NA
PGEN_.00g112190	Scaffold_05	21515241	21515981	Q9UT67	IMT2_SCHPO	Inositol phosphoceramide mannosyltransferase 2 (EC 2.4.-.-) (IPC mannosyltransferase 2)	GO:0000030; GO:0005794; GO:0016021; GO:0031501; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g112200	Scaffold_05	21527642	21544233	Q8BP00	IQCB1_MOUSE	IQ calmodulin-binding motif-containing protein 1	GO:0001750; GO:0005516; GO:0005654; GO:0005737; GO:0005813; GO:0015630; GO:0019899; GO:0032391; GO:0045171; GO:0045494; GO:0048496; GO:0060271; GO:0072686	centrosome [GO:0005813]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]
PGEN_.00g112210	Scaffold_05	21546786	21579834	O70244	CUBN_RAT	Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	GO:0001701; GO:0005509; GO:0005623; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0045177; GO:0070062	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]
PGEN_.00g112220	Scaffold_05	21605927	21621788	Q9TU53	CUBN_CANLF	Cubilin	GO:0005509; GO:0005765; GO:0005768; GO:0005905; GO:0008144; GO:0008203; GO:0015031; GO:0016324; GO:0031419; GO:0031526	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; lysosomal membrane [GO:0005765]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]
PGEN_.00g112230	Scaffold_05	21643999	21659472	O60494	CUBN_HUMAN	Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]
PGEN_.00g112240	Scaffold_05	21659679	21660104	NA	NA	NA	NA	NA
PGEN_.00g112250	Scaffold_05	21660142	21660393	NA	NA	NA	NA	NA
PGEN_.00g112260	Scaffold_05	21677363	21678292	NA	NA	NA	NA	NA
PGEN_.00g112270	Scaffold_05	21689393	21723396	Q13591	SEM5A_HUMAN	Semaphorin-5A (Semaphorin-F) (Sema F)	GO:0001938; GO:0002043; GO:0005886; GO:0007155; GO:0007162; GO:0007267; GO:0007399; GO:0007413; GO:0016020; GO:0016021; GO:0021536; GO:0030215; GO:0030836; GO:0035373; GO:0043395; GO:0045545; GO:0045766; GO:0048675; GO:0048842; GO:0048843; GO:0050918; GO:0051897; GO:0060326; GO:0070062; GO:0090263; GO:0097485; GO:1990256; GO:2000352; GO:2001028	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545]; axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neuron projection guidance [GO:0097485]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; signal clustering [GO:1990256]
PGEN_.00g112280	Scaffold_05	21875871	21876344	NA	NA	NA	NA	NA
PGEN_.00g112290	Scaffold_05	21883004	21933929	Q9BDL1	EPPI_MACMU	Eppin (Epididymal protease inhibitor) (Serine protease inhibitor-like with Kunitz and WAP domains 1)	GO:0004867; GO:0005615; GO:0010466; GO:0042742	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; defense response to bacterium [GO:0042742]; negative regulation of peptidase activity [GO:0010466]
PGEN_.00g112300	Scaffold_05	21966566	21967924	NA	NA	NA	NA	NA
PGEN_.00g112310	Scaffold_05	22001371	22047636	P15146	MTAP2_RAT	Microtubule-associated protein 2 (MAP-2)	GO:0000226; GO:0001578; GO:0002162; GO:0003779; GO:0005516; GO:0005737; GO:0005790; GO:0005791; GO:0005874; GO:0007026; GO:0007409; GO:0008017; GO:0014069; GO:0015629; GO:0015630; GO:0016358; GO:0019901; GO:0021954; GO:0030010; GO:0030425; GO:0030517; GO:0031115; GO:0031175; GO:0032355; GO:0032570; GO:0032587; GO:0032839; GO:0032991; GO:0034399; GO:0043005; GO:0043025; GO:0043194; GO:0043198; GO:0043203; GO:0044294; GO:0044297; GO:0044307; GO:0048813; GO:0071310; GO:0097441; GO:0097442; GO:0150001; GO:0150002; GO:0150014; GO:1901953; GO:1902513; GO:1902737; GO:1903744; GO:1903827; GO:1904527; GO:1990635; GO:1990769; GO:2000575	actin cytoskeleton [GO:0015629]; apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; CA3 pyramidal cell dendrite [GO:0097442]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; postsynaptic density [GO:0014069]; primary dendrite [GO:0150001]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; rough endoplasmic reticulum [GO:0005791]; ruffle membrane [GO:0032587]; smooth endoplasmic reticulum [GO:0005790]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; axonogenesis [GO:0007409]; cellular response to organic substance [GO:0071310]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; establishment of cell polarity [GO:0030010]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule motor activity [GO:2000575]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of cellular protein localization [GO:1903827]; regulation of organelle transport along microtubule [GO:1902513]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]
PGEN_.00g112320	Scaffold_05	22078244	22079821	O02828	TAU_CAPHI	Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau)	GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0008017; GO:0030424; GO:0030425	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]
PGEN_.00g112330	Scaffold_05	22096854	22097915	O02828	TAU_CAPHI	Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau)	GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0008017; GO:0030424; GO:0030425	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]
PGEN_.00g112340	Scaffold_05	22098753	22100099	NA	NA	NA	NA	NA
PGEN_.00g112350	Scaffold_05	22132107	22139083	Q9YGN6	SMUG1_XENLA	Single-strand selective monofunctional uracil DNA glycosylase (EC 3.2.2.-)	GO:0003677; GO:0005634; GO:0006284; GO:0017065	nucleus [GO:0005634]; DNA binding [GO:0003677]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; base-excision repair [GO:0006284]
PGEN_.00g112360	Scaffold_05	22145188	22150208	Q7T339	CHMP5_DANRE	Charged multivesicular body protein 5 (Chromatin-modifying protein 5)	GO:0005829; GO:0007034; GO:0010008; GO:0015031	cytosol [GO:0005829]; endosome membrane [GO:0010008]; protein transport [GO:0015031]; vacuolar transport [GO:0007034]
PGEN_.00g112370	Scaffold_05	22151751	22152293	NA	NA	NA	NA	NA
PGEN_.00g112380	Scaffold_05	22177356	22204327	P09022	HXA1_MOUSE	Homeobox protein Hox-A1 (Early retinoic acid 1) (Homeobox protein Hox-1.6) (Homeoboxless protein ERA-1-399) (Homeotic protein ERA-1-993)	GO:0005654; GO:0006357; GO:0007399; GO:0007605; GO:0007634; GO:0008045; GO:0009653; GO:0009952; GO:0021569; GO:0021570; GO:0021571; GO:0021599; GO:0021612; GO:0021754; GO:0021953; GO:0030902; GO:0042472; GO:0042473; GO:0042802; GO:0043565; GO:0045944; GO:0048646; GO:0048702; GO:0048839; GO:0048844; GO:0050795; GO:0050890; GO:0050905; GO:0060840; GO:0060876; GO:0071300; GO:0071361; GO:0090102; GO:0090103	nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; sequence-specific DNA binding [GO:0043565]; abducens nerve formation [GO:0021599]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; artery morphogenesis [GO:0048844]; cellular response to ethanol [GO:0071361]; cellular response to retinoic acid [GO:0071300]; central nervous system neuron differentiation [GO:0021953]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; cognition [GO:0050890]; embryonic neurocranium morphogenesis [GO:0048702]; facial nerve structural organization [GO:0021612]; facial nucleus development [GO:0021754]; hindbrain development [GO:0030902]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; neuromuscular process [GO:0050905]; optokinetic behavior [GO:0007634]; outer ear morphogenesis [GO:0042473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of behavior [GO:0050795]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere 3 development [GO:0021569]; rhombomere 4 development [GO:0021570]; rhombomere 5 development [GO:0021571]; semicircular canal formation [GO:0060876]; sensory perception of sound [GO:0007605]
PGEN_.00g112390	Scaffold_05	22235741	22236028	NA	NA	NA	NA	NA
PGEN_.00g112400	Scaffold_05	22288760	22323602	O42365	HXA2B_DANRE	Homeobox protein Hox-A2b (Hox-A2)	GO:0000122; GO:0000978; GO:0003700; GO:0005634; GO:0007275; GO:0045944	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g112410	Scaffold_05	22384464	22399453	P50901	HOX3_BRAFL	Homeobox protein HOX3	GO:0003700; GO:0005634; GO:0007275; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]
PGEN_.00g112420	Scaffold_05	22399540	22456325	NA	NA	NA	NA	NA
PGEN_.00g112430	Scaffold_05	22431733	22432050	NA	NA	NA	NA	NA
PGEN_.00g112440	Scaffold_05	22457972	22459896	NA	NA	NA	NA	NA
PGEN_.00g112450	Scaffold_05	22559950	22579709	P17278	HXD4_CHICK	Homeobox protein Hox-D4 (Homeobox protein Hox-A) (Chox-A)	GO:0000977; GO:0001228; GO:0001501; GO:0005634; GO:0009952; GO:0033613; GO:0048704	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; skeletal system development [GO:0001501]"
PGEN_.00g112460	Scaffold_05	22658445	22662784	Q5UR34	YR554_MIMIV	Uncharacterized protein R554		
PGEN_.00g112470	Scaffold_05	22697775	22700854	NA	NA	NA	NA	NA
PGEN_.00g112480	Scaffold_05	22700906	22713318	NA	NA	NA	NA	NA
PGEN_.00g112490	Scaffold_05	22729415	22763249	P09077	SCR_DROME	Homeotic protein Sex combs reduced	GO:0000977; GO:0001228; GO:0005634; GO:0007432; GO:0007494; GO:0007548; GO:0009952; GO:0033613; GO:0042803; GO:0043565; GO:0045498; GO:0045944	"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; midgut development [GO:0007494]; positive regulation of transcription by RNA polymerase II [GO:0045944]; salivary gland boundary specification [GO:0007432]; sex comb development [GO:0045498]; sex differentiation [GO:0007548]"
PGEN_.00g112500	Scaffold_05	22793372	22795393	NA	NA	NA	NA	NA
PGEN_.00g112510	Scaffold_05	22896345	22913788	P09013	HXB5B_DANRE	Homeobox protein Hox-B5b (Homeobox protein Zf-54) (Hox-B5-like)	GO:0000978; GO:0001708; GO:0003700; GO:0005634; GO:0007420; GO:0007507; GO:0009952; GO:0010002	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; cell fate specification [GO:0001708]; heart development [GO:0007507]
PGEN_.00g112520	Scaffold_05	22974926	22975267	NA	NA	NA	NA	NA
PGEN_.00g112530	Scaffold_05	22979592	22980917	NA	NA	NA	NA	NA
PGEN_.00g112540	Scaffold_05	22981214	22982399	NA	NA	NA	NA	NA
PGEN_.00g112550	Scaffold_05	22995702	22995962	NA	NA	NA	NA	NA
PGEN_.00g112560	Scaffold_05	23017842	23018171	NA	NA	NA	NA	NA
PGEN_.00g112570	Scaffold_05	23019052	23019747	NA	NA	NA	NA	NA
PGEN_.00g112580	Scaffold_05	23089878	23092613	NA	NA	NA	NA	NA
PGEN_.00g112590	Scaffold_05	23121975	23144941	A2D5Y4	HXA5_LEMCA	Homeobox protein Hox-A5	GO:0003700; GO:0005634; GO:0007275; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]
PGEN_.00g112600	Scaffold_05	23195989	23197230	NA	NA	NA	NA	NA
PGEN_.00g112610	Scaffold_05	23197919	23198344	NA	NA	NA	NA	NA
PGEN_.00g112620	Scaffold_05	23201496	23201864	NA	NA	NA	NA	NA
PGEN_.00g112630	Scaffold_05	23238526	23283819	Q07961	ABDA_TRICA	Homeobox protein abdominal-A homolog	GO:0005634; GO:0006355; GO:0007275; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g112640	Scaffold_05	23316111	23321154	NA	NA	NA	NA	NA
PGEN_.00g112650	Scaffold_05	23336192	23340854	NA	NA	NA	NA	NA
PGEN_.00g112660	Scaffold_05	23344496	23344861	NA	NA	NA	NA	NA
PGEN_.00g112670	Scaffold_05	23345342	23360741	Q8IVG5	SAM9L_HUMAN	Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like)	GO:0005737; GO:0005769	cytoplasm [GO:0005737]; early endosome [GO:0005769]
PGEN_.00g112680	Scaffold_05	23369824	23373420	NA	NA	NA	NA	NA
PGEN_.00g112690	Scaffold_05	23382961	23435366	Q91V57	CHIN_MOUSE	N-chimaerin (A-chimaerin) (Alpha-chimerin) (N-chimerin) (NC) (Rho GTPase-activating protein 2)	GO:0005096; GO:0008045; GO:0035556; GO:0043087; GO:0046872; GO:0046875; GO:0048013; GO:0050770; GO:0051056	ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g112700	Scaffold_05	23450961	23504585	Q9HCD6	TANC2_HUMAN	"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)"	GO:0001701; GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0098978; GO:0099092; GO:0099519	"axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; dense core granule cytoskeletal transport [GO:0099519]; in utero embryonic development [GO:0001701]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]"
PGEN_.00g112710	Scaffold_05	23575380	23576417	NA	NA	NA	NA	NA
PGEN_.00g112720	Scaffold_05	23614790	23618430	NA	NA	NA	NA	NA
PGEN_.00g112730	Scaffold_05	23652759	23658279	P11415	QOR_CAVPO	Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin)	GO:0003730; GO:0003960; GO:0005212; GO:0005829; GO:0008270; GO:0042178; GO:0051289; GO:0055114; GO:0070402	cytosol [GO:0005829]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; structural constituent of eye lens [GO:0005212]; zinc ion binding [GO:0008270]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]; xenobiotic catabolic process [GO:0042178]
PGEN_.00g112740	Scaffold_05	23672338	23676872	P55087	AQP4_HUMAN	Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4)	GO:0003091; GO:0005576; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006833; GO:0009897; GO:0009992; GO:0010008; GO:0015250; GO:0016021; GO:0016323; GO:0030104; GO:0042383; GO:0042802; GO:0050891; GO:0051289; GO:0071346; GO:0090660; GO:0097450	astrocyte end-foot [GO:0097450]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; identical protein binding [GO:0042802]; water channel activity [GO:0015250]; cellular response to interferon-gamma [GO:0071346]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid circulation [GO:0090660]; multicellular organismal water homeostasis [GO:0050891]; protein homotetramerization [GO:0051289]; renal water homeostasis [GO:0003091]; water homeostasis [GO:0030104]; water transport [GO:0006833]
PGEN_.00g112750	Scaffold_05	23742692	23743327	NA	NA	NA	NA	NA
PGEN_.00g112760	Scaffold_05	23744527	23748801	Q62148	AL1A2_MOUSE	Retinal dehydrogenase 2 (RALDH 2) (RalDH2) (EC 1.2.1.36) (Aldehyde dehydrogenase family 1 member A2) (Retinaldehyde-specific dehydrogenase type 2) (RALDH(II))	GO:0001523; GO:0001568; GO:0001758; GO:0001822; GO:0001889; GO:0001936; GO:0001947; GO:0002138; GO:0003007; GO:0004028; GO:0004029; GO:0005737; GO:0005829; GO:0007494; GO:0007507; GO:0008284; GO:0008285; GO:0009855; GO:0009952; GO:0009954; GO:0010628; GO:0014032; GO:0016331; GO:0016918; GO:0021915; GO:0021983; GO:0030182; GO:0030324; GO:0030326; GO:0030900; GO:0030902; GO:0031016; GO:0031076; GO:0032355; GO:0033189; GO:0034097; GO:0035115; GO:0035799; GO:0042572; GO:0042573; GO:0042574; GO:0042904; GO:0043010; GO:0043065; GO:0048384; GO:0048471; GO:0048566; GO:0048738; GO:0051289; GO:0060324; GO:0071300; GO:0090242	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; retinal binding [GO:0016918]; retinal dehydrogenase activity [GO:0001758]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; camera-type eye development [GO:0043010]; cardiac muscle tissue development [GO:0048738]; cellular response to retinoic acid [GO:0071300]; determination of bilateral symmetry [GO:0009855]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic forelimb morphogenesis [GO:0035115]; embryonic limb morphogenesis [GO:0030326]; face development [GO:0060324]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; liver development [GO:0001889]; lung development [GO:0030324]; midgut development [GO:0007494]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of cell population proliferation [GO:0008285]; neural crest cell development [GO:0014032]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of endothelial cell proliferation [GO:0001936]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to vitamin A [GO:0033189]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; retinoic acid receptor signaling pathway involved in somitogenesis [GO:0090242]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; ureter maturation [GO:0035799]
PGEN_.00g112770	Scaffold_05	23798961	23807195	NA	NA	NA	NA	NA
PGEN_.00g112780	Scaffold_05	23810260	23815722	P20917	MAG_MOUSE	Myelin-associated glycoprotein (Siglec-4a)	GO:0005102; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0010977; GO:0019226; GO:0019901; GO:0022010; GO:0030246; GO:0030517; GO:0031103; GO:0031643; GO:0033270; GO:0033691; GO:0035749; GO:0042803; GO:0043209; GO:0043218; GO:0043220; GO:0043524; GO:0045121; GO:0045665; GO:0048711; GO:0071260; GO:0097453; GO:0098742; GO:1905576	compact myelin [GO:0043218]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mesaxon [GO:0097453]; myelin sheath [GO:0043209]; myelin sheath adaxonal region [GO:0035749]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; carbohydrate binding [GO:0030246]; ganglioside GT1b binding [GO:1905576]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to mechanical stimulus [GO:0071260]; central nervous system myelination [GO:0022010]; negative regulation of axon extension [GO:0030517]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of myelination [GO:0031643]; transmission of nerve impulse [GO:0019226]
PGEN_.00g112790	Scaffold_05	23833739	23850903	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g112800	Scaffold_05	23950392	23952083	NA	NA	NA	NA	NA
PGEN_.00g112810	Scaffold_05	23955830	23957866	Q3ZBR6	SEM1_BOVIN	26S proteasome complex subunit SEM1 (26S proteasome complex subunit DSS1) (Split hand/foot malformation type 1 protein homolog)	GO:0000502; GO:0000724; GO:0006406; GO:0008541; GO:0043248	"proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; double-strand break repair via homologous recombination [GO:0000724]; mRNA export from nucleus [GO:0006406]; proteasome assembly [GO:0043248]"
PGEN_.00g112820	Scaffold_05	23958078	23977870	Q13438	OS9_HUMAN	Protein OS-9 (Amplified in osteosarcoma 9)	GO:0000836; GO:0002020; GO:0005783; GO:0005788; GO:0005789; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030433; GO:0030970; GO:0034976; GO:0044322; GO:0055085; GO:1904153; GO:1904380	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; carbohydrate binding [GO:0030246]; protease binding [GO:0002020]; endoplasmic reticulum mannose trimming [GO:1904380]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g112830	Scaffold_05	23981916	23991369	NA	NA	NA	NA	NA
PGEN_.00g112840	Scaffold_05	24000244	24009184	Q8K2C7	OS9_MOUSE	Protein OS-9	GO:0002020; GO:0005783; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030433; GO:0030970; GO:0034976; GO:1904153	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; carbohydrate binding [GO:0030246]; protease binding [GO:0002020]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g112850	Scaffold_05	24009226	24035299	NA	NA	NA	NA	NA
PGEN_.00g112860	Scaffold_05	24046961	24066446	NA	NA	NA	NA	NA
PGEN_.00g112870	Scaffold_05	24102118	24102435	NA	NA	NA	NA	NA
PGEN_.00g112880	Scaffold_05	24141626	24141889	NA	NA	NA	NA	NA
PGEN_.00g112890	Scaffold_05	24142356	24143016	NA	NA	NA	NA	NA
PGEN_.00g112900	Scaffold_05	24143146	24143496	NA	NA	NA	NA	NA
PGEN_.00g112910	Scaffold_05	24150580	24150981	NA	NA	NA	NA	NA
PGEN_.00g112920	Scaffold_05	24151024	24152771	NA	NA	NA	NA	NA
PGEN_.00g112930	Scaffold_05	24176812	24177024	NA	NA	NA	NA	NA
PGEN_.00g112940	Scaffold_05	24194680	24195838	NA	NA	NA	NA	NA
PGEN_.00g112950	Scaffold_05	24204080	24211088	NA	NA	NA	NA	NA
PGEN_.00g112960	Scaffold_05	24225110	24225691	NA	NA	NA	NA	NA
PGEN_.00g112970	Scaffold_05	24249171	24273736	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g112980	Scaffold_05	24273792	24281934	NA	NA	NA	NA	NA
PGEN_.00g112990	Scaffold_05	24280661	24287231	NA	NA	NA	NA	NA
PGEN_.00g113000	Scaffold_05	24295218	24295463	NA	NA	NA	NA	NA
PGEN_.00g113010	Scaffold_05	24298658	24301763	NA	NA	NA	NA	NA
PGEN_.00g113020	Scaffold_05	24332271	24349396	NA	NA	NA	NA	NA
PGEN_.00g113030	Scaffold_05	24363331	24373795	NA	NA	NA	NA	NA
PGEN_.00g113040	Scaffold_05	24381364	24382257	NA	NA	NA	NA	NA
PGEN_.00g113050	Scaffold_05	24388390	24390484	NA	NA	NA	NA	NA
PGEN_.00g113060	Scaffold_05	24395649	24436018	NA	NA	NA	NA	NA
PGEN_.00g113070	Scaffold_05	24463837	24469961	NA	NA	NA	NA	NA
PGEN_.00g113080	Scaffold_05	24503441	24510729	NA	NA	NA	NA	NA
PGEN_.00g113090	Scaffold_05	24522785	24567463	B4KR21	QVR_DROMO	Protein quiver (Protein sleepless)	GO:0005886; GO:0009897; GO:0030431; GO:0031225; GO:0032222; GO:0034235; GO:0045187; GO:0045837; GO:0045938; GO:0048511; GO:1903049; GO:1903818	"anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; negative regulation of acetylcholine-gated cation channel activity [GO:1903049]; negative regulation of membrane potential [GO:0045837]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]"
PGEN_.00g113100	Scaffold_05	24580402	24580767	NA	NA	NA	NA	NA
PGEN_.00g113110	Scaffold_05	24602769	24614891	NA	NA	NA	NA	NA
PGEN_.00g113120	Scaffold_05	24615164	24628019	NA	NA	NA	NA	NA
PGEN_.00g113130	Scaffold_05	24644452	24656800	NA	NA	NA	NA	NA
PGEN_.00g113140	Scaffold_05	24657073	24669195	NA	NA	NA	NA	NA
PGEN_.00g113150	Scaffold_05	24689196	24691775	NA	NA	NA	NA	NA
PGEN_.00g113160	Scaffold_05	24704715	24749191	B4KR21	QVR_DROMO	Protein quiver (Protein sleepless)	GO:0005886; GO:0009897; GO:0030431; GO:0031225; GO:0032222; GO:0034235; GO:0045187; GO:0045837; GO:0045938; GO:0048511; GO:1903049; GO:1903818	"anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; negative regulation of acetylcholine-gated cation channel activity [GO:1903049]; negative regulation of membrane potential [GO:0045837]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]"
PGEN_.00g113170	Scaffold_05	24761380	24768655	NA	NA	NA	NA	NA
PGEN_.00g113180	Scaffold_05	24772209	24772947	NA	NA	NA	NA	NA
PGEN_.00g113190	Scaffold_05	24780022	24787288	NA	NA	NA	NA	NA
PGEN_.00g113200	Scaffold_05	24790455	24791027	NA	NA	NA	NA	NA
PGEN_.00g113210	Scaffold_05	24811336	24830895	NA	NA	NA	NA	NA
PGEN_.00g113220	Scaffold_05	24847707	24850236	NA	NA	NA	NA	NA
PGEN_.00g113230	Scaffold_05	24851128	24859633	NA	NA	NA	NA	NA
PGEN_.00g113240	Scaffold_05	24866611	24873354	NA	NA	NA	NA	NA
PGEN_.00g113250	Scaffold_05	24887154	24898624	NA	NA	NA	NA	NA
PGEN_.00g113260	Scaffold_05	24901915	24914820	NA	NA	NA	NA	NA
PGEN_.00g113270	Scaffold_05	24915021	24923938	NA	NA	NA	NA	NA
PGEN_.00g113280	Scaffold_05	24931077	24933128	NA	NA	NA	NA	NA
PGEN_.00g113290	Scaffold_05	24937842	24940562	NA	NA	NA	NA	NA
PGEN_.00g113300	Scaffold_05	24963957	24966826	NA	NA	NA	NA	NA
PGEN_.00g113310	Scaffold_05	24968273	24968485	NA	NA	NA	NA	NA
PGEN_.00g113320	Scaffold_05	24972138	24974180	NA	NA	NA	NA	NA
PGEN_.00g113330	Scaffold_05	24981336	24982314	NA	NA	NA	NA	NA
PGEN_.00g113340	Scaffold_05	24982984	24990214	NA	NA	NA	NA	NA
PGEN_.00g113350	Scaffold_05	24990627	25003160	NA	NA	NA	NA	NA
PGEN_.00g113360	Scaffold_05	25007996	25019490	NA	NA	NA	NA	NA
PGEN_.00g113370	Scaffold_05	25037201	25044070	NA	NA	NA	NA	NA
PGEN_.00g113380	Scaffold_05	25051052	25059531	NA	NA	NA	NA	NA
PGEN_.00g113390	Scaffold_05	25060422	25062951	NA	NA	NA	NA	NA
PGEN_.00g113400	Scaffold_05	25079751	25099380	NA	NA	NA	NA	NA
PGEN_.00g113410	Scaffold_05	25119558	25119872	NA	NA	NA	NA	NA
PGEN_.00g113420	Scaffold_05	25123438	25130716	NA	NA	NA	NA	NA
PGEN_.00g113430	Scaffold_05	25186309	25218795	NA	NA	NA	NA	NA
PGEN_.00g113440	Scaffold_05	25220521	25223788	NA	NA	NA	NA	NA
PGEN_.00g113450	Scaffold_05	25231270	25231527	NA	NA	NA	NA	NA
PGEN_.00g113460	Scaffold_05	25260674	25263582	NA	NA	NA	NA	NA
PGEN_.00g113470	Scaffold_05	25305690	25368141	Q91147	FGFR2_NOTVI	Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1)	GO:0005007; GO:0005524; GO:0005794; GO:0005886; GO:0006915; GO:0008284; GO:0016021; GO:0031410	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]
PGEN_.00g113480	Scaffold_05	25375914	25377750	NA	NA	NA	NA	NA
PGEN_.00g113490	Scaffold_05	25379265	25379624	NA	NA	NA	NA	NA
PGEN_.00g113500	Scaffold_05	25381313	25381579	NA	NA	NA	NA	NA
PGEN_.00g113510	Scaffold_05	25432057	25496676	Q9NR16	C163B_HUMAN	Scavenger receptor cysteine-rich type 1 protein M160 (CD163 antigen-like 1) (CD antigen CD163b)	GO:0005044; GO:0005576; GO:0009897; GO:0016021	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]
PGEN_.00g113520	Scaffold_05	25497842	25528491	Q94887	NRX4_DROME	Neurexin-4 (Neurexin IV)	GO:0003015; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0007163; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0016080; GO:0016081; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
PGEN_.00g113530	Scaffold_05	25540253	25556115	P15178	SYDC_RAT	"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	GO:0003723; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006422; GO:0017101; GO:0045202	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422]
PGEN_.00g113540	Scaffold_05	25556378	25600616	Q9UL36	ZN236_HUMAN	Zinc finger protein 236	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g113550	Scaffold_05	25616606	25639259	Q8BX09	RBBP5_MOUSE	Retinoblastoma-binding protein 5 (RBBP-5)	GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0035064; GO:0035097; GO:0042800; GO:0043627; GO:0044212; GO:0044666; GO:0048188; GO:0051568; GO:0071339	histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; methylated histone binding [GO:0035064]; transcription regulatory region DNA binding [GO:0044212]; cellular response to DNA damage stimulus [GO:0006974]; histone H3-K4 methylation [GO:0051568]; response to estrogen [GO:0043627]
PGEN_.00g113560	Scaffold_05	25646526	25652344	P37801	CLPH_ONCVO	Calponin homolog OV9M		
PGEN_.00g113570	Scaffold_05	25653294	25654124	P37801	CLPH_ONCVO	Calponin homolog OV9M		
PGEN_.00g113580	Scaffold_05	25655253	25655486	Q9GK38	CNN1_MUSPF	"Calponin-1 (Basic calponin) (Calponin H1, smooth muscle)"	GO:0003779; GO:0005516; GO:0031032	actin binding [GO:0003779]; calmodulin binding [GO:0005516]; actomyosin structure organization [GO:0031032]
PGEN_.00g113590	Scaffold_05	25655887	25660585	P37801	CLPH_ONCVO	Calponin homolog OV9M		
PGEN_.00g113600	Scaffold_05	25663190	25664617	P37801	CLPH_ONCVO	Calponin homolog OV9M		
PGEN_.00g113610	Scaffold_05	25666329	25667848	P37801	CLPH_ONCVO	Calponin homolog OV9M		
PGEN_.00g113620	Scaffold_05	25668337	25668852	P37801	CLPH_ONCVO	Calponin homolog OV9M		
PGEN_.00g113630	Scaffold_05	25670054	25682970	P37397	CNN3_RAT	"Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform)"	GO:0003779; GO:0005516; GO:0005829; GO:0005874; GO:0005884; GO:0008017; GO:0014069; GO:0030425; GO:0030674; GO:0030855; GO:0031032; GO:0032780; GO:0043025; GO:0043197	"actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding, bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780]"
PGEN_.00g113640	Scaffold_05	25759038	25767308	Q3C1V8	BSH_HUMAN	Brain-specific homeobox protein homolog	GO:0000790; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007626; GO:0042755; GO:0043565; GO:0045944; GO:0060056	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; eating behavior [GO:0042755]; locomotory behavior [GO:0007626]; mammary gland involution [GO:0060056]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g113650	Scaffold_05	25779283	25788358	Q68ED2	GRM7_MOUSE	Metabotropic glutamate receptor 7 (mGluR7)	GO:0001640; GO:0001642; GO:0001661; GO:0001662; GO:0005245; GO:0005246; GO:0005509; GO:0005516; GO:0005791; GO:0005794; GO:0005887; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0007613; GO:0007614; GO:0008066; GO:0008306; GO:0009986; GO:0010855; GO:0014050; GO:0016020; GO:0016021; GO:0016595; GO:0019226; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0032279; GO:0032991; GO:0033555; GO:0042734; GO:0042802; GO:0043025; GO:0043195; GO:0043198; GO:0043235; GO:0043524; GO:0043679; GO:0045202; GO:0045211; GO:0048306; GO:0048786; GO:0048787; GO:0050877; GO:0051966; GO:0070905; GO:0098978; GO:0098982; GO:0099056; GO:0099059; GO:1901214; GO:2000300	"asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; serine binding [GO:0070905]; voltage-gated calcium channel activity [GO:0005245]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult behavior [GO:0030534]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of neuron death [GO:1901214]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226]"
PGEN_.00g113660	Scaffold_05	25800605	25801793	NA	NA	NA	NA	NA
PGEN_.00g113670	Scaffold_05	25840173	25851302	P35448	TSP1_XENLA	Thrombospondin-1 (Glycoprotein G)	GO:0005509; GO:0005615; GO:0005783; GO:0006954; GO:0006986; GO:0007155; GO:0008201; GO:0009986; GO:0016525; GO:0016529; GO:0031012; GO:0050840	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986]
PGEN_.00g113680	Scaffold_05	25862584	25890316	A8MV24	CQ098_HUMAN	Uncharacterized protein C17orf98		
PGEN_.00g113690	Scaffold_05	25899815	25900330	NA	NA	NA	NA	NA
PGEN_.00g113700	Scaffold_05	25906763	25910502	NA	NA	NA	NA	NA
PGEN_.00g113710	Scaffold_05	25946649	25951537	Q9BWU0	NADAP_HUMAN	Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein)	GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]
PGEN_.00g113720	Scaffold_05	25960935	25961240	NA	NA	NA	NA	NA
PGEN_.00g113730	Scaffold_05	25962443	25962757	NA	NA	NA	NA	NA
PGEN_.00g113740	Scaffold_05	25964079	26013601	Q6GNV7	DIRC2_XENLA	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	GO:0005765; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]
PGEN_.00g113750	Scaffold_05	26044093	26048260	NA	NA	NA	NA	NA
PGEN_.00g113760	Scaffold_05	26095476	26095757	NA	NA	NA	NA	NA
PGEN_.00g113770	Scaffold_05	26254255	26255594	NA	NA	NA	NA	NA
PGEN_.00g113780	Scaffold_05	26315477	26315803	NA	NA	NA	NA	NA
PGEN_.00g113790	Scaffold_05	26330176	26330766	Q8BGF9	S2544_MOUSE	Solute carrier family 25 member 44	GO:0005739; GO:0009083; GO:0015658; GO:0015803; GO:0016021; GO:0031966; GO:0120161	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; branched-chain amino acid transmembrane transporter activity [GO:0015658]; branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid transport [GO:0015803]; regulation of cold-induced thermogenesis [GO:0120161]
PGEN_.00g113800	Scaffold_05	26330949	26334470	NA	NA	NA	NA	NA
PGEN_.00g113810	Scaffold_05	26361536	26362252	NA	NA	NA	NA	NA
PGEN_.00g113820	Scaffold_05	26368544	26381199	NA	NA	NA	NA	NA
PGEN_.00g113830	Scaffold_05	26386837	26390539	NA	NA	NA	NA	NA
PGEN_.00g113840	Scaffold_05	26392587	26392955	NA	NA	NA	NA	NA
PGEN_.00g113850	Scaffold_05	26405255	26414780	Q04861	NFKB1_CHICK	Nuclear factor NF-kappa-B p105 subunit (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit]	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003682; GO:0005654; GO:0005739; GO:0005829; GO:0006954; GO:0007249; GO:0010956; GO:0034097; GO:0035994; GO:0038061; GO:0042803; GO:0042805; GO:0045083; GO:0045944; GO:0046982; GO:0050728; GO:0051059; GO:0071222; GO:0071260; GO:0071316; GO:0071347; GO:0071354; GO:0071356; GO:0071359; GO:0090263; GO:1900127; GO:1904385; GO:2000630	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; actinin binding [GO:0042805]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; NF-kappaB binding [GO:0051059]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to angiotensin [GO:1904385]; cellular response to dsRNA [GO:0071359]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cellular response to tumor necrosis factor [GO:0071356]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-12 biosynthetic process [GO:0045083]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cytokine [GO:0034097]; response to muscle stretch [GO:0035994]"
PGEN_.00g113860	Scaffold_05	26427864	26444929	Q3ZBG9	PLS2_BOVIN	Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2)	GO:0005886; GO:0016021; GO:0017121; GO:0017128; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; plasma membrane phospholipid scrambling [GO:0017121]
PGEN_.00g113870	Scaffold_05	26456842	26466621	P31478	VATF_MANSE	V-type proton ATPase subunit F (V-ATPase subunit F) (V-ATPase 14 kDa subunit) (Vacuolar proton pump subunit F)	GO:0033180; GO:0046961	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"
PGEN_.00g113880	Scaffold_05	26505237	26505530	NA	NA	NA	NA	NA
PGEN_.00g113890	Scaffold_05	26512712	26513122	NA	NA	NA	NA	NA
PGEN_.00g113900	Scaffold_05	26521876	26552566	A0JPN2	S39A4_RAT	Zinc transporter ZIP4 (Solute carrier family 39 member 4) (Zrt- and Irt-like protein 4) (ZIP-4)	GO:0005385; GO:0005623; GO:0005768; GO:0005886; GO:0005887; GO:0006829; GO:0006882; GO:0007165; GO:0016324; GO:0031410; GO:0034224; GO:0055038; GO:0071578	apical plasma membrane [GO:0016324]; cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; zinc ion transmembrane transporter activity [GO:0005385]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]
PGEN_.00g113910	Scaffold_05	26569219	26578718	Q5M8F9	ALKMO_XENTR	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]
PGEN_.00g113920	Scaffold_05	26604024	26610822	NA	NA	NA	NA	NA
PGEN_.00g113930	Scaffold_05	26610876	26627972	NA	NA	NA	NA	NA
PGEN_.00g113940	Scaffold_05	26723257	26724862	NA	NA	NA	NA	NA
PGEN_.00g113950	Scaffold_05	26732156	26734782	NA	NA	NA	NA	NA
PGEN_.00g113960	Scaffold_05	26736840	26737451	NA	NA	NA	NA	NA
PGEN_.00g113970	Scaffold_05	26742828	26748772	A7SM54	UFC1_NEMVE	Ubiquitin-fold modifier-conjugating enzyme 1 (Ufm1-conjugating enzyme 1)	GO:0071568; GO:1990592	UFM1 transferase activity [GO:0071568]; protein K69-linked ufmylation [GO:1990592]
PGEN_.00g113980	Scaffold_05	26751860	26758998	P70490	MFGM_RAT	Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1)	GO:0001525; GO:0001786; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0019897; GO:0043277; GO:0043627; GO:0050766	"external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338]"
PGEN_.00g113990	Scaffold_05	26812787	26830196	A1Z6E0	GUS_DROME	Protein gustavus	GO:0005634; GO:0005737; GO:0005938; GO:0006511; GO:0007280; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449	cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole cell migration [GO:0007280]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc morphogenesis [GO:0007472]
PGEN_.00g114000	Scaffold_05	26836601	26845381	NA	NA	NA	NA	NA
PGEN_.00g114010	Scaffold_05	26849865	26855923	NA	NA	NA	NA	NA
PGEN_.00g114020	Scaffold_05	26859499	26860251	NA	NA	NA	NA	NA
PGEN_.00g114030	Scaffold_05	26867169	26888209	P49282	NRAM2_MOUSE	Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2)	GO:0000041; GO:0001666; GO:0005375; GO:0005381; GO:0005384; GO:0005506; GO:0005507; GO:0005623; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005773; GO:0005802; GO:0005886; GO:0005887; GO:0005903; GO:0006778; GO:0006779; GO:0006783; GO:0006824; GO:0006825; GO:0006826; GO:0006828; GO:0006919; GO:0007611; GO:0008270; GO:0009986; GO:0010039; GO:0010042; GO:0012505; GO:0015078; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015099; GO:0015100; GO:0015295; GO:0015675; GO:0015676; GO:0015692; GO:0016021; GO:0016151; GO:0016324; GO:0022890; GO:0030145; GO:0031410; GO:0031526; GO:0031902; GO:0033212; GO:0034599; GO:0034755; GO:0045177; GO:0045178; GO:0046870; GO:0046915; GO:0048471; GO:0048813; GO:0048821; GO:0050897; GO:0055037; GO:0060586; GO:0070574; GO:0070826; GO:0098705; GO:1902600; GO:1903561; GO:1905394	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion binding [GO:0050897]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion binding [GO:0005506]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion binding [GO:0030145]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation binding [GO:0016151]; nickel cation transmembrane transporter activity [GO:0015099]; proton transmembrane transporter activity [GO:0015078]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cadmium ion transmembrane transport [GO:0070574]; cellular response to oxidative stress [GO:0034599]; cobalt ion transport [GO:0006824]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; proton transmembrane transport [GO:1902600]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; transition metal ion transport [GO:0000041]; vanadium ion transport [GO:0015676]
PGEN_.00g114040	Scaffold_05	26902008	26904995	NA	NA	NA	NA	NA
PGEN_.00g114050	Scaffold_05	26905858	26908843	Q32NT4	LRC58_XENLA	Leucine-rich repeat-containing protein 58		
PGEN_.00g114060	Scaffold_05	26928012	26954850	Q5YJC2	GSK3B_SPECI	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	GO:0001837; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005886; GO:0005977; GO:0006468; GO:0007399; GO:0007623; GO:0010508; GO:0016020; GO:0016055; GO:0016301; GO:0018105; GO:0032092; GO:0032886; GO:0036016; GO:0050321; GO:0070885; GO:0097192; GO:1901030	cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cellular response to interleukin-3 [GO:0036016]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of autophagy [GO:0010508]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055]
PGEN_.00g114070	Scaffold_05	26961727	26975220	NA	NA	NA	NA	NA
PGEN_.00g114080	Scaffold_05	26983482	27003896	P0CG08	GPHRB_HUMAN	Golgi pH regulator B (Protein GPR89B)	GO:0005623; GO:0008308; GO:0015031; GO:0016021; GO:0032580; GO:0034765; GO:0051452	cell [GO:0005623]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; voltage-gated anion channel activity [GO:0008308]; intracellular pH reduction [GO:0051452]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g114090	Scaffold_05	27004593	27037170	Q9UHP3	UBP25_HUMAN	Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (USP on chromosome 21) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25)	GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006464; GO:0006508; GO:0006511; GO:0008233; GO:0016579; GO:0019783; GO:0031625; GO:0036459; GO:0043130; GO:0051117; GO:0070536; GO:0071108; GO:1904293	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATPase binding [GO:0051117]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein-specific protease activity [GO:0019783]; cellular protein modification process [GO:0006464]; negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g114100	Scaffold_05	27058068	27069411	NA	NA	NA	NA	NA
PGEN_.00g114110	Scaffold_05	27074710	27083456	NA	NA	NA	NA	NA
PGEN_.00g114120	Scaffold_05	27094865	27101262	NA	NA	NA	NA	NA
PGEN_.00g114130	Scaffold_05	27125725	27137555	Q14CZ7	FAKD3_HUMAN	"FAST kinase domain-containing protein 3, mitochondrial"	GO:0003723; GO:0004672; GO:0005654; GO:0005739; GO:0033617; GO:0044528; GO:0070131	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]
PGEN_.00g114140	Scaffold_05	27168001	27177826	NA	NA	NA	NA	NA
PGEN_.00g114150	Scaffold_05	27190228	27196541	P41321	NPF_CORAP	Neuropeptide F (NPF)	GO:0005179; GO:0005576; GO:0007218	extracellular region [GO:0005576]; hormone activity [GO:0005179]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g114160	Scaffold_05	27203128	27222270	NA	NA	NA	NA	NA
PGEN_.00g114170	Scaffold_05	27230863	27241355	Q32KU6	TSN6_BOVIN	Tetraspanin-6 (Tspan-6)	GO:0005887; GO:0039532; GO:1901223	integral component of plasma membrane [GO:0005887]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]
PGEN_.00g114180	Scaffold_05	27244740	27261929	NA	NA	NA	NA	NA
PGEN_.00g114190	Scaffold_05	27268515	27283718	Q4R7B1	INT10_MACFA	Integrator complex subunit 10 (Int10)	GO:0005634; GO:0016180; GO:0032039	integrator complex [GO:0032039]; nucleus [GO:0005634]; snRNA processing [GO:0016180]
PGEN_.00g114200	Scaffold_05	27284412	27290522	Q05A80	CAPR2_MOUSE	Caprin-2 (C1q domain-containing protein 1) (Cytoplasmic activation/proliferation-associated protein 2) (RNA granule protein 140)	GO:0003723; GO:0005102; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0017148; GO:0030308; GO:0032092; GO:0033138; GO:0043235; GO:0045944; GO:0046872; GO:0050775; GO:0061003; GO:0090263	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; negative regulation of cell growth [GO:0030308]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g114210	Scaffold_05	27292947	27297315	Q6TNU3	INT10_DANRE	Integrator complex subunit 10 (Int10)	GO:0016180; GO:0032039	integrator complex [GO:0032039]; snRNA processing [GO:0016180]
PGEN_.00g114220	Scaffold_05	27298942	27317456	Q91628	ORC2_XENLA	Origin recognition complex subunit 2 (xORC2)	GO:0000808; GO:0003682; GO:0005634; GO:0006260	nucleus [GO:0005634]; origin recognition complex [GO:0000808]; chromatin binding [GO:0003682]; DNA replication [GO:0006260]
PGEN_.00g114230	Scaffold_05	27321789	27321995	NA	NA	NA	NA	NA
PGEN_.00g114240	Scaffold_05	27323095	27330655	NA	NA	NA	NA	NA
PGEN_.00g114250	Scaffold_05	27335701	27336762	NA	NA	NA	NA	NA
PGEN_.00g114260	Scaffold_05	27338796	27448865	Q80ZA4	PKHL1_MOUSE	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)	GO:0005929; GO:0016021	cilium [GO:0005929]; integral component of membrane [GO:0016021]
PGEN_.00g114270	Scaffold_05	27508869	27509384	NA	NA	NA	NA	NA
PGEN_.00g114280	Scaffold_05	27509859	27544629	Q80ZA4	PKHL1_MOUSE	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)	GO:0005929; GO:0016021	cilium [GO:0005929]; integral component of membrane [GO:0016021]
PGEN_.00g114290	Scaffold_05	27555116	27558827	NA	NA	NA	NA	NA
PGEN_.00g114300	Scaffold_05	27595084	27639742	Q9UBG0	MRC2_HUMAN	C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280)	GO:0001649; GO:0004888; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0016021; GO:0030246; GO:0030574	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]
PGEN_.00g114310	Scaffold_05	27642042	27705042	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g114320	Scaffold_05	27715841	27742257	Q9IBG7	KCP_XENLA	Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g114330	Scaffold_05	27752912	27777523	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g114340	Scaffold_05	27787596	27804654	Q6ZWJ8	KCP_HUMAN	Kielin/chordin-like protein (Cysteine-rich BMP regulator 2) (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin/chordin-like protein 1) (KCP-1)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g114350	Scaffold_05	27812895	27825229	Q6ZWJ8	KCP_HUMAN	Kielin/chordin-like protein (Cysteine-rich BMP regulator 2) (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin/chordin-like protein 1) (KCP-1)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g114360	Scaffold_05	27836318	27839995	NA	NA	NA	NA	NA
PGEN_.00g114370	Scaffold_05	27845213	27852248	NA	NA	NA	NA	NA
PGEN_.00g114380	Scaffold_05	27857138	27913563	A6BM72	MEG11_HUMAN	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	GO:0010842; GO:0016021; GO:0016323; GO:0034109	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
PGEN_.00g114390	Scaffold_05	27918926	27920017	Q9NS37	ZHANG_HUMAN	CREB/ATF bZIP transcription factor (Host cell factor-binding transcription factor Zhangfei) (HCF-binding transcription factor Zhangfei)	GO:0000790; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006351; GO:0009615; GO:0042802; GO:0045814; GO:0045892; GO:0051090	"mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA-binding transcription factor activity [GO:0051090]; response to virus [GO:0009615]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g114400	Scaffold_05	27924402	27933790	Q66KB0	UBE2Z_XENTR	Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z)	GO:0004869; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0006915; GO:0043066; GO:0061631	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g114410	Scaffold_05	27934787	27940541	NA	NA	NA	NA	NA
PGEN_.00g114420	Scaffold_05	27942845	27947972	NA	NA	NA	NA	NA
PGEN_.00g114430	Scaffold_05	27967944	28002847	Q8AVM5	VPP1_XENLA	V-type proton ATPase 116 kDa subunit a isoform 1 (V-ATPase 116 kDa isoform a1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)	GO:0000220; GO:0015078; GO:0016021; GO:0030659; GO:0042470	"cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; proton transmembrane transporter activity [GO:0015078]"
PGEN_.00g114440	Scaffold_05	28051490	28066724	NA	NA	NA	NA	NA
PGEN_.00g114450	Scaffold_05	28075613	28078126	NA	NA	NA	NA	NA
PGEN_.00g114460	Scaffold_05	28086644	28089583	NA	NA	NA	NA	NA
PGEN_.00g114470	Scaffold_05	28092204	28097653	NA	NA	NA	NA	NA
PGEN_.00g114480	Scaffold_05	28098535	28101505	NA	NA	NA	NA	NA
PGEN_.00g114490	Scaffold_05	28112736	28122118	NA	NA	NA	NA	NA
PGEN_.00g114500	Scaffold_05	28129338	28129550	NA	NA	NA	NA	NA
PGEN_.00g114510	Scaffold_05	28155955	28157409	Q08890	IDS_MOUSE	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase)	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484	lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]
PGEN_.00g114520	Scaffold_05	28164003	28180356	P35604	COPZ1_BOVIN	Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP)	GO:0000139; GO:0006886; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"
PGEN_.00g114530	Scaffold_05	28199991	28200197	NA	NA	NA	NA	NA
PGEN_.00g114540	Scaffold_05	28201381	28255982	Q1KKV2	HXCBA_TAKRU	Homeobox protein Hox-C11a	GO:0005634; GO:0006355; GO:0007275; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g114550	Scaffold_05	28312370	28312594	NA	NA	NA	NA	NA
PGEN_.00g114560	Scaffold_05	28314330	28314665	NA	NA	NA	NA	NA
PGEN_.00g114570	Scaffold_05	28451577	28452161	NA	NA	NA	NA	NA
PGEN_.00g114580	Scaffold_05	28547154	28562684	P09087	ABDB_DROME	Homeobox protein abdominal-B (Infraabdominal 7) (IAB-7) (P3) (PH189)	GO:0000976; GO:0000978; GO:0003700; GO:0005634; GO:0005704; GO:0007280; GO:0007379; GO:0007385; GO:0007424; GO:0007431; GO:0007484; GO:0007486; GO:0007494; GO:0007506; GO:0007507; GO:0007548; GO:0007621; GO:0008354; GO:0008584; GO:0009997; GO:0030539; GO:0030540; GO:0035215; GO:0035224; GO:0035225; GO:0035261; GO:0035263; GO:0035277; GO:0045705; GO:0045843; GO:0045944; GO:0046693; GO:0048066; GO:0048071; GO:0048087; GO:0048094; GO:0061101; GO:1902339	"nucleus [GO:0005634]; polytene chromosome band [GO:0005704]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; determination of genital disc primordium [GO:0035225]; developmental pigmentation [GO:0048066]; external genitalia morphogenesis [GO:0035261]; female genitalia development [GO:0030540]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc development [GO:0035215]; genital disc sexually dimorphic development [GO:0035263]; germ cell migration [GO:0008354]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; imaginal disc-derived female genitalia development [GO:0007486]; imaginal disc-derived genitalia development [GO:0007484]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; male pigmentation [GO:0048094]; midgut development [GO:0007494]; negative regulation of cardioblast cell fate specification [GO:0009997]; negative regulation of female receptivity [GO:0007621]; negative regulation of salivary gland boundary specification [GO:0045705]; negative regulation of striated muscle tissue development [GO:0045843]; neuroendocrine cell differentiation [GO:0061101]; open tracheal system development [GO:0007424]; pole cell migration [GO:0007280]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; salivary gland development [GO:0007431]; segment specification [GO:0007379]; sex differentiation [GO:0007548]; sex-specific pigmentation [GO:0048071]; specification of segmental identity, abdomen [GO:0007385]; sperm storage [GO:0046693]; spiracle morphogenesis, open tracheal system [GO:0035277]"
PGEN_.00g114590	Scaffold_05	28605116	28616891	Q9QYJ3	DNJB1_MOUSE	DnaJ homolog subfamily B member 1 (Heat shock 40 kDa protein 1) (HSP40) (Heat shock protein 40)	GO:0001671; GO:0003714; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006457; GO:0014069; GO:0030544; GO:0032781; GO:0043025; GO:0043197; GO:0044183; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0061827; GO:0090084; GO:0097201; GO:0098794; GO:0098978; GO:0099524	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; sperm head [GO:0061827]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]
PGEN_.00g114600	Scaffold_05	28636014	28653030	Q9NYG2	ZDHC3_HUMAN	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:1903546	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to photoreceptor outer segment [GO:1903546]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]
PGEN_.00g114610	Scaffold_05	28688175	28694903	Q8JG69	AA2DB_DANRE	Alpha-2Db adrenergic receptor (Alpha-2Db adrenoceptor) (Alpha(2Db)AR) (Alpha-2Db adrenoreceptor)	GO:0004935; GO:0004938; GO:0005887; GO:0006940; GO:0007188; GO:0019229; GO:0030168; GO:0071880; GO:0071881	integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; platelet activation [GO:0030168]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229]
PGEN_.00g114620	Scaffold_05	28701726	28701983	NA	NA	NA	NA	NA
PGEN_.00g114630	Scaffold_05	28702475	28703959	NA	NA	NA	NA	NA
PGEN_.00g114640	Scaffold_05	28709748	28710170	NA	NA	NA	NA	NA
PGEN_.00g114650	Scaffold_05	28749070	28754323	NA	NA	NA	NA	NA
PGEN_.00g114660	Scaffold_05	28755415	28758393	NA	NA	NA	NA	NA
PGEN_.00g114670	Scaffold_05	28765427	28815807	NA	NA	NA	NA	NA
PGEN_.00g114680	Scaffold_05	28828475	28870104	F8WLE0	KIF28_RAT	Kinesin-like protein KIF28P (Kinesin-like protein 6)	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0030705; GO:0031966; GO:0072384	kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]
PGEN_.00g114690	Scaffold_05	28921560	28924561	NA	NA	NA	NA	NA
PGEN_.00g114700	Scaffold_05	29001725	29016585	NA	NA	NA	NA	NA
PGEN_.00g114710	Scaffold_05	29069409	29093704	D3ZXD8	TM245_RAT	Transmembrane protein 245	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g114720	Scaffold_05	29101837	29113237	Q9JJ09	NPT2B_RAT	Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2) (rNaPi IIb)	GO:0001701; GO:0005436; GO:0005623; GO:0005886; GO:0005903; GO:0006817; GO:0007568; GO:0009750; GO:0015321; GO:0016021; GO:0016324; GO:0019904; GO:0030643; GO:0031402; GO:0031526; GO:0031528; GO:0031982; GO:0032355; GO:0042301; GO:0043627; GO:0044341	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; protein domain specific binding [GO:0019904]; sodium ion binding [GO:0031402]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; aging [GO:0007568]; cellular phosphate ion homeostasis [GO:0030643]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fructose [GO:0009750]; sodium-dependent phosphate transport [GO:0044341]
PGEN_.00g114730	Scaffold_05	29125000	29130140	NA	NA	NA	NA	NA
PGEN_.00g114740	Scaffold_05	29135000	29169456	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g114750	Scaffold_05	29184217	29185449	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g114760	Scaffold_05	29199765	29200217	NA	NA	NA	NA	NA
PGEN_.00g114770	Scaffold_05	29200361	29200735	NA	NA	NA	NA	NA
PGEN_.00g114780	Scaffold_05	29209762	29213160	Q7RTX9	MOT14_HUMAN	Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g114790	Scaffold_05	29222862	29223200	NA	NA	NA	NA	NA
PGEN_.00g114800	Scaffold_05	29249673	29249915	NA	NA	NA	NA	NA
PGEN_.00g114810	Scaffold_05	29269846	29296516	Q6VYA3	SOSD1_CHICK	Sclerostin domain-containing protein 1 (Wnt-signaling modulator)	GO:0005615; GO:0007389; GO:0010454; GO:0016055; GO:0030514; GO:0036122; GO:0045662; GO:0090090; GO:0098821; GO:2000016	extracellular space [GO:0005615]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of myoblast differentiation [GO:0045662]; pattern specification process [GO:0007389]; Wnt signaling pathway [GO:0016055]
PGEN_.00g114820	Scaffold_05	29338818	29339075	NA	NA	NA	NA	NA
PGEN_.00g114830	Scaffold_05	29367671	29377508	NA	NA	NA	NA	NA
PGEN_.00g114840	Scaffold_05	29384049	29388168	NA	NA	NA	NA	NA
PGEN_.00g114850	Scaffold_05	29394706	29396931	Q810I1	TRI50_RAT	E3 ubiquitin-protein ligase TRIM50 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM50) (Tripartite motif-containing protein 50)	GO:0005737; GO:0008270; GO:0016235; GO:0016740; GO:0042802; GO:0070201	aggresome [GO:0016235]; cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; regulation of establishment of protein localization [GO:0070201]
PGEN_.00g114860	Scaffold_05	29450669	29459561	Q9QYG6	CP2DR_MESAU	Cytochrome P450 2D27 (EC 1.14.14.-) (CYPIID27)	GO:0005506; GO:0005789; GO:0016712; GO:0020037	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]"
PGEN_.00g114870	Scaffold_05	29470079	29502859	Q96MT7	CFA44_HUMAN	Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52)	GO:0005737; GO:0005856; GO:0007288; GO:0031514; GO:0060271	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288]
PGEN_.00g114880	Scaffold_05	29503496	29509612	Q96MT7	CFA44_HUMAN	Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52)	GO:0005737; GO:0005856; GO:0007288; GO:0031514; GO:0060271	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288]
PGEN_.00g114890	Scaffold_05	29520848	29545072	P56819	BACE1_RAT	Beta-secretase 1 (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2)	GO:0001540; GO:0004175; GO:0004190; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006508; GO:0006509; GO:0008021; GO:0008233; GO:0009314; GO:0009986; GO:0010288; GO:0016020; GO:0019899; GO:0030163; GO:0030424; GO:0030425; GO:0030659; GO:0031410; GO:0042987; GO:0043025; GO:0043525; GO:0045121; GO:0050435; GO:0050804; GO:0050966; GO:0055037; GO:0060134; GO:0071280; GO:0071287; GO:0098686; GO:0098793; GO:1904646; GO:2000300	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta metabolic process [GO:0050435]; cellular response to amyloid-beta [GO:1904646]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane protein ectodomain proteolysis [GO:0006509]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; prepulse inhibition [GO:0060134]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lead ion [GO:0010288]; response to radiation [GO:0009314]
PGEN_.00g114900	Scaffold_05	29552414	29560779	NA	NA	NA	NA	NA
PGEN_.00g114910	Scaffold_05	29612446	29617367	O02833	ALS_PAPHA	Insulin-like growth factor-binding protein complex acid labile subunit (ALS)	GO:0005615; GO:0007155	extracellular space [GO:0005615]; cell adhesion [GO:0007155]
PGEN_.00g114920	Scaffold_05	29632081	29650215	Q64261	CDK6_MOUSE	Cyclin-dependent kinase 6 (EC 2.7.11.22) (CR2 protein kinase) (CRK2) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE)	GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0002244; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0007219; GO:0009615; GO:0010468; GO:0010628; GO:0016301; GO:0030097; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0050680; GO:0051301; GO:0060218; GO:0097132; GO:0098770; GO:1902036; GO:2000773	centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323]
PGEN_.00g114930	Scaffold_05	29669314	29710693	Q9WU78	PDC6I_MOUSE	Programmed cell death 6-interacting protein (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (E2F1-inducible protein) (Eig2)	GO:0000281; GO:0000915; GO:0001772; GO:0005737; GO:0005815; GO:0005829; GO:0005923; GO:0006915; GO:0010824; GO:0015031; GO:0017124; GO:0031871; GO:0039702; GO:0042470; GO:0042641; GO:0042802; GO:0042803; GO:0043209; GO:0043231; GO:0045199; GO:0046755; GO:0046983; GO:0048306; GO:0051260; GO:0061952; GO:0070062; GO:0070830; GO:0070971; GO:0090543; GO:0090559; GO:0090611; GO:1903543; GO:1903551; GO:1903553	actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; immunological synapse [GO:0001772]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; myelin sheath [GO:0043209]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; SH3 domain binding [GO:0017124]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]
PGEN_.00g114940	Scaffold_05	29723049	29731417	NA	NA	NA	NA	NA
PGEN_.00g114950	Scaffold_05	29780942	29783661	NA	NA	NA	NA	NA
PGEN_.00g114960	Scaffold_05	29784165	29789842	Q09324	GCNT1_MOUSE	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT)"	GO:0000139; GO:0003829; GO:0005615; GO:0005802; GO:0006486; GO:0009101; GO:0016021; GO:0031985; GO:0032868; GO:0048729; GO:0050901; GO:0060352; GO:0060993	"extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; protein glycosylation [GO:0006486]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]"
PGEN_.00g114970	Scaffold_05	29796305	29812315	Q6QBQ4	PLS3_RAT	Phospholipid scramblase 3 (PL scramblase 3) (Ca(2+)-dependent phospholipid scramblase 3)	GO:0005886; GO:0006915; GO:0016021; GO:0017121; GO:0017124; GO:0017128; GO:0031966; GO:0042593; GO:0042632; GO:0048306; GO:0071222	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; plasma membrane phospholipid scrambling [GO:0017121]
PGEN_.00g114980	Scaffold_05	29820496	29827028	NA	NA	NA	NA	NA
PGEN_.00g114990	Scaffold_05	29833259	29841837	Q9BSK1	ZN577_HUMAN	Zinc finger protein 577	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g115000	Scaffold_05	29923282	29944791	Q5F364	MRP1_CHICK	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	GO:0005524; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g115010	Scaffold_05	29991131	29993373	NA	NA	NA	NA	NA
PGEN_.00g115020	Scaffold_05	30002186	30003337	NA	NA	NA	NA	NA
PGEN_.00g115030	Scaffold_05	30007882	30008241	NA	NA	NA	NA	NA
PGEN_.00g115040	Scaffold_05	30032142	30032459	NA	NA	NA	NA	NA
PGEN_.00g115050	Scaffold_05	30060290	30101598	Q3ZBL4	LZTL1_BOVIN	Leucine zipper transcription factor-like protein 1	GO:0005829; GO:0042802; GO:0044877; GO:1903568	cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; negative regulation of protein localization to ciliary membrane [GO:1903568]
PGEN_.00g115060	Scaffold_05	30101850	30132934	P23588	IF4B_HUMAN	Eukaryotic translation initiation factor 4B (eIF-4B)	GO:0003723; GO:0003743; GO:0005829; GO:0005844; GO:0006413; GO:0006446; GO:0016281; GO:0033592; GO:0097010	cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; polysome [GO:0005844]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; translation initiation factor activity [GO:0003743]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]
PGEN_.00g115070	Scaffold_05	30147459	30147704	NA	NA	NA	NA	NA
PGEN_.00g115080	Scaffold_05	30158924	30207089	Q9NGC3	CEG1A_DROME	Centaurin-gamma-1A	GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0016020; GO:0043087; GO:0043547; GO:0046872; GO:0072375	membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; medium-term memory [GO:0072375]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]
PGEN_.00g115090	Scaffold_05	30223863	30235634	A2XKU9	COSA_ORYSI	Costars family protein		
PGEN_.00g115100	Scaffold_05	30237299	30237652	NA	NA	NA	NA	NA
PGEN_.00g115110	Scaffold_05	30248173	30259567	Q9VFP2	RDX_DROME	Protein roadkill (Hh-induced MATH and BTB domain-containing protein)	GO:0001654; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007367; GO:0016567; GO:0030162; GO:0031625; GO:0031648; GO:0042067; GO:0042308; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0045879; GO:0046330; GO:0048592; GO:0051865; GO:1901044	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; establishment of ommatidial planar polarity [GO:0042067]; eye development [GO:0001654]; eye morphogenesis [GO:0048592]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process [GO:1901044]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]; segment polarity determination [GO:0007367]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g115120	Scaffold_05	30259637	30291443	P12821	ACE_HUMAN	"Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]"	GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0008144; GO:0008217; GO:0008237; GO:0008238; GO:0008239; GO:0008240; GO:0008241; GO:0008270; GO:0009897; GO:0010608; GO:0010629; GO:0014910; GO:0016021; GO:0019229; GO:0031404; GO:0031434; GO:0031711; GO:0032091; GO:0032092; GO:0032943; GO:0042447; GO:0043171; GO:0045777; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0061098; GO:0070062; GO:0070573; GO:0071838; GO:0097746; GO:1900086; GO:1902033; GO:1903597; GO:2000170	endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; dipeptidyl-peptidase activity [GO:0008239]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel remodeling [GO:0001974]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; mononuclear cell proliferation [GO:0032943]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of blood pressure [GO:0045777]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; spermatogenesis [GO:0007283]
PGEN_.00g115130	Scaffold_05	30292629	30301487	Q6Q4G4	ACE_THETS	Angiotensin-converting enzyme (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (TtACE)	GO:0004180; GO:0005615; GO:0008237; GO:0008241; GO:0016020; GO:0046872	extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]
PGEN_.00g115140	Scaffold_05	30308595	30309236	NA	NA	NA	NA	NA
PGEN_.00g115150	Scaffold_05	30318910	30341228	Q6Q4G4	ACE_THETS	Angiotensin-converting enzyme (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (TtACE)	GO:0004180; GO:0005615; GO:0008237; GO:0008241; GO:0016020; GO:0046872	extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]
PGEN_.00g115160	Scaffold_05	30343798	30344061	NA	NA	NA	NA	NA
PGEN_.00g115170	Scaffold_05	30373565	30374429	NA	NA	NA	NA	NA
PGEN_.00g115180	Scaffold_05	30378689	30385595	NA	NA	NA	NA	NA
PGEN_.00g115190	Scaffold_05	30387169	30397191	O73853	CP17A_ICTPU	"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)"	GO:0004508; GO:0005506; GO:0006694; GO:0007548; GO:0016020; GO:0020037; GO:0047442	membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]
PGEN_.00g115200	Scaffold_05	30418063	30418455	NA	NA	NA	NA	NA
PGEN_.00g115210	Scaffold_05	30418892	30419266	NA	NA	NA	NA	NA
PGEN_.00g115220	Scaffold_05	30427871	30436353	NA	NA	NA	NA	NA
PGEN_.00g115230	Scaffold_05	30447305	30456720	NA	NA	NA	NA	NA
PGEN_.00g115240	Scaffold_05	30498321	30513585	NA	NA	NA	NA	NA
PGEN_.00g115250	Scaffold_05	30618090	30618861	NA	NA	NA	NA	NA
PGEN_.00g115260	Scaffold_05	30619452	30634227	Q9JJZ5	EGFL6_MOUSE	Epidermal growth factor-like protein 6 (EGF-like protein 6) (MAM and EGF domains-containing gene protein) (Protein W80)	GO:0005178; GO:0005509; GO:0005604; GO:0007155; GO:0007275; GO:0010811; GO:0016020; GO:0030154; GO:0030198; GO:0031012	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811]
PGEN_.00g115270	Scaffold_05	30639133	30644014	A1A4P5	PFD2_BOVIN	Prefoldin subunit 2	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0051082; GO:0051495	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]
PGEN_.00g115280	Scaffold_05	30686676	30687509	NA	NA	NA	NA	NA
PGEN_.00g115290	Scaffold_05	30722401	30734975	NA	NA	NA	NA	NA
PGEN_.00g115300	Scaffold_05	30753215	30755365	Q09388	ACM2_CAEEL	Muscarinic acetylcholine receptor gar-2 (G-protein-linked acetylcholine receptor 2)	GO:0004930; GO:0004993; GO:0005887; GO:0007186; GO:0007187; GO:0007213; GO:0007268; GO:0007271; GO:0016907; GO:0030424; GO:0030425; GO:0030594; GO:0032223; GO:0042493; GO:0045202	"axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; response to drug [GO:0042493]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g115310	Scaffold_05	30855053	30855835	NA	NA	NA	NA	NA
PGEN_.00g115320	Scaffold_05	30880898	30881215	NA	NA	NA	NA	NA
PGEN_.00g115330	Scaffold_05	30881256	30881882	NA	NA	NA	NA	NA
PGEN_.00g115340	Scaffold_05	30882130	30882459	NA	NA	NA	NA	NA
PGEN_.00g115350	Scaffold_05	30882499	30882732	NA	NA	NA	NA	NA
PGEN_.00g115360	Scaffold_05	31147770	31148180	NA	NA	NA	NA	NA
PGEN_.00g115370	Scaffold_05	31148689	31156027	NA	NA	NA	NA	NA
PGEN_.00g115380	Scaffold_05	31245244	31247092	NA	NA	NA	NA	NA
PGEN_.00g115390	Scaffold_05	31254913	31268529	Q13185	CBX3_HUMAN	Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (Modifier 2 protein)	GO:0000775; GO:0000779; GO:0000784; GO:0000785; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005719; GO:0005720; GO:0005819; GO:0006338; GO:0006974; GO:0019899; GO:0019904; GO:0031618; GO:0035985; GO:0042802; GO:0045892; GO:0048511; GO:0070317; GO:0071549; GO:0090734; GO:1990226	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"
PGEN_.00g115400	Scaffold_05	31269053	31278407	P07909	ROA1_DROME	Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (PEN repeat clone P9) (hnRNP core protein A1-A)	GO:0000381; GO:0001745; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005703; GO:0007283; GO:0008266; GO:0033119; GO:0034046; GO:0036099; GO:0043565; GO:0045727; GO:0048026; GO:0048027; GO:0048477; GO:1990904	"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell population maintenance [GO:0036099]; negative regulation of RNA splicing [GO:0033119]; oogenesis [GO:0048477]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spermatogenesis [GO:0007283]"
PGEN_.00g115410	Scaffold_05	31294177	31294635	NA	NA	NA	NA	NA
PGEN_.00g115420	Scaffold_05	31294665	31295090	NA	NA	NA	NA	NA
PGEN_.00g115430	Scaffold_05	31299277	31335460	Q9WU81	G6PT3_MOUSE	Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2) (cAMP-inducible protein 2)	GO:0006072; GO:0006127; GO:0008643; GO:0015169; GO:0015760; GO:0015794; GO:0030176; GO:0035435; GO:0061513	integral component of endoplasmic reticulum membrane [GO:0030176]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glycerol-3-phosphate transmembrane transporter activity [GO:0015169]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate transmembrane transport [GO:0015794]; glycerophosphate shuttle [GO:0006127]; phosphate ion transmembrane transport [GO:0035435]
PGEN_.00g115440	Scaffold_05	31344309	31344629	NA	NA	NA	NA	NA
PGEN_.00g115450	Scaffold_05	31387133	31391687	NA	NA	NA	NA	NA
PGEN_.00g115460	Scaffold_05	31395804	31412260	Q91YD4	TRPM2_MOUSE	Transient receptor potential cation channel subfamily M member 2 (Long transient receptor potential channel 2) (LTrpC-2) (LTrpC2) (Transient receptor potential channel 7) (TrpC7)	GO:0001659; GO:0002407; GO:0005261; GO:0005272; GO:0005384; GO:0005509; GO:0005623; GO:0005764; GO:0005765; GO:0005886; GO:0005887; GO:0006828; GO:0009408; GO:0014074; GO:0015278; GO:0030659; GO:0032024; GO:0033194; GO:0035584; GO:0043005; GO:0043025; GO:0043204; GO:0044849; GO:0051209; GO:0051289; GO:0051489; GO:0070301; GO:0070588; GO:0071277; GO:0071415; GO:0071502; GO:0071577; GO:0072571; GO:0097028; GO:0097553; GO:0098703; GO:0099604; GO:1903223; GO:2000249	cell [GO:0005623]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; mono-ADP-D-ribose binding [GO:0072571]; sodium channel activity [GO:0005272]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; manganese ion transport [GO:0006828]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; protein homotetramerization [GO:0051289]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577]
PGEN_.00g115470	Scaffold_05	31413716	31414363	NA	NA	NA	NA	NA
PGEN_.00g115480	Scaffold_05	31414863	31458215	Q9BW91	NUDT9_HUMAN	"ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)"	GO:0005739; GO:0005759; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0034656; GO:0043262; GO:0046032; GO:0046709; GO:0047631; GO:0070062	cell junction [GO:0030054]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule catabolic process [GO:0034656]
PGEN_.00g115490	Scaffold_05	31471118	31524410	Q8MIB8	TF2LX_PONPY	"Homeobox protein TGIF2LX (TGF-beta-induced transcription factor 2-like protein) (TGFB-induced factor 2-like protein, X-linked) (TGIF-like on the X)"	GO:0003677; GO:0005634; GO:0006355	"nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g115500	Scaffold_05	31514681	31515055	NA	NA	NA	NA	NA
PGEN_.00g115510	Scaffold_05	31549259	31570084	Q6P1V8	MCM6Z_XENTR	Zygotic DNA replication licensing factor mcm6 (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 6) (zMCM6)	GO:0000727; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0042555; GO:0046872; GO:1902969	MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]
PGEN_.00g115520	Scaffold_05	31576093	31595187	NA	NA	NA	NA	NA
PGEN_.00g115530	Scaffold_05	31599421	31602488	NA	NA	NA	NA	NA
PGEN_.00g115540	Scaffold_05	31608526	31625001	Q869W9	PKS16_DICDI	Probable polyketide synthase 16 (dipks16) (EC 2.3.1.-)	GO:0016491; GO:0016740; GO:0019953	oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740]; sexual reproduction [GO:0019953]
PGEN_.00g115550	Scaffold_05	31630371	31641592	Q0EEE2	PTHD3_MOUSE	Patched domain-containing protein 3 (RND-type protein RNDEu-3)	GO:0016021; GO:0097225	integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]
PGEN_.00g115560	Scaffold_05	31688473	31692053	NA	NA	NA	NA	NA
PGEN_.00g115570	Scaffold_05	31698508	31700271	NA	NA	NA	NA	NA
PGEN_.00g115580	Scaffold_05	31706464	31706880	Q5ZMC3	WSDU1_CHICK	"WD repeat, SAM and U-box domain-containing protein 1"	GO:0004842	ubiquitin-protein transferase activity [GO:0004842]
PGEN_.00g115590	Scaffold_05	31722926	31773143	Q61139	PCSK7_MOUSE	Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Subtilisin-like proprotein convertase 7) (SPC7) (Subtilisin/kexin-like protease PC7)	GO:0004252; GO:0005788; GO:0005802; GO:0008233; GO:0016020; GO:0016485; GO:0030173	endoplasmic reticulum lumen [GO:0005788]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; protein processing [GO:0016485]
PGEN_.00g115600	Scaffold_05	31779463	31805365	Q9NZI7	UBIP1_HUMAN	Upstream-binding protein 1 (Transcription factor LBP-1)	GO:0000790; GO:0000981; GO:0001525; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0019079; GO:0043565; GO:0045892	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; angiogenesis [GO:0001525]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]"
PGEN_.00g115610	Scaffold_05	31816444	31819634	NA	NA	NA	NA	NA
PGEN_.00g115620	Scaffold_05	31851700	31855195	NA	NA	NA	NA	NA
PGEN_.00g115630	Scaffold_05	31856917	31857546	Q32KJ8	ARSI_RAT	Arylsulfatase I (ASI) (EC 3.1.6.-)	GO:0005576; GO:0005783; GO:0008484; GO:0046872	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]
PGEN_.00g115640	Scaffold_05	31857894	31863961	P50430	ARSB_RAT	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]
PGEN_.00g115650	Scaffold_05	31889259	31893596	NA	NA	NA	NA	NA
PGEN_.00g115660	Scaffold_05	31902664	31915732	A0JPF9	ISPD_DANRE	D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein)	GO:0005829; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0048747; GO:0048854; GO:0060049; GO:0070567	cytosol [GO:0005829]; cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803]; brain morphogenesis [GO:0048854]; isoprenoid biosynthetic process [GO:0008299]; muscle fiber development [GO:0048747]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049]
PGEN_.00g115670	Scaffold_05	31915923	31941474	Q67ER4	R113A_BOVIN	E3 ubiquitin-protein ligase RNF113A (EC 2.3.2.27) (RING finger protein 113A) (Zinc finger protein 183)	GO:0000398; GO:0004842; GO:0005634; GO:0005684; GO:0006281; GO:0016567; GO:0016607; GO:0018276; GO:0034247; GO:0046872; GO:0070100; GO:0071005	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]"
PGEN_.00g115680	Scaffold_05	31954384	31958080	NA	NA	NA	NA	NA
PGEN_.00g115690	Scaffold_05	32030586	32113758	Q9D2L5	CPXM2_MOUSE	Inactive carboxypeptidase-like protein X2	GO:0004181; GO:0005615; GO:0006518; GO:0008270; GO:0016485	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]
PGEN_.00g115700	Scaffold_05	32121131	32123260	Q6NSJ0	MYORG_HUMAN	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161)	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"
PGEN_.00g115710	Scaffold_05	32191280	32210907	Q9UPV0	CE164_HUMAN	Centrosomal protein of 164 kDa (Cep164)	GO:0000086; GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0010389; GO:0043231; GO:0051301; GO:0060271; GO:0097539; GO:0097711	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]
PGEN_.00g115720	Scaffold_05	32215870	32235343	NA	NA	NA	NA	NA
PGEN_.00g115730	Scaffold_05	32244347	32255377	A8MTY0	ZN724_HUMAN	Zinc finger protein 724	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g115740	Scaffold_05	32278496	32284037	NA	NA	NA	NA	NA
PGEN_.00g115750	Scaffold_05	32347458	32348466	NA	NA	NA	NA	NA
PGEN_.00g115760	Scaffold_05	32348931	32381335	NA	NA	NA	NA	NA
PGEN_.00g115770	Scaffold_05	32406080	32418500	Q19204	ADT2_CAEEL	A disintegrin and metalloproteinase with thrombospondin motifs adt-2 (ADAMTS adt-2) (EC 3.4.24.-)	GO:0004222; GO:0005576; GO:0008340; GO:0008361; GO:0030199; GO:0040018; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen fibril organization [GO:0030199]; determination of adult lifespan [GO:0008340]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell size [GO:0008361]
PGEN_.00g115780	Scaffold_05	32421545	32428885	P49013	FBP3_STRPU	Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)	GO:0005509; GO:0005615; GO:0009374	extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]
PGEN_.00g115790	Scaffold_05	32450472	32451044	NA	NA	NA	NA	NA
PGEN_.00g115800	Scaffold_05	32453234	32494332	Q27450	CYP1_BRUMA	Peptidyl-prolyl cis-trans isomerase 1 (PPIase 1) (EC 5.2.1.8) (BmCYP-1) (Cyclophilin) (Rotamase 1)	GO:0003755; GO:0006457	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]
PGEN_.00g115810	Scaffold_05	32499766	32508683	NA	NA	NA	NA	NA
PGEN_.00g115820	Scaffold_05	32514804	32549148	NA	NA	NA	NA	NA
PGEN_.00g115830	Scaffold_05	32609017	32624053	Q5T1A1	DCST2_HUMAN	DC-STAMP domain-containing protein 2	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g115840	Scaffold_05	32624571	32626711	Q9VU52	SNKY_DROME	Protein sneaky	GO:0001669; GO:0002080; GO:0008270; GO:0016021; GO:0035041; GO:0035042; GO:0035045	"acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; zinc ion binding [GO:0008270]; fertilization, exchange of chromosomal proteins [GO:0035042]; sperm chromatin decondensation [GO:0035041]; sperm plasma membrane disassembly [GO:0035045]"
PGEN_.00g115850	Scaffold_05	32643242	32672940	Q5U4X7	LMBR1_XENTR	Limb region 1 protein homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g115860	Scaffold_05	32672999	32684325	Q9UBK8	MTRR_HUMAN	Methionine synthase reductase (MSR) (EC 1.16.1.8)	GO:0000096; GO:0003958; GO:0005829; GO:0006306; GO:0006555; GO:0009086; GO:0009235; GO:0010181; GO:0016491; GO:0016723; GO:0030586; GO:0032259; GO:0033353; GO:0043418; GO:0046655; GO:0050444; GO:0050660; GO:0050661; GO:0050667; GO:0055114; GO:0070402; GO:0071949; GO:1904042	"cytosol [GO:0005829]; [methionine synthase] reductase activity [GO:0030586]; aquacobalamin reductase (NADPH) activity [GO:0050444]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]; cobalamin metabolic process [GO:0009235]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; oxidation-reduction process [GO:0055114]; S-adenosylmethionine cycle [GO:0033353]; sulfur amino acid metabolic process [GO:0000096]"
PGEN_.00g115870	Scaffold_05	32694934	32705972	Q13873	BMPR2_HUMAN	Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II)	GO:0001707; GO:0001893; GO:0001935; GO:0001938; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003148; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0004674; GO:0005024; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0005913; GO:0006366; GO:0006468; GO:0007178; GO:0007420; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010595; GO:0010634; GO:0010862; GO:0014069; GO:0014916; GO:0016324; GO:0016362; GO:0019838; GO:0030166; GO:0030308; GO:0030425; GO:0030501; GO:0030509; GO:0030513; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0044214; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048842; GO:0060173; GO:0060350; GO:0060412; GO:0060413; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0061626; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782; GO:2000279	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214]; activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta-activated receptor activity [GO:0005024]; anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; transcription by RNA polymerase II [GO:0006366]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412]"
PGEN_.00g115880	Scaffold_05	32711156	32714746	Q13873	BMPR2_HUMAN	Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II)	GO:0001707; GO:0001893; GO:0001935; GO:0001938; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003148; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0004674; GO:0005024; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0005913; GO:0006366; GO:0006468; GO:0007178; GO:0007420; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010595; GO:0010634; GO:0010862; GO:0014069; GO:0014916; GO:0016324; GO:0016362; GO:0019838; GO:0030166; GO:0030308; GO:0030425; GO:0030501; GO:0030509; GO:0030513; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0044214; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048842; GO:0060173; GO:0060350; GO:0060412; GO:0060413; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0061626; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782; GO:2000279	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214]; activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta-activated receptor activity [GO:0005024]; anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; transcription by RNA polymerase II [GO:0006366]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412]"
PGEN_.00g115890	Scaffold_05	32744954	32762859	Q90670	AVR2B_CHICK	Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB)	GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0008283; GO:0009798; GO:0017002; GO:0032924; GO:0043235; GO:0043525; GO:0045178; GO:0046872; GO:0048179; GO:0048185; GO:0048333; GO:0061550; GO:0071363; GO:1901389	activin receptor complex [GO:0048179]; basal part of cell [GO:0045178]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activin receptor signaling pathway [GO:0032924]; axis specification [GO:0009798]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cranial ganglion development [GO:0061550]; mesodermal cell differentiation [GO:0048333]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]
PGEN_.00g115900	Scaffold_05	32765221	32767685	NA	NA	NA	NA	NA
PGEN_.00g115910	Scaffold_05	32768433	32769992	NA	NA	NA	NA	NA
PGEN_.00g115920	Scaffold_05	32770139	32770402	NA	NA	NA	NA	NA
PGEN_.00g115930	Scaffold_05	32770440	32770766	NA	NA	NA	NA	NA
PGEN_.00g115940	Scaffold_05	32771268	32774451	NA	NA	NA	NA	NA
PGEN_.00g115950	Scaffold_05	32784457	32786400	Q9UQ80	PA2G4_HUMAN	Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1)	GO:0003676; GO:0003677; GO:0003700; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0016020; GO:0031625; GO:0035578; GO:0043066; GO:0043312; GO:0045597; GO:0045892; GO:0070062	"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"
PGEN_.00g115960	Scaffold_05	32846045	32846404	NA	NA	NA	NA	NA
PGEN_.00g115970	Scaffold_05	32847818	32857734	NA	NA	NA	NA	NA
PGEN_.00g115980	Scaffold_05	32860325	32865509	NA	NA	NA	NA	NA
PGEN_.00g115990	Scaffold_05	32876653	32876931	NA	NA	NA	NA	NA
PGEN_.00g116000	Scaffold_05	32886270	32887454	NA	NA	NA	NA	NA
PGEN_.00g116010	Scaffold_05	32900702	32910295	NA	NA	NA	NA	NA
PGEN_.00g116020	Scaffold_05	32921146	32970923	B3EWY8	SAAR2_ACRMI	Skeletal aspartic acid-rich protein 2 (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g116030	Scaffold_05	32928626	32928988	NA	NA	NA	NA	NA
PGEN_.00g116040	Scaffold_05	32929020	32934011	NA	NA	NA	NA	NA
PGEN_.00g116050	Scaffold_05	32980400	32998043	NA	NA	NA	NA	NA
PGEN_.00g116060	Scaffold_05	33015557	33021080	A8DT10	HXD3_HAPBU	Homeobox protein Hox-D3	GO:0003700; GO:0005634; GO:0007275; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]
PGEN_.00g116070	Scaffold_05	33030123	33041556	Q8R344	CCD12_MOUSE	Coiled-coil domain-containing protein 12	GO:0005684; GO:0071014	post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]
PGEN_.00g116080	Scaffold_05	33046713	33060042	P82279	CRUM1_HUMAN	Protein crumbs homolog 1	GO:0001917; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005913; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0016021; GO:0016324; GO:0032991; GO:0042462; GO:0045197	apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cell-cell signaling [GO:0007267]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; plasma membrane organization [GO:0007009]
PGEN_.00g116090	Scaffold_05	33066114	33075148	Q6P316	S2540_XENTR	Solute carrier family 25 member 40	GO:0005743; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]
PGEN_.00g116100	Scaffold_05	33102032	33102816	Q1L8G7	GATD1_DANRE	GATA zinc finger domain-containing protein 1	GO:0005634; GO:0006355; GO:0008270; GO:0031674; GO:0043565	"I band [GO:0031674]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g116110	Scaffold_05	33114617	33147364	P26221	GUN4_THEFU	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	GO:0008810; GO:0030245; GO:0030248	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]
PGEN_.00g116120	Scaffold_05	33161442	33162479	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g116130	Scaffold_05	33187834	33244598	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g116140	Scaffold_05	33250866	33259494	NA	NA	NA	NA	NA
PGEN_.00g116150	Scaffold_05	33269328	33277243	P13944	COCA1_CHICK	Collagen alpha-1(XII) chain (Fibrochimerin)	GO:0003429; GO:0005581; GO:0005615; GO:0007155; GO:0031012; GO:0035987; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g116160	Scaffold_05	33288116	33288577	NA	NA	NA	NA	NA
PGEN_.00g116170	Scaffold_05	33288656	33288922	NA	NA	NA	NA	NA
PGEN_.00g116180	Scaffold_05	33308197	33309864	Q0PV50	TLR3_BOSTR	Toll-like receptor 3 (CD antigen CD283)	GO:0002756; GO:0003725; GO:0004888; GO:0005769; GO:0005789; GO:0006954; GO:0010008; GO:0016021; GO:0032722; GO:0034138; GO:0043330; GO:0045087; GO:0050729; GO:0051607	early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; double-stranded RNA binding [GO:0003725]; transmembrane signaling receptor activity [GO:0004888]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; positive regulation of chemokine production [GO:0032722]; positive regulation of inflammatory response [GO:0050729]; response to exogenous dsRNA [GO:0043330]; toll-like receptor 3 signaling pathway [GO:0034138]
PGEN_.00g116190	Scaffold_05	33328583	33330857	NA	NA	NA	NA	NA
PGEN_.00g116200	Scaffold_05	33334249	33337992	NA	NA	NA	NA	NA
PGEN_.00g116210	Scaffold_05	33340256	33342488	NA	NA	NA	NA	NA
PGEN_.00g116220	Scaffold_05	33347608	33367318	Q6IRN0	S11IP_XENLA	Serine/threonine-protein kinase 11-interacting protein	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g116230	Scaffold_05	33370525	33373396	NA	NA	NA	NA	NA
PGEN_.00g116240	Scaffold_05	33382003	33396472	Q5F479	S11IP_CHICK	Serine/threonine-protein kinase 11-interacting protein	GO:0005737; GO:0008104; GO:0019901	cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; protein localization [GO:0008104]
PGEN_.00g116250	Scaffold_05	33406302	33421244	NA	NA	NA	NA	NA
PGEN_.00g116260	Scaffold_05	33441519	33446057	NA	NA	NA	NA	NA
PGEN_.00g116270	Scaffold_05	33460617	33485345	NA	NA	NA	NA	NA
PGEN_.00g116280	Scaffold_05	33490849	33518089	NA	NA	NA	NA	NA
PGEN_.00g116290	Scaffold_05	33543719	33544177	NA	NA	NA	NA	NA
PGEN_.00g116300	Scaffold_05	33559224	33559448	NA	NA	NA	NA	NA
PGEN_.00g116310	Scaffold_05	33565441	33566273	NA	NA	NA	NA	NA
PGEN_.00g116320	Scaffold_05	33572248	33575197	NA	NA	NA	NA	NA
PGEN_.00g116330	Scaffold_05	33576204	33631092	Q7ZUW2	HYOU1_DANRE	Hypoxia up-regulated protein 1	GO:0005524; GO:0005783; GO:0005788; GO:0034663; GO:0071456; GO:1903298	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]
PGEN_.00g116340	Scaffold_05	33632770	33633138	NA	NA	NA	NA	NA
PGEN_.00g116350	Scaffold_05	33649613	33660917	Q8N6F8	MET27_HUMAN	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)		
PGEN_.00g116360	Scaffold_05	33663713	33663934	NA	NA	NA	NA	NA
PGEN_.00g116370	Scaffold_05	33665238	33665606	NA	NA	NA	NA	NA
PGEN_.00g116380	Scaffold_05	33665814	33666134	NA	NA	NA	NA	NA
PGEN_.00g116390	Scaffold_05	33666363	33666824	NA	NA	NA	NA	NA
PGEN_.00g116400	Scaffold_05	33691534	33692128	NA	NA	NA	NA	NA
PGEN_.00g116410	Scaffold_05	33698908	33699162	NA	NA	NA	NA	NA
PGEN_.00g116420	Scaffold_05	33699249	33699581	NA	NA	NA	NA	NA
PGEN_.00g116430	Scaffold_05	33703024	33703311	NA	NA	NA	NA	NA
PGEN_.00g116440	Scaffold_05	33706797	33719780	NA	NA	NA	NA	NA
PGEN_.00g116450	Scaffold_05	33726716	33740915	NA	NA	NA	NA	NA
PGEN_.00g116460	Scaffold_05	33747972	33757249	Q9JJ94	SSNA1_MOUSE	Sjoegren syndrome nuclear autoantigen 1 homolog	GO:0005634; GO:0005737; GO:0005813; GO:0036064; GO:0042073; GO:0042802; GO:0060830	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; intraciliary transport [GO:0042073]
PGEN_.00g116470	Scaffold_05	33761749	33766458	NA	NA	NA	NA	NA
PGEN_.00g116480	Scaffold_05	33773624	33787584	P24495	PSA2_XENLA	Proteasome subunit alpha type-2 (EC 3.4.25.1) (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (xC3) (Proteasome component C3)	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0019773	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; threonine-type endopeptidase activity [GO:0004298]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g116490	Scaffold_05	33788447	33823528	Q55EH8	ABCGN_DICDI	ABC transporter G family member 23 (ABC transporter ABCG.23)	GO:0005524; GO:0016021; GO:0016887	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]
PGEN_.00g116500	Scaffold_05	33829831	33831245	NA	NA	NA	NA	NA
PGEN_.00g116510	Scaffold_05	33831512	33831745	NA	NA	NA	NA	NA
PGEN_.00g116520	Scaffold_05	33832160	33832447	NA	NA	NA	NA	NA
PGEN_.00g116530	Scaffold_05	33832862	33833164	NA	NA	NA	NA	NA
PGEN_.00g116540	Scaffold_05	33847585	33847956	NA	NA	NA	NA	NA
PGEN_.00g116550	Scaffold_05	33852078	33856696	NA	NA	NA	NA	NA
PGEN_.00g116560	Scaffold_05	33971406	33972035	NA	NA	NA	NA	NA
PGEN_.00g116570	Scaffold_05	33973507	33975978	NA	NA	NA	NA	NA
PGEN_.00g116580	Scaffold_05	33981832	33982059	NA	NA	NA	NA	NA
PGEN_.00g116590	Scaffold_05	33982088	33982357	NA	NA	NA	NA	NA
PGEN_.00g116600	Scaffold_05	33982401	33982763	NA	NA	NA	NA	NA
PGEN_.00g116610	Scaffold_05	33982819	33983019	NA	NA	NA	NA	NA
PGEN_.00g116620	Scaffold_05	34007972	34044382	Q2EY14	PRTGA_DANRE	Protogenin A	GO:0016021; GO:0050768	integral component of membrane [GO:0016021]; negative regulation of neurogenesis [GO:0050768]
PGEN_.00g116630	Scaffold_05	34020967	34024622	NA	NA	NA	NA	NA
PGEN_.00g116640	Scaffold_05	34088840	34091506	NA	NA	NA	NA	NA
PGEN_.00g116650	Scaffold_05	34091591	34115554	NA	NA	NA	NA	NA
PGEN_.00g116660	Scaffold_05	34125439	34140248	NA	NA	NA	NA	NA
PGEN_.00g116670	Scaffold_05	34158079	34242387	O88307	SORL_MOUSE	Sortilin-related receptor (Gp250) (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (mSorLA)	GO:0000139; GO:0001540; GO:0002024; GO:0005615; GO:0005623; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0016021; GO:0016477; GO:0030169; GO:0030306; GO:0030514; GO:0030658; GO:0031901; GO:0031985; GO:0032091; GO:0032460; GO:0032585; GO:0034067; GO:0038020; GO:0043025; GO:0043407; GO:0045053; GO:0045732; GO:0046628; GO:0048471; GO:0050768; GO:0051604; GO:0055037; GO:0055038; GO:0070863; GO:1900168; GO:1901215; GO:1902430; GO:1902771; GO:1902948; GO:1902953; GO:1902955; GO:1902960; GO:1902963; GO:1902966; GO:1902997; GO:1904179; GO:1990845; GO:2001137	cell [GO:0005623]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; ADP-ribosylation factor binding [GO:0030306]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor secretion [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910]
PGEN_.00g116680	Scaffold_05	34242551	34246022	NA	NA	NA	NA	NA
PGEN_.00g116690	Scaffold_05	34249010	34259142	Q01177	PLMN_RAT	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004175; GO:0004252; GO:0005102; GO:0005615; GO:0005623; GO:0005886; GO:0006508; GO:0007596; GO:0009986; GO:0010812; GO:0019897; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0031232; GO:0034185; GO:0042246; GO:0042730; GO:0043231; GO:0043536; GO:0044218; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051603; GO:0051702; GO:0051918; GO:0051919; GO:0052213; GO:0060707; GO:0060716; GO:0071674; GO:0098685; GO:0098978; GO:0099183; GO:1904854; GO:1990405	"cell [GO:0005623]; cell surface [GO:0009986]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; other organism cell membrane [GO:0044218]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; proteasome core complex binding [GO:1904854]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; interaction with symbiont [GO:0051702]; interaction with symbiont via secreted substance [GO:0052213]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]"
PGEN_.00g116700	Scaffold_05	34266141	34269143	Q8BV57	SRCRL_MOUSE	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D (Scavenger receptor cysteine-rich domain-containing protein LOC284297 homolog)	GO:0001968; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0007275; GO:0016020; GO:0042494; GO:0043236; GO:0045087; GO:0050829; GO:0050830; GO:0050840; GO:0062023; GO:2000482; GO:2000483	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; negative regulation of interleukin-8 secretion [GO:2000483]; regulation of interleukin-8 secretion [GO:2000482]
PGEN_.00g116710	Scaffold_05	34291625	34335232	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g116720	Scaffold_05	34414508	34414915	NA	NA	NA	NA	NA
PGEN_.00g116730	Scaffold_05	34417151	34432205	Q8CI17	MB213_MOUSE	Protein mab-21-like 3		
PGEN_.00g116740	Scaffold_05	34432249	34436865	NA	NA	NA	NA	NA
PGEN_.00g116750	Scaffold_05	34448994	34462391	NA	NA	NA	NA	NA
PGEN_.00g116760	Scaffold_05	34468130	34471411	NA	NA	NA	NA	NA
PGEN_.00g116770	Scaffold_05	34485803	34491460	NA	NA	NA	NA	NA
PGEN_.00g116780	Scaffold_05	34516145	34529935	NA	NA	NA	NA	NA
PGEN_.00g116790	Scaffold_05	34541959	34543643	NA	NA	NA	NA	NA
PGEN_.00g116800	Scaffold_05	34544129	34553031	Q9NRX2	RM17_HUMAN	"39S ribosomal protein L17, mitochondrial (L17mt) (MRP-L17) (LYST-interacting protein 2) (Mitochondrial large ribosomal subunit protein bL17m)"	GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0019904; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]
PGEN_.00g116810	Scaffold_05	34556645	34570066	Q90416	RXRGA_DANRE	Retinoic acid receptor RXR-gamma-A (Nuclear receptor subfamily 2 group B member 3-A) (Retinoic acid receptor RXR-alpha) (Retinoid X receptor alpha) (Retinoid X receptor gamma-A)	GO:0000977; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0032526; GO:0044323; GO:0045893; GO:0045944; GO:0048384; GO:0048856; GO:0090575	"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]"
PGEN_.00g116820	Scaffold_05	34581358	34585076	Q6GNV7	DIRC2_XENLA	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	GO:0005765; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]
PGEN_.00g116830	Scaffold_05	34586274	34587072	NA	NA	NA	NA	NA
PGEN_.00g116840	Scaffold_05	34591597	34601919	Q66H95	DIRC2_RAT	Solute carrier family 49 member 4 (Disrupted in renal carcinoma protein 2 homolog)	GO:0005765; GO:0016021; GO:0043231	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]
PGEN_.00g116850	Scaffold_05	34613914	34618070	NA	NA	NA	NA	NA
PGEN_.00g116860	Scaffold_05	34621136	34630285	NA	NA	NA	NA	NA
PGEN_.00g116870	Scaffold_05	34634042	34634326	NA	NA	NA	NA	NA
PGEN_.00g116880	Scaffold_05	34639714	34647420	NA	NA	NA	NA	NA
PGEN_.00g116890	Scaffold_05	34653083	34676019	Q80T91	MEG11_MOUSE	Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11)	GO:0010842; GO:0016021; GO:0016323; GO:0034109	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
PGEN_.00g116900	Scaffold_05	34684871	34741021	Q61830	MRC1_MOUSE	Macrophage mannose receptor 1 (MMR) (CD antigen CD206)	GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g116910	Scaffold_05	34759779	34875436	O08523	TECTA_MOUSE	Alpha-tectorin	GO:0005201; GO:0005886; GO:0007160; GO:0007605; GO:0031012; GO:0031225; GO:0062023	anchored component of membrane [GO:0031225]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]
PGEN_.00g116920	Scaffold_05	34952712	34979064	NA	NA	NA	NA	NA
PGEN_.00g116930	Scaffold_05	34990877	34992853	NA	NA	NA	NA	NA
PGEN_.00g116940	Scaffold_05	34998896	35002617	G9JJU2	GPX_PROCL	Glutathione peroxidase (PcGPx) (Se-PcGPx) (EC 1.11.1.9)	GO:0004602; GO:0006979	glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979]
PGEN_.00g116950	Scaffold_05	35046648	35072796	Q96DN6	MBD6_HUMAN	Methyl-CpG-binding domain protein 6 (Methyl-CpG-binding protein MBD6)	GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0010369; GO:0016579	chromocenter [GO:0010369]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; protein deubiquitination [GO:0016579]
PGEN_.00g116960	Scaffold_05	35091685	35095142	NA	NA	NA	NA	NA
PGEN_.00g116970	Scaffold_05	35242699	35253607	NA	NA	NA	NA	NA
PGEN_.00g116980	Scaffold_05	35268390	35269423	NA	NA	NA	NA	NA
PGEN_.00g116990	Scaffold_05	35270718	35271197	NA	NA	NA	NA	NA
PGEN_.00g117000	Scaffold_05	35290520	35303139	NA	NA	NA	NA	NA
PGEN_.00g117010	Scaffold_05	35311401	35328263	P10675	FAS1_SCHAM	Fasciclin-1 (Fasciclin I) (FAS I) (FCN)	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g117020	Scaffold_05	35351820	35359744	NA	NA	NA	NA	NA
PGEN_.00g117030	Scaffold_05	35406066	35406371	NA	NA	NA	NA	NA
PGEN_.00g117040	Scaffold_05	35419818	35423585	Q9CPQ8	ATP5L_MOUSE	"ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g)"	GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0008553; GO:0015986; GO:0046034	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]"
PGEN_.00g117050	Scaffold_05	35431872	35435259	Q29AK2	LMLN_DROPS	Leishmanolysin-like peptidase (EC 3.4.24.-)	GO:0004222; GO:0005737; GO:0006338; GO:0007052; GO:0007076; GO:0007100; GO:0007155; GO:0007420; GO:0007444; GO:0008233; GO:0008354; GO:0008406; GO:0016020; GO:0019915; GO:0022900; GO:0045842; GO:0046872; GO:0051298; GO:0051301; GO:1902769	cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of choline O-acetyltransferase activity [GO:1902769]
PGEN_.00g117060	Scaffold_05	35466380	35484118	Q9UH92	MLX_HUMAN	Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4)	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008134; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g117070	Scaffold_05	35487374	35495248	NA	NA	NA	NA	NA
PGEN_.00g117080	Scaffold_05	35510348	35517417	NA	NA	NA	NA	NA
PGEN_.00g117090	Scaffold_05	35517786	35525005	NA	NA	NA	NA	NA
PGEN_.00g117100	Scaffold_05	35529668	35540212	NA	NA	NA	NA	NA
PGEN_.00g117110	Scaffold_05	35546593	35586872	O60921	HUS1_HUMAN	Checkpoint protein HUS1 (hHUS1)	GO:0000077; GO:0000723; GO:0000724; GO:0001932; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0006289; GO:0006468; GO:0006974; GO:0008156; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479; GO:1901796	checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA integrity checkpoint [GO:0044778]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of DNA replication [GO:0008156]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]
PGEN_.00g117120	Scaffold_05	35589257	35590270	NA	NA	NA	NA	NA
PGEN_.00g117130	Scaffold_05	35611229	35621654	Q80TV8	CLAP1_MOUSE	CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1)	GO:0000226; GO:0000776; GO:0000777; GO:0001578; GO:0002162; GO:0005623; GO:0005794; GO:0005813; GO:0005828; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0030953; GO:0030981; GO:0031023; GO:0031111; GO:0031592; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0090091; GO:1903690; GO:1904261	"basal cortex [GO:0045180]; cell [GO:0005623]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]"
PGEN_.00g117140	Scaffold_05	35638982	35641962	NA	NA	NA	NA	NA
PGEN_.00g117150	Scaffold_05	35646801	35686972	A1A5G0	CLAP1_XENTR	CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1)	GO:0000777; GO:0005794; GO:0005815; GO:0005828; GO:0005881; GO:0007020; GO:0007049; GO:0031023; GO:0034453; GO:0043515; GO:0051010; GO:0051301	condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]
PGEN_.00g117160	Scaffold_05	35698187	35733717	Q7Z460	CLAP1_HUMAN	CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1)	GO:0000086; GO:0000226; GO:0000776; GO:0000777; GO:0001578; GO:0002162; GO:0005623; GO:0005794; GO:0005813; GO:0005828; GO:0005829; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010389; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030953; GO:0030981; GO:0031023; GO:0031111; GO:0031116; GO:0031592; GO:0034453; GO:0035371; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0090091; GO:0090162; GO:0090307; GO:0097711; GO:1903690; GO:1904261	"basal cortex [GO:0045180]; cell [GO:0005623]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]"
PGEN_.00g117170	Scaffold_05	35755004	35808414	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g117180	Scaffold_05	35811973	35837394	Q9HCR9	PDE11_HUMAN	"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)"	GO:0004112; GO:0004114; GO:0004118; GO:0005829; GO:0007165; GO:0007186; GO:0008152; GO:0010754; GO:0030553; GO:0043951; GO:0046872; GO:0047555	"cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]; metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]"
PGEN_.00g117190	Scaffold_05	36006509	36011316	NA	NA	NA	NA	NA
PGEN_.00g117200	Scaffold_05	36091770	36092009	NA	NA	NA	NA	NA
PGEN_.00g117210	Scaffold_05	36147967	36153864	NA	NA	NA	NA	NA
PGEN_.00g117220	Scaffold_05	36194464	36195473	NA	NA	NA	NA	NA
PGEN_.00g117230	Scaffold_05	36245890	36281321	NA	NA	NA	NA	NA
PGEN_.00g117240	Scaffold_05	36305456	36306490	NA	NA	NA	NA	NA
PGEN_.00g117250	Scaffold_05	36319845	36321660	NA	NA	NA	NA	NA
PGEN_.00g117260	Scaffold_05	36393322	36394552	NA	NA	NA	NA	NA
PGEN_.00g117270	Scaffold_05	36417519	36417923	NA	NA	NA	NA	NA
PGEN_.00g117280	Scaffold_05	36520372	36521675	NA	NA	NA	NA	NA
PGEN_.00g117290	Scaffold_05	36522297	36551821	Q59228	AAT_GEOSE	Aspartate aminotransferase (AspAT) (EC 2.6.1.1) (Transaminase A)	GO:0004069; GO:0005737; GO:0009058; GO:0030170	cytoplasm [GO:0005737]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]
PGEN_.00g117300	Scaffold_05	36573510	36609110	Q2KIL5	PDIA5_BOVIN	Protein disulfide-isomerase A5 (EC 5.3.4.1)	GO:0003756; GO:0005623; GO:0005788; GO:0015037; GO:0045454	cell [GO:0005623]; endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]
PGEN_.00g117310	Scaffold_05	36612307	36639855	Q5ZMV9	WDR24_CHICK	GATOR complex protein WDR24	GO:0005765; GO:0006914; GO:0032008	lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; positive regulation of TOR signaling [GO:0032008]
PGEN_.00g117320	Scaffold_05	36639900	36643327	Q66GT5	PTPM1_MOUSE	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (Phosphoinositide lipid phosphatase) (Protein-tyrosine phosphatase mitochondrial 1) (EC 3.1.3.16) (EC 3.1.3.48)	GO:0004439; GO:0004725; GO:0005739; GO:0005743; GO:0008138; GO:0008962; GO:0031305; GO:0032049; GO:0046488; GO:0061179; GO:2001242	"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cardiolipin biosynthetic process [GO:0032049]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; phosphatidylinositol metabolic process [GO:0046488]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]"
PGEN_.00g117330	Scaffold_05	36652715	36660835	NA	NA	NA	NA	NA
PGEN_.00g117340	Scaffold_05	36663831	36672492	NA	NA	NA	NA	NA
PGEN_.00g117350	Scaffold_05	36678212	36688952	NA	NA	NA	NA	NA
PGEN_.00g117360	Scaffold_05	36690670	36700944	NA	NA	NA	NA	NA
PGEN_.00g117370	Scaffold_05	36700968	36716961	NA	NA	NA	NA	NA
PGEN_.00g117380	Scaffold_05	36726965	36728074	NA	NA	NA	NA	NA
PGEN_.00g117390	Scaffold_05	36742542	36752781	NA	NA	NA	NA	NA
PGEN_.00g117400	Scaffold_05	36752904	36753944	Q8K3K9	GIMA4_RAT	GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein) (IAN-1) (Immunity-associated protein 4)	GO:0005525; GO:0005829	cytosol [GO:0005829]; GTP binding [GO:0005525]
PGEN_.00g117410	Scaffold_05	36803867	36827692	Q8AXS6	S35B1_XENTR	Solute carrier family 35 member B1	GO:0005459; GO:0005460; GO:0008643; GO:0022857; GO:0030173; GO:0030176; GO:0072334	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; carbohydrate transport [GO:0008643]; UDP-galactose transmembrane transport [GO:0072334]
PGEN_.00g117420	Scaffold_05	36839541	36851104	P51991	ROA3_HUMAN	Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3)	GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0014069; GO:0016070; GO:0035770; GO:0043005; GO:0051028; GO:0051033; GO:0071013; GO:1990124; GO:1990904	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA transmembrane transporter activity [GO:0051033]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; RNA metabolic process [GO:0016070]"
PGEN_.00g117430	Scaffold_05	36862331	36871663	Q8CGR7	UPP2_MOUSE	Uridine phosphorylase 2 (UPase 2) (UrdPase 2) (EC 2.4.2.3) (Liver-specific uridine phosphorylase) (L-UrdPase)	GO:0004850; GO:0005737; GO:0009116; GO:0009166; GO:0042802; GO:0044206; GO:0045098	cytoplasm [GO:0005737]; type III intermediate filament [GO:0045098]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; nucleoside metabolic process [GO:0009116]; nucleotide catabolic process [GO:0009166]; UMP salvage [GO:0044206]
PGEN_.00g117440	Scaffold_05	36878724	36920364	Q92547	TOPB1_HUMAN	DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)	GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006260; GO:0006281; GO:0006974; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802; GO:0043231; GO:1901796	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint [GO:0033314]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]
PGEN_.00g117450	Scaffold_05	36929497	36956422	Q56A18	SMCE1_RAT	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57)	GO:0003677; GO:0003723; GO:0005634; GO:0006337; GO:0006338; GO:0007286; GO:0007420; GO:0008080; GO:0016514; GO:0016922; GO:0022008; GO:0043044; GO:0045892; GO:0047485; GO:0071564; GO:0071565	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; spermatid development [GO:0007286]"
PGEN_.00g117460	Scaffold_05	36965426	36995865	Q63065	PDK1_RAT	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (PDK p48) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1)"	GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005739; GO:0005967; GO:0006006; GO:0006468; GO:0007166; GO:0008283; GO:0008631; GO:0010510; GO:0010906; GO:0018105; GO:0042802; GO:0044877; GO:0045254; GO:0046982; GO:0097411	mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]
PGEN_.00g117470	Scaffold_05	37021961	37022293	NA	NA	NA	NA	NA
PGEN_.00g117480	Scaffold_05	37025327	37028632	Q5U239	TM145_XENLA	Transmembrane protein 145	GO:0007186; GO:0016021; GO:0019236	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]
PGEN_.00g117490	Scaffold_05	37032061	37051558	Q5U239	TM145_XENLA	Transmembrane protein 145	GO:0007186; GO:0016021; GO:0019236	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]
PGEN_.00g117500	Scaffold_05	37159385	37160209	NA	NA	NA	NA	NA
PGEN_.00g117510	Scaffold_05	37175604	37180681	NA	NA	NA	NA	NA
PGEN_.00g117520	Scaffold_05	37180945	37181268	NA	NA	NA	NA	NA
PGEN_.00g117530	Scaffold_05	37190626	37190931	NA	NA	NA	NA	NA
PGEN_.00g117540	Scaffold_05	37292079	37295099	NA	NA	NA	NA	NA
PGEN_.00g117550	Scaffold_05	37515998	37519231	NA	NA	NA	NA	NA
PGEN_.00g117560	Scaffold_05	37519738	37520386	NA	NA	NA	NA	NA
PGEN_.00g117570	Scaffold_05	37527967	37533694	NA	NA	NA	NA	NA
PGEN_.00g117580	Scaffold_05	37547081	37555662	NA	NA	NA	NA	NA
PGEN_.00g117590	Scaffold_05	37565186	37567084	NA	NA	NA	NA	NA
PGEN_.00g117600	Scaffold_05	37586423	37588333	NA	NA	NA	NA	NA
PGEN_.00g117610	Scaffold_05	37597519	37622928	NA	NA	NA	NA	NA
PGEN_.00g117620	Scaffold_05	37636036	37650073	P50219	MNX1_HUMAN	Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9)	GO:0000790; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0006959; GO:0009653; GO:0021520; GO:0031018; GO:0043565; GO:0048812	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520]"
PGEN_.00g117630	Scaffold_05	37732308	37735576	NA	NA	NA	NA	NA
PGEN_.00g117640	Scaffold_05	37747449	37760714	NA	NA	NA	NA	NA
PGEN_.00g117650	Scaffold_05	37776999	37794783	Q9C098	DCLK3_HUMAN	Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3)	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:1900181	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]
PGEN_.00g117660	Scaffold_05	37802051	37802332	NA	NA	NA	NA	NA
PGEN_.00g117670	Scaffold_05	37815503	37828315	O15075	DCLK1_HUMAN	Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1)	GO:0001764; GO:0004672; GO:0004674; GO:0005524; GO:0005887; GO:0006468; GO:0007399; GO:0007417; GO:0009615; GO:0014069; GO:0016197; GO:0018105; GO:0021952; GO:0030900; GO:0035556; GO:0048675; GO:0048813; GO:1900181	integral component of plasma membrane [GO:0005887]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon extension [GO:0048675]; central nervous system development [GO:0007417]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; response to virus [GO:0009615]
PGEN_.00g117680	Scaffold_05	37872094	37872549	NA	NA	NA	NA	NA
PGEN_.00g117690	Scaffold_05	37872612	37898312	Q1ZZH1	GRM3_MACFA	Metabotropic glutamate receptor 3 (mGluR3)	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g117700	Scaffold_05	37923074	37930312	NA	NA	NA	NA	NA
PGEN_.00g117710	Scaffold_05	37934098	37938337	NA	NA	NA	NA	NA
PGEN_.00g117720	Scaffold_05	37945503	37946126	NA	NA	NA	NA	NA
PGEN_.00g117730	Scaffold_05	37948291	37949594	NA	NA	NA	NA	NA
PGEN_.00g117740	Scaffold_05	37950054	37951337	NA	NA	NA	NA	NA
PGEN_.00g117750	Scaffold_05	37951658	37955778	NA	NA	NA	NA	NA
PGEN_.00g117760	Scaffold_05	37956466	37956804	NA	NA	NA	NA	NA
PGEN_.00g117770	Scaffold_05	37957083	37957801	NA	NA	NA	NA	NA
PGEN_.00g117780	Scaffold_05	37957828	37958354	NA	NA	NA	NA	NA
PGEN_.00g117790	Scaffold_05	37971381	37972025	NA	NA	NA	NA	NA
PGEN_.00g117800	Scaffold_05	37976053	37993417	NA	NA	NA	NA	NA
PGEN_.00g117810	Scaffold_05	38004928	38005503	Q68RJ7	ACH92_ONCMY	Neuronal acetylcholine receptor subunit alpha-9-II (Nicotinic acetylcholine receptor subunit alpha-9-II) (NACHR alpha-9-II)	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g117820	Scaffold_05	38010816	38017361	NA	NA	NA	NA	NA
PGEN_.00g117830	Scaffold_05	38021897	38035128	Q7Z4L5	TT21B_HUMAN	Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog)	GO:0000790; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0021591; GO:0021798; GO:0030991; GO:0035721; GO:0035735; GO:0061512; GO:0097542; GO:1905799	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]
PGEN_.00g117840	Scaffold_05	38038442	38038708	NA	NA	NA	NA	NA
PGEN_.00g117850	Scaffold_05	38043163	38051908	NA	NA	NA	NA	NA
PGEN_.00g117860	Scaffold_05	38060083	38094728	NA	NA	NA	NA	NA
PGEN_.00g117870	Scaffold_05	38104439	38108230	NA	NA	NA	NA	NA
PGEN_.00g117880	Scaffold_05	38125535	38147529	NA	NA	NA	NA	NA
PGEN_.00g117890	Scaffold_05	38159056	38159682	NA	NA	NA	NA	NA
PGEN_.00g117900	Scaffold_05	38189596	38243320	Q7Z4L5	TT21B_HUMAN	Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog)	GO:0000790; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0021591; GO:0021798; GO:0030991; GO:0035721; GO:0035735; GO:0061512; GO:0097542; GO:1905799	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]
PGEN_.00g117910	Scaffold_05	38246760	38247035	NA	NA	NA	NA	NA
PGEN_.00g117920	Scaffold_05	38250982	38260083	NA	NA	NA	NA	NA
PGEN_.00g117930	Scaffold_05	38284958	38285428	NA	NA	NA	NA	NA
PGEN_.00g117940	Scaffold_05	38288538	38336913	Q99571	P2RX4_HUMAN	P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor)	GO:0001614; GO:0001894; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005623; GO:0005639; GO:0005765; GO:0005886; GO:0005887; GO:0007165; GO:0007596; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0014069; GO:0016020; GO:0019228; GO:0019233; GO:0019722; GO:0030054; GO:0032308; GO:0033198; GO:0034220; GO:0034405; GO:0035590; GO:0042118; GO:0042803; GO:0043025; GO:0043195; GO:0043197; GO:0043536; GO:0044297; GO:0045296; GO:0045429; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051260; GO:0051897; GO:0051899; GO:0051928; GO:0055117; GO:0055119; GO:0070062; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0099604; GO:1904124; GO:1904141; GO:2001028	cell [GO:0005623]; cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated cation channel activity [GO:0004931]; ligand-gated calcium channel activity [GO:0099604]; protein homodimerization activity [GO:0042803]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; microglial cell migration [GO:1904124]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein kinase B signaling [GO:0051897]; protein homooligomerization [GO:0051260]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]
PGEN_.00g117950	Scaffold_05	38376509	38377273	NA	NA	NA	NA	NA
PGEN_.00g117960	Scaffold_05	38395220	38418883	NA	NA	NA	NA	NA
PGEN_.00g117970	Scaffold_05	38424296	38429654	NA	NA	NA	NA	NA
PGEN_.00g117980	Scaffold_05	38443635	38452248	P81439	EQST_ACTEQ	Equistatin	GO:0004869; GO:0005576	extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]
PGEN_.00g117990	Scaffold_05	38471897	38474291	NA	NA	NA	NA	NA
PGEN_.00g118000	Scaffold_05	38478471	38479437	A5PK61	H3C_BOVIN	Histone H3.3C	GO:0000786; GO:0003677; GO:0005634; GO:0046982	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]
PGEN_.00g118010	Scaffold_05	38481359	38486824	NA	NA	NA	NA	NA
PGEN_.00g118020	Scaffold_05	38494440	38517555	Q68J42	LIPS_PIG	Hormone-sensitive lipase (HSL) (EC 3.1.1.79)	GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0008203; GO:0016042; GO:0016298; GO:0019433; GO:0033878; GO:0042134	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; hormone-sensitive lipase activity [GO:0033878]; lipase activity [GO:0016298]; rRNA primary transcript binding [GO:0042134]; cholesterol metabolic process [GO:0008203]; lipid catabolic process [GO:0016042]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433]
PGEN_.00g118030	Scaffold_05	38519087	38521559	NA	NA	NA	NA	NA
PGEN_.00g118040	Scaffold_05	38523260	38526791	NA	NA	NA	NA	NA
PGEN_.00g118050	Scaffold_05	38536934	38558854	Q5U1V9	TSN31_RAT	Tetraspanin-31 (Tspan-31) (Sarcoma-amplified sequence homolog)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g118060	Scaffold_05	38585292	38585732	NA	NA	NA	NA	NA
PGEN_.00g118070	Scaffold_05	38585850	38586455	NA	NA	NA	NA	NA
PGEN_.00g118080	Scaffold_05	38586609	38586959	NA	NA	NA	NA	NA
PGEN_.00g118090	Scaffold_05	38587743	38587994	NA	NA	NA	NA	NA
PGEN_.00g118100	Scaffold_05	38591297	38591740	NA	NA	NA	NA	NA
PGEN_.00g118110	Scaffold_05	38685044	38722040	P47807	MYO1A_CHICK	Unconventional myosin-Ia (Brush border myosin I) (BBM-I) (BBMI) (Myosin I heavy chain) (MIHC)	GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005884; GO:0005902; GO:0016197; GO:0016328; GO:0016459; GO:0016887; GO:0030027; GO:0030048; GO:0045056	actin filament [GO:0005884]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microvillus [GO:0005902]; myosin complex [GO:0016459]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament-based movement [GO:0030048]; endosomal transport [GO:0016197]; transcytosis [GO:0045056]
PGEN_.00g118120	Scaffold_05	38747565	38787709	Q9H0K1	SIK2_HUMAN	Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2)	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0035556; GO:0046626; GO:0046777	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626]
PGEN_.00g118130	Scaffold_05	38791707	38792192	NA	NA	NA	NA	NA
PGEN_.00g118140	Scaffold_05	38792262	38793310	NA	NA	NA	NA	NA
PGEN_.00g118150	Scaffold_05	38793493	38794644	NA	NA	NA	NA	NA
PGEN_.00g118160	Scaffold_05	38816487	38859746	NA	NA	NA	NA	NA
PGEN_.00g118170	Scaffold_05	38906830	38907330	NA	NA	NA	NA	NA
PGEN_.00g118180	Scaffold_05	38913922	38915079	Q8BKN6	HS3SA_MOUSE	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1) (Heparan sulfate 3-O-sulfotransferase 3A1)	GO:0000139; GO:0008467; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]
PGEN_.00g118190	Scaffold_05	38922437	38922907	NA	NA	NA	NA	NA
PGEN_.00g118200	Scaffold_05	38964491	38965278	NA	NA	NA	NA	NA
PGEN_.00g118210	Scaffold_05	38967906	38969659	NA	NA	NA	NA	NA
PGEN_.00g118220	Scaffold_05	39160398	39196773	Q4V622	CCH2R_DROME	Neuropeptide CCHamide-2 receptor	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g118230	Scaffold_05	39212594	39212884	NA	NA	NA	NA	NA
PGEN_.00g118240	Scaffold_05	39219888	39222278	NA	NA	NA	NA	NA
PGEN_.00g118250	Scaffold_05	39225307	39225570	NA	NA	NA	NA	NA
PGEN_.00g118260	Scaffold_05	39271530	39271928	NA	NA	NA	NA	NA
PGEN_.00g118270	Scaffold_05	39307078	39309154	NA	NA	NA	NA	NA
PGEN_.00g118280	Scaffold_05	39327231	39330726	Q3ZCX4	ZN568_HUMAN	Zinc finger protein 568	GO:0000122; GO:0000976; GO:0001701; GO:0005634; GO:0045892; GO:0046872; GO:0060669	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g118290	Scaffold_05	39353741	39354433	Q8N9K5	ZN565_HUMAN	Zinc finger protein 565	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g118300	Scaffold_05	39364271	39395872	Q8TD23	ZN675_HUMAN	Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein)	GO:0000122; GO:0003677; GO:0005634; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]
PGEN_.00g118310	Scaffold_05	39411534	39428141	Q3B7N9	MYNN_BOVIN	Myoneurin	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g118320	Scaffold_05	39445795	39447359	Q8NDW4	ZN248_HUMAN	Zinc finger protein 248	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g118330	Scaffold_05	39451952	39491273	NA	NA	NA	NA	NA
PGEN_.00g118340	Scaffold_05	39477860	39478111	NA	NA	NA	NA	NA
PGEN_.00g118350	Scaffold_05	39491270	39501021	NA	NA	NA	NA	NA
PGEN_.00g118360	Scaffold_05	39507870	39513566	NA	NA	NA	NA	NA
PGEN_.00g118370	Scaffold_05	39517330	39519348	NA	NA	NA	NA	NA
PGEN_.00g118380	Scaffold_05	39552436	39563129	NA	NA	NA	NA	NA
PGEN_.00g118390	Scaffold_05	39612920	39620605	NA	NA	NA	NA	NA
PGEN_.00g118400	Scaffold_05	39742008	39743227	NA	NA	NA	NA	NA
PGEN_.00g118410	Scaffold_05	39758519	39760819	NA	NA	NA	NA	NA
PGEN_.00g118420	Scaffold_05	39761973	39764167	NA	NA	NA	NA	NA
PGEN_.00g118430	Scaffold_05	39765681	39770043	NA	NA	NA	NA	NA
PGEN_.00g118440	Scaffold_05	39771871	39773935	NA	NA	NA	NA	NA
PGEN_.00g118450	Scaffold_05	39782829	39798649	Q8N865	CG031_HUMAN	Uncharacterized protein C7orf31	GO:0005737; GO:0005813	centrosome [GO:0005813]; cytoplasm [GO:0005737]
PGEN_.00g118460	Scaffold_05	39811415	39820432	NA	NA	NA	NA	NA
PGEN_.00g118470	Scaffold_05	39822670	39839658	P40237	CD82_MOUSE	CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1 homolog) (CD antigen CD82)	GO:0005886; GO:0005887	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]
PGEN_.00g118480	Scaffold_05	39859305	39884403	Q95KD7	CC191_MACFA	Coiled-coil domain-containing protein 191		
PGEN_.00g118490	Scaffold_05	39884982	39891219	B4F6U4	PRD10_XENTR	PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10)	GO:0000979; GO:0005634; GO:0008168; GO:0010468; GO:0032259; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; methylation [GO:0032259]; regulation of gene expression [GO:0010468]
PGEN_.00g118500	Scaffold_05	39924355	39973962	Q9Y345	SC6A5_HUMAN	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g118510	Scaffold_05	39980254	39980892	NA	NA	NA	NA	NA
PGEN_.00g118520	Scaffold_05	39981131	39981511	NA	NA	NA	NA	NA
PGEN_.00g118530	Scaffold_05	39981561	39982833	NA	NA	NA	NA	NA
PGEN_.00g118540	Scaffold_05	39997375	40006345	NA	NA	NA	NA	NA
PGEN_.00g118550	Scaffold_05	40013642	40013914	NA	NA	NA	NA	NA
PGEN_.00g118560	Scaffold_05	40032839	40033300	NA	NA	NA	NA	NA
PGEN_.00g118570	Scaffold_05	40033609	40033839	NA	NA	NA	NA	NA
PGEN_.00g118580	Scaffold_05	40033897	40034148	NA	NA	NA	NA	NA
PGEN_.00g118590	Scaffold_05	40034416	40034625	NA	NA	NA	NA	NA
PGEN_.00g118600	Scaffold_05	40034883	40035146	NA	NA	NA	NA	NA
PGEN_.00g118610	Scaffold_05	40035273	40035641	NA	NA	NA	NA	NA
PGEN_.00g118620	Scaffold_05	40091063	40116077	Q62384	ZPR1_MOUSE	Zinc finger protein ZPR1 (Zinc finger protein 259)	GO:0000226; GO:0001833; GO:0001834; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0010628; GO:0015030; GO:0021510; GO:0030424; GO:0030426; GO:0030576; GO:0030971; GO:0031369; GO:0031641; GO:0033120; GO:0042023; GO:0042307; GO:0043025; GO:0043204; GO:0045927; GO:0048471; GO:0061564; GO:0071364; GO:0071931; GO:0097504; GO:1902742; GO:1990261; GO:2000672	axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834]
PGEN_.00g118630	Scaffold_05	40129783	40137115	NA	NA	NA	NA	NA
PGEN_.00g118640	Scaffold_05	40160840	40179141	NA	NA	NA	NA	NA
PGEN_.00g118650	Scaffold_05	40197314	40197937	NA	NA	NA	NA	NA
PGEN_.00g118660	Scaffold_05	40203591	40221634	NA	NA	NA	NA	NA
PGEN_.00g118670	Scaffold_05	40241879	40242285	NA	NA	NA	NA	NA
PGEN_.00g118680	Scaffold_05	40246180	40265111	NA	NA	NA	NA	NA
PGEN_.00g118690	Scaffold_05	40265243	40295337	Q5E9A1	NACA_BOVIN	Nascent polypeptide-associated complex subunit alpha (NAC-alpha) (Alpha-NAC)	GO:0003677; GO:0003713; GO:0005634; GO:0005737; GO:0005854; GO:0015031; GO:0017025	cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; DNA binding [GO:0003677]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; protein transport [GO:0015031]
PGEN_.00g118700	Scaffold_05	40314683	40347286	P79134	ANXA6_BOVIN	Annexin A6 (Annexin VI) (Annexin-6)	GO:0001725; GO:0001778; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005525; GO:0005544; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006816; GO:0006937; GO:0008201; GO:0015276; GO:0015485; GO:0016020; GO:0016021; GO:0019899; GO:0030061; GO:0031214; GO:0031982; GO:0035374; GO:0038024; GO:0042470; GO:0042584; GO:0042802; GO:0048306; GO:0048471; GO:0051015; GO:0051283; GO:0051560; GO:0070509; GO:0070588; GO:0097190	chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrial crista [GO:0030061]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; phosphatidylserine binding [GO:0001786]; apoptotic signaling pathway [GO:0097190]; biomineral tissue development [GO:0031214]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937]
PGEN_.00g118710	Scaffold_05	40357658	40365125	NA	NA	NA	NA	NA
PGEN_.00g118720	Scaffold_05	40365605	40380669	Q3KNJ2	NHEJ1_MOUSE	Non-homologous end-joining factor 1 (Protein cernunnos) (XRCC4-like factor)	GO:0001650; GO:0005634; GO:0005654; GO:0006303; GO:0010212; GO:0030183; GO:0030217; GO:0032807; GO:0045027; GO:0070419	DNA ligase IV complex [GO:0032807]; fibrillar center [GO:0001650]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA end binding [GO:0045027]; B cell differentiation [GO:0030183]; double-strand break repair via nonhomologous end joining [GO:0006303]; response to ionizing radiation [GO:0010212]; T cell differentiation [GO:0030217]
PGEN_.00g118730	Scaffold_05	40384675	40400900	Q7ZU45	TTC25_DANRE	Tetratricopeptide repeat protein 25 (TPR repeat protein 25)	GO:0005737; GO:0005856; GO:0032474; GO:0042995; GO:0060271; GO:0061371	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]
PGEN_.00g118740	Scaffold_05	40412837	40413049	NA	NA	NA	NA	NA
PGEN_.00g118750	Scaffold_05	40422496	40430111	P17972	KCNAW_DROME	Potassium voltage-gated channel protein Shaw (Shaw2)	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]
PGEN_.00g118760	Scaffold_05	40467120	40471554	NA	NA	NA	NA	NA
PGEN_.00g118770	Scaffold_05	40486793	40503923	Q9GZV3	SC5A7_HUMAN	High affinity choline transporter 1 (Hemicholinium-3-sensitive choline transporter) (CHT) (Solute carrier family 5 member 7)	GO:0001701; GO:0005307; GO:0005886; GO:0007269; GO:0007271; GO:0007274; GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0030054; GO:0030424; GO:0030425; GO:0031594; GO:0033265; GO:0043204; GO:0045202; GO:0055085; GO:0098793	"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871]; in utero embryonic development [GO:0001701]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; synaptic transmission, cholinergic [GO:0007271]; transmembrane transport [GO:0055085]"
PGEN_.00g118780	Scaffold_05	40521104	40529692	P18755	ETS1A_XENLA	Protein c-ets-1-A (C-ets-1A)	GO:0003677; GO:0003700; GO:0005634; GO:0010595; GO:0043565; GO:0045648; GO:0045765; GO:0045893	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of angiogenesis [GO:0045765]"
PGEN_.00g118790	Scaffold_05	40592930	40593253	NA	NA	NA	NA	NA
PGEN_.00g118800	Scaffold_05	40644605	40645440	NA	NA	NA	NA	NA
PGEN_.00g118810	Scaffold_05	40646162	40678652	Q8WZ42	TITIN_HUMAN	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030017; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0071688; GO:0097493	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
PGEN_.00g118820	Scaffold_05	40680589	40680822	NA	NA	NA	NA	NA
PGEN_.00g118830	Scaffold_05	40689514	40697281	NA	NA	NA	NA	NA
PGEN_.00g118840	Scaffold_05	40716315	40736411	Q8WZ42	TITIN_HUMAN	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030017; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0071688; GO:0097493	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
PGEN_.00g118850	Scaffold_05	40765765	40782861	Q64319	SLC31_RAT	"Neutral and basic amino acid transport protein rBAT (D2) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transport protein) (NAA-TR)"	GO:0003824; GO:0005774; GO:0005886; GO:0005887; GO:0005975; GO:0006865; GO:0031526; GO:0044877	brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein-containing complex binding [GO:0044877]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g118860	Scaffold_05	40784159	40784419	NA	NA	NA	NA	NA
PGEN_.00g118870	Scaffold_05	40784486	40784770	NA	NA	NA	NA	NA
PGEN_.00g118880	Scaffold_05	40791251	40799520	Q8HY04	CD209_PAPHA	CD209 antigen (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN1) (CD antigen CD209)	GO:0002250; GO:0005537; GO:0006897; GO:0007155; GO:0016021; GO:0045087; GO:0046872	integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; innate immune response [GO:0045087]
PGEN_.00g118890	Scaffold_05	40805940	40812454	Q91ZW9	C209C_MOUSE	CD209 antigen-like protein C (DC-SIGN-related protein 2) (DC-SIGNR2) (CD antigen CD209)	GO:0005537; GO:0046872	mannose binding [GO:0005537]; metal ion binding [GO:0046872]
PGEN_.00g118900	Scaffold_05	40834506	40834850	NA	NA	NA	NA	NA
PGEN_.00g118910	Scaffold_05	40844126	40847018	NA	NA	NA	NA	NA
PGEN_.00g118920	Scaffold_05	40847220	40848780	NA	NA	NA	NA	NA
PGEN_.00g118930	Scaffold_05	40849282	40851177	NA	NA	NA	NA	NA
PGEN_.00g118940	Scaffold_05	40868400	40868813	NA	NA	NA	NA	NA
PGEN_.00g118950	Scaffold_05	40869011	40869562	Q02879	TBP2_WHEAT	TATA-box-binding protein 2 (TATA sequence-binding protein 2) (TBP-2) (TATA-binding factor 2) (TATA-box factor 2) (Transcription initiation factor TFIID TBP-2 subunit)	GO:0000978; GO:0000979; GO:0003700; GO:0005667; GO:0005669; GO:0006352; GO:0006366; GO:0008134	"transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g118960	Scaffold_05	40870439	40870729	NA	NA	NA	NA	NA
PGEN_.00g118970	Scaffold_05	40885990	40891934	NA	NA	NA	NA	NA
PGEN_.00g118980	Scaffold_05	41006083	41006439	NA	NA	NA	NA	NA
PGEN_.00g118990	Scaffold_05	41006724	41007125	NA	NA	NA	NA	NA
PGEN_.00g119000	Scaffold_05	41027496	41027786	NA	NA	NA	NA	NA
PGEN_.00g119010	Scaffold_05	41037060	41060596	NA	NA	NA	NA	NA
PGEN_.00g119020	Scaffold_05	41074484	41077262	NA	NA	NA	NA	NA
PGEN_.00g119030	Scaffold_05	41094241	41096935	NA	NA	NA	NA	NA
PGEN_.00g119040	Scaffold_05	41194366	41198626	NA	NA	NA	NA	NA
PGEN_.00g119050	Scaffold_05	41271538	41271858	NA	NA	NA	NA	NA
PGEN_.00g119060	Scaffold_05	41369773	41388076	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g119070	Scaffold_05	41428089	41437692	NA	NA	NA	NA	NA
PGEN_.00g119080	Scaffold_05	41437921	41438232	NA	NA	NA	NA	NA
PGEN_.00g119090	Scaffold_05	41457055	41457429	NA	NA	NA	NA	NA
PGEN_.00g119100	Scaffold_05	41472606	41492881	Q80T79	CSMD3_MOUSE	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g119110	Scaffold_05	41501731	41502598	NA	NA	NA	NA	NA
PGEN_.00g119120	Scaffold_05	41539132	41577159	Q5FWH7	S39AC_MOUSE	Zinc transporter ZIP12 (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12)	GO:0005385; GO:0005623; GO:0005886; GO:0005887; GO:0006882; GO:0007165; GO:0010975; GO:0031113; GO:0048471; GO:0071578	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578]
PGEN_.00g119130	Scaffold_05	41632714	41682268	P31422	GRM3_RAT	Metabotropic glutamate receptor 3 (mGluR3)	GO:0001641; GO:0005246; GO:0005886; GO:0005887; GO:0007216; GO:0008066; GO:0014069; GO:0019233; GO:0030424; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097449; GO:0098978; GO:0099055; GO:0099056	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]"
PGEN_.00g119140	Scaffold_05	41693181	41716376	P31422	GRM3_RAT	Metabotropic glutamate receptor 3 (mGluR3)	GO:0001641; GO:0005246; GO:0005886; GO:0005887; GO:0007216; GO:0008066; GO:0014069; GO:0019233; GO:0030424; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097449; GO:0098978; GO:0099055; GO:0099056	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]"
PGEN_.00g119150	Scaffold_05	41763353	41799161	P31422	GRM3_RAT	Metabotropic glutamate receptor 3 (mGluR3)	GO:0001641; GO:0005246; GO:0005886; GO:0005887; GO:0007216; GO:0008066; GO:0014069; GO:0019233; GO:0030424; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097449; GO:0098978; GO:0099055; GO:0099056	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]"
PGEN_.00g119160	Scaffold_05	41803054	41816472	P82596	PLC_HALLA	Perlucin	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g119170	Scaffold_05	41823394	41823621	Q8R034	APC13_MOUSE	Anaphase-promoting complex subunit 13 (APC13) (Cyclosome subunit 13)	GO:0005680; GO:0007049; GO:0051301; GO:0070979	anaphase-promoting complex [GO:0005680]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]
PGEN_.00g119180	Scaffold_05	41827885	41844759	Q9DCM0	ETHE1_MOUSE	"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1 homolog) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)"	GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0050313; GO:0070813	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]"
PGEN_.00g119190	Scaffold_05	41844830	41849730	Q9CQR7	PEN2_MOUSE	Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2)	GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0016485; GO:0032580; GO:0034205; GO:0042982; GO:0043085; GO:0070765; GO:0099056	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]
PGEN_.00g119200	Scaffold_05	41854407	41873229	A1A4K8	U2AF1_BOVIN	Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 snRNP auxiliary factor small subunit)	GO:0000398; GO:0005681; GO:0016607; GO:0030628; GO:0046872; GO:0050733; GO:0089701	"nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RS domain binding [GO:0050733]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g119210	Scaffold_05	41879171	41881597	NA	NA	NA	NA	NA
PGEN_.00g119220	Scaffold_05	41881689	41882399	NA	NA	NA	NA	NA
PGEN_.00g119230	Scaffold_05	41886401	41893511	NA	NA	NA	NA	NA
PGEN_.00g119240	Scaffold_05	41898741	41933329	P07850	SUOX_CHICK	Sulfite oxidase (EC 1.8.3.1)	GO:0005739; GO:0005758; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0042128; GO:0043546	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g119250	Scaffold_05	41946184	41982057	P0DN79	CBSL_HUMAN	Cystathionine beta-synthase-like protein (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	GO:0004122; GO:0004124; GO:0005634; GO:0005737; GO:0006535; GO:0019343; GO:0019346; GO:0020037; GO:0030170; GO:0046872; GO:0050667; GO:0070814	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cystathionine beta-synthase activity [GO:0004122]; cysteine synthase activity [GO:0004124]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; transsulfuration [GO:0019346]
PGEN_.00g119260	Scaffold_05	41953249	41953725	NA	NA	NA	NA	NA
PGEN_.00g119270	Scaffold_05	41953722	41954012	NA	NA	NA	NA	NA
PGEN_.00g119280	Scaffold_05	41961285	41961767	NA	NA	NA	NA	NA
PGEN_.00g119290	Scaffold_05	41992957	42029711	P54612	2AAA_PIG	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)	GO:0000159; GO:0000775; GO:0005634; GO:0005737; GO:0006470; GO:0007059; GO:0016328; GO:0019888; GO:0030425; GO:0065003	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; chromosome segregation [GO:0007059]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]"
PGEN_.00g119300	Scaffold_05	42035290	42045441	Q641Y2	NDUS2_RAT	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)"	GO:0005654; GO:0005747; GO:0006979; GO:0008137; GO:0031625; GO:0042775; GO:0046872; GO:0048038; GO:0051287; GO:0051539	"mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; response to oxidative stress [GO:0006979]"
PGEN_.00g119310	Scaffold_05	42049475	42052765	Q9ES30	C1QT3_MOUSE	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005576; GO:0005581; GO:0005615; GO:0005623; GO:0010629; GO:0032991; GO:0035356; GO:0042593; GO:0042802; GO:0045721; GO:0050715; GO:0050728; GO:0051897; GO:0070165; GO:0070206; GO:0070374; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; cellular triglyceride homeostasis [GO:0035356]; glucose homeostasis [GO:0042593]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; protein trimerization [GO:0070206]
PGEN_.00g119320	Scaffold_05	42063587	42078075	Q28I90	DCAF8_XENTR	DDB1- and CUL4-associated factor 8 (WD repeat-containing protein 42A)	GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g119330	Scaffold_05	42088667	42100218	A7RR34	FLTOP_NEMVE	Protein Flattop homolog (Cilia- and flagella-associated protein 126)	GO:0005737; GO:0005929; GO:0016324; GO:0036064; GO:0044782	apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium organization [GO:0044782]
PGEN_.00g119340	Scaffold_05	42103555	42107577	NA	NA	NA	NA	NA
PGEN_.00g119350	Scaffold_05	42153274	42170082	Q9D4H9	PHF14_MOUSE	PHD finger protein 14	GO:0000122; GO:0005634; GO:0008285; GO:0046872; GO:0048286; GO:0072201; GO:2000584; GO:2000791	nucleus [GO:0005634]; metal ion binding [GO:0046872]; lung alveolus development [GO:0048286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g119360	Scaffold_05	42171062	42188974	NA	NA	NA	NA	NA
PGEN_.00g119370	Scaffold_05	42205112	42241612	Q68FR2	BIN2_RAT	Bridging integrator 2	GO:0001891; GO:0002102; GO:0005543; GO:0005886; GO:0005938; GO:0006911; GO:0030054; GO:0042995; GO:0060326; GO:0071800; GO:0097320	"cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; phospholipid binding [GO:0005543]; cell chemotaxis [GO:0060326]; phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]"
PGEN_.00g119380	Scaffold_05	42253634	42287362	Q6PDG5	SMRC2_MOUSE	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)	GO:0000122; GO:0003677; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0016514; GO:0021882; GO:0042393; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565	"nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]"
PGEN_.00g119390	Scaffold_05	42288025	42310230	Q08BN9	NXPE3_DANRE	NXPE family member 3 (Protein FAM55C)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g119400	Scaffold_05	42323732	42358406	Q8C0I1	ADAS_MOUSE	"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Alkylglycerone-phosphate synthase)"	GO:0005730; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0008609; GO:0008610; GO:0008611; GO:0016491; GO:0071949	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610]
PGEN_.00g119410	Scaffold_05	42372680	42391212	Q5RDF5	JAZF1_PONAB	Juxtaposed with another zinc finger protein 1	GO:0003676; GO:0005634; GO:0006629; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; lipid metabolic process [GO:0006629]
PGEN_.00g119420	Scaffold_05	42393817	42400734	Q9CR84	AT5G1_MOUSE	"ATP synthase F(0) complex subunit C1, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase membrane subunit c locus 1) (ATP synthase proteolipid P1) (ATPase protein 9) (ATPase subunit c)"	GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0006754; GO:0008289; GO:0010917; GO:0015986; GO:0022834; GO:0034703; GO:0043025; GO:0045263; GO:0045773; GO:0046034; GO:0046931; GO:0046933; GO:0150034; GO:1901216; GO:1903427; GO:1905232	"cation channel complex [GO:0034703]; distal axon [GO:0150034]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; ligand-gated channel activity [GO:0022834]; lipid binding [GO:0008289]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to L-glutamate [GO:1905232]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; pore complex assembly [GO:0046931]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron death [GO:1901216]"
PGEN_.00g119430	Scaffold_05	42405587	42406508	NA	NA	NA	NA	NA
PGEN_.00g119440	Scaffold_05	42407947	42409212	NA	NA	NA	NA	NA
PGEN_.00g119450	Scaffold_05	42409748	42411426	NA	NA	NA	NA	NA
PGEN_.00g119460	Scaffold_05	42434748	42449879	H2L0Q3	GABR1_CAEEL	Gamma-aminobutyric acid type B receptor subunit 1	GO:0004965; GO:0007186; GO:0007214; GO:0032223; GO:0038039; GO:0042493; GO:1902712	"G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; response to drug [GO:0042493]"
PGEN_.00g119470	Scaffold_05	42452234	42468048	P05099	MATN1_CHICK	Cartilage matrix protein (Matrilin-1)	GO:0003429; GO:0005201; GO:0005509; GO:0005615; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g119480	Scaffold_05	42472203	42494459	Q9Z1J2	NEK4_MOUSE	Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2)	GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0023014; GO:0030145; GO:0032147; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:1900062; GO:2000772; GO:2001020	"ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]"
PGEN_.00g119490	Scaffold_05	42518959	42534502	NA	NA	NA	NA	NA
PGEN_.00g119500	Scaffold_05	42538101	42540053	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g119510	Scaffold_05	42545064	42549654	NA	NA	NA	NA	NA
PGEN_.00g119520	Scaffold_05	42556627	42557256	NA	NA	NA	NA	NA
PGEN_.00g119530	Scaffold_05	42557328	42557813	NA	NA	NA	NA	NA
PGEN_.00g119540	Scaffold_05	42558929	42573168	Q9Z186	G6PC2_MOUSE	Glucose-6-phosphatase 2 (G-6-Pase 2) (G6Pase 2) (EC 3.1.3.9) (Islet-specific glucose-6-phosphatase catalytic subunit-related protein)	GO:0004346; GO:0005783; GO:0005789; GO:0006094; GO:0016021; GO:0042593; GO:0050796; GO:0051156	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796]
PGEN_.00g119550	Scaffold_05	42574196	42576871	NA	NA	NA	NA	NA
PGEN_.00g119560	Scaffold_05	42576964	42579026	NA	NA	NA	NA	NA
PGEN_.00g119570	Scaffold_05	42587867	42621142	Q924A2	CIC_MOUSE	Protein capicua homolog	GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0007420; GO:0007612; GO:0007613; GO:0032991; GO:0035176; GO:0043231; GO:0045892; GO:0048286	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; social behavior [GO:0035176]"
PGEN_.00g119580	Scaffold_05	42627090	42628882	Q4R5Y0	CK001_MACFA	UPF0686 protein C11orf1 homolog	GO:0005634	nucleus [GO:0005634]
PGEN_.00g119590	Scaffold_05	42655763	42683249	NA	NA	NA	NA	NA
PGEN_.00g119600	Scaffold_05	42692789	42736080	P31335	PUR9_CHICK	Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)]	GO:0003937; GO:0004643; GO:0005829; GO:0006189; GO:0042803	cytosol [GO:0005829]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189]
PGEN_.00g119610	Scaffold_05	42751952	42758912	NA	NA	NA	NA	NA
PGEN_.00g119620	Scaffold_05	42785447	42789506	Q90ZB9	STAR3_SALFO	StAR-related lipid transfer protein 3 (MLN64-like protein) (START domain-containing protein 3) (StARD3) (Fragment)	GO:0005623; GO:0015485; GO:0016021; GO:0030301; GO:0031902; GO:0042803; GO:0044232; GO:0099044; GO:0120020; GO:0140284	cell [GO:0005623]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; protein homodimerization activity [GO:0042803]; cholesterol transport [GO:0030301]; vesicle tethering to endoplasmic reticulum [GO:0099044]
PGEN_.00g119630	Scaffold_05	42795627	42802947	NA	NA	NA	NA	NA
PGEN_.00g119640	Scaffold_05	42831049	42833298	NA	NA	NA	NA	NA
PGEN_.00g119650	Scaffold_05	42841774	42844032	NA	NA	NA	NA	NA
PGEN_.00g119660	Scaffold_05	42853340	42887702	Q0III3	DC1I2_BOVIN	"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)"	GO:0003774; GO:0005737; GO:0005868; GO:0005874; GO:0007018; GO:0031982; GO:0045503; GO:0045504; GO:2000582	"cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"
PGEN_.00g119670	Scaffold_05	42895917	42896474	NA	NA	NA	NA	NA
PGEN_.00g119680	Scaffold_05	42897266	42897508	NA	NA	NA	NA	NA
PGEN_.00g119690	Scaffold_05	43008547	43018388	Q7TM99	MOT9_MOUSE	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g119700	Scaffold_05	43058723	43063824	Q6AZ28	PIAS2_RAT	E3 SUMO-protein ligase PIAS2 (EC 2.3.2.-) (Androgen receptor-interacting protein 3) (ARIP3) (DAB2-interacting protein) (DIP) (E3 SUMO-protein transferase PIAS2) (Msx-interacting-zinc finger protein) (Protein inhibitor of activated STAT x) (Protein inhibitor of activated STAT2)	GO:0001085; GO:0003677; GO:0003712; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0007283; GO:0008134; GO:0008270; GO:0010033; GO:0016604; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019904; GO:0030331; GO:0030521; GO:0031625; GO:0033574; GO:0035259; GO:0043433; GO:0045667; GO:0045893; GO:0045944; GO:0050681; GO:0050775; GO:0060765; GO:0060766; GO:0061665	"nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein sumoylation [GO:0016925]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to organic substance [GO:0010033]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g119710	Scaffold_05	43072270	43106630	Q920Q4	VPS16_MOUSE	Vacuolar protein sorting-associated protein 16 homolog (mVPS16)	GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0007033; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031901; GO:0031902; GO:0032889; GO:0033263; GO:0035542; GO:0043025; GO:0046718; GO:0051015; GO:0055037; GO:0097352	"actin filament [GO:0005884]; autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]; viral entry into host cell [GO:0046718]"
PGEN_.00g119720	Scaffold_05	43115208	43127671	Q8HXQ5	MRP1_BOVIN	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	GO:0005524; GO:0005887; GO:0006855; GO:0008559; GO:0009925; GO:0009986; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1904646	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular response to amyloid-beta [GO:1904646]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g119730	Scaffold_05	43193643	43237556	Q5F364	MRP1_CHICK	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	GO:0005524; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g119740	Scaffold_05	43249326	43260928	E3RPB1	STS1_PYRTT	Tethering factor for nuclear proteasome sts1	GO:0005634; GO:0005737; GO:0015031; GO:0031144; GO:0071630	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; proteasome localization [GO:0031144]; protein transport [GO:0015031]
PGEN_.00g119750	Scaffold_05	43276030	43297063	Q9MZD1	S17A5_SHEEP	Sialin (Membrane glycoprotein SP55) (Sodium/sialic acid cotransporter) (Solute carrier family 17 member 5)	GO:0005765; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]
PGEN_.00g119760	Scaffold_05	43318495	43334907	P97837	DLGP2_RAT	Disks large-associated protein 2 (DAP-2) (PSD-95/SAP90-binding protein 2) (SAP90/PSD-95-associated protein 2) (SAPAP2)	GO:0004385; GO:0005883; GO:0007270; GO:0014069; GO:0019904; GO:0030054; GO:0030425; GO:0043197; GO:0045211; GO:0098962	cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; neurofilament [GO:0005883]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; guanylate kinase activity [GO:0004385]; protein domain specific binding [GO:0019904]; neuron-neuron synaptic transmission [GO:0007270]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]
PGEN_.00g119770	Scaffold_05	43355964	43356179	NA	NA	NA	NA	NA
PGEN_.00g119780	Scaffold_05	43361076	43362870	NA	NA	NA	NA	NA
PGEN_.00g119790	Scaffold_05	43378218	43383244	NA	NA	NA	NA	NA
PGEN_.00g119800	Scaffold_05	43395954	43396463	NA	NA	NA	NA	NA
PGEN_.00g119810	Scaffold_05	43417522	43420276	NA	NA	NA	NA	NA
PGEN_.00g119820	Scaffold_05	43429985	43450220	NA	NA	NA	NA	NA
PGEN_.00g119830	Scaffold_05	43458028	43468339	NA	NA	NA	NA	NA
PGEN_.00g119840	Scaffold_05	43468555	43479558	P38117	ETFB_HUMAN	Electron transfer flavoprotein subunit beta (Beta-ETF)	GO:0005739; GO:0005759; GO:0009055; GO:0022904; GO:0033539	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]
PGEN_.00g119850	Scaffold_05	43486637	43500808	Q96KN3	PKNX2_HUMAN	Homeobox protein PKNOX2 (Homeobox protein PREP-2) (PBX/knotted homeobox 2)	GO:0000977; GO:0000981; GO:0003785; GO:0005654; GO:0005737; GO:0015629; GO:0015630; GO:0045171; GO:0051015	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
PGEN_.00g119860	Scaffold_05	43509059	43522135	Q7Z4T9	CFA91_HUMAN	Cilia- and flagella-associated protein 91 (CFAP91) (AMY-1-associating protein expressed in testis 1) (AAT-1) (MYCBP/AMY-1-associated testis-expressed protein 1) (Protein MAATS1)	GO:0003341; GO:0005739; GO:0005930; GO:0031514	axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; cilium movement [GO:0003341]
PGEN_.00g119870	Scaffold_05	43557939	43560129	NA	NA	NA	NA	NA
PGEN_.00g119880	Scaffold_05	43609162	43609533	NA	NA	NA	NA	NA
PGEN_.00g119890	Scaffold_05	43665246	43713371	NA	NA	NA	NA	NA
PGEN_.00g119900	Scaffold_05	43682441	43682812	NA	NA	NA	NA	NA
PGEN_.00g119910	Scaffold_05	43727380	43741040	Q8VBW5	BBX_MOUSE	HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2)	GO:0003677; GO:0005654; GO:0005829; GO:0060348	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; bone development [GO:0060348]
PGEN_.00g119920	Scaffold_05	43747910	43801070	Q14146	URB2_HUMAN	Unhealthy ribosome biogenesis protein 2 homolog	GO:0005730; GO:0016235; GO:0030496; GO:0042254	aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]
PGEN_.00g119930	Scaffold_05	43805879	43830128	P98066	TSG6_HUMAN	Tumor necrosis factor-inducible gene 6 protein (Hyaluronate-binding protein) (TNF-stimulated gene 6 protein) (TSG-6) (Tumor necrosis factor alpha-induced protein 6) (TNF alpha-induced protein 6)	GO:0005540; GO:0005576; GO:0005615; GO:0006954; GO:0007155; GO:0007165; GO:0007267; GO:0030335; GO:0030728; GO:0043312; GO:0050728; GO:1904724; GO:1904813	extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954]; negative regulation of inflammatory response [GO:0050728]; neutrophil degranulation [GO:0043312]; ovulation [GO:0030728]; positive regulation of cell migration [GO:0030335]; signal transduction [GO:0007165]
PGEN_.00g119940	Scaffold_05	43838220	43848482	Q9Y3D2	MSRB2_HUMAN	"Methionine-R-sulfoxide reductase B2, mitochondrial (MsrB2) (EC 1.8.4.12) (EC 1.8.4.14)"	GO:0003779; GO:0005739; GO:0005829; GO:0006979; GO:0008270; GO:0030041; GO:0030091; GO:0033743; GO:0033745	cytosol [GO:0005829]; mitochondrion [GO:0005739]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; actin filament polymerization [GO:0030041]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]
PGEN_.00g119950	Scaffold_05	43848604	43871991	O94889	KLH18_HUMAN	Kelch-like protein 18	GO:0007049; GO:0016567; GO:0051301; GO:1901992	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]
PGEN_.00g119960	Scaffold_05	43887670	43889112	NA	NA	NA	NA	NA
PGEN_.00g119970	Scaffold_05	43889359	43921020	Q9D4B2	TTC25_MOUSE	Tetratricopeptide repeat protein 25 (TPR repeat protein 25)	GO:0005737; GO:0005856; GO:0005929	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]
PGEN_.00g119980	Scaffold_05	43929041	43931208	NA	NA	NA	NA	NA
PGEN_.00g119990	Scaffold_05	43948740	43949051	NA	NA	NA	NA	NA
PGEN_.00g120000	Scaffold_05	43961773	43963435	NA	NA	NA	NA	NA
PGEN_.00g120010	Scaffold_05	43963517	43971291	NA	NA	NA	NA	NA
PGEN_.00g120020	Scaffold_05	44024270	44030603	NA	NA	NA	NA	NA
PGEN_.00g120030	Scaffold_05	44075549	44146508	P13595	NCAM1_MOUSE	Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)	GO:0001928; GO:0005829; GO:0005886; GO:0005911; GO:0007166; GO:0007413; GO:0007568; GO:0007611; GO:0008201; GO:0009897; GO:0009986; GO:0010288; GO:0019902; GO:0021794; GO:0030275; GO:0030424; GO:0030426; GO:0031175; GO:0031225; GO:0033555; GO:0034109; GO:0042220; GO:0042493; GO:0042802; GO:0043025; GO:0043209; GO:0048666; GO:0050804; GO:0050850; GO:0051930; GO:0060045; GO:0060548; GO:0071679; GO:0098685; GO:0098978; GO:0099055; GO:0099056; GO:2001260	anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; phosphatase binding [GO:0019902]; aging [GO:0007568]; axonal fasciculation [GO:0007413]; cell surface receptor signaling pathway [GO:0007166]; commissural neuron axon guidance [GO:0071679]; homotypic cell-cell adhesion [GO:0034109]; learning or memory [GO:0007611]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of exocyst assembly [GO:0001928]; regulation of semaphorin-plexin signaling pathway [GO:2001260]; regulation of sensory perception of pain [GO:0051930]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to lead ion [GO:0010288]; thalamus development [GO:0021794]
PGEN_.00g120040	Scaffold_05	44157139	44158269	NA	NA	NA	NA	NA
PGEN_.00g120050	Scaffold_05	44166732	44167862	NA	NA	NA	NA	NA
PGEN_.00g120060	Scaffold_05	44178469	44249556	P16170	NCA11_XENLA	Neural cell adhesion molecule 1-A (N-CAM-1-A) (NCAM-1-A)	GO:0005886; GO:0007155; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g120070	Scaffold_05	44294090	44294323	NA	NA	NA	NA	NA
PGEN_.00g120080	Scaffold_05	44396567	44398315	NA	NA	NA	NA	NA
PGEN_.00g120090	Scaffold_05	44406368	44438215	Q9D4B2	TTC25_MOUSE	Tetratricopeptide repeat protein 25 (TPR repeat protein 25)	GO:0005737; GO:0005856; GO:0005929	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]
PGEN_.00g120100	Scaffold_05	44455376	44478954	O94889	KLH18_HUMAN	Kelch-like protein 18	GO:0007049; GO:0016567; GO:0051301; GO:1901992	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]
PGEN_.00g120110	Scaffold_05	44479076	44489381	Q9Y3D2	MSRB2_HUMAN	"Methionine-R-sulfoxide reductase B2, mitochondrial (MsrB2) (EC 1.8.4.12) (EC 1.8.4.14)"	GO:0003779; GO:0005739; GO:0005829; GO:0006979; GO:0008270; GO:0030041; GO:0030091; GO:0033743; GO:0033745	cytosol [GO:0005829]; mitochondrion [GO:0005739]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; actin filament polymerization [GO:0030041]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]
PGEN_.00g120120	Scaffold_05	44497751	44524518	P98066	TSG6_HUMAN	Tumor necrosis factor-inducible gene 6 protein (Hyaluronate-binding protein) (TNF-stimulated gene 6 protein) (TSG-6) (Tumor necrosis factor alpha-induced protein 6) (TNF alpha-induced protein 6)	GO:0005540; GO:0005576; GO:0005615; GO:0006954; GO:0007155; GO:0007165; GO:0007267; GO:0030335; GO:0030728; GO:0043312; GO:0050728; GO:1904724; GO:1904813	extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954]; negative regulation of inflammatory response [GO:0050728]; neutrophil degranulation [GO:0043312]; ovulation [GO:0030728]; positive regulation of cell migration [GO:0030335]; signal transduction [GO:0007165]
PGEN_.00g120130	Scaffold_05	44529333	44582488	Q14146	URB2_HUMAN	Unhealthy ribosome biogenesis protein 2 homolog	GO:0005730; GO:0016235; GO:0030496; GO:0042254	aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]
PGEN_.00g120140	Scaffold_05	44589358	44603006	Q8VBW5	BBX_MOUSE	HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2)	GO:0003677; GO:0005654; GO:0005829; GO:0060348	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; bone development [GO:0060348]
PGEN_.00g120150	Scaffold_05	44617017	44618510	NA	NA	NA	NA	NA
PGEN_.00g120160	Scaffold_05	44627881	44670543	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g120170	Scaffold_05	44648067	44648438	NA	NA	NA	NA	NA
PGEN_.00g120180	Scaffold_05	44769780	44773857	NA	NA	NA	NA	NA
PGEN_.00g120190	Scaffold_05	44807228	44820409	Q7Z4T9	CFA91_HUMAN	Cilia- and flagella-associated protein 91 (CFAP91) (AMY-1-associating protein expressed in testis 1) (AAT-1) (MYCBP/AMY-1-associated testis-expressed protein 1) (Protein MAATS1)	GO:0003341; GO:0005739; GO:0005930; GO:0031514	axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; cilium movement [GO:0003341]
PGEN_.00g120200	Scaffold_05	44830287	44842310	Q96KN3	PKNX2_HUMAN	Homeobox protein PKNOX2 (Homeobox protein PREP-2) (PBX/knotted homeobox 2)	GO:0000977; GO:0000981; GO:0003785; GO:0005654; GO:0005737; GO:0015629; GO:0015630; GO:0045171; GO:0051015	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
PGEN_.00g120210	Scaffold_05	44842342	44861284	P38117	ETFB_HUMAN	Electron transfer flavoprotein subunit beta (Beta-ETF)	GO:0005739; GO:0005759; GO:0009055; GO:0022904; GO:0033539	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]
PGEN_.00g120220	Scaffold_05	44861500	44871810	NA	NA	NA	NA	NA
PGEN_.00g120230	Scaffold_05	44879619	44899865	NA	NA	NA	NA	NA
PGEN_.00g120240	Scaffold_05	44908155	44910895	NA	NA	NA	NA	NA
PGEN_.00g120250	Scaffold_05	44932526	44932753	NA	NA	NA	NA	NA
PGEN_.00g120260	Scaffold_05	44945726	45010371	P97837	DLGP2_RAT	Disks large-associated protein 2 (DAP-2) (PSD-95/SAP90-binding protein 2) (SAP90/PSD-95-associated protein 2) (SAPAP2)	GO:0004385; GO:0005883; GO:0007270; GO:0014069; GO:0019904; GO:0030054; GO:0030425; GO:0043197; GO:0045211; GO:0098962	cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; neurofilament [GO:0005883]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; guanylate kinase activity [GO:0004385]; protein domain specific binding [GO:0019904]; neuron-neuron synaptic transmission [GO:0007270]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]
PGEN_.00g120270	Scaffold_05	44966009	44967808	NA	NA	NA	NA	NA
PGEN_.00g120280	Scaffold_05	45031989	45053038	Q9MZD1	S17A5_SHEEP	Sialin (Membrane glycoprotein SP55) (Sodium/sialic acid cotransporter) (Solute carrier family 17 member 5)	GO:0005765; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]
PGEN_.00g120290	Scaffold_05	45038895	45039416	NA	NA	NA	NA	NA
PGEN_.00g120300	Scaffold_05	45067606	45072215	NA	NA	NA	NA	NA
PGEN_.00g120310	Scaffold_05	45072466	45073395	NA	NA	NA	NA	NA
PGEN_.00g120320	Scaffold_05	45075016	45079543	NA	NA	NA	NA	NA
PGEN_.00g120330	Scaffold_05	45089648	45133072	Q8CG09	MRP1_RAT	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0009925; GO:0009986; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0016887; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042887; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0060548; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1901215; GO:1990961	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]
PGEN_.00g120340	Scaffold_05	45199044	45211547	Q8HXQ5	MRP1_BOVIN	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	GO:0005524; GO:0005887; GO:0006855; GO:0008559; GO:0009925; GO:0009986; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016887; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1904646	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular response to amyloid-beta [GO:1904646]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g120350	Scaffold_05	45223214	45240567	Q920Q4	VPS16_MOUSE	Vacuolar protein sorting-associated protein 16 homolog (mVPS16)	GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0007033; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031901; GO:0031902; GO:0032889; GO:0033263; GO:0035542; GO:0043025; GO:0046718; GO:0051015; GO:0055037; GO:0097352	"actin filament [GO:0005884]; autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion, non-autophagic [GO:0032889]; vacuole organization [GO:0007033]; viral entry into host cell [GO:0046718]"
PGEN_.00g120360	Scaffold_05	45248998	45254689	Q6AZ28	PIAS2_RAT	E3 SUMO-protein ligase PIAS2 (EC 2.3.2.-) (Androgen receptor-interacting protein 3) (ARIP3) (DAB2-interacting protein) (DIP) (E3 SUMO-protein transferase PIAS2) (Msx-interacting-zinc finger protein) (Protein inhibitor of activated STAT x) (Protein inhibitor of activated STAT2)	GO:0001085; GO:0003677; GO:0003712; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0007283; GO:0008134; GO:0008270; GO:0010033; GO:0016604; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019904; GO:0030331; GO:0030521; GO:0031625; GO:0033574; GO:0035259; GO:0043433; GO:0045667; GO:0045893; GO:0045944; GO:0050681; GO:0050775; GO:0060765; GO:0060766; GO:0061665	"nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein sumoylation [GO:0016925]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to organic substance [GO:0010033]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g120370	Scaffold_05	45295989	45305789	Q7TM99	MOT9_MOUSE	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g120380	Scaffold_05	45416815	45417542	NA	NA	NA	NA	NA
PGEN_.00g120390	Scaffold_05	45427622	45464062	Q13409	DC1I2_HUMAN	"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)"	GO:0000086; GO:0003777; GO:0005737; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0007018; GO:0010389; GO:0016032; GO:0019886; GO:0031982; GO:0045503; GO:0045504; GO:0097711; GO:2000582	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; viral process [GO:0016032]"
PGEN_.00g120400	Scaffold_05	45473385	45475643	NA	NA	NA	NA	NA
PGEN_.00g120410	Scaffold_05	45484342	45486591	NA	NA	NA	NA	NA
PGEN_.00g120420	Scaffold_05	45514810	45520133	NA	NA	NA	NA	NA
PGEN_.00g120430	Scaffold_05	45528261	45541254	Q90ZB9	STAR3_SALFO	StAR-related lipid transfer protein 3 (MLN64-like protein) (START domain-containing protein 3) (StARD3) (Fragment)	GO:0005623; GO:0015485; GO:0016021; GO:0030301; GO:0031902; GO:0042803; GO:0044232; GO:0099044; GO:0120020; GO:0140284	cell [GO:0005623]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; protein homodimerization activity [GO:0042803]; cholesterol transport [GO:0030301]; vesicle tethering to endoplasmic reticulum [GO:0099044]
PGEN_.00g120440	Scaffold_05	45558916	45564801	NA	NA	NA	NA	NA
PGEN_.00g120450	Scaffold_05	45573192	45573968	NA	NA	NA	NA	NA
PGEN_.00g120460	Scaffold_05	45575671	45619918	P31335	PUR9_CHICK	Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)]	GO:0003937; GO:0004643; GO:0005829; GO:0006189; GO:0042803	cytosol [GO:0005829]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189]
PGEN_.00g120470	Scaffold_05	45628167	45655982	NA	NA	NA	NA	NA
PGEN_.00g120480	Scaffold_05	45665293	45665589	NA	NA	NA	NA	NA
PGEN_.00g120490	Scaffold_05	45706012	45769289	Q03206	RAC1_CAEEL	Ras-related protein ced-10 (CErac1) (Cell death protein 10) (Cell-corpse engulfment protein ced-10) (Ras-related protein rac-1)	GO:0000132; GO:0001764; GO:0002119; GO:0003924; GO:0005525; GO:0005623; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006915; GO:0007015; GO:0007163; GO:0007264; GO:0007266; GO:0007369; GO:0008045; GO:0008360; GO:0009898; GO:0010171; GO:0010172; GO:0016021; GO:0016477; GO:0019901; GO:0030036; GO:0030334; GO:0030950; GO:0031103; GO:0031115; GO:0031410; GO:0032228; GO:0032956; GO:0033563; GO:0038007; GO:0042995; GO:0043025; GO:0043652; GO:0045138; GO:0048598; GO:0048812; GO:0048846; GO:0050764; GO:0061643; GO:0070986; GO:0097628; GO:1901076; GO:1903356; GO:1905815	"cell [GO:0005623]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon regeneration [GO:0031103]; body morphogenesis [GO:0010171]; cell migration [GO:0016477]; chemorepulsion of axon [GO:0061643]; distal tip cell migration [GO:0097628]; dorsal/ventral axon guidance [GO:0033563]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; engulfment of apoptotic cell [GO:0043652]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation [GO:0007369]; left/right axis specification [GO:0070986]; motor neuron axon guidance [GO:0008045]; negative regulation of microtubule polymerization [GO:0031115]; nematode larval development [GO:0002119]; nematode male tail tip morphogenesis [GO:0045138]; netrin-activated signaling pathway [GO:0038007]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of engulfment of apoptotic cell [GO:1901076]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dorsal/ventral axon guidance [GO:1905815]; regulation of phagocytosis [GO:0050764]; regulation of synaptic transmission, GABAergic [GO:0032228]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]"
PGEN_.00g120500	Scaffold_05	45770751	45786386	Q9R1X4	TIM_MOUSE	Protein timeless homolog (mTim)	GO:0000076; GO:0000122; GO:0000790; GO:0001658; GO:0001822; GO:0002009; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007623; GO:0030324; GO:0031298; GO:0035861; GO:0042752; GO:0042753; GO:0042803; GO:0043111; GO:0044770; GO:0045892; GO:0046982; GO:0048478; GO:0048754; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; kidney development [GO:0001822]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]"
PGEN_.00g120510	Scaffold_05	45800649	45802871	Q8TF66	LRC15_HUMAN	Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid homolog) (hLib)	GO:0001968; GO:0005518; GO:0005615; GO:0016021; GO:0030335; GO:0031012; GO:0043236; GO:0046813; GO:0070062; GO:1903077	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]
PGEN_.00g120520	Scaffold_05	45810099	45836165	Q9R1X4	TIM_MOUSE	Protein timeless homolog (mTim)	GO:0000076; GO:0000122; GO:0000790; GO:0001658; GO:0001822; GO:0002009; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007623; GO:0030324; GO:0031298; GO:0035861; GO:0042752; GO:0042753; GO:0042803; GO:0043111; GO:0044770; GO:0045892; GO:0046982; GO:0048478; GO:0048754; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; kidney development [GO:0001822]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]"
PGEN_.00g120530	Scaffold_05	45840340	45841424	NA	NA	NA	NA	NA
PGEN_.00g120540	Scaffold_05	45841806	45842837	NA	NA	NA	NA	NA
PGEN_.00g120550	Scaffold_05	45843763	45859673	Q9U4L6	TO401_DROME	Mitochondrial import receptor subunit TOM40 homolog 1 (dtom40) (Male sterile protein 15) (Translocase of outer membrane 40 kDa subunit homolog 1)	GO:0005739; GO:0005742; GO:0006626; GO:0006811; GO:0008320; GO:0015288; GO:0015450; GO:0030150; GO:0046930; GO:0071456	mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; porin activity [GO:0015288]; protein transmembrane transporter activity [GO:0008320]; cellular response to hypoxia [GO:0071456]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]
PGEN_.00g120560	Scaffold_05	45872593	45872988	NA	NA	NA	NA	NA
PGEN_.00g120570	Scaffold_05	45873292	45873618	NA	NA	NA	NA	NA
PGEN_.00g120580	Scaffold_05	45884240	45884875	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g120590	Scaffold_05	45892510	45892929	NA	NA	NA	NA	NA
PGEN_.00g120600	Scaffold_05	45893357	45895448	NA	NA	NA	NA	NA
PGEN_.00g120610	Scaffold_05	45902640	45903839	O43825	B3GT2_HUMAN	"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g120620	Scaffold_05	45925785	45926962	NA	NA	NA	NA	NA
PGEN_.00g120630	Scaffold_05	45933659	45938256	Q4R684	AMZ2_MACFA	Archaemetzincin-2 (EC 3.4.-.-) (Archeobacterial metalloproteinase-like protein 2)	GO:0008237; GO:0046872	metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]
PGEN_.00g120640	Scaffold_05	45943359	45956077	NA	NA	NA	NA	NA
PGEN_.00g120650	Scaffold_05	45959680	45974027	Q9VCX3	RM45_DROME	"Probable 39S ribosomal protein L45, mitochondrial (L45mt) (MRP-L45)"	GO:0003735; GO:0005739; GO:0005762; GO:0032543	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g120660	Scaffold_05	45992491	45997468	NA	NA	NA	NA	NA
PGEN_.00g120670	Scaffold_05	46001199	46016189	Q9JLH7	CK5P3_RAT	CDK5 regulatory subunit-associated protein 3 (CDK5 activator-binding protein C53)	GO:0000079; GO:0001933; GO:0005634; GO:0005737; GO:0005813; GO:0007095; GO:0007346; GO:0007420; GO:0008283; GO:0010921; GO:0019901; GO:0030262; GO:0030332; GO:0030968; GO:0031398; GO:0032088; GO:0032991; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0044877; GO:0045664; GO:0045944; GO:0051019; GO:0051059; GO:0071569; GO:0071901; GO:0097371; GO:1900182; GO:1901798; GO:1903363	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; endoplasmic reticulum unfolded protein response [GO:0030968]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron differentiation [GO:0045664]; regulation of phosphatase activity [GO:0010921]
PGEN_.00g120680	Scaffold_05	46026856	46027733	NA	NA	NA	NA	NA
PGEN_.00g120690	Scaffold_05	46028274	46059308	Q8TCJ2	STT3B_HUMAN	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog)	GO:0004579; GO:0005783; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g120700	Scaffold_05	46074700	46100139	Q6P132	TXB1B_DANRE	Tax1-binding protein 1 homolog B	GO:0006915; GO:0046872	metal ion binding [GO:0046872]; apoptotic process [GO:0006915]
PGEN_.00g120710	Scaffold_05	46119214	46124670	G5E8K5	ANK3_MOUSE	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g120720	Scaffold_05	46139442	46144254	G5E8K5	ANK3_MOUSE	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g120730	Scaffold_05	46169658	46178948	Q20930	MIG17_CAEEL	Metalloprotease mig-17 (EC 3.4.24.-) (Abnormal cell migration protein 17)	GO:0004222; GO:0005604; GO:0005615; GO:0008104; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354	basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]
PGEN_.00g120740	Scaffold_05	46183813	46194959	NA	NA	NA	NA	NA
PGEN_.00g120750	Scaffold_05	46199484	46200054	NA	NA	NA	NA	NA
PGEN_.00g120760	Scaffold_05	46207464	46237362	Q5RBT2	DNPEP_PONAB	Aspartyl aminopeptidase (EC 3.4.11.21)	GO:0004177; GO:0005737; GO:0008237; GO:0008270	cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]
PGEN_.00g120770	Scaffold_05	46237975	46238283	NA	NA	NA	NA	NA
PGEN_.00g120780	Scaffold_05	46238337	46239341	O43422	P52K_HUMAN	52 kDa repressor of the inhibitor of the protein kinase (p52rIPK) (58 kDa interferon-induced protein kinase-interacting protein) (p58IPK-interacting protein) (Death-associated protein 4) (THAP domain-containing protein 0) (THAP domain-containing protein 12)	GO:0000790; GO:0000981; GO:0003677; GO:0007165; GO:0008285; GO:0046872; GO:0046983	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; negative regulation of cell population proliferation [GO:0008285]; signal transduction [GO:0007165]"
PGEN_.00g120790	Scaffold_05	46241371	46263227	Q0KIA2	Y9801_DROME	PP2C-like domain-containing protein CG9801	GO:0003824	catalytic activity [GO:0003824]
PGEN_.00g120800	Scaffold_05	46277923	46287355	P53809	PPCT_RAT	Phosphatidylcholine transfer protein (PC-TP) (START domain-containing protein 2) (StARD2) (StAR-related lipid transfer protein 2)	GO:0005829; GO:0008203; GO:0008525; GO:0015914; GO:0031210; GO:0120163	cytosol [GO:0005829]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; cholesterol metabolic process [GO:0008203]; negative regulation of cold-induced thermogenesis [GO:0120163]; phospholipid transport [GO:0015914]
PGEN_.00g120810	Scaffold_05	46294247	46319754	Q5R4G6	CUL1_PONAB	Cullin-1 (CUL-1)	GO:0006513; GO:0006915; GO:0008283; GO:0009887; GO:0019005; GO:0031146; GO:0031625; GO:1990452	Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; protein monoubiquitination [GO:0006513]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g120820	Scaffold_05	46326296	46328036	NA	NA	NA	NA	NA
PGEN_.00g120830	Scaffold_05	46328234	46328515	NA	NA	NA	NA	NA
PGEN_.00g120840	Scaffold_05	46353063	46355993	NA	NA	NA	NA	NA
PGEN_.00g120850	Scaffold_05	46376725	46385028	NA	NA	NA	NA	NA
PGEN_.00g120860	Scaffold_05	46385842	46389504	B8E1A7	PRMA_DICTD	Ribosomal protein L11 methyltransferase (L11 Mtase) (EC 2.1.1.-)	GO:0005737; GO:0008276	cytoplasm [GO:0005737]; protein methyltransferase activity [GO:0008276]
PGEN_.00g120870	Scaffold_05	46399009	46410269	A6H162	PRMC_FLAPJ	Release factor glutamine methyltransferase (RF MTase) (EC 2.1.1.297) (N5-glutamine methyltransferase PrmC) (Protein-(glutamine-N5) MTase PrmC) (Protein-glutamine N-methyltransferase PrmC)	GO:0003676; GO:0018364; GO:0036009; GO:0102559	nucleic acid binding [GO:0003676]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]; protein-glutamine N-methyltransferase activity [GO:0036009]; peptidyl-glutamine methylation [GO:0018364]
PGEN_.00g120880	Scaffold_05	46429472	46433871	Q8R619	PRMC_FUSNN	Release factor glutamine methyltransferase (RF MTase) (EC 2.1.1.297) (N5-glutamine methyltransferase PrmC) (Protein-(glutamine-N5) MTase PrmC) (Protein-glutamine N-methyltransferase PrmC)	GO:0003676; GO:0018364; GO:0036009; GO:0102559	nucleic acid binding [GO:0003676]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]; protein-glutamine N-methyltransferase activity [GO:0036009]; peptidyl-glutamine methylation [GO:0018364]
PGEN_.00g120890	Scaffold_05	46435772	46442636	NA	NA	NA	NA	NA
PGEN_.00g120900	Scaffold_05	46443426	46445978	NA	NA	NA	NA	NA
PGEN_.00g120910	Scaffold_05	46447526	46447897	NA	NA	NA	NA	NA
PGEN_.00g120920	Scaffold_05	46448104	46448824	NA	NA	NA	NA	NA
PGEN_.00g120930	Scaffold_05	46449185	46449553	NA	NA	NA	NA	NA
PGEN_.00g120940	Scaffold_05	46453312	46474617	P49016	MENG_LACLA	Demethylmenaquinone methyltransferase (EC 2.1.1.163)	GO:0009234; GO:0032259; GO:0102955	S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; menaquinone biosynthetic process [GO:0009234]; methylation [GO:0032259]
PGEN_.00g120950	Scaffold_05	46474680	46479490	Q6GL69	MK67I_XENTR	MKI67 FHA domain-interacting nucleolar phosphoprotein-like	GO:0003723; GO:0005730	nucleolus [GO:0005730]; RNA binding [GO:0003723]
PGEN_.00g120960	Scaffold_05	46479775	46484814	Q8T773	MDH1B_BRAFL	Putative malate dehydrogenase 1B (EC 1.1.1.-)	GO:0005623; GO:0005975; GO:0006099; GO:0006108; GO:0009055; GO:0015035; GO:0016615; GO:0016616; GO:0045454	"cell [GO:0005623]; electron transfer activity [GO:0009055]; malate dehydrogenase activity [GO:0016615]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein disulfide oxidoreductase activity [GO:0015035]; carbohydrate metabolic process [GO:0005975]; cell redox homeostasis [GO:0045454]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]"
PGEN_.00g120970	Scaffold_05	46513404	46527969	NA	NA	NA	NA	NA
PGEN_.00g120980	Scaffold_05	46528191	46529270	P0C6X3	R1AB_CVHN2	Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Papain-like proteinase (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.69) (Non-structural protein 3) (nsp3) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); RNA-directed RNA polymerase (Pol) (RdRp) (EC 2.7.7.48) (nsp12) (p100); Helicase (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (nsp13) (p67); Guanine-N7 methyltransferase (ExoN) (EC 2.1.1.-) (EC 3.1.13.-) (nsp14); Uridylate-specific endoribonuclease (EC 3.1.-.-) (NendoU) (nsp15) (p35); 2'-O-methyltransferase (EC 2.1.1.-) (nsp16)]	GO:0003678; GO:0003723; GO:0003724; GO:0003968; GO:0004197; GO:0004519; GO:0005524; GO:0006351; GO:0008168; GO:0008242; GO:0008270; GO:0016021; GO:0016896; GO:0019079; GO:0019082; GO:0032259; GO:0033644; GO:0036459; GO:0039502; GO:0039520; GO:0039579; GO:0039595; GO:0039644; GO:0039648; GO:0044172; GO:0044220	"host cell endoplasmic reticulum-Golgi intermediate compartment [GO:0044172]; host cell membrane [GO:0033644]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; cysteine-type endopeptidase activity [GO:0004197]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; methyltransferase activity [GO:0008168]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; induction by virus of catabolism of host mRNA [GO:0039595]; induction by virus of host autophagy [GO:0039520]; methylation [GO:0032259]; modulation by virus of host protein ubiquitination [GO:0039648]; suppression by virus of host ISG15 activity [GO:0039579]; suppression by virus of host NF-kappaB transcription factor activity [GO:0039644]; suppression by virus of host type I interferon-mediated signaling pathway [GO:0039502]; transcription, DNA-templated [GO:0006351]; viral genome replication [GO:0019079]; viral protein processing [GO:0019082]"
PGEN_.00g120990	Scaffold_05	46529494	46537812	NA	NA	NA	NA	NA
PGEN_.00g121000	Scaffold_05	46540139	46551426	NA	NA	NA	NA	NA
PGEN_.00g121010	Scaffold_05	46554330	46556481	D3YVF0	AKAP5_MOUSE	A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)	GO:0001664; GO:0001934; GO:0003779; GO:0005516; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0006605; GO:0007193; GO:0007194; GO:0008179; GO:0009898; GO:0010524; GO:0010738; GO:0014069; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032991; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0043624; GO:0044877; GO:0045121; GO:0045296; GO:0045762; GO:0048471; GO:0050775; GO:0050811; GO:0060076; GO:0060090; GO:0070886; GO:0097110; GO:0098978; GO:0099092; GO:0099149; GO:1903078	"asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; cellular protein complex disassembly [GO:0043624]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein targeting [GO:0006605]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]"
PGEN_.00g121020	Scaffold_05	46556852	46558667	P24587	AKAP5_RAT	A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)	GO:0001664; GO:0001934; GO:0003779; GO:0005516; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0006605; GO:0007193; GO:0007194; GO:0008179; GO:0009898; GO:0010524; GO:0010738; GO:0014069; GO:0014850; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0021510; GO:0021766; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032991; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0043624; GO:0044877; GO:0045121; GO:0045296; GO:0045762; GO:0048471; GO:0050775; GO:0050811; GO:0051602; GO:0060076; GO:0060090; GO:0060135; GO:0070886; GO:0071417; GO:0097110; GO:0098978; GO:0099092; GO:0099149; GO:1903078	"asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; cellular protein complex disassembly [GO:0043624]; cellular response to organonitrogen compound [GO:0071417]; hippocampus development [GO:0021766]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein targeting [GO:0006605]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; response to electrical stimulus [GO:0051602]; response to muscle activity [GO:0014850]; spinal cord development [GO:0021510]"
PGEN_.00g121030	Scaffold_05	46558840	46559097	P24587	AKAP5_RAT	A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)	GO:0001664; GO:0001934; GO:0003779; GO:0005516; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0006605; GO:0007193; GO:0007194; GO:0008179; GO:0009898; GO:0010524; GO:0010738; GO:0014069; GO:0014850; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0021510; GO:0021766; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032991; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0043624; GO:0044877; GO:0045121; GO:0045296; GO:0045762; GO:0048471; GO:0050775; GO:0050811; GO:0051602; GO:0060076; GO:0060090; GO:0060135; GO:0070886; GO:0071417; GO:0097110; GO:0098978; GO:0099092; GO:0099149; GO:1903078	"asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; cellular protein complex disassembly [GO:0043624]; cellular response to organonitrogen compound [GO:0071417]; hippocampus development [GO:0021766]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein targeting [GO:0006605]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; response to electrical stimulus [GO:0051602]; response to muscle activity [GO:0014850]; spinal cord development [GO:0021510]"
PGEN_.00g121040	Scaffold_05	46719177	46719746	NA	NA	NA	NA	NA
PGEN_.00g121050	Scaffold_05	46754338	46755210	NA	NA	NA	NA	NA
PGEN_.00g121060	Scaffold_05	46805819	46807756	NA	NA	NA	NA	NA
PGEN_.00g121070	Scaffold_05	46807806	46808021	NA	NA	NA	NA	NA
PGEN_.00g121080	Scaffold_05	46808437	46850465	Q9Y6N7	ROBO1_HUMAN	Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1)	GO:0002042; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005886; GO:0005887; GO:0006919; GO:0007155; GO:0007156; GO:0007399; GO:0007411; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035481; GO:0035904; GO:0042802; GO:0043406; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]
PGEN_.00g121090	Scaffold_05	46862478	46862768	NA	NA	NA	NA	NA
PGEN_.00g121100	Scaffold_05	46878602	46879234	Q5R5N9	AAR2_PONAB	Protein AAR2 homolog (AAR2 splicing factor homolog)	GO:0005681; GO:0006397; GO:0008380	spliceosomal complex [GO:0005681]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g121110	Scaffold_05	46893521	46925934	Q13191	CBLB_HUMAN	E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)	GO:0001784; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0006607; GO:0007165; GO:0007166; GO:0007175; GO:0008270; GO:0017124; GO:0030971; GO:0045121; GO:0061630; GO:2000583	cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165]
PGEN_.00g121120	Scaffold_05	46927515	46947475	Q6NRC7	TBC23_XENLA	TBC1 domain family member 23	GO:0005623; GO:0005802; GO:0005829; GO:0031410; GO:0042147; GO:0099041; GO:1990403	"cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; trans-Golgi network [GO:0005802]; embryonic brain development [GO:1990403]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle tethering to Golgi [GO:0099041]"
PGEN_.00g121130	Scaffold_05	46963759	47023179	Q03164	KMT2A_HUMAN	Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.354) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)]	GO:0000981; GO:0003680; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0006915; GO:0008270; GO:0032411; GO:0032922; GO:0035097; GO:0035162; GO:0042800; GO:0042802; GO:0042803; GO:0043984; GO:0044212; GO:0045322; GO:0045652; GO:0045893; GO:0045944; GO:0051568; GO:0051571; GO:0065003; GO:0070577; GO:0071339; GO:0071440; GO:0080182; GO:1902036; GO:1905642; GO:2000615; GO:2001040	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; protein homodimerization activity [GO:0042803]; transcription regulatory region DNA binding [GO:0044212]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; negative regulation of DNA methylation [GO:1905642]; positive regulation of cellular response to drug [GO:2001040]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; protein-containing complex assembly [GO:0065003]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of megakaryocyte differentiation [GO:0045652]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g121140	Scaffold_05	47032719	47035567	NA	NA	NA	NA	NA
PGEN_.00g121150	Scaffold_05	47039987	47074908	Q6PGZ3	MIPT3_DANRE	TRAF3-interacting protein 1	GO:0005813; GO:0005930; GO:0008017; GO:0030992; GO:0031113; GO:0036064; GO:0042073; GO:0043010; GO:0048793; GO:0060271; GO:0070507	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; intraciliary transport particle B [GO:0030992]; microtubule binding [GO:0008017]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]
PGEN_.00g121160	Scaffold_05	47080917	47081291	NA	NA	NA	NA	NA
PGEN_.00g121170	Scaffold_05	47081885	47082193	NA	NA	NA	NA	NA
PGEN_.00g121180	Scaffold_05	47163290	47163547	NA	NA	NA	NA	NA
PGEN_.00g121190	Scaffold_05	47175188	47203779	P20009	DLL_DROME	Homeotic protein distal-less (Protein brista)	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0007449; GO:0007469; GO:0007479; GO:0007480; GO:0007485; GO:0007487; GO:0008587; GO:0010092; GO:0010629; GO:0016319; GO:0021553; GO:0035114; GO:0035215; GO:0042048; GO:0043565; GO:0045893; GO:0048264; GO:0048728	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; analia development [GO:0007487]; antennal development [GO:0007469]; determination of ventral identity [GO:0048264]; genital disc development [GO:0035215]; imaginal disc-derived appendage morphogenesis [GO:0035114]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc proximal/distal pattern formation [GO:0007479]; mushroom body development [GO:0016319]; negative regulation of gene expression [GO:0010629]; olfactory behavior [GO:0042048]; olfactory nerve development [GO:0021553]; positive regulation of transcription, DNA-templated [GO:0045893]; proboscis development [GO:0048728]; proximal/distal pattern formation, imaginal disc [GO:0007449]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]"
PGEN_.00g121200	Scaffold_05	47229138	47229398	NA	NA	NA	NA	NA
PGEN_.00g121210	Scaffold_05	47276204	47280149	NA	NA	NA	NA	NA
PGEN_.00g121220	Scaffold_05	47291515	47305703	O35136	NCAM2_MOUSE	Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12)	GO:0005886; GO:0007155; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0031225; GO:0042802	anchored component of membrane [GO:0031225]; axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; sensory perception of smell [GO:0007608]
PGEN_.00g121230	Scaffold_05	47310867	47318684	Q9U3P2	SYG2_CAEEL	Synaptogenesis protein syg-2 (Synaptogenesis abnormal protein 2)	GO:0005887; GO:0007155; GO:0007267; GO:0007416; GO:0008039; GO:0030054; GO:0035418; GO:0042803; GO:0045202; GO:0048668; GO:0050808; GO:0050839	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; collateral sprouting [GO:0048668]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic target recognition [GO:0008039]
PGEN_.00g121240	Scaffold_05	47346128	47347084	NA	NA	NA	NA	NA
PGEN_.00g121250	Scaffold_05	47354761	47374060	Q9D3D0	TTPAL_MOUSE	Alpha-tocopherol transfer protein-like		
PGEN_.00g121260	Scaffold_05	47385631	47388905	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g121270	Scaffold_05	47403111	47403416	NA	NA	NA	NA	NA
PGEN_.00g121280	Scaffold_05	47403809	47408309	NA	NA	NA	NA	NA
PGEN_.00g121290	Scaffold_05	47422609	47462794	NA	NA	NA	NA	NA
PGEN_.00g121300	Scaffold_05	47475699	47477891	NA	NA	NA	NA	NA
PGEN_.00g121310	Scaffold_05	47490157	47495854	NA	NA	NA	NA	NA
PGEN_.00g121320	Scaffold_05	47511910	47516838	NA	NA	NA	NA	NA
PGEN_.00g121330	Scaffold_05	47521269	47532206	NA	NA	NA	NA	NA
PGEN_.00g121340	Scaffold_05	47553031	47559637	NA	NA	NA	NA	NA
PGEN_.00g121350	Scaffold_05	47560102	47565803	NA	NA	NA	NA	NA
PGEN_.00g121360	Scaffold_05	47570225	47581543	NA	NA	NA	NA	NA
PGEN_.00g121370	Scaffold_05	47587874	47589971	NA	NA	NA	NA	NA
PGEN_.00g121380	Scaffold_05	47607029	47630460	NA	NA	NA	NA	NA
PGEN_.00g121390	Scaffold_05	47637053	47651738	O73630	NFKB2_XENLA	Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit]	GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0007165; GO:0048511	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]
PGEN_.00g121400	Scaffold_05	47674417	47685541	Q5M9H0	ANKS3_RAT	Ankyrin repeat and SAM domain-containing protein 3	GO:0005737; GO:0005929	cilium [GO:0005929]; cytoplasm [GO:0005737]
PGEN_.00g121410	Scaffold_05	47688132	47688380	NA	NA	NA	NA	NA
PGEN_.00g121420	Scaffold_05	47688691	47689323	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g121430	Scaffold_05	47690164	47698486	Q9CZK6	ANKS3_MOUSE	Ankyrin repeat and SAM domain-containing protein 3	GO:0005737; GO:0005929	cilium [GO:0005929]; cytoplasm [GO:0005737]
PGEN_.00g121440	Scaffold_05	47711407	47712451	NA	NA	NA	NA	NA
PGEN_.00g121450	Scaffold_05	47718174	47726423	Q8CBW3	ABI1_MOUSE	Abl interactor 1 (Abelson interactor 1) (Abi-1) (Ablphilin-1) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Spectrin SH3 domain-binding protein 1) (e3B1)	GO:0001756; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0008134; GO:0008154; GO:0014069; GO:0016235; GO:0017124; GO:0018108; GO:0030027; GO:0030054; GO:0030296; GO:0030426; GO:0031209; GO:0031252; GO:0032433; GO:0035855; GO:0043005; GO:0048813; GO:0072673; GO:0098978; GO:0099527	aggresome [GO:0016235]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209]; protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; transcription factor binding [GO:0008134]; actin polymerization or depolymerization [GO:0008154]; dendrite morphogenesis [GO:0048813]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; peptidyl-tyrosine phosphorylation [GO:0018108]; postsynapse to nucleus signaling pathway [GO:0099527]; somitogenesis [GO:0001756]
PGEN_.00g121460	Scaffold_05	47737894	47746019	P39021	MEOX2_XENLA	Homeobox protein MOX-2	GO:0003700; GO:0005634; GO:0007275; GO:0016607; GO:0043565; GO:0045944	nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g121470	Scaffold_05	47762994	47769705	P39021	MEOX2_XENLA	Homeobox protein MOX-2	GO:0003700; GO:0005634; GO:0007275; GO:0016607; GO:0043565; GO:0045944	nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g121480	Scaffold_05	47771929	47801160	Q9VN14	CONT_DROME	Contactin	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]
PGEN_.00g121490	Scaffold_05	47805183	47828820	P34576	MUA3_CAEEL	Transmembrane cell adhesion receptor mua-3 (Muscle attachment abnormal protein 3)	GO:0005509; GO:0005518; GO:0005882; GO:0005886; GO:0007160; GO:0016021; GO:0019215; GO:0030056	hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; intermediate filament binding [GO:0019215]; cell-matrix adhesion [GO:0007160]
PGEN_.00g121500	Scaffold_05	47867503	47881239	Q9DCK3	TSN4_MOUSE	Tetraspanin-4 (Tspan-4) (Transmembrane 4 superfamily member 7)	GO:0003823; GO:0005178; GO:0005886; GO:0005887; GO:0031982; GO:0065003	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; antigen binding [GO:0003823]; integrin binding [GO:0005178]; protein-containing complex assembly [GO:0065003]
PGEN_.00g121510	Scaffold_05	47902627	47926252	Q32KI9	ARSI_MOUSE	Arylsulfatase I (ASI) (EC 3.1.6.-)	GO:0005576; GO:0005783; GO:0008484; GO:0046872	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]
PGEN_.00g121520	Scaffold_05	47908933	47909313	NA	NA	NA	NA	NA
PGEN_.00g121530	Scaffold_05	47926636	47937708	NA	NA	NA	NA	NA
PGEN_.00g121540	Scaffold_05	47939538	47939906	NA	NA	NA	NA	NA
PGEN_.00g121550	Scaffold_05	47962438	48008576	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g121560	Scaffold_05	48008630	48008932	NA	NA	NA	NA	NA
PGEN_.00g121570	Scaffold_05	48009116	48009508	NA	NA	NA	NA	NA
PGEN_.00g121580	Scaffold_05	48014920	48016286	NA	NA	NA	NA	NA
PGEN_.00g121590	Scaffold_05	48016596	48017473	NA	NA	NA	NA	NA
PGEN_.00g121600	Scaffold_05	48018200	48018535	NA	NA	NA	NA	NA
PGEN_.00g121610	Scaffold_05	48019020	48025290	NA	NA	NA	NA	NA
PGEN_.00g121620	Scaffold_05	48052018	48074582	NA	NA	NA	NA	NA
PGEN_.00g121630	Scaffold_05	48087526	48095718	A6NGN9	IGLO5_HUMAN	IgLON family member 5	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g121640	Scaffold_05	48112497	48131315	NA	NA	NA	NA	NA
PGEN_.00g121650	Scaffold_05	48131383	48132521	NA	NA	NA	NA	NA
PGEN_.00g121660	Scaffold_05	48136921	48154606	NA	NA	NA	NA	NA
PGEN_.00g121670	Scaffold_05	48175541	48186540	NA	NA	NA	NA	NA
PGEN_.00g121680	Scaffold_05	48199857	48200582	NA	NA	NA	NA	NA
PGEN_.00g121690	Scaffold_05	48221133	48222102	NA	NA	NA	NA	NA
PGEN_.00g121700	Scaffold_05	48224583	48226115	NA	NA	NA	NA	NA
PGEN_.00g121710	Scaffold_05	48244626	48245018	NA	NA	NA	NA	NA
PGEN_.00g121720	Scaffold_05	48245189	48245419	NA	NA	NA	NA	NA
PGEN_.00g121730	Scaffold_05	48245388	48247473	NA	NA	NA	NA	NA
PGEN_.00g121740	Scaffold_05	48245476	48248909	NA	NA	NA	NA	NA
PGEN_.00g121750	Scaffold_05	48249287	48250180	NA	NA	NA	NA	NA
PGEN_.00g121760	Scaffold_05	48250395	48256628	NA	NA	NA	NA	NA
PGEN_.00g121770	Scaffold_05	48256830	48257180	NA	NA	NA	NA	NA
PGEN_.00g121780	Scaffold_05	48270861	48287931	O60500	NPHN_HUMAN	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g121790	Scaffold_05	48302341	48325909	NA	NA	NA	NA	NA
PGEN_.00g121800	Scaffold_05	48327507	48363101	NA	NA	NA	NA	NA
PGEN_.00g121810	Scaffold_05	48374938	48375195	NA	NA	NA	NA	NA
PGEN_.00g121820	Scaffold_05	48383154	48386135	NA	NA	NA	NA	NA
PGEN_.00g121830	Scaffold_05	48393875	48395859	NA	NA	NA	NA	NA
PGEN_.00g121840	Scaffold_05	48396432	48428261	Q6P2Y1	PAF1_XENTR	RNA polymerase II-associated factor 1 homolog	GO:0000122; GO:0000993; GO:0003682; GO:0006368; GO:0016570; GO:0016593; GO:0032968; GO:0035327; GO:0045944	Cdc73/Paf1 complex [GO:0016593]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; histone modification [GO:0016570]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g121850	Scaffold_05	48428526	48451752	Q08D01	MED29_XENTR	Mediator of RNA polymerase II transcription subunit 29 (Intersex-like protein) (Mediator complex subunit 29)	GO:0016592	mediator complex [GO:0016592]
PGEN_.00g121860	Scaffold_05	48488209	48492321	Q29RK2	PYC_BOVIN	"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)"	GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0042802; GO:0044791; GO:0046872	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074]
PGEN_.00g121870	Scaffold_05	48507689	48516666	NA	NA	NA	NA	NA
PGEN_.00g121880	Scaffold_05	48516881	48520185	NA	NA	NA	NA	NA
PGEN_.00g121890	Scaffold_05	48525822	48526121	NA	NA	NA	NA	NA
PGEN_.00g121900	Scaffold_05	48557952	48603246	Q27567	GPDA_DROEZ	"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD-C) (GPDH-C) (EC 1.1.1.8)"	GO:0004367; GO:0005975; GO:0006650; GO:0009331; GO:0042803; GO:0046168; GO:0051287	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]
PGEN_.00g121910	Scaffold_05	48664940	48667122	Q9DBY8	NVL_MOUSE	Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)	GO:0000176; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275	nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]
PGEN_.00g121920	Scaffold_05	48702273	48704455	Q9DBY8	NVL_MOUSE	Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)	GO:0000176; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275	nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]
PGEN_.00g121930	Scaffold_05	48756559	48758269	NA	NA	NA	NA	NA
PGEN_.00g121940	Scaffold_05	48766175	48810457	Q27567	GPDA_DROEZ	"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD-C) (GPDH-C) (EC 1.1.1.8)"	GO:0004367; GO:0005975; GO:0006650; GO:0009331; GO:0042803; GO:0046168; GO:0051287	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]
PGEN_.00g121950	Scaffold_05	48842674	48842973	NA	NA	NA	NA	NA
PGEN_.00g121960	Scaffold_05	48848504	48859345	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g121970	Scaffold_05	48882591	48906801	NA	NA	NA	NA	NA
PGEN_.00g121980	Scaffold_05	48907147	48907398	NA	NA	NA	NA	NA
PGEN_.00g121990	Scaffold_05	48907441	48907716	NA	NA	NA	NA	NA
PGEN_.00g122000	Scaffold_05	48907784	48908230	NA	NA	NA	NA	NA
PGEN_.00g122010	Scaffold_05	48908274	48909655	NA	NA	NA	NA	NA
PGEN_.00g122020	Scaffold_05	48909929	48910345	P13944	COCA1_CHICK	Collagen alpha-1(XII) chain (Fibrochimerin)	GO:0003429; GO:0005581; GO:0005615; GO:0007155; GO:0031012; GO:0035987; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g122030	Scaffold_05	48914243	48914479	NA	NA	NA	NA	NA
PGEN_.00g122040	Scaffold_05	48917110	48917409	NA	NA	NA	NA	NA
PGEN_.00g122050	Scaffold_05	48921376	48944474	B7Q290	NCAS2_IXOSC	Protein NCBP2AS2 homolog		
PGEN_.00g122060	Scaffold_05	49013653	49049876	Q9N0E7	MOCOS_BOVIN	Molybdenum cofactor sulfurase (MCS) (MOS) (MoCo sulfurase) (EC 2.8.1.9) (Molybdenum cofactor sulfurtransferase)	GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0043545; GO:0102867	lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor metabolic process [GO:0043545]
PGEN_.00g122070	Scaffold_05	49174508	49175807	NA	NA	NA	NA	NA
PGEN_.00g122080	Scaffold_05	49212507	49213010	NA	NA	NA	NA	NA
PGEN_.00g122090	Scaffold_05	49213089	49226511	NA	NA	NA	NA	NA
PGEN_.00g122100	Scaffold_05	49252404	49255857	NA	NA	NA	NA	NA
PGEN_.00g122110	Scaffold_05	49296175	49331665	P57721	PCBP3_HUMAN	Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1)	GO:0001227; GO:0003690; GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0070062; GO:1990829	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]"
PGEN_.00g122120	Scaffold_05	49342447	49354500	Q5RAY0	PFD5_PONAB	Prefoldin subunit 5	GO:0005634; GO:0006457; GO:0016272; GO:0051082	nucleus [GO:0005634]; prefoldin complex [GO:0016272]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]
PGEN_.00g122130	Scaffold_05	49376197	49387000	P9WK87	NLHH_MYCTU	Carboxylesterase NlhH (EC 3.1.1.1)	GO:0009056; GO:0016787; GO:0034338; GO:0080030	hydrolase activity [GO:0016787]; methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056]
PGEN_.00g122140	Scaffold_05	49435083	49449822	NA	NA	NA	NA	NA
PGEN_.00g122150	Scaffold_05	49456719	49459932	Q5NVQ1	HIG1A_PONAB	"HIG1 domain family member 1A, mitochondrial"	GO:0005634; GO:0005743; GO:0016021; GO:0042149; GO:0055114; GO:0070469; GO:0071456; GO:0071902; GO:0090201	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; respirasome [GO:0070469]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidation-reduction process [GO:0055114]; positive regulation of protein serine/threonine kinase activity [GO:0071902]
PGEN_.00g122160	Scaffold_05	49460028	49469611	NA	NA	NA	NA	NA
PGEN_.00g122170	Scaffold_05	49471959	49490557	O43242	PSMD3_HUMAN	26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58)	GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0006521; GO:0008541; GO:0010972; GO:0016020; GO:0016579; GO:0022624; GO:0030234; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0042176; GO:0043161; GO:0043312; GO:0043488; GO:0043687; GO:0050852; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0070498; GO:0090090; GO:0090263; GO:1901990; GO:1902036; GO:1904813	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-1-mediated signaling pathway [GO:0070498]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mRNA stability [GO:0043488]; regulation of protein catabolic process [GO:0042176]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g122180	Scaffold_05	49499792	49528215	Q59E55	NAB_DROME	NGFI-A-binding protein homolog (dNAB)	GO:0003712; GO:0005634; GO:0006355; GO:0007626; GO:0008283; GO:0014019; GO:0035222; GO:0045892; GO:0048666	"nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; cell population proliferation [GO:0008283]; locomotory behavior [GO:0007626]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast development [GO:0014019]; neuron development [GO:0048666]; regulation of transcription, DNA-templated [GO:0006355]; wing disc pattern formation [GO:0035222]"
PGEN_.00g122190	Scaffold_05	49542151	49599351	Q6NSM8	SIK3_DANRE	Serine/threonine-protein kinase SIK3 homolog (EC 2.7.11.1) (Serine/threonine-protein kinase QSK homolog)	GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0050321	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; protein phosphorylation [GO:0006468]
PGEN_.00g122200	Scaffold_05	49621669	49627967	P07314	GGT1_RAT	Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]	GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006750; GO:0006751; GO:0007283; GO:0007568; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0102953; GO:0103068; GO:1901750	"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; transferase activity, transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]"
PGEN_.00g122210	Scaffold_05	49629667	49641344	NA	NA	NA	NA	NA
PGEN_.00g122220	Scaffold_05	49647106	49655241	NA	NA	NA	NA	NA
PGEN_.00g122230	Scaffold_05	49655390	49656016	NA	NA	NA	NA	NA
PGEN_.00g122240	Scaffold_05	49656071	49656938	NA	NA	NA	NA	NA
PGEN_.00g122250	Scaffold_05	49659112	49659411	NA	NA	NA	NA	NA
PGEN_.00g122260	Scaffold_05	49662956	49684340	Q96H40	ZN486_HUMAN	Zinc finger protein 486 (KRAB domain only protein 2)	GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0070062	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g122270	Scaffold_05	49685743	49687644	B0UZC8	VWC2L_DANRE	von Willebrand factor C domain-containing protein 2-like	GO:0005615; GO:0007399; GO:0030054; GO:0030514; GO:0032281; GO:0045202	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; nervous system development [GO:0007399]
PGEN_.00g122280	Scaffold_05	49692164	49692451	NA	NA	NA	NA	NA
PGEN_.00g122290	Scaffold_05	49692911	49694364	NA	NA	NA	NA	NA
PGEN_.00g122300	Scaffold_05	49699639	49717697	NA	NA	NA	NA	NA
PGEN_.00g122310	Scaffold_05	49735691	49736659	NA	NA	NA	NA	NA
PGEN_.00g122320	Scaffold_05	49917588	49918780	NA	NA	NA	NA	NA
PGEN_.00g122330	Scaffold_05	49959359	49962773	Q9H0J4	QRIC2_HUMAN	Glutamine-rich protein 2	GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126]; cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]
PGEN_.00g122340	Scaffold_05	49992184	50032489	Q9HCK4	ROBO2_HUMAN	Roundabout homolog 2	GO:0001656; GO:0001657; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016021; GO:0016199; GO:0021510; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035481; GO:0035904; GO:0042802; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062	axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]
PGEN_.00g122350	Scaffold_05	50039894	50050687	Q8VIG3	RSPH1_MOUSE	Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein)	GO:0000794; GO:0001520; GO:0005737; GO:0007286; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687	condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]
PGEN_.00g122360	Scaffold_05	50055442	50060889	Q5PRB3	PIHD2_DANRE	PIH1 domain-containing protein 2	GO:0000492; GO:0005737; GO:0006364; GO:0070286; GO:0097255	cytoplasm [GO:0005737]; R2TP complex [GO:0097255]; axonemal dynein complex assembly [GO:0070286]; box C/D snoRNP assembly [GO:0000492]; rRNA processing [GO:0006364]
PGEN_.00g122370	Scaffold_05	50066285	50075016	Q24407	ATP5J_DROME	"ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6)"	GO:0000276; GO:0005739; GO:0005753; GO:0005756; GO:0015078; GO:0015986; GO:1902600	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrial proton-transporting ATP synthase, central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]"
PGEN_.00g122380	Scaffold_05	50108664	50164755	Q91VN0	LRP5_MOUSE	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009314; GO:0009952; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060764; GO:0061178; GO:0061299; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1902262	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]"
PGEN_.00g122390	Scaffold_05	50168254	50174005	NA	NA	NA	NA	NA
PGEN_.00g122400	Scaffold_05	50177013	50225869	Q01433	AMPD2_HUMAN	AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L)	GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0043101; GO:0046033; GO:0046872; GO:0052652; GO:0097009	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]
PGEN_.00g122410	Scaffold_05	50227828	50228136	P03934	TC1A_CAEEL	Transposable element Tc1 transposase	GO:0003677; GO:0004519; GO:0005634; GO:0006313; GO:0015074	"nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g122420	Scaffold_05	50239640	50253435	P56671	MAZ_MOUSE	Myc-associated zinc finger protein (MAZI) (Pur-1) (Purine-binding transcription factor)	GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0005737; GO:0006367; GO:0006369; GO:0008284; GO:0010628; GO:0014068; GO:0030335; GO:0045893; GO:0045944; GO:0046872; GO:0051897; GO:2001234	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; termination of RNA polymerase II transcription [GO:0006369]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g122430	Scaffold_05	50268101	50268391	NA	NA	NA	NA	NA
PGEN_.00g122440	Scaffold_05	50313279	50339462	Q9UBP9	GULP1_HUMAN	PTB domain-containing engulfment adapter protein 1 (Cell death protein 6 homolog) (PTB domain adapter protein CED-6) (Protein GULP)	GO:0005737; GO:0006869; GO:0006911; GO:0006915	"cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]"
PGEN_.00g122450	Scaffold_05	50376831	50377691	NA	NA	NA	NA	NA
PGEN_.00g122460	Scaffold_05	50400256	50418982	Q0V8K7	3BP5L_BOVIN	SH3 domain-binding protein 5-like (SH3BP-5-like)	GO:0004860; GO:0005737; GO:0017112; GO:0035556; GO:0061099	cytoplasm [GO:0005737]; protein kinase inhibitor activity [GO:0004860]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]
PGEN_.00g122470	Scaffold_05	50435245	50467907	NA	NA	NA	NA	NA
PGEN_.00g122480	Scaffold_05	50473455	50476550	NA	NA	NA	NA	NA
PGEN_.00g122490	Scaffold_05	50488252	50513574	Q9H2F5	EPC1_HUMAN	Enhancer of polycomb homolog 1	GO:0000122; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0016604; GO:0031965; GO:0032777; GO:0035267; GO:0035886; GO:0040008; GO:0043967; GO:0043968; GO:0045814; GO:0045892; GO:0045893; GO:0045944; GO:0070317	"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; vascular smooth muscle cell differentiation [GO:0035886]"
PGEN_.00g122500	Scaffold_05	50517228	50517767	O75884	RBBP9_HUMAN	Serine hydrolase RBBP9 (EC 3.-.-.-) (B5T-overexpressed gene protein) (Protein BOG) (Retinoblastoma-binding protein 10) (RBBP-10) (Retinoblastoma-binding protein 9) (RBBP-9)	GO:0005654; GO:0016787; GO:0042127	nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; regulation of cell population proliferation [GO:0042127]
PGEN_.00g122510	Scaffold_05	50530451	50546086	NA	NA	NA	NA	NA
PGEN_.00g122520	Scaffold_05	50546141	50547560	NA	NA	NA	NA	NA
PGEN_.00g122530	Scaffold_05	50547776	50550032	NA	NA	NA	NA	NA
PGEN_.00g122540	Scaffold_05	50569140	50569625	Q08890	IDS_MOUSE	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase)	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484	lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]
PGEN_.00g122550	Scaffold_05	50569777	50570661	Q08890	IDS_MOUSE	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase)	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484	lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]
PGEN_.00g122560	Scaffold_05	50575089	50589036	Q5T2R2	DPS1_HUMAN	Decaprenyl-diphosphate synthase subunit 1 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 1) (Decaprenyl pyrophosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1)	GO:0000010; GO:0005759; GO:0006744; GO:0008299; GO:0046872; GO:0046982; GO:0050347; GO:1990234	mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744]
PGEN_.00g122570	Scaffold_05	50598244	50621304	Q8R151	ZNFX1_MOUSE	NFX1-type zinc finger-containing protein 1	GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380	"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]"
PGEN_.00g122580	Scaffold_05	50627491	50628003	NA	NA	NA	NA	NA
PGEN_.00g122590	Scaffold_05	50634886	50649786	Q9P2E3	ZNFX1_HUMAN	NFX1-type zinc finger-containing protein 1	GO:0000775; GO:0000790; GO:0000981; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380	"chromosome, centromeric region [GO:0000775]; nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]"
PGEN_.00g122600	Scaffold_05	50664538	50677463	NA	NA	NA	NA	NA
PGEN_.00g122610	Scaffold_05	50690146	50690901	NA	NA	NA	NA	NA
PGEN_.00g122620	Scaffold_05	50707017	50740696	NA	NA	NA	NA	NA
PGEN_.00g122630	Scaffold_05	50742412	50742828	NA	NA	NA	NA	NA
PGEN_.00g122640	Scaffold_05	50786262	50801487	P48810	RB87F_DROME	Heterogeneous nuclear ribonucleoprotein 87F (HRP36.1 protein) (Protein P11)	GO:0000278; GO:0000381; GO:0000785; GO:0000792; GO:0001745; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0007283; GO:0008266; GO:0008585; GO:0009408; GO:0034046; GO:0035062; GO:0042594; GO:0043565; GO:0048026; GO:1990904	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; female gonad development [GO:0008585]; mitotic cell cycle [GO:0000278]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to heat [GO:0009408]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]"
PGEN_.00g122650	Scaffold_05	50799621	50800071	NA	NA	NA	NA	NA
PGEN_.00g122660	Scaffold_05	50801584	50812547	P07909	ROA1_DROME	Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (PEN repeat clone P9) (hnRNP core protein A1-A)	GO:0000381; GO:0001745; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005703; GO:0007283; GO:0008266; GO:0033119; GO:0034046; GO:0036099; GO:0043565; GO:0045727; GO:0048026; GO:0048027; GO:0048477; GO:1990904	"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell population maintenance [GO:0036099]; negative regulation of RNA splicing [GO:0033119]; oogenesis [GO:0048477]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spermatogenesis [GO:0007283]"
PGEN_.00g122670	Scaffold_05	50814187	50819162	NA	NA	NA	NA	NA
PGEN_.00g122680	Scaffold_05	50826631	50838966	Q9JIF5	PECR_CAVPO	Peroxisomal trans-2-enoyl-CoA reductase (EC 1.3.1.38)	GO:0005102; GO:0005739; GO:0005778; GO:0006633; GO:0019166; GO:0033306; GO:0043231	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; phytol metabolic process [GO:0033306]
PGEN_.00g122690	Scaffold_05	50839011	50847257	Q8VEE0	RPE_MOUSE	Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-epimerase)	GO:0004750; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0019323; GO:0030246; GO:0042802; GO:0042803; GO:0043231; GO:0044262; GO:0046872; GO:0048029	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]; carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"
PGEN_.00g122700	Scaffold_05	50851911	50866674	Q9BQA5	HINFP_HUMAN	Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein)	GO:0000077; GO:0000082; GO:0000083; GO:0000978; GO:0001227; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044212; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0046872	"Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g122710	Scaffold_05	50885142	50888955	P51658	DHB2_MOUSE	Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239)	GO:0001701; GO:0001890; GO:0004303; GO:0006702; GO:0006703; GO:0016021; GO:0032526; GO:0043231; GO:0047035	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen biosynthetic process [GO:0006702]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]
PGEN_.00g122720	Scaffold_05	50895382	50906739	Q2TBP2	HINFP_BOVIN	Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g122730	Scaffold_05	50914816	50988420	Q80ZA4	PKHL1_MOUSE	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)	GO:0005929; GO:0016021	cilium [GO:0005929]; integral component of membrane [GO:0016021]
PGEN_.00g122740	Scaffold_05	51053090	51074399	O76083	PDE9A_HUMAN	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35)"	GO:0004114; GO:0005783; GO:0005794; GO:0005829; GO:0007165; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; signal transduction [GO:0007165]"
PGEN_.00g122750	Scaffold_05	51091282	51128711	Q8QZV1	PDE9A_RAT	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35)"	GO:0005783; GO:0005794; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]"
PGEN_.00g122760	Scaffold_05	51222899	51224306	P29774	ETS3_DROME	DNA-binding protein D-ETS-3	GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0030154; GO:0043565	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g122770	Scaffold_05	51224350	51231386	NA	NA	NA	NA	NA
PGEN_.00g122780	Scaffold_05	51258877	51293805	O57579	AMPN_CHICK	Aminopeptidase Ey (EC 3.4.11.20) (Aminopeptidase N)	GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0016021; GO:0042277; GO:0043171; GO:0070006; GO:0070062	cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]
PGEN_.00g122790	Scaffold_05	51308530	51334003	Q3TUF7	YETS2_MOUSE	YEATS domain-containing protein 2	GO:0000122; GO:0005634; GO:0005671; GO:0017025; GO:0042393; GO:0043966; GO:0045892; GO:0072686; GO:0140030	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; histone binding [GO:0042393]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; histone H3 acetylation [GO:0043966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g122800	Scaffold_05	51339182	51340639	NA	NA	NA	NA	NA
PGEN_.00g122810	Scaffold_05	51344199	51358473	NA	NA	NA	NA	NA
PGEN_.00g122820	Scaffold_05	51367683	51371473	NA	NA	NA	NA	NA
PGEN_.00g122830	Scaffold_05	51375045	51375443	NA	NA	NA	NA	NA
PGEN_.00g122840	Scaffold_05	51385485	51406720	Q13705	AVR2B_HUMAN	Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB)	GO:0000122; GO:0001702; GO:0001822; GO:0001946; GO:0001974; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006355; GO:0006468; GO:0007165; GO:0007178; GO:0007368; GO:0007498; GO:0007507; GO:0009749; GO:0009791; GO:0009952; GO:0017002; GO:0019838; GO:0030073; GO:0030324; GO:0030501; GO:0030509; GO:0031016; GO:0032147; GO:0032924; GO:0032927; GO:0032991; GO:0035265; GO:0042475; GO:0043235; GO:0045669; GO:0046872; GO:0048179; GO:0048185; GO:0048617; GO:0048705; GO:0060021; GO:0060836; GO:0060840; GO:0060841; GO:0061298; GO:0071363; GO:0120163	"activin receptor complex [GO:0048179]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of protein kinase activity [GO:0032147]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic foregut morphogenesis [GO:0048617]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; pancreas development [GO:0031016]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; venous blood vessel development [GO:0060841]"
PGEN_.00g122850	Scaffold_05	51418799	51427003	NA	NA	NA	NA	NA
PGEN_.00g122860	Scaffold_05	51432282	51439734	NA	NA	NA	NA	NA
PGEN_.00g122870	Scaffold_05	51507136	51546470	Q9JHA8	VWA7_MOUSE	von Willebrand factor A domain-containing protein 7 (Protein G7c)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g122880	Scaffold_05	51546690	51549246	Q8ISN9	RS25_BRABE	40S ribosomal protein S25	GO:0005840	ribosome [GO:0005840]
PGEN_.00g122890	Scaffold_05	51551031	51562744	Q08DE5	EI24_BOVIN	Etoposide-induced protein 2.4 homolog	GO:0005783; GO:0016021; GO:0016236	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; macroautophagy [GO:0016236]
PGEN_.00g122900	Scaffold_05	51573206	51600315	Q15853	USF2_HUMAN	Upstream stimulatory factor 2 (Class B basic helix-loop-helix protein 12) (bHLHb12) (FOS-interacting protein) (FIP) (Major late transcription factor 2) (Upstream transcription factor 2)	GO:0000430; GO:0000432; GO:0000790; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006366; GO:0007595; GO:0019086; GO:0042803; GO:0043231; GO:0043425; GO:0043565; GO:0045944; GO:0046982; GO:0055088	"intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g122910	Scaffold_05	51599744	51603493	NA	NA	NA	NA	NA
PGEN_.00g122920	Scaffold_05	51603546	51604175	NA	NA	NA	NA	NA
PGEN_.00g122930	Scaffold_05	51608054	51628629	NA	NA	NA	NA	NA
PGEN_.00g122940	Scaffold_05	51669094	51681105	O93479	ORC4_XENLA	Origin recognition complex subunit 4	GO:0003677; GO:0005524; GO:0005664; GO:0006260	nuclear origin of replication recognition complex [GO:0005664]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA replication [GO:0006260]
PGEN_.00g122950	Scaffold_05	51707095	51744636	NA	NA	NA	NA	NA
PGEN_.00g122960	Scaffold_05	51770285	51776250	Q27556	GPDA_DROAE	"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD-C) (GPDH-C) (EC 1.1.1.8)"	GO:0004367; GO:0005975; GO:0006650; GO:0009331; GO:0042803; GO:0046168; GO:0051287	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]
PGEN_.00g122970	Scaffold_05	51785760	51788494	NA	NA	NA	NA	NA
PGEN_.00g122980	Scaffold_05	51799247	51806745	Q0IIF6	FAIM1_BOVIN	Fas apoptotic inhibitory molecule 1	GO:0005737; GO:0006915; GO:0007249; GO:0050769; GO:1902042	cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of neurogenesis [GO:0050769]
PGEN_.00g122990	Scaffold_05	51859321	51891829	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g123000	Scaffold_05	51926939	51936673	NA	NA	NA	NA	NA
PGEN_.00g123010	Scaffold_05	51942488	51942784	NA	NA	NA	NA	NA
PGEN_.00g123020	Scaffold_05	51955550	51955972	NA	NA	NA	NA	NA
PGEN_.00g123030	Scaffold_05	51962900	51964278	NA	NA	NA	NA	NA
PGEN_.00g123040	Scaffold_05	51978279	51978797	NA	NA	NA	NA	NA
PGEN_.00g123050	Scaffold_05	51991583	51992107	NA	NA	NA	NA	NA
PGEN_.00g123060	Scaffold_05	51992212	51992616	NA	NA	NA	NA	NA
PGEN_.00g123070	Scaffold_05	51992684	51993097	NA	NA	NA	NA	NA
PGEN_.00g123080	Scaffold_05	51993133	51993915	NA	NA	NA	NA	NA
PGEN_.00g123090	Scaffold_05	52000532	52014261	NA	NA	NA	NA	NA
PGEN_.00g123100	Scaffold_05	52033005	52033340	NA	NA	NA	NA	NA
PGEN_.00g123110	Scaffold_05	52033389	52047899	NA	NA	NA	NA	NA
PGEN_.00g123120	Scaffold_05	52063586	52064264	NA	NA	NA	NA	NA
PGEN_.00g123130	Scaffold_05	52064522	52065052	NA	NA	NA	NA	NA
PGEN_.00g123140	Scaffold_05	52084773	52085560	NA	NA	NA	NA	NA
PGEN_.00g123150	Scaffold_05	52102395	52140576	Q6DJ83	CADM2_XENTR	Cell adhesion molecule 2 (Immunoglobulin superfamily member 4D) (IgSF4D)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g123160	Scaffold_05	52143506	52147488	NA	NA	NA	NA	NA
PGEN_.00g123170	Scaffold_05	52148043	52199061	O60469	DSCAM_HUMAN	Down syndrome cell adhesion molecule (CHD2)	GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007162; GO:0007399; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0016020; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:0098632; GO:1990782; GO:1990890	axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cell adhesion [GO:0007155]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]
PGEN_.00g123180	Scaffold_05	52200165	52234564	NA	NA	NA	NA	NA
PGEN_.00g123190	Scaffold_05	52242072	52290522	NA	NA	NA	NA	NA
PGEN_.00g123200	Scaffold_05	52305116	52340542	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g123210	Scaffold_05	52373067	52375562	NA	NA	NA	NA	NA
PGEN_.00g123220	Scaffold_05	52383154	52385143	NA	NA	NA	NA	NA
PGEN_.00g123230	Scaffold_05	52396353	52404461	NA	NA	NA	NA	NA
PGEN_.00g123240	Scaffold_05	52413554	52458173	Q9R044	NPHN_RAT	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0000165; GO:0003094; GO:0005886; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015	cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g123250	Scaffold_05	52608855	52615456	NA	NA	NA	NA	NA
PGEN_.00g123260	Scaffold_05	52623580	52623939	NA	NA	NA	NA	NA
PGEN_.00g123270	Scaffold_05	52632052	52632393	NA	NA	NA	NA	NA
PGEN_.00g123280	Scaffold_05	52636828	52637151	NA	NA	NA	NA	NA
PGEN_.00g123290	Scaffold_05	52679256	52684758	NA	NA	NA	NA	NA
PGEN_.00g123300	Scaffold_05	52687932	52688318	NA	NA	NA	NA	NA
PGEN_.00g123310	Scaffold_05	52689242	52692420	NA	NA	NA	NA	NA
PGEN_.00g123320	Scaffold_05	52693696	52695571	NA	NA	NA	NA	NA
PGEN_.00g123330	Scaffold_05	52725321	52726493	NA	NA	NA	NA	NA
PGEN_.00g123340	Scaffold_05	52743366	52758555	NA	NA	NA	NA	NA
PGEN_.00g123350	Scaffold_05	52762227	52773154	NA	NA	NA	NA	NA
PGEN_.00g123360	Scaffold_05	52778674	52798814	Q8BLK3	LSAMP_MOUSE	Limbic system-associated membrane protein (LSAMP)	GO:0005829; GO:0005886; GO:0007155; GO:0031225; GO:0035641	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; locomotory exploration behavior [GO:0035641]
PGEN_.00g123370	Scaffold_05	52828765	52831654	NA	NA	NA	NA	NA
PGEN_.00g123380	Scaffold_05	52846508	52877860	NA	NA	NA	NA	NA
PGEN_.00g123390	Scaffold_05	52886334	52886663	NA	NA	NA	NA	NA
PGEN_.00g123400	Scaffold_05	52890963	52891232	NA	NA	NA	NA	NA
PGEN_.00g123410	Scaffold_05	52917123	52918870	NA	NA	NA	NA	NA
PGEN_.00g123420	Scaffold_05	52954407	52976461	Q58EG3	NECT3_DANRE	Nectin-3-like protein (Nectin cell adhesion molecule 3) (Poliovirus receptor-related protein 3-like)	GO:0005886; GO:0005913; GO:0007156; GO:0007157; GO:0007286; GO:0016021; GO:0038023; GO:0042803; GO:0050839	cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; spermatid development [GO:0007286]
PGEN_.00g123430	Scaffold_05	53017478	53017849	NA	NA	NA	NA	NA
PGEN_.00g123440	Scaffold_05	53040162	53090622	Q9R044	NPHN_RAT	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0000165; GO:0003094; GO:0005886; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015	cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g123450	Scaffold_05	53083823	53084377	NA	NA	NA	NA	NA
PGEN_.00g123460	Scaffold_05	53085049	53085714	NA	NA	NA	NA	NA
PGEN_.00g123470	Scaffold_05	53093049	53106636	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g123480	Scaffold_05	53106698	53110906	NA	NA	NA	NA	NA
PGEN_.00g123490	Scaffold_05	53112042	53150606	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g123500	Scaffold_05	53206153	53237200	NA	NA	NA	NA	NA
PGEN_.00g123510	Scaffold_05	53273191	53274424	NA	NA	NA	NA	NA
PGEN_.00g123520	Scaffold_05	53274482	53275075	NA	NA	NA	NA	NA
PGEN_.00g123530	Scaffold_05	53275128	53275655	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g123540	Scaffold_05	53284232	53296095	NA	NA	NA	NA	NA
PGEN_.00g123550	Scaffold_05	53305158	53305418	NA	NA	NA	NA	NA
PGEN_.00g123560	Scaffold_05	53333995	53334279	NA	NA	NA	NA	NA
PGEN_.00g123570	Scaffold_05	53400095	53401429	NA	NA	NA	NA	NA
PGEN_.00g123580	Scaffold_05	53408324	53574213	Q9QZS7	NPHN_MOUSE	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0000165; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015	cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g123590	Scaffold_05	53602872	53603396	NA	NA	NA	NA	NA
PGEN_.00g123600	Scaffold_05	53625516	53626807	NA	NA	NA	NA	NA
PGEN_.00g123610	Scaffold_05	53625745	53633343	NA	NA	NA	NA	NA
PGEN_.00g123620	Scaffold_05	53654055	53660436	NA	NA	NA	NA	NA
PGEN_.00g123630	Scaffold_05	53660925	53669476	NA	NA	NA	NA	NA
PGEN_.00g123640	Scaffold_05	53682456	53682761	NA	NA	NA	NA	NA
PGEN_.00g123650	Scaffold_05	53694861	53695409	NA	NA	NA	NA	NA
PGEN_.00g123660	Scaffold_05	53703463	53716559	NA	NA	NA	NA	NA
PGEN_.00g123670	Scaffold_05	53718118	53718642	NA	NA	NA	NA	NA
PGEN_.00g123680	Scaffold_05	53721092	53721415	NA	NA	NA	NA	NA
PGEN_.00g123690	Scaffold_05	53818919	53819362	NA	NA	NA	NA	NA
PGEN_.00g123700	Scaffold_05	53823365	53823862	NA	NA	NA	NA	NA
PGEN_.00g123710	Scaffold_05	53862174	53893214	O60500	NPHN_HUMAN	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g123720	Scaffold_05	53893256	53942526	NA	NA	NA	NA	NA
PGEN_.00g123730	Scaffold_05	53901665	53901979	NA	NA	NA	NA	NA
PGEN_.00g123740	Scaffold_05	54042890	54049042	NA	NA	NA	NA	NA
PGEN_.00g123750	Scaffold_05	54096144	54097097	NA	NA	NA	NA	NA
PGEN_.00g123760	Scaffold_05	54104556	54107160	NA	NA	NA	NA	NA
PGEN_.00g123770	Scaffold_05	54153265	54192575	O60500	NPHN_HUMAN	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g123780	Scaffold_05	54162683	54163114	NA	NA	NA	NA	NA
PGEN_.00g123790	Scaffold_05	54209840	54215829	NA	NA	NA	NA	NA
PGEN_.00g123800	Scaffold_05	54219328	54230356	Q7ZXX1	CADM3_XENLA	Cell adhesion molecule 3 (Immunoglobulin superfamily member 4B) (IgSF4B)	GO:0005886; GO:0007155; GO:0016021; GO:0030054	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g123810	Scaffold_05	54234194	54245848	NA	NA	NA	NA	NA
PGEN_.00g123820	Scaffold_05	54248044	54267756	Q91VN0	LRP5_MOUSE	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009314; GO:0009952; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060764; GO:0061178; GO:0061299; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1902262	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]"
PGEN_.00g123830	Scaffold_05	54279568	54280026	NA	NA	NA	NA	NA
PGEN_.00g123840	Scaffold_05	54281565	54282056	NA	NA	NA	NA	NA
PGEN_.00g123850	Scaffold_05	54292438	54299388	NA	NA	NA	NA	NA
PGEN_.00g123860	Scaffold_05	54303749	54321936	Q80ZE3	SIG10_MOUSE	Sialic acid-binding Ig-like lectin 10 (Siglec-10) (Sialic acid-binding Ig-like lectin G) (Siglec-G) (mSiglec-G)	GO:0002244; GO:0002250; GO:0005886; GO:0007155; GO:0016021; GO:0019902; GO:0030246; GO:0030888; GO:0042169; GO:0045087; GO:0050776; GO:0050849; GO:0051025; GO:0106015	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; phosphatase binding [GO:0019902]; SH2 domain binding [GO:0042169]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; hematopoietic progenitor cell differentiation [GO:0002244]; innate immune response [GO:0045087]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; negative regulation of inflammatory response to wounding [GO:0106015]; regulation of B cell proliferation [GO:0030888]; regulation of immune response [GO:0050776]
PGEN_.00g123870	Scaffold_05	54330867	54333324	NA	NA	NA	NA	NA
PGEN_.00g123880	Scaffold_05	54343288	54350780	NA	NA	NA	NA	NA
PGEN_.00g123890	Scaffold_05	54394836	54395102	NA	NA	NA	NA	NA
PGEN_.00g123900	Scaffold_05	54395177	54409624	NA	NA	NA	NA	NA
PGEN_.00g123910	Scaffold_05	54412829	54416064	Q7Z449	CP2U1_HUMAN	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330; GO:0097267	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g123920	Scaffold_05	54424415	54448483	NA	NA	NA	NA	NA
PGEN_.00g123930	Scaffold_05	54472761	54473927	NA	NA	NA	NA	NA
PGEN_.00g123940	Scaffold_05	54488330	54499545	Q62845	CNTN4_RAT	Contactin-4 (Brain-derived immunoglobulin superfamily protein 2) (BIG-2)	GO:0005576; GO:0005886; GO:0007156; GO:0007399; GO:0007411; GO:0007420; GO:0030424; GO:0031175; GO:0031225; GO:0045665; GO:0070593; GO:0098632	anchored component of membrane [GO:0031225]; axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; brain development [GO:0007420]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]
PGEN_.00g123950	Scaffold_05	54529543	54540885	NA	NA	NA	NA	NA
PGEN_.00g123960	Scaffold_05	54555814	54556125	NA	NA	NA	NA	NA
PGEN_.00g123970	Scaffold_05	54556179	54560901	NA	NA	NA	NA	NA
PGEN_.00g123980	Scaffold_05	54560986	54561231	NA	NA	NA	NA	NA
PGEN_.00g123990	Scaffold_05	54561550	54562079	NA	NA	NA	NA	NA
PGEN_.00g124000	Scaffold_05	54562137	54562541	NA	NA	NA	NA	NA
PGEN_.00g124010	Scaffold_05	54569682	54583493	NA	NA	NA	NA	NA
PGEN_.00g124020	Scaffold_05	54599053	54619258	A2AJ76	HMCN2_MOUSE	Hemicentin-2	GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g124030	Scaffold_05	54622556	54631874	NA	NA	NA	NA	NA
PGEN_.00g124040	Scaffold_05	54626374	54631864	NA	NA	NA	NA	NA
PGEN_.00g124050	Scaffold_05	54646496	54656151	NA	NA	NA	NA	NA
PGEN_.00g124060	Scaffold_05	54699823	54715449	O35136	NCAM2_MOUSE	Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12)	GO:0005886; GO:0007155; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0031225; GO:0042802	anchored component of membrane [GO:0031225]; axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; sensory perception of smell [GO:0007608]
PGEN_.00g124070	Scaffold_05	54719324	54720427	NA	NA	NA	NA	NA
PGEN_.00g124080	Scaffold_05	54746380	54752497	NA	NA	NA	NA	NA
PGEN_.00g124090	Scaffold_05	54767604	54859044	NA	NA	NA	NA	NA
PGEN_.00g124100	Scaffold_05	54859558	54859881	NA	NA	NA	NA	NA
PGEN_.00g124110	Scaffold_05	54860112	54862819	NA	NA	NA	NA	NA
PGEN_.00g124120	Scaffold_05	54877841	54884514	NA	NA	NA	NA	NA
PGEN_.00g124130	Scaffold_05	54899353	55081615	NA	NA	NA	NA	NA
PGEN_.00g124140	Scaffold_05	55103180	55103650	NA	NA	NA	NA	NA
PGEN_.00g124150	Scaffold_05	55113634	55133629	Q9QZS7	NPHN_MOUSE	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0000165; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015	cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g124160	Scaffold_05	55147250	55151710	NA	NA	NA	NA	NA
PGEN_.00g124170	Scaffold_05	55157185	55159454	NA	NA	NA	NA	NA
PGEN_.00g124180	Scaffold_05	55160316	55160663	NA	NA	NA	NA	NA
PGEN_.00g124190	Scaffold_05	55161222	55161659	NA	NA	NA	NA	NA
PGEN_.00g124200	Scaffold_05	55161923	55162618	NA	NA	NA	NA	NA
PGEN_.00g124210	Scaffold_05	55164977	55165531	NA	NA	NA	NA	NA
PGEN_.00g124220	Scaffold_05	55211041	55266571	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g124230	Scaffold_05	55283044	55283580	NA	NA	NA	NA	NA
PGEN_.00g124240	Scaffold_05	55283937	55284308	NA	NA	NA	NA	NA
PGEN_.00g124250	Scaffold_05	55290141	55290422	NA	NA	NA	NA	NA
PGEN_.00g124260	Scaffold_05	55302888	55303625	NA	NA	NA	NA	NA
PGEN_.00g124270	Scaffold_05	55303649	55304824	NA	NA	NA	NA	NA
PGEN_.00g124280	Scaffold_05	55318089	55383742	O60500	NPHN_HUMAN	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g124290	Scaffold_05	55413492	55509493	O35136	NCAM2_MOUSE	Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12)	GO:0005886; GO:0007155; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0031225; GO:0042802	anchored component of membrane [GO:0031225]; axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; sensory perception of smell [GO:0007608]
PGEN_.00g124300	Scaffold_05	55520176	55522399	NA	NA	NA	NA	NA
PGEN_.00g124310	Scaffold_05	55542060	55565738	Q8NDA2	HMCN2_HUMAN	Hemicentin-2	GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g124320	Scaffold_05	55568490	55582323	NA	NA	NA	NA	NA
PGEN_.00g124330	Scaffold_05	55600623	55614269	A2AJ76	HMCN2_MOUSE	Hemicentin-2	GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g124340	Scaffold_05	55617645	55628425	Q05793	PGBM_MOUSE	Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) [Cleaved into: Endorepellin; LG3 peptide]	GO:0001525; GO:0001958; GO:0002020; GO:0002062; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0006898; GO:0007420; GO:0008022; GO:0008104; GO:0009887; GO:0009888; GO:0030198; GO:0031012; GO:0048704; GO:0048738; GO:0060351; GO:0060548; GO:0062023; GO:1905907	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; calcium ion binding [GO:0005509]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of cell death [GO:0060548]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]
PGEN_.00g124350	Scaffold_05	55630066	55648899	P11834	OPCM_BOVIN	Opioid-binding protein/cell adhesion molecule (OBCAM) (OPCML) (Opioid-binding cell adhesion molecule)	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g124360	Scaffold_05	55654040	55667249	NA	NA	NA	NA	NA
PGEN_.00g124370	Scaffold_05	55706874	55707350	NA	NA	NA	NA	NA
PGEN_.00g124380	Scaffold_05	55711035	55732151	NA	NA	NA	NA	NA
PGEN_.00g124390	Scaffold_05	55735448	55750912	O60500	NPHN_HUMAN	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g124400	Scaffold_05	55753452	55758848	NA	NA	NA	NA	NA
PGEN_.00g124410	Scaffold_05	55788313	55823915	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g124420	Scaffold_05	55844475	55851150	NA	NA	NA	NA	NA
PGEN_.00g124430	Scaffold_05	55851507	55854259	NA	NA	NA	NA	NA
PGEN_.00g124440	Scaffold_05	55854337	55857621	NA	NA	NA	NA	NA
PGEN_.00g124450	Scaffold_05	55860954	55872602	NA	NA	NA	NA	NA
PGEN_.00g124460	Scaffold_05	55883713	55883967	NA	NA	NA	NA	NA
PGEN_.00g124470	Scaffold_05	55889942	55890175	NA	NA	NA	NA	NA
PGEN_.00g124480	Scaffold_05	55898341	55935963	P06731	CEAM5_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0050900; GO:0070062; GO:0071575; GO:2000811	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of external side of plasma membrane [GO:0071575]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832]
PGEN_.00g124490	Scaffold_05	55974293	55978301	NA	NA	NA	NA	NA
PGEN_.00g124500	Scaffold_05	55984070	56005004	NA	NA	NA	NA	NA
PGEN_.00g124510	Scaffold_05	56007335	56008291	NA	NA	NA	NA	NA
PGEN_.00g124520	Scaffold_05	56028240	56095510	A2AJ76	HMCN2_MOUSE	Hemicentin-2	GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g124530	Scaffold_05	56108596	56111349	NA	NA	NA	NA	NA
PGEN_.00g124540	Scaffold_05	56119830	56140667	A2AJ76	HMCN2_MOUSE	Hemicentin-2	GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g124550	Scaffold_05	56162794	56163930	NA	NA	NA	NA	NA
PGEN_.00g124560	Scaffold_05	56166071	56175504	NA	NA	NA	NA	NA
PGEN_.00g124570	Scaffold_05	56182677	56182997	NA	NA	NA	NA	NA
PGEN_.00g124580	Scaffold_05	56184816	56185025	NA	NA	NA	NA	NA
PGEN_.00g124590	Scaffold_05	56196081	56196419	NA	NA	NA	NA	NA
PGEN_.00g124600	Scaffold_05	56196532	56197062	NA	NA	NA	NA	NA
PGEN_.00g124610	Scaffold_05	56197601	56197852	NA	NA	NA	NA	NA
PGEN_.00g124620	Scaffold_05	56214426	56215455	NA	NA	NA	NA	NA
PGEN_.00g124630	Scaffold_05	56217682	56219704	NA	NA	NA	NA	NA
PGEN_.00g124640	Scaffold_05	56228401	56230857	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g124650	Scaffold_05	56243024	56243350	NA	NA	NA	NA	NA
PGEN_.00g124660	Scaffold_05	56243662	56247152	NA	NA	NA	NA	NA
PGEN_.00g124670	Scaffold_05	56255886	56256344	NA	NA	NA	NA	NA
PGEN_.00g124680	Scaffold_05	56280597	56282501	NA	NA	NA	NA	NA
PGEN_.00g124690	Scaffold_05	56291083	56300534	NA	NA	NA	NA	NA
PGEN_.00g124700	Scaffold_05	56335797	56341254	NA	NA	NA	NA	NA
PGEN_.00g124710	Scaffold_05	56351707	56355514	NA	NA	NA	NA	NA
PGEN_.00g124720	Scaffold_05	56423431	56430955	NA	NA	NA	NA	NA
PGEN_.00g124730	Scaffold_05	56444581	56455241	NA	NA	NA	NA	NA
PGEN_.00g124740	Scaffold_05	56458296	56459064	NA	NA	NA	NA	NA
PGEN_.00g124750	Scaffold_05	56461551	56466955	NA	NA	NA	NA	NA
PGEN_.00g124760	Scaffold_05	56475921	56507494	O60500	NPHN_HUMAN	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g124770	Scaffold_05	56508838	56513353	O60500	NPHN_HUMAN	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g124780	Scaffold_05	56585576	56585848	NA	NA	NA	NA	NA
PGEN_.00g124790	Scaffold_05	56608504	56608779	NA	NA	NA	NA	NA
PGEN_.00g124800	Scaffold_05	56654192	56656269	NA	NA	NA	NA	NA
PGEN_.00g124810	Scaffold_05	56667151	56674888	NA	NA	NA	NA	NA
PGEN_.00g124820	Scaffold_05	56701940	56702791	NA	NA	NA	NA	NA
PGEN_.00g124830	Scaffold_05	56716258	56795358	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g124840	Scaffold_05	56796944	56797489	NA	NA	NA	NA	NA
PGEN_.00g124850	Scaffold_05	56843549	56845624	NA	NA	NA	NA	NA
PGEN_.00g124860	Scaffold_05	56851660	56853214	Q8BUZ3	TIGD4_MOUSE	Tigger transposable element-derived protein 4	GO:0003677; GO:0005634	nucleus [GO:0005634]; DNA binding [GO:0003677]
PGEN_.00g124870	Scaffold_05	56855377	56908143	NA	NA	NA	NA	NA
PGEN_.00g124880	Scaffold_05	56914849	56915373	NA	NA	NA	NA	NA
PGEN_.00g124890	Scaffold_05	56915802	56916230	NA	NA	NA	NA	NA
PGEN_.00g124900	Scaffold_05	56920358	56921113	NA	NA	NA	NA	NA
PGEN_.00g124910	Scaffold_05	56958351	56961754	NA	NA	NA	NA	NA
PGEN_.00g124920	Scaffold_05	56963634	56967363	NA	NA	NA	NA	NA
PGEN_.00g124930	Scaffold_05	56980891	56987562	NA	NA	NA	NA	NA
PGEN_.00g124940	Scaffold_05	57035720	57036477	NA	NA	NA	NA	NA
PGEN_.00g124950	Scaffold_05	57060569	57063819	NA	NA	NA	NA	NA
PGEN_.00g124960	Scaffold_05	57073550	57135373	A2ASS6	TITIN_MOUSE	Titin (EC 2.7.11.1) (Connectin)	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]
PGEN_.00g124970	Scaffold_05	57170779	57172989	NA	NA	NA	NA	NA
PGEN_.00g124980	Scaffold_05	57175452	57176322	NA	NA	NA	NA	NA
PGEN_.00g124990	Scaffold_05	57200870	57274637	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g125000	Scaffold_05	57287513	57287800	NA	NA	NA	NA	NA
PGEN_.00g125010	Scaffold_05	57290420	57302395	NA	NA	NA	NA	NA
PGEN_.00g125020	Scaffold_05	57307339	57370001	NA	NA	NA	NA	NA
PGEN_.00g125030	Scaffold_05	57387455	57387748	NA	NA	NA	NA	NA
PGEN_.00g125040	Scaffold_05	57399142	57400136	NA	NA	NA	NA	NA
PGEN_.00g125050	Scaffold_05	57404874	57412741	NA	NA	NA	NA	NA
PGEN_.00g125060	Scaffold_05	57415596	57435791	NA	NA	NA	NA	NA
PGEN_.00g125070	Scaffold_05	57440501	57458023	NA	NA	NA	NA	NA
PGEN_.00g125080	Scaffold_05	57487553	57488047	NA	NA	NA	NA	NA
PGEN_.00g125090	Scaffold_05	57495631	57496134	NA	NA	NA	NA	NA
PGEN_.00g125100	Scaffold_05	57498565	57513712	NA	NA	NA	NA	NA
PGEN_.00g125110	Scaffold_05	57531996	57563052	NA	NA	NA	NA	NA
PGEN_.00g125120	Scaffold_05	57575320	57575622	NA	NA	NA	NA	NA
PGEN_.00g125130	Scaffold_05	57590967	57591827	NA	NA	NA	NA	NA
PGEN_.00g125140	Scaffold_05	57596340	57596972	Q86WZ6	ZN227_HUMAN	Zinc finger protein 227	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g125150	Scaffold_05	57599171	57600787	NA	NA	NA	NA	NA
PGEN_.00g125160	Scaffold_05	57601022	57602763	NA	NA	NA	NA	NA
PGEN_.00g125170	Scaffold_05	57603011	57604443	NA	NA	NA	NA	NA
PGEN_.00g125180	Scaffold_05	57626469	57652808	A2AJ76	HMCN2_MOUSE	Hemicentin-2	GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g125190	Scaffold_05	57682498	57710780	O60500	NPHN_HUMAN	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0007588; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0070062; GO:0072015	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g125200	Scaffold_05	57750056	57750439	NA	NA	NA	NA	NA
PGEN_.00g125210	Scaffold_05	57764314	57765855	NA	NA	NA	NA	NA
PGEN_.00g125220	Scaffold_05	57776891	57780663	NA	NA	NA	NA	NA
PGEN_.00g125230	Scaffold_05	57787115	57821863	O15394	NCAM2_HUMAN	Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2)	GO:0005886; GO:0007158; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0042802	axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608]
PGEN_.00g125240	Scaffold_05	57822082	57822408	NA	NA	NA	NA	NA
PGEN_.00g125250	Scaffold_05	57853605	57853892	NA	NA	NA	NA	NA
PGEN_.00g125260	Scaffold_05	57867389	57868147	NA	NA	NA	NA	NA
PGEN_.00g125270	Scaffold_05	57895768	58009943	Q9R044	NPHN_RAT	Nephrin (Renal glomerulus-specific cell adhesion receptor)	GO:0000165; GO:0003094; GO:0005886; GO:0005925; GO:0007155; GO:0007254; GO:0007519; GO:0007520; GO:0016020; GO:0016021; GO:0017022; GO:0019904; GO:0030507; GO:0030838; GO:0032836; GO:0032991; GO:0035418; GO:0036057; GO:0042995; GO:0044062; GO:0045121; GO:0051393; GO:0072015	cell projection [GO:0042995]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; alpha-actinin binding [GO:0051393]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; cell adhesion [GO:0007155]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g125280	Scaffold_05	58033016	58033444	NA	NA	NA	NA	NA
PGEN_.00g125290	Scaffold_05	58038317	58041534	NA	NA	NA	NA	NA
PGEN_.00g125300	Scaffold_05	58041637	58041972	NA	NA	NA	NA	NA
PGEN_.00g125310	Scaffold_05	58046068	58110568	NA	NA	NA	NA	NA
PGEN_.00g125320	Scaffold_05	58128690	58132553	NA	NA	NA	NA	NA
PGEN_.00g125330	Scaffold_05	58216057	58269763	NA	NA	NA	NA	NA
PGEN_.00g125340	Scaffold_05	58280207	58281537	NA	NA	NA	NA	NA
PGEN_.00g125350	Scaffold_05	58287744	58288619	NA	NA	NA	NA	NA
PGEN_.00g125360	Scaffold_05	58312979	58313311	NA	NA	NA	NA	NA
PGEN_.00g125370	Scaffold_05	58319777	58323126	NA	NA	NA	NA	NA
PGEN_.00g125380	Scaffold_05	58355298	58356122	NA	NA	NA	NA	NA
PGEN_.00g125390	Scaffold_05	58356722	58368243	P02707	LECH_CHICK	Hepatic lectin	GO:0006897; GO:0016021; GO:0030246	integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; endocytosis [GO:0006897]
PGEN_.00g125400	Scaffold_05	58371996	58372364	NA	NA	NA	NA	NA
PGEN_.00g125410	Scaffold_05	58408279	58473554	NA	NA	NA	NA	NA
PGEN_.00g125420	Scaffold_05	58474143	58475649	NA	NA	NA	NA	NA
PGEN_.00g125430	Scaffold_05	58482287	58482613	NA	NA	NA	NA	NA
PGEN_.00g125440	Scaffold_05	58482795	58485037	NA	NA	NA	NA	NA
PGEN_.00g125450	Scaffold_05	58495562	58496176	NA	NA	NA	NA	NA
PGEN_.00g125460	Scaffold_05	58535078	58547061	Q9NXL6	SIDT1_HUMAN	SID1 transmembrane family member 1	GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033	integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]
PGEN_.00g125470	Scaffold_05	58604571	58610198	NA	NA	NA	NA	NA
PGEN_.00g125480	Scaffold_05	58620465	58633696	Q9NXL6	SIDT1_HUMAN	SID1 transmembrane family member 1	GO:0003725; GO:0005764; GO:0005886; GO:0016021; GO:0033227; GO:0050658; GO:0051033	integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; dsRNA transport [GO:0033227]; RNA transport [GO:0050658]
PGEN_.00g125490	Scaffold_05	58684510	58693905	NA	NA	NA	NA	NA
PGEN_.00g125500	Scaffold_05	58711874	58810578	Q0VGT2	GLI2_MOUSE	Zinc finger protein GLI2 (Tax helper protein)	GO:0000122; GO:0000978; GO:0001228; GO:0001501; GO:0001649; GO:0001701; GO:0001822; GO:0002009; GO:0002062; GO:0002076; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0007389; GO:0007411; GO:0007418; GO:0007442; GO:0007507; GO:0008134; GO:0008270; GO:0008283; GO:0008284; GO:0009913; GO:0009952; GO:0009953; GO:0009954; GO:0016020; GO:0016607; GO:0021508; GO:0021513; GO:0021517; GO:0021522; GO:0021696; GO:0021775; GO:0021776; GO:0021904; GO:0021915; GO:0021938; GO:0021965; GO:0021983; GO:0030154; GO:0030324; GO:0030879; GO:0030902; GO:0031514; GO:0032331; GO:0035295; GO:0042475; GO:0042733; GO:0043066; GO:0043565; GO:0044212; GO:0045666; GO:0045740; GO:0045893; GO:0045944; GO:0048566; GO:0048589; GO:0048646; GO:0048666; GO:0048754; GO:0048856; GO:0060032; GO:0060322; GO:0060513; GO:0060603; GO:0060831; GO:0071407; GO:0090103; GO:0097542; GO:0098586; GO:1990841	"axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; anatomical structure formation involved in morphogenesis [GO:0048646]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to organic cyclic compound [GO:0071407]; cellular response to virus [GO:0098586]; cerebellar cortex morphogenesis [GO:0021696]; chondrocyte differentiation [GO:0002062]; cochlea morphogenesis [GO:0090103]; developmental growth [GO:0048589]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; floor plate formation [GO:0021508]; head development [GO:0060322]; heart development [GO:0007507]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lung development [GO:0030324]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuron development [GO:0048666]; notochord regression [GO:0060032]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pituitary gland development [GO:0021983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostatic bud formation [GO:0060513]; proximal/distal pattern formation [GO:0009954]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord ventral commissure morphogenesis [GO:0021965]; tube development [GO:0035295]; ventral midline development [GO:0007418]; ventral spinal cord development [GO:0021517]"
PGEN_.00g125510	Scaffold_05	58831397	58843219	Q6H236	PEG3_BOVIN	Paternally-expressed gene 3 protein	GO:0003676; GO:0003700; GO:0005634; GO:0005737; GO:0006915; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915]
PGEN_.00g125520	Scaffold_05	58858656	58859051	NA	NA	NA	NA	NA
PGEN_.00g125530	Scaffold_05	58859330	58859728	NA	NA	NA	NA	NA
PGEN_.00g125540	Scaffold_05	58870123	58870545	NA	NA	NA	NA	NA
PGEN_.00g125550	Scaffold_05	58871091	58871405	NA	NA	NA	NA	NA
PGEN_.00g125560	Scaffold_05	58919179	58943652	Q3SYZ6	XYLB_BOVIN	Xylulose kinase (Xylulokinase) (EC 2.7.1.17)	GO:0004856; GO:0005524; GO:0005829; GO:0005997; GO:0016310; GO:0042732	cytosol [GO:0005829]; ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997]
PGEN_.00g125570	Scaffold_05	58953476	58960821	Q9D8U7	DTWD1_MOUSE	DTW domain-containing protein 1		
PGEN_.00g125580	Scaffold_05	58997847	59006808	Q8NB50	ZFP62_HUMAN	Zinc finger protein 62 homolog (Zfp-62)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g125590	Scaffold_05	59019227	59019517	NA	NA	NA	NA	NA
PGEN_.00g125600	Scaffold_05	59025408	59025758	NA	NA	NA	NA	NA
PGEN_.00g125610	Scaffold_05	59032944	59034011	NA	NA	NA	NA	NA
PGEN_.00g125620	Scaffold_05	59054951	59146252	Q9Y426	C2CD2_HUMAN	C2 domain-containing protein 2 (Transmembrane protein 24-like)	GO:0005634; GO:0005829; GO:0016021	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]
PGEN_.00g125630	Scaffold_05	59104373	59104696	NA	NA	NA	NA	NA
PGEN_.00g125640	Scaffold_05	59104725	59105048	NA	NA	NA	NA	NA
PGEN_.00g125650	Scaffold_05	59105077	59105400	NA	NA	NA	NA	NA
PGEN_.00g125660	Scaffold_05	59105605	59105928	NA	NA	NA	NA	NA
PGEN_.00g125670	Scaffold_05	59146126	59148366	NA	NA	NA	NA	NA
PGEN_.00g125680	Scaffold_05	59148561	59149112	NA	NA	NA	NA	NA
PGEN_.00g125690	Scaffold_05	59149144	59152757	NA	NA	NA	NA	NA
PGEN_.00g125700	Scaffold_05	59152783	59153301	NA	NA	NA	NA	NA
PGEN_.00g125710	Scaffold_05	59168236	59168813	NA	NA	NA	NA	NA
PGEN_.00g125720	Scaffold_05	59199723	59202866	NA	NA	NA	NA	NA
PGEN_.00g125730	Scaffold_05	59202996	59203727	NA	NA	NA	NA	NA
PGEN_.00g125740	Scaffold_05	59213892	59214278	NA	NA	NA	NA	NA
PGEN_.00g125750	Scaffold_05	59227402	59257994	Q7YRZ8	MDM2_FELCA	E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2)	GO:0000122; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0008097; GO:0016567; GO:0016740; GO:0043021; GO:0043066; GO:0043130; GO:0045892; GO:0046872; GO:0071157	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]"
PGEN_.00g125760	Scaffold_05	59263769	59279207	P22232	FBRL_XENLA	rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (Histone-glutamine methyltransferase)	GO:0003723; GO:0005730; GO:0006364; GO:1990258; GO:1990259	nucleolus [GO:0005730]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; histone glutamine methylation [GO:1990258]; rRNA processing [GO:0006364]
PGEN_.00g125770	Scaffold_05	59301478	59305934	NA	NA	NA	NA	NA
PGEN_.00g125780	Scaffold_05	59334096	59337234	NA	NA	NA	NA	NA
PGEN_.00g125790	Scaffold_05	59341131	59342555	NA	NA	NA	NA	NA
PGEN_.00g125800	Scaffold_05	59346214	59348886	NA	NA	NA	NA	NA
PGEN_.00g125810	Scaffold_05	59356025	59383144	Q5RDA4	LG3BP_PONAB	Galectin-3-binding protein (Lectin galactoside-binding soluble 3-binding protein)	GO:0005044; GO:0005576; GO:0007155; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]
PGEN_.00g125820	Scaffold_05	59431128	59609752	Q80ZA4	PKHL1_MOUSE	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)	GO:0005929; GO:0016021	cilium [GO:0005929]; integral component of membrane [GO:0016021]
PGEN_.00g125830	Scaffold_05	59679239	59705274	NA	NA	NA	NA	NA
PGEN_.00g125840	Scaffold_05	59707514	59707957	NA	NA	NA	NA	NA
PGEN_.00g125850	Scaffold_05	59708211	59708510	NA	NA	NA	NA	NA
PGEN_.00g125860	Scaffold_05	59757869	59763916	NA	NA	NA	NA	NA
PGEN_.00g125870	Scaffold_05	59790862	59791964	NA	NA	NA	NA	NA
PGEN_.00g125880	Scaffold_05	59810111	59811917	NA	NA	NA	NA	NA
PGEN_.00g125890	Scaffold_05	59826625	59827692	Q9UL36	ZN236_HUMAN	Zinc finger protein 236	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g125900	Scaffold_05	59839895	59855206	Q09FC8	ZN415_HUMAN	Zinc finger protein 415	GO:0001650; GO:0003677; GO:0005737; GO:0015630; GO:0046872	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g125910	Scaffold_05	59864822	59865601	NA	NA	NA	NA	NA
PGEN_.00g125920	Scaffold_05	59870609	59875659	NA	NA	NA	NA	NA
PGEN_.00g125930	Scaffold_05	59883393	59896589	NA	NA	NA	NA	NA
PGEN_.00g125940	Scaffold_05	59916205	59922735	NA	NA	NA	NA	NA
PGEN_.00g125950	Scaffold_05	59923269	59974780	Q2VUH7	DIXC1_RAT	Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1)	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0019904; GO:0021695; GO:0021795; GO:0021799; GO:0021846; GO:0021869; GO:0030177; GO:0031435; GO:0032956; GO:0032991; GO:0043015; GO:0043025; GO:0043679; GO:0045665; GO:0046330; GO:0050772; GO:0060070; GO:0070507	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebral cortex cell migration [GO:0021795]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507]
PGEN_.00g125960	Scaffold_05	59975398	59981947	NA	NA	NA	NA	NA
PGEN_.00g125970	Scaffold_05	60019617	60020171	NA	NA	NA	NA	NA
PGEN_.00g125980	Scaffold_05	60020238	60020537	NA	NA	NA	NA	NA
PGEN_.00g125990	Scaffold_05	60034986	60036498	D0G895	ACE3_MOUSE	Angiotensin-converting enzyme-like protein Ace3	GO:0001669; GO:0002080; GO:0003081; GO:0003084; GO:0005615; GO:0005886; GO:0008237; GO:0008238; GO:0008239; GO:0008241; GO:0016021; GO:0045777	acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; exopeptidase activity [GO:0008238]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]
PGEN_.00g126000	Scaffold_05	60038570	60040054	NA	NA	NA	NA	NA
PGEN_.00g126010	Scaffold_05	60040996	60041616	NA	NA	NA	NA	NA
PGEN_.00g126020	Scaffold_05	60041885	60065164	Q6Q4G4	ACE_THETS	Angiotensin-converting enzyme (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (TtACE)	GO:0004180; GO:0005615; GO:0008237; GO:0008241; GO:0016020; GO:0046872	extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]
PGEN_.00g126030	Scaffold_05	60066063	60066338	NA	NA	NA	NA	NA
PGEN_.00g126040	Scaffold_05	60066397	60066750	NA	NA	NA	NA	NA
PGEN_.00g126050	Scaffold_05	60066829	60067248	NA	NA	NA	NA	NA
PGEN_.00g126060	Scaffold_05	60067361	60067714	NA	NA	NA	NA	NA
PGEN_.00g126070	Scaffold_05	60067940	60068212	NA	NA	NA	NA	NA
PGEN_.00g126080	Scaffold_05	60068312	60069004	NA	NA	NA	NA	NA
PGEN_.00g126090	Scaffold_05	60069494	60069775	NA	NA	NA	NA	NA
PGEN_.00g126100	Scaffold_05	60069963	60071691	NA	NA	NA	NA	NA
PGEN_.00g126110	Scaffold_05	60087492	60099949	NA	NA	NA	NA	NA
PGEN_.00g126120	Scaffold_05	60104362	60104634	NA	NA	NA	NA	NA
PGEN_.00g126130	Scaffold_05	60115774	60116864	NA	NA	NA	NA	NA
PGEN_.00g126140	Scaffold_05	60117297	60117710	NA	NA	NA	NA	NA
PGEN_.00g126150	Scaffold_05	60117757	60119403	NA	NA	NA	NA	NA
PGEN_.00g126160	Scaffold_05	60122583	60122825	NA	NA	NA	NA	NA
PGEN_.00g126170	Scaffold_05	60122888	60123659	NA	NA	NA	NA	NA
PGEN_.00g126180	Scaffold_05	60146815	60150880	NA	NA	NA	NA	NA
PGEN_.00g126190	Scaffold_05	60178696	60179912	NA	NA	NA	NA	NA
PGEN_.00g126200	Scaffold_05	60188909	60189352	NA	NA	NA	NA	NA
PGEN_.00g126210	Scaffold_05	60263486	60264160	NA	NA	NA	NA	NA
PGEN_.00g126220	Scaffold_05	60320423	60321463	NA	NA	NA	NA	NA
PGEN_.00g126230	Scaffold_05	60351500	60378703	NA	NA	NA	NA	NA
PGEN_.00g126240	Scaffold_05	60381316	60381966	NA	NA	NA	NA	NA
PGEN_.00g126250	Scaffold_05	60399691	60401730	NA	NA	NA	NA	NA
PGEN_.00g126260	Scaffold_05	60418164	60446551	Q9U639	HSP7D_MANSE	Heat shock 70 kDa protein cognate 4 (Hsc 70-4)	GO:0005524; GO:0005634	nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g126270	Scaffold_05	60447963	60454848	NA	NA	NA	NA	NA
PGEN_.00g126280	Scaffold_05	60501840	60502525	NA	NA	NA	NA	NA
PGEN_.00g126290	Scaffold_05	60572596	60574453	NA	NA	NA	NA	NA
PGEN_.00g126300	Scaffold_05	60626367	60660602	NA	NA	NA	NA	NA
PGEN_.00g126310	Scaffold_05	60676299	60676601	NA	NA	NA	NA	NA
PGEN_.00g126320	Scaffold_05	60724803	60730367	NA	NA	NA	NA	NA
PGEN_.00g126330	Scaffold_05	60744225	60744737	NA	NA	NA	NA	NA
PGEN_.00g126340	Scaffold_05	60748693	60749924	NA	NA	NA	NA	NA
PGEN_.00g126350	Scaffold_05	60751077	60796097	A7MBS7	THS7A_DANRE	Thrombospondin type-1 domain-containing protein 7A	GO:0001525; GO:0002040; GO:0003094; GO:0005886; GO:0008593; GO:0016021; GO:0031532; GO:0032835; GO:0042995; GO:0043534; GO:0048675; GO:0072015	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; blood vessel endothelial cell migration [GO:0043534]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; glomerulus development [GO:0032835]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040]
PGEN_.00g126360	Scaffold_05	60831216	60831908	NA	NA	NA	NA	NA
PGEN_.00g126370	Scaffold_05	60832377	60837710	NA	NA	NA	NA	NA
PGEN_.00g126380	Scaffold_05	60838016	60869538	Q69ZU6	THS7A_MOUSE	"Thrombospondin type-1 domain-containing protein 7A [Cleaved into: Thrombospondin type-1 domain-containing protein 7A, soluble form]"	GO:0001525; GO:0005576; GO:0005886; GO:0016021; GO:0030154; GO:0031532; GO:0098846	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; podocyte foot [GO:0098846]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]
PGEN_.00g126390	Scaffold_05	60883429	60978059	Q6P4U0	THS7B_MOUSE	Thrombospondin type-1 domain-containing protein 7B	GO:0005886; GO:0016021; GO:0031532	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin cytoskeleton reorganization [GO:0031532]
PGEN_.00g126400	Scaffold_05	60985224	60985625	NA	NA	NA	NA	NA
PGEN_.00g126410	Scaffold_05	60985688	60986441	NA	NA	NA	NA	NA
PGEN_.00g126420	Scaffold_05	60986465	60987291	NA	NA	NA	NA	NA
PGEN_.00g126430	Scaffold_05	61067459	61070114	NA	NA	NA	NA	NA
PGEN_.00g126440	Scaffold_05	61129531	61129730	NA	NA	NA	NA	NA
PGEN_.00g126450	Scaffold_05	61165707	61167985	NA	NA	NA	NA	NA
PGEN_.00g126460	Scaffold_05	61181829	61183328	NA	NA	NA	NA	NA
PGEN_.00g126470	Scaffold_05	61262132	61263129	NA	NA	NA	NA	NA
PGEN_.00g126480	Scaffold_05	61302125	61302697	NA	NA	NA	NA	NA
PGEN_.00g126490	Scaffold_05	61325521	61327239	NA	NA	NA	NA	NA
PGEN_.00g126500	Scaffold_05	61361007	61361459	NA	NA	NA	NA	NA
PGEN_.00g126510	Scaffold_05	61365376	61369496	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g126520	Scaffold_05	61377462	61377791	NA	NA	NA	NA	NA
PGEN_.00g126530	Scaffold_05	61389694	61390056	NA	NA	NA	NA	NA
PGEN_.00g126540	Scaffold_05	61400889	61429624	O73930	PHS_CHICK	Pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (DCoH) (Dimerization cofactor of HNF1) (cDcoH) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase) (PCD)	GO:0005634; GO:0005737; GO:0006729; GO:0008124	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; tetrahydrobiopterin biosynthetic process [GO:0006729]
PGEN_.00g126550	Scaffold_05	61471818	61510214	Q9BZE4	NOG1_HUMAN	Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB)	GO:0000079; GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0033342; GO:0048471; GO:0050821	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]"
PGEN_.00g126560	Scaffold_05	61525526	61525924	NA	NA	NA	NA	NA
PGEN_.00g126570	Scaffold_05	61529570	61536471	Q9BZE4	NOG1_HUMAN	Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB)	GO:0000079; GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0033342; GO:0048471; GO:0050821	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]"
PGEN_.00g126580	Scaffold_05	61538950	61549147	NA	NA	NA	NA	NA
PGEN_.00g126590	Scaffold_05	61560248	61560490	NA	NA	NA	NA	NA
PGEN_.00g126600	Scaffold_05	61567750	61569095	NA	NA	NA	NA	NA
PGEN_.00g126610	Scaffold_05	61569950	61572236	NA	NA	NA	NA	NA
PGEN_.00g126620	Scaffold_05	61572378	61572806	Q08B72	MYPOP_XENLA	"Myb-related transcription factor, partner of profilin (Myb-related protein p42POP)"	GO:0003677; GO:0005634	nucleus [GO:0005634]; DNA binding [GO:0003677]
PGEN_.00g126630	Scaffold_05	61591745	61602749	Q71RG4	TMUB2_HUMAN	Transmembrane and ubiquitin-like domain-containing protein 2	GO:0016021; GO:0030433	integral component of membrane [GO:0016021]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g126640	Scaffold_05	61611337	61611922	NA	NA	NA	NA	NA
PGEN_.00g126650	Scaffold_05	61612094	61623674	NA	NA	NA	NA	NA
PGEN_.00g126660	Scaffold_05	61625068	61625493	NA	NA	NA	NA	NA
PGEN_.00g126670	Scaffold_05	61626573	61666783	Q32L53	LFG1_BOVIN	Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit)	GO:0005783; GO:0005794; GO:0016021; GO:0032469; GO:0044325; GO:1902236	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ion channel binding [GO:0044325]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]
PGEN_.00g126680	Scaffold_05	61683017	61688094	Q6ZMW2	ZN782_HUMAN	Zinc finger protein 782	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g126690	Scaffold_05	61703676	61704035	NA	NA	NA	NA	NA
PGEN_.00g126700	Scaffold_05	61734807	61737793	NA	NA	NA	NA	NA
PGEN_.00g126710	Scaffold_05	61759056	61764647	NA	NA	NA	NA	NA
PGEN_.00g126720	Scaffold_05	61767274	61779279	NA	NA	NA	NA	NA
PGEN_.00g126730	Scaffold_05	61783483	61795613	NA	NA	NA	NA	NA
PGEN_.00g126740	Scaffold_05	61795654	61795884	NA	NA	NA	NA	NA
PGEN_.00g126750	Scaffold_05	61795997	61796440	NA	NA	NA	NA	NA
PGEN_.00g126760	Scaffold_05	61801950	61804391	O88822	SC5D_MOUSE	Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase)	GO:0000248; GO:0005506; GO:0005789; GO:0016021; GO:0016126; GO:0033490; GO:0043231	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; C-5 sterol desaturase activity [GO:0000248]; iron ion binding [GO:0005506]; cholesterol biosynthetic process via lathosterol [GO:0033490]; sterol biosynthetic process [GO:0016126]
PGEN_.00g126770	Scaffold_05	61804646	61804876	NA	NA	NA	NA	NA
PGEN_.00g126780	Scaffold_05	61805366	61806057	NA	NA	NA	NA	NA
PGEN_.00g126790	Scaffold_05	61806335	61806547	NA	NA	NA	NA	NA
PGEN_.00g126800	Scaffold_05	61807449	61808214	NA	NA	NA	NA	NA
PGEN_.00g126810	Scaffold_05	61808351	61808581	NA	NA	NA	NA	NA
PGEN_.00g126820	Scaffold_05	61808629	61809051	NA	NA	NA	NA	NA
PGEN_.00g126830	Scaffold_05	61834814	61842595	NA	NA	NA	NA	NA
PGEN_.00g126840	Scaffold_05	61855080	61855370	NA	NA	NA	NA	NA
PGEN_.00g126850	Scaffold_05	61869853	61882967	NA	NA	NA	NA	NA
PGEN_.00g126860	Scaffold_05	61884622	61891424	NA	NA	NA	NA	NA
PGEN_.00g126870	Scaffold_05	61912548	61917000	NA	NA	NA	NA	NA
PGEN_.00g126880	Scaffold_05	61954395	61988544	O35158	CDON_RAT	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0001708; GO:0001934; GO:0002088; GO:0005887; GO:0007155; GO:0007224; GO:0007520; GO:0009952; GO:0009986; GO:0010172; GO:0014816; GO:0021987; GO:0043410; GO:0043497; GO:0045663; GO:0045664; GO:0045666; GO:0045944; GO:0048598; GO:0048643; GO:0051057; GO:0051146; GO:0060059; GO:2000179	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; anterior/posterior pattern specification [GO:0009952]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cerebral cortex development [GO:0021987]; embryonic body morphogenesis [GO:0010172]; embryonic morphogenesis [GO:0048598]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; lens development in camera-type eye [GO:0002088]; myoblast fusion [GO:0007520]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]; regulation of protein heterodimerization activity [GO:0043497]; skeletal muscle satellite cell differentiation [GO:0014816]; smoothened signaling pathway [GO:0007224]; striated muscle cell differentiation [GO:0051146]
PGEN_.00g126890	Scaffold_05	61995180	62011862	NA	NA	NA	NA	NA
PGEN_.00g126900	Scaffold_05	62012623	62014457	NA	NA	NA	NA	NA
PGEN_.00g126910	Scaffold_05	62015789	62022800	Q6NYE7	TM192_DANRE	Transmembrane protein 192	GO:0005765; GO:0005770; GO:0016021	integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]
PGEN_.00g126920	Scaffold_05	62024640	62025086	NA	NA	NA	NA	NA
PGEN_.00g126930	Scaffold_05	62045406	62061022	NA	NA	NA	NA	NA
PGEN_.00g126940	Scaffold_05	62070308	62071431	NA	NA	NA	NA	NA
PGEN_.00g126950	Scaffold_05	62073339	62147622	Q63312	PHLB1_RAT	Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha) (Fragment)	GO:0010470; GO:0010717; GO:0045180; GO:0070507; GO:1904261	basal cortex [GO:0045180]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]
PGEN_.00g126960	Scaffold_05	62097881	62098117	NA	NA	NA	NA	NA
PGEN_.00g126970	Scaffold_05	62176193	62183230	NA	NA	NA	NA	NA
PGEN_.00g126980	Scaffold_05	62183301	62184053	NA	NA	NA	NA	NA
PGEN_.00g126990	Scaffold_05	62186682	62188997	NA	NA	NA	NA	NA
PGEN_.00g127000	Scaffold_05	62204297	62205520	NA	NA	NA	NA	NA
PGEN_.00g127010	Scaffold_05	62238812	62239240	NA	NA	NA	NA	NA
PGEN_.00g127020	Scaffold_05	62240227	62240553	NA	NA	NA	NA	NA
PGEN_.00g127030	Scaffold_05	62242266	62247995	NA	NA	NA	NA	NA
PGEN_.00g127040	Scaffold_05	62264896	62307868	Q86UU1	PHLB1_HUMAN	Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha)	GO:0010470; GO:0010717; GO:0045180; GO:0070507; GO:1904261	basal cortex [GO:0045180]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]
PGEN_.00g127050	Scaffold_05	62350169	62360310	Q5E9T4	TPK1_BOVIN	Thiamin pyrophosphokinase 1 (EC 2.7.6.2) (Thiamine pyrophosphokinase 1)	GO:0004788; GO:0005524; GO:0006772; GO:0009229; GO:0016301; GO:0030975	ATP binding [GO:0005524]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]
PGEN_.00g127060	Scaffold_05	62377486	62377845	NA	NA	NA	NA	NA
PGEN_.00g127070	Scaffold_05	62379139	62445755	Q80TI0	ASTRB_MOUSE	Protein Aster-B (GRAM domain-containing protein 1B)	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]
PGEN_.00g127080	Scaffold_05	62450584	62476322	Q9NQC8	IFT46_HUMAN	Intraflagellar transport protein 46 homolog	GO:0005737; GO:0005813; GO:0005929; GO:0007224; GO:0008022; GO:0030992; GO:0031514; GO:0035735; GO:0042073; GO:0050821; GO:0060271; GO:0097542	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; protein C-terminus binding [GO:0008022]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; protein stabilization [GO:0050821]; smoothened signaling pathway [GO:0007224]
PGEN_.00g127090	Scaffold_05	62487306	62542630	Q92542	NICA_HUMAN	Nicastrin	GO:0002262; GO:0004175; GO:0005739; GO:0005765; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0016020; GO:0016021; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0031293; GO:0034205; GO:0035333; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0043065; GO:0043085; GO:0043312; GO:0044267; GO:0048013; GO:0050673; GO:0051402; GO:0070062; GO:0070765; GO:0071277; GO:0099056; GO:1900271; GO:1990926	"azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021]; endopeptidase activity [GO:0004175]; adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular protein metabolic process [GO:0044267]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; dopamine receptor signaling pathway [GO:0007212]; ephrin receptor signaling pathway [GO:0048013]; epithelial cell proliferation [GO:0050673]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; neutrophil degranulation [GO:0043312]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098]"
PGEN_.00g127100	Scaffold_05	62610982	62613291	Q9HAB8	PPCS_HUMAN	Phosphopantothenate--cysteine ligase (EC 6.3.2.51) (Phosphopantothenoylcysteine synthetase) (PPC synthetase)	GO:0003015; GO:0004632; GO:0005524; GO:0005829; GO:0006085; GO:0009108; GO:0015937; GO:0042803	cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphopantothenate--cysteine ligase activity [GO:0004632]; protein homodimerization activity [GO:0042803]; acetyl-CoA biosynthetic process [GO:0006085]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108]; heart process [GO:0003015]
PGEN_.00g127110	Scaffold_05	62613681	62631858	A2VDC2	HIBCH_XENLA	"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H)"	GO:0003860; GO:0005739; GO:0006574	mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574]
PGEN_.00g127120	Scaffold_05	62639615	62658646	Q5ZJ60	HIBCH_CHICK	"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H)"	GO:0003860; GO:0005739; GO:0006574	mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574]
PGEN_.00g127130	Scaffold_05	62663317	62682861	Q4TU93	MRC2_RAT	C-type mannose receptor 2 (Endocytic receptor 180) (Macrophage mannose receptor 2) (CD antigen CD280)	GO:0004888; GO:0005518; GO:0005886; GO:0006897; GO:0016021; GO:0030246; GO:0030574	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]
PGEN_.00g127140	Scaffold_05	62682921	62683346	NA	NA	NA	NA	NA
PGEN_.00g127150	Scaffold_05	62683572	62683829	NA	NA	NA	NA	NA
PGEN_.00g127160	Scaffold_05	62683873	62684430	NA	NA	NA	NA	NA
PGEN_.00g127170	Scaffold_05	62687793	62732736	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g127180	Scaffold_05	62745398	62761514	NA	NA	NA	NA	NA
PGEN_.00g127190	Scaffold_05	62755943	62765086	NA	NA	NA	NA	NA
PGEN_.00g127200	Scaffold_05	62820019	62821179	NA	NA	NA	NA	NA
PGEN_.00g127210	Scaffold_05	62821375	62821668	NA	NA	NA	NA	NA
PGEN_.00g127220	Scaffold_05	62821774	62824423	NA	NA	NA	NA	NA
PGEN_.00g127230	Scaffold_05	62825525	62833060	NA	NA	NA	NA	NA
PGEN_.00g127240	Scaffold_05	62835048	62837019	NA	NA	NA	NA	NA
PGEN_.00g127250	Scaffold_05	62855657	62855920	NA	NA	NA	NA	NA
PGEN_.00g127260	Scaffold_05	62858168	62861819	Q9QX47	SON_MOUSE	Protein SON (Negative regulatory element-binding protein) (NRE-binding protein)	GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726	"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"
PGEN_.00g127270	Scaffold_05	62917754	62947364	Q9D4B2	TTC25_MOUSE	Tetratricopeptide repeat protein 25 (TPR repeat protein 25)	GO:0005737; GO:0005856; GO:0005929	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]
PGEN_.00g127280	Scaffold_05	62964866	62965626	NA	NA	NA	NA	NA
PGEN_.00g127290	Scaffold_05	62966402	62966764	NA	NA	NA	NA	NA
PGEN_.00g127300	Scaffold_05	62966902	62967517	NA	NA	NA	NA	NA
PGEN_.00g127310	Scaffold_05	62981801	62982467	NA	NA	NA	NA	NA
PGEN_.00g127320	Scaffold_05	62982668	62982892	NA	NA	NA	NA	NA
PGEN_.00g127330	Scaffold_05	62983214	62983537	NA	NA	NA	NA	NA
PGEN_.00g127340	Scaffold_05	62983748	62984038	NA	NA	NA	NA	NA
PGEN_.00g127350	Scaffold_05	62990691	62991482	NA	NA	NA	NA	NA
PGEN_.00g127360	Scaffold_05	63024189	63024461	NA	NA	NA	NA	NA
PGEN_.00g127370	Scaffold_05	63032816	63033424	NA	NA	NA	NA	NA
PGEN_.00g127380	Scaffold_05	63038279	63040817	NA	NA	NA	NA	NA
PGEN_.00g127390	Scaffold_05	63040998	63071998	NA	NA	NA	NA	NA
PGEN_.00g127400	Scaffold_05	63124870	63146748	O60563	CCNT1_HUMAN	Cyclin-T1 (CycT1) (Cyclin-T)	GO:0000079; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006368; GO:0006468; GO:0007049; GO:0008024; GO:0008134; GO:0016032; GO:0016538; GO:0019901; GO:0032786; GO:0042795; GO:0043923; GO:0044212; GO:0045944; GO:0050434; GO:0051301; GO:0061575; GO:0070063; GO:0097322; GO:1900364	"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"
PGEN_.00g127410	Scaffold_05	63148851	63174060	Q2NL14	KANL2_BOVIN	KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog)	GO:0000123; GO:0005829; GO:0005886; GO:0015629; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044545; GO:0046972	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; plasma membrane [GO:0005886]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]
PGEN_.00g127420	Scaffold_05	63176603	63176899	NA	NA	NA	NA	NA
PGEN_.00g127430	Scaffold_05	63188988	63189320	NA	NA	NA	NA	NA
PGEN_.00g127440	Scaffold_05	63211979	63212422	NA	NA	NA	NA	NA
PGEN_.00g127450	Scaffold_05	63223298	63225451	NA	NA	NA	NA	NA
PGEN_.00g127460	Scaffold_05	63252204	63252596	NA	NA	NA	NA	NA
PGEN_.00g127470	Scaffold_05	63253092	63253442	NA	NA	NA	NA	NA
PGEN_.00g127480	Scaffold_05	63271307	63272014	NA	NA	NA	NA	NA
PGEN_.00g127490	Scaffold_05	63272526	63307618	A5HNF6	MYD88_CHICK	Myeloid differentiation primary response protein MyD88	GO:0002224; GO:0002238; GO:0002755; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006909; GO:0006954; GO:0008063; GO:0009615; GO:0009682; GO:0010628; GO:0016064; GO:0031663; GO:0032494; GO:0032740; GO:0032747; GO:0032755; GO:0032760; GO:0035325; GO:0043123; GO:0045080; GO:0045087; GO:0045351; GO:0046330; GO:0050671; GO:0050830; GO:0051092; GO:0070976; GO:0090557; GO:0140052; GO:1900017; GO:1901224; GO:1902622; GO:2000338; GO:2000341	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; TIR domain binding [GO:0070976]; Toll-like receptor binding [GO:0035325]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to Gram-positive bacterium [GO:0050830]; establishment of endothelial intestinal barrier [GO:0090557]; immunoglobulin mediated immune response [GO:0016064]; induced systemic resistance [GO:0009682]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; phagocytosis [GO:0006909]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000338]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of neutrophil migration [GO:1902622]; response to molecule of fungal origin [GO:0002238]; response to peptidoglycan [GO:0032494]; response to virus [GO:0009615]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; type I interferon biosynthetic process [GO:0045351]
PGEN_.00g127500	Scaffold_05	63315488	63360499	Q9BQS8	FYCO1_HUMAN	FYVE and coiled-coil domain-containing protein 1 (Zinc finger FYVE domain-containing protein 7)	GO:0005623; GO:0005764; GO:0005770; GO:0005776; GO:0005794; GO:0016020; GO:0043231; GO:0046872; GO:0072383; GO:1901098	autophagosome [GO:0005776]; cell [GO:0005623]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; metal ion binding [GO:0046872]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098]
PGEN_.00g127510	Scaffold_05	63367067	63371325	NA	NA	NA	NA	NA
PGEN_.00g127520	Scaffold_05	63375702	63401800	Q9D2L5	CPXM2_MOUSE	Inactive carboxypeptidase-like protein X2	GO:0004181; GO:0005615; GO:0006518; GO:0008270; GO:0016485	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]
PGEN_.00g127530	Scaffold_05	63414573	63422272	Q9Z1L4	XLRS1_MOUSE	Retinoschisin (X-linked juvenile retinoschisis protein homolog)	GO:0001786; GO:0001917; GO:0005546; GO:0005547; GO:0005576; GO:0005615; GO:0007155; GO:0007601; GO:0010314; GO:0010842; GO:0016062; GO:0019897; GO:0032266; GO:0043325; GO:0051260; GO:0070273; GO:0080025; GO:0098984	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]; adaptation of rhodopsin mediated signaling [GO:0016062]; cell adhesion [GO:0007155]; protein homooligomerization [GO:0051260]; retina layer formation [GO:0010842]; visual perception [GO:0007601]"
PGEN_.00g127540	Scaffold_05	63429434	63430981	NA	NA	NA	NA	NA
PGEN_.00g127550	Scaffold_05	63438782	63447791	NA	NA	NA	NA	NA
PGEN_.00g127560	Scaffold_05	63490478	63494083	NA	NA	NA	NA	NA
PGEN_.00g127570	Scaffold_05	63496499	63500613	NA	NA	NA	NA	NA
PGEN_.00g127580	Scaffold_05	63510581	63516147	NA	NA	NA	NA	NA
PGEN_.00g127590	Scaffold_05	63521771	63522157	NA	NA	NA	NA	NA
PGEN_.00g127600	Scaffold_05	63526920	63527426	NA	NA	NA	NA	NA
PGEN_.00g127610	Scaffold_05	63527463	63527780	NA	NA	NA	NA	NA
PGEN_.00g127620	Scaffold_05	63531426	63532393	NA	NA	NA	NA	NA
PGEN_.00g127630	Scaffold_05	63553637	63574040	Q8N0X2	SPG16_HUMAN	Sperm-associated antigen 16 protein (Pf20 protein homolog)	GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:1990716	axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288]
PGEN_.00g127640	Scaffold_05	63621501	63621767	NA	NA	NA	NA	NA
PGEN_.00g127650	Scaffold_05	63631021	63631239	NA	NA	NA	NA	NA
PGEN_.00g127660	Scaffold_05	63636612	63645074	Q8K3X2	FCL_CRIGR	"GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein)"	GO:0001913; GO:0019673; GO:0042351; GO:0042802; GO:0047918; GO:0050577; GO:0050662	"coenzyme binding [GO:0050662]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; T cell mediated cytotoxicity [GO:0001913]"
PGEN_.00g127670	Scaffold_05	63659585	63667493	NA	NA	NA	NA	NA
PGEN_.00g127680	Scaffold_05	63667529	63668125	NA	NA	NA	NA	NA
PGEN_.00g127690	Scaffold_05	63668180	63669338	NA	NA	NA	NA	NA
PGEN_.00g127700	Scaffold_05	63677326	63690974	NA	NA	NA	NA	NA
PGEN_.00g127710	Scaffold_05	63694380	63703654	NA	NA	NA	NA	NA
PGEN_.00g127720	Scaffold_05	63814252	63815778	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g127730	Scaffold_05	63820705	63866981	Q9VQH2	DUOX_DROME	Dual oxidase (EC 1.11.1.-) (EC 1.6.3.1)	GO:0002385; GO:0004601; GO:0005509; GO:0005886; GO:0006952; GO:0006979; GO:0007476; GO:0008365; GO:0009611; GO:0012505; GO:0016174; GO:0016175; GO:0019221; GO:0020037; GO:0035220; GO:0042335; GO:0042554; GO:0042742; GO:0042744; GO:0043020; GO:0043066; GO:0048085; GO:0050665; GO:0051591; GO:0055114; GO:0072593	endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]
PGEN_.00g127740	Scaffold_05	63895641	63904726	Q1HG43	DOXA1_HUMAN	Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein)	GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016021; GO:0019899; GO:0031252; GO:0034613; GO:0042743; GO:0045666; GO:0050727; GO:2000609	cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609]
PGEN_.00g127750	Scaffold_05	63918751	63920491	NA	NA	NA	NA	NA
PGEN_.00g127760	Scaffold_05	63927013	63941297	P51174	ACADL_MOUSE	"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)"	GO:0000062; GO:0001659; GO:0004466; GO:0005739; GO:0005759; GO:0009062; GO:0009409; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0042802; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0055114; GO:0090181; GO:0120162	"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]"
PGEN_.00g127770	Scaffold_05	63976640	64037847	P49620	DGKG_RAT	Diacylglycerol kinase gamma (DAG kinase gamma) (EC 2.7.1.107) (88 kDa diacylglycerol kinase) (Diglyceride kinase gamma) (DGK-gamma)	GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005886; GO:0007205; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0048666	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; neuron development [GO:0048666]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]
PGEN_.00g127780	Scaffold_05	64085993	64120930	NA	NA	NA	NA	NA
PGEN_.00g127790	Scaffold_05	64141518	64144409	P50549	ETV1_HUMAN	ETS translocation variant 1 (Ets-related protein 81)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0030154; GO:0045944; GO:0048935	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g127800	Scaffold_05	64154825	64161464	O75618	DEDD_HUMAN	Death effector domain-containing protein (DEDPro1) (Death effector domain-containing testicular molecule) (FLDED-1)	GO:0003677; GO:0005730; GO:0005737; GO:0007283; GO:0008625; GO:0042981	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]
PGEN_.00g127810	Scaffold_05	64171469	64172303	NA	NA	NA	NA	NA
PGEN_.00g127820	Scaffold_05	64175331	64176380	Q28113	FUT2_BOVIN	"Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g127830	Scaffold_05	64209772	64215183	NA	NA	NA	NA	NA
PGEN_.00g127840	Scaffold_05	64235786	64240977	NA	NA	NA	NA	NA
PGEN_.00g127850	Scaffold_05	64291284	64298630	NA	NA	NA	NA	NA
PGEN_.00g127860	Scaffold_05	64312321	64327881	NA	NA	NA	NA	NA
PGEN_.00g127870	Scaffold_05	64355444	64356531	NA	NA	NA	NA	NA
PGEN_.00g127880	Scaffold_05	64372718	64394853	NA	NA	NA	NA	NA
PGEN_.00g127890	Scaffold_05	64397751	64419103	NA	NA	NA	NA	NA
PGEN_.00g127900	Scaffold_05	64421092	64421796	NA	NA	NA	NA	NA
PGEN_.00g127910	Scaffold_05	64433827	64434816	Q9NXK6	PAQR5_HUMAN	Membrane progestin receptor gamma (mPR gamma) (Membrane progesterone P4 receptor gamma) (Membrane progesterone receptor gamma) (Progesterone and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member V)	GO:0005496; GO:0005886; GO:0007275; GO:0016021; GO:0038023; GO:0048477	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]
PGEN_.00g127920	Scaffold_05	64453834	64481775	Q92609	TBCD5_HUMAN	TBC1 domain family member 5	GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0010008; GO:0016236; GO:0017137; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:0090630; GO:1905394	"autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]; AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; retromer complex binding [GO:1905394]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g127930	Scaffold_05	64516091	64526879	NA	NA	NA	NA	NA
PGEN_.00g127940	Scaffold_05	64546479	64547540	Q7T3S3	CHSTB_DANRE	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)	GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]
PGEN_.00g127950	Scaffold_05	64610467	64618502	NA	NA	NA	NA	NA
PGEN_.00g127960	Scaffold_05	64633907	64659760	NA	NA	NA	NA	NA
PGEN_.00g127970	Scaffold_05	64687442	64718962	A7MBC7	NEMP1_BOVIN	Nuclear envelope integral membrane protein 1	GO:0005635; GO:0005637; GO:0016021	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]
PGEN_.00g127980	Scaffold_05	64697653	64698470	Q80TC5	POGK_MOUSE	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g127990	Scaffold_05	64728452	64747710	Q60847	COCA1_MOUSE	Collagen alpha-1(XII) chain	GO:0003429; GO:0005595; GO:0005615; GO:0007155; GO:0031012; GO:0035987; GO:0062023	collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g128000	Scaffold_05	64749192	64750004	NA	NA	NA	NA	NA
PGEN_.00g128010	Scaffold_05	64757820	64764445	P0CB92	NDUA8_PONPY	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (Complex I-19kD) (CI-19kD) (NADH-ubiquinone oxidoreductase 19 kDa subunit)	GO:0005739; GO:0005747; GO:0005758; GO:0006120; GO:0032981	"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"
PGEN_.00g128020	Scaffold_05	64774071	64784069	Q22306	YW12_CAEEL	UPF0046 protein T07D4.2	GO:0016787	hydrolase activity [GO:0016787]
PGEN_.00g128030	Scaffold_05	64786746	64795553	O75431	MTX2_HUMAN	Metaxin-2 (Mitochondrial outer membrane import complex protein 2)	GO:0001401; GO:0005730; GO:0005739; GO:0005741; GO:0006839; GO:0015031	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]; mitochondrial transport [GO:0006839]; protein transport [GO:0015031]
PGEN_.00g128040	Scaffold_05	64811016	64821045	NA	NA	NA	NA	NA
PGEN_.00g128050	Scaffold_05	64894995	64895363	NA	NA	NA	NA	NA
PGEN_.00g128060	Scaffold_05	64902894	64911781	Q5I047	ACKMT_XENLA	ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B)	GO:0005739; GO:0016021; GO:0016279; GO:0018022; GO:0018023; GO:0030061; GO:1904058; GO:1905273; GO:1905706	"integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]"
PGEN_.00g128070	Scaffold_05	64920290	64938869	NA	NA	NA	NA	NA
PGEN_.00g128080	Scaffold_05	64972176	64990821	P50430	ARSB_RAT	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]
PGEN_.00g128090	Scaffold_05	64988667	64988966	NA	NA	NA	NA	NA
PGEN_.00g128100	Scaffold_05	64989012	64989269	NA	NA	NA	NA	NA
PGEN_.00g128110	Scaffold_05	64990884	64991823	P50430	ARSB_RAT	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]
PGEN_.00g128120	Scaffold_05	64993902	64999094	B0K019	BAG1_RAT	BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1)	GO:0000774; GO:0001933; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0010226; GO:0014040; GO:0014070; GO:0030182; GO:0031625; GO:0035094; GO:0042493; GO:0043066; GO:0043525; GO:0045944; GO:0048471; GO:0051085; GO:0051087; GO:0051219; GO:0070585; GO:1901423; GO:2000672	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; phosphoprotein binding [GO:0051219]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic process [GO:0043066]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of protein phosphorylation [GO:0001933]; neuron differentiation [GO:0030182]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to mitochondrion [GO:0070585]; response to benzene [GO:1901423]; response to drug [GO:0042493]; response to lithium ion [GO:0010226]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]
PGEN_.00g128130	Scaffold_05	65023994	65034049	Q9JI12	VGLU2_RAT	Vesicular glutamate transporter 2 (VGluT2) (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6)	GO:0001504; GO:0003407; GO:0005313; GO:0005326; GO:0005769; GO:0006814; GO:0007420; GO:0008021; GO:0015293; GO:0016021; GO:0021766; GO:0030054; GO:0030285; GO:0030672; GO:0035249; GO:0050803; GO:0060076; GO:0098700; GO:0098793; GO:1990030	"cell junction [GO:0030054]; early endosome [GO:0005769]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; pericellular basket [GO:1990030]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; brain development [GO:0007420]; hippocampus development [GO:0021766]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter uptake [GO:0001504]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g128140	Scaffold_05	65057916	65073465	Q6INC8	VGLU1_XENLA	Vesicular glutamate transporter 1 (VGluT1) (Solute carrier family 17 member 7)	GO:0006814; GO:0006836; GO:0015293; GO:0016021; GO:0030054; GO:0030672; GO:0043005	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; symporter activity [GO:0015293]; neurotransmitter transport [GO:0006836]; sodium ion transport [GO:0006814]
PGEN_.00g128150	Scaffold_05	65074746	65100060	Q06335	APLP2_MOUSE	Amyloid-like protein 2 (APLP-2) (CDEI box-binding protein) (CDEBP)	GO:0001967; GO:0003677; GO:0005623; GO:0005634; GO:0005886; GO:0006878; GO:0007176; GO:0007617; GO:0007626; GO:0008201; GO:0008203; GO:0016021; GO:0030198; GO:0030900; GO:0030901; GO:0042802; GO:0043393; GO:0046914; GO:0050885	cell [GO:0005623]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914]; cellular copper ion homeostasis [GO:0006878]; cholesterol metabolic process [GO:0008203]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; midbrain development [GO:0030901]; neuromuscular process controlling balance [GO:0050885]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of protein binding [GO:0043393]; suckling behavior [GO:0001967]
PGEN_.00g128160	Scaffold_05	65109466	65134029	P05067	A4_HUMAN	Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]	GO:0000122; GO:0000185; GO:0000187; GO:0000978; GO:0000979; GO:0001664; GO:0001774; GO:0001878; GO:0001934; GO:0001967; GO:0002265; GO:0002576; GO:0003677; GO:0004867; GO:0005102; GO:0005109; GO:0005158; GO:0005178; GO:0005576; GO:0005615; GO:0005623; GO:0005634; GO:0005641; GO:0005737; GO:0005739; GO:0005768; GO:0005769; GO:0005788; GO:0005790; GO:0005791; GO:0005794; GO:0005796; GO:0005798; GO:0005829; GO:0005886; GO:0005887; GO:0005905; GO:0005911; GO:0006357; GO:0006378; GO:0006417; GO:0006468; GO:0006878; GO:0006897; GO:0006979; GO:0007155; GO:0007176; GO:0007186; GO:0007189; GO:0007193; GO:0007204; GO:0007219; GO:0007409; GO:0007611; GO:0007612; GO:0007613; GO:0007617; GO:0007626; GO:0008021; GO:0008088; GO:0008201; GO:0008203; GO:0008285; GO:0008306; GO:0008344; GO:0008542; GO:0009986; GO:0009987; GO:0010288; GO:0010468; GO:0010628; GO:0010629; GO:0010739; GO:0010800; GO:0010823; GO:0010971; GO:0014005; GO:0016020; GO:0016021; GO:0016199; GO:0016322; GO:0016358; GO:0016504; GO:0019722; GO:0019731; GO:0019732; GO:0019899; GO:0030111; GO:0030134; GO:0030198; GO:0030424; GO:0030546; GO:0030549; GO:0030900; GO:0031093; GO:0031175; GO:0031594; GO:0031904; GO:0032092; GO:0032588; GO:0032640; GO:0032930; GO:0032991; GO:0033130; GO:0033138; GO:0034121; GO:0034185; GO:0034363; GO:0034364; GO:0035066; GO:0035235; GO:0035253; GO:0040014; GO:0042056; GO:0042157; GO:0042327; GO:0042535; GO:0042802; GO:0042803; GO:0043065; GO:0043197; GO:0043198; GO:0043204; GO:0043235; GO:0043280; GO:0043395; GO:0043410; GO:0043525; GO:0043687; GO:0044267; GO:0044304; GO:0045080; GO:0045087; GO:0045121; GO:0045177; GO:0045202; GO:0045410; GO:0045429; GO:0045665; GO:0045666; GO:0045745; GO:0045821; GO:0045931; GO:0045944; GO:0046330; GO:0046875; GO:0046914; GO:0046982; GO:0046983; GO:0048143; GO:0048169; GO:0048471; GO:0048669; GO:0048786; GO:0050725; GO:0050730; GO:0050750; GO:0050786; GO:0050803; GO:0050808; GO:0050829; GO:0050830; GO:0050867; GO:0050885; GO:0050890; GO:0051044; GO:0051087; GO:0051091; GO:0051092; GO:0051124; GO:0051233; GO:0051247; GO:0051260; GO:0051262; GO:0051402; GO:0051425; GO:0051563; GO:0051897; GO:0055037; GO:0061098; GO:0061844; GO:0061903; GO:0070062; GO:0070206; GO:0070374; GO:0070381; GO:0070555; GO:0070851; GO:0071280; GO:0071287; GO:0071320; GO:0071874; GO:0090026; GO:0090090; GO:0090647; GO:0097449; GO:0097645; GO:0098815; GO:0106003; GO:0150003; GO:1900122; GO:1900181; GO:1900221; GO:1900272; GO:1900273; GO:1901215; GO:1901216; GO:1901224; GO:1902004; GO:1902715; GO:1902894; GO:1902949; GO:1902950; GO:1902961; GO:1903048; GO:1903223; GO:1903523; GO:1904022; GO:1904399; GO:1904472; GO:1904591; GO:1904646; GO:1905606; GO:1905893; GO:1905896; GO:1905898; GO:1905906; GO:1905908; GO:1905945; GO:1990000; GO:1990090; GO:1990535; GO:1990761; GO:1990777; GO:1990812; GO:2000310; GO:2000406; GO:2000463	amyloid-beta complex [GO:0106003]; apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; axon [GO:0030424]; cell [GO:0005623]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; ciliary rootlet [GO:0035253]; clathrin-coated pit [GO:0005905]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; endosome lumen [GO:0031904]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi-associated vesicle [GO:0005798]; growth cone filopodium [GO:1990812]; growth cone lamellipodium [GO:1990761]; high-density lipoprotein particle [GO:0034364]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate-density lipoprotein particle [GO:0034363]; lipoprotein particle [GO:1990777]; main axon [GO:0044304]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; spindle midzone [GO:0051233]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; acetylcholine receptor activator activity [GO:0030549]; acetylcholine receptor binding [GO:0033130]; amylin binding [GO:0097645]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; chemoattractant activity [GO:0042056]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; heparan sulfate binding [GO:1904399]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; PTB domain binding [GO:0051425]; RAGE receptor binding [GO:0050786]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914]; activation of MAPK activity [GO:0000187]; activation of MAPKKK activity [GO:0000185]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; amyloid fibril formation [GO:1990000]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; associative learning [GO:0008306]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cellular copper ion homeostasis [GO:0006878]; cellular process [GO:0009987]; cellular protein metabolic process [GO:0044267]; cellular response to amyloid-beta [GO:1904646]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to norepinephrine stimulus [GO:0071874]; cholesterol metabolic process [GO:0008203]; cognition [GO:0050890]; collateral sprouting in absence of injury [GO:0048669]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; lipoprotein metabolic process [GO:0042157]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; modulation of age-related behavioral decline [GO:0090647]; modulation of excitatory postsynaptic potential [GO:0098815]; mRNA polyadenylation [GO:0006378]; negative regulation of blood circulation [GO:1903523]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; neuron projection maintenance [GO:1990535]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; platelet degranulation [GO:0002576]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell activation [GO:0050867]; positive regulation of cellular response to thapsigargin [GO:1905893]; positive regulation of cellular response to tunicamycin [GO:1905896]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelin secretion [GO:1904472]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of histone acetylation [GO:0035066]; positive regulation of interferon-gamma secretion [GO:1902715]; positive regulation of interleukin-1 beta biosynthetic process [GO:0050725]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JNK cascade [GO:0046330]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import [GO:1904591]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor binding [GO:1900122]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of T cell migration [GO:2000406]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; post-translational protein modification [GO:0043687]; protein homooligomerization [GO:0051260]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; protein trimerization [GO:0070206]; regulation of acetylcholine-gated cation channel activity [GO:1903048]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid-beta clearance [GO:1900221]; regulation of dendritic spine maintenance [GO:1902950]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of gene expression [GO:0010468]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multicellular organism growth [GO:0040014]; regulation of NMDA receptor activity [GO:2000310]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of presynapse assembly [GO:1905606]; regulation of response to calcium ion [GO:1905945]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse structure or activity [GO:0050803]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; regulation of Wnt signaling pathway [GO:0030111]; response to interleukin-1 [GO:0070555]; response to lead ion [GO:0010288]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; suckling behavior [GO:0001967]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; tumor necrosis factor production [GO:0032640]; visual learning [GO:0008542]
PGEN_.00g128170	Scaffold_05	65142722	65145857	P52741	ZN134_HUMAN	Zinc finger protein 134	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g128180	Scaffold_05	65190308	65220032	P45844	ABCG1_HUMAN	ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog)	GO:0000139; GO:0005524; GO:0005543; GO:0005548; GO:0005739; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0008203; GO:0009720; GO:0009897; GO:0010033; GO:0010745; GO:0010872; GO:0010875; GO:0010887; GO:0015485; GO:0016021; GO:0016887; GO:0019534; GO:0032367; GO:0033344; GO:0033700; GO:0033993; GO:0034041; GO:0034374; GO:0034375; GO:0034436; GO:0042626; GO:0042632; GO:0042803; GO:0042987; GO:0043531; GO:0043691; GO:0045542; GO:0046982; GO:0046983; GO:0050714; GO:0055037; GO:0055085; GO:0055091; GO:0071403; GO:0090554; GO:0120020; GO:0140328; GO:1902004	endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled sterol transmembrane transporter activity [GO:0034041]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534]; amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; detection of hormone stimulus [GO:0009720]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol esterification [GO:0010872]; response to lipid [GO:0033993]; response to organic substance [GO:0010033]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]
PGEN_.00g128190	Scaffold_05	65252991	65253296	NA	NA	NA	NA	NA
PGEN_.00g128200	Scaffold_05	65275472	65368268	Q6V0I7	FAT4_HUMAN	Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
PGEN_.00g128210	Scaffold_05	65369199	65458933	Q2PZL6	FAT4_MOUSE	Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
PGEN_.00g128220	Scaffold_05	65477166	65477498	NA	NA	NA	NA	NA
PGEN_.00g128230	Scaffold_05	65513555	65544346	Q8SQA4	CD97_BOVIN	CD97 antigen (CD antigen CD97)	GO:0004930; GO:0005509; GO:0005887; GO:0007155; GO:0007166; GO:0007189	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g128240	Scaffold_05	65595030	65601970	Q9IAT6	DLLC_DANRE	Delta-like protein C (DeltaC) (delC)	GO:0001756; GO:0001757; GO:0002244; GO:0005112; GO:0005509; GO:0005737; GO:0005886; GO:0007219; GO:0016021; GO:0021514; GO:0030165; GO:0035907; GO:0042802; GO:0045746; GO:0048471; GO:0048514; GO:0048666; GO:0060218; GO:0060842; GO:0061056	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; arterial endothelial cell differentiation [GO:0060842]; blood vessel morphogenesis [GO:0048514]; dorsal aorta development [GO:0035907]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of Notch signaling pathway [GO:0045746]; neuron development [GO:0048666]; Notch signaling pathway [GO:0007219]; sclerotome development [GO:0061056]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; ventral spinal cord interneuron differentiation [GO:0021514]
PGEN_.00g128250	Scaffold_05	65605215	65610208	B0BN95	HARB1_RAT	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g128260	Scaffold_05	65610985	65616282	NA	NA	NA	NA	NA
PGEN_.00g128270	Scaffold_05	65618162	65629210	NA	NA	NA	NA	NA
PGEN_.00g128280	Scaffold_05	65654795	65692716	NA	NA	NA	NA	NA
PGEN_.00g128290	Scaffold_05	65775420	65784860	Q7LGC8	CHST3_HUMAN	Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008146; GO:0008459; GO:0016021; GO:0030206	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g128300	Scaffold_05	65834362	65838743	NA	NA	NA	NA	NA
PGEN_.00g128310	Scaffold_05	65844865	65847306	NA	NA	NA	NA	NA
PGEN_.00g128320	Scaffold_05	65848080	65848601	NA	NA	NA	NA	NA
PGEN_.00g128330	Scaffold_05	65848685	65849223	NA	NA	NA	NA	NA
PGEN_.00g128340	Scaffold_05	65849293	65852718	NA	NA	NA	NA	NA
PGEN_.00g128350	Scaffold_05	65858968	65861701	B2RRE7	OTUD4_MOUSE	OTU domain-containing protein 4 (EC 3.4.19.12)	GO:0004843; GO:0005634; GO:0005829; GO:0034122; GO:0045087; GO:0060090; GO:0061578; GO:0070536; GO:0071108; GO:1901537; GO:1903093; GO:2000660	cytosol [GO:0005829]; nucleus [GO:0005634]; Lys63-specific deubiquitinase activity [GO:0061578]; molecular adaptor activity [GO:0060090]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; innate immune response [GO:0045087]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of DNA demethylation [GO:1901537]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein K48-linked deubiquitination [GO:1903093]
PGEN_.00g128360	Scaffold_05	65871304	65948426	O88196	TTC3_MOUSE	E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Mtprd)	GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005773; GO:0005829; GO:0006511; GO:0010771; GO:0045665; GO:0046872; GO:0070936	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of cell morphogenesis involved in differentiation [GO:0010771]; negative regulation of neuron differentiation [GO:0045665]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g128370	Scaffold_05	65968197	65989473	NA	NA	NA	NA	NA
PGEN_.00g128380	Scaffold_05	66113195	66115056	NA	NA	NA	NA	NA
PGEN_.00g128390	Scaffold_05	66152987	66156228	NA	NA	NA	NA	NA
PGEN_.00g128400	Scaffold_05	66195944	66197506	NA	NA	NA	NA	NA
PGEN_.00g128410	Scaffold_05	66287340	66288458	NA	NA	NA	NA	NA
PGEN_.00g128420	Scaffold_05	66308334	66308870	Q6DE15	B3G5B_XENLA	"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase B (EC 2.4.1.206) (Lactotriaosylceramide synthase B) (Lc(3)Cer synthase B) (Lc3 synthase B) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5B) (BGnT-5B) (Beta-1,3-Gn-T5B) (Beta-1,3-N-acetylglucosaminyltransferase 5B) (Beta3Gn-T5B)"	GO:0000139; GO:0006486; GO:0008378; GO:0016021; GO:0047256	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; protein glycosylation [GO:0006486]"
PGEN_.00g128430	Scaffold_05	66362851	66363834	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g128440	Scaffold_05	66367752	66369106	NA	NA	NA	NA	NA
PGEN_.00g128450	Scaffold_05	66369510	66370444	NA	NA	NA	NA	NA
PGEN_.00g128460	Scaffold_05	66373477	66373746	NA	NA	NA	NA	NA
PGEN_.00g128470	Scaffold_05	66373826	66374149	NA	NA	NA	NA	NA
PGEN_.00g128480	Scaffold_05	66380886	66409782	Q0VCS9	ANKY2_BOVIN	Ankyrin repeat and MYND domain-containing protein 2	GO:0005929; GO:0019899; GO:0046872	cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]
PGEN_.00g128490	Scaffold_05	66412565	66414769	NA	NA	NA	NA	NA
PGEN_.00g128500	Scaffold_05	66417087	66419535	Q9NVX7	KBTB4_HUMAN	Kelch repeat and BTB domain-containing protein 4 (BTB and kelch domain-containing protein 4)		
PGEN_.00g128510	Scaffold_05	66426904	66433835	P09015	HME2A_DANRE	Homeobox protein engrailed-2a (Homeobox protein en-2a) (Zf-En-2)	GO:0001708; GO:0005634; GO:0006357; GO:0009952; GO:0016586; GO:0021555; GO:0030182; GO:0030901; GO:0030917; GO:0043565; GO:0060385; GO:0060561	nucleus [GO:0005634]; RSC-type complex [GO:0016586]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in morphogenesis [GO:0060561]; axonogenesis involved in innervation [GO:0060385]; cell fate specification [GO:0001708]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g128520	Scaffold_05	66443003	66445998	P27609	HMEN_BOMMO	Segmentation polarity homeobox protein engrailed	GO:0005634; GO:0006355; GO:0007367; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]; segment polarity determination [GO:0007367]"
PGEN_.00g128530	Scaffold_05	66447736	66448041	NA	NA	NA	NA	NA
PGEN_.00g128540	Scaffold_05	66464923	66465186	NA	NA	NA	NA	NA
PGEN_.00g128550	Scaffold_05	66495432	66495980	NA	NA	NA	NA	NA
PGEN_.00g128560	Scaffold_05	66496071	66496307	NA	NA	NA	NA	NA
PGEN_.00g128570	Scaffold_05	66518052	66518785	NA	NA	NA	NA	NA
PGEN_.00g128580	Scaffold_05	66519317	66524746	NA	NA	NA	NA	NA
PGEN_.00g128590	Scaffold_05	66590938	66592164	NA	NA	NA	NA	NA
PGEN_.00g128600	Scaffold_05	66602692	66603246	NA	NA	NA	NA	NA
PGEN_.00g128610	Scaffold_05	66620157	66622970	NA	NA	NA	NA	NA
PGEN_.00g128620	Scaffold_05	66656865	66667425	NA	NA	NA	NA	NA
PGEN_.00g128630	Scaffold_05	66661928	66662317	NA	NA	NA	NA	NA
PGEN_.00g128640	Scaffold_05	66699642	66713219	NA	NA	NA	NA	NA
PGEN_.00g128650	Scaffold_05	66738243	66740147	Q9NR97	TLR8_HUMAN	Toll-like receptor 8 (CD antigen CD288)	GO:0000139; GO:0001774; GO:0001932; GO:0002224; GO:0002755; GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0004888; GO:0005789; GO:0005886; GO:0006955; GO:0007249; GO:0008144; GO:0008329; GO:0009615; GO:0009897; GO:0010008; GO:0016021; GO:0016064; GO:0032755; GO:0034158; GO:0034162; GO:0036020; GO:0038023; GO:0042802; GO:0045078; GO:0045087; GO:0045089; GO:0045356; GO:0045359; GO:0045416; GO:0050718; GO:0051607; GO:0071260; GO:2000778; GO:2001183	endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; signaling pattern recognition receptor activity [GO:0008329]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transmembrane signaling receptor activity [GO:0004888]; cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-12 secretion [GO:2001183]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha biosynthetic process [GO:0045356]; positive regulation of interferon-beta biosynthetic process [GO:0045359]; positive regulation of interferon-gamma biosynthetic process [GO:0045078]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 biosynthetic process [GO:0045416]; regulation of protein phosphorylation [GO:0001932]; response to virus [GO:0009615]; toll-like receptor 8 signaling pathway [GO:0034158]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g128660	Scaffold_05	66744313	66744663	NA	NA	NA	NA	NA
PGEN_.00g128670	Scaffold_05	66760347	66781816	Q16831	UPP1_HUMAN	Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3)	GO:0004850; GO:0005654; GO:0005829; GO:0006139; GO:0006218; GO:0009166; GO:0042149; GO:0043097; GO:0044206; GO:0046135	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]
PGEN_.00g128680	Scaffold_05	66784636	66816884	Q9IBG7	KCP_XENLA	Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g128690	Scaffold_05	66818350	66819417	NA	NA	NA	NA	NA
PGEN_.00g128700	Scaffold_05	66819505	66819819	NA	NA	NA	NA	NA
PGEN_.00g128710	Scaffold_05	66821415	66822083	NA	NA	NA	NA	NA
PGEN_.00g128720	Scaffold_05	66826556	66846344	NA	NA	NA	NA	NA
PGEN_.00g128730	Scaffold_05	66863776	66874484	Q8CBE3	WDR37_MOUSE	WD repeat-containing protein 37	GO:0030687; GO:0070545	"PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]"
PGEN_.00g128740	Scaffold_05	66874977	66883966	Q6DDF0	WDR37_XENLA	WD repeat-containing protein 37		
PGEN_.00g128750	Scaffold_05	66891319	66898913	P51400	RED1_RAT	Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)	GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0007420; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]
PGEN_.00g128760	Scaffold_05	66923790	66927727	NA	NA	NA	NA	NA
PGEN_.00g128770	Scaffold_05	66972312	66972680	NA	NA	NA	NA	NA
PGEN_.00g128780	Scaffold_05	66987101	66987433	NA	NA	NA	NA	NA
PGEN_.00g128790	Scaffold_05	66987805	67002306	Q91550	ILF3A_XENLA	Interleukin enhancer-binding factor 3-A (CCAAT box transcription factor subunit) (Double-stranded RNA-binding protein 4F.1) (DsRNA-binding protein 4F.1)	GO:0003725; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007275; GO:0035925; GO:0043565; GO:0044212; GO:0048027; GO:0051607; GO:1990904	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; double-stranded RNA binding [GO:0003725]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 5'-UTR binding [GO:0048027]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; defense response to virus [GO:0051607]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g128800	Scaffold_05	67008351	67013178	Q7T3B2	HRG1A_DANRE	Heme transporter hrg1-A (zHRG-1) (Heme-responsive gene 1 protein homolog A) (HRG-1A) (Solute carrier family 48 member 1-B)	GO:0005765; GO:0005886; GO:0010008; GO:0015232; GO:0015886; GO:0016021; GO:0020037; GO:0048821	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme transporter activity [GO:0015232]; erythrocyte development [GO:0048821]; heme transport [GO:0015886]
PGEN_.00g128810	Scaffold_05	67021217	67033827	NA	NA	NA	NA	NA
PGEN_.00g128820	Scaffold_05	67034556	67041620	NA	NA	NA	NA	NA
PGEN_.00g128830	Scaffold_05	67046502	67052281	NA	NA	NA	NA	NA
PGEN_.00g128840	Scaffold_05	67068676	67090754	Q566I1	IN80D_XENLA	INO80 complex subunit D	GO:0005634; GO:0006281; GO:0006310	nucleus [GO:0005634]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]
PGEN_.00g128850	Scaffold_05	67106164	67111106	NA	NA	NA	NA	NA
PGEN_.00g128860	Scaffold_05	67112597	67113043	P53353	ASPX_VULVU	Sperm acrosomal protein FSA-ACR.1 (Fragment)	GO:0001669	acrosomal vesicle [GO:0001669]
PGEN_.00g128870	Scaffold_05	67117079	67131997	NA	NA	NA	NA	NA
PGEN_.00g128880	Scaffold_05	67155424	67155624	NA	NA	NA	NA	NA
PGEN_.00g128890	Scaffold_05	67164537	67165025	NA	NA	NA	NA	NA
PGEN_.00g128900	Scaffold_05	67178051	67200061	NA	NA	NA	NA	NA
PGEN_.00g128910	Scaffold_05	67215934	67234313	P23128	DDX6_DROME	ATP-dependent RNA helicase me31b (EC 3.6.4.13) (Maternal expression at 31B)	GO:0000932; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005737; GO:0005783; GO:0007279; GO:0010494; GO:0030707; GO:0033962; GO:0034063; GO:0035195; GO:0036464; GO:0043025; GO:0043186; GO:0046959; GO:0050688; GO:0060148; GO:0071598; GO:0071683; GO:0090328; GO:0098794; GO:0150011; GO:1905618; GO:1990120; GO:1990124; GO:2000766	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; endoplasmic reticulum [GO:0005783]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P granule [GO:0043186]; P-body [GO:0000932]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cytoplasmic mRNA processing body assembly [GO:0033962]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328]; stress granule assembly [GO:0034063]
PGEN_.00g128920	Scaffold_06	1758	7450	NA	NA	NA	NA	NA
PGEN_.00g128930	Scaffold_06	13235	20349	Q6DGQ0	SPT4H_DANRE	Transcription elongation factor SPT4 (DRB sensitivity-inducing factor small subunit) (DSIF small subunit)	GO:0000993; GO:0003727; GO:0006325; GO:0008270; GO:0032044; GO:0032786	"DSIF complex [GO:0032044]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription, elongation [GO:0032786]"
PGEN_.00g128940	Scaffold_06	20924	82286	Q92887	MRP2_HUMAN	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	GO:0005524; GO:0005623; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0010629; GO:0015127; GO:0015694; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016887; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0033762; GO:0042626; GO:0042910; GO:0043627; GO:0046581; GO:0046685; GO:0055085; GO:0070327; GO:0070633; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:1901086; GO:1990962	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; xenobiotic transmembrane transporter activity [GO:0042910]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; mercury ion transport [GO:0015694]; negative regulation of gene expression [GO:0010629]; prostaglandin transport [GO:0015732]; response to arsenic-containing substance [GO:0046685]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic transport across blood-brain barrier [GO:1990962]
PGEN_.00g128950	Scaffold_06	90653	91009	NA	NA	NA	NA	NA
PGEN_.00g128960	Scaffold_06	98219	118988	Q9Z0Z5	S13A3_RAT	Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (rNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)	GO:0005310; GO:0005343; GO:0005886; GO:0006835; GO:0015137; GO:0015139; GO:0015141; GO:0015183; GO:0015362; GO:0015744; GO:0015746; GO:0015810; GO:0016020; GO:0016021; GO:0017153	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; L-aspartate transmembrane transporter activity [GO:0015183]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; aspartate transmembrane transport [GO:0015810]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; succinate transport [GO:0015744]
PGEN_.00g128970	Scaffold_06	125224	143233	A2BD89	CV039_XENLA	UPF0545 protein C22orf39 homolog		
PGEN_.00g128980	Scaffold_06	143332	153172	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g128990	Scaffold_06	143584	143886	NA	NA	NA	NA	NA
PGEN_.00g129000	Scaffold_06	181095	181481	NA	NA	NA	NA	NA
PGEN_.00g129010	Scaffold_06	188074	188397	NA	NA	NA	NA	NA
PGEN_.00g129020	Scaffold_06	219839	220279	NA	NA	NA	NA	NA
PGEN_.00g129030	Scaffold_06	220443	220985	NA	NA	NA	NA	NA
PGEN_.00g129040	Scaffold_06	221897	225278	NA	NA	NA	NA	NA
PGEN_.00g129050	Scaffold_06	229722	230883	NA	NA	NA	NA	NA
PGEN_.00g129060	Scaffold_06	243502	262892	NA	NA	NA	NA	NA
PGEN_.00g129070	Scaffold_06	278985	296310	I3J7Q8	HISAT_ORENI	Histidine N-acetyltransferase (EC 2.3.1.33)	GO:0047981	histidine N-acetyltransferase activity [GO:0047981]
PGEN_.00g129080	Scaffold_06	310149	328610	Q64449	MRC2_MOUSE	C-type mannose receptor 2 (Lectin lambda) (Macrophage mannose receptor 2) (CD antigen CD280)	GO:0004888; GO:0005518; GO:0005886; GO:0006897; GO:0009986; GO:0016021; GO:0030246; GO:0030574	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]
PGEN_.00g129090	Scaffold_06	359491	367404	Q8AX98	TBX1A_XENLA	T-box transcription factor TBX1-A (T-box protein 1-A)	GO:0003677; GO:0003700; GO:0005634; GO:0007275; GO:0045944; GO:0050793; GO:0060788; GO:0071300	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cellular response to retinoic acid [GO:0071300]; ectodermal placode formation [GO:0060788]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]
PGEN_.00g129100	Scaffold_06	374668	374958	NA	NA	NA	NA	NA
PGEN_.00g129110	Scaffold_06	376847	377239	NA	NA	NA	NA	NA
PGEN_.00g129120	Scaffold_06	387664	395259	Q9VUL9	FUCTA_DROME	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920	"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]"
PGEN_.00g129130	Scaffold_06	398665	399813	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g129140	Scaffold_06	403569	404497	NA	NA	NA	NA	NA
PGEN_.00g129150	Scaffold_06	410059	413553	NA	NA	NA	NA	NA
PGEN_.00g129160	Scaffold_06	418118	428681	NA	NA	NA	NA	NA
PGEN_.00g129170	Scaffold_06	438762	484017	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g129180	Scaffold_06	486279	488169	NA	NA	NA	NA	NA
PGEN_.00g129190	Scaffold_06	508383	513297	A0A1F4	EYS_DROME	Protein eyes shut (Protein spacemaker)	GO:0000902; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009986; GO:0010378; GO:0016021; GO:0031012; GO:0042052; GO:0097730	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]
PGEN_.00g129200	Scaffold_06	519054	543319	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g129210	Scaffold_06	547875	548363	NA	NA	NA	NA	NA
PGEN_.00g129220	Scaffold_06	548728	549980	NA	NA	NA	NA	NA
PGEN_.00g129230	Scaffold_06	576245	589686	NA	NA	NA	NA	NA
PGEN_.00g129240	Scaffold_06	596091	613681	P51464	ARLY_LITCT	Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)	GO:0000050; GO:0004056; GO:0042450	argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050]
PGEN_.00g129250	Scaffold_06	617013	617489	NA	NA	NA	NA	NA
PGEN_.00g129260	Scaffold_06	617831	618316	NA	NA	NA	NA	NA
PGEN_.00g129270	Scaffold_06	658817	661434	Q071E0	KT5AA_DANRE	N-lysine methyltransferase KMT5A-A (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A-A) (EC 2.1.1.-) (Lysine-specific methylase 5A-A) (SET domain-containing protein 8-A)	GO:0005634; GO:0005694; GO:0007049; GO:0009953; GO:0010628; GO:0018024; GO:0051301	chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; cell cycle [GO:0007049]; cell division [GO:0051301]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of gene expression [GO:0010628]
PGEN_.00g129280	Scaffold_06	672863	690646	NA	NA	NA	NA	NA
PGEN_.00g129290	Scaffold_06	814956	834932	NA	NA	NA	NA	NA
PGEN_.00g129300	Scaffold_06	838174	845744	Q5JXM2	MET24_HUMAN	Methyltransferase-like protein 24 (EC 2.1.1.-)	GO:0005576; GO:0008168; GO:0032259	extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g129310	Scaffold_06	863646	870454	NA	NA	NA	NA	NA
PGEN_.00g129320	Scaffold_06	893241	894023	NA	NA	NA	NA	NA
PGEN_.00g129330	Scaffold_06	944235	947682	Q8K2J9	BTBD6_MOUSE	BTB/POZ domain-containing protein 6	GO:0005829; GO:0022008	cytosol [GO:0005829]; neurogenesis [GO:0022008]
PGEN_.00g129340	Scaffold_06	964916	977218	P27590	UROM_RAT	"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]"	GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0010033; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]; response to organic substance [GO:0010033]
PGEN_.00g129350	Scaffold_06	982390	1064756	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g129360	Scaffold_06	1075535	1075840	NA	NA	NA	NA	NA
PGEN_.00g129370	Scaffold_06	1191637	1191900	NA	NA	NA	NA	NA
PGEN_.00g129380	Scaffold_06	1192229	1193623	NA	NA	NA	NA	NA
PGEN_.00g129390	Scaffold_06	1200577	1200792	NA	NA	NA	NA	NA
PGEN_.00g129400	Scaffold_06	1201372	1201710	NA	NA	NA	NA	NA
PGEN_.00g129410	Scaffold_06	1217000	1252023	E1BD59	TRI56_BOVIN	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0051607; GO:0070534	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
PGEN_.00g129420	Scaffold_06	1271039	1275767	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g129430	Scaffold_06	1278004	1283428	NA	NA	NA	NA	NA
PGEN_.00g129440	Scaffold_06	1320257	1321960	NA	NA	NA	NA	NA
PGEN_.00g129450	Scaffold_06	1332067	1333773	NA	NA	NA	NA	NA
PGEN_.00g129460	Scaffold_06	1353236	1354853	Q9H2X3	CLC4M_HUMAN	C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (DC-SIGN-related protein) (DC-SIGNR) (Dendritic cell-specific ICAM-3-grabbing non-integrin 2) (DC-SIGN2) (Liver/lymph node-specific ICAM-3-grabbing non-integrin) (L-SIGN) (CD antigen CD299)	GO:0001618; GO:0002250; GO:0005537; GO:0005576; GO:0005737; GO:0005887; GO:0006897; GO:0007159; GO:0009988; GO:0016020; GO:0019048; GO:0019062; GO:0019079; GO:0019882; GO:0030246; GO:0030369; GO:0035556; GO:0038023; GO:0042605; GO:0043657; GO:0045087; GO:0046790; GO:0046872; GO:0046968; GO:0048306; GO:0075733	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; modulation by virus of host morphology or physiology [GO:0019048]; peptide antigen transport [GO:0046968]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]
PGEN_.00g129470	Scaffold_06	1359122	1361912	Q67EQ1	CLC4E_RAT	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (Mincle)	GO:0002221; GO:0002292; GO:0005509; GO:0006955; GO:0016020; GO:0016021; GO:0030246; GO:0038023; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; signaling receptor activity [GO:0038023]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; T cell differentiation involved in immune response [GO:0002292]
PGEN_.00g129480	Scaffold_06	1366051	1370012	P55067	NCAN_RAT	Neurocan core protein (245 kDa early postnatal core glycoprotein) (Chondroitin sulfate proteoglycan 3) [Cleaved into: 150 kDa adult core glycoprotein]	GO:0001501; GO:0005509; GO:0005540; GO:0005886; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0045202; GO:0051823; GO:0072534	extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]
PGEN_.00g129490	Scaffold_06	1374659	1375159	NA	NA	NA	NA	NA
PGEN_.00g129500	Scaffold_06	1386581	1424355	NA	NA	NA	NA	NA
PGEN_.00g129510	Scaffold_06	1427014	1427774	NA	NA	NA	NA	NA
PGEN_.00g129520	Scaffold_06	1446166	1456530	A7S8T5	CCD42_NEMVE	Coiled-coil domain-containing protein 42 homolog		
PGEN_.00g129530	Scaffold_06	1458016	1466690	Q9VXK0	NIPSN_DROME	Protein NipSnap	GO:0005739	mitochondrion [GO:0005739]
PGEN_.00g129540	Scaffold_06	1624876	1626321	O15973	OPSD1_MIZYE	"Rhodopsin, GQ-coupled (GQ-rhodopsin)"	GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g129550	Scaffold_06	1691366	1705080	Q9CUS9	SPPL3_MOUSE	Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4)	GO:0005623; GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0032092; GO:0033116; GO:0033619; GO:0035307; GO:0042500; GO:0042803; GO:0043231; GO:0050852; GO:0070886; GO:0071458; GO:0071556	"cell [GO:0005623]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852]"
PGEN_.00g129560	Scaffold_06	1752762	1785097	Q9BGQ3	SEPT5_MACFA	Septin-5	GO:0005525; GO:0005886; GO:0007049; GO:0008021; GO:0017157; GO:0030534; GO:0031105; GO:0035176; GO:0051301; GO:0098793	plasma membrane [GO:0005886]; presynapse [GO:0098793]; septin complex [GO:0031105]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; adult behavior [GO:0030534]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of exocytosis [GO:0017157]; social behavior [GO:0035176]
PGEN_.00g129570	Scaffold_06	1795422	1801806	Q9D5I4	TC1D1_MOUSE	Tctex1 domain-containing protein 1		
PGEN_.00g129580	Scaffold_06	1807587	1812352	Q9H427	KCNKF_HUMAN	Potassium channel subfamily K member 15 (Acid-sensitive potassium channel protein TASK-5) (TWIK-related acid-sensitive K(+) channel 5) (Two pore potassium channel KT3.3) (Two pore K(+) channel KT3.3)	GO:0005886; GO:0005887; GO:0022841; GO:0030322; GO:0034765; GO:0061337; GO:0071805	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium ion leak channel activity [GO:0022841]; cardiac conduction [GO:0061337]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322]
PGEN_.00g129590	Scaffold_06	1960172	1966903	B1AT66	MOT7_MOUSE	Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g129600	Scaffold_06	1971426	1978988	Q7TM99	MOT9_MOUSE	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g129610	Scaffold_06	1991690	2003348	O77775	NCF2_BOVIN	Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (Neutrophil NADPH oxidase factor 2) (p67-phox)	GO:0005829; GO:0006909; GO:0016176; GO:0042554; GO:0043020; GO:0045730; GO:0048365	cytosol [GO:0005829]; NADPH oxidase complex [GO:0043020]; Rac GTPase binding [GO:0048365]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]
PGEN_.00g129620	Scaffold_06	2009668	2010165	NA	NA	NA	NA	NA
PGEN_.00g129630	Scaffold_06	2011560	2012615	Q5RJI4	PKDCC_MOUSE	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g129640	Scaffold_06	2028588	2030309	NA	NA	NA	NA	NA
PGEN_.00g129650	Scaffold_06	2030344	2030694	NA	NA	NA	NA	NA
PGEN_.00g129660	Scaffold_06	2032125	2032394	NA	NA	NA	NA	NA
PGEN_.00g129670	Scaffold_06	2034932	2035390	NA	NA	NA	NA	NA
PGEN_.00g129680	Scaffold_06	2051546	2051944	NA	NA	NA	NA	NA
PGEN_.00g129690	Scaffold_06	2086634	2087554	NA	NA	NA	NA	NA
PGEN_.00g129700	Scaffold_06	2117229	2136500	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g129710	Scaffold_06	2164266	2178094	NA	NA	NA	NA	NA
PGEN_.00g129720	Scaffold_06	2192574	2218594	O43570	CAH12_HUMAN	Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3)	GO:0004089; GO:0005886; GO:0008270; GO:0015701; GO:0016021; GO:0055064	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]; chloride ion homeostasis [GO:0055064]
PGEN_.00g129730	Scaffold_06	2232626	2235710	NA	NA	NA	NA	NA
PGEN_.00g129740	Scaffold_06	2257582	2263253	NA	NA	NA	NA	NA
PGEN_.00g129750	Scaffold_06	2303274	2321541	Q6NYY9	VMP1_DANRE	Vacuole membrane protein 1 (Transmembrane protein 49)	GO:0005774; GO:0005783; GO:0005886; GO:0006914; GO:0007030; GO:0016021; GO:0033116	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; autophagy [GO:0006914]; Golgi organization [GO:0007030]
PGEN_.00g129760	Scaffold_06	2339368	2345010	A8WGS4	TLCD2_DANRE	TLC domain-containing protein 2	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g129770	Scaffold_06	2350240	2353675	NA	NA	NA	NA	NA
PGEN_.00g129780	Scaffold_06	2364924	2385026	P61315	G3ST3_MOUSE	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g129790	Scaffold_06	2387859	2403149	NA	NA	NA	NA	NA
PGEN_.00g129800	Scaffold_06	2420892	2456496	Q04336	YM54_YEAST	Uncharacterized protein YMR196W	GO:0004573; GO:0005737; GO:0009311	cytoplasm [GO:0005737]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311]
PGEN_.00g129810	Scaffold_06	2462731	2462982	NA	NA	NA	NA	NA
PGEN_.00g129820	Scaffold_06	2463015	2463257	NA	NA	NA	NA	NA
PGEN_.00g129830	Scaffold_06	2463453	2463761	NA	NA	NA	NA	NA
PGEN_.00g129840	Scaffold_06	2463991	2464233	NA	NA	NA	NA	NA
PGEN_.00g129850	Scaffold_06	2464295	2464606	NA	NA	NA	NA	NA
PGEN_.00g129860	Scaffold_06	2510092	2522928	Q504A5	TPMT_DANRE	Probable thiopurine S-methyltransferase (Thiopurine methyltransferase) (EC 2.1.1.67)	GO:0005737; GO:0008119; GO:0032259	cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]; methylation [GO:0032259]
PGEN_.00g129870	Scaffold_06	2528275	2532012	NA	NA	NA	NA	NA
PGEN_.00g129880	Scaffold_06	2543038	2564892	Q6P9F0	CCD62_HUMAN	Coiled-coil domain-containing protein 62 (Protein TSP-NY) (Protein aaa)	GO:0001835; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0030331; GO:0030374; GO:0045944; GO:0071392	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; estrogen receptor binding [GO:0030331]; nuclear receptor transcription coactivator activity [GO:0030374]; blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g129890	Scaffold_06	2566019	2572438	Q9VX98	DENR_DROME	Density-regulated protein homolog	GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0008284; GO:0032991; GO:0045948; GO:0046628; GO:0120142	protein-containing complex [GO:0032991]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ecdysone receptor-mediated signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of translational initiation [GO:0045948]; translation reinitiation [GO:0002188]
PGEN_.00g129900	Scaffold_06	2579041	2583181	Q503V3	CL049_DANRE	UPF0454 protein C12orf49 homolog	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g129910	Scaffold_06	2583676	2586322	NA	NA	NA	NA	NA
PGEN_.00g129920	Scaffold_06	2587211	2612377	NA	NA	NA	NA	NA
PGEN_.00g129930	Scaffold_06	2618977	2628355	Q2T9W3	CCD63_BOVIN	Coiled-coil domain-containing protein 63	GO:0003341; GO:0005930; GO:0007286; GO:0036158	axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286]
PGEN_.00g129940	Scaffold_06	2629705	2631253	Q8MJI9	PROP1_BOVIN	Homeobox protein prophet of Pit-1 (PROP-1) (Pituitary-specific homeodomain factor)	GO:0000981; GO:0005634; GO:0021983; GO:0043565	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; pituitary gland development [GO:0021983]"
PGEN_.00g129950	Scaffold_06	2632452	2634213	NA	NA	NA	NA	NA
PGEN_.00g129960	Scaffold_06	2643400	2651685	Q4R7T7	TBD_MACFA	Tubulin delta chain (Delta-tubulin)	GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005814; GO:0005874; GO:0005929; GO:0007017; GO:0007275; GO:0030030; GO:0045880	centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; cell projection organization [GO:0030030]; microtubule-based process [GO:0007017]; multicellular organism development [GO:0007275]; positive regulation of smoothened signaling pathway [GO:0045880]
PGEN_.00g129970	Scaffold_06	2687252	2687602	NA	NA	NA	NA	NA
PGEN_.00g129980	Scaffold_06	2716307	2751967	Q13889	TF2H3_HUMAN	General transcription factor IIH subunit 3 (Basic transcription factor 2 34 kDa subunit) (BTF2 p34) (General transcription factor IIH polypeptide 3) (TFIIH basal transcription factor complex p34 subunit)	GO:0000438; GO:0000439; GO:0000717; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006283; GO:0006289; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0016251; GO:0033683; GO:0046872; GO:0047485; GO:0070816; GO:0070911; GO:0097550	"core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcriptional preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; 7-methylguanosine mRNA capping [GO:0006370]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]"
PGEN_.00g129990	Scaffold_06	2752614	2762268	P92177	1433E_DROME	14-3-3 protein epsilon (Suppressor of Ras1 3-9)	GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:0007093; GO:0007280; GO:0007294; GO:0007411; GO:0007444; GO:0007623; GO:0008103; GO:0008134; GO:0008340; GO:0009314; GO:0009411; GO:0019904; GO:0035332; GO:0040008; GO:0042994; GO:0045172; GO:0045927; GO:0046579; GO:0046982; GO:0048190; GO:0050815	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; axon guidance [GO:0007411]; circadian rhythm [GO:0007623]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; mitotic cell cycle checkpoint [GO:0007093]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190]
PGEN_.00g130000	Scaffold_06	2775917	2781492	Q6DBT3	TXD17_DANRE	Thioredoxin domain-containing protein 17 (Thioredoxin-like protein 5)	GO:0005829; GO:0047134	cytosol [GO:0005829]; protein-disulfide reductase activity [GO:0047134]
PGEN_.00g130010	Scaffold_06	2789503	2796719	NA	NA	NA	NA	NA
PGEN_.00g130020	Scaffold_06	2807331	2819938	Q9UAS2	FABP1_FASGI	Fatty acid-binding protein 1	GO:0008289	lipid binding [GO:0008289]
PGEN_.00g130030	Scaffold_06	2827325	2835163	Q2YDJ8	KMT5A_BOVIN	N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.-) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8)	GO:0000122; GO:0002039; GO:0003714; GO:0005654; GO:0005694; GO:0005829; GO:0007049; GO:0016279; GO:0018024; GO:0018026; GO:0043516; GO:0051301	"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"
PGEN_.00g130040	Scaffold_06	2837054	2849698	Q689Z5	SBNO1_MOUSE	Protein strawberry notch homolog 1 (mSno1)	GO:0005634; GO:0006355; GO:0031490; GO:0042393	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g130050	Scaffold_06	2921939	2955806	Q9JJC6	RIPL1_MOUSE	RILP-like protein 1 (Rab-interacting lysosomal-like protein 1)	GO:0003382; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0031267; GO:0046983; GO:0051959; GO:1901214; GO:1903445	centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of neuron death [GO:1901214]
PGEN_.00g130060	Scaffold_06	2960843	2964770	P49020	TMED2_CRIGR	Transmembrane emp24 domain-containing protein 2 (COPI-coated vesicle membrane protein p24) (p24 family protein beta-1) (p24beta1) (Fragment)	GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0007030; GO:0015031; GO:0016021; GO:0016192; GO:0030137; GO:0030663; GO:0032580; GO:0033116; GO:0034260; GO:0072659	COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g130070	Scaffold_06	2975316	3065774	P30622	CLIP1_HUMAN	CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin)	GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005635; GO:0005768; GO:0005813; GO:0005829; GO:0005874; GO:0005881; GO:0005882; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0035371; GO:0042802; GO:0042803; GO:0044861; GO:0046872; GO:0051010	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; ruffle [GO:0001726]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861]
PGEN_.00g130080	Scaffold_06	2979533	2979790	NA	NA	NA	NA	NA
PGEN_.00g130090	Scaffold_06	3098655	3098972	NA	NA	NA	NA	NA
PGEN_.00g130100	Scaffold_06	3101245	3108485	A0A1D5PXA5	TRPV4_CHICK	Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Vanilloid receptor-related osmotically activated channel) (VR-OAC)	GO:0005216; GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005623; GO:0005886; GO:0005887; GO:0005912; GO:0005929; GO:0006874; GO:0007015; GO:0007231; GO:0008289; GO:0016324; GO:0046872; GO:0071476	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell [GO:0005623]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; actin filament organization [GO:0007015]; cellular calcium ion homeostasis [GO:0006874]; cellular hypotonic response [GO:0071476]; osmosensory signaling pathway [GO:0007231]
PGEN_.00g130110	Scaffold_06	3117585	3126042	NA	NA	NA	NA	NA
PGEN_.00g130120	Scaffold_06	3126097	3135332	NA	NA	NA	NA	NA
PGEN_.00g130130	Scaffold_06	3135394	3166577	Q7X8C5	WAKLB_ARATH	Wall-associated receptor kinase-like 2 (EC 2.7.11.-)	GO:0004674; GO:0005509; GO:0005524; GO:0005886; GO:0009505; GO:0016021; GO:0030247; GO:0046777	integral component of membrane [GO:0016021]; plant-type cell wall [GO:0009505]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; polysaccharide binding [GO:0030247]; protein serine/threonine kinase activity [GO:0004674]; protein autophosphorylation [GO:0046777]
PGEN_.00g130140	Scaffold_06	3219910	3222025	NA	NA	NA	NA	NA
PGEN_.00g130150	Scaffold_06	3261575	3264209	NA	NA	NA	NA	NA
PGEN_.00g130160	Scaffold_06	3270606	3274261	Q8BR93	HARB1_MOUSE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g130170	Scaffold_06	3278979	3281190	NA	NA	NA	NA	NA
PGEN_.00g130180	Scaffold_06	3282673	3298328	G5EFP5	FUTC_CAEEL	"Alpha-(1,3)-fucosyltransferase fut-3 (EC 2.4.1.65) (Fucosyltransferase fut-3)"	GO:0006486; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g130190	Scaffold_06	3324300	3335119	O88630	GOSR1_MOUSE	Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) (GOS-28)	GO:0000139; GO:0005484; GO:0005794; GO:0005797; GO:0005801; GO:0005829; GO:0006888; GO:0006906; GO:0015031; GO:0016021; GO:0031201; GO:0042147; GO:0048209	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; regulation of vesicle targeting, to, from or within Golgi [GO:0048209]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]"
PGEN_.00g130200	Scaffold_06	3346417	3408956	O55028	BCKD_MOUSE	"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)"	GO:0004672; GO:0004674; GO:0005524; GO:0005739; GO:0005947; GO:0009083; GO:0016310; GO:0047323	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; phosphorylation [GO:0016310]
PGEN_.00g130210	Scaffold_06	3422398	3460400	Q640I9	KDM2B_XENLA	Lysine-specific demethylase 2B (EC 1.14.11.27) (F-box and leucine-rich repeat protein 10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) ([Histone-H3]-lysine-36 demethylase 1B)	GO:0005634; GO:0005694; GO:0005730; GO:0008270; GO:0019843; GO:0045322; GO:0051864; GO:0070544	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; histone demethylase activity (H3-K36 specific) [GO:0051864]; rRNA binding [GO:0019843]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; histone H3-K36 demethylation [GO:0070544]
PGEN_.00g130220	Scaffold_06	3487025	3501187	Q5EAU0	CRCM1_XENLA	Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A)	GO:0002115; GO:0002250; GO:0005886; GO:0005887; GO:0015279; GO:0051928	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; store-operated calcium channel activity [GO:0015279]; adaptive immune response [GO:0002250]; positive regulation of calcium ion transport [GO:0051928]; store-operated calcium entry [GO:0002115]
PGEN_.00g130230	Scaffold_06	3509830	3529111	Q9NS39	RED2_HUMAN	Double-stranded RNA-specific editase B2 (EC 3.5.-.-) (RNA-dependent adenosine deaminase 3) (RNA-editing deaminase 2) (RNA-editing enzyme 2) (dsRNA adenosine deaminase B2)	GO:0003723; GO:0003725; GO:0003726; GO:0003727; GO:0004000; GO:0005634; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0008251; GO:0046872	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]
PGEN_.00g130240	Scaffold_06	3597779	3610531	C8V4D4	GRRA_EMENI	SCF E3 ubiquitin ligase complex F-box protein grrA (F-box and leucine-rich repeat protein grrA) (F-box/LRR-repeat protein grrA) (SCF substrate adapter protein grrA)	GO:0000209; GO:0000751; GO:0005737; GO:0019005; GO:0030437; GO:0071406	cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ascospore formation [GO:0030437]; cellular response to methylmercury [GO:0071406]; mitotic cell cycle G1 arrest in response to pheromone [GO:0000751]; protein polyubiquitination [GO:0000209]
PGEN_.00g130250	Scaffold_06	3610587	3618607	Q2YGT9	RL6_PIG	60S ribosomal protein L6	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0014069; GO:0015934; GO:0022625; GO:0036464; GO:0042788; GO:0098556	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]
PGEN_.00g130260	Scaffold_06	3625300	3649985	Q2KIK3	SIM14_BOVIN	Small integral membrane protein 14	GO:0001835; GO:0005783; GO:0005789; GO:0016021	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; blastocyst hatching [GO:0001835]
PGEN_.00g130270	Scaffold_06	3661326	3683088	Q92051	CAHZ_DANRE	Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)	GO:0004089; GO:0008270; GO:0015670; GO:0042539	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]
PGEN_.00g130280	Scaffold_06	3731679	3732212	NA	NA	NA	NA	NA
PGEN_.00g130290	Scaffold_06	3735533	3737493	NA	NA	NA	NA	NA
PGEN_.00g130300	Scaffold_06	3748225	3755208	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g130310	Scaffold_06	3764659	3768394	NA	NA	NA	NA	NA
PGEN_.00g130320	Scaffold_06	3820802	3821716	NA	NA	NA	NA	NA
PGEN_.00g130330	Scaffold_06	3831628	3832272	NA	NA	NA	NA	NA
PGEN_.00g130340	Scaffold_06	3832314	3832988	NA	NA	NA	NA	NA
PGEN_.00g130350	Scaffold_06	3833017	3852985	NA	NA	NA	NA	NA
PGEN_.00g130360	Scaffold_06	3859826	3860467	NA	NA	NA	NA	NA
PGEN_.00g130370	Scaffold_06	3870506	3870721	NA	NA	NA	NA	NA
PGEN_.00g130380	Scaffold_06	3872513	3873012	NA	NA	NA	NA	NA
PGEN_.00g130390	Scaffold_06	3916942	3918931	NA	NA	NA	NA	NA
PGEN_.00g130400	Scaffold_06	3949713	3950344	NA	NA	NA	NA	NA
PGEN_.00g130410	Scaffold_06	3956996	3957820	NA	NA	NA	NA	NA
PGEN_.00g130420	Scaffold_06	3962555	3963857	Q9NWS8	RMND1_HUMAN	Required for meiotic nuclear division protein 1 homolog	GO:0005739; GO:0006412; GO:0070131	mitochondrion [GO:0005739]; positive regulation of mitochondrial translation [GO:0070131]; translation [GO:0006412]
PGEN_.00g130430	Scaffold_06	3965869	3974618	NA	NA	NA	NA	NA
PGEN_.00g130440	Scaffold_06	3977711	3978538	Q9K907	PRPE_BACHD	"Bis(5'-nucleosyl)-tetraphosphatase PrpE [asymmetrical] (EC 3.6.1.17) (Ap4A hydrolase) (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase) (Diadenosine tetraphosphatase)"	GO:0004081; GO:0005525; GO:0016151	bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; GTP binding [GO:0005525]; nickel cation binding [GO:0016151]
PGEN_.00g130450	Scaffold_06	3985981	3995572	Q29RU9	SOX_BOVIN	Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase)	GO:0005777; GO:0008115; GO:0033514; GO:0046653; GO:0050031	peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; tetrahydrofolate metabolic process [GO:0046653]
PGEN_.00g130460	Scaffold_06	3998329	3999171	NA	NA	NA	NA	NA
PGEN_.00g130470	Scaffold_06	4041611	4042804	Q02974	KHK_RAT	Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase)	GO:0004454; GO:0005524; GO:0005634; GO:0005737; GO:0006000; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0016052; GO:0019200; GO:0032868; GO:0070873	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; ketohexokinase activity [GO:0004454]; carbohydrate catabolic process [GO:0016052]; fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]
PGEN_.00g130480	Scaffold_06	4046363	4053755	Q8BGS2	BOLA2_MOUSE	BolA-like protein 2	GO:0005634; GO:0005737; GO:0044571; GO:0097428	cytoplasm [GO:0005737]; nucleus [GO:0005634]; [2Fe-2S] cluster assembly [GO:0044571]; protein maturation by iron-sulfur cluster transfer [GO:0097428]
PGEN_.00g130490	Scaffold_06	4057446	4062319	Q96DY2	DRC10_HUMAN	Dynein regulatory complex protein 10 (IQ domain-containing protein D)	GO:0005737; GO:0005856; GO:0031514	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]
PGEN_.00g130500	Scaffold_06	4062817	4110349	Q9ULQ1	TPC1_HUMAN	Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)	GO:0005245; GO:0005248; GO:0005623; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0010508; GO:0015280; GO:0016021; GO:0034220; GO:0034765; GO:0042802; GO:0042803; GO:0072345; GO:0080025	"cell [GO:0005623]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]"
PGEN_.00g130510	Scaffold_06	4117000	4122896	Q9QY93	DCTP1_MOUSE	dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21-C6)	GO:0000287; GO:0005829; GO:0006253; GO:0009143; GO:0016462; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840	cytosol [GO:0005829]; dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; pyrophosphatase activity [GO:0016462]; dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143]
PGEN_.00g130520	Scaffold_06	4123298	4130328	NA	NA	NA	NA	NA
PGEN_.00g130530	Scaffold_06	4141272	4142916	NA	NA	NA	NA	NA
PGEN_.00g130540	Scaffold_06	4146406	4147120	NA	NA	NA	NA	NA
PGEN_.00g130550	Scaffold_06	4183206	4184489	A0KDV2	RHMD_BURCH	L-rhamnonate dehydratase (RhamD) (EC 4.2.1.90)	GO:0000287; GO:0009063; GO:0050032	L-rhamnonate dehydratase activity [GO:0050032]; magnesium ion binding [GO:0000287]; cellular amino acid catabolic process [GO:0009063]
PGEN_.00g130560	Scaffold_06	4191416	4193652	Q7K237	C1GLT_DROME	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037	"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"
PGEN_.00g130570	Scaffold_06	4194576	4197802	NA	NA	NA	NA	NA
PGEN_.00g130580	Scaffold_06	4201262	4210146	NA	NA	NA	NA	NA
PGEN_.00g130590	Scaffold_06	4210192	4210941	NA	NA	NA	NA	NA
PGEN_.00g130600	Scaffold_06	4232842	4233399	P02718	ACHD_TETCF	Acetylcholine receptor subunit delta	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g130610	Scaffold_06	4305413	4306795	Q8BMN3	ACHB3_MOUSE	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0016020; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0051291; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g130620	Scaffold_06	4330567	4338258	Q8WPD0	LECG_PATPE	Alpha-N-acetylgalactosamine-specific lectin (Alpha-N-acetylgalactosamine-binding lectin) (GalNAc-specific lectin) (Lectin) (ApL) (Tn antigen-specific lectin)	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g130630	Scaffold_06	4338731	4344129	P34927	ASGR1_MOUSE	Asialoglycoprotein receptor 1 (ASGP-R 1) (ASGPR 1) (Hepatic lectin 1) (HL-1) (mHL-1)	GO:0004873; GO:0016021; GO:0030246; GO:0031668; GO:0042803; GO:0046872	integral component of membrane [GO:0016021]; asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; cellular response to extracellular stimulus [GO:0031668]
PGEN_.00g130640	Scaffold_06	4349099	4355203	P02706	ASGR1_RAT	Asialoglycoprotein receptor 1 (ASGP-R 1) (ASGPR 1) (Hepatic lectin 1) (HL-1) (rHL-1)	GO:0004873; GO:0016021; GO:0030246; GO:0031668; GO:0042803; GO:0046872	integral component of membrane [GO:0016021]; asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; cellular response to extracellular stimulus [GO:0031668]
PGEN_.00g130650	Scaffold_06	4401479	4403704	NA	NA	NA	NA	NA
PGEN_.00g130660	Scaffold_06	4421565	4422135	NA	NA	NA	NA	NA
PGEN_.00g130670	Scaffold_06	4458500	4460566	NA	NA	NA	NA	NA
PGEN_.00g130680	Scaffold_06	4480336	4483489	P82596	PLC_HALLA	Perlucin	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g130690	Scaffold_06	4578889	4579551	NA	NA	NA	NA	NA
PGEN_.00g130700	Scaffold_06	4611890	4623896	NA	NA	NA	NA	NA
PGEN_.00g130710	Scaffold_06	4634585	4641589	NA	NA	NA	NA	NA
PGEN_.00g130720	Scaffold_06	4649975	4655733	NA	NA	NA	NA	NA
PGEN_.00g130730	Scaffold_06	4662956	4667307	O00468	AGRIN_HUMAN	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	GO:0001523; GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005829; GO:0005886; GO:0006024; GO:0006027; GO:0007165; GO:0007213; GO:0007528; GO:0008045; GO:0009887; GO:0009888; GO:0016021; GO:0016358; GO:0030054; GO:0030198; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200]; animal organ morphogenesis [GO:0009887]; clustering of voltage-gated sodium channels [GO:0045162]; dendrite development [GO:0016358]; extracellular matrix organization [GO:0030198]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; motor neuron axon guidance [GO:0008045]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]
PGEN_.00g130740	Scaffold_06	4670927	4675082	NA	NA	NA	NA	NA
PGEN_.00g130750	Scaffold_06	4679288	4682529	NA	NA	NA	NA	NA
PGEN_.00g130760	Scaffold_06	4685824	4688923	NA	NA	NA	NA	NA
PGEN_.00g130770	Scaffold_06	4693737	4709802	Q4KLT3	TRM44_XENLA	Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19)	GO:0005737; GO:0008033; GO:0008168; GO:0032259; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; tRNA processing [GO:0008033]
PGEN_.00g130780	Scaffold_06	4711212	4719694	NA	NA	NA	NA	NA
PGEN_.00g130790	Scaffold_06	4730004	4751907	Q5BLE8	RETST_DANRE	"All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase A) (RetSat A) (All-trans-retinol 7,8-reductase)"	GO:0005789; GO:0051786	"endoplasmic reticulum membrane [GO:0005789]; all-trans-retinol 13,14-reductase activity [GO:0051786]"
PGEN_.00g130800	Scaffold_06	4763167	4782011	NA	NA	NA	NA	NA
PGEN_.00g130810	Scaffold_06	4796592	4798119	NA	NA	NA	NA	NA
PGEN_.00g130820	Scaffold_06	4798992	4822531	NA	NA	NA	NA	NA
PGEN_.00g130830	Scaffold_06	4825228	4826562	Q8VHE9	RETST_RAT	"All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat) (PPAR-alpha-regulated and starvation-induced gene protein) (RMT-7)"	GO:0005640; GO:0005789; GO:0016491; GO:0031965; GO:0042572; GO:0051786; GO:0055114	"endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; all-trans-retinol 13,14-reductase activity [GO:0051786]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114]; retinol metabolic process [GO:0042572]"
PGEN_.00g130840	Scaffold_06	4845322	4845705	NA	NA	NA	NA	NA
PGEN_.00g130850	Scaffold_06	4847993	4854118	NA	NA	NA	NA	NA
PGEN_.00g130860	Scaffold_06	4862986	4869161	NA	NA	NA	NA	NA
PGEN_.00g130870	Scaffold_06	4875971	4896390	Q5U4S8	CEGTB_XENLA	Ceramide glucosyltransferase-B (EC 2.4.1.80) (UDP-glucose ceramide glucosyltransferase)	GO:0000139; GO:0005794; GO:0007275; GO:0008120; GO:0016021; GO:0046479; GO:0102769	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ceramide glucosyltransferase activity [GO:0008120]; dihydroceramide glucosyltransferase activity [GO:0102769]; glycosphingolipid catabolic process [GO:0046479]; multicellular organism development [GO:0007275]
PGEN_.00g130880	Scaffold_06	4917089	4977090	Q292Q0	ATC1_DROPS	Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type (EC 7.2.2.10) (Calcium pump) (Sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase)	GO:0005388; GO:0005524; GO:0005783; GO:0016021; GO:0016529; GO:0033017; GO:0046872	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]"
PGEN_.00g130890	Scaffold_06	4919633	4919926	NA	NA	NA	NA	NA
PGEN_.00g130900	Scaffold_06	4982517	4984739	NA	NA	NA	NA	NA
PGEN_.00g130910	Scaffold_06	4997237	4997840	Q8R429	AT2A1_MOUSE	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1) (SR Ca(2+)-ATPase 1) (EC 7.2.2.10) (Calcium pump 1) (Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	GO:0005338; GO:0005388; GO:0005509; GO:0005524; GO:0005623; GO:0005739; GO:0005783; GO:0005789; GO:0005793; GO:0006816; GO:0006874; GO:0006937; GO:0006942; GO:0008553; GO:0008637; GO:0016020; GO:0016021; GO:0016529; GO:0016887; GO:0031448; GO:0031673; GO:0031674; GO:0032470; GO:0032471; GO:0033017; GO:0034976; GO:0042803; GO:0043231; GO:0043434; GO:0045988; GO:0048471; GO:0051561; GO:0051659; GO:0070059; GO:0070296; GO:0070509; GO:0070588; GO:0090076; GO:0106134; GO:1901896; GO:1902082; GO:1990036	"cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; H zone [GO:0031673]; I band [GO:0031674]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; protein homodimerization activity [GO:0042803]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; apoptotic mitochondrial changes [GO:0008637]; calcium ion import [GO:0070509]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; maintenance of mitochondrion location [GO:0051659]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of striated muscle contraction [GO:0045988]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of calcium ion import into sarcoplasmic reticulum [GO:1902082]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of muscle contraction [GO:0006937]; regulation of striated muscle contraction [GO:0006942]; relaxation of skeletal muscle [GO:0090076]; response to endoplasmic reticulum stress [GO:0034976]; response to peptide hormone [GO:0043434]; sarcoplasmic reticulum calcium ion transport [GO:0070296]"
PGEN_.00g130920	Scaffold_06	5061629	5063294	NA	NA	NA	NA	NA
PGEN_.00g130930	Scaffold_06	5116306	5117870	NA	NA	NA	NA	NA
PGEN_.00g130940	Scaffold_06	5121671	5149438	Q6NS15	MED15_XENLA	Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (xARC105) (Mediator complex subunit 15)	GO:0003712; GO:0005737; GO:0006357; GO:0016592	cytoplasm [GO:0005737]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g130950	Scaffold_06	5150096	5150740	NA	NA	NA	NA	NA
PGEN_.00g130960	Scaffold_06	5151126	5151545	NA	NA	NA	NA	NA
PGEN_.00g130970	Scaffold_06	5173245	5176440	Q7M370	AAAD_RABIT	Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase)	GO:0004806; GO:0005789; GO:0016021; GO:0019213	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; deacetylase activity [GO:0019213]; triglyceride lipase activity [GO:0004806]
PGEN_.00g130980	Scaffold_06	5177289	5178072	NA	NA	NA	NA	NA
PGEN_.00g130990	Scaffold_06	5179914	5200837	NA	NA	NA	NA	NA
PGEN_.00g131000	Scaffold_06	5197006	5197347	NA	NA	NA	NA	NA
PGEN_.00g131010	Scaffold_06	5222616	5251917	Q9UMZ2	SYNRG_HUMAN	Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin)	GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130	AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]
PGEN_.00g131020	Scaffold_06	5260479	5288505	Q8TBY9	CF251_HUMAN	Cilia- and flagella-associated protein 251 (CFAP251) (WD repeat-containing protein 66)	GO:0003341; GO:0005930; GO:0030317; GO:0031514; GO:0036126	axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]
PGEN_.00g131030	Scaffold_06	5295042	5305191	Q9NXW9	ALKB4_HUMAN	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 (Alkylated DNA repair protein alkB homolog 4) (DNA N6-methyl adenine demethylase ALKBH4) (EC 1.14.11.51) (Lysine-specific demethylase ALKBH4) (EC 1.14.11.-)	GO:0003779; GO:0005730; GO:0005737; GO:0006325; GO:0006482; GO:0016491; GO:0016706; GO:0030496; GO:0031032; GO:0032451; GO:0035516; GO:0036090; GO:0046872; GO:0070938; GO:0070989; GO:0080111; GO:1902275	contractile ring [GO:0070938]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; actin binding [GO:0003779]; demethylase activity [GO:0032451]; metal ion binding [GO:0046872]; oxidative DNA demethylase activity [GO:0035516]; oxidoreductase activity [GO:0016491]; actomyosin structure organization [GO:0031032]; chromatin organization [GO:0006325]; cleavage furrow ingression [GO:0036090]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; protein demethylation [GO:0006482]; regulation of chromatin organization [GO:1902275]
PGEN_.00g131040	Scaffold_06	5309303	5338565	Q96I76	GPTC3_HUMAN	G patch domain-containing protein 3	GO:0003676; GO:0005634; GO:0005737; GO:0032480; GO:0039536; GO:0045893	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g131050	Scaffold_06	5380121	5387064	Q11131	FUT7_MOUSE	"Alpha-(1,3)-fucosyltransferase 7 (EC 2.4.1.-) (Fucosyltransferase 7) (Fucosyltransferase VII) (Fuc-TVII) (FucT-VII) (Galactoside 3-L-fucosyltransferase)"	GO:0002361; GO:0002522; GO:0005794; GO:0006486; GO:0006672; GO:0007566; GO:0008417; GO:0016021; GO:0022409; GO:0032580; GO:0036065; GO:0046920; GO:0097021; GO:1903238; GO:1904994; GO:1904996; GO:2000389	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; ceramide metabolic process [GO:0006672]; embryo implantation [GO:0007566]; fucosylation [GO:0036065]; leukocyte migration involved in immune response [GO:0002522]; lymphocyte migration into lymphoid organs [GO:0097021]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein glycosylation [GO:0006486]; regulation of leukocyte adhesion to vascular endothelial cell [GO:1904994]; regulation of neutrophil extravasation [GO:2000389]"
PGEN_.00g131060	Scaffold_06	5392816	5393466	NA	NA	NA	NA	NA
PGEN_.00g131070	Scaffold_06	5415566	5442849	Q2XWK0	SVOP_XENLA	Synaptic vesicle 2-related protein (SV2-related protein)	GO:0016021; GO:0022857; GO:0030054; GO:0030672	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]
PGEN_.00g131080	Scaffold_06	5467095	5467538	NA	NA	NA	NA	NA
PGEN_.00g131090	Scaffold_06	5468987	5473973	NA	NA	NA	NA	NA
PGEN_.00g131100	Scaffold_06	5481848	5482144	NA	NA	NA	NA	NA
PGEN_.00g131110	Scaffold_06	5482480	5483493	NA	NA	NA	NA	NA
PGEN_.00g131120	Scaffold_06	5484719	5511681	NA	NA	NA	NA	NA
PGEN_.00g131130	Scaffold_06	5583857	5607351	O94972	TRI37_HUMAN	E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (Mulibrey nanism protein) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37)	GO:0000122; GO:0003682; GO:0004842; GO:0005164; GO:0005737; GO:0005777; GO:0005829; GO:0008270; GO:0016235; GO:0031625; GO:0032088; GO:0035518; GO:0036353; GO:0042803; GO:0046600; GO:0048471; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070842	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]
PGEN_.00g131140	Scaffold_06	5607565	5627749	Q8BYR1	TYW4_MOUSE	tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (p21WAF1/CIP1 promoter-interacting protein) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase)	GO:0003880; GO:0006481; GO:0008175; GO:0030488; GO:0031591	protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; tRNA methyltransferase activity [GO:0008175]; C-terminal protein methylation [GO:0006481]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591]
PGEN_.00g131150	Scaffold_06	5627897	5629990	NA	NA	NA	NA	NA
PGEN_.00g131160	Scaffold_06	5632210	5637992	Q8BYR1	TYW4_MOUSE	tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (p21WAF1/CIP1 promoter-interacting protein) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase)	GO:0003880; GO:0006481; GO:0008175; GO:0030488; GO:0031591	protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; tRNA methyltransferase activity [GO:0008175]; C-terminal protein methylation [GO:0006481]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591]
PGEN_.00g131170	Scaffold_06	5679415	5710599	NA	NA	NA	NA	NA
PGEN_.00g131180	Scaffold_06	5726864	5742393	Q5FVQ4	MLEC_RAT	Malectin	GO:0005783; GO:0005789; GO:0005975; GO:0016021; GO:0019899; GO:0030246	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g131190	Scaffold_06	5747646	5751787	O89001	CBPD_MOUSE	Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180)	GO:0004181; GO:0004185; GO:0005615; GO:0005634; GO:0005802; GO:0005886; GO:0006518; GO:0008270; GO:0016021; GO:0016485; GO:0043231; GO:0044877; GO:0048471; GO:0051721	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; metallocarboxypeptidase activity [GO:0004181]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]
PGEN_.00g131200	Scaffold_06	5814782	5816898	NA	NA	NA	NA	NA
PGEN_.00g131210	Scaffold_06	5824515	5851741	Q90240	CBPD_ANAPL	Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) (p170)	GO:0004181; GO:0004185; GO:0005886; GO:0006508; GO:0008270; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g131220	Scaffold_06	5865607	5867357	A4IFB4	KCTD7_BOVIN	BTB/POZ domain-containing protein KCTD7	GO:0005829; GO:0005886; GO:0051260	cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]
PGEN_.00g131230	Scaffold_06	5885145	5903098	P07314	GGT1_RAT	Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]	GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006750; GO:0006751; GO:0007283; GO:0007568; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0102953; GO:0103068; GO:1901750	"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; transferase activity, transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]"
PGEN_.00g131240	Scaffold_06	5910478	6000603	Q8BTI8	SRRM2_MOUSE	Serine/arginine repetitive matrix protein 2	GO:0000398; GO:0003729; GO:0005634; GO:0015030; GO:0016607; GO:0047485; GO:0070742; GO:0071005; GO:0071007	"Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g131250	Scaffold_06	6013211	6021809	Q5I0D1	GLOD4_RAT	Glyoxalase domain-containing protein 4	GO:0005739	mitochondrion [GO:0005739]
PGEN_.00g131260	Scaffold_06	6027034	6035565	NA	NA	NA	NA	NA
PGEN_.00g131270	Scaffold_06	6040798	6058510	NA	NA	NA	NA	NA
PGEN_.00g131280	Scaffold_06	6100141	6104131	P36975	SNP25_DROME	Synaptosomal-associated protein 25 (SNAP-25) (Synaptosomal-associated 25 kDa protein)	GO:0000149; GO:0005484; GO:0005623; GO:0005737; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0007269; GO:0007274; GO:0016020; GO:0016081; GO:0016082; GO:0016192; GO:0019905; GO:0030054; GO:0031201; GO:0031629; GO:0043195; GO:0048172; GO:0048489	cell [GO:0005623]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]
PGEN_.00g131290	Scaffold_06	6104649	6122831	Q9Y4P3	TBL2_HUMAN	Transducin beta-like protein 2 (WS beta-transducin repeats protein) (WS-betaTRP) (Williams-Beuren syndrome chromosomal region 13 protein)	GO:0003723; GO:0005783; GO:0019901; GO:0030176; GO:0030968; GO:0031369; GO:0042149; GO:0051219; GO:0071456	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968]
PGEN_.00g131300	Scaffold_06	6127902	6138903	Q9CPU4	MGST3_MOUSE	Microsomal glutathione S-transferase 3 (Microsomal GST-3) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (Microsomal glutathione S-transferase III) (Microsomal GST-III)	GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0010243; GO:0016020; GO:0016021; GO:0019370; GO:0043231	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243]
PGEN_.00g131310	Scaffold_06	6150487	6151536	P42573	CED3_CAEEL	Cell death protein 3 (EC 3.4.22.60) (Caspase ced-3) [Cleaved into: Cell death protein 3 subunit p17; Cell death protein 3 subunit p15; Cell death protein 3 subunit p13]	GO:0004175; GO:0004197; GO:0005623; GO:0005737; GO:0005739; GO:0006508; GO:0006915; GO:0006919; GO:0008303; GO:0008656; GO:0009792; GO:0010954; GO:0012501; GO:0016020; GO:0016540; GO:0030042; GO:0030054; GO:0030155; GO:0030163; GO:0031647; GO:0031965; GO:0040012; GO:0040028; GO:0040034; GO:0042659; GO:0042802; GO:0043025; GO:0043204; GO:0043525; GO:0046716; GO:0048471; GO:0050807; GO:0050829; GO:0097153; GO:0097194; GO:0097200; GO:0097202; GO:0098793; GO:1901046; GO:1902742; GO:1904747; GO:1905803; GO:1905808; GO:1905845	"caspase complex [GO:0008303]; cell [GO:0005623]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; execution phase of apoptosis [GO:0097194]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of synapse organization [GO:0050807]; regulation of vulval development [GO:0040028]"
PGEN_.00g131320	Scaffold_06	6152895	6153461	NA	NA	NA	NA	NA
PGEN_.00g131330	Scaffold_06	6153726	6155199	NA	NA	NA	NA	NA
PGEN_.00g131340	Scaffold_06	6166986	6177436	NA	NA	NA	NA	NA
PGEN_.00g131350	Scaffold_06	6182500	6238727	O00291	HIP1_HUMAN	Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I)	GO:0005154; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0006915; GO:0006919; GO:0007015; GO:0016020; GO:0030100; GO:0030136; GO:0030154; GO:0030276; GO:0030479; GO:0030665; GO:0031234; GO:0032051; GO:0032266; GO:0035091; GO:0035254; GO:0035612; GO:0035615; GO:0042803; GO:0042981; GO:0043231; GO:0043325; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0051897; GO:0061024; GO:0072583; GO:0080025; GO:0097190; GO:0098793; GO:0098794; GO:0098888; GO:0098890; GO:0098978; GO:0099637; GO:2000588	"actin cortical patch [GO:0030479]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]"
PGEN_.00g131360	Scaffold_06	6249630	6251571	NA	NA	NA	NA	NA
PGEN_.00g131370	Scaffold_06	6253200	6256477	NA	NA	NA	NA	NA
PGEN_.00g131380	Scaffold_06	6258095	6262358	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g131390	Scaffold_06	6264550	6268006	A5PK65	DOPD_BOVIN	D-dopachrome decarboxylase (EC 4.1.1.84) (D-dopachrome tautomerase)	GO:0005737; GO:0033981; GO:0042438	cytoplasm [GO:0005737]; D-dopachrome decarboxylase activity [GO:0033981]; melanin biosynthetic process [GO:0042438]
PGEN_.00g131400	Scaffold_06	6298951	6313707	A8WHP3	SC5A9_DANRE	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	GO:0005412; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]
PGEN_.00g131410	Scaffold_06	6333619	6338099	NA	NA	NA	NA	NA
PGEN_.00g131420	Scaffold_06	6340824	6341370	NA	NA	NA	NA	NA
PGEN_.00g131430	Scaffold_06	6344103	6346036	NA	NA	NA	NA	NA
PGEN_.00g131440	Scaffold_06	6348838	6353113	NA	NA	NA	NA	NA
PGEN_.00g131450	Scaffold_06	6355593	6357141	NA	NA	NA	NA	NA
PGEN_.00g131460	Scaffold_06	6364095	6445516	Q6ZQB6	VIP2_MOUSE	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (mmVIP2)	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0007605; GO:0032958; GO:0033857; GO:0052723; GO:0052724; GO:0102092	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; sensory perception of sound [GO:0007605]"
PGEN_.00g131470	Scaffold_06	6445568	6449830	NA	NA	NA	NA	NA
PGEN_.00g131480	Scaffold_06	6485303	6496890	Q60596	XRCC1_MOUSE	DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1)	GO:0000012; GO:0000784; GO:0000790; GO:0001666; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006303; GO:0010033; GO:0010836; GO:0019899; GO:0021587; GO:0021766; GO:0032356; GO:0033194; GO:0042493; GO:0050882; GO:0061819; GO:0070522; GO:1903518; GO:1904877; GO:1905765; GO:1990414	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882]"
PGEN_.00g131490	Scaffold_06	6509382	6517228	NA	NA	NA	NA	NA
PGEN_.00g131500	Scaffold_06	6528842	6553422	NA	NA	NA	NA	NA
PGEN_.00g131510	Scaffold_06	6558287	6577811	Q25390	SCRA_LIMPO	Alpha-scruin		
PGEN_.00g131520	Scaffold_06	6584795	6585607	NA	NA	NA	NA	NA
PGEN_.00g131530	Scaffold_06	6612264	6613370	Q969V1	MCHR2_HUMAN	Melanin-concentrating hormone receptor 2 (MCH receptor 2) (MCH-R2) (MCHR-2) (G-protein coupled receptor 145) (GPRv17) (MCH-2R) (MCH2) (MCH2R)	GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0008528	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g131540	Scaffold_06	6620688	6633650	Q64270	EI2BA_RAT	Translation initiation factor eIF-2B subunit alpha (eIF-2B GDP-GTP exchange factor subunit alpha)	GO:0003743; GO:0005525; GO:0005737; GO:0005850; GO:0005851; GO:0005886; GO:0006412; GO:0006413; GO:0006446; GO:0009408; GO:0009749; GO:0014003; GO:0016020; GO:0019003; GO:0042802; GO:0043434; GO:0050852; GO:1905098; GO:1990928	cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; oligodendrocyte development [GO:0014003]; regulation of translational initiation [GO:0006446]; response to amino acid starvation [GO:1990928]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413]
PGEN_.00g131550	Scaffold_06	6656260	6708950	Q92051	CAHZ_DANRE	Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)	GO:0004089; GO:0008270; GO:0015670; GO:0042539	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]
PGEN_.00g131560	Scaffold_06	6694499	6696718	NA	NA	NA	NA	NA
PGEN_.00g131570	Scaffold_06	6721184	6748435	Q9ES88	S13A2_MOUSE	Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g131580	Scaffold_06	6756927	6763201	Q8WWT9	S13A3_HUMAN	Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)	GO:0005886; GO:0015137; GO:0015139; GO:0015141; GO:0015362; GO:0015746; GO:0016021; GO:0017153; GO:0070062	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]
PGEN_.00g131590	Scaffold_06	6763505	6770552	Q28615	S13A2_RABIT	Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g131600	Scaffold_06	6904342	6929486	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g131610	Scaffold_06	6954908	6959723	NA	NA	NA	NA	NA
PGEN_.00g131620	Scaffold_06	6998906	7042323	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g131630	Scaffold_06	7062620	7115125	P11274	BCR_HUMAN	Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26)	GO:0002692; GO:0003014; GO:0004674; GO:0005085; GO:0005089; GO:0005096; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007264; GO:0007420; GO:0014069; GO:0016020; GO:0016301; GO:0030036; GO:0030054; GO:0030216; GO:0030424; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043314; GO:0046777; GO:0048008; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051056; GO:0051171; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0070062; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0099092; GO:2000378	"axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of phagocytosis [GO:0050766]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]"
PGEN_.00g131640	Scaffold_06	7103190	7105047	NA	NA	NA	NA	NA
PGEN_.00g131650	Scaffold_06	7123632	7132516	NA	NA	NA	NA	NA
PGEN_.00g131660	Scaffold_06	7139067	7148841	NA	NA	NA	NA	NA
PGEN_.00g131670	Scaffold_06	7211437	7213201	NA	NA	NA	NA	NA
PGEN_.00g131680	Scaffold_06	7223471	7223713	NA	NA	NA	NA	NA
PGEN_.00g131690	Scaffold_06	7225814	7226269	NA	NA	NA	NA	NA
PGEN_.00g131700	Scaffold_06	7270508	7278051	NA	NA	NA	NA	NA
PGEN_.00g131710	Scaffold_06	7278398	7278727	NA	NA	NA	NA	NA
PGEN_.00g131720	Scaffold_06	7295745	7296074	NA	NA	NA	NA	NA
PGEN_.00g131730	Scaffold_06	7352105	7361869	NA	NA	NA	NA	NA
PGEN_.00g131740	Scaffold_06	7370765	7372971	NA	NA	NA	NA	NA
PGEN_.00g131750	Scaffold_06	7373299	7374261	NA	NA	NA	NA	NA
PGEN_.00g131760	Scaffold_06	7381488	7403306	NA	NA	NA	NA	NA
PGEN_.00g131770	Scaffold_06	7524763	7527080	NA	NA	NA	NA	NA
PGEN_.00g131780	Scaffold_06	7540397	7552583	O43570	CAH12_HUMAN	Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3)	GO:0004089; GO:0005886; GO:0008270; GO:0015701; GO:0016021; GO:0055064	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]; chloride ion homeostasis [GO:0055064]
PGEN_.00g131790	Scaffold_06	7554035	7586598	Q9WVT6	CAH14_MOUSE	Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV)	GO:0004089; GO:0006885; GO:0008270; GO:0015670; GO:0016021	integral component of membrane [GO:0016021]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; regulation of pH [GO:0006885]
PGEN_.00g131800	Scaffold_06	7598385	7602721	NA	NA	NA	NA	NA
PGEN_.00g131810	Scaffold_06	7607085	7607306	NA	NA	NA	NA	NA
PGEN_.00g131820	Scaffold_06	7609717	7627772	Q6NY74	RFA1_DANRE	Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1)	GO:0000723; GO:0000724; GO:0000784; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006289; GO:0007004; GO:0007507; GO:0016605; GO:0034502; GO:0043047; GO:0043565; GO:0046872; GO:0051321	"DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; PML body [GO:0016605]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; heart development [GO:0007507]; meiotic cell cycle [GO:0051321]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]"
PGEN_.00g131830	Scaffold_06	7639108	7661258	A4FUD1	GPN1_BOVIN	GPN-loop GTPase 1 (EC 3.6.5.-) (XPA-binding protein 1)	GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
PGEN_.00g131840	Scaffold_06	7666386	7670272	Q09930	DIRA_CAEEL	GTP-binding protein drn-1 (Di-Ras/Rig/Noey2 Ras-like protein homolog) (Fragment)	GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0019003	plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]
PGEN_.00g131850	Scaffold_06	7684621	7703529	P53442	ALF_SCHMA	Fructose-bisphosphate aldolase (EC 4.1.2.13)	GO:0004332; GO:0006096	fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]
PGEN_.00g131860	Scaffold_06	7723812	7724054	NA	NA	NA	NA	NA
PGEN_.00g131870	Scaffold_06	7835875	7844302	NA	NA	NA	NA	NA
PGEN_.00g131880	Scaffold_06	7858361	7920144	Q2KHM9	MOONR_HUMAN	Protein moonraker (MNR) (OFD1- and FOPNL-interacting protein)	GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0034451; GO:0071539	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; centriole replication [GO:0007099]; protein localization to centrosome [GO:0071539]
PGEN_.00g131890	Scaffold_06	7926197	7929361	NA	NA	NA	NA	NA
PGEN_.00g131900	Scaffold_06	7934545	7943794	Q6E2N3	TRI33_DANRE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]
PGEN_.00g131910	Scaffold_06	7976742	7978832	NA	NA	NA	NA	NA
PGEN_.00g131920	Scaffold_06	7982784	7983089	NA	NA	NA	NA	NA
PGEN_.00g131930	Scaffold_06	7985691	7986299	NA	NA	NA	NA	NA
PGEN_.00g131940	Scaffold_06	7986425	7987153	NA	NA	NA	NA	NA
PGEN_.00g131950	Scaffold_06	8010385	8022876	NA	NA	NA	NA	NA
PGEN_.00g131960	Scaffold_06	8029165	8042472	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g131970	Scaffold_06	8042472	8042738	NA	NA	NA	NA	NA
PGEN_.00g131980	Scaffold_06	8042549	8062995	A5HK05	APBP2_RAT	Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2)	GO:0005634; GO:0005874; GO:0006886; GO:0030659; GO:0046907	cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]
PGEN_.00g131990	Scaffold_06	8086678	8086923	NA	NA	NA	NA	NA
PGEN_.00g132000	Scaffold_06	8094763	8095116	NA	NA	NA	NA	NA
PGEN_.00g132010	Scaffold_06	8096083	8096601	NA	NA	NA	NA	NA
PGEN_.00g132020	Scaffold_06	8124447	8133193	Q9GZV8	PRD14_HUMAN	PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14)	GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0009566; GO:0030718; GO:0031490; GO:0034972; GO:0035019; GO:0040037; GO:0043565; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; somatic stem cell population maintenance [GO:0035019]
PGEN_.00g132030	Scaffold_06	8141725	8157980	Q6PFQ2	EIF3C_DANRE	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8)	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]
PGEN_.00g132040	Scaffold_06	8158407	8163295	B4MRZ8	EIF3C_DROWI	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8)	GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0031369; GO:0033290	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]
PGEN_.00g132050	Scaffold_06	8166822	8172779	Q6GR25	PPTC7_XENLA	Protein phosphatase PTC7 homolog (EC 3.1.3.16)	GO:0004721; GO:0005759; GO:0046872	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]
PGEN_.00g132060	Scaffold_06	8180801	8200333	Q99638	RAD9A_HUMAN	Cell cycle checkpoint control protein RAD9A (hRAD9) (EC 3.1.11.2) (DNA repair exonuclease rad9 homolog A)	GO:0000076; GO:0000077; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006974; GO:0008408; GO:0008853; GO:0017124; GO:0019899; GO:0019901; GO:0030896; GO:0031573; GO:0042826; GO:0071479; GO:1901796; GO:1902231	checkpoint clamp complex [GO:0030896]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; enzyme binding [GO:0019899]; exodeoxyribonuclease III activity [GO:0008853]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; intra-S DNA damage checkpoint [GO:0031573]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; regulation of signal transduction by p53 class mediator [GO:1901796]
PGEN_.00g132070	Scaffold_06	8200598	8205079	Q5R9Z1	VPS29_PONAB	Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29)	GO:0005769; GO:0005770; GO:0005829; GO:0010008; GO:0015031; GO:0030904; GO:0032456; GO:0042147; GO:0046872; GO:1990126	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g132080	Scaffold_06	8211256	8243051	NA	NA	NA	NA	NA
PGEN_.00g132090	Scaffold_06	8251536	8258576	Q5U316	RAB35_RAT	Ras-related protein Rab-35	GO:0000281; GO:0003924; GO:0005525; GO:0005546; GO:0005886; GO:0005905; GO:0006886; GO:0008104; GO:0010008; GO:0016197; GO:0019003; GO:0019882; GO:0031175; GO:0031253; GO:0032456; GO:0032482; GO:0036010; GO:0042470; GO:0045171; GO:0045334; GO:0048227; GO:0098993; GO:1990090	"anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; endosome membrane [GO:0010008]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; Rab protein signal transduction [GO:0032482]"
PGEN_.00g132100	Scaffold_06	8266096	8266436	NA	NA	NA	NA	NA
PGEN_.00g132110	Scaffold_06	8274737	8282770	O00170	AIP_HUMAN	AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9)	GO:0003713; GO:0003755; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0006805; GO:0008134; GO:0010738; GO:0016020; GO:0017162; GO:0022417; GO:0034751; GO:0035722; GO:0036004; GO:0051082; GO:0051344	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g132120	Scaffold_06	8284686	8328313	B0W2S0	CLU_CULQU	Clustered mitochondria protein homolog	GO:0005737; GO:0048312	cytoplasm [GO:0005737]; intracellular distribution of mitochondria [GO:0048312]
PGEN_.00g132130	Scaffold_06	8338802	8350584	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g132140	Scaffold_06	8367601	8379508	A7SG73	NADC_NEMVE	Nicotinate-nucleotide pyrophosphorylase [carboxylating] (EC 2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]) (QAPRTase) (Fragment)	GO:0004514; GO:0005737; GO:0009435; GO:0034213	cytoplasm [GO:0005737]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; quinolinate catabolic process [GO:0034213]
PGEN_.00g132150	Scaffold_06	8379866	8393829	Q99MP8	BRAP_MOUSE	BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING-type E3 ubiquitin transferase BRAP2)	GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0031965; GO:0042802; GO:0061630	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; Ras protein signal transduction [GO:0007265]
PGEN_.00g132160	Scaffold_06	8405709	8411869	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g132170	Scaffold_06	8439221	8439535	NA	NA	NA	NA	NA
PGEN_.00g132180	Scaffold_06	8439668	8440231	NA	NA	NA	NA	NA
PGEN_.00g132190	Scaffold_06	8455948	8461064	NA	NA	NA	NA	NA
PGEN_.00g132200	Scaffold_06	8504102	8511592	NA	NA	NA	NA	NA
PGEN_.00g132210	Scaffold_06	8548181	8554022	Q15399	TLR1_HUMAN	Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281)	GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0034130; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0038123; GO:0042116; GO:0042495; GO:0042535; GO:0042802; GO:0045087; GO:0045121; GO:0045410; GO:0046982; GO:0071723; GO:0071727; GO:2000484	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; cell activation [GO:0001775]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR1:TLR2 signaling pathway [GO:0038123]
PGEN_.00g132220	Scaffold_06	8561026	8576568	Q19980	GCH1_CAEEL	GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I)	GO:0003934; GO:0005525; GO:0005737; GO:0006585; GO:0006729; GO:0008270; GO:0035998; GO:0042438; GO:0046654	"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dopamine biosynthetic process from tyrosine [GO:0006585]; melanin biosynthetic process [GO:0042438]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]"
PGEN_.00g132230	Scaffold_06	8589103	8606157	NA	NA	NA	NA	NA
PGEN_.00g132240	Scaffold_06	8606194	8614648	NA	NA	NA	NA	NA
PGEN_.00g132250	Scaffold_06	8619258	8619524	NA	NA	NA	NA	NA
PGEN_.00g132260	Scaffold_06	8633516	8660119	Q2EI20	REST_DANRE	RE1-silencing transcription factor (Neural-restrictive silencer factor)	GO:0000381; GO:0001666; GO:0001764; GO:0003676; GO:0005634; GO:0005737; GO:0007626; GO:0010629; GO:0014043; GO:0021610; GO:0021754; GO:0021785; GO:0042551; GO:0045666; GO:0045667; GO:0045879; GO:0045892; GO:0046872; GO:0060831; GO:0097475	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve morphogenesis [GO:0021610]; facial nucleus development [GO:0021754]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron maturation [GO:0014043]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]"
PGEN_.00g132270	Scaffold_06	8674963	8708685	Q6ZG77	DCDA_ORYSJ	"Probable diaminopimelate decarboxylase, chloroplastic (DAP decarboxylase) (DAPDC) (EC 4.1.1.20)"	GO:0008836; GO:0009089; GO:0009507	chloroplast [GO:0009507]; diaminopimelate decarboxylase activity [GO:0008836]; lysine biosynthetic process via diaminopimelate [GO:0009089]
PGEN_.00g132280	Scaffold_06	8759047	8782243	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g132290	Scaffold_06	8804463	8806544	NA	NA	NA	NA	NA
PGEN_.00g132300	Scaffold_06	8839184	8839507	NA	NA	NA	NA	NA
PGEN_.00g132310	Scaffold_06	8839694	8839981	NA	NA	NA	NA	NA
PGEN_.00g132320	Scaffold_06	8873979	8876797	NA	NA	NA	NA	NA
PGEN_.00g132330	Scaffold_06	8897000	8899067	NA	NA	NA	NA	NA
PGEN_.00g132340	Scaffold_06	8904268	8904861	NA	NA	NA	NA	NA
PGEN_.00g132350	Scaffold_06	8905174	8908586	NA	NA	NA	NA	NA
PGEN_.00g132360	Scaffold_06	8932847	8935686	NA	NA	NA	NA	NA
PGEN_.00g132370	Scaffold_06	8936356	8940200	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g132380	Scaffold_06	8948321	8961502	NA	NA	NA	NA	NA
PGEN_.00g132390	Scaffold_06	8964200	8964496	NA	NA	NA	NA	NA
PGEN_.00g132400	Scaffold_06	8964922	8986933	NA	NA	NA	NA	NA
PGEN_.00g132410	Scaffold_06	8995847	9026134	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g132420	Scaffold_06	9045645	9046059	NA	NA	NA	NA	NA
PGEN_.00g132430	Scaffold_06	9063849	9065107	NA	NA	NA	NA	NA
PGEN_.00g132440	Scaffold_06	9066808	9097672	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g132450	Scaffold_06	9124343	9138092	Q55GU0	Y9955_DICDI	Probable serine/threonine-protein kinase DDB_G0267514 (EC 2.7.11.1)	GO:0004674; GO:0005524	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g132460	Scaffold_06	9152673	9153917	A5A4K9	GHSR_RABIT	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GO:0001616; GO:0005886; GO:0008154; GO:0008343; GO:0009755; GO:0009986; GO:0016021; GO:0016520; GO:0030252; GO:0032094; GO:0032100; GO:0032691; GO:0032869; GO:0040018; GO:0042536; GO:0043005; GO:0043568; GO:0045121; GO:0045409; GO:0046697; GO:0050728; GO:0051963	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; decidualization [GO:0046697]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of appetite [GO:0032100]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of synapse assembly [GO:0051963]; response to food [GO:0032094]
PGEN_.00g132470	Scaffold_06	9161567	9165069	NA	NA	NA	NA	NA
PGEN_.00g132480	Scaffold_06	9170849	9184041	Q7TNV1	TLC3B_MOUSE	Ceramide synthase (EC 2.3.1.-) (Protein FAM57B) (TLC domain-containing protein 3B)	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0016021; GO:0045599; GO:0046513; GO:0050291	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; negative regulation of fat cell differentiation [GO:0045599]
PGEN_.00g132490	Scaffold_06	9198958	9211271	Q96ES7	SGF29_HUMAN	SAGA-associated factor 29 (Coiled-coil domain-containing protein 101) (SAGA complex-associated factor 29)	GO:0000124; GO:0001135; GO:0005671; GO:0016573; GO:0019899; GO:0035064; GO:0043966; GO:0047485; GO:0070461; GO:0071169	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; protein N-terminus binding [GO:0047485]; RNA polymerase II transcription regulator recruiting activity [GO:0001135]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]
PGEN_.00g132500	Scaffold_06	9220250	9224536	P49658	KCNJ6_MESAU	"G protein-activated inward rectifier potassium channel 2 (GIRK-2) (Inward rectifier K(+) channel Kir3.2) (KATP-2) (Potassium channel, inwardly rectifying subfamily J member 6)"	GO:0015467; GO:0016021; GO:0034765	integral component of membrane [GO:0016021]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g132510	Scaffold_06	9232592	9244716	P25326	CATS_BOVIN	Cathepsin S (EC 3.4.22.27)	GO:0001968; GO:0002250; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0005770; GO:0010447; GO:0016485; GO:0030574; GO:0034769; GO:0043236; GO:0043394; GO:0048002; GO:0051603; GO:0097067; GO:2001259	extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; proteoglycan binding [GO:0043394]; adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; positive regulation of cation channel activity [GO:2001259]; protein processing [GO:0016485]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to acidic pH [GO:0010447]
PGEN_.00g132520	Scaffold_06	9255427	9257685	P48542	KCNJ6_MOUSE	"G protein-activated inward rectifier potassium channel 2 (GIRK-2) (Inward rectifier K(+) channel Kir3.2) (Potassium channel, inwardly rectifying subfamily J member 6)"	GO:0001965; GO:0005242; GO:0005737; GO:0009986; GO:0015467; GO:0030424; GO:0030425; GO:0032809; GO:0034765; GO:0098688; GO:0099056; GO:1990573	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; G-protein alpha-subunit binding [GO:0001965]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g132530	Scaffold_06	9264613	9279981	Q8NHS9	SPT22_HUMAN	Spermatogenesis-associated protein 22 (Testis development protein NYD-SP20)	GO:0000711; GO:0005694; GO:0007129; GO:0007276	chromosome [GO:0005694]; gamete generation [GO:0007276]; meiotic DNA repair synthesis [GO:0000711]; synapsis [GO:0007129]
PGEN_.00g132540	Scaffold_06	9281384	9348453	P61406	EST1A_MOUSE	Telomerase-binding protein EST1A (EC 3.1.-.-) (EST1-like protein A) (Ever shorter telomeres 1A) (Smg-6 homolog) (Telomerase subunit EST1A)	GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0007004; GO:0032204; GO:0032210; GO:0035145; GO:0042162; GO:0043021; GO:0046872; GO:0070034; GO:0070182; GO:1904354	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere maintenance via telomerase [GO:0007004]"
PGEN_.00g132550	Scaffold_06	9359059	9361789	NA	NA	NA	NA	NA
PGEN_.00g132560	Scaffold_06	9362244	9366085	NA	NA	NA	NA	NA
PGEN_.00g132570	Scaffold_06	9375331	9396558	O18973	RABX5_BOVIN	Rab5 GDP/GTP exchange factor (Rabex-5)	GO:0003677; GO:0005769; GO:0006897; GO:0008270; GO:0015031; GO:0055037	early endosome [GO:0005769]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein transport [GO:0015031]
PGEN_.00g132580	Scaffold_06	9396636	9400454	NA	NA	NA	NA	NA
PGEN_.00g132590	Scaffold_06	9400497	9404487	NA	NA	NA	NA	NA
PGEN_.00g132600	Scaffold_06	9413373	9416417	Q5TF39	MFS4B_HUMAN	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g132610	Scaffold_06	9427664	9428008	NA	NA	NA	NA	NA
PGEN_.00g132620	Scaffold_06	9442278	9443501	NA	NA	NA	NA	NA
PGEN_.00g132630	Scaffold_06	9453029	9455194	NA	NA	NA	NA	NA
PGEN_.00g132640	Scaffold_06	9470037	9474022	Q3T9E4	TGTP2_MOUSE	T-cell-specific guanine nucleotide triphosphate-binding protein 2 (EC 3.6.5.-) (Interferon-gamma-inducible GTPase Ifggb6 protein) (T-cell-specific guanine nucleotide triphosphate-binding protein)	GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0006952; GO:0035458; GO:0045087	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-beta [GO:0035458]; defense response [GO:0006952]; innate immune response [GO:0045087]
PGEN_.00g132650	Scaffold_06	9474068	9495986	Q5SPX3	RN215_MOUSE	RING finger protein 215	GO:0005634; GO:0005737; GO:0005770; GO:0005794; GO:0006511; GO:0016021; GO:0046872; GO:0051788; GO:0061630	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; response to misfolded protein [GO:0051788]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g132660	Scaffold_06	9494800	9501671	NA	NA	NA	NA	NA
PGEN_.00g132670	Scaffold_06	9504705	9505043	NA	NA	NA	NA	NA
PGEN_.00g132680	Scaffold_06	9507940	9513292	NA	NA	NA	NA	NA
PGEN_.00g132690	Scaffold_06	9539487	9555280	P04836	CBPE_BOVIN	Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase)	GO:0003214; GO:0004181; GO:0005615; GO:0005794; GO:0006518; GO:0008270; GO:0016055; GO:0016485; GO:0030070; GO:0030072; GO:0030658; GO:0030667; GO:0033366; GO:0042043; GO:0050839; GO:0072657	extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; cell adhesion molecule binding [GO:0050839]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; zinc ion binding [GO:0008270]; cardiac left ventricle morphogenesis [GO:0003214]; insulin processing [GO:0030070]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055]
PGEN_.00g132700	Scaffold_06	9561019	9569091	Q8N1G4	LRC47_HUMAN	Leucine-rich repeat-containing protein 47	GO:0003723; GO:0004826	phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]
PGEN_.00g132710	Scaffold_06	9581291	9609689	Q7K556	TTD14_DROME	TRPL translocation defect protein 14	GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300	cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]
PGEN_.00g132720	Scaffold_06	9614661	9623993	NA	NA	NA	NA	NA
PGEN_.00g132730	Scaffold_06	9633409	9640358	P46635	THTR_CRIGR	Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese)	GO:0004792; GO:0005759; GO:0008097; GO:0035928; GO:0051029	mitochondrial matrix [GO:0005759]; 5S rRNA binding [GO:0008097]; thiosulfate sulfurtransferase activity [GO:0004792]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029]
PGEN_.00g132740	Scaffold_06	9644368	9655508	Q91VA6	PDIP2_MOUSE	Polymerase delta-interacting protein 2	GO:0003677; GO:0005634; GO:0005739; GO:0016242; GO:0030674; GO:0042645; GO:0045931; GO:0070584	"mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]"
PGEN_.00g132750	Scaffold_06	9661938	9662387	NA	NA	NA	NA	NA
PGEN_.00g132760	Scaffold_06	9673064	9674707	NA	NA	NA	NA	NA
PGEN_.00g132770	Scaffold_06	9679451	9681472	NA	NA	NA	NA	NA
PGEN_.00g132780	Scaffold_06	9687378	9694171	NA	NA	NA	NA	NA
PGEN_.00g132790	Scaffold_06	9699226	9699938	NA	NA	NA	NA	NA
PGEN_.00g132800	Scaffold_06	9801240	9803144	P07898	PGCA_CHICK	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g132810	Scaffold_06	9814182	9827004	Q9ES88	S13A2_MOUSE	Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g132820	Scaffold_06	9832145	9832513	NA	NA	NA	NA	NA
PGEN_.00g132830	Scaffold_06	9847849	9860898	Q9QZ25	VNN3_MOUSE	Vascular non-inflammatory molecule 3 (Vanin-3) (EC 3.5.1.92)	GO:0005615; GO:0005886; GO:0015939; GO:0017159; GO:0031225	anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; pantetheine hydrolase activity [GO:0017159]; pantothenate metabolic process [GO:0015939]
PGEN_.00g132840	Scaffold_06	9876123	9883338	Q6GM59	MOT12_XENLA	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0015293; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]
PGEN_.00g132850	Scaffold_06	9887635	9909837	NA	NA	NA	NA	NA
PGEN_.00g132860	Scaffold_06	9950029	9964970	Q9GZT4	SRR_HUMAN	Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17)	GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006563; GO:0006564; GO:0007420; GO:0007568; GO:0008721; GO:0009069; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042803; GO:0042866; GO:0043025; GO:0043278; GO:0045177; GO:0051289; GO:0070178; GO:0070179	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069]
PGEN_.00g132870	Scaffold_06	9989535	10016750	Q54HH2	SRR_DICDI	Probable serine racemase (EC 4.3.1.17) (EC 4.3.1.18) (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (L-serine ammonia-lyase) (L-serine dehydratase)	GO:0000287; GO:0003941; GO:0005524; GO:0005737; GO:0006563; GO:0008721; GO:0018114; GO:0018249; GO:0030170; GO:0030378; GO:0042866; GO:0070179	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; D-serine biosynthetic process [GO:0070179]; L-serine metabolic process [GO:0006563]; protein dehydration [GO:0018249]; pyruvate biosynthetic process [GO:0042866]
PGEN_.00g132880	Scaffold_06	10029043	10030113	NA	NA	NA	NA	NA
PGEN_.00g132890	Scaffold_06	10030251	10030793	NA	NA	NA	NA	NA
PGEN_.00g132900	Scaffold_06	10034648	10035145	NA	NA	NA	NA	NA
PGEN_.00g132910	Scaffold_06	10035200	10037712	P63240	NEC1_MUSCO	Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Furin homolog) (PC3) (Prohormone convertase 1) (Propeptide-processing protease) (Proprotein convertase 1) (PC1)	GO:0004252; GO:0005615; GO:0016020; GO:0016485; GO:0016486; GO:0030133; GO:0043005	extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]
PGEN_.00g132920	Scaffold_06	10042951	10045721	P29119	FURI1_XENLA	Furin-1 (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE)	GO:0004252; GO:0005576; GO:0005794; GO:0005886; GO:0010008; GO:0016021; GO:0046872; GO:1901394	endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; positive regulation of transforming growth factor beta1 activation [GO:1901394]
PGEN_.00g132930	Scaffold_06	10063517	10074095	NA	NA	NA	NA	NA
PGEN_.00g132940	Scaffold_06	10104535	10104792	NA	NA	NA	NA	NA
PGEN_.00g132950	Scaffold_06	10105095	10113518	P63239	NEC1_MOUSE	Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Furin homolog) (PC3) (Prohormone convertase 1) (Propeptide-processing protease) (Proprotein convertase 1) (PC1)	GO:0004175; GO:0004252; GO:0005615; GO:0005788; GO:0016020; GO:0016485; GO:0016486; GO:0030133; GO:0034774; GO:0042802; GO:0043005; GO:0043043	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]
PGEN_.00g132960	Scaffold_06	10130312	10134868	Q4TU93	MRC2_RAT	C-type mannose receptor 2 (Endocytic receptor 180) (Macrophage mannose receptor 2) (CD antigen CD280)	GO:0004888; GO:0005518; GO:0005886; GO:0006897; GO:0016021; GO:0030246; GO:0030574	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]
PGEN_.00g132970	Scaffold_06	10139033	10148598	NA	NA	NA	NA	NA
PGEN_.00g132980	Scaffold_06	10155679	10165937	NA	NA	NA	NA	NA
PGEN_.00g132990	Scaffold_06	10171734	10181102	Q9NSA2	KCND1_HUMAN	Potassium voltage-gated channel subfamily D member 1 (Voltage-gated potassium channel subunit Kv4.1)	GO:0005249; GO:0005250; GO:0005886; GO:0008076; GO:0016021; GO:0030425; GO:0034765; GO:0043025; GO:0046872; GO:0051260; GO:0061337; GO:0071805	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]; cardiac conduction [GO:0061337]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g133000	Scaffold_06	10182526	10182777	NA	NA	NA	NA	NA
PGEN_.00g133010	Scaffold_06	10183163	10183615	NA	NA	NA	NA	NA
PGEN_.00g133020	Scaffold_06	10211690	10216352	NA	NA	NA	NA	NA
PGEN_.00g133030	Scaffold_06	10216495	10217283	Q6XQH0	G3ST2_MOUSE	"Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2)"	GO:0001733; GO:0008146; GO:0009101; GO:0009247; GO:0016020; GO:0016021; GO:0032580; GO:0050694; GO:0051923	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; sulfation [GO:0051923]
PGEN_.00g133040	Scaffold_06	10229104	10230112	NA	NA	NA	NA	NA
PGEN_.00g133050	Scaffold_06	10236345	10239794	NA	NA	NA	NA	NA
PGEN_.00g133060	Scaffold_06	10239904	10248621	NA	NA	NA	NA	NA
PGEN_.00g133070	Scaffold_06	10250889	10254402	NA	NA	NA	NA	NA
PGEN_.00g133080	Scaffold_06	10257931	10259895	P16354	PA23_HELSU	Phospholipase A2 isozymes PA3A/PA3B/PA5 (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase)	GO:0004623; GO:0005576; GO:0006644; GO:0016042; GO:0046872; GO:0050482; GO:0102567; GO:0102568	"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]"
PGEN_.00g133090	Scaffold_06	10262419	10288442	A8WHP3	SC5A9_DANRE	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	GO:0005412; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]
PGEN_.00g133100	Scaffold_06	10292562	10306691	NA	NA	NA	NA	NA
PGEN_.00g133110	Scaffold_06	10318685	10329358	P56839	PEPM_MYTED	Phosphoenolpyruvate phosphomutase (PEP mutase) (PEP phosphomutase) (Phosphoenolpyruvate mutase) (EC 5.4.2.9)	GO:0032923; GO:0046872; GO:0050188	metal ion binding [GO:0046872]; phosphoenolpyruvate mutase activity [GO:0050188]; organic phosphonate biosynthetic process [GO:0032923]
PGEN_.00g133120	Scaffold_06	10335267	10343691	Q5ZJU3	ASNS_CHICK	Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase)	GO:0004066; GO:0005524; GO:0005829; GO:0006529; GO:0006541; GO:0070981	cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]
PGEN_.00g133130	Scaffold_06	10364138	10388043	Q5TC82	RC3H1_HUMAN	Roquin-1 (Roquin) (EC 2.3.2.27) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1) (RING finger protein 198)	GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0001782; GO:0002634; GO:0002635; GO:0003723; GO:0003725; GO:0003730; GO:0004842; GO:0008270; GO:0010494; GO:0010608; GO:0030889; GO:0033962; GO:0035198; GO:0035613; GO:0042098; GO:0043029; GO:0043488; GO:0045623; GO:0046007; GO:0048535; GO:0048536; GO:0050852; GO:0050856; GO:0061014; GO:0061158; GO:0061470; GO:0061630; GO:0071347; GO:1901224; GO:2000320; GO:2000628	"cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; cytoplasmic mRNA processing body assembly [GO:0033962]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]"
PGEN_.00g133140	Scaffold_06	10394983	10420448	P58021	TM9S2_MOUSE	Transmembrane 9 superfamily member 2	GO:0005794; GO:0005856; GO:0010008; GO:0016021; GO:0030054; GO:0045202; GO:0072657	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; protein localization to membrane [GO:0072657]
PGEN_.00g133150	Scaffold_06	10425338	10452365	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g133160	Scaffold_06	10457401	10463552	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g133170	Scaffold_06	10475887	10499435	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g133180	Scaffold_06	10508613	10516408	NA	NA	NA	NA	NA
PGEN_.00g133190	Scaffold_06	10518353	10519549	NA	NA	NA	NA	NA
PGEN_.00g133200	Scaffold_06	10522061	10524232	NA	NA	NA	NA	NA
PGEN_.00g133210	Scaffold_06	10524886	10531459	NA	NA	NA	NA	NA
PGEN_.00g133220	Scaffold_06	10533587	10545950	Q03567	SL172_CAEEL	Uncharacterized transporter slc-17.2	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g133230	Scaffold_06	10569254	10591048	Q9MZD1	S17A5_SHEEP	Sialin (Membrane glycoprotein SP55) (Sodium/sialic acid cotransporter) (Solute carrier family 17 member 5)	GO:0005765; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]
PGEN_.00g133240	Scaffold_06	10603773	10606698	Q86XN6	ZN761_HUMAN	Zinc finger protein 761	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g133250	Scaffold_06	10617826	10621632	O61366	GPRS_DROME	Serine-enriched protein		
PGEN_.00g133260	Scaffold_06	10635685	10644304	Q5E9T8	KIME_BOVIN	Mevalonate kinase (MK) (EC 2.7.1.36)	GO:0000287; GO:0004496; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0019287; GO:0042802; GO:0050728	"cytosol [GO:0005829]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; negative regulation of inflammatory response [GO:0050728]"
PGEN_.00g133270	Scaffold_06	10644499	10659040	Q9D273	MMAB_MOUSE	"Corrinoid adenosyltransferase (EC 2.5.1.17) (Cob(II)alamin adenosyltransferase) (Cob(II)yrinic acid a,c-diamide adenosyltransferase) (Cobinamide/cobalamin adenosyltransferase) (Methylmalonic aciduria type B homolog)"	GO:0005524; GO:0005739; GO:0008817; GO:0009235; GO:0009236; GO:0031419	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin binding [GO:0031419]; cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]"
PGEN_.00g133280	Scaffold_06	10664318	10665661	Q5IS75	ACHB3_PANTR	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g133290	Scaffold_06	10671268	10678044	Q5M865	PAGR1_RAT	PAXIP1-associated glutamate-rich protein 1 (PAXIP1-associated protein 1) (PTIP-associated protein 1)	GO:0005634; GO:0006281; GO:0006310; GO:0030331; GO:0033148; GO:0035097; GO:0044666; GO:0045944; GO:0048304; GO:0051568; GO:0060717; GO:0071557; GO:1902749; GO:1902808; GO:2001022	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; chorion development [GO:0060717]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H3-K27 demethylation [GO:0071557]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle G2/M phase transition [GO:1902749]
PGEN_.00g133300	Scaffold_06	10678201	10706550	Q6P3R1	KIF22_XENTR	Kinesin-like protein KIF22 (Chromokinesin kid)	GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g133310	Scaffold_06	10712319	10715846	Q8WYQ3	CHC10_HUMAN	"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial (Protein N27C7-4)"	GO:0005634; GO:0005739; GO:0005758; GO:0006119; GO:0007005; GO:0030322; GO:0051457; GO:0061617; GO:0065003; GO:0090144; GO:0099558; GO:1901030; GO:1903109; GO:1903852	MICOS complex [GO:0061617]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; maintenance of protein location in nucleus [GO:0051457]; maintenance of synapse structure [GO:0099558]; mitochondrial nucleoid organization [GO:0090144]; mitochondrion organization [GO:0007005]; oxidative phosphorylation [GO:0006119]; positive regulation of cristae formation [GO:1903852]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrial transcription [GO:1903109]; protein-containing complex assembly [GO:0065003]; stabilization of membrane potential [GO:0030322]
PGEN_.00g133320	Scaffold_06	10720368	10725011	NA	NA	NA	NA	NA
PGEN_.00g133330	Scaffold_06	10750467	10789559	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g133340	Scaffold_06	10800916	10802925	Q80VI1	TRI56_MOUSE	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0045087; GO:0046597; GO:0051607; GO:0061630; GO:0070534; GO:1902187	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
PGEN_.00g133350	Scaffold_06	10804156	10804461	O39828	MREP_FBNY2	Master replication protein (M-Rep) (EC 2.7.7.-) (EC 3.1.21.-) (EC 3.6.1.3) (ATP-dependent helicase C2) (Replication-associated protein 2) (Rep2)	GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0006260; GO:0016779; GO:0016888; GO:0018142; GO:0042025; GO:0046872	"host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA replication [GO:0006260]; protein-DNA covalent cross-linking [GO:0018142]"
PGEN_.00g133360	Scaffold_06	10811262	10822629	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g133370	Scaffold_06	10828259	10846113	NA	NA	NA	NA	NA
PGEN_.00g133380	Scaffold_06	10979083	10979898	NA	NA	NA	NA	NA
PGEN_.00g133390	Scaffold_06	10991487	10992467	NA	NA	NA	NA	NA
PGEN_.00g133400	Scaffold_06	10999250	11005741	Q6DFS0	TMX2_XENTR	Thioredoxin-related transmembrane protein 2 (Thioredoxin domain-containing protein 14)	GO:0005623; GO:0016021; GO:0045454	cell [GO:0005623]; integral component of membrane [GO:0016021]; cell redox homeostasis [GO:0045454]
PGEN_.00g133410	Scaffold_06	11012577	11067486	Q503L9	NXN_DANRE	Nucleoredoxin (EC 1.8.1.8)	GO:0005623; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0045454; GO:0047134; GO:0072358	cell [GO:0005623]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]
PGEN_.00g133420	Scaffold_06	11074351	11088280	Q3B7D3	TECT2_RAT	Tectonic-2	GO:0005737; GO:0005856; GO:0007224; GO:0016021; GO:0036038; GO:0060271; GO:1904491	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]
PGEN_.00g133430	Scaffold_06	11088431	11099067	Q5R6R6	PNDC1_PONAB	Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1)	GO:0000184; GO:0000289; GO:0003723; GO:0004535; GO:0005783; GO:0005789; GO:0016021; GO:0046872	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]"
PGEN_.00g133440	Scaffold_06	11104902	11106266	NA	NA	NA	NA	NA
PGEN_.00g133450	Scaffold_06	11106729	11107073	NA	NA	NA	NA	NA
PGEN_.00g133460	Scaffold_06	11109815	11126246	B2RXZ1	PNDC1_MOUSE	Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1)	GO:0000175; GO:0000184; GO:0000289; GO:0001825; GO:0003723; GO:0004535; GO:0005737; GO:0005783; GO:0005789; GO:0016021; GO:0046872	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]"
PGEN_.00g133470	Scaffold_06	11130290	11130526	NA	NA	NA	NA	NA
PGEN_.00g133480	Scaffold_06	11154505	11155566	NA	NA	NA	NA	NA
PGEN_.00g133490	Scaffold_06	11155674	11156045	NA	NA	NA	NA	NA
PGEN_.00g133500	Scaffold_06	11156087	11157231	NA	NA	NA	NA	NA
PGEN_.00g133510	Scaffold_06	11162148	11165963	NA	NA	NA	NA	NA
PGEN_.00g133520	Scaffold_06	11182472	11185448	Q6E2N3	TRI33_DANRE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]
PGEN_.00g133530	Scaffold_06	11241828	11243024	NA	NA	NA	NA	NA
PGEN_.00g133540	Scaffold_06	11250563	11269478	Q969Y0	NXPE3_HUMAN	NXPE family member 3 (Protein FAM55C)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g133550	Scaffold_06	11322188	11389086	Q9Y5R2	MMP24_HUMAN	Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24]	GO:0004222; GO:0005615; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]
PGEN_.00g133560	Scaffold_06	11397452	11412647	Q9JHI0	MMP19_MOUSE	Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI)	GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0005576; GO:0005615; GO:0005886; GO:0008270; GO:0009725; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0051591	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]
PGEN_.00g133570	Scaffold_06	11425358	11436343	NA	NA	NA	NA	NA
PGEN_.00g133580	Scaffold_06	11439962	11454824	NA	NA	NA	NA	NA
PGEN_.00g133590	Scaffold_06	11455402	11459531	NA	NA	NA	NA	NA
PGEN_.00g133600	Scaffold_06	11460343	11460579	NA	NA	NA	NA	NA
PGEN_.00g133610	Scaffold_06	11462949	11491961	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g133620	Scaffold_06	11525155	11541183	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g133630	Scaffold_06	11601920	11605394	A8WGS4	TLCD2_DANRE	TLC domain-containing protein 2	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g133640	Scaffold_06	11625175	11635186	NA	NA	NA	NA	NA
PGEN_.00g133650	Scaffold_06	11637814	11638407	NA	NA	NA	NA	NA
PGEN_.00g133660	Scaffold_06	11641402	11660211	NA	NA	NA	NA	NA
PGEN_.00g133670	Scaffold_06	11668977	11676996	NA	NA	NA	NA	NA
PGEN_.00g133680	Scaffold_06	11680216	11691182	Q7Q968	NTAQ1_ANOGA	Protein N-terminal glutamine amidohydrolase (EC 3.5.1.122) (Protein NH2-terminal glutamine deamidase) (N-terminal Gln amidase) (Nt(Q)-amidase) (Protein tungus)	GO:0005634; GO:0005829; GO:0006464; GO:0008418; GO:0070773	cytosol [GO:0005829]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773]; cellular protein modification process [GO:0006464]
PGEN_.00g133690	Scaffold_06	11691371	11692792	B5X0W9	ISOC1_SALSA	Isochorismatase domain-containing protein 1	GO:0003824	catalytic activity [GO:0003824]
PGEN_.00g133700	Scaffold_06	11696230	11699131	NA	NA	NA	NA	NA
PGEN_.00g133710	Scaffold_06	11701960	11710563	NA	NA	NA	NA	NA
PGEN_.00g133720	Scaffold_06	11714773	11728033	Q8NB50	ZFP62_HUMAN	Zinc finger protein 62 homolog (Zfp-62)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g133730	Scaffold_06	11747832	11786581	Q9CQ33	LZTR1_MOUSE	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	GO:0005794; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; Ras GTPase binding [GO:0017016]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]
PGEN_.00g133740	Scaffold_06	11787616	11788134	NA	NA	NA	NA	NA
PGEN_.00g133750	Scaffold_06	11788157	11792566	Q9CQ33	LZTR1_MOUSE	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	GO:0005794; GO:0012505; GO:0016567; GO:0017016; GO:0031463; GO:0046580; GO:0055038	Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; Ras GTPase binding [GO:0017016]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567]
PGEN_.00g133760	Scaffold_06	11805787	11850377	P00518	PHKG1_RABIT	"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1) (EC 2.7.11.26)"	GO:0004689; GO:0005516; GO:0005524; GO:0005964; GO:0005978; GO:0050321; GO:0098723	phosphorylase kinase complex [GO:0005964]; skeletal muscle myofibril [GO:0098723]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689]; tau-protein kinase activity [GO:0050321]; glycogen biosynthetic process [GO:0005978]
PGEN_.00g133770	Scaffold_06	11851817	11852212	NA	NA	NA	NA	NA
PGEN_.00g133780	Scaffold_06	11852254	11852481	NA	NA	NA	NA	NA
PGEN_.00g133790	Scaffold_06	11859473	11862737	NA	NA	NA	NA	NA
PGEN_.00g133800	Scaffold_06	11889052	11900828	O46644	CELA1_MACFA	Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1)	GO:0004252; GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g133810	Scaffold_06	11894289	11896171	P51910	APOD_MOUSE	Apolipoprotein D (Apo-D) (ApoD)	GO:0000302; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]
PGEN_.00g133820	Scaffold_06	11902355	11909853	NA	NA	NA	NA	NA
PGEN_.00g133830	Scaffold_06	11914190	11921135	P0CB97	NDUS8_PONAB	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit)"	GO:0005739; GO:0005747; GO:0006979; GO:0008137; GO:0032981; GO:0046872; GO:0051539	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979]"
PGEN_.00g133840	Scaffold_06	11992988	11993560	NA	NA	NA	NA	NA
PGEN_.00g133850	Scaffold_06	12012125	12058709	P48742	LHX1_HUMAN	LIM/homeobox protein Lhx1 (LIM homeobox protein 1) (Homeobox protein Lim-1) (hLim-1)	GO:0000790; GO:0000977; GO:0000981; GO:0001158; GO:0001655; GO:0001657; GO:0001658; GO:0001702; GO:0001705; GO:0001706; GO:0001822; GO:0003700; GO:0003714; GO:0005634; GO:0005667; GO:0006366; GO:0007267; GO:0007389; GO:0007399; GO:0008045; GO:0009653; GO:0009791; GO:0009880; GO:0009887; GO:0009948; GO:0009952; GO:0009953; GO:0010468; GO:0010842; GO:0021517; GO:0021527; GO:0021537; GO:0021549; GO:0021702; GO:0021871; GO:0021937; GO:0030182; GO:0032525; GO:0032991; GO:0035502; GO:0035846; GO:0035847; GO:0035849; GO:0035852; GO:0040019; GO:0044344; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048382; GO:0048646; GO:0048703; GO:0048793; GO:0060059; GO:0060065; GO:0060066; GO:0060067; GO:0060068; GO:0060322; GO:0060429; GO:0061205; GO:0072049; GO:0072050; GO:0072077; GO:0072177; GO:0072178; GO:0072197; GO:0072224; GO:0072278; GO:0072283; GO:0072284; GO:0090009; GO:0090190; GO:0097379; GO:0097477; GO:2000543; GO:2000744; GO:2000768	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell signaling [GO:0007267]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; cerebellum development [GO:0021549]; cervix development [GO:0060067]; comma-shaped body morphogenesis [GO:0072049]; dorsal spinal cord interneuron posterior axon guidance [GO:0097379]; dorsal/ventral pattern formation [GO:0009953]; ectoderm formation [GO:0001705]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; endoderm formation [GO:0001706]; epithelium development [GO:0060429]; forebrain regionalization [GO:0021871]; gastrulation with mouth forming second [GO:0001702]; head development [GO:0060322]; horizontal cell localization [GO:0035852]; kidney development [GO:0001822]; lateral motor column neuron migration [GO:0097477]; mesendoderm development [GO:0048382]; mesonephric duct development [GO:0072177]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerulus development [GO:0072224]; metanephric part of ureteric bud development [GO:0035502]; metanephric renal vesicle morphogenesis [GO:0072283]; metanephric S-shaped body morphogenesis [GO:0072284]; motor neuron axon guidance [GO:0008045]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct elongation [GO:0035849]; nephric duct morphogenesis [GO:0072178]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; oviduct development [GO:0060066]; oviduct epithelium development [GO:0035846]; paramesonephric duct development [GO:0061205]; pattern specification process [GO:0007389]; positive regulation of anterior head development [GO:2000744]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primitive streak formation [GO:0090009]; pronephros development [GO:0048793]; regulation of gene expression [GO:0010468]; renal vesicle morphogenesis [GO:0072077]; retina layer formation [GO:0010842]; S-shaped body morphogenesis [GO:0072050]; somite rostral/caudal axis specification [GO:0032525]; spinal cord association neuron differentiation [GO:0021527]; telencephalon development [GO:0021537]; transcription by RNA polymerase II [GO:0006366]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; uterine epithelium development [GO:0035847]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventral spinal cord development [GO:0021517]"
PGEN_.00g133860	Scaffold_06	12141985	12166377	Q90476	LHX1_DANRE	LIM/homeobox protein Lhx1 (LIM homeobox protein 1) (Homeobox protein Lim-1)	GO:0000977; GO:0000981; GO:0001655; GO:0001657; GO:0001702; GO:0001705; GO:0001706; GO:0001822; GO:0003700; GO:0003714; GO:0005634; GO:0006366; GO:0007267; GO:0007389; GO:0008045; GO:0009653; GO:0009791; GO:0009880; GO:0009948; GO:0009952; GO:0009953; GO:0010468; GO:0010842; GO:0021527; GO:0021549; GO:0021702; GO:0021871; GO:0021937; GO:0030182; GO:0032991; GO:0040019; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048646; GO:0060059; GO:0060322; GO:0060429; GO:0061205; GO:0072049; GO:0072050; GO:0072077; GO:0072178; GO:0090009; GO:0090190; GO:0097379; GO:0097477; GO:2000543; GO:2000744; GO:2000768	"nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; cell-cell signaling [GO:0007267]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; cerebellum development [GO:0021549]; comma-shaped body morphogenesis [GO:0072049]; dorsal spinal cord interneuron posterior axon guidance [GO:0097379]; dorsal/ventral pattern formation [GO:0009953]; ectoderm formation [GO:0001705]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endoderm formation [GO:0001706]; epithelium development [GO:0060429]; forebrain regionalization [GO:0021871]; gastrulation with mouth forming second [GO:0001702]; head development [GO:0060322]; kidney development [GO:0001822]; lateral motor column neuron migration [GO:0097477]; motor neuron axon guidance [GO:0008045]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct morphogenesis [GO:0072178]; neuron differentiation [GO:0030182]; paramesonephric duct development [GO:0061205]; pattern specification process [GO:0007389]; positive regulation of anterior head development [GO:2000744]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primitive streak formation [GO:0090009]; regulation of gene expression [GO:0010468]; renal vesicle morphogenesis [GO:0072077]; retina layer formation [GO:0010842]; S-shaped body morphogenesis [GO:0072050]; spinal cord association neuron differentiation [GO:0021527]; transcription by RNA polymerase II [GO:0006366]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]"
PGEN_.00g133870	Scaffold_06	12175303	12175614	NA	NA	NA	NA	NA
PGEN_.00g133880	Scaffold_06	12182353	12193600	Q5ZJU3	ASNS_CHICK	Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase)	GO:0004066; GO:0005524; GO:0005829; GO:0006529; GO:0006541; GO:0070981	cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]
PGEN_.00g133890	Scaffold_06	12194802	12195581	NA	NA	NA	NA	NA
PGEN_.00g133900	Scaffold_06	12195683	12196330	NA	NA	NA	NA	NA
PGEN_.00g133910	Scaffold_06	12241410	12250163	P62255	UB2G1_RAT	"Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed]"	GO:0000209; GO:0004842; GO:0005524; GO:0006511; GO:0016567; GO:0031625; GO:0044257; GO:0061631; GO:0070534; GO:0070936	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g133920	Scaffold_06	12261481	12334357	Q9Y4D8	HECD4_HUMAN	Probable E3 ubiquitin-protein ligase HECTD4 (EC 2.3.2.26) (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4)	GO:0004842; GO:0006006; GO:0016021; GO:0042593	integral component of membrane [GO:0016021]; ubiquitin-protein transferase activity [GO:0004842]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]
PGEN_.00g133930	Scaffold_06	12339088	12340820	Q6DC17	MZT2_DANRE	Mitotic-spindle organizing protein 2 (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2)	GO:0005737; GO:0005813; GO:0005819; GO:0008274	centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; spindle [GO:0005819]
PGEN_.00g133940	Scaffold_06	12342282	12357368	Q9GP32	ALF_ECHMU	Fructose-bisphosphate aldolase (EC 4.1.2.13)	GO:0004332; GO:0006096	fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]
PGEN_.00g133950	Scaffold_06	12365293	12371268	Q6P5U7	NWD2_MOUSE	NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)		
PGEN_.00g133960	Scaffold_06	12377115	12387791	Q9ULI1	NWD2_HUMAN	NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)		
PGEN_.00g133970	Scaffold_06	12399182	12401278	NA	NA	NA	NA	NA
PGEN_.00g133980	Scaffold_06	12443531	12447740	P12545	PLMN_MACMU	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
PGEN_.00g133990	Scaffold_06	12451085	12461824	NA	NA	NA	NA	NA
PGEN_.00g134000	Scaffold_06	12476959	12487124	NA	NA	NA	NA	NA
PGEN_.00g134010	Scaffold_06	12504530	12509891	NA	NA	NA	NA	NA
PGEN_.00g134020	Scaffold_06	12517180	12518040	NA	NA	NA	NA	NA
PGEN_.00g134030	Scaffold_06	12520219	12520596	NA	NA	NA	NA	NA
PGEN_.00g134040	Scaffold_06	12524452	12528033	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g134050	Scaffold_06	12530912	12531718	NA	NA	NA	NA	NA
PGEN_.00g134060	Scaffold_06	12544826	12576596	Q6XQH0	G3ST2_MOUSE	"Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2)"	GO:0001733; GO:0008146; GO:0009101; GO:0009247; GO:0016020; GO:0016021; GO:0032580; GO:0050694; GO:0051923	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; sulfation [GO:0051923]
PGEN_.00g134070	Scaffold_06	12580409	12610327	Q5SW45	MKS1_MOUSE	Meckel syndrome type 1 protein homolog	GO:0001843; GO:0003271; GO:0003279; GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0007368; GO:0008589; GO:0010669; GO:0016020; GO:0035869; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1901620; GO:1905515; GO:1990403; GO:2000095	"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum development [GO:0003279]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway [GO:0008589]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]"
PGEN_.00g134080	Scaffold_06	12614646	12630489	A7SLX5	DPH1_NEMVE	2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)	GO:0016740; GO:0017183	transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]
PGEN_.00g134090	Scaffold_06	12664739	12664993	NA	NA	NA	NA	NA
PGEN_.00g134100	Scaffold_06	12694080	12697151	O14529	CUX2_HUMAN	Homeobox protein cut-like 2 (Homeobox protein cux-2)	GO:0000122; GO:0000139; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0007614; GO:0010628; GO:0043565; GO:0048193; GO:0050775; GO:0050890; GO:0051965; GO:0061003; GO:0070062; GO:0071310; GO:2000463	"extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to organic substance [GO:0071310]; cognition [GO:0050890]; Golgi vesicle transport [GO:0048193]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of synapse assembly [GO:0051965]; short-term memory [GO:0007614]"
PGEN_.00g134110	Scaffold_06	12701240	12842784	Q5R8V1	CASP_PONAB	Protein CASP	GO:0006891; GO:0030173	integral component of Golgi membrane [GO:0030173]; intra-Golgi vesicle-mediated transport [GO:0006891]
PGEN_.00g134120	Scaffold_06	12843042	12875601	O08658	NUP88_RAT	Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup84) (Nucleoporin Nup88)	GO:0000055; GO:0000056; GO:0000278; GO:0005643; GO:0005654; GO:0006406; GO:0006606; GO:0006611; GO:0017056	nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]
PGEN_.00g134130	Scaffold_06	12880298	12883759	NA	NA	NA	NA	NA
PGEN_.00g134140	Scaffold_06	12894609	12921207	NA	NA	NA	NA	NA
PGEN_.00g134150	Scaffold_06	12921412	12947781	NA	NA	NA	NA	NA
PGEN_.00g134160	Scaffold_06	12958817	12962219	NA	NA	NA	NA	NA
PGEN_.00g134170	Scaffold_06	12966907	12999752	O08658	NUP88_RAT	Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup84) (Nucleoporin Nup88)	GO:0000055; GO:0000056; GO:0000278; GO:0005643; GO:0005654; GO:0006406; GO:0006606; GO:0006611; GO:0017056	nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]
PGEN_.00g134180	Scaffold_06	13000010	13140605	Q5R8V1	CASP_PONAB	Protein CASP	GO:0006891; GO:0030173	integral component of Golgi membrane [GO:0030173]; intra-Golgi vesicle-mediated transport [GO:0006891]
PGEN_.00g134190	Scaffold_06	13147970	13151039	O14529	CUX2_HUMAN	Homeobox protein cut-like 2 (Homeobox protein cux-2)	GO:0000122; GO:0000139; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0007614; GO:0010628; GO:0043565; GO:0048193; GO:0050775; GO:0050890; GO:0051965; GO:0061003; GO:0070062; GO:0071310; GO:2000463	"extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to organic substance [GO:0071310]; cognition [GO:0050890]; Golgi vesicle transport [GO:0048193]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of synapse assembly [GO:0051965]; short-term memory [GO:0007614]"
PGEN_.00g134200	Scaffold_06	13179412	13179666	NA	NA	NA	NA	NA
PGEN_.00g134210	Scaffold_06	13212056	13230167	A7SLX5	DPH1_NEMVE	2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)	GO:0016740; GO:0017183	transferase activity [GO:0016740]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]
PGEN_.00g134220	Scaffold_06	13235222	13266849	Q5SW45	MKS1_MOUSE	Meckel syndrome type 1 protein homolog	GO:0001843; GO:0003271; GO:0003279; GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0007368; GO:0008589; GO:0010669; GO:0016020; GO:0035869; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1901620; GO:1905515; GO:1990403; GO:2000095	"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum development [GO:0003279]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway [GO:0008589]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]"
PGEN_.00g134230	Scaffold_06	13272362	13272799	NA	NA	NA	NA	NA
PGEN_.00g134240	Scaffold_06	13302444	13303337	Q6XQH0	G3ST2_MOUSE	"Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2)"	GO:0001733; GO:0008146; GO:0009101; GO:0009247; GO:0016020; GO:0016021; GO:0032580; GO:0050694; GO:0051923	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; sulfation [GO:0051923]
PGEN_.00g134250	Scaffold_06	13314276	13315082	NA	NA	NA	NA	NA
PGEN_.00g134260	Scaffold_06	13318027	13321608	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g134270	Scaffold_06	13325525	13325902	NA	NA	NA	NA	NA
PGEN_.00g134280	Scaffold_06	13336226	13341587	NA	NA	NA	NA	NA
PGEN_.00g134290	Scaffold_06	13359023	13372624	P04630	CALL_CAEEL	Calmodulin-like protein	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g134300	Scaffold_06	13384215	13386457	NA	NA	NA	NA	NA
PGEN_.00g134310	Scaffold_06	13398574	13402847	P12545	PLMN_MACMU	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
PGEN_.00g134320	Scaffold_06	13445538	13447634	NA	NA	NA	NA	NA
PGEN_.00g134330	Scaffold_06	13476138	13492666	NA	NA	NA	NA	NA
PGEN_.00g134340	Scaffold_06	13492710	13494584	NA	NA	NA	NA	NA
PGEN_.00g134350	Scaffold_06	13496643	13499268	NA	NA	NA	NA	NA
PGEN_.00g134360	Scaffold_06	13499293	13499655	NA	NA	NA	NA	NA
PGEN_.00g134370	Scaffold_06	13514985	13516241	O74745	ANP1_SCHPO	Mannan polymerase II complex anp1 subunit (M-Pol II subunit anp1)	GO:0000032; GO:0000136; GO:0000137; GO:0005783; GO:0005789; GO:0005794; GO:0006487; GO:0097502	"alpha-1,6-mannosyltransferase complex [GO:0000136]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; cell wall mannoprotein biosynthetic process [GO:0000032]; mannosylation [GO:0097502]; protein N-linked glycosylation [GO:0006487]"
PGEN_.00g134380	Scaffold_06	13525596	13526852	O74745	ANP1_SCHPO	Mannan polymerase II complex anp1 subunit (M-Pol II subunit anp1)	GO:0000032; GO:0000136; GO:0000137; GO:0005783; GO:0005789; GO:0005794; GO:0006487; GO:0097502	"alpha-1,6-mannosyltransferase complex [GO:0000136]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; cell wall mannoprotein biosynthetic process [GO:0000032]; mannosylation [GO:0097502]; protein N-linked glycosylation [GO:0006487]"
PGEN_.00g134390	Scaffold_06	13533142	13534017	NA	NA	NA	NA	NA
PGEN_.00g134400	Scaffold_06	13548708	13578024	P61315	G3ST3_MOUSE	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g134410	Scaffold_06	13565803	13566132	NA	NA	NA	NA	NA
PGEN_.00g134420	Scaffold_06	13591475	13619660	Q9UA35	S28A3_EPTST	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)	GO:0005337; GO:0005887	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]
PGEN_.00g134430	Scaffold_06	13621197	13623973	P86959	KCP1_PINMA	BPTI/Kunitz domain-containing protein 1 (Prism serine protease inhibitor 1) (PSPI1)	GO:0004867; GO:0005576	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g134440	Scaffold_06	13634700	13637677	NA	NA	NA	NA	NA
PGEN_.00g134450	Scaffold_06	13644073	13648757	O43715	TRIA1_HUMAN	TP53-regulated inhibitor of apoptosis 1 (Protein 15E1.1) (WF-1) (p53-inducible cell-survival factor) (p53CSV)	GO:0002039; GO:0005654; GO:0005739; GO:0005758; GO:0006915; GO:0006977; GO:0015914; GO:0030330; GO:0032991; GO:0034644; GO:0042981; GO:0043066; GO:0043154; GO:0045944; GO:0048471; GO:0090201; GO:0097035; GO:1902166; GO:2001140	"mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; p53 binding [GO:0002039]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid transport [GO:0015914]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of membrane lipid distribution [GO:0097035]"
PGEN_.00g134460	Scaffold_06	13664059	13667329	NA	NA	NA	NA	NA
PGEN_.00g134470	Scaffold_06	13687110	13714486	P06867	PLMN_PIG	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771; GO:0052213	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; interaction with symbiont via secreted substance [GO:0052213]; tissue remodeling [GO:0048771]
PGEN_.00g134480	Scaffold_06	13734980	13735309	NA	NA	NA	NA	NA
PGEN_.00g134490	Scaffold_06	13738002	13738343	NA	NA	NA	NA	NA
PGEN_.00g134500	Scaffold_06	13738625	13740253	NA	NA	NA	NA	NA
PGEN_.00g134510	Scaffold_06	13757047	13772033	P14417	APOA_MACMU	Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-) (Fragment)	GO:0004252; GO:0006869	serine-type endopeptidase activity [GO:0004252]; lipid transport [GO:0006869]
PGEN_.00g134520	Scaffold_06	13775617	13778137	NA	NA	NA	NA	NA
PGEN_.00g134530	Scaffold_06	13783574	13801694	O35643	AP1B1_MOUSE	AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit)	GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019901; GO:0030131; GO:0030276; GO:0030665; GO:0043231; GO:0048268	clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; clathrin coat assembly [GO:0048268]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g134540	Scaffold_06	13803557	13806738	Q8VC48	PEX12_MOUSE	Peroxisome assembly protein 12 (Peroxin-12)	GO:0004842; GO:0005777; GO:0005778; GO:0005779; GO:0006513; GO:0007031; GO:0008022; GO:0008270; GO:0016558; GO:1990429	integral component of peroxisomal membrane [GO:0005779]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]
PGEN_.00g134550	Scaffold_06	13848011	13850763	NA	NA	NA	NA	NA
PGEN_.00g134560	Scaffold_06	13854903	13899904	O15943	CADN_DROME	Neural-cadherin (Cadherin-N) (dN-cadherin)	GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0008013; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]
PGEN_.00g134570	Scaffold_06	13902630	13921481	O15943	CADN_DROME	Neural-cadherin (Cadherin-N) (dN-cadherin)	GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0008013; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]
PGEN_.00g134580	Scaffold_06	13927088	13948073	NA	NA	NA	NA	NA
PGEN_.00g134590	Scaffold_06	13973367	13991722	E1BMP7	DNA2_BOVIN	DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)]	GO:0000076; GO:0000729; GO:0000784; GO:0003677; GO:0003678; GO:0003723; GO:0004518; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005760; GO:0006260; GO:0006264; GO:0006284; GO:0016890; GO:0017108; GO:0017116; GO:0033567; GO:0042645; GO:0043137; GO:0043139; GO:0043504; GO:0045740; GO:0046872; GO:0051539; GO:0071932; GO:1902990	"cytoplasm [GO:0005737]; gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]"
PGEN_.00g134600	Scaffold_06	13997319	14009475	NA	NA	NA	NA	NA
PGEN_.00g134610	Scaffold_06	14014279	14021208	Q54B10	REDA_DICDI	NADPH oxidoreductase A (EC 1.6.-.-)	GO:0003958; GO:0005829; GO:0007275; GO:0010181; GO:0016491; GO:0030587; GO:0050660; GO:0050661	cytosol [GO:0005829]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; multicellular organism development [GO:0007275]; sorocarp development [GO:0030587]
PGEN_.00g134620	Scaffold_06	14022730	14029949	Q54B10	REDA_DICDI	NADPH oxidoreductase A (EC 1.6.-.-)	GO:0003958; GO:0005829; GO:0007275; GO:0010181; GO:0016491; GO:0030587; GO:0050660; GO:0050661	cytosol [GO:0005829]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; multicellular organism development [GO:0007275]; sorocarp development [GO:0030587]
PGEN_.00g134630	Scaffold_06	14047517	14078486	Q9XY92	SPEE_DICDI	Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase)	GO:0004766; GO:0006596; GO:0008295; GO:0036360	spermidine synthase activity [GO:0004766]; polyamine biosynthetic process [GO:0006596]; sorocarp stalk morphogenesis [GO:0036360]; spermidine biosynthetic process [GO:0008295]
PGEN_.00g134640	Scaffold_06	14129656	14130234	NA	NA	NA	NA	NA
PGEN_.00g134650	Scaffold_06	14152162	14153412	NA	NA	NA	NA	NA
PGEN_.00g134660	Scaffold_06	14159068	14159936	NA	NA	NA	NA	NA
PGEN_.00g134670	Scaffold_06	14177454	14184171	NA	NA	NA	NA	NA
PGEN_.00g134680	Scaffold_06	14192115	14192645	NA	NA	NA	NA	NA
PGEN_.00g134690	Scaffold_06	14205452	14206069	NA	NA	NA	NA	NA
PGEN_.00g134700	Scaffold_06	14221459	14221998	A9XE49	IL17L_CRAGI	Interleukin 17-like protein (CgIL-17)	GO:0005125; GO:0005576	extracellular region [GO:0005576]; cytokine activity [GO:0005125]
PGEN_.00g134710	Scaffold_06	14224665	14225706	NA	NA	NA	NA	NA
PGEN_.00g134720	Scaffold_06	14237338	14237856	NA	NA	NA	NA	NA
PGEN_.00g134730	Scaffold_06	14244387	14244905	NA	NA	NA	NA	NA
PGEN_.00g134740	Scaffold_06	14248343	14248570	NA	NA	NA	NA	NA
PGEN_.00g134750	Scaffold_06	14249139	14249471	NA	NA	NA	NA	NA
PGEN_.00g134760	Scaffold_06	14250524	14251042	NA	NA	NA	NA	NA
PGEN_.00g134770	Scaffold_06	14254578	14260474	NA	NA	NA	NA	NA
PGEN_.00g134780	Scaffold_06	14265215	14267170	NA	NA	NA	NA	NA
PGEN_.00g134790	Scaffold_06	14288894	14352831	NA	NA	NA	NA	NA
PGEN_.00g134800	Scaffold_06	14354973	14362967	NA	NA	NA	NA	NA
PGEN_.00g134810	Scaffold_06	14374044	14397031	P18887	XRCC1_HUMAN	DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1)	GO:0000012; GO:0000724; GO:0000784; GO:0000790; GO:0001666; GO:0005634; GO:0005654; GO:0005730; GO:0006283; GO:0006284; GO:0006288; GO:0006297; GO:0006303; GO:0010033; GO:0010836; GO:0019899; GO:0021587; GO:0021766; GO:0032356; GO:0033194; GO:0042493; GO:0050882; GO:0061819; GO:0070522; GO:1903518; GO:1904877; GO:1905765; GO:1990414; GO:1990599	"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; base-excision repair, DNA ligation [GO:0006288]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; voluntary musculoskeletal movement [GO:0050882]"
PGEN_.00g134820	Scaffold_06	14398636	14400382	NA	NA	NA	NA	NA
PGEN_.00g134830	Scaffold_06	14414327	14423074	NA	NA	NA	NA	NA
PGEN_.00g134840	Scaffold_06	14432851	14494417	P26818	ARBK2_BOVIN	Beta-adrenergic receptor kinase 2 (Beta-ARK-2) (EC 2.7.11.15) (G-protein-coupled receptor kinase 3)	GO:0004703; GO:0005524; GO:0007165; GO:0031623; GO:0047696	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]
PGEN_.00g134850	Scaffold_06	14518406	14610428	P35626	ARBK2_HUMAN	Beta-adrenergic receptor kinase 2 (Beta-ARK-2) (EC 2.7.11.15) (G-protein-coupled receptor kinase 3)	GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0007165; GO:0007186; GO:0031623; GO:0047696	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; G protein-coupled receptor signaling pathway [GO:0007186]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]
PGEN_.00g134860	Scaffold_06	14543804	14544352	NA	NA	NA	NA	NA
PGEN_.00g134870	Scaffold_06	14616691	14628558	NA	NA	NA	NA	NA
PGEN_.00g134880	Scaffold_06	14650238	14654341	Q95JD5	ST1B1_CANLF	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (cSULT1B1) (EC 2.8.2.-)	GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008202; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g134890	Scaffold_06	14659924	14666150	P50226	ST1A2_HUMAN	Sulfotransferase 1A2 (ST1A2) (EC 2.8.2.1) (Aryl sulfotransferase 2) (Phenol sulfotransferase 2) (Phenol-sulfating phenol sulfotransferase 2) (P-PST 2)	GO:0004062; GO:0005829; GO:0006068; GO:0006584; GO:0006805; GO:0008146; GO:0008202; GO:0009309; GO:0018958; GO:0047894; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine biosynthetic process [GO:0009309]; catecholamine metabolic process [GO:0006584]; ethanol catabolic process [GO:0006068]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g134900	Scaffold_06	14667697	14670568	P05616	IOVO_CARRE	Ovomucoid (Fragment)	GO:0004867; GO:0005576	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g134910	Scaffold_06	14671399	14673660	NA	NA	NA	NA	NA
PGEN_.00g134920	Scaffold_06	14696785	14700735	NA	NA	NA	NA	NA
PGEN_.00g134930	Scaffold_06	14706508	14708943	Q5U258	GCNT3_XENLA	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (EC 2.4.1.102) (EC 2.4.1.148) (EC 2.4.1.150) (C2GnT-mucin type) (C2GnT-M)"	GO:0000139; GO:0003829; GO:0006486; GO:0008109; GO:0016021; GO:0047225	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0047225]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; protein glycosylation [GO:0006486]"
PGEN_.00g134940	Scaffold_06	14710865	14714640	NA	NA	NA	NA	NA
PGEN_.00g134950	Scaffold_06	14781578	14790299	Q5ZIW1	PEO1_CHICK	"Twinkle protein, mitochondrial (EC 3.6.4.12) (Progressive external ophthalmoplegia 1 protein homolog) (Twinkle mtDNA helicase)"	GO:0003697; GO:0005524; GO:0006264; GO:0042645; GO:0043139	mitochondrial nucleoid [GO:0042645]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; single-stranded DNA binding [GO:0003697]; mitochondrial DNA replication [GO:0006264]
PGEN_.00g134960	Scaffold_06	14801598	14802314	NA	NA	NA	NA	NA
PGEN_.00g134970	Scaffold_06	14819320	14822373	NA	NA	NA	NA	NA
PGEN_.00g134980	Scaffold_06	14831049	14831534	NA	NA	NA	NA	NA
PGEN_.00g134990	Scaffold_06	14839318	14847769	NA	NA	NA	NA	NA
PGEN_.00g135000	Scaffold_06	14853446	14878458	Q00169	PIPNA_HUMAN	Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)	GO:0005737; GO:0005829; GO:0006629; GO:0007409; GO:0007601; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0035722; GO:0070062; GO:1901611	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; axonogenesis [GO:0007409]; interleukin-12-mediated signaling pathway [GO:0035722]; lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601]
PGEN_.00g135010	Scaffold_06	14908334	14916615	Q7Z4N8	P4HA3_HUMAN	"Prolyl 4-hydroxylase subunit alpha-3 (4-PH alpha-3) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3)"	GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"
PGEN_.00g135020	Scaffold_06	14949074	14958991	C4N147	FABP1_DORPE	Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1)	GO:0005737; GO:0008289; GO:0016020	cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289]
PGEN_.00g135030	Scaffold_06	14969293	14969736	Q90W95	PTPS_POERE	6-pyruvoyl tetrahydrobiopterin synthase (PTP synthase) (PTPS) (EC 4.2.3.12)	GO:0003874; GO:0006729; GO:0046872	6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; metal ion binding [GO:0046872]; tetrahydrobiopterin biosynthetic process [GO:0006729]
PGEN_.00g135040	Scaffold_06	14972015	14972452	NA	NA	NA	NA	NA
PGEN_.00g135050	Scaffold_06	15002201	15025554	Q9ES88	S13A2_MOUSE	Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g135060	Scaffold_06	15028913	15032300	NA	NA	NA	NA	NA
PGEN_.00g135070	Scaffold_06	15044593	15045252	Q91WG0	EST2C_MOUSE	Acylcarnitine hydrolase (ACH M1) (EC 3.1.1.28) (Carboxylesterase 2) (CES 2) (Peroxisome proliferator-inducible acylcarnitine hydrolase)	GO:0005615; GO:0005783; GO:0043231; GO:0047619; GO:0052689	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; acylcarnitine hydrolase activity [GO:0047619]; carboxylic ester hydrolase activity [GO:0052689]
PGEN_.00g135080	Scaffold_06	15045431	15048304	NA	NA	NA	NA	NA
PGEN_.00g135090	Scaffold_06	15054236	15065798	Q9ES88	S13A2_MOUSE	Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g135100	Scaffold_06	15092277	15105539	Q86YT5	S13A5_HUMAN	Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter)	GO:0005654; GO:0005829; GO:0005886; GO:0015137; GO:0015141; GO:0015746; GO:0016021; GO:0017153	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]
PGEN_.00g135110	Scaffold_06	15113350	15116103	NA	NA	NA	NA	NA
PGEN_.00g135120	Scaffold_06	15167928	15176244	P61315	G3ST3_MOUSE	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g135130	Scaffold_06	15188882	15191818	NA	NA	NA	NA	NA
PGEN_.00g135140	Scaffold_06	15252353	15257352	NA	NA	NA	NA	NA
PGEN_.00g135150	Scaffold_06	15264205	15279250	Q6P2X9	MOT12_XENTR	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g135160	Scaffold_06	15294155	15309692	NA	NA	NA	NA	NA
PGEN_.00g135170	Scaffold_06	15314091	15314633	NA	NA	NA	NA	NA
PGEN_.00g135180	Scaffold_06	15327289	15328844	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g135190	Scaffold_06	15360211	15364207	NA	NA	NA	NA	NA
PGEN_.00g135200	Scaffold_06	15440425	15440703	NA	NA	NA	NA	NA
PGEN_.00g135210	Scaffold_06	15449755	15481383	O43586	PPIP1_HUMAN	Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1) (CD2-binding protein 1) (H-PIP)	GO:0001931; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0008092; GO:0016020; GO:0030027; GO:0032154; GO:0042802; GO:0045087; GO:0048471	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g135220	Scaffold_06	15489168	15517368	Q32NQ8	RNF10_XENLA	RING finger protein 10	GO:0005634; GO:0005737; GO:0010626; GO:0031643; GO:0044212; GO:0045944; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g135230	Scaffold_06	15524289	15530893	Q08E13	RNF10_BOVIN	RING finger protein 10	GO:0004842; GO:0005634; GO:0005737; GO:0031643; GO:0044212; GO:0045944; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]
PGEN_.00g135240	Scaffold_06	15532725	15535688	NA	NA	NA	NA	NA
PGEN_.00g135250	Scaffold_06	15535717	15540170	Q8N5U6	RNF10_HUMAN	RING finger protein 10	GO:0004842; GO:0005634; GO:0005737; GO:0010626; GO:0031643; GO:0044212; GO:0045893; GO:0045944; GO:0046872; GO:0051865	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]"
PGEN_.00g135260	Scaffold_06	15552307	15554908	NA	NA	NA	NA	NA
PGEN_.00g135270	Scaffold_06	15569439	15572036	P34456	YMD2_CAEEL	Uncharacterized protein F54H12.2	GO:0004748; GO:0005829; GO:0009263	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]"
PGEN_.00g135280	Scaffold_06	15600997	15606632	NA	NA	NA	NA	NA
PGEN_.00g135290	Scaffold_06	15637109	15637468	A1L1C5	URAD_XENLA	2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (OHCU decarboxylase) (EC 4.1.1.97) (Parahox neighbor) (Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase)	GO:0005777; GO:0006144; GO:0016831; GO:0019428; GO:0019628	peroxisome [GO:0005777]; carboxy-lyase activity [GO:0016831]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]
PGEN_.00g135300	Scaffold_06	15654125	15654502	NA	NA	NA	NA	NA
PGEN_.00g135310	Scaffold_06	15666737	15682310	NA	NA	NA	NA	NA
PGEN_.00g135320	Scaffold_06	15710961	15711311	NA	NA	NA	NA	NA
PGEN_.00g135330	Scaffold_06	15714052	15732211	NA	NA	NA	NA	NA
PGEN_.00g135340	Scaffold_06	15793937	15806470	Q0VCA7	OXSM_BOVIN	"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase)"	GO:0004315; GO:0005739; GO:0006633	mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid biosynthetic process [GO:0006633]
PGEN_.00g135350	Scaffold_06	15801495	15818190	NA	NA	NA	NA	NA
PGEN_.00g135360	Scaffold_06	15821138	15822487	Q8R4G9	ACHA3_MOUSE	Neuronal acetylcholine receptor subunit alpha-3	GO:0005887; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007171; GO:0007268; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0008144; GO:0014056; GO:0014069; GO:0015464; GO:0016020; GO:0022848; GO:0030054; GO:0030425; GO:0034220; GO:0035094; GO:0035095; GO:0042166; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0045211; GO:0048814; GO:0050877; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098981; GO:0099060; GO:1904315; GO:1905144; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; ion transmembrane transport [GO:0034220]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to drug [GO:0042493]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g135370	Scaffold_06	15828246	15841389	Q54KL5	WDR5_DICDI	WD repeat-containing protein 5 homolog	GO:0005634; GO:0035097; GO:0042393; GO:0048188; GO:0051568	histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone binding [GO:0042393]; histone H3-K4 methylation [GO:0051568]
PGEN_.00g135380	Scaffold_06	15853941	15854210	NA	NA	NA	NA	NA
PGEN_.00g135390	Scaffold_06	15856123	15856461	NA	NA	NA	NA	NA
PGEN_.00g135400	Scaffold_06	15859416	15859877	NA	NA	NA	NA	NA
PGEN_.00g135410	Scaffold_06	15864560	15865123	NA	NA	NA	NA	NA
PGEN_.00g135420	Scaffold_06	15921659	15934880	P28572	SC6A9_RAT	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)	GO:0001504; GO:0005283; GO:0005328; GO:0005886; GO:0014069; GO:0015187; GO:0015816; GO:0030285; GO:0032279; GO:0061537; GO:0098686; GO:0098688; GO:0099055; GO:0099056	"asymmetric synapse [GO:0032279]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; amino acid:sodium symporter activity [GO:0005283]; glycine transmembrane transporter activity [GO:0015187]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine secretion, neurotransmission [GO:0061537]; glycine transport [GO:0015816]; neurotransmitter uptake [GO:0001504]"
PGEN_.00g135430	Scaffold_06	15936103	15939300	P31651	S6A12_MOUSE	Sodium- and chloride-dependent betaine transporter (Na(+)/Cl(-) betaine/GABA transporter) (Sodium- and chloride-dependent GABA transporter 2) (GAT-2) (Solute carrier family 6 member 12)	GO:0005332; GO:0005623; GO:0005886; GO:0005887; GO:0009992; GO:0016021; GO:0042165; GO:0043005	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; cellular water homeostasis [GO:0009992]
PGEN_.00g135440	Scaffold_06	15965041	15976663	NA	NA	NA	NA	NA
PGEN_.00g135450	Scaffold_06	15981526	15984834	NA	NA	NA	NA	NA
PGEN_.00g135460	Scaffold_06	15988669	16026017	NA	NA	NA	NA	NA
PGEN_.00g135470	Scaffold_06	16041471	16043986	NA	NA	NA	NA	NA
PGEN_.00g135480	Scaffold_06	16060463	16092734	Q9Y345	SC6A5_HUMAN	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g135490	Scaffold_06	16113383	16113733	NA	NA	NA	NA	NA
PGEN_.00g135500	Scaffold_06	16142080	16142376	NA	NA	NA	NA	NA
PGEN_.00g135510	Scaffold_06	16149393	16150707	NA	NA	NA	NA	NA
PGEN_.00g135520	Scaffold_06	16162089	16174410	Q9P0Z9	SOX_HUMAN	Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase)	GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0006625; GO:0008115; GO:0033514; GO:0046653; GO:0050031; GO:0055114	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554]; oxidation-reduction process [GO:0055114]; protein targeting to peroxisome [GO:0006625]; tetrahydrofolate metabolic process [GO:0046653]
PGEN_.00g135530	Scaffold_06	16183090	16191864	NA	NA	NA	NA	NA
PGEN_.00g135540	Scaffold_06	16193244	16196644	NA	NA	NA	NA	NA
PGEN_.00g135550	Scaffold_06	16203201	16221480	P98164	LRP2_HUMAN	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	GO:0001523; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008144; GO:0008283; GO:0008584; GO:0009897; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030665; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0045056; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060982; GO:0061024; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:1904447; GO:1905167	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]
PGEN_.00g135560	Scaffold_06	16224087	16236221	P12263	FA8_PIG	Coagulation factor VIII (Procoagulant component)	GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491; GO:0030168	"extracellular space [GO:0005615]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597]; platelet activation [GO:0030168]"
PGEN_.00g135570	Scaffold_06	16247535	16277016	Q80UK8	INT2_MOUSE	Integrator complex subunit 2 (Int2)	GO:0005634; GO:0005737; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]
PGEN_.00g135580	Scaffold_06	16278555	16279711	Q9H0H0	INT2_HUMAN	Integrator complex subunit 2 (Int2)	GO:0005622; GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472; GO:0042795	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; intracellular [GO:0005622]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]
PGEN_.00g135590	Scaffold_06	16280050	16282732	Q28FE2	MED31_XENTR	Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Mediator complex subunit soh1)	GO:0003713; GO:0006357; GO:0016592; GO:0070847	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g135600	Scaffold_06	16289139	16314353	O15254	ACOX3_HUMAN	Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase)	GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g135610	Scaffold_06	16347476	16348144	NA	NA	NA	NA	NA
PGEN_.00g135620	Scaffold_06	16379820	16390401	Q9NZ20	PA2G3_HUMAN	Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3)	GO:0001675; GO:0005576; GO:0005615; GO:0005814; GO:0005886; GO:0006644; GO:0007288; GO:0016042; GO:0019372; GO:0036148; GO:0036151; GO:0036152; GO:0042629; GO:0043303; GO:0046872; GO:0047498; GO:0050482; GO:0060271; GO:0102567; GO:0102568	"centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; plasma membrane [GO:0005886]; calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cilium assembly [GO:0060271]; lipid catabolic process [GO:0016042]; lipoxygenase pathway [GO:0019372]; mast cell degranulation [GO:0043303]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid metabolic process [GO:0006644]; sperm axoneme assembly [GO:0007288]"
PGEN_.00g135630	Scaffold_06	16478084	16479685	Q57951	Y531_METJA	Universal stress protein MJ0531 (USP MJ0531)		
PGEN_.00g135640	Scaffold_06	16694391	16719290	NA	NA	NA	NA	NA
PGEN_.00g135650	Scaffold_06	16727392	16728428	NA	NA	NA	NA	NA
PGEN_.00g135660	Scaffold_06	16740394	16748393	NA	NA	NA	NA	NA
PGEN_.00g135670	Scaffold_06	16778652	16783537	Q2NL00	GSTT1_BOVIN	Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1)	GO:0004364; GO:0005737; GO:0006749	cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]
PGEN_.00g135680	Scaffold_06	16787454	16788332	Q6JZS3	CP1A1_ORYLA	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)	GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0043231; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]
PGEN_.00g135690	Scaffold_06	16788594	16788959	Q95328	CP17A_HORSE	"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (17-alpha-hydroxyprogesterone aldolase) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17) (Steroid 17-alpha-monooxygenase)"	GO:0004508; GO:0005506; GO:0005789; GO:0006704; GO:0008202; GO:0020037; GO:0042446; GO:0042448; GO:0047442	endoplasmic reticulum membrane [GO:0005789]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; steroid metabolic process [GO:0008202]
PGEN_.00g135700	Scaffold_06	16799859	16803038	Q99L20	GSTT3_MOUSE	Glutathione S-transferase theta-3 (EC 2.5.1.18)	GO:0004364; GO:0005737; GO:0006749	cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]
PGEN_.00g135710	Scaffold_06	16804948	16805217	NA	NA	NA	NA	NA
PGEN_.00g135720	Scaffold_06	16812055	16814174	P20135	GSTT1_CHICK	Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta) (GST-CL1)	GO:0004364; GO:0005737; GO:0006749	cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]
PGEN_.00g135730	Scaffold_06	16834649	16836154	Q92116	CP1A1_STECH	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g135740	Scaffold_06	16872043	16877434	Q2NL00	GSTT1_BOVIN	Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1)	GO:0004364; GO:0005737; GO:0006749	cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]
PGEN_.00g135750	Scaffold_06	16885408	16893784	Q64471	GSTT1_MOUSE	Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1)	GO:0004364; GO:0004602; GO:0005634; GO:0005829; GO:0006304; GO:0006749; GO:0009751; GO:0010269; GO:0018900; GO:0033197; GO:0047651	cytosol [GO:0005829]; nucleus [GO:0005634]; alkylhalidase activity [GO:0047651]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; dichloromethane metabolic process [GO:0018900]; DNA modification [GO:0006304]; glutathione metabolic process [GO:0006749]; response to salicylic acid [GO:0009751]; response to selenium ion [GO:0010269]; response to vitamin E [GO:0033197]
PGEN_.00g135760	Scaffold_06	16912590	16918798	NA	NA	NA	NA	NA
PGEN_.00g135770	Scaffold_06	16934314	16940743	Q8RWN2	ZIF1_ARATH	Protein ZINC INDUCED FACILITATOR 1	GO:0005886; GO:0009624; GO:0009705; GO:0010043; GO:0016021; GO:0022821; GO:0055069; GO:0090333	integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]; plasma membrane [GO:0005886]; potassium ion antiporter activity [GO:0022821]; regulation of stomatal closure [GO:0090333]; response to nematode [GO:0009624]; response to zinc ion [GO:0010043]; zinc ion homeostasis [GO:0055069]
PGEN_.00g135780	Scaffold_06	16969524	16975923	Q8IZ69	TRM2A_HUMAN	tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein)	GO:0003723; GO:0006396; GO:0008173	RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]
PGEN_.00g135790	Scaffold_06	16997391	17026248	Q8IZ69	TRM2A_HUMAN	tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein)	GO:0003723; GO:0006396; GO:0008173	RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396]
PGEN_.00g135800	Scaffold_06	17029971	17030766	NA	NA	NA	NA	NA
PGEN_.00g135810	Scaffold_06	17039205	17041620	NA	NA	NA	NA	NA
PGEN_.00g135820	Scaffold_06	17056097	17084714	F4KF65	IMPA9_ARATH	Importin subunit alpha-9 (IMPa-9)	GO:0005643; GO:0005654; GO:0005829; GO:0006607; GO:0008139; GO:0061608	cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]
PGEN_.00g135830	Scaffold_06	17108876	17143149	P55937	GOGA3_MOUSE	Golgin subfamily A member 3 (Golgin-160) (Male-enhanced antigen 2) (MEA-2)	GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005793; GO:0005794; GO:0005829; GO:0007275; GO:0007283; GO:0017119; GO:0030154; GO:0032580; GO:0090498	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g135840	Scaffold_06	17164604	17170166	NA	NA	NA	NA	NA
PGEN_.00g135850	Scaffold_06	17170271	17172773	NA	NA	NA	NA	NA
PGEN_.00g135860	Scaffold_06	17210984	17213261	NA	NA	NA	NA	NA
PGEN_.00g135870	Scaffold_06	17219742	17282395	O95427	PIGN_HUMAN	GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N)	GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016020; GO:0016021; GO:0016254; GO:0051377	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; mannose-ethanolamine phosphotransferase activity [GO:0051377]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]
PGEN_.00g135880	Scaffold_06	17230824	17231654	NA	NA	NA	NA	NA
PGEN_.00g135890	Scaffold_06	17284214	17296640	O95427	PIGN_HUMAN	GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N)	GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016020; GO:0016021; GO:0016254; GO:0051377	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; mannose-ethanolamine phosphotransferase activity [GO:0051377]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]
PGEN_.00g135900	Scaffold_06	17354955	17355185	NA	NA	NA	NA	NA
PGEN_.00g135910	Scaffold_06	17358823	17368641	NA	NA	NA	NA	NA
PGEN_.00g135920	Scaffold_06	17368848	17370554	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g135930	Scaffold_06	17391076	17395318	NA	NA	NA	NA	NA
PGEN_.00g135940	Scaffold_06	17399028	17399237	NA	NA	NA	NA	NA
PGEN_.00g135950	Scaffold_06	17505767	17563144	B0JZ65	LRWD1_XENTR	Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein)	GO:0000122; GO:0000776; GO:0000777; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005737; GO:0005815; GO:0006260; GO:0006325; GO:0006342; GO:0008327; GO:0031933; GO:0035064; GO:0035098; GO:0070734; GO:0071169	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; telomeric heterochromatin [GO:0031933]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g135960	Scaffold_06	17539041	17539364	NA	NA	NA	NA	NA
PGEN_.00g135970	Scaffold_06	17551416	17551811	NA	NA	NA	NA	NA
PGEN_.00g135980	Scaffold_06	17574307	17574840	NA	NA	NA	NA	NA
PGEN_.00g135990	Scaffold_06	17585190	17587083	NA	NA	NA	NA	NA
PGEN_.00g136000	Scaffold_06	17587130	17588621	NA	NA	NA	NA	NA
PGEN_.00g136010	Scaffold_06	17588976	17591247	NA	NA	NA	NA	NA
PGEN_.00g136020	Scaffold_06	17605416	17605736	NA	NA	NA	NA	NA
PGEN_.00g136030	Scaffold_06	17612063	17613196	NA	NA	NA	NA	NA
PGEN_.00g136040	Scaffold_06	17613343	17613738	NA	NA	NA	NA	NA
PGEN_.00g136050	Scaffold_06	17628267	17664170	NA	NA	NA	NA	NA
PGEN_.00g136060	Scaffold_06	17698759	17724650	Q9C5D2	FBL4_ARATH	F-box/LRR-repeat protein 4 (AtFBL4)	GO:0006289; GO:0006511; GO:0010225; GO:0016567; GO:0019005; GO:0031146	SCF ubiquitin ligase complex [GO:0019005]; nucleotide-excision repair [GO:0006289]; protein ubiquitination [GO:0016567]; response to UV-C [GO:0010225]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g136070	Scaffold_06	17777965	17779510	NA	NA	NA	NA	NA
PGEN_.00g136080	Scaffold_06	17803082	17803906	NA	NA	NA	NA	NA
PGEN_.00g136090	Scaffold_06	17804608	17807822	NA	NA	NA	NA	NA
PGEN_.00g136100	Scaffold_06	17818322	17822889	Q5Y5T5	ZDHC8_MOUSE	Probable palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (DHHC-8)	GO:0005739; GO:0005794; GO:0007626; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030659; GO:0048471	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; locomotory behavior [GO:0007626]; protein palmitoylation [GO:0018345]
PGEN_.00g136110	Scaffold_06	17823279	17843918	NA	NA	NA	NA	NA
PGEN_.00g136120	Scaffold_06	17874865	17875182	NA	NA	NA	NA	NA
PGEN_.00g136130	Scaffold_06	17875276	17877706	NA	NA	NA	NA	NA
PGEN_.00g136140	Scaffold_06	17877799	17878425	NA	NA	NA	NA	NA
PGEN_.00g136150	Scaffold_06	17879040	17879670	NA	NA	NA	NA	NA
PGEN_.00g136160	Scaffold_06	17879751	17880020	NA	NA	NA	NA	NA
PGEN_.00g136170	Scaffold_06	17880667	17880888	NA	NA	NA	NA	NA
PGEN_.00g136180	Scaffold_06	17881225	17881893	NA	NA	NA	NA	NA
PGEN_.00g136190	Scaffold_06	17882012	17882275	NA	NA	NA	NA	NA
PGEN_.00g136200	Scaffold_06	17912442	17926638	A6NMZ7	CO6A6_HUMAN	Collagen alpha-6(VI) chain	GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g136210	Scaffold_06	17939106	17967676	NA	NA	NA	NA	NA
PGEN_.00g136220	Scaffold_06	18026419	18027521	NA	NA	NA	NA	NA
PGEN_.00g136230	Scaffold_06	18132737	18134344	NA	NA	NA	NA	NA
PGEN_.00g136240	Scaffold_06	18135317	18136201	NA	NA	NA	NA	NA
PGEN_.00g136250	Scaffold_06	18136559	18137113	NA	NA	NA	NA	NA
PGEN_.00g136260	Scaffold_06	18162358	18167362	P0C227	GLB_NERAL	Globin (Myoglobin)	GO:0005344; GO:0005576; GO:0005833; GO:0019825; GO:0020037; GO:0046872	extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g136270	Scaffold_06	18271801	18277782	NA	NA	NA	NA	NA
PGEN_.00g136280	Scaffold_06	18319195	18320130	NA	NA	NA	NA	NA
PGEN_.00g136290	Scaffold_06	18395701	18416399	Q9BVR0	HRC23_HUMAN	Putative HERC2-like protein 3	GO:0004842; GO:0046872	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]
PGEN_.00g136300	Scaffold_06	18434592	18440976	NA	NA	NA	NA	NA
PGEN_.00g136310	Scaffold_06	18448357	18448971	NA	NA	NA	NA	NA
PGEN_.00g136320	Scaffold_06	18453386	18466001	NA	NA	NA	NA	NA
PGEN_.00g136330	Scaffold_06	18471646	18472763	NA	NA	NA	NA	NA
PGEN_.00g136340	Scaffold_06	18478113	18512282	NA	NA	NA	NA	NA
PGEN_.00g136350	Scaffold_06	18568906	18569136	NA	NA	NA	NA	NA
PGEN_.00g136360	Scaffold_06	18611714	18612577	NA	NA	NA	NA	NA
PGEN_.00g136370	Scaffold_06	18613457	18616763	NA	NA	NA	NA	NA
PGEN_.00g136380	Scaffold_06	18655947	18656219	NA	NA	NA	NA	NA
PGEN_.00g136390	Scaffold_06	18670744	18714026	NA	NA	NA	NA	NA
PGEN_.00g136400	Scaffold_06	18746611	18751741	NA	NA	NA	NA	NA
PGEN_.00g136410	Scaffold_06	18770692	18771057	NA	NA	NA	NA	NA
PGEN_.00g136420	Scaffold_06	18771784	18772122	NA	NA	NA	NA	NA
PGEN_.00g136430	Scaffold_06	18774147	18774479	NA	NA	NA	NA	NA
PGEN_.00g136440	Scaffold_06	18798953	18799391	NA	NA	NA	NA	NA
PGEN_.00g136450	Scaffold_06	18804086	18882224	NA	NA	NA	NA	NA
PGEN_.00g136460	Scaffold_06	18887606	18907067	A8WGS4	TLCD2_DANRE	TLC domain-containing protein 2	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g136470	Scaffold_06	18918083	18918409	NA	NA	NA	NA	NA
PGEN_.00g136480	Scaffold_06	18918784	18919038	NA	NA	NA	NA	NA
PGEN_.00g136490	Scaffold_06	18919363	18919608	NA	NA	NA	NA	NA
PGEN_.00g136500	Scaffold_06	18925288	18928217	NA	NA	NA	NA	NA
PGEN_.00g136510	Scaffold_06	18942072	18945057	NA	NA	NA	NA	NA
PGEN_.00g136520	Scaffold_06	18955013	19036499	P17405	ASM_HUMAN	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006684; GO:0006685; GO:0006687; GO:0007165; GO:0007399; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0042220; GO:0042599; GO:0043065; GO:0043202; GO:0043407; GO:0046513; GO:0061750; GO:0070062	"endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of MAP kinase activity [GO:0043407]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; termination of signal transduction [GO:0023021]"
PGEN_.00g136530	Scaffold_06	19060608	19063119	NA	NA	NA	NA	NA
PGEN_.00g136540	Scaffold_06	19070915	19072981	NA	NA	NA	NA	NA
PGEN_.00g136550	Scaffold_06	19084007	19087137	NA	NA	NA	NA	NA
PGEN_.00g136560	Scaffold_06	19088431	19134782	Q7RTY0	MOT13_HUMAN	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	GO:0000139; GO:0005794; GO:0005829; GO:0005886; GO:0008028; GO:0015293; GO:0016021	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g136570	Scaffold_06	19102195	19102416	NA	NA	NA	NA	NA
PGEN_.00g136580	Scaffold_06	19102940	19104079	NA	NA	NA	NA	NA
PGEN_.00g136590	Scaffold_06	19143715	19144074	NA	NA	NA	NA	NA
PGEN_.00g136600	Scaffold_06	19157679	19158059	NA	NA	NA	NA	NA
PGEN_.00g136610	Scaffold_06	19163954	19166097	NA	NA	NA	NA	NA
PGEN_.00g136620	Scaffold_06	19210076	19210651	NA	NA	NA	NA	NA
PGEN_.00g136630	Scaffold_06	19211325	19211582	NA	NA	NA	NA	NA
PGEN_.00g136640	Scaffold_06	19217351	19217617	NA	NA	NA	NA	NA
PGEN_.00g136650	Scaffold_06	19217778	19218236	NA	NA	NA	NA	NA
PGEN_.00g136660	Scaffold_06	19219426	19219911	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g136670	Scaffold_06	19220142	19224143	NA	NA	NA	NA	NA
PGEN_.00g136680	Scaffold_06	19224529	19226790	NA	NA	NA	NA	NA
PGEN_.00g136690	Scaffold_06	19248463	19248867	NA	NA	NA	NA	NA
PGEN_.00g136700	Scaffold_06	19295193	19302888	NA	NA	NA	NA	NA
PGEN_.00g136710	Scaffold_06	19316028	19317965	NA	NA	NA	NA	NA
PGEN_.00g136720	Scaffold_06	19326314	19326607	NA	NA	NA	NA	NA
PGEN_.00g136730	Scaffold_06	19332657	19333196	NA	NA	NA	NA	NA
PGEN_.00g136740	Scaffold_06	19351994	19352353	NA	NA	NA	NA	NA
PGEN_.00g136750	Scaffold_06	19364058	19366839	NA	NA	NA	NA	NA
PGEN_.00g136760	Scaffold_06	19367103	19367420	NA	NA	NA	NA	NA
PGEN_.00g136770	Scaffold_06	19367933	19368172	NA	NA	NA	NA	NA
PGEN_.00g136780	Scaffold_06	19369263	19370315	NA	NA	NA	NA	NA
PGEN_.00g136790	Scaffold_06	19370498	19371686	NA	NA	NA	NA	NA
PGEN_.00g136800	Scaffold_06	19372255	19463500	Q5SSG4	GA2L2_MOUSE	GAS2-like protein 2 (Growth arrest-specific protein 2-like 2)	GO:0001578; GO:0001965; GO:0005737; GO:0005884; GO:0005886; GO:0007026; GO:0008017; GO:0008093; GO:0031110; GO:0035371; GO:0036064; GO:0045745; GO:0051015; GO:0060296; GO:1904825	actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; G-protein alpha-subunit binding [GO:0001965]; microtubule binding [GO:0008017]; microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein localization to microtubule plus-end [GO:1904825]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of microtubule polymerization or depolymerization [GO:0031110]
PGEN_.00g136810	Scaffold_06	19466417	19466629	NA	NA	NA	NA	NA
PGEN_.00g136820	Scaffold_06	19476865	19477593	NA	NA	NA	NA	NA
PGEN_.00g136830	Scaffold_06	19480768	19481130	NA	NA	NA	NA	NA
PGEN_.00g136840	Scaffold_06	19482448	19482768	NA	NA	NA	NA	NA
PGEN_.00g136850	Scaffold_06	19485833	19486216	NA	NA	NA	NA	NA
PGEN_.00g136860	Scaffold_06	19486587	19487138	NA	NA	NA	NA	NA
PGEN_.00g136870	Scaffold_06	19487164	19489095	NA	NA	NA	NA	NA
PGEN_.00g136880	Scaffold_06	19489196	19490270	NA	NA	NA	NA	NA
PGEN_.00g136890	Scaffold_06	19490489	19491432	NA	NA	NA	NA	NA
PGEN_.00g136900	Scaffold_06	19493705	19494004	NA	NA	NA	NA	NA
PGEN_.00g136910	Scaffold_06	19504273	19572267	Q2HJH3	CK054_BOVIN	Ester hydrolase C11orf54 homolog (EC 3.1.-.-)	GO:0008270; GO:0016604; GO:0016788	"nuclear body [GO:0016604]; hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"
PGEN_.00g136920	Scaffold_06	19584290	19584568	NA	NA	NA	NA	NA
PGEN_.00g136930	Scaffold_06	19602739	19647938	Q5RF77	CHFR_PONAB	E3 ubiquitin-protein ligase CHFR (EC 2.3.2.27) (Checkpoint with forkhead and RING finger domains protein) (RING-type E3 ubiquitin transferase CHFR)	GO:0000166; GO:0000209; GO:0004842; GO:0005634; GO:0007093; GO:0016605; GO:0019941; GO:0046872; GO:0051301	nucleus [GO:0005634]; PML body [GO:0016605]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; modification-dependent protein catabolic process [GO:0019941]; protein polyubiquitination [GO:0000209]
PGEN_.00g136940	Scaffold_06	19648243	19692856	Q5RF77	CHFR_PONAB	E3 ubiquitin-protein ligase CHFR (EC 2.3.2.27) (Checkpoint with forkhead and RING finger domains protein) (RING-type E3 ubiquitin transferase CHFR)	GO:0000166; GO:0000209; GO:0004842; GO:0005634; GO:0007093; GO:0016605; GO:0019941; GO:0046872; GO:0051301	nucleus [GO:0005634]; PML body [GO:0016605]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; modification-dependent protein catabolic process [GO:0019941]; protein polyubiquitination [GO:0000209]
PGEN_.00g136950	Scaffold_06	19710405	19710683	NA	NA	NA	NA	NA
PGEN_.00g136960	Scaffold_06	19725102	19785487	Q2HJH3	CK054_BOVIN	Ester hydrolase C11orf54 homolog (EC 3.1.-.-)	GO:0008270; GO:0016604; GO:0016788	"nuclear body [GO:0016604]; hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]"
PGEN_.00g136970	Scaffold_06	19795726	19796025	NA	NA	NA	NA	NA
PGEN_.00g136980	Scaffold_06	19798298	19799241	NA	NA	NA	NA	NA
PGEN_.00g136990	Scaffold_06	19799460	19800534	NA	NA	NA	NA	NA
PGEN_.00g137000	Scaffold_06	19800635	19802566	NA	NA	NA	NA	NA
PGEN_.00g137010	Scaffold_06	19802592	19803881	NA	NA	NA	NA	NA
PGEN_.00g137020	Scaffold_06	19806933	19807253	NA	NA	NA	NA	NA
PGEN_.00g137030	Scaffold_06	19808571	19808933	NA	NA	NA	NA	NA
PGEN_.00g137040	Scaffold_06	19812105	19812722	NA	NA	NA	NA	NA
PGEN_.00g137050	Scaffold_06	19823567	19823779	NA	NA	NA	NA	NA
PGEN_.00g137060	Scaffold_06	19826696	19916609	Q5SSG4	GA2L2_MOUSE	GAS2-like protein 2 (Growth arrest-specific protein 2-like 2)	GO:0001578; GO:0001965; GO:0005737; GO:0005884; GO:0005886; GO:0007026; GO:0008017; GO:0008093; GO:0031110; GO:0035371; GO:0036064; GO:0045745; GO:0051015; GO:0060296; GO:1904825	actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; G-protein alpha-subunit binding [GO:0001965]; microtubule binding [GO:0008017]; microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein localization to microtubule plus-end [GO:1904825]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of microtubule polymerization or depolymerization [GO:0031110]
PGEN_.00g137070	Scaffold_06	19917187	19918370	NA	NA	NA	NA	NA
PGEN_.00g137080	Scaffold_06	19918552	19919604	NA	NA	NA	NA	NA
PGEN_.00g137090	Scaffold_06	19921447	19921764	NA	NA	NA	NA	NA
PGEN_.00g137100	Scaffold_06	19922028	19924811	NA	NA	NA	NA	NA
PGEN_.00g137110	Scaffold_06	19928514	19930452	NA	NA	NA	NA	NA
PGEN_.00g137120	Scaffold_06	19936505	19936864	NA	NA	NA	NA	NA
PGEN_.00g137130	Scaffold_06	19939219	19941653	NA	NA	NA	NA	NA
PGEN_.00g137140	Scaffold_06	19955763	19956302	NA	NA	NA	NA	NA
PGEN_.00g137150	Scaffold_06	19962371	19962664	NA	NA	NA	NA	NA
PGEN_.00g137160	Scaffold_06	19971085	19971357	NA	NA	NA	NA	NA
PGEN_.00g137170	Scaffold_06	20017625	20017966	NA	NA	NA	NA	NA
PGEN_.00g137180	Scaffold_06	20036133	20036537	NA	NA	NA	NA	NA
PGEN_.00g137190	Scaffold_06	20057814	20059104	NA	NA	NA	NA	NA
PGEN_.00g137200	Scaffold_06	20059131	20060004	NA	NA	NA	NA	NA
PGEN_.00g137210	Scaffold_06	20060390	20064391	NA	NA	NA	NA	NA
PGEN_.00g137220	Scaffold_06	20064622	20065107	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g137230	Scaffold_06	20066297	20066755	NA	NA	NA	NA	NA
PGEN_.00g137240	Scaffold_06	20066916	20067182	NA	NA	NA	NA	NA
PGEN_.00g137250	Scaffold_06	20069312	20069551	NA	NA	NA	NA	NA
PGEN_.00g137260	Scaffold_06	20072944	20073201	NA	NA	NA	NA	NA
PGEN_.00g137270	Scaffold_06	20073875	20074450	NA	NA	NA	NA	NA
PGEN_.00g137280	Scaffold_06	20135251	20135610	NA	NA	NA	NA	NA
PGEN_.00g137290	Scaffold_06	20144438	20190808	Q7RTY0	MOT13_HUMAN	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	GO:0000139; GO:0005794; GO:0005829; GO:0005886; GO:0008028; GO:0015293; GO:0016021	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g137300	Scaffold_06	20176796	20178472	NA	NA	NA	NA	NA
PGEN_.00g137310	Scaffold_06	20192099	20196757	NA	NA	NA	NA	NA
PGEN_.00g137320	Scaffold_06	20208073	20218452	NA	NA	NA	NA	NA
PGEN_.00g137330	Scaffold_06	20243177	20324629	P17405	ASM_HUMAN	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006684; GO:0006685; GO:0006687; GO:0007165; GO:0007399; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0042220; GO:0042599; GO:0043065; GO:0043202; GO:0043407; GO:0046513; GO:0061750; GO:0070062	"endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of MAP kinase activity [GO:0043407]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; termination of signal transduction [GO:0023021]"
PGEN_.00g137340	Scaffold_06	20336480	20339466	NA	NA	NA	NA	NA
PGEN_.00g137350	Scaffold_06	20353324	20356253	NA	NA	NA	NA	NA
PGEN_.00g137360	Scaffold_06	20362046	20362291	NA	NA	NA	NA	NA
PGEN_.00g137370	Scaffold_06	20362581	20362889	NA	NA	NA	NA	NA
PGEN_.00g137380	Scaffold_06	20363264	20363590	NA	NA	NA	NA	NA
PGEN_.00g137390	Scaffold_06	20374852	20394307	A8WGS4	TLCD2_DANRE	TLC domain-containing protein 2	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g137400	Scaffold_06	20399692	20477962	NA	NA	NA	NA	NA
PGEN_.00g137410	Scaffold_06	20482657	20483047	NA	NA	NA	NA	NA
PGEN_.00g137420	Scaffold_06	20507385	20507717	NA	NA	NA	NA	NA
PGEN_.00g137430	Scaffold_06	20509742	20510080	NA	NA	NA	NA	NA
PGEN_.00g137440	Scaffold_06	20510807	20511172	NA	NA	NA	NA	NA
PGEN_.00g137450	Scaffold_06	20529790	20534916	NA	NA	NA	NA	NA
PGEN_.00g137460	Scaffold_06	20560833	20651143	O88998	NOE1_MOUSE	Noelin (Neuronal olfactomedin-related ER localized protein) (Olfactomedin-1) (Pancortin)	GO:0001540; GO:0003190; GO:0005615; GO:0005783; GO:0010628; GO:0010629; GO:0010718; GO:0023041; GO:0030054; GO:0030424; GO:0030516; GO:0032281; GO:0042802; GO:0043025; GO:0043065; GO:0043204; GO:0044295; GO:0060317; GO:0097060; GO:0098978; GO:0099243; GO:1902003; GO:1902430; GO:2001223	AMPA glutamate receptor complex [GO:0032281]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; extrinsic component of synaptic membrane [GO:0099243]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synaptic membrane [GO:0097060]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron migration [GO:2001223]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of amyloid-beta formation [GO:1902003]; regulation of axon extension [GO:0030516]
PGEN_.00g137470	Scaffold_06	20622468	20623011	NA	NA	NA	NA	NA
PGEN_.00g137480	Scaffold_06	20662368	20667694	NA	NA	NA	NA	NA
PGEN_.00g137490	Scaffold_06	20709732	20709962	NA	NA	NA	NA	NA
PGEN_.00g137500	Scaffold_06	20733629	20823581	H2A0M0	NRP_PINMG	Asparagine-rich protein (Prism uncharacterized shell protein 1) (PUSP1)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g137510	Scaffold_06	20828243	20828632	NA	NA	NA	NA	NA
PGEN_.00g137520	Scaffold_06	20836191	20842580	NA	NA	NA	NA	NA
PGEN_.00g137530	Scaffold_06	20843358	20843726	NA	NA	NA	NA	NA
PGEN_.00g137540	Scaffold_06	20860780	20881850	Q9BVR0	HRC23_HUMAN	Putative HERC2-like protein 3	GO:0004842; GO:0046872	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]
PGEN_.00g137550	Scaffold_06	20959710	20962795	NA	NA	NA	NA	NA
PGEN_.00g137560	Scaffold_06	21009458	21015348	NA	NA	NA	NA	NA
PGEN_.00g137570	Scaffold_06	21111756	21112133	NA	NA	NA	NA	NA
PGEN_.00g137580	Scaffold_06	21116932	21121600	P0C227	GLB_NERAL	Globin (Myoglobin)	GO:0005344; GO:0005576; GO:0005833; GO:0019825; GO:0020037; GO:0046872	extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g137590	Scaffold_06	21146552	21148459	NA	NA	NA	NA	NA
PGEN_.00g137600	Scaffold_06	21149315	21149617	NA	NA	NA	NA	NA
PGEN_.00g137610	Scaffold_06	21149686	21150928	NA	NA	NA	NA	NA
PGEN_.00g137620	Scaffold_06	21256130	21257232	NA	NA	NA	NA	NA
PGEN_.00g137630	Scaffold_06	21317815	21345989	B0BLT4	GLTP_XENTR	Glycolipid transfer protein (GLTP)	GO:0005829; GO:0008289; GO:0035627; GO:0120009; GO:1902387; GO:1902388	cytosol [GO:0005829]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]
PGEN_.00g137640	Scaffold_06	21358735	21372936	A6NMZ7	CO6A6_HUMAN	Collagen alpha-6(VI) chain	GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g137650	Scaffold_06	21403335	21403709	NA	NA	NA	NA	NA
PGEN_.00g137660	Scaffold_06	21403745	21405975	NA	NA	NA	NA	NA
PGEN_.00g137670	Scaffold_06	21406076	21406297	NA	NA	NA	NA	NA
PGEN_.00g137680	Scaffold_06	21407395	21407748	NA	NA	NA	NA	NA
PGEN_.00g137690	Scaffold_06	21408114	21408359	NA	NA	NA	NA	NA
PGEN_.00g137700	Scaffold_06	21408558	21411566	NA	NA	NA	NA	NA
PGEN_.00g137710	Scaffold_06	21441903	21457553	NA	NA	NA	NA	NA
PGEN_.00g137720	Scaffold_06	21457943	21465810	Q5Y5T5	ZDHC8_MOUSE	Probable palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (DHHC-8)	GO:0005739; GO:0005794; GO:0007626; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030659; GO:0048471	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; locomotory behavior [GO:0007626]; protein palmitoylation [GO:0018345]
PGEN_.00g137730	Scaffold_06	21473769	21508377	Q9Y2E6	DTX4_HUMAN	E3 ubiquitin-protein ligase DTX4 (EC 2.3.2.27) (Protein deltex-4) (Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4)	GO:0004842; GO:0005829; GO:0007219; GO:0008270; GO:0032479	cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; regulation of type I interferon production [GO:0032479]
PGEN_.00g137740	Scaffold_06	21514369	21521149	Q8VDN4	CCD92_MOUSE	Coiled-coil domain-containing protein 92	GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0043231	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]
PGEN_.00g137750	Scaffold_06	21549855	21550394	NA	NA	NA	NA	NA
PGEN_.00g137760	Scaffold_06	21550737	21553321	NA	NA	NA	NA	NA
PGEN_.00g137770	Scaffold_06	21564916	21579857	NA	NA	NA	NA	NA
PGEN_.00g137780	Scaffold_06	21580326	21597158	NA	NA	NA	NA	NA
PGEN_.00g137790	Scaffold_06	21597574	21597915	NA	NA	NA	NA	NA
PGEN_.00g137800	Scaffold_06	21598033	21598551	NA	NA	NA	NA	NA
PGEN_.00g137810	Scaffold_06	21598581	21599009	NA	NA	NA	NA	NA
PGEN_.00g137820	Scaffold_06	21599256	21599798	NA	NA	NA	NA	NA
PGEN_.00g137830	Scaffold_06	21605299	21616197	NA	NA	NA	NA	NA
PGEN_.00g137840	Scaffold_06	21672562	21683480	NA	NA	NA	NA	NA
PGEN_.00g137850	Scaffold_06	21712365	21738213	NA	NA	NA	NA	NA
PGEN_.00g137860	Scaffold_06	21739848	21768364	NA	NA	NA	NA	NA
PGEN_.00g137870	Scaffold_06	21768514	21770396	NA	NA	NA	NA	NA
PGEN_.00g137880	Scaffold_06	21770803	21771318	NA	NA	NA	NA	NA
PGEN_.00g137890	Scaffold_06	21779976	21805572	NA	NA	NA	NA	NA
PGEN_.00g137900	Scaffold_06	21891846	21896631	NA	NA	NA	NA	NA
PGEN_.00g137910	Scaffold_06	21904708	21936513	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g137920	Scaffold_06	21959615	21974808	Q6X0I2	VGR_SOLIN	Vitellogenin receptor (SiVgR)	GO:0005509; GO:0006898; GO:0016021; GO:0038024	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g137930	Scaffold_06	22044364	22045957	Q9V6K3	ROR2_DROME	Tyrosine-protein kinase transmembrane receptor Ror2 (dRor2) (EC 2.7.10.1) (Neurospecific receptor tyrosine kinase)	GO:0004713; GO:0004714; GO:0005524; GO:0005623; GO:0005886; GO:0005887; GO:0006468; GO:0007165; GO:0007169; GO:0007399; GO:0010976; GO:0014068; GO:0042052; GO:0043235; GO:0043408; GO:0043410; GO:0046716; GO:0072499	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; muscle cell cellular homeostasis [GO:0046716]; nervous system development [GO:0007399]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408]; rhabdomere development [GO:0042052]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g137940	Scaffold_06	22057626	22058090	NA	NA	NA	NA	NA
PGEN_.00g137950	Scaffold_06	22058875	22059180	NA	NA	NA	NA	NA
PGEN_.00g137960	Scaffold_06	22064885	22072236	Q9ST63	NDA1_SOLTU	"Internal alternative NAD(P)H-ubiquinone oxidoreductase A1, mitochondrial (EC 1.6.5.9) (Internal alternative NADH dehydrogenase NDA1) (Internal non-phosphorylating NAD(P)H dehydrogenase 1) (StNDI1) (NADH:ubiquinone reductase (non-electrogenic) NDA1)"	GO:0003959; GO:0005743; GO:0005759; GO:0005777; GO:0055114	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; peroxisome [GO:0005777]; NADPH dehydrogenase activity [GO:0003959]; oxidation-reduction process [GO:0055114]
PGEN_.00g137970	Scaffold_06	22072555	22072854	Q4V7V8	ADAT2_XENLA	tRNA-specific adenosine deaminase 2 (EC 3.5.4.33) (Deaminase domain-containing protein 1) (tRNA-specific adenosine-34 deaminase subunit ADAT2)	GO:0002100; GO:0008251; GO:0008270	tRNA-specific adenosine deaminase activity [GO:0008251]; zinc ion binding [GO:0008270]; tRNA wobble adenosine to inosine editing [GO:0002100]
PGEN_.00g137980	Scaffold_06	22077281	22096205	NA	NA	NA	NA	NA
PGEN_.00g137990	Scaffold_06	22210935	22211300	NA	NA	NA	NA	NA
PGEN_.00g138000	Scaffold_06	22214184	22214519	NA	NA	NA	NA	NA
PGEN_.00g138010	Scaffold_06	22214676	22215290	NA	NA	NA	NA	NA
PGEN_.00g138020	Scaffold_06	22225464	22227191	NA	NA	NA	NA	NA
PGEN_.00g138030	Scaffold_06	22240250	22255319	NA	NA	NA	NA	NA
PGEN_.00g138040	Scaffold_06	22262873	22263157	NA	NA	NA	NA	NA
PGEN_.00g138050	Scaffold_06	22277242	22277727	NA	NA	NA	NA	NA
PGEN_.00g138060	Scaffold_06	22286589	22288679	NA	NA	NA	NA	NA
PGEN_.00g138070	Scaffold_06	22299381	22301786	NA	NA	NA	NA	NA
PGEN_.00g138080	Scaffold_06	22311094	22312659	NA	NA	NA	NA	NA
PGEN_.00g138090	Scaffold_06	22314442	22314897	NA	NA	NA	NA	NA
PGEN_.00g138100	Scaffold_06	22381392	22390025	Q9LQQ2	RA51D_ARATH	DNA repair protein RAD51 homolog 4 (AtRAD51D)	GO:0000723; GO:0000724; GO:0000784; GO:0003697; GO:0005524; GO:0005657; GO:0005813; GO:0006281; GO:0008094; GO:0016444; GO:0033063; GO:0042148; GO:1900426	"centrosome [GO:0005813]; nuclear chromosome, telomeric region [GO:0000784]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of defense response to bacterium [GO:1900426]; somatic cell DNA recombination [GO:0016444]; strand invasion [GO:0042148]; telomere maintenance [GO:0000723]"
PGEN_.00g138110	Scaffold_06	22421917	22424499	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g138120	Scaffold_06	22445875	22448985	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g138130	Scaffold_06	22456380	22493405	A7Y2W8	SC6A9_XENLA	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9)	GO:0005283; GO:0005328; GO:0005887	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g138140	Scaffold_06	22501661	22506328	NA	NA	NA	NA	NA
PGEN_.00g138150	Scaffold_06	22504313	22505930	NA	NA	NA	NA	NA
PGEN_.00g138160	Scaffold_06	22525622	22531863	NA	NA	NA	NA	NA
PGEN_.00g138170	Scaffold_06	22537525	22537857	NA	NA	NA	NA	NA
PGEN_.00g138180	Scaffold_06	22539675	22543703	NA	NA	NA	NA	NA
PGEN_.00g138190	Scaffold_06	22554714	22555469	NA	NA	NA	NA	NA
PGEN_.00g138200	Scaffold_06	22558837	22559553	NA	NA	NA	NA	NA
PGEN_.00g138210	Scaffold_06	22559687	22559995	NA	NA	NA	NA	NA
PGEN_.00g138220	Scaffold_06	22567069	22619819	Q9VR07	INE_DROME	Sodium- and chloride-dependent GABA transporter ine (Protein inebriated) (Protein receptor oscillation A)	GO:0005034; GO:0005328; GO:0005886; GO:0006836; GO:0009414; GO:0016021; GO:0016323; GO:0019226; GO:0042065; GO:0042066; GO:0047484; GO:0050891	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]; glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; transmission of nerve impulse [GO:0019226]
PGEN_.00g138230	Scaffold_06	22630183	22655920	Q9VT65	CANB_DROME	Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540	cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]
PGEN_.00g138240	Scaffold_06	22671209	22677792	NA	NA	NA	NA	NA
PGEN_.00g138250	Scaffold_06	22694808	22698645	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g138260	Scaffold_06	22700706	22735795	NA	NA	NA	NA	NA
PGEN_.00g138270	Scaffold_06	22707420	22707931	NA	NA	NA	NA	NA
PGEN_.00g138280	Scaffold_06	22737367	22738758	NA	NA	NA	NA	NA
PGEN_.00g138290	Scaffold_06	22739742	22743261	Q58D20	NLE1_BOVIN	Notchless protein homolog 1	GO:0000027; GO:0005730; GO:0007219	nucleolus [GO:0005730]; Notch signaling pathway [GO:0007219]; ribosomal large subunit assembly [GO:0000027]
PGEN_.00g138300	Scaffold_06	22771984	22779051	NA	NA	NA	NA	NA
PGEN_.00g138310	Scaffold_06	22784592	22784873	NA	NA	NA	NA	NA
PGEN_.00g138320	Scaffold_06	22811266	22817452	NA	NA	NA	NA	NA
PGEN_.00g138330	Scaffold_06	22829022	22844254	NA	NA	NA	NA	NA
PGEN_.00g138340	Scaffold_06	22849368	22890155	Q28BL6	AACS_XENTR	Acetoacetyl-CoA synthetase (EC 6.2.1.16)	GO:0005524; GO:0005829; GO:0006631; GO:0030729	cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]
PGEN_.00g138350	Scaffold_06	22893761	22896178	NA	NA	NA	NA	NA
PGEN_.00g138360	Scaffold_06	22896260	22896508	NA	NA	NA	NA	NA
PGEN_.00g138370	Scaffold_06	22939907	22948120	NA	NA	NA	NA	NA
PGEN_.00g138380	Scaffold_06	22960315	22963325	NA	NA	NA	NA	NA
PGEN_.00g138390	Scaffold_06	22967450	22968926	NA	NA	NA	NA	NA
PGEN_.00g138400	Scaffold_06	22977466	22980301	NA	NA	NA	NA	NA
PGEN_.00g138410	Scaffold_06	22988153	22988804	NA	NA	NA	NA	NA
PGEN_.00g138420	Scaffold_06	23051956	23053455	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g138430	Scaffold_06	23053852	23054154	NA	NA	NA	NA	NA
PGEN_.00g138440	Scaffold_06	23073189	23073941	NA	NA	NA	NA	NA
PGEN_.00g138450	Scaffold_06	23111388	23140916	H2A0L1	TYRO2_PINMG	Tyrosinase-like protein 2 (EC 1.14.18.-) (Tyrosinase 2)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g138460	Scaffold_06	23147307	23158550	NA	NA	NA	NA	NA
PGEN_.00g138470	Scaffold_06	23205588	23213623	Q5PPV3	MORN3_XENLA	MORN repeat-containing protein 3		
PGEN_.00g138480	Scaffold_06	23227312	23238206	Q91YT2	RN185_MOUSE	E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) (RING-type E3 ubiquitin transferase RNF185)	GO:0005741; GO:0005783; GO:0005789; GO:0006511; GO:0006914; GO:0016021; GO:0030433; GO:0036503; GO:0043130; GO:0044390; GO:0044877; GO:0046872; GO:0051865; GO:0061630; GO:0071712; GO:1904294	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; autophagy [GO:0006914]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g138490	Scaffold_06	23251358	23252485	NA	NA	NA	NA	NA
PGEN_.00g138500	Scaffold_06	23260054	23261164	NA	NA	NA	NA	NA
PGEN_.00g138510	Scaffold_06	23261553	23262029	NA	NA	NA	NA	NA
PGEN_.00g138520	Scaffold_06	23400427	23462352	P97756	KKCC1_RAT	Calcium/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha)	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0006468; GO:0032147; GO:0035556; GO:0045860	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]
PGEN_.00g138530	Scaffold_06	23477663	23478605	NA	NA	NA	NA	NA
PGEN_.00g138540	Scaffold_06	23487129	23488960	NA	NA	NA	NA	NA
PGEN_.00g138550	Scaffold_06	23507281	23507622	NA	NA	NA	NA	NA
PGEN_.00g138560	Scaffold_06	23513465	23521945	Q9Z2I7	SVOP_RAT	Synaptic vesicle 2-related protein (SV2-related protein)	GO:0008021; GO:0016021; GO:0022857; GO:0030054; GO:0030672	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]
PGEN_.00g138570	Scaffold_06	23554147	23554416	NA	NA	NA	NA	NA
PGEN_.00g138580	Scaffold_06	23554574	23554837	NA	NA	NA	NA	NA
PGEN_.00g138590	Scaffold_06	23556778	23576613	Q20191	NAS13_CAEEL	Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)	GO:0004222; GO:0005576; GO:0008270	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g138600	Scaffold_06	23577121	23583984	P42662	ASTL_COTJA	Astacin-like metalloendopeptidase (EC 3.4.24.-) (Chorioallantoic membrane-1) (CAM-1) (Quail hatching enzyme) (QHE)	GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0030133; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]
PGEN_.00g138610	Scaffold_06	23605944	23612798	P42662	ASTL_COTJA	Astacin-like metalloendopeptidase (EC 3.4.24.-) (Chorioallantoic membrane-1) (CAM-1) (Quail hatching enzyme) (QHE)	GO:0004222; GO:0005737; GO:0005886; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0030133; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]
PGEN_.00g138620	Scaffold_06	23613306	23633289	Q20191	NAS13_CAEEL	Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)	GO:0004222; GO:0005576; GO:0008270	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g138630	Scaffold_06	23635230	23635493	NA	NA	NA	NA	NA
PGEN_.00g138640	Scaffold_06	23635651	23635920	NA	NA	NA	NA	NA
PGEN_.00g138650	Scaffold_06	23668176	23677005	Q9Z2I7	SVOP_RAT	Synaptic vesicle 2-related protein (SV2-related protein)	GO:0008021; GO:0016021; GO:0022857; GO:0030054; GO:0030672	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]
PGEN_.00g138660	Scaffold_06	23702528	23702827	NA	NA	NA	NA	NA
PGEN_.00g138670	Scaffold_06	23706399	23706638	NA	NA	NA	NA	NA
PGEN_.00g138680	Scaffold_06	23718928	23781049	P97756	KKCC1_RAT	Calcium/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha)	GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0006468; GO:0032147; GO:0035556; GO:0045860	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]
PGEN_.00g138690	Scaffold_06	23759057	23760301	NA	NA	NA	NA	NA
PGEN_.00g138700	Scaffold_06	23761528	23761836	NA	NA	NA	NA	NA
PGEN_.00g138710	Scaffold_06	23763447	23763719	NA	NA	NA	NA	NA
PGEN_.00g138720	Scaffold_06	23912444	23912737	NA	NA	NA	NA	NA
PGEN_.00g138730	Scaffold_06	23919598	23920074	NA	NA	NA	NA	NA
PGEN_.00g138740	Scaffold_06	23920463	23921573	NA	NA	NA	NA	NA
PGEN_.00g138750	Scaffold_06	23929141	23930268	NA	NA	NA	NA	NA
PGEN_.00g138760	Scaffold_06	23943414	23954176	Q91YT2	RN185_MOUSE	E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) (RING-type E3 ubiquitin transferase RNF185)	GO:0005741; GO:0005783; GO:0005789; GO:0006511; GO:0006914; GO:0016021; GO:0030433; GO:0036503; GO:0043130; GO:0044390; GO:0044877; GO:0046872; GO:0051865; GO:0061630; GO:0071712; GO:1904294	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; autophagy [GO:0006914]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g138770	Scaffold_06	23967865	23976769	Q5PPV3	MORN3_XENLA	MORN repeat-containing protein 3		
PGEN_.00g138780	Scaffold_06	24025741	24037037	NA	NA	NA	NA	NA
PGEN_.00g138790	Scaffold_06	24043462	24072911	H2A0L1	TYRO2_PINMG	Tyrosinase-like protein 2 (EC 1.14.18.-) (Tyrosinase 2)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g138800	Scaffold_06	24045283	24045717	NA	NA	NA	NA	NA
PGEN_.00g138810	Scaffold_06	24110239	24110991	NA	NA	NA	NA	NA
PGEN_.00g138820	Scaffold_06	24129836	24132185	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g138830	Scaffold_06	24194799	24195450	NA	NA	NA	NA	NA
PGEN_.00g138840	Scaffold_06	24202760	24206163	NA	NA	NA	NA	NA
PGEN_.00g138850	Scaffold_06	24214165	24214431	NA	NA	NA	NA	NA
PGEN_.00g138860	Scaffold_06	24214606	24216139	NA	NA	NA	NA	NA
PGEN_.00g138870	Scaffold_06	24220256	24223225	NA	NA	NA	NA	NA
PGEN_.00g138880	Scaffold_06	24238283	24245203	NA	NA	NA	NA	NA
PGEN_.00g138890	Scaffold_06	24288602	24288850	NA	NA	NA	NA	NA
PGEN_.00g138900	Scaffold_06	24288932	24291349	NA	NA	NA	NA	NA
PGEN_.00g138910	Scaffold_06	24294869	24332975	Q28BL6	AACS_XENTR	Acetoacetyl-CoA synthetase (EC 6.2.1.16)	GO:0005524; GO:0005829; GO:0006631; GO:0030729	cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]
PGEN_.00g138920	Scaffold_06	24336883	24353328	NA	NA	NA	NA	NA
PGEN_.00g138930	Scaffold_06	24365007	24370289	NA	NA	NA	NA	NA
PGEN_.00g138940	Scaffold_06	24397769	24398050	NA	NA	NA	NA	NA
PGEN_.00g138950	Scaffold_06	24406568	24414030	NA	NA	NA	NA	NA
PGEN_.00g138960	Scaffold_06	24442705	24446236	Q58D20	NLE1_BOVIN	Notchless protein homolog 1	GO:0000027; GO:0005730; GO:0007219	nucleolus [GO:0005730]; Notch signaling pathway [GO:0007219]; ribosomal large subunit assembly [GO:0000027]
PGEN_.00g138970	Scaffold_06	24447220	24448617	NA	NA	NA	NA	NA
PGEN_.00g138980	Scaffold_06	24463979	24470393	Q9NVR7	TBCC1_HUMAN	TBCC domain-containing protein 1	GO:0000902; GO:0005737; GO:0008360; GO:0030334; GO:0031616; GO:0051661; GO:0051684	cytoplasm [GO:0005737]; spindle pole centrosome [GO:0031616]; cell morphogenesis [GO:0000902]; maintenance of centrosome location [GO:0051661]; maintenance of Golgi location [GO:0051684]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]
PGEN_.00g138990	Scaffold_06	24471176	24490070	A1L0Z4	TBCC1_XENTR	TBCC domain-containing protein 1	GO:0000902; GO:0000922; GO:0005737; GO:0005815	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; cell morphogenesis [GO:0000902]
PGEN_.00g139000	Scaffold_06	24491673	24500131	P52555	ERP29_RAT	Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 31) (ERp31)	GO:0000187; GO:0001934; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0030133; GO:0034976; GO:0042470; GO:0042803; GO:0050709; GO:0051087; GO:1902235	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g139010	Scaffold_06	24541458	24552881	Q9H3F6	BACD3_HUMAN	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10)	GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0017049; GO:0031463; GO:0035024; GO:0043161; GO:0051260	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTP-Rho binding [GO:0017049]; Notch binding [GO:0005112]; negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g139020	Scaffold_06	24575034	24622465	NA	NA	NA	NA	NA
PGEN_.00g139030	Scaffold_06	24629041	24629746	NA	NA	NA	NA	NA
PGEN_.00g139040	Scaffold_06	24630151	24632970	NA	NA	NA	NA	NA
PGEN_.00g139050	Scaffold_06	24652481	24659999	G5EFP5	FUTC_CAEEL	"Alpha-(1,3)-fucosyltransferase fut-3 (EC 2.4.1.65) (Fucosyltransferase fut-3)"	GO:0006486; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g139060	Scaffold_06	24665507	24677165	Q6ICH7	ASPH2_HUMAN	Aspartate beta-hydroxylase domain-containing protein 2 (EC 1.14.11.-)	GO:0016020; GO:0016021; GO:0018193; GO:0046872; GO:0051213	integral component of membrane [GO:0016021]; membrane [GO:0016020]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; peptidyl-amino acid modification [GO:0018193]
PGEN_.00g139070	Scaffold_06	24677898	24702833	Q9SMH3	DYH1A_CHLRE	"Dynein-1-alpha heavy chain, flagellar inner arm I1 complex (1-alpha DHC) (Dynein-1, subspecies f)"	GO:0003777; GO:0005524; GO:0005874; GO:0008017; GO:0031514; GO:0036156; GO:0036159; GO:0060294	inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]
PGEN_.00g139080	Scaffold_06	24703019	24704007	NA	NA	NA	NA	NA
PGEN_.00g139090	Scaffold_06	24704249	24754795	Q8IVF4	DYH10_HUMAN	"Dynein heavy chain 10, axonemal (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10)"	GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g139100	Scaffold_06	24758816	24762229	NA	NA	NA	NA	NA
PGEN_.00g139110	Scaffold_06	24763410	24763673	NA	NA	NA	NA	NA
PGEN_.00g139120	Scaffold_06	24775311	24775565	NA	NA	NA	NA	NA
PGEN_.00g139130	Scaffold_06	24775701	24776288	NA	NA	NA	NA	NA
PGEN_.00g139140	Scaffold_06	24781069	24803402	A6QQ71	FKBP6_BOVIN	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36)	GO:0000413; GO:0000795; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0042802; GO:0043046; GO:0045070; GO:0051321; GO:0051879	cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; spermatogenesis [GO:0007283]
PGEN_.00g139150	Scaffold_06	24810928	24824241	Q9WVS8	MK07_MOUSE	Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5)	GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007049; GO:0010468; GO:0016605; GO:0018105; GO:0030154; GO:0034115; GO:0035556; GO:0036003; GO:0043066; GO:0043407; GO:0045765; GO:0045944; GO:0051019; GO:0051247; GO:0060761; GO:0070301; GO:0070377; GO:0070885; GO:0071363; GO:0071499; GO:0071560; GO:1902176; GO:2000352; GO:2001240	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to transforming growth factor beta stimulus [GO:0071560]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK5 cascade [GO:0070377]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of response to cytokine stimulus [GO:0060761]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; protein phosphorylation [GO:0006468]; regulation of angiogenesis [GO:0045765]; regulation of gene expression [GO:0010468]
PGEN_.00g139160	Scaffold_06	24826272	24843912	Q9BWT6	MND1_HUMAN	Meiotic nuclear division protein 1 homolog	GO:0003690; GO:0005634; GO:0007131	nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; reciprocal meiotic recombination [GO:0007131]
PGEN_.00g139170	Scaffold_06	24849455	24911808	NA	NA	NA	NA	NA
PGEN_.00g139180	Scaffold_06	24894454	24894729	NA	NA	NA	NA	NA
PGEN_.00g139190	Scaffold_06	24913618	24926561	O14735	CDIPT_HUMAN	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)	GO:0000139; GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]
PGEN_.00g139200	Scaffold_06	24940374	24944255	Q8R0J4	TM134_MOUSE	Transmembrane protein 134	GO:0016021; GO:0048471	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]
PGEN_.00g139210	Scaffold_06	24958685	24965553	P80928	MIF_PIG	Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase)	GO:0001516; GO:0002020; GO:0002906; GO:0004167; GO:0005125; GO:0005126; GO:0005615; GO:0005654; GO:0005829; GO:0005886; GO:0006954; GO:0007166; GO:0007569; GO:0008283; GO:0009986; GO:0010629; GO:0010739; GO:0010760; GO:0030330; GO:0030890; GO:0031666; GO:0032269; GO:0032760; GO:0033033; GO:0033138; GO:0042056; GO:0042802; GO:0043406; GO:0043518; GO:0045087; GO:0048146; GO:0050178; GO:0050715; GO:0050731; GO:0061078; GO:0061081; GO:0070207; GO:0070374; GO:0071157; GO:0090238; GO:0090344; GO:1902166; GO:2000343	"cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]; cell aging [GO:0007569]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cell aging [GO:0090344]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207]"
PGEN_.00g139220	Scaffold_06	24974690	24975028	NA	NA	NA	NA	NA
PGEN_.00g139230	Scaffold_06	24980167	24980451	NA	NA	NA	NA	NA
PGEN_.00g139240	Scaffold_06	24986409	24986849	NA	NA	NA	NA	NA
PGEN_.00g139250	Scaffold_06	24997128	25001850	NA	NA	NA	NA	NA
PGEN_.00g139260	Scaffold_06	25015439	25015690	NA	NA	NA	NA	NA
PGEN_.00g139270	Scaffold_06	25016297	25031537	Q9DB98	LENG1_MOUSE	Leukocyte receptor cluster member 1 homolog		
PGEN_.00g139280	Scaffold_06	25038432	25072886	NA	NA	NA	NA	NA
PGEN_.00g139290	Scaffold_06	25080705	25089589	Q174D3	MED19_AEDAE	Mediator of RNA polymerase II transcription subunit 19 (Mediator complex subunit 19)	GO:0003712; GO:0006357; GO:0016592	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g139300	Scaffold_06	25097669	25098577	NA	NA	NA	NA	NA
PGEN_.00g139310	Scaffold_06	25147210	25149028	NA	NA	NA	NA	NA
PGEN_.00g139320	Scaffold_06	25161521	25166987	NA	NA	NA	NA	NA
PGEN_.00g139330	Scaffold_06	25202654	25233553	Q7TNF8	RIMB1_MOUSE	Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1)	GO:0005737; GO:0005739; GO:0030156; GO:0044305; GO:0098978; GO:0099626	calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]
PGEN_.00g139340	Scaffold_06	25253373	25253651	NA	NA	NA	NA	NA
PGEN_.00g139350	Scaffold_06	25254717	25255043	NA	NA	NA	NA	NA
PGEN_.00g139360	Scaffold_06	25255077	25255367	NA	NA	NA	NA	NA
PGEN_.00g139370	Scaffold_06	25275700	25386965	Q7TNF8	RIMB1_MOUSE	Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1)	GO:0005737; GO:0005739; GO:0030156; GO:0044305; GO:0098978; GO:0099626	calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]
PGEN_.00g139380	Scaffold_06	25420524	25460086	Q76I76	SSH2_HUMAN	Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L)	GO:0000902; GO:0003779; GO:0004721; GO:0004725; GO:0005615; GO:0005737; GO:0005856; GO:0006470; GO:0008138; GO:0030036	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902]; protein dephosphorylation [GO:0006470]
PGEN_.00g139390	Scaffold_06	25478292	25507110	A4FU69	EFCB5_HUMAN	EF-hand calcium-binding domain-containing protein 5	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g139400	Scaffold_06	25565108	25565713	P58544	BTBD1_MOUSE	BTB/POZ domain-containing protein 1 (Glucose signal-repressing protein)	GO:0000932; GO:0005829; GO:0007517; GO:0016567; GO:0022008; GO:0032991	cytosol [GO:0005829]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]
PGEN_.00g139410	Scaffold_06	25581968	25586765	Q9H875	PKRI1_HUMAN	PRKR-interacting protein 1	GO:0003014; GO:0003725; GO:0004860; GO:0005681; GO:0005730; GO:0006397; GO:0006469; GO:0008380; GO:0019901; GO:0042326; GO:0070062	extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; mRNA processing [GO:0006397]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein kinase activity [GO:0006469]; renal system process [GO:0003014]; RNA splicing [GO:0008380]
PGEN_.00g139420	Scaffold_06	25587111	25593920	Q8LGU7	RNZ1_ARATH	tRNase Z TRZ1 (EC 3.1.26.11) (Nuclear ribonuclease Z) (Nuclear RNase Z) (Short tRNase Z 1) (Zinc phosphodiesterase NUZ) (tRNA 3 endonuclease) (tRNase ZS1) (AthTRZS1)	GO:0005634; GO:0005737; GO:0008033; GO:0042780; GO:0042781; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]; tRNA 3'-end processing [GO:0042780]; tRNA processing [GO:0008033]
PGEN_.00g139430	Scaffold_06	25598783	25611921	NA	NA	NA	NA	NA
PGEN_.00g139440	Scaffold_06	25613285	25613758	NA	NA	NA	NA	NA
PGEN_.00g139450	Scaffold_06	25616131	25620589	NA	NA	NA	NA	NA
PGEN_.00g139460	Scaffold_06	25672341	25672685	Q99PP7	TRI33_MOUSE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0017015; GO:0030514; GO:0070410; GO:0070412	nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]
PGEN_.00g139470	Scaffold_06	25678040	25702180	P07314	GGT1_RAT	Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]	GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006750; GO:0006751; GO:0007283; GO:0007568; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0102953; GO:0103068; GO:1901750	"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; transferase activity, transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]"
PGEN_.00g139480	Scaffold_06	25703053	25704132	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g139490	Scaffold_06	25709568	25709789	NA	NA	NA	NA	NA
PGEN_.00g139500	Scaffold_06	25717449	25717676	NA	NA	NA	NA	NA
PGEN_.00g139510	Scaffold_06	25723449	25723829	Q7Z4N8	P4HA3_HUMAN	"Prolyl 4-hydroxylase subunit alpha-3 (4-PH alpha-3) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3)"	GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"
PGEN_.00g139520	Scaffold_06	25725691	25726176	NA	NA	NA	NA	NA
PGEN_.00g139530	Scaffold_06	25730256	25730618	NA	NA	NA	NA	NA
PGEN_.00g139540	Scaffold_06	25730920	25732298	NA	NA	NA	NA	NA
PGEN_.00g139550	Scaffold_06	25734133	25734369	NA	NA	NA	NA	NA
PGEN_.00g139560	Scaffold_06	25734949	25736806	NA	NA	NA	NA	NA
PGEN_.00g139570	Scaffold_06	25736847	25737710	NA	NA	NA	NA	NA
PGEN_.00g139580	Scaffold_06	25812130	25813135	NA	NA	NA	NA	NA
PGEN_.00g139590	Scaffold_06	25874362	25876464	NA	NA	NA	NA	NA
PGEN_.00g139600	Scaffold_06	26029994	26148986	Q01097	NMDE2_MOUSE	"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B)"	GO:0001508; GO:0001662; GO:0001666; GO:0001701; GO:0001964; GO:0001967; GO:0004970; GO:0004972; GO:0005102; GO:0005149; GO:0005234; GO:0005261; GO:0005262; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006812; GO:0006816; GO:0007268; GO:0007423; GO:0007611; GO:0007612; GO:0007613; GO:0008013; GO:0008021; GO:0008066; GO:0008144; GO:0008270; GO:0008306; GO:0009986; GO:0010243; GO:0010738; GO:0010942; GO:0014049; GO:0014069; GO:0016020; GO:0016594; GO:0016595; GO:0017146; GO:0022849; GO:0030018; GO:0030054; GO:0031749; GO:0035235; GO:0035249; GO:0035255; GO:0042165; GO:0042596; GO:0042734; GO:0043005; GO:0043025; GO:0043083; GO:0043113; GO:0043195; GO:0043197; GO:0043408; GO:0044877; GO:0045202; GO:0045211; GO:0045471; GO:0046960; GO:0048167; GO:0048168; GO:0048169; GO:0048266; GO:0048511; GO:0050804; GO:0050806; GO:0050839; GO:0050966; GO:0051290; GO:0060078; GO:0060079; GO:0060291; GO:0097060; GO:0097110; GO:0097440; GO:0097553; GO:0098686; GO:0098688; GO:0098794; GO:0098839; GO:0098978; GO:0098989; GO:0099056; GO:0099061; GO:0099529; GO:0099566; GO:0099583; GO:1901216; GO:1902951; GO:1904315; GO:2001056	"apical dendrite [GO:0097440]; cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; Z disc [GO:0030018]; beta-catenin binding [GO:0008013]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; cell adhesion molecule binding [GO:0050839]; D2 dopamine receptor binding [GO:0031749]; drug binding [GO:0008144]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; interleukin-1 receptor binding [GO:0005149]; ionotropic glutamate receptor activity [GO:0004970]; ionotropic glutamate receptor binding [GO:0035255]; neurotransmitter binding [GO:0042165]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099529]; NMDA glutamate receptor activity [GO:0004972]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; action potential [GO:0001508]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; behavioral response to pain [GO:0048266]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; excitatory postsynaptic potential [GO:0060079]; fear response [GO:0042596]; in utero embryonic development [GO:0001701]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine maintenance [GO:1902951]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of cell death [GO:0010942]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of neuron death [GO:1901216]; positive regulation of synaptic transmission [GO:0050806]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of protein kinase A signaling [GO:0010738]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]; sensitization [GO:0046960]; sensory organ development [GO:0007423]; startle response [GO:0001964]; suckling behavior [GO:0001967]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g139610	Scaffold_06	26155545	26189403	NA	NA	NA	NA	NA
PGEN_.00g139620	Scaffold_06	26195459	26197082	NA	NA	NA	NA	NA
PGEN_.00g139630	Scaffold_06	26206264	26239756	NA	NA	NA	NA	NA
PGEN_.00g139640	Scaffold_06	26276406	26276960	NA	NA	NA	NA	NA
PGEN_.00g139650	Scaffold_06	26290520	26311934	Q9WUK2	IF4H_MOUSE	Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein homolog)	GO:0003743; GO:0005844; GO:0019953; GO:0048471; GO:0048589	perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; translation initiation factor activity [GO:0003743]; developmental growth [GO:0048589]; sexual reproduction [GO:0019953]
PGEN_.00g139660	Scaffold_06	26312116	26333840	Q6DRL5	MBB1A_DANRE	Myb-binding protein 1A-like protein	GO:0003714; GO:0005730; GO:0006355; GO:0008134; GO:0043565; GO:0048511	"nucleolus [GO:0005730]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"
PGEN_.00g139670	Scaffold_06	26335288	26352006	NA	NA	NA	NA	NA
PGEN_.00g139680	Scaffold_06	26356132	26356386	NA	NA	NA	NA	NA
PGEN_.00g139690	Scaffold_06	26360379	26382413	Q6DRL5	MBB1A_DANRE	Myb-binding protein 1A-like protein	GO:0003714; GO:0005730; GO:0006355; GO:0008134; GO:0043565; GO:0048511	"nucleolus [GO:0005730]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"
PGEN_.00g139700	Scaffold_06	26414966	26433421	Q1JPB9	PA2G3_BOVIN	Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3)	GO:0004623; GO:0005576; GO:0005737; GO:0005814; GO:0005886; GO:0006644; GO:0016042; GO:0046872; GO:0050482; GO:0060271; GO:0102567; GO:0102568	"centriole [GO:0005814]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; cilium assembly [GO:0060271]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]"
PGEN_.00g139710	Scaffold_06	26512544	26517967	NA	NA	NA	NA	NA
PGEN_.00g139720	Scaffold_06	26522687	26531848	Q2TU62	CLCA1_HORSE	Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (eCLCA1)	GO:0005229; GO:0005615; GO:0005887; GO:0005902; GO:0006816; GO:0008237; GO:0030141; GO:0046872	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; secretory granule [GO:0030141]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; calcium ion transport [GO:0006816]
PGEN_.00g139730	Scaffold_06	26535891	26569418	Q14CN2	CLCA4_HUMAN	"Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form]"	GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0008237; GO:0016324; GO:0034220; GO:0046872	apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ion transmembrane transport [GO:0034220]
PGEN_.00g139740	Scaffold_06	26575741	26595945	Q6Q473	CLA4A_MOUSE	"Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form]"	GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0006821; GO:0008237; GO:0015276; GO:0016324; GO:0046872	apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; chloride transport [GO:0006821]
PGEN_.00g139750	Scaffold_06	26627204	26629702	NA	NA	NA	NA	NA
PGEN_.00g139760	Scaffold_06	26638357	26638893	NA	NA	NA	NA	NA
PGEN_.00g139770	Scaffold_06	26645853	26650187	Q9C9W3	CAMT1_ARATH	Putative caffeoyl-CoA O-methyltransferase At1g67980 (EC 2.1.1.104) (Trans-caffeoyl-CoA 3-O-methyltransferase) (CCoAMT) (CCoAOMT)	GO:0005829; GO:0009809; GO:0032259; GO:0042409; GO:0046872	cytosol [GO:0005829]; caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; lignin biosynthetic process [GO:0009809]; methylation [GO:0032259]
PGEN_.00g139780	Scaffold_06	26663679	26664092	P31907	HOXX_BRADU	Hydrogenase maturation factor HoxX	GO:0009058; GO:0016742	"hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; biosynthetic process [GO:0009058]"
PGEN_.00g139790	Scaffold_06	26665006	26668210	P31907	HOXX_BRADU	Hydrogenase maturation factor HoxX	GO:0009058; GO:0016742	"hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; biosynthetic process [GO:0009058]"
PGEN_.00g139800	Scaffold_06	26673654	26674304	NA	NA	NA	NA	NA
PGEN_.00g139810	Scaffold_06	26674627	26675010	NA	NA	NA	NA	NA
PGEN_.00g139820	Scaffold_06	26701699	26701986	NA	NA	NA	NA	NA
PGEN_.00g139830	Scaffold_06	26751098	26758147	P83299	CAH1_CHIHA	Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase I) (CA-I) (Ice-CA)	GO:0004089; GO:0005737; GO:0008270	cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
PGEN_.00g139840	Scaffold_06	26760296	26772510	Q9GP32	ALF_ECHMU	Fructose-bisphosphate aldolase (EC 4.1.2.13)	GO:0004332; GO:0006096	fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]
PGEN_.00g139850	Scaffold_06	26825127	26838623	P31907	HOXX_BRADU	Hydrogenase maturation factor HoxX	GO:0009058; GO:0016742	"hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; biosynthetic process [GO:0009058]"
PGEN_.00g139860	Scaffold_06	26854141	26858227	Q9VJE4	RPB11_DROME	DNA-directed RNA polymerase II subunit RPB11 (RNA polymerase II subunit B11) (DNA-directed RNA polymerase II 13.3 kDa polypeptide) (DNA-directed RNA polymerase II subunit J)	GO:0001055; GO:0003677; GO:0003899; GO:0005665; GO:0006366; GO:0046983	"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g139870	Scaffold_06	26883414	26897486	Q5M8K8	IFT22_XENTR	Intraflagellar transport protein 22 homolog (Rab-like protein 5)	GO:0003924; GO:0005525; GO:0006886; GO:0030992; GO:0032482	intraciliary transport particle B [GO:0030992]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g139880	Scaffold_06	26905473	26908951	P55083	MFAP4_HUMAN	Microfibril-associated glycoprotein 4	GO:0001527; GO:0005576; GO:0007155; GO:0009650; GO:0010712; GO:0048251; GO:0062023; GO:0071493; GO:0071953; GO:0097435	collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular region [GO:0005576]; microfibril [GO:0001527]; cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; supramolecular fiber organization [GO:0097435]; UV protection [GO:0009650]
PGEN_.00g139890	Scaffold_06	26916060	26922697	Q95LU3	FBCD1_MACFA	Fibrinogen C domain-containing protein 1	GO:0008061; GO:0016020; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g139900	Scaffold_06	26929914	26935285	NA	NA	NA	NA	NA
PGEN_.00g139910	Scaffold_06	27024201	27025169	Q7LL04	YQK1_SCHPO	UPF0676 protein C1494.01	GO:0005634; GO:0005829; GO:0051213	cytosol [GO:0005829]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]
PGEN_.00g139920	Scaffold_06	27030358	27030942	Q7LL04	YQK1_SCHPO	UPF0676 protein C1494.01	GO:0005634; GO:0005829; GO:0051213	cytosol [GO:0005829]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]
PGEN_.00g139930	Scaffold_06	27034965	27035810	Q7LL04	YQK1_SCHPO	UPF0676 protein C1494.01	GO:0005634; GO:0005829; GO:0051213	cytosol [GO:0005829]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]
PGEN_.00g139940	Scaffold_06	27041439	27042407	Q7LL04	YQK1_SCHPO	UPF0676 protein C1494.01	GO:0005634; GO:0005829; GO:0051213	cytosol [GO:0005829]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]
PGEN_.00g139950	Scaffold_06	27043765	27046938	S3D9F9	GLOC_GLAL2	2-oxoglutarate-dependent dioxygenase gloC (EC 1.14.-.-) (Leucine dioxygenase) (Pneumocandin biosynthesis cluster protein C)	GO:0046872; GO:0051213	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]
PGEN_.00g139960	Scaffold_06	27051637	27052605	Q54RA4	Y3291_DICDI	Probable iron/ascorbate oxidoreductase DDB_G0283291 (EC 1.14.-.-)	GO:0046872; GO:0051213	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]
PGEN_.00g139970	Scaffold_06	27078352	27125094	Q8WWT9	S13A3_HUMAN	Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)	GO:0005886; GO:0015137; GO:0015139; GO:0015141; GO:0015362; GO:0015746; GO:0016021; GO:0017153; GO:0070062	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]
PGEN_.00g139980	Scaffold_06	27181881	27188368	H2A0M0	NRP_PINMG	Asparagine-rich protein (Prism uncharacterized shell protein 1) (PUSP1)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g139990	Scaffold_06	27204231	27227855	NA	NA	NA	NA	NA
PGEN_.00g140000	Scaffold_06	27241827	27248234	Q4KMP7	TB10B_HUMAN	TBC1 domain family member 10B (Rab27A-GAP-beta)	GO:0005096; GO:0005829; GO:0005886; GO:0006886; GO:0017137; GO:0042147; GO:0043087; GO:0090630	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g140010	Scaffold_06	27262273	27264189	A2T812	ZN287_PONPY	Zinc finger protein 287	GO:0003677; GO:0003700; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]
PGEN_.00g140020	Scaffold_06	27284116	27314252	Q6P9A1	ZN530_HUMAN	Zinc finger protein 530	GO:0003677; GO:0005634; GO:0045892; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g140030	Scaffold_06	27303671	27303937	NA	NA	NA	NA	NA
PGEN_.00g140040	Scaffold_06	27322152	27331493	B0S1F7	DNAJ_FINM2	Chaperone protein DnaJ	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]
PGEN_.00g140050	Scaffold_06	27355474	27442419	NA	NA	NA	NA	NA
PGEN_.00g140060	Scaffold_06	27455008	27508078	Q8WZ42	TITIN_HUMAN	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030017; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0071688; GO:0097493	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
PGEN_.00g140070	Scaffold_06	27521862	27532438	Q8IYT8	ULK2_HUMAN	Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2)	GO:0000045; GO:0000407; GO:0004674; GO:0005524; GO:0005829; GO:0006914; GO:0007165; GO:0010506; GO:0016020; GO:0030659; GO:0034045; GO:0042594; GO:0046777; GO:0048671; GO:0048675; GO:0075044	cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; negative regulation of collateral sprouting [GO:0048671]; positive regulation by symbiont of host autophagy [GO:0075044]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; signal transduction [GO:0007165]
PGEN_.00g140080	Scaffold_06	27534263	27565589	Q23023	UNC51_CAEEL	Serine/threonine-protein kinase unc-51 (EC 2.7.11.1) (Uncoordinated protein 51)	GO:0000045; GO:0000407; GO:0004672; GO:0004674; GO:0005524; GO:0005829; GO:0006468; GO:0006914; GO:0007409; GO:0007411; GO:0008340; GO:0008361; GO:0009792; GO:0010506; GO:0012501; GO:0016020; GO:0016477; GO:0030424; GO:0030516; GO:0032880; GO:0040014; GO:0040024; GO:0043005; GO:0043025; GO:0043277; GO:0045138; GO:0046777; GO:0046872	axon [GO:0030424]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic cell clearance [GO:0043277]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880]
PGEN_.00g140090	Scaffold_06	27568029	27576512	O08715	AKAP1_MOUSE	"A-kinase anchor protein 1, mitochondrial (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein) (S-AKAP)"	GO:0003723; GO:0005739; GO:0005741; GO:0005783; GO:0005811; GO:0008017; GO:0010614; GO:0010738; GO:0016021; GO:0019901; GO:0019903; GO:0030061; GO:0030346; GO:0031594; GO:0034237; GO:0035308; GO:0042308; GO:0045211; GO:0048487; GO:0060090	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial crista [GO:0030061]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; molecular adaptor activity [GO:0060090]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein import into nucleus [GO:0042308]; regulation of protein kinase A signaling [GO:0010738]
PGEN_.00g140100	Scaffold_06	27581848	27589560	Q9U641	CMFB_DICDI	Conditioned medium factor receptor 1	GO:0009234; GO:0016021; GO:0016627; GO:0055114; GO:0071949	"integral component of membrane [GO:0016021]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; menaquinone biosynthetic process [GO:0009234]; oxidation-reduction process [GO:0055114]"
PGEN_.00g140110	Scaffold_06	27626631	27639307	NA	NA	NA	NA	NA
PGEN_.00g140120	Scaffold_06	27639411	27639686	NA	NA	NA	NA	NA
PGEN_.00g140130	Scaffold_06	27683830	27709326	NA	NA	NA	NA	NA
PGEN_.00g140140	Scaffold_06	27730139	27744342	Q2KN97	CYTSA_CHICK	Cytospin-A (SPECC1-like protein) (Sperm antigen with calponin homology and coiled-coil domains 1-like)	GO:0005737; GO:0005815; GO:0005819; GO:0005921; GO:0007049; GO:0030036; GO:0031941; GO:0051301	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; actin cytoskeleton organization [GO:0030036]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g140150	Scaffold_06	27769767	27779891	O15297	PPM1D_HUMAN	Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1)	GO:0000086; GO:0004674; GO:0004722; GO:0004724; GO:0005634; GO:0005654; GO:0005829; GO:0006306; GO:0006342; GO:0006367; GO:0006470; GO:0008285; GO:0009267; GO:0009314; GO:0009617; GO:0030330; GO:0035970; GO:0045814; GO:0046872; GO:0051019	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to starvation [GO:0009267]; chromatin silencing [GO:0006342]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g140160	Scaffold_06	27795451	27800861	A4FVI0	ZSWM7_DANRE	Zinc finger SWIM domain-containing protein 7	GO:0000724; GO:0005634; GO:0008270; GO:0097196	nucleus [GO:0005634]; Shu complex [GO:0097196]; zinc ion binding [GO:0008270]; double-strand break repair via homologous recombination [GO:0000724]
PGEN_.00g140170	Scaffold_06	27855066	27860956	Q8H183	BUP1_ARATH	Beta-ureidopropionase (EC 3.5.1.6) (N-carbamoyl-beta-alanine amidohydrolase) (Protein PYRIMIDINE 3)	GO:0003837; GO:0005829; GO:0006212; GO:0019482; GO:0033396; GO:0043562	cytosol [GO:0005829]; beta-ureidopropionase activity [GO:0003837]; beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; beta-alanine metabolic process [GO:0019482]; cellular response to nitrogen levels [GO:0043562]; uracil catabolic process [GO:0006212]
PGEN_.00g140180	Scaffold_06	27864110	27890932	Q27294	CAZ_DROME	RNA-binding protein cabeza (P19) (Sarcoma-associated RNA-binding fly homolog)	GO:0000398; GO:0003682; GO:0003729; GO:0005634; GO:0005654; GO:0005669; GO:0006355; GO:0006367; GO:0008344; GO:0008345; GO:0045887; GO:0046872; GO:0048749; GO:0051124; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; adult locomotory behavior [GO:0008344]; compound eye development [GO:0048749]; larval locomotory behavior [GO:0008345]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; regulation of transcription, DNA-templated [GO:0006355]; synaptic growth at neuromuscular junction [GO:0051124]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g140190	Scaffold_06	27908446	27927838	Q5SPL2	PHF12_MOUSE	PHD finger protein 12 (PHD factor 1) (Pf1)	GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0016580; GO:0017053; GO:0035091; GO:0045892; GO:0046872; GO:0070822	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcriptional repressor complex [GO:0017053]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g140200	Scaffold_06	27936664	27937041	NA	NA	NA	NA	NA
PGEN_.00g140210	Scaffold_06	27941754	27946440	NA	NA	NA	NA	NA
PGEN_.00g140220	Scaffold_06	27959157	27964116	NA	NA	NA	NA	NA
PGEN_.00g140230	Scaffold_06	27978893	28026653	Q5PQT2	MTMR3_RAT	"Myotubularin-related protein 3 (EC 3.1.3.48) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0006470; GO:0016020; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	"cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to glucose starvation [GO:0042149]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"
PGEN_.00g140240	Scaffold_06	28031003	28034898	Q05B89	NIF3L_BOVIN	NIF3-like protein 1	GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:1903507	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]
PGEN_.00g140250	Scaffold_06	28038471	28043444	NA	NA	NA	NA	NA
PGEN_.00g140260	Scaffold_06	28044315	28048768	NA	NA	NA	NA	NA
PGEN_.00g140270	Scaffold_06	28050544	28051011	NA	NA	NA	NA	NA
PGEN_.00g140280	Scaffold_06	28051887	28056469	NA	NA	NA	NA	NA
PGEN_.00g140290	Scaffold_06	28056991	28063400	NA	NA	NA	NA	NA
PGEN_.00g140300	Scaffold_06	28078986	28096431	Q9BW91	NUDT9_HUMAN	"ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)"	GO:0005739; GO:0005759; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0034656; GO:0043262; GO:0046032; GO:0046709; GO:0047631; GO:0070062	cell junction [GO:0030054]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule catabolic process [GO:0034656]
PGEN_.00g140310	Scaffold_06	28097745	28112985	NA	NA	NA	NA	NA
PGEN_.00g140320	Scaffold_06	28127056	28129053	NA	NA	NA	NA	NA
PGEN_.00g140330	Scaffold_06	28132157	28134611	NA	NA	NA	NA	NA
PGEN_.00g140340	Scaffold_06	28148571	28150049	NA	NA	NA	NA	NA
PGEN_.00g140350	Scaffold_06	28176934	28181345	NA	NA	NA	NA	NA
PGEN_.00g140360	Scaffold_06	28185405	28190188	NA	NA	NA	NA	NA
PGEN_.00g140370	Scaffold_06	28193156	28211289	A4FUP9	GL1D1_MOUSE	Glycosyltransferase 1 domain-containing protein 1 (EC 2.4.-.-)	GO:0005576; GO:0005829; GO:0016757	"cytosol [GO:0005829]; extracellular region [GO:0005576]; transferase activity, transferring glycosyl groups [GO:0016757]"
PGEN_.00g140380	Scaffold_06	28252690	28252977	NA	NA	NA	NA	NA
PGEN_.00g140390	Scaffold_06	28253610	28254874	NA	NA	NA	NA	NA
PGEN_.00g140400	Scaffold_06	28255128	28255460	NA	NA	NA	NA	NA
PGEN_.00g140410	Scaffold_06	28259310	28259933	NA	NA	NA	NA	NA
PGEN_.00g140420	Scaffold_06	28276315	28277747	NA	NA	NA	NA	NA
PGEN_.00g140430	Scaffold_06	28283964	28302954	P31907	HOXX_BRADU	Hydrogenase maturation factor HoxX	GO:0009058; GO:0016742	"hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; biosynthetic process [GO:0009058]"
PGEN_.00g140440	Scaffold_06	28306728	28345711	NA	NA	NA	NA	NA
PGEN_.00g140450	Scaffold_06	28369844	28380667	P97328	KHK_MOUSE	Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase)	GO:0004454; GO:0005524; GO:0005634; GO:0005737; GO:0006000; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0019200; GO:0032868; GO:0061624; GO:0061625; GO:0070873	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; ketohexokinase activity [GO:0004454]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; glycolytic process through fructose-1-phosphate [GO:0061625]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]
PGEN_.00g140460	Scaffold_06	28389126	28397733	P12394	CP17A_CHICK	"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)"	GO:0004508; GO:0005506; GO:0006694; GO:0007548; GO:0008202; GO:0016020; GO:0020037; GO:0042446; GO:0042448; GO:0047442	membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]
PGEN_.00g140470	Scaffold_06	28399467	28408915	Q96RQ3	MCCA_HUMAN	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:1905202	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]"
PGEN_.00g140480	Scaffold_06	28410183	28419315	Q99MR8	MCCA_MOUSE	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006552; GO:0046872; GO:1905202	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]"
PGEN_.00g140490	Scaffold_06	28466769	28486039	NA	NA	NA	NA	NA
PGEN_.00g140500	Scaffold_06	28493771	28494214	NA	NA	NA	NA	NA
PGEN_.00g140510	Scaffold_06	28509476	28511362	NA	NA	NA	NA	NA
PGEN_.00g140520	Scaffold_06	28541248	28550041	NA	NA	NA	NA	NA
PGEN_.00g140530	Scaffold_06	28550067	28559260	Q28039	SC6A9_BOVIN	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)	GO:0005283; GO:0005328; GO:0005886; GO:0005887	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g140540	Scaffold_06	28559359	28566156	Q9Y345	SC6A5_HUMAN	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g140550	Scaffold_06	28601974	28602267	NA	NA	NA	NA	NA
PGEN_.00g140560	Scaffold_06	28614608	28650378	O60688	YPEL1_HUMAN	Protein yippee-like 1	GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]
PGEN_.00g140570	Scaffold_06	28666821	28667033	NA	NA	NA	NA	NA
PGEN_.00g140580	Scaffold_06	28702064	28708263	P46662	MERL_MOUSE	Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomin)	GO:0001707; GO:0001726; GO:0003779; GO:0005178; GO:0005634; GO:0005730; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006469; GO:0007398; GO:0007420; GO:0008013; GO:0008285; GO:0014010; GO:0014013; GO:0019904; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030175; GO:0030308; GO:0030864; GO:0031647; GO:0032154; GO:0032991; GO:0035330; GO:0042127; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045121; GO:0045177; GO:0045202; GO:0045216; GO:0045597; GO:0046426; GO:0048471; GO:0050767; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; integrin binding [GO:0005178]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]
PGEN_.00g140590	Scaffold_06	28717290	28717550	NA	NA	NA	NA	NA
PGEN_.00g140600	Scaffold_06	28718090	28719105	NA	NA	NA	NA	NA
PGEN_.00g140610	Scaffold_06	28725250	28731608	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g140620	Scaffold_06	28742000	28752916	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g140630	Scaffold_06	28753890	28755624	NA	NA	NA	NA	NA
PGEN_.00g140640	Scaffold_06	28762445	28766212	NA	NA	NA	NA	NA
PGEN_.00g140650	Scaffold_06	28771603	28771919	NA	NA	NA	NA	NA
PGEN_.00g140660	Scaffold_06	28779298	28793006	P63005	LIS1_MOUSE	Platelet-activating factor acetylhydrolase IB subunit alpha (Lissencephaly-1 protein) (LIS-1) (PAF acetylhydrolase 45 kDa subunit) (PAF-AH 45 kDa subunit) (PAF-AH alpha) (PAFAH alpha)	GO:0000132; GO:0000226; GO:0000235; GO:0000776; GO:0001667; GO:0001675; GO:0001764; GO:0001961; GO:0005623; GO:0005635; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005875; GO:0005881; GO:0005938; GO:0007017; GO:0007097; GO:0007268; GO:0007405; GO:0007611; GO:0008017; GO:0008090; GO:0008344; GO:0009306; GO:0010977; GO:0015630; GO:0016042; GO:0016477; GO:0017145; GO:0019226; GO:0021540; GO:0021766; GO:0021819; GO:0021895; GO:0021987; GO:0030036; GO:0030424; GO:0030426; GO:0031023; GO:0031514; GO:0031965; GO:0031982; GO:0032420; GO:0036035; GO:0040019; GO:0042249; GO:0042803; GO:0043005; GO:0043025; GO:0043087; GO:0043622; GO:0044877; GO:0045202; GO:0045505; GO:0045773; GO:0045931; GO:0046329; GO:0047496; GO:0048471; GO:0048854; GO:0050885; GO:0051010; GO:0051012; GO:0051081; GO:0051130; GO:0051219; GO:0051660; GO:0051661; GO:0060117; GO:0061003; GO:0070507; GO:0070840; GO:0090102; GO:0090176; GO:0090724; GO:1904115	astral microtubule [GO:0000235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell [GO:0005623]; cell cortex [GO:0005938]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; synapse [GO:0045202]; vesicle [GO:0031982]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; acrosome assembly [GO:0001675]; actin cytoskeleton organization [GO:0030036]; adult locomotory behavior [GO:0008344]; ameboidal-type cell migration [GO:0001667]; auditory receptor cell development [GO:0060117]; brain morphogenesis [GO:0048854]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; corpus callosum morphogenesis [GO:0021540]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hippocampus development [GO:0021766]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; lipid catabolic process [GO:0016042]; maintenance of centrosome location [GO:0051661]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; microtubule-based process [GO:0007017]; negative regulation of JNK cascade [GO:0046329]; negative regulation of neuron projection development [GO:0010977]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; osteoclast development [GO:0036035]; positive regulation of axon extension [GO:0045773]; positive regulation of cellular component organization [GO:0051130]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of embryonic development [GO:0040019]; positive regulation of mitotic cell cycle [GO:0045931]; protein secretion [GO:0009306]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde axonal transport [GO:0008090]; stem cell division [GO:0017145]; transmission of nerve impulse [GO:0019226]; vesicle transport along microtubule [GO:0047496]
PGEN_.00g140670	Scaffold_06	28813444	28820114	Q6DC64	MET16_DANRE	RNA N6-adenosine-methyltransferase mettl16 (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (N6-adenosine-methyltransferase METTL16) (EC 2.1.1.348) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346)	GO:0001734; GO:0003723; GO:0005634; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0052907; GO:0061157; GO:0070475; GO:0080009; GO:0120048; GO:0120049	"nucleus [GO:0005634]; 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]"
PGEN_.00g140680	Scaffold_06	28840575	28852170	P48612	PELO_DROME	Protein pelota (EC 3.1.-.-)	GO:0000212; GO:0001745; GO:0004519; GO:0005634; GO:0005737; GO:0007141; GO:0008315; GO:0016441; GO:0030718; GO:0032790; GO:0036098; GO:0043022; GO:0046872; GO:0048132; GO:0048137; GO:0051078; GO:0051321; GO:0070481; GO:0070651; GO:0070966; GO:0071025; GO:1990533	"cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137]"
PGEN_.00g140690	Scaffold_06	28859508	28859840	NA	NA	NA	NA	NA
PGEN_.00g140700	Scaffold_06	28873988	28874836	NA	NA	NA	NA	NA
PGEN_.00g140710	Scaffold_06	28876979	28878190	Q29042	FCN1_PIG	Ficolin-1 (Ficolin-A) (Ficolin-alpha)	GO:0005576; GO:0005581; GO:0005886; GO:0030246; GO:0045087; GO:0046872	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; innate immune response [GO:0045087]
PGEN_.00g140720	Scaffold_06	28882119	28882412	NA	NA	NA	NA	NA
PGEN_.00g140730	Scaffold_06	28882545	28885244	NA	NA	NA	NA	NA
PGEN_.00g140740	Scaffold_06	28893719	28908180	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g140750	Scaffold_06	28911987	28927659	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g140760	Scaffold_06	28929219	28942390	P81282	CSPG2_BOVIN	Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M)	GO:0001501; GO:0001750; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0033165	extracellular matrix [GO:0031012]; interphotoreceptor matrix [GO:0033165]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g140770	Scaffold_06	28943218	28946532	NA	NA	NA	NA	NA
PGEN_.00g140780	Scaffold_06	28947922	28952686	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g140790	Scaffold_06	28956602	28985161	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g140800	Scaffold_06	28991749	28993821	NA	NA	NA	NA	NA
PGEN_.00g140810	Scaffold_06	29110632	29113790	NA	NA	NA	NA	NA
PGEN_.00g140820	Scaffold_06	29118110	29119009	NA	NA	NA	NA	NA
PGEN_.00g140830	Scaffold_06	29121062	29130923	NA	NA	NA	NA	NA
PGEN_.00g140840	Scaffold_06	29163192	29182052	Q09288	YQK4_CAEEL	Uncharacterized protein C56G2.4		
PGEN_.00g140850	Scaffold_06	29225335	29229296	P16273	PRPX_HORVU	Pathogen-related protein	GO:0006952; GO:0009607	defense response [GO:0006952]; response to biotic stimulus [GO:0009607]
PGEN_.00g140860	Scaffold_06	29232296	29267248	Q6YHU6	THADA_HUMAN	Thyroid adenoma-associated protein (Gene inducing thyroid adenomas protein)	GO:0005829; GO:0030488; GO:0032471; GO:0055088; GO:0098554; GO:1901895; GO:1990845	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; adaptive thermogenesis [GO:1990845]; lipid homeostasis [GO:0055088]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]
PGEN_.00g140870	Scaffold_06	29271520	29273352	NA	NA	NA	NA	NA
PGEN_.00g140880	Scaffold_06	29308928	29309581	Q96S79	RSLAB_HUMAN	Ras-like protein family member 10B (Ras-like protein VTS58635) (Ras-related protein 17) (RRP17)	GO:0003050; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0090277	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]; signal transduction [GO:0007165]
PGEN_.00g140890	Scaffold_06	29322620	29322886	P15305	DYHC_ONCMY	Dynein heavy chain (DYHC) (Fragment)	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0031514	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; motor activity [GO:0003774]
PGEN_.00g140900	Scaffold_06	29333639	29334046	P03934	TC1A_CAEEL	Transposable element Tc1 transposase	GO:0003677; GO:0004519; GO:0005634; GO:0006313; GO:0015074	"nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g140910	Scaffold_06	29334105	29334446	NA	NA	NA	NA	NA
PGEN_.00g140920	Scaffold_06	29405921	29411192	NA	NA	NA	NA	NA
PGEN_.00g140930	Scaffold_06	29432551	29453578	P17871	TBP_SCHPO	TATA-box-binding protein (TATA sequence-binding protein) (TBP) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit)	GO:0000120; GO:0000126; GO:0000978; GO:0000979; GO:0000995; GO:0001006; GO:0001016; GO:0001181; GO:0003700; GO:0005634; GO:0005667; GO:0005669; GO:0006361; GO:0006366; GO:0006367; GO:0006384; GO:0008134; GO:0016251; GO:0070898	nucleus [GO:0005634]; RNA polymerase I transcription factor complex [GO:0000120]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIIB complex [GO:0000126]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III regulatory region DNA binding [GO:0001016]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; transcription factor binding [GO:0008134]; RNA polymerase III preinitiation complex assembly [GO:0070898]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase III promoter [GO:0006384]
PGEN_.00g140940	Scaffold_06	29470158	29474718	NA	NA	NA	NA	NA
PGEN_.00g140950	Scaffold_06	29482299	29482628	NA	NA	NA	NA	NA
PGEN_.00g140960	Scaffold_06	29485237	29488942	Q5M8L8	HVCN1_XENTR	Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1)	GO:0005887; GO:0030171; GO:0034765; GO:0071294; GO:0071467; GO:1902600	integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g140970	Scaffold_06	29503020	29504985	Q9DC26	S46A3_MOUSE	Solute carrier family 46 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g140980	Scaffold_06	29519329	29548908	Q5RJI4	PKDCC_MOUSE	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g140990	Scaffold_06	29561359	29568206	NA	NA	NA	NA	NA
PGEN_.00g141000	Scaffold_06	29630757	29631531	NA	NA	NA	NA	NA
PGEN_.00g141010	Scaffold_06	29634092	29646702	NA	NA	NA	NA	NA
PGEN_.00g141020	Scaffold_06	29671255	29684268	Q6GVH4	GGNB2_CHICK	Gametogenetin-binding protein 2 (Protein ZNF403)	GO:0005634; GO:0005737; GO:0007275; GO:0007283; GO:0030154	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g141030	Scaffold_06	29693172	29709086	Q3SZP8	TAD2A_BOVIN	Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein)	GO:0000278; GO:0001932; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0005671; GO:0005694; GO:0006338; GO:0006357; GO:0016573; GO:0031063; GO:0031647; GO:0035066; GO:0070461; GO:0072686; GO:0090043	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; chromosome [GO:0005694]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA-type complex [GO:0070461]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; positive regulation of histone acetylation [GO:0035066]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]
PGEN_.00g141040	Scaffold_06	29719404	29730386	O88845	AKA10_MOUSE	"A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10)"	GO:0005739; GO:0005829; GO:0005886; GO:0008104; GO:0032991; GO:0051018	cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase A binding [GO:0051018]; protein localization [GO:0008104]
PGEN_.00g141050	Scaffold_06	29733467	29744449	O88845	AKA10_MOUSE	"A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10)"	GO:0005739; GO:0005829; GO:0005886; GO:0008104; GO:0032991; GO:0051018	cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase A binding [GO:0051018]; protein localization [GO:0008104]
PGEN_.00g141060	Scaffold_06	29755134	29771120	Q3SZP8	TAD2A_BOVIN	Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein)	GO:0000278; GO:0001932; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0005671; GO:0005694; GO:0006338; GO:0006357; GO:0016573; GO:0031063; GO:0031647; GO:0035066; GO:0070461; GO:0072686; GO:0090043	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; chromosome [GO:0005694]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA-type complex [GO:0070461]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; mitotic cell cycle [GO:0000278]; positive regulation of histone acetylation [GO:0035066]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]
PGEN_.00g141070	Scaffold_06	29771301	29772149	NA	NA	NA	NA	NA
PGEN_.00g141080	Scaffold_06	29780036	29794866	Q6GVH4	GGNB2_CHICK	Gametogenetin-binding protein 2 (Protein ZNF403)	GO:0005634; GO:0005737; GO:0007275; GO:0007283; GO:0030154	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g141090	Scaffold_06	29819226	29831462	NA	NA	NA	NA	NA
PGEN_.00g141100	Scaffold_06	29833367	29835822	NA	NA	NA	NA	NA
PGEN_.00g141110	Scaffold_06	29896784	29899601	NA	NA	NA	NA	NA
PGEN_.00g141120	Scaffold_06	29901381	29903497	NA	NA	NA	NA	NA
PGEN_.00g141130	Scaffold_06	29915913	29943056	Q5RJI4	PKDCC_MOUSE	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g141140	Scaffold_06	29960333	29962298	Q9DC26	S46A3_MOUSE	Solute carrier family 46 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g141150	Scaffold_06	29975123	29978908	Q5M8L8	HVCN1_XENTR	Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1)	GO:0005887; GO:0030171; GO:0034765; GO:0071294; GO:0071467; GO:1902600	integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g141160	Scaffold_06	29981517	29981846	NA	NA	NA	NA	NA
PGEN_.00g141170	Scaffold_06	29990654	29995280	NA	NA	NA	NA	NA
PGEN_.00g141180	Scaffold_06	30013134	30014350	NA	NA	NA	NA	NA
PGEN_.00g141190	Scaffold_06	30028310	30032650	P17871	TBP_SCHPO	TATA-box-binding protein (TATA sequence-binding protein) (TBP) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit)	GO:0000120; GO:0000126; GO:0000978; GO:0000979; GO:0000995; GO:0001006; GO:0001016; GO:0001181; GO:0003700; GO:0005634; GO:0005667; GO:0005669; GO:0006361; GO:0006366; GO:0006367; GO:0006384; GO:0008134; GO:0016251; GO:0070898	nucleus [GO:0005634]; RNA polymerase I transcription factor complex [GO:0000120]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIIB complex [GO:0000126]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III regulatory region DNA binding [GO:0001016]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; transcription factor binding [GO:0008134]; RNA polymerase III preinitiation complex assembly [GO:0070898]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription initiation from RNA polymerase III promoter [GO:0006384]
PGEN_.00g141200	Scaffold_06	30054011	30057049	NA	NA	NA	NA	NA
PGEN_.00g141210	Scaffold_06	30116989	30117234	NA	NA	NA	NA	NA
PGEN_.00g141220	Scaffold_06	30128262	30128603	NA	NA	NA	NA	NA
PGEN_.00g141230	Scaffold_06	30128662	30129069	P03934	TC1A_CAEEL	Transposable element Tc1 transposase	GO:0003677; GO:0004519; GO:0005634; GO:0006313; GO:0015074	"nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g141240	Scaffold_06	30140094	30140360	P15305	DYHC_ONCMY	Dynein heavy chain (DYHC) (Fragment)	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0031514	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; motor activity [GO:0003774]
PGEN_.00g141250	Scaffold_06	30153403	30154056	Q96S79	RSLAB_HUMAN	Ras-like protein family member 10B (Ras-like protein VTS58635) (Ras-related protein 17) (RRP17)	GO:0003050; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0090277	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]; signal transduction [GO:0007165]
PGEN_.00g141260	Scaffold_06	30189210	30191055	NA	NA	NA	NA	NA
PGEN_.00g141270	Scaffold_06	30198351	30247605	A8C752	THADA_CHLAE	Thyroid adenoma-associated protein homolog		
PGEN_.00g141280	Scaffold_06	30254259	30257573	P16273	PRPX_HORVU	Pathogen-related protein	GO:0006952; GO:0009607	defense response [GO:0006952]; response to biotic stimulus [GO:0009607]
PGEN_.00g141290	Scaffold_06	30300408	30318806	Q09288	YQK4_CAEEL	Uncharacterized protein C56G2.4		
PGEN_.00g141300	Scaffold_06	30363493	30364392	NA	NA	NA	NA	NA
PGEN_.00g141310	Scaffold_06	30368334	30371520	NA	NA	NA	NA	NA
PGEN_.00g141320	Scaffold_06	30488133	30490205	NA	NA	NA	NA	NA
PGEN_.00g141330	Scaffold_06	30496785	30524067	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g141340	Scaffold_06	30528554	30538804	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g141350	Scaffold_06	30539632	30552722	P49013	FBP3_STRPU	Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)	GO:0005509; GO:0005615; GO:0009374	extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]
PGEN_.00g141360	Scaffold_06	30554276	30566516	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g141370	Scaffold_06	30570128	30579332	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g141380	Scaffold_06	30583884	30584531	NA	NA	NA	NA	NA
PGEN_.00g141390	Scaffold_06	30597432	30600553	NA	NA	NA	NA	NA
PGEN_.00g141400	Scaffold_06	30606113	30607298	Q29042	FCN1_PIG	Ficolin-1 (Ficolin-A) (Ficolin-alpha)	GO:0005576; GO:0005581; GO:0005886; GO:0030246; GO:0045087; GO:0046872	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; innate immune response [GO:0045087]
PGEN_.00g141410	Scaffold_06	30609441	30610289	NA	NA	NA	NA	NA
PGEN_.00g141420	Scaffold_06	30624430	30624762	NA	NA	NA	NA	NA
PGEN_.00g141430	Scaffold_06	30632119	30643782	P48612	PELO_DROME	Protein pelota (EC 3.1.-.-)	GO:0000212; GO:0001745; GO:0004519; GO:0005634; GO:0005737; GO:0007141; GO:0008315; GO:0016441; GO:0030718; GO:0032790; GO:0036098; GO:0043022; GO:0046872; GO:0048132; GO:0048137; GO:0051078; GO:0051321; GO:0070481; GO:0070651; GO:0070966; GO:0071025; GO:1990533	"cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male germ-line stem cell population maintenance [GO:0036098]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137]"
PGEN_.00g141440	Scaffold_06	30664243	30670575	Q6DC64	MET16_DANRE	RNA N6-adenosine-methyltransferase mettl16 (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (N6-adenosine-methyltransferase METTL16) (EC 2.1.1.348) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346)	GO:0001734; GO:0003723; GO:0005634; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0052907; GO:0061157; GO:0070475; GO:0080009; GO:0120048; GO:0120049	"nucleus [GO:0005634]; 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]"
PGEN_.00g141450	Scaffold_06	30691949	30705741	Q9PTR5	LIS1_CHICK	Lissencephaly-1 homolog	GO:0000132; GO:0000235; GO:0000776; GO:0001667; GO:0001675; GO:0001764; GO:0001961; GO:0005623; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0005938; GO:0007097; GO:0007268; GO:0007405; GO:0007611; GO:0008090; GO:0008344; GO:0009306; GO:0019226; GO:0021540; GO:0021766; GO:0021819; GO:0030036; GO:0031023; GO:0031252; GO:0031514; GO:0032420; GO:0036035; GO:0040019; GO:0042249; GO:0042803; GO:0043005; GO:0043025; GO:0043087; GO:0043622; GO:0045202; GO:0046329; GO:0047496; GO:0048471; GO:0048854; GO:0050885; GO:0051010; GO:0051012; GO:0051081; GO:0051219; GO:0051301; GO:0051661; GO:0060117; GO:0061003; GO:0070507; GO:0070840; GO:0090102; GO:0090176; GO:1904115	astral microtubule [GO:0000235]; axon cytoplasm [GO:1904115]; cell [GO:0005623]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; synapse [GO:0045202]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; acrosome assembly [GO:0001675]; actin cytoskeleton organization [GO:0030036]; adult locomotory behavior [GO:0008344]; ameboidal-type cell migration [GO:0001667]; auditory receptor cell development [GO:0060117]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; corpus callosum morphogenesis [GO:0021540]; cortical microtubule organization [GO:0043622]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hippocampus development [GO:0021766]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; maintenance of centrosome location [GO:0051661]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; negative regulation of JNK cascade [GO:0046329]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; osteoclast development [GO:0036035]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of embryonic development [GO:0040019]; protein secretion [GO:0009306]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde axonal transport [GO:0008090]; transmission of nerve impulse [GO:0019226]; vesicle transport along microtubule [GO:0047496]
PGEN_.00g141460	Scaffold_06	30713116	30713444	NA	NA	NA	NA	NA
PGEN_.00g141470	Scaffold_06	30718833	30722593	NA	NA	NA	NA	NA
PGEN_.00g141480	Scaffold_06	30729398	30731145	NA	NA	NA	NA	NA
PGEN_.00g141490	Scaffold_06	30732120	30743036	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g141500	Scaffold_06	30753442	30760073	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g141510	Scaffold_06	30777728	30783482	P46662	MERL_MOUSE	Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomin)	GO:0001707; GO:0001726; GO:0003779; GO:0005178; GO:0005634; GO:0005730; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006469; GO:0007398; GO:0007420; GO:0008013; GO:0008285; GO:0014010; GO:0014013; GO:0019904; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030175; GO:0030308; GO:0030864; GO:0031647; GO:0032154; GO:0032991; GO:0035330; GO:0042127; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045121; GO:0045177; GO:0045202; GO:0045216; GO:0045597; GO:0046426; GO:0048471; GO:0050767; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; integrin binding [GO:0005178]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]
PGEN_.00g141520	Scaffold_06	30834598	30870044	O60688	YPEL1_HUMAN	Protein yippee-like 1	GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]
PGEN_.00g141530	Scaffold_06	30881872	30882165	NA	NA	NA	NA	NA
PGEN_.00g141540	Scaffold_06	30892065	30893178	NA	NA	NA	NA	NA
PGEN_.00g141550	Scaffold_06	30931528	30932969	Q8BSL4	HS3S5_MOUSE	Heparan sulfate glucosamine 3-O-sulfotransferase 5 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 5) (Heparan sulfate 3-O-sulfotransferase 5)	GO:0000139; GO:0006477; GO:0008467; GO:0015015; GO:0016021; GO:0046596; GO:0050819	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]"
PGEN_.00g141560	Scaffold_06	30942694	30945635	NA	NA	NA	NA	NA
PGEN_.00g141570	Scaffold_06	30947331	31010118	P39057	DYHC_HELCR	"Dynein beta chain, ciliary"	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]
PGEN_.00g141580	Scaffold_06	31022690	31038136	Q6ZQX7	LIAT1_HUMAN	Protein LIAT1 (Ligand of ATE1 protein)	GO:0016598	protein arginylation [GO:0016598]
PGEN_.00g141590	Scaffold_06	31038930	31040626	NA	NA	NA	NA	NA
PGEN_.00g141600	Scaffold_06	31048383	31050371	NA	NA	NA	NA	NA
PGEN_.00g141610	Scaffold_06	31082611	31084073	NA	NA	NA	NA	NA
PGEN_.00g141620	Scaffold_06	31148374	31170261	P97814	PPIP1_MOUSE	Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1)	GO:0001725; GO:0001931; GO:0003779; GO:0005737; GO:0005826; GO:0005856; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0008092; GO:0019903; GO:0030027; GO:0032154; GO:0042802; GO:0045087; GO:0048471	actomyosin contractile ring [GO:0005826]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; uropod [GO:0001931]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]
PGEN_.00g141630	Scaffold_06	31253818	31254354	NA	NA	NA	NA	NA
PGEN_.00g141640	Scaffold_06	31254542	31255123	P23253	TCNA_TRYCR	Sialidase (EC 3.2.1.18) (Major surface antigen) (Neuraminidase) (NA)	GO:0005886; GO:0008152; GO:0009405; GO:0031225; GO:0052794; GO:0052795; GO:0052796	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; metabolic process [GO:0008152]; pathogenesis [GO:0009405]
PGEN_.00g141650	Scaffold_06	31255156	31255485	NA	NA	NA	NA	NA
PGEN_.00g141660	Scaffold_06	31255810	31256463	P23253	TCNA_TRYCR	Sialidase (EC 3.2.1.18) (Major surface antigen) (Neuraminidase) (NA)	GO:0005886; GO:0008152; GO:0009405; GO:0031225; GO:0052794; GO:0052795; GO:0052796	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; metabolic process [GO:0008152]; pathogenesis [GO:0009405]
PGEN_.00g141670	Scaffold_06	31257513	31257842	NA	NA	NA	NA	NA
PGEN_.00g141680	Scaffold_06	31294647	31295231	NA	NA	NA	NA	NA
PGEN_.00g141690	Scaffold_06	31343763	31344362	NA	NA	NA	NA	NA
PGEN_.00g141700	Scaffold_06	31389776	31391074	B3DM66	GP161_XENTR	G-protein coupled receptor 161	GO:0004930; GO:0005929; GO:0007189; GO:0007275; GO:0016021; GO:0055037; GO:0060170; GO:1901621	ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]
PGEN_.00g141710	Scaffold_06	31400560	31400922	NA	NA	NA	NA	NA
PGEN_.00g141720	Scaffold_06	31403155	31406103	NA	NA	NA	NA	NA
PGEN_.00g141730	Scaffold_06	31471162	31472592	NA	NA	NA	NA	NA
PGEN_.00g141740	Scaffold_06	31589240	31594339	NA	NA	NA	NA	NA
PGEN_.00g141750	Scaffold_06	31597826	31599568	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g141760	Scaffold_06	31610852	31641283	NA	NA	NA	NA	NA
PGEN_.00g141770	Scaffold_06	31670597	31671010	NA	NA	NA	NA	NA
PGEN_.00g141780	Scaffold_06	31671259	31674854	NA	NA	NA	NA	NA
PGEN_.00g141790	Scaffold_06	31678794	31679357	NA	NA	NA	NA	NA
PGEN_.00g141800	Scaffold_06	31714098	31717434	NA	NA	NA	NA	NA
PGEN_.00g141810	Scaffold_06	31719115	31727723	NA	NA	NA	NA	NA
PGEN_.00g141820	Scaffold_06	31760587	31786170	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g141830	Scaffold_06	31808232	31904400	Q60974	NCOR1_MOUSE	Nuclear receptor corepressor 1 (N-CoR) (N-CoR1) (Retinoid X receptor-interacting protein 13) (RIP13)	GO:0000118; GO:0000122; GO:0000790; GO:0001012; GO:0001102; GO:0002155; GO:0002361; GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006325; GO:0006357; GO:0008284; GO:0010629; GO:0014067; GO:0017053; GO:0019904; GO:0021794; GO:0030331; GO:0031065; GO:0032922; GO:0035033; GO:0035257; GO:0040014; GO:0042632; GO:0042826; GO:0042974; GO:0042975; GO:0043565; GO:0044212; GO:0045475; GO:0045892; GO:0046329; GO:0046965; GO:0046966; GO:0048471; GO:0051225; GO:0060318; GO:0060766; GO:0072368; GO:0072686; GO:1903799; GO:1904017	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; nuclear hormone receptor binding [GO:0035257]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; definitive erythrocyte differentiation [GO:0060318]; locomotor rhythm [GO:0045475]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone deacetylation [GO:0031065]; regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter [GO:0072368]; regulation of multicellular organism growth [GO:0040014]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle assembly [GO:0051225]; thalamus development [GO:0021794]"
PGEN_.00g141840	Scaffold_06	31905286	31905711	NA	NA	NA	NA	NA
PGEN_.00g141850	Scaffold_06	31906739	31908838	NA	NA	NA	NA	NA
PGEN_.00g141860	Scaffold_06	31915289	31942032	P98153	IDD_HUMAN	Integral membrane protein DGCR2/IDD	GO:0007155; GO:0009887; GO:0016021; GO:0030246; GO:0050890	integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cognition [GO:0050890]
PGEN_.00g141870	Scaffold_06	31943134	31945759	Q2KIY1	PXMP2_BOVIN	Peroxisomal membrane protein 2	GO:0005737; GO:0005778; GO:0016021	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]
PGEN_.00g141880	Scaffold_06	31999503	32008061	E1C7T6	TYW5_CHICK	tRNA wybutosine-synthesizing protein 5 (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase)	GO:0000049; GO:0005506; GO:0016706; GO:0031591; GO:0042803; GO:0102524	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524]; wybutosine biosynthetic process [GO:0031591]
PGEN_.00g141890	Scaffold_06	32037711	32054381	NA	NA	NA	NA	NA
PGEN_.00g141900	Scaffold_06	32076439	32081587	Q7LGC8	CHST3_HUMAN	Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008146; GO:0008459; GO:0016021; GO:0030206	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g141910	Scaffold_06	32112350	32113696	NA	NA	NA	NA	NA
PGEN_.00g141920	Scaffold_06	32222249	32224207	NA	NA	NA	NA	NA
PGEN_.00g141930	Scaffold_06	32236669	32237140	NA	NA	NA	NA	NA
PGEN_.00g141940	Scaffold_06	32275523	32283931	Q6AY62	NEUFC_RAT	Neuferricin (Cytochrome b5 domain-containing protein 2)	GO:0005576; GO:0020037; GO:0045666	extracellular region [GO:0005576]; heme binding [GO:0020037]; positive regulation of neuron differentiation [GO:0045666]
PGEN_.00g141950	Scaffold_06	32331390	32346739	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g141960	Scaffold_06	32352745	32398099	O17468	HIRA_DROME	Protein HIRA homolog (Protein sesame) (dHIRA)	GO:0000070; GO:0000417; GO:0000775; GO:0000790; GO:0001673; GO:0003682; GO:0003714; GO:0005634; GO:0006336; GO:0006338; GO:0006351; GO:0030702; GO:0031935; GO:0035041; GO:0035042; GO:0042585	"chromosome, centromeric region [GO:0000775]; germinal vesicle [GO:0042585]; HIR complex [GO:0000417]; male germ cell nucleus [GO:0001673]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; chromatin silencing at centromere [GO:0030702]; DNA replication-independent nucleosome assembly [GO:0006336]; fertilization, exchange of chromosomal proteins [GO:0035042]; mitotic sister chromatid segregation [GO:0000070]; regulation of chromatin silencing [GO:0031935]; sperm chromatin decondensation [GO:0035041]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g141970	Scaffold_06	32410929	32411270	NA	NA	NA	NA	NA
PGEN_.00g141980	Scaffold_06	32414677	32432703	NA	NA	NA	NA	NA
PGEN_.00g141990	Scaffold_06	32438101	32446434	NA	NA	NA	NA	NA
PGEN_.00g142000	Scaffold_06	32477954	32483980	P58781	ADA2_DANRE	Adenosine deaminase 2-A (EC 3.5.4.4) (Cat eye syndrome critical region protein 1 homolog A)	GO:0004000; GO:0005615; GO:0006154; GO:0008270; GO:0031685; GO:0043394; GO:0046103	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]
PGEN_.00g142010	Scaffold_06	32491949	32502322	NA	NA	NA	NA	NA
PGEN_.00g142020	Scaffold_06	32503141	32507783	NA	NA	NA	NA	NA
PGEN_.00g142030	Scaffold_06	32539725	32574474	Q9EST3	4ET_MOUSE	Eukaryotic translation initiation factor 4E transporter (4E-T) (eIF4E transporter) (Eukaryotic translation initiation factor 4E nuclear import factor 1)	GO:0000932; GO:0003729; GO:0005049; GO:0005634; GO:0005737; GO:0005829; GO:0015031; GO:0016605; GO:0016607; GO:0017148; GO:0019827; GO:0043231; GO:0045665	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; PML body [GO:0016605]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; protein transport [GO:0015031]; stem cell population maintenance [GO:0019827]
PGEN_.00g142040	Scaffold_06	32583666	32589776	P43690	DRG1_XENLA	Developmentally-regulated GTP-binding protein 1 (DRG-1) (xDRG) (Translation factor GTPase DRG1) (TRAFAC GTPase DRG1) (EC 3.6.5.-)	GO:0001578; GO:0005525; GO:0005634; GO:0005737; GO:0008017; GO:0016787; GO:0031116; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule bundle formation [GO:0001578]; positive regulation of microtubule polymerization [GO:0031116]
PGEN_.00g142050	Scaffold_06	32599385	32603114	NA	NA	NA	NA	NA
PGEN_.00g142060	Scaffold_06	32619872	32644288	NA	NA	NA	NA	NA
PGEN_.00g142070	Scaffold_06	32648087	32672755	Q8BHT6	B3GLT_MOUSE	"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)"	GO:0005789; GO:0006004; GO:0006486; GO:0016021; GO:0016757	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]; fucose metabolic process [GO:0006004]; protein glycosylation [GO:0006486]"
PGEN_.00g142080	Scaffold_06	32675531	32756980	Q6ZPQ6	PITM2_MOUSE	"Membrane-associated phosphatidylinositol transfer protein 2 (Drosophila retinal degeneration B homolog 2) (RdgB2) (Phosphatidylinositol transfer protein, membrane-associated 2) (PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3) (NIR-3)"	GO:0005509; GO:0005543; GO:0005737; GO:0005856; GO:0008525; GO:0008526; GO:0012505; GO:0016020; GO:0030971; GO:0031210; GO:0035091; GO:0044297; GO:0048015	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endomembrane system [GO:0012505]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; receptor tyrosine kinase binding [GO:0030971]; phosphatidylinositol-mediated signaling [GO:0048015]
PGEN_.00g142090	Scaffold_06	32764675	32773219	P54797	TNG2_MOUSE	Transport and Golgi organization 2 homolog (Ser/Thr-rich protein T10 in DGCR region)	GO:0005739; GO:0005794; GO:0007030; GO:0009306	Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; Golgi organization [GO:0007030]; protein secretion [GO:0009306]
PGEN_.00g142100	Scaffold_06	32858843	32859496	Q96S79	RSLAB_HUMAN	Ras-like protein family member 10B (Ras-like protein VTS58635) (Ras-related protein 17) (RRP17)	GO:0003050; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0090277	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]; signal transduction [GO:0007165]
PGEN_.00g142110	Scaffold_06	32903448	32903693	NA	NA	NA	NA	NA
PGEN_.00g142120	Scaffold_06	32905222	32938744	Q8R422	CD109_MOUSE	CD109 antigen (GPI-anchored alpha-2 macroglobulin-related protein) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0004867; GO:0005615; GO:0005829; GO:0005886; GO:0010839; GO:0030512; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g142130	Scaffold_06	32956032	32957480	O95395	GCNT3_HUMAN	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (EC 2.4.1.102) (EC 2.4.1.148) (EC 2.4.1.150) (C2GnT-mucin type) (C2GnT-M) (hC2GnT-M) (Core 2/core 4 beta-1,6-N-acetylglucosaminyltransferase) (C2/4GnT)"	GO:0000139; GO:0002426; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0016020; GO:0016021; GO:0016266; GO:0047225; GO:0048729; GO:0050892; GO:0060993; GO:0070062	"extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0047225]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; immunoglobulin production in mucosal tissue [GO:0002426]; intestinal absorption [GO:0050892]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; tissue morphogenesis [GO:0048729]"
PGEN_.00g142140	Scaffold_06	32982692	32983066	NA	NA	NA	NA	NA
PGEN_.00g142150	Scaffold_06	33027233	33049152	NA	NA	NA	NA	NA
PGEN_.00g142160	Scaffold_06	33057874	33058955	NA	NA	NA	NA	NA
PGEN_.00g142170	Scaffold_06	33060098	33070682	Q6NW29	RWDD4_HUMAN	RWD domain-containing protein 4 (Protein FAM28A)		
PGEN_.00g142180	Scaffold_06	33076039	33100392	Q08C92	TYW1_DANRE	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 (EC 4.1.3.44) (Radical S-adenosyl methionine and flavodoxin domain-containing protein 1) (tRNA wybutosine-synthesizing protein 1 homolog) (tRNA-yW-synthesizing protein)	GO:0008033; GO:0010181; GO:0046872; GO:0051539; GO:0055114; GO:0102521	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]; oxidation-reduction process [GO:0055114]; tRNA processing [GO:0008033]"
PGEN_.00g142190	Scaffold_06	33106829	33107919	NA	NA	NA	NA	NA
PGEN_.00g142200	Scaffold_06	33110118	33140138	NA	NA	NA	NA	NA
PGEN_.00g142210	Scaffold_06	33236797	33237666	NA	NA	NA	NA	NA
PGEN_.00g142220	Scaffold_06	33247112	33247483	NA	NA	NA	NA	NA
PGEN_.00g142230	Scaffold_06	33250157	33261632	A6QR44	DGCR8_BOVIN	Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8 homolog)	GO:0003725; GO:0005730; GO:0020037; GO:0031053; GO:0042802; GO:0046872; GO:0070877; GO:0070878; GO:0090502	"microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; primary miRNA processing [GO:0031053]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"
PGEN_.00g142240	Scaffold_06	33269176	33282174	Q6NZQ0	CC189_MOUSE	Coiled-coil domain-containing protein 189		
PGEN_.00g142250	Scaffold_06	33286002	33297211	Q924H5	RA51C_MOUSE	DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2)	GO:0000400; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0008094; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0043231; GO:0048471; GO:0048476	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Holliday junction resolvase complex [GO:0048476]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]; ATP binding [GO:0005524]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA-dependent ATPase activity [GO:0008094]; four-way junction DNA binding [GO:0000400]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]
PGEN_.00g142260	Scaffold_06	33315179	33344036	Q8WY54	PPM1E_HUMAN	Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA)	GO:0004722; GO:0004724; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006469; GO:0032991; GO:0035690; GO:0035970; GO:0046872; GO:0051496	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to drug [GO:0035690]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]
PGEN_.00g142270	Scaffold_06	33359611	33371537	NA	NA	NA	NA	NA
PGEN_.00g142280	Scaffold_06	33389778	33394293	NA	NA	NA	NA	NA
PGEN_.00g142290	Scaffold_06	33482052	33484410	NA	NA	NA	NA	NA
PGEN_.00g142300	Scaffold_06	33516055	33523541	O96006	ZBED1_HUMAN	Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0005813; GO:0019789; GO:0031965; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983	"centrosome [GO:0005813]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g142310	Scaffold_06	33585540	33587942	NA	NA	NA	NA	NA
PGEN_.00g142320	Scaffold_06	33834938	33836146	Q6B9X6	VWKA_DICDI	Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase)	GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177	contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]
PGEN_.00g142330	Scaffold_06	33855789	33864719	Q9JKW1	TIM22_RAT	Mitochondrial import inner membrane translocase subunit Tim22	GO:0008320; GO:0016021; GO:0030943; GO:0042721; GO:0045039	integral component of membrane [GO:0016021]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; mitochondrion targeting sequence binding [GO:0030943]; protein transmembrane transporter activity [GO:0008320]; protein insertion into mitochondrial inner membrane [GO:0045039]
PGEN_.00g142340	Scaffold_06	33866610	33917258	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g142350	Scaffold_06	33917336	33932929	F7ASZ0	BTBD3_CALJA	BTB/POZ domain-containing protein 3	GO:0005634; GO:0005829; GO:0021987; GO:0048813	cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]
PGEN_.00g142360	Scaffold_06	34008332	34011418	NA	NA	NA	NA	NA
PGEN_.00g142370	Scaffold_06	34015692	34022181	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g142380	Scaffold_06	34022241	34023038	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g142390	Scaffold_06	34082706	34085537	P31696	AGRIN_CHICK	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	GO:0002162; GO:0004867; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007275; GO:0007399; GO:0007417; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0016021; GO:0030054; GO:0030154; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978; GO:1902572	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; serine-type endopeptidase inhibitor activity [GO:0004867]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; multicellular organism development [GO:0007275]; negative regulation of neuron projection development [GO:0010977]; negative regulation of serine-type peptidase activity [GO:1902572]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]
PGEN_.00g142400	Scaffold_06	34091241	34105816	Q4FAT7	BGLR_PIG	Beta-glucuronidase (EC 3.2.1.31)	GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0019391; GO:0019904; GO:0030246	extracellular space [GO:0005615]; lysosome [GO:0005764]; beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; glucuronoside catabolic process [GO:0019391]
PGEN_.00g142410	Scaffold_06	34113692	34125665	NA	NA	NA	NA	NA
PGEN_.00g142420	Scaffold_06	34132270	34136219	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g142430	Scaffold_06	34142433	34151854	P22071	3BHS1_RAT	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I) (3-beta-HSD I) (3-beta-hydroxy-5-ene steroid dehydrogenase) (3-beta-hydroxy-Delta(5)-steroid dehydrogenase) (EC 1.1.1.145) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Delta-5-3-ketosteroid isomerase) (Dihydrotestosterone oxidoreductase) (EC 1.1.1.210) (Steroid Delta-isomerase) (EC 5.3.3.1)	GO:0000253; GO:0003854; GO:0004769; GO:0005496; GO:0005743; GO:0005758; GO:0005789; GO:0006082; GO:0006694; GO:0006701; GO:0008202; GO:0008207; GO:0008584; GO:0008585; GO:0009635; GO:0010033; GO:0010038; GO:0010226; GO:0010288; GO:0014070; GO:0014823; GO:0016021; GO:0016101; GO:0016491; GO:0016616; GO:0017143; GO:0018879; GO:0018894; GO:0018958; GO:0018970; GO:0021766; GO:0030061; GO:0030325; GO:0030728; GO:0030851; GO:0031667; GO:0032355; GO:0032869; GO:0033197; GO:0033327; GO:0033591; GO:0035410; GO:0042493; GO:0043231; GO:0043279; GO:0044344; GO:0045471; GO:0046470; GO:0046685; GO:0046686; GO:0047024; GO:0051287; GO:0051412; GO:0051592; GO:0060135; GO:0060992; GO:0061370; GO:0070301; GO:0070542; GO:0071236; GO:0071288; GO:0071320; GO:0071333; GO:0071371; GO:0071372; GO:0071373; GO:0071406; GO:0071549; GO:0071560; GO:0102294	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 3-keto sterol reductase activity [GO:0000253]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; cholesterol dehydrogenase activity [GO:0102294]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid binding [GO:0005496]; steroid delta-isomerase activity [GO:0004769]; adrenal gland development [GO:0030325]; biphenyl metabolic process [GO:0018879]; C21-steroid hormone metabolic process [GO:0008207]; cellular response to antibiotic [GO:0071236]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to insulin stimulus [GO:0032869]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to mercury ion [GO:0071288]; cellular response to methylmercury [GO:0071406]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dibenzo-p-dioxin metabolic process [GO:0018894]; diterpenoid metabolic process [GO:0016101]; female gonad development [GO:0008585]; granulocyte differentiation [GO:0030851]; hippocampus development [GO:0021766]; insecticide metabolic process [GO:0017143]; Leydig cell differentiation [GO:0033327]; male gonad development [GO:0008584]; maternal process involved in female pregnancy [GO:0060135]; organic acid metabolic process [GO:0006082]; ovulation [GO:0030728]; phenol-containing compound metabolic process [GO:0018958]; phosphatidylcholine metabolic process [GO:0046470]; progesterone biosynthetic process [GO:0006701]; response to activity [GO:0014823]; response to alkaloid [GO:0043279]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to fungicide [GO:0060992]; response to herbicide [GO:0009635]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to lithium ion [GO:0010226]; response to metal ion [GO:0010038]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to vitamin E [GO:0033197]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; testosterone biosynthetic process [GO:0061370]; toluene metabolic process [GO:0018970]"
PGEN_.00g142440	Scaffold_06	34161880	34165840	Q9H2F3	3BHS7_HUMAN	"3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181)"	GO:0003854; GO:0005789; GO:0005811; GO:0006699; GO:0016021; GO:0016491; GO:0016616; GO:0035754; GO:0047016	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [GO:0047016]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; B cell chemotaxis [GO:0035754]; bile acid biosynthetic process [GO:0006699]"
PGEN_.00g142450	Scaffold_06	34186350	34208539	NA	NA	NA	NA	NA
PGEN_.00g142460	Scaffold_06	34211905	34212976	NA	NA	NA	NA	NA
PGEN_.00g142470	Scaffold_06	34222444	34233633	Q8BZI6	GUCD1_MOUSE	Protein GUCD1 (Guanylyl cyclase domain-containing protein 1) (Protein LLN4)		
PGEN_.00g142480	Scaffold_06	34262881	34313479	Q5ZLA6	MYO1C_CHICK	Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb)	GO:0001726; GO:0003774; GO:0003779; GO:0005524; GO:0016459; GO:0031410; GO:0060171	cytoplasmic vesicle [GO:0031410]; myosin complex [GO:0016459]; ruffle [GO:0001726]; stereocilium membrane [GO:0060171]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]
PGEN_.00g142490	Scaffold_06	34306211	34306834	NA	NA	NA	NA	NA
PGEN_.00g142500	Scaffold_06	34306967	34307269	NA	NA	NA	NA	NA
PGEN_.00g142510	Scaffold_06	34324308	34345026	Q4QQW8	PLBL2_RAT	Putative phospholipase B-like 2 (EC 3.1.1.-) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2)	GO:0004620; GO:0005764; GO:0016042; GO:0043202	lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]
PGEN_.00g142520	Scaffold_06	34354322	34359245	D3ZL52	SESQ1_RAT	Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase interacting protein A) (IPIP27A) (PH domain-containing endocytic trafficking adaptor 1)	GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037	"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; protein homodimerization activity [GO:0042803]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g142530	Scaffold_06	34369934	34370605	NA	NA	NA	NA	NA
PGEN_.00g142540	Scaffold_06	34370740	34372387	Q3SZZ2	XBP1_BOVIN	"X-box-binding protein 1 (XBP-1) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]"	GO:0000977; GO:0000978; GO:0000981; GO:0001158; GO:0001525; GO:0001889; GO:0001935; GO:0002639; GO:0003700; GO:0005623; GO:0005634; GO:0005737; GO:0005783; GO:0006366; GO:0006511; GO:0006915; GO:0006990; GO:0007517; GO:0010506; GO:0030154; GO:0030176; GO:0031490; GO:0031648; GO:0034976; GO:0035356; GO:0042149; GO:0042632; GO:0043066; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045944; GO:0046982; GO:0055089; GO:0055092; GO:0060612; GO:0071222; GO:0071230; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:1900100; GO:1900103; GO:1903489; GO:1990418; GO:2000347	"cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endothelial cell proliferation [GO:0001935]; fatty acid homeostasis [GO:0055089]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; protein destabilization [GO:0031648]; regulation of autophagy [GO:0010506]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g142550	Scaffold_06	34386074	34386379	NA	NA	NA	NA	NA
PGEN_.00g142560	Scaffold_06	34398733	34418313	Q96AY4	TTC28_HUMAN	Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)	GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]
PGEN_.00g142570	Scaffold_06	34467669	34517964	Q96AY4	TTC28_HUMAN	Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)	GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]
PGEN_.00g142580	Scaffold_06	34521769	34526034	B6NK32	LYRM9_BRAFL	LYR motif-containing protein 9		
PGEN_.00g142590	Scaffold_06	34550025	34561473	Q7L1S5	CHST9_HUMAN	Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)	GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446	extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g142600	Scaffold_06	34569401	34574185	NA	NA	NA	NA	NA
PGEN_.00g142610	Scaffold_06	34616729	34620532	NA	NA	NA	NA	NA
PGEN_.00g142620	Scaffold_06	34754041	34755438	NA	NA	NA	NA	NA
PGEN_.00g142630	Scaffold_06	34785857	34786123	NA	NA	NA	NA	NA
PGEN_.00g142640	Scaffold_06	34796833	34797585	NA	NA	NA	NA	NA
PGEN_.00g142650	Scaffold_06	34816710	34817339	NA	NA	NA	NA	NA
PGEN_.00g142660	Scaffold_06	34821912	34822202	NA	NA	NA	NA	NA
PGEN_.00g142670	Scaffold_06	34829361	34870500	Q9D2Z8	KIF12_MOUSE	Kinesin-like protein KIF12	GO:0003777; GO:0005524; GO:0005737; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g142680	Scaffold_06	34887550	34934314	Q9D2Z8	KIF12_MOUSE	Kinesin-like protein KIF12	GO:0003777; GO:0005524; GO:0005737; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g142690	Scaffold_06	35004973	35025469	P34322	NCX7_CAEEL	Putative sodium/calcium exchanger 7 (Na(+)/Ca(2+)-exchange protein 7)	GO:0006814; GO:0006816; GO:0015297; GO:0016021	integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; calcium ion transport [GO:0006816]; sodium ion transport [GO:0006814]
PGEN_.00g142700	Scaffold_06	35030407	35046873	P06197	PIS_YEAST	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)	GO:0003881; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005794; GO:0006661; GO:0016021	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; phosphatidylinositol biosynthetic process [GO:0006661]
PGEN_.00g142710	Scaffold_06	35053942	35054337	NA	NA	NA	NA	NA
PGEN_.00g142720	Scaffold_06	35054693	35057158	NA	NA	NA	NA	NA
PGEN_.00g142730	Scaffold_06	35064283	35064681	NA	NA	NA	NA	NA
PGEN_.00g142740	Scaffold_06	35099606	35100692	P27465	PISD_CRIGR	"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]"	GO:0004609; GO:0005634; GO:0006646; GO:0016540; GO:0031305	integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]
PGEN_.00g142750	Scaffold_06	35112026	35147808	Q7RTR2	NLRC3_HUMAN	"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)"	GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]
PGEN_.00g142760	Scaffold_06	35167086	35168217	NA	NA	NA	NA	NA
PGEN_.00g142770	Scaffold_06	35273394	35302962	Q99571	P2RX4_HUMAN	P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor)	GO:0001614; GO:0001894; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005623; GO:0005639; GO:0005765; GO:0005886; GO:0005887; GO:0007165; GO:0007596; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0014069; GO:0016020; GO:0019228; GO:0019233; GO:0019722; GO:0030054; GO:0032308; GO:0033198; GO:0034220; GO:0034405; GO:0035590; GO:0042118; GO:0042803; GO:0043025; GO:0043195; GO:0043197; GO:0043536; GO:0044297; GO:0045296; GO:0045429; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051260; GO:0051897; GO:0051899; GO:0051928; GO:0055117; GO:0055119; GO:0070062; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0099604; GO:1904124; GO:1904141; GO:2001028	cell [GO:0005623]; cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated cation channel activity [GO:0004931]; ligand-gated calcium channel activity [GO:0099604]; protein homodimerization activity [GO:0042803]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; microglial cell migration [GO:1904124]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein kinase B signaling [GO:0051897]; protein homooligomerization [GO:0051260]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]
PGEN_.00g142780	Scaffold_06	35314762	35315133	NA	NA	NA	NA	NA
PGEN_.00g142790	Scaffold_06	35316715	35320563	NA	NA	NA	NA	NA
PGEN_.00g142800	Scaffold_06	35345795	35350350	NA	NA	NA	NA	NA
PGEN_.00g142810	Scaffold_06	35351157	35351381	NA	NA	NA	NA	NA
PGEN_.00g142820	Scaffold_06	35353161	35372086	Q8K4C0	FMO5_RAT	Dimethylaniline monooxygenase [N-oxide-forming] 5 (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (FMO 5)	GO:0004497; GO:0004499; GO:0005789; GO:0016021; GO:0050660; GO:0050661	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
PGEN_.00g142830	Scaffold_06	35373957	35374202	NA	NA	NA	NA	NA
PGEN_.00g142840	Scaffold_06	35386227	35389061	NA	NA	NA	NA	NA
PGEN_.00g142850	Scaffold_06	35398410	35404169	NA	NA	NA	NA	NA
PGEN_.00g142860	Scaffold_06	35407028	35408787	NA	NA	NA	NA	NA
PGEN_.00g142870	Scaffold_06	35409462	35410325	NA	NA	NA	NA	NA
PGEN_.00g142880	Scaffold_06	35422303	35465954	Q6P2Q9	PRP8_HUMAN	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	GO:0000244; GO:0000375; GO:0000386; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"
PGEN_.00g142890	Scaffold_06	35491554	35501814	Q0IIF9	CP2U1_BOVIN	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g142900	Scaffold_06	35531008	35532370	NA	NA	NA	NA	NA
PGEN_.00g142910	Scaffold_06	35537540	35539270	NA	NA	NA	NA	NA
PGEN_.00g142920	Scaffold_06	35539380	35543554	NA	NA	NA	NA	NA
PGEN_.00g142930	Scaffold_06	35562532	35564044	NA	NA	NA	NA	NA
PGEN_.00g142940	Scaffold_06	35575079	35643049	Q9R189	UN13D_RAT	Protein unc-13 homolog D (Munc13-4)	GO:0002432; GO:0002467; GO:0005764; GO:0005770; GO:0006909; GO:0016020; GO:0017137; GO:0033093; GO:0043304; GO:0043320; GO:0045921; GO:0046903; GO:0051607; GO:0055037; GO:0061789; GO:0070382; GO:1900026; GO:1903307	exocytic vesicle [GO:0070382]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; recycling endosome [GO:0055037]; Weibel-Palade body [GO:0033093]; Rab GTPase binding [GO:0017137]; defense response to virus [GO:0051607]; dense core granule priming [GO:0061789]; germinal center formation [GO:0002467]; granuloma formation [GO:0002432]; natural killer cell degranulation [GO:0043320]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; positive regulation of regulated secretory pathway [GO:1903307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of mast cell degranulation [GO:0043304]; secretion [GO:0046903]
PGEN_.00g142950	Scaffold_06	35649756	35659280	Q7ZXY0	INO1A_XENLA	Inositol-3-phosphate synthase 1-A (IPS 1-A) (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase A) (MI-1-P synthase A) (MIP synthase A)	GO:0004512; GO:0005737; GO:0006021; GO:0008654	cytoplasm [GO:0005737]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654]
PGEN_.00g142960	Scaffold_06	35730348	35730659	NA	NA	NA	NA	NA
PGEN_.00g142970	Scaffold_06	35731439	35731720	NA	NA	NA	NA	NA
PGEN_.00g142980	Scaffold_06	35813802	35814414	NA	NA	NA	NA	NA
PGEN_.00g142990	Scaffold_06	35937267	35944189	NA	NA	NA	NA	NA
PGEN_.00g143000	Scaffold_06	35953611	35954753	Q6UXT9	ABH15_HUMAN	Protein ABHD15 (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15)	GO:0005576; GO:0016020; GO:0016787; GO:0044255	extracellular region [GO:0005576]; membrane [GO:0016020]; hydrolase activity [GO:0016787]; cellular lipid metabolic process [GO:0044255]
PGEN_.00g143010	Scaffold_06	35976100	35976438	NA	NA	NA	NA	NA
PGEN_.00g143020	Scaffold_06	35988094	35988312	NA	NA	NA	NA	NA
PGEN_.00g143030	Scaffold_06	36125992	36139689	Q9Z0Z5	S13A3_RAT	Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (rNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)	GO:0005310; GO:0005343; GO:0005886; GO:0006835; GO:0015137; GO:0015139; GO:0015141; GO:0015183; GO:0015362; GO:0015744; GO:0015746; GO:0015810; GO:0016020; GO:0016021; GO:0017153	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; L-aspartate transmembrane transporter activity [GO:0015183]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; aspartate transmembrane transport [GO:0015810]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; succinate transport [GO:0015744]
PGEN_.00g143040	Scaffold_06	36179046	36179384	NA	NA	NA	NA	NA
PGEN_.00g143050	Scaffold_06	36179482	36180587	NA	NA	NA	NA	NA
PGEN_.00g143060	Scaffold_06	36183463	36196154	Q8NFD2	ANKK1_HUMAN	Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1) (Protein kinase PKK2) (Sugen kinase 288) (SgK288) (X-kinase)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0010564; GO:0042995	cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; regulation of cell cycle process [GO:0010564]
PGEN_.00g143070	Scaffold_06	36196181	36201726	NA	NA	NA	NA	NA
PGEN_.00g143080	Scaffold_06	36208874	36256492	Q96J94	PIWL1_HUMAN	Piwi-like protein 1 (EC 3.1.26.-)	GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007275; GO:0007283; GO:0007286; GO:0010529; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0035093; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:1905538	"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; single-stranded RNA binding [GO:0003727]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"
PGEN_.00g143090	Scaffold_06	36274435	36281810	A6QNK1	G3ST1_BOVIN	Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)	GO:0000139; GO:0001733; GO:0006665; GO:0009247; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g143100	Scaffold_06	36287637	36300445	Q8BIP0	SYDM_MOUSE	"Aspartate--tRNA ligase, mitochondrial (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)"	GO:0003676; GO:0004815; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0042803; GO:0043039; GO:0050560; GO:0070145	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039]
PGEN_.00g143110	Scaffold_06	36355943	36356314	NA	NA	NA	NA	NA
PGEN_.00g143120	Scaffold_06	36356910	36368042	NA	NA	NA	NA	NA
PGEN_.00g143130	Scaffold_06	36416343	36418796	NA	NA	NA	NA	NA
PGEN_.00g143140	Scaffold_06	36420332	36457462	Q7Z3V4	UBE3B_HUMAN	Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B)	GO:0000209; GO:0006511; GO:0061631	ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g143150	Scaffold_06	36467100	36480245	Q9UJU3	ZN112_HUMAN	Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g143160	Scaffold_06	36490972	36492153	NA	NA	NA	NA	NA
PGEN_.00g143170	Scaffold_06	36508405	36512749	O46419	LIPT_BOVIN	"Lipoyltransferase 1, mitochondrial (EC 2.3.1.-) (Lipoate biosynthesis protein) (Lipoate-protein ligase) (Lipoyl ligase)"	GO:0005739; GO:0009249; GO:0016746	"mitochondrion [GO:0005739]; transferase activity, transferring acyl groups [GO:0016746]; protein lipoylation [GO:0009249]"
PGEN_.00g143180	Scaffold_06	36521416	36522630	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g143190	Scaffold_06	36574781	36607096	Q91W34	RUS1_MOUSE	RUS1 family protein C16orf58 homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g143200	Scaffold_06	36659113	36695090	Q61097	KSR1_MOUSE	Kinase suppressor of Ras 1 (mKSR1) (EC 2.7.11.1) (Protein Hb)	GO:0000185; GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005783; GO:0005789; GO:0007265; GO:0008022; GO:0016020; GO:0019901; GO:0019933; GO:0031434; GO:0032587; GO:0032991; GO:0042127; GO:0043405; GO:0043410; GO:0046872; GO:0046982; GO:0051087; GO:0051879; GO:0071889	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKKK activity [GO:0000185]; cAMP-mediated signaling [GO:0019933]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]
PGEN_.00g143210	Scaffold_06	36695382	36711365	Q9D0F6	RFC5_MOUSE	Replication factor C subunit 5 (Activator 1 36 kDa subunit) (A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit) (RF-C 36 kDa subunit) (RFC36)	GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0017116; GO:0019899; GO:0031390; GO:1900264	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]
PGEN_.00g143220	Scaffold_06	36720156	36723074	NA	NA	NA	NA	NA
PGEN_.00g143230	Scaffold_06	36726672	36733409	NA	NA	NA	NA	NA
PGEN_.00g143240	Scaffold_06	36734036	36783540	Q7K4Y6	DAT_DROME	Sodium-dependent dopamine transporter (Protein fumin)	GO:0005328; GO:0005330; GO:0005886; GO:0005887; GO:0008344; GO:0015872; GO:0015874; GO:0019811; GO:0030431; GO:0032809; GO:0042734; GO:0042745; GO:0043005; GO:0046872; GO:0051583; GO:0099509; GO:1990834	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]
PGEN_.00g143250	Scaffold_06	36879396	36957022	E9PVA8	GCN1_MOUSE	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)	GO:0005829; GO:0005844; GO:0006417; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:1990253	cytosol [GO:0005829]; polysome [GO:0005844]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]
PGEN_.00g143260	Scaffold_06	36966268	36977168	G4WAW9	SELM_ERISI	Selenoprotein M	GO:0005783	endoplasmic reticulum [GO:0005783]
PGEN_.00g143270	Scaffold_06	36978300	36978638	NA	NA	NA	NA	NA
PGEN_.00g143280	Scaffold_06	36983063	37000806	G4WAW9	SELM_ERISI	Selenoprotein M	GO:0005783	endoplasmic reticulum [GO:0005783]
PGEN_.00g143290	Scaffold_06	37016460	37016756	NA	NA	NA	NA	NA
PGEN_.00g143300	Scaffold_06	37025183	37026322	NA	NA	NA	NA	NA
PGEN_.00g143310	Scaffold_06	37043157	37045034	NA	NA	NA	NA	NA
PGEN_.00g143320	Scaffold_06	37045257	37045820	NA	NA	NA	NA	NA
PGEN_.00g143330	Scaffold_06	37052130	37052414	NA	NA	NA	NA	NA
PGEN_.00g143340	Scaffold_06	37054021	37064159	Q4R6C7	TRM1L_MACFA	TRMT1-like protein (EC 2.1.1.-)	GO:0000049; GO:0004809; GO:0007610; GO:0046872	metal ion binding [GO:0046872]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]; behavior [GO:0007610]
PGEN_.00g143350	Scaffold_06	37078977	37082700	NA	NA	NA	NA	NA
PGEN_.00g143360	Scaffold_06	37084821	37085186	NA	NA	NA	NA	NA
PGEN_.00g143370	Scaffold_06	37099174	37150607	Q9BR01	ST4A1_HUMAN	Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (hBR-STL) (hBR-STL-1) (Nervous system sulfotransferase) (NST)	GO:0005829; GO:0008146; GO:0008202; GO:0042802; GO:0050427	cytosol [GO:0005829]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; steroid metabolic process [GO:0008202]
PGEN_.00g143380	Scaffold_06	37151406	37163912	NA	NA	NA	NA	NA
PGEN_.00g143390	Scaffold_06	37170551	37174327	NA	NA	NA	NA	NA
PGEN_.00g143400	Scaffold_06	37176325	37185337	P82596	PLC_HALLA	Perlucin	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g143410	Scaffold_06	37193523	37203291	Q9CWY3	SETD6_MOUSE	N-lysine methyltransferase SETD6 (EC 2.1.1.-) (SET domain-containing protein 6)	GO:0005634; GO:0005654; GO:0005829; GO:0016279; GO:0018026; GO:0019827; GO:0032088; GO:0034968; GO:0048863; GO:0050727; GO:0051059	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; peptidyl-lysine monomethylation [GO:0018026]; regulation of inflammatory response [GO:0050727]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]
PGEN_.00g143420	Scaffold_06	37212970	37229312	Q9HA64	KT3K_HUMAN	Ketosamine-3-kinase (EC 2.7.1.172) (Fructosamine-3-kinase-related protein) (FN3K-RP) (FN3K-related protein) (Protein-psicosamine 3-kinase FN3KRP) (EC 2.7.1.-)	GO:0005524; GO:0005829; GO:0016301; GO:0043687; GO:0102193	cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-ribulosamine 3-kinase activity [GO:0102193]; post-translational protein modification [GO:0043687]
PGEN_.00g143430	Scaffold_06	37240744	37261983	Q9H479	FN3K_HUMAN	Fructosamine-3-kinase (EC 2.7.1.171) (Protein-psicosamine 3-kinase FN3K) (Protein-ribulosamine 3-kinase FN3K) (EC 2.7.1.172)	GO:0005524; GO:0005829; GO:0016301; GO:0030387; GO:0030389; GO:0030393; GO:0030855; GO:0036525; GO:0043687; GO:0102193; GO:0102194	cytosol [GO:0005829]; ATP binding [GO:0005524]; fructosamine-3-kinase activity [GO:0030387]; kinase activity [GO:0016301]; protein-fructosamine 3-kinase activity [GO:0102194]; protein-ribulosamine 3-kinase activity [GO:0102193]; epithelial cell differentiation [GO:0030855]; fructosamine metabolic process [GO:0030389]; fructoselysine metabolic process [GO:0030393]; post-translational protein modification [GO:0043687]; protein deglycation [GO:0036525]
PGEN_.00g143440	Scaffold_06	37263616	37268497	O61463	RLA2_CRYST	60S acidic ribosomal protein P2	GO:0003735; GO:0005840; GO:0006414	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414]
PGEN_.00g143450	Scaffold_06	37270224	37277995	Q16RX1	MED21_AEDAE	Mediator of RNA polymerase II transcription subunit 21 (Mediator complex subunit 21)	GO:0016592	mediator complex [GO:0016592]
PGEN_.00g143460	Scaffold_06	37284251	37288850	NA	NA	NA	NA	NA
PGEN_.00g143470	Scaffold_06	37305007	37305919	NA	NA	NA	NA	NA
PGEN_.00g143480	Scaffold_06	37305955	37306155	NA	NA	NA	NA	NA
PGEN_.00g143490	Scaffold_06	37306633	37307810	Q9TTC1	POL_KORV	Gag-Pol polyprotein (Pr125Pol) [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p87); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42)]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]
PGEN_.00g143500	Scaffold_06	37308227	37308742	NA	NA	NA	NA	NA
PGEN_.00g143510	Scaffold_06	37318425	37325445	NA	NA	NA	NA	NA
PGEN_.00g143520	Scaffold_06	37325474	37338581	NA	NA	NA	NA	NA
PGEN_.00g143530	Scaffold_06	37341788	37349079	NA	NA	NA	NA	NA
PGEN_.00g143540	Scaffold_06	37366067	37367005	Q6UWP8	SBSN_HUMAN	Suprabasin	GO:0070062	extracellular exosome [GO:0070062]
PGEN_.00g143550	Scaffold_06	37373953	37375300	NA	NA	NA	NA	NA
PGEN_.00g143560	Scaffold_06	37377602	37377865	NA	NA	NA	NA	NA
PGEN_.00g143570	Scaffold_06	37383663	37404451	Q8NCF5	NF2IP_HUMAN	"NFATC2-interacting protein (45 kDa NF-AT-interacting protein) (45 kDa NFAT-interacting protein) (Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein)"	GO:0001816; GO:0005634; GO:0005737; GO:0045944	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cytokine production [GO:0001816]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g143580	Scaffold_06	37413480	37425993	NA	NA	NA	NA	NA
PGEN_.00g143590	Scaffold_06	37456565	37504359	E2QWQ2	NLK_CANLF	Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase)	GO:0000287; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0007179; GO:0008134; GO:0010468; GO:0016055; GO:0018107; GO:0030178; GO:0031625; GO:0035556; GO:0042169; GO:0042501; GO:0046777; GO:0050821	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; SH2 domain binding [GO:0042169]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; intracellular signal transduction [GO:0035556]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g143600	Scaffold_06	37519496	37546184	O88664	TAOK1_RAT	Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Thousand and one amino acid protein 1)	GO:0000186; GO:0000226; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0006281; GO:0006468; GO:0006974; GO:0007026; GO:0007095; GO:0008022; GO:0015630; GO:0016301; GO:0016310; GO:0019901; GO:0023014; GO:0030295; GO:0031489; GO:0032147; GO:0032874; GO:0032956; GO:0043014; GO:0043539; GO:0046330; GO:0046777; GO:0048471; GO:0048487; GO:0051493; GO:0070050; GO:0070507; GO:0097194; GO:1901985	cell [GO:0005623]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; MAP kinase kinase kinase activity [GO:0004709]; myosin V binding [GO:0031489]; protein C-terminus binding [GO:0008022]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; phosphorylation [GO:0016310]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g143610	Scaffold_06	37557369	37570935	Q9C086	IN80B_HUMAN	INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog) (hIes2) (PAP-1-associated protein 1) (PAPA-1) (Zinc finger HIT domain-containing protein 4)	GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006338; GO:0016579; GO:0031011; GO:0046872	Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; protein deubiquitination [GO:0016579]
PGEN_.00g143620	Scaffold_06	37573324	37596777	Q03567	SL172_CAEEL	Uncharacterized transporter slc-17.2	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g143630	Scaffold_06	37611088	37615029	P0DN66	ACTP1_CINAN	Tereporin-Ca1 (Actinoporin-like protein) (Fragment)	GO:0005576; GO:0006811; GO:0009405; GO:0016021; GO:0044179; GO:0044218; GO:0090729	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]; pathogenesis [GO:0009405]
PGEN_.00g143640	Scaffold_06	37618944	37619321	NA	NA	NA	NA	NA
PGEN_.00g143650	Scaffold_06	37622033	37622314	NA	NA	NA	NA	NA
PGEN_.00g143660	Scaffold_06	37622476	37624987	NA	NA	NA	NA	NA
PGEN_.00g143670	Scaffold_06	37644723	37644983	NA	NA	NA	NA	NA
PGEN_.00g143680	Scaffold_06	37655520	37664293	NA	NA	NA	NA	NA
PGEN_.00g143690	Scaffold_06	37728501	37728824	NA	NA	NA	NA	NA
PGEN_.00g143700	Scaffold_06	37737178	37744578	P0DN66	ACTP1_CINAN	Tereporin-Ca1 (Actinoporin-like protein) (Fragment)	GO:0005576; GO:0006811; GO:0009405; GO:0016021; GO:0044179; GO:0044218; GO:0090729	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; other organism cell membrane [GO:0044218]; toxin activity [GO:0090729]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]; pathogenesis [GO:0009405]
PGEN_.00g143710	Scaffold_06	37756035	37777608	Q0P426	SKA2_DANRE	Spindle and kinetochore-associated protein 2 (Protein FAM33A)	GO:0000278; GO:0000940; GO:0005737; GO:0005876; GO:0007059; GO:0008017; GO:0031110; GO:0051301	condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110]
PGEN_.00g143720	Scaffold_06	37779898	37784228	Q66H10	FBX39_RAT	F-box only protein 39	GO:0019005; GO:0031146	SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g143730	Scaffold_06	37792374	37817288	Q5XJS5	THOC6_DANRE	THO complex subunit 6 homolog (WD repeat-containing protein 58)	GO:0003723; GO:0006397; GO:0006915; GO:0007275; GO:0008380; GO:0016607; GO:0051028	nuclear speck [GO:0016607]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380]
PGEN_.00g143740	Scaffold_06	37827346	37851996	Q8BGG7	UBS3B_MOUSE	Ubiquitin-associated and SH3 domain-containing protein B (EC 3.1.3.48) (Cbl-interacting protein p70) (Suppressor of T-cell receptor signaling 1) (STS-1) (T-cell ubiquitin ligand 2) (TULA-2) (Tyrosine-protein phosphatase STS1/TULA2)	GO:0004725; GO:0005634; GO:0005737; GO:0006469; GO:0009968; GO:0030168; GO:0031625; GO:0035335; GO:0038063; GO:0038065; GO:0042802; GO:0043393; GO:0045670; GO:0045671; GO:0045779; GO:0051219; GO:0051279; GO:0070527; GO:0090331	cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625]; collagen-activated signaling pathway [GO:0038065]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein binding [GO:0043393]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]
PGEN_.00g143750	Scaffold_06	37853983	37854357	NA	NA	NA	NA	NA
PGEN_.00g143760	Scaffold_06	37859147	37873369	P51947	CCNH_XENLA	Cyclin-H (MO15-associated protein) (p36)	GO:0006351; GO:0007049; GO:0016538; GO:0070985	"transcription factor TFIIK complex [GO:0070985]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell cycle [GO:0007049]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g143770	Scaffold_06	37877954	37884088	NA	NA	NA	NA	NA
PGEN_.00g143780	Scaffold_06	37884776	37885807	NA	NA	NA	NA	NA
PGEN_.00g143790	Scaffold_06	37902638	37902859	NA	NA	NA	NA	NA
PGEN_.00g143800	Scaffold_06	37913712	37985002	NA	NA	NA	NA	NA
PGEN_.00g143810	Scaffold_06	38058950	38060553	NA	NA	NA	NA	NA
PGEN_.00g143820	Scaffold_06	38072653	38076676	NA	NA	NA	NA	NA
PGEN_.00g143830	Scaffold_06	38143308	38150022	NA	NA	NA	NA	NA
PGEN_.00g143840	Scaffold_06	38150051	38162527	Q5EBP3	ARMC5_MOUSE	Armadillo repeat-containing protein 5	GO:0005654; GO:0005737; GO:0005829; GO:0005925	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]
PGEN_.00g143850	Scaffold_06	38183542	38194007	Q00610	CLH1_HUMAN	Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17)	GO:0000278; GO:0001649; GO:0003723; GO:0003725; GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005886; GO:0005925; GO:0006886; GO:0006898; GO:0006914; GO:0016020; GO:0019886; GO:0019901; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0031623; GO:0032051; GO:0032588; GO:0032802; GO:0032991; GO:0033572; GO:0034383; GO:0036020; GO:0042147; GO:0042470; GO:0045334; GO:0048268; GO:0050750; GO:0051301; GO:0060071; GO:0060236; GO:0061024; GO:0070062; GO:0071439; GO:0072583; GO:0072686; GO:0097718; GO:0150093; GO:1900126; GO:1903077; GO:1903561; GO:1990381; GO:1990498	"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; trans-Golgi network membrane [GO:0032588]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]; amyloid-beta clearance by transcytosis [GO:0150093]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; osteoblast differentiation [GO:0001649]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transferrin transport [GO:0033572]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g143860	Scaffold_06	38194377	38212052	Q5RK30	SBDS_RAT	Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog)	GO:0000922; GO:0001833; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0007052; GO:0008017; GO:0008283; GO:0019843; GO:0030282; GO:0030595; GO:0042256; GO:0043022; GO:0048539	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cell population proliferation [GO:0008283]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364]
PGEN_.00g143870	Scaffold_06	38203408	38203830	NA	NA	NA	NA	NA
PGEN_.00g143880	Scaffold_06	38222966	38224669	NA	NA	NA	NA	NA
PGEN_.00g143890	Scaffold_06	38239990	38253896	NA	NA	NA	NA	NA
PGEN_.00g143900	Scaffold_06	38260101	38284594	NA	NA	NA	NA	NA
PGEN_.00g143910	Scaffold_06	38308988	38309883	NA	NA	NA	NA	NA
PGEN_.00g143920	Scaffold_06	38310287	38311460	NA	NA	NA	NA	NA
PGEN_.00g143930	Scaffold_06	38311874	38313949	NA	NA	NA	NA	NA
PGEN_.00g143940	Scaffold_06	38341049	38341303	NA	NA	NA	NA	NA
PGEN_.00g143950	Scaffold_06	38358471	38377616	P86982	IMSP1_RUDPH	Insoluble matrix shell protein 1 (IMSP1) (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g143960	Scaffold_06	38377697	38378278	NA	NA	NA	NA	NA
PGEN_.00g143970	Scaffold_06	38378503	38380189	NA	NA	NA	NA	NA
PGEN_.00g143980	Scaffold_06	38380609	38380989	NA	NA	NA	NA	NA
PGEN_.00g143990	Scaffold_06	38381015	38381218	NA	NA	NA	NA	NA
PGEN_.00g144000	Scaffold_06	38442853	38443266	NA	NA	NA	NA	NA
PGEN_.00g144010	Scaffold_06	38470229	38473298	NA	NA	NA	NA	NA
PGEN_.00g144020	Scaffold_06	38477512	38494288	NA	NA	NA	NA	NA
PGEN_.00g144030	Scaffold_06	38499659	38502359	NA	NA	NA	NA	NA
PGEN_.00g144040	Scaffold_06	38503181	38513709	Q0B880	HCP_BURCM	Hydroxylamine reductase (EC 1.7.99.1) (Hybrid-cluster protein) (HCP) (Prismane protein)	GO:0005737; GO:0046872; GO:0050418; GO:0051539	"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; hydroxylamine reductase activity [GO:0050418]; metal ion binding [GO:0046872]"
PGEN_.00g144050	Scaffold_06	38622545	38626682	NA	NA	NA	NA	NA
PGEN_.00g144060	Scaffold_06	38627092	38627385	NA	NA	NA	NA	NA
PGEN_.00g144070	Scaffold_06	38628497	38628817	NA	NA	NA	NA	NA
PGEN_.00g144080	Scaffold_06	38636939	38653670	Q9GUM2	BRE4_CAEEL	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	"integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"
PGEN_.00g144090	Scaffold_06	38671135	38676917	NA	NA	NA	NA	NA
PGEN_.00g144100	Scaffold_06	38688914	38704764	NA	NA	NA	NA	NA
PGEN_.00g144110	Scaffold_06	38768439	38769870	NA	NA	NA	NA	NA
PGEN_.00g144120	Scaffold_06	38771720	38774467	NA	NA	NA	NA	NA
PGEN_.00g144130	Scaffold_06	38779599	38781439	NA	NA	NA	NA	NA
PGEN_.00g144140	Scaffold_06	38829537	38840026	Q9UHJ6	SHPK_HUMAN	Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein)	GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0016310; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; sedoheptulokinase activity [GO:0050277]; carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]"
PGEN_.00g144150	Scaffold_06	38842370	38848108	P77735	YAJO_ECOLI	1-deoxyxylulose-5-phosphate synthase YajO (EC 1.1.-.-)	GO:0005829; GO:0006772; GO:0016491	cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772]
PGEN_.00g144160	Scaffold_06	38856694	38872041	NA	NA	NA	NA	NA
PGEN_.00g144170	Scaffold_06	38875045	38876384	NA	NA	NA	NA	NA
PGEN_.00g144180	Scaffold_06	38877234	38880025	NA	NA	NA	NA	NA
PGEN_.00g144190	Scaffold_06	38896945	38898708	NA	NA	NA	NA	NA
PGEN_.00g144200	Scaffold_06	38914061	38916772	NA	NA	NA	NA	NA
PGEN_.00g144210	Scaffold_06	38936441	38936812	NA	NA	NA	NA	NA
PGEN_.00g144220	Scaffold_06	38986855	38993438	NA	NA	NA	NA	NA
PGEN_.00g144230	Scaffold_06	39050338	39051021	NA	NA	NA	NA	NA
PGEN_.00g144240	Scaffold_06	39054102	39055161	NA	NA	NA	NA	NA
PGEN_.00g144250	Scaffold_06	39163602	39165740	NA	NA	NA	NA	NA
PGEN_.00g144260	Scaffold_06	39199519	39199911	NA	NA	NA	NA	NA
PGEN_.00g144270	Scaffold_06	39200040	39200249	NA	NA	NA	NA	NA
PGEN_.00g144280	Scaffold_06	39200994	39201743	NA	NA	NA	NA	NA
PGEN_.00g144290	Scaffold_06	39217758	39218519	NA	NA	NA	NA	NA
PGEN_.00g144300	Scaffold_06	39219154	39219912	NA	NA	NA	NA	NA
PGEN_.00g144310	Scaffold_06	39220075	39220515	NA	NA	NA	NA	NA
PGEN_.00g144320	Scaffold_06	39237587	39241995	Q8MRC9	GALT9_DROME	Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9)	GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]
PGEN_.00g144330	Scaffold_06	39250544	39250954	NA	NA	NA	NA	NA
PGEN_.00g144340	Scaffold_06	39251214	39253900	NA	NA	NA	NA	NA
PGEN_.00g144350	Scaffold_06	39256165	39272608	Q9CZR2	NALD2_MOUSE	N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)	GO:0004180; GO:0005886; GO:0006508; GO:0008233; GO:0008237; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; peptidase activity [GO:0008233]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]
PGEN_.00g144360	Scaffold_06	39282670	39306135	NA	NA	NA	NA	NA
PGEN_.00g144370	Scaffold_06	39317251	39360172	P16435	NCPR_HUMAN	NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)	GO:0003420; GO:0003958; GO:0004128; GO:0005739; GO:0005789; GO:0005829; GO:0006805; GO:0007584; GO:0008941; GO:0009055; GO:0009437; GO:0009725; GO:0009812; GO:0010181; GO:0016020; GO:0016021; GO:0016491; GO:0016787; GO:0018393; GO:0019395; GO:0019899; GO:0032332; GO:0032770; GO:0042493; GO:0043154; GO:0043231; GO:0043602; GO:0045542; GO:0045880; GO:0046210; GO:0047726; GO:0050660; GO:0050661; GO:0055114; GO:0060192; GO:0070988; GO:0071372; GO:0071375; GO:0090031; GO:0090346	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g144380	Scaffold_06	39362067	39373085	P80317	TCPZ_MOUSE	T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)	GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0032212; GO:0044297; GO:0050821; GO:0051082; GO:0071987; GO:1901998; GO:1904851	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]
PGEN_.00g144390	Scaffold_06	39385314	39394680	NA	NA	NA	NA	NA
PGEN_.00g144400	Scaffold_06	39405370	39450623	B3DJT0	SART3_DANRE	Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3)	GO:0000245; GO:0000381; GO:0000387; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0008380; GO:0015030; GO:0016607; GO:0017070; GO:0030098; GO:0031017; GO:0042393; GO:0048538; GO:0061574; GO:1903586	"ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; U6 snRNA binding [GO:0017070]; exocrine pancreas development [GO:0031017]; lymphocyte differentiation [GO:0030098]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; thymus development [GO:0048538]"
PGEN_.00g144410	Scaffold_06	39461076	39462200	C7G0B5	PIF_PINFU	Protein PIF [Cleaved into: Protein Pif97; Protein Pif80 (Aragonite-binding protein)]	GO:0005576; GO:0006030; GO:0008061	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]
PGEN_.00g144420	Scaffold_06	39471697	39473904	NA	NA	NA	NA	NA
PGEN_.00g144430	Scaffold_06	39478473	39488980	NA	NA	NA	NA	NA
PGEN_.00g144440	Scaffold_06	39489505	39490491	NA	NA	NA	NA	NA
PGEN_.00g144450	Scaffold_06	39494461	39495102	NA	NA	NA	NA	NA
PGEN_.00g144460	Scaffold_06	39495705	39495974	NA	NA	NA	NA	NA
PGEN_.00g144470	Scaffold_06	39513834	39514325	NA	NA	NA	NA	NA
PGEN_.00g144480	Scaffold_06	39522006	39525816	NA	NA	NA	NA	NA
PGEN_.00g144490	Scaffold_06	39552447	39552866	NA	NA	NA	NA	NA
PGEN_.00g144500	Scaffold_06	39568941	39569246	NA	NA	NA	NA	NA
PGEN_.00g144510	Scaffold_06	39570017	39570472	NA	NA	NA	NA	NA
PGEN_.00g144520	Scaffold_06	39583343	39583564	NA	NA	NA	NA	NA
PGEN_.00g144530	Scaffold_06	39601597	39611060	NA	NA	NA	NA	NA
PGEN_.00g144540	Scaffold_06	39612312	39631497	Q9VVE5	MSIR6_DROME	RNA-binding protein Musashi homolog Rbp6	GO:0003723; GO:0003727; GO:0005634; GO:0005737; GO:0005844; GO:0008266; GO:0048864; GO:1990904	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864]
PGEN_.00g144550	Scaffold_06	39655027	39655682	NA	NA	NA	NA	NA
PGEN_.00g144560	Scaffold_06	39686813	39691717	NA	NA	NA	NA	NA
PGEN_.00g144570	Scaffold_06	39692729	39827858	Q9UNE2	RPH3L_HUMAN	Rab effector Noc2 (No C2 domains protein) (Rabphilin-3A-like protein)	GO:0005737; GO:0006886; GO:0006887; GO:0008092; GO:0017137; GO:0017158; GO:0030274; GO:0030658; GO:0030667; GO:0032024; GO:0042493; GO:0042593; GO:0045744; GO:0046872	cytoplasm [GO:0005737]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; cytoskeletal protein binding [GO:0008092]; LIM domain binding [GO:0030274]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of insulin secretion [GO:0032024]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to drug [GO:0042493]
PGEN_.00g144580	Scaffold_06	39859151	39859393	NA	NA	NA	NA	NA
PGEN_.00g144590	Scaffold_06	39929446	39950240	NA	NA	NA	NA	NA
PGEN_.00g144600	Scaffold_06	39958864	39959109	NA	NA	NA	NA	NA
PGEN_.00g144610	Scaffold_06	39990740	40001263	Q9UNE2	RPH3L_HUMAN	Rab effector Noc2 (No C2 domains protein) (Rabphilin-3A-like protein)	GO:0005737; GO:0006886; GO:0006887; GO:0008092; GO:0017137; GO:0017158; GO:0030274; GO:0030658; GO:0030667; GO:0032024; GO:0042493; GO:0042593; GO:0045744; GO:0046872	cytoplasm [GO:0005737]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; cytoskeletal protein binding [GO:0008092]; LIM domain binding [GO:0030274]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of insulin secretion [GO:0032024]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to drug [GO:0042493]
PGEN_.00g144620	Scaffold_06	40037636	40085053	Q14184	DOC2B_HUMAN	Double C2-like domain-containing protein beta (Doc2-beta)	GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0008104; GO:0019905; GO:0031340; GO:0032024; GO:0045956; GO:0048791; GO:0061669; GO:0098793	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104]; spontaneous neurotransmitter secretion [GO:0061669]
PGEN_.00g144630	Scaffold_06	40112363	40112641	NA	NA	NA	NA	NA
PGEN_.00g144640	Scaffold_06	40115887	40177289	Q1ZXD6	ROCO5_DICDI	Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5)	GO:0004674; GO:0005085; GO:0005524; GO:0005525; GO:0030587	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; sorocarp development [GO:0030587]
PGEN_.00g144650	Scaffold_06	40234884	40236612	NA	NA	NA	NA	NA
PGEN_.00g144660	Scaffold_06	40264215	40268100	NA	NA	NA	NA	NA
PGEN_.00g144670	Scaffold_06	40278489	40284328	NA	NA	NA	NA	NA
PGEN_.00g144680	Scaffold_06	40288322	40288582	NA	NA	NA	NA	NA
PGEN_.00g144690	Scaffold_06	40289554	40290126	NA	NA	NA	NA	NA
PGEN_.00g144700	Scaffold_06	40299617	40303019	P78560	CRADD_HUMAN	Death domain-containing protein CRADD (Caspase and RIP adapter with death domain) (RIP-associated protein with a death domain)	GO:0002020; GO:0005634; GO:0005737; GO:0005829; GO:0006919; GO:0006977; GO:0008625; GO:0030674; GO:0042981; GO:0043065; GO:0070513; GO:0071260; GO:0097190; GO:2001235	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; death domain binding [GO:0070513]; protease binding [GO:0002020]; protein binding, bridging [GO:0030674]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of apoptotic process [GO:0042981]"
PGEN_.00g144710	Scaffold_06	40327749	40339556	NA	NA	NA	NA	NA
PGEN_.00g144720	Scaffold_06	40361982	40397443	P78560	CRADD_HUMAN	Death domain-containing protein CRADD (Caspase and RIP adapter with death domain) (RIP-associated protein with a death domain)	GO:0002020; GO:0005634; GO:0005737; GO:0005829; GO:0006919; GO:0006977; GO:0008625; GO:0030674; GO:0042981; GO:0043065; GO:0070513; GO:0071260; GO:0097190; GO:2001235	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; death domain binding [GO:0070513]; protease binding [GO:0002020]; protein binding, bridging [GO:0030674]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of apoptotic process [GO:0042981]"
PGEN_.00g144730	Scaffold_06	40406463	40406909	NA	NA	NA	NA	NA
PGEN_.00g144740	Scaffold_06	40413983	40414695	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g144750	Scaffold_06	40417734	40428938	NA	NA	NA	NA	NA
PGEN_.00g144760	Scaffold_06	40447409	40450865	NA	NA	NA	NA	NA
PGEN_.00g144770	Scaffold_06	40455775	40456101	NA	NA	NA	NA	NA
PGEN_.00g144780	Scaffold_06	40514574	40516657	NA	NA	NA	NA	NA
PGEN_.00g144790	Scaffold_06	40544693	40545031	NA	NA	NA	NA	NA
PGEN_.00g144800	Scaffold_06	40603446	40605153	NA	NA	NA	NA	NA
PGEN_.00g144810	Scaffold_06	40609139	40609886	NA	NA	NA	NA	NA
PGEN_.00g144820	Scaffold_06	40611864	40618083	NA	NA	NA	NA	NA
PGEN_.00g144830	Scaffold_06	40626035	40627141	NA	NA	NA	NA	NA
PGEN_.00g144840	Scaffold_06	40666191	40670148	Q9BX70	BTBD2_HUMAN	BTB/POZ domain-containing protein 2	GO:0000932; GO:0005829; GO:0022008	cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]
PGEN_.00g144850	Scaffold_06	40792683	40793129	NA	NA	NA	NA	NA
PGEN_.00g144860	Scaffold_06	40851175	40851478	NA	NA	NA	NA	NA
PGEN_.00g144870	Scaffold_06	40907542	40915388	NA	NA	NA	NA	NA
PGEN_.00g144880	Scaffold_06	41008227	41008736	NA	NA	NA	NA	NA
PGEN_.00g144890	Scaffold_06	41009048	41014135	NA	NA	NA	NA	NA
PGEN_.00g144900	Scaffold_06	41025575	41025868	NA	NA	NA	NA	NA
PGEN_.00g144910	Scaffold_06	41042907	41052529	NA	NA	NA	NA	NA
PGEN_.00g144920	Scaffold_06	41082660	41082992	NA	NA	NA	NA	NA
PGEN_.00g144930	Scaffold_06	41220920	41221195	NA	NA	NA	NA	NA
PGEN_.00g144940	Scaffold_06	41243460	41291992	Q0IIH7	ST14_BOVIN	Suppressor of tumorigenicity 14 protein homolog (EC 3.4.21.109) (Serine protease 14)	GO:0004252; GO:0016021; GO:0030216	integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; keratinocyte differentiation [GO:0030216]
PGEN_.00g144950	Scaffold_06	41295714	41296340	NA	NA	NA	NA	NA
PGEN_.00g144960	Scaffold_06	41297464	41298967	NA	NA	NA	NA	NA
PGEN_.00g144970	Scaffold_06	41311471	41311911	NA	NA	NA	NA	NA
PGEN_.00g144980	Scaffold_06	41311943	41313061	NA	NA	NA	NA	NA
PGEN_.00g144990	Scaffold_06	41317941	41318477	NA	NA	NA	NA	NA
PGEN_.00g145000	Scaffold_06	41319676	41322510	NA	NA	NA	NA	NA
PGEN_.00g145010	Scaffold_06	41340665	41344224	NA	NA	NA	NA	NA
PGEN_.00g145020	Scaffold_06	41349180	41355699	Q96PS8	AQP10_HUMAN	Aquaporin-10 (AQP-10) (Aquaglyceroporin-10) (Small intestine aquaporin)	GO:0005811; GO:0005886; GO:0005887; GO:0006833; GO:0009636; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016324; GO:0051289; GO:0071468	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; cellular response to acidic pH [GO:0071468]; glycerol transport [GO:0015793]; protein homotetramerization [GO:0051289]; response to toxic substance [GO:0009636]; water transport [GO:0006833]
PGEN_.00g145030	Scaffold_06	41401886	41426489	Q5XHG1	NSMA3_XENLA	Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III)	GO:0000139; GO:0004767; GO:0005635; GO:0005789; GO:0016021; GO:0046872; GO:0050290	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290]
PGEN_.00g145040	Scaffold_06	41426620	41450898	Q5ZM19	NCBP3_CHICK	Nuclear cap-binding protein subunit 3	GO:0000340; GO:0003729; GO:0005634; GO:0005737; GO:0006370; GO:0051028	cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; 7-methylguanosine mRNA capping [GO:0006370]; mRNA transport [GO:0051028]
PGEN_.00g145050	Scaffold_06	41460066	41460536	NA	NA	NA	NA	NA
PGEN_.00g145060	Scaffold_06	41460608	41470773	NA	NA	NA	NA	NA
PGEN_.00g145070	Scaffold_06	41476391	41481051	NA	NA	NA	NA	NA
PGEN_.00g145080	Scaffold_06	41488542	41494400	NA	NA	NA	NA	NA
PGEN_.00g145090	Scaffold_06	41494771	41496857	NA	NA	NA	NA	NA
PGEN_.00g145100	Scaffold_06	41513564	41515784	NA	NA	NA	NA	NA
PGEN_.00g145110	Scaffold_06	41529187	41529537	NA	NA	NA	NA	NA
PGEN_.00g145120	Scaffold_06	41530578	41530988	NA	NA	NA	NA	NA
PGEN_.00g145130	Scaffold_06	41537013	41537738	NA	NA	NA	NA	NA
PGEN_.00g145140	Scaffold_06	41539657	41550286	Q9FF12	GSXL9_ARATH	Flavin-containing monooxygenase FMO GS-OX-like 9 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 9)	GO:0004499; GO:0050660; GO:0050661	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
PGEN_.00g145150	Scaffold_06	41557327	41574104	NA	NA	NA	NA	NA
PGEN_.00g145160	Scaffold_06	41586903	41600074	Q9V5N8	STAN_DROME	Protocadherin-like wing polarity protein stan (Protein flamingo) (Protein starry night)	GO:0001736; GO:0001738; GO:0004888; GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007367; GO:0007409; GO:0007411; GO:0007464; GO:0016021; GO:0016318; GO:0016319; GO:0016324; GO:0016339; GO:0016358; GO:0035159; GO:0042067; GO:0045773; GO:0048057; GO:0048813; GO:0050770; GO:0050839; GO:0051963; GO:0060071; GO:0070593; GO:0090175; GO:0098609; GO:1902669	"apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of a polarized epithelium [GO:0001738]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; R3/R4 cell fate commitment [GO:0007464]; R3/R4 development [GO:0048057]; regulation of axonogenesis [GO:0050770]; regulation of establishment of planar polarity [GO:0090175]; regulation of synapse assembly [GO:0051963]; regulation of tube length, open tracheal system [GO:0035159]; segment polarity determination [GO:0007367]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g145170	Scaffold_06	41601334	41602192	Q86VP6	CAND1_HUMAN	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (TBP-interacting protein of 120 kDa A) (TBP-interacting protein 120A) (p120 CAND1)	GO:0000151; GO:0005576; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006879; GO:0010265; GO:0016020; GO:0016567; GO:0017025; GO:0030154; GO:0031461; GO:0034774; GO:0043086; GO:0043312; GO:0043687; GO:0045899; GO:0070062; GO:1904813	cell [GO:0005623]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; ubiquitin ligase complex [GO:0000151]; TBP-class protein binding [GO:0017025]; cell differentiation [GO:0030154]; cellular iron ion homeostasis [GO:0006879]; negative regulation of catalytic activity [GO:0043086]; neutrophil degranulation [GO:0043312]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]
PGEN_.00g145180	Scaffold_06	41608114	41613999	NA	NA	NA	NA	NA
PGEN_.00g145190	Scaffold_06	41616265	41632711	NA	NA	NA	NA	NA
PGEN_.00g145200	Scaffold_06	41638969	41650209	Q8BIA4	FBXW8_MOUSE	F-box/WD repeat-containing protein 8 (F-box and WD-40 domain-containing protein 8)	GO:0004842; GO:0005794; GO:0005829; GO:0006511; GO:0007030; GO:0008283; GO:0016567; GO:0019005; GO:0030687; GO:0031467; GO:0048471; GO:0050775; GO:0060712; GO:0060716; GO:0070545; GO:1901485; GO:1990393	"3M complex [GO:1990393]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; PeBoW complex [GO:0070545]; perinuclear region of cytoplasm [GO:0048471]; preribosome, large subunit precursor [GO:0030687]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; cell population proliferation [GO:0008283]; Golgi organization [GO:0007030]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription factor catabolic process [GO:1901485]; protein ubiquitination [GO:0016567]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g145210	Scaffold_06	41652312	41653710	Q8N3Y1	FBXW8_HUMAN	F-box/WD repeat-containing protein 8 (F-box and WD-40 domain-containing protein 8) (F-box only protein 29)	GO:0000209; GO:0005794; GO:0005829; GO:0007030; GO:0008283; GO:0016567; GO:0019005; GO:0031467; GO:0043687; GO:0048471; GO:0050775; GO:0060712; GO:0060716; GO:1901485	Cul7-RING ubiquitin ligase complex [GO:0031467]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; cell population proliferation [GO:0008283]; Golgi organization [GO:0007030]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription factor catabolic process [GO:1901485]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; spongiotrophoblast layer development [GO:0060712]
PGEN_.00g145220	Scaffold_06	41667823	41668882	NA	NA	NA	NA	NA
PGEN_.00g145230	Scaffold_06	41695755	41695985	NA	NA	NA	NA	NA
PGEN_.00g145240	Scaffold_06	41708821	41718104	P49193	RALB_TODPA	Retinal-binding protein (RALBP)	GO:0007601; GO:0050896	response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g145250	Scaffold_06	41718226	41733423	P49193	RALB_TODPA	Retinal-binding protein (RALBP)	GO:0007601; GO:0050896	response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g145260	Scaffold_06	41793243	41794926	A7MBD8	SC5AC_BOVIN	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g145270	Scaffold_06	41798168	41804724	NA	NA	NA	NA	NA
PGEN_.00g145280	Scaffold_06	41806426	41809520	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g145290	Scaffold_06	41810030	41811892	Q49B93	SC5AC_MOUSE	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g145300	Scaffold_06	41814400	41814759	NA	NA	NA	NA	NA
PGEN_.00g145310	Scaffold_06	41814806	41815087	NA	NA	NA	NA	NA
PGEN_.00g145320	Scaffold_06	41818349	41818621	NA	NA	NA	NA	NA
PGEN_.00g145330	Scaffold_06	41830805	41831215	NA	NA	NA	NA	NA
PGEN_.00g145340	Scaffold_06	41839817	41890630	Q99MS0	S14L2_RAT	SEC14-like protein 2 (Alpha-tocopherol-associated protein) (TAP) (Squalene transfer protein) (Supernatant protein factor) (SPF)	GO:0005634; GO:0005829; GO:0008047; GO:0008289; GO:0016765; GO:0045542	"cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; lipid binding [GO:0008289]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; positive regulation of cholesterol biosynthetic process [GO:0045542]"
PGEN_.00g145350	Scaffold_06	41897535	41911690	Q0VGK4	GDPD1_RAT	Lysophospholipase D GDPD1 (EC 3.1.4.39) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)	GO:0004622; GO:0005789; GO:0006644; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0047391; GO:0048471; GO:0070291	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]
PGEN_.00g145360	Scaffold_06	41922580	41926719	Q641W3	NUFP1_RAT	Nuclear fragile X mental retardation-interacting protein 1 (Nuclear FMRP-interacting protein 1)	GO:0000492; GO:0001650; GO:0003723; GO:0005634; GO:0005726; GO:0008023; GO:0016363; GO:0022626; GO:0030515; GO:0030674; GO:0032991; GO:0042802; GO:0045202; GO:0045944; GO:0046872; GO:0048786; GO:0051117; GO:0051259; GO:0070761	"cytosolic ribosome [GO:0022626]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transcription elongation factor complex [GO:0008023]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]"
PGEN_.00g145370	Scaffold_06	41962280	41967602	NA	NA	NA	NA	NA
PGEN_.00g145380	Scaffold_06	41992989	42003442	Q5R5I4	UB2L3_PONAB	Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (Ubiquitin carrier protein L3) (Ubiquitin-protein ligase L3)	GO:0000209; GO:0003713; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0008283; GO:0016567; GO:0044770; GO:0070979; GO:0071383; GO:0071385	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g145390	Scaffold_06	42007610	42016593	Q66L51	COQ5_DANRE	"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial (EC 2.1.1.201) (Ubiquinone biosynthesis methyltransferase COQ5)"	GO:0005739; GO:0006744; GO:0031314; GO:0032259; GO:0043333	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrion [GO:0005739]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"
PGEN_.00g145400	Scaffold_06	42021179	42021442	NA	NA	NA	NA	NA
PGEN_.00g145410	Scaffold_06	42021811	42022029	NA	NA	NA	NA	NA
PGEN_.00g145420	Scaffold_06	42022891	42023112	Q96FJ2	DYL2_HUMAN	"Dynein light chain 2, cytoplasmic (8 kDa dynein light chain b) (DLC8b) (Dynein light chain LC8-type 2)"	GO:0003774; GO:0005634; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005886; GO:0005929; GO:0006888; GO:0014069; GO:0016020; GO:0016236; GO:0019886; GO:0030286; GO:0031475; GO:0035735; GO:0042803; GO:0045505; GO:0046982; GO:0051959; GO:0097110; GO:0097542; GO:0098794; GO:0098978; GO:2000582	"centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intraciliary transport involved in cilium assembly [GO:0035735]; macroautophagy [GO:0016236]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]"
PGEN_.00g145430	Scaffold_06	42082157	42086008	NA	NA	NA	NA	NA
PGEN_.00g145440	Scaffold_06	42086097	42109014	P49025	CTRO_MOUSE	"Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Rho-interacting, serine/threonine-protein kinase 21)"	GO:0000070; GO:0000086; GO:0000278; GO:0000281; GO:0001726; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005773; GO:0005829; GO:0005856; GO:0005886; GO:0007030; GO:0007091; GO:0007283; GO:0008064; GO:0015629; GO:0016358; GO:0017124; GO:0018107; GO:0030165; GO:0030496; GO:0030866; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035556; GO:0043025; GO:0045665; GO:0046872; GO:0048699; GO:0050774; GO:0051402; GO:0097110	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vacuole [GO:0005773]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; dendrite development [GO:0016358]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of neuron differentiation [GO:0045665]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]; spermatogenesis [GO:0007283]
PGEN_.00g145450	Scaffold_06	42110258	42110623	NA	NA	NA	NA	NA
PGEN_.00g145460	Scaffold_06	42110797	42111219	NA	NA	NA	NA	NA
PGEN_.00g145470	Scaffold_06	42115091	42151349	O14578	CTRO_HUMAN	Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21)	GO:0000086; GO:0000278; GO:0000281; GO:0001889; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007030; GO:0008064; GO:0015629; GO:0016020; GO:0017124; GO:0018107; GO:0030165; GO:0030496; GO:0030866; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035556; GO:0043025; GO:0046872; GO:0048699; GO:0051402; GO:0097110	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]
PGEN_.00g145480	Scaffold_06	42159445	42168950	NA	NA	NA	NA	NA
PGEN_.00g145490	Scaffold_06	42184537	42193568	A7MCS3	CP089_DANRE	UPF0764 protein C16orf89 homolog	GO:0005576; GO:0005829; GO:0016020	cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g145500	Scaffold_06	42260204	42267616	Q6DFQ5	SGMR2_XENTR	Sigma intracellular receptor 2 (Sigma-2 receptor) (Sigma2 receptor) (Transmembrane protein 97)	GO:0005764; GO:0005791; GO:0005886; GO:0016021; GO:0030867; GO:0031965; GO:0042632	integral component of membrane [GO:0016021]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; cholesterol homeostasis [GO:0042632]
PGEN_.00g145510	Scaffold_06	42271706	42276525	Q91ZW8	C209D_MOUSE	CD209 antigen-like protein D (DC-SIGN-related protein 3) (DC-SIGNR3) (CD antigen CD209)	GO:0005537; GO:0006897; GO:0016021; GO:0042742; GO:0042803; GO:0046872; GO:0050715	integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; positive regulation of cytokine secretion [GO:0050715]
PGEN_.00g145520	Scaffold_06	42277147	42296527	Q9NP78	ABCB9_HUMAN	ATP-binding cassette sub-family B member 9 (ATP-binding cassette transporter 9) (ABC transporter 9 protein) (hABCB9) (TAP-like protein) (TAPL)	GO:0005524; GO:0005764; GO:0005765; GO:0015031; GO:0015440; GO:0015833; GO:0016021; GO:0016887; GO:0022857; GO:0030176; GO:0042626; GO:0042803; GO:0043231; GO:0055085	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled peptide transmembrane transporter activity [GO:0015440]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]
PGEN_.00g145530	Scaffold_06	42319721	42323338	NA	NA	NA	NA	NA
PGEN_.00g145540	Scaffold_06	42433230	42452613	Q9Y4C8	RBM19_HUMAN	Probable RNA-binding protein 19 (RNA-binding motif protein 19)	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0007275; GO:0016020; GO:0016607; GO:0040019; GO:0045292	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"
PGEN_.00g145550	Scaffold_06	42455473	42471323	NA	NA	NA	NA	NA
PGEN_.00g145560	Scaffold_06	42477877	42504799	P97470	PP4C_MOUSE	Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X)	GO:0004704; GO:0004722; GO:0005521; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0010569; GO:0016311; GO:0016791; GO:0030289; GO:0044877; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; NF-kappaB-inducing kinase activity [GO:0004704]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; dephosphorylation [GO:0016311]; regulation of double-strand break repair via homologous recombination [GO:0010569]
PGEN_.00g145570	Scaffold_06	42510164	42521525	O61492	FLOT2_DROME	Flotillin-2	GO:0005198; GO:0005737; GO:0005829; GO:0005886; GO:0007155; GO:0016600; GO:0035011; GO:0035593; GO:0051491; GO:0061357	cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593]
PGEN_.00g145580	Scaffold_06	42532049	42532486	NA	NA	NA	NA	NA
PGEN_.00g145590	Scaffold_06	42532557	42533060	Q6XQH0	G3ST2_MOUSE	"Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2)"	GO:0001733; GO:0008146; GO:0009101; GO:0009247; GO:0016020; GO:0016021; GO:0032580; GO:0050694; GO:0051923	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; sulfation [GO:0051923]
PGEN_.00g145600	Scaffold_06	42548122	42548382	NA	NA	NA	NA	NA
PGEN_.00g145610	Scaffold_06	42573502	42589979	Q9CY57	CHTOP_MOUSE	Chromatin target of PRMT1 protein (Friend of PRMT1 protein) (Small arginine- and glycine-rich protein) (SRAG)	GO:0000346; GO:0001701; GO:0003723; GO:0005730; GO:0006406; GO:0008284; GO:0008327; GO:0016607; GO:0031062; GO:0036464; GO:0051096	cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; transcription export complex [GO:0000346]; methyl-CpG binding [GO:0008327]; RNA binding [GO:0003723]; in utero embryonic development [GO:0001701]; mRNA export from nucleus [GO:0006406]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of helicase activity [GO:0051096]; positive regulation of histone methylation [GO:0031062]
PGEN_.00g145620	Scaffold_06	42602265	42621720	Q8QFP8	LIMK1_CHICK	LIM domain kinase 1 (LIMK-1) (chLIMK1) (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0016020; GO:0016607; GO:0030027; GO:0030036; GO:0030426; GO:0031072; GO:0043005; GO:0045773; GO:0046872; GO:0046982; GO:0051444; GO:0051496	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]
PGEN_.00g145630	Scaffold_06	42634097	42634417	NA	NA	NA	NA	NA
PGEN_.00g145640	Scaffold_06	42640051	42640707	NA	NA	NA	NA	NA
PGEN_.00g145650	Scaffold_06	42668799	42669458	P05451	REG1A_HUMAN	Lithostathine-1-alpha (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP) (Regenerating islet-derived protein 1-alpha) (REG-1-alpha) (Regenerating protein I alpha)	GO:0001666; GO:0004888; GO:0005615; GO:0005829; GO:0007494; GO:0008083; GO:0008284; GO:0008285; GO:0010628; GO:0019903; GO:0030426; GO:0031667; GO:0032590; GO:0032809; GO:0032991; GO:0042060; GO:0042588; GO:0042803; GO:0042834; GO:0043434; GO:0044278; GO:0045178; GO:0048471; GO:0051289; GO:0055074; GO:0061844; GO:0070062; GO:0070492; GO:0097421; GO:1903492; GO:1903861; GO:1904692; GO:1904699; GO:1990785; GO:1990798; GO:1990864; GO:1990869; GO:1990878	basal part of cell [GO:0045178]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuronal cell body membrane [GO:0032809]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; zymogen granule [GO:0042588]; growth factor activity [GO:0008083]; oligosaccharide binding [GO:0070492]; peptidoglycan binding [GO:0042834]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane signaling receptor activity [GO:0004888]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium ion homeostasis [GO:0055074]; cell wall disruption in other organism [GO:0044278]; cellular response to chemokine [GO:1990869]; cellular response to gastrin [GO:1990878]; liver regeneration [GO:0097421]; midgut development [GO:0007494]; negative regulation of cell population proliferation [GO:0008285]; pancreas regeneration [GO:1990798]; positive regulation of acinar cell proliferation [GO:1904699]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of gene expression [GO:0010628]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; protein homotetramerization [GO:0051289]; response to acetylsalicylate [GO:1903492]; response to growth hormone-releasing hormone [GO:1990864]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to water-immersion restraint stress [GO:1990785]; wound healing [GO:0042060]
PGEN_.00g145660	Scaffold_06	42676851	42677303	NA	NA	NA	NA	NA
PGEN_.00g145670	Scaffold_06	42692095	42692778	NA	NA	NA	NA	NA
PGEN_.00g145680	Scaffold_06	42696136	42702284	Q9N2D1	TRYT_PIG	Tryptase (EC 3.4.21.59)	GO:0004252; GO:0005615; GO:0006508	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]
PGEN_.00g145690	Scaffold_06	42710519	42712969	NA	NA	NA	NA	NA
PGEN_.00g145700	Scaffold_06	42714383	42738501	P67999	KS6B1_RAT	Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA)	GO:0000082; GO:0001662; GO:0003009; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006468; GO:0006915; GO:0007281; GO:0007568; GO:0007584; GO:0007616; GO:0009408; GO:0009611; GO:0009612; GO:0009636; GO:0009749; GO:0009986; GO:0010033; GO:0010243; GO:0014070; GO:0014732; GO:0014878; GO:0014911; GO:0016477; GO:0018105; GO:0030054; GO:0030165; GO:0031667; GO:0031929; GO:0032496; GO:0032868; GO:0032869; GO:0032870; GO:0033574; GO:0033762; GO:0034612; GO:0035556; GO:0042277; GO:0042493; GO:0042802; GO:0043005; GO:0043066; GO:0043200; GO:0043201; GO:0043434; GO:0043491; GO:0044539; GO:0045202; GO:0045471; GO:0045727; GO:0045931; GO:0045948; GO:0046324; GO:0046627; GO:0048471; GO:0048633; GO:0048661; GO:0051384; GO:0051721; GO:0071346; GO:0071363; GO:0071407; GO:0071549; GO:2001237	cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; cellular response to organic cyclic compound [GO:0071407]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of glucose import [GO:0046324]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]
PGEN_.00g145710	Scaffold_06	42751357	42762562	NA	NA	NA	NA	NA
PGEN_.00g145720	Scaffold_06	42862890	42871966	Q6DD45	ZCHC8_XENLA	Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8)	GO:0003676; GO:0005654; GO:0008270	nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]
PGEN_.00g145730	Scaffold_06	42874939	42875416	NA	NA	NA	NA	NA
PGEN_.00g145740	Scaffold_06	42881968	42896924	B0S6U7	ERAL1_DANRE	"GTPase Era, mitochondrial (ERA-like protein 1)"	GO:0000028; GO:0005525; GO:0005743; GO:0005759; GO:0019843; GO:0043024	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; ribosomal small subunit assembly [GO:0000028]
PGEN_.00g145750	Scaffold_06	42903038	42906568	P17972	KCNAW_DROME	Potassium voltage-gated channel protein Shaw (Shaw2)	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]
PGEN_.00g145760	Scaffold_06	42913639	42914067	NA	NA	NA	NA	NA
PGEN_.00g145770	Scaffold_06	42919818	42959982	Q03721	KCNC4_HUMAN	Potassium voltage-gated channel subfamily C member 4 (KSHIIIC) (Voltage-gated potassium channel subunit Kv3.4)	GO:0005249; GO:0005251; GO:0005267; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0016021; GO:0030424; GO:0031594; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0043679; GO:0046928; GO:0051260; GO:0071805	axon [GO:0030424]; axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; regulation of neurotransmitter secretion [GO:0046928]
PGEN_.00g145780	Scaffold_06	42954631	42954873	NA	NA	NA	NA	NA
PGEN_.00g145790	Scaffold_06	42971215	42976988	Q28C22	OGFD2_XENTR	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 (EC 1.14.11.-)	GO:0005506; GO:0016705; GO:0031418; GO:0051213	"dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g145800	Scaffold_06	42984377	42993478	NA	NA	NA	NA	NA
PGEN_.00g145810	Scaffold_06	43017947	43019119	NA	NA	NA	NA	NA
PGEN_.00g145820	Scaffold_06	43040992	43067065	Q61382	TRAF4_MOUSE	TNF receptor-associated factor 4 (Cysteine-rich motif associated to RING and Traf domains protein 1)	GO:0005164; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007250; GO:0007585; GO:0008270; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0032991; GO:0042802; GO:0042981; GO:0045860; GO:0046330; GO:0048471; GO:0050699; GO:0090073	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase activity [GO:0045860]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]
PGEN_.00g145830	Scaffold_06	43077643	43078293	NA	NA	NA	NA	NA
PGEN_.00g145840	Scaffold_06	43088377	43088867	NA	NA	NA	NA	NA
PGEN_.00g145850	Scaffold_06	43088894	43089313	NA	NA	NA	NA	NA
PGEN_.00g145860	Scaffold_06	43089547	43091959	NA	NA	NA	NA	NA
PGEN_.00g145870	Scaffold_06	43094608	43133313	NA	NA	NA	NA	NA
PGEN_.00g145880	Scaffold_06	43137059	43143962	Q8N5N7	RM50_HUMAN	"39S ribosomal protein L50, mitochondrial (L50mt) (MRP-L50) (Mitochondrial large ribosomal subunit protein mL50)"	GO:0005739; GO:0005743; GO:0005762; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]
PGEN_.00g145890	Scaffold_06	43144016	43150210	B3MR30	PGAM5_DROAN	"Serine/threonine-protein phosphatase Pgam5, mitochondrial (EC 3.1.3.16) (Phosphoglycerate mutase family member 5 homolog)"	GO:0004721; GO:0004722; GO:0005741; GO:0006470; GO:0009408; GO:0016021; GO:0019900; GO:0035970; GO:0043539; GO:0072347; GO:0090141	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine phosphatase activity [GO:0004722]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of mitochondrial fission [GO:0090141]; protein dephosphorylation [GO:0006470]; response to anesthetic [GO:0072347]; response to heat [GO:0009408]
PGEN_.00g145900	Scaffold_06	43157669	43171958	Q6GQ82	SNF5_XENLA	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0000228; GO:0003677; GO:0006338; GO:0007399	nuclear chromosome [GO:0000228]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]
PGEN_.00g145910	Scaffold_06	43176985	43177353	NA	NA	NA	NA	NA
PGEN_.00g145920	Scaffold_06	43203390	43213276	Q9W704	RIPA_XENLA	RPA-interacting protein A (RPA-interacting protein alpha) (XRIPalpha)	GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]
PGEN_.00g145930	Scaffold_06	43249438	43251105	A0A1B0GTW7	LMLN2_HUMAN	Leishmanolysin-like peptidase 2 (EC 3.4.24.-)	GO:0004222; GO:0005737; GO:0007155; GO:0008233; GO:0016021; GO:0046872	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; cell adhesion [GO:0007155]
PGEN_.00g145940	Scaffold_06	43253055	43259254	NA	NA	NA	NA	NA
PGEN_.00g145950	Scaffold_06	43298675	43319383	P31421	GRM2_RAT	Metabotropic glutamate receptor 2 (mGluR2)	GO:0001641; GO:0005246; GO:0005887; GO:0007216; GO:0007268; GO:0008066; GO:0014047; GO:0030054; GO:0030424; GO:0030425; GO:0042734; GO:0043005; GO:0046928; GO:0051966; GO:0090461; GO:0099055	"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]"
PGEN_.00g145960	Scaffold_06	43319408	43356597	Q9QYS2	GRM3_MOUSE	Metabotropic glutamate receptor 3 (mGluR3)	GO:0001641; GO:0005246; GO:0005886; GO:0005887; GO:0007216; GO:0008066; GO:0014069; GO:0019233; GO:0030424; GO:0035249; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0048786; GO:0050804; GO:0051930; GO:0051966; GO:0097449; GO:0098978; GO:0099055; GO:0099056	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g145970	Scaffold_06	43373224	43398931	P35400	GRM7_RAT	Metabotropic glutamate receptor 7 (mGluR7)	GO:0001640; GO:0001642; GO:0001661; GO:0001662; GO:0005245; GO:0005246; GO:0005509; GO:0005516; GO:0005791; GO:0005794; GO:0005887; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0007611; GO:0007613; GO:0007614; GO:0008066; GO:0008306; GO:0009986; GO:0010855; GO:0014050; GO:0016020; GO:0016021; GO:0016595; GO:0019226; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0032279; GO:0032991; GO:0033555; GO:0042734; GO:0042802; GO:0043025; GO:0043195; GO:0043198; GO:0043235; GO:0043524; GO:0043679; GO:0045202; GO:0045211; GO:0048306; GO:0048786; GO:0050877; GO:0051966; GO:0070905; GO:0098978; GO:0098982; GO:0099056; GO:0099059; GO:2000300	"asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; serine binding [GO:0070905]; voltage-gated calcium channel activity [GO:0005245]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult behavior [GO:0030534]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226]"
PGEN_.00g145980	Scaffold_06	43405618	43407377	NA	NA	NA	NA	NA
PGEN_.00g145990	Scaffold_06	43405928	43406155	NA	NA	NA	NA	NA
PGEN_.00g146000	Scaffold_06	43456003	43468751	Q8VIP2	MLXPL_RAT	Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein)	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0003700; GO:0005623; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006110; GO:0006357; GO:0008134; GO:0008284; GO:0009749; GO:0010255; GO:0019901; GO:0033137; GO:0035538; GO:0042593; GO:0043565; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0071157; GO:0071333; GO:0090324; GO:0097009	"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; cellular response to glucose stimulus [GO:0071333]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]"
PGEN_.00g146010	Scaffold_06	43469139	43497743	Q9HAP2	MLXIP_HUMAN	MLX-interacting protein (Class E basic helix-loop-helix protein 36) (bHLHe36) (Transcriptional activator MondoA)	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005741; GO:0006357; GO:0045944; GO:0046983	"mitochondrial outer membrane [GO:0005741]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g146020	Scaffold_06	43502360	43523671	NA	NA	NA	NA	NA
PGEN_.00g146030	Scaffold_06	43526282	43537278	NA	NA	NA	NA	NA
PGEN_.00g146040	Scaffold_06	43537840	43561705	Q66J90	SET1B_XENLA	Histone-lysine N-methyltransferase SETD1B (EC 2.1.1.354) (SET domain-containing protein 1B)	GO:0003723; GO:0005694; GO:0016607; GO:0018024; GO:0048188; GO:0051568	chromosome [GO:0005694]; nuclear speck [GO:0016607]; Set1C/COMPASS complex [GO:0048188]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA binding [GO:0003723]; histone H3-K4 methylation [GO:0051568]
PGEN_.00g146050	Scaffold_06	43593369	43608566	A6NFN9	ANKUB_HUMAN	Protein ANKUB1 (Ankyrin repeat and ubiquitin domain-containing 1)		
PGEN_.00g146060	Scaffold_06	43628369	43629745	NA	NA	NA	NA	NA
PGEN_.00g146070	Scaffold_06	43630706	43667218	P09848	LPH_HUMAN	Lactase-phlorizin hydrolase (Lactase-glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Phlorizin hydrolase (EC 3.2.1.62)]	GO:0000016; GO:0005886; GO:0005887; GO:0005975; GO:0008422; GO:0016020; GO:0016324; GO:0017042; GO:0044245	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]
PGEN_.00g146080	Scaffold_06	43732290	43735860	P49579	ACHB_XENLA	Acetylcholine receptor subunit beta (Fragment)	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g146090	Scaffold_06	43738685	43819713	P09848	LPH_HUMAN	Lactase-phlorizin hydrolase (Lactase-glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Phlorizin hydrolase (EC 3.2.1.62)]	GO:0000016; GO:0005886; GO:0005887; GO:0005975; GO:0008422; GO:0016020; GO:0016324; GO:0017042; GO:0044245	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]
PGEN_.00g146100	Scaffold_06	43901045	43902750	NA	NA	NA	NA	NA
PGEN_.00g146110	Scaffold_06	43903683	43924888	NA	NA	NA	NA	NA
PGEN_.00g146120	Scaffold_06	43933910	43936876	Q7L1S5	CHST9_HUMAN	Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)	GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446	extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g146130	Scaffold_06	43937990	43944638	NA	NA	NA	NA	NA
PGEN_.00g146140	Scaffold_06	43976302	44008087	Q04678	SSRP1_CHICK	FACT complex subunit SSRP1 (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (T160)	GO:0000790; GO:0003677; GO:0005730; GO:0006260; GO:0006281; GO:0031491; GO:0035101; GO:0042393	FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; DNA repair [GO:0006281]; DNA replication [GO:0006260]
PGEN_.00g146150	Scaffold_06	44028487	44029035	NA	NA	NA	NA	NA
PGEN_.00g146160	Scaffold_06	44036856	44041931	NA	NA	NA	NA	NA
PGEN_.00g146170	Scaffold_06	44066711	44069714	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g146180	Scaffold_06	44079984	44101493	Q6NU91	NOC4B_XENLA	Nucleolar complex protein 4 homolog B (NOC4 protein homolog B) (NOC4-like protein B) (Nucleolar complex-associated protein 4-like protein B)	GO:0005730; GO:0016021; GO:0031965; GO:0042254	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]
PGEN_.00g146190	Scaffold_06	44103121	44125397	Q6NSI8	K1841_HUMAN	Uncharacterized protein KIAA1841		
PGEN_.00g146200	Scaffold_06	44146535	44157219	NA	NA	NA	NA	NA
PGEN_.00g146210	Scaffold_06	44157499	44158673	NA	NA	NA	NA	NA
PGEN_.00g146220	Scaffold_06	44158008	44158981	NA	NA	NA	NA	NA
PGEN_.00g146230	Scaffold_06	44159281	44159992	NA	NA	NA	NA	NA
PGEN_.00g146240	Scaffold_06	44160032	44160286	NA	NA	NA	NA	NA
PGEN_.00g146250	Scaffold_06	44160332	44173412	NA	NA	NA	NA	NA
PGEN_.00g146260	Scaffold_06	44173167	44193345	Q9Y6I7	WSB1_HUMAN	WD repeat and SOCS box-containing protein 1 (WSB-1) (SOCS box-containing WD protein SWiP-1)	GO:0000209; GO:0005622; GO:0005829; GO:0035556; GO:0043687	cytosol [GO:0005829]; intracellular [GO:0005622]; intracellular signal transduction [GO:0035556]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]
PGEN_.00g146270	Scaffold_06	44212472	44216222	NA	NA	NA	NA	NA
PGEN_.00g146280	Scaffold_06	44240674	44273936	Q569U0	MYO19_XENLA	Unconventional myosin-XIX	GO:0003774; GO:0003779; GO:0005524; GO:0005739; GO:0005741; GO:0016459; GO:0016887; GO:0032465; GO:0090140	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myosin complex [GO:0016459]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; motor activity [GO:0003774]; regulation of cytokinesis [GO:0032465]; regulation of mitochondrial fission [GO:0090140]
PGEN_.00g146290	Scaffold_06	44275232	44297407	Q64471	GSTT1_MOUSE	Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1)	GO:0004364; GO:0004602; GO:0005634; GO:0005829; GO:0006304; GO:0006749; GO:0009751; GO:0010269; GO:0018900; GO:0033197; GO:0047651	cytosol [GO:0005829]; nucleus [GO:0005634]; alkylhalidase activity [GO:0047651]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; dichloromethane metabolic process [GO:0018900]; DNA modification [GO:0006304]; glutathione metabolic process [GO:0006749]; response to salicylic acid [GO:0009751]; response to selenium ion [GO:0010269]; response to vitamin E [GO:0033197]
PGEN_.00g146300	Scaffold_06	44297440	44301340	NA	NA	NA	NA	NA
PGEN_.00g146310	Scaffold_06	44320189	44320854	NA	NA	NA	NA	NA
PGEN_.00g146320	Scaffold_06	44355509	44391743	P32089	TXTP_RAT	"Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)"	GO:0005739; GO:0005743; GO:0006843; GO:0015137; GO:0016021; GO:0071913	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; citrate secondary active transmembrane transporter activity [GO:0071913]; citrate transmembrane transporter activity [GO:0015137]; mitochondrial citrate transmembrane transport [GO:0006843]
PGEN_.00g146330	Scaffold_06	44391813	44399603	Q969V4	TEKT1_HUMAN	Tektin-1	GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0031514; GO:0060271; GO:0060294	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]
PGEN_.00g146340	Scaffold_06	44406104	44406556	NA	NA	NA	NA	NA
PGEN_.00g146350	Scaffold_06	44410836	44429964	Q5R5S1	FBX21_PONAB	F-box only protein 21	GO:0003677	DNA binding [GO:0003677]
PGEN_.00g146360	Scaffold_06	44441207	44452040	P40873	MSOX_ARTST	Monomeric sarcosine oxidase (MSOX) (EC 1.5.3.1)	GO:0005737; GO:0008115; GO:0046653	cytoplasm [GO:0005737]; sarcosine oxidase activity [GO:0008115]; tetrahydrofolate metabolic process [GO:0046653]
PGEN_.00g146370	Scaffold_06	44461960	44478208	P77735	YAJO_ECOLI	1-deoxyxylulose-5-phosphate synthase YajO (EC 1.1.-.-)	GO:0005829; GO:0006772; GO:0016491	cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772]
PGEN_.00g146380	Scaffold_06	44561477	44568800	NA	NA	NA	NA	NA
PGEN_.00g146390	Scaffold_06	44614366	44657975	P12804	FGL2_MOUSE	Fibroleukin (Cytotoxic T-lymphocyte-specific protein) (Fibrinogen-like protein 2) (Prothrombinase)	GO:0002291; GO:0002381; GO:0002605; GO:0002617; GO:0005576; GO:0008233; GO:0019835; GO:0043381; GO:0050687	extracellular region [GO:0005576]; peptidase activity [GO:0008233]; cytolysis [GO:0019835]; immunoglobulin production involved in immunoglobulin mediated immune response [GO:0002381]; negative regulation of defense response to virus [GO:0050687]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of macrophage antigen processing and presentation [GO:0002617]; negative regulation of memory T cell differentiation [GO:0043381]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]
PGEN_.00g146400	Scaffold_06	44659468	44661117	NA	NA	NA	NA	NA
PGEN_.00g146410	Scaffold_06	44678851	44712574	Q8VI36	PAXI_MOUSE	Paxillin	GO:0000187; GO:0001725; GO:0003712; GO:0005178; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008013; GO:0008360; GO:0017166; GO:0018108; GO:0019901; GO:0019903; GO:0030027; GO:0030032; GO:0030159; GO:0031252; GO:0031625; GO:0034446; GO:0038191; GO:0043542; GO:0044877; GO:0045766; GO:0045860; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:0051496; GO:0060396; GO:1901652	adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; beta-catenin binding [GO:0008013]; BH4 domain binding [GO:0051435]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; receptor signaling complex adaptor activity [GO:0030159]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; vinculin binding [GO:0017166]; activation of MAPK activity [GO:0000187]; branching morphogenesis of an epithelial tube [GO:0048754]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; focal adhesion assembly [GO:0048041]; growth hormone receptor signaling pathway [GO:0060396]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g146420	Scaffold_06	44713135	44732170	Q8WVC0	LEO1_HUMAN	RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein)	GO:0001650; GO:0001711; GO:0005634; GO:0005654; GO:0005813; GO:0006366; GO:0006368; GO:0006378; GO:0010390; GO:0016055; GO:0016567; GO:0016593; GO:0019827; GO:0031442; GO:0032968; GO:0033523; GO:0045638; GO:0045944; GO:1904837; GO:1990269	Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; beta-catenin-TCF complex assembly [GO:1904837]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]
PGEN_.00g146430	Scaffold_06	44734815	44753579	Q7ZY69	PESC_XENLA	Pescadillo homolog	GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0030687; GO:0043021; GO:0051726; GO:0070545	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]"
PGEN_.00g146440	Scaffold_06	44759229	44765807	NA	NA	NA	NA	NA
PGEN_.00g146450	Scaffold_06	44766450	44824941	E9Q3L2	PI4KA_MOUSE	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67)	GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0016020; GO:0016301; GO:0016310; GO:0019034; GO:0030660; GO:0039694; GO:0044803; GO:0046786; GO:0046854; GO:0048015	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; viral replication complex [GO:0019034]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; multi-organism membrane organization [GO:0044803]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]
PGEN_.00g146460	Scaffold_06	44825207	44834956	Q9QZR0	RNF25_MOUSE	E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25) (RING finger protein AO7) (RING-type E3 ubiquitin transferase RNF25)	GO:0004842; GO:0005634; GO:0005829; GO:0016567; GO:0046872; GO:0051059; GO:0051092; GO:0061630	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]
PGEN_.00g146470	Scaffold_06	44888749	44889066	NA	NA	NA	NA	NA
PGEN_.00g146480	Scaffold_06	44889093	44889452	NA	NA	NA	NA	NA
PGEN_.00g146490	Scaffold_06	44889680	44889979	NA	NA	NA	NA	NA
PGEN_.00g146500	Scaffold_06	44890056	44890607	NA	NA	NA	NA	NA
PGEN_.00g146510	Scaffold_06	44890719	44891357	NA	NA	NA	NA	NA
PGEN_.00g146520	Scaffold_06	44891402	44891782	NA	NA	NA	NA	NA
PGEN_.00g146530	Scaffold_06	44892042	44892434	NA	NA	NA	NA	NA
PGEN_.00g146540	Scaffold_06	44892495	44892764	NA	NA	NA	NA	NA
PGEN_.00g146550	Scaffold_06	44892791	44893102	NA	NA	NA	NA	NA
PGEN_.00g146560	Scaffold_06	44893203	44893661	NA	NA	NA	NA	NA
PGEN_.00g146570	Scaffold_06	44893722	44894426	NA	NA	NA	NA	NA
PGEN_.00g146580	Scaffold_06	44894496	44895428	NA	NA	NA	NA	NA
PGEN_.00g146590	Scaffold_06	44908079	44908354	NA	NA	NA	NA	NA
PGEN_.00g146600	Scaffold_06	44913372	44915716	NA	NA	NA	NA	NA
PGEN_.00g146610	Scaffold_06	44934570	44938258	NA	NA	NA	NA	NA
PGEN_.00g146620	Scaffold_06	44938313	44944468	NA	NA	NA	NA	NA
PGEN_.00g146630	Scaffold_06	44944562	44945071	NA	NA	NA	NA	NA
PGEN_.00g146640	Scaffold_06	44959818	44960309	NA	NA	NA	NA	NA
PGEN_.00g146650	Scaffold_06	44960346	44960834	NA	NA	NA	NA	NA
PGEN_.00g146660	Scaffold_06	44960871	44961212	NA	NA	NA	NA	NA
PGEN_.00g146670	Scaffold_06	44961339	44961698	NA	NA	NA	NA	NA
PGEN_.00g146680	Scaffold_06	44971154	44982302	NA	NA	NA	NA	NA
PGEN_.00g146690	Scaffold_06	45025793	45034598	NA	NA	NA	NA	NA
PGEN_.00g146700	Scaffold_06	45056660	45063384	NA	NA	NA	NA	NA
PGEN_.00g146710	Scaffold_06	45074783	45075319	NA	NA	NA	NA	NA
PGEN_.00g146720	Scaffold_06	45087713	45113130	P15651	ACADS_RAT	"Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase)"	GO:0000062; GO:0003995; GO:0004085; GO:0005739; GO:0005759; GO:0006635; GO:0031966; GO:0033539; GO:0042594; GO:0042802; GO:0046359; GO:0050660; GO:0051384	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594]
PGEN_.00g146730	Scaffold_06	45190149	45268304	O02811	PI4KA_BOVIN	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67)	GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0016020; GO:0030660; GO:0046854; GO:0048015	cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]
PGEN_.00g146740	Scaffold_06	45303515	45319626	P99177	CSD_STAAN	Probable cysteine desulfurase (EC 2.8.1.7)	GO:0006534; GO:0030170; GO:0031071	cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170]; cysteine metabolic process [GO:0006534]
PGEN_.00g146750	Scaffold_06	45331640	45333211	Q6ZFH6	RCN11_ORYSJ	"Beta-1,2-xylosyltransferase RCN11 (OsXylT) (EC 2.4.2.-) (Protein REDUCED CULM NUMBER 11)"	GO:0000139; GO:0005797; GO:0006487; GO:0016021; GO:0031204; GO:0035252; GO:0048367; GO:0050513	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein 2-beta-D-xylosyltransferase activity [GO:0050513]; UDP-xylosyltransferase activity [GO:0035252]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein N-linked glycosylation [GO:0006487]; shoot system development [GO:0048367]"
PGEN_.00g146760	Scaffold_06	45342558	45374716	Q5HHH0	CSD_STAAC	Probable cysteine desulfurase (EC 2.8.1.7)	GO:0006534; GO:0030170; GO:0031071	cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170]; cysteine metabolic process [GO:0006534]
PGEN_.00g146770	Scaffold_06	45397839	45405685	NA	NA	NA	NA	NA
PGEN_.00g146780	Scaffold_06	45416191	45417914	NA	NA	NA	NA	NA
PGEN_.00g146790	Scaffold_06	45429125	45513875	Q8CEF9	T132C_MOUSE	Transmembrane protein 132C	GO:0010923; GO:0016021	integral component of membrane [GO:0016021]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g146800	Scaffold_06	45521393	45525905	Q5PQ76	CA050_XENLA	Uncharacterized protein C1orf50 homolog		
PGEN_.00g146810	Scaffold_06	45538086	45546846	NA	NA	NA	NA	NA
PGEN_.00g146820	Scaffold_06	45563879	45598909	Q6DFB8	TTC37_XENLA	Tetratricopeptide repeat protein 37 (TPR repeat protein 37) (Thespin homolog)	GO:0005634; GO:0005737; GO:0006401; GO:0035327; GO:0055087	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; RNA catabolic process [GO:0006401]
PGEN_.00g146830	Scaffold_06	45607468	45608252	NA	NA	NA	NA	NA
PGEN_.00g146840	Scaffold_06	45609928	45638608	P40926	MDHM_HUMAN	"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)"	GO:0003723; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0006094; GO:0006099; GO:0006107; GO:0006108; GO:0006475; GO:0006734; GO:0009060; GO:0016020; GO:0030060; GO:0043621; GO:0046554; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; L-malate dehydrogenase activity [GO:0030060]; malate dehydrogenase (NADP+) activity [GO:0046554]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; aerobic respiration [GO:0009060]; gluconeogenesis [GO:0006094]; internal protein amino acid acetylation [GO:0006475]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g146850	Scaffold_06	45639005	45653971	Q9Y6J8	STYL1_HUMAN	Serine/threonine/tyrosine-interacting-like protein 1 (Dual specificity phosphatase inhibitor MK-STYX) (Dual specificity protein phosphatase 24) (Inactive dual specificity protein phosphatase MK-STYX) (Map kinase phosphatase-like protein MK-STYX)	GO:0001691; GO:0004864; GO:0005739; GO:0005759; GO:0008138; GO:0010976; GO:0019903; GO:0032515; GO:0035556; GO:0062030; GO:2001242; GO:2001244	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; pseudophosphatase activity [GO:0001691]; intracellular signal transduction [GO:0035556]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of stress granule assembly [GO:0062030]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]
PGEN_.00g146860	Scaffold_06	45665827	45710328	P29475	NOS1_HUMAN	"Nitric oxide synthase, brain (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Peptidyl-cysteine S-nitrosylase NOS1) (bNOS)"	GO:0001666; GO:0001917; GO:0002028; GO:0003958; GO:0004517; GO:0005516; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0006527; GO:0006809; GO:0006941; GO:0007263; GO:0007520; GO:0009408; GO:0009725; GO:0010181; GO:0010523; GO:0012506; GO:0014069; GO:0016491; GO:0016529; GO:0017080; GO:0018119; GO:0020037; GO:0030018; GO:0030054; GO:0030315; GO:0031284; GO:0032496; GO:0032991; GO:0033017; GO:0033138; GO:0033555; GO:0034617; GO:0034618; GO:0035066; GO:0042136; GO:0042311; GO:0042383; GO:0042738; GO:0043197; GO:0043267; GO:0044305; GO:0044325; GO:0045121; GO:0045202; GO:0045454; GO:0045776; GO:0045893; GO:0045944; GO:0046870; GO:0048306; GO:0048471; GO:0050660; GO:0050661; GO:0050767; GO:0051346; GO:0051612; GO:0051926; GO:0055117; GO:0060314; GO:0071363; GO:0071944; GO:0097110; GO:0098735; GO:0098924; GO:0140196; GO:1902307; GO:1902514; GO:1903779	"calyx of Held [GO:0044305]; caveola [GO:0005901]; cell [GO:0005623]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; T-tubule [GO:0030315]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; ion channel binding [GO:0044325]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; tetrahydrobiopterin binding [GO:0034617]; arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to growth factor stimulus [GO:0071363]; exogenous drug catabolic process [GO:0042738]; multicellular organismal response to stress [GO:0033555]; myoblast fusion [GO:0007520]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; neurotransmitter biosynthetic process [GO:0042136]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140196]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of neurogenesis [GO:0050767]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of sodium ion transport [GO:0002028]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; vasodilation [GO:0042311]"
PGEN_.00g146870	Scaffold_06	45722973	45726581	NA	NA	NA	NA	NA
PGEN_.00g146880	Scaffold_06	45841301	45853776	NA	NA	NA	NA	NA
PGEN_.00g146890	Scaffold_06	45853851	45854444	Q7TS73	RFLA_MOUSE	Refilin-A (Regulator of filamin protein A) (RefilinA)	GO:0005737; GO:0031005; GO:0032432; GO:0048705; GO:0061182; GO:0061572; GO:1900158	actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filamin binding [GO:0031005]; actin filament bundle organization [GO:0061572]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte development [GO:0061182]; skeletal system morphogenesis [GO:0048705]
PGEN_.00g146900	Scaffold_06	45864324	45871653	Q2TA16	DRC2_BOVIN	Dynein regulatory complex subunit 2 (Coiled-coil domain-containing protein 65)	GO:0003352; GO:0005858; GO:0005930; GO:0031514; GO:0060285; GO:0070286	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352]
PGEN_.00g146910	Scaffold_06	45875129	45886047	Q920A6	RISC_RAT	Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)	GO:0004185; GO:0005576; GO:0005829; GO:0042573; GO:0045776; GO:0051603; GO:0097755	cytosol [GO:0005829]; extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood vessel diameter [GO:0097755]; proteolysis involved in cellular protein catabolic process [GO:0051603]; retinoic acid metabolic process [GO:0042573]
PGEN_.00g146920	Scaffold_06	45891242	45896569	NA	NA	NA	NA	NA
PGEN_.00g146930	Scaffold_06	45904650	45907280	NA	NA	NA	NA	NA
PGEN_.00g146940	Scaffold_06	45922110	45926630	NA	NA	NA	NA	NA
PGEN_.00g146950	Scaffold_06	45939236	45939685	NA	NA	NA	NA	NA
PGEN_.00g146960	Scaffold_06	45940098	45946855	Q6XQH0	G3ST2_MOUSE	"Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2)"	GO:0001733; GO:0008146; GO:0009101; GO:0009247; GO:0016020; GO:0016021; GO:0032580; GO:0050694; GO:0051923	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; sulfation [GO:0051923]
PGEN_.00g146970	Scaffold_06	45951151	45955614	NA	NA	NA	NA	NA
PGEN_.00g146980	Scaffold_06	46020876	46022358	NA	NA	NA	NA	NA
PGEN_.00g146990	Scaffold_06	46087173	46127307	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g147000	Scaffold_06	46163702	46165325	NA	NA	NA	NA	NA
PGEN_.00g147010	Scaffold_06	46169510	46169764	NA	NA	NA	NA	NA
PGEN_.00g147020	Scaffold_06	46177944	46178947	NA	NA	NA	NA	NA
PGEN_.00g147030	Scaffold_06	46271550	46275039	NA	NA	NA	NA	NA
PGEN_.00g147040	Scaffold_06	46280946	46290869	NA	NA	NA	NA	NA
PGEN_.00g147050	Scaffold_06	46300564	46313067	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g147060	Scaffold_06	46325743	46333178	P06276	CHLE_HUMAN	Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase)	GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005641; GO:0005788; GO:0007612; GO:0008285; GO:0014016; GO:0016020; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050783; GO:0050805; GO:0051384; GO:0051593; GO:0072562	blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]
PGEN_.00g147070	Scaffold_06	46380913	46401575	P81178	ALDH2_MESAU	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1)"	GO:0004029; GO:0005759; GO:0006068; GO:0043878; GO:0051287	mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; ethanol catabolic process [GO:0006068]
PGEN_.00g147080	Scaffold_06	46409473	46410983	NA	NA	NA	NA	NA
PGEN_.00g147090	Scaffold_06	46418832	46437930	NA	NA	NA	NA	NA
PGEN_.00g147100	Scaffold_06	46456569	46459262	NA	NA	NA	NA	NA
PGEN_.00g147110	Scaffold_06	46468982	46488808	NA	NA	NA	NA	NA
PGEN_.00g147120	Scaffold_06	46560730	46570090	O60507	TPST1_HUMAN	Protein-tyrosine sulfotransferase 1 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 1) (TPST-1)	GO:0000139; GO:0005794; GO:0006478; GO:0006954; GO:0008476; GO:0016020; GO:0030173; GO:0042803; GO:0050427	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inflammatory response [GO:0006954]; peptidyl-tyrosine sulfation [GO:0006478]
PGEN_.00g147130	Scaffold_06	46585088	46598270	O14545	TRAD1_HUMAN	TRAF-type zinc finger domain-containing protein 1 (Protein FLN29)	GO:0045824; GO:0046872	metal ion binding [GO:0046872]; negative regulation of innate immune response [GO:0045824]
PGEN_.00g147140	Scaffold_06	46600485	46607042	Q9W2D6	TIM10_DROME	Mitochondrial import inner membrane translocase subunit Tim10	GO:0005743; GO:0042719; GO:0045039; GO:0045824; GO:0046872; GO:0050829	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; metal ion binding [GO:0046872]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of innate immune response [GO:0045824]; protein insertion into mitochondrial inner membrane [GO:0045039]
PGEN_.00g147150	Scaffold_06	46610401	46633133	Q8JZP3	KLHL2_MOUSE	Kelch-like protein 2	GO:0001725; GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802; GO:0042803	actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein ubiquitination [GO:0016567]
PGEN_.00g147160	Scaffold_06	46643847	46650903	Q0Z7S8	FABP9_HUMAN	Fatty acid-binding protein 9 (Testis lipid-binding protein) (TLBP) (Testis-type fatty acid-binding protein) (T-FABP)	GO:0001669; GO:0001675; GO:0005829; GO:0008289; GO:0019433	acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; lipid binding [GO:0008289]; acrosome assembly [GO:0001675]; triglyceride catabolic process [GO:0019433]
PGEN_.00g147170	Scaffold_06	46663960	46699745	Q00610	CLH1_HUMAN	Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17)	GO:0000278; GO:0001649; GO:0003723; GO:0003725; GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005886; GO:0005925; GO:0006886; GO:0006898; GO:0006914; GO:0016020; GO:0019886; GO:0019901; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0031623; GO:0032051; GO:0032588; GO:0032802; GO:0032991; GO:0033572; GO:0034383; GO:0036020; GO:0042147; GO:0042470; GO:0045334; GO:0048268; GO:0050750; GO:0051301; GO:0060071; GO:0060236; GO:0061024; GO:0070062; GO:0071439; GO:0072583; GO:0072686; GO:0097718; GO:0150093; GO:1900126; GO:1903077; GO:1903561; GO:1990381; GO:1990498	"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; trans-Golgi network membrane [GO:0032588]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]; amyloid-beta clearance by transcytosis [GO:0150093]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; osteoblast differentiation [GO:0001649]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transferrin transport [GO:0033572]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g147180	Scaffold_06	46713838	46715682	NA	NA	NA	NA	NA
PGEN_.00g147190	Scaffold_06	46724851	46745161	Q7XA72	AB21G_ARATH	ABC transporter G family member 21 (ABC transporter ABCG.21) (AtABCG21) (White-brown complex homolog protein 21) (AtWBC21)	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g147200	Scaffold_06	46771692	46772522	NA	NA	NA	NA	NA
PGEN_.00g147210	Scaffold_06	46861408	46863776	NA	NA	NA	NA	NA
PGEN_.00g147220	Scaffold_06	46874982	46875299	NA	NA	NA	NA	NA
PGEN_.00g147230	Scaffold_06	46883186	46883861	NA	NA	NA	NA	NA
PGEN_.00g147240	Scaffold_06	46887563	46888030	NA	NA	NA	NA	NA
PGEN_.00g147250	Scaffold_06	46919430	46922388	NA	NA	NA	NA	NA
PGEN_.00g147260	Scaffold_06	46924932	46928192	NA	NA	NA	NA	NA
PGEN_.00g147270	Scaffold_06	46930673	46934288	NA	NA	NA	NA	NA
PGEN_.00g147280	Scaffold_06	46941045	46967449	Q94986	RAB3_CAEEL	Ras-related protein Rab-3	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006886; GO:0006904; GO:0006935; GO:0007271; GO:0007419; GO:0007617; GO:0008021; GO:0009306; GO:0017157; GO:0031982; GO:0032228; GO:0032482; GO:0040012; GO:0043005; GO:0043051; GO:0072659; GO:1905488	"endosome [GO:0005768]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; chemotaxis [GO:0006935]; intracellular protein transport [GO:0006886]; mating behavior [GO:0007617]; positive regulation of anterior/posterior axon guidance [GO:1905488]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of locomotion [GO:0040012]; regulation of pharyngeal pumping [GO:0043051]; regulation of synaptic transmission, GABAergic [GO:0032228]; synaptic transmission, cholinergic [GO:0007271]; ventral cord development [GO:0007419]; vesicle docking involved in exocytosis [GO:0006904]"
PGEN_.00g147290	Scaffold_06	46986932	46993460	Q94986	RAB3_CAEEL	Ras-related protein Rab-3	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006886; GO:0006904; GO:0006935; GO:0007271; GO:0007419; GO:0007617; GO:0008021; GO:0009306; GO:0017157; GO:0031982; GO:0032228; GO:0032482; GO:0040012; GO:0043005; GO:0043051; GO:0072659; GO:1905488	"endosome [GO:0005768]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; chemotaxis [GO:0006935]; intracellular protein transport [GO:0006886]; mating behavior [GO:0007617]; positive regulation of anterior/posterior axon guidance [GO:1905488]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of locomotion [GO:0040012]; regulation of pharyngeal pumping [GO:0043051]; regulation of synaptic transmission, GABAergic [GO:0032228]; synaptic transmission, cholinergic [GO:0007271]; ventral cord development [GO:0007419]; vesicle docking involved in exocytosis [GO:0006904]"
PGEN_.00g147300	Scaffold_06	47044313	47047115	NA	NA	NA	NA	NA
PGEN_.00g147310	Scaffold_06	47054717	47054971	NA	NA	NA	NA	NA
PGEN_.00g147320	Scaffold_06	47172613	47176601	Q6DCX5	PCFT_XENLA	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)	GO:0005542; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]
PGEN_.00g147330	Scaffold_06	47282576	47286443	NA	NA	NA	NA	NA
PGEN_.00g147340	Scaffold_06	47290923	47300068	NA	NA	NA	NA	NA
PGEN_.00g147350	Scaffold_06	47305012	47308543	Q6ZUX7	LHPL2_HUMAN	LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein)	GO:0002576; GO:0005886; GO:0007338; GO:0016021; GO:0031092; GO:0046545; GO:0046546; GO:1905516	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; platelet degranulation [GO:0002576]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]
PGEN_.00g147360	Scaffold_06	47327477	47339579	NA	NA	NA	NA	NA
PGEN_.00g147370	Scaffold_06	47356483	47366947	P16273	PRPX_HORVU	Pathogen-related protein	GO:0006952; GO:0009607	defense response [GO:0006952]; response to biotic stimulus [GO:0009607]
PGEN_.00g147380	Scaffold_06	47374124	47378795	NA	NA	NA	NA	NA
PGEN_.00g147390	Scaffold_06	47379043	47407145	Q6P5U7	NWD2_MOUSE	NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)		
PGEN_.00g147400	Scaffold_06	47413349	47421277	P55066	NCAN_MOUSE	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	GO:0001501; GO:0005509; GO:0005540; GO:0005886; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0045202; GO:0051823; GO:0072534	extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]
PGEN_.00g147410	Scaffold_06	47431669	47442556	A2VDD2	TC1DB_XENLA	Tctex1 domain-containing protein 1-B (Fragment)		
PGEN_.00g147420	Scaffold_06	47448815	47471011	NA	NA	NA	NA	NA
PGEN_.00g147430	Scaffold_06	47493335	47495074	NA	NA	NA	NA	NA
PGEN_.00g147440	Scaffold_06	47564100	47577725	NA	NA	NA	NA	NA
PGEN_.00g147450	Scaffold_06	47604411	47612018	Q5JXM2	MET24_HUMAN	Methyltransferase-like protein 24 (EC 2.1.1.-)	GO:0005576; GO:0008168; GO:0032259	extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g147460	Scaffold_06	47619476	47645164	B1WB06	MET24_XENTR	Methyltransferase-like protein 24 (EC 2.1.1.-)	GO:0005576; GO:0008168; GO:0032259	extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g147470	Scaffold_06	47647017	47650624	NA	NA	NA	NA	NA
PGEN_.00g147480	Scaffold_06	47654602	47655141	NA	NA	NA	NA	NA
PGEN_.00g147490	Scaffold_06	47687836	47693991	NA	NA	NA	NA	NA
PGEN_.00g147500	Scaffold_06	47694530	47696293	NA	NA	NA	NA	NA
PGEN_.00g147510	Scaffold_06	47717680	47728938	Q2LE78	BTBD6_XENLA	BTB/POZ domain-containing protein 6	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g147520	Scaffold_06	47724449	47724748	NA	NA	NA	NA	NA
PGEN_.00g147530	Scaffold_06	47739058	47762026	NA	NA	NA	NA	NA
PGEN_.00g147540	Scaffold_06	47765632	47782972	Q1RM03	TCHP_DANRE	Trichoplein keratin filament-binding protein (Protein TCHP)	GO:0005737; GO:0006915; GO:0045095	cytoplasm [GO:0005737]; keratin filament [GO:0045095]; apoptotic process [GO:0006915]
PGEN_.00g147550	Scaffold_06	47788377	47788616	NA	NA	NA	NA	NA
PGEN_.00g147560	Scaffold_06	47788768	47789124	NA	NA	NA	NA	NA
PGEN_.00g147570	Scaffold_06	47828451	47828858	NA	NA	NA	NA	NA
PGEN_.00g147580	Scaffold_06	47838780	47847026	NA	NA	NA	NA	NA
PGEN_.00g147590	Scaffold_06	47853820	47854650	NA	NA	NA	NA	NA
PGEN_.00g147600	Scaffold_06	47869596	47870399	NA	NA	NA	NA	NA
PGEN_.00g147610	Scaffold_06	47876614	47916555	NA	NA	NA	NA	NA
PGEN_.00g147620	Scaffold_06	47919553	47984865	NA	NA	NA	NA	NA
PGEN_.00g147630	Scaffold_06	47986935	48045629	NA	NA	NA	NA	NA
PGEN_.00g147640	Scaffold_06	48092068	48107267	NA	NA	NA	NA	NA
PGEN_.00g147650	Scaffold_06	48109998	48123298	P43487	RANG_HUMAN	Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1)	GO:0005092; GO:0005096; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005813; GO:0005829; GO:0007165; GO:0008536; GO:0016032; GO:0045296; GO:0046604; GO:0046907	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165]; viral process [GO:0016032]
PGEN_.00g147660	Scaffold_06	48156588	48209130	Q7Z407	CSMD3_HUMAN	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g147670	Scaffold_06	48302371	48326152	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g147680	Scaffold_06	48370783	48427271	Q5RAJ5	STK36_PONAB	Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007228; GO:0008134; GO:0009791; GO:0045880; GO:0046872; GO:0051090; GO:0060271	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; cilium assembly [GO:0060271]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]
PGEN_.00g147690	Scaffold_06	48440653	48447322	Q9ZSJ0	RGXT2_ARATH	"UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase (EC 2.4.2.-) (Rhamnogalacturonan xylosyltransferase 2)"	GO:0000139; GO:0005794; GO:0010306; GO:0016021; GO:0016757; GO:0035252	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-xylosyltransferase activity [GO:0035252]; rhamnogalacturonan II biosynthetic process [GO:0010306]"
PGEN_.00g147700	Scaffold_06	48479983	48521360	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g147710	Scaffold_06	48522859	48536636	O43854	EDIL3_HUMAN	EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)	GO:0005178; GO:0005509; GO:0007155; GO:0007275; GO:0010811; GO:0062023; GO:0070062; GO:1903561	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811]
PGEN_.00g147720	Scaffold_06	48545994	48578871	NA	NA	NA	NA	NA
PGEN_.00g147730	Scaffold_06	48584098	48585064	NA	NA	NA	NA	NA
PGEN_.00g147740	Scaffold_06	48619073	48642161	NA	NA	NA	NA	NA
PGEN_.00g147750	Scaffold_06	48662027	48697783	Q99550	MPP9_HUMAN	M-phase phosphoprotein 9	GO:0000139; GO:0005794; GO:0005814; GO:0016020	centriole [GO:0005814]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
PGEN_.00g147760	Scaffold_06	48699698	48702617	A5WUX7	CL065_DANRE	"Probable peptide chain release factor C12orf65 homolog, mitochondrial"	GO:0003747; GO:0005762	mitochondrial large ribosomal subunit [GO:0005762]; translation release factor activity [GO:0003747]
PGEN_.00g147770	Scaffold_06	48703945	48720080	Q8L7W2	NUDT8_ARATH	Nudix hydrolase 8 (AtNUDT8) (EC 3.6.1.-)	GO:0005829; GO:0009611; GO:0035529; GO:0046872; GO:0047631; GO:0051287	cytosol [GO:0005829]; ADP-ribose diphosphatase activity [GO:0047631]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529]; response to wounding [GO:0009611]
PGEN_.00g147780	Scaffold_06	48710212	48710508	NA	NA	NA	NA	NA
PGEN_.00g147790	Scaffold_06	48710794	48711186	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g147800	Scaffold_06	48739981	48747071	NA	NA	NA	NA	NA
PGEN_.00g147810	Scaffold_06	48746888	48747184	NA	NA	NA	NA	NA
PGEN_.00g147820	Scaffold_06	48756244	48757938	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g147830	Scaffold_06	48761185	48771754	Q9HC36	MRM3_HUMAN	"rRNA methyltransferase 3, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1)"	GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0070039	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; rRNA 2'-O-methylation [GO:0000451]
PGEN_.00g147840	Scaffold_06	48777568	48778128	NA	NA	NA	NA	NA
PGEN_.00g147850	Scaffold_06	48781202	48814475	Q04690	NF1_MOUSE	Neurofibromin (Neurofibromatosis-related protein NF-1)	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010976; GO:0014044; GO:0014065; GO:0014069; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043005; GO:0043065; GO:0043087; GO:0043407; GO:0043408; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"
PGEN_.00g147860	Scaffold_06	48827886	48906726	P21359	NF1_HUMAN	Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0014044; GO:0014065; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0034605; GO:0035021; GO:0042060; GO:0042308; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"
PGEN_.00g147870	Scaffold_06	48918772	48944484	Q2YDU8	SPNS1_RAT	Protein spinster homolog 1	GO:0005743; GO:0006869; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]
PGEN_.00g147880	Scaffold_06	48955148	48957082	NA	NA	NA	NA	NA
PGEN_.00g147890	Scaffold_06	48973758	48985296	NA	NA	NA	NA	NA
PGEN_.00g147900	Scaffold_06	48991160	48991468	O61397	GALT7_CAEEL	Probable N-acetylgalactosaminyltransferase 7 (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) (pp-GaNTase 7)	GO:0000139; GO:0005794; GO:0006486; GO:0016021; GO:0016757; GO:0030246; GO:0046872	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; protein glycosylation [GO:0006486]"
PGEN_.00g147910	Scaffold_06	49015273	49016352	O14792	HS3S1_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1)	GO:0005796; GO:0006024; GO:0008146; GO:0008467	Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g147920	Scaffold_06	49071127	49071984	P36514	UD2C1_RABIT	UDP-glucuronosyltransferase 2C1 (UDPGT 2C1) (EC 2.4.1.17) (Fragment)	GO:0005789; GO:0015020; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]
PGEN_.00g147930	Scaffold_06	49095544	49114044	Q9VWQ2	S6KL_DROME	Serine/threonine-protein kinase S6KL (EC 2.7.11.-) (Protein kinase-like 17E) (S6 kinase-like protein)	GO:0004674; GO:0004711; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0035556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]
PGEN_.00g147940	Scaffold_06	49117907	49158315	Q13356	PPIL2_HUMAN	RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2)	GO:0000209; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006457; GO:0034450; GO:0050900; GO:0061630; GO:0072659	cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; leukocyte migration [GO:0050900]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]
PGEN_.00g147950	Scaffold_06	49234455	49235966	NA	NA	NA	NA	NA
PGEN_.00g147960	Scaffold_06	49241193	49280463	Q9H6U6	BCAS3_HUMAN	Breast carcinoma-amplified sequence 3 (GAOB1)	GO:0001525; GO:0003682; GO:0005634; GO:0005737; GO:0005881; GO:0007030; GO:0008134; GO:0010595; GO:0010698; GO:0031023; GO:0031252; GO:0034260; GO:0035035; GO:0035148; GO:0035257; GO:0035327; GO:0042393; GO:0042594; GO:0043085; GO:0043547; GO:0045111; GO:0045944; GO:0048487; GO:0051491; GO:0051895; GO:0071391; GO:0071944; GO:0090316; GO:0090630; GO:2000114; GO:2000251	cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear hormone receptor binding [GO:0035257]; transcription factor binding [GO:0008134]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cellular response to estrogen stimulus [GO:0071391]; Golgi organization [GO:0007030]; microtubule organizing center organization [GO:0031023]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of establishment of cell polarity [GO:2000114]; response to starvation [GO:0042594]; tube formation [GO:0035148]
PGEN_.00g147970	Scaffold_06	49295452	49297283	NA	NA	NA	NA	NA
PGEN_.00g147980	Scaffold_06	49319861	49321044	NA	NA	NA	NA	NA
PGEN_.00g147990	Scaffold_06	49444159	49468569	O73718	TBX3_CHICK	T-box transcription factor TBX3 (T-box protein 3) (Fragment)	GO:0000122; GO:0000977; GO:0001102; GO:0001228; GO:0001501; GO:0001708; GO:0001947; GO:0003205; GO:0005634; GO:0007417; GO:0007569; GO:0008284; GO:0008595; GO:0030539; GO:0030540; GO:0032275; GO:0035115; GO:0042733; GO:0043066; GO:0043565; GO:0045662; GO:0045787; GO:0045892; GO:0045944; GO:0046884; GO:0048332	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior/posterior axis specification, embryo [GO:0008595]; cardiac chamber development [GO:0003205]; cell aging [GO:0007569]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; female genitalia development [GO:0030540]; follicle-stimulating hormone secretion [GO:0046884]; heart looping [GO:0001947]; luteinizing hormone secretion [GO:0032275]; male genitalia development [GO:0030539]; mesoderm morphogenesis [GO:0048332]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]"
PGEN_.00g148000	Scaffold_06	49584980	49591510	NA	NA	NA	NA	NA
PGEN_.00g148010	Scaffold_06	49598676	49598984	NA	NA	NA	NA	NA
PGEN_.00g148020	Scaffold_06	49622260	49629639	NA	NA	NA	NA	NA
PGEN_.00g148030	Scaffold_06	49629698	49688806	Q9BX63	FANCJ_HUMAN	Fanconi anemia group J protein (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1)	GO:0000077; GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0008285; GO:0009636; GO:0010629; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0071295; GO:0071456; GO:0072520; GO:1901796; GO:1904385; GO:1990918	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]"
PGEN_.00g148040	Scaffold_06	49691824	49704546	Q8C5K5	CX038_MOUSE	Uncharacterized protein CXorf38 homolog		
PGEN_.00g148050	Scaffold_06	49705377	49732749	Q9BX63	FANCJ_HUMAN	Fanconi anemia group J protein (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1)	GO:0000077; GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0008285; GO:0009636; GO:0010629; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0071295; GO:0071456; GO:0072520; GO:1901796; GO:1904385; GO:1990918	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]"
PGEN_.00g148060	Scaffold_06	49737133	49772945	Q96AX1	VP33A_HUMAN	Vacuolar protein sorting-associated protein 33A (hVPS33A)	GO:0005623; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006904; GO:0008333; GO:0015031; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0035751; GO:0048070; GO:0048471; GO:0097352	autophagosome [GO:0005776]; cell [GO:0005623]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; protein transport [GO:0015031]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]
PGEN_.00g148070	Scaffold_06	49790578	49791174	NA	NA	NA	NA	NA
PGEN_.00g148080	Scaffold_06	49791608	49792936	P15305	DYHC_ONCMY	Dynein heavy chain (DYHC) (Fragment)	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0031514	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; motor activity [GO:0003774]
PGEN_.00g148090	Scaffold_06	49792380	49793078	NA	NA	NA	NA	NA
PGEN_.00g148100	Scaffold_06	49793014	49793355	NA	NA	NA	NA	NA
PGEN_.00g148110	Scaffold_06	49793255	49853924	Q2NKQ1	SGSM1_HUMAN	Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2)	GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0006886; GO:0017137; GO:0030659; GO:0090630	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]
PGEN_.00g148120	Scaffold_06	49851235	49852050	NA	NA	NA	NA	NA
PGEN_.00g148130	Scaffold_06	49852251	49852553	NA	NA	NA	NA	NA
PGEN_.00g148140	Scaffold_06	49891126	49905000	Q0VH32	MNT_XENLA	Max-binding protein MNT (Myc antagonist MNT)	GO:0003677; GO:0005634; GO:0046983	nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]
PGEN_.00g148150	Scaffold_06	49961681	49967798	O96017	CHK2_HUMAN	Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2)	GO:0000077; GO:0000086; GO:0001302; GO:0001934; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0006978; GO:0008630; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:0090399; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210	"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]"
PGEN_.00g148160	Scaffold_06	49974260	49992543	B5DDX6	SMG9_XENTR	Protein SMG9 (Protein smg-9 homolog)	GO:0000184	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"
PGEN_.00g148170	Scaffold_06	50010768	50011814	NA	NA	NA	NA	NA
PGEN_.00g148180	Scaffold_06	50065456	50093167	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g148190	Scaffold_06	50132031	50134344	NA	NA	NA	NA	NA
PGEN_.00g148200	Scaffold_06	50143945	50171764	B3EWZ9	HEPHL_ACRMI	Hephaestin-like protein (EC 1.-.-.-)	GO:0005507; GO:0006825; GO:0016021; GO:0016491	integral component of membrane [GO:0016021]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; copper ion transport [GO:0006825]
PGEN_.00g148210	Scaffold_06	50169325	50170140	NA	NA	NA	NA	NA
PGEN_.00g148220	Scaffold_06	50199299	50199583	NA	NA	NA	NA	NA
PGEN_.00g148230	Scaffold_06	50205992	50220018	A7Y2W8	SC6A9_XENLA	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9)	GO:0005283; GO:0005328; GO:0005887	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g148240	Scaffold_06	50250636	50255780	P20816	CP4A2_RAT	Cytochrome P450 4A2 (CYPIVA2) (Cytochrome P-450 K-2) (Cytochrome P450 K-5) (Cytochrome P450-LA-omega 2) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)	GO:0001822; GO:0005504; GO:0005506; GO:0005789; GO:0008391; GO:0008405; GO:0009725; GO:0018685; GO:0019369; GO:0020037; GO:0042493; GO:0043231; GO:0043651; GO:0046456; GO:0048252; GO:0050544	"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid binding [GO:0050544]; arachidonic acid monooxygenase activity [GO:0008391]; fatty acid binding [GO:0005504]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; linoleic acid metabolic process [GO:0043651]; response to drug [GO:0042493]; response to hormone [GO:0009725]"
PGEN_.00g148250	Scaffold_06	50264482	50280400	Q6NT55	CP4FN_HUMAN	Cytochrome P450 4F22 (EC 1.14.14.-)	GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690]"
PGEN_.00g148260	Scaffold_06	50281148	50296247	P14580	CP4A6_RABIT	Cytochrome P450 4A6 (CYPIVA6) (Cytochrome P450-KA-1) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)	GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g148270	Scaffold_06	50314882	50316303	Q6DCX5	PCFT_XENLA	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)	GO:0005542; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]
PGEN_.00g148280	Scaffold_06	50387115	50393072	Q6DKE0	DHDH_XENLA	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	GO:0047115; GO:0047837	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"
PGEN_.00g148290	Scaffold_06	50403195	50409519	Q8BUJ9	LRP12_MOUSE	Low-density lipoprotein receptor-related protein 12 (LRP-12)	GO:0001764; GO:0005887; GO:0005905; GO:0006897; GO:0031175	clathrin-coated pit [GO:0005905]; integral component of plasma membrane [GO:0005887]; endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]
PGEN_.00g148300	Scaffold_06	50419692	50420441	NA	NA	NA	NA	NA
PGEN_.00g148310	Scaffold_06	50433562	50445528	Q99542	MMP19_HUMAN	Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18)	GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]
PGEN_.00g148320	Scaffold_06	50468319	50475783	NA	NA	NA	NA	NA
PGEN_.00g148330	Scaffold_06	50521016	50522167	Q92847	GHSR_HUMAN	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032869; GO:0036321; GO:0040018; GO:0042536; GO:0042802; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045409; GO:0045923; GO:0046676; GO:0046697; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0099699; GO:0120058; GO:1903672; GO:1904000; GO:1904008; GO:1904349; GO:1904468; GO:1905333; GO:1905564; GO:1990314; GO:2000110	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; negative regulation of tumor necrosis factor secretion [GO:1904468]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]
PGEN_.00g148340	Scaffold_06	50523601	50537706	P16066	ANPRA_HUMAN	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]
PGEN_.00g148350	Scaffold_06	50547433	50550874	NA	NA	NA	NA	NA
PGEN_.00g148360	Scaffold_06	50564594	50567050	NA	NA	NA	NA	NA
PGEN_.00g148370	Scaffold_06	50579694	50579966	NA	NA	NA	NA	NA
PGEN_.00g148380	Scaffold_06	50661961	50665001	O31826	YNGI_BACSU	Putative acyl-CoA synthetase YngI (EC 6.2.1.-)	GO:0005524; GO:0016874	ATP binding [GO:0005524]; ligase activity [GO:0016874]
PGEN_.00g148390	Scaffold_06	50668366	50668632	NA	NA	NA	NA	NA
PGEN_.00g148400	Scaffold_06	50680892	50687077	Q8VCW8	ACSF2_MOUSE	"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)"	GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]
PGEN_.00g148410	Scaffold_06	50688000	50688365	NA	NA	NA	NA	NA
PGEN_.00g148420	Scaffold_06	50688638	50692021	NA	NA	NA	NA	NA
PGEN_.00g148430	Scaffold_06	50757369	50757917	NA	NA	NA	NA	NA
PGEN_.00g148440	Scaffold_06	50792516	50830060	NA	NA	NA	NA	NA
PGEN_.00g148450	Scaffold_06	50834987	50841314	Q92890	UFD1_HUMAN	Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)	GO:0001501; GO:0004843; GO:0005102; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579; GO:0030970; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0043161; GO:0044877; GO:0051117; GO:0070987; GO:0071712	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g148460	Scaffold_06	50841741	50859640	O75419	CDC45_HUMAN	Cell division control protein 45 homolog (PORC-PI-1)	GO:0000076; GO:0000082; GO:0000083; GO:0000727; GO:0003682; GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005656; GO:0005737; GO:0005813; GO:0006260; GO:0006270; GO:0031261; GO:0031298; GO:0031938; GO:0043138; GO:1900087; GO:1902977	centrosome [GO:0005813]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; 3'-5' DNA helicase activity [GO:0043138]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication preinitiation complex assembly [GO:1902977]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of chromatin silencing at telomere [GO:0031938]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]
PGEN_.00g148470	Scaffold_06	50864540	50867563	NA	NA	NA	NA	NA
PGEN_.00g148480	Scaffold_06	50883342	50897378	NA	NA	NA	NA	NA
PGEN_.00g148490	Scaffold_06	50901972	50918828	Q9VGH7	CLCN2_DROME	Chloride channel protein 2 (ClC-2) (DmClC-2) (Chloride channel-a)	GO:0003091; GO:0003097; GO:0005247; GO:0005254; GO:0005887; GO:0006821; GO:0009925; GO:0015629; GO:0016324; GO:0030321; GO:0034707; GO:0034765; GO:0035377; GO:1902476	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; chloride channel activity [GO:0005254]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; transepithelial chloride transport [GO:0030321]; transepithelial water transport [GO:0035377]
PGEN_.00g148500	Scaffold_06	50928675	50928962	NA	NA	NA	NA	NA
PGEN_.00g148510	Scaffold_06	50942067	50962592	Q5U247	EXOC8_XENLA	Exocyst complex component 8	GO:0000145; GO:0006887; GO:0015031; GO:0030426; GO:0048471	exocyst [GO:0000145]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; exocytosis [GO:0006887]; protein transport [GO:0015031]
PGEN_.00g148520	Scaffold_06	50962971	50978716	Q6NVR9	ATAD3_XENTR	ATPase family AAA domain-containing protein 3	GO:0005524; GO:0005739; GO:0005743; GO:0007005; GO:0008270; GO:0016021; GO:0042645	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; mitochondrion organization [GO:0007005]
PGEN_.00g148530	Scaffold_06	50984943	51002421	Q9VLJ9	RM51_DROME	"39S ribosomal protein L51, mitochondrial (L51mt) (MRP-L51)"	GO:0003735; GO:0005761; GO:0005762; GO:0006412; GO:0032543	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
PGEN_.00g148540	Scaffold_06	51027985	51031664	NA	NA	NA	NA	NA
PGEN_.00g148550	Scaffold_06	51069531	51082198	Q8NCG5	CHST4_HUMAN	Carbohydrate sulfotransferase 4 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3) (GST-3) (High endothelial cells N-acetylglucosamine 6-O-sulfotransferase) (HEC-GlcNAc6ST) (L-selectin ligand sulfotransferase) (LSST) (N-acetylglucosamine 6-O-sulfotransferase 2) (GlcNAc6ST-2) (Gn6st-2)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006477; GO:0006790; GO:0006954; GO:0006955; GO:0007155; GO:0007267; GO:0008146; GO:0016021; GO:0016266; GO:0018146; GO:0031228	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; O-glycan processing [GO:0016266]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g148560	Scaffold_06	51088424	51097741	B2RPY5	GP161_MOUSE	G-protein coupled receptor 161	GO:0004930; GO:0005929; GO:0007189; GO:0007275; GO:0016021; GO:0055037; GO:0060170; GO:1901621	ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]
PGEN_.00g148570	Scaffold_06	51110460	51113675	NA	NA	NA	NA	NA
PGEN_.00g148580	Scaffold_06	51116654	51118493	NA	NA	NA	NA	NA
PGEN_.00g148590	Scaffold_06	51116676	51121110	NA	NA	NA	NA	NA
PGEN_.00g148600	Scaffold_06	51144648	51146306	NA	NA	NA	NA	NA
PGEN_.00g148610	Scaffold_06	51146541	51152447	NA	NA	NA	NA	NA
PGEN_.00g148620	Scaffold_06	51170936	51171523	Q9VS77	MTH6_DROME	Probable G-protein coupled receptor Mth-like 6 (Protein methuselah-like 6)	GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0008340; GO:0016021; GO:0042594	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; response to starvation [GO:0042594]
PGEN_.00g148630	Scaffold_06	51192501	51192887	NA	NA	NA	NA	NA
PGEN_.00g148640	Scaffold_06	51195024	51197173	NA	NA	NA	NA	NA
PGEN_.00g148650	Scaffold_06	51231666	51234293	NA	NA	NA	NA	NA
PGEN_.00g148660	Scaffold_06	51234338	51235926	NA	NA	NA	NA	NA
PGEN_.00g148670	Scaffold_06	51238304	51239550	A6NN14	ZN729_HUMAN	Zinc finger protein 729	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g148680	Scaffold_06	51257684	51257947	NA	NA	NA	NA	NA
PGEN_.00g148690	Scaffold_06	51271406	51271669	NA	NA	NA	NA	NA
PGEN_.00g148700	Scaffold_06	51285370	51291049	Q14585	ZN345_HUMAN	Zinc finger protein 345 (Zinc finger protein HZF10)	GO:0000122; GO:0003677; GO:0005634; GO:0006359; GO:0006366; GO:0006383; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g148710	Scaffold_06	51293427	51295015	NA	NA	NA	NA	NA
PGEN_.00g148720	Scaffold_06	51295060	51297687	NA	NA	NA	NA	NA
PGEN_.00g148730	Scaffold_06	51362086	51364713	NA	NA	NA	NA	NA
PGEN_.00g148740	Scaffold_06	51364758	51366346	NA	NA	NA	NA	NA
PGEN_.00g148750	Scaffold_06	51368724	51369970	A6NN14	ZN729_HUMAN	Zinc finger protein 729	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g148760	Scaffold_06	51388104	51388367	NA	NA	NA	NA	NA
PGEN_.00g148770	Scaffold_06	51401826	51402089	NA	NA	NA	NA	NA
PGEN_.00g148780	Scaffold_06	51415790	51421469	Q14585	ZN345_HUMAN	Zinc finger protein 345 (Zinc finger protein HZF10)	GO:0000122; GO:0003677; GO:0005634; GO:0006359; GO:0006366; GO:0006383; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g148790	Scaffold_06	51423847	51425435	NA	NA	NA	NA	NA
PGEN_.00g148800	Scaffold_06	51425480	51428107	NA	NA	NA	NA	NA
PGEN_.00g148810	Scaffold_06	51500153	51500494	NA	NA	NA	NA	NA
PGEN_.00g148820	Scaffold_06	51501097	51503191	NA	NA	NA	NA	NA
PGEN_.00g148830	Scaffold_06	51503247	51507557	NA	NA	NA	NA	NA
PGEN_.00g148840	Scaffold_06	51508048	51509288	NA	NA	NA	NA	NA
PGEN_.00g148850	Scaffold_06	51512171	51516959	Q08C99	VRTN_DANRE	Vertnin	GO:0000122; GO:0000785; GO:0001227	"chromatin [GO:0000785]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g148860	Scaffold_06	51590998	51607627	Q9QYP1	LRP4_RAT	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]
PGEN_.00g148870	Scaffold_06	51626771	51627061	NA	NA	NA	NA	NA
PGEN_.00g148880	Scaffold_06	51638068	51639278	NA	NA	NA	NA	NA
PGEN_.00g148890	Scaffold_06	51675163	51676014	NA	NA	NA	NA	NA
PGEN_.00g148900	Scaffold_06	51683602	51697747	NA	NA	NA	NA	NA
PGEN_.00g148910	Scaffold_06	51720331	51726351	NA	NA	NA	NA	NA
PGEN_.00g148920	Scaffold_06	51728858	51751578	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g148930	Scaffold_06	51759729	51765269	NA	NA	NA	NA	NA
PGEN_.00g148940	Scaffold_06	51807213	51813532	NA	NA	NA	NA	NA
PGEN_.00g148950	Scaffold_06	51823854	51838959	Q00910	SO2A1_RAT	Solute carrier organic anion transporter family member 2A1 (Matrin F/G 1) (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2)	GO:0005887; GO:0015132; GO:0015347; GO:0015732; GO:0043252	integral component of plasma membrane [GO:0005887]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]
PGEN_.00g148960	Scaffold_06	51860924	51872711	G5E8K6	MOT6_MOUSE	Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5)	GO:0005887; GO:0008028; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g148970	Scaffold_06	51922673	51924138	NA	NA	NA	NA	NA
PGEN_.00g148980	Scaffold_06	51932747	51932986	NA	NA	NA	NA	NA
PGEN_.00g148990	Scaffold_06	51934851	51939499	Q9HC77	CENPJ_HUMAN	Centromere protein J (CENP-J) (Centrosomal P4.1-associated protein) (LAG-3-associated protein) (LYST-interacting protein 1)	GO:0000086; GO:0003714; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0005886; GO:0007020; GO:0007099; GO:0007224; GO:0008275; GO:0010389; GO:0015631; GO:0019901; GO:0019904; GO:0036064; GO:0042802; GO:0044458; GO:0046599; GO:0046785; GO:0051301; GO:0061511; GO:0097711; GO:1902857; GO:1903724; GO:1904951; GO:1905515	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; smoothened signaling pathway [GO:0007224]
PGEN_.00g149000	Scaffold_06	51956391	51965215	NA	NA	NA	NA	NA
PGEN_.00g149010	Scaffold_06	51966099	51966371	NA	NA	NA	NA	NA
PGEN_.00g149020	Scaffold_06	51981439	51988593	P43024	CX6A1_MOUSE	"Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c oxidase polypeptide VIa-liver)"	GO:0004129; GO:0005739; GO:0005751; GO:0006123; GO:0009060; GO:0030234; GO:0043209	"mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]; aerobic respiration [GO:0009060]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"
PGEN_.00g149030	Scaffold_06	51996063	51997490	Q9CX98	CP2U1_MOUSE	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g149040	Scaffold_06	51998532	51999260	NA	NA	NA	NA	NA
PGEN_.00g149050	Scaffold_06	52002771	52018346	A4QNN3	UBP30_XENTR	Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30)	GO:0000422; GO:0004197; GO:0004843; GO:0005739; GO:0005741; GO:0006511; GO:0008053; GO:0016021; GO:0016579; GO:0035871; GO:0036459; GO:0044313	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g149060	Scaffold_06	52028956	52043868	NA	NA	NA	NA	NA
PGEN_.00g149070	Scaffold_06	52044155	52045291	NA	NA	NA	NA	NA
PGEN_.00g149080	Scaffold_06	52047108	52068891	P18293	ANPRA_MOUSE	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043235; GO:0048662	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g149090	Scaffold_06	52076231	52086654	NA	NA	NA	NA	NA
PGEN_.00g149100	Scaffold_06	52093756	52110718	Q8CEE7	RDH13_MOUSE	Retinol dehydrogenase 13 (EC 1.1.1.300)	GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]
PGEN_.00g149110	Scaffold_06	52157604	52163213	A4IFI1	CC157_BOVIN	Coiled-coil domain-containing protein 157		
PGEN_.00g149120	Scaffold_06	52175555	52186069	NA	NA	NA	NA	NA
PGEN_.00g149130	Scaffold_06	52203057	52234704	P20735	GGT1_PIG	Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]	GO:0000048; GO:0002682; GO:0005886; GO:0006536; GO:0006750; GO:0006751; GO:0007283; GO:0016021; GO:0031179; GO:0031638; GO:0032355; GO:0032496; GO:0034612; GO:0036374; GO:0050727; GO:0102953; GO:0103068	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; peptidyltransferase activity [GO:0000048]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]
PGEN_.00g149140	Scaffold_06	52263958	52278285	Q16932	STX_APLCA	Syntaxin	GO:0000149; GO:0005484; GO:0006836; GO:0006886; GO:0016021; GO:0016192; GO:0017157	integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; neurotransmitter transport [GO:0006836]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192]
PGEN_.00g149150	Scaffold_06	52279665	52279967	NA	NA	NA	NA	NA
PGEN_.00g149160	Scaffold_06	52341272	52342111	NA	NA	NA	NA	NA
PGEN_.00g149170	Scaffold_06	52342445	52344079	NA	NA	NA	NA	NA
PGEN_.00g149180	Scaffold_06	52349003	52367018	Q24547	STX1A_DROME	Syntaxin-1A (dSynt1)	GO:0000149; GO:0000281; GO:0005484; GO:0005765; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0007269; GO:0007274; GO:0007317; GO:0007349; GO:0007482; GO:0008021; GO:0012505; GO:0016021; GO:0016081; GO:0016192; GO:0017157; GO:0030054; GO:0030672; GO:0031201; GO:0031629; GO:0042734; GO:0043195; GO:0048278; GO:0048787	cell junction [GO:0030054]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; cellularization [GO:0007349]; exocytosis [GO:0006887]; haltere development [GO:0007482]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of exocytosis [GO:0017157]; regulation of pole plasm oskar mRNA localization [GO:0007317]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]
PGEN_.00g149190	Scaffold_06	52367971	52381693	P38542	RAN_BRUMA	GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein TC4)	GO:0003924; GO:0005525; GO:0005634; GO:0006913; GO:0015031	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]
PGEN_.00g149200	Scaffold_06	52388926	52399315	O43709	BUD23_HUMAN	Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein) (rRNA methyltransferase and ribosome maturation factor)	GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0008168; GO:0016435; GO:0031167; GO:0046982; GO:0048471; GO:0070476; GO:2000234	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]
PGEN_.00g149210	Scaffold_06	52403047	52403901	Q8TA83	DNJ10_CAEEL	DnaJ homolog dnj-10 (DnaJ domain protein 10)	GO:0002119; GO:0005524; GO:0005739; GO:0006457; GO:0007005; GO:0009408; GO:0009792; GO:0031072; GO:0046872; GO:0051082	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; embryo development ending in birth or egg hatching [GO:0009792]; mitochondrion organization [GO:0007005]; nematode larval development [GO:0002119]; protein folding [GO:0006457]; response to heat [GO:0009408]
PGEN_.00g149220	Scaffold_06	52415067	52427158	NA	NA	NA	NA	NA
PGEN_.00g149230	Scaffold_06	52455913	52482091	Q9UH65	SWP70_HUMAN	Switch-associated protein 70 (SWAP-70)	GO:0003677; GO:0005509; GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005886; GO:0007204; GO:0015629; GO:0030027; GO:0030835; GO:0032233; GO:0032880; GO:0033633; GO:0045190; GO:0045296; GO:0051017; GO:0060754; GO:1902309	actin cytoskeleton [GO:0015629]; cell [GO:0005623]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; actin filament bundle assembly [GO:0051017]; isotype switching [GO:0045190]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell chemotaxis [GO:0060754]; regulation of protein localization [GO:0032880]
PGEN_.00g149240	Scaffold_06	52511155	52530471	O88451	RDH7_MOUSE	Retinol dehydrogenase 7 (EC 1.1.1.105) (Cis-retinol/3alpha-hydroxysterol short-chain dehydrogenase isozyme 2) (Cis-retinol/androgen dehydrogenase type 2) (CRAD-2)	GO:0003824; GO:0004745; GO:0005783; GO:0042572	endoplasmic reticulum [GO:0005783]; catalytic activity [GO:0003824]; retinol dehydrogenase activity [GO:0004745]; retinol metabolic process [GO:0042572]
PGEN_.00g149250	Scaffold_06	52532315	52545544	Q8VE22	RT23_MOUSE	"28S ribosomal protein S23, mitochondrial (MRP-S23) (S23mt)"	GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0031965	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g149260	Scaffold_06	52557235	52573268	Q9NWM3	CUED1_HUMAN	CUE domain-containing protein 1		
PGEN_.00g149270	Scaffold_06	52589119	52589562	NA	NA	NA	NA	NA
PGEN_.00g149280	Scaffold_06	52589713	52590054	NA	NA	NA	NA	NA
PGEN_.00g149290	Scaffold_06	52590092	52590769	NA	NA	NA	NA	NA
PGEN_.00g149300	Scaffold_06	52597456	52622248	Q14161	GIT2_HUMAN	ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)	GO:0005096; GO:0005654; GO:0005925; GO:0008277; GO:0046872	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]
PGEN_.00g149310	Scaffold_06	52645593	52648818	Q6PAJ1	BCR_MOUSE	Breakpoint cluster region protein (EC 2.7.11.1)	GO:0002692; GO:0003014; GO:0004674; GO:0005085; GO:0005089; GO:0005096; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0007420; GO:0014069; GO:0019899; GO:0030036; GO:0030054; GO:0030216; GO:0030336; GO:0030424; GO:0032496; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043314; GO:0046777; GO:0048008; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051171; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0099092; GO:2000378	"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of phagocytosis [GO:0050766]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; response to lipopolysaccharide [GO:0032496]; small GTPase mediated signal transduction [GO:0007264]"
PGEN_.00g149320	Scaffold_06	52688295	52691691	Q6PAJ1	BCR_MOUSE	Breakpoint cluster region protein (EC 2.7.11.1)	GO:0002692; GO:0003014; GO:0004674; GO:0005085; GO:0005089; GO:0005096; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0007420; GO:0014069; GO:0019899; GO:0030036; GO:0030054; GO:0030216; GO:0030336; GO:0030424; GO:0032496; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043314; GO:0046777; GO:0048008; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051171; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0099092; GO:2000378	"axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of phagocytosis [GO:0050766]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; response to lipopolysaccharide [GO:0032496]; small GTPase mediated signal transduction [GO:0007264]"
PGEN_.00g149330	Scaffold_06	52713729	52738656	Q14161	GIT2_HUMAN	ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)	GO:0005096; GO:0005654; GO:0005925; GO:0008277; GO:0046872	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]
PGEN_.00g149340	Scaffold_06	52746389	52762158	Q6PD24	AN13D_MOUSE	Ankyrin repeat domain-containing protein 13D	GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036	cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091]
PGEN_.00g149350	Scaffold_06	52800594	52805597	Q9JM76	ARPC3_MOUSE	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0030027; GO:0031252; GO:0031941; GO:0034314; GO:0035861; GO:0051015; GO:0061850; GO:1990090	Arp2/3 protein complex [GO:0005885]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]
PGEN_.00g149360	Scaffold_06	52813959	52817315	A2A761	ZFP69_MOUSE	Zinc finger protein 69 (Zinc finger protein 642)	GO:0003700; GO:0005634; GO:0006629; GO:0019216; GO:0043565; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216]
PGEN_.00g149370	Scaffold_06	52826683	52832631	Q6ZM63	GPN3_DANRE	GPN-loop GTPase 3 (ATP-binding domain 1 family member C)	GO:0003924; GO:0005525	GTP binding [GO:0005525]; GTPase activity [GO:0003924]
PGEN_.00g149380	Scaffold_06	52834523	52835077	NA	NA	NA	NA	NA
PGEN_.00g149390	Scaffold_06	52835185	52840856	NA	NA	NA	NA	NA
PGEN_.00g149400	Scaffold_06	52857262	52863544	Q80XH4	WSCD1_MOUSE	WSC domain-containing protein 1	GO:0008146; GO:0016021	integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]
PGEN_.00g149410	Scaffold_06	52871721	52872251	P05179	CP2C7_RAT	Cytochrome P450 2C7 (EC 1.14.14.1) (CYPIIC7) (Cytochrome P450F) (PTF1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0007584; GO:0008392; GO:0008395; GO:0010243; GO:0014070; GO:0016712; GO:0019373; GO:0020037; GO:0032496; GO:0032526; GO:0042493; GO:0042738; GO:0043231; GO:0043434; GO:0045471; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to retinoic acid [GO:0032526]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g149420	Scaffold_06	52884808	52903642	Q8N6F8	MET27_HUMAN	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)		
PGEN_.00g149430	Scaffold_06	52913895	52932222	Q04837	SSBP_HUMAN	"Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) (PWP1-interacting protein 17)"	GO:0003682; GO:0003697; GO:0003723; GO:0005634; GO:0005739; GO:0005759; GO:0006264; GO:0006268; GO:0007005; GO:0042645; GO:0051096; GO:0070062; GO:0070584	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of helicase activity [GO:0051096]
PGEN_.00g149440	Scaffold_06	52959480	52959887	NA	NA	NA	NA	NA
PGEN_.00g149450	Scaffold_06	52980210	52980440	NA	NA	NA	NA	NA
PGEN_.00g149460	Scaffold_06	52988570	52989535	NA	NA	NA	NA	NA
PGEN_.00g149470	Scaffold_06	52991810	52992361	P22152	CRNA_EMENI	Nitrate transporter (Nitrate permease)	GO:0015112; GO:0015113; GO:0015513; GO:0015706; GO:0015707; GO:0016021; GO:0022832; GO:0042128	integral component of membrane [GO:0016021]; high-affinity secondary active nitrite transmembrane transporter activity [GO:0015513]; nitrate transmembrane transporter activity [GO:0015112]; nitrite transmembrane transporter activity [GO:0015113]; voltage-gated channel activity [GO:0022832]; nitrate assimilation [GO:0042128]; nitrate transport [GO:0015706]; nitrite transport [GO:0015707]
PGEN_.00g149480	Scaffold_06	53000191	53009032	Q8IRR5	SIR4_DROME	NAD-dependent protein deacylase Sirt4 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4)	GO:0003950; GO:0004407; GO:0005739; GO:0005759; GO:0006471; GO:0008270; GO:0016575; GO:0034979; GO:0070403	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; histone deacetylase activity [GO:0004407]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; zinc ion binding [GO:0008270]; histone deacetylation [GO:0016575]; protein ADP-ribosylation [GO:0006471]
PGEN_.00g149490	Scaffold_06	53015413	53021226	NA	NA	NA	NA	NA
PGEN_.00g149500	Scaffold_06	53021257	53021655	NA	NA	NA	NA	NA
PGEN_.00g149510	Scaffold_06	53021821	53032201	NA	NA	NA	NA	NA
PGEN_.00g149520	Scaffold_06	53038370	53038600	NA	NA	NA	NA	NA
PGEN_.00g149530	Scaffold_06	53038895	53039365	NA	NA	NA	NA	NA
PGEN_.00g149540	Scaffold_06	53039514	53039759	NA	NA	NA	NA	NA
PGEN_.00g149550	Scaffold_06	53040946	53049740	Q9UHI7	S23A1_HUMAN	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3)	GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016324; GO:0019852; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g149560	Scaffold_06	53063507	53067427	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g149570	Scaffold_06	53077100	53078462	NA	NA	NA	NA	NA
PGEN_.00g149580	Scaffold_06	53078556	53080648	NA	NA	NA	NA	NA
PGEN_.00g149590	Scaffold_06	53093166	53099755	NA	NA	NA	NA	NA
PGEN_.00g149600	Scaffold_06	53099843	53100916	NA	NA	NA	NA	NA
PGEN_.00g149610	Scaffold_06	53110238	53111671	NA	NA	NA	NA	NA
PGEN_.00g149620	Scaffold_06	53125740	53141211	Q96LY2	CC74B_HUMAN	Coiled-coil domain-containing protein 74B		
PGEN_.00g149630	Scaffold_06	53153448	53171682	Q641W4	RFC2_RAT	Replication factor C subunit 2 (Activator 1 subunit C2)	GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0017116; GO:0019899; GO:0031390; GO:1900264	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]
PGEN_.00g149640	Scaffold_06	53208943	53234353	Q80YX1	TENA_MOUSE	Tenascin (TN) (Hexabrachion) (Tenascin-C) (TN-C)	GO:0001968; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009612; GO:0010628; GO:0014012; GO:0031012; GO:0031175; GO:0042060; GO:0042475; GO:0045471; GO:0045545; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0098966	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; perisynaptic extracellular matrix [GO:0098966]; fibronectin binding [GO:0001968]; syndecan binding [GO:0045545]; bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; odontogenesis of dentin-containing tooth [GO:0042475]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060]
PGEN_.00g149650	Scaffold_06	53236781	53264016	Q00546	TENR_CHICK	Tenascin-R (TN-R) (Restrictin)	GO:0007155; GO:0050767; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; cell adhesion [GO:0007155]; regulation of neurogenesis [GO:0050767]
PGEN_.00g149660	Scaffold_06	53266410	53267685	NA	NA	NA	NA	NA
PGEN_.00g149670	Scaffold_06	53301237	53323873	Q641W4	RFC2_RAT	Replication factor C subunit 2 (Activator 1 subunit C2)	GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0017116; GO:0019899; GO:0031390; GO:1900264	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]
PGEN_.00g149680	Scaffold_06	53335825	53354243	Q96LY2	CC74B_HUMAN	Coiled-coil domain-containing protein 74B		
PGEN_.00g149690	Scaffold_06	53365256	53366689	NA	NA	NA	NA	NA
PGEN_.00g149700	Scaffold_06	53391283	53435064	P15101	DOPO_BOVIN	Dopamine beta-hydroxylase (EC 1.14.17.1) (Dopamine beta-monooxygenase) [Cleaved into: Soluble dopamine beta-hydroxylase]	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030658; GO:0030667; GO:0031418; GO:0034466; GO:0034774; GO:0042420; GO:0042421; GO:0042584	"chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g149710	Scaffold_06	53531325	53538795	O35551	RABE1_MOUSE	Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha)	GO:0005096; GO:0005768; GO:0005769; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0043231; GO:0055037; GO:1903441	early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g149720	Scaffold_06	53538873	53539439	NA	NA	NA	NA	NA
PGEN_.00g149730	Scaffold_06	53539534	53539815	NA	NA	NA	NA	NA
PGEN_.00g149740	Scaffold_06	53540088	53540600	NA	NA	NA	NA	NA
PGEN_.00g149750	Scaffold_06	53540718	53558681	O35551	RABE1_MOUSE	Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha)	GO:0005096; GO:0005768; GO:0005769; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0043231; GO:0055037; GO:1903441	early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g149760	Scaffold_06	53564509	53564997	NA	NA	NA	NA	NA
PGEN_.00g149770	Scaffold_06	53567961	53579392	NA	NA	NA	NA	NA
PGEN_.00g149780	Scaffold_06	53582506	53632539	Q7KZ85	SPT6H_HUMAN	Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein)	GO:0001825; GO:0003677; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006366; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0010793; GO:0016032; GO:0031491; GO:0032968; GO:0034728; GO:0035327; GO:0042393; GO:0042789; GO:0045191; GO:0050684; GO:0051028; GO:0051147; GO:0061086; GO:0070827	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; chromatin maintenance [GO:0070827]; chromatin remodeling [GO:0006338]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032]"
PGEN_.00g149790	Scaffold_06	53647054	53665287	Q54HH2	SRR_DICDI	Probable serine racemase (EC 4.3.1.17) (EC 4.3.1.18) (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (L-serine ammonia-lyase) (L-serine dehydratase)	GO:0000287; GO:0003941; GO:0005524; GO:0005737; GO:0006563; GO:0008721; GO:0018114; GO:0018249; GO:0030170; GO:0030378; GO:0042866; GO:0070179	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; D-serine biosynthetic process [GO:0070179]; L-serine metabolic process [GO:0006563]; protein dehydration [GO:0018249]; pyruvate biosynthetic process [GO:0042866]
PGEN_.00g149800	Scaffold_06	53705164	53705793	Q9UT67	IMT2_SCHPO	Inositol phosphoceramide mannosyltransferase 2 (EC 2.4.-.-) (IPC mannosyltransferase 2)	GO:0000030; GO:0005794; GO:0016021; GO:0031501; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g149810	Scaffold_06	53714829	53739703	P9WQE8	PHAS_MYCTO	Phthioceranic/hydroxyphthioceranic acid synthase (EC 2.3.1.-) (Polyketide synthase pks2)	GO:0006633; GO:0016491; GO:0016746; GO:0031177	"oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]; fatty acid biosynthetic process [GO:0006633]"
PGEN_.00g149820	Scaffold_06	53739739	53742786	E9F8M3	SWNK_METRA	Reducing polyketide synthase swnK (EC 2.3.1.-) (Swainsonine biosynthesis gene cluster protein K)	GO:0008168; GO:0016491; GO:0016874; GO:0031177; GO:0032259	ligase activity [GO:0016874]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; methylation [GO:0032259]
PGEN_.00g149830	Scaffold_06	53804428	53816498	NA	NA	NA	NA	NA
PGEN_.00g149840	Scaffold_06	53817455	53817757	NA	NA	NA	NA	NA
PGEN_.00g149850	Scaffold_06	53822458	53822700	NA	NA	NA	NA	NA
PGEN_.00g149860	Scaffold_06	53824636	53826453	NA	NA	NA	NA	NA
PGEN_.00g149870	Scaffold_06	53843408	53854994	Q8VBT2	SDHL_MOUSE	L-serine dehydratase/L-threonine deaminase (SDH) (EC 4.3.1.17) (L-serine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19)	GO:0003941; GO:0004794; GO:0005739; GO:0005829; GO:0006094; GO:0006565; GO:0006567; GO:0030170; GO:0042803; GO:0042866; GO:0065003	cytosol [GO:0005829]; mitochondrion [GO:0005739]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; gluconeogenesis [GO:0006094]; L-serine catabolic process [GO:0006565]; protein-containing complex assembly [GO:0065003]; pyruvate biosynthetic process [GO:0042866]; threonine catabolic process [GO:0006567]
PGEN_.00g149880	Scaffold_06	53857642	53885147	P86860	PSM_MYTCA	Shell matrix protein (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g149890	Scaffold_06	53892841	53894548	Q18161	YBPT_CAEEL	UPF0046 protein C25E10.12	GO:0016787	hydrolase activity [GO:0016787]
PGEN_.00g149900	Scaffold_06	53907243	53921078	Q2NKY7	SEPT2_BOVIN	Septin-2	GO:0000777; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005819; GO:0005930; GO:0005940; GO:0007224; GO:0007283; GO:0015629; GO:0015630; GO:0030154; GO:0030496; GO:0031105; GO:0032154; GO:0032391; GO:0045171; GO:0060170; GO:0060271; GO:0061640; GO:0097227	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]
PGEN_.00g149910	Scaffold_06	53942166	53942816	NA	NA	NA	NA	NA
PGEN_.00g149920	Scaffold_06	53944056	53944811	NA	NA	NA	NA	NA
PGEN_.00g149930	Scaffold_06	53983447	54024764	Q91ZM2	SH2B1_MOUSE	"SH2B adapter protein 1 (Pro-rich, PH and SH2 domain-containing signaling mediator) (PSM) (SH2 domain-containing protein 1B) (SH2-B PH domain-containing signaling mediator 1)"	GO:0001726; GO:0005068; GO:0005634; GO:0005829; GO:0005886; GO:0030032; GO:0035556; GO:0045840; GO:0060391; GO:2000278	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278]
PGEN_.00g149940	Scaffold_06	54026007	54027628	NA	NA	NA	NA	NA
PGEN_.00g149950	Scaffold_06	54042698	54056897	NA	NA	NA	NA	NA
PGEN_.00g149960	Scaffold_06	54059544	54065004	Q969V5	MUL1_HUMAN	Mitochondrial ubiquitin ligase activator of NFKB 1 (EC 2.3.2.27) (E3 SUMO-protein ligase MUL1) (E3 ubiquitin-protein ligase MUL1) (Growth inhibition and death E3 ligase) (Mitochondrial-anchored protein ligase) (MAPL) (Putative NF-kappa-B-activating protein 266) (RING finger protein 218) (RING-type E3 ubiquitin transferase NFKB 1)	GO:0000266; GO:0004842; GO:0005739; GO:0005777; GO:0006915; GO:0006919; GO:0007257; GO:0010637; GO:0010821; GO:0016020; GO:0016567; GO:0019789; GO:0030308; GO:0030424; GO:0031307; GO:0031625; GO:0031648; GO:0033235; GO:0042802; GO:0043025; GO:0043123; GO:0045824; GO:0046872; GO:0050689; GO:0050821; GO:0051646; GO:0051881; GO:0051898; GO:0060339; GO:0071360; GO:0071650; GO:0090141; GO:1901028; GO:1903861; GO:1904925	axon [GO:0030424]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of JUN kinase activity [GO:0007257]; apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; negative regulation of cell growth [GO:0030308]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of innate immune response [GO:0045824]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of dendrite extension [GO:1903861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein sumoylation [GO:0033235]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of mitochondrion organization [GO:0010821]
PGEN_.00g149970	Scaffold_06	54069857	54075649	Q6AXL8	ZMAT5_DANRE	Zinc finger matrin-type protein 5 (U11/U12 small nuclear ribonucleoprotein 20 kDa protein) (U11/U12 snRNP 20 kDa protein)	GO:0005689; GO:0006397; GO:0008270; GO:0008380	U12-type spliceosomal complex [GO:0005689]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g149980	Scaffold_06	54093673	54095016	NA	NA	NA	NA	NA
PGEN_.00g149990	Scaffold_06	54102622	54110052	NA	NA	NA	NA	NA
PGEN_.00g150000	Scaffold_06	54115055	54118574	NA	NA	NA	NA	NA
PGEN_.00g150010	Scaffold_06	54121212	54139374	Q13867	BLMH_HUMAN	Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40)	GO:0000209; GO:0004177; GO:0004180; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008234; GO:0009636; GO:0042493; GO:0042802; GO:0043418; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to drug [GO:0042493]; response to toxic substance [GO:0009636]
PGEN_.00g150020	Scaffold_06	54141658	54149241	NA	NA	NA	NA	NA
PGEN_.00g150030	Scaffold_06	54155773	54156051	NA	NA	NA	NA	NA
PGEN_.00g150040	Scaffold_06	54159332	54184799	P17141	ZFP37_MOUSE	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	GO:0003700; GO:0005634; GO:0007275; GO:0007281; GO:0007283; GO:0008270; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g150050	Scaffold_06	54186667	54187347	NA	NA	NA	NA	NA
PGEN_.00g150060	Scaffold_06	54191449	54259964	Q14CX7	NAA25_HUMAN	"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)"	GO:0005737; GO:0005794; GO:0005829; GO:0017196; GO:0031416	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196]
PGEN_.00g150070	Scaffold_06	54193383	54193694	NA	NA	NA	NA	NA
PGEN_.00g150080	Scaffold_06	54297460	54299404	Q99715	COCA1_HUMAN	Collagen alpha-1(XII) chain	GO:0003429; GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0062023; GO:0070062; GO:1903561	collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g150090	Scaffold_06	54336916	54347819	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g150100	Scaffold_06	54424062	54457910	Q6RX08	TRPV1_RABIT	Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1)	GO:0004888; GO:0005230; GO:0005231; GO:0005516; GO:0005524; GO:0005623; GO:0005887; GO:0015278; GO:0016021; GO:0030054; GO:0031226; GO:0032591; GO:0034605; GO:0035091; GO:0045211; GO:0046872; GO:0051289; GO:0070588; GO:0071312; GO:0071318; GO:0071468; GO:0098703; GO:1901594	cell [GO:0005623]; cell junction [GO:0030054]; dendritic spine membrane [GO:0032591]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular ligand-gated ion channel activity [GO:0005230]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transmembrane signaling receptor activity [GO:0004888]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to acidic pH [GO:0071468]; cellular response to alkaloid [GO:0071312]; cellular response to ATP [GO:0071318]; cellular response to heat [GO:0034605]; protein homotetramerization [GO:0051289]; response to capsazepine [GO:1901594]
PGEN_.00g150110	Scaffold_06	54466958	54473454	NA	NA	NA	NA	NA
PGEN_.00g150120	Scaffold_06	54482795	54494388	Q9Y6X9	MORC2_HUMAN	ATPase MORC2 (EC 3.6.1.3) (MORC family CW-type zinc finger protein 2) (Zinc finger CW-type coiled-coil domain protein 1)	GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006631; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042803; GO:0045814; GO:0045869; GO:0090309	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; fatty acid metabolic process [GO:0006631]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]"
PGEN_.00g150130	Scaffold_06	54495921	54498530	Q69ZX6	MOR2A_MOUSE	ATPase MORC2A (EC 3.6.1.3) (MORC family CW-type zinc finger protein 2A) (Zinc finger CW-type coiled-coil domain protein 1)	GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042393; GO:0042803; GO:0045814; GO:0045869; GO:0090309	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]"
PGEN_.00g150140	Scaffold_06	54499912	54500610	NA	NA	NA	NA	NA
PGEN_.00g150150	Scaffold_06	54501858	54552871	Q9Y6X9	MORC2_HUMAN	ATPase MORC2 (EC 3.6.1.3) (MORC family CW-type zinc finger protein 2) (Zinc finger CW-type coiled-coil domain protein 1)	GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006631; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042803; GO:0045814; GO:0045869; GO:0090309	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; fatty acid metabolic process [GO:0006631]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]"
PGEN_.00g150160	Scaffold_06	54587322	54608397	Q7ZTU9	TBX2_DANRE	T-box transcription factor TBX2b (T-box protein 2b)	GO:0000122; GO:0000977; GO:0001102; GO:0001228; GO:0001708; GO:0001947; GO:0003205; GO:0005634; GO:0007155; GO:0007417; GO:0007420; GO:0008016; GO:0008284; GO:0021538; GO:0021982; GO:0030903; GO:0035050; GO:0036302; GO:0042074; GO:0042461; GO:0043704; GO:0045944; GO:0046548; GO:0046549; GO:0046551; GO:0048318; GO:0048663; GO:0048793; GO:0060219; GO:0072019; GO:0072068	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; atrioventricular canal development [GO:0036302]; axial mesoderm development [GO:0048318]; brain development [GO:0007420]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cardiac chamber development [GO:0003205]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration involved in gastrulation [GO:0042074]; central nervous system development [GO:0007417]; embryonic heart tube development [GO:0035050]; epithalamus development [GO:0021538]; heart looping [GO:0001947]; late distal convoluted tubule development [GO:0072068]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; notochord development [GO:0030903]; photoreceptor cell development [GO:0042461]; photoreceptor cell fate specification [GO:0043704]; pineal gland development [GO:0021982]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; proximal convoluted tubule development [GO:0072019]; regulation of heart contraction [GO:0008016]; retinal cone cell development [GO:0046549]; retinal cone cell fate commitment [GO:0046551]; retinal rod cell development [GO:0046548]"
PGEN_.00g150170	Scaffold_06	54662275	54664287	NA	NA	NA	NA	NA
PGEN_.00g150180	Scaffold_06	54673864	54712101	Q9ET61	C1QR1_RAT	Complement component C1q receptor (C1q/MBL/SPA receptor) (C1qR(p)) (C1qRp) (Cell surface antigen AA4) (Complement component 1 q subcomponent receptor 1) (CD antigen CD93)	GO:0001849; GO:0005509; GO:0005886; GO:0009986; GO:0016021; GO:0030246; GO:0031410; GO:0050431; GO:0098609	cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q binding [GO:0001849]; transforming growth factor beta binding [GO:0050431]; cell-cell adhesion [GO:0098609]
PGEN_.00g150190	Scaffold_06	54790888	54791247	NA	NA	NA	NA	NA
PGEN_.00g150200	Scaffold_06	54797599	54798003	NA	NA	NA	NA	NA
PGEN_.00g150210	Scaffold_06	54810442	54816834	NA	NA	NA	NA	NA
PGEN_.00g150220	Scaffold_06	54816866	54822835	P86982	IMSP1_RUDPH	Insoluble matrix shell protein 1 (IMSP1) (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g150230	Scaffold_06	54866512	54887838	NA	NA	NA	NA	NA
PGEN_.00g150240	Scaffold_06	54878150	54878467	NA	NA	NA	NA	NA
PGEN_.00g150250	Scaffold_06	54891459	54892414	NA	NA	NA	NA	NA
PGEN_.00g150260	Scaffold_06	54892797	54893294	NA	NA	NA	NA	NA
PGEN_.00g150270	Scaffold_06	54900661	54912260	Q8BLF1	NCEH1_MOUSE	Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Arylacetamide deacetylase-like 1) (Chlorpyrifos oxon-binding protein) (CPO-BP)	GO:0005783; GO:0006470; GO:0006805; GO:0009056; GO:0016020; GO:0016021; GO:0016042; GO:0016787; GO:0017171; GO:0034338; GO:0042301; GO:0060395	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; hydrolase activity [GO:0016787]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056]; lipid catabolic process [GO:0016042]; protein dephosphorylation [GO:0006470]; SMAD protein signal transduction [GO:0060395]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g150280	Scaffold_06	54951809	54971334	P07314	GGT1_RAT	Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]	GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006750; GO:0006751; GO:0007283; GO:0007568; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0102953; GO:0103068; GO:1901750	"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; transferase activity, transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]"
PGEN_.00g150290	Scaffold_06	55059495	55065797	NA	NA	NA	NA	NA
PGEN_.00g150300	Scaffold_06	55123640	55123930	NA	NA	NA	NA	NA
PGEN_.00g150310	Scaffold_06	55124389	55134058	NA	NA	NA	NA	NA
PGEN_.00g150320	Scaffold_06	55144739	55145269	NA	NA	NA	NA	NA
PGEN_.00g150330	Scaffold_06	55145605	55145931	NA	NA	NA	NA	NA
PGEN_.00g150340	Scaffold_06	55156677	55164340	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g150350	Scaffold_06	55164860	55169777	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g150360	Scaffold_06	55285723	55286247	NA	NA	NA	NA	NA
PGEN_.00g150370	Scaffold_06	55294578	55294985	NA	NA	NA	NA	NA
PGEN_.00g150380	Scaffold_06	55305786	55314596	NA	NA	NA	NA	NA
PGEN_.00g150390	Scaffold_06	55332124	55332666	NA	NA	NA	NA	NA
PGEN_.00g150400	Scaffold_06	55352421	55352965	NA	NA	NA	NA	NA
PGEN_.00g150410	Scaffold_06	55353623	55384546	A9JRI0	HEAT6_DANRE	HEAT repeat-containing protein 6		
PGEN_.00g150420	Scaffold_06	55451873	55454428	NA	NA	NA	NA	NA
PGEN_.00g150430	Scaffold_06	55493407	55509555	Q96L91	EP400_HUMAN	E1A-binding protein p400 (EC 3.6.4.-) (CAG repeat protein 32) (Domino homolog) (hDomino) (Trinucleotide repeat-containing gene 12 protein) (p400 kDa SWI2/SNF2-related protein)	GO:0000812; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005654; GO:0016607; GO:0035267; GO:0043967; GO:0043968; GO:1990405	NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein antigen binding [GO:1990405]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]
PGEN_.00g150440	Scaffold_06	55514168	55584707	Q6ZRS2	SRCAP_HUMAN	Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator)	GO:0000812; GO:0003677; GO:0003713; GO:0004386; GO:0004402; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0006338; GO:0006357; GO:0016032; GO:0016458; GO:0016604; GO:0016887; GO:0032991; GO:0042393; GO:0043044; GO:0043486; GO:0048471	Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]
PGEN_.00g150450	Scaffold_06	55639730	55641224	NA	NA	NA	NA	NA
PGEN_.00g150460	Scaffold_06	55649740	55657591	E1BY51	TMM17_CHICK	Transmembrane protein 17	GO:0007224; GO:0016021; GO:0035869; GO:0036038; GO:0060170; GO:0060271; GO:1905515	ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]; smoothened signaling pathway [GO:0007224]
PGEN_.00g150470	Scaffold_06	55662680	55698264	NA	NA	NA	NA	NA
PGEN_.00g150480	Scaffold_06	55708332	55744074	Q810B6	ANFY1_MOUSE	Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif)	GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0017137; GO:0030904; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0090160; GO:1901981	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g150490	Scaffold_06	55754299	55755892	NA	NA	NA	NA	NA
PGEN_.00g150500	Scaffold_06	55757105	55758761	NA	NA	NA	NA	NA
PGEN_.00g150510	Scaffold_06	55760094	55760474	NA	NA	NA	NA	NA
PGEN_.00g150520	Scaffold_06	55761751	55772336	NA	NA	NA	NA	NA
PGEN_.00g150530	Scaffold_06	55783673	55784032	NA	NA	NA	NA	NA
PGEN_.00g150540	Scaffold_06	55784366	55792642	NA	NA	NA	NA	NA
PGEN_.00g150550	Scaffold_06	55793990	55796469	NA	NA	NA	NA	NA
PGEN_.00g150560	Scaffold_06	55804926	55805204	NA	NA	NA	NA	NA
PGEN_.00g150570	Scaffold_06	55881925	55882188	NA	NA	NA	NA	NA
PGEN_.00g150580	Scaffold_06	55886663	55903864	Q9UDX5	MTFP1_HUMAN	Mitochondrial fission process protein 1 (Mitochondrial 18 kDa protein) (MTP18)	GO:0000266; GO:0005739; GO:0005743; GO:0006915; GO:0014850; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]; response to muscle activity [GO:0014850]
PGEN_.00g150590	Scaffold_06	55910548	55936884	Q9WVM3	APC7_MOUSE	Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7) (Prediabetic NOD sera-reactive autoantigen)	GO:0005634; GO:0005680; GO:0007049; GO:0019903; GO:0051301; GO:0070979	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]
PGEN_.00g150600	Scaffold_06	55951141	55953936	NA	NA	NA	NA	NA
PGEN_.00g150610	Scaffold_06	55983572	55994478	Q99KR6	RNF34_MOUSE	E3 ubiquitin-protein ligase RNF34 (EC 2.3.2.27) (Phafin-1) (RING finger protein 34) (RING-type E3 ubiquitin transferase RNF34)	GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006915; GO:0012505; GO:0016567; GO:0016604; GO:0016607; GO:0031625; GO:0035872; GO:0043161; GO:0046872; GO:0061630; GO:0070417; GO:0070936; GO:1901797; GO:1901981; GO:1902042; GO:2000374; GO:2001271	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of oxygen metabolic process [GO:2000374]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g150620	Scaffold_06	55998447	55998758	NA	NA	NA	NA	NA
PGEN_.00g150630	Scaffold_06	55998789	56000642	NA	NA	NA	NA	NA
PGEN_.00g150640	Scaffold_06	56000706	56020494	Q969R2	OSBP2_HUMAN	Oxysterol-binding protein 2 (Oxysterol-binding protein-related protein 4) (ORP-4) (OSBP-related protein 4)	GO:0005829; GO:0006869; GO:0007286; GO:0008289; GO:0015485; GO:0016020; GO:0032934; GO:0043231; GO:0097440	apical dendrite [GO:0097440]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; lipid transport [GO:0006869]; spermatid development [GO:0007286]
PGEN_.00g150650	Scaffold_06	56026981	56030737	Q3B7Z2	OSBP1_MOUSE	Oxysterol-binding protein 1	GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0008289; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0043231; GO:0048471; GO:0070273; GO:0120015	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]
PGEN_.00g150660	Scaffold_06	56034053	56034556	NA	NA	NA	NA	NA
PGEN_.00g150670	Scaffold_06	56036630	56036860	NA	NA	NA	NA	NA
PGEN_.00g150680	Scaffold_06	56065159	56125917	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g150690	Scaffold_06	56129460	56141534	Q12979	ABR_HUMAN	Active breakpoint cluster region-related protein	GO:0002692; GO:0005085; GO:0005096; GO:0005829; GO:0005886; GO:0007186; GO:0007264; GO:0007420; GO:0016020; GO:0030036; GO:0030054; GO:0030424; GO:0032496; GO:0042472; GO:0043065; GO:0043114; GO:0043197; GO:0043314; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051056; GO:0060313; GO:0090630; GO:0098685; GO:0098978; GO:0099092	"axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear morphogenesis [GO:0042472]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; neuromuscular process controlling balance [GO:0050885]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phagocytosis [GO:0050766]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of vascular permeability [GO:0043114]; response to lipopolysaccharide [GO:0032496]; small GTPase mediated signal transduction [GO:0007264]"
PGEN_.00g150700	Scaffold_06	56311542	56324970	P40417	ERKA_DROME	Mitogen-activated protein kinase ERK-A (EC 2.7.11.24) (Extracellular-regulated kinase A) (Protein rolled)	GO:0000165; GO:0000278; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007173; GO:0007362; GO:0007430; GO:0007465; GO:0007474; GO:0007476; GO:0007479; GO:0007552; GO:0008134; GO:0008284; GO:0008286; GO:0008293; GO:0008340; GO:0008543; GO:0009267; GO:0010468; GO:0016242; GO:0019901; GO:0030054; GO:0031594; GO:0034334; GO:0034614; GO:0035169; GO:0035170; GO:0035556; GO:0045500; GO:0045793; GO:0046534; GO:0046843; GO:0048010; GO:0048149; GO:0050804; GO:0051091; GO:0051607; GO:0070371; GO:0071243; GO:0071276; GO:0071310; GO:0090303; GO:2000826; GO:2001023	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; adherens junction maintenance [GO:0034334]; behavioral response to ethanol [GO:0048149]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; leg disc proximal/distal pattern formation [GO:0007479]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland plasmatocyte differentiation [GO:0035169]; MAPK cascade [GO:0000165]; metamorphosis [GO:0007552]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of macroautophagy [GO:0016242]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of photoreceptor cell differentiation [GO:0046534]; positive regulation of wound healing [GO:0090303]; R7 cell fate commitment [GO:0007465]; regulation of gene expression [GO:0010468]; regulation of heart morphogenesis [GO:2000826]; regulation of response to drug [GO:2001023]; sevenless signaling pathway [GO:0045500]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"
PGEN_.00g150710	Scaffold_06	56345944	56346261	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g150720	Scaffold_06	56346339	56346725	NA	NA	NA	NA	NA
PGEN_.00g150730	Scaffold_06	56370071	56383108	P46196	MK01_BOVIN	Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)	GO:0001784; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005901; GO:0006468; GO:0006915; GO:0006974; GO:0007049; GO:0008353; GO:0010468; GO:0010628; GO:0010800; GO:0018105; GO:0018107; GO:0019858; GO:0019902; GO:0030278; GO:0030641; GO:0030878; GO:0031143; GO:0031647; GO:0031663; GO:0032212; GO:0033598; GO:0034198; GO:0034614; GO:0035094; GO:0035556; GO:0038127; GO:0042473; GO:0042802; GO:0043330; GO:0045596; GO:0048538; GO:0050852; GO:0050853; GO:0051403; GO:0051973; GO:0060020; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0070371; GO:0070849; GO:0071276; GO:0071310; GO:0071356; GO:0072686; GO:0097011; GO:1903351; GO:1904355	caveola [GO:0005901]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of gene expression [GO:0010468]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]
PGEN_.00g150740	Scaffold_06	56413545	56416356	NA	NA	NA	NA	NA
PGEN_.00g150750	Scaffold_06	56418975	56438422	Q4R7K7	BRE1B_MACFA	E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B)	GO:0000151; GO:0004842; GO:0005634; GO:0010390; GO:0031625; GO:0033503; GO:0033523; GO:0042803; GO:0046872	HULC complex [GO:0033503]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]
PGEN_.00g150760	Scaffold_06	56440280	56454447	Q54PZ6	Y5897_DICDI	Putative uncharacterized protein DDB_G0284213	GO:0000149; GO:0005085; GO:0005096; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0017137; GO:0030133; GO:0045022; GO:0097422; GO:1990126	"cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]; SNARE binding [GO:0000149]; early endosome to late endosome transport [GO:0045022]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g150770	Scaffold_06	56455364	56456749	NA	NA	NA	NA	NA
PGEN_.00g150780	Scaffold_06	56460358	56460720	Q6E2N3	TRI33_DANRE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]
PGEN_.00g150790	Scaffold_06	56462181	56475580	Q5REW9	ANR27_PONAB	Ankyrin repeat domain-containing protein 27	GO:0005764; GO:0005769; GO:0005770; GO:0005886; GO:0015031; GO:0030659; GO:0042470	cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein transport [GO:0015031]
PGEN_.00g150800	Scaffold_06	56487079	56522978	I3L5V6	SARM1_PIG	NAD(+) hydrolase SARM1 (NADase SARM1) (EC 3.2.2.6) (NADP(+) hydrolase SARM1) (EC 3.2.2.-) (Sterile alpha and TIR motif-containing protein 1)	GO:0005737; GO:0005739; GO:0005874; GO:0007165; GO:0030054; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0045202; GO:0048678; GO:0048814; GO:1901214	axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; synapse [GO:0045202]; signaling adaptor activity [GO:0035591]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]
PGEN_.00g150810	Scaffold_06	56557349	56571135	Q24JV4	U390_DANRE	UPF0390 protein zgc136864		
PGEN_.00g150820	Scaffold_06	56573218	56575676	Q6IDD9	SARM1_DROME	NAD(+) hydrolase sarm1 (NADase sarm1) (EC 3.2.2.6) (Sterile alpha and TIR motif-containing protein 1) (dSarm) (Tir-1 homolog)	GO:0005737; GO:0007165; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0043005; GO:0043025; GO:0045087; GO:0048678; GO:1901214	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]
PGEN_.00g150830	Scaffold_06	56592395	56603723	Q6IDD9	SARM1_DROME	NAD(+) hydrolase sarm1 (NADase sarm1) (EC 3.2.2.6) (Sterile alpha and TIR motif-containing protein 1) (dSarm) (Tir-1 homolog)	GO:0005737; GO:0007165; GO:0030424; GO:0030425; GO:0034128; GO:0035591; GO:0043005; GO:0043025; GO:0045087; GO:0048678; GO:1901214	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]
PGEN_.00g150840	Scaffold_06	56605018	56605458	Q9D0E1	HNRPM_MOUSE	Heterogeneous nuclear ribonucleoprotein M (hnRNP M)	GO:0000380; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0009986; GO:0016363; GO:0019904; GO:0042382; GO:0048306; GO:0062023; GO:0071013; GO:0071014; GO:1900182; GO:1904591; GO:1990405; GO:1990904; GO:2000815	"catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; calcium-dependent protein binding [GO:0048306]; mRNA binding [GO:0003729]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; alternative mRNA splicing, via spliceosome [GO:0000380]; positive regulation of protein import [GO:1904591]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]"
PGEN_.00g150850	Scaffold_06	56616052	56668553	P98155	VLDLR_HUMAN	Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R)	GO:0005041; GO:0005509; GO:0005765; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0007165; GO:0007399; GO:0007411; GO:0007613; GO:0008203; GO:0016020; GO:0016021; GO:0021517; GO:0030229; GO:0032802; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0043235; GO:0045860; GO:0048306; GO:0048813; GO:1900006	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; axon guidance [GO:0007411]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; memory [GO:0007613]; nervous system development [GO:0007399]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]
PGEN_.00g150860	Scaffold_06	56675758	56676312	NA	NA	NA	NA	NA
PGEN_.00g150870	Scaffold_06	56688911	56702084	Q91XQ5	CHSTF_MOUSE	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; hexose biosynthetic process [GO:0019319]
PGEN_.00g150880	Scaffold_06	56707022	56714843	Q5RC74	DERL2_PONAB	Derlin-2 (Der1-like protein 2)	GO:0001967; GO:0005769; GO:0005770; GO:0005785; GO:0008284; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0048500; GO:1904153	"early endosome [GO:0005769]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; signal recognition particle [GO:0048500]; signal recognition particle receptor complex [GO:0005785]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g150890	Scaffold_06	56715214	56715492	NA	NA	NA	NA	NA
PGEN_.00g150900	Scaffold_06	56733232	56742159	NA	NA	NA	NA	NA
PGEN_.00g150910	Scaffold_06	56763459	56767399	NA	NA	NA	NA	NA
PGEN_.00g150920	Scaffold_06	56777786	56786903	Q2NKX8	ERC6L_HUMAN	DNA excision repair protein ERCC-6-like (EC 3.6.4.12) (ATP-dependent helicase ERCC6-like) (PLK1-interacting checkpoint helicase) (Tumor antigen BJ-HCC-15)	GO:0000777; GO:0003677; GO:0003678; GO:0005524; GO:0005829; GO:0007049; GO:0015616; GO:0016020; GO:0051301	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g150930	Scaffold_06	56789384	56790145	A2BGR3	ERC6L_DANRE	DNA excision repair protein ERCC-6-like (EC 3.6.4.12) (ATP-dependent helicase ERCC6-like)	GO:0000777; GO:0003677; GO:0003678; GO:0005524; GO:0007049; GO:0015616; GO:0016539; GO:0051301	condensed chromosome kinetochore [GO:0000777]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; cell cycle [GO:0007049]; cell division [GO:0051301]; intein-mediated protein splicing [GO:0016539]
PGEN_.00g150940	Scaffold_06	56791196	56795537	Q39227	SMT2_ARATH	24-methylenesterol C-methyltransferase 2 (24-sterol C-methyltransferase 2) (Sterol-C-methyltransferase 2) (EC 2.1.1.143) (Protein COTYLEDON VASCULAR PATTERN 1)	GO:0005634; GO:0005783; GO:0005794; GO:0007389; GO:0008757; GO:0009825; GO:0010051; GO:0016126; GO:0030797; GO:0032259; GO:0032876	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; 24-methylenesterol C-methyltransferase activity [GO:0030797]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; multidimensional cell growth [GO:0009825]; negative regulation of DNA endoreduplication [GO:0032876]; pattern specification process [GO:0007389]; sterol biosynthetic process [GO:0016126]; xylem and phloem pattern formation [GO:0010051]
PGEN_.00g150950	Scaffold_06	56796548	56836126	NA	NA	NA	NA	NA
PGEN_.00g150960	Scaffold_06	56852820	56861907	O35796	C1QBP_RAT	"Complement component 1 Q subcomponent-binding protein, mitochondrial (GC1q-R protein) (Glycoprotein gC1qBP) (C1qBP)"	GO:0000122; GO:0001849; GO:0003714; GO:0003729; GO:0005080; GO:0005540; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006397; GO:0006915; GO:0006955; GO:0006958; GO:0008134; GO:0008380; GO:0008494; GO:0009986; GO:0014065; GO:0016020; GO:0030449; GO:0030984; GO:0031690; GO:0032689; GO:0032695; GO:0039534; GO:0039536; GO:0042256; GO:0043065; GO:0045087; GO:0045785; GO:0048025; GO:0048786; GO:0050687; GO:0051897; GO:0070131; GO:0090023; GO:0097177; GO:0098793; GO:0098978; GO:0098982; GO:1900026; GO:1901165; GO:2000510	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; protein kinase C binding [GO:0005080]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]; apoptotic process [GO:0006915]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380]"
PGEN_.00g150970	Scaffold_06	56863452	56871924	Q9D0B0	SRSF9_MOUSE	"Serine/arginine-rich splicing factor 9 (Splicing factor, arginine/serine-rich 9)"	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0009636; GO:0016607; GO:0019904; GO:0043279; GO:0045292; GO:0048025	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]"
PGEN_.00g150980	Scaffold_06	56892929	56909635	O43345	ZN208_HUMAN	Zinc finger protein 208 (Zinc finger protein 91-like)	GO:0003677; GO:0005634; GO:0006355; GO:0008270	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g150990	Scaffold_06	56971282	56997807	Q9Y6N5	SQOR_HUMAN	"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)"	GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"
PGEN_.00g151000	Scaffold_06	57006812	57007081	NA	NA	NA	NA	NA
PGEN_.00g151010	Scaffold_06	57007223	57007657	NA	NA	NA	NA	NA
PGEN_.00g151020	Scaffold_06	57014459	57030039	P09479	ACHA_CHICK	Acetylcholine receptor subunit alpha	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g151030	Scaffold_06	57033308	57052137	NA	NA	NA	NA	NA
PGEN_.00g151040	Scaffold_06	57068624	57077018	Q8BLF1	NCEH1_MOUSE	Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Arylacetamide deacetylase-like 1) (Chlorpyrifos oxon-binding protein) (CPO-BP)	GO:0005783; GO:0006470; GO:0006805; GO:0009056; GO:0016020; GO:0016021; GO:0016042; GO:0016787; GO:0017171; GO:0034338; GO:0042301; GO:0060395	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; hydrolase activity [GO:0016787]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056]; lipid catabolic process [GO:0016042]; protein dephosphorylation [GO:0006470]; SMAD protein signal transduction [GO:0060395]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g151050	Scaffold_06	57080071	57136506	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g151060	Scaffold_06	57139358	57143082	Q9Y115	UN93L_DROME	UNC93-like protein	GO:0005886; GO:0006937; GO:0015459; GO:0016021; GO:0043266; GO:0055120	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120]; potassium channel regulator activity [GO:0015459]; regulation of muscle contraction [GO:0006937]; regulation of potassium ion transport [GO:0043266]
PGEN_.00g151070	Scaffold_06	57145850	57146242	NA	NA	NA	NA	NA
PGEN_.00g151080	Scaffold_06	57196426	57196824	NA	NA	NA	NA	NA
PGEN_.00g151090	Scaffold_06	57197207	57201288	Q148G5	PROD_BOVIN	"Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase)"	GO:0004657; GO:0005739; GO:0005759; GO:0010133; GO:0071949	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; proline catabolic process to glutamate [GO:0010133]
PGEN_.00g151100	Scaffold_06	57207003	57207806	NA	NA	NA	NA	NA
PGEN_.00g151110	Scaffold_06	57210902	57236080	Q13769	THOC5_HUMAN	THO complex subunit 5 homolog (Functional spliceosome-associated protein 79) (fSAP79) (NF2/meningioma region protein pK1.3) (Placental protein 39.2) (PP39.2) (hTREX90)	GO:0000228; GO:0000346; GO:0000347; GO:0000445; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0008380; GO:0030224; GO:0031124; GO:0032786; GO:0046784; GO:0060215; GO:2000002	"cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; mRNA binding [GO:0003729]; monocyte differentiation [GO:0030224]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; primitive hemopoiesis [GO:0060215]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]"
PGEN_.00g151120	Scaffold_06	57240769	57254196	NA	NA	NA	NA	NA
PGEN_.00g151130	Scaffold_06	57256204	57256972	NA	NA	NA	NA	NA
PGEN_.00g151140	Scaffold_06	57264910	57304308	O89029	MATN4_MOUSE	Matrilin-4 (MAT-4)	GO:0003429; GO:0005509; GO:0005615; GO:0031012; GO:0048678; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; response to axon injury [GO:0048678]
PGEN_.00g151150	Scaffold_06	57322528	57322857	NA	NA	NA	NA	NA
PGEN_.00g151160	Scaffold_06	57332829	57333161	NA	NA	NA	NA	NA
PGEN_.00g151170	Scaffold_06	57355434	57355955	NA	NA	NA	NA	NA
PGEN_.00g151180	Scaffold_06	57360492	57371285	O89029	MATN4_MOUSE	Matrilin-4 (MAT-4)	GO:0003429; GO:0005509; GO:0005615; GO:0031012; GO:0048678; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; response to axon injury [GO:0048678]
PGEN_.00g151190	Scaffold_06	57385718	57392362	P51942	MATN1_MOUSE	Cartilage matrix protein (Matrilin-1)	GO:0002062; GO:0003429; GO:0005201; GO:0005509; GO:0005615; GO:0030500; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; chondrocyte differentiation [GO:0002062]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; regulation of bone mineralization [GO:0030500]
PGEN_.00g151200	Scaffold_06	57406837	57411270	Q8MP06	SNO1_TYRJA	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	GO:0004499; GO:0005576; GO:0009820; GO:0033784; GO:0050660; GO:0050661; GO:0051289; GO:0055114	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
PGEN_.00g151210	Scaffold_06	57411334	57414634	Q9SXE1	GSOX3_ARATH	Flavin-containing monooxygenase FMO GS-OX3 (EC 1.14.13.237) (Flavin-monooxygenase glucosinolate S-oxygenase 3)	GO:0004499; GO:0016021; GO:0019761; GO:0050660; GO:0050661; GO:0080102; GO:0080103; GO:0080104; GO:0080105; GO:0080106; GO:0080107	"integral component of membrane [GO:0016021]; 3-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080102]; 4-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080103]; 5-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080104]; 6-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080105]; 7-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080106]; 8-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080107]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; glucosinolate biosynthetic process [GO:0019761]"
PGEN_.00g151220	Scaffold_06	57438339	57440532	NA	NA	NA	NA	NA
PGEN_.00g151230	Scaffold_06	57481670	57537417	Q9UPZ6	THS7A_HUMAN	"Thrombospondin type-1 domain-containing protein 7A [Cleaved into: Thrombospondin type-1 domain-containing protein 7A, soluble form]"	GO:0001525; GO:0005576; GO:0005886; GO:0016021; GO:0030154; GO:0031532; GO:0042995	cell projection [GO:0042995]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]
PGEN_.00g151240	Scaffold_06	57552325	57552612	NA	NA	NA	NA	NA
PGEN_.00g151250	Scaffold_06	57564199	57565251	NA	NA	NA	NA	NA
PGEN_.00g151260	Scaffold_06	57579846	57589231	NA	NA	NA	NA	NA
PGEN_.00g151270	Scaffold_06	57589707	57589964	NA	NA	NA	NA	NA
PGEN_.00g151280	Scaffold_06	57595556	57599522	NA	NA	NA	NA	NA
PGEN_.00g151290	Scaffold_06	57692282	57700727	P17141	ZFP37_MOUSE	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	GO:0003700; GO:0005634; GO:0007275; GO:0007281; GO:0007283; GO:0008270; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g151300	Scaffold_06	57701568	57705606	P10078	ZFP28_MOUSE	Zinc finger protein 28 (Zfp-28) (Protein mKR5)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g151310	Scaffold_06	57719181	57719486	NA	NA	NA	NA	NA
PGEN_.00g151320	Scaffold_06	57731502	57732725	Q9TSQ8	CXCR4_CHLAE	C-X-C chemokine receptor type 4 (CXC-R4) (CXCR-4) (CD antigen CD184)	GO:0005764; GO:0005769; GO:0005770; GO:0005886; GO:0006935; GO:0016021; GO:0019955; GO:0030054; GO:0038147; GO:0038160; GO:0071345	cell junction [GO:0030054]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; C-X-C motif chemokine 12 receptor activity [GO:0038147]; cytokine binding [GO:0019955]; cellular response to cytokine stimulus [GO:0071345]; chemotaxis [GO:0006935]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]
PGEN_.00g151330	Scaffold_06	57733648	57735666	NA	NA	NA	NA	NA
PGEN_.00g151340	Scaffold_06	57752473	57756489	NA	NA	NA	NA	NA
PGEN_.00g151350	Scaffold_06	57772879	57774171	Q6ZUK4	TMM26_HUMAN	Transmembrane protein 26	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g151360	Scaffold_06	57783330	57868391	Q9JMH9	MY18A_MOUSE	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	GO:0000139; GO:0005524; GO:0005793; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0030054; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045202; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:1903028	actomyosin [GO:0042641]; brush border [GO:0005903]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]
PGEN_.00g151370	Scaffold_06	57918665	57919756	Q92614	MY18A_HUMAN	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0030054; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045202; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:1903028	actomyosin [GO:0042641]; cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]
PGEN_.00g151380	Scaffold_06	57927443	57957846	Q1RLX4	TPC11_DANRE	Trafficking protein particle complex subunit 11 (Protein foie gras)	GO:0001889; GO:0005794; GO:0006487; GO:0007030; GO:0009306; GO:0016192; GO:0055088; GO:0060041; GO:1905897	Golgi apparatus [GO:0005794]; Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192]
PGEN_.00g151390	Scaffold_06	57964055	57975895	Q9NW13	RBM28_HUMAN	RNA-binding protein 28 (RNA-binding motif protein 28)	GO:0003723; GO:0005634; GO:0005681; GO:0005730; GO:0006397; GO:0008380; GO:1990904	nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g151400	Scaffold_06	58013122	58017692	NA	NA	NA	NA	NA
PGEN_.00g151410	Scaffold_06	58028864	58033057	NA	NA	NA	NA	NA
PGEN_.00g151420	Scaffold_06	58042539	58043807	NA	NA	NA	NA	NA
PGEN_.00g151430	Scaffold_06	58050878	58056320	NA	NA	NA	NA	NA
PGEN_.00g151440	Scaffold_06	58065868	58070670	P53987	MOT1_RAT	Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1)	GO:0005813; GO:0005886; GO:0005887; GO:0006629; GO:0007098; GO:0008028; GO:0009986; GO:0015129; GO:0015293; GO:0015718; GO:0016323; GO:0016324; GO:0030054; GO:0032094; GO:0035873; GO:0035879; GO:0042593; GO:0042802; GO:0043231; GO:0045202; GO:0050796; GO:0051780; GO:0071407; GO:0097159	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; centrosome [GO:0005813]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; organic cyclic compound binding [GO:0097159]; symporter activity [GO:0015293]; behavioral response to nutrient [GO:0051780]; cellular response to organic cyclic compound [GO:0071407]; centrosome cycle [GO:0007098]; glucose homeostasis [GO:0042593]; lactate transmembrane transport [GO:0035873]; lipid metabolic process [GO:0006629]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; regulation of insulin secretion [GO:0050796]; response to food [GO:0032094]
PGEN_.00g151450	Scaffold_06	58072251	58073383	NA	NA	NA	NA	NA
PGEN_.00g151460	Scaffold_06	58085565	58085939	NA	NA	NA	NA	NA
PGEN_.00g151470	Scaffold_06	58086014	58086394	NA	NA	NA	NA	NA
PGEN_.00g151480	Scaffold_06	58096014	58098291	NA	NA	NA	NA	NA
PGEN_.00g151490	Scaffold_06	58099186	58099467	NA	NA	NA	NA	NA
PGEN_.00g151500	Scaffold_06	58105879	58123245	Q0V9K2	ABHDB_XENTR	Protein ABHD11 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11)	GO:0005739; GO:0016787	mitochondrion [GO:0005739]; hydrolase activity [GO:0016787]
PGEN_.00g151510	Scaffold_06	58127738	58144607	Q6ZP65	BICL1_HUMAN	BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A) (CCDC64A)	GO:0005623; GO:0005737; GO:0005813; GO:0017137; GO:0031175; GO:0034452; GO:0047496; GO:0055107	cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin binding [GO:0034452]; Rab GTPase binding [GO:0017137]; Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496]
PGEN_.00g151520	Scaffold_06	58157958	58158741	NA	NA	NA	NA	NA
PGEN_.00g151530	Scaffold_06	58192829	58199013	NA	NA	NA	NA	NA
PGEN_.00g151540	Scaffold_06	58288761	58289021	NA	NA	NA	NA	NA
PGEN_.00g151550	Scaffold_06	58316207	58316719	NA	NA	NA	NA	NA
PGEN_.00g151560	Scaffold_06	58326596	58327394	NA	NA	NA	NA	NA
PGEN_.00g151570	Scaffold_06	58344588	58344947	NA	NA	NA	NA	NA
PGEN_.00g151580	Scaffold_06	58365352	58365750	NA	NA	NA	NA	NA
PGEN_.00g151590	Scaffold_06	58388361	58388804	NA	NA	NA	NA	NA
PGEN_.00g151600	Scaffold_06	58397077	58400531	NA	NA	NA	NA	NA
PGEN_.00g151610	Scaffold_06	58478611	58478832	NA	NA	NA	NA	NA
PGEN_.00g151620	Scaffold_06	58490879	58491283	NA	NA	NA	NA	NA
PGEN_.00g151630	Scaffold_06	58510095	58527405	NA	NA	NA	NA	NA
PGEN_.00g151640	Scaffold_06	58533726	58560502	Q54BU4	ABCB1_DICDI	ABC transporter B family member 1 (ABC transporter ABCB.1)	GO:0005524; GO:0006935; GO:0006972; GO:0016021; GO:0016887; GO:0031154; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085]
PGEN_.00g151650	Scaffold_06	58584333	58585283	NA	NA	NA	NA	NA
PGEN_.00g151660	Scaffold_06	58601995	58607236	NA	NA	NA	NA	NA
PGEN_.00g151670	Scaffold_06	58615206	58636427	NA	NA	NA	NA	NA
PGEN_.00g151680	Scaffold_06	58646913	58647901	NA	NA	NA	NA	NA
PGEN_.00g151690	Scaffold_06	58655906	58667124	NA	NA	NA	NA	NA
PGEN_.00g151700	Scaffold_06	58735950	58736204	NA	NA	NA	NA	NA
PGEN_.00g151710	Scaffold_06	58769794	58770153	NA	NA	NA	NA	NA
PGEN_.00g151720	Scaffold_06	58828261	58883609	Q18120	TWK18_CAEEL	TWiK family of potassium channels protein 18	GO:0005887; GO:0006813; GO:0006936; GO:0015271; GO:0016020; GO:0022841; GO:0030322; GO:0040011; GO:0071805	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]
PGEN_.00g151730	Scaffold_06	58908250	58921822	NA	NA	NA	NA	NA
PGEN_.00g151740	Scaffold_06	58927386	58929973	NA	NA	NA	NA	NA
PGEN_.00g151750	Scaffold_06	58935863	58944467	NA	NA	NA	NA	NA
PGEN_.00g151760	Scaffold_06	58947473	58948198	NA	NA	NA	NA	NA
PGEN_.00g151770	Scaffold_06	58963287	58964402	NA	NA	NA	NA	NA
PGEN_.00g151780	Scaffold_06	58982452	58984489	NA	NA	NA	NA	NA
PGEN_.00g151790	Scaffold_06	58987400	58987786	NA	NA	NA	NA	NA
PGEN_.00g151800	Scaffold_06	59024122	59055713	P51905	SC6A4_DROME	Sodium-dependent serotonin transporter (5HT transporter) (5HTT) (Cocaine-sensitive serotonin transporter) (dSERT1)	GO:0005335; GO:0005886; GO:0006837; GO:0008504; GO:0015844; GO:0016021; GO:0030424; GO:0043005; GO:0043679; GO:0046872; GO:0051378; GO:0051610	axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; serotonin binding [GO:0051378]; serotonin:sodium symporter activity [GO:0005335]; monoamine transport [GO:0015844]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]
PGEN_.00g151810	Scaffold_06	59068064	59075576	NA	NA	NA	NA	NA
PGEN_.00g151820	Scaffold_06	59115060	59132953	P51905	SC6A4_DROME	Sodium-dependent serotonin transporter (5HT transporter) (5HTT) (Cocaine-sensitive serotonin transporter) (dSERT1)	GO:0005335; GO:0005886; GO:0006837; GO:0008504; GO:0015844; GO:0016021; GO:0030424; GO:0043005; GO:0043679; GO:0046872; GO:0051378; GO:0051610	axon [GO:0030424]; axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; serotonin binding [GO:0051378]; serotonin:sodium symporter activity [GO:0005335]; monoamine transport [GO:0015844]; serotonin transport [GO:0006837]; serotonin uptake [GO:0051610]
PGEN_.00g151830	Scaffold_06	59142489	59144388	NA	NA	NA	NA	NA
PGEN_.00g151840	Scaffold_06	59144493	59146666	NA	NA	NA	NA	NA
PGEN_.00g151850	Scaffold_06	59152597	59154753	NA	NA	NA	NA	NA
PGEN_.00g151860	Scaffold_06	59161794	59162090	NA	NA	NA	NA	NA
PGEN_.00g151870	Scaffold_06	59184910	59185422	NA	NA	NA	NA	NA
PGEN_.00g151880	Scaffold_06	59185554	59185871	NA	NA	NA	NA	NA
PGEN_.00g151890	Scaffold_06	59194585	59195731	NA	NA	NA	NA	NA
PGEN_.00g151900	Scaffold_06	59232952	59238733	NA	NA	NA	NA	NA
PGEN_.00g151910	Scaffold_06	59260033	59261740	NA	NA	NA	NA	NA
PGEN_.00g151920	Scaffold_06	59303080	59303932	NA	NA	NA	NA	NA
PGEN_.00g151930	Scaffold_06	59315626	59339518	Q54468	CHB_SERMA	Chitobiase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (N-acetyl-beta-glucosaminidase)	GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0042597; GO:0102148	periplasmic space [GO:0042597]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]
PGEN_.00g151940	Scaffold_06	59346328	59349358	NA	NA	NA	NA	NA
PGEN_.00g151950	Scaffold_06	59355973	59403333	Q6NT55	CP4FN_HUMAN	Cytochrome P450 4F22 (EC 1.14.14.-)	GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690]"
PGEN_.00g151960	Scaffold_06	59403960	59409336	NA	NA	NA	NA	NA
PGEN_.00g151970	Scaffold_06	59415497	59416609	NA	NA	NA	NA	NA
PGEN_.00g151980	Scaffold_06	59431141	59436606	NA	NA	NA	NA	NA
PGEN_.00g151990	Scaffold_06	59471789	59488971	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g152000	Scaffold_06	59497562	59497861	NA	NA	NA	NA	NA
PGEN_.00g152010	Scaffold_06	59497994	59500675	NA	NA	NA	NA	NA
PGEN_.00g152020	Scaffold_06	59516098	59519577	NA	NA	NA	NA	NA
PGEN_.00g152030	Scaffold_06	59547660	59552125	NA	NA	NA	NA	NA
PGEN_.00g152040	Scaffold_06	59554813	59557016	NA	NA	NA	NA	NA
PGEN_.00g152050	Scaffold_06	59559722	59568343	A6H6W9	SDS3_BOVIN	Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog)	GO:0000122; GO:0005634; GO:0006915; GO:0016575; GO:0042826; GO:0043065; GO:0070822	nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; histone deacetylase binding [GO:0042826]; apoptotic process [GO:0006915]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]
PGEN_.00g152060	Scaffold_06	59571873	59585950	Q8BR65	SDS3_MOUSE	Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog)	GO:0000122; GO:0001835; GO:0005634; GO:0005829; GO:0006915; GO:0016575; GO:0016580; GO:0016604; GO:0019899; GO:0042802; GO:0042803; GO:0042826; GO:0043065; GO:0045892; GO:0070822	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; blastocyst hatching [GO:0001835]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]"
PGEN_.00g152070	Scaffold_06	59590602	59592308	NA	NA	NA	NA	NA
PGEN_.00g152080	Scaffold_06	59603177	59603590	NA	NA	NA	NA	NA
PGEN_.00g152090	Scaffold_06	59603630	59616079	Q09324	GCNT1_MOUSE	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT)"	GO:0000139; GO:0003829; GO:0005615; GO:0005802; GO:0006486; GO:0009101; GO:0016021; GO:0031985; GO:0032868; GO:0048729; GO:0050901; GO:0060352; GO:0060993	"extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; protein glycosylation [GO:0006486]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]"
PGEN_.00g152100	Scaffold_06	59658907	59660244	NA	NA	NA	NA	NA
PGEN_.00g152110	Scaffold_06	59671750	59673960	E9QAG8	ZN431_MOUSE	Zinc finger protein 431 (Zinc finger protein 932)	GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872	nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g152120	Scaffold_06	59679965	59686894	P15620	ZN271_MOUSE	Zinc finger protein 271 (Zinc finger protein 35) (Zfp-35)	GO:0000976; GO:0002437; GO:0002829; GO:0005634; GO:0007275; GO:0007283; GO:0030154; GO:0045629; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; multicellular organism development [GO:0007275]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of type 2 immune response [GO:0002829]; spermatogenesis [GO:0007283]
PGEN_.00g152130	Scaffold_06	59702050	59703776	NA	NA	NA	NA	NA
PGEN_.00g152140	Scaffold_06	59711561	59720837	Q9UK13	ZN221_HUMAN	Zinc finger protein 221	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g152150	Scaffold_06	59721159	59724935	Q86Z23	C1QL4_HUMAN	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g152160	Scaffold_06	59756179	59763370	NA	NA	NA	NA	NA
PGEN_.00g152170	Scaffold_06	59792799	59794129	NA	NA	NA	NA	NA
PGEN_.00g152180	Scaffold_06	59799737	59805593	Q8IY37	DHX37_HUMAN	Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37)	GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]"
PGEN_.00g152190	Scaffold_06	59812493	59849607	Q8IY37	DHX37_HUMAN	Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37)	GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]"
PGEN_.00g152200	Scaffold_06	59850152	59871867	Q5ZLD7	VPS53_CHICK	Vacuolar protein sorting-associated protein 53 homolog	GO:0000938; GO:0005802; GO:0005829; GO:0007041; GO:0010008; GO:0015031; GO:0032456; GO:0042147; GO:0048471; GO:0055037; GO:1990745	"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g152210	Scaffold_06	59881196	59899492	NA	NA	NA	NA	NA
PGEN_.00g152220	Scaffold_06	59934384	59969051	Q92176	COR1A_BOVIN	Coronin-1A (Coronin-like protein A) (Clipin-A) (Coronin-like protein p57) (Tryptophan aspartate-containing coat protein) (TACO)	GO:0001772; GO:0001845; GO:0001891; GO:0003785; GO:0005769; GO:0005829; GO:0005884; GO:0005911; GO:0006816; GO:0007015; GO:0008022; GO:0008360; GO:0016477; GO:0030027; GO:0030335; GO:0030424; GO:0030595; GO:0030670; GO:0030864; GO:0031339; GO:0031589; GO:0032036; GO:0032796; GO:0032991; GO:0038180; GO:0042102; GO:0042803; GO:0043029; GO:0043320; GO:0043524; GO:0043548; GO:0048873; GO:0050918; GO:0051015; GO:0051126; GO:0051279; GO:0061502; GO:0071353; GO:0098978	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]
PGEN_.00g152230	Scaffold_06	59997412	59998596	NA	NA	NA	NA	NA
PGEN_.00g152240	Scaffold_06	60033284	60033679	NA	NA	NA	NA	NA
PGEN_.00g152250	Scaffold_06	60039570	60039890	NA	NA	NA	NA	NA
PGEN_.00g152260	Scaffold_06	60086192	60099197	P77735	YAJO_ECOLI	1-deoxyxylulose-5-phosphate synthase YajO (EC 1.1.-.-)	GO:0005829; GO:0006772; GO:0016491	cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772]
PGEN_.00g152270	Scaffold_06	60156262	60179615	NA	NA	NA	NA	NA
PGEN_.00g152280	Scaffold_06	60246167	60246571	NA	NA	NA	NA	NA
PGEN_.00g152290	Scaffold_06	60250713	60256163	NA	NA	NA	NA	NA
PGEN_.00g152300	Scaffold_06	60260304	60260549	B0BN95	HARB1_RAT	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g152310	Scaffold_06	60260843	60262400	NA	NA	NA	NA	NA
PGEN_.00g152320	Scaffold_06	60281246	60282131	NA	NA	NA	NA	NA
PGEN_.00g152330	Scaffold_06	60284829	60286058	Q9Y5Z6	B3GT1_HUMAN	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g152340	Scaffold_06	60309693	60317084	O60494	CUBN_HUMAN	Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]
PGEN_.00g152350	Scaffold_06	60321876	60329126	O60494	CUBN_HUMAN	Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]
PGEN_.00g152360	Scaffold_06	60352576	60353922	Q9Y5Z6	B3GT1_HUMAN	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g152370	Scaffold_06	60356607	60357492	NA	NA	NA	NA	NA
PGEN_.00g152380	Scaffold_06	60376158	60377714	NA	NA	NA	NA	NA
PGEN_.00g152390	Scaffold_06	60382394	60387827	NA	NA	NA	NA	NA
PGEN_.00g152400	Scaffold_06	60388292	60389291	NA	NA	NA	NA	NA
PGEN_.00g152410	Scaffold_06	60391978	60392382	NA	NA	NA	NA	NA
PGEN_.00g152420	Scaffold_06	60476655	60483883	NA	NA	NA	NA	NA
PGEN_.00g152430	Scaffold_06	60543554	60585863	P77735	YAJO_ECOLI	1-deoxyxylulose-5-phosphate synthase YajO (EC 1.1.-.-)	GO:0005829; GO:0006772; GO:0016491	cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772]
PGEN_.00g152440	Scaffold_06	60600835	60601155	NA	NA	NA	NA	NA
PGEN_.00g152450	Scaffold_06	60607043	60607438	NA	NA	NA	NA	NA
PGEN_.00g152460	Scaffold_06	60636709	60753861	Q8WXX7	AUTS2_HUMAN	Autism susceptibility gene 2 protein	GO:0001764; GO:0003682; GO:0005634; GO:0005737; GO:0005856; GO:0010592; GO:0030426; GO:0031532; GO:0035022; GO:0045944; GO:0048675; GO:0051571; GO:0097484; GO:2000620	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g152470	Scaffold_06	60772904	60773443	NA	NA	NA	NA	NA
PGEN_.00g152480	Scaffold_06	60779214	60779414	NA	NA	NA	NA	NA
PGEN_.00g152490	Scaffold_06	60817476	60828186	NA	NA	NA	NA	NA
PGEN_.00g152500	Scaffold_06	60836968	60837381	NA	NA	NA	NA	NA
PGEN_.00g152510	Scaffold_06	60870856	60871101	NA	NA	NA	NA	NA
PGEN_.00g152520	Scaffold_06	60891790	60942793	Q8NFA0	UBP32_HUMAN	Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32)	GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0016020; GO:0016579	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g152530	Scaffold_06	60943594	60944312	NA	NA	NA	NA	NA
PGEN_.00g152540	Scaffold_06	60950578	60965671	Q8NFA0	UBP32_HUMAN	Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32)	GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0016020; GO:0016579	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g152550	Scaffold_06	60969189	60970697	Q923Z3	MTO1_MOUSE	"Protein MTO1 homolog, mitochondrial"	GO:0002098; GO:0005739; GO:0030488; GO:0050660; GO:0070899	mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g152560	Scaffold_06	61013153	61014709	NA	NA	NA	NA	NA
PGEN_.00g152570	Scaffold_06	61016519	61017511	Q5ZMD4	TRI59_CHICK	Tripartite motif-containing protein 59	GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]
PGEN_.00g152580	Scaffold_06	61108939	61130489	Q923Z3	MTO1_MOUSE	"Protein MTO1 homolog, mitochondrial"	GO:0002098; GO:0005739; GO:0030488; GO:0050660; GO:0070899	mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g152590	Scaffold_06	61138289	61149146	Q3ZBL5	PTH2_BOVIN	"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription)"	GO:0004045; GO:0005739; GO:0005829; GO:2000210; GO:2000811	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; negative regulation of anoikis [GO:2000811]; positive regulation of anoikis [GO:2000210]
PGEN_.00g152600	Scaffold_06	61153778	61154541	NA	NA	NA	NA	NA
PGEN_.00g152610	Scaffold_06	61167638	61174231	Q9H9J2	RM44_HUMAN	"39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) (Mitochondrial large ribosomal subunit protein mL44)"	GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0005886; GO:0006396; GO:0030422; GO:0031053; GO:0031054; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; RNA processing [GO:0006396]
PGEN_.00g152620	Scaffold_06	61182059	61217802	Q01484	ANK2_HUMAN	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	GO:0002027; GO:0003283; GO:0005200; GO:0005623; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]"
PGEN_.00g152630	Scaffold_06	61272395	61312080	NA	NA	NA	NA	NA
PGEN_.00g152640	Scaffold_06	61312103	61313074	Q9SAL0	RGLG4_ARATH	E3 ubiquitin-protein ligase RGLG4 (EC 2.3.2.27) (RING domain ligase 4)	GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0009611; GO:0009867; GO:0042742; GO:0046872	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; response to wounding [GO:0009611]
PGEN_.00g152650	Scaffold_06	61326604	61336250	NA	NA	NA	NA	NA
PGEN_.00g152660	Scaffold_06	61343747	61344619	NA	NA	NA	NA	NA
PGEN_.00g152670	Scaffold_06	61349286	61400353	P17972	KCNAW_DROME	Potassium voltage-gated channel protein Shaw (Shaw2)	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]
PGEN_.00g152680	Scaffold_06	61402590	61437197	Q3V0L5	LRC43_MOUSE	Leucine-rich repeat-containing protein 43		
PGEN_.00g152690	Scaffold_06	61439373	61453257	Q5F4A9	AR6P4_CHICK	ADP-ribosylation factor-like protein 6-interacting protein 4 (ARL-6-interacting protein 4) (Aip-4)	GO:0005730; GO:0006397; GO:0008380; GO:0016607	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g152700	Scaffold_06	61455142	61456854	NA	NA	NA	NA	NA
PGEN_.00g152710	Scaffold_06	61471377	61546162	Q9UHV7	MED13_HUMAN	Mediator of RNA polymerase II transcription subunit 13 (Activator-recruited cofactor 250 kDa component) (ARC250) (Mediator complex subunit 13) (Thyroid hormone receptor-associated protein 1) (Thyroid hormone receptor-associated protein complex 240 kDa component) (Trap240) (Vitamin D3 receptor-interacting protein complex component DRIP250) (DRIP250)	GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0016020; GO:0016592; GO:0030374; GO:0042632; GO:0042809; GO:0043433; GO:0045893; GO:0045944; GO:0046966; GO:0070328	"mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; cholesterol homeostasis [GO:0042632]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]; triglyceride homeostasis [GO:0070328]"
PGEN_.00g152720	Scaffold_06	61556990	61710628	Q7X8C5	WAKLB_ARATH	Wall-associated receptor kinase-like 2 (EC 2.7.11.-)	GO:0004674; GO:0005509; GO:0005524; GO:0005886; GO:0009505; GO:0016021; GO:0030247; GO:0046777	integral component of membrane [GO:0016021]; plant-type cell wall [GO:0009505]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; polysaccharide binding [GO:0030247]; protein serine/threonine kinase activity [GO:0004674]; protein autophosphorylation [GO:0046777]
PGEN_.00g152730	Scaffold_06	61721710	61722066	NA	NA	NA	NA	NA
PGEN_.00g152740	Scaffold_06	61728137	61729139	NA	NA	NA	NA	NA
PGEN_.00g152750	Scaffold_06	61743893	61744207	NA	NA	NA	NA	NA
PGEN_.00g152760	Scaffold_07	26023	31112	P0C6X3	R1AB_CVHN2	Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Papain-like proteinase (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.69) (Non-structural protein 3) (nsp3) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); RNA-directed RNA polymerase (Pol) (RdRp) (EC 2.7.7.48) (nsp12) (p100); Helicase (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (nsp13) (p67); Guanine-N7 methyltransferase (ExoN) (EC 2.1.1.-) (EC 3.1.13.-) (nsp14); Uridylate-specific endoribonuclease (EC 3.1.-.-) (NendoU) (nsp15) (p35); 2'-O-methyltransferase (EC 2.1.1.-) (nsp16)]	GO:0003678; GO:0003723; GO:0003724; GO:0003968; GO:0004197; GO:0004519; GO:0005524; GO:0006351; GO:0008168; GO:0008242; GO:0008270; GO:0016021; GO:0016896; GO:0019079; GO:0019082; GO:0032259; GO:0033644; GO:0036459; GO:0039502; GO:0039520; GO:0039579; GO:0039595; GO:0039644; GO:0039648; GO:0044172; GO:0044220	"host cell endoplasmic reticulum-Golgi intermediate compartment [GO:0044172]; host cell membrane [GO:0033644]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; cysteine-type endopeptidase activity [GO:0004197]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; methyltransferase activity [GO:0008168]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; induction by virus of catabolism of host mRNA [GO:0039595]; induction by virus of host autophagy [GO:0039520]; methylation [GO:0032259]; modulation by virus of host protein ubiquitination [GO:0039648]; suppression by virus of host ISG15 activity [GO:0039579]; suppression by virus of host NF-kappaB transcription factor activity [GO:0039644]; suppression by virus of host type I interferon-mediated signaling pathway [GO:0039502]; transcription, DNA-templated [GO:0006351]; viral genome replication [GO:0019079]; viral protein processing [GO:0019082]"
PGEN_.00g152770	Scaffold_07	31420	32012	NA	NA	NA	NA	NA
PGEN_.00g152780	Scaffold_07	32061	32932	NA	NA	NA	NA	NA
PGEN_.00g152790	Scaffold_07	33173	33598	NA	NA	NA	NA	NA
PGEN_.00g152800	Scaffold_07	42524	46534	NA	NA	NA	NA	NA
PGEN_.00g152810	Scaffold_07	72218	96948	O75152	ZC11A_HUMAN	Zinc finger CCCH domain-containing protein 11A	GO:0003723; GO:0003729; GO:0005654; GO:0006405; GO:0006406; GO:0016973; GO:0031124; GO:0046872	nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA export from nucleus [GO:0006405]
PGEN_.00g152820	Scaffold_07	101462	103045	NA	NA	NA	NA	NA
PGEN_.00g152830	Scaffold_07	105520	105768	Q7ZW02	CHPT1_DANRE	Cholinephosphotransferase 1 (EC 2.7.8.2) (Diacylglycerol cholinephosphotransferase 1)	GO:0000139; GO:0004142; GO:0005789; GO:0005794; GO:0016021; GO:0016780; GO:0046872	"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"
PGEN_.00g152840	Scaffold_07	128172	130717	Q7ZYQ3	CEPT1_XENLA	Choline/ethanolaminephosphotransferase 1 (EC 2.7.8.1) (EC 2.7.8.2)	GO:0004142; GO:0004307; GO:0005789; GO:0006646; GO:0016021; GO:0031965; GO:0046872	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphatidylethanolamine biosynthetic process [GO:0006646]
PGEN_.00g152850	Scaffold_07	143508	150185	Q2TBS4	PIFO_BOVIN	Protein pitchfork	GO:0005802; GO:0030030; GO:0031344; GO:0031410; GO:0033674; GO:0036064	ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; cell projection organization [GO:0030030]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344]
PGEN_.00g152860	Scaffold_07	150249	178478	Q641G4	CNDH2_XENLA	Condensin-2 complex subunit H2 (Non-SMC condensin II complex subunit H2)	GO:0005634; GO:0030261	nucleus [GO:0005634]; chromosome condensation [GO:0030261]
PGEN_.00g152870	Scaffold_07	188636	189031	NA	NA	NA	NA	NA
PGEN_.00g152880	Scaffold_07	189403	189693	NA	NA	NA	NA	NA
PGEN_.00g152890	Scaffold_07	189745	190110	NA	NA	NA	NA	NA
PGEN_.00g152900	Scaffold_07	249541	253365	NA	NA	NA	NA	NA
PGEN_.00g152910	Scaffold_07	259724	265237	Q76KA3	RL32_MACFA	60S ribosomal protein L32	GO:0003735; GO:0005840; GO:0006412	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g152920	Scaffold_07	268487	271602	Q5PQ71	ISOC2_XENLA	Isochorismatase domain-containing protein 2	GO:0003824	catalytic activity [GO:0003824]
PGEN_.00g152930	Scaffold_07	274109	298859	P56201	G6PE_RABIT	GDH/6PGL endoplasmic bifunctional protein [Includes: Glucose 1-dehydrogenase (EC 1.1.1.47) (Glucose-6-phosphate dehydrogenase) (EC 1.1.1.363); 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)]	GO:0004345; GO:0005788; GO:0006006; GO:0006098; GO:0017057; GO:0047936; GO:0050661	endoplasmic reticulum lumen [GO:0005788]; 6-phosphogluconolactonase activity [GO:0017057]; glucose 1-dehydrogenase [NAD(P)] activity [GO:0047936]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]
PGEN_.00g152940	Scaffold_07	316171	364097	Q9WVE8	PACN2_MOUSE	Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II) (SdpII)	GO:0005543; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005911; GO:0007010; GO:0007165; GO:0008092; GO:0008289; GO:0016607; GO:0019898; GO:0030036; GO:0030659; GO:0032587; GO:0036010; GO:0042802; GO:0043231; GO:0045806; GO:0048858; GO:0050804; GO:0055038; GO:0070300; GO:0070836; GO:0072584; GO:0097320; GO:0098978	caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]
PGEN_.00g152950	Scaffold_07	378122	433806	B1H349	SOX6_XENTR	Transcription factor Sox-6 (SRY (sex determining region Y)-box 6)	GO:0003677; GO:0005634; GO:0007275; GO:0032332; GO:0045165; GO:0045892; GO:0045944	"nucleus [GO:0005634]; DNA binding [GO:0003677]; cell fate commitment [GO:0045165]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g152960	Scaffold_07	444429	444821	NA	NA	NA	NA	NA
PGEN_.00g152970	Scaffold_07	563395	613824	O70511	ANK3_RAT	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045838; GO:0050808; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g152980	Scaffold_07	614568	648435	A5D7L5	S39AE_BOVIN	Zinc transporter ZIP14 (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14)	GO:0005384; GO:0005385; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006882; GO:0015093; GO:0030027; GO:0071577; GO:0071578	cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ferrous iron transmembrane transporter activity [GO:0015093]; manganese ion transmembrane transporter activity [GO:0005384]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]
PGEN_.00g152990	Scaffold_07	683267	683788	P12812	P40_SCHMA	Major egg antigen (p40)		
PGEN_.00g153000	Scaffold_07	701356	712898	P27701	CD82_HUMAN	CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82)	GO:0005886; GO:0005887; GO:0070062	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]
PGEN_.00g153010	Scaffold_07	717557	718351	NA	NA	NA	NA	NA
PGEN_.00g153020	Scaffold_07	723813	760289	Q9UPZ3	HPS5_HUMAN	Hermansky-Pudlak syndrome 5 protein (Alpha-integrin-binding protein 63) (Ruby-eye protein 2 homolog) (Ru2)	GO:0006996; GO:0007596; GO:0031084; GO:0043473	BLOC-2 complex [GO:0031084]; blood coagulation [GO:0007596]; organelle organization [GO:0006996]; pigmentation [GO:0043473]
PGEN_.00g153030	Scaffold_07	768616	772540	NA	NA	NA	NA	NA
PGEN_.00g153040	Scaffold_07	813439	813747	NA	NA	NA	NA	NA
PGEN_.00g153050	Scaffold_07	813812	814882	NA	NA	NA	NA	NA
PGEN_.00g153060	Scaffold_07	875779	880682	Q2HZX7	FUZZY_XENTR	Protein fuzzy homolog (Xfy)	GO:0001736; GO:0001843; GO:0005737; GO:0005856; GO:0008589; GO:0010172; GO:0015031; GO:0042995; GO:0048704; GO:0060271	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; neural tube closure [GO:0001843]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]
PGEN_.00g153070	Scaffold_07	888967	892246	NA	NA	NA	NA	NA
PGEN_.00g153080	Scaffold_07	892352	924270	Q9UPZ3	HPS5_HUMAN	Hermansky-Pudlak syndrome 5 protein (Alpha-integrin-binding protein 63) (Ruby-eye protein 2 homolog) (Ru2)	GO:0006996; GO:0007596; GO:0031084; GO:0043473	BLOC-2 complex [GO:0031084]; blood coagulation [GO:0007596]; organelle organization [GO:0006996]; pigmentation [GO:0043473]
PGEN_.00g153090	Scaffold_07	929731	930168	NA	NA	NA	NA	NA
PGEN_.00g153100	Scaffold_07	930246	930644	NA	NA	NA	NA	NA
PGEN_.00g153110	Scaffold_07	935802	948345	A1L157	TSN11_HUMAN	Tetraspanin-11 (Tspan-11)	GO:0005887; GO:0016477	integral component of plasma membrane [GO:0005887]; cell migration [GO:0016477]
PGEN_.00g153120	Scaffold_07	965633	966154	P12812	P40_SCHMA	Major egg antigen (p40)		
PGEN_.00g153130	Scaffold_07	1001768	1036411	A5D7L5	S39AE_BOVIN	Zinc transporter ZIP14 (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14)	GO:0005384; GO:0005385; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006882; GO:0015093; GO:0030027; GO:0071577; GO:0071578	cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ferrous iron transmembrane transporter activity [GO:0015093]; manganese ion transmembrane transporter activity [GO:0005384]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]
PGEN_.00g153140	Scaffold_07	1037155	1079880	Q12955	ANK3_HUMAN	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]"
PGEN_.00g153150	Scaffold_07	1208514	1208906	NA	NA	NA	NA	NA
PGEN_.00g153160	Scaffold_07	1238241	1246304	NA	NA	NA	NA	NA
PGEN_.00g153170	Scaffold_07	1261340	1274644	B1H349	SOX6_XENTR	Transcription factor Sox-6 (SRY (sex determining region Y)-box 6)	GO:0003677; GO:0005634; GO:0007275; GO:0032332; GO:0045165; GO:0045892; GO:0045944	"nucleus [GO:0005634]; DNA binding [GO:0003677]; cell fate commitment [GO:0045165]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g153180	Scaffold_07	1285510	1374640	Q9WVE8	PACN2_MOUSE	Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II) (SdpII)	GO:0005543; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005911; GO:0007010; GO:0007165; GO:0008092; GO:0008289; GO:0016607; GO:0019898; GO:0030036; GO:0030659; GO:0032587; GO:0036010; GO:0042802; GO:0043231; GO:0045806; GO:0048858; GO:0050804; GO:0055038; GO:0070300; GO:0070836; GO:0072584; GO:0097320; GO:0098978	caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]
PGEN_.00g153190	Scaffold_07	1374686	1377799	Q5PQ71	ISOC2_XENLA	Isochorismatase domain-containing protein 2	GO:0003824	catalytic activity [GO:0003824]
PGEN_.00g153200	Scaffold_07	1381056	1386539	Q76KA3	RL32_MACFA	60S ribosomal protein L32	GO:0003735; GO:0005840; GO:0006412	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g153210	Scaffold_07	1393132	1396966	NA	NA	NA	NA	NA
PGEN_.00g153220	Scaffold_07	1456410	1456775	NA	NA	NA	NA	NA
PGEN_.00g153230	Scaffold_07	1456827	1457117	NA	NA	NA	NA	NA
PGEN_.00g153240	Scaffold_07	1457489	1457884	NA	NA	NA	NA	NA
PGEN_.00g153250	Scaffold_07	1468021	1495966	Q641G4	CNDH2_XENLA	Condensin-2 complex subunit H2 (Non-SMC condensin II complex subunit H2)	GO:0005634; GO:0030261	nucleus [GO:0005634]; chromosome condensation [GO:0030261]
PGEN_.00g153260	Scaffold_07	1496030	1502770	Q2TBS4	PIFO_BOVIN	Protein pitchfork	GO:0005802; GO:0030030; GO:0031344; GO:0031410; GO:0033674; GO:0036064	ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; cell projection organization [GO:0030030]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344]
PGEN_.00g153270	Scaffold_07	1515548	1518951	Q7ZYQ3	CEPT1_XENLA	Choline/ethanolaminephosphotransferase 1 (EC 2.7.8.1) (EC 2.7.8.2)	GO:0004142; GO:0004307; GO:0005789; GO:0006646; GO:0016021; GO:0031965; GO:0046872	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphatidylethanolamine biosynthetic process [GO:0006646]
PGEN_.00g153280	Scaffold_07	1540975	1541223	Q7ZW02	CHPT1_DANRE	Cholinephosphotransferase 1 (EC 2.7.8.2) (Diacylglycerol cholinephosphotransferase 1)	GO:0000139; GO:0004142; GO:0005789; GO:0005794; GO:0016021; GO:0016780; GO:0046872	"endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"
PGEN_.00g153290	Scaffold_07	1543698	1545494	NA	NA	NA	NA	NA
PGEN_.00g153300	Scaffold_07	1549548	1575197	O75152	ZC11A_HUMAN	Zinc finger CCCH domain-containing protein 11A	GO:0003723; GO:0003729; GO:0005654; GO:0006405; GO:0006406; GO:0016973; GO:0031124; GO:0046872	nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA export from nucleus [GO:0006405]
PGEN_.00g153310	Scaffold_07	1602947	1607561	NA	NA	NA	NA	NA
PGEN_.00g153320	Scaffold_07	1616381	1616806	NA	NA	NA	NA	NA
PGEN_.00g153330	Scaffold_07	1617047	1618085	NA	NA	NA	NA	NA
PGEN_.00g153340	Scaffold_07	1617967	1619340	NA	NA	NA	NA	NA
PGEN_.00g153350	Scaffold_07	1618867	1623944	P0C6X3	R1AB_CVHN2	Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Papain-like proteinase (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.69) (Non-structural protein 3) (nsp3) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); RNA-directed RNA polymerase (Pol) (RdRp) (EC 2.7.7.48) (nsp12) (p100); Helicase (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (nsp13) (p67); Guanine-N7 methyltransferase (ExoN) (EC 2.1.1.-) (EC 3.1.13.-) (nsp14); Uridylate-specific endoribonuclease (EC 3.1.-.-) (NendoU) (nsp15) (p35); 2'-O-methyltransferase (EC 2.1.1.-) (nsp16)]	GO:0003678; GO:0003723; GO:0003724; GO:0003968; GO:0004197; GO:0004519; GO:0005524; GO:0006351; GO:0008168; GO:0008242; GO:0008270; GO:0016021; GO:0016896; GO:0019079; GO:0019082; GO:0032259; GO:0033644; GO:0036459; GO:0039502; GO:0039520; GO:0039579; GO:0039595; GO:0039644; GO:0039648; GO:0044172; GO:0044220	"host cell endoplasmic reticulum-Golgi intermediate compartment [GO:0044172]; host cell membrane [GO:0033644]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; cysteine-type endopeptidase activity [GO:0004197]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; methyltransferase activity [GO:0008168]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; induction by virus of catabolism of host mRNA [GO:0039595]; induction by virus of host autophagy [GO:0039520]; methylation [GO:0032259]; modulation by virus of host protein ubiquitination [GO:0039648]; suppression by virus of host ISG15 activity [GO:0039579]; suppression by virus of host NF-kappaB transcription factor activity [GO:0039644]; suppression by virus of host type I interferon-mediated signaling pathway [GO:0039502]; transcription, DNA-templated [GO:0006351]; viral genome replication [GO:0019079]; viral protein processing [GO:0019082]"
PGEN_.00g153360	Scaffold_07	1651557	1667456	O55055	TRDMT_MOUSE	tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2) (DNA methyltransferase homolog MmuIIP) (DNA MTase homolog MmuIIP) (M.MmuIIP) (Met-2)	GO:0001975; GO:0003723; GO:0005737; GO:0008175; GO:0016428; GO:0030488; GO:0036416	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA methyltransferase activity [GO:0008175]; response to amphetamine [GO:0001975]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]
PGEN_.00g153370	Scaffold_07	1680118	1719148	Q60738	ZNT1_MOUSE	Zinc transporter 1 (ZnT-1) (Solute carrier family 30 member 1)	GO:0001701; GO:0005385; GO:0005623; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006829; GO:0006874; GO:0006882; GO:0016021; GO:0019855; GO:0030315; GO:0031965; GO:0046929; GO:0070509; GO:0070574; GO:0071584; GO:0071585; GO:0090281; GO:0098685; GO:0099061	cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transport [GO:0006829]
PGEN_.00g153380	Scaffold_07	1728516	1739501	P61313	RL15_HUMAN	60S ribosomal protein L15 (Large ribosomal subunit protein eL15)	GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0031672; GO:0045296; GO:0045471	"A band [GO:0031672]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to ethanol [GO:0045471]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
PGEN_.00g153390	Scaffold_07	1753982	1754305	NA	NA	NA	NA	NA
PGEN_.00g153400	Scaffold_07	1770475	1820684	NA	NA	NA	NA	NA
PGEN_.00g153410	Scaffold_07	1891313	1892326	NA	NA	NA	NA	NA
PGEN_.00g153420	Scaffold_07	1915409	1935590	Q5RI75	RASEF_MOUSE	Ras and EF-hand domain-containing protein homolog	GO:0003924; GO:0005525; GO:0005829; GO:0019003; GO:0042802; GO:0048471; GO:0051260	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homooligomerization [GO:0051260]
PGEN_.00g153430	Scaffold_07	1935646	1936029	Q8I335	GUF1_PLAF7	"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)"	GO:0003924; GO:0005525; GO:0005743; GO:0006412	mitochondrial inner membrane [GO:0005743]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation [GO:0006412]
PGEN_.00g153440	Scaffold_07	1957825	2067352	O77245	E75_METEN	Nuclear hormone receptor E75 (Nuclear receptor subfamily 1 group D member 3)	GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]
PGEN_.00g153450	Scaffold_07	2089545	2102507	Q9HB07	MYG1_HUMAN	"UPF0160 protein MYG1, mitochondrial"	GO:0005634; GO:0005654; GO:0005739; GO:0035641	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; locomotory exploration behavior [GO:0035641]
PGEN_.00g153460	Scaffold_07	2103690	2108305	Q58DG1	MYG1_BOVIN	"UPF0160 protein MYG1, mitochondrial"	GO:0005634; GO:0005654; GO:0005739; GO:0035641	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; locomotory exploration behavior [GO:0035641]
PGEN_.00g153470	Scaffold_07	2118876	2128367	P61963	DCAF7_MOUSE	DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog)	GO:0005634; GO:0005654; GO:0005829; GO:0007275; GO:0016363; GO:0016567; GO:0016604; GO:0032991; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]
PGEN_.00g153480	Scaffold_07	2147612	2173400	I0IUP4	MCM9_CHICK	DNA helicase MCM9 (EC 3.6.4.12) (Minichromosome maintenance 9)	GO:0000724; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0006974; GO:0042555; GO:0097362	MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]; double-strand break repair via homologous recombination [GO:0000724]
PGEN_.00g153490	Scaffold_07	2194098	2203853	F6RIX4	MCM9_XENTR	DNA helicase MCM9 (EC 3.6.4.12) (Minichromosome maintenance 9)	GO:0000724; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0006974; GO:0042555; GO:0097362	MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]; double-strand break repair via homologous recombination [GO:0000724]
PGEN_.00g153500	Scaffold_07	2210222	2220526	NA	NA	NA	NA	NA
PGEN_.00g153510	Scaffold_07	2223515	2237152	Q6RY07	CHIA_RAT	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14)	GO:0000272; GO:0001878; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0019900; GO:0052356; GO:0090197	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; kinase binding [GO:0019900]; apoptotic process [GO:0006915]; catabolism by host of symbiont cell wall chitin [GO:0052356]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]; response to yeast [GO:0001878]
PGEN_.00g153520	Scaffold_07	2244026	2260966	Q6RY07	CHIA_RAT	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14)	GO:0000272; GO:0001878; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0019900; GO:0052356; GO:0090197	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; kinase binding [GO:0019900]; apoptotic process [GO:0006915]; catabolism by host of symbiont cell wall chitin [GO:0052356]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]; response to yeast [GO:0001878]
PGEN_.00g153530	Scaffold_07	2286010	2293469	Q3BJS1	FOXN4_XENLA	Forkhead box protein N4	GO:0001158; GO:0001947; GO:0003682; GO:0003700; GO:0005634; GO:0006355; GO:0008016; GO:0010842; GO:0035881; GO:0036302; GO:0043565; GO:0045893; GO:0060579	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; sequence-specific DNA binding [GO:0043565]; amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; heart looping [GO:0001947]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of heart contraction [GO:0008016]; regulation of transcription, DNA-templated [GO:0006355]; retina layer formation [GO:0010842]; ventral spinal cord interneuron fate commitment [GO:0060579]"
PGEN_.00g153540	Scaffold_07	2299118	2323442	Q6DF30	DHDH_XENTR	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)"	GO:0042843; GO:0047115; GO:0047837	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; D-xylose catabolic process [GO:0042843]"
PGEN_.00g153550	Scaffold_07	2317994	2318239	NA	NA	NA	NA	NA
PGEN_.00g153560	Scaffold_07	2318505	2318801	NA	NA	NA	NA	NA
PGEN_.00g153570	Scaffold_07	2320161	2320427	NA	NA	NA	NA	NA
PGEN_.00g153580	Scaffold_07	2326054	2404467	Q3UCV8	OTUL_MOUSE	Ubiquitin thioesterase otulin (EC 3.4.19.12) (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)	GO:0002040; GO:0004843; GO:0005737; GO:0008234; GO:0010803; GO:0016055; GO:0032088; GO:0045087; GO:0050728; GO:0060828; GO:0070431; GO:1990108	cytoplasm [GO:0005737]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]
PGEN_.00g153590	Scaffold_07	2328665	2328967	NA	NA	NA	NA	NA
PGEN_.00g153600	Scaffold_07	2513910	2548015	P54145	AMT1_CAEEL	Putative ammonium transporter 1	GO:0005887; GO:0008519; GO:0072488	integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]
PGEN_.00g153610	Scaffold_07	2568744	2581892	NA	NA	NA	NA	NA
PGEN_.00g153620	Scaffold_07	2589699	2591872	NA	NA	NA	NA	NA
PGEN_.00g153630	Scaffold_07	2623604	2643343	Q63150	DPYS_RAT	Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase)	GO:0002058; GO:0002059; GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0008270; GO:0016597; GO:0016812; GO:0019482; GO:0019860; GO:0042802; GO:0051219; GO:0051289	"cytosol [GO:0005829]; amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]; beta-alanine metabolic process [GO:0019482]; protein homotetramerization [GO:0051289]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860]"
PGEN_.00g153640	Scaffold_07	2652224	2674495	B0BM39	TSN9_XENTR	Tetraspanin-9 (Tspan-9)	GO:0005887	integral component of plasma membrane [GO:0005887]
PGEN_.00g153650	Scaffold_07	2687033	2716548	NA	NA	NA	NA	NA
PGEN_.00g153660	Scaffold_07	2716684	2732231	A6H782	TEKT3_BOVIN	Tektin-3	GO:0002080; GO:0002081; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378	acrosomal membrane [GO:0002080]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378]
PGEN_.00g153670	Scaffold_07	2737119	2746466	NA	NA	NA	NA	NA
PGEN_.00g153680	Scaffold_07	2758769	2766132	A4QN56	MFS4B_DANRE	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g153690	Scaffold_07	2786607	2792090	Q6NV04	ILVBL_DANRE	Acetolactate synthase-like protein (EC 2.2.1.-) (IlvB-like protein)	GO:0000287; GO:0016021; GO:0016740; GO:0030976; GO:0048701	integral component of membrane [GO:0016021]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; transferase activity [GO:0016740]; embryonic cranial skeleton morphogenesis [GO:0048701]
PGEN_.00g153700	Scaffold_07	2798757	2829342	E2RDZ6	SIR5_CANLF	"NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 2.3.1.-) (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5)"	GO:0005634; GO:0005739; GO:0005829; GO:0008270; GO:0010566; GO:0016740; GO:0034979; GO:0036046; GO:0036048; GO:0036054; GO:0036055; GO:0070403	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]
PGEN_.00g153710	Scaffold_07	2830040	2830342	NA	NA	NA	NA	NA
PGEN_.00g153720	Scaffold_07	2831104	2831748	NA	NA	NA	NA	NA
PGEN_.00g153730	Scaffold_07	2834185	2840410	NA	NA	NA	NA	NA
PGEN_.00g153740	Scaffold_07	2858701	2859327	P17644	ACH2_DROME	Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2)	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g153750	Scaffold_07	2871197	2872846	NA	NA	NA	NA	NA
PGEN_.00g153760	Scaffold_07	2876892	2878136	P54131	ACHA7_BOVIN	Neuronal acetylcholine receptor subunit alpha-7	GO:0000187; GO:0001540; GO:0001666; GO:0005623; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890	"acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g153770	Scaffold_07	2903579	2904865	P54131	ACHA7_BOVIN	Neuronal acetylcholine receptor subunit alpha-7	GO:0000187; GO:0001540; GO:0001666; GO:0005623; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890	"acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g153780	Scaffold_07	2907550	2907834	NA	NA	NA	NA	NA
PGEN_.00g153790	Scaffold_07	2927734	2955205	Q91618	PMYT1_XENLA	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase)	GO:0000139; GO:0004674; GO:0005524; GO:0005789; GO:0007049; GO:0010923; GO:0046872	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g153800	Scaffold_07	2962471	2964342	Q5ZL34	CPSF6_CHICK	Cleavage and polyadenylation specificity factor subunit 6	GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005849; GO:0006397; GO:0016607; GO:0035061; GO:0042382; GO:0046833; GO:0051290; GO:0110104; GO:1990120	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; mRNA binding [GO:0003729]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]
PGEN_.00g153810	Scaffold_07	2965734	2987644	NA	NA	NA	NA	NA
PGEN_.00g153820	Scaffold_07	2992471	2992716	NA	NA	NA	NA	NA
PGEN_.00g153830	Scaffold_07	3007901	3008419	Q8N474	SFRP1_HUMAN	Secreted frizzled-related protein 1 (FRP-1) (sFRP-1) (Secreted apoptosis-related protein 2) (SARP-2)	GO:0001649; GO:0001657; GO:0001954; GO:0002244; GO:0004197; GO:0005109; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0008144; GO:0008201; GO:0008284; GO:0008285; GO:0008584; GO:0008585; GO:0009267; GO:0009950; GO:0009986; GO:0010564; GO:0010629; GO:0010719; GO:0010975; GO:0014034; GO:0014070; GO:0017147; GO:0030177; GO:0030178; GO:0030279; GO:0030307; GO:0030308; GO:0030336; GO:0030514; GO:0033689; GO:0035019; GO:0035567; GO:0042493; GO:0042802; GO:0043065; GO:0043066; GO:0043508; GO:0043547; GO:0044344; GO:0044345; GO:0045578; GO:0045600; GO:0045668; GO:0045671; GO:0045765; GO:0045880; GO:0045892; GO:0045893; GO:0046676; GO:0046851; GO:0048147; GO:0048546; GO:0050679; GO:0050680; GO:0050732; GO:0051496; GO:0051894; GO:0060070; GO:0060218; GO:0060346; GO:0060527; GO:0060687; GO:0060766; GO:0062023; GO:0070062; GO:0071305; GO:0071347; GO:0071356; GO:0071363; GO:0071380; GO:0071391; GO:0071392; GO:0071456; GO:0071481; GO:0071504; GO:0071542; GO:0071560; GO:0071773; GO:0090090; GO:0090179; GO:0090244; GO:0090246; GO:0090263; GO:1902043; GO:1904956; GO:2000041; GO:2000052; GO:2000054; GO:2000080; GO:2000270; GO:2000271	"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; drug binding [GO:0008144]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147]; bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cellular response to BMP stimulus [GO:0071773]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heparin [GO:0071504]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cellular response to X-ray [GO:0071481]; convergent extension involved in somitogenesis [GO:0090246]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; male gonad development [GO:0008584]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone remodeling [GO:0046851]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000080]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; neural crest cell fate commitment [GO:0014034]; non-canonical Wnt signaling pathway [GO:0035567]; osteoblast differentiation [GO:0001649]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of angiogenesis [GO:0045765]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell cycle process [GO:0010564]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; somatic stem cell population maintenance [GO:0035019]; stromal-epithelial cell signaling involved in prostate gland development [GO:0044345]; ureteric bud development [GO:0001657]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g153840	Scaffold_07	3025459	3026276	NA	NA	NA	NA	NA
PGEN_.00g153850	Scaffold_07	3026313	3026859	NA	NA	NA	NA	NA
PGEN_.00g153860	Scaffold_07	3028519	3059992	Q8C4U3	SFRP1_MOUSE	Secreted frizzled-related protein 1 (sFRP-1)	GO:0001649; GO:0001657; GO:0001756; GO:0001843; GO:0002244; GO:0004197; GO:0005109; GO:0005615; GO:0005829; GO:0005886; GO:0008144; GO:0008201; GO:0008284; GO:0008285; GO:0008584; GO:0008585; GO:0009267; GO:0009950; GO:0009952; GO:0009986; GO:0010564; GO:0010629; GO:0010719; GO:0010975; GO:0014034; GO:0014070; GO:0017147; GO:0021915; GO:0030036; GO:0030097; GO:0030177; GO:0030178; GO:0030278; GO:0030279; GO:0030307; GO:0030308; GO:0030336; GO:0030514; GO:0033689; GO:0034446; GO:0035019; GO:0035567; GO:0042493; GO:0042802; GO:0043065; GO:0043066; GO:0043508; GO:0044344; GO:0044345; GO:0045578; GO:0045600; GO:0045668; GO:0045671; GO:0045880; GO:0045892; GO:0045893; GO:0046546; GO:0046676; GO:0046851; GO:0048147; GO:0048546; GO:0050679; GO:0050680; GO:0050732; GO:0060070; GO:0060071; GO:0060218; GO:0060346; GO:0060527; GO:0060687; GO:0060766; GO:0062023; GO:0071305; GO:0071347; GO:0071356; GO:0071363; GO:0071380; GO:0071391; GO:0071392; GO:0071456; GO:0071481; GO:0071504; GO:0071542; GO:0071560; GO:0071773; GO:0090090; GO:0090175; GO:0090179; GO:0090244; GO:0090246; GO:0090263; GO:1902043; GO:1904956; GO:2000041; GO:2000052; GO:2000054; GO:2000080; GO:2000270; GO:2000271; GO:2001238	"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; drug binding [GO:0008144]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147]; actin cytoskeleton organization [GO:0030036]; anterior/posterior pattern specification [GO:0009952]; bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cellular response to BMP stimulus [GO:0071773]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heparin [GO:0071504]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cellular response to X-ray [GO:0071481]; convergent extension involved in somitogenesis [GO:0090246]; development of primary male sexual characteristics [GO:0046546]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; male gonad development [GO:0008584]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone remodeling [GO:0046851]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000080]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; neural crest cell fate commitment [GO:0014034]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; non-canonical Wnt signaling pathway [GO:0035567]; osteoblast differentiation [GO:0001649]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell cycle process [GO:0010564]; regulation of establishment of planar polarity [GO:0090175]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; regulation of ossification [GO:0030278]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stromal-epithelial cell signaling involved in prostate gland development [GO:0044345]; substrate adhesion-dependent cell spreading [GO:0034446]; ureteric bud development [GO:0001657]; Wnt signaling pathway involved in somitogenesis [GO:0090244]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g153870	Scaffold_07	3044170	3044664	NA	NA	NA	NA	NA
PGEN_.00g153880	Scaffold_07	3077683	3091667	C0HKD9	MFA1B_MOUSE	Microfibrillar-associated protein 1B (Spliceosome B complex protein MFAP1B)	GO:0000398; GO:0001527; GO:0005634; GO:0005654; GO:0005813; GO:0062023; GO:0071005	"centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; microfibril [GO:0001527]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g153890	Scaffold_07	3094483	3117972	NA	NA	NA	NA	NA
PGEN_.00g153900	Scaffold_07	3152401	3177336	Q6ZMV9	KIF6_HUMAN	Kinesin-like protein KIF6	GO:0001673; GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; male germ cell nucleus [GO:0001673]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g153910	Scaffold_07	3178592	3184159	Q6ZMV9	KIF6_HUMAN	Kinesin-like protein KIF6	GO:0001673; GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; male germ cell nucleus [GO:0001673]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g153920	Scaffold_07	3194725	3196318	Q400C7	AMZ2_RAT	Archaemetzincin-2 (EC 3.4.-.-) (Archeobacterial metalloproteinase-like protein 2)	GO:0008237; GO:0046872	metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]
PGEN_.00g153930	Scaffold_07	3201111	3202401	Q3TTI8	TEX52_MOUSE	Testis-expressed protein 52		
PGEN_.00g153940	Scaffold_07	3207185	3215251	NA	NA	NA	NA	NA
PGEN_.00g153950	Scaffold_07	3225396	3247917	Q9VFC8	GYS_DROME	Glycogen [starch] synthase (EC 2.4.1.11) (Glycogen synthase)	GO:0004373; GO:0005737; GO:0005776; GO:0005977; GO:0005978; GO:0009267; GO:0009744; GO:0031410; GO:0045819; GO:0061723; GO:0071329	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; glycogen (starch) synthase activity [GO:0004373]; cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; positive regulation of glycogen catabolic process [GO:0045819]; response to sucrose [GO:0009744]
PGEN_.00g153960	Scaffold_07	3248051	3264644	A2RRU1	GYS1_RAT	"Glycogen [starch] synthase, muscle (EC 2.4.1.11)"	GO:0004373; GO:0005536; GO:0005737; GO:0005977; GO:0005978; GO:0007507; GO:0016234; GO:0019901; GO:0061547	"cytoplasm [GO:0005737]; inclusion body [GO:0016234]; glucose binding [GO:0005536]; glycogen (starch) synthase activity [GO:0004373]; glycogen synthase activity, transferring glucose-1-phosphate [GO:0061547]; protein kinase binding [GO:0019901]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; heart development [GO:0007507]"
PGEN_.00g153970	Scaffold_07	3265365	3265769	NA	NA	NA	NA	NA
PGEN_.00g153980	Scaffold_07	3266037	3266333	NA	NA	NA	NA	NA
PGEN_.00g153990	Scaffold_07	3266578	3266931	NA	NA	NA	NA	NA
PGEN_.00g154000	Scaffold_07	3267094	3267426	NA	NA	NA	NA	NA
PGEN_.00g154010	Scaffold_07	3267514	3268059	NA	NA	NA	NA	NA
PGEN_.00g154020	Scaffold_07	3304719	3318912	Q91V51	TTLL1_MOUSE	Probable tubulin polyglutamylase TTLL1 (EC 6.-.-.-) (Tubulin polyglutamylase complex subunit 3) (PGs3) (Tubulin--tyrosine ligase-like protein 1) (p49)	GO:0003351; GO:0005524; GO:0005576; GO:0005829; GO:0005874; GO:0007288; GO:0018095; GO:0021702; GO:0035082; GO:0070740; GO:1905419	cytosol [GO:0005829]; extracellular region [GO:0005576]; microtubule [GO:0005874]; ATP binding [GO:0005524]; tubulin-glutamic acid ligase activity [GO:0070740]; axoneme assembly [GO:0035082]; cerebellar Purkinje cell differentiation [GO:0021702]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; sperm flagellum movement involved in flagellated sperm motility [GO:1905419]
PGEN_.00g154030	Scaffold_07	3327103	3334134	B5DEL3	TTC17_RAT	Tetratricopeptide repeat protein 17 (TPR repeat protein 17)	GO:0005737; GO:0005829; GO:0005886; GO:0015629; GO:0030041; GO:0044782	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]
PGEN_.00g154040	Scaffold_07	3334726	3394353	E7F211	TTC17_DANRE	Tetratricopeptide repeat protein 17 (TPR repeat protein 17)	GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]
PGEN_.00g154050	Scaffold_07	3406644	3407260	NA	NA	NA	NA	NA
PGEN_.00g154060	Scaffold_07	3413043	3516761	Q8C8U0	LIPB1_MOUSE	Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1)		
PGEN_.00g154070	Scaffold_07	3498834	3499917	NA	NA	NA	NA	NA
PGEN_.00g154080	Scaffold_07	3544399	3546040	Q86W92	LIPB1_HUMAN	Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2)	GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0045296	cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]
PGEN_.00g154090	Scaffold_07	3603854	3606825	NA	NA	NA	NA	NA
PGEN_.00g154100	Scaffold_07	3628311	3630908	NA	NA	NA	NA	NA
PGEN_.00g154110	Scaffold_07	3637902	3638222	NA	NA	NA	NA	NA
PGEN_.00g154120	Scaffold_07	3642638	3653244	NA	NA	NA	NA	NA
PGEN_.00g154130	Scaffold_07	3684412	3691093	NA	NA	NA	NA	NA
PGEN_.00g154140	Scaffold_07	3720326	3721598	NA	NA	NA	NA	NA
PGEN_.00g154150	Scaffold_07	3726831	3731897	NA	NA	NA	NA	NA
PGEN_.00g154160	Scaffold_07	3771897	3777483	NA	NA	NA	NA	NA
PGEN_.00g154170	Scaffold_07	3778932	3779192	NA	NA	NA	NA	NA
PGEN_.00g154180	Scaffold_07	3789750	3790184	NA	NA	NA	NA	NA
PGEN_.00g154190	Scaffold_07	3832026	3832331	NA	NA	NA	NA	NA
PGEN_.00g154200	Scaffold_07	3834082	3836328	NA	NA	NA	NA	NA
PGEN_.00g154210	Scaffold_07	3856250	3856621	NA	NA	NA	NA	NA
PGEN_.00g154220	Scaffold_07	3871063	3876460	NA	NA	NA	NA	NA
PGEN_.00g154230	Scaffold_07	3888658	3901654	NA	NA	NA	NA	NA
PGEN_.00g154240	Scaffold_07	3901720	3902348	NA	NA	NA	NA	NA
PGEN_.00g154250	Scaffold_07	3974997	3989727	NA	NA	NA	NA	NA
PGEN_.00g154260	Scaffold_07	3992826	3993884	NA	NA	NA	NA	NA
PGEN_.00g154270	Scaffold_07	4008088	4008915	NA	NA	NA	NA	NA
PGEN_.00g154280	Scaffold_07	4012130	4014460	NA	NA	NA	NA	NA
PGEN_.00g154290	Scaffold_07	4018414	4018881	NA	NA	NA	NA	NA
PGEN_.00g154300	Scaffold_07	4018935	4019720	NA	NA	NA	NA	NA
PGEN_.00g154310	Scaffold_07	4030774	4057870	NA	NA	NA	NA	NA
PGEN_.00g154320	Scaffold_07	4098228	4110070	NA	NA	NA	NA	NA
PGEN_.00g154330	Scaffold_07	4124133	4125161	NA	NA	NA	NA	NA
PGEN_.00g154340	Scaffold_07	4125251	4125952	NA	NA	NA	NA	NA
PGEN_.00g154350	Scaffold_07	4137601	4148097	NA	NA	NA	NA	NA
PGEN_.00g154360	Scaffold_07	4153184	4153531	NA	NA	NA	NA	NA
PGEN_.00g154370	Scaffold_07	4156004	4166099	NA	NA	NA	NA	NA
PGEN_.00g154380	Scaffold_07	4256744	4258984	NA	NA	NA	NA	NA
PGEN_.00g154390	Scaffold_07	4286482	4298107	Q0P5B3	RBTN1_BOVIN	Rhombotin-1 (LIM domain only protein 1) (LMO-1)	GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]
PGEN_.00g154400	Scaffold_07	4315627	4315878	NA	NA	NA	NA	NA
PGEN_.00g154410	Scaffold_07	4315943	4316197	NA	NA	NA	NA	NA
PGEN_.00g154420	Scaffold_07	4316300	4317206	NA	NA	NA	NA	NA
PGEN_.00g154430	Scaffold_07	4344384	4344977	NA	NA	NA	NA	NA
PGEN_.00g154440	Scaffold_07	4345057	4345554	NA	NA	NA	NA	NA
PGEN_.00g154450	Scaffold_07	4384626	4397827	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g154460	Scaffold_07	4421153	4428153	NA	NA	NA	NA	NA
PGEN_.00g154470	Scaffold_07	4434501	4449542	NA	NA	NA	NA	NA
PGEN_.00g154480	Scaffold_07	4475229	4475615	NA	NA	NA	NA	NA
PGEN_.00g154490	Scaffold_07	4476807	4479423	NA	NA	NA	NA	NA
PGEN_.00g154500	Scaffold_07	4479462	4479938	NA	NA	NA	NA	NA
PGEN_.00g154510	Scaffold_07	4503273	4503536	NA	NA	NA	NA	NA
PGEN_.00g154520	Scaffold_07	4504716	4510256	NA	NA	NA	NA	NA
PGEN_.00g154530	Scaffold_07	4551322	4589555	NA	NA	NA	NA	NA
PGEN_.00g154540	Scaffold_07	4629477	4630043	NA	NA	NA	NA	NA
PGEN_.00g154550	Scaffold_07	4630873	4631196	NA	NA	NA	NA	NA
PGEN_.00g154560	Scaffold_07	4660988	4672202	NA	NA	NA	NA	NA
PGEN_.00g154570	Scaffold_07	4691251	4726693	P98133	FBN1_BOVIN	Fibrillin-1 (MP340) [Cleaved into: Asprosin]	GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0010737; GO:0031012; GO:0034199; GO:0042593	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]
PGEN_.00g154580	Scaffold_07	4751785	4766218	Q5Y4N8	AGRE1_RAT	Adhesion G protein-coupled receptor E2 (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor)	GO:0002250; GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0007166; GO:0007189; GO:0009897; GO:0071944	cell periphery [GO:0071944]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g154590	Scaffold_07	4791412	4802946	NA	NA	NA	NA	NA
PGEN_.00g154600	Scaffold_07	4821083	4822163	NA	NA	NA	NA	NA
PGEN_.00g154610	Scaffold_07	4838815	4839048	NA	NA	NA	NA	NA
PGEN_.00g154620	Scaffold_07	4843538	4845279	NA	NA	NA	NA	NA
PGEN_.00g154630	Scaffold_07	4845548	4856583	NA	NA	NA	NA	NA
PGEN_.00g154640	Scaffold_07	4860946	4869428	NA	NA	NA	NA	NA
PGEN_.00g154650	Scaffold_07	4870309	4875663	NA	NA	NA	NA	NA
PGEN_.00g154660	Scaffold_07	4881794	4893627	Q03567	SL172_CAEEL	Uncharacterized transporter slc-17.2	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g154670	Scaffold_07	4929851	4948127	Q9WVA4	TAGL2_MOUSE	Transgelin-2 (SM22-beta)	GO:0030855	epithelial cell differentiation [GO:0030855]
PGEN_.00g154680	Scaffold_07	4966574	4986354	Q4R5J4	TAGL3_MACFA	Transgelin-3	GO:0000122; GO:0005634	nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g154690	Scaffold_07	5006577	5010549	Q9Y6C2	EMIL1_HUMAN	EMILIN-1 (Elastin microfibril interface-located protein 1) (Elastin microfibril interfacer 1)	GO:0003180; GO:0005576; GO:0005581; GO:0005615; GO:0007155; GO:0007160; GO:0010628; GO:0010629; GO:0010811; GO:0016477; GO:0016525; GO:0030023; GO:0030512; GO:0030948; GO:0032966; GO:0034668; GO:0042802; GO:0048251; GO:0050866; GO:0060394; GO:0062023; GO:0070062; GO:0070207; GO:0070373; GO:0098640; GO:1901203; GO:1904027; GO:1905522; GO:1990971	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; EMILIN complex [GO:1990971]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integrin alpha4-beta1 complex [GO:0034668]; extracellular matrix constituent conferring elasticity [GO:0030023]; identical protein binding [GO:0042802]; integrin binding involved in cell-matrix adhesion [GO:0098640]; aortic valve morphogenesis [GO:0003180]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; elastic fiber assembly [GO:0048251]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell activation [GO:0050866]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of collagen fibril organization [GO:1904027]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage migration [GO:1905522]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; protein homotrimerization [GO:0070207]
PGEN_.00g154700	Scaffold_07	5014660	5016075	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g154710	Scaffold_07	5021455	5023590	Q9BXX0	EMIL2_HUMAN	EMILIN-2 (Elastin microfibril interface-located protein 2) (Elastin microfibril interfacer 2) (Protein FOAP-10)	GO:0005576; GO:0005581; GO:0007155; GO:0030023; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix constituent conferring elasticity [GO:0030023]; cell adhesion [GO:0007155]
PGEN_.00g154720	Scaffold_07	5033485	5034900	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g154730	Scaffold_07	5041279	5048048	Q9BXX0	EMIL2_HUMAN	EMILIN-2 (Elastin microfibril interface-located protein 2) (Elastin microfibril interfacer 2) (Protein FOAP-10)	GO:0005576; GO:0005581; GO:0007155; GO:0030023; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix constituent conferring elasticity [GO:0030023]; cell adhesion [GO:0007155]
PGEN_.00g154740	Scaffold_07	5074961	5088025	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g154750	Scaffold_07	5098134	5114344	Q8IUH5	ZDH17_HUMAN	Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17) (DHHC-17)	GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016235; GO:0016409; GO:0018345; GO:0019706; GO:0030054; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0042995; GO:0043123; GO:0043231	aggresome [GO:0016235]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]
PGEN_.00g154760	Scaffold_07	5144844	5145341	NA	NA	NA	NA	NA
PGEN_.00g154770	Scaffold_07	5160950	5166887	A0PK84	ZDH22_MOUSE	Palmitoyltransferase ZDHHC22 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 22) (DHHC-22) (zDHHC22)	GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]
PGEN_.00g154780	Scaffold_07	5170473	5218390	P07314	GGT1_RAT	Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]	GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006750; GO:0006751; GO:0007283; GO:0007568; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0102953; GO:0103068; GO:1901750	"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; transferase activity, transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]"
PGEN_.00g154790	Scaffold_07	5254322	5286438	NA	NA	NA	NA	NA
PGEN_.00g154800	Scaffold_07	5292198	5317646	Q9VEC3	ARP5_DROME	Actin-related protein 5	GO:0005634; GO:0005737; GO:0006302; GO:0006310; GO:0006338; GO:0006351; GO:0006355; GO:0031011; GO:0032508; GO:0043044	"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleus [GO:0005634]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g154810	Scaffold_07	5322859	5335290	P59510	ATS20_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM-TS 20) (ADAM-TS20) (ADAMTS-20) (EC 3.4.24.-)	GO:0004222; GO:0005615; GO:0008270; GO:0009967; GO:0030198; GO:0043066; GO:0045636	extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]
PGEN_.00g154820	Scaffold_07	5346153	5348413	P17635	FMO2_RABIT	Dimethylaniline monooxygenase [N-oxide-forming] 2 (EC 1.14.13.8) (Dimethylaniline oxidase 2) (FMO 1B1) (Pulmonary flavin-containing monooxygenase 2) (FMO 2)	GO:0004499; GO:0005789; GO:0016020; GO:0016021; GO:0050660; GO:0050661; GO:0070995	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidation [GO:0070995]"
PGEN_.00g154830	Scaffold_07	5390101	5391414	Q6P829	NOSIP_XENTR	Nitric oxide synthase-interacting protein (E3 ubiquitin-protein ligase NOSIP) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase NOSIP)	GO:0005634; GO:0005737; GO:0007275; GO:0061630	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; multicellular organism development [GO:0007275]
PGEN_.00g154840	Scaffold_07	5392481	5400337	Q6NUH3	NOSIP_XENLA	Nitric oxide synthase-interacting protein (E3 ubiquitin-protein ligase NOSIP) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase NOSIP)	GO:0005634; GO:0005737; GO:0007275; GO:0061630	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; multicellular organism development [GO:0007275]
PGEN_.00g154850	Scaffold_07	5405321	5406310	Q2KNE5	OPN4A_DANRE	Melanopsin-A (Mammalian-like melanopsin) (Melanopsin-M) (Opsin-4-A) (Opsin-4M)	GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0009881; GO:0018298; GO:0071482	integral component of plasma membrane [GO:0005887]; G protein-coupled photoreceptor activity [GO:0008020]; photoreceptor activity [GO:0009881]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g154860	Scaffold_07	5408914	5410821	Q9H8W5	TRI45_HUMAN	Tripartite motif-containing protein 45 (RING finger protein 99)	GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
PGEN_.00g154870	Scaffold_07	5418336	5418920	NA	NA	NA	NA	NA
PGEN_.00g154880	Scaffold_07	5422664	5452265	P79800	RASK_MELGA	GTPase KRas (K-Ras 2) (Ki-Ras) (K-ras)	GO:0003924; GO:0005525; GO:0005737; GO:0007165; GO:0008284; GO:0031234	cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165]
PGEN_.00g154890	Scaffold_07	5469491	5473510	NA	NA	NA	NA	NA
PGEN_.00g154900	Scaffold_07	5474602	5536860	Q8CDK2	CBPC2_MOUSE	Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2)	GO:0004181; GO:0005814; GO:0005829; GO:0008270; GO:0035610; GO:0036064	centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein side chain deglutamylation [GO:0035610]
PGEN_.00g154910	Scaffold_07	5552709	5575834	NA	NA	NA	NA	NA
PGEN_.00g154920	Scaffold_07	5598916	5613426	Q9ULL5	PRR12_HUMAN	Proline-rich protein 12	GO:0005634; GO:0014069; GO:0030054; GO:0043005	cell junction [GO:0030054]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]
PGEN_.00g154930	Scaffold_07	5613594	5627373	P54276	MSH6_MOUSE	DNA mismatch repair protein Msh6 (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)	GO:0000287; GO:0000400; GO:0000710; GO:0000790; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006290; GO:0006298; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016446; GO:0016447; GO:0019899; GO:0030983; GO:0032137; GO:0032142; GO:0032143; GO:0032300; GO:0032301; GO:0032357; GO:0032405; GO:0035064; GO:0036297; GO:0043231; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0051096; GO:0097193	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]
PGEN_.00g154940	Scaffold_07	5640939	5649618	NA	NA	NA	NA	NA
PGEN_.00g154950	Scaffold_07	5663769	5689073	Q8BMU0	ZNF76_MOUSE	Zinc finger protein 76 (Zinc finger protein 523)	GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0007417; GO:0043565; GO:0045944; GO:0046872	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g154960	Scaffold_07	5711659	5778751	A4QP81	FRRS1_DANRE	Putative ferric-chelate reductase 1 (EC 1.-.-.-)	GO:0016021; GO:0016491	integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]
PGEN_.00g154970	Scaffold_07	5790886	5830095	NA	NA	NA	NA	NA
PGEN_.00g154980	Scaffold_07	5837334	5846649	NA	NA	NA	NA	NA
PGEN_.00g154990	Scaffold_07	5937817	5950906	NA	NA	NA	NA	NA
PGEN_.00g155000	Scaffold_07	5992915	6013536	B5DF45	TRAF6_RAT	TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)	GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002726; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007250; GO:0007254; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0019901; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032743; GO:0032991; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043123; GO:0043422; GO:0043507; GO:0045084; GO:0045410; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046849; GO:0047485; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051023; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:1901224; GO:1904996; GO:2000679	"CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 biosynthetic process [GO:0045084]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]"
PGEN_.00g155010	Scaffold_07	6045937	6076107	Q14DH7	ACSS3_MOUSE	"Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 3) (Propionate--CoA ligase) (EC 6.2.1.17)"	GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0047760; GO:0050218	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]
PGEN_.00g155020	Scaffold_07	6083270	6084016	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g155030	Scaffold_07	6161819	6165874	NA	NA	NA	NA	NA
PGEN_.00g155040	Scaffold_07	6188641	6225101	Q28005	LSHR_BOVIN	Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R)	GO:0004964; GO:0005886; GO:0005887; GO:0007189; GO:0007190; GO:0007200; GO:0008528; GO:0009755; GO:0022602; GO:0042700; GO:0071373	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]
PGEN_.00g155050	Scaffold_07	6229214	6230835	NA	NA	NA	NA	NA
PGEN_.00g155060	Scaffold_07	6251374	6338831	F7D3V9	LGR5_XENTR	Leucine-rich repeat-containing G-protein coupled receptor 5	GO:0004888; GO:0005887; GO:0007189; GO:0007190; GO:0008528; GO:0009755; GO:0016500; GO:0032588; GO:0090263	integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of canonical Wnt signaling pathway [GO:0090263]
PGEN_.00g155070	Scaffold_07	6348026	6348661	NA	NA	NA	NA	NA
PGEN_.00g155080	Scaffold_07	6424588	6429638	NA	NA	NA	NA	NA
PGEN_.00g155090	Scaffold_07	6429847	6434201	NA	NA	NA	NA	NA
PGEN_.00g155100	Scaffold_07	6479236	6488372	Q9MYP6	DHB14_BOVIN	17-beta-hydroxysteroid dehydrogenase 14 (17-beta-HSD 14) (EC 1.1.1.-) (17-beta-hydroxysteroid dehydrogenase DHRS10) (Dehydrogenase/reductase SDR family member 10) (Retinal short-chain dehydrogenase/reductase retSDR3)	GO:0004303; GO:0005829; GO:0006706; GO:0042802; GO:0047045	cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706]
PGEN_.00g155110	Scaffold_07	6492461	6495954	NA	NA	NA	NA	NA
PGEN_.00g155120	Scaffold_07	6496019	6496372	NA	NA	NA	NA	NA
PGEN_.00g155130	Scaffold_07	6498112	6499011	NA	NA	NA	NA	NA
PGEN_.00g155140	Scaffold_07	6517405	6578143	Q13136	LIPA1_HUMAN	Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1)	GO:0005737; GO:0005829; GO:0005925; GO:0007160; GO:0007165; GO:0007269; GO:0014047; GO:0048786; GO:0051497; GO:1903077	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; cell-matrix adhesion [GO:0007160]; glutamate secretion [GO:0014047]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; neurotransmitter secretion [GO:0007269]; signal transduction [GO:0007165]
PGEN_.00g155150	Scaffold_07	6616538	6629234	O08782	ALD2_CRIGR	Aldose reductase-related protein 2 (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase)	GO:0004032; GO:0005737	cytoplasm [GO:0005737]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]
PGEN_.00g155160	Scaffold_07	6634151	6642240	O35403	ST3A1_MOUSE	Amine sulfotransferase (EC 2.8.2.3) (SULT-X2) (Sulfotransferase 3A1) (ST3A1)	GO:0005737; GO:0008146; GO:0047685; GO:0051923	cytoplasm [GO:0005737]; amine sulfotransferase activity [GO:0047685]; sulfotransferase activity [GO:0008146]; sulfation [GO:0051923]
PGEN_.00g155170	Scaffold_07	6652391	6657958	Q8JG30	ST1B1_CHICK	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-)	GO:0005737; GO:0008146; GO:0008202	cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]
PGEN_.00g155180	Scaffold_07	6662726	6665379	NA	NA	NA	NA	NA
PGEN_.00g155190	Scaffold_07	6688204	6690444	NA	NA	NA	NA	NA
PGEN_.00g155200	Scaffold_07	6776213	6776524	NA	NA	NA	NA	NA
PGEN_.00g155210	Scaffold_07	6789629	6817360	NA	NA	NA	NA	NA
PGEN_.00g155220	Scaffold_07	6827123	6896321	NA	NA	NA	NA	NA
PGEN_.00g155230	Scaffold_07	6885448	6885693	NA	NA	NA	NA	NA
PGEN_.00g155240	Scaffold_07	6899902	6901863	NA	NA	NA	NA	NA
PGEN_.00g155250	Scaffold_07	6910209	6917387	NA	NA	NA	NA	NA
PGEN_.00g155260	Scaffold_07	6929180	6945667	Q68F99	STAC3_XENTR	SH3 and cysteine-rich domain-containing protein 3	GO:0003009; GO:0005829; GO:0005891; GO:0007274; GO:0030315; GO:0031234; GO:0035556; GO:0045202; GO:0046872; GO:1901387; GO:1903078	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; synapse [GO:0045202]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]
PGEN_.00g155270	Scaffold_07	6959447	6974641	NA	NA	NA	NA	NA
PGEN_.00g155280	Scaffold_07	7002416	7003350	NA	NA	NA	NA	NA
PGEN_.00g155290	Scaffold_07	7010777	7026852	O42409	GFI1B_CHICK	Zinc finger protein Gfi-1b (Growth factor-independent protein 1B)	GO:0000122; GO:0001085; GO:0003677; GO:0005654; GO:0005667; GO:0005886; GO:0006325; GO:0007275; GO:0016363; GO:0046872	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g155300	Scaffold_07	7047381	7083618	NA	NA	NA	NA	NA
PGEN_.00g155310	Scaffold_07	7116663	7117076	NA	NA	NA	NA	NA
PGEN_.00g155320	Scaffold_07	7117168	7117773	NA	NA	NA	NA	NA
PGEN_.00g155330	Scaffold_07	7120848	7121198	NA	NA	NA	NA	NA
PGEN_.00g155340	Scaffold_07	7131260	7132728	NA	NA	NA	NA	NA
PGEN_.00g155350	Scaffold_07	7136276	7137070	NA	NA	NA	NA	NA
PGEN_.00g155360	Scaffold_07	7137098	7137898	NA	NA	NA	NA	NA
PGEN_.00g155370	Scaffold_07	7139351	7175078	Q53H54	TYW2_HUMAN	tRNA wybutosine-synthesizing protein 2 homolog (tRNA-yW-synthesizing protein 2) (EC 2.5.1.114) (tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase)	GO:0005737; GO:0008175; GO:0030488; GO:0031591; GO:0102522	cytoplasm [GO:0005737]; tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591]
PGEN_.00g155380	Scaffold_07	7151610	7152545	NA	NA	NA	NA	NA
PGEN_.00g155390	Scaffold_07	7186719	7190979	Q9VUL9	FUCTA_DROME	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920	"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]"
PGEN_.00g155400	Scaffold_07	7314829	7317182	Q9VUL9	FUCTA_DROME	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920	"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]"
PGEN_.00g155410	Scaffold_07	7323460	7359950	O75954	TSN9_HUMAN	Tetraspanin-9 (Tspan-9) (Tetraspan NET-5)	GO:0005886; GO:0005887; GO:0005925; GO:0097197	focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]
PGEN_.00g155420	Scaffold_07	7379407	7382268	Q6GQU2	KLH23_MOUSE	Kelch-like protein 23		
PGEN_.00g155430	Scaffold_07	7389349	7408010	Q13426	XRCC4_HUMAN	DNA repair protein XRCC4 (X-ray repair cross-complementing protein 4)	GO:0005634; GO:0005654; GO:0005829; GO:0005958; GO:0006302; GO:0006303; GO:0008022; GO:0010165; GO:0032807; GO:0033152; GO:0042802; GO:0051103; GO:0051351; GO:0070419; GO:0071285; GO:0075713	cytosol [GO:0005829]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to lithium ion [GO:0071285]; DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; immunoglobulin V(D)J recombination [GO:0033152]; positive regulation of ligase activity [GO:0051351]; response to X-ray [GO:0010165]
PGEN_.00g155440	Scaffold_07	7408109	7415346	B5G2S6	KISHA_TAEGU	Protein kish-A (Transmembrane protein 167A)	GO:0000139; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]
PGEN_.00g155450	Scaffold_07	7425556	7428456	NA	NA	NA	NA	NA
PGEN_.00g155460	Scaffold_07	7435822	7441055	Q24K15	ANGP4_BOVIN	Angiopoietin-4 (ANG-4)	GO:0001525; GO:0005576; GO:0030971	extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525]
PGEN_.00g155470	Scaffold_07	7446049	7487265	Q8INF0	GCY8E_DROME	Soluble guanylate cyclase 88E (EC 4.6.1.2)	GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026	"guanylate cyclase complex, soluble [GO:0008074]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]"
PGEN_.00g155480	Scaffold_07	7582607	7583374	Q6DG99	KCTD6_DANRE	BTB/POZ domain-containing protein KCTD6	GO:0016567; GO:0051260	protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]
PGEN_.00g155490	Scaffold_07	7586545	7604474	NA	NA	NA	NA	NA
PGEN_.00g155500	Scaffold_07	7614595	7620575	Q6DHN0	TMM53_DANRE	Transmembrane protein 53	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g155510	Scaffold_07	7620935	7621354	NA	NA	NA	NA	NA
PGEN_.00g155520	Scaffold_07	7622443	7622991	NA	NA	NA	NA	NA
PGEN_.00g155530	Scaffold_07	7626832	7806870	B3EWZ6	MLRP2_ACRMI	MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g155540	Scaffold_07	7814684	7850919	Q9HAR2	AGRL3_HUMAN	Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)	GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]
PGEN_.00g155550	Scaffold_07	7853488	7891685	O14514	AGRB1_HUMAN	Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)]	GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016021; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428	"cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]"
PGEN_.00g155560	Scaffold_07	7901849	7915180	A0JM23	NPHP3_XENTR	Nephrocystin-3	GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095	"cilium [GO:0005929]; cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g155570	Scaffold_07	7926871	7940233	NA	NA	NA	NA	NA
PGEN_.00g155580	Scaffold_07	7952679	7954074	NA	NA	NA	NA	NA
PGEN_.00g155590	Scaffold_07	7959430	7959786	NA	NA	NA	NA	NA
PGEN_.00g155600	Scaffold_07	7960330	7962974	NA	NA	NA	NA	NA
PGEN_.00g155610	Scaffold_07	7967444	7980379	NA	NA	NA	NA	NA
PGEN_.00g155620	Scaffold_07	8011409	8018897	NA	NA	NA	NA	NA
PGEN_.00g155630	Scaffold_07	8049894	8079981	NA	NA	NA	NA	NA
PGEN_.00g155640	Scaffold_07	8091762	8115049	NA	NA	NA	NA	NA
PGEN_.00g155650	Scaffold_07	8128019	8137487	H2A0N4	PIF_PINMG	Protein PIF [Cleaved into: Protein Pif97; Protein Pif80 (Aragonite-binding protein)]	GO:0005576; GO:0006030; GO:0008061	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]
PGEN_.00g155660	Scaffold_07	8143791	8156172	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g155670	Scaffold_07	8175071	8198493	NA	NA	NA	NA	NA
PGEN_.00g155680	Scaffold_07	8198861	8208700	NA	NA	NA	NA	NA
PGEN_.00g155690	Scaffold_07	8211659	8211931	NA	NA	NA	NA	NA
PGEN_.00g155700	Scaffold_07	8213237	8219831	Q9D0K0	TBCD7_MOUSE	TBC1 domain family member 7	GO:0005096; GO:0017137; GO:0031398; GO:0031410; GO:0032007; GO:0036064; GO:0043547; GO:0070848; GO:0090630; GO:1902018	ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; negative regulation of TOR signaling [GO:0032007]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein ubiquitination [GO:0031398]; response to growth factor [GO:0070848]
PGEN_.00g155710	Scaffold_07	8226501	8263962	Q0VDN7	RUND1_MOUSE	RUN domain-containing protein 1	GO:0001701; GO:0005096; GO:0006886; GO:0017137; GO:0090630	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]
PGEN_.00g155720	Scaffold_07	8264050	8264307	NA	NA	NA	NA	NA
PGEN_.00g155730	Scaffold_07	8267181	8299650	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g155740	Scaffold_07	8313278	8339767	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g155750	Scaffold_07	8349776	8354950	P48180	ACH1_CAEEL	Acetylcholine receptor subunit alpha-type acr-16	GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0042995; GO:0043005; GO:0045202; GO:0045211; GO:0050877	cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g155760	Scaffold_07	8359881	8388003	A7MB11	TGFA1_BOVIN	Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1)	GO:0005769; GO:0006886; GO:0007165; GO:0016192; GO:0046332	early endosome [GO:0005769]; SMAD binding [GO:0046332]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]
PGEN_.00g155770	Scaffold_07	8391715	8393024	NA	NA	NA	NA	NA
PGEN_.00g155780	Scaffold_07	8398442	8408063	NA	NA	NA	NA	NA
PGEN_.00g155790	Scaffold_07	8413468	8419704	NA	NA	NA	NA	NA
PGEN_.00g155800	Scaffold_07	8425813	8432628	NA	NA	NA	NA	NA
PGEN_.00g155810	Scaffold_07	8437177	8445703	NA	NA	NA	NA	NA
PGEN_.00g155820	Scaffold_07	8455459	8456834	NA	NA	NA	NA	NA
PGEN_.00g155830	Scaffold_07	8484400	8503873	Q8VCB2	MED25_MOUSE	Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25) (mMED25)	GO:0000122; GO:0005654; GO:0008134; GO:0016592; GO:0035563; GO:0042974; GO:0044798; GO:0045944; GO:0046965; GO:0048147; GO:0071158; GO:2001178	mediator complex [GO:0016592]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; transcription factor binding [GO:0008134]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of chromatin binding [GO:0035563]; positive regulation of mediator complex assembly [GO:2001178]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g155840	Scaffold_07	8499623	8503845	NA	NA	NA	NA	NA
PGEN_.00g155850	Scaffold_07	8509893	8523090	NA	NA	NA	NA	NA
PGEN_.00g155860	Scaffold_07	8523647	8524009	NA	NA	NA	NA	NA
PGEN_.00g155870	Scaffold_07	8596291	8598742	NA	NA	NA	NA	NA
PGEN_.00g155880	Scaffold_07	8624903	8652189	Q9LYU4	GH312_ARATH	4-substituted benzoates-glutamate ligase GH3.12 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 12) (AtGH3-12) (Protein GH3-LIKE DEFENSE GENE 1) (Protein GRETCHEN HAGEN 3.12) (Protein HOPW1-1-INTERACTING 3) (Protein avrPPHB SUSCEPTIBLE 3)	GO:0006952; GO:0009626; GO:0009816; GO:0009863; GO:0010112; GO:0016046; GO:0018874; GO:0034052; GO:0042742; GO:0044419; GO:0052625; GO:0052626; GO:0052627; GO:0052628; GO:0071456	"4-aminobenzoate amino acid synthetase activity [GO:0052625]; 4-hydroxybenzoate amino acid synthetase activity [GO:0052628]; benzoate amino acid synthetase activity [GO:0052626]; vanillate amino acid synthetase activity [GO:0052627]; benzoate metabolic process [GO:0018874]; cellular response to hypoxia [GO:0071456]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to bacterium, incompatible interaction [GO:0009816]; detection of fungus [GO:0016046]; interspecies interaction between organisms [GO:0044419]; plant-type hypersensitive response [GO:0009626]; positive regulation of plant-type hypersensitive response [GO:0034052]; regulation of systemic acquired resistance [GO:0010112]; salicylic acid mediated signaling pathway [GO:0009863]"
PGEN_.00g155890	Scaffold_07	8660470	8675434	Q8BYI8	F234B_MOUSE	Protein FAM234B	GO:0005794; GO:0005856; GO:0016021; GO:0030054; GO:0045202	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; synapse [GO:0045202]
PGEN_.00g155900	Scaffold_07	8686263	8686664	NA	NA	NA	NA	NA
PGEN_.00g155910	Scaffold_07	8686756	8687269	NA	NA	NA	NA	NA
PGEN_.00g155920	Scaffold_07	8696311	8719680	NA	NA	NA	NA	NA
PGEN_.00g155930	Scaffold_07	8767241	8772867	A0JN95	MET15_BOVIN	Probable methyltransferase-like protein 15 (EC 2.1.1.-) (Methyltransferase 5 domain-containing protein 1)	GO:0070475; GO:0071424	rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424]; rRNA base methylation [GO:0070475]
PGEN_.00g155940	Scaffold_07	8783782	8837565	Q62132	PTPRR_MOUSE	Receptor-type tyrosine-protein phosphatase R (R-PTP-R) (EC 3.1.3.48) (Phosphotyrosine phosphatase 13) (Protein-tyrosine-phosphatase SL)	GO:0001701; GO:0004725; GO:0005829; GO:0005886; GO:0006470; GO:0010633; GO:0016021; GO:0019901; GO:0030054; GO:0038128; GO:0070373	cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; ERBB2 signaling pathway [GO:0038128]; in utero embryonic development [GO:0001701]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; protein dephosphorylation [GO:0006470]
PGEN_.00g155950	Scaffold_07	8847082	8866967	Q566Y1	ELP4_DANRE	Elongator complex protein 4 (ELP4)	GO:0000993; GO:0002098; GO:0005737; GO:0006357; GO:0008023; GO:0008607; GO:0033588	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; RNA polymerase II complex binding [GO:0000993]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g155960	Scaffold_07	8909899	8959878	Q7Z4S6	KI21A_HUMAN	Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62)	GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:0016887	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g155970	Scaffold_07	8966538	8971441	NA	NA	NA	NA	NA
PGEN_.00g155980	Scaffold_07	8978022	8993328	Q9QXL1	KI21B_MOUSE	Kinesin-like protein KIF21B (Kinesin-like protein KIF6)	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030425; GO:0030426; GO:0031410	cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g155990	Scaffold_07	9024460	9025629	Q61121	GPR19_MOUSE	Probable G-protein coupled receptor 19	GO:0004930; GO:0005886; GO:0005929; GO:0016021	cilium [GO:0005929]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g156000	Scaffold_07	9043487	9052668	A7MAZ4	TAF8_BOVIN	Transcription initiation factor TFIID subunit 8 (TBP-associated factor 8)	GO:0001833; GO:0005669; GO:0030154; GO:0045598; GO:0045893; GO:0046982; GO:0048471; GO:0051457	"perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; cell differentiation [GO:0030154]; inner cell mass cell proliferation [GO:0001833]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fat cell differentiation [GO:0045598]"
PGEN_.00g156010	Scaffold_07	9075625	9093010	Q6ZT07	TBCD9_HUMAN	TBC1 domain family member 9 (TBC1 domain family member 9A)	GO:0005096; GO:0005509; GO:0006886; GO:0017137; GO:0090630	calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]
PGEN_.00g156020	Scaffold_07	9095473	9102916	B0R0W9	TBC8B_DANRE	TBC1 domain family member 8B	GO:0003094; GO:0005096; GO:0005509; GO:0005829; GO:0006886; GO:0016192; GO:0017137; GO:0090630	cytosol [GO:0005829]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; glomerular filtration [GO:0003094]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g156030	Scaffold_07	9113163	9114350	Q7L1S5	CHST9_HUMAN	Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)	GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446	extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g156040	Scaffold_07	9122720	9138591	O00338	ST1C2_HUMAN	Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.-) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)	GO:0005737; GO:0005829; GO:0008146; GO:0009308; GO:0050427; GO:0051923	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]
PGEN_.00g156050	Scaffold_07	9149479	9152826	O00338	ST1C2_HUMAN	Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.-) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)	GO:0005737; GO:0005829; GO:0008146; GO:0009308; GO:0050427; GO:0051923	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]
PGEN_.00g156060	Scaffold_07	9159399	9164838	NA	NA	NA	NA	NA
PGEN_.00g156070	Scaffold_07	9176418	9176711	NA	NA	NA	NA	NA
PGEN_.00g156080	Scaffold_07	9184652	9187742	Q5IZC5	CRY1_ERIRU	Cryptochrome-1	GO:0000166; GO:0003677; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0042622; GO:0045721; GO:0097381	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]
PGEN_.00g156090	Scaffold_07	9201222	9201521	NA	NA	NA	NA	NA
PGEN_.00g156100	Scaffold_07	9211584	9215473	O00338	ST1C2_HUMAN	Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.-) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)	GO:0005737; GO:0005829; GO:0008146; GO:0009308; GO:0050427; GO:0051923	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]
PGEN_.00g156110	Scaffold_07	9222101	9225559	NA	NA	NA	NA	NA
PGEN_.00g156120	Scaffold_07	9231339	9231983	NA	NA	NA	NA	NA
PGEN_.00g156130	Scaffold_07	9256645	9285786	NA	NA	NA	NA	NA
PGEN_.00g156140	Scaffold_07	9286202	9287407	O75901	RASF9_HUMAN	Ras association domain-containing protein 9 (PAM COOH-terminal interactor protein 1) (P-CIP1) (Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor)	GO:0005768; GO:0005829; GO:0006605; GO:0007165; GO:0012510; GO:0016197; GO:0046907; GO:0055037; GO:0070062	cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; recycling endosome [GO:0055037]; trans-Golgi network transport vesicle membrane [GO:0012510]; endosomal transport [GO:0016197]; intracellular transport [GO:0046907]; protein targeting [GO:0006605]; signal transduction [GO:0007165]
PGEN_.00g156150	Scaffold_07	9299605	9341425	NA	NA	NA	NA	NA
PGEN_.00g156160	Scaffold_07	9346144	9348054	NA	NA	NA	NA	NA
PGEN_.00g156170	Scaffold_07	9484808	9488288	NA	NA	NA	NA	NA
PGEN_.00g156180	Scaffold_07	9488350	9488568	NA	NA	NA	NA	NA
PGEN_.00g156190	Scaffold_07	9515929	9556687	Q5W8I7	VGL2B_DANRE	Vesicular glutamate transporter 2.2 (Solute carrier family 17 member 6-A) (Vesicular glutamate transporter 2-B)	GO:0005313; GO:0005326; GO:0006814; GO:0015293; GO:0016021; GO:0030054; GO:0030285; GO:0030672; GO:0035249; GO:0043005; GO:0050803; GO:0060076; GO:0098700	"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g156200	Scaffold_07	9568560	9580397	Q9D6X5	S52A3_MOUSE	"Solute carrier family 52, riboflavin transporter, member 3 (Riboflavin transporter 2) (RFT2)"	GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007605; GO:0032217; GO:0032218; GO:0034605	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; riboflavin transmembrane transporter activity [GO:0032217]; cellular response to heat [GO:0034605]; riboflavin transport [GO:0032218]; sensory perception of sound [GO:0007605]
PGEN_.00g156210	Scaffold_07	9589078	9589659	NA	NA	NA	NA	NA
PGEN_.00g156220	Scaffold_07	9595648	9597133	NA	NA	NA	NA	NA
PGEN_.00g156230	Scaffold_07	9599564	9600784	Q6DIV6	VIAAT_XENTR	Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter)	GO:0003333; GO:0015171; GO:0015495; GO:0030285; GO:0044292; GO:0044306; GO:0098700	dendrite terminus [GO:0044292]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection terminus [GO:0044306]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:proton symporter activity [GO:0015495]; amino acid transmembrane transport [GO:0003333]; neurotransmitter loading into synaptic vesicle [GO:0098700]
PGEN_.00g156240	Scaffold_07	9607906	9618568	P47796	CTRA_GADMO	Chymotrypsin A (EC 3.4.21.1)	GO:0004252; GO:0005615; GO:0007586	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]
PGEN_.00g156250	Scaffold_07	9662166	9673667	Q8BGC4	PTGR3_MOUSE	Prostaglandin reductase-3 (PTGR-3) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 2)	GO:0005739; GO:0005777; GO:0008270; GO:0036132; GO:0045599; GO:0047522	mitochondrion [GO:0005739]; peroxisome [GO:0005777]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270]; negative regulation of fat cell differentiation [GO:0045599]
PGEN_.00g156260	Scaffold_07	9675633	9689431	Q8BGC4	PTGR3_MOUSE	Prostaglandin reductase-3 (PTGR-3) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 2)	GO:0005739; GO:0005777; GO:0008270; GO:0036132; GO:0045599; GO:0047522	mitochondrion [GO:0005739]; peroxisome [GO:0005777]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270]; negative regulation of fat cell differentiation [GO:0045599]
PGEN_.00g156270	Scaffold_07	9701281	9730170	Q6TXD4	DNMBP_MOUSE	Dynamin-binding protein (Scaffold protein Tuba)	GO:0005089; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0008360; GO:0035556; GO:0045202; GO:0098793	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]
PGEN_.00g156280	Scaffold_07	9737945	9786212	Q6NRZ1	UH1BL_XENLA	UHRF1-binding protein 1-like	GO:0005769; GO:0005829	cytosol [GO:0005829]; early endosome [GO:0005769]
PGEN_.00g156290	Scaffold_07	9797942	9808690	Q8VYA5	RSZ33_ARATH	Serine/arginine-rich splicing factor RS2Z33 (RS-containing zinc finger protein 33) (At-RS2Z33) (At-RSZ33) (AtRSZ33)	GO:0000245; GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0008270; GO:0008380; GO:0016607; GO:0045292	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"
PGEN_.00g156300	Scaffold_07	9809021	9814961	P61212	ARL1_RAT	ADP-ribosylation factor-like protein 1	GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007030; GO:0008047; GO:0009404; GO:0016192; GO:0019904; GO:0031584; GO:0034067; GO:0042147; GO:0046872; GO:0048193	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; activation of phospholipase D activity [GO:0031584]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g156310	Scaffold_07	9819585	9852736	Q9BXB4	OSB11_HUMAN	Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)	GO:0005654; GO:0005794; GO:0005829; GO:0006869; GO:0008289; GO:0010890; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0045444	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]
PGEN_.00g156320	Scaffold_07	9862336	9916684	Q8HWS3	RFX6_HUMAN	DNA-binding protein RFX6 (Regulatory factor X 6) (Regulatory factor X domain-containing protein 1)	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003309; GO:0003310; GO:0003311; GO:0003700; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0044212; GO:0045893; GO:0045944; GO:0050796; GO:0090104	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]"
PGEN_.00g156330	Scaffold_07	9980613	10000347	Q5ZKL6	MBOA2_CHICK	Membrane-bound O-acyltransferase domain-containing protein 2 (O-acyltransferase domain-containing protein 2) (EC 2.3.-.-)	GO:0008654; GO:0016021; GO:0016746	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid biosynthetic process [GO:0008654]"
PGEN_.00g156340	Scaffold_07	10000733	10006916	P61082	UBC12_MOUSE	NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.-) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M)	GO:0004842; GO:0005524; GO:0006464; GO:0019788; GO:0043525; GO:0045116	ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; positive regulation of neuron apoptotic process [GO:0043525]; protein neddylation [GO:0045116]
PGEN_.00g156350	Scaffold_07	10053216	10053530	NA	NA	NA	NA	NA
PGEN_.00g156360	Scaffold_07	10065515	10066051	NA	NA	NA	NA	NA
PGEN_.00g156370	Scaffold_07	10066175	10066609	NA	NA	NA	NA	NA
PGEN_.00g156380	Scaffold_07	10074092	10074538	NA	NA	NA	NA	NA
PGEN_.00g156390	Scaffold_07	10074733	10075758	NA	NA	NA	NA	NA
PGEN_.00g156400	Scaffold_07	10086880	10104464	P16562	CRIS2_HUMAN	Cysteine-rich secretory protein 2 (CRISP-2) (Cancer/testis antigen 36) (CT36) (Testis-specific protein TPX-1)	GO:0005615; GO:0098609	extracellular space [GO:0005615]; cell-cell adhesion [GO:0098609]
PGEN_.00g156410	Scaffold_07	10097194	10099048	NA	NA	NA	NA	NA
PGEN_.00g156420	Scaffold_07	10110149	10114686	Q8N2M4	TM86A_HUMAN	Lysoplasmalogenase-like protein TMEM86A (Transmembrane protein 86A)	GO:0016021; GO:0047408; GO:0047409	integral component of membrane [GO:0016021]; alkenylglycerophosphocholine hydrolase activity [GO:0047408]; alkenylglycerophosphoethanolamine hydrolase activity [GO:0047409]
PGEN_.00g156430	Scaffold_07	10135865	10153356	Q9UA35	S28A3_EPTST	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)	GO:0005337; GO:0005887	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]
PGEN_.00g156440	Scaffold_07	10160597	10167969	NA	NA	NA	NA	NA
PGEN_.00g156450	Scaffold_07	10195428	10219594	Q8BFR4	GNS_MOUSE	N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S)	GO:0005539; GO:0005764; GO:0008449; GO:0008484; GO:0030203; GO:0043199; GO:0046872	lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan metabolic process [GO:0030203]
PGEN_.00g156460	Scaffold_07	10219954	10235263	P11064	PPAC_BOVIN	Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2)	GO:0003993; GO:0004725; GO:0004726; GO:0005737	cytoplasm [GO:0005737]; acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]
PGEN_.00g156470	Scaffold_07	10250811	10264115	NA	NA	NA	NA	NA
PGEN_.00g156480	Scaffold_07	10283621	10285229	NA	NA	NA	NA	NA
PGEN_.00g156490	Scaffold_07	10287748	10311595	Q9D4V0	EKI1_MOUSE	Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82)	GO:0004305; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006646	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]
PGEN_.00g156500	Scaffold_07	10319463	10319729	NA	NA	NA	NA	NA
PGEN_.00g156510	Scaffold_07	10336734	10346138	Q24400	MLP2_DROME	Muscle LIM protein Mlp84B	GO:0005634; GO:0005737; GO:0007517; GO:0008307; GO:0030018; GO:0030036; GO:0045214; GO:0046872; GO:0060537; GO:0090175	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214]
PGEN_.00g156520	Scaffold_07	10362749	10363153	NA	NA	NA	NA	NA
PGEN_.00g156530	Scaffold_07	10374788	10378087	NA	NA	NA	NA	NA
PGEN_.00g156540	Scaffold_07	10460291	10476742	Q8IMP6	SPT2_DROME	Protein SPT2 homolog	GO:0003677; GO:0005730; GO:0006334; GO:0006355; GO:0010847; GO:0042393; GO:0043486	"nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g156550	Scaffold_07	10477178	10489864	Q5SSI6	UTP18_MOUSE	U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50)	GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0031965; GO:0032040; GO:0034388	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364]
PGEN_.00g156560	Scaffold_07	10493502	10501174	NA	NA	NA	NA	NA
PGEN_.00g156570	Scaffold_07	10505970	10507169	Q86IA3	PDI1_DICDI	Protein disulfide-isomerase 1 (PDI1) (EC 5.3.4.1)	GO:0003756; GO:0005623; GO:0005783; GO:0005788; GO:0005811; GO:0006457; GO:0042175; GO:0045335; GO:0045454	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; phagocytic vesicle [GO:0045335]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; protein folding [GO:0006457]
PGEN_.00g156580	Scaffold_07	10519739	10520221	NA	NA	NA	NA	NA
PGEN_.00g156590	Scaffold_07	10531312	10537546	NA	NA	NA	NA	NA
PGEN_.00g156600	Scaffold_07	10567184	10569394	Q53533	SAV2_STRVL	Streptavidin-V2 (SA V2)	GO:0005576; GO:0009374	extracellular region [GO:0005576]; biotin binding [GO:0009374]
PGEN_.00g156610	Scaffold_07	10576940	10598866	NA	NA	NA	NA	NA
PGEN_.00g156620	Scaffold_07	10706545	10737556	Q61555	FBN2_MOUSE	Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide]	GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]
PGEN_.00g156630	Scaffold_07	10753321	10820582	P11654	PO210_RAT	Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa)	GO:0005635; GO:0005643; GO:0005789; GO:0015031; GO:0016021; GO:0017056; GO:0031965; GO:0051028; GO:0065003	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]
PGEN_.00g156640	Scaffold_07	10825681	10829289	Q09621	LACT2_CAEEL	Beta-lactamase domain-containing protein 2	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g156650	Scaffold_07	10836034	10840953	Q6AXM9	CL029_RAT	Uncharacterized protein C12orf29 homolog	GO:0002244	hematopoietic progenitor cell differentiation [GO:0002244]
PGEN_.00g156660	Scaffold_07	10859750	10863356	NA	NA	NA	NA	NA
PGEN_.00g156670	Scaffold_07	10868053	10882565	NA	NA	NA	NA	NA
PGEN_.00g156680	Scaffold_07	10888906	10893172	Q20561	HLH13_CAEEL	Helix-loop-helix protein 13 (Fer3-like protein) (Nephew of atonal 3)	GO:0003677; GO:0005634; GO:0005737; GO:0006979; GO:0008134; GO:0008286; GO:0030154; GO:0043054; GO:0046983	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; dauer exit [GO:0043054]; insulin receptor signaling pathway [GO:0008286]; response to oxidative stress [GO:0006979]
PGEN_.00g156690	Scaffold_07	10900260	10903797	NA	NA	NA	NA	NA
PGEN_.00g156700	Scaffold_07	10909222	10915713	P61270	RS11_MACFA	40S ribosomal protein S11	GO:0003735; GO:0006412; GO:0019843; GO:0022627	cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g156710	Scaffold_07	10923402	10941158	Q8IVV2	LOXH1_HUMAN	Lipoxygenase homology domain-containing protein 1	GO:0004096; GO:0007605; GO:0020037; GO:0032420	stereocilium [GO:0032420]; catalase activity [GO:0004096]; heme binding [GO:0020037]; sensory perception of sound [GO:0007605]
PGEN_.00g156720	Scaffold_07	10944884	11036983	C8YR32	LOXH1_MOUSE	Lipoxygenase homology domain-containing protein 1	GO:0004096; GO:0007605; GO:0020037; GO:0032420	stereocilium [GO:0032420]; catalase activity [GO:0004096]; heme binding [GO:0020037]; sensory perception of sound [GO:0007605]
PGEN_.00g156730	Scaffold_07	11007585	11011923	NA	NA	NA	NA	NA
PGEN_.00g156740	Scaffold_07	11046026	11131113	Q28BX9	C2CD5_XENTR	C2 domain-containing protein 5 (138 kDa C2 domain-containing phosphoprotein)	GO:0005509; GO:0005544; GO:0005886; GO:0005938; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0038028; GO:0065002; GO:0090314	cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]
PGEN_.00g156750	Scaffold_07	11133271	11136205	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g156760	Scaffold_07	11204251	11216787	P51589	CP2J2_HUMAN	Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070062; GO:0071614	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g156770	Scaffold_07	11227691	11230261	O88199	CHST3_MOUSE	Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0016021; GO:0030206; GO:0043029; GO:0050698; GO:0051272	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; proteoglycan sulfotransferase activity [GO:0050698]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of cellular component movement [GO:0051272]; sulfur compound metabolic process [GO:0006790]; T cell homeostasis [GO:0043029]
PGEN_.00g156780	Scaffold_07	11246915	11254581	NA	NA	NA	NA	NA
PGEN_.00g156790	Scaffold_07	11256483	11273007	Q9I927	FUCL5_ANGJA	Fucolectin-5	GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088	"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
PGEN_.00g156800	Scaffold_07	11286366	11306143	P00178	CP2B4_RABIT	Cytochrome P450 2B4 (EC 1.14.14.1) (CYPIIB4) (Cytochrome P450 isozyme 2) (Cytochrome P450 LM2) (Cytochrome P450 type B0) (Cytochrome P450 type B1)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g156810	Scaffold_07	11335613	11341405	NA	NA	NA	NA	NA
PGEN_.00g156820	Scaffold_07	11342887	11350240	NA	NA	NA	NA	NA
PGEN_.00g156830	Scaffold_07	11352403	11359809	NA	NA	NA	NA	NA
PGEN_.00g156840	Scaffold_07	11362804	11366968	NA	NA	NA	NA	NA
PGEN_.00g156850	Scaffold_07	11385768	11400351	Q7ZT98	CRVP_OPHHA	Cysteine-rich venom protein ophanin (CRVP) (Opharin)	GO:0005576; GO:0009405; GO:0090729	extracellular region [GO:0005576]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g156860	Scaffold_07	11405558	11437988	Q7YT83	TX31_CONTE	Cysteine-rich venom protein (CRVP) (EC 3.4.-.-) (Substrate-specific endoprotease Tex31)	GO:0005576; GO:0008233	extracellular region [GO:0005576]; peptidase activity [GO:0008233]
PGEN_.00g156870	Scaffold_07	11463095	11589874	Q8WXG6	MADD_HUMAN	MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor)	GO:0000187; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0010803; GO:0016021; GO:0017112; GO:0030295; GO:0032483; GO:0042981; GO:0051726; GO:0097194; GO:1902041; GO:2001236	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; protein kinase activator activity [GO:0030295]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]
PGEN_.00g156880	Scaffold_07	11589963	11603395	NA	NA	NA	NA	NA
PGEN_.00g156890	Scaffold_07	11613458	11621609	Q5RFR0	TTPAL_PONAB	Alpha-tocopherol transfer protein-like		
PGEN_.00g156900	Scaffold_07	11624052	11631995	Q32NG4	GALD1_XENLA	Glutamine amidotransferase-like class 1 domain-containing protein 1 (Parkinson disease 7 domain-containing protein 1)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g156910	Scaffold_07	11649510	11686904	P29294	MYLK_RABIT	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]
PGEN_.00g156920	Scaffold_07	11697359	11704724	Q63ZK1	MI40B_XENLA	Mitochondrial intermembrane space import and assembly protein 40-B (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4-B)	GO:0005758; GO:0015035; GO:0022417; GO:0045041; GO:0051084	mitochondrial intermembrane space [GO:0005758]; protein disulfide oxidoreductase activity [GO:0015035]; 'de novo' posttranslational protein folding [GO:0051084]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]
PGEN_.00g156930	Scaffold_07	11721859	11724423	NA	NA	NA	NA	NA
PGEN_.00g156940	Scaffold_07	11731533	11731769	NA	NA	NA	NA	NA
PGEN_.00g156950	Scaffold_07	11735734	11743935	NA	NA	NA	NA	NA
PGEN_.00g156960	Scaffold_07	11754342	11772391	Q8K375	LRC56_MOUSE	Leucine-rich repeat-containing protein 56	GO:0005929; GO:0030030	cilium [GO:0005929]; cell projection organization [GO:0030030]
PGEN_.00g156970	Scaffold_07	11780320	11810132	Q8IVL5	P3H2_HUMAN	Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) (Myxoid liposarcoma-associated protein 4)	GO:0005506; GO:0005604; GO:0005654; GO:0005783; GO:0005788; GO:0005794; GO:0008285; GO:0016529; GO:0019511; GO:0019797; GO:0031418; GO:0032963	basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum [GO:0016529]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]; collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-proline hydroxylation [GO:0019511]
PGEN_.00g156980	Scaffold_07	11810490	11812341	Q6JHU8	P3H1_CHICK	Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Leucine- and proline-enriched proteoglycan 1 homolog) (Leprecan-1 homolog)	GO:0005506; GO:0005783; GO:0019797; GO:0031418; GO:0032963; GO:0032991; GO:0050708; GO:0050821; GO:0060348; GO:0061077; GO:1901874; GO:1904027	endoplasmic reticulum [GO:0005783]; protein-containing complex [GO:0032991]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen metabolic process [GO:0032963]; negative regulation of collagen fibril organization [GO:1904027]; negative regulation of post-translational protein modification [GO:1901874]; protein stabilization [GO:0050821]; regulation of protein secretion [GO:0050708]
PGEN_.00g156990	Scaffold_07	11826133	11840551	P31684	4CL1_SOLTU	4-coumarate--CoA ligase 1 (4CL 1) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 1)	GO:0005524; GO:0009698; GO:0016207	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]
PGEN_.00g157000	Scaffold_07	11841623	11844935	NA	NA	NA	NA	NA
PGEN_.00g157010	Scaffold_07	11851724	11852923	C7G0B5	PIF_PINFU	Protein PIF [Cleaved into: Protein Pif97; Protein Pif80 (Aragonite-binding protein)]	GO:0005576; GO:0006030; GO:0008061	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]
PGEN_.00g157020	Scaffold_07	11858896	11859603	NA	NA	NA	NA	NA
PGEN_.00g157030	Scaffold_07	11862829	11899326	Q3T906	GNPTA_HUMAN	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0033299; GO:0046835	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]
PGEN_.00g157040	Scaffold_07	12002905	12049836	O75038	PLCH2_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)"	GO:0004435; GO:0005509; GO:0005623; GO:0005737; GO:0005886; GO:0016042; GO:0032959; GO:0043647; GO:0046488; GO:0048015; GO:0051209	cell [GO:0005623]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; release of sequestered calcium ion into cytosol [GO:0051209]
PGEN_.00g157050	Scaffold_07	12084566	12087296	NA	NA	NA	NA	NA
PGEN_.00g157060	Scaffold_07	12088544	12131135	NA	NA	NA	NA	NA
PGEN_.00g157070	Scaffold_07	12146016	12147197	NA	NA	NA	NA	NA
PGEN_.00g157080	Scaffold_07	12147289	12152007	NA	NA	NA	NA	NA
PGEN_.00g157090	Scaffold_07	12161083	12171853	NA	NA	NA	NA	NA
PGEN_.00g157100	Scaffold_07	12181485	12200972	NA	NA	NA	NA	NA
PGEN_.00g157110	Scaffold_07	12208310	12208672	NA	NA	NA	NA	NA
PGEN_.00g157120	Scaffold_07	12208703	12209718	NA	NA	NA	NA	NA
PGEN_.00g157130	Scaffold_07	12209811	12211395	NA	NA	NA	NA	NA
PGEN_.00g157140	Scaffold_07	12211663	12212010	NA	NA	NA	NA	NA
PGEN_.00g157150	Scaffold_07	12218561	12220166	O68008	BACC_BACLI	Bacitracin synthase 3 (BA3) [Includes: ATP-dependent isoleucine adenylase (IleA) (Isoleucine activase); ATP-dependent D-phenylalanine adenylase (D-PheA) (D-phenylalanine activase); ATP-dependent histidine adenylase (HisA) (Histidine activase); ATP-dependent D-aspartate adenylase (D-AspA) (D-aspartate activase); ATP-dependent asparagine adenylase (AsnA) (Asparagine activase); Aspartate racemase (EC 5.1.1.13); Phenylalanine racemase [ATP hydrolyzing] (EC 5.1.1.11)]	GO:0005524; GO:0016788; GO:0016874; GO:0017000; GO:0031177; GO:0047462; GO:0047689	"aspartate racemase activity [GO:0047689]; ATP binding [GO:0005524]; hydrolase activity, acting on ester bonds [GO:0016788]; ligase activity [GO:0016874]; phenylalanine racemase (ATP-hydrolyzing) activity [GO:0047462]; phosphopantetheine binding [GO:0031177]; antibiotic biosynthetic process [GO:0017000]"
PGEN_.00g157160	Scaffold_07	12224845	12226454	NA	NA	NA	NA	NA
PGEN_.00g157170	Scaffold_07	12227760	12230219	Q7WSH3	FADD3_COMTE	"3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl:CoA ligase (HIP:CoA ligase) (EC 6.2.1.41)"	GO:0005524; GO:0008203; GO:0016874	ATP binding [GO:0005524]; ligase activity [GO:0016874]; cholesterol metabolic process [GO:0008203]
PGEN_.00g157180	Scaffold_07	12238282	12243919	Q0P4F7	ACSF2_DANRE	"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)"	GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]
PGEN_.00g157190	Scaffold_07	12248423	12257194	Q5FYB0	ARSJ_HUMAN	Arylsulfatase J (ASJ) (EC 3.1.6.-)	GO:0004065; GO:0005576; GO:0005788; GO:0015629; GO:0046872	actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]
PGEN_.00g157200	Scaffold_07	12258358	12262471	P50429	ARSB_MOUSE	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]
PGEN_.00g157210	Scaffold_07	12267861	12284571	Q7WSH3	FADD3_COMTE	"3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl:CoA ligase (HIP:CoA ligase) (EC 6.2.1.41)"	GO:0005524; GO:0008203; GO:0016874	ATP binding [GO:0005524]; ligase activity [GO:0016874]; cholesterol metabolic process [GO:0008203]
PGEN_.00g157220	Scaffold_07	12271999	12272298	NA	NA	NA	NA	NA
PGEN_.00g157230	Scaffold_07	12295294	12307892	NA	NA	NA	NA	NA
PGEN_.00g157240	Scaffold_07	12311330	12311833	NA	NA	NA	NA	NA
PGEN_.00g157250	Scaffold_07	12312139	12313560	NA	NA	NA	NA	NA
PGEN_.00g157260	Scaffold_07	12334632	12335042	NA	NA	NA	NA	NA
PGEN_.00g157270	Scaffold_07	12337684	12356458	B3EWZ5	MLRP1_ACRMI	MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g157280	Scaffold_07	12388342	12388698	NA	NA	NA	NA	NA
PGEN_.00g157290	Scaffold_07	12395014	12402702	NA	NA	NA	NA	NA
PGEN_.00g157300	Scaffold_07	12412928	12413563	NA	NA	NA	NA	NA
PGEN_.00g157310	Scaffold_07	12415329	12420093	NA	NA	NA	NA	NA
PGEN_.00g157320	Scaffold_07	12479198	12506540	P13670	CHB_VIBHA	"N,N'-diacetylchitobiase (Chitobiase) (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (N-acetyl-beta-glucosaminidase)"	GO:0000272; GO:0004563; GO:0006032; GO:0009279; GO:0030247; GO:0102148	cell outer membrane [GO:0009279]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]
PGEN_.00g157330	Scaffold_07	12538212	12543209	P42891	ECE1_BOVIN	Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)	GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0042803; GO:0046872	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; proteolysis [GO:0006508]
PGEN_.00g157340	Scaffold_07	12545469	12553239	Q8T062	NEP4_DROME	Neprilysin-4 (EC 3.4.24.11)	GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0016529; GO:0046872	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]
PGEN_.00g157350	Scaffold_07	12562498	12564360	Q7WSH3	FADD3_COMTE	"3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl:CoA ligase (HIP:CoA ligase) (EC 6.2.1.41)"	GO:0005524; GO:0008203; GO:0016874	ATP binding [GO:0005524]; ligase activity [GO:0016874]; cholesterol metabolic process [GO:0008203]
PGEN_.00g157360	Scaffold_07	12568413	12579780	Q32KU6	TSN6_BOVIN	Tetraspanin-6 (Tspan-6)	GO:0005887; GO:0039532; GO:1901223	integral component of plasma membrane [GO:0005887]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]
PGEN_.00g157370	Scaffold_07	12585811	12588637	Q5RD73	DUS3_PONAB	Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Vaccinia H1-related phosphatase) (VHR)	GO:0001772; GO:0004725; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0030336; GO:0030971; GO:0033549; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183	cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]
PGEN_.00g157380	Scaffold_07	12592766	12594458	NA	NA	NA	NA	NA
PGEN_.00g157390	Scaffold_07	12597243	12607554	A2R345	DCL21_ASPNC	Dicer-like protein 2-1 [Includes: Endoribonuclease dcl2-1 (EC 3.1.26.-); ATP-dependent helicase dcl2-1 (EC 3.6.4.-)]	GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0006396; GO:0046872; GO:0050688; GO:0051607	ATP binding [GO:0005524]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688]; RNA processing [GO:0006396]
PGEN_.00g157400	Scaffold_07	12607593	12612574	Q8AVN9	ZN346_XENLA	Zinc finger protein 346 (Double-stranded RNA-binding protein ZFa) (DsRBP-ZFa) (ZFa) (Just another zinc finger protein) (Protein jaz)	GO:0003725; GO:0005634; GO:0005737; GO:0008270	cytoplasm [GO:0005737]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; zinc ion binding [GO:0008270]
PGEN_.00g157410	Scaffold_07	12614350	12626223	NA	NA	NA	NA	NA
PGEN_.00g157420	Scaffold_07	12638137	12638352	NA	NA	NA	NA	NA
PGEN_.00g157430	Scaffold_07	12642449	12656424	Q60547	SYCP3_MESAU	Synaptonemal complex protein 3 (SCP-3) (Meiotic chromosome core protein) (Synaptonemal complex protein COR1)	GO:0000775; GO:0000800; GO:0003677; GO:0035093; GO:0051301; GO:0051321	"chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; DNA binding [GO:0003677]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"
PGEN_.00g157440	Scaffold_07	12656972	12660797	Q296J9	NRM_DROPS	Nurim homolog (Nuclear envelope membrane protein) (Nuclear rim protein)	GO:0005635; GO:0005637; GO:0016021	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]
PGEN_.00g157450	Scaffold_07	12671459	12688807	Q7L804	RFIP2_HUMAN	Rab11 family-interacting protein 2 (Rab11-FIP2) (NRip11)	GO:0001891; GO:0003091; GO:0005623; GO:0005654; GO:0005768; GO:0006909; GO:0017137; GO:0019901; GO:0030010; GO:0030659; GO:0035669; GO:0035773; GO:0042802; GO:0042803; GO:0042995; GO:0043231; GO:0043547; GO:0045055; GO:0055038; GO:1903078	cell [GO:0005623]; cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; establishment of cell polarity [GO:0030010]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulated exocytosis [GO:0045055]; renal water homeostasis [GO:0003091]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]
PGEN_.00g157460	Scaffold_07	12693893	12700492	Q9BXF6	RFIP5_HUMAN	Rab11 family-interacting protein 5 (Rab11-FIP5) (Gamma-SNAP-associated factor 1) (Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11)	GO:0000139; GO:0005623; GO:0005741; GO:0005769; GO:0005794; GO:0017137; GO:0030141; GO:0030658; GO:0031901; GO:0034451; GO:0035773; GO:0043015; GO:0043231; GO:0045055; GO:0055037; GO:0055038; GO:0070164; GO:0071468; GO:2000008	cell [GO:0005623]; centriolar satellite [GO:0034451]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658]; gamma-tubulin binding [GO:0043015]; Rab GTPase binding [GO:0017137]; cellular response to acidic pH [GO:0071468]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; negative regulation of adiponectin secretion [GO:0070164]; regulated exocytosis [GO:0045055]; regulation of protein localization to cell surface [GO:2000008]
PGEN_.00g157470	Scaffold_07	12701542	12709681	NA	NA	NA	NA	NA
PGEN_.00g157480	Scaffold_07	12711771	12738249	Q96M20	CNBD2_HUMAN	Cyclic nucleotide-binding domain-containing protein 2	GO:0005829; GO:0007283; GO:0030552	cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
PGEN_.00g157490	Scaffold_07	12782157	12791545	Q6MG82	PRRT1_RAT	Proline-rich transmembrane protein 1 (Dispanin subfamily D member 1) (DSPD1)	GO:0016020; GO:0030054; GO:0098978; GO:0099055	cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]
PGEN_.00g157500	Scaffold_07	12796017	12821698	Q5CZC0	FSIP2_HUMAN	Fibrous sheath-interacting protein 2		
PGEN_.00g157510	Scaffold_07	12830788	12830997	NA	NA	NA	NA	NA
PGEN_.00g157520	Scaffold_07	12865330	12884987	A0JPE1	DIK1B_XENTR	Divergent protein kinase domain 1B (Protein FAM69B)	GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
PGEN_.00g157530	Scaffold_07	12887212	12887544	NA	NA	NA	NA	NA
PGEN_.00g157540	Scaffold_07	12891372	12893708	NA	NA	NA	NA	NA
PGEN_.00g157550	Scaffold_07	12897610	12929710	P28339	DPOD1_BOVIN	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)	GO:0000166; GO:0003682; GO:0003684; GO:0003887; GO:0006260; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0034644; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089	"delta DNA polymerase complex [GO:0043625]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA-dependent DNA replication [GO:0006261]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]"
PGEN_.00g157560	Scaffold_07	12937115	12949514	E0U174	BIRA_BACPZ	Bifunctional ligase/repressor BirA (Biotin--[acetyl-CoA-carboxylase] ligase) (EC 6.3.4.15) (Biotin--protein ligase) (Biotin-[acetyl-CoA carboxylase] synthetase)	GO:0003677; GO:0004077; GO:0005524; GO:0006355; GO:0009305	"ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; DNA binding [GO:0003677]; protein biotinylation [GO:0009305]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g157570	Scaffold_07	12964075	12979458	E0U174	BIRA_BACPZ	Bifunctional ligase/repressor BirA (Biotin--[acetyl-CoA-carboxylase] ligase) (EC 6.3.4.15) (Biotin--protein ligase) (Biotin-[acetyl-CoA carboxylase] synthetase)	GO:0003677; GO:0004077; GO:0005524; GO:0006355; GO:0009305	"ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; DNA binding [GO:0003677]; protein biotinylation [GO:0009305]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g157580	Scaffold_07	12994079	13002796	Q6DE37	GXLT2_XENLA	Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4)	GO:0016021; GO:0016266; GO:0035252	integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]
PGEN_.00g157590	Scaffold_07	13034224	13039170	Q6Q0N1	CNDP2_RAT	Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2)	GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0008237; GO:0016805; GO:0046872; GO:0102008; GO:0103046	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]
PGEN_.00g157600	Scaffold_07	13052227	13080251	O75096	LRP4_HUMAN	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]
PGEN_.00g157610	Scaffold_07	13080767	13081660	NA	NA	NA	NA	NA
PGEN_.00g157620	Scaffold_07	13084172	13089261	Q8VI56	LRP4_MOUSE	Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)	GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]
PGEN_.00g157630	Scaffold_07	13143075	13179488	Q6DGK9	CK049_DANRE	UPF0705 protein C11orf49 homolog		
PGEN_.00g157640	Scaffold_07	13180133	13192540	P17635	FMO2_RABIT	Dimethylaniline monooxygenase [N-oxide-forming] 2 (EC 1.14.13.8) (Dimethylaniline oxidase 2) (FMO 1B1) (Pulmonary flavin-containing monooxygenase 2) (FMO 2)	GO:0004499; GO:0005789; GO:0016020; GO:0016021; GO:0050660; GO:0050661; GO:0070995	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidation [GO:0070995]"
PGEN_.00g157650	Scaffold_07	13206099	13214986	Q8N884	CGAS_HUMAN	Cyclic GMP-AMP synthase (cGAMP synthase) (cGAS) (h-cGAS) (EC 2.7.7.86) (2'3'-cGAMP synthase) (Mab-21 domain-containing protein 1)	GO:0002218; GO:0002230; GO:0002637; GO:0003677; GO:0003682; GO:0003690; GO:0005524; GO:0005525; GO:0005546; GO:0005634; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0008340; GO:0010753; GO:0016032; GO:0032481; GO:0035861; GO:0038001; GO:0043950; GO:0045087; GO:0046872; GO:0050863; GO:0051607; GO:0061501; GO:0071360; GO:2000042; GO:2000774	"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclic-GMP-AMP synthase activity [GO:0061501]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; activation of innate immune response [GO:0002218]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; paracrine signaling [GO:0038001]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of immunoglobulin production [GO:0002637]; regulation of T cell activation [GO:0050863]; viral process [GO:0016032]"
PGEN_.00g157660	Scaffold_07	13225436	13230662	Q08882	HR3_MANSE	Probable nuclear hormone receptor HR3 (mHR3) (Nuclear receptor subfamily 1 group F member 4)	GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]
PGEN_.00g157670	Scaffold_07	13230715	13236589	NA	NA	NA	NA	NA
PGEN_.00g157680	Scaffold_07	13246594	13250562	NA	NA	NA	NA	NA
PGEN_.00g157690	Scaffold_07	13254455	13254853	NA	NA	NA	NA	NA
PGEN_.00g157700	Scaffold_07	13256023	13257240	P54131	ACHA7_BOVIN	Neuronal acetylcholine receptor subunit alpha-7	GO:0000187; GO:0001540; GO:0001666; GO:0005623; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890	"acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g157710	Scaffold_07	13271990	13287566	Q92100	CP1A1_PLEPL	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g157720	Scaffold_07	13299400	13301550	O64900	C80B2_ESCCA	(S)-N-methylcoclaurine 3'-hydroxylase isozyme 2 (EC 1.14.14.102) (Cytochrome P450 80B2)	GO:0005506; GO:0005789; GO:0016021; GO:0020037; GO:0050593	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; N-methylcoclaurine 3'-monooxygenase activity [GO:0050593]
PGEN_.00g157730	Scaffold_07	13431391	13441923	NA	NA	NA	NA	NA
PGEN_.00g157740	Scaffold_07	13490987	13492616	NA	NA	NA	NA	NA
PGEN_.00g157750	Scaffold_07	13500829	13501438	NA	NA	NA	NA	NA
PGEN_.00g157760	Scaffold_07	13533208	13533642	NA	NA	NA	NA	NA
PGEN_.00g157770	Scaffold_07	13540774	13548457	NA	NA	NA	NA	NA
PGEN_.00g157780	Scaffold_07	13551587	13573826	Q6PHK6	PURB_DANRE	Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B)	GO:0000977; GO:0001227; GO:0003690; GO:0005634; GO:0008283; GO:0030154; GO:0032422; GO:0043565	"nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]"
PGEN_.00g157790	Scaffold_07	13589676	13602155	Q3S8M4	ELOV4_MACMU	Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)	GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"
PGEN_.00g157800	Scaffold_07	13639765	13650576	Q9DAN9	CF97D_MOUSE	Uncharacterized protein CFAP97D1 (CFAP97 domain-containing protein 1)		
PGEN_.00g157810	Scaffold_07	13651254	13651544	NA	NA	NA	NA	NA
PGEN_.00g157820	Scaffold_07	13661100	13680494	Q3SZA5	SPSY_BOVIN	Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase)	GO:0006597; GO:0016768	spermine synthase activity [GO:0016768]; spermine biosynthetic process [GO:0006597]
PGEN_.00g157830	Scaffold_07	13696682	13703131	NA	NA	NA	NA	NA
PGEN_.00g157840	Scaffold_07	13704779	13716094	Q7T2D4	ERGI2_DANRE	Endoplasmic reticulum-Golgi intermediate compartment protein 2	GO:0005783; GO:0006888; GO:0006890; GO:0030134; GO:0030173; GO:0030176; GO:0033116	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g157850	Scaffold_07	13725963	13754736	Q8CHH5	BICRL_MOUSE	BRD4-interacting chromatin-remodeling complex-associated protein-like	GO:0016514	SWI/SNF complex [GO:0016514]
PGEN_.00g157860	Scaffold_07	13765016	13765888	Q9DBA6	TYSD1_MOUSE	"Peroxisomal leader peptide-processing protease (EC 3.4.21.-) (Trypsin domain-containing protein 1) [Cleaved into: Peroxisomal leader peptide-processing protease, 10 kDa form; Peroxisomal leader peptide-processing protease, 49 kDa form]"	GO:0002020; GO:0004252; GO:0005777; GO:0005782; GO:0006508; GO:0016485; GO:0031998; GO:0042802; GO:0051260	peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of fatty acid beta-oxidation [GO:0031998]
PGEN_.00g157870	Scaffold_07	13785155	13798805	Q9JLB5	ACH10_RAT	Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10)	GO:0004888; GO:0005262; GO:0005623; GO:0005887; GO:0007165; GO:0007204; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0030424; GO:0034220; GO:0042391; GO:0042472; GO:0043005; GO:0043204; GO:0045202; GO:0050877; GO:0050910; GO:0070373; GO:0098981; GO:0099060; GO:1904315	"axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g157880	Scaffold_07	13840932	13890952	NA	NA	NA	NA	NA
PGEN_.00g157890	Scaffold_07	13928541	13931104	Q90966	RARA_CHICK	Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1)	GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001657; GO:0001843; GO:0001889; GO:0001972; GO:0002068; GO:0003148; GO:0003417; GO:0003707; GO:0003714; GO:0004879; GO:0005102; GO:0005623; GO:0005634; GO:0005654; GO:0005829; GO:0006468; GO:0007275; GO:0007281; GO:0007283; GO:0008134; GO:0008270; GO:0008284; GO:0009755; GO:0015629; GO:0019904; GO:0021575; GO:0030154; GO:0030374; GO:0030853; GO:0031076; GO:0031490; GO:0032526; GO:0032689; GO:0032720; GO:0032736; GO:0032753; GO:0032754; GO:0033993; GO:0035264; GO:0038023; GO:0043066; GO:0043277; GO:0043422; GO:0044323; GO:0045630; GO:0045787; GO:0045944; GO:0046982; GO:0048384; GO:0048732; GO:0051018; GO:0051099; GO:0051393; GO:0055012; GO:0060010; GO:0060173; GO:0060324; GO:0060349; GO:0060429; GO:0060534; GO:0060591; GO:0061037; GO:0071222; GO:0071300; GO:0071391; GO:0090575	"actin cytoskeleton [GO:0015629]; cell [GO:0005623]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; alpha-actinin binding [GO:0051393]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase A binding [GO:0051018]; protein kinase B binding [GO:0043422]; retinoic acid binding [GO:0001972]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; steroid hormone receptor activity [GO:0003707]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; apoptotic cell clearance [GO:0043277]; bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; chondroblast differentiation [GO:0060591]; embryonic camera-type eye development [GO:0031076]; epithelium development [GO:0060429]; face development [GO:0060324]; germ cell development [GO:0007281]; gland development [GO:0048732]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hindbrain morphogenesis [GO:0021575]; hormone-mediated signaling pathway [GO:0009755]; limb development [GO:0060173]; liver development [GO:0001889]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cartilage development [GO:0061037]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; neural tube closure [GO:0001843]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of binding [GO:0051099]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; response to lipid [GO:0033993]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]; Sertoli cell fate commitment [GO:0060010]; spermatogenesis [GO:0007283]; trachea cartilage development [GO:0060534]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]"
PGEN_.00g157900	Scaffold_07	13934190	13936532	P15370	EGON_DROME	Protein embryonic gonad (Nuclear receptor subfamily 0 group A member 3) (Protein eagle) (Protein spready)	GO:0003700; GO:0005634; GO:0006355; GO:0007417; GO:0008270; GO:0030154; GO:0043565; GO:0070491	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g157910	Scaffold_07	13943163	13948151	NA	NA	NA	NA	NA
PGEN_.00g157920	Scaffold_07	13963761	13979388	NA	NA	NA	NA	NA
PGEN_.00g157930	Scaffold_07	13989876	13990718	NA	NA	NA	NA	NA
PGEN_.00g157940	Scaffold_07	14012565	14030024	Q6PFM0	JMJD6_DANRE	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR) (zfpsr)	GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006482; GO:0006909; GO:0008380; GO:0018395; GO:0030154; GO:0032451; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070079; GO:0070815	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; metal ion binding [GO:0046872]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; histone H4-R3 demethylation [GO:0070079]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]"
PGEN_.00g157950	Scaffold_07	14061856	14064553	Q865C0	CAH6_CANLF	Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI)	GO:0004089; GO:0005576; GO:0006730; GO:0008270	extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]
PGEN_.00g157960	Scaffold_07	14069149	14096556	Q5FVY2	RSLBB_XENTR	Ras-like protein family member 11B	GO:0003924; GO:0005525; GO:0007165; GO:0016020	membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]
PGEN_.00g157970	Scaffold_07	14099234	14138272	NA	NA	NA	NA	NA
PGEN_.00g157980	Scaffold_07	14144556	14146188	NA	NA	NA	NA	NA
PGEN_.00g157990	Scaffold_07	14157139	14163059	P42577	FRIS_LYMST	Soma ferritin (EC 1.16.3.1)	GO:0004322; GO:0005623; GO:0005737; GO:0006826; GO:0006879; GO:0008199	cell [GO:0005623]; cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]
PGEN_.00g158000	Scaffold_07	14174684	14193564	NA	NA	NA	NA	NA
PGEN_.00g158010	Scaffold_07	14207336	14226375	Q9QYW0	AATF_RAT	Protein AATF (Apoptosis-antagonizing transcription factor)	GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0006915; GO:0006974; GO:0007155; GO:0007346; GO:0019901; GO:0032929; GO:0040016; GO:0042254; GO:0042985; GO:0043066; GO:0043522; GO:0044798; GO:0045893; GO:0045944; GO:0048156; GO:2000378; GO:2001234	"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nuclear transcription factor complex [GO:0044798]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle [GO:0007346]; ribosome biogenesis [GO:0042254]"
PGEN_.00g158020	Scaffold_07	14240084	14247787	Q8K2W6	PHF13_MOUSE	PHD finger protein 13	GO:0000278; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0007059; GO:0007076; GO:0046872; GO:0051301	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; cell division [GO:0051301]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]
PGEN_.00g158030	Scaffold_07	14247831	14259494	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g158040	Scaffold_07	14274858	14296011	Q5ZLY5	PKHF2_CHICK	Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2)	GO:0005783; GO:0015031; GO:0031901; GO:0035091; GO:0046872	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]
PGEN_.00g158050	Scaffold_07	14301169	14302381	NA	NA	NA	NA	NA
PGEN_.00g158060	Scaffold_07	14312237	14313079	NA	NA	NA	NA	NA
PGEN_.00g158070	Scaffold_07	14318826	14345750	NA	NA	NA	NA	NA
PGEN_.00g158080	Scaffold_07	14349593	14356687	P98164	LRP2_HUMAN	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	GO:0001523; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008144; GO:0008283; GO:0008584; GO:0009897; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030665; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0045056; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060982; GO:0061024; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:1904447; GO:1905167	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; insulin-like growth factor I binding [GO:0031994]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359]
PGEN_.00g158090	Scaffold_07	14386553	14403022	Q61469	PLPP1_MOUSE	Phospholipid phosphatase 1 (EC 3.1.3.4) (35 kDa PAP) (mPAP) (Hydrogen peroxide-inducible protein 53) (Hic53) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a)	GO:0005886; GO:0005887; GO:0006470; GO:0006644; GO:0006651; GO:0006670; GO:0006672; GO:0007165; GO:0008195; GO:0016020; GO:0016791; GO:0042577; GO:0046839	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; sphingosine metabolic process [GO:0006670]
PGEN_.00g158100	Scaffold_07	14410803	14411087	NA	NA	NA	NA	NA
PGEN_.00g158110	Scaffold_07	14431741	14432103	NA	NA	NA	NA	NA
PGEN_.00g158120	Scaffold_07	14440165	14440752	NA	NA	NA	NA	NA
PGEN_.00g158130	Scaffold_07	14463842	14464099	NA	NA	NA	NA	NA
PGEN_.00g158140	Scaffold_07	14511677	14514991	NA	NA	NA	NA	NA
PGEN_.00g158150	Scaffold_07	14524854	14525690	NA	NA	NA	NA	NA
PGEN_.00g158160	Scaffold_07	14536116	14550626	P97302	BACH1_MOUSE	Transcription regulator protein BACH1 (BTB and CNC homolog 1)	GO:0000083; GO:0000117; GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006281; GO:0006355; GO:0045944; GO:0061418	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; DNA repair [GO:0006281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0000117]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g158170	Scaffold_07	14556617	14563777	Q84TH5	AB25G_ARATH	ABC transporter G family member 25 (ABC transporter ABCG.25) (AtABCG25) (White-brown complex homolog protein 26) (AtWBC26)	GO:0005524; GO:0005886; GO:0009737; GO:0016021; GO:0016887; GO:0042626; GO:0055085; GO:0080168	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; abscisic acid transport [GO:0080168]; response to abscisic acid [GO:0009737]; transmembrane transport [GO:0055085]
PGEN_.00g158180	Scaffold_07	14563830	14587177	Q93YS4	AB22G_ARATH	ABC transporter G family member 22 (ABC transporter ABCG.22) (AtABCG22) (White-brown complex homolog protein 23) (AtWBC23)	GO:0005524; GO:0005886; GO:0009414; GO:0010148; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; response to water deprivation [GO:0009414]; transmembrane transport [GO:0055085]; transpiration [GO:0010148]
PGEN_.00g158190	Scaffold_07	14599929	14604392	NA	NA	NA	NA	NA
PGEN_.00g158200	Scaffold_07	14604625	14604918	NA	NA	NA	NA	NA
PGEN_.00g158210	Scaffold_07	14607655	14611520	NA	NA	NA	NA	NA
PGEN_.00g158220	Scaffold_07	14614004	14614420	NA	NA	NA	NA	NA
PGEN_.00g158230	Scaffold_07	14616688	14616972	NA	NA	NA	NA	NA
PGEN_.00g158240	Scaffold_07	14621372	14621647	NA	NA	NA	NA	NA
PGEN_.00g158250	Scaffold_07	14650121	14650390	NA	NA	NA	NA	NA
PGEN_.00g158260	Scaffold_07	14650488	14651215	NA	NA	NA	NA	NA
PGEN_.00g158270	Scaffold_07	14653686	14654048	NA	NA	NA	NA	NA
PGEN_.00g158280	Scaffold_07	14659003	14678155	Q9Z1J2	NEK4_MOUSE	Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2)	GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0023014; GO:0030145; GO:0032147; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:1900062; GO:2000772; GO:2001020	"ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]"
PGEN_.00g158290	Scaffold_07	14685393	14692039	NA	NA	NA	NA	NA
PGEN_.00g158300	Scaffold_07	14697291	14697827	NA	NA	NA	NA	NA
PGEN_.00g158310	Scaffold_07	14709667	14712054	NA	NA	NA	NA	NA
PGEN_.00g158320	Scaffold_07	14715104	14727244	Q7T2B9	MTPN_DANRE	Myotrophin	GO:0005634; GO:0048471	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
PGEN_.00g158330	Scaffold_07	14739576	14745292	Q9W237	RS16_DROME	40S ribosomal protein S16	GO:0000462; GO:0002181; GO:0003723; GO:0003735; GO:0022626; GO:0022627	"cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"
PGEN_.00g158340	Scaffold_07	14757142	14763688	Q0VCD4	MED18_BOVIN	Mediator of RNA polymerase II transcription subunit 18 (Mediator complex subunit 18)	GO:0003712; GO:0006357; GO:0006369; GO:0016592; GO:0070847	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]; termination of RNA polymerase II transcription [GO:0006369]
PGEN_.00g158350	Scaffold_07	14778050	14794079	P30932	CD9_BOVIN	CD9 antigen (CD antigen CD9)	GO:0005178; GO:0005886; GO:0005887; GO:0007155; GO:0007338; GO:0007342; GO:0008285; GO:0009897; GO:0014905; GO:0016020; GO:0030913; GO:0031623; GO:0032991; GO:0035036; GO:0051271; GO:0070062; GO:0071404; GO:0090331; GO:1905521	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular component movement [GO:0051271]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]
PGEN_.00g158360	Scaffold_07	14822849	14824330	NA	NA	NA	NA	NA
PGEN_.00g158370	Scaffold_07	14881738	14890022	NA	NA	NA	NA	NA
PGEN_.00g158380	Scaffold_07	14898192	14901944	Q3UPW2	ELF3_MOUSE	ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1)	GO:0000978; GO:0000981; GO:0001228; GO:0001824; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006954; GO:0009653; GO:0030154; GO:0030198; GO:0030855; GO:0045892; GO:0045893; GO:0045944; GO:0060056	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; anatomical structure morphogenesis [GO:0009653]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g158390	Scaffold_07	14903521	14903910	NA	NA	NA	NA	NA
PGEN_.00g158400	Scaffold_07	14908938	14915531	Q5F4B8	S46A3_CHICK	Solute carrier family 46 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g158410	Scaffold_07	14922211	14927503	A5D7V7	S46A3_BOVIN	Solute carrier family 46 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g158420	Scaffold_07	14931055	14973538	NA	NA	NA	NA	NA
PGEN_.00g158430	Scaffold_07	14987902	14999211	Q8R5M3	LRC15_RAT	Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by amyloid-beta) (rLib)	GO:0001968; GO:0005518; GO:0009986; GO:0016021; GO:0030335; GO:0043236; GO:0046813; GO:1903077	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]
PGEN_.00g158440	Scaffold_07	15009782	15020748	NA	NA	NA	NA	NA
PGEN_.00g158450	Scaffold_07	15033921	15035267	NA	NA	NA	NA	NA
PGEN_.00g158460	Scaffold_07	15110776	15114893	NA	NA	NA	NA	NA
PGEN_.00g158470	Scaffold_07	15121137	15123794	NA	NA	NA	NA	NA
PGEN_.00g158480	Scaffold_07	15238954	15239247	NA	NA	NA	NA	NA
PGEN_.00g158490	Scaffold_07	15242537	15243545	NA	NA	NA	NA	NA
PGEN_.00g158500	Scaffold_07	15259921	15260121	NA	NA	NA	NA	NA
PGEN_.00g158510	Scaffold_07	15260235	15260714	NA	NA	NA	NA	NA
PGEN_.00g158520	Scaffold_07	15280351	15281672	NA	NA	NA	NA	NA
PGEN_.00g158530	Scaffold_07	15312047	15313126	NA	NA	NA	NA	NA
PGEN_.00g158540	Scaffold_07	15448856	15449884	NA	NA	NA	NA	NA
PGEN_.00g158550	Scaffold_07	15452330	15452590	NA	NA	NA	NA	NA
PGEN_.00g158560	Scaffold_07	15455598	15459831	Q8N0W4	NLGNX_HUMAN	"Neuroligin-4, X-linked (Neuroligin X) (HNLX)"	GO:0003360; GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0016021; GO:0021549; GO:0030054; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0071625; GO:0089717; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"
PGEN_.00g158570	Scaffold_07	15543597	15547129	NA	NA	NA	NA	NA
PGEN_.00g158580	Scaffold_07	15558953	15561106	NA	NA	NA	NA	NA
PGEN_.00g158590	Scaffold_07	15637376	15655160	Q04786	HEX_VIBVL	Beta-hexosaminidase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Chitobiase) (N-acetyl-beta-glucosaminidase)	GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0102148	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]
PGEN_.00g158600	Scaffold_07	15756693	15757957	Q04791	SASB_ANAPL	"Fatty acyl-CoA hydrolase precursor, medium chain (EC 3.1.2.-) (Thioesterase B)"	GO:0006633; GO:0016787	hydrolase activity [GO:0016787]; fatty acid biosynthetic process [GO:0006633]
PGEN_.00g158610	Scaffold_07	15768572	15776491	P14417	APOA_MACMU	Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-) (Fragment)	GO:0004252; GO:0006869	serine-type endopeptidase activity [GO:0004252]; lipid transport [GO:0006869]
PGEN_.00g158620	Scaffold_07	15816977	15817768	NA	NA	NA	NA	NA
PGEN_.00g158630	Scaffold_07	15821279	15837504	Q1L8X9	VGLU3_DANRE	Vesicular glutamate transporter 3 (VGluT3) (Solute carrier family 17 member 8)	GO:0005313; GO:0005326; GO:0006814; GO:0015293; GO:0016021; GO:0030054; GO:0030285; GO:0030672; GO:0035249; GO:0043005; GO:0050803; GO:0050957; GO:0060005; GO:0060076; GO:0098700	"cell junction [GO:0030054]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; equilibrioception [GO:0050957]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]; vestibular reflex [GO:0060005]"
PGEN_.00g158640	Scaffold_07	15858772	15863155	O08590	AOC3_RAT	Membrane primary amine oxidase (EC 1.4.3.21) (Copper amine oxidase) (Semicarbazide-sensitive amine oxidase) (SSAO) (VP97) (Vascular adhesion protein 1) (VAP-1)	GO:0002523; GO:0002675; GO:0002687; GO:0005507; GO:0005509; GO:0005615; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005902; GO:0007155; GO:0007568; GO:0008131; GO:0008217; GO:0009308; GO:0009986; GO:0010828; GO:0016021; GO:0035902; GO:0042755; GO:0042802; GO:0043231; GO:0046677; GO:0046982; GO:0048038; GO:0052593; GO:0052594; GO:0052595; GO:0052596; GO:1902283	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; aging [GO:0007568]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; eating behavior [GO:0042755]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of primary amine oxidase activity [GO:1902283]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of leukocyte migration [GO:0002687]; regulation of blood pressure [GO:0008217]; response to antibiotic [GO:0046677]; response to immobilization stress [GO:0035902]
PGEN_.00g158650	Scaffold_07	15881946	15886872	P36633	AOC1_RAT	Amiloride-sensitive amine oxidase [copper-containing] (DAO) (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase)	GO:0005507; GO:0005509; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008144; GO:0008201; GO:0008270; GO:0009308; GO:0035874; GO:0042493; GO:0042803; GO:0044877; GO:0046677; GO:0048038; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0055114; GO:0070062; GO:0071280; GO:0071420; GO:0097185	"bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; drug binding [GO:0008144]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]; amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to histamine [GO:0071420]; oxidation-reduction process [GO:0055114]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]"
PGEN_.00g158660	Scaffold_07	15899061	15910533	Q09FC8	ZN415_HUMAN	Zinc finger protein 415	GO:0001650; GO:0003677; GO:0005737; GO:0015630; GO:0046872	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g158670	Scaffold_07	15924928	15933315	Q8BJ56	PLPL2_MOUSE	Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Desnutrin)	GO:0004806; GO:0005654; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0010891; GO:0010898; GO:0016020; GO:0016021; GO:0019433; GO:0019915; GO:0034389; GO:0044242; GO:0055088	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; triglyceride lipase activity [GO:0004806]; cellular lipid catabolic process [GO:0044242]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]
PGEN_.00g158680	Scaffold_07	15989459	16001876	Q68EH8	FAD1_DANRE	FAD synthase (EC 2.7.7.2) (FAD pyrophosphorylase) (FMN adenylyltransferase) (Flavin adenine dinucleotide synthase) [Includes: Molybdenum cofactor biosynthesis protein-like region; FAD synthase region]	GO:0003919; GO:0005524; GO:0005737; GO:0006747	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; FAD biosynthetic process [GO:0006747]
PGEN_.00g158690	Scaffold_07	16004105	16031239	I0IUP3	MCM8_CHICK	DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8)	GO:0000724; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0006974; GO:0007292; GO:0042555; GO:0048232; GO:0097362	MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]
PGEN_.00g158700	Scaffold_07	16046033	16071638	Q8NCJ5	SPRY3_HUMAN	SPRY domain-containing protein 3		
PGEN_.00g158710	Scaffold_07	16095938	16100589	P15848	ARSB_HUMAN	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	GO:0003943; GO:0004065; GO:0005576; GO:0005739; GO:0005764; GO:0005788; GO:0005791; GO:0005794; GO:0006914; GO:0007040; GO:0007041; GO:0007417; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043312; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]
PGEN_.00g158720	Scaffold_07	16103205	16103756	NA	NA	NA	NA	NA
PGEN_.00g158730	Scaffold_07	16107656	16108516	NA	NA	NA	NA	NA
PGEN_.00g158740	Scaffold_07	16114217	16120247	Q7WSH3	FADD3_COMTE	"3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl:CoA ligase (HIP:CoA ligase) (EC 6.2.1.41)"	GO:0005524; GO:0008203; GO:0016874	ATP binding [GO:0005524]; ligase activity [GO:0016874]; cholesterol metabolic process [GO:0008203]
PGEN_.00g158750	Scaffold_07	16126163	16127356	NA	NA	NA	NA	NA
PGEN_.00g158760	Scaffold_07	16148420	16167003	NA	NA	NA	NA	NA
PGEN_.00g158770	Scaffold_07	16168391	16183853	NA	NA	NA	NA	NA
PGEN_.00g158780	Scaffold_07	16226734	16227372	NA	NA	NA	NA	NA
PGEN_.00g158790	Scaffold_07	16227486	16227704	NA	NA	NA	NA	NA
PGEN_.00g158800	Scaffold_07	16231374	16238454	NA	NA	NA	NA	NA
PGEN_.00g158810	Scaffold_07	16248055	16253220	P07911	UROM_HUMAN	"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]"	GO:0000922; GO:0005509; GO:0005796; GO:0005929; GO:0006968; GO:0007157; GO:0007159; GO:0007588; GO:0008285; GO:0016323; GO:0016324; GO:0019864; GO:0019898; GO:0031225; GO:0050801; GO:0060170; GO:0070062; GO:0072218; GO:0072221; GO:0072233; GO:1990266	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; cellular defense response [GO:0006968]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; negative regulation of cell population proliferation [GO:0008285]; neutrophil migration [GO:1990266]
PGEN_.00g158820	Scaffold_07	16280618	16285757	NA	NA	NA	NA	NA
PGEN_.00g158830	Scaffold_07	16294536	16294814	NA	NA	NA	NA	NA
PGEN_.00g158840	Scaffold_07	16302003	16303569	NA	NA	NA	NA	NA
PGEN_.00g158850	Scaffold_07	16310895	16311281	NA	NA	NA	NA	NA
PGEN_.00g158860	Scaffold_07	16319373	16331522	NA	NA	NA	NA	NA
PGEN_.00g158870	Scaffold_07	16380123	16476519	A0A0R4I9Y1	R213B_DANRE	E3 ubiquitin-protein ligase rnf213-beta (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-B) (Mysterin-beta) (RING finger protein 213-B) (RING finger protein 213-beta) (RING-type E3 ubiquitin transferase rnf213-beta)	GO:0004842; GO:0005829; GO:0006511; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g158880	Scaffold_07	16486303	16487540	NA	NA	NA	NA	NA
PGEN_.00g158890	Scaffold_07	16521390	16522913	NA	NA	NA	NA	NA
PGEN_.00g158900	Scaffold_07	16568906	16592790	NA	NA	NA	NA	NA
PGEN_.00g158910	Scaffold_07	16601398	16601880	NA	NA	NA	NA	NA
PGEN_.00g158920	Scaffold_07	16605373	16748533	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g158930	Scaffold_07	16764007	16764261	NA	NA	NA	NA	NA
PGEN_.00g158940	Scaffold_07	16817160	16817660	NA	NA	NA	NA	NA
PGEN_.00g158950	Scaffold_07	16819838	16820116	NA	NA	NA	NA	NA
PGEN_.00g158960	Scaffold_07	16830782	16836054	NA	NA	NA	NA	NA
PGEN_.00g158970	Scaffold_07	16839586	16843003	B1WAZ6	PA24A_XENTR	Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]	GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0031410; GO:0046475; GO:0047498; GO:0102567; GO:0102568	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; glycerophospholipid catabolic process [GO:0046475]"
PGEN_.00g158980	Scaffold_07	16850469	16875435	NA	NA	NA	NA	NA
PGEN_.00g158990	Scaffold_07	16893743	16897521	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g159000	Scaffold_07	16935846	16940680	NA	NA	NA	NA	NA
PGEN_.00g159010	Scaffold_07	16950080	16971248	P22105	TENX_HUMAN	Tenascin-X (TN-X) (Hexabrachion-like protein)	GO:0005178; GO:0005201; GO:0005576; GO:0005615; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0048251; GO:0062023; GO:0070062; GO:0098633	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
PGEN_.00g159020	Scaffold_07	16979731	16995397	NA	NA	NA	NA	NA
PGEN_.00g159030	Scaffold_07	17003184	17010965	Q8JZM4	DNER_MOUSE	Delta and Notch-like epidermal growth factor-related receptor (Brain EGF repeat-containing transmembrane protein)	GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0007219; GO:0007220; GO:0007417; GO:0010001; GO:0016021; GO:0030425; GO:0043025; GO:0048741	dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]
PGEN_.00g159040	Scaffold_07	17030338	17037857	NA	NA	NA	NA	NA
PGEN_.00g159050	Scaffold_07	17040176	17042325	NA	NA	NA	NA	NA
PGEN_.00g159060	Scaffold_07	17054319	17063798	NA	NA	NA	NA	NA
PGEN_.00g159070	Scaffold_07	17086502	17103529	NA	NA	NA	NA	NA
PGEN_.00g159080	Scaffold_07	17173114	17173356	NA	NA	NA	NA	NA
PGEN_.00g159090	Scaffold_07	17182008	17182400	NA	NA	NA	NA	NA
PGEN_.00g159100	Scaffold_07	17198296	17205192	NA	NA	NA	NA	NA
PGEN_.00g159110	Scaffold_07	17212103	17214014	NA	NA	NA	NA	NA
PGEN_.00g159120	Scaffold_07	17225867	17234363	NA	NA	NA	NA	NA
PGEN_.00g159130	Scaffold_07	17257655	17267457	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g159140	Scaffold_07	17305385	17318737	NA	NA	NA	NA	NA
PGEN_.00g159150	Scaffold_07	17327502	17332392	P63000	RAC1_HUMAN	Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	GO:0000139; GO:0001764; GO:0001934; GO:0002551; GO:0003924; GO:0005525; GO:0005737; GO:0005789; GO:0005802; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006954; GO:0007015; GO:0007155; GO:0007160; GO:0007163; GO:0007266; GO:0007596; GO:0008045; GO:0008283; GO:0008360; GO:0008361; GO:0009611; GO:0009653; GO:0010310; GO:0010591; GO:0010592; GO:0010811; GO:0016020; GO:0016601; GO:0017137; GO:0019899; GO:0019901; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030667; GO:0031116; GO:0031295; GO:0031529; GO:0031996; GO:0032587; GO:0032707; GO:0032956; GO:0034446; GO:0035025; GO:0035556; GO:0035774; GO:0036464; GO:0038095; GO:0038096; GO:0042470; GO:0042826; GO:0042995; GO:0043197; GO:0043312; GO:0043652; GO:0044877; GO:0045428; GO:0045453; GO:0045740; GO:0048010; GO:0048012; GO:0048013; GO:0048261; GO:0048870; GO:0050690; GO:0051022; GO:0051056; GO:0051117; GO:0051492; GO:0051496; GO:0051668; GO:0051894; GO:0051897; GO:0055038; GO:0060071; GO:0060263; GO:0070062; GO:0071260; GO:0071526; GO:0090023; GO:0097178; GO:0098794; GO:0098978; GO:0101003; GO:1900026; GO:1902622	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure morphogenesis [GO:0009653]; blood coagulation [GO:0007596]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; engulfment of apoptotic cell [GO:0043652]; ephrin receptor signaling pathway [GO:0048013]; establishment or maintenance of cell polarity [GO:0007163]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; motor neuron axon guidance [GO:0008045]; negative regulation of interleukin-23 production [GO:0032707]; negative regulation of receptor-mediated endocytosis [GO:0048261]; neuron migration [GO:0001764]; neutrophil degranulation [GO:0043312]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of defense response to virus by virus [GO:0050690]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of lamellipodium assembly [GO:0010591]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of stress fiber assembly [GO:0051492]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; ruffle organization [GO:0031529]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g159160	Scaffold_07	17343840	17346725	NA	NA	NA	NA	NA
PGEN_.00g159170	Scaffold_07	17384745	17406056	P98133	FBN1_BOVIN	Fibrillin-1 (MP340) [Cleaved into: Asprosin]	GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0010737; GO:0031012; GO:0034199; GO:0042593	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]
PGEN_.00g159180	Scaffold_07	17412013	17418846	NA	NA	NA	NA	NA
PGEN_.00g159190	Scaffold_07	17434016	17444602	A2VCU8	NELL2_XENTR	Protein kinase C-binding protein NELL2 (NEL-like protein 2)	GO:0005080; GO:0005509; GO:0005576; GO:0005737; GO:0008201	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080]
PGEN_.00g159200	Scaffold_07	17479086	17491650	Q75N90	FBN3_HUMAN	Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide]	GO:0005201; GO:0005509; GO:0031012	extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]
PGEN_.00g159210	Scaffold_07	17509894	17519891	NA	NA	NA	NA	NA
PGEN_.00g159220	Scaffold_07	17529151	17532820	NA	NA	NA	NA	NA
PGEN_.00g159230	Scaffold_07	17543241	17543984	NA	NA	NA	NA	NA
PGEN_.00g159240	Scaffold_07	17559895	17581815	Q80T79	CSMD3_MOUSE	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g159250	Scaffold_07	17601794	17602537	NA	NA	NA	NA	NA
PGEN_.00g159260	Scaffold_07	17650488	17674496	Q9IAT6	DLLC_DANRE	Delta-like protein C (DeltaC) (delC)	GO:0001756; GO:0001757; GO:0002244; GO:0005112; GO:0005509; GO:0005737; GO:0005886; GO:0007219; GO:0016021; GO:0021514; GO:0030165; GO:0035907; GO:0042802; GO:0045746; GO:0048471; GO:0048514; GO:0048666; GO:0060218; GO:0060842; GO:0061056	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; arterial endothelial cell differentiation [GO:0060842]; blood vessel morphogenesis [GO:0048514]; dorsal aorta development [GO:0035907]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of Notch signaling pathway [GO:0045746]; neuron development [GO:0048666]; Notch signaling pathway [GO:0007219]; sclerotome development [GO:0061056]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; ventral spinal cord interneuron differentiation [GO:0021514]
PGEN_.00g159270	Scaffold_07	17717722	17731133	O35516	NOTC2_MOUSE	Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]	GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005929; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0072602; GO:1990705; GO:2000249; GO:2001204	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060]
PGEN_.00g159280	Scaffold_07	17852383	17864574	NA	NA	NA	NA	NA
PGEN_.00g159290	Scaffold_07	17870666	17883067	NA	NA	NA	NA	NA
PGEN_.00g159300	Scaffold_07	17890447	17906301	P07911	UROM_HUMAN	"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]"	GO:0000922; GO:0005509; GO:0005796; GO:0005929; GO:0006968; GO:0007157; GO:0007159; GO:0007588; GO:0008285; GO:0016323; GO:0016324; GO:0019864; GO:0019898; GO:0031225; GO:0050801; GO:0060170; GO:0070062; GO:0072218; GO:0072221; GO:0072233; GO:1990266	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; cellular defense response [GO:0006968]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; negative regulation of cell population proliferation [GO:0008285]; neutrophil migration [GO:1990266]
PGEN_.00g159310	Scaffold_07	17930926	17936767	NA	NA	NA	NA	NA
PGEN_.00g159320	Scaffold_07	17949558	17955669	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g159330	Scaffold_07	17969287	17987868	NA	NA	NA	NA	NA
PGEN_.00g159340	Scaffold_07	17993987	18008641	Q9TT38	PA24A_RABIT	Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]	GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0009395; GO:0031410; GO:0102567; GO:0102568	"cytoplasmic vesicle [GO:0031410]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; phospholipid catabolic process [GO:0009395]"
PGEN_.00g159350	Scaffold_07	18011822	18016618	O75529	TAF5L_HUMAN	TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L (TAF5L) (PCAF-associated factor 65 beta) (PAF65-beta)	GO:0003713; GO:0005634; GO:0006355; GO:0006366; GO:0016607; GO:0030914; GO:0033276; GO:0036464; GO:0043966; GO:1904672	"cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; transcription coactivator activity [GO:0003713]; histone H3 acetylation [GO:0043966]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g159360	Scaffold_07	18037313	18052202	NA	NA	NA	NA	NA
PGEN_.00g159370	Scaffold_07	18062672	18062935	NA	NA	NA	NA	NA
PGEN_.00g159380	Scaffold_07	18063433	18064913	NA	NA	NA	NA	NA
PGEN_.00g159390	Scaffold_07	18082562	18088521	NA	NA	NA	NA	NA
PGEN_.00g159400	Scaffold_07	18103642	18175569	NA	NA	NA	NA	NA
PGEN_.00g159410	Scaffold_07	18189222	18258026	NA	NA	NA	NA	NA
PGEN_.00g159420	Scaffold_07	18273966	18275475	NA	NA	NA	NA	NA
PGEN_.00g159430	Scaffold_07	18280091	18283212	NA	NA	NA	NA	NA
PGEN_.00g159440	Scaffold_07	18298775	18302105	NA	NA	NA	NA	NA
PGEN_.00g159450	Scaffold_07	18315414	18315659	NA	NA	NA	NA	NA
PGEN_.00g159460	Scaffold_07	18379416	18379670	NA	NA	NA	NA	NA
PGEN_.00g159470	Scaffold_07	18380253	18380730	NA	NA	NA	NA	NA
PGEN_.00g159480	Scaffold_07	18467358	18487589	NA	NA	NA	NA	NA
PGEN_.00g159490	Scaffold_07	18491546	18495278	NA	NA	NA	NA	NA
PGEN_.00g159500	Scaffold_07	18515947	18521936	NA	NA	NA	NA	NA
PGEN_.00g159510	Scaffold_07	18527810	18533279	Q3MHP8	BET1L_BOVIN	BET1-like protein	GO:0000138; GO:0005484; GO:0005829; GO:0015031; GO:0030173; GO:0031201; GO:0042147; GO:2000156	"cytosol [GO:0005829]; Golgi trans cisterna [GO:0000138]; integral component of Golgi membrane [GO:0030173]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; protein transport [GO:0015031]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g159520	Scaffold_07	18544479	18566396	Q01459	DIAC_HUMAN	Di-N-acetylchitobiase (EC 3.2.1.-)	GO:0004568; GO:0005615; GO:0005764; GO:0006032; GO:0008061; GO:0009313	extracellular space [GO:0005615]; lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313]
PGEN_.00g159530	Scaffold_07	18568464	18570850	NA	NA	NA	NA	NA
PGEN_.00g159540	Scaffold_07	18578557	18611074	Q8BTK5	SMYD4_MOUSE	SET and MYND domain-containing protein 4 (EC 2.1.1.-)	GO:0008168; GO:0032259; GO:0046872	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g159550	Scaffold_07	18628435	18628812	NA	NA	NA	NA	NA
PGEN_.00g159560	Scaffold_07	18630560	18631618	NA	NA	NA	NA	NA
PGEN_.00g159570	Scaffold_07	18653643	18676050	NA	NA	NA	NA	NA
PGEN_.00g159580	Scaffold_07	18679511	18687315	NA	NA	NA	NA	NA
PGEN_.00g159590	Scaffold_07	18695706	18699428	P33328	SNC2_YEAST	Synaptobrevin homolog 2	GO:0005484; GO:0005768; GO:0005802; GO:0005933; GO:0006887; GO:0006893; GO:0006897; GO:0006906; GO:0016021; GO:0030658; GO:0031201; GO:0071944	cell periphery [GO:0071944]; cellular bud [GO:0005933]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; vesicle fusion [GO:0006906]
PGEN_.00g159600	Scaffold_07	18700366	18717416	O95373	IPO7_HUMAN	Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7)	GO:0005215; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0007165; GO:0008536; GO:0016020; GO:0016032; GO:0030695; GO:0042393; GO:0045087; GO:0045736; GO:0046332	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; transporter activity [GO:0005215]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165]; viral process [GO:0016032]
PGEN_.00g159610	Scaffold_07	18919736	18932628	NA	NA	NA	NA	NA
PGEN_.00g159620	Scaffold_07	18945168	18945491	NA	NA	NA	NA	NA
PGEN_.00g159630	Scaffold_07	18985416	19036960	A9KNW4	IF2_LACP7	Translation initiation factor IF-2	GO:0003743; GO:0003924; GO:0005525; GO:0005737	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]
PGEN_.00g159640	Scaffold_07	19130999	19146957	NA	NA	NA	NA	NA
PGEN_.00g159650	Scaffold_07	19196592	19228377	NA	NA	NA	NA	NA
PGEN_.00g159660	Scaffold_07	19235771	19278796	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g159670	Scaffold_07	19278900	19284226	A0A0R4I9Y1	R213B_DANRE	E3 ubiquitin-protein ligase rnf213-beta (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-B) (Mysterin-beta) (RING finger protein 213-B) (RING finger protein 213-beta) (RING-type E3 ubiquitin transferase rnf213-beta)	GO:0004842; GO:0005829; GO:0006511; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g159680	Scaffold_07	19388985	19392510	NA	NA	NA	NA	NA
PGEN_.00g159690	Scaffold_07	19426530	19453083	Q63HN8	RN213_HUMAN	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g159700	Scaffold_07	19498613	19532903	E9Q555	RN213_MOUSE	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g159710	Scaffold_07	19533036	19542497	NA	NA	NA	NA	NA
PGEN_.00g159720	Scaffold_07	19542573	19553725	Q63HN8	RN213_HUMAN	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g159730	Scaffold_07	19563629	19565145	NA	NA	NA	NA	NA
PGEN_.00g159740	Scaffold_07	19581475	19583624	NA	NA	NA	NA	NA
PGEN_.00g159750	Scaffold_07	19592057	19596041	P83553	DERM_BIOGL	Dermatopontin (Tyrosine-rich acidic matrix protein) (TRAMP)	GO:0005576; GO:0007155	extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g159760	Scaffold_07	19614490	19624576	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g159770	Scaffold_07	19637027	19692012	Q9C0H5	RHG39_HUMAN	Rho GTPase-activating protein 39	GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007165; GO:0051056; GO:0098978; GO:0099173	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]
PGEN_.00g159780	Scaffold_07	19779232	19779471	NA	NA	NA	NA	NA
PGEN_.00g159790	Scaffold_07	19782032	19787748	Q9D7M1	GID8_MOUSE	Glucose-induced degradation protein 8 homolog (Two hybrid-associated protein 1 with RanBPM) (Twa1)	GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008284; GO:0016055; GO:0030054; GO:0042803; GO:0090263	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; Wnt signaling pathway [GO:0016055]
PGEN_.00g159800	Scaffold_07	19790604	19794042	Q9NX20	RM16_HUMAN	"39S ribosomal protein L16, mitochondrial (L16mt) (MRP-L16) (Mitochondrial large ribosomal subunit protein uL16m)"	GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0019843; GO:0032543; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]
PGEN_.00g159810	Scaffold_07	19798602	19817862	O75140	DEPD5_HUMAN	GATOR complex protein DEPDC5 (DEP domain-containing protein 5)	GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0032007; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130	cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]
PGEN_.00g159820	Scaffold_07	19842555	19917942	O75140	DEPD5_HUMAN	GATOR complex protein DEPDC5 (DEP domain-containing protein 5)	GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0032007; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130	cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]
PGEN_.00g159830	Scaffold_07	19919415	19920902	Q5IS76	ACHA6_PANTR	Neuronal acetylcholine receptor subunit alpha-6	GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007399; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060084	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g159840	Scaffold_07	19933307	19934788	P43143	ACHA6_RAT	Neuronal acetylcholine receptor subunit alpha-6	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0014059; GO:0016020; GO:0022848; GO:0030054; GO:0033603; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0050877; GO:0051899; GO:0098691; GO:0099055; GO:0099056; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g159850	Scaffold_07	19949773	19951254	Q9R0W9	ACHA6_MOUSE	Neuronal acetylcholine receptor subunit alpha-6	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0014059; GO:0016020; GO:0022848; GO:0030054; GO:0033603; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0050877; GO:0051899; GO:0098691; GO:0099055; GO:0099056; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g159860	Scaffold_07	19955107	19956366	NA	NA	NA	NA	NA
PGEN_.00g159870	Scaffold_07	19956460	19956816	NA	NA	NA	NA	NA
PGEN_.00g159880	Scaffold_07	19958472	19958837	NA	NA	NA	NA	NA
PGEN_.00g159890	Scaffold_07	19959008	19959901	NA	NA	NA	NA	NA
PGEN_.00g159900	Scaffold_07	19974432	19996640	Q8INF0	GCY8E_DROME	Soluble guanylate cyclase 88E (EC 4.6.1.2)	GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026	"guanylate cyclase complex, soluble [GO:0008074]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]"
PGEN_.00g159910	Scaffold_07	20003080	20006209	NA	NA	NA	NA	NA
PGEN_.00g159920	Scaffold_07	20096094	20100380	P24587	AKAP5_RAT	A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)	GO:0001664; GO:0001934; GO:0003779; GO:0005516; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0006605; GO:0007193; GO:0007194; GO:0008179; GO:0009898; GO:0010524; GO:0010738; GO:0014069; GO:0014850; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0021510; GO:0021766; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032991; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0043624; GO:0044877; GO:0045121; GO:0045296; GO:0045762; GO:0048471; GO:0050775; GO:0050811; GO:0051602; GO:0060076; GO:0060090; GO:0060135; GO:0070886; GO:0071417; GO:0097110; GO:0098978; GO:0099092; GO:0099149; GO:1903078	"asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; cellular protein complex disassembly [GO:0043624]; cellular response to organonitrogen compound [GO:0071417]; hippocampus development [GO:0021766]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein targeting [GO:0006605]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; response to electrical stimulus [GO:0051602]; response to muscle activity [GO:0014850]; spinal cord development [GO:0021510]"
PGEN_.00g159930	Scaffold_07	20122067	20129247	NA	NA	NA	NA	NA
PGEN_.00g159940	Scaffold_07	20133791	20156517	NA	NA	NA	NA	NA
PGEN_.00g159950	Scaffold_07	20183233	20202872	Q96BD5	PF21A_HUMAN	PHD finger protein 21A (BHC80a) (BRAF35-HDAC complex protein BHC80)	GO:0000118; GO:0000122; GO:0003677; GO:0003682; GO:0005654; GO:0006325; GO:0007596; GO:0046872; GO:1990391	DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; blood coagulation [GO:0007596]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g159960	Scaffold_07	20203125	20218302	Q9UKX7	NUP50_HUMAN	Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50)	GO:0005643; GO:0005654; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0016032; GO:0016925; GO:0019083; GO:0031965; GO:0043231; GO:0043657; GO:0060964; GO:0075733; GO:1900034	host cell [GO:0043657]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]
PGEN_.00g159970	Scaffold_07	20254519	20255613	Q96JT2	S45A3_HUMAN	Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein)	GO:0005886; GO:0008506; GO:0008645; GO:0010907; GO:0015770; GO:0016020; GO:0016021; GO:0045723; GO:0048713; GO:0051119	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]; hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]
PGEN_.00g159980	Scaffold_07	20260594	20285693	NA	NA	NA	NA	NA
PGEN_.00g159990	Scaffold_07	20309001	20340812	Q08D11	PTSS2_XENTR	Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)	GO:0005789; GO:0006659; GO:0016021; GO:0016740	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]
PGEN_.00g160000	Scaffold_07	20354600	20366593	C3Z1P5	RU1C_BRAFL	U1 small nuclear ribonucleoprotein C (U1 snRNP C) (U1-C) (U1C)	GO:0000243; GO:0000387; GO:0000395; GO:0003729; GO:0005685; GO:0008270; GO:0030619; GO:0030627; GO:0071004	commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; pre-mRNA 5'-splice site binding [GO:0030627]; U1 snRNA binding [GO:0030619]; zinc ion binding [GO:0008270]; mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387]
PGEN_.00g160010	Scaffold_07	20377589	20378365	NA	NA	NA	NA	NA
PGEN_.00g160020	Scaffold_07	20378401	20382215	NA	NA	NA	NA	NA
PGEN_.00g160030	Scaffold_07	20395295	20396749	NA	NA	NA	NA	NA
PGEN_.00g160040	Scaffold_07	20572640	20573191	NA	NA	NA	NA	NA
PGEN_.00g160050	Scaffold_07	20637866	20639359	NA	NA	NA	NA	NA
PGEN_.00g160060	Scaffold_07	20641692	20642084	NA	NA	NA	NA	NA
PGEN_.00g160070	Scaffold_07	20686086	20701514	Q58E03	DJC25_XENLA	DnaJ homolog subfamily C member 25	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g160080	Scaffold_07	20752568	20753476	Q8I5R7	SYP_PLAF7	Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)	GO:0004827; GO:0005524; GO:0005737; GO:0006418; GO:0006433; GO:0017101; GO:0042493; GO:0043906	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; Ala-tRNA(Pro) hydrolase activity [GO:0043906]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]; response to drug [GO:0042493]; tRNA aminoacylation for protein translation [GO:0006418]
PGEN_.00g160090	Scaffold_07	20753765	20756568	NA	NA	NA	NA	NA
PGEN_.00g160100	Scaffold_07	20756851	20760269	NA	NA	NA	NA	NA
PGEN_.00g160110	Scaffold_07	20761505	20763887	NA	NA	NA	NA	NA
PGEN_.00g160120	Scaffold_07	20766095	20780895	Q54FB7	XDH_DICDI	Xanthine dehydrogenase (XD) (EC 1.17.1.4)	GO:0004854; GO:0005506; GO:0005777; GO:0009055; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949	"peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine catabolic process [GO:0009115]"
PGEN_.00g160130	Scaffold_07	20789749	20803089	Q8N448	LNX2_HUMAN	Ligand of Numb protein X 2 (Numb-binding protein 2) (PDZ domain-containing RING finger protein 1)	GO:0030165; GO:0042802; GO:0046872	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]
PGEN_.00g160140	Scaffold_07	20826206	20826831	Q6AXT8	SF3A2_RAT	Splicing factor 3A subunit 2	GO:0000245; GO:0000398; GO:0003676; GO:0005634; GO:0005681; GO:0005686; GO:0006397; GO:0008270; GO:0010976; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]"
PGEN_.00g160150	Scaffold_07	20848045	20848287	NA	NA	NA	NA	NA
PGEN_.00g160160	Scaffold_07	20848404	20848799	NA	NA	NA	NA	NA
PGEN_.00g160170	Scaffold_07	20848847	20849092	NA	NA	NA	NA	NA
PGEN_.00g160180	Scaffold_07	20849195	20851313	NA	NA	NA	NA	NA
PGEN_.00g160190	Scaffold_07	20877700	20878098	Q8N448	LNX2_HUMAN	Ligand of Numb protein X 2 (Numb-binding protein 2) (PDZ domain-containing RING finger protein 1)	GO:0030165; GO:0042802; GO:0046872	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]
PGEN_.00g160200	Scaffold_07	20910730	20919339	P50233	DHI2_RAT	Corticosteroid 11-beta-dehydrogenase isozyme 2 (EC 1.1.1.-) (11-beta-hydroxysteroid dehydrogenase type 2) (11-DH2) (11-beta-HSD2) (NAD-dependent 11-beta-hydroxysteroid dehydrogenase)	GO:0001666; GO:0002017; GO:0003845; GO:0005496; GO:0005737; GO:0005783; GO:0007565; GO:0008211; GO:0032094; GO:0032868; GO:0042493; GO:0043231; GO:0048545; GO:0051287; GO:0051384	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity [GO:0003845]; NAD binding [GO:0051287]; steroid binding [GO:0005496]; female pregnancy [GO:0007565]; glucocorticoid metabolic process [GO:0008211]; regulation of blood volume by renal aldosterone [GO:0002017]; response to drug [GO:0042493]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to steroid hormone [GO:0048545]
PGEN_.00g160210	Scaffold_07	20919557	20924881	Q5UCC4	EMC10_HUMAN	ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1)	GO:0001525; GO:0001938; GO:0005576; GO:0010595; GO:0016021; GO:0045766; GO:0072546; GO:1900745	ER membrane protein complex [GO:0072546]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of p38MAPK cascade [GO:1900745]
PGEN_.00g160220	Scaffold_07	20966268	20971994	NA	NA	NA	NA	NA
PGEN_.00g160230	Scaffold_07	20977897	21008628	Q6ITT3	MGT4C_PIG	"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)"	GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0016021; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein N-linked glycosylation [GO:0006487]"
PGEN_.00g160240	Scaffold_07	21017803	21020355	NA	NA	NA	NA	NA
PGEN_.00g160250	Scaffold_07	21059508	21061352	NA	NA	NA	NA	NA
PGEN_.00g160260	Scaffold_07	21115955	21127921	NA	NA	NA	NA	NA
PGEN_.00g160270	Scaffold_07	21141161	21141490	NA	NA	NA	NA	NA
PGEN_.00g160280	Scaffold_07	21147071	21155560	NA	NA	NA	NA	NA
PGEN_.00g160290	Scaffold_07	21165284	21166168	NA	NA	NA	NA	NA
PGEN_.00g160300	Scaffold_07	21181061	21191263	NA	NA	NA	NA	NA
PGEN_.00g160310	Scaffold_07	21195945	21204401	NA	NA	NA	NA	NA
PGEN_.00g160320	Scaffold_07	21230554	21245858	NA	NA	NA	NA	NA
PGEN_.00g160330	Scaffold_07	21245953	21247528	NA	NA	NA	NA	NA
PGEN_.00g160340	Scaffold_07	21345075	21345626	NA	NA	NA	NA	NA
PGEN_.00g160350	Scaffold_07	21345749	21346279	NA	NA	NA	NA	NA
PGEN_.00g160360	Scaffold_07	21347978	21348586	NA	NA	NA	NA	NA
PGEN_.00g160370	Scaffold_07	21357968	21374222	NA	NA	NA	NA	NA
PGEN_.00g160380	Scaffold_07	21381799	21399654	B4L184	WLS_DROMO	Protein wntless	GO:0005887; GO:0007367; GO:0008587; GO:0016055; GO:0017147; GO:0030054; GO:0030177; GO:0030285; GO:0031227; GO:0031228; GO:0031302; GO:0031594; GO:0033157; GO:0042734; GO:0042995; GO:0045211; GO:0050714	cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; intrinsic component of endosome membrane [GO:0031302]; intrinsic component of Golgi membrane [GO:0031228]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Wnt-protein binding [GO:0017147]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; positive regulation of protein secretion [GO:0050714]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of intracellular protein transport [GO:0033157]; segment polarity determination [GO:0007367]; Wnt signaling pathway [GO:0016055]
PGEN_.00g160390	Scaffold_07	21448833	21449084	NA	NA	NA	NA	NA
PGEN_.00g160400	Scaffold_07	21449130	21449552	NA	NA	NA	NA	NA
PGEN_.00g160410	Scaffold_07	21461670	21462065	NA	NA	NA	NA	NA
PGEN_.00g160420	Scaffold_07	21473645	21479650	NA	NA	NA	NA	NA
PGEN_.00g160430	Scaffold_07	21501456	21505531	NA	NA	NA	NA	NA
PGEN_.00g160440	Scaffold_07	21515170	21517108	NA	NA	NA	NA	NA
PGEN_.00g160450	Scaffold_07	21596704	21602976	NA	NA	NA	NA	NA
PGEN_.00g160460	Scaffold_07	21606554	21608520	NA	NA	NA	NA	NA
PGEN_.00g160470	Scaffold_07	21620765	21623159	NA	NA	NA	NA	NA
PGEN_.00g160480	Scaffold_07	21630444	21633783	Q8TER0	SNED1_HUMAN	"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)"	GO:0005112; GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160]
PGEN_.00g160490	Scaffold_07	21654977	21658876	NA	NA	NA	NA	NA
PGEN_.00g160500	Scaffold_07	21664035	21665313	NA	NA	NA	NA	NA
PGEN_.00g160510	Scaffold_07	21683151	21690157	NA	NA	NA	NA	NA
PGEN_.00g160520	Scaffold_07	21693097	21699433	NA	NA	NA	NA	NA
PGEN_.00g160530	Scaffold_07	21723042	21725373	P0C872	JMJD7_MOUSE	Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 (EC 1.14.11.63) (EC 3.4.-.-) (JmjC domain-containing protein 7) (Jumonji domain-containing protein 7) (L-lysine (3S)-hydroxylase Jmjd7)	GO:0004175; GO:0004177; GO:0004497; GO:0005634; GO:0005737; GO:0016706; GO:0018126; GO:0035064; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]; protein hydroxylation [GO:0018126]
PGEN_.00g160540	Scaffold_07	21786529	21795212	NA	NA	NA	NA	NA
PGEN_.00g160550	Scaffold_07	21797651	21805315	NA	NA	NA	NA	NA
PGEN_.00g160560	Scaffold_07	21808864	21831718	Q9FT51	AB27G_ARATH	ABC transporter G family member 27 (ABC transporter ABCG.27) (AtABCG27) (Probable white-brown complex homolog protein 28) (AtWBC28)	GO:0005524; GO:0016021; GO:0016887	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]
PGEN_.00g160570	Scaffold_07	21834384	21837000	P0C872	JMJD7_MOUSE	Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 (EC 1.14.11.63) (EC 3.4.-.-) (JmjC domain-containing protein 7) (Jumonji domain-containing protein 7) (L-lysine (3S)-hydroxylase Jmjd7)	GO:0004175; GO:0004177; GO:0004497; GO:0005634; GO:0005737; GO:0016706; GO:0018126; GO:0035064; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]; protein hydroxylation [GO:0018126]
PGEN_.00g160580	Scaffold_07	21839966	21847740	NA	NA	NA	NA	NA
PGEN_.00g160590	Scaffold_07	21878581	21886548	Q13868	EXOS2_HUMAN	Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4)	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0008312; GO:0030307; GO:0034427; GO:0034475; GO:0043488; GO:0043928; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"
PGEN_.00g160600	Scaffold_07	21890637	21904370	Q66H59	NPL_RAT	N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase)	GO:0005737; GO:0005975; GO:0008747; GO:0019262; GO:0042802	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262]
PGEN_.00g160610	Scaffold_07	21916332	21930031	P46782	RS5_HUMAN	"40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]"	GO:0000028; GO:0000184; GO:0003723; GO:0003729; GO:0003735; GO:0005654; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006450; GO:0006614; GO:0016020; GO:0019083; GO:0019843; GO:0022627; GO:0070062; GO:1990904	"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
PGEN_.00g160620	Scaffold_07	21932105	21934551	G5EFP5	FUTC_CAEEL	"Alpha-(1,3)-fucosyltransferase fut-3 (EC 2.4.1.65) (Fucosyltransferase fut-3)"	GO:0006486; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g160630	Scaffold_07	21955555	21957201	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g160640	Scaffold_07	21976504	21984803	NA	NA	NA	NA	NA
PGEN_.00g160650	Scaffold_07	21985124	21999693	NA	NA	NA	NA	NA
PGEN_.00g160660	Scaffold_07	22000229	22000564	NA	NA	NA	NA	NA
PGEN_.00g160670	Scaffold_07	22003004	22013536	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g160680	Scaffold_07	22036949	22042440	NA	NA	NA	NA	NA
PGEN_.00g160690	Scaffold_07	22044678	22045425	NA	NA	NA	NA	NA
PGEN_.00g160700	Scaffold_07	22046091	22048205	NA	NA	NA	NA	NA
PGEN_.00g160710	Scaffold_07	22060074	22078652	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g160720	Scaffold_07	22079338	22079724	NA	NA	NA	NA	NA
PGEN_.00g160730	Scaffold_07	22079866	22087730	NA	NA	NA	NA	NA
PGEN_.00g160740	Scaffold_07	22092196	22106811	Q21751	EAA6_CAEEL	Putative sodium-dependent excitatory amino acid transporter glt-6	GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]
PGEN_.00g160750	Scaffold_07	22118445	22131261	NA	NA	NA	NA	NA
PGEN_.00g160760	Scaffold_07	22137303	22152753	P15287	AGSA_APLCA	Adenosine deaminase AGSA (EC 3.5.4.4) (Atrial gland-specific antigen) (AGSA) (Mollusk-derived growth factor) (MDGF)	GO:0004000; GO:0005615; GO:0006154; GO:0046872	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154]
PGEN_.00g160770	Scaffold_07	22153535	22156669	NA	NA	NA	NA	NA
PGEN_.00g160780	Scaffold_07	22171876	22185686	NA	NA	NA	NA	NA
PGEN_.00g160790	Scaffold_07	22189464	22221232	Q5RF60	AL3A2_PONAB	Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase)	GO:0005789; GO:0006631; GO:0016021; GO:0043878; GO:0046458; GO:0050061; GO:0052814	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; fatty acid metabolic process [GO:0006631]; hexadecanal metabolic process [GO:0046458]
PGEN_.00g160800	Scaffold_07	22229996	22246027	G3I6Z6	NOTC1_CRIGR	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0016021; GO:0016324; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g160810	Scaffold_07	22270243	22403365	NA	NA	NA	NA	NA
PGEN_.00g160820	Scaffold_07	22407085	22434592	Q4R550	SYCC_MACFA	"Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)"	GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0006423; GO:0046872	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423]
PGEN_.00g160830	Scaffold_07	22467423	22478682	D2HWM5	RFWD3_AILME	E3 ubiquitin-protein ligase RFWD3 (EC 2.3.2.27) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201)	GO:0000724; GO:0002039; GO:0004842; GO:0005634; GO:0005737; GO:0006974; GO:0010212; GO:0016567; GO:0016605; GO:0031297; GO:0031571; GO:0036297; GO:0046872; GO:0090734; GO:0097371	cytoplasm [GO:0005737]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint [GO:0031571]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212]
PGEN_.00g160840	Scaffold_07	22480355	22482738	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g160850	Scaffold_07	22484005	22486278	NA	NA	NA	NA	NA
PGEN_.00g160860	Scaffold_07	22509659	22540502	A1YG61	EHF_PANPA	ETS homologous factor (ETS domain-containing transcription factor)	GO:0000978; GO:0001228; GO:0005654; GO:0005794; GO:0006366; GO:0030855; GO:0050673	"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g160870	Scaffold_07	22589113	22590866	P62875	RPAB5_HUMAN	"DNA-directed RNA polymerases I, II, and III subunit RPABC5 (RNA polymerases I, II, and III subunit ABC5) (DNA-directed RNA polymerase III subunit L) (RNA polymerase II 7.6 kDa subunit) (RPB7.6) (RPB10 homolog)"	GO:0000398; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006283; GO:0006351; GO:0006356; GO:0006360; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008270; GO:0008543; GO:0016070; GO:0032481; GO:0035019; GO:0042795; GO:0042797; GO:0045815; GO:0050434; GO:0060964	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; regulation of transcription by RNA polymerase I [GO:0006356]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]; tRNA transcription by RNA polymerase III [GO:0042797]"
PGEN_.00g160880	Scaffold_07	22592675	22594032	NA	NA	NA	NA	NA
PGEN_.00g160890	Scaffold_07	22598294	22598701	NA	NA	NA	NA	NA
PGEN_.00g160900	Scaffold_07	22602867	22624078	A7SLW1	BCAT_NEMVE	Branched-chain-amino-acid aminotransferase (EC 2.6.1.42)	GO:0004084; GO:0005739; GO:0009098; GO:0009099; GO:0052654; GO:0052655; GO:0052656	mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]
PGEN_.00g160910	Scaffold_07	22631180	22663767	F1NVK6	TM237_CHICK	Transmembrane protein 237	GO:0016021; GO:0030111; GO:0035869; GO:0060271	ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111]
PGEN_.00g160920	Scaffold_07	22664292	22713646	Q14008	CKAP5_HUMAN	Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG)	GO:0000086; GO:0000776; GO:0000777; GO:0000922; GO:0005730; GO:0005813; GO:0005829; GO:0005886; GO:0007019; GO:0007051; GO:0007098; GO:0010389; GO:0016020; GO:0030951; GO:0032991; GO:0045296; GO:0046785; GO:0050658; GO:0051298; GO:0051301; GO:0097711	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051]
PGEN_.00g160930	Scaffold_07	22720658	22739806	Q9Y2P5	S27A5_HUMAN	"Bile acyl-CoA synthetase (BACS) (EC 6.2.1.7) (Bile acid-CoA ligase) (BA-CoA ligase) (BAL) (Cholate--CoA ligase) (Fatty acid transport protein 5) (FATP-5) (Fatty-acid-coenzyme A ligase, very long-chain 3) (Solute carrier family 27 member 5) (Very long-chain acyl-CoA synthetase homolog 2) (VLCS-H2) (VLCSH2) (Very long-chain acyl-CoA synthetase-related protein) (VLACS-related) (VLACSR)"	GO:0000038; GO:0004467; GO:0005324; GO:0005524; GO:0005783; GO:0005789; GO:0006642; GO:0006699; GO:0008206; GO:0009925; GO:0015245; GO:0015721; GO:0015911; GO:0016491; GO:0030176; GO:0031957; GO:0032991; GO:0044877; GO:0046951; GO:0047747	basal plasma membrane [GO:0009925]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oxidoreductase activity [GO:0016491]; protein-containing complex binding [GO:0044877]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; ketone body biosynthetic process [GO:0046951]; long-chain fatty acid import across plasma membrane [GO:0015911]; triglyceride mobilization [GO:0006642]; very long-chain fatty acid metabolic process [GO:0000038]
PGEN_.00g160940	Scaffold_07	22845468	22849348	Q619T5	RASEF_CAEBR	Ras and EF-hand domain-containing protein homolog	GO:0003924; GO:0005509; GO:0005525; GO:0006886; GO:0032482; GO:0048471	perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g160950	Scaffold_07	22849498	22849764	NA	NA	NA	NA	NA
PGEN_.00g160960	Scaffold_07	22850259	22850528	NA	NA	NA	NA	NA
PGEN_.00g160970	Scaffold_07	22856386	22868425	Q8IZ41	RASEF_HUMAN	Ras and EF-hand domain-containing protein (Ras-related protein Rab-45)	GO:0003924; GO:0005509; GO:0005525; GO:0005829; GO:0019003; GO:0042802; GO:0048471; GO:0051260	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homooligomerization [GO:0051260]
PGEN_.00g160980	Scaffold_07	22880512	22922443	Q5RJA1	RFX6_DANRE	DNA-binding protein RFX6 (Regulatory factor X 6)	GO:0000978; GO:0003309; GO:0003310; GO:0003311; GO:0003700; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0044212; GO:0045893; GO:0045944; GO:0050796; GO:0090104	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]"
PGEN_.00g160990	Scaffold_07	22932639	22933325	NA	NA	NA	NA	NA
PGEN_.00g161000	Scaffold_07	22948715	22949008	NA	NA	NA	NA	NA
PGEN_.00g161010	Scaffold_07	22949075	22949302	NA	NA	NA	NA	NA
PGEN_.00g161020	Scaffold_07	22949597	22949866	NA	NA	NA	NA	NA
PGEN_.00g161030	Scaffold_07	22950227	22950454	NA	NA	NA	NA	NA
PGEN_.00g161040	Scaffold_07	23006004	23009689	NA	NA	NA	NA	NA
PGEN_.00g161050	Scaffold_07	23080271	23080762	NA	NA	NA	NA	NA
PGEN_.00g161060	Scaffold_07	23125169	23129656	P13439	UMPS_MOUSE	Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMPdecase)]	GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0006207; GO:0006222; GO:0007565; GO:0007595; GO:0009116; GO:0019856; GO:0035690; GO:0042802; GO:0044205	cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to drug [GO:0035690]; female pregnancy [GO:0007565]; lactation [GO:0007595]; nucleoside metabolic process [GO:0009116]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UMP biosynthetic process [GO:0006222]
PGEN_.00g161070	Scaffold_07	23129778	23151420	NA	NA	NA	NA	NA
PGEN_.00g161080	Scaffold_07	23156526	23164570	Q4FZB7	KMT5B_HUMAN	Histone-lysine N-methyltransferase KMT5B (EC 2.1.1.-) (Lysine N-methyltransferase 5B) (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1)	GO:0000780; GO:0003682; GO:0005654; GO:0006281; GO:0007517; GO:0018024; GO:0034773; GO:0042799; GO:0045830; GO:0046872; GO:1904047; GO:2001034	"condensed nuclear chromosome, centromeric region [GO:0000780]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]; DNA repair [GO:0006281]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]"
PGEN_.00g161090	Scaffold_07	23180401	23203040	Q9P1Y6	PHRF1_HUMAN	PHD and RING finger domain-containing protein 1	GO:0006366; GO:0006397; GO:0016020; GO:0019904; GO:0046872; GO:0070063	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g161100	Scaffold_07	23246823	23258996	Q801S4	K0930_XENLA	Uncharacterized protein KIAA0930 homolog		
PGEN_.00g161110	Scaffold_07	23266402	23281648	Q96GC6	ZN274_HUMAN	Neurotrophin receptor-interacting factor homolog (Zinc finger protein 274) (Zinc finger protein HFB101) (Zinc finger protein with KRAB and SCAN domains 19) (Zinc finger protein zfp2) (Zf2)	GO:0003682; GO:0003700; GO:0003714; GO:0005730; GO:0005737; GO:0006355; GO:0043565; GO:0046872; GO:1900112	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g161120	Scaffold_07	23317817	23354198	Q9UBS5	GABR1_HUMAN	Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)	GO:0004965; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007214; GO:0030054; GO:0030425; GO:0038039; GO:0042734; GO:0045211; GO:0098685; GO:0098982; GO:0099579; GO:0150099	cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]
PGEN_.00g161130	Scaffold_07	23355779	23369876	Q9UBS5	GABR1_HUMAN	Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)	GO:0004965; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007214; GO:0030054; GO:0030425; GO:0038039; GO:0042734; GO:0045211; GO:0098685; GO:0098982; GO:0099579; GO:0150099	cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]
PGEN_.00g161140	Scaffold_07	23375830	23400894	Q5R9I6	PSMD2_PONAB	26S proteasome non-ATPase regulatory subunit 2	GO:0022624; GO:0030234; GO:0042176	proteasome accessory complex [GO:0022624]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]
PGEN_.00g161150	Scaffold_07	23406445	23443163	Q99PW8	KIF17_MOUSE	Kinesin-like protein KIF17 (MmKIF17)	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0007018; GO:0008017; GO:0008574; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0030992; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098971; GO:1990075	"axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g161160	Scaffold_07	23458988	23485455	Q9JLV6	PNKP_MOUSE	Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase (EC 3.1.3.32) (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase (EC 2.7.1.78)]	GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006281; GO:0006979; GO:0010836; GO:0016311; GO:0032212; GO:0042769; GO:0046403; GO:0046404; GO:0046939; GO:0050145; GO:0051973; GO:0098504; GO:1904355	"mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; double-stranded DNA binding [GO:0003690]; nucleoside monophosphate kinase activity [GO:0050145]; polynucleotide 3'-phosphatase activity [GO:0046403]; dephosphorylation [GO:0016311]; DNA 3' dephosphorylation involved in DNA repair [GO:0098504]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]"
PGEN_.00g161170	Scaffold_07	23494856	23516808	P10242	MYB_HUMAN	Transcriptional activator Myb (Proto-oncogene c-Myb)	GO:0000122; GO:0000278; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0005654; GO:0005829; GO:0006338; GO:0006355; GO:0016363; GO:0032967; GO:0043525; GO:0045624; GO:0045892; GO:0045893; GO:0045944; GO:0048661; GO:0051571; GO:0051574; GO:0060252; GO:0070301; GO:0071300; GO:0071636; GO:1902036; GO:1904899; GO:2000491; GO:2000845	"cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"
PGEN_.00g161180	Scaffold_07	23517907	23518606	NA	NA	NA	NA	NA
PGEN_.00g161190	Scaffold_07	23525246	23541190	NA	NA	NA	NA	NA
PGEN_.00g161200	Scaffold_07	23546821	23557122	Q6P3W7	SCYL2_HUMAN	SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa)	GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0008333; GO:0010008; GO:0030136; GO:0048471; GO:0090090; GO:2000286; GO:2000370	clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]
PGEN_.00g161210	Scaffold_07	23566724	23570401	NA	NA	NA	NA	NA
PGEN_.00g161220	Scaffold_07	23571854	23572947	NA	NA	NA	NA	NA
PGEN_.00g161230	Scaffold_07	23589259	23629198	Q6UX65	DRAM2_HUMAN	DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77)	GO:0001917; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016021; GO:0016324; GO:0043231; GO:0045494	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]
PGEN_.00g161240	Scaffold_07	23639808	23642305	B0BLW3	LGR4_XENTR	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0001649; GO:0004888; GO:0005887; GO:0007189; GO:0007190; GO:0007283; GO:0008528; GO:0009755; GO:0016055; GO:0016500; GO:0030282; GO:0034122; GO:0042802; GO:0046849; GO:0048511; GO:0050710; GO:0090263	integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; identical protein binding [GO:0042802]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; rhythmic process [GO:0048511]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]
PGEN_.00g161250	Scaffold_07	23644256	23646841	NA	NA	NA	NA	NA
PGEN_.00g161260	Scaffold_07	23666141	23682365	Q9I9H2	DBX1_XENLA	Homeobox protein DBX1 (Developing brain homeobox protein 1) (Xdbx)	GO:0005634; GO:0006355; GO:0007275; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g161270	Scaffold_07	23757693	23771364	Q8AVY8	DH12B_XENLA	Very-long-chain 3-oxoacyl-CoA reductase-B (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12-B) (17-beta-HSD 12-B) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12-B) (EC 1.1.1.62)	GO:0004303; GO:0005789; GO:0006633; GO:0006703; GO:0016021; GO:0102339; GO:0102340; GO:0102341; GO:0102342	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]
PGEN_.00g161280	Scaffold_07	23775066	23775636	NA	NA	NA	NA	NA
PGEN_.00g161290	Scaffold_07	23786315	23794666	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g161300	Scaffold_07	23794919	23799040	NA	NA	NA	NA	NA
PGEN_.00g161310	Scaffold_07	23799084	23799575	NA	NA	NA	NA	NA
PGEN_.00g161320	Scaffold_07	23805881	23822317	Q5R7K0	HSDL1_PONAB	Inactive hydroxysteroid dehydrogenase-like protein 1	GO:0005739; GO:0045111; GO:0055114	intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; oxidation-reduction process [GO:0055114]
PGEN_.00g161330	Scaffold_07	23829049	23850395	Q8NA31	TERB1_HUMAN	Telomere repeats-binding bouquet formation protein 1 (Coiled-coil domain-containing protein 79)	GO:0000781; GO:0000784; GO:0003677; GO:0005623; GO:0005637; GO:0007129; GO:0045141; GO:0070187; GO:0070197	"cell [GO:0005623]; chromosome, telomeric region [GO:0000781]; nuclear chromosome, telomeric region [GO:0000784]; nuclear inner membrane [GO:0005637]; shelterin complex [GO:0070187]; DNA binding [GO:0003677]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141]; synapsis [GO:0007129]"
PGEN_.00g161340	Scaffold_07	23859058	23860814	Q64259	VHL_RAT	von Hippel-Lindau disease tumor suppressor (pVHL)	GO:0000122; GO:0001525; GO:0001666; GO:0003309; GO:0003310; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005929; GO:0006355; GO:0006582; GO:0008134; GO:0008285; GO:0010468; GO:0010498; GO:0010629; GO:0015031; GO:0016020; GO:0016567; GO:0019899; GO:0030163; GO:0030182; GO:0030198; GO:0030891; GO:0031462; GO:0042069; GO:0043534; GO:0044877; GO:0045471; GO:0045602; GO:0045893; GO:0046426; GO:0048069; GO:0048593; GO:0048877; GO:0050679; GO:0061072; GO:0061073; GO:0061428; GO:0061630; GO:0070243; GO:0070244; GO:0098794; GO:0098978; GO:0099175; GO:0099576; GO:1902072; GO:1903827; GO:2001233	"cilium [GO:0005929]; Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription factor complex [GO:0005667]; VCB complex [GO:0030891]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; camera-type eye morphogenesis [GO:0048593]; ciliary body morphogenesis [GO:0061073]; extracellular matrix organization [GO:0030198]; eye pigmentation [GO:0048069]; homeostasis of number of retina cells [GO:0048877]; iris morphogenesis [GO:0061072]; melanin metabolic process [GO:0006582]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of gene expression [GO:0010629]; negative regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902072]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasomal protein catabolic process [GO:0010498]; protein catabolic process [GO:0030163]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of catecholamine metabolic process [GO:0042069]; regulation of cellular protein localization [GO:1903827]; regulation of gene expression [GO:0010468]; regulation of postsynapse organization [GO:0099175]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of thymocyte apoptotic process [GO:0070243]; regulation of transcription, DNA-templated [GO:0006355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; type B pancreatic cell differentiation [GO:0003309]"
PGEN_.00g161350	Scaffold_07	23872412	23875551	Q8PUA4	PDXT_METMA	Pyridoxal 5'-phosphate synthase subunit PdxT (EC 4.3.3.6) (Pdx2) (Pyridoxal 5'-phosphate synthase glutaminase subunit) (EC 3.5.1.2)	GO:0004359; GO:0006543; GO:0036381; GO:0042823	glutaminase activity [GO:0004359]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; glutamine catabolic process [GO:0006543]; pyridoxal phosphate biosynthetic process [GO:0042823]
PGEN_.00g161360	Scaffold_07	23875900	23892973	Q8WPW2	PDX1_SUBDO	Pyridoxal 5'-phosphate synthase subunit SNZERR (PLP synthase subunit SNZERR) (EC 4.3.3.6) (Ethylene response protein) (PDX1)	GO:0036381; GO:0042823	pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; pyridoxal phosphate biosynthetic process [GO:0042823]
PGEN_.00g161370	Scaffold_07	23910189	23919409	NA	NA	NA	NA	NA
PGEN_.00g161380	Scaffold_07	23929658	23935388	P0C6X2	R1AB_CVHN1	Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Papain-like proteinase (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.69) (Non-structural protein 3) (nsp3) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); RNA-directed RNA polymerase (Pol) (RdRp) (EC 2.7.7.48) (nsp12) (p100); Helicase (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (nsp13) (p67); Guanine-N7 methyltransferase (ExoN) (EC 2.1.1.-) (EC 3.1.13.-) (nsp14); Uridylate-specific endoribonuclease (EC 3.1.-.-) (NendoU) (nsp15) (p35); 2'-O-methyltransferase (EC 2.1.1.-) (nsp16)]	GO:0003678; GO:0003723; GO:0003724; GO:0003968; GO:0004197; GO:0004519; GO:0005524; GO:0006351; GO:0008168; GO:0008242; GO:0008270; GO:0016021; GO:0016896; GO:0019079; GO:0019082; GO:0032259; GO:0033644; GO:0036459; GO:0039502; GO:0039520; GO:0039579; GO:0039595; GO:0039644; GO:0039648; GO:0044172; GO:0044220	"host cell endoplasmic reticulum-Golgi intermediate compartment [GO:0044172]; host cell membrane [GO:0033644]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; cysteine-type endopeptidase activity [GO:0004197]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; methyltransferase activity [GO:0008168]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; induction by virus of catabolism of host mRNA [GO:0039595]; induction by virus of host autophagy [GO:0039520]; methylation [GO:0032259]; modulation by virus of host protein ubiquitination [GO:0039648]; suppression by virus of host ISG15 activity [GO:0039579]; suppression by virus of host NF-kappaB transcription factor activity [GO:0039644]; suppression by virus of host type I interferon-mediated signaling pathway [GO:0039502]; transcription, DNA-templated [GO:0006351]; viral genome replication [GO:0019079]; viral protein processing [GO:0019082]"
PGEN_.00g161390	Scaffold_07	23937854	23939541	NA	NA	NA	NA	NA
PGEN_.00g161400	Scaffold_07	23939589	23953627	Q9XYM0	CRK_DROME	Adapter molecule Crk	GO:0006911; GO:0007298; GO:0007520; GO:0030971; GO:0032956; GO:0043087; GO:0046330; GO:0046529; GO:0048010; GO:0048013	"receptor tyrosine kinase binding [GO:0030971]; border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion, thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"
PGEN_.00g161410	Scaffold_07	23964944	23972996	NA	NA	NA	NA	NA
PGEN_.00g161420	Scaffold_07	24040491	24059277	Q0VCJ7	RERG_BOVIN	Ras-related and estrogen-regulated growth inhibitor	GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0007265; GO:0008285; GO:0009725; GO:0019003; GO:0030308	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]
PGEN_.00g161430	Scaffold_07	24104729	24108131	NA	NA	NA	NA	NA
PGEN_.00g161440	Scaffold_07	24146407	24146934	NA	NA	NA	NA	NA
PGEN_.00g161450	Scaffold_07	24154021	24163246	NA	NA	NA	NA	NA
PGEN_.00g161460	Scaffold_07	24168240	24180716	NA	NA	NA	NA	NA
PGEN_.00g161470	Scaffold_07	24182623	24191791	Q6ITT3	MGT4C_PIG	"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)"	GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0016021; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein N-linked glycosylation [GO:0006487]"
PGEN_.00g161480	Scaffold_07	24213779	24220942	A9GP90	UREG_SORC5	Urease accessory protein UreG	GO:0003924; GO:0005525; GO:0005737; GO:0006807; GO:0016151	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nickel cation binding [GO:0016151]; nitrogen compound metabolic process [GO:0006807]
PGEN_.00g161490	Scaffold_07	24256284	24257211	NA	NA	NA	NA	NA
PGEN_.00g161500	Scaffold_07	24284163	24285704	Q96D21	RHES_HUMAN	GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2)	GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031397; GO:0031624; GO:0031681; GO:0033235; GO:0043548; GO:0043949; GO:0045202; GO:0051897	"plasma membrane [GO:0005886]; synapse [GO:0045202]; G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol 3-kinase binding [GO:0043548]; ubiquitin conjugating enzyme binding [GO:0031624]; locomotory behavior [GO:0007626]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]"
PGEN_.00g161510	Scaffold_07	24289062	24295298	NA	NA	NA	NA	NA
PGEN_.00g161520	Scaffold_07	24299474	24313042	Q5TC84	OGRL1_HUMAN	Opioid growth factor receptor-like protein 1	GO:0004985; GO:0016020	membrane [GO:0016020]; opioid receptor activity [GO:0004985]
PGEN_.00g161530	Scaffold_07	24332310	24332609	NA	NA	NA	NA	NA
PGEN_.00g161540	Scaffold_07	24332691	24333335	NA	NA	NA	NA	NA
PGEN_.00g161550	Scaffold_07	24333649	24334216	NA	NA	NA	NA	NA
PGEN_.00g161560	Scaffold_07	24334660	24334938	NA	NA	NA	NA	NA
PGEN_.00g161570	Scaffold_07	24380950	24435722	Q593B6	FA5_PSETE	Coagulation factor V [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]	GO:0005507; GO:0005576; GO:0007596; GO:0009405; GO:0016504; GO:0090729	extracellular region [GO:0005576]; copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; toxin activity [GO:0090729]; blood coagulation [GO:0007596]; pathogenesis [GO:0009405]
PGEN_.00g161580	Scaffold_07	24530231	24530581	NA	NA	NA	NA	NA
PGEN_.00g161590	Scaffold_07	24530734	24531042	NA	NA	NA	NA	NA
PGEN_.00g161600	Scaffold_07	24531085	24531657	NA	NA	NA	NA	NA
PGEN_.00g161610	Scaffold_07	24546759	24547679	NA	NA	NA	NA	NA
PGEN_.00g161620	Scaffold_07	24566924	24583101	Q9UKZ1	CNO11_HUMAN	CCR4-NOT transcription complex subunit 11	GO:0000289; GO:0005634; GO:0005829; GO:0006417; GO:0006977; GO:0008283; GO:0030014; GO:0031047	"CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell population proliferation [GO:0008283]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]"
PGEN_.00g161630	Scaffold_07	24583310	24594209	Q22472	RIC3_CAEEL	Resistance to inhibitors of cholinesterase protein 3	GO:0005783; GO:0005789; GO:0006937; GO:0007271; GO:0016021; GO:0032224; GO:0033130; GO:0034394; GO:0043005; GO:0043025; GO:0043231; GO:0045202	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; acetylcholine receptor binding [GO:0033130]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; regulation of muscle contraction [GO:0006937]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g161640	Scaffold_07	24619960	24632294	NA	NA	NA	NA	NA
PGEN_.00g161650	Scaffold_07	24632431	24654980	Q5HYC2	K2026_HUMAN	Uncharacterized protein KIAA2026		
PGEN_.00g161660	Scaffold_07	24668466	24685263	Q2KJ84	TMED5_BOVIN	Transmembrane emp24 domain-containing protein 5 (p24 family protein gamma 2) (p24gamma2)	GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0033116; GO:0090161	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]
PGEN_.00g161670	Scaffold_07	24701820	24735079	Q17RS7	GEN_HUMAN	Flap endonuclease GEN homolog 1 (EC 3.1.-.-)	GO:0000287; GO:0000400; GO:0000724; GO:0005654; GO:0005813; GO:0008821; GO:0010824; GO:0017108; GO:0031297; GO:0042803; GO:0048256; GO:0071139; GO:0071140; GO:0090267	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; flap endonuclease activity [GO:0048256]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; resolution of recombination intermediates [GO:0071139]
PGEN_.00g161680	Scaffold_07	24736636	24783897	Q9Z277	BAZ1B_MOUSE	Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor homolog) (Williams-Beuren syndrome chromosomal region 9 protein homolog)	GO:0000793; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005721; GO:0006333; GO:0006338; GO:0006974; GO:0016572; GO:0016604; GO:0035173; GO:0042393; GO:0043596; GO:0046872	condensed chromosome [GO:0000793]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; cellular response to DNA damage stimulus [GO:0006974]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone phosphorylation [GO:0016572]
PGEN_.00g161690	Scaffold_07	24795998	24796219	NA	NA	NA	NA	NA
PGEN_.00g161700	Scaffold_07	24823241	24871078	P13796	PLSL_HUMAN	Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1)	GO:0001726; GO:0001891; GO:0002102; GO:0002286; GO:0003779; GO:0005178; GO:0005509; GO:0005615; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0010737; GO:0015629; GO:0016477; GO:0022617; GO:0030054; GO:0030175; GO:0031100; GO:0032432; GO:0032587; GO:0033157; GO:0035722; GO:0042802; GO:0051015; GO:0051017; GO:0051020; GO:0051639; GO:0070062; GO:0071803	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]
PGEN_.00g161710	Scaffold_07	24920021	24941924	P54680	FIMB_DICDI	Fimbrin	GO:0001891; GO:0005509; GO:0005737; GO:0005884; GO:0019953; GO:0030027; GO:0031252; GO:0032432; GO:0045335; GO:0051015; GO:0051017; GO:0051639	actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; sexual reproduction [GO:0019953]
PGEN_.00g161720	Scaffold_07	24942441	24942956	NA	NA	NA	NA	NA
PGEN_.00g161730	Scaffold_07	24943105	24943521	NA	NA	NA	NA	NA
PGEN_.00g161740	Scaffold_07	24943838	24944260	NA	NA	NA	NA	NA
PGEN_.00g161750	Scaffold_07	24945324	24951619	NA	NA	NA	NA	NA
PGEN_.00g161760	Scaffold_07	24960470	24963688	P82921	RT21_HUMAN	"28S ribosomal protein S21, mitochondrial (MRP-S21) (S21mt) (Mitochondrial small ribosomal subunit protein bS21m)"	GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0032543; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]
PGEN_.00g161770	Scaffold_07	24963997	24976412	Q9BUK6	MSTO1_HUMAN	Protein misato homolog 1	GO:0000002; GO:0000070; GO:0005737; GO:0005741; GO:0007005; GO:0048311; GO:0090307	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]
PGEN_.00g161780	Scaffold_07	24988463	25009968	Q9BXF3	CECR2_HUMAN	Cat eye syndrome critical region protein 2	GO:0005634; GO:0006309; GO:0007010; GO:0016192; GO:0043044; GO:0061640; GO:0090537; GO:0097194	CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; vesicle-mediated transport [GO:0016192]
PGEN_.00g161790	Scaffold_07	25021898	25022128	NA	NA	NA	NA	NA
PGEN_.00g161800	Scaffold_07	25041740	25042111	NA	NA	NA	NA	NA
PGEN_.00g161810	Scaffold_07	25047370	25075069	E9Q2Z1	CECR2_MOUSE	Cat eye syndrome critical region protein 2 homolog	GO:0001842; GO:0001843; GO:0005634; GO:0005719; GO:0007338; GO:0021915; GO:0031010; GO:0043044; GO:0060122; GO:0090102; GO:0090537; GO:0097194	CERF complex [GO:0090537]; ISWI-type complex [GO:0031010]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; ATP-dependent chromatin remodeling [GO:0043044]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338]
PGEN_.00g161820	Scaffold_07	25075325	25111343	Q2KHR3	QSER1_HUMAN	Glutamine and serine-rich protein 1		
PGEN_.00g161830	Scaffold_07	25125554	25128239	Q00546	TENR_CHICK	Tenascin-R (TN-R) (Restrictin)	GO:0007155; GO:0050767; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; cell adhesion [GO:0007155]; regulation of neurogenesis [GO:0050767]
PGEN_.00g161840	Scaffold_07	25137423	25145123	NA	NA	NA	NA	NA
PGEN_.00g161850	Scaffold_07	25145784	25146218	NA	NA	NA	NA	NA
PGEN_.00g161860	Scaffold_07	25146277	25147017	NA	NA	NA	NA	NA
PGEN_.00g161870	Scaffold_07	25147204	25161180	NA	NA	NA	NA	NA
PGEN_.00g161880	Scaffold_07	25178109	25178852	Q71SG7	GCNT4_DANRE	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102)"	GO:0000139; GO:0003829; GO:0006486; GO:0016021	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; protein glycosylation [GO:0006486]"
PGEN_.00g161890	Scaffold_07	25182482	25183027	NA	NA	NA	NA	NA
PGEN_.00g161900	Scaffold_07	25198247	25198804	NA	NA	NA	NA	NA
PGEN_.00g161910	Scaffold_07	25211225	25217109	O70594	S22A5_RAT	Solute carrier family 22 member 5 (CT1) (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2) (UST2r)	GO:0005524; GO:0006814; GO:0007005; GO:0007512; GO:0007626; GO:0009437; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016021; GO:0016323; GO:0016324; GO:0030165; GO:0031526; GO:0048608; GO:0052106; GO:0060731; GO:0070715	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; adult heart development [GO:0007512]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; locomotory behavior [GO:0007626]; mitochondrion organization [GO:0007005]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; quorum sensing involved in interaction with host [GO:0052106]; reproductive structure development [GO:0048608]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]
PGEN_.00g161920	Scaffold_07	25226354	25234560	NA	NA	NA	NA	NA
PGEN_.00g161930	Scaffold_07	25267719	25270147	NA	NA	NA	NA	NA
PGEN_.00g161940	Scaffold_07	25295690	25299782	NA	NA	NA	NA	NA
PGEN_.00g161950	Scaffold_07	25355814	25380554	Q9VL78	FKB59_DROME	FK506-binding protein 59 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase) (dFKBP59)	GO:0000413; GO:0003755; GO:0005528; GO:0005737; GO:0016027; GO:0031072; GO:0050908; GO:0051924; GO:0061077	cytoplasm [GO:0005737]; inaD signaling complex [GO:0016027]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; detection of light stimulus involved in visual perception [GO:0050908]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of calcium ion transport [GO:0051924]
PGEN_.00g161960	Scaffold_07	25365305	25365577	NA	NA	NA	NA	NA
PGEN_.00g161970	Scaffold_07	25395736	25410219	Q6GMK6	TSN9_DANRE	Tetraspanin-9 (Tspan-9)	GO:0005887	integral component of plasma membrane [GO:0005887]
PGEN_.00g161980	Scaffold_07	25418540	25434134	Q8N7B6	PACRL_HUMAN	PACRG-like protein		
PGEN_.00g161990	Scaffold_07	25438502	25449921	Q5R903	SNX14_PONAB	Sorting nexin-14	GO:0005737; GO:0015031; GO:0030425; GO:0080025	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein transport [GO:0015031]"
PGEN_.00g162000	Scaffold_07	25459185	25461928	Q5R9U9	RWD2B_PONAB	RWD domain-containing protein 2B		
PGEN_.00g162010	Scaffold_07	25478145	25482170	Q961D9	BCL9_DROME	Protein BCL9 homolog (Protein legless)	GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0007367; GO:0007491; GO:0008587; GO:0035223; GO:0035293; GO:0045944; GO:0060070; GO:1990907	"beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc pattern formation [GO:0035223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; sternite morphogenesis [GO:0007491]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g162020	Scaffold_07	25483759	25484613	NA	NA	NA	NA	NA
PGEN_.00g162030	Scaffold_07	25493860	25494510	NA	NA	NA	NA	NA
PGEN_.00g162040	Scaffold_07	25495389	25508149	Q961D9	BCL9_DROME	Protein BCL9 homolog (Protein legless)	GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0007367; GO:0007491; GO:0008587; GO:0035223; GO:0035293; GO:0045944; GO:0060070; GO:1990907	"beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc pattern formation [GO:0035223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; sternite morphogenesis [GO:0007491]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g162050	Scaffold_07	25519895	25520347	NA	NA	NA	NA	NA
PGEN_.00g162060	Scaffold_07	25536899	25537579	NA	NA	NA	NA	NA
PGEN_.00g162070	Scaffold_07	25639472	25646671	NA	NA	NA	NA	NA
PGEN_.00g162080	Scaffold_07	25662375	25691424	O57321	EAA1_AMBTI	Excitatory amino acid transporter 1 (SEAAT1) (Sodium-dependent glutamate/aspartate transporter) (GLAST)	GO:0005314; GO:0005887; GO:0015501; GO:0046872; GO:0070779; GO:0071805; GO:0098712; GO:0140009; GO:1902476	integral component of plasma membrane [GO:0005887]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; potassium ion transmembrane transport [GO:0071805]
PGEN_.00g162090	Scaffold_07	25749563	25753858	Q2XWK0	SVOP_XENLA	Synaptic vesicle 2-related protein (SV2-related protein)	GO:0016021; GO:0022857; GO:0030054; GO:0030672	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]
PGEN_.00g162100	Scaffold_07	25753353	25755495	NA	NA	NA	NA	NA
PGEN_.00g162110	Scaffold_07	25758387	25767125	Q9BXC9	BBS2_HUMAN	Bardet-Biedl syndrome 2 protein	GO:0001103; GO:0005623; GO:0005829; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032402; GO:0032420; GO:0033365; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:1905515	BBSome [GO:0034464]; cell [GO:0005623]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420]; RNA polymerase II repressing transcription factor binding [GO:0001103]; adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; melanosome transport [GO:0032402]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]
PGEN_.00g162120	Scaffold_07	25769831	25804040	A4IH88	K2013_XENTR	Uncharacterized protein KIAA2013 homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g162130	Scaffold_07	25804439	25826143	Q09927	ACA1_SCHPO	N-acetyltransferase aca1 (EC 2.3.1.271) ((S)-1-pyrroline-5-carboxylate acetyltransferase) (L-azetidine-2-carboxylate acetyltransferase) (AZC acetyltransferase)	GO:0005634; GO:0005739; GO:0005829; GO:0006526; GO:0006562; GO:0046941	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; azetidine-2-carboxylic acid acetyltransferase activity [GO:0046941]; arginine biosynthetic process [GO:0006526]; proline catabolic process [GO:0006562]
PGEN_.00g162140	Scaffold_07	25849609	25850988	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g162150	Scaffold_07	26051590	26054788	NA	NA	NA	NA	NA
PGEN_.00g162160	Scaffold_07	26071423	26073659	NA	NA	NA	NA	NA
PGEN_.00g162170	Scaffold_07	26081486	26144954	O46037	VINC_DROME	Vinculin	GO:0005198; GO:0005623; GO:0005737; GO:0005925; GO:0007016; GO:0007155; GO:0015629; GO:0051015; GO:0098592	actin cytoskeleton [GO:0015629]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]
PGEN_.00g162180	Scaffold_07	26158730	26172569	P84103	SRSF3_HUMAN	"Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Splicing factor, arginine/serine-rich 3)"	GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0016607; GO:0031124; GO:0043274; GO:0045292; GO:0048024; GO:1990825; GO:1990830	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phospholipase binding [GO:0043274]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA export from nucleus [GO:0006405]"
PGEN_.00g162190	Scaffold_07	26231002	26232165	NA	NA	NA	NA	NA
PGEN_.00g162200	Scaffold_07	26240033	26242849	Q4J781	ADH_SULAC	NAD-dependent alcohol dehydrogenase (EC 1.1.1.1)	GO:0004022; GO:0008270	alcohol dehydrogenase (NAD+) activity [GO:0004022]; zinc ion binding [GO:0008270]
PGEN_.00g162210	Scaffold_07	26246477	26249018	A8MUU9	YV023_HUMAN	Putative uncharacterized protein ENSP00000383309		
PGEN_.00g162220	Scaffold_07	26259054	26268045	P80303	NUCB2_HUMAN	Nucleobindin-2 (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1]	GO:0001965; GO:0003677; GO:0005085; GO:0005509; GO:0005615; GO:0005640; GO:0005783; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0032099; GO:0070062	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of appetite [GO:0032099]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g162230	Scaffold_07	26269080	26279848	Q63083	NUCB1_RAT	Nucleobindin-1 (Bone 63 kDa calcium-binding protein) (CALNUC)	GO:0001965; GO:0003677; GO:0005085; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005791; GO:0005793; GO:0005794; GO:0005798; GO:0005801; GO:0005802; GO:0007264; GO:0032580; GO:0072718; GO:0090498; GO:0098547; GO:1903533	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle [GO:0005798]; lumenal side of Golgi membrane [GO:0098547]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of protein targeting [GO:1903533]; response to cisplatin [GO:0072718]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g162240	Scaffold_07	26296972	26303849	O08564	PLPP1_RAT	Phospholipid phosphatase 1 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a)	GO:0005887; GO:0006470; GO:0006644; GO:0008195; GO:0016020; GO:0016791; GO:0042577; GO:0046839	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; protein dephosphorylation [GO:0006470]
PGEN_.00g162250	Scaffold_07	26315791	26374737	Q6ZRR9	NA	NA	NA	NA
PGEN_.00g162260	Scaffold_07	26376868	26425008	P17427	AP2A2_MOUSE	AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit)	GO:0006886; GO:0008021; GO:0016192; GO:0019901; GO:0019904; GO:0030117; GO:0030122; GO:0030141; GO:0031410; GO:0035091; GO:0035615; GO:0044877; GO:0072583; GO:0097718; GO:1902036	AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; membrane coat [GO:0030117]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; regulation of hematopoietic stem cell differentiation [GO:1902036]; vesicle-mediated transport [GO:0016192]
PGEN_.00g162270	Scaffold_07	26426967	26429768	NA	NA	NA	NA	NA
PGEN_.00g162280	Scaffold_07	26429814	26431957	NA	NA	NA	NA	NA
PGEN_.00g162290	Scaffold_07	26571572	26595681	Q8TE57	ATS16_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-)	GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0046872; GO:0048232; GO:1902017	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]
PGEN_.00g162300	Scaffold_07	26602225	26612568	NA	NA	NA	NA	NA
PGEN_.00g162310	Scaffold_07	26625126	26633900	NA	NA	NA	NA	NA
PGEN_.00g162320	Scaffold_07	26635028	26639377	P41247	PLPL4_HUMAN	Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Protein GS2)	GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0019433; GO:0050253; GO:0055088	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806]; lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433]
PGEN_.00g162330	Scaffold_07	26646045	26670138	Q24306	DIAP1_DROME	Death-associated inhibitor of apoptosis 1 (EC 2.3.2.27) (Apoptosis 1 inhibitor) (E3 ubiquitin-protein ligase th) (Inhibitor of apoptosis 1) (Protein thread) (RING-type E3 ubiquitin transferase Diap1)	GO:0000209; GO:0004842; GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0007275; GO:0007283; GO:0007289; GO:0007298; GO:0008270; GO:0008354; GO:0016055; GO:0022416; GO:0031398; GO:0031624; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0044390; GO:0045035; GO:0045116; GO:0046673; GO:0048800; GO:0051865; GO:0061630; GO:0061663; GO:0070936; GO:0089720; GO:0090263; GO:0097340; GO:1903688; GO:1990001; GO:1990381; GO:2001271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; NEDD8 ligase activity [GO:0061663]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; germ cell migration [GO:0008354]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g162340	Scaffold_07	26681573	26682229	NA	NA	NA	NA	NA
PGEN_.00g162350	Scaffold_07	26682260	26682511	NA	NA	NA	NA	NA
PGEN_.00g162360	Scaffold_07	26682558	26683365	NA	NA	NA	NA	NA
PGEN_.00g162370	Scaffold_07	26700160	26705191	NA	NA	NA	NA	NA
PGEN_.00g162380	Scaffold_07	26725208	26725528	NA	NA	NA	NA	NA
PGEN_.00g162390	Scaffold_07	26763936	26766909	NA	NA	NA	NA	NA
PGEN_.00g162400	Scaffold_07	26772604	26778933	Q7RTX9	MOT14_HUMAN	Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g162410	Scaffold_07	26788673	26805534	Q8VE52	OGRL1_MOUSE	Opioid growth factor receptor-like protein 1	GO:0004985; GO:0016020	membrane [GO:0016020]; opioid receptor activity [GO:0004985]
PGEN_.00g162420	Scaffold_07	26811407	26812348	Q6ZMW2	ZN782_HUMAN	Zinc finger protein 782	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g162430	Scaffold_07	26824187	26827953	NA	NA	NA	NA	NA
PGEN_.00g162440	Scaffold_07	26848195	26863979	NA	NA	NA	NA	NA
PGEN_.00g162450	Scaffold_07	26864033	26871835	Q9BYE2	TMPSD_HUMAN	Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease)	GO:0004252; GO:0005044; GO:0016021; GO:0072562	blood microparticle [GO:0072562]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g162460	Scaffold_07	26948604	27010831	Q5G271	NETR_PANTR	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; zymogen activation [GO:0031638]
PGEN_.00g162470	Scaffold_07	27067412	27074370	NA	NA	NA	NA	NA
PGEN_.00g162480	Scaffold_07	27084010	27171725	Q9VPF0	ATK_DROME	Protein artichoke	GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0050896; GO:0060271	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]
PGEN_.00g162490	Scaffold_07	27190706	27200240	NA	NA	NA	NA	NA
PGEN_.00g162500	Scaffold_07	27200745	27204356	NA	NA	NA	NA	NA
PGEN_.00g162510	Scaffold_07	27204655	27209072	Q9JJW0	PXMP4_MOUSE	Peroxisomal membrane protein 4 (24 kDa peroxisomal intrinsic membrane protein)	GO:0005777; GO:0005778; GO:0016021	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
PGEN_.00g162520	Scaffold_07	27213152	27248659	Q54P77	4CL1_DICDI	Probable 4-coumarate--CoA ligase 1 (4CL 1) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 1)	GO:0005524; GO:0009698; GO:0016207	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]
PGEN_.00g162530	Scaffold_07	27248702	27279934	Q8CF97	VCIP1_RAT	Deubiquitinating protein VCIP135 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135)	GO:0000278; GO:0004843; GO:0005783; GO:0005795; GO:0007030; GO:0016320; GO:0016567; GO:0035871; GO:0045202; GO:0071108; GO:0090168	endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; synapse [GO:0045202]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]
PGEN_.00g162540	Scaffold_07	27292663	27318544	O35887	CALU_MOUSE	Calumenin (Crocalbin)	GO:0004857; GO:0005509; GO:0005576; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0019899; GO:0033018; GO:0042470; GO:0043231	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]
PGEN_.00g162550	Scaffold_07	27318852	27319510	NA	NA	NA	NA	NA
PGEN_.00g162560	Scaffold_07	27325043	27327168	NA	NA	NA	NA	NA
PGEN_.00g162570	Scaffold_07	27434971	27441768	NA	NA	NA	NA	NA
PGEN_.00g162580	Scaffold_07	27448585	27449049	NA	NA	NA	NA	NA
PGEN_.00g162590	Scaffold_07	27460133	27463069	NA	NA	NA	NA	NA
PGEN_.00g162600	Scaffold_07	27506298	27506978	NA	NA	NA	NA	NA
PGEN_.00g162610	Scaffold_07	27510994	27547383	NA	NA	NA	NA	NA
PGEN_.00g162620	Scaffold_07	27566038	27566343	NA	NA	NA	NA	NA
PGEN_.00g162630	Scaffold_07	27613311	27627457	Q6DJC8	TM53B_XENLA	Transmembrane protein 53-B	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g162640	Scaffold_07	27685231	27685449	NA	NA	NA	NA	NA
PGEN_.00g162650	Scaffold_07	27697069	27697425	NA	NA	NA	NA	NA
PGEN_.00g162660	Scaffold_07	27705067	27736319	Q3T001	H17B6_BOVIN	17-beta-hydroxysteroid dehydrogenase type 6 (17-beta-HSD 6) (17-beta-HSD6) (EC 1.1.1.105) (EC 1.1.1.239) (EC 1.1.1.62) (3-alpha->beta-hydroxysteroid epimerase) (3-alpha->beta-HSE) (Oxidative 3-alpha hydroxysteroid dehydrogenase)	GO:0004303; GO:0004745; GO:0005789; GO:0008202; GO:0047035	endoplasmic reticulum membrane [GO:0005789]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; steroid metabolic process [GO:0008202]
PGEN_.00g162670	Scaffold_07	27742794	27744665	A8WQK3	ACH1_CAEBR	Acetylcholine receptor subunit alpha-type acr-16	GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g162680	Scaffold_07	27756852	27781949	P78344	IF4G2_HUMAN	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Death-associated protein 5) (DAP-5) (p97)	GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0005913; GO:0006446; GO:0007050; GO:0008135; GO:0008219; GO:0010507; GO:0016020; GO:0016281; GO:0030307; GO:0034645; GO:0045296	"cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cell cycle arrest [GO:0007050]; cell death [GO:0008219]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; regulation of translational initiation [GO:0006446]"
PGEN_.00g162690	Scaffold_07	27788046	27799738	Q9NUP9	LIN7C_HUMAN	Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3)	GO:0002011; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008092; GO:0015031; GO:0016323; GO:0019904; GO:0030165; GO:0045199; GO:0045202; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:0098978; GO:1903361	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]; cytoskeletal protein binding [GO:0008092]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; morphogenesis of an epithelial sheet [GO:0002011]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]
PGEN_.00g162700	Scaffold_07	27812691	27828547	Q5RBG3	NSF1C_PONAB	NSFL1 cofactor p47 (p97 cofactor p47)	GO:0000132; GO:0005623; GO:0005654; GO:0005694; GO:0005795; GO:0005815; GO:0005829; GO:0005886; GO:0008289; GO:0045111; GO:0046604; GO:1904780	cell [GO:0005623]; chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; intermediate filament cytoskeleton [GO:0045111]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to centrosome [GO:1904780]; positive regulation of mitotic centrosome separation [GO:0046604]
PGEN_.00g162710	Scaffold_07	27841144	27855960	P48861	DDC_MANSE	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC)	GO:0004058; GO:0006520; GO:0030170; GO:0042423	aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]
PGEN_.00g162720	Scaffold_07	27859940	27861616	NA	NA	NA	NA	NA
PGEN_.00g162730	Scaffold_07	27870931	27871854	B5FXA0	ETFR1_TAEGU	Electron transfer flavoprotein regulatory factor 1 (LYR motif-containing protein 5)	GO:0005739; GO:0022904	mitochondrion [GO:0005739]; respiratory electron transport chain [GO:0022904]
PGEN_.00g162740	Scaffold_07	27874086	27892705	A6H8T2	CASC1_DANRE	Protein CASC1 (Cancer susceptibility candidate gene 1 protein homolog)		
PGEN_.00g162750	Scaffold_07	27897987	27900662	P48181	ACH2_CAEEL	Acetylcholine receptor subunit beta-type unc-29 (Uncoordinated protein 29)	GO:0004888; GO:0005887; GO:0006937; GO:0007165; GO:0007268; GO:0007274; GO:0014057; GO:0022848; GO:0030054; GO:0034220; GO:0040011; GO:0042391; GO:0043005; GO:0043025; GO:0043051; GO:0045202; GO:0045211; GO:0046662; GO:0050877	"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; locomotion [GO:0040011]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]; signal transduction [GO:0007165]"
PGEN_.00g162760	Scaffold_07	27903042	27903428	NA	NA	NA	NA	NA
PGEN_.00g162770	Scaffold_07	27905615	27916596	Q8T880	AXP83_CIOIN	Axonemal 84 kDa protein (Ci-AXP83.9) (p83.9)		
PGEN_.00g162780	Scaffold_07	27921617	27951482	Q5BJ68	NB5R2_XENTR	NADH-cytochrome b5 reductase 2 (b5R.2) (EC 1.6.2.2)	GO:0004128; GO:0016021; GO:0016126; GO:0071949	"integral component of membrane [GO:0016021]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; sterol biosynthetic process [GO:0016126]"
PGEN_.00g162790	Scaffold_07	27961870	27962373	NA	NA	NA	NA	NA
PGEN_.00g162800	Scaffold_07	27962649	27964199	NA	NA	NA	NA	NA
PGEN_.00g162810	Scaffold_07	28007835	28022312	NA	NA	NA	NA	NA
PGEN_.00g162820	Scaffold_07	28024906	28029513	NA	NA	NA	NA	NA
PGEN_.00g162830	Scaffold_07	28034966	28043292	NA	NA	NA	NA	NA
PGEN_.00g162840	Scaffold_07	28055941	28069619	Q8K2D0	F199X_MOUSE	Protein FAM199X		
PGEN_.00g162850	Scaffold_07	28069713	28071455	NA	NA	NA	NA	NA
PGEN_.00g162860	Scaffold_07	28071544	28114450	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g162870	Scaffold_07	28122841	28126910	NA	NA	NA	NA	NA
PGEN_.00g162880	Scaffold_07	28127941	28133861	NA	NA	NA	NA	NA
PGEN_.00g162890	Scaffold_07	28138989	28139480	NA	NA	NA	NA	NA
PGEN_.00g162900	Scaffold_07	28142167	28143996	NA	NA	NA	NA	NA
PGEN_.00g162910	Scaffold_07	28156178	28161097	Q5ZKV9	VPS50_CHICK	Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50)	GO:0005829; GO:0015031; GO:0032456; GO:0055037; GO:1990745	cytosol [GO:0005829]; EARP complex [GO:1990745]; recycling endosome [GO:0055037]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]
PGEN_.00g162920	Scaffold_07	28190825	28202165	Q96JG6	VPS50_HUMAN	Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50)	GO:0000149; GO:0005829; GO:0015031; GO:0016020; GO:0032456; GO:0055037; GO:0070062; GO:1990745	cytosol [GO:0005829]; EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; recycling endosome [GO:0055037]; SNARE binding [GO:0000149]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]
PGEN_.00g162930	Scaffold_07	28202362	28203045	Q9CXF7	CHD1L_MOUSE	Chromodomain-helicase-DNA-binding protein 1-like (EC 3.6.4.12)	GO:0000166; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006338; GO:0006974; GO:0016887	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA helicase activity [GO:0003678]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]
PGEN_.00g162940	Scaffold_07	28203742	28204122	NA	NA	NA	NA	NA
PGEN_.00g162950	Scaffold_07	28204197	28204673	NA	NA	NA	NA	NA
PGEN_.00g162960	Scaffold_07	28205164	28248145	Q86WJ1	CHD1L_HUMAN	Chromodomain-helicase-DNA-binding protein 1-like (EC 3.6.4.12) (Amplified in liver cancer protein 1)	GO:0000166; GO:0000717; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006338; GO:0006974; GO:0016887; GO:0033683; GO:0070911	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA helicase activity [GO:0003678]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]"
PGEN_.00g162970	Scaffold_07	28267625	28269630	Q86Z23	C1QL4_HUMAN	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g162980	Scaffold_07	28291806	28292159	NA	NA	NA	NA	NA
PGEN_.00g162990	Scaffold_07	28300505	28300753	NA	NA	NA	NA	NA
PGEN_.00g163000	Scaffold_07	28316845	28318992	NA	NA	NA	NA	NA
PGEN_.00g163010	Scaffold_07	28413079	28416287	NA	NA	NA	NA	NA
PGEN_.00g163020	Scaffold_07	28503291	28522193	Q8BQ89	LIX1L_MOUSE	LIX1-like protein	GO:0005737; GO:0006914; GO:0097352	cytoplasm [GO:0005737]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]
PGEN_.00g163030	Scaffold_07	28523068	28528338	NA	NA	NA	NA	NA
PGEN_.00g163040	Scaffold_07	28564593	28577097	Q9JJB9	TM183_MOUSE	Transmembrane protein 183	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g163050	Scaffold_07	28587097	28602299	P55161	NCKP1_RAT	Nck-associated protein 1 (NAP 1) (Membrane-associated protein HEM-2) (p125Nap1)	GO:0000902; GO:0001701; GO:0001726; GO:0001756; GO:0001843; GO:0007354; GO:0007492; GO:0008078; GO:0010172; GO:0010592; GO:0016021; GO:0016477; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0030838; GO:0030866; GO:0030903; GO:0030950; GO:0031209; GO:0031258; GO:0031941; GO:0032880; GO:0035050; GO:0042074; GO:0045175; GO:0045176; GO:0048339; GO:0048340; GO:0048570; GO:0048617; GO:0048812; GO:0050821; GO:0098794; GO:2000601	"filamentous actin [GO:0031941]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; apical protein localization [GO:0045176]; basal protein localization [GO:0045175]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; embryonic body morphogenesis [GO:0010172]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; mesodermal cell migration [GO:0008078]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; notochord development [GO:0030903]; notochord morphogenesis [GO:0048570]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm morphogenesis [GO:0048340]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; protein stabilization [GO:0050821]; Rac protein signal transduction [GO:0016601]; regulation of protein localization [GO:0032880]; somitogenesis [GO:0001756]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]"
PGEN_.00g163060	Scaffold_07	28602352	28625108	P28660	NCKP1_MOUSE	Nck-associated protein 1 (NAP 1) (Brain protein H19) (MH19) (Membrane-associated protein HEM-2) (p125Nap1)	GO:0000902; GO:0001701; GO:0001726; GO:0001756; GO:0001843; GO:0007354; GO:0007492; GO:0008078; GO:0010172; GO:0010592; GO:0016021; GO:0016477; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0030838; GO:0030866; GO:0030903; GO:0030950; GO:0031209; GO:0031258; GO:0031941; GO:0032880; GO:0035050; GO:0042074; GO:0045175; GO:0045176; GO:0048339; GO:0048340; GO:0048570; GO:0048617; GO:0048812; GO:0050821; GO:0098794; GO:2000601	"filamentous actin [GO:0031941]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; apical protein localization [GO:0045176]; basal protein localization [GO:0045175]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; embryonic body morphogenesis [GO:0010172]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; mesodermal cell migration [GO:0008078]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; notochord development [GO:0030903]; notochord morphogenesis [GO:0048570]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm morphogenesis [GO:0048340]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; protein stabilization [GO:0050821]; Rac protein signal transduction [GO:0016601]; regulation of protein localization [GO:0032880]; somitogenesis [GO:0001756]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]"
PGEN_.00g163070	Scaffold_07	28628588	28632560	B0S6R1	NCKP1_DANRE	Nck-associated protein 1 (NAP 1)	GO:0000902; GO:0016021; GO:0016477; GO:0030031; GO:0030866; GO:0031209; GO:0031258; GO:0048812	integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; SCAR complex [GO:0031209]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; neuron projection morphogenesis [GO:0048812]
PGEN_.00g163080	Scaffold_07	28642429	28643286	NA	NA	NA	NA	NA
PGEN_.00g163090	Scaffold_07	28643369	28648455	NA	NA	NA	NA	NA
PGEN_.00g163100	Scaffold_07	28648589	28649008	NA	NA	NA	NA	NA
PGEN_.00g163110	Scaffold_07	28651434	28656340	NA	NA	NA	NA	NA
PGEN_.00g163120	Scaffold_07	28656498	28657127	NA	NA	NA	NA	NA
PGEN_.00g163130	Scaffold_07	28657232	28657618	NA	NA	NA	NA	NA
PGEN_.00g163140	Scaffold_07	28657756	28659078	NA	NA	NA	NA	NA
PGEN_.00g163150	Scaffold_07	28659437	28660273	NA	NA	NA	NA	NA
PGEN_.00g163160	Scaffold_07	28661701	28665564	NA	NA	NA	NA	NA
PGEN_.00g163170	Scaffold_07	28666493	28669871	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g163180	Scaffold_07	28671234	28673825	NA	NA	NA	NA	NA
PGEN_.00g163190	Scaffold_07	28675379	28683220	Q9ZQ47	GRDP1_ARATH	Glycine-rich domain-containing protein 1 (AtGRDP1)	GO:0005886; GO:0009738; GO:0009787; GO:0071470	plasma membrane [GO:0005886]; abscisic acid-activated signaling pathway [GO:0009738]; cellular response to osmotic stress [GO:0071470]; regulation of abscisic acid-activated signaling pathway [GO:0009787]
PGEN_.00g163200	Scaffold_07	28693288	28706068	NA	NA	NA	NA	NA
PGEN_.00g163210	Scaffold_07	28709119	28709984	NA	NA	NA	NA	NA
PGEN_.00g163220	Scaffold_07	28726007	28728646	Q8C2S0	UBP44_MOUSE	Ubiquitin carboxyl-terminal hydrolase 44 (EC 3.4.19.12) (Deubiquitinating enzyme 44) (Ubiquitin thioesterase 44) (Ubiquitin-specific-processing protease 44)	GO:0004843; GO:0005634; GO:0007049; GO:0007059; GO:0008270; GO:0016579; GO:0036459; GO:0043161; GO:0051301; GO:0090266; GO:1904667	nucleus [GO:0005634]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]
PGEN_.00g163230	Scaffold_07	28729987	28730723	NA	NA	NA	NA	NA
PGEN_.00g163240	Scaffold_07	28741694	28744896	NA	NA	NA	NA	NA
PGEN_.00g163250	Scaffold_07	28749910	28769643	NA	NA	NA	NA	NA
PGEN_.00g163260	Scaffold_07	28800403	28800795	NA	NA	NA	NA	NA
PGEN_.00g163270	Scaffold_07	28806861	28808690	Q9ES30	C1QT3_MOUSE	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005576; GO:0005581; GO:0005615; GO:0005623; GO:0010629; GO:0032991; GO:0035356; GO:0042593; GO:0042802; GO:0045721; GO:0050715; GO:0050728; GO:0051897; GO:0070165; GO:0070206; GO:0070374; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; cellular triglyceride homeostasis [GO:0035356]; glucose homeostasis [GO:0042593]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; protein trimerization [GO:0070206]
PGEN_.00g163280	Scaffold_07	28813148	28813567	NA	NA	NA	NA	NA
PGEN_.00g163290	Scaffold_07	28816045	28851140	NA	NA	NA	NA	NA
PGEN_.00g163300	Scaffold_07	28854624	28894796	Q20930	MIG17_CAEEL	Metalloprotease mig-17 (EC 3.4.24.-) (Abnormal cell migration protein 17)	GO:0004222; GO:0005604; GO:0005615; GO:0008104; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354	basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]
PGEN_.00g163310	Scaffold_07	28902820	28907458	Q96GX5	GWL_HUMAN	Serine/threonine-protein kinase greatwall (GW) (GWL) (hGWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L)	GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006974; GO:0007147; GO:0016301; GO:0018105; GO:0032154; GO:0032515; GO:0035556; GO:0051301; GO:0051721; GO:0051726; GO:1904668	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726]
PGEN_.00g163320	Scaffold_07	29045321	29051761	NA	NA	NA	NA	NA
PGEN_.00g163330	Scaffold_07	29056625	29061851	Q9BY15	AGRE3_HUMAN	Adhesion G protein-coupled receptor E3 (EGF-like module receptor 3) (EGF-like module-containing mucin-like hormone receptor-like 3)	GO:0004930; GO:0005509; GO:0005576; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021; GO:0030667; GO:0043312; GO:0101003	extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neutrophil degranulation [GO:0043312]
PGEN_.00g163340	Scaffold_07	29076619	29088906	P61284	RL12_BOVIN	60S ribosomal protein L12	GO:0000027; GO:0003735; GO:0006412; GO:0015934; GO:0019843; GO:0022625; GO:0070180	cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]
PGEN_.00g163350	Scaffold_07	29090347	29092718	NA	NA	NA	NA	NA
PGEN_.00g163360	Scaffold_07	29093167	29093538	NA	NA	NA	NA	NA
PGEN_.00g163370	Scaffold_07	29101554	29102033	NA	NA	NA	NA	NA
PGEN_.00g163380	Scaffold_07	29104716	29138063	NA	NA	NA	NA	NA
PGEN_.00g163390	Scaffold_07	29164202	29166781	Q9JKQ2	S26A5_MERUN	Prestin (Solute carrier family 26 member 5)	GO:0007605; GO:0008271; GO:0008360; GO:0016021; GO:0016323	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; secondary active sulfate transmembrane transporter activity [GO:0008271]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]
PGEN_.00g163400	Scaffold_07	29225234	29243012	NA	NA	NA	NA	NA
PGEN_.00g163410	Scaffold_07	29243038	29245170	A8E4S7	MB213_DANRE	Protein mab-21-like 3		
PGEN_.00g163420	Scaffold_07	29255368	29261365	Q8IYB1	M21D2_HUMAN	Protein MB21D2 (Mab-21 domain-containing protein 2)	GO:0044877; GO:0045296	cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]
PGEN_.00g163430	Scaffold_07	29263311	29263694	NA	NA	NA	NA	NA
PGEN_.00g163440	Scaffold_07	29263721	29273542	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g163450	Scaffold_07	29274613	29283998	NA	NA	NA	NA	NA
PGEN_.00g163460	Scaffold_07	29287212	29295936	Q9Z0W3	NU160_MOUSE	Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Gene trap locus 1-13 protein) (GTL-13) (Nucleoporin Nup160)	GO:0000776; GO:0005643; GO:0006406; GO:0017056; GO:0031080; GO:0072006	kinetochore [GO:0000776]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]
PGEN_.00g163470	Scaffold_07	29296966	29328878	Q9Z0W3	NU160_MOUSE	Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Gene trap locus 1-13 protein) (GTL-13) (Nucleoporin Nup160)	GO:0000776; GO:0005643; GO:0006406; GO:0017056; GO:0031080; GO:0072006	kinetochore [GO:0000776]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]
PGEN_.00g163480	Scaffold_07	29383979	29446436	Q4FZU8	RIPR1_RAT	Rho family-interacting cell polarization regulator 1	GO:0005623; GO:0005737; GO:0005794; GO:0007266; GO:0009267; GO:0009611; GO:0016020; GO:0030335; GO:0031252; GO:0034067; GO:0035024; GO:0051683; GO:0071889; GO:0090316; GO:1990869; GO:2001107	cell [GO:0005623]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; 14-3-3 protein binding [GO:0071889]; cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]
PGEN_.00g163490	Scaffold_07	29459660	29459932	NA	NA	NA	NA	NA
PGEN_.00g163500	Scaffold_07	29477507	29485243	NA	NA	NA	NA	NA
PGEN_.00g163510	Scaffold_07	29485359	29527470	A1A4K3	DDB1_BOVIN	DNA damage-binding protein 1 (Damage-specific DNA-binding protein 1)	GO:0003684; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006511; GO:0016567; GO:0031464; GO:0031465; GO:0042752; GO:0043161; GO:0045722; GO:0048511; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA repair [GO:0006281]; positive regulation of gluconeogenesis [GO:0045722]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g163520	Scaffold_07	29540112	29581301	Q28619	NHRF1_RABIT	Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)	GO:0001726; GO:0005737; GO:0005902; GO:0010642; GO:0012505; GO:0014067; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0030175; GO:0031528; GO:0032782; GO:0034635; GO:0045859; GO:0051898; GO:0060090; GO:0070293; GO:0071944; GO:0097225; GO:0097291; GO:2000146	apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; chloride channel regulator activity [GO:0017081]; molecular adaptor activity [GO:0060090]; bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; Wnt signaling pathway [GO:0016055]
PGEN_.00g163530	Scaffold_07	29592706	29593113	Q8SQG9	NHRF2_RABIT	Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (PDZ domain-containing protein NHERF-2) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2)	GO:0005634; GO:0008022; GO:0012505; GO:0016324; GO:0060090	apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]
PGEN_.00g163540	Scaffold_07	29593192	29598179	NA	NA	NA	NA	NA
PGEN_.00g163550	Scaffold_07	29626545	29626956	NA	NA	NA	NA	NA
PGEN_.00g163560	Scaffold_07	29652927	29710657	Q6NTN5	MTMRD_XENLA	Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2)	GO:0005085; GO:0005737; GO:0006914; GO:0016020; GO:0019208; GO:0043087	cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; autophagy [GO:0006914]; regulation of GTPase activity [GO:0043087]
PGEN_.00g163570	Scaffold_07	29720251	29738793	P09480	ACHA2_CHICK	Neuronal acetylcholine receptor subunit alpha-2	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g163580	Scaffold_07	29743518	29763370	Q0P5J1	FACR2_BOVIN	Fatty acyl-CoA reductase 2 (EC 1.2.1.84)	GO:0005777; GO:0005779; GO:0006629; GO:0035336; GO:0080019; GO:0102965	integral component of peroxisomal membrane [GO:0005779]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; lipid metabolic process [GO:0006629]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]
PGEN_.00g163590	Scaffold_07	29772732	29777338	P62277	RS13_HUMAN	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	GO:0000184; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0014069; GO:0016020; GO:0019083; GO:0022627; GO:0033119; GO:0048027; GO:0070062; GO:0070181	"cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; negative regulation of RNA splicing [GO:0033119]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
PGEN_.00g163600	Scaffold_07	29788897	29792198	NA	NA	NA	NA	NA
PGEN_.00g163610	Scaffold_07	29794409	29800483	NA	NA	NA	NA	NA
PGEN_.00g163620	Scaffold_07	29813663	29821302	NA	NA	NA	NA	NA
PGEN_.00g163630	Scaffold_07	29832300	29836210	Q95SX7	RTBS_DROME	Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)	GO:0003964; GO:0006313	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g163640	Scaffold_07	29850189	29850596	NA	NA	NA	NA	NA
PGEN_.00g163650	Scaffold_07	29852030	29854740	Q7L1S5	CHST9_HUMAN	Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)	GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446	extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g163660	Scaffold_07	29867733	29869586	Q3ZMH1	SC5A8_DANRE	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (zSMCTe) (Sodium solute symporter family 5 member 8 protein) (Solute carrier family 5 member 8)	GO:0006814; GO:0015293; GO:0015355; GO:0016021	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g163670	Scaffold_07	29877718	29892399	Q9CQU8	IMP1L_MOUSE	Mitochondrial inner membrane protease subunit 1 (EC 3.4.21.-) (IMP1-like protein)	GO:0005739; GO:0006627; GO:0008236; GO:0042720	mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]; serine-type peptidase activity [GO:0008236]; protein processing involved in protein targeting to mitochondrion [GO:0006627]
PGEN_.00g163680	Scaffold_07	29898858	29899307	P51865	TDGF1_MOUSE	Teratocarcinoma-derived growth factor (Cripto growth factor) (Epidermal growth factor-like Cripto protein)	GO:0000187; GO:0001570; GO:0001701; GO:0001763; GO:0001954; GO:0002042; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0007368; GO:0007369; GO:0007507; GO:0008083; GO:0008284; GO:0008595; GO:0009948; GO:0009952; GO:0009966; GO:0009986; GO:0010595; GO:0015026; GO:0016324; GO:0017147; GO:0018105; GO:0019897; GO:0030154; GO:0030334; GO:0030335; GO:0030509; GO:0030512; GO:0031225; GO:0035729; GO:0038092; GO:0038100; GO:0043066; GO:0044344; GO:0045121; GO:0045944; GO:0048146; GO:0048471; GO:0048856; GO:0050731; GO:0055007; GO:0070697; GO:0070698; GO:0071346; GO:0071354; GO:0071356; GO:0071364	"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; activin receptor binding [GO:0070697]; coreceptor activity [GO:0015026]; growth factor activity [GO:0008083]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102]; type I activin receptor binding [GO:0070698]; Wnt-protein binding [GO:0017147]; activation of MAPK activity [GO:0000187]; anatomical structure development [GO:0048856]; anterior/posterior axis specification [GO:0009948]; anterior/posterior axis specification, embryo [GO:0008595]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cardiac muscle cell differentiation [GO:0055007]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-6 [GO:0071354]; cellular response to tumor necrosis factor [GO:0071356]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; morphogenesis of a branching structure [GO:0001763]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nodal signaling pathway [GO:0038092]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of signal transduction [GO:0009966]; vasculogenesis [GO:0001570]"
PGEN_.00g163690	Scaffold_07	29902486	29903073	P51865	TDGF1_MOUSE	Teratocarcinoma-derived growth factor (Cripto growth factor) (Epidermal growth factor-like Cripto protein)	GO:0000187; GO:0001570; GO:0001701; GO:0001763; GO:0001954; GO:0002042; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0007368; GO:0007369; GO:0007507; GO:0008083; GO:0008284; GO:0008595; GO:0009948; GO:0009952; GO:0009966; GO:0009986; GO:0010595; GO:0015026; GO:0016324; GO:0017147; GO:0018105; GO:0019897; GO:0030154; GO:0030334; GO:0030335; GO:0030509; GO:0030512; GO:0031225; GO:0035729; GO:0038092; GO:0038100; GO:0043066; GO:0044344; GO:0045121; GO:0045944; GO:0048146; GO:0048471; GO:0048856; GO:0050731; GO:0055007; GO:0070697; GO:0070698; GO:0071346; GO:0071354; GO:0071356; GO:0071364	"anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; activin receptor binding [GO:0070697]; coreceptor activity [GO:0015026]; growth factor activity [GO:0008083]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102]; type I activin receptor binding [GO:0070698]; Wnt-protein binding [GO:0017147]; activation of MAPK activity [GO:0000187]; anatomical structure development [GO:0048856]; anterior/posterior axis specification [GO:0009948]; anterior/posterior axis specification, embryo [GO:0008595]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cardiac muscle cell differentiation [GO:0055007]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-6 [GO:0071354]; cellular response to tumor necrosis factor [GO:0071356]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; morphogenesis of a branching structure [GO:0001763]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nodal signaling pathway [GO:0038092]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of signal transduction [GO:0009966]; vasculogenesis [GO:0001570]"
PGEN_.00g163700	Scaffold_07	30003528	30012504	O60494	CUBN_HUMAN	Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]
PGEN_.00g163710	Scaffold_07	30016166	30030893	NA	NA	NA	NA	NA
PGEN_.00g163720	Scaffold_07	30149832	30158998	Q5D1D6	GBP1_CHLAE	Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 1) (GBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1)	GO:0000139; GO:0003924; GO:0005525; GO:0005576; GO:0005886; GO:0042742; GO:0051607	extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]
PGEN_.00g163730	Scaffold_07	30177229	30177588	Q5R5U3	ZN271_PONAB	Zinc finger protein 271	GO:0000976; GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]
PGEN_.00g163740	Scaffold_07	30177810	30178673	NA	NA	NA	NA	NA
PGEN_.00g163750	Scaffold_07	30179630	30180166	NA	NA	NA	NA	NA
PGEN_.00g163760	Scaffold_07	30180233	30180541	NA	NA	NA	NA	NA
PGEN_.00g163770	Scaffold_07	30180728	30182659	NA	NA	NA	NA	NA
PGEN_.00g163780	Scaffold_07	30186967	30205332	NA	NA	NA	NA	NA
PGEN_.00g163790	Scaffold_07	30206136	30207323	NA	NA	NA	NA	NA
PGEN_.00g163800	Scaffold_07	30208389	30211557	NA	NA	NA	NA	NA
PGEN_.00g163810	Scaffold_07	30237543	30246212	P32456	GBP2_HUMAN	Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2)	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0015629; GO:0020005; GO:0031410; GO:0034504; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0060333; GO:0060337; GO:0071346; GO:0071347; GO:0071356	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; protein localization to nucleus [GO:0034504]; type I interferon signaling pathway [GO:0060337]
PGEN_.00g163820	Scaffold_07	30260449	30270991	NA	NA	NA	NA	NA
PGEN_.00g163830	Scaffold_07	30277942	30283521	NA	NA	NA	NA	NA
PGEN_.00g163840	Scaffold_07	30288515	30288919	NA	NA	NA	NA	NA
PGEN_.00g163850	Scaffold_07	30291012	30296038	NA	NA	NA	NA	NA
PGEN_.00g163860	Scaffold_07	30297776	30308771	NA	NA	NA	NA	NA
PGEN_.00g163870	Scaffold_07	30336834	30342117	P18426	SCR11_NOTSL	S-crystallin SL11 (Major lens polypeptide)	GO:0005212	structural constituent of eye lens [GO:0005212]
PGEN_.00g163880	Scaffold_07	30441959	30455906	NA	NA	NA	NA	NA
PGEN_.00g163890	Scaffold_07	30459526	30464893	NA	NA	NA	NA	NA
PGEN_.00g163900	Scaffold_07	30475380	30492399	Q7A5L8	TDCB_STAAN	L-threonine dehydratase catabolic TdcB (EC 4.3.1.19) (Threonine deaminase)	GO:0000166; GO:0004794; GO:0030170; GO:0070689	L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; L-threonine catabolic process to propionate [GO:0070689]
PGEN_.00g163910	Scaffold_07	30494979	30512233	P79101	CPSF3_BOVIN	Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73)	GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0046872	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]
PGEN_.00g163920	Scaffold_07	30512431	30514057	NA	NA	NA	NA	NA
PGEN_.00g163930	Scaffold_07	30519051	30520580	B4U955	RF1_HYDS0	Peptide chain release factor 1 (RF-1)	GO:0005737; GO:0016149	"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]"
PGEN_.00g163940	Scaffold_07	30521718	30537850	P70694	DHB5_MOUSE	Estradiol 17 beta-dehydrogenase 5 (EC 1.1.1.-) (17-beta-HSD 5)	GO:0001758; GO:0004032; GO:0004033; GO:0004303; GO:0005634; GO:0005737; GO:0005829; GO:0006693; GO:0006694; GO:0008106; GO:0008202; GO:0016229; GO:0016491; GO:0016655; GO:0032052; GO:0042448; GO:0042493; GO:0043627; GO:0044597; GO:0044598; GO:0047006; GO:0047023; GO:0047045; GO:0047086; GO:0048025; GO:0071395	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; retinal dehydrogenase activity [GO:0001758]; steroid dehydrogenase activity [GO:0016229]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; cellular response to jasmonic acid stimulus [GO:0071395]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]"
PGEN_.00g163950	Scaffold_07	30548398	30550473	Q5IS75	ACHB3_PANTR	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g163960	Scaffold_07	30554822	30560531	NA	NA	NA	NA	NA
PGEN_.00g163970	Scaffold_07	30562873	30575275	NA	NA	NA	NA	NA
PGEN_.00g163980	Scaffold_07	30575518	30575817	NA	NA	NA	NA	NA
PGEN_.00g163990	Scaffold_07	30575843	30576460	NA	NA	NA	NA	NA
PGEN_.00g164000	Scaffold_07	30576572	30577395	NA	NA	NA	NA	NA
PGEN_.00g164010	Scaffold_07	30591624	30592511	NA	NA	NA	NA	NA
PGEN_.00g164020	Scaffold_07	30603488	30671660	P16066	ANPRA_HUMAN	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]
PGEN_.00g164030	Scaffold_07	30715559	30721600	NA	NA	NA	NA	NA
PGEN_.00g164040	Scaffold_07	30723361	30755201	O95628	CNOT4_HUMAN	CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4)	GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0006977; GO:0016567; GO:0030014; GO:0045652; GO:0046872; GO:0051865	"CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g164050	Scaffold_07	30757282	30782253	NA	NA	NA	NA	NA
PGEN_.00g164060	Scaffold_07	30784544	30796326	Q9D3W1	RSP14_MOUSE	Radial spoke head 14 homolog (Rhabdoid tumor deletion region protein 1)		
PGEN_.00g164070	Scaffold_07	30887151	30888397	NA	NA	NA	NA	NA
PGEN_.00g164080	Scaffold_07	31068217	31068839	NA	NA	NA	NA	NA
PGEN_.00g164090	Scaffold_07	31070737	31080237	O73874	EFNB2_DANRE	Ephrin-B2a	GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0016021; GO:0021654; GO:0035475; GO:0046875; GO:0048013; GO:0050920	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]
PGEN_.00g164100	Scaffold_07	31102331	31136077	Q62735	NR1H4_RAT	Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14)	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001678; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005623; GO:0005634; GO:0005719; GO:0006109; GO:0006355; GO:0006357; GO:0006629; GO:0006954; GO:0007043; GO:0007219; GO:0007275; GO:0008134; GO:0008206; GO:0008270; GO:0009749; GO:0010628; GO:0010804; GO:0010988; GO:0030154; GO:0030374; GO:0030522; GO:0032052; GO:0032088; GO:0032496; GO:0032689; GO:0032692; GO:0032703; GO:0032715; GO:0032720; GO:0034142; GO:0034162; GO:0034255; GO:0034971; GO:0035356; GO:0035774; GO:0038023; GO:0038181; GO:0038183; GO:0038185; GO:0042277; GO:0042593; GO:0042632; GO:0042742; GO:0043066; GO:0043124; GO:0043565; GO:0044877; GO:0045087; GO:0045944; GO:0046628; GO:0046965; GO:0048565; GO:0050728; GO:0055088; GO:0055089; GO:0061178; GO:0070328; GO:0070858; GO:0071222; GO:0071398; GO:0071417; GO:0071638; GO:0072615; GO:0090575; GO:1902122; GO:1902714; GO:1904179; GO:1904468; GO:1905695; GO:2000213; GO:2001250	"cell [GO:0005623]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; bile acid binding [GO:0032052]; bile acid receptor activity [GO:0038181]; chenodeoxycholic acid binding [GO:1902122]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; cell differentiation [GO:0030154]; cell-cell junction assembly [GO:0007043]; cellular glucose homeostasis [GO:0001678]; cellular response to fatty acid [GO:0071398]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organonitrogen compound [GO:0071417]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; defense response to bacterium [GO:0042742]; digestive tract development [GO:0048565]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; histone H3-R17 methylation [GO:0034971]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17 secretion [GO:0072615]; intracellular bile acid receptor signaling pathway [GO:0038185]; intracellular receptor signaling pathway [GO:0030522]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor secretion [GO:1904468]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; Notch signaling pathway [GO:0007219]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of ammonia assimilation cycle [GO:2001250]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate metabolic process [GO:2000213]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phosphatidic acid biosynthetic process [GO:1905695]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of carbohydrate metabolic process [GO:0006109]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of urea metabolic process [GO:0034255]; response to glucose [GO:0009749]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 9 signaling pathway [GO:0034162]; triglyceride homeostasis [GO:0070328]"
PGEN_.00g164110	Scaffold_07	31156152	31175758	NA	NA	NA	NA	NA
PGEN_.00g164120	Scaffold_07	31189222	31222150	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g164130	Scaffold_07	31239337	31257389	Q92058	PPBT_CHICK	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1)"	GO:0004035; GO:0005886; GO:0031225; GO:0046872; GO:0065010	anchored component of membrane [GO:0031225]; extracellular membrane-bounded organelle [GO:0065010]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]
PGEN_.00g164140	Scaffold_07	31275365	31370097	O88871	GABR2_RAT	Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51)	GO:0004965; GO:0005737; GO:0005887; GO:0007214; GO:0016021; GO:0030054; GO:0030425; GO:0038039; GO:0043005; GO:0043204; GO:0046982; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0150099; GO:1902710	cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]
PGEN_.00g164150	Scaffold_07	31387393	31388008	NA	NA	NA	NA	NA
PGEN_.00g164160	Scaffold_07	31415817	31418749	NA	NA	NA	NA	NA
PGEN_.00g164170	Scaffold_07	31437886	31453210	Q5ZKF5	SKP1_CHICK	S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1)	GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0008013; GO:0019005; GO:0019904; GO:0031146; GO:0031467; GO:0031519; GO:0035518; GO:0051457; GO:0061630; GO:0097602	centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; protein domain specific binding [GO:0019904]; ubiquitin protein ligase activity [GO:0061630]; histone H2A monoubiquitination [GO:0035518]; maintenance of protein location in nucleus [GO:0051457]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g164180	Scaffold_07	31468089	31488078	P97393	RHG05_MOUSE	Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B)	GO:0002053; GO:0003924; GO:0005096; GO:0005525; GO:0005783; GO:0005829; GO:0005886; GO:0007165; GO:0008361; GO:0030335; GO:0042169	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; SH2 domain binding [GO:0042169]; positive regulation of cell migration [GO:0030335]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; signal transduction [GO:0007165]
PGEN_.00g164190	Scaffold_07	31498086	31563109	P97393	RHG05_MOUSE	Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B)	GO:0002053; GO:0003924; GO:0005096; GO:0005525; GO:0005783; GO:0005829; GO:0005886; GO:0007165; GO:0008361; GO:0030335; GO:0042169	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; SH2 domain binding [GO:0042169]; positive regulation of cell migration [GO:0030335]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; signal transduction [GO:0007165]
PGEN_.00g164200	Scaffold_07	31583921	31601722	Q56A55	MITOS_DANRE	"Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial sulfonylurea-receptor) (MITOSUR)"	GO:0005524; GO:0005743; GO:0016021; GO:0016887; GO:0042626; GO:0055085; GO:0062157; GO:0071805	integral component of membrane [GO:0016021]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085]
PGEN_.00g164210	Scaffold_07	31602634	31603983	NA	NA	NA	NA	NA
PGEN_.00g164220	Scaffold_07	31604316	31611195	Q56A55	MITOS_DANRE	"Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial sulfonylurea-receptor) (MITOSUR)"	GO:0005524; GO:0005743; GO:0016021; GO:0016887; GO:0042626; GO:0055085; GO:0062157; GO:0071805	integral component of membrane [GO:0016021]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085]
PGEN_.00g164230	Scaffold_07	31612089	31645074	NA	NA	NA	NA	NA
PGEN_.00g164240	Scaffold_07	31645122	31646756	NA	NA	NA	NA	NA
PGEN_.00g164250	Scaffold_07	31646961	31662131	NA	NA	NA	NA	NA
PGEN_.00g164260	Scaffold_07	31665176	31665658	NA	NA	NA	NA	NA
PGEN_.00g164270	Scaffold_07	31665993	31685992	NA	NA	NA	NA	NA
PGEN_.00g164280	Scaffold_07	31698548	31724429	Q0P5X1	LRIQ1_MOUSE	Leucine-rich repeat and IQ domain-containing protein 1	GO:0005737; GO:0019901	cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]
PGEN_.00g164290	Scaffold_07	31725551	31755954	A0JNA8	PAXI1_BOVIN	PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein)	GO:0005694; GO:0006281; GO:0006310; GO:0016363; GO:0043433	chromosome [GO:0005694]; nuclear matrix [GO:0016363]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of DNA-binding transcription factor activity [GO:0043433]
PGEN_.00g164300	Scaffold_07	31771452	31780075	NA	NA	NA	NA	NA
PGEN_.00g164310	Scaffold_07	31780359	31782968	NA	NA	NA	NA	NA
PGEN_.00g164320	Scaffold_07	31783038	31783574	NA	NA	NA	NA	NA
PGEN_.00g164330	Scaffold_07	31783611	31784192	NA	NA	NA	NA	NA
PGEN_.00g164340	Scaffold_07	31784397	31786799	NA	NA	NA	NA	NA
PGEN_.00g164350	Scaffold_07	31786878	31787429	NA	NA	NA	NA	NA
PGEN_.00g164360	Scaffold_07	31787711	31805637	NA	NA	NA	NA	NA
PGEN_.00g164370	Scaffold_07	31846957	31872455	NA	NA	NA	NA	NA
PGEN_.00g164380	Scaffold_07	31887164	31888623	NA	NA	NA	NA	NA
PGEN_.00g164390	Scaffold_07	31917257	31917727	NA	NA	NA	NA	NA
PGEN_.00g164400	Scaffold_07	31942385	31994901	Q9QZR5	HIPK2_MOUSE	Homeodomain-interacting protein kinase 2 (EC 2.7.11.1) (Nuclear body-associated kinase 1) (Sialophorin tail-associated nuclear serine/threonine-protein kinase)	GO:0000122; GO:0001102; GO:0001934; GO:0003714; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006978; GO:0007179; GO:0007224; GO:0007628; GO:0008284; GO:0008344; GO:0009952; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0018107; GO:0030182; GO:0030511; GO:0030514; GO:0032092; GO:0042771; GO:0043388; GO:0043524; GO:0045766; GO:0045893; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051091; GO:0060059; GO:0060235; GO:0060395; GO:0061072; GO:0090575; GO:2000059	"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription factor complex [GO:0090575]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II activating transcription factor binding [GO:0001102]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790]; adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]"
PGEN_.00g164410	Scaffold_07	32002050	32011416	Q6PFY8	TRI45_MOUSE	Tripartite motif-containing protein 45	GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
PGEN_.00g164420	Scaffold_07	32013768	32025202	NA	NA	NA	NA	NA
PGEN_.00g164430	Scaffold_07	32039531	32081933	Q9NRA2	S17A5_HUMAN	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672	cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]
PGEN_.00g164440	Scaffold_07	32043796	32045176	NA	NA	NA	NA	NA
PGEN_.00g164450	Scaffold_07	32097907	32105025	NA	NA	NA	NA	NA
PGEN_.00g164460	Scaffold_07	32116007	32134507	Q5M8L8	HVCN1_XENTR	Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1)	GO:0005887; GO:0030171; GO:0034765; GO:0071294; GO:0071467; GO:1902600	integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g164470	Scaffold_07	32379507	32381359	NA	NA	NA	NA	NA
PGEN_.00g164480	Scaffold_07	32384007	32399040	Q3T0R7	THIM_BOVIN	"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)"	GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0006635; GO:0016290; GO:0047617; GO:0102991; GO:1901029	mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]
PGEN_.00g164490	Scaffold_07	32403478	32409230	NA	NA	NA	NA	NA
PGEN_.00g164500	Scaffold_07	32413633	32421485	NA	NA	NA	NA	NA
PGEN_.00g164510	Scaffold_07	32428464	32431606	NA	NA	NA	NA	NA
PGEN_.00g164520	Scaffold_07	32436042	32458199	Q9Z306	S22A4_MOUSE	Solute carrier family 22 member 4 (Organic cation/carnitine transporter 1)	GO:0005524; GO:0005739; GO:0006641; GO:0006814; GO:0009437; GO:0015101; GO:0015226; GO:0015293; GO:0015491; GO:0015651; GO:0015697; GO:0015879; GO:0016021; GO:0016324; GO:0030165	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; organic cation transmembrane transporter activity [GO:0015101]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; quaternary ammonium group transport [GO:0015697]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]
PGEN_.00g164530	Scaffold_07	32478251	32481247	Q0ZDF7	URAD_AMICA	2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (OHCU decarboxylase) (EC 4.1.1.97) (Parahox neighbor) (Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase)	GO:0005777; GO:0006144; GO:0016831; GO:0019428; GO:0019628	peroxisome [GO:0005777]; carboxy-lyase activity [GO:0016831]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]
PGEN_.00g164540	Scaffold_07	32500597	32501784	Q16820	MEP1B_HUMAN	Meprin A subunit beta (EC 3.4.24.63) (Endopeptidase-2) (Meprin B) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit beta) (PABA peptide hydrolase) (PPH beta)	GO:0004222; GO:0005576; GO:0005887; GO:0006954; GO:0008270; GO:0017090; GO:0042802; GO:1901998	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998]
PGEN_.00g164550	Scaffold_07	32502999	32504309	Q64230	MEP1A_RAT	Meprin A subunit alpha (EC 3.4.24.18) (Endopeptidase-2) (Endopeptidase-24.18 subunit alpha) (E-24.18) (MEP-1)	GO:0004222; GO:0006508; GO:0008270; GO:0016020; GO:0017090	membrane [GO:0016020]; meprin A complex [GO:0017090]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g164560	Scaffold_07	32509023	32517361	NA	NA	NA	NA	NA
PGEN_.00g164570	Scaffold_07	32518180	32542528	O96019	ACL6A_HUMAN	Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K)	GO:0000790; GO:0001825; GO:0003407; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007165; GO:0007399; GO:0016514; GO:0016579; GO:0021510; GO:0031011; GO:0032991; GO:0035267; GO:0040008; GO:0043044; GO:0043967; GO:0043968; GO:0071564	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]
PGEN_.00g164580	Scaffold_07	32554167	32578858	NA	NA	NA	NA	NA
PGEN_.00g164590	Scaffold_07	32579532	32579867	NA	NA	NA	NA	NA
PGEN_.00g164600	Scaffold_07	32596827	32597312	NA	NA	NA	NA	NA
PGEN_.00g164610	Scaffold_07	32602878	32607776	NA	NA	NA	NA	NA
PGEN_.00g164620	Scaffold_07	32617229	32652091	NA	NA	NA	NA	NA
PGEN_.00g164630	Scaffold_07	32663730	32687800	O96019	ACL6A_HUMAN	Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K)	GO:0000790; GO:0001825; GO:0003407; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007165; GO:0007399; GO:0016514; GO:0016579; GO:0021510; GO:0031011; GO:0032991; GO:0035267; GO:0040008; GO:0043044; GO:0043967; GO:0043968; GO:0071564	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]
PGEN_.00g164640	Scaffold_07	32688619	32696957	NA	NA	NA	NA	NA
PGEN_.00g164650	Scaffold_07	32701671	32702981	Q64230	MEP1A_RAT	Meprin A subunit alpha (EC 3.4.24.18) (Endopeptidase-2) (Endopeptidase-24.18 subunit alpha) (E-24.18) (MEP-1)	GO:0004222; GO:0006508; GO:0008270; GO:0016020; GO:0017090	membrane [GO:0016020]; meprin A complex [GO:0017090]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g164660	Scaffold_07	32704196	32705401	Q16820	MEP1B_HUMAN	Meprin A subunit beta (EC 3.4.24.63) (Endopeptidase-2) (Meprin B) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit beta) (PABA peptide hydrolase) (PPH beta)	GO:0004222; GO:0005576; GO:0005887; GO:0006954; GO:0008270; GO:0017090; GO:0042802; GO:1901998	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998]
PGEN_.00g164670	Scaffold_07	32722280	32725293	Q0ZDF7	URAD_AMICA	2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (OHCU decarboxylase) (EC 4.1.1.97) (Parahox neighbor) (Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase)	GO:0005777; GO:0006144; GO:0016831; GO:0019428; GO:0019628	peroxisome [GO:0005777]; carboxy-lyase activity [GO:0016831]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]
PGEN_.00g164680	Scaffold_07	32729823	32730671	NA	NA	NA	NA	NA
PGEN_.00g164690	Scaffold_07	32743461	32749730	NA	NA	NA	NA	NA
PGEN_.00g164700	Scaffold_07	32759098	32793189	O55192	SC6A2_MOUSE	Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2)	GO:0003779; GO:0005328; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0006836; GO:0008504; GO:0009986; GO:0015844; GO:0015874; GO:0032809; GO:0042734; GO:0043005; GO:0043014; GO:0045121; GO:0046872; GO:0048265; GO:0048487; GO:0051583; GO:0098810	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; response to pain [GO:0048265]
PGEN_.00g164710	Scaffold_07	32797242	32797559	NA	NA	NA	NA	NA
PGEN_.00g164720	Scaffold_07	32804500	32845962	P59015	VPS18_DANRE	Vacuolar protein sorting-associated protein 18 homolog	GO:0005765; GO:0005768; GO:0006886; GO:0006904; GO:0007032; GO:0007033; GO:0007040; GO:0007634; GO:0008333; GO:0015721; GO:0030674; GO:0030897; GO:0031902; GO:0035542; GO:0043485; GO:0045176; GO:0046872; GO:0048069; GO:0048757; GO:0060036	"endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; pigment granule maturation [GO:0048757]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]"
PGEN_.00g164730	Scaffold_07	32850622	32873363	Q9UHR5	S30BP_HUMAN	SAP30-binding protein (Transcriptional regulator protein HCNGP)	GO:0005634; GO:0005654; GO:0006355; GO:0006915; GO:0010942; GO:0045111	"intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of cell death [GO:0010942]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g164740	Scaffold_07	32879160	32939450	Q86VH2	KIF27_HUMAN	Kinesin-like protein KIF27	GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0060271	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]
PGEN_.00g164750	Scaffold_07	32950920	32955678	NA	NA	NA	NA	NA
PGEN_.00g164760	Scaffold_07	32966918	32967331	NA	NA	NA	NA	NA
PGEN_.00g164770	Scaffold_07	32969499	32989042	Q60865	CAPR1_MOUSE	Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105)	GO:0000932; GO:0003723; GO:0005829; GO:0010494; GO:0017148; GO:0030425; GO:0045202; GO:0050775; GO:0061003; GO:0098794; GO:0098978	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; P-body [GO:0000932]; postsynapse [GO:0098794]; synapse [GO:0045202]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]
PGEN_.00g164780	Scaffold_07	33005038	33034982	Q8IWQ3	BRSK2_HUMAN	Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A)	GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0018105; GO:0019901; GO:0030010; GO:0030182; GO:0031532; GO:0035556; GO:0036503; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0150034; GO:1904152; GO:2000807	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cell division [GO:0051301]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of ATPase activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]"
PGEN_.00g164790	Scaffold_07	33051954	33066222	B2DD29	BRSK1_RAT	Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B)	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0006974; GO:0007095; GO:0007269; GO:0007409; GO:0008021; GO:0008306; GO:0009411; GO:0010975; GO:0019901; GO:0030010; GO:0030054; GO:0030182; GO:0035556; GO:0043015; GO:0046777; GO:0048167; GO:0048786; GO:0048812; GO:0050321; GO:0050770; GO:0051298; GO:0090176; GO:0099504; GO:0150034	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; centrosome duplication [GO:0051298]; establishment of cell polarity [GO:0030010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; mitotic G2 DNA damage checkpoint [GO:0007095]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; neurotransmitter secretion [GO:0007269]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of neuron projection development [GO:0010975]; regulation of synaptic plasticity [GO:0048167]; response to UV [GO:0009411]; synaptic vesicle cycle [GO:0099504]
PGEN_.00g164800	Scaffold_07	33096541	33165998	Q8TDC3	BRSK1_HUMAN	Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1)	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0006974; GO:0007095; GO:0007269; GO:0007409; GO:0008021; GO:0008306; GO:0009411; GO:0010975; GO:0019901; GO:0030010; GO:0030054; GO:0030182; GO:0035556; GO:0043015; GO:0048156; GO:0048167; GO:0048786; GO:0050321; GO:0050770; GO:0051298; GO:0090176; GO:0099504; GO:0150034; GO:2000807	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; centrosome duplication [GO:0051298]; establishment of cell polarity [GO:0030010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; mitotic G2 DNA damage checkpoint [GO:0007095]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of neuron projection development [GO:0010975]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle clustering [GO:2000807]; response to UV [GO:0009411]; synaptic vesicle cycle [GO:0099504]
PGEN_.00g164810	Scaffold_07	33193069	33194217	NA	NA	NA	NA	NA
PGEN_.00g164820	Scaffold_07	33274209	33274478	NA	NA	NA	NA	NA
PGEN_.00g164830	Scaffold_07	33281542	33281937	NA	NA	NA	NA	NA
PGEN_.00g164840	Scaffold_07	33308386	33308724	NA	NA	NA	NA	NA
PGEN_.00g164850	Scaffold_07	33308790	33309221	NA	NA	NA	NA	NA
PGEN_.00g164860	Scaffold_07	33309429	33310281	NA	NA	NA	NA	NA
PGEN_.00g164870	Scaffold_07	33315735	33316055	NA	NA	NA	NA	NA
PGEN_.00g164880	Scaffold_07	33317324	33319135	NA	NA	NA	NA	NA
PGEN_.00g164890	Scaffold_07	33326673	33352690	Q9NZJ4	SACS_HUMAN	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]
PGEN_.00g164900	Scaffold_07	33332408	33333028	NA	NA	NA	NA	NA
PGEN_.00g164910	Scaffold_07	33355647	33368095	P15103	GLNA_BOVIN	Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)	GO:0001525; GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006542; GO:0010594; GO:0018345; GO:0019706; GO:0046872; GO:1903670	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670]
PGEN_.00g164920	Scaffold_07	33376363	33377774	NA	NA	NA	NA	NA
PGEN_.00g164930	Scaffold_07	33378260	33380474	Q6ZQX7	LIAT1_HUMAN	Protein LIAT1 (Ligand of ATE1 protein)	GO:0016598	protein arginylation [GO:0016598]
PGEN_.00g164940	Scaffold_07	33397430	33397906	NA	NA	NA	NA	NA
PGEN_.00g164950	Scaffold_07	33398220	33403842	NA	NA	NA	NA	NA
PGEN_.00g164960	Scaffold_07	33403969	33404373	NA	NA	NA	NA	NA
PGEN_.00g164970	Scaffold_07	33467297	33473768	Q04831	GLNA_PANAR	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]
PGEN_.00g164980	Scaffold_07	33476363	33476827	NA	NA	NA	NA	NA
PGEN_.00g164990	Scaffold_07	33499293	33508011	NA	NA	NA	NA	NA
PGEN_.00g165000	Scaffold_07	33523190	33523474	NA	NA	NA	NA	NA
PGEN_.00g165010	Scaffold_07	33528934	33529206	NA	NA	NA	NA	NA
PGEN_.00g165020	Scaffold_07	33536512	33536976	NA	NA	NA	NA	NA
PGEN_.00g165030	Scaffold_07	33551647	33605366	P04818	TYSY_HUMAN	Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)	GO:0000083; GO:0000166; GO:0000900; GO:0004799; GO:0005542; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0007568; GO:0007623; GO:0015949; GO:0017148; GO:0019088; GO:0019860; GO:0032259; GO:0032570; GO:0033189; GO:0034097; GO:0035999; GO:0042803; GO:0045471; GO:0046078; GO:0046683; GO:0048037; GO:0048589; GO:0051216; GO:0051384; GO:0051593; GO:0060574; GO:0071897; GO:0097421; GO:1990825	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cofactor binding [GO:0048037]; folic acid binding [GO:0005542]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; dUMP metabolic process [GO:0046078]; immortalization of host cell by virus [GO:0019088]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; negative regulation of translation [GO:0017148]; nucleobase-containing small molecule interconversion [GO:0015949]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to cytokine [GO:0034097]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860]"
PGEN_.00g165040	Scaffold_07	33638746	33651150	Q5F3N9	ILRUN_CHICK	Protein ILRUN	GO:0000407; GO:0005634; GO:0005776; GO:0016236; GO:0032480; GO:0032720; GO:0043130; GO:0043392; GO:0045087; GO:0050687; GO:1900181	autophagosome [GO:0005776]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; ubiquitin binding [GO:0043130]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon production [GO:0032480]
PGEN_.00g165050	Scaffold_07	33677075	33680459	Q03562	BRE3_CAEEL	"Beta-1,4-mannosyltransferase bre-3 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 3) (Bt toxin-resistant protein 3)"	GO:0005737; GO:0006486; GO:0006688; GO:0009636; GO:0019187	"cytoplasm [GO:0005737]; beta-1,4-mannosyltransferase activity [GO:0019187]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"
PGEN_.00g165060	Scaffold_07	33718905	33719444	NA	NA	NA	NA	NA
PGEN_.00g165070	Scaffold_07	33719583	33720467	NA	NA	NA	NA	NA
PGEN_.00g165080	Scaffold_07	33720834	33721637	NA	NA	NA	NA	NA
PGEN_.00g165090	Scaffold_07	33742865	33745985	NA	NA	NA	NA	NA
PGEN_.00g165100	Scaffold_07	33770724	33771688	NA	NA	NA	NA	NA
PGEN_.00g165110	Scaffold_07	33822987	33824142	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g165120	Scaffold_07	33824172	33825951	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g165130	Scaffold_07	33826138	33826482	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g165140	Scaffold_07	33827946	33835751	NA	NA	NA	NA	NA
PGEN_.00g165150	Scaffold_07	33857631	33865715	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g165160	Scaffold_07	33873742	33874071	NA	NA	NA	NA	NA
PGEN_.00g165170	Scaffold_07	33874099	33881587	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g165180	Scaffold_07	33892848	33895152	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g165190	Scaffold_07	33898911	33909115	NA	NA	NA	NA	NA
PGEN_.00g165200	Scaffold_07	33924446	33924805	NA	NA	NA	NA	NA
PGEN_.00g165210	Scaffold_07	34016066	34016380	NA	NA	NA	NA	NA
PGEN_.00g165220	Scaffold_07	34022273	34022677	NA	NA	NA	NA	NA
PGEN_.00g165230	Scaffold_07	34059828	34064039	Q8IWY4	SCUB1_HUMAN	"Signal peptide, CUB and EGF-like domain-containing protein 1"	GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0019897; GO:0022617; GO:0042802; GO:0045446; GO:0045880; GO:0046982; GO:0051260	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; extracellular matrix disassembly [GO:0022617]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein homooligomerization [GO:0051260]
PGEN_.00g165240	Scaffold_07	34073585	34108839	NA	NA	NA	NA	NA
PGEN_.00g165250	Scaffold_07	34108949	34109203	NA	NA	NA	NA	NA
PGEN_.00g165260	Scaffold_07	34109383	34109682	NA	NA	NA	NA	NA
PGEN_.00g165270	Scaffold_07	34121748	34122041	NA	NA	NA	NA	NA
PGEN_.00g165280	Scaffold_07	34124552	34136300	NA	NA	NA	NA	NA
PGEN_.00g165290	Scaffold_07	34137253	34137894	NA	NA	NA	NA	NA
PGEN_.00g165300	Scaffold_07	34176256	34182783	Q32NQ7	DAAF3_XENLA	"Dynein assembly factor 3, axonemal"	GO:0005737; GO:0044458; GO:0070286	cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]; motile cilium assembly [GO:0044458]
PGEN_.00g165310	Scaffold_07	34193568	34215736	Q6DDJ3	DFI8A_XENLA	Differentially expressed in FDCP 8 homolog A (DEF-8-A)	GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029	metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]
PGEN_.00g165320	Scaffold_07	34244742	34245195	NA	NA	NA	NA	NA
PGEN_.00g165330	Scaffold_07	34246381	34246644	NA	NA	NA	NA	NA
PGEN_.00g165340	Scaffold_07	34247365	34247628	NA	NA	NA	NA	NA
PGEN_.00g165350	Scaffold_07	34247681	34248973	NA	NA	NA	NA	NA
PGEN_.00g165360	Scaffold_07	34251745	34258868	NA	NA	NA	NA	NA
PGEN_.00g165370	Scaffold_07	34267906	34286024	P62205	PLK1_XENTR	Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1)	GO:0000278; GO:0000776; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006468; GO:0030496; GO:0032465; GO:0051301; GO:0071168; GO:0072425	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; protein localization to chromatin [GO:0071168]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]
PGEN_.00g165380	Scaffold_07	34286442	34295316	A4L691	PINX1_RAT	PIN2/TERF1-interacting telomerase inhibitor 1 (Pin2-interacting protein X1)	GO:0000228; GO:0000776; GO:0000777; GO:0000781; GO:0000784; GO:0005623; GO:0005654; GO:0005730; GO:0005819; GO:0007004; GO:0007080; GO:0010521; GO:0010972; GO:0031397; GO:0031647; GO:0032211; GO:0044877; GO:0051974; GO:0070034; GO:0070198; GO:1902570; GO:1904744; GO:1904751	"cell [GO:0005623]; chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]; mitotic metaphase plate congression [GO:0007080]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; telomere maintenance via telomerase [GO:0007004]"
PGEN_.00g165390	Scaffold_07	34306734	34319732	Q9BZF1	OSBL8_HUMAN	Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8)	GO:0001786; GO:0005548; GO:0005783; GO:0005789; GO:0005829; GO:0008289; GO:0010891; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0036150; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]
PGEN_.00g165400	Scaffold_07	34404753	34405016	NA	NA	NA	NA	NA
PGEN_.00g165410	Scaffold_07	34410212	34423584	NA	NA	NA	NA	NA
PGEN_.00g165420	Scaffold_07	34417663	34417965	NA	NA	NA	NA	NA
PGEN_.00g165430	Scaffold_07	34554395	34577471	Q5FB27	AOXA_MACFA	Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-)	GO:0004031; GO:0005506; GO:0005737; GO:0009055; GO:0043546; GO:0051287; GO:0051537; GO:0071949; GO:0102797; GO:0102798	"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]"
PGEN_.00g165440	Scaffold_07	34585466	34587818	NA	NA	NA	NA	NA
PGEN_.00g165450	Scaffold_07	34587848	34589525	NA	NA	NA	NA	NA
PGEN_.00g165460	Scaffold_07	34630366	34634954	NA	NA	NA	NA	NA
PGEN_.00g165470	Scaffold_07	34728255	34730227	NA	NA	NA	NA	NA
PGEN_.00g165480	Scaffold_07	34756086	34756352	NA	NA	NA	NA	NA
PGEN_.00g165490	Scaffold_07	34759777	34811484	Q9UKW6	ELF5_HUMAN	ETS-related transcription factor Elf-5 (E74-like factor 5) (Epithelium-restricted ESE-1-related Ets factor) (Epithelium-specific Ets transcription factor 2) (ESE-2)	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0001712; GO:0005634; GO:0005737; GO:0006357; GO:0030154; GO:0035019; GO:0045596; GO:0060644	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of cell differentiation [GO:0045596]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]"
PGEN_.00g165500	Scaffold_07	34861261	34883825	Q6GM59	MOT12_XENLA	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0015293; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]
PGEN_.00g165510	Scaffold_07	34911029	34919969	Q8BGC3	MOT12_MOUSE	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g165520	Scaffold_07	34923861	34934276	P79153	CP11A_CAPHI	"Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (CYPXIA1) (Cholesterol desmolase) (Cytochrome P450 11A1) (Cytochrome P450(scc))"	GO:0005506; GO:0005743; GO:0006700; GO:0008203; GO:0008386; GO:0020037	mitochondrial inner membrane [GO:0005743]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; C21-steroid hormone biosynthetic process [GO:0006700]; cholesterol metabolic process [GO:0008203]
PGEN_.00g165530	Scaffold_07	34967905	34979256	P26323	FLI1_MOUSE	Friend leukemia integration 1 transcription factor (Retroviral integration site protein Fli-1)	GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0008015; GO:0009887; GO:0009987; GO:0016604; GO:0030154; GO:0035855; GO:0043565; GO:0045893; GO:0045944	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell differentiation [GO:0030154]; cellular process [GO:0009987]; megakaryocyte development [GO:0035855]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g165540	Scaffold_07	35021197	35021616	NA	NA	NA	NA	NA
PGEN_.00g165550	Scaffold_07	35021909	35055420	E9Q3S4	M3K19_MOUSE	Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (SPS1/STE20-related protein kinase YSK4)	GO:0004674; GO:0005524; GO:0005737; GO:0023014; GO:0032147	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g165560	Scaffold_07	35099545	35108970	NA	NA	NA	NA	NA
PGEN_.00g165570	Scaffold_07	35109072	35119405	P48509	CD151_HUMAN	CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151)	GO:0005178; GO:0005604; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0009986; GO:0016020; GO:0016477; GO:0030335; GO:0031581; GO:0042098; GO:0044319; GO:0045807	"basement membrane [GO:0005604]; cell surface [GO:0009986]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; hemidesmosome assembly [GO:0031581]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]"
PGEN_.00g165580	Scaffold_07	35129852	35131244	NA	NA	NA	NA	NA
PGEN_.00g165590	Scaffold_07	35137770	35145393	Q3UY23	FDXA1_MOUSE	Ferredoxin-fold anticodon-binding domain-containing protein 1 homolog (FDX-ACDB domain-containing protein 1)	GO:0005737; GO:0070042; GO:0070475	cytoplasm [GO:0005737]; rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]; rRNA base methylation [GO:0070475]
PGEN_.00g165600	Scaffold_07	35152661	35153887	P93484	VSR1_PEA	Vacuolar-sorting receptor 1 (80 kDa proaleurein-binding protein) (BP-80)	GO:0000139; GO:0005509; GO:0015031; GO:0016021; GO:0030665; GO:0031902	clathrin-coated vesicle membrane [GO:0030665]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]
PGEN_.00g165610	Scaffold_07	35153933	35154985	NA	NA	NA	NA	NA
PGEN_.00g165620	Scaffold_07	35178111	35180595	Q07001	ACHD_HUMAN	Acetylcholine receptor subunit delta	GO:0003009; GO:0004888; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005892; GO:0006936; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0031594; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0048630; GO:0050877; GO:0050881; GO:0050905; GO:0099060; GO:1904315	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle contraction [GO:0006936]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g165630	Scaffold_07	35192344	35194408	P43143	ACHA6_RAT	Neuronal acetylcholine receptor subunit alpha-6	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0014059; GO:0016020; GO:0022848; GO:0030054; GO:0033603; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0050877; GO:0051899; GO:0098691; GO:0099055; GO:0099056; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g165640	Scaffold_07	35201139	35213273	A0A1P8AWH8	XYN1_ARATH	"Endo-1,4-beta-xylanase 1 (AtXyn1) (Xylan endohydrolase 1) (Xylanase 1) (EC 3.2.1.8)"	GO:0005576; GO:0005618; GO:0031176; GO:0045493	"cell wall [GO:0005618]; extracellular region [GO:0005576]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g165650	Scaffold_07	35213429	35239776	A3DH97	RSGI6_HUNT2	"Anti-sigma-I factor RsgI6 (Endo-1,4-beta-xylanase) (EC 3.2.1.8)"	GO:0005886; GO:0016021; GO:0031176; GO:0045493	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g165660	Scaffold_07	35252313	35255477	NA	NA	NA	NA	NA
PGEN_.00g165670	Scaffold_07	35264982	35266511	P20720	UD12_RAT	UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (B2) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2)	GO:0001889; GO:0001972; GO:0005783; GO:0005789; GO:0014070; GO:0015020; GO:0016021; GO:0019899; GO:0031100; GO:0042803; GO:0046982; GO:0052695; GO:0052696; GO:0052697	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; animal organ regeneration [GO:0031100]; cellular glucuronidation [GO:0052695]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; response to organic cyclic compound [GO:0014070]; xenobiotic glucuronidation [GO:0052697]
PGEN_.00g165680	Scaffold_07	35287115	35314378	Q6EAS5	GLGB_HORSE	"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)"	GO:0003844; GO:0004553; GO:0005975; GO:0005978; GO:0043169; GO:0102752	"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]"
PGEN_.00g165690	Scaffold_07	35322864	35334155	Q2KIB3	TM101_BOVIN	Transmembrane protein 101	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g165700	Scaffold_07	35341195	35379690	Q2KJ22	MINY1_BOVIN	Ubiquitin carboxyl-terminal hydrolase MINDY-1 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-1) (Protein FAM63A)	GO:0004843; GO:0005829; GO:0016807; GO:0036435; GO:0071108; GO:1990380	cytosol [GO:0005829]; cysteine-type carboxypeptidase activity [GO:0016807]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K48-linked deubiquitination [GO:0071108]
PGEN_.00g165710	Scaffold_07	35353305	35362960	NA	NA	NA	NA	NA
PGEN_.00g165720	Scaffold_07	35385631	35393962	NA	NA	NA	NA	NA
PGEN_.00g165730	Scaffold_07	35397832	35421088	Q91880	SUH_XENLA	Suppressor of hairless protein homolog (X-Su(H))	GO:0000978; GO:0001228; GO:0005634; GO:0005737; GO:0007221; GO:0007275; GO:0043565; GO:0061419	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]"
PGEN_.00g165740	Scaffold_07	35566757	35567581	NA	NA	NA	NA	NA
PGEN_.00g165750	Scaffold_07	35572356	35572631	NA	NA	NA	NA	NA
PGEN_.00g165760	Scaffold_07	35688361	35700453	NA	NA	NA	NA	NA
PGEN_.00g165770	Scaffold_07	35719533	35721409	NA	NA	NA	NA	NA
PGEN_.00g165780	Scaffold_07	35788408	35802705	Q9Y259	CHKB_HUMAN	Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB)	GO:0004103; GO:0004305; GO:0005524; GO:0005829; GO:0006646; GO:0006656; GO:0007517	cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]
PGEN_.00g165790	Scaffold_07	35810263	35822891	Q9Y259	CHKB_HUMAN	Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB)	GO:0004103; GO:0004305; GO:0005524; GO:0005829; GO:0006646; GO:0006656; GO:0007517	cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]
PGEN_.00g165800	Scaffold_07	35829376	35834037	Q66IZ5	TAD3B_XENLA	Transcriptional adapter 3-B (ADA3 homolog B) (Transcriptional adapter 3-like B) (ADA3-like protein B)	GO:0005634	nucleus [GO:0005634]
PGEN_.00g165810	Scaffold_07	35842130	35858899	NA	NA	NA	NA	NA
PGEN_.00g165820	Scaffold_07	35860313	35860868	NA	NA	NA	NA	NA
PGEN_.00g165830	Scaffold_07	35895177	35895560	NA	NA	NA	NA	NA
PGEN_.00g165840	Scaffold_07	35900829	35924362	Q8IXQ6	PARP9_HUMAN	Protein mono-ADP-ribosyltransferase PARP9 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 9) (ARTD9) (B aggressive lymphoma protein) (Poly [ADP-ribose] polymerase 9) (PARP-9)	GO:0000122; GO:0002230; GO:0003714; GO:0003950; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006471; GO:0010608; GO:0010629; GO:0016020; GO:0016477; GO:0019899; GO:0032991; GO:0034356; GO:0035563; GO:0042393; GO:0042531; GO:0043086; GO:0044389; GO:0045087; GO:0045893; GO:0051607; GO:0060330; GO:0060335; GO:0072570; GO:0090734; GO:0097677; GO:1900182; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; ADP-D-ribose binding [GO:0072570]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; STAT family protein binding [GO:0097677]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein ligase binding [GO:0044389]; cell migration [GO:0016477]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of catalytic activity [GO:0043086]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; posttranscriptional regulation of gene expression [GO:0010608]; protein ADP-ribosylation [GO:0006471]; regulation of response to interferon-gamma [GO:0060330]"
PGEN_.00g165850	Scaffold_07	35957819	35974736	Q460N3	PAR15_HUMAN	Protein mono-ADP-ribosyltransferase PARP15 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15) (PARP-15)	GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0070212; GO:0070403; GO:0140289; GO:1990404	nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g165860	Scaffold_07	35978864	35988247	NA	NA	NA	NA	NA
PGEN_.00g165870	Scaffold_07	36196559	36202011	NA	NA	NA	NA	NA
PGEN_.00g165880	Scaffold_07	36272658	36297344	NA	NA	NA	NA	NA
PGEN_.00g165890	Scaffold_07	36304435	36315079	NA	NA	NA	NA	NA
PGEN_.00g165900	Scaffold_07	36318403	36320664	NA	NA	NA	NA	NA
PGEN_.00g165910	Scaffold_07	36320720	36322467	NA	NA	NA	NA	NA
PGEN_.00g165920	Scaffold_07	36328596	36335345	NA	NA	NA	NA	NA
PGEN_.00g165930	Scaffold_07	36336619	36339387	NA	NA	NA	NA	NA
PGEN_.00g165940	Scaffold_07	36339821	36340135	NA	NA	NA	NA	NA
PGEN_.00g165950	Scaffold_07	36354168	36362990	NA	NA	NA	NA	NA
PGEN_.00g165960	Scaffold_07	36422398	36445220	Q60674	NR1D2_MOUSE	Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear receptor RVR) (Rev-erb-beta)	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007275; GO:0008134; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030374; GO:0033993; GO:0038023; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0090575; GO:0097009; GO:2001014	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; multicellular organism development [GO:0007275]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]; response to lipid [GO:0033993]"
PGEN_.00g165970	Scaffold_07	36457374	36465713	NA	NA	NA	NA	NA
PGEN_.00g165980	Scaffold_07	36474361	36489359	Q91WI7	ITFG2_MOUSE	KICSTOR complex protein ITFG2 (Integrin-alpha FG-GAP repeat-containing protein 2)	GO:0002314; GO:0005654; GO:0005765; GO:0005829; GO:0034198; GO:0042149; GO:0140007; GO:1904262	cytosol [GO:0005829]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; germinal center B cell differentiation [GO:0002314]; negative regulation of TORC1 signaling [GO:1904262]
PGEN_.00g165990	Scaffold_07	36490343	36497413	Q5ZKJ4	FGOP2_CHICK	FGFR1 oncogene partner 2 homolog	GO:0005737; GO:0009611; GO:0042060; GO:0042803	cytoplasm [GO:0005737]; protein homodimerization activity [GO:0042803]; response to wounding [GO:0009611]; wound healing [GO:0042060]
PGEN_.00g166000	Scaffold_07	36505433	36527326	Q5FVF4	TM7S3_RAT	Transmembrane 7 superfamily member 3	GO:0005886; GO:0016021; GO:0032024; GO:0034620; GO:0043069	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellular response to unfolded protein [GO:0034620]; negative regulation of programmed cell death [GO:0043069]; positive regulation of insulin secretion [GO:0032024]
PGEN_.00g166010	Scaffold_07	36528001	36531904	Q28F07	ANM1_XENTR	Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1)	GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006479; GO:0007552; GO:0008170; GO:0008276; GO:0008284; GO:0016274; GO:0016571; GO:0018216; GO:0022008; GO:0031056; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0043985; GO:0044020; GO:0045652; GO:0045653; GO:0045893; GO:0051260; GO:1904047	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; transcription coactivator activity [GO:0003713]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; metamorphosis [GO:0007552]; negative regulation of megakaryocyte differentiation [GO:0045653]; neurogenesis [GO:0022008]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of histone modification [GO:0031056]; regulation of megakaryocyte differentiation [GO:0045652]"
PGEN_.00g166020	Scaffold_07	36548971	36565008	Q4KM31	LIMD2_RAT	LIM domain-containing protein 2	GO:0005654; GO:0005829; GO:0046872	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]
PGEN_.00g166030	Scaffold_07	36576741	36618877	NA	NA	NA	NA	NA
PGEN_.00g166040	Scaffold_07	36625979	36640156	NA	NA	NA	NA	NA
PGEN_.00g166050	Scaffold_07	36713742	36714423	NA	NA	NA	NA	NA
PGEN_.00g166060	Scaffold_07	36714723	36720884	O88480	CABIN_RAT	Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN)	GO:0004864; GO:0005634; GO:0005737; GO:0006336; GO:0014823; GO:0019904; GO:0030346; GO:0060548	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase inhibitor activity [GO:0004864]; DNA replication-independent nucleosome assembly [GO:0006336]; negative regulation of cell death [GO:0060548]; response to activity [GO:0014823]
PGEN_.00g166070	Scaffold_07	36728941	36738562	NA	NA	NA	NA	NA
PGEN_.00g166080	Scaffold_07	36738700	36805242	Q9Y6J0	CABIN_HUMAN	Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN)	GO:0004864; GO:0005634; GO:0005654; GO:0005829; GO:0006336; GO:0007166; GO:0016235	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase inhibitor activity [GO:0004864]; cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent nucleosome assembly [GO:0006336]
PGEN_.00g166090	Scaffold_07	36829602	36831545	Q5F478	ANR44_CHICK	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)		
PGEN_.00g166100	Scaffold_07	36855239	36860677	NA	NA	NA	NA	NA
PGEN_.00g166110	Scaffold_07	36873156	36879861	NA	NA	NA	NA	NA
PGEN_.00g166120	Scaffold_07	36881979	36891035	Q7Z6B0	CCD91_HUMAN	Coiled-coil domain-containing protein 91 (GGA-binding partner) (p56 accessory protein)	GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0015031; GO:0016020; GO:0042802; GO:0090160	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]
PGEN_.00g166130	Scaffold_07	36895596	36896051	NA	NA	NA	NA	NA
PGEN_.00g166140	Scaffold_07	36929916	36950526	P70180	ANPRC_MOUSE	Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C) (EF-2)	GO:0001501; GO:0002158; GO:0007193; GO:0007194; GO:0007200; GO:0008217; GO:0008528; GO:0016020; GO:0016021; GO:0016941; GO:0017046; GO:0030157; GO:0031404; GO:0032991; GO:0033688; GO:0035810; GO:0042277; GO:0042562; GO:0042802; GO:0042803; GO:0048015; GO:0048662; GO:0051000; GO:0120163	integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoclast proliferation [GO:0002158]; pancreatic juice secretion [GO:0030157]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; skeletal system development [GO:0001501]
PGEN_.00g166150	Scaffold_07	36961836	36962255	P83877	TXN4A_MOUSE	Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD)	GO:0000398; GO:0005634; GO:0005654; GO:0005682; GO:0005737; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g166160	Scaffold_07	36972086	36998113	Q0MQB3	NDUA9_GORGO	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)"	GO:0003954; GO:0005747; GO:0005759; GO:0032981; GO:0050662; GO:1901006	mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; coenzyme binding [GO:0050662]; NADH dehydrogenase activity [GO:0003954]; mitochondrial respiratory chain complex I assembly [GO:0032981]; ubiquinone-6 biosynthetic process [GO:1901006]
PGEN_.00g166170	Scaffold_07	37009014	37033691	NA	NA	NA	NA	NA
PGEN_.00g166180	Scaffold_07	37083168	37085095	NA	NA	NA	NA	NA
PGEN_.00g166190	Scaffold_07	37094386	37101061	Q9U5N1	VATC_MANSE	V-type proton ATPase subunit C (V-ATPase subunit C) (Vacuolar proton pump subunit C)	GO:0015078; GO:0033180	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; proton transmembrane transporter activity [GO:0015078]"
PGEN_.00g166200	Scaffold_07	37109652	37116819	Q3SYS4	DAAF1_BOVIN	"Dynein assembly factor 1, axonemal (Leucine-rich repeat-containing protein 50)"	GO:0005930; GO:0044458; GO:0060271; GO:0070840	axoneme [GO:0005930]; dynein complex binding [GO:0070840]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]
PGEN_.00g166210	Scaffold_07	37122758	37123045	NA	NA	NA	NA	NA
PGEN_.00g166220	Scaffold_07	37126246	37137693	P26990	ARF6_CHICK	ADP-ribosylation factor 6	GO:0001726; GO:0001889; GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005938; GO:0006886; GO:0016192; GO:0030139; GO:0030838; GO:0030866; GO:0031527; GO:0031996; GO:0032154; GO:0032456; GO:0032587; GO:0033028; GO:0034394; GO:0035020; GO:0036010; GO:0047485; GO:0050714; GO:0051489; GO:0051549; GO:0055038; GO:0060998; GO:0090073; GO:0090162; GO:0090543; GO:0097178; GO:0097284; GO:1903078; GO:1903393; GO:2000009	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; myeloid cell apoptotic process [GO:0033028]; negative regulation of protein localization to cell surface [GO:2000009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; vesicle-mediated transport [GO:0016192]
PGEN_.00g166230	Scaffold_07	37141121	37142389	NA	NA	NA	NA	NA
PGEN_.00g166240	Scaffold_07	37143570	37143875	NA	NA	NA	NA	NA
PGEN_.00g166250	Scaffold_07	37144035	37144439	NA	NA	NA	NA	NA
PGEN_.00g166260	Scaffold_07	37165561	37176147	Q7ZWN0	LMF2_XENLA	Lipase maturation factor 2	GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
PGEN_.00g166270	Scaffold_07	37204056	37205338	NA	NA	NA	NA	NA
PGEN_.00g166280	Scaffold_07	37205442	37209239	Q9Y4C4	MFHA1_HUMAN	Malignant fibrous histiocytoma-amplified sequence 1 (Malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1)	GO:0005525; GO:0005737; GO:0006954; GO:0030218; GO:0031625; GO:0034136; GO:0034137; GO:0034144; GO:0035308; GO:0043030; GO:0045087; GO:0046330; GO:0050728; GO:0051721; GO:0051897; GO:0070374; GO:1900181; GO:1900745	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625]; erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]
PGEN_.00g166290	Scaffold_07	37220014	37222176	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g166300	Scaffold_07	37230247	37240391	Q5ZKZ9	LMF2_CHICK	Lipase maturation factor 2	GO:0005789; GO:0016021; GO:0051604	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein maturation [GO:0051604]
PGEN_.00g166310	Scaffold_07	37240682	37270941	Q9DBA9	TF2H1_MOUSE	General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit) (BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit)	GO:0000439; GO:0003682; GO:0005634; GO:0005654; GO:0005675; GO:0006289; GO:0006360; GO:0006366; GO:0045944; GO:0070816; GO:1990830	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; chromatin binding [GO:0003682]; cellular response to leukemia inhibitory factor [GO:1990830]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g166320	Scaffold_07	37312315	37313097	NA	NA	NA	NA	NA
PGEN_.00g166330	Scaffold_07	37325364	37326062	NA	NA	NA	NA	NA
PGEN_.00g166340	Scaffold_07	37374889	37375500	NA	NA	NA	NA	NA
PGEN_.00g166350	Scaffold_07	37375581	37375796	NA	NA	NA	NA	NA
PGEN_.00g166360	Scaffold_07	37379002	37417469	P98133	FBN1_BOVIN	Fibrillin-1 (MP340) [Cleaved into: Asprosin]	GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0010737; GO:0031012; GO:0034199; GO:0042593	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]
PGEN_.00g166370	Scaffold_07	37419910	37426925	NA	NA	NA	NA	NA
PGEN_.00g166380	Scaffold_07	37429226	37443993	Q9ESX4	NO40_MOUSE	Nucleolar protein of 40 kDa (pNO40) (Putative S1 RNA-binding domain protein) (PS1D protein) (Zinc finger CCHC domain-containing protein 17)	GO:0003723; GO:0005730; GO:0008270; GO:0022625	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]
PGEN_.00g166390	Scaffold_07	37456333	37521639	Q5R9H4	A1CF_PONAB	APOBEC1 complementation factor (APOBEC1-stimulating protein)	GO:0003727; GO:0005737; GO:0005783; GO:0006397; GO:0016556; GO:0030895; GO:0050821	apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; single-stranded RNA binding [GO:0003727]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; protein stabilization [GO:0050821]
PGEN_.00g166400	Scaffold_07	37534147	37541105	Q9HB96	FANCE_HUMAN	Fanconi anemia group E protein (Protein FACE)	GO:0005634; GO:0005654; GO:0036297; GO:0043240	Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; interstrand cross-link repair [GO:0036297]
PGEN_.00g166410	Scaffold_07	37547181	37582496	Q8BKZ9	ODPX_MOUSE	"Pyruvate dehydrogenase protein X component, mitochondrial (Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex) (Lipoyl-containing pyruvate dehydrogenase complex component X)"	GO:0005739; GO:0005759; GO:0016746; GO:0034604; GO:0045254; GO:0061732	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity, transferring acyl groups [GO:0016746]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]"
PGEN_.00g166420	Scaffold_07	37582773	37601551	C1BYA3	MTNB_ESOLU	Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein homolog)	GO:0005737; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0046570	cytoplasm [GO:0005737]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]
PGEN_.00g166430	Scaffold_07	37601627	37601902	NA	NA	NA	NA	NA
PGEN_.00g166440	Scaffold_07	37601999	37602502	NA	NA	NA	NA	NA
PGEN_.00g166450	Scaffold_07	37602581	37604347	NA	NA	NA	NA	NA
PGEN_.00g166460	Scaffold_07	37605304	37608834	Q5FW37	MTNB_XENTR	Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein homolog)	GO:0005737; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0046570	cytoplasm [GO:0005737]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]
PGEN_.00g166470	Scaffold_07	37650849	37652604	NA	NA	NA	NA	NA
PGEN_.00g166480	Scaffold_07	37706218	37729740	NA	NA	NA	NA	NA
PGEN_.00g166490	Scaffold_07	37730941	37732485	P08510	KCNAS_DROME	Potassium voltage-gated channel protein Shaker (Protein minisleep)	GO:0001508; GO:0005249; GO:0005251; GO:0006813; GO:0007611; GO:0007619; GO:0007637; GO:0008076; GO:0008345; GO:0009584; GO:0016021; GO:0022843; GO:0030431; GO:0034765; GO:0045187; GO:0045838; GO:0045938; GO:0048047; GO:0048150; GO:0048675; GO:0050909; GO:0051260; GO:0060025; GO:0071805; GO:1903351	"integral component of membrane [GO:0016021]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; axon extension [GO:0048675]; behavioral response to ether [GO:0048150]; cellular response to dopamine [GO:1903351]; courtship behavior [GO:0007619]; detection of visible light [GO:0009584]; larval locomotory behavior [GO:0008345]; learning or memory [GO:0007611]; mating behavior, sex discrimination [GO:0048047]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of membrane potential [GO:0045838]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proboscis extension reflex [GO:0007637]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]; sensory perception of taste [GO:0050909]; sleep [GO:0030431]"
PGEN_.00g166500	Scaffold_07	37733720	37849872	Q66II8	RU17_XENTR	U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)	GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0016607; GO:0030619; GO:0043484; GO:0071004	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]"
PGEN_.00g166510	Scaffold_07	37874552	37875209	NA	NA	NA	NA	NA
PGEN_.00g166520	Scaffold_07	37879744	37880428	NA	NA	NA	NA	NA
PGEN_.00g166530	Scaffold_07	37881004	37904577	Q29RK9	MOB3B_BOVIN	MOB kinase activator 3B (Mob1 homolog 2b) (Mps one binder kinase activator-like 2B)	GO:0035330; GO:0046872	metal ion binding [GO:0046872]; regulation of hippo signaling [GO:0035330]
PGEN_.00g166540	Scaffold_07	37922111	37948121	O42196	DNJC5_XENLA	DnaJ homolog subfamily C member 5 (Cysteine string protein) (CSP) (Xcsp)	GO:0016020	membrane [GO:0016020]
PGEN_.00g166550	Scaffold_07	37957458	37981966	P46871	KRP95_STRPU	Kinesin-II 95 kDa subunit (KRP-85/95 95 kDa subunit)	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g166560	Scaffold_07	37982702	37994005	P46871	KRP95_STRPU	Kinesin-II 95 kDa subunit (KRP-85/95 95 kDa subunit)	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g166570	Scaffold_07	38015835	38071078	Q8I4E2	LST4_CAEEL	Sorting nexin lst-4 (Lateral signaling target protein 4)	GO:0000278; GO:0005546; GO:0005547; GO:0005737; GO:0015031; GO:0019902; GO:0030670; GO:0032009; GO:0035091; GO:0043621; GO:0045335; GO:0051020; GO:0090386; GO:0090387; GO:0090389; GO:0097194	"cytoplasm [GO:0005737]; early phagosome [GO:0032009]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; GTPase binding [GO:0051020]; phosphatase binding [GO:0019902]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein self-association [GO:0043621]; execution phase of apoptosis [GO:0097194]; mitotic cell cycle [GO:0000278]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; phagosome maturation involved in apoptotic cell clearance [GO:0090386]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein transport [GO:0015031]"
PGEN_.00g166580	Scaffold_07	38107110	38148800	Q2MV58	TECT1_HUMAN	Tectonic-1	GO:0001701; GO:0001841; GO:0005615; GO:0005829; GO:0005856; GO:0008589; GO:0016020; GO:0021523; GO:0021537; GO:0021904; GO:0021956; GO:0036038; GO:0060271; GO:0097711; GO:1904491	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; MKS complex [GO:0036038]; central nervous system interneuron axonogenesis [GO:0021956]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; dorsal/ventral neural tube patterning [GO:0021904]; in utero embryonic development [GO:0001701]; neural tube formation [GO:0001841]; protein localization to ciliary transition zone [GO:1904491]; regulation of smoothened signaling pathway [GO:0008589]; somatic motor neuron differentiation [GO:0021523]; telencephalon development [GO:0021537]
PGEN_.00g166590	Scaffold_07	38154649	38196728	Q5ZMW3	API5_CHICK	Apoptosis inhibitor 5 (API-5)	GO:0005634; GO:0005737; GO:0006915; GO:0017134; GO:0043066	cytoplasm [GO:0005737]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]
PGEN_.00g166600	Scaffold_07	38225083	38300800	NA	NA	NA	NA	NA
PGEN_.00g166610	Scaffold_07	38320620	38332327	Q2KII7	PEX16_BOVIN	Peroxisomal membrane protein PEX16 (Peroxin-16) (Peroxisomal biogenesis factor 16)	GO:0005777; GO:0005778; GO:0005779; GO:0005789; GO:0006625; GO:0007031; GO:0008022; GO:0016557; GO:0032581; GO:0045046	endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein C-terminus binding [GO:0008022]; ER-dependent peroxisome organization [GO:0032581]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g166620	Scaffold_07	38338160	38340104	NA	NA	NA	NA	NA
PGEN_.00g166630	Scaffold_07	38352217	38352741	NA	NA	NA	NA	NA
PGEN_.00g166640	Scaffold_07	38352993	38353394	NA	NA	NA	NA	NA
PGEN_.00g166650	Scaffold_07	38354745	38365451	Q2KII7	PEX16_BOVIN	Peroxisomal membrane protein PEX16 (Peroxin-16) (Peroxisomal biogenesis factor 16)	GO:0005777; GO:0005778; GO:0005779; GO:0005789; GO:0006625; GO:0007031; GO:0008022; GO:0016557; GO:0032581; GO:0045046	endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein C-terminus binding [GO:0008022]; ER-dependent peroxisome organization [GO:0032581]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g166660	Scaffold_07	38367216	38398493	O95461	LARG1_HUMAN	"LARGE xylosyl- and glucuronyltransferase 1 (EC 2.4.-.-) (Acetylglucosaminyltransferase-like 1A) (Glycosyltransferase-like protein) [Includes: Xylosyltransferase LARGE (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE (EC 2.4.1.-)]"	GO:0000139; GO:0005623; GO:0005794; GO:0006044; GO:0006486; GO:0006493; GO:0006688; GO:0008375; GO:0009101; GO:0015020; GO:0016757; GO:0030145; GO:0030173; GO:0035252; GO:0035269; GO:0042285; GO:0043403; GO:0046716; GO:0060538	"cell [GO:0005623]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; muscle cell cellular homeostasis [GO:0046716]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403]"
PGEN_.00g166670	Scaffold_07	38441210	38441620	NA	NA	NA	NA	NA
PGEN_.00g166680	Scaffold_07	38443348	38444096	NA	NA	NA	NA	NA
PGEN_.00g166690	Scaffold_07	38456235	38468534	NA	NA	NA	NA	NA
PGEN_.00g166700	Scaffold_07	38472396	38473094	NA	NA	NA	NA	NA
PGEN_.00g166710	Scaffold_07	38473351	38473725	NA	NA	NA	NA	NA
PGEN_.00g166720	Scaffold_07	38501537	38503351	NA	NA	NA	NA	NA
PGEN_.00g166730	Scaffold_07	38516552	38526081	O35874	SATT_MOUSE	Neutral amino acid transporter A (Alanine/serine/cysteine/threonine transporter 1) (ASCT-1) (SATT) (Solute carrier family 1 member 4)	GO:0005254; GO:0005813; GO:0005882; GO:0015175; GO:0015180; GO:0015184; GO:0015193; GO:0015194; GO:0015195; GO:0015293; GO:0015808; GO:0015824; GO:0015825; GO:0015826; GO:0016021; GO:0030425; GO:0034589; GO:0034590; GO:0042470; GO:0043025; GO:0050890	centrosome [GO:0005813]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; neuronal cell body [GO:0043025]; chloride channel activity [GO:0005254]; L-alanine transmembrane transporter activity [GO:0015180]; L-cystine transmembrane transporter activity [GO:0015184]; L-hydroxyproline transmembrane transporter activity [GO:0034590]; L-proline transmembrane transporter activity [GO:0015193]; L-serine transmembrane transporter activity [GO:0015194]; L-threonine transmembrane transporter activity [GO:0015195]; neutral amino acid transmembrane transporter activity [GO:0015175]; symporter activity [GO:0015293]; cognition [GO:0050890]; hydroxyproline transport [GO:0034589]; L-alanine transport [GO:0015808]; L-serine transport [GO:0015825]; proline transport [GO:0015824]; threonine transport [GO:0015826]
PGEN_.00g166740	Scaffold_07	38526153	38532327	NA	NA	NA	NA	NA
PGEN_.00g166750	Scaffold_07	38601451	38604697	NA	NA	NA	NA	NA
PGEN_.00g166760	Scaffold_07	38604768	38605115	NA	NA	NA	NA	NA
PGEN_.00g166770	Scaffold_07	38621563	38623059	P34992	NPY1R_XENLA	Neuropeptide Y receptor type 1 (NPY1-R)	GO:0004983; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]
PGEN_.00g166780	Scaffold_07	38628524	38629024	NA	NA	NA	NA	NA
PGEN_.00g166790	Scaffold_07	38678202	38678608	NA	NA	NA	NA	NA
PGEN_.00g166800	Scaffold_07	38678911	38761703	Q803G5	SAM5A_DANRE	Sorting and assembly machinery component 50 homolog A	GO:0001401; GO:0001889; GO:0016021; GO:0033108; GO:0034622; GO:0042407; GO:0045040	integral component of membrane [GO:0016021]; SAM complex [GO:0001401]; cellular protein-containing complex assembly [GO:0034622]; cristae formation [GO:0042407]; liver development [GO:0001889]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein insertion into mitochondrial outer membrane [GO:0045040]
PGEN_.00g166810	Scaffold_07	38782555	38783166	NA	NA	NA	NA	NA
PGEN_.00g166820	Scaffold_07	38790804	38792012	NA	NA	NA	NA	NA
PGEN_.00g166830	Scaffold_07	38849648	38899833	Q54F25	CLN3_DICDI	Battenin (Protein CLN3 homolog)	GO:0000281; GO:0000331; GO:0005623; GO:0005765; GO:0005794; GO:0006907; GO:0006971; GO:0006972; GO:0008285; GO:0009992; GO:0015809; GO:0016021; GO:0030139; GO:0031152; GO:0031156; GO:0031589; GO:0050708; GO:0050709; GO:0050714; GO:0051453; GO:0098609	cell [GO:0005623]; contractile vacuole [GO:0000331]; endocytic vesicle [GO:0030139]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; aggregation involved in sorocarp development [GO:0031152]; arginine transport [GO:0015809]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; cellular water homeostasis [GO:0009992]; hyperosmotic response [GO:0006972]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein secretion [GO:0050709]; pinocytosis [GO:0006907]; positive regulation of protein secretion [GO:0050714]; regulation of intracellular pH [GO:0051453]; regulation of protein secretion [GO:0050708]; regulation of sorocarp development [GO:0031156]
PGEN_.00g166840	Scaffold_07	38927630	38982700	Q54F25	CLN3_DICDI	Battenin (Protein CLN3 homolog)	GO:0000281; GO:0000331; GO:0005623; GO:0005765; GO:0005794; GO:0006907; GO:0006971; GO:0006972; GO:0008285; GO:0009992; GO:0015809; GO:0016021; GO:0030139; GO:0031152; GO:0031156; GO:0031589; GO:0050708; GO:0050709; GO:0050714; GO:0051453; GO:0098609	cell [GO:0005623]; contractile vacuole [GO:0000331]; endocytic vesicle [GO:0030139]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; aggregation involved in sorocarp development [GO:0031152]; arginine transport [GO:0015809]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; cellular water homeostasis [GO:0009992]; hyperosmotic response [GO:0006972]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein secretion [GO:0050709]; pinocytosis [GO:0006907]; positive regulation of protein secretion [GO:0050714]; regulation of intracellular pH [GO:0051453]; regulation of protein secretion [GO:0050708]; regulation of sorocarp development [GO:0031156]
PGEN_.00g166850	Scaffold_07	39009722	39012687	NA	NA	NA	NA	NA
PGEN_.00g166860	Scaffold_07	39151134	39171283	Q7M3Y3	TNNI_CHLNI	Troponin I (TnI)	GO:0003779; GO:0005861; GO:0046872	troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]
PGEN_.00g166870	Scaffold_07	39209299	39277582	NA	NA	NA	NA	NA
PGEN_.00g166880	Scaffold_07	39281791	39282093	NA	NA	NA	NA	NA
PGEN_.00g166890	Scaffold_07	39284662	39284994	NA	NA	NA	NA	NA
PGEN_.00g166900	Scaffold_07	39285306	39285977	NA	NA	NA	NA	NA
PGEN_.00g166910	Scaffold_07	39370140	39370409	NA	NA	NA	NA	NA
PGEN_.00g166920	Scaffold_07	39372131	39388207	Q68EK9	CDC26_DANRE	Anaphase-promoting complex subunit CDC26 (Cell division cycle protein 26 homolog)	GO:0000278; GO:0005654; GO:0005680; GO:0007346; GO:0030071; GO:0031145; GO:0051301; GO:0070979	anaphase-promoting complex [GO:0005680]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]
PGEN_.00g166930	Scaffold_07	39388645	39503142	Q6DCC6	GTPB6_XENLA	Putative GTP-binding protein 6	GO:0005525; GO:0046872	GTP binding [GO:0005525]; metal ion binding [GO:0046872]
PGEN_.00g166940	Scaffold_07	39434443	39434892	NA	NA	NA	NA	NA
PGEN_.00g166950	Scaffold_07	39514543	39516845	NA	NA	NA	NA	NA
PGEN_.00g166960	Scaffold_07	39517604	39527641	NA	NA	NA	NA	NA
PGEN_.00g166970	Scaffold_07	39527994	39528617	NA	NA	NA	NA	NA
PGEN_.00g166980	Scaffold_07	39541446	39542450	NA	NA	NA	NA	NA
PGEN_.00g166990	Scaffold_07	39543710	39546959	NA	NA	NA	NA	NA
PGEN_.00g167000	Scaffold_07	39548661	39551027	NA	NA	NA	NA	NA
PGEN_.00g167010	Scaffold_07	39560791	39590312	Q5EA33	ANR49_BOVIN	Ankyrin repeat domain-containing protein 49	GO:0005634; GO:0007283; GO:0030154; GO:0045893	"nucleus [GO:0005634]; cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]"
PGEN_.00g167020	Scaffold_07	39595194	39595922	NA	NA	NA	NA	NA
PGEN_.00g167030	Scaffold_07	39597728	39602799	NA	NA	NA	NA	NA
PGEN_.00g167040	Scaffold_07	39607318	39612904	NA	NA	NA	NA	NA
PGEN_.00g167050	Scaffold_07	39617077	39634598	NA	NA	NA	NA	NA
PGEN_.00g167060	Scaffold_07	39636849	39637181	NA	NA	NA	NA	NA
PGEN_.00g167070	Scaffold_07	39672988	39703548	B3EWZ5	MLRP1_ACRMI	MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g167080	Scaffold_07	39705313	39705642	NA	NA	NA	NA	NA
PGEN_.00g167090	Scaffold_07	39715333	39719466	NA	NA	NA	NA	NA
PGEN_.00g167100	Scaffold_07	39722048	39722338	NA	NA	NA	NA	NA
PGEN_.00g167110	Scaffold_07	39725124	39733548	NA	NA	NA	NA	NA
PGEN_.00g167120	Scaffold_07	39733682	39734870	NA	NA	NA	NA	NA
PGEN_.00g167130	Scaffold_07	39734983	39736300	NA	NA	NA	NA	NA
PGEN_.00g167140	Scaffold_07	39737081	39742334	Q9DGD1	MGT4C_CHICK	"Alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.201) (N-acetylglucosaminyltransferase VI) (GnT-VI)"	GO:0000139; GO:0006487; GO:0008375; GO:0016021; GO:0046872; GO:0047253	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,6-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0047253]; metal ion binding [GO:0046872]; protein N-linked glycosylation [GO:0006487]"
PGEN_.00g167150	Scaffold_07	39748769	39757096	NA	NA	NA	NA	NA
PGEN_.00g167160	Scaffold_07	39758552	39759154	NA	NA	NA	NA	NA
PGEN_.00g167170	Scaffold_07	39761079	39761429	NA	NA	NA	NA	NA
PGEN_.00g167180	Scaffold_07	39788870	39789746	NA	NA	NA	NA	NA
PGEN_.00g167190	Scaffold_07	39820437	39820757	NA	NA	NA	NA	NA
PGEN_.00g167200	Scaffold_07	39821798	39822100	NA	NA	NA	NA	NA
PGEN_.00g167210	Scaffold_07	39865782	39867553	NA	NA	NA	NA	NA
PGEN_.00g167220	Scaffold_07	39867648	39876587	NA	NA	NA	NA	NA
PGEN_.00g167230	Scaffold_07	39889323	39890575	Q9QWG7	ST1B1_MOUSE	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (DOPA/tyrosine sulfotransferase)	GO:0004062; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g167240	Scaffold_07	39894872	39898587	NA	NA	NA	NA	NA
PGEN_.00g167250	Scaffold_07	39899671	39900090	NA	NA	NA	NA	NA
PGEN_.00g167260	Scaffold_07	39931616	39942693	NA	NA	NA	NA	NA
PGEN_.00g167270	Scaffold_07	39993720	40005559	Q9CQ02	COMD4_MOUSE	COMM domain-containing protein 4	GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g167280	Scaffold_07	40006753	40006971	NA	NA	NA	NA	NA
PGEN_.00g167290	Scaffold_07	40014509	40015132	NA	NA	NA	NA	NA
PGEN_.00g167300	Scaffold_07	40024901	40035753	O46640	ST3A1_RABIT	Amine sulfotransferase (EC 2.8.2.3) (AST-RB1) (Sulfotransferase 3A1) (ST3A1)	GO:0005737; GO:0047685	cytoplasm [GO:0005737]; amine sulfotransferase activity [GO:0047685]
PGEN_.00g167310	Scaffold_07	40063309	40065047	NA	NA	NA	NA	NA
PGEN_.00g167320	Scaffold_07	40079438	40090270	NA	NA	NA	NA	NA
PGEN_.00g167330	Scaffold_07	40113712	40113915	NA	NA	NA	NA	NA
PGEN_.00g167340	Scaffold_07	40114024	40114266	NA	NA	NA	NA	NA
PGEN_.00g167350	Scaffold_07	40128322	40151289	P23708	NFYA_MOUSE	Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA)	GO:0000978; GO:0001221; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0008134; GO:0016602; GO:0032993; GO:0043565; GO:0045893; GO:0045944; GO:0048511; GO:0090575; GO:2000036; GO:2000648	"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; transcription factor binding [GO:0008134]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"
PGEN_.00g167360	Scaffold_07	40155381	40164801	Q80YD6	SRGEF_MOUSE	Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor) (DelGEF) (Guanine nucleotide exchange factor-related protein)	GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0050709	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; negative regulation of protein secretion [GO:0050709]
PGEN_.00g167370	Scaffold_07	40165396	40180493	Q9UGK8	SRGEF_HUMAN	Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor) (DelGEF) (Guanine nucleotide exchange factor-related protein)	GO:0005087; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0050709	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; negative regulation of protein secretion [GO:0050709]; signal transduction [GO:0007165]
PGEN_.00g167380	Scaffold_07	40206651	40221144	Q7TPV2	DZIP3_MOUSE	E3 ubiquitin-protein ligase DZIP3 (EC 2.3.2.27) (DAZ-interacting protein 3 homolog) (RING-type E3 ubiquitin transferase DZIP3)	GO:0000209; GO:0003723; GO:0004842; GO:0005737; GO:0019902; GO:0031593; GO:0046872; GO:0061630	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]
PGEN_.00g167390	Scaffold_07	40237854	40240070	Q96DM1	PGBD4_HUMAN	PiggyBac transposable element-derived protein 4		
PGEN_.00g167400	Scaffold_07	40242088	40259439	NA	NA	NA	NA	NA
PGEN_.00g167410	Scaffold_07	40269117	40309203	Q9Y2V3	RX_HUMAN	Retinal homeobox protein Rx (Retina and anterior neural fold homeobox protein)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0007389; GO:0007601; GO:0021854; GO:0043010; GO:0045944; GO:0060173	"nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; camera-type eye development [GO:0043010]; hypothalamus development [GO:0021854]; limb development [GO:0060173]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; visual perception [GO:0007601]"
PGEN_.00g167420	Scaffold_07	40313910	40314563	NA	NA	NA	NA	NA
PGEN_.00g167430	Scaffold_07	40346990	40347220	NA	NA	NA	NA	NA
PGEN_.00g167440	Scaffold_07	40358585	40374968	Q5F4C0	HVCN1_CHICK	Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1)	GO:0005887; GO:0009268; GO:0010043; GO:0016021; GO:0030171; GO:0034765; GO:0071294; GO:0071467; GO:1902600	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]; response to pH [GO:0009268]; response to zinc ion [GO:0010043]
PGEN_.00g167450	Scaffold_07	40385088	40387551	NA	NA	NA	NA	NA
PGEN_.00g167460	Scaffold_07	40412980	40413282	NA	NA	NA	NA	NA
PGEN_.00g167470	Scaffold_07	40468628	40506772	Q3U2S8	HVCN1_MOUSE	Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1) (Voltage sensor domain-only protein) (mVSOP)	GO:0005887; GO:0009268; GO:0010043; GO:0016021; GO:0022843; GO:0030171; GO:0034765; GO:0042802; GO:0071294; GO:0071467; GO:1902600	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; voltage-gated cation channel activity [GO:0022843]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]; response to pH [GO:0009268]; response to zinc ion [GO:0010043]
PGEN_.00g167480	Scaffold_07	40510580	40511457	NA	NA	NA	NA	NA
PGEN_.00g167490	Scaffold_07	40523949	40525096	NA	NA	NA	NA	NA
PGEN_.00g167500	Scaffold_07	40609273	40649840	NA	NA	NA	NA	NA
PGEN_.00g167510	Scaffold_07	40691652	40692188	O43422	P52K_HUMAN	52 kDa repressor of the inhibitor of the protein kinase (p52rIPK) (58 kDa interferon-induced protein kinase-interacting protein) (p58IPK-interacting protein) (Death-associated protein 4) (THAP domain-containing protein 0) (THAP domain-containing protein 12)	GO:0000790; GO:0000981; GO:0003677; GO:0007165; GO:0008285; GO:0046872; GO:0046983	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; negative regulation of cell population proliferation [GO:0008285]; signal transduction [GO:0007165]"
PGEN_.00g167520	Scaffold_07	40693024	40693935	NA	NA	NA	NA	NA
PGEN_.00g167530	Scaffold_07	40696251	40702335	NA	NA	NA	NA	NA
PGEN_.00g167540	Scaffold_07	40703277	40706475	NA	NA	NA	NA	NA
PGEN_.00g167550	Scaffold_07	40706568	40707320	NA	NA	NA	NA	NA
PGEN_.00g167560	Scaffold_07	40708042	40708644	NA	NA	NA	NA	NA
PGEN_.00g167570	Scaffold_07	40718739	40723252	Q07079	IBP5_MOUSE	Insulin-like growth factor-binding protein 5 (IBP-5) (IGF-binding protein 5) (IGFBP-5)	GO:0001558; GO:0001649; GO:0001968; GO:0005520; GO:0005615; GO:0007565; GO:0007568; GO:0014912; GO:0016942; GO:0017148; GO:0030336; GO:0031069; GO:0031994; GO:0031995; GO:0035556; GO:0040008; GO:0042567; GO:0042593; GO:0043567; GO:0043568; GO:0043569; GO:0044342; GO:0045668; GO:0045926; GO:0048286; GO:0048662; GO:0051146; GO:0051897; GO:0060056; GO:0060416; GO:0071320; GO:0071407; GO:1901862; GO:1904205; GO:1904707; GO:1904754	extracellular space [GO:0005615]; insulin-like growth factor binding protein complex [GO:0016942]; insulin-like growth factor ternary complex [GO:0042567]; fibronectin binding [GO:0001968]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; aging [GO:0007568]; cellular response to cAMP [GO:0071320]; cellular response to organic cyclic compound [GO:0071407]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; intracellular signal transduction [GO:0035556]; lung alveolus development [GO:0048286]; mammary gland involution [GO:0060056]; negative regulation of cell migration [GO:0030336]; negative regulation of growth [GO:0045926]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of skeletal muscle hypertrophy [GO:1904205]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; regulation of cell growth [GO:0001558]; regulation of growth [GO:0040008]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; response to growth hormone [GO:0060416]; striated muscle cell differentiation [GO:0051146]; type B pancreatic cell proliferation [GO:0044342]
PGEN_.00g167580	Scaffold_07	40733609	40734226	NA	NA	NA	NA	NA
PGEN_.00g167590	Scaffold_07	40734297	40747326	NA	NA	NA	NA	NA
PGEN_.00g167600	Scaffold_07	40747442	40760613	Q3T106	SRSF7_BOVIN	"Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7)"	GO:0000381; GO:0003723; GO:0005634; GO:0005737; GO:0008270; GO:0016607; GO:0019904; GO:0045292; GO:0048025; GO:0051028; GO:1990830	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"
PGEN_.00g167610	Scaffold_07	40767095	40790383	NA	NA	NA	NA	NA
PGEN_.00g167620	Scaffold_07	40796170	40796640	NA	NA	NA	NA	NA
PGEN_.00g167630	Scaffold_07	40802311	40803324	Q9W534	MOODY_DROME	G-protein coupled receptor moody	GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; G protein-coupled receptor activity [GO:0004930]; axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]
PGEN_.00g167640	Scaffold_07	40850718	40855852	Q7ZVG6	SIAH1_DANRE	E3 ubiquitin-protein ligase Siah1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1)	GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007275; GO:0008270; GO:0031624; GO:0043161; GO:0051402; GO:0061630	cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; neuron apoptotic process [GO:0051402]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g167650	Scaffold_07	40879795	40884206	NA	NA	NA	NA	NA
PGEN_.00g167660	Scaffold_07	40886524	40888949	NA	NA	NA	NA	NA
PGEN_.00g167670	Scaffold_07	40891606	40907423	Q6DRI7	DDX51_DANRE	ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51)	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]
PGEN_.00g167680	Scaffold_07	40922171	40923235	Q9BVA6	FICD_HUMAN	Protein adenylyltransferase FICD (EC 2.7.7.n1) (AMPylator FICD) (De-AMPylase FICD) (EC 3.1.4.-) (FIC domain-containing protein) (Huntingtin yeast partner E) (Huntingtin-interacting protein 13) (HIP-13) (Huntingtin-interacting protein E)	GO:0005524; GO:0006986; GO:0018117; GO:0030176; GO:0030544; GO:0034260; GO:0034976; GO:0042802; GO:0042803; GO:0044602; GO:0044603; GO:0051087; GO:0070733; GO:1903894	integral component of endoplasmic reticulum membrane [GO:0030176]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein adenylylhydrolase activity [GO:0044603]; protein adenylyltransferase activity [GO:0070733]; protein homodimerization activity [GO:0042803]; negative regulation of GTPase activity [GO:0034260]; protein adenylylation [GO:0018117]; protein deadenylylation [GO:0044602]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]
PGEN_.00g167690	Scaffold_07	40959891	40972554	NA	NA	NA	NA	NA
PGEN_.00g167700	Scaffold_07	40985364	41016975	P98169	ZXDB_HUMAN	Zinc finger X-linked protein ZXDB	GO:0003676; GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]
PGEN_.00g167710	Scaffold_07	41025179	41033015	Q4V7T8	ROP1L_XENLA	Ropporin-1-like protein	GO:0031514	motile cilium [GO:0031514]
PGEN_.00g167720	Scaffold_07	41033310	41071222	Q2KIY6	HORM1_BOVIN	HORMA domain-containing protein 1	GO:0000795; GO:0001824; GO:0005634; GO:0005694; GO:0007130; GO:0007283; GO:0042138; GO:0048477; GO:0051177; GO:0051321; GO:0051598; GO:0060629	chromosome [GO:0005694]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]
PGEN_.00g167730	Scaffold_07	41091564	41118252	Q642H7	RIC8A_DANRE	Synembryn-A (Protein Ric-8A)	GO:0001965; GO:0005085; GO:0005096; GO:0005737; GO:0005886; GO:0007186	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g167740	Scaffold_07	41121124	41121779	NA	NA	NA	NA	NA
PGEN_.00g167750	Scaffold_07	41134276	41161785	NA	NA	NA	NA	NA
PGEN_.00g167760	Scaffold_07	41162956	41167039	Q8N3X1	FNBP4_HUMAN	Formin-binding protein 4 (Formin-binding protein 30)	GO:0016607	nuclear speck [GO:0016607]
PGEN_.00g167770	Scaffold_07	41173410	41189367	NA	NA	NA	NA	NA
PGEN_.00g167780	Scaffold_07	41196971	41216395	NA	NA	NA	NA	NA
PGEN_.00g167790	Scaffold_07	41211809	41249114	NA	NA	NA	NA	NA
PGEN_.00g167800	Scaffold_07	41282297	41284948	NA	NA	NA	NA	NA
PGEN_.00g167810	Scaffold_07	41298491	41304177	NA	NA	NA	NA	NA
PGEN_.00g167820	Scaffold_07	41318671	41321057	NA	NA	NA	NA	NA
PGEN_.00g167830	Scaffold_07	41327792	41341147	Q9QY33	TSN3_MOUSE	Tetraspanin-3 (Tspan-3) (OSP-associated protein 1) (OAP-1) (Tetraspanin TM4-A) (Transmembrane 4 superfamily member 8)	GO:0005887; GO:0016477	integral component of plasma membrane [GO:0005887]; cell migration [GO:0016477]
PGEN_.00g167840	Scaffold_07	41329750	41329971	NA	NA	NA	NA	NA
PGEN_.00g167850	Scaffold_07	41435450	41435713	NA	NA	NA	NA	NA
PGEN_.00g167860	Scaffold_07	41537608	41537931	NA	NA	NA	NA	NA
PGEN_.00g167870	Scaffold_07	41551425	41590299	G5EFC3	KCNAG_CAEEL	Potassium voltage-gated channel protein egl-36 (Egg-laying defective protein 36)	GO:0005244; GO:0005249; GO:0005251; GO:0008076; GO:0016021; GO:0030424; GO:0032590; GO:0032809; GO:0034220; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g167880	Scaffold_07	41598339	41600129	P48058	GRIA4_HUMAN	"Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4)"	GO:0001540; GO:0004970; GO:0004971; GO:0005886; GO:0007215; GO:0008066; GO:0030054; GO:0030666; GO:0032281; GO:0035249; GO:0043025; GO:0043197; GO:0045211; GO:0050804; GO:0098839; GO:1903561; GO:1904315; GO:2000310	"AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; regulation of NMDA receptor activity [GO:2000310]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g167890	Scaffold_07	41687471	41690284	Q91755	GRIK2_XENLA	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Fragment)"	GO:0005234; GO:0016021; GO:0030054; GO:0038023; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; signaling receptor activity [GO:0038023]
PGEN_.00g167900	Scaffold_07	41690990	41696947	P39087	GRIK2_MOUSE	"Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Glutamate receptor beta-2) (GluR beta-2)"	GO:0001662; GO:0004970; GO:0005234; GO:0005623; GO:0005886; GO:0005887; GO:0006874; GO:0006886; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0016020; GO:0019228; GO:0030054; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060079; GO:0060080; GO:0098686; GO:0098794; GO:0098839; GO:0098978; GO:0099507; GO:1904315	"axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g167910	Scaffold_07	41719067	41740522	P37198	NUP62_HUMAN	Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62)	GO:0000922; GO:0003682; GO:0005543; GO:0005623; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005813; GO:0006110; GO:0006351; GO:0006406; GO:0006409; GO:0006606; GO:0007080; GO:0007098; GO:0007100; GO:0007166; GO:0007283; GO:0007569; GO:0008219; GO:0008285; GO:0009755; GO:0009966; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0019894; GO:0030159; GO:0030544; GO:0031965; GO:0042059; GO:0042169; GO:0042306; GO:0043066; GO:0043069; GO:0043123; GO:0043130; GO:0043407; GO:0043657; GO:0044613; GO:0045742; GO:0045840; GO:0045893; GO:0046578; GO:0046580; GO:0046601; GO:0046966; GO:0051425; GO:0051879; GO:0060236; GO:0060964; GO:0070208; GO:0072686; GO:0075733; GO:0090543; GO:0098534; GO:1900034; GO:1903438; GO:1904781; GO:1990904	"annulate lamellae [GO:0005642]; cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; host cell [GO:0043657]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; receptor signaling complex adaptor activity [GO:0030159]; SH2 domain binding [GO:0042169]; structural constituent of nuclear pore [GO:0017056]; thyroid hormone receptor binding [GO:0046966]; ubiquitin binding [GO:0043130]; cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; hormone-mediated signaling pathway [GO:0009755]; intracellular transport of virus [GO:0075733]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA export from nucleus [GO:0006406]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription, DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; regulation of Ras protein signal transduction [GO:0046578]; regulation of signal transduction [GO:0009966]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]"
PGEN_.00g167920	Scaffold_07	41751342	41755113	NA	NA	NA	NA	NA
PGEN_.00g167930	Scaffold_07	41762256	41764553	NA	NA	NA	NA	NA
PGEN_.00g167940	Scaffold_07	41793512	41795041	NA	NA	NA	NA	NA
PGEN_.00g167950	Scaffold_07	41825713	41825958	NA	NA	NA	NA	NA
PGEN_.00g167960	Scaffold_07	41833414	41835333	O54750	CP2J6_MOUSE	Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)	GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g167970	Scaffold_07	41842759	41855522	NA	NA	NA	NA	NA
PGEN_.00g167980	Scaffold_07	41860042	41860359	NA	NA	NA	NA	NA
PGEN_.00g167990	Scaffold_07	41999987	42000286	NA	NA	NA	NA	NA
PGEN_.00g168000	Scaffold_07	42005566	42005880	NA	NA	NA	NA	NA
PGEN_.00g168010	Scaffold_07	42008816	42009169	NA	NA	NA	NA	NA
PGEN_.00g168020	Scaffold_07	42013161	42013526	NA	NA	NA	NA	NA
PGEN_.00g168030	Scaffold_07	42071433	42072464	NA	NA	NA	NA	NA
PGEN_.00g168040	Scaffold_07	42130459	42130971	NA	NA	NA	NA	NA
PGEN_.00g168050	Scaffold_07	42174061	42174519	NA	NA	NA	NA	NA
PGEN_.00g168060	Scaffold_07	42192381	42202577	O97039	RX_DUGJA	Retinal homeobox protein Rax (DjRax) (Fragment)	GO:0003700; GO:0005634; GO:0006366; GO:0007275; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g168070	Scaffold_07	42236821	42237171	NA	NA	NA	NA	NA
PGEN_.00g168080	Scaffold_07	42276990	42324423	NA	NA	NA	NA	NA
PGEN_.00g168090	Scaffold_07	42343515	42344551	NA	NA	NA	NA	NA
PGEN_.00g168100	Scaffold_07	42351039	42372548	P0C8Q4	Y4990_ARATH	Uncharacterized protein At4g19900		
PGEN_.00g168110	Scaffold_07	42385456	42386208	Q8IIG7	YPF05_PLAF7	Uncharacterized protein PF11_0207	GO:0005737; GO:0016020	cytoplasm [GO:0005737]; membrane [GO:0016020]
PGEN_.00g168120	Scaffold_07	42386421	42418867	Q9H0A0	NAT10_HUMAN	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)	GO:0000154; GO:0000784; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0008080; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	"membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]"
PGEN_.00g168130	Scaffold_07	42422750	42457956	Q9Z0E1	M1AP_MOUSE	Meiosis 1 arrest protein (Meiosis 1-arresting protein) (Meiosis 1-associated protein) (Spermatogenesis-associated protein 37)	GO:0005737; GO:0006396; GO:0007127; GO:0007283; GO:0007292; GO:0016021; GO:0030154; GO:0031497; GO:0042802; GO:0051308	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; chromatin assembly [GO:0031497]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]
PGEN_.00g168140	Scaffold_07	42467536	42498651	NA	NA	NA	NA	NA
PGEN_.00g168150	Scaffold_07	42515825	42516898	NA	NA	NA	NA	NA
PGEN_.00g168160	Scaffold_07	42586823	42597298	Q9WTP3	SPDEF_MOUSE	SAM pointed domain-containing Ets transcription factor (Prostate epithelium-specific Ets transcription factor) (Prostate-specific Ets) (Prostate-derived Ets factor)	GO:0000122; GO:0000981; GO:0005634; GO:0006357; GO:0010454; GO:0010455; GO:0030154; GO:0043065; GO:0043565; GO:0045944; GO:0060480; GO:0060576	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; intestinal epithelial cell development [GO:0060576]; lung goblet cell differentiation [GO:0060480]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g168170	Scaffold_07	42635920	42636523	NA	NA	NA	NA	NA
PGEN_.00g168180	Scaffold_07	42762608	42795666	Q4R899	LMTD1_MACFA	Lamin tail domain-containing protein 1 (Intermediate filament tail domain-containing protein 1)	GO:0005882	intermediate filament [GO:0005882]
PGEN_.00g168190	Scaffold_07	42809697	42847083	Q03427	LAMC_DROME	Lamin-C (pG-IF)	GO:0005200; GO:0005635; GO:0005638; GO:0005652; GO:0006325; GO:0006342; GO:0007112; GO:0016020; GO:0030833; GO:0031081; GO:0034399; GO:0035989; GO:0060415; GO:0070732	lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear periphery [GO:0034399]; spindle envelope [GO:0070732]; structural constituent of cytoskeleton [GO:0005200]; chromatin organization [GO:0006325]; chromatin silencing [GO:0006342]; male meiosis cytokinesis [GO:0007112]; muscle tissue morphogenesis [GO:0060415]; nuclear pore distribution [GO:0031081]; regulation of actin filament polymerization [GO:0030833]; tendon development [GO:0035989]
PGEN_.00g168200	Scaffold_07	42859784	42860293	NA	NA	NA	NA	NA
PGEN_.00g168210	Scaffold_07	42863828	42864151	NA	NA	NA	NA	NA
PGEN_.00g168220	Scaffold_07	42875047	42875502	NA	NA	NA	NA	NA
PGEN_.00g168230	Scaffold_07	42876858	42889901	A6H603	NWD1_MOUSE	NACHT domain- and WD repeat-containing protein 1	GO:0005524; GO:0005829; GO:0010628; GO:0032088	cytosol [GO:0005829]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]
PGEN_.00g168240	Scaffold_07	42895227	42913154	A6H603	NWD1_MOUSE	NACHT domain- and WD repeat-containing protein 1	GO:0005524; GO:0005829; GO:0010628; GO:0032088	cytosol [GO:0005829]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]
PGEN_.00g168250	Scaffold_07	42915784	42915990	NA	NA	NA	NA	NA
PGEN_.00g168260	Scaffold_07	42918764	42930432	Q9Z2K9	IDHC_MICME	Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	GO:0000287; GO:0004450; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0051287	cytosol [GO:0005829]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g168270	Scaffold_07	42983788	42984306	NA	NA	NA	NA	NA
PGEN_.00g168280	Scaffold_07	43005285	43025337	P46063	RECQ1_HUMAN	"ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)"	GO:0000724; GO:0000733; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0032508; GO:0036310	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]
PGEN_.00g168290	Scaffold_07	43028199	43033875	NA	NA	NA	NA	NA
PGEN_.00g168300	Scaffold_07	43048783	43069795	NA	NA	NA	NA	NA
PGEN_.00g168310	Scaffold_07	43069859	43092847	NA	NA	NA	NA	NA
PGEN_.00g168320	Scaffold_07	43112384	43113115	NA	NA	NA	NA	NA
PGEN_.00g168330	Scaffold_07	43113226	43113492	NA	NA	NA	NA	NA
PGEN_.00g168340	Scaffold_07	43113658	43113870	NA	NA	NA	NA	NA
PGEN_.00g168350	Scaffold_07	43114241	43114453	NA	NA	NA	NA	NA
PGEN_.00g168360	Scaffold_07	43114619	43114885	NA	NA	NA	NA	NA
PGEN_.00g168370	Scaffold_07	43114996	43115727	NA	NA	NA	NA	NA
PGEN_.00g168380	Scaffold_07	43116280	43116492	NA	NA	NA	NA	NA
PGEN_.00g168390	Scaffold_07	43116658	43116924	NA	NA	NA	NA	NA
PGEN_.00g168400	Scaffold_07	43117035	43117766	NA	NA	NA	NA	NA
PGEN_.00g168410	Scaffold_07	43118501	43119232	NA	NA	NA	NA	NA
PGEN_.00g168420	Scaffold_07	43119343	43119609	NA	NA	NA	NA	NA
PGEN_.00g168430	Scaffold_07	43119775	43119987	NA	NA	NA	NA	NA
PGEN_.00g168440	Scaffold_08	23521	27220	NA	NA	NA	NA	NA
PGEN_.00g168450	Scaffold_08	44712	68804	O70244	CUBN_RAT	Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	GO:0001701; GO:0005509; GO:0005623; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0045177; GO:0070062	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]
PGEN_.00g168460	Scaffold_08	103082	125488	NA	NA	NA	NA	NA
PGEN_.00g168470	Scaffold_08	153669	153926	NA	NA	NA	NA	NA
PGEN_.00g168480	Scaffold_08	156176	158362	NA	NA	NA	NA	NA
PGEN_.00g168490	Scaffold_08	161138	207892	Q8VDB9	S620A_MOUSE	Sodium- and chloride-dependent transporter XTRP3A (IMINO-B) (Solute carrier family 6 member 20A) (X transporter protein 3 similar 1)	GO:0005328; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015193; GO:0015816; GO:0015824; GO:0015838; GO:0016324; GO:0035524	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-proline transmembrane transporter activity [GO:0015193]; neurotransmitter:sodium symporter activity [GO:0005328]; amino acid transport [GO:0006865]; amino-acid betaine transport [GO:0015838]; glycine transport [GO:0015816]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]
PGEN_.00g168500	Scaffold_08	244980	254637	Q9H0I3	CC113_HUMAN	Coiled-coil domain-containing protein 113	GO:0005737; GO:0032991; GO:0034451; GO:0060271	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; cilium assembly [GO:0060271]
PGEN_.00g168510	Scaffold_08	262660	292063	Q16181	SEPT7_HUMAN	Septin-7 (CDC10 protein homolog)	GO:0000777; GO:0001725; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005819; GO:0005829; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030336; GO:0030496; GO:0031105; GO:0032154; GO:0042802; GO:0043065; GO:0045296; GO:0051291; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730; GO:1902857; GO:2000134	axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]
PGEN_.00g168520	Scaffold_08	305454	315517	NA	NA	NA	NA	NA
PGEN_.00g168530	Scaffold_08	371157	380550	NA	NA	NA	NA	NA
PGEN_.00g168540	Scaffold_08	382066	382806	NA	NA	NA	NA	NA
PGEN_.00g168550	Scaffold_08	383705	384482	NA	NA	NA	NA	NA
PGEN_.00g168560	Scaffold_08	386808	387128	NA	NA	NA	NA	NA
PGEN_.00g168570	Scaffold_08	388725	413495	NA	NA	NA	NA	NA
PGEN_.00g168580	Scaffold_08	423911	446920	NA	NA	NA	NA	NA
PGEN_.00g168590	Scaffold_08	451086	458064	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g168600	Scaffold_08	465674	470181	NA	NA	NA	NA	NA
PGEN_.00g168610	Scaffold_08	480780	487228	NA	NA	NA	NA	NA
PGEN_.00g168620	Scaffold_08	487484	502778	NA	NA	NA	NA	NA
PGEN_.00g168630	Scaffold_08	503862	504562	O75818	RPP40_HUMAN	Ribonuclease P protein subunit p40 (RNaseP protein p40) (EC 3.1.26.5) (RNase P subunit 1)	GO:0001682; GO:0004526; GO:0005634; GO:0005654; GO:0005655; GO:0006364; GO:0030681; GO:0033204	multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]
PGEN_.00g168640	Scaffold_08	545683	556860	Q5RDP4	SYLM_PONAB	"Probable leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	GO:0002161; GO:0004823; GO:0005524; GO:0005759; GO:0006429	mitochondrial matrix [GO:0005759]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]
PGEN_.00g168650	Scaffold_08	577700	592506	P54254	ATX1_MOUSE	Ataxin-1 (Spinocerebellar ataxia type 1 protein homolog)	GO:0000122; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0008022; GO:0008266; GO:0008344; GO:0008542; GO:0016363; GO:0032991; GO:0034046; GO:0035176; GO:0042326; GO:0042405; GO:0042802; GO:0043569; GO:0043621; GO:0045892; GO:0045944; GO:0048286; GO:0048856; GO:0051168; GO:0060079; GO:0060252; GO:0098794	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]; visual learning [GO:0008542]"
PGEN_.00g168660	Scaffold_08	592729	593286	NA	NA	NA	NA	NA
PGEN_.00g168670	Scaffold_08	643850	644272	NA	NA	NA	NA	NA
PGEN_.00g168680	Scaffold_08	669573	671512	NA	NA	NA	NA	NA
PGEN_.00g168690	Scaffold_08	684089	702237	Q5R4X4	SSRA_PONAB	Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)	GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
PGEN_.00g168700	Scaffold_08	741918	748253	NA	NA	NA	NA	NA
PGEN_.00g168710	Scaffold_08	758348	762826	NA	NA	NA	NA	NA
PGEN_.00g168720	Scaffold_08	762757	763881	Q1H9T6	TZAP_MOUSE	Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48)	GO:0000781; GO:0003691; GO:0005654; GO:0005829; GO:0010833; GO:0042802; GO:0044212; GO:0045893; GO:0046872	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]"
PGEN_.00g168730	Scaffold_08	772048	775515	Q4V8D1	CP2U1_RAT	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g168740	Scaffold_08	862622	881699	Q4V8D1	CP2U1_RAT	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g168750	Scaffold_08	888527	899608	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g168760	Scaffold_08	919380	938969	Q9XTY1	GCY22_CAEEL	Receptor-type guanylate cyclase gcy-22 (EC 4.6.1.2)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006935; GO:0007165; GO:0007168; GO:0007635; GO:0008306; GO:0010035; GO:0010226; GO:0016021; GO:0032026; GO:0035556; GO:0050850; GO:1902074; GO:1904640	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; associative learning [GO:0008306]; cGMP biosynthetic process [GO:0006182]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; positive regulation of calcium-mediated signaling [GO:0050850]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to inorganic substance [GO:0010035]; response to lithium ion [GO:0010226]; response to magnesium ion [GO:0032026]; response to methionine [GO:1904640]; response to salt [GO:1902074]; signal transduction [GO:0007165]
PGEN_.00g168770	Scaffold_08	974287	975411	NA	NA	NA	NA	NA
PGEN_.00g168780	Scaffold_08	977038	982301	H2A0L0	TYRO1_PINMG	Tyrosinase-like protein 1 (EC 1.14.18.-) (Tyrosinase 1)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g168790	Scaffold_08	995854	1007211	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g168800	Scaffold_08	1019375	1030389	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g168810	Scaffold_08	1043971	1049343	H2A0L0	TYRO1_PINMG	Tyrosinase-like protein 1 (EC 1.14.18.-) (Tyrosinase 1)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g168820	Scaffold_08	1050969	1054877	NA	NA	NA	NA	NA
PGEN_.00g168830	Scaffold_08	1087403	1107237	Q9XTY1	GCY22_CAEEL	Receptor-type guanylate cyclase gcy-22 (EC 4.6.1.2)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006935; GO:0007165; GO:0007168; GO:0007635; GO:0008306; GO:0010035; GO:0010226; GO:0016021; GO:0032026; GO:0035556; GO:0050850; GO:1902074; GO:1904640	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; associative learning [GO:0008306]; cGMP biosynthetic process [GO:0006182]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; positive regulation of calcium-mediated signaling [GO:0050850]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to inorganic substance [GO:0010035]; response to lithium ion [GO:0010226]; response to magnesium ion [GO:0032026]; response to methionine [GO:1904640]; response to salt [GO:1902074]; signal transduction [GO:0007165]
PGEN_.00g168840	Scaffold_08	1126975	1135631	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g168850	Scaffold_08	1137104	1138551	NA	NA	NA	NA	NA
PGEN_.00g168860	Scaffold_08	1139385	1140357	NA	NA	NA	NA	NA
PGEN_.00g168870	Scaffold_08	1149901	1168978	Q4V8D1	CP2U1_RAT	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g168880	Scaffold_08	1256257	1259748	Q4V8D1	CP2U1_RAT	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g168890	Scaffold_08	1267689	1273221	P17098	ZNF8_HUMAN	Zinc finger protein 8 (Zinc finger protein HF.18)	GO:0000122; GO:0003677; GO:0005634; GO:0008270; GO:0030509	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g168900	Scaffold_08	1283156	1289867	NA	NA	NA	NA	NA
PGEN_.00g168910	Scaffold_08	1329538	1347344	Q5R4X4	SSRA_PONAB	Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)	GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
PGEN_.00g168920	Scaffold_08	1354741	1365250	NA	NA	NA	NA	NA
PGEN_.00g168930	Scaffold_08	1382143	1382556	NA	NA	NA	NA	NA
PGEN_.00g168940	Scaffold_08	1432251	1432808	NA	NA	NA	NA	NA
PGEN_.00g168950	Scaffold_08	1433031	1447766	P54254	ATX1_MOUSE	Ataxin-1 (Spinocerebellar ataxia type 1 protein homolog)	GO:0000122; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0008022; GO:0008266; GO:0008344; GO:0008542; GO:0016363; GO:0032991; GO:0034046; GO:0035176; GO:0042326; GO:0042405; GO:0042802; GO:0043569; GO:0043621; GO:0045892; GO:0045944; GO:0048286; GO:0048856; GO:0051168; GO:0060079; GO:0060252; GO:0098794	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]; visual learning [GO:0008542]"
PGEN_.00g168960	Scaffold_08	1468645	1479881	Q5RDP4	SYLM_PONAB	"Probable leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)"	GO:0002161; GO:0004823; GO:0005524; GO:0005759; GO:0006429	mitochondrial matrix [GO:0005759]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]
PGEN_.00g168970	Scaffold_08	1521002	1521703	O75818	RPP40_HUMAN	Ribonuclease P protein subunit p40 (RNaseP protein p40) (EC 3.1.26.5) (RNase P subunit 1)	GO:0001682; GO:0004526; GO:0005634; GO:0005654; GO:0005655; GO:0006364; GO:0030681; GO:0033204	multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]
PGEN_.00g168980	Scaffold_08	1522505	1538052	NA	NA	NA	NA	NA
PGEN_.00g168990	Scaffold_08	1538077	1544774	NA	NA	NA	NA	NA
PGEN_.00g169000	Scaffold_08	1555373	1559881	NA	NA	NA	NA	NA
PGEN_.00g169010	Scaffold_08	1567491	1574464	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g169020	Scaffold_08	1578629	1601649	NA	NA	NA	NA	NA
PGEN_.00g169030	Scaffold_08	1612221	1637026	NA	NA	NA	NA	NA
PGEN_.00g169040	Scaffold_08	1638623	1638943	NA	NA	NA	NA	NA
PGEN_.00g169050	Scaffold_08	1641266	1642043	NA	NA	NA	NA	NA
PGEN_.00g169060	Scaffold_08	1642942	1643682	NA	NA	NA	NA	NA
PGEN_.00g169070	Scaffold_08	1645198	1656058	NA	NA	NA	NA	NA
PGEN_.00g169080	Scaffold_08	1708314	1718363	NA	NA	NA	NA	NA
PGEN_.00g169090	Scaffold_08	1732528	1761417	Q16181	SEPT7_HUMAN	Septin-7 (CDC10 protein homolog)	GO:0000777; GO:0001725; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005819; GO:0005829; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030336; GO:0030496; GO:0031105; GO:0032154; GO:0042802; GO:0043065; GO:0045296; GO:0051291; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730; GO:1902857; GO:2000134	axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; negative regulation of cell migration [GO:0030336]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of apoptotic process [GO:0043065]; positive regulation of non-motile cilium assembly [GO:1902857]; protein heterooligomerization [GO:0051291]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]
PGEN_.00g169100	Scaffold_08	1769481	1778907	Q9H0I3	CC113_HUMAN	Coiled-coil domain-containing protein 113	GO:0005737; GO:0032991; GO:0034451; GO:0060271	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; cilium assembly [GO:0060271]
PGEN_.00g169110	Scaffold_08	1815997	1861573	Q8VDB9	S620A_MOUSE	Sodium- and chloride-dependent transporter XTRP3A (IMINO-B) (Solute carrier family 6 member 20A) (X transporter protein 3 similar 1)	GO:0005328; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015193; GO:0015816; GO:0015824; GO:0015838; GO:0016324; GO:0035524	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-proline transmembrane transporter activity [GO:0015193]; neurotransmitter:sodium symporter activity [GO:0005328]; amino acid transport [GO:0006865]; amino-acid betaine transport [GO:0015838]; glycine transport [GO:0015816]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]
PGEN_.00g169120	Scaffold_08	1864375	1866561	NA	NA	NA	NA	NA
PGEN_.00g169130	Scaffold_08	1868811	1869068	NA	NA	NA	NA	NA
PGEN_.00g169140	Scaffold_08	1895737	1977111	Q8BNA6	FAT3_MOUSE	Protocadherin Fat 3 (FAT tumor suppressor homolog 3)	GO:0000904; GO:0001764; GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016021; GO:0030425; GO:0098609; GO:2000171	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; retina layer formation [GO:0010842]
PGEN_.00g169150	Scaffold_08	1994553	1998580	NA	NA	NA	NA	NA
PGEN_.00g169160	Scaffold_08	2027199	2060658	NA	NA	NA	NA	NA
PGEN_.00g169170	Scaffold_08	2066296	2070323	Q9H2C0	GAN_HUMAN	Gigaxonin (Kelch-like protein 16)	GO:0005737; GO:0005829; GO:0005856; GO:0007010; GO:0016567; GO:0031463; GO:0043687	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeleton organization [GO:0007010]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]
PGEN_.00g169180	Scaffold_08	2083077	2084162	Q03017	CACT_DROME	NF-kappa-B inhibitor cactus	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]
PGEN_.00g169190	Scaffold_08	2096777	2102582	NA	NA	NA	NA	NA
PGEN_.00g169200	Scaffold_08	2102753	2103248	NA	NA	NA	NA	NA
PGEN_.00g169210	Scaffold_08	2108657	2110633	E7FAM5	LIN41_DANRE	E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)	GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177	P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]
PGEN_.00g169220	Scaffold_08	2115331	2127941	Q28ES8	CTU2_XENTR	Cytoplasmic tRNA 2-thiolation protein 2	GO:0000049; GO:0002098; GO:0002143; GO:0005829; GO:0016779; GO:0016783; GO:0032447; GO:0034227	cytosol [GO:0005829]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g169230	Scaffold_08	2137506	2138135	NA	NA	NA	NA	NA
PGEN_.00g169240	Scaffold_08	2196312	2203404	Q9NQP4	PFD4_HUMAN	Prefoldin subunit 4 (Protein C-1)	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082; GO:0051087	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]
PGEN_.00g169250	Scaffold_08	2212819	2217627	Q9VJ33	NEDD8_DROME	NEDD8 (Neddylin) (Ubiquitin-like protein Nedd8)	GO:0005634; GO:0005737; GO:0007275; GO:0008283; GO:0008589; GO:0019941; GO:0030162; GO:0030431; GO:0031386; GO:0031625; GO:0031647; GO:0036099; GO:0045116; GO:0051438; GO:2000736	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein tag [GO:0031386]; ubiquitin protein ligase binding [GO:0031625]; cell population proliferation [GO:0008283]; female germ-line stem cell population maintenance [GO:0036099]; modification-dependent protein catabolic process [GO:0019941]; multicellular organism development [GO:0007275]; protein neddylation [GO:0045116]; regulation of protein stability [GO:0031647]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589]; regulation of stem cell differentiation [GO:2000736]; regulation of ubiquitin-protein transferase activity [GO:0051438]; sleep [GO:0030431]
PGEN_.00g169260	Scaffold_08	2229271	2235227	NA	NA	NA	NA	NA
PGEN_.00g169270	Scaffold_08	2255921	2257102	Q02284	5HT1F_MOUSE	5-hydroxytryptamine receptor 1F (5-HT-1F) (5-HT1F) (5-HT-1E-beta) (Serotonin receptor 1F)	GO:0004930; GO:0004993; GO:0005887; GO:0007187; GO:0007193; GO:0007198; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0051378	"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]"
PGEN_.00g169280	Scaffold_08	2271499	2272728	P97718	ADA1A_MOUSE	Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor)	GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0003084; GO:0004935; GO:0004937; GO:0005623; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0007188; GO:0007200; GO:0007202; GO:0007204; GO:0007512; GO:0007568; GO:0009725; GO:0010460; GO:0010507; GO:0010613; GO:0016020; GO:0030018; GO:0030315; GO:0031965; GO:0032230; GO:0035024; GO:0035265; GO:0042493; GO:0043410; GO:0045760; GO:0045907; GO:0045987; GO:0046982; GO:0060073; GO:0060402; GO:0060452; GO:0061049; GO:0070374; GO:0071880; GO:0090037; GO:0097195; GO:0098691; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0150099; GO:1903997; GO:2000300	"caveola [GO:0005901]; cell [GO:0005623]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; adrenergic receptor activity [GO:0004935]; alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adult heart development [GO:0007512]; aging [GO:0007568]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; micturition [GO:0060073]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate [GO:0010460]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to drug [GO:0042493]; response to hormone [GO:0009725]"
PGEN_.00g169290	Scaffold_08	2273993	2275192	Q8ITC9	PK1R_DROME	Pyrokinin-1 receptor	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0036401; GO:0070328; GO:0090278	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]
PGEN_.00g169300	Scaffold_08	2288564	2295264	E9QAG8	ZN431_MOUSE	Zinc finger protein 431 (Zinc finger protein 932)	GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0042826; GO:0043433; GO:0045668; GO:0046872	nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g169310	Scaffold_08	2306233	2317302	Q91XV4	DCXR_MESAU	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g169320	Scaffold_08	2319558	2319812	NA	NA	NA	NA	NA
PGEN_.00g169330	Scaffold_08	2338728	2389253	Q9BVG8	KIFC3_HUMAN	Kinesin-like protein KIFC3	GO:0003777; GO:0005524; GO:0005794; GO:0005813; GO:0005871; GO:0005874; GO:0005915; GO:0007018; GO:0007030; GO:0007601; GO:0008017; GO:0008569; GO:0016887; GO:0030659; GO:0045218; GO:0070062; GO:0090136	"centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218]"
PGEN_.00g169340	Scaffold_08	2428107	2428763	NA	NA	NA	NA	NA
PGEN_.00g169350	Scaffold_08	2430640	2431236	NA	NA	NA	NA	NA
PGEN_.00g169360	Scaffold_08	2435528	2456485	Q80TS5	ZN423_MOUSE	Zinc finger protein 423 (Early B-cell factor-associated zinc finger protein) (Olf1/EBF-associated zinc finger protein) (Smad- and Olf-interacting zinc finger protein)	GO:0005634; GO:0005654; GO:0007219; GO:0007399; GO:0030154; GO:0030513; GO:0042802; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:0046872; GO:0120163	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g169370	Scaffold_08	2481298	2493083	P78417	GSTO1_HUMAN	Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R)	GO:0004364; GO:0005623; GO:0005654; GO:0005737; GO:0005829; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0032259; GO:0035722; GO:0042178; GO:0045174; GO:0050610; GO:0055114; GO:0060315; GO:0060316; GO:0070062; GO:0071243; GO:1901687	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]
PGEN_.00g169380	Scaffold_08	2503748	2505367	NA	NA	NA	NA	NA
PGEN_.00g169390	Scaffold_08	2511471	2513591	Q9VSL3	SEPIA_DROME	Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia)	GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0016782; GO:0042803; GO:0045174; GO:0055114	"cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]"
PGEN_.00g169400	Scaffold_08	2531040	2532002	A9JTP3	BIRC7_XENTR	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7)	GO:0005634; GO:0005737; GO:0007275; GO:0031398; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865; GO:0061630; GO:1990001	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]
PGEN_.00g169410	Scaffold_08	2546178	2548766	NA	NA	NA	NA	NA
PGEN_.00g169420	Scaffold_08	2558573	2559139	NA	NA	NA	NA	NA
PGEN_.00g169430	Scaffold_08	2559580	2560137	NA	NA	NA	NA	NA
PGEN_.00g169440	Scaffold_08	2581062	2600385	Q9R088	KITM_MOUSE	"Thymidine kinase 2, mitochondrial (EC 2.7.1.21) (Mt-TK)"	GO:0004137; GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0006264; GO:0009262; GO:0019136; GO:0032042; GO:0046092; GO:0046104; GO:0071897	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; deoxynucleoside kinase activity [GO:0019136]; thymidine kinase activity [GO:0004797]; deoxycytidine metabolic process [GO:0046092]; deoxyribonucleotide metabolic process [GO:0009262]; DNA biosynthetic process [GO:0071897]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA replication [GO:0006264]; thymidine metabolic process [GO:0046104]
PGEN_.00g169450	Scaffold_08	2600667	2616306	Q9GKX2	DHRS4_RABIT	Dehydrogenase/reductase SDR family member 4 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase/NADP-retinol dehydrogenase) (CR) (PHCR) (NADPH-dependent retinol dehydrogenase/reductase) (NDRD) (Peroxisomal short-chain alcohol dehydrogenase) (PSCD) (rabNRDR) (Fragment)	GO:0004090; GO:0005739; GO:0005777	mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carbonyl reductase (NADPH) activity [GO:0004090]
PGEN_.00g169460	Scaffold_08	2620452	2648284	NA	NA	NA	NA	NA
PGEN_.00g169470	Scaffold_08	2662015	2663925	NA	NA	NA	NA	NA
PGEN_.00g169480	Scaffold_08	2675353	2699052	Q13231	CHIT1_HUMAN	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]"
PGEN_.00g169490	Scaffold_08	2702281	2705713	Q13231	CHIT1_HUMAN	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]"
PGEN_.00g169500	Scaffold_08	2791673	2798680	Q5ZJJ5	AKTIP_CHICK	AKT-interacting protein (Fused toes protein homolog)	GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0006974; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0045022; GO:0061631; GO:0070695	cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein transport [GO:0015031]
PGEN_.00g169510	Scaffold_08	2809168	2829744	Q8NCC3	PAG15_HUMAN	Group XV phospholipase A2 (EC 2.3.1.-) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2)	GO:0004622; GO:0005543; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006644; GO:0006650; GO:0006672; GO:0008374; GO:0009062; GO:0016020; GO:0034638; GO:0043231; GO:0046338; GO:0047499; GO:0070062	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]; ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644]
PGEN_.00g169520	Scaffold_08	2840779	2841921	NA	NA	NA	NA	NA
PGEN_.00g169530	Scaffold_08	2842060	2842482	NA	NA	NA	NA	NA
PGEN_.00g169540	Scaffold_08	2850252	2853832	NA	NA	NA	NA	NA
PGEN_.00g169550	Scaffold_08	2870453	2892706	Q9VEG6	PERC_DROME	Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt)	GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872	extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]
PGEN_.00g169560	Scaffold_08	2896463	2903124	NA	NA	NA	NA	NA
PGEN_.00g169570	Scaffold_08	2907418	2921636	Q8VI56	LRP4_MOUSE	Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)	GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]
PGEN_.00g169580	Scaffold_08	2945624	2949158	NA	NA	NA	NA	NA
PGEN_.00g169590	Scaffold_08	2954405	2983674	Q9P243	ZFAT_HUMAN	Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406)	GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0046872; GO:0060712	"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]"
PGEN_.00g169600	Scaffold_08	2992529	2994478	NA	NA	NA	NA	NA
PGEN_.00g169610	Scaffold_08	3119271	3141743	Q28GH3	SAE2_XENTR	SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2)	GO:0005524; GO:0005737; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032446; GO:0046872	cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925]
PGEN_.00g169620	Scaffold_08	3162093	3192723	NA	NA	NA	NA	NA
PGEN_.00g169630	Scaffold_08	3196391	3196882	NA	NA	NA	NA	NA
PGEN_.00g169640	Scaffold_08	3200464	3210899	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g169650	Scaffold_08	3211686	3212168	NA	NA	NA	NA	NA
PGEN_.00g169660	Scaffold_08	3212518	3222414	NA	NA	NA	NA	NA
PGEN_.00g169670	Scaffold_08	3222632	3223174	NA	NA	NA	NA	NA
PGEN_.00g169680	Scaffold_08	3223290	3225639	NA	NA	NA	NA	NA
PGEN_.00g169690	Scaffold_08	3247985	3253297	Q9DAR0	CE049_MOUSE	Uncharacterized protein C5orf49 homolog (Y regulated sperm protein)		
PGEN_.00g169700	Scaffold_08	3253380	3273808	Q68DL7	CR063_HUMAN	Uncharacterized protein C18orf63		
PGEN_.00g169710	Scaffold_08	3281764	3305226	Q8NDA8	MROH1_HUMAN	Maestro heat-like repeat-containing protein family member 1 (HEAT repeat-containing protein 7A)		
PGEN_.00g169720	Scaffold_08	3368434	3443308	P28666	MUG2_MOUSE	Murinoglobulin-2 (MuG2)	GO:0002020; GO:0004866; GO:0004867; GO:0005615	extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g169730	Scaffold_08	3450101	3451282	NA	NA	NA	NA	NA
PGEN_.00g169740	Scaffold_08	3551281	3551619	NA	NA	NA	NA	NA
PGEN_.00g169750	Scaffold_08	3672795	3676360	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g169760	Scaffold_08	3845318	3949567	Q03626	MUG1_RAT	Murinoglobulin-1 (Alpha-1 inhibitor 3 variant I) (Alpha-X protein)	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0006953; GO:0006954; GO:0007566; GO:0030414	extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]
PGEN_.00g169770	Scaffold_08	3967089	4000926	Q9CZX2	CEP89_MOUSE	Centrosomal protein of 89 kDa (Cep89) (Coiled-coil domain-containing protein 123)	GO:0000922; GO:0005758; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007005; GO:0007268; GO:0031514; GO:0045202; GO:0060271; GO:0097539; GO:0097730; GO:1905515	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; synapse [GO:0045202]; chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515]
PGEN_.00g169780	Scaffold_08	4038526	4053848	Q6GM59	MOT12_XENLA	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0015293; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]
PGEN_.00g169790	Scaffold_08	4120211	4182838	NA	NA	NA	NA	NA
PGEN_.00g169800	Scaffold_08	4270101	4270544	NA	NA	NA	NA	NA
PGEN_.00g169810	Scaffold_08	4272514	4320099	A2AX52	CO6A4_MOUSE	Collagen alpha-4(VI) chain	GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; collagen binding [GO:0005518]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]
PGEN_.00g169820	Scaffold_08	4325270	4332882	Q8IVS2	FABD_HUMAN	"Malonyl-CoA-acyl carrier protein transacylase, mitochondrial (MCT) (EC 2.3.1.39) (Mitochondrial malonyl CoA:ACP acyltransferase) (Mitochondrial malonyltransferase) ([Acyl-carrier-protein] malonyltransferase)"	GO:0003723; GO:0004312; GO:0004314; GO:0005739; GO:0005759; GO:0006633; GO:0006635	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; fatty acid synthase activity [GO:0004312]; RNA binding [GO:0003723]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]
PGEN_.00g169830	Scaffold_08	4332950	4349265	Q6GL41	MCM4_XENTR	DNA replication licensing factor mcm4 (EC 3.6.4.12) (Minichromosome maintenance protein 4)	GO:0000727; GO:0000785; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006271; GO:0030174; GO:0042555; GO:0046872; GO:1902975	chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA-dependent DNA replication initiation [GO:0030174]
PGEN_.00g169840	Scaffold_08	4367071	4388923	P51798	CLCN7_HUMAN	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	GO:0005247; GO:0005254; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016020; GO:0016021; GO:0022857; GO:0031410; GO:0034220; GO:0043231	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]
PGEN_.00g169850	Scaffold_08	4457013	4465847	NA	NA	NA	NA	NA
PGEN_.00g169860	Scaffold_08	4494431	4495159	NA	NA	NA	NA	NA
PGEN_.00g169870	Scaffold_08	4532688	4532954	NA	NA	NA	NA	NA
PGEN_.00g169880	Scaffold_08	4558476	4572956	O75340	PDCD6_HUMAN	Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2)	GO:0000139; GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006919; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043280; GO:0043495; GO:0045766; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:0051898; GO:0070062; GO:0070971; GO:0097190; GO:1902527; GO:1990756	"COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein binding, bridging [GO:0030674]; protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]"
PGEN_.00g169890	Scaffold_08	4629623	4702456	P41044	CAB32_DROME	Calbindin-32	GO:0005509; GO:0005634; GO:0005829; GO:0030425; GO:0043005; GO:0045202; GO:0061175; GO:0097467; GO:0099509; GO:1900271; GO:1903035	cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; type II terminal bouton [GO:0061175]; type III terminal bouton [GO:0097467]; calcium ion binding [GO:0005509]; negative regulation of response to wounding [GO:1903035]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]
PGEN_.00g169900	Scaffold_08	4708961	4709206	NA	NA	NA	NA	NA
PGEN_.00g169910	Scaffold_08	4731777	4732019	NA	NA	NA	NA	NA
PGEN_.00g169920	Scaffold_08	4786058	4787701	Q61572	FOXC1_MOUSE	Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3) (Mesoderm/mesenchyme forkhead 1) (MF-1) (Transcription factor FKH-1)	GO:0000122; GO:0000977; GO:0000981; GO:0001223; GO:0001501; GO:0001503; GO:0001525; GO:0001541; GO:0001568; GO:0001654; GO:0001657; GO:0001701; GO:0001756; GO:0001822; GO:0001945; GO:0001958; GO:0001974; GO:0003007; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005720; GO:0005829; GO:0006355; GO:0006357; GO:0007219; GO:0007420; GO:0007507; GO:0008134; GO:0008283; GO:0008301; GO:0008354; GO:0009653; GO:0010628; GO:0010718; GO:0014031; GO:0014032; GO:0016477; GO:0016525; GO:0021549; GO:0030154; GO:0030199; GO:0030203; GO:0032808; GO:0035050; GO:0036438; GO:0038084; GO:0042475; GO:0043010; GO:0043388; GO:0043565; GO:0044212; GO:0045618; GO:0045893; GO:0045930; GO:0045944; GO:0046620; GO:0048010; GO:0048341; GO:0048762; GO:0048844; GO:0055010; GO:0060038; GO:0070098; GO:0071364; GO:0072010; GO:0097746; GO:1901491; GO:1901534; GO:1902038; GO:1902257; GO:1904798; GO:1990841; GO:1990869	"cytosol [GO:0005829]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to chemokine [GO:1990869]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellum development [GO:0021549]; chemokine-mediated signaling pathway [GO:0070098]; collagen fibril organization [GO:0030199]; embryonic heart tube development [GO:0035050]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; germ cell migration [GO:0008354]; glomerular epithelium development [GO:0072010]; glycosaminoglycan metabolic process [GO:0030203]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lacrimal gland development [GO:0032808]; lymph vessel development [GO:0001945]; maintenance of lens transparency [GO:0036438]; mesenchymal cell development [GO:0014031]; mesenchymal cell differentiation [GO:0048762]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902257]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; paraxial mesoderm formation [GO:0048341]; positive regulation of core promoter binding [GO:1904798]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of blood vessel diameter [GO:0097746]; regulation of organ growth [GO:0046620]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]; somitogenesis [GO:0001756]; ureteric bud development [GO:0001657]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]"
PGEN_.00g169930	Scaffold_08	4811448	4813328	NA	NA	NA	NA	NA
PGEN_.00g169940	Scaffold_08	4824078	4824872	NA	NA	NA	NA	NA
PGEN_.00g169950	Scaffold_08	4829810	4830370	NA	NA	NA	NA	NA
PGEN_.00g169960	Scaffold_08	4855673	4863915	A5PLK6	RGSL_HUMAN	Regulator of G-protein signaling protein-like	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g169970	Scaffold_08	4871075	4901565	NA	NA	NA	NA	NA
PGEN_.00g169980	Scaffold_08	4913533	4913850	NA	NA	NA	NA	NA
PGEN_.00g169990	Scaffold_08	4925804	4938439	P55859	PNPH_BOVIN	Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase)	GO:0004731; GO:0005737; GO:0005856; GO:0009116	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; purine-nucleoside phosphorylase activity [GO:0004731]; nucleoside metabolic process [GO:0009116]
PGEN_.00g170000	Scaffold_08	4940079	4957846	NA	NA	NA	NA	NA
PGEN_.00g170010	Scaffold_08	5050520	5055437	NA	NA	NA	NA	NA
PGEN_.00g170020	Scaffold_08	5065435	5067598	O94761	RECQ4_HUMAN	"ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)"	GO:0000405; GO:0000723; GO:0000724; GO:0000733; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0007275; GO:0009378; GO:0016020; GO:0032357; GO:0032508; GO:0036310; GO:0043138; GO:0061820; GO:0061821	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; multicellular organism development [GO:0007275]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"
PGEN_.00g170030	Scaffold_08	5077540	5079154	NA	NA	NA	NA	NA
PGEN_.00g170040	Scaffold_08	5079602	5079811	NA	NA	NA	NA	NA
PGEN_.00g170050	Scaffold_08	5080058	5080648	NA	NA	NA	NA	NA
PGEN_.00g170060	Scaffold_08	5081388	5082725	NA	NA	NA	NA	NA
PGEN_.00g170070	Scaffold_08	5146309	5146578	NA	NA	NA	NA	NA
PGEN_.00g170080	Scaffold_08	5225057	5226358	Q11082	YT66_CAEEL	Probable G-protein coupled receptor B0563.6	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g170090	Scaffold_08	5329879	5348799	O94761	RECQ4_HUMAN	"ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)"	GO:0000405; GO:0000723; GO:0000724; GO:0000733; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0007275; GO:0009378; GO:0016020; GO:0032357; GO:0032508; GO:0036310; GO:0043138; GO:0061820; GO:0061821	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; multicellular organism development [GO:0007275]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"
PGEN_.00g170100	Scaffold_08	5377887	5384103	O94761	RECQ4_HUMAN	"ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)"	GO:0000405; GO:0000723; GO:0000724; GO:0000733; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0007275; GO:0009378; GO:0016020; GO:0032357; GO:0032508; GO:0036310; GO:0043138; GO:0061820; GO:0061821	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; multicellular organism development [GO:0007275]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"
PGEN_.00g170110	Scaffold_08	5403460	5418960	Q6DIJ4	UBP10_XENTR	Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10)	GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006511; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0036459; GO:0043124; GO:0044325; GO:0071347	"cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g170120	Scaffold_08	5420143	5438004	Q6DIJ4	UBP10_XENTR	Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10)	GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006511; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0036459; GO:0043124; GO:0044325; GO:0071347	"cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g170130	Scaffold_08	5468064	5468693	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g170140	Scaffold_08	5473055	5482966	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g170150	Scaffold_08	5492752	5502190	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g170160	Scaffold_08	5505258	5505599	NA	NA	NA	NA	NA
PGEN_.00g170170	Scaffold_08	5519648	5526863	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g170180	Scaffold_08	5530918	5535176	NA	NA	NA	NA	NA
PGEN_.00g170190	Scaffold_08	5575014	5575505	NA	NA	NA	NA	NA
PGEN_.00g170200	Scaffold_08	5580739	5584503	NA	NA	NA	NA	NA
PGEN_.00g170210	Scaffold_08	5586320	5587301	NA	NA	NA	NA	NA
PGEN_.00g170220	Scaffold_08	5587346	5588427	NA	NA	NA	NA	NA
PGEN_.00g170230	Scaffold_08	5589730	5594164	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g170240	Scaffold_08	5603144	5620287	P35440	TSP2_CHICK	Thrombospondin-2	GO:0005509; GO:0007155; GO:0008201; GO:0016525; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]
PGEN_.00g170250	Scaffold_08	5633158	5634384	NA	NA	NA	NA	NA
PGEN_.00g170260	Scaffold_08	5642147	5649223	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g170270	Scaffold_08	5696711	5697331	NA	NA	NA	NA	NA
PGEN_.00g170280	Scaffold_08	5706881	5711116	NA	NA	NA	NA	NA
PGEN_.00g170290	Scaffold_08	5711522	5711785	NA	NA	NA	NA	NA
PGEN_.00g170300	Scaffold_08	5719659	5720228	NA	NA	NA	NA	NA
PGEN_.00g170310	Scaffold_08	5742714	5766811	Q80V03	ADCK5_MOUSE	Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-)	GO:0004674; GO:0005739; GO:0016021	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g170320	Scaffold_08	5774870	5775778	P86437	CBLN1_BOVIN	Cerebellin-1 (Precerebellin) [Cleaved into: Cerebellin (CER); [des-Ser1]-cerebellin]	GO:0007157; GO:0009306; GO:0021707; GO:0030054; GO:0042803; GO:0043083; GO:0045211; GO:0051965; GO:0090394; GO:0098688; GO:0098978; GO:0099151; GO:1900454; GO:1905606	cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; synaptic cleft [GO:0043083]; protein homodimerization activity [GO:0042803]; cerebellar granule cell differentiation [GO:0021707]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of excitatory postsynaptic potential [GO:0090394]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein secretion [GO:0009306]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]
PGEN_.00g170330	Scaffold_08	5781561	5788345	Q5R9K8	AR2BP_PONAB	ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein)	GO:0003713; GO:0005634; GO:0005758; GO:0005813; GO:0005819; GO:0005929; GO:0030496; GO:0042531; GO:0051457	centrosome [GO:0005813]; cilium [GO:0005929]; midbody [GO:0030496]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription coactivator activity [GO:0003713]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]
PGEN_.00g170340	Scaffold_08	5789988	5796762	NA	NA	NA	NA	NA
PGEN_.00g170350	Scaffold_08	5804387	5884088	O57415	RREB1_CHICK	Ras-responsive element-binding protein 1 (RREB-1)	GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0046872	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g170360	Scaffold_08	5895822	5923008	NA	NA	NA	NA	NA
PGEN_.00g170370	Scaffold_08	5941846	5990817	D3YXS5	KIF28_MOUSE	Kinesin-like protein KIF28P (Kinesin-like protein 6)	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0030705; GO:0031966; GO:0072384	kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]
PGEN_.00g170380	Scaffold_08	6016672	6036635	Q2T9Q1	TBC20_BOVIN	TBC1 domain family member 20	GO:0001675; GO:0005096; GO:0005789; GO:0006888; GO:0007030; GO:0017137; GO:0019068; GO:0030173; GO:0031965; GO:0034389; GO:0044829; GO:0046726; GO:0070309; GO:0072520; GO:0090110; GO:1902953	endoplasmic reticulum membrane [GO:0005789]; integral component of Golgi membrane [GO:0030173]; nuclear membrane [GO:0031965]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; acrosome assembly [GO:0001675]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lens fiber cell morphogenesis [GO:0070309]; lipid droplet organization [GO:0034389]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; seminiferous tubule development [GO:0072520]; virion assembly [GO:0019068]
PGEN_.00g170390	Scaffold_08	6036967	6061931	Q9Z2A7	DGAT1_MOUSE	Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase)	GO:0003846; GO:0004144; GO:0005504; GO:0005789; GO:0005886; GO:0010867; GO:0016020; GO:0016021; GO:0016746; GO:0019432; GO:0019915; GO:0019992; GO:0030073; GO:0034379; GO:0035336; GO:0043231; GO:0046321; GO:0046339; GO:0046486; GO:0050252; GO:0055089; GO:1901738; GO:1902224; GO:1903998; GO:1904729; GO:2000491	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]; diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379]"
PGEN_.00g170400	Scaffold_08	6068142	6077463	NA	NA	NA	NA	NA
PGEN_.00g170410	Scaffold_08	6078175	6082724	G8HTB6	ZPP_ACRMI	ZP domain-containing protein	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g170420	Scaffold_08	6086093	6088186	NA	NA	NA	NA	NA
PGEN_.00g170430	Scaffold_08	6088295	6110739	Q99MN1	SYK_MOUSE	Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	GO:0000049; GO:0000187; GO:0002276; GO:0002741; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:0097110; GO:1900017; GO:1900745; GO:1905050	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"
PGEN_.00g170440	Scaffold_08	6127541	6128554	NA	NA	NA	NA	NA
PGEN_.00g170450	Scaffold_08	6134866	6139067	NA	NA	NA	NA	NA
PGEN_.00g170460	Scaffold_08	6181327	6184629	NA	NA	NA	NA	NA
PGEN_.00g170470	Scaffold_08	6185077	6226363	Q61140	BCAR1_MOUSE	Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (p130cas)	GO:0001726; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007015; GO:0007155; GO:0007173; GO:0007186; GO:0007229; GO:0008286; GO:0010595; GO:0015629; GO:0016477; GO:0017124; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030335; GO:0035729; GO:0048008; GO:0048010; GO:0048011; GO:0048012; GO:0050851; GO:0050853; GO:0060326; GO:0071732; GO:0086100; GO:0090527; GO:1900025; GO:1990859	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to endothelin [GO:1990859]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to nitric oxide [GO:0071732]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]
PGEN_.00g170480	Scaffold_08	6242578	6250132	P44121	DNLI_HAEIN	DNA ligase (EC 6.5.1.1) (Polydeoxyribonucleotide synthase [ATP])	GO:0003910; GO:0005524; GO:0006260; GO:0006310; GO:0046872; GO:0051103	ATP binding [GO:0005524]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]
PGEN_.00g170490	Scaffold_08	6277000	6333911	O94916	NFAT5_HUMAN	Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein) (TonE-binding protein) (TonEBP)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001816; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006366; GO:0006970; GO:0007165; GO:0007588; GO:0008134; GO:0033173; GO:0044798; GO:0045944; GO:0070884; GO:0071345; GO:1901224; GO:1904996	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; cytokine production [GO:0001816]; excretion [GO:0007588]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; response to osmotic stress [GO:0006970]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g170500	Scaffold_08	6295542	6299684	NA	NA	NA	NA	NA
PGEN_.00g170510	Scaffold_08	6341730	6357004	Q8GYB1	NUD15_ARATH	"Nudix hydrolase 15, mitochondrial (AtNUDT15) (EC 3.6.1.-) (Coenzyme A diphosphatase NUDT15)"	GO:0003986; GO:0005739; GO:0006104; GO:0006753; GO:0008893; GO:0010945; GO:0015937; GO:0015938; GO:0046872	"mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; CoA pyrophosphatase activity [GO:0010945]; guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A catabolic process [GO:0015938]; nucleoside phosphate metabolic process [GO:0006753]; succinyl-CoA metabolic process [GO:0006104]"
PGEN_.00g170520	Scaffold_08	6383033	6398531	P44121	DNLI_HAEIN	DNA ligase (EC 6.5.1.1) (Polydeoxyribonucleotide synthase [ATP])	GO:0003910; GO:0005524; GO:0006260; GO:0006310; GO:0046872; GO:0051103	ATP binding [GO:0005524]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]
PGEN_.00g170530	Scaffold_08	6442325	6442783	NA	NA	NA	NA	NA
PGEN_.00g170540	Scaffold_08	6442967	6443374	NA	NA	NA	NA	NA
PGEN_.00g170550	Scaffold_08	6444039	6444584	NA	NA	NA	NA	NA
PGEN_.00g170560	Scaffold_08	6444813	6445118	NA	NA	NA	NA	NA
PGEN_.00g170570	Scaffold_08	6449182	6485333	P82600	PERC_AEDAE	Chorion peroxidase (EC 1.11.1.7)	GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0020037; GO:0042743; GO:0042744; GO:0046872	extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; response to oxidative stress [GO:0006979]
PGEN_.00g170580	Scaffold_08	6544306	6553551	NA	NA	NA	NA	NA
PGEN_.00g170590	Scaffold_08	6574986	6584840	Q9BQI3	E2AK1_HUMAN	Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (Hemin-sensitive initiation factor 2-alpha kinase)	GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005737; GO:0006909; GO:0008285; GO:0010999; GO:0020037; GO:0030225; GO:0042803; GO:0045993; GO:0046501; GO:0046777; GO:0046986; GO:0055072; GO:1990641	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; acute inflammatory response [GO:0002526]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641]
PGEN_.00g170600	Scaffold_08	6627872	6629923	NA	NA	NA	NA	NA
PGEN_.00g170610	Scaffold_08	6636363	6637274	Q8BQT2	DIK1C_MOUSE	Divergent protein kinase domain 1C (Protein FAM69C)	GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
PGEN_.00g170620	Scaffold_08	6646177	6647361	NA	NA	NA	NA	NA
PGEN_.00g170630	Scaffold_08	6658466	6662331	A6QQY2	KLH13_BOVIN	Kelch-like protein 13	GO:0004842; GO:0007049; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0051301	Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]
PGEN_.00g170640	Scaffold_08	6666403	6667193	NA	NA	NA	NA	NA
PGEN_.00g170650	Scaffold_08	6667399	6696072	O75131	CPNE3_HUMAN	Copine-3 (Copine III)	GO:0003723; GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0035577; GO:0038128; GO:0043312; GO:0046474; GO:0048306; GO:0070062; GO:0071277; GO:0071363	azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; glycerophospholipid biosynthetic process [GO:0046474]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]
PGEN_.00g170660	Scaffold_08	6705160	6705423	NA	NA	NA	NA	NA
PGEN_.00g170670	Scaffold_08	6716110	6722205	D4A1R8	CPNE1_RAT	Copine-1 (Copine I)	GO:0001786; GO:0004175; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0010629; GO:0016020; GO:0042803; GO:0043122; GO:0043392; GO:0045666; GO:0051059; GO:0051897; GO:0071277; GO:1901223; GO:1903265; GO:1990138	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; cellular response to calcium ion [GO:0071277]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]
PGEN_.00g170680	Scaffold_08	6763716	6763985	NA	NA	NA	NA	NA
PGEN_.00g170690	Scaffold_08	6793246	6797565	NA	NA	NA	NA	NA
PGEN_.00g170700	Scaffold_08	6848846	6853993	NA	NA	NA	NA	NA
PGEN_.00g170710	Scaffold_08	6868995	6877623	NA	NA	NA	NA	NA
PGEN_.00g170720	Scaffold_08	6883676	6889445	NA	NA	NA	NA	NA
PGEN_.00g170730	Scaffold_08	6902674	6913917	Q2KJ63	KLKB1_BOVIN	Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]	GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0042803; GO:0051919	extracellular space [GO:0005615]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]
PGEN_.00g170740	Scaffold_08	6923561	6927907	NA	NA	NA	NA	NA
PGEN_.00g170750	Scaffold_08	6929769	6931343	A9ULZ2	BIR7B_XENLA	Baculoviral IAP repeat-containing protein 7-B (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-B) (Embryonic/Egg IAP-B) (EIAP/XLX-B) (RING-type E3 ubiquitin transferase EIAP-B)	GO:0005737; GO:0007275; GO:0016740; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0051865	cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865]
PGEN_.00g170760	Scaffold_08	6942228	6943733	NA	NA	NA	NA	NA
PGEN_.00g170770	Scaffold_08	7029028	7042926	NA	NA	NA	NA	NA
PGEN_.00g170780	Scaffold_08	7050164	7050889	NA	NA	NA	NA	NA
PGEN_.00g170790	Scaffold_08	7051219	7051578	NA	NA	NA	NA	NA
PGEN_.00g170800	Scaffold_08	7051770	7052159	NA	NA	NA	NA	NA
PGEN_.00g170810	Scaffold_08	7063822	7079481	Q8R0N9	ZDHC1_MOUSE	Probable palmitoyltransferase ZDHHC1 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 1) (DHHC-1)	GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]
PGEN_.00g170820	Scaffold_08	7079534	7080025	NA	NA	NA	NA	NA
PGEN_.00g170830	Scaffold_08	7080156	7080686	NA	NA	NA	NA	NA
PGEN_.00g170840	Scaffold_08	7080735	7081223	NA	NA	NA	NA	NA
PGEN_.00g170850	Scaffold_08	7081922	7082596	NA	NA	NA	NA	NA
PGEN_.00g170860	Scaffold_08	7082691	7083152	NA	NA	NA	NA	NA
PGEN_.00g170870	Scaffold_08	7145219	7156062	Q9UII5	ZN107_HUMAN	Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g170880	Scaffold_08	7278626	7279788	NA	NA	NA	NA	NA
PGEN_.00g170890	Scaffold_08	7291153	7297427	NA	NA	NA	NA	NA
PGEN_.00g170900	Scaffold_08	7303671	7326424	Q969X6	UTP4_HUMAN	U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component)	GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0006364; GO:0030490; GO:0030686; GO:0032040; GO:0034455	"90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]"
PGEN_.00g170910	Scaffold_08	7349976	7384544	Q8R2N2	UTP4_MOUSE	U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (Testis-expressed gene 292 protein)	GO:0000462; GO:0001650; GO:0005694; GO:0005730; GO:0006355; GO:0030490; GO:0030686; GO:0032040; GO:0034455	"90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g170920	Scaffold_08	7407420	7484228	NA	NA	NA	NA	NA
PGEN_.00g170930	Scaffold_08	7424648	7424923	NA	NA	NA	NA	NA
PGEN_.00g170940	Scaffold_08	7429286	7436006	NA	NA	NA	NA	NA
PGEN_.00g170950	Scaffold_08	7436823	7437083	NA	NA	NA	NA	NA
PGEN_.00g170960	Scaffold_08	7437211	7437441	NA	NA	NA	NA	NA
PGEN_.00g170970	Scaffold_08	7509414	7511164	NA	NA	NA	NA	NA
PGEN_.00g170980	Scaffold_08	7591652	7592488	NA	NA	NA	NA	NA
PGEN_.00g170990	Scaffold_08	7592613	7598910	NA	NA	NA	NA	NA
PGEN_.00g171000	Scaffold_08	7603603	7603998	P16884	NFH_RAT	Neurofilament heavy polypeptide (NF-H) (200 kDa neurofilament protein) (Neurofilament triplet H protein)	GO:0000226; GO:0001552; GO:0005200; GO:0005634; GO:0005737; GO:0005856; GO:0005882; GO:0005883; GO:0007420; GO:0014069; GO:0015643; GO:0019901; GO:0021510; GO:0021766; GO:0021987; GO:0030424; GO:0030674; GO:0031103; GO:0031175; GO:0033693; GO:0034599; GO:0042220; GO:0043204; GO:0044877; GO:0045104; GO:0045110; GO:0048936; GO:0060052; GO:0061564; GO:0071392; GO:0097418; GO:0098685; GO:0099160; GO:0099184; GO:1902513; GO:1903935; GO:1903937; GO:1990830	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intermediate filament [GO:0005882]; neurofibrillary tangle [GO:0097418]; neurofilament [GO:0005883]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; postsynaptic intermediate filament cytoskeleton [GO:0099160]; Schaffer collateral - CA1 synapse [GO:0098685]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic intermediate filament cytoskeleton [GO:0099184]; toxic substance binding [GO:0015643]; axon development [GO:0061564]; axon regeneration [GO:0031103]; brain development [GO:0007420]; cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to oxidative stress [GO:0034599]; cerebral cortex development [GO:0021987]; hippocampus development [GO:0021766]; intermediate filament bundle assembly [GO:0045110]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; neurofilament bundle assembly [GO:0033693]; neurofilament cytoskeleton organization [GO:0060052]; neuron projection development [GO:0031175]; ovarian follicle atresia [GO:0001552]; peripheral nervous system neuron axonogenesis [GO:0048936]; regulation of organelle transport along microtubule [GO:1902513]; response to acrylamide [GO:1903937]; response to cocaine [GO:0042220]; response to sodium arsenite [GO:1903935]; spinal cord development [GO:0021510]"
PGEN_.00g171010	Scaffold_08	7623277	7623628	NA	NA	NA	NA	NA
PGEN_.00g171020	Scaffold_08	7646702	7649949	Q9H1P6	CT085_HUMAN	Uncharacterized protein C20orf85		
PGEN_.00g171030	Scaffold_08	7655271	7655498	NA	NA	NA	NA	NA
PGEN_.00g171040	Scaffold_08	7658107	7667368	Q8VHK0	ACOT8_RAT	Acyl-coenzyme A thioesterase 8 (Acyl-CoA thioesterase 8) (EC 3.1.2.1) (EC 3.1.2.11) (EC 3.1.2.2) (EC 3.1.2.3) (EC 3.1.2.5) (Choloyl-coenzyme A thioesterase) (EC 3.1.2.27) (Peroxisomal acyl-coenzyme A thioester hydrolase 1) (PTE-1) (Peroxisomal long-chain acyl-CoA thioesterase 1)	GO:0003986; GO:0004778; GO:0005777; GO:0005782; GO:0006637; GO:0009062; GO:0016290; GO:0016559; GO:0033882; GO:0043649; GO:0045225; GO:0047603; GO:0047617; GO:0047994; GO:0052689; GO:0052815; GO:0102991	peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acetoacetyl-CoA hydrolase activity [GO:0047603]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; hydroxymethylglutaryl-CoA hydrolase activity [GO:0047994]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; succinyl-CoA hydrolase activity [GO:0004778]; acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; fatty acid catabolic process [GO:0009062]; negative regulation of CD4 biosynthetic process [GO:0045225]; peroxisome fission [GO:0016559]
PGEN_.00g171050	Scaffold_08	7705155	7708232	NA	NA	NA	NA	NA
PGEN_.00g171060	Scaffold_08	7708278	7708832	NA	NA	NA	NA	NA
PGEN_.00g171070	Scaffold_08	7708927	7709247	NA	NA	NA	NA	NA
PGEN_.00g171080	Scaffold_08	7709373	7709669	NA	NA	NA	NA	NA
PGEN_.00g171090	Scaffold_08	7709978	7712361	O88741	GDAP1_MOUSE	Ganglioside-induced differentiation-associated protein 1 (GDAP1)	GO:0000266; GO:0005739; GO:0005829; GO:0006626; GO:0007005; GO:0008053; GO:0031307; GO:0032526; GO:0071305	cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; cellular response to vitamin D [GO:0071305]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion organization [GO:0007005]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526]
PGEN_.00g171100	Scaffold_08	7752971	7756988	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g171110	Scaffold_08	7757301	7758233	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g171120	Scaffold_08	7759134	7770919	D4GU72	AGL12_HALVD	Low-salt glycan biosynthesis protein Agl12 (EC 4.2.1.-)	GO:0006486; GO:0008460; GO:0009225; GO:0045232	"dTDP-glucose 4,6-dehydratase activity [GO:0008460]; nucleotide-sugar metabolic process [GO:0009225]; protein glycosylation [GO:0006486]; S-layer organization [GO:0045232]"
PGEN_.00g171130	Scaffold_08	7783578	7783883	NA	NA	NA	NA	NA
PGEN_.00g171140	Scaffold_08	7933689	7935674	NA	NA	NA	NA	NA
PGEN_.00g171150	Scaffold_08	7964600	7964902	NA	NA	NA	NA	NA
PGEN_.00g171160	Scaffold_08	7965273	7965494	NA	NA	NA	NA	NA
PGEN_.00g171170	Scaffold_08	8005768	8006049	NA	NA	NA	NA	NA
PGEN_.00g171180	Scaffold_08	8006128	8006412	P22304	IDS_HUMAN	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain]	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484; GO:0030207; GO:0043202	lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]
PGEN_.00g171190	Scaffold_08	8006484	8006897	Q08890	IDS_MOUSE	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase)	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484	lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]
PGEN_.00g171200	Scaffold_08	8009907	8024360	P17972	KCNAW_DROME	Potassium voltage-gated channel protein Shaw (Shaw2)	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]
PGEN_.00g171210	Scaffold_08	8035262	8035708	NA	NA	NA	NA	NA
PGEN_.00g171220	Scaffold_08	8036567	8037169	NA	NA	NA	NA	NA
PGEN_.00g171230	Scaffold_08	8037320	8038039	NA	NA	NA	NA	NA
PGEN_.00g171240	Scaffold_08	8038704	8039033	Q5VIY5	ZN468_HUMAN	Zinc finger protein 468	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g171250	Scaffold_08	8039239	8042861	P22373	DPOM_CLAPU	Probable DNA polymerase (EC 2.7.7.7)	GO:0000166; GO:0003677; GO:0003887; GO:0005739; GO:0006260	mitochondrion [GO:0005739]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]
PGEN_.00g171260	Scaffold_08	8096107	8096415	NA	NA	NA	NA	NA
PGEN_.00g171270	Scaffold_08	8096909	8097205	NA	NA	NA	NA	NA
PGEN_.00g171280	Scaffold_08	8100863	8105823	NA	NA	NA	NA	NA
PGEN_.00g171290	Scaffold_08	8105904	8189841	Q9Y4E6	WDR7_HUMAN	WD repeat-containing protein 7 (Rabconnectin-3 beta) (TGF-beta resistance-associated protein TRAG)	GO:0002244; GO:0008021	synaptic vesicle [GO:0008021]; hematopoietic progenitor cell differentiation [GO:0002244]
PGEN_.00g171300	Scaffold_08	8238840	8286550	Q80WQ2	VAC14_MOUSE	Protein VAC14 homolog	GO:0000306; GO:0005774; GO:0005783; GO:0005829; GO:0006661; GO:0006970; GO:0010008; GO:0019209; GO:0043231; GO:0070772	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; intracellular membrane-bounded organelle [GO:0043231]; PAS complex [GO:0070772]; vacuolar membrane [GO:0005774]; kinase activator activity [GO:0019209]; phosphatidylinositol biosynthetic process [GO:0006661]; response to osmotic stress [GO:0006970]
PGEN_.00g171310	Scaffold_08	8339965	8348444	O43312	MTSS1_HUMAN	Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein)	GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g171320	Scaffold_08	8369838	8370230	NA	NA	NA	NA	NA
PGEN_.00g171330	Scaffold_08	8391469	8391702	NA	NA	NA	NA	NA
PGEN_.00g171340	Scaffold_08	8392053	8447234	O43312	MTSS1_HUMAN	Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein)	GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g171350	Scaffold_08	8447286	8475295	Q8R1S4	MTSS1_MOUSE	Protein MTSS 1 (Metastasis suppressor protein 1) (Missing in metastasis protein)	GO:0001701; GO:0003779; GO:0003785; GO:0005102; GO:0005737; GO:0005912; GO:0007009; GO:0007015; GO:0007399; GO:0007517; GO:0010960; GO:0015629; GO:0030041; GO:0030282; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0051015; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:0072170; GO:2001013	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]
PGEN_.00g171360	Scaffold_08	8453611	8454285	NA	NA	NA	NA	NA
PGEN_.00g171370	Scaffold_08	8488255	8493791	NA	NA	NA	NA	NA
PGEN_.00g171380	Scaffold_08	8494200	8494565	NA	NA	NA	NA	NA
PGEN_.00g171390	Scaffold_08	8495334	8497270	NA	NA	NA	NA	NA
PGEN_.00g171400	Scaffold_08	8501539	8507340	Q9NUP1	BL1S4_HUMAN	Biogenesis of lysosome-related organelles complex 1 subunit 4 (BLOC-1 subunit 4) (Protein cappuccino homolog)	GO:0005737; GO:0005829; GO:0008089; GO:0031083; GO:0031175; GO:0032438; GO:0048490; GO:0050885; GO:0070527; GO:1904115	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; melanosome organization [GO:0032438]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; platelet aggregation [GO:0070527]
PGEN_.00g171410	Scaffold_08	8512736	8528390	P28572	SC6A9_RAT	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)	GO:0001504; GO:0005283; GO:0005328; GO:0005886; GO:0014069; GO:0015187; GO:0015816; GO:0030285; GO:0032279; GO:0061537; GO:0098686; GO:0098688; GO:0099055; GO:0099056	"asymmetric synapse [GO:0032279]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; amino acid:sodium symporter activity [GO:0005283]; glycine transmembrane transporter activity [GO:0015187]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine secretion, neurotransmission [GO:0061537]; glycine transport [GO:0015816]; neurotransmitter uptake [GO:0001504]"
PGEN_.00g171420	Scaffold_08	8528539	8529580	NA	NA	NA	NA	NA
PGEN_.00g171430	Scaffold_08	8530042	8530600	NA	NA	NA	NA	NA
PGEN_.00g171440	Scaffold_08	8559395	8561791	NA	NA	NA	NA	NA
PGEN_.00g171450	Scaffold_08	8562086	8588752	Q5U2U7	MCES_RAT	mRNA cap guanine-N7 methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7)-)-methyltransferase) (mRNA cap methyltransferase)	GO:0001650; GO:0003723; GO:0004482; GO:0005634; GO:0005654; GO:0005845; GO:0006370; GO:0031533; GO:0043235; GO:1990830	fibrillar center [GO:0001650]; mRNA cap binding complex [GO:0005845]; mRNA cap methyltransferase complex [GO:0031533]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; cellular response to leukemia inhibitory factor [GO:1990830]
PGEN_.00g171460	Scaffold_08	8598225	8617944	Q6DEY8	TBC31_XENTR	TBC1 domain family member 31 (WD repeat-containing protein 67)	GO:0005813	centrosome [GO:0005813]
PGEN_.00g171470	Scaffold_08	8621860	8622762	Q54F11	HBX3_DICDI	Homeobox protein 3 (DdHbx-3)	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g171480	Scaffold_08	8632210	8686144	Q6DDI6	TBC31_XENLA	TBC1 domain family member 31 (WD repeat-containing protein 67)		
PGEN_.00g171490	Scaffold_08	8698198	8698521	NA	NA	NA	NA	NA
PGEN_.00g171500	Scaffold_08	8706201	8706518	NA	NA	NA	NA	NA
PGEN_.00g171510	Scaffold_08	8719095	8725530	Q9BUN8	DERL1_HUMAN	Derlin-1 (Degradation in endoplasmic reticulum protein 1) (DERtrin-1) (Der1-like protein 1)	GO:0000839; GO:0002020; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0006457; GO:0006986; GO:0016020; GO:0016021; GO:0016032; GO:0016567; GO:0030176; GO:0030433; GO:0030968; GO:0030970; GO:0031398; GO:0031625; GO:0031648; GO:0032092; GO:0036502; GO:0036503; GO:0036513; GO:0038023; GO:0042288; GO:0042802; GO:0045184; GO:0051117; GO:0051787; GO:0055085; GO:0071712; GO:1990381	"Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; misfolded protein binding [GO:0051787]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein folding [GO:0006457]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]"
PGEN_.00g171520	Scaffold_08	8726631	8736822	Q5R9W3	DERL1_PONAB	Derlin-1 (Der1-like protein 1)	GO:0005789; GO:0006986; GO:0015031; GO:0016021; GO:0031648	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein destabilization [GO:0031648]; protein transport [GO:0015031]; response to unfolded protein [GO:0006986]
PGEN_.00g171530	Scaffold_08	8835332	8962704	O08654	CP070_RAT	UPF0183 protein C16orf70 homolog	GO:0005802; GO:0016020; GO:0030165; GO:0030425; GO:0030672; GO:0035254; GO:0043001	dendrite [GO:0030425]; membrane [GO:0016020]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; glutamate receptor binding [GO:0035254]; PDZ domain binding [GO:0030165]; Golgi to plasma membrane protein transport [GO:0043001]
PGEN_.00g171540	Scaffold_08	8985606	9007847	Q13951	PEBB_HUMAN	Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit)	GO:0000122; GO:0000209; GO:0000981; GO:0001649; GO:0001959; GO:0003677; GO:0003700; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006366; GO:0006367; GO:0016020; GO:0016513; GO:0030098; GO:0030099; GO:0030111; GO:0033146; GO:0043371; GO:0043378; GO:0043565; GO:0045589; GO:0045616; GO:0045637; GO:0045652; GO:0045944; GO:0048469; GO:0050855; GO:0060216; GO:1902036; GO:2000810	"core-binding factor complex [GO:0016513]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cell maturation [GO:0048469]; definitive hemopoiesis [GO:0060216]; lymphocyte differentiation [GO:0030098]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cytokine-mediated signaling pathway [GO:0001959]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of keratinocyte differentiation [GO:0045616]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of myeloid cell differentiation [GO:0045637]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of Wnt signaling pathway [GO:0030111]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g171550	Scaffold_08	9009646	9015963	B8I6E7	IF2_RUMCH	Translation initiation factor IF-2	GO:0003743; GO:0003924; GO:0005525; GO:0005737	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]
PGEN_.00g171560	Scaffold_08	9029793	9030221	NA	NA	NA	NA	NA
PGEN_.00g171570	Scaffold_08	9031322	9032104	NA	NA	NA	NA	NA
PGEN_.00g171580	Scaffold_08	9051106	9052664	NA	NA	NA	NA	NA
PGEN_.00g171590	Scaffold_08	9080836	9081138	NA	NA	NA	NA	NA
PGEN_.00g171600	Scaffold_08	9090229	9090456	NA	NA	NA	NA	NA
PGEN_.00g171610	Scaffold_08	9090625	9091341	NA	NA	NA	NA	NA
PGEN_.00g171620	Scaffold_08	9091374	9097060	NA	NA	NA	NA	NA
PGEN_.00g171630	Scaffold_08	9134530	9234155	O61585	KTNB1_STRPU	Katanin p80 WD40 repeat-containing subunit B1 (Katanin p80 subunit B1) (p80 katanin)	GO:0000922; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007049; GO:0008017; GO:0008352; GO:0051013; GO:0051301	centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule severing [GO:0051013]
PGEN_.00g171640	Scaffold_08	9273477	9299114	Q6P1X6	CH082_HUMAN	UPF0598 protein C8orf82		
PGEN_.00g171650	Scaffold_08	9299577	9350433	Q66IJ4	PIGM_XENTR	GPI mannosyltransferase 1 (EC 2.4.1.-) (GPI mannosyltransferase I) (GPI-MT-I) (Phosphatidylinositol-glycan biosynthesis class M protein) (PIG-M)	GO:0005789; GO:0006506; GO:0016021; GO:0016758	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transferase activity, transferring hexosyl groups [GO:0016758]; GPI anchor biosynthetic process [GO:0006506]"
PGEN_.00g171660	Scaffold_08	9359642	9362780	NA	NA	NA	NA	NA
PGEN_.00g171670	Scaffold_08	9367370	9375212	NA	NA	NA	NA	NA
PGEN_.00g171680	Scaffold_08	9392503	9398575	NA	NA	NA	NA	NA
PGEN_.00g171690	Scaffold_08	9399035	9399946	NA	NA	NA	NA	NA
PGEN_.00g171700	Scaffold_08	9416953	9419909	NA	NA	NA	NA	NA
PGEN_.00g171710	Scaffold_08	9446642	9446986	NA	NA	NA	NA	NA
PGEN_.00g171720	Scaffold_08	9488335	9489592	NA	NA	NA	NA	NA
PGEN_.00g171730	Scaffold_08	9498099	9499238	Q18321	DAF37_CAEEL	G-protein coupled receptor daf-37 (Abnormal dauer formation protein 37)	GO:0005794; GO:0005886; GO:0008528; GO:0016021; GO:0042803; GO:0046982; GO:0097730; GO:1904066; GO:1904067; GO:1904068	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ascr#2 binding [GO:1904067]; G protein-coupled peptide receptor activity [GO:0008528]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; G protein-coupled receptor signaling pathway involved in dauer larval development [GO:1904066]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]
PGEN_.00g171740	Scaffold_08	9527991	9534985	Q6DJ25	MED10_XENTR	Mediator of RNA polymerase II transcription subunit 10 (Mediator complex subunit 10)	GO:0003712; GO:0005634; GO:0016592; GO:0036302; GO:0045944; GO:1905072	mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; atrioventricular canal development [GO:0036302]; cardiac jelly development [GO:1905072]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g171750	Scaffold_08	9550878	9561847	Q9BYG5	PAR6B_HUMAN	Partitioning defective 6 homolog beta (PAR-6 beta) (PAR-6B)	GO:0005080; GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007043; GO:0007098; GO:0007163; GO:0007409; GO:0016324; GO:0017048; GO:0030334; GO:0032991; GO:0051301; GO:0060341; GO:0065003; GO:0070062; GO:0070830	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell division [GO:0051301]; cell-cell junction assembly [GO:0007043]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cell migration [GO:0030334]; regulation of cellular localization [GO:0060341]
PGEN_.00g171760	Scaffold_08	9562221	9617008	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g171770	Scaffold_08	9651426	9664838	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g171780	Scaffold_08	9763601	9786077	P97363	SPTC2_MOUSE	Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)	GO:0004758; GO:0005739; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]
PGEN_.00g171790	Scaffold_08	9790022	9790303	NA	NA	NA	NA	NA
PGEN_.00g171800	Scaffold_08	9795069	9798357	P82916	RT17_BOVIN	"28S ribosomal protein S17, mitochondrial (MRP-S17) (S17mt)"	GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0019843	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g171810	Scaffold_08	9890934	9895308	NA	NA	NA	NA	NA
PGEN_.00g171820	Scaffold_08	9895631	9896083	NA	NA	NA	NA	NA
PGEN_.00g171830	Scaffold_08	9896681	9902179	NA	NA	NA	NA	NA
PGEN_.00g171840	Scaffold_08	9935561	9935821	NA	NA	NA	NA	NA
PGEN_.00g171850	Scaffold_08	9948288	9948578	NA	NA	NA	NA	NA
PGEN_.00g171860	Scaffold_08	10085491	10085748	NA	NA	NA	NA	NA
PGEN_.00g171870	Scaffold_08	10129994	10169804	Q13507	TRPC3_HUMAN	Short transient receptor potential channel 3 (TrpC3) (Transient receptor protein 3) (TRP-3) (hTrp-3) (hTrp3)	GO:0005262; GO:0005623; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007338; GO:0007602; GO:0010524; GO:0015279; GO:0030168; GO:0033198; GO:0034703; GO:0051480; GO:0051592; GO:0070588; GO:0070679; GO:1903244	"cation channel complex [GO:0034703]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; platelet activation [GO:0030168]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]"
PGEN_.00g171880	Scaffold_08	10195695	10196051	NA	NA	NA	NA	NA
PGEN_.00g171890	Scaffold_08	10244630	10255739	NA	NA	NA	NA	NA
PGEN_.00g171900	Scaffold_08	10266301	10291594	P86952	TYRO_PINMA	Tyrosinase-like protein (Tyrosinase-2)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g171910	Scaffold_08	10295278	10297334	NA	NA	NA	NA	NA
PGEN_.00g171920	Scaffold_08	10310313	10311025	NA	NA	NA	NA	NA
PGEN_.00g171930	Scaffold_08	10424277	10430119	Q9NX74	DUS2L_HUMAN	tRNA-dihydrouridine(20) synthase [NAD(P)+]-like (EC 1.3.1.91) (Dihydrouridine synthase 2) (Up-regulated in lung cancer protein 8) (URLC8) (tRNA-dihydrouridine synthase 2-like) (hDUS2)	GO:0002943; GO:0003725; GO:0004860; GO:0005783; GO:0005829; GO:0010181; GO:0017150; GO:0050660; GO:0060548; GO:0070402; GO:0102264	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine20 synthase activity [GO:0102264]; negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943]
PGEN_.00g171940	Scaffold_08	10432470	10439776	NA	NA	NA	NA	NA
PGEN_.00g171950	Scaffold_08	10454916	10455125	NA	NA	NA	NA	NA
PGEN_.00g171960	Scaffold_08	10461514	10524640	Q61329	ZFHX3_MOUSE	Zinc finger homeobox protein 3 (AT motif-binding factor 1) (AT-binding transcription factor 1) (Alpha-fetoprotein enhancer-binding protein) (Zinc finger homeodomain protein 3) (ZFH-3)	GO:0000122; GO:0000978; GO:0005634; GO:0005667; GO:0005737; GO:0005739; GO:0007420; GO:0007517; GO:0008270; GO:0016604; GO:0019899; GO:0032922; GO:0044212; GO:0045662; GO:0045663; GO:0045664; GO:0045785; GO:0045892; GO:0045893; GO:0045944; GO:0071559; GO:1904059	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; response to transforming growth factor beta [GO:0071559]"
PGEN_.00g171970	Scaffold_08	10510511	10510717	NA	NA	NA	NA	NA
PGEN_.00g171980	Scaffold_08	10601447	10601962	NA	NA	NA	NA	NA
PGEN_.00g171990	Scaffold_08	10616839	10617468	Q95WA4	SWP2_ENCIN	Spore wall protein 2	GO:0030435; GO:0031160	spore wall [GO:0031160]; sporulation resulting in formation of a cellular spore [GO:0030435]
PGEN_.00g172000	Scaffold_08	10617737	10618093	NA	NA	NA	NA	NA
PGEN_.00g172010	Scaffold_08	10623081	10625617	NA	NA	NA	NA	NA
PGEN_.00g172020	Scaffold_08	10653816	10654109	NA	NA	NA	NA	NA
PGEN_.00g172030	Scaffold_08	10686163	10686615	NA	NA	NA	NA	NA
PGEN_.00g172040	Scaffold_08	10766809	10772123	NA	NA	NA	NA	NA
PGEN_.00g172050	Scaffold_08	10772323	10775583	Q8CGV7	THTPA_RAT	Thiamine-triphosphatase (ThTPase) (EC 3.6.1.28)	GO:0000287; GO:0005737; GO:0006772; GO:0016311; GO:0042357; GO:0050333	cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333]; dephosphorylation [GO:0016311]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772]
PGEN_.00g172060	Scaffold_08	10789378	10789662	NA	NA	NA	NA	NA
PGEN_.00g172070	Scaffold_08	10839329	10875700	Q8C0M0	WDR59_MOUSE	GATOR complex protein WDR59 (CUL4- and DDB1-associated WDR protein 12) (WD repeat-containing protein 59)	GO:0005765; GO:0032008; GO:0034198; GO:0061700	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]
PGEN_.00g172080	Scaffold_08	10893401	10897688	O00522	KRIT1_HUMAN	Krev interaction trapped protein 1 (Krev interaction trapped 1) (Cerebral cavernous malformations 1 protein)	GO:0001525; GO:0001937; GO:0005546; GO:0005615; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0007264; GO:0008017; GO:0010596; GO:0016525; GO:0030695; GO:0045454; GO:2000114; GO:2000352	"cell [GO:0005623]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; angiogenesis [GO:0001525]; cell redox homeostasis [GO:0045454]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; regulation of establishment of cell polarity [GO:2000114]; small GTPase mediated signal transduction [GO:0007264]"
PGEN_.00g172090	Scaffold_08	10924887	10929979	Q13263	TIF1B_HUMAN	Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28)	GO:0000122; GO:0000785; GO:0001837; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005719; GO:0005720; GO:0006281; GO:0006325; GO:0006367; GO:0007265; GO:0007566; GO:0008270; GO:0016032; GO:0016925; GO:0019789; GO:0031625; GO:0035851; GO:0042307; GO:0043045; GO:0043388; GO:0043565; GO:0045087; GO:0045739; GO:0045869; GO:0045892; GO:0045893; GO:0046777; GO:0051259; GO:0060028; GO:0060669; GO:0070087; GO:0090309; GO:0090575; GO:1901536; GO:1902187; GO:1990841; GO:2000653	"chromatin [GO:0000785]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation involved in embryo development [GO:0043045]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; innate immune response [GO:0045087]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral release from host cell [GO:1902187]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA repair [GO:0045739]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; protein sumoylation [GO:0016925]; Ras protein signal transduction [GO:0007265]; regulation of genetic imprinting [GO:2000653]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]"
PGEN_.00g172100	Scaffold_08	10936323	10937333	NA	NA	NA	NA	NA
PGEN_.00g172110	Scaffold_08	10937785	10939536	NA	NA	NA	NA	NA
PGEN_.00g172120	Scaffold_08	10940882	10942825	NA	NA	NA	NA	NA
PGEN_.00g172130	Scaffold_08	10991044	11004293	P51877	GNAO_PLATR	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0003924; GO:0005525; GO:0007188; GO:0031683; GO:0046872	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]
PGEN_.00g172140	Scaffold_08	11034133	11035989	P91924	ARF_DUGJA	ADP-ribosylation factor	GO:0005525; GO:0005794; GO:0015031; GO:0016192	Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g172150	Scaffold_08	11037192	11037581	NA	NA	NA	NA	NA
PGEN_.00g172160	Scaffold_08	11062581	11117360	Q05187	TGMH_TACTR	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)	GO:0003810; GO:0016020; GO:0018149; GO:0046872	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]
PGEN_.00g172170	Scaffold_08	11146741	11147079	NA	NA	NA	NA	NA
PGEN_.00g172180	Scaffold_08	11165500	11177551	NA	NA	NA	NA	NA
PGEN_.00g172190	Scaffold_08	11178596	11201609	Q05187	TGMH_TACTR	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)	GO:0003810; GO:0016020; GO:0018149; GO:0046872	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]
PGEN_.00g172200	Scaffold_08	11209251	11209598	NA	NA	NA	NA	NA
PGEN_.00g172210	Scaffold_08	11209785	11212542	NA	NA	NA	NA	NA
PGEN_.00g172220	Scaffold_08	11246975	11286797	P52183	ANNU_SCHAM	Annulin (Protein-glutamine gamma-glutamyltransferase) (EC 2.3.2.13) (Transglutaminase)	GO:0003810; GO:0005886; GO:0018149; GO:0046872	plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]
PGEN_.00g172230	Scaffold_08	11297155	11316542	O34363	YOBN_BACSU	Putative L-amino-acid oxidase YobN (EC 1.4.3.2)	GO:0001716; GO:0009063; GO:0016491	L-amino-acid oxidase activity [GO:0001716]; oxidoreductase activity [GO:0016491]; cellular amino acid catabolic process [GO:0009063]
PGEN_.00g172240	Scaffold_08	11316573	11317358	NA	NA	NA	NA	NA
PGEN_.00g172250	Scaffold_08	11320536	11330674	NA	NA	NA	NA	NA
PGEN_.00g172260	Scaffold_08	11361918	11369940	Q05187	TGMH_TACTR	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)	GO:0003810; GO:0016020; GO:0018149; GO:0046872	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]
PGEN_.00g172270	Scaffold_08	11386479	11400352	O35298	AOAH_MOUSE	Acyloxyacyl hydrolase (EC 3.1.1.77) [Cleaved into: Acyloxyacyl hydrolase small subunit; Acyloxyacyl hydrolase large subunit]	GO:0005509; GO:0005576; GO:0006631; GO:0008653; GO:0009104; GO:0031410; GO:0050528; GO:0050728	cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509]; fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]; lipopolysaccharide metabolic process [GO:0008653]; negative regulation of inflammatory response [GO:0050728]
PGEN_.00g172280	Scaffold_08	11408711	11408983	NA	NA	NA	NA	NA
PGEN_.00g172290	Scaffold_08	11432413	11470185	Q8K298	ANLN_MOUSE	Anillin	GO:0000281; GO:0000915; GO:0002244; GO:0003779; GO:0005654; GO:0005826; GO:0015629; GO:0017049; GO:0030496; GO:0030865; GO:0031106; GO:0032059; GO:0090521; GO:0099738; GO:1904172; GO:1904498	actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex region [GO:0099738]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; GTP-Rho binding [GO:0017049]; actomyosin contractile ring assembly [GO:0000915]; cortical cytoskeleton organization [GO:0030865]; glomerular visceral epithelial cell migration [GO:0090521]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; protein localization to mitotic actomyosin contractile ring [GO:1904498]; septin ring organization [GO:0031106]
PGEN_.00g172300	Scaffold_08	11480840	11481155	NA	NA	NA	NA	NA
PGEN_.00g172310	Scaffold_08	11484489	11505925	Q921F2	TADBP_MOUSE	TAR DNA-binding protein 43 (TDP-43)	GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0010467; GO:0010494; GO:0010629; GO:0031647; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043565; GO:0043922; GO:0048511; GO:0051726; GO:0070935; GO:0071765; GO:0097157; GO:1990837; GO:1990904	cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; gene expression [GO:0010467]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]
PGEN_.00g172320	Scaffold_08	11511844	11535798	Q9HCD5	NCOA5_HUMAN	Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA)	GO:0003682; GO:0003723; GO:0005615; GO:0005654; GO:0015629; GO:0042593; GO:0046627	actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627]
PGEN_.00g172330	Scaffold_08	11541145	11541591	NA	NA	NA	NA	NA
PGEN_.00g172340	Scaffold_08	11543666	11557442	Q5M8F7	NEPR1_XENTR	Nuclear envelope phosphatase-regulatory subunit 1 (Transmembrane protein 188)	GO:0005737; GO:0006629; GO:0010867; GO:0016021; GO:0031965; GO:0035307; GO:0071595	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear membrane [GO:0031965]; lipid metabolic process [GO:0006629]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of triglyceride biosynthetic process [GO:0010867]
PGEN_.00g172350	Scaffold_08	11565073	11566677	NA	NA	NA	NA	NA
PGEN_.00g172360	Scaffold_08	11594453	11662950	P59114	CAPAM_MOUSE	mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (EC 2.1.1.62) (Cap-specific adenosine methyltransferase) (CAPAM) (Phosphorylated CTD-interacting factor 1)	GO:0005634; GO:0005654; GO:0010923; GO:0015630; GO:0016422; GO:0017148; GO:0045171; GO:0045727; GO:0080009; GO:0099122; GO:1904047	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]
PGEN_.00g172370	Scaffold_08	11677091	11679759	NA	NA	NA	NA	NA
PGEN_.00g172380	Scaffold_08	11684465	11694241	Q86V88	MGDP1_HUMAN	Magnesium-dependent phosphatase 1 (MDP-1) (EC 3.1.3.-) (EC 3.1.3.48)	GO:0003993; GO:0004725; GO:0046872	acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]
PGEN_.00g172390	Scaffold_08	11694329	11694706	NA	NA	NA	NA	NA
PGEN_.00g172400	Scaffold_08	11694973	11695281	NA	NA	NA	NA	NA
PGEN_.00g172410	Scaffold_08	11727212	11727892	Q3U145	TMM64_MOUSE	Transmembrane protein 64	GO:0005623; GO:0005783; GO:0016021; GO:0043462; GO:0045600; GO:0045668; GO:0045672; GO:0045780; GO:0051480; GO:0090090	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of bone resorption [GO:0045780]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoclast differentiation [GO:0045672]; regulation of ATPase activity [GO:0043462]; regulation of cytosolic calcium ion concentration [GO:0051480]
PGEN_.00g172420	Scaffold_08	11728278	11743207	NA	NA	NA	NA	NA
PGEN_.00g172430	Scaffold_08	11753443	11757973	P18142	D2_DICDI	cAMP-regulated D2 protein	GO:0005938; GO:0033118; GO:0052689	cell cortex [GO:0005938]; esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689]
PGEN_.00g172440	Scaffold_08	11767203	11767457	NA	NA	NA	NA	NA
PGEN_.00g172450	Scaffold_08	11870669	11886152	Q7ZVA0	SMU1_DANRE	WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog)	GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"
PGEN_.00g172460	Scaffold_08	11901250	11902055	NA	NA	NA	NA	NA
PGEN_.00g172470	Scaffold_08	11913420	11915597	NA	NA	NA	NA	NA
PGEN_.00g172480	Scaffold_08	11921598	11922128	NA	NA	NA	NA	NA
PGEN_.00g172490	Scaffold_08	11929199	11929804	NA	NA	NA	NA	NA
PGEN_.00g172500	Scaffold_08	11940017	11942367	NA	NA	NA	NA	NA
PGEN_.00g172510	Scaffold_08	11950085	11950330	NA	NA	NA	NA	NA
PGEN_.00g172520	Scaffold_08	11969046	11992466	Q9BRR8	GPTC1_HUMAN	G patch domain-containing protein 1 (Evolutionarily conserved G-patch domain-containing protein)	GO:0000398; GO:0003723; GO:0005634; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g172530	Scaffold_08	11998483	12009103	O75506	HSBP1_HUMAN	Heat shock factor-binding protein 1 (Nasopharyngeal carcinoma-associated antigen 13) (NPC-A-13)	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006936; GO:0035987; GO:0042802; GO:0070370; GO:1900034	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; cellular heat acclimation [GO:0070370]; endodermal cell differentiation [GO:0035987]; muscle contraction [GO:0006936]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cellular response to heat [GO:1900034]
PGEN_.00g172540	Scaffold_08	12029846	12030091	NA	NA	NA	NA	NA
PGEN_.00g172550	Scaffold_08	12052947	12085632	NA	NA	NA	NA	NA
PGEN_.00g172560	Scaffold_08	12093378	12110320	P97608	OPLA_RAT	5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)	GO:0005524; GO:0005829; GO:0006749; GO:0017168	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione metabolic process [GO:0006749]
PGEN_.00g172570	Scaffold_08	12215140	12268714	Q8TDF5	NETO1_HUMAN	Neuropilin and tolloid-like protein 1 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1)	GO:0005576; GO:0007613; GO:0008542; GO:0014069; GO:0030054; GO:0035255; GO:0048169; GO:0060076; GO:0097120; GO:0098839; GO:0098978; GO:0099061; GO:2000312; GO:2000463	cell junction [GO:0030054]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; ionotropic glutamate receptor binding [GO:0035255]; memory [GO:0007613]; positive regulation of excitatory postsynaptic potential [GO:2000463]; receptor localization to synapse [GO:0097120]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; visual learning [GO:0008542]
PGEN_.00g172580	Scaffold_08	12277854	12278396	NA	NA	NA	NA	NA
PGEN_.00g172590	Scaffold_08	12283207	12283686	NA	NA	NA	NA	NA
PGEN_.00g172600	Scaffold_08	12283810	12284379	NA	NA	NA	NA	NA
PGEN_.00g172610	Scaffold_08	12289074	12304519	NA	NA	NA	NA	NA
PGEN_.00g172620	Scaffold_08	12325839	12347296	Q9QXA6	BAT1_MOUSE	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016021; GO:0016324; GO:0031526; GO:0042605	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]
PGEN_.00g172630	Scaffold_08	12390638	12402361	NA	NA	NA	NA	NA
PGEN_.00g172640	Scaffold_08	12534666	12538569	NA	NA	NA	NA	NA
PGEN_.00g172650	Scaffold_08	12546921	12578252	P37153	APOD_RABIT	Apolipoprotein D (Apo-D) (ApoD)	GO:0000302; GO:0005615; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405	cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]
PGEN_.00g172660	Scaffold_08	12586531	12588778	P85315	BURS_CULPP	Bursicon (Bursicon subunit alpha)	GO:0005179; GO:0005576; GO:0007593; GO:0048067	extracellular region [GO:0005576]; hormone activity [GO:0005179]; chitin-based cuticle sclerotization [GO:0007593]; cuticle pigmentation [GO:0048067]
PGEN_.00g172670	Scaffold_08	12596231	12596530	NA	NA	NA	NA	NA
PGEN_.00g172680	Scaffold_08	12596632	12596985	NA	NA	NA	NA	NA
PGEN_.00g172690	Scaffold_08	12608436	12632909	Q7M456	RNOY_CRAGI	Ribonuclease Oy (RNase Oy) (EC 3.1.27.-)	GO:0003723; GO:0005576; GO:0033897	extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]
PGEN_.00g172700	Scaffold_08	12669917	12738381	Q8TE60	ATS18_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-)	GO:0001654; GO:0004222; GO:0005576; GO:0046872; GO:0090331	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]
PGEN_.00g172710	Scaffold_08	12766896	12775367	Q5RAA9	NPS3A_PONAB	Protein NipSnap homolog 3A (NipSnap3A)	GO:0005829	cytosol [GO:0005829]
PGEN_.00g172720	Scaffold_08	12782467	12782766	NA	NA	NA	NA	NA
PGEN_.00g172730	Scaffold_08	12783560	12785621	NA	NA	NA	NA	NA
PGEN_.00g172740	Scaffold_08	12791902	12823569	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g172750	Scaffold_08	12845393	12959964	Q8TE60	ATS18_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-)	GO:0001654; GO:0004222; GO:0005576; GO:0046872; GO:0090331	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]
PGEN_.00g172760	Scaffold_08	12966772	12967233	NA	NA	NA	NA	NA
PGEN_.00g172770	Scaffold_08	13002423	13002832	NA	NA	NA	NA	NA
PGEN_.00g172780	Scaffold_08	13002883	13003242	NA	NA	NA	NA	NA
PGEN_.00g172790	Scaffold_08	13004227	13025548	NA	NA	NA	NA	NA
PGEN_.00g172800	Scaffold_08	13047257	13047990	NA	NA	NA	NA	NA
PGEN_.00g172810	Scaffold_08	13048029	13048322	NA	NA	NA	NA	NA
PGEN_.00g172820	Scaffold_08	13048413	13049271	NA	NA	NA	NA	NA
PGEN_.00g172830	Scaffold_08	13049372	13049857	NA	NA	NA	NA	NA
PGEN_.00g172840	Scaffold_08	13056275	13145275	Q5VZK9	CARL1_HUMAN	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	GO:0005654; GO:0005829; GO:0005886; GO:0007015; GO:0007596; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813	cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]
PGEN_.00g172850	Scaffold_08	13164564	13191067	NA	NA	NA	NA	NA
PGEN_.00g172860	Scaffold_08	13202403	13214478	NA	NA	NA	NA	NA
PGEN_.00g172870	Scaffold_08	13227270	13227638	P79761	CP1A5_CHICK	Cytochrome P450 1A5 (EC 1.14.14.1) (CYPIA5) (Cytochrome P450 TCDDAA)	GO:0004497; GO:0005506; GO:0005623; GO:0005789; GO:0017144; GO:0019825; GO:0020037; GO:0043231; GO:0043385; GO:0046677; GO:0070330; GO:0070989; GO:0071615	cell [GO:0005623]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; drug metabolic process [GO:0017144]; mycotoxin metabolic process [GO:0043385]; oxidative deethylation [GO:0071615]; oxidative demethylation [GO:0070989]; response to antibiotic [GO:0046677]
PGEN_.00g172880	Scaffold_08	13263915	13277005	P51871	CP4F6_RAT	Cytochrome P450 4F6 (EC 1.14.14.1) (CYPIVF6)	GO:0005506; GO:0005789; GO:0006691; GO:0006954; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; inflammatory response [GO:0006954]; leukotriene metabolic process [GO:0006691]
PGEN_.00g172890	Scaffold_08	13287092	13304465	NA	NA	NA	NA	NA
PGEN_.00g172900	Scaffold_08	13336825	13343692	NA	NA	NA	NA	NA
PGEN_.00g172910	Scaffold_08	13367143	13374880	NA	NA	NA	NA	NA
PGEN_.00g172920	Scaffold_08	13486935	13500494	NA	NA	NA	NA	NA
PGEN_.00g172930	Scaffold_08	13530187	13530930	NA	NA	NA	NA	NA
PGEN_.00g172940	Scaffold_08	13539967	13540338	NA	NA	NA	NA	NA
PGEN_.00g172950	Scaffold_08	13550385	13553621	P51909	APOD_CAVPO	Apolipoprotein D (Apo-D) (ApoD)	GO:0000302; GO:0005615; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405	cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]
PGEN_.00g172960	Scaffold_08	13555522	13557657	P05090	APOD_HUMAN	Apolipoprotein D (Apo-D) (ApoD)	GO:0000302; GO:0001525; GO:0005319; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0070062; GO:0071638; GO:1900016; GO:2000098; GO:2000405	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]
PGEN_.00g172970	Scaffold_08	13562665	13565438	Q32KY0	APOD_BOVIN	Apolipoprotein D (Apo-D) (ApoD)	GO:0000302; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]
PGEN_.00g172980	Scaffold_08	13571246	13593743	P31228	OXDD_BOVIN	D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1)	GO:0005777; GO:0006531; GO:0006533; GO:0008445; GO:0046416; GO:0071949	peroxisome [GO:0005777]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid metabolic process [GO:0046416]
PGEN_.00g172990	Scaffold_08	13612656	13639771	C0HL13	LRP2_PIG	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	GO:0001702; GO:0001843; GO:0002076; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005886; GO:0005905; GO:0006898; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0009952; GO:0016021; GO:0016324; GO:0017124; GO:0017147; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0042632; GO:0042813; GO:0043235; GO:0045944; GO:0046849; GO:0048539; GO:0050769; GO:0051087; GO:0060068; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060982; GO:0061156; GO:0061178; GO:0061304; GO:0070447; GO:0140058; GO:1904447; GO:1905167	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; SH3 domain binding [GO:0017124]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; gastrulation with mouth forming second [GO:0001702]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; osteoblast development [GO:0002076]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retinal blood vessel morphogenesis [GO:0061304]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]
PGEN_.00g173000	Scaffold_08	13643713	13651877	NA	NA	NA	NA	NA
PGEN_.00g173010	Scaffold_08	13665225	13687105	Q6NRS2	S66A2_XENLA	Solute carrier family 66 member 2 (PQ-loop repeat-containing protein 1)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g173020	Scaffold_08	13693541	13693795	NA	NA	NA	NA	NA
PGEN_.00g173030	Scaffold_08	13704159	13726943	P76482	YFBL_ECOLI	Uncharacterized protein YfbL	GO:0004177; GO:0006508; GO:0016021	integral component of membrane [GO:0016021]; aminopeptidase activity [GO:0004177]; proteolysis [GO:0006508]
PGEN_.00g173040	Scaffold_08	13754696	13787220	Q8BG18	NECA1_MOUSE	N-terminal EF-hand calcium-binding protein 1 (EF-hand calcium-binding protein 1)	GO:0001835; GO:0005509; GO:0005654; GO:0005737; GO:0005829; GO:0042984	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984]
PGEN_.00g173050	Scaffold_08	13808639	13822882	Q5T089	MORN1_HUMAN	MORN repeat-containing protein 1		
PGEN_.00g173060	Scaffold_08	13832725	13866812	NA	NA	NA	NA	NA
PGEN_.00g173070	Scaffold_08	13877317	13894977	Q15306	IRF4_HUMAN	Interferon regulatory factor 4 (IRF-4) (Lymphocyte-specific interferon regulatory factor) (LSIRF) (Multiple myeloma oncogene 1) (NF-EM5)	GO:0000788; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0008134; GO:0016020; GO:0019221; GO:0034122; GO:0042110; GO:0042832; GO:0043011; GO:0043388; GO:0043565; GO:0043966; GO:0043967; GO:0045082; GO:0045086; GO:0045368; GO:0045404; GO:0045622; GO:0045893; GO:0045944; GO:0060333; GO:0060337; GO:0072540; GO:0120162	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nuclear nucleosome [GO:0000788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; immune system process [GO:0002376]; interferon-gamma-mediated signaling pathway [GO:0060333]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA binding [GO:0043388]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of interleukin-13 biosynthetic process [GO:0045368]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of interleukin-4 biosynthetic process [GO:0045404]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of T-helper cell differentiation [GO:0045622]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540]; type I interferon signaling pathway [GO:0060337]"
PGEN_.00g173080	Scaffold_08	13906333	13970589	Q91VN0	LRP5_MOUSE	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009314; GO:0009952; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060764; GO:0061178; GO:0061299; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1902262	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]"
PGEN_.00g173090	Scaffold_08	14049309	14055327	P55088	AQP4_MOUSE	Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4)	GO:0005576; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006833; GO:0007605; GO:0009897; GO:0009925; GO:0009992; GO:0010008; GO:0010574; GO:0015250; GO:0015288; GO:0015670; GO:0016020; GO:0016021; GO:0016323; GO:0030104; GO:0030315; GO:0031253; GO:0032691; GO:0032715; GO:0032991; GO:0042383; GO:0042802; GO:0051289; GO:0060354; GO:0070295; GO:0071333; GO:0071346; GO:0090660; GO:0097450; GO:0098609	astrocyte end-foot [GO:0097450]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; identical protein binding [GO:0042802]; porin activity [GO:0015288]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to glucose stimulus [GO:0071333]; cellular response to interferon-gamma [GO:0071346]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid circulation [GO:0090660]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water absorption [GO:0070295]; sensory perception of sound [GO:0007605]; water homeostasis [GO:0030104]; water transport [GO:0006833]
PGEN_.00g173100	Scaffold_08	14081252	14081584	NA	NA	NA	NA	NA
PGEN_.00g173110	Scaffold_08	14094283	14104045	NA	NA	NA	NA	NA
PGEN_.00g173120	Scaffold_08	14122093	14123130	Q9H2A9	CHST8_HUMAN	Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1)	GO:0000139; GO:0001537; GO:0006790; GO:0007417; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0042446	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g173130	Scaffold_08	14137852	14142207	Q9YH64	CP1A1_PLAFE	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g173140	Scaffold_08	14146033	14159517	Q8N0N3	BGBP_PENMO	"Beta-1,3-glucan-binding protein (GBP)"	GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087	"extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]"
PGEN_.00g173150	Scaffold_08	14196292	14207757	NA	NA	NA	NA	NA
PGEN_.00g173160	Scaffold_08	14245661	14245933	NA	NA	NA	NA	NA
PGEN_.00g173170	Scaffold_08	14250731	14265345	NA	NA	NA	NA	NA
PGEN_.00g173180	Scaffold_08	14275648	14276720	NA	NA	NA	NA	NA
PGEN_.00g173190	Scaffold_08	14281072	14281371	NA	NA	NA	NA	NA
PGEN_.00g173200	Scaffold_08	14281549	14285017	NA	NA	NA	NA	NA
PGEN_.00g173210	Scaffold_08	14297590	14298600	P35412	GPR12_MOUSE	G-protein coupled receptor 12 (GPCR01)	GO:0004930; GO:0005623; GO:0005886; GO:0006874; GO:0007186; GO:0016021; GO:0031210	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210]; cellular calcium ion homeostasis [GO:0006874]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g173220	Scaffold_08	14303641	14315034	NA	NA	NA	NA	NA
PGEN_.00g173230	Scaffold_08	14322432	14325365	NA	NA	NA	NA	NA
PGEN_.00g173240	Scaffold_08	14327901	14335218	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g173250	Scaffold_08	14353462	14364211	NA	NA	NA	NA	NA
PGEN_.00g173260	Scaffold_08	14367351	14367794	NA	NA	NA	NA	NA
PGEN_.00g173270	Scaffold_08	14372467	14404485	NA	NA	NA	NA	NA
PGEN_.00g173280	Scaffold_08	14409660	14409896	NA	NA	NA	NA	NA
PGEN_.00g173290	Scaffold_08	14416697	14425857	Q28062	PGCB_BOVIN	Brevican core protein	GO:0001501; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g173300	Scaffold_08	14428460	14429971	P15305	DYHC_ONCMY	Dynein heavy chain (DYHC) (Fragment)	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0031514	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; motor activity [GO:0003774]
PGEN_.00g173310	Scaffold_08	14435705	14442257	NA	NA	NA	NA	NA
PGEN_.00g173320	Scaffold_08	14474571	14477818	NA	NA	NA	NA	NA
PGEN_.00g173330	Scaffold_08	14477841	14486199	P00423	COX41_BOVIN	"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1) (COX IV-1)"	GO:0004129; GO:0005654; GO:0005751; GO:0005829; GO:0006123; GO:0016021; GO:0045277	"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; nucleoplasm [GO:0005654]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"
PGEN_.00g173340	Scaffold_08	14503848	14515434	NA	NA	NA	NA	NA
PGEN_.00g173350	Scaffold_08	14542454	14559095	Q80T79	CSMD3_MOUSE	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g173360	Scaffold_08	14667857	14668718	NA	NA	NA	NA	NA
PGEN_.00g173370	Scaffold_08	14673380	14680036	NA	NA	NA	NA	NA
PGEN_.00g173380	Scaffold_08	14696026	14701550	Q6NSJ0	MYORG_HUMAN	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161)	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"
PGEN_.00g173390	Scaffold_08	14701626	14709599	NA	NA	NA	NA	NA
PGEN_.00g173400	Scaffold_08	14712780	14777742	Q8IY22	CMIP_HUMAN	C-Maf-inducing protein (c-Mip) (Truncated c-Maf-inducing protein) (Tc-Mip)	GO:0001701; GO:0005654; GO:0005829	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; in utero embryonic development [GO:0001701]
PGEN_.00g173410	Scaffold_08	14806836	14855137	Q9MYW0	TRPC6_BOVIN	Short transient receptor potential channel 6 (TrpC6)	GO:0005261; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006828; GO:0007204; GO:0007338; GO:0015279; GO:0032414; GO:0034703; GO:0036057; GO:0042803; GO:0051480; GO:0051928; GO:0070588; GO:0070679	"cation channel complex [GO:0034703]; cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ion transmembrane transporter activity [GO:0032414]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]"
PGEN_.00g173420	Scaffold_08	14857430	14857768	NA	NA	NA	NA	NA
PGEN_.00g173430	Scaffold_08	14910917	14912099	NA	NA	NA	NA	NA
PGEN_.00g173440	Scaffold_08	14972196	14975684	NA	NA	NA	NA	NA
PGEN_.00g173450	Scaffold_08	14989700	14991535	NA	NA	NA	NA	NA
PGEN_.00g173460	Scaffold_08	15024610	15029864	O88667	RAD_MOUSE	GTP-binding protein RAD	GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0030308; GO:1901842	plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]
PGEN_.00g173470	Scaffold_08	15084085	15084708	NA	NA	NA	NA	NA
PGEN_.00g173480	Scaffold_08	15099216	15099839	NA	NA	NA	NA	NA
PGEN_.00g173490	Scaffold_08	15170500	15207568	Q9Y2L5	TPPC8_HUMAN	Trafficking protein particle complex subunit 8 (Protein TRS85 homolog)	GO:0000045; GO:0000407; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0030242; GO:0031410; GO:0032258; GO:0034497; GO:1990072	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; cytoplasm to vacuole transport by the Cvt pathway [GO:0032258]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization to phagophore assembly site [GO:0034497]
PGEN_.00g173500	Scaffold_08	15214889	15222837	P60521	GBRL2_MOUSE	Gamma-aminobutyric acid receptor-associated protein-like 2 (GABA(A) receptor-associated protein-like 2) (Golgi-associated ATPase enhancer of 16 kDa) (GATE-16)	GO:0000045; GO:0000139; GO:0000421; GO:0000422; GO:0005737; GO:0005776; GO:0005794; GO:0005829; GO:0006891; GO:0006995; GO:0008017; GO:0015031; GO:0016236; GO:0031410; GO:0031625; GO:0097352; GO:1901799	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; intra-Golgi vesicle-mediated transport [GO:0006891]; macroautophagy [GO:0016236]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein transport [GO:0015031]
PGEN_.00g173510	Scaffold_08	15227577	15236438	O88204	LRP3_RAT	Low-density lipoprotein receptor-related protein 3 (LRP-3) (105 kDa low-density lipoprotein receptor-related protein) (rLRp105)	GO:0005905; GO:0006897; GO:0016021	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; endocytosis [GO:0006897]
PGEN_.00g173520	Scaffold_08	15243740	15244405	NA	NA	NA	NA	NA
PGEN_.00g173530	Scaffold_08	15274504	15278062	NA	NA	NA	NA	NA
PGEN_.00g173540	Scaffold_08	15291321	15330303	O55192	SC6A2_MOUSE	Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2)	GO:0003779; GO:0005328; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0006836; GO:0008504; GO:0009986; GO:0015844; GO:0015874; GO:0032809; GO:0042734; GO:0043005; GO:0043014; GO:0045121; GO:0046872; GO:0048265; GO:0048487; GO:0051583; GO:0098810	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; response to pain [GO:0048265]
PGEN_.00g173550	Scaffold_08	15334911	15339055	Q9GKT2	FXDC2_MACFA	Fatty acid hydroxylase domain-containing protein 2	GO:0001934; GO:0005506; GO:0005737; GO:0008610; GO:0016021; GO:0016491; GO:0045654	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; lipid biosynthetic process [GO:0008610]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]
PGEN_.00g173560	Scaffold_08	15340183	15362557	P18428	LBP_HUMAN	Lipopolysaccharide-binding protein (LBP)	GO:0001530; GO:0002224; GO:0002232; GO:0002281; GO:0005102; GO:0005576; GO:0005615; GO:0006953; GO:0006968; GO:0008228; GO:0009986; GO:0015920; GO:0016020; GO:0019221; GO:0031663; GO:0032490; GO:0032496; GO:0032720; GO:0032722; GO:0032755; GO:0032757; GO:0032760; GO:0033036; GO:0034142; GO:0034145; GO:0042535; GO:0043032; GO:0045087; GO:0045919; GO:0050829; GO:0050830; GO:0060265; GO:0070062; GO:0070891; GO:0071222; GO:0071223; GO:0071723; GO:0090023	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g173570	Scaffold_08	15381528	15400610	P17213	BPI_HUMAN	Bactericidal permeability-increasing protein (BPI) (CAP 57)	GO:0001530; GO:0005576; GO:0005615; GO:0010494; GO:0016020; GO:0019730; GO:0019731; GO:0031663; GO:0032715; GO:0032717; GO:0032720; GO:0035578; GO:0035580; GO:0043031; GO:0043312; GO:0045087; GO:0050829; GO:0061844; GO:0070062; GO:0071222	azurophil granule lumen [GO:0035578]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; lipopolysaccharide binding [GO:0001530]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of macrophage activation [GO:0043031]; negative regulation of tumor necrosis factor production [GO:0032720]; neutrophil degranulation [GO:0043312]
PGEN_.00g173580	Scaffold_08	15411858	15456350	P17213	BPI_HUMAN	Bactericidal permeability-increasing protein (BPI) (CAP 57)	GO:0001530; GO:0005576; GO:0005615; GO:0010494; GO:0016020; GO:0019730; GO:0019731; GO:0031663; GO:0032715; GO:0032717; GO:0032720; GO:0035578; GO:0035580; GO:0043031; GO:0043312; GO:0045087; GO:0050829; GO:0061844; GO:0070062; GO:0071222	azurophil granule lumen [GO:0035578]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; lipopolysaccharide binding [GO:0001530]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of macrophage activation [GO:0043031]; negative regulation of tumor necrosis factor production [GO:0032720]; neutrophil degranulation [GO:0043312]
PGEN_.00g173590	Scaffold_08	15457510	15475774	Q8BGA9	OXA1L_MOUSE	Mitochondrial inner membrane protein OXA1L (Oxidase assembly 1-like protein) (OXA1-like protein)	GO:0005739; GO:0005743; GO:0009060; GO:0031305; GO:0031966; GO:0032592; GO:0032780; GO:0032977; GO:0032979; GO:0032981; GO:0032991; GO:0033615; GO:0033617; GO:0042803; GO:0051205; GO:0051262; GO:0051354; GO:0097177	integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262]
PGEN_.00g173600	Scaffold_08	15485900	15493565	Q7SYR1	OSGEP_XENLA	Probable tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgep) (tRNA threonylcarbamoyladenosine biosynthesis protein osgep)	GO:0000408; GO:0002949; GO:0005634; GO:0005737; GO:0046872; GO:0061711	cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]
PGEN_.00g173610	Scaffold_08	15494764	15505254	Q5D1E8	ZC12A_HUMAN	Endoribonuclease ZC3H12A (EC 3.1.-.-) (Monocyte chemotactic protein-induced protein 1) (MCP-induced protein 1) (MCPIP-1) (Regnase-1) (Reg1) (Zinc finger CCCH domain-containing protein 12A)	GO:0000294; GO:0000932; GO:0001525; GO:0001933; GO:0002230; GO:0002757; GO:0003677; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0004521; GO:0004532; GO:0004540; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0005856; GO:0006915; GO:0006954; GO:0006974; GO:0007399; GO:0010468; GO:0010508; GO:0010595; GO:0010628; GO:0010629; GO:0010656; GO:0010884; GO:0010942; GO:0016579; GO:0030154; GO:0030867; GO:0032088; GO:0032715; GO:0032720; GO:0032991; GO:0034599; GO:0035198; GO:0035613; GO:0035925; GO:0036464; GO:0042149; GO:0042307; GO:0042406; GO:0043022; GO:0043031; GO:0043124; GO:0044828; GO:0045019; GO:0045600; GO:0045766; GO:0045944; GO:0046872; GO:0050713; GO:0050852; GO:0051259; GO:0051607; GO:0055118; GO:0061014; GO:0061158; GO:0071222; GO:0071347; GO:0071356; GO:0090501; GO:0090502; GO:0098586; GO:1900016; GO:1900119; GO:1900165; GO:1900745; GO:1901223; GO:1902714; GO:1903003; GO:1903799; GO:1903936; GO:1904468; GO:1904637; GO:1990869; GO:2000320; GO:2000379; GO:2000627	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; ribonuclease activity [GO:0004540]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; immune response-activating signal transduction [GO:0002757]; inflammatory response [GO:0006954]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of macrophage activation [GO:0043031]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor secretion [GO:1904468]; nervous system development [GO:0007399]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; regulation of gene expression [GO:0010468]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852]"
PGEN_.00g173620	Scaffold_08	15544673	15548805	P55006	RDH7_RAT	Retinol dehydrogenase 7 (EC 1.1.1.105) (Retinol dehydrogenase 3) (Retinol dehydrogenase type III) (RODH III)	GO:0004745; GO:0005783; GO:0042572	endoplasmic reticulum [GO:0005783]; retinol dehydrogenase activity [GO:0004745]; retinol metabolic process [GO:0042572]
PGEN_.00g173630	Scaffold_08	15559120	15582700	NA	NA	NA	NA	NA
PGEN_.00g173640	Scaffold_08	15591101	15595624	Q13148	TADBP_HUMAN	TAR DNA-binding protein 43 (TDP-43)	GO:0001933; GO:0003690; GO:0003700; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005726; GO:0006366; GO:0006397; GO:0008380; GO:0010494; GO:0010629; GO:0016607; GO:0031647; GO:0032024; GO:0034976; GO:0035061; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043565; GO:0043922; GO:0048511; GO:0051726; GO:0070935; GO:0071765; GO:0097157; GO:1990837; GO:1990904	cytoplasmic stress granule [GO:0010494]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g173650	Scaffold_08	15607249	15638050	Q3ZAU7	CENPL_RAT	Centromere protein L (CENP-L)	GO:0000775; GO:0005634	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]"
PGEN_.00g173660	Scaffold_08	15638325	15650302	Q9Y5B0	CTDP1_HUMAN	RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase)	GO:0000922; GO:0001096; GO:0004721; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006366; GO:0006368; GO:0006470; GO:0008420; GO:0010458; GO:0030496; GO:0030957; GO:0032991; GO:0043231; GO:0043923; GO:0050434; GO:0051233; GO:0051301; GO:0061052; GO:0070940	centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of viral transcription [GO:0050434]; protein dephosphorylation [GO:0006470]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g173670	Scaffold_08	15657125	15675135	Q7ZXX9	BOP1B_XENLA	Ribosome biogenesis protein bop1-B (Block of proliferation 1 protein B)	GO:0000463; GO:0000466; GO:0005654; GO:0030687; GO:0043021; GO:0051726; GO:0070545	"nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]"
PGEN_.00g173680	Scaffold_08	15682002	15688721	Q5XHB2	DUS22_XENTR	Dual specificity protein phosphatase 22 (EC 3.1.3.16) (EC 3.1.3.48)	GO:0004725; GO:0005634; GO:0005829; GO:0007179; GO:0008138; GO:0042127; GO:0046330	cytosol [GO:0005829]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g173690	Scaffold_08	15693538	15693972	NA	NA	NA	NA	NA
PGEN_.00g173700	Scaffold_08	15696019	15696252	NA	NA	NA	NA	NA
PGEN_.00g173710	Scaffold_08	15697961	15698260	B5EEZ1	HLDE_GEOBB	Bifunctional protein HldE [Includes: D-beta-D-heptose 7-phosphate kinase (EC 2.7.1.167) (D-beta-D-heptose 7-phosphotransferase) (D-glycero-beta-D-manno-heptose-7-phosphate kinase); D-beta-D-heptose 1-phosphate adenylyltransferase (EC 2.7.7.70) (D-glycero-beta-D-manno-heptose 1-phosphate adenylyltransferase)]	GO:0005524; GO:0016773; GO:0033785; GO:0033786; GO:0097171	"ATP binding [GO:0005524]; heptose 7-phosphate kinase activity [GO:0033785]; heptose-1-phosphate adenylyltransferase activity [GO:0033786]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; ADP-L-glycero-beta-D-manno-heptose biosynthetic process [GO:0097171]"
PGEN_.00g173720	Scaffold_08	15701772	15706956	P0C0T0	LITAF_RAT	Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) (Estrogen-enhanced transcript protein 1) (Eet-1)	GO:0000139; GO:0000978; GO:0001817; GO:0005576; GO:0005654; GO:0005765; GO:0005794; GO:0005829; GO:0005886; GO:0007568; GO:0008270; GO:0009898; GO:0032496; GO:0043123; GO:0045944; GO:0050699; GO:0071222; GO:0098559; GO:0098560; GO:0098574; GO:1901223	cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production [GO:0001817]; response to lipopolysaccharide [GO:0032496]
PGEN_.00g173730	Scaffold_08	15710906	15711142	NA	NA	NA	NA	NA
PGEN_.00g173740	Scaffold_08	15719728	15723557	NA	NA	NA	NA	NA
PGEN_.00g173750	Scaffold_08	15724774	15730651	Q9VSL3	SEPIA_DROME	Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia)	GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0016782; GO:0042803; GO:0045174; GO:0055114	"cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity, transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728]"
PGEN_.00g173760	Scaffold_08	15749399	15749647	NA	NA	NA	NA	NA
PGEN_.00g173770	Scaffold_08	15823646	15823918	NA	NA	NA	NA	NA
PGEN_.00g173780	Scaffold_08	15838694	15860137	Q6ZZY0	CRY1_SYLBO	Cryptochrome-1	GO:0000166; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0042622; GO:0045721; GO:0097381	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]
PGEN_.00g173790	Scaffold_08	15872762	15873058	NA	NA	NA	NA	NA
PGEN_.00g173800	Scaffold_08	15908774	15909386	NA	NA	NA	NA	NA
PGEN_.00g173810	Scaffold_08	15909492	15910578	NA	NA	NA	NA	NA
PGEN_.00g173820	Scaffold_08	15923585	15934630	Q02241	KIF23_HUMAN	Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1)	GO:0000022; GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0006890; GO:0007018; GO:0008017; GO:0016887; GO:0019886; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149	"cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g173830	Scaffold_08	15934761	15938471	E9Q5G3	KIF23_MOUSE	Kinesin-like protein KIF23	GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149	cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]
PGEN_.00g173840	Scaffold_08	16033200	16033547	NA	NA	NA	NA	NA
PGEN_.00g173850	Scaffold_08	16040330	16040860	NA	NA	NA	NA	NA
PGEN_.00g173860	Scaffold_08	16042178	16042555	NA	NA	NA	NA	NA
PGEN_.00g173870	Scaffold_08	16042588	16045325	NA	NA	NA	NA	NA
PGEN_.00g173880	Scaffold_08	16046953	16059307	NA	NA	NA	NA	NA
PGEN_.00g173890	Scaffold_08	16073705	16083764	Q99L88	SNTB1_MOUSE	Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (Syntrophin-2)	GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0016010; GO:0030054; GO:0030165; GO:0032991; GO:0042383; GO:0045202	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]
PGEN_.00g173900	Scaffold_08	16092145	16140217	Q8CG73	FTM_MOUSE	Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein)	GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005879; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0007420; GO:0008589; GO:0021532; GO:0021537; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035108; GO:0035115; GO:0035116; GO:0035253; GO:0035869; GO:0036064; GO:0043010; GO:0043584; GO:0045744; GO:0060039; GO:0060271; GO:0060322; GO:0090102; GO:1905515	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; telencephalon development [GO:0021537]
PGEN_.00g173910	Scaffold_08	16150525	16164726	Q5U4I3	CCDB1_XENLA	Cyclin-D1-binding protein 1 homolog	GO:0005634; GO:0005737; GO:0007049; GO:0051726	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726]
PGEN_.00g173920	Scaffold_08	16172356	16172832	NA	NA	NA	NA	NA
PGEN_.00g173930	Scaffold_08	16183916	16189496	NA	NA	NA	NA	NA
PGEN_.00g173940	Scaffold_08	16195700	16197331	Q9I9E1	FOXH1_DANRE	Forkhead box protein H1 (Forkhead activin signal transducer 1) (Fast-1) (Schmalspur protein)	GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001227; GO:0001568; GO:0001706; GO:0001707; GO:0001947; GO:0003143; GO:0005634; GO:0006357; GO:0007368; GO:0009653; GO:0009953; GO:0010159; GO:0010468; GO:0014028; GO:0021501; GO:0021508; GO:0021854; GO:0030154; GO:0030903; GO:0032525; GO:0033504; GO:0042074; GO:0043565; GO:0045944; GO:0046332; GO:0046619; GO:0048319; GO:0048327; GO:0048382; GO:0048854; GO:0060063; GO:0060971; GO:0071345; GO:2000223	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; axial mesoderm morphogenesis [GO:0048319]; axial mesodermal cell fate specification [GO:0048327]; blood vessel development [GO:0001568]; brain morphogenesis [GO:0048854]; cell differentiation [GO:0030154]; cell migration involved in gastrulation [GO:0042074]; cellular response to cytokine stimulus [GO:0071345]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; endoderm formation [GO:0001706]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; heart looping [GO:0001947]; hypothalamus development [GO:0021854]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; negative regulation of transcription by RNA polymerase II [GO:0000122]; notochord development [GO:0030903]; notochord formation [GO:0014028]; optic placode formation involved in camera-type eye formation [GO:0046619]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; regulation of BMP signaling pathway involved in heart jogging [GO:2000223]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; somite rostral/caudal axis specification [GO:0032525]; specification of animal organ position [GO:0010159]; Spemann organizer formation at the embryonic shield [GO:0060063]"
PGEN_.00g173950	Scaffold_08	16211272	16212143	NA	NA	NA	NA	NA
PGEN_.00g173960	Scaffold_08	16232633	16268000	P24792	ASO_CUCMA	L-ascorbate oxidase (ASO) (Ascorbase) (EC 1.10.3.3)	GO:0005507; GO:0005576; GO:0008447	extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447]
PGEN_.00g173970	Scaffold_08	16330160	16331167	NA	NA	NA	NA	NA
PGEN_.00g173980	Scaffold_08	16369932	16376679	O93603	TRFR_CHICK	Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor)	GO:0004997; GO:0005886; GO:0007200; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyrotropin-releasing hormone receptor activity [GO:0004997]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]
PGEN_.00g173990	Scaffold_08	16445900	16448053	O93603	TRFR_CHICK	Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor)	GO:0004997; GO:0005886; GO:0007200; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyrotropin-releasing hormone receptor activity [GO:0004997]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]
PGEN_.00g174000	Scaffold_08	16492247	16493053	NA	NA	NA	NA	NA
PGEN_.00g174010	Scaffold_08	16511806	16512075	NA	NA	NA	NA	NA
PGEN_.00g174020	Scaffold_08	16513908	16520976	NA	NA	NA	NA	NA
PGEN_.00g174030	Scaffold_08	16522567	16522821	NA	NA	NA	NA	NA
PGEN_.00g174040	Scaffold_08	16593270	16597066	NA	NA	NA	NA	NA
PGEN_.00g174050	Scaffold_08	16616915	16617391	NA	NA	NA	NA	NA
PGEN_.00g174060	Scaffold_08	16617911	16618429	NA	NA	NA	NA	NA
PGEN_.00g174070	Scaffold_08	16664770	16666160	NA	NA	NA	NA	NA
PGEN_.00g174080	Scaffold_08	16758803	16765152	NA	NA	NA	NA	NA
PGEN_.00g174090	Scaffold_08	16829014	16871286	Q8BZZ3	WWP1_MOUSE	NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase WWP1) (WW domain-containing protein 1)	GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0030217; GO:0030324; GO:0043161; GO:0045732; GO:0045892; GO:0061630	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; lung development [GO:0030324]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g174100	Scaffold_08	16908531	16910591	NA	NA	NA	NA	NA
PGEN_.00g174110	Scaffold_08	16947644	16975296	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g174120	Scaffold_08	16981667	17006614	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g174130	Scaffold_08	17019627	17049333	Q8WXW3	PIBF1_HUMAN	Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90)	GO:0002376; GO:0005136; GO:0005615; GO:0005623; GO:0005634; GO:0005737; GO:0005813; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515	cell [GO:0005623]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; interleukin-4 receptor binding [GO:0005136]; activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539]
PGEN_.00g174140	Scaffold_08	17054595	17061225	Q9Y248	PSF2_HUMAN	DNA replication complex GINS protein PSF2 (GINS complex subunit 2)	GO:0000727; GO:0000811; GO:0005654; GO:0006271; GO:0031298; GO:0032508	GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; DNA duplex unwinding [GO:0032508]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]
PGEN_.00g174150	Scaffold_08	17061489	17074631	Q96AN5	TM143_HUMAN	Transmembrane protein 143	GO:0005739; GO:0016021	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]
PGEN_.00g174160	Scaffold_08	17085779	17109206	Q8BNJ6	NETO2_MOUSE	Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2)	GO:0005886; GO:0014069; GO:0016021; GO:0035255; GO:0045202; GO:2000312	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; regulation of kainate selective glutamate receptor activity [GO:2000312]
PGEN_.00g174170	Scaffold_08	17109556	17115285	NA	NA	NA	NA	NA
PGEN_.00g174180	Scaffold_08	17116164	17128350	NA	NA	NA	NA	NA
PGEN_.00g174190	Scaffold_08	17140846	17151177	NA	NA	NA	NA	NA
PGEN_.00g174200	Scaffold_08	17158619	17193684	NA	NA	NA	NA	NA
PGEN_.00g174210	Scaffold_08	17207316	17207934	NA	NA	NA	NA	NA
PGEN_.00g174220	Scaffold_08	17232379	17240996	Q90W33	HIC2_DANRE	Hypermethylated in cancer 2 protein	GO:0003677; GO:0005634; GO:0006974; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]
PGEN_.00g174230	Scaffold_08	17244995	17246993	NA	NA	NA	NA	NA
PGEN_.00g174240	Scaffold_08	17250483	17250818	NA	NA	NA	NA	NA
PGEN_.00g174250	Scaffold_08	17281497	17309878	Q9WTW7	S23A1_RAT	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1)	GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g174260	Scaffold_08	17310302	17329747	Q9EPR4	S23A2_MOUSE	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2)	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g174270	Scaffold_08	17340447	17345761	Q9D7X8	GGCT_MOUSE	Gamma-glutamylcyclotransferase (EC 4.3.2.9)	GO:0001836; GO:0003839; GO:0005829; GO:0042803	cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]; release of cytochrome c from mitochondria [GO:0001836]
PGEN_.00g174280	Scaffold_08	17349225	17357933	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g174290	Scaffold_08	17360795	17365874	NA	NA	NA	NA	NA
PGEN_.00g174300	Scaffold_08	17379923	17417576	Q91766	HNF4A_XENLA	Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1)	GO:0003323; GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0042752; GO:0043565; GO:0045893; GO:0048511; GO:0050796; GO:0055088; GO:0070365	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of insulin secretion [GO:0050796]; rhythmic process [GO:0048511]; type B pancreatic cell development [GO:0003323]"
PGEN_.00g174310	Scaffold_08	17425854	17427498	Q86Z23	C1QL4_HUMAN	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g174320	Scaffold_08	17434928	17446729	NA	NA	NA	NA	NA
PGEN_.00g174330	Scaffold_08	17486328	17491238	Q70AD6	CRY1_SPAJD	Cryptochrome-1	GO:0000122; GO:0000166; GO:0005634; GO:0005737; GO:0006094; GO:0006975; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0018298; GO:0031397; GO:0032922; GO:0033762; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:2000001; GO:2000323	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to light stimulus [GO:0009416]"
PGEN_.00g174340	Scaffold_08	17516933	17526914	NA	NA	NA	NA	NA
PGEN_.00g174350	Scaffold_08	17531314	17534378	NA	NA	NA	NA	NA
PGEN_.00g174360	Scaffold_08	17574998	17590353	NA	NA	NA	NA	NA
PGEN_.00g174370	Scaffold_08	17592540	17594404	NA	NA	NA	NA	NA
PGEN_.00g174380	Scaffold_08	17594483	17594881	NA	NA	NA	NA	NA
PGEN_.00g174390	Scaffold_08	17596679	17597672	NA	NA	NA	NA	NA
PGEN_.00g174400	Scaffold_08	17601956	17611927	NA	NA	NA	NA	NA
PGEN_.00g174410	Scaffold_08	17602167	17602418	NA	NA	NA	NA	NA
PGEN_.00g174420	Scaffold_08	17617366	17620156	Q5ZMH6	METL9_CHICK	Methyltransferase-like protein 9		
PGEN_.00g174430	Scaffold_08	17624396	17624754	NA	NA	NA	NA	NA
PGEN_.00g174440	Scaffold_08	17650050	17654626	P08953	TOLL_DROME	Protein toll	GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]
PGEN_.00g174450	Scaffold_08	17664561	17675077	Q5ZMH6	METL9_CHICK	Methyltransferase-like protein 9		
PGEN_.00g174460	Scaffold_08	17675115	17698406	NA	NA	NA	NA	NA
PGEN_.00g174470	Scaffold_08	17704262	17705722	Q6GNV7	DIRC2_XENLA	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	GO:0005765; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]
PGEN_.00g174480	Scaffold_08	17716102	17733783	NA	NA	NA	NA	NA
PGEN_.00g174490	Scaffold_08	17737222	17745745	NA	NA	NA	NA	NA
PGEN_.00g174500	Scaffold_08	17757067	17757774	Q8BFQ6	DIRC2_MOUSE	Solute carrier family 49 member 4 (Disrupted in renal carcinoma protein 2 homolog)	GO:0005765; GO:0016021; GO:0043231	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]
PGEN_.00g174510	Scaffold_08	17765348	17766312	Q6GNV7	DIRC2_XENLA	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	GO:0005765; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]
PGEN_.00g174520	Scaffold_08	17772550	17778058	NA	NA	NA	NA	NA
PGEN_.00g174530	Scaffold_08	17778672	17780123	Q6GNV7	DIRC2_XENLA	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	GO:0005765; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]
PGEN_.00g174540	Scaffold_08	17784084	17804644	Q8NA66	CNBD1_HUMAN	Cyclic nucleotide-binding domain-containing protein 1		
PGEN_.00g174550	Scaffold_08	17807176	17807526	NA	NA	NA	NA	NA
PGEN_.00g174560	Scaffold_08	17814502	17821426	Q8BFR6	ZFAN1_MOUSE	AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1)	GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843	cytoplasmic stress granule [GO:0010494]; proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]; cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617]
PGEN_.00g174570	Scaffold_08	17824575	17826032	Q6GNV7	DIRC2_XENLA	Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)	GO:0005765; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]
PGEN_.00g174580	Scaffold_08	17830082	17868311	Q5ZKJ5	MF13A_CHICK	Transmembrane protein 180 (Major facilitator superfamily domain-containing 13A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g174590	Scaffold_08	17876569	17893145	NA	NA	NA	NA	NA
PGEN_.00g174600	Scaffold_08	17893932	17894186	NA	NA	NA	NA	NA
PGEN_.00g174610	Scaffold_08	17895351	17896028	NA	NA	NA	NA	NA
PGEN_.00g174620	Scaffold_08	17896777	17919286	NA	NA	NA	NA	NA
PGEN_.00g174630	Scaffold_08	17921029	17921400	NA	NA	NA	NA	NA
PGEN_.00g174640	Scaffold_08	17921550	17921957	NA	NA	NA	NA	NA
PGEN_.00g174650	Scaffold_08	17933233	17942113	NA	NA	NA	NA	NA
PGEN_.00g174660	Scaffold_08	17969070	17970952	NA	NA	NA	NA	NA
PGEN_.00g174670	Scaffold_08	17971462	17990059	Q8AVJ2	L14AB_XENLA	Protein LSM14 homolog A-B (RNA-associated protein 55A-B) (RAP55A-B)	GO:0000932; GO:0003723; GO:0005737; GO:0007275; GO:0010494; GO:0017148; GO:0017151; GO:1990904	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; DEAD/H-box RNA helicase binding [GO:0017151]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; negative regulation of translation [GO:0017148]
PGEN_.00g174680	Scaffold_08	17990253	18022671	O00268	TAF4_HUMAN	Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit) (TAF(II)130) (TAFII-130) (TAFII130) (Transcription initiation factor TFIID 135 kDa subunit) (TAF(II)135) (TAFII-135) (TAFII135)	GO:0000790; GO:0001541; GO:0003677; GO:0003700; GO:0003713; GO:0005654; GO:0005669; GO:0005829; GO:0006352; GO:0006366; GO:0006367; GO:0008134; GO:0016032; GO:0017162; GO:0032991; GO:0033276; GO:0045893; GO:0045944; GO:0046982; GO:0071339; GO:1901796	"cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; ovarian follicle development [GO:0001541]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]"
PGEN_.00g174690	Scaffold_08	18025385	18055653	O54921	EXOC2_RAT	Exocyst complex component 2 (Exocyst complex component Sec5) (rSec5)	GO:0000145; GO:0006887; GO:0006893; GO:0015031; GO:0016192; GO:0017160; GO:0019901; GO:0047485; GO:0090543; GO:2000535	exocyst [GO:0000145]; Flemming body [GO:0090543]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle-mediated transport [GO:0016192]
PGEN_.00g174700	Scaffold_08	18066354	18069173	NA	NA	NA	NA	NA
PGEN_.00g174710	Scaffold_08	18082373	18093454	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g174720	Scaffold_08	18094090	18122881	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g174730	Scaffold_08	18133441	18137346	NA	NA	NA	NA	NA
PGEN_.00g174740	Scaffold_08	18198750	18201337	Q9ER75	IRX6_MOUSE	Iroquois-class homeodomain protein IRX-6 (Homeodomain protein IRXB3) (Iroquois homeobox protein 6)	GO:0001227; GO:0001228; GO:0005634; GO:0009584; GO:0010842; GO:0043565; GO:0045892; GO:0045893; GO:0060040	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; detection of visible light [GO:0009584]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; retina layer formation [GO:0010842]; retinal bipolar neuron differentiation [GO:0060040]"
PGEN_.00g174750	Scaffold_08	18205952	18212839	NA	NA	NA	NA	NA
PGEN_.00g174760	Scaffold_08	18226203	18227807	P10273	POL_FLV	Gag-Pol polyprotein [Cleaved into: Matrix protein p15; RNA-binding phosphoprotein p12 (pp12); Capsid protein p30; Nucleocapsid protein p10-Pol (NC-pol); Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713	host cell late endosome membrane [GO:0044185]; host cell plasma membrane [GO:0020002]; host multivesicular body [GO:0072494]; membrane [GO:0016020]; viral nucleocapsid [GO:0019013]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural constituent of virion [GO:0039660]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]
PGEN_.00g174770	Scaffold_08	18240926	18241192	NA	NA	NA	NA	NA
PGEN_.00g174780	Scaffold_08	18250185	18278397	NA	NA	NA	NA	NA
PGEN_.00g174790	Scaffold_08	18293506	18313906	NA	NA	NA	NA	NA
PGEN_.00g174800	Scaffold_08	18318857	18319270	NA	NA	NA	NA	NA
PGEN_.00g174810	Scaffold_08	18320891	18327380	NA	NA	NA	NA	NA
PGEN_.00g174820	Scaffold_08	18329936	18331173	NA	NA	NA	NA	NA
PGEN_.00g174830	Scaffold_08	18347662	18351781	NA	NA	NA	NA	NA
PGEN_.00g174840	Scaffold_08	18354043	18375320	NA	NA	NA	NA	NA
PGEN_.00g174850	Scaffold_08	18380440	18381868	NA	NA	NA	NA	NA
PGEN_.00g174860	Scaffold_08	18472376	18474653	NA	NA	NA	NA	NA
PGEN_.00g174870	Scaffold_08	18493715	18553741	A2AIV2	VIR_MOUSE	Protein virilizer homolog	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0007275; GO:0008380; GO:0016604; GO:0016607; GO:0036396; GO:0080009; GO:0110104	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380]
PGEN_.00g174880	Scaffold_08	18563476	18566160	NA	NA	NA	NA	NA
PGEN_.00g174890	Scaffold_08	18578716	18595173	P55261	CBPB1_CANLF	Carboxypeptidase B (EC 3.4.17.2) (47 kDa zymogen granule membrane-associated protein) (ZAP47)	GO:0004181; GO:0005615; GO:0006508; GO:0008270	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g174900	Scaffold_08	18613719	18618789	NA	NA	NA	NA	NA
PGEN_.00g174910	Scaffold_08	18622854	18652778	P22735	TGM1_HUMAN	Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)	GO:0001533; GO:0003810; GO:0005829; GO:0005886; GO:0006464; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031224; GO:0043163; GO:0045787; GO:0046872; GO:0070062; GO:0070268	cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; cell envelope organization [GO:0043163]; cellular protein modification process [GO:0006464]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]
PGEN_.00g174920	Scaffold_08	18690257	18691006	NA	NA	NA	NA	NA
PGEN_.00g174930	Scaffold_08	18698349	18698648	NA	NA	NA	NA	NA
PGEN_.00g174940	Scaffold_08	18705188	18715490	NA	NA	NA	NA	NA
PGEN_.00g174950	Scaffold_08	18723338	18728031	NA	NA	NA	NA	NA
PGEN_.00g174960	Scaffold_08	18742268	18742543	Q9BX70	BTBD2_HUMAN	BTB/POZ domain-containing protein 2	GO:0000932; GO:0005829; GO:0022008	cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]
PGEN_.00g174970	Scaffold_08	18815616	18817693	NA	NA	NA	NA	NA
PGEN_.00g174980	Scaffold_08	18823789	18824235	NA	NA	NA	NA	NA
PGEN_.00g174990	Scaffold_08	18824440	18825612	NA	NA	NA	NA	NA
PGEN_.00g175000	Scaffold_08	18833756	18868321	Q5R2J4	APCD1_PELSI	Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein homolog) (PsAPCDD1)	GO:0005615; GO:0005887; GO:0016055; GO:0017147; GO:0030178	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; Wnt-protein binding [GO:0017147]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]
PGEN_.00g175010	Scaffold_08	18872176	18874245	NA	NA	NA	NA	NA
PGEN_.00g175020	Scaffold_08	18890560	18895216	NA	NA	NA	NA	NA
PGEN_.00g175030	Scaffold_08	18901816	18913824	NA	NA	NA	NA	NA
PGEN_.00g175040	Scaffold_08	18914165	18939493	O45583	GMD2_CAEEL	"GDP-mannose 4,6 dehydratase 2 (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)"	GO:0005737; GO:0008446; GO:0019673; GO:0042350; GO:0042351	"cytoplasm [GO:0005737]; GDP-mannose 4,6-dehydratase activity [GO:0008446]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-L-fucose biosynthetic process [GO:0042350]; GDP-mannose metabolic process [GO:0019673]"
PGEN_.00g175050	Scaffold_08	18967488	18972878	NA	NA	NA	NA	NA
PGEN_.00g175060	Scaffold_08	19020009	19021340	Q9DE24	FXC1B_DANRE	Forkhead box C1-B	GO:0000981; GO:0001568; GO:0001755; GO:0001944; GO:0005634; GO:0006357; GO:0009653; GO:0030154; GO:0043010; GO:0043114; GO:0043565; GO:0051216; GO:0060059; GO:0061300; GO:2000583	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; blood vessel development [GO:0001568]; camera-type eye development [GO:0043010]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cerebellum vasculature development [GO:0061300]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; neural crest cell migration [GO:0001755]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vascular permeability [GO:0043114]; vasculature development [GO:0001944]"
PGEN_.00g175070	Scaffold_08	19030443	19042207	Q86WA6	BPHL_HUMAN	Valacyclovir hydrolase (VACVase) (Valacyclovirase) (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA)	GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0047658	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; alpha-amino-acid esterase activity [GO:0047658]; cellular amino acid metabolic process [GO:0006520]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g175080	Scaffold_08	19148329	19148661	NA	NA	NA	NA	NA
PGEN_.00g175090	Scaffold_08	19148752	19149246	NA	NA	NA	NA	NA
PGEN_.00g175100	Scaffold_08	19150906	19151634	NA	NA	NA	NA	NA
PGEN_.00g175110	Scaffold_08	19203383	19219928	NA	NA	NA	NA	NA
PGEN_.00g175120	Scaffold_08	19228231	19243391	Q6NSR8	PEPL1_MOUSE	Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1)	GO:0004177; GO:0005737; GO:0008235; GO:0030145	cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]
PGEN_.00g175130	Scaffold_08	19249058	19260370	NA	NA	NA	NA	NA
PGEN_.00g175140	Scaffold_08	19267922	19278224	NA	NA	NA	NA	NA
PGEN_.00g175150	Scaffold_08	19312474	19321602	Q6NYP0	TM208_DANRE	Transmembrane protein 208	GO:0005773; GO:0005789; GO:0006624; GO:0006914; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vacuole [GO:0005773]; autophagy [GO:0006914]; vacuolar protein processing [GO:0006624]
PGEN_.00g175160	Scaffold_08	19329269	19335280	NA	NA	NA	NA	NA
PGEN_.00g175170	Scaffold_08	19336185	19340524	NA	NA	NA	NA	NA
PGEN_.00g175180	Scaffold_08	19341408	19365307	NA	NA	NA	NA	NA
PGEN_.00g175190	Scaffold_08	19372332	19386861	Q05975	RAB2_LYMST	Ras-related protein Rab-2	GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0015031; GO:0016192; GO:0033116	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g175200	Scaffold_08	19394687	19401674	NA	NA	NA	NA	NA
PGEN_.00g175210	Scaffold_08	19401729	19453266	Q06A37	CHD7_CHICK	Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7)	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006325; GO:0006364	nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; chromatin organization [GO:0006325]; rRNA processing [GO:0006364]
PGEN_.00g175220	Scaffold_08	19454735	19456010	NA	NA	NA	NA	NA
PGEN_.00g175230	Scaffold_08	19463746	19476937	Q149F1	RUSD2_MOUSE	RNA pseudouridylate synthase domain-containing protein 2	GO:0000455; GO:0003723; GO:0009982	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]
PGEN_.00g175240	Scaffold_08	19481607	19481942	Q6R7D0	IAP3_OSHVF	Putative apoptosis inhibitor ORF99		
PGEN_.00g175250	Scaffold_08	19487627	19487971	NA	NA	NA	NA	NA
PGEN_.00g175260	Scaffold_08	19490130	19490432	NA	NA	NA	NA	NA
PGEN_.00g175270	Scaffold_08	19491886	19492841	NA	NA	NA	NA	NA
PGEN_.00g175280	Scaffold_08	19493085	19493459	NA	NA	NA	NA	NA
PGEN_.00g175290	Scaffold_08	19502325	19503120	NA	NA	NA	NA	NA
PGEN_.00g175300	Scaffold_08	19504619	19516617	Q149F1	RUSD2_MOUSE	RNA pseudouridylate synthase domain-containing protein 2	GO:0000455; GO:0003723; GO:0009982	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]
PGEN_.00g175310	Scaffold_08	19521788	19538093	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g175320	Scaffold_08	19544928	19553854	Q92485	ASM3B_HUMAN	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
PGEN_.00g175330	Scaffold_08	19560969	19569227	NA	NA	NA	NA	NA
PGEN_.00g175340	Scaffold_08	19578912	19588615	Q92485	ASM3B_HUMAN	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
PGEN_.00g175350	Scaffold_08	19590132	19594505	NA	NA	NA	NA	NA
PGEN_.00g175360	Scaffold_08	19603874	19605142	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g175370	Scaffold_08	19614033	19620834	NA	NA	NA	NA	NA
PGEN_.00g175380	Scaffold_08	19630345	19657743	Q8VBW6	ULA1_MOUSE	"NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa) (APP-BP1) (Amyloid protein-binding protein 1)"	GO:0005737; GO:0005769; GO:0005886; GO:0019781; GO:0031625; GO:0032446; GO:0032991; GO:0033314; GO:0042981; GO:0043523; GO:0045116; GO:0045121; GO:0046982; GO:0051402	cytoplasm [GO:0005737]; early endosome [GO:0005769]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625]; mitotic DNA replication checkpoint [GO:0033314]; neuron apoptotic process [GO:0051402]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g175390	Scaffold_08	19715037	19732412	Q63707	PYRD_RAT	"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)"	GO:0004152; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006207; GO:0007565; GO:0007595; GO:0008144; GO:0009220; GO:0010181; GO:0014070; GO:0016021; GO:0031000; GO:0042493; GO:0042594; GO:0043025; GO:0043065; GO:0044205; GO:0048039; GO:0090140; GO:1903576	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; dihydroorotate dehydrogenase activity [GO:0004152]; drug binding [GO:0008144]; FMN binding [GO:0010181]; ubiquinone binding [GO:0048039]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; female pregnancy [GO:0007565]; lactation [GO:0007595]; positive regulation of apoptotic process [GO:0043065]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; regulation of mitochondrial fission [GO:0090140]; response to caffeine [GO:0031000]; response to drug [GO:0042493]; response to L-arginine [GO:1903576]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]
PGEN_.00g175400	Scaffold_08	19732712	19750702	Q9VNV3	DDX1_DROME	ATP-dependent RNA helicase Ddx1 (DEAD box protein 1) (EC 3.6.4.13)	GO:0001700; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0006302; GO:0007283; GO:0008143; GO:0032508; GO:0033677; GO:0042254; GO:0048477	nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; ribosome biogenesis [GO:0042254]; spermatogenesis [GO:0007283]
PGEN_.00g175410	Scaffold_08	19751158	19752036	NA	NA	NA	NA	NA
PGEN_.00g175420	Scaffold_08	19752162	19752683	NA	NA	NA	NA	NA
PGEN_.00g175430	Scaffold_08	19752841	19753410	NA	NA	NA	NA	NA
PGEN_.00g175440	Scaffold_08	19757736	19787727	Q9VNV3	DDX1_DROME	ATP-dependent RNA helicase Ddx1 (DEAD box protein 1) (EC 3.6.4.13)	GO:0001700; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0006302; GO:0007283; GO:0008143; GO:0032508; GO:0033677; GO:0042254; GO:0048477	nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; ribosome biogenesis [GO:0042254]; spermatogenesis [GO:0007283]
PGEN_.00g175450	Scaffold_08	19879489	19886034	NA	NA	NA	NA	NA
PGEN_.00g175460	Scaffold_08	19903040	19904511	NA	NA	NA	NA	NA
PGEN_.00g175470	Scaffold_08	19931111	19955015	Q0IIK5	DDX1_BOVIN	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)	GO:0003677; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0008143; GO:0010494; GO:0032508; GO:0033677; GO:0043123; GO:0045087; GO:0051607; GO:0071920; GO:0072669	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
PGEN_.00g175480	Scaffold_08	19994905	20008605	Q641Y8	DDX1_RAT	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)	GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0007275; GO:0008143; GO:0009615; GO:0010494; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:0090305; GO:1903608; GO:1990904	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
PGEN_.00g175490	Scaffold_08	20056358	20061513	Q5RD73	DUS3_PONAB	Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Vaccinia H1-related phosphatase) (VHR)	GO:0001772; GO:0004725; GO:0005654; GO:0005829; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0030336; GO:0030971; GO:0033549; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183	cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893]
PGEN_.00g175500	Scaffold_08	20078063	20082926	Q4U5R4	RN114_BOVIN	E3 ubiquitin-protein ligase RNF114 (EC 2.3.2.27) (RING finger protein 114) (RING-type E3 ubiquitin transferase RNF114) (Zinc finger protein 313)	GO:0005634; GO:0005829; GO:0005886; GO:0007275; GO:0007283; GO:0016567; GO:0016740; GO:0030154; GO:0046872	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g175510	Scaffold_08	20125024	20125374	NA	NA	NA	NA	NA
PGEN_.00g175520	Scaffold_08	20127363	20133989	Q8IXH7	NELFD_HUMAN	Negative elongation factor C/D (NELF-C/D) (TH1-like protein)	GO:0003723; GO:0005654; GO:0006366; GO:0006368; GO:0016020; GO:0032021; GO:0034244; GO:0050434	membrane [GO:0016020]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of viral transcription [GO:0050434]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g175530	Scaffold_08	20135146	20135808	NA	NA	NA	NA	NA
PGEN_.00g175540	Scaffold_08	20137679	20140021	NA	NA	NA	NA	NA
PGEN_.00g175550	Scaffold_08	20144628	20151783	Q2TAD9	CYR1B_XENLA	Cysteine and histidine-rich protein 1-B	GO:0005737; GO:0008270	cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]
PGEN_.00g175560	Scaffold_08	20170829	20171239	NA	NA	NA	NA	NA
PGEN_.00g175570	Scaffold_08	20190731	20201527	Q8CD54	PIEZ2_MOUSE	Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B)	GO:0005261; GO:0005886; GO:0006812; GO:0008381; GO:0009612; GO:0016021; GO:0042391; GO:0050974; GO:0050982; GO:0071260	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612]
PGEN_.00g175580	Scaffold_08	20236994	20298336	Q0KL00	PIEZ1_RAT	Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A)	GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0016021; GO:0031258; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0042802; GO:0050982; GO:0071260	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; regulation of membrane potential [GO:0042391]
PGEN_.00g175590	Scaffold_08	20305511	20307778	NA	NA	NA	NA	NA
PGEN_.00g175600	Scaffold_08	20307961	20335131	Q8BGT5	ALAT2_MOUSE	Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)	GO:0004021; GO:0005615; GO:0005739; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853; GO:0045722	extracellular space [GO:0005615]; mitochondrion [GO:0005739]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]; positive regulation of gluconeogenesis [GO:0045722]
PGEN_.00g175610	Scaffold_08	20371107	20389623	Q9BYN7	ZN341_HUMAN	Zinc finger protein 341	GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g175620	Scaffold_08	20411036	20417812	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g175630	Scaffold_08	20428306	20444059	NA	NA	NA	NA	NA
PGEN_.00g175640	Scaffold_08	20452040	20472502	Q14703	MBTP1_HUMAN	Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1)	GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0043687; GO:0044267; GO:0045540; GO:0060627	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; ATF6-mediated unfolded protein response [GO:0036500]; cellular protein metabolic process [GO:0044267]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; post-translational protein modification [GO:0043687]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g175650	Scaffold_08	20493096	20500208	Q0MQI9	NDUV2_PANTR	"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit)"	GO:0005747; GO:0006120; GO:0008137; GO:0046872; GO:0051537	"mitochondrial respiratory chain complex I [GO:0005747]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"
PGEN_.00g175660	Scaffold_08	20500779	20535991	Q9BZ19	ANR60_HUMAN	Ankyrin repeat domain-containing protein 60		
PGEN_.00g175670	Scaffold_08	20544455	20552504	Q9UBD0	HSFX1_HUMAN	"Heat shock transcription factor, X-linked"	GO:0000790; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0034605; GO:0043565; GO:0061408	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to heat [GO:0034605]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]"
PGEN_.00g175680	Scaffold_08	20555051	20574228	Q9H6D7	HAUS4_HUMAN	HAUS augmin-like complex subunit 4	GO:0000086; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0007098; GO:0010389; GO:0051011; GO:0051225; GO:0051301; GO:0070652; GO:0097711	centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; spindle [GO:0005819]; microtubule minus-end binding [GO:0051011]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]
PGEN_.00g175690	Scaffold_08	20583197	20583562	NA	NA	NA	NA	NA
PGEN_.00g175700	Scaffold_08	20604316	20611400	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g175710	Scaffold_08	20622013	20622330	NA	NA	NA	NA	NA
PGEN_.00g175720	Scaffold_08	20633760	20645149	P13944	COCA1_CHICK	Collagen alpha-1(XII) chain (Fibrochimerin)	GO:0003429; GO:0005581; GO:0005615; GO:0007155; GO:0031012; GO:0035987; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g175730	Scaffold_08	20695460	20701558	NA	NA	NA	NA	NA
PGEN_.00g175740	Scaffold_08	20702382	20727958	Q8NG66	NEK11_HUMAN	Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11)	GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006468; GO:0007059; GO:0016572; GO:0031573; GO:0035556; GO:0044772; GO:0046872; GO:1901990	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; intra-S DNA damage checkpoint [GO:0031573]; intracellular signal transduction [GO:0035556]; mitotic cell cycle phase transition [GO:0044772]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990]
PGEN_.00g175750	Scaffold_08	20730207	20737578	Q96E29	MTEF3_HUMAN	"Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3) (mTERF3) (mTERF domain-containing protein 1, mitochondrial)"	GO:0003690; GO:0005654; GO:0005739; GO:0005741; GO:0006390; GO:0016236; GO:0032543; GO:0044212; GO:0045892; GO:0061668	"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; double-stranded DNA binding [GO:0003690]; transcription regulatory region DNA binding [GO:0044212]; macroautophagy [GO:0016236]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial transcription [GO:0006390]; mitochondrial translation [GO:0032543]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g175760	Scaffold_08	20745940	20746200	NA	NA	NA	NA	NA
PGEN_.00g175770	Scaffold_08	20832646	20832972	NA	NA	NA	NA	NA
PGEN_.00g175780	Scaffold_08	20854663	20854923	NA	NA	NA	NA	NA
PGEN_.00g175790	Scaffold_08	20867413	20870898	NA	NA	NA	NA	NA
PGEN_.00g175800	Scaffold_08	20872019	20931633	Q08462	ADCY2_HUMAN	Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2)	GO:0000287; GO:0003091; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007186; GO:0007188; GO:0007189; GO:0007190; GO:0007193; GO:0008179; GO:0016020; GO:0019933; GO:0030145; GO:0030425; GO:0034199; GO:0045121; GO:0046982; GO:0071377; GO:1904322	cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein heterodimerization activity [GO:0046982]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; G protein-coupled receptor signaling pathway [GO:0007186]; renal water homeostasis [GO:0003091]
PGEN_.00g175810	Scaffold_08	20942838	20947386	Q5NDE7	PMGT2_XENLA	"Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGnT2) (EC 2.4.1.312) (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2)"	GO:0001764; GO:0005783; GO:0005789; GO:0006493; GO:0008375; GO:0016021; GO:0035269	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]
PGEN_.00g175820	Scaffold_08	20953818	20954099	NA	NA	NA	NA	NA
PGEN_.00g175830	Scaffold_08	20973193	20975742	NA	NA	NA	NA	NA
PGEN_.00g175840	Scaffold_08	20976152	20993345	Q9D0M0	EXOS7_MOUSE	Exosome complex exonuclease RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42)	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005730; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"
PGEN_.00g175850	Scaffold_08	21008653	21011265	P32017	CO9A3_CHICK	Collagen alpha-3(IX) chain	GO:0005201; GO:0005594; GO:0005615; GO:0008584; GO:0008585; GO:0030198; GO:0031012	collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; female gonad development [GO:0008585]; male gonad development [GO:0008584]
PGEN_.00g175860	Scaffold_08	21016583	21046264	Q9NYG2	ZDHC3_HUMAN	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:1903546	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to photoreceptor outer segment [GO:1903546]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]
PGEN_.00g175870	Scaffold_08	21102935	21112239	NA	NA	NA	NA	NA
PGEN_.00g175880	Scaffold_08	21138782	21139258	NA	NA	NA	NA	NA
PGEN_.00g175890	Scaffold_08	21263174	21263857	NA	NA	NA	NA	NA
PGEN_.00g175900	Scaffold_08	21362722	21413946	Q8C419	GP158_MOUSE	Probable G-protein coupled receptor 158	GO:0004930; GO:0005886; GO:0007186; GO:0016020; GO:0016021; GO:0072659	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; protein localization to plasma membrane [GO:0072659]
PGEN_.00g175910	Scaffold_08	21442660	21446105	NA	NA	NA	NA	NA
PGEN_.00g175920	Scaffold_08	21446495	21447959	Q8BH75	RNF41_MOUSE	E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1)	GO:0000209; GO:0004842; GO:0005128; GO:0005135; GO:0006914; GO:0008270; GO:0008285; GO:0010468; GO:0010498; GO:0016567; GO:0017160; GO:0019904; GO:0030336; GO:0030971; GO:0043408; GO:0045619; GO:0045637; GO:0045732; GO:0048471; GO:0051091; GO:0051865; GO:0051896; GO:0061630; GO:0071782; GO:0097191; GO:1901525; GO:2000114; GO:2000377; GO:2000379	endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]; erythropoietin receptor binding [GO:0005128]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377]
PGEN_.00g175930	Scaffold_08	21458026	21459135	Q70LM4	LGRD_BREPA	Linear gramicidin synthase subunit D [Includes: ATP-dependent D-leucine adenylase (D-LeuA) (D-leucine activase); Leucine racemase [ATP-hydrolyzing] (EC 5.1.1.-); ATP-dependent tryptophan adenylase (TrpA) (Tryptophan activase); ATP-dependent glycine adenylase (GlyA) (Glycine activase); Linear gramicidin--PCP reductase (EC 1.-.-.-)]	GO:0016491; GO:0016853; GO:0016874; GO:0017000; GO:0031177	isomerase activity [GO:0016853]; ligase activity [GO:0016874]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; antibiotic biosynthetic process [GO:0017000]
PGEN_.00g175940	Scaffold_08	21464323	21484378	Q8C190	VP9D1_MOUSE	VPS9 domain-containing protein 1 (5-day ovary-specific transcript 1 protein)		
PGEN_.00g175950	Scaffold_08	21484676	21521333	Q9UKV3	ACINU_HUMAN	Apoptotic chromatin condensation inducer in the nucleus (Acinus)	GO:0003676; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0016607; GO:0016887; GO:0019899; GO:0030218; GO:0030263; GO:0043065; GO:0045657; GO:0048025; GO:0061574	"ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATPase activity [GO:0016887]; enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic chromosome condensation [GO:0030263]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]"
PGEN_.00g175960	Scaffold_08	21536447	21537931	Q1LWG3	RM36_DANRE	"39S ribosomal protein L36, mitochondrial (L36mt) (MRP-L36)"	GO:0003735; GO:0005762; GO:0006412; GO:0042254	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; ribosome biogenesis [GO:0042254]; translation [GO:0006412]
PGEN_.00g175970	Scaffold_08	21536911	21543774	NA	NA	NA	NA	NA
PGEN_.00g175980	Scaffold_08	21549524	21550834	NA	NA	NA	NA	NA
PGEN_.00g175990	Scaffold_08	21587168	21592094	NA	NA	NA	NA	NA
PGEN_.00g176000	Scaffold_08	21598326	21605256	NA	NA	NA	NA	NA
PGEN_.00g176010	Scaffold_08	21609255	21609641	NA	NA	NA	NA	NA
PGEN_.00g176020	Scaffold_08	21629297	21636084	P56395	CYB5_MOUSE	Cytochrome b5	GO:0004768; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0006631; GO:0016020; GO:0016021; GO:0019899; GO:0020037; GO:0043231; GO:0046686; GO:0046872	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty acid metabolic process [GO:0006631]; response to cadmium ion [GO:0046686]
PGEN_.00g176030	Scaffold_08	21645041	21687137	Q8VCC1	PGDH_MOUSE	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	GO:0001822; GO:0003824; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0042803; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g176040	Scaffold_08	21689544	21694134	Q9JI18	LRP1B_MOUSE	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	GO:0001701; GO:0005041; GO:0005509; GO:0016020; GO:0016021; GO:0043235; GO:0050750	integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]; in utero embryonic development [GO:0001701]
PGEN_.00g176050	Scaffold_08	21702607	21722170	Q86U38	NOP9_HUMAN	Nucleolar protein 9	GO:0003723	RNA binding [GO:0003723]
PGEN_.00g176060	Scaffold_08	21722520	21753127	Q8JZQ2	AFG32_MOUSE	AFG3-like protein 2 (EC 3.4.24.-)	GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007005; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]
PGEN_.00g176070	Scaffold_08	21758266	21773404	Q9HCJ6	VAT1L_HUMAN	Synaptic vesicle membrane protein VAT-1 homolog-like (EC 1.-.-.-)	GO:0008270; GO:0016491	oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]
PGEN_.00g176080	Scaffold_08	21782577	21787759	Q9HCJ6	VAT1L_HUMAN	Synaptic vesicle membrane protein VAT-1 homolog-like (EC 1.-.-.-)	GO:0008270; GO:0016491	oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]
PGEN_.00g176090	Scaffold_08	21792865	21797910	Q80TB8	VAT1L_MOUSE	Synaptic vesicle membrane protein VAT-1 homolog-like (EC 1.-.-.-)	GO:0008270; GO:0016491	oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]
PGEN_.00g176100	Scaffold_08	21803143	21834009	Q8JZQ2	AFG32_MOUSE	AFG3-like protein 2 (EC 3.4.24.-)	GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007005; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0021675; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0048747; GO:0051560; GO:0060013	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]
PGEN_.00g176110	Scaffold_08	21834359	21853922	Q86U38	NOP9_HUMAN	Nucleolar protein 9	GO:0003723	RNA binding [GO:0003723]
PGEN_.00g176120	Scaffold_08	21862395	21866972	Q9NZR2	LRP1B_HUMAN	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	GO:0005509; GO:0006898; GO:0015031; GO:0016021; GO:0043235	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g176130	Scaffold_08	21869425	21870031	NA	NA	NA	NA	NA
PGEN_.00g176140	Scaffold_08	21876123	21876383	NA	NA	NA	NA	NA
PGEN_.00g176150	Scaffold_08	21900568	21901230	NA	NA	NA	NA	NA
PGEN_.00g176160	Scaffold_08	21901344	21901679	NA	NA	NA	NA	NA
PGEN_.00g176170	Scaffold_08	21901833	21916167	Q8VCC1	PGDH_MOUSE	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	GO:0001822; GO:0003824; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0042803; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g176180	Scaffold_08	21925188	21931709	P56395	CYB5_MOUSE	Cytochrome b5	GO:0004768; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0006631; GO:0016020; GO:0016021; GO:0019899; GO:0020037; GO:0043231; GO:0046686; GO:0046872	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty acid metabolic process [GO:0006631]; response to cadmium ion [GO:0046686]
PGEN_.00g176190	Scaffold_08	21955921	21962804	NA	NA	NA	NA	NA
PGEN_.00g176200	Scaffold_08	21972505	21973966	NA	NA	NA	NA	NA
PGEN_.00g176210	Scaffold_08	22010649	22011959	NA	NA	NA	NA	NA
PGEN_.00g176220	Scaffold_08	22017709	22024572	NA	NA	NA	NA	NA
PGEN_.00g176230	Scaffold_08	22038525	22075282	Q9JIX8	ACINU_MOUSE	Apoptotic chromatin condensation inducer in the nucleus (Acinus)	GO:0003676; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006397; GO:0006915; GO:0008380; GO:0016607; GO:0030218; GO:0030263; GO:0043065; GO:0045657; GO:0048025; GO:0061574	"ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; apoptotic chromosome condensation [GO:0030263]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]"
PGEN_.00g176240	Scaffold_08	22075580	22090773	Q8C190	VP9D1_MOUSE	VPS9 domain-containing protein 1 (5-day ovary-specific transcript 1 protein)		
PGEN_.00g176250	Scaffold_08	22092433	22095654	Q8C190	VP9D1_MOUSE	VPS9 domain-containing protein 1 (5-day ovary-specific transcript 1 protein)		
PGEN_.00g176260	Scaffold_08	22100815	22101951	Q70LM4	LGRD_BREPA	Linear gramicidin synthase subunit D [Includes: ATP-dependent D-leucine adenylase (D-LeuA) (D-leucine activase); Leucine racemase [ATP-hydrolyzing] (EC 5.1.1.-); ATP-dependent tryptophan adenylase (TrpA) (Tryptophan activase); ATP-dependent glycine adenylase (GlyA) (Glycine activase); Linear gramicidin--PCP reductase (EC 1.-.-.-)]	GO:0016491; GO:0016853; GO:0016874; GO:0017000; GO:0031177	isomerase activity [GO:0016853]; ligase activity [GO:0016874]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; antibiotic biosynthetic process [GO:0017000]
PGEN_.00g176270	Scaffold_08	22112153	22113617	Q8BH75	RNF41_MOUSE	E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1)	GO:0000209; GO:0004842; GO:0005128; GO:0005135; GO:0006914; GO:0008270; GO:0008285; GO:0010468; GO:0010498; GO:0016567; GO:0017160; GO:0019904; GO:0030336; GO:0030971; GO:0043408; GO:0045619; GO:0045637; GO:0045732; GO:0048471; GO:0051091; GO:0051865; GO:0051896; GO:0061630; GO:0071782; GO:0097191; GO:1901525; GO:2000114; GO:2000377; GO:2000379	endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]; erythropoietin receptor binding [GO:0005128]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377]
PGEN_.00g176280	Scaffold_08	22114007	22117451	NA	NA	NA	NA	NA
PGEN_.00g176290	Scaffold_08	22145939	22178402	Q9VKA4	Y1760_DROME	Probable G-protein coupled receptor CG31760	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g176300	Scaffold_08	22178889	22185281	NA	NA	NA	NA	NA
PGEN_.00g176310	Scaffold_08	22298012	22298695	NA	NA	NA	NA	NA
PGEN_.00g176320	Scaffold_08	22419423	22419764	NA	NA	NA	NA	NA
PGEN_.00g176330	Scaffold_08	22419876	22420325	NA	NA	NA	NA	NA
PGEN_.00g176340	Scaffold_08	22444910	22455006	NA	NA	NA	NA	NA
PGEN_.00g176350	Scaffold_08	22512254	22542676	Q9NYG2	ZDHC3_HUMAN	Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3)	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:1903546	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to photoreceptor outer segment [GO:1903546]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]
PGEN_.00g176360	Scaffold_08	22548013	22549470	Q01149	CO1A2_MOUSE	Collagen alpha-2(I) chain (Alpha-2 type I collagen)	GO:0001501; GO:0001568; GO:0002020; GO:0005201; GO:0005581; GO:0005584; GO:0005615; GO:0005783; GO:0007179; GO:0007266; GO:0008217; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0085029	"collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein binding, bridging [GO:0030674]; SMAD binding [GO:0046332]; blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g176370	Scaffold_08	22549595	22550843	NA	NA	NA	NA	NA
PGEN_.00g176380	Scaffold_08	22566712	22584616	Q9D0M0	EXOS7_MOUSE	Exosome complex exonuclease RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42)	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005730; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"
PGEN_.00g176390	Scaffold_08	22591810	22648412	NA	NA	NA	NA	NA
PGEN_.00g176400	Scaffold_08	22666433	22676246	NA	NA	NA	NA	NA
PGEN_.00g176410	Scaffold_08	22704409	22715430	NA	NA	NA	NA	NA
PGEN_.00g176420	Scaffold_08	22722550	22728496	NA	NA	NA	NA	NA
PGEN_.00g176430	Scaffold_08	22753543	22756966	P55088	AQP4_MOUSE	Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4)	GO:0005576; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006833; GO:0007605; GO:0009897; GO:0009925; GO:0009992; GO:0010008; GO:0010574; GO:0015250; GO:0015288; GO:0015670; GO:0016020; GO:0016021; GO:0016323; GO:0030104; GO:0030315; GO:0031253; GO:0032691; GO:0032715; GO:0032991; GO:0042383; GO:0042802; GO:0051289; GO:0060354; GO:0070295; GO:0071333; GO:0071346; GO:0090660; GO:0097450; GO:0098609	astrocyte end-foot [GO:0097450]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; identical protein binding [GO:0042802]; porin activity [GO:0015288]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to glucose stimulus [GO:0071333]; cellular response to interferon-gamma [GO:0071346]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid circulation [GO:0090660]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water absorption [GO:0070295]; sensory perception of sound [GO:0007605]; water homeostasis [GO:0030104]; water transport [GO:0006833]
PGEN_.00g176440	Scaffold_08	22779970	22780290	NA	NA	NA	NA	NA
PGEN_.00g176450	Scaffold_08	22846839	22856795	NA	NA	NA	NA	NA
PGEN_.00g176460	Scaffold_08	22864808	22865143	NA	NA	NA	NA	NA
PGEN_.00g176470	Scaffold_08	22865219	22865710	NA	NA	NA	NA	NA
PGEN_.00g176480	Scaffold_08	22933333	22948780	P08684	CP3A4_HUMAN	"Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)"	GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006629; GO:0006706; GO:0006805; GO:0008202; GO:0008203; GO:0008209; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016021; GO:0016098; GO:0016491; GO:0017144; GO:0019825; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042359; GO:0042572; GO:0042573; GO:0042737; GO:0042738; GO:0042759; GO:0043231; GO:0046483; GO:0050591; GO:0050649; GO:0055114; GO:0070330; GO:0070576; GO:0070989; GO:0101020; GO:0101021; GO:0102320	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 1,8-cineole 2-exo-monooxygenase activity [GO:0102320]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; quinine 3-monooxygenase activity [GO:0050591]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]; alkaloid catabolic process [GO:0009822]; androgen metabolic process [GO:0008209]; cholesterol metabolic process [GO:0008203]; drug catabolic process [GO:0042737]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; exogenous drug catabolic process [GO:0042738]; heterocycle metabolic process [GO:0046483]; lipid hydroxylation [GO:0002933]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D metabolic process [GO:0042359]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g176490	Scaffold_08	22959377	22959613	NA	NA	NA	NA	NA
PGEN_.00g176500	Scaffold_08	22959733	22960245	NA	NA	NA	NA	NA
PGEN_.00g176510	Scaffold_08	22966205	22971154	NA	NA	NA	NA	NA
PGEN_.00g176520	Scaffold_08	22983942	23000048	NA	NA	NA	NA	NA
PGEN_.00g176530	Scaffold_08	23013262	23020508	NA	NA	NA	NA	NA
PGEN_.00g176540	Scaffold_08	23028412	23034363	NA	NA	NA	NA	NA
PGEN_.00g176550	Scaffold_08	23037471	23044488	Q9CR22	TMM42_MOUSE	Transmembrane protein 42	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g176560	Scaffold_08	23046924	23055560	O43402	EMC8_HUMAN	ER membrane protein complex subunit 8 (Neighbor of COX4) (Protein FAM158B)	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0016020; GO:0072546	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ER membrane protein complex [GO:0072546]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
PGEN_.00g176570	Scaffold_08	23063623	23099248	Q9GYZ0	KIF15_STRPU	Kinesin-like protein KIF15 (Kinesin-related protein KRP180)	GO:0003777; GO:0005524; GO:0005737; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g176580	Scaffold_08	23151036	23160335	Q3SZP0	IRF1_BOVIN	Interferon regulatory factor 1 (IRF-1)	GO:0000981; GO:0002376; GO:0005634; GO:0005737; GO:0006915; GO:0007050; GO:0008285; GO:0032481; GO:0032728; GO:0034124; GO:0044212; GO:0045590; GO:0045892; GO:0045893; GO:0051607; GO:0060333; GO:2000564	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription regulatory region DNA binding [GO:0044212]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of regulatory T cell differentiation [GO:0045590]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of MyD88-dependent toll-like receptor signaling pathway [GO:0034124]"
PGEN_.00g176590	Scaffold_08	23160532	23169146	NA	NA	NA	NA	NA
PGEN_.00g176600	Scaffold_08	23187632	23426944	Q69ZB0	LRCC1_MOUSE	Leucine-rich repeat and coiled-coil domain-containing protein 1	GO:0005737; GO:0005813; GO:0005814; GO:0007049; GO:0051301	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g176610	Scaffold_08	23443463	23445691	NA	NA	NA	NA	NA
PGEN_.00g176620	Scaffold_08	23463808	23465535	NA	NA	NA	NA	NA
PGEN_.00g176630	Scaffold_08	23493703	23507491	NA	NA	NA	NA	NA
PGEN_.00g176640	Scaffold_08	23511820	23524487	NA	NA	NA	NA	NA
PGEN_.00g176650	Scaffold_08	23530984	23552083	NA	NA	NA	NA	NA
PGEN_.00g176660	Scaffold_08	23554425	23573625	Q9XT77	SC5A6_RABIT	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g176670	Scaffold_08	23560827	23561845	NA	NA	NA	NA	NA
PGEN_.00g176680	Scaffold_08	23583901	23584281	NA	NA	NA	NA	NA
PGEN_.00g176690	Scaffold_08	23588588	23589892	NA	NA	NA	NA	NA
PGEN_.00g176700	Scaffold_08	23637928	23638197	NA	NA	NA	NA	NA
PGEN_.00g176710	Scaffold_08	23638456	23638656	NA	NA	NA	NA	NA
PGEN_.00g176720	Scaffold_08	23638767	23639180	NA	NA	NA	NA	NA
PGEN_.00g176730	Scaffold_08	23648618	23648887	NA	NA	NA	NA	NA
PGEN_.00g176740	Scaffold_08	23656868	23660249	P55088	AQP4_MOUSE	Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4)	GO:0005576; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006833; GO:0007605; GO:0009897; GO:0009925; GO:0009992; GO:0010008; GO:0010574; GO:0015250; GO:0015288; GO:0015670; GO:0016020; GO:0016021; GO:0016323; GO:0030104; GO:0030315; GO:0031253; GO:0032691; GO:0032715; GO:0032991; GO:0042383; GO:0042802; GO:0051289; GO:0060354; GO:0070295; GO:0071333; GO:0071346; GO:0090660; GO:0097450; GO:0098609	astrocyte end-foot [GO:0097450]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; identical protein binding [GO:0042802]; porin activity [GO:0015288]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to glucose stimulus [GO:0071333]; cellular response to interferon-gamma [GO:0071346]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid circulation [GO:0090660]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water absorption [GO:0070295]; sensory perception of sound [GO:0007605]; water homeostasis [GO:0030104]; water transport [GO:0006833]
PGEN_.00g176750	Scaffold_08	23666599	23666946	NA	NA	NA	NA	NA
PGEN_.00g176760	Scaffold_08	23667823	23671245	P55088	AQP4_MOUSE	Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4)	GO:0005576; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006833; GO:0007605; GO:0009897; GO:0009925; GO:0009992; GO:0010008; GO:0010574; GO:0015250; GO:0015288; GO:0015670; GO:0016020; GO:0016021; GO:0016323; GO:0030104; GO:0030315; GO:0031253; GO:0032691; GO:0032715; GO:0032991; GO:0042383; GO:0042802; GO:0051289; GO:0060354; GO:0070295; GO:0071333; GO:0071346; GO:0090660; GO:0097450; GO:0098609	astrocyte end-foot [GO:0097450]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; identical protein binding [GO:0042802]; porin activity [GO:0015288]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to glucose stimulus [GO:0071333]; cellular response to interferon-gamma [GO:0071346]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid circulation [GO:0090660]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water absorption [GO:0070295]; sensory perception of sound [GO:0007605]; water homeostasis [GO:0030104]; water transport [GO:0006833]
PGEN_.00g176770	Scaffold_08	23674127	23678179	NA	NA	NA	NA	NA
PGEN_.00g176780	Scaffold_08	23680469	23686092	NA	NA	NA	NA	NA
PGEN_.00g176790	Scaffold_08	23699681	23707139	NA	NA	NA	NA	NA
PGEN_.00g176800	Scaffold_08	23709293	23717199	NA	NA	NA	NA	NA
PGEN_.00g176810	Scaffold_08	23727595	23729002	NA	NA	NA	NA	NA
PGEN_.00g176820	Scaffold_08	23729073	23729477	NA	NA	NA	NA	NA
PGEN_.00g176830	Scaffold_08	23729479	23776490	P48764	SL9A3_HUMAN	Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3)	GO:0005623; GO:0005886; GO:0005903; GO:0006811; GO:0009986; GO:0015385; GO:0015386; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0051453; GO:0070062; GO:0071805; GO:0098719	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]
PGEN_.00g176840	Scaffold_08	23844837	23859800	NA	NA	NA	NA	NA
PGEN_.00g176850	Scaffold_08	23868475	23869779	Q5IS75	ACHB3_PANTR	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g176860	Scaffold_08	23874840	23887698	NA	NA	NA	NA	NA
PGEN_.00g176870	Scaffold_08	23892450	23905167	NA	NA	NA	NA	NA
PGEN_.00g176880	Scaffold_08	23909648	23910757	NA	NA	NA	NA	NA
PGEN_.00g176890	Scaffold_08	23934635	23946601	NA	NA	NA	NA	NA
PGEN_.00g176900	Scaffold_08	23973540	23973863	NA	NA	NA	NA	NA
PGEN_.00g176910	Scaffold_08	23979725	23980555	NA	NA	NA	NA	NA
PGEN_.00g176920	Scaffold_08	23988938	24000842	NA	NA	NA	NA	NA
PGEN_.00g176930	Scaffold_08	24032353	24033654	NA	NA	NA	NA	NA
PGEN_.00g176940	Scaffold_08	24036727	24037092	NA	NA	NA	NA	NA
PGEN_.00g176950	Scaffold_08	24118151	24119203	NA	NA	NA	NA	NA
PGEN_.00g176960	Scaffold_08	24138343	24149100	NA	NA	NA	NA	NA
PGEN_.00g176970	Scaffold_08	24197897	24204785	NA	NA	NA	NA	NA
PGEN_.00g176980	Scaffold_08	24210979	24230514	Q99489	OXDD_HUMAN	D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1)	GO:0005777; GO:0005782; GO:0005829; GO:0006531; GO:0006533; GO:0006625; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0034641; GO:0042445; GO:0048037; GO:0071949	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; cofactor binding [GO:0048037]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular nitrogen compound metabolic process [GO:0034641]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g176990	Scaffold_08	24263709	24284490	A5D6U8	ACP7_DANRE	Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)	GO:0003993; GO:0005576; GO:0046872	extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]
PGEN_.00g177000	Scaffold_08	24274003	24274455	NA	NA	NA	NA	NA
PGEN_.00g177010	Scaffold_08	24301289	24309626	Q6ZNF0	ACP7_HUMAN	Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)	GO:0003993; GO:0005576; GO:0046872	extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]
PGEN_.00g177020	Scaffold_08	24319353	24333241	Q3URE1	ACSF3_MOUSE	"Malonate--CoA ligase ACSF3, mitochondrial (EC 6.2.1.n3) (Acyl-CoA synthetase family member 3)"	GO:0005524; GO:0005739; GO:0006631; GO:0006633; GO:0016878; GO:0031957; GO:0090409; GO:0090410	mitochondrion [GO:0005739]; acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; malonate catabolic process [GO:0090410]
PGEN_.00g177030	Scaffold_08	24338027	24338802	NA	NA	NA	NA	NA
PGEN_.00g177040	Scaffold_08	24339505	24340133	NA	NA	NA	NA	NA
PGEN_.00g177050	Scaffold_08	24340148	24350129	NA	NA	NA	NA	NA
PGEN_.00g177060	Scaffold_08	24340460	24340762	NA	NA	NA	NA	NA
PGEN_.00g177070	Scaffold_08	24353793	24359910	O88554	PARP2_MOUSE	Poly [ADP-ribose] polymerase 2 (PARP-2) (mPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-)	GO:0003677; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0018312; GO:0030592; GO:0061051; GO:0070212; GO:0097191; GO:0140294; GO:1901215; GO:1990404	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g177080	Scaffold_08	24370136	24370828	NA	NA	NA	NA	NA
PGEN_.00g177090	Scaffold_08	24394004	24429599	O88554	PARP2_MOUSE	Poly [ADP-ribose] polymerase 2 (PARP-2) (mPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-)	GO:0003677; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0018312; GO:0030592; GO:0061051; GO:0070212; GO:0097191; GO:0140294; GO:1901215; GO:1990404	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g177100	Scaffold_08	24435103	24436741	NA	NA	NA	NA	NA
PGEN_.00g177110	Scaffold_08	24462472	24495151	Q9PVZ4	INSR_XENLA	Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta]	GO:0004713; GO:0004714; GO:0005009; GO:0005524; GO:0005886; GO:0005887; GO:0007275; GO:0008286; GO:0016020; GO:0042169; GO:0043548; GO:0043559; GO:0043560; GO:0046777; GO:0051290; GO:0051425	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; insulin receptor signaling pathway [GO:0008286]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; protein heterotetramerization [GO:0051290]
PGEN_.00g177120	Scaffold_08	24502525	24505002	Q9CR78	MSD3_MOUSE	Myb/SANT-like DNA-binding domain-containing protein 3	GO:0042802	identical protein binding [GO:0042802]
PGEN_.00g177130	Scaffold_08	24508625	24619344	NA	NA	NA	NA	NA
PGEN_.00g177140	Scaffold_08	24591517	24601661	NA	NA	NA	NA	NA
PGEN_.00g177150	Scaffold_08	24632029	24704106	NA	NA	NA	NA	NA
PGEN_.00g177160	Scaffold_08	24706201	24869597	E9Q7X6	HEG1_MOUSE	Protein HEG homolog 1	GO:0001570; GO:0001701; GO:0001885; GO:0001886; GO:0001944; GO:0001945; GO:0003017; GO:0003209; GO:0003222; GO:0003281; GO:0005509; GO:0005911; GO:0007043; GO:0007507; GO:0009791; GO:0009897; GO:0009986; GO:0016021; GO:0030324; GO:0035024; GO:0035264; GO:0045216; GO:0048845; GO:0050878; GO:0055017; GO:0060039; GO:0090271; GO:1902414; GO:1905709; GO:2000299	cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; endothelial cell development [GO:0001885]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222]
PGEN_.00g177170	Scaffold_08	24874085	24877138	Q8IYB1	M21D2_HUMAN	Protein MB21D2 (Mab-21 domain-containing protein 2)	GO:0044877; GO:0045296	cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]
PGEN_.00g177180	Scaffold_08	24878738	24879370	NA	NA	NA	NA	NA
PGEN_.00g177190	Scaffold_08	24880041	24882667	NA	NA	NA	NA	NA
PGEN_.00g177200	Scaffold_08	24884946	24893982	P62314	SMD1_HUMAN	Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (Sm-D autoantigen) (snRNP core protein D1)	GO:0000243; GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0008380; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0051170; GO:0071005; GO:0071007; GO:0071013; GO:1990446	"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]"
PGEN_.00g177210	Scaffold_08	24899720	24905179	NA	NA	NA	NA	NA
PGEN_.00g177220	Scaffold_08	24907230	24907655	NA	NA	NA	NA	NA
PGEN_.00g177230	Scaffold_08	24911967	24934933	Q07954	LRP1_HUMAN	Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]	GO:0001523; GO:0001540; GO:0002020; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005623; GO:0005634; GO:0005765; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0007568; GO:0008283; GO:0010715; GO:0010875; GO:0010942; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030226; GO:0030425; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038023; GO:0038024; GO:0042157; GO:0042953; GO:0043025; GO:0043235; GO:0043277; GO:0043395; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045056; GO:0045177; GO:0045202; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051481; GO:0051895; GO:0061642; GO:0070325; GO:0070374; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905049; GO:1905167; GO:2000587	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; synapse [GO:0045202]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]
PGEN_.00g177240	Scaffold_08	24934997	24937817	NA	NA	NA	NA	NA
PGEN_.00g177250	Scaffold_08	24950423	24969243	Q9JI18	LRP1B_MOUSE	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	GO:0001701; GO:0005041; GO:0005509; GO:0016020; GO:0016021; GO:0043235; GO:0050750	integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]; in utero embryonic development [GO:0001701]
PGEN_.00g177260	Scaffold_08	24978191	25008038	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g177270	Scaffold_08	25017449	25028378	Q95116	TSP2_BOVIN	Thrombospondin-2 (Corticotropin-induced secreted protein) (CISP)	GO:0005509; GO:0007155; GO:0008201; GO:0016525; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]
PGEN_.00g177280	Scaffold_08	25074583	25089212	P55040	GEM_HUMAN	GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR)	GO:0000278; GO:0000287; GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005623; GO:0005634; GO:0005886; GO:0006955; GO:0007165; GO:0007166; GO:0009898; GO:0019003; GO:0030496; GO:0051233; GO:0051276; GO:0051310; GO:0072686; GO:1901842	cell [GO:0005623]; cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]
PGEN_.00g177290	Scaffold_08	25146194	25149245	NA	NA	NA	NA	NA
PGEN_.00g177300	Scaffold_08	25194861	25196719	NA	NA	NA	NA	NA
PGEN_.00g177310	Scaffold_08	25240883	25262783	A2RT91	ANKAR_MOUSE	Ankyrin and armadillo repeat-containing protein	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g177320	Scaffold_08	25279230	25288598	Q9CY94	PSF3_MOUSE	DNA replication complex GINS protein PSF3 (GINS complex subunit 3)	GO:0005654; GO:0006260	nucleoplasm [GO:0005654]; DNA replication [GO:0006260]
PGEN_.00g177330	Scaffold_08	25306185	25333821	P77619	YFEW_ECOLI	Putative D-alanyl-D-alanine carboxypeptidase (EC 3.4.16.4) (DD-carboxypeptidase) (DD-CPase) (Penicillin binding protein 4B)	GO:0008658; GO:0009002; GO:0016021; GO:0031226	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; penicillin binding [GO:0008658]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]
PGEN_.00g177340	Scaffold_08	25340227	25346937	NA	NA	NA	NA	NA
PGEN_.00g177350	Scaffold_08	25356059	25381258	P23606	TGM1_RAT	Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)	GO:0003810; GO:0005913; GO:0009887; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031224; GO:0031424; GO:0045787; GO:0046872	cell-cell adherens junction [GO:0005913]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; animal organ morphogenesis [GO:0009887]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]
PGEN_.00g177360	Scaffold_08	25400788	25401063	NA	NA	NA	NA	NA
PGEN_.00g177370	Scaffold_08	25401236	25401751	NA	NA	NA	NA	NA
PGEN_.00g177380	Scaffold_08	25416380	25436366	Q05187	TGMH_TACTR	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)	GO:0003810; GO:0016020; GO:0018149; GO:0046872	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]
PGEN_.00g177390	Scaffold_08	25443238	25452358	NA	NA	NA	NA	NA
PGEN_.00g177400	Scaffold_08	25452436	25454043	NA	NA	NA	NA	NA
PGEN_.00g177410	Scaffold_08	25463381	25465585	NA	NA	NA	NA	NA
PGEN_.00g177420	Scaffold_08	25470117	25471201	NA	NA	NA	NA	NA
PGEN_.00g177430	Scaffold_08	25471864	25493248	NA	NA	NA	NA	NA
PGEN_.00g177440	Scaffold_08	25507638	25509784	P11404	FABPH_MOUSE	"Fatty acid-binding protein, heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein) (H-FABP) (Mammary-derived growth inhibitor) (MDGI)"	GO:0005324; GO:0005504; GO:0005615; GO:0005737; GO:0005829; GO:0006631; GO:0008092; GO:0015909; GO:0016528; GO:0032365; GO:0032868; GO:0036041; GO:0042493; GO:0042632; GO:0046320; GO:0050543; GO:0050873; GO:0055091; GO:0070538; GO:0070542; GO:0071073; GO:0140214; GO:2001245	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; sarcoplasm [GO:0016528]; cytoskeletal protein binding [GO:0008092]; fatty acid binding [GO:0005504]; icosatetraenoic acid binding [GO:0050543]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; oleic acid binding [GO:0070538]; brown fat cell differentiation [GO:0050873]; cholesterol homeostasis [GO:0042632]; fatty acid metabolic process [GO:0006631]; intracellular lipid transport [GO:0032365]; long-chain fatty acid transport [GO:0015909]; phospholipid homeostasis [GO:0055091]; positive regulation of long-chain fatty acid import into cell [GO:0140214]; positive regulation of phospholipid biosynthetic process [GO:0071073]; regulation of fatty acid oxidation [GO:0046320]; regulation of phosphatidylcholine biosynthetic process [GO:2001245]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to insulin [GO:0032868]
PGEN_.00g177450	Scaffold_08	25517693	25530222	NA	NA	NA	NA	NA
PGEN_.00g177460	Scaffold_08	25545123	25549578	NA	NA	NA	NA	NA
PGEN_.00g177470	Scaffold_08	25632738	25655239	Q4R591	G6PI_MACFA	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)	GO:0004347; GO:0005125; GO:0005615; GO:0005737; GO:0006094; GO:0006096; GO:0051156	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]
PGEN_.00g177480	Scaffold_08	25667212	25678154	NA	NA	NA	NA	NA
PGEN_.00g177490	Scaffold_08	25690482	25698833	Q98T89	TWSG1_CHICK	Twisted gastrulation protein homolog 1	GO:0001503; GO:0001707; GO:0001818; GO:0005615; GO:0007179; GO:0007435; GO:0010862; GO:0030097; GO:0030154; GO:0030509; GO:0030513; GO:0030514; GO:0030900; GO:0043010; GO:0045668; GO:0050431; GO:2000562	"extracellular space [GO:0005615]; transforming growth factor beta binding [GO:0050431]; BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; forebrain development [GO:0030900]; hemopoiesis [GO:0030097]; mesoderm formation [GO:0001707]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of cytokine production [GO:0001818]; negative regulation of osteoblast differentiation [GO:0045668]; ossification [GO:0001503]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; salivary gland morphogenesis [GO:0007435]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g177500	Scaffold_08	25707877	25714357	NA	NA	NA	NA	NA
PGEN_.00g177510	Scaffold_08	25719503	25729899	Q9W4P5	VA0D1_DROME	V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (V-ATPase 39 kDa subunit) (Vacuolar H+ ATPase subunit AC39-1) (Vacuolar proton pump subunit d 1)	GO:0000220; GO:0005623; GO:0005765; GO:0005769; GO:0005886; GO:0006879; GO:0007034; GO:0007035; GO:0007430; GO:0008553; GO:0016471; GO:0033181; GO:0036295; GO:0046961; GO:1902600	"cell [GO:0005623]; early endosome [GO:0005769]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; proton transmembrane transport [GO:1902600]; terminal branching, open tracheal system [GO:0007430]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]"
PGEN_.00g177520	Scaffold_08	25735361	25749581	P51893	SAHHA_XENLA	Adenosylhomocysteinase A (AdoHcyase A) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase A)	GO:0004013; GO:0006730	adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]
PGEN_.00g177530	Scaffold_08	25758663	25764358	NA	NA	NA	NA	NA
PGEN_.00g177540	Scaffold_08	25775426	25785947	Q80YR9	R12BA_MOUSE	RNA-binding protein 12B-A (RNA-binding motif protein 12B-A)	GO:0003723	RNA binding [GO:0003723]
PGEN_.00g177550	Scaffold_08	25822028	25828064	Q5HYA8	MKS3_HUMAN	Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67)	GO:0005789; GO:0005813; GO:0010826; GO:0016021; GO:0030433; GO:0030659; GO:0031005; GO:0035869; GO:0036038; GO:0051082; GO:0060170; GO:0060271; GO:0097711	centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; filamin binding [GO:0031005]; unfolded protein binding [GO:0051082]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; negative regulation of centrosome duplication [GO:0010826]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g177560	Scaffold_08	25872963	25889020	Q7ZXB8	PAB2B_XENLA	Polyadenylate-binding protein 2-B (PABP-2-B) (Poly(A)-binding protein 2-B) (Nuclear poly(A)-binding protein 1-B) (Poly(A)-binding protein II-B) (PABII-B) (Polyadenylate-binding nuclear protein 1-B) (XLnPABP2-B) (nPABP2-B) (xPABPII-B)	GO:0000165; GO:0003723; GO:0005634; GO:0005737; GO:0006378; GO:0008143; GO:0042405; GO:0070063; GO:0071222; GO:1904247; GO:1990904	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]
PGEN_.00g177570	Scaffold_08	25903774	25985208	P30684	GNAS_LYMST	Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein)	GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g177580	Scaffold_08	26014041	26038251	Q9DE07	NBN_CHICK	Nibrin (Nijmegen breakage syndrome protein 1 homolog)	GO:0000723; GO:0000724; GO:0000784; GO:0003684; GO:0005654; GO:0006281; GO:0006302; GO:0007093; GO:0007095; GO:0008134; GO:0016233; GO:0030870; GO:0032508; GO:0042405; GO:0042770; GO:0047485; GO:0048145; GO:0051321	"Mre11 complex [GO:0030870]; nuclear chromosome, telomeric region [GO:0000784]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; damaged DNA binding [GO:0003684]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mitotic cell cycle checkpoint [GO:0007093]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of fibroblast proliferation [GO:0048145]; signal transduction in response to DNA damage [GO:0042770]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]"
PGEN_.00g177590	Scaffold_08	26073495	26092539	NA	NA	NA	NA	NA
PGEN_.00g177600	Scaffold_08	26112590	26118269	NA	NA	NA	NA	NA
PGEN_.00g177610	Scaffold_08	26179902	26187036	Q8WYA6	CTBL1_HUMAN	Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) (Testis development protein NYD-SP19)	GO:0000398; GO:0000974; GO:0005634; GO:0005654; GO:0005681; GO:0005813; GO:0005829; GO:0006915; GO:0016020; GO:0016445; GO:0019899; GO:0043065	"centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; enzyme binding [GO:0019899]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]"
PGEN_.00g177620	Scaffold_08	26197984	26230816	Q6TQE1	ZCH18_RAT	Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1)	GO:0005634; GO:0032991; GO:0046872	nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]
PGEN_.00g177630	Scaffold_08	26238200	26242635	NA	NA	NA	NA	NA
PGEN_.00g177640	Scaffold_08	26252036	26256533	NA	NA	NA	NA	NA
PGEN_.00g177650	Scaffold_08	26261936	26264149	NA	NA	NA	NA	NA
PGEN_.00g177660	Scaffold_08	26272737	26273402	NA	NA	NA	NA	NA
PGEN_.00g177670	Scaffold_08	26274096	26281591	Q95SS8	TMM70_DROME	"Transmembrane protein 70 homolog, mitochondrial"	GO:0032592; GO:0033615	integral component of mitochondrial membrane [GO:0032592]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]
PGEN_.00g177680	Scaffold_08	26288313	26408459	O15943	CADN_DROME	Neural-cadherin (Cadherin-N) (dN-cadherin)	GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0008013; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609	axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]
PGEN_.00g177690	Scaffold_08	26397653	26397880	NA	NA	NA	NA	NA
PGEN_.00g177700	Scaffold_08	26419147	26428155	Q5C9L6	CNMT_THLFG	(S)-coclaurine N-methyltransferase (TfCNMT) (EC 2.1.1.140)	GO:0005737; GO:0030794; GO:0032259	cytoplasm [GO:0005737]; (S)-coclaurine-N-methyltransferase activity [GO:0030794]; methylation [GO:0032259]
PGEN_.00g177710	Scaffold_08	26430985	26440434	O94817	ATG12_HUMAN	Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like)	GO:0000045; GO:0000422; GO:0005776; GO:0005829; GO:0006501; GO:0016236; GO:0019776; GO:0030670; GO:0034045; GO:0034274	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; cytosol [GO:0005829]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]
PGEN_.00g177720	Scaffold_08	26447477	26455333	NA	NA	NA	NA	NA
PGEN_.00g177730	Scaffold_08	26458639	26459031	NA	NA	NA	NA	NA
PGEN_.00g177740	Scaffold_08	26515927	26619749	Q9NSC2	SALL1_HUMAN	Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1) (HSal1) (Sal-1)	GO:0000122; GO:0000792; GO:0000978; GO:0001227; GO:0001657; GO:0001658; GO:0001822; GO:0003281; GO:0003337; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007507; GO:0008013; GO:0008406; GO:0010369; GO:0021553; GO:0021889; GO:0021983; GO:0030177; GO:0030325; GO:0031129; GO:0035019; GO:0042473; GO:0042733; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048566; GO:0060173; GO:0061034; GO:0072073; GO:0072092	"chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; gonad development [GO:0008406]; heart development [GO:0007507]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; outer ear morphogenesis [GO:0042473]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]"
PGEN_.00g177750	Scaffold_08	26628035	26629266	NA	NA	NA	NA	NA
PGEN_.00g177760	Scaffold_08	26676167	26676553	NA	NA	NA	NA	NA
PGEN_.00g177770	Scaffold_08	26683203	26684621	NA	NA	NA	NA	NA
PGEN_.00g177780	Scaffold_08	26685261	26685509	NA	NA	NA	NA	NA
PGEN_.00g177790	Scaffold_08	26756314	26775189	F1QYJ6	ST6B1_DANRE	Sulfotransferase 6B1 (EC 2.8.2.-) (Thyroxine sulfotransferase) (EC 2.8.2.n2)	GO:0008146; GO:0071466	sulfotransferase activity [GO:0008146]; cellular response to xenobiotic stimulus [GO:0071466]
PGEN_.00g177800	Scaffold_08	26778126	26778371	NA	NA	NA	NA	NA
PGEN_.00g177810	Scaffold_08	26787824	26788102	NA	NA	NA	NA	NA
PGEN_.00g177820	Scaffold_08	26788680	26789222	NA	NA	NA	NA	NA
PGEN_.00g177830	Scaffold_08	26799727	26820278	Q9ESD6	CKLF7_MOUSE	CKLF-like MARVEL transmembrane domain-containing protein 7 (Chemokine-like factor superfamily member 7) (LNV)	GO:0002337; GO:0005125; GO:0005615; GO:0006935; GO:0016021	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; cytokine activity [GO:0005125]; B-1a B cell differentiation [GO:0002337]; chemotaxis [GO:0006935]
PGEN_.00g177840	Scaffold_08	26833450	26835963	Q5RJT2	SPB1_RAT	pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (EC 2.1.1.-) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)	GO:0000453; GO:0000463; GO:0000466; GO:0001510; GO:0005654; GO:0005730; GO:0008650; GO:0016435; GO:0030687; GO:0030688; GO:0031167; GO:0062105	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA 2'-O-methyltransferase activity [GO:0062105]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]"
PGEN_.00g177850	Scaffold_08	26853245	26858437	Q8C827	ZFP62_MOUSE	Zinc finger protein 62 (Zfp-62) (ZT3)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g177860	Scaffold_08	26866001	26866792	NA	NA	NA	NA	NA
PGEN_.00g177870	Scaffold_08	26872420	26876969	P61804	DAD1_MOUSE	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (Oligosaccharyl transferase subunit DAD1) (Defender against cell death 1) (DAD-1)	GO:0001824; GO:0004579; GO:0006486; GO:0006487; GO:0006915; GO:0007584; GO:0008250; GO:0016021; GO:0042493; GO:0043066	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of apoptotic process [GO:0043066]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; response to drug [GO:0042493]; response to nutrient [GO:0007584]
PGEN_.00g177880	Scaffold_08	26883109	26905213	Q9UKV5	AMFR_HUMAN	E3 ubiquitin-protein ligase AMFR (EC 2.3.2.27) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (RING-type E3 ubiquitin transferase AMFR) (gp78)	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006457; GO:0006511; GO:0007165; GO:0007568; GO:0007611; GO:0016020; GO:0016021; GO:0016055; GO:0016567; GO:0030176; GO:0030425; GO:0030426; GO:0030433; GO:0030674; GO:0030968; GO:0032092; GO:0032991; GO:0034450; GO:0036513; GO:0038023; GO:0042802; GO:0043025; GO:0044322; GO:0046872; GO:0048471; GO:0051087; GO:0051259; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1904380; GO:1990381	"cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein binding, bridging [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein complex oligomerization [GO:0051259]; protein folding [GO:0006457]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g177890	Scaffold_08	26905685	26929763	Q17QH8	D39U1_BOVIN	Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1)	GO:0016491; GO:0050662	coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]
PGEN_.00g177900	Scaffold_08	26936132	26937607	P35816	PDP1_BOVIN	"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial (PDP 1) (EC 3.1.3.43) (Protein phosphatase 2C) (Pyruvate dehydrogenase phosphatase catalytic subunit 1) (PDPC 1)"	GO:0000287; GO:0004722; GO:0004724; GO:0004741; GO:0005509; GO:0005739; GO:0005759; GO:0016311; GO:1904184	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; protein serine/threonine phosphatase activity [GO:0004722]; dephosphorylation [GO:0016311]; positive regulation of pyruvate dehydrogenase activity [GO:1904184]
PGEN_.00g177910	Scaffold_08	26961810	26962778	P67962	KC1A_CHICK	Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)	GO:0000777; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007049; GO:0016055; GO:0016607; GO:0018105; GO:0036064; GO:0045104; GO:0051301; GO:0090090	ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]
PGEN_.00g177920	Scaffold_08	26963037	27007730	Q502J0	PCAT2_DANRE	Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1)	GO:0000139; GO:0003841; GO:0005509; GO:0005789; GO:0005811; GO:0008654; GO:0016021; GO:0047184; GO:0047192	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; calcium ion binding [GO:0005509]; phospholipid biosynthetic process [GO:0008654]
PGEN_.00g177930	Scaffold_08	27021843	27051983	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g177940	Scaffold_08	27073202	27083362	Q5M882	RPP29_RAT	Ribonuclease P protein subunit p29 (EC 3.1.26.5)	GO:0000172; GO:0001682; GO:0004526; GO:0005730; GO:0006364; GO:0030677; GO:0030681; GO:0033204	multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]; ribonuclease MRP complex [GO:0000172]; ribonuclease P complex [GO:0030677]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]
PGEN_.00g177950	Scaffold_08	27083428	27086887	Q5M8Z2	PREY_XENTR	"Protein preY, mitochondrial"	GO:0000506; GO:0005739; GO:0005829; GO:0006506	cytosol [GO:0005829]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; mitochondrion [GO:0005739]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g177960	Scaffold_08	27095656	27121867	Q60855	RIPK1_MOUSE	Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1)	GO:0001934; GO:0004672; GO:0004674; GO:0004706; GO:0005123; GO:0005524; GO:0005739; GO:0005829; GO:0006915; GO:0007257; GO:0008219; GO:0010940; GO:0010942; GO:0016032; GO:0031264; GO:0031625; GO:0032757; GO:0032760; GO:0032991; GO:0034612; GO:0036289; GO:0042327; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043068; GO:0043123; GO:0043124; GO:0043235; GO:0043410; GO:0044257; GO:0044877; GO:0045121; GO:0045651; GO:0045944; GO:0046330; GO:0046777; GO:0051092; GO:0051260; GO:0051291; GO:0060044; GO:0060545; GO:0070231; GO:0070266; GO:0070301; GO:0070513; GO:0070926; GO:0071356; GO:0071363; GO:0097191; GO:0097300; GO:0097342; GO:0097343; GO:0097527; GO:1901026; GO:1903265; GO:1903800; GO:1905206; GO:1990000; GO:2000134; GO:2000377; GO:2001237; GO:2001238; GO:2001240	cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ripoptosome [GO:0097342]; ATP binding [GO:0005524]; death domain binding [GO:0070513]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; activation of JUN kinase activity [GO:0007257]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular protein catabolic process [GO:0044257]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway [GO:0097191]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of necroptotic process [GO:0060545]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of ATP:ADP antiporter activity [GO:0070926]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to tumor necrosis factor [GO:0034612]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; viral process [GO:0016032]
PGEN_.00g177970	Scaffold_08	27126520	27137709	Q28IB1	NUDC1_XENTR	NudC domain-containing protein 1	GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g177980	Scaffold_08	27179225	27190044	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g177990	Scaffold_08	27201061	27201354	NA	NA	NA	NA	NA
PGEN_.00g178000	Scaffold_08	27201436	27202259	NA	NA	NA	NA	NA
PGEN_.00g178010	Scaffold_08	27207400	27215521	NA	NA	NA	NA	NA
PGEN_.00g178020	Scaffold_08	27225371	27260227	Q9WTR6	XCT_MOUSE	Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (xCT)	GO:0005791; GO:0005856; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0014070; GO:0015179; GO:0016020; GO:0016021; GO:0021591; GO:0021756; GO:0030534; GO:0031526; GO:0033029; GO:0034599; GO:0034775; GO:0035094; GO:0042127; GO:0043231; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070306; GO:0070527; GO:0071702; GO:0090461; GO:0097449; GO:0098712; GO:0140206; GO:1900407; GO:1901494; GO:1903204; GO:1903786; GO:1904717; GO:2000211	apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; L-amino acid transmembrane transporter activity [GO:0015179]; adult behavior [GO:0030534]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; organic substance transport [GO:0071702]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542]
PGEN_.00g178030	Scaffold_08	27264317	27266577	NA	NA	NA	NA	NA
PGEN_.00g178040	Scaffold_08	27273100	27296031	Q8R4E1	TIP_RAT	T-cell immunomodulatory protein (Protein TIP) (CDA08-like protein) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin)	GO:0005576; GO:0005886; GO:0016021	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g178050	Scaffold_08	27296153	27311857	NA	NA	NA	NA	NA
PGEN_.00g178060	Scaffold_08	27322710	27326916	P70172	NTCP2_MOUSE	"Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2)"	GO:0000502; GO:0005634; GO:0005902; GO:0008508; GO:0009617; GO:0015721; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721]; response to bacterium [GO:0009617]
PGEN_.00g178070	Scaffold_08	27328426	27331766	Q28727	NTCP2_RABIT	"Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2)"	GO:0008508; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; bile acid:sodium symporter activity [GO:0008508]
PGEN_.00g178080	Scaffold_08	27340736	27388959	Q76IQ7	TOX2_RAT	TOX high mobility group box family member 2 (Granulosa cell HMG box protein 1) (GCX-1)	GO:0000978; GO:0001085; GO:0001228; GO:0005634; GO:0008585; GO:0034698; GO:0045944	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; female gonad development [GO:0008585]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to gonadotropin [GO:0034698]"
PGEN_.00g178090	Scaffold_08	27352013	27352468	NA	NA	NA	NA	NA
PGEN_.00g178100	Scaffold_08	27412184	27424743	Q7JWG9	RM52_DROME	"39S ribosomal protein L52, mitochondrial (L52mt) (MRP-L52)"	GO:0003735; GO:0005762; GO:0006412; GO:0032543	mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
PGEN_.00g178110	Scaffold_08	27426448	27447742	Q5RJI4	PKDCC_MOUSE	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g178120	Scaffold_08	27501083	27503134	Q8N884	CGAS_HUMAN	Cyclic GMP-AMP synthase (cGAMP synthase) (cGAS) (h-cGAS) (EC 2.7.7.86) (2'3'-cGAMP synthase) (Mab-21 domain-containing protein 1)	GO:0002218; GO:0002230; GO:0002637; GO:0003677; GO:0003682; GO:0003690; GO:0005524; GO:0005525; GO:0005546; GO:0005634; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0008340; GO:0010753; GO:0016032; GO:0032481; GO:0035861; GO:0038001; GO:0043950; GO:0045087; GO:0046872; GO:0050863; GO:0051607; GO:0061501; GO:0071360; GO:2000042; GO:2000774	"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclic-GMP-AMP synthase activity [GO:0061501]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; activation of innate immune response [GO:0002218]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; paracrine signaling [GO:0038001]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of immunoglobulin production [GO:0002637]; regulation of T cell activation [GO:0050863]; viral process [GO:0016032]"
PGEN_.00g178130	Scaffold_08	27515117	27532585	O88576	S6A18_MOUSE	Sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3)	GO:0003333; GO:0005328; GO:0005886; GO:0005887; GO:0015175; GO:0016324; GO:0031526	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transmembrane transport [GO:0003333]
PGEN_.00g178140	Scaffold_08	27569778	27587811	NA	NA	NA	NA	NA
PGEN_.00g178150	Scaffold_08	27595083	27606363	Q06136	KDSR_HUMAN	3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1)	GO:0005615; GO:0005783; GO:0005789; GO:0006666; GO:0016020; GO:0016021; GO:0030148; GO:0047560	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3-dehydrosphinganine reductase activity [GO:0047560]; 3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g178160	Scaffold_08	27623113	27645475	Q9NW15	ANO10_HUMAN	Anoctamin-10 (Transmembrane protein 16K)	GO:0005227; GO:0005229; GO:0005886; GO:0006812; GO:0006821; GO:0016020; GO:0016021; GO:0034220; GO:0043231	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; intracellular calcium activated chloride channel activity [GO:0005229]; cation transport [GO:0006812]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]
PGEN_.00g178170	Scaffold_08	27662118	27662330	NA	NA	NA	NA	NA
PGEN_.00g178180	Scaffold_08	27669500	27674370	P40197	GPV_HUMAN	Platelet glycoprotein V (GPV) (Glycoprotein 5) (CD antigen CD42d)	GO:0005886; GO:0005887; GO:0007155; GO:0007596; GO:0007597; GO:0030168; GO:0070062	"extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; platelet activation [GO:0030168]"
PGEN_.00g178190	Scaffold_08	27687942	27728812	P76482	YFBL_ECOLI	Uncharacterized protein YfbL	GO:0004177; GO:0006508; GO:0016021	integral component of membrane [GO:0016021]; aminopeptidase activity [GO:0004177]; proteolysis [GO:0006508]
PGEN_.00g178200	Scaffold_08	27731631	27732790	NA	NA	NA	NA	NA
PGEN_.00g178210	Scaffold_08	27733364	27737069	NA	NA	NA	NA	NA
PGEN_.00g178220	Scaffold_08	27737279	27737626	NA	NA	NA	NA	NA
PGEN_.00g178230	Scaffold_08	27814844	27816175	Q8C8R3	ANK2_MOUSE	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin)	GO:0002027; GO:0005623; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0005887; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0030018; GO:0030315; GO:0030674; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001257; GO:2001259	"A band [GO:0031672]; cell [GO:0005623]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; protein binding, bridging [GO:0030674]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]"
PGEN_.00g178240	Scaffold_08	27819506	27839625	Q9BRT2	UQCC2_HUMAN	Ubiquinol-cytochrome-c reductase complex assembly factor 2 (Breast cancer-associated protein SGA-81M) (Mitochondrial nucleoid factor 1) (Mitochondrial protein M19)	GO:0002082; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0016604; GO:0034551; GO:0042645; GO:0050796; GO:0070131; GO:1903364; GO:2001014	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of mitochondrial translation [GO:0070131]; regulation of insulin secretion [GO:0050796]; regulation of oxidative phosphorylation [GO:0002082]; regulation of skeletal muscle cell differentiation [GO:2001014]
PGEN_.00g178250	Scaffold_08	27849713	27883042	O70583	TRI18_MOUSE	E3 ubiquitin-protein ligase Midline-1 (EC 2.3.2.27) (Midin) (RING finger protein Midline-1) (RING-type E3 ubiquitin transferase Midline-1) (Tripartite motif-containing protein 18)	GO:0005737; GO:0005874; GO:0005881; GO:0007026; GO:0008017; GO:0008270; GO:0015630; GO:0016740; GO:0031625; GO:0032874; GO:0035372; GO:0042802; GO:0042803; GO:0046982; GO:0051219	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372]
PGEN_.00g178260	Scaffold_08	27884873	27885403	NA	NA	NA	NA	NA
PGEN_.00g178270	Scaffold_08	27888855	27910563	Q9H8M2	BRD9_HUMAN	Bromodomain-containing protein 9 (Rhabdomyosarcoma antigen MU-RMS-40.8)	GO:0003676; GO:0006325; GO:0016514; GO:0070577	SWI/SNF complex [GO:0016514]; lysine-acetylated histone binding [GO:0070577]; nucleic acid binding [GO:0003676]; chromatin organization [GO:0006325]
PGEN_.00g178280	Scaffold_08	27916464	27918296	NA	NA	NA	NA	NA
PGEN_.00g178290	Scaffold_08	27921280	27921564	NA	NA	NA	NA	NA
PGEN_.00g178300	Scaffold_08	27924938	27954702	Q8BJ64	CHDH_MOUSE	"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)"	GO:0005739; GO:0005743; GO:0008812; GO:0019285; GO:0050660	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285]
PGEN_.00g178310	Scaffold_08	27966495	27968961	NA	NA	NA	NA	NA
PGEN_.00g178320	Scaffold_08	28002520	28038133	Q9NRH2	SNRK_HUMAN	SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase)	GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0030099; GO:0035556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]
PGEN_.00g178330	Scaffold_08	28048477	28048704	NA	NA	NA	NA	NA
PGEN_.00g178340	Scaffold_08	28065415	28163181	Q8TE73	DYH5_HUMAN	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)"	GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"
PGEN_.00g178350	Scaffold_08	28187083	28189487	NA	NA	NA	NA	NA
PGEN_.00g178360	Scaffold_08	28231638	28233018	NA	NA	NA	NA	NA
PGEN_.00g178370	Scaffold_08	28280121	28293794	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g178380	Scaffold_08	28298017	28298460	NA	NA	NA	NA	NA
PGEN_.00g178390	Scaffold_08	28298853	28299476	NA	NA	NA	NA	NA
PGEN_.00g178400	Scaffold_08	28299679	28300812	NA	NA	NA	NA	NA
PGEN_.00g178410	Scaffold_08	28315138	28316718	NA	NA	NA	NA	NA
PGEN_.00g178420	Scaffold_08	28338609	28340900	NA	NA	NA	NA	NA
PGEN_.00g178430	Scaffold_08	28407786	28408082	A1ADJ6	NEUO_ECOK1	Polysialic acid O-acetyltransferase (EC 2.3.1.136) (Capsule O-acetyl transferase)	GO:0050208; GO:0070207	polysialic-acid O-acetyltransferase activity [GO:0050208]; protein homotrimerization [GO:0070207]
PGEN_.00g178440	Scaffold_08	28408475	28408909	A1ADJ6	NEUO_ECOK1	Polysialic acid O-acetyltransferase (EC 2.3.1.136) (Capsule O-acetyl transferase)	GO:0050208; GO:0070207	polysialic-acid O-acetyltransferase activity [GO:0050208]; protein homotrimerization [GO:0070207]
PGEN_.00g178450	Scaffold_08	28409165	28409392	NA	NA	NA	NA	NA
PGEN_.00g178460	Scaffold_08	28409461	28410042	A1ADJ6	NEUO_ECOK1	Polysialic acid O-acetyltransferase (EC 2.3.1.136) (Capsule O-acetyl transferase)	GO:0050208; GO:0070207	polysialic-acid O-acetyltransferase activity [GO:0050208]; protein homotrimerization [GO:0070207]
PGEN_.00g178470	Scaffold_08	28410470	28414154	NA	NA	NA	NA	NA
PGEN_.00g178480	Scaffold_08	28426647	28441363	NA	NA	NA	NA	NA
PGEN_.00g178490	Scaffold_08	28515126	28518708	NA	NA	NA	NA	NA
PGEN_.00g178500	Scaffold_08	28521330	28533661	NA	NA	NA	NA	NA
PGEN_.00g178510	Scaffold_08	28584095	28585355	NA	NA	NA	NA	NA
PGEN_.00g178520	Scaffold_08	28638823	28639473	NA	NA	NA	NA	NA
PGEN_.00g178530	Scaffold_08	28639515	28640069	NA	NA	NA	NA	NA
PGEN_.00g178540	Scaffold_08	28640299	28640580	NA	NA	NA	NA	NA
PGEN_.00g178550	Scaffold_08	28640648	28642141	NA	NA	NA	NA	NA
PGEN_.00g178560	Scaffold_08	28645668	28655772	Q8CG65	SSPO_MOUSE	SCO-spondin	GO:0005615; GO:0005737; GO:0007155; GO:0007399; GO:0030154; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g178570	Scaffold_08	28679106	28679936	NA	NA	NA	NA	NA
PGEN_.00g178580	Scaffold_08	28694282	28694557	NA	NA	NA	NA	NA
PGEN_.00g178590	Scaffold_08	28694613	28695751	NA	NA	NA	NA	NA
PGEN_.00g178600	Scaffold_08	28696009	28696347	NA	NA	NA	NA	NA
PGEN_.00g178610	Scaffold_08	28697038	28697664	NA	NA	NA	NA	NA
PGEN_.00g178620	Scaffold_08	28719136	28726514	NA	NA	NA	NA	NA
PGEN_.00g178630	Scaffold_08	28733659	28734132	NA	NA	NA	NA	NA
PGEN_.00g178640	Scaffold_08	28781284	28781598	NA	NA	NA	NA	NA
PGEN_.00g178650	Scaffold_08	28818582	28819148	NA	NA	NA	NA	NA
PGEN_.00g178660	Scaffold_08	28820081	28821035	NA	NA	NA	NA	NA
PGEN_.00g178670	Scaffold_08	28826052	28826411	NA	NA	NA	NA	NA
PGEN_.00g178680	Scaffold_08	28826501	28826767	NA	NA	NA	NA	NA
PGEN_.00g178690	Scaffold_08	28827143	28835046	NA	NA	NA	NA	NA
PGEN_.00g178700	Scaffold_08	28836395	28841522	NA	NA	NA	NA	NA
PGEN_.00g178710	Scaffold_08	28841690	28842052	NA	NA	NA	NA	NA
PGEN_.00g178720	Scaffold_08	28850882	28855355	NA	NA	NA	NA	NA
PGEN_.00g178730	Scaffold_08	28856436	28860454	NA	NA	NA	NA	NA
PGEN_.00g178740	Scaffold_08	28860535	28861023	NA	NA	NA	NA	NA
PGEN_.00g178750	Scaffold_08	28863374	28866108	NA	NA	NA	NA	NA
PGEN_.00g178760	Scaffold_08	28898033	28899199	NA	NA	NA	NA	NA
PGEN_.00g178770	Scaffold_08	28904589	28905936	Q505H7	IWS1_XENTR	Protein IWS1 homolog (IWS1-like protein)	GO:0005634; GO:0006397; GO:0008380; GO:0010793; GO:0050684; GO:0051028; GO:2001253	nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]
PGEN_.00g178780	Scaffold_08	28932285	28933677	Q5RDX1	Z585A_PONAB	Zinc finger protein 585A	GO:0003676; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g178790	Scaffold_08	28935420	28937569	NA	NA	NA	NA	NA
PGEN_.00g178800	Scaffold_08	28937791	28938621	NA	NA	NA	NA	NA
PGEN_.00g178810	Scaffold_08	28938736	28940590	NA	NA	NA	NA	NA
PGEN_.00g178820	Scaffold_08	28942885	28947671	NA	NA	NA	NA	NA
PGEN_.00g178830	Scaffold_08	28959209	28959529	NA	NA	NA	NA	NA
PGEN_.00g178840	Scaffold_08	28973366	28981022	Q924H0	NPFF2_MOUSE	Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408; GO:0045761; GO:2000479	actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]
PGEN_.00g178850	Scaffold_08	28992432	28992779	NA	NA	NA	NA	NA
PGEN_.00g178860	Scaffold_08	29015785	29016138	NA	NA	NA	NA	NA
PGEN_.00g178870	Scaffold_08	29018958	29019245	NA	NA	NA	NA	NA
PGEN_.00g178880	Scaffold_08	29023060	29029510	Q9Z137	B3GA2_RAT	"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 2) (GlcAT-D) (UDP-glucuronosyltransferase S) (GlcAT-S) (Glucuronosyltransferase S)"	GO:0000139; GO:0006486; GO:0015018; GO:0016021; GO:0016051; GO:0046872; GO:0050650	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; protein glycosylation [GO:0006486]
PGEN_.00g178890	Scaffold_08	29061321	29068002	Q08347	BDS1_YEAST	Alkyl/aryl-sulfatase BDS1 (EC 3.1.6.-) (Bacterially-derived sulfatase 1)	GO:0004065; GO:0018741; GO:0018909; GO:0046872; GO:0046983	alkyl sulfatase activity [GO:0018741]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; dodecyl sulfate metabolic process [GO:0018909]
PGEN_.00g178900	Scaffold_08	29081721	29095969	NA	NA	NA	NA	NA
PGEN_.00g178910	Scaffold_08	29107730	29131459	NA	NA	NA	NA	NA
PGEN_.00g178920	Scaffold_08	29135547	29135894	O94762	RECQ5_HUMAN	"ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5)"	GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0032508; GO:0034244; GO:0042802; GO:0051301; GO:0051304; GO:0072757; GO:1990414; GO:2000042	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]"
PGEN_.00g178930	Scaffold_08	29135947	29140189	NA	NA	NA	NA	NA
PGEN_.00g178940	Scaffold_08	29221961	29245015	NA	NA	NA	NA	NA
PGEN_.00g178950	Scaffold_08	29262642	29266414	Q6NZW0	C102A_DANRE	Coiled-coil domain-containing protein 102A	GO:0003774; GO:0016459	myosin complex [GO:0016459]; motor activity [GO:0003774]
PGEN_.00g178960	Scaffold_08	29276325	29285641	Q94F47	UBC28_ARATH	Ubiquitin-conjugating enzyme E2 28 (EC 2.3.2.23) (AtUBC9A) (E2 ubiquitin-conjugating enzyme 28) (Ubiquitin carrier protein 28)	GO:0005524; GO:0006511; GO:0061631	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g178970	Scaffold_08	29293578	29306556	Q6DGL2	KBRS2_DANRE	NF-kappa-B inhibitor-interacting Ras-like protein 2 (I-kappa-B-interacting Ras-like protein 2) (Kappa B-Ras protein 2) (KappaB-Ras2)	GO:0003924; GO:0005525; GO:0005737; GO:0007249	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]
PGEN_.00g178980	Scaffold_08	29320380	29351731	P22892	AP1G1_MOUSE	AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1)	GO:0000226; GO:0005518; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0008022; GO:0015630; GO:0016192; GO:0017137; GO:0019894; GO:0030121; GO:0030136; GO:0030742; GO:0035646; GO:0043231; GO:0043323; GO:0045954; GO:0048471; GO:0055037; GO:0090160	AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; collagen binding [GO:0005518]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; protein C-terminus binding [GO:0008022]; Rab GTPase binding [GO:0017137]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; intracellular protein transport [GO:0006886]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; vesicle-mediated transport [GO:0016192]
PGEN_.00g178990	Scaffold_08	29380878	29386749	Q8QGW7	LITAF_CHICK	Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) (Small integral membrane protein of lysosome/late endosome)	GO:0000139; GO:0001816; GO:0003677; GO:0005125; GO:0005634; GO:0005765; GO:0008270; GO:0009898; GO:0019953; GO:0098559; GO:0098560; GO:0098574	cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytokine production [GO:0001816]; sexual reproduction [GO:0019953]
PGEN_.00g179000	Scaffold_08	29399935	29408019	NA	NA	NA	NA	NA
PGEN_.00g179010	Scaffold_08	29415984	29419437	NA	NA	NA	NA	NA
PGEN_.00g179020	Scaffold_08	29477517	29516042	Q24248	ARA_DROME	Homeobox protein araucan	GO:0000981; GO:0001745; GO:0005634; GO:0005737; GO:0007474; GO:0007476; GO:0035310; GO:0042693; GO:0043565; GO:0045317; GO:0045893; GO:0045926; GO:0045944; GO:0048813	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; dendrite morphogenesis [GO:0048813]; equator specification [GO:0045317]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; notum cell fate specification [GO:0035310]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g179030	Scaffold_08	29579374	29589987	NA	NA	NA	NA	NA
PGEN_.00g179040	Scaffold_08	29596918	29601101	P48966	MPIP2_RAT	M-phase inducer phosphatase 2 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25B)	GO:0000086; GO:0000278; GO:0000922; GO:0001556; GO:0004725; GO:0005634; GO:0005737; GO:0005813; GO:0006468; GO:0007144; GO:0010971; GO:0019901; GO:0032467; GO:0045860; GO:0045931; GO:0051301; GO:0110032	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]
PGEN_.00g179050	Scaffold_08	29602212	29602748	NA	NA	NA	NA	NA
PGEN_.00g179060	Scaffold_08	29608722	29609806	P30304	MPIP1_HUMAN	M-phase inducer phosphatase 1 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25A)	GO:0000079; GO:0000082; GO:0000086; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008283; GO:0009314; GO:0010971; GO:0016579; GO:0019901; GO:0034644; GO:0045931; GO:0051087; GO:0051301; GO:0051726; GO:0110032	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to radiation [GO:0009314]
PGEN_.00g179070	Scaffold_08	29650678	29672970	P48637	GSHB_HUMAN	Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)	GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0006520; GO:0006750; GO:0006979; GO:0007399; GO:0007568; GO:0009410; GO:0016594; GO:0031667; GO:0034612; GO:0042802; GO:0042803; GO:0043200; GO:0043295; GO:0046686; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; glutathione biosynthetic process [GO:0006750]; nervous system development [GO:0007399]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]
PGEN_.00g179080	Scaffold_08	29682071	29689357	NA	NA	NA	NA	NA
PGEN_.00g179090	Scaffold_08	29693374	29695020	NA	NA	NA	NA	NA
PGEN_.00g179100	Scaffold_08	29701326	29703065	Q03601	NHL1_CAEEL	RING finger protein nhl-1	GO:0000209; GO:0004842; GO:0016567; GO:0043161; GO:0046872; GO:0061630	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]
PGEN_.00g179110	Scaffold_08	29706422	29712035	Q95044	UBE2C_SPISO	Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C)	GO:0005524; GO:0007049; GO:0016567; GO:0016740; GO:0051301	ATP binding [GO:0005524]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]
PGEN_.00g179120	Scaffold_08	29718869	29731525	Q9P2J3	KLHL9_HUMAN	Kelch-like protein 9	GO:0005829; GO:0007049; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0043687; GO:0051301	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]
PGEN_.00g179130	Scaffold_08	29733158	29751082	NA	NA	NA	NA	NA
PGEN_.00g179140	Scaffold_08	29789726	29790112	NA	NA	NA	NA	NA
PGEN_.00g179150	Scaffold_08	29831739	29907362	Q58EX7	PKHG4_HUMAN	Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1)	GO:0005085; GO:0090630	guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]
PGEN_.00g179160	Scaffold_08	29918232	29923594	Q52KB5	ZBT24_DANRE	Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450)	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g179170	Scaffold_08	29923891	29930420	Q2T9W1	SNX20_BOVIN	Sorting nexin-20	GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266	"early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein transport [GO:0015031]"
PGEN_.00g179180	Scaffold_08	29959215	29961752	NA	NA	NA	NA	NA
PGEN_.00g179190	Scaffold_08	29968431	29969190	NA	NA	NA	NA	NA
PGEN_.00g179200	Scaffold_08	29975641	30008703	Q68ED3	PAPD5_MOUSE	Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2)	GO:0003677; GO:0003723; GO:0003887; GO:0004652; GO:0005730; GO:0005737; GO:0006364; GO:0006378; GO:0007049; GO:0010587; GO:0031499; GO:0032211; GO:0033500; GO:0043629; GO:0043630; GO:0046872; GO:0051301; GO:0060212; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; rRNA processing [GO:0006364]; snoRNA polyadenylation [GO:0071050]
PGEN_.00g179210	Scaffold_08	30035665	30076266	P68827	NAGPA_BOVIN	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase)	GO:0003944; GO:0006486; GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [GO:0003944]; protein glycosylation [GO:0006486]
PGEN_.00g179220	Scaffold_08	30076533	30076964	Q9CQZ7	RPC10_MOUSE	DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III subunit C11) (RPC11)	GO:0003676; GO:0003899; GO:0005666; GO:0005730; GO:0006386; GO:0008270; GO:0042779; GO:0045087; GO:0051607	nucleolus [GO:0005730]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; termination of RNA polymerase III transcription [GO:0006386]; tRNA 3'-trailer cleavage [GO:0042779]
PGEN_.00g179230	Scaffold_08	30086412	30093419	P04069	CBPB_ASTAS	Carboxypeptidase B (EC 3.4.17.2)	GO:0004181; GO:0005576; GO:0008270	extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]
PGEN_.00g179240	Scaffold_08	30096712	30098856	Q54RR9	Y9844_DICDI	Probable serine/threonine-protein kinase DDB_G0282963 (EC 2.7.11.1)	GO:0004674; GO:0005524	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g179250	Scaffold_08	30101379	30122199	A0A0H5BMX5	TCEB1_TULGE	"Tuliposide B-converting enzyme 1, amyloplastic (TgTCEB1) (EC 4.2.99.23)"	GO:0006952; GO:0009501; GO:0016787; GO:0016829	amyloplast [GO:0009501]; hydrolase activity [GO:0016787]; lyase activity [GO:0016829]; defense response [GO:0006952]
PGEN_.00g179260	Scaffold_08	30164150	30165331	NA	NA	NA	NA	NA
PGEN_.00g179270	Scaffold_08	30165455	30165721	NA	NA	NA	NA	NA
PGEN_.00g179280	Scaffold_08	30189269	30240410	P55042	RAD_HUMAN	GTP-binding protein RAD (RAD1) (Ras associated with diabetes)	GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007264; GO:1901842	plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g179290	Scaffold_08	30298797	30307132	O01393	UNC9_CAEEL	Innexin unc-9 (Uncoordinated protein 9)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
PGEN_.00g179300	Scaffold_08	30315168	30315662	NA	NA	NA	NA	NA
PGEN_.00g179310	Scaffold_08	30323677	30346706	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g179320	Scaffold_08	30417601	30417807	A1ADJ6	NEUO_ECOK1	Polysialic acid O-acetyltransferase (EC 2.3.1.136) (Capsule O-acetyl transferase)	GO:0050208; GO:0070207	polysialic-acid O-acetyltransferase activity [GO:0050208]; protein homotrimerization [GO:0070207]
PGEN_.00g179330	Scaffold_08	30417913	30418293	A1ADJ6	NEUO_ECOK1	Polysialic acid O-acetyltransferase (EC 2.3.1.136) (Capsule O-acetyl transferase)	GO:0050208; GO:0070207	polysialic-acid O-acetyltransferase activity [GO:0050208]; protein homotrimerization [GO:0070207]
PGEN_.00g179340	Scaffold_08	30418345	30418671	NA	NA	NA	NA	NA
PGEN_.00g179350	Scaffold_08	30418790	30419164	A1ADJ6	NEUO_ECOK1	Polysialic acid O-acetyltransferase (EC 2.3.1.136) (Capsule O-acetyl transferase)	GO:0050208; GO:0070207	polysialic-acid O-acetyltransferase activity [GO:0050208]; protein homotrimerization [GO:0070207]
PGEN_.00g179360	Scaffold_08	30419647	30421568	A1ADJ6	NEUO_ECOK1	Polysialic acid O-acetyltransferase (EC 2.3.1.136) (Capsule O-acetyl transferase)	GO:0050208; GO:0070207	polysialic-acid O-acetyltransferase activity [GO:0050208]; protein homotrimerization [GO:0070207]
PGEN_.00g179370	Scaffold_08	30421632	30421847	NA	NA	NA	NA	NA
PGEN_.00g179380	Scaffold_08	30455234	30455506	NA	NA	NA	NA	NA
PGEN_.00g179390	Scaffold_08	30462632	30462919	NA	NA	NA	NA	NA
PGEN_.00g179400	Scaffold_08	30467205	30474440	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g179410	Scaffold_08	30488483	30488800	NA	NA	NA	NA	NA
PGEN_.00g179420	Scaffold_08	30489289	30489807	NA	NA	NA	NA	NA
PGEN_.00g179430	Scaffold_08	30489888	30491695	NA	NA	NA	NA	NA
PGEN_.00g179440	Scaffold_08	30529883	30530979	NA	NA	NA	NA	NA
PGEN_.00g179450	Scaffold_08	30551402	30556591	O60229	KALRN_HUMAN	Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)	GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007165; GO:0007186; GO:0007399; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0015629; GO:0016192; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043065; GO:0043547; GO:0046872; GO:0046959; GO:0048013; GO:0051056; GO:0060125; GO:0060137; GO:0061003; GO:0070062	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192]
PGEN_.00g179460	Scaffold_08	30557817	30576017	NA	NA	NA	NA	NA
PGEN_.00g179470	Scaffold_08	30621498	30623699	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g179480	Scaffold_08	30660844	30668022	NA	NA	NA	NA	NA
PGEN_.00g179490	Scaffold_08	30672483	30672902	NA	NA	NA	NA	NA
PGEN_.00g179500	Scaffold_08	30673252	30673704	NA	NA	NA	NA	NA
PGEN_.00g179510	Scaffold_08	30687940	30705108	Q502K2	SAMH1_DANRE	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]
PGEN_.00g179520	Scaffold_08	30713504	30713737	NA	NA	NA	NA	NA
PGEN_.00g179530	Scaffold_08	30725412	30725633	NA	NA	NA	NA	NA
PGEN_.00g179540	Scaffold_08	30725874	30726161	NA	NA	NA	NA	NA
PGEN_.00g179550	Scaffold_08	30742392	30759448	Q9VBP3	TNKS_DROME	Poly [ADP-ribose] polymerase tankyrase (dTNKS) (EC 2.4.2.30) (Poly [ADP-ribose] polymerase) (Protein poly-ADP-ribosyltransferase tankyrase) (EC 2.4.2.-)	GO:0003950; GO:0005634; GO:0005737; GO:0006471; GO:0032436; GO:0045732; GO:0046872; GO:0070198; GO:0070212; GO:0090090; GO:0090263; GO:1904355; GO:2000060	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of telomere capping [GO:1904355]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein ADP-ribosylation [GO:0006471]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]"
PGEN_.00g179560	Scaffold_08	30772088	30796826	P86952	TYRO_PINMA	Tyrosinase-like protein (Tyrosinase-2)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g179570	Scaffold_08	30827429	30866104	Q8NHG8	ZNRF2_HUMAN	E3 ubiquitin-protein ligase ZNRF2 (EC 2.3.2.27) (Protein Ells2) (RING finger protein 202) (RING-type E3 ubiquitin transferase ZNRF2) (Zinc/RING finger protein 2)	GO:0000209; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0010008; GO:0030054; GO:0030659; GO:0032991; GO:0042734; GO:0042995; GO:0046872; GO:0061630	cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]
PGEN_.00g179580	Scaffold_08	30866691	30880871	Q5R9F5	S38A7_PONAB	Putative sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7)	GO:0006814; GO:0015179; GO:0015186; GO:0016021; GO:0030424; GO:0043025	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; L-amino acid transmembrane transporter activity [GO:0015179]; L-glutamine transmembrane transporter activity [GO:0015186]; sodium ion transport [GO:0006814]
PGEN_.00g179590	Scaffold_08	30892999	30909863	Q5RC80	RBM39_PONAB	RNA-binding protein 39 (RNA-binding motif protein 39)	GO:0003723; GO:0006397; GO:0008380; GO:0016607	nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g179600	Scaffold_08	30915181	30916758	NA	NA	NA	NA	NA
PGEN_.00g179610	Scaffold_08	30916808	30918409	P08953	TOLL_DROME	Protein toll	GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]
PGEN_.00g179620	Scaffold_08	30966325	30970660	Q5FW05	CTU1_XENTR	Cytoplasmic tRNA 2-thiolation protein 1 (EC 2.7.7.-) (ATP-binding domain-containing protein 3) (Cytoplasmic tRNA adenylyltransferase 1)	GO:0000049; GO:0002098; GO:0002143; GO:0002144; GO:0005829; GO:0016779; GO:0032447; GO:0034227	cytosol [GO:0005829]; cytosolic tRNA wobble base thiouridylase complex [GO:0002144]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g179630	Scaffold_08	31119326	31119715	NA	NA	NA	NA	NA
PGEN_.00g179640	Scaffold_08	31136445	31136729	NA	NA	NA	NA	NA
PGEN_.00g179650	Scaffold_08	31140532	31148401	Q61909	MTG8_MOUSE	Protein CBFA2T1 (Protein MTG8)	GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0006355; GO:0010977; GO:0016363; GO:0017053; GO:0042803; GO:0045444; GO:0045599; GO:0045892; GO:0046872; GO:0051101	"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; fat cell differentiation [GO:0045444]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA binding [GO:0051101]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g179660	Scaffold_08	31155658	31156158	NA	NA	NA	NA	NA
PGEN_.00g179670	Scaffold_08	31162514	31164570	NA	NA	NA	NA	NA
PGEN_.00g179680	Scaffold_08	31164598	31191339	Q5RDE7	NFS1_PONAB	"Cysteine desulfurase, mitochondrial (EC 2.8.1.7)"	GO:0005634; GO:0005739; GO:0006777; GO:0030170; GO:0031071; GO:0044571; GO:0046872; GO:0051536	mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]
PGEN_.00g179690	Scaffold_08	31194084	31200901	Q08DG8	ZN135_BOVIN	Zinc finger protein 135	GO:0003677; GO:0005634; GO:0006355; GO:0007010; GO:0022604; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g179700	Scaffold_08	31215286	31229356	O75581	LRP6_HUMAN	Low-density lipoprotein receptor-related protein 6 (LRP-6)	GO:0001702; GO:0001843; GO:0001933; GO:0003344; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005623; GO:0005783; GO:0005886; GO:0005901; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009952; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021987; GO:0030326; GO:0030901; GO:0030917; GO:0031410; GO:0031901; GO:0034185; GO:0034392; GO:0035261; GO:0042475; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0051091; GO:0060021; GO:0060026; GO:0060059; GO:0060070; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090090; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:1904886; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g179710	Scaffold_08	31295468	31321780	O75096	LRP4_HUMAN	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]
PGEN_.00g179720	Scaffold_08	31324357	31327760	NA	NA	NA	NA	NA
PGEN_.00g179730	Scaffold_08	31341795	31348099	NA	NA	NA	NA	NA
PGEN_.00g179740	Scaffold_08	31353009	31380110	Q0P4J6	MCUR1_XENTR	"Mitochondrial calcium uniporter regulator 1 (MCU regulator 1) (Coiled-coil domain-containing protein 90A, mitochondrial)"	GO:0005739; GO:0006851; GO:0031305; GO:0036444; GO:0051561; GO:0070509	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]
PGEN_.00g179750	Scaffold_08	31393678	31427252	Q5E9I8	DCA11_BOVIN	DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23)	GO:0016567; GO:0043161; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]
PGEN_.00g179760	Scaffold_08	31456016	31459710	NA	NA	NA	NA	NA
PGEN_.00g179770	Scaffold_08	31460954	31475318	P18910	ANPRA_RAT	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043235; GO:0048662	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g179780	Scaffold_08	31484915	31497046	Q6VVW5	ANPRB_MOUSE	Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)	GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]
PGEN_.00g179790	Scaffold_08	31504332	31523104	O75460	ERN1_HUMAN	Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	GO:0000287; GO:0001935; GO:0004521; GO:0004672; GO:0004674; GO:0005161; GO:0005524; GO:0005623; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006379; GO:0006402; GO:0006468; GO:0007050; GO:0007257; GO:0016241; GO:0019899; GO:0030176; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036289; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0071333; GO:0098787; GO:1900103; GO:1901142; GO:1904707; GO:1990332; GO:1990579; GO:1990597; GO:1990604; GO:1990630	"AIP1-IRE1 complex [GO:1990597]; cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976]"
PGEN_.00g179800	Scaffold_08	31538383	31538679	NA	NA	NA	NA	NA
PGEN_.00g179810	Scaffold_08	31543537	31549966	NA	NA	NA	NA	NA
PGEN_.00g179820	Scaffold_08	31576566	31577567	NA	NA	NA	NA	NA
PGEN_.00g179830	Scaffold_08	31649809	31680628	Q96RK4	BBS4_HUMAN	Bardet-Biedl syndrome 4 protein	GO:0000226; GO:0000242; GO:0000281; GO:0001103; GO:0001750; GO:0001764; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0003777; GO:0005623; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010629; GO:0015031; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0033365; GO:0034260; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0046907; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0071539; GO:0097730; GO:1902855; GO:1903546; GO:1905515	BBSome [GO:0034464]; cell [GO:0005623]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; microtubule motor activity [GO:0003777]; RNA polymerase II repressing transcription factor binding [GO:0001103]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]
PGEN_.00g179840	Scaffold_08	31691777	31694761	Q94521	DNAT_DROME	Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase)	GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066	"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]"
PGEN_.00g179850	Scaffold_08	31710764	31743191	P26323	FLI1_MOUSE	Friend leukemia integration 1 transcription factor (Retroviral integration site protein Fli-1)	GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0008015; GO:0009887; GO:0009987; GO:0016604; GO:0030154; GO:0035855; GO:0043565; GO:0045893; GO:0045944	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell differentiation [GO:0030154]; cellular process [GO:0009987]; megakaryocyte development [GO:0035855]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g179860	Scaffold_08	31796206	31808082	P29774	ETS3_DROME	DNA-binding protein D-ETS-3	GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0030154; GO:0043565	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g179870	Scaffold_08	31843023	31846098	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g179880	Scaffold_08	31855967	31860322	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g179890	Scaffold_08	31862804	31877082	Q6DEF6	USB1_DANRE	U6 snRNA phosphodiesterase (EC 3.1.4.-)	GO:0000175; GO:0005634; GO:0030097; GO:0030223; GO:0034477; GO:0043484; GO:1990838	"nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]; hemopoiesis [GO:0030097]; neutrophil differentiation [GO:0030223]; regulation of RNA splicing [GO:0043484]; U6 snRNA 3'-end processing [GO:0034477]"
PGEN_.00g179900	Scaffold_08	31887488	31903730	Q5R4X0	IMPA1_PONAB	Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1)	GO:0000287; GO:0005737; GO:0006021; GO:0008934; GO:0030145; GO:0031403; GO:0046854; GO:0046855; GO:0052832; GO:0052833; GO:0052834	cytoplasm [GO:0005737]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]
PGEN_.00g179910	Scaffold_08	31908479	31910071	NA	NA	NA	NA	NA
PGEN_.00g179920	Scaffold_08	31910205	31910507	NA	NA	NA	NA	NA
PGEN_.00g179930	Scaffold_08	31912483	31927113	P23606	TGM1_RAT	Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)	GO:0003810; GO:0005913; GO:0009887; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031224; GO:0031424; GO:0045787; GO:0046872	cell-cell adherens junction [GO:0005913]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; animal organ morphogenesis [GO:0009887]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]
PGEN_.00g179940	Scaffold_08	31936023	31952963	Q6IQ20	NAPEP_HUMAN	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54)	GO:0000139; GO:0001523; GO:0001659; GO:0005635; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0007568; GO:0008270; GO:0009395; GO:0031901; GO:0035900; GO:0042622; GO:0042802; GO:0043227; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0102200; GO:1903999	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659]
PGEN_.00g179950	Scaffold_08	31966974	31967522	NA	NA	NA	NA	NA
PGEN_.00g179960	Scaffold_08	31967556	31970542	NA	NA	NA	NA	NA
PGEN_.00g179970	Scaffold_08	31983976	32024075	Q58CN9	NAPEP_BOVIN	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54)	GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0008270; GO:0009395; GO:0031901; GO:0042802; GO:0043227; GO:0048874; GO:0050729; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0102200	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; temperature homeostasis [GO:0001659]
PGEN_.00g179980	Scaffold_08	32031338	32042726	Q5RCU3	NAPEP_PONAB	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54)	GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0031901; GO:0048874; GO:0050729; GO:0070290; GO:0070292; GO:0090336; GO:0102200	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; temperature homeostasis [GO:0001659]
PGEN_.00g179990	Scaffold_08	32064519	32098351	Q6IQ20	NAPEP_HUMAN	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54)	GO:0000139; GO:0001523; GO:0001659; GO:0005635; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0007568; GO:0008270; GO:0009395; GO:0031901; GO:0035900; GO:0042622; GO:0042802; GO:0043227; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0102200; GO:1903999	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659]
PGEN_.00g180000	Scaffold_08	32110163	32110711	NA	NA	NA	NA	NA
PGEN_.00g180010	Scaffold_08	32110843	32114182	NA	NA	NA	NA	NA
PGEN_.00g180020	Scaffold_08	32114221	32138296	Q6IQ20	NAPEP_HUMAN	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54)	GO:0000139; GO:0001523; GO:0001659; GO:0005635; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0007568; GO:0008270; GO:0009395; GO:0031901; GO:0035900; GO:0042622; GO:0042802; GO:0043227; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0102200; GO:1903999	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659]
PGEN_.00g180030	Scaffold_08	32140497	32141015	NA	NA	NA	NA	NA
PGEN_.00g180040	Scaffold_08	32159290	32164770	NA	NA	NA	NA	NA
PGEN_.00g180050	Scaffold_08	32169751	32172874	NA	NA	NA	NA	NA
PGEN_.00g180060	Scaffold_08	32173005	32173526	NA	NA	NA	NA	NA
PGEN_.00g180070	Scaffold_08	32173634	32174758	NA	NA	NA	NA	NA
PGEN_.00g180080	Scaffold_08	32175155	32200016	O15360	FANCA_HUMAN	Fanconi anemia group A protein (Protein FACA)	GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0007140; GO:0008584; GO:0008585; GO:0036297; GO:0042127; GO:0043240; GO:0045589; GO:0050727; GO:0051090; GO:0065003; GO:2000348	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]
PGEN_.00g180090	Scaffold_08	32231013	32231513	NA	NA	NA	NA	NA
PGEN_.00g180100	Scaffold_08	32271195	32272218	NA	NA	NA	NA	NA
PGEN_.00g180110	Scaffold_08	32273740	32274102	NA	NA	NA	NA	NA
PGEN_.00g180120	Scaffold_08	32275942	32283431	P10730	ANPRC_BOVIN	Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C)	GO:0001501; GO:0002158; GO:0008217; GO:0016021; GO:0016941; GO:0033688; GO:0035810	integral component of membrane [GO:0016021]; natriuretic peptide receptor activity [GO:0016941]; osteoclast proliferation [GO:0002158]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; skeletal system development [GO:0001501]
PGEN_.00g180130	Scaffold_08	32291003	32291290	NA	NA	NA	NA	NA
PGEN_.00g180140	Scaffold_08	32293216	32293578	NA	NA	NA	NA	NA
PGEN_.00g180150	Scaffold_08	32306030	32314839	Q5ZJL9	SAMH1_CHICK	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0005654; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0042802; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0097197; GO:0110025	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]
PGEN_.00g180160	Scaffold_08	32316481	32331796	NA	NA	NA	NA	NA
PGEN_.00g180170	Scaffold_08	32336436	32338522	Q6B9X6	VWKA_DICDI	Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase)	GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177	contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]
PGEN_.00g180180	Scaffold_08	32342173	32342433	NA	NA	NA	NA	NA
PGEN_.00g180190	Scaffold_08	32342516	32342755	NA	NA	NA	NA	NA
PGEN_.00g180200	Scaffold_08	32377401	32387273	NA	NA	NA	NA	NA
PGEN_.00g180210	Scaffold_08	32394313	32395507	NA	NA	NA	NA	NA
PGEN_.00g180220	Scaffold_08	32396814	32414130	NA	NA	NA	NA	NA
PGEN_.00g180230	Scaffold_08	32431000	32438252	Q7ZXT3	EDC4_XENLA	Enhancer of mRNA-decapping protein 4	GO:0000932; GO:0005634	nucleus [GO:0005634]; P-body [GO:0000932]
PGEN_.00g180240	Scaffold_08	32441475	32448370	NA	NA	NA	NA	NA
PGEN_.00g180250	Scaffold_08	32451517	32474594	Q1LUT1	EDC4_DANRE	Enhancer of mRNA-decapping protein 4	GO:0000932; GO:0005634; GO:0031087	nucleus [GO:0005634]; P-body [GO:0000932]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]
PGEN_.00g180260	Scaffold_08	32477118	32520220	NA	NA	NA	NA	NA
PGEN_.00g180270	Scaffold_08	32520907	32521140	NA	NA	NA	NA	NA
PGEN_.00g180280	Scaffold_08	32536302	32563221	P0C0T2	ANKS6_RAT	Ankyrin repeat and SAM domain-containing protein 6 (Polycystic kidney disease protein 1) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6)	GO:0001701; GO:0005737; GO:0005929; GO:0007368; GO:0007507; GO:0042802	cilium [GO:0005929]; cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]
PGEN_.00g180290	Scaffold_08	32567581	32567985	NA	NA	NA	NA	NA
PGEN_.00g180300	Scaffold_08	32581575	32584906	Q9ESH6	GLRX1_RAT	Glutaredoxin-1 (Thioltransferase-1) (TTase-1)	GO:0002931; GO:0005623; GO:0005634; GO:0005737; GO:0005758; GO:0005829; GO:0007568; GO:0009055; GO:0015035; GO:0015038; GO:0022602; GO:0030425; GO:0032024; GO:0043025; GO:0045454; GO:0045838; GO:0045921; GO:0047485; GO:0060355; GO:0071333; GO:0071392; GO:1901224; GO:1901299; GO:2000587; GO:2000651	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; protein disulfide oxidoreductase activity [GO:0015035]; protein N-terminus binding [GO:0047485]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; ovulation cycle process [GO:0022602]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane potential [GO:0045838]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; response to ischemia [GO:0002931]
PGEN_.00g180310	Scaffold_08	32588430	32589195	Q0DAE4	GRXC8_ORYSJ	Glutaredoxin-C8 (Glutaredoxin-C4 homolog)	GO:0004362; GO:0005623; GO:0005737; GO:0009055; GO:0015035; GO:0034599; GO:0045454	cell [GO:0005623]; cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]
PGEN_.00g180320	Scaffold_08	32590609	32595977	O36032	GLRX1_SCHPO	Glutaredoxin-1	GO:0004362; GO:0004602; GO:0005623; GO:0005634; GO:0005829; GO:0009055; GO:0015035; GO:0015038; GO:0019430; GO:0034599; GO:0045454	cell [GO:0005623]; cytosol [GO:0005829]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; glutathione peroxidase activity [GO:0004602]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; removal of superoxide radicals [GO:0019430]
PGEN_.00g180330	Scaffold_08	32604271	32628380	NA	NA	NA	NA	NA
PGEN_.00g180340	Scaffold_08	32652234	32653964	NA	NA	NA	NA	NA
PGEN_.00g180350	Scaffold_08	32717742	32718041	NA	NA	NA	NA	NA
PGEN_.00g180360	Scaffold_08	32737495	32755597	NA	NA	NA	NA	NA
PGEN_.00g180370	Scaffold_08	32755626	32790676	Q9NZJ4	SACS_HUMAN	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]
PGEN_.00g180380	Scaffold_08	32800504	32840268	Q5F361	TBCK_CHICK	TBC domain-containing protein kinase-like protein	GO:0004672; GO:0005096; GO:0005524; GO:0005737; GO:0005819; GO:0006886; GO:0017137; GO:0030496; GO:0090630	cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]
PGEN_.00g180390	Scaffold_08	32859764	32901968	Q9QXG2	RAE1_MOUSE	Rab proteins geranylgeranyltransferase component A 1 (Choroideremia protein homolog) (Rab escort protein 1) (REP-1)	GO:0001568; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005968; GO:0006612; GO:0007264; GO:0016192; GO:0017137; GO:0018344; GO:0044877; GO:0065003	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; blood vessel development [GO:0001568]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]
PGEN_.00g180400	Scaffold_08	32873693	32889153	NA	NA	NA	NA	NA
PGEN_.00g180410	Scaffold_08	32931615	32933750	NA	NA	NA	NA	NA
PGEN_.00g180420	Scaffold_08	32944469	32959773	Q60710	SAMH1_MOUSE	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Interferon-gamma-inducible protein Mg11) (SAM domain and HD domain-containing protein 1) (mSAMHD1)	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0004540; GO:0005525; GO:0005634; GO:0005654; GO:0005886; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0042802; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0097197; GO:0110025	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]
PGEN_.00g180430	Scaffold_08	32969038	32996610	Q502K2	SAMH1_DANRE	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]
PGEN_.00g180440	Scaffold_08	33005214	33005609	NA	NA	NA	NA	NA
PGEN_.00g180450	Scaffold_08	33009188	33012967	NA	NA	NA	NA	NA
PGEN_.00g180460	Scaffold_08	33045896	33070295	Q502K2	SAMH1_DANRE	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]
PGEN_.00g180470	Scaffold_08	33080992	33086225	NA	NA	NA	NA	NA
PGEN_.00g180480	Scaffold_08	33086456	33102693	NA	NA	NA	NA	NA
PGEN_.00g180490	Scaffold_08	33119113	33124619	NA	NA	NA	NA	NA
PGEN_.00g180500	Scaffold_08	33140848	33141135	NA	NA	NA	NA	NA
PGEN_.00g180510	Scaffold_08	33177449	33179254	NA	NA	NA	NA	NA
PGEN_.00g180520	Scaffold_08	33184450	33215377	O15360	FANCA_HUMAN	Fanconi anemia group A protein (Protein FACA)	GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0007140; GO:0008584; GO:0008585; GO:0036297; GO:0042127; GO:0043240; GO:0045589; GO:0050727; GO:0051090; GO:0065003; GO:2000348	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]
PGEN_.00g180530	Scaffold_08	33232045	33244765	NA	NA	NA	NA	NA
PGEN_.00g180540	Scaffold_08	33250694	33263299	NA	NA	NA	NA	NA
PGEN_.00g180550	Scaffold_08	33317099	33320141	NA	NA	NA	NA	NA
PGEN_.00g180560	Scaffold_08	33330794	33335881	NA	NA	NA	NA	NA
PGEN_.00g180570	Scaffold_08	33341997	33342419	NA	NA	NA	NA	NA
PGEN_.00g180580	Scaffold_08	33358517	33369142	NA	NA	NA	NA	NA
PGEN_.00g180590	Scaffold_08	33376774	33394486	NA	NA	NA	NA	NA
PGEN_.00g180600	Scaffold_08	33404163	33458076	Q6IQ20	NAPEP_HUMAN	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54)	GO:0000139; GO:0001523; GO:0001659; GO:0005635; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0007568; GO:0008270; GO:0009395; GO:0031901; GO:0035900; GO:0042622; GO:0042802; GO:0043227; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0102200; GO:1903999	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659]
PGEN_.00g180610	Scaffold_08	33464036	33464548	Q9V1F8	DEGLY_PYRAB	Deglycase PYRAB04690 (EC 3.5.1.124) (Intracellular protease PYRAB04690) (EC 3.4.22.-)	GO:0005737; GO:0008233	cytoplasm [GO:0005737]; peptidase activity [GO:0008233]
PGEN_.00g180620	Scaffold_08	33470922	33477951	Q80T32	AGRD1_MOUSE	Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)	GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g180630	Scaffold_08	33479529	33489119	P78417	GSTO1_HUMAN	Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R)	GO:0004364; GO:0005623; GO:0005654; GO:0005737; GO:0005829; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0032259; GO:0035722; GO:0042178; GO:0045174; GO:0050610; GO:0055114; GO:0060315; GO:0060316; GO:0070062; GO:0071243; GO:1901687	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]
PGEN_.00g180640	Scaffold_08	33498552	33511682	Q62513	ZN260_MOUSE	Zinc finger protein 260 (Zfp-260)	GO:0003677; GO:0005654; GO:0005829; GO:0007275; GO:0046872	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]
PGEN_.00g180650	Scaffold_08	33518303	33518518	NA	NA	NA	NA	NA
PGEN_.00g180660	Scaffold_08	33556811	33569865	A4QN56	MFS4B_DANRE	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g180670	Scaffold_08	33591145	33595027	NA	NA	NA	NA	NA
PGEN_.00g180680	Scaffold_08	33605218	33611851	Q2QL34	MP17L_HUMAN	Mpv17-like protein (M-LP homolog) (M-LPH)	GO:0005737; GO:0005739; GO:0005777; GO:0005778; GO:0010730; GO:0016021; GO:0043231; GO:0072593; GO:1901029	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; reactive oxygen species metabolic process [GO:0072593]
PGEN_.00g180690	Scaffold_08	33617028	33617324	NA	NA	NA	NA	NA
PGEN_.00g180700	Scaffold_08	33623384	33636924	Q8VBU8	BANP_MOUSE	Protein BANP (Btg3-associated nuclear protein) (Scaffold/matrix-associated region-1-binding protein)	GO:0002039; GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0007049; GO:0007275; GO:0016604; GO:0034504; GO:0042177; GO:0042802; GO:0045893	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]"
PGEN_.00g180710	Scaffold_08	33640093	33658983	Q7ZVE6	PLGT2_DANRE	Protein O-glucosyltransferase 2 (EC 2.4.1.-) (KDEL motif-containing protein 1) (Protein O-xylosyltransferase POGLUT2) (EC 2.4.2.26)	GO:0005788; GO:0018242; GO:0030158; GO:0035251; GO:0035252; GO:0046527	endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; protein xylosyltransferase activity [GO:0030158]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242]
PGEN_.00g180720	Scaffold_08	33682745	33714855	Q8TEL6	TP4AP_HUMAN	Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS)	GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048820; GO:0070588	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g180730	Scaffold_08	33715666	33717372	NA	NA	NA	NA	NA
PGEN_.00g180740	Scaffold_08	33750844	33754039	NA	NA	NA	NA	NA
PGEN_.00g180750	Scaffold_08	33754190	33777896	NA	NA	NA	NA	NA
PGEN_.00g180760	Scaffold_08	33755073	33756848	NA	NA	NA	NA	NA
PGEN_.00g180770	Scaffold_08	33790823	33793194	NA	NA	NA	NA	NA
PGEN_.00g180780	Scaffold_08	33793400	33794542	Q03112	MECOM_HUMAN	Histone-lysine N-methyltransferase MECOM (EC 2.1.1.-) (Ecotropic virus integration site 1 protein homolog) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein) (Myelodysplasia syndrome-associated protein 1)	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0016607; GO:0030154; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0046329; GO:0046872; GO:0046974; GO:0051726; GO:0070828; GO:0071425	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]"
PGEN_.00g180790	Scaffold_08	33795077	33795475	NA	NA	NA	NA	NA
PGEN_.00g180800	Scaffold_08	33795521	33795961	NA	NA	NA	NA	NA
PGEN_.00g180810	Scaffold_08	33796117	33797024	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g180820	Scaffold_08	33857704	33869001	Q9BWW7	SCRT1_HUMAN	Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (hScrt)	GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0043565; GO:0046872; GO:2001222	"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g180830	Scaffold_08	33902445	33903035	NA	NA	NA	NA	NA
PGEN_.00g180840	Scaffold_08	33920173	33921702	NA	NA	NA	NA	NA
PGEN_.00g180850	Scaffold_08	33952965	33953808	NA	NA	NA	NA	NA
PGEN_.00g180860	Scaffold_08	33959608	33960750	O14792	HS3S1_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1)	GO:0005796; GO:0006024; GO:0008146; GO:0008467	Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g180870	Scaffold_08	34031713	34041669	NA	NA	NA	NA	NA
PGEN_.00g180880	Scaffold_08	34111557	34154487	NA	NA	NA	NA	NA
PGEN_.00g180890	Scaffold_08	34169399	34182122	NA	NA	NA	NA	NA
PGEN_.00g180900	Scaffold_08	34205166	34209676	NA	NA	NA	NA	NA
PGEN_.00g180910	Scaffold_08	34215415	34227244	Q4V885	COL12_RAT	Collectin-12 (Collectin placenta protein 1) (CL-P1) (Nurse cell scavenger receptor 2)	GO:0004888; GO:0005581; GO:0006910; GO:0006955; GO:0008329; GO:0016021; GO:0030169; GO:0030246; GO:0034138; GO:0046872; GO:0060355; GO:0071360	"collagen trimer [GO:0005581]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; transmembrane signaling receptor activity [GO:0004888]; cellular response to exogenous dsRNA [GO:0071360]; immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]"
PGEN_.00g180920	Scaffold_08	34231385	34232173	NA	NA	NA	NA	NA
PGEN_.00g180930	Scaffold_08	34363656	34391461	P54269	CAUP_DROME	Homeobox protein caupolican	GO:0000981; GO:0001745; GO:0003700; GO:0005634; GO:0007346; GO:0007474; GO:0042693; GO:0043565; GO:0045317; GO:0045926; GO:0045944	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; equator specification [GO:0045317]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]"
PGEN_.00g180940	Scaffold_08	34396754	34398653	NA	NA	NA	NA	NA
PGEN_.00g180950	Scaffold_08	34462665	34463807	O14792	HS3S1_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1)	GO:0005796; GO:0006024; GO:0008146; GO:0008467	Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g180960	Scaffold_08	34469551	34471391	NA	NA	NA	NA	NA
PGEN_.00g180970	Scaffold_08	34471855	34472127	NA	NA	NA	NA	NA
PGEN_.00g180980	Scaffold_08	34475878	34496508	Q9Y345	SC6A5_HUMAN	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g180990	Scaffold_08	34508042	34511099	NA	NA	NA	NA	NA
PGEN_.00g181000	Scaffold_08	34515044	34560639	Q8C0J6	SWAHC_MOUSE	Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C)		
PGEN_.00g181010	Scaffold_08	34565414	34580061	Q96EP0	RNF31_HUMAN	E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) (Zinc in-between-RING-finger ubiquitin-associated domain protein)	GO:0000209; GO:0004842; GO:0005829; GO:0007249; GO:0009898; GO:0010803; GO:0023035; GO:0031625; GO:0035631; GO:0043123; GO:0043130; GO:0046872; GO:0050852; GO:0051092; GO:0071797; GO:0097039; GO:1903955	CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; CD40 signaling pathway [GO:0023035]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; T cell receptor signaling pathway [GO:0050852]
PGEN_.00g181020	Scaffold_08	34616770	34618519	NA	NA	NA	NA	NA
PGEN_.00g181030	Scaffold_08	34650407	34650997	NA	NA	NA	NA	NA
PGEN_.00g181040	Scaffold_08	34676096	34676701	NA	NA	NA	NA	NA
PGEN_.00g181050	Scaffold_08	34676774	34677208	NA	NA	NA	NA	NA
PGEN_.00g181060	Scaffold_08	34679863	34687817	Q3B725	ZBT24_RAT	Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Zinc finger protein 450)	GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g181070	Scaffold_08	34691514	34713160	NA	NA	NA	NA	NA
PGEN_.00g181080	Scaffold_08	34725424	34747061	Q60737	CSK21_MOUSE	Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1)	GO:0000785; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005956; GO:0006468; GO:0006915; GO:0007049; GO:0008013; GO:0008284; GO:0016055; GO:0016301; GO:0016580; GO:0016581; GO:0018105; GO:0018107; GO:0019888; GO:0021987; GO:0030177; GO:0030307; GO:0033574; GO:0042802; GO:0043021; GO:0043154; GO:0045732; GO:0046777; GO:0047485; GO:0048511; GO:0051726; GO:0097421; GO:1903076; GO:1905818; GO:2000059	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; plasma membrane [GO:0005886]; protein kinase CK2 complex [GO:0005956]; Sin3 complex [GO:0016580]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein N-terminus binding [GO:0047485]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine kinase activity [GO:0004674]; ribonucleoprotein complex binding [GO:0043021]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cerebral cortex development [GO:0021987]; liver regeneration [GO:0097421]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; regulation of protein localization to plasma membrane [GO:1903076]; response to testosterone [GO:0033574]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g181090	Scaffold_08	34761721	34762785	NA	NA	NA	NA	NA
PGEN_.00g181100	Scaffold_08	34764377	34764841	NA	NA	NA	NA	NA
PGEN_.00g181110	Scaffold_08	34769522	34780006	P29774	ETS3_DROME	DNA-binding protein D-ETS-3	GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0030154; GO:0043565	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g181120	Scaffold_08	34786573	34792791	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g181130	Scaffold_08	34803590	34803931	NA	NA	NA	NA	NA
PGEN_.00g181140	Scaffold_08	34808625	34821134	Q7TS63	ZFAT_MOUSE	Zinc finger protein ZFAT (Zinc finger protein 406)	GO:0001228; GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006355; GO:0030097; GO:0046872; GO:0060712	"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]"
PGEN_.00g181150	Scaffold_08	34821239	34825157	NA	NA	NA	NA	NA
PGEN_.00g181160	Scaffold_08	34832861	34838217	NA	NA	NA	NA	NA
PGEN_.00g181170	Scaffold_08	34847940	34849197	NA	NA	NA	NA	NA
PGEN_.00g181180	Scaffold_08	34863191	34863583	NA	NA	NA	NA	NA
PGEN_.00g181190	Scaffold_08	34915957	34916280	NA	NA	NA	NA	NA
PGEN_.00g181200	Scaffold_08	34923878	34933930	NA	NA	NA	NA	NA
PGEN_.00g181210	Scaffold_08	34951124	34951588	NA	NA	NA	NA	NA
PGEN_.00g181220	Scaffold_08	34951789	34957506	NA	NA	NA	NA	NA
PGEN_.00g181230	Scaffold_08	35025580	35025858	NA	NA	NA	NA	NA
PGEN_.00g181240	Scaffold_08	35025912	35026409	NA	NA	NA	NA	NA
PGEN_.00g181250	Scaffold_08	35026615	35026965	NA	NA	NA	NA	NA
PGEN_.00g181260	Scaffold_08	35027266	35027667	NA	NA	NA	NA	NA
PGEN_.00g181270	Scaffold_08	35032637	35107107	NA	NA	NA	NA	NA
PGEN_.00g181280	Scaffold_08	35118531	35120400	NA	NA	NA	NA	NA
PGEN_.00g181290	Scaffold_08	35130272	35137089	NA	NA	NA	NA	NA
PGEN_.00g181300	Scaffold_08	35130391	35204997	P21783	NOTC1_XENLA	Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]
PGEN_.00g181310	Scaffold_08	35208035	35216324	Q55BZ5	DCD1A_DICDI	Protein dcd1A (Acid ceramidase-like protein A)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g181320	Scaffold_08	35217799	35224853	Q54CS6	DCD1B_DICDI	Protein dcd1B (Acid ceramidase-like protein B)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g181330	Scaffold_08	35229972	35231966	NA	NA	NA	NA	NA
PGEN_.00g181340	Scaffold_08	35233005	35233931	NA	NA	NA	NA	NA
PGEN_.00g181350	Scaffold_08	35250453	35250794	NA	NA	NA	NA	NA
PGEN_.00g181360	Scaffold_08	35254388	35259738	Q0V7M8	F167A_BOVIN	Protein FAM167A		
PGEN_.00g181370	Scaffold_08	35316336	35317475	P69003	ACT1_HELTB	"Actin CyI, cytoplasmic"	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g181380	Scaffold_08	35322160	35331964	P27169	PON1_HUMAN	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]
PGEN_.00g181390	Scaffold_08	35353594	35363159	NA	NA	NA	NA	NA
PGEN_.00g181400	Scaffold_08	35401057	35403321	NA	NA	NA	NA	NA
PGEN_.00g181410	Scaffold_08	35414650	35415024	P48057	SC6A1_MUSCO	Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)	GO:0005332; GO:0005886; GO:0007612; GO:0009636; GO:0009986; GO:0010033; GO:0014054; GO:0014074; GO:0015734; GO:0030054; GO:0030424; GO:0032229; GO:0042165; GO:0042802; GO:0043005; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056	"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; identical protein binding [GO:0042802]; neurotransmitter binding [GO:0042165]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to organic substance [GO:0010033]; response to purine-containing compound [GO:0014074]; response to toxic substance [GO:0009636]; taurine transport [GO:0015734]"
PGEN_.00g181420	Scaffold_08	35463137	35480236	Q62687	S6A18_RAT	Sodium-dependent neutral amino acid transporter B(0)AT3 (Renal osmotic stress-induced Na-Cl organic solute cotransporter) (ROSIT) (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3)	GO:0003333; GO:0005328; GO:0005886; GO:0005887; GO:0006970; GO:0006972; GO:0015175; GO:0016324; GO:0031526	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transmembrane transport [GO:0003333]; hyperosmotic response [GO:0006972]; response to osmotic stress [GO:0006970]
PGEN_.00g181430	Scaffold_08	35506031	35506531	NA	NA	NA	NA	NA
PGEN_.00g181440	Scaffold_08	35530381	35531236	NA	NA	NA	NA	NA
PGEN_.00g181450	Scaffold_08	35542842	35543231	P08953	TOLL_DROME	Protein toll	GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]
PGEN_.00g181460	Scaffold_08	35560578	35562674	Q689D1	TLR2_CANLF	Toll-like receptor 2 (CD antigen CD282)	GO:0002224; GO:0002755; GO:0005794; GO:0005887; GO:0006954; GO:0030670; GO:0031226; GO:0034134; GO:0045087; GO:0045121; GO:0050707; GO:0050729; GO:0071726; GO:0071727	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g181470	Scaffold_08	35562712	35565587	NA	NA	NA	NA	NA
PGEN_.00g181480	Scaffold_08	35623499	35651640	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g181490	Scaffold_08	35661007	35670946	Q6ZMY6	WDR88_HUMAN	WD repeat-containing protein 88 (PQQ repeat and WD repeat-containing protein)		
PGEN_.00g181500	Scaffold_08	35671262	35704092	Q6ZQ89	MARH6_MOUSE	E3 ubiquitin-protein ligase MARCH6 (EC 2.3.2.27) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI) (MARCH-VI) (RING-type E3 ubiquitin transferase MARCH6)	GO:0004842; GO:0005783; GO:0008270; GO:0010498; GO:0016021; GO:0016567; GO:0019899; GO:0030176; GO:0030433; GO:0031624; GO:0043161; GO:0061630; GO:0070936; GO:1990381	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; enzyme binding [GO:0019899]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g181510	Scaffold_08	35709290	35715118	NA	NA	NA	NA	NA
PGEN_.00g181520	Scaffold_08	35797634	35799718	NA	NA	NA	NA	NA
PGEN_.00g181530	Scaffold_08	35820344	35839886	NA	NA	NA	NA	NA
PGEN_.00g181540	Scaffold_08	35836280	35836573	NA	NA	NA	NA	NA
PGEN_.00g181550	Scaffold_08	35836632	35837245	NA	NA	NA	NA	NA
PGEN_.00g181560	Scaffold_08	35845795	35846713	NA	NA	NA	NA	NA
PGEN_.00g181570	Scaffold_08	35855271	35857526	Q15399	TLR1_HUMAN	Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281)	GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0034130; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0038123; GO:0042116; GO:0042495; GO:0042535; GO:0042802; GO:0045087; GO:0045121; GO:0045410; GO:0046982; GO:0071723; GO:0071727; GO:2000484	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; cell activation [GO:0001775]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR1:TLR2 signaling pathway [GO:0038123]
PGEN_.00g181580	Scaffold_08	35862414	35878281	Q2KJ97	NCDN_BOVIN	Neurochondrin	GO:0005829; GO:0030425; GO:0031175; GO:0043025; GO:0045453	cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; bone resorption [GO:0045453]; neuron projection development [GO:0031175]
PGEN_.00g181590	Scaffold_08	35878454	35884308	Q7YRA3	EXOS4_BOVIN	Exosome complex component RRP41 (Exosome component 4) (Ribosomal RNA-processing protein 41)	GO:0000176; GO:0000177; GO:0000178; GO:0000460; GO:0004527; GO:0005730; GO:0005829; GO:0016075; GO:0030307; GO:0034427; GO:0034475; GO:0035327; GO:0035925; GO:0045006; GO:0045111; GO:0051607; GO:0071028; GO:0071044; GO:0071051	"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; intermediate filament cytoskeleton [GO:0045111]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; transcriptionally active chromatin [GO:0035327]; exonuclease activity [GO:0004527]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; rRNA catabolic process [GO:0016075]; U4 snRNA 3'-end processing [GO:0034475]"
PGEN_.00g181600	Scaffold_08	35886600	35888646	Q2TAA8	TXIP1_HUMAN	Translin-associated factor X-interacting protein 1 (Trax-interacting protein 1)	GO:0007275; GO:0007283; GO:0030154; GO:0048471	perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g181610	Scaffold_08	35907218	35939034	P69566	RANB9_MOUSE	Ran-binding protein 9 (RanBP9) (B-cell antigen receptor Ig beta-associated protein 1) (IBAP-1) (Ran-binding protein M) (RanBPM)	GO:0000151; GO:0005634; GO:0005737; GO:0005886; GO:0008536; GO:0019899; GO:0070373	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; enzyme binding [GO:0019899]; Ran GTPase binding [GO:0008536]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]
PGEN_.00g181620	Scaffold_08	35949445	35977775	Q3UJP5	CH037_MOUSE	Protein C8orf37 homolog	GO:0001917; GO:0005737; GO:0005829; GO:0005886; GO:0008594; GO:0030054; GO:0097546	cell junction [GO:0030054]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; photoreceptor cell morphogenesis [GO:0008594]
PGEN_.00g181630	Scaffold_08	35978179	35992004	Q16943	VP33_APLCA	Vesicle-associated membrane protein/synaptobrevin-binding protein (VAP-33)	GO:0005789; GO:0016021; GO:0030054; GO:0033149; GO:0043005; GO:0045202; GO:0070972	cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synapse [GO:0045202]; FFAT motif binding [GO:0033149]; protein localization to endoplasmic reticulum [GO:0070972]
PGEN_.00g181640	Scaffold_08	35999897	36021354	Q924N4	S12A6_MOUSE	Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3)	GO:0005623; GO:0005887; GO:0006811; GO:0006884; GO:0007268; GO:0015079; GO:0015379; GO:0016323; GO:0019901; GO:0030424; GO:0045202; GO:0055064; GO:0055075; GO:0071476; GO:0071477; GO:1902476; GO:1990573	axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]
PGEN_.00g181650	Scaffold_08	36065579	36067265	NA	NA	NA	NA	NA
PGEN_.00g181660	Scaffold_08	36088834	36134084	NA	NA	NA	NA	NA
PGEN_.00g181670	Scaffold_08	36140478	36146431	NA	NA	NA	NA	NA
PGEN_.00g181680	Scaffold_08	36185194	36194129	Q8N6F8	MET27_HUMAN	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)		
PGEN_.00g181690	Scaffold_08	36216691	36219662	NA	NA	NA	NA	NA
PGEN_.00g181700	Scaffold_08	36235880	36236572	NA	NA	NA	NA	NA
PGEN_.00g181710	Scaffold_08	36247738	36248175	NA	NA	NA	NA	NA
PGEN_.00g181720	Scaffold_08	36354333	36355562	Q8NGA4	G32P1_HUMAN	Putative G-protein coupled receptor GPR32P1 (G-protein coupled 32 pseudogene) (G-protein coupled 32 pseudogene 1) (G-protein coupled receptor GPCR39) (hGPCR39)	GO:0002430; GO:0004930; GO:0004982; GO:0005623; GO:0005886; GO:0006954; GO:0007200; GO:0007204; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g181730	Scaffold_08	36376595	36386542	NA	NA	NA	NA	NA
PGEN_.00g181740	Scaffold_08	36412058	36422051	Q86VV8	RTTN_HUMAN	Rotatin	GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0032053; GO:0036064	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368]
PGEN_.00g181750	Scaffold_08	36482476	36484060	Q8R4Y8	RTTN_MOUSE	Rotatin	GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0016021; GO:0032053; GO:0036064	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368]
PGEN_.00g181760	Scaffold_08	36489748	36504137	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g181770	Scaffold_08	36511255	36532041	Q8R1Q8	DC1L1_MOUSE	"Cytoplasmic dynein 1 light intermediate chain 1 (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic)"	GO:0000226; GO:0000776; GO:0000777; GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0007049; GO:0019003; GO:0042802; GO:0045504; GO:0046605; GO:0051301; GO:0090267; GO:1990090	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; microtubule [GO:0005874]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome cycle [GO:0046605]
PGEN_.00g181780	Scaffold_08	36552446	36561327	P61019	RAB2A_HUMAN	Ras-related protein Rab-2A	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0007030; GO:0019003; GO:0032482; GO:0033116; GO:0042470; GO:0043687; GO:0070062	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; post-translational protein modification [GO:0043687]; Rab protein signal transduction [GO:0032482]
PGEN_.00g181790	Scaffold_08	36603971	36607285	Q19546	WRN_CAEEL	Probable Werner syndrome ATP-dependent helicase homolog 1 (EC 3.6.4.12)	GO:0000723; GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006259; GO:0006268; GO:0006281; GO:0006310; GO:0008340; GO:0009378; GO:0010212; GO:0010259; GO:0032508; GO:0035861; GO:0043138; GO:0044806	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]
PGEN_.00g181800	Scaffold_08	36607388	36609247	NA	NA	NA	NA	NA
PGEN_.00g181810	Scaffold_08	36618213	36649469	Q6UB99	ANR11_HUMAN	Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1)	GO:0001701; GO:0001894; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0035264; GO:0042475; GO:0048705; GO:0060325; GO:0060348	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; bone development [GO:0060348]; face morphogenesis [GO:0060325]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705]; tissue homeostasis [GO:0001894]
PGEN_.00g181820	Scaffold_08	36659526	36661287	NA	NA	NA	NA	NA
PGEN_.00g181830	Scaffold_08	36781937	36811554	A0A1D5P556	DAAM2_CHICK	Disheveled-associated activator of morphogenesis 2	GO:0003779; GO:0016055; GO:0017048; GO:0021516; GO:0030036; GO:0048715; GO:0060828; GO:0090263; GO:2000050	actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; dorsal spinal cord development [GO:0021516]; negative regulation of oligodendrocyte differentiation [GO:0048715]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; Wnt signaling pathway [GO:0016055]
PGEN_.00g181840	Scaffold_08	36824659	36826329	NA	NA	NA	NA	NA
PGEN_.00g181850	Scaffold_08	36838058	36854733	NA	NA	NA	NA	NA
PGEN_.00g181860	Scaffold_08	36869589	36871745	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g181870	Scaffold_08	36885323	36887672	NA	NA	NA	NA	NA
PGEN_.00g181880	Scaffold_08	36891666	36893092	NA	NA	NA	NA	NA
PGEN_.00g181890	Scaffold_08	36893155	36893649	NA	NA	NA	NA	NA
PGEN_.00g181900	Scaffold_08	36895507	36895965	NA	NA	NA	NA	NA
PGEN_.00g181910	Scaffold_08	36900374	36900691	NA	NA	NA	NA	NA
PGEN_.00g181920	Scaffold_08	36900851	36914277	Q22549	INX10_CAEEL	Innexin-10 (Protein opu-10)	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0016021; GO:0055077	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transport [GO:0006811]
PGEN_.00g181930	Scaffold_08	36920548	36933749	A8WVX4	INX19_CAEBR	Innexin-19	GO:0005243; GO:0005886; GO:0005921; GO:0006811; GO:0007399; GO:0016021; GO:0030154; GO:0055077	gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; cell differentiation [GO:0030154]; ion transport [GO:0006811]; nervous system development [GO:0007399]
PGEN_.00g181940	Scaffold_08	36958527	36959993	Q9VQB7	EOGT_DROME	EGF domain-specific O-linked N-acetylglucosamine transferase (EC 2.4.1.255) (Extracellular O-linked N-acetylglucosamine transferase)	GO:0005788; GO:0006493; GO:0008363; GO:0016262; GO:0097363; GO:0097370	endoplasmic reticulum lumen [GO:0005788]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; larval chitin-based cuticle development [GO:0008363]; protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493]
PGEN_.00g181950	Scaffold_08	36960910	36962922	NA	NA	NA	NA	NA
PGEN_.00g181960	Scaffold_08	37038541	37039335	NA	NA	NA	NA	NA
PGEN_.00g181970	Scaffold_08	37048021	37057362	NA	NA	NA	NA	NA
PGEN_.00g181980	Scaffold_08	37058047	37058520	NA	NA	NA	NA	NA
PGEN_.00g181990	Scaffold_08	37059292	37065061	NA	NA	NA	NA	NA
PGEN_.00g182000	Scaffold_08	37067259	37067657	NA	NA	NA	NA	NA
PGEN_.00g182010	Scaffold_08	37067784	37068002	NA	NA	NA	NA	NA
PGEN_.00g182020	Scaffold_08	37068333	37068647	NA	NA	NA	NA	NA
PGEN_.00g182030	Scaffold_08	37088905	37091317	NA	NA	NA	NA	NA
PGEN_.00g182040	Scaffold_08	37102124	37102417	NA	NA	NA	NA	NA
PGEN_.00g182050	Scaffold_08	37102517	37103011	NA	NA	NA	NA	NA
PGEN_.00g182060	Scaffold_08	37104155	37109686	NA	NA	NA	NA	NA
PGEN_.00g182070	Scaffold_08	37118851	37119447	NA	NA	NA	NA	NA
PGEN_.00g182080	Scaffold_08	37120283	37122526	P13821	SANT_PLAFW	S-antigen protein	GO:0020003	symbiont-containing vacuole [GO:0020003]
PGEN_.00g182090	Scaffold_08	37122676	37124142	NA	NA	NA	NA	NA
PGEN_.00g182100	Scaffold_08	37143818	37145116	P0DMS8	AA3R_HUMAN	Adenosine receptor A3	GO:0001609; GO:0005886; GO:0005887; GO:0006954; GO:0007165; GO:0007186; GO:0007190; GO:0008016; GO:0008285; GO:0009611; GO:0030336; GO:0032088	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled adenosine receptor activity [GO:0001609]; activation of adenylate cyclase activity [GO:0007190]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; regulation of heart contraction [GO:0008016]; response to wounding [GO:0009611]; signal transduction [GO:0007165]
PGEN_.00g182110	Scaffold_08	37176919	37183986	Q3SYW0	FBX15_BOVIN	F-box only protein 15		
PGEN_.00g182120	Scaffold_08	37185520	37208688	Q5ZLV4	NSUN2_CHICK	RNA cytosine-C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (EC 2.1.1.203)	GO:0000049; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0008168; GO:0010793; GO:0016428; GO:0030488; GO:0036416; GO:0062152; GO:0070062; GO:0080009; GO:2000736	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]
PGEN_.00g182130	Scaffold_08	37212474	37240710	Q1HFZ0	NSUN2_MOUSE	RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (EC 2.1.1.203)	GO:0000049; GO:0001701; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0007286; GO:0008168; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:0080009; GO:2000736	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]
PGEN_.00g182140	Scaffold_08	37258236	37259117	NA	NA	NA	NA	NA
PGEN_.00g182150	Scaffold_08	37282239	37283171	NA	NA	NA	NA	NA
PGEN_.00g182160	Scaffold_08	37313694	37322735	NA	NA	NA	NA	NA
PGEN_.00g182170	Scaffold_08	37323918	37338335	Q8N0N3	BGBP_PENMO	"Beta-1,3-glucan-binding protein (GBP)"	GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087	"extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]"
PGEN_.00g182180	Scaffold_08	37349914	37350795	NA	NA	NA	NA	NA
PGEN_.00g182190	Scaffold_08	37353451	37354011	NA	NA	NA	NA	NA
PGEN_.00g182200	Scaffold_08	37366834	37368976	NA	NA	NA	NA	NA
PGEN_.00g182210	Scaffold_08	37371149	37371736	NA	NA	NA	NA	NA
PGEN_.00g182220	Scaffold_08	37375586	37375957	NA	NA	NA	NA	NA
PGEN_.00g182230	Scaffold_08	37470074	37475011	NA	NA	NA	NA	NA
PGEN_.00g182240	Scaffold_08	37487139	37496781	NA	NA	NA	NA	NA
PGEN_.00g182250	Scaffold_08	37535382	37549842	Q75N73	S39AE_MOUSE	Zinc transporter ZIP14 (Factor for adipocyte differentiation 123) (FAD-123) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14)	GO:0005384; GO:0005385; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006826; GO:0006829; GO:0006882; GO:0015093; GO:0016021; GO:0030027; GO:0071577; GO:0071578	cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ferrous iron transmembrane transporter activity [GO:0015093]; manganese ion transmembrane transporter activity [GO:0005384]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; iron ion transport [GO:0006826]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]
PGEN_.00g182260	Scaffold_08	37561342	37570512	Q5FWH7	S39AC_MOUSE	Zinc transporter ZIP12 (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12)	GO:0005385; GO:0005623; GO:0005886; GO:0005887; GO:0006882; GO:0007165; GO:0010975; GO:0031113; GO:0048471; GO:0071578	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578]
PGEN_.00g182270	Scaffold_08	37575658	37584738	NA	NA	NA	NA	NA
PGEN_.00g182280	Scaffold_08	37590440	37597032	P57768	SNX16_HUMAN	Sorting nexin-16	GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006622; GO:0008333; GO:0031313; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0043231; GO:0045022	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]
PGEN_.00g182290	Scaffold_08	37603912	37604166	NA	NA	NA	NA	NA
PGEN_.00g182300	Scaffold_08	37612811	37630855	Q3UHG7	DEN11_MOUSE	DENN domain-containing protein 11 (DENND11) (Protein LCHN)	GO:0005085	guanyl-nucleotide exchange factor activity [GO:0005085]
PGEN_.00g182310	Scaffold_08	37631739	37634014	NA	NA	NA	NA	NA
PGEN_.00g182320	Scaffold_08	37635750	37726425	NA	NA	NA	NA	NA
PGEN_.00g182330	Scaffold_08	37749531	37751374	NA	NA	NA	NA	NA
PGEN_.00g182340	Scaffold_08	37757557	37765772	NA	NA	NA	NA	NA
PGEN_.00g182350	Scaffold_08	37776961	37780229	NA	NA	NA	NA	NA
PGEN_.00g182360	Scaffold_08	37782576	37785844	NA	NA	NA	NA	NA
PGEN_.00g182370	Scaffold_08	37797033	37805248	NA	NA	NA	NA	NA
PGEN_.00g182380	Scaffold_08	37811430	37813273	NA	NA	NA	NA	NA
PGEN_.00g182390	Scaffold_08	37833609	37923573	NA	NA	NA	NA	NA
PGEN_.00g182400	Scaffold_08	37925309	37927584	NA	NA	NA	NA	NA
PGEN_.00g182410	Scaffold_08	37928468	37946545	Q3UHG7	DEN11_MOUSE	DENN domain-containing protein 11 (DENND11) (Protein LCHN)	GO:0005085	guanyl-nucleotide exchange factor activity [GO:0005085]
PGEN_.00g182420	Scaffold_08	37962353	37969013	Q5R6Q7	SNX16_PONAB	Sorting nexin-16	GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006622; GO:0008333; GO:0031313; GO:0031901; GO:0031902; GO:0035091; GO:0045022	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; phosphatidylinositol binding [GO:0035091]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]
PGEN_.00g182430	Scaffold_08	37975324	37984404	NA	NA	NA	NA	NA
PGEN_.00g182440	Scaffold_08	37989562	37995954	A4IGY6	S39AE_XENTR	Zinc transporter ZIP14 (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14)	GO:0005384; GO:0005385; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006882; GO:0030027; GO:0071577; GO:0071578	cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; manganese ion transmembrane transporter activity [GO:0005384]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]
PGEN_.00g182450	Scaffold_08	38007519	38021969	Q9ULF5	S39AA_HUMAN	Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10)	GO:0002903; GO:0005385; GO:0005623; GO:0005887; GO:0006882; GO:0030890; GO:0050861; GO:0071578; GO:1903615	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578]
PGEN_.00g182460	Scaffold_08	38060402	38069718	NA	NA	NA	NA	NA
PGEN_.00g182470	Scaffold_08	38079457	38086595	NA	NA	NA	NA	NA
PGEN_.00g182480	Scaffold_08	38157015	38170428	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g182490	Scaffold_08	38175870	38178545	NA	NA	NA	NA	NA
PGEN_.00g182500	Scaffold_08	38198878	38231952	NA	NA	NA	NA	NA
PGEN_.00g182510	Scaffold_08	38256498	38258548	NA	NA	NA	NA	NA
PGEN_.00g182520	Scaffold_08	38271915	38282027	NA	NA	NA	NA	NA
PGEN_.00g182530	Scaffold_08	38294482	38294838	NA	NA	NA	NA	NA
PGEN_.00g182540	Scaffold_08	38321632	38339398	Q63HN8	RN213_HUMAN	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g182550	Scaffold_08	38353083	38354225	NA	NA	NA	NA	NA
PGEN_.00g182560	Scaffold_08	38355055	38355318	NA	NA	NA	NA	NA
PGEN_.00g182570	Scaffold_08	38365151	38375386	NA	NA	NA	NA	NA
PGEN_.00g182580	Scaffold_08	38381786	38382028	NA	NA	NA	NA	NA
PGEN_.00g182590	Scaffold_08	38398123	38406846	NA	NA	NA	NA	NA
PGEN_.00g182600	Scaffold_08	38444183	38444425	NA	NA	NA	NA	NA
PGEN_.00g182610	Scaffold_08	38450666	38463148	NA	NA	NA	NA	NA
PGEN_.00g182620	Scaffold_08	38464727	38468244	NA	NA	NA	NA	NA
PGEN_.00g182630	Scaffold_08	38477336	38550489	Q63HN8	RN213_HUMAN	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g182640	Scaffold_08	38554406	38554669	NA	NA	NA	NA	NA
PGEN_.00g182650	Scaffold_08	38572972	38625223	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g182660	Scaffold_08	38634887	38650082	Q6NYE4	ALKMO_DANRE	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]
PGEN_.00g182670	Scaffold_08	38658190	38672905	Q6NYE4	ALKMO_DANRE	Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]
PGEN_.00g182680	Scaffold_08	38686844	38688674	NA	NA	NA	NA	NA
PGEN_.00g182690	Scaffold_08	38691251	38722872	O23300	ECI3_ARATH	"Enoyl-CoA delta isomerase 3 (EC 5.3.3.8) (3-hydroxyacyl-CoA dehydratase 1) (Delta(3),Delta(2)-enoyl CoA isomerase 3) (AtECI3)"	GO:0004165; GO:0004300; GO:0005634; GO:0005777; GO:0005829; GO:0006635; GO:0009062; GO:0080167	cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; response to karrikin [GO:0080167]
PGEN_.00g182700	Scaffold_08	38728612	38729022	NA	NA	NA	NA	NA
PGEN_.00g182710	Scaffold_08	38730144	38734114	P86952	TYRO_PINMA	Tyrosinase-like protein (Tyrosinase-2)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g182720	Scaffold_08	38735814	38746820	NA	NA	NA	NA	NA
PGEN_.00g182730	Scaffold_08	38749499	38761554	NA	NA	NA	NA	NA
PGEN_.00g182740	Scaffold_08	38762551	38778008	NA	NA	NA	NA	NA
PGEN_.00g182750	Scaffold_08	38796994	38801361	A0A060WQA3	OTOL1_ONCMY	Otolin-1	GO:0005509; GO:0005576; GO:0005581; GO:0005623; GO:0045299	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; otolith mineralization [GO:0045299]
PGEN_.00g182760	Scaffold_08	38810770	38813909	P25067	CO8A2_HUMAN	Collagen alpha-2(VIII) chain (Endothelial collagen)	GO:0001525; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0030674; GO:0031012; GO:0048593; GO:0050673; GO:0062023; GO:0098609	"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein binding, bridging [GO:0030674]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]"
PGEN_.00g182770	Scaffold_08	38819704	38820177	NA	NA	NA	NA	NA
PGEN_.00g182780	Scaffold_08	38820264	38825036	NA	NA	NA	NA	NA
PGEN_.00g182790	Scaffold_08	38833337	38834443	B5XF11	KDM8_SALSA	Lysine-specific demethylase 8 (EC 1.14.11.27) (JmjC domain-containing protein 5) (Jumonji domain-containing protein 5)	GO:0000086; GO:0003682; GO:0005634; GO:0032922; GO:0045893; GO:0046872; GO:0051864; GO:0070544	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g182800	Scaffold_08	38834550	38837326	NA	NA	NA	NA	NA
PGEN_.00g182810	Scaffold_08	38841575	38850758	NA	NA	NA	NA	NA
PGEN_.00g182820	Scaffold_08	38892218	38892649	NA	NA	NA	NA	NA
PGEN_.00g182830	Scaffold_08	38976000	38988388	P21761	TRFR_MOUSE	Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor)	GO:0004997; GO:0005623; GO:0005886; GO:0007200; GO:0007204; GO:0009986; GO:0016021; GO:0031334; GO:0042802	cell [GO:0005623]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; thyrotropin-releasing hormone receptor activity [GO:0004997]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein complex assembly [GO:0031334]
PGEN_.00g182840	Scaffold_08	39133747	39134100	NA	NA	NA	NA	NA
PGEN_.00g182850	Scaffold_08	39233813	39234151	NA	NA	NA	NA	NA
PGEN_.00g182860	Scaffold_08	39235623	39235958	NA	NA	NA	NA	NA
PGEN_.00g182870	Scaffold_08	39309764	39318887	P86952	TYRO_PINMA	Tyrosinase-like protein (Tyrosinase-2)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g182880	Scaffold_08	39318955	39324020	NA	NA	NA	NA	NA
PGEN_.00g182890	Scaffold_08	39324045	39324344	NA	NA	NA	NA	NA
PGEN_.00g182900	Scaffold_08	39324423	39324980	NA	NA	NA	NA	NA
PGEN_.00g182910	Scaffold_08	39328147	39328707	NA	NA	NA	NA	NA
PGEN_.00g182920	Scaffold_08	39328758	39329192	NA	NA	NA	NA	NA
PGEN_.00g182930	Scaffold_08	39329261	39329524	NA	NA	NA	NA	NA
PGEN_.00g182940	Scaffold_08	39329557	39330186	NA	NA	NA	NA	NA
PGEN_.00g182950	Scaffold_08	39330344	39330634	NA	NA	NA	NA	NA
PGEN_.00g182960	Scaffold_08	39330832	39356906	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g182970	Scaffold_08	39334569	39334925	NA	NA	NA	NA	NA
PGEN_.00g182980	Scaffold_08	39370707	39389331	NA	NA	NA	NA	NA
PGEN_.00g182990	Scaffold_08	39393087	39400642	NA	NA	NA	NA	NA
PGEN_.00g183000	Scaffold_08	39407582	39415461	Q99547	MPH6_HUMAN	M-phase phosphoprotein 6	GO:0000176; GO:0000178; GO:0000460; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364	cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; rRNA processing [GO:0006364]
PGEN_.00g183010	Scaffold_08	39424876	39495261	Q587J7	TDR12_HUMAN	Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12)	GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007275; GO:0007283; GO:0009566; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:1990923	PET complex [GO:1990923]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
PGEN_.00g183020	Scaffold_08	39500240	39534683	Q6PF21	SYMC_XENLA	"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)"	GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005829; GO:0006431; GO:0017101	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; methionyl-tRNA aminoacylation [GO:0006431]
PGEN_.00g183030	Scaffold_08	39535733	39543323	P98156	VLDLR_MOUSE	Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R)	GO:0005509; GO:0005615; GO:0005634; GO:0005905; GO:0006869; GO:0006898; GO:0008203; GO:0009986; GO:0016020; GO:0016021; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0043235; GO:0045177; GO:0045860; GO:0048306; GO:0048471; GO:0048813; GO:0071456; GO:1900006	apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cellular response to hypoxia [GO:0071456]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]
PGEN_.00g183040	Scaffold_08	39560893	39561336	NA	NA	NA	NA	NA
PGEN_.00g183050	Scaffold_08	39574458	39574742	NA	NA	NA	NA	NA
PGEN_.00g183060	Scaffold_08	39574801	39575376	NA	NA	NA	NA	NA
PGEN_.00g183070	Scaffold_08	39625601	39626044	Q9P215	POGK_HUMAN	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g183080	Scaffold_08	39626761	39688239	NA	NA	NA	NA	NA
PGEN_.00g183090	Scaffold_08	39688967	39689287	NA	NA	NA	NA	NA
PGEN_.00g183100	Scaffold_08	39694718	39694939	NA	NA	NA	NA	NA
PGEN_.00g183110	Scaffold_08	39694962	39697184	NA	NA	NA	NA	NA
PGEN_.00g183120	Scaffold_08	39701022	39702182	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g183130	Scaffold_08	39710995	39711327	NA	NA	NA	NA	NA
PGEN_.00g183140	Scaffold_08	39711375	39711710	NA	NA	NA	NA	NA
PGEN_.00g183150	Scaffold_08	39721673	39729333	P35903	ACHC_ACHFU	Achacin	GO:0016491; GO:0042742	oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]
PGEN_.00g183160	Scaffold_08	39730458	39731539	Q17043	APLY_APLKU	Aplysianin-A	GO:0016491; GO:0042742	oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]
PGEN_.00g183170	Scaffold_08	39734270	39745105	Q17043	APLY_APLKU	Aplysianin-A	GO:0016491; GO:0042742	oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]
PGEN_.00g183180	Scaffold_08	39755934	39773921	P35903	ACHC_ACHFU	Achacin	GO:0016491; GO:0042742	oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]
PGEN_.00g183190	Scaffold_08	39785896	39790453	Q9W1A4	TAMO_DROME	Protein tamozhennic	GO:0005737; GO:0007275; GO:0008536; GO:0015031; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]
PGEN_.00g183200	Scaffold_08	39803988	39813787	O95995	DRC4_HUMAN	Dynein regulatory complex subunit 4 (Growth arrest-specific protein 11) (GAS-11) (Growth arrest-specific protein 8) (GAS-8)	GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0005929; GO:0005930; GO:0007368; GO:0007420; GO:0008017; GO:0008285; GO:0017137; GO:0030317; GO:0031514; GO:0034613; GO:0035082; GO:0036064; GO:0036126; GO:0045880; GO:0060294; GO:1903566; GO:1904526	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of microtubule binding [GO:1904526]
PGEN_.00g183210	Scaffold_08	39826825	39848428	Q8WY64	MYLIP_HUMAN	E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP)	GO:0000209; GO:0004842; GO:0005829; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032802; GO:0032803; GO:0042632; GO:0045732; GO:0046872; GO:0061630	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cholesterol homeostasis [GO:0042632]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g183220	Scaffold_08	39862267	39869544	P0CG11	CTF8_BOVIN	Chromosome transmission fidelity protein 8 homolog	GO:0003677; GO:0005634; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264	Ctf18 RFC-like complex [GO:0031390]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]
PGEN_.00g183230	Scaffold_08	39873793	39874961	NA	NA	NA	NA	NA
PGEN_.00g183240	Scaffold_08	39898333	39898641	NA	NA	NA	NA	NA
PGEN_.00g183250	Scaffold_08	39920350	39920895	NA	NA	NA	NA	NA
PGEN_.00g183260	Scaffold_08	39926040	39926246	NA	NA	NA	NA	NA
PGEN_.00g183270	Scaffold_08	39958410	39967717	NA	NA	NA	NA	NA
PGEN_.00g183280	Scaffold_08	39967756	39972103	Q6ZPT1	KLHL9_MOUSE	Kelch-like protein 9	GO:0004842; GO:0007049; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0051301	Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]
PGEN_.00g183290	Scaffold_08	39977365	39977580	NA	NA	NA	NA	NA
PGEN_.00g183300	Scaffold_08	39982046	39988248	NA	NA	NA	NA	NA
PGEN_.00g183310	Scaffold_08	39995189	40002158	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g183320	Scaffold_08	40133731	40134024	NA	NA	NA	NA	NA
PGEN_.00g183330	Scaffold_08	40142861	40144530	NA	NA	NA	NA	NA
PGEN_.00g183340	Scaffold_08	40191075	40191485	NA	NA	NA	NA	NA
PGEN_.00g183350	Scaffold_08	40191524	40194723	NA	NA	NA	NA	NA
PGEN_.00g183360	Scaffold_08	40197558	40201106	Q9U3V5	TIPT_DROME	Protein tiptop	GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007380; GO:0046872; GO:0048730; GO:0048749; GO:0061330	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; compound eye development [GO:0048749]; epidermis morphogenesis [GO:0048730]; Malpighian tubule stellate cell differentiation [GO:0061330]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of segmental identity, head [GO:0007380]"
PGEN_.00g183370	Scaffold_08	40214292	40219336	NA	NA	NA	NA	NA
PGEN_.00g183380	Scaffold_08	40220128	40236519	Q9UL36	ZN236_HUMAN	Zinc finger protein 236	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872; GO:0071333	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g183390	Scaffold_08	40240924	40252028	NA	NA	NA	NA	NA
PGEN_.00g183400	Scaffold_08	40340487	40382566	A4FUD6	ELMO2_BOVIN	Engulfment and cell motility protein 2	GO:0005829; GO:0006909; GO:0006915; GO:0007010; GO:0016020; GO:0017124; GO:0060326; GO:0098609	cytosol [GO:0005829]; membrane [GO:0016020]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cytoskeleton organization [GO:0007010]; phagocytosis [GO:0006909]
PGEN_.00g183410	Scaffold_08	40374118	40383662	NA	NA	NA	NA	NA
PGEN_.00g183420	Scaffold_08	40477577	40510159	Q6AXR4	HEXB_RAT	Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta)	GO:0001501; GO:0001669; GO:0004563; GO:0005615; GO:0005623; GO:0005764; GO:0006044; GO:0006687; GO:0006689; GO:0006874; GO:0007040; GO:0007338; GO:0007341; GO:0007605; GO:0007626; GO:0008049; GO:0008360; GO:0008375; GO:0008654; GO:0009313; GO:0015929; GO:0016020; GO:0016231; GO:0016787; GO:0019915; GO:0019953; GO:0030203; GO:0030246; GO:0031323; GO:0042552; GO:0042582; GO:0042802; GO:0042803; GO:0043615; GO:0044267; GO:0044877; GO:0045944; GO:0046982; GO:0048477; GO:0050885; GO:0050905; GO:0102148	acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; cell [GO:0005623]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; hexosaminidase activity [GO:0015929]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; glycosphingolipid metabolic process [GO:0006687]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; N-acetylglucosamine metabolic process [GO:0006044]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of cellular metabolic process [GO:0031323]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]
PGEN_.00g183430	Scaffold_08	40512680	40513702	Q24248	ARA_DROME	Homeobox protein araucan	GO:0000981; GO:0001745; GO:0005634; GO:0005737; GO:0007474; GO:0007476; GO:0035310; GO:0042693; GO:0043565; GO:0045317; GO:0045893; GO:0045926; GO:0045944; GO:0048813	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; dendrite morphogenesis [GO:0048813]; equator specification [GO:0045317]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; notum cell fate specification [GO:0035310]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g183440	Scaffold_08	40522488	40529860	Q91924	SNAI2_XENLA	Zinc finger protein SNAI2 (Protein slug-alpha) (Protein snail homolog 2) (Snail protein homolog Slug) (xSlu)	GO:0001755; GO:0003677; GO:0005634; GO:0014029; GO:0014036; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; neural crest cell fate specification [GO:0014036]; neural crest cell migration [GO:0001755]; neural crest formation [GO:0014029]
PGEN_.00g183450	Scaffold_08	40588250	40594872	NA	NA	NA	NA	NA
PGEN_.00g183460	Scaffold_08	40611805	40612181	NA	NA	NA	NA	NA
PGEN_.00g183470	Scaffold_08	40615771	40700608	A4ZNR5	NKD2L_DANRE	Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B)	GO:0005509; GO:0005737; GO:0005886; GO:0016055; GO:0030178	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]
PGEN_.00g183480	Scaffold_08	40675301	40675636	NA	NA	NA	NA	NA
PGEN_.00g183490	Scaffold_08	40704948	40706001	NA	NA	NA	NA	NA
PGEN_.00g183500	Scaffold_08	40706680	40706970	NA	NA	NA	NA	NA
PGEN_.00g183510	Scaffold_08	40756133	40759446	NA	NA	NA	NA	NA
PGEN_.00g183520	Scaffold_08	40777164	40783438	P24369	PPIB_MOUSE	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)	GO:0000413; GO:0003755; GO:0005654; GO:0005783; GO:0005788; GO:0005790; GO:0016018; GO:0032991; GO:0034663; GO:0040018; GO:0042026; GO:0042470; GO:0044794; GO:0044829; GO:0048471; GO:0050821; GO:0051082; GO:0060348; GO:0061077; GO:0070063	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral process [GO:0044794]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]
PGEN_.00g183530	Scaffold_08	40783620	40802463	Q1RMU2	CYLD_BOVIN	Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)	GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005881; GO:0006511; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0030496; GO:0031234; GO:0032088; GO:0036064; GO:0043369; GO:0043393; GO:0045087; GO:0045577; GO:0045582; GO:0046329; GO:0048471; GO:0048872; GO:0050727; GO:0050862; GO:0060544; GO:0061578; GO:0070064; GO:0070266; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901026; GO:1901223; GO:1902017; GO:1903753; GO:1903829; GO:1990108; GO:1990380; GO:2001238; GO:2001242	"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g183540	Scaffold_08	40813325	40830218	Q6PGU2	MAF1_DANRE	Repressor of RNA polymerase III transcription MAF1 homolog	GO:0000994; GO:0001030; GO:0001031; GO:0001032; GO:0005634; GO:0005737; GO:0016480	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; negative regulation of transcription by RNA polymerase III [GO:0016480]
PGEN_.00g183550	Scaffold_08	40840568	40871296	A9JTG5	HOIL1_DANRE	RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog)	GO:0004842; GO:0043123; GO:0043130; GO:0043161; GO:0046872; GO:0048701; GO:0071600; GO:0071797; GO:0097039	LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]
PGEN_.00g183560	Scaffold_08	40879408	40882278	Q99PW4	PRPK_MOUSE	EKC/KEOPS complex subunit Tp53rk (EC 3.6.-.-) (Atypical serine/threonine protein kinase Tp53rk) (Nori-2) (TP53-regulating kinase) (EC 2.7.11.1) (p53-related protein kinase)	GO:0000408; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008033; GO:0016787; GO:0070525	cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525]
PGEN_.00g183570	Scaffold_08	40882501	40894950	Q5PQN9	RM38_RAT	"39S ribosomal protein L38, mitochondrial (L38mt) (MRP-L38)"	GO:0005739; GO:0005762	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
PGEN_.00g183580	Scaffold_08	40902745	40903134	P53568	CEBPG_MOUSE	CCAAT/enhancer-binding protein gamma (C/EBP gamma) (Granulocyte colony-stimulating factor promoter element 1-binding protein) (GPE1-BP) (GPE1-binding protein) (Immunoglobulin enhancer-binding protein 1) (IG/EBP-1)	GO:0000978; GO:0001228; GO:0001889; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0006955; GO:0008134; GO:0016071; GO:0030183; GO:0042267; GO:0042803; GO:0043353; GO:0043433; GO:0043565; GO:0044377; GO:0044877; GO:0045078; GO:0045739; GO:0045944; GO:0046982	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II cis-regulatory region sequence-specific DNA binding, bending [GO:0044377]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; B cell differentiation [GO:0030183]; chromatin remodeling [GO:0006338]; enucleate erythrocyte differentiation [GO:0043353]; immune response [GO:0006955]; liver development [GO:0001889]; mRNA metabolic process [GO:0016071]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; nucleosome disassembly [GO:0006337]; positive regulation of DNA repair [GO:0045739]; positive regulation of interferon-gamma biosynthetic process [GO:0045078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g183590	Scaffold_08	40907244	40908584	Q15744	CEBPE_HUMAN	CCAAT/enhancer-binding protein epsilon (C/EBP epsilon)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006909; GO:0006952; GO:0030225; GO:0030851; GO:0042089; GO:0042742; GO:0042803; GO:0045944; GO:0046982; GO:0071222	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to lipopolysaccharide [GO:0071222]; cytokine biosynthetic process [GO:0042089]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; phagocytosis [GO:0006909]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g183600	Scaffold_08	40912691	40913800	NA	NA	NA	NA	NA
PGEN_.00g183610	Scaffold_08	40933257	40938860	NA	NA	NA	NA	NA
PGEN_.00g183620	Scaffold_08	40947104	40947806	NA	NA	NA	NA	NA
PGEN_.00g183630	Scaffold_08	40949210	40950523	NA	NA	NA	NA	NA
PGEN_.00g183640	Scaffold_08	40953995	40994638	P82251	BAT1_HUMAN	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	GO:0005886; GO:0005887; GO:0006865; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0050900; GO:0065003	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]
PGEN_.00g183650	Scaffold_08	41009083	41009355	NA	NA	NA	NA	NA
PGEN_.00g183660	Scaffold_08	41009397	41009714	NA	NA	NA	NA	NA
PGEN_.00g183670	Scaffold_08	41034299	41051512	Q9QXA6	BAT1_MOUSE	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016021; GO:0016324; GO:0031526; GO:0042605	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]
PGEN_.00g183680	Scaffold_08	41083183	41083443	NA	NA	NA	NA	NA
PGEN_.00g183690	Scaffold_08	41091132	41100540	Q9SMR4	RAH1C_ARATH	Ras-related protein RABH1c (AtRABH1c)	GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0032482; GO:0042147	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g183700	Scaffold_08	41105848	41122448	NA	NA	NA	NA	NA
PGEN_.00g183710	Scaffold_08	41141281	41152322	NA	NA	NA	NA	NA
PGEN_.00g183720	Scaffold_08	41177148	41177810	NA	NA	NA	NA	NA
PGEN_.00g183730	Scaffold_08	41242126	41242755	NA	NA	NA	NA	NA
PGEN_.00g183740	Scaffold_08	41271104	41271412	NA	NA	NA	NA	NA
PGEN_.00g183750	Scaffold_08	41339078	41340379	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g183760	Scaffold_08	41426094	41433169	Q5RBD4	DHX35_PONAB	Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35)	GO:0003724; GO:0005524; GO:0005681; GO:0006397; GO:0008380	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g183770	Scaffold_08	41433872	41486020	Q9VY77	AJUBA_DROME	LIM domain-containing protein jub	GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005911; GO:0005912; GO:0007010; GO:0030707; GO:0035331; GO:0045177; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:2000637	adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666]
PGEN_.00g183780	Scaffold_08	41495671	41497341	Q2TB18	ASTE1_HUMAN	Protein asteroid homolog 1	GO:0004518; GO:0006281	nuclease activity [GO:0004518]; DNA repair [GO:0006281]
PGEN_.00g183790	Scaffold_08	41506068	41506370	NA	NA	NA	NA	NA
PGEN_.00g183800	Scaffold_08	41511334	41540303	Q28E61	NSUN2_XENTR	RNA cytosine-C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (EC 2.1.1.203)	GO:0000049; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0008168; GO:0010793; GO:0016428; GO:0030488; GO:0036416; GO:0062152; GO:0070062; GO:0080009; GO:2000736	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]
PGEN_.00g183810	Scaffold_08	41545120	41552592	NA	NA	NA	NA	NA
PGEN_.00g183820	Scaffold_08	41567015	41568731	NA	NA	NA	NA	NA
PGEN_.00g183830	Scaffold_08	41575362	41577767	NA	NA	NA	NA	NA
PGEN_.00g183840	Scaffold_08	41577851	41580551	NA	NA	NA	NA	NA
PGEN_.00g183850	Scaffold_08	41596030	41596263	NA	NA	NA	NA	NA
PGEN_.00g183860	Scaffold_08	41600031	41600438	NA	NA	NA	NA	NA
PGEN_.00g183870	Scaffold_08	41616437	41630057	NA	NA	NA	NA	NA
PGEN_.00g183880	Scaffold_08	41644440	41659729	P21894	SYAC_BOMMO	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)"	GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270	cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]
PGEN_.00g183890	Scaffold_08	41660585	41679776	Q8BGQ7	SYAC_MOUSE	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Protein sticky) (Sti)"	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0021680; GO:0043524; GO:0045182; GO:0050885; GO:0050905; GO:0070143; GO:0140018	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400]
PGEN_.00g183900	Scaffold_08	41684354	41684842	NA	NA	NA	NA	NA
PGEN_.00g183910	Scaffold_08	41686161	41708881	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g183920	Scaffold_08	41734473	41745338	NA	NA	NA	NA	NA
PGEN_.00g183930	Scaffold_08	41754515	41754757	NA	NA	NA	NA	NA
PGEN_.00g183940	Scaffold_08	41774132	41774347	NA	NA	NA	NA	NA
PGEN_.00g183950	Scaffold_08	41804592	41811157	Q5RDW1	MTG2_PONAB	Mitochondrial ribosome-associated GTPase 2 (GTP-binding protein 5)	GO:0000287; GO:0003924; GO:0005525; GO:0005743; GO:0005759; GO:0005761; GO:0042254; GO:0044065; GO:0070129	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]; ribosome biogenesis [GO:0042254]
PGEN_.00g183960	Scaffold_08	41835540	41839783	A5PLL7	TM189_HUMAN	Transmembrane protein 189	GO:0005783; GO:0005789; GO:0016021	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
PGEN_.00g183970	Scaffold_08	41854041	41890480	Q8C3P7	MTA70_MOUSE	N6-adenosine-methyltransferase subunit METTL3 (EC 2.1.1.348) (Methyltransferase-like protein 3) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70)	GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005737; GO:0006382; GO:0006397; GO:0006402; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016422; GO:0016556; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0051445; GO:0060339; GO:0061157; GO:0080009; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990744	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"
PGEN_.00g183980	Scaffold_08	41919876	41926073	NA	NA	NA	NA	NA
PGEN_.00g183990	Scaffold_08	41926313	41927401	P61315	G3ST3_MOUSE	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g184000	Scaffold_08	41931068	41931328	NA	NA	NA	NA	NA
PGEN_.00g184010	Scaffold_08	41937399	41939933	NA	NA	NA	NA	NA
PGEN_.00g184020	Scaffold_08	41969805	41983018	Q5E9D0	IF2B_BOVIN	Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta)	GO:0001731; GO:0001732; GO:0003729; GO:0003743; GO:0005850; GO:0031369; GO:0046872	eukaryotic translation initiation factor 2 complex [GO:0005850]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]
PGEN_.00g184030	Scaffold_08	41987256	41997289	NA	NA	NA	NA	NA
PGEN_.00g184040	Scaffold_08	41999497	42000213	NA	NA	NA	NA	NA
PGEN_.00g184050	Scaffold_08	42005113	42021870	NA	NA	NA	NA	NA
PGEN_.00g184060	Scaffold_08	42236168	42330241	NA	NA	NA	NA	NA
PGEN_.00g184070	Scaffold_08	42349340	42414819	P70227	ITPR3_MOUSE	"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)"	GO:0000822; GO:0005220; GO:0005509; GO:0005623; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005903; GO:0006816; GO:0007186; GO:0007204; GO:0007613; GO:0015278; GO:0016529; GO:0030176; GO:0030425; GO:0030659; GO:0030667; GO:0035091; GO:0042802; GO:0043025; GO:0043209; GO:0043235; GO:0043533; GO:0044877; GO:0045177; GO:0048471; GO:0050913; GO:0050916; GO:0050917; GO:0051209; GO:0051592; GO:0060291; GO:0060402; GO:0070679; GO:0071320; GO:0098793	"apical part of cell [GO:0045177]; brush border [GO:0005903]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; identical protein binding [GO:0042802]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; inositol hexakisphosphate binding [GO:0000822]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cellular response to cAMP [GO:0071320]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol [GO:0051209]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917]"
PGEN_.00g184080	Scaffold_08	42422032	42422385	NA	NA	NA	NA	NA
PGEN_.00g184090	Scaffold_08	42435336	42452897	P12345	AATM_RABIT	"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)"	GO:0004069; GO:0005739; GO:0005759; GO:0005886; GO:0006103; GO:0006457; GO:0006531; GO:0006536; GO:0006869; GO:0009058; GO:0016212; GO:0030170	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; lipid transport [GO:0006869]; protein folding [GO:0006457]
PGEN_.00g184100	Scaffold_08	42462660	42476889	Q08DJ0	RALYL_BOVIN	RNA-binding Raly-like protein	GO:0003723; GO:0005634	nucleus [GO:0005634]; RNA binding [GO:0003723]
PGEN_.00g184110	Scaffold_08	42501729	42521440	Q5M8L0	OTU6B_XENTR	Deubiquitinase OTUD6B (EC 3.4.19.12)	GO:0004843; GO:0016579; GO:0036459	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]
PGEN_.00g184120	Scaffold_08	42521682	42542097	A5A779	PGTA_PIG	Geranylgeranyl transferase type-2 subunit alpha (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha)	GO:0004663; GO:0005737; GO:0005968; GO:0008270; GO:0017137; GO:0018344	cytoplasm [GO:0005737]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]
PGEN_.00g184130	Scaffold_08	42556635	42557249	Q9CX98	CP2U1_MOUSE	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g184140	Scaffold_08	42565090	42574322	Q51330	OXLT_OXAFO	Oxalate:formate antiporter (OFA) (Oxalate:formate antiport protein) (Oxalate:formate exchange protein)	GO:0005886; GO:0015297; GO:0016021; GO:0019531	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; oxalate transmembrane transporter activity [GO:0019531]
PGEN_.00g184150	Scaffold_08	42579512	42633182	Q9VN14	CONT_DROME	Contactin	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]
PGEN_.00g184160	Scaffold_08	42633540	42634851	O14792	HS3S1_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1)	GO:0005796; GO:0006024; GO:0008146; GO:0008467	Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g184170	Scaffold_08	42641867	42662298	Q16609	LPAL2_HUMAN	Putative apolipoprotein(a)-like protein 2 (Apo(a)-like protein 2) (Lp(a)-liker protein 2) (Apolipoprotein a-related gene C protein) (Apo(a)rg-C)	GO:0004252; GO:0005576	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g184180	Scaffold_08	42663708	42665829	Q9VGW1	CAD86_DROME	Cadherin-86C	GO:0005509; GO:0005887; GO:0007156; GO:0008360; GO:0016339; GO:0035003; GO:0044331; GO:0098609	integral component of plasma membrane [GO:0005887]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell shape [GO:0008360]
PGEN_.00g184190	Scaffold_08	42690073	42708236	O43292	GPAA1_HUMAN	Glycosylphosphatidylinositol anchor attachment 1 protein (GPI anchor attachment protein 1) (GAA1 protein homolog) (hGAA1)	GO:0005789; GO:0006621; GO:0015631; GO:0016020; GO:0016255; GO:0042765; GO:0065003	endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; tubulin binding [GO:0015631]; attachment of GPI anchor to protein [GO:0016255]; protein retention in ER lumen [GO:0006621]; protein-containing complex assembly [GO:0065003]
PGEN_.00g184200	Scaffold_08	42713491	42722087	P00125	CY1_BOVIN	"Cytochrome c1, heme protein, mitochondrial (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1)"	GO:0005739; GO:0005743; GO:0005750; GO:0005829; GO:0006122; GO:0016021; GO:0016604; GO:0020037; GO:0042776; GO:0045153; GO:0046872	"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity [GO:0045153]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"
PGEN_.00g184210	Scaffold_08	42822176	42833609	P51798	CLCN7_HUMAN	H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7)	GO:0005247; GO:0005254; GO:0005524; GO:0005654; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016020; GO:0016021; GO:0022857; GO:0031410; GO:0034220; GO:0043231	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; transmembrane transporter activity [GO:0022857]; voltage-gated chloride channel activity [GO:0005247]; ion transmembrane transport [GO:0034220]; response to pH [GO:0009268]
PGEN_.00g184220	Scaffold_08	42841536	42843162	NA	NA	NA	NA	NA
PGEN_.00g184230	Scaffold_08	42852638	42855831	Q7ZVR8	ESRP2_DANRE	Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B)	GO:0003729; GO:0005634; GO:0006397; GO:0008380; GO:0043484	nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]
PGEN_.00g184240	Scaffold_08	42866986	42879494	B2RYD2	ESRP1_RAT	Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A)	GO:0000380; GO:0003729; GO:0005634; GO:0042669; GO:0043484; GO:0050679; GO:0060441; GO:0060445	"nucleus [GO:0005634]; mRNA binding [GO:0003729]; alternative mRNA splicing, via spliceosome [GO:0000380]; branching involved in salivary gland morphogenesis [GO:0060445]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484]"
PGEN_.00g184250	Scaffold_08	42885032	42889521	NA	NA	NA	NA	NA
PGEN_.00g184260	Scaffold_08	42897739	42903324	NA	NA	NA	NA	NA
PGEN_.00g184270	Scaffold_08	42909071	42911913	NA	NA	NA	NA	NA
PGEN_.00g184280	Scaffold_08	42942275	42950398	Q6P9S1	ATMIN_MOUSE	ATM interactor (ATM/ATR-substrate CHK2-interacting zinc finger protein) (ASCIZ)	GO:0006974; GO:0010628; GO:0016604; GO:0044212; GO:0044458; GO:0045893; GO:0046872; GO:0070840; GO:1902857	"nuclear body [GO:0016604]; dynein complex binding [GO:0070840]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cellular response to DNA damage stimulus [GO:0006974]; motile cilium assembly [GO:0044458]; positive regulation of gene expression [GO:0010628]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g184290	Scaffold_08	42959103	42970363	P97477	AURKA_MOUSE	Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A)	GO:0000212; GO:0000226; GO:0000278; GO:0000780; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005815; GO:0005819; GO:0005829; GO:0005876; GO:0005929; GO:0006468; GO:0007051; GO:0007052; GO:0007057; GO:0007098; GO:0007100; GO:0009611; GO:0009948; GO:0010629; GO:0015630; GO:0018105; GO:0019901; GO:0031616; GO:0031625; GO:0031647; GO:0032091; GO:0032133; GO:0032436; GO:0032465; GO:0035174; GO:0042585; GO:0043066; GO:0043203; GO:0045120; GO:0046982; GO:0048471; GO:0051233; GO:0051301; GO:0051321; GO:0051642; GO:0071539; GO:0072686; GO:0072687; GO:0097421; GO:0097431; GO:1900195; GO:1990138	"axon hillock [GO:0043203]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cilium [GO:0005929]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; meiotic spindle [GO:0072687]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; anterior/posterior axis specification [GO:0009948]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; liver regeneration [GO:0097421]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; regulation of protein stability [GO:0031647]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051]"
PGEN_.00g184300	Scaffold_08	42980076	42985928	Q8IRG6	SPT16_DROME	FACT complex subunit spt16 (Facilitates chromatin transcription complex subunit SPT16) (dSPT16)	GO:0001672; GO:0003682; GO:0005634; GO:0005703; GO:0005730; GO:0005829; GO:0006260; GO:0006281; GO:0006368; GO:0031491; GO:0032968; GO:0034724; GO:0035101; GO:0042393; GO:0046982; GO:0047485	cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g184310	Scaffold_08	43018655	43024473	B5XGE7	TPC2L_SALSA	Trafficking protein particle complex subunit 2-like protein	GO:0005783; GO:0005794; GO:0006888; GO:0048471	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]
PGEN_.00g184320	Scaffold_08	43027435	43028055	NA	NA	NA	NA	NA
PGEN_.00g184330	Scaffold_08	43028298	43028561	NA	NA	NA	NA	NA
PGEN_.00g184340	Scaffold_08	43035396	43050787	P11387	TOP1_HUMAN	DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)	GO:0000932; GO:0000978; GO:0001650; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003723; GO:0003917; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0007623; GO:0012501; GO:0016032; GO:0016310; GO:0018105; GO:0019904; GO:0031298; GO:0032922; GO:0032993; GO:0040016; GO:0042493; GO:0043204; GO:0097100	"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993]; replication fork protection complex [GO:0031298]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; programmed cell death [GO:0012501]; response to drug [GO:0042493]; viral process [GO:0016032]"
PGEN_.00g184350	Scaffold_08	43051001	43055559	NA	NA	NA	NA	NA
PGEN_.00g184360	Scaffold_08	43070432	43070641	NA	NA	NA	NA	NA
PGEN_.00g184370	Scaffold_08	43076985	43083946	NA	NA	NA	NA	NA
PGEN_.00g184380	Scaffold_08	43091020	43092380	NA	NA	NA	NA	NA
PGEN_.00g184390	Scaffold_08	43094098	43120465	NA	NA	NA	NA	NA
PGEN_.00g184400	Scaffold_08	43144225	43152039	Q8CI17	MB213_MOUSE	Protein mab-21-like 3		
PGEN_.00g184410	Scaffold_08	43154585	43161308	NA	NA	NA	NA	NA
PGEN_.00g184420	Scaffold_08	43161463	43217701	P22735	TGM1_HUMAN	Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)	GO:0001533; GO:0003810; GO:0005829; GO:0005886; GO:0006464; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031224; GO:0043163; GO:0045787; GO:0046872; GO:0070062; GO:0070268	cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; cell envelope organization [GO:0043163]; cellular protein modification process [GO:0006464]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]
PGEN_.00g184430	Scaffold_08	43220026	43226620	NA	NA	NA	NA	NA
PGEN_.00g184440	Scaffold_08	43227039	43244921	Q15329	E2F5_HUMAN	Transcription factor E2F5 (E2F-5)	GO:0000122; GO:0000790; GO:0000981; GO:0001650; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0008134; GO:0009887; GO:0030030; GO:0043231; GO:0043565; GO:0045944; GO:0046983; GO:0051726; GO:0090575	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; animal organ morphogenesis [GO:0009887]; cell projection organization [GO:0030030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]"
PGEN_.00g184450	Scaffold_08	43358847	43384941	NA	NA	NA	NA	NA
PGEN_.00g184460	Scaffold_08	43416323	43417473	NA	NA	NA	NA	NA
PGEN_.00g184470	Scaffold_08	43419940	43420671	NA	NA	NA	NA	NA
PGEN_.00g184480	Scaffold_08	43553836	43561861	P20678	CP2H2_CHICK	Cytochrome P450 2H2 (EC 1.14.14.1) (CYPIIH2) (Cytochrome P450 PCHP7)	GO:0005506; GO:0005623; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0016712; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g184490	Scaffold_08	43568858	43573563	NA	NA	NA	NA	NA
PGEN_.00g184500	Scaffold_08	43578235	43621701	Q9EPU4	CPSF1_MOUSE	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0019899; GO:0035925	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA polyadenylation [GO:0006378]
PGEN_.00g184510	Scaffold_08	43628752	43632975	NA	NA	NA	NA	NA
PGEN_.00g184520	Scaffold_08	43633514	43643861	Q96QK1	VPS35_HUMAN	Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35)	GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0007416; GO:0010008; GO:0010628; GO:0010629; GO:0010821; GO:0014069; GO:0016032; GO:0016055; GO:0016241; GO:0030904; GO:0030906; GO:0031647; GO:0031648; GO:0031748; GO:0032268; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0060548; GO:0061357; GO:0070062; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1905606; GO:1990126; GO:2000331	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde transport, endosome to plasma membrane [GO:1990126]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; viral process [GO:0016032]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g184530	Scaffold_08	43664143	43693550	Q10569	CPSF1_BOVIN	Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)	GO:0003723; GO:0005634; GO:0005847; GO:0006378	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]
PGEN_.00g184540	Scaffold_08	43700129	43707698	NA	NA	NA	NA	NA
PGEN_.00g184550	Scaffold_08	43712541	43742674	O23300	ECI3_ARATH	"Enoyl-CoA delta isomerase 3 (EC 5.3.3.8) (3-hydroxyacyl-CoA dehydratase 1) (Delta(3),Delta(2)-enoyl CoA isomerase 3) (AtECI3)"	GO:0004165; GO:0004300; GO:0005634; GO:0005777; GO:0005829; GO:0006635; GO:0009062; GO:0080167	cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; response to karrikin [GO:0080167]
PGEN_.00g184560	Scaffold_08	43749448	43754837	O23300	ECI3_ARATH	"Enoyl-CoA delta isomerase 3 (EC 5.3.3.8) (3-hydroxyacyl-CoA dehydratase 1) (Delta(3),Delta(2)-enoyl CoA isomerase 3) (AtECI3)"	GO:0004165; GO:0004300; GO:0005634; GO:0005777; GO:0005829; GO:0006635; GO:0009062; GO:0080167	cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; response to karrikin [GO:0080167]
PGEN_.00g184570	Scaffold_08	43768098	43778743	O45782	ARD17_CAEEL	Arrestin domain-containing protein 17 (Calcineurin-interacting protein 1)	GO:0007610; GO:0030346	protein phosphatase 2B binding [GO:0030346]; behavior [GO:0007610]
PGEN_.00g184580	Scaffold_08	43781098	43836430	Q8TEX9	IPO4_HUMAN	Importin-4 (Imp4) (Importin-4b) (Imp4b) (Ran-binding protein 4) (RanBP4)	GO:0000790; GO:0005634; GO:0005737; GO:0006335; GO:0006336; GO:0006606; GO:0008139; GO:0008536; GO:0016020; GO:0032991; GO:0061608	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; protein import into nucleus [GO:0006606]
PGEN_.00g184590	Scaffold_08	43843690	43848206	NA	NA	NA	NA	NA
PGEN_.00g184600	Scaffold_08	43848265	43851153	NA	NA	NA	NA	NA
PGEN_.00g184610	Scaffold_08	43854504	43854917	NA	NA	NA	NA	NA
PGEN_.00g184620	Scaffold_08	43860765	43899746	Q5REW9	ANR27_PONAB	Ankyrin repeat domain-containing protein 27	GO:0005764; GO:0005769; GO:0005770; GO:0005886; GO:0015031; GO:0030659; GO:0042470	cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein transport [GO:0015031]
PGEN_.00g184630	Scaffold_08	43901732	43905818	Q96NW4	ANR27_HUMAN	Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein)	GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0015031; GO:0016020; GO:0017137; GO:0030133; GO:0030659; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0045022; GO:0048812; GO:0050775; GO:0097422; GO:1990126	"cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]; SNARE binding [GO:0000149]; early endosome to late endosome transport [GO:0045022]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g184640	Scaffold_08	43911971	43928123	Q4KTY1	KPSH1_PINFU	Serine/threonine-protein kinase H1 homolog (EC 2.7.11.1)	GO:0004674; GO:0005524	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g184650	Scaffold_08	43928425	43928901	NA	NA	NA	NA	NA
PGEN_.00g184660	Scaffold_08	43931976	43932251	NA	NA	NA	NA	NA
PGEN_.00g184670	Scaffold_08	43932478	43932834	NA	NA	NA	NA	NA
PGEN_.00g184680	Scaffold_08	43933447	43934371	NA	NA	NA	NA	NA
PGEN_.00g184690	Scaffold_08	43937141	43937817	NA	NA	NA	NA	NA
PGEN_.00g184700	Scaffold_08	44055864	44061457	Q1LWV7	MEAK7_DANRE	MTOR-associated protein MEAK7 (MEAK7) (TBC/LysM-associated domain-containing protein 1) (TLD domain-containing protein 1)	GO:0005737; GO:0005765; GO:0016020; GO:0030334; GO:0031667; GO:0031929; GO:0032868; GO:0042127; GO:0043200; GO:0150032	cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; TOR signaling [GO:0031929]
PGEN_.00g184710	Scaffold_08	44070000	44070473	NA	NA	NA	NA	NA
PGEN_.00g184720	Scaffold_08	44082422	44082697	NA	NA	NA	NA	NA
PGEN_.00g184730	Scaffold_08	44090616	44090981	NA	NA	NA	NA	NA
PGEN_.00g184740	Scaffold_08	44109599	44110531	NA	NA	NA	NA	NA
PGEN_.00g184750	Scaffold_08	44111078	44111458	NA	NA	NA	NA	NA
PGEN_.00g184760	Scaffold_08	44111839	44112330	NA	NA	NA	NA	NA
PGEN_.00g184770	Scaffold_08	44112362	44113611	NA	NA	NA	NA	NA
PGEN_.00g184780	Scaffold_08	44114039	44115400	NA	NA	NA	NA	NA
PGEN_.00g184790	Scaffold_08	44115663	44115998	NA	NA	NA	NA	NA
PGEN_.00g184800	Scaffold_08	44118019	44119458	NA	NA	NA	NA	NA
PGEN_.00g184810	Scaffold_08	44119496	44124475	NA	NA	NA	NA	NA
PGEN_.00g184820	Scaffold_08	44145530	44146270	Q6DGV7	M17L2_DANRE	Mpv17-like protein 2	GO:0005737; GO:0005743; GO:0016021; GO:0061668	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome assembly [GO:0061668]
PGEN_.00g184830	Scaffold_08	44150653	44151246	NA	NA	NA	NA	NA
PGEN_.00g184840	Scaffold_08	44151887	44152330	NA	NA	NA	NA	NA
PGEN_.00g184850	Scaffold_08	44230789	44231019	NA	NA	NA	NA	NA
PGEN_.00g184860	Scaffold_08	44231076	44240276	A8MW92	P20L1_HUMAN	PHD finger protein 20-like protein 1	GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g184870	Scaffold_08	44255972	44257040	NA	NA	NA	NA	NA
PGEN_.00g184880	Scaffold_08	44257177	44258469	NA	NA	NA	NA	NA
PGEN_.00g184890	Scaffold_08	44262148	44291826	NA	NA	NA	NA	NA
PGEN_.00g184900	Scaffold_08	44326449	44326772	NA	NA	NA	NA	NA
PGEN_.00g184910	Scaffold_08	44342964	44405259	A2VE56	P20L1_BOVIN	PHD finger protein 20-like protein 1	GO:0005634; GO:0006355	"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g184920	Scaffold_08	44409489	44409809	NA	NA	NA	NA	NA
PGEN_.00g184930	Scaffold_08	44425120	44425428	NA	NA	NA	NA	NA
PGEN_.00g184940	Scaffold_08	44426224	44426616	NA	NA	NA	NA	NA
PGEN_.00g184950	Scaffold_08	44428649	44431807	NA	NA	NA	NA	NA
PGEN_.00g184960	Scaffold_08	44443059	44449032	Q9H0A9	SPC1L_HUMAN	Speriolin-like protein (Spermatogenesis and centriole-associated protein 1-like protein)	GO:0005813	centrosome [GO:0005813]
PGEN_.00g184970	Scaffold_08	44490515	44515046	NA	NA	NA	NA	NA
PGEN_.00g184980	Scaffold_08	44523129	44546712	Q8BVI5	STX16_MOUSE	Syntaxin-16	GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031985; GO:0042147; GO:0043231; GO:0048278; GO:0048471; GO:0090161	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"
PGEN_.00g184990	Scaffold_08	44546769	44547140	NA	NA	NA	NA	NA
PGEN_.00g185000	Scaffold_08	44547543	44548001	NA	NA	NA	NA	NA
PGEN_.00g185010	Scaffold_08	44550419	44563488	Q8BVI5	STX16_MOUSE	Syntaxin-16	GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031985; GO:0042147; GO:0043231; GO:0048278; GO:0048471; GO:0090161	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"
PGEN_.00g185020	Scaffold_08	44555247	44557803	NA	NA	NA	NA	NA
PGEN_.00g185030	Scaffold_08	44672053	44737967	Q8BJS8	MTBP_MOUSE	Mdm2-binding protein (mMTBP)	GO:0000776; GO:0000785; GO:0007050; GO:0007089; GO:0008285; GO:0031396; GO:0034501; GO:0045839	chromatin [GO:0000785]; kinetochore [GO:0000776]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic nuclear division [GO:0045839]; protein localization to kinetochore [GO:0034501]; regulation of protein ubiquitination [GO:0031396]; traversing start control point of mitotic cell cycle [GO:0007089]
PGEN_.00g185040	Scaffold_08	44710038	44710706	NA	NA	NA	NA	NA
PGEN_.00g185050	Scaffold_08	44739064	44741817	NA	NA	NA	NA	NA
PGEN_.00g185060	Scaffold_08	44744410	44763735	NA	NA	NA	NA	NA
PGEN_.00g185070	Scaffold_08	44763808	44764718	NA	NA	NA	NA	NA
PGEN_.00g185080	Scaffold_08	44796607	44826300	Q9Y2H8	ZN510_HUMAN	Zinc finger protein 510	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g185090	Scaffold_08	44841600	44841968	NA	NA	NA	NA	NA
PGEN_.00g185100	Scaffold_08	44842314	44845704	NA	NA	NA	NA	NA
PGEN_.00g185110	Scaffold_08	44875762	44877066	Q5RCM6	SOCS6_PONAB	Suppressor of cytokine signaling 6 (SOCS-6)	GO:0001772; GO:0005942; GO:0009968; GO:0010498; GO:0016567; GO:0035556; GO:0040008; GO:0046854; GO:0046935; GO:0050868	immunological synapse [GO:0001772]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; negative regulation of T cell activation [GO:0050868]; phosphatidylinositol phosphorylation [GO:0046854]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]
PGEN_.00g185120	Scaffold_08	44924354	44952707	Q3ZBD0	PSMD7_BOVIN	26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8)	GO:0000502; GO:0005838; GO:0043161	proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]
PGEN_.00g185130	Scaffold_08	44980641	45028569	NA	NA	NA	NA	NA
PGEN_.00g185140	Scaffold_08	45059602	45075597	NA	NA	NA	NA	NA
PGEN_.00g185150	Scaffold_08	45076242	45078695	NA	NA	NA	NA	NA
PGEN_.00g185160	Scaffold_08	45083352	45087484	NA	NA	NA	NA	NA
PGEN_.00g185170	Scaffold_08	45087820	45088137	NA	NA	NA	NA	NA
PGEN_.00g185180	Scaffold_08	45106278	45108371	Q8BTU1	CFA20_MOUSE	Cilia- and flagella-associated protein 20 (Gene trap locus 3 protein)	GO:0005654; GO:0005737; GO:0005814; GO:0005874; GO:0005929; GO:0018095; GO:0031514; GO:0036064; GO:0060271; GO:0060296; GO:2000147; GO:2000253	centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; cilium assembly [GO:0060271]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]
PGEN_.00g185190	Scaffold_08	45158590	45188336	NA	NA	NA	NA	NA
PGEN_.00g185200	Scaffold_08	45240011	45256572	NA	NA	NA	NA	NA
PGEN_.00g185210	Scaffold_08	45269240	45278775	Q96KR6	F210B_HUMAN	"Protein FAM210B, mitochondrial"	GO:0005741; GO:0016021; GO:0031224; GO:0043249; GO:0045648; GO:0071392	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; cellular response to estradiol stimulus [GO:0071392]; erythrocyte maturation [GO:0043249]; positive regulation of erythrocyte differentiation [GO:0045648]
PGEN_.00g185220	Scaffold_08	45291995	45300715	Q9Y236	OSGI2_HUMAN	Oxidative stress-induced growth inhibitor 2 (hT41)	GO:0008083; GO:0030308; GO:0051321	growth factor activity [GO:0008083]; meiotic cell cycle [GO:0051321]; negative regulation of cell growth [GO:0030308]
PGEN_.00g185230	Scaffold_08	45358285	45358803	NA	NA	NA	NA	NA
PGEN_.00g185240	Scaffold_08	45358840	45360448	NA	NA	NA	NA	NA
PGEN_.00g185250	Scaffold_08	45363283	45370188	Q28DH9	CEP76_XENTR	Centrosomal protein of 76 kDa (Cep76)	GO:0005737; GO:0005814; GO:0046599	centriole [GO:0005814]; cytoplasm [GO:0005737]; regulation of centriole replication [GO:0046599]
PGEN_.00g185260	Scaffold_08	45411844	45427271	Q28DH9	CEP76_XENTR	Centrosomal protein of 76 kDa (Cep76)	GO:0005737; GO:0005814; GO:0046599	centriole [GO:0005814]; cytoplasm [GO:0005737]; regulation of centriole replication [GO:0046599]
PGEN_.00g185270	Scaffold_08	45435113	45510521	Q3U2U7	MET17_MOUSE	"Methyltransferase-like protein 17, mitochondrial (EC 2.1.1.-) (Methyltransferase 11 domain-containing protein 1) (Protein RSM22 homolog, mitochondrial)"	GO:0005654; GO:0005739; GO:0005840; GO:0006412; GO:0008168; GO:0032259	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; translation [GO:0006412]
PGEN_.00g185280	Scaffold_08	45510955	45535157	Q99JF5	MVD1_MOUSE	Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase)	GO:0004163; GO:0005524; GO:0005777; GO:0005782; GO:0005829; GO:0006695; GO:0008284; GO:0008299; GO:0019287; GO:0030544; GO:0042803	"cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284]"
PGEN_.00g185290	Scaffold_08	45606465	45643122	Q9WTK2	CDYL_MOUSE	Chromodomain Y-like protein (CDY-like) (Crotonyl-CoA hydratase) (EC 4.2.1.-) (Putative histone acetyltransferase Cdyl) (EC 2.3.1.48)	GO:0003682; GO:0003714; GO:0004402; GO:0005634; GO:0005694; GO:0005737; GO:0007286; GO:0016607; GO:0030674; GO:0035064; GO:0060816; GO:0120092; GO:0120094	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; crotonyl-CoA hydratase activity [GO:0120092]; histone acetyltransferase activity [GO:0004402]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; transcription corepressor activity [GO:0003714]; negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; spermatid development [GO:0007286]"
PGEN_.00g185300	Scaffold_08	45643175	45648560	NA	NA	NA	NA	NA
PGEN_.00g185310	Scaffold_08	45667206	45669819	O75521	ECI2_HUMAN	"Enoyl-CoA delta isomerase 2, mitochondrial (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)"	GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0009062; GO:0016020; GO:0033540; GO:0043231	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g185320	Scaffold_08	45670254	45670673	NA	NA	NA	NA	NA
PGEN_.00g185330	Scaffold_08	45670709	45672224	Q5XIC0	ECI2_RAT	"Enoyl-CoA delta isomerase 2, mitochondrial (EC 5.3.3.8) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI)"	GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0006635; GO:0009062; GO:0016863	"mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]"
PGEN_.00g185340	Scaffold_08	45678550	45678816	NA	NA	NA	NA	NA
PGEN_.00g185350	Scaffold_08	45688885	45692390	NA	NA	NA	NA	NA
PGEN_.00g185360	Scaffold_08	45703686	45705086	NA	NA	NA	NA	NA
PGEN_.00g185370	Scaffold_08	45715688	45716125	NA	NA	NA	NA	NA
PGEN_.00g185380	Scaffold_08	45716183	45716455	NA	NA	NA	NA	NA
PGEN_.00g185390	Scaffold_08	45716489	45717436	NA	NA	NA	NA	NA
PGEN_.00g185400	Scaffold_08	45717526	45717897	NA	NA	NA	NA	NA
PGEN_.00g185410	Scaffold_08	45725536	45727171	NA	NA	NA	NA	NA
PGEN_.00g185420	Scaffold_08	45734784	45735683	NA	NA	NA	NA	NA
PGEN_.00g185430	Scaffold_08	45736495	45747110	NA	NA	NA	NA	NA
PGEN_.00g185440	Scaffold_08	45768589	45769621	NA	NA	NA	NA	NA
PGEN_.00g185450	Scaffold_08	45796458	45796964	NA	NA	NA	NA	NA
PGEN_.00g185460	Scaffold_08	45829571	45834917	NA	NA	NA	NA	NA
PGEN_.00g185470	Scaffold_08	45857205	45857498	NA	NA	NA	NA	NA
PGEN_.00g185480	Scaffold_08	45873218	45873964	Q7TQN8	GP119_RAT	Glucose-dependent insulinotropic receptor (G-protein coupled receptor 119)	GO:0004930; GO:0005886; GO:0016021; GO:0030073; GO:0031210; GO:0043235	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210]; insulin secretion [GO:0030073]
PGEN_.00g185490	Scaffold_08	45874416	45874685	NA	NA	NA	NA	NA
PGEN_.00g185500	Scaffold_08	45884773	45885177	NA	NA	NA	NA	NA
PGEN_.00g185510	Scaffold_08	45885252	45885611	NA	NA	NA	NA	NA
PGEN_.00g185520	Scaffold_08	45887406	45887885	NA	NA	NA	NA	NA
PGEN_.00g185530	Scaffold_08	45971166	45989936	NA	NA	NA	NA	NA
PGEN_.00g185540	Scaffold_08	46001618	46002460	NA	NA	NA	NA	NA
PGEN_.00g185550	Scaffold_08	46003438	46003800	NA	NA	NA	NA	NA
PGEN_.00g185560	Scaffold_08	46028882	46029097	NA	NA	NA	NA	NA
PGEN_.00g185570	Scaffold_08	46043323	46043763	NA	NA	NA	NA	NA
PGEN_.00g185580	Scaffold_08	46068226	46075837	NA	NA	NA	NA	NA
PGEN_.00g185590	Scaffold_08	46118576	46119733	NA	NA	NA	NA	NA
PGEN_.00g185600	Scaffold_08	46135051	46135476	NA	NA	NA	NA	NA
PGEN_.00g185610	Scaffold_08	46137363	46156090	Q9HCI6	K1586_HUMAN	E3 SUMO-protein ligase KIAA1586 (EC 2.3.2.-) (E3 SUMO-protein transferase KIAA1586)	GO:0016925; GO:0061665	SUMO ligase activity [GO:0061665]; protein sumoylation [GO:0016925]
PGEN_.00g185620	Scaffold_08	46184260	46189671	NA	NA	NA	NA	NA
PGEN_.00g185630	Scaffold_08	46220214	46225401	NA	NA	NA	NA	NA
PGEN_.00g185640	Scaffold_08	46225679	46226014	NA	NA	NA	NA	NA
PGEN_.00g185650	Scaffold_08	46226040	46226528	NA	NA	NA	NA	NA
PGEN_.00g185660	Scaffold_08	46228758	46236939	NA	NA	NA	NA	NA
PGEN_.00g185670	Scaffold_08	46256551	46300379	NA	NA	NA	NA	NA
PGEN_.00g185680	Scaffold_08	46383672	46390149	Q8R1Q3	ANGL7_MOUSE	Angiopoietin-related protein 7 (Angiopoietin-like protein 7)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g185690	Scaffold_08	46395224	46413668	NA	NA	NA	NA	NA
PGEN_.00g185700	Scaffold_08	46404999	46405292	NA	NA	NA	NA	NA
PGEN_.00g185710	Scaffold_08	46476730	46490787	NA	NA	NA	NA	NA
PGEN_.00g185720	Scaffold_08	46493140	46497333	NA	NA	NA	NA	NA
PGEN_.00g185730	Scaffold_08	46497395	46540125	Q8BWU8	AT2L1_MOUSE	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	GO:0005739; GO:0008483; GO:0030170; GO:0050459	mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]
PGEN_.00g185740	Scaffold_08	46544010	46544474	NA	NA	NA	NA	NA
PGEN_.00g185750	Scaffold_08	46551131	46561455	NA	NA	NA	NA	NA
PGEN_.00g185760	Scaffold_08	46561531	46603508	Q7ZU29	NUP93_DANRE	Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Dead eye protein) (Nucleoporin Nup93)	GO:0005643; GO:0006606; GO:0016973; GO:0017056; GO:0031965; GO:0034399; GO:0051292	nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; nuclear pore complex assembly [GO:0051292]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]
PGEN_.00g185770	Scaffold_08	46608544	46613599	NA	NA	NA	NA	NA
PGEN_.00g185780	Scaffold_08	46613848	46621875	Q6C9E7	SET5_YARLI	Potential protein lysine methyltransferase SET5 (EC 2.1.1.-) (SET domain-containing protein 5)	GO:0005634; GO:0005737; GO:0008168; GO:0032259	cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g185790	Scaffold_08	46632185	46639251	F7B645	TM231_XENTR	Transmembrane protein 231	GO:0007224; GO:0016021; GO:0032880; GO:0035869; GO:0036038; GO:0060170; GO:0060271	ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]
PGEN_.00g185800	Scaffold_08	46646905	46666829	Q6GM29	SAC1_XENLA	Phosphatidylinositide phosphatase SAC1 (EC 3.1.3.-) (Suppressor of actin mutations 1-like protein)	GO:0005789; GO:0016021; GO:0016791; GO:0043812; GO:0046856	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol dephosphorylation [GO:0046856]
PGEN_.00g185810	Scaffold_08	46716052	46731529	Q9FZK4	NTF2A_ARATH	"Nuclear transport factor 2A (AtNTF2a) [Cleaved into: Nuclear transport factor 2A, N-terminally processed]"	GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0006913; GO:0044613	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore central transport channel [GO:0044613]; nucleus [GO:0005634]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]
PGEN_.00g185820	Scaffold_08	46748906	46770662	Q9NPA5	NA	NA	NA	NA
PGEN_.00g185830	Scaffold_08	46812540	46813022	NA	NA	NA	NA	NA
PGEN_.00g185840	Scaffold_08	46813068	46813568	NA	NA	NA	NA	NA
PGEN_.00g185850	Scaffold_08	46817038	46821073	Q55CU8	PITC_DICDI	Phosphatidylinositol transfer protein 3 (CRAL-TRIO domain-containing protein pitC) (Random slug protein 5)	GO:0008526	phosphatidylinositol transfer activity [GO:0008526]
PGEN_.00g185860	Scaffold_08	46837591	46843852	Q7TQE7	K0895_MOUSE	Uncharacterized protein KIAA0895		
PGEN_.00g185870	Scaffold_08	46867443	46884299	Q32P85	DLRB2_BOVIN	"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)"	GO:0003774; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018]
PGEN_.00g185880	Scaffold_08	46884354	46886188	NA	NA	NA	NA	NA
PGEN_.00g185890	Scaffold_08	46886297	46887827	NA	NA	NA	NA	NA
PGEN_.00g185900	Scaffold_08	46887943	46888522	NA	NA	NA	NA	NA
PGEN_.00g185910	Scaffold_08	46894005	46918388	Q9UN37	VPS4A_HUMAN	Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4)	GO:0000916; GO:0000922; GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005774; GO:0005813; GO:0005829; GO:0005886; GO:0006622; GO:0006900; GO:0006997; GO:0006998; GO:0007033; GO:0007080; GO:0008022; GO:0009838; GO:0010008; GO:0016192; GO:0016197; GO:0016236; GO:0016887; GO:0019058; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0031902; GO:0032367; GO:0032466; GO:0032880; GO:0034058; GO:0036258; GO:0039702; GO:0042623; GO:0043162; GO:0044877; GO:0044878; GO:0048471; GO:0051301; GO:0061640; GO:0061738; GO:0061952; GO:0070062; GO:0072319; GO:0090543; GO:0090611; GO:1902188; GO:1903076; GO:1903543; GO:1903774; GO:1903902; GO:1904896; GO:1904903	"cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]"
PGEN_.00g185920	Scaffold_08	46932108	46950995	O75351	VPS4B_HUMAN	Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1)	GO:0000922; GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0006813; GO:0006997; GO:0007033; GO:0007080; GO:0008022; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016236; GO:0016887; GO:0019058; GO:0019076; GO:0030301; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042623; GO:0042802; GO:0042803; GO:0043162; GO:0048524; GO:0050792; GO:0051261; GO:0060548; GO:0061738; GO:0061952; GO:0070062; GO:0090543; GO:0090611; GO:1901673; GO:1902188; GO:1903542; GO:1903543; GO:1903724; GO:1903902; GO:1904903	"cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]"
PGEN_.00g185930	Scaffold_08	46977668	46977979	NA	NA	NA	NA	NA
PGEN_.00g185940	Scaffold_08	46980140	46980391	NA	NA	NA	NA	NA
PGEN_.00g185950	Scaffold_08	46980646	46981095	NA	NA	NA	NA	NA
PGEN_.00g185960	Scaffold_08	46983841	46990079	NA	NA	NA	NA	NA
PGEN_.00g185970	Scaffold_08	46990272	46990715	NA	NA	NA	NA	NA
PGEN_.00g185980	Scaffold_08	46991354	46991770	NA	NA	NA	NA	NA
PGEN_.00g185990	Scaffold_08	47053800	47071753	NA	NA	NA	NA	NA
PGEN_.00g186000	Scaffold_08	47080088	47080369	NA	NA	NA	NA	NA
PGEN_.00g186010	Scaffold_08	47080864	47083520	NA	NA	NA	NA	NA
PGEN_.00g186020	Scaffold_08	47128527	47139299	NA	NA	NA	NA	NA
PGEN_.00g186030	Scaffold_08	47162118	47162879	NA	NA	NA	NA	NA
PGEN_.00g186040	Scaffold_08	47168601	47174990	NA	NA	NA	NA	NA
PGEN_.00g186050	Scaffold_08	47175053	47201809	Q3USW5	FXRD2_MOUSE	FAD-dependent oxidoreductase domain-containing protein 2	GO:0005788; GO:0016491; GO:0030433; GO:0050660	endoplasmic reticulum lumen [GO:0005788]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g186060	Scaffold_08	47210194	47243257	Q9WTR8	PHLP1_RAT	PH domain leucine-rich repeat protein phosphatase 1 (EC 3.1.3.16) (Pleckstrin homology domain-containing family E member 1) (PH domain-containing family E member 1) (Suprachiasmatic nucleus circadian oscillatory protein)	GO:0001932; GO:0002667; GO:0004722; GO:0005654; GO:0005737; GO:0005886; GO:0006470; GO:0006915; GO:0007623; GO:0009649; GO:0021766; GO:0031965; GO:0042981; GO:0043408; GO:0046328; GO:0046872; GO:0051897; GO:0051898; GO:0070373; GO:0090037; GO:0090038; GO:1900744	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; hippocampus development [GO:0021766]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein kinase C signaling [GO:0090038]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; protein dephosphorylation [GO:0006470]; regulation of apoptotic process [GO:0042981]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein phosphorylation [GO:0001932]; regulation of T cell anergy [GO:0002667]
PGEN_.00g186070	Scaffold_08	47306291	47306545	NA	NA	NA	NA	NA
PGEN_.00g186080	Scaffold_08	47306870	47308339	NA	NA	NA	NA	NA
PGEN_.00g186090	Scaffold_08	47310209	47310508	NA	NA	NA	NA	NA
PGEN_.00g186100	Scaffold_08	47353040	47358032	Q9BS92	NPS3B_HUMAN	Protein NipSnap homolog 3B (NipSnap3B) (SNAP1)	GO:0005739	mitochondrion [GO:0005739]
PGEN_.00g186110	Scaffold_08	47366697	47367830	NA	NA	NA	NA	NA
PGEN_.00g186120	Scaffold_08	47374480	47398001	Q5R7R6	COG4_PONAB	Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4)	GO:0000139; GO:0005829; GO:0015031	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; protein transport [GO:0015031]
PGEN_.00g186130	Scaffold_08	47406980	47448457	NA	NA	NA	NA	NA
PGEN_.00g186140	Scaffold_08	47449292	47461343	Q62737	CY24A_RAT	Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox) (p22phox)	GO:0001666; GO:0001725; GO:0001938; GO:0003106; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005925; GO:0006801; GO:0006954; GO:0009055; GO:0014823; GO:0014895; GO:0016175; GO:0016324; GO:0017004; GO:0017124; GO:0020037; GO:0030307; GO:0030425; GO:0031667; GO:0032755; GO:0032760; GO:0032930; GO:0033864; GO:0034137; GO:0042493; GO:0042554; GO:0043020; GO:0043025; GO:0045087; GO:0045730; GO:0045777; GO:0046872; GO:0046982; GO:0048661; GO:0050665; GO:0050766; GO:0051279; GO:0055114; GO:0070257; GO:0070555; GO:0071230; GO:0071260; GO:0071310; GO:0071333; GO:0071356; GO:0071407; GO:0071480; GO:0072593; GO:1900426; GO:1903428; GO:1904044; GO:1904385; GO:1904845	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; NADPH oxidase complex [GO:0043020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; stress fiber [GO:0001725]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; superoxide-generating NADPH oxidase activity [GO:0016175]; cellular response to amino acid stimulus [GO:0071230]; cellular response to angiotensin [GO:1904385]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to L-glutamine [GO:1904845]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; cellular response to tumor necrosis factor [GO:0071356]; cytochrome complex assembly [GO:0017004]; hydrogen peroxide biosynthetic process [GO:0050665]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of glomerular filtration by angiotensin [GO:0003106]; oxidation-reduction process [GO:0055114]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell growth [GO:0030307]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mucus secretion [GO:0070257]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; reactive oxygen species metabolic process [GO:0072593]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; respiratory burst [GO:0045730]; response to activity [GO:0014823]; response to aldosterone [GO:1904044]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to nutrient levels [GO:0031667]; smooth muscle hypertrophy [GO:0014895]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]
PGEN_.00g186150	Scaffold_08	47467082	47497465	Q9R1S3	PIGN_MOUSE	GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N)	GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016021; GO:0016780; GO:0051377	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; mannose-ethanolamine phosphotransferase activity [GO:0051377]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]"
PGEN_.00g186160	Scaffold_08	47555071	47570928	NA	NA	NA	NA	NA
PGEN_.00g186170	Scaffold_08	47597455	47626960	P82251	BAT1_HUMAN	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	GO:0005886; GO:0005887; GO:0006865; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0050900; GO:0065003	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]
PGEN_.00g186180	Scaffold_08	47638996	47650178	Q5XLR4	BORE1_DANRE	Borealin (Cell division cycle-associated protein 8) (Dasra-B) (DasraB) (DrDasraB)	GO:0000070; GO:0000775; GO:0005634; GO:0005737; GO:0007507; GO:0032133; GO:0051233; GO:0051301	"chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; cell division [GO:0051301]; heart development [GO:0007507]; mitotic sister chromatid segregation [GO:0000070]"
PGEN_.00g186190	Scaffold_08	47654700	47663346	Q8JHH5	CA109_DANRE	Uncharacterized protein C1orf109 homolog	GO:0005634; GO:0005737; GO:0007275	cytoplasm [GO:0005737]; nucleus [GO:0005634]; multicellular organism development [GO:0007275]
PGEN_.00g186200	Scaffold_08	47667217	47677636	NA	NA	NA	NA	NA
PGEN_.00g186210	Scaffold_08	47677958	47711315	O43861	ATP9B_HUMAN	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0048471; GO:0140326	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g186220	Scaffold_08	47717105	47719311	NA	NA	NA	NA	NA
PGEN_.00g186230	Scaffold_08	47725415	47734546	F1Q4S1	ATP9B_DANRE	Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B)	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0045332; GO:0140326	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g186240	Scaffold_08	47743839	47748292	Q8MP06	SNO1_TYRJA	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	GO:0004499; GO:0005576; GO:0009820; GO:0033784; GO:0050660; GO:0050661; GO:0051289; GO:0055114	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
PGEN_.00g186250	Scaffold_08	47769511	47778459	NA	NA	NA	NA	NA
PGEN_.00g186260	Scaffold_08	47812165	47824604	Q9FWW6	GSXL1_ARATH	Flavin-containing monooxygenase FMO GS-OX-like 1 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 1)	GO:0004499; GO:0009751; GO:0009753; GO:0019761; GO:0050660; GO:0050661	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; glucosinolate biosynthetic process [GO:0019761]; response to jasmonic acid [GO:0009753]; response to salicylic acid [GO:0009751]"
PGEN_.00g186270	Scaffold_08	47853679	47911468	P55043	RAD_RAT	GTP-binding protein RAD (RAD1) (Ras associated with diabetes)	GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0030308; GO:1901842	plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]
PGEN_.00g186280	Scaffold_08	47905498	47906460	NA	NA	NA	NA	NA
PGEN_.00g186290	Scaffold_08	47925610	47932879	NA	NA	NA	NA	NA
PGEN_.00g186300	Scaffold_08	47934863	47949367	P05186	PPBT_HUMAN	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme)"	GO:0001501; GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0005576; GO:0005886; GO:0016020; GO:0016462; GO:0031012; GO:0031225; GO:0032496; GO:0033280; GO:0046677; GO:0046872; GO:0051384; GO:0065010; GO:0070062; GO:0071407; GO:0071529	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; osteoblast differentiation [GO:0001649]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]
PGEN_.00g186310	Scaffold_08	47965153	47979895	P05186	PPBT_HUMAN	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme)"	GO:0001501; GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0005576; GO:0005886; GO:0016020; GO:0016462; GO:0031012; GO:0031225; GO:0032496; GO:0033280; GO:0046677; GO:0046872; GO:0051384; GO:0065010; GO:0070062; GO:0071407; GO:0071529	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; osteoblast differentiation [GO:0001649]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]
PGEN_.00g186320	Scaffold_08	47984489	47995381	Q8BW10	NOB1_MOUSE	RNA-binding protein NOB1 (EC 3.1.-.-)	GO:0000469; GO:0004521; GO:0005634; GO:0005730; GO:0005737; GO:0007601; GO:0030490; GO:0030688; GO:0042274; GO:0046872	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274]; visual perception [GO:0007601]"
PGEN_.00g186330	Scaffold_08	48016478	48019663	NA	NA	NA	NA	NA
PGEN_.00g186340	Scaffold_08	48023289	48087407	Q69ZB8	ZCHC2_MOUSE	Zinc finger CCHC domain-containing protein 2	GO:0003676; GO:0005737; GO:0008270; GO:0035091	cytoplasm [GO:0005737]; nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270]
PGEN_.00g186350	Scaffold_08	48095514	48125139	Q6XQG9	G3ST2_PIG	"Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g186360	Scaffold_08	48164013	48186479	Q921I2	KLDC4_MOUSE	Kelch domain-containing protein 4		
PGEN_.00g186370	Scaffold_08	48191686	48196926	Q4W5G0	TIGD2_HUMAN	Tigger transposable element-derived protein 2	GO:0003677; GO:0005634	nucleus [GO:0005634]; DNA binding [GO:0003677]
PGEN_.00g186380	Scaffold_08	48255645	48260714	Q42688	GLNA1_CHLRE	Glutamine synthetase cytosolic isozyme (EC 6.3.1.2) (GS1) (Glutamate--ammonia ligase)	GO:0004356; GO:0005524; GO:0005737; GO:0006542	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamine biosynthetic process [GO:0006542]
PGEN_.00g186390	Scaffold_08	48285409	48300983	P15104	GLNA_HUMAN	Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)	GO:0000287; GO:0001504; GO:0001525; GO:0004356; GO:0005524; GO:0005634; GO:0005739; GO:0005791; GO:0005829; GO:0005886; GO:0006538; GO:0006542; GO:0008283; GO:0008652; GO:0009267; GO:0009749; GO:0010594; GO:0016595; GO:0018345; GO:0019676; GO:0019706; GO:0030145; GO:0032024; GO:0032991; GO:0042254; GO:0042802; GO:0043204; GO:0043209; GO:0043679; GO:0045503; GO:0050679; GO:0051260; GO:0051968; GO:0070062; GO:0097386; GO:1903670; GO:1904749	"axon terminus [GO:0043679]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate binding [GO:0016595]; glutamate-ammonia ligase activity [GO:0004356]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to starvation [GO:0009267]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter uptake [GO:0001504]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein homooligomerization [GO:0051260]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]"
PGEN_.00g186400	Scaffold_08	48313603	48335334	Q8VD66	ABHD4_MOUSE	(Lyso)-N-acylphosphatidylethanolamine lipase (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 4) (Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4)	GO:0004622; GO:0005811; GO:0016042; GO:0052689; GO:0055088; GO:0070291; GO:0070292	lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]
PGEN_.00g186410	Scaffold_08	48335468	48338002	NA	NA	NA	NA	NA
PGEN_.00g186420	Scaffold_08	48348208	48355640	Q9QXA6	BAT1_MOUSE	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016021; GO:0016324; GO:0031526; GO:0042605	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]
PGEN_.00g186430	Scaffold_08	48416133	48416462	NA	NA	NA	NA	NA
PGEN_.00g186440	Scaffold_08	48426084	48443751	P82251	BAT1_HUMAN	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	GO:0005886; GO:0005887; GO:0006865; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0050900; GO:0065003	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]
PGEN_.00g186450	Scaffold_08	48469912	48483717	A5D6U8	ACP7_DANRE	Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)	GO:0003993; GO:0005576; GO:0046872	extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]
PGEN_.00g186460	Scaffold_08	48484723	48485334	NA	NA	NA	NA	NA
PGEN_.00g186470	Scaffold_08	48500364	48520529	Q05187	TGMH_TACTR	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)	GO:0003810; GO:0016020; GO:0018149; GO:0046872	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]
PGEN_.00g186480	Scaffold_08	48526445	48533382	Q99489	OXDD_HUMAN	D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1)	GO:0005777; GO:0005782; GO:0005829; GO:0006531; GO:0006533; GO:0006625; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0034641; GO:0042445; GO:0048037; GO:0071949	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; cofactor binding [GO:0048037]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular nitrogen compound metabolic process [GO:0034641]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g186490	Scaffold_08	48538537	48547920	P63047	ST4A1_RAT	Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (rBR-STL) (Nervous system sulfotransferase) (NST)	GO:0005737; GO:0006790; GO:0008146; GO:0008202; GO:0042802	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g186500	Scaffold_08	48557270	48566959	P31228	OXDD_BOVIN	D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1)	GO:0005777; GO:0006531; GO:0006533; GO:0008445; GO:0046416; GO:0071949	peroxisome [GO:0005777]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid metabolic process [GO:0046416]
PGEN_.00g186510	Scaffold_08	48570835	48583430	NA	NA	NA	NA	NA
PGEN_.00g186520	Scaffold_08	48586826	48619865	NA	NA	NA	NA	NA
PGEN_.00g186530	Scaffold_08	48621762	48640533	P38714	SYRM_YEAST	"Arginine--tRNA ligase, mitochondrial (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)"	GO:0004814; GO:0005524; GO:0005739; GO:0005759; GO:0006420; GO:0032543; GO:0070144	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial arginyl-tRNA aminoacylation [GO:0070144]; mitochondrial translation [GO:0032543]
PGEN_.00g186540	Scaffold_08	48646138	48646503	NA	NA	NA	NA	NA
PGEN_.00g186550	Scaffold_08	48649511	48650418	NA	NA	NA	NA	NA
PGEN_.00g186560	Scaffold_08	48652675	48653610	NA	NA	NA	NA	NA
PGEN_.00g186570	Scaffold_08	48661054	48661966	NA	NA	NA	NA	NA
PGEN_.00g186580	Scaffold_08	48662353	48674060	Q84P21	4CLL5_ARATH	4-coumarate--CoA ligase-like 5 (EC 6.2.1.-) (4-coumarate--CoA ligase isoform 9) (At4CL9) (Peroxisomal OPC-8:0-CoA ligase 1)	GO:0005524; GO:0005777; GO:0009611; GO:0009695; GO:0016874	peroxisome [GO:0005777]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; jasmonic acid biosynthetic process [GO:0009695]; response to wounding [GO:0009611]
PGEN_.00g186590	Scaffold_08	48754108	48780920	F1NPG5	CENPT_CHICK	Centromere protein T (CENP-T)	GO:0000777; GO:0003677; GO:0005634; GO:0007049; GO:0046982; GO:0051301; GO:0051382	condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; cell cycle [GO:0007049]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]
PGEN_.00g186600	Scaffold_08	48784744	48785115	NA	NA	NA	NA	NA
PGEN_.00g186610	Scaffold_08	48814510	48862736	Q8NC67	NETO2_HUMAN	Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2)	GO:0014069; GO:0016021; GO:0035255; GO:2000312	integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; ionotropic glutamate receptor binding [GO:0035255]; regulation of kainate selective glutamate receptor activity [GO:2000312]
PGEN_.00g186620	Scaffold_08	48871796	48874523	Q8WV35	LRC29_HUMAN	Leucine-rich repeat-containing protein 29 (F-box and leucine-rich repeat protein 9) (F-box protein FBL9) (F-box/LRR-repeat protein 9)	GO:0006511; GO:0016567; GO:0019005; GO:0031146	SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g186630	Scaffold_08	48877635	48885633	Q5PQY6	LONP2_DANRE	"Lon protease homolog 2, peroxisomal (EC 3.4.21.53)"	GO:0004176; GO:0004252; GO:0005524; GO:0005782; GO:0006515; GO:0006625; GO:0016485; GO:0016558	peroxisomal matrix [GO:0005782]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g186640	Scaffold_08	48926231	48926686	NA	NA	NA	NA	NA
PGEN_.00g186650	Scaffold_08	48938578	48947247	Q9DBN5	LONP2_MOUSE	"Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease)"	GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005737; GO:0005777; GO:0005782; GO:0006515; GO:0006625; GO:0008233; GO:0014070; GO:0016485; GO:0016558; GO:0019899; GO:0031998	cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]
PGEN_.00g186660	Scaffold_08	48961305	48989052	NA	NA	NA	NA	NA
PGEN_.00g186670	Scaffold_08	48992657	48996391	NA	NA	NA	NA	NA
PGEN_.00g186680	Scaffold_08	49008964	49010321	A2VB89	BURS_APIME	Bursicon (Bursicon subunit alpha) (Single-chain bursicon)	GO:0005179; GO:0005576; GO:0007593; GO:0048067	extracellular region [GO:0005576]; hormone activity [GO:0005179]; chitin-based cuticle sclerotization [GO:0007593]; cuticle pigmentation [GO:0048067]
PGEN_.00g186690	Scaffold_08	49053969	49058181	Q5XGW6	CHM4B_XENLA	Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b)	GO:0000281; GO:0000815; GO:0005635; GO:0005829; GO:0007034; GO:0010458; GO:0015031; GO:0030496; GO:0031468; GO:0031902; GO:0090148	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]; vacuolar transport [GO:0007034]
PGEN_.00g186700	Scaffold_08	49065042	49065470	NA	NA	NA	NA	NA
PGEN_.00g186710	Scaffold_08	49065869	49067049	NA	NA	NA	NA	NA
PGEN_.00g186720	Scaffold_08	49070973	49071275	NA	NA	NA	NA	NA
PGEN_.00g186730	Scaffold_08	49075831	49082975	NA	NA	NA	NA	NA
PGEN_.00g186740	Scaffold_08	49177146	49190272	Q8IYK8	REM2_HUMAN	GTP-binding protein REM 2 (Rad and Gem-like GTP-binding protein 2)	GO:0003924; GO:0005246; GO:0005525; GO:0005886; GO:0007165; GO:1901842	plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]
PGEN_.00g186750	Scaffold_08	49198158	49200086	NA	NA	NA	NA	NA
PGEN_.00g186760	Scaffold_08	49285177	49285596	NA	NA	NA	NA	NA
PGEN_.00g186770	Scaffold_08	49348404	49384398	Q9BUB4	ADAT1_HUMAN	tRNA-specific adenosine deaminase 1 (hADAT1) (EC 3.5.4.34) (tRNA-specific adenosine-37 deaminase)	GO:0003723; GO:0008033; GO:0008251; GO:0046872	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; tRNA processing [GO:0008033]
PGEN_.00g186780	Scaffold_08	49395751	49426782	Q58DW2	CGL_BOVIN	Cystathionine gamma-lyase (EC 4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase)	GO:0004123; GO:0005516; GO:0005737; GO:0016846; GO:0018272; GO:0019343; GO:0019344; GO:0019346; GO:0030170; GO:0043066; GO:0043123; GO:0044524; GO:0044540; GO:0051092; GO:0070814; GO:0080146	cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; hydrogen sulfide biosynthetic process [GO:0070814]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; transsulfuration [GO:0019346]
PGEN_.00g186790	Scaffold_08	49447365	49558986	Q2V2M9	FHOD3_HUMAN	FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2)	GO:0003779; GO:0005865; GO:0007015; GO:0030018; GO:0030837; GO:0045214; GO:0055003	striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]
PGEN_.00g186800	Scaffold_08	49534554	49534820	NA	NA	NA	NA	NA
PGEN_.00g186810	Scaffold_08	49560343	49577060	NA	NA	NA	NA	NA
PGEN_.00g186820	Scaffold_08	49585196	49616803	A6NE52	WDR97_HUMAN	WD repeat-containing protein 97		
PGEN_.00g186830	Scaffold_08	49617990	49626767	NA	NA	NA	NA	NA
PGEN_.00g186840	Scaffold_08	49628191	49628745	NA	NA	NA	NA	NA
PGEN_.00g186850	Scaffold_08	49628784	49630523	NA	NA	NA	NA	NA
PGEN_.00g186860	Scaffold_08	49630696	49640448	Q9UPY5	XCT_HUMAN	Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT)	GO:0005791; GO:0005856; GO:0005886; GO:0006749; GO:0006865; GO:0008542; GO:0009636; GO:0009986; GO:0014070; GO:0015179; GO:0015327; GO:0016021; GO:0021591; GO:0021756; GO:0030534; GO:0031526; GO:0033029; GO:0034599; GO:0034775; GO:0035094; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050900; GO:0051223; GO:0051775; GO:0060173; GO:0070306; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0140206; GO:1901494; GO:1903204; GO:1903786; GO:1904717; GO:2000211	apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; adult behavior [GO:0030534]; amino acid transport [GO:0006865]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; leukocyte migration [GO:0050900]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542]
PGEN_.00g186870	Scaffold_08	49660745	49677553	Q08705	CTCF_CHICK	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g186880	Scaffold_08	49682244	49685584	Q62633	NTCP2_RAT	"Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate-cotransporting polypeptide, ileal) (Solute carrier family 10 member 2)"	GO:0000502; GO:0005634; GO:0005902; GO:0006814; GO:0008206; GO:0008508; GO:0009617; GO:0015721; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; response to bacterium [GO:0009617]; sodium ion transport [GO:0006814]
PGEN_.00g186890	Scaffold_08	49712457	49715425	NA	NA	NA	NA	NA
PGEN_.00g186900	Scaffold_08	49716920	49717174	NA	NA	NA	NA	NA
PGEN_.00g186910	Scaffold_08	49791891	49792145	NA	NA	NA	NA	NA
PGEN_.00g186920	Scaffold_08	49817055	49819959	NA	NA	NA	NA	NA
PGEN_.00g186930	Scaffold_08	49872632	49872970	NA	NA	NA	NA	NA
PGEN_.00g186940	Scaffold_08	49996346	49996768	NA	NA	NA	NA	NA
PGEN_.00g186950	Scaffold_08	50003961	50004197	NA	NA	NA	NA	NA
PGEN_.00g186960	Scaffold_08	50021196	50022599	O02213	SER2_CAEEL	Tyramine receptor Ser-2	GO:0004935; GO:0004989; GO:0005887; GO:0007188; GO:0007211; GO:0007212; GO:0008226; GO:0016021; GO:0071880	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dopamine receptor signaling pathway [GO:0007212]; octopamine or tyramine signaling pathway [GO:0007211]
PGEN_.00g186970	Scaffold_08	50042728	50043759	NA	NA	NA	NA	NA
PGEN_.00g186980	Scaffold_08	50104241	50104564	NA	NA	NA	NA	NA
PGEN_.00g186990	Scaffold_08	50154221	50154957	NA	NA	NA	NA	NA
PGEN_.00g187000	Scaffold_08	50155095	50158652	NA	NA	NA	NA	NA
PGEN_.00g187010	Scaffold_08	50174504	50222854	P36189	FAS_ANSAN	Fatty acid synthase (EC 2.3.1.85) (Fragment)	GO:0004312; GO:0006633; GO:0016491; GO:0016787; GO:0016874	fatty acid synthase activity [GO:0004312]; hydrolase activity [GO:0016787]; ligase activity [GO:0016874]; oxidoreductase activity [GO:0016491]; fatty acid biosynthetic process [GO:0006633]
PGEN_.00g187020	Scaffold_08	50223211	50223639	NA	NA	NA	NA	NA
PGEN_.00g187030	Scaffold_08	50260299	50282359	P09478	ACH1_DROME	Acetylcholine receptor subunit alpha-like 1 (Nicotinic acetylcholine receptor alpha 1)	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g187040	Scaffold_08	50300294	50302611	NA	NA	NA	NA	NA
PGEN_.00g187050	Scaffold_08	50302873	50305257	O76554	ACH4_CAEEL	Acetylcholine receptor subunit alpha-type des-2	GO:0004888; GO:0005230; GO:0005887; GO:0007165; GO:0007268; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0050877	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; extracellular ligand-gated ion channel activity [GO:0005230]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g187060	Scaffold_08	50324681	50326813	NA	NA	NA	NA	NA
PGEN_.00g187070	Scaffold_08	50352704	50354187	Q78S06	SYS1_MOUSE	Protein SYS1 homolog	GO:0005802; GO:0005829; GO:0006895; GO:0030173; GO:0034067; GO:0043001	cytosol [GO:0005829]; integral component of Golgi membrane [GO:0030173]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; Golgi to plasma membrane protein transport [GO:0043001]; protein localization to Golgi apparatus [GO:0034067]
PGEN_.00g187080	Scaffold_08	50374034	50377056	Q8UW76	TBX20_CHICK	T-box transcription factor TBX20 (T-box protein 20) (cTbx20)	GO:0000122; GO:0000977; GO:0000978; GO:0001085; GO:0001102; GO:0001228; GO:0001569; GO:0001570; GO:0001708; GO:0001764; GO:0001947; GO:0003148; GO:0003175; GO:0003180; GO:0003193; GO:0003207; GO:0003215; GO:0003272; GO:0003344; GO:0005634; GO:0005737; GO:0006936; GO:0008015; GO:0009953; GO:0010628; GO:0010629; GO:0010991; GO:0021524; GO:0030335; GO:0035922; GO:0036306; GO:0045944; GO:0055008; GO:0060045; GO:0060413; GO:0060577; GO:0060973; GO:2000793	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]"
PGEN_.00g187090	Scaffold_08	50389301	50392262	Q9ES03	TBX20_MOUSE	T-box transcription factor TBX20 (T-box protein 20)	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001085; GO:0001102; GO:0001228; GO:0001569; GO:0001570; GO:0001708; GO:0001764; GO:0001947; GO:0003143; GO:0003148; GO:0003151; GO:0003175; GO:0003176; GO:0003180; GO:0003193; GO:0003203; GO:0003207; GO:0003215; GO:0003272; GO:0003279; GO:0003344; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006936; GO:0008015; GO:0008283; GO:0009953; GO:0010717; GO:0010991; GO:0021524; GO:0035050; GO:0035922; GO:0036306; GO:0045892; GO:0045893; GO:0045944; GO:0055008; GO:0060045; GO:0060413; GO:0060577	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; aortic valve development [GO:0003176]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum development [GO:0003279]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; embryonic heart tube elongation [GO:0036306]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; regulation of epithelial to mesenchymal transition [GO:0010717]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]"
PGEN_.00g187100	Scaffold_08	50495365	50507659	Q8UW76	TBX20_CHICK	T-box transcription factor TBX20 (T-box protein 20) (cTbx20)	GO:0000122; GO:0000977; GO:0000978; GO:0001085; GO:0001102; GO:0001228; GO:0001569; GO:0001570; GO:0001708; GO:0001764; GO:0001947; GO:0003148; GO:0003175; GO:0003180; GO:0003193; GO:0003207; GO:0003215; GO:0003272; GO:0003344; GO:0005634; GO:0005737; GO:0006936; GO:0008015; GO:0009953; GO:0010628; GO:0010629; GO:0010991; GO:0021524; GO:0030335; GO:0035922; GO:0036306; GO:0045944; GO:0055008; GO:0060045; GO:0060413; GO:0060577; GO:0060973; GO:2000793	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]"
PGEN_.00g187110	Scaffold_08	50513927	50515648	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g187120	Scaffold_08	50551463	50562980	Q13636	RAB31_HUMAN	Ras-related protein Rab-31 (Ras-related protein Rab-22B)	GO:0001891; GO:0003924; GO:0005525; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0019003; GO:0030667; GO:0031623; GO:0031901; GO:0032482; GO:0032588; GO:0032869; GO:0036186; GO:0043001; GO:0043312; GO:0045055; GO:0045335; GO:0060100; GO:0090382	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome membrane [GO:0036186]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to insulin stimulus [GO:0032869]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; phagosome maturation [GO:0090382]; positive regulation of phagocytosis, engulfment [GO:0060100]; Rab protein signal transduction [GO:0032482]; receptor internalization [GO:0031623]; regulated exocytosis [GO:0045055]"
PGEN_.00g187130	Scaffold_08	50583384	50596437	NA	NA	NA	NA	NA
PGEN_.00g187140	Scaffold_08	50607438	50617047	NA	NA	NA	NA	NA
PGEN_.00g187150	Scaffold_08	50618437	50625706	NA	NA	NA	NA	NA
PGEN_.00g187160	Scaffold_08	50672246	50679951	NA	NA	NA	NA	NA
PGEN_.00g187170	Scaffold_08	50686473	50686856	NA	NA	NA	NA	NA
PGEN_.00g187180	Scaffold_08	50724474	50731179	Q502K2	SAMH1_DANRE	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)	GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]
PGEN_.00g187190	Scaffold_08	50805151	50806552	NA	NA	NA	NA	NA
PGEN_.00g187200	Scaffold_08	50840591	50885327	Q9GLK0	TGM1_CANLF	Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)	GO:0003810; GO:0010838; GO:0016020; GO:0018149; GO:0031424; GO:0045787; GO:0046872	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]
PGEN_.00g187210	Scaffold_08	50890295	50890633	NA	NA	NA	NA	NA
PGEN_.00g187220	Scaffold_08	50903305	51075982	NA	NA	NA	NA	NA
PGEN_.00g187230	Scaffold_08	51078331	51087999	NA	NA	NA	NA	NA
PGEN_.00g187240	Scaffold_08	51088148	51137965	NA	NA	NA	NA	NA
PGEN_.00g187250	Scaffold_08	51147502	51166945	P38529	HSF1_CHICK	Heat shock factor protein 1 (HSF 1) (HSF 3A) (HSTF 3A) (Heat shock transcription factor 1) (HSTF 1)	GO:0000122; GO:0000165; GO:0000776; GO:0000777; GO:0000978; GO:0001046; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006281; GO:0006397; GO:0008284; GO:0009408; GO:0009416; GO:0010628; GO:0016605; GO:0031072; GO:0031490; GO:0034605; GO:0042803; GO:0043497; GO:0043565; GO:0043621; GO:0045931; GO:0045944; GO:0048471; GO:0051028; GO:0051260; GO:0061408; GO:0070207; GO:0071276; GO:0071480; GO:0097165; GO:0097431; GO:1900365; GO:1902751; GO:1902808; GO:1990841; GO:2001033	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heat shock protein binding [GO:0031072]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to cadmium ion [GO:0071276]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to heat [GO:0009408]; response to light stimulus [GO:0009416]
PGEN_.00g187260	Scaffold_08	51188320	51196694	Q6IMH0	TEPP_MOUSE	"Testis, prostate and placenta-expressed protein"		
PGEN_.00g187270	Scaffold_08	51201317	51220272	Q5R662	LRP12_PONAB	Low-density lipoprotein receptor-related protein 12 (LRP-12)	GO:0001764; GO:0005887; GO:0005905; GO:0006897; GO:0031175	clathrin-coated pit [GO:0005905]; integral component of plasma membrane [GO:0005887]; endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]
PGEN_.00g187280	Scaffold_08	51236569	51238659	NA	NA	NA	NA	NA
PGEN_.00g187290	Scaffold_08	51238842	51254204	NA	NA	NA	NA	NA
PGEN_.00g187300	Scaffold_08	51254248	51281688	P29190	PCKG_HAECO	Phosphoenolpyruvate carboxykinase [GTP] (PEPCK) (EC 4.1.1.32)	GO:0004613; GO:0005525; GO:0006094; GO:0046872	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094]
PGEN_.00g187310	Scaffold_08	51301230	51308073	Q16822	PCKGM_HUMAN	"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)"	GO:0004611; GO:0004613; GO:0005525; GO:0005623; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0019543; GO:0030145; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549	cell [GO:0005623]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]
PGEN_.00g187320	Scaffold_08	51438506	51469245	Q80SU7	GVIN1_MOUSE	Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g187330	Scaffold_08	51485801	51487027	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g187340	Scaffold_08	51573525	51592921	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g187350	Scaffold_08	51601099	51626682	Q9ET80	JPH1_MOUSE	Junctophilin-1 (JP-1) (Junctophilin type 1)	GO:0005623; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0007517; GO:0008307; GO:0014701; GO:0015278; GO:0016021; GO:0016529; GO:0030018; GO:0030314	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; calcium-release channel activity [GO:0015278]; structural constituent of muscle [GO:0008307]; muscle organ development [GO:0007517]
PGEN_.00g187360	Scaffold_08	51698060	51701165	Q91924	SNAI2_XENLA	Zinc finger protein SNAI2 (Protein slug-alpha) (Protein snail homolog 2) (Snail protein homolog Slug) (xSlu)	GO:0001755; GO:0003677; GO:0005634; GO:0014029; GO:0014036; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; neural crest cell fate specification [GO:0014036]; neural crest cell migration [GO:0001755]; neural crest formation [GO:0014029]
PGEN_.00g187370	Scaffold_08	51704594	51705652	NA	NA	NA	NA	NA
PGEN_.00g187380	Scaffold_08	51708987	51747226	Q96HA7	TONSL_HUMAN	Tonsoku-like protein (Inhibitor of kappa B-related protein) (I-kappa-B-related protein) (IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2)	GO:0000724; GO:0003714; GO:0005654; GO:0005737; GO:0016604; GO:0031297; GO:0042393; GO:0042994; GO:0043596	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cytoplasmic sequestering of transcription factor [GO:0042994]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]
PGEN_.00g187390	Scaffold_08	51753814	51758371	NA	NA	NA	NA	NA
PGEN_.00g187400	Scaffold_08	51758446	51758790	NA	NA	NA	NA	NA
PGEN_.00g187410	Scaffold_08	51765918	51767636	Q56R14	TRI33_XENLA	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g187420	Scaffold_08	51788739	51791248	Q99J23	GHDC_MOUSE	GH3 domain-containing protein	GO:0005635; GO:0005737; GO:0005783; GO:0016881	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nuclear envelope [GO:0005635]; acid-amino acid ligase activity [GO:0016881]
PGEN_.00g187430	Scaffold_08	51797385	51798161	NA	NA	NA	NA	NA
PGEN_.00g187440	Scaffold_08	51808759	51815586	O55234	PSB5_MOUSE	Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit X)	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005839; GO:0006508; GO:0006979; GO:0008233; GO:0010498; GO:0010499; GO:0019774; GO:0043161	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]; response to oxidative stress [GO:0006979]"
PGEN_.00g187450	Scaffold_08	51820793	51842498	NA	NA	NA	NA	NA
PGEN_.00g187460	Scaffold_08	51845212	51872605	Q4KLC4	NGDNA_XENLA	Neuroguidin-A (EIF4E-binding protein A)	GO:0005634; GO:0005737; GO:0006417	cytoplasm [GO:0005737]; nucleus [GO:0005634]; regulation of translation [GO:0006417]
PGEN_.00g187470	Scaffold_08	51878443	51879798	NA	NA	NA	NA	NA
PGEN_.00g187480	Scaffold_08	51895741	51896727	Q95M54	OPRM_MACFA	Mu-type opioid receptor (M-OR-1) (MOR-1)	GO:0001965; GO:0004930; GO:0004979; GO:0005245; GO:0005623; GO:0005768; GO:0005886; GO:0007197; GO:0007200; GO:0016021; GO:0019233; GO:0030424; GO:0030425; GO:0038003; GO:0038047; GO:0043204; GO:0043951; GO:0045019; GO:0045202; GO:0050769; GO:0051481; GO:0061358; GO:0070374; GO:2000310	axon [GO:0030424]; cell [GO:0005623]; dendrite [GO:0030425]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; beta-endorphin receptor activity [GO:0004979]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; morphine receptor activity [GO:0038047]; voltage-gated calcium channel activity [GO:0005245]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of Wnt protein secretion [GO:0061358]; opioid receptor signaling pathway [GO:0038003]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; regulation of NMDA receptor activity [GO:2000310]; sensory perception of pain [GO:0019233]
PGEN_.00g187490	Scaffold_08	51919871	51931090	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g187500	Scaffold_08	51939887	51954742	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g187510	Scaffold_08	51956951	51967464	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g187520	Scaffold_08	51973402	51975234	Q99PP7	TRI33_MOUSE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0017015; GO:0030514; GO:0070410; GO:0070412	nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]
PGEN_.00g187530	Scaffold_08	51984750	52001970	A6NN14	ZN729_HUMAN	Zinc finger protein 729	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g187540	Scaffold_08	52012094	52030876	O15974	OPSD2_MIZYE	"Rhodopsin, G0-coupled (G0-rhodopsin)"	GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g187550	Scaffold_08	52035132	52040246	NA	NA	NA	NA	NA
PGEN_.00g187560	Scaffold_08	52043742	52044128	NA	NA	NA	NA	NA
PGEN_.00g187570	Scaffold_08	52083472	52084521	Q90888	MAFB_CHICK	Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B)	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007379; GO:0007585; GO:0008134; GO:0021571; GO:0021572; GO:0021599; GO:0033077; GO:0035284; GO:0042472; GO:0043565; GO:0045647; GO:0045671; GO:0048538	"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; abducens nerve formation [GO:0021599]; brain segmentation [GO:0035284]; inner ear morphogenesis [GO:0042472]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of osteoclast differentiation [GO:0045671]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; rhombomere 5 development [GO:0021571]; rhombomere 6 development [GO:0021572]; segment specification [GO:0007379]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]"
PGEN_.00g187580	Scaffold_08	52097425	52097655	NA	NA	NA	NA	NA
PGEN_.00g187590	Scaffold_08	52117309	52139991	Q8CHP0	ZC3H3_MOUSE	Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor)	GO:0003677; GO:0005634; GO:0005847; GO:0031124; GO:0032927; GO:0046332; GO:0046872; GO:0051028; GO:0070412; GO:1900363	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363]
PGEN_.00g187600	Scaffold_08	52200282	52241073	Q8TEP8	CE192_HUMAN	Centrosomal protein of 192 kDa (Cep192) (Cep192/SPD-2)	GO:0000086; GO:0000242; GO:0005813; GO:0005814; GO:0005829; GO:0009617; GO:0010389; GO:0010923; GO:0019902; GO:0051298; GO:0071539; GO:0090222; GO:0090307; GO:0097711	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; phosphatase binding [GO:0019902]; centrosome duplication [GO:0051298]; centrosome-templated microtubule nucleation [GO:0090222]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic spindle assembly [GO:0090307]; negative regulation of phosphatase activity [GO:0010923]; protein localization to centrosome [GO:0071539]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; response to bacterium [GO:0009617]
PGEN_.00g187610	Scaffold_08	52253832	52263248	P27623	TAGD_BACSU	Glycerol-3-phosphate cytidylyltransferase (GCT) (GCTase) (Gro-PCT) (EC 2.7.7.39) (CDP-glycerol pyrophosphorylase) (Teichoic acid biosynthesis protein D)	GO:0005737; GO:0019350; GO:0046872; GO:0047348; GO:0071555	cytoplasm [GO:0005737]; glycerol-3-phosphate cytidylyltransferase activity [GO:0047348]; metal ion binding [GO:0046872]; cell wall organization [GO:0071555]; teichoic acid biosynthetic process [GO:0019350]
PGEN_.00g187620	Scaffold_08	52264959	52280309	Q29496	CP3AO_SHEEP	Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)	GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]
PGEN_.00g187630	Scaffold_08	52293780	52311948	Q64417	CP3AE_CAVPO	Cytochrome P450 3A14 (EC 1.14.14.1) (CYPIIIA14)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g187640	Scaffold_08	52312047	52318800	Q29496	CP3AO_SHEEP	Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)	GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]
PGEN_.00g187650	Scaffold_08	52421665	52435781	Q5RFR0	TTPAL_PONAB	Alpha-tocopherol transfer protein-like		
PGEN_.00g187660	Scaffold_08	52453766	52463427	NA	NA	NA	NA	NA
PGEN_.00g187670	Scaffold_08	52473309	52505306	Q9C0B7	TNG6_HUMAN	Transport and Golgi organization protein 6 homolog (Transmembrane and coiled-coil domain-containing protein 7)	GO:0009306; GO:0016021	integral component of membrane [GO:0016021]; protein secretion [GO:0009306]
PGEN_.00g187680	Scaffold_08	52509028	52511931	P08953	TOLL_DROME	Protein toll	GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]
PGEN_.00g187690	Scaffold_08	52572271	52581544	NA	NA	NA	NA	NA
PGEN_.00g187700	Scaffold_08	52593219	52611970	Q6P6Y1	RELCH_DANRE	"RAB11-binding protein RELCH homolog (LisH domain and HEAT repeat-containing protein KIAA1468) (RAB11-binding and LisH domain, coiled-coil and HEAT repeat-containing protein RELCH)"	GO:0005802; GO:0032367; GO:0055037	recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; intracellular cholesterol transport [GO:0032367]
PGEN_.00g187710	Scaffold_08	52622775	52623185	NA	NA	NA	NA	NA
PGEN_.00g187720	Scaffold_08	52639055	52663575	Q6P6Y1	RELCH_DANRE	"RAB11-binding protein RELCH homolog (LisH domain and HEAT repeat-containing protein KIAA1468) (RAB11-binding and LisH domain, coiled-coil and HEAT repeat-containing protein RELCH)"	GO:0005802; GO:0032367; GO:0055037	recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; intracellular cholesterol transport [GO:0032367]
PGEN_.00g187730	Scaffold_08	52663737	52671600	Q9I9A7	CDT1_XENLA	DNA replication factor Cdt1 (XCDT1)	GO:0005634; GO:0006260; GO:0007049; GO:0031490	nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cell cycle [GO:0007049]; DNA replication [GO:0006260]
PGEN_.00g187740	Scaffold_08	52671662	52677929	Q5PQ50	NUD19_XENLA	Nucleoside diphosphate-linked moiety X motif 19 (Nudix motif 19) (EC 3.6.1.-)	GO:0005777; GO:0016787; GO:0046872	peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]
PGEN_.00g187750	Scaffold_08	52678187	52699378	P12955	PEPD_HUMAN	Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)	GO:0004177; GO:0004181; GO:0006508; GO:0006520; GO:0030145; GO:0030574; GO:0070062; GO:0102009	extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]
PGEN_.00g187760	Scaffold_08	52706656	52717018	O60884	DNJA2_HUMAN	DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3) (Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14)	GO:0001671; GO:0005524; GO:0005829; GO:0008284; GO:0009408; GO:0016020; GO:0031072; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408]
PGEN_.00g187770	Scaffold_08	52728099	52756333	P11881	ITPR1_MOUSE	"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Inositol 1,4,5-trisphosphate-binding protein P400) (Protein PCD-6) (Purkinje cell protein 1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)"	GO:0001666; GO:0005220; GO:0005509; GO:0005623; GO:0005635; GO:0005637; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005955; GO:0006816; GO:0007204; GO:0008022; GO:0009791; GO:0010976; GO:0014069; GO:0015278; GO:0016529; GO:0019855; GO:0019903; GO:0030176; GO:0030425; GO:0030658; GO:0030659; GO:0030667; GO:0030868; GO:0031088; GO:0031094; GO:0032469; GO:0032991; GO:0035091; GO:0042045; GO:0042802; GO:0043025; GO:0043065; GO:0043231; GO:0044325; GO:0044877; GO:0045121; GO:0048471; GO:0050849; GO:0050882; GO:0051209; GO:0051928; GO:0070059; GO:0070679; GO:0071320; GO:0097060; GO:0097421; GO:0098685; GO:0098695; GO:0098793; GO:0098794; GO:0098982; GO:1901215; GO:2000347	"calcineurin complex [GO:0005955]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum membrane [GO:0030868]; synaptic membrane [GO:0097060]; transport vesicle membrane [GO:0030658]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; identical protein binding [GO:0042802]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; ion channel binding [GO:0044325]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; calcium ion transport [GO:0006816]; cellular response to cAMP [GO:0071320]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of neuron death [GO:1901215]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of neuron projection development [GO:0010976]; post-embryonic development [GO:0009791]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; voluntary musculoskeletal movement [GO:0050882]"
PGEN_.00g187780	Scaffold_08	52758964	52787410	NA	NA	NA	NA	NA
PGEN_.00g187790	Scaffold_08	52829746	52914696	P70227	ITPR3_MOUSE	"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)"	GO:0000822; GO:0005220; GO:0005509; GO:0005623; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005903; GO:0006816; GO:0007186; GO:0007204; GO:0007613; GO:0015278; GO:0016529; GO:0030176; GO:0030425; GO:0030659; GO:0030667; GO:0035091; GO:0042802; GO:0043025; GO:0043209; GO:0043235; GO:0043533; GO:0044877; GO:0045177; GO:0048471; GO:0050913; GO:0050916; GO:0050917; GO:0051209; GO:0051592; GO:0060291; GO:0060402; GO:0070679; GO:0071320; GO:0098793	"apical part of cell [GO:0045177]; brush border [GO:0005903]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; identical protein binding [GO:0042802]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; inositol hexakisphosphate binding [GO:0000822]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cellular response to cAMP [GO:0071320]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol [GO:0051209]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917]"
PGEN_.00g187800	Scaffold_08	52918234	52923499	Q9WVB4	SLIT3_MOUSE	Slit homolog 3 protein (Slit-3) (Slit3)	GO:0003180; GO:0003181; GO:0005102; GO:0005509; GO:0005615; GO:0005886; GO:0007411; GO:0008201; GO:0008285; GO:0009887; GO:0010629; GO:0016020; GO:0030308; GO:0032870; GO:0035385; GO:0048495; GO:0048846; GO:0050919; GO:0051414; GO:0060412; GO:0061364; GO:0070100	extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]
PGEN_.00g187810	Scaffold_08	52925987	52976918	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g187820	Scaffold_08	52984920	52988135	Q10323	IMT3_SCHPO	Inositol phosphoceramide mannosyltransferase 3 (EC 2.4.-.-) (IPC mannosyltransferase 3)	GO:0000030; GO:0005783; GO:0005789; GO:0005794; GO:0016021; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g187830	Scaffold_08	52999641	53002129	Q5IS75	ACHB3_PANTR	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g187840	Scaffold_08	53006068	53018131	NA	NA	NA	NA	NA
PGEN_.00g187850	Scaffold_08	53023787	53025985	NA	NA	NA	NA	NA
PGEN_.00g187860	Scaffold_08	53027427	53040175	NA	NA	NA	NA	NA
PGEN_.00g187870	Scaffold_08	53058358	53076133	NA	NA	NA	NA	NA
PGEN_.00g187880	Scaffold_08	53078068	53078400	NA	NA	NA	NA	NA
PGEN_.00g187890	Scaffold_08	53125881	53129143	Q02369	NDUB9_BOVIN	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit)	GO:0005747; GO:0006120; GO:0032981	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"
PGEN_.00g187900	Scaffold_08	53130280	53130552	NA	NA	NA	NA	NA
PGEN_.00g187910	Scaffold_08	53137258	53166263	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g187920	Scaffold_08	53189019	53203137	Q5SPF7	UN93A_DANRE	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g187930	Scaffold_08	53205499	53232168	Q8NCN5	PDPR_HUMAN	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	GO:0005737; GO:0005739; GO:0005759; GO:0010510; GO:0016491	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]
PGEN_.00g187940	Scaffold_08	53270105	53293112	P34528	YM67_CAEEL	Putative serine protease K12H4.7 (EC 3.4.-.-)	GO:0005764; GO:0005768; GO:0006508; GO:0008236; GO:0008239; GO:0045087	endosome [GO:0005768]; lysosome [GO:0005764]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; innate immune response [GO:0045087]; proteolysis [GO:0006508]
PGEN_.00g187950	Scaffold_08	53294987	53296105	NA	NA	NA	NA	NA
PGEN_.00g187960	Scaffold_08	53305786	53310243	Q6TFL4	KLH24_HUMAN	Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1)	GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312	adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]
PGEN_.00g187970	Scaffold_08	53315760	53322311	Q69ZK9	NLGN2_MOUSE	Neuroligin-2	GO:0001966; GO:0002087; GO:0005737; GO:0005886; GO:0005887; GO:0007158; GO:0007416; GO:0007630; GO:0008284; GO:0009986; GO:0019233; GO:0030054; GO:0032024; GO:0032230; GO:0035176; GO:0035418; GO:0035641; GO:0038023; GO:0042043; GO:0042734; GO:0042802; GO:0043198; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0060076; GO:0060077; GO:0060999; GO:0072553; GO:0097104; GO:0097105; GO:0097116; GO:0097119; GO:0097151; GO:0097470; GO:0098690; GO:0098691; GO:0098698; GO:0098982; GO:0099055; GO:0099060; GO:1901142; GO:1902474; GO:1904034; GO:1904862; GO:1905606; GO:2000311; GO:2000463; GO:2000809	"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dopaminergic synapse [GO:0098691]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; inhibitory synapse assembly [GO:1904862]; insulin metabolic process [GO:1901142]; jump response [GO:0007630]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of t-SNARE clustering [GO:1904034]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; regulation of AMPA receptor activity [GO:2000311]; regulation of presynapse assembly [GO:1905606]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; terminal button organization [GO:0072553]; thigmotaxis [GO:0001966]"
PGEN_.00g187980	Scaffold_08	53330970	53332100	NA	NA	NA	NA	NA
PGEN_.00g187990	Scaffold_08	53332167	53332850	NA	NA	NA	NA	NA
PGEN_.00g188000	Scaffold_08	53352223	53352699	NA	NA	NA	NA	NA
PGEN_.00g188010	Scaffold_08	53356124	53356555	NA	NA	NA	NA	NA
PGEN_.00g188020	Scaffold_08	53363356	53364405	NA	NA	NA	NA	NA
PGEN_.00g188030	Scaffold_08	53364473	53368263	NA	NA	NA	NA	NA
PGEN_.00g188040	Scaffold_08	53408237	53443820	Q3SZH6	TTLL9_BOVIN	Probable tubulin polyglutamylase TTLL9 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 9)	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0006464; GO:0016874	cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; cellular protein modification process [GO:0006464]
PGEN_.00g188050	Scaffold_08	53452192	53536461	Q92620	PRP16_HUMAN	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38)	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0006405; GO:0006406; GO:0016020; GO:0031124; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"
PGEN_.00g188060	Scaffold_08	53478745	53479584	NA	NA	NA	NA	NA
PGEN_.00g188070	Scaffold_08	53542835	53563691	Q3KQF4	LRC69_XENLA	Leucine-rich repeat-containing protein 69		
PGEN_.00g188080	Scaffold_08	53554855	53555727	NA	NA	NA	NA	NA
PGEN_.00g188090	Scaffold_08	53583119	53617977	Q7TSH2	KPBB_MOUSE	Phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta)	GO:0004689; GO:0005516; GO:0005886; GO:0005964; GO:0005977	phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689]; glycogen metabolic process [GO:0005977]
PGEN_.00g188100	Scaffold_08	53623671	53643740	O13016	PTN1_CHICK	Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (CPTP1) (Protein-tyrosine phosphatase 1B) (PTP-1B)	GO:0004725; GO:0005769; GO:0005789; GO:0009966; GO:0030100; GO:0030968; GO:0031532; GO:0035335	early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; protein tyrosine phosphatase activity [GO:0004725]; actin cytoskeleton reorganization [GO:0031532]; endoplasmic reticulum unfolded protein response [GO:0030968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of endocytosis [GO:0030100]; regulation of signal transduction [GO:0009966]
PGEN_.00g188110	Scaffold_08	53650396	53659347	NA	NA	NA	NA	NA
PGEN_.00g188120	Scaffold_08	53660672	53691276	Q96GQ7	DDX27_HUMAN	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)	GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364	chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]
PGEN_.00g188130	Scaffold_08	53691599	53708078	A7RRJ0	FEN1_NEMVE	Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1)	GO:0000287; GO:0003677; GO:0004523; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006260; GO:0006284; GO:0008409; GO:0017108; GO:0030145; GO:0043137; GO:0048256	"mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]"
PGEN_.00g188140	Scaffold_08	53711858	53712586	NA	NA	NA	NA	NA
PGEN_.00g188150	Scaffold_08	53716415	53716621	NA	NA	NA	NA	NA
PGEN_.00g188160	Scaffold_08	53716732	53724987	A4FUZ6	HSDL2_BOVIN	Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-)	GO:0005739; GO:0005777; GO:0016491	mitochondrion [GO:0005739]; peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491]
PGEN_.00g188170	Scaffold_08	53739013	53743827	Q8CHJ0	PIGU_CRIGR	Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1) (Protein CDC91-like 1) (GPI transamidase component PIG-U)	GO:0003923; GO:0005886; GO:0016255; GO:0034235; GO:0042765; GO:0046425	GPI-anchor transamidase complex [GO:0042765]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; GPI-anchor transamidase activity [GO:0003923]; attachment of GPI anchor to protein [GO:0016255]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]
PGEN_.00g188180	Scaffold_08	53751979	53756592	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g188190	Scaffold_08	53757690	53763885	Q6NUB3	S22AF_XENLA	Solute carrier family 22 member 15	GO:0006811; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]
PGEN_.00g188200	Scaffold_08	53764611	53771932	Q8CHJ1	PIGU_RAT	Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1) (Protein CDC91-like 1) (GPI transamidase component PIG-U) (Liver regeneration-related protein LRRGT00059)	GO:0005886; GO:0006506; GO:0016255; GO:0034394; GO:0042765; GO:0046425	GPI-anchor transamidase complex [GO:0042765]; plasma membrane [GO:0005886]; attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]
PGEN_.00g188210	Scaffold_08	53776681	53789870	Q8SQC1	SCRB1_PIG	Scavenger receptor class B member 1 (SRB1) (High density lipoprotein receptor SR-BI) (SR-BI)	GO:0001530; GO:0001540; GO:0001875; GO:0001935; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0006707; GO:0008035; GO:0009986; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0016323; GO:0016324; GO:0030169; GO:0032497; GO:0033344; GO:0034186; GO:0034375; GO:0034383; GO:0034384; GO:0035461; GO:0042632; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0045056; GO:0050892; GO:0051000; GO:0070328; GO:0070506; GO:0070508	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; transcytosis [GO:0045056]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]
PGEN_.00g188220	Scaffold_08	53792693	53796098	Q5R5W9	CE022_PONAB	UPF0489 protein C5orf22 homolog		
PGEN_.00g188230	Scaffold_08	53800647	53805508	Q6PAE6	CE022_XENLA	UPF0489 protein C5orf22 homolog		
PGEN_.00g188240	Scaffold_08	53817331	53817564	NA	NA	NA	NA	NA
PGEN_.00g188250	Scaffold_08	53817648	53906668	P15941	MUC1_HUMAN	Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]	GO:0000790; GO:0000978; GO:0002039; GO:0002223; GO:0003712; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0006977; GO:0006978; GO:0010944; GO:0016266; GO:0016324; GO:0019221; GO:0031982; GO:0033629; GO:0036003; GO:0043618; GO:0070062; GO:0090240; GO:1902166	"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
PGEN_.00g188260	Scaffold_08	53910770	53911060	NA	NA	NA	NA	NA
PGEN_.00g188270	Scaffold_08	53932848	53975252	Q62315	JARD2_MOUSE	Protein Jumonji (Jumonji/ARID domain-containing protein 2)	GO:0000122; GO:0000977; GO:0001227; GO:0001889; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005739; GO:0006338; GO:0008134; GO:0008285; GO:0010614; GO:0031061; GO:0032452; GO:0034721; GO:0035097; GO:0035098; GO:0042127; GO:0045892; GO:0048536; GO:0048538; GO:0048863; GO:0051574; GO:0060044; GO:1990830	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone demethylase activity [GO:0032452]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; liver development [GO:0001889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; regulation of cell population proliferation [GO:0042127]; spleen development [GO:0048536]; stem cell differentiation [GO:0048863]; thymus development [GO:0048538]"
PGEN_.00g188280	Scaffold_08	53981235	54002647	Q969N2	PIGT_HUMAN	GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein)	GO:0003923; GO:0005789; GO:0016020; GO:0016255; GO:0030176; GO:0030182; GO:0031410; GO:0042765; GO:0051402	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; GPI-anchor transamidase activity [GO:0003923]; attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]
PGEN_.00g188290	Scaffold_08	54096619	54102951	NA	NA	NA	NA	NA
PGEN_.00g188300	Scaffold_08	54147408	54157264	O15995	CCNE_HEMPU	G1/S-specific cyclin-E	GO:0005634; GO:0007049; GO:0051301	nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g188310	Scaffold_08	54178047	54193104	Q3TLD5	RMP_MOUSE	Unconventional prefoldin RPB5 interactor (Protein NNX3) (Protein phosphatase 1 regulatory subunit 19) (RNA polymerase II subunit 5-mediating protein) (RPB5-mediating protein)	GO:0000122; GO:0000993; GO:0001558; GO:0003682; GO:0003714; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0009615; GO:0010923; GO:0019212; GO:0030425; GO:0051219; GO:0071363; GO:0071383; GO:2001243	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714]; cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]
PGEN_.00g188320	Scaffold_08	54193333	54199513	P18665	RM03_RAT	"39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3)"	GO:0003735; GO:0005739; GO:0005762; GO:0006412	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g188330	Scaffold_08	54199825	54206904	P09001	RM03_HUMAN	"39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3) (Mitochondrial large ribosomal subunit protein uL3m)"	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]
PGEN_.00g188340	Scaffold_08	54227300	54257016	Q64566	AT2C1_RAT	Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1)	GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005623; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0008553; GO:0015410; GO:0016021; GO:0016339; GO:0030026; GO:0030133; GO:0030141; GO:0030145; GO:0031532; GO:0032468; GO:0032472; GO:0043123; GO:0043231; GO:0070509; GO:0070588	"cell [GO:0005623]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; manganese ion binding [GO:0030145]; manganese transmembrane transporter activity, phosphorylative mechanism [GO:0015410]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]"
PGEN_.00g188350	Scaffold_08	54270252	54272699	Q5EAB6	PMGT1_BOVIN	"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)"	GO:0006493; GO:0008375; GO:0016021; GO:0016266; GO:0030145; GO:0030173; GO:0047223	"integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g188360	Scaffold_08	54273473	54279720	NA	NA	NA	NA	NA
PGEN_.00g188370	Scaffold_08	54288181	54312808	A2A5K6	ZN335_MOUSE	Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1)	GO:0000978; GO:0000979; GO:0001701; GO:0002052; GO:0005634; GO:0005654; GO:0007420; GO:0010468; GO:0021895; GO:0035097; GO:0040029; GO:0044212; GO:0046872; GO:0048812; GO:0048854; GO:0050671; GO:0050767; GO:0050769; GO:0051569; GO:0080182	"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region DNA binding [GO:0044212]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of neurogenesis [GO:0050767]"
PGEN_.00g188380	Scaffold_08	54313490	54315824	NA	NA	NA	NA	NA
PGEN_.00g188390	Scaffold_08	54378116	54395507	Q0P5J9	RPR1A_BOVIN	Regulation of nuclear pre-mRNA domain-containing protein 1A (Cyclin-dependent kinase inhibitor 2B-related protein) (p15INK4B-related protein)	GO:0000993; GO:0016591; GO:0031124; GO:0070940	"RNA polymerase II, holoenzyme [GO:0016591]; RNA polymerase II complex binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]"
PGEN_.00g188400	Scaffold_08	54396802	54408094	Q3T0Q3	RPB3_BOVIN	DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II subunit C)	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005829; GO:0006366; GO:0015630; GO:0046983	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g188410	Scaffold_08	54488543	54546081	O15440	MRP5_HUMAN	Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP) (pABC11)	GO:0005524; GO:0005886; GO:0005887; GO:0008514; GO:0009986; GO:0015562; GO:0016020; GO:0016323; GO:0016887; GO:0030213; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0140115	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]; export across plasma membrane [GO:0140115]; hyaluronan biosynthetic process [GO:0030213]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g188420	Scaffold_08	54548397	54551872	NA	NA	NA	NA	NA
PGEN_.00g188430	Scaffold_08	54566308	54567729	NA	NA	NA	NA	NA
PGEN_.00g188440	Scaffold_08	54574518	54633570	NA	NA	NA	NA	NA
PGEN_.00g188450	Scaffold_08	54634261	54758904	NA	NA	NA	NA	NA
PGEN_.00g188460	Scaffold_08	54760869	54802068	NA	NA	NA	NA	NA
PGEN_.00g188470	Scaffold_08	54844925	54850018	P83858	QRFPR_RAT	Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)	GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016021; GO:0097730	integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g188480	Scaffold_08	54861205	54861855	NA	NA	NA	NA	NA
PGEN_.00g188490	Scaffold_08	54879477	54892912	NA	NA	NA	NA	NA
PGEN_.00g188500	Scaffold_08	54946555	54948759	E1BD59	TRI56_BOVIN	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0051607; GO:0070534	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
PGEN_.00g188510	Scaffold_08	54954323	54982327	A8MTL3	R212B_HUMAN	RING finger protein 212B	GO:0000795; GO:0007129; GO:0016925; GO:0019789; GO:0046872	synaptonemal complex [GO:0000795]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; protein sumoylation [GO:0016925]; synapsis [GO:0007129]
PGEN_.00g188520	Scaffold_08	54982515	55000750	Q1LU86	FA92A_DANRE	Protein FAM92A	GO:0005737; GO:0005814; GO:0005929; GO:0035869; GO:0045880; GO:0060271; GO:0097546	centriole [GO:0005814]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880]
PGEN_.00g188530	Scaffold_08	55018433	55044125	Q1RMK1	FA92B_BOVIN	Protein FAM92B	GO:0005737; GO:0005814; GO:0030030; GO:0042995	cell projection [GO:0042995]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cell projection organization [GO:0030030]
PGEN_.00g188540	Scaffold_08	55047494	55052169	NA	NA	NA	NA	NA
PGEN_.00g188550	Scaffold_08	55052531	55054156	Q9DGB6	TLR22_CHICK	Toll-like receptor 2 type-2	GO:0002224; GO:0002755; GO:0005887; GO:0006954; GO:0031226; GO:0034134; GO:0042494; GO:0045087; GO:0050707; GO:0050729	integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; detection of bacterial lipoprotein [GO:0042494]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g188560	Scaffold_08	55059720	55079262	NA	NA	NA	NA	NA
PGEN_.00g188570	Scaffold_08	55086908	55112537	Q5ZKJ0	CLP1L_CHICK	Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein)	GO:0006915; GO:0016021	integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]
PGEN_.00g188580	Scaffold_08	55124907	55126561	NA	NA	NA	NA	NA
PGEN_.00g188590	Scaffold_08	55230404	55244344	A8WGA0	C27C1_DANRE	"Cytochrome P450 27C1 (EC 1.14.19.53) (All-trans retinol 3,4-desaturase)"	GO:0004497; GO:0005506; GO:0016020; GO:0016705; GO:0020037	"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g188600	Scaffold_08	55265261	55270608	NA	NA	NA	NA	NA
PGEN_.00g188610	Scaffold_08	55277314	55290778	P24367	PPIB_CHICK	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)	GO:0000413; GO:0003755; GO:0005788; GO:0016018; GO:0032991; GO:0042026; GO:0042470; GO:0051082; GO:0061077; GO:1904027	endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]
PGEN_.00g188620	Scaffold_08	55354098	55363873	NA	NA	NA	NA	NA
PGEN_.00g188630	Scaffold_08	55368795	55369250	NA	NA	NA	NA	NA
PGEN_.00g188640	Scaffold_08	55402747	55408991	Q09415	SET14_CAEEL	SET domain-containing protein 14	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g188650	Scaffold_08	55429088	55430615	NA	NA	NA	NA	NA
PGEN_.00g188660	Scaffold_08	55436118	55448493	NA	NA	NA	NA	NA
PGEN_.00g188670	Scaffold_08	55486009	55496642	P49614	HEXB_FELCA	Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta)	GO:0004563; GO:0005764; GO:0005975; GO:0102148	lysosome [GO:0005764]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g188680	Scaffold_08	55497487	55513688	P20060	HEXB_MOUSE	Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta)	GO:0001501; GO:0001669; GO:0004563; GO:0005615; GO:0005623; GO:0005764; GO:0006044; GO:0006687; GO:0006689; GO:0006874; GO:0007040; GO:0007338; GO:0007341; GO:0007605; GO:0007626; GO:0008049; GO:0008360; GO:0008375; GO:0008654; GO:0009313; GO:0015929; GO:0016020; GO:0016231; GO:0016787; GO:0019915; GO:0019953; GO:0030203; GO:0030246; GO:0031323; GO:0042552; GO:0042582; GO:0042802; GO:0042803; GO:0043615; GO:0044267; GO:0044877; GO:0045944; GO:0046982; GO:0048477; GO:0050885; GO:0050905; GO:0102148	acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; cell [GO:0005623]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; hexosaminidase activity [GO:0015929]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; glycosphingolipid metabolic process [GO:0006687]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; N-acetylglucosamine metabolic process [GO:0006044]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of cellular metabolic process [GO:0031323]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]
PGEN_.00g188690	Scaffold_08	55524376	55534796	NA	NA	NA	NA	NA
PGEN_.00g188700	Scaffold_08	55554026	55601967	C0HL13	LRP2_PIG	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	GO:0001702; GO:0001843; GO:0002076; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005886; GO:0005905; GO:0006898; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0009952; GO:0016021; GO:0016324; GO:0017124; GO:0017147; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0042632; GO:0042813; GO:0043235; GO:0045944; GO:0046849; GO:0048539; GO:0050769; GO:0051087; GO:0060068; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060982; GO:0061156; GO:0061178; GO:0061304; GO:0070447; GO:0140058; GO:1904447; GO:1905167	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; SH3 domain binding [GO:0017124]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; gastrulation with mouth forming second [GO:0001702]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; osteoblast development [GO:0002076]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retinal blood vessel morphogenesis [GO:0061304]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]
PGEN_.00g188710	Scaffold_08	55610180	55651670	Q04833	LRP_CAEEL	Low-density lipoprotein receptor-related protein (LRP)	GO:0002119; GO:0005509; GO:0005905; GO:0006897; GO:0015248; GO:0015918; GO:0016021; GO:0016324; GO:0030139; GO:0030334; GO:0040017; GO:0040018; GO:0042395	"apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; sterol transporter activity [GO:0015248]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918]"
PGEN_.00g188720	Scaffold_08	55682459	55712842	Q08DZ2	PRP4B_BOVIN	Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog)	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005681; GO:0006397; GO:0006468; GO:0008380	nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380]
PGEN_.00g188730	Scaffold_08	55722128	55726205	Q0PV50	TLR3_BOSTR	Toll-like receptor 3 (CD antigen CD283)	GO:0002756; GO:0003725; GO:0004888; GO:0005769; GO:0005789; GO:0006954; GO:0010008; GO:0016021; GO:0032722; GO:0034138; GO:0043330; GO:0045087; GO:0050729; GO:0051607	early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; double-stranded RNA binding [GO:0003725]; transmembrane signaling receptor activity [GO:0004888]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; positive regulation of chemokine production [GO:0032722]; positive regulation of inflammatory response [GO:0050729]; response to exogenous dsRNA [GO:0043330]; toll-like receptor 3 signaling pathway [GO:0034138]
PGEN_.00g188740	Scaffold_08	55739585	55741438	NA	NA	NA	NA	NA
PGEN_.00g188750	Scaffold_08	55748053	55748736	NA	NA	NA	NA	NA
PGEN_.00g188760	Scaffold_08	55756507	55817116	A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]
PGEN_.00g188770	Scaffold_08	55817153	55832059	Q5ZK82	MPPE1_CHICK	Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5)	GO:0005654; GO:0005793; GO:0005801; GO:0006506; GO:0006888; GO:0008081; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0070971	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; GPI anchor binding [GO:0034235]; manganese ion binding [GO:0030145]; phosphoric diester hydrolase activity [GO:0008081]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g188780	Scaffold_08	55869657	55911964	Q8R0A7	K0513_MOUSE	Uncharacterized protein KIAA0513		
PGEN_.00g188790	Scaffold_08	55918556	55918870	NA	NA	NA	NA	NA
PGEN_.00g188800	Scaffold_08	55918947	55919393	NA	NA	NA	NA	NA
PGEN_.00g188810	Scaffold_08	55924516	55947159	O60268	K0513_HUMAN	Uncharacterized protein KIAA0513	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g188820	Scaffold_08	55962137	55964635	NA	NA	NA	NA	NA
PGEN_.00g188830	Scaffold_08	55965896	55996811	Q75QN2	INT8_HUMAN	Integrator complex subunit 8 (Int8) (Protein kaonashi-1)	GO:0005654; GO:0016180; GO:0032039; GO:0034472; GO:0042795	integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795]
PGEN_.00g188840	Scaffold_08	55997526	56015473	Q3TQF0	FBX31_MOUSE	F-box only protein 31	GO:0005813; GO:0006974; GO:0016567; GO:0019005; GO:0030332; GO:0031145; GO:0031146; GO:0031571; GO:0043025; GO:0050775; GO:2001224	centrosome [GO:0005813]; neuronal cell body [GO:0043025]; SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular response to DNA damage stimulus [GO:0006974]; mitotic G1 DNA damage checkpoint [GO:0031571]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron migration [GO:2001224]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g188850	Scaffold_08	56026550	56026909	NA	NA	NA	NA	NA
PGEN_.00g188860	Scaffold_08	56038917	56053007	NA	NA	NA	NA	NA
PGEN_.00g188870	Scaffold_08	56056018	56060261	NA	NA	NA	NA	NA
PGEN_.00g188880	Scaffold_08	56065055	56071941	Q04831	GLNA_PANAR	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]
PGEN_.00g188890	Scaffold_08	56078429	56082773	NA	NA	NA	NA	NA
PGEN_.00g188900	Scaffold_08	56085358	56088487	Q9R0W9	ACHA6_MOUSE	Neuronal acetylcholine receptor subunit alpha-6	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0014059; GO:0016020; GO:0022848; GO:0030054; GO:0033603; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0050877; GO:0051899; GO:0098691; GO:0099055; GO:0099056; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g188910	Scaffold_08	56093768	56109441	NA	NA	NA	NA	NA
PGEN_.00g188920	Scaffold_08	56112569	56115866	NA	NA	NA	NA	NA
PGEN_.00g188930	Scaffold_08	56124887	56141711	Q86T03	PP4P1_HUMAN	"Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B)"	GO:0005654; GO:0005765; GO:0005886; GO:0006644; GO:0006991; GO:0008203; GO:0016021; GO:0030670; GO:0031902; GO:0032418; GO:0034597; GO:0046856; GO:0070070; GO:1904263	"integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; phospholipid metabolic process [GO:0006644]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; response to sterol depletion [GO:0006991]"
PGEN_.00g188940	Scaffold_08	56147183	56169882	Q5ZIW2	CNO10_CHICK	CCR4-NOT transcription complex subunit 10	GO:0005634; GO:0005737; GO:0006402; GO:0017148; GO:0030014; GO:0031047	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]
PGEN_.00g188950	Scaffold_08	56205411	56207708	E7FAM5	LIN41_DANRE	E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)	GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177	P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]
PGEN_.00g188960	Scaffold_08	56222731	56223921	Q3UHD2	GFOD1_MOUSE	Glucose-fructose oxidoreductase domain-containing protein 1 (EC 1.-.-.-)	GO:0005576; GO:0016491	extracellular region [GO:0005576]; oxidoreductase activity [GO:0016491]
PGEN_.00g188970	Scaffold_08	56225294	56228706	P08761	MSRA_DROME	Peptide methionine sulfoxide reductase (EC 1.8.4.11) (Ecdysone-induced protein 28/29 kDa) (Methionine-S-sulfoxide reductase) (Peptide-methionine (S)-S-oxide reductase)	GO:0000096; GO:0005737; GO:0006979; GO:0008113; GO:0008340; GO:0034599; GO:0036456	cytoplasm [GO:0005737]; L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; response to oxidative stress [GO:0006979]; sulfur amino acid metabolic process [GO:0000096]
PGEN_.00g188980	Scaffold_08	56246608	56252370	Q32KJ6	GALNS_RAT	N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase)	GO:0004065; GO:0005764; GO:0008484; GO:0043890; GO:0046872	lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]
PGEN_.00g188990	Scaffold_08	56252602	56253033	NA	NA	NA	NA	NA
PGEN_.00g189000	Scaffold_08	56253090	56253464	NA	NA	NA	NA	NA
PGEN_.00g189010	Scaffold_08	56253602	56260224	Q571E4	GALNS_MOUSE	N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase)	GO:0004065; GO:0005764; GO:0008484; GO:0043890; GO:0046872	lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]
PGEN_.00g189020	Scaffold_08	56271681	56272688	NA	NA	NA	NA	NA
PGEN_.00g189030	Scaffold_08	56284644	56316580	Q5RHR6	BROMI_DANRE	Protein broad-minded (TBC1 domain family member 32)	GO:0005737; GO:0005929; GO:0007275; GO:0035082; GO:0060271; GO:1905515	cilium [GO:0005929]; cytoplasm [GO:0005737]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; multicellular organism development [GO:0007275]; non-motile cilium assembly [GO:1905515]
PGEN_.00g189040	Scaffold_08	56317367	56331734	Q9GKX2	DHRS4_RABIT	Dehydrogenase/reductase SDR family member 4 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase/NADP-retinol dehydrogenase) (CR) (PHCR) (NADPH-dependent retinol dehydrogenase/reductase) (NDRD) (Peroxisomal short-chain alcohol dehydrogenase) (PSCD) (rabNRDR) (Fragment)	GO:0004090; GO:0005739; GO:0005777	mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carbonyl reductase (NADPH) activity [GO:0004090]
PGEN_.00g189050	Scaffold_08	56336398	56356245	Q9BTX7	TTPAL_HUMAN	Alpha-tocopherol transfer protein-like	GO:0016020	membrane [GO:0016020]
PGEN_.00g189060	Scaffold_08	56435740	56436759	Q64326	ACTHR_MOUSE	Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R)	GO:0001890; GO:0004978; GO:0005737; GO:0005886; GO:0007189; GO:0016021	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; corticotropin receptor activity [GO:0004978]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; placenta development [GO:0001890]
PGEN_.00g189070	Scaffold_08	56443696	56447198	NA	NA	NA	NA	NA
PGEN_.00g189080	Scaffold_08	56457084	56464021	NA	NA	NA	NA	NA
PGEN_.00g189090	Scaffold_08	56469837	56477202	O46160	RL14_LUMRU	60S ribosomal protein L14	GO:0003723; GO:0003735; GO:0005840; GO:0006412	ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g189100	Scaffold_08	56479960	56495591	Q86WU2	LDHD_HUMAN	"Probable D-lactate dehydrogenase, mitochondrial (DLD) (Lactate dehydrogenase D) (EC 1.1.2.4)"	GO:0004458; GO:0005739; GO:0005743; GO:0008720; GO:0050660; GO:0071949; GO:1903457	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; lactate catabolic process [GO:1903457]
PGEN_.00g189110	Scaffold_08	56505479	56519506	NA	NA	NA	NA	NA
PGEN_.00g189120	Scaffold_08	56542353	56549818	C3YFB4	DRE2_BRAFL	Anamorsin homolog (Fe-S cluster assembly protein DRE2 homolog)	GO:0005737; GO:0005758; GO:0009055; GO:0016226; GO:0046872; GO:0051537; GO:0051539	"cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"
PGEN_.00g189130	Scaffold_08	56556589	56576628	E2RYF8	TPX2_PATPE	Targeting protein for Xklp2 homolog (TPX2 homolog) (Microtubule-associated protein TPX2 homolog)	GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0032147; GO:0060236	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; activation of protein kinase activity [GO:0032147]; regulation of mitotic spindle organization [GO:0060236]
PGEN_.00g189140	Scaffold_08	56585328	56587963	Q1LXS2	PSMG2_DANRE	Proteasome assembly chaperone 2 (Tumor necrosis factor superfamily member 5-induced protein 1 homolog)	GO:0005634; GO:0005829; GO:0043248	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome assembly [GO:0043248]
PGEN_.00g189150	Scaffold_08	56618935	56623407	NA	NA	NA	NA	NA
PGEN_.00g189160	Scaffold_08	56660377	56663875	P82198	BGH3_MOUSE	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3)	GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]
PGEN_.00g189170	Scaffold_08	56687870	56691096	P54269	CAUP_DROME	Homeobox protein caupolican	GO:0000981; GO:0001745; GO:0003700; GO:0005634; GO:0007346; GO:0007474; GO:0042693; GO:0043565; GO:0045317; GO:0045926; GO:0045944	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; equator specification [GO:0045317]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]"
PGEN_.00g189180	Scaffold_08	56714581	56722436	Q9BZ19	ANR60_HUMAN	Ankyrin repeat domain-containing protein 60		
PGEN_.00g189190	Scaffold_08	56771049	56778940	Q90XW6	IRX4A_XENLA	Iroquois-class homeodomain protein irx-4-A (Iroquois homeobox protein 4-A)	GO:0005634; GO:0006355; GO:0007420; GO:0007507; GO:0009953; GO:0009954; GO:0030154; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; heart development [GO:0007507]; proximal/distal pattern formation [GO:0009954]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g189200	Scaffold_08	56792056	56798652	A4VCL2	FA20C_DROME	Extracellular serine/threonine protein CG31145 (EC 2.7.11.1) (Golgi casein kinase) (Golgi-enriched fraction casein kinase) (GEF-CK)	GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005794; GO:0006468; GO:0016021; GO:0016773; GO:0046872	"extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]"
PGEN_.00g189210	Scaffold_08	56803503	56803820	NA	NA	NA	NA	NA
PGEN_.00g189220	Scaffold_08	56805760	56812730	NA	NA	NA	NA	NA
PGEN_.00g189230	Scaffold_08	56818691	56818981	NA	NA	NA	NA	NA
PGEN_.00g189240	Scaffold_08	56819314	56819724	NA	NA	NA	NA	NA
PGEN_.00g189250	Scaffold_08	56819768	56820616	NA	NA	NA	NA	NA
PGEN_.00g189260	Scaffold_08	56820854	56839675	Q00589	SC6A6_CANLF	Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6)	GO:0005332; GO:0005369; GO:0005886; GO:0005887; GO:0015734; GO:0042165; GO:0043005	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; taurine:sodium symporter activity [GO:0005369]; taurine transport [GO:0015734]
PGEN_.00g189270	Scaffold_08	56872537	56875028	NA	NA	NA	NA	NA
PGEN_.00g189280	Scaffold_08	56890220	56894560	Q99M85	SCRT1_MOUSE	Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (mScrt)	GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0043565; GO:0046872; GO:2001222	"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g189290	Scaffold_08	56927775	56928818	NA	NA	NA	NA	NA
PGEN_.00g189300	Scaffold_08	56937382	56954371	Q66KD0	BTBDH_XENTR	BTB/POZ domain-containing protein 17	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g189310	Scaffold_08	56960613	56964451	NA	NA	NA	NA	NA
PGEN_.00g189320	Scaffold_08	56969623	56983927	NA	NA	NA	NA	NA
PGEN_.00g189330	Scaffold_08	57005272	57024672	NA	NA	NA	NA	NA
PGEN_.00g189340	Scaffold_08	57027797	57036580	Q9NPA8	ENY2_HUMAN	Transcription and mRNA export factor ENY2 (Enhancer of yellow 2 transcription factor homolog)	GO:0000124; GO:0003682; GO:0003713; GO:0005654; GO:0005739; GO:0006357; GO:0006368; GO:0016578; GO:0016973; GO:0030374; GO:0044615; GO:0045893; GO:0061179; GO:0070390; GO:0071819	"DUBm complex [GO:0071819]; mitochondrion [GO:0005739]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]"
PGEN_.00g189350	Scaffold_08	57043004	57046255	NA	NA	NA	NA	NA
PGEN_.00g189360	Scaffold_08	57058186	57059934	NA	NA	NA	NA	NA
PGEN_.00g189370	Scaffold_08	57060643	57086819	Q9CSH3	RRP44_MOUSE	Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0016075; GO:0071034	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]
PGEN_.00g189380	Scaffold_08	57093809	57096616	Q8IXM3	RM41_HUMAN	"39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) (39S ribosomal protein L27 homolog) (Bcl-2-interacting mitochondrial ribosomal protein L41) (Cell proliferation-inducing gene 3 protein) (MRP-L27 homolog) (Mitochondrial large ribosomal subunit protein mL41)"	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0006915; GO:0007049; GO:0070125; GO:0070126; GO:1990904	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]
PGEN_.00g189390	Scaffold_08	57107056	57121601	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g189400	Scaffold_08	57123186	57135963	P86952	TYRO_PINMA	Tyrosinase-like protein (Tyrosinase-2)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g189410	Scaffold_08	57146874	57156342	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g189420	Scaffold_08	57183346	57195545	P91550	GCY15_CAEEL	Receptor-type guanylate cyclase gcy-15 (EC 4.6.1.2)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0016021; GO:0035556	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g189430	Scaffold_08	57212961	57224547	Q8BV66	IFI44_MOUSE	Interferon-induced protein 44 (Microtubule-associated protein 44)	GO:0005737; GO:0006955; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]
PGEN_.00g189440	Scaffold_08	57233195	57240993	Q9BDB7	IF44L_MOUSE	Interferon-induced protein 44-like [Cleaved into: Minor histocompatibility antigen HA-28 (HLA-HA28) (IFL8)]	GO:0005737; GO:0006955; GO:0051607	cytoplasm [GO:0005737]; defense response to virus [GO:0051607]; immune response [GO:0006955]
PGEN_.00g189450	Scaffold_08	57333689	57360511	Q03529	SCS7_YEAST	Ceramide very long chain fatty acid hydroxylase SCS7 (Ceramide VLCFA hydroxylase SCS7) (4-hydroxysphinganine ceramide fatty acyl 2-hydroxylase SCS7) (EC 1.14.18.6) (Dihydroceramide fatty acyl 2-hydroxylase SCS7) (EC 1.14.18.7) (Sphingolipid alpha-hydroxylase) (Suppressor of calcium sensitivity 7)	GO:0005506; GO:0005783; GO:0005789; GO:0006631; GO:0006633; GO:0006673; GO:0008270; GO:0016021; GO:0020037; GO:0046513; GO:0080132	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; fatty acid alpha-hydroxylase activity [GO:0080132]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; inositol phosphoceramide metabolic process [GO:0006673]
PGEN_.00g189460	Scaffold_08	57379089	57386902	NA	NA	NA	NA	NA
PGEN_.00g189470	Scaffold_08	57389884	57407695	Q9Z221	PMFBP_RAT	Polyamine-modulated factor 1-binding protein 1 (PMF-1-binding protein) (Outer dense fiber protein 3)	GO:0001520; GO:0005737; GO:0007010; GO:0007283; GO:0097224	cytoplasm [GO:0005737]; outer dense fiber [GO:0001520]; sperm connecting piece [GO:0097224]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283]
PGEN_.00g189480	Scaffold_08	57420011	57423951	NA	NA	NA	NA	NA
PGEN_.00g189490	Scaffold_08	57427444	57498359	NA	NA	NA	NA	NA
PGEN_.00g189500	Scaffold_08	57503166	57504686	Q7Z449	CP2U1_HUMAN	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330; GO:0097267	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g189510	Scaffold_08	57506881	57507282	Q9QYG5	CP2DK_MESAU	Cytochrome P450 2D20 (EC 1.14.14.-) (CYPIID20)	GO:0005506; GO:0005789; GO:0016712; GO:0020037	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]"
PGEN_.00g189520	Scaffold_08	57512776	57515087	NA	NA	NA	NA	NA
PGEN_.00g189530	Scaffold_08	57521569	57547335	A0JP85	CNOT1_XENTR	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1)	GO:0000122; GO:0000288; GO:0000932; GO:0005634; GO:0010606; GO:0017148; GO:0030014; GO:0030015; GO:0030331; GO:0031047; GO:0033147; GO:0042974; GO:0048387; GO:0060213; GO:1900153	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; estrogen receptor binding [GO:0030331]; retinoic acid receptor binding [GO:0042974]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"
PGEN_.00g189540	Scaffold_08	57562663	57585531	Q9M571	PEAMT_SPIOL	Phosphoethanolamine N-methyltransferase (EC 2.1.1.103)	GO:0000234; GO:0005737; GO:0006656; GO:0032259	cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]
PGEN_.00g189550	Scaffold_08	57596312	57596557	NA	NA	NA	NA	NA
PGEN_.00g189560	Scaffold_08	57597581	57605642	NA	NA	NA	NA	NA
PGEN_.00g189570	Scaffold_08	57637493	57654179	Q14832	GRM3_HUMAN	Metabotropic glutamate receptor 3 (mGluR3)	GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0005887; GO:0007186; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0014069; GO:0030424; GO:0043197; GO:0051966; GO:0098978; GO:0099055; GO:0099056	"axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission, glutamatergic [GO:0051966]"
PGEN_.00g189580	Scaffold_08	57657427	57658245	NA	NA	NA	NA	NA
PGEN_.00g189590	Scaffold_08	57662488	57662823	NA	NA	NA	NA	NA
PGEN_.00g189600	Scaffold_08	57698547	57709002	Q9N121	GCSH_RABIT	"Glycine cleavage system H protein, mitochondrial (Lipoic acid-containing protein)"	GO:0005739; GO:0005960; GO:0009249; GO:0019464	glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249]
PGEN_.00g189610	Scaffold_08	57722959	57793952	Q14028	CNGB1_HUMAN	Cyclic nucleotide-gated cation channel beta-1 (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP)	GO:0000139; GO:0001750; GO:0001895; GO:0005222; GO:0005223; GO:0005623; GO:0005886; GO:0006812; GO:0007601; GO:0007608; GO:0015276; GO:0016056; GO:0017071; GO:0022400; GO:0030552; GO:0030553; GO:0030660; GO:0033365; GO:0035845; GO:0043195; GO:0045494; GO:0050908; GO:0051290; GO:0051480; GO:0060170; GO:1902495	cell [GO:0005623]; ciliary membrane [GO:0060170]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; transmembrane transporter complex [GO:1902495]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; protein heterotetramerization [GO:0051290]; protein localization to organelle [GO:0033365]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; retina homeostasis [GO:0001895]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]
PGEN_.00g189620	Scaffold_08	57802691	57806270	NA	NA	NA	NA	NA
PGEN_.00g189630	Scaffold_08	57808038	57810716	NA	NA	NA	NA	NA
PGEN_.00g189640	Scaffold_08	57815982	57816614	NA	NA	NA	NA	NA
PGEN_.00g189650	Scaffold_08	57816666	57817016	NA	NA	NA	NA	NA
PGEN_.00g189660	Scaffold_08	57937288	57952820	P00918	CAH2_HUMAN	Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II)	GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005623; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0015701; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0070062; GO:0071498; GO:2001150; GO:2001225	"apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]"
PGEN_.00g189670	Scaffold_08	57958333	57980657	Q95NI4	CALM_HALOK	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g189680	Scaffold_08	57990389	58023783	Q9N1Q4	LAT2_RABIT	Large neutral amino acids transporter small subunit 2 (4F2-LC5) (L-type amino acid transporter 2) (Solute carrier family 7 member 8)	GO:0005737; GO:0015101; GO:0015171; GO:0015179; GO:0015804; GO:0016021; GO:0016323; GO:0019534; GO:0042605	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]; neutral amino acid transport [GO:0015804]
PGEN_.00g189690	Scaffold_08	58040639	58066337	Q8BGK6	YLAT2_MOUSE	Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)	GO:0005886; GO:0015179; GO:0015297; GO:0016021; GO:0016323; GO:0043231	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]
PGEN_.00g189700	Scaffold_08	58077142	58090264	NA	NA	NA	NA	NA
PGEN_.00g189710	Scaffold_08	58105837	58120546	NA	NA	NA	NA	NA
PGEN_.00g189720	Scaffold_08	58121960	58135818	Q9SJ44	UEV1C_ARATH	Ubiquitin-conjugating enzyme E2 variant 1C (Ubc enzyme variant 1C) (Protein MMS ZWEI HOMOLOG 3)	GO:0005634; GO:0005783; GO:0005829; GO:0006301; GO:0031372; GO:0061631; GO:0070534	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme activity [GO:0061631]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]
PGEN_.00g189730	Scaffold_08	58140787	58158312	Q3UMM4	CDK10_MOUSE	Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10)	GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:0097472; GO:1902018	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]
PGEN_.00g189740	Scaffold_08	58162047	58174077	Q9DCT2	NDUS3_MOUSE	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)"	GO:0003954; GO:0005739; GO:0005743; GO:0005747; GO:0008137; GO:0016604; GO:0030308; GO:0031966; GO:0043209; GO:0072593; GO:2001243	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]
PGEN_.00g189750	Scaffold_08	58183894	58184103	NA	NA	NA	NA	NA
PGEN_.00g189760	Scaffold_08	58184470	58184796	NA	NA	NA	NA	NA
PGEN_.00g189770	Scaffold_08	58190854	58191201	NA	NA	NA	NA	NA
PGEN_.00g189780	Scaffold_08	58200420	58209297	O08590	AOC3_RAT	Membrane primary amine oxidase (EC 1.4.3.21) (Copper amine oxidase) (Semicarbazide-sensitive amine oxidase) (SSAO) (VP97) (Vascular adhesion protein 1) (VAP-1)	GO:0002523; GO:0002675; GO:0002687; GO:0005507; GO:0005509; GO:0005615; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005902; GO:0007155; GO:0007568; GO:0008131; GO:0008217; GO:0009308; GO:0009986; GO:0010828; GO:0016021; GO:0035902; GO:0042755; GO:0042802; GO:0043231; GO:0046677; GO:0046982; GO:0048038; GO:0052593; GO:0052594; GO:0052595; GO:0052596; GO:1902283	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; aging [GO:0007568]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; eating behavior [GO:0042755]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of primary amine oxidase activity [GO:1902283]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of leukocyte migration [GO:0002687]; regulation of blood pressure [GO:0008217]; response to antibiotic [GO:0046677]; response to immobilization stress [GO:0035902]
PGEN_.00g189790	Scaffold_08	58213107	58225172	O34363	YOBN_BACSU	Putative L-amino-acid oxidase YobN (EC 1.4.3.2)	GO:0001716; GO:0009063; GO:0016491	L-amino-acid oxidase activity [GO:0001716]; oxidoreductase activity [GO:0016491]; cellular amino acid catabolic process [GO:0009063]
PGEN_.00g189800	Scaffold_08	58263011	58268852	O34363	YOBN_BACSU	Putative L-amino-acid oxidase YobN (EC 1.4.3.2)	GO:0001716; GO:0009063; GO:0016491	L-amino-acid oxidase activity [GO:0001716]; oxidoreductase activity [GO:0016491]; cellular amino acid catabolic process [GO:0009063]
PGEN_.00g189810	Scaffold_08	58280056	58289072	NA	NA	NA	NA	NA
PGEN_.00g189820	Scaffold_08	58310622	58339131	Q12542	LAC2_AGABI	Laccase-2 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 2) (Diphenol oxidase 2) (Laccase II) (Urishiol oxidase 2)	GO:0005507; GO:0005576; GO:0046274; GO:0052716	extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]
PGEN_.00g189830	Scaffold_08	58350711	58351337	NA	NA	NA	NA	NA
PGEN_.00g189840	Scaffold_08	58394201	58395586	Q7KVW5	KCNN_DROME	Small conductance calcium-activated potassium channel protein (Protein SK) (dSK)	GO:0005516; GO:0005886; GO:0006813; GO:0009881; GO:0016021; GO:0016057; GO:0016286; GO:0043005; GO:0043025; GO:0071805	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057]
PGEN_.00g189850	Scaffold_08	58440831	58441163	NA	NA	NA	NA	NA
PGEN_.00g189860	Scaffold_08	58496035	58505996	Q32KL4	RMD1_BOVIN	Regulator of microtubule dynamics protein 1 (RMD-1) (Protein FAM82B)	GO:0000922; GO:0005737; GO:0005874	cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle pole [GO:0000922]
PGEN_.00g189870	Scaffold_08	58506055	58506771	NA	NA	NA	NA	NA
PGEN_.00g189880	Scaffold_08	58508500	58512587	NA	NA	NA	NA	NA
PGEN_.00g189890	Scaffold_08	58513801	58514295	NA	NA	NA	NA	NA
PGEN_.00g189900	Scaffold_08	58514962	58515252	NA	NA	NA	NA	NA
PGEN_.00g189910	Scaffold_08	58519765	58528284	P78417	GSTO1_HUMAN	Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R)	GO:0004364; GO:0005623; GO:0005654; GO:0005737; GO:0005829; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0032259; GO:0035722; GO:0042178; GO:0045174; GO:0050610; GO:0055114; GO:0060315; GO:0060316; GO:0070062; GO:0071243; GO:1901687	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]
PGEN_.00g189920	Scaffold_08	58548432	58550075	NA	NA	NA	NA	NA
PGEN_.00g189930	Scaffold_08	58553536	58563824	NA	NA	NA	NA	NA
PGEN_.00g189940	Scaffold_08	58568752	58569060	NA	NA	NA	NA	NA
PGEN_.00g189950	Scaffold_08	58574948	58577403	Q5ZKD4	NPL_CHICK	N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase)	GO:0005737; GO:0005975; GO:0008747; GO:0019262	cytoplasm [GO:0005737]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262]
PGEN_.00g189960	Scaffold_08	58577492	58581948	Q5ZKD4	NPL_CHICK	N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase)	GO:0005737; GO:0005975; GO:0008747; GO:0019262	cytoplasm [GO:0005737]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262]
PGEN_.00g189970	Scaffold_08	58599225	58606995	NA	NA	NA	NA	NA
PGEN_.00g189980	Scaffold_08	58618030	58628845	Q99715	COCA1_HUMAN	Collagen alpha-1(XII) chain	GO:0003429; GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0062023; GO:0070062; GO:1903561	collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g189990	Scaffold_08	58641023	58656899	NA	NA	NA	NA	NA
PGEN_.00g190000	Scaffold_08	58662327	58663124	NA	NA	NA	NA	NA
PGEN_.00g190010	Scaffold_08	58675614	58677901	NA	NA	NA	NA	NA
PGEN_.00g190020	Scaffold_08	58684433	58685632	NA	NA	NA	NA	NA
PGEN_.00g190030	Scaffold_08	58690347	58691102	NA	NA	NA	NA	NA
PGEN_.00g190040	Scaffold_08	58695240	58696403	NA	NA	NA	NA	NA
PGEN_.00g190050	Scaffold_08	58697735	58709186	NA	NA	NA	NA	NA
PGEN_.00g190060	Scaffold_08	58714991	58715257	NA	NA	NA	NA	NA
PGEN_.00g190070	Scaffold_08	58715676	58716131	NA	NA	NA	NA	NA
PGEN_.00g190080	Scaffold_08	58716326	58716805	NA	NA	NA	NA	NA
PGEN_.00g190090	Scaffold_08	58716884	58717189	NA	NA	NA	NA	NA
PGEN_.00g190100	Scaffold_08	58717976	58718806	NA	NA	NA	NA	NA
PGEN_.00g190110	Scaffold_08	58719291	58719767	NA	NA	NA	NA	NA
PGEN_.00g190120	Scaffold_08	58719807	58720672	NA	NA	NA	NA	NA
PGEN_.00g190130	Scaffold_08	58721315	58722511	NA	NA	NA	NA	NA
PGEN_.00g190140	Scaffold_08	58728782	58730584	NA	NA	NA	NA	NA
PGEN_.00g190150	Scaffold_08	58749325	58749750	NA	NA	NA	NA	NA
PGEN_.00g190160	Scaffold_08	58759776	58787903	Q8TF05	PP4R1_HUMAN	Serine/threonine-protein phosphatase 4 regulatory subunit 1	GO:0006468; GO:0006470; GO:0007165; GO:0019888; GO:0030289	protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]
PGEN_.00g190170	Scaffold_08	58810299	58821520	NA	NA	NA	NA	NA
PGEN_.00g190180	Scaffold_08	58827967	58845774	Q96DX4	RSPRY_HUMAN	RING finger and SPRY domain-containing protein 1	GO:0004842; GO:0005576; GO:0005737; GO:0046872; GO:0051603	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g190190	Scaffold_08	58848673	58858006	Q9DAR0	CE049_MOUSE	Uncharacterized protein C5orf49 homolog (Y regulated sperm protein)		
PGEN_.00g190200	Scaffold_08	58871767	58879484	Q21502	MEP1_CAEEL	MOG interacting and ectopic P-granules protein 1 (Nuclear zinc finger protein)	GO:0000979; GO:0002119; GO:0003723; GO:0005634; GO:0007506; GO:0008134; GO:0008406; GO:0010468; GO:0017151; GO:0040025; GO:0040035; GO:0042802; GO:0042826; GO:0046872; GO:0048599	nucleus [GO:0005634]; DEAD/H-box RNA helicase binding [GO:0017151]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription factor binding [GO:0008134]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; hermaphrodite genitalia development [GO:0040035]; nematode larval development [GO:0002119]; oocyte development [GO:0048599]; regulation of gene expression [GO:0010468]; vulval development [GO:0040025]
PGEN_.00g190210	Scaffold_08	58894010	58897771	Q5ZJ97	K1143_CHICK	Uncharacterized protein KIAA1143 homolog		
PGEN_.00g190220	Scaffold_08	58901545	58964484	Q4G0P3	HYDIN_HUMAN	Hydrocephalus-inducing protein homolog	GO:0002064; GO:0003341; GO:0021591; GO:0060438; GO:1904158; GO:1990718	axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591]
PGEN_.00g190230	Scaffold_08	58964733	58995088	Q80W93	HYDIN_MOUSE	Hydrocephalus-inducing protein (Protein Hy-3)	GO:0002064; GO:0003341; GO:0007275; GO:0007420; GO:0021591; GO:0060438; GO:1904158; GO:1990718	axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; brain development [GO:0007420]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; multicellular organism development [GO:0007275]; trachea development [GO:0060438]; ventricular system development [GO:0021591]
PGEN_.00g190240	Scaffold_08	58995132	59006165	A5GFX0	PLD3B_PIG	PRELI domain containing protein 3B (Protein slowmo homolog 2)	GO:0005758; GO:0015914; GO:1990050	mitochondrial intermembrane space [GO:0005758]; phosphatidic acid transfer activity [GO:1990050]; phospholipid transport [GO:0015914]
PGEN_.00g190250	Scaffold_08	59014787	59071294	Q64701	RBL1_MOUSE	Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1)	GO:0000122; GO:0000785; GO:0001012; GO:0001102; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0007049; GO:0007346; GO:0008134; GO:0010629; GO:0030154; GO:0043550; GO:0051302; GO:1990841; GO:2000134; GO:2000773	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]
PGEN_.00g190260	Scaffold_08	59079830	59102983	Q8GWT4	ANM15_ARATH	Protein arginine N-methyltransferase 1.5 (AtPMRT15) (AtPMRT5) (EC 2.1.1.319) (Shk1 kinase-binding protein 1 homolog)	GO:0005634; GO:0005829; GO:0008276; GO:0008469; GO:0009909; GO:0010220; GO:0034969; GO:0035242; GO:0043985	cytosol [GO:0005829]; nucleus [GO:0005634]; histone-arginine N-methyltransferase activity [GO:0008469]; protein methyltransferase activity [GO:0008276]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; positive regulation of vernalization response [GO:0010220]; regulation of flower development [GO:0009909]
PGEN_.00g190270	Scaffold_08	59106253	59134038	A7YY75	SEH1_BOVIN	Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit SEH1)	GO:0000777; GO:0002534; GO:0005198; GO:0005623; GO:0005765; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0034198; GO:0034629; GO:0035859; GO:0050830; GO:0051028; GO:0051301; GO:0051315; GO:0061700; GO:1904263	cell [GO:0005623]; condensed chromosome kinetochore [GO:0000777]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; cytokine production involved in inflammatory response [GO:0002534]; defense response to Gram-positive bacterium [GO:0050830]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]
PGEN_.00g190280	Scaffold_08	59170120	59195477	O34313	NTPES_BACSU	"Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)]"	GO:0000166; GO:0005576; GO:0005618; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872	"cell wall [GO:0005618]; extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]; 2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166]"
PGEN_.00g190290	Scaffold_08	59202413	59203064	NA	NA	NA	NA	NA
PGEN_.00g190300	Scaffold_08	59203265	59206078	NA	NA	NA	NA	NA
PGEN_.00g190310	Scaffold_08	59219707	59226822	NA	NA	NA	NA	NA
PGEN_.00g190320	Scaffold_08	59231743	59255996	NA	NA	NA	NA	NA
PGEN_.00g190330	Scaffold_08	59256520	59256882	NA	NA	NA	NA	NA
PGEN_.00g190340	Scaffold_08	59259342	59280061	NA	NA	NA	NA	NA
PGEN_.00g190350	Scaffold_08	59321145	59350218	NA	NA	NA	NA	NA
PGEN_.00g190360	Scaffold_08	59388840	59391858	NA	NA	NA	NA	NA
PGEN_.00g190370	Scaffold_08	59406152	59418073	Q75QI0	CFDP1_CHICK	Craniofacial development protein 1 (Bucentaur)	GO:0000777; GO:0007275	condensed chromosome kinetochore [GO:0000777]; multicellular organism development [GO:0007275]
PGEN_.00g190380	Scaffold_08	59418533	59420847	Q9D342	T170A_MOUSE	Transmembrane protein 170A	GO:0005635; GO:0005789; GO:0006998; GO:0016021; GO:0051292; GO:0071786	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; endoplasmic reticulum tubular network organization [GO:0071786]; nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]
PGEN_.00g190390	Scaffold_08	59424523	59425344	NA	NA	NA	NA	NA
PGEN_.00g190400	Scaffold_08	59439198	59447067	Q9CWZ7	SNAG_MOUSE	Gamma-soluble NSF attachment protein (SNAP-gamma) (N-ethylmaleimide-sensitive factor attachment protein gamma)	GO:0005483; GO:0005739; GO:0005774; GO:0006886; GO:0016192; GO:0019905; GO:0031201; GO:0043209; GO:0045202	mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; SNARE complex [GO:0031201]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g190410	Scaffold_08	59462549	59506048	Q96T49	PP16B_HUMAN	Protein phosphatase 1 regulatory inhibitor subunit 16B (Ankyrin repeat domain-containing protein 4) (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein) (hTIMAP)	GO:0001938; GO:0005634; GO:0005886; GO:0014066; GO:0016607; GO:0019888; GO:0035304; GO:0035307; GO:0035308; GO:0042995; GO:0048471; GO:0051489; GO:0061028; GO:1902309; GO:1903589	cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein phosphatase regulator activity [GO:0019888]; establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]
PGEN_.00g190420	Scaffold_08	59595786	59608352	Q0P5H9	TTC5_BOVIN	Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Strap)	GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006281; GO:0045944	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g190430	Scaffold_08	59613122	59676228	O75096	LRP4_HUMAN	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]
PGEN_.00g190440	Scaffold_08	59707422	59726081	O54743	FOXF2_MOUSE	Forkhead box protein F2 (Protein LUN)	GO:0000977; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0008134; GO:0030198; GO:0032434; GO:0042249; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048566; GO:0048596; GO:0048806; GO:0060021; GO:1902914	"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract development [GO:0048566]; establishment of planar polarity of embryonic epithelium [GO:0042249]; extracellular matrix organization [GO:0030198]; genitalia development [GO:0048806]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein polyubiquitination [GO:1902914]; roof of mouth development [GO:0060021]"
PGEN_.00g190450	Scaffold_08	59770721	59779417	NA	NA	NA	NA	NA
PGEN_.00g190460	Scaffold_08	59801866	59827188	Q9Y345	SC6A5_HUMAN	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g190470	Scaffold_08	59829115	59849541	Q9UHI7	S23A1_HUMAN	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3)	GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016324; GO:0019852; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g190480	Scaffold_08	59894510	59941792	NA	NA	NA	NA	NA
PGEN_.00g190490	Scaffold_08	59951371	59958738	P56812	PDCD5_MOUSE	Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19)	GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0008201; GO:0008285; GO:0010628; GO:0010698; GO:0043065; GO:0043280; GO:0048487; GO:0071560; GO:0090200; GO:1903638; GO:1903645	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]
PGEN_.00g190500	Scaffold_08	59975043	59999078	NA	NA	NA	NA	NA
PGEN_.00g190510	Scaffold_08	60022805	60028417	NA	NA	NA	NA	NA
PGEN_.00g190520	Scaffold_08	60054325	60054552	NA	NA	NA	NA	NA
PGEN_.00g190530	Scaffold_08	60075939	60086442	P05689	CATZ_BOVIN	Cathepsin Z (EC 3.4.18.1)	GO:0004197; GO:0005615; GO:0005764; GO:0051603	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g190540	Scaffold_08	60089818	60107131	E2R222	PCH2_CANLF	Pachytene checkpoint protein 2 homolog (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13) (TR-interacting protein 13) (TRIP-13)	GO:0001556; GO:0001673; GO:0005524; GO:0005694; GO:0006302; GO:0007094; GO:0007130; GO:0007131; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0042802; GO:0048477; GO:0051598	chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint [GO:0051598]; mitotic spindle assembly checkpoint [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]
PGEN_.00g190550	Scaffold_08	60119529	60120722	P70606	KCNN1_RAT	Small conductance calcium-activated potassium channel protein 1 (SK1) (SKCa 1) (SKCa1) (KCa2.1)	GO:0005516; GO:0005737; GO:0005886; GO:0016021; GO:0016286; GO:0043005; GO:0043025; GO:0043197; GO:0044877; GO:0071805	cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]
PGEN_.00g190560	Scaffold_08	60159478	60159933	NA	NA	NA	NA	NA
PGEN_.00g190570	Scaffold_08	60228833	60233858	NA	NA	NA	NA	NA
PGEN_.00g190580	Scaffold_08	60264820	60265443	NA	NA	NA	NA	NA
PGEN_.00g190590	Scaffold_08	60297709	60300059	Q80VI1	TRI56_MOUSE	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0045087; GO:0046597; GO:0051607; GO:0061630; GO:0070534; GO:1902187	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
PGEN_.00g190600	Scaffold_08	60301069	60324362	NA	NA	NA	NA	NA
PGEN_.00g190610	Scaffold_08	60325637	60328723	Q8BYI9	TENR_MOUSE	Tenascin-R (TN-R) (Janusin) (Neural recognition molecule J1-160/180) (Restrictin)	GO:0005178; GO:0007158; GO:0007162; GO:0008306; GO:0009986; GO:0010977; GO:0022029; GO:0022408; GO:0030198; GO:0030517; GO:0031012; GO:0035641; GO:0045121; GO:0046625; GO:0048692; GO:0050804; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0072534; GO:0098685; GO:0098686; GO:0098966; GO:0098978	"cell surface [GO:0009986]; extracellular matrix [GO:0031012]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; perisynaptic extracellular matrix [GO:0098966]; Schaffer collateral - CA1 synapse [GO:0098685]; integrin binding [GO:0005178]; sphingolipid binding [GO:0046625]; associative learning [GO:0008306]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic transmission [GO:0050805]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; synapse organization [GO:0050808]; telencephalon cell migration [GO:0022029]"
PGEN_.00g190620	Scaffold_08	60332251	60337950	P58392	KCNN3_PIG	Small conductance calcium-activated potassium channel protein 3 (SK3) (SKCa 3) (SKCa3) (KCa2.3)	GO:0005516; GO:0005886; GO:0016021; GO:0016286; GO:0043005; GO:0043025; GO:0071805	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]
PGEN_.00g190630	Scaffold_08	60350336	60350659	NA	NA	NA	NA	NA
PGEN_.00g190640	Scaffold_08	60350684	60351046	NA	NA	NA	NA	NA
PGEN_.00g190650	Scaffold_08	60351166	60351402	NA	NA	NA	NA	NA
PGEN_.00g190660	Scaffold_08	60351888	60353018	NA	NA	NA	NA	NA
PGEN_.00g190670	Scaffold_08	60355922	60361233	NA	NA	NA	NA	NA
PGEN_.00g190680	Scaffold_08	60367727	60384237	NA	NA	NA	NA	NA
PGEN_.00g190690	Scaffold_08	60389408	60399717	NA	NA	NA	NA	NA
PGEN_.00g190700	Scaffold_08	60403641	60414407	NA	NA	NA	NA	NA
PGEN_.00g190710	Scaffold_08	60442351	60451215	NA	NA	NA	NA	NA
PGEN_.00g190720	Scaffold_08	60459681	60460022	NA	NA	NA	NA	NA
PGEN_.00g190730	Scaffold_08	60489370	60492183	NA	NA	NA	NA	NA
PGEN_.00g190740	Scaffold_08	60507156	60544720	Q7Z2Y8	GVIN1_HUMAN	Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g190750	Scaffold_08	60545348	60545788	NA	NA	NA	NA	NA
PGEN_.00g190760	Scaffold_08	60546071	60546373	NA	NA	NA	NA	NA
PGEN_.00g190770	Scaffold_08	60577336	60579278	NA	NA	NA	NA	NA
PGEN_.00g190780	Scaffold_08	60586284	60593309	NA	NA	NA	NA	NA
PGEN_.00g190790	Scaffold_08	60610273	60623979	P56395	CYB5_MOUSE	Cytochrome b5	GO:0004768; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0006631; GO:0016020; GO:0016021; GO:0019899; GO:0020037; GO:0043231; GO:0046686; GO:0046872	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty acid metabolic process [GO:0006631]; response to cadmium ion [GO:0046686]
PGEN_.00g190800	Scaffold_08	60664991	60666471	Q58CZ9	ATTY_BOVIN	Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase)	GO:0004838; GO:0005739; GO:0006520; GO:0006536; GO:0006559; GO:0006572; GO:0009058; GO:0016597; GO:0030170	mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]
PGEN_.00g190810	Scaffold_08	60670991	60671365	NA	NA	NA	NA	NA
PGEN_.00g190820	Scaffold_08	60675156	60680911	Q08BG1	TMPPE_DANRE	Transmembrane protein with metallophosphoesterase domain (EC 3.1.-.-)	GO:0016021; GO:0016787; GO:0046872	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]
PGEN_.00g190830	Scaffold_08	60684741	60687483	NA	NA	NA	NA	NA
PGEN_.00g190840	Scaffold_08	60723244	60740065	Q17QN3	RSMN_BOVIN	Small nuclear ribonucleoprotein-associated protein N (snRNP-N) (Sm protein N) (Sm-N) (SmN)	GO:0000398; GO:0003723; GO:0005654; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005737; GO:0046540; GO:0071004; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g190850	Scaffold_08	60741529	60751002	NA	NA	NA	NA	NA
PGEN_.00g190860	Scaffold_08	60768208	60771722	C7G0B5	PIF_PINFU	Protein PIF [Cleaved into: Protein Pif97; Protein Pif80 (Aragonite-binding protein)]	GO:0005576; GO:0006030; GO:0008061	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]
PGEN_.00g190870	Scaffold_08	60794240	60794587	NA	NA	NA	NA	NA
PGEN_.00g190880	Scaffold_08	60795447	60805255	NA	NA	NA	NA	NA
PGEN_.00g190890	Scaffold_08	60810952	60827213	NA	NA	NA	NA	NA
PGEN_.00g190900	Scaffold_08	60827295	60832179	NA	NA	NA	NA	NA
PGEN_.00g190910	Scaffold_08	60836082	60845890	NA	NA	NA	NA	NA
PGEN_.00g190920	Scaffold_08	60846034	60846234	NA	NA	NA	NA	NA
PGEN_.00g190930	Scaffold_08	60846814	60847161	NA	NA	NA	NA	NA
PGEN_.00g190940	Scaffold_08	60869168	60872631	C7G0B5	PIF_PINFU	Protein PIF [Cleaved into: Protein Pif97; Protein Pif80 (Aragonite-binding protein)]	GO:0005576; GO:0006030; GO:0008061	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]
PGEN_.00g190950	Scaffold_08	60884986	60900108	NA	NA	NA	NA	NA
PGEN_.00g190960	Scaffold_08	60901571	60916192	Q17QN3	RSMN_BOVIN	Small nuclear ribonucleoprotein-associated protein N (snRNP-N) (Sm protein N) (Sm-N) (SmN)	GO:0000398; GO:0003723; GO:0005654; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005737; GO:0046540; GO:0071004; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g190970	Scaffold_08	60923813	60942000	Q5XJ34	KC15L_DANRE	BTB/POZ domain-containing protein kctd15-like	GO:0007420; GO:0014033; GO:0014036; GO:0051260; GO:0060037; GO:0060070; GO:2001141	brain development [GO:0007420]; canonical Wnt signaling pathway [GO:0060070]; neural crest cell differentiation [GO:0014033]; neural crest cell fate specification [GO:0014036]; pharyngeal system development [GO:0060037]; protein homooligomerization [GO:0051260]; regulation of RNA biosynthetic process [GO:2001141]
PGEN_.00g190980	Scaffold_08	60951937	60954686	NA	NA	NA	NA	NA
PGEN_.00g190990	Scaffold_08	60958481	60964025	Q08BG1	TMPPE_DANRE	Transmembrane protein with metallophosphoesterase domain (EC 3.1.-.-)	GO:0016021; GO:0016787; GO:0046872	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]
PGEN_.00g191000	Scaffold_08	60967774	60968160	NA	NA	NA	NA	NA
PGEN_.00g191010	Scaffold_08	60971702	60973295	Q58CZ9	ATTY_BOVIN	Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase)	GO:0004838; GO:0005739; GO:0006520; GO:0006536; GO:0006559; GO:0006572; GO:0009058; GO:0016597; GO:0030170	mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]
PGEN_.00g191020	Scaffold_08	61014584	61029540	P56395	CYB5_MOUSE	Cytochrome b5	GO:0004768; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0006631; GO:0016020; GO:0016021; GO:0019899; GO:0020037; GO:0043231; GO:0046686; GO:0046872	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty acid metabolic process [GO:0006631]; response to cadmium ion [GO:0046686]
PGEN_.00g191030	Scaffold_08	61064084	61064488	NA	NA	NA	NA	NA
PGEN_.00g191040	Scaffold_08	61073095	61076198	NA	NA	NA	NA	NA
PGEN_.00g191050	Scaffold_08	61101233	61101601	NA	NA	NA	NA	NA
PGEN_.00g191060	Scaffold_08	61108821	61109084	NA	NA	NA	NA	NA
PGEN_.00g191070	Scaffold_08	61109491	61114014	NA	NA	NA	NA	NA
PGEN_.00g191080	Scaffold_08	61114306	61115193	NA	NA	NA	NA	NA
PGEN_.00g191090	Scaffold_08	61115431	61116123	NA	NA	NA	NA	NA
PGEN_.00g191100	Scaffold_08	61127502	61141161	NA	NA	NA	NA	NA
PGEN_.00g191110	Scaffold_09	5140	6958	NA	NA	NA	NA	NA
PGEN_.00g191120	Scaffold_09	16915	19478	NA	NA	NA	NA	NA
PGEN_.00g191130	Scaffold_09	36568	36987	NA	NA	NA	NA	NA
PGEN_.00g191140	Scaffold_09	38854	39525	Q9LF88	Y3304_ARATH	Late embryogenesis abundant protein At3g53040 (LEA domain-containing protein At3g53040)	GO:0005829; GO:0010227	cytosol [GO:0005829]; floral organ abscission [GO:0010227]
PGEN_.00g191150	Scaffold_09	39774	40001	NA	NA	NA	NA	NA
PGEN_.00g191160	Scaffold_09	40043	40357	Q8SVY9	Y3G1_ENCCU	Uncharacterized protein ECU03_1610		
PGEN_.00g191170	Scaffold_09	48149	49216	Q80SU7	GVIN1_MOUSE	Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g191180	Scaffold_09	49702	52554	Q80SU7	GVIN1_MOUSE	Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g191190	Scaffold_09	151493	152011	NA	NA	NA	NA	NA
PGEN_.00g191200	Scaffold_09	192839	214412	NA	NA	NA	NA	NA
PGEN_.00g191210	Scaffold_09	243941	244639	NA	NA	NA	NA	NA
PGEN_.00g191220	Scaffold_09	325163	325561	NA	NA	NA	NA	NA
PGEN_.00g191230	Scaffold_09	367164	367400	NA	NA	NA	NA	NA
PGEN_.00g191240	Scaffold_09	398064	400990	NA	NA	NA	NA	NA
PGEN_.00g191250	Scaffold_09	479588	488799	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g191260	Scaffold_09	493799	495508	Q21565	AMT3_CAEEL	Putative ammonium transporter 3	GO:0005887; GO:0008519; GO:0072488	integral component of plasma membrane [GO:0005887]; ammonium transmembrane transporter activity [GO:0008519]; ammonium transmembrane transport [GO:0072488]
PGEN_.00g191270	Scaffold_09	498333	498734	NA	NA	NA	NA	NA
PGEN_.00g191280	Scaffold_09	532617	556947	Q5IS52	ACHA2_PANTR	Neuronal acetylcholine receptor subunit alpha-2	GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g191290	Scaffold_09	609698	610201	NA	NA	NA	NA	NA
PGEN_.00g191300	Scaffold_09	673489	678598	Q29496	CP3AO_SHEEP	Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)	GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]
PGEN_.00g191310	Scaffold_09	739842	740132	NA	NA	NA	NA	NA
PGEN_.00g191320	Scaffold_09	741693	742613	Q96WV6	YHU2_SCHPO	Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02	GO:0010339; GO:0031362; GO:0098631	anchored component of external side of plasma membrane [GO:0031362]; external side of cell wall [GO:0010339]; cell adhesion mediator activity [GO:0098631]
PGEN_.00g191330	Scaffold_09	751946	753181	NA	NA	NA	NA	NA
PGEN_.00g191340	Scaffold_09	848570	862541	P05933	CALM_SCHPO	Calmodulin (CaM)	GO:0000935; GO:0005509; GO:0005634; GO:0005823; GO:0005829; GO:0019722; GO:0030437; GO:0031322; GO:0032153; GO:0035838; GO:0035840; GO:0035841; GO:0035974; GO:0043332; GO:0044732; GO:0045160; GO:0051300; GO:0061493; GO:0090307; GO:1990954	cell division site [GO:0032153]; central plaque of mitotic spindle pole body [GO:0061493]; central plaque of spindle pole body [GO:0005823]; cytosol [GO:0005829]; division septum [GO:0000935]; growing cell tip [GO:0035838]; mating projection tip [GO:0043332]; meiotic spindle pole body [GO:0035974]; mitotic spindle pole body [GO:0044732]; myosin I complex [GO:0045160]; new growing cell tip [GO:0035841]; nucleus [GO:0005634]; old growing cell tip [GO:0035840]; calcium ion binding [GO:0005509]; ascospore formation [GO:0030437]; ascospore-type prospore-specific spindle pole body remodeling [GO:0031322]; calcium-mediated signaling [GO:0019722]; establishment of protein localization to meiotic spindle pole body [GO:1990954]; mitotic spindle assembly [GO:0090307]; spindle pole body organization [GO:0051300]
PGEN_.00g191350	Scaffold_09	873819	903000	NA	NA	NA	NA	NA
PGEN_.00g191360	Scaffold_09	905075	907455	NA	NA	NA	NA	NA
PGEN_.00g191370	Scaffold_09	914897	929592	Q5D018	RBM8A_DANRE	RNA-binding protein 8A (RNA-binding motif protein 8A) (Ribonucleoprotein RBM8A)	GO:0000184; GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005737; GO:0006417; GO:0016607; GO:0035145; GO:0051028; GO:0071006	"cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; mRNA binding [GO:0003729]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]"
PGEN_.00g191380	Scaffold_09	930033	946324	Q6NS86	ZN366_MOUSE	Zinc finger protein 366 (Dendritic cell-specific transcript protein) (DC-SCRIPT)	GO:0000122; GO:0003677; GO:0003714; GO:0005634; GO:0030331; GO:0033147; GO:0043627; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to estrogen [GO:0043627]
PGEN_.00g191390	Scaffold_09	958635	1003463	P55199	ELL_HUMAN	RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein)	GO:0001701; GO:0005654; GO:0006366; GO:0006368; GO:0008023; GO:0010923; GO:0015030; GO:0016607; GO:0019902; GO:0032786; GO:0032968; GO:0035327; GO:0035363; GO:0042795; GO:0042796; GO:0045945	"Cajal body [GO:0015030]; histone locus body [GO:0035363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; phosphatase binding [GO:0019902]; in utero embryonic development [GO:0001701]; negative regulation of phosphatase activity [GO:0010923]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"
PGEN_.00g191400	Scaffold_09	1018233	1039415	P54830	PTN5_MOUSE	Tyrosine-protein phosphatase non-receptor type 5 (EC 3.1.3.48) (Neural-specific protein-tyrosine phosphatase) (Striatum-enriched protein-tyrosine phosphatase) (STEP)	GO:0001784; GO:0001934; GO:0002092; GO:0004725; GO:0005783; GO:0005789; GO:0005829; GO:0006470; GO:0008021; GO:0010976; GO:0016020; GO:0016021; GO:0019901; GO:0030424; GO:0035254; GO:0035335; GO:0035640; GO:0035902; GO:0042307; GO:0042802; GO:0043025; GO:0043204; GO:0043407; GO:0051019; GO:0097060; GO:1900273; GO:1901216; GO:1903955; GO:1990635; GO:2001025	axon [GO:0030424]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; proximal dendrite [GO:1990635]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; exploration behavior [GO:0035640]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of receptor internalization [GO:0002092]; positive regulation of response to drug [GO:2001025]; protein dephosphorylation [GO:0006470]; response to immobilization stress [GO:0035902]
PGEN_.00g191410	Scaffold_09	1074468	1084825	Q9H6S0	YTDC2_HUMAN	3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (YTH domain-containing protein 2) (hYTHDC2)	GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0007286; GO:0008186; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA-dependent ATPase activity [GO:0008186]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"
PGEN_.00g191420	Scaffold_09	1099428	1100942	NA	NA	NA	NA	NA
PGEN_.00g191430	Scaffold_09	1112393	1116493	NA	NA	NA	NA	NA
PGEN_.00g191440	Scaffold_09	1125874	1128864	NA	NA	NA	NA	NA
PGEN_.00g191450	Scaffold_09	1157812	1158189	NA	NA	NA	NA	NA
PGEN_.00g191460	Scaffold_09	1209922	1210527	NA	NA	NA	NA	NA
PGEN_.00g191470	Scaffold_09	1220647	1225964	NA	NA	NA	NA	NA
PGEN_.00g191480	Scaffold_09	1255235	1309042	Q91YK0	LRC49_MOUSE	Leucine-rich repeat-containing protein 49 (Tubulin polyglutamylase complex subunit 4) (PGs4) (p79)	GO:0005737; GO:0005829; GO:0005874; GO:0018095; GO:0036158	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; outer dynein arm assembly [GO:0036158]; protein polyglutamylation [GO:0018095]
PGEN_.00g191490	Scaffold_09	1312201	1319870	Q91YK0	LRC49_MOUSE	Leucine-rich repeat-containing protein 49 (Tubulin polyglutamylase complex subunit 4) (PGs4) (p79)	GO:0005737; GO:0005829; GO:0005874; GO:0018095; GO:0036158	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; outer dynein arm assembly [GO:0036158]; protein polyglutamylation [GO:0018095]
PGEN_.00g191500	Scaffold_09	1351486	1351890	NA	NA	NA	NA	NA
PGEN_.00g191510	Scaffold_09	1377188	1377776	NA	NA	NA	NA	NA
PGEN_.00g191520	Scaffold_09	1386886	1387125	NA	NA	NA	NA	NA
PGEN_.00g191530	Scaffold_09	1401200	1402786	NA	NA	NA	NA	NA
PGEN_.00g191540	Scaffold_09	1402893	1408163	NA	NA	NA	NA	NA
PGEN_.00g191550	Scaffold_09	1425067	1426963	NA	NA	NA	NA	NA
PGEN_.00g191560	Scaffold_09	1445416	1452747	NA	NA	NA	NA	NA
PGEN_.00g191570	Scaffold_09	1456093	1456383	NA	NA	NA	NA	NA
PGEN_.00g191580	Scaffold_09	1459720	1464301	NA	NA	NA	NA	NA
PGEN_.00g191590	Scaffold_09	1468858	1469292	NA	NA	NA	NA	NA
PGEN_.00g191600	Scaffold_09	1471039	1471650	NA	NA	NA	NA	NA
PGEN_.00g191610	Scaffold_09	1471788	1474145	NA	NA	NA	NA	NA
PGEN_.00g191620	Scaffold_09	1475356	1492890	NA	NA	NA	NA	NA
PGEN_.00g191630	Scaffold_09	1496973	1498187	Q9Y5Z6	B3GT1_HUMAN	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g191640	Scaffold_09	1538787	1547829	Q15650	TRIP4_HUMAN	Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4)	GO:0002020; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0006355; GO:0008270; GO:0016604; GO:0016922; GO:0019901; GO:0030331; GO:0030520; GO:0031594; GO:0032991; GO:0035035; GO:0044389; GO:0045661; GO:0045893; GO:0099053; GO:1901998	"activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription, DNA-templated [GO:0006355]; toxin transport [GO:1901998]"
PGEN_.00g191650	Scaffold_09	1552284	1577494	P97390	VPS45_MOUSE	Vacuolar protein sorting-associated protein 45 (mVps45)	GO:0000139; GO:0005794; GO:0006904; GO:0008021; GO:0010008; GO:0015031; GO:0016021	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]
PGEN_.00g191660	Scaffold_09	1582445	1582822	NA	NA	NA	NA	NA
PGEN_.00g191670	Scaffold_09	1583909	1584340	NA	NA	NA	NA	NA
PGEN_.00g191680	Scaffold_09	1588970	1650442	Q5R4V3	KC1G3_PONAB	Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005737; GO:0016055	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Wnt signaling pathway [GO:0016055]
PGEN_.00g191690	Scaffold_09	1651260	1678909	Q8N960	CE120_HUMAN	Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100)	GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0008022; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0045724; GO:1903724; GO:1904951	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein C-terminus binding [GO:0008022]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]
PGEN_.00g191700	Scaffold_09	1685533	1693452	P08928	LAM0_DROME	Lamin Dm0	GO:0000922; GO:0001745; GO:0003682; GO:0005102; GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005641; GO:0005652; GO:0005737; GO:0006342; GO:0006997; GO:0006998; GO:0007084; GO:0007097; GO:0007110; GO:0007112; GO:0007283; GO:0007417; GO:0007430; GO:0007569; GO:0008285; GO:0008344; GO:0030838; GO:0031081; GO:0035262; GO:0040003; GO:0048137; GO:0048546; GO:0050777; GO:0070870; GO:0071763; GO:0090435; GO:1900182; GO:1905832; GO:2000433	"cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]"
PGEN_.00g191710	Scaffold_09	1722607	1723011	P21910	LAML2_XENLA	Lamin-L(II)	GO:0005637; GO:0005882	intermediate filament [GO:0005882]; nuclear inner membrane [GO:0005637]
PGEN_.00g191720	Scaffold_09	1733572	1733997	NA	NA	NA	NA	NA
PGEN_.00g191730	Scaffold_09	1734053	1735315	NA	NA	NA	NA	NA
PGEN_.00g191740	Scaffold_09	1749443	1753554	Q0V9C8	KXDL1_XENTR	KxDL motif-containing protein 1	GO:0005765; GO:0016192; GO:0032418; GO:0099078	BORC complex [GO:0099078]; lysosomal membrane [GO:0005765]; lysosome localization [GO:0032418]; vesicle-mediated transport [GO:0016192]
PGEN_.00g191750	Scaffold_09	1807925	1847440	P98199	AT8B2_MOUSE	Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)	GO:0000287; GO:0005524; GO:0005789; GO:0005794; GO:0005886; GO:0007030; GO:0016021; GO:0045332; GO:0140326	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332]
PGEN_.00g191760	Scaffold_09	1869216	1882348	Q9ESW8	PGPI_MOUSE	Pyroglutamyl-peptidase 1 (EC 3.4.19.3) (5-oxoprolyl-peptidase) (Pyroglutamyl aminopeptidase I) (PAP-I) (Pyroglutamyl-peptidase I) (PGP-I) (Pyrrolidone-carboxylate peptidase)	GO:0005829; GO:0006508; GO:0008233; GO:0008234; GO:0016920	cytosol [GO:0005829]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; pyroglutamyl-peptidase activity [GO:0016920]; proteolysis [GO:0006508]
PGEN_.00g191770	Scaffold_09	1889382	1891400	NA	NA	NA	NA	NA
PGEN_.00g191780	Scaffold_09	2046484	2047680	NA	NA	NA	NA	NA
PGEN_.00g191790	Scaffold_09	2057434	2057763	NA	NA	NA	NA	NA
PGEN_.00g191800	Scaffold_09	2061994	2071187	P22770	ACHA7_CHICK	Neuronal acetylcholine receptor subunit alpha-7	GO:0000187; GO:0001540; GO:0001666; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030054; GO:0030424; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043204; GO:0045202; GO:0045211; GO:0045766; GO:0050877; GO:0050890	"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g191810	Scaffold_09	2079367	2082362	NA	NA	NA	NA	NA
PGEN_.00g191820	Scaffold_09	2097012	2099736	NA	NA	NA	NA	NA
PGEN_.00g191830	Scaffold_09	2108138	2112598	NA	NA	NA	NA	NA
PGEN_.00g191840	Scaffold_09	2124462	2127325	NA	NA	NA	NA	NA
PGEN_.00g191850	Scaffold_09	2154015	2159465	NA	NA	NA	NA	NA
PGEN_.00g191860	Scaffold_09	2181746	2181964	NA	NA	NA	NA	NA
PGEN_.00g191870	Scaffold_09	2190679	2222660	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g191880	Scaffold_09	2235263	2247208	Q9CRC3	CO040_MOUSE	UPF0235 protein C15orf40 homolog		
PGEN_.00g191890	Scaffold_09	2247437	2247859	Q8QZX5	LSM10_MOUSE	U7 snRNA-associated Sm-like protein LSm10	GO:0005654; GO:0005683; GO:0006397; GO:0008380; GO:0015030; GO:0016604; GO:0017069; GO:0071208; GO:0071209; GO:1900087	Cajal body [GO:0015030]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; U7 snRNP [GO:0005683]; histone pre-mRNA DCP binding [GO:0071208]; snRNA binding [GO:0017069]; U7 snRNA binding [GO:0071209]; mRNA processing [GO:0006397]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA splicing [GO:0008380]
PGEN_.00g191900	Scaffold_09	2258196	2280648	Q6NT55	CP4FN_HUMAN	Cytochrome P450 4F22 (EC 1.14.14.-)	GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037	"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690]"
PGEN_.00g191910	Scaffold_09	2283173	2285244	NA	NA	NA	NA	NA
PGEN_.00g191920	Scaffold_09	2286902	2291329	NA	NA	NA	NA	NA
PGEN_.00g191930	Scaffold_09	2389767	2391269	Q8CG64	FKRP_MOUSE	Fukutin-related protein (EC 2.4.2.-) (Ribitol-5-phosphate transferase)	GO:0000139; GO:0002162; GO:0005615; GO:0005654; GO:0005791; GO:0005794; GO:0005829; GO:0009101; GO:0016021; GO:0016485; GO:0016740; GO:0035269; GO:0042383	cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; dystroglycan binding [GO:0002162]; transferase activity [GO:0016740]; glycoprotein biosynthetic process [GO:0009101]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]
PGEN_.00g191940	Scaffold_09	2395065	2395613	NA	NA	NA	NA	NA
PGEN_.00g191950	Scaffold_09	2396089	2396664	NA	NA	NA	NA	NA
PGEN_.00g191960	Scaffold_09	2401685	2441282	Q16959	DYI2_HELCR	"Dynein intermediate chain 2, ciliary"	GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]
PGEN_.00g191970	Scaffold_09	2441798	2446632	NA	NA	NA	NA	NA
PGEN_.00g191980	Scaffold_09	2473187	2481355	NA	NA	NA	NA	NA
PGEN_.00g191990	Scaffold_09	2481397	2498303	NA	NA	NA	NA	NA
PGEN_.00g192000	Scaffold_09	2498415	2499453	NA	NA	NA	NA	NA
PGEN_.00g192010	Scaffold_09	2506834	2519746	Q91WA1	TIPIN_MOUSE	TIMELESS-interacting protein	GO:0000076; GO:0000077; GO:0000790; GO:0003677; GO:0005634; GO:0005737; GO:0008284; GO:0009411; GO:0031298; GO:0031573; GO:0043111; GO:0044770; GO:0048478; GO:0051301	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA damage checkpoint [GO:0000077]; DNA replication checkpoint [GO:0000076]; intra-S DNA damage checkpoint [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; response to UV [GO:0009411]
PGEN_.00g192020	Scaffold_09	2525649	2531757	Q9Y6G5	COMDA_HUMAN	COMM domain-containing protein 10	GO:0005654; GO:0005737	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]
PGEN_.00g192030	Scaffold_09	2537444	2546047	Q6PUR6	GPN2_DANRE	GPN-loop GTPase 2 (ATP-binding domain 1 family member B)	GO:0003924; GO:0005525	GTP binding [GO:0005525]; GTPase activity [GO:0003924]
PGEN_.00g192040	Scaffold_09	2554476	2554766	NA	NA	NA	NA	NA
PGEN_.00g192050	Scaffold_09	2555734	2556534	NA	NA	NA	NA	NA
PGEN_.00g192060	Scaffold_09	2573274	2584838	NA	NA	NA	NA	NA
PGEN_.00g192070	Scaffold_09	2584966	2598546	NA	NA	NA	NA	NA
PGEN_.00g192080	Scaffold_09	2602569	2612130	Q5ZM57	HACD3_CHICK	Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase) (HACD) (Protein-tyrosine phosphatase-like A domain-containing protein 1)	GO:0005783; GO:0007249; GO:0007254; GO:0007266; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:0102343; GO:0102344; GO:0102345	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]
PGEN_.00g192090	Scaffold_09	2612455	2618652	Q8K2C9	HACD3_MOUSE	Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1)	GO:0005783; GO:0007249; GO:0007254; GO:0007266; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:0102343; GO:0102344; GO:0102345	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]
PGEN_.00g192100	Scaffold_09	2626259	2641580	NA	NA	NA	NA	NA
PGEN_.00g192110	Scaffold_09	2641655	2670923	Q864S8	BRCA2_FELCA	Breast cancer type 2 susceptibility protein homolog (Fanconi anemia group D1 protein homolog)	GO:0000724; GO:0003677; GO:0005634; GO:0005813; GO:0006289; GO:0006302; GO:0030141; GO:0032991; GO:0033593; GO:0033600; GO:0043015; GO:0045893; GO:0051298	"BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; centrosome duplication [GO:0051298]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g192120	Scaffold_09	2676220	2689005	Q9WTY1	PDCD7_MOUSE	Programmed cell death protein 7 (ES18)	GO:0005689; GO:0006915; GO:0051384; GO:0070234; GO:2001235	U12-type spliceosomal complex [GO:0005689]; apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of T cell apoptotic process [GO:0070234]; response to glucocorticoid [GO:0051384]
PGEN_.00g192130	Scaffold_09	2696307	2705342	NA	NA	NA	NA	NA
PGEN_.00g192140	Scaffold_09	2717886	2720477	NA	NA	NA	NA	NA
PGEN_.00g192150	Scaffold_09	2721773	2722141	NA	NA	NA	NA	NA
PGEN_.00g192160	Scaffold_09	2730186	2734034	NA	NA	NA	NA	NA
PGEN_.00g192170	Scaffold_09	2742702	2743890	NA	NA	NA	NA	NA
PGEN_.00g192180	Scaffold_09	2749757	2750482	NA	NA	NA	NA	NA
PGEN_.00g192190	Scaffold_09	2772171	2773697	NA	NA	NA	NA	NA
PGEN_.00g192200	Scaffold_09	2774862	2784531	Q5ZK63	TCP4_CHICK	Activated RNA polymerase II transcriptional coactivator p15 (SUB1 homolog)	GO:0003677; GO:0003713; GO:0005634; GO:0005667; GO:0060261	nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]
PGEN_.00g192210	Scaffold_09	2788676	2789122	NA	NA	NA	NA	NA
PGEN_.00g192220	Scaffold_09	2791678	2792586	NA	NA	NA	NA	NA
PGEN_.00g192230	Scaffold_09	2793874	2794272	NA	NA	NA	NA	NA
PGEN_.00g192240	Scaffold_09	2804534	2806920	Q923X4	GLRX2_MOUSE	"Glutaredoxin-2, mitochondrial"	GO:0005623; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0009055; GO:0010033; GO:0015035; GO:0030425; GO:0042542; GO:0043025; GO:0043231; GO:0045454; GO:0046872; GO:0051537	"cell [GO:0005623]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]"
PGEN_.00g192250	Scaffold_09	2808710	2809604	Q9UTI2	GLRX2_SCHPO	Glutaredoxin-2	GO:0004362; GO:0004602; GO:0005623; GO:0005634; GO:0005739; GO:0009055; GO:0015035; GO:0015038; GO:0019430; GO:0034599; GO:0045454	cell [GO:0005623]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; glutathione peroxidase activity [GO:0004602]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; removal of superoxide radicals [GO:0019430]
PGEN_.00g192260	Scaffold_09	2820643	2934300	Q8TDJ6	DMXL2_HUMAN	DmX-like protein 2 (Rabconnectin-3)	GO:0005615; GO:0005623; GO:0007035; GO:0008021; GO:0017137; GO:0030054; GO:0030672; GO:0043291	cell [GO:0005623]; cell junction [GO:0030054]; extracellular space [GO:0005615]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; Rab GTPase binding [GO:0017137]; vacuolar acidification [GO:0007035]
PGEN_.00g192270	Scaffold_09	2956130	2956390	NA	NA	NA	NA	NA
PGEN_.00g192280	Scaffold_09	2958261	2969813	O14975	S27A2_HUMAN	"Very long-chain acyl-CoA synthetase (VLACS) (VLCS) (EC 6.2.1.-) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Phytanate--CoA ligase) (EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase) (EC 6.2.1.7) (Very long-chain-fatty-acid-CoA ligase)"	GO:0001561; GO:0001676; GO:0003996; GO:0004467; GO:0005324; GO:0005524; GO:0005778; GO:0005779; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006625; GO:0006635; GO:0006699; GO:0015245; GO:0019899; GO:0030176; GO:0031957; GO:0035579; GO:0042760; GO:0043312; GO:0044539; GO:0047676; GO:0047747; GO:0050197; GO:0070062; GO:0070251; GO:0097089; GO:0102391	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; decanoate-CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid catabolic process [GO:0042760]
PGEN_.00g192290	Scaffold_09	2981978	2996893	NA	NA	NA	NA	NA
PGEN_.00g192300	Scaffold_09	3024856	3097422	Q5TYW4	NBAS_DANRE	Neuroblastoma-amplified sequence (Neuroblastoma-amplified gene protein homolog)	GO:0000184; GO:0000956; GO:0005783; GO:0006890; GO:0015031; GO:0043009; GO:2000623	"endoplasmic reticulum [GO:0005783]; chordate embryonic development [GO:0043009]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g192310	Scaffold_09	3133721	3147837	A2RRP1	NBAS_HUMAN	Neuroblastoma-amplified sequence (Neuroblastoma-amplified gene protein)	GO:0000149; GO:0000956; GO:0005783; GO:0005789; GO:0005829; GO:0006890; GO:0015031; GO:0016020; GO:0070939; GO:2000623	"cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; SNARE binding [GO:0000149]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g192320	Scaffold_09	3160735	3171941	Q5BL38	CEGT_XENTR	Ceramide glucosyltransferase (EC 2.4.1.80) (UDP-glucose ceramide glucosyltransferase)	GO:0000139; GO:0005794; GO:0006679; GO:0007275; GO:0008120; GO:0016021; GO:0046479; GO:0102769	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ceramide glucosyltransferase activity [GO:0008120]; dihydroceramide glucosyltransferase activity [GO:0102769]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid catabolic process [GO:0046479]; multicellular organism development [GO:0007275]
PGEN_.00g192330	Scaffold_09	3211514	3211771	NA	NA	NA	NA	NA
PGEN_.00g192340	Scaffold_09	3211818	3217332	P58727	TLR4_FELCA	Toll-like receptor 4 (CD antigen CD284)	GO:0001530; GO:0001726; GO:0001875; GO:0002224; GO:0005769; GO:0005887; GO:0006954; GO:0032497; GO:0042116; GO:0045087; GO:0046696; GO:0050702; GO:0050829; GO:1900227	early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; lipopolysaccharide receptor complex [GO:0046696]; ruffle [GO:0001726]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; defense response to Gram-negative bacterium [GO:0050829]; detection of lipopolysaccharide [GO:0032497]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; macrophage activation [GO:0042116]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g192350	Scaffold_09	3223134	3223571	NA	NA	NA	NA	NA
PGEN_.00g192360	Scaffold_09	3223735	3224702	NA	NA	NA	NA	NA
PGEN_.00g192370	Scaffold_09	3230347	3238628	Q501Z5	GTPB3_DANRE	"tRNA modification GTPase GTPBP3, mitochondrial (GTP-binding protein 3)"	GO:0002098; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0030488; GO:0048568	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; embryonic organ development [GO:0048568]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g192380	Scaffold_09	3240252	3245894	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g192390	Scaffold_09	3246272	3254071	Q4FNR7	MNME_PELUB	tRNA modification GTPase MnmE (EC 3.6.-.-)	GO:0003924; GO:0005525; GO:0005737; GO:0006400; GO:0046872	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; tRNA modification [GO:0006400]
PGEN_.00g192400	Scaffold_09	3256988	3259247	NA	NA	NA	NA	NA
PGEN_.00g192410	Scaffold_09	3257007	3263981	NA	NA	NA	NA	NA
PGEN_.00g192420	Scaffold_09	3290367	3297514	NA	NA	NA	NA	NA
PGEN_.00g192430	Scaffold_09	3302536	3306502	O18920	ANGP1_BOVIN	Angiopoietin-1 (ANG-1)	GO:0001701; GO:0001933; GO:0002040; GO:0002092; GO:0002740; GO:0005615; GO:0005886; GO:0005902; GO:0007162; GO:0007171; GO:0014068; GO:0014842; GO:0030097; GO:0030154; GO:0030210; GO:0030971; GO:0031398; GO:0031589; GO:0032680; GO:0033138; GO:0034394; GO:0042308; GO:0043116; GO:0043122; GO:0043393; GO:0043524; GO:0043536; GO:0045121; GO:0045785; GO:0048014; GO:0050731; GO:0050918; GO:0051897; GO:0070374; GO:0072012; GO:2000352; GO:2000446	extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor tyrosine kinase binding [GO:0030971]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine secretion involved in immune response [GO:0002740]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; positive chemotaxis [GO:0050918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014]
PGEN_.00g192440	Scaffold_09	3314008	3352505	P31596	EAA2_RAT	Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (GLUT-R) (Solute carrier family 1 member 2)	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006836; GO:0007399; GO:0007632; GO:0008509; GO:0009416; GO:0009611; GO:0009986; GO:0010259; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0042493; GO:0042734; GO:0043005; GO:0043197; GO:0043198; GO:0043200; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070779; GO:0098656; GO:0098712; GO:0098810; GO:0098978; GO:0099056	axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]
PGEN_.00g192450	Scaffold_09	3424138	3440331	Q9NWW6	NRK1_HUMAN	Nicotinamide riboside kinase 1 (NRK 1) (NmR-K 1) (EC 2.7.1.22) (Nicotinic acid riboside kinase 1) (EC 2.7.1.173) (Ribosylnicotinamide kinase 1) (RNK 1) (Ribosylnicotinic acid kinase 1)	GO:0005524; GO:0005829; GO:0009435; GO:0016301; GO:0019674; GO:0046872; GO:0050262; GO:0061769	cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; ribosylnicotinamide kinase activity [GO:0050262]; ribosylnicotinate kinase activity [GO:0061769]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]
PGEN_.00g192460	Scaffold_09	3506042	3506413	NA	NA	NA	NA	NA
PGEN_.00g192470	Scaffold_09	3635185	3640297	NA	NA	NA	NA	NA
PGEN_.00g192480	Scaffold_09	3645374	3652122	Q8BGC3	MOT12_MOUSE	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g192490	Scaffold_09	3659987	3661075	Q99P50	GHSR_MOUSE	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032869; GO:0036321; GO:0040018; GO:0042536; GO:0042562; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045409; GO:0045923; GO:0045927; GO:0046676; GO:0046697; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060259; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0099699; GO:0120058; GO:1903672; GO:1904000; GO:1904008; GO:1904349; GO:1904468; GO:1905333; GO:1905564; GO:1990314; GO:2000110	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; hormone binding [GO:0042562]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; negative regulation of tumor necrosis factor secretion [GO:1904468]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of growth [GO:0045927]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of feeding behavior [GO:0060259]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]
PGEN_.00g192500	Scaffold_09	3666954	3668225	NA	NA	NA	NA	NA
PGEN_.00g192510	Scaffold_09	3682056	3683234	NA	NA	NA	NA	NA
PGEN_.00g192520	Scaffold_09	3709945	3715973	P27088	XPA_XENLA	DNA repair protein complementing XP-A cells homolog (Xeroderma pigmentosum group A-complementing protein homolog)	GO:0000715; GO:0003684; GO:0003690; GO:0005634; GO:0005662; GO:0006289; GO:0008270; GO:0070914; GO:1990391	"DNA repair complex [GO:1990391]; DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; UV-damage excision repair [GO:0070914]"
PGEN_.00g192530	Scaffold_09	3719407	3719724	NA	NA	NA	NA	NA
PGEN_.00g192540	Scaffold_09	3721099	3731684	Q68EY7	C124A_XENLA	Coiled-coil domain-containing protein 124-A	GO:0005737; GO:0005815; GO:0007049; GO:0030496; GO:0051301	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g192550	Scaffold_09	3745338	3759362	Q66IF1	REEP6_DANRE	Receptor expression-enhancing protein 6	GO:0005789; GO:0010842; GO:0016021; GO:0030665; GO:0060059	clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; retina layer formation [GO:0010842]
PGEN_.00g192560	Scaffold_09	3779820	3780602	NA	NA	NA	NA	NA
PGEN_.00g192570	Scaffold_09	3781200	3781826	NA	NA	NA	NA	NA
PGEN_.00g192580	Scaffold_09	3781889	3793910	NA	NA	NA	NA	NA
PGEN_.00g192590	Scaffold_09	3794049	3794471	NA	NA	NA	NA	NA
PGEN_.00g192600	Scaffold_09	3794615	3794842	NA	NA	NA	NA	NA
PGEN_.00g192610	Scaffold_09	3795033	3805193	Q5IZC5	CRY1_ERIRU	Cryptochrome-1	GO:0000166; GO:0003677; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0042622; GO:0045721; GO:0097381	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]
PGEN_.00g192620	Scaffold_09	3860325	3869202	NA	NA	NA	NA	NA
PGEN_.00g192630	Scaffold_09	3869236	3870561	NA	NA	NA	NA	NA
PGEN_.00g192640	Scaffold_09	3882559	3889574	NA	NA	NA	NA	NA
PGEN_.00g192650	Scaffold_09	3908433	3917708	NA	NA	NA	NA	NA
PGEN_.00g192660	Scaffold_09	3922545	3922916	NA	NA	NA	NA	NA
PGEN_.00g192670	Scaffold_09	3927333	3933785	NA	NA	NA	NA	NA
PGEN_.00g192680	Scaffold_09	3939199	3945720	NA	NA	NA	NA	NA
PGEN_.00g192690	Scaffold_09	3945761	3961209	NA	NA	NA	NA	NA
PGEN_.00g192700	Scaffold_09	3974151	3984384	NA	NA	NA	NA	NA
PGEN_.00g192710	Scaffold_09	3985824	3995920	NA	NA	NA	NA	NA
PGEN_.00g192720	Scaffold_09	3999859	4012420	NA	NA	NA	NA	NA
PGEN_.00g192730	Scaffold_09	4015416	4018796	NA	NA	NA	NA	NA
PGEN_.00g192740	Scaffold_09	4018942	4020589	P34456	YMD2_CAEEL	Uncharacterized protein F54H12.2	GO:0004748; GO:0005829; GO:0009263	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]"
PGEN_.00g192750	Scaffold_09	4022072	4022410	O08863	BIRC3_MOUSE	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 2) (C-IAP2) (Inhibitor of apoptosis protein 1) (mIAP1) (RING-type E3 ubiquitin transferase BIRC3)	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016740; GO:0031398; GO:0032991; GO:0042326; GO:0042981; GO:0043027; GO:0043154; GO:0044877; GO:0045121; GO:0046872; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0071356; GO:1901222; GO:1902916; GO:1990001; GO:2000378	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to tumor necrosis factor [GO:0071356]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; necroptotic process [GO:0070266]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of phosphorylation [GO:0042326]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]
PGEN_.00g192760	Scaffold_09	4024192	4060681	Q96L92	SNX27_HUMAN	Sorting nexin-27	GO:0001770; GO:0001772; GO:0005654; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0008333; GO:0016197; GO:0031901; GO:0032266; GO:0035091; GO:1990126	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; establishment of natural killer cell polarity [GO:0001770]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"
PGEN_.00g192770	Scaffold_09	4078761	4088956	Q3UHD6	SNX27_MOUSE	Sorting nexin-27	GO:0001772; GO:0005654; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0007165; GO:0008333; GO:0014069; GO:0016197; GO:0030904; GO:0031901; GO:0032266; GO:0035091; GO:0035255; GO:0061951; GO:0071203; GO:0099638; GO:1903609; GO:1904719; GO:1990126	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; retromer complex [GO:0030904]; WASH complex [GO:0071203]; ionotropic glutamate receptor binding [GO:0035255]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; endosome to plasma membrane protein transport [GO:0099638]; establishment of protein localization to plasma membrane [GO:0061951]; intracellular protein transport [GO:0006886]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"
PGEN_.00g192780	Scaffold_09	4115782	4129189	Q5RE18	SMN_PONAB	Survival motor neuron protein	GO:0000387; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006353; GO:0007399; GO:0015030; GO:0030018; GO:0030424; GO:0032797; GO:0034719; GO:0036464; GO:0043005; GO:0043204; GO:0097504	"axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; Z disc [GO:0030018]; RNA binding [GO:0003723]; DNA-templated transcription, termination [GO:0006353]; nervous system development [GO:0007399]; spliceosomal snRNP assembly [GO:0000387]"
PGEN_.00g192790	Scaffold_09	4129415	4139868	Q15937	ZNF79_HUMAN	Zinc finger protein 79 (ZNFpT7)	GO:0003700; GO:0005634; GO:0043565; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]
PGEN_.00g192800	Scaffold_09	4156311	4166102	NA	NA	NA	NA	NA
PGEN_.00g192810	Scaffold_09	4171634	4175854	NA	NA	NA	NA	NA
PGEN_.00g192820	Scaffold_09	4184014	4204805	Q9NXG0	CNTLN_HUMAN	Centlein (Centrosomal protein)	GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0033365; GO:0070062	"centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365]"
PGEN_.00g192830	Scaffold_09	4204967	4208395	NA	NA	NA	NA	NA
PGEN_.00g192840	Scaffold_09	4254247	4275017	Q9NXG0	CNTLN_HUMAN	Centlein (Centrosomal protein)	GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0033365; GO:0070062	"centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365]"
PGEN_.00g192850	Scaffold_09	4321108	4325740	NA	NA	NA	NA	NA
PGEN_.00g192860	Scaffold_09	4356462	4364977	NA	NA	NA	NA	NA
PGEN_.00g192870	Scaffold_09	4389947	4402767	Q6ZN30	BNC2_HUMAN	Zinc finger protein basonuclin-2	GO:0003416; GO:0003677; GO:0005654; GO:0043586; GO:0046872; GO:0060021; GO:0060485	nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; roof of mouth development [GO:0060021]; tongue development [GO:0043586]
PGEN_.00g192880	Scaffold_09	4421949	4476323	Q8T5G8	CHS_MELAT	Chitin synthase (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase)	GO:0004100; GO:0005886; GO:0009792; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; embryo development ending in birth or egg hatching [GO:0009792]
PGEN_.00g192890	Scaffold_09	4480503	4491014	Q8WXR4	MYO3B_HUMAN	Myosin-IIIb (EC 2.7.11.1)	GO:0003774; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0032426; GO:0050896; GO:0090103	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g192900	Scaffold_09	4499984	4528743	B6CHA3	UHRF1_XENLA	E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (Nuclear zinc finger protein Np95) (XNp95) (RING-type E3 ubiquitin transferase UHRF1) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (Ubiquitin-like-containing PHD and RING finger domains protein 1)	GO:0000122; GO:0000790; GO:0000791; GO:0000792; GO:0004842; GO:0005657; GO:0006511; GO:0007049; GO:0008270; GO:0010216; GO:0016574; GO:0035064; GO:0042393; GO:0044729; GO:0051865	euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; replication fork [GO:0005657]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g192910	Scaffold_09	4535554	4541696	O60140	YNS9_SCHPO	Uncharacterized protein C18H10.09	GO:0005737; GO:0008270	cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]
PGEN_.00g192920	Scaffold_09	4589838	4590203	P49894	IOD1_CANLF	Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)	GO:0004800; GO:0005789; GO:0016021; GO:0042403; GO:0042446	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]
PGEN_.00g192930	Scaffold_09	4591227	4597026	NA	NA	NA	NA	NA
PGEN_.00g192940	Scaffold_09	4602064	4608046	NA	NA	NA	NA	NA
PGEN_.00g192950	Scaffold_09	4617498	4618970	NA	NA	NA	NA	NA
PGEN_.00g192960	Scaffold_09	4641173	4641622	Q9Z2Q2	KNOP1_MOUSE	Lysine-rich nucleolar protein 1 (Testis-specific gene 118 protein)	GO:0005730	nucleolus [GO:0005730]
PGEN_.00g192970	Scaffold_09	4666918	4670491	NA	NA	NA	NA	NA
PGEN_.00g192980	Scaffold_09	4762286	4765533	Q619W7	HEXA_CAEBR	Beta-hexosaminidase A (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (N-acetyl-beta-glucosaminidase)	GO:0004563; GO:0005764; GO:0005975; GO:0102148	lysosome [GO:0005764]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g192990	Scaffold_09	4787077	4800924	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g193000	Scaffold_09	4801839	4802375	NA	NA	NA	NA	NA
PGEN_.00g193010	Scaffold_09	4847684	4864676	Q3UTY6	THSD4_MOUSE	Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4)	GO:0001527; GO:0008233; GO:0031012; GO:0048251	extracellular matrix [GO:0031012]; microfibril [GO:0001527]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251]
PGEN_.00g193020	Scaffold_09	4873793	4909667	Q80TA6	MTMRC_MOUSE	Myotubularin-related protein 12 (Inactive phosphatidylinositol 3-phosphatase 12)	GO:0005737; GO:0016529; GO:0019208; GO:0030017; GO:1901998	cytoplasm [GO:0005737]; sarcomere [GO:0030017]; sarcoplasmic reticulum [GO:0016529]; phosphatase regulator activity [GO:0019208]; toxin transport [GO:1901998]
PGEN_.00g193030	Scaffold_09	4924886	4945817	O95847	UCP4_HUMAN	Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27)	GO:0005623; GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0016021; GO:0031966; GO:0035356; GO:0043025; GO:0043066; GO:0045177; GO:0046324; GO:0048839; GO:0051562; GO:0070997; GO:1902600	apical part of cell [GO:0045177]; cell [GO:0005623]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; cellular triglyceride homeostasis [GO:0035356]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; neuron death [GO:0070997]; positive regulation of cell population proliferation [GO:0008284]; proton transmembrane transport [GO:1902600]; regulation of glucose import [GO:0046324]; response to cold [GO:0009409]
PGEN_.00g193040	Scaffold_09	4955077	4962832	P15870	H1D_STRPU	Histone H1-delta	GO:0000786; GO:0003690; GO:0005634; GO:0006334; GO:0006355; GO:0016584; GO:0030261; GO:0031492; GO:0031936; GO:0045910	"nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g193050	Scaffold_09	4963942	4965033	NA	NA	NA	NA	NA
PGEN_.00g193060	Scaffold_09	4987164	4994436	Q9XSL6	ADA28_MACFA	"Disintegrin and metalloproteinase domain-containing protein 28 (ADAM 28) (EC 3.4.24.-) (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II) (eMDC II)"	GO:0004222; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]
PGEN_.00g193070	Scaffold_09	5016898	5017164	NA	NA	NA	NA	NA
PGEN_.00g193080	Scaffold_09	5017332	5050834	Q9UKP4	ATS7_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) (COMPase)	GO:0004222; GO:0005576; GO:0005788; GO:0008237; GO:0009986; GO:0032331; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of chondrocyte differentiation [GO:0032331]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g193090	Scaffold_09	5053414	5068118	Q68SA9	ATS7_MOUSE	A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) (COMPase)	GO:0004222; GO:0005615; GO:0006508; GO:0008237; GO:0009986; GO:0032331; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773	cell surface [GO:0009986]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of chondrocyte differentiation [GO:0032331]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g193100	Scaffold_09	5070143	5095799	Q8CH02	SUGP1_MOUSE	SURP and G-patch domain-containing protein 1 (Splicing factor 4)	GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g193110	Scaffold_09	5097498	5122897	Q8CH02	SUGP1_MOUSE	SURP and G-patch domain-containing protein 1 (Splicing factor 4)	GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g193120	Scaffold_09	5124892	5206554	Q9UKP4	ATS7_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) (COMPase)	GO:0004222; GO:0005576; GO:0005788; GO:0008237; GO:0009986; GO:0032331; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of chondrocyte differentiation [GO:0032331]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g193130	Scaffold_09	5320293	5321734	NA	NA	NA	NA	NA
PGEN_.00g193140	Scaffold_09	5329626	5339597	NA	NA	NA	NA	NA
PGEN_.00g193150	Scaffold_09	5342586	5350688	NA	NA	NA	NA	NA
PGEN_.00g193160	Scaffold_09	5372336	5377989	NA	NA	NA	NA	NA
PGEN_.00g193170	Scaffold_09	5388775	5433445	Q9PTS8	ACHA9_CHICK	Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9)	GO:0004888; GO:0005262; GO:0005623; GO:0005887; GO:0005892; GO:0007165; GO:0007204; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0042472; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0050910	acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g193180	Scaffold_09	5437658	5485549	P02640	VILI_CHICK	Villin-1	GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008360; GO:0009617; GO:0010634; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392	"actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]"
PGEN_.00g193190	Scaffold_09	5531573	5532382	NA	NA	NA	NA	NA
PGEN_.00g193200	Scaffold_09	5533150	5533380	NA	NA	NA	NA	NA
PGEN_.00g193210	Scaffold_09	5559892	5560134	NA	NA	NA	NA	NA
PGEN_.00g193220	Scaffold_09	5560295	5560828	NA	NA	NA	NA	NA
PGEN_.00g193230	Scaffold_09	5560854	5561099	NA	NA	NA	NA	NA
PGEN_.00g193240	Scaffold_09	5561481	5562515	NA	NA	NA	NA	NA
PGEN_.00g193250	Scaffold_09	5563351	5582691	O94779	CNTN5_HUMAN	Contactin-5 (Neural recognition molecule NB-2) (hNB-2)	GO:0005576; GO:0005886; GO:0007155; GO:0007605; GO:0098982; GO:0099026; GO:0099054	anchored component of presynaptic membrane [GO:0099026]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; presynapse assembly [GO:0099054]; sensory perception of sound [GO:0007605]
PGEN_.00g193260	Scaffold_09	5596058	5614898	NA	NA	NA	NA	NA
PGEN_.00g193270	Scaffold_09	5640500	5641664	NA	NA	NA	NA	NA
PGEN_.00g193280	Scaffold_09	5673608	5675821	NA	NA	NA	NA	NA
PGEN_.00g193290	Scaffold_09	5738096	5740300	NA	NA	NA	NA	NA
PGEN_.00g193300	Scaffold_09	5882171	5882404	NA	NA	NA	NA	NA
PGEN_.00g193310	Scaffold_09	5894591	5895412	NA	NA	NA	NA	NA
PGEN_.00g193320	Scaffold_09	5895445	5896101	NA	NA	NA	NA	NA
PGEN_.00g193330	Scaffold_09	6035605	6035859	NA	NA	NA	NA	NA
PGEN_.00g193340	Scaffold_09	6035903	6036427	NA	NA	NA	NA	NA
PGEN_.00g193350	Scaffold_09	6046177	6055975	NA	NA	NA	NA	NA
PGEN_.00g193360	Scaffold_09	6084486	6084977	NA	NA	NA	NA	NA
PGEN_.00g193370	Scaffold_09	6085156	6086139	NA	NA	NA	NA	NA
PGEN_.00g193380	Scaffold_09	6086468	6086881	NA	NA	NA	NA	NA
PGEN_.00g193390	Scaffold_09	6147629	6167037	NA	NA	NA	NA	NA
PGEN_.00g193400	Scaffold_09	6171295	6172044	NA	NA	NA	NA	NA
PGEN_.00g193410	Scaffold_09	6237559	6237843	NA	NA	NA	NA	NA
PGEN_.00g193420	Scaffold_09	6336950	6337267	P28818	RGRF1_RAT	Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (P140 Ras-GRF)	GO:0001975; GO:0005088; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0008022; GO:0008283; GO:0016323; GO:0016327; GO:0017016; GO:0019901; GO:0030426; GO:0030971; GO:0031175; GO:0032869; GO:0034976; GO:0035020; GO:0035023; GO:0035254; GO:0043025; GO:0043547; GO:0046578; GO:0046579; GO:0048146; GO:0048167; GO:0048168; GO:0071236; GO:0090630; GO:0097440; GO:2000310	apical dendrite [GO:0097440]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; glutamate receptor binding [GO:0035254]; GTPase activator activity [GO:0005096]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; receptor tyrosine kinase binding [GO:0030971]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; cellular response to antibiotic [GO:0071236]; cellular response to insulin stimulus [GO:0032869]; neuron projection development [GO:0031175]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to amphetamine [GO:0001975]; response to endoplasmic reticulum stress [GO:0034976]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g193430	Scaffold_09	6416462	6416815	NA	NA	NA	NA	NA
PGEN_.00g193440	Scaffold_09	6463802	6472738	A2CEA7	RGRF2_DANRE	Ras-specific guanine nucleotide-releasing factor 2 (Ras-GRF2) (Ras guanine nucleotide exchange factor 2)	GO:0005085; GO:0005516; GO:0005789; GO:0005886; GO:0007264	endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g193450	Scaffold_09	6492320	6501189	Q13972	RGRF1_HUMAN	Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25)	GO:0000165; GO:0005085; GO:0005088; GO:0005829; GO:0005886; GO:0007165; GO:0007264; GO:0007616; GO:0008283; GO:0030426; GO:0031175; GO:0034976; GO:0035020; GO:0035023; GO:0035254; GO:0043005; GO:0043547; GO:0046578; GO:0046579; GO:0048167; GO:0048168; GO:0090630; GO:2000310	cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g193460	Scaffold_09	6506397	6521812	Q13972	RGRF1_HUMAN	Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25)	GO:0000165; GO:0005085; GO:0005088; GO:0005829; GO:0005886; GO:0007165; GO:0007264; GO:0007616; GO:0008283; GO:0030426; GO:0031175; GO:0034976; GO:0035020; GO:0035023; GO:0035254; GO:0043005; GO:0043547; GO:0046578; GO:0046579; GO:0048167; GO:0048168; GO:0090630; GO:2000310	cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g193470	Scaffold_09	6522301	6539117	P28818	RGRF1_RAT	Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (P140 Ras-GRF)	GO:0001975; GO:0005088; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0008022; GO:0008283; GO:0016323; GO:0016327; GO:0017016; GO:0019901; GO:0030426; GO:0030971; GO:0031175; GO:0032869; GO:0034976; GO:0035020; GO:0035023; GO:0035254; GO:0043025; GO:0043547; GO:0046578; GO:0046579; GO:0048146; GO:0048167; GO:0048168; GO:0071236; GO:0090630; GO:0097440; GO:2000310	apical dendrite [GO:0097440]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; glutamate receptor binding [GO:0035254]; GTPase activator activity [GO:0005096]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; receptor tyrosine kinase binding [GO:0030971]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; cellular response to antibiotic [GO:0071236]; cellular response to insulin stimulus [GO:0032869]; neuron projection development [GO:0031175]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to amphetamine [GO:0001975]; response to endoplasmic reticulum stress [GO:0034976]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g193480	Scaffold_09	6559298	6571920	Q9CQS4	S2546_MOUSE	Solute carrier family 25 member 46	GO:0005739; GO:0005741; GO:0007005; GO:0007416; GO:0016021; GO:0016358; GO:0090149	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; dendrite development [GO:0016358]; mitochondrial membrane fission [GO:0090149]; mitochondrion organization [GO:0007005]; synapse assembly [GO:0007416]
PGEN_.00g193490	Scaffold_09	6572095	6587043	P0DMQ6	DHSO_CHICK	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase)	GO:0003939; GO:0006000; GO:0006061; GO:0006062; GO:0006116; GO:0006735; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0032991; GO:0042802; GO:0046370; GO:0051160; GO:0051287; GO:0070062	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]
PGEN_.00g193500	Scaffold_09	6590798	6591385	NA	NA	NA	NA	NA
PGEN_.00g193510	Scaffold_09	6604058	6640473	Q05187	TGMH_TACTR	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)	GO:0003810; GO:0016020; GO:0018149; GO:0046872	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]
PGEN_.00g193520	Scaffold_09	6640641	6668036	Q05187	TGMH_TACTR	Hemocyte protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) (Hemocyte transglutaminase) (TGase)	GO:0003810; GO:0016020; GO:0018149; GO:0046872	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]
PGEN_.00g193530	Scaffold_09	6678979	6679278	NA	NA	NA	NA	NA
PGEN_.00g193540	Scaffold_09	6679440	6682589	NA	NA	NA	NA	NA
PGEN_.00g193550	Scaffold_09	6700637	6701146	NA	NA	NA	NA	NA
PGEN_.00g193560	Scaffold_09	6704870	6709132	NA	NA	NA	NA	NA
PGEN_.00g193570	Scaffold_09	6723787	6724917	Q9GZQ4	NMUR2_HUMAN	Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1)	GO:0001607; GO:0002023; GO:0004930; GO:0005229; GO:0005525; GO:0005623; GO:0005886; GO:0006816; GO:0006940; GO:0007186; GO:0007200; GO:0007204; GO:0007218; GO:0007267; GO:0007417; GO:0007625; GO:0007631; GO:0016021; GO:0019722; GO:0042924; GO:0043006; GO:0048016; GO:0048265; GO:0050482; GO:0051930	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; regulation of smooth muscle contraction [GO:0006940]; response to pain [GO:0048265]
PGEN_.00g193580	Scaffold_09	6755290	6760729	NA	NA	NA	NA	NA
PGEN_.00g193590	Scaffold_09	6762215	6762706	NA	NA	NA	NA	NA
PGEN_.00g193600	Scaffold_09	6828107	6836835	NA	NA	NA	NA	NA
PGEN_.00g193610	Scaffold_09	6911923	6917957	Q9BMX5	RS6_APLCA	40S ribosomal protein S6	GO:0003735; GO:0005840; GO:0006412	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g193620	Scaffold_09	6923652	6930499	NA	NA	NA	NA	NA
PGEN_.00g193630	Scaffold_09	6937841	6961006	NA	NA	NA	NA	NA
PGEN_.00g193640	Scaffold_09	6970892	6979034	Q6UVK1	CSPG4_HUMAN	Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan)	GO:0000187; GO:0001525; GO:0005576; GO:0005654; GO:0005796; GO:0005886; GO:0005887; GO:0005925; GO:0007169; GO:0008283; GO:0008347; GO:0009986; GO:0016324; GO:0019901; GO:0030206; GO:0030207; GO:0030208; GO:0031258; GO:0035556; GO:0043202; GO:0048771; GO:0050731; GO:0062023; GO:0070062	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; lysosomal lumen [GO:0043202]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; activation of MAPK activity [GO:0000187]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; glial cell migration [GO:0008347]; intracellular signal transduction [GO:0035556]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; tissue remodeling [GO:0048771]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g193650	Scaffold_09	7028665	7040648	D3IUT5	TICRR_XENLA	"Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)"	GO:0005634; GO:0006260; GO:0006281; GO:0010212; GO:0033314	nucleus [GO:0005634]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint [GO:0033314]; response to ionizing radiation [GO:0010212]
PGEN_.00g193660	Scaffold_09	7048377	7064109	NA	NA	NA	NA	NA
PGEN_.00g193670	Scaffold_09	7067904	7078330	NA	NA	NA	NA	NA
PGEN_.00g193680	Scaffold_09	7086149	7104016	NA	NA	NA	NA	NA
PGEN_.00g193690	Scaffold_09	7111373	7113589	NA	NA	NA	NA	NA
PGEN_.00g193700	Scaffold_09	7119401	7121152	Q6ZNA1	ZN836_HUMAN	Zinc finger protein 836	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g193710	Scaffold_09	7121483	7128136	NA	NA	NA	NA	NA
PGEN_.00g193720	Scaffold_09	7131148	7140609	Q9R194	CRY2_MOUSE	Cryptochrome-2	GO:0000122; GO:0000976; GO:0003677; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006606; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0016607; GO:0018298; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0032515; GO:0032868; GO:0032922; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949; GO:2000323; GO:2000850	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein import into nucleus [GO:0006606]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"
PGEN_.00g193730	Scaffold_09	7195292	7197172	NA	NA	NA	NA	NA
PGEN_.00g193740	Scaffold_09	7207234	7210719	Q4VBS4	MAP12_DANRE	"Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D)"	GO:0005739; GO:0046872; GO:0070006; GO:0070084	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]
PGEN_.00g193750	Scaffold_09	7295316	7296764	NA	NA	NA	NA	NA
PGEN_.00g193760	Scaffold_09	7330982	7424771	Q495B1	AKD1A_HUMAN	Ankyrin repeat and death domain-containing protein 1A	GO:0007165	signal transduction [GO:0007165]
PGEN_.00g193770	Scaffold_09	7430058	7436510	NA	NA	NA	NA	NA
PGEN_.00g193780	Scaffold_09	7442843	7443424	NA	NA	NA	NA	NA
PGEN_.00g193790	Scaffold_09	7469143	7473489	Q9QZR8	PDZD2_RAT	PDZ domain-containing protein 2 (PDZ domain-containing protein 3) (Plakophilin-related armadillo repeat protein-interacting PDZ protein) [Cleaved into: Processed PDZ domain-containing protein 2]	GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005911; GO:0007155; GO:0014069; GO:0035556; GO:0043005; GO:0045177	apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]
PGEN_.00g193800	Scaffold_09	7541457	7547844	NA	NA	NA	NA	NA
PGEN_.00g193810	Scaffold_09	7558496	7559074	A8YPR9	SVMI1_CERCE	Snake venom metalloprotease inhibitor 02A10 (01F09) [Cleaved into: Tripeptide pEKW 1; Tripeptide pEKW 2; Tripeptide pEKW 3; Tripeptide pEKW 4; Tripeptide pEKW 5; Tripeptide pEKW 6; Tripeptide pEKW 7; Tripeptide pEKW 8; Tripeptide pEKW 9; Tripeptide pEKW 10; Tripeptide pEKW 11; Tripeptide pEKW 12; Tripeptide pEKW 13; Tripeptide pEKW 14; Tripeptide pEKW 15; Tripeptide pEKW 16; Tripeptide pEKW 17; C-type natriuretic peptide (CNP)]	GO:0005576; GO:0008191; GO:0008217; GO:0009405; GO:0042311; GO:0090729	extracellular region [GO:0005576]; metalloendopeptidase inhibitor activity [GO:0008191]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]; regulation of blood pressure [GO:0008217]; vasodilation [GO:0042311]
PGEN_.00g193820	Scaffold_09	7570771	7594260	O62675	IL16_MACMU	Pro-interleukin-16 [Cleaved into: Interleukin-16 (IL-16) (Lymphocyte chemoattractant factor) (LCF)]	GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0030595; GO:0042609; GO:0050930	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]
PGEN_.00g193830	Scaffold_09	7606784	7622039	Q9H4A6	GOLP3_HUMAN	Golgi phosphoprotein 3 (Coat protein GPP34) (Mitochondrial DNA absence factor) (MIDAS)	GO:0005623; GO:0005739; GO:0005758; GO:0005768; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006890; GO:0007030; GO:0008283; GO:0009101; GO:0009306; GO:0010467; GO:0010821; GO:0016477; GO:0019899; GO:0030032; GO:0031985; GO:0032008; GO:0032580; GO:0043001; GO:0043066; GO:0043231; GO:0045053; GO:0048194; GO:0050714; GO:0050901; GO:0060352; GO:0070273; GO:0090161; GO:0090164	"cell [GO:0005623]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; enzyme binding [GO:0019899]; phosphatidylinositol-4-phosphate binding [GO:0070273]; asymmetric Golgi ribbon formation [GO:0090164]; cell adhesion molecule production [GO:0060352]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; lamellipodium assembly [GO:0030032]; leukocyte tethering or rolling [GO:0050901]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein secretion [GO:0050714]; positive regulation of TOR signaling [GO:0032008]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; regulation of mitochondrion organization [GO:0010821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g193840	Scaffold_09	7622386	7627943	Q568D2	CF161_DANRE	Cilia- and flagella-associated protein 161	GO:0031514; GO:0060271	motile cilium [GO:0031514]; cilium assembly [GO:0060271]
PGEN_.00g193850	Scaffold_09	7639117	7639521	NA	NA	NA	NA	NA
PGEN_.00g193860	Scaffold_09	7705524	7711565	Q8NCG5	CHST4_HUMAN	Carbohydrate sulfotransferase 4 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3) (GST-3) (High endothelial cells N-acetylglucosamine 6-O-sulfotransferase) (HEC-GlcNAc6ST) (L-selectin ligand sulfotransferase) (LSST) (N-acetylglucosamine 6-O-sulfotransferase 2) (GlcNAc6ST-2) (Gn6st-2)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006477; GO:0006790; GO:0006954; GO:0006955; GO:0007155; GO:0007267; GO:0008146; GO:0016021; GO:0016266; GO:0018146; GO:0031228	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; O-glycan processing [GO:0016266]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g193870	Scaffold_09	7755694	7813895	Q6UUV9	CRTC1_HUMAN	CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1) (Transducer of regulated cAMP response element-binding protein 1) (TORC-1) (Transducer of CREB protein 1)	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007613; GO:0008140; GO:0014069; GO:0016032; GO:0016604; GO:0030425; GO:0032793; GO:0043025; GO:0043153; GO:0045944; GO:0048511; GO:0051289; GO:0097009; GO:0098978; GO:0099527; GO:1900006; GO:1900273; GO:1902631	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cAMP response element binding protein binding [GO:0008140]; energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511]; viral process [GO:0016032]
PGEN_.00g193880	Scaffold_09	7831735	7832061	Q6ZNG9	KRBA2_HUMAN	KRAB-A domain-containing protein 2	GO:0003676; GO:0006355; GO:0015074	"nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g193890	Scaffold_09	7833408	7833758	NA	NA	NA	NA	NA
PGEN_.00g193900	Scaffold_09	7833880	7837023	NA	NA	NA	NA	NA
PGEN_.00g193910	Scaffold_09	7839667	7846758	NA	NA	NA	NA	NA
PGEN_.00g193920	Scaffold_09	7893152	7922168	Q7Z4H7	HAUS6_HUMAN	HAUS augmin-like complex subunit 6	GO:0000086; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0007098; GO:0010389; GO:0016607; GO:0034451; GO:0051225; GO:0051301; GO:0070652; GO:0097711	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; nuclear speck [GO:0016607]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]
PGEN_.00g193930	Scaffold_09	7929167	7975584	NA	NA	NA	NA	NA
PGEN_.00g193940	Scaffold_09	7953238	7953525	NA	NA	NA	NA	NA
PGEN_.00g193950	Scaffold_09	7982073	7984754	Q6NXR4	TTI2_HUMAN	TELO2-interacting protein 2	GO:0005654; GO:0005813; GO:0005829; GO:0070209	ASTRA complex [GO:0070209]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]
PGEN_.00g193960	Scaffold_09	7986665	7987237	NA	NA	NA	NA	NA
PGEN_.00g193970	Scaffold_09	7995336	7996298	P59889	S39A1_DANRE	Zinc transporter ZIP1 (DrZIP1) (Solute carrier family 39 member 1) (Zrt- and Irt-like protein 1) (ZIP-1)	GO:0005385; GO:0005886; GO:0006829; GO:0008270; GO:0016021; GO:0071577	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]
PGEN_.00g193980	Scaffold_09	7997392	8007506	NA	NA	NA	NA	NA
PGEN_.00g193990	Scaffold_09	8007552	8007914	NA	NA	NA	NA	NA
PGEN_.00g194000	Scaffold_09	8036122	8114777	NA	NA	NA	NA	NA
PGEN_.00g194010	Scaffold_09	8180232	8181005	NA	NA	NA	NA	NA
PGEN_.00g194020	Scaffold_09	8202910	8203536	NA	NA	NA	NA	NA
PGEN_.00g194030	Scaffold_09	8213588	8222107	Q9H2B2	SYT4_HUMAN	Synaptotagmin-4 (Synaptotagmin IV) (SytIV)	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007269; GO:0007420; GO:0007613; GO:0014049; GO:0014059; GO:0016192; GO:0017075; GO:0017156; GO:0017158; GO:0030054; GO:0030100; GO:0030173; GO:0030276; GO:0030285; GO:0030348; GO:0030424; GO:0030425; GO:0031339; GO:0032127; GO:0033604; GO:0042803; GO:0043005; GO:0043025; GO:0043231; GO:0044306; GO:0045955; GO:0045956; GO:0046982; GO:0048174; GO:0048471; GO:0050709; GO:0061782; GO:0061792; GO:0070382; GO:0071277; GO:0097449; GO:0098978; GO:0099066; GO:0099161; GO:0099183; GO:1903861; GO:1905414; GO:1905415; GO:1905433; GO:1990742; GO:2000301	"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dense core granule membrane [GO:0032127]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; integral component of Golgi membrane [GO:0030173]; integral component of neuronal dense core vesicle membrane [GO:0099066]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; microvesicle [GO:1990742]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]; brain development [GO:0007420]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of dense core granule exocytosis [GO:1905414]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of vesicle fusion [GO:0031339]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; secretory granule maturation [GO:0061792]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vesicle fusion with vesicle [GO:0061782]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g194040	Scaffold_09	8263447	8265083	NA	NA	NA	NA	NA
PGEN_.00g194050	Scaffold_09	8265748	8280569	NA	NA	NA	NA	NA
PGEN_.00g194060	Scaffold_09	8289057	8324545	Q9WV92	E41L3_MOUSE	"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (DAL1P) (mDAL-1) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]"	GO:0001558; GO:0002175; GO:0003779; GO:0005200; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0006915; GO:0007016; GO:0008360; GO:0014069; GO:0030054; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0043217; GO:0044224; GO:0048812; GO:0071205; GO:0072659	cell [GO:0005623]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]
PGEN_.00g194070	Scaffold_09	8388029	8394777	NA	NA	NA	NA	NA
PGEN_.00g194080	Scaffold_09	8417246	8424161	NA	NA	NA	NA	NA
PGEN_.00g194090	Scaffold_09	8502377	8506473	NA	NA	NA	NA	NA
PGEN_.00g194100	Scaffold_09	8512521	8525755	NA	NA	NA	NA	NA
PGEN_.00g194110	Scaffold_09	8530414	8530845	NA	NA	NA	NA	NA
PGEN_.00g194120	Scaffold_09	8531423	8550580	NA	NA	NA	NA	NA
PGEN_.00g194130	Scaffold_09	8552793	8565810	Q3TTL0	CC038_MOUSE	Uncharacterized protein C3orf38 homolog	GO:0005634; GO:0006915; GO:0043065	nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]
PGEN_.00g194140	Scaffold_09	8575733	8581381	Q5RD86	DDA1_PONAB	DET1- and DDB1-associated protein 1	GO:0032434; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]
PGEN_.00g194150	Scaffold_09	8581449	8597404	P61201	CSN2_HUMAN	COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15)	GO:0000122; GO:0000338; GO:0000715; GO:0001833; GO:0003714; GO:0005654; GO:0005737; GO:0005829; GO:0006283; GO:0006366; GO:0006468; GO:0007165; GO:0008180; GO:0030182; GO:0035914; GO:0043687; GO:0045892; GO:1903507	"COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription corepressor activity [GO:0003714]; inner cell mass cell proliferation [GO:0001833]; negative regulation of nucleic acid-templated transcription [GO:1903507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]"
PGEN_.00g194160	Scaffold_09	8599193	8623796	P98068	SPAN_STRPU	Protein SpAN (EC 3.4.24.-)	GO:0004222; GO:0007275; GO:0008270	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]
PGEN_.00g194170	Scaffold_09	8630694	8643634	NA	NA	NA	NA	NA
PGEN_.00g194180	Scaffold_09	8653394	8654714	NA	NA	NA	NA	NA
PGEN_.00g194190	Scaffold_09	8715538	8715777	NA	NA	NA	NA	NA
PGEN_.00g194200	Scaffold_09	8765855	8774091	Q07263	ACHA3_BOVIN	Neuronal acetylcholine receptor subunit alpha-3	GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007399; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0060084	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g194210	Scaffold_09	8900055	8921617	O45782	ARD17_CAEEL	Arrestin domain-containing protein 17 (Calcineurin-interacting protein 1)	GO:0007610; GO:0030346	protein phosphatase 2B binding [GO:0030346]; behavior [GO:0007610]
PGEN_.00g194220	Scaffold_09	8925013	8925471	NA	NA	NA	NA	NA
PGEN_.00g194230	Scaffold_09	8939080	8939706	Q9HCI6	K1586_HUMAN	E3 SUMO-protein ligase KIAA1586 (EC 2.3.2.-) (E3 SUMO-protein transferase KIAA1586)	GO:0016925; GO:0061665	SUMO ligase activity [GO:0061665]; protein sumoylation [GO:0016925]
PGEN_.00g194240	Scaffold_09	8939873	8940385	NA	NA	NA	NA	NA
PGEN_.00g194250	Scaffold_09	8948055	9009891	Q0J9V3	KN14H_ORYSJ	Kinesin-like protein KIN-14H	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0051225	kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225]
PGEN_.00g194260	Scaffold_09	9020449	9020772	NA	NA	NA	NA	NA
PGEN_.00g194270	Scaffold_09	9024570	9030476	NA	NA	NA	NA	NA
PGEN_.00g194280	Scaffold_09	9064284	9065720	P10155	RO60_HUMAN	60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (Ro60) (RoRNP) (Ro 60 kDa autoantigen) (Ro60 autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen) (SS-A) (TROVE domain family member 2)	GO:0002520; GO:0003723; GO:0005654; GO:0005829; GO:0006383; GO:0007224; GO:0009411; GO:0010468; GO:0030620; GO:0035457; GO:0046872; GO:0060271; GO:1990904	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cellular response to interferon-alpha [GO:0035457]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; regulation of gene expression [GO:0010468]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g194290	Scaffold_09	9066099	9067814	P18899	DDR48_YEAST	Stress protein DDR48 (DNA damage-responsive protein 48) (DDRP 48) (Flocculent-specific protein) (YP 75)	GO:0003924; GO:0005737; GO:0005829; GO:0006281; GO:0016887	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATPase activity [GO:0016887]; GTPase activity [GO:0003924]; DNA repair [GO:0006281]
PGEN_.00g194300	Scaffold_09	9068225	9069709	NA	NA	NA	NA	NA
PGEN_.00g194310	Scaffold_09	9105788	9108251	NA	NA	NA	NA	NA
PGEN_.00g194320	Scaffold_09	9163833	9167412	NA	NA	NA	NA	NA
PGEN_.00g194330	Scaffold_09	9193256	9196064	NA	NA	NA	NA	NA
PGEN_.00g194340	Scaffold_09	9277967	9300748	Q9NRA2	S17A5_HUMAN	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672	cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]
PGEN_.00g194350	Scaffold_09	9300927	9312313	Q5E9M5	SNPC3_BOVIN	snRNA-activating protein complex subunit 3 (SNAPc subunit 3) (Small nuclear RNA-activating complex polypeptide 3)	GO:0003677; GO:0005634	nucleus [GO:0005634]; DNA binding [GO:0003677]
PGEN_.00g194360	Scaffold_09	9318442	9318702	NA	NA	NA	NA	NA
PGEN_.00g194370	Scaffold_09	9376361	9388552	NA	NA	NA	NA	NA
PGEN_.00g194380	Scaffold_09	9404060	9409487	NA	NA	NA	NA	NA
PGEN_.00g194390	Scaffold_09	9417719	9483336	Q9UGM3	DMBT1_HUMAN	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0007275; GO:0008329; GO:0009897; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]
PGEN_.00g194400	Scaffold_09	9523864	9524178	NA	NA	NA	NA	NA
PGEN_.00g194410	Scaffold_09	9533231	9533521	NA	NA	NA	NA	NA
PGEN_.00g194420	Scaffold_09	9535146	9535541	NA	NA	NA	NA	NA
PGEN_.00g194430	Scaffold_09	9541356	9552161	Q9CPT4	MYDGF_MOUSE	Myeloid-derived growth factor (MYDGF)	GO:0001525; GO:0001934; GO:0001938; GO:0005576; GO:0005615; GO:0005783; GO:0005793; GO:0005794; GO:0006915; GO:0014068; GO:0043066; GO:0043410; GO:0045766; GO:0045944; GO:0051897	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g194440	Scaffold_09	9554605	9555348	P18899	DDR48_YEAST	Stress protein DDR48 (DNA damage-responsive protein 48) (DDRP 48) (Flocculent-specific protein) (YP 75)	GO:0003924; GO:0005737; GO:0005829; GO:0006281; GO:0016887	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATPase activity [GO:0016887]; GTPase activity [GO:0003924]; DNA repair [GO:0006281]
PGEN_.00g194450	Scaffold_09	9555420	9555752	NA	NA	NA	NA	NA
PGEN_.00g194460	Scaffold_09	9566816	9585653	Q5IS61	OPCM_PANTR	Opioid-binding protein/cell adhesion molecule (OBCAM) (OPCML) (Opioid-binding cell adhesion molecule)	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g194470	Scaffold_09	9721255	9722931	NA	NA	NA	NA	NA
PGEN_.00g194480	Scaffold_09	9729011	9790265	Q2UVX4	CO3_BOVIN	Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; C3-beta-c (C3bc); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]	GO:0001798; GO:0001934; GO:0001970; GO:0004866; GO:0005615; GO:0006631; GO:0006954; GO:0006956; GO:0006957; GO:0006958; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0031715; GO:0032991; GO:0045745; GO:0045766; GO:0048260; GO:0060100; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:1905114; GO:2000427	"cell surface [GO:0009986]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; C5L2 anaphylatoxin chemotactic receptor binding [GO:0031715]; endopeptidase inhibitor activity [GO:0004866]; amyloid-beta clearance [GO:0097242]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of lipid storage [GO:0010884]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; vertebrate eye-specific patterning [GO:0150064]"
PGEN_.00g194490	Scaffold_09	9791286	9799160	NA	NA	NA	NA	NA
PGEN_.00g194500	Scaffold_09	9811057	9814504	NA	NA	NA	NA	NA
PGEN_.00g194510	Scaffold_09	9819389	9825317	Q86UF1	TSN33_HUMAN	Tetraspanin-33 (Tspan-33) (Penumbra) (hPen) (Proerythroblast new membrane)	GO:0005788; GO:0005886; GO:0005887; GO:0005912; GO:0009986; GO:0019899; GO:0044267; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197	adherens junction [GO:0005912]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197]; enzyme binding [GO:0019899]; cellular protein metabolic process [GO:0044267]; pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]
PGEN_.00g194520	Scaffold_09	9833478	9858687	Q5ZHV2	NAA35_CHICK	"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Protein MAK10 homolog)"	GO:0004596; GO:0005737; GO:0006474; GO:0017196; GO:0031417; GO:0043066; GO:0048659	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659]
PGEN_.00g194530	Scaffold_09	9866677	9870987	P55013	S12A2_SQUAC	Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1) (NKCC) (Na-K-CL symporter)	GO:0006813; GO:0006814; GO:0015377; GO:0016021	integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]
PGEN_.00g194540	Scaffold_09	9897295	9933664	P55013	S12A2_SQUAC	Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1) (NKCC) (Na-K-CL symporter)	GO:0006813; GO:0006814; GO:0015377; GO:0016021	integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814]
PGEN_.00g194550	Scaffold_09	9945180	9945668	NA	NA	NA	NA	NA
PGEN_.00g194560	Scaffold_09	9946439	9946648	NA	NA	NA	NA	NA
PGEN_.00g194570	Scaffold_09	9989977	9990318	NA	NA	NA	NA	NA
PGEN_.00g194580	Scaffold_09	9993046	9993702	NA	NA	NA	NA	NA
PGEN_.00g194590	Scaffold_09	9993751	9994158	NA	NA	NA	NA	NA
PGEN_.00g194600	Scaffold_09	9994491	9995054	NA	NA	NA	NA	NA
PGEN_.00g194610	Scaffold_09	10079525	10079824	NA	NA	NA	NA	NA
PGEN_.00g194620	Scaffold_09	10080238	10118258	O42329	GNRR2_CLAGA	Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor)	GO:0004930; GO:0005886; GO:0016021; GO:0016500	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]
PGEN_.00g194630	Scaffold_09	10156810	10171046	Q9D7J9	ECHD3_MOUSE	"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial"	GO:0003824; GO:0005739; GO:0006631	mitochondrion [GO:0005739]; catalytic activity [GO:0003824]; fatty acid metabolic process [GO:0006631]
PGEN_.00g194640	Scaffold_09	10175899	10191617	P00636	F16P1_PIG	"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	GO:0000122; GO:0001085; GO:0005634; GO:0005737; GO:0005829; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0030388; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0051289; GO:0071286	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II transcription factor binding [GO:0001085]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]"
PGEN_.00g194650	Scaffold_09	10207026	10207825	NA	NA	NA	NA	NA
PGEN_.00g194660	Scaffold_09	10207862	10208077	NA	NA	NA	NA	NA
PGEN_.00g194670	Scaffold_09	10208340	10216351	NA	NA	NA	NA	NA
PGEN_.00g194680	Scaffold_09	10258801	10260181	NA	NA	NA	NA	NA
PGEN_.00g194690	Scaffold_09	10260216	10266415	NA	NA	NA	NA	NA
PGEN_.00g194700	Scaffold_09	10266422	10266688	NA	NA	NA	NA	NA
PGEN_.00g194710	Scaffold_09	10275192	10275908	NA	NA	NA	NA	NA
PGEN_.00g194720	Scaffold_09	10275972	10276289	NA	NA	NA	NA	NA
PGEN_.00g194730	Scaffold_09	10309588	10310241	NA	NA	NA	NA	NA
PGEN_.00g194740	Scaffold_09	10310375	10310575	NA	NA	NA	NA	NA
PGEN_.00g194750	Scaffold_09	10310658	10311496	NA	NA	NA	NA	NA
PGEN_.00g194760	Scaffold_09	10315046	10324136	NA	NA	NA	NA	NA
PGEN_.00g194770	Scaffold_09	10393527	10395138	NA	NA	NA	NA	NA
PGEN_.00g194780	Scaffold_09	10421521	10422723	NA	NA	NA	NA	NA
PGEN_.00g194790	Scaffold_09	10422846	10423577	NA	NA	NA	NA	NA
PGEN_.00g194800	Scaffold_09	10423719	10427855	NA	NA	NA	NA	NA
PGEN_.00g194810	Scaffold_09	10493726	10494148	NA	NA	NA	NA	NA
PGEN_.00g194820	Scaffold_09	10503347	10503727	NA	NA	NA	NA	NA
PGEN_.00g194830	Scaffold_09	10506570	10506896	NA	NA	NA	NA	NA
PGEN_.00g194840	Scaffold_09	10516964	10518175	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g194850	Scaffold_09	10579316	10579678	NA	NA	NA	NA	NA
PGEN_.00g194860	Scaffold_09	10618147	10634397	Q6PB70	ANO8_MOUSE	Anoctamin-8 (Transmembrane protein 16H)	GO:0005229; GO:0005886; GO:0006821; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; chloride transport [GO:0006821]
PGEN_.00g194870	Scaffold_09	10636089	10647575	Q9HCE9	ANO8_HUMAN	Anoctamin-8 (Transmembrane protein 16H)	GO:0005229; GO:0005788; GO:0005886; GO:0006821; GO:0016021; GO:0034220; GO:0043687; GO:0044267	endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; cellular protein metabolic process [GO:0044267]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; post-translational protein modification [GO:0043687]
PGEN_.00g194880	Scaffold_09	10656270	10656626	NA	NA	NA	NA	NA
PGEN_.00g194890	Scaffold_09	10657276	10657638	NA	NA	NA	NA	NA
PGEN_.00g194900	Scaffold_09	10661848	10663035	NA	NA	NA	NA	NA
PGEN_.00g194910	Scaffold_09	10736587	10736880	NA	NA	NA	NA	NA
PGEN_.00g194920	Scaffold_09	10772388	10772663	NA	NA	NA	NA	NA
PGEN_.00g194930	Scaffold_09	10796359	10796658	NA	NA	NA	NA	NA
PGEN_.00g194940	Scaffold_09	10802776	10803117	NA	NA	NA	NA	NA
PGEN_.00g194950	Scaffold_09	10809479	10846269	O42329	GNRR2_CLAGA	Gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor)	GO:0004930; GO:0005886; GO:0016021; GO:0016500	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]
PGEN_.00g194960	Scaffold_09	10854961	10855565	NA	NA	NA	NA	NA
PGEN_.00g194970	Scaffold_09	10927697	10928314	NA	NA	NA	NA	NA
PGEN_.00g194980	Scaffold_09	10928340	10928678	NA	NA	NA	NA	NA
PGEN_.00g194990	Scaffold_09	10929091	10929339	NA	NA	NA	NA	NA
PGEN_.00g195000	Scaffold_09	10978863	10980192	NA	NA	NA	NA	NA
PGEN_.00g195010	Scaffold_09	11026716	11100521	NA	NA	NA	NA	NA
PGEN_.00g195020	Scaffold_09	11126052	11136100	NA	NA	NA	NA	NA
PGEN_.00g195030	Scaffold_09	11145054	11145383	NA	NA	NA	NA	NA
PGEN_.00g195040	Scaffold_09	11244508	11262494	Q9GZZ6	ACH10_HUMAN	Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10)	GO:0004888; GO:0005102; GO:0005262; GO:0005623; GO:0005887; GO:0007165; GO:0007204; GO:0007268; GO:0007271; GO:0016020; GO:0022848; GO:0030054; GO:0030424; GO:0034220; GO:0042127; GO:0042391; GO:0042472; GO:0043005; GO:0043204; GO:0045202; GO:0050877; GO:0050910; GO:0070373; GO:0098981; GO:0099060	"axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g195050	Scaffold_09	11285912	11287741	NA	NA	NA	NA	NA
PGEN_.00g195060	Scaffold_09	11295581	11297582	NA	NA	NA	NA	NA
PGEN_.00g195070	Scaffold_09	11320139	11321993	NA	NA	NA	NA	NA
PGEN_.00g195080	Scaffold_09	11338247	11343106	Q95NQ0	MTH2_DROSI	G-protein coupled receptor Mth2 (Protein methuselah-2)	GO:0004930; GO:0005886; GO:0007166; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g195090	Scaffold_09	11345735	11350527	NA	NA	NA	NA	NA
PGEN_.00g195100	Scaffold_09	11356823	11357146	Q95N00	IOD1_SUNMU	Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)	GO:0004800; GO:0005789; GO:0016021; GO:0042446	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]
PGEN_.00g195110	Scaffold_09	11357204	11357930	O42412	IOD3_CHICK	Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase) (Fragment)	GO:0004800; GO:0005886; GO:0010008; GO:0016021; GO:0033798; GO:0042403; GO:0042446	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]
PGEN_.00g195120	Scaffold_09	11366098	11373210	NA	NA	NA	NA	NA
PGEN_.00g195130	Scaffold_09	11379095	11385044	NA	NA	NA	NA	NA
PGEN_.00g195140	Scaffold_09	11389881	11391425	NA	NA	NA	NA	NA
PGEN_.00g195150	Scaffold_09	11414688	11422349	Q7XA72	AB21G_ARATH	ABC transporter G family member 21 (ABC transporter ABCG.21) (AtABCG21) (White-brown complex homolog protein 21) (AtWBC21)	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g195160	Scaffold_09	11423136	11425582	Q8N988	ZN557_HUMAN	Zinc finger protein 557	GO:0003700; GO:0005634; GO:0043565; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]
PGEN_.00g195170	Scaffold_09	11466627	11468212	Q9CR35	CTRB1_MOUSE	Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]	GO:0004252; GO:0005615; GO:0005737; GO:0005764; GO:0006508; GO:0007586; GO:0008233; GO:0030163; GO:0034097; GO:0043065	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to cytokine [GO:0034097]
PGEN_.00g195180	Scaffold_09	11469888	11470148	NA	NA	NA	NA	NA
PGEN_.00g195190	Scaffold_09	11640428	11640667	NA	NA	NA	NA	NA
PGEN_.00g195200	Scaffold_09	11693376	11775075	Q6UXM1	LRIG3_HUMAN	Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3)	GO:0005615; GO:0005886; GO:0016021; GO:0030659; GO:0031012; GO:0032474	cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474]
PGEN_.00g195210	Scaffold_09	11797379	11849879	Q9NR16	C163B_HUMAN	Scavenger receptor cysteine-rich type 1 protein M160 (CD163 antigen-like 1) (CD antigen CD163b)	GO:0005044; GO:0005576; GO:0009897; GO:0016021	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]
PGEN_.00g195220	Scaffold_09	11817160	11817609	Q9Z175	LOXL3_MOUSE	Lysyl oxidase homolog 3 (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3) (Lysyl oxidase-related protein 2)	GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]"
PGEN_.00g195230	Scaffold_09	11854085	11854525	NA	NA	NA	NA	NA
PGEN_.00g195240	Scaffold_09	11855480	11856142	NA	NA	NA	NA	NA
PGEN_.00g195250	Scaffold_09	11912935	11922787	O60140	YNS9_SCHPO	Uncharacterized protein C18H10.09	GO:0005737; GO:0008270	cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]
PGEN_.00g195260	Scaffold_09	11932946	11938271	Q5XIS7	UBAP1_RAT	Ubiquitin-associated protein 1 (UBAP-1)	GO:0000813; GO:0005829; GO:0005886; GO:0015031; GO:0043130; GO:0043162; GO:0043231	cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin binding [GO:0043130]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]
PGEN_.00g195270	Scaffold_09	11957516	11959084	O14770	MEIS2_HUMAN	Homeobox protein Meis2 (Meis1-related protein 1)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003677; GO:0003700; GO:0003712; GO:0003714; GO:0006366; GO:0008134; GO:0008542; GO:0009612; GO:0031016; GO:0043565; GO:0045638; GO:0045931; GO:0045944; GO:0048471; GO:0070848; GO:0110024	"nuclear chromatin [GO:0000790]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542]"
PGEN_.00g195280	Scaffold_09	12033895	12044152	P36578	RL4_HUMAN	60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)	GO:0000184; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005791; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0070062; GO:1990904	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
PGEN_.00g195290	Scaffold_09	12044528	12052448	Q92733	PRCC_HUMAN	Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein)	GO:0000398; GO:0005634; GO:0005654; GO:0007093; GO:0016607	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mitotic cell cycle checkpoint [GO:0007093]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g195300	Scaffold_09	12064755	12110163	P46940	IQGA1_HUMAN	Ras GTPase-activating-like protein IQGAP1 (p195)	GO:0001726; GO:0001817; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0016032; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0031234; GO:0031267; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043312; GO:0043406; GO:0043539; GO:0044548; GO:0044877; GO:0045121; GO:0045296; GO:0045860; GO:0048008; GO:0048365; GO:0051019; GO:0051894; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776; GO:1990904	"actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]"
PGEN_.00g195310	Scaffold_09	12138671	12145318	Q13576	IQGA2_HUMAN	Ras GTPase-activating-like protein IQGAP2	GO:0003779; GO:0005095; GO:0005516; GO:0005547; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0005902; GO:0007165; GO:0009986; GO:0015629; GO:0017048; GO:0030027; GO:0030175; GO:0030667; GO:0034314; GO:0043312; GO:0048365; GO:0051015; GO:0070062; GO:0070493; GO:0071933	"actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; calmodulin binding [GO:0005516]; GTPase inhibitor activity [GO:0005095]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; Rac GTPase binding [GO:0048365]; Rho GTPase binding [GO:0017048]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165]; thrombin-activated receptor signaling pathway [GO:0070493]"
PGEN_.00g195320	Scaffold_09	12177136	12179046	NA	NA	NA	NA	NA
PGEN_.00g195330	Scaffold_09	12184846	12190730	Q92847	GHSR_HUMAN	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032869; GO:0036321; GO:0040018; GO:0042536; GO:0042802; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045409; GO:0045923; GO:0046676; GO:0046697; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0099699; GO:0120058; GO:1903672; GO:1904000; GO:1904008; GO:1904349; GO:1904468; GO:1905333; GO:1905564; GO:1990314; GO:2000110	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; negative regulation of tumor necrosis factor secretion [GO:1904468]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]
PGEN_.00g195340	Scaffold_09	12191426	12202094	NA	NA	NA	NA	NA
PGEN_.00g195350	Scaffold_09	12204055	12223187	Q95R48	OCTL_DROME	Organic cation transporter-like protein	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]
PGEN_.00g195360	Scaffold_09	12226606	12229533	NA	NA	NA	NA	NA
PGEN_.00g195370	Scaffold_09	12229646	12229936	NA	NA	NA	NA	NA
PGEN_.00g195380	Scaffold_09	12229964	12230230	NA	NA	NA	NA	NA
PGEN_.00g195390	Scaffold_09	12230659	12230991	NA	NA	NA	NA	NA
PGEN_.00g195400	Scaffold_09	12231041	12231664	NA	NA	NA	NA	NA
PGEN_.00g195410	Scaffold_09	12231889	12232854	NA	NA	NA	NA	NA
PGEN_.00g195420	Scaffold_09	12235665	12336543	P06684	CO5_MOUSE	Complement C5 (Hemolytic complement) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]	GO:0001701; GO:0004866; GO:0005579; GO:0005615; GO:0006954; GO:0006957; GO:0006958; GO:0010575; GO:0010760; GO:0019835; GO:0045766; GO:0090197	"extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; endopeptidase inhibitor activity [GO:0004866]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of angiogenesis [GO:0045766]; positive regulation of chemokine secretion [GO:0090197]; positive regulation of vascular endothelial growth factor production [GO:0010575]"
PGEN_.00g195430	Scaffold_09	12361981	12370237	O70370	CATS_MOUSE	Cathepsin S (EC 3.4.22.27)	GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0008233; GO:0008234; GO:0009986; GO:0010447; GO:0016020; GO:0016485; GO:0030574; GO:0031905; GO:0034769; GO:0043231; GO:0043236; GO:0043394; GO:0045453; GO:0048002; GO:0050729; GO:0051603; GO:0051930; GO:2001259	cell surface [GO:0009986]; early endosome lumen [GO:0031905]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; positive regulation of cation channel activity [GO:2001259]; positive regulation of inflammatory response [GO:0050729]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of sensory perception of pain [GO:0051930]; response to acidic pH [GO:0010447]
PGEN_.00g195440	Scaffold_09	12373444	12382976	Q5E968	CATK_BOVIN	Cathepsin K (EC 3.4.22.38)	GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005654; GO:0005764; GO:0030574; GO:0043394; GO:0045453; GO:0051603; GO:0061037	extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; negative regulation of cartilage development [GO:0061037]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g195450	Scaffold_09	12392323	12402653	Q5E968	CATK_BOVIN	Cathepsin K (EC 3.4.22.38)	GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005654; GO:0005764; GO:0030574; GO:0043394; GO:0045453; GO:0051603; GO:0061037	extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; negative regulation of cartilage development [GO:0061037]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g195460	Scaffold_09	12414492	12420959	NA	NA	NA	NA	NA
PGEN_.00g195470	Scaffold_09	12449016	12463443	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g195480	Scaffold_09	12471709	12472077	NA	NA	NA	NA	NA
PGEN_.00g195490	Scaffold_09	12476205	12522580	Q9H2S1	KCNN2_HUMAN	Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2)	GO:0005516; GO:0005886; GO:0006813; GO:0009986; GO:0015269; GO:0016021; GO:0016286; GO:0019904; GO:0030018; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0051393; GO:0071805; GO:0098914; GO:1901379	cell surface [GO:0009986]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; small conductance calcium-activated potassium channel activity [GO:0016286]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379]
PGEN_.00g195500	Scaffold_09	12588017	12598314	NA	NA	NA	NA	NA
PGEN_.00g195510	Scaffold_09	12630248	12631664	Q7KVW5	KCNN_DROME	Small conductance calcium-activated potassium channel protein (Protein SK) (dSK)	GO:0005516; GO:0005886; GO:0006813; GO:0009881; GO:0016021; GO:0016057; GO:0016286; GO:0043005; GO:0043025; GO:0071805	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057]
PGEN_.00g195520	Scaffold_09	12806575	12812551	NA	NA	NA	NA	NA
PGEN_.00g195530	Scaffold_09	12821458	12826225	P00767	CTRB_BOVIN	Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]	GO:0004252; GO:0005615; GO:0007586	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]
PGEN_.00g195540	Scaffold_09	12835346	12850071	Q6P2X9	MOT12_XENTR	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g195550	Scaffold_09	12855764	12866979	Q96Q77	CIB3_HUMAN	Calcium and integrin-binding family member 3 (Kinase-interacting protein 3) (KIP 3)	GO:0000287; GO:0005509	calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]
PGEN_.00g195560	Scaffold_09	12923779	12930504	NA	NA	NA	NA	NA
PGEN_.00g195570	Scaffold_09	12938600	12946365	A5PJA1	KAD6_BOVIN	Adenylate kinase isoenzyme 6 (AK6) (EC 2.7.4.3) (Coilin-interacting nuclear ATPase protein) (Dual activity adenylate kinase/ATPase) (AK/ATPase)	GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0015030; GO:0016887	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]
PGEN_.00g195580	Scaffold_09	12961039	12972565	Q9W0Y8	SCN60_DROME	Sodium channel protein 60E (Drosophila ion channel 60) (Drosophila sodium channel 1) (Protein smell-impaired 60E) (Sodium channel 2) (DmNav2)	GO:0001518; GO:0005248; GO:0005886; GO:0006814; GO:0007608; GO:0019228; GO:0022843; GO:0034765; GO:0035725; GO:0042048; GO:0086010	plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]
PGEN_.00g195590	Scaffold_09	12971304	12971546	NA	NA	NA	NA	NA
PGEN_.00g195600	Scaffold_09	12993290	12996897	NA	NA	NA	NA	NA
PGEN_.00g195610	Scaffold_09	12999658	12999945	NA	NA	NA	NA	NA
PGEN_.00g195620	Scaffold_09	13002161	13051320	Q9W0Y8	SCN60_DROME	Sodium channel protein 60E (Drosophila ion channel 60) (Drosophila sodium channel 1) (Protein smell-impaired 60E) (Sodium channel 2) (DmNav2)	GO:0001518; GO:0005248; GO:0005886; GO:0006814; GO:0007608; GO:0019228; GO:0022843; GO:0034765; GO:0035725; GO:0042048; GO:0086010	plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]
PGEN_.00g195630	Scaffold_09	13087783	13095253	B5FXU9	MOC2B_TAEGU	Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B)	GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366	cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]
PGEN_.00g195640	Scaffold_09	13098913	13101483	Q9BUI4	RPC3_HUMAN	DNA-directed RNA polymerase III subunit RPC3 (RNA polymerase III subunit C3) (DNA-directed RNA polymerase III subunit C) (RNA polymerase III 62 kDa subunit) (RPC62)	GO:0003697; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0032481; GO:0032728; GO:0045087; GO:0045089; GO:0051607	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g195650	Scaffold_09	13102484	13105054	Q9BUI4	RPC3_HUMAN	DNA-directed RNA polymerase III subunit RPC3 (RNA polymerase III subunit C3) (DNA-directed RNA polymerase III subunit C) (RNA polymerase III 62 kDa subunit) (RPC62)	GO:0003697; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0032481; GO:0032728; GO:0045087; GO:0045089; GO:0051607	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon production [GO:0032481]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g195660	Scaffold_09	13108706	13116482	B5FXU9	MOC2B_TAEGU	Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B)	GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366	cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]
PGEN_.00g195670	Scaffold_09	13151973	13210506	Q9W0Y8	SCN60_DROME	Sodium channel protein 60E (Drosophila ion channel 60) (Drosophila sodium channel 1) (Protein smell-impaired 60E) (Sodium channel 2) (DmNav2)	GO:0001518; GO:0005248; GO:0005886; GO:0006814; GO:0007608; GO:0019228; GO:0022843; GO:0034765; GO:0035725; GO:0042048; GO:0086010	plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]
PGEN_.00g195680	Scaffold_09	13232486	13244022	Q9W0Y8	SCN60_DROME	Sodium channel protein 60E (Drosophila ion channel 60) (Drosophila sodium channel 1) (Protein smell-impaired 60E) (Sodium channel 2) (DmNav2)	GO:0001518; GO:0005248; GO:0005886; GO:0006814; GO:0007608; GO:0019228; GO:0022843; GO:0034765; GO:0035725; GO:0042048; GO:0086010	plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]
PGEN_.00g195690	Scaffold_09	13258761	13264928	A5PJA1	KAD6_BOVIN	Adenylate kinase isoenzyme 6 (AK6) (EC 2.7.4.3) (Coilin-interacting nuclear ATPase protein) (Dual activity adenylate kinase/ATPase) (AK/ATPase)	GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0015030; GO:0016887	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]
PGEN_.00g195700	Scaffold_09	13273056	13279843	NA	NA	NA	NA	NA
PGEN_.00g195710	Scaffold_09	13336622	13346006	Q96Q77	CIB3_HUMAN	Calcium and integrin-binding family member 3 (Kinase-interacting protein 3) (KIP 3)	GO:0000287; GO:0005509	calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]
PGEN_.00g195720	Scaffold_09	13351985	13366786	Q6P2X9	MOT12_XENTR	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g195730	Scaffold_09	13374585	13382223	P00767	CTRB_BOVIN	Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]	GO:0004252; GO:0005615; GO:0007586	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]
PGEN_.00g195740	Scaffold_09	13389707	13394849	NA	NA	NA	NA	NA
PGEN_.00g195750	Scaffold_09	13517985	13518215	NA	NA	NA	NA	NA
PGEN_.00g195760	Scaffold_09	13571424	13572840	Q7KVW5	KCNN_DROME	Small conductance calcium-activated potassium channel protein (Protein SK) (dSK)	GO:0005516; GO:0005886; GO:0006813; GO:0009881; GO:0016021; GO:0016057; GO:0016286; GO:0043005; GO:0043025; GO:0071805	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057]
PGEN_.00g195770	Scaffold_09	13604963	13615607	NA	NA	NA	NA	NA
PGEN_.00g195780	Scaffold_09	13681028	13713104	P70604	KCNN2_RAT	Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2)	GO:0005216; GO:0005516; GO:0005790; GO:0005886; GO:0006811; GO:0006813; GO:0009986; GO:0015269; GO:0016021; GO:0016286; GO:0019904; GO:0030018; GO:0030315; GO:0042383; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0048168; GO:0051393; GO:0071805; GO:0098914; GO:1901379	cell surface [GO:0009986]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; small conductance calcium-activated potassium channel activity [GO:0016286]; ion transport [GO:0006811]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of potassium ion transmembrane transport [GO:1901379]
PGEN_.00g195790	Scaffold_09	13723233	13727414	NA	NA	NA	NA	NA
PGEN_.00g195800	Scaffold_09	13731541	13731909	NA	NA	NA	NA	NA
PGEN_.00g195810	Scaffold_09	13740141	13761185	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g195820	Scaffold_09	13770563	13773304	NA	NA	NA	NA	NA
PGEN_.00g195830	Scaffold_09	13780343	13786199	NA	NA	NA	NA	NA
PGEN_.00g195840	Scaffold_09	13797978	13804307	Q28944	CATL1_PIG	Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]	GO:0004175; GO:0004197; GO:0005615; GO:0005764; GO:0051603	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g195850	Scaffold_09	13817597	13827131	Q5E968	CATK_BOVIN	Cathepsin K (EC 3.4.22.38)	GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005654; GO:0005764; GO:0030574; GO:0043394; GO:0045453; GO:0051603; GO:0061037	extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; negative regulation of cartilage development [GO:0061037]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g195860	Scaffold_09	13830338	13837273	O70370	CATS_MOUSE	Cathepsin S (EC 3.4.22.27)	GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0008233; GO:0008234; GO:0009986; GO:0010447; GO:0016020; GO:0016485; GO:0030574; GO:0031905; GO:0034769; GO:0043231; GO:0043236; GO:0043394; GO:0045453; GO:0048002; GO:0050729; GO:0051603; GO:0051930; GO:2001259	cell surface [GO:0009986]; early endosome lumen [GO:0031905]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; positive regulation of cation channel activity [GO:2001259]; positive regulation of inflammatory response [GO:0050729]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of sensory perception of pain [GO:0051930]; response to acidic pH [GO:0010447]
PGEN_.00g195870	Scaffold_09	13862863	13961758	P06684	CO5_MOUSE	Complement C5 (Hemolytic complement) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]	GO:0001701; GO:0004866; GO:0005579; GO:0005615; GO:0006954; GO:0006957; GO:0006958; GO:0010575; GO:0010760; GO:0019835; GO:0045766; GO:0090197	"extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; endopeptidase inhibitor activity [GO:0004866]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of angiogenesis [GO:0045766]; positive regulation of chemokine secretion [GO:0090197]; positive regulation of vascular endothelial growth factor production [GO:0010575]"
PGEN_.00g195880	Scaffold_09	13964582	13965547	NA	NA	NA	NA	NA
PGEN_.00g195890	Scaffold_09	13965772	13966395	NA	NA	NA	NA	NA
PGEN_.00g195900	Scaffold_09	13966445	13967897	NA	NA	NA	NA	NA
PGEN_.00g195910	Scaffold_09	13967957	13968433	NA	NA	NA	NA	NA
PGEN_.00g195920	Scaffold_09	13968503	13968937	NA	NA	NA	NA	NA
PGEN_.00g195930	Scaffold_09	13968965	13969267	NA	NA	NA	NA	NA
PGEN_.00g195940	Scaffold_09	13974252	13993620	Q95R48	OCTL_DROME	Organic cation transporter-like protein	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]
PGEN_.00g195950	Scaffold_09	13995624	14012895	Q95254	GHSR_PIG	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0016021; GO:0016520; GO:0030252; GO:0032094; GO:0032100; GO:0032691; GO:0032869; GO:0040018; GO:0042536; GO:0043005; GO:0043568; GO:0045121; GO:0045409; GO:0046697; GO:0050728; GO:0051963	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of appetite [GO:0032100]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of synapse assembly [GO:0051963]; response to food [GO:0032094]; response to hormone [GO:0009725]
PGEN_.00g195960	Scaffold_09	14018699	14020609	NA	NA	NA	NA	NA
PGEN_.00g195970	Scaffold_09	14052841	14059524	Q13576	IQGA2_HUMAN	Ras GTPase-activating-like protein IQGAP2	GO:0003779; GO:0005095; GO:0005516; GO:0005547; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0005902; GO:0007165; GO:0009986; GO:0015629; GO:0017048; GO:0030027; GO:0030175; GO:0030667; GO:0034314; GO:0043312; GO:0048365; GO:0051015; GO:0070062; GO:0070493; GO:0071933	"actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; calmodulin binding [GO:0005516]; GTPase inhibitor activity [GO:0005095]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; Rac GTPase binding [GO:0048365]; Rho GTPase binding [GO:0017048]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165]; thrombin-activated receptor signaling pathway [GO:0070493]"
PGEN_.00g195980	Scaffold_09	14086408	14131816	P46940	IQGA1_HUMAN	Ras GTPase-activating-like protein IQGAP1 (p195)	GO:0001726; GO:0001817; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0016032; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0031234; GO:0031267; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043312; GO:0043406; GO:0043539; GO:0044548; GO:0044877; GO:0045121; GO:0045296; GO:0045860; GO:0048008; GO:0048365; GO:0051019; GO:0051894; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1900006; GO:1900086; GO:1903829; GO:1904754; GO:1990138; GO:1990776; GO:1990904	"actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165]; viral process [GO:0016032]"
PGEN_.00g195990	Scaffold_09	14140470	14140889	NA	NA	NA	NA	NA
PGEN_.00g196000	Scaffold_09	14144569	14152542	Q92733	PRCC_HUMAN	Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein)	GO:0000398; GO:0005634; GO:0005654; GO:0007093; GO:0016607	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mitotic cell cycle checkpoint [GO:0007093]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g196010	Scaffold_09	14152918	14162143	P36578	RL4_HUMAN	60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)	GO:0000184; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005791; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0070062; GO:1990904	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
PGEN_.00g196020	Scaffold_09	14236987	14238555	O14770	MEIS2_HUMAN	Homeobox protein Meis2 (Meis1-related protein 1)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003677; GO:0003700; GO:0003712; GO:0003714; GO:0006366; GO:0008134; GO:0008542; GO:0009612; GO:0031016; GO:0043565; GO:0045638; GO:0045931; GO:0045944; GO:0048471; GO:0070848; GO:0110024	"nuclear chromatin [GO:0000790]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542]"
PGEN_.00g196030	Scaffold_09	14257842	14263238	Q5XIS7	UBAP1_RAT	Ubiquitin-associated protein 1 (UBAP-1)	GO:0000813; GO:0005829; GO:0005886; GO:0015031; GO:0043130; GO:0043162; GO:0043231	cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin binding [GO:0043130]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]
PGEN_.00g196040	Scaffold_09	14275408	14285241	O60140	YNS9_SCHPO	Uncharacterized protein C18H10.09	GO:0005737; GO:0008270	cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]
PGEN_.00g196050	Scaffold_09	14342034	14342405	NA	NA	NA	NA	NA
PGEN_.00g196060	Scaffold_09	14343849	14344082	NA	NA	NA	NA	NA
PGEN_.00g196070	Scaffold_09	14348295	14409122	Q9UGM3	DMBT1_HUMAN	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0007275; GO:0008329; GO:0009897; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]
PGEN_.00g196080	Scaffold_09	14413796	14414458	NA	NA	NA	NA	NA
PGEN_.00g196090	Scaffold_09	14449431	14462491	Q5G267	NETR_MACMU	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0031638; GO:0043083; GO:0043195	axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; zymogen activation [GO:0031638]
PGEN_.00g196100	Scaffold_09	14464380	14477828	F7J220	SRCR1_PATPE	Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1)	GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]
PGEN_.00g196110	Scaffold_09	14628709	14632518	P34975	OPRK_RAT	Kappa-type opioid receptor (K-OR-1) (KOR-1)	GO:0004930; GO:0004985; GO:0005623; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0006955; GO:0007200; GO:0007218; GO:0007626; GO:0009314; GO:0016021; GO:0019233; GO:0030285; GO:0030425; GO:0031635; GO:0032868; GO:0033603; GO:0033612; GO:0033685; GO:0038003; GO:0038048; GO:0040017; GO:0042220; GO:0042277; GO:0042711; GO:0042755; GO:0042923; GO:0043025; GO:0043204; GO:0043278; GO:0043627; GO:0043679; GO:0044849; GO:0045202; GO:0045471; GO:0046877; GO:0048148; GO:0050951; GO:0051607; GO:0051930; GO:0071222; GO:0071333; GO:0099055; GO:0099056; GO:1900745; GO:1901381; GO:1903937; GO:1904000; GO:1990708	axon terminus [GO:0043679]; cell [GO:0005623]; cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; dynorphin receptor activity [GO:0038048]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; opioid receptor activity [GO:0004985]; peptide binding [GO:0042277]; receptor serine/threonine kinase binding [GO:0033612]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to cocaine [GO:0048148]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; conditioned place preference [GO:1990708]; defense response to virus [GO:0051607]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; immune response [GO:0006955]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; negative regulation of luteinizing hormone secretion [GO:0033685]; neuropeptide signaling pathway [GO:0007218]; opioid receptor signaling pathway [GO:0038003]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of eating behavior [GO:1904000]; positive regulation of locomotion [GO:0040017]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of saliva secretion [GO:0046877]; regulation of sensory perception of pain [GO:0051930]; response to acrylamide [GO:1903937]; response to cocaine [GO:0042220]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951]
PGEN_.00g196120	Scaffold_09	14714103	14725868	NA	NA	NA	NA	NA
PGEN_.00g196130	Scaffold_09	14730396	14733158	NA	NA	NA	NA	NA
PGEN_.00g196140	Scaffold_09	14799359	14816874	Q40784	AAPC_CENCI	Putative glucose-6-phosphate 1-epimerase (EC 5.1.3.15) (Putative D-hexose-6-phosphate mutarotase) (Putative apospory-associated protein C)	GO:0005975; GO:0030246; GO:0047938	carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g196150	Scaffold_09	14827178	14845951	Q40784	AAPC_CENCI	Putative glucose-6-phosphate 1-epimerase (EC 5.1.3.15) (Putative D-hexose-6-phosphate mutarotase) (Putative apospory-associated protein C)	GO:0005975; GO:0030246; GO:0047938	carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g196160	Scaffold_09	14857401	14873196	Q40784	AAPC_CENCI	Putative glucose-6-phosphate 1-epimerase (EC 5.1.3.15) (Putative D-hexose-6-phosphate mutarotase) (Putative apospory-associated protein C)	GO:0005975; GO:0030246; GO:0047938	carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g196170	Scaffold_09	14881960	14886218	NA	NA	NA	NA	NA
PGEN_.00g196180	Scaffold_09	14894073	14897221	NA	NA	NA	NA	NA
PGEN_.00g196190	Scaffold_09	14897915	14904646	Q3UU96	MRCKA_MOUSE	Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha)	GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005911; GO:0006468; GO:0007010; GO:0007097; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031532; GO:0035556; GO:0042641; GO:0042802; GO:0051056	actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; nuclear migration [GO:0007097]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g196200	Scaffold_09	14905958	14907772	NA	NA	NA	NA	NA
PGEN_.00g196210	Scaffold_09	14909824	14915564	NA	NA	NA	NA	NA
PGEN_.00g196220	Scaffold_09	14909994	14910374	NA	NA	NA	NA	NA
PGEN_.00g196230	Scaffold_09	14910427	14911932	NA	NA	NA	NA	NA
PGEN_.00g196240	Scaffold_09	14915927	14916883	NA	NA	NA	NA	NA
PGEN_.00g196250	Scaffold_09	14916986	14917219	NA	NA	NA	NA	NA
PGEN_.00g196260	Scaffold_09	14917259	14919724	NA	NA	NA	NA	NA
PGEN_.00g196270	Scaffold_09	14919784	14920589	NA	NA	NA	NA	NA
PGEN_.00g196280	Scaffold_09	14924558	14933778	NA	NA	NA	NA	NA
PGEN_.00g196290	Scaffold_09	14933832	14937791	NA	NA	NA	NA	NA
PGEN_.00g196300	Scaffold_09	14940874	14947489	NA	NA	NA	NA	NA
PGEN_.00g196310	Scaffold_09	14948906	14955659	NA	NA	NA	NA	NA
PGEN_.00g196320	Scaffold_09	14970872	14985658	NA	NA	NA	NA	NA
PGEN_.00g196330	Scaffold_09	14988352	15000788	NA	NA	NA	NA	NA
PGEN_.00g196340	Scaffold_09	15004750	15005555	NA	NA	NA	NA	NA
PGEN_.00g196350	Scaffold_09	15007197	15008079	NA	NA	NA	NA	NA
PGEN_.00g196360	Scaffold_09	15008119	15008352	NA	NA	NA	NA	NA
PGEN_.00g196370	Scaffold_09	15008455	15009409	NA	NA	NA	NA	NA
PGEN_.00g196380	Scaffold_09	15009763	15015551	NA	NA	NA	NA	NA
PGEN_.00g196390	Scaffold_09	15013354	15014999	NA	NA	NA	NA	NA
PGEN_.00g196400	Scaffold_09	15017605	15019419	NA	NA	NA	NA	NA
PGEN_.00g196410	Scaffold_09	15020656	15031234	Q3UU96	MRCKA_MOUSE	Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha)	GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005911; GO:0006468; GO:0007010; GO:0007097; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031532; GO:0035556; GO:0042641; GO:0042802; GO:0051056	actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; nuclear migration [GO:0007097]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g196420	Scaffold_09	15039107	15043360	NA	NA	NA	NA	NA
PGEN_.00g196430	Scaffold_09	15052114	15068007	Q40784	AAPC_CENCI	Putative glucose-6-phosphate 1-epimerase (EC 5.1.3.15) (Putative D-hexose-6-phosphate mutarotase) (Putative apospory-associated protein C)	GO:0005975; GO:0030246; GO:0047938	carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g196440	Scaffold_09	15079456	15082349	NA	NA	NA	NA	NA
PGEN_.00g196450	Scaffold_09	15091264	15098246	Q40784	AAPC_CENCI	Putative glucose-6-phosphate 1-epimerase (EC 5.1.3.15) (Putative D-hexose-6-phosphate mutarotase) (Putative apospory-associated protein C)	GO:0005975; GO:0030246; GO:0047938	carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g196460	Scaffold_09	15108485	15136426	Q40784	AAPC_CENCI	Putative glucose-6-phosphate 1-epimerase (EC 5.1.3.15) (Putative D-hexose-6-phosphate mutarotase) (Putative apospory-associated protein C)	GO:0005975; GO:0030246; GO:0047938	carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g196470	Scaffold_09	15194597	15199111	NA	NA	NA	NA	NA
PGEN_.00g196480	Scaffold_09	15301245	15305054	P34975	OPRK_RAT	Kappa-type opioid receptor (K-OR-1) (KOR-1)	GO:0004930; GO:0004985; GO:0005623; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0006955; GO:0007200; GO:0007218; GO:0007626; GO:0009314; GO:0016021; GO:0019233; GO:0030285; GO:0030425; GO:0031635; GO:0032868; GO:0033603; GO:0033612; GO:0033685; GO:0038003; GO:0038048; GO:0040017; GO:0042220; GO:0042277; GO:0042711; GO:0042755; GO:0042923; GO:0043025; GO:0043204; GO:0043278; GO:0043627; GO:0043679; GO:0044849; GO:0045202; GO:0045471; GO:0046877; GO:0048148; GO:0050951; GO:0051607; GO:0051930; GO:0071222; GO:0071333; GO:0099055; GO:0099056; GO:1900745; GO:1901381; GO:1903937; GO:1904000; GO:1990708	axon terminus [GO:0043679]; cell [GO:0005623]; cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; dynorphin receptor activity [GO:0038048]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; opioid receptor activity [GO:0004985]; peptide binding [GO:0042277]; receptor serine/threonine kinase binding [GO:0033612]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to cocaine [GO:0048148]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; conditioned place preference [GO:1990708]; defense response to virus [GO:0051607]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; immune response [GO:0006955]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; negative regulation of luteinizing hormone secretion [GO:0033685]; neuropeptide signaling pathway [GO:0007218]; opioid receptor signaling pathway [GO:0038003]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of eating behavior [GO:1904000]; positive regulation of locomotion [GO:0040017]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of saliva secretion [GO:0046877]; regulation of sensory perception of pain [GO:0051930]; response to acrylamide [GO:1903937]; response to cocaine [GO:0042220]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951]
PGEN_.00g196490	Scaffold_09	15456703	15470511	F7J220	SRCR1_PATPE	Scavenger receptor cysteine-rich domain superfamily protein (ApSRCR1)	GO:0005044; GO:0006909; GO:0016021; GO:0030659; GO:0045087	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]
PGEN_.00g196500	Scaffold_09	15472400	15483747	Q2VL90	C163A_PIG	Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)]	GO:0001618; GO:0005044; GO:0005576; GO:0006953; GO:0009897; GO:0016021	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; virus receptor activity [GO:0001618]; acute-phase response [GO:0006953]
PGEN_.00g196510	Scaffold_09	15519091	15519753	NA	NA	NA	NA	NA
PGEN_.00g196520	Scaffold_09	15524397	15536652	Q4A3R3	DMBT1_PIG	Deleted in malignant brain tumors 1 protein (Hensin)	GO:0005044; GO:0007275; GO:0009897; GO:0015031; GO:0016021; GO:0019898; GO:0030154; GO:0030658; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830	external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]
PGEN_.00g196530	Scaffold_09	15571561	15572324	NA	NA	NA	NA	NA
PGEN_.00g196540	Scaffold_09	15584488	15588060	NA	NA	NA	NA	NA
PGEN_.00g196550	Scaffold_09	15629545	15679525	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g196560	Scaffold_09	15685856	15689762	NA	NA	NA	NA	NA
PGEN_.00g196570	Scaffold_09	15689885	15690313	NA	NA	NA	NA	NA
PGEN_.00g196580	Scaffold_09	15700108	15725157	Q9VD44	GLD2A_DROME	Poly(A) RNA polymerase gld-2 homolog A (DmGLD2) (EC 2.7.7.19)	GO:0003723; GO:0004652; GO:0005524; GO:0005654; GO:0005737; GO:0006397; GO:0007616; GO:0043005; GO:0043631; GO:0046872	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; long-term memory [GO:0007616]; mRNA processing [GO:0006397]; RNA polyadenylation [GO:0043631]
PGEN_.00g196590	Scaffold_09	15727262	15751881	Q98TR3	RENT1_TAKRU	Putative regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1)	GO:0000184; GO:0000932; GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0008270	"P-body [GO:0000932]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"
PGEN_.00g196600	Scaffold_09	15759173	15759763	Q6ID18	LAC10_ARATH	Laccase-10 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 10) (Diphenol oxidase 10) (Urishiol oxidase 10)	GO:0004322; GO:0005507; GO:0005886; GO:0006826; GO:0046274; GO:0048046; GO:0052716; GO:0055072	apoplast [GO:0048046]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; lignin catabolic process [GO:0046274]
PGEN_.00g196610	Scaffold_09	15771680	15773417	NA	NA	NA	NA	NA
PGEN_.00g196620	Scaffold_09	15781737	15789213	O45782	ARD17_CAEEL	Arrestin domain-containing protein 17 (Calcineurin-interacting protein 1)	GO:0007610; GO:0030346	protein phosphatase 2B binding [GO:0030346]; behavior [GO:0007610]
PGEN_.00g196630	Scaffold_09	15807603	15811337	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g196640	Scaffold_09	15824384	15857366	Q9P3U1	YKX5_SCHPO	Uncharacterized RNA-binding protein C328.05	GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0016973; GO:0071014; GO:0071028; GO:1990904; GO:2000815	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]
PGEN_.00g196650	Scaffold_09	15899198	15901292	NA	NA	NA	NA	NA
PGEN_.00g196660	Scaffold_09	15909467	15911359	Q8N695	SC5A8_HUMAN	Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)	GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]
PGEN_.00g196670	Scaffold_09	15919177	15938698	P82650	RT22_HUMAN	"28S ribosomal protein S22, mitochondrial (MRP-S22) (S22mt) (Mitochondrial small ribosomal subunit protein mS22)"	GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005763; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]
PGEN_.00g196680	Scaffold_09	15938887	15949477	Q4KKZ1	CA158_MOUSE	Uncharacterized protein C1orf158 homolog		
PGEN_.00g196690	Scaffold_09	15964825	15968558	H2A0M3	AMO_PINMG	Putative amine oxidase [copper-containing] (EC 1.4.3.-)	GO:0005507; GO:0005576; GO:0008131; GO:0009308; GO:0048038	extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308]
PGEN_.00g196700	Scaffold_09	15984096	15992883	NA	NA	NA	NA	NA
PGEN_.00g196710	Scaffold_09	15995276	16004755	Q09638	NPR15_CAEEL	Neuropeptide receptor 15	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g196720	Scaffold_09	16008524	16009236	NA	NA	NA	NA	NA
PGEN_.00g196730	Scaffold_09	16016630	16041849	P53355	DAPK1_HUMAN	Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)	GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:2000310	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]
PGEN_.00g196740	Scaffold_09	16043441	16046273	Q55CU2	ACT26_DICDI	Putative actin-26	GO:0005200; GO:0005524; GO:0005737; GO:0006909; GO:0015629; GO:0017022	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; phagocytosis [GO:0006909]
PGEN_.00g196750	Scaffold_09	16048097	16055642	NA	NA	NA	NA	NA
PGEN_.00g196760	Scaffold_09	16058912	16067503	NA	NA	NA	NA	NA
PGEN_.00g196770	Scaffold_09	16078185	16099431	Q9Y639	NPTN_HUMAN	Neuroplastin (Stromal cell-derived receptor 1) (SDR-1)	GO:0001772; GO:0001818; GO:0001934; GO:0005105; GO:0005623; GO:0005886; GO:0006874; GO:0007156; GO:0007204; GO:0007411; GO:0008542; GO:0009986; GO:0010976; GO:0030054; GO:0030424; GO:0030425; GO:0042734; GO:0044325; GO:0045743; GO:0048170; GO:0050839; GO:0060077; GO:0060291; GO:0070374; GO:0070593; GO:0098632; GO:0098685; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:0099557; GO:1900273; GO:1902683; GO:1903829; GO:1904861	"axon [GO:0030424]; cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; inhibitory synapse [GO:0060077]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]; ion channel binding [GO:0044325]; type 1 fibroblast growth factor receptor binding [GO:0005105]; axon guidance [GO:0007411]; cellular calcium ion homeostasis [GO:0006874]; dendrite self-avoidance [GO:0070593]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; long-term synaptic potentiation [GO:0060291]; negative regulation of cytokine production [GO:0001818]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; regulation of receptor localization to synapse [GO:1902683]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; visual learning [GO:0008542]"
PGEN_.00g196780	Scaffold_09	16105917	16107336	NA	NA	NA	NA	NA
PGEN_.00g196790	Scaffold_09	16107366	16114983	NA	NA	NA	NA	NA
PGEN_.00g196800	Scaffold_09	16116086	16120272	NA	NA	NA	NA	NA
PGEN_.00g196810	Scaffold_09	16120937	16151698	Q9NVE4	CCD87_HUMAN	Coiled-coil domain-containing protein 87	GO:0007283; GO:0007338; GO:0030154; GO:1905516; GO:2000344	cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]
PGEN_.00g196820	Scaffold_09	16163120	16203131	NA	NA	NA	NA	NA
PGEN_.00g196830	Scaffold_09	16221902	16222753	O09116	SPRR3_MOUSE	Small proline-rich protein 3 (Cornifin beta)	GO:0005794; GO:0031424; GO:0048471	Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; keratinization [GO:0031424]
PGEN_.00g196840	Scaffold_09	16233051	16278153	Q86YT6	MIB1_HUMAN	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]
PGEN_.00g196850	Scaffold_09	16295448	16299457	Q7XA72	AB21G_ARATH	ABC transporter G family member 21 (ABC transporter ABCG.21) (AtABCG21) (White-brown complex homolog protein 21) (AtWBC21)	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g196860	Scaffold_09	16300081	16316425	Q7XA72	AB21G_ARATH	ABC transporter G family member 21 (ABC transporter ABCG.21) (AtABCG21) (White-brown complex homolog protein 21) (AtWBC21)	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g196870	Scaffold_09	16364731	16385152	Q9Y6I4	UBP3_HUMAN	Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3)	GO:0000122; GO:0000278; GO:0000790; GO:0000978; GO:0004843; GO:0005634; GO:0005654; GO:0006281; GO:0006511; GO:0008270; GO:0016578; GO:0016579; GO:0031647; GO:0036464; GO:0042393; GO:0090543; GO:1990841	cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g196880	Scaffold_09	16398054	16450792	Q9NSB8	HOME2_HUMAN	Homer protein homolog 2 (Homer-2) (Cupidin)	GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0019904; GO:0030054; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035256; GO:0035584; GO:0042803; GO:0043005; GO:0043025; GO:0045177; GO:0046982; GO:0048148; GO:0048875; GO:0070885; GO:0098978; GO:2001256	apical part of cell [GO:0045177]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; GKAP/Homer scaffold activity [GO:0030160]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605]
PGEN_.00g196890	Scaffold_09	16506196	16517075	NA	NA	NA	NA	NA
PGEN_.00g196900	Scaffold_09	16523234	16525363	P82915	RT16_BOVIN	"28S ribosomal protein S16, mitochondrial (MRP-S16) (S16mt)"	GO:0003735; GO:0005743; GO:0005763; GO:0032543	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g196910	Scaffold_09	16533486	16534550	Q10323	IMT3_SCHPO	Inositol phosphoceramide mannosyltransferase 3 (EC 2.4.-.-) (IPC mannosyltransferase 3)	GO:0000030; GO:0005783; GO:0005789; GO:0005794; GO:0016021; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g196920	Scaffold_09	16550070	16576768	P50904	RASA1_RAT	Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP)	GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001934; GO:0001953; GO:0005096; GO:0005102; GO:0005161; GO:0005829; GO:0005886; GO:0007155; GO:0007162; GO:0007165; GO:0008134; GO:0016020; GO:0019900; GO:0030036; GO:0030539; GO:0030833; GO:0030971; GO:0031965; GO:0032868; GO:0036120; GO:0042493; GO:0043066; GO:0043422; GO:0043524; GO:0043547; GO:0044325; GO:0044344; GO:0044877; GO:0046326; GO:0046580; GO:0048146; GO:0048514; GO:0050731; GO:0051020; GO:0071364; GO:0090630; GO:1990782	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase B binding [GO:0043422]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male genitalia development [GO:0030539]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glucose import [GO:0046326]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of actin filament polymerization [GO:0030833]; response to drug [GO:0042493]; response to insulin [GO:0032868]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]
PGEN_.00g196930	Scaffold_09	16584106	16588333	NA	NA	NA	NA	NA
PGEN_.00g196940	Scaffold_09	16597748	16609696	NA	NA	NA	NA	NA
PGEN_.00g196950	Scaffold_09	16610169	16616055	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g196960	Scaffold_09	16622163	16625434	Q9U2M7	AP4A_CAEEL	"Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] (EC 3.6.1.-) (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase) (Ap4A hydrolase) (Ap4Aase) (Diadenosine tetraphosphatase) (Nudix hydrolase 4)"	GO:0004081; GO:0005524; GO:0006167; GO:0006172; GO:0006754; GO:0006915; GO:0015967; GO:0019693; GO:0043135	5-phosphoribosyl 1-pyrophosphate pyrophosphatase activity [GO:0043135]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; ADP biosynthetic process [GO:0006172]; AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; diadenosine tetraphosphate catabolic process [GO:0015967]; ribose phosphate metabolic process [GO:0019693]
PGEN_.00g196970	Scaffold_09	16625886	16647225	Q5R533	SERC3_PONAB	Serine incorporator 3	GO:0000139; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016021; GO:0045087; GO:0051607; GO:1902237	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g196980	Scaffold_09	16649229	16670445	Q5R533	SERC3_PONAB	Serine incorporator 3	GO:0000139; GO:0005886; GO:0006658; GO:0006665; GO:0009597; GO:0016021; GO:0045087; GO:0051607; GO:1902237	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g196990	Scaffold_09	16670897	16674373	Q9U2M7	AP4A_CAEEL	"Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] (EC 3.6.1.-) (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase) (Ap4A hydrolase) (Ap4Aase) (Diadenosine tetraphosphatase) (Nudix hydrolase 4)"	GO:0004081; GO:0005524; GO:0006167; GO:0006172; GO:0006754; GO:0006915; GO:0015967; GO:0019693; GO:0043135	5-phosphoribosyl 1-pyrophosphate pyrophosphatase activity [GO:0043135]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; ADP biosynthetic process [GO:0006172]; AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; diadenosine tetraphosphate catabolic process [GO:0015967]; ribose phosphate metabolic process [GO:0019693]
PGEN_.00g197000	Scaffold_09	16680496	16686381	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g197010	Scaffold_09	16686856	16697830	NA	NA	NA	NA	NA
PGEN_.00g197020	Scaffold_09	16717062	16743809	P50904	RASA1_RAT	Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP)	GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001934; GO:0001953; GO:0005096; GO:0005102; GO:0005161; GO:0005829; GO:0005886; GO:0007155; GO:0007162; GO:0007165; GO:0008134; GO:0016020; GO:0019900; GO:0030036; GO:0030539; GO:0030833; GO:0030971; GO:0031965; GO:0032868; GO:0036120; GO:0042493; GO:0043066; GO:0043422; GO:0043524; GO:0043547; GO:0044325; GO:0044344; GO:0044877; GO:0046326; GO:0046580; GO:0048146; GO:0048514; GO:0050731; GO:0051020; GO:0071364; GO:0090630; GO:1990782	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase B binding [GO:0043422]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male genitalia development [GO:0030539]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glucose import [GO:0046326]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of actin filament polymerization [GO:0030833]; response to drug [GO:0042493]; response to insulin [GO:0032868]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]
PGEN_.00g197030	Scaffold_09	16759233	16760297	Q10323	IMT3_SCHPO	Inositol phosphoceramide mannosyltransferase 3 (EC 2.4.-.-) (IPC mannosyltransferase 3)	GO:0000030; GO:0005783; GO:0005789; GO:0005794; GO:0016021; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g197040	Scaffold_09	16769067	16770687	P82915	RT16_BOVIN	"28S ribosomal protein S16, mitochondrial (MRP-S16) (S16mt)"	GO:0003735; GO:0005743; GO:0005763; GO:0032543	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g197050	Scaffold_09	16781820	16782482	NA	NA	NA	NA	NA
PGEN_.00g197060	Scaffold_09	16786687	16786953	NA	NA	NA	NA	NA
PGEN_.00g197070	Scaffold_09	16813753	16827173	NA	NA	NA	NA	NA
PGEN_.00g197080	Scaffold_09	16831314	16855617	P53355	DAPK1_HUMAN	Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)	GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:2000310	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]
PGEN_.00g197090	Scaffold_09	16893054	16910571	P53355	DAPK1_HUMAN	Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)	GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:2000310	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]
PGEN_.00g197100	Scaffold_09	16919759	16928759	Q712K3	UB2R2_HUMAN	Ubiquitin-conjugating enzyme E2 R2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R2) (Ubiquitin carrier protein R2) (Ubiquitin-conjugating enzyme E2-CDC34B) (Ubiquitin-protein ligase R2)	GO:0004842; GO:0005524; GO:0005829; GO:0006513; GO:0016567; GO:0061631; GO:0070936	cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]
PGEN_.00g197110	Scaffold_09	16929158	16946659	Q641Z2	PTN9_RAT	Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48)	GO:0004725; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:1903078	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]
PGEN_.00g197120	Scaffold_09	16963171	16964049	NA	NA	NA	NA	NA
PGEN_.00g197130	Scaffold_09	16966524	16972845	NA	NA	NA	NA	NA
PGEN_.00g197140	Scaffold_09	16977896	17006729	NA	NA	NA	NA	NA
PGEN_.00g197150	Scaffold_09	17010375	17012424	NA	NA	NA	NA	NA
PGEN_.00g197160	Scaffold_09	17115583	17133711	Q4KUS2	UN13A_MOUSE	Protein unc-13 homolog A (Munc13-1)	GO:0000149; GO:0001956; GO:0005509; GO:0005516; GO:0005543; GO:0005798; GO:0005886; GO:0007269; GO:0007528; GO:0010807; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019904; GO:0019905; GO:0019992; GO:0030054; GO:0030424; GO:0030507; GO:0030672; GO:0031594; GO:0031915; GO:0032991; GO:0035249; GO:0035556; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044305; GO:0044877; GO:0045202; GO:0047485; GO:0048172; GO:0048786; GO:0050435; GO:0060076; GO:0060291; GO:0060384; GO:0061789; GO:0097060; GO:0098793; GO:0098831; GO:0098978; GO:0099525; GO:1900451; GO:1902991; GO:1903861	"axon [GO:0030424]; calyx of Held [GO:0044305]; cell junction [GO:0030054]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi-associated vesicle [GO:0005798]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; amyloid-beta metabolic process [GO:0050435]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; neuromuscular junction development [GO:0007528]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of synaptic plasticity [GO:0031915]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"
PGEN_.00g197170	Scaffold_09	17136034	17136435	NA	NA	NA	NA	NA
PGEN_.00g197180	Scaffold_09	17136936	17137268	NA	NA	NA	NA	NA
PGEN_.00g197190	Scaffold_09	17154004	17185643	NA	NA	NA	NA	NA
PGEN_.00g197200	Scaffold_09	17200685	17239396	P27715	UNC13_CAEEL	Phorbol ester/diacylglycerol-binding protein unc-13 (Uncoordinated protein 13)	GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007283; GO:0007528; GO:0016079; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030672; GO:0031594; GO:0035249; GO:0035556; GO:0042734; GO:0043051; GO:0043195; GO:0045202; GO:0046662; GO:0048786; GO:0060282; GO:0061789; GO:0098831; GO:0099525	"neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; dense core granule priming [GO:0061789]; intracellular signal transduction [GO:0035556]; neuromuscular junction development [GO:0007528]; positive regulation of oocyte development [GO:0060282]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]; spermatogenesis [GO:0007283]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"
PGEN_.00g197210	Scaffold_09	17256039	17256611	NA	NA	NA	NA	NA
PGEN_.00g197220	Scaffold_09	17408118	17416756	NA	NA	NA	NA	NA
PGEN_.00g197230	Scaffold_09	17525712	17555944	Q8IYX7	SAXO1_HUMAN	Stabilizer of axonemal microtubules 1	GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0034453; GO:0036064; GO:0036126; GO:0045724; GO:0050821; GO:0070417	axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; microtubule anchoring [GO:0034453]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821]
PGEN_.00g197240	Scaffold_09	17575047	17604547	NA	NA	NA	NA	NA
PGEN_.00g197250	Scaffold_09	17622046	17623656	Q9D0N7	CAF1B_MOUSE	Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60)	GO:0000790; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186; GO:0042393	CAF-1 complex [GO:0033186]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]
PGEN_.00g197260	Scaffold_09	17672431	17675718	Q6DHG8	SKA1_DANRE	Spindle and kinetochore-associated protein 1	GO:0000278; GO:0000940; GO:0005737; GO:0005876; GO:0007059; GO:0008017; GO:0031110; GO:0051301; GO:0072686	condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110]
PGEN_.00g197270	Scaffold_09	17682225	17736159	Q5R4N8	A2MG_PONAB	Alpha-2-macroglobulin (Alpha-2-M)	GO:0004867; GO:0005615	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g197280	Scaffold_09	17744008	17798839	O17583	LIN10_CAEEL	Protein lin-10 (Abnormal cell lineage protein 10)	GO:0000138; GO:0005737; GO:0005794; GO:0005886; GO:0007268; GO:0007270; GO:0007399; GO:0008104; GO:0009612; GO:0017137; GO:0030054; GO:0030140; GO:0030425; GO:0032580; GO:0040026; GO:0043005; GO:0043025; GO:0043058; GO:0043197; GO:0045202; GO:0050975; GO:0097120; GO:1902946; GO:1903361; GO:1905852	cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; Rab GTPase binding [GO:0017137]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of backward locomotion [GO:1905852]; positive regulation of vulval development [GO:0040026]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to early endosome [GO:1902946]; receptor localization to synapse [GO:0097120]; regulation of backward locomotion [GO:0043058]; response to mechanical stimulus [GO:0009612]; sensory perception of touch [GO:0050975]
PGEN_.00g197290	Scaffold_09	17831120	17842131	Q99767	APBA2_HUMAN	Amyloid-beta A4 precursor protein-binding family A member 2 (Adapter protein X11beta) (Neuron-specific X11L protein) (Neuronal Munc18-1-interacting protein 2) (Mint-2)	GO:0001540; GO:0001701; GO:0005737; GO:0005886; GO:0007268; GO:0007399; GO:0007626; GO:0008021; GO:0010468; GO:0015031; GO:0035264; GO:0042802; GO:0043197; GO:0045202; GO:0098685; GO:2000300	cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; chemical synaptic transmission [GO:0007268]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; protein transport [GO:0015031]; regulation of gene expression [GO:0010468]; regulation of synaptic vesicle exocytosis [GO:2000300]
PGEN_.00g197300	Scaffold_09	17853865	17869118	Q6R3M4	POLI_MOUSE	DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B)	GO:0003684; GO:0003887; GO:0006260; GO:0016607; GO:0019985; GO:0036464; GO:0046872; GO:0071494	cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to UV-C [GO:0071494]; DNA replication [GO:0006260]; translesion synthesis [GO:0019985]
PGEN_.00g197310	Scaffold_09	17873198	17879162	Q7ZTZ2	RLP24_DANRE	Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1)	GO:0000027; GO:0003723; GO:0003735; GO:0005730; GO:0006412; GO:0022625; GO:1902626	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]
PGEN_.00g197320	Scaffold_09	17882110	17882552	NA	NA	NA	NA	NA
PGEN_.00g197330	Scaffold_09	17882621	17937605	B6ZLK2	CHD1_CHICK	Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1)	GO:0000775; GO:0003677; GO:0003678; GO:0005524; GO:0005634	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
PGEN_.00g197340	Scaffold_09	17958239	17967781	Q18120	TWK18_CAEEL	TWiK family of potassium channels protein 18	GO:0005887; GO:0006813; GO:0006936; GO:0015271; GO:0016020; GO:0022841; GO:0030322; GO:0040011; GO:0071805	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]
PGEN_.00g197350	Scaffold_09	18014637	18019029	A6H584	CO6A5_MOUSE	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)	GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g197360	Scaffold_09	18035694	18038444	P51942	MATN1_MOUSE	Cartilage matrix protein (Matrilin-1)	GO:0002062; GO:0003429; GO:0005201; GO:0005509; GO:0005615; GO:0030500; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; chondrocyte differentiation [GO:0002062]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; regulation of bone mineralization [GO:0030500]
PGEN_.00g197370	Scaffold_09	18061432	18063714	Q6R5N8	TLR13_MOUSE	Toll-like receptor 13	GO:0002224; GO:0002755; GO:0005737; GO:0005768; GO:0005887; GO:0006954; GO:0009615; GO:0010008; GO:0019843; GO:0034178; GO:0042802; GO:0042803; GO:0043408; GO:0045087	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; rRNA binding [GO:0019843]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g197380	Scaffold_09	18067207	18073946	NA	NA	NA	NA	NA
PGEN_.00g197390	Scaffold_09	18074970	18075335	P49894	IOD1_CANLF	Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)	GO:0004800; GO:0005789; GO:0016021; GO:0042403; GO:0042446	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]
PGEN_.00g197400	Scaffold_09	18143631	18148091	O97341	CALM_SUBDO	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g197410	Scaffold_09	18151905	18195953	NA	NA	NA	NA	NA
PGEN_.00g197420	Scaffold_09	18222350	18222559	NA	NA	NA	NA	NA
PGEN_.00g197430	Scaffold_09	18224522	18224767	NA	NA	NA	NA	NA
PGEN_.00g197440	Scaffold_09	18255144	18256457	NA	NA	NA	NA	NA
PGEN_.00g197450	Scaffold_09	18292718	18339530	Q98892	OBCAM_CHICK	Opioid-binding protein/cell adhesion molecule homolog (Neurite inhibitor GP55-A) (OBCAM protein gamma isoform)	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g197460	Scaffold_09	18293647	18294850	NA	NA	NA	NA	NA
PGEN_.00g197470	Scaffold_09	18371378	18371629	NA	NA	NA	NA	NA
PGEN_.00g197480	Scaffold_09	18371831	18372160	NA	NA	NA	NA	NA
PGEN_.00g197490	Scaffold_09	18485093	18516287	Q6ZPY2	SMG5_MOUSE	Protein SMG5 (EST1-like protein B) (SMG-5 homolog)	GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0007004; GO:0031625; GO:0032204; GO:0032210; GO:0035303; GO:0042162; GO:0042826; GO:0051721; GO:0070034	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere maintenance via telomerase [GO:0007004]"
PGEN_.00g197500	Scaffold_09	18544476	18545154	NA	NA	NA	NA	NA
PGEN_.00g197510	Scaffold_09	18603770	18680862	Q24323	SEM2A_DROME	Semaphorin-2A (Semaphorin-II) (Sema II)	GO:0001755; GO:0005576; GO:0005615; GO:0005829; GO:0007411; GO:0007629; GO:0007632; GO:0012505; GO:0016201; GO:0030215; GO:0030335; GO:0030534; GO:0042756; GO:0045499; GO:0048843; GO:0050919; GO:0070983; GO:0071526; GO:0071678; GO:0097374	cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; dendrite guidance [GO:0070983]; drinking behavior [GO:0042756]; flight behavior [GO:0007629]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; olfactory bulb axon guidance [GO:0071678]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synaptic target inhibition [GO:0016201]; visual behavior [GO:0007632]
PGEN_.00g197520	Scaffold_09	18682264	18682668	NA	NA	NA	NA	NA
PGEN_.00g197530	Scaffold_09	18712773	18728864	Q0V9S0	SYTC2_XENTR	"Threonine--tRNA ligase 2, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase-like protein 2)"	GO:0004829; GO:0005524; GO:0005634; GO:0005737; GO:0006435	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435]
PGEN_.00g197540	Scaffold_09	18737557	18752780	Q9Y2B0	CNPY2_HUMAN	Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4)	GO:0005783; GO:0010629; GO:0010988; GO:0045716	endoplasmic reticulum [GO:0005783]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988]
PGEN_.00g197550	Scaffold_09	18774897	18786590	Q6VV64	KCNKI_MOUSE	Potassium channel subfamily K member 18 (Two-pore-domain potassium channel TRESK)	GO:0005886; GO:0005887; GO:0006813; GO:0015269; GO:0015271; GO:0022841; GO:0030322; GO:0071467; GO:0071805; GO:0097623	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]
PGEN_.00g197560	Scaffold_09	18865381	18874034	Q03147	CDK7_MOUSE	Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit)	GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005675; GO:0005737; GO:0005829; GO:0005856; GO:0006281; GO:0006366; GO:0006468; GO:0007049; GO:0008022; GO:0008094; GO:0008353; GO:0016020; GO:0016301; GO:0019907; GO:0044877; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0070985	cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA-dependent ATPase activity [GO:0008094]; kinase activity [GO:0016301]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g197570	Scaffold_09	18876049	18879604	NA	NA	NA	NA	NA
PGEN_.00g197580	Scaffold_09	18879678	18895035	Q9R1R2	TRIM3_MOUSE	Tripartite motif-containing protein 3 (RING finger protein 22) (RING finger protein HAC1)	GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0043161; GO:0061630; GO:0098794; GO:0098978	cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]
PGEN_.00g197590	Scaffold_09	18911683	18912720	D2GXS7	TRIM2_AILME	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	GO:0004842; GO:0005737; GO:0008270; GO:0043523	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g197600	Scaffold_09	18921642	18929981	NA	NA	NA	NA	NA
PGEN_.00g197610	Scaffold_09	18936172	18945934	Q5JZQ8	CLN6_CANLF	Ceroid-lipofuscinosis neuronal protein 6 homolog (Protein CLN6)	GO:0001573; GO:0005623; GO:0005783; GO:0005788; GO:0005789; GO:0007040; GO:0007042; GO:0008203; GO:0016021; GO:0030203; GO:0042803; GO:0045862	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; cholesterol metabolic process [GO:0008203]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; positive regulation of proteolysis [GO:0045862]
PGEN_.00g197620	Scaffold_09	18955852	18981179	Q01986	MP2K1_RAT	Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1)	GO:0000187; GO:0000278; GO:0003056; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006468; GO:0006979; GO:0007050; GO:0007507; GO:0008022; GO:0008283; GO:0008285; GO:0010508; GO:0010628; GO:0010629; GO:0014069; GO:0017016; GO:0018107; GO:0019901; GO:0021697; GO:0023014; GO:0030182; GO:0030216; GO:0030335; GO:0030424; GO:0030425; GO:0030878; GO:0031435; GO:0032147; GO:0032402; GO:0032839; GO:0032872; GO:0032968; GO:0034111; GO:0035556; GO:0042593; GO:0043204; GO:0043497; GO:0043539; GO:0043547; GO:0044877; GO:0045597; GO:0045893; GO:0045933; GO:0046579; GO:0047485; GO:0047496; GO:0048313; GO:0048471; GO:0048538; GO:0048678; GO:0048679; GO:0048812; GO:0048870; GO:0050772; GO:0051384; GO:0060020; GO:0060324; GO:0060425; GO:0060440; GO:0060502; GO:0060674; GO:0060711; GO:0070328; GO:0070371; GO:0070372; GO:0070374; GO:0071902; GO:0090170; GO:0090398; GO:0097110; GO:0098696; GO:0098978; GO:1903298; GO:1903800; GO:2000641; GO:2001171	"axon [GO:0030424]; cell [GO:0005623]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; Ras GTPase binding [GO:0017016]; scaffold protein binding [GO:0097110]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; Bergmann glial cell differentiation [GO:0060020]; cell cycle arrest [GO:0007050]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cellular senescence [GO:0090398]; cerebellar cortex formation [GO:0021697]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; glucose homeostasis [GO:0042593]; Golgi inheritance [GO:0048313]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; labyrinthine layer development [GO:0060711]; lung morphogenesis [GO:0060425]; melanosome transport [GO:0032402]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; peptidyl-threonine phosphorylation [GO:0018107]; placenta blood vessel development [GO:0060674]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of autophagy [GO:0010508]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of muscle contraction [GO:0045933]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of Golgi inheritance [GO:0090170]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein heterodimerization activity [GO:0043497]; regulation of stress-activated MAPK cascade [GO:0032872]; regulation of vascular smooth muscle contraction [GO:0003056]; response to axon injury [GO:0048678]; response to glucocorticoid [GO:0051384]; response to oxidative stress [GO:0006979]; signal transduction by protein phosphorylation [GO:0023014]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; triglyceride homeostasis [GO:0070328]; vesicle transport along microtubule [GO:0047496]"
PGEN_.00g197630	Scaffold_09	18994112	19031226	A9JRL3	CBPC1_XENTR	Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (ATP/GTP-binding protein 1)	GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0008270; GO:0015631; GO:0021702; GO:0021772; GO:0035609; GO:0035610; GO:0050905	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]
PGEN_.00g197640	Scaffold_09	19043375	19050862	Q5XIM4	ATP5S_RAT	"ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B) (Distal membrane arm assembly complex 2-like protein) (Mitochondrial ATP synthase regulatory component factor B)"	GO:0005743; GO:0006754; GO:0006811; GO:0045263; GO:0046872	"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; metal ion binding [GO:0046872]; ATP biosynthetic process [GO:0006754]; ion transport [GO:0006811]"
PGEN_.00g197650	Scaffold_09	19054392	19072619	NA	NA	NA	NA	NA
PGEN_.00g197660	Scaffold_09	19159324	19159833	P48039	MTR1A_HUMAN	Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007193; GO:0007617; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0097159	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502]; organic cyclic compound binding [GO:0097159]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617]"
PGEN_.00g197670	Scaffold_09	19247942	19250470	NA	NA	NA	NA	NA
PGEN_.00g197680	Scaffold_09	19259544	19259813	NA	NA	NA	NA	NA
PGEN_.00g197690	Scaffold_09	19266716	19268089	NA	NA	NA	NA	NA
PGEN_.00g197700	Scaffold_09	19270427	19284696	A6QQM4	ZN474_BOVIN	Zinc finger protein 474	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g197710	Scaffold_09	19289654	19297395	Q9CQS5	RIOK2_MOUSE	Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2)	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:2000208; GO:2000234	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]"
PGEN_.00g197720	Scaffold_09	19298746	19300301	NA	NA	NA	NA	NA
PGEN_.00g197730	Scaffold_09	19324685	19324999	NA	NA	NA	NA	NA
PGEN_.00g197740	Scaffold_09	19339311	19344186	NA	NA	NA	NA	NA
PGEN_.00g197750	Scaffold_09	19389516	19397825	P42739	UBIQP_ACEPE	Polyubiquitin [Cleaved into: Ubiquitin; Ubiquitin-related 1; Ubiquitin-related 2] (Fragment)	GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g197760	Scaffold_09	19400582	19414009	Q9P2K5	MYEF2_HUMAN	Myelin expression factor 2 (MEF-2) (MyEF-2) (MST156)	GO:0000978; GO:0000981; GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0014902; GO:0030182; GO:0071014; GO:1990904; GO:2000815	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; myotube differentiation [GO:0014902]; neuron differentiation [GO:0030182]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]"
PGEN_.00g197770	Scaffold_09	19423187	19454254	Q5RE70	INT3_PONAB	Integrator complex subunit 3 (Int3) (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A) (SOSS-A) (Sensor of ssDNA subunit A)	GO:0005634; GO:0005737; GO:0006281; GO:0006974; GO:0007093; GO:0010212; GO:0070876	cytoplasm [GO:0005737]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]
PGEN_.00g197780	Scaffold_09	19463834	19495031	Q2KJG3	SYNC_BOVIN	"Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS)"	GO:0003676; GO:0004816; GO:0005524; GO:0005737; GO:0006421	cytoplasm [GO:0005737]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421]
PGEN_.00g197790	Scaffold_09	19597225	19600344	NA	NA	NA	NA	NA
PGEN_.00g197800	Scaffold_09	19602801	19608438	NA	NA	NA	NA	NA
PGEN_.00g197810	Scaffold_09	19629105	19629386	NA	NA	NA	NA	NA
PGEN_.00g197820	Scaffold_09	19629580	19652548	A2A3L6	TTC24_HUMAN	Tetratricopeptide repeat protein 24 (TPR repeat protein 24)		
PGEN_.00g197830	Scaffold_09	19657354	19665956	A0JMG9	S35A4_DANRE	Probable UDP-sugar transporter protein SLC35A4 (Solute carrier family 35 member A4)	GO:0005794; GO:0008643; GO:0015165; GO:0030173	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; carbohydrate transport [GO:0008643]
PGEN_.00g197840	Scaffold_09	19671007	19671303	NA	NA	NA	NA	NA
PGEN_.00g197850	Scaffold_09	19674359	19682910	NA	NA	NA	NA	NA
PGEN_.00g197860	Scaffold_09	19696434	19698976	Q9Z0K8	VNN1_MOUSE	Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1)	GO:0002526; GO:0002544; GO:0005886; GO:0006954; GO:0015939; GO:0016021; GO:0017159; GO:0031225; GO:0033089; GO:0034235; GO:0045087; GO:0098609; GO:1902176	anchored component of membrane [GO:0031225]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; pantetheine hydrolase activity [GO:0017159]; acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; pantothenate metabolic process [GO:0015939]; positive regulation of T cell differentiation in thymus [GO:0033089]
PGEN_.00g197870	Scaffold_09	19730106	19730507	NA	NA	NA	NA	NA
PGEN_.00g197880	Scaffold_09	19730987	19732683	NA	NA	NA	NA	NA
PGEN_.00g197890	Scaffold_09	19754592	19755525	NA	NA	NA	NA	NA
PGEN_.00g197900	Scaffold_09	19790116	19792494	NA	NA	NA	NA	NA
PGEN_.00g197910	Scaffold_09	19945391	19952512	Q2V2K5	GNRHR_OCTVU	Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R) (oct-GnRHR)	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g197920	Scaffold_09	20054067	20059708	NA	NA	NA	NA	NA
PGEN_.00g197930	Scaffold_09	20066473	20068616	NA	NA	NA	NA	NA
PGEN_.00g197940	Scaffold_09	20114065	20114475	NA	NA	NA	NA	NA
PGEN_.00g197950	Scaffold_09	20114678	20115515	NA	NA	NA	NA	NA
PGEN_.00g197960	Scaffold_09	20125162	20128967	NA	NA	NA	NA	NA
PGEN_.00g197970	Scaffold_09	20129009	20135848	NA	NA	NA	NA	NA
PGEN_.00g197980	Scaffold_09	20142227	20144491	NA	NA	NA	NA	NA
PGEN_.00g197990	Scaffold_09	20149141	20167527	NA	NA	NA	NA	NA
PGEN_.00g198000	Scaffold_09	20184905	20192086	Q17QS1	SNX24_BOVIN	Sorting nexin-24	GO:0015031; GO:0030659; GO:0035091	cytoplasmic vesicle membrane [GO:0030659]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]
PGEN_.00g198010	Scaffold_09	20195697	20233222	P05099	MATN1_CHICK	Cartilage matrix protein (Matrilin-1)	GO:0003429; GO:0005201; GO:0005509; GO:0005615; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g198020	Scaffold_09	20248314	20250724	NA	NA	NA	NA	NA
PGEN_.00g198030	Scaffold_09	20265508	20273610	NA	NA	NA	NA	NA
PGEN_.00g198040	Scaffold_09	20284986	20289604	NA	NA	NA	NA	NA
PGEN_.00g198050	Scaffold_09	20299291	20317325	NA	NA	NA	NA	NA
PGEN_.00g198060	Scaffold_09	20322104	20325390	NA	NA	NA	NA	NA
PGEN_.00g198070	Scaffold_09	20332111	20332518	NA	NA	NA	NA	NA
PGEN_.00g198080	Scaffold_09	20342621	20384954	NA	NA	NA	NA	NA
PGEN_.00g198090	Scaffold_09	20421536	20435737	P47990	XDH_CHICK	Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]	GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0005829; GO:0009055; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949	"cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]"
PGEN_.00g198100	Scaffold_09	20517960	20532119	A8WQK3	ACH1_CAEBR	Acetylcholine receptor subunit alpha-type acr-16	GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g198110	Scaffold_09	20543862	20553822	Q95R48	OCTL_DROME	Organic cation transporter-like protein	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]
PGEN_.00g198120	Scaffold_09	20561870	20569383	NA	NA	NA	NA	NA
PGEN_.00g198130	Scaffold_09	20578932	20587220	Q9SF85	ADK1_ARATH	Adenosine kinase 1 (AK 1) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase 1)	GO:0004001; GO:0005507; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006169; GO:0009506; GO:0016032; GO:0044209; GO:0046686; GO:0048046; GO:0080094	apoplast [GO:0048046]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032]
PGEN_.00g198140	Scaffold_09	20599112	20603866	Q7Z2Y8	GVIN1_HUMAN	Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g198150	Scaffold_09	20612395	20616489	Q80SU7	GVIN1_MOUSE	Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g198160	Scaffold_09	20632372	20637042	Q80SU7	GVIN1_MOUSE	Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g198170	Scaffold_09	20639486	20648129	Q7TPQ9	ARRD3_MOUSE	Arrestin domain-containing protein 3	GO:0001659; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0031651; GO:0031699; GO:0043588; GO:0051443; GO:0060613; GO:0071878; GO:0090327; GO:0120163	early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]
PGEN_.00g198180	Scaffold_09	20658586	20710085	NA	NA	NA	NA	NA
PGEN_.00g198190	Scaffold_09	20738762	20739079	NA	NA	NA	NA	NA
PGEN_.00g198200	Scaffold_09	20766379	20768507	NA	NA	NA	NA	NA
PGEN_.00g198210	Scaffold_09	20774344	20776910	NA	NA	NA	NA	NA
PGEN_.00g198220	Scaffold_09	20798600	20805367	NA	NA	NA	NA	NA
PGEN_.00g198230	Scaffold_09	20841063	20851483	NA	NA	NA	NA	NA
PGEN_.00g198240	Scaffold_09	20862678	20867222	NA	NA	NA	NA	NA
PGEN_.00g198250	Scaffold_09	20869266	20902269	Q2TBA3	MALT1_MOUSE	Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase)	GO:0001650; GO:0001923; GO:0002020; GO:0002237; GO:0002726; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0007250; GO:0008233; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043280; GO:0043621; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051092; GO:0051168; GO:0051259; GO:2000321	CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; response to molecule of bacterial origin [GO:0002237]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]
PGEN_.00g198260	Scaffold_09	20903493	20930412	Q96KR1	ZFR_HUMAN	Zinc finger RNA-binding protein (hZFR) (M-phase phosphoprotein homolog)	GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0007275; GO:0008270	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]
PGEN_.00g198270	Scaffold_09	21061957	21086204	Q98892	OBCAM_CHICK	Opioid-binding protein/cell adhesion molecule homolog (Neurite inhibitor GP55-A) (OBCAM protein gamma isoform)	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g198280	Scaffold_09	21103677	21119182	NA	NA	NA	NA	NA
PGEN_.00g198290	Scaffold_09	21131080	21133028	NA	NA	NA	NA	NA
PGEN_.00g198300	Scaffold_09	21135471	21140973	NA	NA	NA	NA	NA
PGEN_.00g198310	Scaffold_09	21146354	21172791	Q9NZJ4	SACS_HUMAN	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]
PGEN_.00g198320	Scaffold_09	21183717	21184325	NA	NA	NA	NA	NA
PGEN_.00g198330	Scaffold_09	21185728	21189110	Q05A80	CAPR2_MOUSE	Caprin-2 (C1q domain-containing protein 1) (Cytoplasmic activation/proliferation-associated protein 2) (RNA granule protein 140)	GO:0003723; GO:0005102; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0017148; GO:0030308; GO:0032092; GO:0033138; GO:0043235; GO:0045944; GO:0046872; GO:0050775; GO:0061003; GO:0090263	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; negative regulation of cell growth [GO:0030308]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g198340	Scaffold_09	21208179	21237163	E9Q1U1	CC171_MOUSE	Coiled-coil domain-containing protein 171		
PGEN_.00g198350	Scaffold_09	21240306	21241004	NA	NA	NA	NA	NA
PGEN_.00g198360	Scaffold_09	21272186	21317627	Q9Y345	SC6A5_HUMAN	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g198370	Scaffold_09	21322909	21328440	Q78JE5	FBX22_MOUSE	F-box only protein 22	GO:0000209; GO:0005634; GO:0005737; GO:0006913; GO:0009267; GO:0010830; GO:0030018; GO:0032436; GO:0048742; GO:2000060	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]; cellular response to starvation [GO:0009267]; nucleocytoplasmic transport [GO:0006913]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein polyubiquitination [GO:0000209]; regulation of myotube differentiation [GO:0010830]; regulation of skeletal muscle fiber development [GO:0048742]
PGEN_.00g198380	Scaffold_09	21329318	21342924	Q03111	ENL_HUMAN	Protein ENL (YEATS domain-containing protein 1)	GO:0000981; GO:0001650; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0006368; GO:0006469; GO:0008023	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; negative regulation of protein kinase activity [GO:0006469]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"
PGEN_.00g198390	Scaffold_09	21352772	21377213	Q95RN0	F172A_DROME	FAM172 family protein homolog CG10038	GO:0005634; GO:0031048	nucleus [GO:0005634]; chromatin silencing by small RNA [GO:0031048]
PGEN_.00g198400	Scaffold_09	21408872	21422816	Q3KR37	ASTRB_HUMAN	Protein Aster-B (GRAM domain-containing protein 1B)	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]
PGEN_.00g198410	Scaffold_09	21455573	21456712	Q8BZ39	NMUR2_MOUSE	Neuromedin-U receptor 2 (NMU-R2)	GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005623; GO:0005886; GO:0006816; GO:0007200; GO:0007204; GO:0007218; GO:0007417; GO:0007625; GO:0008188; GO:0016021; GO:0042924; GO:0043006; GO:0048016; GO:0048265; GO:0050482; GO:0051930	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; central nervous system development [GO:0007417]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265]
PGEN_.00g198420	Scaffold_09	21503317	21534216	Q502K3	ANR52_DANRE	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C)		
PGEN_.00g198430	Scaffold_09	21542760	21592845	NA	NA	NA	NA	NA
PGEN_.00g198440	Scaffold_09	21599524	21606380	NA	NA	NA	NA	NA
PGEN_.00g198450	Scaffold_09	21606292	21608865	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g198460	Scaffold_09	21620820	21621323	NA	NA	NA	NA	NA
PGEN_.00g198470	Scaffold_09	21621349	21621954	NA	NA	NA	NA	NA
PGEN_.00g198480	Scaffold_09	21639791	21640183	NA	NA	NA	NA	NA
PGEN_.00g198490	Scaffold_09	21693301	21727255	O15014	ZN609_HUMAN	Zinc finger protein 609	GO:0003676; GO:0005634; GO:0005654; GO:0006357; GO:0007517; GO:0032039; GO:0045944; GO:0046872; GO:2000291; GO:2001224	integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g198500	Scaffold_09	21818778	21820225	NA	NA	NA	NA	NA
PGEN_.00g198510	Scaffold_09	21825300	21826341	NA	NA	NA	NA	NA
PGEN_.00g198520	Scaffold_09	21832704	21833060	NA	NA	NA	NA	NA
PGEN_.00g198530	Scaffold_09	21843647	21869202	Q9CWK8	SNX2_MOUSE	Sorting nexin-2	GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042803; GO:0046982; GO:0051259; GO:0072673; GO:1990459; GO:1990460	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g198540	Scaffold_09	21905089	21940071	Q5GLZ8	HERC4_HUMAN	Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)	GO:0001650; GO:0004842; GO:0005829; GO:0007283; GO:0030154	cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]
PGEN_.00g198550	Scaffold_09	21942684	21943193	NA	NA	NA	NA	NA
PGEN_.00g198560	Scaffold_09	21943644	21943892	NA	NA	NA	NA	NA
PGEN_.00g198570	Scaffold_09	21944021	21950000	NA	NA	NA	NA	NA
PGEN_.00g198580	Scaffold_09	22046722	22072252	Q9TTR8	COT1_BOVIN	COUP transcription factor 1 (COUP-TF1) (COUP transcription factor I) (COUP-TF I) (Nuclear receptor subfamily 2 group F member 1)	GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0003700; GO:0003707; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048856	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g198590	Scaffold_09	22168579	22170994	NA	NA	NA	NA	NA
PGEN_.00g198600	Scaffold_09	22193104	22194330	NA	NA	NA	NA	NA
PGEN_.00g198610	Scaffold_09	22199096	22199413	NA	NA	NA	NA	NA
PGEN_.00g198620	Scaffold_09	22237617	22253252	Q863A5	DAAF4_GORGO	"Dynein assembly factor 4, axonemal (Dyslexia susceptibility 1 candidate gene 1 protein homolog)"	GO:0001764; GO:0003341; GO:0003351; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0030331; GO:0033146; GO:0036158; GO:0036159; GO:0061136; GO:0097730	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; estrogen receptor binding [GO:0030331]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; inner dynein arm assembly [GO:0036159]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136]
PGEN_.00g198630	Scaffold_09	22255789	22262576	B0BML1	GNTK_XENTR	Probable gluconokinase (EC 2.7.1.12) (Gluconate kinase)	GO:0005524; GO:0046177; GO:0046316	ATP binding [GO:0005524]; gluconokinase activity [GO:0046316]; D-gluconate catabolic process [GO:0046177]
PGEN_.00g198640	Scaffold_09	22262936	22337772	Q0P4Q4	FRMD3_XENTR	FERM domain-containing protein 3	GO:0005856; GO:0008092; GO:0016021; GO:0031032	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]
PGEN_.00g198650	Scaffold_09	22432585	22457632	Q26474	LACH_SCHAM	Lachesin	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g198660	Scaffold_09	22514838	22517062	NA	NA	NA	NA	NA
PGEN_.00g198670	Scaffold_09	22642306	22722392	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g198680	Scaffold_09	22920108	22920650	NA	NA	NA	NA	NA
PGEN_.00g198690	Scaffold_09	22921571	22922695	NA	NA	NA	NA	NA
PGEN_.00g198700	Scaffold_09	22922801	22924567	NA	NA	NA	NA	NA
PGEN_.00g198710	Scaffold_09	22987045	22988571	NA	NA	NA	NA	NA
PGEN_.00g198720	Scaffold_09	22988655	22997561	Q5U2Q4	PAR16_RAT	Protein mono-ADP-ribosyltransferase PARP16 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 15) (Poly [ADP-ribose] polymerase 16) (PARP-16)	GO:0003950; GO:0005635; GO:0005783; GO:0005789; GO:0006471; GO:0016021; GO:0019900; GO:0030968; GO:0036498; GO:0043539; GO:0060548; GO:0070213; GO:0071782; GO:0071902; GO:0140289; GO:1990404; GO:1990830	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein serine/threonine kinase activator activity [GO:0043539]; cellular response to leukemia inhibitory factor [GO:1990830]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell death [GO:0060548]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]
PGEN_.00g198730	Scaffold_09	23045128	23059186	Q9ULI1	NWD2_HUMAN	NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)		
PGEN_.00g198740	Scaffold_09	23081582	23083604	NA	NA	NA	NA	NA
PGEN_.00g198750	Scaffold_09	23091234	23096070	H2A0M3	AMO_PINMG	Putative amine oxidase [copper-containing] (EC 1.4.3.-)	GO:0005507; GO:0005576; GO:0008131; GO:0009308; GO:0048038	extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308]
PGEN_.00g198760	Scaffold_09	23103550	23105004	NA	NA	NA	NA	NA
PGEN_.00g198770	Scaffold_09	23126150	23135422	Q8N9B5	JMY_HUMAN	Junction-mediating and -regulatory protein	GO:0003713; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006281; GO:0006357; GO:0007050; GO:0031252; GO:0034314; GO:0043065; GO:0051091; GO:0070060; GO:0070358; GO:0071933; GO:0072332; GO:1901796	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; transcription coactivator activity [GO:0003713]; 'de novo' actin filament nucleation [GO:0070060]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell cycle arrest [GO:0007050]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g198780	Scaffold_09	23178732	23178974	NA	NA	NA	NA	NA
PGEN_.00g198790	Scaffold_09	23187292	23190456	NA	NA	NA	NA	NA
PGEN_.00g198800	Scaffold_09	23195640	23196929	Q2KI97	GPR84_BOVIN	G-protein coupled receptor 84	GO:0001604; GO:0005887; GO:0007218; GO:0008528	integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; urotensin II receptor activity [GO:0001604]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g198810	Scaffold_09	23200128	23205481	NA	NA	NA	NA	NA
PGEN_.00g198820	Scaffold_09	23206369	23215920	Q8K4Q6	NEIL1_MOUSE	Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (Nei homolog 1) (NEH1) (Nei-like protein 1)	GO:0003684; GO:0003906; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0006281; GO:0006284; GO:0006289; GO:0006979; GO:0008022; GO:0008270; GO:0016798; GO:0016829; GO:0019104; GO:0032074; GO:0140078	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; lyase activity [GO:0016829]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; negative regulation of nuclease activity [GO:0032074]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979]"
PGEN_.00g198830	Scaffold_09	23240648	23257237	NA	NA	NA	NA	NA
PGEN_.00g198840	Scaffold_09	23263561	23264290	NA	NA	NA	NA	NA
PGEN_.00g198850	Scaffold_09	23264723	23264980	NA	NA	NA	NA	NA
PGEN_.00g198860	Scaffold_09	23265020	23265442	NA	NA	NA	NA	NA
PGEN_.00g198870	Scaffold_09	23274509	23313511	P12394	CP17A_CHICK	"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)"	GO:0004508; GO:0005506; GO:0006694; GO:0007548; GO:0008202; GO:0016020; GO:0020037; GO:0042446; GO:0042448; GO:0047442	membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]
PGEN_.00g198880	Scaffold_09	23293273	23293554	NA	NA	NA	NA	NA
PGEN_.00g198890	Scaffold_09	23321399	23398963	Q9HCS5	E41LA_HUMAN	Band 4.1-like protein 4A (Protein NBL4)	GO:0005737; GO:0005856; GO:0008092; GO:0031032	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]
PGEN_.00g198900	Scaffold_09	23407885	23419957	Q9HCE3	ZN532_HUMAN	Zinc finger protein 532	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g198910	Scaffold_09	23434736	23463374	NA	NA	NA	NA	NA
PGEN_.00g198920	Scaffold_09	23470700	23497654	P35445	COMP_BOVIN	Cartilage oligomeric matrix protein (COMP)	GO:0002020; GO:0002063; GO:0003417; GO:0005178; GO:0005509; GO:0005518; GO:0005615; GO:0006915; GO:0006986; GO:0008201; GO:0009306; GO:0010259; GO:0010260; GO:0014829; GO:0016485; GO:0030199; GO:0030282; GO:0030500; GO:0030509; GO:0032991; GO:0035264; GO:0035988; GO:0035989; GO:0036122; GO:0043066; GO:0043395; GO:0043588; GO:0048747; GO:0048844; GO:0050881; GO:0050905; GO:0060173; GO:0062023; GO:0070527; GO:0097084; GO:1900047; GO:1902732	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020]; animal organ senescence [GO:0010260]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; muscle fiber development [GO:0048747]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; neuromuscular process [GO:0050905]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; response to unfolded protein [GO:0006986]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular smooth muscle cell development [GO:0097084]; vascular smooth muscle contraction [GO:0014829]
PGEN_.00g198930	Scaffold_09	23499982	23513346	Q9PVY0	RX1_CHICK	Retinal homeobox protein Rx1 (cRax1)	GO:0005634; GO:0006355; GO:0007275; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g198940	Scaffold_09	23537238	23552531	Q6NWC9	GKAP1_DANRE	G kinase-anchoring protein 1	GO:0005794; GO:0007165	Golgi apparatus [GO:0005794]; signal transduction [GO:0007165]
PGEN_.00g198950	Scaffold_09	23556646	23587245	P42674	BP10_PARLI	Blastula protease 10 (EC 3.4.24.-)	GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471	cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g198960	Scaffold_09	23592047	23612219	NA	NA	NA	NA	NA
PGEN_.00g198970	Scaffold_09	23619270	23627953	NA	NA	NA	NA	NA
PGEN_.00g198980	Scaffold_09	23643108	23644804	NA	NA	NA	NA	NA
PGEN_.00g198990	Scaffold_09	23652415	23656154	NA	NA	NA	NA	NA
PGEN_.00g199000	Scaffold_09	23659138	23665069	NA	NA	NA	NA	NA
PGEN_.00g199010	Scaffold_09	23683068	23691309	NA	NA	NA	NA	NA
PGEN_.00g199020	Scaffold_09	23702962	23703504	NA	NA	NA	NA	NA
PGEN_.00g199030	Scaffold_09	23712151	23713633	NA	NA	NA	NA	NA
PGEN_.00g199040	Scaffold_09	23776234	23789765	NA	NA	NA	NA	NA
PGEN_.00g199050	Scaffold_09	23794415	23794990	NA	NA	NA	NA	NA
PGEN_.00g199060	Scaffold_09	23818325	23987970	Q2VWP7	PRTG_HUMAN	Protogenin (Protein Shen-Dan)	GO:0005615; GO:0005886; GO:0016021; GO:0038023; GO:0042802; GO:0050768	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; negative regulation of neurogenesis [GO:0050768]
PGEN_.00g199070	Scaffold_09	23981137	23981985	Q96WV6	YHU2_SCHPO	Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02	GO:0010339; GO:0031362; GO:0098631	anchored component of external side of plasma membrane [GO:0031362]; external side of cell wall [GO:0010339]; cell adhesion mediator activity [GO:0098631]
PGEN_.00g199080	Scaffold_09	23994343	24015842	Q8TDY8	IGDC4_HUMAN	Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36) (hDDM36)	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g199090	Scaffold_09	24022053	24024121	NA	NA	NA	NA	NA
PGEN_.00g199100	Scaffold_09	24037083	24082352	Q91W86	VPS11_MOUSE	Vacuolar protein sorting-associated protein 11 homolog	GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0046872; GO:0048786; GO:1901998; GO:1902115; GO:1903364; GO:2000643	"actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynaptic active zone [GO:0048786]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; regulation of organelle assembly [GO:1902115]; regulation of SNARE complex assembly [GO:0035542]; toxin transport [GO:1901998]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]"
PGEN_.00g199110	Scaffold_09	24082916	24096273	NA	NA	NA	NA	NA
PGEN_.00g199120	Scaffold_09	24148857	24156066	Q9UKP5	ATS6_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)	GO:0003279; GO:0004222; GO:0005576; GO:0008237; GO:0035904; GO:0046872; GO:0060976	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]
PGEN_.00g199130	Scaffold_09	24228578	24228778	NA	NA	NA	NA	NA
PGEN_.00g199140	Scaffold_09	24242579	24280267	Q3UTY6	THSD4_MOUSE	Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4)	GO:0001527; GO:0008233; GO:0031012; GO:0048251	extracellular matrix [GO:0031012]; microfibril [GO:0001527]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251]
PGEN_.00g199150	Scaffold_09	24280554	24302247	Q9Z160	COG1_MOUSE	Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1) (Low density lipoprotein receptor defect B-complementing protein)	GO:0000139; GO:0005794; GO:0006891; GO:0015031; GO:0017119	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]
PGEN_.00g199160	Scaffold_09	24302436	24310544	Q3V0Q6	SPAG8_MOUSE	Sperm-associated antigen 8 (Sperm membrane protein 1) (SMP-1) (Sperm membrane protein BS-84)	GO:0001669; GO:0005634; GO:0005737; GO:0005819; GO:0007049; GO:0007283; GO:0007338; GO:0008017; GO:0030154; GO:0032092; GO:0045944	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]
PGEN_.00g199170	Scaffold_09	24314302	24315081	NA	NA	NA	NA	NA
PGEN_.00g199180	Scaffold_09	24315415	24316167	NA	NA	NA	NA	NA
PGEN_.00g199190	Scaffold_09	24324240	24329954	NA	NA	NA	NA	NA
PGEN_.00g199200	Scaffold_09	24341954	24343106	NA	NA	NA	NA	NA
PGEN_.00g199210	Scaffold_09	24343461	24343757	NA	NA	NA	NA	NA
PGEN_.00g199220	Scaffold_09	24351915	24366701	NA	NA	NA	NA	NA
PGEN_.00g199230	Scaffold_09	24396425	24399810	NA	NA	NA	NA	NA
PGEN_.00g199240	Scaffold_09	24423247	24423585	NA	NA	NA	NA	NA
PGEN_.00g199250	Scaffold_09	24423955	24424347	NA	NA	NA	NA	NA
PGEN_.00g199260	Scaffold_09	24424357	24424623	NA	NA	NA	NA	NA
PGEN_.00g199270	Scaffold_09	24431349	24451408	A2AKG8	FOCAD_MOUSE	Focadhesin	GO:0005925; GO:0016021	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]
PGEN_.00g199280	Scaffold_09	24451534	24452007	NA	NA	NA	NA	NA
PGEN_.00g199290	Scaffold_09	24452048	24457570	Q5VW36	FOCAD_HUMAN	Focadhesin	GO:0005925; GO:0016021	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]
PGEN_.00g199300	Scaffold_09	24466235	24466712	NA	NA	NA	NA	NA
PGEN_.00g199310	Scaffold_09	24472523	24508709	NA	NA	NA	NA	NA
PGEN_.00g199320	Scaffold_09	24527376	24527786	NA	NA	NA	NA	NA
PGEN_.00g199330	Scaffold_09	24529940	24531010	NA	NA	NA	NA	NA
PGEN_.00g199340	Scaffold_09	24547904	24574731	Q5VW36	FOCAD_HUMAN	Focadhesin	GO:0005925; GO:0016021	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]
PGEN_.00g199350	Scaffold_09	24586042	24586704	NA	NA	NA	NA	NA
PGEN_.00g199360	Scaffold_09	24688842	24690263	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g199370	Scaffold_09	24696263	24696928	NA	NA	NA	NA	NA
PGEN_.00g199380	Scaffold_09	24697234	24697554	NA	NA	NA	NA	NA
PGEN_.00g199390	Scaffold_09	24697695	24697982	NA	NA	NA	NA	NA
PGEN_.00g199400	Scaffold_09	24698152	24698373	NA	NA	NA	NA	NA
PGEN_.00g199410	Scaffold_09	24698584	24698838	NA	NA	NA	NA	NA
PGEN_.00g199420	Scaffold_09	24718422	24718622	NA	NA	NA	NA	NA
PGEN_.00g199430	Scaffold_09	24720315	24725280	P13952	CCNB_SPISO	G2/mitotic-specific cyclin-B	GO:0005634; GO:0007049; GO:0051301	nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g199440	Scaffold_09	24733594	24756668	P15801	DPOG_YEAST	DNA polymerase gamma (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit)	GO:0000002; GO:0003677; GO:0003887; GO:0005739; GO:0005760; GO:0006264; GO:0008408; GO:0032043	gamma DNA polymerase complex [GO:0005760]; mitochondrion [GO:0005739]; 3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; mitochondrial DNA catabolic process [GO:0032043]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002]
PGEN_.00g199450	Scaffold_09	24758289	24760670	Q8IYB1	M21D2_HUMAN	Protein MB21D2 (Mab-21 domain-containing protein 2)	GO:0044877; GO:0045296	cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]
PGEN_.00g199460	Scaffold_09	24761743	24763317	Q9QYV8	DPOG1_RAT	DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha)	GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0004527; GO:0005739; GO:0005760; GO:0006261; GO:0006264; GO:0006287; GO:0007568; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0055093; GO:0071333	"gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; protease binding [GO:0002020]; aging [GO:0007568]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; DNA-dependent DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]"
PGEN_.00g199470	Scaffold_09	24772356	24784831	Q8TB03	CX038_HUMAN	Uncharacterized protein CXorf38		
PGEN_.00g199480	Scaffold_09	24809820	24817126	P54098	DPOG1_HUMAN	DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha)	GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0005623; GO:0005739; GO:0005760; GO:0006259; GO:0006261; GO:0006264; GO:0006287; GO:0007568; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0055093; GO:0071333	"cell [GO:0005623]; gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]; aging [GO:0007568]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; DNA metabolic process [GO:0006259]; DNA-dependent DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]"
PGEN_.00g199490	Scaffold_09	24817156	24820287	NA	NA	NA	NA	NA
PGEN_.00g199500	Scaffold_09	24820501	24844517	Q9JJP9	UBQL1_RAT	Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)	GO:0000045; GO:0000502; GO:0005634; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0019904; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1903071	aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g199510	Scaffold_09	24866431	24866790	NA	NA	NA	NA	NA
PGEN_.00g199520	Scaffold_09	24866889	24868805	NA	NA	NA	NA	NA
PGEN_.00g199530	Scaffold_09	24869980	24870249	NA	NA	NA	NA	NA
PGEN_.00g199540	Scaffold_09	24874107	24874646	Q9VUL9	FUCTA_DROME	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920	"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]"
PGEN_.00g199550	Scaffold_09	24878281	24894330	Q3SX11	NSA2_BOVIN	Ribosome biogenesis protein NSA2 homolog (TGF-beta-inducible nuclear protein 1)	GO:0005730; GO:0006364; GO:0030687	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; rRNA processing [GO:0006364]"
PGEN_.00g199560	Scaffold_09	24895241	24903206	Q5XH48	EDC3_XENLA	Enhancer of mRNA-decapping protein 3 (YjeF domain-containing protein 1)	GO:0000932; GO:0003729; GO:0031087	P-body [GO:0000932]; mRNA binding [GO:0003729]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]
PGEN_.00g199570	Scaffold_09	24920274	24925015	Q9VVI3	NEDD4_DROME	E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4)	GO:0000209; GO:0002092; GO:0004842; GO:0005112; GO:0005737; GO:0005886; GO:0006511; GO:0007219; GO:0007411; GO:0007528; GO:0008586; GO:0016199; GO:0016567; GO:0017022; GO:0019904; GO:0031623; GO:0043161; GO:0045732; GO:0045746; GO:0045807; GO:0045879; GO:0048814; GO:0051965; GO:0061630; GO:1905062; GO:1905306; GO:2000650	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g199580	Scaffold_09	24927413	24953480	P46935	NEDD4_MOUSE	E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4)	GO:0000122; GO:0000151; GO:0000209; GO:0000785; GO:0002250; GO:0003151; GO:0003197; GO:0004842; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006511; GO:0006513; GO:0006622; GO:0007528; GO:0008022; GO:0010766; GO:0010768; GO:0014068; GO:0016020; GO:0016567; GO:0019089; GO:0019871; GO:0019904; GO:0030948; GO:0031175; GO:0031623; GO:0031698; GO:0032801; GO:0035255; GO:0042110; GO:0042391; GO:0042921; GO:0043130; GO:0043161; GO:0043162; GO:0043197; GO:0044111; GO:0045121; GO:0045732; GO:0046824; GO:0048471; GO:0048514; GO:0048814; GO:0050807; GO:0050815; GO:0050816; GO:0050847; GO:0061630; GO:0070063; GO:0070064; GO:0070534; GO:0098978; GO:0099149; GO:0099524; GO:0099576; GO:1901016; GO:2000650	"cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ubiquitin ligase complex [GO:0000151]; beta-2 adrenergic receptor binding [GO:0031698]; ionotropic glutamate receptor binding [GO:0035255]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; adaptive immune response [GO:0002250]; blood vessel morphogenesis [GO:0048514]; development involved in symbiotic interaction [GO:0044111]; endocardial cushion development [GO:0003197]; glucocorticoid receptor signaling pathway [GO:0042921]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; outflow tract morphogenesis [GO:0003151]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; T cell activation [GO:0042110]; transmission of virus [GO:0019089]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"
PGEN_.00g199590	Scaffold_09	24960762	24961007	NA	NA	NA	NA	NA
PGEN_.00g199600	Scaffold_09	24977246	24977806	O16277	H16_CAEEL	Putative histone H1.6 (Histone H1-like protein 6)	GO:0000786; GO:0003690; GO:0005634; GO:0006334; GO:0006355; GO:0016584; GO:0030261; GO:0031492; GO:0031936; GO:0045910	"nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g199610	Scaffold_09	24984582	24988592	P49914	MTHFS_HUMAN	"5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase)"	GO:0005524; GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006536; GO:0009396; GO:0015942; GO:0030272; GO:0035999; GO:0046653; GO:0046655; GO:0046657; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]; folic acid catabolic process [GO:0046657]; folic acid metabolic process [GO:0046655]; folic acid-containing compound biosynthetic process [GO:0009396]; formate metabolic process [GO:0015942]; glutamate metabolic process [GO:0006536]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]
PGEN_.00g199620	Scaffold_09	25022248	25022595	NA	NA	NA	NA	NA
PGEN_.00g199630	Scaffold_09	25024593	25049699	NA	NA	NA	NA	NA
PGEN_.00g199640	Scaffold_09	25074931	25113661	Q7Z401	MYCPP_HUMAN	C-myc promoter-binding protein (DENN domain-containing protein 4A)	GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0017112	"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g199650	Scaffold_09	25117841	25118080	NA	NA	NA	NA	NA
PGEN_.00g199660	Scaffold_09	25123535	25140746	Q8JG64	PDIA3_CHICK	Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein)	GO:0003756; GO:0005615; GO:0005623; GO:0005783; GO:0005788; GO:0006457; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0042802; GO:0042824; GO:0045454; GO:0098761; GO:2001238	cell [GO:0005623]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g199670	Scaffold_09	25148401	25154699	Q9JJZ6	KLF13_MOUSE	Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Erythroid transcription factor FKLF-2) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3)	GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0006366; GO:0008285; GO:0045647; GO:0045944; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g199680	Scaffold_09	25176467	25176769	NA	NA	NA	NA	NA
PGEN_.00g199690	Scaffold_09	25203752	25203991	NA	NA	NA	NA	NA
PGEN_.00g199700	Scaffold_09	25249453	25259028	O95714	HERC2_HUMAN	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g199710	Scaffold_09	25280112	25280900	NA	NA	NA	NA	NA
PGEN_.00g199720	Scaffold_09	25324233	25377874	Q5F3D7	UTP15_CHICK	U3 small nucleolar RNA-associated protein 15 homolog	GO:0001650; GO:0005730; GO:0005783; GO:0006364; GO:0045943; GO:2000234	endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]
PGEN_.00g199730	Scaffold_09	25411842	25451648	Q4H3P5	DRI_CIOIN	Protein dead ringer homolog	GO:0000977; GO:0001228; GO:0005634	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]"
PGEN_.00g199740	Scaffold_09	25485099	25502449	NA	NA	NA	NA	NA
PGEN_.00g199750	Scaffold_09	25514623	25522766	NA	NA	NA	NA	NA
PGEN_.00g199760	Scaffold_09	25522797	25528095	NA	NA	NA	NA	NA
PGEN_.00g199770	Scaffold_09	25535868	25601984	Q8NDA2	HMCN2_HUMAN	Hemicentin-2	GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g199780	Scaffold_09	25775864	25776967	NA	NA	NA	NA	NA
PGEN_.00g199790	Scaffold_09	25895334	25902765	NA	NA	NA	NA	NA
PGEN_.00g199800	Scaffold_09	25926123	25930333	NA	NA	NA	NA	NA
PGEN_.00g199810	Scaffold_09	25944203	25973566	P28840	NEC1_RAT	Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Prohormone convertase 1) (Proprotein convertase 1) (PC1)	GO:0004175; GO:0004252; GO:0005615; GO:0005791; GO:0005802; GO:0006508; GO:0009749; GO:0010035; GO:0010157; GO:0014070; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0021983; GO:0022008; GO:0030133; GO:0030141; GO:0030425; GO:0031016; GO:0031667; GO:0032496; GO:0034774; GO:0042493; GO:0042802; GO:0043005; GO:0043025; GO:0043043; GO:0043204; GO:0043278; GO:0043434; GO:0043559; GO:0043679; GO:0044877; GO:0048471; GO:0048678; GO:0050714; GO:0051087; GO:0051384; GO:0051592; GO:0070542; GO:0070555	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to inorganic substance [GO:0010035]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]
PGEN_.00g199820	Scaffold_09	25978559	25979857	NA	NA	NA	NA	NA
PGEN_.00g199830	Scaffold_09	25985571	25988336	NA	NA	NA	NA	NA
PGEN_.00g199840	Scaffold_09	26007076	26008062	NA	NA	NA	NA	NA
PGEN_.00g199850	Scaffold_09	26026223	26047929	NA	NA	NA	NA	NA
PGEN_.00g199860	Scaffold_09	26079371	26088003	NA	NA	NA	NA	NA
PGEN_.00g199870	Scaffold_09	26093792	26094052	NA	NA	NA	NA	NA
PGEN_.00g199880	Scaffold_09	26098419	26101173	NA	NA	NA	NA	NA
PGEN_.00g199890	Scaffold_09	26109740	26109985	NA	NA	NA	NA	NA
PGEN_.00g199900	Scaffold_09	26195092	26202087	NA	NA	NA	NA	NA
PGEN_.00g199910	Scaffold_09	26229661	26251055	NA	NA	NA	NA	NA
PGEN_.00g199920	Scaffold_09	26251086	26278614	P20000	ALDH2_BOVIN	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)"	GO:0004029; GO:0005759; GO:0006068; GO:0043878; GO:0051287	mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; ethanol catabolic process [GO:0006068]
PGEN_.00g199930	Scaffold_09	26285605	26287080	NA	NA	NA	NA	NA
PGEN_.00g199940	Scaffold_09	26316208	26320648	NA	NA	NA	NA	NA
PGEN_.00g199950	Scaffold_09	26325687	26339962	Q6NWW5	KIF24_MOUSE	Kinesin-like protein KIF24	GO:0003777; GO:0005524; GO:0005737; GO:0005814; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0016887; GO:0032991; GO:0042802; GO:0060271	centriole [GO:0005814]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]
PGEN_.00g199960	Scaffold_09	26354583	26372783	NA	NA	NA	NA	NA
PGEN_.00g199970	Scaffold_09	26374034	26380651	Q5FVK8	AL14E_RAT	ARL14 effector protein (ARF7 effector protein)	GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0005925; GO:0043231	cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
PGEN_.00g199980	Scaffold_09	26387289	26410778	NA	NA	NA	NA	NA
PGEN_.00g199990	Scaffold_09	26417866	26418231	NA	NA	NA	NA	NA
PGEN_.00g200000	Scaffold_09	26431071	26432074	NA	NA	NA	NA	NA
PGEN_.00g200010	Scaffold_09	26432196	26432756	NA	NA	NA	NA	NA
PGEN_.00g200020	Scaffold_09	26440636	26482464	P90884	MADD4_CAEEL	Protein madd-4 (Punctin)	GO:0005102; GO:0005615; GO:0008233; GO:0030054; GO:0030424; GO:0033563; GO:0045202; GO:0050808	axon [GO:0030424]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; dorsal/ventral axon guidance [GO:0033563]; synapse organization [GO:0050808]
PGEN_.00g200030	Scaffold_09	26484235	26496482	Q5RET3	AAGAB_PONAB	Alpha- and gamma-adaptin-binding protein p34	GO:0005829; GO:0015031	cytosol [GO:0005829]; protein transport [GO:0015031]
PGEN_.00g200040	Scaffold_09	26510079	26543191	Q9D2K4	IQCH_MOUSE	IQ domain-containing protein H		
PGEN_.00g200050	Scaffold_09	26548521	26556446	Q3TX08	TRM1_MOUSE	"tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase)"	GO:0000049; GO:0002940; GO:0004809; GO:0046872	metal ion binding [GO:0046872]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]; tRNA N2-guanine methylation [GO:0002940]
PGEN_.00g200060	Scaffold_09	26560120	26582633	Q15126	PMVK_HUMAN	Phosphomevalonate kinase (PMKase) (hPMK) (EC 2.7.4.2)	GO:0004631; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0016020; GO:0016126; GO:0019287; GO:0045540; GO:0070062; GO:0070723	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; regulation of cholesterol biosynthetic process [GO:0045540]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]"
PGEN_.00g200070	Scaffold_09	26582681	26605868	Q3T0D0	HNRPK_BOVIN	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)	GO:0002102; GO:0003677; GO:0003723; GO:0005654; GO:0005681; GO:0005737; GO:0006357; GO:0006397; GO:0008380; GO:0030054; GO:0042995	cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; podosome [GO:0002102]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]
PGEN_.00g200080	Scaffold_09	26621567	26628217	Q8TBF8	FA81A_HUMAN	Protein FAM81A		
PGEN_.00g200090	Scaffold_09	26630982	26633434	NA	NA	NA	NA	NA
PGEN_.00g200100	Scaffold_09	26640175	26646505	Q8TBF8	FA81A_HUMAN	Protein FAM81A		
PGEN_.00g200110	Scaffold_09	26747690	26753876	Q02078	MEF2A_HUMAN	Myocyte-specific enhancer factor 2A (Serum response factor-like protein 1)	GO:0000002; GO:0000122; GO:0000165; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001085; GO:0001228; GO:0003682; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006351; GO:0006915; GO:0007275; GO:0007507; GO:0007517; GO:0008134; GO:0010613; GO:0019901; GO:0033613; GO:0035035; GO:0042826; GO:0043565; GO:0044212; GO:0045944; GO:0046326; GO:0046332; GO:0046982; GO:0048311; GO:0048813; GO:0051149; GO:0055005; GO:0061337; GO:0070375; GO:0071277	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glucose import [GO:0046326]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]; ventricular cardiac myofibril assembly [GO:0055005]"
PGEN_.00g200120	Scaffold_09	26763516	26763911	NA	NA	NA	NA	NA
PGEN_.00g200130	Scaffold_09	26791629	26791982	NA	NA	NA	NA	NA
PGEN_.00g200140	Scaffold_09	26807214	26807456	NA	NA	NA	NA	NA
PGEN_.00g200150	Scaffold_09	26807523	26807927	NA	NA	NA	NA	NA
PGEN_.00g200160	Scaffold_09	26827974	26837212	Q14814	MEF2D_HUMAN	Myocyte-specific enhancer factor 2D	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0001958; GO:0002062; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006915; GO:0007275; GO:0007399; GO:0007512; GO:0007517; GO:0008134; GO:0033613; GO:0035914; GO:0042803; GO:0042826; GO:0043231; GO:0043565; GO:0044212; GO:0045944; GO:0046982; GO:1904707	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; adult heart development [GO:0007512]; apoptotic process [GO:0006915]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; osteoblast differentiation [GO:0001649]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; skeletal muscle cell differentiation [GO:0035914]"
PGEN_.00g200170	Scaffold_09	26844118	26850315	O96011	PX11B_HUMAN	Peroxisomal membrane protein 11B (Peroxin-11B) (Peroxisomal biogenesis factor 11B) (Protein PEX11 homolog beta) (PEX11-beta)	GO:0005739; GO:0005777; GO:0005778; GO:0005779; GO:0007031; GO:0007165; GO:0016020; GO:0016559; GO:0032991; GO:0042803; GO:0043231; GO:0044375; GO:0051260	integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; protein homodimerization activity [GO:0042803]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; protein homooligomerization [GO:0051260]; regulation of peroxisome size [GO:0044375]; signal transduction [GO:0007165]
PGEN_.00g200180	Scaffold_09	26850656	26916113	Q6P2C0	WDR93_HUMAN	WD repeat-containing protein 93	GO:0005747; GO:0008137; GO:0022900	mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; electron transport chain [GO:0022900]
PGEN_.00g200190	Scaffold_09	26920774	26921175	NA	NA	NA	NA	NA
PGEN_.00g200200	Scaffold_09	26933957	26957093	Q8WXR4	MYO3B_HUMAN	Myosin-IIIb (EC 2.7.11.1)	GO:0003774; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0032426; GO:0050896; GO:0090103	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g200210	Scaffold_09	26958379	26970357	G5EBQ8	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063	cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]
PGEN_.00g200220	Scaffold_09	27076573	27076809	NA	NA	NA	NA	NA
PGEN_.00g200230	Scaffold_09	27088092	27103673	NA	NA	NA	NA	NA
PGEN_.00g200240	Scaffold_09	27123812	27124222	NA	NA	NA	NA	NA
PGEN_.00g200250	Scaffold_09	27220204	27222026	Q8JIT6	FOXB2_XENLA	Forkhead box protein B2 (FoxB2) (xFoxB2) (Fork head domain-related protein 5) (FD-5) (xFD-5)	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0043565	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g200260	Scaffold_09	27251039	27251883	NA	NA	NA	NA	NA
PGEN_.00g200270	Scaffold_09	27266743	27281357	P75063	Y051_MYCPN	Uncharacterized protein MG039 homolog	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g200280	Scaffold_09	27293053	27303238	Q96P65	QRFPR_HUMAN	Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)	GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g200290	Scaffold_09	27362787	27375588	NA	NA	NA	NA	NA
PGEN_.00g200300	Scaffold_09	27453540	27469338	NA	NA	NA	NA	NA
PGEN_.00g200310	Scaffold_09	27474713	27479645	P70412	CUZD1_MOUSE	CUB and zona pellucida-like domain-containing protein 1 (CUB and ZP domain-containing protein 1) (Integral membrane-associated protein 1)	GO:0007049; GO:0007155; GO:0007565; GO:0009755; GO:0016021; GO:0030658; GO:0032023; GO:0042588; GO:0042589; GO:0051301	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; zymogen granule [GO:0042588]; zymogen granule membrane [GO:0042589]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; female pregnancy [GO:0007565]; hormone-mediated signaling pathway [GO:0009755]; trypsinogen activation [GO:0032023]
PGEN_.00g200320	Scaffold_09	27485102	27492420	B8NR70	DTPB_ASPFN	N-methyltransferase dtpB (EC 2.1.1.-) (Ditryptophenaline biosynthesis protein B)	GO:0008168; GO:0009820; GO:0032259	methyltransferase activity [GO:0008168]; alkaloid metabolic process [GO:0009820]; methylation [GO:0032259]
PGEN_.00g200330	Scaffold_09	27711346	27711585	NA	NA	NA	NA	NA
PGEN_.00g200340	Scaffold_09	27812726	27812977	NA	NA	NA	NA	NA
PGEN_.00g200350	Scaffold_09	27833320	27836314	A1L3F4	MEX3B_XENLA	RNA-binding protein MEX3B (RING finger and KH domain-containing protein 3)	GO:0000932; GO:0003723; GO:0005634; GO:0046872	nucleus [GO:0005634]; P-body [GO:0000932]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]
PGEN_.00g200360	Scaffold_09	27867207	27867548	NA	NA	NA	NA	NA
PGEN_.00g200370	Scaffold_09	27878686	27879006	NA	NA	NA	NA	NA
PGEN_.00g200380	Scaffold_09	27879543	27880592	NA	NA	NA	NA	NA
PGEN_.00g200390	Scaffold_09	27880653	27881291	NA	NA	NA	NA	NA
PGEN_.00g200400	Scaffold_09	27890607	27890948	NA	NA	NA	NA	NA
PGEN_.00g200410	Scaffold_09	27910462	27920344	Q5RBJ7	TM6S1_PONAB	Transmembrane 6 superfamily member 1	GO:0005765; GO:0016021	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]
PGEN_.00g200420	Scaffold_09	27924637	27932139	P24368	PPIB_RAT	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)	GO:0000413; GO:0003755; GO:0005654; GO:0005788; GO:0005790; GO:0016018; GO:0032991; GO:0034663; GO:0040018; GO:0042026; GO:0042470; GO:0044794; GO:0044829; GO:0048471; GO:0050821; GO:0051082; GO:0051169; GO:0060348; GO:0061077; GO:0070063	endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; nuclear transport [GO:0051169]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral process [GO:0044794]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]
PGEN_.00g200430	Scaffold_09	27935991	27945090	NA	NA	NA	NA	NA
PGEN_.00g200440	Scaffold_09	27945427	27964441	NA	NA	NA	NA	NA
PGEN_.00g200450	Scaffold_09	27964573	28008106	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g200460	Scaffold_09	28073332	28073745	NA	NA	NA	NA	NA
PGEN_.00g200470	Scaffold_09	28082395	28085045	NA	NA	NA	NA	NA
PGEN_.00g200480	Scaffold_09	28087159	28155909	Q62441	TLE4_MOUSE	Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4)	GO:0000122; GO:0000981; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0045892; GO:0070491; GO:0090090; GO:1990830; GO:1990907	"beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g200490	Scaffold_09	28165669	28166115	NA	NA	NA	NA	NA
PGEN_.00g200500	Scaffold_09	28173007	28180553	NA	NA	NA	NA	NA
PGEN_.00g200510	Scaffold_09	28180619	28213042	F6S215	AP5B1_XENTR	AP-5 complex subunit beta-1 (Adaptor-related protein complex 5 beta subunit) (Beta5)	GO:0015031; GO:0016197; GO:0030119	AP-type membrane coat adaptor complex [GO:0030119]; endosomal transport [GO:0016197]; protein transport [GO:0015031]
PGEN_.00g200520	Scaffold_09	28217191	28217712	NA	NA	NA	NA	NA
PGEN_.00g200530	Scaffold_09	28218826	28219110	NA	NA	NA	NA	NA
PGEN_.00g200540	Scaffold_09	28223451	28243694	Q5F478	ANR44_CHICK	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)		
PGEN_.00g200550	Scaffold_09	28245124	28278846	Q26474	LACH_SCHAM	Lachesin	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g200560	Scaffold_09	28308444	28310020	NA	NA	NA	NA	NA
PGEN_.00g200570	Scaffold_09	28349312	28367832	Q6GQQ9	OTU7B_HUMAN	OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Cezanne) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne)	GO:0000122; GO:0001701; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0008234; GO:0008270; GO:0016579; GO:0032717; GO:0035871; GO:0036459; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947; GO:1900181; GO:1990380	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]
PGEN_.00g200580	Scaffold_09	28376202	28382981	Q6ZSB9	ZBT49_HUMAN	Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509)	GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g200590	Scaffold_09	28408825	28411520	P41239	CSK_CHICK	Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase)	GO:0002250; GO:0004715; GO:0005524; GO:0005737; GO:0034332; GO:0046872; GO:0060368	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]
PGEN_.00g200600	Scaffold_09	28422440	28424702	P41239	CSK_CHICK	Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase)	GO:0002250; GO:0004715; GO:0005524; GO:0005737; GO:0034332; GO:0046872; GO:0060368	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]
PGEN_.00g200610	Scaffold_09	28426574	28427706	G5ECJ6	CSK1_CAEEL	Tyrosine-protein kinase csk-1 (EC 2.7.10.2) (C-terminal src kinase)	GO:0002119; GO:0004713; GO:0004715; GO:0005524; GO:0005886; GO:0005911; GO:0009792; GO:0030536; GO:0043050; GO:0046872; GO:0048747	cell-cell junction [GO:0005911]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; embryo development ending in birth or egg hatching [GO:0009792]; larval feeding behavior [GO:0030536]; muscle fiber development [GO:0048747]; nematode larval development [GO:0002119]; pharyngeal pumping [GO:0043050]
PGEN_.00g200620	Scaffold_09	28437759	28481690	O15031	PLXB2_HUMAN	Plexin-B2 (MM1)	GO:0001843; GO:0001932; GO:0002116; GO:0005887; GO:0007156; GO:0007162; GO:0007405; GO:0007420; GO:0008360; GO:0009986; GO:0010976; GO:0017154; GO:0030334; GO:0043087; GO:0050772; GO:0070062; GO:0071526; GO:1902287; GO:1904861; GO:2001222	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]
PGEN_.00g200630	Scaffold_09	28628392	28629063	NA	NA	NA	NA	NA
PGEN_.00g200640	Scaffold_09	28634461	28696201	Q98919	LSAMP_CHICK	Limbic system-associated membrane protein (CHLAMP G19-isoform) (E19S)	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g200650	Scaffold_09	28890431	28904423	Q4R3J7	DCA12_MACFA	DDB1- and CUL4-associated factor 12 (WD repeat-containing protein 40A)	GO:0005737; GO:0005813; GO:0016567; GO:0080008	centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; protein ubiquitination [GO:0016567]
PGEN_.00g200660	Scaffold_09	28909392	28920202	NA	NA	NA	NA	NA
PGEN_.00g200670	Scaffold_09	29011439	29040199	Q9DEY9	BLM_XENLA	Bloom syndrome protein homolog (xBLM) (EC 3.6.4.12) (RecQ helicase homolog)	GO:0000400; GO:0000729; GO:0003677; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006310; GO:0008094; GO:0008270; GO:0009378; GO:0032508; GO:0042803; GO:0043138; GO:0051259; GO:0051260; GO:0061749; GO:0090329	nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of DNA-dependent DNA replication [GO:0090329]
PGEN_.00g200680	Scaffold_09	29052120	29073298	Q6NUT3	MFS12_HUMAN	Major facilitator superfamily domain-containing protein 12	GO:0005765; GO:0005887; GO:0008643; GO:0015293; GO:0071702	integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; organic substance transport [GO:0071702]
PGEN_.00g200690	Scaffold_09	29083039	29090703	P40854	MSOX_STRSB	Monomeric sarcosine oxidase (MSOX) (EC 1.5.3.1)	GO:0005737; GO:0008115; GO:0046653	cytoplasm [GO:0005737]; sarcosine oxidase activity [GO:0008115]; tetrahydrofolate metabolic process [GO:0046653]
PGEN_.00g200700	Scaffold_09	29095367	29114428	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g200710	Scaffold_09	29120834	29140416	Q4U2R1	HERC2_MOUSE	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g200720	Scaffold_09	29141392	29149743	NA	NA	NA	NA	NA
PGEN_.00g200730	Scaffold_09	29151844	29167025	NA	NA	NA	NA	NA
PGEN_.00g200740	Scaffold_09	29174275	29199030	Q5ZIJ9	MIB2_CHICK	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)	GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g200750	Scaffold_09	29219489	29221999	NA	NA	NA	NA	NA
PGEN_.00g200760	Scaffold_09	29229711	29249504	Q9VR91	HERC2_DROME	Probable E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005634; GO:0005737; GO:0005814; GO:0016567; GO:0046872	centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]
PGEN_.00g200770	Scaffold_09	29295377	29299129	NA	NA	NA	NA	NA
PGEN_.00g200780	Scaffold_09	29301125	29303535	NA	NA	NA	NA	NA
PGEN_.00g200790	Scaffold_09	29304497	29305909	P86789	GIGA6_CRAGI	Gigasin-6	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g200800	Scaffold_09	29312810	29313630	P86789	GIGA6_CRAGI	Gigasin-6	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g200810	Scaffold_09	29334506	29338411	NA	NA	NA	NA	NA
PGEN_.00g200820	Scaffold_09	29338873	29340144	NA	NA	NA	NA	NA
PGEN_.00g200830	Scaffold_09	29342728	29347137	NA	NA	NA	NA	NA
PGEN_.00g200840	Scaffold_09	29398434	29398715	NA	NA	NA	NA	NA
PGEN_.00g200850	Scaffold_09	29400862	29405828	NA	NA	NA	NA	NA
PGEN_.00g200860	Scaffold_09	29451972	29454451	NA	NA	NA	NA	NA
PGEN_.00g200870	Scaffold_09	29460355	29461355	NA	NA	NA	NA	NA
PGEN_.00g200880	Scaffold_09	29462387	29468193	P82912	RT11_HUMAN	"28S ribosomal protein S11, mitochondrial (MRP-S11) (S11mt) (Cervical cancer proto-oncogene 2 protein) (HCC-2) (Mitochondrial small ribosomal subunit protein uS11m)"	GO:0000028; GO:0000462; GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0032543; GO:0042769; GO:0048027; GO:0070125; GO:0070126; GO:0070181	"mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; DNA damage response, detection of DNA damage [GO:0042769]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"
PGEN_.00g200890	Scaffold_09	29482226	29507978	Q3B7U9	FKBP8_RAT	Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (FK506-binding protein 8) (FKBP-8) (Rotamase)	GO:0001708; GO:0001933; GO:0003755; GO:0005740; GO:0005829; GO:0006915; GO:0007224; GO:0009953; GO:0010468; GO:0021904; GO:0021915; GO:0030176; GO:0030510; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0042802; GO:0043010; GO:0043066; GO:0097718	cytosol [GO:0005829]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial envelope [GO:0005740]; mitochondrial membrane [GO:0031966]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; neural tube development [GO:0021915]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of BMP signaling pathway [GO:0030510]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]
PGEN_.00g200900	Scaffold_09	29508164	29511708	Q5U1W5	U1SBP_RAT	U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U1 snRNP-binding protein homolog)	GO:0000398; GO:0003729; GO:0005634; GO:0005689	"nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; mRNA binding [GO:0003729]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g200910	Scaffold_09	29531263	29547119	Q5ZJ01	AB17B_CHICK	Alpha/beta hydrolase domain-containing protein 17B (Abhydrolase domain-containing protein 17B) (EC 3.1.2.22)	GO:0008474; GO:0030054; GO:0043197; GO:0055038; GO:0098839	cell junction [GO:0030054]; dendritic spine [GO:0043197]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]
PGEN_.00g200920	Scaffold_09	29552870	29589518	Q5T6F2	UBAP2_HUMAN	Ubiquitin-associated protein 2 (UBAP-2)	GO:0003723; GO:0005737; GO:0045296	cytoplasm [GO:0005737]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]
PGEN_.00g200930	Scaffold_09	29617516	29639336	Q54728	Y1686_STRPN	Uncharacterized oxidoreductase SP_1686 (EC 1.-.-.-)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g200940	Scaffold_09	29656570	29656863	NA	NA	NA	NA	NA
PGEN_.00g200950	Scaffold_09	29656926	29682713	NA	NA	NA	NA	NA
PGEN_.00g200960	Scaffold_09	29694645	29720143	NA	NA	NA	NA	NA
PGEN_.00g200970	Scaffold_09	29758490	29760181	NA	NA	NA	NA	NA
PGEN_.00g200980	Scaffold_09	29807729	29807995	NA	NA	NA	NA	NA
PGEN_.00g200990	Scaffold_09	29871362	29915749	Q92824	PCSK5_HUMAN	Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (hPC6) (Subtilisin/kexin-like protease PC5)	GO:0001822; GO:0002001; GO:0003279; GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005794; GO:0005796; GO:0005802; GO:0006465; GO:0007267; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030141; GO:0030173; GO:0030323; GO:0032455; GO:0035108; GO:0042089; GO:0042277; GO:0043043; GO:0048566; GO:0048706; GO:0051004; GO:0060976	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; cell-cell signaling [GO:0007267]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; nerve growth factor processing [GO:0032455]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]
PGEN_.00g201000	Scaffold_09	29967216	29985960	NA	NA	NA	NA	NA
PGEN_.00g201010	Scaffold_09	29985993	29987418	Q924T9	CLTR2_RAT	Cysteinyl leukotriene receptor 2 (CysLTR2) (RSBPT32)	GO:0001631; GO:0004966; GO:0005887; GO:0007218; GO:0008528; GO:0010942; GO:0016020; GO:0045766; GO:0070374	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cysteinyl leukotriene receptor activity [GO:0001631]; G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; neuropeptide signaling pathway [GO:0007218]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell death [GO:0010942]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]
PGEN_.00g201020	Scaffold_09	30055311	30055556	NA	NA	NA	NA	NA
PGEN_.00g201030	Scaffold_09	30155240	30168794	Q91W67	UBL7_MOUSE	Ubiquitin-like protein 7	GO:0005829; GO:0006511; GO:0031593	cytosol [GO:0005829]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g201040	Scaffold_09	30171536	30187331	P05099	MATN1_CHICK	Cartilage matrix protein (Matrilin-1)	GO:0003429; GO:0005201; GO:0005509; GO:0005615; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g201050	Scaffold_09	30194307	30206575	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g201060	Scaffold_09	30212897	30214356	NA	NA	NA	NA	NA
PGEN_.00g201070	Scaffold_09	30252727	30253164	NA	NA	NA	NA	NA
PGEN_.00g201080	Scaffold_09	30263053	30267080	NA	NA	NA	NA	NA
PGEN_.00g201090	Scaffold_09	30297986	30298246	NA	NA	NA	NA	NA
PGEN_.00g201100	Scaffold_09	30378526	30397548	E9PV86	MCTP1_MOUSE	Multiple C2 and transmembrane domain-containing protein 1	GO:0005509; GO:0005789; GO:0016021; GO:0030054; GO:0030336; GO:0030672; GO:0045806; GO:0046928; GO:0055037; GO:1902883	cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]; regulation of neurotransmitter secretion [GO:0046928]
PGEN_.00g201110	Scaffold_09	30404079	30404381	NA	NA	NA	NA	NA
PGEN_.00g201120	Scaffold_09	30405955	30406965	P03360	POL_AVIRE	Gag-Pol polyprotein [Cleaved into: Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)] (Fragment)	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0046872; GO:0075713	aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]
PGEN_.00g201130	Scaffold_09	30407066	30407557	NA	NA	NA	NA	NA
PGEN_.00g201140	Scaffold_09	30413544	30425969	NA	NA	NA	NA	NA
PGEN_.00g201150	Scaffold_09	30445073	30445966	NA	NA	NA	NA	NA
PGEN_.00g201160	Scaffold_09	30458399	30458722	NA	NA	NA	NA	NA
PGEN_.00g201170	Scaffold_09	30469255	30481690	P13234	KCC4_RAT	Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) (Calspermin)	GO:0001650; GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006913; GO:0006954; GO:0007165; GO:0007270; GO:0007616; GO:0009931; GO:0018105; GO:0035556; GO:0043011; GO:0045893; GO:0046777; GO:0046827; GO:0098794; GO:0098978; GO:0098982; GO:0099527	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; neuron-neuron synaptic transmission [GO:0007270]; nucleocytoplasmic transport [GO:0006913]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse to nucleus signaling pathway [GO:0099527]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]"
PGEN_.00g201180	Scaffold_09	30492923	30497126	P0CB96	NDUS4_PONPY	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (NADH-ubiquinone oxidoreductase 18 kDa subunit)"	GO:0005747; GO:0007420; GO:0016651; GO:0019933; GO:0022900; GO:0032981; GO:0045333; GO:0048146; GO:0051591; GO:0072593	"mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]"
PGEN_.00g201190	Scaffold_09	30530773	30539958	NA	NA	NA	NA	NA
PGEN_.00g201200	Scaffold_09	30554468	30556287	NA	NA	NA	NA	NA
PGEN_.00g201210	Scaffold_09	30591446	30594504	Q8C0L6	PAOX_MOUSE	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase)	GO:0005782; GO:0006598; GO:0009446; GO:0009447; GO:0016491; GO:0046203; GO:0046208; GO:0046592; GO:0052899; GO:0052901; GO:0052902; GO:0052903; GO:0052904; GO:1901307	"peroxisomal matrix [GO:0005782]; N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]"
PGEN_.00g201220	Scaffold_09	30607513	30607959	NA	NA	NA	NA	NA
PGEN_.00g201230	Scaffold_09	30639467	30700784	NA	NA	NA	NA	NA
PGEN_.00g201240	Scaffold_09	30718318	30729415	NA	NA	NA	NA	NA
PGEN_.00g201250	Scaffold_09	30733524	30734483	NA	NA	NA	NA	NA
PGEN_.00g201260	Scaffold_09	30751502	30770539	Q96P44	COLA1_HUMAN	Collagen alpha-1(XXI) chain	GO:0005576; GO:0005581; GO:0005788; GO:0005829; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]
PGEN_.00g201270	Scaffold_09	30789072	30803156	O08746	MATN2_MOUSE	Matrilin-2	GO:0001764; GO:0003429; GO:0005509; GO:0005604; GO:0005615; GO:0007411; GO:0008347; GO:0031012; GO:0031104; GO:0031175; GO:0048678; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; glial cell migration [GO:0008347]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678]
PGEN_.00g201280	Scaffold_09	30807850	30834566	Q9JII5	DAZP1_MOUSE	DAZ-associated protein 1 (Deleted in azoospermia-associated protein 1)	GO:0001893; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008266; GO:0008283; GO:0030154; GO:0034046; GO:0035613; GO:0048026; GO:1990904	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]"
PGEN_.00g201290	Scaffold_09	30838698	30844911	Q6ZHE5	DCYD1_ORYSJ	"Putative D-cysteine desulfhydrase 1, mitochondrial (EC 4.4.1.15) (OsD-CDes1) (D-CDes1)"	GO:0005739; GO:0019148	mitochondrion [GO:0005739]; D-cysteine desulfhydrase activity [GO:0019148]
PGEN_.00g201300	Scaffold_09	30845780	30857233	Q8BMI4	GEN_MOUSE	Flap endonuclease GEN homolog 1 (EC 3.1.-.-)	GO:0000287; GO:0000400; GO:0000724; GO:0005634; GO:0005813; GO:0008821; GO:0010824; GO:0017108; GO:0031297; GO:0042803; GO:0048256; GO:0071139; GO:0071140; GO:0090267	centrosome [GO:0005813]; nucleus [GO:0005634]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; flap endonuclease activity [GO:0048256]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; resolution of recombination intermediates [GO:0071139]
PGEN_.00g201310	Scaffold_09	30865425	30885127	Q8C170	MYO9A_MOUSE	Unconventional myosin-IXa (Unconventional myosin-9a)	GO:0003774; GO:0003779; GO:0005096; GO:0005524; GO:0005737; GO:0016021; GO:0016459; GO:0030054; GO:0034329; GO:0035556; GO:0044295; GO:0045198; GO:0045202; GO:0046872; GO:0150011	axonal growth cone [GO:0044295]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; myosin complex [GO:0016459]; synapse [GO:0045202]; actin binding [GO:0003779]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; motor activity [GO:0003774]; cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; regulation of neuron projection arborization [GO:0150011]
PGEN_.00g201320	Scaffold_09	30923182	30976963	B2RTY4	MYO9A_HUMAN	Unconventional myosin-IXa (Unconventional myosin-9a)	GO:0003774; GO:0003779; GO:0005096; GO:0005524; GO:0005829; GO:0007601; GO:0016021; GO:0016461; GO:0030054; GO:0034329; GO:0035556; GO:0044295; GO:0045198; GO:0045202; GO:0046872; GO:0051056; GO:0150011	axonal growth cone [GO:0044295]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; motor activity [GO:0003774]; cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; regulation of neuron projection arborization [GO:0150011]; regulation of small GTPase mediated signal transduction [GO:0051056]; visual perception [GO:0007601]
PGEN_.00g201330	Scaffold_09	31006369	31014628	Q3T0L1	CENPH_BOVIN	Centromere protein H (CENP-H)	GO:0000776; GO:0000777; GO:0005654; GO:0005730; GO:0043515; GO:0051382	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; kinetochore binding [GO:0043515]; kinetochore assembly [GO:0051382]
PGEN_.00g201340	Scaffold_09	31023799	31030059	G5EDL5	CEEH2_CAEEL	Epoxide hydrolase 2 (EC 3.3.2.10)	GO:0004301; GO:0044255	epoxide hydrolase activity [GO:0004301]; cellular lipid metabolic process [GO:0044255]
PGEN_.00g201350	Scaffold_09	31037564	31042318	Q8IUS5	EPHX4_HUMAN	Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein)	GO:0016021; GO:0016787	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]
PGEN_.00g201360	Scaffold_09	31072520	31089685	B4ZIX8	SCC4_XENLA	MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog)	GO:0000785; GO:0005634; GO:0005654; GO:0032116; GO:0034088; GO:0051301; GO:0071921; GO:0090694	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; cell division [GO:0051301]; cohesin loading [GO:0071921]; maintenance of mitotic sister chromatid cohesion [GO:0034088]
PGEN_.00g201370	Scaffold_09	31103805	31104431	NA	NA	NA	NA	NA
PGEN_.00g201380	Scaffold_09	31105589	31108327	NA	NA	NA	NA	NA
PGEN_.00g201390	Scaffold_09	31114371	31153455	Q6WV19	GALT2_DROME	Polypeptide N-acetylgalactosaminyltransferase 2 (pp-GaNTase 2) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2)	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]
PGEN_.00g201400	Scaffold_09	31193527	31196089	NA	NA	NA	NA	NA
PGEN_.00g201410	Scaffold_09	31221516	31228600	P55954	COX5A_CAEEL	"Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)"	GO:0004129; GO:0005751; GO:0006123; GO:0046872	"mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"
PGEN_.00g201420	Scaffold_09	31235376	31245356	NA	NA	NA	NA	NA
PGEN_.00g201430	Scaffold_09	31258428	31271362	Q7SZ59	RASLC_DANRE	Ras-like protein family member 12 (RAS-like protein Ris)	GO:0003924; GO:0005516; GO:0005525; GO:0005886; GO:0007265; GO:0019003	plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265]
PGEN_.00g201440	Scaffold_09	31275603	31280309	Q8N567	ZCHC9_HUMAN	Zinc finger CCHC domain-containing protein 9	GO:0003723; GO:0005654; GO:0005730; GO:0008270; GO:0010923	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g201450	Scaffold_09	31388371	31388658	NA	NA	NA	NA	NA
PGEN_.00g201460	Scaffold_09	31388794	31389018	NA	NA	NA	NA	NA
PGEN_.00g201470	Scaffold_09	31417028	31421653	NA	NA	NA	NA	NA
PGEN_.00g201480	Scaffold_09	31432410	31437644	NA	NA	NA	NA	NA
PGEN_.00g201490	Scaffold_09	31444784	31517471	P39057	DYHC_HELCR	"Dynein beta chain, ciliary"	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]
PGEN_.00g201500	Scaffold_09	31518989	31519681	NA	NA	NA	NA	NA
PGEN_.00g201510	Scaffold_09	31524623	31529487	Q9SX38	DRL4_ARATH	Putative disease resistance protein At1g50180	GO:0005524; GO:0006952; GO:0009506; GO:0043531	plasmodesma [GO:0009506]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; defense response [GO:0006952]
PGEN_.00g201520	Scaffold_09	31531189	31533717	NA	NA	NA	NA	NA
PGEN_.00g201530	Scaffold_09	31536894	31537289	NA	NA	NA	NA	NA
PGEN_.00g201540	Scaffold_09	31537501	31537875	NA	NA	NA	NA	NA
PGEN_.00g201550	Scaffold_09	31539833	31548685	Q9BQG2	NUD12_HUMAN	Peroxisomal NADH pyrophosphatase NUDT12 (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 12) (Nudix motif 12)	GO:0000210; GO:0000287; GO:0005634; GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0006402; GO:0006734; GO:0006742; GO:0008270; GO:0016787; GO:0019677; GO:0034356; GO:0035529; GO:0110153; GO:0110155	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; zinc ion binding [GO:0008270]; mRNA catabolic process [GO:0006402]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD catabolic process [GO:0019677]; NAD-cap decapping [GO:0110155]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]
PGEN_.00g201560	Scaffold_09	31549981	31567768	Q9UPQ8	DOLK_HUMAN	Dolichol kinase (EC 2.7.1.108) (Transmembrane protein 15)	GO:0004168; GO:0005789; GO:0006489; GO:0030176; GO:0043048	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; dolichol kinase activity [GO:0004168]; dolichyl diphosphate biosynthetic process [GO:0006489]; dolichyl monophosphate biosynthetic process [GO:0043048]
PGEN_.00g201570	Scaffold_09	31580477	31595687	NA	NA	NA	NA	NA
PGEN_.00g201580	Scaffold_09	31698962	31714768	NA	NA	NA	NA	NA
PGEN_.00g201590	Scaffold_09	31719181	31722955	NA	NA	NA	NA	NA
PGEN_.00g201600	Scaffold_09	31731139	31764479	NA	NA	NA	NA	NA
PGEN_.00g201610	Scaffold_09	31767843	31777259	Q9D494	TERB2_MOUSE	Telomere repeats-binding bouquet formation protein 2	GO:0000784; GO:0005623; GO:0005637; GO:0007129; GO:0045141; GO:0070197	"cell [GO:0005623]; nuclear chromosome, telomeric region [GO:0000784]; nuclear inner membrane [GO:0005637]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141]; synapsis [GO:0007129]"
PGEN_.00g201620	Scaffold_09	31777354	31786004	Q6DHV7	ADAL_HUMAN	Adenosine deaminase-like protein (EC 3.5.4.-) (Adenosine deaminase-like protein isoform 1) (N6-mAMP deaminase) (HsMAPDA) (N6-methyl-AMP aminohydrolase)	GO:0004000; GO:0005829; GO:0006154; GO:0009117; GO:0017144; GO:0043101; GO:0046103; GO:0046872	cytosol [GO:0005829]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154]; drug metabolic process [GO:0017144]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine-containing compound salvage [GO:0043101]
PGEN_.00g201630	Scaffold_09	31788189	31790655	NA	NA	NA	NA	NA
PGEN_.00g201640	Scaffold_09	31793743	31807024	Q8NEF3	CC112_HUMAN	Coiled-coil domain-containing protein 112 (Mutated in bladder cancer protein 1)		
PGEN_.00g201650	Scaffold_09	31807290	31813259	Q503I8	NGLY1_DANRE	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase)	GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006515; GO:0006516; GO:0006517; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]
PGEN_.00g201660	Scaffold_09	31819408	31822445	NA	NA	NA	NA	NA
PGEN_.00g201670	Scaffold_09	31835350	31837720	A6NNX1	RIAD1_HUMAN	RIIa domain-containing protein 1		
PGEN_.00g201680	Scaffold_09	31841349	31841906	NA	NA	NA	NA	NA
PGEN_.00g201690	Scaffold_09	31843465	31858843	Q2KJC9	AL7A1_BOVIN	Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase)	GO:0004043; GO:0005634; GO:0005739; GO:0005829; GO:0008802; GO:0019285; GO:0043878	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; glycine betaine biosynthetic process from choline [GO:0019285]
PGEN_.00g201700	Scaffold_09	31861438	31866439	NA	NA	NA	NA	NA
PGEN_.00g201710	Scaffold_09	31920515	31926998	NA	NA	NA	NA	NA
PGEN_.00g201720	Scaffold_09	31931405	31935398	NA	NA	NA	NA	NA
PGEN_.00g201730	Scaffold_09	31947868	31958340	Q6P773	TAF1C_RAT	"TATA box-binding protein-associated factor, RNA polymerase I, subunit C (TATA box-binding protein-associated factor 1C) (TBP-associated factor 1C) (Transcription initiation factor SL1/TIF-IB subunit C)"	GO:0001164; GO:0001650; GO:0005654; GO:0005730	fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]
PGEN_.00g201740	Scaffold_09	31965353	31978542	Q6P773	TAF1C_RAT	"TATA box-binding protein-associated factor, RNA polymerase I, subunit C (TATA box-binding protein-associated factor 1C) (TBP-associated factor 1C) (Transcription initiation factor SL1/TIF-IB subunit C)"	GO:0001164; GO:0001650; GO:0005654; GO:0005730	fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]
PGEN_.00g201750	Scaffold_09	31989715	31990437	Q1LZ95	IDI1_BOVIN	Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) (IPPI1)	GO:0004452; GO:0005777; GO:0006695; GO:0009240; GO:0016787; GO:0046872; GO:0050992	peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240]
PGEN_.00g201760	Scaffold_09	31998360	32002755	Q8BWA5	KLH31_MOUSE	Kelch-like protein 31 (Kelch repeat and BTB domain-containing protein 1) (Kelch-like protein KLHL)	GO:0001933; GO:0005634; GO:0005737; GO:0046329	cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein phosphorylation [GO:0001933]
PGEN_.00g201770	Scaffold_09	32007789	32025065	Q2KJC9	AL7A1_BOVIN	Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase)	GO:0004043; GO:0005634; GO:0005739; GO:0005829; GO:0008802; GO:0019285; GO:0043878	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; glycine betaine biosynthetic process from choline [GO:0019285]
PGEN_.00g201780	Scaffold_09	32030582	32047454	O95714	HERC2_HUMAN	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006303; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g201790	Scaffold_09	32060953	32067315	NA	NA	NA	NA	NA
PGEN_.00g201800	Scaffold_09	32067355	32078317	NA	NA	NA	NA	NA
PGEN_.00g201810	Scaffold_09	32079343	32080698	NA	NA	NA	NA	NA
PGEN_.00g201820	Scaffold_09	32086617	32091173	NA	NA	NA	NA	NA
PGEN_.00g201830	Scaffold_09	32091228	32091446	NA	NA	NA	NA	NA
PGEN_.00g201840	Scaffold_09	32141616	32204735	O95263	PDE8B_HUMAN	"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (HsPDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein)"	GO:0004115; GO:0005829; GO:0006198; GO:0007186; GO:0046872	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; G protein-coupled receptor signaling pathway [GO:0007186]"
PGEN_.00g201850	Scaffold_09	32255272	32255523	E9Q4S1	PDE8B_MOUSE	"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (PDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein)"	GO:0001662; GO:0004115; GO:0006198; GO:0007165; GO:0008542; GO:0035106; GO:0046676; GO:0046872; GO:0050885; GO:0061179; GO:0090032	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]; behavioral fear response [GO:0001662]; cAMP catabolic process [GO:0006198]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of steroid hormone biosynthetic process [GO:0090032]; neuromuscular process controlling balance [GO:0050885]; operant conditioning [GO:0035106]; signal transduction [GO:0007165]; visual learning [GO:0008542]"
PGEN_.00g201860	Scaffold_09	32352782	32354762	NA	NA	NA	NA	NA
PGEN_.00g201870	Scaffold_09	32366834	32376954	O42357	RX2_DANRE	Retinal homeobox protein Rx2	GO:0005634; GO:0006355; GO:0043565; GO:0060219	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; camera-type eye photoreceptor cell differentiation [GO:0060219]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g201880	Scaffold_09	32397908	32398738	NA	NA	NA	NA	NA
PGEN_.00g201890	Scaffold_09	32407280	32417586	NA	NA	NA	NA	NA
PGEN_.00g201900	Scaffold_09	32418316	32425268	NA	NA	NA	NA	NA
PGEN_.00g201910	Scaffold_09	32431546	32431920	NA	NA	NA	NA	NA
PGEN_.00g201920	Scaffold_09	32439296	32447329	Q53HC5	KLH26_HUMAN	Kelch-like protein 26		
PGEN_.00g201930	Scaffold_09	32478507	32480612	NA	NA	NA	NA	NA
PGEN_.00g201940	Scaffold_09	32528873	32530591	NA	NA	NA	NA	NA
PGEN_.00g201950	Scaffold_09	32544243	32553212	NA	NA	NA	NA	NA
PGEN_.00g201960	Scaffold_09	32553483	32553905	NA	NA	NA	NA	NA
PGEN_.00g201970	Scaffold_09	32556665	32561751	Q9Y5Z4	HEBP2_HUMAN	Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL)	GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]
PGEN_.00g201980	Scaffold_09	32587096	32591019	NA	NA	NA	NA	NA
PGEN_.00g201990	Scaffold_09	32593278	32610296	Q3UHC2	LRRK1_MOUSE	Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0050731; GO:0050732; GO:0090263; GO:1902533	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; bone resorption [GO:0045453]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]
PGEN_.00g202000	Scaffold_09	32619450	32638946	Q8NEF9	SRFB1_HUMAN	Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein) (p49/STRAP)	GO:0003723; GO:0005634; GO:0030490; GO:0030686; GO:0048471	90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]
PGEN_.00g202010	Scaffold_09	32649270	32664422	Q9Y6V7	DDX49_HUMAN	Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49)	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0006364	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]
PGEN_.00g202020	Scaffold_09	32676224	32684102	NA	NA	NA	NA	NA
PGEN_.00g202030	Scaffold_09	32694206	32694553	NA	NA	NA	NA	NA
PGEN_.00g202040	Scaffold_09	32694619	32695026	NA	NA	NA	NA	NA
PGEN_.00g202050	Scaffold_09	32699696	32726702	NA	NA	NA	NA	NA
PGEN_.00g202060	Scaffold_09	32749694	32755389	G5CTG7	AQP10_MILTA	Aquaporin-10 (AQP-10)	GO:0005886; GO:0015267; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; channel activity [GO:0015267]
PGEN_.00g202070	Scaffold_09	32760000	32766373	Q9DE14	ATR_XENLA	Serine/threonine-protein kinase atr (Xatr) (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein)	GO:0003677; GO:0004674; GO:0005524; GO:0006281; GO:0016605; GO:0018105; GO:0046982	PML body [GO:0016605]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; DNA repair [GO:0006281]; peptidyl-serine phosphorylation [GO:0018105]
PGEN_.00g202080	Scaffold_09	32847998	32857195	NA	NA	NA	NA	NA
PGEN_.00g202090	Scaffold_09	32859453	32860169	NA	NA	NA	NA	NA
PGEN_.00g202100	Scaffold_09	32860809	32861231	NA	NA	NA	NA	NA
PGEN_.00g202110	Scaffold_09	32869567	32870817	NA	NA	NA	NA	NA
PGEN_.00g202120	Scaffold_09	32875684	32876208	NA	NA	NA	NA	NA
PGEN_.00g202130	Scaffold_09	32876513	32882503	Q4R684	AMZ2_MACFA	Archaemetzincin-2 (EC 3.4.-.-) (Archeobacterial metalloproteinase-like protein 2)	GO:0008237; GO:0046872	metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]
PGEN_.00g202140	Scaffold_09	32893591	32936528	Q9UGJ1	GCP4_HUMAN	Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76)	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008274; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415; GO:0055037; GO:0065003	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]
PGEN_.00g202150	Scaffold_09	32940310	32984314	P81178	ALDH2_MESAU	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1)"	GO:0004029; GO:0005759; GO:0006068; GO:0043878; GO:0051287	mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; ethanol catabolic process [GO:0006068]
PGEN_.00g202160	Scaffold_09	32979278	32979538	NA	NA	NA	NA	NA
PGEN_.00g202170	Scaffold_09	32992057	32992428	NA	NA	NA	NA	NA
PGEN_.00g202180	Scaffold_09	32992478	32992765	NA	NA	NA	NA	NA
PGEN_.00g202190	Scaffold_09	33001455	33008372	NA	NA	NA	NA	NA
PGEN_.00g202200	Scaffold_09	33043767	33043979	NA	NA	NA	NA	NA
PGEN_.00g202210	Scaffold_09	33049442	33050110	NA	NA	NA	NA	NA
PGEN_.00g202220	Scaffold_09	33053445	33053795	NA	NA	NA	NA	NA
PGEN_.00g202230	Scaffold_09	33076450	33077289	NA	NA	NA	NA	NA
PGEN_.00g202240	Scaffold_09	33083602	33092078	Q6SR68	OTP_HELTB	Homeobox protein orthopedia	GO:0005634; GO:0006355; GO:0007275; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g202250	Scaffold_09	33095212	33095729	NA	NA	NA	NA	NA
PGEN_.00g202260	Scaffold_09	33095813	33096201	NA	NA	NA	NA	NA
PGEN_.00g202270	Scaffold_09	33113121	33114795	Q6SR68	OTP_HELTB	Homeobox protein orthopedia	GO:0005634; GO:0006355; GO:0007275; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g202280	Scaffold_09	33124819	33147312	Q810V0	MPP10_MOUSE	U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10)	GO:0005694; GO:0005730; GO:0005732; GO:0006364; GO:0010923; GO:0032040; GO:0034457	chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; negative regulation of phosphatase activity [GO:0010923]; rRNA processing [GO:0006364]
PGEN_.00g202290	Scaffold_09	33145313	33177573	Q5M7P5	NOL6_XENTR	Nucleolar protein 6	GO:0003723; GO:0006364; GO:0006409; GO:0032040; GO:0032545; GO:0034456	CURI complex [GO:0032545]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409]
PGEN_.00g202300	Scaffold_09	33177863	33201044	Q6NRY2	NOL6_XENLA	Nucleolar protein 6	GO:0003723; GO:0005730	nucleolus [GO:0005730]; RNA binding [GO:0003723]
PGEN_.00g202310	Scaffold_09	33219636	33232510	Q8R092	CA043_MOUSE	Uncharacterized protein C1orf43 homolog	GO:0001701; GO:0016021	integral component of membrane [GO:0016021]; in utero embryonic development [GO:0001701]
PGEN_.00g202320	Scaffold_09	33233392	33233886	NA	NA	NA	NA	NA
PGEN_.00g202330	Scaffold_09	33234001	33234285	Q9WVL2	STAT2_MOUSE	Signal transducer and activator of transcription 2	GO:0000978; GO:0001228; GO:0001932; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006952; GO:0007259; GO:0019221; GO:0042127; GO:0042802; GO:0043434; GO:0044389; GO:0045944; GO:0051607; GO:0060337; GO:0090140	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-like protein ligase binding [GO:0044389]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mitochondrial fission [GO:0090140]; regulation of protein phosphorylation [GO:0001932]; response to peptide hormone [GO:0043434]; type I interferon signaling pathway [GO:0060337]"
PGEN_.00g202340	Scaffold_09	33241918	33252092	Q5R546	ATPA_PONAB	"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)"	GO:0005524; GO:0005753; GO:0005886; GO:0015986; GO:0045261; GO:0046933	"mitochondrial proton-transporting ATP synthase complex [GO:0005753]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]"
PGEN_.00g202350	Scaffold_09	33263426	33271945	P48427	TBCA_BOVIN	Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A) (CFA)	GO:0005730; GO:0005829; GO:0005874; GO:0006457; GO:0007021; GO:0007023; GO:0015630; GO:0015631; GO:0048487	cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]
PGEN_.00g202360	Scaffold_09	33279134	33282296	NA	NA	NA	NA	NA
PGEN_.00g202370	Scaffold_09	33283864	33288694	Q8R2R9	AP3M2_MOUSE	AP-3 complex subunit mu-2 (Adaptor-related protein complex 3 subunit mu-2) (Clathrin assembly protein assembly protein complex 3 mu-2 medium chain) (Clathrin coat assembly protein AP47 homolog 2) (Clathrin coat-associated protein AP47 homolog 2) (Golgi adaptor AP-1 47 kDa protein homolog 2) (HA1 47 kDa subunit homolog 2) (Mu3B-adaptin) (m3B) (P47B)	GO:0005794; GO:0006886; GO:0008089; GO:0016192; GO:0030131; GO:0030659; GO:0048490; GO:1904115	axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g202380	Scaffold_09	33291124	33305851	P53677	AP3M2_HUMAN	AP-3 complex subunit mu-2 (Adaptor-related protein complex 3 subunit mu-2) (Clathrin assembly protein assembly protein complex 3 mu-2 medium chain) (Clathrin coat assembly protein AP47 homolog 2) (Clathrin coat-associated protein AP47 homolog 2) (Golgi adaptor AP-1 47 kDa protein homolog 2) (HA1 47 kDa subunit homolog 2) (Mu3B-adaptin) (P47B)	GO:0005794; GO:0006886; GO:0008089; GO:0016192; GO:0030119; GO:0030131; GO:0030659; GO:0048490; GO:1904115	AP-type membrane coat adaptor complex [GO:0030119]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g202390	Scaffold_09	33309252	33315026	NA	NA	NA	NA	NA
PGEN_.00g202400	Scaffold_09	33319387	33319785	NA	NA	NA	NA	NA
PGEN_.00g202410	Scaffold_09	33350777	33366503	P30122	CEL_BOVIN	Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase) (Fragment)	GO:0004771; GO:0004806; GO:0005576; GO:0005737; GO:0005887; GO:0007158; GO:0008126; GO:0009986; GO:0016042; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0097104; GO:0097105; GO:0098793	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; synapse [GO:0045202]; acetylesterase activity [GO:0008126]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g202420	Scaffold_09	33366636	33372354	P30122	CEL_BOVIN	Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase) (Fragment)	GO:0004771; GO:0004806; GO:0005576; GO:0005737; GO:0005887; GO:0007158; GO:0008126; GO:0009986; GO:0016042; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0097104; GO:0097105; GO:0098793	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; synapse [GO:0045202]; acetylesterase activity [GO:0008126]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g202430	Scaffold_09	33383807	33386525	NA	NA	NA	NA	NA
PGEN_.00g202440	Scaffold_09	33390969	33413241	Q01237	HMDH_MOUSE	3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)	GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0006743; GO:0007568; GO:0007584; GO:0008284; GO:0008299; GO:0008542; GO:0010664; GO:0010666; GO:0015936; GO:0016021; GO:0016126; GO:0032874; GO:0042177; GO:0042282; GO:0042802; GO:0042803; GO:0043066; GO:0043231; GO:0043407; GO:0045445; GO:0045471; GO:0048643; GO:0048661; GO:0050662; GO:0050709; GO:0051262; GO:0051721; GO:0061045; GO:0061179; GO:0070374; GO:0070402; GO:0097756; GO:1900222	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; coenzyme binding [GO:0050662]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; aging [GO:0007568]; cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; myoblast differentiation [GO:0045445]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of wound healing [GO:0061045]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein tetramerization [GO:0051262]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; sterol biosynthetic process [GO:0016126]; ubiquinone metabolic process [GO:0006743]; visual learning [GO:0008542]
PGEN_.00g202450	Scaffold_09	33417422	33425210	Q9BX70	BTBD2_HUMAN	BTB/POZ domain-containing protein 2	GO:0000932; GO:0005829; GO:0022008	cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008]
PGEN_.00g202460	Scaffold_09	33442618	33449789	Q99578	RIT2_HUMAN	GTP-binding protein Rit2 (Ras-like protein expressed in neurons) (Ras-like without CAAX protein 2)	GO:0003682; GO:0003924; GO:0005516; GO:0005525; GO:0005623; GO:0005634; GO:0005737; GO:0005886; GO:0007189; GO:0007264; GO:0007265; GO:0007268; GO:0010976; GO:0010977; GO:0019003; GO:0030100; GO:0030215; GO:0032489; GO:0032507; GO:0035556; GO:0043005; GO:0043410; GO:0044297; GO:0045121; GO:0045202; GO:0045944; GO:0050848; GO:0097447	cell [GO:0005623]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dendritic tree [GO:0097447]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g202470	Scaffold_09	33462352	33478949	Q6P502	TCPG_RAT	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)	GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0005886; GO:0006457; GO:0007339; GO:0032212; GO:0044297; GO:0046931; GO:0050821; GO:0051082; GO:1901998; GO:1904851	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]
PGEN_.00g202480	Scaffold_09	33496684	33498153	Q8BN59	LARP6_MOUSE	La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6)	GO:0005634; GO:0005737; GO:0005844; GO:0006396; GO:0017022; GO:0032967; GO:0035613; GO:0045727; GO:0048027; GO:1902416; GO:1990825; GO:1990904	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396]
PGEN_.00g202490	Scaffold_09	33507410	33512271	Q54VI1	FHKE_DICDI	Probable serine/threonine-protein kinase fhkE (EC 2.7.11.1) (Forkhead-associated kinase protein E)	GO:0000077; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006974; GO:0042770; GO:0044773	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint [GO:0000077]; mitotic DNA damage checkpoint [GO:0044773]; signal transduction in response to DNA damage [GO:0042770]
PGEN_.00g202500	Scaffold_09	33522581	33526860	Q9Y5Z4	HEBP2_HUMAN	Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL)	GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]
PGEN_.00g202510	Scaffold_09	33572783	33589827	A4QN56	MFS4B_DANRE	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g202520	Scaffold_09	33589901	33607798	Q8VCV9	MF4B1_MOUSE	Sodium-dependent glucose transporter 1A (Major facilitator superfamily domain-containing protein 4B1)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g202530	Scaffold_09	33617486	33617740	NA	NA	NA	NA	NA
PGEN_.00g202540	Scaffold_09	33621049	33625746	Q80T22	MFS4B_RAT	Sodium-dependent glucose transporter 1 (rNaGLT1) (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g202550	Scaffold_09	33625845	33626270	NA	NA	NA	NA	NA
PGEN_.00g202560	Scaffold_09	33653747	33654196	NA	NA	NA	NA	NA
PGEN_.00g202570	Scaffold_09	33654247	33654474	NA	NA	NA	NA	NA
PGEN_.00g202580	Scaffold_09	33660208	33665000	NA	NA	NA	NA	NA
PGEN_.00g202590	Scaffold_09	33667708	33677980	NA	NA	NA	NA	NA
PGEN_.00g202600	Scaffold_09	33687257	33694452	Q8TAD4	ZNT5_HUMAN	Zinc transporter 5 (ZnT-5) (Solute carrier family 30 member 5) (ZnT-like transporter 1) (hZTL1)	GO:0005385; GO:0005623; GO:0005654; GO:0005730; GO:0005794; GO:0005887; GO:0006824; GO:0006829; GO:0006882; GO:0008270; GO:0010043; GO:0010155; GO:0016020; GO:0016324; GO:0030141; GO:0030667	apical plasma membrane [GO:0016324]; cell [GO:0005623]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; cobalt ion transport [GO:0006824]; regulation of proton transport [GO:0010155]; response to zinc ion [GO:0010043]; zinc ion transport [GO:0006829]
PGEN_.00g202610	Scaffold_09	33725078	33737501	Q8K2V6	IPO11_MOUSE	Importin-11 (Imp11) (Ran-binding protein 11) (RanBP11)	GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0006610; GO:0008536; GO:0061608	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]
PGEN_.00g202620	Scaffold_09	33739456	33747667	Q9UI26	IPO11_HUMAN	Importin-11 (Imp11) (Ran-binding protein 11) (RanBP11)	GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0006610; GO:0008536; GO:0061608	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]
PGEN_.00g202630	Scaffold_09	33758018	33844971	Q3UTY6	THSD4_MOUSE	Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4)	GO:0001527; GO:0008233; GO:0031012; GO:0048251	extracellular matrix [GO:0031012]; microfibril [GO:0001527]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251]
PGEN_.00g202640	Scaffold_09	33905137	34010923	P20742	PZP_HUMAN	Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6)	GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007565; GO:0070062; GO:0072562	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565]
PGEN_.00g202650	Scaffold_09	34037679	34038998	NA	NA	NA	NA	NA
PGEN_.00g202660	Scaffold_09	34048561	34070389	P70549	NAC3_RAT	Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3)	GO:0002244; GO:0005432; GO:0005516; GO:0005623; GO:0005739; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006851; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0030054; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0060402; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0099055; GO:0099580; GO:1905060; GO:1990034	cell [GO:0005623]; cell junction [GO:0030054]; cell projection [GO:0042995]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity [GO:0015368]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]
PGEN_.00g202670	Scaffold_09	34081665	34151598	Q9UPR5	NAC2_HUMAN	Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2)	GO:0005432; GO:0005516; GO:0005623; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0016323; GO:0030054; GO:0035725; GO:0043197; GO:0043204; GO:0046872; GO:0048172; GO:0060291; GO:0070588; GO:1903779	basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; regulation of cardiac conduction [GO:1903779]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; sodium ion transmembrane transport [GO:0035725]
PGEN_.00g202680	Scaffold_09	34256192	34256683	NA	NA	NA	NA	NA
PGEN_.00g202690	Scaffold_09	34263411	34272283	Q9GUM2	BRE4_CAEEL	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	"integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"
PGEN_.00g202700	Scaffold_09	34308168	34341003	NA	NA	NA	NA	NA
PGEN_.00g202710	Scaffold_09	34372427	34375607	NA	NA	NA	NA	NA
PGEN_.00g202720	Scaffold_09	34375912	34378925	NA	NA	NA	NA	NA
PGEN_.00g202730	Scaffold_09	34379320	34379808	NA	NA	NA	NA	NA
PGEN_.00g202740	Scaffold_09	34402757	34432653	Q8CG80	SHF_MOUSE	SH2 domain-containing adapter protein F	GO:0001784; GO:0006915	phosphotyrosine residue binding [GO:0001784]; apoptotic process [GO:0006915]
PGEN_.00g202750	Scaffold_09	34432978	34446207	Q9UBB5	MBD2_HUMAN	Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2)	GO:0000118; GO:0000122; GO:0000183; GO:0000790; GO:0000792; GO:0003682; GO:0003696; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006346; GO:0007507; GO:0007568; GO:0008327; GO:0009612; GO:0019904; GO:0030177; GO:0031667; GO:0032355; GO:0032991; GO:0034622; GO:0035197; GO:0035563; GO:0042127; GO:0042711; GO:0043044; GO:0044030; GO:0045892; GO:0048568; GO:0070742; GO:0071407	"cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]; aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]"
PGEN_.00g202760	Scaffold_09	34459721	34484932	P56603	SCAM1_RAT	Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1) (SCAMP 37)	GO:0000139; GO:0005794; GO:0005802; GO:0006887; GO:0006897; GO:0015031; GO:0016021; GO:0019904; GO:0030136; GO:0030285; GO:0030659; GO:0030672; GO:0032588; GO:0042589; GO:0043195; GO:0045202; GO:0055038	clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; protein transport [GO:0015031]
PGEN_.00g202770	Scaffold_09	34496062	34502023	P02723	ADT_NEUCR	"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT)"	GO:0005471; GO:0005743; GO:0016021; GO:0140021; GO:1990544	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP:ADP antiporter activity [GO:0005471]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]
PGEN_.00g202780	Scaffold_09	34505419	34519944	P51398	RT29_HUMAN	"28S ribosomal protein S29, mitochondrial (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3) (Ionizing radiation resistance conferring protein) (Mitochondrial small ribosomal subunit protein mS29)"	GO:0003723; GO:0003735; GO:0005525; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0070125; GO:0070126; GO:0097190	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic signaling pathway [GO:0097190]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]
PGEN_.00g202790	Scaffold_09	34522195	34584633	Q99MY8	ASH1L_MOUSE	Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.-) (ASH1-like protein) (Absent small and homeotic disks protein 1 homolog)	GO:0001501; GO:0002674; GO:0003677; GO:0003682; GO:0005654; GO:0005694; GO:0005794; GO:0005923; GO:0007338; GO:0009791; GO:0010468; GO:0030317; GO:0032635; GO:0042800; GO:0043124; GO:0043409; GO:0045944; GO:0046697; GO:0046872; GO:0046974; GO:0046975; GO:0048733; GO:0050728; GO:0051568; GO:0061038; GO:0097676; GO:1903699; GO:1903709	bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K4 methylation [GO:0051568]; interleukin-6 production [GO:0032635]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; sebaceous gland development [GO:0048733]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038]
PGEN_.00g202800	Scaffold_09	34598908	34614050	Q8K0E3	SC5AB_MOUSE	Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11)	GO:0005412; GO:0005886; GO:0006915; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; apoptotic process [GO:0006915]
PGEN_.00g202810	Scaffold_09	34614086	34626142	Q9UGH3	S23A2_HUMAN	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2) (hSVCT2) (Yolk sac permease-like molecule 2)	GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006979; GO:0009925; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g202820	Scaffold_09	34626410	34645232	B0JZG0	S23A2_XENTR	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	GO:0016021; GO:0019852; GO:0070890	integral component of membrane [GO:0016021]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]
PGEN_.00g202830	Scaffold_09	34649802	34666856	O88685	PRS6A_MOUSE	26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Tat-binding protein 1) (TBP-1)	GO:0000502; GO:0000932; GO:0001824; GO:0005524; GO:0005634; GO:0005737; GO:0008540; GO:0016787; GO:0022624; GO:0030163; GO:0042802; GO:0043921; GO:0045899; GO:0045944; GO:0048471	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; blastocyst development [GO:0001824]; modulation by host of viral transcription [GO:0043921]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]"
PGEN_.00g202840	Scaffold_09	34674523	34681434	NA	NA	NA	NA	NA
PGEN_.00g202850	Scaffold_09	34722406	34722819	NA	NA	NA	NA	NA
PGEN_.00g202860	Scaffold_09	34863610	34864767	NA	NA	NA	NA	NA
PGEN_.00g202870	Scaffold_09	34884454	34925950	Q868T3	CCAPR_DROME	Cardioacceleratory peptide receptor (Crustacean cardioactive peptide receptor)	GO:0005000; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0018990	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g202880	Scaffold_09	34953898	34954599	Q868T3	CCAPR_DROME	Cardioacceleratory peptide receptor (Crustacean cardioactive peptide receptor)	GO:0005000; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0018990	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g202890	Scaffold_09	34966465	34976473	Q5WA50	CTR2_OCTVU	Cephalotocin receptor 2	GO:0005000; GO:0005886; GO:0007186; GO:0016021; GO:0016500; GO:0046887	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of hormone secretion [GO:0046887]
PGEN_.00g202900	Scaffold_09	35015059	35015403	NA	NA	NA	NA	NA
PGEN_.00g202910	Scaffold_09	35016092	35016802	NA	NA	NA	NA	NA
PGEN_.00g202920	Scaffold_09	35034179	35035087	NA	NA	NA	NA	NA
PGEN_.00g202930	Scaffold_09	35036342	35037559	NA	NA	NA	NA	NA
PGEN_.00g202940	Scaffold_09	35142062	35147798	NA	NA	NA	NA	NA
PGEN_.00g202950	Scaffold_09	35162520	35165506	Q96WV6	YHU2_SCHPO	Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02	GO:0010339; GO:0031362; GO:0098631	anchored component of external side of plasma membrane [GO:0031362]; external side of cell wall [GO:0010339]; cell adhesion mediator activity [GO:0098631]
PGEN_.00g202960	Scaffold_09	35178050	35178319	NA	NA	NA	NA	NA
PGEN_.00g202970	Scaffold_09	35208709	35209287	NA	NA	NA	NA	NA
PGEN_.00g202980	Scaffold_09	35211649	35212842	NA	NA	NA	NA	NA
PGEN_.00g202990	Scaffold_09	35224047	35267050	Q9DBV3	DHX34_MOUSE	Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34)	GO:0000184; GO:0000956; GO:0003723; GO:0003724; GO:0005524; GO:2000623	"ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"
PGEN_.00g203000	Scaffold_09	35296705	35326056	Q9GKI7	CERT_BOVIN	Ceramide transfer protein (CERT) (Collagen type IV alpha-3-binding protein) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11)	GO:0000902; GO:0001701; GO:0003007; GO:0005654; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006672; GO:0006936; GO:0007029; GO:0007165; GO:0008283; GO:0008289; GO:0016301; GO:0034976; GO:0035621; GO:0035627; GO:0048471; GO:0055088; GO:0070273; GO:0070584; GO:0120009; GO:0120012; GO:1902387; GO:1902388	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi ceramide transport [GO:0035621]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; intermembrane lipid transfer [GO:0120009]; intermembrane sphingolipid transfer [GO:0120012]; lipid homeostasis [GO:0055088]; mitochondrion morphogenesis [GO:0070584]; muscle contraction [GO:0006936]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]
PGEN_.00g203010	Scaffold_09	35365135	35365971	NA	NA	NA	NA	NA
PGEN_.00g203020	Scaffold_09	35366039	35366791	NA	NA	NA	NA	NA
PGEN_.00g203030	Scaffold_09	35381868	35382788	NA	NA	NA	NA	NA
PGEN_.00g203040	Scaffold_09	35460482	35467968	Q08CW8	CR3L4_XENTR	Cyclic AMP-responsive element-binding protein 3-like protein 4 (cAMP-responsive element-binding protein 3-like protein 4) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 4]	GO:0003700; GO:0005634; GO:0005789; GO:0016021; GO:0030968; GO:0035497; GO:0045944	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity [GO:0003700]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g203050	Scaffold_09	35472425	35472709	NA	NA	NA	NA	NA
PGEN_.00g203060	Scaffold_09	35477972	35525136	Q9VQH2	DUOX_DROME	Dual oxidase (EC 1.11.1.-) (EC 1.6.3.1)	GO:0002385; GO:0004601; GO:0005509; GO:0005886; GO:0006952; GO:0006979; GO:0007476; GO:0008365; GO:0009611; GO:0012505; GO:0016174; GO:0016175; GO:0019221; GO:0020037; GO:0035220; GO:0042335; GO:0042554; GO:0042742; GO:0042744; GO:0043020; GO:0043066; GO:0048085; GO:0050665; GO:0051591; GO:0055114; GO:0072593	endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220]
PGEN_.00g203070	Scaffold_09	35526675	35527622	NA	NA	NA	NA	NA
PGEN_.00g203080	Scaffold_09	35532088	35578434	Q8HZK2	DUOX2_PIG	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	GO:0004601; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006590; GO:0006952; GO:0006979; GO:0016174; GO:0016175; GO:0016324; GO:0019221; GO:0020037; GO:0030054; GO:0042335; GO:0042446; GO:0042554; GO:0042744; GO:0043020; GO:0045177; GO:0050665; GO:0051591; GO:0055114	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NADPH oxidase activity [GO:0016175]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590]
PGEN_.00g203090	Scaffold_09	35624393	35624662	NA	NA	NA	NA	NA
PGEN_.00g203100	Scaffold_09	35711968	35717966	NA	NA	NA	NA	NA
PGEN_.00g203110	Scaffold_09	35743711	35745535	NA	NA	NA	NA	NA
PGEN_.00g203120	Scaffold_09	35745668	35745979	NA	NA	NA	NA	NA
PGEN_.00g203130	Scaffold_09	35746163	35748497	NA	NA	NA	NA	NA
PGEN_.00g203140	Scaffold_09	35756789	35757076	NA	NA	NA	NA	NA
PGEN_.00g203150	Scaffold_09	35757201	35757443	NA	NA	NA	NA	NA
PGEN_.00g203160	Scaffold_09	35757521	35757778	NA	NA	NA	NA	NA
PGEN_.00g203170	Scaffold_09	35758051	35758368	NA	NA	NA	NA	NA
PGEN_.00g203180	Scaffold_09	35758446	35758703	NA	NA	NA	NA	NA
PGEN_.00g203190	Scaffold_09	35768822	35769151	NA	NA	NA	NA	NA
PGEN_.00g203200	Scaffold_09	35838586	35839386	NA	NA	NA	NA	NA
PGEN_.00g203210	Scaffold_09	35860456	35860959	NA	NA	NA	NA	NA
PGEN_.00g203220	Scaffold_09	35868546	35880745	Q86XN6	ZN761_HUMAN	Zinc finger protein 761	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g203230	Scaffold_09	35889878	35893779	NA	NA	NA	NA	NA
PGEN_.00g203240	Scaffold_09	35893859	35895523	NA	NA	NA	NA	NA
PGEN_.00g203250	Scaffold_09	35906950	35916567	Q4R7M4	DTWD2_MACFA	DTW domain-containing protein 2		
PGEN_.00g203260	Scaffold_09	35947011	35959366	NA	NA	NA	NA	NA
PGEN_.00g203270	Scaffold_09	35966553	35972671	Q5RD03	ARMC6_PONAB	Armadillo repeat-containing protein 6		
PGEN_.00g203280	Scaffold_09	35977769	36019180	NA	NA	NA	NA	NA
PGEN_.00g203290	Scaffold_09	36021047	36021319	NA	NA	NA	NA	NA
PGEN_.00g203300	Scaffold_09	36021717	36022440	NA	NA	NA	NA	NA
PGEN_.00g203310	Scaffold_09	36022849	36023151	NA	NA	NA	NA	NA
PGEN_.00g203320	Scaffold_09	36029194	36029592	NA	NA	NA	NA	NA
PGEN_.00g203330	Scaffold_09	36036852	36039031	NA	NA	NA	NA	NA
PGEN_.00g203340	Scaffold_09	36039731	36080013	Q32L09	SHFL_BOVIN	Shiftless antiviral inhibitor of ribosomal frameshifting protein homolog (SHFL) (Repressor of yield of DENV protein homolog) (RyDEN)	GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0006449; GO:0034340; GO:0034341; GO:0034342; GO:0043022; GO:0045071; GO:0051607; GO:0075523; GO:1990825; GO:2001125	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; defense response to virus [GO:0051607]; negative regulation of translational frameshifting [GO:2001125]; negative regulation of viral genome replication [GO:0045071]; regulation of translational termination [GO:0006449]; response to interferon-gamma [GO:0034341]; response to type I interferon [GO:0034340]; response to type III interferon [GO:0034342]; viral translational frameshifting [GO:0075523]
PGEN_.00g203350	Scaffold_09	36055175	36055450	NA	NA	NA	NA	NA
PGEN_.00g203360	Scaffold_09	36080998	36083660	NA	NA	NA	NA	NA
PGEN_.00g203370	Scaffold_09	36084070	36084444	NA	NA	NA	NA	NA
PGEN_.00g203380	Scaffold_09	36084491	36084808	NA	NA	NA	NA	NA
PGEN_.00g203390	Scaffold_09	36097458	36116126	Q2PFV2	CASP3_MACFA	Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	GO:0005737; GO:0006508; GO:0031647; GO:0097199; GO:1902004	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]
PGEN_.00g203400	Scaffold_09	36117168	36122713	NA	NA	NA	NA	NA
PGEN_.00g203410	Scaffold_09	36122747	36123151	NA	NA	NA	NA	NA
PGEN_.00g203420	Scaffold_09	36132235	36132999	A4IFB4	KCTD7_BOVIN	BTB/POZ domain-containing protein KCTD7	GO:0005829; GO:0005886; GO:0051260	cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]
PGEN_.00g203430	Scaffold_09	36139594	36141517	NA	NA	NA	NA	NA
PGEN_.00g203440	Scaffold_09	36179724	36207851	D3ZV31	ZCHC4_RAT	rRNA N6-adenosine-methyltransferase ZCCHC4 (EC 2.1.1.-) (Zinc finger CCHC domain-containing protein 4)	GO:0003676; GO:0005730; GO:0005737; GO:0008270; GO:0008988; GO:0016746; GO:0031167; GO:0045727	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; transferase activity, transferring acyl groups [GO:0016746]; zinc ion binding [GO:0008270]; positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]"
PGEN_.00g203450	Scaffold_09	36210214	36218864	Q9BV99	LRC61_HUMAN	Leucine-rich repeat-containing protein 61	GO:0005737; GO:0008104; GO:0019901	cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; protein localization [GO:0008104]
PGEN_.00g203460	Scaffold_09	36231420	36239071	NA	NA	NA	NA	NA
PGEN_.00g203470	Scaffold_09	36262650	36273280	P56211	ARP19_HUMAN	cAMP-regulated phosphoprotein 19 (ARPP-19)	GO:0000086; GO:0000278; GO:0004864; GO:0005102; GO:0005654; GO:0005737; GO:0015459; GO:0019212; GO:0019888; GO:0035308; GO:0045722; GO:0046326; GO:0051301; GO:0051721	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; phosphatase inhibitor activity [GO:0019212]; potassium channel regulator activity [GO:0015459]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; signaling receptor binding [GO:0005102]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of glucose import [GO:0046326]
PGEN_.00g203480	Scaffold_09	36317019	36400871	Q7TN88	PK1L2_MOUSE	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g203490	Scaffold_09	36445359	36446489	NA	NA	NA	NA	NA
PGEN_.00g203500	Scaffold_09	36450776	36466102	NA	NA	NA	NA	NA
PGEN_.00g203510	Scaffold_09	36472763	36474545	NA	NA	NA	NA	NA
PGEN_.00g203520	Scaffold_09	36478411	36478962	Q6GUR1	CP1A1_MACMU	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0002933; GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0008391; GO:0009308; GO:0009404; GO:0009636; GO:0016829; GO:0020037; GO:0030544; GO:0042572; GO:0043231; GO:0046483; GO:0050665; GO:0051879; GO:0070330; GO:0070576; GO:0071407; GO:0101020; GO:0101021	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; vitamin D 24-hydroxylase activity [GO:0070576]; amine metabolic process [GO:0009308]; cellular response to organic cyclic compound [GO:0071407]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid hydroxylation [GO:0002933]; response to toxic substance [GO:0009636]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; toxin metabolic process [GO:0009404]
PGEN_.00g203530	Scaffold_09	36527210	36557501	Q5RDY7	GNB5_PONAB	Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)	GO:0007212; GO:0016020; GO:0031682; GO:0051087; GO:1901386	membrane [GO:0016020]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; dopamine receptor signaling pathway [GO:0007212]; negative regulation of voltage-gated calcium channel activity [GO:1901386]
PGEN_.00g203540	Scaffold_09	36566011	36566286	NA	NA	NA	NA	NA
PGEN_.00g203550	Scaffold_09	36566530	36569155	NA	NA	NA	NA	NA
PGEN_.00g203560	Scaffold_09	36571724	36572780	NA	NA	NA	NA	NA
PGEN_.00g203570	Scaffold_09	36579409	36589660	Q8VCC1	PGDH_MOUSE	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	GO:0001822; GO:0003824; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0042803; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g203580	Scaffold_09	36635563	36635835	NA	NA	NA	NA	NA
PGEN_.00g203590	Scaffold_09	36697556	36697804	NA	NA	NA	NA	NA
PGEN_.00g203600	Scaffold_09	36698358	36703822	NA	NA	NA	NA	NA
PGEN_.00g203610	Scaffold_09	36703994	36704275	NA	NA	NA	NA	NA
PGEN_.00g203620	Scaffold_09	36706825	36707241	NA	NA	NA	NA	NA
PGEN_.00g203630	Scaffold_09	36712942	36713346	NA	NA	NA	NA	NA
PGEN_.00g203640	Scaffold_09	36713406	36714005	NA	NA	NA	NA	NA
PGEN_.00g203650	Scaffold_09	36717425	36717769	NA	NA	NA	NA	NA
PGEN_.00g203660	Scaffold_09	36719118	36720950	NA	NA	NA	NA	NA
PGEN_.00g203670	Scaffold_09	36722455	36723670	NA	NA	NA	NA	NA
PGEN_.00g203680	Scaffold_09	36724212	36729655	NA	NA	NA	NA	NA
PGEN_.00g203690	Scaffold_09	36730368	36730610	NA	NA	NA	NA	NA
PGEN_.00g203700	Scaffold_09	36730959	36731618	NA	NA	NA	NA	NA
PGEN_.00g203710	Scaffold_09	36731775	36732578	NA	NA	NA	NA	NA
PGEN_.00g203720	Scaffold_09	36732669	36733325	NA	NA	NA	NA	NA
PGEN_.00g203730	Scaffold_09	36734514	36734735	NA	NA	NA	NA	NA
PGEN_.00g203740	Scaffold_09	36755930	36756431	NA	NA	NA	NA	NA
PGEN_.00g203750	Scaffold_09	36875670	36876808	NA	NA	NA	NA	NA
PGEN_.00g203760	Scaffold_09	36882434	36884856	NA	NA	NA	NA	NA
PGEN_.00g203770	Scaffold_09	36905518	36905781	NA	NA	NA	NA	NA
PGEN_.00g203780	Scaffold_09	36961893	36969219	NA	NA	NA	NA	NA
PGEN_.00g203790	Scaffold_09	36986848	36987129	NA	NA	NA	NA	NA
PGEN_.00g203800	Scaffold_09	37010911	37011285	NA	NA	NA	NA	NA
PGEN_.00g203810	Scaffold_09	37021675	37023392	NA	NA	NA	NA	NA
PGEN_.00g203820	Scaffold_09	37027015	37083837	NA	NA	NA	NA	NA
PGEN_.00g203830	Scaffold_09	37083945	37084316	NA	NA	NA	NA	NA
PGEN_.00g203840	Scaffold_09	37088376	37088897	NA	NA	NA	NA	NA
PGEN_.00g203850	Scaffold_09	37089105	37090312	NA	NA	NA	NA	NA
PGEN_.00g203860	Scaffold_09	37123078	37129020	NA	NA	NA	NA	NA
PGEN_.00g203870	Scaffold_09	37237668	37313129	Q4V8V2	NUD17_DANRE	Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-)	GO:0005777; GO:0005829; GO:0006734; GO:0006742; GO:0016787; GO:0019677; GO:0035529; GO:0046872	cytosol [GO:0005829]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]
PGEN_.00g203880	Scaffold_09	37344840	37345373	NA	NA	NA	NA	NA
PGEN_.00g203890	Scaffold_09	37352762	37411836	NA	NA	NA	NA	NA
PGEN_.00g203900	Scaffold_09	37430049	37451297	NA	NA	NA	NA	NA
PGEN_.00g203910	Scaffold_09	37484832	37500899	Q28DG6	LYSM3_XENTR	LysM and putative peptidoglycan-binding domain-containing protein 3	GO:0005794; GO:0005886; GO:0007030; GO:0016021	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Golgi organization [GO:0007030]
PGEN_.00g203920	Scaffold_09	37576427	37576639	NA	NA	NA	NA	NA
PGEN_.00g203930	Scaffold_09	37577115	37577704	NA	NA	NA	NA	NA
PGEN_.00g203940	Scaffold_09	37577888	37618735	NA	NA	NA	NA	NA
PGEN_.00g203950	Scaffold_09	37624601	37626259	NA	NA	NA	NA	NA
PGEN_.00g203960	Scaffold_09	37629189	37631979	NA	NA	NA	NA	NA
PGEN_.00g203970	Scaffold_09	37637514	37637840	NA	NA	NA	NA	NA
PGEN_.00g203980	Scaffold_09	37638150	37656529	NA	NA	NA	NA	NA
PGEN_.00g203990	Scaffold_09	37686574	37688911	NA	NA	NA	NA	NA
PGEN_.00g204000	Scaffold_09	37730051	37731308	NA	NA	NA	NA	NA
PGEN_.00g204010	Scaffold_09	37731336	37731641	NA	NA	NA	NA	NA
PGEN_.00g204020	Scaffold_09	37789127	37826203	Q6NSJ0	MYORG_HUMAN	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161)	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"
PGEN_.00g204030	Scaffold_09	37854550	37860901	NA	NA	NA	NA	NA
PGEN_.00g204040	Scaffold_09	37937540	37942135	Q2T9K6	FEM1C_XENLA	Protein fem-1 homolog C (FEM1c) (FEM1-gamma)	GO:0005737; GO:0016567	cytoplasm [GO:0005737]; protein ubiquitination [GO:0016567]
PGEN_.00g204050	Scaffold_09	37954146	37954445	NA	NA	NA	NA	NA
PGEN_.00g204060	Scaffold_09	37970485	38018984	Q8BMC3	SHC2_MOUSE	SHC-transforming protein 2 (Protein Sck) (Protein Sli) (SHC-transforming protein B) (Src homology 2 domain-containing-transforming protein C2) (SH2 domain protein C2)	GO:0000187; GO:0005886; GO:0019901; GO:0030971; GO:0035556	plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; activation of MAPK activity [GO:0000187]; intracellular signal transduction [GO:0035556]
PGEN_.00g204070	Scaffold_09	38043764	38054066	Q9D0G0	RT30_MOUSE	"28S ribosomal protein S30, mitochondrial (MRP-S30) (S30mt)"	GO:0003735; GO:0005739; GO:0005762; GO:0006412	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g204080	Scaffold_09	38059184	38087669	Q01415	GALK2_HUMAN	N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2)	GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0005975; GO:0033499; GO:0033858	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; N-acetylgalactosamine kinase activity [GO:0033858]; carbohydrate metabolic process [GO:0005975]; galactose catabolic process via UDP-galactose [GO:0033499]
PGEN_.00g204090	Scaffold_09	38106690	38107259	NA	NA	NA	NA	NA
PGEN_.00g204100	Scaffold_09	38126164	38134407	P68372	TBB4B_MOUSE	Tubulin beta-4B chain (Tubulin beta-2C chain)	GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0043209; GO:0045298	cytoplasm [GO:0005737]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; tubulin complex [GO:0045298]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]
PGEN_.00g204110	Scaffold_09	38156631	38158155	Q8VHN7	AGRV1_MOUSE	Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1) (MASS1) (Neurepin) (Very large G-protein coupled receptor 1) (VLGR1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta (VLGR1 subunit beta) (Vbeta)]	GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005576; GO:0005737; GO:0005886; GO:0007166; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010739; GO:0010855; GO:0016020; GO:0016021; GO:0016787; GO:0017022; GO:0030501; GO:0031647; GO:0032391; GO:0032420; GO:0043235; GO:0045184; GO:0045202; GO:0045494; GO:0048471; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060122; GO:0060171; GO:0071277; GO:0090037; GO:0097264; GO:0098609; GO:1990075; GO:1990696	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]; myosin binding [GO:0017022]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear development [GO:0048839]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g204120	Scaffold_09	38167058	38171563	Q8WXG9	AGRV1_HUMAN	Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta]	GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010739; GO:0010855; GO:0016020; GO:0016021; GO:0016787; GO:0030501; GO:0031647; GO:0043235; GO:0045184; GO:0045202; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0090037; GO:0097264; GO:0098609; GO:1990075; GO:1990696	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g204130	Scaffold_09	38175455	38175802	NA	NA	NA	NA	NA
PGEN_.00g204140	Scaffold_09	38176245	38176601	NA	NA	NA	NA	NA
PGEN_.00g204150	Scaffold_09	38177160	38271248	Q6JAN0	AGRV1_DANRE	Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1)	GO:0001917; GO:0001965; GO:0004930; GO:0007166; GO:0007194; GO:0010739; GO:0010855; GO:0016021; GO:0016787; GO:0031647; GO:0042462; GO:0060171; GO:0071277; GO:0090037; GO:0097264	integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; stereocilium membrane [GO:0060171]; adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]
PGEN_.00g204160	Scaffold_09	38301491	38367409	Q8VHN7	AGRV1_MOUSE	Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1) (MASS1) (Neurepin) (Very large G-protein coupled receptor 1) (VLGR1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta (VLGR1 subunit beta) (Vbeta)]	GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005576; GO:0005737; GO:0005886; GO:0007166; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010739; GO:0010855; GO:0016020; GO:0016021; GO:0016787; GO:0017022; GO:0030501; GO:0031647; GO:0032391; GO:0032420; GO:0043235; GO:0045184; GO:0045202; GO:0045494; GO:0048471; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060122; GO:0060171; GO:0071277; GO:0090037; GO:0097264; GO:0098609; GO:1990075; GO:1990696	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]; myosin binding [GO:0017022]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear development [GO:0048839]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g204170	Scaffold_09	38370993	38371403	Q49537	VLPE_MYCHR	Variant surface antigen E (VlpE prolipoprotein)	GO:0005886	plasma membrane [GO:0005886]
PGEN_.00g204180	Scaffold_09	38373321	38375276	Q6UXB4	CLC4G_HUMAN	C-type lectin domain family 4 member G (Liver and lymph node sinusoidal endothelial cell C-type lectin) (LSECtin)	GO:0001618; GO:0002710; GO:0005886; GO:0016021; GO:0030247; GO:0042130; GO:0050776	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; polysaccharide binding [GO:0030247]; virus receptor activity [GO:0001618]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell proliferation [GO:0042130]; regulation of immune response [GO:0050776]
PGEN_.00g204190	Scaffold_09	38376973	38386315	Q8WXG9	AGRV1_HUMAN	Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta]	GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010739; GO:0010855; GO:0016020; GO:0016021; GO:0016787; GO:0030501; GO:0031647; GO:0043235; GO:0045184; GO:0045202; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0090037; GO:0097264; GO:0098609; GO:1990075; GO:1990696	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g204200	Scaffold_09	38404308	38424613	Q8WXG9	AGRV1_HUMAN	Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta]	GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010739; GO:0010855; GO:0016020; GO:0016021; GO:0016787; GO:0030501; GO:0031647; GO:0043235; GO:0045184; GO:0045202; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0090037; GO:0097264; GO:0098609; GO:1990075; GO:1990696	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g204210	Scaffold_09	38471431	38471739	NA	NA	NA	NA	NA
PGEN_.00g204220	Scaffold_09	38477682	38480372	NA	NA	NA	NA	NA
PGEN_.00g204230	Scaffold_09	38504763	38509438	NA	NA	NA	NA	NA
PGEN_.00g204240	Scaffold_09	38509869	38510574	NA	NA	NA	NA	NA
PGEN_.00g204250	Scaffold_09	38519381	38520865	NA	NA	NA	NA	NA
PGEN_.00g204260	Scaffold_09	38521334	38523124	P53563	B2CL1_RAT	Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X)	GO:0001541; GO:0001666; GO:0001701; GO:0001836; GO:0002931; GO:0005737; GO:0005739; GO:0005740; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0006897; GO:0006915; GO:0006979; GO:0007093; GO:0007281; GO:0007283; GO:0007568; GO:0008134; GO:0008283; GO:0008284; GO:0008584; GO:0008630; GO:0009314; GO:0009566; GO:0009615; GO:0010035; GO:0010243; GO:0010288; GO:0014070; GO:0016020; GO:0016021; GO:0019050; GO:0019901; GO:0021987; GO:0030054; GO:0030276; GO:0030672; GO:0031965; GO:0031966; GO:0032465; GO:0032496; GO:0034097; GO:0035690; GO:0036017; GO:0036018; GO:0036466; GO:0040008; GO:0042493; GO:0042542; GO:0042802; GO:0042803; GO:0042981; GO:0043027; GO:0043065; GO:0043066; GO:0043434; GO:0043524; GO:0044877; GO:0046898; GO:0046902; GO:0046982; GO:0051020; GO:0051400; GO:0051402; GO:0051434; GO:0051602; GO:0051881; GO:0060154; GO:0070584; GO:0071230; GO:0071312; GO:0071320; GO:0071347; GO:0071356; GO:0071456; GO:0071480; GO:0071549; GO:0071839; GO:0090201; GO:0097136; GO:0097192; GO:0097284; GO:0097371; GO:0098793; GO:1900118; GO:1900244; GO:1900452; GO:1902042; GO:1902230; GO:1902236; GO:1903077; GO:1904579; GO:1905218; GO:1990646; GO:2000302; GO:2000809; GO:2000811; GO:2001171; GO:2001243	Bcl-2 family protein complex [GO:0097136]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; presynapse [GO:0098793]; synaptic vesicle membrane [GO:0030672]; BH domain binding [GO:0051400]; BH3 domain binding [GO:0051434]; clathrin binding [GO:0030276]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic process in bone marrow cell [GO:0071839]; cell population proliferation [GO:0008283]; cellular process regulating host cell cycle in response to virus [GO:0060154]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to erythropoietin [GO:0036018]; cellular response to gamma radiation [GO:0071480]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prolactin [GO:1990646]; cellular response to thapsigargin [GO:1904579]; cellular response to tumor necrosis factor [GO:0071356]; cerebral cortex development [GO:0021987]; endocytosis [GO:0006897]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; mitochondrion morphogenesis [GO:0070584]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of long-term synaptic depression [GO:1900452]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; suppression by virus of host apoptotic process [GO:0019050]; synaptic vesicle recycling via endosome [GO:0036466]
PGEN_.00g204270	Scaffold_09	38530185	38531573	NA	NA	NA	NA	NA
PGEN_.00g204280	Scaffold_09	38531900	38570450	Q924S5	LONM_RAT	"Lon protease homolog, mitochondrial (EC 3.4.21.53) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)"	GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006508; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016887; GO:0034599; GO:0034622; GO:0042645; GO:0043531; GO:0043565; GO:0051131; GO:0051260; GO:0051603; GO:0051880; GO:0070182; GO:0070407	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]
PGEN_.00g204290	Scaffold_09	38572236	38575909	NA	NA	NA	NA	NA
PGEN_.00g204300	Scaffold_10	2	1145	NA	NA	NA	NA	NA
PGEN_.00g204310	Scaffold_10	19540	36845	F1MNN4	FBXW7_BOVIN	F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7)	GO:0005623; GO:0005634; GO:0005737; GO:0010992; GO:0031146; GO:0043130; GO:0043161; GO:0050816	cell [GO:0005623]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin recycling [GO:0010992]
PGEN_.00g204320	Scaffold_10	36984	37535	NA	NA	NA	NA	NA
PGEN_.00g204330	Scaffold_10	41157	41960	NA	NA	NA	NA	NA
PGEN_.00g204340	Scaffold_10	61914	82099	Q3KRG3	TSR2_DANRE	Pre-rRNA-processing protein TSR2 homolog	GO:0000462	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"
PGEN_.00g204350	Scaffold_10	90961	109412	NA	NA	NA	NA	NA
PGEN_.00g204360	Scaffold_10	135015	215664	Q7TMY8	HUWE1_MOUSE	"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (E3Histone) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)"	GO:0000209; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0061630	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; histone ubiquitination [GO:0016574]; positive regulation of protein ubiquitination [GO:0031398]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g204370	Scaffold_10	218087	218780	NA	NA	NA	NA	NA
PGEN_.00g204380	Scaffold_10	218756	219013	NA	NA	NA	NA	NA
PGEN_.00g204390	Scaffold_10	225103	230053	NA	NA	NA	NA	NA
PGEN_.00g204400	Scaffold_10	232786	259596	Q91WM2	HDHD5_MOUSE	Haloacid dehalogenase-like hydrolase domain-containing 5 (Cat eye syndrome critical region protein 5 homolog)	GO:0005739; GO:0046474	mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474]
PGEN_.00g204410	Scaffold_10	263382	274418	Q6AYB3	ISY1_RAT	Pre-mRNA-splicing factor ISY1 homolog	GO:0000350; GO:0000389; GO:0000398; GO:0000974; GO:0005634; GO:0071006; GO:0071013; GO:0071014; GO:0071020	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g204420	Scaffold_10	274719	281546	Q5PQR5	IMP4_RAT	U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4)	GO:0001650; GO:0005730; GO:0006364; GO:0030515; GO:0030684; GO:0032040; GO:0034457	fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]
PGEN_.00g204430	Scaffold_10	304693	319712	Q9BXW7	HDHD5_HUMAN	Haloacid dehalogenase-like hydrolase domain-containing 5 (Cat eye syndrome critical region protein 5)	GO:0005739; GO:0046474	mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474]
PGEN_.00g204440	Scaffold_10	324599	325345	NA	NA	NA	NA	NA
PGEN_.00g204450	Scaffold_10	328404	367325	Q99JW2	ACY1_MOUSE	Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)	GO:0004046; GO:0005737; GO:0006520; GO:0008237; GO:0042802; GO:0046872; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cellular amino acid metabolic process [GO:0006520]
PGEN_.00g204460	Scaffold_10	399167	400375	Q8N1E6	FXL14_HUMAN	F-box/LRR-repeat protein 14 (F-box and leucine-rich repeat protein 14)	GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0019005; GO:0031146; GO:0043687	cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g204470	Scaffold_10	450153	503366	P41221	WNT5A_HUMAN	Protein Wnt-5a	GO:0000187; GO:0001736; GO:0001756; GO:0001837; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002741; GO:0003323; GO:0003402; GO:0003408; GO:0003700; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007223; GO:0007257; GO:0007411; GO:0007442; GO:0007494; GO:0008584; GO:0008595; GO:0009986; GO:0010033; GO:0010595; GO:0010628; GO:0010800; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030514; GO:0030665; GO:0030666; GO:0030669; GO:0031012; GO:0032092; GO:0032148; GO:0032729; GO:0032755; GO:0033138; GO:0034613; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0038031; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0044212; GO:0045080; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045745; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048850; GO:0050680; GO:0050718; GO:0050727; GO:0050729; GO:0050807; GO:0051092; GO:0051216; GO:0051885; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060775; GO:0060809; GO:0060907; GO:0061024; GO:0061036; GO:0061347; GO:0061348; GO:0061349; GO:0061350; GO:0061354; GO:0062009; GO:0070062; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090037; GO:0090090; GO:0090103; GO:0090179; GO:0090630; GO:0097325; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:0099566; GO:0150012; GO:1900020; GO:1901216; GO:1902379; GO:1902474; GO:1903827; GO:1904469; GO:1904861; GO:1904862; GO:1904934; GO:1904938; GO:1904953; GO:1904955; GO:2000049; GO:2000052; GO:2000484	"cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; DNA-binding transcription factor activity [GO:0003700]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115]; transcription regulatory region DNA binding [GO:0044212]; activation of GTPase activity [GO:0090630]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; keratinocyte differentiation [GO:0030216]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; melanocyte proliferation [GO:0097325]; membrane organization [GO:0061024]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primitive streak formation [GO:0090009]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cellular protein localization [GO:1903827]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"
PGEN_.00g204480	Scaffold_10	555343	560534	Q7SXW4	EMC3_DANRE	ER membrane protein complex subunit 3 (Protein pob) (Transmembrane protein 111)	GO:0005794; GO:0016021; GO:0030140; GO:0045494; GO:0060041; GO:0072546	ER membrane protein complex [GO:0072546]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network transport vesicle [GO:0030140]; photoreceptor cell maintenance [GO:0045494]; retina development in camera-type eye [GO:0060041]
PGEN_.00g204490	Scaffold_10	571882	583856	Q8N0U4	F185A_HUMAN	Protein FAM185A	GO:0005829	cytosol [GO:0005829]
PGEN_.00g204500	Scaffold_10	588981	594140	P51638	CAV3_RAT	Caveolin-3	GO:0000139; GO:0001778; GO:0002027; GO:0005246; GO:0005623; GO:0005737; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006469; GO:0006641; GO:0006897; GO:0007009; GO:0007015; GO:0007204; GO:0007520; GO:0008016; GO:0008022; GO:0008104; GO:0008284; GO:0009986; GO:0010614; GO:0010831; GO:0014819; GO:0014902; GO:0016010; GO:0016020; GO:0016021; GO:0017015; GO:0017080; GO:0019870; GO:0019899; GO:0030154; GO:0030315; GO:0031116; GO:0031122; GO:0031579; GO:0031594; GO:0031982; GO:0032991; GO:0035995; GO:0038009; GO:0042383; GO:0042391; GO:0042593; GO:0042632; GO:0043014; GO:0043407; GO:0043409; GO:0044325; GO:0044877; GO:0045121; GO:0045792; GO:0046716; GO:0050998; GO:0051001; GO:0051394; GO:0051647; GO:0051896; GO:0051924; GO:0051926; GO:0055013; GO:0055117; GO:0060090; GO:0060299; GO:0060307; GO:0060347; GO:0060373; GO:0060762; GO:0061052; GO:0070836; GO:0071253; GO:0071417; GO:0072659; GO:0086005; GO:0090279; GO:0098909; GO:1900744; GO:1900825; GO:1900826; GO:1901017; GO:1901019; GO:1901380; GO:2000649; GO:2001288	caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982]; alpha-tubulin binding [GO:0043014]; calcium channel regulator activity [GO:0005246]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; potassium channel inhibitor activity [GO:0019870]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; sodium channel regulator activity [GO:0017080]; actin filament organization [GO:0007015]; cardiac muscle cell development [GO:0055013]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; cholesterol homeostasis [GO:0042632]; cytoplasmic microtubule organization [GO:0031122]; detection of muscle stretch [GO:0035995]; endocytosis [GO:0006897]; glucose homeostasis [GO:0042593]; heart trabecula formation [GO:0060347]; membrane raft organization [GO:0031579]; muscle cell cellular homeostasis [GO:0046716]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell size [GO:0045792]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900826]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of sarcomere organization [GO:0060299]; nucleus localization [GO:0051647]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of myotube differentiation [GO:0010831]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of calcium ion import [GO:0090279]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart contraction [GO:0008016]; regulation of heart rate [GO:0002027]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of membrane potential [GO:0042391]; regulation of nerve growth factor receptor activity [GO:0051394]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by receptor internalization [GO:0038009]; regulation of skeletal muscle contraction [GO:0014819]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; triglyceride metabolic process [GO:0006641]; ventricular cardiac muscle cell action potential [GO:0086005]
PGEN_.00g204510	Scaffold_10	596685	599463	NA	NA	NA	NA	NA
PGEN_.00g204520	Scaffold_10	603678	614989	Q2QL79	CAV1_DIDVI	Caveolin-1	GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836	caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g204530	Scaffold_10	614670	617308	Q9YGM8	CAV1_TAKRU	Caveolin-1	GO:0000139; GO:0005768; GO:0005783; GO:0005901; GO:0031295; GO:0045121; GO:0070836	caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; T cell costimulation [GO:0031295]
PGEN_.00g204540	Scaffold_10	630937	631996	Q9YGM8	CAV1_TAKRU	Caveolin-1	GO:0000139; GO:0005768; GO:0005783; GO:0005901; GO:0031295; GO:0045121; GO:0070836	caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; T cell costimulation [GO:0031295]
PGEN_.00g204550	Scaffold_10	632711	634871	Q2QL79	CAV1_DIDVI	Caveolin-1	GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836	caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g204560	Scaffold_10	640716	643195	Q07DV9	CAV1_AOTNA	Caveolin-1	GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836	caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g204570	Scaffold_10	649562	650313	Q9YGM8	CAV1_TAKRU	Caveolin-1	GO:0000139; GO:0005768; GO:0005783; GO:0005901; GO:0031295; GO:0045121; GO:0070836	caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; T cell costimulation [GO:0031295]
PGEN_.00g204580	Scaffold_10	654727	655873	Q2QLG6	CAV1_CALJA	Caveolin-1	GO:0000122; GO:0000139; GO:0000188; GO:0001525; GO:0001570; GO:0001666; GO:0001937; GO:0001960; GO:0002080; GO:0002095; GO:0002931; GO:0003057; GO:0005102; GO:0005623; GO:0005768; GO:0005783; GO:0005887; GO:0005901; GO:0005925; GO:0005929; GO:0005938; GO:0006641; GO:0006816; GO:0006940; GO:0007519; GO:0007595; GO:0008104; GO:0009617; GO:0010524; GO:0010608; GO:0010628; GO:0016504; GO:0019065; GO:0019217; GO:0019901; GO:0019915; GO:0030193; GO:0030335; GO:0030512; GO:0030674; GO:0030857; GO:0031295; GO:0031397; GO:0031398; GO:0031623; GO:0032091; GO:0032092; GO:0032570; GO:0033137; GO:0033138; GO:0033484; GO:0034141; GO:0042310; GO:0042532; GO:0042632; GO:0042802; GO:0043627; GO:0044325; GO:0044877; GO:0045019; GO:0045121; GO:0045907; GO:0046982; GO:0048365; GO:0048471; GO:0048550; GO:0050998; GO:0051001; GO:0051092; GO:0051117; GO:0051592; GO:0051899; GO:0060056; GO:0060355; GO:0060546; GO:0061099; GO:0070320; GO:0070836; GO:0071360; GO:0071455; GO:0071560; GO:0071711; GO:0072584; GO:0086091; GO:0086098; GO:0090090; GO:0090263; GO:0097190; GO:0098903; GO:0098911; GO:0120162; GO:1900027; GO:1900085; GO:1901844; GO:1903071; GO:1903598; GO:1903609; GO:2000286; GO:2000535; GO:2000811; GO:2001238; GO:2001244	"acrosomal membrane [GO:0002080]; caveola [GO:0005901]; caveolar macromolecular signaling complex [GO:0002095]; cell [GO:0005623]; cell cortex [GO:0005938]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; inward rectifier potassium channel inhibitor activity [GO:0070320]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; peptidase activator activity [GO:0016504]; protein binding, bridging [GO:0030674]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; apoptotic signaling pathway [GO:0097190]; basement membrane organization [GO:0071711]; calcium ion transport [GO:0006816]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to hyperoxia [GO:0071455]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cholesterol homeostasis [GO:0042632]; inactivation of MAPK activity [GO:0000188]; lactation [GO:0007595]; lipid storage [GO:0019915]; mammary gland involution [GO:0060056]; membrane depolarization [GO:0051899]; negative regulation of anoikis [GO:2000811]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; negative regulation of necroptotic process [GO:0060546]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-tyrosine autophosphorylation [GO:1900085]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein binding [GO:0032091]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nitric oxide homeostasis [GO:0033484]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of vasoconstriction [GO:0045907]; posttranscriptional regulation of gene expression [GO:0010608]; protein localization [GO:0008104]; receptor internalization [GO:0031623]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of blood coagulation [GO:0030193]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of ruffle assembly [GO:1900027]; regulation of smooth muscle contraction [GO:0006940]; regulation of the force of heart contraction by chemical signal [GO:0003057]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; response to bacterium [GO:0009617]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to progesterone [GO:0032570]; skeletal muscle tissue development [GO:0007519]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]; vasculogenesis [GO:0001570]; vasoconstriction [GO:0042310]"
PGEN_.00g204590	Scaffold_10	657794	658984	Q07E49	CAV1_DASNO	Caveolin-1	GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836	caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g204600	Scaffold_10	668214	670039	P51637	CAV3_MOUSE	Caveolin-3 (M-caveolin)	GO:0000139; GO:0001778; GO:0002027; GO:0005246; GO:0005623; GO:0005737; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006469; GO:0006641; GO:0006897; GO:0007009; GO:0007015; GO:0007204; GO:0007520; GO:0008016; GO:0008022; GO:0008104; GO:0008284; GO:0009986; GO:0010614; GO:0010831; GO:0014704; GO:0014819; GO:0014902; GO:0016010; GO:0016020; GO:0017015; GO:0017080; GO:0019870; GO:0019899; GO:0030018; GO:0030154; GO:0030315; GO:0031116; GO:0031122; GO:0031579; GO:0031594; GO:0031982; GO:0032991; GO:0035995; GO:0038009; GO:0042383; GO:0042391; GO:0042593; GO:0042632; GO:0043014; GO:0043231; GO:0043407; GO:0043409; GO:0044325; GO:0044877; GO:0045121; GO:0045792; GO:0046716; GO:0050998; GO:0051001; GO:0051394; GO:0051647; GO:0051896; GO:0051924; GO:0051926; GO:0055013; GO:0055117; GO:0060090; GO:0060299; GO:0060307; GO:0060347; GO:0060373; GO:0060762; GO:0061052; GO:0070836; GO:0071253; GO:0071417; GO:0072659; GO:0086005; GO:0090279; GO:0098909; GO:1900744; GO:1900825; GO:1900826; GO:1901017; GO:1901019; GO:1901380; GO:2000649; GO:2001288	caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982]; Z disc [GO:0030018]; alpha-tubulin binding [GO:0043014]; calcium channel regulator activity [GO:0005246]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; potassium channel inhibitor activity [GO:0019870]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; sodium channel regulator activity [GO:0017080]; actin filament organization [GO:0007015]; cardiac muscle cell development [GO:0055013]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; cholesterol homeostasis [GO:0042632]; cytoplasmic microtubule organization [GO:0031122]; detection of muscle stretch [GO:0035995]; endocytosis [GO:0006897]; glucose homeostasis [GO:0042593]; heart trabecula formation [GO:0060347]; membrane raft organization [GO:0031579]; muscle cell cellular homeostasis [GO:0046716]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell size [GO:0045792]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900826]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of sarcomere organization [GO:0060299]; nucleus localization [GO:0051647]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of myotube differentiation [GO:0010831]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of calcium ion import [GO:0090279]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart contraction [GO:0008016]; regulation of heart rate [GO:0002027]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of membrane potential [GO:0042391]; regulation of nerve growth factor receptor activity [GO:0051394]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by receptor internalization [GO:0038009]; regulation of skeletal muscle contraction [GO:0014819]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; triglyceride metabolic process [GO:0006641]; ventricular cardiac muscle cell action potential [GO:0086005]
PGEN_.00g204610	Scaffold_10	677549	678345	Q2QL79	CAV1_DIDVI	Caveolin-1	GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836	caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g204620	Scaffold_10	679627	682036	Q07E02	CAV1_ORNAN	Caveolin-1	GO:0000139; GO:0001937; GO:0005623; GO:0005768; GO:0005794; GO:0005887; GO:0005901; GO:0006874; GO:0019901; GO:0030154; GO:0030512; GO:0031295; GO:0031410; GO:0031623; GO:0044325; GO:0045121; GO:0048471; GO:0061099; GO:0070836	caveola [GO:0005901]; cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; ion channel binding [GO:0044325]; protein kinase binding [GO:0019901]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g204630	Scaffold_10	683535	684419	P51638	CAV3_RAT	Caveolin-3	GO:0000139; GO:0001778; GO:0002027; GO:0005246; GO:0005623; GO:0005737; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006469; GO:0006641; GO:0006897; GO:0007009; GO:0007015; GO:0007204; GO:0007520; GO:0008016; GO:0008022; GO:0008104; GO:0008284; GO:0009986; GO:0010614; GO:0010831; GO:0014819; GO:0014902; GO:0016010; GO:0016020; GO:0016021; GO:0017015; GO:0017080; GO:0019870; GO:0019899; GO:0030154; GO:0030315; GO:0031116; GO:0031122; GO:0031579; GO:0031594; GO:0031982; GO:0032991; GO:0035995; GO:0038009; GO:0042383; GO:0042391; GO:0042593; GO:0042632; GO:0043014; GO:0043407; GO:0043409; GO:0044325; GO:0044877; GO:0045121; GO:0045792; GO:0046716; GO:0050998; GO:0051001; GO:0051394; GO:0051647; GO:0051896; GO:0051924; GO:0051926; GO:0055013; GO:0055117; GO:0060090; GO:0060299; GO:0060307; GO:0060347; GO:0060373; GO:0060762; GO:0061052; GO:0070836; GO:0071253; GO:0071417; GO:0072659; GO:0086005; GO:0090279; GO:0098909; GO:1900744; GO:1900825; GO:1900826; GO:1901017; GO:1901019; GO:1901380; GO:2000649; GO:2001288	caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982]; alpha-tubulin binding [GO:0043014]; calcium channel regulator activity [GO:0005246]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; potassium channel inhibitor activity [GO:0019870]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; sodium channel regulator activity [GO:0017080]; actin filament organization [GO:0007015]; cardiac muscle cell development [GO:0055013]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; cholesterol homeostasis [GO:0042632]; cytoplasmic microtubule organization [GO:0031122]; detection of muscle stretch [GO:0035995]; endocytosis [GO:0006897]; glucose homeostasis [GO:0042593]; heart trabecula formation [GO:0060347]; membrane raft organization [GO:0031579]; muscle cell cellular homeostasis [GO:0046716]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell size [GO:0045792]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900826]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of sarcomere organization [GO:0060299]; nucleus localization [GO:0051647]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of myotube differentiation [GO:0010831]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of calcium ion import [GO:0090279]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart contraction [GO:0008016]; regulation of heart rate [GO:0002027]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of membrane potential [GO:0042391]; regulation of nerve growth factor receptor activity [GO:0051394]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by receptor internalization [GO:0038009]; regulation of skeletal muscle contraction [GO:0014819]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; triglyceride metabolic process [GO:0006641]; ventricular cardiac muscle cell action potential [GO:0086005]
PGEN_.00g204640	Scaffold_10	690169	692050	P51638	CAV3_RAT	Caveolin-3	GO:0000139; GO:0001778; GO:0002027; GO:0005246; GO:0005623; GO:0005737; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006469; GO:0006641; GO:0006897; GO:0007009; GO:0007015; GO:0007204; GO:0007520; GO:0008016; GO:0008022; GO:0008104; GO:0008284; GO:0009986; GO:0010614; GO:0010831; GO:0014819; GO:0014902; GO:0016010; GO:0016020; GO:0016021; GO:0017015; GO:0017080; GO:0019870; GO:0019899; GO:0030154; GO:0030315; GO:0031116; GO:0031122; GO:0031579; GO:0031594; GO:0031982; GO:0032991; GO:0035995; GO:0038009; GO:0042383; GO:0042391; GO:0042593; GO:0042632; GO:0043014; GO:0043407; GO:0043409; GO:0044325; GO:0044877; GO:0045121; GO:0045792; GO:0046716; GO:0050998; GO:0051001; GO:0051394; GO:0051647; GO:0051896; GO:0051924; GO:0051926; GO:0055013; GO:0055117; GO:0060090; GO:0060299; GO:0060307; GO:0060347; GO:0060373; GO:0060762; GO:0061052; GO:0070836; GO:0071253; GO:0071417; GO:0072659; GO:0086005; GO:0090279; GO:0098909; GO:1900744; GO:1900825; GO:1900826; GO:1901017; GO:1901019; GO:1901380; GO:2000649; GO:2001288	caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982]; alpha-tubulin binding [GO:0043014]; calcium channel regulator activity [GO:0005246]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; potassium channel inhibitor activity [GO:0019870]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; sodium channel regulator activity [GO:0017080]; actin filament organization [GO:0007015]; cardiac muscle cell development [GO:0055013]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; cholesterol homeostasis [GO:0042632]; cytoplasmic microtubule organization [GO:0031122]; detection of muscle stretch [GO:0035995]; endocytosis [GO:0006897]; glucose homeostasis [GO:0042593]; heart trabecula formation [GO:0060347]; membrane raft organization [GO:0031579]; muscle cell cellular homeostasis [GO:0046716]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell size [GO:0045792]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900826]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of sarcomere organization [GO:0060299]; nucleus localization [GO:0051647]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of myotube differentiation [GO:0010831]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of calcium ion import [GO:0090279]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart contraction [GO:0008016]; regulation of heart rate [GO:0002027]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of membrane potential [GO:0042391]; regulation of nerve growth factor receptor activity [GO:0051394]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by receptor internalization [GO:0038009]; regulation of skeletal muscle contraction [GO:0014819]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; triglyceride metabolic process [GO:0006641]; ventricular cardiac muscle cell action potential [GO:0086005]
PGEN_.00g204650	Scaffold_10	691898	694344	NA	NA	NA	NA	NA
PGEN_.00g204660	Scaffold_10	695942	696994	P35431	CAV1_CHICK	Caveolin-1	GO:0000139; GO:0001937; GO:0005623; GO:0005768; GO:0005794; GO:0005887; GO:0005901; GO:0006874; GO:0019901; GO:0030154; GO:0031295; GO:0031410; GO:0044325; GO:0048471; GO:0061099; GO:0070836	caveola [GO:0005901]; cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; ion channel binding [GO:0044325]; protein kinase binding [GO:0019901]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of protein tyrosine kinase activity [GO:0061099]; T cell costimulation [GO:0031295]
PGEN_.00g204670	Scaffold_10	702741	706885	Q2QL79	CAV1_DIDVI	Caveolin-1	GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836	caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g204680	Scaffold_10	714472	717334	Q2QL79	CAV1_DIDVI	Caveolin-1	GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836	caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g204690	Scaffold_10	724747	725402	NA	NA	NA	NA	NA
PGEN_.00g204700	Scaffold_10	731893	732930	Q2QL79	CAV1_DIDVI	Caveolin-1	GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836	caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g204710	Scaffold_10	736396	737684	Q2QL79	CAV1_DIDVI	Caveolin-1	GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836	caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g204720	Scaffold_10	746371	751695	NA	NA	NA	NA	NA
PGEN_.00g204730	Scaffold_10	755305	765532	NA	NA	NA	NA	NA
PGEN_.00g204740	Scaffold_10	785013	804563	Q6DDH2	RMI1_XENLA	RecQ-mediated genome instability protein 1	GO:0000166; GO:0005634; GO:0006260	nucleus [GO:0005634]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]
PGEN_.00g204750	Scaffold_10	806919	826631	Q8WUA7	TB22A_HUMAN	TBC1 domain family member 22A	GO:0005096; GO:0006886; GO:0017137; GO:0042803; GO:0071889; GO:0090630	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]
PGEN_.00g204760	Scaffold_10	827479	830447	NA	NA	NA	NA	NA
PGEN_.00g204770	Scaffold_10	843339	860605	P17141	ZFP37_MOUSE	Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)	GO:0003700; GO:0005634; GO:0007275; GO:0007281; GO:0007283; GO:0008270; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g204780	Scaffold_10	874371	875678	NA	NA	NA	NA	NA
PGEN_.00g204790	Scaffold_10	887582	900870	Q6IV77	TAZ_MACMU	Tafazzin	GO:0005739; GO:0007007; GO:0007507; GO:0016021; GO:0016746; GO:0035965	"integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; transferase activity, transferring acyl groups [GO:0016746]; cardiolipin acyl-chain remodeling [GO:0035965]; heart development [GO:0007507]; inner mitochondrial membrane organization [GO:0007007]"
PGEN_.00g204800	Scaffold_10	901218	913404	Q6IV78	TAZ_SAISC	Tafazzin	GO:0006644; GO:0016021; GO:0016746	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid metabolic process [GO:0006644]"
PGEN_.00g204810	Scaffold_10	926861	933137	Q8N1B3	CCNQ_HUMAN	Cyclin-Q (CDK10-activating cyclin) (Cyclin-M) (Cyclin-related protein FAM58A)	GO:0005634; GO:0006357; GO:0016538	nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g204820	Scaffold_10	937363	953938	Q28I85	POC1A_XENTR	POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A)	GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]
PGEN_.00g204830	Scaffold_10	960195	963290	NA	NA	NA	NA	NA
PGEN_.00g204840	Scaffold_10	963317	970180	NA	NA	NA	NA	NA
PGEN_.00g204850	Scaffold_10	994136	1030885	NA	NA	NA	NA	NA
PGEN_.00g204860	Scaffold_10	1034525	1035841	O54910	IKBE_MOUSE	NF-kappa-B inhibitor epsilon (NF-kappa-BIE) (I-kappa-B-epsilon) (IkB-E) (IkB-epsilon) (IkappaBepsilon)	GO:0001650; GO:0005654; GO:0005794; GO:0005829; GO:0042942; GO:0048471	cytosol [GO:0005829]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; D-serine transport [GO:0042942]
PGEN_.00g204870	Scaffold_10	1043129	1043569	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g204880	Scaffold_10	1056139	1074090	NA	NA	NA	NA	NA
PGEN_.00g204890	Scaffold_10	1081948	1097696	Q62165	DAG1_MOUSE	Dystroglycan (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)]	GO:0001954; GO:0002011; GO:0002162; GO:0003779; GO:0005509; GO:0005604; GO:0005615; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0005913; GO:0005925; GO:0006509; GO:0007016; GO:0007568; GO:0008307; GO:0009897; GO:0010470; GO:0010717; GO:0014044; GO:0014894; GO:0015631; GO:0016010; GO:0016011; GO:0016020; GO:0016021; GO:0016323; GO:0016340; GO:0017166; GO:0019048; GO:0021682; GO:0022011; GO:0030027; GO:0030175; GO:0030336; GO:0031103; GO:0031643; GO:0033268; GO:0034399; GO:0034453; GO:0042169; GO:0042383; GO:0043034; GO:0043236; GO:0043237; GO:0043403; GO:0043409; GO:0043434; GO:0044853; GO:0045121; GO:0045202; GO:0045211; GO:0045860; GO:0048714; GO:0050807; GO:0051393; GO:0051898; GO:0060055; GO:0060441; GO:0060445; GO:0070938; GO:0071260; GO:0071397; GO:0071679; GO:0071711; GO:0098696; GO:0098942; GO:0098978; GO:0098982; GO:0099524; GO:1904261	basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; modulation by virus of host morphology or physiology [GO:0019048]; morphogenesis of an epithelial sheet [GO:0002011]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; Schwann cell development [GO:0014044]; skeletal muscle tissue regeneration [GO:0043403]
PGEN_.00g204900	Scaffold_10	1149521	1190195	NA	NA	NA	NA	NA
PGEN_.00g204910	Scaffold_10	1152941	1153366	NA	NA	NA	NA	NA
PGEN_.00g204920	Scaffold_10	1230641	1231108	NA	NA	NA	NA	NA
PGEN_.00g204930	Scaffold_10	1239306	1239860	NA	NA	NA	NA	NA
PGEN_.00g204940	Scaffold_10	1262390	1262911	NA	NA	NA	NA	NA
PGEN_.00g204950	Scaffold_10	1262969	1263484	NA	NA	NA	NA	NA
PGEN_.00g204960	Scaffold_10	1274038	1274709	P18583	SON_HUMAN	Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3)	GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726	"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"
PGEN_.00g204970	Scaffold_10	1283949	1293839	A0M8U1	ST7_CHICK	Suppressor of tumorigenicity 7 protein homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g204980	Scaffold_10	1329001	1330851	NA	NA	NA	NA	NA
PGEN_.00g204990	Scaffold_10	1331969	1349353	A9X1A9	RM09_PAPAN	"39S ribosomal protein L9, mitochondrial (L9mt) (MRP-L9)"	GO:0003735; GO:0005739; GO:0005762; GO:0006412	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g205000	Scaffold_10	1412421	1416915	Q6QM28	SYN_HELPO	Synapsin (helSyn)	GO:0005524; GO:0007269; GO:0008021; GO:0030054; GO:0042995; GO:0046872	cell junction [GO:0030054]; cell projection [GO:0042995]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; neurotransmitter secretion [GO:0007269]
PGEN_.00g205010	Scaffold_10	1464290	1468356	P16035	TIMP2_HUMAN	Metalloproteinase inhibitor 2 (CSC-21K) (Tissue inhibitor of metalloproteinases 2) (TIMP-2)	GO:0002020; GO:0005178; GO:0005576; GO:0005615; GO:0007417; GO:0007568; GO:0008191; GO:0008270; GO:0008285; GO:0009725; GO:0009986; GO:0010033; GO:0010951; GO:0022617; GO:0030414; GO:0030426; GO:0031012; GO:0032487; GO:0034097; GO:0035580; GO:0042493; GO:0043025; GO:0043312; GO:0043410; GO:0045666; GO:0045762; GO:0045930; GO:0046580; GO:0051045; GO:0062023; GO:1904724; GO:1904813; GO:1905049	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; integrin binding [GO:0005178]; metalloendopeptidase inhibitor activity [GO:0008191]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]; aging [GO:0007568]; central nervous system development [GO:0007417]; extracellular matrix disassembly [GO:0022617]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of Ras protein signal transduction [GO:0046580]; neutrophil degranulation [GO:0043312]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; regulation of Rap protein signal transduction [GO:0032487]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to organic substance [GO:0010033]
PGEN_.00g205020	Scaffold_10	1487904	1501194	Q6QM28	SYN_HELPO	Synapsin (helSyn)	GO:0005524; GO:0007269; GO:0008021; GO:0030054; GO:0042995; GO:0046872	cell junction [GO:0030054]; cell projection [GO:0042995]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; neurotransmitter secretion [GO:0007269]
PGEN_.00g205030	Scaffold_10	1514312	1525349	Q56JV6	TWF1_BOVIN	Twinfilin-1	GO:0003779; GO:0003785; GO:0005623; GO:0005737; GO:0005884; GO:0010591; GO:0010976; GO:0030016; GO:0030042; GO:0042989; GO:0051015; GO:0051016	actin filament [GO:0005884]; cell [GO:0005623]; cytoplasm [GO:0005737]; myofibril [GO:0030016]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; positive regulation of neuron projection development [GO:0010976]; regulation of lamellipodium assembly [GO:0010591]; sequestering of actin monomers [GO:0042989]
PGEN_.00g205040	Scaffold_10	1528136	1555397	Q9JJY4	DDX20_MOUSE	Probable ATP-dependent RNA helicase DDX20 (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3) (Regulator of steroidogenic factor 1) (ROSF-1)	GO:0000122; GO:0000387; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0005829; GO:0008285; GO:0017053; GO:0019904; GO:0030674; GO:0032797; GO:0034719; GO:0042826; GO:0043065; GO:0045892; GO:0048477; GO:0050810; GO:0070491; GO:0090571; GO:0097504	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; RNA polymerase II transcription repressor complex [GO:0090571]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; transcriptional repressor complex [GO:0017053]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein binding, bridging [GO:0030674]; protein domain specific binding [GO:0019904]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal snRNP assembly [GO:0000387]"
PGEN_.00g205050	Scaffold_10	1556591	1581296	Q5E9U9	NPRL2_BOVIN	GATOR complex protein NPRL2 (Nitrogen permease regulator 2-like protein) (NPR2-like protein)	GO:0005096; GO:0005765; GO:0006995; GO:0010508; GO:0032007; GO:0034198; GO:1990130; GO:2000785	GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; GTPase activator activity [GO:0005096]; cellular response to amino acid starvation [GO:0034198]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; regulation of autophagosome assembly [GO:2000785]
PGEN_.00g205060	Scaffold_10	1586181	1586477	NA	NA	NA	NA	NA
PGEN_.00g205070	Scaffold_10	1586720	1587503	NA	NA	NA	NA	NA
PGEN_.00g205080	Scaffold_10	1590713	1594121	NA	NA	NA	NA	NA
PGEN_.00g205090	Scaffold_10	1604294	1605490	Q1LZE9	PRS23_BOVIN	Serine protease 23 (EC 3.4.21.-)	GO:0004252; GO:0005576; GO:0005634	extracellular region [GO:0005576]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g205100	Scaffold_10	1615625	1652572	Q14766	LTBP1_HUMAN	Latent-transforming growth factor beta-binding protein 1 (LTBP-1) (Transforming growth factor beta-1-binding protein 1) (TGF-beta1-BP-1)	GO:0001527; GO:0003281; GO:0005024; GO:0005509; GO:0005576; GO:0005788; GO:0031012; GO:0032991; GO:0035583; GO:0035904; GO:0043687; GO:0044267; GO:0050431; GO:0050436; GO:0060976; GO:0062023; GO:1901388	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; aorta development [GO:0035904]; cellular protein metabolic process [GO:0044267]; coronary vasculature development [GO:0060976]; post-translational protein modification [GO:0043687]; regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; ventricular septum development [GO:0003281]
PGEN_.00g205110	Scaffold_10	1785764	1801388	Q9ZQ47	GRDP1_ARATH	Glycine-rich domain-containing protein 1 (AtGRDP1)	GO:0005886; GO:0009738; GO:0009787; GO:0071470	plasma membrane [GO:0005886]; abscisic acid-activated signaling pathway [GO:0009738]; cellular response to osmotic stress [GO:0071470]; regulation of abscisic acid-activated signaling pathway [GO:0009787]
PGEN_.00g205120	Scaffold_10	1801448	1814433	Q68FS3	FBX7_RAT	F-box only protein 7	GO:0000151; GO:0000422; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006626; GO:0010975; GO:0016567; GO:0019901; GO:0031625; GO:0031647; GO:0040012; GO:0043130; GO:0045620; GO:0045736; GO:0046982; GO:0097409; GO:0097414; GO:0097462; GO:1901215; GO:1903204; GO:1903208; GO:1903599; GO:1990037; GO:1990038; GO:2000134	classical Lewy body [GO:0097414]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cytoplasmic inclusion [GO:0097409]; Lewy body core [GO:1990037]; Lewy body corona [GO:1990038]; Lewy neurite [GO:0097462]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; autophagy of mitochondrion [GO:0000422]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of lymphocyte differentiation [GO:0045620]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of autophagy of mitochondrion [GO:1903599]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]; regulation of locomotion [GO:0040012]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g205130	Scaffold_10	1819377	1824036	NA	NA	NA	NA	NA
PGEN_.00g205140	Scaffold_10	1824100	1838584	NA	NA	NA	NA	NA
PGEN_.00g205150	Scaffold_10	1839971	1846277	NA	NA	NA	NA	NA
PGEN_.00g205160	Scaffold_10	1852707	1859156	NA	NA	NA	NA	NA
PGEN_.00g205170	Scaffold_10	1869034	1871556	NA	NA	NA	NA	NA
PGEN_.00g205180	Scaffold_10	1874301	1876526	NA	NA	NA	NA	NA
PGEN_.00g205190	Scaffold_10	1879532	1882872	NA	NA	NA	NA	NA
PGEN_.00g205200	Scaffold_10	1883302	1902150	Q9TT91	MKRN1_MACEU	E3 ubiquitin-protein ligase makorin-1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase makorin-1)	GO:0016567; GO:0016740; GO:0046872	metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567]
PGEN_.00g205210	Scaffold_10	1916144	1927726	NA	NA	NA	NA	NA
PGEN_.00g205220	Scaffold_10	1933040	1938075	NA	NA	NA	NA	NA
PGEN_.00g205230	Scaffold_10	1977020	1977514	Q66Q82	BURS_ANOGA	Bursicon (Bursicon subunit alpha) (Cuticle-tanning hormone)	GO:0005179; GO:0005576	extracellular region [GO:0005576]; hormone activity [GO:0005179]
PGEN_.00g205240	Scaffold_10	1985089	1993469	NA	NA	NA	NA	NA
PGEN_.00g205250	Scaffold_10	1998637	2002294	NA	NA	NA	NA	NA
PGEN_.00g205260	Scaffold_10	1998962	1999676	NA	NA	NA	NA	NA
PGEN_.00g205270	Scaffold_10	2017913	2053640	G3V9H8	RET_RAT	Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]	GO:0000165; GO:0000187; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0005887; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042493; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241	"axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]"
PGEN_.00g205280	Scaffold_10	2071049	2084395	Q9NZV8	KCND2_HUMAN	Potassium voltage-gated channel subfamily D member 2 (Voltage-gated potassium channel subunit Kv4.2)	GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0005887; GO:0007268; GO:0008076; GO:0014069; GO:0016021; GO:0019228; GO:0019233; GO:0030054; GO:0030425; GO:0031226; GO:0032809; GO:0034765; GO:0043197; GO:0043204; GO:0044853; GO:0045211; GO:0045475; GO:0046872; GO:0051260; GO:0061337; GO:0071456; GO:0071805; GO:0098978; GO:0098982; GO:0099060; GO:1905030	cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cardiac conduction [GO:0061337]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; locomotor rhythm [GO:0045475]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]
PGEN_.00g205290	Scaffold_10	2280891	2282627	NA	NA	NA	NA	NA
PGEN_.00g205300	Scaffold_10	2318672	2358529	Q8VD04	GRAP1_MOUSE	GRIP1-associated protein 1 (GRASP-1) (HCMV-interacting protein) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)]	GO:0005654; GO:0005829; GO:0030054; GO:0030424; GO:0030425; GO:0043231; GO:0055038; GO:0098837; GO:0098887; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1905244	"axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"
PGEN_.00g205310	Scaffold_10	2365004	2376341	Q5ZIH2	MON1A_CHICK	Vacuolar fusion protein MON1 homolog A	GO:0005085; GO:0006623; GO:0009306	guanyl-nucleotide exchange factor activity [GO:0005085]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]
PGEN_.00g205320	Scaffold_10	2391685	2497351	Q9P2N4	ATS9_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-)	GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0006516; GO:0007275; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192]
PGEN_.00g205330	Scaffold_10	2507944	2543922	Q9P2N4	ATS9_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-)	GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0006516; GO:0007275; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192]
PGEN_.00g205340	Scaffold_10	2547507	2592736	P55201	BRPF1_HUMAN	Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140)	GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0043966; GO:0043972; GO:0045893; GO:0046872; GO:0070776; GO:1901796	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; histone H3 acetylation [GO:0043966]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]"
PGEN_.00g205350	Scaffold_10	2602505	2603815	NA	NA	NA	NA	NA
PGEN_.00g205360	Scaffold_10	2613116	2641720	Q9ULR3	PPM1H_HUMAN	Protein phosphatase 1H (EC 3.1.3.16)	GO:0004721; GO:0004722; GO:0004724; GO:0004741; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0098978; GO:1904184	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; positive regulation of pyruvate dehydrogenase activity [GO:1904184]
PGEN_.00g205370	Scaffold_10	2651775	2665154	Q9VLN1	WDR82_DROME	WD repeat-containing protein 82	GO:0003682; GO:0035097; GO:0048188; GO:0051568; GO:0080182	histone methyltransferase complex [GO:0035097]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]
PGEN_.00g205380	Scaffold_10	2668517	2677272	Q0VGK3	GLCTK_RAT	Glycerate kinase (EC 2.7.1.31)	GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0008887	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; glycerate kinase activity [GO:0008887]; protein phosphorylation [GO:0006468]
PGEN_.00g205390	Scaffold_10	2686386	2689971	Q2M389	WASC4_HUMAN	WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP)	GO:0005654; GO:0005768; GO:0005769; GO:0007032; GO:0015031; GO:0016197; GO:0071203	early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031]
PGEN_.00g205400	Scaffold_10	2690840	2720213	Q2M389	WASC4_HUMAN	WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP)	GO:0005654; GO:0005768; GO:0005769; GO:0007032; GO:0015031; GO:0016197; GO:0071203	early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031]
PGEN_.00g205410	Scaffold_10	2736989	2749434	Q9Y2F9	BTBD3_HUMAN	BTB/POZ domain-containing protein 3	GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813	cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]
PGEN_.00g205420	Scaffold_10	2852182	2854206	NA	NA	NA	NA	NA
PGEN_.00g205430	Scaffold_10	2856307	2859500	A4FUB8	TM115_BOVIN	Transmembrane protein 115	GO:0005794; GO:0006486; GO:0006890; GO:0016021; GO:0032580; GO:0042802	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; protein glycosylation [GO:0006486]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g205440	Scaffold_10	2868289	2870277	Q63362	NDUA5_RAT	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (Complex I subunit B13) (Complex I-13kD-B) (CI-13kD-B) (NADH-ubiquinone oxidoreductase 13 kDa-B subunit)	GO:0005739; GO:0005747; GO:0008137; GO:0022904; GO:0032981; GO:0032991; GO:0045271	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; respiratory chain complex I [GO:0045271]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial respiratory chain complex I assembly [GO:0032981]; respiratory electron transport chain [GO:0022904]
PGEN_.00g205450	Scaffold_10	2873031	2880171	NA	NA	NA	NA	NA
PGEN_.00g205460	Scaffold_10	2889255	2957384	P91685	GRM_DROME	Metabotropic glutamate receptor (DmGluRA)	GO:0001641; GO:0004930; GO:0005886; GO:0005887; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016021; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553	"G protein-coupled receptor homodimeric complex [GO:0038038]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553]"
PGEN_.00g205470	Scaffold_10	3065216	3066170	NA	NA	NA	NA	NA
PGEN_.00g205480	Scaffold_10	3240831	3262034	Q9QY44	ABCD2_RAT	ATP-binding cassette sub-family D member 2 (Adrenoleukodystrophy-related protein)	GO:0000038; GO:0005524; GO:0005777; GO:0005778; GO:0006635; GO:0009617; GO:0016021; GO:0016887; GO:0032000; GO:0042626; GO:0042760; GO:0042803; GO:0043217; GO:1900016; GO:1903427; GO:1990535; GO:2001280	integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; response to bacterium [GO:0009617]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]
PGEN_.00g205490	Scaffold_10	3262268	3284052	NA	NA	NA	NA	NA
PGEN_.00g205500	Scaffold_10	3289432	3395139	Q96QE2	MYCT_HUMAN	Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13)	GO:0005366; GO:0005886; GO:0005887; GO:0015798	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]
PGEN_.00g205510	Scaffold_10	3405484	3405876	Q86UL8	MAGI2_HUMAN	"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Atrophin-1-interacting protein 1) (AIP-1) (Atrophin-1-interacting protein A) (Membrane-associated guanylate kinase inverted 2) (MAGI-2)"	GO:0002092; GO:0003402; GO:0005634; GO:0005737; GO:0005770; GO:0005886; GO:0005911; GO:0005923; GO:0007165; GO:0008285; GO:0010976; GO:0014069; GO:0019902; GO:0030159; GO:0030336; GO:0030425; GO:0031697; GO:0032516; GO:0032926; GO:0032991; GO:0036057; GO:0038180; GO:0043113; GO:0045202; GO:0046332; GO:0048471; GO:0051291; GO:0051898; GO:0060395; GO:0070699; GO:0071850; GO:0072015; GO:0097118; GO:1990090; GO:2000809	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; phosphatase binding [GO:0019902]; receptor signaling complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; planar cell polarity pathway involved in axis elongation [GO:0003402]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic vesicle clustering [GO:2000809]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]
PGEN_.00g205520	Scaffold_10	3418302	3418556	NA	NA	NA	NA	NA
PGEN_.00g205530	Scaffold_10	3418921	3419619	Q9P215	POGK_HUMAN	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g205540	Scaffold_10	3420796	3441648	Q6RHR9	MAGI1_MOUSE	"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1)"	GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0060090; GO:0071944	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165]
PGEN_.00g205550	Scaffold_10	3441986	3442252	NA	NA	NA	NA	NA
PGEN_.00g205560	Scaffold_10	3462897	3463220	NA	NA	NA	NA	NA
PGEN_.00g205570	Scaffold_10	3472735	3511254	Q6RHR9	MAGI1_MOUSE	"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1)"	GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0060090; GO:0071944	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165]
PGEN_.00g205580	Scaffold_10	3526531	3528900	NA	NA	NA	NA	NA
PGEN_.00g205590	Scaffold_10	3534958	3564156	Q9CU62	SMC1A_MOUSE	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Chromosome segregation protein SmcB) (Sb1.8)	GO:0000776; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0007062; GO:0007064; GO:0008278; GO:0009314; GO:0016363; GO:0019827; GO:0030893; GO:0036033; GO:0046982; GO:0051301; GO:0051321; GO:0072423; GO:0097431; GO:1901673	cohesin complex [GO:0008278]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; regulation of mitotic spindle assembly [GO:1901673]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]
PGEN_.00g205600	Scaffold_10	3576201	3583392	Q21751	EAA6_CAEEL	Putative sodium-dependent excitatory amino acid transporter glt-6	GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]
PGEN_.00g205610	Scaffold_10	3619279	3621354	NA	NA	NA	NA	NA
PGEN_.00g205620	Scaffold_10	3621475	3622950	NA	NA	NA	NA	NA
PGEN_.00g205630	Scaffold_10	3634716	3646431	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g205640	Scaffold_10	3679071	3725320	NA	NA	NA	NA	NA
PGEN_.00g205650	Scaffold_10	3743142	3833070	NA	NA	NA	NA	NA
PGEN_.00g205660	Scaffold_10	3841489	3844397	Q5PPN7	MITOK_RAT	Mitochondrial potassium channel (MITOK) (Coiled-coil domain-containing protein 51)	GO:0031305; GO:0062156; GO:0062157; GO:0071805	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial ATP-gated potassium channel activity [GO:0062156]; potassium ion transmembrane transport [GO:0071805]
PGEN_.00g205670	Scaffold_10	3848416	3871130	Q96MG7	NSE3_HUMAN	Non-structural maintenance of chromosomes element 3 homolog (Non-SMC element 3 homolog) (Hepatocellular carcinoma-associated protein 4) (MAGE-G1 antigen) (Melanoma-associated antigen G1) (Necdin-like protein 2)	GO:0000781; GO:0005654; GO:0005737; GO:0006281; GO:0006310; GO:0006355; GO:0030915; GO:0031398; GO:0034644; GO:0040008; GO:0046983; GO:0071478; GO:0072711	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Smc5-Smc6 complex [GO:0030915]; protein dimerization activity [GO:0046983]; cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g205680	Scaffold_10	3977264	3981910	Q0D2E8	RFT1_XENTR	Protein RFT1 homolog	GO:0005319; GO:0005789; GO:0008643; GO:0016021; GO:0034203	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid transporter activity [GO:0005319]; carbohydrate transport [GO:0008643]; glycolipid translocation [GO:0034203]
PGEN_.00g205690	Scaffold_10	3991345	4008379	Q9Z1J2	NEK4_MOUSE	Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2)	GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0023014; GO:0030145; GO:0032147; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:1900062; GO:2000772; GO:2001020	"ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]"
PGEN_.00g205700	Scaffold_10	4019751	4029735	Q9CPV3	RM42_MOUSE	"39S ribosomal protein L42, mitochondrial (L42mt) (MRP-L42) (28S ribosomal protein S32, mitochondrial) (MRP-S32) (S32mt) (39S ribosomal protein L31, mitochondrial) (L31mt) (MRP-L31)"	GO:0005739; GO:0005762; GO:0005763; GO:0005886	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
PGEN_.00g205710	Scaffold_10	4037424	4037837	NA	NA	NA	NA	NA
PGEN_.00g205720	Scaffold_10	4037887	4080979	P13676	ACPH_RAT	Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase)	GO:0004252; GO:0005737; GO:0006508; GO:0008242; GO:0042802; GO:0050435	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508]
PGEN_.00g205730	Scaffold_10	4082592	4083772	P13676	ACPH_RAT	Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase)	GO:0004252; GO:0005737; GO:0006508; GO:0008242; GO:0042802; GO:0050435	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508]
PGEN_.00g205740	Scaffold_10	4087361	4107158	Q58A42	DD3_DICDI	Protein DD3-3	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g205750	Scaffold_10	4111154	4135596	Q58A42	DD3_DICDI	Protein DD3-3	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g205760	Scaffold_10	4164615	4170463	Q40588	ASO_TOBAC	L-ascorbate oxidase (ASO) (Ascorbase) (EC 1.10.3.3)	GO:0005507; GO:0005576; GO:0008447; GO:0009506	extracellular region [GO:0005576]; plasmodesma [GO:0009506]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447]
PGEN_.00g205770	Scaffold_10	4170629	4187414	NA	NA	NA	NA	NA
PGEN_.00g205780	Scaffold_10	4187441	4189278	Q27409	FP1_MYTGA	Adhesive plaque matrix protein (Foot protein 1) (MGFP-1) (MGFP1)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g205790	Scaffold_10	4189390	4189791	NA	NA	NA	NA	NA
PGEN_.00g205800	Scaffold_10	4199123	4220805	NA	NA	NA	NA	NA
PGEN_.00g205810	Scaffold_10	4221980	4223728	NA	NA	NA	NA	NA
PGEN_.00g205820	Scaffold_10	4263582	4268876	Q9UGM3	DMBT1_HUMAN	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0007275; GO:0008329; GO:0009897; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]
PGEN_.00g205830	Scaffold_10	4268906	4271528	NA	NA	NA	NA	NA
PGEN_.00g205840	Scaffold_10	4271858	4295258	Q9UGM3	DMBT1_HUMAN	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0007275; GO:0008329; GO:0009897; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]
PGEN_.00g205850	Scaffold_10	4356284	4377649	NA	NA	NA	NA	NA
PGEN_.00g205860	Scaffold_10	4390556	4480398	Q60997	DMBT1_MOUSE	Deleted in malignant brain tumors 1 protein (Apactin) (CRP-ductin) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80)	GO:0001530; GO:0001824; GO:0001833; GO:0003677; GO:0005044; GO:0005615; GO:0005737; GO:0006898; GO:0009617; GO:0009897; GO:0015031; GO:0016021; GO:0019898; GO:0030154; GO:0030658; GO:0030670; GO:0030858; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0050829; GO:0050830; GO:0061844; GO:0062023; GO:0070891; GO:1904399	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; induction of bacterial agglutination [GO:0043152]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]
PGEN_.00g205870	Scaffold_10	4484525	4492641	NA	NA	NA	NA	NA
PGEN_.00g205880	Scaffold_10	4495796	4499467	NA	NA	NA	NA	NA
PGEN_.00g205890	Scaffold_10	4542755	4548213	NA	NA	NA	NA	NA
PGEN_.00g205900	Scaffold_10	4555031	4585092	P31661	SC6A8_RABIT	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	GO:0005309; GO:0005328; GO:0005887; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine:sodium symporter activity [GO:0005309]; neurotransmitter:sodium symporter activity [GO:0005328]; creatine transmembrane transport [GO:0015881]
PGEN_.00g205910	Scaffold_10	4609332	4609937	NA	NA	NA	NA	NA
PGEN_.00g205920	Scaffold_10	4631728	4660609	Q8VBW1	SC6A8_MOUSE	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	GO:0005308; GO:0005309; GO:0005332; GO:0005886; GO:0015220; GO:0015881; GO:0042165; GO:0043005; GO:0098978; GO:0099055; GO:1990403	glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; creatine transmembrane transporter activity [GO:0005308]; creatine:sodium symporter activity [GO:0005309]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; creatine transmembrane transport [GO:0015881]; embryonic brain development [GO:1990403]
PGEN_.00g205930	Scaffold_10	4667492	4669222	NA	NA	NA	NA	NA
PGEN_.00g205940	Scaffold_10	4681637	4693427	P63139	NFYB_MOUSE	Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB)	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0016602; GO:0032993; GO:0043565; GO:0044212; GO:0044877; GO:0045893; GO:0046982; GO:0070491; GO:0090575; GO:1990830	"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g205950	Scaffold_10	4699205	4699789	NA	NA	NA	NA	NA
PGEN_.00g205960	Scaffold_10	4723547	4729322	NA	NA	NA	NA	NA
PGEN_.00g205970	Scaffold_10	4748339	4748602	NA	NA	NA	NA	NA
PGEN_.00g205980	Scaffold_10	4799336	4800869	NA	NA	NA	NA	NA
PGEN_.00g205990	Scaffold_10	4804602	4807040	NA	NA	NA	NA	NA
PGEN_.00g206000	Scaffold_10	4836142	4836579	NA	NA	NA	NA	NA
PGEN_.00g206010	Scaffold_10	4845909	4846794	NA	NA	NA	NA	NA
PGEN_.00g206020	Scaffold_10	4886836	4888218	P08510	KCNAS_DROME	Potassium voltage-gated channel protein Shaker (Protein minisleep)	GO:0001508; GO:0005249; GO:0005251; GO:0006813; GO:0007611; GO:0007619; GO:0007637; GO:0008076; GO:0008345; GO:0009584; GO:0016021; GO:0022843; GO:0030431; GO:0034765; GO:0045187; GO:0045838; GO:0045938; GO:0048047; GO:0048150; GO:0048675; GO:0050909; GO:0051260; GO:0060025; GO:0071805; GO:1903351	"integral component of membrane [GO:0016021]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; axon extension [GO:0048675]; behavioral response to ether [GO:0048150]; cellular response to dopamine [GO:1903351]; courtship behavior [GO:0007619]; detection of visible light [GO:0009584]; larval locomotory behavior [GO:0008345]; learning or memory [GO:0007611]; mating behavior, sex discrimination [GO:0048047]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of membrane potential [GO:0045838]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proboscis extension reflex [GO:0007637]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic activity [GO:0060025]; sensory perception of taste [GO:0050909]; sleep [GO:0030431]"
PGEN_.00g206030	Scaffold_10	4945202	4945477	NA	NA	NA	NA	NA
PGEN_.00g206040	Scaffold_10	4945711	4946363	NA	NA	NA	NA	NA
PGEN_.00g206050	Scaffold_10	4955366	4956112	NA	NA	NA	NA	NA
PGEN_.00g206060	Scaffold_10	4999211	5015897	NA	NA	NA	NA	NA
PGEN_.00g206070	Scaffold_10	5018932	5026803	Q8BR07	BICD1_MOUSE	Protein bicaudal D homolog 1 (Bic-D 1)	GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005881; GO:0008093; GO:0016020; GO:0016032; GO:0017137; GO:0019901; GO:0031410; GO:0031871; GO:0033365; GO:0034063; GO:0034452; GO:0045505; GO:0048260; GO:0048471; GO:0070507; GO:0070840; GO:0072385; GO:0072393; GO:0072517; GO:1900275; GO:1900276; GO:1900737; GO:1904781	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; host cell viral assembly compartment [GO:0072517]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; cytoskeletal adaptor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; Rab GTPase binding [GO:0017137]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; stress granule assembly [GO:0034063]; viral process [GO:0016032]
PGEN_.00g206080	Scaffold_10	5051270	5066797	Q9QY36	NAA10_MOUSE	N-alpha-acetyltransferase 10 (EC 2.3.1.255) (N-terminal acetyltransferase complex ARD1 subunit homolog A) (NatA catalytic subunit Naa10)	GO:0004596; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006473; GO:0006474; GO:0008080; GO:0017198; GO:0018002; GO:0031415; GO:0043022; GO:1990189; GO:1990190; GO:2000719	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-N-acetyltransferase activity [GO:1990190]; peptide-serine-N-acetyltransferase activity [GO:1990189]; ribosome binding [GO:0043022]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-serine acetylation [GO:0017198]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000719]; protein acetylation [GO:0006473]"
PGEN_.00g206090	Scaffold_10	5070658	5079470	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g206100	Scaffold_10	5091604	5131142	Q52I78	NAMPT_PIG	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)	GO:0004514; GO:0005125; GO:0005615; GO:0005737; GO:0009435; GO:0016607; GO:0030054; GO:0032922; GO:0042802; GO:0045944; GO:0047280; GO:0051770	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g206110	Scaffold_10	5135586	5136733	NA	NA	NA	NA	NA
PGEN_.00g206120	Scaffold_10	5136765	5137073	NA	NA	NA	NA	NA
PGEN_.00g206130	Scaffold_10	5150383	5208233	A6PVC2	TTLL8_HUMAN	Protein monoglycylase TTLL8 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 8)	GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0070735; GO:0070736	"axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; protein polyglycylation [GO:0018094]"
PGEN_.00g206140	Scaffold_10	5208296	5215447	NA	NA	NA	NA	NA
PGEN_.00g206150	Scaffold_10	5215667	5218306	NA	NA	NA	NA	NA
PGEN_.00g206160	Scaffold_10	5289970	5297737	Q8R316	HBP1_MOUSE	HMG box-containing protein 1 (HMG box transcription factor 1) (High mobility group box transcription factor 1)	GO:0000122; GO:0000978; GO:0001227; GO:0003723; GO:0005654; GO:0010745; GO:0016055; GO:0016607; GO:0032369; GO:0043268; GO:1903427	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of potassium ion transport [GO:0043268]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g206170	Scaffold_10	5353922	5354263	NA	NA	NA	NA	NA
PGEN_.00g206180	Scaffold_10	5354458	5354715	NA	NA	NA	NA	NA
PGEN_.00g206190	Scaffold_10	5363471	5445301	A2VEC9	SSPO_HUMAN	SCO-spondin	GO:0005615; GO:0007155; GO:0007399; GO:0030154; GO:0030414	extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g206200	Scaffold_10	5473849	5588944	Q700K0	SSPO_RAT	SCO-spondin	GO:0005615; GO:0005737; GO:0007155; GO:0007399; GO:0030154	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g206210	Scaffold_10	5592958	5593741	NA	NA	NA	NA	NA
PGEN_.00g206220	Scaffold_10	5594752	5614794	Q9Y6F1	PARP3_HUMAN	Protein mono-ADP-ribosyltransferase PARP3 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 3) (ARTD3) (DNA ADP-ribosyltransferase PARP3) (EC 2.4.2.-) (IRT1) (NAD(+) ADP-ribosyltransferase 3) (ADPRT-3) (Poly [ADP-ribose] polymerase 3) (PARP-3) (hPARP-3) (Poly[ADP-ribose] synthase 3) (pADPRT-3)	GO:0000723; GO:0003824; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006281; GO:0006302; GO:0006471; GO:0016604; GO:0030592; GO:0035861; GO:0045829; GO:0051106; GO:0060236; GO:0070212; GO:0070213; GO:0140289; GO:0140294; GO:1905662; GO:1990166; GO:1990404; GO:2001034	centriole [GO:0005814]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of isotype switching [GO:0045829]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to site of double-strand break [GO:1990166]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723]
PGEN_.00g206230	Scaffold_10	5622227	5625205	NA	NA	NA	NA	NA
PGEN_.00g206240	Scaffold_10	5646436	5675953	J9VY90	LAC1_CRYNH	Laccase-1 (EC 1.10.3.2) (Diphenol oxidase 1)	GO:0005507; GO:0005576; GO:0005618; GO:0052716	cell wall [GO:0005618]; extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]
PGEN_.00g206250	Scaffold_10	5676066	5711762	Q9DC53	CPNE8_MOUSE	Copine-8 (Copine VIII)	GO:0005544; GO:0005886; GO:0071277	plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]
PGEN_.00g206260	Scaffold_10	5719529	5732890	Q9DC53	CPNE8_MOUSE	Copine-8 (Copine VIII)	GO:0005544; GO:0005886; GO:0071277	plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]
PGEN_.00g206270	Scaffold_10	5773653	5808029	C6KFA3	AGRG6_DANRE	Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	GO:0001503; GO:0004930; GO:0005518; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0007507; GO:0014037; GO:0019933; GO:0022011; GO:0032290; GO:0042552; GO:0043236; GO:0043583; GO:0048932; GO:0050840; GO:0060347; GO:0060879; GO:1903670	integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879]
PGEN_.00g206280	Scaffold_10	5883065	5891228	Q8N488	RYBP_HUMAN	RING1 and YY1-binding protein (Apoptin-associating protein 1) (APAP-1) (Death effector domain-associated factor) (DED-associated factor) (YY1 and E4TF1-associated factor 1)	GO:0000122; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006915; GO:0007275; GO:0032435; GO:0035518; GO:0043065; GO:0045893; GO:0046872; GO:0070317	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; histone H2A monoubiquitination [GO:0035518]; multicellular organism development [GO:0007275]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g206290	Scaffold_10	5952945	5954571	Q64505	CP7A1_MOUSE	Cytochrome P450 7A1 (24-hydroxycholesterol 7-alpha-hydroxylase) (EC 1.14.14.26) (CYPVII) (Cholesterol 7-alpha-hydroxylase) (Cholesterol 7-alpha-monooxygenase) (EC 1.14.14.23)	GO:0005506; GO:0005623; GO:0005789; GO:0006699; GO:0006707; GO:0008123; GO:0016021; GO:0020037; GO:0042632; GO:0043231; GO:0045542; GO:0045717; GO:0070857; GO:0070859; GO:0071333; GO:0071397	cell [GO:0005623]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; cholesterol 7-alpha-monooxygenase activity [GO:0008123]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; bile acid biosynthetic process [GO:0006699]; cellular response to cholesterol [GO:0071397]; cellular response to glucose stimulus [GO:0071333]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of bile acid biosynthetic process [GO:0070857]
PGEN_.00g206300	Scaffold_10	5954672	5957149	NA	NA	NA	NA	NA
PGEN_.00g206310	Scaffold_10	5993121	5993426	NA	NA	NA	NA	NA
PGEN_.00g206320	Scaffold_10	6044854	6046044	NA	NA	NA	NA	NA
PGEN_.00g206330	Scaffold_10	6122748	6123173	NA	NA	NA	NA	NA
PGEN_.00g206340	Scaffold_10	6126815	6135340	O11780	BGH3_PIG	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP)	GO:0005178; GO:0005518; GO:0005615; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; extracellular matrix organization [GO:0030198]
PGEN_.00g206350	Scaffold_10	6143818	6227931	Q8CDU4	DRC6_MOUSE	Dynein regulatory complex subunit 6 (F-box and leucine-rich repeat protein 13) (F-box/LRR-repeat protein 13)	GO:0005737; GO:0005856; GO:0006511; GO:0016567; GO:0019005; GO:0031146; GO:0031514	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g206360	Scaffold_10	6241218	6252350	Q5XIU1	ABTB1_RAT	Ankyrin repeat and BTB/POZ domain-containing protein 1	GO:0000151; GO:0003746; GO:0005730; GO:0005829; GO:0005886	cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; translation elongation factor activity [GO:0003746]
PGEN_.00g206370	Scaffold_10	6269751	6306243	Q9ULK2	AT7L1_HUMAN	Ataxin-7-like protein 1 (Ataxin-7-like protein 4)		
PGEN_.00g206380	Scaffold_10	6306468	6326331	Q3SZ60	THOC7_BOVIN	THO complex subunit 7 homolog	GO:0000445; GO:0000784; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0046784	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex part of transcription export complex [GO:0000445]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]"
PGEN_.00g206390	Scaffold_10	6338530	6373626	Q6ZUG5	YC006_HUMAN	Uncharacterized protein FLJ43738		
PGEN_.00g206400	Scaffold_10	6428365	6446893	NA	NA	NA	NA	NA
PGEN_.00g206410	Scaffold_10	6454468	6469238	Q9BTV4	TMM43_HUMAN	Transmembrane protein 43 (Protein LUMA)	GO:0005639; GO:0005788; GO:0005794; GO:0016020; GO:0043621; GO:0071763	endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; protein self-association [GO:0043621]; nuclear membrane organization [GO:0071763]
PGEN_.00g206420	Scaffold_10	6477884	6484172	B0V2S2	DCR1B_DANRE	5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B)	GO:0000723; GO:0000781; GO:0000784; GO:0003684; GO:0005813; GO:0006303; GO:0007093; GO:0008409; GO:0031627; GO:0031848; GO:0031860; GO:0035312; GO:0036297	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; nuclear chromosome, telomeric region [GO:0000784]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; protection from non-homologous end joining at telomere [GO:0031848]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]"
PGEN_.00g206430	Scaffold_10	6490151	6494286	NA	NA	NA	NA	NA
PGEN_.00g206440	Scaffold_10	6499792	6535264	P51612	XPC_MOUSE	DNA repair protein complementing XP-C cells homolog (Xeroderma pigmentosum group C-complementing protein homolog) (p125)	GO:0000109; GO:0000111; GO:0000715; GO:0000720; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006281; GO:0006289; GO:0006298; GO:0006974; GO:0010224; GO:0010996; GO:0031573; GO:0042493; GO:0043231; GO:0044877; GO:0070914; GO:0071942; GO:0090734; GO:1901990; GO:1990731	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of DNA damage [GO:0090734]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intra-S DNA damage checkpoint [GO:0031573]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to auditory stimulus [GO:0010996]; response to drug [GO:0042493]; response to UV-B [GO:0010224]; UV-damage excision repair [GO:0070914]; UV-damage excision repair, DNA incision [GO:1990731]"
PGEN_.00g206450	Scaffold_10	6546573	6547031	C3XVM1	GATC_BRAFL	"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-)"	GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]
PGEN_.00g206460	Scaffold_10	6552450	6555364	Q9W3T5	SMIM4_DROME	Small integral membrane protein 4	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g206470	Scaffold_10	6559056	6571724	P56581	TDG_MOUSE	G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (C-JUN leucine zipper interactive protein JZA-3) (Thymine-DNA glycosylase)	GO:0000122; GO:0000287; GO:0003677; GO:0003690; GO:0003712; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0006298; GO:0006325; GO:0008134; GO:0008263; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032091; GO:0032183; GO:0035562; GO:0040029; GO:0042803; GO:0043621; GO:0043739; GO:0045995; GO:0080111; GO:1902544	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]"
PGEN_.00g206480	Scaffold_10	6574974	6598334	NA	NA	NA	NA	NA
PGEN_.00g206490	Scaffold_10	6603430	6603648	NA	NA	NA	NA	NA
PGEN_.00g206500	Scaffold_10	6603672	6603977	NA	NA	NA	NA	NA
PGEN_.00g206510	Scaffold_10	6607054	6626882	Q9H6T3	RPAP3_HUMAN	RNA polymerase II-associated protein 3	GO:0005829; GO:0097255	cytosol [GO:0005829]; R2TP complex [GO:0097255]
PGEN_.00g206520	Scaffold_10	6654295	6664797	NA	NA	NA	NA	NA
PGEN_.00g206530	Scaffold_10	6665103	6672036	NA	NA	NA	NA	NA
PGEN_.00g206540	Scaffold_10	6676702	6689483	O07552	NHAX_BACSU	Stress response protein NhaX		
PGEN_.00g206550	Scaffold_10	6695555	6696478	Q4ZHW1	PTF1A_XENLA	Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (Transcription factor Ptf1a/p48)	GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0009888; GO:0030902; GO:0031017; GO:0045893; GO:0046983; GO:0048384; GO:0048699	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]"
PGEN_.00g206560	Scaffold_10	6702095	6711004	Q29504	UBA1_RABIT	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1)	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]
PGEN_.00g206570	Scaffold_10	6713250	6758807	P22314	UBA1_HUMAN	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g206580	Scaffold_10	6765395	6765667	NA	NA	NA	NA	NA
PGEN_.00g206590	Scaffold_10	6766342	6767364	NA	NA	NA	NA	NA
PGEN_.00g206600	Scaffold_10	6807337	6855063	O60285	NUAK1_HUMAN	NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1)	GO:0001650; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0035507; GO:0035556; GO:0042127; GO:0046872; GO:1901796; GO:2000772	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]
PGEN_.00g206610	Scaffold_10	6855784	6880548	O08816	WASL_RAT	Neural Wiskott-Aldrich syndrome protein (N-WASP)	GO:0000139; GO:0000147; GO:0005623; GO:0005634; GO:0005829; GO:0005884; GO:0006897; GO:0006900; GO:0008092; GO:0009617; GO:0010324; GO:0016050; GO:0030027; GO:0030036; GO:0030041; GO:0030048; GO:0030050; GO:0030478; GO:0030479; GO:0031252; GO:0031410; GO:0032880; GO:0034629; GO:0042802; GO:0045944; GO:0051015; GO:0051301; GO:0051491; GO:0051653; GO:0051666; GO:0060997; GO:0097320; GO:0098794; GO:0098974; GO:0098978; GO:1903526; GO:2000370; GO:2000402; GO:2000601	actin cap [GO:0030478]; actin cortical patch [GO:0030479]; actin filament [GO:0005884]; cell [GO:0005623]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; postsynapse [GO:0098794]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; membrane invagination [GO:0010324]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of membrane tubulation [GO:1903526]; plasma membrane tubulation [GO:0097320]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of protein localization [GO:0032880]; response to bacterium [GO:0009617]; spindle localization [GO:0051653]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050]
PGEN_.00g206620	Scaffold_10	6892005	6937926	A2VCW9	AASS_RAT	"Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)]"	GO:0004753; GO:0005737; GO:0005739; GO:0019477; GO:0019878; GO:0033512; GO:0047130; GO:0047131	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; L-lysine catabolic process [GO:0019477]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]"
PGEN_.00g206630	Scaffold_10	6939251	6950824	Q5E9V5	KLD8B_BOVIN	Kelch domain-containing protein 8B	GO:0005737; GO:0030496; GO:0045171; GO:0098813; GO:0110070; GO:0140014; GO:1902410	cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]
PGEN_.00g206640	Scaffold_10	6966749	6970189	NA	NA	NA	NA	NA
PGEN_.00g206650	Scaffold_10	7011144	7015427	P70245	EBP_MOUSE	"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein)"	GO:0000247; GO:0004769; GO:0005635; GO:0005783; GO:0005789; GO:0006695; GO:0016021; GO:0016126; GO:0030097; GO:0031410; GO:0043231; GO:0047750	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; C-8 sterol isomerase activity [GO:0000247]; cholestenol delta-isomerase activity [GO:0047750]; steroid delta-isomerase activity [GO:0004769]; cholesterol biosynthetic process [GO:0006695]; hemopoiesis [GO:0030097]; sterol biosynthetic process [GO:0016126]
PGEN_.00g206660	Scaffold_10	7024995	7042715	B3VSC2	TSN9_SHEEP	Tetraspanin-9 (Tspan-9) (Tetraspan NET-5)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g206670	Scaffold_10	7071535	7071756	NA	NA	NA	NA	NA
PGEN_.00g206680	Scaffold_10	7089902	7090372	NA	NA	NA	NA	NA
PGEN_.00g206690	Scaffold_10	7140545	7144179	NA	NA	NA	NA	NA
PGEN_.00g206700	Scaffold_10	7183927	7213674	Q57951	Y531_METJA	Universal stress protein MJ0531 (USP MJ0531)		
PGEN_.00g206710	Scaffold_10	7228524	7367665	Q6ZR37	PKHG7_HUMAN	Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7)	GO:0005085	guanyl-nucleotide exchange factor activity [GO:0005085]
PGEN_.00g206720	Scaffold_10	7383917	7386011	NA	NA	NA	NA	NA
PGEN_.00g206730	Scaffold_10	7417349	7421356	NA	NA	NA	NA	NA
PGEN_.00g206740	Scaffold_10	7429485	7429871	NA	NA	NA	NA	NA
PGEN_.00g206750	Scaffold_10	7429921	7430241	NA	NA	NA	NA	NA
PGEN_.00g206760	Scaffold_10	7430282	7430852	NA	NA	NA	NA	NA
PGEN_.00g206770	Scaffold_10	7522677	7523468	NA	NA	NA	NA	NA
PGEN_.00g206780	Scaffold_10	7536620	7537534	NA	NA	NA	NA	NA
PGEN_.00g206790	Scaffold_10	7547122	7574549	Q5RB79	RPP14_PONAB	Ribonuclease P protein subunit p14 (EC 3.1.26.5)	GO:0001682; GO:0004526; GO:0005730; GO:0030681; GO:0033204	multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; tRNA 5'-leader removal [GO:0001682]
PGEN_.00g206800	Scaffold_10	7574634	7575467	Q567C3	CA074_DANRE	UPF0739 protein C1orf74 homolog		
PGEN_.00g206810	Scaffold_10	7584310	7700085	Q8BW94	DYH3_MOUSE	"Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)"	GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959	"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]"
PGEN_.00g206820	Scaffold_10	7702299	7703327	F6ZQ54	TRI13_XENTR	Tripartite motif containing 13	GO:0005789; GO:0008270; GO:0016021; GO:0016567; GO:0016874	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ligase activity [GO:0016874]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g206830	Scaffold_10	7705122	7770823	Q8BW94	DYH3_MOUSE	"Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)"	GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959	"dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]"
PGEN_.00g206840	Scaffold_10	7804938	7859954	Q292U5	ESN_DROPS	Protein espinas	GO:0008270	zinc ion binding [GO:0008270]
PGEN_.00g206850	Scaffold_10	7864436	7866522	NA	NA	NA	NA	NA
PGEN_.00g206860	Scaffold_10	7930124	7930366	NA	NA	NA	NA	NA
PGEN_.00g206870	Scaffold_10	7943852	7949453	P70617	NINJ1_RAT	Ninjurin-1 (Nerve injury-induced protein 1)	GO:0001954; GO:0007155; GO:0016021; GO:0042246; GO:1990384	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]
PGEN_.00g206880	Scaffold_10	7960975	7982243	P28028	BRAF_MOUSE	Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf)	GO:0000186; GO:0002318; GO:0004672; GO:0004674; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0008542; GO:0010628; GO:0010764; GO:0010828; GO:0016020; GO:0017016; GO:0030154; GO:0030878; GO:0031434; GO:0033138; GO:0035019; GO:0035690; GO:0042127; GO:0042802; GO:0043005; GO:0043066; GO:0043231; GO:0043367; GO:0043368; GO:0043369; GO:0043434; GO:0043524; GO:0044297; GO:0044877; GO:0045580; GO:0046632; GO:0046982; GO:0048538; GO:0048679; GO:0048680; GO:0050772; GO:0050852; GO:0051291; GO:0051496; GO:0051591; GO:0060291; GO:0060323; GO:0060324; GO:0070374; GO:0070413; GO:0071277; GO:0090150; GO:1900026; GO:1990090; GO:2000301; GO:2000352	"cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; Ras GTPase binding [GO:0017016]; activation of MAPKK activity [GO:0000186]; alpha-beta T cell differentiation [GO:0046632]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive T cell selection [GO:0043368]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; response to cAMP [GO:0051591]; response to peptide hormone [GO:0043434]; somatic stem cell population maintenance [GO:0035019]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trehalose metabolism in response to stress [GO:0070413]; visual learning [GO:0008542]"
PGEN_.00g206890	Scaffold_10	7987370	7987981	NA	NA	NA	NA	NA
PGEN_.00g206900	Scaffold_10	7998816	7999121	NA	NA	NA	NA	NA
PGEN_.00g206910	Scaffold_10	7999590	7999973	NA	NA	NA	NA	NA
PGEN_.00g206920	Scaffold_10	8001554	8019394	P04627	ARAF_MOUSE	Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf)	GO:0004674; GO:0004709; GO:0005524; GO:0005739; GO:0005829; GO:0006468; GO:0020021; GO:0032006; GO:0032434; GO:0033138; GO:0043066; GO:0046872	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; immortalization of host cell [GO:0020021]; negative regulation of apoptotic process [GO:0043066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]
PGEN_.00g206930	Scaffold_10	8027155	8030141	NA	NA	NA	NA	NA
PGEN_.00g206940	Scaffold_10	8106575	8145410	Q921Y4	MFSD5_MOUSE	Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog)	GO:0005886; GO:0015098; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]
PGEN_.00g206950	Scaffold_10	8144707	8147603	NA	NA	NA	NA	NA
PGEN_.00g206960	Scaffold_10	8211855	8248267	P19602	LKHA4_CAVPO	Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase)	GO:0004177; GO:0004301; GO:0004463; GO:0005737; GO:0008237; GO:0008270; GO:0019370; GO:0043171	cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171]
PGEN_.00g206970	Scaffold_10	8248312	8248833	NA	NA	NA	NA	NA
PGEN_.00g206980	Scaffold_10	8266522	8267139	NA	NA	NA	NA	NA
PGEN_.00g206990	Scaffold_10	8267217	8275857	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g207000	Scaffold_10	8294685	8369477	Q9H1D0	TRPV6_HUMAN	Transient receptor potential cation channel subfamily V member 6 (TrpV6) (CaT-like) (CaT-L) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2)	GO:0005216; GO:0005262; GO:0005516; GO:0005623; GO:0005886; GO:0005887; GO:0006816; GO:0017158; GO:0046872; GO:0051592; GO:0055074; GO:0070588; GO:0098703	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592]
PGEN_.00g207010	Scaffold_10	8384138	8388833	NA	NA	NA	NA	NA
PGEN_.00g207020	Scaffold_10	8388884	8394291	NA	NA	NA	NA	NA
PGEN_.00g207030	Scaffold_10	8401508	8415758	O14427	CLA4_CANAX	Serine/threonine-protein kinase CLA4 (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0009405	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; pathogenesis [GO:0009405]
PGEN_.00g207040	Scaffold_10	8420350	8427015	Q10473	GALT1_RAT	Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]	GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0016021; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g207050	Scaffold_10	8442828	8455168	Q9P2S5	WRP73_HUMAN	WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene)	GO:0005737; GO:0005813; GO:0005814; GO:0030030; GO:0036064; GO:0090307; GO:1902857	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cell projection organization [GO:0030030]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]
PGEN_.00g207060	Scaffold_10	8457887	8461826	NA	NA	NA	NA	NA
PGEN_.00g207070	Scaffold_10	8485753	8491415	NA	NA	NA	NA	NA
PGEN_.00g207080	Scaffold_10	8496574	8496909	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g207090	Scaffold_10	8515748	8516143	NA	NA	NA	NA	NA
PGEN_.00g207100	Scaffold_10	8516052	8517185	NA	NA	NA	NA	NA
PGEN_.00g207110	Scaffold_10	8519063	8521763	NA	NA	NA	NA	NA
PGEN_.00g207120	Scaffold_10	8531015	8531461	NA	NA	NA	NA	NA
PGEN_.00g207130	Scaffold_10	8531992	8532399	NA	NA	NA	NA	NA
PGEN_.00g207140	Scaffold_10	8542924	8543331	NA	NA	NA	NA	NA
PGEN_.00g207150	Scaffold_10	8559717	8560700	NA	NA	NA	NA	NA
PGEN_.00g207160	Scaffold_10	8578027	8621737	Q9BH05	THNS1_MACFA	Threonine synthase-like 1 (TSH1)		
PGEN_.00g207170	Scaffold_10	8651466	8652107	NA	NA	NA	NA	NA
PGEN_.00g207180	Scaffold_10	8652409	8652765	NA	NA	NA	NA	NA
PGEN_.00g207190	Scaffold_10	8653842	8654168	NA	NA	NA	NA	NA
PGEN_.00g207200	Scaffold_10	8658384	8658692	NA	NA	NA	NA	NA
PGEN_.00g207210	Scaffold_10	8659639	8660743	NA	NA	NA	NA	NA
PGEN_.00g207220	Scaffold_10	8716112	8716432	NA	NA	NA	NA	NA
PGEN_.00g207230	Scaffold_10	8728476	8729618	Q92847	GHSR_HUMAN	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032869; GO:0036321; GO:0040018; GO:0042536; GO:0042802; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045409; GO:0045923; GO:0046676; GO:0046697; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0099699; GO:0120058; GO:1903672; GO:1904000; GO:1904008; GO:1904349; GO:1904468; GO:1905333; GO:1905564; GO:1990314; GO:2000110	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; negative regulation of tumor necrosis factor secretion [GO:1904468]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]
PGEN_.00g207240	Scaffold_10	8765074	8765352	NA	NA	NA	NA	NA
PGEN_.00g207250	Scaffold_10	8787690	8788973	NA	NA	NA	NA	NA
PGEN_.00g207260	Scaffold_10	8801655	8802227	NA	NA	NA	NA	NA
PGEN_.00g207270	Scaffold_10	8805028	8807263	NA	NA	NA	NA	NA
PGEN_.00g207280	Scaffold_10	8811844	8873237	Q1JQ66	S35E3_DANRE	Solute carrier family 35 member E3	GO:0005338; GO:0005794; GO:0015297; GO:0016021; GO:0022857	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; transmembrane transporter activity [GO:0022857]
PGEN_.00g207290	Scaffold_10	8876594	8878256	NA	NA	NA	NA	NA
PGEN_.00g207300	Scaffold_10	8878341	8879009	NA	NA	NA	NA	NA
PGEN_.00g207310	Scaffold_10	8909682	8932743	NA	NA	NA	NA	NA
PGEN_.00g207320	Scaffold_10	8941808	8944198	NA	NA	NA	NA	NA
PGEN_.00g207330	Scaffold_10	8946105	8948296	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g207340	Scaffold_10	8950459	8950770	NA	NA	NA	NA	NA
PGEN_.00g207350	Scaffold_10	8957959	8966763	Q9NXS3	KLH28_HUMAN	Kelch-like protein 28 (BTB/POZ domain-containing protein 5)		
PGEN_.00g207360	Scaffold_10	8967692	8972505	Q25390	SCRA_LIMPO	Alpha-scruin		
PGEN_.00g207370	Scaffold_10	8972605	8973141	NA	NA	NA	NA	NA
PGEN_.00g207380	Scaffold_10	8982240	8982509	NA	NA	NA	NA	NA
PGEN_.00g207390	Scaffold_10	8982552	8987188	P48965	MPIP1_RAT	M-phase inducer phosphatase 1 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25A)	GO:0000082; GO:0000086; GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0009314; GO:0010971; GO:0019901; GO:0034644; GO:0045931; GO:0051087; GO:0051301; GO:0110032; GO:1904056	cytoplasm [GO:0005737]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; response to radiation [GO:0009314]
PGEN_.00g207400	Scaffold_10	9080930	9082432	NA	NA	NA	NA	NA
PGEN_.00g207410	Scaffold_10	9084967	9088666	NA	NA	NA	NA	NA
PGEN_.00g207420	Scaffold_10	9092050	9092535	NA	NA	NA	NA	NA
PGEN_.00g207430	Scaffold_10	9104180	9112636	NA	NA	NA	NA	NA
PGEN_.00g207440	Scaffold_10	9121394	9125388	NA	NA	NA	NA	NA
PGEN_.00g207450	Scaffold_10	9125526	9126206	NA	NA	NA	NA	NA
PGEN_.00g207460	Scaffold_10	9126833	9127573	NA	NA	NA	NA	NA
PGEN_.00g207470	Scaffold_10	9127807	9128094	NA	NA	NA	NA	NA
PGEN_.00g207480	Scaffold_10	9132735	9133046	NA	NA	NA	NA	NA
PGEN_.00g207490	Scaffold_10	9133878	9134174	NA	NA	NA	NA	NA
PGEN_.00g207500	Scaffold_10	9134882	9135232	NA	NA	NA	NA	NA
PGEN_.00g207510	Scaffold_10	9195629	9206699	NA	NA	NA	NA	NA
PGEN_.00g207520	Scaffold_10	9231297	9231527	NA	NA	NA	NA	NA
PGEN_.00g207530	Scaffold_10	9251922	9298180	P74148	Y1388_SYNY3	Universal stress protein Sll1388 (USP Sll1388)		
PGEN_.00g207540	Scaffold_10	9296424	9296879	NA	NA	NA	NA	NA
PGEN_.00g207550	Scaffold_10	9309942	9310361	NA	NA	NA	NA	NA
PGEN_.00g207560	Scaffold_10	9310431	9310712	NA	NA	NA	NA	NA
PGEN_.00g207570	Scaffold_10	9312541	9313965	NA	NA	NA	NA	NA
PGEN_.00g207580	Scaffold_10	9315206	9321573	NA	NA	NA	NA	NA
PGEN_.00g207590	Scaffold_10	9332169	9333895	NA	NA	NA	NA	NA
PGEN_.00g207600	Scaffold_10	9333994	9335273	NA	NA	NA	NA	NA
PGEN_.00g207610	Scaffold_10	9352718	9354621	NA	NA	NA	NA	NA
PGEN_.00g207620	Scaffold_10	9379993	9392870	NA	NA	NA	NA	NA
PGEN_.00g207630	Scaffold_10	9412442	9415884	NA	NA	NA	NA	NA
PGEN_.00g207640	Scaffold_10	9534095	9537643	NA	NA	NA	NA	NA
PGEN_.00g207650	Scaffold_10	9537801	9540117	NA	NA	NA	NA	NA
PGEN_.00g207660	Scaffold_10	9540286	9542729	NA	NA	NA	NA	NA
PGEN_.00g207670	Scaffold_10	9551846	9552328	NA	NA	NA	NA	NA
PGEN_.00g207680	Scaffold_10	9555364	9586773	Q6P8G1	ILF2_XENTR	Interleukin enhancer-binding factor 2 homolog	GO:0003677; GO:0003725; GO:0005524; GO:0005634; GO:0005730; GO:0006351; GO:0006955; GO:0016740; GO:0045893	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; transferase activity [GO:0016740]; immune response [GO:0006955]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g207690	Scaffold_10	9587871	9590112	NA	NA	NA	NA	NA
PGEN_.00g207700	Scaffold_10	9603001	9604018	NA	NA	NA	NA	NA
PGEN_.00g207710	Scaffold_10	9604745	9666293	Q6NZ06	ILF2_DANRE	Interleukin enhancer-binding factor 2 homolog	GO:0003677; GO:0003725; GO:0005524; GO:0005634; GO:0005730; GO:0006351; GO:0006955; GO:0016740; GO:0045893	"nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; transferase activity [GO:0016740]; immune response [GO:0006955]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g207720	Scaffold_10	9662281	9663707	A0A1B0GUU1	CQ113_HUMAN	Transmembrane protein C17orf113	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g207730	Scaffold_10	9688411	9743151	Q8Q0U0	Y045_METMA	Putative ankyrin repeat protein MM_0045		
PGEN_.00g207740	Scaffold_10	9757339	9757782	NA	NA	NA	NA	NA
PGEN_.00g207750	Scaffold_10	9798131	9819576	NA	NA	NA	NA	NA
PGEN_.00g207760	Scaffold_10	9816793	9818566	NA	NA	NA	NA	NA
PGEN_.00g207770	Scaffold_10	9839252	9840224	NA	NA	NA	NA	NA
PGEN_.00g207780	Scaffold_10	9854899	9855213	NA	NA	NA	NA	NA
PGEN_.00g207790	Scaffold_10	9869871	9870191	NA	NA	NA	NA	NA
PGEN_.00g207800	Scaffold_10	9885740	9910032	NA	NA	NA	NA	NA
PGEN_.00g207810	Scaffold_10	9929572	9930462	NA	NA	NA	NA	NA
PGEN_.00g207820	Scaffold_10	9933492	9933848	NA	NA	NA	NA	NA
PGEN_.00g207830	Scaffold_10	9934009	9934329	NA	NA	NA	NA	NA
PGEN_.00g207840	Scaffold_10	9939942	9940187	NA	NA	NA	NA	NA
PGEN_.00g207850	Scaffold_10	9950424	9981211	Q86I06	NEK3_DICDI	Probable serine/threonine-protein kinase nek3 (EC 2.7.11.1) (Never in mitosis protein A-related protein kinase 3) (NimA-related protein kinase 3)	GO:0004674; GO:0005524; GO:0005737; GO:0023014; GO:0032147	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g207860	Scaffold_10	10005654	10011326	NA	NA	NA	NA	NA
PGEN_.00g207870	Scaffold_10	10021647	10021979	NA	NA	NA	NA	NA
PGEN_.00g207880	Scaffold_10	10022149	10023558	NA	NA	NA	NA	NA
PGEN_.00g207890	Scaffold_10	10027568	10029271	D3YZI9	PGBD5_MOUSE	PiggyBac transposable element-derived protein 5 (EC 3.1.-.-) (PiggyBac transposase 5)	GO:0004519; GO:0004803; GO:0005634; GO:0098038	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; transposase activity [GO:0004803]; non-replicative transposition, DNA-mediated [GO:0098038]"
PGEN_.00g207900	Scaffold_10	10029927	10030454	Q96DM1	PGBD4_HUMAN	PiggyBac transposable element-derived protein 4		
PGEN_.00g207910	Scaffold_10	10042133	10115253	Q8IPH9	SLOB_DROME	Slowpoke-binding protein	GO:0004672; GO:0005737; GO:0005886; GO:0007274; GO:0032780; GO:0042391; GO:0042594; GO:0043271; GO:0045202; GO:0050804	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein kinase activity [GO:0004672]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to starvation [GO:0042594]
PGEN_.00g207920	Scaffold_10	10117156	10117530	NA	NA	NA	NA	NA
PGEN_.00g207930	Scaffold_10	10138336	10157652	NA	NA	NA	NA	NA
PGEN_.00g207940	Scaffold_10	10175934	10176179	NA	NA	NA	NA	NA
PGEN_.00g207950	Scaffold_10	10212955	10295441	Q8C0L8	COG5_MOUSE	Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5)	GO:0000139; GO:0005654; GO:0005794; GO:0005829; GO:0006891; GO:0015031; GO:0017119; GO:0048219	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; nucleoplasm [GO:0005654]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]
PGEN_.00g207960	Scaffold_10	10296009	10296515	NA	NA	NA	NA	NA
PGEN_.00g207970	Scaffold_10	10345769	10352494	Q9UP83	COG5_HUMAN	Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (13S Golgi transport complex 90 kDa subunit) (GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1)	GO:0000139; GO:0005654; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0015031; GO:0016020; GO:0017119; GO:0032588	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]
PGEN_.00g207980	Scaffold_10	10352670	10352951	NA	NA	NA	NA	NA
PGEN_.00g207990	Scaffold_10	10353001	10353537	Q96DM1	PGBD4_HUMAN	PiggyBac transposable element-derived protein 4		
PGEN_.00g208000	Scaffold_10	10376124	10377207	NA	NA	NA	NA	NA
PGEN_.00g208010	Scaffold_10	10383608	10405786	NA	NA	NA	NA	NA
PGEN_.00g208020	Scaffold_10	10408738	10409109	NA	NA	NA	NA	NA
PGEN_.00g208030	Scaffold_10	10411940	10412227	NA	NA	NA	NA	NA
PGEN_.00g208040	Scaffold_10	10412654	10413001	NA	NA	NA	NA	NA
PGEN_.00g208050	Scaffold_10	10439193	10482181	Q32M08	DUS4L_MOUSE	tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 4-like)	GO:0017150; GO:0050660	flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]
PGEN_.00g208060	Scaffold_10	10501267	10501698	NA	NA	NA	NA	NA
PGEN_.00g208070	Scaffold_10	10501797	10505990	Q640V9	TATD1_XENLA	Putative deoxyribonuclease TATDN1 (EC 3.1.21.-)	GO:0005634; GO:0016888; GO:0046872	"nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"
PGEN_.00g208080	Scaffold_10	10516575	10529655	P0DOV9	SLAD_PSEPU	3-sulfolactaldehyde dehydrogenase (SLA dehydrogenase) (EC 1.2.1.97)	GO:0009013; GO:0009450	succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; gamma-aminobutyric acid catabolic process [GO:0009450]
PGEN_.00g208090	Scaffold_10	10547613	10548191	NA	NA	NA	NA	NA
PGEN_.00g208100	Scaffold_10	10587710	10613576	P51644	ARF4_XENLA	ADP-ribosylation factor 4	GO:0005525; GO:0005794; GO:0015031; GO:0016192	Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g208110	Scaffold_10	10623626	10624042	NA	NA	NA	NA	NA
PGEN_.00g208120	Scaffold_10	10624110	10624424	NA	NA	NA	NA	NA
PGEN_.00g208130	Scaffold_10	10634848	10636108	NA	NA	NA	NA	NA
PGEN_.00g208140	Scaffold_10	10636250	10647851	NA	NA	NA	NA	NA
PGEN_.00g208150	Scaffold_10	10648012	10649175	Q9LDH0	XYLT_ARATH	"Beta-1,2-xylosyltransferase (AtXYLT) (EC 2.4.2.38)"	GO:0000138; GO:0000139; GO:0005794; GO:0005797; GO:0006487; GO:0016021; GO:0031204; GO:0042285; GO:0048367; GO:0050513	"Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; glycoprotein 2-beta-D-xylosyltransferase activity [GO:0050513]; xylosyltransferase activity [GO:0042285]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein N-linked glycosylation [GO:0006487]; shoot system development [GO:0048367]"
PGEN_.00g208160	Scaffold_10	10656955	10661202	NA	NA	NA	NA	NA
PGEN_.00g208170	Scaffold_10	10665233	10669496	A7SMR0	MEIG1_NEMVE	Meiosis expressed gene 1 protein homolog	GO:0005634	nucleus [GO:0005634]
PGEN_.00g208180	Scaffold_10	10670181	10670498	NA	NA	NA	NA	NA
PGEN_.00g208190	Scaffold_10	10735251	10735798	NA	NA	NA	NA	NA
PGEN_.00g208200	Scaffold_10	10751872	10752150	NA	NA	NA	NA	NA
PGEN_.00g208210	Scaffold_10	10753487	10753747	NA	NA	NA	NA	NA
PGEN_.00g208220	Scaffold_10	10760007	10760210	NA	NA	NA	NA	NA
PGEN_.00g208230	Scaffold_10	10791078	10793345	P21158	CSGA_MYXXA	C-factor (C signal)	GO:0005576; GO:0030435	extracellular region [GO:0005576]; sporulation resulting in formation of a cellular spore [GO:0030435]
PGEN_.00g208240	Scaffold_10	10801578	10803460	NA	NA	NA	NA	NA
PGEN_.00g208250	Scaffold_10	10803491	10805183	NA	NA	NA	NA	NA
PGEN_.00g208260	Scaffold_10	10804867	10805136	NA	NA	NA	NA	NA
PGEN_.00g208270	Scaffold_10	10805149	10821912	Q7Z9I2	YCP9_SCHPO	Uncharacterized oxidoreductase C663.09c (EC 1.-.-.-)	GO:0005634; GO:0005829; GO:0016491; GO:0110095	cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095]
PGEN_.00g208280	Scaffold_10	10822995	10839587	Q8K2M3	SRR1L_MOUSE	SRR1-like protein (SRR1 domain-containing protein)	GO:0005634; GO:0005737; GO:0006783; GO:0007017; GO:0007623; GO:0042752; GO:0070453	cytoplasm [GO:0005737]; nucleus [GO:0005634]; circadian rhythm [GO:0007623]; heme biosynthetic process [GO:0006783]; microtubule-based process [GO:0007017]; regulation of circadian rhythm [GO:0042752]; regulation of heme biosynthetic process [GO:0070453]
PGEN_.00g208290	Scaffold_10	10839621	10839842	NA	NA	NA	NA	NA
PGEN_.00g208300	Scaffold_10	10839981	10840364	NA	NA	NA	NA	NA
PGEN_.00g208310	Scaffold_10	10841283	10854066	Q9UH36	SRR1L_HUMAN	SRR1-like protein (SRR1 domain-containing protein)	GO:0005634; GO:0005737; GO:0006783; GO:0007017; GO:0007623; GO:0042752; GO:0070453	cytoplasm [GO:0005737]; nucleus [GO:0005634]; circadian rhythm [GO:0007623]; heme biosynthetic process [GO:0006783]; microtubule-based process [GO:0007017]; regulation of circadian rhythm [GO:0042752]; regulation of heme biosynthetic process [GO:0070453]
PGEN_.00g208320	Scaffold_10	10877070	10892830	Q6GLL2	ABH6A_XENLA	Monoacylglycerol lipase abhd6-A (EC 3.1.1.23) (Abhydrolase domain-containing protein 6-A)	GO:0005765; GO:0016021; GO:0031902; GO:0031966; GO:0046464; GO:0047372; GO:0052651; GO:2001311	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; acylglycerol lipase activity [GO:0047372]; acylglycerol catabolic process [GO:0046464]; lysobisphosphatidic acid metabolic process [GO:2001311]; monoacylglycerol catabolic process [GO:0052651]
PGEN_.00g208330	Scaffold_10	10897229	10946372	Q95M18	ENPL_BOVIN	Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1)	GO:0001666; GO:0003723; GO:0005524; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006457; GO:0019903; GO:0030433; GO:0030496; GO:0030970; GO:0031247; GO:0033018; GO:0034663; GO:0042470; GO:0043066; GO:0043666; GO:0048471; GO:0050750; GO:0051082; GO:0071318	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; ATP binding [GO:0005524]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g208340	Scaffold_10	10978789	10984277	NA	NA	NA	NA	NA
PGEN_.00g208350	Scaffold_10	10995413	11017045	NA	NA	NA	NA	NA
PGEN_.00g208360	Scaffold_10	11014788	11015120	NA	NA	NA	NA	NA
PGEN_.00g208370	Scaffold_10	11019831	11021221	NA	NA	NA	NA	NA
PGEN_.00g208380	Scaffold_10	11040726	11041451	NA	NA	NA	NA	NA
PGEN_.00g208390	Scaffold_10	11041816	11042178	NA	NA	NA	NA	NA
PGEN_.00g208400	Scaffold_10	11056774	11059615	Q29043	FUT1_PIG	"Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g208410	Scaffold_10	11083379	11095825	P23758	POXN_DROME	Paired box pox-neuro protein (Paired box neuronal protein)	GO:0003677; GO:0005634; GO:0006355; GO:0007399; GO:0007423; GO:0007476; GO:0007480; GO:0008049; GO:0008343; GO:0009415; GO:0030154; GO:0048800	"nucleus [GO:0005634]; DNA binding [GO:0003677]; adult feeding behavior [GO:0008343]; antennal morphogenesis [GO:0048800]; cell differentiation [GO:0030154]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; male courtship behavior [GO:0008049]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; response to water [GO:0009415]; sensory organ development [GO:0007423]"
PGEN_.00g208420	Scaffold_10	11112293	11113880	NA	NA	NA	NA	NA
PGEN_.00g208430	Scaffold_10	11134742	11134963	NA	NA	NA	NA	NA
PGEN_.00g208440	Scaffold_10	11142757	11143697	NA	NA	NA	NA	NA
PGEN_.00g208450	Scaffold_10	11148836	11154872	NA	NA	NA	NA	NA
PGEN_.00g208460	Scaffold_10	11181765	11182085	NA	NA	NA	NA	NA
PGEN_.00g208470	Scaffold_10	11188252	11188467	NA	NA	NA	NA	NA
PGEN_.00g208480	Scaffold_10	11188670	11188951	NA	NA	NA	NA	NA
PGEN_.00g208490	Scaffold_10	11189003	11189917	NA	NA	NA	NA	NA
PGEN_.00g208500	Scaffold_10	11198308	11212465	NA	NA	NA	NA	NA
PGEN_.00g208510	Scaffold_10	11244588	11255033	O18404	HCD2_DROME	3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Scully protein) (Type II HADH)	GO:0003857; GO:0004303; GO:0005739; GO:0005829; GO:0006631; GO:0006637; GO:0008202; GO:0008205; GO:0008209; GO:0008210; GO:0016229; GO:0018454; GO:0030678; GO:0035410; GO:0047015; GO:0047022; GO:0047035; GO:0090502; GO:0090646	"cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202]"
PGEN_.00g208520	Scaffold_10	11255266	11259339	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g208530	Scaffold_10	11259584	11261382	O18404	HCD2_DROME	3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Scully protein) (Type II HADH)	GO:0003857; GO:0004303; GO:0005739; GO:0005829; GO:0006631; GO:0006637; GO:0008202; GO:0008205; GO:0008209; GO:0008210; GO:0016229; GO:0018454; GO:0030678; GO:0035410; GO:0047015; GO:0047022; GO:0047035; GO:0090502; GO:0090646	"cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202]"
PGEN_.00g208540	Scaffold_10	11261461	11271482	Q9ER24	ATX10_RAT	Ataxin-10 (Neuronal beta-catenin-like protein) (Spinocerebellar ataxia type 10 protein homolog)	GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0019899; GO:0030425; GO:0031175; GO:0042802; GO:0043025; GO:0048471; GO:0060271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]
PGEN_.00g208550	Scaffold_10	11300384	11301070	NA	NA	NA	NA	NA
PGEN_.00g208560	Scaffold_10	11321311	11329467	NA	NA	NA	NA	NA
PGEN_.00g208570	Scaffold_10	11332609	11333046	NA	NA	NA	NA	NA
PGEN_.00g208580	Scaffold_10	11353032	11413765	Q3L254	WNT7B_CHICK	Protein Wnt-7b	GO:0005109; GO:0005615; GO:0016055; GO:0021871; GO:0030182; GO:0045165; GO:0046330; GO:0048018; GO:0048144; GO:0060070; GO:0070307; GO:0071300; GO:0072089	extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089]; Wnt signaling pathway [GO:0016055]
PGEN_.00g208590	Scaffold_10	11422506	11423877	NA	NA	NA	NA	NA
PGEN_.00g208600	Scaffold_10	11423894	11424609	NA	NA	NA	NA	NA
PGEN_.00g208610	Scaffold_10	11425037	11426478	NA	NA	NA	NA	NA
PGEN_.00g208620	Scaffold_10	11439756	11440052	NA	NA	NA	NA	NA
PGEN_.00g208630	Scaffold_10	11445367	11445600	NA	NA	NA	NA	NA
PGEN_.00g208640	Scaffold_10	11478307	11485224	NA	NA	NA	NA	NA
PGEN_.00g208650	Scaffold_10	11503481	11526626	NA	NA	NA	NA	NA
PGEN_.00g208660	Scaffold_10	11595444	11623909	NA	NA	NA	NA	NA
PGEN_.00g208670	Scaffold_10	11626244	11664860	NA	NA	NA	NA	NA
PGEN_.00g208680	Scaffold_10	11676984	11730904	Q9UPS8	ANR26_HUMAN	Ankyrin repeat domain-containing protein 26	GO:0005813; GO:0045599	centrosome [GO:0005813]; negative regulation of fat cell differentiation [GO:0045599]
PGEN_.00g208690	Scaffold_10	11734347	11739013	NA	NA	NA	NA	NA
PGEN_.00g208700	Scaffold_10	11747772	11749199	NA	NA	NA	NA	NA
PGEN_.00g208710	Scaffold_10	11761861	11780299	Q5R7A4	RAB7L_PONAB	Ras-related protein Rab-7L1 (Rab-7-like protein 1)	GO:0001921; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005769; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0015031; GO:0017137; GO:0019003; GO:0019894; GO:0020003; GO:0039694; GO:0042110; GO:0042147; GO:0048471; GO:0050862; GO:0055037; GO:0070840; GO:0072657; GO:0090316; GO:1990967	"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694]"
PGEN_.00g208720	Scaffold_10	11780404	11795239	NA	NA	NA	NA	NA
PGEN_.00g208730	Scaffold_10	11805043	11831928	P41594	GRM5_HUMAN	Metabotropic glutamate receptor 5 (mGluR5)	GO:0001932; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0006417; GO:0006448; GO:0007186; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007612; GO:0007626; GO:0008066; GO:0030296; GO:0035584; GO:0042802; GO:0043005; GO:0048169; GO:0050808; GO:0050890; GO:0051966; GO:0061098; GO:0090647; GO:0098685; GO:0098839; GO:0099170; GO:0099530; GO:0099553; GO:0099583; GO:1902938; GO:1904646; GO:1990782	"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of age-related behavioral decline [GO:0090647]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]"
PGEN_.00g208740	Scaffold_10	11841680	11844619	NA	NA	NA	NA	NA
PGEN_.00g208750	Scaffold_10	11884521	11887696	NA	NA	NA	NA	NA
PGEN_.00g208760	Scaffold_10	11892149	11898936	Q86FP7	RS23_DERVA	40S ribosomal protein S23	GO:0002181; GO:0003735; GO:0005791; GO:0022627; GO:0042788	cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]
PGEN_.00g208770	Scaffold_10	11906201	11923504	Q96I25	SPF45_HUMAN	Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17)	GO:0000380; GO:0000381; GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0006281	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"
PGEN_.00g208780	Scaffold_10	11924253	11936368	Q3ZCJ8	CATC_BOVIN	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]	GO:0004197; GO:0005615; GO:0005764; GO:0031638; GO:0051603	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]; zymogen activation [GO:0031638]
PGEN_.00g208790	Scaffold_10	11955454	11969736	Q3MII6	TBC25_HUMAN	TBC1 domain family member 25	GO:0005096; GO:0005776; GO:0006886; GO:0006914; GO:0017137; GO:0031410; GO:0090630; GO:1901096	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of autophagosome maturation [GO:1901096]
PGEN_.00g208800	Scaffold_10	11999119	12040036	P70207	PLXA2_MOUSE	Plexin-A2 (Plex 2) (Plexin-2)	GO:0001756; GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007166; GO:0008360; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0043087; GO:0050772; GO:0051642; GO:0060037; GO:0060174; GO:0062023; GO:0071526; GO:1902287	collagen-containing extracellular matrix [GO:0062023]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; cell surface receptor signaling pathway [GO:0007166]; centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756]
PGEN_.00g208810	Scaffold_10	12101130	12209456	O75051	PLXA2_HUMAN	Plexin-A2 (Semaphorin receptor OCT)	GO:0001756; GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0043087; GO:0050772; GO:0051642; GO:0060037; GO:0060174; GO:0071526; GO:1902287	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756]
PGEN_.00g208820	Scaffold_10	12239899	12241592	B0S5N4	PLXA3_DANRE	Plexin A3	GO:0002116; GO:0005887; GO:0007162; GO:0008045; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0043087; GO:0048675; GO:0048696; GO:0048755; GO:0050772; GO:0060272; GO:1902287	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon extension [GO:0048675]; branching morphogenesis of a nerve [GO:0048755]; embryonic skeletal joint morphogenesis [GO:0060272]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of collateral sprouting in absence of injury [GO:0048696]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]
PGEN_.00g208830	Scaffold_10	12258216	12265982	Q9Y6I9	TX264_HUMAN	Testis-expressed protein 264 (Putative secreted protein Zsig11)	GO:0000421; GO:0002576; GO:0005576; GO:0005789; GO:0016021; GO:0031093; GO:0061709	autophagosome membrane [GO:0000421]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; platelet alpha granule lumen [GO:0031093]; platelet degranulation [GO:0002576]; reticulophagy [GO:0061709]
PGEN_.00g208840	Scaffold_10	12275178	12289770	Q5R4M0	GRIA2_PONAB	"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"	GO:0004970; GO:0004971; GO:0005789; GO:0005887; GO:0015277; GO:0030054; GO:0032281; GO:0035235; GO:0045211	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ionotropic glutamate receptor signaling pathway [GO:0035235]
PGEN_.00g208850	Scaffold_10	12303200	12308246	P97770	THUM3_MOUSE	THUMP domain-containing protein 3 (GtROSA26asSor)	GO:0003723; GO:0005730; GO:0005829; GO:0016423; GO:0030488	cytosol [GO:0005829]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA methylation [GO:0030488]
PGEN_.00g208860	Scaffold_10	12308629	12382320	Q08CD5	RXLT1_DANRE	"Ribitol-5-phosphate xylosyltransferase 1 (EC 2.4.2.-) (Transmembrane protein 5) (UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase)"	GO:0000139; GO:0005794; GO:0016021; GO:0035269; GO:0120053	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ribitol beta-1,4-xylosyltransferase activity [GO:0120053]; protein O-linked mannosylation [GO:0035269]"
PGEN_.00g208870	Scaffold_10	12357774	12360345	Q5UQ13	COLL2_MIMIV	Collagen-like protein 2	GO:0019012	virion [GO:0019012]
PGEN_.00g208880	Scaffold_10	12396372	12444131	Q24118	PIGE_DROME	Protein pigeon (Protein linotte)		
PGEN_.00g208890	Scaffold_10	12457780	12469104	NA	NA	NA	NA	NA
PGEN_.00g208900	Scaffold_10	12506397	12507497	NA	NA	NA	NA	NA
PGEN_.00g208910	Scaffold_10	12522641	12557412	Q5QJ74	TBCEL_HUMAN	Tubulin-specific chaperone cofactor E-like protein (EL) (Leucine-rich repeat-containing protein 35)	GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]
PGEN_.00g208920	Scaffold_10	12576629	12612632	Q9D9V7	DEN6B_MOUSE	Protein DENND6B (DENN domain-containing protein 6B)	GO:0017112; GO:0055037	recycling endosome [GO:0055037]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]
PGEN_.00g208930	Scaffold_10	12651635	12692367	Q14BN4	SLMAP_HUMAN	Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein)	GO:0005790; GO:0005815; GO:0005887; GO:0006936; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]
PGEN_.00g208940	Scaffold_10	12708807	12720892	Q96QE2	MYCT_HUMAN	Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13)	GO:0005366; GO:0005886; GO:0005887; GO:0015798	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]
PGEN_.00g208950	Scaffold_10	12723640	12733666	NA	NA	NA	NA	NA
PGEN_.00g208960	Scaffold_10	12741202	12744069	Q92172	TEF_CHICK	Transcription factor VBP (Thyrotroph embryonic factor homolog) (Vitellogenin gene-binding protein)	GO:0000977; GO:0003677; GO:0003700; GO:0005634; GO:0045893; GO:0045944	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g208970	Scaffold_10	12750079	12752673	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g208980	Scaffold_10	12761196	12765738	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g208990	Scaffold_10	12766794	12770903	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g209000	Scaffold_10	12776607	12785996	Q498T4	RM02_RAT	"39S ribosomal protein L2, mitochondrial (L2mt) (MRP-L2)"	GO:0003735; GO:0005739; GO:0005762; GO:0032543	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g209010	Scaffold_10	12786355	12789523	Q6ZWM4	LSM8_MOUSE	U6 snRNA-associated Sm-like protein LSm8	GO:0000398; GO:0003723; GO:0005634; GO:0005688; GO:0016070; GO:0046540; GO:0071005; GO:0120115	"Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]"
PGEN_.00g209020	Scaffold_10	12795001	12822990	D5LMJ3	VM3A_NAJAT	Zinc metalloproteinase-disintegrin-like atrase-A (EC 3.4.24.-) (Snake venom metalloproteinase) (SVMP)	GO:0004222; GO:0005576; GO:0009405; GO:0046872; GO:0090729	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g209030	Scaffold_10	12834636	12846200	NA	NA	NA	NA	NA
PGEN_.00g209040	Scaffold_10	12862588	12862953	NA	NA	NA	NA	NA
PGEN_.00g209050	Scaffold_10	12866881	12867201	NA	NA	NA	NA	NA
PGEN_.00g209060	Scaffold_10	12884783	12885448	Q40358	PRP_MEDSA	Repetitive proline-rich cell wall protein (MSPRP)	GO:0005199; GO:0005576; GO:0005618; GO:0007275	cell wall [GO:0005618]; extracellular region [GO:0005576]; structural constituent of cell wall [GO:0005199]; multicellular organism development [GO:0007275]
PGEN_.00g209070	Scaffold_10	12908191	12939158	Q66H61	SYQ_RAT	Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)	GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005829; GO:0006425; GO:0006469; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g209080	Scaffold_10	12944400	12983742	Q9NH13	RP43_RIFPA	Exoskeleton protein RP43	GO:0006033; GO:0030198	chitin localization [GO:0006033]; extracellular matrix organization [GO:0030198]
PGEN_.00g209090	Scaffold_10	13008149	13052098	Q6ZR98	PRS43_HUMAN	Deleted.		
PGEN_.00g209100	Scaffold_10	13073862	13119089	NA	NA	NA	NA	NA
PGEN_.00g209110	Scaffold_10	13151588	13154220	NA	NA	NA	NA	NA
PGEN_.00g209120	Scaffold_10	13177463	13179535	Q8C6L5	CGAS_MOUSE	Cyclic GMP-AMP synthase (cGAMP synthase) (cGAS) (m-cGAS) (EC 2.7.7.86) (2'3'-cGAMP synthase) (Mab-21 domain-containing protein 1)	GO:0002218; GO:0002230; GO:0002637; GO:0003677; GO:0003682; GO:0003690; GO:0005524; GO:0005525; GO:0005546; GO:0005634; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0008340; GO:0010753; GO:0032479; GO:0032481; GO:0035861; GO:0038001; GO:0043950; GO:0045087; GO:0046872; GO:0050776; GO:0050863; GO:0051607; GO:0061501; GO:0071360; GO:2000042; GO:2000774	"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclic-GMP-AMP synthase activity [GO:0061501]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; activation of innate immune response [GO:0002218]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; paracrine signaling [GO:0038001]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of immune response [GO:0050776]; regulation of immunoglobulin production [GO:0002637]; regulation of T cell activation [GO:0050863]; regulation of type I interferon production [GO:0032479]"
PGEN_.00g209130	Scaffold_10	13180206	13180631	NA	NA	NA	NA	NA
PGEN_.00g209140	Scaffold_10	13184398	13190291	Q5E965	C56D2_BOVIN	Cytochrome b561 domain-containing protein 2 (EC 7.2.1.3) (Putative tumor suppressor protein 101F6) (Transmembrane ascorbate ferrireductase)	GO:0004322; GO:0005783; GO:0005789; GO:0016021; GO:0020037; GO:0030659; GO:0031982; GO:0046872	cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; ferroxidase activity [GO:0004322]; heme binding [GO:0020037]; metal ion binding [GO:0046872]
PGEN_.00g209150	Scaffold_10	13199552	13213011	NA	NA	NA	NA	NA
PGEN_.00g209160	Scaffold_10	13217866	13254627	Q9P2Q2	FRM4A_HUMAN	FERM domain-containing protein 4A	GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162	"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein binding, bridging [GO:0030674]; establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714]"
PGEN_.00g209170	Scaffold_10	13257089	13316568	Q8BIE6	FRM4A_MOUSE	FERM domain-containing protein 4A	GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162	"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein binding, bridging [GO:0030674]; establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714]"
PGEN_.00g209180	Scaffold_10	13331769	13332056	NA	NA	NA	NA	NA
PGEN_.00g209190	Scaffold_10	13346782	13347012	NA	NA	NA	NA	NA
PGEN_.00g209200	Scaffold_10	13347077	13347325	NA	NA	NA	NA	NA
PGEN_.00g209210	Scaffold_10	13362784	13363119	NA	NA	NA	NA	NA
PGEN_.00g209220	Scaffold_10	13386155	13411269	Q9VN14	CONT_DROME	Contactin	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]
PGEN_.00g209230	Scaffold_10	13421482	13422825	NA	NA	NA	NA	NA
PGEN_.00g209240	Scaffold_10	13428619	13442357	Q8T6A5	TBA1_APLCA	Tubulin alpha-1 chain	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g209250	Scaffold_10	13446506	13456856	P53590	SUCB2_PIG	"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG) (Fragment)"	GO:0004776; GO:0005524; GO:0005525; GO:0005739; GO:0006099; GO:0006104; GO:0042709; GO:0046872	mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g209260	Scaffold_10	13458810	13479776	Q6DG03	DMTF1_DANRE	Cyclin-D-binding Myb-like transcription factor 1	GO:0000978; GO:0005654; GO:0007049	nucleoplasm [GO:0005654]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]
PGEN_.00g209270	Scaffold_10	13502507	13502917	NA	NA	NA	NA	NA
PGEN_.00g209280	Scaffold_10	13591488	13594484	NA	NA	NA	NA	NA
PGEN_.00g209290	Scaffold_10	13616480	13622893	Q9BU79	TM243_HUMAN	Transmembrane protein 243 (MDR1- and mitochondrial taxol resistance-associated protein) (MM-TRAG)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g209300	Scaffold_10	13637328	13686852	Q7Z6B7	SRGP1_HUMAN	SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13)	GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0048365; GO:0051056	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]
PGEN_.00g209310	Scaffold_10	13756412	13757633	NA	NA	NA	NA	NA
PGEN_.00g209320	Scaffold_10	13758132	13761034	Q86X60	FA72B_HUMAN	Protein FAM72B	GO:0005829; GO:0016020; GO:0043231	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
PGEN_.00g209330	Scaffold_10	13765783	13864147	Q96N23	CFA54_HUMAN	Cilia- and flagella-associated protein 54	GO:0005930; GO:0007283; GO:0030154; GO:0060271; GO:0060294	axoneme [GO:0005930]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; spermatogenesis [GO:0007283]
PGEN_.00g209340	Scaffold_10	13871518	13934138	Q7L0X2	ERIP6_HUMAN	Glutamate-rich protein 6 (Protein FAM194A)		
PGEN_.00g209350	Scaffold_10	13942588	13949092	NA	NA	NA	NA	NA
PGEN_.00g209360	Scaffold_10	13949696	13953404	NA	NA	NA	NA	NA
PGEN_.00g209370	Scaffold_10	13964677	13984388	Q7JQD3	GELS1_LUMTE	Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1)	GO:0003779; GO:0005509; GO:0005737; GO:0005856; GO:0007275; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275]
PGEN_.00g209380	Scaffold_10	13986729	13987333	NA	NA	NA	NA	NA
PGEN_.00g209390	Scaffold_10	14086579	14087575	NA	NA	NA	NA	NA
PGEN_.00g209400	Scaffold_10	14147436	14278859	P20241	NRG_DROME	Neuroglian	GO:0005509; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016319; GO:0019991; GO:0021682; GO:0030175; GO:0035011; GO:0035151; GO:0045924; GO:0048036; GO:0048675; GO:0048813; GO:0050808; GO:0050839; GO:0060857; GO:0061343; GO:0072499; GO:0098609	"bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"
PGEN_.00g209410	Scaffold_10	14308459	14377304	Q16875	F263_HUMAN	"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme) (Renal carcinoma antigen NY-REN-56) (iPFK-2) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]"	GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0045821	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glycolytic process [GO:0045821]"
PGEN_.00g209420	Scaffold_10	14380747	14383765	Q567B1	OTU1_DANRE	Ubiquitin thioesterase OTU1 (EC 3.4.19.12)	GO:0004843; GO:0005737; GO:0005829; GO:0016236; GO:0016579; GO:0030433; GO:0030968; GO:0035523; GO:0035871; GO:0046872; GO:0070536; GO:0071108; GO:1990167; GO:1990168	cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; endoplasmic reticulum unfolded protein response [GO:0030968]; macroautophagy [GO:0016236]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g209430	Scaffold_10	14388637	14403592	Q5RCY2	NUDT5_PONAB	ADP-sugar pyrophosphatase (EC 3.6.1.13) (8-oxo-dGDP phosphatase) (EC 3.6.1.58) (Nuclear ATP-synthesis protein NUDIX5) (EC 2.7.7.96) (Nucleoside diphosphate-linked moiety X motif 5) (Nudix motif 5)	GO:0000287; GO:0005634; GO:0006338; GO:0009191; GO:0016779; GO:0019144; GO:0019303; GO:0030515; GO:0042803; GO:0044715; GO:0047631	nucleus [GO:0005634]; 8-oxo-dGDP phosphatase activity [GO:0044715]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; ribonucleoside diphosphate catabolic process [GO:0009191]
PGEN_.00g209440	Scaffold_10	14435438	14435653	NA	NA	NA	NA	NA
PGEN_.00g209450	Scaffold_10	14524321	14531716	NA	NA	NA	NA	NA
PGEN_.00g209460	Scaffold_10	14581016	14616467	Q924Y4	GATA2_RAT	Endothelial transcription factor GATA-2 (GATA-binding protein 2)	GO:0000122; GO:0000978; GO:0000981; GO:0001158; GO:0001228; GO:0001655; GO:0001709; GO:0001764; GO:0001892; GO:0003677; GO:0003682; GO:0003700; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006909; GO:0007204; GO:0008134; GO:0008270; GO:0010628; GO:0010629; GO:0010725; GO:0021514; GO:0021533; GO:0021902; GO:0021954; GO:0021983; GO:0030154; GO:0030182; GO:0032991; GO:0033993; GO:0035019; GO:0035065; GO:0035854; GO:0042472; GO:0043306; GO:0043565; GO:0045599; GO:0045638; GO:0045648; GO:0045650; GO:0045654; GO:0045666; GO:0045746; GO:0045766; GO:0045944; GO:0048469; GO:0048663; GO:0048873; GO:0050766; GO:0060100; GO:0060216; GO:0060872; GO:0070345; GO:0070742; GO:0090050; GO:0090102; GO:0097154; GO:1902895; GO:1903589; GO:2000178; GO:2000352; GO:2000977	"cell [GO:0005623]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cell differentiation in hindbrain [GO:0021533]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; cochlea development [GO:0090102]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; definitive hemopoiesis [GO:0060216]; embryonic placenta development [GO:0001892]; eosinophil fate commitment [GO:0035854]; GABAergic neuron differentiation [GO:0097154]; homeostasis of number of cells within a tissue [GO:0048873]; inner ear morphogenesis [GO:0042472]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron migration [GO:0001764]; phagocytosis [GO:0006909]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of forebrain neuron differentiation [GO:2000977]; regulation of histone acetylation [GO:0035065]; regulation of primitive erythrocyte differentiation [GO:0010725]; response to lipid [GO:0033993]; semicircular canal development [GO:0060872]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; urogenital system development [GO:0001655]; ventral spinal cord interneuron differentiation [GO:0021514]"
PGEN_.00g209470	Scaffold_10	14693530	14703552	Q62746	SYT6_RAT	Synaptotagmin-6 (Synaptotagmin VI) (SytVI)	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030054; GO:0030276; GO:0030672; GO:0042802; GO:0042803; GO:0046982; GO:0048306; GO:0060478; GO:0070382; GO:0071277; GO:0097038; GO:0098978; GO:0099525; GO:0099699	cell junction [GO:0030054]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of synaptic membrane [GO:0099699]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; acrosomal vesicle exocytosis [GO:0060478]; acrosome reaction [GO:0007340]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]
PGEN_.00g209480	Scaffold_10	14705237	14711204	NA	NA	NA	NA	NA
PGEN_.00g209490	Scaffold_10	14711276	14714138	NA	NA	NA	NA	NA
PGEN_.00g209500	Scaffold_10	14729993	14731153	O02751	CFDP2_BOVIN	Craniofacial development protein 2 (p97 bucentaur protein)	GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g209510	Scaffold_10	14732192	14748928	Q14624	ITIH4_HUMAN	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	GO:0002576; GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0006953; GO:0030212; GO:0031089; GO:0034097; GO:0062023; GO:0070062; GO:0072562	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
PGEN_.00g209520	Scaffold_10	14768270	14779165	P33587	PROC_MOUSE	Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide]	GO:0001889; GO:0004252; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0007596; GO:0008233; GO:0030195; GO:0043066; GO:0043621; GO:0044537; GO:0050728; GO:0050819; GO:0070012; GO:1903142	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; oligopeptidase activity [GO:0070012]; peptidase activity [GO:0008233]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]; proteolysis [GO:0006508]; regulation of circulating fibrinogen levels [GO:0044537]
PGEN_.00g209530	Scaffold_10	14783379	14783825	NA	NA	NA	NA	NA
PGEN_.00g209540	Scaffold_10	14794493	14800385	P23216	GLBP1_GLYDI	"Globin, major polymeric component P1"	GO:0005344; GO:0019825; GO:0020037; GO:0046872	heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g209550	Scaffold_10	14802720	14807717	O97341	CALM_SUBDO	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g209560	Scaffold_10	14832748	14860457	A4D0V7	CPED1_HUMAN	Cadherin-like and PC-esterase domain-containing protein 1	GO:0005783	endoplasmic reticulum [GO:0005783]
PGEN_.00g209570	Scaffold_10	14864796	14869542	NA	NA	NA	NA	NA
PGEN_.00g209580	Scaffold_10	14874678	14874980	NA	NA	NA	NA	NA
PGEN_.00g209590	Scaffold_10	14876790	14877290	NA	NA	NA	NA	NA
PGEN_.00g209600	Scaffold_10	14877356	14877652	NA	NA	NA	NA	NA
PGEN_.00g209610	Scaffold_10	14886593	14886967	NA	NA	NA	NA	NA
PGEN_.00g209620	Scaffold_10	14892327	14892776	NA	NA	NA	NA	NA
PGEN_.00g209630	Scaffold_10	14904695	14905141	NA	NA	NA	NA	NA
PGEN_.00g209640	Scaffold_10	14909762	14910082	NA	NA	NA	NA	NA
PGEN_.00g209650	Scaffold_10	14921269	14942406	Q7ZVX6	UBA3_DANRE	NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.-) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3)	GO:0005524; GO:0005634; GO:0005737; GO:0019781; GO:0032446; GO:0045116	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 activating enzyme activity [GO:0019781]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]
PGEN_.00g209660	Scaffold_10	14945310	14952234	Q4R4I9	PRAF2_MACFA	PRA1 family protein 2	GO:0010008; GO:0015031; GO:0016021	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]
PGEN_.00g209670	Scaffold_10	14963974	14967179	NA	NA	NA	NA	NA
PGEN_.00g209680	Scaffold_10	14970110	14978602	NA	NA	NA	NA	NA
PGEN_.00g209690	Scaffold_10	15079121	15119000	Q9MZ34	SC6A6_BOVIN	Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6)	GO:0005332; GO:0005369; GO:0005886; GO:0005887; GO:0015734; GO:0042165; GO:0043005	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; taurine:sodium symporter activity [GO:0005369]; taurine transport [GO:0015734]
PGEN_.00g209700	Scaffold_10	15119280	15120125	Q9Y493	ZAN_HUMAN	Zonadhesin	GO:0005886; GO:0007339; GO:0016021; GO:0098609	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609]
PGEN_.00g209710	Scaffold_10	15122945	15126790	Q91502	SC6A8_TORMA	Creatine transporter	GO:0005328; GO:0016021	integral component of membrane [GO:0016021]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g209720	Scaffold_10	15225297	15225671	NA	NA	NA	NA	NA
PGEN_.00g209730	Scaffold_10	15267507	15268875	NA	NA	NA	NA	NA
PGEN_.00g209740	Scaffold_10	15283009	15285219	NA	NA	NA	NA	NA
PGEN_.00g209750	Scaffold_10	15368022	15369133	NA	NA	NA	NA	NA
PGEN_.00g209760	Scaffold_10	15369226	15369958	NA	NA	NA	NA	NA
PGEN_.00g209770	Scaffold_10	15377716	15455976	Q8CFG5	CA2D3_RAT	Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3]	GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0034765; GO:0046872; GO:1990314	voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g209780	Scaffold_10	15466928	15470905	NA	NA	NA	NA	NA
PGEN_.00g209790	Scaffold_10	15476411	15505301	Q6GNL7	AL1L1_XENLA	Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1)	GO:0005737; GO:0006730; GO:0009058; GO:0009258; GO:0016155; GO:0016620; GO:0016742	"cytoplasm [GO:0005737]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730]"
PGEN_.00g209800	Scaffold_10	15545997	15557699	NA	NA	NA	NA	NA
PGEN_.00g209810	Scaffold_10	15647879	15655868	Q7SXB7	MFD4A_DANRE	Major facilitator superfamily domain-containing protein 4A	GO:0005355; GO:0016021	integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]
PGEN_.00g209820	Scaffold_10	15679845	15686233	NA	NA	NA	NA	NA
PGEN_.00g209830	Scaffold_10	15701514	15719605	Q99K85	SERC_MOUSE	Phosphoserine aminotransferase (PSAT) (EC 2.6.1.52) (Endometrial progesterone-induced protein) (EPIP) (Phosphohydroxythreonine aminotransferase)	GO:0004648; GO:0005829; GO:0006564	cytosol [GO:0005829]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]
PGEN_.00g209840	Scaffold_10	15732858	15740256	Q5ZII3	TPRA1_CHICK	Transmembrane protein adipocyte-associated 1 homolog (Integral membrane protein GPR175)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g209850	Scaffold_10	15741425	15743304	NA	NA	NA	NA	NA
PGEN_.00g209860	Scaffold_10	15743335	15745970	NA	NA	NA	NA	NA
PGEN_.00g209870	Scaffold_10	15746013	15746399	NA	NA	NA	NA	NA
PGEN_.00g209880	Scaffold_10	15746607	15750784	NA	NA	NA	NA	NA
PGEN_.00g209890	Scaffold_10	15767912	15777941	Q9Z2D6	MECP2_MOUSE	Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2)	GO:0000122; GO:0000400; GO:0000785; GO:0000790; GO:0000792; GO:0001227; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003700; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0006020; GO:0006122; GO:0006342; GO:0006349; GO:0006355; GO:0006541; GO:0006576; GO:0007052; GO:0007268; GO:0007416; GO:0007420; GO:0007585; GO:0007612; GO:0007613; GO:0007616; GO:0008104; GO:0008134; GO:0008211; GO:0008284; GO:0008327; GO:0008344; GO:0008542; GO:0009314; GO:0009405; GO:0009791; GO:0010385; GO:0010468; GO:0010628; GO:0010629; GO:0010971; GO:0016358; GO:0016525; GO:0016571; GO:0016573; GO:0019230; GO:0019233; GO:0019899; GO:0019904; GO:0021549; GO:0021591; GO:0030182; GO:0031175; GO:0031490; GO:0031915; GO:0032048; GO:0032091; GO:0032991; GO:0033555; GO:0035176; GO:0035197; GO:0035865; GO:0040029; GO:0042220; GO:0042551; GO:0042826; GO:0043524; GO:0043537; GO:0044030; GO:0045322; GO:0045892; GO:0045893; GO:0046470; GO:0047485; GO:0048167; GO:0048712; GO:0050432; GO:0050807; GO:0050884; GO:0050905; GO:0051151; GO:0060079; GO:0060291; GO:0060999; GO:0061000; GO:0071317; GO:0090063; GO:0098794; GO:0098978; GO:1900114; GO:1901953; GO:1901956; GO:1903860; GO:1903861; GO:1905492; GO:1905643; GO:1990841; GO:2000635; GO:2000820	"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; transcription factor binding [GO:0008134]; unmethylated CpG binding [GO:0045322]; adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chromatin silencing [GO:0006342]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitotic spindle organization [GO:0007052]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of protein binding [GO:0032091]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; pathogenesis [GO:0009405]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to hypoxia [GO:0001666]; response to radiation [GO:0009314]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]"
PGEN_.00g209900	Scaffold_10	15778100	15794856	O95243	MBD4_HUMAN	Methyl-CpG-binding domain protein 4 (EC 3.2.2.-) (Methyl-CpG-binding endonuclease 1) (Methyl-CpG-binding protein MBD4) (Mismatch-specific DNA N-glycosylase)	GO:0000785; GO:0003677; GO:0003696; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0008263; GO:0009314; GO:0016607; GO:0019104; GO:0032355; GO:0045008	chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; response to estradiol [GO:0032355]; response to radiation [GO:0009314]
PGEN_.00g209910	Scaffold_10	15820890	15821249	NA	NA	NA	NA	NA
PGEN_.00g209920	Scaffold_10	15823719	15840499	NA	NA	NA	NA	NA
PGEN_.00g209930	Scaffold_10	15875239	15875607	NA	NA	NA	NA	NA
PGEN_.00g209940	Scaffold_10	15875650	15876438	NA	NA	NA	NA	NA
PGEN_.00g209950	Scaffold_10	15876482	15877369	NA	NA	NA	NA	NA
PGEN_.00g209960	Scaffold_10	15890590	15897584	Q3B725	ZBT24_RAT	Zinc finger and BTB domain-containing protein 24 (Bone morphogenetic protein-induced factor 1) (Zinc finger protein 450)	GO:0002244; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g209970	Scaffold_10	15919729	15940624	D9IQ16	GXN_ACRMI	Galaxin	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g209980	Scaffold_10	15977597	16015990	O01761	UNC89_CAEEL	Muscle M-line assembly protein unc-89 (Obscurin) (Uncoordinated protein 89)	GO:0004672; GO:0005089; GO:0005524; GO:0010628; GO:0014722; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0034613; GO:0040017; GO:0045214; GO:0045989; GO:0060298; GO:0071688; GO:0090736; GO:1905552; GO:1905905	A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]
PGEN_.00g209990	Scaffold_10	16058695	16058985	NA	NA	NA	NA	NA
PGEN_.00g210000	Scaffold_10	16059068	16059499	NA	NA	NA	NA	NA
PGEN_.00g210010	Scaffold_10	16059736	16059978	NA	NA	NA	NA	NA
PGEN_.00g210020	Scaffold_10	16060275	16060970	NA	NA	NA	NA	NA
PGEN_.00g210030	Scaffold_10	16061114	16061560	NA	NA	NA	NA	NA
PGEN_.00g210040	Scaffold_10	16062276	16085872	Q640H3	OTU5B_XENLA	OTU domain-containing protein 5-B (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA)	GO:0004843; GO:0032496; GO:0070536; GO:0071108	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496]
PGEN_.00g210050	Scaffold_10	16095644	16095895	NA	NA	NA	NA	NA
PGEN_.00g210060	Scaffold_10	16128524	16164788	Q96S16	JMJD8_HUMAN	JmjC domain-containing protein 8 (Jumonji domain-containing protein 8)	GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006110; GO:0043123; GO:1903302; GO:1903672	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302]
PGEN_.00g210070	Scaffold_10	16171727	16172794	NA	NA	NA	NA	NA
PGEN_.00g210080	Scaffold_10	16235958	16262421	NA	NA	NA	NA	NA
PGEN_.00g210090	Scaffold_10	16263276	16283138	NA	NA	NA	NA	NA
PGEN_.00g210100	Scaffold_10	16309903	16320651	NA	NA	NA	NA	NA
PGEN_.00g210110	Scaffold_10	16332956	16333477	NA	NA	NA	NA	NA
PGEN_.00g210120	Scaffold_10	16333766	16334002	NA	NA	NA	NA	NA
PGEN_.00g210130	Scaffold_10	16334191	16334841	NA	NA	NA	NA	NA
PGEN_.00g210140	Scaffold_10	16336892	16337107	NA	NA	NA	NA	NA
PGEN_.00g210150	Scaffold_10	16348516	16357210	NA	NA	NA	NA	NA
PGEN_.00g210160	Scaffold_10	16375416	16380841	P33005	KALM_CHICK	Anosmin-1 (Kallmann syndrome protein homolog)	GO:0004867; GO:0005576; GO:0007155; GO:0009986	cell surface [GO:0009986]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
PGEN_.00g210170	Scaffold_10	16402337	16415578	P51690	ARSE_HUMAN	Arylsulfatase E (ASE) (EC 3.1.6.-)	GO:0001501; GO:0004065; GO:0005788; GO:0005794; GO:0005795; GO:0046872; GO:0070062	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; skeletal system development [GO:0001501]
PGEN_.00g210180	Scaffold_10	16422946	16434167	NA	NA	NA	NA	NA
PGEN_.00g210190	Scaffold_10	16453018	16453344	NA	NA	NA	NA	NA
PGEN_.00g210200	Scaffold_10	16456575	16469123	NA	NA	NA	NA	NA
PGEN_.00g210210	Scaffold_10	16487709	16542397	Q6DFJ6	TBK1_XENLA	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107; GO:0032479; GO:0045087	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]
PGEN_.00g210220	Scaffold_10	16547740	16549677	NA	NA	NA	NA	NA
PGEN_.00g210230	Scaffold_10	16556132	16564062	Q96B70	LENG9_HUMAN	Leukocyte receptor cluster member 9	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g210240	Scaffold_10	16586489	16589888	NA	NA	NA	NA	NA
PGEN_.00g210250	Scaffold_10	16592762	16593397	NA	NA	NA	NA	NA
PGEN_.00g210260	Scaffold_10	16596492	16596878	NA	NA	NA	NA	NA
PGEN_.00g210270	Scaffold_10	16614960	16633359	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g210280	Scaffold_10	16655794	16656450	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g210290	Scaffold_10	16663752	16669755	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g210300	Scaffold_10	16686466	16687589	NA	NA	NA	NA	NA
PGEN_.00g210310	Scaffold_10	16759671	16768231	NA	NA	NA	NA	NA
PGEN_.00g210320	Scaffold_10	16782257	16788619	Q16943	VP33_APLCA	Vesicle-associated membrane protein/synaptobrevin-binding protein (VAP-33)	GO:0005789; GO:0016021; GO:0030054; GO:0033149; GO:0043005; GO:0045202; GO:0070972	cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synapse [GO:0045202]; FFAT motif binding [GO:0033149]; protein localization to endoplasmic reticulum [GO:0070972]
PGEN_.00g210330	Scaffold_10	16789441	16790536	NA	NA	NA	NA	NA
PGEN_.00g210340	Scaffold_10	16790565	16796574	NA	NA	NA	NA	NA
PGEN_.00g210350	Scaffold_10	16820875	16841961	P48057	SC6A1_MUSCO	Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)	GO:0005332; GO:0005886; GO:0007612; GO:0009636; GO:0009986; GO:0010033; GO:0014054; GO:0014074; GO:0015734; GO:0030054; GO:0030424; GO:0032229; GO:0042165; GO:0042802; GO:0043005; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056	"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; identical protein binding [GO:0042802]; neurotransmitter binding [GO:0042165]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to organic substance [GO:0010033]; response to purine-containing compound [GO:0014074]; response to toxic substance [GO:0009636]; taurine transport [GO:0015734]"
PGEN_.00g210360	Scaffold_10	16843296	16854762	O35316	SC6A6_MOUSE	Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6)	GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0005887; GO:0015734; GO:0030977; GO:0042165; GO:0043005; GO:0050804; GO:0098982; GO:0099055	GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; taurine binding [GO:0030977]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369]; modulation of chemical synaptic transmission [GO:0050804]; taurine transport [GO:0015734]
PGEN_.00g210370	Scaffold_10	16865291	16873582	Q29RU9	SOX_BOVIN	Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase)	GO:0005777; GO:0008115; GO:0033514; GO:0046653; GO:0050031	peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; tetrahydrofolate metabolic process [GO:0046653]
PGEN_.00g210380	Scaffold_10	16874303	16881501	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g210390	Scaffold_10	16892385	16904468	NA	NA	NA	NA	NA
PGEN_.00g210400	Scaffold_10	16906831	16908887	NA	NA	NA	NA	NA
PGEN_.00g210410	Scaffold_10	16949854	16968212	P21783	NOTC1_XENLA	Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]
PGEN_.00g210420	Scaffold_10	16984036	17001494	C6KFA3	AGRG6_DANRE	Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	GO:0001503; GO:0004930; GO:0005518; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0007507; GO:0014037; GO:0019933; GO:0022011; GO:0032290; GO:0042552; GO:0043236; GO:0043583; GO:0048932; GO:0050840; GO:0060347; GO:0060879; GO:1903670	integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879]
PGEN_.00g210430	Scaffold_10	17056178	17056417	NA	NA	NA	NA	NA
PGEN_.00g210440	Scaffold_10	17066284	17066490	NA	NA	NA	NA	NA
PGEN_.00g210450	Scaffold_10	17130600	17167870	NA	NA	NA	NA	NA
PGEN_.00g210460	Scaffold_10	17192033	17192794	Q0VCM2	TM187_BOVIN	Transmembrane protein 187	GO:0016021; GO:0030133	integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]
PGEN_.00g210470	Scaffold_10	17193873	17221677	P51610	HCFC1_HUMAN	Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]	GO:0000122; GO:0000123; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007005; GO:0007049; GO:0010628; GO:0016020; GO:0016579; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0032991; GO:0033613; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0045296; GO:0045787; GO:0045893; GO:0048188; GO:0050821; GO:0071339; GO:0071407	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"
PGEN_.00g210480	Scaffold_10	17231434	17234748	NA	NA	NA	NA	NA
PGEN_.00g210490	Scaffold_10	17234826	17235215	NA	NA	NA	NA	NA
PGEN_.00g210500	Scaffold_10	17282428	17298315	Q969S8	HDA10_HUMAN	Polyamine deacetylase HDAC10 (EC 3.5.1.48) (EC 3.5.1.62) (Histone deacetylase 10) (HD10)	GO:0000118; GO:0000122; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006325; GO:0006355; GO:0006476; GO:0008270; GO:0014003; GO:0016236; GO:0016575; GO:0019213; GO:0019899; GO:0032425; GO:0033558; GO:0034983; GO:0035825; GO:0042826; GO:0045892; GO:0047609; GO:0047611; GO:0106047; GO:0106048	"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oligodendrocyte development [GO:0014003]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; protein deacetylation [GO:0006476]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]"
PGEN_.00g210510	Scaffold_10	17298312	17299529	A4FV14	MB211_BOVIN	Putative nucleotidyltransferase MAB21L1 (EC 2.7.7.-) (Protein mab-21-like 1)	GO:0000166; GO:0005634; GO:0008284; GO:0016779; GO:0043010; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; camera-type eye development [GO:0043010]; positive regulation of cell population proliferation [GO:0008284]
PGEN_.00g210520	Scaffold_10	17299573	17348353	Q9UBN7	HDAC6_HUMAN	Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-)	GO:0000118; GO:0000209; GO:0000978; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005829; GO:0005874; GO:0005875; GO:0005881; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0006914; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0009636; GO:0009967; GO:0010033; GO:0010469; GO:0010506; GO:0010634; GO:0010727; GO:0010870; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0032041; GO:0032418; GO:0032984; GO:0033138; GO:0033558; GO:0034983; GO:0035967; GO:0040029; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051354; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0090035; GO:0090042; GO:1901300; GO:1903146	"aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"
PGEN_.00g210530	Scaffold_10	17386526	17387509	Q9NDM2	GUTR1_DROME	Protein trapped in endoderm-1	GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234	cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]
PGEN_.00g210540	Scaffold_10	17458352	17459335	Q9NDM2	GUTR1_DROME	Protein trapped in endoderm-1	GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234	cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; pole cell migration [GO:0007280]
PGEN_.00g210550	Scaffold_10	17467279	17467498	NA	NA	NA	NA	NA
PGEN_.00g210560	Scaffold_10	17540154	17554202	Q20296	HDA6_CAEEL	Histone deacetylase 6 (EC 3.5.1.98)	GO:0005634; GO:0008270; GO:0032041; GO:0033558	nucleus [GO:0005634]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]
PGEN_.00g210570	Scaffold_10	17554246	17555402	A4FV14	MB211_BOVIN	Putative nucleotidyltransferase MAB21L1 (EC 2.7.7.-) (Protein mab-21-like 1)	GO:0000166; GO:0005634; GO:0008284; GO:0016779; GO:0043010; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; camera-type eye development [GO:0043010]; positive regulation of cell population proliferation [GO:0008284]
PGEN_.00g210580	Scaffold_10	17555460	17571560	Q969S8	HDA10_HUMAN	Polyamine deacetylase HDAC10 (EC 3.5.1.48) (EC 3.5.1.62) (Histone deacetylase 10) (HD10)	GO:0000118; GO:0000122; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006325; GO:0006355; GO:0006476; GO:0008270; GO:0014003; GO:0016236; GO:0016575; GO:0019213; GO:0019899; GO:0032425; GO:0033558; GO:0034983; GO:0035825; GO:0042826; GO:0045892; GO:0047609; GO:0047611; GO:0106047; GO:0106048	"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oligodendrocyte development [GO:0014003]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; protein deacetylation [GO:0006476]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]"
PGEN_.00g210590	Scaffold_10	17623189	17627854	NA	NA	NA	NA	NA
PGEN_.00g210600	Scaffold_10	17637984	17664979	P51610	HCFC1_HUMAN	Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]	GO:0000122; GO:0000123; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007005; GO:0007049; GO:0010628; GO:0016020; GO:0016579; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0032991; GO:0033613; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0045296; GO:0045787; GO:0045893; GO:0048188; GO:0050821; GO:0071339; GO:0071407	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein binding, bridging [GO:0030674]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"
PGEN_.00g210610	Scaffold_10	17666050	17666811	Q0VCM2	TM187_BOVIN	Transmembrane protein 187	GO:0016021; GO:0030133	integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]
PGEN_.00g210620	Scaffold_10	17690557	17728297	NA	NA	NA	NA	NA
PGEN_.00g210630	Scaffold_10	17791041	17791582	NA	NA	NA	NA	NA
PGEN_.00g210640	Scaffold_10	17801443	17801682	NA	NA	NA	NA	NA
PGEN_.00g210650	Scaffold_10	17856063	17873308	C6KFA3	AGRG6_DANRE	Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	GO:0001503; GO:0004930; GO:0005518; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0007507; GO:0014037; GO:0019933; GO:0022011; GO:0032290; GO:0042552; GO:0043236; GO:0043583; GO:0048932; GO:0050840; GO:0060347; GO:0060879; GO:1903670	integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879]
PGEN_.00g210660	Scaffold_10	17881738	17907219	P21783	NOTC1_XENLA	Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]
PGEN_.00g210670	Scaffold_10	17948754	17950832	NA	NA	NA	NA	NA
PGEN_.00g210680	Scaffold_10	17953202	17965056	NA	NA	NA	NA	NA
PGEN_.00g210690	Scaffold_10	17978500	17978877	Q6R7D0	IAP3_OSHVF	Putative apoptosis inhibitor ORF99		
PGEN_.00g210700	Scaffold_10	17980113	17981688	NA	NA	NA	NA	NA
PGEN_.00g210710	Scaffold_10	17984450	17998538	Q5U580	KLD10_XENLA	Kelch domain-containing protein 10	GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g210720	Scaffold_10	18004738	18011810	Q9Y3C6	PPIL1_HUMAN	Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1)	GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0006457; GO:0016018; GO:0071007; GO:0071013; GO:0097718	"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"
PGEN_.00g210730	Scaffold_10	18013651	18016592	P49410	EFTU_BOVIN	"Elongation factor Tu, mitochondrial (EF-Tu)"	GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006414; GO:0042645; GO:0070125	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; translational elongation [GO:0006414]
PGEN_.00g210740	Scaffold_10	18045174	18048422	NA	NA	NA	NA	NA
PGEN_.00g210750	Scaffold_10	18060993	18065242	NA	NA	NA	NA	NA
PGEN_.00g210760	Scaffold_10	18082671	18092387	NA	NA	NA	NA	NA
PGEN_.00g210770	Scaffold_10	18094342	18109875	NA	NA	NA	NA	NA
PGEN_.00g210780	Scaffold_10	18116385	18124440	P00639	DNAS1_BOVIN	Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I)	GO:0000737; GO:0002283; GO:0002673; GO:0003677; GO:0003779; GO:0004530; GO:0004536; GO:0005576; GO:0005634; GO:0005635; GO:0006308; GO:0006915; GO:0070948	"extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; actin binding [GO:0003779]; deoxyribonuclease activity [GO:0004536]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]"
PGEN_.00g210790	Scaffold_10	18124489	18136383	Q6R5A3	TRPV1_CAVPO	Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1)	GO:0000122; GO:0001660; GO:0002024; GO:0002790; GO:0004888; GO:0005230; GO:0005231; GO:0005516; GO:0005524; GO:0005623; GO:0005887; GO:0006629; GO:0015278; GO:0016021; GO:0030054; GO:0031226; GO:0032591; GO:0034605; GO:0035091; GO:0045211; GO:0046872; GO:0048266; GO:0050954; GO:0050960; GO:0050965; GO:0050968; GO:0051219; GO:0051289; GO:0060083; GO:0070588; GO:0071312; GO:0071318; GO:0071468; GO:0097603; GO:0098703; GO:1901594	cell [GO:0005623]; cell junction [GO:0030054]; dendritic spine membrane [GO:0032591]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular ligand-gated ion channel activity [GO:0005230]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphoprotein binding [GO:0051219]; temperature-gated ion channel activity [GO:0097603]; transmembrane signaling receptor activity [GO:0004888]; behavioral response to pain [GO:0048266]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to acidic pH [GO:0071468]; cellular response to alkaloid [GO:0071312]; cellular response to ATP [GO:0071318]; cellular response to heat [GO:0034605]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; diet induced thermogenesis [GO:0002024]; fever generation [GO:0001660]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptide secretion [GO:0002790]; protein homotetramerization [GO:0051289]; response to capsazepine [GO:1901594]; sensory perception of mechanical stimulus [GO:0050954]; smooth muscle contraction involved in micturition [GO:0060083]
PGEN_.00g210800	Scaffold_10	18139780	18166868	P10041	DL_DROME	Neurogenic locus protein delta	GO:0001708; GO:0005112; GO:0005509; GO:0005768; GO:0005769; GO:0005886; GO:0005912; GO:0007015; GO:0007219; GO:0007298; GO:0007398; GO:0007422; GO:0007423; GO:0007451; GO:0007475; GO:0007476; GO:0007480; GO:0007498; GO:0008284; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009986; GO:0016021; GO:0016330; GO:0030139; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0031410; GO:0035003; GO:0036011; GO:0042067; GO:0042676; GO:0043208; GO:0045179; GO:0045746; GO:0045931; GO:0046331; GO:0046667; GO:0048018; GO:0048100; GO:0048190; GO:0048477; GO:0048665; GO:0048800; GO:0048863; GO:0050768	"adherens junction [GO:0005912]; apical cortex [GO:0045179]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; glycosphingolipid binding [GO:0043208]; Notch binding [GO:0005112]; receptor ligand activity [GO:0048018]; actin filament organization [GO:0007015]; antennal morphogenesis [GO:0048800]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; asymmetric cell division [GO:0008356]; border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; chaeta morphogenesis [GO:0008407]; compound eye cone cell fate commitment [GO:0042676]; compound eye retinal cell programmed cell death [GO:0046667]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; ectoderm development [GO:0007398]; establishment of ommatidial planar polarity [GO:0042067]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; lateral inhibition [GO:0046331]; mesoderm development [GO:0007498]; negative regulation of neurogenesis [GO:0050768]; negative regulation of Notch signaling pathway [GO:0045746]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; stem cell differentiation [GO:0048863]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190]"
PGEN_.00g210810	Scaffold_10	18172390	18189349	Q6BEA2	PRS27_RAT	Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin)	GO:0004252; GO:0005576; GO:0005886	extracellular region [GO:0005576]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g210820	Scaffold_10	18193228	18194579	NA	NA	NA	NA	NA
PGEN_.00g210830	Scaffold_10	18196240	18233919	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g210840	Scaffold_10	18251261	18258749	O35516	NOTC2_MOUSE	Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]	GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005929; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0072602; GO:1990705; GO:2000249; GO:2001204	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060]
PGEN_.00g210850	Scaffold_10	18295476	18313660	P46530	NOTC1_DANRE	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0016021; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor-mediated endocytosis [GO:0048259]; regulation of transcription, DNA-templated [GO:0006355]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514]"
PGEN_.00g210860	Scaffold_10	18315266	18328144	P46530	NOTC1_DANRE	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0016021; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor-mediated endocytosis [GO:0048259]; regulation of transcription, DNA-templated [GO:0006355]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514]"
PGEN_.00g210870	Scaffold_10	18338988	18364953	O35516	NOTC2_MOUSE	Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]	GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005929; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0072602; GO:1990705; GO:2000249; GO:2001204	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060]
PGEN_.00g210880	Scaffold_10	18370865	18377326	NA	NA	NA	NA	NA
PGEN_.00g210890	Scaffold_10	18387512	18391852	Q9UBS3	DNJB9_HUMAN	DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4) (ER-resident protein ERdj4) (ERdj4) (Microvascular endothelial differentiation gene 1 protein) (Mdg-1)	GO:0002377; GO:0005730; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0030183; GO:0030433; GO:0030544; GO:0034976; GO:0036498; GO:0051087; GO:0051787; GO:0070062; GO:1903895	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; B cell differentiation [GO:0030183]; immunoglobulin production [GO:0002377]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g210900	Scaffold_10	18394232	18405308	P0CF65	CRBN_CHICK	Protein cereblon	GO:0005634; GO:0005737; GO:0016567; GO:0031464; GO:0043161; GO:0046872	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]
PGEN_.00g210910	Scaffold_10	18410116	18420252	NA	NA	NA	NA	NA
PGEN_.00g210920	Scaffold_10	18421527	18422452	NA	NA	NA	NA	NA
PGEN_.00g210930	Scaffold_10	18431595	18450899	P62257	UBE2H_MOUSE	Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H)	GO:0004842; GO:0005524; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g210940	Scaffold_10	18455933	18456833	P62257	UBE2H_MOUSE	Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H)	GO:0004842; GO:0005524; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g210950	Scaffold_10	18464894	18465677	NA	NA	NA	NA	NA
PGEN_.00g210960	Scaffold_10	18466334	18479761	Q96NR8	RDH12_HUMAN	Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2)	GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0110095	endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]
PGEN_.00g210970	Scaffold_10	18485597	18491436	Q9NPF2	CHSTB_HUMAN	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)	GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]
PGEN_.00g210980	Scaffold_10	18508076	18519055	Q14118	DAG1_HUMAN	Dystroglycan (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)]	GO:0001618; GO:0001954; GO:0002011; GO:0002162; GO:0003779; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005623; GO:0005654; GO:0005737; GO:0005788; GO:0005796; GO:0005829; GO:0005856; GO:0005886; GO:0005913; GO:0005925; GO:0006509; GO:0007016; GO:0007568; GO:0008307; GO:0009897; GO:0010470; GO:0010717; GO:0014894; GO:0015631; GO:0016010; GO:0016011; GO:0016021; GO:0016323; GO:0016340; GO:0016476; GO:0017166; GO:0019048; GO:0021682; GO:0022011; GO:0030027; GO:0030175; GO:0030198; GO:0030336; GO:0031103; GO:0031643; GO:0033268; GO:0034399; GO:0034453; GO:0042169; GO:0042383; GO:0043034; GO:0043237; GO:0043403; GO:0043409; GO:0043434; GO:0044853; GO:0045211; GO:0045860; GO:0048714; GO:0050807; GO:0051393; GO:0051898; GO:0060055; GO:0060441; GO:0060445; GO:0062023; GO:0070062; GO:0070938; GO:0071260; GO:0071397; GO:0071679; GO:0071711; GO:0098696; GO:0098942; GO:0098978; GO:0098982; GO:0099524; GO:1904261	basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell-cell adherens junction [GO:0005913]; collagen-containing extracellular matrix [GO:0062023]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; extracellular matrix organization [GO:0030198]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; modulation by virus of host morphology or physiology [GO:0019048]; morphogenesis of an epithelial sheet [GO:0002011]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of embryonic cell shape [GO:0016476]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; skeletal muscle tissue regeneration [GO:0043403]
PGEN_.00g210990	Scaffold_10	18512551	18512817	NA	NA	NA	NA	NA
PGEN_.00g211000	Scaffold_10	18533457	18533852	NA	NA	NA	NA	NA
PGEN_.00g211010	Scaffold_10	18555730	18556970	NA	NA	NA	NA	NA
PGEN_.00g211020	Scaffold_10	18557632	18564854	NA	NA	NA	NA	NA
PGEN_.00g211030	Scaffold_10	18579598	18603607	NA	NA	NA	NA	NA
PGEN_.00g211040	Scaffold_10	18606575	18608388	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g211050	Scaffold_10	18661799	18670647	Q86UV5	UBP48_HUMAN	Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Deubiquitinating enzyme 48) (Ubiquitin thioesterase 48) (Ubiquitin-specific peptidase 48) (Ubiquitin-specific protease 48) (Ubiquitin-specific-processing protease 48)	GO:0004197; GO:0004843; GO:0005654; GO:0005739; GO:0005829; GO:0006511; GO:0016579	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g211060	Scaffold_10	18676788	18684210	P49578	ACM3_CHICK	Muscarinic acetylcholine receptor M3	GO:0003056; GO:0004930; GO:0004993; GO:0005887; GO:0007187; GO:0007197; GO:0007268; GO:0016907; GO:0030054; GO:0030425; GO:0030594; GO:0045211; GO:0045987; GO:0046541	"cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of vascular smooth muscle contraction [GO:0003056]; saliva secretion [GO:0046541]"
PGEN_.00g211070	Scaffold_10	18684713	18686188	NA	NA	NA	NA	NA
PGEN_.00g211080	Scaffold_10	18701758	18714263	NA	NA	NA	NA	NA
PGEN_.00g211090	Scaffold_10	18715866	18725282	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g211100	Scaffold_10	18734096	18745756	NA	NA	NA	NA	NA
PGEN_.00g211110	Scaffold_10	18747671	18758905	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g211120	Scaffold_10	18766416	18772841	NA	NA	NA	NA	NA
PGEN_.00g211130	Scaffold_10	18773418	18773826	NA	NA	NA	NA	NA
PGEN_.00g211140	Scaffold_10	18775838	18780986	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g211150	Scaffold_10	18787946	18788395	NA	NA	NA	NA	NA
PGEN_.00g211160	Scaffold_10	18807074	18807370	NA	NA	NA	NA	NA
PGEN_.00g211170	Scaffold_10	18830903	18837597	NA	NA	NA	NA	NA
PGEN_.00g211180	Scaffold_10	18843016	18843312	NA	NA	NA	NA	NA
PGEN_.00g211190	Scaffold_10	18850057	18854802	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g211200	Scaffold_10	18859302	18871251	NA	NA	NA	NA	NA
PGEN_.00g211210	Scaffold_10	18880586	18884360	NA	NA	NA	NA	NA
PGEN_.00g211220	Scaffold_10	18888772	18894369	NA	NA	NA	NA	NA
PGEN_.00g211230	Scaffold_10	18904493	18922000	Q14BI2	GRM2_MOUSE	Metabotropic glutamate receptor 2 (mGluR2)	GO:0001641; GO:0005246; GO:0005887; GO:0007216; GO:0007268; GO:0008066; GO:0014047; GO:0030054; GO:0030424; GO:0030425; GO:0042734; GO:0043005; GO:0051966; GO:0090461; GO:0099055	"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of synaptic transmission, glutamatergic [GO:0051966]"
PGEN_.00g211240	Scaffold_10	18934450	18949105	Q9QXZ6	SO1A1_MOUSE	Solute carrier organic anion transporter family member 1A1 (Sodium-independent organic anion-transporting polypeptide 1) (OATP-1) (Solute carrier family 21 member 1)	GO:0005887; GO:0008514; GO:0015125; GO:0015347; GO:0015711; GO:0015721; GO:0016020; GO:0016323; GO:0033574; GO:0035634; GO:0043252	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; bile acid and bile salt transport [GO:0015721]; organic anion transport [GO:0015711]; response to stilbenoid [GO:0035634]; response to testosterone [GO:0033574]; sodium-independent organic anion transport [GO:0043252]
PGEN_.00g211250	Scaffold_10	18962248	18982369	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g211260	Scaffold_10	18988838	18992674	P23216	GLBP1_GLYDI	"Globin, major polymeric component P1"	GO:0005344; GO:0019825; GO:0020037; GO:0046872	heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g211270	Scaffold_10	18996740	18998650	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g211280	Scaffold_10	18999286	19001938	P23286	CALM_CANAX	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g211290	Scaffold_10	19010071	19011929	P09967	GLB1_PETMA	Globin-1 (Globin I)	GO:0005344; GO:0005506; GO:0019825; GO:0020037	heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g211300	Scaffold_10	19014732	19018704	NA	NA	NA	NA	NA
PGEN_.00g211310	Scaffold_10	19023444	19025076	NA	NA	NA	NA	NA
PGEN_.00g211320	Scaffold_10	19027411	19034275	Q32KV6	SIL1_BOVIN	Nucleotide exchange factor SIL1	GO:0000774; GO:0005737; GO:0005783; GO:0005788; GO:0015031	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; adenyl-nucleotide exchange factor activity [GO:0000774]; protein transport [GO:0015031]
PGEN_.00g211330	Scaffold_10	19041707	19045337	Q6UVY6	MOXD1_HUMAN	DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g211340	Scaffold_10	19086812	19087686	NA	NA	NA	NA	NA
PGEN_.00g211350	Scaffold_10	19087581	19092300	NA	NA	NA	NA	NA
PGEN_.00g211360	Scaffold_10	19115289	19174093	Q9BXW9	FACD2_HUMAN	Fanconi anemia group D2 protein (Protein FACD2)	GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:2000348	condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]; synapsis [GO:0007129]
PGEN_.00g211370	Scaffold_10	19182690	19183982	NA	NA	NA	NA	NA
PGEN_.00g211380	Scaffold_10	19185024	19186677	NA	NA	NA	NA	NA
PGEN_.00g211390	Scaffold_10	19193243	19207589	Q6GP04	MON2_XENLA	Protein MON2 homolog	GO:0015031	protein transport [GO:0015031]
PGEN_.00g211400	Scaffold_10	19308915	19310084	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g211410	Scaffold_10	19311085	19324084	NA	NA	NA	NA	NA
PGEN_.00g211420	Scaffold_10	19332698	19333003	NA	NA	NA	NA	NA
PGEN_.00g211430	Scaffold_10	19333378	19333713	NA	NA	NA	NA	NA
PGEN_.00g211440	Scaffold_10	19333769	19334167	NA	NA	NA	NA	NA
PGEN_.00g211450	Scaffold_10	19501820	19502581	Q94126	CES2_CAEEL	Cell death specification protein 2	GO:0000977; GO:0001012; GO:0003700; GO:0005634; GO:0006357; GO:0006915; GO:0043068; GO:1990837	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region DNA binding [GO:0001012]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; apoptotic process [GO:0006915]; positive regulation of programmed cell death [GO:0043068]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g211460	Scaffold_10	19515181	19522967	Q80TL7	MON2_MOUSE	Protein MON2 homolog (Protein SF21)	GO:0005829; GO:0006895; GO:0015031	cytosol [GO:0005829]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]
PGEN_.00g211470	Scaffold_10	19524097	19531706	P82198	BGH3_MOUSE	Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3)	GO:0001525; GO:0002062; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]
PGEN_.00g211480	Scaffold_10	19589035	19612143	Q8NCE2	MTMRE_HUMAN	Myotubularin-related protein 14 (EC 3.1.3.-) (HCV NS5A-transactivated protein 4 splice variant A-binding protein 1) (NS5ATP4ABP1) (hJumpy)	GO:0001726; GO:0004438; GO:0004725; GO:0005829; GO:0006661; GO:0016236; GO:0048471	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]
PGEN_.00g211490	Scaffold_10	19612537	19621434	O75648	MTU1_HUMAN	Mitochondrial tRNA-specific 2-thiouridylase 1 (EC 2.8.1.14) (MTO2 homolog)	GO:0000049; GO:0002143; GO:0005524; GO:0005654; GO:0005739; GO:0016783	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; tRNA wobble position uridine thiolation [GO:0002143]
PGEN_.00g211500	Scaffold_10	19621566	19641266	Q80VN0	CP100_MOUSE	Cilia- and flagella-associated protein 100 (Coiled-coil domain-containing protein 37)	GO:0003341; GO:0031514; GO:0036159; GO:0070840; GO:0097545; GO:2000574	axonemal outer doublet [GO:0097545]; motile cilium [GO:0031514]; dynein complex binding [GO:0070840]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; regulation of microtubule motor activity [GO:2000574]
PGEN_.00g211510	Scaffold_10	19647095	19659739	Q8CHI9	CHSTF_RAT	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; hexose biosynthetic process [GO:0019319]
PGEN_.00g211520	Scaffold_10	19678513	19698278	NA	NA	NA	NA	NA
PGEN_.00g211530	Scaffold_10	19715817	19729376	P30531	SC6A1_HUMAN	Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)	GO:0005332; GO:0005886; GO:0007268; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0015734; GO:0016020; GO:0016021; GO:0030054; GO:0030424; GO:0032229; GO:0032355; GO:0042165; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056	"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter binding [GO:0042165]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; taurine transport [GO:0015734]"
PGEN_.00g211540	Scaffold_10	19773458	19779369	NA	NA	NA	NA	NA
PGEN_.00g211550	Scaffold_10	19803778	19804796	NA	NA	NA	NA	NA
PGEN_.00g211560	Scaffold_10	19804841	19805413	NA	NA	NA	NA	NA
PGEN_.00g211570	Scaffold_10	19932894	19960865	NA	NA	NA	NA	NA
PGEN_.00g211580	Scaffold_10	19963598	19985170	NA	NA	NA	NA	NA
PGEN_.00g211590	Scaffold_10	20015776	20019314	Q5FWU8	ZMY10_XENLA	Zinc finger MYND domain-containing protein 10	GO:0005737; GO:0005929; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044458; GO:0046872; GO:1905505	apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cilium [GO:0005929]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]
PGEN_.00g211600	Scaffold_10	20019604	20020407	Q5FWU8	ZMY10_XENLA	Zinc finger MYND domain-containing protein 10	GO:0005737; GO:0005929; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044458; GO:0046872; GO:1905505	apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cilium [GO:0005929]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]
PGEN_.00g211610	Scaffold_10	20030253	20085347	P02469	LAMB1_MOUSE	Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)	GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007566; GO:0007611; GO:0009887; GO:0009888; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0048471; GO:0062023; GO:0070831	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]
PGEN_.00g211620	Scaffold_10	20104812	20155961	P43090	HEM0_OPSTA	"5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS-E) (EC 2.3.1.37) (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)"	GO:0001666; GO:0003870; GO:0005743; GO:0005759; GO:0006782; GO:0030170	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]
PGEN_.00g211630	Scaffold_10	20183726	20193198	P20241	NRG_DROME	Neuroglian	GO:0005509; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016319; GO:0019991; GO:0021682; GO:0030175; GO:0035011; GO:0035151; GO:0045924; GO:0048036; GO:0048675; GO:0048813; GO:0050808; GO:0050839; GO:0060857; GO:0061343; GO:0072499; GO:0098609	"bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"
PGEN_.00g211640	Scaffold_10	20323661	20334740	Q9Y2M2	SSUH2_HUMAN	Protein SSUH2 homolog (Protein ssu-2 homolog)	GO:0005634; GO:0005737; GO:0042476	cytoplasm [GO:0005737]; nucleus [GO:0005634]; odontogenesis [GO:0042476]
PGEN_.00g211650	Scaffold_10	20337108	20402652	Q63170	DYH7_RAT	"Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Axonemal dynein heavy chain b) (Ciliary dynein heavy chain 7) (Dynein-like protein 7)"	GO:0003341; GO:0005509; GO:0005524; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045505; GO:0051959	"cilium [GO:0005929]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]"
PGEN_.00g211660	Scaffold_10	20403981	20417579	Q4R6T7	IQUB_MACFA	IQ and ubiquitin-like domain-containing protein	GO:0030030	cell projection organization [GO:0030030]
PGEN_.00g211670	Scaffold_10	20498618	20529736	Q9N0A8	ARHG3_MACFA	Rho guanine nucleotide exchange factor 3	GO:0005085; GO:0005737; GO:0035556	cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085]; intracellular signal transduction [GO:0035556]
PGEN_.00g211680	Scaffold_10	20542070	20577348	Q5VWG9	TAF3_HUMAN	Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit) (TAF(II)140) (TAF140) (TAFII-140) (TAFII140)	GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005669; GO:0006366; GO:0006367; GO:0031965; GO:0043433; GO:0046872; GO:0046982; GO:0051457; GO:1901796	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]
PGEN_.00g211690	Scaffold_10	20579702	20583382	P0DKY8	NUD16_HOMVI	U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (m7GpppN-mRNA hydrolase)	GO:0000166; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0009117; GO:0016787; GO:0046872	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; nucleotide metabolic process [GO:0009117]
PGEN_.00g211700	Scaffold_10	20609976	20610935	NA	NA	NA	NA	NA
PGEN_.00g211710	Scaffold_10	20663260	20663499	NA	NA	NA	NA	NA
PGEN_.00g211720	Scaffold_10	20708235	20709563	NA	NA	NA	NA	NA
PGEN_.00g211730	Scaffold_10	20786983	20787486	NA	NA	NA	NA	NA
PGEN_.00g211740	Scaffold_10	20787640	20789141	NA	NA	NA	NA	NA
PGEN_.00g211750	Scaffold_10	20790272	20790784	NA	NA	NA	NA	NA
PGEN_.00g211760	Scaffold_10	20798257	20799834	NA	NA	NA	NA	NA
PGEN_.00g211770	Scaffold_10	20807150	20813499	NA	NA	NA	NA	NA
PGEN_.00g211780	Scaffold_10	20816495	20820872	NA	NA	NA	NA	NA
PGEN_.00g211790	Scaffold_10	20824123	20829664	Q5BK75	S46A3_RAT	Solute carrier family 46 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g211800	Scaffold_10	20830603	20832303	NA	NA	NA	NA	NA
PGEN_.00g211810	Scaffold_10	20846708	20892354	P51049	MR1BB_DANRE	Melatonin receptor type 1B-B (Mel-1B-R-B) (Mel1b receptor B) (Melatonin receptor Mel1b Z2.6-4) (zMel1b-1)	GO:0004930; GO:0005886; GO:0008502; GO:0016021; GO:0048511	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502]; rhythmic process [GO:0048511]
PGEN_.00g211820	Scaffold_10	20949120	21022858	Q9WUN2	TBK1_MOUSE	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1)	GO:0002218; GO:0003676; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0010468; GO:0010629; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0031323; GO:0032479; GO:0032727; GO:0032728; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045359; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060340; GO:1904417	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta biosynthetic process [GO:0045359]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of cellular metabolic process [GO:0031323]; regulation of gene expression [GO:0010468]; regulation of type I interferon production [GO:0032479]
PGEN_.00g211830	Scaffold_10	21025397	21043857	P16056	MET_MOUSE	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	GO:0000122; GO:0000187; GO:0001764; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0004713; GO:0004714; GO:0005008; GO:0005524; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0008013; GO:0009925; GO:0010628; GO:0010629; GO:0010800; GO:0010801; GO:0010828; GO:0010976; GO:0014069; GO:0014812; GO:0014902; GO:0016020; GO:0017154; GO:0019903; GO:0030182; GO:0030317; GO:0030425; GO:0030534; GO:0031016; GO:0031116; GO:0032675; GO:0033138; GO:0035024; GO:0036126; GO:0042593; GO:0042802; GO:0043005; GO:0043025; GO:0043235; GO:0043274; GO:0043548; GO:0044877; GO:0045211; GO:0045740; GO:0045840; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050775; GO:0050804; GO:0050918; GO:0051450; GO:0051497; GO:0051897; GO:0055013; GO:0060048; GO:0060076; GO:0060079; GO:0060665; GO:0061436; GO:0070495; GO:0071526; GO:0071635; GO:0072593; GO:1900407; GO:1900745; GO:1901299; GO:1905098; GO:2001028	basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; hepatocyte growth factor-activated receptor activity [GO:0005008]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase binding [GO:0043274]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of chemical synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta production [GO:0071635]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g211840	Scaffold_10	21044379	21046157	NA	NA	NA	NA	NA
PGEN_.00g211850	Scaffold_10	21048315	21067966	Q108U6	MET_LOXAF	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	GO:0004714; GO:0005524; GO:0007169; GO:0016021; GO:0017154; GO:0050918; GO:0071526; GO:2001028	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; semaphorin-plexin signaling pathway [GO:0071526]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g211860	Scaffold_10	21078909	21118237	O94966	UBP19_HUMAN	Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) (Zinc finger MYND domain-containing protein 9)	GO:0004843; GO:0005789; GO:0005829; GO:0016021; GO:0016579; GO:0030433; GO:0031625; GO:0031647; GO:0034976; GO:0036459; GO:0046872; GO:0048642; GO:0050821; GO:0051879; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g211870	Scaffold_10	21118518	21126021	M9PBE2	HAKAI_DROME	E3 ubiquitin-protein ligase Hakai (EC 2.3.2.27)	GO:0004842; GO:0005634; GO:0005886; GO:0007015; GO:0007391; GO:0007427; GO:0007494; GO:0008258; GO:0008270; GO:0016567; GO:0031410; GO:0035282; GO:0036396; GO:0040003; GO:0045296; GO:0048471; GO:0060429; GO:0061630	"cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration, open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; segmentation [GO:0035282]"
PGEN_.00g211880	Scaffold_10	21134501	21136193	Q9D8X0	MANBL_MOUSE	Protein MANBAL	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g211890	Scaffold_10	21139171	21162078	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g211900	Scaffold_10	21228406	21231150	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g211910	Scaffold_10	21244796	21263400	P0DPD6	ECE2_HUMAN	Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71)	GO:0000139; GO:0004222; GO:0007267; GO:0008168; GO:0016021; GO:0016486; GO:0030658; GO:0030659; GO:0032259; GO:0046872	cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168]; cell-cell signaling [GO:0007267]; methylation [GO:0032259]; peptide hormone processing [GO:0016486]
PGEN_.00g211920	Scaffold_10	21266414	21270232	B2RXA1	PLCX2_MOUSE	PI-PLC X domain-containing protein 2	GO:0005634; GO:0007165; GO:0008081; GO:0016042	nucleus [GO:0005634]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]
PGEN_.00g211930	Scaffold_10	21279431	21279820	NA	NA	NA	NA	NA
PGEN_.00g211940	Scaffold_10	21289758	21319001	P50096	IMDH1_MOUSE	Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205) (IMPDH-I)	GO:0000166; GO:0003676; GO:0003677; GO:0003938; GO:0005634; GO:0005737; GO:0005829; GO:0006164; GO:0006177; GO:0006183; GO:0046651; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; purine nucleotide biosynthetic process [GO:0006164]
PGEN_.00g211950	Scaffold_10	21324980	21325309	NA	NA	NA	NA	NA
PGEN_.00g211960	Scaffold_10	21343090	21344051	NA	NA	NA	NA	NA
PGEN_.00g211970	Scaffold_10	21344515	21358391	Q9QUK3	CLN8_MOUSE	Protein CLN8	GO:0001306; GO:0005739; GO:0005783; GO:0005789; GO:0005793; GO:0006644; GO:0006672; GO:0007006; GO:0007040; GO:0007399; GO:0007601; GO:0007628; GO:0008203; GO:0008306; GO:0008344; GO:0008361; GO:0016021; GO:0021522; GO:0021523; GO:0033116; GO:0035176; GO:0043066; GO:0044257; GO:0044265; GO:0044267; GO:0045494; GO:0050881; GO:0050884; GO:0050885; GO:0051935; GO:0060041; GO:0060052; GO:0098793	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; presynapse [GO:0098793]; adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; age-dependent response to oxidative stress [GO:0001306]; associative learning [GO:0008306]; cellular macromolecule catabolic process [GO:0044265]; cellular protein catabolic process [GO:0044257]; cellular protein metabolic process [GO:0044267]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; glutamate reuptake [GO:0051935]; lysosome organization [GO:0007040]; mitochondrial membrane organization [GO:0007006]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; phospholipid metabolic process [GO:0006644]; photoreceptor cell maintenance [GO:0045494]; regulation of cell size [GO:0008361]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic motor neuron differentiation [GO:0021523]; spinal cord motor neuron differentiation [GO:0021522]; visual perception [GO:0007601]
PGEN_.00g211980	Scaffold_10	21380982	21392024	O54715	VAS1_RAT	V-type proton ATPase subunit S1 (V-ATPase subunit S1) (C7-1 protein) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1)	GO:0005524; GO:0005623; GO:0005789; GO:0006879; GO:0007568; GO:0008219; GO:0016021; GO:0017137; GO:0030641; GO:0033116; GO:0033180; GO:0033181; GO:0036295; GO:0045669; GO:0045780; GO:0045851; GO:0045921; GO:0046933; GO:0046961; GO:0051656; GO:0070374; GO:2001206	"cell [GO:0005623]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; Rab GTPase binding [GO:0017137]; aging [GO:0007568]; cell death [GO:0008219]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; establishment of organelle localization [GO:0051656]; pH reduction [GO:0045851]; positive regulation of bone resorption [GO:0045780]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast development [GO:2001206]; regulation of cellular pH [GO:0030641]"
PGEN_.00g211990	Scaffold_10	21392852	21393256	NA	NA	NA	NA	NA
PGEN_.00g212000	Scaffold_10	21415061	21418438	NA	NA	NA	NA	NA
PGEN_.00g212010	Scaffold_10	21429003	21437546	NA	NA	NA	NA	NA
PGEN_.00g212020	Scaffold_10	21449213	21461341	O35678	MGLL_MOUSE	Monoglyceride lipase (MGL) (EC 3.1.1.23) (Monoacylglycerol lipase) (MAGL)	GO:0005654; GO:0005829; GO:0006633; GO:0009966; GO:0016020; GO:0016787; GO:0019369; GO:0019433; GO:0019898; GO:0030424; GO:0030516; GO:0042803; GO:0043196; GO:0045202; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:0060292; GO:0097756; GO:2000124	axon [GO:0030424]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; varicosity [GO:0043196]; acylglycerol lipase activity [GO:0047372]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; long-term synaptic depression [GO:0060292]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of blood vessel diameter [GO:0097756]; regulation of axon extension [GO:0030516]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]
PGEN_.00g212030	Scaffold_10	21461788	21486246	Q6NWJ4	DNJC2_DANRE	DnaJ homolog subfamily C member 2	GO:0003677; GO:0003682; GO:0005634; GO:0005829; GO:0006325; GO:0042393; GO:0045893; GO:0061649	"cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g212040	Scaffold_10	21499628	21500116	Q92982	NINJ1_HUMAN	Ninjurin-1 (Nerve injury-induced protein 1)	GO:0001954; GO:0007155; GO:0007399; GO:0016021; GO:0042246; GO:1990384	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; nervous system development [GO:0007399]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]
PGEN_.00g212050	Scaffold_10	21573378	21582657	NA	NA	NA	NA	NA
PGEN_.00g212060	Scaffold_10	21601075	21610195	NA	NA	NA	NA	NA
PGEN_.00g212070	Scaffold_10	21643049	21655389	Q5XGY1	TSR1_XENLA	Pre-rRNA-processing protein TSR1 homolog	GO:0005730; GO:0042254	nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]
PGEN_.00g212080	Scaffold_10	21657416	21660926	NA	NA	NA	NA	NA
PGEN_.00g212090	Scaffold_10	21664350	21672861	Q5SWD9	TSR1_MOUSE	Pre-rRNA-processing protein TSR1 homolog	GO:0000462; GO:0003924; GO:0005525; GO:0005730; GO:0030688; GO:0034511	"nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U3 snoRNA binding [GO:0034511]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"
PGEN_.00g212100	Scaffold_10	21675201	21680103	NA	NA	NA	NA	NA
PGEN_.00g212110	Scaffold_10	21680667	21688353	NA	NA	NA	NA	NA
PGEN_.00g212120	Scaffold_10	21743529	21745226	NA	NA	NA	NA	NA
PGEN_.00g212130	Scaffold_10	21782610	21787865	Q25011	FANA_CORAP	FMRFamide-activated amiloride-sensitive sodium channel (FANACH)	GO:0005272; GO:0016021	integral component of membrane [GO:0016021]; sodium channel activity [GO:0005272]
PGEN_.00g212140	Scaffold_10	21808290	21815632	Q6DIK0	INT13_XENTR	Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95)	GO:0005634; GO:0005737; GO:0007049; GO:0007275; GO:0007346; GO:0030317; GO:0051301; GO:0080154	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; flagellated sperm motility [GO:0030317]; multicellular organism development [GO:0007275]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]
PGEN_.00g212150	Scaffold_10	21817816	21822770	Q9D581	EFC10_MOUSE	EF-hand calcium-binding domain-containing protein 10	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g212160	Scaffold_10	21826358	21853485	Q9NRM2	ZN277_HUMAN	Zinc finger protein 277 (Nuclear receptor-interacting factor 4)	GO:0000978; GO:0005634; GO:0046872; GO:0070301; GO:2000772	nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772]
PGEN_.00g212170	Scaffold_10	21869683	21872178	NA	NA	NA	NA	NA
PGEN_.00g212180	Scaffold_10	21893167	21894412	NA	NA	NA	NA	NA
PGEN_.00g212190	Scaffold_10	21894651	21895244	NA	NA	NA	NA	NA
PGEN_.00g212200	Scaffold_10	21896721	21902466	NA	NA	NA	NA	NA
PGEN_.00g212210	Scaffold_10	21911945	21920109	Q8N1A6	CD033_HUMAN	UPF0462 protein C4orf33		
PGEN_.00g212220	Scaffold_10	21924766	21937676	Q5BKN5	CD123_XENTR	Cell division cycle protein 123 homolog	GO:0005737; GO:0007049; GO:0051301	cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g212230	Scaffold_10	21946200	21946757	NA	NA	NA	NA	NA
PGEN_.00g212240	Scaffold_10	21947432	21949697	NA	NA	NA	NA	NA
PGEN_.00g212250	Scaffold_10	21953743	21954261	NA	NA	NA	NA	NA
PGEN_.00g212260	Scaffold_10	21997352	21998973	NA	NA	NA	NA	NA
PGEN_.00g212270	Scaffold_10	22001116	22013943	P49025	CTRO_MOUSE	"Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Rho-interacting, serine/threonine-protein kinase 21)"	GO:0000070; GO:0000086; GO:0000278; GO:0000281; GO:0001726; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005773; GO:0005829; GO:0005856; GO:0005886; GO:0007030; GO:0007091; GO:0007283; GO:0008064; GO:0015629; GO:0016358; GO:0017124; GO:0018107; GO:0030165; GO:0030496; GO:0030866; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035556; GO:0043025; GO:0045665; GO:0046872; GO:0048699; GO:0050774; GO:0051402; GO:0097110	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vacuole [GO:0005773]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; dendrite development [GO:0016358]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of neuron differentiation [GO:0045665]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]; spermatogenesis [GO:0007283]
PGEN_.00g212280	Scaffold_10	22024479	22029195	NA	NA	NA	NA	NA
PGEN_.00g212290	Scaffold_10	22037000	22063515	NA	NA	NA	NA	NA
PGEN_.00g212300	Scaffold_10	22070532	22074527	NA	NA	NA	NA	NA
PGEN_.00g212310	Scaffold_10	22078450	22089580	Q4V8A0	NSE2_RAT	E3 SUMO-protein ligase NSE2 (EC 2.3.2.-) (E3 SUMO-protein transferase NSE2) (MMS21 homolog) (Non-structural maintenance of chromosomes element 2 homolog) (Non-SMC element 2 homolog)	GO:0000722; GO:0000724; GO:0000781; GO:0004842; GO:0007049; GO:0008270; GO:0016605; GO:0019789; GO:0030915; GO:0034184; GO:0045842; GO:0051301; GO:0090398	"chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; SUMO transferase activity [GO:0019789]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; telomere maintenance via recombination [GO:0000722]"
PGEN_.00g212320	Scaffold_10	22100142	22105353	A4IG59	WASH1_DANRE	WASH complex subunit 1 (WAS protein family homolog 1)	GO:0003779; GO:0005769; GO:0005829; GO:0015031; GO:0016197; GO:0031901; GO:0034314; GO:0042147; GO:0043014; GO:0055037; GO:0055038; GO:0071203	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g212330	Scaffold_10	22114656	22140622	NA	NA	NA	NA	NA
PGEN_.00g212340	Scaffold_10	22150922	22166148	NA	NA	NA	NA	NA
PGEN_.00g212350	Scaffold_10	22183725	22198722	P30548	NK1R_MOUSE	Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)	GO:0002118; GO:0002687; GO:0003051; GO:0004995; GO:0005623; GO:0005737; GO:0005886; GO:0007204; GO:0007217; GO:0007611; GO:0007616; GO:0008217; GO:0008306; GO:0009408; GO:0009725; GO:0009986; GO:0010193; GO:0010634; GO:0010996; GO:0014070; GO:0014910; GO:0016021; GO:0016496; GO:0019233; GO:0030425; GO:0032224; GO:0032230; GO:0035094; GO:0035106; GO:0035815; GO:0036126; GO:0042713; GO:0042755; GO:0043117; GO:0044297; GO:0045471; GO:0045760; GO:0045777; GO:0045778; GO:0045907; GO:0046878; GO:0046887; GO:0048265; GO:0048266; GO:0048660; GO:0050671; GO:0050679; GO:0051496; GO:0060083; GO:0061827; GO:0070472; GO:0070474; GO:0071944; GO:0097225; GO:1902093	"cell [GO:0005623]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; substance P receptor activity [GO:0016496]; tachykinin receptor activity [GO:0004995]; aggressive behavior [GO:0002118]; angiotensin-mediated drinking behavior [GO:0003051]; associative learning [GO:0008306]; behavioral response to pain [GO:0048266]; eating behavior [GO:0042755]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; operant conditioning [GO:0035106]; positive regulation of action potential [GO:0045760]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of hormone secretion [GO:0046887]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of ossification [GO:0045778]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of saliva secretion [GO:0046878]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of uterine smooth muscle contraction [GO:0070472]; response to auditory stimulus [GO:0010996]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to ozone [GO:0010193]; response to pain [GO:0048265]; sensory perception of pain [GO:0019233]; smooth muscle contraction involved in micturition [GO:0060083]; sperm ejaculation [GO:0042713]; tachykinin receptor signaling pathway [GO:0007217]"
PGEN_.00g212360	Scaffold_10	22237884	22238312	O02835	NPY1R_PIG	Neuropeptide Y receptor type 1 (NPY1-R)	GO:0001602; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pancreatic polypeptide receptor activity [GO:0001602]
PGEN_.00g212370	Scaffold_10	22351059	22353668	NA	NA	NA	NA	NA
PGEN_.00g212380	Scaffold_10	22390222	22401784	O73853	CP17A_ICTPU	"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)"	GO:0004508; GO:0005506; GO:0006694; GO:0007548; GO:0016020; GO:0020037; GO:0047442	membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]
PGEN_.00g212390	Scaffold_10	22408554	22409084	NA	NA	NA	NA	NA
PGEN_.00g212400	Scaffold_10	22415677	22419123	NA	NA	NA	NA	NA
PGEN_.00g212410	Scaffold_10	22431230	22432995	NA	NA	NA	NA	NA
PGEN_.00g212420	Scaffold_10	22440694	22459102	Q96GE4	CEP95_HUMAN	Centrosomal protein of 95 kDa (Cep95) (Coiled-coil domain-containing protein 45)	GO:0000922; GO:0005737; GO:0005813	centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]
PGEN_.00g212430	Scaffold_10	22479266	22514624	Q00612	G6PD1_MOUSE	Glucose-6-phosphate 1-dehydrogenase X (G6PD) (EC 1.1.1.49)	GO:0001816; GO:0001998; GO:0002033; GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006741; GO:0006749; GO:0006979; GO:0009051; GO:0009898; GO:0010734; GO:0019322; GO:0030246; GO:0032613; GO:0032615; GO:0034451; GO:0034599; GO:0040014; GO:0042802; GO:0042803; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0048821; GO:0050661; GO:0051156; GO:0055114; GO:0061052; GO:1904879; GO:2000378	"centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; cytokine production [GO:0001816]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; NADP biosynthetic process [GO:0006741]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of multicellular organism growth [GO:0040014]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; ribose phosphate biosynthetic process [GO:0046390]"
PGEN_.00g212440	Scaffold_10	22523062	22532735	Q921L7	HEMK1_MOUSE	MTRF1L release factor glutamine methyltransferase (EC 2.1.1.297) (HemK methyltransferase family member 1)	GO:0003676; GO:0005739; GO:0008276; GO:0102559	mitochondrion [GO:0005739]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]
PGEN_.00g212450	Scaffold_10	22538875	22563939	Q6DFJ6	TBK1_XENLA	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107; GO:0032479; GO:0045087	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]
PGEN_.00g212460	Scaffold_10	22568680	22568907	NA	NA	NA	NA	NA
PGEN_.00g212470	Scaffold_10	22569455	22570229	NA	NA	NA	NA	NA
PGEN_.00g212480	Scaffold_10	22570423	22570635	NA	NA	NA	NA	NA
PGEN_.00g212490	Scaffold_10	22570808	22571029	NA	NA	NA	NA	NA
PGEN_.00g212500	Scaffold_10	22571533	22571799	NA	NA	NA	NA	NA
PGEN_.00g212510	Scaffold_10	22572431	22572823	NA	NA	NA	NA	NA
PGEN_.00g212520	Scaffold_10	22574444	22614066	Q80SY4	MIB1_MOUSE	E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1)	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005886; GO:0006897; GO:0007219; GO:0007507; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]
PGEN_.00g212530	Scaffold_10	22620816	22627088	Q3KNW5	SOAT_HUMAN	Solute carrier family 10 member 6 (Sodium-dependent organic anion transporter)	GO:0005886; GO:0008508; GO:0015721; GO:0016021; GO:0043250; GO:0043251; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]; bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]; transmembrane transport [GO:0055085]
PGEN_.00g212540	Scaffold_10	22628018	22637366	NA	NA	NA	NA	NA
PGEN_.00g212550	Scaffold_10	22637484	22637750	NA	NA	NA	NA	NA
PGEN_.00g212560	Scaffold_10	22638194	22648336	Q6PFX9	TNKS1_MOUSE	Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1)	GO:0000139; GO:0000209; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005815; GO:0005829; GO:0006471; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g212570	Scaffold_10	22657402	22661859	Q6DGH9	OTBP_DANRE	Homeobox protein orthopedia B	GO:0005634; GO:0006355; GO:0021767; GO:0021854; GO:0021884; GO:0030182; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; forebrain neuron development [GO:0021884]; hypothalamus development [GO:0021854]; mammillary body development [GO:0021767]; neuron differentiation [GO:0030182]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g212580	Scaffold_10	22665404	22673482	Q6JEL2	KLH10_HUMAN	Kelch-like protein 10	GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873	cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]
PGEN_.00g212590	Scaffold_10	22675245	22676027	NA	NA	NA	NA	NA
PGEN_.00g212600	Scaffold_10	22676158	22677003	NA	NA	NA	NA	NA
PGEN_.00g212610	Scaffold_10	22677028	22677549	NA	NA	NA	NA	NA
PGEN_.00g212620	Scaffold_10	22685515	22699224	A7RKF6	RTCB_NEMVE	RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)	GO:0000971; GO:0003972; GO:0005524; GO:0005634; GO:0006388; GO:0046872; GO:0072669	"nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
PGEN_.00g212630	Scaffold_10	22715183	22721666	Q5E9N9	APEX2_BOVIN	DNA-(apurinic or apyrimidinic site) lyase 2 (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease 2) (Apurinic-apyrimidinic endonuclease 2) (AP endonuclease 2)	GO:0003677; GO:0003906; GO:0004519; GO:0004528; GO:0005634; GO:0005739; GO:0006284; GO:0006310; GO:0007049; GO:0008270; GO:0008311; GO:0140078	mitochondrion [GO:0005739]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphodiesterase I activity [GO:0004528]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310]
PGEN_.00g212640	Scaffold_10	22733575	22741487	Q62733	LAP2_RAT	"Lamina-associated polypeptide 2, isoform beta (Thymopoietin isoform beta) (TP beta)"	GO:0000785; GO:0003677; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0006355; GO:0016021; GO:0031468; GO:0042802	"chromatin [GO:0000785]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; nuclear envelope reassembly [GO:0031468]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g212650	Scaffold_10	22743174	22743449	NA	NA	NA	NA	NA
PGEN_.00g212660	Scaffold_10	22750028	22783581	NA	NA	NA	NA	NA
PGEN_.00g212670	Scaffold_10	22801648	22805365	NA	NA	NA	NA	NA
PGEN_.00g212680	Scaffold_10	22810629	22829429	Q91WC1	POTE1_MOUSE	Protection of telomeres protein 1 (mPot1) (POT1-like telomere end-binding protein)	GO:0000781; GO:0000783; GO:0000784; GO:0005654; GO:0007004; GO:0010521; GO:0016233; GO:0017151; GO:0032202; GO:0032210; GO:0032211; GO:0032212; GO:0032508; GO:0042162; GO:0043047; GO:0051096; GO:0051276; GO:0051973; GO:0051974; GO:0060383; GO:0061820; GO:0061821; GO:0070187; GO:0070200; GO:0098505; GO:1905773; GO:1905774; GO:1905776; GO:1990955	"chromosome, telomeric region [GO:0000781]; nuclear chromosome, telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; DEAD/H-box RNA helicase binding [GO:0017151]; G-rich single-stranded DNA binding [GO:1990955]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded telomeric DNA binding [GO:0043047]; telomerase inhibitor activity [GO:0010521]; telomeric D-loop binding [GO:0061821]; telomeric DNA binding [GO:0042162]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; establishment of protein localization to telomere [GO:0070200]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA helicase activity [GO:1905776]; positive regulation of DNA strand elongation [GO:0060383]; positive regulation of helicase activity [GO:0051096]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of DNA helicase activity [GO:1905774]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820]"
PGEN_.00g212690	Scaffold_10	22847208	22850408	NA	NA	NA	NA	NA
PGEN_.00g212700	Scaffold_10	22860320	22862437	NA	NA	NA	NA	NA
PGEN_.00g212710	Scaffold_10	22961395	22961811	NA	NA	NA	NA	NA
PGEN_.00g212720	Scaffold_10	22962779	22968707	NA	NA	NA	NA	NA
PGEN_.00g212730	Scaffold_10	22973377	22990294	Q6P3R8	NEK5_HUMAN	Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (Never in mitosis A-related kinase 5) (NimA-related protein kinase 5)	GO:0004674; GO:0005524; GO:0046872	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g212740	Scaffold_10	22994923	23016613	Q5REY7	UBXN7_PONAB	UBX domain-containing protein 7	GO:0008134; GO:0016604; GO:0031625; GO:0034098; GO:0043130	nuclear body [GO:0016604]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; transcription factor binding [GO:0008134]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]
PGEN_.00g212750	Scaffold_10	23003265	23005447	NA	NA	NA	NA	NA
PGEN_.00g212760	Scaffold_10	23030663	23062503	Q9TV36	FBN1_PIG	Fibrillin-1 [Cleaved into: Asprosin]	GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0010737; GO:0031012; GO:0034199; GO:0042593	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]
PGEN_.00g212770	Scaffold_10	23063866	23070264	NA	NA	NA	NA	NA
PGEN_.00g212780	Scaffold_10	23070519	23070842	NA	NA	NA	NA	NA
PGEN_.00g212790	Scaffold_10	23071029	23071745	NA	NA	NA	NA	NA
PGEN_.00g212800	Scaffold_10	23084203	23085168	NA	NA	NA	NA	NA
PGEN_.00g212810	Scaffold_10	23096817	23112231	NA	NA	NA	NA	NA
PGEN_.00g212820	Scaffold_10	23128759	23132325	A3R064	DOK3_CHICK	Docking protein 3 (Downstream of tyrosine kinase 3)	GO:0005737; GO:0005886	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]
PGEN_.00g212830	Scaffold_10	23133490	23139835	A3KG59	P20D2_MOUSE	Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2)	GO:0005654; GO:0006508; GO:0016805; GO:0032268	nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]
PGEN_.00g212840	Scaffold_10	23141878	23149531	A3KG59	P20D2_MOUSE	Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2)	GO:0005654; GO:0006508; GO:0016805; GO:0032268	nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]
PGEN_.00g212850	Scaffold_10	23151302	23182994	NA	NA	NA	NA	NA
PGEN_.00g212860	Scaffold_10	23192257	23206856	NA	NA	NA	NA	NA
PGEN_.00g212870	Scaffold_10	23219368	23233343	O09171	BHMT1_RAT	Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)	GO:0005829; GO:0006479; GO:0006577; GO:0006579; GO:0008168; GO:0008270; GO:0009086; GO:0010243; GO:0032991; GO:0044877; GO:0047150; GO:0070062; GO:0071267	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]; response to organonitrogen compound [GO:0010243]
PGEN_.00g212880	Scaffold_10	23233030	23233314	NA	NA	NA	NA	NA
PGEN_.00g212890	Scaffold_10	23242788	23245465	NA	NA	NA	NA	NA
PGEN_.00g212900	Scaffold_10	23256413	23267008	Q9VQ91	TDRKH_DROME	Tudor and KH domain-containing protein homolog (Partner of PIWIs protein)	GO:0000932; GO:0003723; GO:0005634; GO:0032991; GO:0043186; GO:0047485; GO:0070895; GO:1903829	nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; negative regulation of transposon integration [GO:0070895]; positive regulation of cellular protein localization [GO:1903829]
PGEN_.00g212910	Scaffold_10	23275946	23276218	NA	NA	NA	NA	NA
PGEN_.00g212920	Scaffold_10	23276277	23276564	NA	NA	NA	NA	NA
PGEN_.00g212930	Scaffold_10	23293668	23295748	NA	NA	NA	NA	NA
PGEN_.00g212940	Scaffold_10	23306837	23324213	Q9BXT4	TDRD1_HUMAN	Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1)	GO:0005737; GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546; GO:1990904	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
PGEN_.00g212950	Scaffold_10	23329436	23345437	NA	NA	NA	NA	NA
PGEN_.00g212960	Scaffold_10	23353416	23354925	NA	NA	NA	NA	NA
PGEN_.00g212970	Scaffold_10	23369263	23424321	NA	NA	NA	NA	NA
PGEN_.00g212980	Scaffold_10	23425795	23428968	NA	NA	NA	NA	NA
PGEN_.00g212990	Scaffold_10	23432672	23446886	D9IQ16	GXN_ACRMI	Galaxin	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g213000	Scaffold_10	23502543	23502809	NA	NA	NA	NA	NA
PGEN_.00g213010	Scaffold_10	23540448	23541122	NA	NA	NA	NA	NA
PGEN_.00g213020	Scaffold_10	23541320	23541631	NA	NA	NA	NA	NA
PGEN_.00g213030	Scaffold_10	23604431	23604883	NA	NA	NA	NA	NA
PGEN_.00g213040	Scaffold_10	23610258	23610860	NA	NA	NA	NA	NA
PGEN_.00g213050	Scaffold_10	23740343	23741629	Q9V4A7	PLXB_DROME	Plexin-B	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0035021; GO:0035025; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; negative regulation of Rac protein signal transduction [GO:0035021]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]
PGEN_.00g213060	Scaffold_10	23759887	23811941	O75051	PLXA2_HUMAN	Plexin-A2 (Semaphorin receptor OCT)	GO:0001756; GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0043087; GO:0050772; GO:0051642; GO:0060037; GO:0060174; GO:0071526; GO:1902287	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756]
PGEN_.00g213070	Scaffold_10	23824000	23824428	NA	NA	NA	NA	NA
PGEN_.00g213080	Scaffold_10	23824479	23825190	NA	NA	NA	NA	NA
PGEN_.00g213090	Scaffold_10	23826001	23826291	NA	NA	NA	NA	NA
PGEN_.00g213100	Scaffold_10	23842885	23847319	NA	NA	NA	NA	NA
PGEN_.00g213110	Scaffold_10	23849122	23853690	NA	NA	NA	NA	NA
PGEN_.00g213120	Scaffold_10	23863306	23896039	Q5SUV2	MYBPP_MOUSE	MYCBP-associated protein (AMAM-1) (AMY-1-binding protein 1) (AMAP-1)	GO:0005737; GO:0007268; GO:0007275; GO:0007283; GO:0016020; GO:0030154; GO:0045202	cytoplasm [GO:0005737]; membrane [GO:0016020]; synapse [GO:0045202]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g213130	Scaffold_10	23904519	23941525	Q8SWN8	ACT_ENCCU	Actin	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g213140	Scaffold_10	23957579	23960376	NA	NA	NA	NA	NA
PGEN_.00g213150	Scaffold_10	23967620	23967955	NA	NA	NA	NA	NA
PGEN_.00g213160	Scaffold_10	23974119	23983303	NA	NA	NA	NA	NA
PGEN_.00g213170	Scaffold_10	24003250	24014434	Q5ZMU6	PP4R2_CHICK	Serine/threonine-protein phosphatase 4 regulatory subunit 2	GO:0005634; GO:0005737; GO:0006470; GO:0019888; GO:0030289	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]
PGEN_.00g213180	Scaffold_10	24021181	24022242	NA	NA	NA	NA	NA
PGEN_.00g213190	Scaffold_10	24028467	24046655	O95352	ATG7_HUMAN	Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) (hAGP7) (Ubiquitin-activating enzyme E1-like protein)	GO:0000045; GO:0000407; GO:0000422; GO:0004839; GO:0005576; GO:0005737; GO:0005829; GO:0005930; GO:0006464; GO:0006497; GO:0006501; GO:0006914; GO:0006995; GO:0007568; GO:0008134; GO:0009267; GO:0009749; GO:0015031; GO:0016236; GO:0019778; GO:0019779; GO:0030424; GO:0031401; GO:0032446; GO:0034727; GO:0034774; GO:0039521; GO:0042752; GO:0042803; GO:0043065; GO:0043312; GO:0044805; GO:0045732; GO:0048511; GO:0051607; GO:0061025; GO:0061684; GO:0071315; GO:0071455; GO:0075044; GO:0090298; GO:1902617; GO:1903204; GO:1904813	axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagophore assembly site [GO:0000407]; secretory granule lumen [GO:0034774]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; ubiquitin activating enzyme activity [GO:0004839]; aging [GO:0007568]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cellular protein modification process [GO:0006464]; cellular response to hyperoxia [GO:0071455]; cellular response to morphine [GO:0071315]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; membrane fusion [GO:0061025]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; neutrophil degranulation [GO:0043312]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation by symbiont of host autophagy [GO:0075044]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; response to fluoride [GO:1902617]; response to glucose [GO:0009749]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521]
PGEN_.00g213200	Scaffold_10	24052834	24058696	NA	NA	NA	NA	NA
PGEN_.00g213210	Scaffold_10	24061598	24062293	NA	NA	NA	NA	NA
PGEN_.00g213220	Scaffold_10	24062526	24066384	NA	NA	NA	NA	NA
PGEN_.00g213230	Scaffold_10	24077085	24078425	NA	NA	NA	NA	NA
PGEN_.00g213240	Scaffold_10	24088363	24089643	P35373	AGTRB_XENLA	"Type-1 angiotensin II receptor B (Angiotensin 2 receptor, type 1-B) (Angiotensin II receptor, type 1-B) (Angiotensin type 1 receptor) (AT1) (XAT-1)"	GO:0001595; GO:0004945; GO:0005623; GO:0005886; GO:0016021; GO:0019229; GO:0019722; GO:0051482	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; angiotensin receptor activity [GO:0001595]; angiotensin type II receptor activity [GO:0004945]; calcium-mediated signaling [GO:0019722]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of vasoconstriction [GO:0019229]
PGEN_.00g213250	Scaffold_10	24112233	24113718	NA	NA	NA	NA	NA
PGEN_.00g213260	Scaffold_10	24121176	24123194	Q5BIM1	TRI45_BOVIN	Tripartite motif-containing protein 45	GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
PGEN_.00g213270	Scaffold_10	24124669	24160619	Q6PCB5	RSBNL_HUMAN	Lysine-specific demethylase RSBN1L (EC 1.14.11.-) (Round spermatid basic protein 1-like protein)	GO:0005634; GO:0046872; GO:0051213	nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]
PGEN_.00g213280	Scaffold_10	24175971	24176707	NA	NA	NA	NA	NA
PGEN_.00g213290	Scaffold_10	24176769	24205717	Q96DB2	HDA11_HUMAN	Histone deacetylase 11 (HD11) (EC 3.5.1.98)	GO:0000118; GO:0004407; GO:0005634; GO:0005886; GO:0006325; GO:0008134; GO:0014003; GO:0016575; GO:0032041	histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; oligodendrocyte development [GO:0014003]
PGEN_.00g213300	Scaffold_10	24209627	24224627	Q14517	FAT1_HUMAN	"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]"	GO:0003382; GO:0005509; GO:0005634; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0045197; GO:0048471; GO:0048593; GO:0070062; GO:0098609	apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g213310	Scaffold_10	24258153	24260624	NA	NA	NA	NA	NA
PGEN_.00g213320	Scaffold_10	24273637	24276962	NA	NA	NA	NA	NA
PGEN_.00g213330	Scaffold_10	24277838	24286442	Q66H43	BORC6_RAT	BLOC-1-related complex subunit 6	GO:0005765; GO:0032418; GO:0099078	BORC complex [GO:0099078]; lysosomal membrane [GO:0005765]; lysosome localization [GO:0032418]
PGEN_.00g213340	Scaffold_10	24286511	24307629	Q5RB35	MKLN1_PONAB	Muskelin	GO:0001726; GO:0002090; GO:0005654; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030054; GO:0031532; GO:0042803; GO:0098794	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; ruffle [GO:0001726]; protein homodimerization activity [GO:0042803]; actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]
PGEN_.00g213350	Scaffold_10	24367809	24391529	Q5U3U3	CPT2_DANRE	"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)"	GO:0004095; GO:0005739; GO:0005743; GO:0006635	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; fatty acid beta-oxidation [GO:0006635]
PGEN_.00g213360	Scaffold_10	24403902	24509214	Q14995	NR1D2_HUMAN	Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R)	GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006367; GO:0007275; GO:0008134; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030374; GO:0033993; GO:0038023; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0090575; GO:0097009; GO:2001014	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; multicellular organism development [GO:0007275]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]; response to lipid [GO:0033993]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g213370	Scaffold_10	24509598	24511653	Q08E02	NR1D1_BOVIN	Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) (EAR-1)	GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0001222; GO:0003707; GO:0005634; GO:0005737; GO:0005978; GO:0007275; GO:0008134; GO:0008270; GO:0009755; GO:0010498; GO:0019216; GO:0030054; GO:0030154; GO:0030374; GO:0030425; GO:0031648; GO:0032922; GO:0033993; GO:0035947; GO:0038023; GO:0042632; GO:0042749; GO:0042752; GO:0043124; GO:0043197; GO:0044321; GO:0045598; GO:0045892; GO:0045893; GO:0045944; GO:0050728; GO:0060086; GO:0061178; GO:0061469; GO:0061889; GO:0070859; GO:0070888; GO:0071347; GO:0071356; GO:0090575; GO:0150079; GO:1903979	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription corepressor binding [GO:0001222]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; circadian temperature homeostasis [GO:0060086]; glycogen biosynthetic process [GO:0005978]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism development [GO:0007275]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasomal protein catabolic process [GO:0010498]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of fat cell differentiation [GO:0045598]; regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter [GO:0035947]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of lipid metabolic process [GO:0019216]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to leptin [GO:0044321]; response to lipid [GO:0033993]"
PGEN_.00g213380	Scaffold_10	24517140	24517925	NA	NA	NA	NA	NA
PGEN_.00g213390	Scaffold_10	24549483	24556721	Q14BV6	YDJC_MOUSE	Carbohydrate deacetylase (EC 3.5.1.-)	GO:0000287; GO:0005975; GO:0019213	deacetylase activity [GO:0019213]; magnesium ion binding [GO:0000287]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g213400	Scaffold_10	24564339	24567182	P30568	GSTA_PLEPL	Glutathione S-transferase A (GST-A) (EC 2.5.1.18) (GST class-theta)	GO:0004364; GO:0005737	cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]
PGEN_.00g213410	Scaffold_10	24569849	24571238	P30568	GSTA_PLEPL	Glutathione S-transferase A (GST-A) (EC 2.5.1.18) (GST class-theta)	GO:0004364; GO:0005737	cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]
PGEN_.00g213420	Scaffold_10	24583979	24602888	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g213430	Scaffold_10	24603587	24627171	Q5MJS3	FA20C_MOUSE	Extracellular serine/threonine protein kinase FAM20C (EC 2.7.11.1) (Dentin matrix protein 4) (DMP-4) (Golgi-enriched fraction casein kinase) (GEF-CK)	GO:0001501; GO:0004674; GO:0005509; GO:0005524; GO:0005615; GO:0005737; GO:0005794; GO:0006468; GO:0016773; GO:0030145; GO:0030501; GO:0031214; GO:0036179; GO:0040036; GO:0045669; GO:0046034; GO:0051174; GO:0070166; GO:0071895; GO:0097187	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein serine/threonine kinase activity [GO:0004674]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]; skeletal system development [GO:0001501]"
PGEN_.00g213440	Scaffold_10	24634406	24635729	NA	NA	NA	NA	NA
PGEN_.00g213450	Scaffold_10	24648771	24676124	O02812	MK14_CANLF	Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha)	GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006915; GO:0006939; GO:0010468; GO:0010831; GO:0016310; GO:0035556; GO:0038066; GO:0042327; GO:0045663; GO:0048870; GO:0051091; GO:1901741	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; phosphorylation [GO:0016310]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; smooth muscle contraction [GO:0006939]
PGEN_.00g213460	Scaffold_10	24677640	24679248	O61443	MK38B_DROME	Mitogen-activated protein kinase p38b (MAP kinase p38b) (MAPK p38b) (EC 2.7.11.24)	GO:0000165; GO:0001934; GO:0003007; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006955; GO:0007476; GO:0007623; GO:0008340; GO:0009408; GO:0009617; GO:0009651; GO:0010468; GO:0016909; GO:0030510; GO:0034614; GO:0035556; GO:0038001; GO:0040018; GO:0042542; GO:0042594; GO:0042742; GO:0045088; GO:0045793; GO:0048082; GO:0050832; GO:0071243; GO:0071276; GO:1900407; GO:2000331	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; SAP kinase activity [GO:0016909]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; heart morphogenesis [GO:0003007]; imaginal disc-derived wing morphogenesis [GO:0007476]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; paracrine signaling [GO:0038001]; positive regulation of cell size [GO:0045793]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]; regulation of BMP signaling pathway [GO:0030510]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; regulation of innate immune response [GO:0045088]; regulation of terminal button organization [GO:2000331]; response to bacterium [GO:0009617]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to salt stress [GO:0009651]; response to starvation [GO:0042594]
PGEN_.00g213470	Scaffold_10	24695030	24695596	Q5M9P8	ARL6_DANRE	ADP-ribosylation factor-like protein 6	GO:0003924; GO:0005525; GO:0005623; GO:0005737; GO:0005930; GO:0006886; GO:0007368; GO:0007369; GO:0007601; GO:0008593; GO:0016192; GO:0032402; GO:0033339; GO:0046872; GO:0050896; GO:0060170; GO:0060271; GO:0061512; GO:0070121	axoneme [GO:0005930]; cell [GO:0005623]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular protein transport [GO:0006886]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pectoral fin development [GO:0033339]; protein localization to cilium [GO:0061512]; regulation of Notch signaling pathway [GO:0008593]; response to stimulus [GO:0050896]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]
PGEN_.00g213480	Scaffold_10	24698778	24741898	P20241	NRG_DROME	Neuroglian	GO:0005509; GO:0005886; GO:0005887; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016319; GO:0019991; GO:0021682; GO:0030175; GO:0035011; GO:0035151; GO:0045924; GO:0048036; GO:0048675; GO:0048813; GO:0050808; GO:0050839; GO:0060857; GO:0061343; GO:0072499; GO:0098609	"bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"
PGEN_.00g213490	Scaffold_10	24702646	24709218	NA	NA	NA	NA	NA
PGEN_.00g213500	Scaffold_10	24757026	24779906	P9WQE8	PHAS_MYCTO	Phthioceranic/hydroxyphthioceranic acid synthase (EC 2.3.1.-) (Polyketide synthase pks2)	GO:0006633; GO:0016491; GO:0016746; GO:0031177	"oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]; fatty acid biosynthetic process [GO:0006633]"
PGEN_.00g213510	Scaffold_10	24789089	24789637	NA	NA	NA	NA	NA
PGEN_.00g213520	Scaffold_10	24795091	24811351	Q6DRC0	SYSC_DANRE	"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS)"	GO:0000049; GO:0000122; GO:0000978; GO:0001525; GO:0001569; GO:0001944; GO:0004828; GO:0005524; GO:0005634; GO:0005829; GO:0006434; GO:0016525; GO:0061300; GO:1901342; GO:1903671; GO:1904046	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cerebellum vasculature development [GO:0061300]; negative regulation of angiogenesis [GO:0016525]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; regulation of vasculature development [GO:1901342]; seryl-tRNA aminoacylation [GO:0006434]; vasculature development [GO:0001944]
PGEN_.00g213530	Scaffold_10	24815196	24840273	Q96RT7	GCP6_HUMAN	Gamma-tubulin complex component 6 (GCP-6)	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008017; GO:0008274; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]
PGEN_.00g213540	Scaffold_10	24840709	24858298	G5E8P0	GCP6_MOUSE	Gamma-tubulin complex component 6 (GCP-6)	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0005737; GO:0005813; GO:0005874; GO:0007020; GO:0008017; GO:0008274; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0051415	centrosome [GO:0005813]; cytoplasm [GO:0005737]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]
PGEN_.00g213550	Scaffold_10	24862558	24880270	C3YWU0	FUCO_BRAFL	Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)	GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139	extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]
PGEN_.00g213560	Scaffold_10	24896266	24944406	O81635	KN14G_ARATH	Kinesin-like protein KIN-14G (Kinesin-like protein KatD)	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g213570	Scaffold_10	24978739	25011933	NA	NA	NA	NA	NA
PGEN_.00g213580	Scaffold_10	25022787	25028180	Q2HJE9	TI17B_BOVIN	Mitochondrial import inner membrane translocase subunit Tim17-B	GO:0005744; GO:0015450; GO:0030150; GO:0031305	integral component of mitochondrial inner membrane [GO:0031305]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein import into mitochondrial matrix [GO:0030150]
PGEN_.00g213590	Scaffold_10	25063733	25153790	P02751	FINC_HUMAN	Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3]	GO:0001525; GO:0001932; GO:0002020; GO:0002576; GO:0005102; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005577; GO:0005604; GO:0005615; GO:0005788; GO:0005793; GO:0006953; GO:0007044; GO:0007155; GO:0007161; GO:0008022; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010628; GO:0016324; GO:0016504; GO:0018149; GO:0019221; GO:0019899; GO:0030198; GO:0031012; GO:0031093; GO:0033622; GO:0034446; GO:0035987; GO:0042060; GO:0042802; GO:0043394; GO:0043687; GO:0044267; GO:0045773; GO:0048146; GO:0050900; GO:0051087; GO:0051702; GO:0052047; GO:0062023; GO:0070062; GO:0070372; GO:0072562; GO:0097718; GO:1901166; GO:1904237; GO:2001202	"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule lumen [GO:0031093]; chaperone binding [GO:0051087]; collagen binding [GO:0005518]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-substrate junction assembly [GO:0007044]; cellular protein metabolic process [GO:0044267]; cytokine-mediated signaling pathway [GO:0019221]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; integrin activation [GO:0033622]; interaction with symbiont [GO:0051702]; leukocyte migration [GO:0050900]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet degranulation [GO:0002576]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; post-translational protein modification [GO:0043687]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; response to wounding [GO:0009611]; substrate adhesion-dependent cell spreading [GO:0034446]; symbiotic process mediated by secreted substance [GO:0052047]; wound healing [GO:0042060]"
PGEN_.00g213600	Scaffold_10	25159041	25170053	Q99JI4	PSMD6_MOUSE	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (p42A)	GO:0000502; GO:0005838; GO:0022624; GO:0030234; GO:0043161	proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]
PGEN_.00g213610	Scaffold_10	25170321	25218333	Q9UKG1	DP13A_HUMAN	"DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)"	GO:0001726; GO:0001786; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006606; GO:0007049; GO:0007165; GO:0007179; GO:0008283; GO:0008286; GO:0010008; GO:0010762; GO:0012506; GO:0016020; GO:0023052; GO:0031410; GO:0031901; GO:0032009; GO:0033211; GO:0034143; GO:0035091; GO:0035729; GO:0042802; GO:0042803; GO:0043422; GO:0044354; GO:0044877; GO:0045088; GO:0046324; GO:0046326; GO:0048023; GO:0048487; GO:0070062; GO:0097192; GO:0097708; GO:1900017; GO:1903076; GO:1905303; GO:1905450	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g213620	Scaffold_10	25257620	25257904	NA	NA	NA	NA	NA
PGEN_.00g213630	Scaffold_10	25275374	25308837	P61215	CAH10_MOUSE	Carbonic anhydrase-related protein 10 (Carbonic anhydrase-related protein X) (CA-RP X) (CARP X)	GO:0004089; GO:0008270	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
PGEN_.00g213640	Scaffold_10	25316934	25327843	Q04073	P3A2_STRPU	DNA-binding protein P3A2	GO:0000978; GO:0003700; GO:0005634; GO:0006357	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g213650	Scaffold_10	25338228	25343215	Q9UBU6	FA8A1_HUMAN	Protein FAM8A1 (Autosomal highly conserved protein)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g213660	Scaffold_10	25350084	25360181	Q75N90	FBN3_HUMAN	Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide]	GO:0005201; GO:0005509; GO:0031012	extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]
PGEN_.00g213670	Scaffold_10	25365785	25372400	Q4R8M1	SELK_MACFA	Selenoprotein K (SelK)	GO:0005783; GO:0005789; GO:0005886; GO:0006816; GO:0016021; GO:0018345	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion transport [GO:0006816]; protein palmitoylation [GO:0018345]
PGEN_.00g213680	Scaffold_10	25385146	25416382	Q96M20	CNBD2_HUMAN	Cyclic nucleotide-binding domain-containing protein 2	GO:0005829; GO:0007283; GO:0030552	cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
PGEN_.00g213690	Scaffold_10	25423673	25428308	O09111	NDUBB_MOUSE	"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (Complex I-ESSS) (CI-ESSS) (NADH-ubiquinone oxidoreductase ESSS subunit) (Neuronal protein 15.6) (Np15.6) (p15.6)"	GO:0005739; GO:0005747; GO:0016021; GO:0032981; GO:0055114	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114]
PGEN_.00g213700	Scaffold_10	25436509	25444441	P09436	SYIC_YEAST	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)"	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005829; GO:0006428	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]
PGEN_.00g213710	Scaffold_10	25444701	25446536	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g213720	Scaffold_10	25446650	25446886	NA	NA	NA	NA	NA
PGEN_.00g213730	Scaffold_10	25449295	25476822	P41252	SYIC_HUMAN	"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)"	GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]
PGEN_.00g213740	Scaffold_10	25488497	25494826	P42577	FRIS_LYMST	Soma ferritin (EC 1.16.3.1)	GO:0004322; GO:0005623; GO:0005737; GO:0006826; GO:0006879; GO:0008199	cell [GO:0005623]; cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]
PGEN_.00g213750	Scaffold_10	25499810	25502397	NA	NA	NA	NA	NA
PGEN_.00g213760	Scaffold_10	25502316	25518472	NA	NA	NA	NA	NA
PGEN_.00g213770	Scaffold_10	25535389	25535919	NA	NA	NA	NA	NA
PGEN_.00g213780	Scaffold_10	25539397	25541769	NA	NA	NA	NA	NA
PGEN_.00g213790	Scaffold_10	25544800	25549730	NA	NA	NA	NA	NA
PGEN_.00g213800	Scaffold_10	25558071	25582871	Q9UBN7	HDAC6_HUMAN	Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-)	GO:0000118; GO:0000209; GO:0000978; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005829; GO:0005874; GO:0005875; GO:0005881; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0006914; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0009636; GO:0009967; GO:0010033; GO:0010469; GO:0010506; GO:0010634; GO:0010727; GO:0010870; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0032041; GO:0032418; GO:0032984; GO:0033138; GO:0033558; GO:0034983; GO:0035967; GO:0040029; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051354; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0090035; GO:0090042; GO:1901300; GO:1903146	"aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"
PGEN_.00g213810	Scaffold_10	25621225	25640117	NA	NA	NA	NA	NA
PGEN_.00g213820	Scaffold_10	25644339	25658932	Q13105	ZBT17_HUMAN	Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60)	GO:0000978; GO:0001047; GO:0001223; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0007398; GO:0008134; GO:0008285; GO:0032991; GO:0032993; GO:0036498; GO:0045786; GO:0045944; GO:0046872; GO:0071158	"nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter binding [GO:0001047]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; ectoderm development [GO:0007398]; gastrulation with mouth forming second [GO:0001702]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g213830	Scaffold_10	25660544	25688321	F1ND48	FBH1_CHICK	F-box DNA helicase 1 (EC 3.6.4.12) (F-box only protein 18)	GO:0000724; GO:0000725; GO:0000785; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006974; GO:0008219; GO:0016567; GO:0019005; GO:0031297; GO:0043138; GO:0048478; GO:2000042	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]
PGEN_.00g213840	Scaffold_10	25697156	25703509	Q9Z2U1	PSA5_MOUSE	Proteasome subunit alpha type-5 (EC 3.4.25.1) (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain)	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019773; GO:0043161	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"
PGEN_.00g213850	Scaffold_10	25708730	25718502	A4QND0	UBL4A_XENTR	Ubiquitin-like protein 4A	GO:0005634; GO:0005829; GO:0071816; GO:0071818	BAT3 complex [GO:0071818]; cytosol [GO:0005829]; nucleus [GO:0005634]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]
PGEN_.00g213860	Scaffold_10	25718830	25724429	A8Y5T1	CA194_DANRE	Uncharacterized protein C1orf194 homolog	GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]
PGEN_.00g213870	Scaffold_10	25733034	25741103	A6NGJ6	TRI64_HUMAN	Tripartite motif-containing protein 64	GO:0008270	zinc ion binding [GO:0008270]
PGEN_.00g213880	Scaffold_10	25746155	25760384	Q96DM3	RMC1_HUMAN	Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1) (Mic-1) (WD repeat-containing protein 98)	GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]
PGEN_.00g213890	Scaffold_10	25777043	25781459	Q8VC42	RMC1_MOUSE	Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1) (Mic-1)	GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]
PGEN_.00g213900	Scaffold_10	25796479	25825536	NA	NA	NA	NA	NA
PGEN_.00g213910	Scaffold_10	25848110	25848466	NA	NA	NA	NA	NA
PGEN_.00g213920	Scaffold_10	25850648	25871616	P09623	DLDH_PIG	"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)"	GO:0001669; GO:0004148; GO:0005623; GO:0005634; GO:0005739; GO:0005759; GO:0009055; GO:0031514; GO:0045252; GO:0045454; GO:0050660; GO:0106077	acrosomal vesicle [GO:0001669]; cell [GO:0005623]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]
PGEN_.00g213930	Scaffold_10	25871824	25929001	Q8BL66	EEA1_MOUSE	Early endosome antigen 1	GO:0003676; GO:0005545; GO:0005768; GO:0005769; GO:0005829; GO:0005969; GO:0006897; GO:0006906; GO:0019897; GO:0030742; GO:0031410; GO:0031901; GO:0039694; GO:0042803; GO:0044308; GO:0046872; GO:0055037	axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; GTP-dependent protein binding [GO:0030742]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; endocytosis [GO:0006897]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]
PGEN_.00g213940	Scaffold_10	25937532	25940265	NA	NA	NA	NA	NA
PGEN_.00g213950	Scaffold_10	25981732	25982118	NA	NA	NA	NA	NA
PGEN_.00g213960	Scaffold_10	25984300	25984644	NA	NA	NA	NA	NA
PGEN_.00g213970	Scaffold_10	26009361	26009834	NA	NA	NA	NA	NA
PGEN_.00g213980	Scaffold_10	26023001	26023306	NA	NA	NA	NA	NA
PGEN_.00g213990	Scaffold_10	26023979	26024278	NA	NA	NA	NA	NA
PGEN_.00g214000	Scaffold_10	26171593	26183992	NA	NA	NA	NA	NA
PGEN_.00g214010	Scaffold_10	26191787	26193028	NA	NA	NA	NA	NA
PGEN_.00g214020	Scaffold_10	26201742	26204172	NA	NA	NA	NA	NA
PGEN_.00g214030	Scaffold_10	26215268	26216920	NA	NA	NA	NA	NA
PGEN_.00g214040	Scaffold_10	26234210	26234927	NA	NA	NA	NA	NA
PGEN_.00g214050	Scaffold_10	26240442	26244689	Q94521	DNAT_DROME	Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase)	GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066	"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]"
PGEN_.00g214060	Scaffold_10	26273834	26282241	Q94521	DNAT_DROME	Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase)	GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066	"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]"
PGEN_.00g214070	Scaffold_10	26310131	26316148	NA	NA	NA	NA	NA
PGEN_.00g214080	Scaffold_10	26328349	26331025	NA	NA	NA	NA	NA
PGEN_.00g214090	Scaffold_10	26367559	26371208	NA	NA	NA	NA	NA
PGEN_.00g214100	Scaffold_10	26419424	26421395	NA	NA	NA	NA	NA
PGEN_.00g214110	Scaffold_10	26429343	26431641	NA	NA	NA	NA	NA
PGEN_.00g214120	Scaffold_10	26444952	26452216	NA	NA	NA	NA	NA
PGEN_.00g214130	Scaffold_10	26465068	26472918	Q3T0F5	RAB7A_BOVIN	Ras-related protein Rab-7a	GO:0000421; GO:0003924; GO:0005525; GO:0005623; GO:0005764; GO:0005770; GO:0005811; GO:0005829; GO:0006886; GO:0008333; GO:0016042; GO:0030670; GO:0031902; GO:0032419; GO:0032482; GO:0033162; GO:0045022; GO:0045335; GO:0061724; GO:0090383; GO:0090385	autophagosome membrane [GO:0000421]; cell [GO:0005623]; cytosol [GO:0005829]; extrinsic component of lysosome membrane [GO:0032419]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; Rab protein signal transduction [GO:0032482]
PGEN_.00g214140	Scaffold_10	26473749	26481170	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g214150	Scaffold_10	26481312	26492371	Q5D013	EFMT2_DANRE	EEF1A lysine methyltransferase 2 (EC 2.1.1.-) (Methyltransferase-like protein 10) (Protein-lysine N-methyltransferase mettl10)	GO:0005634; GO:0005737; GO:0008168; GO:0016279; GO:0018022; GO:0018026; GO:0018027	cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]
PGEN_.00g214160	Scaffold_10	26501167	26539860	A6H7H1	F120A_BOVIN	Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A)	GO:0003723; GO:0005634; GO:0005737; GO:0005886	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]
PGEN_.00g214170	Scaffold_10	26540083	26564626	Q9DC53	CPNE8_MOUSE	Copine-8 (Copine VIII)	GO:0005544; GO:0005886; GO:0071277	plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]
PGEN_.00g214180	Scaffold_10	26572663	26575474	Q3UGP8	AG10B_MOUSE	"Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-B) (Asparagine-linked glycosylation protein 10 homolog B)"	GO:0004583; GO:0005886; GO:0006488; GO:0007605; GO:0016021; GO:0060117; GO:0071805; GO:0106073	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity [GO:0106073]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; auditory receptor cell development [GO:0060117]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; potassium ion transmembrane transport [GO:0071805]; sensory perception of sound [GO:0007605]"
PGEN_.00g214190	Scaffold_10	26575925	26604663	D3ZHS6	BAP1_RAT	Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1)	GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0010035; GO:0016579; GO:0035517; GO:0035520; GO:0035522; GO:0036459; GO:0045892; GO:0050727; GO:0051726; GO:0061519; GO:0071108; GO:1900015	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; macrophage homeostasis [GO:0061519]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of transcription, DNA-templated [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of inflammatory response [GO:0050727]; response to inorganic substance [GO:0010035]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g214200	Scaffold_10	26607556	26617587	NA	NA	NA	NA	NA
PGEN_.00g214210	Scaffold_10	26633946	26634710	NA	NA	NA	NA	NA
PGEN_.00g214220	Scaffold_10	26652529	26671370	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g214230	Scaffold_10	26753437	26754240	Q86MA7	PRQFV_APLCA	Protein PRQFV-amide [Cleaved into: AREFV-amide; PRQFV-amide (PRQFVa); VRDFV-amide; VREFV-amide; IREFV-amide]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g214240	Scaffold_10	26759279	26760082	Q86MA7	PRQFV_APLCA	Protein PRQFV-amide [Cleaved into: AREFV-amide; PRQFV-amide (PRQFVa); VRDFV-amide; VREFV-amide; IREFV-amide]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g214250	Scaffold_10	26923719	26925467	NA	NA	NA	NA	NA
PGEN_.00g214260	Scaffold_10	26926594	26930384	NA	NA	NA	NA	NA
PGEN_.00g214270	Scaffold_10	26958948	26959445	NA	NA	NA	NA	NA
PGEN_.00g214280	Scaffold_10	26978028	26988842	Q5XTS1	PLPL8_RABIT	Calcium-independent phospholipase A2-gamma (EC 3.1.1.5) (Group VIB calcium-independent phospholipase A2) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (Patatin-like phospholipase domain-containing protein 8)	GO:0000139; GO:0004622; GO:0005789; GO:0016021; GO:0016042; GO:0048471	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042]
PGEN_.00g214290	Scaffold_10	26996750	27004463	Q8CFA2	GCST_MOUSE	"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)"	GO:0004047; GO:0005654; GO:0005739; GO:0008483; GO:0019464	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine decarboxylation via glycine cleavage system [GO:0019464]
PGEN_.00g214300	Scaffold_10	27009980	27059872	NA	NA	NA	NA	NA
PGEN_.00g214310	Scaffold_10	27060117	27077151	Q08BB2	P2012_DANRE	N-fatty-acyl-amino acid synthase/hydrolase PM20D1.2 (EC 3.5.1.-) (EC 4.3.-.-) (Peptidase M20 domain-containing protein 1.2)	GO:0004181; GO:0005615; GO:0006520; GO:0006807; GO:0016811; GO:0016829; GO:0043604; GO:0043605; GO:0044255; GO:0046872; GO:0097009; GO:1990845; GO:2000275	"extracellular space [GO:0005615]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; cellular amide catabolic process [GO:0043605]; cellular amino acid metabolic process [GO:0006520]; cellular lipid metabolic process [GO:0044255]; energy homeostasis [GO:0097009]; nitrogen compound metabolic process [GO:0006807]; regulation of oxidative phosphorylation uncoupler activity [GO:2000275]"
PGEN_.00g214320	Scaffold_10	27087386	27095033	B0G143	UCPB_DICDI	Mitochondrial substrate carrier family protein ucpB (Solute carrier family 25 member 30 homolog) (Uncoupler protein B)	GO:0005743; GO:0006839; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial transport [GO:0006839]
PGEN_.00g214330	Scaffold_10	27100992	27175149	O88278	CELR3_RAT	Cadherin EGF LAG seven-pass G-type receptor 3 (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2)	GO:0001764; GO:0001932; GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007413; GO:0016021; GO:0032880; GO:0036514; GO:0036515; GO:0060271; GO:0098609; GO:1904938	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; axonal fasciculation [GO:0007413]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]
PGEN_.00g214340	Scaffold_10	27179831	27196140	Q3SZ71	MPPB_BOVIN	Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP)	GO:0004222; GO:0005739; GO:0005743; GO:0006627; GO:0017087; GO:0046872	mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627]
PGEN_.00g214350	Scaffold_10	27201079	27206248	Q6IQ20	NAPEP_HUMAN	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54)	GO:0000139; GO:0001523; GO:0001659; GO:0005635; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0007568; GO:0008270; GO:0009395; GO:0031901; GO:0035900; GO:0042622; GO:0042802; GO:0043227; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0102200; GO:1903999	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659]
PGEN_.00g214360	Scaffold_10	27217842	27223001	NA	NA	NA	NA	NA
PGEN_.00g214370	Scaffold_10	27227608	27273617	Q8IZD9	DOCK3_HUMAN	Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP)	GO:0005829; GO:0007264; GO:0017124; GO:0030676; GO:1903997	cytosol [GO:0005829]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; SH3 domain binding [GO:0017124]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g214380	Scaffold_10	27291479	27306221	NA	NA	NA	NA	NA
PGEN_.00g214390	Scaffold_10	27307730	27360212	Q8IZD9	DOCK3_HUMAN	Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP)	GO:0005829; GO:0007264; GO:0017124; GO:0030676; GO:1903997	cytosol [GO:0005829]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; SH3 domain binding [GO:0017124]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g214400	Scaffold_10	27399847	27403006	NA	NA	NA	NA	NA
PGEN_.00g214410	Scaffold_10	27403223	27404729	NA	NA	NA	NA	NA
PGEN_.00g214420	Scaffold_10	27404877	27406669	P15941	MUC1_HUMAN	Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]	GO:0000790; GO:0000978; GO:0002039; GO:0002223; GO:0003712; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0006977; GO:0006978; GO:0010944; GO:0016266; GO:0016324; GO:0019221; GO:0031982; GO:0033629; GO:0036003; GO:0043618; GO:0070062; GO:0090240; GO:1902166	"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
PGEN_.00g214430	Scaffold_10	27409720	27427133	Q9WU00	NRF1_MOUSE	Nuclear respiratory factor 1 (NRF-1) (Alpha palindromic-binding protein) (Alpha-pal)	GO:0000978; GO:0000979; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006357; GO:0007005; GO:0042803; GO:0045944; GO:0051602	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]"
PGEN_.00g214440	Scaffold_10	27427170	27446973	NA	NA	NA	NA	NA
PGEN_.00g214450	Scaffold_10	27451522	27454873	NA	NA	NA	NA	NA
PGEN_.00g214460	Scaffold_10	27471297	27484017	P33215	NEDD1_MOUSE	Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1)	GO:0000242; GO:0000922; GO:0000924; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005886; GO:0007019; GO:0007049; GO:0031109; GO:0036064; GO:0045177; GO:0051301; GO:0070201; GO:0071539	"apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; gamma-tubulin ring complex, centrosomal [GO:0000924]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule polymerization or depolymerization [GO:0031109]; protein localization to centrosome [GO:0071539]; regulation of establishment of protein localization [GO:0070201]"
PGEN_.00g214470	Scaffold_10	27491064	27512586	Q9Y2V7	COG6_HUMAN	Conserved oligomeric Golgi complex subunit 6 (COG complex subunit 6) (Component of oligomeric Golgi complex 6)	GO:0000139; GO:0006888; GO:0006891; GO:0015031; GO:0017119; GO:0032588; GO:0070085	Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycosylation [GO:0070085]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]
PGEN_.00g214480	Scaffold_10	27517563	27526354	C3YWU0	FUCO_BRAFL	Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)	GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139	extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]
PGEN_.00g214490	Scaffold_10	27543489	27544190	Q3T9E4	TGTP2_MOUSE	T-cell-specific guanine nucleotide triphosphate-binding protein 2 (EC 3.6.5.-) (Interferon-gamma-inducible GTPase Ifggb6 protein) (T-cell-specific guanine nucleotide triphosphate-binding protein)	GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0006952; GO:0035458; GO:0045087	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-beta [GO:0035458]; defense response [GO:0006952]; innate immune response [GO:0045087]
PGEN_.00g214500	Scaffold_10	27544343	27544747	NA	NA	NA	NA	NA
PGEN_.00g214510	Scaffold_10	27550115	27551383	Q6NXR0	IIGP5_HUMAN	Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1)	GO:0005525; GO:0016020; GO:0016787	membrane [GO:0016020]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]
PGEN_.00g214520	Scaffold_10	27561431	27566135	O08900	IKZF3_MOUSE	Zinc finger protein Aiolos (Ikaros family zinc finger protein 3)	GO:0000977; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0009617; GO:0030888; GO:0042113; GO:0042802; GO:0042803; GO:0042981; GO:0043565; GO:0044212; GO:0045577; GO:0045619; GO:0045944; GO:0046872; GO:0046982	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; B cell activation [GO:0042113]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of B cell proliferation [GO:0030888]; regulation of lymphocyte differentiation [GO:0045619]; response to bacterium [GO:0009617]"
PGEN_.00g214530	Scaffold_10	27575407	27576315	NA	NA	NA	NA	NA
PGEN_.00g214540	Scaffold_10	27586199	27591798	NA	NA	NA	NA	NA
PGEN_.00g214550	Scaffold_10	27605138	27647030	Q9UPQ7	PZRN3_HUMAN	E3 ubiquitin-protein ligase PDZRN3 (EC 2.3.2.27) (Ligand of Numb protein X 3) (PDZ domain-containing RING finger protein 3) (RING-type E3 ubiquitin transferase PDZRN3) (Semaphorin cytoplasmic domain-associated protein 3) (Protein SEMACAP3)	GO:0004842; GO:0005737; GO:0007528; GO:0008270; GO:0016567; GO:0030054; GO:0031594; GO:0061630	cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]
PGEN_.00g214560	Scaffold_10	27652425	27652736	NA	NA	NA	NA	NA
PGEN_.00g214570	Scaffold_10	27787498	27813119	E7FDW2	PZR3B_DANRE	E3 ubiquitin-protein ligase PDZRN3-B (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3-B)	GO:0005737; GO:0007528; GO:0016567; GO:0030054; GO:0045202; GO:0046872; GO:0061630	cell junction [GO:0030054]; cytoplasm [GO:0005737]; synapse [GO:0045202]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]
PGEN_.00g214580	Scaffold_10	27851157	27879909	A6QLP2	SAHH3_BOVIN	Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.3.1.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT)	GO:0005783; GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]
PGEN_.00g214590	Scaffold_10	27882404	27884639	NA	NA	NA	NA	NA
PGEN_.00g214600	Scaffold_10	27913667	27918712	NA	NA	NA	NA	NA
PGEN_.00g214610	Scaffold_10	27956288	27983469	Q99NH7	S26A5_MOUSE	Prestin (Solute carrier family 26 member 5)	GO:0002931; GO:0005737; GO:0005886; GO:0005887; GO:0007605; GO:0008134; GO:0008271; GO:0008360; GO:0009751; GO:0010996; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015755; GO:0016323; GO:0016328; GO:0019531; GO:0030507; GO:0034220; GO:0034766; GO:0035864; GO:0042391; GO:0042802; GO:0042803; GO:0045793; GO:0051262; GO:0090102; GO:0097066; GO:0098656; GO:1902074; GO:1902476; GO:2000147	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; identical protein binding [GO:0042802]; oxalate transmembrane transporter activity [GO:0019531]; protein homodimerization activity [GO:0042803]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]; transcription factor binding [GO:0008134]; anion transmembrane transport [GO:0098656]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; ion transmembrane transport [GO:0034220]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; protein tetramerization [GO:0051262]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605]
PGEN_.00g214620	Scaffold_10	28008404	28028942	P16066	ANPRA_HUMAN	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]
PGEN_.00g214630	Scaffold_10	28035351	28043851	NA	NA	NA	NA	NA
PGEN_.00g214640	Scaffold_10	28058790	28062955	NA	NA	NA	NA	NA
PGEN_.00g214650	Scaffold_10	28080887	28081138	NA	NA	NA	NA	NA
PGEN_.00g214660	Scaffold_10	28105386	28105991	P70174	HRH1_MOUSE	Histamine H1 receptor (H1R) (HH1R)	GO:0004930; GO:0004969; GO:0004993; GO:0005829; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0010894; GO:0015085; GO:0030425; GO:0030594; GO:0043114; GO:0045202; GO:0045429; GO:0045907; GO:0048167; GO:0048245; GO:0048511; GO:0051381; GO:0070509; GO:0071420; GO:0071421	"cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine binding [GO:0051381]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; calcium ion import [GO:0070509]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; manganese ion transmembrane transport [GO:0071421]; memory [GO:0007613]; negative regulation of steroid biosynthetic process [GO:0010894]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; regulation of vascular permeability [GO:0043114]; rhythmic process [GO:0048511]; visual learning [GO:0008542]"
PGEN_.00g214670	Scaffold_10	28161463	28162290	NA	NA	NA	NA	NA
PGEN_.00g214680	Scaffold_10	28176027	28176344	NA	NA	NA	NA	NA
PGEN_.00g214690	Scaffold_10	28193996	28197463	NA	NA	NA	NA	NA
PGEN_.00g214700	Scaffold_10	28208296	28208676	NA	NA	NA	NA	NA
PGEN_.00g214710	Scaffold_10	28213574	28214125	Q03650	CRAM_TRYBB	"Cysteine-rich, acidic integral membrane protein"	GO:0005886; GO:0006897; GO:0016021; GO:0020016	ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]
PGEN_.00g214720	Scaffold_10	28214198	28214650	Q03650	CRAM_TRYBB	"Cysteine-rich, acidic integral membrane protein"	GO:0005886; GO:0006897; GO:0016021; GO:0020016	ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]
PGEN_.00g214730	Scaffold_10	28221805	28267641	A8WHP3	SC5A9_DANRE	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	GO:0005412; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]
PGEN_.00g214740	Scaffold_10	28279555	28295864	Q9VCY8	ADRL_DROME	Adiponectin receptor protein	GO:0005886; GO:0009755; GO:0016021; GO:0016500; GO:0019395; GO:0032024; GO:0033211; GO:0036099; GO:0038023; GO:0042593; GO:0046872; GO:0070328	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-hormone receptor activity [GO:0016500]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female germ-line stem cell population maintenance [GO:0036099]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; triglyceride homeostasis [GO:0070328]
PGEN_.00g214750	Scaffold_10	28305653	28312963	Q9VCY8	ADRL_DROME	Adiponectin receptor protein	GO:0005886; GO:0009755; GO:0016021; GO:0016500; GO:0019395; GO:0032024; GO:0033211; GO:0036099; GO:0038023; GO:0042593; GO:0046872; GO:0070328	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-hormone receptor activity [GO:0016500]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; female germ-line stem cell population maintenance [GO:0036099]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; triglyceride homeostasis [GO:0070328]
PGEN_.00g214760	Scaffold_10	28317295	28327755	Q9H2W6	RM46_HUMAN	"39S ribosomal protein L46, mitochondrial (L46mt) (MRP-L46) (Mitochondrial large ribosomal subunit protein mL46) (P2ECSL)"	GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0016787; GO:0030054; GO:0070125; GO:0070126	cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]
PGEN_.00g214770	Scaffold_10	28331332	28351944	Q5EA28	CXXC1_BOVIN	CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1)	GO:0005634; GO:0005829; GO:0008270; GO:0016363; GO:0016607; GO:0035064; GO:0042800; GO:0045322; GO:0045893; GO:0048188	"cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; methylated histone binding [GO:0035064]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g214780	Scaffold_10	28471245	28471757	NA	NA	NA	NA	NA
PGEN_.00g214790	Scaffold_10	28475290	28494747	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g214800	Scaffold_10	28496581	28500375	NA	NA	NA	NA	NA
PGEN_.00g214810	Scaffold_10	28517558	28525982	Q9VQ56	ERM_DROME	Fez family zinc finger protein erm (Earmuff)	GO:0005634; GO:0007406; GO:0007412; GO:0010628; GO:0010629; GO:0019827; GO:0021579; GO:0043025; GO:0043565; GO:0043697; GO:0044212; GO:0044295; GO:0045666; GO:0045892; GO:0046872; GO:0050767; GO:0060385; GO:0072499; GO:1902692; GO:1902843	"axonal growth cone [GO:0044295]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; axon target recognition [GO:0007412]; axonogenesis involved in innervation [GO:0060385]; cell dedifferentiation [GO:0043697]; medulla oblongata morphogenesis [GO:0021579]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of gene expression [GO:0010628]; positive regulation of netrin-activated signaling pathway [GO:1902843]; positive regulation of neuron differentiation [GO:0045666]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; stem cell population maintenance [GO:0019827]"
PGEN_.00g214820	Scaffold_10	28594965	28600726	NA	NA	NA	NA	NA
PGEN_.00g214830	Scaffold_10	28596613	28619652	NA	NA	NA	NA	NA
PGEN_.00g214840	Scaffold_10	28655004	28666714	P20488	SYPH_BOVIN	Synaptophysin (Major synaptic vesicle protein p38)	GO:0006897; GO:0016021; GO:0017075; GO:0030054; GO:0030136; GO:0030672; GO:0042584; GO:0042802; GO:0043005; GO:0045920; GO:0048168; GO:0048786; GO:0051020; GO:2000474	cell junction [GO:0030054]; chromaffin granule membrane [GO:0042584]; clathrin-coated vesicle [GO:0030136]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; syntaxin-1 binding [GO:0017075]; endocytosis [GO:0006897]; negative regulation of exocytosis [GO:0045920]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of opioid receptor signaling pathway [GO:2000474]
PGEN_.00g214850	Scaffold_10	28680542	28681552	NA	NA	NA	NA	NA
PGEN_.00g214860	Scaffold_10	28691919	28692872	NA	NA	NA	NA	NA
PGEN_.00g214870	Scaffold_10	28721869	28726859	NA	NA	NA	NA	NA
PGEN_.00g214880	Scaffold_10	28729004	28739714	NA	NA	NA	NA	NA
PGEN_.00g214890	Scaffold_10	28746472	28779158	Q5RB37	ITIH3_PONAB	Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3)	GO:0004867; GO:0005576; GO:0030212	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]
PGEN_.00g214900	Scaffold_10	28792672	28803145	Q96PY6	NEK1_HUMAN	Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)	GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0023014; GO:0032147; GO:0034451; GO:0042769; GO:0046872; GO:0051301; GO:0060271; GO:0071889	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response, detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]"
PGEN_.00g214910	Scaffold_10	28811223	28844544	P51957	NEK4_HUMAN	Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-protein kinase NRK2)	GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0023014; GO:0030145; GO:0032147; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:1900062; GO:2000772; GO:2001020	"ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]"
PGEN_.00g214920	Scaffold_10	28854291	28868814	G3V9D0	PGLT1_RAT	Protein O-glucosyltransferase 1 (EC 2.4.1.-) (O-glucosyltransferase Rumi homolog) (Protein O-xylosyltransferase) (EC 2.4.2.26)	GO:0001756; GO:0005788; GO:0006493; GO:0007369; GO:0008593; GO:0010470; GO:0018242; GO:0030158; GO:0035251; GO:0035252; GO:0045747; GO:0046527; GO:0048318; GO:0048339; GO:0060537; GO:0072358	endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; protein xylosyltransferase activity [GO:0030158]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; axial mesoderm development [GO:0048318]; cardiovascular system development [GO:0072358]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756]
PGEN_.00g214930	Scaffold_10	28879192	28887179	NA	NA	NA	NA	NA
PGEN_.00g214940	Scaffold_10	28894026	28908168	H3BNL1	CC084_HUMAN	Uncharacterized protein C3orf84		
PGEN_.00g214950	Scaffold_10	28909752	28910006	NA	NA	NA	NA	NA
PGEN_.00g214960	Scaffold_10	28910066	28939149	NA	NA	NA	NA	NA
PGEN_.00g214970	Scaffold_10	28942609	28950142	NA	NA	NA	NA	NA
PGEN_.00g214980	Scaffold_10	28956315	29002817	Q6B855	TKT_BOVIN	Transketolase (TK) (EC 2.2.1.1)	GO:0004802; GO:0040008; GO:0046872	metal ion binding [GO:0046872]; transketolase activity [GO:0004802]; regulation of growth [GO:0040008]
PGEN_.00g214990	Scaffold_10	29014722	29038977	P01122	RHO_APLCA	Ras-like GTP-binding protein RHO	GO:0003924; GO:0005525; GO:0005886; GO:0007264	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g215000	Scaffold_10	29039086	29047237	NA	NA	NA	NA	NA
PGEN_.00g215010	Scaffold_10	29049027	29058432	NA	NA	NA	NA	NA
PGEN_.00g215020	Scaffold_10	29064160	29069963	NA	NA	NA	NA	NA
PGEN_.00g215030	Scaffold_10	29070897	29092998	B2RX12	MRP3_MOUSE	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multidrug resistance-associated protein 3)	GO:0005524; GO:0005886; GO:0005887; GO:0015722; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0098656	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g215040	Scaffold_10	29107849	29112503	Q9QUP4	CHST5_MOUSE	Carbohydrate sulfotransferase 5 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4) (GST4) (Intestinal N-acetylglucosamine-6-O-sulfotransferase) (I-GlcNAc6ST) (Intestinal GlcNAc-6-sulfotransferase) (mIGn6ST) (N-acetylglucosamine 6-O-sulfotransferase 3) (GlcNAc6ST-3) (Gn6st-3)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0016021; GO:0018146	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g215050	Scaffold_10	29125819	29126361	NA	NA	NA	NA	NA
PGEN_.00g215060	Scaffold_10	29126386	29126868	NA	NA	NA	NA	NA
PGEN_.00g215070	Scaffold_10	29127336	29167752	Q99NF3	CEP41_MOUSE	Centrosomal protein of 41 kDa (Cep41) (Testis-specific gene A14 protein)	GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0015031; GO:0018095; GO:0036064; GO:0060271	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]; protein polyglutamylation [GO:0018095]; protein transport [GO:0015031]
PGEN_.00g215080	Scaffold_10	29215235	29215540	NA	NA	NA	NA	NA
PGEN_.00g215090	Scaffold_10	29224633	29242189	NA	NA	NA	NA	NA
PGEN_.00g215100	Scaffold_10	29245380	29276123	Q96M20	CNBD2_HUMAN	Cyclic nucleotide-binding domain-containing protein 2	GO:0005829; GO:0007283; GO:0030552	cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
PGEN_.00g215110	Scaffold_10	29282185	29282550	NA	NA	NA	NA	NA
PGEN_.00g215120	Scaffold_10	29288277	29290887	NA	NA	NA	NA	NA
PGEN_.00g215130	Scaffold_10	29326827	29327600	Q866E8	FUT1_SAPAP	"Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]
PGEN_.00g215140	Scaffold_10	29357604	29370517	P21266	GSTM3_HUMAN	Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3)	GO:0004364; GO:0005634; GO:0005737; GO:0005829; GO:0006749; GO:0008065; GO:0018916; GO:0019899; GO:0035686; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043627; GO:0045171; GO:0070062; GO:0070458; GO:1901687	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]
PGEN_.00g215150	Scaffold_10	29386400	29396499	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g215160	Scaffold_10	29424955	29425275	NA	NA	NA	NA	NA
PGEN_.00g215170	Scaffold_10	29425549	29426349	O43422	P52K_HUMAN	52 kDa repressor of the inhibitor of the protein kinase (p52rIPK) (58 kDa interferon-induced protein kinase-interacting protein) (p58IPK-interacting protein) (Death-associated protein 4) (THAP domain-containing protein 0) (THAP domain-containing protein 12)	GO:0000790; GO:0000981; GO:0003677; GO:0007165; GO:0008285; GO:0046872; GO:0046983	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; negative regulation of cell population proliferation [GO:0008285]; signal transduction [GO:0007165]"
PGEN_.00g215180	Scaffold_10	29426445	29427455	NA	NA	NA	NA	NA
PGEN_.00g215190	Scaffold_10	29452837	29478493	Q8JZL1	I17RD_MOUSE	Interleukin-17 receptor D (IL-17 receptor D) (IL-17RD) (Interleukin-17 receptor-like protein) (Sef homolog) (mSef)	GO:0000139; GO:0003676; GO:0005654; GO:0005794; GO:0005886; GO:0016021; GO:0030368	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; interleukin-17 receptor activity [GO:0030368]; nucleic acid binding [GO:0003676]
PGEN_.00g215200	Scaffold_10	29488050	29494085	Q58588	Y1187_METJA	Uncharacterized protein MJ1187 (EC 3.2.2.-)	GO:0016787	hydrolase activity [GO:0016787]
PGEN_.00g215210	Scaffold_10	29504225	29514209	A7S1L6	FUCT1_NEMVE	GDP-fucose transporter 1 (Solute carrier family 35 member C1 homolog)	GO:0000139; GO:0005457; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0022857; GO:0036066; GO:0036085	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; protein O-linked fucosylation [GO:0036066]
PGEN_.00g215220	Scaffold_10	29539136	29551291	Q9NZQ3	SPN90_HUMAN	NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (54 kDa vimentin-interacting protein) (VIP54) (90 kDa SH3 protein interacting with Nck) (AF3p21) (Dia-interacting protein 1) (DIP-1) (Diaphanous protein-interacting protein) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein) (WISH) (Wiskott-Aldrich syndrome protein-interacting protein)	GO:0005634; GO:0005829; GO:0005882; GO:0007010; GO:0008092; GO:0010976; GO:0017124; GO:0038096	cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; positive regulation of neuron projection development [GO:0010976]
PGEN_.00g215230	Scaffold_10	29556886	29563887	NA	NA	NA	NA	NA
PGEN_.00g215240	Scaffold_10	29571049	29580488	NA	NA	NA	NA	NA
PGEN_.00g215250	Scaffold_10	29617838	29622808	NA	NA	NA	NA	NA
PGEN_.00g215260	Scaffold_10	29627697	29630055	NA	NA	NA	NA	NA
PGEN_.00g215270	Scaffold_10	29637479	29678019	Q8WWW0	RASF5_HUMAN	Ras association domain-containing protein 5 (New ras effector 1) (Regulator for cell adhesion and polarization enriched in lymphoid tissues) (RAPL)	GO:0005634; GO:0005737; GO:0005874; GO:0006915; GO:0008285; GO:0017016; GO:0031398; GO:0035556; GO:0042802; GO:0042981; GO:0046872; GO:1900180	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; Ras GTPase binding [GO:0017016]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to nucleus [GO:1900180]
PGEN_.00g215280	Scaffold_10	29689223	29689573	Q9NS23	RASF1_HUMAN	Ras association domain-containing protein 1	GO:0000922; GO:0005634; GO:0005737; GO:0005815; GO:0005874; GO:0006974; GO:0007050; GO:0007265; GO:0008270; GO:0015630; GO:0031398; GO:0042802; GO:0046982; GO:0047485; GO:0050821; GO:0070507; GO:0071157	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; zinc ion binding [GO:0008270]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of microtubule cytoskeleton organization [GO:0070507]
PGEN_.00g215290	Scaffold_10	29694592	29756923	P41564	IDH3G_MACFA	"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma) (Fragment)"	GO:0000287; GO:0004449; GO:0005524; GO:0005739; GO:0006099; GO:0006102; GO:0051287	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g215300	Scaffold_10	29758414	29761524	Q5PQ63	IMP2L_XENLA	Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein)	GO:0006465; GO:0006627; GO:0008236; GO:0016021; GO:0042720	integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]; serine-type peptidase activity [GO:0008236]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; signal peptide processing [GO:0006465]
PGEN_.00g215310	Scaffold_10	29784066	29786297	Q6UXK5	LRRN1_HUMAN	Leucine-rich repeat neuronal protein 1 (Neuronal leucine-rich repeat protein 1) (NLRR-1)	GO:0005615; GO:0016021; GO:0031012; GO:0051965	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]
PGEN_.00g215320	Scaffold_10	29833915	29834211	NA	NA	NA	NA	NA
PGEN_.00g215330	Scaffold_10	29836898	29857518	Q96T52	IMP2L_HUMAN	Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein)	GO:0001541; GO:0006465; GO:0006627; GO:0006801; GO:0006974; GO:0007283; GO:0007420; GO:0008015; GO:0008233; GO:0008236; GO:0016021; GO:0022904; GO:0030728; GO:0033108; GO:0042720; GO:0061300	integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]; peptidase activity [GO:0008233]; serine-type peptidase activity [GO:0008236]; blood circulation [GO:0008015]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum vasculature development [GO:0061300]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]
PGEN_.00g215340	Scaffold_10	29842209	29842742	NA	NA	NA	NA	NA
PGEN_.00g215350	Scaffold_10	29868614	29881421	NA	NA	NA	NA	NA
PGEN_.00g215360	Scaffold_10	29885306	29897000	Q8IYE0	CC146_HUMAN	Coiled-coil domain-containing protein 146	GO:0005737; GO:0005814	centriole [GO:0005814]; cytoplasm [GO:0005737]
PGEN_.00g215370	Scaffold_10	29899806	29909809	Q9DE26	RUVB1_XENLA	RuvB-like 1 (EC 3.6.4.12) (Pontin)	GO:0000812; GO:0005524; GO:0006281; GO:0006310; GO:0031011; GO:0035267; GO:0043139; GO:0071339; GO:0097255	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]
PGEN_.00g215380	Scaffold_10	29912600	29915326	Q5NCC9	TRI58_MOUSE	E3 ubiquitin-protein ligase TRIM58 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM58) (Tripartite motif-containing protein 58)	GO:0000209; GO:0006511; GO:0008270; GO:0045504; GO:0045505; GO:0051865; GO:0061630; GO:0061931; GO:1902838	dynein heavy chain binding [GO:0045504]; dynein intermediate chain binding [GO:0045505]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; positive regulation of erythrocyte enucleation [GO:0061931]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of nuclear migration along microtubule [GO:1902838]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g215390	Scaffold_10	29916405	29917285	NA	NA	NA	NA	NA
PGEN_.00g215400	Scaffold_10	29921912	29923592	NA	NA	NA	NA	NA
PGEN_.00g215410	Scaffold_10	29925498	29939790	Q9ESN5	CENPK_MOUSE	Centromere protein K (CENP-K) (SoxLZ/Sox6 leucine zipper-binding protein in testis)	GO:0000070; GO:0000941; GO:0005634; GO:0045944; GO:0051382	condensed nuclear chromosome inner kinetochore [GO:0000941]; nucleus [GO:0005634]; kinetochore assembly [GO:0051382]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g215420	Scaffold_10	29948453	29965546	P23249	MOV10_MOUSE	Putative helicase MOV-10 (EC 3.6.4.13) (Moloney leukemia virus 10 protein)	GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0019034; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0051607; GO:0061014; GO:0061158; GO:0150011	"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; viral replication complex [GO:0019034]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]"
PGEN_.00g215430	Scaffold_10	29967162	29977929	Q1LXK5	M10B2_DANRE	Putative helicase mov-10-B.2 (EC 3.6.4.13)	GO:0000932; GO:0003723; GO:0005524; GO:0005829; GO:0032574; GO:0035194; GO:0035279; GO:0043186	cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; posttranscriptional gene silencing by RNA [GO:0035194]
PGEN_.00g215440	Scaffold_10	29980863	29983503	NA	NA	NA	NA	NA
PGEN_.00g215450	Scaffold_10	29993983	30007446	P32138	SQASE_ECOLI	Sulfoquinovosidase (SQase) (EC 3.2.1.199)	GO:0004553; GO:0005975; GO:0030246; GO:0061720; GO:1990929	"carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; sulfoquinovosidase activity [GO:1990929]; 6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde [GO:0061720]; carbohydrate metabolic process [GO:0005975]"
PGEN_.00g215460	Scaffold_10	30014314	30014592	NA	NA	NA	NA	NA
PGEN_.00g215470	Scaffold_10	30015446	30045867	Q06278	AOXA_HUMAN	Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-)	GO:0004031; GO:0004854; GO:0005506; GO:0005829; GO:0009055; GO:0009115; GO:0017144; GO:0042802; GO:0042803; GO:0042816; GO:0043546; GO:0050660; GO:0051287; GO:0051537; GO:0055114; GO:0070062; GO:0071949; GO:0102797; GO:0102798	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; vitamin B6 metabolic process [GO:0042816]; xanthine catabolic process [GO:0009115]"
PGEN_.00g215480	Scaffold_10	30054407	30085450	Q852M1	ALDO2_ORYSJ	Probable aldehyde oxidase 2 (AO-2) (EC 1.2.3.1)	GO:0004031; GO:0005506; GO:0009055; GO:0009688; GO:0009851; GO:0051537; GO:0071949; GO:0102797; GO:0102798	"2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; iron ion binding [GO:0005506]; abscisic acid biosynthetic process [GO:0009688]; auxin biosynthetic process [GO:0009851]"
PGEN_.00g215490	Scaffold_10	30088757	30107077	Q8VC12	HUTU_MOUSE	Urocanate hydratase (Urocanase) (EC 4.2.1.49) (Imidazolonepropionate hydrolase)	GO:0005829; GO:0006548; GO:0016153; GO:0019556; GO:0019557	cytosol [GO:0005829]; urocanate hydratase activity [GO:0016153]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]
PGEN_.00g215500	Scaffold_10	30113887	30131648	Q58DA6	S35A2_BOVIN	UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT)	GO:0005459; GO:0005794; GO:0008643; GO:0030173	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]
PGEN_.00g215510	Scaffold_10	30150248	30151233	NA	NA	NA	NA	NA
PGEN_.00g215520	Scaffold_10	30175072	30177790	Q58DA6	S35A2_BOVIN	UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT)	GO:0005459; GO:0005794; GO:0008643; GO:0030173	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]
PGEN_.00g215530	Scaffold_10	30187584	30198234	E7FAM5	LIN41_DANRE	E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)	GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177	P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]
PGEN_.00g215540	Scaffold_10	30261882	30264236	NA	NA	NA	NA	NA
PGEN_.00g215550	Scaffold_10	30264333	30264686	NA	NA	NA	NA	NA
PGEN_.00g215560	Scaffold_10	30269630	30293035	Q6DFJ6	TBK1_XENLA	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107; GO:0032479; GO:0045087	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; innate immune response [GO:0045087]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of type I interferon production [GO:0032479]
PGEN_.00g215570	Scaffold_10	30309569	30311537	NA	NA	NA	NA	NA
PGEN_.00g215580	Scaffold_10	30333693	30336682	P74148	Y1388_SYNY3	Universal stress protein Sll1388 (USP Sll1388)		
PGEN_.00g215590	Scaffold_10	30345280	30345636	NA	NA	NA	NA	NA
PGEN_.00g215600	Scaffold_10	30348253	30348492	NA	NA	NA	NA	NA
PGEN_.00g215610	Scaffold_10	30353938	30357483	NA	NA	NA	NA	NA
PGEN_.00g215620	Scaffold_10	30365582	30372881	Q6G8L7	Y1637_STAAS	Putative universal stress protein SAS1637	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g215630	Scaffold_10	30402016	30406450	P72745	Y1101_SYNY3	Universal stress protein Slr1101 (USP Slr1101)		
PGEN_.00g215640	Scaffold_10	30415197	30436438	NA	NA	NA	NA	NA
PGEN_.00g215650	Scaffold_10	30441502	30457556	Q76FK4	NOL8_HUMAN	Nucleolar protein 8 (Nucleolar protein Nop132)	GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:1902570; GO:1990904	nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364]
PGEN_.00g215660	Scaffold_10	30460645	30467546	Q6E2N3	TRI33_DANRE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]
PGEN_.00g215670	Scaffold_10	30467569	30468387	NA	NA	NA	NA	NA
PGEN_.00g215680	Scaffold_10	30482539	30569120	Q24270	CAC1D_DROME	Voltage-dependent calcium channel type D subunit alpha-1 (DmCa1D)	GO:0005245; GO:0005891; GO:0006816; GO:0006936; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0034765; GO:0042045; GO:0046872; GO:0070509; GO:0070588	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g215690	Scaffold_10	30586100	30586342	NA	NA	NA	NA	NA
PGEN_.00g215700	Scaffold_10	30595407	30599133	Q24270	CAC1D_DROME	Voltage-dependent calcium channel type D subunit alpha-1 (DmCa1D)	GO:0005245; GO:0005891; GO:0006816; GO:0006936; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0034765; GO:0042045; GO:0046872; GO:0070509; GO:0070588	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; epithelial fluid transport [GO:0042045]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g215710	Scaffold_10	30604840	30609324	NA	NA	NA	NA	NA
PGEN_.00g215720	Scaffold_10	30639897	30701595	Q5R413	DCP1B_PONAB	mRNA-decapping enzyme 1B (EC 3.-.-.-)	GO:0000184; GO:0000290; GO:0005634; GO:0005737; GO:0008047; GO:0016787	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"
PGEN_.00g215730	Scaffold_10	30730708	30829939	Q9NY47	CA2D2_HUMAN	Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2]	GO:0005245; GO:0005886; GO:0005891; GO:0007528; GO:0034765; GO:0040014; GO:0046622; GO:0046872; GO:0048747; GO:0050796; GO:0060024; GO:0061337	plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; cardiac conduction [GO:0061337]; muscle fiber development [GO:0048747]; neuromuscular junction development [GO:0007528]; positive regulation of organ growth [GO:0046622]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of multicellular organism growth [GO:0040014]; rhythmic synaptic transmission [GO:0060024]
PGEN_.00g215740	Scaffold_10	30826344	30826777	NA	NA	NA	NA	NA
PGEN_.00g215750	Scaffold_10	30870153	30870785	NA	NA	NA	NA	NA
PGEN_.00g215760	Scaffold_10	30886393	30894857	Q86YS6	RAB43_HUMAN	Ras-related protein Rab-43 (Ras-related protein Rab-41)	GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0007030; GO:0019068; GO:0030670; GO:0032482; GO:0032588; GO:0035526; GO:0045335; GO:0070062; GO:0071346; GO:0090382; GO:1901998	"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; Rab protein signal transduction [GO:0032482]; retrograde transport, plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068]"
PGEN_.00g215770	Scaffold_10	30903124	30906682	NA	NA	NA	NA	NA
PGEN_.00g215780	Scaffold_10	30919167	30924994	B3EWZ3	CADN_ACRMI	Coadhesin (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g215790	Scaffold_10	30934020	30934874	NA	NA	NA	NA	NA
PGEN_.00g215800	Scaffold_10	30948800	30956834	NA	NA	NA	NA	NA
PGEN_.00g215810	Scaffold_10	30978009	30978422	NA	NA	NA	NA	NA
PGEN_.00g215820	Scaffold_10	30978534	30979543	NA	NA	NA	NA	NA
PGEN_.00g215830	Scaffold_10	30986533	30990777	NA	NA	NA	NA	NA
PGEN_.00g215840	Scaffold_10	30995508	31006920	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g215850	Scaffold_10	31023926	31032919	P07207	NOTCH_DROME	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	GO:0001708; GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0005915; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007455; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035003; GO:0035153; GO:0035162; GO:0035165; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043525; GO:0043697; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048	"adherens junction [GO:0005912]; cell [GO:0005623]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
PGEN_.00g215860	Scaffold_10	31033675	31035527	NA	NA	NA	NA	NA
PGEN_.00g215870	Scaffold_10	31110336	31111877	NA	NA	NA	NA	NA
PGEN_.00g215880	Scaffold_10	31129466	31141628	Q9WUB4	DCTN6_MOUSE	Dynactin subunit 6 (Dynactin subunit p27) (Protein WS-3)	GO:0000777; GO:0003824; GO:0005739; GO:0005813; GO:0005869; GO:0007005; GO:0007052; GO:0008610; GO:0070840	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; dynactin complex [GO:0005869]; mitochondrion [GO:0005739]; catalytic activity [GO:0003824]; dynein complex binding [GO:0070840]; lipid biosynthetic process [GO:0008610]; mitochondrion organization [GO:0007005]; mitotic spindle organization [GO:0007052]
PGEN_.00g215890	Scaffold_10	31180294	31180572	NA	NA	NA	NA	NA
PGEN_.00g215900	Scaffold_10	31181712	31186521	NA	NA	NA	NA	NA
PGEN_.00g215910	Scaffold_10	31209411	31245125	P09215	KPCD_RAT	Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	GO:0001666; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006979; GO:0007049; GO:0007568; GO:0008047; GO:0009408; GO:0009612; GO:0009749; GO:0010243; GO:0014070; GO:0016020; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030837; GO:0032079; GO:0032147; GO:0032613; GO:0032615; GO:0032869; GO:0032930; GO:0032956; GO:0032963; GO:0034351; GO:0034599; GO:0035307; GO:0035556; GO:0042100; GO:0042119; GO:0042149; GO:0042307; GO:0042325; GO:0042493; GO:0042542; GO:0042742; GO:0043065; GO:0043200; GO:0043406; GO:0043407; GO:0043410; GO:0043560; GO:0045471; GO:0046326; GO:0046627; GO:0046777; GO:0046872; GO:0048471; GO:0050732; GO:0051490; GO:0060326; GO:0070301; GO:0070779; GO:0070976; GO:0071447; GO:0090331; GO:0090398; GO:0099524; GO:1900163; GO:1904385; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; TIR domain binding [GO:0070976]; activation of protein kinase activity [GO:0032147]; aging [GO:0007568]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of phosphorylation [GO:0042325]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; termination of signal transduction [GO:0023021]
PGEN_.00g215920	Scaffold_10	31266332	31274221	P07746	HMGT_ONCMY	High mobility group-T protein (HMG-T) (HMG-T1) (HMG-1)	GO:0000790; GO:0003690	nuclear chromatin [GO:0000790]; double-stranded DNA binding [GO:0003690]
PGEN_.00g215930	Scaffold_10	31282682	31282996	NA	NA	NA	NA	NA
PGEN_.00g215940	Scaffold_10	31288863	31300209	NA	NA	NA	NA	NA
PGEN_.00g215950	Scaffold_10	31317883	31328101	NA	NA	NA	NA	NA
PGEN_.00g215960	Scaffold_10	31335825	31340349	NA	NA	NA	NA	NA
PGEN_.00g215970	Scaffold_10	31342578	31365902	Q6TEN1	RAP1B_DANRE	Ras-related protein Rap-1b	GO:0001756; GO:0003428; GO:0003924; GO:0004708; GO:0005525; GO:0005829; GO:0005886; GO:0005911; GO:0007507; GO:0019003; GO:0032486; GO:0032525; GO:0060026; GO:0060536; GO:0071320; GO:2000301	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; MAP kinase kinase activity [GO:0004708]; cartilage morphogenesis [GO:0060536]; cellular response to cAMP [GO:0071320]; chondrocyte intercalation involved in growth plate cartilage morphogenesis [GO:0003428]; convergent extension [GO:0060026]; heart development [GO:0007507]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; Rap protein signal transduction [GO:0032486]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]
PGEN_.00g215980	Scaffold_10	31374107	31386877	NA	NA	NA	NA	NA
PGEN_.00g215990	Scaffold_10	31429605	31503831	Q9QYS1	WNT16_MOUSE	Protein Wnt-16	GO:0005109; GO:0005615; GO:0005737; GO:0010628; GO:0014068; GO:0016055; GO:0030182; GO:0030216; GO:0043616; GO:0045165; GO:0046330; GO:0046849; GO:0060317; GO:0060548; GO:0090399; GO:0090403	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; frizzled binding [GO:0005109]; bone remodeling [GO:0046849]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399]; Wnt signaling pathway [GO:0016055]
PGEN_.00g216000	Scaffold_10	31504731	31515123	Q91WM3	U3IP2_MOUSE	U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K)	GO:0005730; GO:0006364; GO:0031428; GO:0032040; GO:0034511	box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; U3 snoRNA binding [GO:0034511]; rRNA processing [GO:0006364]
PGEN_.00g216010	Scaffold_10	31515800	31516132	NA	NA	NA	NA	NA
PGEN_.00g216020	Scaffold_10	31516498	31519971	NA	NA	NA	NA	NA
PGEN_.00g216030	Scaffold_10	31526513	31531266	Q9JJJ7	PORCN_MOUSE	Protein-serine O-palmitoleoyltransferase porcupine (mPORC) (EC 2.3.1.250)	GO:0005783; GO:0005789; GO:0006497; GO:0008374; GO:0009100; GO:0016055; GO:0017147; GO:0030176; GO:0032281; GO:0045234; GO:0060070; GO:0098978; GO:0099072; GO:1990698	AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; O-acyltransferase activity [GO:0008374]; palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; glycoprotein metabolic process [GO:0009100]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt signaling pathway [GO:0016055]
PGEN_.00g216040	Scaffold_10	31564974	31566231	NA	NA	NA	NA	NA
PGEN_.00g216050	Scaffold_10	31568463	31587629	NA	NA	NA	NA	NA
PGEN_.00g216060	Scaffold_10	31605298	31637529	NA	NA	NA	NA	NA
PGEN_.00g216070	Scaffold_10	31650943	31660580	NA	NA	NA	NA	NA
PGEN_.00g216080	Scaffold_10	31706082	31726091	Q2HJE4	UBP15_BOVIN	Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15)	GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005739; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0060389	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g216090	Scaffold_10	31737580	31744658	P51523	ZNF84_HUMAN	Zinc finger protein 84 (Zinc finger protein HPF2)	GO:0003677; GO:0005634; GO:0006355; GO:0008270	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g216100	Scaffold_10	31753071	31760563	NA	NA	NA	NA	NA
PGEN_.00g216110	Scaffold_10	31773333	31773644	NA	NA	NA	NA	NA
PGEN_.00g216120	Scaffold_10	31779354	31784084	P41971	ELK3_MOUSE	ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET)	GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0006357; GO:0030154; GO:0032422; GO:0042060; GO:0043565; GO:0045892; GO:0045944	"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; wound healing [GO:0042060]"
PGEN_.00g216130	Scaffold_10	31860007	31860648	NA	NA	NA	NA	NA
PGEN_.00g216140	Scaffold_10	31865764	31866072	Q98943	CASP2_CHICK	Caspase-2 (CASP-2) (EC 3.4.22.55) (ICH-1L/1S) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]	GO:0005737; GO:0006915; GO:0042981; GO:0097153; GO:0097192; GO:0097200	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]
PGEN_.00g216150	Scaffold_10	31871126	31874135	Q80UJ9	SETMR_MOUSE	Histone-lysine N-methyltransferase SETMAR (EC 2.1.1.-) (SET domain without mariner transposase fusion protein)	GO:0005634; GO:0005694; GO:0008270; GO:0010452; GO:0042800; GO:0046975; GO:0051568	chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; histone H3-K36 methylation [GO:0010452]; histone H3-K4 methylation [GO:0051568]
PGEN_.00g216160	Scaffold_10	31878342	31909885	NA	NA	NA	NA	NA
PGEN_.00g216170	Scaffold_10	31915907	31931050	NA	NA	NA	NA	NA
PGEN_.00g216180	Scaffold_10	31938795	31945476	NA	NA	NA	NA	NA
PGEN_.00g216190	Scaffold_10	32050024	32050980	NA	NA	NA	NA	NA
PGEN_.00g216200	Scaffold_10	32122669	32150554	O02298	GCY35_CAEEL	Soluble guanylate cyclase gcy-35 (EC 4.6.1.2)	GO:0004383; GO:0005525; GO:0005737; GO:0007610; GO:0009454; GO:0019825; GO:0019826; GO:0019934; GO:0020037; GO:0030425; GO:0043025; GO:0046872; GO:0050829; GO:0055093; GO:0070025; GO:0070026; GO:0070482	cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; carbon monoxide binding [GO:0070025]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; aerotaxis [GO:0009454]; behavior [GO:0007610]; cGMP-mediated signaling [GO:0019934]; defense response to Gram-negative bacterium [GO:0050829]; response to hyperoxia [GO:0055093]; response to oxygen levels [GO:0070482]
PGEN_.00g216210	Scaffold_10	32199920	32215870	Q09660	CC44_CAEEL	Probable cytochrome P450 CYP44 (EC 1.14.-.-)	GO:0004497; GO:0005506; GO:0016705; GO:0020037	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g216220	Scaffold_10	32219007	32224920	NA	NA	NA	NA	NA
PGEN_.00g216230	Scaffold_10	32299645	32310251	NA	NA	NA	NA	NA
PGEN_.00g216240	Scaffold_10	32335284	32355358	NA	NA	NA	NA	NA
PGEN_.00g216250	Scaffold_10	32357052	32361208	NA	NA	NA	NA	NA
PGEN_.00g216260	Scaffold_10	32411559	32411807	NA	NA	NA	NA	NA
PGEN_.00g216270	Scaffold_10	32412815	32419095	Q9Y2R2	PTN22_HUMAN	Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP)	GO:0004725; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006914; GO:0009898; GO:0010507; GO:0010628; GO:0010629; GO:0016791; GO:0017124; GO:0019900; GO:0030217; GO:0031625; GO:0031663; GO:0032481; GO:0032496; GO:0032720; GO:0032817; GO:0034141; GO:0034145; GO:0035644; GO:0043508; GO:0045088; GO:0048471; GO:0050852; GO:0050855; GO:0050860; GO:0050868; GO:0070374; GO:0070433; GO:0071225; GO:1900165; GO:1901222; GO:1902523; GO:1902715; GO:1903753; GO:2000483	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma secretion [GO:1902715]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]
PGEN_.00g216280	Scaffold_10	32466355	32475164	NA	NA	NA	NA	NA
PGEN_.00g216290	Scaffold_10	32485490	32510624	Q5XPI4	RN123_HUMAN	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	GO:0004842; GO:0005737; GO:0005829; GO:0016579; GO:0031965; GO:0046872; GO:0051603	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g216300	Scaffold_10	32511111	32531595	Q5XPI4	RN123_HUMAN	E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)	GO:0004842; GO:0005737; GO:0005829; GO:0016579; GO:0031965; GO:0046872; GO:0051603	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g216310	Scaffold_10	32536789	32561806	P50397	GDIB_BOVIN	Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2)	GO:0005093; GO:0005096; GO:0005737; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0017137	cytoplasm [GO:0005737]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]
PGEN_.00g216320	Scaffold_10	32570457	32581928	P42124	EZ_DROME	Histone-lysine N-methyltransferase E(z) (EC 2.1.1.-) (Lysine N-methyltransferase 6) (Protein enhancer of zeste)	GO:0000790; GO:0003677; GO:0005634; GO:0007411; GO:0016458; GO:0016571; GO:0022008; GO:0031062; GO:0034968; GO:0035097; GO:0035098; GO:0035186; GO:0042054; GO:0043565; GO:0045892; GO:0046974; GO:0046976; GO:0051567; GO:0070734; GO:1902692	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; sequence-specific DNA binding [GO:0043565]; axon guidance [GO:0007411]; gene silencing [GO:0016458]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone methylation [GO:0031062]; regulation of neuroblast proliferation [GO:1902692]; syncytial blastoderm mitotic cell cycle [GO:0035186]"
PGEN_.00g216330	Scaffold_10	32612839	32625126	Q4R381	EZH2_MACFA	Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.-) (Enhancer of zeste homolog 2)	GO:0000122; GO:0000978; GO:0003682; GO:0010718; GO:0018024; GO:0035098; GO:0042752; GO:0043406; GO:0043547; GO:0045814; GO:0045892; GO:0048387; GO:0048511; GO:0070734; GO:0071902; GO:1990841	"ESC/E(Z) complex [GO:0035098]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; histone H3-K27 methylation [GO:0070734]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]"
PGEN_.00g216340	Scaffold_10	32627233	32637826	Q7ZY86	TM168_XENLA	Transmembrane protein 168	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g216350	Scaffold_10	32648261	32650960	NA	NA	NA	NA	NA
PGEN_.00g216360	Scaffold_10	32652608	32658877	NA	NA	NA	NA	NA
PGEN_.00g216370	Scaffold_10	32667230	32670499	NA	NA	NA	NA	NA
PGEN_.00g216380	Scaffold_10	32724549	32740565	NA	NA	NA	NA	NA
PGEN_.00g216390	Scaffold_10	32744701	32747375	NA	NA	NA	NA	NA
PGEN_.00g216400	Scaffold_10	32753427	32763497	Q9BIW4	LIMD_DICDI	LIM domain-containing protein D	GO:0001891; GO:0005886; GO:0005938; GO:0006970; GO:0007015; GO:0015629; GO:0030010; GO:0030866; GO:0031143; GO:0031941; GO:0043327; GO:0044354; GO:0046872; GO:0051015; GO:0051017	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; filamentous actin [GO:0031941]; macropinosome [GO:0044354]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; chemotaxis to cAMP [GO:0043327]; cortical actin cytoskeleton organization [GO:0030866]; establishment of cell polarity [GO:0030010]; response to osmotic stress [GO:0006970]
PGEN_.00g216410	Scaffold_10	32765727	32774963	P16537	SPC3_STRPU	Protein SPEC3	GO:0000139; GO:0005929; GO:0016021	cilium [GO:0005929]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]
PGEN_.00g216420	Scaffold_10	32780008	32780811	NA	NA	NA	NA	NA
PGEN_.00g216430	Scaffold_10	32788713	32808734	Q93075	TATD2_HUMAN	Putative deoxyribonuclease TATDN2 (EC 3.1.21.-)	GO:0005634; GO:0005654; GO:0016888; GO:0036498; GO:0046872	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]"
PGEN_.00g216440	Scaffold_10	32819684	32822422	NA	NA	NA	NA	NA
PGEN_.00g216450	Scaffold_10	32837531	32850823	NA	NA	NA	NA	NA
PGEN_.00g216460	Scaffold_10	32873662	32893726	NA	NA	NA	NA	NA
PGEN_.00g216470	Scaffold_10	32901908	32919065	NA	NA	NA	NA	NA
PGEN_.00g216480	Scaffold_10	32926075	32937873	Q9VGZ5	CWO_DROME	Transcription factor cwo (Protein clockwork orange)	GO:0000122; GO:0000977; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0007623; GO:0009952; GO:0030154; GO:0032922; GO:0042752; GO:0046983; GO:0048813; GO:0050767	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dendrite morphogenesis [GO:0048813]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g216490	Scaffold_10	32951119	32952069	NA	NA	NA	NA	NA
PGEN_.00g216500	Scaffold_10	32953110	32972410	P50750	CDK9_HUMAN	Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit)	GO:0000307; GO:0000790; GO:0000978; GO:0001223; GO:0003677; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006282; GO:0006366; GO:0006367; GO:0006368; GO:0006468; GO:0008023; GO:0008024; GO:0008134; GO:0008283; GO:0008353; GO:0010613; GO:0016020; GO:0016301; GO:0016605; GO:0019901; GO:0030332; GO:0031056; GO:0031297; GO:0032968; GO:0033129; GO:0036464; GO:0042493; GO:0042795; GO:0044212; GO:0045944; GO:0050434; GO:0051147; GO:0070816; GO:0071157; GO:0071345; GO:0097322; GO:1900364; GO:1903839; GO:2001168	chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of viral transcription [GO:0050434]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]
PGEN_.00g216510	Scaffold_10	32985473	32996906	Q5RAL3	GRM3_PONAB	Metabotropic glutamate receptor 3 (mGluR3)	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g216520	Scaffold_10	33011250	33023211	Q9EPW2	KLF15_MOUSE	Krueppel-like factor 15 (Cardiovascular Krueppel-like factor)	GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001678; GO:0003677; GO:0003700; GO:0005623; GO:0005634; GO:0005654; GO:0006357; GO:0010001; GO:0010468; GO:0014898; GO:0032868; GO:0044212; GO:0045893; GO:0045944; GO:0046326; GO:0046872; GO:0072112; GO:1901653; GO:2000757	"cell [GO:0005623]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular glucose homeostasis [GO:0001678]; cellular response to peptide [GO:1901653]; glial cell differentiation [GO:0010001]; glomerular visceral epithelial cell differentiation [GO:0072112]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]"
PGEN_.00g216530	Scaffold_10	33043451	33049903	NA	NA	NA	NA	NA
PGEN_.00g216540	Scaffold_10	33056774	33067623	Q8BG94	COMD7_MOUSE	COMM domain-containing protein 7	GO:0031410; GO:0032088; GO:0033209; GO:0045892; GO:0051059	"cytoplasmic vesicle [GO:0031410]; NF-kappaB binding [GO:0051059]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"
PGEN_.00g216550	Scaffold_10	33068123	33073223	A5PMU4	ANS1B_DANRE	Ankyrin repeat and sterile alpha motif domain-containing protein 1B	GO:0005737; GO:1900383	cytoplasm [GO:0005737]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]
PGEN_.00g216560	Scaffold_10	33092773	33107282	NA	NA	NA	NA	NA
PGEN_.00g216570	Scaffold_10	33120854	33173519	Q9JME2	CHSTB_MOUSE	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)	GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]
PGEN_.00g216580	Scaffold_10	33196997	33205510	Q17LR9	MED20_AEDAE	Mediator of RNA polymerase II transcription subunit 20 (Mediator complex subunit 20)	GO:0003712; GO:0006357; GO:0016592	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g216590	Scaffold_10	33205854	33218118	P62307	RUXF_MOUSE	Small nuclear ribonucleoprotein F (snRNP-F) (Sm protein F) (Sm-F) (SmF)	GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005683; GO:0005685; GO:0005687; GO:0005689; GO:0005732; GO:0005829; GO:0008380; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]"
PGEN_.00g216600	Scaffold_10	33288293	33294405	Q7SXK5	HUTI_DANRE	Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1)	GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480	cytoplasm [GO:0005737]; imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]
PGEN_.00g216610	Scaffold_10	33303945	33314200	Q66HY7	IF4E3_DANRE	Eukaryotic translation initiation factor 4E type 3 (eIF-4E type 3) (eIF-4E3) (eIF4E type 3) (eIF4E-3)	GO:0000340; GO:0003743; GO:0005845; GO:0016281	eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]
PGEN_.00g216620	Scaffold_10	33337235	33346862	Q32P12	CQ053_MOUSE	Uncharacterized protein C17orf53 homolog		
PGEN_.00g216630	Scaffold_10	33347775	33352890	Q99LW0	ANR10_MOUSE	Ankyrin repeat domain-containing protein 10		
PGEN_.00g216640	Scaffold_10	33366292	33373124	P0CG71	UBIQ1_CAEEL	Polyubiquitin-A [Cleaved into: Ubiquitin; Ubiquitin-related]	GO:0005634; GO:0005737; GO:0016567; GO:0019941; GO:0031386; GO:0031625	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein tag [GO:0031386]; ubiquitin protein ligase binding [GO:0031625]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]
PGEN_.00g216650	Scaffold_10	33376302	33382227	B6LI37	U722_BRAFL	UPF0722 protein		
PGEN_.00g216660	Scaffold_10	33397952	33398434	NA	NA	NA	NA	NA
PGEN_.00g216670	Scaffold_10	33398481	33405148	NA	NA	NA	NA	NA
PGEN_.00g216680	Scaffold_10	33405330	33490117	NA	NA	NA	NA	NA
PGEN_.00g216690	Scaffold_10	33510881	33523553	NA	NA	NA	NA	NA
PGEN_.00g216700	Scaffold_10	33516106	33516528	NA	NA	NA	NA	NA
PGEN_.00g216710	Scaffold_10	33525837	33542143	Q13177	PAK2_HUMAN	Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)]	GO:0002223; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006469; GO:0006915; GO:0007165; GO:0014069; GO:0016310; GO:0018105; GO:0019901; GO:0023014; GO:0030296; GO:0031267; GO:0031295; GO:0032147; GO:0034333; GO:0035722; GO:0038095; GO:0040008; GO:0042802; GO:0043066; GO:0045296; GO:0046777; GO:0048010; GO:0048365; GO:0048471; GO:0050690; GO:0050731; GO:0050852; GO:0051493; GO:0051497; GO:0060996; GO:0070830; GO:0071407; GO:0098978; GO:0150105; GO:2001238; GO:2001271	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; activation of protein kinase activity [GO:0032147]; adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cellular response to organic cyclic compound [GO:0071407]; dendritic spine development [GO:0060996]; Fc-epsilon receptor signaling pathway [GO:0038095]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of cytoskeleton organization [GO:0051493]; regulation of defense response to virus by virus [GO:0050690]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]
PGEN_.00g216720	Scaffold_10	33587247	33587834	NA	NA	NA	NA	NA
PGEN_.00g216730	Scaffold_10	33588498	33592120	NA	NA	NA	NA	NA
PGEN_.00g216740	Scaffold_10	33598946	33601043	NA	NA	NA	NA	NA
PGEN_.00g216750	Scaffold_10	33671830	33672108	NA	NA	NA	NA	NA
PGEN_.00g216760	Scaffold_10	33672430	33672672	NA	NA	NA	NA	NA
PGEN_.00g216770	Scaffold_10	33693818	33698620	Q95P23	ENPP_APLCA	Enterin neuropeptides [Cleaved into: ENa; ENb; ENc; ENd; ENe; ENf; ENg; ENh; ENi; ENj; ENk; ENl; ENm; ENn; ENo; ENp; ENq; ENr; ENs; ENt]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g216780	Scaffold_10	33718302	33723024	NA	NA	NA	NA	NA
PGEN_.00g216790	Scaffold_10	33781580	33782014	NA	NA	NA	NA	NA
PGEN_.00g216800	Scaffold_10	33782852	33783484	NA	NA	NA	NA	NA
PGEN_.00g216810	Scaffold_10	33814621	33814836	NA	NA	NA	NA	NA
PGEN_.00g216820	Scaffold_10	33815464	33815790	NA	NA	NA	NA	NA
PGEN_.00g216830	Scaffold_10	33837327	33841851	NA	NA	NA	NA	NA
PGEN_.00g216840	Scaffold_10	33852528	33852842	NA	NA	NA	NA	NA
PGEN_.00g216850	Scaffold_10	33853565	33865692	NA	NA	NA	NA	NA
PGEN_.00g216860	Scaffold_10	33871103	33872292	P58780	ADA2_PIG	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	GO:0004000; GO:0005615; GO:0006154; GO:0008201; GO:0008270; GO:0031685; GO:0043394; GO:0046103	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]
PGEN_.00g216870	Scaffold_10	33872525	33883227	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g216880	Scaffold_10	33895808	33896128	NA	NA	NA	NA	NA
PGEN_.00g216890	Scaffold_10	33929182	33936119	NA	NA	NA	NA	NA
PGEN_.00g216900	Scaffold_10	33937850	33953170	Q3ZBV2	DD19A_BOVIN	ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box protein 19A)	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005643; GO:0010494; GO:0016973; GO:0031965	cytoplasmic stress granule [GO:0010494]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973]
PGEN_.00g216910	Scaffold_10	33959247	33966914	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g216920	Scaffold_10	33985342	34000223	NA	NA	NA	NA	NA
PGEN_.00g216930	Scaffold_10	34026508	34027047	NA	NA	NA	NA	NA
PGEN_.00g216940	Scaffold_10	34039859	34041566	Q32KH8	ARSH_CANLF	Arylsulfatase H (ASH) (EC 3.1.6.-)	GO:0004065; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]
PGEN_.00g216950	Scaffold_10	34041776	34042141	NA	NA	NA	NA	NA
PGEN_.00g216960	Scaffold_10	34042203	34042595	NA	NA	NA	NA	NA
PGEN_.00g216970	Scaffold_10	34042770	34043174	NA	NA	NA	NA	NA
PGEN_.00g216980	Scaffold_10	34044629	34067892	P15589	STS_RAT	Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)	GO:0004065; GO:0004773; GO:0005635; GO:0005789; GO:0007565; GO:0007611; GO:0008202; GO:0008284; GO:0008484; GO:0009268; GO:0014070; GO:0016021; GO:0043231; GO:0043434; GO:0043588; GO:0043627; GO:0046872	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; female pregnancy [GO:0007565]; learning or memory [GO:0007611]; positive regulation of cell population proliferation [GO:0008284]; response to estrogen [GO:0043627]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to pH [GO:0009268]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]
PGEN_.00g216990	Scaffold_10	34076454	34082512	Q3ZC89	MAP2_BOVIN	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)	GO:0005737; GO:0046872; GO:0070006; GO:0070084	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]
PGEN_.00g217000	Scaffold_10	34085640	34101209	Q9CQM0	NICN1_MOUSE	Nicolin-1 (Tubulin polyglutamylase complex subunit 5) (PGs5) (p24)	GO:0005654; GO:0005829; GO:0005874; GO:0018095	cytosol [GO:0005829]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; protein polyglutamylation [GO:0018095]
PGEN_.00g217010	Scaffold_10	34107608	34126751	Q9W2N0	CAPZA_DROME	F-actin-capping protein subunit alpha	GO:0000902; GO:0007015; GO:0007294; GO:0008290; GO:0010591; GO:0016324; GO:0030036; GO:0030479; GO:0030837; GO:0035220; GO:0046329; GO:0046982; GO:0051015; GO:0051016; GO:0051489; GO:0051490; GO:0051491; GO:0071203	actin cortical patch [GO:0030479]; apical plasma membrane [GO:0016324]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; germarium-derived oocyte fate determination [GO:0007294]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; positive regulation of filopodium assembly [GO:0051491]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]
PGEN_.00g217020	Scaffold_10	34146704	34152255	NA	NA	NA	NA	NA
PGEN_.00g217030	Scaffold_10	34152828	34153956	NA	NA	NA	NA	NA
PGEN_.00g217040	Scaffold_10	34169858	34180059	NA	NA	NA	NA	NA
PGEN_.00g217050	Scaffold_10	34211754	34214975	NA	NA	NA	NA	NA
PGEN_.00g217060	Scaffold_10	34219781	34235489	Q4JL91	IPPK_DANRE	"Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase) (InsP5 2-kinase)"	GO:0005524; GO:0005576; GO:0005623; GO:0005634; GO:0005737; GO:0005813; GO:0007368; GO:0032402; GO:0032958; GO:0035299; GO:0036064; GO:0052746; GO:0060287	cell [GO:0005623]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphorylation [GO:0052746]; melanosome transport [GO:0032402]
PGEN_.00g217070	Scaffold_10	34236147	34240579	NA	NA	NA	NA	NA
PGEN_.00g217080	Scaffold_10	34242174	34275466	Q9H8X2	IPPK_HUMAN	"Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) (IPK1 homolog) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase) (InsP5 2-kinase)"	GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0032958; GO:0035299; GO:0043647; GO:0052746; GO:0060090; GO:1901838	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; molecular adaptor activity [GO:0060090]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol phosphorylation [GO:0052746]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]
PGEN_.00g217090	Scaffold_10	34286256	34286918	P34743	BTG1_CHICK	Protein BTG1 (B-cell translocation gene 1 protein)	GO:0005634; GO:0005737; GO:0008285; GO:0019899; GO:0045603; GO:0045766; GO:0045930; GO:2000271	cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]
PGEN_.00g217100	Scaffold_10	34311547	34311885	NA	NA	NA	NA	NA
PGEN_.00g217110	Scaffold_10	34316388	34323669	NA	NA	NA	NA	NA
PGEN_.00g217120	Scaffold_10	34339876	34340280	NA	NA	NA	NA	NA
PGEN_.00g217130	Scaffold_10	34344920	34367251	Q61704	ITIH3_MOUSE	Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3)	GO:0004867; GO:0030212; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]
PGEN_.00g217140	Scaffold_10	34368133	34369214	NA	NA	NA	NA	NA
PGEN_.00g217150	Scaffold_10	34374513	34389053	Q7T010	GATB_DANRE	"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome c oxidase assembly factor PET112 homolog) (PET112-like)"	GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]
PGEN_.00g217160	Scaffold_10	34414473	34414958	NA	NA	NA	NA	NA
PGEN_.00g217170	Scaffold_10	34415052	34429637	F1R4Y7	CEP83_DANRE	Centrosomal protein of 83 kDa (Cep83) (Coiled-coil domain-containing protein 41)	GO:0005737; GO:0005814; GO:0048278; GO:0060271	centriole [GO:0005814]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]; vesicle docking [GO:0048278]
PGEN_.00g217180	Scaffold_10	34430449	34438822	NA	NA	NA	NA	NA
PGEN_.00g217190	Scaffold_10	34525839	34533787	NA	NA	NA	NA	NA
PGEN_.00g217200	Scaffold_10	34536733	34568961	A7Y2X0	SC6A5_XENLA	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (xGlyT2) (Solute carrier family 6 member 5)	GO:0005328; GO:0005886; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g217210	Scaffold_10	34570694	34575175	Q9BRZ2	TRI56_HUMAN	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING finger protein 109) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0003723; GO:0004842; GO:0005737; GO:0005829; GO:0008270; GO:0032479; GO:0032608; GO:0034340; GO:0051607; GO:0070534	cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340]
PGEN_.00g217220	Scaffold_10	34577093	34592607	Q9Y345	SC6A5_HUMAN	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g217230	Scaffold_10	34597679	34623911	O57382	TLL2_XENLA	Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid)	GO:0004222; GO:0005509; GO:0005576; GO:0007275; GO:0008270; GO:0030154	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]
PGEN_.00g217240	Scaffold_10	34627461	34671526	Q8BMG1	ATRIP_MOUSE	ATR-interacting protein (ATM and Rad3-related-interacting protein)	GO:0000077; GO:0005634; GO:0005654; GO:0006281; GO:0070530	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]
PGEN_.00g217250	Scaffold_10	34677702	34678961	NA	NA	NA	NA	NA
PGEN_.00g217260	Scaffold_10	34695058	34697580	Q8IS44	DRD2L_DROME	Dopamine D2-like receptor (DD2R)	GO:0001591; GO:0004930; GO:0004935; GO:0005887; GO:0007186; GO:0007188; GO:0007212; GO:0007615; GO:0008227; GO:0016021; GO:0045202; GO:0071880	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; adrenergic receptor activity [GO:0004935]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; anesthesia-resistant memory [GO:0007615]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]"
PGEN_.00g217270	Scaffold_10	34776623	34779728	NA	NA	NA	NA	NA
PGEN_.00g217280	Scaffold_10	34841781	34852308	NA	NA	NA	NA	NA
PGEN_.00g217290	Scaffold_10	34860524	34932197	Q9JIH7	WNK1_RAT	Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1)	GO:0000287; GO:0002028; GO:0003084; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0010766; GO:0010820; GO:0010923; GO:0016020; GO:0018105; GO:0019869; GO:0019870; GO:0019901; GO:0019902; GO:0023016; GO:0030291; GO:0030295; GO:0032414; GO:0033633; GO:0033673; GO:0034115; GO:0034260; GO:0035556; GO:0038116; GO:0046777; GO:0050794; GO:0050801; GO:0050852; GO:0071277; GO:0090188; GO:0090263; GO:0097022; GO:1903038; GO:1903288; GO:1990869; GO:2000651	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of kinase activity [GO:0033673]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852]
PGEN_.00g217300	Scaffold_10	34945307	34945699	NA	NA	NA	NA	NA
PGEN_.00g217310	Scaffold_10	34948342	34948839	NA	NA	NA	NA	NA
PGEN_.00g217320	Scaffold_10	34950957	34951220	NA	NA	NA	NA	NA
PGEN_.00g217330	Scaffold_10	34967113	35038571	Q9JIH7	WNK1_RAT	Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1)	GO:0000287; GO:0002028; GO:0003084; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0010766; GO:0010820; GO:0010923; GO:0016020; GO:0018105; GO:0019869; GO:0019870; GO:0019901; GO:0019902; GO:0023016; GO:0030291; GO:0030295; GO:0032414; GO:0033633; GO:0033673; GO:0034115; GO:0034260; GO:0035556; GO:0038116; GO:0046777; GO:0050794; GO:0050801; GO:0050852; GO:0071277; GO:0090188; GO:0090263; GO:0097022; GO:1903038; GO:1903288; GO:1990869; GO:2000651	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of kinase activity [GO:0033673]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852]
PGEN_.00g217340	Scaffold_10	35046799	35059569	NA	NA	NA	NA	NA
PGEN_.00g217350	Scaffold_10	35120453	35121079	NA	NA	NA	NA	NA
PGEN_.00g217360	Scaffold_10	35159542	35163777	NA	NA	NA	NA	NA
PGEN_.00g217370	Scaffold_10	35200965	35203487	P20905	5HT1R_DROME	5-hydroxytryptamine receptor 1 (5-HT receptor) (5HT-dro) (Serotonin receptor 1)	GO:0004930; GO:0004993; GO:0005887; GO:0007187; GO:0007192; GO:0007210; GO:0007268; GO:0007619; GO:0008227; GO:0016021; GO:0016543; GO:0016545; GO:0016546; GO:0030425; GO:0030594; GO:0045202; GO:0060179; GO:0060180	"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; female mating behavior [GO:0060180]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, proboscis-mediated licking [GO:0016546]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; serotonin receptor signaling pathway [GO:0007210]"
PGEN_.00g217380	Scaffold_10	35218151	35219410	NA	NA	NA	NA	NA
PGEN_.00g217390	Scaffold_10	35225090	35248894	Q8BMG1	ATRIP_MOUSE	ATR-interacting protein (ATM and Rad3-related-interacting protein)	GO:0000077; GO:0005634; GO:0005654; GO:0006281; GO:0070530	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]
PGEN_.00g217400	Scaffold_10	35252388	35269297	NA	NA	NA	NA	NA
PGEN_.00g217410	Scaffold_10	35275967	35283176	NA	NA	NA	NA	NA
PGEN_.00g217420	Scaffold_10	35283202	35298762	O57382	TLL2_XENLA	Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid)	GO:0004222; GO:0005509; GO:0005576; GO:0007275; GO:0008270; GO:0030154	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]
PGEN_.00g217430	Scaffold_10	35303542	35320828	Q9Y345	SC6A5_HUMAN	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g217440	Scaffold_10	35321790	35326265	Q9BRZ2	TRI56_HUMAN	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING finger protein 109) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0003723; GO:0004842; GO:0005737; GO:0005829; GO:0008270; GO:0032479; GO:0032608; GO:0034340; GO:0051607; GO:0070534	cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340]
PGEN_.00g217450	Scaffold_10	35327998	35344219	A7Y2X0	SC6A5_XENLA	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (xGlyT2) (Solute carrier family 6 member 5)	GO:0005328; GO:0005886; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g217460	Scaffold_10	35352438	35360291	P48065	S6A12_HUMAN	Sodium- and chloride-dependent betaine transporter (BGT-1) (Na(+)/Cl(-) betaine/GABA transporter) (Solute carrier family 6 member 12)	GO:0005332; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0016021; GO:0042165; GO:0043005	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; amino acid transport [GO:0006865]
PGEN_.00g217470	Scaffold_10	35363236	35370552	NA	NA	NA	NA	NA
PGEN_.00g217480	Scaffold_10	35457482	35465843	NA	NA	NA	NA	NA
PGEN_.00g217490	Scaffold_10	35466641	35481742	F1R4Y7	CEP83_DANRE	Centrosomal protein of 83 kDa (Cep83) (Coiled-coil domain-containing protein 41)	GO:0005737; GO:0005814; GO:0048278; GO:0060271	centriole [GO:0005814]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]; vesicle docking [GO:0048278]
PGEN_.00g217500	Scaffold_10	35507237	35521776	Q7T010	GATB_DANRE	"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome c oxidase assembly factor PET112 homolog) (PET112-like)"	GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]
PGEN_.00g217510	Scaffold_10	35527074	35528155	NA	NA	NA	NA	NA
PGEN_.00g217520	Scaffold_10	35529037	35551429	Q61704	ITIH3_MOUSE	Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3)	GO:0004867; GO:0030212; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]
PGEN_.00g217530	Scaffold_10	35556019	35556423	NA	NA	NA	NA	NA
PGEN_.00g217540	Scaffold_10	35572596	35580402	NA	NA	NA	NA	NA
PGEN_.00g217550	Scaffold_10	35584762	35585136	NA	NA	NA	NA	NA
PGEN_.00g217560	Scaffold_10	35609933	35610595	P34743	BTG1_CHICK	Protein BTG1 (B-cell translocation gene 1 protein)	GO:0005634; GO:0005737; GO:0008285; GO:0019899; GO:0045603; GO:0045766; GO:0045930; GO:2000271	cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]
PGEN_.00g217570	Scaffold_10	35627124	35654327	Q9H8X2	IPPK_HUMAN	"Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) (IPK1 homolog) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase) (InsP5 2-kinase)"	GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0032958; GO:0035299; GO:0043647; GO:0052746; GO:0060090; GO:1901838	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; molecular adaptor activity [GO:0060090]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol phosphorylation [GO:0052746]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]
PGEN_.00g217580	Scaffold_10	35664428	35675227	Q4JL91	IPPK_DANRE	"Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase) (InsP5 2-kinase)"	GO:0005524; GO:0005576; GO:0005623; GO:0005634; GO:0005737; GO:0005813; GO:0007368; GO:0032402; GO:0032958; GO:0035299; GO:0036064; GO:0052746; GO:0060287	cell [GO:0005623]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphorylation [GO:0052746]; melanosome transport [GO:0032402]
PGEN_.00g217590	Scaffold_10	35680012	35683233	NA	NA	NA	NA	NA
PGEN_.00g217600	Scaffold_10	35712616	35723568	NA	NA	NA	NA	NA
PGEN_.00g217610	Scaffold_10	35716263	35716484	NA	NA	NA	NA	NA
PGEN_.00g217620	Scaffold_10	35737733	35743736	NA	NA	NA	NA	NA
PGEN_.00g217630	Scaffold_10	35763802	35783012	Q9W2N0	CAPZA_DROME	F-actin-capping protein subunit alpha	GO:0000902; GO:0007015; GO:0007294; GO:0008290; GO:0010591; GO:0016324; GO:0030036; GO:0030479; GO:0030837; GO:0035220; GO:0046329; GO:0046982; GO:0051015; GO:0051016; GO:0051489; GO:0051490; GO:0051491; GO:0071203	actin cortical patch [GO:0030479]; apical plasma membrane [GO:0016324]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; germarium-derived oocyte fate determination [GO:0007294]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; positive regulation of filopodium assembly [GO:0051491]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220]
PGEN_.00g217640	Scaffold_10	35792536	35807682	Q9CQM0	NICN1_MOUSE	Nicolin-1 (Tubulin polyglutamylase complex subunit 5) (PGs5) (p24)	GO:0005654; GO:0005829; GO:0005874; GO:0018095	cytosol [GO:0005829]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; protein polyglutamylation [GO:0018095]
PGEN_.00g217650	Scaffold_10	35810796	35815546	Q3ZC89	MAP2_BOVIN	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)	GO:0005737; GO:0046872; GO:0070006; GO:0070084	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084]
PGEN_.00g217660	Scaffold_10	35829161	35848777	P15589	STS_RAT	Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)	GO:0004065; GO:0004773; GO:0005635; GO:0005789; GO:0007565; GO:0007611; GO:0008202; GO:0008284; GO:0008484; GO:0009268; GO:0014070; GO:0016021; GO:0043231; GO:0043434; GO:0043588; GO:0043627; GO:0046872	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; female pregnancy [GO:0007565]; learning or memory [GO:0007611]; positive regulation of cell population proliferation [GO:0008284]; response to estrogen [GO:0043627]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to pH [GO:0009268]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]
PGEN_.00g217670	Scaffold_10	35850219	35850623	NA	NA	NA	NA	NA
PGEN_.00g217680	Scaffold_10	35850798	35851190	NA	NA	NA	NA	NA
PGEN_.00g217690	Scaffold_10	35851252	35851617	NA	NA	NA	NA	NA
PGEN_.00g217700	Scaffold_10	35851827	35854840	NA	NA	NA	NA	NA
PGEN_.00g217710	Scaffold_10	35867404	35867883	NA	NA	NA	NA	NA
PGEN_.00g217720	Scaffold_10	35894147	35908196	NA	NA	NA	NA	NA
PGEN_.00g217730	Scaffold_10	35934924	35942145	Q86TL2	STIMA_HUMAN	Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110)	GO:0005246; GO:0005789; GO:0016020; GO:0016021; GO:0032237; GO:0032541; GO:0035584; GO:0070886; GO:0140268	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel regulator activity [GO:0005246]; activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]
PGEN_.00g217740	Scaffold_10	35954001	35987102	Q78TU8	F107A_MOUSE	Actin-associated protein FAM107A	GO:0001558; GO:0001725; GO:0003779; GO:0005634; GO:0005737; GO:0005925; GO:0007049; GO:0015629; GO:0016607; GO:0030041; GO:0030335; GO:0031398; GO:0031647; GO:0031669; GO:0032587; GO:0032956; GO:0043005; GO:0045202; GO:0050890; GO:0051017; GO:0051895; GO:0070507; GO:0071385; GO:1900272; GO:2000134	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; stress fiber [GO:0001725]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cell cycle [GO:0007049]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to nutrient levels [GO:0031669]; cognition [GO:0050890]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of long-term synaptic potentiation [GO:1900272]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein stability [GO:0031647]
PGEN_.00g217750	Scaffold_10	35988769	35989020	NA	NA	NA	NA	NA
PGEN_.00g217760	Scaffold_10	35994547	36002715	NA	NA	NA	NA	NA
PGEN_.00g217770	Scaffold_10	36007542	36032828	NA	NA	NA	NA	NA
PGEN_.00g217780	Scaffold_10	36059440	36060732	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g217790	Scaffold_10	36062202	36063842	NA	NA	NA	NA	NA
PGEN_.00g217800	Scaffold_10	36076941	36094895	Q6IC98	GRAM4_HUMAN	GRAM domain-containing protein 4 (Death-inducing protein)	GO:0005739; GO:0005789; GO:0006915; GO:0016021; GO:0031966; GO:0034164; GO:0043280	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]
PGEN_.00g217810	Scaffold_10	36106697	36132481	P29375	KDM5A_HUMAN	Lysine-specific demethylase 5A (EC 1.14.11.-) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2)	GO:0000122; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0033169; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0044212; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"
PGEN_.00g217820	Scaffold_10	36133030	36148005	Q6DFC2	CCD77_XENLA	Coiled-coil domain-containing protein 77		
PGEN_.00g217830	Scaffold_10	36151460	36152593	NA	NA	NA	NA	NA
PGEN_.00g217840	Scaffold_10	36152665	36154374	NA	NA	NA	NA	NA
PGEN_.00g217850	Scaffold_10	36154618	36158543	NA	NA	NA	NA	NA
PGEN_.00g217860	Scaffold_10	36170542	36174322	NA	NA	NA	NA	NA
PGEN_.00g217870	Scaffold_10	36193131	36198704	NA	NA	NA	NA	NA
PGEN_.00g217880	Scaffold_10	36210992	36212206	Q6ZFH6	RCN11_ORYSJ	"Beta-1,2-xylosyltransferase RCN11 (OsXylT) (EC 2.4.2.-) (Protein REDUCED CULM NUMBER 11)"	GO:0000139; GO:0005797; GO:0006487; GO:0016021; GO:0031204; GO:0035252; GO:0048367; GO:0050513	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein 2-beta-D-xylosyltransferase activity [GO:0050513]; UDP-xylosyltransferase activity [GO:0035252]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein N-linked glycosylation [GO:0006487]; shoot system development [GO:0048367]"
PGEN_.00g217890	Scaffold_10	36236159	36279559	Q99758	ABCA3_HUMAN	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]
PGEN_.00g217900	Scaffold_10	36279695	36280144	NA	NA	NA	NA	NA
PGEN_.00g217910	Scaffold_10	36280423	36280632	NA	NA	NA	NA	NA
PGEN_.00g217920	Scaffold_10	36280972	36281247	NA	NA	NA	NA	NA
PGEN_.00g217930	Scaffold_10	36298550	36298852	NA	NA	NA	NA	NA
PGEN_.00g217940	Scaffold_10	36320362	36332442	Q6P6B7	ANR16_HUMAN	Ankyrin repeat domain-containing protein 16	GO:0005634; GO:0005737; GO:0006400	cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA modification [GO:0006400]
PGEN_.00g217950	Scaffold_10	36344109	36395068	NA	NA	NA	NA	NA
PGEN_.00g217960	Scaffold_10	36610477	36623437	NA	NA	NA	NA	NA
PGEN_.00g217970	Scaffold_10	36614258	36614644	NA	NA	NA	NA	NA
PGEN_.00g217980	Scaffold_10	36623580	36634040	NA	NA	NA	NA	NA
PGEN_.00g217990	Scaffold_10	36637297	36637650	NA	NA	NA	NA	NA
PGEN_.00g218000	Scaffold_10	36653037	36656681	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g218010	Scaffold_10	36662354	36662695	NA	NA	NA	NA	NA
PGEN_.00g218020	Scaffold_10	36662749	36663648	NA	NA	NA	NA	NA
PGEN_.00g218030	Scaffold_10	36677702	36679303	NA	NA	NA	NA	NA
PGEN_.00g218040	Scaffold_10	36695120	36696843	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g218050	Scaffold_10	36740816	36744065	NA	NA	NA	NA	NA
PGEN_.00g218060	Scaffold_10	36756872	36761772	Q647I9	NALP5_BOVIN	"NACHT, LRR and PYD domains-containing protein 5 (Mater protein homolog)"	GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005938; GO:0042585; GO:0048471	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]
PGEN_.00g218070	Scaffold_10	36775776	36783985	A8WIP6	CDK20_DANRE	Cyclin-dependent kinase 20 (EC 2.7.11.22) (Cell cycle-related kinase) (Cell division protein kinase 20)	GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0006468; GO:0007049; GO:0007275; GO:0051301; GO:0060271	cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; multicellular organism development [GO:0007275]; protein phosphorylation [GO:0006468]
PGEN_.00g218080	Scaffold_10	36872020	36876358	NA	NA	NA	NA	NA
PGEN_.00g218090	Scaffold_10	36880038	36893652	Q4R335	S41A2_MACFA	Solute carrier family 41 member 2	GO:0008324; GO:0016021	integral component of membrane [GO:0016021]; cation transmembrane transporter activity [GO:0008324]
PGEN_.00g218100	Scaffold_10	36905745	36921819	P49137	MAPK2_HUMAN	MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1)	GO:0000165; GO:0000187; GO:0002224; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0006691; GO:0006954; GO:0006974; GO:0009931; GO:0018105; GO:0032496; GO:0032675; GO:0032680; GO:0034097; GO:0035556; GO:0035924; GO:0038066; GO:0042535; GO:0043488; GO:0044351; GO:0046777; GO:0048010; GO:0048839; GO:0051019; GO:0070062; GO:0070935; GO:1900034	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; activation of MAPK activity [GO:0000187]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; leukotriene metabolic process [GO:0006691]; macropinocytosis [GO:0044351]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of interleukin-6 production [GO:0032675]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]
PGEN_.00g218110	Scaffold_10	36986794	36989013	Q7KMJ6	NITO_DROME	RNA-binding protein spenito	GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0007548; GO:0010628; GO:0030154; GO:0035222; GO:0036396; GO:0048749; GO:0071011; GO:0080009; GO:0090263; GO:2000737	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]"
PGEN_.00g218120	Scaffold_10	36994366	36995173	NA	NA	NA	NA	NA
PGEN_.00g218130	Scaffold_10	37012355	37051468	O15083	ERC2_HUMAN	ERC protein 2	GO:0005856; GO:0016082; GO:0030054; GO:0030426; GO:0042734; GO:0048786; GO:0098831; GO:0098882; GO:0098978; GO:0098982	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; structural constituent of presynaptic active zone [GO:0098882]; synaptic vesicle priming [GO:0016082]
PGEN_.00g218140	Scaffold_10	37052274	37068096	P43352	RAD52_MOUSE	DNA repair protein RAD52 homolog	GO:0000724; GO:0000730; GO:0003677; GO:0003697; GO:0005634; GO:0006310; GO:0006312; GO:0006974; GO:0010792; GO:0032991; GO:0032993; GO:0034599; GO:0042802; GO:0045002; GO:0051260; GO:2000819	nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to oxidative stress [GO:0034599]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via single-strand annealing [GO:0045002]; mitotic recombination [GO:0006312]; protein homooligomerization [GO:0051260]; regulation of nucleotide-excision repair [GO:2000819]
PGEN_.00g218150	Scaffold_10	37072529	37073053	NA	NA	NA	NA	NA
PGEN_.00g218160	Scaffold_10	37073973	37078244	NA	NA	NA	NA	NA
PGEN_.00g218170	Scaffold_10	37100189	37119733	Q08879	FBLN1_MOUSE	Fibulin-1 (FIBL-1) (Basement-membrane protein 90) (BM-90)	GO:0001933; GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007162; GO:0007566; GO:0008022; GO:0010628; GO:0016504; GO:0030198; GO:0031012; GO:0042802; GO:0044877; GO:0048146; GO:0062023; GO:0070051; GO:0070373; GO:0071953; GO:0072378; GO:1900025; GO:1904188; GO:1904237; GO:2000146; GO:2000647; GO:2001202	"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]"
PGEN_.00g218180	Scaffold_10	37122382	37123711	NA	NA	NA	NA	NA
PGEN_.00g218190	Scaffold_10	37128173	37145096	Q86UP9	LHPL3_HUMAN	LHFPL tetraspan subfamily member 3 protein (Lipoma HMGIC fusion partner-like 3 protein)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g218200	Scaffold_10	37149206	37151391	NA	NA	NA	NA	NA
PGEN_.00g218210	Scaffold_10	37154823	37187080	Q86UP9	LHPL3_HUMAN	LHFPL tetraspan subfamily member 3 protein (Lipoma HMGIC fusion partner-like 3 protein)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g218220	Scaffold_10	37205508	37226707	O43913	ORC5_HUMAN	Origin recognition complex subunit 5	GO:0000082; GO:0000166; GO:0000784; GO:0000785; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270; GO:0006275	"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of DNA replication [GO:0006275]"
PGEN_.00g218230	Scaffold_10	37274019	37313573	P58751	RELN_RAT	Reelin (EC 3.4.21.-)	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007494; GO:0007612; GO:0007613; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0009612; GO:0009636; GO:0009725; GO:0010001; GO:0010226; GO:0010468; GO:0010976; GO:0014068; GO:0014070; GO:0016358; GO:0016477; GO:0017085; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021769; GO:0021800; GO:0021819; GO:0021854; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032570; GO:0032793; GO:0035176; GO:0035418; GO:0038026; GO:0042493; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0045471; GO:0045860; GO:0046872; GO:0048265; GO:0048678; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051412; GO:0051602; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0070542; GO:0071549; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; midgut development [GO:0007494]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"
PGEN_.00g218240	Scaffold_10	37414348	37417034	P58751	RELN_RAT	Reelin (EC 3.4.21.-)	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007494; GO:0007612; GO:0007613; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0009612; GO:0009636; GO:0009725; GO:0010001; GO:0010226; GO:0010468; GO:0010976; GO:0014068; GO:0014070; GO:0016358; GO:0016477; GO:0017085; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021769; GO:0021800; GO:0021819; GO:0021854; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032570; GO:0032793; GO:0035176; GO:0035418; GO:0038026; GO:0042493; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0045471; GO:0045860; GO:0046872; GO:0048265; GO:0048678; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051412; GO:0051602; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0070542; GO:0071549; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; midgut development [GO:0007494]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"
PGEN_.00g218250	Scaffold_10	37426421	37426741	NA	NA	NA	NA	NA
PGEN_.00g218260	Scaffold_10	37427336	37460706	Q6P2K3	CC067_MOUSE	Uncharacterized protein C3orf67 homolog		
PGEN_.00g218270	Scaffold_10	37471375	37476454	P06620	ICEN_PSESY	Ice nucleation protein	GO:0009279; GO:0050825	cell outer membrane [GO:0009279]; ice binding [GO:0050825]
PGEN_.00g218280	Scaffold_10	37487751	37499329	NA	NA	NA	NA	NA
PGEN_.00g218290	Scaffold_10	37504340	37504681	NA	NA	NA	NA	NA
PGEN_.00g218300	Scaffold_10	37524725	37531800	Q8WZ42	TITIN_HUMAN	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030017; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0071688; GO:0097493	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
PGEN_.00g218310	Scaffold_10	37539098	37555272	Q28CQ7	SUV92_XENTR	Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)	GO:0000775; GO:0005634; GO:0007049; GO:0008270; GO:0030154; GO:0034968; GO:0046974	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]"
PGEN_.00g218320	Scaffold_10	37623078	37630371	Q96PZ0	PUS7_HUMAN	Pseudouridylate synthase 7 homolog (EC 5.4.99.-)	GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380	nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]
PGEN_.00g218330	Scaffold_10	37638323	37679182	Q96QE2	MYCT_HUMAN	Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13)	GO:0005366; GO:0005886; GO:0005887; GO:0015798	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]
PGEN_.00g218340	Scaffold_10	37681686	37696127	Q9D8P7	TF3C6_MOUSE	General transcription factor 3C polypeptide 6 (Transcription factor IIIC 35 kDa subunit) (TFIIIC 35 kDa subunit) (TFIIIC35) (Transcription factor IIIC subunit 6)	GO:0000127; GO:0003677; GO:0005654; GO:0006383; GO:0016604	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g218350	Scaffold_10	37705698	37715603	Q7T2L7	I17RD_CHICK	Interleukin-17 receptor D (IL-17 receptor D) (IL-17RD) (Sef homolog) (cSEF)	GO:0016021; GO:0030368	integral component of membrane [GO:0016021]; interleukin-17 receptor activity [GO:0030368]
PGEN_.00g218360	Scaffold_10	37719949	37732295	NA	NA	NA	NA	NA
PGEN_.00g218370	Scaffold_10	37735247	37736650	NA	NA	NA	NA	NA
PGEN_.00g218380	Scaffold_10	37743388	37757538	NA	NA	NA	NA	NA
PGEN_.00g218390	Scaffold_10	37783807	37793626	Q9H4I3	TRABD_HUMAN	TraB domain-containing protein (Protein TTG2)		
PGEN_.00g218400	Scaffold_10	37797664	37811546	Q9ERV7	PIDD1_MOUSE	p53-induced death domain-containing protein 1 (EC 3.4.21.-) (Leucine-rich repeat and death domain-containing protein) [Cleaved into: PIDD-N; PIDD-C; PIDD-CC]	GO:0004175; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0008625; GO:0016540; GO:0043066; GO:0043122; GO:0097190; GO:0097191	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; protein autoprocessing [GO:0016540]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]"
PGEN_.00g218410	Scaffold_10	37818728	37826016	NA	NA	NA	NA	NA
PGEN_.00g218420	Scaffold_10	37837040	37839199	Q3URR7	ZSC10_MOUSE	Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206)	GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0046872; GO:0048863	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]"
PGEN_.00g218430	Scaffold_10	37850830	37856668	Q8BGT5	ALAT2_MOUSE	Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)	GO:0004021; GO:0005615; GO:0005739; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853; GO:0045722	extracellular space [GO:0005615]; mitochondrion [GO:0005739]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]; positive regulation of gluconeogenesis [GO:0045722]
PGEN_.00g218440	Scaffold_10	37892447	37893688	Q5TZE1	BTB6B_DANRE	BTB/POZ domain-containing protein 6-B	GO:0005634; GO:0005829; GO:0022008	cytosol [GO:0005829]; nucleus [GO:0005634]; neurogenesis [GO:0022008]
PGEN_.00g218450	Scaffold_10	37897720	37909583	NA	NA	NA	NA	NA
PGEN_.00g218460	Scaffold_10	37926532	37935762	P86729	EPDR2_HALAI	Ependymin-related protein 2	GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g218470	Scaffold_10	37942795	37962271	O14594	NCAN_HUMAN	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0043202	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]
PGEN_.00g218480	Scaffold_10	37962305	37964415	NA	NA	NA	NA	NA
PGEN_.00g218490	Scaffold_10	37965049	37965561	NA	NA	NA	NA	NA
PGEN_.00g218500	Scaffold_10	37973044	37982167	P86729	EPDR2_HALAI	Ependymin-related protein 2	GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g218510	Scaffold_10	37991100	38010033	NA	NA	NA	NA	NA
PGEN_.00g218520	Scaffold_10	38012625	38015249	Q9Y2F9	BTBD3_HUMAN	BTB/POZ domain-containing protein 3	GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813	cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]
PGEN_.00g218530	Scaffold_10	38050913	38056755	Q8BGT5	ALAT2_MOUSE	Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)	GO:0004021; GO:0005615; GO:0005739; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853; GO:0045722	extracellular space [GO:0005615]; mitochondrion [GO:0005739]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]; positive regulation of gluconeogenesis [GO:0045722]
PGEN_.00g218540	Scaffold_10	38068348	38070507	Q3URR7	ZSC10_MOUSE	Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206)	GO:0003700; GO:0005634; GO:0043565; GO:0045892; GO:0046872; GO:0048863	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; stem cell differentiation [GO:0048863]"
PGEN_.00g218550	Scaffold_10	38081595	38089053	NA	NA	NA	NA	NA
PGEN_.00g218560	Scaffold_10	38096013	38109612	Q9ERV7	PIDD1_MOUSE	p53-induced death domain-containing protein 1 (EC 3.4.21.-) (Leucine-rich repeat and death domain-containing protein) [Cleaved into: PIDD-N; PIDD-C; PIDD-CC]	GO:0004175; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0008625; GO:0016540; GO:0043066; GO:0043122; GO:0097190; GO:0097191	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; protein autoprocessing [GO:0016540]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]"
PGEN_.00g218570	Scaffold_10	38113651	38123490	Q9H4I3	TRABD_HUMAN	TraB domain-containing protein (Protein TTG2)		
PGEN_.00g218580	Scaffold_10	38142279	38163086	NA	NA	NA	NA	NA
PGEN_.00g218590	Scaffold_10	38169838	38186190	NA	NA	NA	NA	NA
PGEN_.00g218600	Scaffold_10	38190497	38200402	Q7T2L7	I17RD_CHICK	Interleukin-17 receptor D (IL-17 receptor D) (IL-17RD) (Sef homolog) (cSEF)	GO:0016021; GO:0030368	integral component of membrane [GO:0016021]; interleukin-17 receptor activity [GO:0030368]
PGEN_.00g218610	Scaffold_10	38208769	38221638	Q9D8P7	TF3C6_MOUSE	General transcription factor 3C polypeptide 6 (Transcription factor IIIC 35 kDa subunit) (TFIIIC 35 kDa subunit) (TFIIIC35) (Transcription factor IIIC subunit 6)	GO:0000127; GO:0003677; GO:0005654; GO:0006383; GO:0016604	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g218620	Scaffold_10	38224142	38262326	Q96QE2	MYCT_HUMAN	Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13)	GO:0005366; GO:0005886; GO:0005887; GO:0015798	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myo-inositol:proton symporter activity [GO:0005366]; myo-inositol transport [GO:0015798]
PGEN_.00g218630	Scaffold_10	38270248	38278104	Q96PZ0	PUS7_HUMAN	Pseudouridylate synthase 7 homolog (EC 5.4.99.-)	GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380	nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]
PGEN_.00g218640	Scaffold_10	38345833	38362008	Q28CQ7	SUV92_XENTR	Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2)	GO:0000775; GO:0005634; GO:0007049; GO:0008270; GO:0030154; GO:0034968; GO:0046974	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; histone lysine methylation [GO:0034968]"
PGEN_.00g218650	Scaffold_10	38367649	38374254	A2ASS6	TITIN_MOUSE	Titin (EC 2.7.11.1) (Connectin)	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]
PGEN_.00g218660	Scaffold_10	38393559	38405397	NA	NA	NA	NA	NA
PGEN_.00g218670	Scaffold_10	38416668	38421802	O33479	ICEV_PSESX	Ice nucleation protein	GO:0009279; GO:0050825	cell outer membrane [GO:0009279]; ice binding [GO:0050825]
PGEN_.00g218680	Scaffold_10	38432483	38466303	Q6P2K3	CC067_MOUSE	Uncharacterized protein C3orf67 homolog		
PGEN_.00g218690	Scaffold_10	38476646	38479338	P58751	RELN_RAT	Reelin (EC 3.4.21.-)	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007494; GO:0007612; GO:0007613; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0009612; GO:0009636; GO:0009725; GO:0010001; GO:0010226; GO:0010468; GO:0010976; GO:0014068; GO:0014070; GO:0016358; GO:0016477; GO:0017085; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021769; GO:0021800; GO:0021819; GO:0021854; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032570; GO:0032793; GO:0035176; GO:0035418; GO:0038026; GO:0042493; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0045471; GO:0045860; GO:0046872; GO:0048265; GO:0048678; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051412; GO:0051602; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0070542; GO:0071549; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; midgut development [GO:0007494]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"
PGEN_.00g218700	Scaffold_10	38580192	38617872	P58751	RELN_RAT	Reelin (EC 3.4.21.-)	GO:0000904; GO:0001764; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007494; GO:0007612; GO:0007613; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0009612; GO:0009636; GO:0009725; GO:0010001; GO:0010226; GO:0010468; GO:0010976; GO:0014068; GO:0014070; GO:0016358; GO:0016477; GO:0017085; GO:0018108; GO:0021511; GO:0021517; GO:0021542; GO:0021766; GO:0021769; GO:0021800; GO:0021819; GO:0021854; GO:0021987; GO:0030424; GO:0030425; GO:0030900; GO:0031012; GO:0032008; GO:0032570; GO:0032793; GO:0035176; GO:0035418; GO:0038026; GO:0042493; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0045471; GO:0045860; GO:0046872; GO:0048265; GO:0048678; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051412; GO:0051602; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0070542; GO:0071549; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	"axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain development [GO:0030900]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; learning [GO:0007612]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; midgut development [GO:0007494]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of gene expression [GO:0010468]; regulation of NMDA receptor activity [GO:2000310]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"
PGEN_.00g218710	Scaffold_10	38665564	38670819	O43913	ORC5_HUMAN	Origin recognition complex subunit 5	GO:0000082; GO:0000166; GO:0000784; GO:0000785; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270; GO:0006275	"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of DNA replication [GO:0006275]"
PGEN_.00g218720	Scaffold_10	38680426	38687188	O43913	ORC5_HUMAN	Origin recognition complex subunit 5	GO:0000082; GO:0000166; GO:0000784; GO:0000785; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270; GO:0006275	"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of DNA replication [GO:0006275]"
PGEN_.00g218730	Scaffold_10	38706619	38707038	Q6DHB5	LHPL3_DANRE	LHFPL tetraspan subfamily member 3 protein (Lipoma HMGIC fusion partner-like 3 protein)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g218740	Scaffold_10	38735743	38739190	Q86UP9	LHPL3_HUMAN	LHFPL tetraspan subfamily member 3 protein (Lipoma HMGIC fusion partner-like 3 protein)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g218750	Scaffold_10	38742613	38744702	NA	NA	NA	NA	NA
PGEN_.00g218760	Scaffold_10	38749263	38765992	Q86UP9	LHPL3_HUMAN	LHFPL tetraspan subfamily member 3 protein (Lipoma HMGIC fusion partner-like 3 protein)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g218770	Scaffold_10	38770452	38771781	NA	NA	NA	NA	NA
PGEN_.00g218780	Scaffold_10	38774430	38793053	Q8MJJ9	FBLN1_CHLAE	Fibulin-1 (FIBL-1) (Fragment)	GO:0005509; GO:0016504; GO:0030198; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; peptidase activator activity [GO:0016504]; extracellular matrix organization [GO:0030198]
PGEN_.00g218790	Scaffold_10	38814998	38819269	NA	NA	NA	NA	NA
PGEN_.00g218800	Scaffold_10	38819918	38820666	NA	NA	NA	NA	NA
PGEN_.00g218810	Scaffold_10	38825042	38840558	P43352	RAD52_MOUSE	DNA repair protein RAD52 homolog	GO:0000724; GO:0000730; GO:0003677; GO:0003697; GO:0005634; GO:0006310; GO:0006312; GO:0006974; GO:0010792; GO:0032991; GO:0032993; GO:0034599; GO:0042802; GO:0045002; GO:0051260; GO:2000819	nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to oxidative stress [GO:0034599]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via single-strand annealing [GO:0045002]; mitotic recombination [GO:0006312]; protein homooligomerization [GO:0051260]; regulation of nucleotide-excision repair [GO:2000819]
PGEN_.00g218820	Scaffold_10	38841363	38881193	O15083	ERC2_HUMAN	ERC protein 2	GO:0005856; GO:0016082; GO:0030054; GO:0030426; GO:0042734; GO:0048786; GO:0098831; GO:0098882; GO:0098978; GO:0098982	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; structural constituent of presynaptic active zone [GO:0098882]; synaptic vesicle priming [GO:0016082]
PGEN_.00g218830	Scaffold_10	38898379	38899174	NA	NA	NA	NA	NA
PGEN_.00g218840	Scaffold_10	38904461	38906680	Q7KMJ6	NITO_DROME	RNA-binding protein spenito	GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0007548; GO:0010628; GO:0030154; GO:0035222; GO:0036396; GO:0048749; GO:0071011; GO:0080009; GO:0090263; GO:2000737	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222]"
PGEN_.00g218850	Scaffold_10	38972893	38988844	P49137	MAPK2_HUMAN	MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1)	GO:0000165; GO:0000187; GO:0002224; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0006691; GO:0006954; GO:0006974; GO:0009931; GO:0018105; GO:0032496; GO:0032675; GO:0032680; GO:0034097; GO:0035556; GO:0035924; GO:0038066; GO:0042535; GO:0043488; GO:0044351; GO:0046777; GO:0048010; GO:0048839; GO:0051019; GO:0070062; GO:0070935; GO:1900034	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; activation of MAPK activity [GO:0000187]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; leukotriene metabolic process [GO:0006691]; macropinocytosis [GO:0044351]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of interleukin-6 production [GO:0032675]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]
PGEN_.00g218860	Scaffold_10	39001556	39015512	Q5R839	S41A1_PONAB	Solute carrier family 41 member 1	GO:0005623; GO:0010961; GO:0015095; GO:0016021; GO:0016323; GO:0032991; GO:0061768; GO:0071286; GO:0072509	basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]
PGEN_.00g218870	Scaffold_10	39019194	39023606	NA	NA	NA	NA	NA
PGEN_.00g218880	Scaffold_10	39112304	39120713	A8WIP6	CDK20_DANRE	Cyclin-dependent kinase 20 (EC 2.7.11.22) (Cell cycle-related kinase) (Cell division protein kinase 20)	GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0006468; GO:0007049; GO:0007275; GO:0051301; GO:0060271	cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; multicellular organism development [GO:0007275]; protein phosphorylation [GO:0006468]
PGEN_.00g218890	Scaffold_10	39134345	39139257	Q7RTR2	NLRC3_HUMAN	"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)"	GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]
PGEN_.00g218900	Scaffold_10	39152023	39155288	NA	NA	NA	NA	NA
PGEN_.00g218910	Scaffold_10	39199551	39201274	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g218920	Scaffold_10	39217024	39218628	NA	NA	NA	NA	NA
PGEN_.00g218930	Scaffold_10	39232298	39233197	NA	NA	NA	NA	NA
PGEN_.00g218940	Scaffold_10	39233251	39233592	NA	NA	NA	NA	NA
PGEN_.00g218950	Scaffold_10	39239659	39243307	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g218960	Scaffold_10	39258664	39259017	NA	NA	NA	NA	NA
PGEN_.00g218970	Scaffold_10	39262938	39273741	NA	NA	NA	NA	NA
PGEN_.00g218980	Scaffold_10	39273884	39287024	NA	NA	NA	NA	NA
PGEN_.00g218990	Scaffold_10	39503788	39561534	NA	NA	NA	NA	NA
PGEN_.00g219000	Scaffold_10	39573203	39585284	Q6P6B7	ANR16_HUMAN	Ankyrin repeat domain-containing protein 16	GO:0005634; GO:0005737; GO:0006400	cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA modification [GO:0006400]
PGEN_.00g219010	Scaffold_10	39606881	39607183	NA	NA	NA	NA	NA
PGEN_.00g219020	Scaffold_10	39624484	39624759	NA	NA	NA	NA	NA
PGEN_.00g219030	Scaffold_10	39625099	39625308	NA	NA	NA	NA	NA
PGEN_.00g219040	Scaffold_10	39625389	39626036	NA	NA	NA	NA	NA
PGEN_.00g219050	Scaffold_10	39626172	39669477	Q99758	ABCA3_HUMAN	ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3)	GO:0005319; GO:0005524; GO:0005615; GO:0005886; GO:0006869; GO:0016021; GO:0016887; GO:0042493; GO:0042626; GO:0043231; GO:0044267; GO:0051384; GO:0055085; GO:0097208; GO:0097232; GO:0097233	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085]
PGEN_.00g219060	Scaffold_10	39692360	39693574	Q6ZFH6	RCN11_ORYSJ	"Beta-1,2-xylosyltransferase RCN11 (OsXylT) (EC 2.4.2.-) (Protein REDUCED CULM NUMBER 11)"	GO:0000139; GO:0005797; GO:0006487; GO:0016021; GO:0031204; GO:0035252; GO:0048367; GO:0050513	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein 2-beta-D-xylosyltransferase activity [GO:0050513]; UDP-xylosyltransferase activity [GO:0035252]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein N-linked glycosylation [GO:0006487]; shoot system development [GO:0048367]"
PGEN_.00g219070	Scaffold_10	39705765	39711285	NA	NA	NA	NA	NA
PGEN_.00g219080	Scaffold_10	39745599	39749524	NA	NA	NA	NA	NA
PGEN_.00g219090	Scaffold_10	39749768	39754136	NA	NA	NA	NA	NA
PGEN_.00g219100	Scaffold_10	39755350	39767985	Q6DFC2	CCD77_XENLA	Coiled-coil domain-containing protein 77		
PGEN_.00g219110	Scaffold_10	39768534	39803990	P29375	KDM5A_HUMAN	Lysine-specific demethylase 5A (EC 1.14.11.-) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2)	GO:0000122; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0033169; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0035097; GO:0042393; GO:0044212; GO:0045893; GO:0051090; GO:0051213; GO:1901726	"histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]"
PGEN_.00g219120	Scaffold_10	39804052	39829520	Q6IC98	GRAM4_HUMAN	GRAM domain-containing protein 4 (Death-inducing protein)	GO:0005739; GO:0005789; GO:0006915; GO:0016021; GO:0031966; GO:0034164; GO:0043280	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]
PGEN_.00g219130	Scaffold_10	39844149	39845441	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g219140	Scaffold_10	39871989	39908880	O44252	ROST_DROME	Protein rolling stone	GO:0007275; GO:0007520; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; multicellular organism development [GO:0007275]; myoblast fusion [GO:0007520]
PGEN_.00g219150	Scaffold_10	39915679	39918106	Q78TU8	F107A_MOUSE	Actin-associated protein FAM107A	GO:0001558; GO:0001725; GO:0003779; GO:0005634; GO:0005737; GO:0005925; GO:0007049; GO:0015629; GO:0016607; GO:0030041; GO:0030335; GO:0031398; GO:0031647; GO:0031669; GO:0032587; GO:0032956; GO:0043005; GO:0045202; GO:0050890; GO:0051017; GO:0051895; GO:0070507; GO:0071385; GO:1900272; GO:2000134	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; stress fiber [GO:0001725]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cell cycle [GO:0007049]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to nutrient levels [GO:0031669]; cognition [GO:0050890]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of long-term synaptic potentiation [GO:1900272]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein stability [GO:0031647]
PGEN_.00g219160	Scaffold_10	39959887	39967224	Q86TL2	STIMA_HUMAN	Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110)	GO:0005246; GO:0005789; GO:0016020; GO:0016021; GO:0032237; GO:0032541; GO:0035584; GO:0070886; GO:0140268	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel regulator activity [GO:0005246]; activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]
PGEN_.00g219170	Scaffold_10	39985396	39995799	NA	NA	NA	NA	NA
PGEN_.00g219180	Scaffold_10	40005295	40061100	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g219190	Scaffold_10	40132866	40172657	A7E2Z9	K132L_BOVIN	UPF0577 protein KIAA1324-like homolog (Estrogen-induced gene 121-like protein) (EIG121L)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g219200	Scaffold_10	40181684	40197398	P72745	Y1101_SYNY3	Universal stress protein Slr1101 (USP Slr1101)		
PGEN_.00g219210	Scaffold_10	40215816	40216199	NA	NA	NA	NA	NA
PGEN_.00g219220	Scaffold_10	40216300	40217010	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g219230	Scaffold_10	40217124	40222736	NA	NA	NA	NA	NA
PGEN_.00g219240	Scaffold_10	40224809	40228151	NA	NA	NA	NA	NA
PGEN_.00g219250	Scaffold_10	40287761	40296966	Q08DK3	KLH20_BOVIN	Kelch-like protein 20	GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390	axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]
PGEN_.00g219260	Scaffold_10	40308678	40318491	NA	NA	NA	NA	NA
PGEN_.00g219270	Scaffold_10	40328810	40334920	B2RXA1	PLCX2_MOUSE	PI-PLC X domain-containing protein 2	GO:0005634; GO:0007165; GO:0008081; GO:0016042	nucleus [GO:0005634]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]
PGEN_.00g219280	Scaffold_10	40342123	40346918	P36007	LTHAD_YEAST	L-threo-3-hydroxyaspartate ammonia-lyase (EC 4.3.1.16) (L-threo-3-hydroxyaspartate dehydratase)	GO:0000287; GO:0003941; GO:0005524; GO:0006563; GO:0008721; GO:0018114; GO:0030170; GO:0030378; GO:0030848; GO:0042219; GO:0042866; GO:0070179	ATP binding [GO:0005524]; D-serine ammonia-lyase activity [GO:0008721]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threo-3-hydroxyaspartate ammonia-lyase activity [GO:0030848]; threonine racemase activity [GO:0018114]; cellular modified amino acid catabolic process [GO:0042219]; D-serine biosynthetic process [GO:0070179]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]
PGEN_.00g219290	Scaffold_10	40376351	40393125	Q8K4Q7	CERK1_MOUSE	Ceramide kinase (mCERK) (EC 2.7.1.138) (Acylsphingosine kinase)	GO:0000287; GO:0001729; GO:0003951; GO:0005524; GO:0005739; GO:0005886; GO:0006672; GO:0016020; GO:0016021; GO:0102773	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]
PGEN_.00g219300	Scaffold_10	40411395	40413346	P97879	GRIP1_RAT	Glutamate receptor-interacting protein 1 (GRIP-1) (AMPA receptor-interacting protein GRIP1)	GO:0005102; GO:0005789; GO:0005886; GO:0007399; GO:0008022; GO:0008104; GO:0014069; GO:0015031; GO:0016358; GO:0030054; GO:0030159; GO:0030425; GO:0035259; GO:0043005; GO:0043025; GO:0043204; GO:0045121; GO:0045211; GO:0055037; GO:0098794; GO:0098887; GO:0098978; GO:0099003; GO:0150012	"cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; glucocorticoid receptor binding [GO:0035259]; protein C-terminus binding [GO:0008022]; receptor signaling complex adaptor activity [GO:0030159]; signaling receptor binding [GO:0005102]; dendrite development [GO:0016358]; nervous system development [GO:0007399]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of neuron projection arborization [GO:0150012]; protein localization [GO:0008104]; protein transport [GO:0015031]; vesicle-mediated transport in synapse [GO:0099003]"
PGEN_.00g219310	Scaffold_10	40413883	40453209	A8E0R9	GRIP2_XENLA	Glutamate receptor-interacting protein 2 (xGRIP2) (xGRIP2.1)	GO:0005737; GO:0005938; GO:0007275; GO:0007281; GO:0008354; GO:0030159; GO:0032019; GO:0045495	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; mitochondrial cloud [GO:0032019]; pole plasm [GO:0045495]; receptor signaling complex adaptor activity [GO:0030159]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; multicellular organism development [GO:0007275]
PGEN_.00g219320	Scaffold_10	40456727	40457056	NA	NA	NA	NA	NA
PGEN_.00g219330	Scaffold_10	40468121	40469248	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g219340	Scaffold_10	40565416	40566016	O54750	CP2J6_MOUSE	Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)	GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g219350	Scaffold_10	40566589	40578284	Q0IIF9	CP2U1_BOVIN	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g219360	Scaffold_10	40586178	40587194	NA	NA	NA	NA	NA
PGEN_.00g219370	Scaffold_10	40605508	40626862	Q92830	KAT2A_HUMAN	Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (hGCN5) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)	GO:0000790; GO:0001701; GO:0001756; GO:0001816; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005615; GO:0005634; GO:0005654; GO:0005671; GO:0005737; GO:0005813; GO:0006338; GO:0006357; GO:0007507; GO:0007616; GO:0008134; GO:0008283; GO:0010484; GO:0014070; GO:0016032; GO:0016578; GO:0016579; GO:0018393; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0030914; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035066; GO:0035264; GO:0035948; GO:0042826; GO:0043966; GO:0043997; GO:0044154; GO:0045589; GO:0045815; GO:0045944; GO:0046600; GO:0048167; GO:0048312; GO:0050863; GO:0060173; GO:0061733; GO:0071356; GO:0071929; GO:0072686; GO:0106077; GO:0106078; GO:1990090; GO:2000727	"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter [GO:0035948]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]; viral process [GO:0016032]"
PGEN_.00g219380	Scaffold_10	40627651	40629104	Q92831	KAT2B_HUMAN	Histone acetyltransferase KAT2B (EC 2.3.1.48) (Histone acetyltransferase PCAF) (Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor) (P/CAF) (Spermidine acetyltransferase KAT2B) (EC 2.3.1.57)	GO:0000125; GO:0000776; GO:0000977; GO:0003682; GO:0003712; GO:0003713; GO:0004145; GO:0004402; GO:0004468; GO:0004861; GO:0005634; GO:0005654; GO:0005671; GO:0005813; GO:0006338; GO:0006367; GO:0006473; GO:0007050; GO:0007219; GO:0007221; GO:0007507; GO:0008134; GO:0008285; GO:0010835; GO:0016032; GO:0016407; GO:0016579; GO:0018076; GO:0018393; GO:0018394; GO:0019901; GO:0031672; GO:0031674; GO:0032869; GO:0032991; GO:0035948; GO:0042641; GO:0042826; GO:0043966; GO:0043970; GO:0045652; GO:0045747; GO:0045815; GO:0045944; GO:0046600; GO:0048511; GO:0060173; GO:0061733	"A band [GO:0031672]; actomyosin [GO:0042641]; Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; I band [GO:0031674]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; protein-containing complex [GO:0032991]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; diamine N-acetyltransferase activity [GO:0004145]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein kinase binding [GO:0019901]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; cellular response to insulin stimulus [GO:0032869]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3 acetylation [GO:0043966]; histone H3-K9 acetylation [GO:0043970]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centriole replication [GO:0046600]; Notch signaling pathway [GO:0007219]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter [GO:0035948]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; protein acetylation [GO:0006473]; protein deubiquitination [GO:0016579]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of protein ADP-ribosylation [GO:0010835]; rhythmic process [GO:0048511]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]"
PGEN_.00g219390	Scaffold_10	40637396	40648946	Q9D1M0	SEC13_MOUSE	Protein SEC13 homolog (GATOR complex protein SEC13) (SEC13-like protein 1) (SEC13-related protein)	GO:0000139; GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0030127; GO:0031080; GO:0032008; GO:0032527; GO:0032991; GO:0042802; GO:0043231; GO:0051028; GO:0061700; GO:0072659; GO:0090110; GO:0090114; GO:1904263	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659]
PGEN_.00g219400	Scaffold_10	40738712	40832067	Q6GLR7	CAPS1_XENLA	Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1)	GO:0008289; GO:0015031; GO:0016020; GO:0016079; GO:0030054; GO:0030133; GO:0046872; GO:0098793; GO:1990504	cell junction [GO:0030054]; membrane [GO:0016020]; presynapse [GO:0098793]; transport vesicle [GO:0030133]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; dense core granule exocytosis [GO:1990504]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079]
PGEN_.00g219410	Scaffold_10	40838015	40874679	Q9C0A6	SETD5_HUMAN	Histone-lysine N-methyltransferase SETD5 (EC 2.1.1.-) (SET domain-containing protein 5)	GO:0005634; GO:0005654; GO:0016569; GO:0016593; GO:0035065; GO:0046974; GO:1902275	Cdc73/Paf1 complex [GO:0016593]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; covalent chromatin modification [GO:0016569]; regulation of chromatin organization [GO:1902275]; regulation of histone acetylation [GO:0035065]
PGEN_.00g219420	Scaffold_10	40904956	40933322	D9IQ16	GXN_ACRMI	Galaxin	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g219430	Scaffold_10	40943334	40943681	NA	NA	NA	NA	NA
PGEN_.00g219440	Scaffold_10	40947026	40983609	NA	NA	NA	NA	NA
PGEN_.00g219450	Scaffold_10	40996365	40996901	NA	NA	NA	NA	NA
PGEN_.00g219460	Scaffold_10	41043718	41109882	Q01814	AT2B2_HUMAN	Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2)	GO:0005388; GO:0005509; GO:0005516; GO:0005524; GO:0005623; GO:0005737; GO:0005886; GO:0006816; GO:0006874; GO:0007605; GO:0008022; GO:0016021; GO:0030054; GO:0030165; GO:0030182; GO:0034220; GO:0046872; GO:0051480; GO:0070062; GO:0098793; GO:0098839; GO:0098978; GO:0098982; GO:1903779; GO:1905056; GO:1905059	"cell [GO:0005623]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905059]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; neuron differentiation [GO:0030182]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of sound [GO:0007605]"
PGEN_.00g219470	Scaffold_10	41140988	41142578	NA	NA	NA	NA	NA
PGEN_.00g219480	Scaffold_10	41151707	41171799	O76463	NFT1_CAEEL	"Nitrilase and fragile histidine triad fusion protein NitFhit [Includes: Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase); Nitrilase homolog (EC 3.5.-.-)]"	GO:0000166; GO:0006139; GO:0016810; GO:0047710	"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]; nucleobase-containing compound metabolic process [GO:0006139]"
PGEN_.00g219490	Scaffold_10	41193185	41201264	Q7JQD3	GELS1_LUMTE	Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1)	GO:0003779; GO:0005509; GO:0005737; GO:0005856; GO:0007275; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275]
PGEN_.00g219500	Scaffold_10	41202442	41208785	Q24800	SEVE_ECHGR	Severin	GO:0005509; GO:0045010; GO:0051014; GO:0051015; GO:0051016	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; barbed-end actin filament capping [GO:0051016]
PGEN_.00g219510	Scaffold_10	41219423	41222373	NA	NA	NA	NA	NA
PGEN_.00g219520	Scaffold_10	41238610	41252080	NA	NA	NA	NA	NA
PGEN_.00g219530	Scaffold_10	41266008	41266343	NA	NA	NA	NA	NA
PGEN_.00g219540	Scaffold_10	41272864	41273211	NA	NA	NA	NA	NA
PGEN_.00g219550	Scaffold_10	41297227	41316013	O34363	YOBN_BACSU	Putative L-amino-acid oxidase YobN (EC 1.4.3.2)	GO:0001716; GO:0009063; GO:0016491	L-amino-acid oxidase activity [GO:0001716]; oxidoreductase activity [GO:0016491]; cellular amino acid catabolic process [GO:0009063]
PGEN_.00g219560	Scaffold_10	41327277	41328437	Q5IS77	ACHA4_PANTR	Neuronal acetylcholine receptor subunit alpha-4	GO:0001666; GO:0005887; GO:0005892; GO:0006281; GO:0006979; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0050890	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g219570	Scaffold_10	41336532	41336795	NA	NA	NA	NA	NA
PGEN_.00g219580	Scaffold_10	41341757	41360918	NA	NA	NA	NA	NA
PGEN_.00g219590	Scaffold_10	41369986	41370261	NA	NA	NA	NA	NA
PGEN_.00g219600	Scaffold_10	41378483	41388079	Q2HJM9	MEST_BOVIN	Mesoderm-specific transcript homolog protein (EC 3.-.-.-) (Paternally-expressed gene 1 protein)	GO:0005783; GO:0005789; GO:0010883; GO:0016021; GO:0016787	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; regulation of lipid storage [GO:0010883]
PGEN_.00g219610	Scaffold_10	41389636	41395804	NA	NA	NA	NA	NA
PGEN_.00g219620	Scaffold_10	41407246	41447102	Q4VSN1	DUSTY_DANRE	Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5)	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0030054; GO:0048568	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; embryonic organ development [GO:0048568]
PGEN_.00g219630	Scaffold_10	41457651	41463234	B7LTA2	GHRA_ESCF3	Glyoxylate/hydroxypyruvate reductase A (EC 1.1.1.79) (EC 1.1.1.81) (2-ketoacid reductase)	GO:0005737; GO:0005886; GO:0016618; GO:0030267; GO:0051287	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]
PGEN_.00g219640	Scaffold_10	41490421	41490687	NA	NA	NA	NA	NA
PGEN_.00g219650	Scaffold_10	41494277	41494801	NA	NA	NA	NA	NA
PGEN_.00g219660	Scaffold_10	41495992	41496894	NA	NA	NA	NA	NA
PGEN_.00g219670	Scaffold_10	41513049	41513926	NA	NA	NA	NA	NA
PGEN_.00g219680	Scaffold_10	41519016	41522162	Q8BRK9	MA2A2_MOUSE	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016799; GO:0030246; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"
PGEN_.00g219690	Scaffold_10	41527608	41528378	NA	NA	NA	NA	NA
PGEN_.00g219700	Scaffold_10	41533369	41542620	P91254	GST8_CAEEL	Probable glutathione S-transferase 8 (EC 2.5.1.18) (GST class-sigma)	GO:0004364; GO:0006749	glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]
PGEN_.00g219710	Scaffold_10	41551487	41565940	NA	NA	NA	NA	NA
PGEN_.00g219720	Scaffold_10	41606371	41622120	Q04832	HEXP_LEIMA	DNA-binding protein HEXBP (Hexamer-binding protein)	GO:0003677; GO:0005634; GO:0008270	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]
PGEN_.00g219730	Scaffold_10	41632106	41636121	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g219740	Scaffold_10	41657448	41657954	NA	NA	NA	NA	NA
PGEN_.00g219750	Scaffold_10	41690761	41697705	Q6ZPT1	KLHL9_MOUSE	Kelch-like protein 9	GO:0004842; GO:0007049; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0051301	Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]
PGEN_.00g219760	Scaffold_10	41701834	41703516	NA	NA	NA	NA	NA
PGEN_.00g219770	Scaffold_10	41704871	41705311	NA	NA	NA	NA	NA
PGEN_.00g219780	Scaffold_10	41705641	41705922	NA	NA	NA	NA	NA
PGEN_.00g219790	Scaffold_10	41706023	41706379	NA	NA	NA	NA	NA
PGEN_.00g219800	Scaffold_10	41707033	41707851	NA	NA	NA	NA	NA
PGEN_.00g219810	Scaffold_10	41708343	41708633	NA	NA	NA	NA	NA
PGEN_.00g219820	Scaffold_10	41709148	41709759	NA	NA	NA	NA	NA
PGEN_.00g219830	Scaffold_10	41710376	41710672	NA	NA	NA	NA	NA
PGEN_.00g219840	Scaffold_10	41710774	41711680	NA	NA	NA	NA	NA
PGEN_.00g219850	Scaffold_10	41712462	41713106	NA	NA	NA	NA	NA
PGEN_.00g219860	Scaffold_10	41713451	41714801	NA	NA	NA	NA	NA
PGEN_.00g219870	Scaffold_10	41720012	41746190	Q5JXM2	MET24_HUMAN	Methyltransferase-like protein 24 (EC 2.1.1.-)	GO:0005576; GO:0008168; GO:0032259	extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g219880	Scaffold_10	41753479	41768840	Q8CJH3	PLXB1_MOUSE	Plexin-B1	GO:0002116; GO:0005887; GO:0007162; GO:0008360; GO:0014068; GO:0017154; GO:0030334; GO:0032794; GO:0033689; GO:0043087; GO:0043547; GO:0043931; GO:0048812; GO:0050772; GO:0051493; GO:0071526; GO:1900220; GO:1902287; GO:1904862	integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; GTPase activating protein binding [GO:0032794]; semaphorin receptor activity [GO:0017154]; inhibitory synapse assembly [GO:1904862]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis [GO:1900220]
PGEN_.00g219890	Scaffold_10	41781086	41789582	NA	NA	NA	NA	NA
PGEN_.00g219900	Scaffold_10	41795516	41812300	NA	NA	NA	NA	NA
PGEN_.00g219910	Scaffold_10	41815558	41815911	NA	NA	NA	NA	NA
PGEN_.00g219920	Scaffold_10	41816306	41824638	NA	NA	NA	NA	NA
PGEN_.00g219930	Scaffold_10	41827029	41845895	P91253	GST7_CAEEL	Probable glutathione S-transferase 7 (EC 2.5.1.18) (GST class-sigma)	GO:0004364; GO:0006749; GO:0045087	glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]; innate immune response [GO:0045087]
PGEN_.00g219940	Scaffold_10	41852702	41863696	P91254	GST8_CAEEL	Probable glutathione S-transferase 8 (EC 2.5.1.18) (GST class-sigma)	GO:0004364; GO:0006749	glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]
PGEN_.00g219950	Scaffold_10	41876252	41879960	O73888	HPGDS_CHICK	Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase)	GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005654; GO:0005829; GO:0006693; GO:0006749; GO:0042803; GO:2000255	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]
PGEN_.00g219960	Scaffold_10	41882688	41904789	P91253	GST7_CAEEL	Probable glutathione S-transferase 7 (EC 2.5.1.18) (GST class-sigma)	GO:0004364; GO:0006749; GO:0045087	glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]; innate immune response [GO:0045087]
PGEN_.00g219970	Scaffold_10	41910034	41918429	Q5RC19	ACOX1_PONAB	"Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]"	GO:0003997; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0019395; GO:0033540; GO:0071949	peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]
PGEN_.00g219980	Scaffold_10	41921931	41922698	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g219990	Scaffold_10	41923013	41923807	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g220000	Scaffold_10	41924174	41940332	Q9Z1N0	ACOX1_CAVPO	"Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]"	GO:0003997; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0019395; GO:0033540; GO:0071949	peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]
PGEN_.00g220010	Scaffold_10	41953067	41954839	Q17902	EGAL1_CAEEL	Egalitarian protein homolog	GO:0003676; GO:0005635; GO:0008408	nuclear envelope [GO:0005635]; 3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676]
PGEN_.00g220020	Scaffold_10	41963282	41972726	Q9C585	UBP8_ARATH	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (AtUBP8) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	GO:0006511; GO:0016579; GO:0036459	thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g220030	Scaffold_10	41985874	41998273	NA	NA	NA	NA	NA
PGEN_.00g220040	Scaffold_10	41998538	42016197	Q8BM39	PRP18_MOUSE	Pre-mRNA-splicing factor 18 (PRP18 homolog)	GO:0000350; GO:0005682; GO:0016020; GO:0016607; GO:0032269; GO:0046540; GO:0071021; GO:0071048	membrane [GO:0016020]; nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; negative regulation of cellular protein metabolic process [GO:0032269]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]
PGEN_.00g220050	Scaffold_10	42021052	42021381	NA	NA	NA	NA	NA
PGEN_.00g220060	Scaffold_10	42026705	42029275	NA	NA	NA	NA	NA
PGEN_.00g220070	Scaffold_10	42029362	42029682	NA	NA	NA	NA	NA
PGEN_.00g220080	Scaffold_10	42030850	42031509	NA	NA	NA	NA	NA
PGEN_.00g220090	Scaffold_10	42033979	42038556	NA	NA	NA	NA	NA
PGEN_.00g220100	Scaffold_10	42038613	42038873	NA	NA	NA	NA	NA
PGEN_.00g220110	Scaffold_10	42044060	42105769	Q8WWQ8	STAB2_HUMAN	"Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)]"	GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0005887; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830	cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein disulfide oxidoreductase activity [GO:0015035]; scavenger receptor activity [GO:0005044]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g220120	Scaffold_10	42220728	42232855	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g220130	Scaffold_10	42237606	42237968	NA	NA	NA	NA	NA
PGEN_.00g220140	Scaffold_10	42285859	42326064	Q8R4U0	STAB2_MOUSE	"Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) [Cleaved into: Short form stabilin-2]"	GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005887; GO:0006897; GO:0007155; GO:0009897; GO:0030169; GO:0042742; GO:0050830	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]
PGEN_.00g220150	Scaffold_10	42326629	42336336	Q5ZKB8	CDPF1_CHICK	Cysteine-rich DPF motif domain-containing protein 1		
PGEN_.00g220160	Scaffold_10	42337730	42338020	NA	NA	NA	NA	NA
PGEN_.00g220170	Scaffold_10	42353046	42360497	NA	NA	NA	NA	NA
PGEN_.00g220180	Scaffold_10	42372903	42377408	NA	NA	NA	NA	NA
PGEN_.00g220190	Scaffold_10	42392748	42419148	Q26622	SHR2_STRPU	Orphan steroid hormone receptor 2 (SpSHR2)	GO:0000977; GO:0003677; GO:0003700; GO:0003707; GO:0005634; GO:0005652; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0045177; GO:0048471; GO:0048856	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g220200	Scaffold_10	42433893	42434417	NA	NA	NA	NA	NA
PGEN_.00g220210	Scaffold_10	42434626	42435075	NA	NA	NA	NA	NA
PGEN_.00g220220	Scaffold_10	42436603	42443609	NA	NA	NA	NA	NA
PGEN_.00g220230	Scaffold_10	42452385	42456198	NA	NA	NA	NA	NA
PGEN_.00g220240	Scaffold_10	42471691	42485403	NA	NA	NA	NA	NA
PGEN_.00g220250	Scaffold_10	42514969	42520865	NA	NA	NA	NA	NA
PGEN_.00g220260	Scaffold_10	42525065	42525490	NA	NA	NA	NA	NA
PGEN_.00g220270	Scaffold_10	42525520	42526056	NA	NA	NA	NA	NA
PGEN_.00g220280	Scaffold_10	42526527	42526790	NA	NA	NA	NA	NA
PGEN_.00g220290	Scaffold_10	42526816	42527166	NA	NA	NA	NA	NA
PGEN_.00g220300	Scaffold_10	42535374	42598372	Q96SB4	SRPK1_HUMAN	SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1)	GO:0000245; GO:0000287; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0010468; GO:0016032; GO:0016363; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm chromatin condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]; viral process [GO:0016032]"
PGEN_.00g220310	Scaffold_10	42609879	42637226	Q6V0I7	FAT4_HUMAN	Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
PGEN_.00g220320	Scaffold_10	42643167	42653040	Q4R4I1	UBE2N_MACFA	Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme N) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N)	GO:0000151; GO:0004842; GO:0005524; GO:0006281; GO:0035370; GO:0070534	UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; protein K63-linked ubiquitination [GO:0070534]
PGEN_.00g220330	Scaffold_10	42657917	42659632	NA	NA	NA	NA	NA
PGEN_.00g220340	Scaffold_10	42667641	42681174	Q9WU00	NRF1_MOUSE	Nuclear respiratory factor 1 (NRF-1) (Alpha palindromic-binding protein) (Alpha-pal)	GO:0000978; GO:0000979; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006357; GO:0007005; GO:0042803; GO:0045944; GO:0051602	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]"
PGEN_.00g220350	Scaffold_10	42681200	42685312	NA	NA	NA	NA	NA
PGEN_.00g220360	Scaffold_10	42690879	42699566	Q9JLR1	S61A2_MOUSE	Protein transport protein Sec61 subunit alpha isoform 2 (Sec61 alpha-2)	GO:0005048; GO:0005783; GO:0005784; GO:0005789; GO:0006616; GO:0006620; GO:0008320; GO:0016021; GO:0043022	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"
PGEN_.00g220370	Scaffold_10	42710930	42711580	NA	NA	NA	NA	NA
PGEN_.00g220380	Scaffold_10	42739240	42908587	Q9UHD2	TBK1_HUMAN	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)	GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010008; GO:0010629; GO:0016032; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032480; GO:0032481; GO:0032606; GO:0032727; GO:0032728; GO:0033138; GO:0035666; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045359; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060340; GO:0071345; GO:1901214; GO:1904417	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; cellular response to cytokine stimulus [GO:0071345]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type I interferon production [GO:0032480]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta biosynthetic process [GO:0045359]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon production [GO:0032606]; viral process [GO:0016032]
PGEN_.00g220390	Scaffold_10	42926714	42930458	NA	NA	NA	NA	NA
PGEN_.00g220400	Scaffold_10	42933573	42976784	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g220410	Scaffold_10	42983836	42985393	NA	NA	NA	NA	NA
PGEN_.00g220420	Scaffold_10	43010790	43015226	NA	NA	NA	NA	NA
PGEN_.00g220430	Scaffold_10	43044391	43048121	NA	NA	NA	NA	NA
PGEN_.00g220440	Scaffold_10	43055658	43089902	NA	NA	NA	NA	NA
PGEN_.00g220450	Scaffold_10	43103157	43103978	NA	NA	NA	NA	NA
PGEN_.00g220460	Scaffold_10	43116886	43117749	NA	NA	NA	NA	NA
PGEN_.00g220470	Scaffold_10	43124602	43126969	Q8IUC8	GLT13_HUMAN	Polypeptide N-acetylgalactosaminyltransferase 13 (EC 2.4.1.41) (Polypeptide GalNAc transferase 13) (GalNAc-T13) (pp-GaNTase 13) (Protein-UDP acetylgalactosaminyltransferase 13) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13)	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g220480	Scaffold_10	43136309	43149298	Q07DZ7	ASZ1_ORNAN	"Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein)"	GO:0007140; GO:0007275; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071546	pi-body [GO:0071546]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
PGEN_.00g220490	Scaffold_10	43149485	43157227	Q9N2W7	NDUAC_CAEEL	Probable NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 (NADH-ubiquinone oxidoreductase 17.0 kDa subunit)	GO:0005739; GO:0005747; GO:0006979; GO:0008137; GO:0009055	mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; response to oxidative stress [GO:0006979]
PGEN_.00g220500	Scaffold_10	43162313	43166856	Q5RBA1	ING3_PONAB	Inhibitor of growth protein 3	GO:0000812; GO:0032777; GO:0035267; GO:0040008; GO:0043065; GO:0043967; GO:0043968; GO:0046872	NuA4 histone acetyltransferase complex [GO:0035267]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; metal ion binding [GO:0046872]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; regulation of growth [GO:0040008]
PGEN_.00g220510	Scaffold_10	43197980	43201162	NA	NA	NA	NA	NA
PGEN_.00g220520	Scaffold_10	43249358	43263425	NA	NA	NA	NA	NA
PGEN_.00g220530	Scaffold_10	43318112	43332657	NA	NA	NA	NA	NA
PGEN_.00g220540	Scaffold_10	43338362	43339386	NA	NA	NA	NA	NA
PGEN_.00g220550	Scaffold_10	43341248	43341853	NA	NA	NA	NA	NA
PGEN_.00g220560	Scaffold_10	43341952	43342467	NA	NA	NA	NA	NA
PGEN_.00g220570	Scaffold_10	43378127	43378732	NA	NA	NA	NA	NA
PGEN_.00g220580	Scaffold_10	43389732	43390334	NA	NA	NA	NA	NA
PGEN_.00g220590	Scaffold_10	43392476	43404318	NA	NA	NA	NA	NA
PGEN_.00g220600	Scaffold_10	43404376	43419366	Q90Z16	OPTN_CHICK	Optineurin (Ag9-C5) (FIP-2)	GO:0005634; GO:0005737; GO:0005776; GO:0005794; GO:0006914; GO:0016192; GO:0034067; GO:0046872; GO:0048471; GO:0055037; GO:0070530; GO:0090161	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi ribbon formation [GO:0090161]; protein localization to Golgi apparatus [GO:0034067]; vesicle-mediated transport [GO:0016192]
PGEN_.00g220610	Scaffold_10	43433146	43529214	Q29116	TENA_PIG	Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (P230) (Tenascin-C) (TN-C)	GO:0007155; GO:0042127; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; cell adhesion [GO:0007155]; regulation of cell population proliferation [GO:0042127]
PGEN_.00g220620	Scaffold_10	43530866	43580488	NA	NA	NA	NA	NA
PGEN_.00g220630	Scaffold_10	43581766	43598632	NA	NA	NA	NA	NA
PGEN_.00g220640	Scaffold_10	43601538	43602656	NA	NA	NA	NA	NA
PGEN_.00g220650	Scaffold_10	43608277	43664578	NA	NA	NA	NA	NA
PGEN_.00g220660	Scaffold_10	43706817	43718383	B0UZC8	VWC2L_DANRE	von Willebrand factor C domain-containing protein 2-like	GO:0005615; GO:0007399; GO:0030054; GO:0030514; GO:0032281; GO:0045202	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; nervous system development [GO:0007399]
PGEN_.00g220670	Scaffold_10	43720450	43720737	NA	NA	NA	NA	NA
PGEN_.00g220680	Scaffold_10	43731947	43733296	NA	NA	NA	NA	NA
PGEN_.00g220690	Scaffold_10	43733847	43734239	NA	NA	NA	NA	NA
PGEN_.00g220700	Scaffold_10	43755696	43758286	NA	NA	NA	NA	NA
PGEN_.00g220710	Scaffold_10	43758340	43762603	NA	NA	NA	NA	NA
PGEN_.00g220720	Scaffold_10	43768253	43768540	NA	NA	NA	NA	NA
PGEN_.00g220730	Scaffold_10	43770320	43783754	B0UZC8	VWC2L_DANRE	von Willebrand factor C domain-containing protein 2-like	GO:0005615; GO:0007399; GO:0030054; GO:0030514; GO:0032281; GO:0045202	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; nervous system development [GO:0007399]
PGEN_.00g220740	Scaffold_10	43798551	43799042	NA	NA	NA	NA	NA
PGEN_.00g220750	Scaffold_10	43805042	43806598	NA	NA	NA	NA	NA
PGEN_.00g220760	Scaffold_10	43826703	43827191	NA	NA	NA	NA	NA
PGEN_.00g220770	Scaffold_10	43835393	43842464	Q95KB4	S35B4_MACFA	UDP-xylose and UDP-N-acetylglucosamine transporter (Solute carrier family 35 member B4)	GO:0000139; GO:0008643; GO:0016021; GO:0055085	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate transport [GO:0008643]; transmembrane transport [GO:0055085]
PGEN_.00g220780	Scaffold_10	43842844	43851903	Q9W429	S35B4_DROME	UDP-xylose and UDP-N-acetylglucosamine transporter (ER GDP-fucose transporter) (Solute carrier family 35 member B4 homolog)	GO:0005457; GO:0005462; GO:0005464; GO:0005783; GO:0005794; GO:0008643; GO:0015012; GO:0015782; GO:0015783; GO:0015786; GO:0015787; GO:0015790; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0036066; GO:0036084; GO:1990569; GO:1990570	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; GDP-fucose transmembrane transporter activity [GO:0005457]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; GDP-fucose import into endoplasmic reticulum lumen [GO:0036084]; GDP-fucose transmembrane transport [GO:0015783]; GDP-mannose transmembrane transport [GO:1990570]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]; UDP-glucuronic acid transmembrane transport [GO:0015787]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]
PGEN_.00g220790	Scaffold_10	43860217	43871755	A5WUT8	EPG5_DANRE	Ectopic P granules protein 5 homolog	GO:0005737; GO:0006914; GO:0097352	cytoplasm [GO:0005737]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]
PGEN_.00g220800	Scaffold_10	43913060	43948477	Q80TA9	EPG5_MOUSE	Ectopic P granules protein 5 homolog	GO:0005737; GO:0005764; GO:0006862; GO:0006914; GO:0008333; GO:0032456; GO:0034162; GO:0048471; GO:0097352; GO:1990786	cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162]
PGEN_.00g220810	Scaffold_10	43948580	43978221	A5WUT8	EPG5_DANRE	Ectopic P granules protein 5 homolog	GO:0005737; GO:0006914; GO:0097352	cytoplasm [GO:0005737]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]
PGEN_.00g220820	Scaffold_10	44014628	44089460	Q00537	CDK17_HUMAN	Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)	GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]
PGEN_.00g220830	Scaffold_10	44050305	44050634	NA	NA	NA	NA	NA
PGEN_.00g220840	Scaffold_10	44050727	44051152	NA	NA	NA	NA	NA
PGEN_.00g220850	Scaffold_10	44051529	44051876	NA	NA	NA	NA	NA
PGEN_.00g220860	Scaffold_10	44110013	44181938	Q26619	KAPR_STRPU	cAMP-dependent protein kinase type II regulatory subunit	GO:0005829; GO:0005952; GO:0008603; GO:0019934; GO:0030552; GO:0047555	"cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]; cGMP-mediated signaling [GO:0019934]"
PGEN_.00g220870	Scaffold_10	44195682	44271994	Q86U86	PB1_HUMAN	Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D)	GO:0000228; GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0006337; GO:0006338; GO:0006368; GO:0008285; GO:0016586; GO:0043044	nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g220880	Scaffold_10	44275621	44277695	Q90941	PB1_CHICK	Protein polybromo-1	GO:0003677; GO:0003682; GO:0006337; GO:0006368; GO:0016586; GO:0043044	RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ATP-dependent chromatin remodeling [GO:0043044]; nucleosome disassembly [GO:0006337]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g220890	Scaffold_10	44292009	44293169	P48594	SPB4_HUMAN	Serpin B4 (Leupin) (Peptidase inhibitor 11) (PI-11) (Squamous cell carcinoma antigen 2) (SCCA-2)	GO:0002020; GO:0004867; GO:0005615; GO:0005737; GO:0010466; GO:0010951; GO:0019899; GO:0030162; GO:0042270	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; enzyme binding [GO:0019899]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of peptidase activity [GO:0010466]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of proteolysis [GO:0030162]
PGEN_.00g220900	Scaffold_10	44298912	44299229	NA	NA	NA	NA	NA
PGEN_.00g220910	Scaffold_10	44303364	44321791	Q9Z1J2	NEK4_MOUSE	Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2)	GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0023014; GO:0030145; GO:0032147; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:1900062; GO:2000772; GO:2001020	"ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]"
PGEN_.00g220920	Scaffold_10	44331166	44342344	Q96M69	LRGUK_HUMAN	Leucine-rich repeat and guanylate kinase domain-containing protein	GO:0001669; GO:0002177; GO:0004385; GO:0005524; GO:0005829; GO:0007283; GO:0030154; GO:0035082; GO:0042995	acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]
PGEN_.00g220930	Scaffold_10	44342435	44348452	Q9D5S7	LRGUK_MOUSE	Leucine-rich repeat and guanylate kinase domain-containing protein	GO:0001669; GO:0002177; GO:0004385; GO:0005524; GO:0005829; GO:0007283; GO:0030154; GO:0035082; GO:0042995	acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]
PGEN_.00g220940	Scaffold_10	44364333	44366610	NA	NA	NA	NA	NA
PGEN_.00g220950	Scaffold_10	44455340	44458462	P82926	RT33_BOVIN	"28S ribosomal protein S33, mitochondrial (MRP-S33) (S33mt)"	GO:0005743; GO:0005763	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]
PGEN_.00g220960	Scaffold_10	44465698	44469356	O88843	CRADD_MOUSE	Death domain-containing protein CRADD (Caspase and RIP adapter with death domain) (RIP-associated protein with a death domain)	GO:0002020; GO:0005634; GO:0005737; GO:0006919; GO:0006977; GO:0030674; GO:0043065; GO:0070513; GO:0071260; GO:0097190; GO:2001235	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; death domain binding [GO:0070513]; protease binding [GO:0002020]; protein binding, bridging [GO:0030674]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]"
PGEN_.00g220970	Scaffold_10	44487264	44499923	P23470	PTPRG_HUMAN	Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48)	GO:0004725; GO:0005001; GO:0005887; GO:0006470; GO:0007169; GO:0007420; GO:0010633; GO:0010977; GO:0042802; GO:0070062	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g220980	Scaffold_10	44500204	44534374	Q69Z26	CNTN4_MOUSE	Contactin-4 (Brain-derived immunoglobulin superfamily protein 2) (BIG-2)	GO:0005576; GO:0005886; GO:0007155; GO:0007399; GO:0007411; GO:0007420; GO:0031175; GO:0031225; GO:0045665	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]
PGEN_.00g220990	Scaffold_10	44551700	44552924	NA	NA	NA	NA	NA
PGEN_.00g221000	Scaffold_10	44572480	44611236	Q16829	DUS7_HUMAN	Dual specificity protein phosphatase 7 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST2)	GO:0000165; GO:0000187; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008138; GO:0017017; GO:0035335; GO:0043407	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; activation of MAPK activity [GO:0000187]; MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]
PGEN_.00g221010	Scaffold_10	44613723	44626619	NA	NA	NA	NA	NA
PGEN_.00g221020	Scaffold_10	44626648	44677094	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g221030	Scaffold_10	44693254	44693541	NA	NA	NA	NA	NA
PGEN_.00g221040	Scaffold_10	44707151	44719962	P20695	IFRD1_RAT	Interferon-related developmental regulator 1 (IRPR) (Nerve growth factor-inducible protein PC4)	GO:0005634; GO:0005737; GO:0005886; GO:0007405; GO:0014009; GO:0014706; GO:0030517; GO:0042692; GO:0043403; GO:0045944; GO:0048671; GO:0051091; GO:0061629	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; glial cell proliferation [GO:0014009]; muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; neuroblast proliferation [GO:0007405]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]
PGEN_.00g221050	Scaffold_10	44728199	44738730	O43772	MCAT_HUMAN	Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (Solute carrier family 25 member 20)	GO:0001701; GO:0005739; GO:0005743; GO:0005829; GO:0006853; GO:0015227; GO:0016021	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; carnitine shuttle [GO:0006853]; in utero embryonic development [GO:0001701]
PGEN_.00g221060	Scaffold_10	44744324	44746938	NA	NA	NA	NA	NA
PGEN_.00g221070	Scaffold_10	44753338	44767585	Q641G7	ARPC4_XENLA	Actin-related protein 2/3 complex subunit 4	GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030041; GO:0034314; GO:0035861; GO:0042995	Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]
PGEN_.00g221080	Scaffold_10	44769772	44771771	NA	NA	NA	NA	NA
PGEN_.00g221090	Scaffold_10	44784289	44800401	Q6ZNG1	ZN600_HUMAN	Zinc finger protein 600	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g221100	Scaffold_10	44806089	44826222	P28841	NEC2_RAT	Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2) (PC2)	GO:0004175; GO:0004252; GO:0005615; GO:0005654; GO:0005802; GO:0006508; GO:0007399; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030173; GO:0030425; GO:0034230; GO:0034231; GO:0034774; GO:0043025; GO:0043204; GO:0044877	dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; endopeptidase activity [GO:0004175]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]
PGEN_.00g221110	Scaffold_10	44832044	44866655	Q9R1X5	MRP5_MOUSE	Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP)	GO:0005524; GO:0008514; GO:0009986; GO:0015562; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0042910; GO:0048471; GO:0055085; GO:0140115	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]; export across plasma membrane [GO:0140115]; transmembrane transport [GO:0055085]
PGEN_.00g221120	Scaffold_10	44880784	44882043	Q8N539	FBCD1_HUMAN	Fibrinogen C domain-containing protein 1	GO:0008061; GO:0016020; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g221130	Scaffold_10	44888288	44912474	Q9R1X5	MRP5_MOUSE	Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP)	GO:0005524; GO:0008514; GO:0009986; GO:0015562; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0042910; GO:0048471; GO:0055085; GO:0140115	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]; export across plasma membrane [GO:0140115]; transmembrane transport [GO:0055085]
PGEN_.00g221140	Scaffold_10	44920344	44925669	NA	NA	NA	NA	NA
PGEN_.00g221150	Scaffold_10	44934639	44941926	O15440	MRP5_HUMAN	Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP) (pABC11)	GO:0005524; GO:0005886; GO:0005887; GO:0008514; GO:0009986; GO:0015562; GO:0016020; GO:0016323; GO:0016887; GO:0030213; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0140115	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]; export across plasma membrane [GO:0140115]; hyaluronan biosynthetic process [GO:0030213]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g221160	Scaffold_10	44952493	44966610	Q6Y306	MRP9_RAT	Multidrug resistance-associated protein 9 (ATP-binding cassette sub-family C member 12)	GO:0005524; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g221170	Scaffold_10	44991172	44991543	NA	NA	NA	NA	NA
PGEN_.00g221180	Scaffold_10	44991646	44993324	NA	NA	NA	NA	NA
PGEN_.00g221190	Scaffold_10	44996409	44997050	NA	NA	NA	NA	NA
PGEN_.00g221200	Scaffold_10	45006008	45006457	NA	NA	NA	NA	NA
PGEN_.00g221210	Scaffold_10	45008686	45010462	NA	NA	NA	NA	NA
PGEN_.00g221220	Scaffold_10	45012222	45012551	NA	NA	NA	NA	NA
PGEN_.00g221230	Scaffold_10	45013064	45013495	NA	NA	NA	NA	NA
PGEN_.00g221240	Scaffold_10	45019980	45020390	NA	NA	NA	NA	NA
PGEN_.00g221250	Scaffold_10	45024835	45031787	Q90640	KIF4_CHICK	Chromosome-associated kinesin KIF4 (Chromokinesin)	GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0008017; GO:0016887	chromosome [GO:0005694]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]
PGEN_.00g221260	Scaffold_10	45032559	45032843	F8WLE0	KIF28_RAT	Kinesin-like protein KIF28P (Kinesin-like protein 6)	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0030705; GO:0031966; GO:0072384	kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]
PGEN_.00g221270	Scaffold_10	45036885	45038737	NA	NA	NA	NA	NA
PGEN_.00g221280	Scaffold_10	45039820	45040170	NA	NA	NA	NA	NA
PGEN_.00g221290	Scaffold_10	45043092	45048624	NA	NA	NA	NA	NA
PGEN_.00g221300	Scaffold_10	45059180	45088121	O76924	ARI2_DROME	Potential E3 ubiquitin-protein ligase ariadne-2 (EC 2.3.2.31) (Protein ariadne-2) (RING-type E3 ubiquitin transferase ariadne-2)	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0031624; GO:0032436; GO:0061630	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g221310	Scaffold_10	45091685	45126045	Q5ZKD7	MOV10_CHICK	Putative helicase MOV-10 (EC 3.6.4.13)	GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0061014; GO:0061158; GO:0150011	"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]"
PGEN_.00g221320	Scaffold_10	45126197	45126460	NA	NA	NA	NA	NA
PGEN_.00g221330	Scaffold_10	45140324	45147009	Q66K08	CILP1_MOUSE	Cartilage intermediate layer protein 1 (CILP-1) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2]	GO:0005615; GO:0010629; GO:0043569; GO:0060392; GO:0062023; GO:0071560	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]
PGEN_.00g221340	Scaffold_10	45153150	45155085	NA	NA	NA	NA	NA
PGEN_.00g221350	Scaffold_10	45155330	45159944	NA	NA	NA	NA	NA
PGEN_.00g221360	Scaffold_10	45165219	45175573	P31907	HOXX_BRADU	Hydrogenase maturation factor HoxX	GO:0009058; GO:0016742	"hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; biosynthetic process [GO:0009058]"
PGEN_.00g221370	Scaffold_10	45199510	45202674	NA	NA	NA	NA	NA
PGEN_.00g221380	Scaffold_10	45219442	45227286	P07897	PGCA_RAT	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0001502; GO:0001503; GO:0002063; GO:0005509; GO:0005540; GO:0005604; GO:0005615; GO:0007155; GO:0007417; GO:0007507; GO:0009314; GO:0009612; GO:0009629; GO:0009749; GO:0010259; GO:0010447; GO:0014070; GO:0021510; GO:0030166; GO:0030199; GO:0030246; GO:0030336; GO:0031012; GO:0042493; GO:0043005; GO:0043025; GO:0060591; GO:0071363; GO:0072534; GO:0098966; GO:0098978; GO:0098982	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; perisynaptic extracellular matrix [GO:0098966]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; central nervous system development [GO:0007417]; chondroblast differentiation [GO:0060591]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; heart development [GO:0007507]; multicellular organism aging [GO:0010259]; negative regulation of cell migration [GO:0030336]; ossification [GO:0001503]; proteoglycan biosynthetic process [GO:0030166]; response to acidic pH [GO:0010447]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to gravity [GO:0009629]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; skeletal system development [GO:0001501]; spinal cord development [GO:0021510]
PGEN_.00g221390	Scaffold_10	45232311	45232883	NA	NA	NA	NA	NA
PGEN_.00g221400	Scaffold_10	45250023	45250595	NA	NA	NA	NA	NA
PGEN_.00g221410	Scaffold_10	45303711	45304208	Q9P215	POGK_HUMAN	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g221420	Scaffold_10	45315287	45318201	Q8N414	PGBD5_HUMAN	PiggyBac transposable element-derived protein 5 (EC 3.1.-.-) (PiggyBac domain-related protein 5) (PiggyBac transposase 5)	GO:0004519; GO:0004803; GO:0005634; GO:0098038	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; transposase activity [GO:0004803]; non-replicative transposition, DNA-mediated [GO:0098038]"
PGEN_.00g221430	Scaffold_10	45332339	45332587	NA	NA	NA	NA	NA
PGEN_.00g221440	Scaffold_10	45332617	45333048	NA	NA	NA	NA	NA
PGEN_.00g221450	Scaffold_10	45333204	45333443	NA	NA	NA	NA	NA
PGEN_.00g221460	Scaffold_10	45333572	45334847	NA	NA	NA	NA	NA
PGEN_.00g221470	Scaffold_10	45335180	45336777	NA	NA	NA	NA	NA
PGEN_.00g221480	Scaffold_10	45336938	45337543	NA	NA	NA	NA	NA
PGEN_.00g221490	Scaffold_10	45410351	45416217	Q9U2C4	GALT9_CAEEL	Probable N-acetylgalactosaminyltransferase 9 (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9) (pp-GaNTase 9)	GO:0000139; GO:0005794; GO:0006486; GO:0016021; GO:0016757; GO:0030246; GO:0046872	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; protein glycosylation [GO:0006486]"
PGEN_.00g221500	Scaffold_10	45425673	45425927	NA	NA	NA	NA	NA
PGEN_.00g221510	Scaffold_10	45427722	45427997	NA	NA	NA	NA	NA
PGEN_.00g221520	Scaffold_10	45448592	45449140	NA	NA	NA	NA	NA
PGEN_.00g221530	Scaffold_10	45450295	45450783	NA	NA	NA	NA	NA
PGEN_.00g221540	Scaffold_10	45454140	45454811	NA	NA	NA	NA	NA
PGEN_.00g221550	Scaffold_10	45455000	45455308	NA	NA	NA	NA	NA
PGEN_.00g221560	Scaffold_10	45455794	45456180	NA	NA	NA	NA	NA
PGEN_.00g221570	Scaffold_10	45456359	45467049	NA	NA	NA	NA	NA
PGEN_.00g221580	Scaffold_10	45467486	45475194	NA	NA	NA	NA	NA
PGEN_.00g221590	Scaffold_10	45488000	45488537	NA	NA	NA	NA	NA
PGEN_.00g221600	Scaffold_10	45523642	45594212	W0LYS5	CAMKI_MACNP	Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (MnCaMKI)	GO:0004683; GO:0005516; GO:0005524; GO:0006468; GO:0022404	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]
PGEN_.00g221610	Scaffold_10	45613505	45615295	NA	NA	NA	NA	NA
PGEN_.00g221620	Scaffold_10	45615372	45616232	NA	NA	NA	NA	NA
PGEN_.00g221630	Scaffold_10	45650259	45650573	NA	NA	NA	NA	NA
PGEN_.00g221640	Scaffold_10	45650709	45650981	NA	NA	NA	NA	NA
PGEN_.00g221650	Scaffold_10	45662793	45680274	Q8BX57	PXK_MOUSE	"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)"	GO:0003779; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0008022; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0042391; GO:0043271; GO:0050804	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391]
PGEN_.00g221660	Scaffold_10	45736797	45760815	P27765	AMID_PSECL	Amidase (EC 3.5.1.4)	GO:0004040; GO:0043864	amidase activity [GO:0004040]; indoleacetamide hydrolase activity [GO:0043864]
PGEN_.00g221670	Scaffold_10	45763203	45792570	Q86VQ6	TRXR3_HUMAN	Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2)	GO:0004791; GO:0005623; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0007275; GO:0007283; GO:0009055; GO:0015035; GO:0030154; GO:0045454; GO:0050660	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g221680	Scaffold_10	45798590	45810381	Q6DIH3	MCM2_XENTR	DNA replication licensing factor mcm2 (EC 3.6.4.12) (Minichromosome maintenance protein 2)	GO:0000727; GO:0000785; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0030174; GO:0042555; GO:0046872; GO:1902975; GO:1905775	chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA-dependent DNA replication initiation [GO:0030174]
PGEN_.00g221690	Scaffold_10	45843961	45856448	Q04786	HEX_VIBVL	Beta-hexosaminidase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Chitobiase) (N-acetyl-beta-glucosaminidase)	GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0102148	beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]
PGEN_.00g221700	Scaffold_10	45873549	45879824	Q6NSJ0	MYORG_HUMAN	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161)	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"
PGEN_.00g221710	Scaffold_10	45879879	45889450	NA	NA	NA	NA	NA
PGEN_.00g221720	Scaffold_10	46025091	46064421	Q5DRA7	PCDGH_PANTR	Protocadherin gamma-B5 (PCDH-gamma-B5)	GO:0005509; GO:0005887; GO:0007155; GO:0007156	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g221730	Scaffold_10	46103590	46114437	Q3T0Y3	ST1B1_BOVIN	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-)	GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008202; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g221740	Scaffold_10	46120476	46126757	Q3T0Y3	ST1B1_BOVIN	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-)	GO:0004062; GO:0005737; GO:0006068; GO:0006805; GO:0008202; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g221750	Scaffold_10	46130348	46130692	NA	NA	NA	NA	NA
PGEN_.00g221760	Scaffold_10	46135667	46136508	NA	NA	NA	NA	NA
PGEN_.00g221770	Scaffold_10	46140054	46147964	Q6GDV6	Y2567_STAAR	Uncharacterized oxidoreductase SAR2567 (EC 1.-.-.-)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g221780	Scaffold_10	46150577	46161799	Q0VG85	CC162_MOUSE	Coiled-coil domain-containing protein 162		
PGEN_.00g221790	Scaffold_10	46185520	46187629	Q09YN6	CAV1_RABIT	Caveolin-1	GO:0000122; GO:0000139; GO:0000188; GO:0001525; GO:0001570; GO:0001666; GO:0001937; GO:0001960; GO:0002080; GO:0002095; GO:0002931; GO:0003057; GO:0005102; GO:0005623; GO:0005768; GO:0005783; GO:0005887; GO:0005901; GO:0005925; GO:0005929; GO:0005938; GO:0006641; GO:0006816; GO:0006940; GO:0007519; GO:0007595; GO:0008104; GO:0009617; GO:0010524; GO:0010608; GO:0010628; GO:0016504; GO:0019065; GO:0019217; GO:0019901; GO:0019915; GO:0030193; GO:0030335; GO:0030512; GO:0030674; GO:0030857; GO:0031295; GO:0031397; GO:0031398; GO:0031623; GO:0032091; GO:0032092; GO:0032570; GO:0033137; GO:0033138; GO:0033484; GO:0034141; GO:0042310; GO:0042532; GO:0042632; GO:0042802; GO:0043627; GO:0044325; GO:0044877; GO:0045019; GO:0045121; GO:0045907; GO:0046982; GO:0048365; GO:0048471; GO:0048550; GO:0050998; GO:0051001; GO:0051092; GO:0051117; GO:0051592; GO:0051899; GO:0060056; GO:0060355; GO:0060546; GO:0061099; GO:0070320; GO:0070836; GO:0071360; GO:0071455; GO:0071560; GO:0071711; GO:0072584; GO:0086091; GO:0086098; GO:0090090; GO:0090263; GO:0097190; GO:0098903; GO:0098911; GO:0120162; GO:1900027; GO:1900085; GO:1901844; GO:1903071; GO:1903598; GO:1903609; GO:2000286; GO:2000535; GO:2000811; GO:2001238; GO:2001244	"acrosomal membrane [GO:0002080]; caveola [GO:0005901]; caveolar macromolecular signaling complex [GO:0002095]; cell [GO:0005623]; cell cortex [GO:0005938]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; inward rectifier potassium channel inhibitor activity [GO:0070320]; ion channel binding [GO:0044325]; nitric-oxide synthase binding [GO:0050998]; peptidase activator activity [GO:0016504]; protein binding, bridging [GO:0030674]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; apoptotic signaling pathway [GO:0097190]; basement membrane organization [GO:0071711]; calcium ion transport [GO:0006816]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to hyperoxia [GO:0071455]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cholesterol homeostasis [GO:0042632]; inactivation of MAPK activity [GO:0000188]; lactation [GO:0007595]; lipid storage [GO:0019915]; mammary gland involution [GO:0060056]; membrane depolarization [GO:0051899]; negative regulation of anoikis [GO:2000811]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; negative regulation of necroptotic process [GO:0060546]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-tyrosine autophosphorylation [GO:1900085]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein binding [GO:0032091]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nitric oxide homeostasis [GO:0033484]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of vasoconstriction [GO:0045907]; posttranscriptional regulation of gene expression [GO:0010608]; protein localization [GO:0008104]; receptor internalization [GO:0031623]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of blood coagulation [GO:0030193]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of ruffle assembly [GO:1900027]; regulation of smooth muscle contraction [GO:0006940]; regulation of the force of heart contraction by chemical signal [GO:0003057]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; response to bacterium [GO:0009617]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to progesterone [GO:0032570]; skeletal muscle tissue development [GO:0007519]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]; vasculogenesis [GO:0001570]; vasoconstriction [GO:0042310]"
PGEN_.00g221800	Scaffold_10	46267135	46271468	Q53G59	KLH12_HUMAN	Kelch-like protein 12 (CUL3-interacting protein 1) (DKIR homolog) (hDKIR)	GO:0000139; GO:0005829; GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0034451; GO:0042802; GO:0043231; GO:0048208; GO:0090090	centriolar satellite [GO:0034451]; COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]
PGEN_.00g221810	Scaffold_10	46285605	46285817	NA	NA	NA	NA	NA
PGEN_.00g221820	Scaffold_10	46286015	46286230	NA	NA	NA	NA	NA
PGEN_.00g221830	Scaffold_10	46286590	46286826	NA	NA	NA	NA	NA
PGEN_.00g221840	Scaffold_10	46286950	46294318	NA	NA	NA	NA	NA
PGEN_.00g221850	Scaffold_10	46294824	46295060	NA	NA	NA	NA	NA
PGEN_.00g221860	Scaffold_10	46295342	46296058	NA	NA	NA	NA	NA
PGEN_.00g221870	Scaffold_10	46302661	46312199	NA	NA	NA	NA	NA
PGEN_.00g221880	Scaffold_10	46335992	46339894	NA	NA	NA	NA	NA
PGEN_.00g221890	Scaffold_10	46343791	46347018	NA	NA	NA	NA	NA
PGEN_.00g221900	Scaffold_10	46348064	46348348	NA	NA	NA	NA	NA
PGEN_.00g221910	Scaffold_10	46348595	46349293	NA	NA	NA	NA	NA
PGEN_.00g221920	Scaffold_10	46349436	46350399	NA	NA	NA	NA	NA
PGEN_.00g221930	Scaffold_10	46350565	46351647	NA	NA	NA	NA	NA
PGEN_.00g221940	Scaffold_10	46404646	46412552	P57788	MOT4_CHICK	Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3)	GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g221950	Scaffold_10	46433645	46436167	NA	NA	NA	NA	NA
PGEN_.00g221960	Scaffold_10	46446364	46447020	NA	NA	NA	NA	NA
PGEN_.00g221970	Scaffold_10	46455849	46456109	NA	NA	NA	NA	NA
PGEN_.00g221980	Scaffold_10	46477780	46484448	NA	NA	NA	NA	NA
PGEN_.00g221990	Scaffold_10	46492274	46518816	Q9Y2I1	NISCH_HUMAN	Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor antisera-selected protein) (hIRAS) (Imidazoline-1 receptor) (I1R) (Imidazoline-1 receptor candidate protein) (I-1 receptor candidate protein) (I1R candidate protein)	GO:0005178; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006006; GO:0006915; GO:0008217; GO:0016020; GO:0016601; GO:0019901; GO:0030036; GO:0030336; GO:0032228; GO:0035091; GO:0042802; GO:0048243; GO:0055037	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228]"
PGEN_.00g222000	Scaffold_10	46525396	46525671	NA	NA	NA	NA	NA
PGEN_.00g222010	Scaffold_10	46526052	46533243	NA	NA	NA	NA	NA
PGEN_.00g222020	Scaffold_10	46550738	46551166	NA	NA	NA	NA	NA
PGEN_.00g222030	Scaffold_10	46574587	46583169	Q9PRJ8	FXD5A_XENLA	Forkhead box protein D5-A (FoxD5-A) (FoxD5a) (Fork head domain-related protein 12) (xFD-12) (XlFoxD5a)	GO:0001840; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007399; GO:0009953; GO:0030154; GO:0043565; GO:0045892	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural plate development [GO:0001840]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g222040	Scaffold_10	46592401	46598300	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g222050	Scaffold_10	46623897	46624443	NA	NA	NA	NA	NA
PGEN_.00g222060	Scaffold_10	46625409	46631710	NA	NA	NA	NA	NA
PGEN_.00g222070	Scaffold_10	46632501	46632818	NA	NA	NA	NA	NA
PGEN_.00g222080	Scaffold_10	46731067	46884693	Q14643	ITPR1_HUMAN	"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)"	GO:0001666; GO:0005220; GO:0005509; GO:0005623; GO:0005637; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0005955; GO:0006816; GO:0007165; GO:0009791; GO:0010506; GO:0014069; GO:0015085; GO:0015278; GO:0016020; GO:0016021; GO:0016529; GO:0019855; GO:0030168; GO:0030658; GO:0030659; GO:0030667; GO:0031088; GO:0031094; GO:0031095; GO:0032469; GO:0035091; GO:0042045; GO:0048471; GO:0050796; GO:0050849; GO:0050882; GO:0051209; GO:0070059; GO:0070679; GO:0098685; GO:0098695; GO:1903779	"calcineurin complex [GO:0005955]; cell [GO:0005623]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; regulation of cardiac conduction [GO:1903779]; regulation of insulin secretion [GO:0050796]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]"
PGEN_.00g222090	Scaffold_10	46915715	46915981	NA	NA	NA	NA	NA
PGEN_.00g222100	Scaffold_10	46916072	46920202	NA	NA	NA	NA	NA
PGEN_.00g222110	Scaffold_10	46920685	46926181	Q5ZJ87	SAMTR_CHICK	S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog) (EC 2.1.1.-)	GO:0005730; GO:0016433; GO:0034198; GO:0140007; GO:1904047; GO:1904262; GO:1990130	GATOR1 complex [GO:1990130]; KICSTOR complex [GO:0140007]; nucleolus [GO:0005730]; rRNA (adenine) methyltransferase activity [GO:0016433]; S-adenosyl-L-methionine binding [GO:1904047]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]
PGEN_.00g222120	Scaffold_10	46979411	46984935	NA	NA	NA	NA	NA
PGEN_.00g222130	Scaffold_10	46999577	47038381	Q58NQ4	FOXP1_CHICK	Forkhead box protein P1	GO:0000122; GO:0000978; GO:0000981; GO:0002053; GO:0002329; GO:0002639; GO:0003682; GO:0005634; GO:0007519; GO:0008045; GO:0021517; GO:0033152; GO:0042803; GO:0045214; GO:0045893; GO:0045944; GO:0046872; GO:0046982; GO:0048745; GO:0050679; GO:0055007; GO:0060043; GO:0061140; GO:0061470; GO:0072358; GO:0072619; GO:0098582; GO:0098900; GO:1901250	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cardiac muscle cell differentiation [GO:0055007]; cardiovascular system development [GO:0072358]; immunoglobulin V(D)J recombination [GO:0033152]; innate vocalization behavior [GO:0098582]; interleukin-21 secretion [GO:0072619]; lung secretory cell differentiation [GO:0061140]; motor neuron axon guidance [GO:0008045]; negative regulation of lung goblet cell differentiation [GO:1901250]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pre-B cell differentiation [GO:0002329]; regulation of action potential [GO:0098900]; regulation of cardiac muscle cell proliferation [GO:0060043]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; T follicular helper cell differentiation [GO:0061470]; ventral spinal cord development [GO:0021517]"
PGEN_.00g222140	Scaffold_10	47053413	47080877	Q5T699	CF183_HUMAN	Deleted.		
PGEN_.00g222150	Scaffold_10	47081032	47083336	NA	NA	NA	NA	NA
PGEN_.00g222160	Scaffold_10	47084321	47106915	Q0VG85	CC162_MOUSE	Coiled-coil domain-containing protein 162		
PGEN_.00g222170	Scaffold_10	47143681	47143956	NA	NA	NA	NA	NA
PGEN_.00g222180	Scaffold_10	47152291	47159456	NA	NA	NA	NA	NA
PGEN_.00g222190	Scaffold_10	47160994	47161398	NA	NA	NA	NA	NA
PGEN_.00g222200	Scaffold_10	47196896	47199454	NA	NA	NA	NA	NA
PGEN_.00g222210	Scaffold_10	47201238	47206717	NA	NA	NA	NA	NA
PGEN_.00g222220	Scaffold_10	47228031	47230149	NA	NA	NA	NA	NA
PGEN_.00g222230	Scaffold_10	47238142	47238735	NA	NA	NA	NA	NA
PGEN_.00g222240	Scaffold_10	47244108	47245581	NA	NA	NA	NA	NA
PGEN_.00g222250	Scaffold_10	47261760	47266690	NA	NA	NA	NA	NA
PGEN_.00g222260	Scaffold_10	47266740	47315064	NA	NA	NA	NA	NA
PGEN_.00g222270	Scaffold_10	47322664	47339733	D9IQ16	GXN_ACRMI	Galaxin	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g222280	Scaffold_10	47340210	47340527	NA	NA	NA	NA	NA
PGEN_.00g222290	Scaffold_10	47357562	47368971	D2I1E3	ARP8_AILME	Actin-related protein 8	GO:0005524; GO:0005654; GO:0005813; GO:0006281; GO:0006310; GO:0006338; GO:0007049; GO:0031011; GO:0051301	centrosome [GO:0005813]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]
PGEN_.00g222300	Scaffold_10	47371347	47371745	NA	NA	NA	NA	NA
PGEN_.00g222310	Scaffold_10	47377113	47377439	NA	NA	NA	NA	NA
PGEN_.00g222320	Scaffold_10	47377530	47377775	NA	NA	NA	NA	NA
PGEN_.00g222330	Scaffold_10	47388112	47389307	NA	NA	NA	NA	NA
PGEN_.00g222340	Scaffold_10	47393745	47399031	NA	NA	NA	NA	NA
PGEN_.00g222350	Scaffold_10	47408781	47409790	NA	NA	NA	NA	NA
PGEN_.00g222360	Scaffold_10	47461867	47517659	Q9W3W5	WIF1_DROME	Protein shifted (WIF-1-like protein)	GO:0005576; GO:0007224; GO:0008039; GO:0031012; GO:0045880; GO:0050821; GO:0071692	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to extracellular region [GO:0071692]; protein stabilization [GO:0050821]; smoothened signaling pathway [GO:0007224]; synaptic target recognition [GO:0008039]
PGEN_.00g222370	Scaffold_10	47522522	47527251	NA	NA	NA	NA	NA
PGEN_.00g222380	Scaffold_10	47533219	47534451	Q8BX37	ACP7_MOUSE	Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)	GO:0003993; GO:0005576; GO:0046872	extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]
PGEN_.00g222390	Scaffold_10	47542420	47596258	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g222400	Scaffold_10	47618136	47632902	Q9NX63	MIC19_HUMAN	MICOS complex subunit MIC19 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 3)	GO:0000122; GO:0001227; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0007007; GO:0008053; GO:0019902; GO:0042407; GO:0060090; GO:0061617; GO:0070062	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g222410	Scaffold_10	47636827	47637300	NA	NA	NA	NA	NA
PGEN_.00g222420	Scaffold_10	47649575	47663064	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g222430	Scaffold_10	47672260	47672625	NA	NA	NA	NA	NA
PGEN_.00g222440	Scaffold_10	47672859	47673179	NA	NA	NA	NA	NA
PGEN_.00g222450	Scaffold_10	47677263	47691168	NA	NA	NA	NA	NA
PGEN_.00g222460	Scaffold_10	47746689	47754109	NA	NA	NA	NA	NA
PGEN_.00g222470	Scaffold_10	47873793	47875022	NA	NA	NA	NA	NA
PGEN_.00g222480	Scaffold_10	47912144	47914321	NA	NA	NA	NA	NA
PGEN_.00g222490	Scaffold_10	47917778	47920824	P51186	CAN3_BOVIN	Calpain-3 (EC 3.4.22.54) (Calcium-activated neutral proteinase 3) (CANP 3) (Calpain L3) (Calpain p94) (Muscle-specific calcium-activated neutral protease 3) (New calpain 1) (nCL-1)	GO:0003824; GO:0004198; GO:0005509; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0008233; GO:0008307; GO:0014718; GO:0014850; GO:0030016; GO:0030018; GO:0030239; GO:0030315; GO:0031402; GO:0031432; GO:0032991; GO:0033234; GO:0043066; GO:0043122; GO:0045214; GO:0045862; GO:0045892; GO:0045893; GO:0050790; GO:0051092; GO:0051281; GO:0051592; GO:0055103; GO:0060090; GO:0061061; GO:0065003; GO:0071277; GO:0071472; GO:0072657; GO:0097264; GO:1990092	"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; catalytic activity [GO:0003824]; ligase regulator activity [GO:0055103]; molecular adaptor activity [GO:0060090]; peptidase activity [GO:0008233]; sodium ion binding [GO:0031402]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; calcium-dependent self proteolysis [GO:1990092]; cellular response to calcium ion [GO:0071277]; cellular response to salt stress [GO:0071472]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to membrane [GO:0072657]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to calcium ion [GO:0051592]; response to muscle activity [GO:0014850]; sarcomere organization [GO:0045214]; self proteolysis [GO:0097264]"
PGEN_.00g222500	Scaffold_10	47930151	47930435	NA	NA	NA	NA	NA
PGEN_.00g222510	Scaffold_10	47930466	47930957	NA	NA	NA	NA	NA
PGEN_.00g222520	Scaffold_10	47931882	47932685	NA	NA	NA	NA	NA
PGEN_.00g222530	Scaffold_10	47933273	47935852	NA	NA	NA	NA	NA
PGEN_.00g222540	Scaffold_10	47948022	47948846	NA	NA	NA	NA	NA
PGEN_.00g222550	Scaffold_10	47950006	47953935	NA	NA	NA	NA	NA
PGEN_.00g222560	Scaffold_10	47965807	47966622	NA	NA	NA	NA	NA
PGEN_.00g222570	Scaffold_10	47976656	47977507	Q8R151	ZNFX1_MOUSE	NFX1-type zinc finger-containing protein 1	GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380	"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]"
PGEN_.00g222580	Scaffold_10	47977580	47982145	Q8R151	ZNFX1_MOUSE	NFX1-type zinc finger-containing protein 1	GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380	"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]"
PGEN_.00g222590	Scaffold_10	47982250	47984161	NA	NA	NA	NA	NA
PGEN_.00g222600	Scaffold_10	48027860	48028213	NA	NA	NA	NA	NA
PGEN_.00g222610	Scaffold_10	48028266	48028502	NA	NA	NA	NA	NA
PGEN_.00g222620	Scaffold_10	48028904	48029428	NA	NA	NA	NA	NA
PGEN_.00g222630	Scaffold_10	48029511	48029759	NA	NA	NA	NA	NA
PGEN_.00g222640	Scaffold_10	48029852	48030331	NA	NA	NA	NA	NA
PGEN_.00g222650	Scaffold_10	48030390	48030704	NA	NA	NA	NA	NA
PGEN_.00g222660	Scaffold_10	48036294	48042521	Q3SZZ7	FGL1_BOVIN	Fibrinogen-like protein 1	GO:0002250; GO:0005576; GO:0050776; GO:0050868; GO:0072574	extracellular region [GO:0005576]; adaptive immune response [GO:0002250]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776]
PGEN_.00g222670	Scaffold_10	48049071	48074726	A4IGK4	RBM5_XENTR	RNA-binding protein 5 (RNA-binding motif protein 5)	GO:0000245; GO:0000381; GO:0003729; GO:0005634; GO:0005681; GO:0043065; GO:0046872	"nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]"
PGEN_.00g222680	Scaffold_10	48077850	48082925	Q9Y678	COPG1_HUMAN	Coatomer subunit gamma-1 (Gamma-1-coat protein) (Gamma-1-COP)	GO:0000139; GO:0005198; GO:0005623; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0009306; GO:0030126; GO:0030133; GO:0051683; GO:0072384	"cell [GO:0005623]; COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of Golgi localization [GO:0051683]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g222690	Scaffold_10	48158501	48158824	NA	NA	NA	NA	NA
PGEN_.00g222700	Scaffold_10	48160819	48161974	NA	NA	NA	NA	NA
PGEN_.00g222710	Scaffold_10	48171992	48221103	P70579	GRM8_RAT	Metabotropic glutamate receptor 8 (mGluR8)	GO:0001642; GO:0004930; GO:0005887; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0019233; GO:0035249; GO:0042734; GO:0043005; GO:0043025; GO:0045211; GO:0046928; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099059; GO:1901214; GO:2000300	"GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of neuron death [GO:1901214]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g222720	Scaffold_10	48306532	48315596	Q9QYS2	GRM3_MOUSE	Metabotropic glutamate receptor 3 (mGluR3)	GO:0001641; GO:0005246; GO:0005886; GO:0005887; GO:0007216; GO:0008066; GO:0014069; GO:0019233; GO:0030424; GO:0035249; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0048786; GO:0050804; GO:0051930; GO:0051966; GO:0097449; GO:0098978; GO:0099055; GO:0099056	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g222730	Scaffold_10	48351159	48351446	NA	NA	NA	NA	NA
PGEN_.00g222740	Scaffold_10	48429227	48458630	Q9Y6V0	PCLO_HUMAN	Protein piccolo (Aczonin)	GO:0005509; GO:0005522; GO:0005544; GO:0005856; GO:0007010; GO:0007416; GO:0014069; GO:0016079; GO:0017157; GO:0019933; GO:0030054; GO:0030073; GO:0035418; GO:0042995; GO:0045202; GO:0048788; GO:0070062; GO:0097091; GO:0098882; GO:0099526	cell junction [GO:0030054]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular exosome [GO:0070062]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; profilin binding [GO:0005522]; structural constituent of presynaptic active zone [GO:0098882]; cAMP-mediated signaling [GO:0019933]; cytoskeleton organization [GO:0007010]; insulin secretion [GO:0030073]; presynapse to nucleus signaling pathway [GO:0099526]; protein localization to synapse [GO:0035418]; regulation of exocytosis [GO:0017157]; synapse assembly [GO:0007416]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079]
PGEN_.00g222750	Scaffold_10	48461433	48476706	NA	NA	NA	NA	NA
PGEN_.00g222760	Scaffold_10	48526491	48526697	NA	NA	NA	NA	NA
PGEN_.00g222770	Scaffold_10	48544635	48544976	NA	NA	NA	NA	NA
PGEN_.00g222780	Scaffold_10	48578776	48586205	P23049	SEA_AVIET	Tyrosine-protein kinase transforming protein SEA (EC 2.7.10.2)	GO:0004715; GO:0005524	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]
PGEN_.00g222790	Scaffold_10	48600638	48603049	Q8UUZ1	MB212_DANRE	Protein mab-21-like 2	GO:0001654; GO:0002088; GO:0005634; GO:0005737; GO:0043010; GO:0048048; GO:0048701; GO:0060041	cytoplasm [GO:0005737]; nucleus [GO:0005634]; camera-type eye development [GO:0043010]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic eye morphogenesis [GO:0048048]; eye development [GO:0001654]; lens development in camera-type eye [GO:0002088]; retina development in camera-type eye [GO:0060041]
PGEN_.00g222800	Scaffold_10	48604857	48645790	Q108U6	MET_LOXAF	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	GO:0004714; GO:0005524; GO:0007169; GO:0016021; GO:0017154; GO:0050918; GO:0071526; GO:2001028	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; semaphorin-plexin signaling pathway [GO:0071526]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g222810	Scaffold_10	48655077	48670554	Q21086	GNL3_CAEEL	Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1)	GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]
PGEN_.00g222820	Scaffold_10	48670823	48678374	A7RT29	LTOR5_NEMVE	Ragulator complex protein LAMTOR5 homolog (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5)	GO:0005764; GO:0008361; GO:0019079; GO:0032008; GO:0043154; GO:0061462; GO:0071230; GO:0071986; GO:1904263	lysosome [GO:0005764]; Ragulator complex [GO:0071986]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to lysosome [GO:0061462]; regulation of cell size [GO:0008361]; viral genome replication [GO:0019079]
PGEN_.00g222830	Scaffold_10	48689502	48698078	NA	NA	NA	NA	NA
PGEN_.00g222840	Scaffold_10	48726665	48738126	Q8NDA2	HMCN2_HUMAN	Hemicentin-2	GO:0005509; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g222850	Scaffold_10	48747612	48748974	NA	NA	NA	NA	NA
PGEN_.00g222860	Scaffold_10	48750163	48765244	A2AJ76	HMCN2_MOUSE	Hemicentin-2	GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g222870	Scaffold_10	48769086	48769781	NA	NA	NA	NA	NA
PGEN_.00g222880	Scaffold_10	48781358	48781588	NA	NA	NA	NA	NA
PGEN_.00g222890	Scaffold_10	48787994	48788290	NA	NA	NA	NA	NA
PGEN_.00g222900	Scaffold_10	48805308	48805577	NA	NA	NA	NA	NA
PGEN_.00g222910	Scaffold_10	48837557	48862066	P19532	TFE3_HUMAN	Transcription factor E3 (Class E basic helix-loop-helix protein 33) (bHLHe33)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0002250; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006959; GO:0044212; GO:0045670; GO:0045785; GO:0045893; GO:0045944; GO:0046983; GO:0120163	"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of osteoclast differentiation [GO:0045670]"
PGEN_.00g222920	Scaffold_10	48873806	48908354	Q90YH9	TES_CHICK	Testin	GO:0005737; GO:0005925; GO:0008270; GO:0042127	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; zinc ion binding [GO:0008270]; regulation of cell population proliferation [GO:0042127]
PGEN_.00g222930	Scaffold_10	48979830	48980042	NA	NA	NA	NA	NA
PGEN_.00g222940	Scaffold_10	49006506	49008623	NA	NA	NA	NA	NA
PGEN_.00g222950	Scaffold_10	49008785	49009303	NA	NA	NA	NA	NA
PGEN_.00g222960	Scaffold_10	49014868	49015146	NA	NA	NA	NA	NA
PGEN_.00g222970	Scaffold_10	49041346	49043349	NA	NA	NA	NA	NA
PGEN_.00g222980	Scaffold_10	49062103	49062342	NA	NA	NA	NA	NA
PGEN_.00g222990	Scaffold_10	49067410	49067658	NA	NA	NA	NA	NA
PGEN_.00g223000	Scaffold_10	49082255	49082872	NA	NA	NA	NA	NA
PGEN_.00g223010	Scaffold_10	49083115	49083843	NA	NA	NA	NA	NA
PGEN_.00g223020	Scaffold_10	49181878	49182543	NA	NA	NA	NA	NA
PGEN_.00g223030	Scaffold_10	49190720	49202719	NA	NA	NA	NA	NA
PGEN_.00g223040	Scaffold_10	49203257	49205234	NA	NA	NA	NA	NA
PGEN_.00g223050	Scaffold_10	49217051	49238656	NA	NA	NA	NA	NA
PGEN_.00g223060	Scaffold_10	49241911	49261322	NA	NA	NA	NA	NA
PGEN_.00g223070	Scaffold_10	49269624	49285817	Q9NX63	MIC19_HUMAN	MICOS complex subunit MIC19 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 3)	GO:0000122; GO:0001227; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0007007; GO:0008053; GO:0019902; GO:0042407; GO:0060090; GO:0061617; GO:0070062	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g223080	Scaffold_10	49301071	49309832	NA	NA	NA	NA	NA
PGEN_.00g223090	Scaffold_10	49335449	49356780	Q640L2	SPX3_XENLA	Sugar phosphate exchanger 3 (Solute carrier family 37 member 3)	GO:0008643; GO:0022857; GO:0030176	integral component of endoplasmic reticulum membrane [GO:0030176]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]
PGEN_.00g223100	Scaffold_10	49364311	49381721	Q8BKT8	HAUS7_MOUSE	HAUS augmin-like complex subunit 7 (26S proteasome-associated UCH37-interacting protein 1) (UCHL5-interacting protein)	GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007098; GO:0031996; GO:0051011; GO:0051225; GO:0051301; GO:0070652	centrosome [GO:0005813]; cytoplasm [GO:0005737]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; spindle [GO:0005819]; microtubule minus-end binding [GO:0051011]; thioesterase binding [GO:0031996]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]
PGEN_.00g223110	Scaffold_10	49389501	49390232	NA	NA	NA	NA	NA
PGEN_.00g223120	Scaffold_10	49395364	49401834	Q9H4K1	RIBC2_HUMAN	RIB43A-like with coiled-coils protein 2	GO:0005634	nucleus [GO:0005634]
PGEN_.00g223130	Scaffold_10	49409929	49434406	Q5K651	SAMD9_HUMAN	Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9)	GO:0005737; GO:0005829; GO:0034058; GO:0043231	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058]
PGEN_.00g223140	Scaffold_10	49445171	49476449	Q6P2S7	TTC41_HUMAN	Putative tetratricopeptide repeat protein 41 (TPR repeat protein 41) (Grp94-neighboring nucleotidase)	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g223150	Scaffold_10	49487230	49520052	Q8WNU8	NEK11_MACFA	Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11)	GO:0004674; GO:0005524; GO:0005730; GO:0006468; GO:0031573; GO:0035556; GO:0046872	nucleolus [GO:0005730]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intra-S DNA damage checkpoint [GO:0031573]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]
PGEN_.00g223160	Scaffold_10	49563409	49579736	B2IZD3	BDLP_NOSP7	Bacterial dynamin-like protein (BDLP) (EC 3.6.5.5)	GO:0003924; GO:0005525; GO:0005886; GO:0008289; GO:0016021; GO:0042802	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]
PGEN_.00g223170	Scaffold_10	49582328	49582994	NA	NA	NA	NA	NA
PGEN_.00g223180	Scaffold_10	49598400	49602419	NA	NA	NA	NA	NA
PGEN_.00g223190	Scaffold_10	49613764	49622997	Q7RZD3	STE20_NEUCR	Serine/threonine-protein kinase ste20 (EC 2.7.11.1) (Serine/threonine protein kinase 4)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0019236; GO:0023014; GO:0032147	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; response to pheromone [GO:0019236]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g223200	Scaffold_10	49628458	49636759	Q5SY16	NOL9_HUMAN	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0045111; GO:0051731	"intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; rRNA processing [GO:0006364]"
PGEN_.00g223210	Scaffold_10	49650164	49654593	NA	NA	NA	NA	NA
PGEN_.00g223220	Scaffold_10	49760686	49768039	Q28C33	TBC30_XENTR	TBC1 domain family member 30	GO:0005096; GO:0006886; GO:0017137; GO:0090630	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]
PGEN_.00g223230	Scaffold_10	49768137	49769219	Q8BUH1	TXN4B_MOUSE	Thioredoxin-like protein 4B	GO:0000398; GO:0005634; GO:0005654; GO:0005682; GO:0005829; GO:0007049; GO:0008284; GO:0046540	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell population proliferation [GO:0008284]"
PGEN_.00g223240	Scaffold_10	49770215	49783079	NA	NA	NA	NA	NA
PGEN_.00g223250	Scaffold_10	49783192	49784244	NA	NA	NA	NA	NA
PGEN_.00g223260	Scaffold_10	49784550	49787130	NA	NA	NA	NA	NA
PGEN_.00g223270	Scaffold_10	49788762	49834585	Q803T2	STRP1_DANRE	Striatin-interacting protein 1 homolog	GO:0005737; GO:0022604; GO:0030866; GO:0060047	cytoplasm [GO:0005737]; cortical actin cytoskeleton organization [GO:0030866]; heart contraction [GO:0060047]; regulation of cell morphogenesis [GO:0022604]
PGEN_.00g223280	Scaffold_10	49846134	49868144	Q7Z9I2	YCP9_SCHPO	Uncharacterized oxidoreductase C663.09c (EC 1.-.-.-)	GO:0005634; GO:0005829; GO:0016491; GO:0110095	cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095]
PGEN_.00g223290	Scaffold_10	49868404	49869443	NA	NA	NA	NA	NA
PGEN_.00g223300	Scaffold_10	49869566	49879180	O18373	SPS1_DROME	"Inactive selenide, water dikinase-like protein (Protein patufet) (dSelD)"	GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0007049; GO:0007275; GO:0010637; GO:0016260; GO:0070329; GO:2000378	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; selenide, water dikinase activity [GO:0004756]; cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329]"
PGEN_.00g223310	Scaffold_10	49891823	49895663	Q99PL6	UBXN6_MOUSE	UBX domain-containing protein 6 (UBX domain-containing protein 1)	GO:0005634; GO:0005737; GO:0005765; GO:0005815; GO:0005829; GO:0016236; GO:0019898; GO:0031901; GO:0031902; GO:0032510; GO:0032991; GO:0036503	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]
PGEN_.00g223320	Scaffold_10	49907155	49914275	Q86T20	SIM29_HUMAN	Small integral membrane protein 29 (Protein LBH)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g223330	Scaffold_10	49924072	49938201	NA	NA	NA	NA	NA
PGEN_.00g223340	Scaffold_10	49946203	49994914	Q9Y4B6	DCAF1_HUMAN	DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)	GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016032; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0080008; GO:1990244; GO:1990245	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]; B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032]
PGEN_.00g223350	Scaffold_10	50025465	50042206	NA	NA	NA	NA	NA
PGEN_.00g223360	Scaffold_10	50067850	50089233	Q8BTZ7	GMPPB_MOUSE	Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta)	GO:0004475; GO:0005525; GO:0005737; GO:0005739; GO:0009298	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]
PGEN_.00g223370	Scaffold_10	50082119	50114523	Q7SXF6	CREL2_DANRE	Cysteine-rich with EGF-like domain protein 2	GO:0005509; GO:0005576; GO:0005783	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g223380	Scaffold_10	50124186	50158327	Q9ZQ47	GRDP1_ARATH	Glycine-rich domain-containing protein 1 (AtGRDP1)	GO:0005886; GO:0009738; GO:0009787; GO:0071470	plasma membrane [GO:0005886]; abscisic acid-activated signaling pathway [GO:0009738]; cellular response to osmotic stress [GO:0071470]; regulation of abscisic acid-activated signaling pathway [GO:0009787]
PGEN_.00g223390	Scaffold_10	50158576	50175270	NA	NA	NA	NA	NA
PGEN_.00g223400	Scaffold_10	50233099	50240428	Q86XH1	DRC11_HUMAN	Dynein regulatory complex protein 11 (IQ and AAA domain-containing protein 1)	GO:0005524; GO:0005737; GO:0005856; GO:0031514	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; ATP binding [GO:0005524]
PGEN_.00g223410	Scaffold_10	50242387	50319551	Q6YHK3	CD109_HUMAN	CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)	GO:0001933; GO:0001942; GO:0002576; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0045616; GO:0050431; GO:0061045; GO:0072675	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616]
PGEN_.00g223420	Scaffold_10	50326554	50327363	NA	NA	NA	NA	NA
PGEN_.00g223430	Scaffold_10	50339490	50344145	Q9LX66	HERK_ARATH	Receptor-like protein kinase HERK 1 (EC 2.7.11.-) (Protein HERCULES RECEPTOR KINASE 1)	GO:0004672; GO:0004674; GO:0005524; GO:0005886; GO:0009506; GO:0009741; GO:0009826; GO:0016021; GO:0046777	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein autophosphorylation [GO:0046777]; response to brassinosteroid [GO:0009741]; unidimensional cell growth [GO:0009826]
PGEN_.00g223440	Scaffold_10	50346559	50347044	NA	NA	NA	NA	NA
PGEN_.00g223450	Scaffold_10	50348186	50358251	A9TXT1	CERK1_PHYPA	Chitin elicitor receptor kinase 1 (PpCERK1) (EC 2.7.11.1) (Chitin receptor CERK1) (LysM domain receptor-like kinase 1) (LysM-containing receptor-like kinase 1)	GO:0004674; GO:0005524; GO:0005886; GO:0006952; GO:0008061; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; chitin binding [GO:0008061]; protein serine/threonine kinase activity [GO:0004674]; defense response [GO:0006952]
PGEN_.00g223460	Scaffold_10	50386028	50386255	NA	NA	NA	NA	NA
PGEN_.00g223470	Scaffold_10	50388195	50403233	Q9UHI7	S23A1_HUMAN	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3)	GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016324; GO:0019852; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g223480	Scaffold_10	50415182	50421715	NA	NA	NA	NA	NA
PGEN_.00g223490	Scaffold_10	50424639	50428317	B0JZG0	S23A2_XENTR	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	GO:0016021; GO:0019852; GO:0070890	integral component of membrane [GO:0016021]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]
PGEN_.00g223500	Scaffold_10	50431710	50446645	Q9Y2M2	SSUH2_HUMAN	Protein SSUH2 homolog (Protein ssu-2 homolog)	GO:0005634; GO:0005737; GO:0042476	cytoplasm [GO:0005737]; nucleus [GO:0005634]; odontogenesis [GO:0042476]
PGEN_.00g223510	Scaffold_10	50451470	50455863	Q9Y2M2	SSUH2_HUMAN	Protein SSUH2 homolog (Protein ssu-2 homolog)	GO:0005634; GO:0005737; GO:0042476	cytoplasm [GO:0005737]; nucleus [GO:0005634]; odontogenesis [GO:0042476]
PGEN_.00g223520	Scaffold_10	50458214	50473400	Q9Y2M2	SSUH2_HUMAN	Protein SSUH2 homolog (Protein ssu-2 homolog)	GO:0005634; GO:0005737; GO:0042476	cytoplasm [GO:0005737]; nucleus [GO:0005634]; odontogenesis [GO:0042476]
PGEN_.00g223530	Scaffold_10	50477005	50483855	B0JZG0	S23A2_XENTR	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	GO:0016021; GO:0019852; GO:0070890	integral component of membrane [GO:0016021]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]
PGEN_.00g223540	Scaffold_10	50484048	50485027	NA	NA	NA	NA	NA
PGEN_.00g223550	Scaffold_10	50502710	50517826	Q9WTW8	S23A2_RAT	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g223560	Scaffold_10	50547539	50562533	A9TXT1	CERK1_PHYPA	Chitin elicitor receptor kinase 1 (PpCERK1) (EC 2.7.11.1) (Chitin receptor CERK1) (LysM domain receptor-like kinase 1) (LysM-containing receptor-like kinase 1)	GO:0004674; GO:0005524; GO:0005886; GO:0006952; GO:0008061; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; chitin binding [GO:0008061]; protein serine/threonine kinase activity [GO:0004674]; defense response [GO:0006952]
PGEN_.00g223570	Scaffold_10	50563777	50564085	NA	NA	NA	NA	NA
PGEN_.00g223580	Scaffold_10	50566489	50571164	Q9LX66	HERK_ARATH	Receptor-like protein kinase HERK 1 (EC 2.7.11.-) (Protein HERCULES RECEPTOR KINASE 1)	GO:0004672; GO:0004674; GO:0005524; GO:0005886; GO:0009506; GO:0009741; GO:0009826; GO:0016021; GO:0046777	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein autophosphorylation [GO:0046777]; response to brassinosteroid [GO:0009741]; unidimensional cell growth [GO:0009826]
PGEN_.00g223590	Scaffold_10	50592140	50594954	NA	NA	NA	NA	NA
PGEN_.00g223600	Scaffold_10	50607522	50633029	NA	NA	NA	NA	NA
PGEN_.00g223610	Scaffold_10	50635037	50638429	NA	NA	NA	NA	NA
PGEN_.00g223620	Scaffold_10	50725108	50764929	B0JYW5	ANM6_XENTR	Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT6)	GO:0005634; GO:0006281; GO:0008469; GO:0019919; GO:0034970; GO:0035241; GO:0035242; GO:0035246; GO:0042054; GO:0042393; GO:0044020; GO:0045892; GO:0070611; GO:0070612	"nucleus [GO:0005634]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; DNA repair [GO:0006281]; histone H3-R2 methylation [GO:0034970]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine N-methylation [GO:0035246]"
PGEN_.00g223630	Scaffold_10	50766455	50771639	Q8BK48	EST2E_MOUSE	Pyrethroid hydrolase Ces2e (EC 3.1.1.88) (carboxylesterase 2E)	GO:0005615; GO:0005783; GO:0052689; GO:0102209	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; trans-permethrin hydrolase activity [GO:0102209]
PGEN_.00g223640	Scaffold_10	50771762	50803715	Q9UPP1	PHF8_HUMAN	Histone lysine demethylase PHF8 (EC 1.14.11.27) (PHD finger protein 8)	GO:0000082; GO:0003682; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0007420; GO:0008270; GO:0016706; GO:0031965; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0045943; GO:0051864; GO:0061188; GO:0070544; GO:0071557; GO:0071558	"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of chromatin silencing at rDNA [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g223650	Scaffold_10	50803931	50806681	Q9UPP1	PHF8_HUMAN	Histone lysine demethylase PHF8 (EC 1.14.11.27) (PHD finger protein 8)	GO:0000082; GO:0003682; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0007420; GO:0008270; GO:0016706; GO:0031965; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0045943; GO:0051864; GO:0061188; GO:0070544; GO:0071557; GO:0071558	"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of chromatin silencing at rDNA [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g223660	Scaffold_10	50822664	50863011	Q6NUT7	SORT1_DANRE	Sortilin	GO:0005794; GO:0005829; GO:0006892; GO:0006895; GO:0006897; GO:0016021; GO:0016050; GO:0032580	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; endocytosis [GO:0006897]; Golgi to endosome transport [GO:0006895]; post-Golgi vesicle-mediated transport [GO:0006892]; vesicle organization [GO:0016050]
PGEN_.00g223670	Scaffold_10	50864917	50881078	Q99523	SORT_HUMAN	Sortilin (100 kDa NT receptor) (Glycoprotein 95) (Gp95) (Neurotensin receptor 3) (NT3) (NTR3)	GO:0001503; GO:0005764; GO:0005765; GO:0005769; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006892; GO:0006895; GO:0006897; GO:0007186; GO:0007218; GO:0007275; GO:0008333; GO:0008625; GO:0009986; GO:0010008; GO:0010465; GO:0010468; GO:0014902; GO:0016021; GO:0016050; GO:0019899; GO:0030136; GO:0030140; GO:0030379; GO:0030425; GO:0030659; GO:0031410; GO:0031965; GO:0032509; GO:0032580; GO:0032868; GO:0043025; GO:0045599; GO:0046323; GO:0048011; GO:0048227; GO:0048406; GO:0048471; GO:0051005; GO:1904037	"cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140]; enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose import [GO:0046323]; Golgi to endosome transport [GO:0006895]; multicellular organism development [GO:0007275]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of lipoprotein lipase activity [GO:0051005]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; positive regulation of epithelial cell apoptotic process [GO:1904037]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050]"
PGEN_.00g223680	Scaffold_10	50910847	50911713	NA	NA	NA	NA	NA
PGEN_.00g223690	Scaffold_10	50916878	50918566	Q92630	DYRK2_HUMAN	Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1)	GO:0000151; GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0006974; GO:0007224; GO:0018105; GO:0018107; GO:0030145; GO:0042771; GO:0045725; GO:0070885; GO:1901796; GO:1990904	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224]
PGEN_.00g223700	Scaffold_10	51078541	51115986	NA	NA	NA	NA	NA
PGEN_.00g223710	Scaffold_10	51118699	51120705	Q9U3W6	MAB21_DROME	Protein mab-21		
PGEN_.00g223720	Scaffold_10	51120947	51135080	NA	NA	NA	NA	NA
PGEN_.00g223730	Scaffold_10	51146141	51148636	NA	NA	NA	NA	NA
PGEN_.00g223740	Scaffold_10	51168059	51168514	NA	NA	NA	NA	NA
PGEN_.00g223750	Scaffold_10	51173535	51188666	NA	NA	NA	NA	NA
PGEN_.00g223760	Scaffold_10	51189877	51264879	Q6ZV73	FGD6_HUMAN	"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)"	GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]
PGEN_.00g223770	Scaffold_10	51265445	51272722	Q69ZL1	FGD6_MOUSE	"FYVE, RhoGEF and PH domain-containing protein 6"	GO:0005085; GO:0005737; GO:0005856; GO:0043087; GO:0046872	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; regulation of GTPase activity [GO:0043087]
PGEN_.00g223780	Scaffold_10	51281711	51292771	Q6ZV73	FGD6_HUMAN	"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)"	GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]
PGEN_.00g223790	Scaffold_10	51314488	51330061	Q24155	TRUNK_DROME	Protein trunk	GO:0005122; GO:0005615; GO:0007362; GO:0008293; GO:0048018	extracellular space [GO:0005615]; receptor ligand activity [GO:0048018]; torso binding [GO:0005122]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]
PGEN_.00g223800	Scaffold_10	51340125	51357949	Q24155	TRUNK_DROME	Protein trunk	GO:0005122; GO:0005615; GO:0007362; GO:0008293; GO:0048018	extracellular space [GO:0005615]; receptor ligand activity [GO:0048018]; torso binding [GO:0005122]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]
PGEN_.00g223810	Scaffold_10	51373920	51394782	NA	NA	NA	NA	NA
PGEN_.00g223820	Scaffold_10	51425621	51445885	NA	NA	NA	NA	NA
PGEN_.00g223830	Scaffold_10	51447161	51448336	NA	NA	NA	NA	NA
PGEN_.00g223840	Scaffold_10	51457140	51459590	Q9R1R2	TRIM3_MOUSE	Tripartite motif-containing protein 3 (RING finger protein 22) (RING finger protein HAC1)	GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0043161; GO:0061630; GO:0098794; GO:0098978	cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]
PGEN_.00g223850	Scaffold_10	51464026	51466929	NA	NA	NA	NA	NA
PGEN_.00g223860	Scaffold_10	51490329	51501613	Q21355	GST4_CAEEL	Glutathione S-transferase 4 (EC 2.5.1.18) (CeGST1) (GST class-sigma)	GO:0004364; GO:0006749; GO:0043292	contractile fiber [GO:0043292]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]
PGEN_.00g223870	Scaffold_10	51506974	51512707	P18426	SCR11_NOTSL	S-crystallin SL11 (Major lens polypeptide)	GO:0005212	structural constituent of eye lens [GO:0005212]
PGEN_.00g223880	Scaffold_10	51522542	51526312	NA	NA	NA	NA	NA
PGEN_.00g223890	Scaffold_10	51541724	51551879	Q7Z3Z2	RD3_HUMAN	Protein RD3 (Retinal degeneration protein 3)	GO:0001750; GO:0001917; GO:0005634; GO:0005737; GO:0005768; GO:0007601; GO:0015031; GO:0031283; GO:0048471; GO:0050896; GO:0060041; GO:0120199; GO:0120200	cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; rod photoreceptor outer segment [GO:0120200]; negative regulation of guanylate cyclase activity [GO:0031283]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]
PGEN_.00g223900	Scaffold_10	51553565	51557556	Q91VR8	BRK1_MOUSE	Protein BRICK1 (BRK1)	GO:0001701; GO:0005856; GO:0007015; GO:0008064; GO:0008284; GO:0010592; GO:0016601; GO:0030027; GO:0030036; GO:0031209; GO:0031334; GO:0042802; GO:0044877; GO:0048365; GO:0048870; GO:0070207; GO:2000601	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein complex assembly [GO:0031334]; protein homotrimerization [GO:0070207]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]
PGEN_.00g223910	Scaffold_10	51567644	51570700	P0DPH8	TBA3D_HUMAN	Tubulin alpha-3D chain (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g223920	Scaffold_10	51587097	51587996	NA	NA	NA	NA	NA
PGEN_.00g223930	Scaffold_10	51593740	51606820	Q6VVW5	ANPRB_MOUSE	Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)	GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]
PGEN_.00g223940	Scaffold_10	51643293	51643553	NA	NA	NA	NA	NA
PGEN_.00g223950	Scaffold_10	51660677	51726627	Q9HAU5	RENT2_HUMAN	Regulator of nonsense transcripts 2 (Nonsense mRNA reducing factor 2) (Up-frameshift suppressor 2 homolog) (hUpf2)	GO:0000184; GO:0001889; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006406; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"
PGEN_.00g223960	Scaffold_10	51736731	51737057	NA	NA	NA	NA	NA
PGEN_.00g223970	Scaffold_10	51748622	51800065	NA	NA	NA	NA	NA
PGEN_.00g223980	Scaffold_10	51805394	51807094	NA	NA	NA	NA	NA
PGEN_.00g223990	Scaffold_10	51809886	51875230	Q96M96	FGD4_HUMAN	"FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6)"	GO:0001726; GO:0003779; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007010; GO:0007186; GO:0008360; GO:0030027; GO:0030036; GO:0030175; GO:0031267; GO:0043065; GO:0043087; GO:0046847; GO:0046872; GO:0051056	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g224000	Scaffold_10	51881879	51899542	O01666	ATPG_DROME	"ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit)"	GO:0000275; GO:0005739; GO:0006754; GO:0015986; GO:0046933; GO:1902600	"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]"
PGEN_.00g224010	Scaffold_10	51902321	51913864	P41350	CAV1_RAT	Caveolin-1	GO:0000122; GO:0000139; GO:0000149; GO:0000188; GO:0001525; GO:0001570; GO:0001666; GO:0001937; GO:0001938; GO:0001960; GO:0002026; GO:0002080; GO:0002931; GO:0003057; GO:0005102; GO:0005623; GO:0005737; GO:0005739; GO:0005768; GO:0005778; GO:0005783; GO:0005794; GO:0005811; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0005925; GO:0005929; GO:0005938; GO:0006641; GO:0006816; GO:0006874; GO:0006940; GO:0007519; GO:0007584; GO:0007595; GO:0008104; GO:0008285; GO:0009267; GO:0009612; GO:0009617; GO:0009925; GO:0009967; GO:0009968; GO:0009986; GO:0010332; GO:0010524; GO:0010608; GO:0010628; GO:0010656; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016504; GO:0019065; GO:0019217; GO:0019899; GO:0019900; GO:0019901; GO:0019905; GO:0019915; GO:0030154; GO:0030193; GO:0030335; GO:0030512; GO:0030514; GO:0030674; GO:0030857; GO:0030879; GO:0031100; GO:0031116; GO:0031295; GO:0031397; GO:0031398; GO:0031410; GO:0031623; GO:0032091; GO:0032092; GO:0032507; GO:0032570; GO:0032991; GO:0033137; GO:0033138; GO:0033344; GO:0033484; GO:0033612; GO:0034141; GO:0042060; GO:0042310; GO:0042493; GO:0042532; GO:0042632; GO:0042802; GO:0043085; GO:0043407; GO:0043409; GO:0043627; GO:0044325; GO:0044877; GO:0045019; GO:0045121; GO:0045665; GO:0045807; GO:0045907; GO:0046426; GO:0046785; GO:0046982; GO:0048365; GO:0048471; GO:0048550; GO:0048662; GO:0050998; GO:0051001; GO:0051092; GO:0051117; GO:0051259; GO:0051260; GO:0051384; GO:0051480; GO:0051592; GO:0051899; GO:0052547; GO:0055074; GO:0060056; GO:0060090; GO:0060355; GO:0060546; GO:0061099; GO:0070320; GO:0070373; GO:0070836; GO:0071260; GO:0071360; GO:0071375; GO:0071455; GO:0071560; GO:0072584; GO:0086091; GO:0086098; GO:0090090; GO:0090263; GO:0090398; GO:0097190; GO:0098903; GO:0098911; GO:0120162; GO:1900027; GO:1900085; GO:1901380; GO:1901844; GO:1903071; GO:1903598; GO:1903609; GO:2000286; GO:2000535; GO:2000811; GO:2001238; GO:2001244; GO:2001258	"acrosomal membrane [GO:0002080]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell [GO:0005623]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lipid droplet [GO:0005811]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inward rectifier potassium channel inhibitor activity [GO:0070320]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; peptidase activator activity [GO:0016504]; protein binding, bridging [GO:0030674]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; receptor serine/threonine kinase binding [GO:0033612]; signaling receptor binding [GO:0005102]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; angiogenesis [GO:0001525]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; animal organ regeneration [GO:0031100]; apoptotic signaling pathway [GO:0097190]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to hyperoxia [GO:0071455]; cellular response to mechanical stimulus [GO:0071260]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; inactivation of MAPK activity [GO:0000188]; lactation [GO:0007595]; lipid storage [GO:0019915]; maintenance of protein location in cell [GO:0032507]; mammary gland development [GO:0030879]; mammary gland involution [GO:0060056]; membrane depolarization [GO:0051899]; microtubule polymerization [GO:0046785]; negative regulation of anoikis [GO:2000811]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-tyrosine autophosphorylation [GO:1900085]; negative regulation of pinocytosis [GO:0048550]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of protein binding [GO:0032091]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of signal transduction [GO:0009968]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nitric oxide homeostasis [GO:0033484]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction [GO:0009967]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of vasoconstriction [GO:0045907]; posttranscriptional regulation of gene expression [GO:0010608]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; receptor internalization [GO:0031623]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of blood coagulation [GO:0030193]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of peptidase activity [GO:0052547]; regulation of ruffle assembly [GO:1900027]; regulation of smooth muscle contraction [GO:0006940]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by chemical signal [GO:0003057]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; response to bacterium [GO:0009617]; response to calcium ion [GO:0051592]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to gamma radiation [GO:0010332]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to progesterone [GO:0032570]; skeletal muscle tissue development [GO:0007519]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]; vasculogenesis [GO:0001570]; vasoconstriction [GO:0042310]; wound healing [GO:0042060]"
PGEN_.00g224020	Scaffold_10	51929215	51937467	Q05B81	PCFT_BOVIN	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Retinal pigment epithelium transporter) (Solute carrier family 46 member 1)	GO:0005542; GO:0005737; GO:0008517; GO:0015078; GO:0015232; GO:0015884; GO:0015886; GO:0016021; GO:0016324; GO:0051958; GO:1904447	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; heme transporter activity [GO:0015232]; proton transmembrane transporter activity [GO:0015078]; folate import across plasma membrane [GO:1904447]; folic acid transport [GO:0015884]; heme transport [GO:0015886]; methotrexate transport [GO:0051958]
PGEN_.00g224030	Scaffold_10	51939148	51939489	NA	NA	NA	NA	NA
PGEN_.00g224040	Scaffold_10	52057912	52066242	Q05B81	PCFT_BOVIN	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Retinal pigment epithelium transporter) (Solute carrier family 46 member 1)	GO:0005542; GO:0005737; GO:0008517; GO:0015078; GO:0015232; GO:0015884; GO:0015886; GO:0016021; GO:0016324; GO:0051958; GO:1904447	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; heme transporter activity [GO:0015232]; proton transmembrane transporter activity [GO:0015078]; folate import across plasma membrane [GO:1904447]; folic acid transport [GO:0015884]; heme transport [GO:0015886]; methotrexate transport [GO:0051958]
PGEN_.00g224050	Scaffold_10	52081613	52090673	Q2IBC1	CAV1_RHIFE	Caveolin-1	GO:0000139; GO:0005768; GO:0005901; GO:0030512; GO:0031295; GO:0031623; GO:0045121; GO:0070836	caveola [GO:0005901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; caveola assembly [GO:0070836]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; receptor internalization [GO:0031623]; T cell costimulation [GO:0031295]
PGEN_.00g224060	Scaffold_10	52096450	52115196	O01666	ATPG_DROME	"ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit)"	GO:0000275; GO:0005739; GO:0006754; GO:0015986; GO:0046933; GO:1902600	"mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]"
PGEN_.00g224070	Scaffold_10	52121861	52188491	Q96M96	FGD4_HUMAN	"FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6)"	GO:0001726; GO:0003779; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007010; GO:0007186; GO:0008360; GO:0030027; GO:0030036; GO:0030175; GO:0031267; GO:0043065; GO:0043087; GO:0046847; GO:0046872; GO:0051056	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g224080	Scaffold_10	52191267	52192967	NA	NA	NA	NA	NA
PGEN_.00g224090	Scaffold_10	52198640	52251019	NA	NA	NA	NA	NA
PGEN_.00g224100	Scaffold_10	52217459	52218709	NA	NA	NA	NA	NA
PGEN_.00g224110	Scaffold_10	52262584	52262910	NA	NA	NA	NA	NA
PGEN_.00g224120	Scaffold_10	52273203	52339146	Q9HAU5	RENT2_HUMAN	Regulator of nonsense transcripts 2 (Nonsense mRNA reducing factor 2) (Up-frameshift suppressor 2 homolog) (hUpf2)	GO:0000184; GO:0001889; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006406; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"
PGEN_.00g224130	Scaffold_10	52345308	52350487	NA	NA	NA	NA	NA
PGEN_.00g224140	Scaffold_10	52354675	52354935	NA	NA	NA	NA	NA
PGEN_.00g224150	Scaffold_10	52396360	52409576	Q6VVW5	ANPRB_MOUSE	Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)	GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]
PGEN_.00g224160	Scaffold_10	52414833	52415321	NA	NA	NA	NA	NA
PGEN_.00g224170	Scaffold_10	52415524	52416216	NA	NA	NA	NA	NA
PGEN_.00g224180	Scaffold_10	52432596	52435645	P0DPH8	TBA3D_HUMAN	Tubulin alpha-3D chain (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g224190	Scaffold_10	52446350	52451140	Q91VR8	BRK1_MOUSE	Protein BRICK1 (BRK1)	GO:0001701; GO:0005856; GO:0007015; GO:0008064; GO:0008284; GO:0010592; GO:0016601; GO:0030027; GO:0030036; GO:0031209; GO:0031334; GO:0042802; GO:0044877; GO:0048365; GO:0048870; GO:0070207; GO:2000601	cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; SCAR complex [GO:0031209]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell motility [GO:0048870]; in utero embryonic development [GO:0001701]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein complex assembly [GO:0031334]; protein homotrimerization [GO:0070207]; Rac protein signal transduction [GO:0016601]; regulation of actin polymerization or depolymerization [GO:0008064]
PGEN_.00g224200	Scaffold_10	52452732	52462885	Q7Z3Z2	RD3_HUMAN	Protein RD3 (Retinal degeneration protein 3)	GO:0001750; GO:0001917; GO:0005634; GO:0005737; GO:0005768; GO:0007601; GO:0015031; GO:0031283; GO:0048471; GO:0050896; GO:0060041; GO:0120199; GO:0120200	cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; rod photoreceptor outer segment [GO:0120200]; negative regulation of guanylate cyclase activity [GO:0031283]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]
PGEN_.00g224210	Scaffold_10	52478461	52482826	NA	NA	NA	NA	NA
PGEN_.00g224220	Scaffold_10	52493972	52499560	P18426	SCR11_NOTSL	S-crystallin SL11 (Major lens polypeptide)	GO:0005212	structural constituent of eye lens [GO:0005212]
PGEN_.00g224230	Scaffold_10	52506723	52517999	Q21355	GST4_CAEEL	Glutathione S-transferase 4 (EC 2.5.1.18) (CeGST1) (GST class-sigma)	GO:0004364; GO:0006749; GO:0043292	contractile fiber [GO:0043292]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]
PGEN_.00g224240	Scaffold_10	52548817	52551297	Q9R1R2	TRIM3_MOUSE	Tripartite motif-containing protein 3 (RING finger protein 22) (RING finger protein HAC1)	GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0043161; GO:0061630; GO:0098794; GO:0098978	cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]
PGEN_.00g224250	Scaffold_10	52560094	52561269	NA	NA	NA	NA	NA
PGEN_.00g224260	Scaffold_10	52563326	52582344	NA	NA	NA	NA	NA
PGEN_.00g224270	Scaffold_10	52604546	52604929	NA	NA	NA	NA	NA
PGEN_.00g224280	Scaffold_10	52605155	52610729	NA	NA	NA	NA	NA
PGEN_.00g224290	Scaffold_10	52615596	52626669	NA	NA	NA	NA	NA
PGEN_.00g224300	Scaffold_10	52648598	52664981	Q24155	TRUNK_DROME	Protein trunk	GO:0005122; GO:0005615; GO:0007362; GO:0008293; GO:0048018	extracellular space [GO:0005615]; receptor ligand activity [GO:0048018]; torso binding [GO:0005122]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]
PGEN_.00g224310	Scaffold_10	52672003	52673647	NA	NA	NA	NA	NA
PGEN_.00g224320	Scaffold_10	52716593	52736953	Q6ZV73	FGD6_HUMAN	"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)"	GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]
PGEN_.00g224330	Scaffold_10	52737315	52744894	Q69ZL1	FGD6_MOUSE	"FYVE, RhoGEF and PH domain-containing protein 6"	GO:0005085; GO:0005737; GO:0005856; GO:0043087; GO:0046872	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; regulation of GTPase activity [GO:0043087]
PGEN_.00g224340	Scaffold_10	52745460	52817739	Q6ZV73	FGD6_HUMAN	"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)"	GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]
PGEN_.00g224350	Scaffold_10	52819062	52834451	NA	NA	NA	NA	NA
PGEN_.00g224360	Scaffold_10	52839493	52839948	NA	NA	NA	NA	NA
PGEN_.00g224370	Scaffold_10	52859370	52861865	NA	NA	NA	NA	NA
PGEN_.00g224380	Scaffold_10	52874462	52876611	NA	NA	NA	NA	NA
PGEN_.00g224390	Scaffold_10	52877380	52888102	NA	NA	NA	NA	NA
PGEN_.00g224400	Scaffold_10	52888390	52890396	A4IIW0	MB212_XENTR	Protein mab-21-like 2	GO:0001654; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; eye development [GO:0001654]
PGEN_.00g224410	Scaffold_10	52893100	52930627	NA	NA	NA	NA	NA
PGEN_.00g224420	Scaffold_10	53090420	53092108	Q92630	DYRK2_HUMAN	Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1)	GO:0000151; GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0006974; GO:0007224; GO:0018105; GO:0018107; GO:0030145; GO:0042771; GO:0045725; GO:0070885; GO:1901796; GO:1990904	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224]
PGEN_.00g224430	Scaffold_10	53097380	53098246	NA	NA	NA	NA	NA
PGEN_.00g224440	Scaffold_10	53126563	53142566	Q99523	SORT_HUMAN	Sortilin (100 kDa NT receptor) (Glycoprotein 95) (Gp95) (Neurotensin receptor 3) (NT3) (NTR3)	GO:0001503; GO:0005764; GO:0005765; GO:0005769; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006892; GO:0006895; GO:0006897; GO:0007186; GO:0007218; GO:0007275; GO:0008333; GO:0008625; GO:0009986; GO:0010008; GO:0010465; GO:0010468; GO:0014902; GO:0016021; GO:0016050; GO:0019899; GO:0030136; GO:0030140; GO:0030379; GO:0030425; GO:0030659; GO:0031410; GO:0031965; GO:0032509; GO:0032580; GO:0032868; GO:0043025; GO:0045599; GO:0046323; GO:0048011; GO:0048227; GO:0048406; GO:0048471; GO:0051005; GO:1904037	"cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140]; enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose import [GO:0046323]; Golgi to endosome transport [GO:0006895]; multicellular organism development [GO:0007275]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of lipoprotein lipase activity [GO:0051005]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; positive regulation of epithelial cell apoptotic process [GO:1904037]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050]"
PGEN_.00g224450	Scaffold_10	53144458	53184499	Q6NUT7	SORT1_DANRE	Sortilin	GO:0005794; GO:0005829; GO:0006892; GO:0006895; GO:0006897; GO:0016021; GO:0016050; GO:0032580	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; endocytosis [GO:0006897]; Golgi to endosome transport [GO:0006895]; post-Golgi vesicle-mediated transport [GO:0006892]; vesicle organization [GO:0016050]
PGEN_.00g224460	Scaffold_10	53199219	53202150	Q9UPP1	PHF8_HUMAN	Histone lysine demethylase PHF8 (EC 1.14.11.27) (PHD finger protein 8)	GO:0000082; GO:0003682; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0007420; GO:0008270; GO:0016706; GO:0031965; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0045943; GO:0051864; GO:0061188; GO:0070544; GO:0071557; GO:0071558	"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of chromatin silencing at rDNA [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g224470	Scaffold_10	53202366	53236600	Q9UPP1	PHF8_HUMAN	Histone lysine demethylase PHF8 (EC 1.14.11.27) (PHD finger protein 8)	GO:0000082; GO:0003682; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0007420; GO:0008270; GO:0016706; GO:0031965; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0045943; GO:0051864; GO:0061188; GO:0070544; GO:0071557; GO:0071558	"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of chromatin silencing at rDNA [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g224480	Scaffold_10	53236664	53241548	Q8BK48	EST2E_MOUSE	Pyrethroid hydrolase Ces2e (EC 3.1.1.88) (carboxylesterase 2E)	GO:0005615; GO:0005783; GO:0052689; GO:0102209	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; trans-permethrin hydrolase activity [GO:0102209]
PGEN_.00g224490	Scaffold_10	53243415	53282754	B0JYW5	ANM6_XENTR	Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT6)	GO:0005634; GO:0006281; GO:0008469; GO:0019919; GO:0034970; GO:0035241; GO:0035242; GO:0035246; GO:0042054; GO:0042393; GO:0044020; GO:0045892; GO:0070611; GO:0070612	"nucleus [GO:0005634]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; DNA repair [GO:0006281]; histone H3-R2 methylation [GO:0034970]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine N-methylation [GO:0035246]"
PGEN_.00g224500	Scaffold_10	53369675	53373070	NA	NA	NA	NA	NA
PGEN_.00g224510	Scaffold_10	53375079	53400871	NA	NA	NA	NA	NA
PGEN_.00g224520	Scaffold_10	53413505	53416294	NA	NA	NA	NA	NA
PGEN_.00g224530	Scaffold_10	53435773	53436345	NA	NA	NA	NA	NA
PGEN_.00g224540	Scaffold_10	53450181	53450468	NA	NA	NA	NA	NA
PGEN_.00g224550	Scaffold_10	53487009	53488592	NA	NA	NA	NA	NA
PGEN_.00g224560	Scaffold_10	53488601	53488870	NA	NA	NA	NA	NA
PGEN_.00g224570	Scaffold_10	53493749	53496622	NA	NA	NA	NA	NA
PGEN_.00g224580	Scaffold_10	53719849	53722248	NA	NA	NA	NA	NA
PGEN_.00g224590	Scaffold_10	53731085	53732240	NA	NA	NA	NA	NA
PGEN_.00g224600	Scaffold_10	53750002	53758310	NA	NA	NA	NA	NA
PGEN_.00g224610	Scaffold_10	53761709	53763789	Q9PU85	PIM3_COTJA	Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim)	GO:0004674; GO:0005524; GO:0005737; GO:0043066	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]
PGEN_.00g224620	Scaffold_10	53776746	53806591	Q9WU40	MAN1_MOUSE	Inner nuclear membrane protein Man1 (LEM domain-containing protein 3)	GO:0001525; GO:0002044; GO:0003677; GO:0005635; GO:0005637; GO:0006997; GO:0016021; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:0035914; GO:0051726; GO:1902531; GO:1903053	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration involved in intussusceptive angiogenesis [GO:0002044]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nucleus organization [GO:0006997]; regulation of cell cycle [GO:0051726]; regulation of extracellular matrix organization [GO:1903053]; regulation of intracellular signal transduction [GO:1902531]; skeletal muscle cell differentiation [GO:0035914]
PGEN_.00g224630	Scaffold_10	53823375	53824926	Q9CUL5	DRC11_MOUSE	Dynein regulatory complex protein 11 (IQ and AAA domain-containing protein 1)	GO:0005524; GO:0005737; GO:0005856; GO:0031514	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; ATP binding [GO:0005524]
PGEN_.00g224640	Scaffold_10	53860963	53862217	NA	NA	NA	NA	NA
PGEN_.00g224650	Scaffold_10	53917594	53927802	NA	NA	NA	NA	NA
PGEN_.00g224660	Scaffold_10	53947757	53955334	NA	NA	NA	NA	NA
PGEN_.00g224670	Scaffold_11	21430	33788	Q24307	DIAP2_DROME	Death-associated inhibitor of apoptosis 2 (Apoptosis 2 inhibitor) (IAP homolog A) (IAP-like protein) (ILP) (dILP) (Inhibitor of apoptosis 2)	GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006964; GO:0008270; GO:0016567; GO:0022416; GO:0031398; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0043281; GO:0045087; GO:0048471; GO:0050829; GO:0061057; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chaeta development [GO:0022416]; defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g224680	Scaffold_11	93161	129868	NA	NA	NA	NA	NA
PGEN_.00g224690	Scaffold_11	131506	137044	P16895	IELA_ANESU	PI-actitoxin-Avd5a (PI-AITX-Avd5a) (Non-classical Kazal-type elastase inhibitor)	GO:0004867	serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g224700	Scaffold_11	183502	183825	NA	NA	NA	NA	NA
PGEN_.00g224710	Scaffold_11	188934	196268	O00468	AGRIN_HUMAN	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	GO:0001523; GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005829; GO:0005886; GO:0006024; GO:0006027; GO:0007165; GO:0007213; GO:0007528; GO:0008045; GO:0009887; GO:0009888; GO:0016021; GO:0016358; GO:0030054; GO:0030198; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200]; animal organ morphogenesis [GO:0009887]; clustering of voltage-gated sodium channels [GO:0045162]; dendrite development [GO:0016358]; extracellular matrix organization [GO:0030198]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; motor neuron axon guidance [GO:0008045]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]
PGEN_.00g224720	Scaffold_11	259556	288712	Q1L8J7	YAP1_DANRE	Transcriptional coactivator YAP1 (Yes-associated protein 1) (zYAP) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog)	GO:0000785; GO:0001570; GO:0001944; GO:0003139; GO:0003406; GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0007420; GO:0007492; GO:0009950; GO:0010629; GO:0030509; GO:0031016; GO:0031101; GO:0035162; GO:0035329; GO:0039022; GO:0043066; GO:0045944; GO:0046620; GO:0048514; GO:0048566; GO:0048916; GO:0051216; GO:0060271; GO:0060914; GO:1905480	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; blood vessel morphogenesis [GO:0048514]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; cartilage development [GO:0051216]; cilium assembly [GO:0060271]; dorsal/ventral axis specification [GO:0009950]; embryonic digestive tract development [GO:0048566]; embryonic hemopoiesis [GO:0035162]; endoderm development [GO:0007492]; fin regeneration [GO:0031101]; heart formation [GO:0060914]; hippo signaling [GO:0035329]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; pancreas development [GO:0031016]; positive regulation of glutamate-ammonia ligase activity [GO:1905480]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; regulation of organ growth [GO:0046620]; retinal pigment epithelium development [GO:0003406]; secondary heart field specification [GO:0003139]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]
PGEN_.00g224730	Scaffold_11	295526	307140	Q9DCT6	BAP18_MOUSE	Chromatin complexes subunit BAP18 (BPTF-associated protein of 18 kDa)	GO:0003677; GO:0005654; GO:0005829; GO:0006325; GO:0016589; GO:0071339	cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; chromatin organization [GO:0006325]
PGEN_.00g224740	Scaffold_11	320656	367897	P46976	GLYG_HUMAN	Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)	GO:0005576; GO:0005829; GO:0005978; GO:0008466; GO:0016020; GO:0030145; GO:0034774; GO:0042803; GO:0043202; GO:0043312; GO:0102751; GO:1904813	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978]; neutrophil degranulation [GO:0043312]
PGEN_.00g224750	Scaffold_11	370549	375229	NA	NA	NA	NA	NA
PGEN_.00g224760	Scaffold_11	384177	392803	NA	NA	NA	NA	NA
PGEN_.00g224770	Scaffold_11	394052	402322	O35474	EDIL3_MOUSE	EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)	GO:0005178; GO:0005509; GO:0005576; GO:0007155; GO:0007275; GO:0010811	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811]
PGEN_.00g224780	Scaffold_11	405285	413804	O75343	GCYB2_HUMAN	Guanylate cyclase soluble subunit beta-2 (GCS-beta-2) (EC 4.6.1.2)	GO:0004383; GO:0005525; GO:0005737; GO:0019934; GO:0020037; GO:0046872	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; cGMP-mediated signaling [GO:0019934]
PGEN_.00g224790	Scaffold_11	414601	418295	NA	NA	NA	NA	NA
PGEN_.00g224800	Scaffold_11	419711	426355	NA	NA	NA	NA	NA
PGEN_.00g224810	Scaffold_11	476788	500036	NA	NA	NA	NA	NA
PGEN_.00g224820	Scaffold_11	521815	523190	NA	NA	NA	NA	NA
PGEN_.00g224830	Scaffold_11	633808	640611	NA	NA	NA	NA	NA
PGEN_.00g224840	Scaffold_11	642835	645564	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g224850	Scaffold_11	699551	702212	NA	NA	NA	NA	NA
PGEN_.00g224860	Scaffold_11	726800	728414	NA	NA	NA	NA	NA
PGEN_.00g224870	Scaffold_11	737353	744759	Q8C8H8	KY_MOUSE	Kyphoscoliosis peptidase (EC 3.4.-.-)	GO:0005856; GO:0007517; GO:0007528; GO:0008233; GO:0030018	cytoskeleton [GO:0005856]; Z disc [GO:0030018]; peptidase activity [GO:0008233]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]
PGEN_.00g224880	Scaffold_11	754222	754587	NA	NA	NA	NA	NA
PGEN_.00g224890	Scaffold_11	789841	793167	P08953	TOLL_DROME	Protein toll	GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]
PGEN_.00g224900	Scaffold_11	840527	841279	NA	NA	NA	NA	NA
PGEN_.00g224910	Scaffold_11	841934	843273	NA	NA	NA	NA	NA
PGEN_.00g224920	Scaffold_11	857968	947736	O16011	MBL_DROME	Protein muscleblind (Protein mindmelt)	GO:0000381; GO:0001654; GO:0001751; GO:0003676; GO:0003723; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0006915; GO:0007517; GO:0007601; GO:0010468; GO:0030018; GO:0031673; GO:0042052; GO:0045924; GO:0046716; GO:0046872; GO:0048471; GO:0050896	"cell [GO:0005623]; cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601]"
PGEN_.00g224930	Scaffold_11	973434	973841	NA	NA	NA	NA	NA
PGEN_.00g224940	Scaffold_11	1005567	1006993	NA	NA	NA	NA	NA
PGEN_.00g224950	Scaffold_11	1008930	1009618	NA	NA	NA	NA	NA
PGEN_.00g224960	Scaffold_11	1195272	1225019	Q9P2H3	IFT80_HUMAN	Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56)	GO:0001649; GO:0002062; GO:0005737; GO:0005813; GO:0005929; GO:0007224; GO:0030992; GO:0035735; GO:0050680; GO:0060271; GO:0060349; GO:0097542; GO:1905515; GO:2000051	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; bone morphogenesis [GO:0060349]; chondrocyte differentiation [GO:0002062]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-motile cilium assembly [GO:1905515]; osteoblast differentiation [GO:0001649]; smoothened signaling pathway [GO:0007224]
PGEN_.00g224970	Scaffold_11	1227042	1247629	Q96LI9	CX058_HUMAN	Putative uncharacterized protein CXorf58		
PGEN_.00g224980	Scaffold_11	1247719	1277056	O61122	SVKA_DICDI	Serine/threonine-protein kinase svkA (EC 2.7.11.1) (Severin kinase A)	GO:0003779; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0006468; GO:0006972; GO:0007049; GO:0015629; GO:0023014; GO:0031156; GO:0032147; GO:0032154; GO:0032956; GO:0035329; GO:0046777; GO:0046872; GO:0051301; GO:0051781; GO:1903438	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; actin binding [GO:0003779]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; hippo signaling [GO:0035329]; hyperosmotic response [GO:0006972]; positive regulation of cell division [GO:0051781]; positive regulation of mitotic cytokinetic process [GO:1903438]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of sorocarp development [GO:0031156]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g224990	Scaffold_11	1292638	1292997	NA	NA	NA	NA	NA
PGEN_.00g225000	Scaffold_11	1294174	1294524	NA	NA	NA	NA	NA
PGEN_.00g225010	Scaffold_11	1299551	1321136	NA	NA	NA	NA	NA
PGEN_.00g225020	Scaffold_11	1324110	1330246	NA	NA	NA	NA	NA
PGEN_.00g225030	Scaffold_11	1330581	1330892	NA	NA	NA	NA	NA
PGEN_.00g225040	Scaffold_11	1331101	1331469	NA	NA	NA	NA	NA
PGEN_.00g225050	Scaffold_11	1331803	1332147	NA	NA	NA	NA	NA
PGEN_.00g225060	Scaffold_11	1416794	1423429	NA	NA	NA	NA	NA
PGEN_.00g225070	Scaffold_11	1421288	1425546	NA	NA	NA	NA	NA
PGEN_.00g225080	Scaffold_11	1425635	1427647	NA	NA	NA	NA	NA
PGEN_.00g225090	Scaffold_11	1427692	1432117	NA	NA	NA	NA	NA
PGEN_.00g225100	Scaffold_11	1432447	1436718	NA	NA	NA	NA	NA
PGEN_.00g225110	Scaffold_11	1447858	1483824	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g225120	Scaffold_11	1497417	1511744	Q5RA50	F124A_PONAB	Protein FAM124A		
PGEN_.00g225130	Scaffold_11	1527918	1534841	NA	NA	NA	NA	NA
PGEN_.00g225140	Scaffold_11	1538913	1548447	Q0IIF9	CP2U1_BOVIN	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g225150	Scaffold_11	1553043	1556913	NA	NA	NA	NA	NA
PGEN_.00g225160	Scaffold_11	1558040	1559572	Q29496	CP3AO_SHEEP	Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)	GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]
PGEN_.00g225170	Scaffold_11	1610995	1611861	P08684	CP3A4_HUMAN	"Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)"	GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006629; GO:0006706; GO:0006805; GO:0008202; GO:0008203; GO:0008209; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016021; GO:0016098; GO:0016491; GO:0017144; GO:0019825; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042359; GO:0042572; GO:0042573; GO:0042737; GO:0042738; GO:0042759; GO:0043231; GO:0046483; GO:0050591; GO:0050649; GO:0055114; GO:0070330; GO:0070576; GO:0070989; GO:0101020; GO:0101021; GO:0102320	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 1,8-cineole 2-exo-monooxygenase activity [GO:0102320]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; quinine 3-monooxygenase activity [GO:0050591]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]; alkaloid catabolic process [GO:0009822]; androgen metabolic process [GO:0008209]; cholesterol metabolic process [GO:0008203]; drug catabolic process [GO:0042737]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; exogenous drug catabolic process [GO:0042738]; heterocycle metabolic process [GO:0046483]; lipid hydroxylation [GO:0002933]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D metabolic process [GO:0042359]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g225180	Scaffold_11	1615141	1615413	NA	NA	NA	NA	NA
PGEN_.00g225190	Scaffold_11	1626888	1636373	P51869	CP4F4_RAT	Cytochrome P450 4F4 (EC 1.14.14.1) (CYPIVF4)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g225200	Scaffold_11	1650631	1651032	P51538	CP3A9_RAT	Cytochrome P450 3A9 (EC 1.14.14.1) (3AH15) (CYPIIIA9) (Cytochrome P450 olfactive 3) (Cytochrome P450-OLF3)	GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0007565; GO:0007608; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0010043; GO:0010628; GO:0016491; GO:0020037; GO:0032355; GO:0042573; GO:0042737; GO:0043627; GO:0045471; GO:0050649; GO:0070330; GO:0070989; GO:0071548; GO:0101020	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; alkaloid catabolic process [GO:0009822]; drug catabolic process [GO:0042737]; estrogen metabolic process [GO:0008210]; female pregnancy [GO:0007565]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; positive regulation of gene expression [GO:0010628]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to zinc ion [GO:0010043]; retinoic acid metabolic process [GO:0042573]; sensory perception of smell [GO:0007608]; steroid metabolic process [GO:0008202]
PGEN_.00g225210	Scaffold_11	1651158	1651415	Q64406	CP3AF_CAVPO	Cytochrome P450 3A15 (EC 1.14.14.1) (CYPIIIA15)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g225220	Scaffold_11	1660411	1669453	P78329	CP4F2_HUMAN	Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78)	GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0007596; GO:0008217; GO:0008392; GO:0016324; GO:0016709; GO:0017144; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0052872; GO:0055078; GO:0055114; GO:0070330; GO:0097267	"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid omega-hydroxylase activity [GO:0052869]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]"
PGEN_.00g225230	Scaffold_11	1704555	1715012	Q9CQ66	TC1D2_MOUSE	Tctex1 domain-containing protein 2	GO:0005868; GO:0045505; GO:0060271; GO:1902017; GO:1905799	cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; cilium assembly [GO:0060271]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799]
PGEN_.00g225240	Scaffold_11	1721785	1753419	P07290	MLE_MIZYE	"Myosin, essential light chain, adductor muscle (Sulfhydryl light chain) (SHLC)"	GO:0005509; GO:0016459	myosin complex [GO:0016459]; calcium ion binding [GO:0005509]
PGEN_.00g225250	Scaffold_11	1760601	1780774	P52299	NCBP2_XENLA	Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (NCBP 20 kDa subunit) (CBP20)	GO:0000184; GO:0000340; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005845; GO:0005846; GO:0006408; GO:0006446; GO:0008380; GO:0017069; GO:0031047; GO:0045292; GO:0046833; GO:0051028	"cytoplasm [GO:0005737]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; gene silencing by RNA [GO:0031047]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of translational initiation [GO:0006446]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]"
PGEN_.00g225260	Scaffold_11	1783208	1790498	Q86VD9	PIGZ_HUMAN	GPI mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein) (PIG-Z) (SMP3 homolog) (hSMP3)	GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016021; GO:0016254	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]"
PGEN_.00g225270	Scaffold_11	1796948	1819913	Q80VI1	TRI56_MOUSE	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0045087; GO:0046597; GO:0051607; GO:0061630; GO:0070534; GO:1902187	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
PGEN_.00g225280	Scaffold_11	1853382	1878225	NA	NA	NA	NA	NA
PGEN_.00g225290	Scaffold_11	1883443	1905788	NA	NA	NA	NA	NA
PGEN_.00g225300	Scaffold_11	1928516	1931715	Q80X72	LRC15_MOUSE	Leucine-rich repeat-containing protein 15	GO:0001968; GO:0005518; GO:0005615; GO:0009986; GO:0016021; GO:0030335; GO:0031012; GO:0043236; GO:0046813; GO:0062023; GO:1903077	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]
PGEN_.00g225310	Scaffold_11	1987496	1987903	NA	NA	NA	NA	NA
PGEN_.00g225320	Scaffold_11	1993583	2003948	NA	NA	NA	NA	NA
PGEN_.00g225330	Scaffold_11	2024196	2024639	NA	NA	NA	NA	NA
PGEN_.00g225340	Scaffold_11	2033007	2034356	P43679	ACHB3_CHICK	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g225350	Scaffold_11	2062189	2078650	Q01345	NHEB_ONCMY	Na(+)/H(+) exchanger beta (Beta-NHE) (Na(+)/H(+) antiporter)	GO:0006885; GO:0015385; GO:0016021; GO:0016323	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; sodium:proton antiporter activity [GO:0015385]; regulation of pH [GO:0006885]
PGEN_.00g225360	Scaffold_11	2097840	2126274	O00571	DDX3X_HUMAN	"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2)"	GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016032; GO:0016055; GO:0016607; GO:0016887; GO:0017111; GO:0017148; GO:0030154; GO:0030307; GO:0030308; GO:0031053; GO:0031333; GO:0031369; GO:0032728; GO:0033592; GO:0034063; GO:0034774; GO:0035556; GO:0035613; GO:0042256; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043186; GO:0043273; GO:0043280; GO:0043312; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0070062; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0072559; GO:0090263; GO:0097193; GO:1900087; GO:1900227; GO:1903608; GO:1904813; GO:2001243	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrial outer membrane [GO:0005741]; NLRP3 inflammasome complex [GO:0072559]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]; cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; primary miRNA processing [GO:0031053]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]
PGEN_.00g225370	Scaffold_11	2151721	2168646	Q96GW9	SYMM_HUMAN	"Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS)"	GO:0004825; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006431	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; methionyl-tRNA aminoacylation [GO:0006431]; tRNA aminoacylation for protein translation [GO:0006418]
PGEN_.00g225380	Scaffold_11	2174548	2175582	Q9DB94	WDR53_MOUSE	WD repeat-containing protein 53		
PGEN_.00g225390	Scaffold_11	2209315	2210881	NA	NA	NA	NA	NA
PGEN_.00g225400	Scaffold_11	2219586	2219876	NA	NA	NA	NA	NA
PGEN_.00g225410	Scaffold_11	2224085	2228988	NA	NA	NA	NA	NA
PGEN_.00g225420	Scaffold_11	2250141	2289807	Q66HE2	MOT13_RAT	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	GO:0000139; GO:0005794; GO:0005829; GO:0005886; GO:0008028; GO:0015293; GO:0016021	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g225430	Scaffold_11	2293939	2294864	NA	NA	NA	NA	NA
PGEN_.00g225440	Scaffold_11	2295370	2295681	NA	NA	NA	NA	NA
PGEN_.00g225450	Scaffold_11	2296093	2296617	NA	NA	NA	NA	NA
PGEN_.00g225460	Scaffold_11	2298604	2307606	Q6NUB2	CW15A_XENLA	Protein CWC15 homolog A	GO:0000398; GO:0003723; GO:0005634; GO:0071007	"nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g225470	Scaffold_11	2395849	2413302	Q5U3C3	TM164_HUMAN	Transmembrane protein 164	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g225480	Scaffold_11	2435803	2449673	P35521	ICLN_CANLF	"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln))"	GO:0000387; GO:0005229; GO:0005267; GO:0005623; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006884; GO:0016020; GO:0032991; GO:0034709; GO:0034715; GO:0071805; GO:1902476; GO:1990935	cell [GO:0005623]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; intracellular calcium activated chloride channel activity [GO:0005229]; potassium channel activity [GO:0005267]; splicing factor binding [GO:1990935]; cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; potassium ion transmembrane transport [GO:0071805]; spliceosomal snRNP assembly [GO:0000387]
PGEN_.00g225490	Scaffold_11	2495517	2515340	Q8N9B4	ANR42_HUMAN	Ankyrin repeat domain-containing protein 42		
PGEN_.00g225500	Scaffold_11	2534581	2551355	G5E8K6	MOT6_MOUSE	Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5)	GO:0005887; GO:0008028; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g225510	Scaffold_11	2560280	2579959	Q80TS3	AGRL3_MOUSE	Adhesion G protein-coupled receptor L3 (Latrophilin-3) (Lectomedin-3)	GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007189; GO:0007416; GO:0007420; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0050808; GO:0051965; GO:0098742; GO:0098978	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]
PGEN_.00g225520	Scaffold_11	2588924	2590210	Q9HCI7	MSL2_HUMAN	E3 ubiquitin-protein ligase MSL2 (EC 2.3.2.-) (E3 ubiquitin-protein transferase MSL2) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184)	GO:0005654; GO:0016567; GO:0043984; GO:0046872; GO:0061630; GO:0072487	MSL complex [GO:0072487]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; histone H4-K16 acetylation [GO:0043984]; protein ubiquitination [GO:0016567]
PGEN_.00g225530	Scaffold_11	2657918	2661152	NA	NA	NA	NA	NA
PGEN_.00g225540	Scaffold_11	2668810	2675143	P79345	NPC2_BOVIN	NPC intracellular cholesterol transporter 2 (EPV20) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog)	GO:0005576; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0015918; GO:0030301; GO:0032367; GO:0032934; GO:0033344	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]
PGEN_.00g225550	Scaffold_11	2678775	2679095	NA	NA	NA	NA	NA
PGEN_.00g225560	Scaffold_11	2841020	2841493	Q99K10	NLGN1_MOUSE	Neuroligin-1	GO:0002087; GO:0005623; GO:0005794; GO:0005886; GO:0005887; GO:0006605; GO:0007157; GO:0007158; GO:0007399; GO:0007416; GO:0009897; GO:0009986; GO:0010841; GO:0014069; GO:0016080; GO:0016339; GO:0017146; GO:0030054; GO:0030165; GO:0030425; GO:0031175; GO:0032230; GO:0032433; GO:0035418; GO:0038023; GO:0042043; GO:0042802; GO:0043083; GO:0043197; GO:0043198; GO:0043235; GO:0044877; GO:0045184; GO:0045202; GO:0045664; GO:0046983; GO:0048488; GO:0048489; GO:0048511; GO:0048789; GO:0050804; GO:0050808; GO:0050839; GO:0051290; GO:0051491; GO:0051965; GO:0051968; GO:0060076; GO:0060291; GO:0060999; GO:0061002; GO:0071277; GO:0072553; GO:0097091; GO:0097104; GO:0097105; GO:0097110; GO:0097113; GO:0097114; GO:0097115; GO:0097119; GO:0097120; GO:0098698; GO:0098793; GO:0098942; GO:0098978; GO:0099060; GO:0099174; GO:0099560; GO:0140058; GO:1900029; GO:1900244; GO:1902474; GO:1902533; GO:1904861; GO:1905520; GO:2000302; GO:2000310; GO:2000311; GO:2000463; GO:2000809	"cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; receptor complex [GO:0043235]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular response to calcium ion [GO:0071277]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of presynaptic active zone assembly [GO:1905520]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; regulation of presynapse organization [GO:0099174]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic membrane adhesion [GO:0099560]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]"
PGEN_.00g225570	Scaffold_11	2868978	2869223	NA	NA	NA	NA	NA
PGEN_.00g225580	Scaffold_11	2942666	2949441	NA	NA	NA	NA	NA
PGEN_.00g225590	Scaffold_11	2960352	2960813	NA	NA	NA	NA	NA
PGEN_.00g225600	Scaffold_11	3007701	3008120	NA	NA	NA	NA	NA
PGEN_.00g225610	Scaffold_11	3103030	3103440	NA	NA	NA	NA	NA
PGEN_.00g225620	Scaffold_11	3214605	3215015	Q8N2Q7	NLGN1_HUMAN	Neuroligin-1	GO:0001540; GO:0002087; GO:0005623; GO:0005794; GO:0005886; GO:0005887; GO:0006605; GO:0007157; GO:0007158; GO:0007399; GO:0007416; GO:0009897; GO:0009986; GO:0010841; GO:0014069; GO:0016080; GO:0016339; GO:0017146; GO:0023041; GO:0030054; GO:0030165; GO:0030425; GO:0031175; GO:0032230; GO:0032433; GO:0035418; GO:0038023; GO:0042043; GO:0042802; GO:0043083; GO:0043197; GO:0043198; GO:0043235; GO:0045184; GO:0045202; GO:0045664; GO:0046983; GO:0048488; GO:0048489; GO:0048511; GO:0048789; GO:0050804; GO:0050839; GO:0051290; GO:0051491; GO:0051965; GO:0051968; GO:0060076; GO:0060291; GO:0060999; GO:0061002; GO:0071277; GO:0072553; GO:0089717; GO:0097091; GO:0097104; GO:0097105; GO:0097110; GO:0097113; GO:0097114; GO:0097115; GO:0097119; GO:0097120; GO:0098698; GO:0098793; GO:0098794; GO:0098942; GO:0098985; GO:0099054; GO:0099055; GO:0099060; GO:0099560; GO:0140058; GO:1900029; GO:1900244; GO:1902474; GO:1902533; GO:1904861; GO:1905520; GO:2000302; GO:2000310; GO:2000311; GO:2000463; GO:2000809	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; receptor complex [GO:0043235]; spanning component of membrane [GO:0089717]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular response to calcium ion [GO:0071277]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neuronal signal transduction [GO:0023041]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of presynaptic active zone assembly [GO:1905520]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]"
PGEN_.00g225630	Scaffold_11	3338616	3340153	B0F2B4	NLGN4_MOUSE	Neuroligin 4-like (Neuroligin-4) (NL-4)	GO:0002124; GO:0003360; GO:0005886; GO:0005887; GO:0007158; GO:0008049; GO:0009986; GO:0021549; GO:0030054; GO:0030425; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0060076; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0098690; GO:0098793; GO:0099060	cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; male courtship behavior [GO:0008049]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; territorial aggressive behavior [GO:0002124]; vocalization behavior [GO:0071625]
PGEN_.00g225640	Scaffold_11	3409176	3429967	Q69ZK9	NLGN2_MOUSE	Neuroligin-2	GO:0001966; GO:0002087; GO:0005737; GO:0005886; GO:0005887; GO:0007158; GO:0007416; GO:0007630; GO:0008284; GO:0009986; GO:0019233; GO:0030054; GO:0032024; GO:0032230; GO:0035176; GO:0035418; GO:0035641; GO:0038023; GO:0042043; GO:0042734; GO:0042802; GO:0043198; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0060076; GO:0060077; GO:0060999; GO:0072553; GO:0097104; GO:0097105; GO:0097116; GO:0097119; GO:0097151; GO:0097470; GO:0098690; GO:0098691; GO:0098698; GO:0098982; GO:0099055; GO:0099060; GO:1901142; GO:1902474; GO:1904034; GO:1904862; GO:1905606; GO:2000311; GO:2000463; GO:2000809	"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dopaminergic synapse [GO:0098691]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; inhibitory synapse assembly [GO:1904862]; insulin metabolic process [GO:1901142]; jump response [GO:0007630]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of t-SNARE clustering [GO:1904034]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; regulation of AMPA receptor activity [GO:2000311]; regulation of presynapse assembly [GO:1905606]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; terminal button organization [GO:0072553]; thigmotaxis [GO:0001966]"
PGEN_.00g225650	Scaffold_11	3605424	3606341	NA	NA	NA	NA	NA
PGEN_.00g225660	Scaffold_11	3620288	3622065	NA	NA	NA	NA	NA
PGEN_.00g225670	Scaffold_11	3622551	3628195	P86982	IMSP1_RUDPH	Insoluble matrix shell protein 1 (IMSP1) (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g225680	Scaffold_11	3639638	3640750	P86982	IMSP1_RUDPH	Insoluble matrix shell protein 1 (IMSP1) (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g225690	Scaffold_11	3650327	3654201	NA	NA	NA	NA	NA
PGEN_.00g225700	Scaffold_11	3750527	3758069	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g225710	Scaffold_11	3763552	3764183	NA	NA	NA	NA	NA
PGEN_.00g225720	Scaffold_11	3764594	3765224	NA	NA	NA	NA	NA
PGEN_.00g225730	Scaffold_11	3770752	3780104	Q6GM59	MOT12_XENLA	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0015293; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]
PGEN_.00g225740	Scaffold_11	3876430	3880282	NA	NA	NA	NA	NA
PGEN_.00g225750	Scaffold_11	3890681	3892881	P86982	IMSP1_RUDPH	Insoluble matrix shell protein 1 (IMSP1) (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g225760	Scaffold_11	3904168	3909331	P86982	IMSP1_RUDPH	Insoluble matrix shell protein 1 (IMSP1) (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g225770	Scaffold_11	3909786	3910142	NA	NA	NA	NA	NA
PGEN_.00g225780	Scaffold_11	3924994	3925911	NA	NA	NA	NA	NA
PGEN_.00g225790	Scaffold_11	4102320	4123077	Q69ZK9	NLGN2_MOUSE	Neuroligin-2	GO:0001966; GO:0002087; GO:0005737; GO:0005886; GO:0005887; GO:0007158; GO:0007416; GO:0007630; GO:0008284; GO:0009986; GO:0019233; GO:0030054; GO:0032024; GO:0032230; GO:0035176; GO:0035418; GO:0035641; GO:0038023; GO:0042043; GO:0042734; GO:0042802; GO:0043198; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0060076; GO:0060077; GO:0060999; GO:0072553; GO:0097104; GO:0097105; GO:0097116; GO:0097119; GO:0097151; GO:0097470; GO:0098690; GO:0098691; GO:0098698; GO:0098982; GO:0099055; GO:0099060; GO:1901142; GO:1902474; GO:1904034; GO:1904862; GO:1905606; GO:2000311; GO:2000463; GO:2000809	"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dopaminergic synapse [GO:0098691]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; inhibitory synapse assembly [GO:1904862]; insulin metabolic process [GO:1901142]; jump response [GO:0007630]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of t-SNARE clustering [GO:1904034]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; regulation of AMPA receptor activity [GO:2000311]; regulation of presynapse assembly [GO:1905606]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; terminal button organization [GO:0072553]; thigmotaxis [GO:0001966]"
PGEN_.00g225800	Scaffold_11	4192090	4193964	B0F2B4	NLGN4_MOUSE	Neuroligin 4-like (Neuroligin-4) (NL-4)	GO:0002124; GO:0003360; GO:0005886; GO:0005887; GO:0007158; GO:0008049; GO:0009986; GO:0021549; GO:0030054; GO:0030425; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0060076; GO:0071625; GO:0090394; GO:0097104; GO:0097105; GO:0098690; GO:0098793; GO:0099060	cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; male courtship behavior [GO:0008049]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; territorial aggressive behavior [GO:0002124]; vocalization behavior [GO:0071625]
PGEN_.00g225810	Scaffold_11	4314686	4315114	Q8N2Q7	NLGN1_HUMAN	Neuroligin-1	GO:0001540; GO:0002087; GO:0005623; GO:0005794; GO:0005886; GO:0005887; GO:0006605; GO:0007157; GO:0007158; GO:0007399; GO:0007416; GO:0009897; GO:0009986; GO:0010841; GO:0014069; GO:0016080; GO:0016339; GO:0017146; GO:0023041; GO:0030054; GO:0030165; GO:0030425; GO:0031175; GO:0032230; GO:0032433; GO:0035418; GO:0038023; GO:0042043; GO:0042802; GO:0043083; GO:0043197; GO:0043198; GO:0043235; GO:0045184; GO:0045202; GO:0045664; GO:0046983; GO:0048488; GO:0048489; GO:0048511; GO:0048789; GO:0050804; GO:0050839; GO:0051290; GO:0051491; GO:0051965; GO:0051968; GO:0060076; GO:0060291; GO:0060999; GO:0061002; GO:0071277; GO:0072553; GO:0089717; GO:0097091; GO:0097104; GO:0097105; GO:0097110; GO:0097113; GO:0097114; GO:0097115; GO:0097119; GO:0097120; GO:0098698; GO:0098793; GO:0098794; GO:0098942; GO:0098985; GO:0099054; GO:0099055; GO:0099060; GO:0099560; GO:0140058; GO:1900029; GO:1900244; GO:1902474; GO:1902533; GO:1904861; GO:1905520; GO:2000302; GO:2000310; GO:2000311; GO:2000463; GO:2000809	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; receptor complex [GO:0043235]; spanning component of membrane [GO:0089717]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular response to calcium ion [GO:0071277]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neuronal signal transduction [GO:0023041]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of presynaptic active zone assembly [GO:1905520]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]"
PGEN_.00g225820	Scaffold_11	4425702	4426232	P10419	FMR1_ANTEL	Antho-RFamide neuropeptides type 1 [Cleaved into: Antho-RFamide]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g225830	Scaffold_11	4522192	4522611	NA	NA	NA	NA	NA
PGEN_.00g225840	Scaffold_11	4565110	4565664	NA	NA	NA	NA	NA
PGEN_.00g225850	Scaffold_11	4579477	4579716	NA	NA	NA	NA	NA
PGEN_.00g225860	Scaffold_11	4653252	4653497	NA	NA	NA	NA	NA
PGEN_.00g225870	Scaffold_11	4681227	4681700	Q99K10	NLGN1_MOUSE	Neuroligin-1	GO:0002087; GO:0005623; GO:0005794; GO:0005886; GO:0005887; GO:0006605; GO:0007157; GO:0007158; GO:0007399; GO:0007416; GO:0009897; GO:0009986; GO:0010841; GO:0014069; GO:0016080; GO:0016339; GO:0017146; GO:0030054; GO:0030165; GO:0030425; GO:0031175; GO:0032230; GO:0032433; GO:0035418; GO:0038023; GO:0042043; GO:0042802; GO:0043083; GO:0043197; GO:0043198; GO:0043235; GO:0044877; GO:0045184; GO:0045202; GO:0045664; GO:0046983; GO:0048488; GO:0048489; GO:0048511; GO:0048789; GO:0050804; GO:0050808; GO:0050839; GO:0051290; GO:0051491; GO:0051965; GO:0051968; GO:0060076; GO:0060291; GO:0060999; GO:0061002; GO:0071277; GO:0072553; GO:0097091; GO:0097104; GO:0097105; GO:0097110; GO:0097113; GO:0097114; GO:0097115; GO:0097119; GO:0097120; GO:0098698; GO:0098793; GO:0098942; GO:0098978; GO:0099060; GO:0099174; GO:0099560; GO:0140058; GO:1900029; GO:1900244; GO:1902474; GO:1902533; GO:1904861; GO:1905520; GO:2000302; GO:2000310; GO:2000311; GO:2000463; GO:2000809	"cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; receptor complex [GO:0043235]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular response to calcium ion [GO:0071277]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of presynaptic active zone assembly [GO:1905520]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; regulation of presynapse organization [GO:0099174]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic membrane adhesion [GO:0099560]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]"
PGEN_.00g225880	Scaffold_11	4843547	4849966	P79345	NPC2_BOVIN	NPC intracellular cholesterol transporter 2 (EPV20) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog)	GO:0005576; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0015918; GO:0030301; GO:0032367; GO:0032934; GO:0033344	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; sterol transport [GO:0015918]
PGEN_.00g225890	Scaffold_11	4859137	4862395	NA	NA	NA	NA	NA
PGEN_.00g225900	Scaffold_11	4925793	4927079	Q9HCI7	MSL2_HUMAN	E3 ubiquitin-protein ligase MSL2 (EC 2.3.2.-) (E3 ubiquitin-protein transferase MSL2) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184)	GO:0005654; GO:0016567; GO:0043984; GO:0046872; GO:0061630; GO:0072487	MSL complex [GO:0072487]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; histone H4-K16 acetylation [GO:0043984]; protein ubiquitination [GO:0016567]
PGEN_.00g225910	Scaffold_11	4937532	4940136	Q6QNK2	AGRD1_HUMAN	Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)	GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g225920	Scaffold_11	4945451	4954969	NA	NA	NA	NA	NA
PGEN_.00g225930	Scaffold_11	4966675	4981108	O15375	MOT6_HUMAN	Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5)	GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g225940	Scaffold_11	4992720	4997480	NA	NA	NA	NA	NA
PGEN_.00g225950	Scaffold_11	5000572	5025416	Q3V096	ANR42_MOUSE	Ankyrin repeat domain-containing protein 42	GO:0005634; GO:0051059; GO:0051091; GO:0051092; GO:1900017	nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]
PGEN_.00g225960	Scaffold_11	5067762	5081381	P35521	ICLN_CANLF	"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln))"	GO:0000387; GO:0005229; GO:0005267; GO:0005623; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006884; GO:0016020; GO:0032991; GO:0034709; GO:0034715; GO:0071805; GO:1902476; GO:1990935	cell [GO:0005623]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; intracellular calcium activated chloride channel activity [GO:0005229]; potassium channel activity [GO:0005267]; splicing factor binding [GO:1990935]; cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; potassium ion transmembrane transport [GO:0071805]; spliceosomal snRNP assembly [GO:0000387]
PGEN_.00g225970	Scaffold_11	5100838	5114881	Q5U3C3	TM164_HUMAN	Transmembrane protein 164	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g225980	Scaffold_11	5119987	5122420	Q5U3C3	TM164_HUMAN	Transmembrane protein 164	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g225990	Scaffold_11	5210047	5219274	Q6NUB2	CW15A_XENLA	Protein CWC15 homolog A	GO:0000398; GO:0003723; GO:0005634; GO:0071007	"nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g226000	Scaffold_11	5221262	5221786	NA	NA	NA	NA	NA
PGEN_.00g226010	Scaffold_11	5222198	5222509	NA	NA	NA	NA	NA
PGEN_.00g226020	Scaffold_11	5223015	5223608	NA	NA	NA	NA	NA
PGEN_.00g226030	Scaffold_11	5224533	5224736	NA	NA	NA	NA	NA
PGEN_.00g226040	Scaffold_11	5224867	5270761	Q66HE2	MOT13_RAT	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	GO:0000139; GO:0005794; GO:0005829; GO:0005886; GO:0008028; GO:0015293; GO:0016021	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g226050	Scaffold_11	5292849	5294679	NA	NA	NA	NA	NA
PGEN_.00g226060	Scaffold_11	5298796	5299146	NA	NA	NA	NA	NA
PGEN_.00g226070	Scaffold_11	5308009	5309536	NA	NA	NA	NA	NA
PGEN_.00g226080	Scaffold_11	5343471	5344505	Q9DB94	WDR53_MOUSE	WD repeat-containing protein 53		
PGEN_.00g226090	Scaffold_11	5350513	5366774	Q499X9	SYMM_MOUSE	"Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS)"	GO:0004825; GO:0005524; GO:0005739; GO:0005759; GO:0006431	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; methionyl-tRNA aminoacylation [GO:0006431]
PGEN_.00g226100	Scaffold_11	5392221	5420733	O00571	DDX3X_HUMAN	"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2)"	GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016032; GO:0016055; GO:0016607; GO:0016887; GO:0017111; GO:0017148; GO:0030154; GO:0030307; GO:0030308; GO:0031053; GO:0031333; GO:0031369; GO:0032728; GO:0033592; GO:0034063; GO:0034774; GO:0035556; GO:0035613; GO:0042256; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043186; GO:0043273; GO:0043280; GO:0043312; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0070062; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0072559; GO:0090263; GO:0097193; GO:1900087; GO:1900227; GO:1903608; GO:1904813; GO:2001243	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrial outer membrane [GO:0005741]; NLRP3 inflammasome complex [GO:0072559]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]; cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; primary miRNA processing [GO:0031053]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]
PGEN_.00g226110	Scaffold_11	5439859	5456456	Q01345	NHEB_ONCMY	Na(+)/H(+) exchanger beta (Beta-NHE) (Na(+)/H(+) antiporter)	GO:0006885; GO:0015385; GO:0016021; GO:0016323	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; sodium:proton antiporter activity [GO:0015385]; regulation of pH [GO:0006885]
PGEN_.00g226120	Scaffold_11	5484285	5485634	Q8BMN3	ACHB3_MOUSE	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0016020; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0051291; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g226130	Scaffold_11	5493821	5494264	NA	NA	NA	NA	NA
PGEN_.00g226140	Scaffold_11	5514297	5525917	NA	NA	NA	NA	NA
PGEN_.00g226150	Scaffold_11	5583283	5584602	Q80X72	LRC15_MOUSE	Leucine-rich repeat-containing protein 15	GO:0001968; GO:0005518; GO:0005615; GO:0009986; GO:0016021; GO:0030335; GO:0031012; GO:0043236; GO:0046813; GO:0062023; GO:1903077	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]
PGEN_.00g226160	Scaffold_11	5610552	5626639	Q9VEN1	FLNA_DROME	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"
PGEN_.00g226170	Scaffold_11	5639926	5642412	NA	NA	NA	NA	NA
PGEN_.00g226180	Scaffold_11	5654653	5656320	NA	NA	NA	NA	NA
PGEN_.00g226190	Scaffold_11	5657249	5666727	NA	NA	NA	NA	NA
PGEN_.00g226200	Scaffold_11	5668964	5672217	NA	NA	NA	NA	NA
PGEN_.00g226210	Scaffold_11	5675984	5677681	NA	NA	NA	NA	NA
PGEN_.00g226220	Scaffold_11	5682824	5685066	NA	NA	NA	NA	NA
PGEN_.00g226230	Scaffold_11	5798372	5802725	Q3SWT4	IWS1_RAT	Protein IWS1 homolog (IWS1-like protein)	GO:0005634; GO:0006397; GO:0008380; GO:0010793; GO:0050684; GO:0051028; GO:0090239; GO:2001253	nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]
PGEN_.00g226240	Scaffold_11	5802945	5845098	Q3SWT4	IWS1_RAT	Protein IWS1 homolog (IWS1-like protein)	GO:0005634; GO:0006397; GO:0008380; GO:0010793; GO:0050684; GO:0051028; GO:0090239; GO:2001253	nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]
PGEN_.00g226250	Scaffold_11	5845788	5855274	Q9QZ73	DCNL1_MOUSE	DCN1-like protein 1 (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Testis-specific protein 3)	GO:0000151; GO:0005654; GO:0005829; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602; GO:2000436	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]
PGEN_.00g226260	Scaffold_11	5862854	5863234	NA	NA	NA	NA	NA
PGEN_.00g226270	Scaffold_11	5899978	5925856	Q8VHG2	AMOT_MOUSE	Angiomotin	GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005654; GO:0005737; GO:0005884; GO:0005923; GO:0006935; GO:0008180; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030054; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0034613; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0048514; GO:0051056	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]
PGEN_.00g226280	Scaffold_11	5935381	5942597	NA	NA	NA	NA	NA
PGEN_.00g226290	Scaffold_11	5953398	5964902	O88572	LRP6_MOUSE	Low-density lipoprotein receptor-related protein 6 (LRP-6)	GO:0001702; GO:0001756; GO:0001843; GO:0001933; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005623; GO:0005769; GO:0005783; GO:0005886; GO:0005901; GO:0006355; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0016020; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051091; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0061310; GO:0061324; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:2000051; GO:2000149; GO:2000151; GO:2000162; GO:2000164; GO:2000166; GO:2000168	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g226300	Scaffold_11	5972875	5991032	Q91VN0	LRP5_MOUSE	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009314; GO:0009952; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060764; GO:0061178; GO:0061299; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1902262	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]"
PGEN_.00g226310	Scaffold_11	5997223	6024209	NA	NA	NA	NA	NA
PGEN_.00g226320	Scaffold_11	6032972	6034694	NA	NA	NA	NA	NA
PGEN_.00g226330	Scaffold_11	6041459	6080504	Q66II0	W11B1_XENTR	Protein Wnt-11b-1	GO:0005109; GO:0005576; GO:0005615; GO:0007369; GO:0016055; GO:0030182; GO:0045165	extracellular region [GO:0005576]; extracellular space [GO:0005615]; frizzled binding [GO:0005109]; cell fate commitment [GO:0045165]; gastrulation [GO:0007369]; neuron differentiation [GO:0030182]; Wnt signaling pathway [GO:0016055]
PGEN_.00g226340	Scaffold_11	6081957	6085458	NA	NA	NA	NA	NA
PGEN_.00g226350	Scaffold_11	6128777	6129334	NA	NA	NA	NA	NA
PGEN_.00g226360	Scaffold_11	6149553	6151031	NA	NA	NA	NA	NA
PGEN_.00g226370	Scaffold_11	6176193	6202138	Q9QXE7	TBL1X_MOUSE	F-box-like/WD repeat-containing protein TBL1X (Transducin beta-like protein 1X)	GO:0000118; GO:0000122; GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006508; GO:0007605; GO:0008013; GO:0008022; GO:0008134; GO:0016575; GO:0017053; GO:0019904; GO:0042393; GO:0042802; GO:0043161; GO:0043627; GO:0044212; GO:0045444; GO:0045892; GO:0045893; GO:0045944; GO:0048545; GO:0050821; GO:0072686; GO:0090263	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; fat cell differentiation [GO:0045444]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to steroid hormone [GO:0048545]; sensory perception of sound [GO:0007605]"
PGEN_.00g226380	Scaffold_11	6210552	6227831	O60907	TBL1X_HUMAN	"F-box-like/WD repeat-containing protein TBL1X (SMAP55) (Transducin beta-like protein 1X) (Transducin-beta-like protein 1, X-linked)"	GO:0000118; GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0006508; GO:0007605; GO:0008013; GO:0008022; GO:0008134; GO:0016575; GO:0017053; GO:0019216; GO:0019904; GO:0042393; GO:0042802; GO:0043161; GO:0044212; GO:0045893; GO:0045944; GO:0050821; GO:0072686; GO:0090263	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]"
PGEN_.00g226390	Scaffold_11	6260913	6261146	NA	NA	NA	NA	NA
PGEN_.00g226400	Scaffold_11	6269991	6274886	NA	NA	NA	NA	NA
PGEN_.00g226410	Scaffold_11	6341566	6349278	NA	NA	NA	NA	NA
PGEN_.00g226420	Scaffold_11	6380247	6386768	NA	NA	NA	NA	NA
PGEN_.00g226430	Scaffold_11	6386885	6397447	NA	NA	NA	NA	NA
PGEN_.00g226440	Scaffold_11	6416764	6429854	NA	NA	NA	NA	NA
PGEN_.00g226450	Scaffold_11	6437305	6439206	NA	NA	NA	NA	NA
PGEN_.00g226460	Scaffold_11	6439561	6440016	NA	NA	NA	NA	NA
PGEN_.00g226470	Scaffold_11	6440944	6453338	NA	NA	NA	NA	NA
PGEN_.00g226480	Scaffold_11	6453916	6462643	NA	NA	NA	NA	NA
PGEN_.00g226490	Scaffold_11	6464434	6465400	NA	NA	NA	NA	NA
PGEN_.00g226500	Scaffold_11	6465546	6465860	NA	NA	NA	NA	NA
PGEN_.00g226510	Scaffold_11	6465980	6466264	NA	NA	NA	NA	NA
PGEN_.00g226520	Scaffold_11	6475633	6488753	NA	NA	NA	NA	NA
PGEN_.00g226530	Scaffold_11	6508638	6525812	NA	NA	NA	NA	NA
PGEN_.00g226540	Scaffold_11	6556730	6564480	NA	NA	NA	NA	NA
PGEN_.00g226550	Scaffold_11	6622851	6632724	NA	NA	NA	NA	NA
PGEN_.00g226560	Scaffold_11	6671710	6689143	Q8BHJ5	TBL1R_MOUSE	F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1)	GO:0000118; GO:0000122; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0008013; GO:0010468; GO:0016042; GO:0016575; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872]"
PGEN_.00g226570	Scaffold_11	6698995	6727847	Q9QXE7	TBL1X_MOUSE	F-box-like/WD repeat-containing protein TBL1X (Transducin beta-like protein 1X)	GO:0000118; GO:0000122; GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006508; GO:0007605; GO:0008013; GO:0008022; GO:0008134; GO:0016575; GO:0017053; GO:0019904; GO:0042393; GO:0042802; GO:0043161; GO:0043627; GO:0044212; GO:0045444; GO:0045892; GO:0045893; GO:0045944; GO:0048545; GO:0050821; GO:0072686; GO:0090263	"histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; fat cell differentiation [GO:0045444]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to steroid hormone [GO:0048545]; sensory perception of sound [GO:0007605]"
PGEN_.00g226580	Scaffold_11	6751511	6752989	NA	NA	NA	NA	NA
PGEN_.00g226590	Scaffold_11	6771899	6772354	NA	NA	NA	NA	NA
PGEN_.00g226600	Scaffold_11	6815668	6819163	NA	NA	NA	NA	NA
PGEN_.00g226610	Scaffold_11	6820616	6857621	Q66II0	W11B1_XENTR	Protein Wnt-11b-1	GO:0005109; GO:0005576; GO:0005615; GO:0007369; GO:0016055; GO:0030182; GO:0045165	extracellular region [GO:0005576]; extracellular space [GO:0005615]; frizzled binding [GO:0005109]; cell fate commitment [GO:0045165]; gastrulation [GO:0007369]; neuron differentiation [GO:0030182]; Wnt signaling pathway [GO:0016055]
PGEN_.00g226620	Scaffold_11	6864276	6865767	NA	NA	NA	NA	NA
PGEN_.00g226630	Scaffold_11	6874530	6901520	NA	NA	NA	NA	NA
PGEN_.00g226640	Scaffold_11	6907704	6921619	Q91VN0	LRP5_MOUSE	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009314; GO:0009952; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060764; GO:0061178; GO:0061299; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1902262	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]"
PGEN_.00g226650	Scaffold_11	6929746	6941316	O88572	LRP6_MOUSE	Low-density lipoprotein receptor-related protein 6 (LRP-6)	GO:0001702; GO:0001756; GO:0001843; GO:0001933; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005623; GO:0005769; GO:0005783; GO:0005886; GO:0005901; GO:0006355; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0016020; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051091; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0061310; GO:0061324; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:2000051; GO:2000149; GO:2000151; GO:2000162; GO:2000164; GO:2000166; GO:2000168	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g226660	Scaffold_11	6947124	6947735	NA	NA	NA	NA	NA
PGEN_.00g226670	Scaffold_11	6947991	6948572	NA	NA	NA	NA	NA
PGEN_.00g226680	Scaffold_11	6948620	6949012	NA	NA	NA	NA	NA
PGEN_.00g226690	Scaffold_11	6949137	6949490	NA	NA	NA	NA	NA
PGEN_.00g226700	Scaffold_11	6949578	6950372	NA	NA	NA	NA	NA
PGEN_.00g226710	Scaffold_11	6950460	6950877	NA	NA	NA	NA	NA
PGEN_.00g226720	Scaffold_11	6952396	6959661	NA	NA	NA	NA	NA
PGEN_.00g226730	Scaffold_11	6971266	6971958	NA	NA	NA	NA	NA
PGEN_.00g226740	Scaffold_11	6980882	6997720	Q8VHG2	AMOT_MOUSE	Angiomotin	GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005654; GO:0005737; GO:0005884; GO:0005923; GO:0006935; GO:0008180; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030054; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0034613; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0048514; GO:0051056	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell migration involved in gastrulation [GO:0042074]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of embryonic development [GO:0040019]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]
PGEN_.00g226750	Scaffold_11	7043438	7053279	Q9QZ73	DCNL1_MOUSE	DCN1-like protein 1 (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Testis-specific protein 3)	GO:0000151; GO:0005654; GO:0005829; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602; GO:2000436	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]
PGEN_.00g226760	Scaffold_11	7053969	7093129	Q8C1D8	IWS1_MOUSE	Protein IWS1 homolog (IWS1-like protein)	GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0010793; GO:0050684; GO:0051028; GO:0090239; GO:2001253	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]
PGEN_.00g226770	Scaffold_11	7093349	7097731	Q3SWT4	IWS1_RAT	Protein IWS1 homolog (IWS1-like protein)	GO:0005634; GO:0006397; GO:0008380; GO:0010793; GO:0050684; GO:0051028; GO:0090239; GO:2001253	nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]
PGEN_.00g226780	Scaffold_11	7212406	7216851	NA	NA	NA	NA	NA
PGEN_.00g226790	Scaffold_11	7220450	7222147	NA	NA	NA	NA	NA
PGEN_.00g226800	Scaffold_11	7227194	7230459	NA	NA	NA	NA	NA
PGEN_.00g226810	Scaffold_11	7232504	7236489	NA	NA	NA	NA	NA
PGEN_.00g226820	Scaffold_11	7242911	7244362	NA	NA	NA	NA	NA
PGEN_.00g226830	Scaffold_11	7256835	7259321	NA	NA	NA	NA	NA
PGEN_.00g226840	Scaffold_11	7272683	7370846	Q9VEN1	FLNA_DROME	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)	GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495	"actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"
PGEN_.00g226850	Scaffold_11	7375727	7380852	Q22460	BCA1_CAEEL	Beta carbonic anhydrase 1 (EC 4.2.1.1)	GO:0004089; GO:0008270	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
PGEN_.00g226860	Scaffold_11	7385718	7391936	A8XKV0	BCA1_CAEBR	Beta carbonic anhydrase 1 (EC 4.2.1.1)	GO:0004089; GO:0008270	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
PGEN_.00g226870	Scaffold_11	7399286	7405906	Q22460	BCA1_CAEEL	Beta carbonic anhydrase 1 (EC 4.2.1.1)	GO:0004089; GO:0008270	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
PGEN_.00g226880	Scaffold_11	7442129	7454921	A0JPN2	S39A4_RAT	Zinc transporter ZIP4 (Solute carrier family 39 member 4) (Zrt- and Irt-like protein 4) (ZIP-4)	GO:0005385; GO:0005623; GO:0005768; GO:0005886; GO:0005887; GO:0006829; GO:0006882; GO:0007165; GO:0016324; GO:0031410; GO:0034224; GO:0055038; GO:0071578	apical plasma membrane [GO:0016324]; cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; zinc ion transmembrane transporter activity [GO:0005385]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]
PGEN_.00g226890	Scaffold_11	7464891	7483816	NA	NA	NA	NA	NA
PGEN_.00g226900	Scaffold_11	7529436	7532071	NA	NA	NA	NA	NA
PGEN_.00g226910	Scaffold_11	7538218	7540172	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g226920	Scaffold_11	7546382	7569639	O15123	ANGP2_HUMAN	Angiopoietin-2 (ANG-2)	GO:0001525; GO:0001666; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0007165; GO:0007281; GO:0009314; GO:0009612; GO:0009749; GO:0010812; GO:0014070; GO:0014823; GO:0016525; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045766; GO:0046872; GO:0048014; GO:0050900; GO:0050928; GO:0060135; GO:0071363; GO:0072012	cell projection [GO:0042995]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; leukocyte migration [GO:0050900]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]
PGEN_.00g226930	Scaffold_11	7613247	7616777	NA	NA	NA	NA	NA
PGEN_.00g226940	Scaffold_11	7689021	7698317	NA	NA	NA	NA	NA
PGEN_.00g226950	Scaffold_11	7729619	7731740	Q9UIC8	LCMT1_HUMAN	Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1)	GO:0000086; GO:0003880; GO:0005654; GO:0005829; GO:0006464; GO:0006479; GO:0006481; GO:0008757; GO:0010906; GO:0018423; GO:0031333; GO:0042981; GO:0090266	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; C-terminal protein methylation [GO:0006481]; cellular protein modification process [GO:0006464]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]
PGEN_.00g226960	Scaffold_11	7733633	7761544	P14629	ERCC5_XENLA	DNA repair protein complementing XP-G cells homolog (EC 3.1.-.-) (Xeroderma pigmentosum group G-complementing protein homolog)	GO:0003697; GO:0004519; GO:0005634; GO:0006289; GO:0046872	nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; nucleotide-excision repair [GO:0006289]
PGEN_.00g226970	Scaffold_11	7812562	7815530	Q8LAX0	HMT3_ARATH	Homocysteine S-methyltransferase 3 (EC 2.1.1.10) (S-methylmethionine:homocysteine methyltransferase 3) (AtHMT-3) (SMM:Hcy S-methyltransferase 3)	GO:0005886; GO:0008270; GO:0008898; GO:0009086; GO:0032259; GO:0033528; GO:0047150	plasma membrane [GO:0005886]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; S-methylmethionine cycle [GO:0033528]
PGEN_.00g226980	Scaffold_11	7816514	7829970	Q6PHH3	PD10A_DANRE	Programmed cell death protein 10-A	GO:0000139; GO:0001525; GO:0001568; GO:0001944; GO:0003007; GO:0005886; GO:0006915; GO:0007507; GO:0043009; GO:0048514	Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; chordate embryonic development [GO:0043009]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; vasculature development [GO:0001944]
PGEN_.00g226990	Scaffold_11	7854420	7892933	Q8K2K6	AGFG1_MOUSE	Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein homolog) (Nucleoporin-like protein RIP)	GO:0001675; GO:0003677; GO:0005096; GO:0005634; GO:0007275; GO:0007289; GO:0031410; GO:0042995; GO:0043025; GO:0043231; GO:0045109; GO:0046872	cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; multicellular organism development [GO:0007275]; spermatid nucleus differentiation [GO:0007289]
PGEN_.00g227000	Scaffold_11	7897842	7902811	Q5U3Y0	KLD10_RAT	Kelch domain-containing protein 10	GO:0005634; GO:0005737; GO:0032874	cytoplasm [GO:0005737]; nucleus [GO:0005634]; positive regulation of stress-activated MAPK cascade [GO:0032874]
PGEN_.00g227010	Scaffold_11	7917985	7953269	P0CB05	CEP63_CHICK	Centrosomal protein of 63 kDa (Cep63)	GO:0000077; GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0042770; GO:0051225; GO:0051301; GO:0098535	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; cell division [GO:0051301]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; DNA damage checkpoint [GO:0000077]; signal transduction in response to DNA damage [GO:0042770]; spindle assembly [GO:0051225]
PGEN_.00g227020	Scaffold_11	7972850	7982005	NA	NA	NA	NA	NA
PGEN_.00g227030	Scaffold_11	7982102	7982602	NA	NA	NA	NA	NA
PGEN_.00g227040	Scaffold_11	7990608	8025551	P0CB05	CEP63_CHICK	Centrosomal protein of 63 kDa (Cep63)	GO:0000077; GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0042770; GO:0051225; GO:0051301; GO:0098535	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; cell division [GO:0051301]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; DNA damage checkpoint [GO:0000077]; signal transduction in response to DNA damage [GO:0042770]; spindle assembly [GO:0051225]
PGEN_.00g227050	Scaffold_11	8040501	8045223	Q5U3Y0	KLD10_RAT	Kelch domain-containing protein 10	GO:0005634; GO:0005737; GO:0032874	cytoplasm [GO:0005737]; nucleus [GO:0005634]; positive regulation of stress-activated MAPK cascade [GO:0032874]
PGEN_.00g227060	Scaffold_11	8050359	8087915	Q8K2K6	AGFG1_MOUSE	Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein homolog) (Nucleoporin-like protein RIP)	GO:0001675; GO:0003677; GO:0005096; GO:0005634; GO:0007275; GO:0007289; GO:0031410; GO:0042995; GO:0043025; GO:0043231; GO:0045109; GO:0046872	cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; multicellular organism development [GO:0007275]; spermatid nucleus differentiation [GO:0007289]
PGEN_.00g227070	Scaffold_11	8112431	8125851	Q8AVR4	PDC10_XENLA	Programmed cell death protein 10	GO:0000139; GO:0001525; GO:0005886; GO:0006915	Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]
PGEN_.00g227080	Scaffold_11	8126829	8129889	Q8LAX0	HMT3_ARATH	Homocysteine S-methyltransferase 3 (EC 2.1.1.10) (S-methylmethionine:homocysteine methyltransferase 3) (AtHMT-3) (SMM:Hcy S-methyltransferase 3)	GO:0005886; GO:0008270; GO:0008898; GO:0009086; GO:0032259; GO:0033528; GO:0047150	plasma membrane [GO:0005886]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; S-methylmethionine cycle [GO:0033528]
PGEN_.00g227090	Scaffold_11	8183163	8210591	P14629	ERCC5_XENLA	DNA repair protein complementing XP-G cells homolog (EC 3.1.-.-) (Xeroderma pigmentosum group G-complementing protein homolog)	GO:0003697; GO:0004519; GO:0005634; GO:0006289; GO:0046872	nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; nucleotide-excision repair [GO:0006289]
PGEN_.00g227100	Scaffold_11	8212477	8214525	Q9UIC8	LCMT1_HUMAN	Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1)	GO:0000086; GO:0003880; GO:0005654; GO:0005829; GO:0006464; GO:0006479; GO:0006481; GO:0008757; GO:0010906; GO:0018423; GO:0031333; GO:0042981; GO:0090266	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; C-terminal protein methylation [GO:0006481]; cellular protein modification process [GO:0006464]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]
PGEN_.00g227110	Scaffold_11	8244632	8254318	NA	NA	NA	NA	NA
PGEN_.00g227120	Scaffold_11	8327379	8330922	NA	NA	NA	NA	NA
PGEN_.00g227130	Scaffold_11	8373907	8396988	P14480	FIBB_RAT	Fibrinogen beta chain (Liver regeneration-related protein LRRG036/LRRG043/LRRG189) [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain]	GO:0002250; GO:0005102; GO:0005198; GO:0005577; GO:0005615; GO:0005737; GO:0005783; GO:0005938; GO:0007160; GO:0009897; GO:0009986; GO:0031091; GO:0031639; GO:0034116; GO:0034622; GO:0042730; GO:0043152; GO:0044320; GO:0045087; GO:0045202; GO:0045907; GO:0045921; GO:0050714; GO:0050839; GO:0051087; GO:0051258; GO:0051592; GO:0070374; GO:0070527; GO:0071347; GO:0072378; GO:0072562; GO:0090277; GO:1902042; GO:2000352	"blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chaperone binding [GO:0051087]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; cellular protein-containing complex assembly [GO:0034622]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; response to calcium ion [GO:0051592]"
PGEN_.00g227140	Scaffold_11	8403198	8405152	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g227150	Scaffold_11	8411654	8413934	NA	NA	NA	NA	NA
PGEN_.00g227160	Scaffold_11	8458708	8477222	NA	NA	NA	NA	NA
PGEN_.00g227170	Scaffold_11	8487191	8500084	A0JPN2	S39A4_RAT	Zinc transporter ZIP4 (Solute carrier family 39 member 4) (Zrt- and Irt-like protein 4) (ZIP-4)	GO:0005385; GO:0005623; GO:0005768; GO:0005886; GO:0005887; GO:0006829; GO:0006882; GO:0007165; GO:0016324; GO:0031410; GO:0034224; GO:0055038; GO:0071578	apical plasma membrane [GO:0016324]; cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; zinc ion transmembrane transporter activity [GO:0005385]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]
PGEN_.00g227180	Scaffold_11	8536336	8557466	A8XKV0	BCA1_CAEBR	Beta carbonic anhydrase 1 (EC 4.2.1.1)	GO:0004089; GO:0008270	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
PGEN_.00g227190	Scaffold_11	8562400	8567510	Q22460	BCA1_CAEEL	Beta carbonic anhydrase 1 (EC 4.2.1.1)	GO:0004089; GO:0008270	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]
PGEN_.00g227200	Scaffold_11	8572399	8637707	O75369	FLNB_HUMAN	Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP)	GO:0001725; GO:0003334; GO:0003382; GO:0003723; GO:0003779; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005925; GO:0005938; GO:0007016; GO:0007165; GO:0007519; GO:0015629; GO:0016021; GO:0030018; GO:0030036; GO:0042802; GO:0043005; GO:0043025; GO:0045296; GO:0045335; GO:0070062; GO:0071346	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell [GO:0005623]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g227210	Scaffold_11	8667240	8672429	NA	NA	NA	NA	NA
PGEN_.00g227220	Scaffold_11	8686750	8722449	Q96T23	RSF1_HUMAN	Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex)	GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0016584; GO:0031213; GO:0034080; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434	"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]"
PGEN_.00g227230	Scaffold_11	8735832	8746857	NA	NA	NA	NA	NA
PGEN_.00g227240	Scaffold_11	8880683	8881132	NA	NA	NA	NA	NA
PGEN_.00g227250	Scaffold_11	8896812	8992175	NA	NA	NA	NA	NA
PGEN_.00g227260	Scaffold_11	9015411	9019262	NA	NA	NA	NA	NA
PGEN_.00g227270	Scaffold_11	9022913	9026432	Q9Y305	ACOT9_HUMAN	"Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9)"	GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0047617; GO:0052689	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]
PGEN_.00g227280	Scaffold_11	9063589	9065278	NA	NA	NA	NA	NA
PGEN_.00g227290	Scaffold_11	9067328	9099651	H2A0M0	NRP_PINMG	Asparagine-rich protein (Prism uncharacterized shell protein 1) (PUSP1)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g227300	Scaffold_11	9113024	9116017	A0MGZ7	H6S3B_DANRE	Heparan-sulfate 6-O-sulfotransferase 3-B (HS 6-OST-3-B) (EC 2.8.2.-)	GO:0008146; GO:0015015; GO:0016021; GO:0017095; GO:0050656; GO:0070492	"integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; oligosaccharide binding [GO:0070492]; sulfotransferase activity [GO:0008146]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]"
PGEN_.00g227310	Scaffold_11	9181845	9183364	A7TX81	CSN6_PIG	COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6)	GO:0000338; GO:0005654; GO:0005737; GO:0008180	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338]
PGEN_.00g227320	Scaffold_11	9189590	9226740	Q8WVM7	STAG1_HUMAN	Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1)	GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0051301; GO:0097431; GO:1901673	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; regulation of mitotic spindle assembly [GO:1901673]; sister chromatid cohesion [GO:0007062]"
PGEN_.00g227330	Scaffold_11	9229953	9234297	NA	NA	NA	NA	NA
PGEN_.00g227340	Scaffold_11	9238447	9240426	E1BD59	TRI56_BOVIN	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0051607; GO:0070534	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
PGEN_.00g227350	Scaffold_11	9246468	9275667	Q2TAF4	INT6A_XENLA	Integrator complex subunit 6-A (Int6-A)	GO:0005634	nucleus [GO:0005634]
PGEN_.00g227360	Scaffold_11	9291478	9299435	Q5BJI9	SPCS2_DANRE	Probable signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit)	GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0045047	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]
PGEN_.00g227370	Scaffold_11	9299515	9307284	Q8AYC9	CHK1_CHICK	Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Checkpoint kinase-1)	GO:0000077; GO:0000724; GO:0000785; GO:0000794; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0006974; GO:0006975; GO:0007049; GO:0010569; GO:0010767; GO:0018107; GO:0035402; GO:0035556; GO:0045839; GO:0046602; GO:0048096; GO:0072425; GO:2000615	centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; histone kinase activity (H3-T11 specific) [GO:0035402]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin-mediated maintenance of transcription [GO:0048096]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; double-strand break repair via homologous recombination [GO:0000724]; intracellular signal transduction [GO:0035556]; negative regulation of mitotic nuclear division [GO:0045839]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of mitotic centrosome separation [GO:0046602]; regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010767]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]
PGEN_.00g227380	Scaffold_11	9314208	9317021	NA	NA	NA	NA	NA
PGEN_.00g227390	Scaffold_11	9317125	9317859	NA	NA	NA	NA	NA
PGEN_.00g227400	Scaffold_11	9318072	9318428	NA	NA	NA	NA	NA
PGEN_.00g227410	Scaffold_11	9318913	9321426	NA	NA	NA	NA	NA
PGEN_.00g227420	Scaffold_11	9324960	9342097	Q6DE87	CHK1_XENLA	Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Checkpoint kinase-1) (xChk1)	GO:0000077; GO:0000785; GO:0000794; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006468; GO:0006974; GO:0006975; GO:0007049; GO:0007275; GO:0010569; GO:0010767; GO:0018107; GO:0035402; GO:0045839; GO:0046602; GO:0048096; GO:0072425; GO:2000615	centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; histone kinase activity (H3-T11 specific) [GO:0035402]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin-mediated maintenance of transcription [GO:0048096]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; multicellular organism development [GO:0007275]; negative regulation of mitotic nuclear division [GO:0045839]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of mitotic centrosome separation [GO:0046602]; regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010767]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]
PGEN_.00g227430	Scaffold_11	9351783	9399330	Q1T769	MIS12_CHICK	Protein MIS12 homolog	GO:0000070; GO:0000444; GO:0000818; GO:0005623; GO:0007059; GO:0034501; GO:0051301; GO:0051315; GO:0051382	cell [GO:0005623]; MIS12/MIND type complex [GO:0000444]; nuclear MIS12/MIND complex [GO:0000818]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic sister chromatid segregation [GO:0000070]; protein localization to kinetochore [GO:0034501]
PGEN_.00g227440	Scaffold_11	9403640	9404101	NA	NA	NA	NA	NA
PGEN_.00g227450	Scaffold_11	9404305	9417515	Q7LFX5	CHSTF_HUMAN	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]
PGEN_.00g227460	Scaffold_11	9425060	9429801	NA	NA	NA	NA	NA
PGEN_.00g227470	Scaffold_11	9433977	9453919	Q93008	USP9X_HUMAN	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0036459; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g227480	Scaffold_11	9457960	9474225	NA	NA	NA	NA	NA
PGEN_.00g227490	Scaffold_11	9482652	9485795	NA	NA	NA	NA	NA
PGEN_.00g227500	Scaffold_11	9487051	9493609	Q6P3R8	NEK5_HUMAN	Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (Never in mitosis A-related kinase 5) (NimA-related protein kinase 5)	GO:0004674; GO:0005524; GO:0046872	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g227510	Scaffold_11	9494784	9499439	Q5ZHV7	SPRY7_CHICK	SPRY domain-containing protein 7 (Chronic lymphocytic leukemia deletion region gene 6 protein homolog) (CLL deletion region gene 6 protein homolog)		
PGEN_.00g227520	Scaffold_11	9517456	9568849	Q17LW0	MYO7A_AEDAE	Myosin-VIIa (Protein crinkled)	GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]
PGEN_.00g227530	Scaffold_11	9570501	9571619	NA	NA	NA	NA	NA
PGEN_.00g227540	Scaffold_11	9598367	9604091	NA	NA	NA	NA	NA
PGEN_.00g227550	Scaffold_11	9611674	9614239	NA	NA	NA	NA	NA
PGEN_.00g227560	Scaffold_11	9732794	9734441	NA	NA	NA	NA	NA
PGEN_.00g227570	Scaffold_11	9752167	9752496	NA	NA	NA	NA	NA
PGEN_.00g227580	Scaffold_11	9765587	9765931	NA	NA	NA	NA	NA
PGEN_.00g227590	Scaffold_11	9777453	9794200	P0DPB3	SCHI1_HUMAN	Schwannomin-interacting protein 1 (SCHIP-1)	GO:0005737; GO:0042802	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]
PGEN_.00g227600	Scaffold_11	9807383	9867968	Q5F3U0	SP130_CHICK	Histone deacetylase complex subunit SAP130 (130 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p130)	GO:0000122; GO:0070822	Sin3-type complex [GO:0070822]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g227610	Scaffold_11	9871119	9871460	NA	NA	NA	NA	NA
PGEN_.00g227620	Scaffold_11	9902690	9922290	Q06190	P2R3A_HUMAN	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B)	GO:0000159; GO:0001754; GO:0005509; GO:0006470; GO:0007525; GO:0019888; GO:0030674; GO:0045732; GO:0061053; GO:0090090; GO:0090244; GO:0090249; GO:0090263	"protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein binding, bridging [GO:0030674]; protein phosphatase regulator activity [GO:0019888]; eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell motility involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g227630	Scaffold_11	9925314	9931411	Q06190	P2R3A_HUMAN	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B)	GO:0000159; GO:0001754; GO:0005509; GO:0006470; GO:0007525; GO:0019888; GO:0030674; GO:0045732; GO:0061053; GO:0090090; GO:0090244; GO:0090249; GO:0090263	"protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein binding, bridging [GO:0030674]; protein phosphatase regulator activity [GO:0019888]; eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell motility involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g227640	Scaffold_11	9939102	9947593	Q2KHV4	PARL_BOVIN	"Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]"	GO:0004252; GO:0005634; GO:0005739; GO:0005743; GO:0010821; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; regulation of mitochondrion organization [GO:0010821]
PGEN_.00g227650	Scaffold_11	9948110	9981659	Q8CI04	COG3_MOUSE	Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3)	GO:0005794; GO:0005801; GO:0005829; GO:0005886; GO:0006486; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0007030; GO:0017119; GO:0032580; GO:0033365; GO:0050821	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g227660	Scaffold_11	9983181	9990211	P60843	IF4A1_MOUSE	Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1)	GO:0002183; GO:0003723; GO:0003724; GO:0003725; GO:0003743; GO:0005524; GO:0005737	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]
PGEN_.00g227670	Scaffold_11	10009603	10023600	A8X4W9	AT1B3_CAEBR	Probable sodium/potassium-transporting ATPase subunit beta-3 (Sodium/potassium-dependent ATPase subunit beta-3)	GO:0001671; GO:0005623; GO:0005890; GO:0006883; GO:0010248; GO:0030007; GO:0036376; GO:1990573	cell [GO:0005623]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376]
PGEN_.00g227680	Scaffold_11	10051303	10060058	Q8JFP1	IF4A2_CHICK	Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)	GO:0002183; GO:0003723; GO:0003724; GO:0003743; GO:0005524	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]
PGEN_.00g227690	Scaffold_11	10070009	10089052	P47791	GSHR_MOUSE	"Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7)"	GO:0004362; GO:0005623; GO:0005739; GO:0005829; GO:0006749; GO:0007283; GO:0009055; GO:0009897; GO:0034599; GO:0042802; GO:0043295; GO:0045454; GO:0050660; GO:0050661	cell [GO:0005623]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione binding [GO:0043295]; glutathione-disulfide reductase activity [GO:0004362]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283]
PGEN_.00g227700	Scaffold_11	10097342	10098210	NA	NA	NA	NA	NA
PGEN_.00g227710	Scaffold_11	10117617	10134719	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g227720	Scaffold_11	10138441	10140038	NA	NA	NA	NA	NA
PGEN_.00g227730	Scaffold_11	10144925	10145507	NA	NA	NA	NA	NA
PGEN_.00g227740	Scaffold_11	10157014	10170904	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g227750	Scaffold_11	10178534	10181220	NA	NA	NA	NA	NA
PGEN_.00g227760	Scaffold_11	10219650	10221540	NA	NA	NA	NA	NA
PGEN_.00g227770	Scaffold_11	10231333	10244189	NA	NA	NA	NA	NA
PGEN_.00g227780	Scaffold_11	10300518	10318471	NA	NA	NA	NA	NA
PGEN_.00g227790	Scaffold_11	10332077	10334750	Q8I0T3	H2A_MYTED	Histone H2A	GO:0000786; GO:0003677; GO:0005634; GO:0046982	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]
PGEN_.00g227800	Scaffold_11	10335021	10340984	P24140	GPT_CRIGR	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase)	GO:0003975; GO:0003976; GO:0005789; GO:0006488; GO:0008963; GO:0016021; GO:0016757; GO:0019408; GO:0030176; GO:0046872; GO:0051259	"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein complex oligomerization [GO:0051259]"
PGEN_.00g227810	Scaffold_11	10342202	10355183	Q5EA65	GPT_BOVIN	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase)	GO:0003975; GO:0005789; GO:0006487; GO:0006488; GO:0006489; GO:0008963; GO:0016020; GO:0016021; GO:0016757; GO:0019408; GO:0046872; GO:0051259	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; dolichol biosynthetic process [GO:0019408]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; protein complex oligomerization [GO:0051259]; protein N-linked glycosylation [GO:0006487]"
PGEN_.00g227820	Scaffold_11	10364737	10364979	NA	NA	NA	NA	NA
PGEN_.00g227830	Scaffold_11	10382302	10403871	A0JC51	ZIC4_XENLA	Zinc finger protein ZIC 4 (XlZic4) (Zinc finger protein of the cerebellum 4)	GO:0003677; GO:0005634; GO:0007399; GO:0014029; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neural crest formation [GO:0014029]
PGEN_.00g227840	Scaffold_11	10432213	10432419	NA	NA	NA	NA	NA
PGEN_.00g227850	Scaffold_11	10432844	10433074	NA	NA	NA	NA	NA
PGEN_.00g227860	Scaffold_11	10476758	10477579	NA	NA	NA	NA	NA
PGEN_.00g227870	Scaffold_11	10478692	10479771	NA	NA	NA	NA	NA
PGEN_.00g227880	Scaffold_11	10479886	10493170	NA	NA	NA	NA	NA
PGEN_.00g227890	Scaffold_11	10499671	10500093	NA	NA	NA	NA	NA
PGEN_.00g227900	Scaffold_11	10500683	10501729	NA	NA	NA	NA	NA
PGEN_.00g227910	Scaffold_11	10529763	10535610	NA	NA	NA	NA	NA
PGEN_.00g227920	Scaffold_11	10540230	10550733	NA	NA	NA	NA	NA
PGEN_.00g227930	Scaffold_11	10560205	10560555	NA	NA	NA	NA	NA
PGEN_.00g227940	Scaffold_11	10560812	10561108	NA	NA	NA	NA	NA
PGEN_.00g227950	Scaffold_11	10574533	10574919	NA	NA	NA	NA	NA
PGEN_.00g227960	Scaffold_11	10581190	10588335	NA	NA	NA	NA	NA
PGEN_.00g227970	Scaffold_11	10603779	10615503	F8RP11	HSOP_WHEAT	Hsp70-Hsp90 organizing protein (TaHop)	GO:0005634; GO:0005737; GO:0051131; GO:0051879; GO:0070678	cytoplasm [GO:0005737]; nucleus [GO:0005634]; Hsp90 protein binding [GO:0051879]; preprotein binding [GO:0070678]; chaperone-mediated protein complex assembly [GO:0051131]
PGEN_.00g227980	Scaffold_11	10619328	10620749	Q22795	SET1_CAEEL	Histone-lysine N-methyltransferase set-1 (EC 2.1.1.-)	GO:0005634; GO:0005694; GO:0009792; GO:0018024	chromosome [GO:0005694]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; embryo development ending in birth or egg hatching [GO:0009792]
PGEN_.00g227990	Scaffold_11	10625023	10625726	NA	NA	NA	NA	NA
PGEN_.00g228000	Scaffold_11	10661575	10663543	NA	NA	NA	NA	NA
PGEN_.00g228010	Scaffold_11	10673967	10674392	NA	NA	NA	NA	NA
PGEN_.00g228020	Scaffold_11	10675911	10678385	NA	NA	NA	NA	NA
PGEN_.00g228030	Scaffold_11	10678791	10679084	NA	NA	NA	NA	NA
PGEN_.00g228040	Scaffold_11	10680095	10680700	NA	NA	NA	NA	NA
PGEN_.00g228050	Scaffold_11	10697291	10698564	NA	NA	NA	NA	NA
PGEN_.00g228060	Scaffold_11	10699689	10700153	NA	NA	NA	NA	NA
PGEN_.00g228070	Scaffold_11	10700226	10712002	NA	NA	NA	NA	NA
PGEN_.00g228080	Scaffold_11	10712402	10716286	NA	NA	NA	NA	NA
PGEN_.00g228090	Scaffold_11	10727968	10728537	NA	NA	NA	NA	NA
PGEN_.00g228100	Scaffold_11	10731973	10752417	NA	NA	NA	NA	NA
PGEN_.00g228110	Scaffold_11	10755830	10759875	NA	NA	NA	NA	NA
PGEN_.00g228120	Scaffold_11	10797006	10802184	NA	NA	NA	NA	NA
PGEN_.00g228130	Scaffold_11	10802253	10807009	NA	NA	NA	NA	NA
PGEN_.00g228140	Scaffold_11	10814466	10820244	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g228150	Scaffold_11	10826601	10842600	A2A825	CPLN2_MOUSE	Ciliogenesis and planar polarity effector 2 (REM2- and Rab-like small GTPase 1)	GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0006887; GO:0015031; GO:0017157; GO:0031338; GO:0034613; GO:0036064; GO:0060271	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of vesicle fusion [GO:0031338]
PGEN_.00g228160	Scaffold_11	10847057	10910240	P27393	CO4A2_ASCSU	Collagen alpha-2(IV) chain	GO:0005201; GO:0005581; GO:0005604	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201]
PGEN_.00g228170	Scaffold_11	10911440	10967092	P17139	CO4A1_CAEEL	Collagen alpha-1(IV) chain	GO:0002119; GO:0005201; GO:0005581; GO:0005604; GO:0005615; GO:0007517; GO:0009792; GO:0030198; GO:0031012; GO:0048680; GO:0050714	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; embryo development ending in birth or egg hatching [GO:0009792]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein secretion [GO:0050714]
PGEN_.00g228180	Scaffold_11	10978437	11023562	Q5R7X2	SR140_PONAB	U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)	GO:0003723; GO:0005634; GO:0006396	nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396]
PGEN_.00g228190	Scaffold_11	11028607	11051404	Q6P2D8	XRRA1_HUMAN	X-ray radiation resistance-associated protein 1	GO:0005634; GO:0005654; GO:0005737; GO:0010165; GO:0016604	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; response to X-ray [GO:0010165]
PGEN_.00g228200	Scaffold_11	11058039	11065451	NA	NA	NA	NA	NA
PGEN_.00g228210	Scaffold_11	11077902	11078651	Q7Z4W1	DCXR_HUMAN	L-xylulose reductase (XR) (EC 1.1.1.10) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H)	GO:0004090; GO:0005634; GO:0005881; GO:0005886; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016655; GO:0019640; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289; GO:0055114; GO:0070062	"brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g228220	Scaffold_11	11083059	11084578	NA	NA	NA	NA	NA
PGEN_.00g228230	Scaffold_11	11088844	11112622	B0S733	REN3A_DANRE	Regulator of nonsense transcripts 3A (Up-frameshift suppressor 3 homolog A)	GO:0000184; GO:0003723; GO:0005730; GO:0005737; GO:0045727; GO:0051028	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]"
PGEN_.00g228240	Scaffold_11	11112961	11115500	NA	NA	NA	NA	NA
PGEN_.00g228250	Scaffold_11	11123797	11167469	NA	NA	NA	NA	NA
PGEN_.00g228260	Scaffold_11	11188262	11189572	NA	NA	NA	NA	NA
PGEN_.00g228270	Scaffold_11	11189615	11190334	NA	NA	NA	NA	NA
PGEN_.00g228280	Scaffold_11	11190370	11190636	NA	NA	NA	NA	NA
PGEN_.00g228290	Scaffold_11	11190838	11191341	NA	NA	NA	NA	NA
PGEN_.00g228300	Scaffold_11	11191446	11193014	NA	NA	NA	NA	NA
PGEN_.00g228310	Scaffold_11	11214067	11214372	NA	NA	NA	NA	NA
PGEN_.00g228320	Scaffold_11	11216510	11217493	Q3SYK4	VRTN_MOUSE	Vertnin	GO:0000122; GO:0001227	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g228330	Scaffold_11	11219725	11220450	Q91X52	DCXR_MOUSE	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase)	GO:0004090; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016324; GO:0016614; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289; GO:0055114	"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; microvillus [GO:0005902]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g228340	Scaffold_11	11234682	11256049	Q76MJ5	ERN2_HUMAN	Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (hIRE2p) (Ire1-beta) (IRE1b) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	GO:0000287; GO:0004519; GO:0004521; GO:0004672; GO:0004674; GO:0005524; GO:0005789; GO:0006397; GO:0006468; GO:0007050; GO:0007257; GO:0016021; GO:0016075; GO:0030263; GO:0030968; GO:0034976; GO:0036498; GO:0045892; GO:0051082; GO:0070059; GO:1990604	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; apoptotic chromosome condensation [GO:0030263]; cell cycle arrest [GO:0007050]; endoplasmic reticulum unfolded protein response [GO:0030968]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]"
PGEN_.00g228350	Scaffold_11	11274805	11275221	NA	NA	NA	NA	NA
PGEN_.00g228360	Scaffold_11	11282149	11310288	Q76MJ5	ERN2_HUMAN	Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (hIRE2p) (Ire1-beta) (IRE1b) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	GO:0000287; GO:0004519; GO:0004521; GO:0004672; GO:0004674; GO:0005524; GO:0005789; GO:0006397; GO:0006468; GO:0007050; GO:0007257; GO:0016021; GO:0016075; GO:0030263; GO:0030968; GO:0034976; GO:0036498; GO:0045892; GO:0051082; GO:0070059; GO:1990604	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; apoptotic chromosome condensation [GO:0030263]; cell cycle arrest [GO:0007050]; endoplasmic reticulum unfolded protein response [GO:0030968]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]"
PGEN_.00g228370	Scaffold_11	11317166	11317414	Q91XV4	DCXR_MESAU	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g228380	Scaffold_11	11319166	11319915	Q91X52	DCXR_MOUSE	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase)	GO:0004090; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016324; GO:0016614; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289; GO:0055114	"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; microvillus [GO:0005902]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g228390	Scaffold_11	11325549	11326298	Q29529	CBR2_PIG	Carbonyl reductase [NADPH] 2 (EC 1.1.1.184) (Lung carbonyl reductase) (LCR) (NADPH-dependent carbonyl reductase 2)	GO:0004090; GO:0005759; GO:0005997; GO:0006006; GO:0050038	mitochondrial matrix [GO:0005759]; carbonyl reductase (NADPH) activity [GO:0004090]; L-xylulose reductase (NADP+) activity [GO:0050038]; glucose metabolic process [GO:0006006]; xylulose metabolic process [GO:0005997]
PGEN_.00g228400	Scaffold_11	11335572	11336321	Q7Z4W1	DCXR_HUMAN	L-xylulose reductase (XR) (EC 1.1.1.10) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H)	GO:0004090; GO:0005634; GO:0005881; GO:0005886; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016655; GO:0019640; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289; GO:0055114; GO:0070062	"brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g228410	Scaffold_11	11341432	11359963	NA	NA	NA	NA	NA
PGEN_.00g228420	Scaffold_11	11365756	11366988	NA	NA	NA	NA	NA
PGEN_.00g228430	Scaffold_11	11384006	11385614	NA	NA	NA	NA	NA
PGEN_.00g228440	Scaffold_11	11413511	11421319	P97353	SEC1_MOUSE	"Galactoside 2-alpha-L-fucosyltransferase 3 (EC 2.4.1.69) (Alpha(1,2)FT 3) (Fucosyltransferase 10) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 3) (Secretory blood group protein 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g228450	Scaffold_11	11424271	11424483	NA	NA	NA	NA	NA
PGEN_.00g228460	Scaffold_11	11424520	11429805	NA	NA	NA	NA	NA
PGEN_.00g228470	Scaffold_11	11459108	11462721	B4J6Q0	FBSP1_DROGR	F-box/SPRY domain-containing protein 1	GO:0005634; GO:0005938; GO:0007274; GO:0007399; GO:0010629; GO:0016567; GO:0019005; GO:0030054; GO:0031594; GO:0045495; GO:0045732; GO:0045886	cell cortex [GO:0005938]; cell junction [GO:0030054]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005]; negative regulation of gene expression [GO:0010629]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]
PGEN_.00g228480	Scaffold_11	11464828	11497042	A6H611	MIPEP_MOUSE	Mitochondrial intermediate peptidase (MIP) (EC 3.4.24.59)	GO:0004175; GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006518; GO:0006627; GO:0046872	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]
PGEN_.00g228490	Scaffold_11	11503935	11574873	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g228500	Scaffold_11	11704339	11707477	Q8N4V1	MMGT1_HUMAN	Membrane magnesium transporter 1 (ER membrane protein complex subunit 5) (Transmembrane protein 32)	GO:0000139; GO:0005769; GO:0005794; GO:0005886; GO:0006825; GO:0015087; GO:0015093; GO:0015095; GO:0015693; GO:0016020; GO:0016021; GO:0022890; GO:0031901; GO:0072546	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; ER membrane protein complex [GO:0072546]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cobalt ion transmembrane transporter activity [GO:0015087]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; copper ion transport [GO:0006825]; magnesium ion transport [GO:0015693]
PGEN_.00g228510	Scaffold_11	11741426	11742589	NA	NA	NA	NA	NA
PGEN_.00g228520	Scaffold_11	11769279	11769707	NA	NA	NA	NA	NA
PGEN_.00g228530	Scaffold_11	11813709	11813948	NA	NA	NA	NA	NA
PGEN_.00g228540	Scaffold_11	11903887	11904937	NA	NA	NA	NA	NA
PGEN_.00g228550	Scaffold_11	11976401	11981350	Q8K3Y6	ZCCHV_RAT	Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Inactive Poly [ADP-ribose] polymerase 13) (PARP13) (Zinc finger antiviral protein) (ZAP) (rZAP)	GO:0003723; GO:0005634; GO:0005737; GO:0005764; GO:0005770; GO:0006471; GO:0009615; GO:0032481; GO:0032727; GO:0032728; GO:0042802; GO:0043123; GO:0045071; GO:0045087; GO:0046872; GO:0050691; GO:0051607; GO:0061014; GO:0071360; GO:0098586; GO:1900246	cytoplasm [GO:0005737]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; protein ADP-ribosylation [GO:0006471]; regulation of defense response to virus by host [GO:0050691]; response to virus [GO:0009615]
PGEN_.00g228560	Scaffold_11	12051056	12052853	NA	NA	NA	NA	NA
PGEN_.00g228570	Scaffold_11	12056314	12064523	NA	NA	NA	NA	NA
PGEN_.00g228580	Scaffold_11	12074186	12074398	NA	NA	NA	NA	NA
PGEN_.00g228590	Scaffold_11	12074666	12088201	O35344	IMA4_MOUSE	Importin subunit alpha-4 (Importin alpha Q2) (Qip2) (Karyopherin subunit alpha-3)	GO:0005643; GO:0005654; GO:0005829; GO:0006607; GO:0008022; GO:0008139; GO:0061608	cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein C-terminus binding [GO:0008022]; NLS-bearing protein import into nucleus [GO:0006607]
PGEN_.00g228600	Scaffold_11	12090399	12096406	Q9D0P0	EBPL_MOUSE	Emopamil-binding protein-like (Emopamil-binding-related protein)	GO:0005783; GO:0005789; GO:0016021; GO:0016125; GO:0047750	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cholestenol delta-isomerase activity [GO:0047750]; sterol metabolic process [GO:0016125]
PGEN_.00g228610	Scaffold_11	12113442	12148207	P46530	NOTC1_DANRE	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0016021; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor-mediated endocytosis [GO:0048259]; regulation of transcription, DNA-templated [GO:0006355]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514]"
PGEN_.00g228620	Scaffold_11	12148652	12150596	NA	NA	NA	NA	NA
PGEN_.00g228630	Scaffold_11	12151485	12228373	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g228640	Scaffold_11	12237863	12292993	NA	NA	NA	NA	NA
PGEN_.00g228650	Scaffold_11	12326227	12333009	Q56R14	TRI33_XENLA	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g228660	Scaffold_11	12343172	12348986	NA	NA	NA	NA	NA
PGEN_.00g228670	Scaffold_11	12406534	12407163	P58307	OX1R_MOUSE	Orexin receptor type 1 (Ox-1-R) (Ox1-R) (Ox1R) (Hypocretin receptor type 1)	GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007218; GO:0007631; GO:0016499; GO:0017046; GO:0032870; GO:0051480; GO:0070374	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; cellular response to hormone stimulus [GO:0032870]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]
PGEN_.00g228680	Scaffold_11	12498444	12508304	P56719	OX2R_RAT	Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2)	GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0051480	"cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]"
PGEN_.00g228690	Scaffold_11	12519600	12520016	NA	NA	NA	NA	NA
PGEN_.00g228700	Scaffold_11	12520334	12522468	NA	NA	NA	NA	NA
PGEN_.00g228710	Scaffold_11	12554875	12557126	NA	NA	NA	NA	NA
PGEN_.00g228720	Scaffold_11	12593804	12645269	NA	NA	NA	NA	NA
PGEN_.00g228730	Scaffold_11	12654695	12662254	Q6P3Z3	THAP4_MOUSE	THAP domain-containing protein 4	GO:0003677; GO:0020037; GO:0042803; GO:0046872	DNA binding [GO:0003677]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]
PGEN_.00g228740	Scaffold_11	12668559	12672072	Q0P3X8	LTOR4_DANRE	Ragulator complex protein LAMTOR4 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 4)	GO:0005764; GO:0008361; GO:0032008; GO:0061462; GO:0071230; GO:0071986	lysosome [GO:0005764]; Ragulator complex [GO:0071986]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; protein localization to lysosome [GO:0061462]; regulation of cell size [GO:0008361]
PGEN_.00g228750	Scaffold_11	12674049	12685308	Q8K245	UVRAG_MOUSE	UV radiation resistance-associated protein	GO:0000149; GO:0000421; GO:0000775; GO:0005764; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0006914; GO:0007051; GO:0007059; GO:0007098; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035493; GO:0045335; GO:0046718; GO:0051684; GO:0070418; GO:0071900; GO:0097352; GO:0097680	"autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; protein-containing complex [GO:0032991]; SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of protein serine/threonine kinase activity [GO:0071900]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; viral entry into host cell [GO:0046718]"
PGEN_.00g228760	Scaffold_11	12693254	12698108	NA	NA	NA	NA	NA
PGEN_.00g228770	Scaffold_11	12702799	12703934	NA	NA	NA	NA	NA
PGEN_.00g228780	Scaffold_11	12704526	12710400	NA	NA	NA	NA	NA
PGEN_.00g228790	Scaffold_11	12768873	12770186	NA	NA	NA	NA	NA
PGEN_.00g228800	Scaffold_11	12806774	12808135	NA	NA	NA	NA	NA
PGEN_.00g228810	Scaffold_11	12808550	12809056	NA	NA	NA	NA	NA
PGEN_.00g228820	Scaffold_11	12814946	12817192	Q0ZUL9	TLR6_DASNO	Toll-like receptor 6 (CD antigen CD286)	GO:0002755; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0016021; GO:0030670; GO:0034150; GO:0042496; GO:0042802; GO:0045087; GO:0045121; GO:0050702; GO:0050707; GO:0071726; GO:1900227	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; detection of diacyl bacterial lipopeptide [GO:0042496]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 6 signaling pathway [GO:0034150]
PGEN_.00g228830	Scaffold_11	12825190	12830414	NA	NA	NA	NA	NA
PGEN_.00g228840	Scaffold_11	12838049	12840286	Q9EPQ1	TLR1_MOUSE	Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281)	GO:0001774; GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005794; GO:0005887; GO:0006952; GO:0006954; GO:0007250; GO:0016020; GO:0030670; GO:0032493; GO:0034130; GO:0034137; GO:0035354; GO:0035663; GO:0042116; GO:0042495; GO:0042497; GO:0042535; GO:0042802; GO:0045087; GO:0045121; GO:0045335; GO:0045410; GO:0046982; GO:0071723; GO:0071727; GO:2000484	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; triacyl lipopeptide binding [GO:0042497]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; defense response [GO:0006952]; detection of triacyl bacterial lipopeptide [GO:0042495]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; response to bacterial lipoprotein [GO:0032493]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g228850	Scaffold_11	12870803	12876538	NA	NA	NA	NA	NA
PGEN_.00g228860	Scaffold_11	12877902	12878993	NA	NA	NA	NA	NA
PGEN_.00g228870	Scaffold_11	12889290	12889790	NA	NA	NA	NA	NA
PGEN_.00g228880	Scaffold_11	12892630	12894876	Q9Y2C9	TLR6_HUMAN	Toll-like receptor 6 (CD antigen CD286)	GO:0001540; GO:0001774; GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005102; GO:0005623; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0007250; GO:0010628; GO:0030670; GO:0034136; GO:0034150; GO:0035355; GO:0035663; GO:0035666; GO:0038023; GO:0038124; GO:0042496; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043507; GO:0045087; GO:0045121; GO:0045410; GO:0045429; GO:0046209; GO:0046982; GO:0050702; GO:0051092; GO:0071723; GO:0071726; GO:0140052; GO:1900017; GO:1900227; GO:1903223; GO:1903428; GO:1904646; GO:2000483	cell [GO:0005623]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; nitric oxide metabolic process [GO:0046209]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]
PGEN_.00g228890	Scaffold_11	12905755	12945967	P05987	KAPR_DICDI	"cAMP-dependent protein kinase regulatory subunit (Protein kinase A, regulatory subunit) (Rapid development protein C)"	GO:0000187; GO:0004862; GO:0005813; GO:0005829; GO:0005952; GO:0008603; GO:0010468; GO:0010628; GO:0010738; GO:0019934; GO:0030435; GO:0030552; GO:0031154; GO:0031156; GO:0031285; GO:0031288; GO:0034236; GO:0043949; GO:0045859; GO:0047555; GO:0061939; GO:1904643; GO:2000480	"cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein kinase A catalytic subunit binding [GO:0034236]; activation of MAPK activity [GO:0000187]; c-di-GMP signaling [GO:0061939]; cGMP-mediated signaling [GO:0019934]; culmination involved in sorocarp development [GO:0031154]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; positive regulation of gene expression [GO:0010628]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of gene expression [GO:0010468]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein kinase activity [GO:0045859]; regulation of sorocarp development [GO:0031156]; regulation of sorocarp stalk cell differentiation [GO:0031285]; response to curcumin [GO:1904643]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435]"
PGEN_.00g228900	Scaffold_11	12967827	13013627	Q62829	PAK3_RAT	Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (p21-activated kinase 3) (PAK-3) (p65-PAK)	GO:0004672; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0005768; GO:0006468; GO:0007409; GO:0010763; GO:0010975; GO:0014069; GO:0016358; GO:0017048; GO:0017124; GO:0023014; GO:0030833; GO:0032147; GO:0032956; GO:0035556; GO:0043525; GO:0046872; GO:0050770; GO:0051020; GO:0060996; GO:0060997; GO:0061003; GO:0071407; GO:0098978; GO:2000573	cytoplasm [GO:0005737]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of neuron projection development [GO:0010975]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g228910	Scaffold_11	13015484	13029530	Q3ZBG9	PLS2_BOVIN	Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2)	GO:0005886; GO:0016021; GO:0017121; GO:0017128; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; plasma membrane phospholipid scrambling [GO:0017121]
PGEN_.00g228920	Scaffold_11	13033752	13074099	Q64560	TPP2_RAT	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II)	GO:0004177; GO:0004252; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042277; GO:0042802	cytosol [GO:0005829]; nuclear body [GO:0016604]; aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; proteolysis [GO:0006508]
PGEN_.00g228930	Scaffold_11	13155197	13170894	NA	NA	NA	NA	NA
PGEN_.00g228940	Scaffold_11	13209723	13210514	Q9VUL9	FUCTA_DROME	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920	"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]"
PGEN_.00g228950	Scaffold_11	13239655	13274267	Q9DB50	AP1S2_MOUSE	AP-1 complex subunit sigma-2 (Adaptor protein complex AP-1 subunit sigma-1B) (Adaptor-related protein complex 1 subunit sigma-1B) (Clathrin assembly protein complex 1 sigma-1B small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1B subunit) (Sigma 1B subunit of AP-1 clathrin) (Sigma-adaptin 1B) (Sigma1B-adaptin)	GO:0005623; GO:0005794; GO:0005905; GO:0006886; GO:0008542; GO:0016182; GO:0016192; GO:0030117; GO:0030659; GO:0036465; GO:0043231; GO:0045444; GO:0050885; GO:0060612; GO:0098793	cell [GO:0005623]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane coat [GO:0030117]; presynapse [GO:0098793]; adipose tissue development [GO:0060612]; fat cell differentiation [GO:0045444]; intracellular protein transport [GO:0006886]; neuromuscular process controlling balance [GO:0050885]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; visual learning [GO:0008542]
PGEN_.00g228960	Scaffold_11	13287717	13324583	Q9EPR4	S23A2_MOUSE	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2)	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g228970	Scaffold_11	13327447	13362929	Q9WTW8	S23A2_RAT	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g228980	Scaffold_11	13400778	13401614	NA	NA	NA	NA	NA
PGEN_.00g228990	Scaffold_11	13435940	13436896	NA	NA	NA	NA	NA
PGEN_.00g229000	Scaffold_11	13436965	13437396	NA	NA	NA	NA	NA
PGEN_.00g229010	Scaffold_11	13437601	13438065	NA	NA	NA	NA	NA
PGEN_.00g229020	Scaffold_11	13447951	13451202	NA	NA	NA	NA	NA
PGEN_.00g229030	Scaffold_11	13452559	13453002	NA	NA	NA	NA	NA
PGEN_.00g229040	Scaffold_11	13456758	13462513	NA	NA	NA	NA	NA
PGEN_.00g229050	Scaffold_11	13466906	13502059	D3ZHA0	FLNC_RAT	Filamin-C (FLN-C) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin)	GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0048747	costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle fiber development [GO:0048747]
PGEN_.00g229060	Scaffold_11	13537472	13539785	NA	NA	NA	NA	NA
PGEN_.00g229070	Scaffold_11	13622765	13623070	NA	NA	NA	NA	NA
PGEN_.00g229080	Scaffold_11	13681658	13726708	Q16992	LWA_ANTEL	LWamide neuropeptides [Cleaved into: LWamide I; Metamorphosin A (MMA) (LWamide II); LWamide III; LWamide IV; LWamide V; LWamide VI; LWamide VII; LWamide VIII; LWamide IX]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g229090	Scaffold_11	13737913	13738965	Q504Y2	PKDCC_HUMAN	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g229100	Scaffold_11	13740775	13753828	P48637	GSHB_HUMAN	Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)	GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0006520; GO:0006750; GO:0006979; GO:0007399; GO:0007568; GO:0009410; GO:0016594; GO:0031667; GO:0034612; GO:0042802; GO:0042803; GO:0043200; GO:0043295; GO:0046686; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; glutathione biosynthetic process [GO:0006750]; nervous system development [GO:0007399]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]
PGEN_.00g229110	Scaffold_11	13769009	13769488	NA	NA	NA	NA	NA
PGEN_.00g229120	Scaffold_11	13783564	13783956	NA	NA	NA	NA	NA
PGEN_.00g229130	Scaffold_11	13810566	13810988	NA	NA	NA	NA	NA
PGEN_.00g229140	Scaffold_11	13852338	13854978	NA	NA	NA	NA	NA
PGEN_.00g229150	Scaffold_11	13889594	13889866	NA	NA	NA	NA	NA
PGEN_.00g229160	Scaffold_11	14010214	14021370	NA	NA	NA	NA	NA
PGEN_.00g229170	Scaffold_11	14028848	14032452	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g229180	Scaffold_11	14126809	14148410	Q8NBZ7	UXS1_HUMAN	UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1)	GO:0005737; GO:0016021; GO:0032580; GO:0033320; GO:0042803; GO:0048040; GO:0051262; GO:0070062; GO:0070403	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; UDP-glucuronate decarboxylase activity [GO:0048040]; protein tetramerization [GO:0051262]; UDP-D-xylose biosynthetic process [GO:0033320]
PGEN_.00g229190	Scaffold_11	14149273	14156627	Q6P0V6	RL8_DANRE	60S ribosomal protein L8	GO:0002181; GO:0003735; GO:0019843; GO:0022625	cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]
PGEN_.00g229200	Scaffold_11	14164833	14190029	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g229210	Scaffold_11	14196346	14207740	G3V9R3	ST1D1_RAT	Sulfotransferase 1 family member D1 (ST1D1) (EC 2.8.2.-) (Dopamine sulfotransferase Sult1d1) (Tyrosine-ester sulfotransferase)	GO:0005737; GO:0006584; GO:0006629; GO:0008146	cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; catecholamine metabolic process [GO:0006584]; lipid metabolic process [GO:0006629]
PGEN_.00g229220	Scaffold_11	14207846	14225063	NA	NA	NA	NA	NA
PGEN_.00g229230	Scaffold_11	14225315	14229904	E9Q784	ZC3HD_MOUSE	Zinc finger CCCH domain-containing protein 13	GO:0005654; GO:0006397; GO:0007275; GO:0008380; GO:0016607; GO:0036396; GO:0046872; GO:0080009; GO:2000036	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; metal ion binding [GO:0046872]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380]
PGEN_.00g229240	Scaffold_11	14282842	14283174	NA	NA	NA	NA	NA
PGEN_.00g229250	Scaffold_11	14287800	14303084	Q9EP75	CP4FE_MOUSE	Leukotriene-B4 omega-hydroxylase 3 (EC 1.14.14.94) (Cyp4f-14) (Cytochrome P450 4F14) (Cytochrome P450-LTB-omega) (Leukotriene-B4 20-monooxygenase 3)	GO:0005506; GO:0005789; GO:0006690; GO:0008391; GO:0019369; GO:0020037; GO:0043231; GO:0050051; GO:0050544	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid binding [GO:0050544]; arachidonic acid monooxygenase activity [GO:0008391]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; arachidonic acid metabolic process [GO:0019369]; icosanoid metabolic process [GO:0006690]
PGEN_.00g229260	Scaffold_11	14323873	14336805	Q9EP75	CP4FE_MOUSE	Leukotriene-B4 omega-hydroxylase 3 (EC 1.14.14.94) (Cyp4f-14) (Cytochrome P450 4F14) (Cytochrome P450-LTB-omega) (Leukotriene-B4 20-monooxygenase 3)	GO:0005506; GO:0005789; GO:0006690; GO:0008391; GO:0019369; GO:0020037; GO:0043231; GO:0050051; GO:0050544	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid binding [GO:0050544]; arachidonic acid monooxygenase activity [GO:0008391]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; arachidonic acid metabolic process [GO:0019369]; icosanoid metabolic process [GO:0006690]
PGEN_.00g229270	Scaffold_11	14336813	14361245	P33274	CP4F1_RAT	Cytochrome P450 4F1 (EC 1.14.14.1) (CYPIVF1) (Cytochrome P450-A3)	GO:0005506; GO:0005789; GO:0006690; GO:0008391; GO:0009636; GO:0019369; GO:0020037; GO:0043231; GO:0050544; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid binding [GO:0050544]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; icosanoid metabolic process [GO:0006690]; response to toxic substance [GO:0009636]
PGEN_.00g229280	Scaffold_11	14365853	14384704	NA	NA	NA	NA	NA
PGEN_.00g229290	Scaffold_11	14384730	14401505	P33274	CP4F1_RAT	Cytochrome P450 4F1 (EC 1.14.14.1) (CYPIVF1) (Cytochrome P450-A3)	GO:0005506; GO:0005789; GO:0006690; GO:0008391; GO:0009636; GO:0019369; GO:0020037; GO:0043231; GO:0050544; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid binding [GO:0050544]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; icosanoid metabolic process [GO:0006690]; response to toxic substance [GO:0009636]
PGEN_.00g229300	Scaffold_11	14402558	14406168	P15128	CP4B1_RABIT	Cytochrome P450 4B1 (EC 1.14.14.1) (CYPIVB1) (Cytochrome P450 isozyme 5)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g229310	Scaffold_11	14410850	14431306	P78329	CP4F2_HUMAN	Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78)	GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0007596; GO:0008217; GO:0008392; GO:0016324; GO:0016709; GO:0017144; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0052872; GO:0055078; GO:0055114; GO:0070330; GO:0097267	"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid omega-hydroxylase activity [GO:0052869]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]"
PGEN_.00g229320	Scaffold_11	14490193	14535360	P98158	LRP2_RAT	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005623; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007568; GO:0007605; GO:0008144; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0035904; GO:0038023; GO:0042493; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]
PGEN_.00g229330	Scaffold_11	14536223	14545306	A2ARV4	LRP2_MOUSE	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005623; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008144; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035258; GO:0035904; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; steroid hormone receptor binding [GO:0035258]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]
PGEN_.00g229340	Scaffold_11	14546295	14578924	P98158	LRP2_RAT	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005623; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007568; GO:0007605; GO:0008144; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0010951; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031100; GO:0031526; GO:0031904; GO:0031994; GO:0032526; GO:0032991; GO:0033280; GO:0035258; GO:0035904; GO:0038023; GO:0042493; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; animal organ regeneration [GO:0031100]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]
PGEN_.00g229350	Scaffold_11	14602348	14613437	Q27312	NADA_APLKU	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase)	GO:0007338; GO:0016740; GO:0031410; GO:0050135; GO:0061809	"cytoplasmic vesicle [GO:0031410]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; transferase activity [GO:0016740]; single fertilization [GO:0007338]"
PGEN_.00g229360	Scaffold_11	14619196	14620329	NA	NA	NA	NA	NA
PGEN_.00g229370	Scaffold_11	14620841	14622878	NA	NA	NA	NA	NA
PGEN_.00g229380	Scaffold_11	14628671	14629633	NA	NA	NA	NA	NA
PGEN_.00g229390	Scaffold_11	14657719	14662052	NA	NA	NA	NA	NA
PGEN_.00g229400	Scaffold_11	14682246	14697237	NA	NA	NA	NA	NA
PGEN_.00g229410	Scaffold_11	14698335	14704107	Q9VW47	MED12_DROME	Mediator of RNA polymerase II transcription subunit 12 (Mediator complex subunit 12) (Mediator complex subunit Kohtalo) (dTRAP230)	GO:0003712; GO:0003713; GO:0005634; GO:0005700; GO:0006357; GO:0016592; GO:0022416; GO:0035072; GO:0036011; GO:0045498; GO:0048749; GO:0070847; GO:0090263	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; ecdysone-mediated induction of salivary gland cell autophagic cell death [GO:0035072]; imaginal disc-derived leg segmentation [GO:0036011]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]
PGEN_.00g229420	Scaffold_11	14723703	14724186	NA	NA	NA	NA	NA
PGEN_.00g229430	Scaffold_11	14724239	14724951	NA	NA	NA	NA	NA
PGEN_.00g229440	Scaffold_11	14727740	14730743	Q805E5	CHSTE_DANRE	Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1)	GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0050655	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655]
PGEN_.00g229450	Scaffold_11	14777204	14790061	Q0WW55	ZEUS1_ARATH	Thymidylate kinase (AtTMPK) (EC 2.7.4.9) (Protein ZEUS1)	GO:0004550; GO:0004798; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006227; GO:0006233; GO:0006235; GO:0009041; GO:0009793	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; embryo development ending in seed dormancy [GO:0009793]
PGEN_.00g229460	Scaffold_11	14804516	14812101	P23919	KTHY_HUMAN	Thymidylate kinase (EC 2.7.4.9) (dTMP kinase)	GO:0004550; GO:0004798; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005829; GO:0006227; GO:0006233; GO:0006235; GO:0009041; GO:0015949; GO:0043627; GO:0045445; GO:0046105; GO:0046686; GO:0071363	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; myoblast differentiation [GO:0045445]; nucleobase-containing small molecule interconversion [GO:0015949]; response to cadmium ion [GO:0046686]; response to estrogen [GO:0043627]; thymidine biosynthetic process [GO:0046105]
PGEN_.00g229470	Scaffold_11	14832491	14836075	NA	NA	NA	NA	NA
PGEN_.00g229480	Scaffold_11	14837458	14844323	NA	NA	NA	NA	NA
PGEN_.00g229490	Scaffold_11	14852088	14857214	P50464	UNC97_CAEEL	LIM domain-containing protein unc-97 (PINCH homolog) (Uncoordinated protein 97)	GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005911; GO:0005912; GO:0005925; GO:0007005; GO:0007517; GO:0009925; GO:0017022; GO:0031430; GO:0040017; GO:0045216; GO:0046716; GO:0046872; GO:0050954; GO:0055120; GO:0060298; GO:0098609; GO:1900026; GO:2001046	adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; cell [GO:0005623]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; M band [GO:0031430]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; sensory perception of mechanical stimulus [GO:0050954]
PGEN_.00g229500	Scaffold_11	14864500	14893587	P50464	UNC97_CAEEL	LIM domain-containing protein unc-97 (PINCH homolog) (Uncoordinated protein 97)	GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005911; GO:0005912; GO:0005925; GO:0007005; GO:0007517; GO:0009925; GO:0017022; GO:0031430; GO:0040017; GO:0045216; GO:0046716; GO:0046872; GO:0050954; GO:0055120; GO:0060298; GO:0098609; GO:1900026; GO:2001046	adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; cell [GO:0005623]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; M band [GO:0031430]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; sensory perception of mechanical stimulus [GO:0050954]
PGEN_.00g229510	Scaffold_11	14905733	14909975	Q9Z2J0	S23A1_MOUSE	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)	GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016021; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g229520	Scaffold_11	14938444	14959941	Q9SKB3	PARG1_ARATH	Poly(ADP-ribose) glycohydrolase 1 (EC 3.2.1.143)	GO:0004649; GO:0005634; GO:0005737; GO:0005975; GO:0006282; GO:0006970; GO:0006974; GO:0006979; GO:0009225; GO:0009414; GO:0048511; GO:0050832; GO:0090332; GO:1990966	cytoplasm [GO:0005737]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; cellular response to DNA damage stimulus [GO:0006974]; defense response to fungus [GO:0050832]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; response to osmotic stress [GO:0006970]; response to oxidative stress [GO:0006979]; response to water deprivation [GO:0009414]; rhythmic process [GO:0048511]; stomatal closure [GO:0090332]
PGEN_.00g229530	Scaffold_11	14998824	14999105	NA	NA	NA	NA	NA
PGEN_.00g229540	Scaffold_11	15025370	15025627	NA	NA	NA	NA	NA
PGEN_.00g229550	Scaffold_11	15126492	15127697	NA	NA	NA	NA	NA
PGEN_.00g229560	Scaffold_11	15152309	15154935	NA	NA	NA	NA	NA
PGEN_.00g229570	Scaffold_11	15248294	15248695	NA	NA	NA	NA	NA
PGEN_.00g229580	Scaffold_11	15277086	15283585	NA	NA	NA	NA	NA
PGEN_.00g229590	Scaffold_11	15301107	15301523	NA	NA	NA	NA	NA
PGEN_.00g229600	Scaffold_11	15304723	15304986	NA	NA	NA	NA	NA
PGEN_.00g229610	Scaffold_11	15421542	15424085	NA	NA	NA	NA	NA
PGEN_.00g229620	Scaffold_11	15448574	15450323	NA	NA	NA	NA	NA
PGEN_.00g229630	Scaffold_11	15489480	15502343	NA	NA	NA	NA	NA
PGEN_.00g229640	Scaffold_11	15507711	15512245	NA	NA	NA	NA	NA
PGEN_.00g229650	Scaffold_11	15527666	15528593	NA	NA	NA	NA	NA
PGEN_.00g229660	Scaffold_11	15535697	15544970	Q9CQ92	FIS1_MOUSE	Mitochondrial fission 1 protein (FIS1 homolog) (Tetratricopeptide repeat protein 11) (TPR repeat protein 11)	GO:0000266; GO:0000422; GO:0001836; GO:0005623; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005779; GO:0005783; GO:0006626; GO:0006915; GO:0007204; GO:0008053; GO:0010821; GO:0016559; GO:0031307; GO:0032471; GO:0032991; GO:0035584; GO:0042802; GO:0043280; GO:0043525; GO:0043653; GO:0044877; GO:0051260; GO:0051561; GO:0070584; GO:0090141; GO:0090314; GO:1901653; GO:1904579; GO:2001244	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; integral component of peroxisomal membrane [GO:0005779]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; apoptotic process [GO:0006915]; autophagy of mitochondrion [GO:0000422]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to peptide [GO:1901653]; cellular response to thapsigargin [GO:1904579]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peroxisome fission [GO:0016559]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; protein targeting to mitochondrion [GO:0006626]; regulation of mitochondrion organization [GO:0010821]; release of cytochrome c from mitochondria [GO:0001836]
PGEN_.00g229670	Scaffold_11	15552145	15583865	P68372	TBB4B_MOUSE	Tubulin beta-4B chain (Tubulin beta-2C chain)	GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0043209; GO:0045298	cytoplasm [GO:0005737]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; tubulin complex [GO:0045298]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]
PGEN_.00g229680	Scaffold_11	15583911	15610287	A4IIK1	MFHA1_XENTR	Malignant fibrous histiocytoma-amplified sequence 1 homolog	GO:0005525; GO:0005737; GO:0006954; GO:0045087	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]
PGEN_.00g229690	Scaffold_11	15626763	15627104	NA	NA	NA	NA	NA
PGEN_.00g229700	Scaffold_11	15640958	15645087	NA	NA	NA	NA	NA
PGEN_.00g229710	Scaffold_11	15690549	15715145	NA	NA	NA	NA	NA
PGEN_.00g229720	Scaffold_11	15727570	15727812	NA	NA	NA	NA	NA
PGEN_.00g229730	Scaffold_11	15733752	15759017	Q8BX90	FND3A_MOUSE	Fibronectin type-III domain-containing protein 3A	GO:0000139; GO:0001669; GO:0005794; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0016021; GO:0031410; GO:0060009; GO:0098609	acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle membrane [GO:0012506]; cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]
PGEN_.00g229740	Scaffold_11	15739323	15740381	NA	NA	NA	NA	NA
PGEN_.00g229750	Scaffold_11	15740502	15740726	NA	NA	NA	NA	NA
PGEN_.00g229760	Scaffold_11	15773868	15803110	NA	NA	NA	NA	NA
PGEN_.00g229770	Scaffold_11	15804623	15867780	P07207	NOTCH_DROME	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	GO:0001708; GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0005915; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007455; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035003; GO:0035153; GO:0035162; GO:0035165; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043525; GO:0043697; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048	"adherens junction [GO:0005912]; cell [GO:0005623]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
PGEN_.00g229780	Scaffold_11	15875763	15877870	Q8BU85	MSRB3_MOUSE	"Methionine-R-sulfoxide reductase B3, mitochondrial (MsrB3) (EC 1.8.4.12) (EC 1.8.4.14)"	GO:0005739; GO:0005783; GO:0006979; GO:0008270; GO:0030091; GO:0033743; GO:0033745	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]
PGEN_.00g229790	Scaffold_11	15883024	15886833	Q5R930	MSRB3_PONAB	Methionine-R-sulfoxide reductase B3 (MsrB3) (EC 1.8.4.12) (EC 1.8.4.14)	GO:0005739; GO:0005783; GO:0006979; GO:0008270; GO:0030091; GO:0033743; GO:0033745	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]
PGEN_.00g229800	Scaffold_11	16016385	16020484	NA	NA	NA	NA	NA
PGEN_.00g229810	Scaffold_11	16020599	16021929	P21733	YCR2_BACTK	Uncharacterized 29.1 kDa protein in cryB1 5'region (ORF2)		
PGEN_.00g229820	Scaffold_11	16022555	16025412	NA	NA	NA	NA	NA
PGEN_.00g229830	Scaffold_11	16076092	16132402	Q61555	FBN2_MOUSE	Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide]	GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]
PGEN_.00g229840	Scaffold_11	16138231	16169174	NA	NA	NA	NA	NA
PGEN_.00g229850	Scaffold_11	16219053	16240020	NA	NA	NA	NA	NA
PGEN_.00g229860	Scaffold_11	16251948	16256093	NA	NA	NA	NA	NA
PGEN_.00g229870	Scaffold_11	16257355	16312941	P98133	FBN1_BOVIN	Fibrillin-1 (MP340) [Cleaved into: Asprosin]	GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0010737; GO:0031012; GO:0034199; GO:0042593	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]
PGEN_.00g229880	Scaffold_11	16372127	16381559	NA	NA	NA	NA	NA
PGEN_.00g229890	Scaffold_11	16391853	16392494	NA	NA	NA	NA	NA
PGEN_.00g229900	Scaffold_11	16400190	16448315	Q95R48	OCTL_DROME	Organic cation transporter-like protein	GO:0015101; GO:0015695; GO:0016021; GO:0030307; GO:0040018	integral component of membrane [GO:0016021]; organic cation transmembrane transporter activity [GO:0015101]; organic cation transport [GO:0015695]; positive regulation of cell growth [GO:0030307]; positive regulation of multicellular organism growth [GO:0040018]
PGEN_.00g229910	Scaffold_11	16462276	16469698	Q8R151	ZNFX1_MOUSE	NFX1-type zinc finger-containing protein 1	GO:0000775; GO:0003700; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380	"chromosome, centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]"
PGEN_.00g229920	Scaffold_11	16501956	16502789	NA	NA	NA	NA	NA
PGEN_.00g229930	Scaffold_11	16514241	16514606	NA	NA	NA	NA	NA
PGEN_.00g229940	Scaffold_11	16544353	16549999	NA	NA	NA	NA	NA
PGEN_.00g229950	Scaffold_11	16579299	16597864	Q9C6W5	AB14G_ARATH	ABC transporter G family member 14 (ABC transporter ABCG.14) (AtABCG14) (White-brown complex homolog protein 14) (AtWBC14)	GO:0005524; GO:0005886; GO:0010222; GO:0010588; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cotyledon vascular tissue pattern formation [GO:0010588]; stem vascular tissue pattern formation [GO:0010222]; transmembrane transport [GO:0055085]
PGEN_.00g229960	Scaffold_11	16633624	16689767	Q9C6W5	AB14G_ARATH	ABC transporter G family member 14 (ABC transporter ABCG.14) (AtABCG14) (White-brown complex homolog protein 14) (AtWBC14)	GO:0005524; GO:0005886; GO:0010222; GO:0010588; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cotyledon vascular tissue pattern formation [GO:0010588]; stem vascular tissue pattern formation [GO:0010222]; transmembrane transport [GO:0055085]
PGEN_.00g229970	Scaffold_11	16700463	16700732	NA	NA	NA	NA	NA
PGEN_.00g229980	Scaffold_11	16701496	16715876	Q503M4	MT12B_DANRE	Monocarboxylate transporter 12-B (MCT 12-B) (Solute carrier family 16 member 12-B)	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g229990	Scaffold_11	16720894	16732070	Q8R0M8	MOT5_MOUSE	Monocarboxylate transporter 5 (MCT 5)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g230000	Scaffold_11	16745613	16747233	NA	NA	NA	NA	NA
PGEN_.00g230010	Scaffold_11	16747282	16748515	NA	NA	NA	NA	NA
PGEN_.00g230020	Scaffold_11	16753260	16761682	Q8R0M8	MOT5_MOUSE	Monocarboxylate transporter 5 (MCT 5)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g230030	Scaffold_11	16761708	16762617	NA	NA	NA	NA	NA
PGEN_.00g230040	Scaffold_11	16768931	16770408	NA	NA	NA	NA	NA
PGEN_.00g230050	Scaffold_11	16779134	16795429	NA	NA	NA	NA	NA
PGEN_.00g230060	Scaffold_11	16802229	16803615	NA	NA	NA	NA	NA
PGEN_.00g230070	Scaffold_11	16834009	16869815	Q5R8A5	PA24A_PONAB	Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]	GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0009395; GO:0031410; GO:0102567; GO:0102568	"cytoplasmic vesicle [GO:0031410]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; phospholipid catabolic process [GO:0009395]"
PGEN_.00g230080	Scaffold_11	16939573	16942671	NA	NA	NA	NA	NA
PGEN_.00g230090	Scaffold_11	17047764	17048063	NA	NA	NA	NA	NA
PGEN_.00g230100	Scaffold_11	17138446	17139609	Q92847	GHSR_HUMAN	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032869; GO:0036321; GO:0040018; GO:0042536; GO:0042802; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045409; GO:0045923; GO:0046676; GO:0046697; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0099699; GO:0120058; GO:1903672; GO:1904000; GO:1904008; GO:1904349; GO:1904468; GO:1905333; GO:1905564; GO:1990314; GO:2000110	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; negative regulation of tumor necrosis factor secretion [GO:1904468]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]
PGEN_.00g230110	Scaffold_11	17284952	17288338	Q6DG99	KCTD6_DANRE	BTB/POZ domain-containing protein KCTD6	GO:0016567; GO:0051260	protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]
PGEN_.00g230120	Scaffold_11	17294608	17302856	NA	NA	NA	NA	NA
PGEN_.00g230130	Scaffold_11	17308631	17318696	A8J4S9	TREA_APIME	"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)"	GO:0004555; GO:0005991; GO:0016021	"integral component of membrane [GO:0016021]; alpha,alpha-trehalase activity [GO:0004555]; trehalose metabolic process [GO:0005991]"
PGEN_.00g230140	Scaffold_11	17320638	17324418	P19813	TREA_RABIT	"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)"	GO:0004555; GO:0005886; GO:0005993; GO:0031225	"anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; alpha,alpha-trehalase activity [GO:0004555]; trehalose catabolic process [GO:0005993]"
PGEN_.00g230150	Scaffold_11	17327155	17332788	P17972	KCNAW_DROME	Potassium voltage-gated channel protein Shaw (Shaw2)	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]
PGEN_.00g230160	Scaffold_11	17345464	17347663	G5EFC3	KCNAG_CAEEL	Potassium voltage-gated channel protein egl-36 (Egg-laying defective protein 36)	GO:0005244; GO:0005249; GO:0005251; GO:0008076; GO:0016021; GO:0030424; GO:0032590; GO:0032809; GO:0034220; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g230170	Scaffold_11	17352907	17355833	G5EFC3	KCNAG_CAEEL	Potassium voltage-gated channel protein egl-36 (Egg-laying defective protein 36)	GO:0005244; GO:0005249; GO:0005251; GO:0008076; GO:0016021; GO:0030424; GO:0032590; GO:0032809; GO:0034220; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g230180	Scaffold_11	17365530	17369165	NA	NA	NA	NA	NA
PGEN_.00g230190	Scaffold_11	17371962	17390709	Q9D4V0	EKI1_MOUSE	Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82)	GO:0004305; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006646	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]
PGEN_.00g230200	Scaffold_11	17400881	17409089	NA	NA	NA	NA	NA
PGEN_.00g230210	Scaffold_11	17409840	17411749	NA	NA	NA	NA	NA
PGEN_.00g230220	Scaffold_11	17434541	17435161	NA	NA	NA	NA	NA
PGEN_.00g230230	Scaffold_11	17461016	17462431	NA	NA	NA	NA	NA
PGEN_.00g230240	Scaffold_11	17469653	17477975	Q3SZI0	MPI_BOVIN	Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI)	GO:0000032; GO:0004476; GO:0005829; GO:0006486; GO:0008270; GO:0009298; GO:0061611	cytosol [GO:0005829]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate metabolic process [GO:0061611]; protein glycosylation [GO:0006486]
PGEN_.00g230250	Scaffold_11	17481833	17498723	Q16206	ENOX2_HUMAN	Ecto-NOX disulfide-thiol exchanger 2 (APK1 antigen) (Cytosolic ovarian carcinoma antigen 1) (Tumor-associated hydroquinone oxidase) (tNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]	GO:0003676; GO:0005615; GO:0005829; GO:0005886; GO:0007624; GO:0009897; GO:0015035; GO:0040008; GO:0055114	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; protein disulfide oxidoreductase activity [GO:0015035]; oxidation-reduction process [GO:0055114]; regulation of growth [GO:0040008]; ultradian rhythm [GO:0007624]
PGEN_.00g230260	Scaffold_11	17522356	17554674	O95258	UCP5_HUMAN	Brain mitochondrial carrier protein 1 (BMCP-1) (Mitochondrial uncoupling protein 5) (UCP 5) (Solute carrier family 25 member 14)	GO:0005739; GO:0005743; GO:0005887; GO:0006839; GO:0009060; GO:1902600	integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial transport [GO:0006839]; proton transmembrane transport [GO:1902600]
PGEN_.00g230270	Scaffold_11	17561377	17561721	NA	NA	NA	NA	NA
PGEN_.00g230280	Scaffold_11	17578325	17586132	P49129	LAMP1_CRIGR	Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (Lysosomal membrane glycoprotein A) (LGP-A) (CD antigen CD107a)	GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0010008; GO:0016021; GO:0050821	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; protein stabilization [GO:0050821]
PGEN_.00g230290	Scaffold_11	17586156	17603934	NA	NA	NA	NA	NA
PGEN_.00g230300	Scaffold_11	17604265	17616752	NA	NA	NA	NA	NA
PGEN_.00g230310	Scaffold_11	17640031	17640297	NA	NA	NA	NA	NA
PGEN_.00g230320	Scaffold_11	17644267	17648063	P82251	BAT1_HUMAN	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	GO:0005886; GO:0005887; GO:0006865; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0050900; GO:0065003	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]
PGEN_.00g230330	Scaffold_11	17654964	17691916	Q99PW6	MMP24_RAT	Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24]	GO:0004222; GO:0005615; GO:0005887; GO:0006508; GO:0008233; GO:0008270; GO:0010001; GO:0016021; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508]
PGEN_.00g230340	Scaffold_11	17719889	17720173	NA	NA	NA	NA	NA
PGEN_.00g230350	Scaffold_11	17772591	17773600	Q9ES30	C1QT3_MOUSE	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005576; GO:0005581; GO:0005615; GO:0005623; GO:0010629; GO:0032991; GO:0035356; GO:0042593; GO:0042802; GO:0045721; GO:0050715; GO:0050728; GO:0051897; GO:0070165; GO:0070206; GO:0070374; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; cellular triglyceride homeostasis [GO:0035356]; glucose homeostasis [GO:0042593]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; protein trimerization [GO:0070206]
PGEN_.00g230360	Scaffold_11	17777242	17777553	NA	NA	NA	NA	NA
PGEN_.00g230370	Scaffold_11	17784197	17785219	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g230380	Scaffold_11	17794880	17809627	NA	NA	NA	NA	NA
PGEN_.00g230390	Scaffold_11	17816028	17818193	NA	NA	NA	NA	NA
PGEN_.00g230400	Scaffold_11	17819180	17819827	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g230410	Scaffold_11	17819887	17820915	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g230420	Scaffold_11	17821028	17848070	Q62311	TAF6_MOUSE	Transcription initiation factor TFIID subunit 6 (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70) (Transcription initiation factor TFIID 80 kDa subunit) (TAF(II)80) (TAFII-80) (TAFII80) (p80)	GO:0000124; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006325; GO:0006352; GO:0006366; GO:0006367; GO:0008285; GO:0017162; GO:0032991; GO:0033276; GO:0043065; GO:0045786; GO:0046695; GO:0046982; GO:0051123; GO:0060261; GO:0071339; GO:2001244	"cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g230430	Scaffold_11	17852178	17863325	Q6P5L7	ARGLA_DANRE	Arginine and glutamate-rich protein 1-A	GO:0005654; GO:0005739	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
PGEN_.00g230440	Scaffold_11	17869290	17873465	NA	NA	NA	NA	NA
PGEN_.00g230450	Scaffold_11	17887571	17891591	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g230460	Scaffold_11	17898334	17898597	NA	NA	NA	NA	NA
PGEN_.00g230470	Scaffold_11	17901091	18017681	Q01887	RYK_MOUSE	Tyrosine-protein kinase RYK (EC 2.7.10.1) (Kinase VIK) (Met-related kinase) (NYK-R)	GO:0004672; GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007399; GO:0007409; GO:0007411; GO:0016020; GO:0016055; GO:0017147; GO:0018108; GO:0022038; GO:0030182; GO:0031175; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0050919; GO:0061643; GO:0071679; GO:1904938; GO:1904948; GO:1904953	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; frizzled binding [GO:0005109]; protein kinase activity [GO:0004672]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; chemorepulsion of axon [GO:0061643]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; peptidyl-tyrosine phosphorylation [GO:0018108]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of MAPK cascade [GO:0043410]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]
PGEN_.00g230480	Scaffold_11	18026334	18029989	A2VDN6	SF3A1_BOVIN	Splicing factor 3A subunit 1	GO:0000398; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"
PGEN_.00g230490	Scaffold_11	18031648	18044350	A2VDN6	SF3A1_BOVIN	Splicing factor 3A subunit 1	GO:0000398; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"
PGEN_.00g230500	Scaffold_11	18048284	18048565	NA	NA	NA	NA	NA
PGEN_.00g230510	Scaffold_11	18051440	18051793	NA	NA	NA	NA	NA
PGEN_.00g230520	Scaffold_11	18053248	18069523	P30122	CEL_BOVIN	Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase) (Fragment)	GO:0004771; GO:0004806; GO:0005576; GO:0005737; GO:0005887; GO:0007158; GO:0008126; GO:0009986; GO:0016042; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0097104; GO:0097105; GO:0098793	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; synapse [GO:0045202]; acetylesterase activity [GO:0008126]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g230530	Scaffold_11	18076970	18091607	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g230540	Scaffold_11	18095503	18112469	Q9GKX2	DHRS4_RABIT	Dehydrogenase/reductase SDR family member 4 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase/NADP-retinol dehydrogenase) (CR) (PHCR) (NADPH-dependent retinol dehydrogenase/reductase) (NDRD) (Peroxisomal short-chain alcohol dehydrogenase) (PSCD) (rabNRDR) (Fragment)	GO:0004090; GO:0005739; GO:0005777	mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carbonyl reductase (NADPH) activity [GO:0004090]
PGEN_.00g230550	Scaffold_11	18115177	18153817	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g230560	Scaffold_11	18162377	18174337	Q3UHX9	CI114_MOUSE	Putative methyltransferase C9orf114 homolog (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (SPOUT domain-containing methyltransferase 1)	GO:0000776; GO:0000777; GO:0005737; GO:0007049; GO:0008168; GO:0010608; GO:0031616; GO:0032259; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0072686	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616]; methyltransferase activity [GO:0008168]; miRNA binding [GO:0035198]; cell cycle [GO:0007049]; cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; methylation [GO:0032259]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]
PGEN_.00g230570	Scaffold_11	18224225	18237244	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g230580	Scaffold_11	18237297	18238781	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g230590	Scaffold_11	18239256	18241323	NA	NA	NA	NA	NA
PGEN_.00g230600	Scaffold_11	18266555	18278095	NA	NA	NA	NA	NA
PGEN_.00g230610	Scaffold_11	18303434	18339272	Q5ZJ66	SYEM_CHICK	"Probable glutamate--tRNA ligase, mitochondrial (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS)"	GO:0000049; GO:0004818; GO:0005524; GO:0005759; GO:0006424; GO:0008270	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; glutamyl-tRNA aminoacylation [GO:0006424]
PGEN_.00g230620	Scaffold_11	18400504	18451055	A6QP05	DHR12_BOVIN	Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g230630	Scaffold_11	18456028	18462524	NA	NA	NA	NA	NA
PGEN_.00g230640	Scaffold_11	18472918	18473181	NA	NA	NA	NA	NA
PGEN_.00g230650	Scaffold_11	18477189	18480847	NA	NA	NA	NA	NA
PGEN_.00g230660	Scaffold_11	18550245	18573194	Q8BUB4	WDFY2_MOUSE	WD repeat and FYVE domain-containing protein 2 (Propeller-FYVE protein) (Prof) (WD40- and FYVE domain-containing protein 2)	GO:0001934; GO:0005737; GO:0005769; GO:0031982; GO:0045600; GO:0046872	cytoplasm [GO:0005737]; early endosome [GO:0005769]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934]
PGEN_.00g230670	Scaffold_11	18579964	18590614	NA	NA	NA	NA	NA
PGEN_.00g230680	Scaffold_11	18597337	18599013	NA	NA	NA	NA	NA
PGEN_.00g230690	Scaffold_11	18608356	18609758	NA	NA	NA	NA	NA
PGEN_.00g230700	Scaffold_11	18614442	18614837	NA	NA	NA	NA	NA
PGEN_.00g230710	Scaffold_11	18667916	18668407	NA	NA	NA	NA	NA
PGEN_.00g230720	Scaffold_11	18679692	18680740	NA	NA	NA	NA	NA
PGEN_.00g230730	Scaffold_11	18692197	18692535	NA	NA	NA	NA	NA
PGEN_.00g230740	Scaffold_11	18734156	18785506	Q9VMW8	MPU1_DROME	Mannose-P-dolichol utilization defect 1 protein homolog	GO:0006486; GO:0009312; GO:0016021	integral component of membrane [GO:0016021]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]
PGEN_.00g230750	Scaffold_11	18795443	18823754	NA	NA	NA	NA	NA
PGEN_.00g230760	Scaffold_11	18856605	18856886	NA	NA	NA	NA	NA
PGEN_.00g230770	Scaffold_11	18879292	18879690	NA	NA	NA	NA	NA
PGEN_.00g230780	Scaffold_11	18964527	18967542	NA	NA	NA	NA	NA
PGEN_.00g230790	Scaffold_11	18971431	18972971	Q68FA4	SOX3_XENTR	Transcription factor Sox-3	GO:0000122; GO:0000981; GO:0001704; GO:0005634; GO:0005737; GO:0006355; GO:0008013; GO:0030154; GO:0043565; GO:0044798; GO:0045892	"cytoplasm [GO:0005737]; nuclear transcription factor complex [GO:0044798]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; formation of primary germ layer [GO:0001704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g230800	Scaffold_11	18981855	18989111	NA	NA	NA	NA	NA
PGEN_.00g230810	Scaffold_11	19027291	19027584	NA	NA	NA	NA	NA
PGEN_.00g230820	Scaffold_11	19122396	19133500	Q5FVR2	TYPH_RAT	Thymidine phosphorylase (TP) (EC 2.4.2.4) (TdRPase)	GO:0000002; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0009032; GO:0016154; GO:0031641; GO:0042803; GO:0051969; GO:1905333	cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]
PGEN_.00g230830	Scaffold_11	19157012	19164267	NA	NA	NA	NA	NA
PGEN_.00g230840	Scaffold_11	19205852	19206145	NA	NA	NA	NA	NA
PGEN_.00g230850	Scaffold_11	19259629	19303586	NA	NA	NA	NA	NA
PGEN_.00g230860	Scaffold_11	19372950	19435915	Q5D1E8	ZC12A_HUMAN	Endoribonuclease ZC3H12A (EC 3.1.-.-) (Monocyte chemotactic protein-induced protein 1) (MCP-induced protein 1) (MCPIP-1) (Regnase-1) (Reg1) (Zinc finger CCCH domain-containing protein 12A)	GO:0000294; GO:0000932; GO:0001525; GO:0001933; GO:0002230; GO:0002757; GO:0003677; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0004521; GO:0004532; GO:0004540; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0005856; GO:0006915; GO:0006954; GO:0006974; GO:0007399; GO:0010468; GO:0010508; GO:0010595; GO:0010628; GO:0010629; GO:0010656; GO:0010884; GO:0010942; GO:0016579; GO:0030154; GO:0030867; GO:0032088; GO:0032715; GO:0032720; GO:0032991; GO:0034599; GO:0035198; GO:0035613; GO:0035925; GO:0036464; GO:0042149; GO:0042307; GO:0042406; GO:0043022; GO:0043031; GO:0043124; GO:0044828; GO:0045019; GO:0045600; GO:0045766; GO:0045944; GO:0046872; GO:0050713; GO:0050852; GO:0051259; GO:0051607; GO:0055118; GO:0061014; GO:0061158; GO:0071222; GO:0071347; GO:0071356; GO:0090501; GO:0090502; GO:0098586; GO:1900016; GO:1900119; GO:1900165; GO:1900745; GO:1901223; GO:1902714; GO:1903003; GO:1903799; GO:1903936; GO:1904468; GO:1904637; GO:1990869; GO:2000320; GO:2000379; GO:2000627	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; ribonuclease activity [GO:0004540]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; immune response-activating signal transduction [GO:0002757]; inflammatory response [GO:0006954]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of macrophage activation [GO:0043031]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor secretion [GO:1904468]; nervous system development [GO:0007399]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; regulation of gene expression [GO:0010468]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852]"
PGEN_.00g230870	Scaffold_11	19449166	19487906	NA	NA	NA	NA	NA
PGEN_.00g230880	Scaffold_11	19489886	19506431	NA	NA	NA	NA	NA
PGEN_.00g230890	Scaffold_11	19521005	19556090	NA	NA	NA	NA	NA
PGEN_.00g230900	Scaffold_11	19556376	19571285	NA	NA	NA	NA	NA
PGEN_.00g230910	Scaffold_11	19623657	19625923	NA	NA	NA	NA	NA
PGEN_.00g230920	Scaffold_11	19696939	19706556	NA	NA	NA	NA	NA
PGEN_.00g230930	Scaffold_11	19726296	19736947	NA	NA	NA	NA	NA
PGEN_.00g230940	Scaffold_11	19786556	19788688	NA	NA	NA	NA	NA
PGEN_.00g230950	Scaffold_11	19824685	19830926	NA	NA	NA	NA	NA
PGEN_.00g230960	Scaffold_11	19844950	19853585	NA	NA	NA	NA	NA
PGEN_.00g230970	Scaffold_11	19866012	19868106	NA	NA	NA	NA	NA
PGEN_.00g230980	Scaffold_11	19891634	19901249	NA	NA	NA	NA	NA
PGEN_.00g230990	Scaffold_11	19910012	19910626	NA	NA	NA	NA	NA
PGEN_.00g231000	Scaffold_11	19944080	19944937	NA	NA	NA	NA	NA
PGEN_.00g231010	Scaffold_11	19947970	19948660	NA	NA	NA	NA	NA
PGEN_.00g231020	Scaffold_11	19949145	19949420	NA	NA	NA	NA	NA
PGEN_.00g231030	Scaffold_11	19949989	19950336	NA	NA	NA	NA	NA
PGEN_.00g231040	Scaffold_11	19960001	19978699	NA	NA	NA	NA	NA
PGEN_.00g231050	Scaffold_11	19982066	19982362	NA	NA	NA	NA	NA
PGEN_.00g231060	Scaffold_11	19983593	19984021	NA	NA	NA	NA	NA
PGEN_.00g231070	Scaffold_11	19991914	19992453	NA	NA	NA	NA	NA
PGEN_.00g231080	Scaffold_11	19992502	19999366	NA	NA	NA	NA	NA
PGEN_.00g231090	Scaffold_11	20012369	20015751	NA	NA	NA	NA	NA
PGEN_.00g231100	Scaffold_11	20082837	20085417	NA	NA	NA	NA	NA
PGEN_.00g231110	Scaffold_11	20098811	20103850	NA	NA	NA	NA	NA
PGEN_.00g231120	Scaffold_11	20109322	20114798	NA	NA	NA	NA	NA
PGEN_.00g231130	Scaffold_11	20119148	20120870	NA	NA	NA	NA	NA
PGEN_.00g231140	Scaffold_11	20122964	20155977	NA	NA	NA	NA	NA
PGEN_.00g231150	Scaffold_11	20175201	20183753	Q9Y5B8	NDK7_HUMAN	Nucleoside diphosphate kinase 7 (NDK 7) (NDP kinase 7) (EC 2.7.4.6) (nm23-H7)	GO:0004550; GO:0005524; GO:0005813; GO:0005829; GO:0006183; GO:0006228; GO:0006241; GO:0046872	centrosome [GO:0005813]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]
PGEN_.00g231160	Scaffold_11	20183792	20188059	Q9Y5B8	NDK7_HUMAN	Nucleoside diphosphate kinase 7 (NDK 7) (NDP kinase 7) (EC 2.7.4.6) (nm23-H7)	GO:0004550; GO:0005524; GO:0005813; GO:0005829; GO:0006183; GO:0006228; GO:0006241; GO:0046872	centrosome [GO:0005813]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]
PGEN_.00g231170	Scaffold_11	20197639	20241304	O55043	ARHG7_RAT	Rho guanine nucleotide exchange factor 7 (Beta-Pix) (PAK-interacting exchange factor beta)	GO:0000322; GO:0001726; GO:0002244; GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007030; GO:0007264; GO:0019901; GO:0030027; GO:0030032; GO:0030426; GO:0032092; GO:0032991; GO:0043005; GO:0043025; GO:0043065; GO:0043547; GO:0043615; GO:0060124; GO:0098974; GO:0098982; GO:0099140; GO:1904424	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; storage vacuole [GO:0000322]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; astrocyte cell migration [GO:0043615]; Golgi organization [GO:0007030]; hematopoietic progenitor cell differentiation [GO:0002244]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; regulation of GTP binding [GO:1904424]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g231180	Scaffold_11	20250936	20264774	NA	NA	NA	NA	NA
PGEN_.00g231190	Scaffold_11	20266148	20275912	Q2YDJ4	HINT3_BOVIN	Histidine triad nucleotide-binding protein 3 (HINT-3) (EC 3.-.-.-) (HINT-4)	GO:0000166; GO:0005634; GO:0005737; GO:0016787; GO:0042803; GO:0051289	cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; protein homotetramerization [GO:0051289]
PGEN_.00g231200	Scaffold_11	20286573	20293205	Q9BR01	ST4A1_HUMAN	Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (hBR-STL) (hBR-STL-1) (Nervous system sulfotransferase) (NST)	GO:0005829; GO:0008146; GO:0008202; GO:0042802; GO:0050427	cytosol [GO:0005829]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; steroid metabolic process [GO:0008202]
PGEN_.00g231210	Scaffold_11	20301596	20302591	NA	NA	NA	NA	NA
PGEN_.00g231220	Scaffold_11	20386178	20392862	Q13042	CDC16_HUMAN	Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6) (APC6) (CDC16 homolog) (CDC16Hs) (Cyclosome subunit 6)	GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0006511; GO:0007049; GO:0031145; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g231230	Scaffold_11	20395481	20407000	O35817	AKA14_RAT	A-kinase anchor protein 14 (AKAP-14) (TAKAP-1.2) (Testis-specific A-kinase-anchoring protein TAKAP-80)	GO:0005930; GO:0005952; GO:0007283; GO:0034237; GO:0035686; GO:0051018	axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; sperm fibrous sheath [GO:0035686]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; spermatogenesis [GO:0007283]
PGEN_.00g231240	Scaffold_11	20413113	20437773	B2RV13	CF97D_HUMAN	Uncharacterized protein CFAP97D1 (CFAP97 domain-containing protein 1)		
PGEN_.00g231250	Scaffold_11	20455184	20514132	Q03049	YD541_YEAST	Putative uncharacterized oxidoreductase YDR541C (EC 1.1.1.-)	GO:0016491; GO:0016616; GO:0033721; GO:0050662; GO:1901426	"aldehyde dehydrogenase (NADP+) activity [GO:0033721]; coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; response to furfural [GO:1901426]"
PGEN_.00g231260	Scaffold_11	20477443	20477979	NA	NA	NA	NA	NA
PGEN_.00g231270	Scaffold_11	20542163	20544516	NA	NA	NA	NA	NA
PGEN_.00g231280	Scaffold_11	20577048	20578253	O46635	5HT2A_CANLF	5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-hydroxytryptamine receptor) (Serotonin receptor 2A)	GO:0004930; GO:0004993; GO:0005623; GO:0005886; GO:0005887; GO:0005901; GO:0007187; GO:0007200; GO:0007268; GO:0007610; GO:0008144; GO:0030054; GO:0030424; GO:0030425; GO:0030594; GO:0031410; GO:0042493; GO:0051209; GO:0051378; GO:0098793	"axon [GO:0030424]; caveola [GO:0005901]; cell [GO:0005623]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; behavior [GO:0007610]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]"
PGEN_.00g231290	Scaffold_11	20590605	20592224	NA	NA	NA	NA	NA
PGEN_.00g231300	Scaffold_11	20655713	20656439	NA	NA	NA	NA	NA
PGEN_.00g231310	Scaffold_11	20656810	20657085	NA	NA	NA	NA	NA
PGEN_.00g231320	Scaffold_11	20657979	20662560	NA	NA	NA	NA	NA
PGEN_.00g231330	Scaffold_11	20667762	20679917	NA	NA	NA	NA	NA
PGEN_.00g231340	Scaffold_11	20690795	20713136	NA	NA	NA	NA	NA
PGEN_.00g231350	Scaffold_11	20751293	20751832	Q8BU31	RAP2C_MOUSE	Ras-related protein Rap-2c	GO:0003713; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0016020; GO:0019003; GO:0030336; GO:0031954; GO:0032486; GO:0044291; GO:0055037; GO:0055038; GO:0061097; GO:0090557	bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; transcription coactivator activity [GO:0003713]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of protein tyrosine kinase activity [GO:0061097]
PGEN_.00g231360	Scaffold_11	20760775	20811655	A2RUV5	HFM1_XENTR	Probable ATP-dependent DNA helicase HFM1 (EC 3.6.4.12)	GO:0000712; GO:0003676; GO:0003678; GO:0005524	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676]; resolution of meiotic recombination intermediates [GO:0000712]
PGEN_.00g231370	Scaffold_11	20818822	20819634	P48626	FAD3E_TOBAC	"Omega-3 fatty acid desaturase, endoplasmic reticulum (EC 1.14.19.-)"	GO:0005789; GO:0006636; GO:0016021; GO:0016717	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; unsaturated fatty acid biosynthetic process [GO:0006636]"
PGEN_.00g231380	Scaffold_11	20841859	20865113	Q5ZK28	DPOD3_CHICK	DNA polymerase delta subunit 3 (DNA polymerase delta subunit p66)	GO:0003887; GO:0005654; GO:0005737; GO:0006271; GO:0006297; GO:0043625; GO:1904161	"cytoplasm [GO:0005737]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; DNA-directed DNA polymerase activity [GO:0003887]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; nucleotide-excision repair, DNA gap filling [GO:0006297]"
PGEN_.00g231390	Scaffold_11	20869244	20873708	NA	NA	NA	NA	NA
PGEN_.00g231400	Scaffold_11	20876641	20908697	NA	NA	NA	NA	NA
PGEN_.00g231410	Scaffold_11	20920280	20931324	P58195	PLS1_RAT	Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1)	GO:0001228; GO:0003677; GO:0005154; GO:0005509; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0006955; GO:0010628; GO:0015914; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030099; GO:0032091; GO:0033003; GO:0035455; GO:0035456; GO:0042609; GO:0043065; GO:0045071; GO:0045089; GO:0045121; GO:0045944; GO:0048471; GO:0051607; GO:0060368; GO:0062023; GO:0070782; GO:0071222; GO:0071345; GO:0097193; GO:1902231; GO:2000373	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; phospholipid transport [GO:0015914]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]"
PGEN_.00g231420	Scaffold_11	20947410	20954109	NA	NA	NA	NA	NA
PGEN_.00g231430	Scaffold_11	20961314	20965575	NA	NA	NA	NA	NA
PGEN_.00g231440	Scaffold_11	20974910	20982793	NA	NA	NA	NA	NA
PGEN_.00g231450	Scaffold_11	20989019	20995975	Q9H2G9	GO45_HUMAN	Golgin-45 (Basic leucine zipper nuclear factor 1) (JEM-1) (p45 basic leucine-zipper nuclear factor)	GO:0000139; GO:0001558; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; regulation of cell growth [GO:0001558]
PGEN_.00g231460	Scaffold_11	21001533	21007416	Q9DBB9	CPN2_MOUSE	Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit)	GO:0005615; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]
PGEN_.00g231470	Scaffold_11	21012176	21015486	Q8CBX9	BIVM_MOUSE	Basic immunoglobulin-like variable motif-containing protein	GO:0003697; GO:0004520; GO:0005634; GO:0005737; GO:0006295	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; endodeoxyribonuclease activity [GO:0004520]; single-stranded DNA binding [GO:0003697]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]"
PGEN_.00g231480	Scaffold_11	21033912	21035245	Q569D5	SBP1_XENTR	Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1)	GO:0005634; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031]
PGEN_.00g231490	Scaffold_11	21044286	21070550	Q8JZM4	DNER_MOUSE	Delta and Notch-like epidermal growth factor-related receptor (Brain EGF repeat-containing transmembrane protein)	GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0007219; GO:0007220; GO:0007417; GO:0010001; GO:0016021; GO:0030425; GO:0043025; GO:0048741	dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]
PGEN_.00g231500	Scaffold_11	21159136	21159414	NA	NA	NA	NA	NA
PGEN_.00g231510	Scaffold_11	21160818	21161358	NA	NA	NA	NA	NA
PGEN_.00g231520	Scaffold_11	21201328	21201609	NA	NA	NA	NA	NA
PGEN_.00g231530	Scaffold_11	21218156	21221175	NA	NA	NA	NA	NA
PGEN_.00g231540	Scaffold_11	21260106	21271782	NA	NA	NA	NA	NA
PGEN_.00g231550	Scaffold_11	21270087	21272284	NA	NA	NA	NA	NA
PGEN_.00g231560	Scaffold_11	21338483	21343750	NA	NA	NA	NA	NA
PGEN_.00g231570	Scaffold_11	21344152	21346266	NA	NA	NA	NA	NA
PGEN_.00g231580	Scaffold_11	21346886	21347254	NA	NA	NA	NA	NA
PGEN_.00g231590	Scaffold_11	21347522	21348007	NA	NA	NA	NA	NA
PGEN_.00g231600	Scaffold_11	21348352	21348795	NA	NA	NA	NA	NA
PGEN_.00g231610	Scaffold_11	21363602	21460794	NA	NA	NA	NA	NA
PGEN_.00g231620	Scaffold_11	21507011	21518143	NA	NA	NA	NA	NA
PGEN_.00g231630	Scaffold_11	21524841	21538934	NA	NA	NA	NA	NA
PGEN_.00g231640	Scaffold_11	21563679	21615420	Q16760	DGKD_HUMAN	Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) (130 kDa diacylglycerol kinase) (Diglyceride kinase delta) (DGK-delta)	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0007173; GO:0007205; GO:0007275; GO:0010033; GO:0015031; GO:0019932; GO:0019992; GO:0030168; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0046982; GO:0051260	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; platelet activation [GO:0030168]; protein homooligomerization [GO:0051260]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165]
PGEN_.00g231650	Scaffold_11	21616581	21617045	NA	NA	NA	NA	NA
PGEN_.00g231660	Scaffold_11	21719938	21721836	D2GXS7	TRIM2_AILME	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	GO:0004842; GO:0005737; GO:0008270; GO:0043523	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g231670	Scaffold_11	21733190	21753718	A8MYZ0	MIY4B_HUMAN	Inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B (Protein FAM188B2)	GO:0016807; GO:1990380	cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]
PGEN_.00g231680	Scaffold_11	21780728	21803723	P53356	HTK16_HYDVU	Tyrosine-protein kinase HTK16 (EC 2.7.10.2)	GO:0004715; GO:0005524	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]
PGEN_.00g231690	Scaffold_11	21844038	21844913	NA	NA	NA	NA	NA
PGEN_.00g231700	Scaffold_11	21852476	21869391	Q9UT67	IMT2_SCHPO	Inositol phosphoceramide mannosyltransferase 2 (EC 2.4.-.-) (IPC mannosyltransferase 2)	GO:0000030; GO:0005794; GO:0016021; GO:0031501; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g231710	Scaffold_11	21883265	21886516	NA	NA	NA	NA	NA
PGEN_.00g231720	Scaffold_11	21888483	21889067	NA	NA	NA	NA	NA
PGEN_.00g231730	Scaffold_11	22079267	22080424	NA	NA	NA	NA	NA
PGEN_.00g231740	Scaffold_11	22102280	22102558	NA	NA	NA	NA	NA
PGEN_.00g231750	Scaffold_11	22112230	22113501	NA	NA	NA	NA	NA
PGEN_.00g231760	Scaffold_11	22193689	22195934	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g231770	Scaffold_11	22208396	22220228	NA	NA	NA	NA	NA
PGEN_.00g231780	Scaffold_11	22244170	22258726	NA	NA	NA	NA	NA
PGEN_.00g231790	Scaffold_11	22261969	22273709	NA	NA	NA	NA	NA
PGEN_.00g231800	Scaffold_11	22277450	22278220	O60779	S19A2_HUMAN	Thiamine transporter 1 (ThTr-1) (ThTr1) (Solute carrier family 19 member 2) (Thiamine carrier 1) (TC1)	GO:0005886; GO:0008517; GO:0015234; GO:0015888; GO:0016021; GO:0042723; GO:0055085; GO:0071934	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085]
PGEN_.00g231810	Scaffold_11	22278224	22279932	NA	NA	NA	NA	NA
PGEN_.00g231820	Scaffold_11	22334966	22342250	Q9VCA8	ANKHM_DROME	Ankyrin repeat and KH domain-containing protein mask (Multiple ankyrin repeat single KH domain-containing protein)	GO:0001751; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0007005; GO:0007169; GO:0019901; GO:0030018; GO:0031430; GO:0043066; GO:0045214; GO:0060361; GO:0090210; GO:1903147	cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; compound eye photoreceptor cell differentiation [GO:0001751]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy of mitochondrion [GO:1903147]; regulation of establishment of blood-brain barrier [GO:0090210]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g231830	Scaffold_11	22350691	22377649	O15439	MRP4_HUMAN	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	GO:0002576; GO:0005524; GO:0005886; GO:0009986; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]"
PGEN_.00g231840	Scaffold_11	22394131	22394460	NA	NA	NA	NA	NA
PGEN_.00g231850	Scaffold_11	22407739	22411577	NA	NA	NA	NA	NA
PGEN_.00g231860	Scaffold_11	22418870	22422790	NA	NA	NA	NA	NA
PGEN_.00g231870	Scaffold_11	22455001	22506226	O15439	MRP4_HUMAN	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	GO:0002576; GO:0005524; GO:0005886; GO:0009986; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]"
PGEN_.00g231880	Scaffold_11	22515351	22527154	O43257	ZNHI1_HUMAN	Zinc finger HIT domain-containing protein 1 (Cyclin-G1-binding protein 1) (Zinc finger protein subfamily 4A member 1) (p18 Hamlet)	GO:0000812; GO:0005634; GO:0005654; GO:0031063; GO:0031491; GO:0042826; GO:0043486; GO:0046872	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]; regulation of histone deacetylation [GO:0031063]
PGEN_.00g231890	Scaffold_11	22530720	22533963	NA	NA	NA	NA	NA
PGEN_.00g231900	Scaffold_11	22547302	22548180	NA	NA	NA	NA	NA
PGEN_.00g231910	Scaffold_11	22562604	22563603	NA	NA	NA	NA	NA
PGEN_.00g231920	Scaffold_11	22583318	22587628	Q9Y6Q3	ZFP37_HUMAN	Zinc finger protein 37 homolog (Zfp-37)	GO:0003700; GO:0005634; GO:0006355; GO:0008270; GO:0043565	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g231930	Scaffold_11	22599266	22603120	NA	NA	NA	NA	NA
PGEN_.00g231940	Scaffold_11	22606470	22681919	Q8BXR5	NALCN_MOUSE	Sodium leak channel non-selective protein (Voltage gated channel-like protein 1)	GO:0005244; GO:0005261; GO:0005272; GO:0016021; GO:0022840; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805	integral component of membrane [GO:0016021]; cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]
PGEN_.00g231950	Scaffold_11	22741006	22761264	NA	NA	NA	NA	NA
PGEN_.00g231960	Scaffold_11	22789874	22804834	NA	NA	NA	NA	NA
PGEN_.00g231970	Scaffold_11	22804960	22815909	NA	NA	NA	NA	NA
PGEN_.00g231980	Scaffold_11	22826925	22827530	NA	NA	NA	NA	NA
PGEN_.00g231990	Scaffold_11	22839337	22839675	NA	NA	NA	NA	NA
PGEN_.00g232000	Scaffold_11	22843900	22860470	Q9QYM0	MRP5_RAT	Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5)	GO:0005524; GO:0008514; GO:0009986; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0032496; GO:0032868; GO:0042626; GO:0048471; GO:0055085	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; organic anion transmembrane transporter activity [GO:0008514]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; transmembrane transport [GO:0055085]
PGEN_.00g232010	Scaffold_11	22876433	22900909	O15440	MRP5_HUMAN	Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP) (pABC11)	GO:0005524; GO:0005886; GO:0005887; GO:0008514; GO:0009986; GO:0015562; GO:0016020; GO:0016323; GO:0016887; GO:0030213; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0140115	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]; export across plasma membrane [GO:0140115]; hyaluronan biosynthetic process [GO:0030213]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g232020	Scaffold_11	22910890	22952125	O70589	CSKP_MOUSE	Peripheral plasma membrane protein CASK (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase)	GO:0001953; GO:0004674; GO:0005516; GO:0005524; GO:0005604; GO:0005634; GO:0005652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006357; GO:0008022; GO:0010839; GO:0014069; GO:0016020; GO:0016323; GO:0016363; GO:0030165; GO:0030425; GO:0031982; GO:0032024; GO:0032991; GO:0042043; GO:0042734; GO:0043025; GO:0044877; GO:0045121; GO:0045202; GO:0045944; GO:0060170; GO:0061003; GO:0061045; GO:0070509; GO:0072659; GO:0090280; GO:0090288; GO:0097060; GO:0097440; GO:0098685; GO:0098846; GO:2000300	apical dendrite [GO:0097440]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podocyte foot [GO:0098846]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; calcium ion import [GO:0070509]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g232030	Scaffold_11	22993355	22993816	NA	NA	NA	NA	NA
PGEN_.00g232040	Scaffold_11	22997238	22998593	NA	NA	NA	NA	NA
PGEN_.00g232050	Scaffold_11	22999712	23001474	NA	NA	NA	NA	NA
PGEN_.00g232060	Scaffold_11	23152245	23152829	NA	NA	NA	NA	NA
PGEN_.00g232070	Scaffold_11	23155123	23156709	NA	NA	NA	NA	NA
PGEN_.00g232080	Scaffold_11	23186886	23201786	NA	NA	NA	NA	NA
PGEN_.00g232090	Scaffold_11	23222226	23287551	Q63406	MCF2L_RAT	Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein) (OST oncogene)	GO:0005089; GO:0005545; GO:0005737; GO:0007266; GO:0012505; GO:0016020; GO:0019898; GO:0030027; GO:0031234; GO:0035025; GO:0035091; GO:0045944	cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; lamellipodium [GO:0030027]; membrane [GO:0016020]; 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol binding [GO:0035091]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rho protein signal transduction [GO:0007266]
PGEN_.00g232100	Scaffold_11	23311939	23313689	NA	NA	NA	NA	NA
PGEN_.00g232110	Scaffold_11	23319216	23383401	NA	NA	NA	NA	NA
PGEN_.00g232120	Scaffold_11	23393000	23405291	NA	NA	NA	NA	NA
PGEN_.00g232130	Scaffold_11	23409154	23413412	NA	NA	NA	NA	NA
PGEN_.00g232140	Scaffold_11	23424767	23428120	NA	NA	NA	NA	NA
PGEN_.00g232150	Scaffold_11	23443399	23444619	NA	NA	NA	NA	NA
PGEN_.00g232160	Scaffold_11	23452975	23453508	NA	NA	NA	NA	NA
PGEN_.00g232170	Scaffold_11	23454029	23454808	NA	NA	NA	NA	NA
PGEN_.00g232180	Scaffold_11	23455808	23456122	NA	NA	NA	NA	NA
PGEN_.00g232190	Scaffold_11	23525178	23526605	O02300	NTR1_CAEEL	Nematocin receptor 1	GO:0004930; GO:0005886; GO:0007610; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; behavior [GO:0007610]
PGEN_.00g232200	Scaffold_11	23535374	23535736	NA	NA	NA	NA	NA
PGEN_.00g232210	Scaffold_11	23543544	23543933	NA	NA	NA	NA	NA
PGEN_.00g232220	Scaffold_11	23564788	23573835	Q9Z306	S22A4_MOUSE	Solute carrier family 22 member 4 (Organic cation/carnitine transporter 1)	GO:0005524; GO:0005739; GO:0006641; GO:0006814; GO:0009437; GO:0015101; GO:0015226; GO:0015293; GO:0015491; GO:0015651; GO:0015697; GO:0015879; GO:0016021; GO:0016324; GO:0030165	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; organic cation transmembrane transporter activity [GO:0015101]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; quaternary ammonium group transport [GO:0015697]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]
PGEN_.00g232230	Scaffold_11	23596776	23626726	E1BD59	TRI56_BOVIN	E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56)	GO:0004842; GO:0005737; GO:0008270; GO:0032608; GO:0034340; GO:0051607; GO:0070534	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340]
PGEN_.00g232240	Scaffold_11	23638340	23638723	NA	NA	NA	NA	NA
PGEN_.00g232250	Scaffold_11	23647819	23648967	NA	NA	NA	NA	NA
PGEN_.00g232260	Scaffold_11	23692203	23699563	NA	NA	NA	NA	NA
PGEN_.00g232270	Scaffold_11	23703887	23716730	NA	NA	NA	NA	NA
PGEN_.00g232280	Scaffold_11	23806179	23807287	NA	NA	NA	NA	NA
PGEN_.00g232290	Scaffold_11	23898995	23899360	NA	NA	NA	NA	NA
PGEN_.00g232300	Scaffold_11	23915140	23915403	NA	NA	NA	NA	NA
PGEN_.00g232310	Scaffold_11	23927226	23927735	NA	NA	NA	NA	NA
PGEN_.00g232320	Scaffold_11	23985033	24098518	Q8CGN4	BCOR_MOUSE	BCL-6 corepressor (BCoR)	GO:0000122; GO:0000415; GO:0000977; GO:0001835; GO:0003714; GO:0004842; GO:0005634; GO:0005654; GO:0007507; GO:0008134; GO:0030502; GO:0031072; GO:0035518; GO:0042476; GO:0042826; GO:0044212; GO:0045892; GO:0051572; GO:0060021; GO:0065001; GO:0070171; GO:0140261	"BCOR complex [GO:0140261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin-protein transferase activity [GO:0004842]; blastocyst hatching [GO:0001835]; heart development [GO:0007507]; histone H2A monoubiquitination [GO:0035518]; negative regulation of bone mineralization [GO:0030502]; negative regulation of histone H3-K36 methylation [GO:0000415]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]"
PGEN_.00g232330	Scaffold_11	24106365	24106652	NA	NA	NA	NA	NA
PGEN_.00g232340	Scaffold_11	24120523	24179210	Q8C0W1	ANMY1_MOUSE	Ankyrin repeat and MYND domain-containing protein 1	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g232350	Scaffold_11	24185390	24185671	NA	NA	NA	NA	NA
PGEN_.00g232360	Scaffold_11	24190600	24209588	Q28811	PHR_POTTR	Deoxyribodipyrimidine photo-lyase (EC 4.1.99.3) (DNA photolyase) (Photoreactivating enzyme)	GO:0003677; GO:0003904; GO:0006281; GO:0018298	deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298]
PGEN_.00g232370	Scaffold_11	24217597	24230653	Q52N47	ITM2B_PIG	"Integral membrane protein 2B (Immature BRI2) (imBRI2) (Transmembrane protein BRI) (Bri) [Cleaved into: BRI2, membrane form (Mature BRI2) (mBRI2); BRI2 intracellular domain (BRI2 ICD); BRI2C, soluble form; Bri23 peptide (Bri2-23) (ABri23) (C-terminal peptide) (P23 peptide)]"	GO:0000139; GO:0001540; GO:0005615; GO:0005794; GO:0005886; GO:0010008; GO:0030660; GO:0031301; GO:0042985	endosome membrane [GO:0010008]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of organelle membrane [GO:0031301]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]
PGEN_.00g232380	Scaffold_11	24248036	24255815	Q8BGC3	MOT12_MOUSE	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g232390	Scaffold_11	24276800	24338887	Q90600	RB_CHICK	Retinoblastoma-associated protein (p104) (pRb) (Rb)	GO:0000785; GO:0001012; GO:0001102; GO:0005634; GO:0005667; GO:0006325; GO:0006357; GO:0006915; GO:0007049; GO:0007346; GO:0008285; GO:0016032; GO:0030154; GO:0030182; GO:0030308; GO:0031175; GO:0035189; GO:0045892; GO:0048667; GO:2000134	"chromatin [GO:0000785]; nucleus [GO:0005634]; Rb-E2F complex [GO:0035189]; transcription factor complex [GO:0005667]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell morphogenesis involved in neuron differentiation [GO:0048667]; chromatin organization [GO:0006325]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]"
PGEN_.00g232400	Scaffold_11	24348070	24349338	NA	NA	NA	NA	NA
PGEN_.00g232410	Scaffold_11	24376799	24377278	NA	NA	NA	NA	NA
PGEN_.00g232420	Scaffold_11	24377515	24378618	NA	NA	NA	NA	NA
PGEN_.00g232430	Scaffold_11	24393680	24394615	P02707	LECH_CHICK	Hepatic lectin	GO:0006897; GO:0016021; GO:0030246	integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; endocytosis [GO:0006897]
PGEN_.00g232440	Scaffold_11	24409324	24439011	NA	NA	NA	NA	NA
PGEN_.00g232450	Scaffold_11	24440909	24460570	NA	NA	NA	NA	NA
PGEN_.00g232460	Scaffold_11	24486915	24494498	NA	NA	NA	NA	NA
PGEN_.00g232470	Scaffold_11	24498979	24503433	NA	NA	NA	NA	NA
PGEN_.00g232480	Scaffold_11	24505224	24506195	NA	NA	NA	NA	NA
PGEN_.00g232490	Scaffold_11	24506686	24507009	NA	NA	NA	NA	NA
PGEN_.00g232500	Scaffold_11	24508165	24522347	NA	NA	NA	NA	NA
PGEN_.00g232510	Scaffold_11	24540511	24560772	NA	NA	NA	NA	NA
PGEN_.00g232520	Scaffold_11	24574465	24747099	O54697	NALDL_RAT	Aminopeptidase NAALADL1 (EC 3.4.11.-) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L)	GO:0004177; GO:0004180; GO:0005509; GO:0008237; GO:0008270; GO:0016021; GO:0016324; GO:0042803; GO:0043171	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]
PGEN_.00g232530	Scaffold_11	24709701	24710889	NA	NA	NA	NA	NA
PGEN_.00g232540	Scaffold_11	24756176	24758083	NA	NA	NA	NA	NA
PGEN_.00g232550	Scaffold_11	24758162	24758428	NA	NA	NA	NA	NA
PGEN_.00g232560	Scaffold_11	24821343	24824490	NA	NA	NA	NA	NA
PGEN_.00g232570	Scaffold_11	24824549	24840120	NA	NA	NA	NA	NA
PGEN_.00g232580	Scaffold_11	24861044	24873696	NA	NA	NA	NA	NA
PGEN_.00g232590	Scaffold_11	24904902	24918924	NA	NA	NA	NA	NA
PGEN_.00g232600	Scaffold_11	24938065	24938412	NA	NA	NA	NA	NA
PGEN_.00g232610	Scaffold_11	24977766	24978191	NA	NA	NA	NA	NA
PGEN_.00g232620	Scaffold_11	24979890	24980741	NA	NA	NA	NA	NA
PGEN_.00g232630	Scaffold_11	24994661	24995284	NA	NA	NA	NA	NA
PGEN_.00g232640	Scaffold_11	24996251	25037771	NA	NA	NA	NA	NA
PGEN_.00g232650	Scaffold_11	25002144	25004028	NA	NA	NA	NA	NA
PGEN_.00g232660	Scaffold_11	25038342	25053222	NA	NA	NA	NA	NA
PGEN_.00g232670	Scaffold_11	25057048	25058789	NA	NA	NA	NA	NA
PGEN_.00g232680	Scaffold_11	25074762	25075897	NA	NA	NA	NA	NA
PGEN_.00g232690	Scaffold_11	25146303	25146608	NA	NA	NA	NA	NA
PGEN_.00g232700	Scaffold_11	25147512	25150376	NA	NA	NA	NA	NA
PGEN_.00g232710	Scaffold_11	25174581	25175411	NA	NA	NA	NA	NA
PGEN_.00g232720	Scaffold_11	25175869	25176267	NA	NA	NA	NA	NA
PGEN_.00g232730	Scaffold_11	25179679	25190803	NA	NA	NA	NA	NA
PGEN_.00g232740	Scaffold_11	25261872	25262270	NA	NA	NA	NA	NA
PGEN_.00g232750	Scaffold_11	25270558	25278860	NA	NA	NA	NA	NA
PGEN_.00g232760	Scaffold_11	25279747	25281287	NA	NA	NA	NA	NA
PGEN_.00g232770	Scaffold_11	25286587	25286913	NA	NA	NA	NA	NA
PGEN_.00g232780	Scaffold_11	25314589	25316457	NA	NA	NA	NA	NA
PGEN_.00g232790	Scaffold_11	25375436	25375819	NA	NA	NA	NA	NA
PGEN_.00g232800	Scaffold_11	25377391	25378354	NA	NA	NA	NA	NA
PGEN_.00g232810	Scaffold_11	25427820	25430173	NA	NA	NA	NA	NA
PGEN_.00g232820	Scaffold_11	25430969	25436714	NA	NA	NA	NA	NA
PGEN_.00g232830	Scaffold_11	25443248	25443583	NA	NA	NA	NA	NA
PGEN_.00g232840	Scaffold_11	25443817	25444494	NA	NA	NA	NA	NA
PGEN_.00g232850	Scaffold_11	25445452	25446288	NA	NA	NA	NA	NA
PGEN_.00g232860	Scaffold_11	25447153	25447416	NA	NA	NA	NA	NA
PGEN_.00g232870	Scaffold_11	25448323	25448943	NA	NA	NA	NA	NA
PGEN_.00g232880	Scaffold_11	25449197	25449466	NA	NA	NA	NA	NA
PGEN_.00g232890	Scaffold_11	25473290	25473715	NA	NA	NA	NA	NA
PGEN_.00g232900	Scaffold_11	25473760	25474363	NA	NA	NA	NA	NA
PGEN_.00g232910	Scaffold_11	25478137	25481494	NA	NA	NA	NA	NA
PGEN_.00g232920	Scaffold_11	25481778	25482689	NA	NA	NA	NA	NA
PGEN_.00g232930	Scaffold_11	25589630	25589986	NA	NA	NA	NA	NA
PGEN_.00g232940	Scaffold_11	25590024	25590458	NA	NA	NA	NA	NA
PGEN_.00g232950	Scaffold_11	25590685	25590957	NA	NA	NA	NA	NA
PGEN_.00g232960	Scaffold_11	25595859	25597625	NA	NA	NA	NA	NA
PGEN_.00g232970	Scaffold_11	25610442	25612796	NA	NA	NA	NA	NA
PGEN_.00g232980	Scaffold_11	25612895	25622551	NA	NA	NA	NA	NA
PGEN_.00g232990	Scaffold_11	25626623	25627294	NA	NA	NA	NA	NA
PGEN_.00g233000	Scaffold_11	25701390	25704656	Q66H30	GIN1_RAT	Gypsy retrotransposon integrase-like protein 1 (GIN-1)	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g233010	Scaffold_11	25706150	25707118	NA	NA	NA	NA	NA
PGEN_.00g233020	Scaffold_11	25733058	25739752	NA	NA	NA	NA	NA
PGEN_.00g233030	Scaffold_11	25748514	25760470	NA	NA	NA	NA	NA
PGEN_.00g233040	Scaffold_11	25794709	25795032	NA	NA	NA	NA	NA
PGEN_.00g233050	Scaffold_11	25795145	25795372	NA	NA	NA	NA	NA
PGEN_.00g233060	Scaffold_11	25795452	25795721	NA	NA	NA	NA	NA
PGEN_.00g233070	Scaffold_11	25855189	25855977	NA	NA	NA	NA	NA
PGEN_.00g233080	Scaffold_11	25856186	25856464	NA	NA	NA	NA	NA
PGEN_.00g233090	Scaffold_11	25867741	25868016	NA	NA	NA	NA	NA
PGEN_.00g233100	Scaffold_11	25868297	25869313	NA	NA	NA	NA	NA
PGEN_.00g233110	Scaffold_11	25920129	25921548	NA	NA	NA	NA	NA
PGEN_.00g233120	Scaffold_11	25921610	25922215	NA	NA	NA	NA	NA
PGEN_.00g233130	Scaffold_11	25925606	25927942	NA	NA	NA	NA	NA
PGEN_.00g233140	Scaffold_11	25930443	25933142	Q5U538	HARB1_XENLA	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g233150	Scaffold_11	25936492	25937247	NA	NA	NA	NA	NA
PGEN_.00g233160	Scaffold_11	25957487	25957747	NA	NA	NA	NA	NA
PGEN_.00g233170	Scaffold_11	25995672	25996360	NA	NA	NA	NA	NA
PGEN_.00g233180	Scaffold_11	26005089	26005337	NA	NA	NA	NA	NA
PGEN_.00g233190	Scaffold_11	26006377	26006787	NA	NA	NA	NA	NA
PGEN_.00g233200	Scaffold_11	26172934	26173822	NA	NA	NA	NA	NA
PGEN_.00g233210	Scaffold_11	26238685	26239065	NA	NA	NA	NA	NA
PGEN_.00g233220	Scaffold_11	26255803	26261640	NA	NA	NA	NA	NA
PGEN_.00g233230	Scaffold_11	26281237	26281512	NA	NA	NA	NA	NA
PGEN_.00g233240	Scaffold_11	26282555	26282848	NA	NA	NA	NA	NA
PGEN_.00g233250	Scaffold_11	26299350	26299601	NA	NA	NA	NA	NA
PGEN_.00g233260	Scaffold_11	26331770	26340630	O15266	SHOX_HUMAN	Short stature homeobox protein (Pseudoautosomal homeobox-containing osteogenic protein) (Short stature homeobox-containing protein)	GO:0000790; GO:0000981; GO:0001228; GO:0001501; GO:0003700; GO:0005654; GO:0006366; GO:0043231; GO:0043565; GO:0045944	"intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g233270	Scaffold_11	26342921	26343349	NA	NA	NA	NA	NA
PGEN_.00g233280	Scaffold_11	26365210	26386491	NA	NA	NA	NA	NA
PGEN_.00g233290	Scaffold_11	26401021	26421722	NA	NA	NA	NA	NA
PGEN_.00g233300	Scaffold_11	26424398	26424826	NA	NA	NA	NA	NA
PGEN_.00g233310	Scaffold_11	26425512	26425832	NA	NA	NA	NA	NA
PGEN_.00g233320	Scaffold_11	26447032	26505756	Q8WXR4	MYO3B_HUMAN	Myosin-IIIb (EC 2.7.11.1)	GO:0003774; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0032426; GO:0050896; GO:0090103	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g233330	Scaffold_11	26456902	26457231	NA	NA	NA	NA	NA
PGEN_.00g233340	Scaffold_11	26510005	26545358	Q9Y6X6	MYO16_HUMAN	Unconventional myosin-XVI (Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3) (Unconventional myosin-16)	GO:0003774; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0008285; GO:0016459; GO:0021549; GO:0048471; GO:0051015; GO:2000134	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]
PGEN_.00g233350	Scaffold_11	26578056	26578325	NA	NA	NA	NA	NA
PGEN_.00g233360	Scaffold_11	26583481	26583714	NA	NA	NA	NA	NA
PGEN_.00g233370	Scaffold_11	26639441	26640485	O00602	FCN1_HUMAN	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	GO:0001664; GO:0001867; GO:0002752; GO:0005576; GO:0005581; GO:0006956; GO:0007186; GO:0008329; GO:0030246; GO:0031232; GO:0033691; GO:0034394; GO:0034774; GO:0043312; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:1904813; GO:2000484	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; carbohydrate binding [GO:0030246]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; sialic acid binding [GO:0033691]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-8 secretion [GO:2000484]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654]"
PGEN_.00g233380	Scaffold_11	26642241	26643166	NA	NA	NA	NA	NA
PGEN_.00g233390	Scaffold_11	26643221	26647008	NA	NA	NA	NA	NA
PGEN_.00g233400	Scaffold_11	26658288	26659058	NA	NA	NA	NA	NA
PGEN_.00g233410	Scaffold_11	26666832	26703047	P35352	CAR3_DICDI	Cyclic AMP receptor 3 (cAMP receptor 3)	GO:0001646; GO:0005887; GO:0006935; GO:0007190; GO:0019933; GO:0019934; GO:0030552; GO:0031152; GO:0046578; GO:0090630	integral component of plasma membrane [GO:0005887]; cAMP binding [GO:0030552]; cAMP receptor activity [GO:0001646]; activation of adenylate cyclase activity [GO:0007190]; activation of GTPase activity [GO:0090630]; aggregation involved in sorocarp development [GO:0031152]; cAMP-mediated signaling [GO:0019933]; cGMP-mediated signaling [GO:0019934]; chemotaxis [GO:0006935]; regulation of Ras protein signal transduction [GO:0046578]
PGEN_.00g233420	Scaffold_11	26711905	26733109	Q8WYA0	IFT81_HUMAN	Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1)	GO:0005813; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0031514; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0097542	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283]
PGEN_.00g233430	Scaffold_11	26762401	26771764	Q8N2R8	FA43A_HUMAN	Protein FAM43A		
PGEN_.00g233440	Scaffold_11	26778293	26780997	NA	NA	NA	NA	NA
PGEN_.00g233450	Scaffold_11	26781022	26781646	NA	NA	NA	NA	NA
PGEN_.00g233460	Scaffold_11	26804107	26810567	NA	NA	NA	NA	NA
PGEN_.00g233470	Scaffold_11	26825231	26833308	NA	NA	NA	NA	NA
PGEN_.00g233480	Scaffold_11	26836767	26837063	NA	NA	NA	NA	NA
PGEN_.00g233490	Scaffold_11	26883222	26883689	NA	NA	NA	NA	NA
PGEN_.00g233500	Scaffold_11	26895502	26905842	NA	NA	NA	NA	NA
PGEN_.00g233510	Scaffold_11	26916359	26917135	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g233520	Scaffold_11	26917184	26917666	NA	NA	NA	NA	NA
PGEN_.00g233530	Scaffold_11	26918931	26921665	NA	NA	NA	NA	NA
PGEN_.00g233540	Scaffold_11	26922136	26966093	Q14186	TFDP1_HUMAN	Transcription factor Dp-1 (DRTF1-polypeptide 1) (DRTF1) (E2F dimerization partner 1)	GO:0000083; GO:0000790; GO:0000981; GO:0000987; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0006977; GO:0008134; GO:0008544; GO:0019904; GO:0043276; GO:0045944; GO:0070317; GO:0070345; GO:0090575; GO:1900740; GO:2000278	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; proximal promoter sequence-specific DNA binding [GO:0000987]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; anoikis [GO:0043276]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"
PGEN_.00g233550	Scaffold_11	26966357	26979644	Q80W94	MOGT2_MOUSE	2-acylglycerol O-acyltransferase 2 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 1-like) (Monoacylglycerol O-acyltransferase 2)	GO:0003846; GO:0005783; GO:0005789; GO:0006071; GO:0006629; GO:0006651; GO:0016021; GO:0016407; GO:0019432; GO:0046462; GO:0050892; GO:1990578	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407]; diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol metabolic process [GO:0046462]; triglyceride biosynthetic process [GO:0019432]
PGEN_.00g233560	Scaffold_11	26992313	27006977	Q8CHI9	CHSTF_RAT	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; hexose biosynthetic process [GO:0019319]
PGEN_.00g233570	Scaffold_11	27034459	27054774	Q0V9R4	CCD39_XENTR	Coiled-coil domain-containing protein 39	GO:0003341; GO:0005576; GO:0005930; GO:0036159; GO:0060285; GO:0060287; GO:0070286	axoneme [GO:0005930]; extracellular region [GO:0005576]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; inner dynein arm assembly [GO:0036159]
PGEN_.00g233580	Scaffold_11	27099534	27108460	P68372	TBB4B_MOUSE	Tubulin beta-4B chain (Tubulin beta-2C chain)	GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0043209; GO:0045298	cytoplasm [GO:0005737]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; tubulin complex [GO:0045298]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]
PGEN_.00g233590	Scaffold_11	27109919	27110170	NA	NA	NA	NA	NA
PGEN_.00g233600	Scaffold_11	27110571	27115204	P68372	TBB4B_MOUSE	Tubulin beta-4B chain (Tubulin beta-2C chain)	GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0043209; GO:0045298	cytoplasm [GO:0005737]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; tubulin complex [GO:0045298]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]
PGEN_.00g233610	Scaffold_11	27130927	27139133	P68372	TBB4B_MOUSE	Tubulin beta-4B chain (Tubulin beta-2C chain)	GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0043209; GO:0045298	cytoplasm [GO:0005737]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; tubulin complex [GO:0045298]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]
PGEN_.00g233620	Scaffold_11	27170439	27183873	NA	NA	NA	NA	NA
PGEN_.00g233630	Scaffold_11	27200412	27229167	NA	NA	NA	NA	NA
PGEN_.00g233640	Scaffold_11	27236491	27243606	NA	NA	NA	NA	NA
PGEN_.00g233650	Scaffold_11	27248475	27249525	NA	NA	NA	NA	NA
PGEN_.00g233660	Scaffold_11	27335801	27337840	NA	NA	NA	NA	NA
PGEN_.00g233670	Scaffold_11	27353953	27366482	NA	NA	NA	NA	NA
PGEN_.00g233680	Scaffold_11	27391131	27391529	NA	NA	NA	NA	NA
PGEN_.00g233690	Scaffold_11	27402733	27405797	NA	NA	NA	NA	NA
PGEN_.00g233700	Scaffold_11	27507423	27511537	NA	NA	NA	NA	NA
PGEN_.00g233710	Scaffold_11	27513804	27572799	Q99KH8	STK24_MOUSE	Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 35 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]	GO:0000139; GO:0004674; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008631; GO:0009267; GO:0023014; GO:0030336; GO:0032147; GO:0042542; GO:0046777; GO:0046872; GO:0048679; GO:0048680; GO:0097194	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; positive regulation of axon regeneration [GO:0048680]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g233720	Scaffold_11	27591135	27591648	NA	NA	NA	NA	NA
PGEN_.00g233730	Scaffold_11	27592004	27602347	Q9D0B5	TSTD3_MOUSE	Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 (Rhodanese domain-containing protein 3)	GO:0004792	thiosulfate sulfurtransferase activity [GO:0004792]
PGEN_.00g233740	Scaffold_11	27615478	27626570	Q8BGC3	MOT12_MOUSE	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g233750	Scaffold_11	27632457	27642615	NA	NA	NA	NA	NA
PGEN_.00g233760	Scaffold_11	27650986	27651537	NA	NA	NA	NA	NA
PGEN_.00g233770	Scaffold_11	27658467	27661179	P11833	TBB_PARLI	Tubulin beta chain (Beta-tubulin)	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g233780	Scaffold_11	27661206	27669450	NA	NA	NA	NA	NA
PGEN_.00g233790	Scaffold_11	27699329	27719458	NA	NA	NA	NA	NA
PGEN_.00g233800	Scaffold_11	27755025	27765120	NA	NA	NA	NA	NA
PGEN_.00g233810	Scaffold_11	27765532	27768479	NA	NA	NA	NA	NA
PGEN_.00g233820	Scaffold_11	27770004	27770363	NA	NA	NA	NA	NA
PGEN_.00g233830	Scaffold_11	27770677	27771182	NA	NA	NA	NA	NA
PGEN_.00g233840	Scaffold_11	27774635	27785011	Q7L622	G2E3_HUMAN	G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)	GO:0004842; GO:0005730; GO:0005794; GO:0005829; GO:0006915; GO:0007275; GO:0043231; GO:0046872	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; multicellular organism development [GO:0007275]
PGEN_.00g233850	Scaffold_11	27785283	27787857	NA	NA	NA	NA	NA
PGEN_.00g233860	Scaffold_11	27869617	27870999	NA	NA	NA	NA	NA
PGEN_.00g233870	Scaffold_11	27889395	27895659	NA	NA	NA	NA	NA
PGEN_.00g233880	Scaffold_11	27906227	27918617	NA	NA	NA	NA	NA
PGEN_.00g233890	Scaffold_11	27924750	27949966	NA	NA	NA	NA	NA
PGEN_.00g233900	Scaffold_11	27979270	27993313	Q6PFS7	ATG3_DANRE	Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like)	GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0015031; GO:0019776; GO:0019777; GO:0043653	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; protein transport [GO:0015031]
PGEN_.00g233910	Scaffold_11	27993460	27995801	Q0P5B9	ANR39_BOVIN	Ankyrin repeat domain-containing protein 39		
PGEN_.00g233920	Scaffold_11	28000783	28021170	O73787	GCP3_XENLA	Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p)	GO:0000922; GO:0005737; GO:0005815; GO:0005874; GO:0007020; GO:0043015	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule nucleation [GO:0007020]
PGEN_.00g233930	Scaffold_11	28048929	28049577	NA	NA	NA	NA	NA
PGEN_.00g233940	Scaffold_11	28056610	28058308	NA	NA	NA	NA	NA
PGEN_.00g233950	Scaffold_11	28065680	28077267	NA	NA	NA	NA	NA
PGEN_.00g233960	Scaffold_11	28081981	28085546	NA	NA	NA	NA	NA
PGEN_.00g233970	Scaffold_11	28108871	28135897	Q86UY8	NT5D3_HUMAN	5'-nucleotidase domain-containing protein 3 (EC 3.1.3.-) (GRP94-neighboring nucleotidase)	GO:0008253; GO:0043235; GO:0046872	receptor complex [GO:0043235]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]
PGEN_.00g233980	Scaffold_11	28147622	28166459	B5DF89	CUL3_RAT	Cullin-3	GO:0000122; GO:0000139; GO:0000209; GO:0000278; GO:0000902; GO:0000922; GO:0001701; GO:0001831; GO:0005112; GO:0005623; GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005827; GO:0006357; GO:0006511; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0007369; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0035024; GO:0036126; GO:0040016; GO:0042803; GO:0043149; GO:0043161; GO:0044346; GO:0045842; GO:0046982; GO:0048208; GO:0071630; GO:0072576; GO:0072686; GO:1901992	cell [GO:0005623]; centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cyclin binding [GO:0030332]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; liver morphogenesis [GO:0072576]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g233990	Scaffold_11	28170285	28171247	NA	NA	NA	NA	NA
PGEN_.00g234000	Scaffold_11	28179585	28180366	NA	NA	NA	NA	NA
PGEN_.00g234010	Scaffold_11	28195317	28217934	NA	NA	NA	NA	NA
PGEN_.00g234020	Scaffold_11	28218241	28234853	Q9R0P3	ESTD_MOUSE	S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase 10) (Esterase D) (Sid 478)	GO:0005829; GO:0016788; GO:0018738; GO:0031410; GO:0042802; GO:0046294; GO:0052689	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294]"
PGEN_.00g234030	Scaffold_11	28245993	28250367	Q9I3S3	GBUA_PSEAE	Guanidinobutyrase (EC 3.5.3.7)	GO:0006527; GO:0008783; GO:0033389; GO:0046872; GO:0047971	"agmatinase activity [GO:0008783]; guanidinobutyrase activity [GO:0047971]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]"
PGEN_.00g234040	Scaffold_11	28252807	28270988	A6H694	LRC63_MOUSE	Leucine-rich repeat-containing protein 63		
PGEN_.00g234050	Scaffold_11	28276542	28310230	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g234060	Scaffold_11	28313463	28313816	NA	NA	NA	NA	NA
PGEN_.00g234070	Scaffold_11	28318861	28319271	NA	NA	NA	NA	NA
PGEN_.00g234080	Scaffold_11	28319696	28320121	NA	NA	NA	NA	NA
PGEN_.00g234090	Scaffold_11	28321788	28322510	NA	NA	NA	NA	NA
PGEN_.00g234100	Scaffold_11	28322560	28322904	NA	NA	NA	NA	NA
PGEN_.00g234110	Scaffold_11	28322987	28323947	NA	NA	NA	NA	NA
PGEN_.00g234120	Scaffold_11	28335457	28336632	O14792	HS3S1_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1)	GO:0005796; GO:0006024; GO:0008146; GO:0008467	Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]
PGEN_.00g234130	Scaffold_11	28341571	28341975	NA	NA	NA	NA	NA
PGEN_.00g234140	Scaffold_11	28344507	28366653	NA	NA	NA	NA	NA
PGEN_.00g234150	Scaffold_11	28368307	28368690	NA	NA	NA	NA	NA
PGEN_.00g234160	Scaffold_11	28371374	28378981	Q6WV19	GALT2_DROME	Polypeptide N-acetylgalactosaminyltransferase 2 (pp-GaNTase 2) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2)	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]
PGEN_.00g234170	Scaffold_11	28411023	28427512	P63029	TCTP_RAT	Translationally-controlled tumor protein (TCTP) (Lens epithelial protein)	GO:0000922; GO:0005509; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005881; GO:0007283; GO:0008134; GO:0008283; GO:0009615; GO:0019827; GO:1902230; GO:2000384	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; extracellular space [GO:0005615]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; transcription factor binding [GO:0008134]; cell population proliferation [GO:0008283]; negative regulation of ectoderm development [GO:2000384]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]
PGEN_.00g234180	Scaffold_11	28437264	28459562	O60832	DKC1_HUMAN	H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)	GO:0000455; GO:0000495; GO:0001650; GO:0003720; GO:0003723; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0005737; GO:0006364; GO:0006396; GO:0007004; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:0032212; GO:0034513; GO:0051973; GO:0070034; GO:0072589; GO:0090661; GO:0090666; GO:0090669; GO:1904851; GO:1904871; GO:1904872; GO:1904874; GO:1990481	box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004]
PGEN_.00g234190	Scaffold_11	28478588	28507370	Q6GM59	MOT12_XENLA	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0015293; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]
PGEN_.00g234200	Scaffold_11	28525265	28549488	Q7ZWA3	RBMX_DANRE	"RNA-binding motif protein, X chromosome (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G)"	GO:0000381; GO:0000398; GO:0000978; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005685; GO:0005719; GO:0006366; GO:0006509; GO:0007275; GO:0030619; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071004; GO:0071013; GO:0071347	"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; U1 snRNA binding [GO:0030619]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g234210	Scaffold_11	28556809	28586868	NA	NA	NA	NA	NA
PGEN_.00g234220	Scaffold_11	28589425	28597017	NA	NA	NA	NA	NA
PGEN_.00g234230	Scaffold_11	28604178	28606306	NA	NA	NA	NA	NA
PGEN_.00g234240	Scaffold_11	28664148	28670065	NA	NA	NA	NA	NA
PGEN_.00g234250	Scaffold_11	28672475	28685998	NA	NA	NA	NA	NA
PGEN_.00g234260	Scaffold_11	28713243	28717905	NA	NA	NA	NA	NA
PGEN_.00g234270	Scaffold_11	28806913	28808559	Q8IN35	SIFAR_DROME	Neuropeptide SIFamide receptor	GO:0004930; GO:0004983; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016021; GO:0032870; GO:0048047	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g234280	Scaffold_11	28813941	28840543	P11884	ALDH2_RAT	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1)"	GO:0001889; GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0032355; GO:0032496; GO:0032570; GO:0032870; GO:0033574; GO:0035094; GO:0042802; GO:0043066; GO:0043878; GO:0055093; GO:0070404; GO:0071398	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; ethanol catabolic process [GO:0006068]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; response to estradiol [GO:0032355]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]
PGEN_.00g234290	Scaffold_11	28843192	28869214	O08688	CAN5_MOUSE	Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3)	GO:0004198; GO:0005737; GO:0006508; GO:0009986; GO:0045202	cell surface [GO:0009986]; cytoplasm [GO:0005737]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]
PGEN_.00g234300	Scaffold_11	28882294	28903468	NA	NA	NA	NA	NA
PGEN_.00g234310	Scaffold_11	28903536	28913137	NA	NA	NA	NA	NA
PGEN_.00g234320	Scaffold_11	28934706	28946207	NA	NA	NA	NA	NA
PGEN_.00g234330	Scaffold_11	28965331	28992833	Q80U62	RUBIC_MOUSE	Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon)	GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006914; GO:0010507; GO:0043231; GO:0043553; GO:0045806; GO:1901097	cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]
PGEN_.00g234340	Scaffold_11	29004912	29009783	NA	NA	NA	NA	NA
PGEN_.00g234350	Scaffold_11	29009879	29026147	Q7QB13	CCNC_ANOGA	Cyclin-C	GO:0005634; GO:0006357; GO:0016538; GO:0016592; GO:0045944	mediator complex [GO:0016592]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g234360	Scaffold_11	29026601	29033983	NA	NA	NA	NA	NA
PGEN_.00g234370	Scaffold_11	29079036	29082527	NA	NA	NA	NA	NA
PGEN_.00g234380	Scaffold_11	29111157	29112002	NA	NA	NA	NA	NA
PGEN_.00g234390	Scaffold_11	29119139	29119396	NA	NA	NA	NA	NA
PGEN_.00g234400	Scaffold_11	29120887	29121165	NA	NA	NA	NA	NA
PGEN_.00g234410	Scaffold_11	29121384	29122403	NA	NA	NA	NA	NA
PGEN_.00g234420	Scaffold_11	29142548	29164673	NA	NA	NA	NA	NA
PGEN_.00g234430	Scaffold_11	29221089	29221723	NA	NA	NA	NA	NA
PGEN_.00g234440	Scaffold_11	29222271	29222615	NA	NA	NA	NA	NA
PGEN_.00g234450	Scaffold_11	29237746	29242988	NA	NA	NA	NA	NA
PGEN_.00g234460	Scaffold_11	29247242	29248336	C9JTQ0	ANR63_HUMAN	Ankyrin repeat domain-containing protein 63		
PGEN_.00g234470	Scaffold_11	29276639	29277283	NA	NA	NA	NA	NA
PGEN_.00g234480	Scaffold_11	29293920	29361948	Q3TXS7	PSMD1_MOUSE	26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1)	GO:0000502; GO:0005634; GO:0008540; GO:0022624; GO:0030234; GO:0031625; GO:0034515; GO:0042176; GO:0043161	"nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"
PGEN_.00g234490	Scaffold_11	29379709	29381754	Q8UUG8	5HT2B_TETFL	5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B)	GO:0001587; GO:0005887; GO:0006939; GO:0007507; GO:0007610; GO:0030054; GO:0030594; GO:0042310; GO:0043005; GO:0045202; GO:0048598; GO:0050795	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; Gq/11-coupled serotonin receptor activity [GO:0001587]; neurotransmitter receptor activity [GO:0030594]; behavior [GO:0007610]; embryonic morphogenesis [GO:0048598]; heart development [GO:0007507]; regulation of behavior [GO:0050795]; smooth muscle contraction [GO:0006939]; vasoconstriction [GO:0042310]
PGEN_.00g234500	Scaffold_11	29459649	29460296	NA	NA	NA	NA	NA
PGEN_.00g234510	Scaffold_11	29471115	29472290	P18599	5HT2A_CRIGR	5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A)	GO:0004993; GO:0005623; GO:0005887; GO:0005901; GO:0007202; GO:0007610; GO:0010513; GO:0014065; GO:0030054; GO:0030424; GO:0030425; GO:0031410; GO:0033674; GO:0044380; GO:0045600; GO:0045821; GO:0050731; GO:0051209; GO:0051378; GO:0070374; GO:0071886; GO:0098793	"axon [GO:0030424]; caveola [GO:0005901]; cell [GO:0005623]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; G protein-coupled serotonin receptor activity [GO:0004993]; serotonin binding [GO:0051378]; activation of phospholipase C activity [GO:0007202]; behavior [GO:0007610]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glycolytic process [GO:0045821]; positive regulation of kinase activity [GO:0033674]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein localization to cytoskeleton [GO:0044380]; release of sequestered calcium ion into cytosol [GO:0051209]"
PGEN_.00g234520	Scaffold_11	29514193	29541037	NA	NA	NA	NA	NA
PGEN_.00g234530	Scaffold_11	29561726	29581584	P49109	FMO5_CAVPO	Dimethylaniline monooxygenase [N-oxide-forming] 5 (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (FMO 5)	GO:0004499; GO:0005789; GO:0005829; GO:0016021; GO:0050660; GO:0050661	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
PGEN_.00g234540	Scaffold_11	29574705	29575145	NA	NA	NA	NA	NA
PGEN_.00g234550	Scaffold_11	29587362	29587601	NA	NA	NA	NA	NA
PGEN_.00g234560	Scaffold_11	29592314	29612579	O18334	RAB6_DROME	Ras-related protein Rab6 (Protein warthog)	GO:0000139; GO:0001745; GO:0003779; GO:0003924; GO:0005525; GO:0005794; GO:0005829; GO:0006886; GO:0006887; GO:0006890; GO:0006891; GO:0007293; GO:0007411; GO:0007602; GO:0008103; GO:0016192; GO:0030054; GO:0031410; GO:0031982; GO:0032482; GO:0042147; GO:0043025; GO:0043204; GO:0045202; GO:0045451; GO:0045467; GO:0050832; GO:0060078	"cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; vesicle [GO:0031982]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g234570	Scaffold_11	29633879	29643946	NA	NA	NA	NA	NA
PGEN_.00g234580	Scaffold_11	29668667	29669980	NA	NA	NA	NA	NA
PGEN_.00g234590	Scaffold_11	29672078	29689104	Q7T308	RN168_DANRE	E3 ubiquitin-protein ligase rnf168 (EC 2.3.2.27) (RING finger protein 168) (RING-type E3 ubiquitin transferase rnf168)	GO:0000151; GO:0003682; GO:0004842; GO:0005634; GO:0006302; GO:0006511; GO:0006974; GO:0010212; GO:0016567; GO:0034244; GO:0035518; GO:0035861; GO:0036351; GO:0036352; GO:0042393; GO:0043130; GO:0045190; GO:0045739; GO:0046872; GO:0070530; GO:0070534; GO:0070535	nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g234600	Scaffold_11	29706979	29708419	NA	NA	NA	NA	NA
PGEN_.00g234610	Scaffold_11	29716337	29717347	NA	NA	NA	NA	NA
PGEN_.00g234620	Scaffold_11	29727571	29727828	NA	NA	NA	NA	NA
PGEN_.00g234630	Scaffold_11	29732741	29772906	P23352	KALM_HUMAN	Anosmin-1 (Adhesion molecule-like X-linked) (Kallmann syndrome protein)	GO:0004867; GO:0005201; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0007155; GO:0007411; GO:0008201; GO:0008543; GO:0031012	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; fibroblast growth factor receptor signaling pathway [GO:0008543]
PGEN_.00g234640	Scaffold_11	29817110	29817481	NA	NA	NA	NA	NA
PGEN_.00g234650	Scaffold_11	29823780	29826965	NA	NA	NA	NA	NA
PGEN_.00g234660	Scaffold_11	29827062	29855787	Q9QUJ7	ACSL4_MOUSE	Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4) (mACS4)	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0007584; GO:0008610; GO:0015908; GO:0016021; GO:0019217; GO:0019432; GO:0030182; GO:0030307; GO:0031957; GO:0031966; GO:0032024; GO:0032307; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0102391	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]
PGEN_.00g234670	Scaffold_11	29864412	29868401	NA	NA	NA	NA	NA
PGEN_.00g234680	Scaffold_11	29888119	29888388	NA	NA	NA	NA	NA
PGEN_.00g234690	Scaffold_11	29892422	29892841	NA	NA	NA	NA	NA
PGEN_.00g234700	Scaffold_11	29901008	29943477	Q6DDL7	UN93A_XENLA	Protein unc-93 homolog A (Unc-93A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g234710	Scaffold_11	29955972	29967639	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g234720	Scaffold_11	29974375	29986682	Q6DBY9	CHST1_DANRE	Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0016021; GO:0042339; GO:0045130	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g234730	Scaffold_11	29999788	30004296	Q64374	RGN_MOUSE	Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30)	GO:0001822; GO:0001933; GO:0004341; GO:0005509; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0006469; GO:0006874; GO:0007283; GO:0007568; GO:0008270; GO:0010867; GO:0010907; GO:0010922; GO:0019853; GO:0030234; GO:0032515; GO:0032781; GO:0034260; GO:0043066; GO:0043547; GO:0045019; GO:0045723; GO:0050680; GO:0050848; GO:0051344; GO:0097421; GO:1901318; GO:1901671; GO:1901896; GO:1902679; GO:1903011; GO:1903052; GO:1903611; GO:1903625; GO:1903629; GO:1903634; GO:2000279	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of calcium-dependent ATPase activity [GO:1903611]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of GTPase activity [GO:0034260]; negative regulation of leucine-tRNA ligase activity [GO:1903634]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATPase activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of dUTP diphosphatase activity [GO:1903629]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283]
PGEN_.00g234740	Scaffold_11	30019766	30020122	NA	NA	NA	NA	NA
PGEN_.00g234750	Scaffold_11	30020279	30020749	NA	NA	NA	NA	NA
PGEN_.00g234760	Scaffold_11	30020842	30021150	NA	NA	NA	NA	NA
PGEN_.00g234770	Scaffold_11	30021241	30021633	NA	NA	NA	NA	NA
PGEN_.00g234780	Scaffold_11	30021748	30030199	NA	NA	NA	NA	NA
PGEN_.00g234790	Scaffold_11	30055692	30056840	NA	NA	NA	NA	NA
PGEN_.00g234800	Scaffold_11	30059584	30060135	NA	NA	NA	NA	NA
PGEN_.00g234810	Scaffold_11	30060486	30076339	Q32TF8	EFHC2_DANRE	EF-hand domain-containing family member C2	GO:0010975; GO:0039010; GO:1903251	multi-ciliated epithelial cell differentiation [GO:1903251]; regulation of neuron projection development [GO:0010975]; specification of pronephric distal tubule identity [GO:0039010]
PGEN_.00g234820	Scaffold_11	30080183	30096763	NA	NA	NA	NA	NA
PGEN_.00g234830	Scaffold_11	30105076	30105300	NA	NA	NA	NA	NA
PGEN_.00g234840	Scaffold_11	30111476	30115339	NA	NA	NA	NA	NA
PGEN_.00g234850	Scaffold_11	30123123	30161807	NA	NA	NA	NA	NA
PGEN_.00g234860	Scaffold_11	30206233	30206604	NA	NA	NA	NA	NA
PGEN_.00g234870	Scaffold_11	30304671	30307768	NA	NA	NA	NA	NA
PGEN_.00g234880	Scaffold_11	30321901	30373669	NA	NA	NA	NA	NA
PGEN_.00g234890	Scaffold_11	30402931	30404466	P82251	BAT1_HUMAN	"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)"	GO:0005886; GO:0005887; GO:0006865; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0050900; GO:0065003	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]
PGEN_.00g234900	Scaffold_11	30419627	30422435	NA	NA	NA	NA	NA
PGEN_.00g234910	Scaffold_11	30428926	30429261	NA	NA	NA	NA	NA
PGEN_.00g234920	Scaffold_11	30429298	30430197	NA	NA	NA	NA	NA
PGEN_.00g234930	Scaffold_11	30435093	30445965	NA	NA	NA	NA	NA
PGEN_.00g234940	Scaffold_11	30475721	30486741	NA	NA	NA	NA	NA
PGEN_.00g234950	Scaffold_11	30519033	30522969	NA	NA	NA	NA	NA
PGEN_.00g234960	Scaffold_11	30523886	30525005	NA	NA	NA	NA	NA
PGEN_.00g234970	Scaffold_11	30529611	30533169	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g234980	Scaffold_11	30547980	30566299	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g234990	Scaffold_11	30669952	30693688	NA	NA	NA	NA	NA
PGEN_.00g235000	Scaffold_11	30698432	30698989	NA	NA	NA	NA	NA
PGEN_.00g235010	Scaffold_11	30705610	30725530	NA	NA	NA	NA	NA
PGEN_.00g235020	Scaffold_11	30763922	30788118	Q9VFK6	KMT5A_DROME	Histone-lysine N-methyltransferase PR-Set7 (EC 2.1.1.-) (Lysine N-methyltransferase 5A) (PR/SET domain-containing protein 07) (dSET8)	GO:0000077; GO:0005634; GO:0005700; GO:0007049; GO:0016571; GO:0030261; GO:0034771; GO:0035067; GO:0042799; GO:0051301	nucleus [GO:0005634]; polytene chromosome [GO:0005700]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]; DNA damage checkpoint [GO:0000077]; histone H4-K20 monomethylation [GO:0034771]; histone methylation [GO:0016571]; negative regulation of histone acetylation [GO:0035067]
PGEN_.00g235030	Scaffold_11	30788662	30795275	NA	NA	NA	NA	NA
PGEN_.00g235040	Scaffold_11	30826223	30827449	NA	NA	NA	NA	NA
PGEN_.00g235050	Scaffold_11	30855328	30861438	Q5ZJQ8	UBAC2_CHICK	Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1)	GO:0005789; GO:0016021; GO:0016055; GO:0070972; GO:0090090; GO:1904153	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g235060	Scaffold_11	30872783	30909212	Q13619	CUL4A_HUMAN	Cullin-4A (CUL-4A)	GO:0000082; GO:0000715; GO:0000717; GO:0001701; GO:0005654; GO:0006283; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006511; GO:0008284; GO:0016032; GO:0016567; GO:0019005; GO:0030097; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0033683; GO:0035019; GO:0042254; GO:0042769; GO:0043161; GO:0043687; GO:0048511; GO:0051246; GO:0070911; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; DNA damage response, detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"
PGEN_.00g235070	Scaffold_11	30921160	30924775	Q96KE9	BTBD6_HUMAN	BTB/POZ domain-containing protein 6 (Lens BTB domain protein)	GO:0005829; GO:0022008; GO:0043687	cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]
PGEN_.00g235080	Scaffold_11	30932726	30945953	Q66HE2	MOT13_RAT	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	GO:0000139; GO:0005794; GO:0005829; GO:0005886; GO:0008028; GO:0015293; GO:0016021	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g235090	Scaffold_11	30952769	30953110	NA	NA	NA	NA	NA
PGEN_.00g235100	Scaffold_11	30961314	30996909	Q687X5	STEA4_HUMAN	"Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9)"	GO:0000139; GO:0005654; GO:0005768; GO:0005886; GO:0008823; GO:0009055; GO:0015677; GO:0016021; GO:0020037; GO:0031901; GO:0045444; GO:0046872; GO:0052851; GO:0055072; GO:0055114; GO:0070062; GO:0070207; GO:0071949; GO:0098706	early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron ion homeostasis [GO:0055072]; iron ion import across cell outer membrane [GO:0098706]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]
PGEN_.00g235110	Scaffold_11	31010166	31086558	P21783	NOTC1_XENLA	Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]
PGEN_.00g235120	Scaffold_11	31117167	31147515	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g235130	Scaffold_11	31165882	31186919	NA	NA	NA	NA	NA
PGEN_.00g235140	Scaffold_11	31188970	31190583	NA	NA	NA	NA	NA
PGEN_.00g235150	Scaffold_11	31191070	31191510	NA	NA	NA	NA	NA
PGEN_.00g235160	Scaffold_11	31192708	31194293	NA	NA	NA	NA	NA
PGEN_.00g235170	Scaffold_11	31194847	31198578	NA	NA	NA	NA	NA
PGEN_.00g235180	Scaffold_11	31198949	31206446	NA	NA	NA	NA	NA
PGEN_.00g235190	Scaffold_11	31280035	31326586	Q61555	FBN2_MOUSE	Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide]	GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]
PGEN_.00g235200	Scaffold_11	31434951	31435292	NA	NA	NA	NA	NA
PGEN_.00g235210	Scaffold_11	31456812	31457528	NA	NA	NA	NA	NA
PGEN_.00g235220	Scaffold_11	31493963	31569885	Q9Y2L9	LRCH1_HUMAN	Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81) (NP81)	GO:0005737; GO:0034260; GO:1990869; GO:2000405	cytoplasm [GO:0005737]; cellular response to chemokine [GO:1990869]; negative regulation of GTPase activity [GO:0034260]; negative regulation of T cell migration [GO:2000405]
PGEN_.00g235230	Scaffold_11	31558839	31559207	NA	NA	NA	NA	NA
PGEN_.00g235240	Scaffold_11	31588402	31619378	Q6P2Y2	DAW1_XENTR	Dynein assembly factor with WDR repeat domains 1 (Outer row dynein assembly protein 16 homolog) (WD repeat-containing protein 69)	GO:0005929	cilium [GO:0005929]
PGEN_.00g235250	Scaffold_11	31632684	31633160	NA	NA	NA	NA	NA
PGEN_.00g235260	Scaffold_11	31637551	31638054	G5EFC3	KCNAG_CAEEL	Potassium voltage-gated channel protein egl-36 (Egg-laying defective protein 36)	GO:0005244; GO:0005249; GO:0005251; GO:0008076; GO:0016021; GO:0030424; GO:0032590; GO:0032809; GO:0034220; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g235270	Scaffold_11	31656674	31666510	Q9HBU6	EKI1_HUMAN	Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82)	GO:0004305; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006646; GO:0016020	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]
PGEN_.00g235280	Scaffold_11	31673730	31683409	Q9D4V0	EKI1_MOUSE	Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82)	GO:0004305; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006646	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]
PGEN_.00g235290	Scaffold_11	31698850	31718776	Q9H6U8	ALG9_HUMAN	"Alpha-1,2-mannosyltransferase ALG9 (EC 2.4.1.259) (EC 2.4.1.261) (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase)"	GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006488; GO:0016020; GO:0016021; GO:0052918; GO:0052926	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,2-mannosyltransferase activity [GO:0000026]; dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052926]; dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052918]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]"
PGEN_.00g235300	Scaffold_11	31718963	31725728	Q99MN9	PCCB_MOUSE	"Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit beta) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit beta)"	GO:0004658; GO:0005524; GO:0005739; GO:0005759	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]
PGEN_.00g235310	Scaffold_11	31730306	31732105	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g235320	Scaffold_11	31732493	31751960	NA	NA	NA	NA	NA
PGEN_.00g235330	Scaffold_11	31758584	31769856	P79384	PCCB_PIG	"Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit beta) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit beta)"	GO:0004658; GO:0005524; GO:0005759; GO:0019626	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; short-chain fatty acid catabolic process [GO:0019626]
PGEN_.00g235340	Scaffold_11	31775262	31776939	NA	NA	NA	NA	NA
PGEN_.00g235350	Scaffold_11	31779627	31796919	NA	NA	NA	NA	NA
PGEN_.00g235360	Scaffold_11	31830448	31844266	NA	NA	NA	NA	NA
PGEN_.00g235370	Scaffold_11	31851125	31860336	NA	NA	NA	NA	NA
PGEN_.00g235380	Scaffold_11	31864674	31924334	P09884	DPOLA_HUMAN	DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180)	GO:0000082; GO:0000083; GO:0000166; GO:0000731; GO:0001882; GO:0003677; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006281; GO:0006303; GO:0016032; GO:0016363; GO:0017076; GO:0019103; GO:0019901; GO:0032201; GO:0046872; GO:0051539; GO:1902975	"alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleoside binding [GO:0001882]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; G1/S transition of mitotic cell cycle [GO:0000082]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]"
PGEN_.00g235390	Scaffold_11	31925061	31950946	Q16S14	EFGM_AEDAE	"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)"	GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]
PGEN_.00g235400	Scaffold_11	31956361	31957656	G5E8K5	ANK3_MOUSE	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g235410	Scaffold_11	31963380	31964675	P53355	DAPK1_HUMAN	Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)	GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:2000310	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]
PGEN_.00g235420	Scaffold_11	31969579	31998188	Q16S14	EFGM_AEDAE	"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)"	GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]
PGEN_.00g235430	Scaffold_11	31998477	32058151	Q9DE46	DPOLA_XENLA	DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180)	GO:0000166; GO:0001882; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006303; GO:0016363; GO:0046872; GO:0051539	"alpha DNA polymerase:primase complex [GO:0005658]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleoside binding [GO:0001882]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]"
PGEN_.00g235440	Scaffold_11	32056997	32057242	NA	NA	NA	NA	NA
PGEN_.00g235450	Scaffold_11	32062496	32073826	NA	NA	NA	NA	NA
PGEN_.00g235460	Scaffold_11	32078785	32079120	Q9UPY5	XCT_HUMAN	Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT)	GO:0005791; GO:0005856; GO:0005886; GO:0006749; GO:0006865; GO:0008542; GO:0009636; GO:0009986; GO:0014070; GO:0015179; GO:0015327; GO:0016021; GO:0021591; GO:0021756; GO:0030534; GO:0031526; GO:0033029; GO:0034599; GO:0034775; GO:0035094; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050900; GO:0051223; GO:0051775; GO:0060173; GO:0070306; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0140206; GO:1901494; GO:1903204; GO:1903786; GO:1904717; GO:2000211	apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; adult behavior [GO:0030534]; amino acid transport [GO:0006865]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; leukocyte migration [GO:0050900]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542]
PGEN_.00g235470	Scaffold_11	32082048	32093345	NA	NA	NA	NA	NA
PGEN_.00g235480	Scaffold_11	32169012	32169254	NA	NA	NA	NA	NA
PGEN_.00g235490	Scaffold_11	32169682	32170179	NA	NA	NA	NA	NA
PGEN_.00g235500	Scaffold_11	32184984	32308588	Q16281	CNGA3_HUMAN	Cyclic nucleotide-gated cation channel alpha-3 (Cone photoreceptor cGMP-gated channel subunit alpha) (Cyclic nucleotide-gated channel alpha-3) (CNG channel alpha-3) (CNG-3) (CNG3)	GO:0005222; GO:0005223; GO:0005737; GO:0005886; GO:0006812; GO:0007165; GO:0007601; GO:0008022; GO:0015276; GO:0030425; GO:0030553; GO:0031960; GO:0032026; GO:0043194; GO:0043204; GO:0051591; GO:0097386; GO:0098659; GO:1902495	axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; protein C-terminus binding [GO:0008022]; cation transport [GO:0006812]; inorganic cation import across plasma membrane [GO:0098659]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601]
PGEN_.00g235510	Scaffold_11	32327958	32330772	NA	NA	NA	NA	NA
PGEN_.00g235520	Scaffold_11	32331493	32335735	Q17QR8	HARB1_BOVIN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g235530	Scaffold_11	32497740	32498297	NA	NA	NA	NA	NA
PGEN_.00g235540	Scaffold_11	32502179	32514334	O15974	OPSD2_MIZYE	"Rhodopsin, G0-coupled (G0-rhodopsin)"	GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g235550	Scaffold_11	32569962	32571931	NA	NA	NA	NA	NA
PGEN_.00g235560	Scaffold_11	32627462	32629977	NA	NA	NA	NA	NA
PGEN_.00g235570	Scaffold_11	32630065	32630990	NA	NA	NA	NA	NA
PGEN_.00g235580	Scaffold_11	32632131	32633981	NA	NA	NA	NA	NA
PGEN_.00g235590	Scaffold_11	32640423	32642266	NA	NA	NA	NA	NA
PGEN_.00g235600	Scaffold_11	32658158	32659174	A0A0P0XM10	PAO6_ORYSJ	Polyamine oxidase 6 (OsPAO6) (EC 1.5.3.-) (Polyamine oxidase B)	GO:0016491; GO:0046208; GO:0048046	apoplast [GO:0048046]; oxidoreductase activity [GO:0016491]; spermine catabolic process [GO:0046208]
PGEN_.00g235610	Scaffold_11	32659309	32659656	NA	NA	NA	NA	NA
PGEN_.00g235620	Scaffold_11	32663178	32663567	NA	NA	NA	NA	NA
PGEN_.00g235630	Scaffold_11	32682016	32692858	NA	NA	NA	NA	NA
PGEN_.00g235640	Scaffold_11	32728840	32736025	P10586	PTPRF_HUMAN	Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:0099560; GO:1900121	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]
PGEN_.00g235650	Scaffold_11	32753987	32768544	NA	NA	NA	NA	NA
PGEN_.00g235660	Scaffold_11	32769834	32774242	NA	NA	NA	NA	NA
PGEN_.00g235670	Scaffold_11	32775372	32782243	NA	NA	NA	NA	NA
PGEN_.00g235680	Scaffold_11	32790259	32790978	NA	NA	NA	NA	NA
PGEN_.00g235690	Scaffold_11	32801118	32812095	NA	NA	NA	NA	NA
PGEN_.00g235700	Scaffold_11	32847373	32848989	NA	NA	NA	NA	NA
PGEN_.00g235710	Scaffold_11	32862716	32877476	NA	NA	NA	NA	NA
PGEN_.00g235720	Scaffold_11	32935708	32954656	Q0EEE2	PTHD3_MOUSE	Patched domain-containing protein 3 (RND-type protein RNDEu-3)	GO:0016021; GO:0097225	integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]
PGEN_.00g235730	Scaffold_11	32969011	33000001	A8MT70	ZBBX_HUMAN	Zinc finger B-box domain-containing protein 1	GO:0003341; GO:0008270; GO:0031514	motile cilium [GO:0031514]; zinc ion binding [GO:0008270]; cilium movement [GO:0003341]
PGEN_.00g235740	Scaffold_11	33000035	33002721	NA	NA	NA	NA	NA
PGEN_.00g235750	Scaffold_11	33058899	33059486	NA	NA	NA	NA	NA
PGEN_.00g235760	Scaffold_11	33061802	33087064	NA	NA	NA	NA	NA
PGEN_.00g235770	Scaffold_11	33127395	33159449	Q9ERA5	SMC4_MICAR	Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (XCAP-C homolog) (Fragment)	GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0007076; GO:0046982; GO:0051301	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]
PGEN_.00g235780	Scaffold_11	33217558	33231714	Q9C0D2	CE295_HUMAN	Centrosomal protein of 295 kDa	GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005856; GO:0005886; GO:0008017; GO:0010825; GO:0046599; GO:1901985; GO:1903724; GO:1904951; GO:1990498	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599]
PGEN_.00g235790	Scaffold_11	33232319	33262069	NA	NA	NA	NA	NA
PGEN_.00g235800	Scaffold_11	33274831	33297324	Q63503	NR1D1_RAT	Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) (EAR-1)	GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0003677; GO:0003700; GO:0003707; GO:0005634; GO:0005737; GO:0005978; GO:0006355; GO:0007275; GO:0007623; GO:0008134; GO:0008270; GO:0009648; GO:0009755; GO:0010498; GO:0010871; GO:0019216; GO:0020037; GO:0030054; GO:0030154; GO:0030374; GO:0030425; GO:0031648; GO:0032922; GO:0033993; GO:0034144; GO:0035947; GO:0038023; GO:0042632; GO:0042749; GO:0042752; GO:0042753; GO:0043025; GO:0043124; GO:0043197; GO:0044212; GO:0044321; GO:0045598; GO:0045892; GO:0045893; GO:0045944; GO:0050728; GO:0060086; GO:0061178; GO:0061469; GO:0061889; GO:0070859; GO:0070888; GO:0071222; GO:0071347; GO:0071356; GO:0090575; GO:0120163; GO:0150079; GO:1903979; GO:1990837; GO:2000489	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; heme binding [GO:0020037]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription corepressor binding [GO:0001222]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; circadian temperature homeostasis [GO:0060086]; glycogen biosynthetic process [GO:0005978]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism development [GO:0007275]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of receptor biosynthetic process [GO:0010871]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; photoperiodism [GO:0009648]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasomal protein catabolic process [GO:0010498]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of fat cell differentiation [GO:0045598]; regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter [GO:0035947]; regulation of hepatic stellate cell activation [GO:2000489]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to leptin [GO:0044321]; response to lipid [GO:0033993]"
PGEN_.00g235810	Scaffold_11	33310927	33323612	NA	NA	NA	NA	NA
PGEN_.00g235820	Scaffold_11	33336742	33346732	Q8R0M8	MOT5_MOUSE	Monocarboxylate transporter 5 (MCT 5)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g235830	Scaffold_11	33387273	33401697	Q5PRC1	LHPL6_DANRE	LHFPL tetraspan subfamily member 6 protein	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g235840	Scaffold_11	33477640	33495396	NA	NA	NA	NA	NA
PGEN_.00g235850	Scaffold_11	33497142	33498123	NA	NA	NA	NA	NA
PGEN_.00g235860	Scaffold_11	33501472	33502856	Q9DAK4	FBP12_MOUSE	Fatty acid-binding protein 12	GO:0008289	lipid binding [GO:0008289]
PGEN_.00g235870	Scaffold_11	33559755	33561338	NA	NA	NA	NA	NA
PGEN_.00g235880	Scaffold_11	33562537	33574307	NA	NA	NA	NA	NA
PGEN_.00g235890	Scaffold_11	33586812	33587478	NA	NA	NA	NA	NA
PGEN_.00g235900	Scaffold_11	33587676	33587909	NA	NA	NA	NA	NA
PGEN_.00g235910	Scaffold_11	33662271	33662615	NA	NA	NA	NA	NA
PGEN_.00g235920	Scaffold_11	33663009	33663581	NA	NA	NA	NA	NA
PGEN_.00g235930	Scaffold_11	33663993	33664394	NA	NA	NA	NA	NA
PGEN_.00g235940	Scaffold_11	33688830	33694844	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g235950	Scaffold_11	33741321	33742124	NA	NA	NA	NA	NA
PGEN_.00g235960	Scaffold_11	33748789	33750973	NA	NA	NA	NA	NA
PGEN_.00g235970	Scaffold_11	33753759	33771147	NA	NA	NA	NA	NA
PGEN_.00g235980	Scaffold_11	33759393	33761426	NA	NA	NA	NA	NA
PGEN_.00g235990	Scaffold_11	33772041	33774123	NA	NA	NA	NA	NA
PGEN_.00g236000	Scaffold_11	33774181	33775275	NA	NA	NA	NA	NA
PGEN_.00g236010	Scaffold_11	33776998	33802957	NA	NA	NA	NA	NA
PGEN_.00g236020	Scaffold_11	33816919	33839900	Q9C6W5	AB14G_ARATH	ABC transporter G family member 14 (ABC transporter ABCG.14) (AtABCG14) (White-brown complex homolog protein 14) (AtWBC14)	GO:0005524; GO:0005886; GO:0010222; GO:0010588; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cotyledon vascular tissue pattern formation [GO:0010588]; stem vascular tissue pattern formation [GO:0010222]; transmembrane transport [GO:0055085]
PGEN_.00g236030	Scaffold_11	33850651	33864966	Q7XA72	AB21G_ARATH	ABC transporter G family member 21 (ABC transporter ABCG.21) (AtABCG21) (White-brown complex homolog protein 21) (AtWBC21)	GO:0005524; GO:0005886; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g236040	Scaffold_11	33922231	33934488	Q498J9	MBLC1_XENLA	Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-)	GO:0016787; GO:0046872	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]
PGEN_.00g236050	Scaffold_11	33965245	33973322	Q9TU25	RAC2_BOVIN	Ras-related C3 botulinum toxin substrate 2 (p21-Rac2)	GO:0003924; GO:0005525; GO:0005635; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007186; GO:0007266; GO:0008045; GO:0008284; GO:0008360; GO:0010592; GO:0010810; GO:0016601; GO:0019887; GO:0019901; GO:0030027; GO:0030031; GO:0030036; GO:0032956; GO:0042129; GO:0042995; GO:0043304; GO:0043652; GO:0060263; GO:0060753; GO:0071593; GO:0090023; GO:1902622	actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of cell-substrate adhesion [GO:0010810]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of T cell proliferation [GO:0042129]; Rho protein signal transduction [GO:0007266]
PGEN_.00g236060	Scaffold_11	33990030	34003309	Q9P2E3	ZNFX1_HUMAN	NFX1-type zinc finger-containing protein 1	GO:0000775; GO:0000790; GO:0000981; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380	"chromosome, centromeric region [GO:0000775]; nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]"
PGEN_.00g236070	Scaffold_11	34033480	34064551	Q8BGQ7	SYAC_MOUSE	"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Protein sticky) (Sti)"	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0021680; GO:0043524; GO:0045182; GO:0050885; GO:0050905; GO:0070143; GO:0140018	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400]
PGEN_.00g236080	Scaffold_11	34078111	34083398	O55033	NCK2_MOUSE	Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta)	GO:0001771; GO:0001784; GO:0005070; GO:0005737; GO:0005783; GO:0005829; GO:0007015; GO:0012506; GO:0014069; GO:0016477; GO:0030032; GO:0030838; GO:0033137; GO:0036493; GO:0042102; GO:0044877; GO:0045202; GO:0045944; GO:0048013; GO:0060996; GO:0097110; GO:1902237; GO:1903898; GO:1903912; GO:1990441	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3/SH2 adaptor activity [GO:0005070]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]
PGEN_.00g236090	Scaffold_11	34117461	34122107	NA	NA	NA	NA	NA
PGEN_.00g236100	Scaffold_11	34122741	34125303	Q8CE94	MOT13_MOUSE	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	GO:0000139; GO:0005794; GO:0005829; GO:0005886; GO:0008028; GO:0015293; GO:0016021	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g236110	Scaffold_11	34159579	34189288	Q8IYY4	DZI1L_HUMAN	Zinc finger protein DZIP1L (DAZ-interacting protein 1-like protein)	GO:0003676; GO:0005814; GO:0005930; GO:0007224; GO:0021532; GO:0032880; GO:0033504; GO:0036064; GO:0046872; GO:0060271; GO:0061512; GO:1905349	axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; floor plate development [GO:0033504]; neural tube patterning [GO:0021532]; protein localization to cilium [GO:0061512]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]
PGEN_.00g236120	Scaffold_11	34190037	34202863	Q27968	DNJC3_BOVIN	"DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)"	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0034975; GO:0036494; GO:0051087; GO:0051787; GO:0070417; GO:1903912	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; response to unfolded protein [GO:0006986]
PGEN_.00g236130	Scaffold_11	34219849	34315207	P78333	GPC5_HUMAN	Glypican-5 [Cleaved into: Secreted glypican-5]	GO:0001523; GO:0005576; GO:0005615; GO:0005796; GO:0005886; GO:0006024; GO:0006027; GO:0009986; GO:0016021; GO:0016477; GO:0043202; GO:0046658; GO:0062023; GO:0090263; GO:1905475	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; cell migration [GO:0016477]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475]; retinoid metabolic process [GO:0001523]
PGEN_.00g236140	Scaffold_11	34321723	34329807	B7K079	MSRA_RIPO1	Peptide methionine sulfoxide reductase MsrA (Protein-methionine-S-oxide reductase) (EC 1.8.4.11) (Peptide-methionine (S)-S-oxide reductase) (Peptide Met(O) reductase)	GO:0006464; GO:0008113	peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular protein modification process [GO:0006464]
PGEN_.00g236150	Scaffold_11	34339932	34352339	Q8C8H8	KY_MOUSE	Kyphoscoliosis peptidase (EC 3.4.-.-)	GO:0005856; GO:0007517; GO:0007528; GO:0008233; GO:0030018	cytoskeleton [GO:0005856]; Z disc [GO:0030018]; peptidase activity [GO:0008233]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]
PGEN_.00g236160	Scaffold_11	34365239	34403118	Q9UKP5	ATS6_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)	GO:0003279; GO:0004222; GO:0005576; GO:0008237; GO:0035904; GO:0046872; GO:0060976	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]
PGEN_.00g236170	Scaffold_11	34409540	34410664	NA	NA	NA	NA	NA
PGEN_.00g236180	Scaffold_11	34416268	34416804	O43422	P52K_HUMAN	52 kDa repressor of the inhibitor of the protein kinase (p52rIPK) (58 kDa interferon-induced protein kinase-interacting protein) (p58IPK-interacting protein) (Death-associated protein 4) (THAP domain-containing protein 0) (THAP domain-containing protein 12)	GO:0000790; GO:0000981; GO:0003677; GO:0007165; GO:0008285; GO:0046872; GO:0046983	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; negative regulation of cell population proliferation [GO:0008285]; signal transduction [GO:0007165]"
PGEN_.00g236190	Scaffold_11	34418323	34419525	NA	NA	NA	NA	NA
PGEN_.00g236200	Scaffold_11	34426819	34455162	Q96T23	RSF1_HUMAN	Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex)	GO:0000123; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0016584; GO:0031213; GO:0034080; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434	"histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]"
PGEN_.00g236210	Scaffold_11	34570523	34574393	NA	NA	NA	NA	NA
PGEN_.00g236220	Scaffold_11	34576388	34583364	NA	NA	NA	NA	NA
PGEN_.00g236230	Scaffold_11	34593161	34594102	Q6ZQM8	UD17C_MOUSE	UDP-glucuronosyltransferase 1-7C (UDPGT 1-7C) (UGT1*7C) (UGT1-07C) (UGT1.7C) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1A7C) (UGT1A10)	GO:0005789; GO:0006711; GO:0015020; GO:0016020; GO:0016021; GO:0019439; GO:0046226; GO:0052696; GO:0052697	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; aromatic compound catabolic process [GO:0019439]; coumarin catabolic process [GO:0046226]; estrogen catabolic process [GO:0006711]; flavonoid glucuronidation [GO:0052696]; xenobiotic glucuronidation [GO:0052697]
PGEN_.00g236240	Scaffold_11	34604677	34621138	NA	NA	NA	NA	NA
PGEN_.00g236250	Scaffold_11	34633280	34637311	NA	NA	NA	NA	NA
PGEN_.00g236260	Scaffold_11	34702635	34734580	NA	NA	NA	NA	NA
PGEN_.00g236270	Scaffold_11	34736769	34739042	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g236280	Scaffold_11	34746933	34790463	NA	NA	NA	NA	NA
PGEN_.00g236290	Scaffold_11	34801121	34843695	Q5F371	SBNO1_CHICK	Protein strawberry notch homolog 1	GO:0005634; GO:0006355; GO:0031490; GO:0042393	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g236300	Scaffold_11	34858658	34867079	NA	NA	NA	NA	NA
PGEN_.00g236310	Scaffold_11	34872969	34896798	NA	NA	NA	NA	NA
PGEN_.00g236320	Scaffold_11	34879023	34882351	NA	NA	NA	NA	NA
PGEN_.00g236330	Scaffold_11	34917905	34919388	NA	NA	NA	NA	NA
PGEN_.00g236340	Scaffold_11	34931598	34936400	NA	NA	NA	NA	NA
PGEN_.00g236350	Scaffold_11	34960139	34972289	NA	NA	NA	NA	NA
PGEN_.00g236360	Scaffold_11	34978914	34992314	NA	NA	NA	NA	NA
PGEN_.00g236370	Scaffold_11	35057535	35063805	NA	NA	NA	NA	NA
PGEN_.00g236380	Scaffold_11	35079155	35081281	NA	NA	NA	NA	NA
PGEN_.00g236390	Scaffold_11	35092412	35102290	Q7TM99	MOT9_MOUSE	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g236400	Scaffold_11	35114607	35122250	Q7TM99	MOT9_MOUSE	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g236410	Scaffold_11	35141062	35149554	E9Q9A9	OAS2_MOUSE	"2'-5'-oligoadenylate synthase 2 ((2-5')oligo(A) synthase 2) (2-5A synthase 2) (EC 2.7.7.84) (2',5'-oligoadenylate synthetase-like 11)"	GO:0001730; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006401; GO:0009615; GO:0009617; GO:0045071; GO:0046872; GO:0048471; GO:0051607; GO:0060337; GO:0060700; GO:1903487	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; regulation of lactation [GO:1903487]; regulation of ribonuclease activity [GO:0060700]; response to bacterium [GO:0009617]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337]
PGEN_.00g236420	Scaffold_11	35184577	35205244	E9Q9A9	OAS2_MOUSE	"2'-5'-oligoadenylate synthase 2 ((2-5')oligo(A) synthase 2) (2-5A synthase 2) (EC 2.7.7.84) (2',5'-oligoadenylate synthetase-like 11)"	GO:0001730; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006401; GO:0009615; GO:0009617; GO:0045071; GO:0046872; GO:0048471; GO:0051607; GO:0060337; GO:0060700; GO:1903487	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; regulation of lactation [GO:1903487]; regulation of ribonuclease activity [GO:0060700]; response to bacterium [GO:0009617]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337]
PGEN_.00g236430	Scaffold_11	35207332	35212727	P35668	GSHB_XENLA	Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)	GO:0000287; GO:0004363; GO:0005524; GO:0042803; GO:0043295	ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]
PGEN_.00g236440	Scaffold_11	35298375	35310857	F1N3B8	OAS2_BOVIN	2'-5'-oligoadenylate synthase 2 ((2-5')oligo(A) synthase 2) (2-5A synthase 2) (EC 2.7.7.84)	GO:0001730; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006401; GO:0009615; GO:0009617; GO:0045071; GO:0046872; GO:0048471; GO:0051607; GO:0060337; GO:0060700; GO:1903487	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; regulation of lactation [GO:1903487]; regulation of ribonuclease activity [GO:0060700]; response to bacterium [GO:0009617]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337]
PGEN_.00g236450	Scaffold_11	35323780	35336748	Q5EAC2	GSHB_BOVIN	Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)	GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0042803; GO:0043295	cytosol [GO:0005829]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]
PGEN_.00g236460	Scaffold_11	35364756	35368355	NA	NA	NA	NA	NA
PGEN_.00g236470	Scaffold_11	35379100	35379501	NA	NA	NA	NA	NA
PGEN_.00g236480	Scaffold_11	35383475	35384798	Q10323	IMT3_SCHPO	Inositol phosphoceramide mannosyltransferase 3 (EC 2.4.-.-) (IPC mannosyltransferase 3)	GO:0000030; GO:0005783; GO:0005789; GO:0005794; GO:0016021; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g236490	Scaffold_11	35401007	35405509	P38287	CSH1_YEAST	Mannosyl phosphorylinositol ceramide synthase CSH1 (EC 2.-.-.-) (CSG1/SUR1 homolog 1)	GO:0000030; GO:0000324; GO:0005774; GO:0006688; GO:0016021; GO:0030148; GO:0051999	fungal-type vacuole [GO:0000324]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; mannosyltransferase activity [GO:0000030]; glycosphingolipid biosynthetic process [GO:0006688]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g236500	Scaffold_11	35406719	35408919	NA	NA	NA	NA	NA
PGEN_.00g236510	Scaffold_11	35426466	35430169	Q9UT67	IMT2_SCHPO	Inositol phosphoceramide mannosyltransferase 2 (EC 2.4.-.-) (IPC mannosyltransferase 2)	GO:0000030; GO:0005794; GO:0016021; GO:0031501; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g236520	Scaffold_11	35465139	35465705	NA	NA	NA	NA	NA
PGEN_.00g236530	Scaffold_11	35492898	35508846	P33300	SUR1_YEAST	Mannosyl phosphorylinositol ceramide synthase SUR1 (EC 2.4.-.-)	GO:0000030; GO:0000324; GO:0000329; GO:0006675; GO:0006688; GO:0016021; GO:0030148; GO:0051999	fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; glycosphingolipid biosynthetic process [GO:0006688]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]; mannosyl-inositol phosphorylceramide metabolic process [GO:0006675]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g236540	Scaffold_11	35534586	35555561	O86034	BDHA_RHIME	D-beta-hydroxybutyrate dehydrogenase (BDH) (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (3-HBDH)	GO:0003858	3-hydroxybutyrate dehydrogenase activity [GO:0003858]
PGEN_.00g236550	Scaffold_11	35555590	35558362	NA	NA	NA	NA	NA
PGEN_.00g236560	Scaffold_11	35563520	35604542	P48763	SL9A2_RAT	Sodium/hydrogen exchanger 2 (H7) (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2)	GO:0005623; GO:0005886; GO:0006814; GO:0006885; GO:0008104; GO:0015385; GO:0015386; GO:0016021; GO:0016324; GO:0051453; GO:0071805; GO:0098719	apical plasma membrane [GO:0016324]; cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]
PGEN_.00g236570	Scaffold_11	35722156	35727360	NA	NA	NA	NA	NA
PGEN_.00g236580	Scaffold_11	35739834	35756670	Q6GQ34	F124A_XENLA	Protein FAM124A		
PGEN_.00g236590	Scaffold_11	35791298	35792296	NA	NA	NA	NA	NA
PGEN_.00g236600	Scaffold_11	35795743	35808524	NA	NA	NA	NA	NA
PGEN_.00g236610	Scaffold_11	35837104	35837545	NA	NA	NA	NA	NA
PGEN_.00g236620	Scaffold_11	35844491	35876334	NA	NA	NA	NA	NA
PGEN_.00g236630	Scaffold_11	35846548	35846988	NA	NA	NA	NA	NA
PGEN_.00g236640	Scaffold_11	35881604	35882542	NA	NA	NA	NA	NA
PGEN_.00g236650	Scaffold_11	35886716	35926943	Q96N96	SPT13_HUMAN	Spermatogenesis-associated protein 13 (APC-stimulated guanine nucleotide exchange factor 2) (Asef2)	GO:0005085; GO:0005654; GO:0005737; GO:0005829; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0030334; GO:0030676; GO:0032587; GO:0042802; GO:0046847	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; cell migration [GO:0016477]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; regulation of cell migration [GO:0030334]
PGEN_.00g236660	Scaffold_11	35968989	35995199	NA	NA	NA	NA	NA
PGEN_.00g236670	Scaffold_11	35995733	35996056	NA	NA	NA	NA	NA
PGEN_.00g236680	Scaffold_11	35996516	36022669	P10078	ZFP28_MOUSE	Zinc finger protein 28 (Zfp-28) (Protein mKR5)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g236690	Scaffold_11	36037134	36043854	NA	NA	NA	NA	NA
PGEN_.00g236700	Scaffold_11	36045168	36045695	NA	NA	NA	NA	NA
PGEN_.00g236710	Scaffold_11	36045744	36046154	C6KSS5	LRR2_PLAF7	Protein PFF0380w		
PGEN_.00g236720	Scaffold_11	36047390	36051105	Q86WV6	STING_HUMAN	Stimulator of interferon genes protein (hSTING) (Endoplasmic reticulum interferon stimulator) (ERIS) (Mediator of IRF3 activation) (hMITA) (Transmembrane protein 173)	GO:0000045; GO:0000421; GO:0002218; GO:0002230; GO:0005654; GO:0005741; GO:0005768; GO:0005776; GO:0005777; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0008134; GO:0016032; GO:0016239; GO:0019901; GO:0030176; GO:0030659; GO:0030667; GO:0031625; GO:0032092; GO:0032479; GO:0032481; GO:0032608; GO:0035438; GO:0035458; GO:0039528; GO:0042802; GO:0042803; GO:0043312; GO:0045087; GO:0045944; GO:0048471; GO:0050727; GO:0051091; GO:0051259; GO:0051607; GO:0061507; GO:0061709; GO:0071360; GO:0071407; GO:1990701	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990701]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; neutrophil degranulation [GO:0043312]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein complex oligomerization [GO:0051259]; regulation of inflammatory response [GO:0050727]; regulation of type I interferon production [GO:0032479]; reticulophagy [GO:0061709]; viral process [GO:0016032]
PGEN_.00g236730	Scaffold_11	36051202	36063595	NA	NA	NA	NA	NA
PGEN_.00g236740	Scaffold_11	36071490	36085162	A8E5V9	STING_XENTR	Stimulator of interferon genes protein (STING) (Transmembrane protein 173)	GO:0000045; GO:0000421; GO:0002218; GO:0002230; GO:0005737; GO:0005789; GO:0016021; GO:0016239; GO:0031410; GO:0032481; GO:0032608; GO:0033116; GO:0035438; GO:0039528; GO:0042803; GO:0045087; GO:0048471; GO:0051607; GO:0061507; GO:0061709; GO:0071360	autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; protein homodimerization activity [GO:0042803]; activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of macroautophagy [GO:0016239]; positive regulation of type I interferon production [GO:0032481]; reticulophagy [GO:0061709]
PGEN_.00g236750	Scaffold_11	36086685	36098014	NA	NA	NA	NA	NA
PGEN_.00g236760	Scaffold_11	36116069	36117295	NA	NA	NA	NA	NA
PGEN_.00g236770	Scaffold_11	36148972	36156887	NA	NA	NA	NA	NA
PGEN_.00g236780	Scaffold_11	36163027	36168817	NA	NA	NA	NA	NA
PGEN_.00g236790	Scaffold_11	36192243	36212234	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g236800	Scaffold_11	36217950	36231648	A8E5V9	STING_XENTR	Stimulator of interferon genes protein (STING) (Transmembrane protein 173)	GO:0000045; GO:0000421; GO:0002218; GO:0002230; GO:0005737; GO:0005789; GO:0016021; GO:0016239; GO:0031410; GO:0032481; GO:0032608; GO:0033116; GO:0035438; GO:0039528; GO:0042803; GO:0045087; GO:0048471; GO:0051607; GO:0061507; GO:0061709; GO:0071360	autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; protein homodimerization activity [GO:0042803]; activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of macroautophagy [GO:0016239]; positive regulation of type I interferon production [GO:0032481]; reticulophagy [GO:0061709]
PGEN_.00g236810	Scaffold_11	36249091	36261162	NA	NA	NA	NA	NA
PGEN_.00g236820	Scaffold_11	36262864	36298955	P51116	FXR2_HUMAN	Fragile X mental retardation syndrome-related protein 2	GO:0000381; GO:0001934; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0014069; GO:0016020; GO:0017148; GO:0022625; GO:0030424; GO:0030426; GO:0035770; GO:0036464; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043488; GO:0044326; GO:0045182; GO:0045727; GO:0046982; GO:0051489; GO:0098793; GO:1902737; GO:2001022	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ribonucleoprotein granule [GO:0035770]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; negative regulation of translation [GO:0017148]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]"
PGEN_.00g236830	Scaffold_11	36299881	36303046	Q28107	FA5_BOVIN	Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]	GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091	extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; copper ion binding [GO:0005507]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]
PGEN_.00g236840	Scaffold_11	36313070	36342907	Q9XSC3	WDR44_BOVIN	WD repeat-containing protein 44 (Rab11-binding protein) (Rabphilin-11)	GO:0005794; GO:0005829; GO:0010008; GO:0017137; GO:0048471	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Rab GTPase binding [GO:0017137]
PGEN_.00g236850	Scaffold_11	36354277	36378052	P41732	TSN7_HUMAN	Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1) (TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231)	GO:0005887; GO:0016032	integral component of plasma membrane [GO:0005887]; viral process [GO:0016032]
PGEN_.00g236860	Scaffold_11	36394022	36425683	Q9H8V3	ECT2_HUMAN	Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)	GO:0000281; GO:0000902; GO:0005089; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0007186; GO:0015031; GO:0016604; GO:0030496; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431	"bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]"
PGEN_.00g236870	Scaffold_11	36425907	36428196	NA	NA	NA	NA	NA
PGEN_.00g236880	Scaffold_11	36430238	36430612	NA	NA	NA	NA	NA
PGEN_.00g236890	Scaffold_11	36444387	36445555	NA	NA	NA	NA	NA
PGEN_.00g236900	Scaffold_11	36445587	36445928	NA	NA	NA	NA	NA
PGEN_.00g236910	Scaffold_11	36476009	36477371	Q9VN27	LIPT2_DROME	"Putative lipoyltransferase 2, mitochondrial (EC 2.3.1.181) (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase)"	GO:0005739; GO:0009249; GO:0033819; GO:0102555	mitochondrion [GO:0005739]; lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]; protein lipoylation [GO:0009249]
PGEN_.00g236920	Scaffold_11	36489547	36496896	Q5I0R4	CF300_XENTR	Cilia- and flagella-associated protein 300	GO:0005737; GO:0005856; GO:0031514	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]
PGEN_.00g236930	Scaffold_11	36516390	36516965	NA	NA	NA	NA	NA
PGEN_.00g236940	Scaffold_11	36530750	36534558	Q5ZJU0	MOT9_CHICK	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g236950	Scaffold_11	36604054	36613506	Q6GM59	MOT12_XENLA	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0015293; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]
PGEN_.00g236960	Scaffold_11	36626696	36634069	P57788	MOT4_CHICK	Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3)	GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g236970	Scaffold_11	36648517	36652080	NA	NA	NA	NA	NA
PGEN_.00g236980	Scaffold_11	36653671	36654069	NA	NA	NA	NA	NA
PGEN_.00g236990	Scaffold_11	36660580	36669636	Q7RTY1	MOT9_HUMAN	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g237000	Scaffold_11	36670988	36682839	Q9GPR3	TM2D1_DICDI	TM2 domain-containing protein DDB_G0277895	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g237010	Scaffold_11	36765123	36768791	NA	NA	NA	NA	NA
PGEN_.00g237020	Scaffold_11	36781812	36789725	Q8R0M8	MOT5_MOUSE	Monocarboxylate transporter 5 (MCT 5)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g237030	Scaffold_11	36798941	36821084	Q8R0M8	MOT5_MOUSE	Monocarboxylate transporter 5 (MCT 5)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g237040	Scaffold_11	36821778	36823913	NA	NA	NA	NA	NA
PGEN_.00g237050	Scaffold_11	36879673	36888829	Q7RTY1	MOT9_HUMAN	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g237060	Scaffold_11	36897215	36913077	Q23356	MIG15_CAEEL	Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15)	GO:0000003; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0023014; GO:0030334; GO:0032147; GO:0032228; GO:0033563; GO:0048812	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]; signal transduction by protein phosphorylation [GO:0023014]"
PGEN_.00g237070	Scaffold_11	36931395	36938444	NA	NA	NA	NA	NA
PGEN_.00g237080	Scaffold_11	36964470	37007580	Q9UKE5	TNIK_HUMAN	TRAF2 and NCK-interacting protein kinase (EC 2.7.11.1)	GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0007256; GO:0016055; GO:0016324; GO:0023014; GO:0030033; GO:0031532; GO:0032147; GO:0035556; GO:0046777; GO:0048812; GO:0048814; GO:0055037; GO:0070062; GO:0072659; GO:0098793; GO:0098978; GO:0099092	"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; activation of JNKK activity [GO:0007256]; activation of protein kinase activity [GO:0032147]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; microvillus assembly [GO:0030033]; neuron projection morphogenesis [GO:0048812]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction by protein phosphorylation [GO:0023014]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g237090	Scaffold_11	37008770	37009009	NA	NA	NA	NA	NA
PGEN_.00g237100	Scaffold_11	37016358	37020121	NA	NA	NA	NA	NA
PGEN_.00g237110	Scaffold_11	37024753	37026706	NA	NA	NA	NA	NA
PGEN_.00g237120	Scaffold_11	37034793	37045501	NA	NA	NA	NA	NA
PGEN_.00g237130	Scaffold_11	37058087	37059025	NA	NA	NA	NA	NA
PGEN_.00g237140	Scaffold_11	37059315	37101163	Q12834	CDC20_HUMAN	Cell division cycle protein 20 homolog (p55CDC)	GO:0000922; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0006511; GO:0007064; GO:0007094; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0016579; GO:0019899; GO:0031145; GO:0031915; GO:0032991; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:0097027; GO:1901990; GO:1904668	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activator activity [GO:0097027]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g237150	Scaffold_11	37110048	37301714	Q8WSR4	ITPR_PATPE	"Inositol 1,4,5-trisphosphate receptor (ApIP3R)"	GO:0005220; GO:0005789; GO:0007275; GO:0007338; GO:0016021; GO:0070679	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; multicellular organism development [GO:0007275]; single fertilization [GO:0007338]"
PGEN_.00g237160	Scaffold_11	37315909	37334232	O15550	KDM6A_HUMAN	Lysine-specific demethylase 6A (EC 1.14.11.-) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein)	GO:0000790; GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0010628; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048570; GO:0051213; GO:0051568; GO:0060070; GO:0071558; GO:0072358	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]
PGEN_.00g237170	Scaffold_11	37334454	37334750	NA	NA	NA	NA	NA
PGEN_.00g237180	Scaffold_11	37345457	37375680	O15550	KDM6A_HUMAN	Lysine-specific demethylase 6A (EC 1.14.11.-) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein)	GO:0000790; GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0010628; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048570; GO:0051213; GO:0051568; GO:0060070; GO:0071558; GO:0072358	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]
PGEN_.00g237190	Scaffold_11	37392889	37425575	O15550	KDM6A_HUMAN	Lysine-specific demethylase 6A (EC 1.14.11.-) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein)	GO:0000790; GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0010628; GO:0031490; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0043565; GO:0044666; GO:0046872; GO:0048333; GO:0048570; GO:0051213; GO:0051568; GO:0060070; GO:0071558; GO:0072358	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]
PGEN_.00g237200	Scaffold_11	37439336	37444751	Q503Y7	PIN4_DANRE	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Rotamase Pin4)	GO:0003677; GO:0003755; GO:0005730; GO:0005737; GO:0005819	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; spindle [GO:0005819]; DNA binding [GO:0003677]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
PGEN_.00g237210	Scaffold_11	37445504	37452388	Q5R863	GPAM1_PONAB	GPALPP motifs-containing protein 1		
PGEN_.00g237220	Scaffold_11	37457250	37465135	B7XHR6	KIN1_ENTBH	Probable serine/threonine-protein kinase KIN1 homolog (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006887	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; exocytosis [GO:0006887]
PGEN_.00g237230	Scaffold_11	37475735	37482603	NA	NA	NA	NA	NA
PGEN_.00g237240	Scaffold_11	37483561	37483899	NA	NA	NA	NA	NA
PGEN_.00g237250	Scaffold_11	37483937	37486348	NA	NA	NA	NA	NA
PGEN_.00g237260	Scaffold_11	37496515	37498074	O94898	LRIG2_HUMAN	Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2)	GO:0005102; GO:0005615; GO:0005737; GO:0005886; GO:0007605; GO:0010640; GO:0016021; GO:0030426; GO:0031012; GO:0043025; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]
PGEN_.00g237270	Scaffold_11	37521794	37531819	Q9Y2M5	KLH20_HUMAN	Kelch-like protein 20 (Kelch-like ECT2-interacting protein) (Kelch-like protein X)	GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0007010; GO:0015031; GO:0015629; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0035455; GO:0043066; GO:0043161; GO:0043687; GO:0048471; GO:1990390	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]; cytoskeleton organization [GO:0007010]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; response to interferon-alpha [GO:0035455]
PGEN_.00g237280	Scaffold_11	37545254	37570513	Q66HG5	TM9S2_RAT	Transmembrane 9 superfamily member 2	GO:0005794; GO:0005856; GO:0010008; GO:0016021; GO:0030054; GO:0045202; GO:0072657	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; protein localization to membrane [GO:0072657]
PGEN_.00g237290	Scaffold_11	37579161	37588214	NA	NA	NA	NA	NA
PGEN_.00g237300	Scaffold_11	37598267	37607098	Q8RWW1	TMN10_ARATH	Transmembrane 9 superfamily member 10 (Endomembrane protein 3) (Transmembrane nine protein 10) (AtTMN10)	GO:0000139; GO:0005794; GO:0010008; GO:0016021; GO:0072657	endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein localization to membrane [GO:0072657]
PGEN_.00g237310	Scaffold_11	37609666	37618440	NA	NA	NA	NA	NA
PGEN_.00g237320	Scaffold_11	37676912	37677706	Q08C99	VRTN_DANRE	Vertnin	GO:0000122; GO:0000785; GO:0001227	"chromatin [GO:0000785]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g237330	Scaffold_11	37685076	37686323	NA	NA	NA	NA	NA
PGEN_.00g237340	Scaffold_11	37700149	37734658	Q91ZA3	PCCA_MOUSE	"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)"	GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0019899; GO:0046872	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; lipid catabolic process [GO:0016042]
PGEN_.00g237350	Scaffold_11	37742941	37752218	NA	NA	NA	NA	NA
PGEN_.00g237360	Scaffold_11	37784142	37784402	NA	NA	NA	NA	NA
PGEN_.00g237370	Scaffold_11	37796656	37799112	NA	NA	NA	NA	NA
PGEN_.00g237380	Scaffold_11	37805510	37813165	NA	NA	NA	NA	NA
PGEN_.00g237390	Scaffold_11	37820559	37930012	P52785	GUC2E_MOUSE	Retinal guanylyl cyclase 1 (Guanylate cyclase 2E) (Guanylyl cyclase GC-E) (EC 4.6.1.2)	GO:0001653; GO:0001750; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005789; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0007601; GO:0016021; GO:0016941; GO:0017046; GO:0019934; GO:0042622; GO:0042802; GO:0042803; GO:0044877	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]; visual perception [GO:0007601]
PGEN_.00g237400	Scaffold_11	37971851	37972453	NA	NA	NA	NA	NA
PGEN_.00g237410	Scaffold_11	38127444	38127677	NA	NA	NA	NA	NA
PGEN_.00g237420	Scaffold_11	38157952	38187848	Q9D099	ACER3_MOUSE	Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC)	GO:0005509; GO:0005783; GO:0006954; GO:0008270; GO:0008284; GO:0016021; GO:0017040; GO:0030173; GO:0030176; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0070774; GO:0071602; GO:0071633; GO:0102121	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]; ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512]
PGEN_.00g237430	Scaffold_11	38201652	38237190	Q5RAV9	GUAD_PONAB	Guanine deaminase (Guanase) (Guanine aminase) (EC 3.5.4.3) (Guanine aminohydrolase) (GAH)	GO:0006147; GO:0008270; GO:0008892	guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]; guanine catabolic process [GO:0006147]
PGEN_.00g237440	Scaffold_11	38256377	38265511	NA	NA	NA	NA	NA
PGEN_.00g237450	Scaffold_11	38269382	38314338	P15684	AMPN_RAT	Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13)	GO:0001525; GO:0004177; GO:0005615; GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0031526; GO:0035814; GO:0042277; GO:0043171; GO:0070006; GO:0070062	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of renal sodium excretion [GO:0035814]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]
PGEN_.00g237460	Scaffold_11	38355543	38378045	NA	NA	NA	NA	NA
PGEN_.00g237470	Scaffold_11	38408214	38456136	Q8C6K9	CO6A6_MOUSE	Collagen alpha-6(VI) chain	GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g237480	Scaffold_11	38463275	38463613	NA	NA	NA	NA	NA
PGEN_.00g237490	Scaffold_11	38472668	38495111	F1RAX4	STRA6_DANRE	Receptor for retinol uptake stra6 (Stimulated by retinoic acid gene 6 protein homolog)	GO:0005516; GO:0005886; GO:0005887; GO:0016918; GO:0019841; GO:0034632; GO:0034633; GO:0038023; GO:0043009; GO:0071939	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023]; chordate embryonic development [GO:0043009]; retinol transport [GO:0034633]; vitamin A import [GO:0071939]
PGEN_.00g237500	Scaffold_11	38518375	38544058	F1RAX4	STRA6_DANRE	Receptor for retinol uptake stra6 (Stimulated by retinoic acid gene 6 protein homolog)	GO:0005516; GO:0005886; GO:0005887; GO:0016918; GO:0019841; GO:0034632; GO:0034633; GO:0038023; GO:0043009; GO:0071939	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023]; chordate embryonic development [GO:0043009]; retinol transport [GO:0034633]; vitamin A import [GO:0071939]
PGEN_.00g237510	Scaffold_11	38560470	38572043	F1RAX4	STRA6_DANRE	Receptor for retinol uptake stra6 (Stimulated by retinoic acid gene 6 protein homolog)	GO:0005516; GO:0005886; GO:0005887; GO:0016918; GO:0019841; GO:0034632; GO:0034633; GO:0038023; GO:0043009; GO:0071939	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023]; chordate embryonic development [GO:0043009]; retinol transport [GO:0034633]; vitamin A import [GO:0071939]
PGEN_.00g237520	Scaffold_11	38636260	38649071	P61315	G3ST3_MOUSE	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g237530	Scaffold_11	38654933	38670731	P54315	LIPR1_HUMAN	Inactive pancreatic lipase-related protein 1 (PL-RP1)	GO:0004806; GO:0005509; GO:0005576; GO:0006629	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]
PGEN_.00g237540	Scaffold_11	38672140	38672451	NA	NA	NA	NA	NA
PGEN_.00g237550	Scaffold_11	38698263	38704479	P61315	G3ST3_MOUSE	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g237560	Scaffold_11	38709023	38725861	NA	NA	NA	NA	NA
PGEN_.00g237570	Scaffold_11	38737943	38774348	Q03001	DYST_HUMAN	Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein)	GO:0000226; GO:0003779; GO:0005178; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008022; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031122; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]
PGEN_.00g237580	Scaffold_11	38778299	38798523	Q64425	LIPP_MYOCO	Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) (Fragment)	GO:0004806; GO:0005576; GO:0016042; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]
PGEN_.00g237590	Scaffold_11	38806653	38854275	P23819	GRIA2_MOUSE	"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)"	GO:0000149; GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005234; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007268; GO:0008021; GO:0008066; GO:0008092; GO:0009986; GO:0014069; GO:0015277; GO:0016020; GO:0019865; GO:0019901; GO:0030054; GO:0030165; GO:0030425; GO:0030426; GO:0030672; GO:0031623; GO:0032279; GO:0032281; GO:0032839; GO:0032991; GO:0035235; GO:0035249; GO:0036477; GO:0038023; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0045184; GO:0045202; GO:0045211; GO:0050804; GO:0050806; GO:0051117; GO:0051262; GO:0051966; GO:0097060; GO:0098685; GO:0098839; GO:0098978; GO:0099055; GO:0099056; GO:0099061; GO:1904315	"AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]; SNARE binding [GO:0000149]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; establishment of protein localization [GO:0045184]; ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic transmission [GO:0050806]; protein tetramerization [GO:0051262]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g237600	Scaffold_11	38863114	38864286	NA	NA	NA	NA	NA
PGEN_.00g237610	Scaffold_11	38932717	38933244	NA	NA	NA	NA	NA
PGEN_.00g237620	Scaffold_11	38977426	38992960	P13406	FYN_XENLA	Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn)	GO:0004715; GO:0005524; GO:0007275; GO:0046872	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; multicellular organism development [GO:0007275]
PGEN_.00g237630	Scaffold_11	39006676	39058626	Q7L0X2	ERIP6_HUMAN	Glutamate-rich protein 6 (Protein FAM194A)		
PGEN_.00g237640	Scaffold_11	39063706	39070954	Q8R0F5	RBMX2_MOUSE	"RNA-binding motif protein, X-linked 2"	GO:0000398; GO:0003723; GO:0005634; GO:0005686; GO:0071005	"nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g237650	Scaffold_11	39076792	39086867	Q86V85	GP180_HUMAN	Integral membrane protein GPR180 (Intimal thickness-related receptor)	GO:0007186; GO:0016021; GO:0019236	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]
PGEN_.00g237660	Scaffold_11	39092744	39180442	O75369	FLNB_HUMAN	Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP)	GO:0001725; GO:0003334; GO:0003382; GO:0003723; GO:0003779; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005925; GO:0005938; GO:0007016; GO:0007165; GO:0007519; GO:0015629; GO:0016021; GO:0030018; GO:0030036; GO:0042802; GO:0043005; GO:0043025; GO:0045296; GO:0045335; GO:0070062; GO:0071346	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell [GO:0005623]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g237670	Scaffold_11	39187668	39230883	Q8AYS7	CENPI_CHICK	Centromere protein I (CENP-I)	GO:0000776; GO:0005829; GO:0016604; GO:0034508	cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; centromere complex assembly [GO:0034508]
PGEN_.00g237680	Scaffold_11	39235056	39235610	NA	NA	NA	NA	NA
PGEN_.00g237690	Scaffold_11	39236082	39236321	NA	NA	NA	NA	NA
PGEN_.00g237700	Scaffold_11	39249856	39250443	NA	NA	NA	NA	NA
PGEN_.00g237710	Scaffold_11	39250031	39250537	NA	NA	NA	NA	NA
PGEN_.00g237720	Scaffold_11	39251236	39251523	NA	NA	NA	NA	NA
PGEN_.00g237730	Scaffold_11	39252044	39252595	NA	NA	NA	NA	NA
PGEN_.00g237740	Scaffold_11	39253097	39253657	NA	NA	NA	NA	NA
PGEN_.00g237750	Scaffold_11	39253699	39257683	NA	NA	NA	NA	NA
PGEN_.00g237760	Scaffold_11	39260331	39262123	NA	NA	NA	NA	NA
PGEN_.00g237770	Scaffold_11	39262260	39262490	NA	NA	NA	NA	NA
PGEN_.00g237780	Scaffold_11	39287483	39291798	NA	NA	NA	NA	NA
PGEN_.00g237790	Scaffold_11	39313421	39319078	NA	NA	NA	NA	NA
PGEN_.00g237800	Scaffold_11	39330661	39346596	Q9QXE5	TSSP_MOUSE	Thymus-specific serine protease (EC 3.4.-.-) (Serine protease 16)	GO:0005764; GO:0005768; GO:0006508; GO:0008236; GO:0008239	endosome [GO:0005768]; lysosome [GO:0005764]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]
PGEN_.00g237810	Scaffold_11	39348138	39359230	NA	NA	NA	NA	NA
PGEN_.00g237820	Scaffold_11	39371040	39376039	NA	NA	NA	NA	NA
PGEN_.00g237830	Scaffold_11	39482572	39487625	NA	NA	NA	NA	NA
PGEN_.00g237840	Scaffold_11	39501606	39522370	NA	NA	NA	NA	NA
PGEN_.00g237850	Scaffold_11	39544531	39570857	NA	NA	NA	NA	NA
PGEN_.00g237860	Scaffold_11	39582685	39608344	NA	NA	NA	NA	NA
PGEN_.00g237870	Scaffold_11	39619604	39647290	Q6PZ02	ATG4B_CHICK	Cysteine protease ATG4B (EC 3.4.22.-) (Autophagy-related cysteine endopeptidase 2B) (Autophagin-2B) (cAut2B) (Autophagy-related protein 4 homolog B)	GO:0004197; GO:0005737; GO:0006914; GO:0015031; GO:0051697	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; autophagy [GO:0006914]; protein delipidation [GO:0051697]; protein transport [GO:0015031]
PGEN_.00g237880	Scaffold_11	39686157	39788739	NA	NA	NA	NA	NA
PGEN_.00g237890	Scaffold_11	39796619	39800172	Q84R16	GT14_ARATH	Probable xyloglucan galactosyltransferase GT14 (EC 2.4.1.-) (Glycosyltransferase 14) (AtGT14)	GO:0000139; GO:0005618; GO:0006486; GO:0016020; GO:0016021; GO:0016757	"cell wall [GO:0005618]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transferase activity, transferring glycosyl groups [GO:0016757]; protein glycosylation [GO:0006486]"
PGEN_.00g237900	Scaffold_11	39804920	39833811	F1P065	FARP1_CHICK	"FERM, ARHGEF and pleckstrin domain-containing protein 1 (FERM, RhoGEF and pleckstrin domain-containing protein 1)"	GO:0005829; GO:0005856; GO:0007416; GO:0008092; GO:0030054; GO:0030175; GO:0030425; GO:0030676; GO:0031234; GO:0043197; GO:0048813	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; filopodium [GO:0030175]; cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; dendrite morphogenesis [GO:0048813]; synapse assembly [GO:0007416]
PGEN_.00g237910	Scaffold_11	39847749	39848654	NA	NA	NA	NA	NA
PGEN_.00g237920	Scaffold_11	39863981	39881990	Q91VS8	FARP2_MOUSE	"FERM, ARHGEF and pleckstrin domain-containing protein 2 (FERM domain including RhoGEF) (FIR) (FERM, RhoGEF and pleckstrin domain-containing protein 2)"	GO:0005089; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0008092; GO:0016322; GO:0016601; GO:0022405; GO:0030316; GO:0030676; GO:0031532; GO:0033623; GO:0071526; GO:0071800	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; semaphorin-plexin signaling pathway [GO:0071526]
PGEN_.00g237930	Scaffold_11	39928835	39930830	NA	NA	NA	NA	NA
PGEN_.00g237940	Scaffold_11	39971676	39995289	NA	NA	NA	NA	NA
PGEN_.00g237950	Scaffold_11	40032946	40036079	P41047	TNFL6_MOUSE	"Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]"	GO:0000122; GO:0005123; GO:0005125; GO:0005164; GO:0005615; GO:0005623; GO:0005634; GO:0005886; GO:0005901; GO:0006919; GO:0006925; GO:0006955; GO:0008284; GO:0008625; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030644; GO:0031410; GO:0032496; GO:0043065; GO:0043123; GO:0043202; GO:0043525; GO:0045121; GO:0045742; GO:0046666; GO:0048388; GO:0048471; GO:0060205; GO:0070062; GO:0070231; GO:0070266; GO:0070848; GO:0097190; GO:0097191; GO:0097527; GO:1903514; GO:2000353	caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle lumen [GO:0060205]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; death receptor binding [GO:0005123]; tumor necrosis factor receptor binding [GO:0005164]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular chloride ion homeostasis [GO:0030644]; endosomal lumen acidification [GO:0048388]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; immune response [GO:0006955]; inflammatory cell apoptotic process [GO:0006925]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron apoptotic process [GO:0043525]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; retinal cell programmed cell death [GO:0046666]; T cell apoptotic process [GO:0070231]
PGEN_.00g237960	Scaffold_11	40054430	40055627	NA	NA	NA	NA	NA
PGEN_.00g237970	Scaffold_11	40058476	40058814	NA	NA	NA	NA	NA
PGEN_.00g237980	Scaffold_11	40084197	40086095	NA	NA	NA	NA	NA
PGEN_.00g237990	Scaffold_11	40093768	40112182	Q8JFG3	TNFA_SPAAU	Tumor necrosis factor (TNF-alpha)	GO:0005125; GO:0005164; GO:0005615; GO:0006955; GO:0016021	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; cytokine activity [GO:0005125]; tumor necrosis factor receptor binding [GO:0005164]; immune response [GO:0006955]
PGEN_.00g238000	Scaffold_11	40135005	40138420	NA	NA	NA	NA	NA
PGEN_.00g238010	Scaffold_11	40141928	40143570	NA	NA	NA	NA	NA
PGEN_.00g238020	Scaffold_11	40154439	40158882	NA	NA	NA	NA	NA
PGEN_.00g238030	Scaffold_11	40165439	40169672	NA	NA	NA	NA	NA
PGEN_.00g238040	Scaffold_11	40181472	40183400	Q5RDJ4	LIGO1_PONAB	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g238050	Scaffold_11	40190216	40193888	Q9VPF0	ATK_DROME	Protein artichoke	GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0050896; GO:0060271	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]
PGEN_.00g238060	Scaffold_11	40202481	40207836	O94898	LRIG2_HUMAN	Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2)	GO:0005102; GO:0005615; GO:0005737; GO:0005886; GO:0007605; GO:0010640; GO:0016021; GO:0030426; GO:0031012; GO:0043025; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]
PGEN_.00g238070	Scaffold_11	40225327	40226478	NA	NA	NA	NA	NA
PGEN_.00g238080	Scaffold_11	40227129	40240568	B3LWU3	SUR8_DROAN	Leucine-rich repeat protein soc-2 homolog (Protein Sur-8 homolog) (Protein soc-2 homolog)		
PGEN_.00g238090	Scaffold_11	40233784	40235574	NA	NA	NA	NA	NA
PGEN_.00g238100	Scaffold_11	40251613	40254227	Q8BZ20	PAR12_MOUSE	Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)	GO:0003950; GO:0005634; GO:0046872; GO:0070213; GO:0140289; GO:1990404	nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]
PGEN_.00g238110	Scaffold_11	40256869	40262937	Q7Z2W4	ZCCHV_HUMAN	Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Inactive Poly [ADP-ribose] polymerase 13) (PARP13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP)	GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006471; GO:0009615; GO:0032727; GO:0032728; GO:0043123; GO:0045071; GO:0045087; GO:0045296; GO:0046872; GO:0051607; GO:0061014; GO:1900246	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein ADP-ribosylation [GO:0006471]; response to virus [GO:0009615]
PGEN_.00g238120	Scaffold_11	40268014	40302792	Q9NYU2	UGGG1_HUMAN	UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (hUGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1)	GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0044322; GO:0051082; GO:0051084; GO:0070062; GO:0071712; GO:1904380	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; 'de novo' posttranslational protein folding [GO:0051084]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]
PGEN_.00g238130	Scaffold_11	40402770	40405510	B0ZTE2	SOX14_XENLA	Transcription factor Sox-14 (SRY (sex determining region Y)-box 14)	GO:0000122; GO:0005634; GO:0007399; GO:0043565; GO:0045892	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]"
PGEN_.00g238140	Scaffold_11	40444199	40444909	NA	NA	NA	NA	NA
PGEN_.00g238150	Scaffold_11	40450273	40450962	NA	NA	NA	NA	NA
PGEN_.00g238160	Scaffold_11	40453174	40457757	NA	NA	NA	NA	NA
PGEN_.00g238170	Scaffold_11	40472440	40502969	O43933	PEX1_HUMAN	Peroxisome biogenesis factor 1 (Peroxin-1) (Peroxisome biogenesis disorder protein 1)	GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016887; GO:0042623; GO:0044877; GO:0060152; GO:0070062	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]"
PGEN_.00g238180	Scaffold_11	40510776	40514183	NA	NA	NA	NA	NA
PGEN_.00g238190	Scaffold_11	40520975	40524811	NA	NA	NA	NA	NA
PGEN_.00g238200	Scaffold_11	40528610	40544750	P13549	EF1A0_XENLA	"Elongation factor 1-alpha, somatic form (EF-1-alpha-S)"	GO:0003746; GO:0003924; GO:0005525; GO:0005737	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]
PGEN_.00g238210	Scaffold_11	40547686	40549318	D3ZF77	AK1CA_RAT	Aldo-keto reductase family 1 member C15 (EC 1.1.1.-) (EC 1.1.1.216) (RAKc)	GO:0004032; GO:0004033; GO:0005737; GO:0005829; GO:0008106; GO:0008202; GO:0016229; GO:0016491; GO:0047086; GO:0047886	cytoplasm [GO:0005737]; cytosol [GO:0005829]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; farnesol dehydrogenase activity [GO:0047886]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; steroid metabolic process [GO:0008202]
PGEN_.00g238220	Scaffold_11	40554076	40560345	NA	NA	NA	NA	NA
PGEN_.00g238230	Scaffold_11	40564347	40571022	P21397	AOFA_HUMAN	Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A)	GO:0005739; GO:0005741; GO:0005829; GO:0006576; GO:0008131; GO:0009967; GO:0016021; GO:0019221; GO:0042133; GO:0042135; GO:0042420	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; primary amine oxidase activity [GO:0008131]; cellular biogenic amine metabolic process [GO:0006576]; cytokine-mediated signaling pathway [GO:0019221]; dopamine catabolic process [GO:0042420]; neurotransmitter catabolic process [GO:0042135]; neurotransmitter metabolic process [GO:0042133]; positive regulation of signal transduction [GO:0009967]
PGEN_.00g238240	Scaffold_11	40572095	40585123	Q7YRB7	AOFB_CANLF	Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B)	GO:0005741; GO:0016021; GO:0016491	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; oxidoreductase activity [GO:0016491]
PGEN_.00g238250	Scaffold_11	40594501	40620213	NA	NA	NA	NA	NA
PGEN_.00g238260	Scaffold_11	40703170	40720989	P91891	MO25_DROME	Protein Mo25 (dMo25)	GO:0005634; GO:0005737; GO:0023014	cytoplasm [GO:0005737]; nucleus [GO:0005634]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g238270	Scaffold_11	40745567	40764737	NA	NA	NA	NA	NA
PGEN_.00g238280	Scaffold_11	40767193	40778903	Q9D8Z1	ASCC1_MOUSE	Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50)	GO:0003723; GO:0005634; GO:0005667; GO:0006281; GO:0006355; GO:0016607; GO:0031594	"neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g238290	Scaffold_11	40779273	40808323	A6QR55	UBP4_BOVIN	Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4)	GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g238300	Scaffold_11	40816930	40818838	Q9VB74	NKAP_DROME	NKAP family protein CG6066	GO:0000398; GO:0003682; GO:0007219; GO:0045892; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; chromatin binding [GO:0003682]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]"
PGEN_.00g238310	Scaffold_11	40819494	40821203	NA	NA	NA	NA	NA
PGEN_.00g238320	Scaffold_11	40824009	40824920	NA	NA	NA	NA	NA
PGEN_.00g238330	Scaffold_11	40856348	40867112	Q9VB74	NKAP_DROME	NKAP family protein CG6066	GO:0000398; GO:0003682; GO:0007219; GO:0045892; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; chromatin binding [GO:0003682]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]"
PGEN_.00g238340	Scaffold_11	40867135	40877053	I3J7Q8	HISAT_ORENI	Histidine N-acetyltransferase (EC 2.3.1.33)	GO:0047981	histidine N-acetyltransferase activity [GO:0047981]
PGEN_.00g238350	Scaffold_11	40884421	40888348	Q0P4Y1	HISAT_XENTR	Histidine N-acetyltransferase (EC 2.3.1.33)	GO:0016747; GO:0047981	"histidine N-acetyltransferase activity [GO:0047981]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]"
PGEN_.00g238360	Scaffold_11	40890843	40893107	NA	NA	NA	NA	NA
PGEN_.00g238370	Scaffold_11	40903701	40920663	Q95223	ARRB1_RABIT	Beta-arrestin-1 (Arrestin beta-1)	GO:0001934; GO:0002092; GO:0005634; GO:0005886; GO:0005905; GO:0006511; GO:0007165; GO:0015031; GO:0031143; GO:0031410; GO:0045746	clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g238380	Scaffold_11	40930217	41021092	Q4R562	ARRB1_MACFA	Beta-arrestin-1 (Arrestin beta-1)	GO:0001934; GO:0002092; GO:0005634; GO:0005886; GO:0005905; GO:0006511; GO:0007165; GO:0015031; GO:0031143; GO:0031410; GO:0045746	clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g238390	Scaffold_11	41023079	41023659	NA	NA	NA	NA	NA
PGEN_.00g238400	Scaffold_11	41029474	41051707	P50544	ACADV_MOUSE	"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.9) (MVLCAD) (VLCAD)"	GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005829; GO:0006635; GO:0009062; GO:0009409; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0042645; GO:0045717; GO:0046322; GO:0050660; GO:0090181	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]
PGEN_.00g238410	Scaffold_11	41051843	41054644	Q17NH9	MED11_AEDAE	Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11)	GO:0003712; GO:0006357; GO:0016592	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g238420	Scaffold_11	41054867	41055511	H3BPM6	MKROS_HUMAN	MKRN2 opposite strand protein (MKRN2 antisense RNA 1) (MKRN2 antisense gene protein 1)		
PGEN_.00g238430	Scaffold_11	41062172	41080578	Q6P549	SHIP2_MOUSE	"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (AblSH3-binding protein) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)"	GO:0001958; GO:0002376; GO:0003779; GO:0004445; GO:0005547; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006006; GO:0006661; GO:0006897; GO:0007015; GO:0007155; GO:0008156; GO:0008285; GO:0009791; GO:0010629; GO:0010642; GO:0010977; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0032957; GO:0042169; GO:0043407; GO:0043569; GO:0044255; GO:0046627; GO:0046856; GO:0097178	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cellular lipid metabolic process [GO:0044255]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; inositol trisphosphate metabolic process [GO:0032957]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178]"
PGEN_.00g238440	Scaffold_11	41081058	41122912	O15357	SHIP2_HUMAN	"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)"	GO:0001958; GO:0002376; GO:0003779; GO:0005634; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006006; GO:0006661; GO:0006897; GO:0007015; GO:0007155; GO:0008285; GO:0009791; GO:0010629; GO:0016607; GO:0016787; GO:0017124; GO:0019221; GO:0030027; GO:0030175; GO:0032868; GO:0042169; GO:0043647; GO:0046856; GO:0097178	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; hydrolase activity [GO:0016787]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cytokine-mediated signaling pathway [GO:0019221]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178]
PGEN_.00g238450	Scaffold_11	41174720	41175010	NA	NA	NA	NA	NA
PGEN_.00g238460	Scaffold_11	41178839	41181138	NA	NA	NA	NA	NA
PGEN_.00g238470	Scaffold_11	41196352	41225842	Q676U5	A16L1_HUMAN	Autophagy-related protein 16-1 (APG16-like 1)	GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0015031; GO:0016236; GO:0019787; GO:0034045; GO:0039689; GO:0042802; GO:0051020; GO:0051260	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ubiquitin-like protein transferase activity [GO:0019787]; autophagosome assembly [GO:0000045]; macroautophagy [GO:0016236]; negative stranded viral RNA replication [GO:0039689]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]
PGEN_.00g238480	Scaffold_11	41240032	41242007	NA	NA	NA	NA	NA
PGEN_.00g238490	Scaffold_11	41242788	41247350	NA	NA	NA	NA	NA
PGEN_.00g238500	Scaffold_11	41248243	41249436	NA	NA	NA	NA	NA
PGEN_.00g238510	Scaffold_11	41255416	41289467	D4D8P3	SCONB_TRIVH	Probable E3 ubiquitin ligase complex SCF subunit sconB (Sulfur controller B) (Sulfur metabolite repression control protein B)	GO:0016567	protein ubiquitination [GO:0016567]
PGEN_.00g238520	Scaffold_11	41291661	41293300	NA	NA	NA	NA	NA
PGEN_.00g238530	Scaffold_11	41297717	41306748	Q9D864	ARP6_MOUSE	Actin-related protein 6 (mArp6)	GO:0000812; GO:0005634; GO:0005737; GO:0005856; GO:0031491; GO:0043486	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]
PGEN_.00g238540	Scaffold_11	41341774	41360553	NA	NA	NA	NA	NA
PGEN_.00g238550	Scaffold_11	41408579	41410589	NA	NA	NA	NA	NA
PGEN_.00g238560	Scaffold_11	41415667	41444993	NA	NA	NA	NA	NA
PGEN_.00g238570	Scaffold_11	41451634	41458554	NA	NA	NA	NA	NA
PGEN_.00g238580	Scaffold_11	41458665	41472373	NA	NA	NA	NA	NA
PGEN_.00g238590	Scaffold_11	41476602	41476874	NA	NA	NA	NA	NA
PGEN_.00g238600	Scaffold_11	41476978	41477806	NA	NA	NA	NA	NA
PGEN_.00g238610	Scaffold_11	41477846	41478283	NA	NA	NA	NA	NA
PGEN_.00g238620	Scaffold_11	41478349	41478687	NA	NA	NA	NA	NA
PGEN_.00g238630	Scaffold_11	41478840	41479313	NA	NA	NA	NA	NA
PGEN_.00g238640	Scaffold_11	41479690	41480079	NA	NA	NA	NA	NA
PGEN_.00g238650	Scaffold_11	41480108	41482342	NA	NA	NA	NA	NA
PGEN_.00g238660	Scaffold_11	41487515	41497821	NA	NA	NA	NA	NA
PGEN_.00g238670	Scaffold_11	41500947	41517226	NA	NA	NA	NA	NA
PGEN_.00g238680	Scaffold_11	41521681	41531151	NA	NA	NA	NA	NA
PGEN_.00g238690	Scaffold_11	41536202	41552764	Q3UTZ3	MA11_MOUSE	Microtubule-associated protein 11 (Uncharacterized protein C7orf43 homolog)	GO:0005737; GO:0005886; GO:0030496; GO:0034451; GO:0042127; GO:0043014; GO:0043231; GO:0072686	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; alpha-tubulin binding [GO:0043014]; regulation of cell population proliferation [GO:0042127]
PGEN_.00g238700	Scaffold_11	41587753	41592924	Q9NQX1	PRDM5_HUMAN	PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5)	GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0022008; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0051574; GO:0070491; GO:1990226; GO:1990830	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone H3-K9 methylation [GO:0051574]"
PGEN_.00g238710	Scaffold_11	41718180	41744431	Q9VIH7	SKY_DROME	GTPase-activating protein skywalker	GO:0003924; GO:0005096; GO:0005737; GO:0007268; GO:0007274; GO:0008289; GO:0010008; GO:0030054; GO:0030672; GO:0031175; GO:0031594; GO:0036466; GO:0043087; GO:0043195; GO:0046929; GO:0098794; GO:1903422	cell junction [GO:0030054]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; neuromuscular junction [GO:0031594]; postsynapse [GO:0098794]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; chemical synaptic transmission [GO:0007268]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; regulation of GTPase activity [GO:0043087]; synaptic vesicle recycling via endosome [GO:0036466]
PGEN_.00g238720	Scaffold_11	41761545	41763757	NA	NA	NA	NA	NA
PGEN_.00g238730	Scaffold_11	41790982	41796921	Q8HY12	CLC4M_HYLLA	C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (CD antigen CD299)	GO:0002250; GO:0005537; GO:0006897; GO:0016021; GO:0045087; GO:0046872	integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]
PGEN_.00g238740	Scaffold_11	41816238	41828440	NA	NA	NA	NA	NA
PGEN_.00g238750	Scaffold_11	41927657	41941968	P24733	MYS_ARGIR	"Myosin heavy chain, striated muscle"	GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0030016; GO:0032982; GO:0051015	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]
PGEN_.00g238760	Scaffold_11	41995113	42002884	NA	NA	NA	NA	NA
PGEN_.00g238770	Scaffold_11	42008313	42009206	NA	NA	NA	NA	NA
PGEN_.00g238780	Scaffold_11	42017208	42026382	Q8R0M8	MOT5_MOUSE	Monocarboxylate transporter 5 (MCT 5)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g238790	Scaffold_11	42034032	42047391	P70398	USP9X_MOUSE	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets homolog) (Fat facets protein-related, X-linked) (Ubiquitin carboxyl-terminal hydrolase FAM) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	GO:0001701; GO:0001764; GO:0004197; GO:0004843; GO:0005737; GO:0005829; GO:0007049; GO:0007059; GO:0007179; GO:0009791; GO:0016579; GO:0021698; GO:0021766; GO:0030426; GO:0030509; GO:0031625; GO:0036459; GO:0042752; GO:0045177; GO:0048511; GO:0048675; GO:0050821; GO:0050856; GO:0051301; GO:0070410; GO:0071560; GO:0071947; GO:0101005; GO:1901537; GO:1990138; GO:1990380	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar cortex structural organization [GO:0021698]; chromosome segregation [GO:0007059]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; positive regulation of DNA demethylation [GO:1901537]; post-embryonic development [GO:0009791]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of T cell receptor signaling pathway [GO:0050856]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g238800	Scaffold_11	42047641	42090041	Q93008	USP9X_HUMAN	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0036459; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g238810	Scaffold_11	42117742	42118296	NA	NA	NA	NA	NA
PGEN_.00g238820	Scaffold_11	42129924	42150491	NA	NA	NA	NA	NA
PGEN_.00g238830	Scaffold_11	42199437	42199751	NA	NA	NA	NA	NA
PGEN_.00g238840	Scaffold_11	42199815	42200168	NA	NA	NA	NA	NA
PGEN_.00g238850	Scaffold_11	42201070	42212970	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g238860	Scaffold_11	42224373	42224657	NA	NA	NA	NA	NA
PGEN_.00g238870	Scaffold_11	42228539	42236967	NA	NA	NA	NA	NA
PGEN_.00g238880	Scaffold_11	42245996	42274134	Q8BKC5	IPO5_MOUSE	Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5)	GO:0005634; GO:0005737; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0008536; GO:0042307; GO:0061608; GO:0071230	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; cellular response to amino acid stimulus [GO:0071230]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]
PGEN_.00g238890	Scaffold_11	42274492	42279362	NA	NA	NA	NA	NA
PGEN_.00g238900	Scaffold_11	42279637	42279918	NA	NA	NA	NA	NA
PGEN_.00g238910	Scaffold_11	42296707	42301503	NA	NA	NA	NA	NA
PGEN_.00g238920	Scaffold_11	42306820	42336253	P68182	KAPCB_RAT	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	GO:0000287; GO:0001843; GO:0004691; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007186; GO:0010737; GO:0031625; GO:0034237; GO:0045171; GO:0048471; GO:0051447; GO:0070613; GO:0097338; GO:0097546; GO:1901621	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin protein ligase binding [GO:0031625]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; response to clozapine [GO:0097338]
PGEN_.00g238930	Scaffold_11	42341843	42368834	P68182	KAPCB_RAT	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	GO:0000287; GO:0001843; GO:0004691; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007186; GO:0010737; GO:0031625; GO:0034237; GO:0045171; GO:0048471; GO:0051447; GO:0070613; GO:0097338; GO:0097546; GO:1901621	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin protein ligase binding [GO:0031625]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; response to clozapine [GO:0097338]
PGEN_.00g238940	Scaffold_11	42373669	42375542	NA	NA	NA	NA	NA
PGEN_.00g238950	Scaffold_11	42377140	42382226	NA	NA	NA	NA	NA
PGEN_.00g238960	Scaffold_11	42399027	42399308	NA	NA	NA	NA	NA
PGEN_.00g238970	Scaffold_11	42399583	42399825	NA	NA	NA	NA	NA
PGEN_.00g238980	Scaffold_11	42415094	42432397	Q8BKC5	IPO5_MOUSE	Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5)	GO:0005634; GO:0005737; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0008536; GO:0042307; GO:0061608; GO:0071230	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; Ran GTPase binding [GO:0008536]; cellular response to amino acid stimulus [GO:0071230]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]
PGEN_.00g238990	Scaffold_11	42441212	42449608	NA	NA	NA	NA	NA
PGEN_.00g239000	Scaffold_11	42453835	42454119	NA	NA	NA	NA	NA
PGEN_.00g239010	Scaffold_11	42465849	42477833	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g239020	Scaffold_11	42478735	42479088	NA	NA	NA	NA	NA
PGEN_.00g239030	Scaffold_11	42479152	42479466	NA	NA	NA	NA	NA
PGEN_.00g239040	Scaffold_11	42528440	42548818	NA	NA	NA	NA	NA
PGEN_.00g239050	Scaffold_11	42560719	42561273	NA	NA	NA	NA	NA
PGEN_.00g239060	Scaffold_11	42588974	42629843	Q93008	USP9X_HUMAN	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005737; GO:0005829; GO:0006625; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008234; GO:0016020; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0036459; GO:0042752; GO:0044267; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0070410; GO:0071947; GO:0101005; GO:1901537; GO:1990380	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g239070	Scaffold_11	42630093	42643292	P70398	USP9X_MOUSE	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets homolog) (Fat facets protein-related, X-linked) (Ubiquitin carboxyl-terminal hydrolase FAM) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	GO:0001701; GO:0001764; GO:0004197; GO:0004843; GO:0005737; GO:0005829; GO:0007049; GO:0007059; GO:0007179; GO:0009791; GO:0016579; GO:0021698; GO:0021766; GO:0030426; GO:0030509; GO:0031625; GO:0036459; GO:0042752; GO:0045177; GO:0048511; GO:0048675; GO:0050821; GO:0050856; GO:0051301; GO:0070410; GO:0071560; GO:0071947; GO:0101005; GO:1901537; GO:1990138; GO:1990380	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar cortex structural organization [GO:0021698]; chromosome segregation [GO:0007059]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; positive regulation of DNA demethylation [GO:1901537]; post-embryonic development [GO:0009791]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of T cell receptor signaling pathway [GO:0050856]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g239080	Scaffold_11	42651367	42660389	Q8R0M8	MOT5_MOUSE	Monocarboxylate transporter 5 (MCT 5)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g239090	Scaffold_11	42668826	42669197	NA	NA	NA	NA	NA
PGEN_.00g239100	Scaffold_11	42674530	42682286	NA	NA	NA	NA	NA
PGEN_.00g239110	Scaffold_11	42735454	42749039	P24733	MYS_ARGIR	"Myosin heavy chain, striated muscle"	GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0030016; GO:0032982; GO:0051015	myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]
PGEN_.00g239120	Scaffold_11	42849098	42861521	Q9P2N4	ATS9_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-)	GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0006516; GO:0007275; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192]
PGEN_.00g239130	Scaffold_11	42880816	42887755	Q8HY12	CLC4M_HYLLA	C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (CD antigen CD299)	GO:0002250; GO:0005537; GO:0006897; GO:0016021; GO:0045087; GO:0046872	integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]
PGEN_.00g239140	Scaffold_11	42914743	42916026	NA	NA	NA	NA	NA
PGEN_.00g239150	Scaffold_11	42916209	42916955	NA	NA	NA	NA	NA
PGEN_.00g239160	Scaffold_11	42933378	42959986	Q9VIH7	SKY_DROME	GTPase-activating protein skywalker	GO:0003924; GO:0005096; GO:0005737; GO:0007268; GO:0007274; GO:0008289; GO:0010008; GO:0030054; GO:0030672; GO:0031175; GO:0031594; GO:0036466; GO:0043087; GO:0043195; GO:0046929; GO:0098794; GO:1903422	cell junction [GO:0030054]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; neuromuscular junction [GO:0031594]; postsynapse [GO:0098794]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; chemical synaptic transmission [GO:0007268]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of synaptic vesicle recycling [GO:1903422]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; regulation of GTPase activity [GO:0043087]; synaptic vesicle recycling via endosome [GO:0036466]
PGEN_.00g239170	Scaffold_11	43085515	43090695	Q9NQX1	PRDM5_HUMAN	PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5)	GO:0000122; GO:0000278; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0008168; GO:0016575; GO:0016604; GO:0022008; GO:0031490; GO:0043565; GO:0044212; GO:0045892; GO:0046872; GO:0051567; GO:0051574; GO:0070491; GO:1990226; GO:1990830	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cellular response to leukemia inhibitory factor [GO:1990830]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of histone H3-K9 methylation [GO:0051574]"
PGEN_.00g239180	Scaffold_11	43125803	43143604	Q3UTZ3	MA11_MOUSE	Microtubule-associated protein 11 (Uncharacterized protein C7orf43 homolog)	GO:0005737; GO:0005886; GO:0030496; GO:0034451; GO:0042127; GO:0043014; GO:0043231; GO:0072686	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; alpha-tubulin binding [GO:0043014]; regulation of cell population proliferation [GO:0042127]
PGEN_.00g239190	Scaffold_11	43148761	43158557	NA	NA	NA	NA	NA
PGEN_.00g239200	Scaffold_11	43151332	43179640	NA	NA	NA	NA	NA
PGEN_.00g239210	Scaffold_11	43182835	43189003	NA	NA	NA	NA	NA
PGEN_.00g239220	Scaffold_11	43197925	43200063	G4SLH0	TTN1_CAEEL	Titin homolog (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0017022; GO:0031672; GO:0031674; GO:0031965; GO:0046872; GO:0051015	A band [GO:0031672]; I band [GO:0031674]; nuclear membrane [GO:0031965]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g239230	Scaffold_11	43200092	43200391	NA	NA	NA	NA	NA
PGEN_.00g239240	Scaffold_11	43200858	43201331	NA	NA	NA	NA	NA
PGEN_.00g239250	Scaffold_11	43201484	43201822	NA	NA	NA	NA	NA
PGEN_.00g239260	Scaffold_11	43201888	43202325	NA	NA	NA	NA	NA
PGEN_.00g239270	Scaffold_11	43202365	43203193	NA	NA	NA	NA	NA
PGEN_.00g239280	Scaffold_11	43203321	43207447	NA	NA	NA	NA	NA
PGEN_.00g239290	Scaffold_11	43207787	43221446	NA	NA	NA	NA	NA
PGEN_.00g239300	Scaffold_11	43221557	43228494	NA	NA	NA	NA	NA
PGEN_.00g239310	Scaffold_11	43235099	43251734	NA	NA	NA	NA	NA
PGEN_.00g239320	Scaffold_11	43256569	43264445	NA	NA	NA	NA	NA
PGEN_.00g239330	Scaffold_11	43269522	43270250	NA	NA	NA	NA	NA
PGEN_.00g239340	Scaffold_11	43270323	43271012	NA	NA	NA	NA	NA
PGEN_.00g239350	Scaffold_11	43271066	43275641	NA	NA	NA	NA	NA
PGEN_.00g239360	Scaffold_11	43334405	43334701	NA	NA	NA	NA	NA
PGEN_.00g239370	Scaffold_11	43337724	43338386	NA	NA	NA	NA	NA
PGEN_.00g239380	Scaffold_11	43373952	43384272	NA	NA	NA	NA	NA
PGEN_.00g239390	Scaffold_11	43418215	43429031	NA	NA	NA	NA	NA
PGEN_.00g239400	Scaffold_11	43516916	43517602	NA	NA	NA	NA	NA
PGEN_.00g239410	Scaffold_11	43557717	43582614	P63047	ST4A1_RAT	Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (rBR-STL) (Nervous system sulfotransferase) (NST)	GO:0005737; GO:0006790; GO:0008146; GO:0008202; GO:0042802	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g239420	Scaffold_11	43589493	43589956	NA	NA	NA	NA	NA
PGEN_.00g239430	Scaffold_11	43596158	43612616	O00338	ST1C2_HUMAN	Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.-) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)	GO:0005737; GO:0005829; GO:0008146; GO:0009308; GO:0050427; GO:0051923	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]
PGEN_.00g239440	Scaffold_11	43625050	43637067	Q6R7M4	C15A1_DIPPU	Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1)	GO:0005506; GO:0006718; GO:0016709; GO:0020037	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]"
PGEN_.00g239450	Scaffold_11	43637157	43637561	Q92116	CP1A1_STECH	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g239460	Scaffold_11	43637692	43637961	Q64678	CP1B1_RAT	Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) (Cytochrome P450RAP) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0001525; GO:0002930; GO:0004497; GO:0005506; GO:0005634; GO:0005739; GO:0005789; GO:0006304; GO:0006725; GO:0006805; GO:0006809; GO:0007155; GO:0007584; GO:0008202; GO:0008210; GO:0008285; GO:0008584; GO:0008631; GO:0009404; GO:0009636; GO:0010033; GO:0010575; GO:0014070; GO:0014911; GO:0016491; GO:0016712; GO:0016829; GO:0019369; GO:0020037; GO:0030199; GO:0030325; GO:0030336; GO:0032088; GO:0032354; GO:0032355; GO:0033629; GO:0042537; GO:0042572; GO:0042574; GO:0043065; GO:0043231; GO:0043542; GO:0044849; GO:0045727; GO:0045766; GO:0046427; GO:0046466; GO:0046685; GO:0048514; GO:0048545; GO:0061298; GO:0061304; GO:0061548; GO:0070301; GO:0070330; GO:0071320; GO:0071356; GO:0071373; GO:0071387; GO:0071393; GO:0071407; GO:0071548; GO:0071603; GO:0071680; GO:0101020; GO:2000377; GO:2000379; GO:2000573	"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; adrenal gland development [GO:0030325]; angiogenesis [GO:0001525]; arachidonic acid metabolic process [GO:0019369]; benzene-containing compound metabolic process [GO:0042537]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular aromatic compound metabolic process [GO:0006725]; cellular response to cAMP [GO:0071320]; cellular response to cortisol stimulus [GO:0071387]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to organic cyclic compound [GO:0071407]; cellular response to progesterone stimulus [GO:0071393]; cellular response to tumor necrosis factor [GO:0071356]; collagen fibril organization [GO:0030199]; DNA modification [GO:0006304]; endothelial cell migration [GO:0043542]; endothelial cell-cell adhesion [GO:0071603]; estrogen metabolic process [GO:0008210]; estrous cycle [GO:0044849]; ganglion development [GO:0061548]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; male gonad development [GO:0008584]; membrane lipid catabolic process [GO:0046466]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of translation [GO:0045727]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to arsenic-containing substance [GO:0046685]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to indole-3-methanol [GO:0071680]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; retina vasculature development in camera-type eye [GO:0061298]; retinal blood vessel morphogenesis [GO:0061304]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]; trabecular meshwork development [GO:0002930]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g239470	Scaffold_11	43645371	43650681	NA	NA	NA	NA	NA
PGEN_.00g239480	Scaffold_11	43652472	43656723	NA	NA	NA	NA	NA
PGEN_.00g239490	Scaffold_11	43756428	43781579	O75096	LRP4_HUMAN	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]
PGEN_.00g239500	Scaffold_11	43847086	43866415	O88572	LRP6_MOUSE	Low-density lipoprotein receptor-related protein 6 (LRP-6)	GO:0001702; GO:0001756; GO:0001843; GO:0001933; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005623; GO:0005769; GO:0005783; GO:0005886; GO:0005901; GO:0006355; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0016020; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051091; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0061310; GO:0061324; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:2000051; GO:2000149; GO:2000151; GO:2000162; GO:2000164; GO:2000166; GO:2000168	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g239510	Scaffold_11	43868094	43868315	NA	NA	NA	NA	NA
PGEN_.00g239520	Scaffold_11	43870828	43871118	NA	NA	NA	NA	NA
PGEN_.00g239530	Scaffold_11	43874565	43879933	Q1RMT8	IRAK4_BOVIN	Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1)	GO:0000287; GO:0001816; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005634; GO:0005737; GO:0019221; GO:0035556; GO:0043123; GO:0045087; GO:1990266	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]
PGEN_.00g239540	Scaffold_11	43887214	43888707	Q00557	CP1A1_MESAU	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P-450MC) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0016829; GO:0020037; GO:0030544; GO:0042572; GO:0051879; GO:0070330; GO:0101020; GO:0101021	endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]
PGEN_.00g239550	Scaffold_11	43899352	43899774	NA	NA	NA	NA	NA
PGEN_.00g239560	Scaffold_11	43903912	43905405	P56590	CP1A1_CANLF	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (DAH1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0016829; GO:0020037; GO:0030544; GO:0042572; GO:0043231; GO:0051879; GO:0070330; GO:0101020; GO:0101021	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]
PGEN_.00g239570	Scaffold_11	43912575	43917049	Q76LW2	H6ST2_CHICK	Heparan-sulfate 6-O-sulfotransferase 2 (HS6ST-2) (cHS6ST-2) (EC 2.8.2.-)	GO:0015015; GO:0016021; GO:0017095; GO:0060173	"integral component of membrane [GO:0016021]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; limb development [GO:0060173]"
PGEN_.00g239580	Scaffold_11	43930136	43949180	Q9CQ24	FBX36_MOUSE	F-box only protein 36		
PGEN_.00g239590	Scaffold_11	43958664	43959254	NA	NA	NA	NA	NA
PGEN_.00g239600	Scaffold_11	43968929	44004023	Q14669	TRIPC_HUMAN	E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (E3 ubiquitin-protein ligase for Arf) (ULF) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12)	GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006511; GO:0006974; GO:0016607; GO:0045995; GO:0046966; GO:1901315; GO:2000780	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; thyroid hormone receptor binding [GO:0046966]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g239610	Scaffold_11	44008586	44015368	Q99J62	RFC4_MOUSE	Replication factor C subunit 4 (Activator 1 subunit 4)	GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0017116; GO:0019899; GO:0031390; GO:0031391; GO:1900264	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]
PGEN_.00g239620	Scaffold_11	44021248	44029947	NA	NA	NA	NA	NA
PGEN_.00g239630	Scaffold_11	44055334	44070145	NA	NA	NA	NA	NA
PGEN_.00g239640	Scaffold_11	44077855	44091720	NA	NA	NA	NA	NA
PGEN_.00g239650	Scaffold_11	44093158	44129401	NA	NA	NA	NA	NA
PGEN_.00g239660	Scaffold_11	44154949	44164022	NA	NA	NA	NA	NA
PGEN_.00g239670	Scaffold_11	44169754	44176536	Q99J62	RFC4_MOUSE	Replication factor C subunit 4 (Activator 1 subunit 4)	GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0017116; GO:0019899; GO:0031390; GO:0031391; GO:1900264	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]
PGEN_.00g239680	Scaffold_11	44181066	44215983	Q14669	TRIPC_HUMAN	E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (E3 ubiquitin-protein ligase for Arf) (ULF) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12)	GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006511; GO:0006974; GO:0016607; GO:0045995; GO:0046966; GO:1901315; GO:2000780	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; thyroid hormone receptor binding [GO:0046966]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g239690	Scaffold_11	44224853	44225443	NA	NA	NA	NA	NA
PGEN_.00g239700	Scaffold_11	44234772	44253716	Q9CQ24	FBX36_MOUSE	F-box only protein 36		
PGEN_.00g239710	Scaffold_11	44266805	44271279	Q76LW2	H6ST2_CHICK	Heparan-sulfate 6-O-sulfotransferase 2 (HS6ST-2) (cHS6ST-2) (EC 2.8.2.-)	GO:0015015; GO:0016021; GO:0017095; GO:0060173	"integral component of membrane [GO:0016021]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; limb development [GO:0060173]"
PGEN_.00g239720	Scaffold_11	44278449	44279942	P56590	CP1A1_CANLF	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (DAH1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0016829; GO:0020037; GO:0030544; GO:0042572; GO:0043231; GO:0051879; GO:0070330; GO:0101020; GO:0101021	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]
PGEN_.00g239730	Scaffold_11	44283648	44284260	P00184	CP1A1_MOUSE	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0001666; GO:0002933; GO:0003824; GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0006778; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0008395; GO:0009308; GO:0009404; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009636; GO:0009804; GO:0009812; GO:0010041; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0016829; GO:0017143; GO:0017144; GO:0019341; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0033189; GO:0035902; GO:0042493; GO:0042572; GO:0042904; GO:0043010; GO:0043231; GO:0046483; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0055114; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0101020; GO:0101021; GO:1900087	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; maternal process involved in parturition [GO:0060137]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]"
PGEN_.00g239740	Scaffold_11	44292883	44294376	Q5KQT7	CP1A1_FELCA	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0016829; GO:0020037; GO:0030544; GO:0042572; GO:0043231; GO:0051879; GO:0070330; GO:0101020; GO:0101021	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]
PGEN_.00g239750	Scaffold_11	44301646	44306988	Q1RMT8	IRAK4_BOVIN	Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1)	GO:0000287; GO:0001816; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005634; GO:0005737; GO:0019221; GO:0035556; GO:0043123; GO:0045087; GO:1990266	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]
PGEN_.00g239760	Scaffold_11	44315287	44334292	O88572	LRP6_MOUSE	Low-density lipoprotein receptor-related protein 6 (LRP-6)	GO:0001702; GO:0001756; GO:0001843; GO:0001933; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005623; GO:0005769; GO:0005783; GO:0005886; GO:0005901; GO:0006355; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0016020; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051091; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0061310; GO:0061324; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:2000051; GO:2000149; GO:2000151; GO:2000162; GO:2000164; GO:2000166; GO:2000168	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g239770	Scaffold_11	44399742	44424873	O75096	LRP4_HUMAN	Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]
PGEN_.00g239780	Scaffold_11	44523961	44528075	NA	NA	NA	NA	NA
PGEN_.00g239790	Scaffold_11	44529654	44534786	NA	NA	NA	NA	NA
PGEN_.00g239800	Scaffold_11	44542196	44542465	Q64678	CP1B1_RAT	Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) (Cytochrome P450RAP) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0001525; GO:0002930; GO:0004497; GO:0005506; GO:0005634; GO:0005739; GO:0005789; GO:0006304; GO:0006725; GO:0006805; GO:0006809; GO:0007155; GO:0007584; GO:0008202; GO:0008210; GO:0008285; GO:0008584; GO:0008631; GO:0009404; GO:0009636; GO:0010033; GO:0010575; GO:0014070; GO:0014911; GO:0016491; GO:0016712; GO:0016829; GO:0019369; GO:0020037; GO:0030199; GO:0030325; GO:0030336; GO:0032088; GO:0032354; GO:0032355; GO:0033629; GO:0042537; GO:0042572; GO:0042574; GO:0043065; GO:0043231; GO:0043542; GO:0044849; GO:0045727; GO:0045766; GO:0046427; GO:0046466; GO:0046685; GO:0048514; GO:0048545; GO:0061298; GO:0061304; GO:0061548; GO:0070301; GO:0070330; GO:0071320; GO:0071356; GO:0071373; GO:0071387; GO:0071393; GO:0071407; GO:0071548; GO:0071603; GO:0071680; GO:0101020; GO:2000377; GO:2000379; GO:2000573	"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; adrenal gland development [GO:0030325]; angiogenesis [GO:0001525]; arachidonic acid metabolic process [GO:0019369]; benzene-containing compound metabolic process [GO:0042537]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular aromatic compound metabolic process [GO:0006725]; cellular response to cAMP [GO:0071320]; cellular response to cortisol stimulus [GO:0071387]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to organic cyclic compound [GO:0071407]; cellular response to progesterone stimulus [GO:0071393]; cellular response to tumor necrosis factor [GO:0071356]; collagen fibril organization [GO:0030199]; DNA modification [GO:0006304]; endothelial cell migration [GO:0043542]; endothelial cell-cell adhesion [GO:0071603]; estrogen metabolic process [GO:0008210]; estrous cycle [GO:0044849]; ganglion development [GO:0061548]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; male gonad development [GO:0008584]; membrane lipid catabolic process [GO:0046466]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of translation [GO:0045727]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to arsenic-containing substance [GO:0046685]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to indole-3-methanol [GO:0071680]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; retina vasculature development in camera-type eye [GO:0061298]; retinal blood vessel morphogenesis [GO:0061304]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]; trabecular meshwork development [GO:0002930]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g239810	Scaffold_11	44542596	44543000	Q92116	CP1A1_STECH	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g239820	Scaffold_11	44543090	44555049	Q6R7M4	C15A1_DIPPU	Methyl farnesoate epoxidase (EC 1.14.14.127) (Cytochrome P450 CYP15A1)	GO:0005506; GO:0006718; GO:0016709; GO:0020037	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; juvenile hormone biosynthetic process [GO:0006718]"
PGEN_.00g239830	Scaffold_11	44558830	44559162	NA	NA	NA	NA	NA
PGEN_.00g239840	Scaffold_11	44562821	44565103	NA	NA	NA	NA	NA
PGEN_.00g239850	Scaffold_11	44570964	44583358	Q9BR01	ST4A1_HUMAN	Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (hBR-STL) (hBR-STL-1) (Nervous system sulfotransferase) (NST)	GO:0005829; GO:0008146; GO:0008202; GO:0042802; GO:0050427	cytosol [GO:0005829]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; steroid metabolic process [GO:0008202]
PGEN_.00g239860	Scaffold_11	44589578	44590041	NA	NA	NA	NA	NA
PGEN_.00g239870	Scaffold_11	44596826	44621662	P63047	ST4A1_RAT	Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (rBR-STL) (Nervous system sulfotransferase) (NST)	GO:0005737; GO:0006790; GO:0008146; GO:0008202; GO:0042802	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g239880	Scaffold_11	44663349	44663954	NA	NA	NA	NA	NA
PGEN_.00g239890	Scaffold_11	44746712	44759867	NA	NA	NA	NA	NA
PGEN_.00g239900	Scaffold_11	44789179	44789508	NA	NA	NA	NA	NA
PGEN_.00g239910	Scaffold_11	44793677	44804005	NA	NA	NA	NA	NA
PGEN_.00g239920	Scaffold_11	44811282	44811740	NA	NA	NA	NA	NA
PGEN_.00g239930	Scaffold_11	44811876	44812388	NA	NA	NA	NA	NA
PGEN_.00g239940	Scaffold_11	44823903	44878623	O16025	AOSL_PLEHO	Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (EC 4.2.1.92) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]	GO:0004096; GO:0005506; GO:0005737; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0047677; GO:0047987	cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408]
PGEN_.00g239950	Scaffold_11	45004142	45004525	NA	NA	NA	NA	NA
PGEN_.00g239960	Scaffold_11	45005184	45005537	NA	NA	NA	NA	NA
PGEN_.00g239970	Scaffold_11	45090668	45092035	NA	NA	NA	NA	NA
PGEN_.00g239980	Scaffold_11	45104578	45107752	Q9VEX9	SAP18_DROME	Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (Bicoid-interacting protein 1) (dSAP18)	GO:0000398; GO:0003714; GO:0005737; GO:0006342; GO:0007275; GO:0008134; GO:0016580; GO:0045892; GO:0071011; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; precatalytic spliceosome [GO:0071011]; Sin3 complex [GO:0016580]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; chromatin silencing [GO:0006342]; mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g239990	Scaffold_11	45111847	45119907	NA	NA	NA	NA	NA
PGEN_.00g240000	Scaffold_11	45127464	45129285	NA	NA	NA	NA	NA
PGEN_.00g240010	Scaffold_11	45152791	45162406	NA	NA	NA	NA	NA
PGEN_.00g240020	Scaffold_11	45171379	45177195	NA	NA	NA	NA	NA
PGEN_.00g240030	Scaffold_11	45193681	45193959	NA	NA	NA	NA	NA
PGEN_.00g240040	Scaffold_11	45194223	45208220	NA	NA	NA	NA	NA
PGEN_.00g240050	Scaffold_11	45219234	45220706	NA	NA	NA	NA	NA
PGEN_.00g240060	Scaffold_11	45220758	45227895	NA	NA	NA	NA	NA
PGEN_.00g240070	Scaffold_11	45233098	45240728	NA	NA	NA	NA	NA
PGEN_.00g240080	Scaffold_11	45244074	45253417	P13667	PDIA4_HUMAN	Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72)	GO:0003723; GO:0003756; GO:0005615; GO:0005623; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015037; GO:0034976; GO:0042470; GO:0045454; GO:0061077	cell [GO:0005623]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g240090	Scaffold_11	45262693	45263858	NA	NA	NA	NA	NA
PGEN_.00g240100	Scaffold_11	45264221	45272682	NA	NA	NA	NA	NA
PGEN_.00g240110	Scaffold_11	45285917	45308352	O54826	AF10_MOUSE	Protein AF-10	GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0031491; GO:0032991; GO:0042393; GO:0045944; GO:0046872	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g240120	Scaffold_11	45308465	45308773	NA	NA	NA	NA	NA
PGEN_.00g240130	Scaffold_11	45316287	45331566	Q9Z1W9	STK39_MOUSE	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (Serine/threonine-protein kinase 39)	GO:0000187; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0008217; GO:0010820; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0019898; GO:0019901; GO:0023014; GO:0023016; GO:0032147; GO:0032414; GO:0035556; GO:0036438; GO:0038146; GO:0043231; GO:0043268; GO:0046777; GO:0050727; GO:0050801; GO:0071476; GO:0090188; GO:1901017; GO:1901380; GO:1905408; GO:1990869; GO:2000650	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]
PGEN_.00g240140	Scaffold_11	45371858	45372664	NA	NA	NA	NA	NA
PGEN_.00g240150	Scaffold_11	45373506	45373823	NA	NA	NA	NA	NA
PGEN_.00g240160	Scaffold_11	45393334	45399999	NA	NA	NA	NA	NA
PGEN_.00g240170	Scaffold_11	45402231	45419797	Q99M80	PTPRT_MOUSE	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0050807; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:0098978; GO:0099061; GO:1904893; GO:1990264	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g240180	Scaffold_11	45427832	45462358	Q64487	PTPRD_MOUSE	Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)	GO:0004725; GO:0005102; GO:0006470; GO:0007157; GO:0030182; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099056; GO:0099151; GO:0099560	glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]
PGEN_.00g240190	Scaffold_11	45467515	45470807	NA	NA	NA	NA	NA
PGEN_.00g240200	Scaffold_11	45472422	45472718	NA	NA	NA	NA	NA
PGEN_.00g240210	Scaffold_11	45475798	45490619	NA	NA	NA	NA	NA
PGEN_.00g240220	Scaffold_11	45513020	45517468	NA	NA	NA	NA	NA
PGEN_.00g240230	Scaffold_11	45553545	45562853	NA	NA	NA	NA	NA
PGEN_.00g240240	Scaffold_11	45575701	45625377	P50592	TNF10_MOUSE	Tumor necrosis factor ligand superfamily member 10 (TNF-related apoptosis-inducing ligand) (Protein TRAIL) (CD antigen CD253)	GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0006915; GO:0006955; GO:0008270; GO:0008584; GO:0016021; GO:0032813; GO:0032868; GO:0042802; GO:0043065; GO:0043123; GO:0043280; GO:0045569; GO:0090200; GO:2001238	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; TRAIL binding [GO:0045569]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; immune response [GO:0006955]; male gonad development [GO:0008584]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; response to insulin [GO:0032868]
PGEN_.00g240250	Scaffold_11	45677023	45691915	P04052	RPB1_DROME	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0046872	"nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g240260	Scaffold_11	45711006	45717612	Q2T9Z7	KLHL9_BOVIN	Kelch-like protein 9	GO:0007049; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0051301	Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]
PGEN_.00g240270	Scaffold_11	45726432	45736314	P07291	MLE_ARGIR	"Myosin essential light chain, striated adductor muscle (E-LC) (Sulfhydryl light chain) (SHLC)"	GO:0005509; GO:0016459	myosin complex [GO:0016459]; calcium ion binding [GO:0005509]
PGEN_.00g240280	Scaffold_11	45751610	45757690	Q2KMM2	TPPC1_RAT	Trafficking protein particle complex subunit 1	GO:0005783; GO:0005794; GO:0006888; GO:0017112; GO:0030008	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]
PGEN_.00g240290	Scaffold_11	45765029	45772565	P62322	LSM5_MOUSE	U6 snRNA-associated Sm-like protein LSm5	GO:0000398; GO:0003723; GO:0005634; GO:0005688; GO:0005737; GO:0006402; GO:0009617; GO:0046540; GO:0046982; GO:0071005; GO:0120115; GO:1990726	"cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; response to bacterium [GO:0009617]"
PGEN_.00g240300	Scaffold_11	45833594	45871836	Q9Y2G3	AT11B_HUMAN	Probable phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)	GO:0000287; GO:0005524; GO:0005637; GO:0005769; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0034220; GO:0035577; GO:0043312; GO:0045332; GO:0055037; GO:0055038; GO:0140326	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]
PGEN_.00g240310	Scaffold_11	45876458	45913221	NA	NA	NA	NA	NA
PGEN_.00g240320	Scaffold_11	45929291	45930865	NA	NA	NA	NA	NA
PGEN_.00g240330	Scaffold_11	45958864	45983896	NA	NA	NA	NA	NA
PGEN_.00g240340	Scaffold_11	46016167	46035226	P43006	EAA2_MOUSE	Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2)	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0007399; GO:0007632; GO:0008509; GO:0009416; GO:0009611; GO:0009986; GO:0010259; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0042493; GO:0042734; GO:0043005; GO:0043197; GO:0043198; GO:0043200; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070779; GO:0098656; GO:0098712; GO:0098810; GO:0098978; GO:0099056	axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]
PGEN_.00g240350	Scaffold_11	46053702	46074088	P18761	CAH6_MOUSE	Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase)	GO:0001580; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0006730; GO:0008270	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; one-carbon metabolic process [GO:0006730]
PGEN_.00g240360	Scaffold_11	46074679	46087095	NA	NA	NA	NA	NA
PGEN_.00g240370	Scaffold_11	46091987	46095713	NA	NA	NA	NA	NA
PGEN_.00g240380	Scaffold_11	46096080	46096724	NA	NA	NA	NA	NA
PGEN_.00g240390	Scaffold_11	46103341	46104584	NA	NA	NA	NA	NA
PGEN_.00g240400	Scaffold_11	46117019	46123639	NA	NA	NA	NA	NA
PGEN_.00g240410	Scaffold_11	46126183	46153831	Q9CS00	CATIN_MOUSE	Cactin	GO:0001933; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0007275; GO:0008380; GO:0016607; GO:0031665; GO:0032088; GO:0032688; GO:0032717; GO:0032720; GO:0034122; GO:0045087; GO:0060339; GO:0071013; GO:0071222; GO:0071347; GO:0071356	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; RNA splicing [GO:0008380]
PGEN_.00g240420	Scaffold_11	46165589	46168382	NA	NA	NA	NA	NA
PGEN_.00g240430	Scaffold_11	46176013	46223711	P0C6F1	DYH2_MOUSE	"Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2)"	GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036156; GO:0045505; GO:0051959	"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g240440	Scaffold_11	46224292	46279004	P0C6F1	DYH2_MOUSE	"Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2)"	GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036156; GO:0045505; GO:0051959	"axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g240450	Scaffold_11	46280009	46281119	NA	NA	NA	NA	NA
PGEN_.00g240460	Scaffold_11	46291754	46301249	B1H2T2	DIK2A_XENTR	Divergent protein kinase domain 2A (Deleted in autism protein 1 homolog)	GO:0005615; GO:0014066; GO:0030126; GO:0060038	COPI vesicle coat [GO:0030126]; extracellular space [GO:0005615]; cardiac muscle cell proliferation [GO:0060038]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]
PGEN_.00g240470	Scaffold_11	46326503	46391025	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g240480	Scaffold_11	46393500	46394993	NA	NA	NA	NA	NA
PGEN_.00g240490	Scaffold_11	46395580	46401196	NA	NA	NA	NA	NA
PGEN_.00g240500	Scaffold_11	46415567	46441498	Q99J21	MCLN1_MOUSE	Mucolipin-1 (Mucolipidin) (Transient receptor potential-mucolipin 1) (TRPML1)	GO:0001891; GO:0002250; GO:0005261; GO:0005623; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005886; GO:0008289; GO:0016020; GO:0016021; GO:0016197; GO:0030670; GO:0031902; GO:0042995; GO:0043231; GO:0043235; GO:0051209; GO:0051289; GO:0070588; GO:0071277; GO:0071467; GO:0072345; GO:0097352; GO:0097682; GO:0097708; GO:0098655; GO:0099604	"cell [GO:0005623]; cell projection [GO:0042995]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cation channel activity [GO:0005261]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated calcium channel activity [GO:0099604]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; autophagosome maturation [GO:0097352]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cellular response to calcium ion [GO:0071277]; cellular response to pH [GO:0071467]; endosomal transport [GO:0016197]; protein homotetramerization [GO:0051289]; release of sequestered calcium ion into cytosol [GO:0051209]"
PGEN_.00g240510	Scaffold_11	46455129	46473489	Q99J21	MCLN1_MOUSE	Mucolipin-1 (Mucolipidin) (Transient receptor potential-mucolipin 1) (TRPML1)	GO:0001891; GO:0002250; GO:0005261; GO:0005623; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005886; GO:0008289; GO:0016020; GO:0016021; GO:0016197; GO:0030670; GO:0031902; GO:0042995; GO:0043231; GO:0043235; GO:0051209; GO:0051289; GO:0070588; GO:0071277; GO:0071467; GO:0072345; GO:0097352; GO:0097682; GO:0097708; GO:0098655; GO:0099604	"cell [GO:0005623]; cell projection [GO:0042995]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cation channel activity [GO:0005261]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated calcium channel activity [GO:0099604]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; autophagosome maturation [GO:0097352]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cellular response to calcium ion [GO:0071277]; cellular response to pH [GO:0071467]; endosomal transport [GO:0016197]; protein homotetramerization [GO:0051289]; release of sequestered calcium ion into cytosol [GO:0051209]"
PGEN_.00g240520	Scaffold_11	46498780	46511423	NA	NA	NA	NA	NA
PGEN_.00g240530	Scaffold_11	46511481	46516467	NA	NA	NA	NA	NA
PGEN_.00g240540	Scaffold_11	46528628	46548632	Q6PBU5	GRT1A_DANRE	Growth hormone-regulated TBC protein 1-A	GO:0005096; GO:0006886; GO:0017137; GO:0090630	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]
PGEN_.00g240550	Scaffold_11	46563061	46573211	NA	NA	NA	NA	NA
PGEN_.00g240560	Scaffold_11	46585303	46587258	Q24523	BUN2_DROME	"Protein bunched, class 2/F/G isoform (Protein shortsighted)"	GO:0001751; GO:0002052; GO:0003700; GO:0005634; GO:0005829; GO:0007297; GO:0007304; GO:0008284; GO:0008340; GO:0009996; GO:0016319; GO:0030307; GO:0030707; GO:0036335; GO:0042246; GO:0042803; GO:0043066; GO:0046843	cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; chorion-containing eggshell formation [GO:0007304]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; intestinal stem cell homeostasis [GO:0036335]; mushroom body development [GO:0016319]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell fate specification [GO:0009996]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuroblast proliferation [GO:0002052]; tissue regeneration [GO:0042246]
PGEN_.00g240570	Scaffold_11	46612583	46612825	NA	NA	NA	NA	NA
PGEN_.00g240580	Scaffold_11	46630887	46631171	NA	NA	NA	NA	NA
PGEN_.00g240590	Scaffold_11	46636608	46638281	NA	NA	NA	NA	NA
PGEN_.00g240600	Scaffold_11	46660028	46705434	Q3MHL6	T22D1_BOVIN	TSC22 domain family protein 1	GO:0003700; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]
PGEN_.00g240610	Scaffold_11	46716213	46726559	Q9H095	DRC9_HUMAN	Dynein regulatory complex protein 9 (IQ domain-containing protein G)	GO:0002177; GO:0005516; GO:0005737; GO:0007286; GO:0007288; GO:0030544; GO:0031514; GO:0036126; GO:0044782; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]
PGEN_.00g240620	Scaffold_11	46729009	46734021	P04646	RL35A_RAT	60S ribosomal protein L35a	GO:0000049; GO:0002181; GO:0003735; GO:0022625; GO:0042273	cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]
PGEN_.00g240630	Scaffold_11	46743567	46743872	NA	NA	NA	NA	NA
PGEN_.00g240640	Scaffold_11	46746000	46751857	Q5SGD2	PPM1L_HUMAN	Protein phosphatase 1L (EC 3.1.3.16) (Protein phosphatase 1-like) (Protein phosphatase 2C isoform epsilon) (PP2C-epsilon)	GO:0000165; GO:0004722; GO:0004724; GO:0005789; GO:0007178; GO:0016021; GO:0030148; GO:0046872; GO:0070062	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; MAPK cascade [GO:0000165]; sphingolipid biosynthetic process [GO:0030148]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]
PGEN_.00g240650	Scaffold_11	46767880	46783990	Q6NX31	MCM7_XENTR	DNA replication licensing factor mcm7 (EC 3.6.4.12) (CDC47 homolog) (Minichromosome maintenance protein 7)	GO:0000727; GO:0000785; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006267; GO:0006268; GO:0006270; GO:0006271; GO:0030174; GO:0042555; GO:0046872	chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA-dependent DNA replication initiation [GO:0030174]
PGEN_.00g240660	Scaffold_11	46787660	46800829	A2ARI4	LGR4_MOUSE	Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48)	GO:0001649; GO:0001942; GO:0004888; GO:0005887; GO:0007186; GO:0007283; GO:0007411; GO:0007623; GO:0008201; GO:0016500; GO:0030282; GO:0030539; GO:0032922; GO:0034122; GO:0035239; GO:0036335; GO:0045087; GO:0045892; GO:0045893; GO:0046849; GO:0048495; GO:0048565; GO:0050673; GO:0050710; GO:0050919; GO:0061290; GO:0072202; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013	"integral component of plasma membrane [GO:0005887]; heparin binding [GO:0008201]; protein-hormone receptor activity [GO:0016500]; Roundabout binding [GO:0048495]; transmembrane signaling receptor activity [GO:0004888]; axon guidance [GO:0007411]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; digestive tract development [GO:0048565]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative chemotaxis [GO:0050919]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]; tube morphogenesis [GO:0035239]"
PGEN_.00g240670	Scaffold_11	46800888	46808375	Q9WYP5	IOLG_THEMA	Myo-inositol 2-dehydrogenase (EC 1.1.1.18)	GO:0006020; GO:0006740; GO:0016491; GO:0050112	inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]; inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740]
PGEN_.00g240680	Scaffold_11	46817908	46826397	NA	NA	NA	NA	NA
PGEN_.00g240690	Scaffold_11	46829729	46832325	NA	NA	NA	NA	NA
PGEN_.00g240700	Scaffold_11	46839325	46846952	NA	NA	NA	NA	NA
PGEN_.00g240710	Scaffold_11	46857318	46861887	NA	NA	NA	NA	NA
PGEN_.00g240720	Scaffold_11	46885197	46891460	NA	NA	NA	NA	NA
PGEN_.00g240730	Scaffold_11	46895346	46897975	NA	NA	NA	NA	NA
PGEN_.00g240740	Scaffold_11	46907977	46927506	NA	NA	NA	NA	NA
PGEN_.00g240750	Scaffold_11	46928576	46932553	NA	NA	NA	NA	NA
PGEN_.00g240760	Scaffold_11	46933826	46937093	NA	NA	NA	NA	NA
PGEN_.00g240770	Scaffold_11	46937847	46941922	NA	NA	NA	NA	NA
PGEN_.00g240780	Scaffold_11	46949927	46953463	NA	NA	NA	NA	NA
PGEN_.00g240790	Scaffold_11	46960627	46962369	Q9WYP5	IOLG_THEMA	Myo-inositol 2-dehydrogenase (EC 1.1.1.18)	GO:0006020; GO:0006740; GO:0016491; GO:0050112	inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]; inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740]
PGEN_.00g240800	Scaffold_11	46967151	46992946	NA	NA	NA	NA	NA
PGEN_.00g240810	Scaffold_11	46993064	46998196	Q91X17	UROM_MOUSE	"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]"	GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]
PGEN_.00g240820	Scaffold_11	47001872	47011737	NA	NA	NA	NA	NA
PGEN_.00g240830	Scaffold_11	47012047	47019924	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g240840	Scaffold_11	47025144	47047461	P11884	ALDH2_RAT	"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1)"	GO:0001889; GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0032355; GO:0032496; GO:0032570; GO:0032870; GO:0033574; GO:0035094; GO:0042802; GO:0043066; GO:0043878; GO:0055093; GO:0070404; GO:0071398	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; ethanol catabolic process [GO:0006068]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; response to estradiol [GO:0032355]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]
PGEN_.00g240850	Scaffold_11	47052438	47075006	Q9CSP9	TTC14_MOUSE	Tetratricopeptide repeat protein 14 (TPR repeat protein 14)	GO:0003676	nucleic acid binding [GO:0003676]
PGEN_.00g240860	Scaffold_11	47072145	47072447	NA	NA	NA	NA	NA
PGEN_.00g240870	Scaffold_11	47095109	47161102	O17482	TIM_DROVI	Protein timeless	GO:0005634; GO:0048471; GO:0048511	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; rhythmic process [GO:0048511]
PGEN_.00g240880	Scaffold_11	47200762	47228814	NA	NA	NA	NA	NA
PGEN_.00g240890	Scaffold_11	47229240	47253658	Q3KTM2	GDPD5_CHICK	Glycerophosphodiester phosphodiesterase domain-containing protein 5 (EC 3.1.4.11) (Glycerophosphodiester phosphodiesterase 2)	GO:0004435; GO:0006629; GO:0008889; GO:0012505; GO:0016021; GO:0030426; GO:0045666; GO:0048471	endomembrane system [GO:0012505]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphatidylinositol phospholipase C activity [GO:0004435]; lipid metabolic process [GO:0006629]; positive regulation of neuron differentiation [GO:0045666]
PGEN_.00g240900	Scaffold_11	47264815	47267829	NA	NA	NA	NA	NA
PGEN_.00g240910	Scaffold_11	47280891	47326767	Q8BRK9	MA2A2_MOUSE	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016799; GO:0030246; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"
PGEN_.00g240920	Scaffold_11	47329062	47330668	NA	NA	NA	NA	NA
PGEN_.00g240930	Scaffold_11	47344018	47363586	Q32LQ6	MFSD1_DANRE	Major facilitator superfamily domain-containing protein 1	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g240940	Scaffold_11	47366761	47375556	NA	NA	NA	NA	NA
PGEN_.00g240950	Scaffold_11	47381208	47391142	P11833	TBB_PARLI	Tubulin beta chain (Beta-tubulin)	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g240960	Scaffold_11	47539193	47539471	NA	NA	NA	NA	NA
PGEN_.00g240970	Scaffold_11	47543769	47560502	O35161	CELR1_MOUSE	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0001702; GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004888; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005887; GO:0007156; GO:0007165; GO:0007186; GO:0007266; GO:0007267; GO:0007417; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0046928; GO:0046983; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090179; GO:0090251; GO:0098609	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; protein dimerization activity [GO:0046983]; transmembrane signaling receptor activity [GO:0004888]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of neurotransmitter secretion [GO:0046928]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; wound healing [GO:0042060]
PGEN_.00g240980	Scaffold_11	47560573	47560902	NA	NA	NA	NA	NA
PGEN_.00g240990	Scaffold_11	47596283	47603663	NA	NA	NA	NA	NA
PGEN_.00g241000	Scaffold_11	47655014	47666480	Q9NZJ4	SACS_HUMAN	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]
PGEN_.00g241010	Scaffold_11	47673853	47674080	NA	NA	NA	NA	NA
PGEN_.00g241020	Scaffold_11	47685479	47686069	NA	NA	NA	NA	NA
PGEN_.00g241030	Scaffold_11	47691686	47691970	NA	NA	NA	NA	NA
PGEN_.00g241040	Scaffold_11	47692339	47692656	NA	NA	NA	NA	NA
PGEN_.00g241050	Scaffold_11	47692680	47700774	NA	NA	NA	NA	NA
PGEN_.00g241060	Scaffold_11	47896230	47933024	P56490	ACM5_MACMU	Muscarinic acetylcholine receptor M5	GO:0001696; GO:0004930; GO:0004993; GO:0005887; GO:0007187; GO:0007197; GO:0007268; GO:0015872; GO:0016907; GO:0019226; GO:0030054; GO:0030425; GO:0030594; GO:0045211	"cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; dopamine transport [GO:0015872]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; transmission of nerve impulse [GO:0019226]"
PGEN_.00g241070	Scaffold_11	47933715	47936930	NA	NA	NA	NA	NA
PGEN_.00g241080	Scaffold_11	47937051	47937344	NA	NA	NA	NA	NA
PGEN_.00g241090	Scaffold_11	47937426	47937671	NA	NA	NA	NA	NA
PGEN_.00g241100	Scaffold_11	47937526	47950956	NA	NA	NA	NA	NA
PGEN_.00g241110	Scaffold_11	47951873	47952556	NA	NA	NA	NA	NA
PGEN_.00g241120	Scaffold_11	47965325	47965603	NA	NA	NA	NA	NA
PGEN_.00g241130	Scaffold_11	47965842	47966108	NA	NA	NA	NA	NA
PGEN_.00g241140	Scaffold_11	47987386	47993097	P08953	TOLL_DROME	Protein toll	GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]
PGEN_.00g241150	Scaffold_11	48004449	48023107	Q9Y289	SC5A6_HUMAN	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	GO:0005886; GO:0005887; GO:0006768; GO:0008523; GO:0012506; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0031526; GO:0055085	brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; transmembrane transport [GO:0055085]
PGEN_.00g241160	Scaffold_11	48025462	48046422	Q58HI1	PELP1_XENLA	"Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor)"	GO:0003682; GO:0005737; GO:0035327; GO:0045944; GO:0071339; GO:0071391	cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g241170	Scaffold_11	48069668	48073891	NA	NA	NA	NA	NA
PGEN_.00g241180	Scaffold_11	48075203	48083901	NA	NA	NA	NA	NA
PGEN_.00g241190	Scaffold_11	48092089	48092304	NA	NA	NA	NA	NA
PGEN_.00g241200	Scaffold_11	48096066	48097009	NA	NA	NA	NA	NA
PGEN_.00g241210	Scaffold_11	48099434	48132714	NA	NA	NA	NA	NA
PGEN_.00g241220	Scaffold_11	48135625	48138788	NA	NA	NA	NA	NA
PGEN_.00g241230	Scaffold_11	48139976	48164503	Q61625	GRID2_MOUSE	"Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)"	GO:0004970; GO:0005886; GO:0007157; GO:0008066; GO:0008328; GO:0010975; GO:0014069; GO:0016020; GO:0021707; GO:0030054; GO:0030165; GO:0034613; GO:0035249; GO:0036477; GO:0042802; GO:0043197; GO:0043523; GO:0045202; GO:0045211; GO:0050804; GO:0051965; GO:0060079; GO:0060134; GO:0097110; GO:0098688; GO:0098839; GO:0098978; GO:0099061; GO:0099151; GO:1900454; GO:1904315; GO:1904861; GO:1905606	"cell junction [GO:0030054]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular protein localization [GO:0034613]; cerebellar granule cell differentiation [GO:0021707]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; prepulse inhibition [GO:0060134]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic transmission, glutamatergic [GO:0035249]"
PGEN_.00g241240	Scaffold_11	48172320	48205226	NA	NA	NA	NA	NA
PGEN_.00g241250	Scaffold_11	48226735	48226974	NA	NA	NA	NA	NA
PGEN_.00g241260	Scaffold_11	48230472	48260030	NA	NA	NA	NA	NA
PGEN_.00g241270	Scaffold_11	48270628	48290140	Q8BGC3	MOT12_MOUSE	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g241280	Scaffold_11	48318220	48327588	NA	NA	NA	NA	NA
PGEN_.00g241290	Scaffold_11	48327759	48328343	NA	NA	NA	NA	NA
PGEN_.00g241300	Scaffold_11	48328396	48334365	NA	NA	NA	NA	NA
PGEN_.00g241310	Scaffold_11	48348240	48377442	Q8CB62	CNTRB_MOUSE	Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8)	GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0051299; GO:1902017; GO:1902410	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein domain specific binding [GO:0019904]; centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017]
PGEN_.00g241320	Scaffold_11	48397374	48405335	NA	NA	NA	NA	NA
PGEN_.00g241330	Scaffold_11	48459113	48465693	NA	NA	NA	NA	NA
PGEN_.00g241340	Scaffold_11	48468016	48469338	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g241350	Scaffold_11	48480584	48501682	Q8IYB9	ZN595_HUMAN	Zinc finger protein 595	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g241360	Scaffold_11	48505863	48517073	Q9GMA3	VSX1_BOVIN	Visual system homeobox 1 (Homeodomain protein RINX) (Retinal inner nuclear layer homeobox protein) (Transcription factor VSX1)	GO:0003682; GO:0005634; GO:0006355; GO:0007601; GO:0043565; GO:0044212; GO:0048666; GO:0050896	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; neuron development [GO:0048666]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]"
PGEN_.00g241370	Scaffold_11	48527449	48554883	NA	NA	NA	NA	NA
PGEN_.00g241380	Scaffold_11	48547926	48548651	NA	NA	NA	NA	NA
PGEN_.00g241390	Scaffold_11	48584220	48652249	NA	NA	NA	NA	NA
PGEN_.00g241400	Scaffold_11	48663383	48687188	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g241410	Scaffold_11	48695062	48695763	NA	NA	NA	NA	NA
PGEN_.00g241420	Scaffold_11	48698070	48705359	NA	NA	NA	NA	NA
PGEN_.00g241430	Scaffold_11	48735461	48736000	NA	NA	NA	NA	NA
PGEN_.00g241440	Scaffold_11	48751923	48761741	P9WN47	EGTD_MYCTU	Histidine N-alpha-methyltransferase (EC 2.1.1.44) (Histidine trimethyltransferase)	GO:0005886; GO:0008276; GO:0030745; GO:0052704; GO:0052707	"plasma membrane [GO:0005886]; dimethylhistidine N-methyltransferase activity [GO:0030745]; protein methyltransferase activity [GO:0008276]; ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]; N-alpha,N-alpha,N-alpha-trimethyl-L-histidine biosynthesis from histidine [GO:0052707]"
PGEN_.00g241450	Scaffold_11	48794406	48828512	P48180	ACH1_CAEEL	Acetylcholine receptor subunit alpha-type acr-16	GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0042995; GO:0043005; GO:0045202; GO:0045211; GO:0050877	cell junction [GO:0030054]; cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g241460	Scaffold_11	48896369	48903706	Q93373	LET4_CAEEL	Leucine-rich repeat-containing protein let-4 (Lethal protein 4)	GO:0002064; GO:0002119; GO:0009792; GO:0016021; GO:0016324; GO:0035150; GO:0045177; GO:1905710	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; embryo development ending in birth or egg hatching [GO:0009792]; epithelial cell development [GO:0002064]; nematode larval development [GO:0002119]; positive regulation of membrane permeability [GO:1905710]; regulation of tube size [GO:0035150]
PGEN_.00g241470	Scaffold_11	48913123	48913434	NA	NA	NA	NA	NA
PGEN_.00g241480	Scaffold_11	48936104	48944320	Q8K1C7	MOT14_MOUSE	Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g241490	Scaffold_11	49008053	49009350	NA	NA	NA	NA	NA
PGEN_.00g241500	Scaffold_11	49013433	49014510	NA	NA	NA	NA	NA
PGEN_.00g241510	Scaffold_11	49014544	49015589	NA	NA	NA	NA	NA
PGEN_.00g241520	Scaffold_11	49016358	49019370	Q91XV4	DCXR_MESAU	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g241530	Scaffold_11	49026157	49050084	Q7SYH5	SC5A8_XENLA	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (xSMCTe) (Sodium solute transporter Vito) (Solute carrier family 5 member 8)	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g241540	Scaffold_11	49054376	49082947	Q9XT77	SC5A6_RABIT	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g241550	Scaffold_11	49128554	49131539	I3J7Q8	HISAT_ORENI	Histidine N-acetyltransferase (EC 2.3.1.33)	GO:0047981	histidine N-acetyltransferase activity [GO:0047981]
PGEN_.00g241560	Scaffold_11	49134480	49146489	NA	NA	NA	NA	NA
PGEN_.00g241570	Scaffold_11	49146643	49146954	NA	NA	NA	NA	NA
PGEN_.00g241580	Scaffold_11	49147032	49147484	NA	NA	NA	NA	NA
PGEN_.00g241590	Scaffold_11	49157186	49163979	NA	NA	NA	NA	NA
PGEN_.00g241600	Scaffold_11	49171695	49176685	NA	NA	NA	NA	NA
PGEN_.00g241610	Scaffold_11	49198782	49202134	NA	NA	NA	NA	NA
PGEN_.00g241620	Scaffold_11	49224112	49225561	NA	NA	NA	NA	NA
PGEN_.00g241630	Scaffold_11	49226205	49229927	NA	NA	NA	NA	NA
PGEN_.00g241640	Scaffold_11	49304303	49304575	NA	NA	NA	NA	NA
PGEN_.00g241650	Scaffold_11	49315200	49317471	I3J7Q8	HISAT_ORENI	Histidine N-acetyltransferase (EC 2.3.1.33)	GO:0047981	histidine N-acetyltransferase activity [GO:0047981]
PGEN_.00g241660	Scaffold_11	49322657	49346421	Q8BYF6	SC5A8_MOUSE	Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8)	GO:0005343; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015718; GO:0015730; GO:0015913; GO:0016021; GO:0016324; GO:0031526; GO:0140161	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; apoptotic process [GO:0006915]; monocarboxylic acid transport [GO:0015718]; propanoate transport [GO:0015730]; short-chain fatty acid import [GO:0015913]
PGEN_.00g241670	Scaffold_11	49356250	49381889	Q9XT77	SC5A6_RABIT	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g241680	Scaffold_11	49391229	49397848	P9WN47	EGTD_MYCTU	Histidine N-alpha-methyltransferase (EC 2.1.1.44) (Histidine trimethyltransferase)	GO:0005886; GO:0008276; GO:0030745; GO:0052704; GO:0052707	"plasma membrane [GO:0005886]; dimethylhistidine N-methyltransferase activity [GO:0030745]; protein methyltransferase activity [GO:0008276]; ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]; N-alpha,N-alpha,N-alpha-trimethyl-L-histidine biosynthesis from histidine [GO:0052707]"
PGEN_.00g241690	Scaffold_11	49409575	49409934	NA	NA	NA	NA	NA
PGEN_.00g241700	Scaffold_11	49421566	49421832	NA	NA	NA	NA	NA
PGEN_.00g241710	Scaffold_11	49421911	49422375	NA	NA	NA	NA	NA
PGEN_.00g241720	Scaffold_11	49447597	49448493	NA	NA	NA	NA	NA
PGEN_.00g241730	Scaffold_11	49459600	49460919	NA	NA	NA	NA	NA
PGEN_.00g241740	Scaffold_11	49461513	49461860	NA	NA	NA	NA	NA
PGEN_.00g241750	Scaffold_11	49466118	49534141	B3EWZ3	CADN_ACRMI	Coadhesin (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g241760	Scaffold_11	49546221	49546886	NA	NA	NA	NA	NA
PGEN_.00g241770	Scaffold_11	49556163	49562480	NA	NA	NA	NA	NA
PGEN_.00g241780	Scaffold_11	49567261	49568174	NA	NA	NA	NA	NA
PGEN_.00g241790	Scaffold_11	49576887	49609147	Q7ZUV7	EMSY_DANRE	BRCA2-interacting transcriptional repressor EMSY	GO:0005634; GO:0006281; GO:0006325; GO:0006355	"nucleus [GO:0005634]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g241800	Scaffold_11	49620567	49621073	A6H7C9	CEP19_BOVIN	Centrosomal protein of 19 kDa (Cep19)	GO:0000922; GO:0005623; GO:0005737; GO:0005813; GO:0005814; GO:0034454; GO:0036064; GO:0060271; GO:0097712	"cell [GO:0005623]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]"
PGEN_.00g241810	Scaffold_11	49630985	49644475	NA	NA	NA	NA	NA
PGEN_.00g241820	Scaffold_11	49650529	49668860	Q967F4	HMR1_CAEEL	Cadherin-related hmr-1 (Protein Hammerhead)	GO:0000132; GO:0003384; GO:0005509; GO:0005623; GO:0005913; GO:0007016; GO:0007156; GO:0007369; GO:0007399; GO:0008013; GO:0009792; GO:0016342; GO:0016477; GO:0030866; GO:0042074; GO:0044214; GO:0070097; GO:0098609	catenin complex [GO:0016342]; cell [GO:0005623]; cell-cell adherens junction [GO:0005913]; spanning component of plasma membrane [GO:0044214]; beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; apical constriction involved in gastrulation [GO:0003384]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]
PGEN_.00g241830	Scaffold_11	49807666	49813670	Q5ZIT9	MFSD1_CHICK	Major facilitator superfamily domain-containing protein 1	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g241840	Scaffold_11	49883513	49894803	Q32LQ6	MFSD1_DANRE	Major facilitator superfamily domain-containing protein 1	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g241850	Scaffold_11	49901008	49930924	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g241860	Scaffold_11	49940648	49956128	Q9UT67	IMT2_SCHPO	Inositol phosphoceramide mannosyltransferase 2 (EC 2.4.-.-) (IPC mannosyltransferase 2)	GO:0000030; GO:0005794; GO:0016021; GO:0031501; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; trans-Golgi network membrane [GO:0032588]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g241870	Scaffold_11	49970153	49976633	NA	NA	NA	NA	NA
PGEN_.00g241880	Scaffold_11	49992427	50031780	NA	NA	NA	NA	NA
PGEN_.00g241890	Scaffold_11	50036800	50099792	Q8IVB4	SL9A9_HUMAN	Sodium/hydrogen exchanger 9 (Na(+)/H(+) exchanger 9) (NHE-9) (Solute carrier family 9 member 9)	GO:0005623; GO:0005886; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0031902; GO:0051453; GO:0055037; GO:0071805; GO:0098719	cell [GO:0005623]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]
PGEN_.00g241900	Scaffold_11	50148903	50178993	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g241910	Scaffold_11	50185283	50208318	Q01705	NOTC1_MOUSE	Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000122; GO:0000139; GO:0000978; GO:0001228; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003700; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005887; GO:0005912; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061344; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027	"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
PGEN_.00g241920	Scaffold_11	50227700	50244643	Q86GC8	ACES_CULPI	Acetylcholinesterase (AChE) (EC 3.1.1.7)	GO:0003990; GO:0005576; GO:0005886; GO:0030054; GO:0042135; GO:0045202	cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]
PGEN_.00g241930	Scaffold_11	50372306	50385995	NA	NA	NA	NA	NA
PGEN_.00g241940	Scaffold_11	50387233	50387868	NA	NA	NA	NA	NA
PGEN_.00g241950	Scaffold_11	50435973	50436281	NA	NA	NA	NA	NA
PGEN_.00g241960	Scaffold_11	50444480	50444824	NA	NA	NA	NA	NA
PGEN_.00g241970	Scaffold_11	50445541	50455823	NA	NA	NA	NA	NA
PGEN_.00g241980	Scaffold_11	50457861	50458596	NA	NA	NA	NA	NA
PGEN_.00g241990	Scaffold_11	50458654	50459587	NA	NA	NA	NA	NA
PGEN_.00g242000	Scaffold_11	50459621	50460223	NA	NA	NA	NA	NA
PGEN_.00g242010	Scaffold_11	50479851	50484086	Q6DCL6	DIK1A_XENLA	Divergent protein kinase domain 1A (Protein FAM69A)	GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
PGEN_.00g242020	Scaffold_11	50496100	50498999	NA	NA	NA	NA	NA
PGEN_.00g242030	Scaffold_11	50506993	50511629	NA	NA	NA	NA	NA
PGEN_.00g242040	Scaffold_11	50522181	50527956	Q5UBV8	TNF15_MOUSE	Tumor necrosis factor ligand superfamily member 15 (TNF ligand-related molecule 1) (Vascular endothelial cell growth inhibitor)	GO:0005123; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0006915; GO:0006919; GO:0006955; GO:0007250; GO:0016021; GO:0042107; GO:0050715	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; death receptor binding [GO:0005123]; tumor necrosis factor receptor binding [GO:0005164]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cytokine metabolic process [GO:0042107]; immune response [GO:0006955]; positive regulation of cytokine secretion [GO:0050715]
PGEN_.00g242050	Scaffold_11	50530616	50541387	NA	NA	NA	NA	NA
PGEN_.00g242060	Scaffold_11	50549333	50551826	NA	NA	NA	NA	NA
PGEN_.00g242070	Scaffold_11	50625009	50627200	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g242080	Scaffold_11	50637318	50649129	P81134	RENR_BOVIN	Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (V-ATPase M8.9 subunit) [Cleaved into: Renin receptor extracellular fragment; Renin receptor cytoplasmic fragment]	GO:0000421; GO:0005765; GO:0005789; GO:0009897; GO:0016021; GO:0030054; GO:0030177; GO:0030424; GO:0031410; GO:0032591; GO:0038023; GO:0045211	autophagosome membrane [GO:0000421]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; postsynaptic membrane [GO:0045211]; signaling receptor activity [GO:0038023]; positive regulation of Wnt signaling pathway [GO:0030177]
PGEN_.00g242090	Scaffold_11	50652115	50719466	A2AF47	DOC11_MOUSE	Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2)	GO:0001782; GO:0002315; GO:0005085; GO:0005089; GO:0007264; GO:0017048; GO:0043547; GO:0051491	guanyl-nucleotide exchange factor activity [GO:0005085]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g242100	Scaffold_11	50731005	50770396	Q5JSL3	DOC11_HUMAN	Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2)	GO:0001782; GO:0002315; GO:0005085; GO:0005089; GO:0005829; GO:0007264; GO:0007596; GO:0043547; GO:0051491	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; B cell homeostasis [GO:0001782]; blood coagulation [GO:0007596]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g242110	Scaffold_11	50781182	50799181	Q9BZ29	DOCK9_HUMAN	Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1)	GO:0005085; GO:0005829; GO:0007264; GO:0007596; GO:0012505; GO:0016020; GO:0043547; GO:0045296	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g242120	Scaffold_11	50825513	50917258	Q9Y625	GPC6_HUMAN	Glypican-6 [Cleaved into: Secreted glypican-6]	GO:0001523; GO:0005576; GO:0005615; GO:0005634; GO:0005796; GO:0005886; GO:0006024; GO:0006027; GO:0009966; GO:0009986; GO:0016477; GO:0043202; GO:0045202; GO:0046658; GO:0062023; GO:0098696; GO:0098978; GO:0099560; GO:1904929; GO:1905475; GO:1905606	"anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; cell migration [GO:0016477]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; retinoid metabolic process [GO:0001523]; synaptic membrane adhesion [GO:0099560]"
PGEN_.00g242130	Scaffold_11	50967046	50972239	NA	NA	NA	NA	NA
PGEN_.00g242140	Scaffold_11	50986771	50987235	NA	NA	NA	NA	NA
PGEN_.00g242150	Scaffold_11	50992368	50994933	NA	NA	NA	NA	NA
PGEN_.00g242160	Scaffold_11	50998721	51005120	A4FUB0	CE034_BOVIN	Uncharacterized protein C5orf34 homolog		
PGEN_.00g242170	Scaffold_11	51019238	51020503	NA	NA	NA	NA	NA
PGEN_.00g242180	Scaffold_11	51043749	51044426	NA	NA	NA	NA	NA
PGEN_.00g242190	Scaffold_11	51044664	51045548	NA	NA	NA	NA	NA
PGEN_.00g242200	Scaffold_11	51045778	51046170	NA	NA	NA	NA	NA
PGEN_.00g242210	Scaffold_11	51058572	51059864	Q5RJI4	PKDCC_MOUSE	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g242220	Scaffold_11	51063561	51063878	NA	NA	NA	NA	NA
PGEN_.00g242230	Scaffold_11	51128318	51135312	P30122	CEL_BOVIN	Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase) (Fragment)	GO:0004771; GO:0004806; GO:0005576; GO:0005737; GO:0005887; GO:0007158; GO:0008126; GO:0009986; GO:0016042; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0097104; GO:0097105; GO:0098793	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; synapse [GO:0045202]; acetylesterase activity [GO:0008126]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g242240	Scaffold_11	51141317	51142992	NA	NA	NA	NA	NA
PGEN_.00g242250	Scaffold_11	51155576	51166799	Q92035	ACES_BUNFA	Acetylcholinesterase (BfAChE) (EC 3.1.1.7)	GO:0001507; GO:0003990; GO:0005886; GO:0009405; GO:0030054; GO:0043083; GO:0090729	cell junction [GO:0030054]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; acetylcholinesterase activity [GO:0003990]; toxin activity [GO:0090729]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; pathogenesis [GO:0009405]
PGEN_.00g242260	Scaffold_11	51172730	51181259	P30122	CEL_BOVIN	Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase) (Fragment)	GO:0004771; GO:0004806; GO:0005576; GO:0005737; GO:0005887; GO:0007158; GO:0008126; GO:0009986; GO:0016042; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0097104; GO:0097105; GO:0098793	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; synapse [GO:0045202]; acetylesterase activity [GO:0008126]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g242270	Scaffold_11	51219730	51220026	NA	NA	NA	NA	NA
PGEN_.00g242280	Scaffold_11	51220409	51220693	NA	NA	NA	NA	NA
PGEN_.00g242290	Scaffold_11	51227286	51236608	P34528	YM67_CAEEL	Putative serine protease K12H4.7 (EC 3.4.-.-)	GO:0005764; GO:0005768; GO:0006508; GO:0008236; GO:0008239; GO:0045087	endosome [GO:0005768]; lysosome [GO:0005764]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; innate immune response [GO:0045087]; proteolysis [GO:0006508]
PGEN_.00g242300	Scaffold_11	51247987	51268358	Q0DZP5	CML17_ORYSJ	Probable calcium-binding protein CML17 (Calmodulin-like protein 17)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g242310	Scaffold_11	51341704	51346683	NA	NA	NA	NA	NA
PGEN_.00g242320	Scaffold_11	51353676	51354017	NA	NA	NA	NA	NA
PGEN_.00g242330	Scaffold_11	51356226	51356993	NA	NA	NA	NA	NA
PGEN_.00g242340	Scaffold_11	51359268	51378202	Q01705	NOTC1_MOUSE	Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000122; GO:0000139; GO:0000978; GO:0001228; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003700; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005887; GO:0005912; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061344; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027	"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
PGEN_.00g242350	Scaffold_11	51378229	51387855	P07207	NOTCH_DROME	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	GO:0001708; GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0005915; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007455; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035003; GO:0035153; GO:0035162; GO:0035165; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043525; GO:0043697; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048	"adherens junction [GO:0005912]; cell [GO:0005623]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
PGEN_.00g242360	Scaffold_12	42825	45088	NA	NA	NA	NA	NA
PGEN_.00g242370	Scaffold_12	81215	82294	E2RYF6	MUC22_HUMAN	Mucin-22 (Panbronchiolitis-related mucin-like protein 1)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g242380	Scaffold_12	93444	95202	Q5VV17	OTUD1_HUMAN	OTU domain-containing protein 1 (EC 3.4.19.12) (DUBA-7)	GO:0004843; GO:0070536	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K63-linked deubiquitination [GO:0070536]
PGEN_.00g242390	Scaffold_12	106459	107742	NA	NA	NA	NA	NA
PGEN_.00g242400	Scaffold_12	110868	123686	NA	NA	NA	NA	NA
PGEN_.00g242410	Scaffold_12	137724	158194	Q8BP78	F10C1_MOUSE	Protein FRA10AC1 homolog	GO:0005634	nucleus [GO:0005634]
PGEN_.00g242420	Scaffold_12	162890	175075	Q58DA0	PSMD4_BOVIN	26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10)	GO:0005634; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0043161; GO:0043248	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"
PGEN_.00g242430	Scaffold_12	177904	180766	Q9SE95	FIP2_ARATH	FH protein interacting protein FIP2 (BTB/POZ domain-containing protein At5g55000)	GO:0016567; GO:0051260	protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]
PGEN_.00g242440	Scaffold_12	180790	185569	NA	NA	NA	NA	NA
PGEN_.00g242450	Scaffold_12	188807	220560	NA	NA	NA	NA	NA
PGEN_.00g242460	Scaffold_12	229420	254267	Q8R3N1	NOP14_MOUSE	Nucleolar protein 14 (Nucleolar complex protein 14)	GO:0005654; GO:0005730; GO:0006364; GO:0019899; GO:0030515; GO:0030692; GO:0032040; GO:0042274	Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; enzyme binding [GO:0019899]; snoRNA binding [GO:0030515]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]
PGEN_.00g242470	Scaffold_12	254632	271244	Q8R010	AIMP2_MOUSE	Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (Multisynthase complex auxiliary component p38) (Protein JTV-1)	GO:0005634; GO:0005829; GO:0006412; GO:0006915; GO:0008285; GO:0017101; GO:0031398; GO:0060090; GO:0060510; GO:0065003; GO:1901216; GO:1903632	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of neuron death [GO:1901216]; positive regulation of protein ubiquitination [GO:0031398]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510]
PGEN_.00g242480	Scaffold_12	271725	278041	NA	NA	NA	NA	NA
PGEN_.00g242490	Scaffold_12	281027	296768	Q8IVU9	CBCO1_HUMAN	Ciliary-associated calcium-binding coiled-coil protein 1	GO:0005509; GO:0005737; GO:0005813; GO:0036126	centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; calcium ion binding [GO:0005509]
PGEN_.00g242500	Scaffold_12	323544	377696	Q49AM3	TTC31_HUMAN	Tetratricopeptide repeat protein 31 (TPR repeat protein 31)		
PGEN_.00g242510	Scaffold_12	404887	409534	NA	NA	NA	NA	NA
PGEN_.00g242520	Scaffold_12	419827	420381	NA	NA	NA	NA	NA
PGEN_.00g242530	Scaffold_12	425411	453165	Q8BUL6	PKHA1_MOUSE	Pleckstrin homology domain-containing family A member 1 (PH domain-containing family A member 1) (Tandem PH domain-containing protein 1) (TAPP-1)	GO:0001553; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007283; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0014065; GO:0016020; GO:0030165; GO:0031529; GO:0032587; GO:0033327; GO:0035264; GO:0043325; GO:0045184; GO:0048008; GO:0048705; GO:0050853; GO:0051898; GO:0060021; GO:0060325; GO:0070301	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; androgen metabolic process [GO:0008209]; B cell receptor signaling pathway [GO:0050853]; cellular response to hydrogen peroxide [GO:0070301]; establishment of protein localization [GO:0045184]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; multicellular organism growth [GO:0035264]; negative regulation of protein kinase B signaling [GO:0051898]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; ruffle organization [GO:0031529]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]"
PGEN_.00g242540	Scaffold_12	519012	527677	Q9CZB3	THUM2_MOUSE	THUMP domain-containing protein 2	GO:0003723; GO:0016423; GO:0030488	RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA methylation [GO:0030488]
PGEN_.00g242550	Scaffold_12	528780	536661	Q6UWH6	TX261_HUMAN	Protein TEX261	GO:0006888; GO:0030134; GO:0030173; GO:0030176; GO:0097020	COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; COPII adaptor activity [GO:0097020]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]
PGEN_.00g242560	Scaffold_12	549337	560255	Q8N9V6	ANR53_HUMAN	Ankyrin repeat domain-containing protein 53	GO:0000922; GO:0005623; GO:0005737; GO:0005819; GO:0007080; GO:0031116; GO:0051301; GO:0060236; GO:1902412	cell [GO:0005623]; cytoplasm [GO:0005737]; spindle [GO:0005819]; spindle pole [GO:0000922]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic cytokinesis [GO:1902412]; regulation of mitotic spindle organization [GO:0060236]
PGEN_.00g242570	Scaffold_12	567580	569235	A2VDP6	NXPE3_BOVIN	NXPE family member 3 (Protein FAM55C)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g242580	Scaffold_12	639966	640766	NA	NA	NA	NA	NA
PGEN_.00g242590	Scaffold_12	641082	650354	NA	NA	NA	NA	NA
PGEN_.00g242600	Scaffold_12	737941	738210	NA	NA	NA	NA	NA
PGEN_.00g242610	Scaffold_12	738399	738701	NA	NA	NA	NA	NA
PGEN_.00g242620	Scaffold_12	748461	749078	NA	NA	NA	NA	NA
PGEN_.00g242630	Scaffold_12	804007	812449	NA	NA	NA	NA	NA
PGEN_.00g242640	Scaffold_12	817258	847234	D6REC4	CFA99_HUMAN	Cilia- and flagella-associated protein 99	GO:0031514	motile cilium [GO:0031514]
PGEN_.00g242650	Scaffold_12	854235	901930	O02485	YDJ1_CAEEL	Uncharacterized protein ZK1073.1		
PGEN_.00g242660	Scaffold_12	915512	971213	P29348	GNAT3_RAT	Guanine nucleotide-binding protein G(t) subunit alpha-3 (Gustducin alpha-3 chain)	GO:0001664; GO:0001669; GO:0003924; GO:0005525; GO:0005737; GO:0005834; GO:0005930; GO:0007186; GO:0007188; GO:0007601; GO:0016324; GO:0031683; GO:0032991; GO:0035094; GO:0046872; GO:0050909; GO:0050913; GO:0050916; GO:0050917	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; protein-containing complex [GO:0032991]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; response to nicotine [GO:0035094]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of taste [GO:0050909]; sensory perception of umami taste [GO:0050917]; visual perception [GO:0007601]
PGEN_.00g242670	Scaffold_12	1021506	1059898	NA	NA	NA	NA	NA
PGEN_.00g242680	Scaffold_12	1079611	1084279	NA	NA	NA	NA	NA
PGEN_.00g242690	Scaffold_12	1088421	1091612	NA	NA	NA	NA	NA
PGEN_.00g242700	Scaffold_12	1091703	1116164	Q803A7	SPCS_DANRE	O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (Soluble liver antigen/liver pancreas antigen-like) (UGA suppressor tRNA-associated protein homolog)	GO:0000049; GO:0005737; GO:0006412; GO:0016785; GO:0097056	"cytoplasm [GO:0005737]; transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; translation [GO:0006412]"
PGEN_.00g242710	Scaffold_12	1116286	1116837	NA	NA	NA	NA	NA
PGEN_.00g242720	Scaffold_12	1116961	1132528	Q6P6M7	SPCS_MOUSE	O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (UGA suppressor tRNA-associated protein)	GO:0000049; GO:0001514; GO:0005634; GO:0005737; GO:0016785; GO:0097056	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transferase activity, transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]"
PGEN_.00g242730	Scaffold_12	1139161	1144392	Q9VVN2	RT26_DROME	"Probable 28S ribosomal protein S26, mitochondrial (MRP-S26) (S26mt)"	GO:0003735; GO:0005739; GO:0005763; GO:0006412; GO:0032543	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
PGEN_.00g242740	Scaffold_12	1144594	1168251	Q9NVH0	EXD2_HUMAN	Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2)	GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0008852; GO:0016021; GO:0030145; GO:0031297; GO:0042803; GO:0090305; GO:0090734	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297]
PGEN_.00g242750	Scaffold_12	1179324	1252062	A6H5Z3	EXC6B_MOUSE	Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2)	GO:0000145; GO:0006887; GO:0006893; GO:0006904	exocyst [GO:0000145]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; vesicle docking involved in exocytosis [GO:0006904]
PGEN_.00g242760	Scaffold_12	1261980	1262963	NA	NA	NA	NA	NA
PGEN_.00g242770	Scaffold_12	1318406	1318783	NA	NA	NA	NA	NA
PGEN_.00g242780	Scaffold_12	1319247	1319810	NA	NA	NA	NA	NA
PGEN_.00g242790	Scaffold_12	1324044	1324595	NA	NA	NA	NA	NA
PGEN_.00g242800	Scaffold_12	1327052	1338223	NA	NA	NA	NA	NA
PGEN_.00g242810	Scaffold_12	1341227	1341811	NA	NA	NA	NA	NA
PGEN_.00g242820	Scaffold_12	1341930	1342148	NA	NA	NA	NA	NA
PGEN_.00g242830	Scaffold_12	1365218	1369808	NA	NA	NA	NA	NA
PGEN_.00g242840	Scaffold_12	1370532	1370861	NA	NA	NA	NA	NA
PGEN_.00g242850	Scaffold_12	1374490	1381243	NA	NA	NA	NA	NA
PGEN_.00g242860	Scaffold_12	1399614	1403787	NA	NA	NA	NA	NA
PGEN_.00g242870	Scaffold_12	1450080	1464004	Q9UHI7	S23A1_HUMAN	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3)	GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016324; GO:0019852; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g242880	Scaffold_12	1469740	1470243	NA	NA	NA	NA	NA
PGEN_.00g242890	Scaffold_12	1502986	1510854	A2RU49	HYKK_HUMAN	Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1)	GO:0005759; GO:0006554; GO:0016301; GO:0047992	mitochondrial matrix [GO:0005759]; hydroxylysine kinase activity [GO:0047992]; kinase activity [GO:0016301]; lysine catabolic process [GO:0006554]
PGEN_.00g242900	Scaffold_12	1511740	1512567	NA	NA	NA	NA	NA
PGEN_.00g242910	Scaffold_12	1521614	1522459	NA	NA	NA	NA	NA
PGEN_.00g242920	Scaffold_12	1524660	1525222	NA	NA	NA	NA	NA
PGEN_.00g242930	Scaffold_12	1534521	1534760	NA	NA	NA	NA	NA
PGEN_.00g242940	Scaffold_12	1534983	1535183	NA	NA	NA	NA	NA
PGEN_.00g242950	Scaffold_12	1536618	1536932	NA	NA	NA	NA	NA
PGEN_.00g242960	Scaffold_12	1555518	1561111	NA	NA	NA	NA	NA
PGEN_.00g242970	Scaffold_12	1580090	1637346	Q9BXT4	TDRD1_HUMAN	Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1)	GO:0005737; GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546; GO:1990904	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
PGEN_.00g242980	Scaffold_12	1640258	1642334	NA	NA	NA	NA	NA
PGEN_.00g242990	Scaffold_12	1642536	1666886	Q5R9B3	CC186_PONAB	Coiled-coil domain-containing protein 186 (Fragment)		
PGEN_.00g243000	Scaffold_12	1682180	1714276	P48441	IDUA_MOUSE	Alpha-L-iduronidase (EC 3.2.1.76)	GO:0000902; GO:0003940; GO:0005102; GO:0005615; GO:0005764; GO:0005975; GO:0006027; GO:0007040; GO:0007613; GO:0007626; GO:0007628; GO:0008344; GO:0008542; GO:0030135; GO:0030198; GO:0030209; GO:0030211; GO:0035108; GO:0045780; GO:0048705; GO:0048878; GO:0060348; GO:0061037; GO:0090341; GO:0120158; GO:1990079	coated vesicle [GO:0030135]; extracellular space [GO:0005615]; lysosome [GO:0005764]; L-iduronidase activity [GO:0003940]; signaling receptor binding [GO:0005102]; adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; bone development [GO:0060348]; carbohydrate metabolic process [GO:0005975]; cartilage homeostasis [GO:1990079]; cell morphogenesis [GO:0000902]; chemical homeostasis [GO:0048878]; dermatan sulfate catabolic process [GO:0030209]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; heparin catabolic process [GO:0030211]; limb morphogenesis [GO:0035108]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; memory [GO:0007613]; negative regulation of cartilage development [GO:0061037]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; positive regulation of bone resorption [GO:0045780]; positive regulation of collagen catabolic process [GO:0120158]; skeletal system morphogenesis [GO:0048705]; visual learning [GO:0008542]
PGEN_.00g243010	Scaffold_12	1730670	1738675	NA	NA	NA	NA	NA
PGEN_.00g243020	Scaffold_12	1739092	1747331	O35910	MOT4_RAT	Monocarboxylate transporter 4 (MCT 4) (Monocarboxylate transporter 3) (MCT 3) (Solute carrier family 16 member 3)	GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0031965; GO:0035879; GO:0098688; GO:0099061	integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]
PGEN_.00g243030	Scaffold_12	1747537	1776496	Q8K1C7	MOT14_MOUSE	Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g243040	Scaffold_12	1764474	1767018	NA	NA	NA	NA	NA
PGEN_.00g243050	Scaffold_12	1789885	1821202	Q7Z5Q5	DPOLN_HUMAN	DNA polymerase nu (EC 2.7.7.7)	GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005737; GO:0006261; GO:0019985; GO:0030332; GO:0036297	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; translesion synthesis [GO:0019985]
PGEN_.00g243060	Scaffold_12	1824876	1825091	NA	NA	NA	NA	NA
PGEN_.00g243070	Scaffold_12	1834455	1842718	Q9NFT7	HXK2_DROME	Hexokinase type 2 (EC 2.7.1.1)	GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005623; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158	cell [GO:0005623]; cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]
PGEN_.00g243080	Scaffold_12	1856191	1900578	Q9NFT7	HXK2_DROME	Hexokinase type 2 (EC 2.7.1.1)	GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005623; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158	cell [GO:0005623]; cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013]
PGEN_.00g243090	Scaffold_12	1918536	1941096	Q6PBN5	AUP1_DANRE	Ancient ubiquitous protein 1	GO:0000839; GO:0016020; GO:0030176; GO:0030433; GO:0043130; GO:0097027	Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g243100	Scaffold_12	1944561	1960450	NA	NA	NA	NA	NA
PGEN_.00g243110	Scaffold_12	1964008	2014260	Q6QHF9	PAOX_HUMAN	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase)	GO:0005782; GO:0005829; GO:0006596; GO:0006598; GO:0006625; GO:0009446; GO:0009447; GO:0016491; GO:0046203; GO:0046208; GO:0046592; GO:0052899; GO:0052901; GO:0052902; GO:0052903; GO:0052904; GO:1901307	"cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; protein targeting to peroxisome [GO:0006625]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]"
PGEN_.00g243120	Scaffold_12	2015031	2025800	NA	NA	NA	NA	NA
PGEN_.00g243130	Scaffold_12	2040751	2073783	NA	NA	NA	NA	NA
PGEN_.00g243140	Scaffold_12	2085572	2086597	NA	NA	NA	NA	NA
PGEN_.00g243150	Scaffold_12	2093682	2117326	P18505	GBRB1_HUMAN	Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1)	GO:0004890; GO:0005635; GO:0005737; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007214; GO:0007268; GO:0009636; GO:0015276; GO:0021954; GO:0022851; GO:0030054; GO:0030425; GO:0032570; GO:0034220; GO:0034707; GO:0042391; GO:0042698; GO:0043005; GO:0045202; GO:0045211; GO:0050811; GO:0050877; GO:0071420; GO:0098982; GO:1902476; GO:1902711; GO:1904315	cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated ion channel activity [GO:0015276]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]
PGEN_.00g243160	Scaffold_12	2122468	2123694	P13908	ACHN2_CARAU	Neuronal acetylcholine receptor subunit non-alpha-2 (GFN-alpha-2)	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g243170	Scaffold_12	2124589	2125806	P12391	ACHB3_RAT	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0016020; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g243180	Scaffold_12	2142602	2142961	NA	NA	NA	NA	NA
PGEN_.00g243190	Scaffold_12	2144756	2183991	Q8TCU4	ALMS1_HUMAN	Alstrom syndrome protein 1	GO:0000086; GO:0000922; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0008017; GO:0010389; GO:0016197; GO:0046599; GO:0051492; GO:0097711; GO:0120162	centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ciliary basal body-plasma membrane docking [GO:0097711]; endosomal transport [GO:0016197]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of stress fiber assembly [GO:0051492]
PGEN_.00g243200	Scaffold_12	2187403	2190013	NA	NA	NA	NA	NA
PGEN_.00g243210	Scaffold_12	2196455	2197837	Q9NY64	GTR8_HUMAN	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)"	GO:0001666; GO:0005351; GO:0005353; GO:0005355; GO:0005536; GO:0005765; GO:0005886; GO:0005887; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0030665; GO:0033300; GO:0061024; GO:0070837; GO:1904659	clathrin-coated vesicle membrane [GO:0030665]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; carbohydrate:proton symporter activity [GO:0005351]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; membrane organization [GO:0061024]; response to hypoxia [GO:0001666]
PGEN_.00g243220	Scaffold_12	2203514	2212275	Q8R087	B4GT7_MOUSE	"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)"	GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"
PGEN_.00g243230	Scaffold_12	2221183	2228825	NA	NA	NA	NA	NA
PGEN_.00g243240	Scaffold_12	2262348	2293052	NA	NA	NA	NA	NA
PGEN_.00g243250	Scaffold_12	2293276	2295895	NA	NA	NA	NA	NA
PGEN_.00g243260	Scaffold_12	2316373	2344038	Q9H2G2	SLK_HUMAN	STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2)	GO:0004674; GO:0005524; GO:0005737; GO:0006915; GO:0023014; GO:0030334; GO:0031122; GO:0031252; GO:0032147; GO:0042802; GO:0042803; GO:0042981; GO:0045296; GO:0046777; GO:0048471; GO:0051893; GO:0070062	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g243270	Scaffold_12	2391573	2400061	NA	NA	NA	NA	NA
PGEN_.00g243280	Scaffold_12	2416633	2426107	O08815	SLK_RAT	STE20-like serine/threonine-protein kinase (STE20-like kinase) (EC 2.7.11.1) (STE20-related serine/threonine-protein kinase) (STE20-related kinase)	GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0023014; GO:0030334; GO:0031122; GO:0031252; GO:0032147; GO:0033129; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0046777; GO:0048471; GO:0051893; GO:0071356	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of histone phosphorylation [GO:0033129]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g243290	Scaffold_12	2449158	2451199	NA	NA	NA	NA	NA
PGEN_.00g243300	Scaffold_12	2451247	2453775	NA	NA	NA	NA	NA
PGEN_.00g243310	Scaffold_12	2457247	2464071	NA	NA	NA	NA	NA
PGEN_.00g243320	Scaffold_12	2495922	2516529	NA	NA	NA	NA	NA
PGEN_.00g243330	Scaffold_12	2498579	2499574	NA	NA	NA	NA	NA
PGEN_.00g243340	Scaffold_12	2518047	2518547	NA	NA	NA	NA	NA
PGEN_.00g243350	Scaffold_12	2519648	2520016	NA	NA	NA	NA	NA
PGEN_.00g243360	Scaffold_12	2528964	2529950	P97288	5HT4R_MOUSE	5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)	GO:0004930; GO:0004993; GO:0005737; GO:0005768; GO:0005887; GO:0007187; GO:0007189; GO:0007214; GO:0007268; GO:0016020; GO:0030425; GO:0030594; GO:0032098; GO:0045202	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of appetite [GO:0032098]"
PGEN_.00g243370	Scaffold_12	2548113	2582713	Q155U0	VPS51_DANRE	Vacuolar protein sorting-associated protein 51 homolog (Protein fat-free)	GO:0000938; GO:0005829; GO:0006869; GO:0007030; GO:0007041; GO:0010517; GO:0015031; GO:0016020; GO:0030306; GO:0032456; GO:0042147; GO:0044241; GO:0048193; GO:0055037; GO:1990745	"cytosol [GO:0005829]; EARP complex [GO:1990745]; GARP complex [GO:0000938]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ADP-ribosylation factor binding [GO:0030306]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; lipid digestion [GO:0044241]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; regulation of phospholipase activity [GO:0010517]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g243380	Scaffold_12	2591752	2610732	Q8WP19	CRY1_MACFA	Cryptochrome-1	GO:0000122; GO:0000166; GO:0005634; GO:0005737; GO:0006094; GO:0006975; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0018298; GO:0031397; GO:0031398; GO:0032922; GO:0033762; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:2000001; GO:2000323	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to light stimulus [GO:0009416]"
PGEN_.00g243390	Scaffold_12	2612402	2614602	NA	NA	NA	NA	NA
PGEN_.00g243400	Scaffold_12	2640239	2650402	NA	NA	NA	NA	NA
PGEN_.00g243410	Scaffold_12	2664370	2667330	NA	NA	NA	NA	NA
PGEN_.00g243420	Scaffold_12	2667376	2668792	NA	NA	NA	NA	NA
PGEN_.00g243430	Scaffold_12	2670857	2671144	NA	NA	NA	NA	NA
PGEN_.00g243440	Scaffold_12	2688483	2693571	NA	NA	NA	NA	NA
PGEN_.00g243450	Scaffold_12	2697461	2699815	NA	NA	NA	NA	NA
PGEN_.00g243460	Scaffold_12	2720425	2720766	NA	NA	NA	NA	NA
PGEN_.00g243470	Scaffold_12	2736617	2739986	NA	NA	NA	NA	NA
PGEN_.00g243480	Scaffold_12	2770668	2805066	Q9JLC8	SACS_MOUSE	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	GO:0005737; GO:0050750	cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750]
PGEN_.00g243490	Scaffold_12	2827149	2848594	Q14203	DCTN1_HUMAN	Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p135) (p150-glued)	GO:0000086; GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0003774; GO:0005623; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0005938; GO:0006888; GO:0007399; GO:0007528; GO:0008017; GO:0010389; GO:0010457; GO:0010970; GO:0015630; GO:0015631; GO:0016020; GO:0019886; GO:0019901; GO:0021517; GO:0030286; GO:0030424; GO:0031116; GO:0034454; GO:0035371; GO:0036498; GO:0042147; GO:0043005; GO:0043025; GO:0045171; GO:0048156; GO:0050905; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0097711; GO:0099558; GO:0099738; GO:0120103; GO:1904398; GO:1905515; GO:1990535	"axon [GO:0030424]; cell [GO:0005623]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517]"
PGEN_.00g243500	Scaffold_12	2851803	2869803	Q6PCJ1	DCTN1_XENLA	Dynactin subunit 1	GO:0000132; GO:0000776; GO:0003774; GO:0005623; GO:0005813; GO:0005814; GO:0005819; GO:0005874; GO:0005938; GO:0008017; GO:0010970; GO:0030286; GO:0031122; GO:0035371; GO:0051301; GO:0060236; GO:0090316; GO:0099738	cell [GO:0005623]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; spindle [GO:0005819]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; positive regulation of intracellular protein transport [GO:0090316]; regulation of mitotic spindle organization [GO:0060236]; transport along microtubule [GO:0010970]
PGEN_.00g243510	Scaffold_12	2876734	2877276	NA	NA	NA	NA	NA
PGEN_.00g243520	Scaffold_12	2898442	2909516	NA	NA	NA	NA	NA
PGEN_.00g243530	Scaffold_12	2909563	2913944	E9Q5G3	KIF23_MOUSE	Kinesin-like protein KIF23	GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149	cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]
PGEN_.00g243540	Scaffold_12	2918739	2919835	NA	NA	NA	NA	NA
PGEN_.00g243550	Scaffold_12	2963166	2966135	NA	NA	NA	NA	NA
PGEN_.00g243560	Scaffold_12	2966272	2968994	NA	NA	NA	NA	NA
PGEN_.00g243570	Scaffold_12	2974087	3010317	Q5ZLL7	WDR91_CHICK	WD repeat-containing protein 91	GO:0005829; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0043551; GO:0045022	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]
PGEN_.00g243580	Scaffold_12	3013387	3014238	Q28IE5	NIT2_XENTR	Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2)	GO:0005737; GO:0006107; GO:0006528; GO:0006541; GO:0050152	cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107]
PGEN_.00g243590	Scaffold_12	3022735	3042034	Q6GPB6	KCMF1_XENLA	E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase KCMF1)	GO:0003676; GO:0008270; GO:0061630	nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]
PGEN_.00g243600	Scaffold_12	3042432	3052130	P11348	DHPR_RAT	Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase)	GO:0001889; GO:0004155; GO:0005737; GO:0005829; GO:0006559; GO:0006729; GO:0010044; GO:0010288; GO:0033762; GO:0035690; GO:0042802; GO:0043005; GO:0070402; GO:0070404	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; 6,7-dihydropteridine reductase activity [GO:0004155]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; cellular response to drug [GO:0035690]; L-phenylalanine catabolic process [GO:0006559]; liver development [GO:0001889]; response to aluminum ion [GO:0010044]; response to glucagon [GO:0033762]; response to lead ion [GO:0010288]; tetrahydrobiopterin biosynthetic process [GO:0006729]"
PGEN_.00g243610	Scaffold_12	3058682	3061485	NA	NA	NA	NA	NA
PGEN_.00g243620	Scaffold_12	3063167	3070672	Q62633	NTCP2_RAT	"Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate-cotransporting polypeptide, ileal) (Solute carrier family 10 member 2)"	GO:0000502; GO:0005634; GO:0005902; GO:0006814; GO:0008206; GO:0008508; GO:0009617; GO:0015721; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; response to bacterium [GO:0009617]; sodium ion transport [GO:0006814]
PGEN_.00g243630	Scaffold_12	3072306	3081667	O94673	GPC1_SCHPO	Glycerophosphocholine acyltransferase 1 (GPCAT) (EC 2.3.1.-)	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006656; GO:0016021; GO:0106158	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycero-3-phosphocholine acyltransferase activity [GO:0106158]; phosphatidylcholine biosynthetic process [GO:0006656]
PGEN_.00g243640	Scaffold_12	3097195	3101860	Q8C8H8	KY_MOUSE	Kyphoscoliosis peptidase (EC 3.4.-.-)	GO:0005856; GO:0007517; GO:0007528; GO:0008233; GO:0030018	cytoskeleton [GO:0005856]; Z disc [GO:0030018]; peptidase activity [GO:0008233]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]
PGEN_.00g243650	Scaffold_12	3117135	3117815	NA	NA	NA	NA	NA
PGEN_.00g243660	Scaffold_12	3124806	3129186	NA	NA	NA	NA	NA
PGEN_.00g243670	Scaffold_12	3135163	3144299	NA	NA	NA	NA	NA
PGEN_.00g243680	Scaffold_12	3153624	3173355	Q5RAZ4	DHX15_PONAB	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (DEAH box protein 15)	GO:0003676; GO:0003724; GO:0005524; GO:0005730; GO:0006397; GO:0008380	nucleolus [GO:0005730]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g243690	Scaffold_12	3173576	3208512	Q9NY93	DDX56_HUMAN	Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56)	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0010976; GO:0016020	membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]
PGEN_.00g243700	Scaffold_12	3231749	3234624	Q6GQH4	EGR1A_XENLA	Early growth response protein 1-A (EGR-1-A) (Xegr-1)	GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0008270; GO:0010385; GO:0032922; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:1990841	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g243710	Scaffold_12	3298253	3325545	Q91YP6	ELMD3_MOUSE	ELMO domain-containing protein 3 (RNA-binding motif and ELMO domain-containing protein 1)	GO:0005737; GO:0005856; GO:0032420; GO:0043547; GO:0060091	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; stereocilium [GO:0032420]; positive regulation of GTPase activity [GO:0043547]
PGEN_.00g243720	Scaffold_12	3326220	3341981	Q9Y3D5	RT18C_HUMAN	"28S ribosomal protein S18c, mitochondrial (MRP-S18-c) (Mrps18-c) (S18mt-c) (28S ribosomal protein S18-1, mitochondrial) (MRP-S18-1) (Mitochondrial small ribosomal subunit protein bS18c) (Mitochondrial small ribosomal subunit protein bS18m)"	GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0070125; GO:0070126; GO:0070181	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]
PGEN_.00g243730	Scaffold_12	3355915	3361951	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g243740	Scaffold_12	3364453	3365499	Q6AX44	FBCDA_XENLA	Fibrinogen C domain-containing protein 1-A	GO:0008061; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g243750	Scaffold_12	3369377	3386495	NA	NA	NA	NA	NA
PGEN_.00g243760	Scaffold_12	3386530	3388194	NA	NA	NA	NA	NA
PGEN_.00g243770	Scaffold_12	3393811	3414635	NA	NA	NA	NA	NA
PGEN_.00g243780	Scaffold_12	3414874	3427545	Q5REG4	DTX3_PONAB	Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3)	GO:0005737; GO:0007219; GO:0016567; GO:0016740; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g243790	Scaffold_12	3435635	3457239	Q5QJC4	DCR1A_CHICK	DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A)	GO:0000715; GO:0000784; GO:0003684; GO:0005654; GO:0006281; GO:0006303; GO:0031848; GO:0035312; GO:0036297; GO:0046872	"nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; protection from non-homologous end joining at telomere [GO:0031848]"
PGEN_.00g243800	Scaffold_12	3464417	3464671	NA	NA	NA	NA	NA
PGEN_.00g243810	Scaffold_12	3465794	3506694	Q13231	CHIT1_HUMAN	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]"
PGEN_.00g243820	Scaffold_12	3590664	3597156	NA	NA	NA	NA	NA
PGEN_.00g243830	Scaffold_12	3608340	3610444	NA	NA	NA	NA	NA
PGEN_.00g243840	Scaffold_12	3640716	3641222	NA	NA	NA	NA	NA
PGEN_.00g243850	Scaffold_12	3647729	3651530	NA	NA	NA	NA	NA
PGEN_.00g243860	Scaffold_12	3655599	3655940	NA	NA	NA	NA	NA
PGEN_.00g243870	Scaffold_12	3714101	3714400	NA	NA	NA	NA	NA
PGEN_.00g243880	Scaffold_12	3717290	3719050	P22270	OAR_DROME	Tyramine/octopamine receptor (Tyr/Oct-Dro)	GO:0004935; GO:0004989; GO:0005886; GO:0005887; GO:0007188; GO:0007211; GO:0007608; GO:0008227; GO:0010578; GO:0016021; GO:0071880; GO:1900738	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adrenergic receptor activity [GO:0004935]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; octopamine or tyramine signaling pathway [GO:0007211]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway [GO:0010578]; sensory perception of smell [GO:0007608]
PGEN_.00g243890	Scaffold_12	3745167	3747362	NA	NA	NA	NA	NA
PGEN_.00g243900	Scaffold_12	3747521	3748177	NA	NA	NA	NA	NA
PGEN_.00g243910	Scaffold_12	3751786	3753555	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g243920	Scaffold_12	3755744	3757206	NA	NA	NA	NA	NA
PGEN_.00g243930	Scaffold_12	3757285	3757851	NA	NA	NA	NA	NA
PGEN_.00g243940	Scaffold_12	3799545	3837114	NA	NA	NA	NA	NA
PGEN_.00g243950	Scaffold_12	3851903	3867179	NA	NA	NA	NA	NA
PGEN_.00g243960	Scaffold_12	3894531	3894794	NA	NA	NA	NA	NA
PGEN_.00g243970	Scaffold_12	3894853	3899539	NA	NA	NA	NA	NA
PGEN_.00g243980	Scaffold_12	3911938	3930145	A6H7G2	DBNL_BOVIN	Drebrin-like protein	GO:0000139; GO:0001726; GO:0002102; GO:0002250; GO:0005769; GO:0005829; GO:0005886; GO:0006898; GO:0007416; GO:0014069; GO:0030027; GO:0030054; GO:0030425; GO:0030427; GO:0030665; GO:0030833; GO:0030864; GO:0043204; GO:0045211; GO:0045773; GO:0048812; GO:0051015; GO:0061003; GO:0071800; GO:0097178; GO:0098974	cell junction [GO:0030054]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; actin filament binding [GO:0051015]; adaptive immune response [GO:0002250]; neuron projection morphogenesis [GO:0048812]; podosome assembly [GO:0071800]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; postsynaptic actin cytoskeleton organization [GO:0098974]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; ruffle assembly [GO:0097178]; synapse assembly [GO:0007416]
PGEN_.00g243990	Scaffold_12	3933310	3940739	O94844	RHBT1_HUMAN	Rho-related BTB domain-containing protein 1	GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007015; GO:0007266; GO:0008360; GO:0019901; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0043231; GO:0051017; GO:0051056	cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]
PGEN_.00g244000	Scaffold_12	3965773	3983922	O95786	DDX58_HUMAN	Antiviral innate immune response receptor RIG-I (DEAD box protein 58) (Probable ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I)	GO:0002230; GO:0002735; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0016032; GO:0016579; GO:0030334; GO:0031625; GO:0032480; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0034344; GO:0035549; GO:0039528; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051091; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1902741; GO:1904469; GO:1990904; GO:2000778	actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032]
PGEN_.00g244010	Scaffold_12	3996042	4006106	NA	NA	NA	NA	NA
PGEN_.00g244020	Scaffold_12	4006146	4011136	Q9R194	CRY2_MOUSE	Cryptochrome-2	GO:0000122; GO:0000976; GO:0003677; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006606; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0016607; GO:0018298; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0032515; GO:0032868; GO:0032922; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949; GO:2000323; GO:2000850	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein import into nucleus [GO:0006606]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]"
PGEN_.00g244030	Scaffold_12	4041884	4047996	NA	NA	NA	NA	NA
PGEN_.00g244040	Scaffold_12	4094323	4095993	NA	NA	NA	NA	NA
PGEN_.00g244050	Scaffold_12	4096356	4101929	NA	NA	NA	NA	NA
PGEN_.00g244060	Scaffold_12	4148734	4171033	Q5ZJ69	ARI5B_CHICK	AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B)	GO:0003713; GO:0005634; GO:0006357; GO:0044212; GO:0051091; GO:0060612	nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g244070	Scaffold_12	4208533	4210492	E1BLP6	ARI5B_BOVIN	AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B)	GO:0003713; GO:0005634; GO:0006357; GO:0044212; GO:0051091; GO:0060612	nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g244080	Scaffold_12	4212763	4238673	Q9MYU4	ENTP1_PIG	Ectonucleoside triphosphate diphosphohydrolase 1 (NTPDase 1) (EC 3.6.1.5) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (CD antigen CD39) [Cleaved into: Ectonucleoside triphosphate diphosphohydrolase 1 27 kDa subunit; Ectonucleoside triphosphate diphosphohydrolase 1 54 kDa subunit]	GO:0005524; GO:0005975; GO:0016021; GO:0016616; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491	"integral component of membrane [GO:0016021]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; carbohydrate metabolic process [GO:0005975]"
PGEN_.00g244090	Scaffold_12	4297813	4298127	NA	NA	NA	NA	NA
PGEN_.00g244100	Scaffold_12	4344131	4397547	O08791	COE3_MOUSE	Transcription factor COE3 (Early B-cell factor 3) (EBF-3) (Olf-1/EBF-like 2) (O/E-2) (OE-2)	GO:0000978; GO:0001228; GO:0005634; GO:0007275; GO:0045893; GO:0045944; GO:0046872; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g244110	Scaffold_12	4420905	4421324	NA	NA	NA	NA	NA
PGEN_.00g244120	Scaffold_12	4422137	4424134	NA	NA	NA	NA	NA
PGEN_.00g244130	Scaffold_12	4433771	4434634	NA	NA	NA	NA	NA
PGEN_.00g244140	Scaffold_12	4439020	4454698	Q920R0	ALS2_MOUSE	Alsin (Amyotrophic lateral sclerosis 2 protein homolog)	GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0017112; GO:0017137; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0030676; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043087; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048365; GO:0048812; GO:0051036; GO:0051260	"axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of GTPase activity [GO:0043087]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]"
PGEN_.00g244150	Scaffold_12	4458694	4460145	NA	NA	NA	NA	NA
PGEN_.00g244160	Scaffold_12	4460916	4492895	P0C5Y8	ALS2_RAT	Alsin (Amyotrophic lateral sclerosis 2 protein homolog)	GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0017112; GO:0017137; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0030676; GO:0031982; GO:0032991; GO:0035249; GO:0042803; GO:0043005; GO:0043025; GO:0043087; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036	"axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of GTPase activity [GO:0043087]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]"
PGEN_.00g244170	Scaffold_12	4551645	4561241	Q8C827	ZFP62_MOUSE	Zinc finger protein 62 (Zfp-62) (ZT3)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g244180	Scaffold_12	4563948	4580751	NA	NA	NA	NA	NA
PGEN_.00g244190	Scaffold_12	4698380	4777428	Q8IS64	ECE_LOCMI	Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)	GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g244200	Scaffold_12	4794732	4804090	NA	NA	NA	NA	NA
PGEN_.00g244210	Scaffold_12	4822366	4822908	NA	NA	NA	NA	NA
PGEN_.00g244220	Scaffold_12	4823005	4823337	NA	NA	NA	NA	NA
PGEN_.00g244230	Scaffold_12	4837778	4840360	NA	NA	NA	NA	NA
PGEN_.00g244240	Scaffold_12	4863253	4876072	F1QQC3	LOL2A_DANRE	Lysyl oxidase homolog 2A (EC 1.4.3.13) (Lysyl oxidase-like protein 2A)	GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005044; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005783; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0043542; GO:0045892; GO:0070828; GO:1902455	"basement membrane [GO:0005604]; chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]"
PGEN_.00g244250	Scaffold_12	4892567	4892863	P70117	LG3BP_MESAU	Galectin-3-binding protein (Lectin galactoside-binding soluble 3-binding protein) (Mac-2-binding protein) (MAC2BP) (Mac-2 BP) (Pancreas cancer-associated protein 4)	GO:0005044; GO:0005576; GO:0007155; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]
PGEN_.00g244260	Scaffold_12	4917515	4919384	NA	NA	NA	NA	NA
PGEN_.00g244270	Scaffold_12	4923338	4984680	Q5RD78	HECD2_PONAB	Probable E3 ubiquitin-protein ligase HECTD2 (EC 2.3.2.26) (HECT domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECTD2)	GO:0004842	ubiquitin-protein transferase activity [GO:0004842]
PGEN_.00g244280	Scaffold_12	4995297	5009921	Q9UJL9	ZF69B_HUMAN	Zinc finger protein 69 homolog B (Zinc finger protein 643)	GO:0003700; GO:0005634; GO:0005730; GO:0007030; GO:0043565; GO:0046872	nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; Golgi organization [GO:0007030]
PGEN_.00g244290	Scaffold_12	5026191	5032798	NA	NA	NA	NA	NA
PGEN_.00g244300	Scaffold_12	5044890	5147021	P24014	SLIT_DROME	Protein slit (dSlit) [Cleaved into: Protein slit N-product; Protein slit C-product]	GO:0001764; GO:0003151; GO:0005509; GO:0005576; GO:0005886; GO:0007411; GO:0007427; GO:0007432; GO:0007502; GO:0007509; GO:0008078; GO:0008201; GO:0008347; GO:0008406; GO:0010632; GO:0016199; GO:0016201; GO:0022409; GO:0030182; GO:0030335; GO:0035050; GO:0035385; GO:0048495; GO:0048813; GO:0050929; GO:0071666; GO:2000274	"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; Slit-Robo signaling complex [GO:0071666]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; digestive tract mesoderm development [GO:0007502]; embryonic heart tube development [GO:0035050]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell migration [GO:0008347]; gonad development [GO:0008406]; induction of negative chemotaxis [GO:0050929]; mesoderm migration involved in gastrulation [GO:0007509]; mesodermal cell migration [GO:0008078]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of epithelial cell migration [GO:0010632]; regulation of epithelial cell migration, open tracheal system [GO:2000274]; Roundabout signaling pathway [GO:0035385]; salivary gland boundary specification [GO:0007432]; synaptic target inhibition [GO:0016201]"
PGEN_.00g244310	Scaffold_12	5237746	5245927	Q60554	NKX61_MESAU	Homeobox protein Nkx-6.1 (Homeobox protein NK-6 homolog A)	GO:0000122; GO:0001764; GO:0003700; GO:0005634; GO:0030516; GO:0031016; GO:0043565; GO:0044342; GO:0045944; GO:0050796; GO:0051091; GO:0051594; GO:0072560; GO:2000078	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; detection of glucose [GO:0051594]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of axon extension [GO:0030516]; regulation of insulin secretion [GO:0050796]; type B pancreatic cell maturation [GO:0072560]; type B pancreatic cell proliferation [GO:0044342]
PGEN_.00g244320	Scaffold_12	5287264	5290014	O35762	NKX61_RAT	Homeobox protein Nkx-6.1 (Homeobox protein NK-6 homolog A)	GO:0000122; GO:0000978; GO:0001227; GO:0001764; GO:0003323; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007224; GO:0008283; GO:0021912; GO:0021913; GO:0021953; GO:0022008; GO:0030154; GO:0030516; GO:0031018; GO:0032024; GO:0035094; GO:0042493; GO:0043565; GO:0044342; GO:0045666; GO:0045686; GO:0045687; GO:0045944; GO:0048709; GO:0071345; GO:0071375; GO:2001222	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system neuron differentiation [GO:0021953]; endocrine pancreas development [GO:0031018]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; oligodendrocyte differentiation [GO:0048709]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axon extension [GO:0030516]; regulation of neuron migration [GO:2001222]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification [GO:0021912]; regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [GO:0021913]; response to drug [GO:0042493]; response to nicotine [GO:0035094]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342]"
PGEN_.00g244330	Scaffold_12	5297246	5297761	Q9C056	NKX62_HUMAN	Homeobox protein Nkx-6.2 (Homeobox protein NK-6 homolog B)	GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0010454; GO:0010455; GO:0021912; GO:0021913; GO:0022010; GO:0030154; GO:0031018; GO:0031641; GO:0043565; GO:0045686; GO:0045687; GO:0045892; GO:0045944; GO:0050885	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; central nervous system myelination [GO:0022010]; endocrine pancreas development [GO:0031018]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myelination [GO:0031641]; regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification [GO:0021912]; regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification [GO:0021913]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g244340	Scaffold_12	5336364	5347930	Q7QH73	PERC_ANOGA	Chorion peroxidase (EC 1.11.1.7)	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0048477	extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; oogenesis [GO:0048477]; response to oxidative stress [GO:0006979]
PGEN_.00g244350	Scaffold_12	5352454	5361158	NA	NA	NA	NA	NA
PGEN_.00g244360	Scaffold_12	5375330	5376075	NA	NA	NA	NA	NA
PGEN_.00g244370	Scaffold_12	5379050	5380592	NA	NA	NA	NA	NA
PGEN_.00g244380	Scaffold_12	5380997	5381398	NA	NA	NA	NA	NA
PGEN_.00g244390	Scaffold_12	5381594	5382465	NA	NA	NA	NA	NA
PGEN_.00g244400	Scaffold_12	5408117	5525280	Q7TQM3	FGRL1_RAT	Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1)	GO:0000139; GO:0001501; GO:0003179; GO:0005007; GO:0005794; GO:0005886; GO:0008201; GO:0008285; GO:0016021; GO:0017134; GO:0030133; GO:0030658; GO:0044291; GO:0051260; GO:0060412; GO:0060539; GO:0098742	cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; transport vesicle membrane [GO:0030658]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; protein homooligomerization [GO:0051260]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]
PGEN_.00g244410	Scaffold_12	5623598	5624191	Q8IXT5	RB12B_HUMAN	RNA-binding protein 12B (RNA-binding motif protein 12B)	GO:0003723	RNA binding [GO:0003723]
PGEN_.00g244420	Scaffold_12	5624450	5635684	NA	NA	NA	NA	NA
PGEN_.00g244430	Scaffold_12	5637558	5641442	Q503M4	MT12B_DANRE	Monocarboxylate transporter 12-B (MCT 12-B) (Solute carrier family 16 member 12-B)	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g244440	Scaffold_12	5642027	5642260	NA	NA	NA	NA	NA
PGEN_.00g244450	Scaffold_12	5684426	5718759	NA	NA	NA	NA	NA
PGEN_.00g244460	Scaffold_12	5777194	5794315	Q8BJM3	R3HCL_MOUSE	Coiled-coil domain-containing protein R3HCC1L (Growth inhibition and differentiation-related protein 88 homolog) (R3H and coiled-coil domain-containing protein 1-like)	GO:0035145	exon-exon junction complex [GO:0035145]
PGEN_.00g244470	Scaffold_12	5799521	5815954	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g244480	Scaffold_12	5816784	5821038	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g244490	Scaffold_12	5828382	5835950	Q8K4Q8	COL12_MOUSE	Collectin-12 (Collectin placenta protein 1) (CL-P1) (Scavenger receptor with C-type lectin)	GO:0004888; GO:0005581; GO:0006910; GO:0006955; GO:0008329; GO:0016021; GO:0030169; GO:0030246; GO:0034138; GO:0046872; GO:0060355; GO:0062023; GO:0071360	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; transmembrane signaling receptor activity [GO:0004888]; cellular response to exogenous dsRNA [GO:0071360]; immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]"
PGEN_.00g244500	Scaffold_12	5837854	5856481	D8VNS6	LECM_CERRY	C-type lectin (CTL)	GO:0005576; GO:0009405; GO:0030246; GO:0046872; GO:0090729	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g244510	Scaffold_12	5856475	5857830	NA	NA	NA	NA	NA
PGEN_.00g244520	Scaffold_12	5860334	5861161	NA	NA	NA	NA	NA
PGEN_.00g244530	Scaffold_12	5861574	5864794	NA	NA	NA	NA	NA
PGEN_.00g244540	Scaffold_12	5886014	5886415	NA	NA	NA	NA	NA
PGEN_.00g244550	Scaffold_12	5889596	5892296	P97864	CASP7_MOUSE	Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]	GO:0004190; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0007507; GO:0007568; GO:0008233; GO:0008234; GO:0009411; GO:0016485; GO:0043231; GO:0051146; GO:0051402; GO:0071887; GO:0072734; GO:0097153; GO:0097194; GO:0097200	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146]
PGEN_.00g244560	Scaffold_12	5899556	5920607	P70584	ACDSB_RAT	"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)"	GO:0003995; GO:0005739; GO:0005759; GO:0006631; GO:0006635; GO:0006637; GO:0009055; GO:0016937; GO:0050660	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; short-branched-chain-acyl-CoA dehydrogenase activity [GO:0016937]; acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]
PGEN_.00g244570	Scaffold_12	5937475	5944552	NA	NA	NA	NA	NA
PGEN_.00g244580	Scaffold_12	5944832	5949896	Q5FVR4	ERI1_RAT	3'-5' exoribonuclease 1 (EC 3.1.-.-) (Histone mRNA 3'-exonuclease 1)	GO:0000175; GO:0000467; GO:0000738; GO:0005634; GO:0005730; GO:0005737; GO:0008408; GO:0019843; GO:0031047; GO:0031125; GO:0043022; GO:0046872; GO:0071204; GO:0071207	"cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; histone pre-mRNA stem-loop binding [GO:0071207]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; DNA catabolic process, exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; gene silencing by RNA [GO:0031047]; rRNA 3'-end processing [GO:0031125]"
PGEN_.00g244590	Scaffold_12	5954664	5958175	NA	NA	NA	NA	NA
PGEN_.00g244600	Scaffold_12	5968928	5978433	O35516	NOTC2_MOUSE	Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]	GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005929; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0072602; GO:1990705; GO:2000249; GO:2001204	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060]
PGEN_.00g244610	Scaffold_12	5992031	6008519	Q8K2C8	GPAT4_MOUSE	Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7)	GO:0002071; GO:0004366; GO:0005783; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016024; GO:0019432; GO:0030176; GO:0030879; GO:0040014; GO:0046339; GO:0102420	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]
PGEN_.00g244620	Scaffold_12	6018434	6035566	Q6P1B1	XPP1_MOUSE	"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]
PGEN_.00g244630	Scaffold_12	6046346	6067391	Q8CAQ8	MIC60_MOUSE	MICOS complex subunit Mic60 (Mitochondrial inner membrane protein) (Mitofilin)	GO:0005739; GO:0005743; GO:0005758; GO:0042407; GO:0043209; GO:0051560; GO:0061617; GO:0070584	MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion morphogenesis [GO:0070584]
PGEN_.00g244640	Scaffold_12	6067457	6072635	Q8MS27	RM35_DROME	"39S ribosomal protein L35, mitochondrial (L35mt) (MRP-L35)"	GO:0003735; GO:0005739; GO:0005762; GO:0032543	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g244650	Scaffold_12	6079738	6080238	NA	NA	NA	NA	NA
PGEN_.00g244660	Scaffold_12	6080484	6080964	NA	NA	NA	NA	NA
PGEN_.00g244670	Scaffold_12	6086694	6095634	Q9D172	GAL3A_MOUSE	"Glutamine amidotransferase-like class 1 domain-containing protein 3A, mitochondrial"	GO:0005739	mitochondrion [GO:0005739]
PGEN_.00g244680	Scaffold_12	6098038	6106267	NA	NA	NA	NA	NA
PGEN_.00g244690	Scaffold_12	6117647	6120542	P35290	RAB24_MOUSE	Ras-related protein Rab-24 (Rab-16)	GO:0003924; GO:0005525; GO:0005739; GO:0005776; GO:0005829; GO:0006886; GO:0006914; GO:0016020; GO:0032482	autophagosome [GO:0005776]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g244700	Scaffold_12	6120597	6124691	NA	NA	NA	NA	NA
PGEN_.00g244710	Scaffold_12	6188411	6200760	Q9JI90	RNF14_MOUSE	E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (Protein Triad2) (RING finger protein 14)	GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006511; GO:0019787; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g244720	Scaffold_12	6200790	6204248	NA	NA	NA	NA	NA
PGEN_.00g244730	Scaffold_12	6208537	6227509	P28025	KI11B_XENLA	Kinesin-like protein KIF11-B (Kinesin-5) (Kinesin-related motor protein Eg5-1) (XLEg5K1) (XlEg5)	GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005876; GO:0007018; GO:0007049; GO:0008017; GO:0019901; GO:0051301	centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]
PGEN_.00g244740	Scaffold_12	6232466	6237222	Q9BR01	ST4A1_HUMAN	Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (hBR-STL) (hBR-STL-1) (Nervous system sulfotransferase) (NST)	GO:0005829; GO:0008146; GO:0008202; GO:0042802; GO:0050427	cytosol [GO:0005829]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; steroid metabolic process [GO:0008202]
PGEN_.00g244750	Scaffold_12	6239349	6249086	NA	NA	NA	NA	NA
PGEN_.00g244760	Scaffold_12	6249125	6252767	NA	NA	NA	NA	NA
PGEN_.00g244770	Scaffold_12	6255066	6265258	Q9BXY0	MAK16_HUMAN	Protein MAK16 homolog (NNP78) (Protein RBM13)	GO:0003723; GO:0005730; GO:0030687; GO:0043231	"intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]"
PGEN_.00g244780	Scaffold_12	6265635	6307455	NA	NA	NA	NA	NA
PGEN_.00g244790	Scaffold_12	6297468	6328384	NA	NA	NA	NA	NA
PGEN_.00g244800	Scaffold_12	6333198	6333422	Q7LFX5	CHSTF_HUMAN	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]
PGEN_.00g244810	Scaffold_12	6345243	6345749	NA	NA	NA	NA	NA
PGEN_.00g244820	Scaffold_12	6370167	6373764	NA	NA	NA	NA	NA
PGEN_.00g244830	Scaffold_12	6428217	6428597	NA	NA	NA	NA	NA
PGEN_.00g244840	Scaffold_12	6436316	6447771	Q86NP2	NELFA_DROME	Negative elongation factor A	GO:0000122; GO:0003723; GO:0005634; GO:0005694; GO:0007275; GO:0017053; GO:0032021; GO:0034244	chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]
PGEN_.00g244850	Scaffold_12	6452127	6472393	Q05024	TRI1_YEAST	Protein TRI1	GO:0005634; GO:0005730; GO:0005737	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]
PGEN_.00g244860	Scaffold_12	6481550	6503147	Q9UGP5	DPOLL_HUMAN	DNA polymerase lambda (Pol Lambda) (EC 2.7.7.7) (EC 4.2.99.-) (DNA polymerase beta-2) (Pol beta2) (DNA polymerase kappa)	GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006284; GO:0006287; GO:0006289; GO:0006303; GO:0016446; GO:0046872; GO:0051575; GO:0071897	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]; somatic hypermutation of immunoglobulin genes [GO:0016446]"
PGEN_.00g244870	Scaffold_12	6510009	6510404	NA	NA	NA	NA	NA
PGEN_.00g244880	Scaffold_12	6514236	6515527	NA	NA	NA	NA	NA
PGEN_.00g244890	Scaffold_12	6548123	6557235	Q9UGP5	DPOLL_HUMAN	DNA polymerase lambda (Pol Lambda) (EC 2.7.7.7) (EC 4.2.99.-) (DNA polymerase beta-2) (Pol beta2) (DNA polymerase kappa)	GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006284; GO:0006287; GO:0006289; GO:0006303; GO:0016446; GO:0046872; GO:0051575; GO:0071897	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]; somatic hypermutation of immunoglobulin genes [GO:0016446]"
PGEN_.00g244900	Scaffold_12	6557664	6558728	A2VE15	FADS6_BOVIN	Fatty acid desaturase 6 (EC 1.14.19.-)	GO:0006633; GO:0016021; GO:0016491	integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; fatty acid biosynthetic process [GO:0006633]
PGEN_.00g244910	Scaffold_12	6577461	6580309	Q9VUV9	U520_DROME	Putative U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Protein lethal (3) 72Ab)	GO:0000278; GO:0000381; GO:0000388; GO:0000398; GO:0003676; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005682; GO:0007283; GO:0007419; GO:0008380; GO:0030532; GO:0046540; GO:0071011; GO:0071013; GO:0071014	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]; ventral cord development [GO:0007419]"
PGEN_.00g244920	Scaffold_12	6583164	6587029	NA	NA	NA	NA	NA
PGEN_.00g244930	Scaffold_12	6587386	6625648	Q6P4T2	U520_MOUSE	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)	GO:0000388; GO:0000398; GO:0003676; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013; GO:0071014	"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"
PGEN_.00g244940	Scaffold_12	6688061	6691752	NA	NA	NA	NA	NA
PGEN_.00g244950	Scaffold_12	6701273	6716820	Q8XBI9	YFEX_ECO57	Dye-decolorizing peroxidase YfeX (EC 1.11.1.-)	GO:0004601; GO:0005737; GO:0020037; GO:0046872	cytoplasm [GO:0005737]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]
PGEN_.00g244960	Scaffold_12	6723291	6745189	Q6DCT2	ARMD3_XENLA	Armadillo-like helical domain-containing protein 3	GO:0000139; GO:0005829; GO:0016021; GO:1903358	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358]
PGEN_.00g244970	Scaffold_12	6747384	6766071	Q969X5	ERGI1_HUMAN	Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32)	GO:0005654; GO:0005783; GO:0005793; GO:0006888; GO:0006890; GO:0016020; GO:0030134; GO:0030173; GO:0030176; GO:0033116; GO:0043231	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g244980	Scaffold_12	6777271	6801027	NA	NA	NA	NA	NA
PGEN_.00g244990	Scaffold_12	6801747	6821269	Q8BH74	NU107_MOUSE	Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107)	GO:0000777; GO:0000973; GO:0005643; GO:0006406; GO:0006606; GO:0008585; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0051292; GO:0072006	condensed chromosome kinetochore [GO:0000777]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]
PGEN_.00g245000	Scaffold_12	6824286	6878381	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g245010	Scaffold_12	6888495	6916130	P34410	TWK7_CAEEL	TWiK family of potassium channels protein 7	GO:0005887; GO:0022841; GO:0030322; GO:0071805	integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]
PGEN_.00g245020	Scaffold_12	6953382	6957114	Q5RCC0	TM2D2_PONAB	TM2 domain-containing protein 2	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g245030	Scaffold_12	6959162	6969542	Q99NA9	PCGF6_MOUSE	Polycomb group RING finger protein 6 (Mel18 and Bmi1-like RING finger) (RING finger protein 134)	GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0019904; GO:0031519; GO:0035102; GO:0036353; GO:0045892; GO:0045944; GO:0046872; GO:0060819	"nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genetic imprinting [GO:0060819]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g245040	Scaffold_12	6973996	6974723	NA	NA	NA	NA	NA
PGEN_.00g245050	Scaffold_12	6975104	6975487	NA	NA	NA	NA	NA
PGEN_.00g245060	Scaffold_12	6980655	6981755	NA	NA	NA	NA	NA
PGEN_.00g245070	Scaffold_12	6988869	6993166	NA	NA	NA	NA	NA
PGEN_.00g245080	Scaffold_12	6998775	7025046	Q6PCR7	EIF3A_DANRE	Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta)	GO:0001732; GO:0002188; GO:0003729; GO:0003743; GO:0005852; GO:0016282; GO:0033290; GO:0043614; GO:0071540; GO:0071541	"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188]"
PGEN_.00g245090	Scaffold_12	7030269	7032077	NA	NA	NA	NA	NA
PGEN_.00g245100	Scaffold_12	7033401	7064411	Q460N5	PAR14_HUMAN	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g245110	Scaffold_12	7067025	7074068	P68943	MED28_RAT	Mediator of RNA polymerase II transcription subunit 28 (Mediator complex subunit 28)	GO:0003779; GO:0005856; GO:0016020; GO:0016592; GO:0019827; GO:0030864; GO:0051151	cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; mediator complex [GO:0016592]; membrane [GO:0016020]; actin binding [GO:0003779]; negative regulation of smooth muscle cell differentiation [GO:0051151]; stem cell population maintenance [GO:0019827]
PGEN_.00g245120	Scaffold_12	7083871	7106871	NA	NA	NA	NA	NA
PGEN_.00g245130	Scaffold_12	7122587	7136838	NA	NA	NA	NA	NA
PGEN_.00g245140	Scaffold_12	7186252	7204994	Q504H8	HMX3_DANRE	Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1)	GO:0005634; GO:0006355; GO:0007399; GO:0030154; GO:0042472; GO:0043565; GO:0048916	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; nervous system development [GO:0007399]; posterior lateral line development [GO:0048916]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g245150	Scaffold_12	7209232	7210877	NA	NA	NA	NA	NA
PGEN_.00g245160	Scaffold_12	7292158	7315820	P48057	SC6A1_MUSCO	Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)	GO:0005332; GO:0005886; GO:0007612; GO:0009636; GO:0009986; GO:0010033; GO:0014054; GO:0014074; GO:0015734; GO:0030054; GO:0030424; GO:0032229; GO:0042165; GO:0042802; GO:0043005; GO:0051939; GO:0098810; GO:0098982; GO:0099055; GO:0099056	"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; identical protein binding [GO:0042802]; neurotransmitter binding [GO:0042165]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to organic substance [GO:0010033]; response to purine-containing compound [GO:0014074]; response to toxic substance [GO:0009636]; taurine transport [GO:0015734]"
PGEN_.00g245170	Scaffold_12	7321652	7345689	P48055	S6A12_RABIT	Sodium- and chloride-dependent betaine transporter (Na(+)/Cl(-) betaine/GABA transporter) (Solute carrier family 6 member 12)	GO:0005332; GO:0005887	integral component of plasma membrane [GO:0005887]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]
PGEN_.00g245180	Scaffold_12	7411821	7413187	NA	NA	NA	NA	NA
PGEN_.00g245190	Scaffold_12	7413512	7413805	NA	NA	NA	NA	NA
PGEN_.00g245200	Scaffold_12	7414852	7415151	NA	NA	NA	NA	NA
PGEN_.00g245210	Scaffold_12	7415661	7416537	NA	NA	NA	NA	NA
PGEN_.00g245220	Scaffold_12	7421898	7425051	Q9LFD1	LAC9_ARATH	Laccase-9 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 9) (Diphenol oxidase 9) (Urishiol oxidase 9)	GO:0004322; GO:0005507; GO:0005886; GO:0006826; GO:0046274; GO:0048046; GO:0052716; GO:0055072	apoplast [GO:0048046]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; lignin catabolic process [GO:0046274]
PGEN_.00g245230	Scaffold_12	7439124	7439684	NA	NA	NA	NA	NA
PGEN_.00g245240	Scaffold_12	7441198	7452873	P78314	3BP2_HUMAN	SH3 domain-binding protein 2 (3BP-2)	GO:0001784; GO:0005070; GO:0007165; GO:0017124	phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; signal transduction [GO:0007165]
PGEN_.00g245250	Scaffold_12	7506104	7513215	NA	NA	NA	NA	NA
PGEN_.00g245260	Scaffold_12	7518377	7546413	Q01827	VMAT2_RAT	Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2)	GO:0001975; GO:0005275; GO:0005335; GO:0005737; GO:0006836; GO:0007568; GO:0007626; GO:0008021; GO:0008144; GO:0008504; GO:0009635; GO:0009636; GO:0009791; GO:0010038; GO:0010043; GO:0015842; GO:0015844; GO:0019899; GO:0030073; GO:0030285; GO:0030672; GO:0031045; GO:0031072; GO:0032456; GO:0035690; GO:0042220; GO:0042493; GO:0042593; GO:0042594; GO:0042910; GO:0042995; GO:0043005; GO:0043025; GO:0043195; GO:0043679; GO:0044297; GO:0051412; GO:0051589; GO:0071242; GO:0098691; GO:0098700; GO:0098794; GO:0098992; GO:0099066	axon terminus [GO:0043679]; cell body [GO:0044297]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dense core granule [GO:0031045]; dopaminergic synapse [GO:0098691]; integral component of neuronal dense core vesicle membrane [GO:0099066]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle [GO:0098992]; postsynapse [GO:0098794]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; amine transmembrane transporter activity [GO:0005275]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; xenobiotic transmembrane transporter activity [GO:0042910]; aging [GO:0007568]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular response to ammonium ion [GO:0071242]; cellular response to drug [GO:0035690]; endocytic recycling [GO:0032456]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; negative regulation of neurotransmitter transport [GO:0051589]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter transport [GO:0006836]; post-embryonic development [GO:0009791]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to herbicide [GO:0009635]; response to metal ion [GO:0010038]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to zinc ion [GO:0010043]
PGEN_.00g245270	Scaffold_12	7555040	7559184	NA	NA	NA	NA	NA
PGEN_.00g245280	Scaffold_12	7664072	7674905	NA	NA	NA	NA	NA
PGEN_.00g245290	Scaffold_12	7695290	7709653	NA	NA	NA	NA	NA
PGEN_.00g245300	Scaffold_12	7726961	7733523	NA	NA	NA	NA	NA
PGEN_.00g245310	Scaffold_12	7749868	7757903	Q3T000	YKT6_BOVIN	Synaptobrevin homolog YKT6 (EC 2.3.1.-)	GO:0000139; GO:0005484; GO:0005623; GO:0005739; GO:0005768; GO:0005783; GO:0005829; GO:0005887; GO:0006888; GO:0006903; GO:0006904; GO:0015031; GO:0019706; GO:0030659; GO:0042147	"cell [GO:0005623]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]"
PGEN_.00g245320	Scaffold_12	7767469	7788747	Q6NSI3	FA53A_HUMAN	Protein FAM53A (Dorsal neural-tube nuclear protein)	GO:0005634; GO:0006606	nucleus [GO:0005634]; protein import into nucleus [GO:0006606]
PGEN_.00g245330	Scaffold_12	7829746	7861693	NA	NA	NA	NA	NA
PGEN_.00g245340	Scaffold_12	7836953	7837204	NA	NA	NA	NA	NA
PGEN_.00g245350	Scaffold_12	7886205	7888718	NA	NA	NA	NA	NA
PGEN_.00g245360	Scaffold_12	7920984	7951238	P50540	MXI1_MOUSE	Max-interacting protein 1 (Max interactor 1)	GO:0000122; GO:0001825; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0046983; GO:0090575	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; blastocyst formation [GO:0001825]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g245370	Scaffold_12	7952007	7961145	NA	NA	NA	NA	NA
PGEN_.00g245380	Scaffold_12	7977198	7979532	NA	NA	NA	NA	NA
PGEN_.00g245390	Scaffold_12	8000091	8000324	NA	NA	NA	NA	NA
PGEN_.00g245400	Scaffold_12	8000470	8001231	NA	NA	NA	NA	NA
PGEN_.00g245410	Scaffold_12	8026297	8034751	NA	NA	NA	NA	NA
PGEN_.00g245420	Scaffold_12	8035254	8044525	Q9JM99	PRG4_MOUSE	Proteoglycan 4 (Lubricin) (Megakaryocyte-stimulating factor) (Superficial zone proteoglycan) [Cleaved into: Proteoglycan 4 C-terminal part]	GO:0005044; GO:0005615; GO:0006955; GO:0030247; GO:0042127; GO:0045409; GO:0071425	extracellular space [GO:0005615]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; hematopoietic stem cell proliferation [GO:0071425]; immune response [GO:0006955]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; regulation of cell population proliferation [GO:0042127]
PGEN_.00g245430	Scaffold_12	8055492	8056478	P51814	ZNF41_HUMAN	Zinc finger protein 41	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g245440	Scaffold_12	8075663	8077702	NA	NA	NA	NA	NA
PGEN_.00g245450	Scaffold_12	8083660	8091909	NA	NA	NA	NA	NA
PGEN_.00g245460	Scaffold_12	8097980	8102156	NA	NA	NA	NA	NA
PGEN_.00g245470	Scaffold_12	8106979	8114665	Q8JIS3	DER_CHICK	D-erythrulose reductase (EC 1.1.1.162) (Probable L-xylulose reductase) (XR) (EC 1.1.1.10)	GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0047880; GO:0050038; GO:0051289	"cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g245480	Scaffold_12	8114887	8115204	NA	NA	NA	NA	NA
PGEN_.00g245490	Scaffold_12	8156955	8189634	NA	NA	NA	NA	NA
PGEN_.00g245500	Scaffold_12	8193359	8194402	NA	NA	NA	NA	NA
PGEN_.00g245510	Scaffold_12	8212362	8217776	NA	NA	NA	NA	NA
PGEN_.00g245520	Scaffold_12	8225885	8228030	NA	NA	NA	NA	NA
PGEN_.00g245530	Scaffold_12	8249714	8263815	Q9UHX1	PUF60_HUMAN	Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) (FUSE-binding protein-interacting repressor) (FBP-interacting repressor) (Ro-binding protein 1) (RoBP1) (Siah-binding protein 1) (Siah-BP1)	GO:0000398; GO:0003677; GO:0003723; GO:0005654; GO:0006915; GO:0030054; GO:0042802; GO:0045296	"cell junction [GO:0030054]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g245540	Scaffold_12	8266569	8275250	Q3T186	RPIA_BOVIN	Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase) (Fragment)	GO:0004751; GO:0006014; GO:0009052; GO:0043231	"intracellular membrane-bounded organelle [GO:0043231]; ribose-5-phosphate isomerase activity [GO:0004751]; D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"
PGEN_.00g245550	Scaffold_12	8277634	8280136	Q8NC60	NOA1_HUMAN	Nitric oxide-associated protein 1	GO:0003723; GO:0005525; GO:0005739; GO:0005743; GO:0006915; GO:0010941; GO:0032543; GO:0043457	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]; regulation of cell death [GO:0010941]; regulation of cellular respiration [GO:0043457]
PGEN_.00g245560	Scaffold_12	8281990	8282379	NA	NA	NA	NA	NA
PGEN_.00g245570	Scaffold_12	8282566	8304091	Q5TEA3	CT194_HUMAN	Uncharacterized protein C20orf194		
PGEN_.00g245580	Scaffold_12	8316782	8328351	Q7TT23	CT194_MOUSE	Uncharacterized protein C20orf194 homolog		
PGEN_.00g245590	Scaffold_12	8316806	8317924	NA	NA	NA	NA	NA
PGEN_.00g245600	Scaffold_12	8336625	8344743	NA	NA	NA	NA	NA
PGEN_.00g245610	Scaffold_12	8350405	8507926	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g245620	Scaffold_12	8508526	8509892	NA	NA	NA	NA	NA
PGEN_.00g245630	Scaffold_12	8530796	8538454	NA	NA	NA	NA	NA
PGEN_.00g245640	Scaffold_12	8550967	8607050	Q5U4W1	LZTS2_XENLA	Leucine zipper putative tumor suppressor 2 homolog (Protein lapser1)	GO:0000281; GO:0005737; GO:0005813; GO:0005874; GO:0016055; GO:0030178; GO:0030496; GO:0051013; GO:0051168; GO:0051255	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; negative regulation of Wnt signaling pathway [GO:0030178]; nuclear export [GO:0051168]; spindle midzone assembly [GO:0051255]; Wnt signaling pathway [GO:0016055]
PGEN_.00g245650	Scaffold_12	8617605	8634750	A5PN28	OTO1A_DANRE	Otolin-1-A (zOtolin1)	GO:0005201; GO:0005509; GO:0005581; GO:0005615; GO:0030198; GO:0031012; GO:0045299; GO:0048840	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; otolith development [GO:0048840]; otolith mineralization [GO:0045299]
PGEN_.00g245660	Scaffold_12	8645197	8645781	NA	NA	NA	NA	NA
PGEN_.00g245670	Scaffold_12	8647830	8648725	NA	NA	NA	NA	NA
PGEN_.00g245680	Scaffold_12	8649284	8652258	NA	NA	NA	NA	NA
PGEN_.00g245690	Scaffold_12	8658020	8661327	NA	NA	NA	NA	NA
PGEN_.00g245700	Scaffold_12	8724186	8734232	P78539	SRPX_HUMAN	Sushi repeat-containing protein SRPX	GO:0001845; GO:0005776; GO:0005783; GO:0006914; GO:0007155; GO:0009986; GO:0016020; GO:0034976; GO:0060244; GO:0062023; GO:2001241	autophagosome [GO:0005776]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; autophagy [GO:0006914]; cell adhesion [GO:0007155]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g245710	Scaffold_12	8742028	8772056	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g245720	Scaffold_12	8783160	8788475	Q9NPC7	MYNN_HUMAN	Myoneurin (Zinc finger and BTB domain-containing protein 31)	GO:0003677; GO:0003700; GO:0005654; GO:0006351; GO:0008270; GO:1990830	"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g245730	Scaffold_12	8791967	8797551	Q05481	ZNF91_HUMAN	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]"
PGEN_.00g245740	Scaffold_12	8805817	8824565	Q99ME2	WDR6_MOUSE	WD repeat-containing protein 6 (mWDR6)	GO:0005737; GO:0005829; GO:0005886; GO:0007050; GO:0008285; GO:0010507; GO:0032991; GO:0043560	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; insulin receptor substrate binding [GO:0043560]; cell cycle arrest [GO:0007050]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]
PGEN_.00g245750	Scaffold_12	8830025	8834429	Q9D1K7	CT027_MOUSE	UPF0687 protein C20orf27 homolog		
PGEN_.00g245760	Scaffold_12	8836768	8845571	A6QP16	ZRAN1_BOVIN	Ubiquitin thioesterase ZRANB1 (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1)	GO:0004843; GO:0005634; GO:0005737; GO:0007010; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0035523; GO:0036459; GO:0046872; GO:0070530; GO:0070536; GO:0071947; GO:1990168	cytoplasm [GO:0005737]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055]
PGEN_.00g245770	Scaffold_12	8863510	8864004	NA	NA	NA	NA	NA
PGEN_.00g245780	Scaffold_12	8868783	8869118	NA	NA	NA	NA	NA
PGEN_.00g245790	Scaffold_12	8879895	8881978	NA	NA	NA	NA	NA
PGEN_.00g245800	Scaffold_12	8982989	8984092	NA	NA	NA	NA	NA
PGEN_.00g245810	Scaffold_12	8984203	8988235	NA	NA	NA	NA	NA
PGEN_.00g245820	Scaffold_12	9024392	9040847	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g245830	Scaffold_12	9041730	9069316	Q7Z5L3	C1QL2_HUMAN	Complement C1q-like protein 2 (C1q and tumor necrosis factor-related protein 10) (C1q/TNF-related protein 10)	GO:0005576; GO:0005581; GO:0042802	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]
PGEN_.00g245840	Scaffold_12	9081968	9085971	Q03692	COAA1_HUMAN	Collagen alpha-1(X) chain	GO:0001501; GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]
PGEN_.00g245850	Scaffold_12	9088976	9108872	Q5NC05	TTF2_MOUSE	Transcription termination factor 2 (EC 3.6.4.-) (RNA polymerase II termination factor) (Transcription release factor 2)	GO:0003677; GO:0004386; GO:0005524; GO:0005681; GO:0005829; GO:0006353; GO:0006397; GO:0008270; GO:0008380	"cytosol [GO:0005829]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; zinc ion binding [GO:0008270]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]"
PGEN_.00g245860	Scaffold_12	9113105	9114325	NA	NA	NA	NA	NA
PGEN_.00g245870	Scaffold_12	9120498	9137441	Q9ESD7	DYSF_MOUSE	Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1)	GO:0001525; GO:0001778; GO:0001938; GO:0002280; GO:0002281; GO:0005509; GO:0005543; GO:0005544; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005874; GO:0005886; GO:0006071; GO:0006906; GO:0008017; GO:0010629; GO:0016021; GO:0019915; GO:0030027; GO:0030139; GO:0030315; GO:0030659; GO:0031410; GO:0033292; GO:0034451; GO:0042177; GO:0042383; GO:0043014; GO:0043403; GO:0045444; GO:0045785; GO:0048747; GO:0050663; GO:0050765; GO:0071470; GO:0090023; GO:0090279; GO:0098857; GO:1901842; GO:1902915	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome [GO:0005770]; membrane microdomain [GO:0098857]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; angiogenesis [GO:0001525]; cellular response to osmotic stress [GO:0071470]; cytokine secretion [GO:0050663]; fat cell differentiation [GO:0045444]; glycerol metabolic process [GO:0006071]; lipid storage [GO:0019915]; macrophage activation involved in immune response [GO:0002281]; monocyte activation involved in immune response [GO:0002280]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein polyubiquitination [GO:1902915]; plasma membrane repair [GO:0001778]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; regulation of calcium ion import [GO:0090279]; skeletal muscle tissue regeneration [GO:0043403]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906]
PGEN_.00g245880	Scaffold_12	9154713	9227764	O75923	DYSF_HUMAN	Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1)	GO:0001525; GO:0001778; GO:0001938; GO:0002280; GO:0002281; GO:0005509; GO:0005543; GO:0005544; GO:0005634; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005874; GO:0005886; GO:0006071; GO:0006906; GO:0006936; GO:0008017; GO:0010629; GO:0016021; GO:0019915; GO:0030027; GO:0030139; GO:0030315; GO:0030659; GO:0033292; GO:0034451; GO:0042177; GO:0042383; GO:0043014; GO:0043403; GO:0045444; GO:0045785; GO:0048747; GO:0050663; GO:0050765; GO:0070062; GO:0071470; GO:0090023; GO:0090279; GO:0098857; GO:1901842; GO:1902915	centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome [GO:0005770]; membrane microdomain [GO:0098857]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; angiogenesis [GO:0001525]; cellular response to osmotic stress [GO:0071470]; cytokine secretion [GO:0050663]; fat cell differentiation [GO:0045444]; glycerol metabolic process [GO:0006071]; lipid storage [GO:0019915]; macrophage activation involved in immune response [GO:0002281]; monocyte activation involved in immune response [GO:0002280]; muscle contraction [GO:0006936]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein polyubiquitination [GO:1902915]; plasma membrane repair [GO:0001778]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; regulation of calcium ion import [GO:0090279]; skeletal muscle tissue regeneration [GO:0043403]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906]
PGEN_.00g245890	Scaffold_12	9234166	9243236	Q6NY77	HOGA1_DANRE	"4-hydroxy-2-oxoglutarate aldolase, mitochondrial (EC 4.1.3.16) (Dihydrodipicolinate synthase-like) (DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase) (Probable KHG-aldolase)"	GO:0005739; GO:0008700; GO:0009436	mitochondrion [GO:0005739]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]; glyoxylate catabolic process [GO:0009436]
PGEN_.00g245900	Scaffold_12	9247026	9256405	NA	NA	NA	NA	NA
PGEN_.00g245910	Scaffold_12	9259608	9265087	NA	NA	NA	NA	NA
PGEN_.00g245920	Scaffold_12	9268299	9326841	Q99973	TEP1_HUMAN	Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog)	GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]"
PGEN_.00g245930	Scaffold_12	9327669	9348846	Q99973	TEP1_HUMAN	Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog)	GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]"
PGEN_.00g245940	Scaffold_12	9370263	9377564	NA	NA	NA	NA	NA
PGEN_.00g245950	Scaffold_12	9444803	9452227	NA	NA	NA	NA	NA
PGEN_.00g245960	Scaffold_12	9505564	9507288	NA	NA	NA	NA	NA
PGEN_.00g245970	Scaffold_12	9507563	9507829	NA	NA	NA	NA	NA
PGEN_.00g245980	Scaffold_12	9508192	9554635	NA	NA	NA	NA	NA
PGEN_.00g245990	Scaffold_12	9540266	9540604	NA	NA	NA	NA	NA
PGEN_.00g246000	Scaffold_12	9554719	9609232	B4QZU1	PDE6_DROSI	"cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35)"	GO:0005886; GO:0007165; GO:0016020; GO:0046068; GO:0046872; GO:0047555	"membrane [GO:0016020]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]"
PGEN_.00g246010	Scaffold_12	9622541	9688483	Q9YHB5	CND3_XENLA	Condensin complex subunit 3 (Chromosome assembly protein xCAP-G) (Chromosome-associated protein G) (Condensin subunit CAP-G) (Non-SMC condensin I complex subunit G)	GO:0000796; GO:0005634; GO:0005829; GO:0007076; GO:0051301	condensin complex [GO:0000796]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]
PGEN_.00g246020	Scaffold_12	9695979	9696488	NA	NA	NA	NA	NA
PGEN_.00g246030	Scaffold_12	9701598	9702935	P35363	5HT2A_MOUSE	5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A)	GO:0001659; GO:0001965; GO:0004930; GO:0004993; GO:0005623; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0006874; GO:0007186; GO:0007187; GO:0007200; GO:0007202; GO:0007204; GO:0007208; GO:0007210; GO:0007268; GO:0007568; GO:0007613; GO:0008144; GO:0008219; GO:0008284; GO:0010513; GO:0014059; GO:0014065; GO:0014824; GO:0014832; GO:0016020; GO:0019233; GO:0030054; GO:0030424; GO:0030425; GO:0030431; GO:0030594; GO:0031410; GO:0033674; GO:0042493; GO:0043025; GO:0043198; GO:0043267; GO:0043406; GO:0044380; GO:0044877; GO:0045600; GO:0045821; GO:0045907; GO:0048148; GO:0050731; GO:0050965; GO:0050966; GO:0051209; GO:0051378; GO:0051967; GO:0070374; GO:0070852; GO:0071886; GO:0098978; GO:0099055; GO:0099056; GO:2000300	"axon [GO:0030424]; caveola [GO:0005901]; cell [GO:0005623]; cell body fiber [GO:0070852]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; G-protein alpha-subunit binding [GO:0001965]; neurotransmitter receptor activity [GO:0030594]; protein-containing complex binding [GO:0044877]; serotonin binding [GO:0051378]; activation of phospholipase C activity [GO:0007202]; aging [GO:0007568]; artery smooth muscle contraction [GO:0014824]; behavioral response to cocaine [GO:0048148]; cell death [GO:0008219]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; memory [GO:0007613]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glycolytic process [GO:0045821]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; positive regulation of vasoconstriction [GO:0045907]; protein localization to cytoskeleton [GO:0044380]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]; sensory perception of pain [GO:0019233]; serotonin receptor signaling pathway [GO:0007210]; sleep [GO:0030431]; temperature homeostasis [GO:0001659]; urinary bladder smooth muscle contraction [GO:0014832]"
PGEN_.00g246040	Scaffold_12	9765816	9812572	O35382	EXOC4_MOUSE	Exocyst complex component 4 (Exocyst complex component Sec8)	GO:0000145; GO:0005623; GO:0005737; GO:0005886; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0017160; GO:0030010; GO:0030165; GO:0030426; GO:0031252; GO:0032584; GO:0032991; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0043209; GO:0044091; GO:0044877; GO:0045202; GO:0047485; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0090522; GO:0090543	cell [GO:0005623]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; Ral GTPase binding [GO:0017160]; chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]
PGEN_.00g246050	Scaffold_12	9814166	9832406	Q6GMF8	RHDF1_DANRE	Inactive rhomboid protein 1 (iRhom1) (Rhomboid family member 1)	GO:0000139; GO:0005789; GO:0006508; GO:0008283; GO:0015031; GO:0016021; GO:0016477; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0061136	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; growth factor binding [GO:0019838]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708]
PGEN_.00g246060	Scaffold_12	9833490	9847773	Q3SZ21	RPP30_BOVIN	Ribonuclease P protein subunit p30 (RNaseP protein p30) (EC 3.1.26.5) (RNase P subunit 2)	GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005655; GO:0006364; GO:0008033; GO:0033204	nucleolar ribonuclease P complex [GO:0005655]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]
PGEN_.00g246070	Scaffold_12	9848044	9864242	Q9Y297	FBW1A_HUMAN	F-box/WD repeat-containing protein 1A (E3RSIkappaB) (Epididymis tissue protein Li 2a) (F-box and WD repeats protein beta-TrCP) (pIkappaBalpha-E3 receptor subunit)	GO:0000086; GO:0000209; GO:0000462; GO:0002223; GO:0005654; GO:0005829; GO:0006470; GO:0006511; GO:0007165; GO:0008013; GO:0016032; GO:0016055; GO:0016567; GO:0016874; GO:0019005; GO:0031146; GO:0031648; GO:0032040; GO:0033598; GO:0034388; GO:0038061; GO:0038095; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0043433; GO:0043687; GO:0045309; GO:0045862; GO:0045879; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0050852; GO:0051403; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070498; GO:0071407; GO:1901990	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; SCF ubiquitin ligase complex [GO:0019005]; small-subunit processome [GO:0032040]; beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin protein ligase activity [GO:0061630]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; Fc-epsilon receptor signaling pathway [GO:0038095]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; mammary gland epithelial cell proliferation [GO:0033598]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g246080	Scaffold_12	9873773	9874225	NA	NA	NA	NA	NA
PGEN_.00g246090	Scaffold_12	9874445	9898533	O93309	SMC3_XENLA	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3)	GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0030893; GO:0051276; GO:0051301; GO:0051321	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]"
PGEN_.00g246100	Scaffold_12	9898632	9913293	O93309	SMC3_XENLA	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3)	GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0030893; GO:0051276; GO:0051301; GO:0051321	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]"
PGEN_.00g246110	Scaffold_12	9944029	9944767	NA	NA	NA	NA	NA
PGEN_.00g246120	Scaffold_12	9951586	9954453	NA	NA	NA	NA	NA
PGEN_.00g246130	Scaffold_12	9954548	9963911	Q00808	HETE1_PODAS	Vegetative incompatibility protein HET-E-1	GO:0005525	GTP binding [GO:0005525]
PGEN_.00g246140	Scaffold_12	9969195	9969443	NA	NA	NA	NA	NA
PGEN_.00g246150	Scaffold_12	10074215	10075925	NA	NA	NA	NA	NA
PGEN_.00g246160	Scaffold_12	10162378	10164141	O77408	OAR1_LYMST	Octopamine receptor 1 (OA1)	GO:0005887; GO:0016907; GO:0045202	integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]
PGEN_.00g246170	Scaffold_12	10200610	10200903	NA	NA	NA	NA	NA
PGEN_.00g246180	Scaffold_12	10201918	10222232	Q8R4S6	AHR_MUSMC	Aryl hydrocarbon receptor (Ah receptor) (AhR)	GO:0000122; GO:0000981; GO:0001094; GO:0001223; GO:0001541; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006805; GO:0007049; GO:0008134; GO:0009410; GO:0009636; GO:0010468; GO:0010693; GO:0014070; GO:0015643; GO:0017025; GO:0019933; GO:0030850; GO:0030888; GO:0032922; GO:0032991; GO:0033689; GO:0034751; GO:0035326; GO:0042802; GO:0042803; GO:0043565; GO:0044212; GO:0045668; GO:0045892; GO:0045893; GO:0045899; GO:0045944; GO:0046982; GO:0048608; GO:0048732; GO:0051879; GO:0070888; GO:0071320; GO:1903170; GO:1904322; GO:1904613; GO:1904682; GO:1990837; GO:2000279	"aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enhancer binding [GO:0035326]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; toxic substance binding [GO:0015643]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to 3-methylcholanthrene [GO:1904682]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; circadian regulation of gene expression [GO:0032922]; gland development [GO:0048732]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ovarian follicle development [GO:0001541]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; regulation of B cell proliferation [GO:0030888]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; reproductive structure development [GO:0048608]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; transcription by RNA polymerase II [GO:0006366]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g246190	Scaffold_12	10222766	10250277	Q9BZH6	WDR11_HUMAN	WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15)	GO:0005623; GO:0005634; GO:0005737; GO:0005765; GO:0005802; GO:0005829; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0016020; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041	axoneme [GO:0005930]; cell [GO:0005623]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041]
PGEN_.00g246200	Scaffold_12	10252685	10260561	Q0VBU9	PLPP4_MOUSE	Phospholipid phosphatase 4 (EC 3.1.3.4) (Phosphatidic acid phosphatase type 2 domain-containing protein 1A)	GO:0001835; GO:0005887; GO:0006644; GO:0008195; GO:0016791; GO:0042802; GO:0046839	integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; blastocyst hatching [GO:0001835]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]
PGEN_.00g246210	Scaffold_12	10269331	10271586	NA	NA	NA	NA	NA
PGEN_.00g246220	Scaffold_12	10279973	10313257	Q8K1X1	WDR11_MOUSE	WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2)	GO:0005623; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041	axoneme [GO:0005930]; cell [GO:0005623]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041]
PGEN_.00g246230	Scaffold_12	10319907	10323843	Q9R1R2	TRIM3_MOUSE	Tripartite motif-containing protein 3 (RING finger protein 22) (RING finger protein HAC1)	GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0043161; GO:0061630; GO:0098794; GO:0098978	cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]
PGEN_.00g246240	Scaffold_12	10383968	10392074	Q9NWX6	THG1_HUMAN	Probable tRNA(His) guanylyltransferase (EC 2.7.7.79) (Interphase cytoplasmic foci protein 45) (tRNA-histidine guanylyltransferase)	GO:0000049; GO:0000287; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0006400; GO:0008033; GO:0008193; GO:0016779; GO:0042802; GO:0051289; GO:1990234	cytosol [GO:0005829]; mitochondrion [GO:0005739]; transferase complex [GO:1990234]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; tRNA guanylyltransferase activity [GO:0008193]; protein homotetramerization [GO:0051289]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]
PGEN_.00g246250	Scaffold_12	10393364	10393717	NA	NA	NA	NA	NA
PGEN_.00g246260	Scaffold_12	10394240	10405081	NA	NA	NA	NA	NA
PGEN_.00g246270	Scaffold_12	10406082	10410197	NA	NA	NA	NA	NA
PGEN_.00g246280	Scaffold_12	10421404	10448530	O19071	MGAT2_PIG	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)"	GO:0000139; GO:0005795; GO:0008455; GO:0009312; GO:0016021; GO:0018279; GO:0030145; GO:0042803	"Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation via asparagine [GO:0018279]"
PGEN_.00g246290	Scaffold_12	10453298	10467435	NA	NA	NA	NA	NA
PGEN_.00g246300	Scaffold_12	10479702	10480270	NA	NA	NA	NA	NA
PGEN_.00g246310	Scaffold_12	10489480	10490130	NA	NA	NA	NA	NA
PGEN_.00g246320	Scaffold_12	10527316	10531547	NA	NA	NA	NA	NA
PGEN_.00g246330	Scaffold_12	10532765	10568997	Q969F9	HPS3_HUMAN	Hermansky-Pudlak syndrome 3 protein	GO:0005737; GO:0006996; GO:0031084; GO:0043473	BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; organelle organization [GO:0006996]; pigmentation [GO:0043473]
PGEN_.00g246340	Scaffold_12	10569473	10585600	Q8C9M2	CCD15_MOUSE	Coiled-coil domain-containing protein 15	GO:0005813	centrosome [GO:0005813]
PGEN_.00g246350	Scaffold_12	10587489	10589736	NA	NA	NA	NA	NA
PGEN_.00g246360	Scaffold_12	10634682	10636010	NA	NA	NA	NA	NA
PGEN_.00g246370	Scaffold_12	10643909	10656204	P38673	ACTZ_NEUCR	Actin-like protein (Centractin)	GO:0000132; GO:0005524; GO:0005623; GO:0005813; GO:0005869; GO:0030473; GO:0099738	cell [GO:0005623]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; dynactin complex [GO:0005869]; ATP binding [GO:0005524]; establishment of mitotic spindle orientation [GO:0000132]; nuclear migration along microtubule [GO:0030473]
PGEN_.00g246380	Scaffold_12	10659181	10676462	Q5SNQ7	SRAC1_DANRE	Protein SERAC1 (Serine active site-containing protein 1)	GO:0005739; GO:0005783; GO:0008654; GO:0016021	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; phospholipid biosynthetic process [GO:0008654]
PGEN_.00g246390	Scaffold_12	10692183	10703494	Q8IZJ3	CPMD8_HUMAN	C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8	GO:0001654; GO:0004867; GO:0005615; GO:0005886	extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; eye development [GO:0001654]
PGEN_.00g246400	Scaffold_12	10705498	10712178	NA	NA	NA	NA	NA
PGEN_.00g246410	Scaffold_12	10716464	10717018	NA	NA	NA	NA	NA
PGEN_.00g246420	Scaffold_12	10727104	10729389	NA	NA	NA	NA	NA
PGEN_.00g246430	Scaffold_12	10736857	10737246	NA	NA	NA	NA	NA
PGEN_.00g246440	Scaffold_12	10741188	10754245	Q969Q5	RAB24_HUMAN	Ras-related protein Rab-24	GO:0003924; GO:0005525; GO:0005776; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0030667; GO:0032482; GO:0043312	autophagosome [GO:0005776]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; Rab protein signal transduction [GO:0032482]
PGEN_.00g246450	Scaffold_12	10762636	10772502	Q8CIR4	TRPM6_MOUSE	Transient receptor potential cation channel subfamily M member 6 (EC 2.7.11.1) (Channel kinase 2) (Melastatin-related TRP cation channel 6)	GO:0004674; GO:0005261; GO:0005262; GO:0005524; GO:0009636; GO:0016021; GO:0016324; GO:0030001; GO:0031526; GO:0046872; GO:0051262	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; metal ion transport [GO:0030001]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636]
PGEN_.00g246460	Scaffold_12	10772856	10783434	Q9BX84	TRPM6_HUMAN	Transient receptor potential cation channel subfamily M member 6 (EC 2.7.11.1) (Channel kinase 2) (Melastatin-related TRP cation channel 6)	GO:0004674; GO:0005262; GO:0005524; GO:0005886; GO:0009636; GO:0016021; GO:0016324; GO:0031526; GO:0046872; GO:0051262; GO:0070588	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; calcium ion transmembrane transport [GO:0070588]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636]
PGEN_.00g246470	Scaffold_12	10791898	10803707	Q969Q5	RAB24_HUMAN	Ras-related protein Rab-24	GO:0003924; GO:0005525; GO:0005776; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0030667; GO:0032482; GO:0043312	autophagosome [GO:0005776]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; Rab protein signal transduction [GO:0032482]
PGEN_.00g246480	Scaffold_12	10807690	10808079	NA	NA	NA	NA	NA
PGEN_.00g246490	Scaffold_12	10815504	10817480	NA	NA	NA	NA	NA
PGEN_.00g246500	Scaffold_12	10821236	10822323	NA	NA	NA	NA	NA
PGEN_.00g246510	Scaffold_12	10827923	10828477	NA	NA	NA	NA	NA
PGEN_.00g246520	Scaffold_12	10832760	10839440	NA	NA	NA	NA	NA
PGEN_.00g246530	Scaffold_12	10841441	10852811	Q8IZJ3	CPMD8_HUMAN	C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8	GO:0001654; GO:0004867; GO:0005615; GO:0005886	extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; eye development [GO:0001654]
PGEN_.00g246540	Scaffold_12	10868528	10888049	Q5SNQ7	SRAC1_DANRE	Protein SERAC1 (Serine active site-containing protein 1)	GO:0005739; GO:0005783; GO:0008654; GO:0016021	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; phospholipid biosynthetic process [GO:0008654]
PGEN_.00g246550	Scaffold_12	10888833	10902661	Q4R6J9	ACTZ_MACFA	Alpha-centractin	GO:0005524; GO:0005815; GO:0005938	cell cortex [GO:0005938]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]
PGEN_.00g246560	Scaffold_12	10910705	10912034	NA	NA	NA	NA	NA
PGEN_.00g246570	Scaffold_12	10956943	10959177	NA	NA	NA	NA	NA
PGEN_.00g246580	Scaffold_12	10961065	10977238	Q8C9M2	CCD15_MOUSE	Coiled-coil domain-containing protein 15	GO:0005813	centrosome [GO:0005813]
PGEN_.00g246590	Scaffold_12	10977736	11007629	Q969F9	HPS3_HUMAN	Hermansky-Pudlak syndrome 3 protein	GO:0005737; GO:0006996; GO:0031084; GO:0043473	BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; organelle organization [GO:0006996]; pigmentation [GO:0043473]
PGEN_.00g246600	Scaffold_12	11008859	11010802	NA	NA	NA	NA	NA
PGEN_.00g246610	Scaffold_12	11049643	11050851	NA	NA	NA	NA	NA
PGEN_.00g246620	Scaffold_12	11060082	11061353	NA	NA	NA	NA	NA
PGEN_.00g246630	Scaffold_12	11091327	11116449	O19071	MGAT2_PIG	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)"	GO:0000139; GO:0005795; GO:0008455; GO:0009312; GO:0016021; GO:0018279; GO:0030145; GO:0042803	"Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation via asparagine [GO:0018279]"
PGEN_.00g246640	Scaffold_12	11116488	11119120	Q09326	MGAT2_RAT	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)"	GO:0000139; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016021; GO:0018279; GO:0030145; GO:0030246; GO:0042803	"Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"
PGEN_.00g246650	Scaffold_12	11129631	11133703	NA	NA	NA	NA	NA
PGEN_.00g246660	Scaffold_12	11133423	11133665	NA	NA	NA	NA	NA
PGEN_.00g246670	Scaffold_12	11133774	11145048	NA	NA	NA	NA	NA
PGEN_.00g246680	Scaffold_12	11145511	11163579	NA	NA	NA	NA	NA
PGEN_.00g246690	Scaffold_12	11223536	11230168	NA	NA	NA	NA	NA
PGEN_.00g246700	Scaffold_12	11239118	11281640	Q4J9D2	Y1252_SULAC	Uncharacterized protein Saci_1252		
PGEN_.00g246710	Scaffold_12	11297767	11308121	NA	NA	NA	NA	NA
PGEN_.00g246720	Scaffold_12	11354991	11355206	NA	NA	NA	NA	NA
PGEN_.00g246730	Scaffold_12	11373674	11489684	Q8TDB6	DTX3L_HUMAN	E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2)	GO:0000209; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g246740	Scaffold_12	11490868	11581389	Q3UIR3	DTX3L_MOUSE	E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L)	GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g246750	Scaffold_12	11638367	11699893	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g246760	Scaffold_12	11711826	11714602	NA	NA	NA	NA	NA
PGEN_.00g246770	Scaffold_12	11721946	11733330	NA	NA	NA	NA	NA
PGEN_.00g246780	Scaffold_12	11733072	11733311	NA	NA	NA	NA	NA
PGEN_.00g246790	Scaffold_12	11770275	11772463	NA	NA	NA	NA	NA
PGEN_.00g246800	Scaffold_12	11772595	11777224	NA	NA	NA	NA	NA
PGEN_.00g246810	Scaffold_12	11819898	11825312	NA	NA	NA	NA	NA
PGEN_.00g246820	Scaffold_12	11840703	11841110	NA	NA	NA	NA	NA
PGEN_.00g246830	Scaffold_12	11842241	11845916	NA	NA	NA	NA	NA
PGEN_.00g246840	Scaffold_12	11870211	11873457	NA	NA	NA	NA	NA
PGEN_.00g246850	Scaffold_12	11875777	11876860	NA	NA	NA	NA	NA
PGEN_.00g246860	Scaffold_12	11877427	11898566	NA	NA	NA	NA	NA
PGEN_.00g246870	Scaffold_12	11898594	11898974	NA	NA	NA	NA	NA
PGEN_.00g246880	Scaffold_12	11899161	11899673	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g246890	Scaffold_12	11899797	11903829	NA	NA	NA	NA	NA
PGEN_.00g246900	Scaffold_12	11906088	11955088	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g246910	Scaffold_12	11962573	11967780	Q0IJ33	TM129_XENTR	E3 ubiquitin-protein ligase TM129 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TM129)	GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0046872; GO:0061630	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; response to unfolded protein [GO:0006986]
PGEN_.00g246920	Scaffold_12	11991244	12013097	NA	NA	NA	NA	NA
PGEN_.00g246930	Scaffold_12	12014712	12022712	Q5ZI51	ARHL2_CHICK	ADP-ribose glycohydrolase ARH3 (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-)	GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005739; GO:0005759; GO:0006281; GO:0061463; GO:0090734; GO:0140290; GO:0140292	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; DNA repair [GO:0006281]; peptidyl-serine ADP-deribosylation [GO:0140290]"
PGEN_.00g246940	Scaffold_12	12060821	12064349	P48964	MPIP1_MOUSE	M-phase inducer phosphatase 1 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25A)	GO:0000082; GO:0000086; GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0009314; GO:0010971; GO:0019901; GO:0034644; GO:0045931; GO:0051087; GO:0051301; GO:0110032; GO:1904056	cytoplasm [GO:0005737]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; response to radiation [GO:0009314]
PGEN_.00g246950	Scaffold_12	12071708	12075982	NA	NA	NA	NA	NA
PGEN_.00g246960	Scaffold_12	12093937	12095924	NA	NA	NA	NA	NA
PGEN_.00g246970	Scaffold_12	12099929	12111271	Q8ZXT3	Y1111_PYRAE	Uncharacterized protein PAE1111		
PGEN_.00g246980	Scaffold_12	12113450	12122253	NA	NA	NA	NA	NA
PGEN_.00g246990	Scaffold_12	12123091	12123856	NA	NA	NA	NA	NA
PGEN_.00g247000	Scaffold_12	12131400	12149899	NA	NA	NA	NA	NA
PGEN_.00g247010	Scaffold_12	12142127	12144321	NA	NA	NA	NA	NA
PGEN_.00g247020	Scaffold_12	12150017	12155753	Q80T79	CSMD3_MOUSE	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g247030	Scaffold_12	12157998	12158471	NA	NA	NA	NA	NA
PGEN_.00g247040	Scaffold_12	12158862	12159134	NA	NA	NA	NA	NA
PGEN_.00g247050	Scaffold_12	12165330	12165755	NA	NA	NA	NA	NA
PGEN_.00g247060	Scaffold_12	12165923	12267196	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g247070	Scaffold_12	12276933	12283347	NA	NA	NA	NA	NA
PGEN_.00g247080	Scaffold_12	12306709	12307281	NA	NA	NA	NA	NA
PGEN_.00g247090	Scaffold_12	12322493	12327740	Q6NRH0	KLH12_XENLA	Kelch-like protein 12	GO:0000139; GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0048208	COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]
PGEN_.00g247100	Scaffold_12	12338032	12345205	NA	NA	NA	NA	NA
PGEN_.00g247110	Scaffold_12	12395326	12425214	Q9NRA2	S17A5_HUMAN	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672	cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]
PGEN_.00g247120	Scaffold_12	12442156	12479777	NA	NA	NA	NA	NA
PGEN_.00g247130	Scaffold_12	12490292	12491439	NA	NA	NA	NA	NA
PGEN_.00g247140	Scaffold_12	12506998	12508084	P08995	NO26_SOYBN	Nodulin-26 (N-26)	GO:0009877; GO:0015267; GO:0016021; GO:0043661	integral component of membrane [GO:0016021]; peribacteroid membrane [GO:0043661]; channel activity [GO:0015267]; nodulation [GO:0009877]
PGEN_.00g247150	Scaffold_12	12521673	12556753	P0C588	CNNM4_RAT	Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4)	GO:0005886; GO:0007601; GO:0010960; GO:0015081; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0030425; GO:0032991; GO:0043025; GO:0050896; GO:0055065; GO:0070166	basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]; enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g247160	Scaffold_12	12547312	12547668	NA	NA	NA	NA	NA
PGEN_.00g247170	Scaffold_12	12571179	12577244	Q9H977	WDR54_HUMAN	WD repeat-containing protein 54	GO:0002091; GO:0031982; GO:0042058; GO:0042803; GO:0043408	vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; negative regulation of receptor internalization [GO:0002091]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of MAPK cascade [GO:0043408]
PGEN_.00g247180	Scaffold_12	12653927	12656153	NA	NA	NA	NA	NA
PGEN_.00g247190	Scaffold_12	12673148	12679308	NA	NA	NA	NA	NA
PGEN_.00g247200	Scaffold_12	12759460	12759675	NA	NA	NA	NA	NA
PGEN_.00g247210	Scaffold_12	12764637	12766007	Q9DDN6	NPY2R_CHICK	Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor)	GO:0001601; GO:0003151; GO:0003214; GO:0005886; GO:0007193; GO:0016021; GO:0097730	integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; peptide YY receptor activity [GO:0001601]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cardiac left ventricle morphogenesis [GO:0003214]; outflow tract morphogenesis [GO:0003151]
PGEN_.00g247220	Scaffold_12	12809647	12817959	NA	NA	NA	NA	NA
PGEN_.00g247230	Scaffold_12	12825456	12856177	P18433	PTPRA_HUMAN	Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)	GO:0000165; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0008286; GO:0043235; GO:0050804; GO:0070062; GO:0098685; GO:0099699	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]
PGEN_.00g247240	Scaffold_12	12859714	12863783	P08542	UDB17_RAT	"UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (EC 2.4.1.17) (17-beta-hydroxysteroid-specific UDPGT) (RLUG38) (Testosterone, dihydrotestosterone, and beta-estradiol-specific UDPGT) (UDP-glucuronosyltransferase 2B5) (UDPGT 2B5) (UDPGTr-3)"	GO:0005789; GO:0008194; GO:0015020; GO:0016021; GO:0032496; GO:0043231; GO:0071361; GO:0071378; GO:0071385; GO:0071394	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to testosterone stimulus [GO:0071394]; response to lipopolysaccharide [GO:0032496]
PGEN_.00g247250	Scaffold_12	12872061	12878482	P17717	UDB17_MOUSE	UDP-glucuronosyltransferase 2B17 (EC 2.4.1.17) (M-1) (UDP-glucuronosyltransferase 2B5) (UDPGT 2B5)	GO:0005640; GO:0005743; GO:0005783; GO:0005789; GO:0008194; GO:0015020; GO:0016021; GO:0043231	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; nuclear outer membrane [GO:0005640]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]
PGEN_.00g247260	Scaffold_12	12881662	12890467	P43679	ACHB3_CHICK	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g247270	Scaffold_12	12894966	12917488	P49580	ACHE_XENLA	Acetylcholine receptor subunit epsilon	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g247280	Scaffold_12	12942656	12956001	Q8NCG5	CHST4_HUMAN	Carbohydrate sulfotransferase 4 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3) (GST-3) (High endothelial cells N-acetylglucosamine 6-O-sulfotransferase) (HEC-GlcNAc6ST) (L-selectin ligand sulfotransferase) (LSST) (N-acetylglucosamine 6-O-sulfotransferase 2) (GlcNAc6ST-2) (Gn6st-2)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006477; GO:0006790; GO:0006954; GO:0006955; GO:0007155; GO:0007267; GO:0008146; GO:0016021; GO:0016266; GO:0018146; GO:0031228	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; O-glycan processing [GO:0016266]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g247290	Scaffold_12	12959458	12959838	NA	NA	NA	NA	NA
PGEN_.00g247300	Scaffold_12	12962256	12962474	NA	NA	NA	NA	NA
PGEN_.00g247310	Scaffold_12	12968431	12990784	Q61830	MRC1_MOUSE	Macrophage mannose receptor 1 (MMR) (CD antigen CD206)	GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g247320	Scaffold_12	12999655	12999981	NA	NA	NA	NA	NA
PGEN_.00g247330	Scaffold_12	13004954	13069061	Q9UHI7	S23A1_HUMAN	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3)	GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016324; GO:0019852; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g247340	Scaffold_12	13084887	13117882	P78314	3BP2_HUMAN	SH3 domain-binding protein 2 (3BP-2)	GO:0001784; GO:0005070; GO:0007165; GO:0017124	phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; signal transduction [GO:0007165]
PGEN_.00g247350	Scaffold_12	13187254	13195159	O75897	ST1C4_HUMAN	Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2)	GO:0004062; GO:0005829; GO:0006068; GO:0008146; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923]
PGEN_.00g247360	Scaffold_12	13199868	13201299	P63046	ST4A1_MOUSE	Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (mBR-STL) (Nervous system sulfotransferase) (NST)	GO:0005737; GO:0006790; GO:0008146; GO:0008202; GO:0042802	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g247370	Scaffold_12	13210946	13211596	Q9QWG7	ST1B1_MOUSE	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (DOPA/tyrosine sulfotransferase)	GO:0004062; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g247380	Scaffold_12	13213470	13222150	P63047	ST4A1_RAT	Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (rBR-STL) (Nervous system sulfotransferase) (NST)	GO:0005737; GO:0006790; GO:0008146; GO:0008202; GO:0042802	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g247390	Scaffold_12	13228665	13256315	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g247400	Scaffold_12	13269384	13278438	P30114	GST28_SCHHA	Glutathione S-transferase class-mu 28 kDa isozyme (GST 28) (EC 2.5.1.18) (Sh28GST)	GO:0004364	glutathione transferase activity [GO:0004364]
PGEN_.00g247410	Scaffold_12	13295163	13301998	P26624	GST28_SCHJA	Glutathione S-transferase class-mu 28 kDa isozyme (GST 28) (EC 2.5.1.18) (Sj28 antigen) (Sj28GST) (Fragment)	GO:0004364	glutathione transferase activity [GO:0004364]
PGEN_.00g247420	Scaffold_12	13384347	13384733	NA	NA	NA	NA	NA
PGEN_.00g247430	Scaffold_12	13384758	13385529	NA	NA	NA	NA	NA
PGEN_.00g247440	Scaffold_12	13393772	13395355	Q90WY6	ADA2C_DANRE	Alpha-2C adrenergic receptor (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR)	GO:0004935; GO:0004938; GO:0005886; GO:0005887; GO:0006940; GO:0007186; GO:0007188; GO:0019229; GO:0030168; GO:0071880; GO:0071881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; platelet activation [GO:0030168]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229]
PGEN_.00g247450	Scaffold_12	13431549	13432919	NA	NA	NA	NA	NA
PGEN_.00g247460	Scaffold_12	13464090	13485708	Q0VCA3	LETM1_BOVIN	Mitochondrial proton/calcium exchanger protein (Leucine zipper-EF-hand-containing transmembrane protein 1)	GO:0005509; GO:0005623; GO:0005743; GO:0006851; GO:0015369; GO:0016021; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0051562; GO:0099093; GO:1900069	cell [GO:0005623]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022]; calcium export from the mitochondrion [GO:0099093]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069]
PGEN_.00g247470	Scaffold_12	13500728	13503382	NA	NA	NA	NA	NA
PGEN_.00g247480	Scaffold_12	13505397	13529119	Q5PQR6	THEGL_RAT	Testicular haploid expressed gene protein-like		
PGEN_.00g247490	Scaffold_12	13534609	13546010	Q5ZJK8	TCPH_CHICK	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)	GO:0005524; GO:0005832; GO:0006457; GO:0051082	chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]
PGEN_.00g247500	Scaffold_12	13546082	13546978	NA	NA	NA	NA	NA
PGEN_.00g247510	Scaffold_12	13550675	13553048	Q9PTK2	FOXE4_XENLA	Forkhead box protein E4 (FoxE4) (Xlens1)	GO:0002088; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0043565	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; lens development in camera-type eye [GO:0002088]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g247520	Scaffold_12	13559719	13570428	Q91770	NOT2_XENLA	Homeobox protein not2 (Xnot-2) (Xnot2)	GO:0005634; GO:0014028; GO:0043565; GO:0045892	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; notochord formation [GO:0014028]"
PGEN_.00g247530	Scaffold_12	13580320	13584882	NA	NA	NA	NA	NA
PGEN_.00g247540	Scaffold_12	13595037	13599397	NA	NA	NA	NA	NA
PGEN_.00g247550	Scaffold_12	13607375	13613713	Q9Y606	TRUA_HUMAN	tRNA pseudouridine synthase A (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I)	GO:0000049; GO:0002153; GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0009982; GO:0031119; GO:0070902; GO:0106029; GO:1990481	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]
PGEN_.00g247560	Scaffold_12	13616467	13618103	NA	NA	NA	NA	NA
PGEN_.00g247570	Scaffold_12	13618151	13620526	NA	NA	NA	NA	NA
PGEN_.00g247580	Scaffold_12	13621431	13632824	Q9NRA2	S17A5_HUMAN	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672	cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]
PGEN_.00g247590	Scaffold_12	13708477	13724833	NA	NA	NA	NA	NA
PGEN_.00g247600	Scaffold_12	13726861	13728105	NA	NA	NA	NA	NA
PGEN_.00g247610	Scaffold_12	13742097	13753254	NA	NA	NA	NA	NA
PGEN_.00g247620	Scaffold_12	13753344	13798734	NA	NA	NA	NA	NA
PGEN_.00g247630	Scaffold_12	13809569	13831832	O95394	AGM1_HUMAN	Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3)	GO:0000287; GO:0004610; GO:0004614; GO:0005829; GO:0005975; GO:0006041; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0019255; GO:0030097	cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]
PGEN_.00g247640	Scaffold_12	13833046	13836341	F1RQM2	AGM1_PIG	Phosphoacetylglucosamine mutase (PAGM) (PGlcNAc mutase) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3)	GO:0000287; GO:0004610; GO:0004614; GO:0005975; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0019255; GO:0030097	magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]
PGEN_.00g247650	Scaffold_12	13838065	13857726	NA	NA	NA	NA	NA
PGEN_.00g247660	Scaffold_12	13901973	13903139	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g247670	Scaffold_12	13918883	13935344	NA	NA	NA	NA	NA
PGEN_.00g247680	Scaffold_12	13943318	13953847	Q6GR10	MAEA_XENLA	E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Macrophage erythroblast attacher)	GO:0003779; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0007049; GO:0016363; GO:0016740; GO:0043249; GO:0045721; GO:0046872; GO:0051301	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; erythrocyte maturation [GO:0043249]; negative regulation of gluconeogenesis [GO:0045721]
PGEN_.00g247690	Scaffold_12	13980867	13982758	O46036	CTBP_DROME	C-terminal-binding protein (CtBP protein) (dCtBP)	GO:0000122; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0016360; GO:0016616; GO:0022416; GO:0031010; GO:0035220; GO:0042802; GO:0042803; GO:0043044; GO:0045892; GO:0045944; GO:0051287; GO:0070491; GO:0090090; GO:0090263	"ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220]"
PGEN_.00g247700	Scaffold_12	14003052	14022450	NA	NA	NA	NA	NA
PGEN_.00g247710	Scaffold_12	14025257	14036778	NA	NA	NA	NA	NA
PGEN_.00g247720	Scaffold_12	14041469	14052266	Q925N0	SFXN5_MOUSE	Sideroflexin-5	GO:0005739; GO:0005743; GO:0006865; GO:0015137; GO:0015746; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; citrate transmembrane transporter activity [GO:0015137]; amino acid transport [GO:0006865]; citrate transport [GO:0015746]
PGEN_.00g247730	Scaffold_12	14063143	14063475	NA	NA	NA	NA	NA
PGEN_.00g247740	Scaffold_12	14071895	14084148	Q04742	EMX1_MOUSE	Homeobox protein EMX1 (Empty spiracles homolog 1) (Empty spiracles-like protein 1)	GO:0000978; GO:0001162; GO:0001227; GO:0001701; GO:0005634; GO:0005730; GO:0006357; GO:0007417; GO:0007420; GO:0009791; GO:0021537; GO:0021796; GO:0021895; GO:0021987; GO:0030182; GO:0042493; GO:0048854; GO:0048872; GO:0060019; GO:0060563; GO:0070445; GO:1990138	"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; neuron projection extension [GO:1990138]; post-embryonic development [GO:0009791]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; telencephalon development [GO:0021537]"
PGEN_.00g247750	Scaffold_12	14098304	14099293	NA	NA	NA	NA	NA
PGEN_.00g247760	Scaffold_12	14131702	14146376	Q04742	EMX1_MOUSE	Homeobox protein EMX1 (Empty spiracles homolog 1) (Empty spiracles-like protein 1)	GO:0000978; GO:0001162; GO:0001227; GO:0001701; GO:0005634; GO:0005730; GO:0006357; GO:0007417; GO:0007420; GO:0009791; GO:0021537; GO:0021796; GO:0021895; GO:0021987; GO:0030182; GO:0042493; GO:0048854; GO:0048872; GO:0060019; GO:0060563; GO:0070445; GO:1990138	"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; neuron projection extension [GO:1990138]; post-embryonic development [GO:0009791]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; telencephalon development [GO:0021537]"
PGEN_.00g247770	Scaffold_12	14171579	14187324	P18488	EMS_DROME	Homeotic protein empty spiracles	GO:0000977; GO:0000978; GO:0001700; GO:0003700; GO:0005634; GO:0007389; GO:0007409; GO:0007419; GO:0007420; GO:0007424; GO:0010468; GO:0014019; GO:0030154; GO:0035277; GO:0035284; GO:0035288; GO:0043565; GO:0045944; GO:0048813	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior head segmentation [GO:0035288]; axonogenesis [GO:0007409]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cell differentiation [GO:0030154]; dendrite morphogenesis [GO:0048813]; embryonic development via the syncytial blastoderm [GO:0001700]; neuroblast development [GO:0014019]; open tracheal system development [GO:0007424]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spiracle morphogenesis, open tracheal system [GO:0035277]; ventral cord development [GO:0007419]"
PGEN_.00g247780	Scaffold_12	14196864	14220502	NA	NA	NA	NA	NA
PGEN_.00g247790	Scaffold_12	14242584	14245160	Q96A46	MFRN2_HUMAN	Mitoferrin-2 (Mitochondrial RNA-splicing protein 3/4 homolog) (MRS3/4) (hMRS3/4) (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28)	GO:0005381; GO:0005743; GO:0016021; GO:0048250; GO:0055072	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; iron ion transmembrane transporter activity [GO:0005381]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]
PGEN_.00g247800	Scaffold_12	14267021	14272605	Q5RFI2	RAB28_PONAB	Ras-related protein Rab-28	GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0019003; GO:0035253; GO:0036064	ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]
PGEN_.00g247810	Scaffold_12	14273211	14337825	Q59I72	CTNA1_RABIT	Catenin alpha-1	GO:0005198; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0015629; GO:0045296; GO:0051015	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]
PGEN_.00g247820	Scaffold_12	14341546	14364645	Q2T9K2	AP2E_XENLA	Transcription factor AP-2-epsilon (AP-2-epsilon)	GO:0003677; GO:0003700; GO:0005634	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]
PGEN_.00g247830	Scaffold_12	14374039	14409207	Q96XY5	Y2383_SULTO	Uncharacterized protein STK_23830		
PGEN_.00g247840	Scaffold_12	14456857	14457717	NA	NA	NA	NA	NA
PGEN_.00g247850	Scaffold_12	14458237	14459511	NA	NA	NA	NA	NA
PGEN_.00g247860	Scaffold_12	14475321	14480190	Q0V9L1	MMS19_XENTR	MMS19 nucleotide excision repair protein homolog (MMS19-like protein)	GO:0005634; GO:0005737; GO:0006259; GO:0006281; GO:0006974; GO:0007059; GO:0016226; GO:0045893; GO:0071817; GO:0097361; GO:0097428; GO:1905168	"CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation by iron-sulfur cluster transfer [GO:0097428]"
PGEN_.00g247870	Scaffold_12	14501199	14532031	E1BP36	MMS19_BOVIN	MMS19 nucleotide excision repair protein homolog (MMS19-like protein)	GO:0003713; GO:0005654; GO:0005737; GO:0006259; GO:0006281; GO:0006974; GO:0007059; GO:0016226; GO:0019899; GO:0030331; GO:0045893; GO:0071817; GO:0097361; GO:0097428; GO:1905168	"CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; transcription coactivator activity [GO:0003713]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation by iron-sulfur cluster transfer [GO:0097428]"
PGEN_.00g247880	Scaffold_12	14532304	14536159	Q6PGH0	UBTD2_MOUSE	Ubiquitin domain-containing protein 2	GO:0005737	cytoplasm [GO:0005737]
PGEN_.00g247890	Scaffold_12	14595677	14636519	NA	NA	NA	NA	NA
PGEN_.00g247900	Scaffold_12	14663547	14693621	NA	NA	NA	NA	NA
PGEN_.00g247910	Scaffold_12	14730113	14740606	NA	NA	NA	NA	NA
PGEN_.00g247920	Scaffold_12	14806926	14813443	NA	NA	NA	NA	NA
PGEN_.00g247930	Scaffold_12	14828932	14853741	Q5XH07	THNS2_XENLA	Threonine synthase-like 2 (TSH2) (EC 4.2.3.-)	GO:0016829	lyase activity [GO:0016829]
PGEN_.00g247940	Scaffold_12	14855296	14856669	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g247950	Scaffold_12	14876042	14889260	NA	NA	NA	NA	NA
PGEN_.00g247960	Scaffold_12	14894146	14896583	Q9WV75	SPON2_RAT	Spondin-2 (Mindin)	GO:0001530; GO:0002448; GO:0003823; GO:0005102; GO:0005615; GO:0007155; GO:0008228; GO:0031012; GO:0032496; GO:0032755; GO:0032760; GO:0042742; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0071222	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496]
PGEN_.00g247970	Scaffold_12	14918129	14919804	NA	NA	NA	NA	NA
PGEN_.00g247980	Scaffold_12	14926083	14932866	Q8IYB9	ZN595_HUMAN	Zinc finger protein 595	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g247990	Scaffold_12	14939492	14945184	NA	NA	NA	NA	NA
PGEN_.00g248000	Scaffold_12	14976649	14980532	Q8BMS2	SPON2_MOUSE	Spondin-2 (Mindin)	GO:0001530; GO:0002448; GO:0003823; GO:0005102; GO:0005615; GO:0007155; GO:0008228; GO:0031012; GO:0032496; GO:0032755; GO:0032760; GO:0042742; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0071222	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496]
PGEN_.00g248010	Scaffold_12	14981482	14982070	NA	NA	NA	NA	NA
PGEN_.00g248020	Scaffold_12	14997397	15000133	NA	NA	NA	NA	NA
PGEN_.00g248030	Scaffold_12	15036709	15049884	NA	NA	NA	NA	NA
PGEN_.00g248040	Scaffold_12	15067180	15074191	P47845	LEG3_RABIT	Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (IgE-binding protein) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen)	GO:0005576; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0019863; GO:0030154; GO:0030246; GO:0045087	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; spliceosomal complex [GO:0005681]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g248050	Scaffold_12	15119521	15124243	NA	NA	NA	NA	NA
PGEN_.00g248060	Scaffold_12	15134039	15142313	Q8VCV9	MF4B1_MOUSE	Sodium-dependent glucose transporter 1A (Major facilitator superfamily domain-containing protein 4B1)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g248070	Scaffold_12	15147741	15171684	Q9Z2B5	E2AK3_MOUSE	Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase)	GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0006412; GO:0006468; GO:0006919; GO:0006983; GO:0007029; GO:0007595; GO:0009967; GO:0010575; GO:0010628; GO:0010629; GO:0010998; GO:0016021; GO:0017148; GO:0018105; GO:0019217; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031016; GO:0031018; GO:0031642; GO:0032055; GO:0032092; GO:0032933; GO:0034198; GO:0034976; GO:0036492; GO:0036499; GO:0042149; GO:0042802; GO:0043066; GO:0045444; GO:0045943; GO:0046777; GO:0048009; GO:0048471; GO:0051260; GO:0051879; GO:0060734; GO:0070059; GO:0070417; GO:0071074; GO:1900182; GO:1902010; GO:1902235; GO:1902237; GO:1903788; GO:1990440	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic initiation factor eIF2 binding [GO:0071074]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein homooligomerization [GO:0051260]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412]
PGEN_.00g248080	Scaffold_12	15180965	15187642	P48723	HSP13_HUMAN	Heat shock 70 kDa protein 13 (Microsomal stress-70 protein ATPase core) (Stress-70 protein chaperone microsome-associated 60 kDa protein)	GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0031072; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0043231; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0070062	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g248090	Scaffold_12	15192994	15195222	NA	NA	NA	NA	NA
PGEN_.00g248100	Scaffold_12	15234675	15235055	NA	NA	NA	NA	NA
PGEN_.00g248110	Scaffold_12	15257376	15257723	NA	NA	NA	NA	NA
PGEN_.00g248120	Scaffold_12	15265833	15267327	NA	NA	NA	NA	NA
PGEN_.00g248130	Scaffold_12	15273540	15276714	NA	NA	NA	NA	NA
PGEN_.00g248140	Scaffold_12	15276994	15284267	NA	NA	NA	NA	NA
PGEN_.00g248150	Scaffold_12	15284827	15309802	Q3UIR3	DTX3L_MOUSE	E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L)	GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g248160	Scaffold_12	15335784	15342194	Q5REG4	DTX3_PONAB	Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3)	GO:0005737; GO:0007219; GO:0016567; GO:0016740; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g248170	Scaffold_12	15389197	15394332	Q3UIR3	DTX3L_MOUSE	E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L)	GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g248180	Scaffold_12	15428989	15504329	Q8CAS9	PARP9_MOUSE	Protein mono-ADP-ribosyltransferase PARP9 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 9) (ARTD9) (B aggressive lymphoma protein homolog) (Poly [ADP-ribose] polymerase 9) (PARP-9)	GO:0000122; GO:0002230; GO:0003714; GO:0003950; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006471; GO:0010608; GO:0010629; GO:0019899; GO:0032991; GO:0035563; GO:0042393; GO:0042531; GO:0043086; GO:0044389; GO:0045087; GO:0045893; GO:0051607; GO:0060330; GO:0060335; GO:0072570; GO:0090734; GO:0097677; GO:1900182; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; ADP-D-ribose binding [GO:0072570]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; STAT family protein binding [GO:0097677]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein ligase binding [GO:0044389]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; negative regulation of catalytic activity [GO:0043086]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; posttranscriptional regulation of gene expression [GO:0010608]; protein ADP-ribosylation [GO:0006471]; regulation of response to interferon-gamma [GO:0060330]"
PGEN_.00g248190	Scaffold_12	15524121	15527272	NA	NA	NA	NA	NA
PGEN_.00g248200	Scaffold_12	15540631	15540945	NA	NA	NA	NA	NA
PGEN_.00g248210	Scaffold_12	15543709	15544668	Q08C99	VRTN_DANRE	Vertnin	GO:0000122; GO:0000785; GO:0001227	"chromatin [GO:0000785]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g248220	Scaffold_12	15545091	15545363	NA	NA	NA	NA	NA
PGEN_.00g248230	Scaffold_12	15547839	15549104	NA	NA	NA	NA	NA
PGEN_.00g248240	Scaffold_12	15549364	15551904	NA	NA	NA	NA	NA
PGEN_.00g248250	Scaffold_12	15570446	15575417	NA	NA	NA	NA	NA
PGEN_.00g248260	Scaffold_12	15611784	15612383	NA	NA	NA	NA	NA
PGEN_.00g248270	Scaffold_12	15617826	15618188	NA	NA	NA	NA	NA
PGEN_.00g248280	Scaffold_12	15624993	15625379	NA	NA	NA	NA	NA
PGEN_.00g248290	Scaffold_12	15641261	15644024	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g248300	Scaffold_12	15644125	15650207	NA	NA	NA	NA	NA
PGEN_.00g248310	Scaffold_12	15661718	15662077	NA	NA	NA	NA	NA
PGEN_.00g248320	Scaffold_12	15669949	15673188	NA	NA	NA	NA	NA
PGEN_.00g248330	Scaffold_12	15675825	15676280	NA	NA	NA	NA	NA
PGEN_.00g248340	Scaffold_12	15701726	15722102	Q9P2M4	TBC14_HUMAN	TBC1 domain family member 14	GO:0005096; GO:0005654; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0010507; GO:0017137; GO:0019901; GO:0043231; GO:0055037; GO:0071955; GO:0090630; GO:2000785	autophagosome [GO:0005776]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; negative regulation of autophagy [GO:0010507]; recycling endosome to Golgi transport [GO:0071955]; regulation of autophagosome assembly [GO:2000785]
PGEN_.00g248350	Scaffold_12	15736198	15749383	NA	NA	NA	NA	NA
PGEN_.00g248360	Scaffold_12	15752088	15781610	NA	NA	NA	NA	NA
PGEN_.00g248370	Scaffold_12	15795510	15795974	NA	NA	NA	NA	NA
PGEN_.00g248380	Scaffold_12	15796019	15796399	NA	NA	NA	NA	NA
PGEN_.00g248390	Scaffold_12	15805007	15837316	G5EGQ5	MBR1_CAEEL	Mblk-1-related factor 1	GO:0003677; GO:0005634; GO:0007399	nucleus [GO:0005634]; DNA binding [GO:0003677]; nervous system development [GO:0007399]
PGEN_.00g248400	Scaffold_12	15839352	15839656	Q0VD26	MORN4_BOVIN	MORN repeat-containing protein 4 (Retinophilin)	GO:0005737; GO:0032426; GO:0032433; GO:0048678	cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; stereocilium tip [GO:0032426]; response to axon injury [GO:0048678]
PGEN_.00g248410	Scaffold_12	15846814	15847113	NA	NA	NA	NA	NA
PGEN_.00g248420	Scaffold_12	15847141	15847383	NA	NA	NA	NA	NA
PGEN_.00g248430	Scaffold_12	15847423	15848193	Q03650	CRAM_TRYBB	"Cysteine-rich, acidic integral membrane protein"	GO:0005886; GO:0006897; GO:0016021; GO:0020016	ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]
PGEN_.00g248440	Scaffold_12	15848221	15848649	NA	NA	NA	NA	NA
PGEN_.00g248450	Scaffold_12	15849069	15852986	Q0VD26	MORN4_BOVIN	MORN repeat-containing protein 4 (Retinophilin)	GO:0005737; GO:0032426; GO:0032433; GO:0048678	cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; stereocilium tip [GO:0032426]; response to axon injury [GO:0048678]
PGEN_.00g248460	Scaffold_12	15867603	15898470	Q6NZN1	PPRC1_MOUSE	Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PGC-1-related coactivator) (PRC)	GO:0003712; GO:0003723; GO:0005634; GO:0005654; GO:0008134; GO:0030374; GO:0045944; GO:0051091	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g248470	Scaffold_12	15899501	15905785	NA	NA	NA	NA	NA
PGEN_.00g248480	Scaffold_12	15931403	15934619	P35789	ZNF93_HUMAN	Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34)	GO:0000976; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]"
PGEN_.00g248490	Scaffold_12	15944951	15950995	F4KGU4	DEAHC_ARATH	"ATP-dependent RNA helicase DEAH12, chloroplastic (EC 3.6.4.13)"	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0009507; GO:0016740; GO:0046872	"chloroplast [GO:0009507]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transferase activity [GO:0016740]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g248500	Scaffold_12	15968890	15969711	NA	NA	NA	NA	NA
PGEN_.00g248510	Scaffold_12	15990589	15992228	NA	NA	NA	NA	NA
PGEN_.00g248520	Scaffold_12	15992289	16021373	Q9VEU1	CAD89_DROME	Cadherin-89D	GO:0005509; GO:0005887; GO:0007156; GO:0016339; GO:0017022; GO:0044331; GO:0098609	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g248530	Scaffold_12	16023476	16025191	NA	NA	NA	NA	NA
PGEN_.00g248540	Scaffold_12	16034651	16036474	Q92982	NINJ1_HUMAN	Ninjurin-1 (Nerve injury-induced protein 1)	GO:0001954; GO:0007155; GO:0007399; GO:0016021; GO:0042246; GO:1990384	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; nervous system development [GO:0007399]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]
PGEN_.00g248550	Scaffold_12	16091778	16103626	NA	NA	NA	NA	NA
PGEN_.00g248560	Scaffold_12	16103685	16103948	NA	NA	NA	NA	NA
PGEN_.00g248570	Scaffold_12	16147222	16159777	Q9QYF1	RDH11_MOUSE	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (Cell line MC/9.IL4-derived protein 1) (M42C60) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short-chain aldehyde dehydrogenase) (SCALD)	GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0016021; GO:0016062; GO:0033721; GO:0042572; GO:0042574; GO:0052650; GO:0110095	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; aldehyde dehydrogenase (NADP+) activity [GO:0033721]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; adaptation of rhodopsin mediated signaling [GO:0016062]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]
PGEN_.00g248580	Scaffold_12	16204821	16205174	NA	NA	NA	NA	NA
PGEN_.00g248590	Scaffold_12	16220982	16241784	Q58DA1	SPEF1_BOVIN	Sperm flagellar protein 1	GO:0005930; GO:0007026; GO:0008017; GO:0016477; GO:0031514; GO:0051493	axoneme [GO:0005930]; motile cilium [GO:0031514]; microtubule binding [GO:0008017]; cell migration [GO:0016477]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cytoskeleton organization [GO:0051493]
PGEN_.00g248600	Scaffold_12	16251742	16262805	NA	NA	NA	NA	NA
PGEN_.00g248610	Scaffold_12	16263177	16364738	Q9IBG7	KCP_XENLA	Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g248620	Scaffold_12	16380218	16390477	NA	NA	NA	NA	NA
PGEN_.00g248630	Scaffold_12	16403527	16432318	Q0VCP9	CC149_BOVIN	Coiled-coil domain-containing protein 149	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g248640	Scaffold_12	16435294	16455344	B4NKL0	TMEDE_DROWI	Transmembrane emp24 domain-containing protein eca	GO:0005789; GO:0009953; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953]
PGEN_.00g248650	Scaffold_12	16468333	16469135	NA	NA	NA	NA	NA
PGEN_.00g248660	Scaffold_12	16469290	16475966	NA	NA	NA	NA	NA
PGEN_.00g248670	Scaffold_12	16487007	16497306	NA	NA	NA	NA	NA
PGEN_.00g248680	Scaffold_12	16564300	16568541	NA	NA	NA	NA	NA
PGEN_.00g248690	Scaffold_12	16626075	16627869	NA	NA	NA	NA	NA
PGEN_.00g248700	Scaffold_12	16670635	16736721	Q0KK55	KNDC1_MOUSE	Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2)	GO:0001934; GO:0005088; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773	dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g248710	Scaffold_12	16829837	16834883	NA	NA	NA	NA	NA
PGEN_.00g248720	Scaffold_12	16835012	16842287	NA	NA	NA	NA	NA
PGEN_.00g248730	Scaffold_12	16899692	16900897	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g248740	Scaffold_12	17023584	17024192	NA	NA	NA	NA	NA
PGEN_.00g248750	Scaffold_12	17042246	17047220	NA	NA	NA	NA	NA
PGEN_.00g248760	Scaffold_12	17104598	17104882	NA	NA	NA	NA	NA
PGEN_.00g248770	Scaffold_12	17105174	17107666	NA	NA	NA	NA	NA
PGEN_.00g248780	Scaffold_12	17187993	17188592	NA	NA	NA	NA	NA
PGEN_.00g248790	Scaffold_12	17211341	17211646	NA	NA	NA	NA	NA
PGEN_.00g248800	Scaffold_12	17316868	17334287	Q6Q899	DDX58_MOUSE	Antiviral innate immune response receptor RIG-I (DEAD box protein 58) (Probable ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I)	GO:0002230; GO:0002735; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0035549; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051091; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1902741; GO:1904469; GO:1990904; GO:2000778	actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]
PGEN_.00g248810	Scaffold_12	17338091	17338378	NA	NA	NA	NA	NA
PGEN_.00g248820	Scaffold_12	17342262	17342786	NA	NA	NA	NA	NA
PGEN_.00g248830	Scaffold_12	17345086	17349254	NA	NA	NA	NA	NA
PGEN_.00g248840	Scaffold_12	17358206	17407123	Q6DRN3	NOC3L_DANRE	Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)	GO:0003682; GO:0005634; GO:0005730; GO:0007517; GO:0019216	nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; muscle organ development [GO:0007517]; regulation of lipid metabolic process [GO:0019216]
PGEN_.00g248850	Scaffold_12	17422690	17423277	NA	NA	NA	NA	NA
PGEN_.00g248860	Scaffold_12	17441649	17451585	NA	NA	NA	NA	NA
PGEN_.00g248870	Scaffold_12	17454021	17458036	NA	NA	NA	NA	NA
PGEN_.00g248880	Scaffold_12	17458147	17459337	NA	NA	NA	NA	NA
PGEN_.00g248890	Scaffold_12	17464547	17468155	NA	NA	NA	NA	NA
PGEN_.00g248900	Scaffold_12	17470244	17480556	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g248910	Scaffold_12	17535373	17535603	NA	NA	NA	NA	NA
PGEN_.00g248920	Scaffold_12	17544291	17544554	NA	NA	NA	NA	NA
PGEN_.00g248930	Scaffold_12	17550680	17562005	Q5R5M4	MOT9_PONAB	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]
PGEN_.00g248940	Scaffold_12	17565363	17573804	Q7RTY1	MOT9_HUMAN	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g248950	Scaffold_12	17592148	17606488	Q63344	MOT2_RAT	Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7)	GO:0005737; GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0035873; GO:0035879; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098978; GO:0099061; GO:1901475	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]; lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475]
PGEN_.00g248960	Scaffold_12	17610937	17612799	Q63008	SC5A5_RAT	Sodium/iodide cotransporter (Na(+)/I(-) cotransporter) (Sodium-iodide symporter) (Na(+)/I(-) symporter) (Solute carrier family 5 member 5)	GO:0005634; GO:0005886; GO:0006590; GO:0006814; GO:0008507; GO:0015111; GO:0015293; GO:0015705; GO:0016021; GO:0071320; GO:0071371	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; iodide transmembrane transporter activity [GO:0015111]; sodium:iodide symporter activity [GO:0008507]; symporter activity [GO:0015293]; cellular response to cAMP [GO:0071320]; cellular response to gonadotropin stimulus [GO:0071371]; iodide transport [GO:0015705]; sodium ion transport [GO:0006814]; thyroid hormone generation [GO:0006590]
PGEN_.00g248970	Scaffold_12	17615393	17618449	NA	NA	NA	NA	NA
PGEN_.00g248980	Scaffold_12	17634744	17637436	NA	NA	NA	NA	NA
PGEN_.00g248990	Scaffold_12	17648628	17649434	NA	NA	NA	NA	NA
PGEN_.00g249000	Scaffold_12	17691939	17692175	NA	NA	NA	NA	NA
PGEN_.00g249010	Scaffold_12	17705111	17713265	O60669	MOT2_HUMAN	Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7)	GO:0005477; GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0035873; GO:0050833; GO:1901475	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]; lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; pyruvate transmembrane transport [GO:1901475]
PGEN_.00g249020	Scaffold_12	17721274	17721615	NA	NA	NA	NA	NA
PGEN_.00g249030	Scaffold_12	17785956	17786375	NA	NA	NA	NA	NA
PGEN_.00g249040	Scaffold_12	17793197	17795333	NA	NA	NA	NA	NA
PGEN_.00g249050	Scaffold_12	17970095	17971270	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g249060	Scaffold_12	18020477	18024899	Q8QG61	CRY1_CHICK	Cryptochrome-1	GO:0000166; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0031398; GO:0042622; GO:0045721; GO:0097381	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]
PGEN_.00g249070	Scaffold_12	18056916	18062876	NA	NA	NA	NA	NA
PGEN_.00g249080	Scaffold_12	18062944	18100249	Q9PTG8	TACC3_XENLA	Transforming acidic coiled-coil-containing protein 3 (Cytoplasmic polyadenylation element-binding protein-associated factor Maskin) (CPEB-associated factor Maskin)	GO:0000922; GO:0005737; GO:0007052; GO:0017148; GO:0031369; GO:0032991; GO:0051301	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; translation initiation factor binding [GO:0031369]; cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; negative regulation of translation [GO:0017148]
PGEN_.00g249090	Scaffold_12	18153908	18156502	P08046	EGR1_MOUSE	Early growth response protein 1 (EGR-1) (Nerve growth factor-induced protein A) (NGFI-A) (Transcription factor Zif268) (Zinc finger protein Krox-24)	GO:0000122; GO:0000976; GO:0000977; GO:0000979; GO:0000981; GO:0001228; GO:0001666; GO:0002931; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0006366; GO:0007611; GO:0007616; GO:0008134; GO:0008270; GO:0009749; GO:0010385; GO:0010628; GO:0010942; GO:0014911; GO:0030217; GO:0030509; GO:0032868; GO:0032922; GO:0033233; GO:0035035; GO:0035914; GO:0042981; GO:0043525; GO:0043565; GO:0044212; GO:0044729; GO:0044849; GO:0045080; GO:0045475; GO:0045893; GO:0045944; GO:0046886; GO:0048169; GO:0048661; GO:0050725; GO:0060086; GO:0061418; GO:0070498; GO:0071310; GO:0071480; GO:0071504; GO:0071506; GO:0072110; GO:0072303; GO:0090090; GO:0098759; GO:1901216; GO:1902949; GO:1990841; GO:2000182	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; histone acetyltransferase binding [GO:0035035]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; BMP signaling pathway [GO:0030509]; cellular response to gamma radiation [GO:0071480]; cellular response to heparin [GO:0071504]; cellular response to interleukin-8 [GO:0098759]; cellular response to mycophenolic acid [GO:0071506]; cellular response to organic substance [GO:0071310]; circadian regulation of gene expression [GO:0032922]; circadian temperature homeostasis [GO:0060086]; estrous cycle [GO:0044849]; glomerular mesangial cell proliferation [GO:0072110]; interleukin-1-mediated signaling pathway [GO:0070498]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular metanephric mesangial cell proliferation [GO:0072303]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of interleukin-1 beta biosynthetic process [GO:0050725]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of protein sumoylation [GO:0033233]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to ischemia [GO:0002931]; skeletal muscle cell differentiation [GO:0035914]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g249100	Scaffold_12	18162221	18168967	NA	NA	NA	NA	NA
PGEN_.00g249110	Scaffold_12	18172551	18182935	Q28EW4	SOX13_XENTR	Transcription factor Sox-13	GO:0005634; GO:0043565; GO:0045165; GO:0045892; GO:0045944	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; cell fate commitment [GO:0045165]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g249120	Scaffold_12	18218974	18229547	Q6AYQ1	GOGA7_RAT	Golgin subfamily A member 7	GO:0002178; GO:0005795; GO:0006612; GO:0018230; GO:0031228; GO:0043001; GO:0050821	Golgi stack [GO:0005795]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]; Golgi to plasma membrane protein transport [GO:0043001]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612]
PGEN_.00g249130	Scaffold_12	18245291	18255930	P18173	DHGL_DROME	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0006006; GO:0008364; GO:0016614; GO:0046693; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]"
PGEN_.00g249140	Scaffold_12	18260870	18261412	NA	NA	NA	NA	NA
PGEN_.00g249150	Scaffold_12	18274407	18319708	B3EWZ6	MLRP2_ACRMI	MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g249160	Scaffold_12	18342953	18345175	NA	NA	NA	NA	NA
PGEN_.00g249170	Scaffold_12	18376953	18380669	Q8R0F8	FAHD1_MOUSE	"Acylpyruvase FAHD1, mitochondrial (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112)"	GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0008948; GO:0016787; GO:0018773; GO:0034545; GO:0046872; GO:0047621	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]
PGEN_.00g249180	Scaffold_12	18390030	18391013	Q5HZI2	C2C4C_MOUSE	C2 calcium-dependent domain-containing protein 4C (Nuclear-localized factor 3) (Protein FAM148C)	GO:0005829	cytosol [GO:0005829]
PGEN_.00g249190	Scaffold_12	18452205	18453581	Q9IAV3	HHEX_DANRE	Hematopoietically-expressed homeobox protein hhex (Homeobox protein hex)	GO:0000122; GO:0000977; GO:0001227; GO:0001889; GO:0001946; GO:0002040; GO:0005634; GO:0007368; GO:0007507; GO:0009952; GO:0009953; GO:0030154; GO:0030878; GO:0031017; GO:0035162; GO:0043565; GO:0045603; GO:0045892; GO:0046620; GO:0048565	"nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; dorsal/ventral pattern formation [GO:0009953]; embryonic hemopoiesis [GO:0035162]; exocrine pancreas development [GO:0031017]; heart development [GO:0007507]; liver development [GO:0001889]; lymphangiogenesis [GO:0001946]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of endothelial cell differentiation [GO:0045603]; regulation of organ growth [GO:0046620]; sprouting angiogenesis [GO:0002040]; thyroid gland development [GO:0030878]"
PGEN_.00g249200	Scaffold_12	18488335	18489924	NA	NA	NA	NA	NA
PGEN_.00g249210	Scaffold_12	18496055	18497134	NA	NA	NA	NA	NA
PGEN_.00g249220	Scaffold_12	18519052	18519366	NA	NA	NA	NA	NA
PGEN_.00g249230	Scaffold_12	18559854	18560899	NA	NA	NA	NA	NA
PGEN_.00g249240	Scaffold_12	18565273	18565536	NA	NA	NA	NA	NA
PGEN_.00g249250	Scaffold_12	18603633	18604597	NA	NA	NA	NA	NA
PGEN_.00g249260	Scaffold_12	18677922	18679145	Q93127	GPR18_AMPAM	Probable G-protein coupled receptor No18	GO:0004989; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]
PGEN_.00g249270	Scaffold_12	18828909	18829379	NA	NA	NA	NA	NA
PGEN_.00g249280	Scaffold_12	18847497	18857526	Q9HA90	EFCC1_HUMAN	EF-hand and coiled-coil domain-containing protein 1 (Coiled-coil domain-containing protein 48)	GO:0005509; GO:0005829	cytosol [GO:0005829]; calcium ion binding [GO:0005509]
PGEN_.00g249290	Scaffold_12	18865504	18871569	NA	NA	NA	NA	NA
PGEN_.00g249300	Scaffold_12	18873950	18877772	NA	NA	NA	NA	NA
PGEN_.00g249310	Scaffold_12	18879047	18892778	O70461	MOT3_RAT	Monocarboxylate transporter 3 (MCT 3) (Solute carrier family 16 member 8)	GO:0005887; GO:0008028; GO:0009925; GO:0015129; GO:0015293; GO:0015355; GO:0015718	basal plasma membrane [GO:0009925]; integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g249320	Scaffold_12	18939005	18939759	NA	NA	NA	NA	NA
PGEN_.00g249330	Scaffold_12	18979879	18980202	NA	NA	NA	NA	NA
PGEN_.00g249340	Scaffold_12	19063665	19064822	Q5IS62	NPY2R_PANTR	Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor)	GO:0004983; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]
PGEN_.00g249350	Scaffold_12	19133929	19134679	NA	NA	NA	NA	NA
PGEN_.00g249360	Scaffold_12	19183766	19184056	NA	NA	NA	NA	NA
PGEN_.00g249370	Scaffold_12	19184557	19186430	NA	NA	NA	NA	NA
PGEN_.00g249380	Scaffold_12	19187480	19187719	NA	NA	NA	NA	NA
PGEN_.00g249390	Scaffold_12	19279485	19281895	NA	NA	NA	NA	NA
PGEN_.00g249400	Scaffold_12	19371361	19377021	NA	NA	NA	NA	NA
PGEN_.00g249410	Scaffold_12	19404917	19405621	NA	NA	NA	NA	NA
PGEN_.00g249420	Scaffold_12	19433675	19433908	NA	NA	NA	NA	NA
PGEN_.00g249430	Scaffold_12	19442126	19448830	Q6MWY2	PPE54_MYCTU	Uncharacterized PPE family protein PPE54	GO:0052170	negative regulation by symbiont of host innate immune response [GO:0052170]
PGEN_.00g249440	Scaffold_12	19453718	19478030	Q95J53	BTBDG_MACFA	BTB/POZ domain-containing protein 16		
PGEN_.00g249450	Scaffold_12	19478079	19478651	Q9GLP1	FA5_PIG	Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]	GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091	extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; copper ion binding [GO:0005507]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]
PGEN_.00g249460	Scaffold_12	19485922	19519283	Q32M84	BTBDG_HUMAN	BTB/POZ domain-containing protein 16		
PGEN_.00g249470	Scaffold_12	19525676	19526671	NA	NA	NA	NA	NA
PGEN_.00g249480	Scaffold_12	19535214	19542964	Q95KE5	RM43_BOVIN	"39S ribosomal protein L43, mitochondrial (L43mt) (MRP-L43) (Retina-specific 15.7 kDa protein)"	GO:0003735; GO:0005743; GO:0005762; GO:0032543	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g249490	Scaffold_12	19548143	19559535	Q8CEF1	FEM1C_MOUSE	Protein fem-1 homolog C (FEM1c) (FEM1-gamma)	GO:0005654; GO:0005829; GO:0016567	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567]
PGEN_.00g249500	Scaffold_12	19582816	19584246	P20905	5HT1R_DROME	5-hydroxytryptamine receptor 1 (5-HT receptor) (5HT-dro) (Serotonin receptor 1)	GO:0004930; GO:0004993; GO:0005887; GO:0007187; GO:0007192; GO:0007210; GO:0007268; GO:0007619; GO:0008227; GO:0016021; GO:0016543; GO:0016545; GO:0016546; GO:0030425; GO:0030594; GO:0045202; GO:0060179; GO:0060180	"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; female mating behavior [GO:0060180]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; male courtship behavior, orientation prior to leg tapping and wing vibration [GO:0016543]; male courtship behavior, proboscis-mediated licking [GO:0016546]; male courtship behavior, veined wing vibration [GO:0016545]; male mating behavior [GO:0060179]; serotonin receptor signaling pathway [GO:0007210]"
PGEN_.00g249510	Scaffold_12	19611707	19612330	Q68DN1	CB016_HUMAN	Uncharacterized protein C2orf16	GO:0005634; GO:0070062	extracellular exosome [GO:0070062]; nucleus [GO:0005634]
PGEN_.00g249520	Scaffold_12	19874412	19874657	NA	NA	NA	NA	NA
PGEN_.00g249530	Scaffold_12	19903571	19904302	NA	NA	NA	NA	NA
PGEN_.00g249540	Scaffold_12	20012968	20028818	Q5ZIG2	SLU7_CHICK	Pre-mRNA-splicing factor SLU7	GO:0000386; GO:0000398; GO:0005681; GO:0005737; GO:0016607; GO:0030628; GO:0046872	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g249550	Scaffold_12	20059338	20059952	NA	NA	NA	NA	NA
PGEN_.00g249560	Scaffold_12	20065978	20067293	NA	NA	NA	NA	NA
PGEN_.00g249570	Scaffold_12	20067914	20071138	NA	NA	NA	NA	NA
PGEN_.00g249580	Scaffold_12	20098267	20123571	Q5R416	CTNA2_PONAB	Catenin alpha-2 (Alpha N-catenin)	GO:0005198; GO:0005634; GO:0005737; GO:0005912; GO:0005913; GO:0007409; GO:0010975; GO:0015629; GO:0016323; GO:0021942; GO:0030027; GO:0030424; GO:0034316; GO:0042802; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:0098686; GO:0098688; GO:0098831; GO:0098885; GO:0098888; GO:0098890; GO:0099092; GO:2001222	"actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; presynaptic active zone cytoplasmic component [GO:0098831]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823]"
PGEN_.00g249590	Scaffold_12	20132034	20138219	O35648	CETN3_MOUSE	Centrin-3	GO:0005509; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0008017; GO:0015031; GO:0030474; GO:0031683; GO:0032391; GO:0035869; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; microtubule binding [GO:0008017]; cell division [GO:0051301]; mRNA transport [GO:0051028]; protein transport [GO:0015031]; spindle pole body duplication [GO:0030474]
PGEN_.00g249600	Scaffold_12	20362319	20362892	NA	NA	NA	NA	NA
PGEN_.00g249610	Scaffold_12	20369161	20369559	NA	NA	NA	NA	NA
PGEN_.00g249620	Scaffold_12	20413812	20414750	NA	NA	NA	NA	NA
PGEN_.00g249630	Scaffold_12	20415362	20419019	NA	NA	NA	NA	NA
PGEN_.00g249640	Scaffold_12	20625037	20637523	NA	NA	NA	NA	NA
PGEN_.00g249650	Scaffold_12	20637614	20656080	NA	NA	NA	NA	NA
PGEN_.00g249660	Scaffold_12	20712627	20712953	NA	NA	NA	NA	NA
PGEN_.00g249670	Scaffold_12	20722316	20732838	NA	NA	NA	NA	NA
PGEN_.00g249680	Scaffold_12	20957139	20957528	NA	NA	NA	NA	NA
PGEN_.00g249690	Scaffold_12	20981988	20982827	Q8N695	SC5A8_HUMAN	Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)	GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]
PGEN_.00g249700	Scaffold_12	20983154	20983492	NA	NA	NA	NA	NA
PGEN_.00g249710	Scaffold_12	20986259	20987768	NA	NA	NA	NA	NA
PGEN_.00g249720	Scaffold_12	20990277	21004447	NA	NA	NA	NA	NA
PGEN_.00g249730	Scaffold_12	21070241	21080773	Q9I8X3	FGFR3_DANRE	Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1)	GO:0004714; GO:0005007; GO:0005524; GO:0005887; GO:0006915; GO:0007169; GO:0008284; GO:0017134; GO:0043235; GO:0043410; GO:1902036	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of hematopoietic stem cell differentiation [GO:1902036]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g249740	Scaffold_12	21131163	21133667	NA	NA	NA	NA	NA
PGEN_.00g249750	Scaffold_12	21150594	21161200	NA	NA	NA	NA	NA
PGEN_.00g249760	Scaffold_12	21163134	21165312	NA	NA	NA	NA	NA
PGEN_.00g249770	Scaffold_12	21204002	21204748	NA	NA	NA	NA	NA
PGEN_.00g249780	Scaffold_12	21206059	21209389	NA	NA	NA	NA	NA
PGEN_.00g249790	Scaffold_12	21215322	21216812	NA	NA	NA	NA	NA
PGEN_.00g249800	Scaffold_12	21238151	21257364	Q3V1L4	5NTC_MOUSE	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	GO:0000166; GO:0005737; GO:0008253; GO:0046040; GO:0046085; GO:0046872	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; IMP metabolic process [GO:0046040]
PGEN_.00g249810	Scaffold_12	21326363	21327007	NA	NA	NA	NA	NA
PGEN_.00g249820	Scaffold_12	21327084	21358359	Q6DKB0	5NTC_XENLA	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	GO:0000166; GO:0005737; GO:0008253; GO:0009117; GO:0046872	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117]
PGEN_.00g249830	Scaffold_12	21368704	21396019	NA	NA	NA	NA	NA
PGEN_.00g249840	Scaffold_12	21434751	21459829	B4JHI7	LST2_DROGR	Lateral signaling target protein 2 homolog	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g249850	Scaffold_12	21478039	21486446	Q2VPA6	HELQ_MOUSE	Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase)	GO:0000724; GO:0003677; GO:0005524; GO:0006259; GO:0017116; GO:0017117; GO:0030490	single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; single-stranded DNA helicase activity [GO:0017116]; DNA metabolic process [GO:0006259]; double-strand break repair via homologous recombination [GO:0000724]; maturation of SSU-rRNA [GO:0030490]
PGEN_.00g249860	Scaffold_12	21491364	21506250	Q8WUX9	CHMP7_HUMAN	Charged multivesicular body protein 7 (Chromatin-modifying protein 7)	GO:0000815; GO:0005623; GO:0005635; GO:0005654; GO:0005829; GO:0006997; GO:0007080; GO:0010458; GO:0015031; GO:0016197; GO:0019058; GO:0031468; GO:0036258; GO:0039702; GO:0045324; GO:0061952; GO:0071168; GO:1904903	cell [GO:0005623]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; endosomal transport [GO:0016197]; ESCRT III complex disassembly [GO:1904903]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; protein localization to chromatin [GO:0071168]; protein transport [GO:0015031]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]
PGEN_.00g249870	Scaffold_12	21511863	21535818	Q12901	ZN155_HUMAN	Zinc finger protein 155	GO:0003677; GO:0003700; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]
PGEN_.00g249880	Scaffold_12	21563988	21578185	P33731	SRP72_CANLF	Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein)	GO:0005047; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030911; GO:0042493; GO:0043022	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; ribosome binding [GO:0043022]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"
PGEN_.00g249890	Scaffold_12	21582774	21599030	Q460N3	PAR15_HUMAN	Protein mono-ADP-ribosyltransferase PARP15 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15) (PARP-15)	GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0070212; GO:0070403; GO:0140289; GO:1990404	nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g249900	Scaffold_12	21599062	21611601	NA	NA	NA	NA	NA
PGEN_.00g249910	Scaffold_12	21614496	21615676	NA	NA	NA	NA	NA
PGEN_.00g249920	Scaffold_12	21627156	21634714	NA	NA	NA	NA	NA
PGEN_.00g249930	Scaffold_12	21636250	21642495	NA	NA	NA	NA	NA
PGEN_.00g249940	Scaffold_12	21663876	21666637	NA	NA	NA	NA	NA
PGEN_.00g249950	Scaffold_12	21678177	21678629	NA	NA	NA	NA	NA
PGEN_.00g249960	Scaffold_12	21724589	21726421	Q8JJ64	HMX3_XENLA	Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1) (X-nkx-5.1)	GO:0005634; GO:0006355; GO:0007399; GO:0030154; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g249970	Scaffold_12	21732646	21753548	Q28ID3	GLRX3_XENTR	Glutaredoxin-3 (Thioredoxin-like protein 2)	GO:0005623; GO:0005634; GO:0005829; GO:0006879; GO:0009055; GO:0015035; GO:0044571; GO:0045454; GO:0046872; GO:0051536; GO:0097428	cell [GO:0005623]; cytosol [GO:0005829]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; protein maturation by iron-sulfur cluster transfer [GO:0097428]
PGEN_.00g249980	Scaffold_12	21770572	21775454	NA	NA	NA	NA	NA
PGEN_.00g249990	Scaffold_12	21782727	21784502	NA	NA	NA	NA	NA
PGEN_.00g250000	Scaffold_12	21793408	21793656	NA	NA	NA	NA	NA
PGEN_.00g250010	Scaffold_12	21809465	21809833	NA	NA	NA	NA	NA
PGEN_.00g250020	Scaffold_12	21845334	21845669	NA	NA	NA	NA	NA
PGEN_.00g250030	Scaffold_12	21863625	21877493	Q5REG4	DTX3_PONAB	Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3)	GO:0005737; GO:0007219; GO:0016567; GO:0016740; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g250040	Scaffold_12	21886203	21908158	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g250050	Scaffold_12	21930515	21942659	NA	NA	NA	NA	NA
PGEN_.00g250060	Scaffold_12	21945006	21948883	NA	NA	NA	NA	NA
PGEN_.00g250070	Scaffold_12	21949024	21954050	NA	NA	NA	NA	NA
PGEN_.00g250080	Scaffold_12	21966572	21979837	Q8TDB6	DTX3L_HUMAN	E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2)	GO:0000209; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g250090	Scaffold_12	22001558	22015219	NA	NA	NA	NA	NA
PGEN_.00g250100	Scaffold_12	22016228	22016878	NA	NA	NA	NA	NA
PGEN_.00g250110	Scaffold_12	22022034	22024795	Q5E9Z8	LSM1_BOVIN	U6 snRNA-associated Sm-like protein LSm1	GO:0000290; GO:0000339; GO:0000932; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016070; GO:0019827; GO:0045665; GO:0071044; GO:1990726	Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; stem cell population maintenance [GO:0019827]
PGEN_.00g250120	Scaffold_12	22029724	22032282	B3DM66	GP161_XENTR	G-protein coupled receptor 161	GO:0004930; GO:0005929; GO:0007189; GO:0007275; GO:0016021; GO:0055037; GO:0060170; GO:1901621	ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]
PGEN_.00g250130	Scaffold_12	22054982	22069172	NA	NA	NA	NA	NA
PGEN_.00g250140	Scaffold_12	22069350	22070387	Q9H8W5	TRI45_HUMAN	Tripartite motif-containing protein 45 (RING finger protein 99)	GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
PGEN_.00g250150	Scaffold_12	22077694	22083415	C6KFA3	AGRG6_DANRE	Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	GO:0001503; GO:0004930; GO:0005518; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0007507; GO:0014037; GO:0019933; GO:0022011; GO:0032290; GO:0042552; GO:0043236; GO:0043583; GO:0048932; GO:0050840; GO:0060347; GO:0060879; GO:1903670	integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879]
PGEN_.00g250160	Scaffold_12	22092982	22106835	Q28CF8	ENTP7_XENTR	Ectonucleoside triphosphate diphosphohydrolase 7 (NTPDase 7) (EC 3.6.1.-)	GO:0016021; GO:0016787; GO:0030659; GO:0046872	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]
PGEN_.00g250170	Scaffold_12	22109405	22113242	NA	NA	NA	NA	NA
PGEN_.00g250180	Scaffold_12	22117078	22128423	Q8TDB6	DTX3L_HUMAN	E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2)	GO:0000209; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g250190	Scaffold_12	22133397	22133942	NA	NA	NA	NA	NA
PGEN_.00g250200	Scaffold_12	22134137	22134547	NA	NA	NA	NA	NA
PGEN_.00g250210	Scaffold_12	22136609	22137262	NA	NA	NA	NA	NA
PGEN_.00g250220	Scaffold_12	22137521	22169638	Q9WYX8	Y508_THEMA	Uncharacterized protein TM_0508	GO:0003677; GO:0005524; GO:0006261; GO:0006281; GO:0006282; GO:0006310; GO:0008047; GO:0009378	ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; four-way junction helicase activity [GO:0009378]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; regulation of DNA repair [GO:0006282]
PGEN_.00g250230	Scaffold_12	22169669	22182588	NA	NA	NA	NA	NA
PGEN_.00g250240	Scaffold_12	22187814	22188098	NA	NA	NA	NA	NA
PGEN_.00g250250	Scaffold_12	22297258	22298758	NA	NA	NA	NA	NA
PGEN_.00g250260	Scaffold_12	22307218	22312454	NA	NA	NA	NA	NA
PGEN_.00g250270	Scaffold_12	22326107	22330903	NA	NA	NA	NA	NA
PGEN_.00g250280	Scaffold_12	22336055	22348224	Q32KV6	SIL1_BOVIN	Nucleotide exchange factor SIL1	GO:0000774; GO:0005737; GO:0005783; GO:0005788; GO:0015031	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; adenyl-nucleotide exchange factor activity [GO:0000774]; protein transport [GO:0015031]
PGEN_.00g250290	Scaffold_12	22348732	22363061	NA	NA	NA	NA	NA
PGEN_.00g250300	Scaffold_12	22498616	22557551	O89101	FGF18_MOUSE	Fibroblast growth factor 18 (FGF-18) (zFGF5)	GO:0001503; GO:0001525; GO:0001957; GO:0001958; GO:0002063; GO:0005104; GO:0005105; GO:0005111; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0007165; GO:0007399; GO:0008083; GO:0008283; GO:0008284; GO:0008543; GO:0030324; GO:0030949; GO:0032332; GO:0043406; GO:0043536; GO:0045766; GO:0070374; GO:2000546	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; nucleus [GO:0005634]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; chondrocyte development [GO:0002063]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intramembranous ossification [GO:0001957]; lung development [GO:0030324]; nervous system development [GO:0007399]; ossification [GO:0001503]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; signal transduction [GO:0007165]
PGEN_.00g250310	Scaffold_12	22590078	22590371	NA	NA	NA	NA	NA
PGEN_.00g250320	Scaffold_12	22663961	22664182	NA	NA	NA	NA	NA
PGEN_.00g250330	Scaffold_12	22721531	22737595	Q13231	CHIT1_HUMAN	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0043312; GO:0044245; GO:1904724	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]"
PGEN_.00g250340	Scaffold_12	22741410	22748592	A5PJU6	HYKK_BOVIN	Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1)	GO:0005737; GO:0016301; GO:0047992	cytoplasm [GO:0005737]; hydroxylysine kinase activity [GO:0047992]; kinase activity [GO:0016301]
PGEN_.00g250350	Scaffold_12	22757150	22771481	A2RU49	HYKK_HUMAN	Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1)	GO:0005759; GO:0006554; GO:0016301; GO:0047992	mitochondrial matrix [GO:0005759]; hydroxylysine kinase activity [GO:0047992]; kinase activity [GO:0016301]; lysine catabolic process [GO:0006554]
PGEN_.00g250360	Scaffold_12	22784451	22784858	NA	NA	NA	NA	NA
PGEN_.00g250370	Scaffold_12	22785232	22785708	NA	NA	NA	NA	NA
PGEN_.00g250380	Scaffold_12	22785964	22786329	NA	NA	NA	NA	NA
PGEN_.00g250390	Scaffold_12	22786371	22800887	A5PJU6	HYKK_BOVIN	Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1)	GO:0005737; GO:0016301; GO:0047992	cytoplasm [GO:0005737]; hydroxylysine kinase activity [GO:0047992]; kinase activity [GO:0016301]
PGEN_.00g250400	Scaffold_12	22839073	22854965	Q5IZC5	CRY1_ERIRU	Cryptochrome-1	GO:0000166; GO:0003677; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0042622; GO:0045721; GO:0097381	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]
PGEN_.00g250410	Scaffold_12	22883727	22888987	NA	NA	NA	NA	NA
PGEN_.00g250420	Scaffold_12	22897825	22967782	Q68CJ6	SLIP_HUMAN	Nuclear GTPase SLIP-GC (EC 3.6.1.-) (Speckled-like pattern in the germinal center)	GO:0003924; GO:0005525; GO:0016607; GO:0033262; GO:0043066; GO:0071222	nuclear speck [GO:0016607]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of apoptotic process [GO:0043066]; regulation of nuclear cell cycle DNA replication [GO:0033262]
PGEN_.00g250430	Scaffold_12	22983584	22986070	NA	NA	NA	NA	NA
PGEN_.00g250440	Scaffold_12	22987477	23008952	NA	NA	NA	NA	NA
PGEN_.00g250450	Scaffold_12	22991984	22993092	NA	NA	NA	NA	NA
PGEN_.00g250460	Scaffold_12	23030413	23090840	Q8ZXT3	Y1111_PYRAE	Uncharacterized protein PAE1111		
PGEN_.00g250470	Scaffold_12	23107764	23112935	P58545	BTBD3_MOUSE	BTB/POZ domain-containing protein 3	GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813	cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]
PGEN_.00g250480	Scaffold_12	23135760	23137550	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g250490	Scaffold_12	23142775	23151199	NA	NA	NA	NA	NA
PGEN_.00g250500	Scaffold_12	23166782	23167603	NA	NA	NA	NA	NA
PGEN_.00g250510	Scaffold_12	23170688	23173375	NA	NA	NA	NA	NA
PGEN_.00g250520	Scaffold_12	23188500	23189370	NA	NA	NA	NA	NA
PGEN_.00g250530	Scaffold_12	23199935	23256369	Q460N5	PAR14_HUMAN	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g250540	Scaffold_12	23266349	23271817	NA	NA	NA	NA	NA
PGEN_.00g250550	Scaffold_12	23272041	23304356	NA	NA	NA	NA	NA
PGEN_.00g250560	Scaffold_12	23304765	23332164	Q97UU4	Y2899_SACS2	Uncharacterized protein SSO2899		
PGEN_.00g250570	Scaffold_12	23352366	23361579	NA	NA	NA	NA	NA
PGEN_.00g250580	Scaffold_12	23391095	23438571	Q31125	S39A7_MOUSE	"Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7)"	GO:0005385; GO:0005623; GO:0005654; GO:0005783; GO:0005789; GO:0005794; GO:0006882; GO:0016021; GO:0071577	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577]
PGEN_.00g250590	Scaffold_12	23444797	23468408	P34284	FBXL_CAEEL	F-box/LRR-repeat protein fbxl-1 (F-box and leucine-rich repeat protein 1)	GO:0005929; GO:0006511; GO:0016567; GO:0019005; GO:0030424; GO:0030425; GO:0031146; GO:0035882; GO:0043053; GO:0043204; GO:1905909; GO:2000746	axon [GO:0030424]; cilium [GO:0005929]; dendrite [GO:0030425]; perikaryon [GO:0043204]; SCF ubiquitin ligase complex [GO:0019005]; dauer entry [GO:0043053]; defecation rhythm [GO:0035882]; protein ubiquitination [GO:0016567]; regulation of dauer entry [GO:1905909]; regulation of defecation rhythm [GO:2000746]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g250600	Scaffold_12	23488642	23493320	NA	NA	NA	NA	NA
PGEN_.00g250610	Scaffold_12	23494302	23494721	NA	NA	NA	NA	NA
PGEN_.00g250620	Scaffold_12	23501513	23503577	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g250630	Scaffold_12	23516238	23517627	Q9VNM1	NPFR_DROME	Neuropeptide F receptor (DmNPFR1)	GO:0004983; GO:0004995; GO:0005887; GO:0007186; GO:0007194; GO:0007217; GO:0007218; GO:0008188; GO:0016021; GO:0030536; GO:0038002; GO:0042048; GO:0042263; GO:1990834	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide F receptor activity [GO:0042263]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; tachykinin receptor activity [GO:0004995]; endocrine signaling [GO:0038002]; G protein-coupled receptor signaling pathway [GO:0007186]; larval feeding behavior [GO:0030536]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; response to odorant [GO:1990834]; tachykinin receptor signaling pathway [GO:0007217]
PGEN_.00g250640	Scaffold_12	23621666	23704564	P07207	NOTCH_DROME	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	GO:0001708; GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0005915; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007455; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035003; GO:0035153; GO:0035162; GO:0035165; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043525; GO:0043697; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048	"adherens junction [GO:0005912]; cell [GO:0005623]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
PGEN_.00g250650	Scaffold_12	23711023	23717586	F1MV99	SSR5_BOVIN	Somatostatin receptor type 5 (SS-5-R) (SS5-R) (SS5R)	GO:0004930; GO:0004994; GO:0005887; GO:0007218; GO:0032467; GO:0042277; GO:0042593; GO:0042923; GO:0050796; GO:0071385	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; cellular response to glucocorticoid stimulus [GO:0071385]; glucose homeostasis [GO:0042593]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]; regulation of insulin secretion [GO:0050796]
PGEN_.00g250660	Scaffold_12	23722785	23738737	Q9C5D2	FBL4_ARATH	F-box/LRR-repeat protein 4 (AtFBL4)	GO:0006289; GO:0006511; GO:0010225; GO:0016567; GO:0019005; GO:0031146	SCF ubiquitin ligase complex [GO:0019005]; nucleotide-excision repair [GO:0006289]; protein ubiquitination [GO:0016567]; response to UV-C [GO:0010225]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g250670	Scaffold_12	23758780	23760012	NA	NA	NA	NA	NA
PGEN_.00g250680	Scaffold_12	23806382	23815115	NA	NA	NA	NA	NA
PGEN_.00g250690	Scaffold_12	23819733	23829020	NA	NA	NA	NA	NA
PGEN_.00g250700	Scaffold_12	23831128	23916537	Q90Y57	JAG1A_DANRE	Protein jagged-1a (Jagged1) (Jagged1a)	GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0016021; GO:0030878; GO:0045746; GO:0060218	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; thyroid gland development [GO:0030878]
PGEN_.00g250710	Scaffold_12	23929652	23979331	Q07008	NOTC1_RAT	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000122; GO:0000978; GO:0001228; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003700; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007420; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0046982; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027	"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
PGEN_.00g250720	Scaffold_12	23979493	23979927	NA	NA	NA	NA	NA
PGEN_.00g250730	Scaffold_12	23980048	23980287	NA	NA	NA	NA	NA
PGEN_.00g250740	Scaffold_12	23980807	23981085	NA	NA	NA	NA	NA
PGEN_.00g250750	Scaffold_12	23987020	23992606	Q6DCW1	GFI1B_XENLA	Zinc finger protein Gfi-1b (Growth factor independent protein 1B)	GO:0003677; GO:0005634; GO:0006325; GO:0007275; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]
PGEN_.00g250760	Scaffold_12	24041307	24069480	Q86B91	TINC_DROME	Protein tincar	GO:0016021; GO:0042478	integral component of membrane [GO:0016021]; regulation of eye photoreceptor cell development [GO:0042478]
PGEN_.00g250770	Scaffold_12	24226155	24231296	NA	NA	NA	NA	NA
PGEN_.00g250780	Scaffold_12	24232196	24233906	NA	NA	NA	NA	NA
PGEN_.00g250790	Scaffold_12	24243468	24244883	Q4J9D2	Y1252_SULAC	Uncharacterized protein Saci_1252		
PGEN_.00g250800	Scaffold_12	24245254	24252350	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g250810	Scaffold_12	24261830	24277487	Q8TDB6	DTX3L_HUMAN	E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2)	GO:0000209; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g250820	Scaffold_12	24318216	24341560	Q8N9I9	DTX3_HUMAN	Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING finger protein 154) (RING-type E3 ubiquitin transferase DTX3)	GO:0005737; GO:0007219; GO:0016567; GO:0016740; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g250830	Scaffold_12	24434137	24435375	P41596	DOPR1_DROME	Dopamine receptor 1 (D-DOP1) (DmDop1) (dDA1) (Dopamine 1-like receptor 1)	GO:0001588; GO:0004930; GO:0004952; GO:0004993; GO:0005887; GO:0007187; GO:0007191; GO:0007212; GO:0007268; GO:0007612; GO:0007613; GO:0008306; GO:0008355; GO:0008542; GO:0009744; GO:0016021; GO:0030425; GO:0030594; GO:0040040; GO:0042594; GO:0043052; GO:0071329; GO:0090328; GO:0098793; GO:0099509; GO:1990834	"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; associative learning [GO:0008306]; cellular response to sucrose stimulus [GO:0071329]; chemical synaptic transmission [GO:0007268]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; learning [GO:0007612]; memory [GO:0007613]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; visual learning [GO:0008542]"
PGEN_.00g250840	Scaffold_12	24474784	24475062	NA	NA	NA	NA	NA
PGEN_.00g250850	Scaffold_12	24536082	24536758	NA	NA	NA	NA	NA
PGEN_.00g250860	Scaffold_12	24658190	24665185	NA	NA	NA	NA	NA
PGEN_.00g250870	Scaffold_12	24665823	24666337	NA	NA	NA	NA	NA
PGEN_.00g250880	Scaffold_12	24728047	24744864	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g250890	Scaffold_12	24808721	24871073	Q4KM52	BLNK_RAT	B-cell linker protein (Cytoplasmic adapter protein)	GO:0005070; GO:0005737; GO:0005886; GO:0007169; GO:0035556; GO:0036464; GO:0042113	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g250900	Scaffold_12	24877416	24884563	Q505D1	ANR28_MOUSE	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK)	GO:0005654	nucleoplasm [GO:0005654]
PGEN_.00g250910	Scaffold_12	24890211	24917403	Q92902	HPS1_HUMAN	Hermansky-Pudlak syndrome 1 protein	GO:0005085; GO:0005737; GO:0005764; GO:0005829; GO:0007040; GO:0007601; GO:0031085; GO:0031410; GO:0046983; GO:0050896; GO:1903232	BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosome [GO:0005764]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
PGEN_.00g250920	Scaffold_12	24919442	24922603	Q9P0L1	ZKSC7_HUMAN	Zinc finger protein with KRAB and SCAN domains 7 (Zinc finger protein 167) (Zinc finger protein 448) (Zinc finger protein 64)	GO:0003677; GO:0003700; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]
PGEN_.00g250930	Scaffold_12	24923359	24923619	NA	NA	NA	NA	NA
PGEN_.00g250940	Scaffold_12	24927131	24927388	NA	NA	NA	NA	NA
PGEN_.00g250950	Scaffold_12	24929182	24929481	NA	NA	NA	NA	NA
PGEN_.00g250960	Scaffold_12	24929942	24930295	NA	NA	NA	NA	NA
PGEN_.00g250970	Scaffold_12	24933582	24939757	NA	NA	NA	NA	NA
PGEN_.00g250980	Scaffold_12	24939874	24941255	NA	NA	NA	NA	NA
PGEN_.00g250990	Scaffold_12	24950001	24968825	Q96JA1	LRIG1_HUMAN	Leucine-rich repeats and immunoglobulin-like domains protein 1 (LIG-1)	GO:0005615; GO:0005886; GO:0007605; GO:0016021; GO:0022405; GO:0031012; GO:0032474; GO:0060384	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605]
PGEN_.00g251000	Scaffold_12	24969583	24969861	NA	NA	NA	NA	NA
PGEN_.00g251010	Scaffold_12	24988615	24989416	NA	NA	NA	NA	NA
PGEN_.00g251020	Scaffold_12	25013547	25014020	NA	NA	NA	NA	NA
PGEN_.00g251030	Scaffold_12	25050462	25062503	NA	NA	NA	NA	NA
PGEN_.00g251040	Scaffold_12	25066244	25073350	Q4V9P0	SAMC_DANRE	S-adenosylmethionine mitochondrial carrier protein (Mitochondrial S-adenosylmethionine transporter) (Solute carrier family 25 member 26)	GO:0000095; GO:0005743; GO:0015805; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; S-adenosyl-L-methionine transmembrane transporter activity [GO:0000095]; S-adenosyl-L-methionine transport [GO:0015805]
PGEN_.00g251050	Scaffold_12	25078828	25088739	NA	NA	NA	NA	NA
PGEN_.00g251060	Scaffold_12	25093798	25116076	NA	NA	NA	NA	NA
PGEN_.00g251070	Scaffold_12	25138212	25150327	O13124	VDR_XENLA	"Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1)"	GO:0003707; GO:0004879; GO:0005634; GO:0005737; GO:0008270; GO:0043565; GO:0070561	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; vitamin D receptor signaling pathway [GO:0070561]
PGEN_.00g251080	Scaffold_12	25154791	25155006	Q1L8Y6	BBIP1_DANRE	BBSome-interacting protein 1 (BBSome-interacting protein of 10 kDa)	GO:0005623; GO:0005737; GO:0032402; GO:0034464; GO:0060271; GO:0070121; GO:0097500	BBSome [GO:0034464]; cell [GO:0005623]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; receptor localization to non-motile cilium [GO:0097500]
PGEN_.00g251090	Scaffold_12	25155336	25155863	Q6NWF4	VPS25_DANRE	Vacuolar protein-sorting-associated protein 25 (ESCRT-II complex subunit VPS25)	GO:0000814; GO:0005198; GO:0042803; GO:0043328	ESCRT II complex [GO:0000814]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]
PGEN_.00g251100	Scaffold_12	25165956	25167695	Q5VV17	OTUD1_HUMAN	OTU domain-containing protein 1 (EC 3.4.19.12) (DUBA-7)	GO:0004843; GO:0070536	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K63-linked deubiquitination [GO:0070536]
PGEN_.00g251110	Scaffold_12	25211061	25211498	NA	NA	NA	NA	NA
PGEN_.00g251120	Scaffold_12	25214728	25216137	Q9M2U3	ALPL_ARATH	Protein ALP1-like (EC 3.1.-.-)	GO:0004518; GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g251130	Scaffold_12	25219085	25223111	NA	NA	NA	NA	NA
PGEN_.00g251140	Scaffold_12	25223519	25230219	NA	NA	NA	NA	NA
PGEN_.00g251150	Scaffold_12	25234791	25235594	Q7T0P7	ATP23_XENLA	Mitochondrial inner membrane protease ATP23 homolog (EC 3.4.24.-)	GO:0004222; GO:0046872	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]
PGEN_.00g251160	Scaffold_12	25243539	25278868	P48729	KC1A_HUMAN	Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)	GO:0000777; GO:0000902; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0007030; GO:0007049; GO:0007165; GO:0007166; GO:0016020; GO:0016055; GO:0016301; GO:0016607; GO:0018105; GO:0030877; GO:0032436; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:1904424; GO:1904885; GO:1904886; GO:1990904	beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]
PGEN_.00g251170	Scaffold_12	25282685	25283891	NA	NA	NA	NA	NA
PGEN_.00g251180	Scaffold_12	25296431	25309572	Q8C6C7	F204A_MOUSE	Protein FAM204A		
PGEN_.00g251190	Scaffold_12	25422224	25425525	Q8AYB8	HOP_DANRE	Homeodomain-only protein	GO:0003677; GO:0005634; GO:0005737; GO:0007507; GO:0030154	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; heart development [GO:0007507]
PGEN_.00g251200	Scaffold_12	25444717	25455712	Q8TBZ5	ZN502_HUMAN	Zinc finger protein 502	GO:0003677; GO:0005634; GO:0044791; GO:0044794; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791]
PGEN_.00g251210	Scaffold_12	25491583	25493064	Q93126	GPR9_AMPAM	Probable G-protein coupled receptor No9	GO:0004935; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adrenergic receptor activity [GO:0004935]
PGEN_.00g251220	Scaffold_12	25628389	25628970	NA	NA	NA	NA	NA
PGEN_.00g251230	Scaffold_12	25629023	25629262	NA	NA	NA	NA	NA
PGEN_.00g251240	Scaffold_12	25703646	25711266	Q9NX58	LYAR_HUMAN	Cell growth-regulating nucleolar protein	GO:0000122; GO:0001750; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0045087; GO:0046872; GO:0048821; GO:0050766	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; rRNA processing [GO:0006364]
PGEN_.00g251250	Scaffold_12	25714474	25715640	Q9ESG5	HS3S1_RAT	Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (Heparan sulfate 3-O-sulfotransferase 1)	GO:0005796; GO:0008467	Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]
PGEN_.00g251260	Scaffold_12	25718747	25754171	NA	NA	NA	NA	NA
PGEN_.00g251270	Scaffold_12	25754630	25777998	NA	NA	NA	NA	NA
PGEN_.00g251280	Scaffold_12	25829245	25833389	NA	NA	NA	NA	NA
PGEN_.00g251290	Scaffold_12	25838418	25941930	Q8IYW2	CFA46_HUMAN	Cilia- and flagella-associated protein 46 (Tetratricopeptide repeat protein 40)	GO:0005930; GO:0035082; GO:0060294	axoneme [GO:0005930]; axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294]
PGEN_.00g251300	Scaffold_12	25945334	25962851	Q9NYT6	ZN226_HUMAN	Zinc finger protein 226	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g251310	Scaffold_12	25977283	26027280	Q9DAM9	FANK1_MOUSE	Fibronectin type 3 and ankyrin repeat domains 1 protein (Germ cell-specific gene 1 protein) (GSG1)	GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0036064; GO:0043065; GO:0043066; GO:0045893; GO:0051091; GO:0097546	"chromatin [GO:0000785]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g251320	Scaffold_12	26028628	26055802	Q86WZ0	HEAT4_HUMAN	HEAT repeat-containing protein 4		
PGEN_.00g251330	Scaffold_12	26117360	26127129	NA	NA	NA	NA	NA
PGEN_.00g251340	Scaffold_12	26160919	26161512	NA	NA	NA	NA	NA
PGEN_.00g251350	Scaffold_12	26161536	26162588	NA	NA	NA	NA	NA
PGEN_.00g251360	Scaffold_12	26179269	26181437	Q9ULH4	LRFN2_HUMAN	Leucine-rich repeat and fibronectin type-III domain-containing protein 2 (Synaptic adhesion-like molecule 1)	GO:0005886; GO:0009986; GO:0030054; GO:0050804; GO:0098685; GO:0099061; GO:0099175	cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; modulation of chemical synaptic transmission [GO:0050804]; regulation of postsynapse organization [GO:0099175]
PGEN_.00g251370	Scaffold_12	26227082	26240959	NA	NA	NA	NA	NA
PGEN_.00g251380	Scaffold_12	26297484	26302873	Q5R9G4	XPO7_PONAB	Exportin-7 (Exp7)	GO:0005643; GO:0005737; GO:0006886; GO:0008536; GO:0051028; GO:0051169	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; Ran GTPase binding [GO:0008536]; intracellular protein transport [GO:0006886]; mRNA transport [GO:0051028]; nuclear transport [GO:0051169]
PGEN_.00g251390	Scaffold_12	26303731	26333996	Q5ZLT0	XPO7_CHICK	Exportin-7	GO:0005049; GO:0005643; GO:0005737; GO:0006611; GO:0008536	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]
PGEN_.00g251400	Scaffold_12	26335544	26342924	NA	NA	NA	NA	NA
PGEN_.00g251410	Scaffold_12	26342977	26367799	Q9P2N6	KANL3_HUMAN	KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog) (Serum inhibited-related protein) (Testis development protein PRTD)	GO:0000123; GO:0005634; GO:0005654; GO:0043231; GO:0043981; GO:0043982; GO:0043984; GO:0044545	histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]
PGEN_.00g251420	Scaffold_12	26371624	26407548	Q8K385	FRRS1_MOUSE	Ferric-chelate reductase 1 (EC 1.-.-.-) (Stromal cell-derived receptor 2) (SDR-2)	GO:0000293; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872]
PGEN_.00g251430	Scaffold_12	26420860	26440914	Q5EAJ7	MVP_STRPU	Major vault protein (MVP)	GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g251440	Scaffold_12	26443184	26445517	NA	NA	NA	NA	NA
PGEN_.00g251450	Scaffold_12	26447292	26454339	Q5ZMI4	MVP_CHICK	Major vault protein (MVP)	GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g251460	Scaffold_12	26454712	26465402	Q05481	ZNF91_HUMAN	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]"
PGEN_.00g251470	Scaffold_12	26471246	26472367	NA	NA	NA	NA	NA
PGEN_.00g251480	Scaffold_12	26519376	26526636	NA	NA	NA	NA	NA
PGEN_.00g251490	Scaffold_12	26532527	26551940	Q9UMX1	SUFU_HUMAN	Suppressor of fused homolog (SUFUH)	GO:0000122; GO:0001501; GO:0001843; GO:0001947; GO:0003281; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006508; GO:0007165; GO:0007275; GO:0008013; GO:0008134; GO:0019901; GO:0021775; GO:0021776; GO:0035904; GO:0042308; GO:0042994; GO:0043433; GO:0043588; GO:0045668; GO:0045879; GO:0060976; GO:0097542; GO:0097546; GO:1901621; GO:2000059	"ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; cytoplasmic sequestering of transcription factor [GO:0042994]; heart looping [GO:0001947]; multicellular organism development [GO:0007275]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; proteolysis [GO:0006508]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; ventricular septum development [GO:0003281]"
PGEN_.00g251500	Scaffold_12	26563805	26587433	P11247	PERM_MOUSE	Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase light chain; Myeloperoxidase heavy chain]	GO:0001878; GO:0002149; GO:0002679; GO:0004601; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0042582; GO:0042742; GO:0042744; GO:0043231; GO:0046872; GO:0050832; GO:0055114; GO:1990268	azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]
PGEN_.00g251510	Scaffold_12	26592982	26593290	NA	NA	NA	NA	NA
PGEN_.00g251520	Scaffold_12	26610307	26613033	Q504G0	TM127_DANRE	Transmembrane protein 127	GO:0005886; GO:0008285; GO:0016021; GO:0032007	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of TOR signaling [GO:0032007]
PGEN_.00g251530	Scaffold_12	26618088	26630800	Q6NS60	FBX41_MOUSE	F-box only protein 41		
PGEN_.00g251540	Scaffold_12	26632510	26642582	NA	NA	NA	NA	NA
PGEN_.00g251550	Scaffold_12	26652732	26653019	NA	NA	NA	NA	NA
PGEN_.00g251560	Scaffold_12	26673150	26709072	NA	NA	NA	NA	NA
PGEN_.00g251570	Scaffold_12	26718864	26719082	NA	NA	NA	NA	NA
PGEN_.00g251580	Scaffold_12	26733440	26766357	O42392	VDR_CHICK	"Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1)"	GO:0003707; GO:0004879; GO:0005499; GO:0005634; GO:0005737; GO:0005886; GO:0005901; GO:0006816; GO:0008270; GO:0033280; GO:0043565; GO:0070561	caveola [GO:0005901]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]; calcium ion transport [GO:0006816]; response to vitamin D [GO:0033280]; vitamin D receptor signaling pathway [GO:0070561]
PGEN_.00g251590	Scaffold_12	26858237	26872169	NA	NA	NA	NA	NA
PGEN_.00g251600	Scaffold_12	26888819	26889052	NA	NA	NA	NA	NA
PGEN_.00g251610	Scaffold_12	26891784	26892191	NA	NA	NA	NA	NA
PGEN_.00g251620	Scaffold_12	26893218	26893940	NA	NA	NA	NA	NA
PGEN_.00g251630	Scaffold_12	26894894	26908585	NA	NA	NA	NA	NA
PGEN_.00g251640	Scaffold_12	26933475	26937099	Q6GM59	MOT12_XENLA	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0015293; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]
PGEN_.00g251650	Scaffold_12	26942859	26952212	Q8K1C7	MOT14_MOUSE	Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g251660	Scaffold_12	26969590	26978361	Q6GM59	MOT12_XENLA	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0015293; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]
PGEN_.00g251670	Scaffold_12	26987678	26990603	NA	NA	NA	NA	NA
PGEN_.00g251680	Scaffold_12	26990687	27029519	Q460N5	PAR14_HUMAN	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g251690	Scaffold_12	27054349	27054597	NA	NA	NA	NA	NA
PGEN_.00g251700	Scaffold_12	27054720	27069535	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g251710	Scaffold_12	27171177	27240372	Q460N5	PAR14_HUMAN	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g251720	Scaffold_12	27283923	27293116	NA	NA	NA	NA	NA
PGEN_.00g251730	Scaffold_12	27314255	27314569	NA	NA	NA	NA	NA
PGEN_.00g251740	Scaffold_12	27337415	27368419	Q149M9	NWD1_HUMAN	NACHT domain- and WD repeat-containing protein 1	GO:0005524; GO:0005829; GO:0010628; GO:0032088	cytosol [GO:0005829]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]
PGEN_.00g251750	Scaffold_12	27379259	27380791	NA	NA	NA	NA	NA
PGEN_.00g251760	Scaffold_12	27382755	27414141	NA	NA	NA	NA	NA
PGEN_.00g251770	Scaffold_12	27416489	27435089	Q28FF3	S49A3_XENTR	Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7-a) (Major facilitator superfamily domain-containing protein 7-b) (Myosin light polypeptide 5 regulatory protein) (MYL5)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g251780	Scaffold_12	27445230	27445604	NA	NA	NA	NA	NA
PGEN_.00g251790	Scaffold_12	27464270	27525376	Q08CG8	RNF44_DANRE	RING finger protein 44	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g251800	Scaffold_12	27525346	27527466	NA	NA	NA	NA	NA
PGEN_.00g251810	Scaffold_12	27527517	27533945	Q63647	PNRC1_RAT	Proline-rich nuclear receptor coactivator 1 (Proline-rich protein 2)	GO:0005634	nucleus [GO:0005634]
PGEN_.00g251820	Scaffold_12	27556907	27576588	O43663	PRC1_HUMAN	Protein regulator of cytokinesis 1	GO:0000022; GO:0000922; GO:0001578; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0008017; GO:0008284; GO:0015630; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0045171; GO:0051301; GO:0070938	contractile ring [GO:0070938]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic spindle elongation [GO:0000022]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465]
PGEN_.00g251830	Scaffold_12	27581902	27608318	Q5RH71	TSN33_DANRE	Tetraspanin-33 (Tspan-33)	GO:0005887; GO:0051604; GO:0072659	integral component of plasma membrane [GO:0005887]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]
PGEN_.00g251840	Scaffold_12	27610680	27622212	Q9NTM9	CUTC_HUMAN	Copper homeostasis protein cutC homolog	GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262]
PGEN_.00g251850	Scaffold_12	27622608	27630149	Q8BJ03	COX15_MOUSE	Cytochrome c oxidase assembly protein COX15 homolog	GO:0005654; GO:0005739; GO:0005743; GO:0006784; GO:0008535; GO:0016021; GO:0016627; GO:0016653; GO:0060090; GO:0070069; GO:1902600	"cytochrome complex [GO:0070069]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; molecular adaptor activity [GO:0060090]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; heme a biosynthetic process [GO:0006784]; proton transmembrane transport [GO:1902600]; respiratory chain complex IV assembly [GO:0008535]"
PGEN_.00g251860	Scaffold_12	27636112	27643019	P50238	CRIP1_HUMAN	Cysteine-rich protein 1 (CRP-1) (Cysteine-rich heart protein) (CRHP) (hCRHP) (Cysteine-rich intestinal protein) (CRIP)	GO:0003680; GO:0005737; GO:0006955; GO:0007507; GO:0008270; GO:0008301; GO:0008630; GO:0010033; GO:0010043; GO:0010468; GO:0042277; GO:0060741; GO:0071236; GO:0071493	"cytoplasm [GO:0005737]; AT DNA binding [GO:0003680]; DNA binding, bending [GO:0008301]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; heart development [GO:0007507]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; prostate gland stromal morphogenesis [GO:0060741]; regulation of gene expression [GO:0010468]; response to organic substance [GO:0010033]; response to zinc ion [GO:0010043]"
PGEN_.00g251870	Scaffold_12	27649363	27655341	A8E7G4	DEN10_DANRE	DENN domain-containing protein 10 (Protein FAM45) (Protein FAM45A)	GO:0005085; GO:0005623; GO:0005770; GO:0015031; GO:0032509; GO:2000641	cell [GO:0005623]; late endosome [GO:0005770]; guanyl-nucleotide exchange factor activity [GO:0005085]; endosome transport via multivesicular body sorting pathway [GO:0032509]; protein transport [GO:0015031]; regulation of early endosome to late endosome transport [GO:2000641]
PGEN_.00g251880	Scaffold_12	27688627	27690953	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g251890	Scaffold_12	27758339	27768732	P56718	OX1R_RAT	Orexin receptor type 1 (Ox-1-R) (Ox1-R) (Ox1R) (Hypocretin receptor type 1)	GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007218; GO:0007631; GO:0016499; GO:0017046; GO:0032870; GO:0051480; GO:0070374	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; cellular response to hormone stimulus [GO:0032870]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480]
PGEN_.00g251900	Scaffold_12	27835930	27844837	NA	NA	NA	NA	NA
PGEN_.00g251910	Scaffold_12	27917873	27931309	Q12907	LMAN2_HUMAN	Vesicular integral-membrane protein VIP36 (Glycoprotein GP36b) (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36)	GO:0000139; GO:0005537; GO:0005615; GO:0005789; GO:0005793; GO:0005794; GO:0005887; GO:0006888; GO:0006890; GO:0007029; GO:0007030; GO:0009986; GO:0015031; GO:0030134; GO:0030246; GO:0031072; GO:0033116; GO:0046872; GO:0050766; GO:0070062	"cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; heat shock protein binding [GO:0031072]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of phagocytosis [GO:0050766]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g251920	Scaffold_12	27940226	27950702	B5X1P9	ABRX1_SALSA	BRCA1-A complex subunit Abraxas 1 (Coiled-coil domain-containing protein 98) (Protein FAM175A)	GO:0005634; GO:0006302; GO:0006325; GO:0010212; GO:0031593; GO:0045739; GO:0070531; GO:0072425	BRCA1-A complex [GO:0070531]; nucleus [GO:0005634]; polyubiquitin modification-dependent protein binding [GO:0031593]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]
PGEN_.00g251930	Scaffold_12	27959363	27962086	NA	NA	NA	NA	NA
PGEN_.00g251940	Scaffold_12	27967154	27993888	B3EWZ9	HEPHL_ACRMI	Hephaestin-like protein (EC 1.-.-.-)	GO:0005507; GO:0006825; GO:0016021; GO:0016491	integral component of membrane [GO:0016021]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; copper ion transport [GO:0006825]
PGEN_.00g251950	Scaffold_12	28012341	28013511	Q94521	DNAT_DROME	Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase)	GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066	"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]"
PGEN_.00g251960	Scaffold_12	28018137	28045585	Q9W735	PRM1A_DANRE	Prominin-1-A (Prominin-like protein 1)	GO:0005783; GO:0005793; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0015485; GO:0016324; GO:0031528; GO:0071914	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; cholesterol binding [GO:0015485]
PGEN_.00g251970	Scaffold_12	28054480	28060225	NA	NA	NA	NA	NA
PGEN_.00g251980	Scaffold_12	28062473	28064239	NA	NA	NA	NA	NA
PGEN_.00g251990	Scaffold_12	28064281	28072126	NA	NA	NA	NA	NA
PGEN_.00g252000	Scaffold_12	28078785	28171543	Q80ZA4	PKHL1_MOUSE	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)	GO:0005929; GO:0016021	cilium [GO:0005929]; integral component of membrane [GO:0016021]
PGEN_.00g252010	Scaffold_12	28180826	28186673	Q6NWH1	DCA10_DANRE	DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32)	GO:0016567; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; protein ubiquitination [GO:0016567]
PGEN_.00g252020	Scaffold_12	28224175	28239355	NA	NA	NA	NA	NA
PGEN_.00g252030	Scaffold_12	28245155	28287624	Q9UPU3	SORC3_HUMAN	VPS10 domain-containing receptor SorCS3	GO:0007218; GO:0007612; GO:0007613; GO:0008188; GO:0016020; GO:0016021; GO:0098978; GO:0099061; GO:1900452	glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; neuropeptide receptor activity [GO:0008188]; learning [GO:0007612]; memory [GO:0007613]; neuropeptide signaling pathway [GO:0007218]; regulation of long-term synaptic depression [GO:1900452]
PGEN_.00g252040	Scaffold_12	28289478	28289738	NA	NA	NA	NA	NA
PGEN_.00g252050	Scaffold_12	28296846	28309348	Q9BYV6	TRI55_HUMAN	Tripartite motif-containing protein 55 (Muscle-specific RING finger protein 2) (MuRF-2) (MuRF2) (RING finger protein 29)	GO:0005634; GO:0005737; GO:0005874; GO:0007165; GO:0008270; GO:0042802	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; signal transduction [GO:0007165]
PGEN_.00g252060	Scaffold_12	28315975	28322060	Q5XIH9	HPDL_RAT	4-hydroxyphenylpyruvate dioxygenase-like protein (EC 1.13.-.-) (Glyoxalase domain-containing protein 1)	GO:0003868; GO:0009072; GO:0046872	4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; aromatic amino acid family metabolic process [GO:0009072]
PGEN_.00g252070	Scaffold_12	28331535	28340398	P23708	NFYA_MOUSE	Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA)	GO:0000978; GO:0001221; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0008134; GO:0016602; GO:0032993; GO:0043565; GO:0045893; GO:0045944; GO:0048511; GO:0090575; GO:2000036; GO:2000648	"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cofactor binding [GO:0001221]; transcription factor binding [GO:0008134]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"
PGEN_.00g252080	Scaffold_12	28346705	28359699	Q9Y5Z4	HEBP2_HUMAN	Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL)	GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940]
PGEN_.00g252090	Scaffold_12	28393089	28402069	Q13115	DUS4_HUMAN	Dual specificity protein phosphatase 4 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2) (MAP kinase phosphatase 2) (MKP-2)	GO:0000188; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0008138; GO:0008330; GO:0016311; GO:0016791; GO:0017017; GO:0035335; GO:0035970; GO:0070373; GO:1990439	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]
PGEN_.00g252100	Scaffold_12	28408954	28415878	P89116	CASP1_SPOFR	Caspase-1 (EC 3.4.22.-) [Cleaved into: Caspase-1 subunit p19/18; Caspase-1 subunit p12]	GO:0004197; GO:0006915	cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]
PGEN_.00g252110	Scaffold_12	28436540	28454289	NA	NA	NA	NA	NA
PGEN_.00g252120	Scaffold_12	28528035	28530185	NA	NA	NA	NA	NA
PGEN_.00g252130	Scaffold_12	28549585	28550994	NA	NA	NA	NA	NA
PGEN_.00g252140	Scaffold_12	28554253	28555689	NA	NA	NA	NA	NA
PGEN_.00g252150	Scaffold_12	28559174	28559521	NA	NA	NA	NA	NA
PGEN_.00g252160	Scaffold_12	28560354	28571302	Q6GMV2	SMYD5_HUMAN	SET and MYND domain-containing protein 5 (EC 2.1.1.-) (Protein NN8-4AG) (Retinoic acid-induced protein 15)	GO:0008168; GO:0032259; GO:0046872	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g252170	Scaffold_12	28575158	28587916	Q8CIC2	NUP42_MOUSE	Nucleoporin NUP42 (NLP-1) (Nucleoporin-like protein 2)	GO:0001750; GO:0005049; GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0006611; GO:0031965; GO:0046872; GO:0051028	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]
PGEN_.00g252180	Scaffold_12	28589670	28597658	O43174	CP26A_HUMAN	Cytochrome P450 26A1 (EC 1.14.13.-) (Cytochrome P450 retinoic acid-inactivating 1) (Cytochrome P450RAI) (hP450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome)	GO:0000249; GO:0001822; GO:0001972; GO:0004497; GO:0005506; GO:0005789; GO:0006696; GO:0006766; GO:0006805; GO:0008401; GO:0016125; GO:0016709; GO:0019825; GO:0020037; GO:0032526; GO:0033189; GO:0034653; GO:0042573; GO:0048387; GO:0055114	"endoplasmic reticulum membrane [GO:0005789]; C-22 sterol desaturase activity [GO:0000249]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; ergosterol biosynthetic process [GO:0006696]; kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; oxidation-reduction process [GO:0055114]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g252190	Scaffold_12	28604143	28627697	P08051	MLR_SPISA	"Myosin regulatory light chain, smooth muscle"	GO:0005509; GO:0016459	myosin complex [GO:0016459]; calcium ion binding [GO:0005509]
PGEN_.00g252200	Scaffold_12	28641937	28648651	Q90673	PRLD1_CHICK	"PRELI domain-containing protein 1, mitochondrial (Px19-like protein)"	GO:0005739; GO:0005758; GO:0006915; GO:0015914; GO:1990050	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; phosphatidic acid transfer activity [GO:1990050]; apoptotic process [GO:0006915]; phospholipid transport [GO:0015914]
PGEN_.00g252210	Scaffold_12	28650019	28654406	NA	NA	NA	NA	NA
PGEN_.00g252220	Scaffold_12	28667061	28687324	Q8TAU0	NKX23_HUMAN	Homeobox protein Nkx-2.3 (Homeobox protein NK-2 homolog C)	GO:0000790; GO:0000978; GO:0000981; GO:0001776; GO:0002317; GO:0003700; GO:0005634; GO:0006641; GO:0022612; GO:0030154; GO:0030225; GO:0042127; GO:0042475; GO:0043367; GO:0043565; GO:0045944; GO:0048535; GO:0048536; GO:0048541; GO:0048621; GO:0050900	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cell differentiation [GO:0030154]; gland morphogenesis [GO:0022612]; leukocyte homeostasis [GO:0001776]; leukocyte migration [GO:0050900]; lymph node development [GO:0048535]; macrophage differentiation [GO:0030225]; odontogenesis of dentin-containing tooth [GO:0042475]; Peyer's patch development [GO:0048541]; plasma cell differentiation [GO:0002317]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic digestive tract morphogenesis [GO:0048621]; regulation of cell population proliferation [GO:0042127]; spleen development [GO:0048536]; triglyceride metabolic process [GO:0006641]"
PGEN_.00g252230	Scaffold_12	28746144	28747005	NA	NA	NA	NA	NA
PGEN_.00g252240	Scaffold_12	28767278	28772329	NA	NA	NA	NA	NA
PGEN_.00g252250	Scaffold_12	28776805	28777236	Q1RMU8	NPY1R_BOVIN	Neuropeptide Y receptor type 1 (NPY1-R)	GO:0001601; GO:0001602; GO:0003151; GO:0005886; GO:0006006; GO:0007626; GO:0007631; GO:0008217; GO:0016021; GO:0019233; GO:0040014	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601]; feeding behavior [GO:0007631]; glucose metabolic process [GO:0006006]; locomotory behavior [GO:0007626]; outflow tract morphogenesis [GO:0003151]; regulation of blood pressure [GO:0008217]; regulation of multicellular organism growth [GO:0040014]; sensory perception of pain [GO:0019233]
PGEN_.00g252260	Scaffold_12	28787660	28790468	Q6BD04	GPR54_ORENI	G-protein coupled receptor 54	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g252270	Scaffold_12	28824504	28866544	Q61824	ADA12_MOUSE	Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha)	GO:0004222; GO:0005615; GO:0005654; GO:0005886; GO:0007155; GO:0016021; GO:0017124; GO:0045766; GO:0046872	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]; cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]
PGEN_.00g252280	Scaffold_12	28869980	28884465	O75792	RNH2A_HUMAN	Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Aicardi-Goutieres syndrome 4 protein) (AGS4) (RNase H(35)) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A)	GO:0003723; GO:0004523; GO:0004540; GO:0005654; GO:0005829; GO:0006260; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]"
PGEN_.00g252290	Scaffold_12	28897729	28920325	NA	NA	NA	NA	NA
PGEN_.00g252300	Scaffold_12	28951989	28955675	NA	NA	NA	NA	NA
PGEN_.00g252310	Scaffold_12	29134948	29137639	P32246	CCR1_HUMAN	C-C chemokine receptor type 1 (C-C CKR-1) (CC-CKR-1) (CCR-1) (CCR1) (HM145) (LD78 receptor) (Macrophage inflammatory protein 1-alpha receptor) (MIP-1alpha-R) (RANTES-R) (CD antigen CD191)	GO:0002407; GO:0004435; GO:0004950; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0006874; GO:0006887; GO:0006935; GO:0006954; GO:0006955; GO:0007155; GO:0007166; GO:0007186; GO:0007187; GO:0007204; GO:0007267; GO:0009611; GO:0009897; GO:0010629; GO:0016493; GO:0019221; GO:0019722; GO:0019956; GO:0019957; GO:0030335; GO:0030502; GO:0035717; GO:0045672; GO:0051928; GO:0060326; GO:0070098; GO:0070374; GO:0071791; GO:0090026	"cell [GO:0005623]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine (C-C motif) ligand 5 binding [GO:0071791]; chemokine (C-C motif) ligand 7 binding [GO:0035717]; chemokine binding [GO:0019956]; chemokine receptor activity [GO:0004950]; phosphatidylinositol phospholipase C activity [GO:0004435]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell chemotaxis [GO:0002407]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of gene expression [GO:0010629]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of osteoclast differentiation [GO:0045672]; response to wounding [GO:0009611]"
PGEN_.00g252320	Scaffold_12	29235532	29236719	G3M4F8	OCTB2_CHISP	Octopamine receptor beta-2R (CsOA2B2)	GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016021; GO:0071418; GO:0071927; GO:0071928	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; tyramine signaling pathway [GO:0071928]
PGEN_.00g252330	Scaffold_12	29352288	29353527	NA	NA	NA	NA	NA
PGEN_.00g252340	Scaffold_12	29354120	29354917	NA	NA	NA	NA	NA
PGEN_.00g252350	Scaffold_12	29355138	29356406	NA	NA	NA	NA	NA
PGEN_.00g252360	Scaffold_12	29380243	29384988	Q4R3S3	ANKR7_MACFA	Ankyrin repeat domain-containing protein 7		
PGEN_.00g252370	Scaffold_12	29388219	29435612	Q96T66	NMNA3_HUMAN	Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 (NMN/NaMN adenylyltransferase 3) (Nicotinamide-nucleotide adenylyltransferase 3) (NMN adenylyltransferase 3) (Nicotinate-nucleotide adenylyltransferase 3) (NaMN adenylyltransferase 3) (EC 2.7.7.18) (Pyridine nucleotide adenylyltransferase 3) (PNAT-3) (EC 2.7.7.1)	GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0009165; GO:0009435; GO:0019674	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; nucleotide biosynthetic process [GO:0009165]
PGEN_.00g252380	Scaffold_12	29457095	29465946	NA	NA	NA	NA	NA
PGEN_.00g252390	Scaffold_12	29472703	29474232	NA	NA	NA	NA	NA
PGEN_.00g252400	Scaffold_12	29474453	29484858	NA	NA	NA	NA	NA
PGEN_.00g252410	Scaffold_12	29523990	29525042	Q9H8Y1	VRTN_HUMAN	Vertnin	GO:0000122; GO:0001227; GO:0004803; GO:0006313; GO:0043565	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; transposase activity [GO:0004803]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g252420	Scaffold_12	29533916	29561237	P48820	RBP2_BOVIN	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) (Fragment)	GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0006457; GO:0006607; GO:0008536; GO:0016740; GO:0016925; GO:0031965; GO:0042405; GO:0043547; GO:0044615; GO:0051028	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; transferase activity [GO:0016740]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]
PGEN_.00g252430	Scaffold_12	29597621	29600766	NA	NA	NA	NA	NA
PGEN_.00g252440	Scaffold_12	29603545	29607828	NA	NA	NA	NA	NA
PGEN_.00g252450	Scaffold_12	29624775	29706958	Q8C3J5	DOCK2_MOUSE	Dedicator of cytokinesis protein 2 (Protein Hch)	GO:0001766; GO:0001768; GO:0001771; GO:0002277; GO:0005096; GO:0005737; GO:0005856; GO:0006935; GO:0007010; GO:0007264; GO:0012505; GO:0016020; GO:0030036; GO:0030676; GO:0035022; GO:0042098; GO:0042110; GO:0042608; GO:0044351; GO:0045059; GO:0045060; GO:0046631; GO:0046633; GO:0050766	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endomembrane system [GO:0012505]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; T cell receptor binding [GO:0042608]; actin cytoskeleton organization [GO:0030036]; alpha-beta T cell activation [GO:0046631]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; positive regulation of phagocytosis [GO:0050766]; positive regulation of Rac protein signal transduction [GO:0035022]; positive thymic T cell selection [GO:0045059]; small GTPase mediated signal transduction [GO:0007264]; T cell activation [GO:0042110]; T cell proliferation [GO:0042098]
PGEN_.00g252460	Scaffold_12	29714451	29728380	Q29RL1	CF206_BOVIN	Cilia- and flagella-associated protein 206	GO:0001534; GO:0003341; GO:0031514; GO:0035082	motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]
PGEN_.00g252470	Scaffold_12	29731418	29745653	Q5U4F6	WDR34_MOUSE	WD repeat-containing protein 34	GO:0005814; GO:0005829; GO:0005868; GO:0005930; GO:0007018; GO:0036064; GO:0042073; GO:0045503; GO:0045504; GO:0060271	axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]
PGEN_.00g252480	Scaffold_12	29754039	29763748	Q8R023	PCGF1_MOUSE	Polycomb group RING finger protein 1 (Nervous system Polycomb-1) (NSPc1) (RING finger protein 68)	GO:0000122; GO:0005634; GO:0005654; GO:0006342; GO:0008022; GO:0031519; GO:0035102; GO:0035518; GO:0036353; GO:0046872; GO:1990841	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; chromatin silencing [GO:0006342]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g252490	Scaffold_12	29773397	29773957	NA	NA	NA	NA	NA
PGEN_.00g252500	Scaffold_12	29774094	29784454	Q5ZKJ5	MF13A_CHICK	Transmembrane protein 180 (Major facilitator superfamily domain-containing 13A)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g252510	Scaffold_12	29796663	29802948	Q6PBU0	F136A_DANRE	Protein FAM136A		
PGEN_.00g252520	Scaffold_12	29825231	29832248	NA	NA	NA	NA	NA
PGEN_.00g252530	Scaffold_12	29840506	29853913	NA	NA	NA	NA	NA
PGEN_.00g252540	Scaffold_12	29891403	29895813	NA	NA	NA	NA	NA
PGEN_.00g252550	Scaffold_12	29895914	29915122	NA	NA	NA	NA	NA
PGEN_.00g252560	Scaffold_12	29915448	29915771	NA	NA	NA	NA	NA
PGEN_.00g252570	Scaffold_12	29916985	29921093	NA	NA	NA	NA	NA
PGEN_.00g252580	Scaffold_12	29965800	29976944	Q9WVA3	BUB3_MOUSE	Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5)	GO:0000070; GO:0000776; GO:0000777; GO:0005654; GO:0007059; GO:0007094; GO:0008608; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:0051983; GO:1990298	bub1-bub3 complex [GO:1990298]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; ubiquitin binding [GO:0043130]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983]
PGEN_.00g252590	Scaffold_12	29984525	29988679	X4Y2L4	LHYAL_HIRNI	Hyaluronoglucuronidase (LHyal) (EC 3.2.1.36) (Hyaluronate 3-glycanohydrolase)	GO:0016020; GO:0016740; GO:0030214; GO:0033906	membrane [GO:0016020]; hyaluronoglucuronidase activity [GO:0033906]; transferase activity [GO:0016740]; hyaluronan catabolic process [GO:0030214]
PGEN_.00g252600	Scaffold_12	30019155	30020424	NA	NA	NA	NA	NA
PGEN_.00g252610	Scaffold_12	30025277	30025892	NA	NA	NA	NA	NA
PGEN_.00g252620	Scaffold_12	30027692	30059838	Q9JJX8	ST32B_MOUSE	Serine/threonine-protein kinase 32B (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0018105; GO:0035556; GO:0046872	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]
PGEN_.00g252630	Scaffold_12	30099002	30138805	Q9C0I9	LRC27_HUMAN	Leucine-rich repeat-containing protein 27		
PGEN_.00g252640	Scaffold_12	30196407	30196748	NA	NA	NA	NA	NA
PGEN_.00g252650	Scaffold_12	30210761	30211051	NA	NA	NA	NA	NA
PGEN_.00g252660	Scaffold_12	30211159	30211710	NA	NA	NA	NA	NA
PGEN_.00g252670	Scaffold_12	30214828	30230904	NA	NA	NA	NA	NA
PGEN_.00g252680	Scaffold_12	30246144	30263616	NA	NA	NA	NA	NA
PGEN_.00g252690	Scaffold_12	30267456	30270592	P49013	FBP3_STRPU	Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)	GO:0005509; GO:0005615; GO:0009374	extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]
PGEN_.00g252700	Scaffold_12	30351169	30367057	Q9ESQ5	TRPM4_RAT	Transient receptor potential cation channel subfamily M member 4 (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (MLS2s) (Melastatin-like 2)	GO:0002250; GO:0002407; GO:0002724; GO:0005227; GO:0005262; GO:0005509; GO:0005516; GO:0005524; GO:0005623; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006816; GO:0007204; GO:0008284; GO:0010460; GO:0016925; GO:0019722; GO:0030502; GO:0034706; GO:0035774; GO:0042310; GO:0043025; GO:0044214; GO:0045600; GO:0045668; GO:0045907; GO:0051289; GO:0071318; GO:0086045; GO:0086047; GO:0086048; GO:0086091; GO:0089717; GO:0090263; GO:0098662; GO:0098719; GO:0098911; GO:1903949; GO:1904179; GO:1904199	cell [GO:0005623]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; spanning component of membrane [GO:0089717]; spanning component of plasma membrane [GO:0044214]; ATP binding [GO:0005524]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; adaptive immune response [GO:0002250]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; dendritic cell chemotaxis [GO:0002407]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; negative regulation of bone mineralization [GO:0030502]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of atrial cardiac muscle cell action potential [GO:1903949]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of regulation of vascular smooth muscle cell membrane depolarization [GO:1904199]; positive regulation of vasoconstriction [GO:0045907]; protein homotetramerization [GO:0051289]; protein sumoylation [GO:0016925]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of T cell cytokine production [GO:0002724]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; sodium ion import across plasma membrane [GO:0098719]; vasoconstriction [GO:0042310]
PGEN_.00g252710	Scaffold_12	30367634	30375217	NA	NA	NA	NA	NA
PGEN_.00g252720	Scaffold_12	30381073	30391138	Q7SY09	AGRL4_DANRE	Adhesion G protein-coupled receptor L4	GO:0004930; GO:0005509; GO:0005887; GO:0007166; GO:0007189	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g252730	Scaffold_12	30403384	30410871	NA	NA	NA	NA	NA
PGEN_.00g252740	Scaffold_12	30443468	30444640	NA	NA	NA	NA	NA
PGEN_.00g252750	Scaffold_12	30453274	30453633	NA	NA	NA	NA	NA
PGEN_.00g252760	Scaffold_12	30476068	30488880	Q6DHU4	PR38A_DANRE	Pre-mRNA-splicing factor 38A	GO:0000398; GO:0005634; GO:0071005; GO:0071011	"nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g252770	Scaffold_12	30498877	30511673	NA	NA	NA	NA	NA
PGEN_.00g252780	Scaffold_12	30530659	30550979	Q9NR09	BIRC6_HUMAN	Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)	GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0006468; GO:0006511; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237	endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g252790	Scaffold_12	30563429	30595111	O88667	RAD_MOUSE	GTP-binding protein RAD	GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0030308; GO:1901842	plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell growth [GO:0030308]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]
PGEN_.00g252800	Scaffold_12	30621974	30669140	Q8BG58	P4HTM_MOUSE	Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)	GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0016706; GO:0018401; GO:0031418; GO:0045646	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646]
PGEN_.00g252810	Scaffold_12	30692206	30702542	Q8BG58	P4HTM_MOUSE	Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)	GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0016706; GO:0018401; GO:0031418; GO:0045646	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646]
PGEN_.00g252820	Scaffold_12	30758285	30759586	NA	NA	NA	NA	NA
PGEN_.00g252830	Scaffold_12	30786163	30787357	NA	NA	NA	NA	NA
PGEN_.00g252840	Scaffold_12	30832378	30921817	A6QLU6	AGRD1_BOVIN	Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)	GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g252850	Scaffold_12	30942064	30943548	P00185	CP1A1_RAT	Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Cytochrome P450MT2) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B]	GO:0001666; GO:0001889; GO:0002933; GO:0003824; GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0006778; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0008395; GO:0009308; GO:0009404; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009636; GO:0009804; GO:0009812; GO:0010033; GO:0010041; GO:0014070; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0016829; GO:0017143; GO:0017144; GO:0018894; GO:0019341; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0032502; GO:0033189; GO:0035902; GO:0042493; GO:0042572; GO:0042904; GO:0043010; GO:0043231; GO:0046483; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0055114; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0101020; GO:0101021; GO:1900087	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; developmental process [GO:0032502]; dibenzo-p-dioxin catabolic process [GO:0019341]; dibenzo-p-dioxin metabolic process [GO:0018894]; digestive tract development [GO:0048565]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; liver development [GO:0001889]; maternal process involved in parturition [GO:0060137]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]"
PGEN_.00g252860	Scaffold_12	30978369	30978797	NA	NA	NA	NA	NA
PGEN_.00g252870	Scaffold_12	30981325	31003022	Q503P5	S49A3_DANRE	Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g252880	Scaffold_12	31035393	31048475	NA	NA	NA	NA	NA
PGEN_.00g252890	Scaffold_12	31064712	31078438	Q7KRW1	TRC8_DROME	Protein TRC8 homolog	GO:0004842; GO:0005783; GO:0005789; GO:0007418; GO:0008270; GO:0012505; GO:0016021; GO:0016567; GO:0036503; GO:0045926; GO:0061630	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ERAD pathway [GO:0036503]; negative regulation of growth [GO:0045926]; protein ubiquitination [GO:0016567]; ventral midline development [GO:0007418]
PGEN_.00g252900	Scaffold_12	31091437	31179763	Q499W2	SLD5_RAT	"DNA replication complex GINS protein SLD5 (GINS complex subunit 4) [Cleaved into: DNA replication complex GINS protein SLD5, N-terminally processed]"	GO:0000727; GO:0000811; GO:0001833; GO:0005634; GO:0005737; GO:0006261; GO:0031298; GO:0032508	cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA duplex unwinding [GO:0032508]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via break-induced replication [GO:0000727]; inner cell mass cell proliferation [GO:0001833]
PGEN_.00g252910	Scaffold_12	31190845	31196062	Q803M0	PPR3B_DANRE	Protein phosphatase 1 regulatory subunit 3B	GO:0000164; GO:0005977; GO:0005981; GO:0019888	protein phosphatase type 1 complex [GO:0000164]; protein phosphatase regulator activity [GO:0019888]; glycogen metabolic process [GO:0005977]; regulation of glycogen catabolic process [GO:0005981]
PGEN_.00g252920	Scaffold_12	31215063	31215509	NA	NA	NA	NA	NA
PGEN_.00g252930	Scaffold_12	31229690	31258741	NA	NA	NA	NA	NA
PGEN_.00g252940	Scaffold_12	31258039	31258515	NA	NA	NA	NA	NA
PGEN_.00g252950	Scaffold_12	31269213	31273483	NA	NA	NA	NA	NA
PGEN_.00g252960	Scaffold_12	31274115	31274351	NA	NA	NA	NA	NA
PGEN_.00g252970	Scaffold_12	31274886	31278062	NA	NA	NA	NA	NA
PGEN_.00g252980	Scaffold_12	31294597	31295160	Q90W04	NGB_TETNG	Neuroglobin	GO:0001666; GO:0005344; GO:0005737; GO:0019825; GO:0020037; GO:0043204; GO:0046872; GO:0098809	cytoplasm [GO:0005737]; perikaryon [GO:0043204]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitrite reductase activity [GO:0098809]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; response to hypoxia [GO:0001666]
PGEN_.00g252990	Scaffold_12	31315021	31322035	NA	NA	NA	NA	NA
PGEN_.00g253000	Scaffold_12	31328163	31329154	Q8WY91	THAP4_HUMAN	THAP domain-containing protein 4	GO:0000790; GO:0000981; GO:0003677; GO:0020037; GO:0042803; GO:0046872	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"
PGEN_.00g253010	Scaffold_12	31331316	31332944	NA	NA	NA	NA	NA
PGEN_.00g253020	Scaffold_12	31333486	31334235	NA	NA	NA	NA	NA
PGEN_.00g253030	Scaffold_12	31357845	31385459	NA	NA	NA	NA	NA
PGEN_.00g253040	Scaffold_12	31404939	31449765	P49354	FNTA_HUMAN	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha)	GO:0004660; GO:0004661; GO:0004662; GO:0004663; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0005953; GO:0005965; GO:0007179; GO:0008017; GO:0018343; GO:0018344; GO:0022400; GO:0030548; GO:0030971; GO:0043014; GO:0045213; GO:0071340; GO:0090044; GO:0090045	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g253050	Scaffold_12	31452668	31452991	NA	NA	NA	NA	NA
PGEN_.00g253060	Scaffold_12	31453790	31455794	Q96N64	PWP2A_HUMAN	PWWP domain-containing protein 2A	GO:0003682; GO:0005634; GO:0042393	nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]
PGEN_.00g253070	Scaffold_12	31490968	31491618	NA	NA	NA	NA	NA
PGEN_.00g253080	Scaffold_12	31491729	31492118	NA	NA	NA	NA	NA
PGEN_.00g253090	Scaffold_12	31492287	31496792	Q3ZBR5	TTC1_BOVIN	Tetratricopeptide repeat protein 1 (TPR repeat protein 1)	GO:0005829	cytosol [GO:0005829]
PGEN_.00g253100	Scaffold_12	31503138	31526409	NA	NA	NA	NA	NA
PGEN_.00g253110	Scaffold_12	31538347	31558544	Q9WYX8	Y508_THEMA	Uncharacterized protein TM_0508	GO:0003677; GO:0005524; GO:0006261; GO:0006281; GO:0006282; GO:0006310; GO:0008047; GO:0009378	ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; four-way junction helicase activity [GO:0009378]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; regulation of DNA repair [GO:0006282]
PGEN_.00g253120	Scaffold_12	31563482	31586722	NA	NA	NA	NA	NA
PGEN_.00g253130	Scaffold_12	31613341	31636050	Q8HYN7	KCIP4_MACFA	Kv channel-interacting protein 4 (KChIP4) (A-type potassium channel modulatory protein 4) (Potassium channel-interacting protein 4)	GO:0005244; GO:0005267; GO:0005509; GO:0005829; GO:0005886; GO:0008076; GO:0015459; GO:0072659; GO:1901379	cytosol [GO:0005829]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]
PGEN_.00g253140	Scaffold_12	31638209	31639163	NA	NA	NA	NA	NA
PGEN_.00g253150	Scaffold_12	31677469	31677786	NA	NA	NA	NA	NA
PGEN_.00g253160	Scaffold_12	31864556	31864903	NA	NA	NA	NA	NA
PGEN_.00g253170	Scaffold_12	31872704	31873138	NA	NA	NA	NA	NA
PGEN_.00g253180	Scaffold_12	32021150	32022650	NA	NA	NA	NA	NA
PGEN_.00g253190	Scaffold_12	32179390	32187159	NA	NA	NA	NA	NA
PGEN_.00g253200	Scaffold_12	32213940	32214377	NA	NA	NA	NA	NA
PGEN_.00g253210	Scaffold_12	32214591	32215282	NA	NA	NA	NA	NA
PGEN_.00g253220	Scaffold_12	32227311	32238589	Q9WUM5	SUCA_MOUSE	"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha)"	GO:0004550; GO:0004775; GO:0004776; GO:0005739; GO:0005743; GO:0005829; GO:0005886; GO:0006099; GO:0006104; GO:0006105; GO:0009142; GO:0019003; GO:0032991; GO:0044877; GO:0045244; GO:0048037	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; cofactor binding [GO:0048037]; GDP binding [GO:0019003]; nucleoside diphosphate kinase activity [GO:0004550]; protein-containing complex binding [GO:0044877]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g253230	Scaffold_12	32256172	32276150	Q5SVQ0	KAT7_MOUSE	"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)"	GO:0000123; GO:0000790; GO:0003688; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0008270; GO:0018393; GO:0031098; GO:0042393; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0044212; GO:0045892; GO:0045944; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090240; GO:1900182	"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA replication origin binding [GO:0003688]; DNA-binding transcription factor activity [GO:0003700]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"
PGEN_.00g253240	Scaffold_12	32330553	32355644	Q9BZD2	S29A3_HUMAN	Equilibrative nucleoside transporter 3 (hENT3) (Solute carrier family 29 member 3)	GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0016021; GO:0031902; GO:0043231	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; nucleoside transmembrane transporter activity [GO:0005337]
PGEN_.00g253250	Scaffold_12	32398837	32413347	Q13115	DUS4_HUMAN	Dual specificity protein phosphatase 4 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2) (MAP kinase phosphatase 2) (MKP-2)	GO:0000188; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0008138; GO:0008330; GO:0016311; GO:0016791; GO:0017017; GO:0035335; GO:0035970; GO:0070373; GO:1990439	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]
PGEN_.00g253260	Scaffold_12	32435204	32445292	NA	NA	NA	NA	NA
PGEN_.00g253270	Scaffold_12	32458094	32469088	Q14728	MFS10_HUMAN	Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein)	GO:0005637; GO:0006915; GO:0008493; GO:0008514; GO:0016021; GO:0030659; GO:0031526; GO:0043252	brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; organic anion transmembrane transporter activity [GO:0008514]; tetracycline transmembrane transporter activity [GO:0008493]; apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252]
PGEN_.00g253280	Scaffold_12	32511998	32512348	NA	NA	NA	NA	NA
PGEN_.00g253290	Scaffold_12	32517605	32518063	NA	NA	NA	NA	NA
PGEN_.00g253300	Scaffold_12	32518120	32518395	NA	NA	NA	NA	NA
PGEN_.00g253310	Scaffold_12	32518492	32518803	NA	NA	NA	NA	NA
PGEN_.00g253320	Scaffold_12	32518919	32519197	NA	NA	NA	NA	NA
PGEN_.00g253330	Scaffold_12	32519243	32519656	NA	NA	NA	NA	NA
PGEN_.00g253340	Scaffold_12	32519702	32520055	NA	NA	NA	NA	NA
PGEN_.00g253350	Scaffold_12	32520109	32520390	NA	NA	NA	NA	NA
PGEN_.00g253360	Scaffold_12	32529735	32530082	NA	NA	NA	NA	NA
PGEN_.00g253370	Scaffold_12	32538147	32538746	NA	NA	NA	NA	NA
PGEN_.00g253380	Scaffold_12	32591780	32592421	NA	NA	NA	NA	NA
PGEN_.00g253390	Scaffold_12	32594075	32594326	NA	NA	NA	NA	NA
PGEN_.00g253400	Scaffold_12	32631507	32637147	NA	NA	NA	NA	NA
PGEN_.00g253410	Scaffold_12	32659576	32660571	NA	NA	NA	NA	NA
PGEN_.00g253420	Scaffold_12	32693616	32693924	NA	NA	NA	NA	NA
PGEN_.00g253430	Scaffold_12	32694322	32694657	Q6R7D0	IAP3_OSHVF	Putative apoptosis inhibitor ORF99		
PGEN_.00g253440	Scaffold_12	32698291	32698635	NA	NA	NA	NA	NA
PGEN_.00g253450	Scaffold_12	32698834	32699100	NA	NA	NA	NA	NA
PGEN_.00g253460	Scaffold_12	32701404	32706314	NA	NA	NA	NA	NA
PGEN_.00g253470	Scaffold_12	32718699	32718923	NA	NA	NA	NA	NA
PGEN_.00g253480	Scaffold_12	32719624	32721497	Q9NP08	HMX1_HUMAN	Homeobox protein HMX1 (Homeobox protein H6)	GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0007275; GO:0045892	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g253490	Scaffold_12	32725271	32725825	NA	NA	NA	NA	NA
PGEN_.00g253500	Scaffold_12	32801400	32806776	NA	NA	NA	NA	NA
PGEN_.00g253510	Scaffold_12	32814745	32815385	NA	NA	NA	NA	NA
PGEN_.00g253520	Scaffold_12	32827328	32827729	NA	NA	NA	NA	NA
PGEN_.00g253530	Scaffold_12	32881205	32881756	NA	NA	NA	NA	NA
PGEN_.00g253540	Scaffold_12	32883144	32884356	NA	NA	NA	NA	NA
PGEN_.00g253550	Scaffold_12	32964549	32965328	NA	NA	NA	NA	NA
PGEN_.00g253560	Scaffold_12	32975553	33021510	E9Q7R9	CFA43_MOUSE	Cilia- and flagella-associated protein 43	GO:0005930; GO:0007288; GO:0031514; GO:1905419	axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm axoneme assembly [GO:0007288]; sperm flagellum movement involved in flagellated sperm motility [GO:1905419]
PGEN_.00g253570	Scaffold_12	33044456	33084027	E9Q7R9	CFA43_MOUSE	Cilia- and flagella-associated protein 43	GO:0005930; GO:0007288; GO:0031514; GO:1905419	axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm axoneme assembly [GO:0007288]; sperm flagellum movement involved in flagellated sperm motility [GO:1905419]
PGEN_.00g253580	Scaffold_12	33113393	33177467	Q8NDM7	CFA43_HUMAN	Cilia- and flagella-associated protein 43 (WD repeat-containing protein 96)	GO:0005930; GO:0007288; GO:0031514; GO:1905419	axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm axoneme assembly [GO:0007288]; sperm flagellum movement involved in flagellated sperm motility [GO:1905419]
PGEN_.00g253590	Scaffold_12	33191152	33191673	NA	NA	NA	NA	NA
PGEN_.00g253600	Scaffold_12	33252113	33253510	P30731	GPR83_MOUSE	Probable G-protein coupled receptor 83 (Glucocorticoid-induced receptor)	GO:0004983; GO:0005886; GO:0005929; GO:0016021; GO:0051384; GO:0097730	cilium [GO:0005929]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]; response to glucocorticoid [GO:0051384]
PGEN_.00g253610	Scaffold_12	33280852	33281319	NA	NA	NA	NA	NA
PGEN_.00g253620	Scaffold_12	33289914	33290387	NA	NA	NA	NA	NA
PGEN_.00g253630	Scaffold_12	33290413	33295940	NA	NA	NA	NA	NA
PGEN_.00g253640	Scaffold_12	33295986	33296462	NA	NA	NA	NA	NA
PGEN_.00g253650	Scaffold_12	33296532	33296849	NA	NA	NA	NA	NA
PGEN_.00g253660	Scaffold_12	33296873	33297145	NA	NA	NA	NA	NA
PGEN_.00g253670	Scaffold_12	33297383	33297685	NA	NA	NA	NA	NA
PGEN_.00g253680	Scaffold_12	33314817	33315017	NA	NA	NA	NA	NA
PGEN_.00g253690	Scaffold_12	33417976	33418308	NA	NA	NA	NA	NA
PGEN_.00g253700	Scaffold_12	33460859	33461284	NA	NA	NA	NA	NA
PGEN_.00g253710	Scaffold_12	33482736	33484003	NA	NA	NA	NA	NA
PGEN_.00g253720	Scaffold_12	33524082	33530771	Q9H999	PANK3_HUMAN	Pantothenate kinase 3 (hPanK3) (EC 2.7.1.33) (Pantothenic acid kinase 3)	GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016310; GO:0019842; GO:0042803; GO:1905502	cytosol [GO:0005829]; nucleus [GO:0005634]; acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803]; vitamin binding [GO:0019842]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]
PGEN_.00g253730	Scaffold_12	33647825	33651971	NA	NA	NA	NA	NA
PGEN_.00g253740	Scaffold_12	33659032	33659881	NA	NA	NA	NA	NA
PGEN_.00g253750	Scaffold_12	33683666	33733745	NA	NA	NA	NA	NA
PGEN_.00g253760	Scaffold_12	33753664	33794571	A0MZ66	SHOT1_HUMAN	Shootin-1 (Shootin1)	GO:0005737; GO:0005874; GO:0005875; GO:0006930; GO:0007265; GO:0007409; GO:0015630; GO:0019894; GO:0030027; GO:0030175; GO:0030424; GO:0030426; GO:0031252; GO:0032488; GO:0038007; GO:0043204; GO:0044295; GO:0045296; GO:0045773; GO:0048471; GO:0048812; GO:0051015; GO:0060327; GO:0061163; GO:0061573; GO:2000114; GO:2001224	"axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration, cell extension [GO:0006930]"
PGEN_.00g253770	Scaffold_12	33832048	33833571	Q08890	IDS_MOUSE	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase)	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484	lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]
PGEN_.00g253780	Scaffold_12	33866129	33892979	Q8N7Q3	ZN676_HUMAN	Zinc finger protein 676	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g253790	Scaffold_12	33900736	33909355	Q96B45	BORC7_HUMAN	BLOC-1-related complex subunit 7 (Diaskedin)	GO:0005765; GO:0099078	BORC complex [GO:0099078]; lysosomal membrane [GO:0005765]
PGEN_.00g253800	Scaffold_12	33916090	33916428	NA	NA	NA	NA	NA
PGEN_.00g253810	Scaffold_12	33926744	33951956	F7AEX0	UVSSA_XENTR	UV-stimulated scaffold protein A	GO:0000993; GO:0005694; GO:0006283; GO:0009411; GO:0016567	chromosome [GO:0005694]; RNA polymerase II complex binding [GO:0000993]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283]
PGEN_.00g253820	Scaffold_12	33953038	33953295	NA	NA	NA	NA	NA
PGEN_.00g253830	Scaffold_12	33953515	33953835	NA	NA	NA	NA	NA
PGEN_.00g253840	Scaffold_12	33955639	33956322	NA	NA	NA	NA	NA
PGEN_.00g253850	Scaffold_12	33963291	33995343	Q98TX3	PDCD4_CHICK	Programmed cell death protein 4 (Protein I11/6)	GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0007569; GO:0043508; GO:0045892	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cell aging [GO:0007569]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g253860	Scaffold_12	34000917	34053671	P48964	MPIP1_MOUSE	M-phase inducer phosphatase 1 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25A)	GO:0000082; GO:0000086; GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0009314; GO:0010971; GO:0019901; GO:0034644; GO:0045931; GO:0051087; GO:0051301; GO:0110032; GO:1904056	cytoplasm [GO:0005737]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; response to radiation [GO:0009314]
PGEN_.00g253870	Scaffold_12	34054447	34068457	P79943	SLBP1_XENLA	Histone RNA hairpin-binding protein (Histone stem-loop-binding protein 1)	GO:0003729; GO:0005634; GO:0005737; GO:0006397	cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]
PGEN_.00g253880	Scaffold_12	34081663	34093822	P13360	GLAS_DROME	Protein glass	GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]"
PGEN_.00g253890	Scaffold_12	34119607	34149865	P49724	OAT_DROAN	"Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)"	GO:0004587; GO:0005759; GO:0030170; GO:0055129	mitochondrial matrix [GO:0005759]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; L-proline biosynthetic process [GO:0055129]
PGEN_.00g253900	Scaffold_12	34155186	34189052	Q6NZC7	S23IP_MOUSE	SEC23-interacting protein	GO:0001675; GO:0004620; GO:0005794; GO:0005801; GO:0006888; GO:0007286; GO:0007338; GO:0012507; GO:0030134; GO:0043231; GO:0046872; GO:0048471; GO:0070971; GO:0097038	cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; acrosome assembly [GO:0001675]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; single fertilization [GO:0007338]; spermatid development [GO:0007286]
PGEN_.00g253910	Scaffold_12	34224956	34226065	Q7TMA4	FFAR4_MOUSE	Free fatty acid receptor 4 (G-protein coupled receptor 120) (G-protein coupled receptor GT01) (Omega-3 fatty acid receptor 1)	GO:0004930; GO:0005504; GO:0005886; GO:0005887; GO:0007186; GO:0008527; GO:0010827; GO:0030139; GO:0043066; GO:0045444; GO:0046879; GO:0050710; GO:0050728; GO:0070374; GO:0120162	endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; fatty acid binding [GO:0005504]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone secretion [GO:0046879]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of inflammatory response [GO:0050728]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of glucose transmembrane transport [GO:0010827]
PGEN_.00g253920	Scaffold_12	34242091	34242840	NA	NA	NA	NA	NA
PGEN_.00g253930	Scaffold_12	34254384	34261715	Q3KP44	ANR55_HUMAN	Ankyrin repeat domain-containing protein 55		
PGEN_.00g253940	Scaffold_12	34288203	34289237	NA	NA	NA	NA	NA
PGEN_.00g253950	Scaffold_12	34291944	34293791	NA	NA	NA	NA	NA
PGEN_.00g253960	Scaffold_12	34335983	34359048	Q95PA1	CPLX_DORPE	Complexin (Synaphin)	GO:0005829; GO:0006836; GO:0006887; GO:0016020; GO:0019905	cytosol [GO:0005829]; membrane [GO:0016020]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; neurotransmitter transport [GO:0006836]
PGEN_.00g253970	Scaffold_12	34471467	34473772	NA	NA	NA	NA	NA
PGEN_.00g253980	Scaffold_12	34604257	34620513	Q9BSG0	PADC1_HUMAN	Protease-associated domain-containing protein 1 (Protease-associated domain-containing protein of 21 kDa) (hPAP21)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g253990	Scaffold_12	34644189	34644653	NA	NA	NA	NA	NA
PGEN_.00g254000	Scaffold_12	34658430	34662222	P47832	RL26_CHICK	60S ribosomal protein L26 (Fragment)	GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]
PGEN_.00g254010	Scaffold_12	34670141	34680250	Q4VBI7	STX18_DANRE	Syntaxin-18	GO:0005484; GO:0005783; GO:0005789; GO:0006886; GO:0006890; GO:0016021; GO:0031201	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g254020	Scaffold_12	34680434	34692838	O00567	NOP56_HUMAN	Nucleolar protein 56 (Nucleolar protein 5A)	GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226	box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]
PGEN_.00g254030	Scaffold_12	34714553	34724928	Q9QZ08	NAGK_MOUSE	N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase)	GO:0005524; GO:0006044; GO:0009384; GO:0019262; GO:0045127	ATP binding [GO:0005524]; N-acetylglucosamine kinase activity [GO:0045127]; N-acylmannosamine kinase activity [GO:0009384]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylneuraminate catabolic process [GO:0019262]
PGEN_.00g254040	Scaffold_12	34738980	34756462	Q6ZQY2	LR74B_HUMAN	Leucine-rich repeat-containing protein 74B		
PGEN_.00g254050	Scaffold_12	34761390	34789684	Q8K385	FRRS1_MOUSE	Ferric-chelate reductase 1 (EC 1.-.-.-) (Stromal cell-derived receptor 2) (SDR-2)	GO:0000293; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872]
PGEN_.00g254060	Scaffold_12	34796700	34797530	NA	NA	NA	NA	NA
PGEN_.00g254070	Scaffold_12	34817620	34822326	NA	NA	NA	NA	NA
PGEN_.00g254080	Scaffold_12	34823599	34827957	NA	NA	NA	NA	NA
PGEN_.00g254090	Scaffold_12	34856050	34859288	Q5UAW9	GP157_HUMAN	G-protein coupled receptor 157	GO:0004930; GO:0005623; GO:0007166; GO:0007186; GO:0016021; GO:0048512; GO:0051482; GO:0060019; GO:0060170	cell [GO:0005623]; ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; radial glial cell differentiation [GO:0060019]
PGEN_.00g254100	Scaffold_12	34868124	34895978	Q25060	LWA_HYDEC	LWamide neuropeptides [Cleaved into: LWamide I; LWamide II; LWS]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g254110	Scaffold_12	34896629	34900500	NA	NA	NA	NA	NA
PGEN_.00g254120	Scaffold_12	34911311	34914124	P22304	IDS_HUMAN	Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain]	GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484; GO:0030207; GO:0043202	lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]
PGEN_.00g254130	Scaffold_12	34922211	34923917	NA	NA	NA	NA	NA
PGEN_.00g254140	Scaffold_12	34938824	34947034	NA	NA	NA	NA	NA
PGEN_.00g254150	Scaffold_12	34960296	34979480	H2A0N4	PIF_PINMG	Protein PIF [Cleaved into: Protein Pif97; Protein Pif80 (Aragonite-binding protein)]	GO:0005576; GO:0006030; GO:0008061	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]
PGEN_.00g254160	Scaffold_12	34985578	35025973	E9NA96	IR25A_DROME	Ionotropic receptor 25a	GO:0004970; GO:0005886; GO:0005929; GO:0007610; GO:0008066; GO:0009649; GO:0010378; GO:0015026; GO:0015276; GO:0016021; GO:0019226; GO:0030424; GO:0035249; GO:0043204; GO:0045211; GO:0048511; GO:0050804; GO:0050907; GO:0050911; GO:0071683; GO:0098839; GO:1904315	"axon [GO:0030424]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; sensory dendrite [GO:0071683]; coreceptor activity [GO:0015026]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; behavior [GO:0007610]; detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; entrainment of circadian clock [GO:0009649]; modulation of chemical synaptic transmission [GO:0050804]; rhythmic process [GO:0048511]; synaptic transmission, glutamatergic [GO:0035249]; temperature compensation of the circadian clock [GO:0010378]; transmission of nerve impulse [GO:0019226]"
PGEN_.00g254170	Scaffold_12	35074143	35079327	NA	NA	NA	NA	NA
PGEN_.00g254180	Scaffold_12	35079386	35084852	NA	NA	NA	NA	NA
PGEN_.00g254190	Scaffold_12	35095040	35097346	NA	NA	NA	NA	NA
PGEN_.00g254200	Scaffold_12	35099182	35133287	NA	NA	NA	NA	NA
PGEN_.00g254210	Scaffold_12	35138477	35141382	NA	NA	NA	NA	NA
PGEN_.00g254220	Scaffold_12	35149478	35170904	NA	NA	NA	NA	NA
PGEN_.00g254230	Scaffold_12	35204982	35220942	NA	NA	NA	NA	NA
PGEN_.00g254240	Scaffold_12	35223057	35224031	NA	NA	NA	NA	NA
PGEN_.00g254250	Scaffold_12	35257499	35260565	NA	NA	NA	NA	NA
PGEN_.00g254260	Scaffold_12	35340430	35348925	Q03358	MSX2_MOUSE	Homeobox protein MSX-2 (Homeobox protein Hox-8-1)	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001649; GO:0002063; GO:0002076; GO:0003148; GO:0003151; GO:0003198; GO:0003416; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0008134; GO:0008285; GO:0009952; GO:0010942; GO:0016607; GO:0023019; GO:0030326; GO:0030509; GO:0030513; GO:0032792; GO:0035115; GO:0035116; GO:0035313; GO:0035880; GO:0042060; GO:0042476; GO:0042733; GO:0042981; GO:0043065; GO:0043066; GO:0043565; GO:0044212; GO:0045599; GO:0045617; GO:0045669; GO:0045892; GO:0048598; GO:0048863; GO:0051216; GO:0051795; GO:0060346; GO:0060349; GO:0060364; GO:0060444; GO:0061180; GO:0061312; GO:0070166; GO:0071363; GO:0071392; GO:0090427; GO:2000678; GO:2001055	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; activation of meiosis [GO:0090427]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; bone morphogenesis [GO:0060349]; bone trabecula formation [GO:0060346]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cartilage development [GO:0051216]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic morphogenesis [GO:0048598]; embryonic nail plate morphogenesis [GO:0035880]; enamel mineralization [GO:0070166]; endochondral bone growth [GO:0003416]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; frontal suture morphogenesis [GO:0060364]; mammary gland epithelium development [GO:0061180]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell death [GO:0010942]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of timing of catagen [GO:0051795]; regulation of apoptotic process [GO:0042981]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]"
PGEN_.00g254270	Scaffold_12	35372806	35373153	NA	NA	NA	NA	NA
PGEN_.00g254280	Scaffold_12	35418486	35420314	G5EFI8	PLCE1_CAEEL	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-epsilon plc-1) (Phosphoinositide-specific phospholipase PLC210) (Phospholipase C-epsilon plc-1) (PLC-epsilon plc-1)"	GO:0002253; GO:0004435; GO:0005085; GO:0005095; GO:0005623; GO:0007264; GO:0008340; GO:0017016; GO:0032959; GO:0042307; GO:0046872; GO:0048015; GO:0050830; GO:0051209; GO:1902477; GO:1902634	"cell [GO:0005623]; GTPase inhibitor activity [GO:0005095]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; Ras GTPase binding [GO:0017016]; 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process [GO:1902634]; activation of immune response [GO:0002253]; defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; inositol trisphosphate biosynthetic process [GO:0032959]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein import into nucleus [GO:0042307]; regulation of defense response to bacterium, incompatible interaction [GO:1902477]; release of sequestered calcium ion into cytosol [GO:0051209]; small GTPase mediated signal transduction [GO:0007264]"
PGEN_.00g254290	Scaffold_12	35448114	35448386	NA	NA	NA	NA	NA
PGEN_.00g254300	Scaffold_12	35458559	35459167	NA	NA	NA	NA	NA
PGEN_.00g254310	Scaffold_12	35497998	35536495	Q8C261	NCKX5_MOUSE	Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5)	GO:0005262; GO:0005623; GO:0005802; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0030318; GO:0034220; GO:0042470; GO:0048022; GO:0050896; GO:0070588	"cell [GO:0005623]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; melanocyte differentiation [GO:0030318]; negative regulation of melanin biosynthetic process [GO:0048022]; response to stimulus [GO:0050896]"
PGEN_.00g254320	Scaffold_12	35553941	35557119	Q8SPP7	PGRP1_BOVIN	Peptidoglycan recognition protein 1 (Oligosaccharide-binding protein) (OBP) (Peptidoglycan recognition protein short) (PGRP-S)	GO:0005615; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0016045; GO:0019730; GO:0031640; GO:0032689; GO:0032827; GO:0042834; GO:0044117; GO:0045087; GO:0050728; GO:0050830; GO:0050832; GO:0051714; GO:0061844	extracellular space [GO:0005615]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; zinc ion binding [GO:0008270]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; growth of symbiont in host [GO:0044117]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253]; positive regulation of cytolysis in other organism [GO:0051714]
PGEN_.00g254330	Scaffold_12	35570584	35599349	Q9VN03	SUV3_DROME	"ATP-dependent RNA helicase SUV3 homolog, mitochondrial (EC 3.6.4.13)"	GO:0000963; GO:0000965; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005739; GO:0005759; GO:0006401; GO:0032508; GO:0044528; GO:0045025; GO:0070131; GO:0090646; GO:0097222	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA catabolic process [GO:0006401]
PGEN_.00g254340	Scaffold_12	35605949	35606956	NA	NA	NA	NA	NA
PGEN_.00g254350	Scaffold_12	35632797	35633975	C7G0B5	PIF_PINFU	Protein PIF [Cleaved into: Protein Pif97; Protein Pif80 (Aragonite-binding protein)]	GO:0005576; GO:0006030; GO:0008061	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]
PGEN_.00g254360	Scaffold_12	35645883	35659986	NA	NA	NA	NA	NA
PGEN_.00g254370	Scaffold_12	35668296	35674777	NA	NA	NA	NA	NA
PGEN_.00g254380	Scaffold_12	35709516	35712774	NA	NA	NA	NA	NA
PGEN_.00g254390	Scaffold_12	35715961	35727588	NA	NA	NA	NA	NA
PGEN_.00g254400	Scaffold_12	35727679	35733787	NA	NA	NA	NA	NA
PGEN_.00g254410	Scaffold_12	35743309	35748502	NA	NA	NA	NA	NA
PGEN_.00g254420	Scaffold_12	35749772	35765093	E9PVX6	KI67_MOUSE	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog)	GO:0000775; GO:0000793; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0007088; GO:0008022; GO:0008283; GO:0016604; GO:0051321; GO:0051983; GO:0072574; GO:1902275; GO:1990705	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]"
PGEN_.00g254430	Scaffold_12	35778058	35790510	P79739	CP26A_DANRE	Cytochrome P450 26A1 (EC 1.14.13.-) (Cytochrome P450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome)	GO:0000249; GO:0001568; GO:0001756; GO:0001944; GO:0003131; GO:0003151; GO:0004497; GO:0005506; GO:0005789; GO:0006696; GO:0007507; GO:0008401; GO:0016125; GO:0020037; GO:0021661; GO:0021797; GO:0030902; GO:0030917; GO:0031016; GO:0034653; GO:0034672; GO:0042573; GO:0042574; GO:0048854; GO:0055014; GO:0055114; GO:0071299; GO:0090242	endoplasmic reticulum membrane [GO:0005789]; C-22 sterol desaturase activity [GO:0000249]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid 4-hydroxylase activity [GO:0008401]; anterior/posterior pattern specification involved in pronephros development [GO:0034672]; atrial cardiac muscle cell development [GO:0055014]; blood vessel development [GO:0001568]; brain morphogenesis [GO:0048854]; cellular response to vitamin A [GO:0071299]; ergosterol biosynthetic process [GO:0006696]; forebrain anterior/posterior pattern specification [GO:0021797]; heart development [GO:0007507]; hindbrain development [GO:0030902]; mesodermal-endodermal cell signaling [GO:0003131]; midbrain-hindbrain boundary development [GO:0030917]; outflow tract morphogenesis [GO:0003151]; oxidation-reduction process [GO:0055114]; pancreas development [GO:0031016]; retinal metabolic process [GO:0042574]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway involved in somitogenesis [GO:0090242]; rhombomere 4 morphogenesis [GO:0021661]; somitogenesis [GO:0001756]; sterol metabolic process [GO:0016125]; vasculature development [GO:0001944]
PGEN_.00g254440	Scaffold_12	35798563	35832270	Q9VU68	WDR1_DROME	Actin-interacting protein 1 (AIP1) (Protein flare)	GO:0001736; GO:0005856; GO:0007298; GO:0030042; GO:0030833; GO:0030834; GO:0030836; GO:0030864; GO:0034316; GO:0035317; GO:0040011; GO:0042643; GO:0045214; GO:0051015	"actomyosin, actin portion [GO:0042643]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214]"
PGEN_.00g254450	Scaffold_12	35838323	35848212	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g254460	Scaffold_12	35849935	35856084	NA	NA	NA	NA	NA
PGEN_.00g254470	Scaffold_12	35861175	35892486	Q7SIC1	FUCL_ANGAN	Fucolectin	GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088	"extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
PGEN_.00g254480	Scaffold_12	35901817	35919952	NA	NA	NA	NA	NA
PGEN_.00g254490	Scaffold_12	35968898	35981228	Q8K4S1	PLCE1_MOUSE	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1) (PLC-epsilon-1)"	GO:0000139; GO:0000187; GO:0004435; GO:0004629; GO:0005085; GO:0005623; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007200; GO:0007265; GO:0008277; GO:0016042; GO:0017016; GO:0019899; GO:0032835; GO:0032959; GO:0045859; GO:0046578; GO:0046872; GO:0048015; GO:0051209	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; Ras GTPase binding [GO:0017016]; activation of MAPK activity [GO:0000187]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerulus development [GO:0032835]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; Ras protein signal transduction [GO:0007265]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; release of sequestered calcium ion into cytosol [GO:0051209]
PGEN_.00g254500	Scaffold_12	35982116	35999119	Q99P84	PLCE1_RAT	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1) (PLC-epsilon-1)"	GO:0000139; GO:0000187; GO:0004435; GO:0004629; GO:0005085; GO:0005623; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007200; GO:0007265; GO:0008277; GO:0016042; GO:0017016; GO:0019899; GO:0032835; GO:0032959; GO:0045859; GO:0046578; GO:0046872; GO:0048015; GO:0051209	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; Ras GTPase binding [GO:0017016]; activation of MAPK activity [GO:0000187]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerulus development [GO:0032835]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; Ras protein signal transduction [GO:0007265]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; release of sequestered calcium ion into cytosol [GO:0051209]
PGEN_.00g254510	Scaffold_12	35999170	36034000	G5EFI8	PLCE1_CAEEL	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-epsilon plc-1) (Phosphoinositide-specific phospholipase PLC210) (Phospholipase C-epsilon plc-1) (PLC-epsilon plc-1)"	GO:0002253; GO:0004435; GO:0005085; GO:0005095; GO:0005623; GO:0007264; GO:0008340; GO:0017016; GO:0032959; GO:0042307; GO:0046872; GO:0048015; GO:0050830; GO:0051209; GO:1902477; GO:1902634	"cell [GO:0005623]; GTPase inhibitor activity [GO:0005095]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; Ras GTPase binding [GO:0017016]; 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process [GO:1902634]; activation of immune response [GO:0002253]; defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; inositol trisphosphate biosynthetic process [GO:0032959]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein import into nucleus [GO:0042307]; regulation of defense response to bacterium, incompatible interaction [GO:1902477]; release of sequestered calcium ion into cytosol [GO:0051209]; small GTPase mediated signal transduction [GO:0007264]"
PGEN_.00g254520	Scaffold_12	36041777	36063725	NA	NA	NA	NA	NA
PGEN_.00g254530	Scaffold_12	36088684	36088941	NA	NA	NA	NA	NA
PGEN_.00g254540	Scaffold_12	36095555	36095809	NA	NA	NA	NA	NA
PGEN_.00g254550	Scaffold_12	36111185	36131386	Q91WK7	ANR54_MOUSE	Ankyrin repeat domain-containing protein 54 (Lyn-interacting ankyrin repeat protein)	GO:0005634; GO:0005737; GO:0006913; GO:0019887; GO:0030496; GO:0044877; GO:0045648; GO:0045859; GO:1902531	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859]
PGEN_.00g254560	Scaffold_12	36379869	36381732	NA	NA	NA	NA	NA
PGEN_.00g254570	Scaffold_12	36385722	36427562	Q2KI62	PTCD3_BOVIN	"Pentatricopeptide repeat domain-containing protein 3, mitochondrial (28S ribosomal protein S39, mitochondrial) (MRP-S39)"	GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0005840; GO:0005886; GO:0006417; GO:0019843; GO:0032543; GO:0043024	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ribosome [GO:0005840]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]
PGEN_.00g254580	Scaffold_12	36434087	36509775	Q14642	I5P1_HUMAN	"Inositol polyphosphate-5-phosphatase A (EC 3.1.3.56) (43 kDa inositol polyphosphate 5-phosphatase) (Type I inositol 1,4,5-trisphosphate 5-phosphatase) (5PTase)"	GO:0004445; GO:0005886; GO:0016020; GO:0042731; GO:0043647; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659	"membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; phosphatidylinositol dephosphorylation [GO:0046856]"
PGEN_.00g254590	Scaffold_12	36519325	36520082	NA	NA	NA	NA	NA
PGEN_.00g254600	Scaffold_12	36526465	36535902	A6NED2	RCCD1_HUMAN	RCC1 domain-containing protein 1	GO:0005694; GO:0005829; GO:0005886; GO:0006325	chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; chromatin organization [GO:0006325]
PGEN_.00g254610	Scaffold_12	36549321	36555188	Q925H1	TRPS1_MOUSE	Zinc finger transcription factor Trps1	GO:0000122; GO:0000790; GO:0000977; GO:0001501; GO:0001942; GO:0002062; GO:0003700; GO:0005634; GO:0005654; GO:0007178; GO:0008270; GO:0019904; GO:0032330; GO:0032991; GO:0045892; GO:0051291; GO:1902043	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; chondrocyte differentiation [GO:0002062]; hair follicle development [GO:0001942]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; protein heterooligomerization [GO:0051291]; regulation of chondrocyte differentiation [GO:0032330]; skeletal system development [GO:0001501]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"
PGEN_.00g254620	Scaffold_12	36582205	36620206	NA	NA	NA	NA	NA
PGEN_.00g254630	Scaffold_12	36633458	36667035	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g254640	Scaffold_12	36667135	36667713	NA	NA	NA	NA	NA
PGEN_.00g254650	Scaffold_12	36667854	36668426	NA	NA	NA	NA	NA
PGEN_.00g254660	Scaffold_12	36668674	36669189	NA	NA	NA	NA	NA
PGEN_.00g254670	Scaffold_12	36683395	36693556	NA	NA	NA	NA	NA
PGEN_.00g254680	Scaffold_12	36716372	36718828	NA	NA	NA	NA	NA
PGEN_.00g254690	Scaffold_12	36724775	36725812	NA	NA	NA	NA	NA
PGEN_.00g254700	Scaffold_12	36727737	36731846	NA	NA	NA	NA	NA
PGEN_.00g254710	Scaffold_12	36750322	36752712	NA	NA	NA	NA	NA
PGEN_.00g254720	Scaffold_12	36759089	36760461	NA	NA	NA	NA	NA
PGEN_.00g254730	Scaffold_12	36772189	36773560	NA	NA	NA	NA	NA
PGEN_.00g254740	Scaffold_12	36817590	36818080	NA	NA	NA	NA	NA
PGEN_.00g254750	Scaffold_12	36818262	36821104	NA	NA	NA	NA	NA
PGEN_.00g254760	Scaffold_12	36828492	36837634	NA	NA	NA	NA	NA
PGEN_.00g254770	Scaffold_12	36859773	36875835	NA	NA	NA	NA	NA
PGEN_.00g254780	Scaffold_12	37002587	37008120	Q86UF1	TSN33_HUMAN	Tetraspanin-33 (Tspan-33) (Penumbra) (hPen) (Proerythroblast new membrane)	GO:0005788; GO:0005886; GO:0005887; GO:0005912; GO:0009986; GO:0019899; GO:0044267; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197	adherens junction [GO:0005912]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197]; enzyme binding [GO:0019899]; cellular protein metabolic process [GO:0044267]; pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]
PGEN_.00g254790	Scaffold_12	37077650	37235290	P14730	WFD18_RAT	WAP four-disulfide core domain protein 18 (Extracellular peptidase inhibitor) (Protein WDNM1) (Fragment)	GO:0005576; GO:0030414	extracellular region [GO:0005576]; peptidase inhibitor activity [GO:0030414]
PGEN_.00g254800	Scaffold_12	37235658	37388110	NA	NA	NA	NA	NA
PGEN_.00g254810	Scaffold_12	37389895	37391344	NA	NA	NA	NA	NA
PGEN_.00g254820	Scaffold_12	37425978	37464475	NA	NA	NA	NA	NA
PGEN_.00g254830	Scaffold_12	37489295	37490377	NA	NA	NA	NA	NA
PGEN_.00g254840	Scaffold_12	37507745	37565085	P70318	TIAR_MOUSE	Nucleolysin TIAR (TIA-1-related protein)	GO:0003677; GO:0005634; GO:0005737; GO:0006915; GO:0007281; GO:0008284; GO:0010494; GO:0017145; GO:0035925; GO:1990904	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; apoptotic process [GO:0006915]; germ cell development [GO:0007281]; positive regulation of cell population proliferation [GO:0008284]; stem cell division [GO:0017145]
PGEN_.00g254850	Scaffold_12	37584424	37588779	NA	NA	NA	NA	NA
PGEN_.00g254860	Scaffold_12	37597400	37597774	NA	NA	NA	NA	NA
PGEN_.00g254870	Scaffold_12	37630887	37637214	NA	NA	NA	NA	NA
PGEN_.00g254880	Scaffold_12	37643862	37703992	Q01085	TIAR_HUMAN	Nucleolysin TIAR (TIA-1-related protein)	GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0006357; GO:0006915; GO:0006952; GO:0007281; GO:0008284; GO:0008543; GO:0010494; GO:0017145; GO:0035925; GO:1990904	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; defense response [GO:0006952]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell division [GO:0017145]
PGEN_.00g254890	Scaffold_12	37743822	37787899	O95271	TNKS1_HUMAN	Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1)	GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g254900	Scaffold_12	37870554	37880011	NA	NA	NA	NA	NA
PGEN_.00g254910	Scaffold_12	37890496	37891056	NA	NA	NA	NA	NA
PGEN_.00g254920	Scaffold_12	37898836	37911914	NA	NA	NA	NA	NA
PGEN_.00g254930	Scaffold_12	37900770	37904298	Q868Z9	PPN_DROME	Papilin	GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198	basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]
PGEN_.00g254940	Scaffold_12	37919641	37934452	Q7QH73	PERC_ANOGA	Chorion peroxidase (EC 1.11.1.7)	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0048477	extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; oogenesis [GO:0048477]; response to oxidative stress [GO:0006979]
PGEN_.00g254950	Scaffold_12	37936097	37954300	Q7QH73	PERC_ANOGA	Chorion peroxidase (EC 1.11.1.7)	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0048477	extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; oogenesis [GO:0048477]; response to oxidative stress [GO:0006979]
PGEN_.00g254960	Scaffold_12	37970482	37993760	Q92628	K0232_HUMAN	Uncharacterized protein KIAA0232	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g254970	Scaffold_12	37993784	38005981	NA	NA	NA	NA	NA
PGEN_.00g254980	Scaffold_12	38006783	38055492	Q9NVI1	FANCI_HUMAN	Fanconi anemia group I protein (Protein FACI)	GO:0003677; GO:0005654; GO:0005829; GO:0007049; GO:0016020; GO:0031398; GO:0036297; GO:0070182	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; cell cycle [GO:0007049]; interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398]
PGEN_.00g254990	Scaffold_12	38063451	38080451	Q59990	CP120_SYNY3	Putative cytochrome P450 120 (EC 1.14.-.-)	GO:0000249; GO:0004497; GO:0005506; GO:0006696; GO:0016125; GO:0020037; GO:0055114	C-22 sterol desaturase activity [GO:0000249]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; ergosterol biosynthetic process [GO:0006696]; oxidation-reduction process [GO:0055114]; sterol metabolic process [GO:0016125]
PGEN_.00g255000	Scaffold_12	38086467	38091871	Q9D0B6	PBDC1_MOUSE	Protein PBDC1 (Polysaccharide biosynthesis domain-containing protein 1)		
PGEN_.00g255010	Scaffold_12	38093838	38099813	Q68FN7	DHSDB_DANRE	"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit B, mitochondrial (CybS-B) (Succinate dehydrogenase complex subunit D-B) (Succinate-ubiquinone oxidoreductase cytochrome b small subunit B) (Succinate-ubiquinone reductase membrane anchor subunit B)"	GO:0005743; GO:0005749; GO:0006099; GO:0006121; GO:0016021; GO:0020037; GO:0046872; GO:0048039	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; ubiquinone binding [GO:0048039]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]"
PGEN_.00g255020	Scaffold_12	38101714	38130791	NA	NA	NA	NA	NA
PGEN_.00g255030	Scaffold_12	38165887	38209794	NA	NA	NA	NA	NA
PGEN_.00g255040	Scaffold_12	38250653	38272098	NA	NA	NA	NA	NA
PGEN_.00g255050	Scaffold_12	38273150	38278878	NA	NA	NA	NA	NA
PGEN_.00g255060	Scaffold_12	38297593	38326228	Q9VC61	CRERF_DROME	Protein CREBRF homolog (Protein Repressed by Tor)	GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006986; GO:0038202; GO:0042594; GO:0045893; GO:0046982	"cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; positive regulation of transcription, DNA-templated [GO:0045893]; response to starvation [GO:0042594]; response to unfolded protein [GO:0006986]; TORC1 signaling [GO:0038202]"
PGEN_.00g255070	Scaffold_12	38340621	38366811	Q6AYJ2	BOD1_RAT	Biorientation of chromosomes in cell division protein 1 (Biorientation defective protein 1) (Protein FAM44B)	GO:0000922; GO:0000940; GO:0004864; GO:0005623; GO:0005737; GO:0005813; GO:0005876; GO:0007080; GO:0032515; GO:0051301; GO:0051721; GO:0071459; GO:0071962; GO:1990758	"cell [GO:0005623]; centrosome [GO:0005813]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid biorientation [GO:1990758]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; protein localization to chromosome, centromeric region [GO:0071459]"
PGEN_.00g255080	Scaffold_12	38366980	38383996	Q5XGB9	AMPL_XENTR	Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)	GO:0004177; GO:0005737; GO:0008235; GO:0030145	cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]
PGEN_.00g255090	Scaffold_12	38389170	38395517	Q80T79	CSMD3_MOUSE	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g255100	Scaffold_12	38397886	38404040	NA	NA	NA	NA	NA
PGEN_.00g255110	Scaffold_12	38404579	38406126	NA	NA	NA	NA	NA
PGEN_.00g255120	Scaffold_12	38436253	38448738	P22807	SLOU_DROME	Homeobox protein slou (Homeobox protein NK-1) (Protein slouch) (S59/2)	GO:0000122; GO:0000978; GO:0003700; GO:0005634; GO:0007501; GO:0007517; GO:0007521; GO:0030154; GO:0043565; GO:0045944	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; mesodermal cell fate specification [GO:0007501]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g255130	Scaffold_12	38469717	38472920	NA	NA	NA	NA	NA
PGEN_.00g255140	Scaffold_12	38473956	38485403	P22807	SLOU_DROME	Homeobox protein slou (Homeobox protein NK-1) (Protein slouch) (S59/2)	GO:0000122; GO:0000978; GO:0003700; GO:0005634; GO:0007501; GO:0007517; GO:0007521; GO:0030154; GO:0043565; GO:0045944	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; mesodermal cell fate specification [GO:0007501]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g255150	Scaffold_12	38518887	38537729	NA	NA	NA	NA	NA
PGEN_.00g255160	Scaffold_12	38541898	38551872	Q6DGA6	ALLC_DANRE	Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)	GO:0000256; GO:0004037; GO:0006144	allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]
PGEN_.00g255170	Scaffold_12	38556212	38556499	NA	NA	NA	NA	NA
PGEN_.00g255180	Scaffold_12	38565119	38580143	Q5ZL36	ZFY27_CHICK	Protrudin (Zinc finger FYVE domain-containing protein 27)	GO:0005783; GO:0016021; GO:0016192; GO:0030176; GO:0030424; GO:0030425; GO:0031175; GO:0032584; GO:0043621; GO:0045773; GO:0046872; GO:0048011; GO:0055038; GO:0071782; GO:0071787; GO:0072659	axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; recycling endosome membrane [GO:0055038]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]
PGEN_.00g255190	Scaffold_12	38588592	38593710	Q54NE6	PGAM_DICDI	Probable phosphoglycerate mutase (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM) (dPGM)	GO:0004082; GO:0004619; GO:0005829; GO:0006094; GO:0006096; GO:0016787; GO:0045335	cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]
PGEN_.00g255200	Scaffold_12	38594470	38606523	NA	NA	NA	NA	NA
PGEN_.00g255210	Scaffold_12	38636577	38638264	NA	NA	NA	NA	NA
PGEN_.00g255220	Scaffold_12	38638298	38669811	Q7Z2W7	TRPM8_HUMAN	Transient receptor potential cation channel subfamily M member 8 (Long transient receptor potential channel 6) (LTrpC-6) (LTrpC6) (Transient receptor potential p8) (Trp-p8)	GO:0005262; GO:0005623; GO:0005789; GO:0005886; GO:0006874; GO:0009409; GO:0009897; GO:0016021; GO:0016048; GO:0042802; GO:0045121; GO:0050955; GO:0070588; GO:0120162	cell [GO:0005623]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; detection of temperature stimulus [GO:0016048]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to cold [GO:0009409]; thermoception [GO:0050955]
PGEN_.00g255230	Scaffold_12	38676779	38677641	NA	NA	NA	NA	NA
PGEN_.00g255240	Scaffold_12	38684397	38714296	NA	NA	NA	NA	NA
PGEN_.00g255250	Scaffold_12	38737596	38745470	NA	NA	NA	NA	NA
PGEN_.00g255260	Scaffold_12	38776030	38802350	NA	NA	NA	NA	NA
PGEN_.00g255270	Scaffold_12	38805143	38807260	NA	NA	NA	NA	NA
PGEN_.00g255280	Scaffold_12	38808043	38821803	P30122	CEL_BOVIN	Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase) (Fragment)	GO:0004771; GO:0004806; GO:0005576; GO:0005737; GO:0005887; GO:0007158; GO:0008126; GO:0009986; GO:0016042; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0097104; GO:0097105; GO:0098793	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; synapse [GO:0045202]; acetylesterase activity [GO:0008126]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g255290	Scaffold_12	38822608	38824062	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g255300	Scaffold_12	38828887	38848052	Q5BKM3	CHMP3_XENTR	Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein-sorting-associated protein 24)	GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324	cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]
PGEN_.00g255310	Scaffold_12	38864592	38897338	Q6AZM3	REEP4_XENLA	Receptor expression-enhancing protein 4	GO:0005783; GO:0005789; GO:0005874; GO:0006998; GO:0007084; GO:0008017; GO:0016021; GO:0051301	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; microtubule [GO:0005874]; microtubule binding [GO:0008017]; cell division [GO:0051301]; mitotic nuclear envelope reassembly [GO:0007084]; nuclear envelope organization [GO:0006998]
PGEN_.00g255320	Scaffold_12	38899457	38912003	NA	NA	NA	NA	NA
PGEN_.00g255330	Scaffold_12	38931458	38935572	NA	NA	NA	NA	NA
PGEN_.00g255340	Scaffold_12	38938641	38940767	NA	NA	NA	NA	NA
PGEN_.00g255350	Scaffold_12	38940861	38941112	NA	NA	NA	NA	NA
PGEN_.00g255360	Scaffold_12	38943227	38943538	NA	NA	NA	NA	NA
PGEN_.00g255370	Scaffold_12	38944431	38945120	NA	NA	NA	NA	NA
PGEN_.00g255380	Scaffold_12	38945430	38945675	NA	NA	NA	NA	NA
PGEN_.00g255390	Scaffold_12	38946270	38946722	NA	NA	NA	NA	NA
PGEN_.00g255400	Scaffold_12	38947301	38947969	NA	NA	NA	NA	NA
PGEN_.00g255410	Scaffold_12	38948215	38948535	NA	NA	NA	NA	NA
PGEN_.00g255420	Scaffold_12	38948593	38948829	NA	NA	NA	NA	NA
PGEN_.00g255430	Scaffold_12	38948958	38949209	NA	NA	NA	NA	NA
PGEN_.00g255440	Scaffold_12	38949249	38949689	NA	NA	NA	NA	NA
PGEN_.00g255450	Scaffold_12	38949763	38950344	NA	NA	NA	NA	NA
PGEN_.00g255460	Scaffold_12	38950723	38954288	A2RU49	HYKK_HUMAN	Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1)	GO:0005759; GO:0006554; GO:0016301; GO:0047992	mitochondrial matrix [GO:0005759]; hydroxylysine kinase activity [GO:0047992]; kinase activity [GO:0016301]; lysine catabolic process [GO:0006554]
PGEN_.00g255470	Scaffold_12	38960251	38960505	NA	NA	NA	NA	NA
PGEN_.00g255480	Scaffold_12	38978072	38980573	O93441	OPSD_GALML	Rhodopsin	GO:0005502; GO:0007601; GO:0008020; GO:0016021; GO:0016038; GO:0016056; GO:0018298; GO:0097381	integral component of membrane [GO:0016021]; photoreceptor disc membrane [GO:0097381]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; absorption of visible light [GO:0016038]; protein-chromophore linkage [GO:0018298]; rhodopsin mediated signaling pathway [GO:0016056]; visual perception [GO:0007601]
PGEN_.00g255490	Scaffold_12	39009071	39009400	NA	NA	NA	NA	NA
PGEN_.00g255500	Scaffold_12	39012751	39020030	Q8IE95	SETVS_PLAF7	Variant-silencing SET domain-containing protein (PfSETvs) (EC 2.1.1.-) (SET domain-containing protein 2) (PfSET2)	GO:0000785; GO:0003682; GO:0005634; GO:0005694; GO:0006355; GO:0010452; GO:0018024; GO:0020012; GO:0020033; GO:0034399; GO:0046872; GO:0046975; GO:0097198	"chromatin [GO:0000785]; chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; antigenic variation [GO:0020033]; evasion or tolerance of host immune response [GO:0020012]; histone H3-K36 methylation [GO:0010452]; histone H3-K36 trimethylation [GO:0097198]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g255510	Scaffold_12	39102880	39104301	P30731	GPR83_MOUSE	Probable G-protein coupled receptor 83 (Glucocorticoid-induced receptor)	GO:0004983; GO:0005886; GO:0005929; GO:0016021; GO:0051384; GO:0097730	cilium [GO:0005929]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; neuropeptide Y receptor activity [GO:0004983]; response to glucocorticoid [GO:0051384]
PGEN_.00g255520	Scaffold_12	39131985	39153951	Q498K0	GALC_XENLA	Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase)	GO:0004336; GO:0005764; GO:0006683	lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683]
PGEN_.00g255530	Scaffold_12	39166388	39169879	NA	NA	NA	NA	NA
PGEN_.00g255540	Scaffold_12	39190831	39196150	NA	NA	NA	NA	NA
PGEN_.00g255550	Scaffold_12	39234876	39242188	NA	NA	NA	NA	NA
PGEN_.00g255560	Scaffold_12	39246523	39259231	Q3V124	EID3_MOUSE	EP300-interacting inhibitor of differentiation 3 (EID-3) (EID-1-like inhibitor of differentiation 3) (Non-structural maintenance of chromosomes element 4 homolog B) (NS4EB) (Non-SMC element 4 homolog B)	GO:0000781; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006281; GO:0006310; GO:0030915; GO:2001022	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022]"
PGEN_.00g255570	Scaffold_12	39266789	39328079	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g255580	Scaffold_12	39362099	39363304	Q28558	MTR1L_SHEEP	Melatonin-related receptor (G protein-coupled receptor 50) (H9)	GO:0005886; GO:0008502; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; melatonin receptor activity [GO:0008502]
PGEN_.00g255590	Scaffold_12	39368621	39379674	Q5E999	DUS11_BOVIN	RNA/RNP complex-1-interacting phosphatase (EC 3.1.3.-) (Dual specificity protein phosphatase 11) (Phosphatase that interacts with RNA/RNP complex 1)	GO:0003723; GO:0004651; GO:0004725; GO:0005634; GO:0008138; GO:0016070; GO:0016607; GO:0016791; GO:0098507; GO:0098519	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; polynucleotide 5' dephosphorylation [GO:0098507]; RNA metabolic process [GO:0016070]"
PGEN_.00g255600	Scaffold_12	39386755	39397218	NA	NA	NA	NA	NA
PGEN_.00g255610	Scaffold_12	39398911	39405507	NA	NA	NA	NA	NA
PGEN_.00g255620	Scaffold_12	39410500	39432991	Q61586	GPAT1_MOUSE	"Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15) (P90)"	GO:0004366; GO:0005739; GO:0005741; GO:0005743; GO:0005886; GO:0006072; GO:0006631; GO:0006637; GO:0006641; GO:0006650; GO:0008654; GO:0009749; GO:0010867; GO:0014823; GO:0016021; GO:0016024; GO:0019432; GO:0031966; GO:0032869; GO:0040018; GO:0042104; GO:0050707; GO:0051607; GO:0055089; GO:0055091; GO:0070236; GO:0070970; GO:0102420	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; cellular response to insulin stimulus [GO:0032869]; defense response to virus [GO:0051607]; fatty acid homeostasis [GO:0055089]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerophospholipid metabolic process [GO:0006650]; interleukin-2 secretion [GO:0070970]; negative regulation of activation-induced cell death of T cells [GO:0070236]; phospholipid biosynthetic process [GO:0008654]; phospholipid homeostasis [GO:0055091]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cytokine secretion [GO:0050707]; response to activity [GO:0014823]; response to glucose [GO:0009749]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]
PGEN_.00g255630	Scaffold_12	39464432	39570305	Q7TT36	AGRA3_MOUSE	Adhesion G protein-coupled receptor A3 (G-protein coupled receptor 125)	GO:0004930; GO:0007166; GO:0009897; GO:0016021	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g255640	Scaffold_12	39578516	39583091	NA	NA	NA	NA	NA
PGEN_.00g255650	Scaffold_12	39583143	39589603	NA	NA	NA	NA	NA
PGEN_.00g255660	Scaffold_12	39589656	39590558	NA	NA	NA	NA	NA
PGEN_.00g255670	Scaffold_12	39594810	39595514	NA	NA	NA	NA	NA
PGEN_.00g255680	Scaffold_12	39596271	39601852	NA	NA	NA	NA	NA
PGEN_.00g255690	Scaffold_12	39606392	39606793	NA	NA	NA	NA	NA
PGEN_.00g255700	Scaffold_12	39686658	39725227	A7Z035	EPN4_BOVIN	Clathrin interactor 1 (Epsin-4)	GO:0005654; GO:0005798; GO:0005802; GO:0006897; GO:0008289; GO:0016020; GO:0030136; GO:0030276; GO:0048471	clathrin-coated vesicle [GO:0030136]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]; endocytosis [GO:0006897]
PGEN_.00g255710	Scaffold_12	39729889	39731272	NA	NA	NA	NA	NA
PGEN_.00g255720	Scaffold_12	39758515	39769734	Q923Y8	TAAR1_MOUSE	Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1)	GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0007191; GO:0008227; GO:0016021; GO:0043950	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]
PGEN_.00g255730	Scaffold_12	39770903	39776478	Q923Y8	TAAR1_MOUSE	Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1)	GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0007191; GO:0008227; GO:0016021; GO:0043950	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]
PGEN_.00g255740	Scaffold_12	39800549	39812910	B3EWZ3	CADN_ACRMI	Coadhesin (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g255750	Scaffold_12	39874696	39876153	NA	NA	NA	NA	NA
PGEN_.00g255760	Scaffold_12	39885653	39886759	P97353	SEC1_MOUSE	"Galactoside 2-alpha-L-fucosyltransferase 3 (EC 2.4.1.69) (Alpha(1,2)FT 3) (Fucosyltransferase 10) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 3) (Secretory blood group protein 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g255770	Scaffold_12	39893341	39893628	NA	NA	NA	NA	NA
PGEN_.00g255780	Scaffold_12	39903987	39904307	NA	NA	NA	NA	NA
PGEN_.00g255790	Scaffold_12	39904345	39904596	NA	NA	NA	NA	NA
PGEN_.00g255800	Scaffold_12	39907758	39909681	Q866C9	FUT1_LAGLA	"Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]
PGEN_.00g255810	Scaffold_12	39929609	39949628	O93367	TLX3_CHICK	T-cell leukemia homeobox protein 3 (Homeobox TLX-3) (Homeobox protein Hox-11L2)	GO:0003700; GO:0005634; GO:0007275; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]
PGEN_.00g255820	Scaffold_12	39980642	40002587	O93366	TLX1_CHICK	T-cell leukemia homeobox protein 1 (Homeobox TLX-1) (Homeobox protein Hox-11)	GO:0000978; GO:0001228; GO:0005634; GO:0007275	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]"
PGEN_.00g255830	Scaffold_12	40016612	40016917	NA	NA	NA	NA	NA
PGEN_.00g255840	Scaffold_12	40023168	40054368	A9CB34	SFI1_PAPAN	Protein SFI1 homolog	GO:0005737; GO:0005813; GO:0005814; GO:0010923; GO:0019902	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; phosphatase binding [GO:0019902]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g255850	Scaffold_12	40054494	40069150	NA	NA	NA	NA	NA
PGEN_.00g255860	Scaffold_12	40069305	40081129	NA	NA	NA	NA	NA
PGEN_.00g255870	Scaffold_12	40087774	40110117	Q3ZCH0	GRP75_BOVIN	"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)"	GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0006611; GO:0006986; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0034605; GO:0034620; GO:0042026; GO:0042623; GO:0042645; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0051787; GO:1902037; GO:1903707	"cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986]"
PGEN_.00g255880	Scaffold_12	40122569	40166097	Q9Y2H2	SAC2_HUMAN	Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2)	GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0008934; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0033137; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0043231; GO:0043812; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0051896; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135	axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896]
PGEN_.00g255890	Scaffold_12	40175151	40206337	Q9ERQ8	CAH7_MOUSE	Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII)	GO:0004089; GO:0005623; GO:0005829; GO:0008270; GO:0032230; GO:0032849; GO:2001225	"cell [GO:0005623]; cytosol [GO:0005829]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]"
PGEN_.00g255900	Scaffold_12	40398613	40400328	O01670	OAR2_LYMST	Octopamine receptor 2 (OA2)	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g255910	Scaffold_12	40420491	40420838	NA	NA	NA	NA	NA
PGEN_.00g255920	Scaffold_12	40516313	40551491	A8E7C5	SAC2_DANRE	Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2)	GO:0005769; GO:0005905; GO:0008934; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2001135	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]
PGEN_.00g255930	Scaffold_12	40551801	40568427	Q8CFI7	RPB2_MOUSE	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)	GO:0000784; GO:0003677; GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006366; GO:0032549; GO:0046872	"nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g255940	Scaffold_12	40634811	40636622	Q5RJ80	CAPR2_DANRE	Caprin-2 (RNA granule protein 140)	GO:0003723; GO:0005737; GO:0005886; GO:0009953; GO:0017148; GO:0030177; GO:0040008; GO:0046872; GO:0050775; GO:0061003; GO:0090263; GO:2000055	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008]
PGEN_.00g255950	Scaffold_12	40641023	40654947	Q8CGF7	TCRG1_MOUSE	Transcription elongation regulator 1 (Formin-binding protein 28) (FBP 28) (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) (p144)	GO:0000122; GO:0001103; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0042802; GO:0070064	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g255960	Scaffold_12	40655000	40663269	Q8CGF7	TCRG1_MOUSE	Transcription elongation regulator 1 (Formin-binding protein 28) (FBP 28) (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) (p144)	GO:0000122; GO:0001103; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0042802; GO:0070064	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g255970	Scaffold_12	40674417	40681954	Q8TF32	ZN431_HUMAN	Zinc finger protein 431	GO:0000122; GO:0000978; GO:0003682; GO:0005634; GO:0030154; GO:0043433; GO:0046872	nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]
PGEN_.00g255980	Scaffold_12	40684898	40689749	NA	NA	NA	NA	NA
PGEN_.00g255990	Scaffold_12	40742630	40751961	NA	NA	NA	NA	NA
PGEN_.00g256000	Scaffold_12	40756065	40791352	Q5RC62	BBS12_PONAB	Bardet-Biedl syndrome 12 protein homolog	GO:0005524; GO:0005929; GO:0051131	cilium [GO:0005929]; ATP binding [GO:0005524]; chaperone-mediated protein complex assembly [GO:0051131]
PGEN_.00g256010	Scaffold_12	40795432	40798208	Q20591	VA0E_CAEEL	V-type proton ATPase subunit e (V-ATPase subunit e) (Vacuolar proton pump subunit e)	GO:0009792; GO:0010172; GO:0015078; GO:0016021; GO:0016324; GO:0016787; GO:0033179; GO:0033181; GO:0043296; GO:0055085; GO:0060142	"apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; hydrolase activity [GO:0016787]; proton transmembrane transporter activity [GO:0015078]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; regulation of syncytium formation by plasma membrane fusion [GO:0060142]; transmembrane transport [GO:0055085]"
PGEN_.00g256020	Scaffold_12	40800658	40831196	Q3MHH6	PYRD2_BOVIN	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 (EC 1.-.-.-)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g256030	Scaffold_12	40850373	40858529	Q6QHC5	DEGS2_HUMAN	Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2 (EC 1.14.18.5) (EC 1.14.19.17) (Degenerative spermatocyte homolog 2) (Sphingolipid 4-desaturase) (Sphingolipid C4-monooxygenase)	GO:0000170; GO:0005789; GO:0006667; GO:0016021; GO:0030148; GO:0042284; GO:0046513	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sphingolipid delta-4 desaturase activity [GO:0042284]; sphingosine hydroxylase activity [GO:0000170]; ceramide biosynthetic process [GO:0046513]; sphinganine metabolic process [GO:0006667]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g256040	Scaffold_12	40863217	40865289	Q16706	MA2A1_HUMAN	"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062	"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]"
PGEN_.00g256050	Scaffold_12	40868869	40869810	Q8BRK9	MA2A2_MOUSE	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016799; GO:0030246; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"
PGEN_.00g256060	Scaffold_12	40898757	40906092	Q8BRK9	MA2A2_MOUSE	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016799; GO:0030246; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"
PGEN_.00g256070	Scaffold_12	40923424	40923864	NA	NA	NA	NA	NA
PGEN_.00g256080	Scaffold_12	40942353	40942890	NA	NA	NA	NA	NA
PGEN_.00g256090	Scaffold_12	40942942	40943721	NA	NA	NA	NA	NA
PGEN_.00g256100	Scaffold_12	40955964	40974936	B5X3C1	GALC_SALSA	Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase)	GO:0004336; GO:0005764; GO:0006683	lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683]
PGEN_.00g256110	Scaffold_12	40981464	40992346	Q9FYC8	Y3482_ARATH	BTB/POZ domain-containing protein At3g44820	GO:0016567	protein ubiquitination [GO:0016567]
PGEN_.00g256120	Scaffold_12	40998764	40999348	NA	NA	NA	NA	NA
PGEN_.00g256130	Scaffold_12	41009463	41010944	NA	NA	NA	NA	NA
PGEN_.00g256140	Scaffold_12	41018383	41019528	NA	NA	NA	NA	NA
PGEN_.00g256150	Scaffold_12	41023022	41028486	NA	NA	NA	NA	NA
PGEN_.00g256160	Scaffold_12	41033326	41034468	NA	NA	NA	NA	NA
PGEN_.00g256170	Scaffold_12	41038268	41057163	O13786	PEP7_SCHPO	Vacuolar segregation protein pep7	GO:0003676; GO:0005737; GO:0005794; GO:0006896; GO:0006904; GO:0006906; GO:0010009; GO:0032266; GO:0046872	cytoplasm [GO:0005737]; cytoplasmic side of endosome membrane [GO:0010009]; Golgi apparatus [GO:0005794]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Golgi to vacuole transport [GO:0006896]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]
PGEN_.00g256180	Scaffold_12	41062867	41109136	Q14690	RRP5_HUMAN	Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11)	GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006397; GO:0008134; GO:0032040	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364]
PGEN_.00g256190	Scaffold_12	41115303	41132567	P49259	PLA2R_BOVIN	Secretory phospholipase A2 receptor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor (Soluble PLA2-R) (Soluble PLA2R)]	GO:0001816; GO:0004888; GO:0005576; GO:0005886; GO:0006898; GO:0016021; GO:0030246; GO:0038023; GO:0043274; GO:0043517; GO:0072593; GO:0090238; GO:0090399; GO:0090403	"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; phospholipase binding [GO:0043274]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; cytokine production [GO:0001816]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; replicative senescence [GO:0090399]"
PGEN_.00g256200	Scaffold_12	41136918	41145955	P78317	RNF4_HUMAN	E3 ubiquitin-protein ligase RNF4 (EC 2.3.2.27) (RING finger protein 4) (RING-type E3 ubiquitin transferase RNF4) (Small nuclear ring finger protein) (Protein SNURF)	GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0008134; GO:0008270; GO:0016604; GO:0016605; GO:0030374; GO:0030521; GO:0031491; GO:0032184; GO:0042802; GO:0043161; GO:0045893; GO:0045944; GO:0046685; GO:0050681; GO:0051865; GO:0070534; GO:0070936; GO:0070979; GO:0085020; GO:0090169; GO:0090234; GO:1990752	"cytoplasm [GO:0005737]; microtubule end [GO:1990752]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; nuclear receptor transcription coactivator activity [GO:0030374]; nucleosome binding [GO:0031491]; SUMO polymer binding [GO:0032184]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]; response to arsenic-containing substance [GO:0046685]"
PGEN_.00g256210	Scaffold_12	41155703	41157911	A1YF12	ZNF16_GORGO	Zinc finger protein 16	GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0045648; GO:0045654; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]
PGEN_.00g256220	Scaffold_12	41161078	41171648	NA	NA	NA	NA	NA
PGEN_.00g256230	Scaffold_12	41173630	41177881	NA	NA	NA	NA	NA
PGEN_.00g256240	Scaffold_12	41200322	41216293	NA	NA	NA	NA	NA
PGEN_.00g256250	Scaffold_12	41223949	41229858	NA	NA	NA	NA	NA
PGEN_.00g256260	Scaffold_12	41263483	41264295	NA	NA	NA	NA	NA
PGEN_.00g256270	Scaffold_12	41264508	41266792	NA	NA	NA	NA	NA
PGEN_.00g256280	Scaffold_12	41267609	41297324	O95786	DDX58_HUMAN	Antiviral innate immune response receptor RIG-I (DEAD box protein 58) (Probable ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I)	GO:0002230; GO:0002735; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0016032; GO:0016579; GO:0030334; GO:0031625; GO:0032480; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0034344; GO:0035549; GO:0039528; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051091; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1902741; GO:1904469; GO:1990904; GO:2000778	actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032]
PGEN_.00g256290	Scaffold_12	41306475	41323713	NA	NA	NA	NA	NA
PGEN_.00g256300	Scaffold_12	41331968	41334370	NA	NA	NA	NA	NA
PGEN_.00g256310	Scaffold_12	41338656	41350281	A7Y2W8	SC6A9_XENLA	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9)	GO:0005283; GO:0005328; GO:0005887	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g256320	Scaffold_12	41355053	41368665	Q4U2R1	HERC2_MOUSE	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g256330	Scaffold_12	41370057	41390992	Q01603	PERO_DROME	Peroxidase (DmPO) (EC 1.11.1.7) (Chorion peroxidase)	GO:0004601; GO:0005576; GO:0006979; GO:0007306; GO:0018149; GO:0018212; GO:0020037; GO:0042600; GO:0042744; GO:0046872	chorion [GO:0042600]; extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; peptide cross-linking [GO:0018149]; peptidyl-tyrosine modification [GO:0018212]; response to oxidative stress [GO:0006979]
PGEN_.00g256340	Scaffold_12	41391758	41392945	NA	NA	NA	NA	NA
PGEN_.00g256350	Scaffold_12	41393048	41393503	NA	NA	NA	NA	NA
PGEN_.00g256360	Scaffold_12	41393664	41394086	NA	NA	NA	NA	NA
PGEN_.00g256370	Scaffold_12	41430562	41446149	P56407	HM09_CAEEL	Homeobox protein ceh-9	GO:0000978; GO:0003700; GO:0005634; GO:0007275; GO:0030154; GO:0043565; GO:0045944	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g256380	Scaffold_12	41464978	41476704	Q5IZC5	CRY1_ERIRU	Cryptochrome-1	GO:0000166; GO:0003677; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0042622; GO:0045721; GO:0097381	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]
PGEN_.00g256390	Scaffold_12	41478310	41490936	NA	NA	NA	NA	NA
PGEN_.00g256400	Scaffold_12	41503203	41505095	O94941	RNF37_HUMAN	RING finger protein 37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RNF37) (U-box domain-containing protein 5) (UbcM4-interacting protein 5) (hUIP5) (Ubiquitin-conjugating enzyme 7-interacting protein 5)	GO:0000209; GO:0005634; GO:0005654; GO:0005925; GO:0016604; GO:0031625; GO:0034450; GO:0046872; GO:0061630	focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]
PGEN_.00g256410	Scaffold_12	41516988	41519181	Q9Y225	RNF24_HUMAN	RING finger protein 24	GO:0000139; GO:0005794; GO:0008270; GO:0012505; GO:0016021; GO:0061630	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]
PGEN_.00g256420	Scaffold_12	41580594	41613683	NA	NA	NA	NA	NA
PGEN_.00g256430	Scaffold_12	41623048	41636433	Q28039	SC6A9_BOVIN	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)	GO:0005283; GO:0005328; GO:0005886; GO:0005887	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g256440	Scaffold_12	41638724	41640688	NA	NA	NA	NA	NA
PGEN_.00g256450	Scaffold_12	41648467	41651125	NA	NA	NA	NA	NA
PGEN_.00g256460	Scaffold_12	41659398	41660503	P57016	LAD1_MOUSE	Ladinin-1 (Lad-1) (Linear IgA disease antigen homolog) (LADA)	GO:0005198; GO:0005604; GO:0015629	actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; structural molecule activity [GO:0005198]
PGEN_.00g256470	Scaffold_12	41662591	41662806	NA	NA	NA	NA	NA
PGEN_.00g256480	Scaffold_12	41663247	41689502	A7Y2X0	SC6A5_XENLA	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (xGlyT2) (Solute carrier family 6 member 5)	GO:0005328; GO:0005886; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g256490	Scaffold_12	41693852	41703568	NA	NA	NA	NA	NA
PGEN_.00g256500	Scaffold_12	41706342	41722646	A7Y2W8	SC6A9_XENLA	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9)	GO:0005283; GO:0005328; GO:0005887	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]
PGEN_.00g256510	Scaffold_12	41748090	41754692	Q8TDB6	DTX3L_HUMAN	E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2)	GO:0000209; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g256520	Scaffold_12	41760237	41764385	NA	NA	NA	NA	NA
PGEN_.00g256530	Scaffold_12	41767202	41774400	Q8TDB6	DTX3L_HUMAN	E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2)	GO:0000209; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g256540	Scaffold_12	41781776	41787022	Q5QD13	TAAR6_MOUSE	Trace amine-associated receptor 6 (TaR-6) (Trace amine receptor 6) (mTaar6)	GO:0001594; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trace-amine receptor activity [GO:0001594]
PGEN_.00g256550	Scaffold_12	41804381	41812650	NA	NA	NA	NA	NA
PGEN_.00g256560	Scaffold_12	41818812	41821156	NA	NA	NA	NA	NA
PGEN_.00g256570	Scaffold_12	41831270	41838535	NA	NA	NA	NA	NA
PGEN_.00g256580	Scaffold_12	41838677	41851810	NA	NA	NA	NA	NA
PGEN_.00g256590	Scaffold_12	41913188	41954666	B1WAZ6	PA24A_XENTR	Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]	GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0031410; GO:0046475; GO:0047498; GO:0102567; GO:0102568	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; glycerophospholipid catabolic process [GO:0046475]"
PGEN_.00g256600	Scaffold_12	41983638	41984294	NA	NA	NA	NA	NA
PGEN_.00g256610	Scaffold_12	41987247	41988737	Q9CX98	CP2U1_MOUSE	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g256620	Scaffold_12	41995718	42007362	P78312	F193A_HUMAN	Protein FAM193A (Protein IT14)		
PGEN_.00g256630	Scaffold_12	42011738	42043013	P78312	F193A_HUMAN	Protein FAM193A (Protein IT14)		
PGEN_.00g256640	Scaffold_12	42053942	42056054	NA	NA	NA	NA	NA
PGEN_.00g256650	Scaffold_12	42057762	42058988	NA	NA	NA	NA	NA
PGEN_.00g256660	Scaffold_12	42060204	42060545	NA	NA	NA	NA	NA
PGEN_.00g256670	Scaffold_12	42062088	42063371	NA	NA	NA	NA	NA
PGEN_.00g256680	Scaffold_12	42094235	42094513	NA	NA	NA	NA	NA
PGEN_.00g256690	Scaffold_12	42102986	42104188	NA	NA	NA	NA	NA
PGEN_.00g256700	Scaffold_12	42120026	42126074	O43174	CP26A_HUMAN	Cytochrome P450 26A1 (EC 1.14.13.-) (Cytochrome P450 retinoic acid-inactivating 1) (Cytochrome P450RAI) (hP450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome)	GO:0000249; GO:0001822; GO:0001972; GO:0004497; GO:0005506; GO:0005789; GO:0006696; GO:0006766; GO:0006805; GO:0008401; GO:0016125; GO:0016709; GO:0019825; GO:0020037; GO:0032526; GO:0033189; GO:0034653; GO:0042573; GO:0048387; GO:0055114	"endoplasmic reticulum membrane [GO:0005789]; C-22 sterol desaturase activity [GO:0000249]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; ergosterol biosynthetic process [GO:0006696]; kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; oxidation-reduction process [GO:0055114]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g256710	Scaffold_12	42144547	42169490	Q3SA47	TBX5_XENTR	T-box transcription factor TBX5 (T-box protein 5)	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001102; GO:0001228; GO:0001708; GO:0003218; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0007267; GO:0007389; GO:0007507; GO:0008285; GO:0030326; GO:0030336; GO:0032991; GO:0032993; GO:0035115; GO:0043565; GO:0045893; GO:0045944; GO:0048513; GO:0051891; GO:0060039; GO:0060044	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; animal organ development [GO:0048513]; cardiac left ventricle formation [GO:0003218]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; embryonic forelimb morphogenesis [GO:0035115]; embryonic limb morphogenesis [GO:0030326]; heart development [GO:0007507]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pattern specification process [GO:0007389]; pericardium development [GO:0060039]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g256720	Scaffold_12	42190142	42198890	NA	NA	NA	NA	NA
PGEN_.00g256730	Scaffold_12	42199385	42199612	NA	NA	NA	NA	NA
PGEN_.00g256740	Scaffold_12	42200070	42200832	Q9BYR4	KRA43_HUMAN	Keratin-associated protein 4-3 (Keratin-associated protein 4.3) (Ultrahigh sulfur keratin-associated protein 4.3)	GO:0005829; GO:0007568; GO:0031424; GO:0042633; GO:0045095	cytosol [GO:0005829]; keratin filament [GO:0045095]; aging [GO:0007568]; hair cycle [GO:0042633]; keratinization [GO:0031424]
PGEN_.00g256750	Scaffold_12	42201194	42201541	NA	NA	NA	NA	NA
PGEN_.00g256760	Scaffold_12	42201601	42287630	Q7Z442	PK1L2_HUMAN	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g256770	Scaffold_12	42289651	42290628	NA	NA	NA	NA	NA
PGEN_.00g256780	Scaffold_12	42290754	42291524	NA	NA	NA	NA	NA
PGEN_.00g256790	Scaffold_12	42291688	42293886	Q96DM1	PGBD4_HUMAN	PiggyBac transposable element-derived protein 4		
PGEN_.00g256800	Scaffold_12	42295047	42301578	NA	NA	NA	NA	NA
PGEN_.00g256810	Scaffold_12	42332604	42383822	O55203	LDB2_MOUSE	LIM domain-binding protein 2 (LDB-2) (Carboxyl-terminal LIM domain-binding protein 1) (CLIM-1) (LIM domain-binding factor CLIM1)	GO:0000122; GO:0001102; GO:0001942; GO:0003712; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005886; GO:0007275; GO:0010669; GO:0019899; GO:0030274; GO:0030334; GO:0031252; GO:0035019; GO:0043549; GO:0044089; GO:0045892; GO:0045944	"cell leading edge [GO:0031252]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; epithelial structure maintenance [GO:0010669]; hair follicle development [GO:0001942]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cellular component biogenesis [GO:0044089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of kinase activity [GO:0043549]; somatic stem cell population maintenance [GO:0035019]"
PGEN_.00g256820	Scaffold_12	42385101	42400467	Q8WXF0	SRS12_HUMAN	"Serine/arginine-rich splicing factor 12 (35 kDa SR repressor protein) (SRrp35) (Splicing factor, arginine/serine-rich 13B) (Splicing factor, arginine/serine-rich 19)"	GO:0000244; GO:0000381; GO:0000395; GO:0003723; GO:0005634; GO:0005654; GO:0016607; GO:0045292; GO:0048025; GO:0050733; GO:0051082	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082]; mRNA 5'-splice site recognition [GO:0000395]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal tri-snRNP complex assembly [GO:0000244]"
PGEN_.00g256830	Scaffold_12	42405062	42405451	NA	NA	NA	NA	NA
PGEN_.00g256840	Scaffold_12	42415558	42441687	NA	NA	NA	NA	NA
PGEN_.00g256850	Scaffold_12	42441866	42479242	P14735	IDE_HUMAN	Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin)	GO:0001540; GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005623; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0006625; GO:0008270; GO:0008286; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032461; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045732; GO:0045861; GO:0050435; GO:0051260; GO:0051289; GO:0051291; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715	basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein oligomerization [GO:0032461]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; protein targeting to peroxisome [GO:0006625]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]
PGEN_.00g256860	Scaffold_12	42479596	42485555	Q24K02	IDE_BOVIN	Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)	GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005623; GO:0005634; GO:0005739; GO:0005782; GO:0005829; GO:0008270; GO:0008340; GO:0009897; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0032461; GO:0042447; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0050435; GO:0051260; GO:0051603; GO:0140036; GO:0150094; GO:1901143; GO:1903715	basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein homooligomerization [GO:0051260]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]
PGEN_.00g256870	Scaffold_12	42493364	42494881	NA	NA	NA	NA	NA
PGEN_.00g256880	Scaffold_12	42506979	42508532	NA	NA	NA	NA	NA
PGEN_.00g256890	Scaffold_12	42511605	42513161	NA	NA	NA	NA	NA
PGEN_.00g256900	Scaffold_12	42523976	42555326	G5ECB1	ZIG4_CAEEL	Zwei Ig domain protein zig-4 (2 Ig domain protein zig-4)	GO:0005576; GO:0048666	extracellular region [GO:0005576]; neuron development [GO:0048666]
PGEN_.00g256910	Scaffold_12	42696322	42709453	NA	NA	NA	NA	NA
PGEN_.00g256920	Scaffold_12	42719889	42747321	O95786	DDX58_HUMAN	Antiviral innate immune response receptor RIG-I (DEAD box protein 58) (Probable ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I)	GO:0002230; GO:0002735; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0016032; GO:0016579; GO:0030334; GO:0031625; GO:0032480; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0034344; GO:0035549; GO:0039528; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051091; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1902741; GO:1904469; GO:1990904; GO:2000778	actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032]
PGEN_.00g256930	Scaffold_12	42763615	42778873	NA	NA	NA	NA	NA
PGEN_.00g256940	Scaffold_12	42788776	42789024	NA	NA	NA	NA	NA
PGEN_.00g256950	Scaffold_12	42801766	42812315	A0JPG1	F16B1_XENLA	Protein FAM160B1		
PGEN_.00g256960	Scaffold_12	42812350	42829997	Q8CDM8	F16B1_MOUSE	Protein FAM160B1		
PGEN_.00g256970	Scaffold_12	42831294	42846463	Q86Y37	CACL1_HUMAN	CDK2-associated and cullin domain-containing protein 1 (Cdk-associated cullin1)	GO:0000082; GO:0006511; GO:0008284; GO:0019901; GO:0031625; GO:0045860	protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g256980	Scaffold_12	42877551	42878983	NA	NA	NA	NA	NA
PGEN_.00g256990	Scaffold_12	42907705	42908850	Q25461	ARNP_MYTED	APGW-amide-related neuropeptide [Cleaved into: RPGW-amide; KPGW-amide; TPGW-amide]	GO:0007218	neuropeptide signaling pathway [GO:0007218]
PGEN_.00g257000	Scaffold_12	42944001	42950406	NA	NA	NA	NA	NA
PGEN_.00g257010	Scaffold_12	42957046	42957999	NA	NA	NA	NA	NA
PGEN_.00g257020	Scaffold_12	42996875	42997201	NA	NA	NA	NA	NA
PGEN_.00g257030	Scaffold_12	43014424	43020604	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g257040	Scaffold_12	43025064	43025309	NA	NA	NA	NA	NA
PGEN_.00g257050	Scaffold_12	43040597	43041259	NA	NA	NA	NA	NA
PGEN_.00g257060	Scaffold_12	43058716	43060736	Q8BGT1	FLRT3_MOUSE	Leucine-rich repeat transmembrane protein FLRT3 (Fibronectin leucine rich transmembrane protein 3)	GO:0003345; GO:0005104; GO:0005615; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007411; GO:0007416; GO:0007507; GO:0008543; GO:0014069; GO:0030054; GO:0031175; GO:0032584; GO:0042803; GO:0043679; GO:0044295; GO:0045499; GO:0048598; GO:0048678; GO:0050808; GO:0051965; GO:0060322; GO:0097060; GO:0098742; GO:0098978; GO:0099055; GO:0099560; GO:1990138	axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone membrane [GO:0032584]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic membrane adhesion [GO:0099560]
PGEN_.00g257070	Scaffold_12	43069307	43069693	NA	NA	NA	NA	NA
PGEN_.00g257080	Scaffold_12	43107616	43131617	Q8R3B7	BRD8_MOUSE	Bromodomain-containing protein 8	GO:0000812; GO:0005654; GO:0005739; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0045944	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]
PGEN_.00g257090	Scaffold_12	43153234	43215999	Q15652	JHD2C_HUMAN	Probable JmjC domain-containing histone demethylation protein 2C (EC 1.14.11.-) (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8) (TR-interacting protein 8) (TRIP-8)	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006355; GO:0007596; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0046966; GO:0051213	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; thyroid hormone receptor binding [GO:0046966]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; blood coagulation [GO:0007596]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g257100	Scaffold_12	43226214	43226519	NA	NA	NA	NA	NA
PGEN_.00g257110	Scaffold_12	43228351	43289671	Q6ZPY7	KDM3B_MOUSE	Lysine-specific demethylase 3B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B)	GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0016209; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0051213; GO:0072718	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718]
PGEN_.00g257120	Scaffold_12	43302478	43310495	Q551H0	MUS81_DICDI	Probable crossover junction endonuclease mus81 (EC 3.1.22.-)	GO:0000712; GO:0000727; GO:0003677; GO:0005634; GO:0031573; GO:0046872; GO:0048257; GO:0048476	Holliday junction resolvase complex [GO:0048476]; nucleus [GO:0005634]; 3'-flap endonuclease activity [GO:0048257]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; double-strand break repair via break-induced replication [GO:0000727]; intra-S DNA damage checkpoint [GO:0031573]; resolution of meiotic recombination intermediates [GO:0000712]
PGEN_.00g257130	Scaffold_12	43313404	43321375	Q5F478	ANR44_CHICK	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)		
PGEN_.00g257140	Scaffold_12	43345094	43352247	NA	NA	NA	NA	NA
PGEN_.00g257150	Scaffold_12	43354650	43357836	NA	NA	NA	NA	NA
PGEN_.00g257160	Scaffold_12	43600415	43601647	Q13639	5HT4R_HUMAN	5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)	GO:0004930; GO:0004993; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007268; GO:0016020; GO:0030425; GO:0030594; GO:0032098; GO:0045202	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of appetite [GO:0032098]"
PGEN_.00g257170	Scaffold_12	43618972	43620204	Q13639	5HT4R_HUMAN	5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)	GO:0004930; GO:0004993; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007268; GO:0016020; GO:0030425; GO:0030594; GO:0032098; GO:0045202	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of appetite [GO:0032098]"
PGEN_.00g257180	Scaffold_12	43631698	43632336	NA	NA	NA	NA	NA
PGEN_.00g257190	Scaffold_12	43638198	43647429	Q9NQZ5	STAR7_HUMAN	"StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7) (StARD7)"	GO:0005741; GO:0006656; GO:0008289	mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; phosphatidylcholine biosynthetic process [GO:0006656]
PGEN_.00g257200	Scaffold_12	43688343	43689691	NA	NA	NA	NA	NA
PGEN_.00g257210	Scaffold_12	43689723	43697319	NA	NA	NA	NA	NA
PGEN_.00g257220	Scaffold_12	43716530	43718854	Q3MHH9	ECM2_BOVIN	Extracellular matrix protein 2	GO:0008201; GO:0010811; GO:0030198; GO:0031012; GO:0070052	extracellular matrix [GO:0031012]; collagen V binding [GO:0070052]; heparin binding [GO:0008201]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]
PGEN_.00g257230	Scaffold_12	43730064	43731848	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g257240	Scaffold_12	43747494	43791239	P42859	HD_MOUSE	"Huntingtin (Huntington disease protein homolog) (HD protein homolog) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]"	GO:0000050; GO:0000052; GO:0000132; GO:0002039; GO:0005102; GO:0005522; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005814; GO:0005829; GO:0006839; GO:0006888; GO:0006890; GO:0007005; GO:0007029; GO:0007030; GO:0007212; GO:0007283; GO:0007369; GO:0007417; GO:0007420; GO:0007569; GO:0007611; GO:0007612; GO:0007625; GO:0007626; GO:0008088; GO:0008134; GO:0008306; GO:0008340; GO:0008542; GO:0009653; GO:0009952; GO:0010468; GO:0014069; GO:0016197; GO:0016234; GO:0019244; GO:0019805; GO:0019900; GO:0021756; GO:0021988; GO:0021990; GO:0022008; GO:0030072; GO:0030073; GO:0030136; GO:0030424; GO:0030425; GO:0030659; GO:0031072; GO:0031410; GO:0031587; GO:0031648; GO:0032991; GO:0034452; GO:0034504; GO:0035176; GO:0042297; GO:0042445; GO:0042802; GO:0043025; GO:0043065; GO:0043066; GO:0043523; GO:0043666; GO:0044325; GO:0045505; GO:0045724; GO:0047496; GO:0048167; GO:0048341; GO:0048471; GO:0048487; GO:0048666; GO:0050809; GO:0051028; GO:0051592; GO:0055072; GO:0071539; GO:0071598; GO:0097060; GO:0098978; GO:0099523; GO:0099524; GO:0099527; GO:1900180; GO:1902857; GO:1903599; GO:1904504; GO:1904580; GO:1905289; GO:1905337; GO:1905505; GO:2000117; GO:2000479; GO:2001237	"autophagosome [GO:0005776]; axon [GO:0030424]; cell [GO:0005623]; centriole [GO:0005814]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]; beta-tubulin binding [GO:0048487]; diazepam binding [GO:0050809]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; axo-dendritic transport [GO:0008088]; brain development [GO:0007420]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; citrulline metabolic process [GO:0000052]; determination of adult lifespan [GO:0008340]; dopamine receptor signaling pathway [GO:0007212]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; iron ion homeostasis [GO:0055072]; lactate biosynthetic process from pyruvate [GO:0019244]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neural plate formation [GO:0021990]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; olfactory lobe development [GO:0021988]; paraxial mesoderm formation [GO:0048341]; peptide hormone secretion [GO:0030072]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; positive regulation of motile cilium assembly [GO:1905505]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse to nucleus signaling pathway [GO:0099527]; protein destabilization [GO:0031648]; protein localization to centrosome [GO:0071539]; protein localization to nucleus [GO:0034504]; quinolinate biosynthetic process [GO:0019805]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of neuron apoptotic process [GO:0043523]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein localization to nucleus [GO:1900180]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; social behavior [GO:0035176]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; urea cycle [GO:0000050]; vesicle transport along microtubule [GO:0047496]; visual learning [GO:0008542]; vocal learning [GO:0042297]"
PGEN_.00g257250	Scaffold_12	43796426	43835852	P51111	HD_RAT	"Huntingtin (Huntington disease protein homolog) (HD protein homolog) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]"	GO:0000050; GO:0000052; GO:0000132; GO:0002039; GO:0005102; GO:0005522; GO:0005623; GO:0005634; GO:0005737; GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005814; GO:0005829; GO:0006839; GO:0006888; GO:0006890; GO:0007005; GO:0007029; GO:0007030; GO:0007212; GO:0007283; GO:0007369; GO:0007417; GO:0007420; GO:0007569; GO:0007611; GO:0007612; GO:0007625; GO:0007626; GO:0008088; GO:0008134; GO:0008306; GO:0008340; GO:0008542; GO:0009653; GO:0009952; GO:0010468; GO:0014069; GO:0016197; GO:0016234; GO:0019244; GO:0019805; GO:0019900; GO:0021756; GO:0021988; GO:0021990; GO:0022008; GO:0030072; GO:0030073; GO:0030136; GO:0030424; GO:0030425; GO:0030659; GO:0031072; GO:0031410; GO:0031587; GO:0031648; GO:0032991; GO:0034452; GO:0034504; GO:0035176; GO:0042297; GO:0042445; GO:0042802; GO:0043025; GO:0043065; GO:0043066; GO:0043523; GO:0043666; GO:0044325; GO:0045505; GO:0045724; GO:0047496; GO:0048167; GO:0048341; GO:0048471; GO:0048487; GO:0048666; GO:0050809; GO:0051028; GO:0051592; GO:0055072; GO:0071539; GO:0071598; GO:0097060; GO:0098978; GO:0099523; GO:0099524; GO:0099527; GO:1900180; GO:1902857; GO:1903599; GO:1904504; GO:1904580; GO:1905289; GO:1905337; GO:1905505; GO:2000117; GO:2000479; GO:2001237	"autophagosome [GO:0005776]; axon [GO:0030424]; cell [GO:0005623]; centriole [GO:0005814]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]; beta-tubulin binding [GO:0048487]; diazepam binding [GO:0050809]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; axo-dendritic transport [GO:0008088]; brain development [GO:0007420]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; citrulline metabolic process [GO:0000052]; determination of adult lifespan [GO:0008340]; dopamine receptor signaling pathway [GO:0007212]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; iron ion homeostasis [GO:0055072]; lactate biosynthetic process from pyruvate [GO:0019244]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neural plate formation [GO:0021990]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; olfactory lobe development [GO:0021988]; paraxial mesoderm formation [GO:0048341]; peptide hormone secretion [GO:0030072]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; positive regulation of motile cilium assembly [GO:1905505]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse to nucleus signaling pathway [GO:0099527]; protein destabilization [GO:0031648]; protein localization to centrosome [GO:0071539]; protein localization to nucleus [GO:0034504]; quinolinate biosynthetic process [GO:0019805]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of neuron apoptotic process [GO:0043523]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein localization to nucleus [GO:1900180]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; social behavior [GO:0035176]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; urea cycle [GO:0000050]; vesicle transport along microtubule [GO:0047496]; visual learning [GO:0008542]; vocal learning [GO:0042297]"
PGEN_.00g257260	Scaffold_12	43837856	43843965	P51112	HD_TAKRU	Huntingtin (Huntington disease protein homolog) (HD protein homolog)	GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g257270	Scaffold_12	43854280	43864603	P31401	VATB_MANSE	V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B)	GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:1902600	"proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]"
PGEN_.00g257280	Scaffold_12	43873497	43882401	Q5BJJ7	BCCIP_DANRE	Protein BCCIP homolog	GO:0000079; GO:0000132; GO:0000226; GO:0005623; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0006281; GO:0006974; GO:0007052; GO:0015631; GO:0019207; GO:0034453; GO:0090307; GO:0097431	cell [GO:0005623]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; kinase regulator activity [GO:0019207]; tubulin binding [GO:0015631]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]
PGEN_.00g257290	Scaffold_12	43884502	43903440	Q8BZW8	NHLC2_MOUSE	NHL repeat-containing protein 2	GO:0005623; GO:0005829; GO:0045454	cell [GO:0005623]; cytosol [GO:0005829]; cell redox homeostasis [GO:0045454]
PGEN_.00g257300	Scaffold_12	43888636	43889660	NA	NA	NA	NA	NA
PGEN_.00g257310	Scaffold_12	43915315	43916118	NA	NA	NA	NA	NA
PGEN_.00g257320	Scaffold_12	43941062	43978957	NA	NA	NA	NA	NA
PGEN_.00g257330	Scaffold_12	43953376	43953843	NA	NA	NA	NA	NA
PGEN_.00g257340	Scaffold_12	43996057	43999351	NA	NA	NA	NA	NA
PGEN_.00g257350	Scaffold_12	44004427	44007973	NA	NA	NA	NA	NA
PGEN_.00g257360	Scaffold_12	44036249	44050128	Q27513	C13A4_CAEEL	Putative cytochrome P450 CYP13A4 (EC 1.14.-.-)	GO:0004497; GO:0005506; GO:0016705; GO:0020037	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g257370	Scaffold_12	44100080	44100403	NA	NA	NA	NA	NA
PGEN_.00g257380	Scaffold_12	44117185	44128593	NA	NA	NA	NA	NA
PGEN_.00g257390	Scaffold_12	44133394	44164811	Q5R9R1	EDRF1_PONAB	Erythroid differentiation-related factor 1	GO:0005634	nucleus [GO:0005634]
PGEN_.00g257400	Scaffold_12	44165000	44171359	Q29RH4	THOC3_BOVIN	THO complex subunit 3 (Tho3)	GO:0000445; GO:0000784; GO:0003723; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0046784	"nuclear chromosome, telomeric region [GO:0000784]; nuclear speck [GO:0016607]; THO complex part of transcription export complex [GO:0000445]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]"
PGEN_.00g257410	Scaffold_12	44176557	44213032	NA	NA	NA	NA	NA
PGEN_.00g257420	Scaffold_12	44229803	44259589	NA	NA	NA	NA	NA
PGEN_.00g257430	Scaffold_12	44263737	44265530	NA	NA	NA	NA	NA
PGEN_.00g257440	Scaffold_12	44266515	44288977	NA	NA	NA	NA	NA
PGEN_.00g257450	Scaffold_12	44292049	44321490	Q8MI28	LBN_BOVIN	Limbin	GO:0005634; GO:0005737; GO:0005856; GO:0007224; GO:0016021; GO:0060170	ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; smoothened signaling pathway [GO:0007224]
PGEN_.00g257460	Scaffold_12	44329327	44335838	Q80UM7	MOGS_MOUSE	Mannosyl-oligosaccharide glucosidase (EC 3.2.1.106) (Glucosidase 1) (Glycoprotein-processing glucosidase I)	GO:0004573; GO:0005783; GO:0005789; GO:0006487; GO:0009311; GO:0016021	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487]
PGEN_.00g257470	Scaffold_12	44336115	44348214	B2RW38	CFA58_MOUSE	Cilia- and flagella-associated protein 58	GO:0005929	cilium [GO:0005929]
PGEN_.00g257480	Scaffold_12	44369237	44432127	P43249	GRK5_BOVIN	G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5)	GO:0004674; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0006915; GO:0007217; GO:0008284; GO:0008289; GO:0016055; GO:0016607; GO:0031965; GO:0043066; GO:0045444; GO:0046777; GO:0047696; GO:0051726	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; lipid binding [GO:0008289]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055]
PGEN_.00g257490	Scaffold_12	44423834	44424034	NA	NA	NA	NA	NA
PGEN_.00g257500	Scaffold_12	44440263	44441937	NA	NA	NA	NA	NA
PGEN_.00g257510	Scaffold_12	44485639	44486031	NA	NA	NA	NA	NA
PGEN_.00g257520	Scaffold_12	44495208	44499803	NA	NA	NA	NA	NA
PGEN_.00g257530	Scaffold_12	44513973	44542014	Q8I7X7	NHP2_BRABE	H/ACA ribonucleoprotein complex subunit 2-like protein	GO:0003723; GO:0005697; GO:0005730; GO:0005732; GO:0007004; GO:0031118	nucleolus [GO:0005730]; small nucleolar ribonucleoprotein complex [GO:0005732]; telomerase holoenzyme complex [GO:0005697]; RNA binding [GO:0003723]; rRNA pseudouridine synthesis [GO:0031118]; telomere maintenance via telomerase [GO:0007004]
PGEN_.00g257540	Scaffold_12	44547871	44583712	Q17QJ5	TSN5_BOVIN	Tetraspanin-5 (Tspan-5)	GO:0005887; GO:0019899; GO:0045747; GO:0051604; GO:0072659	integral component of plasma membrane [GO:0005887]; enzyme binding [GO:0019899]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]
PGEN_.00g257550	Scaffold_12	44755029	44767405	Q5F3G0	RHG19_CHICK	Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19)	GO:0005096; GO:0005737; GO:0007165; GO:0051056	cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]
PGEN_.00g257560	Scaffold_12	44799018	44820420	Q9UJX5	APC4_HUMAN	Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4)	GO:0004842; GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0007049; GO:0019903; GO:0031145; GO:0034399; GO:0045842; GO:0051301; GO:0070979; GO:1901990	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g257570	Scaffold_12	44855415	44856248	NA	NA	NA	NA	NA
PGEN_.00g257580	Scaffold_12	44868902	44871253	Q810C0	SLIK2_MOUSE	SLIT and NTRK-like protein 2	GO:0007409; GO:0016021; GO:0050807; GO:0051965; GO:0098978; GO:0098982; GO:0099055; GO:0099560; GO:1905606	GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; axonogenesis [GO:0007409]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807]; synaptic membrane adhesion [GO:0099560]
PGEN_.00g257590	Scaffold_12	44994516	44996268	NA	NA	NA	NA	NA
PGEN_.00g257600	Scaffold_12	45004072	45037825	P24705	SODC_NPVAC	Putative superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	GO:0004784; GO:0046872	metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]
PGEN_.00g257610	Scaffold_12	45037876	45057802	NA	NA	NA	NA	NA
PGEN_.00g257620	Scaffold_12	45066618	45131362	Q9W735	PRM1A_DANRE	Prominin-1-A (Prominin-like protein 1)	GO:0005783; GO:0005793; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0015485; GO:0016324; GO:0031528; GO:0071914	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; cholesterol binding [GO:0015485]
PGEN_.00g257630	Scaffold_12	45192217	45199239	P18841	ADA1B_MESAU	Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor)	GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005901; GO:0016021; GO:0019229; GO:0031965; GO:0043410; GO:0046982; GO:0055117	caveola [GO:0005901]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]; positive regulation of MAPK cascade [GO:0043410]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229]
PGEN_.00g257640	Scaffold_12	45207891	45217836	NA	NA	NA	NA	NA
PGEN_.00g257650	Scaffold_12	45339924	45344882	NA	NA	NA	NA	NA
PGEN_.00g257660	Scaffold_12	45348108	45359518	Q5ZJV4	MCMBP_CHICK	Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein)	GO:0000790; GO:0003682; GO:0005634; GO:0006261; GO:0007062; GO:0051301	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062]
PGEN_.00g257670	Scaffold_12	45360630	45378473	Q803A6	MCMBP_DANRE	Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein)	GO:0000790; GO:0003682; GO:0005634; GO:0006261; GO:0007062; GO:0051301	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062]
PGEN_.00g257680	Scaffold_12	45426841	45428637	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g257690	Scaffold_12	45461546	45494055	O93470	MMP21_XENLA	Matrix metalloproteinase-21 (MMP-21) (xMMP) (EC 3.4.24.-)	GO:0004222; GO:0007368; GO:0008270; GO:0031012; GO:0061371	extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]
PGEN_.00g257700	Scaffold_12	45626187	45632187	NA	NA	NA	NA	NA
PGEN_.00g257710	Scaffold_12	45657564	45671222	Q9WTW7	S23A1_RAT	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1)	GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g257720	Scaffold_12	45686144	45686732	NA	NA	NA	NA	NA
PGEN_.00g257730	Scaffold_12	45687436	45698135	NA	NA	NA	NA	NA
PGEN_.00g257740	Scaffold_12	45698413	45705717	Q92485	ASM3B_HUMAN	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
PGEN_.00g257750	Scaffold_12	45710593	45710847	NA	NA	NA	NA	NA
PGEN_.00g257760	Scaffold_12	45712658	45728425	Q92485	ASM3B_HUMAN	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
PGEN_.00g257770	Scaffold_12	45730814	45731980	NA	NA	NA	NA	NA
PGEN_.00g257780	Scaffold_12	45735159	45743627	P07207	NOTCH_DROME	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	GO:0001708; GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0005915; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007455; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035003; GO:0035153; GO:0035162; GO:0035165; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043525; GO:0043697; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048	"adherens junction [GO:0005912]; cell [GO:0005623]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
PGEN_.00g257790	Scaffold_12	45746396	45747923	NA	NA	NA	NA	NA
PGEN_.00g257800	Scaffold_12	45754198	45757606	NA	NA	NA	NA	NA
PGEN_.00g257810	Scaffold_12	45764673	45798024	Q91W97	HKDC1_MOUSE	Hexokinase HKDC1 (EC 2.7.1.1) (Hexokinase domain-containing protein 1)	GO:0001678; GO:0004340; GO:0005524; GO:0005536; GO:0005623; GO:0005739; GO:0005829; GO:0006096; GO:0008865; GO:0019158; GO:0019318; GO:0031966; GO:0051156	cell [GO:0005623]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318]
PGEN_.00g257820	Scaffold_12	45826447	45853326	NA	NA	NA	NA	NA
PGEN_.00g257830	Scaffold_12	45827709	45831937	NA	NA	NA	NA	NA
PGEN_.00g257840	Scaffold_12	45887558	45907430	Q2PYN8	LBX1_XENLA	Transcription factor LBX1 (Ladybird homeobox protein homolog 1)	GO:0000122; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007517; GO:0030154; GO:0043565; GO:0051450	"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g257850	Scaffold_12	45915613	45916184	NA	NA	NA	NA	NA
PGEN_.00g257860	Scaffold_12	45980213	45985108	NA	NA	NA	NA	NA
PGEN_.00g257870	Scaffold_12	45996389	45996691	NA	NA	NA	NA	NA
PGEN_.00g257880	Scaffold_12	45999069	45999679	NA	NA	NA	NA	NA
PGEN_.00g257890	Scaffold_12	46007261	46008154	NA	NA	NA	NA	NA
PGEN_.00g257900	Scaffold_12	46028906	46057987	Q2PYN8	LBX1_XENLA	Transcription factor LBX1 (Ladybird homeobox protein homolog 1)	GO:0000122; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007517; GO:0030154; GO:0043565; GO:0051450	"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g257910	Scaffold_12	46098418	46113244	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g257920	Scaffold_12	46125555	46130180	NA	NA	NA	NA	NA
PGEN_.00g257930	Scaffold_12	46136536	46145346	NA	NA	NA	NA	NA
PGEN_.00g257940	Scaffold_12	46165500	46166281	NA	NA	NA	NA	NA
PGEN_.00g257950	Scaffold_12	46168722	46173694	NA	NA	NA	NA	NA
PGEN_.00g257960	Scaffold_12	46197835	46216413	Q0X0A5	MARH5_CHLAE	E3 ubiquitin-protein ligase MARCH5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (RING-type E3 ubiquitin transferase MARCH5)	GO:0004842; GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0051865; GO:0090140; GO:0090344	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of cell aging [GO:0090344]; protein autoubiquitination [GO:0051865]; regulation of mitochondrial fission [GO:0090140]
PGEN_.00g257970	Scaffold_12	46245346	46283046	Q812E0	CPEB2_MOUSE	Cytoplasmic polyadenylation element-binding protein 2 (CPE-BP2) (CPE-binding protein 2) (mCPEB-2)	GO:0000900; GO:0003730; GO:0005095; GO:0005634; GO:0005737; GO:0005844; GO:0008135; GO:0008187; GO:0032869; GO:0034260; GO:0034599; GO:0035925; GO:0043005; GO:0043022; GO:0043023; GO:0043024; GO:0045202; GO:0045900; GO:0071243; GO:0071456; GO:1900248; GO:1990124; GO:2000766	"cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; polysome [GO:0005844]; synapse [GO:0045202]; GTPase inhibitor activity [GO:0005095]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly-pyrimidine tract binding [GO:0008187]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of GTPase activity [GO:0034260]; negative regulation of translational elongation [GO:0045900]"
PGEN_.00g257980	Scaffold_12	46331576	46335338	NA	NA	NA	NA	NA
PGEN_.00g257990	Scaffold_12	46335483	46351183	A5A761	SFXN1_PIG	Sideroflexin-1	GO:0006730; GO:0006826; GO:0015194; GO:0015825; GO:0030218; GO:0031305; GO:0042942; GO:0042945; GO:0140300	integral component of mitochondrial inner membrane [GO:0031305]; D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]
PGEN_.00g258000	Scaffold_12	46361302	46365607	NA	NA	NA	NA	NA
PGEN_.00g258010	Scaffold_12	46385314	46388511	NA	NA	NA	NA	NA
PGEN_.00g258020	Scaffold_12	46392417	46404810	Q8R0F8	FAHD1_MOUSE	"Acylpyruvase FAHD1, mitochondrial (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112)"	GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0008948; GO:0016787; GO:0018773; GO:0034545; GO:0046872; GO:0047621	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]
PGEN_.00g258030	Scaffold_12	46412205	46412729	NA	NA	NA	NA	NA
PGEN_.00g258040	Scaffold_12	46414553	46418119	NA	NA	NA	NA	NA
PGEN_.00g258050	Scaffold_12	46515558	46519432	NA	NA	NA	NA	NA
PGEN_.00g258060	Scaffold_12	46551921	46577721	P08582	TRFM_HUMAN	Melanotransferrin (Melanoma-associated antigen p97) (CD antigen CD228)	GO:0005506; GO:0005576; GO:0005788; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0043687; GO:0044267; GO:0046658; GO:0055072; GO:0070062; GO:0090091; GO:1900025	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; iron ion binding [GO:0005506]; cellular protein metabolic process [GO:0044267]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]; post-translational protein modification [GO:0043687]
PGEN_.00g258070	Scaffold_12	46652792	46656037	P70031	CCKAR_XENLA	Cholecystokinin receptor (CCK-XLR)	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g258080	Scaffold_12	46744038	46751615	Q8IN35	SIFAR_DROME	Neuropeptide SIFamide receptor	GO:0004930; GO:0004983; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016021; GO:0032870; GO:0048047	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g258090	Scaffold_12	46781192	46782007	Q8ITC7	CAPAR_DROME	Neuropeptides capa receptor (Cap2b receptor) (Capability receptor)	GO:0001607; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016021; GO:0016323; GO:0051928; GO:0071465	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]
PGEN_.00g258100	Scaffold_12	46922429	46922995	NA	NA	NA	NA	NA
PGEN_.00g258110	Scaffold_12	46988616	46990133	NA	NA	NA	NA	NA
PGEN_.00g258120	Scaffold_12	47041335	47076330	P14740	DPP4_RAT	Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)]	GO:0001618; GO:0001662; GO:0001666; GO:0002020; GO:0002709; GO:0004252; GO:0005102; GO:0005518; GO:0005576; GO:0005783; GO:0005794; GO:0005886; GO:0006508; GO:0007155; GO:0008236; GO:0008239; GO:0008284; GO:0009986; GO:0010716; GO:0016021; GO:0016324; GO:0030027; GO:0030139; GO:0031258; GO:0031295; GO:0033632; GO:0035641; GO:0036343; GO:0042110; GO:0042277; GO:0042802; GO:0042803; GO:0043542; GO:0045121; GO:0046581; GO:0051234; GO:0071438	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]; behavioral fear response [GO:0001662]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; establishment of localization [GO:0051234]; locomotory exploration behavior [GO:0035641]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; psychomotor behavior [GO:0036343]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; regulation of T cell mediated immunity [GO:0002709]; response to hypoxia [GO:0001666]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]
PGEN_.00g258130	Scaffold_12	47079142	47080911	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g258140	Scaffold_12	47100219	47103824	NA	NA	NA	NA	NA
PGEN_.00g258150	Scaffold_12	47105776	47107003	Q9P215	POGK_HUMAN	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g258160	Scaffold_12	47124238	47130192	NA	NA	NA	NA	NA
PGEN_.00g258170	Scaffold_12	47130240	47145218	NA	NA	NA	NA	NA
PGEN_.00g258180	Scaffold_12	47145283	47162755	Q7Z9I4	YCP6_SCHPO	Uncharacterized oxidoreductase C663.06c (EC 1.-.-.-)	GO:0005634; GO:0005829; GO:0016491; GO:0110095	cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095]
PGEN_.00g258190	Scaffold_12	47166527	47181337	Q8TF76	HASP_HUMAN	Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase)	GO:0000278; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007064; GO:0035556; GO:0071459; GO:0072354; GO:2000751	"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]"
PGEN_.00g258200	Scaffold_12	47181445	47181672	NA	NA	NA	NA	NA
PGEN_.00g258210	Scaffold_12	47203731	47229291	Q5TCZ1	SPD2A_HUMAN	SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains)	GO:0001701; GO:0002020; GO:0002102; GO:0005546; GO:0005829; GO:0006801; GO:0010314; GO:0016176; GO:0030054; GO:0030198; GO:0032266; GO:0035091; GO:0042995; GO:0043325; GO:0070273; GO:0072675	"cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; podosome [GO:0002102]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protease binding [GO:0002020]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; osteoclast fusion [GO:0072675]; superoxide metabolic process [GO:0006801]"
PGEN_.00g258220	Scaffold_12	47234780	47236521	NA	NA	NA	NA	NA
PGEN_.00g258230	Scaffold_12	47254266	47288157	NA	NA	NA	NA	NA
PGEN_.00g258240	Scaffold_12	47292517	47300321	Q9H2C0	GAN_HUMAN	Gigaxonin (Kelch-like protein 16)	GO:0005737; GO:0005829; GO:0005856; GO:0007010; GO:0016567; GO:0031463; GO:0043687	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeleton organization [GO:0007010]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]
PGEN_.00g258250	Scaffold_12	47313099	47314184	Q03017	CACT_DROME	NF-kappa-B inhibitor cactus	GO:0002789; GO:0005737; GO:0005829; GO:0007253; GO:0007399; GO:0008063; GO:0009620; GO:0009950; GO:0009953; GO:0019730; GO:0030097; GO:0031594; GO:0045611; GO:0045751; GO:0046843; GO:0048477; GO:0051059	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; NF-kappaB binding [GO:0051059]; antimicrobial humoral response [GO:0019730]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; hemopoiesis [GO:0030097]; negative regulation of antifungal peptide production [GO:0002789]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of Toll signaling pathway [GO:0045751]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063]
PGEN_.00g258260	Scaffold_12	47327129	47332766	NA	NA	NA	NA	NA
PGEN_.00g258270	Scaffold_12	47332956	47333451	NA	NA	NA	NA	NA
PGEN_.00g258280	Scaffold_12	47338917	47340893	Q56R14	TRI33_XENLA	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g258290	Scaffold_12	47341838	47356538	Q32NV1	CTU2B_XENLA	Cytoplasmic tRNA 2-thiolation protein 2-B	GO:0000049; GO:0002098; GO:0005829; GO:0016779; GO:0032447; GO:0034227	cytosol [GO:0005829]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g258300	Scaffold_12	47363132	47363761	NA	NA	NA	NA	NA
PGEN_.00g258310	Scaffold_12	47421906	47428287	Q9NQP4	PFD4_HUMAN	Prefoldin subunit 4 (Protein C-1)	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082; GO:0051087	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]
PGEN_.00g258320	Scaffold_12	47438536	47443151	Q9VJ33	NEDD8_DROME	NEDD8 (Neddylin) (Ubiquitin-like protein Nedd8)	GO:0005634; GO:0005737; GO:0007275; GO:0008283; GO:0008589; GO:0019941; GO:0030162; GO:0030431; GO:0031386; GO:0031625; GO:0031647; GO:0036099; GO:0045116; GO:0051438; GO:2000736	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein tag [GO:0031386]; ubiquitin protein ligase binding [GO:0031625]; cell population proliferation [GO:0008283]; female germ-line stem cell population maintenance [GO:0036099]; modification-dependent protein catabolic process [GO:0019941]; multicellular organism development [GO:0007275]; protein neddylation [GO:0045116]; regulation of protein stability [GO:0031647]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589]; regulation of stem cell differentiation [GO:2000736]; regulation of ubiquitin-protein transferase activity [GO:0051438]; sleep [GO:0030431]
PGEN_.00g258330	Scaffold_12	47454795	47460751	NA	NA	NA	NA	NA
PGEN_.00g258340	Scaffold_12	47483526	47484707	P30939	5HT1F_HUMAN	5-hydroxytryptamine receptor 1F (5-HT-1F) (5-HT1F) (Serotonin receptor 1F)	GO:0004930; GO:0004993; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007193; GO:0007198; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0051378	"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]"
PGEN_.00g258350	Scaffold_12	47499202	47500431	P97718	ADA1A_MOUSE	Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor)	GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0003084; GO:0004935; GO:0004937; GO:0005623; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0007188; GO:0007200; GO:0007202; GO:0007204; GO:0007512; GO:0007568; GO:0009725; GO:0010460; GO:0010507; GO:0010613; GO:0016020; GO:0030018; GO:0030315; GO:0031965; GO:0032230; GO:0035024; GO:0035265; GO:0042493; GO:0043410; GO:0045760; GO:0045907; GO:0045987; GO:0046982; GO:0060073; GO:0060402; GO:0060452; GO:0061049; GO:0070374; GO:0071880; GO:0090037; GO:0097195; GO:0098691; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0150099; GO:1903997; GO:2000300	"caveola [GO:0005901]; cell [GO:0005623]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; adrenergic receptor activity [GO:0004935]; alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adult heart development [GO:0007512]; aging [GO:0007568]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; micturition [GO:0060073]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate [GO:0010460]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to drug [GO:0042493]; response to hormone [GO:0009725]"
PGEN_.00g258360	Scaffold_12	47501671	47502870	Q8ITC9	PK1R_DROME	Pyrokinin-1 receptor	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0036401; GO:0070328; GO:0090278	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]
PGEN_.00g258370	Scaffold_12	47510720	47511379	NA	NA	NA	NA	NA
PGEN_.00g258380	Scaffold_12	47516462	47523189	Q9NPA5	NA	NA	NA	NA
PGEN_.00g258390	Scaffold_12	47530855	47551230	Q9WYX8	Y508_THEMA	Uncharacterized protein TM_0508	GO:0003677; GO:0005524; GO:0006261; GO:0006281; GO:0006282; GO:0006310; GO:0008047; GO:0009378	ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; four-way junction helicase activity [GO:0009378]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; regulation of DNA repair [GO:0006282]
PGEN_.00g258400	Scaffold_12	47557323	47565343	Q54EQ8	NUP98_DICDI	Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (Nucleoporin Nup98); Nuclear pore complex protein Nup96 (Nucleoporin Nup96)]	GO:0000973; GO:0003723; GO:0005643; GO:0006405; GO:0006606; GO:0008139; GO:0017056; GO:0031965; GO:0034398; GO:0044614; GO:0051028; GO:0051292	nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]
PGEN_.00g258410	Scaffold_12	47564110	47565531	NA	NA	NA	NA	NA
PGEN_.00g258420	Scaffold_12	47568658	47570041	NA	NA	NA	NA	NA
PGEN_.00g258430	Scaffold_12	47589069	47589802	NA	NA	NA	NA	NA
PGEN_.00g258440	Scaffold_12	47591519	47599841	Q8R3S2	TSN33_MOUSE	Tetraspanin-33 (Tspan-33) (Penumbra) (mPen) (Proerythroblast new membrane)	GO:0005737; GO:0005886; GO:0005887; GO:0005912; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197]; enzyme binding [GO:0019899]; pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]
PGEN_.00g258450	Scaffold_12	47603594	47608728	NA	NA	NA	NA	NA
PGEN_.00g258460	Scaffold_12	47613647	47615506	Q8N695	SC5A8_HUMAN	Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)	GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]
PGEN_.00g258470	Scaffold_12	47625299	47630572	NA	NA	NA	NA	NA
PGEN_.00g258480	Scaffold_12	47715815	47726768	Q8IXQ6	PARP9_HUMAN	Protein mono-ADP-ribosyltransferase PARP9 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 9) (ARTD9) (B aggressive lymphoma protein) (Poly [ADP-ribose] polymerase 9) (PARP-9)	GO:0000122; GO:0002230; GO:0003714; GO:0003950; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006471; GO:0010608; GO:0010629; GO:0016020; GO:0016477; GO:0019899; GO:0032991; GO:0034356; GO:0035563; GO:0042393; GO:0042531; GO:0043086; GO:0044389; GO:0045087; GO:0045893; GO:0051607; GO:0060330; GO:0060335; GO:0072570; GO:0090734; GO:0097677; GO:1900182; GO:2001034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; ADP-D-ribose binding [GO:0072570]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; STAT family protein binding [GO:0097677]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein ligase binding [GO:0044389]; cell migration [GO:0016477]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of catalytic activity [GO:0043086]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; posttranscriptional regulation of gene expression [GO:0010608]; protein ADP-ribosylation [GO:0006471]; regulation of response to interferon-gamma [GO:0060330]"
PGEN_.00g258490	Scaffold_12	47730047	47745047	NA	NA	NA	NA	NA
PGEN_.00g258500	Scaffold_12	47761240	47770660	Q8IZC4	RTKN2_HUMAN	Rhotekin-2 (Pleckstrin homology domain-containing family K member 1) (PH domain-containing family K member 1)	GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0008284; GO:0030097; GO:0051092; GO:1901224; GO:2001243	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]
PGEN_.00g258510	Scaffold_12	47778840	47780426	NA	NA	NA	NA	NA
PGEN_.00g258520	Scaffold_12	47809784	47815233	NA	NA	NA	NA	NA
PGEN_.00g258530	Scaffold_12	47819800	47832936	NA	NA	NA	NA	NA
PGEN_.00g258540	Scaffold_12	47863911	47873468	NA	NA	NA	NA	NA
PGEN_.00g258550	Scaffold_12	47875878	47904594	Q0VAA2	LR74A_HUMAN	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g258560	Scaffold_12	47911389	47919607	P36633	AOC1_RAT	Amiloride-sensitive amine oxidase [copper-containing] (DAO) (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase)	GO:0005507; GO:0005509; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008144; GO:0008201; GO:0008270; GO:0009308; GO:0035874; GO:0042493; GO:0042803; GO:0044877; GO:0046677; GO:0048038; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0055114; GO:0070062; GO:0071280; GO:0071420; GO:0097185	"bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; drug binding [GO:0008144]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]; amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to histamine [GO:0071420]; oxidation-reduction process [GO:0055114]; response to antibiotic [GO:0046677]; response to drug [GO:0042493]"
PGEN_.00g258570	Scaffold_12	47929396	47935613	NA	NA	NA	NA	NA
PGEN_.00g258580	Scaffold_12	47986488	47986853	NA	NA	NA	NA	NA
PGEN_.00g258590	Scaffold_12	47996714	47997124	NA	NA	NA	NA	NA
PGEN_.00g258600	Scaffold_12	48002160	48002459	NA	NA	NA	NA	NA
PGEN_.00g258610	Scaffold_12	48102721	48103673	NA	NA	NA	NA	NA
PGEN_.00g258620	Scaffold_12	48107787	48108074	NA	NA	NA	NA	NA
PGEN_.00g258630	Scaffold_12	48111776	48112087	NA	NA	NA	NA	NA
PGEN_.00g258640	Scaffold_12	48124546	48142548	Q5EAY8	TAPT1_XENLA	Transmembrane anterior posterior transformation protein 1 homolog	GO:0001503; GO:0005737; GO:0005813; GO:0014032; GO:0016021; GO:0030030; GO:0036064; GO:0045724; GO:0051216; GO:0061036; GO:1903012	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; cartilage development [GO:0051216]; cell projection organization [GO:0030030]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724]
PGEN_.00g258650	Scaffold_12	48195902	48202570	NA	NA	NA	NA	NA
PGEN_.00g258660	Scaffold_12	48226025	48226976	NA	NA	NA	NA	NA
PGEN_.00g258670	Scaffold_12	48232783	48234810	NA	NA	NA	NA	NA
PGEN_.00g258680	Scaffold_12	48235444	48248789	NA	NA	NA	NA	NA
PGEN_.00g258690	Scaffold_12	48255541	48256200	NA	NA	NA	NA	NA
PGEN_.00g258700	Scaffold_12	48256248	48256550	NA	NA	NA	NA	NA
PGEN_.00g258710	Scaffold_12	48265932	48270880	NA	NA	NA	NA	NA
PGEN_.00g258720	Scaffold_12	48274538	48276436	NA	NA	NA	NA	NA
PGEN_.00g258730	Scaffold_12	48285804	48286421	NA	NA	NA	NA	NA
PGEN_.00g258740	Scaffold_12	48309027	48327379	O60502	OGA_HUMAN	Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT)	GO:0004415; GO:0005634; GO:0005829; GO:0006044; GO:0006493; GO:0006516; GO:0006517; GO:0009100; GO:0016020; GO:0016032; GO:0016231; GO:0102166; GO:0102167; GO:0102571	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]; viral process [GO:0016032]
PGEN_.00g258750	Scaffold_12	48345586	48354482	NA	NA	NA	NA	NA
PGEN_.00g258760	Scaffold_12	48372808	48389034	NA	NA	NA	NA	NA
PGEN_.00g258770	Scaffold_12	48425548	48429778	P97503	NKX32_MOUSE	Homeobox protein Nkx-3.2 (Bagpipe homeobox protein homolog 1) (Homeobox protein NK-3 homolog B)	GO:0000122; GO:0000978; GO:0001227; GO:0001501; GO:0003700; GO:0005634; GO:0005654; GO:0007368; GO:0030154; GO:0031016; GO:0032331; GO:0042474; GO:0043066; GO:0043565; GO:0045944; GO:0048513; GO:0048536; GO:0048645; GO:0048705; GO:0048706; GO:0055123; GO:0060576	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; animal organ development [GO:0048513]; animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; digestive system development [GO:0055123]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]"
PGEN_.00g258780	Scaffold_12	48438275	48453621	NA	NA	NA	NA	NA
PGEN_.00g258790	Scaffold_12	48453653	48460278	NA	NA	NA	NA	NA
PGEN_.00g258800	Scaffold_12	48469355	48483208	NA	NA	NA	NA	NA
PGEN_.00g258810	Scaffold_12	48520024	48520413	NA	NA	NA	NA	NA
PGEN_.00g258820	Scaffold_12	48536013	48540335	P09838	TDT_MOUSE	DNA nucleotidylexotransferase (EC 2.7.7.31) (EC 3.1.11.-) (Terminal addition enzyme) (Terminal deoxynucleotidyltransferase) (TDT) (Terminal transferase)	GO:0000790; GO:0000791; GO:0003677; GO:0003887; GO:0003912; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006259; GO:0006284; GO:0006303; GO:0006304; GO:0016363; GO:0016787; GO:0033198; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA nucleotidylexotransferase activity [GO:0003912]; DNA-directed DNA polymerase activity [GO:0003887]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; double-strand break repair via nonhomologous end joining [GO:0006303]; response to ATP [GO:0033198]
PGEN_.00g258830	Scaffold_12	48545233	48606485	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g258840	Scaffold_12	48668759	48674554	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g258850	Scaffold_12	48684551	48686912	NA	NA	NA	NA	NA
PGEN_.00g258860	Scaffold_12	48687905	48700294	O43174	CP26A_HUMAN	Cytochrome P450 26A1 (EC 1.14.13.-) (Cytochrome P450 retinoic acid-inactivating 1) (Cytochrome P450RAI) (hP450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome)	GO:0000249; GO:0001822; GO:0001972; GO:0004497; GO:0005506; GO:0005789; GO:0006696; GO:0006766; GO:0006805; GO:0008401; GO:0016125; GO:0016709; GO:0019825; GO:0020037; GO:0032526; GO:0033189; GO:0034653; GO:0042573; GO:0048387; GO:0055114	"endoplasmic reticulum membrane [GO:0005789]; C-22 sterol desaturase activity [GO:0000249]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; ergosterol biosynthetic process [GO:0006696]; kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; oxidation-reduction process [GO:0055114]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g258870	Scaffold_12	48707110	48723608	Q5ZKD5	RRP12_CHICK	RRP12-like protein	GO:0005730; GO:0016021; GO:0031965	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]
PGEN_.00g258880	Scaffold_12	48739927	48758930	Q6P5B0	RRP12_MOUSE	RRP12-like protein	GO:0005730; GO:0005829; GO:0005886; GO:0016021; GO:0031965; GO:0043231	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]
PGEN_.00g258890	Scaffold_12	48764137	48770398	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g258900	Scaffold_12	48777921	48781482	Q90632	MOT3_CHICK	Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8)	GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g258910	Scaffold_12	48786953	48797606	Q9Z2E3	ERN2_MOUSE	Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (Ire1-beta) (IRE1b) (mIre1) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	GO:0000287; GO:0004519; GO:0004521; GO:0004672; GO:0004674; GO:0005524; GO:0005789; GO:0006355; GO:0006397; GO:0006468; GO:0007050; GO:0007257; GO:0016021; GO:0016075; GO:0030263; GO:0030968; GO:0034976; GO:0036498; GO:0045892; GO:0051082; GO:0070059; GO:1990604	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; apoptotic chromosome condensation [GO:0030263]; cell cycle arrest [GO:0007050]; endoplasmic reticulum unfolded protein response [GO:0030968]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]"
PGEN_.00g258920	Scaffold_12	48808139	48817239	Q9Z2E3	ERN2_MOUSE	Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (Ire1-beta) (IRE1b) (mIre1) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	GO:0000287; GO:0004519; GO:0004521; GO:0004672; GO:0004674; GO:0005524; GO:0005789; GO:0006355; GO:0006397; GO:0006468; GO:0007050; GO:0007257; GO:0016021; GO:0016075; GO:0030263; GO:0030968; GO:0034976; GO:0036498; GO:0045892; GO:0051082; GO:0070059; GO:1990604	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; apoptotic chromosome condensation [GO:0030263]; cell cycle arrest [GO:0007050]; endoplasmic reticulum unfolded protein response [GO:0030968]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]"
PGEN_.00g258930	Scaffold_12	48892915	48897020	P48181	ACH2_CAEEL	Acetylcholine receptor subunit beta-type unc-29 (Uncoordinated protein 29)	GO:0004888; GO:0005887; GO:0006937; GO:0007165; GO:0007268; GO:0007274; GO:0014057; GO:0022848; GO:0030054; GO:0034220; GO:0040011; GO:0042391; GO:0043005; GO:0043025; GO:0043051; GO:0045202; GO:0045211; GO:0046662; GO:0050877	"cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; locomotion [GO:0040011]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]; signal transduction [GO:0007165]"
PGEN_.00g258940	Scaffold_12	48897090	48897518	P04756	ACHA_MOUSE	Acetylcholine receptor subunit alpha	GO:0003009; GO:0004888; GO:0005623; GO:0005886; GO:0005887; GO:0005892; GO:0006812; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007528; GO:0009986; GO:0016020; GO:0019228; GO:0022848; GO:0030054; GO:0031594; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0046716; GO:0048630; GO:0050877; GO:0050881; GO:0050905; GO:0070050; GO:0099060; GO:1904315	"acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell cellular homeostasis [GO:0046716]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neuronal action potential [GO:0019228]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g258950	Scaffold_12	48910685	48928497	A8WHP3	SC5A9_DANRE	Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (Solute carrier family 5 member 9)	GO:0005412; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]
PGEN_.00g258960	Scaffold_12	48932359	48934959	NA	NA	NA	NA	NA
PGEN_.00g258970	Scaffold_12	48943287	48970059	Q923S6	NEUL1_MOUSE	E3 ubiquitin-protein ligase NEURL1 (EC 2.3.2.27) (Neuralized-like protein 1A) (m-neu1) (m-neuralized 1) (Neuralized1) (RING-type E3 ubiquitin transferase NEURL1)	GO:0004842; GO:0005737; GO:0005886; GO:0006513; GO:0007219; GO:0007288; GO:0007399; GO:0007420; GO:0007519; GO:0007595; GO:0008285; GO:0014069; GO:0030054; GO:0030317; GO:0043065; GO:0043197; GO:0043204; GO:0045183; GO:0045741; GO:0045746; GO:0046872; GO:0048170; GO:0048471; GO:0051491; GO:0060999; GO:0061630; GO:0071230; GO:0090129; GO:0097440	"apical dendrite [GO:0097440]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; metal ion binding [GO:0046872]; translation factor activity, non-nucleic acid binding [GO:0045183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; flagellated sperm motility [GO:0030317]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288]"
PGEN_.00g258980	Scaffold_12	48972662	48980116	NA	NA	NA	NA	NA
PGEN_.00g258990	Scaffold_12	48992686	49006880	Q9QYF1	RDH11_MOUSE	Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (Cell line MC/9.IL4-derived protein 1) (M42C60) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short-chain aldehyde dehydrogenase) (SCALD)	GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0016021; GO:0016062; GO:0033721; GO:0042572; GO:0042574; GO:0052650; GO:0110095	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; aldehyde dehydrogenase (NADP+) activity [GO:0033721]; NADP-retinol dehydrogenase activity [GO:0052650]; retinol dehydrogenase activity [GO:0004745]; adaptation of rhodopsin mediated signaling [GO:0016062]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]
PGEN_.00g259000	Scaffold_12	49015640	49027925	Q9GR88	ERF1_POLMI	Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1)	GO:0003747; GO:0005737	cytoplasm [GO:0005737]; translation release factor activity [GO:0003747]
PGEN_.00g259010	Scaffold_12	49036408	49038051	NA	NA	NA	NA	NA
PGEN_.00g259020	Scaffold_12	49040781	49041383	NA	NA	NA	NA	NA
PGEN_.00g259030	Scaffold_12	49046506	49051118	Q07001	ACHD_HUMAN	Acetylcholine receptor subunit delta	GO:0003009; GO:0004888; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005892; GO:0006936; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0031594; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0048630; GO:0050877; GO:0050881; GO:0050905; GO:0099060; GO:1904315	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle contraction [GO:0006936]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g259040	Scaffold_12	49056195	49072802	Q3SZL5	PIGS_BOVIN	GPI transamidase component PIG-S (Phosphatidylinositol-glycan biosynthesis class S protein)	GO:0016255; GO:0042765	GPI-anchor transamidase complex [GO:0042765]; attachment of GPI anchor to protein [GO:0016255]
PGEN_.00g259050	Scaffold_12	49075833	49116575	Q0IH24	SPEF1_XENLA	Sperm flagellar protein 1	GO:0005930; GO:0007026; GO:0008017; GO:0016477	axoneme [GO:0005930]; microtubule binding [GO:0008017]; cell migration [GO:0016477]; negative regulation of microtubule depolymerization [GO:0007026]
PGEN_.00g259060	Scaffold_12	49121297	49126606	NA	NA	NA	NA	NA
PGEN_.00g259070	Scaffold_12	49173118	49174186	NA	NA	NA	NA	NA
PGEN_.00g259080	Scaffold_12	49175364	49192614	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g259090	Scaffold_12	49197468	49235693	Q969W1	ZDH16_HUMAN	Palmitoyltransferase ZDHHC16 (EC 2.3.1.225) (Abl-philin 2) (Zinc finger DHHC domain-containing protein 16) (DHHC-16)	GO:0001654; GO:0005789; GO:0005794; GO:0006915; GO:0006974; GO:0007507; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0021537	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537]
PGEN_.00g259100	Scaffold_12	49244807	49270256	O96028	NSD2_HUMAN	Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.-) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein)	GO:0000122; GO:0000785; GO:0000981; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006303; GO:0006355; GO:0042799; GO:0043565; GO:0046872; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:2001032	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; double-strand break repair via nonhomologous end joining [GO:0006303]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g259110	Scaffold_12	49282970	49346357	Q99666	RGPD5_HUMAN	RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63)	GO:0005634; GO:0005643; GO:0005737; GO:0006607; GO:0008536; GO:0043547	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of GTPase activity [GO:0043547]
PGEN_.00g259120	Scaffold_12	49354940	49380084	Q8NB25	F184A_HUMAN	Protein FAM184A	GO:0005615	extracellular space [GO:0005615]
PGEN_.00g259130	Scaffold_12	49382976	49402461	Q8CGE9	RGS12_MOUSE	Regulator of G-protein signaling 12 (RGS12)	GO:0001965; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0030054; GO:0030425; GO:0030695; GO:0032991; GO:0038032; GO:0043025; GO:0045202; GO:0097440	apical dendrite [GO:0097440]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; signal transduction [GO:0007165]; termination of G protein-coupled receptor signaling pathway [GO:0038032]
PGEN_.00g259140	Scaffold_12	49414187	49414552	NA	NA	NA	NA	NA
PGEN_.00g259150	Scaffold_12	49420286	49444879	O08774	RGS12_RAT	Regulator of G-protein signaling 12 (RGS12)	GO:0001965; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0030054; GO:0030425; GO:0030695; GO:0032991; GO:0038032; GO:0043025; GO:0045202; GO:0045744; GO:0097440	apical dendrite [GO:0097440]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; signal transduction [GO:0007165]; termination of G protein-coupled receptor signaling pathway [GO:0038032]
PGEN_.00g259160	Scaffold_12	49455015	49462828	Q9NWW7	CB042_HUMAN	Uncharacterized protein C2orf42	GO:0005634; GO:0005654; GO:0031965	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
PGEN_.00g259170	Scaffold_12	49529384	49538457	NA	NA	NA	NA	NA
PGEN_.00g259180	Scaffold_12	49538979	49567797	Q8N9I9	DTX3_HUMAN	Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING finger protein 154) (RING-type E3 ubiquitin transferase DTX3)	GO:0005737; GO:0007219; GO:0016567; GO:0016740; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g259190	Scaffold_12	49567829	49576492	NA	NA	NA	NA	NA
PGEN_.00g259200	Scaffold_12	49597522	49599889	NA	NA	NA	NA	NA
PGEN_.00g259210	Scaffold_12	49629583	49639647	Q9UN76	S6A14_HUMAN	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) (Amino acid transporter ATB0+) (Solute carrier family 6 member 14)	GO:0003333; GO:0005328; GO:0005886; GO:0006865; GO:0009636; GO:0015171; GO:0016021; GO:0031982; GO:0070062	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; amino acid transmembrane transporter activity [GO:0015171]; neurotransmitter:sodium symporter activity [GO:0005328]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; response to toxic substance [GO:0009636]
PGEN_.00g259220	Scaffold_12	49647221	49653111	NA	NA	NA	NA	NA
PGEN_.00g259230	Scaffold_12	49657207	49659039	NA	NA	NA	NA	NA
PGEN_.00g259240	Scaffold_12	49699760	49724757	NA	NA	NA	NA	NA
PGEN_.00g259250	Scaffold_12	49734907	49735614	NA	NA	NA	NA	NA
PGEN_.00g259260	Scaffold_12	49752448	49770135	O14639	ABLM1_HUMAN	Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin)	GO:0001725; GO:0003779; GO:0005737; GO:0007010; GO:0007601; GO:0009887; GO:0015629; GO:0030027; GO:0030032; GO:0046872; GO:0051015; GO:0060271	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; visual perception [GO:0007601]
PGEN_.00g259270	Scaffold_12	49790592	49794810	P46825	KLC_DORPE	Kinesin light chain (KLC)	GO:0003777; GO:0005737; GO:0005871; GO:0005874	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule motor activity [GO:0003777]
PGEN_.00g259280	Scaffold_12	49888855	49898248	NA	NA	NA	NA	NA
PGEN_.00g259290	Scaffold_12	49898285	49901591	NA	NA	NA	NA	NA
PGEN_.00g259300	Scaffold_12	49909001	49909288	NA	NA	NA	NA	NA
PGEN_.00g259310	Scaffold_12	49909432	49909974	NA	NA	NA	NA	NA
PGEN_.00g259320	Scaffold_12	49910046	49910330	NA	NA	NA	NA	NA
PGEN_.00g259330	Scaffold_12	49926856	49932875	NA	NA	NA	NA	NA
PGEN_.00g259340	Scaffold_12	50005173	50023132	NA	NA	NA	NA	NA
PGEN_.00g259350	Scaffold_12	50050184	50057109	Q8R3C6	RBM19_MOUSE	Probable RNA-binding protein 19 (RNA-binding motif protein 19)	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0007275; GO:0016607; GO:0040019; GO:0045292	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"
PGEN_.00g259360	Scaffold_12	50073545	50075749	NA	NA	NA	NA	NA
PGEN_.00g259370	Scaffold_12	50086279	50086581	NA	NA	NA	NA	NA
PGEN_.00g259380	Scaffold_12	50097680	50120972	Q5PQR6	THEGL_RAT	Testicular haploid expressed gene protein-like		
PGEN_.00g259390	Scaffold_12	50124099	50126047	NA	NA	NA	NA	NA
PGEN_.00g259400	Scaffold_12	50140267	50161308	Q0VCA3	LETM1_BOVIN	Mitochondrial proton/calcium exchanger protein (Leucine zipper-EF-hand-containing transmembrane protein 1)	GO:0005509; GO:0005623; GO:0005743; GO:0006851; GO:0015369; GO:0016021; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0051562; GO:0099093; GO:1900069	cell [GO:0005623]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022]; calcium export from the mitochondrion [GO:0099093]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069]
PGEN_.00g259410	Scaffold_12	50169742	50181495	NA	NA	NA	NA	NA
PGEN_.00g259420	Scaffold_12	50181533	50182950	NA	NA	NA	NA	NA
PGEN_.00g259430	Scaffold_12	50183760	50187093	NA	NA	NA	NA	NA
PGEN_.00g259440	Scaffold_12	50187194	50187830	NA	NA	NA	NA	NA
PGEN_.00g259450	Scaffold_12	50194713	50196859	NA	NA	NA	NA	NA
PGEN_.00g259460	Scaffold_12	50196973	50198712	NA	NA	NA	NA	NA
PGEN_.00g259470	Scaffold_12	50199301	50209285	NA	NA	NA	NA	NA
PGEN_.00g259480	Scaffold_12	50217087	50224320	NA	NA	NA	NA	NA
PGEN_.00g259490	Scaffold_12	50233002	50236356	NA	NA	NA	NA	NA
PGEN_.00g259500	Scaffold_12	50248167	50262258	P41436	IAP_GVCPM	Apoptosis inhibitor IAP	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g259510	Scaffold_12	50268911	50271106	NA	NA	NA	NA	NA
PGEN_.00g259520	Scaffold_12	50283938	50287549	NA	NA	NA	NA	NA
PGEN_.00g259530	Scaffold_12	50345296	50356586	NA	NA	NA	NA	NA
PGEN_.00g259540	Scaffold_12	50379096	50400292	NA	NA	NA	NA	NA
PGEN_.00g259550	Scaffold_12	50402077	50405917	NA	NA	NA	NA	NA
PGEN_.00g259560	Scaffold_12	50406419	50407562	NA	NA	NA	NA	NA
PGEN_.00g259570	Scaffold_12	50407607	50408185	NA	NA	NA	NA	NA
PGEN_.00g259580	Scaffold_13	5120	11062	NA	NA	NA	NA	NA
PGEN_.00g259590	Scaffold_13	11114	11347	NA	NA	NA	NA	NA
PGEN_.00g259600	Scaffold_13	39475	45301	NA	NA	NA	NA	NA
PGEN_.00g259610	Scaffold_13	62051	77102	NA	NA	NA	NA	NA
PGEN_.00g259620	Scaffold_13	97030	101409	NA	NA	NA	NA	NA
PGEN_.00g259630	Scaffold_13	103283	106981	NA	NA	NA	NA	NA
PGEN_.00g259640	Scaffold_13	110520	111104	NA	NA	NA	NA	NA
PGEN_.00g259650	Scaffold_13	111953	124247	NA	NA	NA	NA	NA
PGEN_.00g259660	Scaffold_13	124448	124675	NA	NA	NA	NA	NA
PGEN_.00g259670	Scaffold_13	124701	125033	NA	NA	NA	NA	NA
PGEN_.00g259680	Scaffold_13	125108	127688	NA	NA	NA	NA	NA
PGEN_.00g259690	Scaffold_13	134650	134913	NA	NA	NA	NA	NA
PGEN_.00g259700	Scaffold_13	165980	166321	NA	NA	NA	NA	NA
PGEN_.00g259710	Scaffold_13	193343	196837	NA	NA	NA	NA	NA
PGEN_.00g259720	Scaffold_13	212307	212651	NA	NA	NA	NA	NA
PGEN_.00g259730	Scaffold_13	212807	213229	NA	NA	NA	NA	NA
PGEN_.00g259740	Scaffold_13	213706	217139	NA	NA	NA	NA	NA
PGEN_.00g259750	Scaffold_13	253331	260720	NA	NA	NA	NA	NA
PGEN_.00g259760	Scaffold_13	260781	261095	NA	NA	NA	NA	NA
PGEN_.00g259770	Scaffold_13	263491	269082	NA	NA	NA	NA	NA
PGEN_.00g259780	Scaffold_13	278468	291382	D9IQ16	GXN_ACRMI	Galaxin	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g259790	Scaffold_13	291983	293395	NA	NA	NA	NA	NA
PGEN_.00g259800	Scaffold_13	311350	344241	P11584	ITBX_DROME	Integrin beta-PS (Position-specific antigen beta subunit) (Protein myospheroid) (Protein olfactory C)	GO:0003344; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0005927; GO:0006930; GO:0007015; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007377; GO:0007391; GO:0007411; GO:0007417; GO:0007419; GO:0007431; GO:0007475; GO:0007494; GO:0007508; GO:0007517; GO:0007601; GO:0007608; GO:0007629; GO:0008305; GO:0008340; GO:0008360; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016339; GO:0016340; GO:0016477; GO:0021551; GO:0030336; GO:0030425; GO:0030718; GO:0031252; GO:0031589; GO:0033627; GO:0034446; GO:0035001; GO:0035099; GO:0035160; GO:0042734; GO:0043034; GO:0045211; GO:0045214; GO:0046982; GO:0048803; GO:0051492; GO:0090129	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth, open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601]"
PGEN_.00g259810	Scaffold_13	359603	364922	NA	NA	NA	NA	NA
PGEN_.00g259820	Scaffold_13	372104	378173	Q4R6W9	SNPC1_MACFA	snRNA-activating protein complex subunit 1 (SNAPc subunit 1) (Small nuclear RNA-activating complex polypeptide 1) (snRNA-activating protein complex 43 kDa subunit) (SNAPc 43 kDa subunit)	GO:0003677; GO:0005654; GO:0005730	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]
PGEN_.00g259830	Scaffold_13	387037	389601	NA	NA	NA	NA	NA
PGEN_.00g259840	Scaffold_13	399257	417278	Q2PZI1	D19L1_HUMAN	Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1)	GO:0000030; GO:0005637; GO:0016020; GO:0016021; GO:0018406	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]
PGEN_.00g259850	Scaffold_13	417740	419197	NA	NA	NA	NA	NA
PGEN_.00g259860	Scaffold_13	419294	419959	NA	NA	NA	NA	NA
PGEN_.00g259870	Scaffold_13	421162	421587	NA	NA	NA	NA	NA
PGEN_.00g259880	Scaffold_13	424588	442148	Q2PZI1	D19L1_HUMAN	Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1)	GO:0000030; GO:0005637; GO:0016020; GO:0016021; GO:0018406	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]
PGEN_.00g259890	Scaffold_13	442514	455783	A4D263	SPT48_HUMAN	Spermatogenesis-associated protein 48		
PGEN_.00g259900	Scaffold_13	458680	470735	Q08CH6	CATIP_DANRE	Ciliogenesis-associated TTC17-interacting protein	GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0060271; GO:0061371	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]
PGEN_.00g259910	Scaffold_13	475991	523016	Q9NVE5	UBP40_HUMAN	Ubiquitin carboxyl-terminal hydrolase 40 (EC 3.4.19.12) (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40)	GO:0004197; GO:0004843; GO:0006511; GO:0016579	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g259920	Scaffold_13	562517	563999	NA	NA	NA	NA	NA
PGEN_.00g259930	Scaffold_13	568004	579560	Q9UG63	ABCF2_HUMAN	ATP-binding cassette sub-family F member 2 (Iron-inhibited ABC transporter 2)	GO:0005524; GO:0016020; GO:0016887	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]
PGEN_.00g259940	Scaffold_13	589600	597947	Q6PWL5	TEBP_MACFA	Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES)	GO:0001516; GO:0005737; GO:0050220	cytoplasm [GO:0005737]; prostaglandin-E synthase activity [GO:0050220]; prostaglandin biosynthetic process [GO:0001516]
PGEN_.00g259950	Scaffold_13	600857	601373	NA	NA	NA	NA	NA
PGEN_.00g259960	Scaffold_13	613918	628831	Q8IVI9	NOSTN_HUMAN	Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer)	GO:0003677; GO:0005634; GO:0005856; GO:0005886; GO:0006897; GO:0030666; GO:0045892; GO:0050999	"cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]"
PGEN_.00g259970	Scaffold_13	637202	641353	NA	NA	NA	NA	NA
PGEN_.00g259980	Scaffold_13	643400	646177	Q25390	SCRA_LIMPO	Alpha-scruin		
PGEN_.00g259990	Scaffold_13	661264	670350	Q8WWB3	DYDC1_HUMAN	DPY30 domain-containing protein 1	GO:0044666; GO:0048188; GO:0051568	MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568]
PGEN_.00g260000	Scaffold_13	672671	677103	NA	NA	NA	NA	NA
PGEN_.00g260010	Scaffold_13	679237	823740	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g260020	Scaffold_13	803872	804792	NA	NA	NA	NA	NA
PGEN_.00g260030	Scaffold_13	837197	838851	NA	NA	NA	NA	NA
PGEN_.00g260040	Scaffold_13	838876	856851	Q8N9W6	BOLL_HUMAN	Protein boule-like	GO:0003730; GO:0005737; GO:0007275; GO:0007283; GO:0008494; GO:0030154; GO:0045948; GO:0051321; GO:0070935	cytoplasm [GO:0005737]; mRNA 3'-UTR binding [GO:0003730]; translation activator activity [GO:0008494]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283]
PGEN_.00g260050	Scaffold_13	858741	869118	NA	NA	NA	NA	NA
PGEN_.00g260060	Scaffold_13	869988	878217	NA	NA	NA	NA	NA
PGEN_.00g260070	Scaffold_13	882647	885584	NA	NA	NA	NA	NA
PGEN_.00g260080	Scaffold_13	887344	898126	NA	NA	NA	NA	NA
PGEN_.00g260090	Scaffold_13	914836	925056	NA	NA	NA	NA	NA
PGEN_.00g260100	Scaffold_13	930822	937379	NA	NA	NA	NA	NA
PGEN_.00g260110	Scaffold_13	982329	983610	NA	NA	NA	NA	NA
PGEN_.00g260120	Scaffold_13	994460	1001547	Q86JG6	CLN5A_DICDI	Cln5-like protein 1	GO:0005764; GO:0016021	integral component of membrane [GO:0016021]; lysosome [GO:0005764]
PGEN_.00g260130	Scaffold_13	1022696	1034254	Q62773	S28A2_RAT	Sodium/nucleoside cotransporter 2 (Concentrative nucleoside transporter 2) (CNT 2) (rCNT2) (Na(+)/nucleoside cotransporter 2) (Sodium-coupled nucleoside transporter 2) (Sodium/purine nucleoside cotransporter) (SPNT) (Solute carrier family 28 member 2)	GO:0001895; GO:0005337; GO:0005415; GO:0005887; GO:0015211; GO:0034394; GO:1901642	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleoside transmembrane transporter activity [GO:0015211]; nucleoside transmembrane transport [GO:1901642]; protein localization to cell surface [GO:0034394]; retina homeostasis [GO:0001895]
PGEN_.00g260140	Scaffold_13	1064875	1076042	Q9ERH8	S28A3_MOUSE	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (mCNT3)	GO:0001895; GO:0005337; GO:0005415; GO:0005887; GO:0015389; GO:0015390; GO:0015860; GO:0015864; GO:1901642	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; nucleoside transmembrane transport [GO:1901642]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; retina homeostasis [GO:0001895]
PGEN_.00g260150	Scaffold_13	1079508	1081547	P16112	PGCA_HUMAN	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2]	GO:0001501; GO:0001502; GO:0002063; GO:0005201; GO:0005540; GO:0005576; GO:0005604; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0007507; GO:0018146; GO:0030166; GO:0030198; GO:0030199; GO:0030246; GO:0031012; GO:0042340; GO:0043202; GO:0046872; GO:0062023; GO:0098966; GO:0098978; GO:0098982	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perisynaptic extracellular matrix [GO:0098966]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate catabolic process [GO:0042340]; proteoglycan biosynthetic process [GO:0030166]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]
PGEN_.00g260160	Scaffold_13	1096404	1112421	Q8VIH3	S28A3_RAT	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (rCNT3)	GO:0001895; GO:0005337; GO:0005415; GO:0005887; GO:0015389; GO:0015390; GO:0015860; GO:0015864; GO:1901642	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; nucleoside transmembrane transport [GO:1901642]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; retina homeostasis [GO:0001895]
PGEN_.00g260170	Scaffold_13	1118043	1123536	P55067	NCAN_RAT	Neurocan core protein (245 kDa early postnatal core glycoprotein) (Chondroitin sulfate proteoglycan 3) [Cleaved into: 150 kDa adult core glycoprotein]	GO:0001501; GO:0005509; GO:0005540; GO:0005886; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0045202; GO:0051823; GO:0072534	extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]
PGEN_.00g260180	Scaffold_13	1144586	1146683	NA	NA	NA	NA	NA
PGEN_.00g260190	Scaffold_13	1146843	1147130	NA	NA	NA	NA	NA
PGEN_.00g260200	Scaffold_13	1148190	1156169	NA	NA	NA	NA	NA
PGEN_.00g260210	Scaffold_13	1158311	1166275	NA	NA	NA	NA	NA
PGEN_.00g260220	Scaffold_13	1167334	1167621	NA	NA	NA	NA	NA
PGEN_.00g260230	Scaffold_13	1167781	1169848	NA	NA	NA	NA	NA
PGEN_.00g260240	Scaffold_13	1190965	1196458	P55067	NCAN_RAT	Neurocan core protein (245 kDa early postnatal core glycoprotein) (Chondroitin sulfate proteoglycan 3) [Cleaved into: 150 kDa adult core glycoprotein]	GO:0001501; GO:0005509; GO:0005540; GO:0005886; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0045202; GO:0051823; GO:0072534	extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]
PGEN_.00g260250	Scaffold_13	1202080	1218140	Q8VIH3	S28A3_RAT	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (rCNT3)	GO:0001895; GO:0005337; GO:0005415; GO:0005887; GO:0015389; GO:0015390; GO:0015860; GO:0015864; GO:1901642	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; nucleoside transmembrane transport [GO:1901642]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; retina homeostasis [GO:0001895]
PGEN_.00g260260	Scaffold_13	1232996	1235035	P16112	PGCA_HUMAN	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2]	GO:0001501; GO:0001502; GO:0002063; GO:0005201; GO:0005540; GO:0005576; GO:0005604; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0007507; GO:0018146; GO:0030166; GO:0030198; GO:0030199; GO:0030246; GO:0031012; GO:0042340; GO:0043202; GO:0046872; GO:0062023; GO:0098966; GO:0098978; GO:0098982	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perisynaptic extracellular matrix [GO:0098966]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate catabolic process [GO:0042340]; proteoglycan biosynthetic process [GO:0030166]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]
PGEN_.00g260270	Scaffold_13	1238501	1249655	Q9ERH8	S28A3_MOUSE	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (mCNT3)	GO:0001895; GO:0005337; GO:0005415; GO:0005887; GO:0015389; GO:0015390; GO:0015860; GO:0015864; GO:1901642	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; nucleoside transmembrane transport [GO:1901642]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; retina homeostasis [GO:0001895]
PGEN_.00g260280	Scaffold_13	1279806	1291295	Q9UA35	S28A3_EPTST	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)	GO:0005337; GO:0005887	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]
PGEN_.00g260290	Scaffold_13	1316711	1323843	Q86JG6	CLN5A_DICDI	Cln5-like protein 1	GO:0005764; GO:0016021	integral component of membrane [GO:0016021]; lysosome [GO:0005764]
PGEN_.00g260300	Scaffold_13	1335209	1335661	NA	NA	NA	NA	NA
PGEN_.00g260310	Scaffold_13	1380182	1384357	NA	NA	NA	NA	NA
PGEN_.00g260320	Scaffold_13	1384642	1386323	NA	NA	NA	NA	NA
PGEN_.00g260330	Scaffold_13	1387806	1398077	NA	NA	NA	NA	NA
PGEN_.00g260340	Scaffold_13	1414783	1425435	NA	NA	NA	NA	NA
PGEN_.00g260350	Scaffold_13	1427195	1430132	NA	NA	NA	NA	NA
PGEN_.00g260360	Scaffold_13	1434290	1442527	NA	NA	NA	NA	NA
PGEN_.00g260370	Scaffold_13	1443397	1453759	NA	NA	NA	NA	NA
PGEN_.00g260380	Scaffold_13	1455649	1473655	Q8N9W6	BOLL_HUMAN	Protein boule-like	GO:0003730; GO:0005737; GO:0007275; GO:0007283; GO:0008494; GO:0030154; GO:0045948; GO:0051321; GO:0070935	cytoplasm [GO:0005737]; mRNA 3'-UTR binding [GO:0003730]; translation activator activity [GO:0008494]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283]
PGEN_.00g260390	Scaffold_13	1473680	1475332	NA	NA	NA	NA	NA
PGEN_.00g260400	Scaffold_13	1485699	1632381	Q96M86	DNHD1_HUMAN	Dynein heavy chain domain-containing protein 1 (Dynein heavy chain domain 1-like protein) (Protein CCDC35)	GO:0005524; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0070062	"axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g260410	Scaffold_13	1634510	1639159	NA	NA	NA	NA	NA
PGEN_.00g260420	Scaffold_13	1641483	1650418	Q8WWB3	DYDC1_HUMAN	DPY30 domain-containing protein 1	GO:0044666; GO:0048188; GO:0051568	MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568]
PGEN_.00g260430	Scaffold_13	1665868	1668645	Q25390	SCRA_LIMPO	Alpha-scruin		
PGEN_.00g260440	Scaffold_13	1670692	1674843	NA	NA	NA	NA	NA
PGEN_.00g260450	Scaffold_13	1684585	1698061	Q8IVI9	NOSTN_HUMAN	Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer)	GO:0003677; GO:0005634; GO:0005856; GO:0005886; GO:0006897; GO:0030666; GO:0045892; GO:0050999	"cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999]"
PGEN_.00g260460	Scaffold_13	1714019	1722343	Q6PWL5	TEBP_MACFA	Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES)	GO:0001516; GO:0005737; GO:0050220	cytoplasm [GO:0005737]; prostaglandin-E synthase activity [GO:0050220]; prostaglandin biosynthetic process [GO:0001516]
PGEN_.00g260470	Scaffold_13	1732240	1743751	Q9UG63	ABCF2_HUMAN	ATP-binding cassette sub-family F member 2 (Iron-inhibited ABC transporter 2)	GO:0005524; GO:0016020; GO:0016887	membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]
PGEN_.00g260480	Scaffold_13	1747884	1749366	NA	NA	NA	NA	NA
PGEN_.00g260490	Scaffold_13	1787784	1792159	NA	NA	NA	NA	NA
PGEN_.00g260500	Scaffold_13	1793100	1795362	NA	NA	NA	NA	NA
PGEN_.00g260510	Scaffold_13	1800124	1800462	NA	NA	NA	NA	NA
PGEN_.00g260520	Scaffold_13	1802945	1827684	Q9NVE5	UBP40_HUMAN	Ubiquitin carboxyl-terminal hydrolase 40 (EC 3.4.19.12) (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40)	GO:0004197; GO:0004843; GO:0006511; GO:0016579	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g260530	Scaffold_13	1832923	1844433	Q08CH6	CATIP_DANRE	Ciliogenesis-associated TTC17-interacting protein	GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0060271; GO:0061371	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]
PGEN_.00g260540	Scaffold_13	1847259	1860284	A4D263	SPT48_HUMAN	Spermatogenesis-associated protein 48		
PGEN_.00g260550	Scaffold_13	1860650	1877371	Q2PZI1	D19L1_HUMAN	Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1)	GO:0000030; GO:0005637; GO:0016020; GO:0016021; GO:0018406	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]
PGEN_.00g260560	Scaffold_13	1880540	1880803	NA	NA	NA	NA	NA
PGEN_.00g260570	Scaffold_13	1882019	1884233	NA	NA	NA	NA	NA
PGEN_.00g260580	Scaffold_13	1884694	1903773	Q2PZI1	D19L1_HUMAN	Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1)	GO:0000030; GO:0005637; GO:0016020; GO:0016021; GO:0018406	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]
PGEN_.00g260590	Scaffold_13	1913533	1916098	NA	NA	NA	NA	NA
PGEN_.00g260600	Scaffold_13	1924997	1931095	Q4R6W9	SNPC1_MACFA	snRNA-activating protein complex subunit 1 (SNAPc subunit 1) (Small nuclear RNA-activating complex polypeptide 1) (snRNA-activating protein complex 43 kDa subunit) (SNAPc 43 kDa subunit)	GO:0003677; GO:0005654; GO:0005730	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]
PGEN_.00g260610	Scaffold_13	1938453	1943771	NA	NA	NA	NA	NA
PGEN_.00g260620	Scaffold_13	1959130	1992080	B0FYY4	ITB1_SHEEP	Integrin beta-1 (Fibronectin receptor subunit beta) (Integrin subunit beta-1) (VLA-4 subunit beta) (CD antigen CD29)	GO:0005925; GO:0007160; GO:0007229; GO:0008305; GO:0009986; GO:0010710; GO:0016020; GO:0030027; GO:0030335; GO:0031623; GO:0032587; GO:0033627; GO:0038023; GO:0042470; GO:0046872; GO:0046982; GO:0055037; GO:0071404; GO:0071438; GO:1903078	cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710]
PGEN_.00g260630	Scaffold_13	2012810	2015738	NA	NA	NA	NA	NA
PGEN_.00g260640	Scaffold_13	2016452	2030552	D9IQ16	GXN_ACRMI	Galaxin	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g260650	Scaffold_13	2043150	2046488	NA	NA	NA	NA	NA
PGEN_.00g260660	Scaffold_13	2048797	2049111	NA	NA	NA	NA	NA
PGEN_.00g260670	Scaffold_13	2049172	2064965	NA	NA	NA	NA	NA
PGEN_.00g260680	Scaffold_13	2086684	2088588	NA	NA	NA	NA	NA
PGEN_.00g260690	Scaffold_13	2094047	2101432	NA	NA	NA	NA	NA
PGEN_.00g260700	Scaffold_13	2101880	2102473	NA	NA	NA	NA	NA
PGEN_.00g260710	Scaffold_13	2119046	2119564	NA	NA	NA	NA	NA
PGEN_.00g260720	Scaffold_13	2132264	2182487	P82197	PDXK_SHEEP	Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase)	GO:0005524; GO:0005737; GO:0008478; GO:0009443; GO:0046872	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyridoxal kinase activity [GO:0008478]; pyridoxal 5'-phosphate salvage [GO:0009443]
PGEN_.00g260730	Scaffold_13	2199090	2213618	NA	NA	NA	NA	NA
PGEN_.00g260740	Scaffold_13	2219605	2230687	Q7T0X7	OXND1_XENLA	Oxidoreductase NAD-binding domain-containing protein 1 (EC 1.-.-.-)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g260750	Scaffold_13	2244778	2303773	Q9D6K9	CERS5_MOUSE	Ceramide synthase 5 (CerS5) (EC 2.3.1.-) (LAG1 longevity assurance homolog 5) (Sphingosine N-acyltransferase CERS5) (EC 2.3.1.24) (Translocating chain-associating membrane protein homolog 4) (TRAM homolog 4)	GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0030148; GO:0046513; GO:0050291	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g260760	Scaffold_13	2303831	2308836	P61355	RL27_CHICK	60S ribosomal protein L27	GO:0003735; GO:0006412; GO:0015934; GO:0022625; GO:0098556	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g260770	Scaffold_13	2315802	2318224	Q8R2R6	MTG1_MOUSE	Mitochondrial ribosome-associated GTPase 1 (GTP-binding protein 7) (Mitochondrial GTPase 1)	GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0005761; GO:0044065; GO:0070129	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]
PGEN_.00g260780	Scaffold_13	2335203	2442679	Q13324	CRFR2_HUMAN	Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2)	GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007188; GO:0015056; GO:0017046; GO:0030424; GO:0030425; GO:0043404; GO:0043679; GO:0060291	axon [GO:0030424]; axon terminus [GO:0043679]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; peptide hormone binding [GO:0017046]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term synaptic potentiation [GO:0060291]
PGEN_.00g260790	Scaffold_13	2652601	2653902	NA	NA	NA	NA	NA
PGEN_.00g260800	Scaffold_13	2676330	2690298	Q08AW5	CG025_XENLA	UPF0415 protein C7orf25 homolog		
PGEN_.00g260810	Scaffold_13	2777556	2789578	P14173	DDC_RAT	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC)	GO:0004058; GO:0005737; GO:0006520; GO:0007623; GO:0008021; GO:0009636; GO:0010259; GO:0015842; GO:0016597; GO:0019899; GO:0019904; GO:0030170; GO:0030424; GO:0033076; GO:0035690; GO:0036468; GO:0042416; GO:0042417; GO:0042423; GO:0042427; GO:0043025; GO:0046684; GO:0052314; GO:0071312; GO:0071363	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]; amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; enzyme binding [GO:0019899]; L-dopa decarboxylase activity [GO:0036468]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to drug [GO:0035690]; cellular response to growth factor stimulus [GO:0071363]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; dopamine metabolic process [GO:0042417]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; response to toxic substance [GO:0009636]; serotonin biosynthetic process [GO:0042427]
PGEN_.00g260820	Scaffold_13	2845319	2856422	Q01460	DIAC_RAT	Di-N-acetylchitobiase (EC 3.2.1.-)	GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313; GO:0016798	"lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313]"
PGEN_.00g260830	Scaffold_13	2858290	2902001	NA	NA	NA	NA	NA
PGEN_.00g260840	Scaffold_13	2942256	2942966	Q923Z4	FER3L_MOUSE	Fer3-like protein (Basic helix-loop-helix protein N-twist) (Nephew of atonal 3) (Neuronal twist)	GO:0000122; GO:0000977; GO:0001227; GO:0005634; GO:0033504; GO:0045892; GO:0046983; GO:0048468; GO:0050767	"nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell development [GO:0048468]; floor plate development [GO:0033504]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of neurogenesis [GO:0050767]"
PGEN_.00g260850	Scaffold_13	2957711	2959360	Q5TYW1	ZN658_HUMAN	Zinc finger protein 658	GO:0000976; GO:0005634; GO:0042254; GO:0045892; GO:0046872; GO:0071294	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254]"
PGEN_.00g260860	Scaffold_13	2976890	2984057	Q5R833	ACO13_PONAB	"Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Thioesterase superfamily member 2) [Cleaved into: Acyl-coenzyme A thioesterase 13, N-terminally processed]"	GO:0005634; GO:0005739; GO:0005819; GO:0005829; GO:0047617	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819]; acyl-CoA hydrolase activity [GO:0047617]
PGEN_.00g260870	Scaffold_13	2994348	2994626	NA	NA	NA	NA	NA
PGEN_.00g260880	Scaffold_13	2996932	2997186	NA	NA	NA	NA	NA
PGEN_.00g260890	Scaffold_13	2998618	2999079	NA	NA	NA	NA	NA
PGEN_.00g260900	Scaffold_13	3021907	3023233	NA	NA	NA	NA	NA
PGEN_.00g260910	Scaffold_13	3023309	3033628	NA	NA	NA	NA	NA
PGEN_.00g260920	Scaffold_13	3047235	3069130	Q5IZC5	CRY1_ERIRU	Cryptochrome-1	GO:0000166; GO:0003677; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0042622; GO:0045721; GO:0097381	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]
PGEN_.00g260930	Scaffold_13	3070077	3070742	NA	NA	NA	NA	NA
PGEN_.00g260940	Scaffold_13	3113527	3125994	Q7SIB2	CO4A1_BOVIN	Collagen alpha-1(IV) chain [Cleaved into: Arresten]	GO:0001569; GO:0005201; GO:0005587; GO:0005615; GO:0007420; GO:0007528; GO:0030020; GO:0030198; GO:0031012; GO:0038063; GO:0048407; GO:0061304; GO:0061333; GO:0071230; GO:0071711	collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407]; basement membrane organization [GO:0071711]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]; renal tubule morphogenesis [GO:0061333]; retinal blood vessel morphogenesis [GO:0061304]
PGEN_.00g260950	Scaffold_13	3129866	3148589	NA	NA	NA	NA	NA
PGEN_.00g260960	Scaffold_13	3202041	3213049	NA	NA	NA	NA	NA
PGEN_.00g260970	Scaffold_13	3239944	3241382	NA	NA	NA	NA	NA
PGEN_.00g260980	Scaffold_13	3247706	3259190	NA	NA	NA	NA	NA
PGEN_.00g260990	Scaffold_13	3264307	3265188	NA	NA	NA	NA	NA
PGEN_.00g261000	Scaffold_13	3278124	3303206	Q17320	WHITE_CERCA	Protein white	GO:0005524; GO:0016021; GO:0016887; GO:0031409; GO:0055085	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; pigment binding [GO:0031409]; transmembrane transport [GO:0055085]
PGEN_.00g261010	Scaffold_13	3313527	3317980	Q8C3I8	HGH1_MOUSE	Protein HGH1 homolog		
PGEN_.00g261020	Scaffold_13	3323626	3339739	Q5ZI03	CIR1_CHICK	Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor)	GO:0003714; GO:0005813; GO:0006397; GO:0008380; GO:0016607; GO:0019901; GO:0032991; GO:0044877; GO:0045892	"centrosome [GO:0005813]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]"
PGEN_.00g261030	Scaffold_13	3407647	3408649	NA	NA	NA	NA	NA
PGEN_.00g261040	Scaffold_13	3409221	3409484	NA	NA	NA	NA	NA
PGEN_.00g261050	Scaffold_13	3433769	3487913	NA	NA	NA	NA	NA
PGEN_.00g261060	Scaffold_13	3508292	3510639	O46503	ST1C2_RABIT	Sulfotransferase 1C2 (ST1C2) (rabSULT1C2) (EC 2.8.2.-) (Sulfotransferase 1C1)	GO:0005737; GO:0008146; GO:0051923	cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; sulfation [GO:0051923]
PGEN_.00g261070	Scaffold_13	3511250	3514369	Q9BR01	ST4A1_HUMAN	Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (hBR-STL) (hBR-STL-1) (Nervous system sulfotransferase) (NST)	GO:0005829; GO:0008146; GO:0008202; GO:0042802; GO:0050427	cytosol [GO:0005829]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; steroid metabolic process [GO:0008202]
PGEN_.00g261080	Scaffold_13	3523749	3564318	O75400	PR40A_HUMAN	Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6)	GO:0000398; GO:0003723; GO:0005654; GO:0005685; GO:0005829; GO:0007010; GO:0007049; GO:0008360; GO:0016020; GO:0016363; GO:0016477; GO:0016607; GO:0032465; GO:0045292; GO:0051301; GO:0070064; GO:0071004	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
PGEN_.00g261090	Scaffold_13	3573283	3575094	NA	NA	NA	NA	NA
PGEN_.00g261100	Scaffold_13	3639071	3645517	P49442	INPP_MOUSE	Inositol polyphosphate 1-phosphatase (IPP) (IPPase) (EC 3.1.3.57)	GO:0004441; GO:0046854; GO:0046855; GO:0046872	"inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]"
PGEN_.00g261110	Scaffold_13	3648503	3661355	B5DE93	CDK12_XENTR	Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 12)	GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0006397; GO:0006468; GO:0008353; GO:0008380; GO:0016607; GO:0019908; GO:0032968; GO:0043405; GO:0070816	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; mRNA processing [GO:0006397]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; RNA splicing [GO:0008380]
PGEN_.00g261120	Scaffold_13	3673443	3677691	NA	NA	NA	NA	NA
PGEN_.00g261130	Scaffold_13	3700335	3701602	NA	NA	NA	NA	NA
PGEN_.00g261140	Scaffold_13	3709888	3724335	O43345	ZN208_HUMAN	Zinc finger protein 208 (Zinc finger protein 91-like)	GO:0003677; GO:0005634; GO:0006355; GO:0008270	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g261150	Scaffold_13	3736869	3745059	NA	NA	NA	NA	NA
PGEN_.00g261160	Scaffold_13	3746926	3785565	NA	NA	NA	NA	NA
PGEN_.00g261170	Scaffold_13	3788560	3826937	NA	NA	NA	NA	NA
PGEN_.00g261180	Scaffold_13	3849096	3873378	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g261190	Scaffold_13	3875331	3898602	Q9ULI1	NWD2_HUMAN	NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)		
PGEN_.00g261200	Scaffold_13	3906805	3917858	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g261210	Scaffold_13	3922060	3938174	Q86W10	CP4Z1_HUMAN	Cytochrome P450 4Z1 (EC 1.14.14.1) (CYPIVZ1)	GO:0005506; GO:0005789; GO:0016021; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g261220	Scaffold_13	4119099	4212913	Q76LL8	CRFR1_MACMU	Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1)	GO:0005768; GO:0007166; GO:0007189; GO:0015056; GO:0016021; GO:0017046; GO:0031226; GO:0043404; GO:0051424; GO:0051458; GO:0071376; GO:2000852	endosome [GO:0005768]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone binding [GO:0051424]; corticotropin-releasing hormone receptor activity [GO:0043404]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852]
PGEN_.00g261230	Scaffold_13	4221286	4222305	O75094	SLIT3_HUMAN	Slit homolog 3 protein (Slit-3) (Multiple epidermal growth factor-like domains protein 5) (Multiple EGF-like domains protein 5)	GO:0003180; GO:0003181; GO:0005509; GO:0005615; GO:0005739; GO:0007411; GO:0008201; GO:0008285; GO:0010629; GO:0030308; GO:0032870; GO:0035385; GO:0048495; GO:0048846; GO:0050919; GO:0051414; GO:0060412; GO:0061364; GO:0070100	extracellular space [GO:0005615]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]
PGEN_.00g261240	Scaffold_13	4223676	4325173	P25107	PTH1R_DIDVI	Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor)	GO:0004991; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0017046; GO:0042803; GO:0043621	integral component of plasma membrane [GO:0005887]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g261250	Scaffold_13	4405357	4408892	Q17766	FOLT1_CAEEL	Folate transporter 1	GO:0005542; GO:0005886; GO:0016021; GO:0055085; GO:0090482	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid binding [GO:0005542]; vitamin transmembrane transporter activity [GO:0090482]; transmembrane transport [GO:0055085]
PGEN_.00g261260	Scaffold_13	4408917	4416783	NA	NA	NA	NA	NA
PGEN_.00g261270	Scaffold_13	4433937	4434254	NA	NA	NA	NA	NA
PGEN_.00g261280	Scaffold_13	4437266	4448447	O14807	RASM_HUMAN	Ras-related protein M-Ras (Ras-related protein R-Ras3)	GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0007275; GO:0007517; GO:0019003; GO:0030036; GO:0030742; GO:1990830	plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; multicellular organism development [GO:0007275]; muscle organ development [GO:0007517]; Ras protein signal transduction [GO:0007265]
PGEN_.00g261290	Scaffold_13	4456628	4468983	Q9I9R3	S40A1_DANRE	Solute carrier family 40 member 1 (Ferroportin-1)	GO:0005381; GO:0005623; GO:0006826; GO:0006879; GO:0010039; GO:0016021; GO:0016323; GO:0017046; GO:0030282; GO:0034755; GO:0035162; GO:0042541; GO:0043362; GO:0046688; GO:0055072	basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; integral component of membrane [GO:0016021]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; bone mineralization [GO:0030282]; cellular iron ion homeostasis [GO:0006879]; embryonic hemopoiesis [GO:0035162]; hemoglobin biosynthetic process [GO:0042541]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; nucleate erythrocyte maturation [GO:0043362]; response to copper ion [GO:0046688]; response to iron ion [GO:0010039]
PGEN_.00g261300	Scaffold_13	4480245	4487065	Q5TF39	MFS4B_HUMAN	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g261310	Scaffold_13	4490707	4490973	NA	NA	NA	NA	NA
PGEN_.00g261320	Scaffold_13	4494581	4509130	Q8HZY8	CC148_MACFA	Coiled-coil domain-containing protein 148		
PGEN_.00g261330	Scaffold_13	4516674	4523927	Q9JLI7	SPAG6_MOUSE	Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog)	GO:0005874; GO:0007288; GO:0015630; GO:0021591; GO:0030317; GO:0097228; GO:1990716	axonemal central apparatus [GO:1990716]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; ventricular system development [GO:0021591]
PGEN_.00g261340	Scaffold_13	4524235	4531195	B1AR13	CISD3_MOUSE	"CDGSH iron-sulfur domain-containing protein 3, mitochondrial (Melanoma nuclear protein 13)"	GO:0005739; GO:0046872; GO:0051537; GO:0106034	"mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]"
PGEN_.00g261350	Scaffold_13	4539042	4539308	NA	NA	NA	NA	NA
PGEN_.00g261360	Scaffold_13	4541211	4546730	P20533	CHIA1_BACCI	Chitinase A1 (EC 3.2.1.14)	GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]
PGEN_.00g261370	Scaffold_13	4552423	4576790	NA	NA	NA	NA	NA
PGEN_.00g261380	Scaffold_13	4630833	4653003	NA	NA	NA	NA	NA
PGEN_.00g261390	Scaffold_13	4701059	4701313	NA	NA	NA	NA	NA
PGEN_.00g261400	Scaffold_13	4871996	4886472	NA	NA	NA	NA	NA
PGEN_.00g261410	Scaffold_13	4936613	4953354	Q91WG5	AAKG2_MOUSE	5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2)	GO:0004679; GO:0004862; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0006110; GO:0006469; GO:0006633; GO:0008603; GO:0008607; GO:0010800; GO:0016208; GO:0019217; GO:0019901; GO:0030295; GO:0031588; GO:0035556; GO:0043531; GO:0045860; GO:0050790	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]
PGEN_.00g261420	Scaffold_13	4953677	4956404	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g261430	Scaffold_13	4958377	4960128	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g261440	Scaffold_13	4962954	4966636	Q91WG5	AAKG2_MOUSE	5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2)	GO:0004679; GO:0004862; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0006110; GO:0006469; GO:0006633; GO:0008603; GO:0008607; GO:0010800; GO:0016208; GO:0019217; GO:0019901; GO:0030295; GO:0031588; GO:0035556; GO:0043531; GO:0045860; GO:0050790	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]
PGEN_.00g261450	Scaffold_13	4980321	4988211	Q7PQ25	CCDCX_ANOGA	Coiled-coil domain-containing protein AGAP005037		
PGEN_.00g261460	Scaffold_13	4995393	4996736	NA	NA	NA	NA	NA
PGEN_.00g261470	Scaffold_13	4996801	5035901	Q7KW14	CCDCX_DROME	Coiled-coil domain-containing protein CG32809		
PGEN_.00g261480	Scaffold_13	5039147	5041532	NA	NA	NA	NA	NA
PGEN_.00g261490	Scaffold_13	5068298	5085384	NA	NA	NA	NA	NA
PGEN_.00g261500	Scaffold_13	5138473	5144714	NA	NA	NA	NA	NA
PGEN_.00g261510	Scaffold_13	5158685	5163476	NA	NA	NA	NA	NA
PGEN_.00g261520	Scaffold_13	5163879	5165158	NA	NA	NA	NA	NA
PGEN_.00g261530	Scaffold_13	5165810	5170669	NA	NA	NA	NA	NA
PGEN_.00g261540	Scaffold_13	5175548	5179246	NA	NA	NA	NA	NA
PGEN_.00g261550	Scaffold_13	5207818	5214348	NA	NA	NA	NA	NA
PGEN_.00g261560	Scaffold_13	5219867	5221248	NA	NA	NA	NA	NA
PGEN_.00g261570	Scaffold_13	5263128	5272836	NA	NA	NA	NA	NA
PGEN_.00g261580	Scaffold_13	5277068	5288152	NA	NA	NA	NA	NA
PGEN_.00g261590	Scaffold_13	5295505	5298777	NA	NA	NA	NA	NA
PGEN_.00g261600	Scaffold_13	5300349	5320892	Q5TYS5	SCRN2_DANRE	Secernin-2	GO:0016805	dipeptidase activity [GO:0016805]
PGEN_.00g261610	Scaffold_13	5331871	5338599	NA	NA	NA	NA	NA
PGEN_.00g261620	Scaffold_13	5337755	5340668	NA	NA	NA	NA	NA
PGEN_.00g261630	Scaffold_13	5347087	5369508	Q5F450	PAN2_CHICK	PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2)	GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872	nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]
PGEN_.00g261640	Scaffold_13	5378889	5380895	Q8N695	SC5A8_HUMAN	Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)	GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]
PGEN_.00g261650	Scaffold_13	5382062	5404556	Q5F450	PAN2_CHICK	PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2)	GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872	nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]
PGEN_.00g261660	Scaffold_13	5406767	5410837	Q24307	DIAP2_DROME	Death-associated inhibitor of apoptosis 2 (Apoptosis 2 inhibitor) (IAP homolog A) (IAP-like protein) (ILP) (dILP) (Inhibitor of apoptosis 2)	GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006964; GO:0008270; GO:0016567; GO:0022416; GO:0031398; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0043281; GO:0045087; GO:0048471; GO:0050829; GO:0061057; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chaeta development [GO:0022416]; defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g261670	Scaffold_13	5435893	5453255	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g261680	Scaffold_13	5455684	5456025	NA	NA	NA	NA	NA
PGEN_.00g261690	Scaffold_13	5456103	5456683	NA	NA	NA	NA	NA
PGEN_.00g261700	Scaffold_13	5501577	5539820	NA	NA	NA	NA	NA
PGEN_.00g261710	Scaffold_13	5543828	5547201	Q5VV17	OTUD1_HUMAN	OTU domain-containing protein 1 (EC 3.4.19.12) (DUBA-7)	GO:0004843; GO:0070536	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K63-linked deubiquitination [GO:0070536]
PGEN_.00g261720	Scaffold_13	5549764	5554762	NA	NA	NA	NA	NA
PGEN_.00g261730	Scaffold_13	5561476	5567556	Q5ZJL4	CLP1_CHICK	Polyribonucleotide 5'-hydroxyl-kinase Clp1 (EC 2.7.1.78) (Polyadenylation factor Clp1) (Polynucleotide kinase Clp1) (Pre-mRNA cleavage complex II protein Clp1)	GO:0000214; GO:0005524; GO:0005634; GO:0005829; GO:0005849; GO:0006378; GO:0006388; GO:0021695; GO:0030423; GO:0035087; GO:0046404; GO:0051731; GO:0051733; GO:0051736	"cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polydeoxyribonucleotide kinase activity [GO:0051733]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; cerebellar cortex development [GO:0021695]; mRNA polyadenylation [GO:0006378]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
PGEN_.00g261740	Scaffold_13	5568452	5582806	Q5ZJL4	CLP1_CHICK	Polyribonucleotide 5'-hydroxyl-kinase Clp1 (EC 2.7.1.78) (Polyadenylation factor Clp1) (Polynucleotide kinase Clp1) (Pre-mRNA cleavage complex II protein Clp1)	GO:0000214; GO:0005524; GO:0005634; GO:0005829; GO:0005849; GO:0006378; GO:0006388; GO:0021695; GO:0030423; GO:0035087; GO:0046404; GO:0051731; GO:0051733; GO:0051736	"cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polydeoxyribonucleotide kinase activity [GO:0051733]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; cerebellar cortex development [GO:0021695]; mRNA polyadenylation [GO:0006378]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
PGEN_.00g261750	Scaffold_13	5596042	5630393	P08183	MDR1_HUMAN	ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)	GO:0000086; GO:0005215; GO:0005524; GO:0005886; GO:0008559; GO:0009986; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0016887; GO:0031625; GO:0042493; GO:0042626; GO:0042910; GO:0045332; GO:0047484; GO:0055085; GO:0070062; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1990962; GO:2001225	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transporter activity [GO:0005215]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic transport across blood-brain barrier [GO:1990962]
PGEN_.00g261760	Scaffold_13	5673343	5673582	NA	NA	NA	NA	NA
PGEN_.00g261770	Scaffold_13	5715043	5731027	Q9CZQ9	BBS5_MOUSE	Bardet-Biedl syndrome 5 protein homolog	GO:0001103; GO:0005929; GO:0005930; GO:0015031; GO:0032266; GO:0034451; GO:0034464; GO:0036064; GO:0046907; GO:0060170; GO:0060271	axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II repressing transcription factor binding [GO:0001103]; cilium assembly [GO:0060271]; intracellular transport [GO:0046907]; protein transport [GO:0015031]
PGEN_.00g261780	Scaffold_13	5732930	5736405	NA	NA	NA	NA	NA
PGEN_.00g261790	Scaffold_13	5737690	5743230	NA	NA	NA	NA	NA
PGEN_.00g261800	Scaffold_13	5758375	5758881	NA	NA	NA	NA	NA
PGEN_.00g261810	Scaffold_13	5759331	5759630	NA	NA	NA	NA	NA
PGEN_.00g261820	Scaffold_13	5769026	5776622	NA	NA	NA	NA	NA
PGEN_.00g261830	Scaffold_13	5800955	5809055	Q7SY09	AGRL4_DANRE	Adhesion G protein-coupled receptor L4	GO:0004930; GO:0005509; GO:0005887; GO:0007166; GO:0007189	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g261840	Scaffold_13	5811995	5850411	Q868Z9	PPN_DROME	Papilin	GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198	basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275]
PGEN_.00g261850	Scaffold_13	5856699	5857034	NA	NA	NA	NA	NA
PGEN_.00g261860	Scaffold_13	5880028	5882643	A4IF63	TRIM2_BOVIN	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g261870	Scaffold_13	5904563	5904946	NA	NA	NA	NA	NA
PGEN_.00g261880	Scaffold_13	5925589	5927623	NA	NA	NA	NA	NA
PGEN_.00g261890	Scaffold_13	5927048	5930237	NA	NA	NA	NA	NA
PGEN_.00g261900	Scaffold_13	5936848	5960600	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g261910	Scaffold_13	5969489	5983022	NA	NA	NA	NA	NA
PGEN_.00g261920	Scaffold_13	6010519	6010851	NA	NA	NA	NA	NA
PGEN_.00g261930	Scaffold_13	6012854	6015886	NA	NA	NA	NA	NA
PGEN_.00g261940	Scaffold_13	6028683	6028964	NA	NA	NA	NA	NA
PGEN_.00g261950	Scaffold_13	6032899	6039732	NA	NA	NA	NA	NA
PGEN_.00g261960	Scaffold_13	6100822	6117868	P13944	COCA1_CHICK	Collagen alpha-1(XII) chain (Fibrochimerin)	GO:0003429; GO:0005581; GO:0005615; GO:0007155; GO:0031012; GO:0035987; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g261970	Scaffold_13	6120051	6124791	NA	NA	NA	NA	NA
PGEN_.00g261980	Scaffold_13	6137511	6139208	NA	NA	NA	NA	NA
PGEN_.00g261990	Scaffold_13	6171029	6172638	NA	NA	NA	NA	NA
PGEN_.00g262000	Scaffold_13	6193086	6193355	NA	NA	NA	NA	NA
PGEN_.00g262010	Scaffold_13	6213093	6235880	P55006	RDH7_RAT	Retinol dehydrogenase 7 (EC 1.1.1.105) (Retinol dehydrogenase 3) (Retinol dehydrogenase type III) (RODH III)	GO:0004745; GO:0005783; GO:0042572	endoplasmic reticulum [GO:0005783]; retinol dehydrogenase activity [GO:0004745]; retinol metabolic process [GO:0042572]
PGEN_.00g262020	Scaffold_13	6237593	6239313	NA	NA	NA	NA	NA
PGEN_.00g262030	Scaffold_13	6259081	6263471	Q3TD49	SPP2B_MOUSE	Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-)	GO:0000139; GO:0005654; GO:0005765; GO:0005813; GO:0005886; GO:0006509; GO:0010008; GO:0015629; GO:0016020; GO:0030660; GO:0031293; GO:0033619; GO:0042500; GO:0042803; GO:0050776; GO:0071458; GO:0071556	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]"
PGEN_.00g262040	Scaffold_13	6274238	6286077	Q9UA35	S28A3_EPTST	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)	GO:0005337; GO:0005887	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]
PGEN_.00g262050	Scaffold_13	6394534	6442449	Q99558	M3K14_HUMAN	Mitogen-activated protein kinase kinase kinase 14 (EC 2.7.11.25) (NF-kappa-beta-inducing kinase) (HsNIK) (Serine/threonine-protein kinase NIK)	GO:0001650; GO:0004672; GO:0004674; GO:0004704; GO:0004709; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006955; GO:0007249; GO:0016301; GO:0023014; GO:0032147; GO:0033209; GO:0038061; GO:0043123; GO:0043231; GO:0051607; GO:0071260	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; MAP kinase kinase kinase activity [GO:0004709]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; signal transduction by protein phosphorylation [GO:0023014]; tumor necrosis factor-mediated signaling pathway [GO:0033209]
PGEN_.00g262060	Scaffold_13	6518846	6537485	Q91836	PRKAB_XENLA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog B (Double-stranded RNA-binding protein A) (XlRBPA)	GO:0003725; GO:0005730; GO:0005737; GO:0008047; GO:0030422; GO:0048471	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; production of siRNA involved in RNA interference [GO:0030422]
PGEN_.00g262070	Scaffold_13	6544202	6554946	Q9I9R3	S40A1_DANRE	Solute carrier family 40 member 1 (Ferroportin-1)	GO:0005381; GO:0005623; GO:0006826; GO:0006879; GO:0010039; GO:0016021; GO:0016323; GO:0017046; GO:0030282; GO:0034755; GO:0035162; GO:0042541; GO:0043362; GO:0046688; GO:0055072	basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; integral component of membrane [GO:0016021]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; bone mineralization [GO:0030282]; cellular iron ion homeostasis [GO:0006879]; embryonic hemopoiesis [GO:0035162]; hemoglobin biosynthetic process [GO:0042541]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; nucleate erythrocyte maturation [GO:0043362]; response to copper ion [GO:0046688]; response to iron ion [GO:0010039]
PGEN_.00g262080	Scaffold_13	6565802	6586977	Q9NZC9	SMAL1_HUMAN	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (EC 3.6.4.-) (HepA-related protein) (hHARP) (Sucrose nonfermenting protein 2-like 1)	GO:0004386; GO:0005524; GO:0005634; GO:0006259; GO:0006281; GO:0006357; GO:0006974; GO:0008094; GO:0031297; GO:0035861; GO:0036292; GO:0036310; GO:0043596; GO:0048478; GO:0090656	nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; t-circle formation [GO:0090656]
PGEN_.00g262090	Scaffold_13	6591569	6595714	NA	NA	NA	NA	NA
PGEN_.00g262100	Scaffold_13	6596648	6605845	B2ZFP3	SMAL1_DANRE	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (EC 3.6.4.-) (HepA-related protein) (Sucrose nonfermenting protein 2-like 1)	GO:0000278; GO:0001525; GO:0004386; GO:0005524; GO:0005634; GO:0006259; GO:0006281; GO:0006357; GO:0006974; GO:0008094; GO:0010172; GO:0030097; GO:0031297; GO:0036292; GO:0036310; GO:0043596; GO:0048478; GO:0048589; GO:0051216	nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; angiogenesis [GO:0001525]; cartilage development [GO:0051216]; cellular response to DNA damage stimulus [GO:0006974]; developmental growth [GO:0048589]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; embryonic body morphogenesis [GO:0010172]; hemopoiesis [GO:0030097]; mitotic cell cycle [GO:0000278]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]
PGEN_.00g262110	Scaffold_13	6620935	6636637	C5FP82	M28P2_ARTOC	Probable zinc metalloprotease MCYG_04217 (EC 3.4.-.-)	GO:0005576; GO:0008237; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]
PGEN_.00g262120	Scaffold_13	6644140	6651588	Q5RAM8	EAF1_PONAB	ELL-associated factor 1	GO:0006355; GO:0008023; GO:0015030; GO:0016607; GO:0032783	"Cajal body [GO:0015030]; ELL-EAF complex [GO:0032783]; nuclear speck [GO:0016607]; transcription elongation factor complex [GO:0008023]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g262130	Scaffold_13	6658210	6666777	Q5RDV8	METL6_PONAB	tRNA N(3)-methylcytidine methyltransferase METTL6 (EC 2.1.1.-) (Methyltransferase-like protein 6)	GO:0008033; GO:0008168; GO:0032259	methyltransferase activity [GO:0008168]; methylation [GO:0032259]; tRNA processing [GO:0008033]
PGEN_.00g262140	Scaffold_13	6673919	6674874	NA	NA	NA	NA	NA
PGEN_.00g262150	Scaffold_13	6718962	6738274	NA	NA	NA	NA	NA
PGEN_.00g262160	Scaffold_13	6738892	6751729	Q86TJ5	ZN554_HUMAN	Zinc finger protein 554	GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0043565; GO:0046872	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]
PGEN_.00g262170	Scaffold_13	6806463	6826163	NA	NA	NA	NA	NA
PGEN_.00g262180	Scaffold_13	6828639	6830123	Q0VFV7	KCTD7_DANRE	BTB/POZ domain-containing protein KCTD7	GO:0005829; GO:0005886; GO:0051260	cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260]
PGEN_.00g262190	Scaffold_13	6835132	6848819	Q5ZM41	TEX10_CHICK	Testis-expressed protein 10 homolog	GO:0005730; GO:0071339; GO:0097344	MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; Rix1 complex [GO:0097344]
PGEN_.00g262200	Scaffold_13	6853481	6864860	O35047	HOP2_MOUSE	Homologous-pairing protein 2 homolog (PSMC3-interacting protein) (Proteasome 26S ATPase subunit 3-interacting protein) (Tat-binding protein 1-interacting protein) (TBP-1-interacting protein)	GO:0003677; GO:0005634; GO:0005654; GO:0007131; GO:0030331; GO:0030374; GO:0035259; GO:0044877; GO:0045944; GO:0046966; GO:0050681; GO:0050692	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; DBD domain binding [GO:0050692]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; thyroid hormone receptor binding [GO:0046966]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reciprocal meiotic recombination [GO:0007131]
PGEN_.00g262210	Scaffold_13	6902681	6911839	NA	NA	NA	NA	NA
PGEN_.00g262220	Scaffold_13	6925866	6927500	NA	NA	NA	NA	NA
PGEN_.00g262230	Scaffold_13	6945002	6973925	NA	NA	NA	NA	NA
PGEN_.00g262240	Scaffold_13	6981257	6981616	NA	NA	NA	NA	NA
PGEN_.00g262250	Scaffold_13	7036665	7038119	P20814	CP2CD_RAT	"Cytochrome P450 2C13, male-specific (EC 1.14.14.1) (CYPIIC13) (Cytochrome P-450g) (Cytochrome P450-G) (Cytochrome P450-UT-5)"	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0016712; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g262260	Scaffold_13	7046426	7048626	NA	NA	NA	NA	NA
PGEN_.00g262270	Scaffold_13	7057796	7083432	NA	NA	NA	NA	NA
PGEN_.00g262280	Scaffold_13	7085991	7086323	NA	NA	NA	NA	NA
PGEN_.00g262290	Scaffold_13	7086438	7086905	NA	NA	NA	NA	NA
PGEN_.00g262300	Scaffold_13	7152785	7217466	Q6BD04	GPR54_ORENI	G-protein coupled receptor 54	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g262310	Scaffold_13	7241753	7243668	NA	NA	NA	NA	NA
PGEN_.00g262320	Scaffold_13	7248480	7248689	NA	NA	NA	NA	NA
PGEN_.00g262330	Scaffold_13	7402052	7402510	NA	NA	NA	NA	NA
PGEN_.00g262340	Scaffold_13	7574044	7606978	P31651	S6A12_MOUSE	Sodium- and chloride-dependent betaine transporter (Na(+)/Cl(-) betaine/GABA transporter) (Sodium- and chloride-dependent GABA transporter 2) (GAT-2) (Solute carrier family 6 member 12)	GO:0005332; GO:0005623; GO:0005886; GO:0005887; GO:0009992; GO:0016021; GO:0042165; GO:0043005	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; cellular water homeostasis [GO:0009992]
PGEN_.00g262350	Scaffold_13	7614858	7620998	Q9H6P5	TASP1_HUMAN	Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta]	GO:0004298; GO:0005737; GO:0006508; GO:0042802; GO:0045893; GO:0051604	"cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]"
PGEN_.00g262360	Scaffold_13	7624311	7627406	NA	NA	NA	NA	NA
PGEN_.00g262370	Scaffold_13	7635687	7643180	NA	NA	NA	NA	NA
PGEN_.00g262380	Scaffold_13	7650381	7653308	Q7ZSX3	PTF1A_DANRE	Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48)	GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048699	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; pancreas development [GO:0031016]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]"
PGEN_.00g262390	Scaffold_13	7663961	7669826	NA	NA	NA	NA	NA
PGEN_.00g262400	Scaffold_13	7672781	7679279	NA	NA	NA	NA	NA
PGEN_.00g262410	Scaffold_13	7679612	7679884	NA	NA	NA	NA	NA
PGEN_.00g262420	Scaffold_13	7680693	7685346	NA	NA	NA	NA	NA
PGEN_.00g262430	Scaffold_13	7688908	7689156	NA	NA	NA	NA	NA
PGEN_.00g262440	Scaffold_13	7694030	7711718	P91929	NDUAA_DROME	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)"	GO:0003954; GO:0005737; GO:0005739; GO:0005747; GO:0005759; GO:0006120; GO:0008137	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"
PGEN_.00g262450	Scaffold_13	7712928	7714744	NA	NA	NA	NA	NA
PGEN_.00g262460	Scaffold_13	7721451	7728443	NA	NA	NA	NA	NA
PGEN_.00g262470	Scaffold_13	7741086	7741872	Q03692	COAA1_HUMAN	Collagen alpha-1(X) chain	GO:0001501; GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]
PGEN_.00g262480	Scaffold_13	7744641	7745725	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g262490	Scaffold_13	7745784	7746050	NA	NA	NA	NA	NA
PGEN_.00g262500	Scaffold_13	7746286	7747294	NA	NA	NA	NA	NA
PGEN_.00g262510	Scaffold_13	7754820	7756715	NA	NA	NA	NA	NA
PGEN_.00g262520	Scaffold_13	7759857	7761797	NA	NA	NA	NA	NA
PGEN_.00g262530	Scaffold_13	7765476	7792571	Q5NVS7	CAN1_PONAB	Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Micromolar-calpain) (muCANP)	GO:0004198; GO:0005509; GO:0005829; GO:0005886; GO:0006508; GO:0050790; GO:0097264	cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; self proteolysis [GO:0097264]
PGEN_.00g262540	Scaffold_13	7775651	7776190	NA	NA	NA	NA	NA
PGEN_.00g262550	Scaffold_13	7796874	7797227	NA	NA	NA	NA	NA
PGEN_.00g262560	Scaffold_13	7851376	7858756	NA	NA	NA	NA	NA
PGEN_.00g262570	Scaffold_13	7858826	7859917	NA	NA	NA	NA	NA
PGEN_.00g262580	Scaffold_13	7860335	7860667	NA	NA	NA	NA	NA
PGEN_.00g262590	Scaffold_13	7870356	7876289	Q95LP4	CAN10_MACFA	Calpain-10 (EC 3.4.22.-) (Calcium-activated neutral proteinase 10) (CANP 10)	GO:0004198; GO:0032869	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cellular response to insulin stimulus [GO:0032869]
PGEN_.00g262600	Scaffold_13	7876833	7906651	Q9GLG2	CAN1_MACFA	Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Micromolar-calpain) (muCANP)	GO:0004198; GO:0005509; GO:0005737; GO:0005886; GO:0006508	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]
PGEN_.00g262610	Scaffold_13	7913883	7916115	G5CTG8	AQP11_MILTA	Aquaporin-11 (AQP-11)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g262620	Scaffold_13	7927102	7934223	Q5REE8	RPA2_PONAB	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (RPA135)	GO:0003677; GO:0003899; GO:0005730; GO:0006351; GO:0032549; GO:0046872	"nucleolus [GO:0005730]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g262630	Scaffold_13	7974661	7977054	Q5REE8	RPA2_PONAB	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (RPA135)	GO:0003677; GO:0003899; GO:0005730; GO:0006351; GO:0032549; GO:0046872	"nucleolus [GO:0005730]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g262640	Scaffold_13	7980076	7981761	NA	NA	NA	NA	NA
PGEN_.00g262650	Scaffold_13	7988916	7989278	NA	NA	NA	NA	NA
PGEN_.00g262660	Scaffold_13	7991852	8029229	P49282	NRAM2_MOUSE	Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2)	GO:0000041; GO:0001666; GO:0005375; GO:0005381; GO:0005384; GO:0005506; GO:0005507; GO:0005623; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005773; GO:0005802; GO:0005886; GO:0005887; GO:0005903; GO:0006778; GO:0006779; GO:0006783; GO:0006824; GO:0006825; GO:0006826; GO:0006828; GO:0006919; GO:0007611; GO:0008270; GO:0009986; GO:0010039; GO:0010042; GO:0012505; GO:0015078; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015099; GO:0015100; GO:0015295; GO:0015675; GO:0015676; GO:0015692; GO:0016021; GO:0016151; GO:0016324; GO:0022890; GO:0030145; GO:0031410; GO:0031526; GO:0031902; GO:0033212; GO:0034599; GO:0034755; GO:0045177; GO:0045178; GO:0046870; GO:0046915; GO:0048471; GO:0048813; GO:0048821; GO:0050897; GO:0055037; GO:0060586; GO:0070574; GO:0070826; GO:0098705; GO:1902600; GO:1903561; GO:1905394	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion binding [GO:0050897]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion binding [GO:0005506]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion binding [GO:0030145]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation binding [GO:0016151]; nickel cation transmembrane transporter activity [GO:0015099]; proton transmembrane transporter activity [GO:0015078]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cadmium ion transmembrane transport [GO:0070574]; cellular response to oxidative stress [GO:0034599]; cobalt ion transport [GO:0006824]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; proton transmembrane transport [GO:1902600]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; transition metal ion transport [GO:0000041]; vanadium ion transport [GO:0015676]
PGEN_.00g262670	Scaffold_13	7995648	7995851	NA	NA	NA	NA	NA
PGEN_.00g262680	Scaffold_13	8035147	8035551	NA	NA	NA	NA	NA
PGEN_.00g262690	Scaffold_13	8037449	8045818	Q9CQQ4	GEMI2_MOUSE	Gem-associated protein 2 (Gemin-2) (Component of gems 2) (Survival of motor neuron protein-interacting protein 1) (SMN-interacting protein 1)	GO:0000245; GO:0000387; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0097504	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]
PGEN_.00g262700	Scaffold_13	8056921	8073596	P21613	KINH_DORPE	Kinesin heavy chain	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017; GO:0030424	axon [GO:0030424]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g262710	Scaffold_13	8089727	8092332	P21613	KINH_DORPE	Kinesin heavy chain	GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017; GO:0030424	axon [GO:0030424]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
PGEN_.00g262720	Scaffold_13	8106001	8208334	O95622	ADCY5_HUMAN	Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5)	GO:0001973; GO:0003091; GO:0004016; GO:0005524; GO:0005623; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007186; GO:0007189; GO:0007190; GO:0007191; GO:0007193; GO:0007195; GO:0007204; GO:0007626; GO:0008179; GO:0016021; GO:0034199; GO:0045111; GO:0046872; GO:0046982; GO:0050885; GO:0061178; GO:0071377; GO:0097110; GO:1904322	cell [GO:0005623]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; scaffold protein binding [GO:0097110]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase A activity [GO:0034199]; adenosine receptor signaling pathway [GO:0001973]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; renal water homeostasis [GO:0003091]
PGEN_.00g262730	Scaffold_13	8228251	8229939	NA	NA	NA	NA	NA
PGEN_.00g262740	Scaffold_13	8235924	8236535	NA	NA	NA	NA	NA
PGEN_.00g262750	Scaffold_13	8301729	8302010	NA	NA	NA	NA	NA
PGEN_.00g262760	Scaffold_13	8408921	8409259	NA	NA	NA	NA	NA
PGEN_.00g262770	Scaffold_13	8426651	8436336	NA	NA	NA	NA	NA
PGEN_.00g262780	Scaffold_13	8437465	8438019	NA	NA	NA	NA	NA
PGEN_.00g262790	Scaffold_13	8470786	8472141	NA	NA	NA	NA	NA
PGEN_.00g262800	Scaffold_13	8483325	8483540	NA	NA	NA	NA	NA
PGEN_.00g262810	Scaffold_13	8486145	8487939	NA	NA	NA	NA	NA
PGEN_.00g262820	Scaffold_13	8513203	8514393	Q96K80	ZC3HA_HUMAN	Zinc finger CCCH domain-containing protein 10	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0010608; GO:0035198; GO:0046872; GO:1903799	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"
PGEN_.00g262830	Scaffold_13	8558224	8586278	NA	NA	NA	NA	NA
PGEN_.00g262840	Scaffold_13	8597880	8603124	NA	NA	NA	NA	NA
PGEN_.00g262850	Scaffold_13	8651339	8708262	P49754	VPS41_HUMAN	Vacuolar protein sorting-associated protein 41 homolog (S53)	GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006886; GO:0006914; GO:0008017; GO:0008333; GO:0010008; GO:0015630; GO:0016020; GO:0030123; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0035542; GO:0042144; GO:0042802; GO:0043621; GO:0045055; GO:0046872; GO:0048193; GO:1902774	"AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulated exocytosis [GO:0045055]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]"
PGEN_.00g262860	Scaffold_13	8713155	8713556	NA	NA	NA	NA	NA
PGEN_.00g262870	Scaffold_13	8719789	8736827	P56223	PO6F1_RAT	"POU domain, class 6, transcription factor 1 (Brain-specific homeobox/POU domain protein 5) (Brain-5) (Brn-5)"	GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0005634; GO:0043565	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g262880	Scaffold_13	8764369	8774639	P87061	TEA1_SCHPO	Tip elongation aberrant protein 1 (Altered polarity protein 8) (Cell polarity protein tea1)	GO:0000935; GO:0008360; GO:0015630; GO:0031115; GO:0031500; GO:0032153; GO:0034613; GO:0035838; GO:0035839; GO:0035840; GO:0051285; GO:0051286; GO:0061246; GO:0099070; GO:1904511; GO:1904758; GO:1990752; GO:1990896; GO:2000771	cell cortex of cell tip [GO:0051285]; cell division site [GO:0032153]; cell tip [GO:0051286]; cytoplasmic microtubule plus-end [GO:1904511]; division septum [GO:0000935]; growing cell tip [GO:0035838]; microtubule cytoskeleton [GO:0015630]; microtubule end [GO:1990752]; non-growing cell tip [GO:0035839]; old growing cell tip [GO:0035840]; static microtubule bundle [GO:0099070]; Tea1 cell-end complex [GO:0031500]; cellular protein localization [GO:0034613]; establishment or maintenance of bipolar cell polarity regulating cell shape [GO:0061246]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000771]; protein localization to cell cortex of cell tip [GO:1990896]; protein localization to new growing cell tip [GO:1904758]; regulation of cell shape [GO:0008360]
PGEN_.00g262890	Scaffold_13	8807828	8808412	NA	NA	NA	NA	NA
PGEN_.00g262900	Scaffold_13	8855786	8858608	NA	NA	NA	NA	NA
PGEN_.00g262910	Scaffold_13	8925123	8930038	Q9HAC7	SUCHY_HUMAN	Succinate--hydroxymethylglutarate CoA-transferase (EC 2.8.3.13) (Dermal papilla-derived protein 13) (SuccinylCoA:glutarate-CoA transferase)	GO:0005739; GO:0047369	mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369]
PGEN_.00g262920	Scaffold_13	8943246	8959262	NA	NA	NA	NA	NA
PGEN_.00g262930	Scaffold_13	8968110	8979856	Q6JEL3	KLH10_RAT	Kelch-like protein 10	GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873	cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]
PGEN_.00g262940	Scaffold_13	8970659	8971063	NA	NA	NA	NA	NA
PGEN_.00g262950	Scaffold_13	8981577	8998119	NA	NA	NA	NA	NA
PGEN_.00g262960	Scaffold_13	8999323	9002368	NA	NA	NA	NA	NA
PGEN_.00g262970	Scaffold_13	9007881	9008384	NA	NA	NA	NA	NA
PGEN_.00g262980	Scaffold_13	9134863	9165916	NA	NA	NA	NA	NA
PGEN_.00g262990	Scaffold_13	9173410	9178353	NA	NA	NA	NA	NA
PGEN_.00g263000	Scaffold_13	9187128	9187814	NA	NA	NA	NA	NA
PGEN_.00g263010	Scaffold_13	9188030	9189438	NA	NA	NA	NA	NA
PGEN_.00g263020	Scaffold_13	9191236	9191646	NA	NA	NA	NA	NA
PGEN_.00g263030	Scaffold_13	9199321	9232997	O57683	SF3B1_XENLA	Splicing factor 3B subunit 1 (146 kDa nuclear protein) (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	GO:0000245; GO:0003729; GO:0005634; GO:0005681	nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; spliceosomal complex assembly [GO:0000245]
PGEN_.00g263040	Scaffold_13	9233108	9240821	Q9H8M1	CQ10B_HUMAN	"Coenzyme Q-binding protein COQ10 homolog B, mitochondrial"	GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]
PGEN_.00g263050	Scaffold_13	9279070	9346892	Q68EK2	CALRL_DANRE	Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)	GO:0001525; GO:0001756; GO:0004948; GO:0005886; GO:0007166; GO:0016021; GO:0048844; GO:0055064	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]
PGEN_.00g263060	Scaffold_13	9392179	9396387	Q9WVL2	STAT2_MOUSE	Signal transducer and activator of transcription 2	GO:0000978; GO:0001228; GO:0001932; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006952; GO:0007259; GO:0019221; GO:0042127; GO:0042802; GO:0043434; GO:0044389; GO:0045944; GO:0051607; GO:0060337; GO:0090140	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-like protein ligase binding [GO:0044389]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mitochondrial fission [GO:0090140]; regulation of protein phosphorylation [GO:0001932]; response to peptide hormone [GO:0043434]; type I interferon signaling pathway [GO:0060337]"
PGEN_.00g263070	Scaffold_13	9392438	9394263	NA	NA	NA	NA	NA
PGEN_.00g263080	Scaffold_13	9407434	9415738	NA	NA	NA	NA	NA
PGEN_.00g263090	Scaffold_13	9575660	9582612	Q8IUL8	CILP2_HUMAN	Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2]	GO:0016311; GO:0070062	extracellular exosome [GO:0070062]; dephosphorylation [GO:0016311]
PGEN_.00g263100	Scaffold_13	9594342	9600723	Q9Y2H8	ZN510_HUMAN	Zinc finger protein 510	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g263110	Scaffold_13	9622995	9640681	Q9D4P0	ARL5B_MOUSE	ADP-ribosylation factor-like protein 5B (ADP-ribosylation factor-like protein 8)	GO:0005525; GO:0005737; GO:0005802; GO:0006886; GO:0016192; GO:1903292	cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192]
PGEN_.00g263120	Scaffold_13	9645694	9649013	Q8NCW6	GLT11_HUMAN	Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11)	GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0007220; GO:0007368; GO:0008593; GO:0016021; GO:0016266; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; O-glycan processing [GO:0016266]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593]
PGEN_.00g263130	Scaffold_13	9650898	9658122	NA	NA	NA	NA	NA
PGEN_.00g263140	Scaffold_13	9658303	9659247	NA	NA	NA	NA	NA
PGEN_.00g263150	Scaffold_13	9663826	9668529	NA	NA	NA	NA	NA
PGEN_.00g263160	Scaffold_13	9695317	9700694	Q6DJR8	GLT11_XENTR	Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11)	GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0007220; GO:0007368; GO:0008593; GO:0016021; GO:0018243; GO:0030246; GO:0060271; GO:0061314	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593]
PGEN_.00g263170	Scaffold_13	9706343	9711571	O70172	PI42A_MOUSE	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(5)P-4-kinase isoform 2-alpha)	GO:0005524; GO:0005634; GO:0005776; GO:0005886; GO:0010506; GO:0016309; GO:0035855; GO:2000786	autophagosome [GO:0005776]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; megakaryocyte development [GO:0035855]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]
PGEN_.00g263180	Scaffold_13	9784488	9788170	NA	NA	NA	NA	NA
PGEN_.00g263190	Scaffold_13	9804301	9804714	NA	NA	NA	NA	NA
PGEN_.00g263200	Scaffold_13	9807112	9807606	NA	NA	NA	NA	NA
PGEN_.00g263210	Scaffold_13	9813245	9813580	NA	NA	NA	NA	NA
PGEN_.00g263220	Scaffold_13	9827084	9827425	NA	NA	NA	NA	NA
PGEN_.00g263230	Scaffold_13	9838461	9860599	NA	NA	NA	NA	NA
PGEN_.00g263240	Scaffold_13	9894619	9910439	Q5R8L2	BMI1_PONAB	Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4)	GO:0000122; GO:0000151; GO:0000792; GO:0000978; GO:0001701; GO:0005737; GO:0006306; GO:0006959; GO:0007420; GO:0008270; GO:0016573; GO:0016604; GO:0021903; GO:0030890; GO:0031519; GO:0033092; GO:0036353; GO:0045814; GO:0048103; GO:0048704; GO:0051443; GO:0097027; GO:1990841; GO:2000011; GO:2001234	"cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; ubiquitin ligase complex [GO:0000151]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103]"
PGEN_.00g263250	Scaffold_13	9949380	9950397	NA	NA	NA	NA	NA
PGEN_.00g263260	Scaffold_13	9950463	9950729	NA	NA	NA	NA	NA
PGEN_.00g263270	Scaffold_13	9951974	9952294	NA	NA	NA	NA	NA
PGEN_.00g263280	Scaffold_13	9952381	9952731	NA	NA	NA	NA	NA
PGEN_.00g263290	Scaffold_13	10010191	10020897	Q32KX7	BMI1_BOVIN	Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4)	GO:0000122; GO:0000151; GO:0000792; GO:0000978; GO:0001701; GO:0005737; GO:0006306; GO:0006342; GO:0006959; GO:0007420; GO:0008270; GO:0016573; GO:0016604; GO:0021903; GO:0030890; GO:0031519; GO:0033092; GO:0035102; GO:0036353; GO:0045814; GO:0048103; GO:0048704; GO:0051443; GO:0097027; GO:1990841; GO:2000011; GO:2001234	"cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103]"
PGEN_.00g263300	Scaffold_13	10047803	10059054	Q91648	BMI1A_XENLA	Polycomb complex protein BMI-1-A (Polycomb group RING finger protein 4-A)	GO:0006325; GO:0031519; GO:0045814; GO:0046872; GO:1990841	"PcG protein complex [GO:0031519]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; chromatin organization [GO:0006325]; negative regulation of gene expression, epigenetic [GO:0045814]"
PGEN_.00g263310	Scaffold_13	10094817	10100931	Q03938	ZNF90_HUMAN	Zinc finger protein 90 (Zinc finger protein HTF9)	GO:0003677; GO:0003700; GO:0005634; GO:0008270	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]
PGEN_.00g263320	Scaffold_13	10125970	10129157	NA	NA	NA	NA	NA
PGEN_.00g263330	Scaffold_13	10178770	10181787	Q6NS86	ZN366_MOUSE	Zinc finger protein 366 (Dendritic cell-specific transcript protein) (DC-SCRIPT)	GO:0000122; GO:0003677; GO:0003714; GO:0005634; GO:0030331; GO:0033147; GO:0043627; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to estrogen [GO:0043627]
PGEN_.00g263340	Scaffold_13	10181923	10187462	NA	NA	NA	NA	NA
PGEN_.00g263350	Scaffold_13	10194101	10199902	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g263360	Scaffold_13	10205069	10205443	NA	NA	NA	NA	NA
PGEN_.00g263370	Scaffold_13	10224939	10318553	Q2PC93	SSPO_CHICK	SCO-spondin	GO:0005615; GO:0007155; GO:0007399; GO:0030154	extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g263380	Scaffold_13	10326629	10333268	Q9P0K9	FRS1L_HUMAN	DOMON domain-containing protein FRRS1L (Brain protein CG-6) (Ferric-chelate reductase 1-like protein)	GO:0005886; GO:0016021; GO:0030054; GO:0045202; GO:0099072; GO:1900449	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]
PGEN_.00g263390	Scaffold_13	10418184	10435851	NA	NA	NA	NA	NA
PGEN_.00g263400	Scaffold_13	10435902	10442953	Q9WUW8	ST1C2_RAT	Sulfotransferase 1C2 (ST1C2) (rSULT1C2) (EC 2.8.2.-) (Sulfotransferase K1)	GO:0005764; GO:0008146	lysosome [GO:0005764]; sulfotransferase activity [GO:0008146]
PGEN_.00g263410	Scaffold_13	10546271	10548941	NA	NA	NA	NA	NA
PGEN_.00g263420	Scaffold_13	10555054	10587339	Q9Z2J0	S23A1_MOUSE	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)	GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016021; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g263430	Scaffold_13	10592701	10595727	NA	NA	NA	NA	NA
PGEN_.00g263440	Scaffold_13	10675692	10704123	Q70E73	RAPH1_HUMAN	Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1)	GO:0005829; GO:0005856; GO:0005886; GO:0007165; GO:0016604; GO:0030027; GO:0030175; GO:0048675	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; axon extension [GO:0048675]; signal transduction [GO:0007165]
PGEN_.00g263450	Scaffold_13	10716235	10716768	NA	NA	NA	NA	NA
PGEN_.00g263460	Scaffold_13	10717089	10725689	Q8R5A3	AB1IP_MOUSE	Amyloid beta A4 precursor protein-binding family B member 1-interacting protein (APBB1-interacting protein 1) (Proline-rich EVH1 ligand 1) (PREL-1) (Proline-rich protein 48)	GO:0002291; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007165; GO:0030027; GO:0042101; GO:0045785	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; positive regulation of cell adhesion [GO:0045785]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]
PGEN_.00g263470	Scaffold_13	10735609	10747653	B0JZG0	S23A2_XENTR	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	GO:0016021; GO:0019852; GO:0070890	integral component of membrane [GO:0016021]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]
PGEN_.00g263480	Scaffold_13	10752471	10765506	NA	NA	NA	NA	NA
PGEN_.00g263490	Scaffold_13	10831179	10836905	NA	NA	NA	NA	NA
PGEN_.00g263500	Scaffold_13	10860916	10873214	A2AWP0	BIRC7_MOUSE	Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (Livin) (RING-type E3 ubiquitin transferase BIRC7) [Cleaved into: Baculoviral IAP repeat-containing protein 7 30 kDa subunit (Truncated livin) (p30-Livin) (tLivin)]	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0016567; GO:0031398; GO:0042127; GO:0043027; GO:0043066; GO:0043154; GO:0046872; GO:0061630; GO:0070247; GO:1990001	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of natural killer cell apoptotic process [GO:0070247]
PGEN_.00g263510	Scaffold_13	10909300	10927122	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g263520	Scaffold_13	10931239	10950251	Q9Z2J0	S23A1_MOUSE	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)	GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016021; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g263530	Scaffold_13	10952465	10952875	NA	NA	NA	NA	NA
PGEN_.00g263540	Scaffold_13	10959600	10979453	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g263550	Scaffold_13	10985839	10993739	NA	NA	NA	NA	NA
PGEN_.00g263560	Scaffold_13	11015640	11016461	NA	NA	NA	NA	NA
PGEN_.00g263570	Scaffold_13	11033790	11087602	Q8IYJ2	CJ067_HUMAN	"Uncharacterized protein C10orf67, mitochondrial"	GO:0005739	mitochondrion [GO:0005739]
PGEN_.00g263580	Scaffold_13	11097655	11114473	Q9VL06	UFD4_DROME	E3 ubiquitin-protein ligase Ufd4 (EC 2.3.2.26) (Ubiquitin fusion-degradation 4-like)	GO:0004842; GO:0005634; GO:0006511; GO:0046872; GO:0070534	nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K63-linked ubiquitination [GO:0070534]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g263590	Scaffold_13	11118386	11137086	Q4U2R1	HERC2_MOUSE	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g263600	Scaffold_13	11151830	11172663	Q4U2R1	HERC2_MOUSE	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g263610	Scaffold_13	11177964	11178389	NA	NA	NA	NA	NA
PGEN_.00g263620	Scaffold_13	11180167	11182153	Q4U2R1	HERC2_MOUSE	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g263630	Scaffold_13	11190844	11199899	Q8N693	ESX1_HUMAN	"Homeobox protein ESX1 (Extraembryonic, spermatogenesis, homeobox 1) [Cleaved into: Homeobox protein ESX1-N; Homeobox protein ESX1-C]"	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005737; GO:0016607; GO:0043565; GO:0045892; GO:0051726	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]"
PGEN_.00g263640	Scaffold_13	11229552	11255398	Q5U4E6	GOGA4_RAT	Golgin subfamily A member 4	GO:0000139; GO:0005737; GO:0005794; GO:0043001; GO:0045773; GO:0051020	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]
PGEN_.00g263650	Scaffold_13	11257828	11258879	NA	NA	NA	NA	NA
PGEN_.00g263660	Scaffold_13	11265482	11268831	P58780	ADA2_PIG	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	GO:0004000; GO:0005615; GO:0006154; GO:0008201; GO:0008270; GO:0031685; GO:0043394; GO:0046103	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]
PGEN_.00g263670	Scaffold_13	11275092	11280404	P58780	ADA2_PIG	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	GO:0004000; GO:0005615; GO:0006154; GO:0008201; GO:0008270; GO:0031685; GO:0043394; GO:0046103	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]
PGEN_.00g263680	Scaffold_13	11281679	11294010	P58780	ADA2_PIG	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	GO:0004000; GO:0005615; GO:0006154; GO:0008201; GO:0008270; GO:0031685; GO:0043394; GO:0046103	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]
PGEN_.00g263690	Scaffold_13	11299652	11302295	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g263700	Scaffold_13	11302603	11303412	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g263710	Scaffold_13	11308861	11313788	NA	NA	NA	NA	NA
PGEN_.00g263720	Scaffold_13	11317812	11319549	NA	NA	NA	NA	NA
PGEN_.00g263730	Scaffold_13	11342910	11343182	NA	NA	NA	NA	NA
PGEN_.00g263740	Scaffold_13	11355818	11386345	NA	NA	NA	NA	NA
PGEN_.00g263750	Scaffold_13	11393034	11399271	Q7Z6J8	UBE3D_HUMAN	E3 ubiquitin-protein ligase E3D (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase E3D) (UbcH10-binding protein with a HECT-like domain) (Ubiquitin-conjugating enzyme E2C-binding protein)	GO:0000151; GO:0000209; GO:0005634; GO:0005829; GO:0006513; GO:0030332; GO:0031624; GO:0043161; GO:0044390; GO:0051865; GO:0061630	cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cyclin binding [GO:0030332]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]
PGEN_.00g263760	Scaffold_13	11399802	11403111	NA	NA	NA	NA	NA
PGEN_.00g263770	Scaffold_13	11416111	11438914	Q9XTA0	DOPO_HORSE	Dopamine beta-hydroxylase (EC 1.14.17.1) [Cleaved into: Soluble dopamine beta-hydroxylase]	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030658; GO:0030667; GO:0031418; GO:0034466; GO:0034774; GO:0042420; GO:0042421; GO:0042584	"chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g263780	Scaffold_13	11462418	11464204	NA	NA	NA	NA	NA
PGEN_.00g263790	Scaffold_13	11481800	11500700	Q9I926	FUCL6_ANGJA	Fucolectin-6	GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088	"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
PGEN_.00g263800	Scaffold_13	11553636	11556572	NA	NA	NA	NA	NA
PGEN_.00g263810	Scaffold_13	11556678	11557127	NA	NA	NA	NA	NA
PGEN_.00g263820	Scaffold_13	11558052	11564103	O75973	C1QRF_HUMAN	C1q-related factor (C1q and tumor necrosis factor-related protein 14) (C1q/TNF-related protein 14) (Complement component 1 Q subcomponent-like 1)	GO:0005102; GO:0005581; GO:0005737; GO:0007626; GO:0016322; GO:0043083; GO:0044301; GO:0061743; GO:0098793; GO:0099558	climbing fiber [GO:0044301]; collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; presynapse [GO:0098793]; synaptic cleft [GO:0043083]; signaling receptor binding [GO:0005102]; locomotory behavior [GO:0007626]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; neuron remodeling [GO:0016322]
PGEN_.00g263830	Scaffold_13	11567892	11573093	NA	NA	NA	NA	NA
PGEN_.00g263840	Scaffold_13	11679745	11681494	NA	NA	NA	NA	NA
PGEN_.00g263850	Scaffold_13	11688550	11716282	A5A8Y8	EGFL8_PIG	Epidermal growth factor-like protein 8 (EGF-like protein 8)	GO:0005102; GO:0005509; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g263860	Scaffold_13	11722657	11741290	P61290	PSME3_MOUSE	Proteasome activator complex subunit 3 (11S regulator complex subunit gamma) (REG-gamma) (Activator of multicatalytic protease subunit 3) (Ki nuclear autoantigen) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma)	GO:0002039; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007049; GO:0008537; GO:0010950; GO:0042802; GO:0061133; GO:0061136; GO:0097371; GO:2000045; GO:2001237	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]
PGEN_.00g263870	Scaffold_13	11746092	11793296	Q17R14	MYO1D_BOVIN	Unconventional myosin-Id	GO:0000146; GO:0005516; GO:0005524; GO:0005768; GO:0005769; GO:0005790; GO:0005829; GO:0005903; GO:0005938; GO:0010923; GO:0015031; GO:0016323; GO:0016459; GO:0030424; GO:0030673; GO:0030898; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0048306; GO:0051015; GO:0051641; GO:0061502; GO:0097440	apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; smooth endoplasmic reticulum [GO:0005790]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; negative regulation of phosphatase activity [GO:0010923]; protein transport [GO:0015031]
PGEN_.00g263880	Scaffold_13	11814526	11830199	NA	NA	NA	NA	NA
PGEN_.00g263890	Scaffold_13	11830793	11831227	NA	NA	NA	NA	NA
PGEN_.00g263900	Scaffold_13	11831965	11889896	Q9VZZ4	PXDN_DROME	Peroxidasin (EC 1.11.1.7)	GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]
PGEN_.00g263910	Scaffold_13	11942034	11960406	P35419	PERT_MOUSE	Thyroid peroxidase (TPO) (EC 1.11.1.8)	GO:0004447; GO:0004601; GO:0005509; GO:0005615; GO:0005739; GO:0005886; GO:0006590; GO:0006979; GO:0009986; GO:0016021; GO:0020037; GO:0035162; GO:0042446; GO:0042744	cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]; embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]
PGEN_.00g263920	Scaffold_13	11995022	12009433	Q23490	MLT7_CAEEL	Peroxidase mlt-7 (EC 1.11.1.7) (Molting defective protein 7) (MoLT-7) [Cleaved into: Peroxidase mlt-7 light chain; Peroxidase mlt-7 heavy chain]	GO:0002119; GO:0004601; GO:0005615; GO:0006979; GO:0018149; GO:0020037; GO:0040032; GO:0042338; GO:0046872	extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]; nematode larval development [GO:0002119]; peptide cross-linking [GO:0018149]; post-embryonic body morphogenesis [GO:0040032]; response to oxidative stress [GO:0006979]
PGEN_.00g263930	Scaffold_13	12039790	12071064	Q1ENI8	PXDN_CAEEL	Peroxidasin homolog (EC 1.11.1.7)	GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0010172; GO:0020037; GO:0042744; GO:0046872; GO:0048679	basement membrane [GO:0005604]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]
PGEN_.00g263940	Scaffold_13	12114143	12117381	NA	NA	NA	NA	NA
PGEN_.00g263950	Scaffold_13	12119520	12122701	NA	NA	NA	NA	NA
PGEN_.00g263960	Scaffold_13	12137406	12137756	NA	NA	NA	NA	NA
PGEN_.00g263970	Scaffold_13	12138113	12138460	NA	NA	NA	NA	NA
PGEN_.00g263980	Scaffold_13	12141208	12141498	NA	NA	NA	NA	NA
PGEN_.00g263990	Scaffold_13	12141769	12142089	NA	NA	NA	NA	NA
PGEN_.00g264000	Scaffold_13	12165790	12166578	NA	NA	NA	NA	NA
PGEN_.00g264010	Scaffold_13	12168010	12168267	NA	NA	NA	NA	NA
PGEN_.00g264020	Scaffold_13	12187070	12223834	Q92626	PXDN_HUMAN	Peroxidasin homolog (EC 1.11.1.7) (Melanoma-associated antigen MG50) (Vascular peroxidase 1) (p53-responsive gene 2 protein)	GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0046872; GO:0055114; GO:0062023; GO:0070062; GO:0070831	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]
PGEN_.00g264030	Scaffold_13	12224991	12225587	NA	NA	NA	NA	NA
PGEN_.00g264040	Scaffold_13	12226016	12226426	NA	NA	NA	NA	NA
PGEN_.00g264050	Scaffold_13	12226964	12227281	NA	NA	NA	NA	NA
PGEN_.00g264060	Scaffold_13	12227762	12228556	NA	NA	NA	NA	NA
PGEN_.00g264070	Scaffold_13	12228751	12230173	NA	NA	NA	NA	NA
PGEN_.00g264080	Scaffold_13	12237213	12239233	NA	NA	NA	NA	NA
PGEN_.00g264090	Scaffold_13	12330460	12336250	Q5XWD5	IF_CANLF	Cobalamin binding intrinsic factor (Gastric intrinsic factor) (Intrinsic factor) (IF) (INF) (Pancreatic intrinsic factor)	GO:0005576; GO:0006824; GO:0015889; GO:0031419	extracellular region [GO:0005576]; cobalamin binding [GO:0031419]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824]
PGEN_.00g264100	Scaffold_13	12338565	12339392	NA	NA	NA	NA	NA
PGEN_.00g264110	Scaffold_13	12357142	12361139	NA	NA	NA	NA	NA
PGEN_.00g264120	Scaffold_13	12367849	12368379	NA	NA	NA	NA	NA
PGEN_.00g264130	Scaffold_13	12373443	12376482	Q3U5Q7	CMPK2_MOUSE	"UMP-CMP kinase 2, mitochondrial (EC 2.7.4.14) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Thymidylate kinase LPS-inducible member) (TYKi)"	GO:0004127; GO:0004550; GO:0004798; GO:0005524; GO:0005737; GO:0005739; GO:0006165; GO:0006227; GO:0006233; GO:0006235; GO:0009041; GO:0009142; GO:0033862; GO:0071222	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]; uridylate kinase activity [GO:0009041]; cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]
PGEN_.00g264140	Scaffold_13	12376625	12411350	Q9BUQ8	DDX23_HUMAN	Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD)	GO:0000354; GO:0000375; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0070062; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"
PGEN_.00g264150	Scaffold_13	12411773	12441851	Q05AM5	ELP2_DANRE	Elongator complex protein 2 (ELP2)	GO:0002098; GO:0005737; GO:0008023; GO:0033588	cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; transcription elongation factor complex [GO:0008023]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g264160	Scaffold_13	12446421	12475644	Q9P2P5	HECW2_HUMAN	"E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2)"	GO:0000209; GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0043161; GO:0045732; GO:0048814; GO:0061630; GO:0072686; GO:2000650	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g264170	Scaffold_13	12486706	12504870	Q6I6G8	HECW2_MOUSE	"E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2)"	GO:0000209; GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0043161; GO:0045732; GO:0048814; GO:0061630; GO:0072686; GO:2000650	cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g264180	Scaffold_13	12520399	12549648	Q99728	BARD1_HUMAN	BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1)	GO:0000151; GO:0000729; GO:0001894; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006303; GO:0006974; GO:0007050; GO:0016567; GO:0016579; GO:0016607; GO:0019900; GO:0031436; GO:0031441; GO:0036464; GO:0042325; GO:0042803; GO:0043065; GO:0043066; GO:0045732; GO:0046826; GO:0046872; GO:0046982; GO:0070531; GO:0085020; GO:1901796	BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein deubiquitination [GO:0016579]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of phosphorylation [GO:0042325]; regulation of signal transduction by p53 class mediator [GO:1901796]; tissue homeostasis [GO:0001894]
PGEN_.00g264190	Scaffold_13	12556872	12557264	NA	NA	NA	NA	NA
PGEN_.00g264200	Scaffold_13	12557345	12557818	NA	NA	NA	NA	NA
PGEN_.00g264210	Scaffold_13	12559918	12565804	Q3T001	H17B6_BOVIN	17-beta-hydroxysteroid dehydrogenase type 6 (17-beta-HSD 6) (17-beta-HSD6) (EC 1.1.1.105) (EC 1.1.1.239) (EC 1.1.1.62) (3-alpha->beta-hydroxysteroid epimerase) (3-alpha->beta-HSE) (Oxidative 3-alpha hydroxysteroid dehydrogenase)	GO:0004303; GO:0004745; GO:0005789; GO:0008202; GO:0047035	endoplasmic reticulum membrane [GO:0005789]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; steroid metabolic process [GO:0008202]
PGEN_.00g264220	Scaffold_13	12569524	12587027	Q9WV72	ASB3_MOUSE	Ankyrin repeat and SOCS box protein 3 (ASB-3)	GO:0016567; GO:0035556	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]
PGEN_.00g264230	Scaffold_13	12623243	12624118	NA	NA	NA	NA	NA
PGEN_.00g264240	Scaffold_13	12624160	12624966	NA	NA	NA	NA	NA
PGEN_.00g264250	Scaffold_13	12636199	12637347	NA	NA	NA	NA	NA
PGEN_.00g264260	Scaffold_13	12658239	12658643	NA	NA	NA	NA	NA
PGEN_.00g264270	Scaffold_13	12662468	12665496	O61643	INHB_DROME	Inhibin beta chain (Activin beta chain) (dAct) (dActivin)	GO:0002052; GO:0005125; GO:0005160; GO:0005615; GO:0008083; GO:0009749; GO:0010862; GO:0016319; GO:0032924; GO:0042593; GO:0042981; GO:0043408; GO:0044719; GO:0045464; GO:0045572; GO:0048468; GO:0050803; GO:0060395	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; activin receptor signaling pathway [GO:0032924]; cell development [GO:0048468]; glucose homeostasis [GO:0042593]; mushroom body development [GO:0016319]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; R8 cell fate specification [GO:0045464]; regulation of apoptotic process [GO:0042981]; regulation of imaginal disc-derived wing size [GO:0044719]; regulation of MAPK cascade [GO:0043408]; regulation of synapse structure or activity [GO:0050803]; response to glucose [GO:0009749]; SMAD protein signal transduction [GO:0060395]
PGEN_.00g264280	Scaffold_13	12670996	12673689	NA	NA	NA	NA	NA
PGEN_.00g264290	Scaffold_13	12722387	12729622	Q6AY55	DCAKD_RAT	Dephospho-CoA kinase domain-containing protein	GO:0004140; GO:0005524; GO:0015937	ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; coenzyme A biosynthetic process [GO:0015937]
PGEN_.00g264300	Scaffold_13	12729674	12738286	Q8K2X2	RBM48_MOUSE	RNA-binding protein 48	GO:0003723; GO:0005654	nucleoplasm [GO:0005654]; RNA binding [GO:0003723]
PGEN_.00g264310	Scaffold_13	12738444	12741401	NA	NA	NA	NA	NA
PGEN_.00g264320	Scaffold_13	12745295	12745561	NA	NA	NA	NA	NA
PGEN_.00g264330	Scaffold_13	12745841	12746239	NA	NA	NA	NA	NA
PGEN_.00g264340	Scaffold_13	12746334	12746600	NA	NA	NA	NA	NA
PGEN_.00g264350	Scaffold_13	12746658	12747110	NA	NA	NA	NA	NA
PGEN_.00g264360	Scaffold_13	12747151	12747429	NA	NA	NA	NA	NA
PGEN_.00g264370	Scaffold_13	12748263	12769870	Q49MI3	CERKL_HUMAN	Ceramide kinase-like protein	GO:0001750; GO:0001917; GO:0003951; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0030148; GO:0043066; GO:0046625; GO:0048471	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; NAD+ kinase activity [GO:0003951]; sphingolipid binding [GO:0046625]; negative regulation of apoptotic process [GO:0043066]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g264380	Scaffold_13	12759130	12762861	NA	NA	NA	NA	NA
PGEN_.00g264390	Scaffold_13	12820637	12824774	NA	NA	NA	NA	NA
PGEN_.00g264400	Scaffold_13	12825284	12842927	Q9H0H5	RGAP1_HUMAN	Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4)	GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005874; GO:0006890; GO:0007018; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019886; GO:0019901; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0035556; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149	"acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]"
PGEN_.00g264410	Scaffold_13	12849238	12854086	A4QN56	MFS4B_DANRE	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g264420	Scaffold_13	12854715	12855408	NA	NA	NA	NA	NA
PGEN_.00g264430	Scaffold_13	12858494	12862672	NA	NA	NA	NA	NA
PGEN_.00g264440	Scaffold_13	12876432	12897709	Q9JLJ2	AL9A1_MOUSE	4-trimethylaminobutyraldehyde dehydrogenase (TMABA-DH) (TMABADH) (EC 1.2.1.47) (Aldehyde dehydrogenase family 9 member A1) (EC 1.2.1.3)	GO:0004029; GO:0005739; GO:0005829; GO:0006081; GO:0009437; GO:0016620; GO:0019145; GO:0042136; GO:0042802; GO:0043176; GO:0043878; GO:0045329; GO:0047105; GO:0051287; GO:0051289; GO:0055114	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; amine binding [GO:0043176]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process [GO:0009437]; cellular aldehyde metabolic process [GO:0006081]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
PGEN_.00g264450	Scaffold_13	12898512	12928992	NA	NA	NA	NA	NA
PGEN_.00g264460	Scaffold_13	12941316	12946250	NA	NA	NA	NA	NA
PGEN_.00g264470	Scaffold_13	12954151	12955365	NA	NA	NA	NA	NA
PGEN_.00g264480	Scaffold_13	12970327	12989881	O61267	LOK_DROME	Ovarian-specific serine/threonine-protein kinase Lok (EC 2.7.11.1) (Protein loki) (dMNK)	GO:0000077; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006282; GO:0006468; GO:0006915; GO:0006919; GO:0006974; GO:0007281; GO:0008630; GO:0016607; GO:0030717; GO:0035234; GO:0042770; GO:0044773; GO:0045944; GO:0050321; GO:0051091; GO:0071480; GO:0071481; GO:0072332	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint [GO:0000077]; ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic DNA damage checkpoint [GO:0044773]; oocyte karyosome formation [GO:0030717]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; signal transduction in response to DNA damage [GO:0042770]
PGEN_.00g264490	Scaffold_13	13000296	13000628	NA	NA	NA	NA	NA
PGEN_.00g264500	Scaffold_13	13013582	13027276	NA	NA	NA	NA	NA
PGEN_.00g264510	Scaffold_13	13027439	13131780	P83038	HDAC4_CHICK	Histone deacetylase 4 (HD4) (EC 3.5.1.98)	GO:0000118; GO:0000978; GO:0001085; GO:0001501; GO:0002076; GO:0003682; GO:0003714; GO:0004407; GO:0005829; GO:0006325; GO:0006338; GO:0006954; GO:0007399; GO:0008134; GO:0008270; GO:0008284; GO:0008285; GO:0010832; GO:0010882; GO:0014894; GO:0016607; GO:0017053; GO:0019901; GO:0030183; GO:0030955; GO:0031594; GO:0032041; GO:0033235; GO:0033613; GO:0034983; GO:0040029; GO:0042113; GO:0042641; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0045668; GO:0045820; GO:0045843; GO:0045892; GO:0045944; GO:0048742; GO:0051091; GO:0070491; GO:0070555; GO:0070933; GO:1902894	"actomyosin [GO:0042641]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]"
PGEN_.00g264520	Scaffold_13	13132310	13152318	NA	NA	NA	NA	NA
PGEN_.00g264530	Scaffold_13	13169352	13191007	Q5FW42	DCTN2_XENTR	Dynactin subunit 2	GO:0003774; GO:0005737; GO:0005813; GO:0005869; GO:0005874; GO:0007052; GO:0016020; GO:0030286; GO:0031982	centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; motor activity [GO:0003774]; mitotic spindle organization [GO:0007052]
PGEN_.00g264540	Scaffold_13	13212428	13244218	Q99MU3	DSRAD_MOUSE	Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (RNA adenosine deaminase 1)	GO:0001649; GO:0001701; GO:0002244; GO:0002566; GO:0003692; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016553; GO:0016607; GO:0030218; GO:0031054; GO:0035196; GO:0035280; GO:0035455; GO:0043066; GO:0044387; GO:0044530; GO:0045070; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0098586; GO:1900369	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; left-handed Z-DNA binding [GO:0003692]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566]
PGEN_.00g264550	Scaffold_13	13261799	13266758	NA	NA	NA	NA	NA
PGEN_.00g264560	Scaffold_13	13286033	13286362	NA	NA	NA	NA	NA
PGEN_.00g264570	Scaffold_13	13286411	13286656	NA	NA	NA	NA	NA
PGEN_.00g264580	Scaffold_13	13298401	13299879	NA	NA	NA	NA	NA
PGEN_.00g264590	Scaffold_13	13324640	13326946	NA	NA	NA	NA	NA
PGEN_.00g264600	Scaffold_13	13342742	13367275	Q91687	ITA4_XENLA	Integrin alpha-4 (Integrin alpha-IV) (VLA-4 subunit alpha)	GO:0007155; GO:0007229; GO:0008305; GO:0046872	integrin complex [GO:0008305]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]
PGEN_.00g264610	Scaffold_13	13378275	13378949	NA	NA	NA	NA	NA
PGEN_.00g264620	Scaffold_13	13385815	13396965	P61158	ARP3_HUMAN	Actin-related protein 3 (Actin-like protein 3)	GO:0003779; GO:0005200; GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0005903; GO:0005911; GO:0005925; GO:0007163; GO:0008356; GO:0015629; GO:0016020; GO:0016344; GO:0030027; GO:0030479; GO:0033206; GO:0034314; GO:0035861; GO:0038096; GO:0045944; GO:0048013; GO:0051653; GO:0060271; GO:0061024; GO:0070062; GO:0070358; GO:0071346	actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; brush border [GO:0005903]; cell [GO:0005623]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cilium assembly [GO:0060271]; ephrin receptor signaling pathway [GO:0048013]; establishment or maintenance of cell polarity [GO:0007163]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; membrane organization [GO:0061024]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spindle localization [GO:0051653]
PGEN_.00g264630	Scaffold_13	13398495	13399796	NA	NA	NA	NA	NA
PGEN_.00g264640	Scaffold_13	13400281	13407446	Q503Y4	OVCA2_DANRE	Esterase OVCA2 (EC 3.1.2.-) (Ovarian cancer-associated gene 2 protein homolog)	GO:0005634; GO:0005737; GO:0016787; GO:0032526	cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; response to retinoic acid [GO:0032526]
PGEN_.00g264650	Scaffold_13	13412321	13417093	Q00420	GABP1_MOUSE	GA-binding protein subunit beta-1 (GABP subunit beta-1) (GABPB-1) (GABP subunit beta-2) (GABPB-2)	GO:0005634; GO:0005654; GO:0036464; GO:0044212; GO:0045944; GO:0046982	cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g264660	Scaffold_13	13418375	13442672	A4QN56	MFS4B_DANRE	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g264670	Scaffold_13	13514597	13516032	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g264680	Scaffold_13	13521607	13531420	NA	NA	NA	NA	NA
PGEN_.00g264690	Scaffold_13	13567513	13568624	NA	NA	NA	NA	NA
PGEN_.00g264700	Scaffold_13	13578879	13639233	Q9WV18	GABR1_MOUSE	Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)	GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005887; GO:0007193; GO:0007194; GO:0007214; GO:0008021; GO:0008134; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030054; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0038037; GO:0038039; GO:0042734; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043231; GO:0045121; GO:0045211; GO:0046982; GO:0050805; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099579; GO:0150099; GO:1902710; GO:1990430	axolemma [GO:0030673]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]
PGEN_.00g264710	Scaffold_13	13640532	13658032	Q95ZJ1	GALT5_CAEEL	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g264720	Scaffold_13	13661096	13716211	NA	NA	NA	NA	NA
PGEN_.00g264730	Scaffold_13	13722935	13732116	Q5R5Z5	ARPC2_PONAB	Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC)	GO:0005200; GO:0005634; GO:0005768; GO:0005885; GO:0005925; GO:0010592; GO:0030027; GO:0030041; GO:0034314; GO:0035861; GO:0036195; GO:0043005; GO:0051015; GO:0098978; GO:1900026	Arp2/3 protein complex [GO:0005885]; endosome [GO:0005768]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; muscle cell projection membrane [GO:0036195]; neuron projection [GO:0043005]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]
PGEN_.00g264740	Scaffold_13	13737433	13773337	A0JPH4	SCAP_XENLA	Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein)	GO:0000139; GO:0005789; GO:0008203; GO:0012507; GO:0016021; GO:0032933; GO:0032934	endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sterol binding [GO:0032934]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]
PGEN_.00g264750	Scaffold_13	13783981	13786863	NA	NA	NA	NA	NA
PGEN_.00g264760	Scaffold_13	13792676	13795246	NA	NA	NA	NA	NA
PGEN_.00g264770	Scaffold_13	13799938	13820287	Q504Y3	ZCPW2_HUMAN	Zinc finger CW-type PWWP domain protein 2	GO:0008270	zinc ion binding [GO:0008270]
PGEN_.00g264780	Scaffold_13	13843720	13863414	Q9Y2Y6	TMM98_HUMAN	Transmembrane protein 98 (Protein TADA1)	GO:0005615; GO:0005783; GO:0005789; GO:0005886; GO:0010955; GO:0016021; GO:0031642; GO:0045063; GO:0048715; GO:0070062; GO:1900181	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of myelination [GO:0031642]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein processing [GO:0010955]; T-helper 1 cell differentiation [GO:0045063]
PGEN_.00g264790	Scaffold_13	13880310	13887390	NA	NA	NA	NA	NA
PGEN_.00g264800	Scaffold_13	13915171	13923228	Q5F485	DDX42_CHICK	ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42)	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0008104; GO:0042981	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]
PGEN_.00g264810	Scaffold_13	13948486	13948905	NA	NA	NA	NA	NA
PGEN_.00g264820	Scaffold_13	13954259	13968532	NA	NA	NA	NA	NA
PGEN_.00g264830	Scaffold_13	14076203	14076475	NA	NA	NA	NA	NA
PGEN_.00g264840	Scaffold_13	14082680	14087538	NA	NA	NA	NA	NA
PGEN_.00g264850	Scaffold_13	14098745	14109705	NA	NA	NA	NA	NA
PGEN_.00g264860	Scaffold_13	14153269	14153517	NA	NA	NA	NA	NA
PGEN_.00g264870	Scaffold_13	14203891	14205337	NA	NA	NA	NA	NA
PGEN_.00g264880	Scaffold_13	14225603	14235629	NA	NA	NA	NA	NA
PGEN_.00g264890	Scaffold_13	14248673	14248987	NA	NA	NA	NA	NA
PGEN_.00g264900	Scaffold_13	14250444	14259886	Q14679	TTLL4_HUMAN	Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4)	GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0070739	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]
PGEN_.00g264910	Scaffold_13	14276691	14279847	P70097	C560_CRIGR	"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1) (QPs1)"	GO:0000104; GO:0005743; GO:0005749; GO:0006099; GO:0009055; GO:0016021; GO:0020037; GO:0046872	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]; tricarboxylic acid cycle [GO:0006099]"
PGEN_.00g264920	Scaffold_13	14302835	14308368	NA	NA	NA	NA	NA
PGEN_.00g264930	Scaffold_13	14329998	14335606	Q6DFQ7	TM198_XENTR	Transmembrane protein 198	GO:0005886; GO:0007275; GO:0012506; GO:0016021; GO:0016055; GO:0031410; GO:0090263	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; multicellular organism development [GO:0007275]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]
PGEN_.00g264940	Scaffold_13	14421555	14435848	Q5USV6	GDF8_SYLGR	Growth/differentiation factor 8 (GDF-8) (Myostatin)	GO:0005125; GO:0005615; GO:0008083; GO:0008201; GO:0010592; GO:0010759; GO:0014839; GO:0042802	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]
PGEN_.00g264950	Scaffold_13	14442124	14470697	Q28G67	ABITM_XENTR	Protein Abitram (Actin-binding transcription modulator) (Protein Simiate)	GO:0016607; GO:0030027; GO:0030425; GO:0030426; GO:0030833; GO:0032433; GO:0048813; GO:0051489	dendrite [GO:0030425]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; dendrite morphogenesis [GO:0048813]; regulation of actin filament polymerization [GO:0030833]; regulation of filopodium assembly [GO:0051489]
PGEN_.00g264960	Scaffold_13	14478292	14521761	O08912	GALT1_MOUSE	Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]	GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0016021; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g264970	Scaffold_13	14532819	14541587	P0DMQ6	DHSO_CHICK	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase)	GO:0003939; GO:0006000; GO:0006061; GO:0006062; GO:0006116; GO:0006735; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0032991; GO:0042802; GO:0046370; GO:0051160; GO:0051287; GO:0070062	extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]
PGEN_.00g264980	Scaffold_13	14544405	14551830	Q503F2	BARX1_DANRE	Homeobox protein BarH-like 1 (BarH-class homeodomain transcription factor 4)	GO:0000977; GO:0001228; GO:0002053; GO:0005634; GO:0006357; GO:0009888; GO:0048513; GO:0051216; GO:0060037	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; animal organ development [GO:0048513]; cartilage development [GO:0051216]; pharyngeal system development [GO:0060037]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue development [GO:0009888]"
PGEN_.00g264990	Scaffold_13	14559606	14563426	NA	NA	NA	NA	NA
PGEN_.00g265000	Scaffold_13	14578820	14604895	NA	NA	NA	NA	NA
PGEN_.00g265010	Scaffold_13	14727726	14737022	B0JZG0	S23A2_XENTR	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	GO:0016021; GO:0019852; GO:0070890	integral component of membrane [GO:0016021]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]
PGEN_.00g265020	Scaffold_13	14803400	14839203	P41593	PTH1R_MOUSE	Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor)	GO:0001501; GO:0001503; GO:0001701; GO:0002062; GO:0002076; GO:0004991; GO:0005623; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006874; GO:0007166; GO:0007187; GO:0007188; GO:0007189; GO:0007200; GO:0007204; GO:0007568; GO:0008284; GO:0008285; GO:0008528; GO:0016323; GO:0016324; GO:0017046; GO:0030282; GO:0031526; GO:0042803; GO:0043235; GO:0043621; GO:0045453; GO:0048469; GO:0060732	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled peptide receptor activity [GO:0008528]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; aging [GO:0007568]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cell maturation [GO:0048469]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; chondrocyte differentiation [GO:0002062]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; in utero embryonic development [GO:0001701]; negative regulation of cell population proliferation [GO:0008285]; ossification [GO:0001503]; osteoblast development [GO:0002076]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; skeletal system development [GO:0001501]"
PGEN_.00g265030	Scaffold_13	14842775	14854983	NA	NA	NA	NA	NA
PGEN_.00g265040	Scaffold_13	14856534	14862691	Q9H8Y5	ANKZ1_HUMAN	Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744)	GO:0003676; GO:0005737; GO:0016020; GO:0030433; GO:0036266; GO:0046872; GO:0070301; GO:0071630; GO:0072671	Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g265050	Scaffold_13	14892031	14895571	NA	NA	NA	NA	NA
PGEN_.00g265060	Scaffold_13	14934482	14936817	NA	NA	NA	NA	NA
PGEN_.00g265070	Scaffold_13	15053395	15053742	NA	NA	NA	NA	NA
PGEN_.00g265080	Scaffold_13	15102735	15128216	NA	NA	NA	NA	NA
PGEN_.00g265090	Scaffold_13	15128684	15133212	Q25414	5HTR_LYMST	5-hydroxytryptamine receptor (5-HT receptor) (Serotonin receptor)	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g265100	Scaffold_13	15166449	15176430	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g265110	Scaffold_13	15177067	15197366	Q5FWI3	CEIP2_MOUSE	Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2)	GO:0001525; GO:0004415; GO:0005509; GO:0005886; GO:0005887; GO:0030214; GO:0043231; GO:1903670	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]
PGEN_.00g265120	Scaffold_13	15200800	15201015	NA	NA	NA	NA	NA
PGEN_.00g265130	Scaffold_13	15201064	15201297	NA	NA	NA	NA	NA
PGEN_.00g265140	Scaffold_13	15201327	15201647	NA	NA	NA	NA	NA
PGEN_.00g265150	Scaffold_13	15201833	15202048	NA	NA	NA	NA	NA
PGEN_.00g265160	Scaffold_13	15202111	15202431	NA	NA	NA	NA	NA
PGEN_.00g265170	Scaffold_13	15205868	15225089	Q95ZJ1	GALT5_CAEEL	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g265180	Scaffold_13	15311296	15312291	NA	NA	NA	NA	NA
PGEN_.00g265190	Scaffold_13	15322775	15333753	Q1RMT1	ERCC3_BOVIN	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA excision repair protein ERCC-3)	GO:0000112; GO:0000717; GO:0003677; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006362; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008134; GO:0008353; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0045944; GO:0047485; GO:0048568; GO:0097550; GO:1901990; GO:1990841	"nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH holo complex [GO:0005675]; transcriptional preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"
PGEN_.00g265200	Scaffold_13	15334632	15347334	P49135	ERCC3_MOUSE	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH 89 kDa subunit) (Xeroderma pigmentosum group B-complementing protein)	GO:0000112; GO:0000439; GO:0000717; GO:0001666; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006362; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008134; GO:0008353; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0045944; GO:0047485; GO:0048568; GO:0097550; GO:1901990; GO:1990841	"nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcriptional preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"
PGEN_.00g265210	Scaffold_13	15351064	15354140	Q16X15	MED24_AEDAE	Mediator of RNA polymerase II transcription subunit 24 (Mediator complex subunit 24)	GO:0016592	mediator complex [GO:0016592]
PGEN_.00g265220	Scaffold_13	15355412	15377988	Q2PW47	MED24_DANRE	Mediator of RNA polymerase II transcription subunit 24 (Mediator complex subunit 24) (Protein lessen) (Thyroid hormone receptor-associated protein 4 homolog) (Trap100 homolog)	GO:0003712; GO:0016592; GO:0046549; GO:0048484; GO:0048538; GO:0061453	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; enteric nervous system development [GO:0048484]; interstitial cell of Cajal differentiation [GO:0061453]; retinal cone cell development [GO:0046549]; thymus development [GO:0048538]
PGEN_.00g265230	Scaffold_13	15380769	15408930	NA	NA	NA	NA	NA
PGEN_.00g265240	Scaffold_13	15416658	15419404	NA	NA	NA	NA	NA
PGEN_.00g265250	Scaffold_13	15419478	15434872	B7PY76	WDR12_IXOSC	Ribosome biogenesis protein WDR12 homolog	GO:0000463; GO:0000466; GO:0005654; GO:0030687; GO:0043021; GO:0070545	"nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"
PGEN_.00g265260	Scaffold_13	15440723	15450498	A9JRX0	MSL1_DANRE	Male-specific lethal 1-like 1 (MSL1-like 1) (Male-specific lethal-1 homolog 1) (MSL-1)	GO:0003682; GO:0005634; GO:0005654; GO:0016607; GO:0043984; GO:0072487	MSL complex [GO:0072487]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone H4-K16 acetylation [GO:0043984]
PGEN_.00g265270	Scaffold_13	15459124	15489821	NA	NA	NA	NA	NA
PGEN_.00g265280	Scaffold_13	15495976	15499087	NA	NA	NA	NA	NA
PGEN_.00g265290	Scaffold_13	15499354	15509559	P62996	TRA2B_MOUSE	"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (Silica-induced gene 41 protein) (SIG-41) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)"	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005623; GO:0005634; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0036002; GO:0042802; GO:0043484; GO:0048026; GO:0048471; GO:0051259; GO:0070717; GO:0071333; GO:1990403; GO:1990904	"cell [GO:0005623]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly-purine tract binding [GO:0070717]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein complex oligomerization [GO:0051259]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]"
PGEN_.00g265300	Scaffold_13	15517405	15538393	Q659A1	ICE2_HUMAN	Little elongation complex subunit 2 (Interactor of little elongator complex ELL subunit 2) (NMDA receptor-regulated protein 2)	GO:0005654; GO:0005829; GO:0008023; GO:0015030; GO:0016604; GO:0035327; GO:0035363; GO:0042795; GO:0042796; GO:0045945	Cajal body [GO:0015030]; cytosol [GO:0005829]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]
PGEN_.00g265310	Scaffold_13	15540534	15553804	Q9TXH9	UBXN1_CAEEL	UBX domain-containing protein 1	GO:0003676; GO:0007283; GO:0030154; GO:0036435; GO:0042006; GO:0048471; GO:1903364	perinuclear region of cytoplasm [GO:0048471]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; nucleic acid binding [GO:0003676]; cell differentiation [GO:0030154]; masculinization of hermaphroditic germ-line [GO:0042006]; positive regulation of cellular protein catabolic process [GO:1903364]; spermatogenesis [GO:0007283]
PGEN_.00g265320	Scaffold_13	15553937	15565322	NA	NA	NA	NA	NA
PGEN_.00g265330	Scaffold_13	15593547	15616994	P70490	MFGM_RAT	Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1)	GO:0001525; GO:0001786; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0019897; GO:0043277; GO:0043627; GO:0050766	"external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338]"
PGEN_.00g265340	Scaffold_13	15618204	15682638	Q2PC93	SSPO_CHICK	SCO-spondin	GO:0005615; GO:0007155; GO:0007399; GO:0030154	extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g265350	Scaffold_13	15684978	15687423	NA	NA	NA	NA	NA
PGEN_.00g265360	Scaffold_13	15689575	15689835	NA	NA	NA	NA	NA
PGEN_.00g265370	Scaffold_13	15696814	15706071	NA	NA	NA	NA	NA
PGEN_.00g265380	Scaffold_13	15709449	15723656	A2A6Q5	CDC27_MOUSE	Cell division cycle protein 27 homolog	GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005876; GO:0007091; GO:0019903; GO:0070979	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; protein phosphatase binding [GO:0019903]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]
PGEN_.00g265390	Scaffold_13	15725160	15726187	P30260	CDC27_HUMAN	Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC)	GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0007091; GO:0019903; GO:0031145; GO:0070979; GO:1901990	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g265400	Scaffold_13	15738578	15776517	NA	NA	NA	NA	NA
PGEN_.00g265410	Scaffold_13	15782674	15820442	Q00651	ITA4_MOUSE	Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (Lymphocyte Peyer patch adhesion molecules subunit alpha) (LPAM subunit alpha) (VLA-4 subunit alpha) (CD antigen CD49d)	GO:0001968; GO:0001974; GO:0002687; GO:0003366; GO:0003823; GO:0005623; GO:0005886; GO:0005911; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007229; GO:0007507; GO:0009897; GO:0009986; GO:0016477; GO:0030426; GO:0033631; GO:0034113; GO:0034446; GO:0034669; GO:0043025; GO:0043113; GO:0046872; GO:0050839; GO:0050901; GO:0050904; GO:0060324; GO:0060385; GO:0060485; GO:0060710; GO:0061032; GO:0070062; GO:0072678; GO:0090074; GO:0098609; GO:0098657; GO:0140039; GO:1903039; GO:1903238; GO:1904646; GO:1905564; GO:1990138; GO:1990405; GO:1990771; GO:2000353; GO:2000406	cell [GO:0005623]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integrin alpha4-beta7 complex [GO:0034669]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; cell adhesion molecule binding [GO:0050839]; fibronectin binding [GO:0001968]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; cellular response to amyloid-beta [GO:1904646]; chorio-allantoic fusion [GO:0060710]; clathrin-dependent extracellular exosome endocytosis [GO:1990771]; diapedesis [GO:0050904]; face development [GO:0060324]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; import into cell [GO:0098657]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; mesenchyme development [GO:0060485]; negative regulation of protein homodimerization activity [GO:0090074]; neuron projection extension [GO:1990138]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; receptor clustering [GO:0043113]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell migration [GO:0072678]; visceral serous pericardium development [GO:0061032]
PGEN_.00g265420	Scaffold_13	15829900	15836218	Q9Y3M9	ZN337_HUMAN	Zinc finger protein 337	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g265430	Scaffold_13	15847021	15860947	Q3UF64	RNFT2_MOUSE	RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118)	GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]
PGEN_.00g265440	Scaffold_13	15867585	15896011	Q62773	S28A2_RAT	Sodium/nucleoside cotransporter 2 (Concentrative nucleoside transporter 2) (CNT 2) (rCNT2) (Na(+)/nucleoside cotransporter 2) (Sodium-coupled nucleoside transporter 2) (Sodium/purine nucleoside cotransporter) (SPNT) (Solute carrier family 28 member 2)	GO:0001895; GO:0005337; GO:0005415; GO:0005887; GO:0015211; GO:0034394; GO:1901642	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleoside transmembrane transporter activity [GO:0015211]; nucleoside transmembrane transport [GO:1901642]; protein localization to cell surface [GO:0034394]; retina homeostasis [GO:0001895]
PGEN_.00g265450	Scaffold_13	15973432	16001493	Q62773	S28A2_RAT	Sodium/nucleoside cotransporter 2 (Concentrative nucleoside transporter 2) (CNT 2) (rCNT2) (Na(+)/nucleoside cotransporter 2) (Sodium-coupled nucleoside transporter 2) (Sodium/purine nucleoside cotransporter) (SPNT) (Solute carrier family 28 member 2)	GO:0001895; GO:0005337; GO:0005415; GO:0005887; GO:0015211; GO:0034394; GO:1901642	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleoside transmembrane transporter activity [GO:0015211]; nucleoside transmembrane transport [GO:1901642]; protein localization to cell surface [GO:0034394]; retina homeostasis [GO:0001895]
PGEN_.00g265460	Scaffold_13	16007988	16022624	Q3UF64	RNFT2_MOUSE	RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118)	GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]
PGEN_.00g265470	Scaffold_13	16032808	16039308	Q9Y3M9	ZN337_HUMAN	Zinc finger protein 337	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g265480	Scaffold_13	16045677	16087334	NA	NA	NA	NA	NA
PGEN_.00g265490	Scaffold_13	16093523	16131439	NA	NA	NA	NA	NA
PGEN_.00g265500	Scaffold_13	16143785	16144812	P30260	CDC27_HUMAN	Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC)	GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0007091; GO:0019903; GO:0031145; GO:0070979; GO:1901990	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g265510	Scaffold_13	16146315	16156026	A2A6Q5	CDC27_MOUSE	Cell division cycle protein 27 homolog	GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005876; GO:0007091; GO:0019903; GO:0070979	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; protein phosphatase binding [GO:0019903]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]
PGEN_.00g265520	Scaffold_13	16159412	16168448	NA	NA	NA	NA	NA
PGEN_.00g265530	Scaffold_13	16177843	16180325	NA	NA	NA	NA	NA
PGEN_.00g265540	Scaffold_13	16182732	16222287	Q2PC93	SSPO_CHICK	SCO-spondin	GO:0005615; GO:0007155; GO:0007399; GO:0030154	extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g265550	Scaffold_13	16248328	16271948	P70490	MFGM_RAT	Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1)	GO:0001525; GO:0001786; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0019897; GO:0043277; GO:0043627; GO:0050766	"external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338]"
PGEN_.00g265560	Scaffold_13	16300169	16310510	NA	NA	NA	NA	NA
PGEN_.00g265570	Scaffold_13	16310661	16323858	Q9TXH9	UBXN1_CAEEL	UBX domain-containing protein 1	GO:0003676; GO:0007283; GO:0030154; GO:0036435; GO:0042006; GO:0048471; GO:1903364	perinuclear region of cytoplasm [GO:0048471]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; nucleic acid binding [GO:0003676]; cell differentiation [GO:0030154]; masculinization of hermaphroditic germ-line [GO:0042006]; positive regulation of cellular protein catabolic process [GO:1903364]; spermatogenesis [GO:0007283]
PGEN_.00g265580	Scaffold_13	16327468	16349700	Q659A1	ICE2_HUMAN	Little elongation complex subunit 2 (Interactor of little elongator complex ELL subunit 2) (NMDA receptor-regulated protein 2)	GO:0005654; GO:0005829; GO:0008023; GO:0015030; GO:0016604; GO:0035327; GO:0035363; GO:0042795; GO:0042796; GO:0045945	Cajal body [GO:0015030]; cytosol [GO:0005829]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]
PGEN_.00g265590	Scaffold_13	16357121	16371394	P62996	TRA2B_MOUSE	"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (Silica-induced gene 41 protein) (SIG-41) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)"	GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005623; GO:0005634; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0036002; GO:0042802; GO:0043484; GO:0048026; GO:0048471; GO:0051259; GO:0070717; GO:0071333; GO:1990403; GO:1990904	"cell [GO:0005623]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly-purine tract binding [GO:0070717]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein complex oligomerization [GO:0051259]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]"
PGEN_.00g265600	Scaffold_13	16372114	16372497	NA	NA	NA	NA	NA
PGEN_.00g265610	Scaffold_13	16373339	16375405	NA	NA	NA	NA	NA
PGEN_.00g265620	Scaffold_13	16382570	16412785	NA	NA	NA	NA	NA
PGEN_.00g265630	Scaffold_13	16420476	16429882	A9JRX0	MSL1_DANRE	Male-specific lethal 1-like 1 (MSL1-like 1) (Male-specific lethal-1 homolog 1) (MSL-1)	GO:0003682; GO:0005634; GO:0005654; GO:0016607; GO:0043984; GO:0072487	MSL complex [GO:0072487]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone H4-K16 acetylation [GO:0043984]
PGEN_.00g265640	Scaffold_13	16435713	16451379	B7PY76	WDR12_IXOSC	Ribosome biogenesis protein WDR12 homolog	GO:0000463; GO:0000466; GO:0005654; GO:0030687; GO:0043021; GO:0070545	"nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"
PGEN_.00g265650	Scaffold_13	16451453	16454201	NA	NA	NA	NA	NA
PGEN_.00g265660	Scaffold_13	16462147	16488086	NA	NA	NA	NA	NA
PGEN_.00g265670	Scaffold_13	16490751	16513188	Q2PW47	MED24_DANRE	Mediator of RNA polymerase II transcription subunit 24 (Mediator complex subunit 24) (Protein lessen) (Thyroid hormone receptor-associated protein 4 homolog) (Trap100 homolog)	GO:0003712; GO:0016592; GO:0046549; GO:0048484; GO:0048538; GO:0061453	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; enteric nervous system development [GO:0048484]; interstitial cell of Cajal differentiation [GO:0061453]; retinal cone cell development [GO:0046549]; thymus development [GO:0048538]
PGEN_.00g265680	Scaffold_13	16514460	16517556	Q16X15	MED24_AEDAE	Mediator of RNA polymerase II transcription subunit 24 (Mediator complex subunit 24)	GO:0016592	mediator complex [GO:0016592]
PGEN_.00g265690	Scaffold_13	16521274	16533934	P49135	ERCC3_MOUSE	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH 89 kDa subunit) (Xeroderma pigmentosum group B-complementing protein)	GO:0000112; GO:0000439; GO:0000717; GO:0001666; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006362; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008134; GO:0008353; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0045944; GO:0047485; GO:0048568; GO:0097550; GO:1901990; GO:1990841	"nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcriptional preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"
PGEN_.00g265700	Scaffold_13	16535112	16546133	Q1RMT1	ERCC3_BOVIN	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (DNA excision repair protein ERCC-3)	GO:0000112; GO:0000717; GO:0003677; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006362; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0008134; GO:0008353; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0045944; GO:0047485; GO:0048568; GO:0097550; GO:1901990; GO:1990841	"nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH holo complex [GO:0005675]; transcriptional preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"
PGEN_.00g265710	Scaffold_13	16556613	16558121	NA	NA	NA	NA	NA
PGEN_.00g265720	Scaffold_13	16644328	16661856	Q95ZJ1	GALT5_CAEEL	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g265730	Scaffold_13	16665500	16665703	NA	NA	NA	NA	NA
PGEN_.00g265740	Scaffold_13	16665746	16666135	NA	NA	NA	NA	NA
PGEN_.00g265750	Scaffold_13	16666165	16666509	NA	NA	NA	NA	NA
PGEN_.00g265760	Scaffold_13	16666539	16666772	NA	NA	NA	NA	NA
PGEN_.00g265770	Scaffold_13	16666821	16667036	NA	NA	NA	NA	NA
PGEN_.00g265780	Scaffold_13	16669920	16701193	Q5FWI3	CEIP2_MOUSE	Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2)	GO:0001525; GO:0004415; GO:0005509; GO:0005886; GO:0005887; GO:0030214; GO:0043231; GO:1903670	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]
PGEN_.00g265790	Scaffold_13	16734308	16738821	Q25414	5HTR_LYMST	5-hydroxytryptamine receptor (5-HT receptor) (Serotonin receptor)	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g265800	Scaffold_13	16739289	16764808	NA	NA	NA	NA	NA
PGEN_.00g265810	Scaffold_13	16766712	16767794	NA	NA	NA	NA	NA
PGEN_.00g265820	Scaffold_13	16767831	16769265	NA	NA	NA	NA	NA
PGEN_.00g265830	Scaffold_13	16811912	16818021	NA	NA	NA	NA	NA
PGEN_.00g265840	Scaffold_13	16818552	16818899	NA	NA	NA	NA	NA
PGEN_.00g265850	Scaffold_13	16975605	16979365	NA	NA	NA	NA	NA
PGEN_.00g265860	Scaffold_13	17008615	17014653	Q9H8Y5	ANKZ1_HUMAN	Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744)	GO:0003676; GO:0005737; GO:0016020; GO:0030433; GO:0036266; GO:0046872; GO:0070301; GO:0071630; GO:0072671	Cdc48p-Npl4p-Vms1p AAA ATPase complex [GO:0036266]; cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cellular response to hydrogen peroxide [GO:0070301]; mitochondria-associated ubiquitin-dependent protein catabolic process [GO:0072671]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g265870	Scaffold_13	17016311	17028377	NA	NA	NA	NA	NA
PGEN_.00g265880	Scaffold_13	17031957	17067724	NA	NA	NA	NA	NA
PGEN_.00g265890	Scaffold_13	17155003	17158615	NA	NA	NA	NA	NA
PGEN_.00g265900	Scaffold_13	17159090	17164885	NA	NA	NA	NA	NA
PGEN_.00g265910	Scaffold_13	17168288	17171213	NA	NA	NA	NA	NA
PGEN_.00g265920	Scaffold_13	17171372	17186196	NA	NA	NA	NA	NA
PGEN_.00g265930	Scaffold_13	17196054	17209081	NA	NA	NA	NA	NA
PGEN_.00g265940	Scaffold_13	17216066	17226454	Q7Z408	CSMD2_HUMAN	CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2)	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g265950	Scaffold_13	17269823	17311734	Q9HAR2	AGRL3_HUMAN	Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)	GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742; GO:0098978	axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]
PGEN_.00g265960	Scaffold_13	17331222	17331824	NA	NA	NA	NA	NA
PGEN_.00g265970	Scaffold_13	17338006	17349896	NA	NA	NA	NA	NA
PGEN_.00g265980	Scaffold_13	17368076	17370043	Q8K4T5	DUS19_MOUSE	Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1)	GO:0000188; GO:0004725; GO:0004860; GO:0005078; GO:0005737; GO:0006469; GO:0006470; GO:0007254; GO:0008138; GO:0008330; GO:0008579; GO:0030295; GO:0031434; GO:0031435; GO:0043405; GO:0043410; GO:0043507; GO:0043508; GO:0045860; GO:0046329; GO:0046330	cytoplasm [GO:0005737]; JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; inactivation of MAPK activity [GO:0000188]; JNK cascade [GO:0007254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; protein dephosphorylation [GO:0006470]; regulation of MAP kinase activity [GO:0043405]
PGEN_.00g265990	Scaffold_13	17374985	17391187	O35952	GLO2_RAT	"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II) (Round spermatid protein RSP29)"	GO:0004416; GO:0005737; GO:0005759; GO:0005975; GO:0006749; GO:0006750; GO:0007283; GO:0019243; GO:0046872	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; spermatogenesis [GO:0007283]
PGEN_.00g266000	Scaffold_13	17392364	17399565	Q96IW7	SC22A_HUMAN	Vesicle-trafficking protein SEC22a (SEC22 vesicle-trafficking protein homolog A) (SEC22 vesicle-trafficking protein-like 2)	GO:0005215; GO:0005789; GO:0006888; GO:0015031; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transporter activity [GO:0005215]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]
PGEN_.00g266010	Scaffold_13	17427501	17433364	Q08BL3	C1GTA_DANRE	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-A (EC 2.4.1.122) (Core 1 O-glycan T-synthase A) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1-A) (Core 1 beta1,3-galactosyltransferase 1-A) (C1GalT1-A) (Core 1 beta3-Gal-T1-A)"	GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016267; GO:0046872	"integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]"
PGEN_.00g266020	Scaffold_13	17453507	17464347	NA	NA	NA	NA	NA
PGEN_.00g266030	Scaffold_13	17473792	17482092	Q9BSH4	TACO1_HUMAN	Translational activator of cytochrome c oxidase 1 (Coiled-coil domain-containing protein 44) (Translational activator of mitochondrially-encoded cytochrome c oxidase I)	GO:0005739; GO:0006417	mitochondrion [GO:0005739]; regulation of translation [GO:0006417]
PGEN_.00g266040	Scaffold_13	17493462	17513941	D9IQ16	GXN_ACRMI	Galaxin	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g266050	Scaffold_13	17522706	17543326	Q9IBG7	KCP_XENLA	Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g266060	Scaffold_13	17587510	17587968	NA	NA	NA	NA	NA
PGEN_.00g266070	Scaffold_13	17652166	17655345	Q9Y4A5	TRRAP_HUMAN	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g266080	Scaffold_13	17657227	17658915	NA	NA	NA	NA	NA
PGEN_.00g266090	Scaffold_13	17660971	17666122	NA	NA	NA	NA	NA
PGEN_.00g266100	Scaffold_13	17666158	17666451	NA	NA	NA	NA	NA
PGEN_.00g266110	Scaffold_13	17668192	17668704	NA	NA	NA	NA	NA
PGEN_.00g266120	Scaffold_13	17682454	17687817	NA	NA	NA	NA	NA
PGEN_.00g266130	Scaffold_13	17696471	17708939	Q5XWD5	IF_CANLF	Cobalamin binding intrinsic factor (Gastric intrinsic factor) (Intrinsic factor) (IF) (INF) (Pancreatic intrinsic factor)	GO:0005576; GO:0006824; GO:0015889; GO:0031419	extracellular region [GO:0005576]; cobalamin binding [GO:0031419]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824]
PGEN_.00g266140	Scaffold_13	17720725	17723263	NA	NA	NA	NA	NA
PGEN_.00g266150	Scaffold_13	17738987	17740789	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g266160	Scaffold_13	17740841	17748489	Q6DET9	EF1B_XENTR	Elongation factor 1-beta (EF-1-beta)	GO:0003746; GO:0005085; GO:0005829; GO:0005853; GO:0006414	cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]
PGEN_.00g266170	Scaffold_13	17750102	17762122	Q94511	NDUS1_DROME	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)"	GO:0003954; GO:0005739; GO:0005747; GO:0008137; GO:0009055; GO:0042773; GO:0045333; GO:0046872; GO:0051537; GO:0051539; GO:0072593	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]"
PGEN_.00g266180	Scaffold_13	17772509	17774999	P15690	NDUS1_BOVIN	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)"	GO:0005739; GO:0005747; GO:0005758; GO:0008137; GO:0008637; GO:0009055; GO:0042773; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593	"mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"
PGEN_.00g266190	Scaffold_13	17780493	17787932	Q91XQ0	DYH8_MOUSE	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0097228	"dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"
PGEN_.00g266200	Scaffold_13	17793192	17828035	Q96JB1	DYH8_HUMAN	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285	"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"
PGEN_.00g266210	Scaffold_13	17833849	17898804	Q96JB1	DYH8_HUMAN	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285	"axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"
PGEN_.00g266220	Scaffold_13	17900538	17901128	NA	NA	NA	NA	NA
PGEN_.00g266230	Scaffold_13	17901247	17902062	NA	NA	NA	NA	NA
PGEN_.00g266240	Scaffold_13	17902118	17904376	NA	NA	NA	NA	NA
PGEN_.00g266250	Scaffold_13	17910174	17927274	Q8TE73	DYH5_HUMAN	"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)"	GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060271; GO:0097729	"9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"
PGEN_.00g266260	Scaffold_13	17932937	17935935	NA	NA	NA	NA	NA
PGEN_.00g266270	Scaffold_13	17942382	17951065	Q91XQ0	DYH8_MOUSE	"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)"	GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0097228	"dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]"
PGEN_.00g266280	Scaffold_13	17962634	17963800	NA	NA	NA	NA	NA
PGEN_.00g266290	Scaffold_13	17975438	17995423	NA	NA	NA	NA	NA
PGEN_.00g266300	Scaffold_13	17998617	17999628	NA	NA	NA	NA	NA
PGEN_.00g266310	Scaffold_13	17999811	18000329	NA	NA	NA	NA	NA
PGEN_.00g266320	Scaffold_13	18000513	18001945	NA	NA	NA	NA	NA
PGEN_.00g266330	Scaffold_13	18002007	18012305	NA	NA	NA	NA	NA
PGEN_.00g266340	Scaffold_13	18013305	18020639	P00533	EGFR_HUMAN	Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)	GO:0000139; GO:0000165; GO:0001503; GO:0001618; GO:0001892; GO:0001934; GO:0001942; GO:0003682; GO:0003690; GO:0004709; GO:0004713; GO:0004714; GO:0004888; GO:0005006; GO:0005178; GO:0005516; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005768; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0006357; GO:0006412; GO:0006970; GO:0007165; GO:0007166; GO:0007169; GO:0007173; GO:0007202; GO:0007435; GO:0007494; GO:0007611; GO:0007623; GO:0008283; GO:0008284; GO:0009925; GO:0009986; GO:0010008; GO:0010750; GO:0010960; GO:0014066; GO:0016020; GO:0016101; GO:0016323; GO:0016324; GO:0018108; GO:0019899; GO:0019901; GO:0019903; GO:0021795; GO:0030054; GO:0030139; GO:0030154; GO:0030307; GO:0030324; GO:0030335; GO:0030665; GO:0031625; GO:0031901; GO:0031965; GO:0032930; GO:0032991; GO:0033138; GO:0033590; GO:0033594; GO:0034614; GO:0038083; GO:0038128; GO:0042059; GO:0042060; GO:0042177; GO:0042327; GO:0042698; GO:0042743; GO:0042802; GO:0043006; GO:0043066; GO:0043235; GO:0043406; GO:0043586; GO:0045121; GO:0045202; GO:0045296; GO:0045737; GO:0045739; GO:0045740; GO:0045746; GO:0045780; GO:0045893; GO:0045907; GO:0045930; GO:0045944; GO:0046328; GO:0046777; GO:0046982; GO:0048143; GO:0048146; GO:0048408; GO:0048471; GO:0048546; GO:0048661; GO:0048812; GO:0050679; GO:0050729; GO:0050730; GO:0050999; GO:0051015; GO:0051117; GO:0051205; GO:0051592; GO:0051897; GO:0051968; GO:0060571; GO:0061024; GO:0061029; GO:0070141; GO:0070372; GO:0070374; GO:0070435; GO:0071230; GO:0071260; GO:0071276; GO:0071364; GO:0071392; GO:0071549; GO:0090263; GO:0097421; GO:0097489; GO:0097755; GO:0098609; GO:1900020; GO:1900087; GO:1901185; GO:1901224; GO:1902722; GO:1903078; GO:1903800; GO:1905208; GO:2000145	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; Shc-EGFR complex [GO:0070435]; synapse [GO:0045202]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; MAP kinase kinase kinase activity [GO:0004709]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; activation of phospholipase C activity [GO:0007202]; astrocyte activation [GO:0048143]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; magnesium ion homeostasis [GO:0010960]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein catabolic process [GO:0042177]; neuron projection morphogenesis [GO:0048812]; ossification [GO:0001503]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of cell motility [GO:2000145]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of transcription by RNA polymerase II [GO:0006357]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to osmotic stress [GO:0006970]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]"
PGEN_.00g266350	Scaffold_13	18022960	18027004	Q6P2X9	MOT12_XENTR	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g266360	Scaffold_13	18030670	18036635	Q91ZV3	DCBD2_MOUSE	"Discoidin, CUB and LCCL domain-containing protein 2 (Endothelial and smooth muscle cell-derived neuropilin-like protein)"	GO:0005887; GO:0009986; GO:0030308; GO:0042060	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060]
PGEN_.00g266370	Scaffold_13	18038035	18040232	NA	NA	NA	NA	NA
PGEN_.00g266380	Scaffold_13	18053492	18088021	Q58CU2	E41L5_BOVIN	Band 4.1-like protein 5	GO:0005737; GO:0005856; GO:0005912; GO:0008092; GO:0031032	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]
PGEN_.00g266390	Scaffold_13	18104140	18133305	Q6IQX7	CHSS2_MOUSE	Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2)	GO:0005759; GO:0005829; GO:0016021; GO:0016757; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510	"cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity, transferring glycosyl groups [GO:0016757]; chondroitin sulfate biosynthetic process [GO:0030206]"
PGEN_.00g266400	Scaffold_13	18137599	18153932	P62196	PRS8_MOUSE	26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (p45/SUG) (mSUG1)	GO:0000502; GO:0005102; GO:0005524; GO:0005634; GO:0005675; GO:0005737; GO:0005838; GO:0006357; GO:0008134; GO:0008540; GO:0016234; GO:0016887; GO:0017025; GO:0022624; GO:0031410; GO:0031531; GO:0031595; GO:0031597; GO:0043161; GO:0045892; GO:0045899; GO:0050804; GO:0090261; GO:0098794	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosolic proteasome complex [GO:0031597]; inclusion body [GO:0016234]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; transcription factor TFIIH holo complex [GO:0005675]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; signaling receptor binding [GO:0005102]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g266410	Scaffold_13	18162330	18172746	Q96DF8	ESS2_HUMAN	Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H) (DGS-H) (Protein ES2)	GO:0000398; GO:0005634; GO:0007399; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"
PGEN_.00g266420	Scaffold_13	18174271	18175082	NA	NA	NA	NA	NA
PGEN_.00g266430	Scaffold_13	18194130	18195309	NA	NA	NA	NA	NA
PGEN_.00g266440	Scaffold_13	18195479	18196818	NA	NA	NA	NA	NA
PGEN_.00g266450	Scaffold_13	18196903	18197872	NA	NA	NA	NA	NA
PGEN_.00g266460	Scaffold_13	18206516	18210028	NA	NA	NA	NA	NA
PGEN_.00g266470	Scaffold_13	18225644	18229011	NA	NA	NA	NA	NA
PGEN_.00g266480	Scaffold_13	18230602	18234935	NA	NA	NA	NA	NA
PGEN_.00g266490	Scaffold_13	18278645	18279418	NA	NA	NA	NA	NA
PGEN_.00g266500	Scaffold_13	18300304	18322532	A9C3R8	RP65C_DANRE	Retinal Mueller cells isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl ester 13-cis isomerohydrolase C) (EC 3.1.1.90) (All-trans-retinylester 11-cis isomerohydrolase C) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein homolog C) (RPE56c)	GO:0001523; GO:0004744; GO:0005789; GO:0005829; GO:0005886; GO:0016020; GO:0016702; GO:0042574; GO:0046872; GO:0050251; GO:0052884; GO:0052885; GO:1901827	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]; retinol isomerase activity [GO:0050251]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; zeaxanthin biosynthetic process [GO:1901827]"
PGEN_.00g266510	Scaffold_13	18338015	18339951	NA	NA	NA	NA	NA
PGEN_.00g266520	Scaffold_13	18349624	18371523	NA	NA	NA	NA	NA
PGEN_.00g266530	Scaffold_13	18371803	18375793	NA	NA	NA	NA	NA
PGEN_.00g266540	Scaffold_13	18378230	18381047	Q9YI25	RPE65_AMBTI	Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase)	GO:0001523; GO:0001786; GO:0004744; GO:0005789; GO:0005886; GO:0007601; GO:0016020; GO:0016702; GO:0016853; GO:0031210; GO:0046872; GO:0050896; GO:0052884; GO:0052885; GO:1901612; GO:1901827	"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinal isomerase activity [GO:0004744]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]; zeaxanthin biosynthetic process [GO:1901827]"
PGEN_.00g266550	Scaffold_13	18389838	18443163	Q9GM70	ST17A_RABIT	Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) (rDRAK1)	GO:0004674; GO:0005524; GO:0005634; GO:0006915; GO:0035556; GO:0043065; GO:2000377	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; regulation of reactive oxygen species metabolic process [GO:2000377]
PGEN_.00g266560	Scaffold_13	18454989	18478570	Q13609	DNSL3_HUMAN	Deoxyribonuclease gamma (DNase gamma) (EC 3.1.21.-) (DNase I homolog protein DHP2) (Deoxyribonuclease I-like 3) (DNase I-like 3) (Liver and spleen DNase) (LS-DNase) (LSD)	GO:0000737; GO:0002283; GO:0002673; GO:0003677; GO:0004530; GO:0004536; GO:0005509; GO:0005576; GO:0005634; GO:0005783; GO:0006259; GO:0006308; GO:0006309; GO:0010623; GO:0070948	"endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; deoxyribonuclease activity [GO:0004536]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA metabolic process [GO:0006259]; neutrophil activation involved in immune response [GO:0002283]; programmed cell death involved in cell development [GO:0010623]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]"
PGEN_.00g266570	Scaffold_13	18482288	18483005	NA	NA	NA	NA	NA
PGEN_.00g266580	Scaffold_13	18490987	18522350	Q4G0U5	PCDP1_HUMAN	Cilia- and flagella-associated protein 221 (Primary ciliary dyskinesia protein 1)	GO:0003341; GO:0005516; GO:0005929; GO:0005930; GO:0044458; GO:0060271	axoneme [GO:0005930]; cilium [GO:0005929]; calmodulin binding [GO:0005516]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; motile cilium assembly [GO:0044458]
PGEN_.00g266590	Scaffold_13	18528684	18565172	P40692	MLH1_HUMAN	DNA mismatch repair protein Mlh1 (MutL protein homolog 1)	GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032300; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257	cell [GO:0005623]; chiasma [GO:0005712]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]
PGEN_.00g266600	Scaffold_13	18647780	18649072	Q8K4Z4	ADRB2_CAVPO	Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)	GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0002032; GO:0004941; GO:0005634; GO:0005769; GO:0005887; GO:0006898; GO:0007189; GO:0007190; GO:0008179; GO:0009409; GO:0010739; GO:0015459; GO:0016324; GO:0030501; GO:0031398; GO:0031649; GO:0040015; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045453; GO:0045944; GO:0045986; GO:0050873; GO:0051380; GO:0061885; GO:0071902; GO:0120162; GO:1901098; GO:1904504; GO:1904646; GO:2000969	apical plasma membrane [GO:0016324]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; receptor complex [GO:0043235]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; beta2-adrenergic receptor activity [GO:0004941]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; diet induced thermogenesis [GO:0002024]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]
PGEN_.00g266610	Scaffold_13	18686390	18687529	Q864F6	MSHR_EULFU	Melanocyte-stimulating hormone receptor (MSH-R) (Melanocortin receptor 1) (MC1-R)	GO:0004980; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; melanocyte-stimulating hormone receptor activity [GO:0004980]
PGEN_.00g266620	Scaffold_13	18743510	18743866	NA	NA	NA	NA	NA
PGEN_.00g266630	Scaffold_13	18810250	18878786	Q9JK91	MLH1_MOUSE	DNA mismatch repair protein Mlh1 (MutL protein homolog 1)	GO:0000289; GO:0000712; GO:0000793; GO:0000794; GO:0000795; GO:0001673; GO:0002204; GO:0003682; GO:0003697; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005694; GO:0005712; GO:0005715; GO:0006281; GO:0006298; GO:0006303; GO:0006974; GO:0007060; GO:0007129; GO:0007131; GO:0007140; GO:0007283; GO:0008630; GO:0009617; GO:0016321; GO:0016446; GO:0016447; GO:0016887; GO:0019899; GO:0032137; GO:0032300; GO:0032389; GO:0032407; GO:0043060; GO:0045132; GO:0045141; GO:0045143; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257; GO:0051321	cell [GO:0005623]; chiasma [GO:0005712]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; MutSalpha complex binding [GO:0032407]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome segregation [GO:0045143]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; male meiotic nuclear division [GO:0007140]; meiotic cell cycle [GO:0051321]; meiotic chromosome segregation [GO:0045132]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]
PGEN_.00g266640	Scaffold_13	18889931	18909064	Q5SF07	IF2B2_MOUSE	Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)	GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006417; GO:0048027; GO:0051028	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]
PGEN_.00g266650	Scaffold_13	18909239	18911005	NA	NA	NA	NA	NA
PGEN_.00g266660	Scaffold_13	18983746	18984021	NA	NA	NA	NA	NA
PGEN_.00g266670	Scaffold_13	19002692	19006718	P29074	PTN4_HUMAN	Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1)	GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0071345	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]
PGEN_.00g266680	Scaffold_13	19007967	19025337	P29074	PTN4_HUMAN	Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1)	GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0071345	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]
PGEN_.00g266690	Scaffold_13	19038594	19127187	P29074	PTN4_HUMAN	Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1)	GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0071345	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cytoskeletal protein binding [GO:0008092]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; cellular response to cytokine stimulus [GO:0071345]; protein dephosphorylation [GO:0006470]
PGEN_.00g266700	Scaffold_13	19128891	19133792	NA	NA	NA	NA	NA
PGEN_.00g266710	Scaffold_13	19140460	19142733	NA	NA	NA	NA	NA
PGEN_.00g266720	Scaffold_13	19159464	19159901	NA	NA	NA	NA	NA
PGEN_.00g266730	Scaffold_13	19173047	19173319	NA	NA	NA	NA	NA
PGEN_.00g266740	Scaffold_13	19186211	19187686	NA	NA	NA	NA	NA
PGEN_.00g266750	Scaffold_13	19234664	19235357	NA	NA	NA	NA	NA
PGEN_.00g266760	Scaffold_13	19238272	19238874	NA	NA	NA	NA	NA
PGEN_.00g266770	Scaffold_13	19379393	19418328	Q5RB68	IF2B2_PONAB	Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)	GO:0003730; GO:0005634; GO:0005737; GO:0005856; GO:0006417; GO:0048027; GO:0051028	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA transport [GO:0051028]; regulation of translation [GO:0006417]
PGEN_.00g266780	Scaffold_13	19435939	19446324	NA	NA	NA	NA	NA
PGEN_.00g266790	Scaffold_13	19463310	19466543	NA	NA	NA	NA	NA
PGEN_.00g266800	Scaffold_13	19471640	19472041	NA	NA	NA	NA	NA
PGEN_.00g266810	Scaffold_13	19472090	19472575	NA	NA	NA	NA	NA
PGEN_.00g266820	Scaffold_13	19478283	19481075	NA	NA	NA	NA	NA
PGEN_.00g266830	Scaffold_13	19481586	19483954	NA	NA	NA	NA	NA
PGEN_.00g266840	Scaffold_13	19492811	19496826	NA	NA	NA	NA	NA
PGEN_.00g266850	Scaffold_13	19537653	19543326	P22124	RAL_DIPOM	Ras-related protein O-RAL	GO:0003924; GO:0005525; GO:0005886; GO:0007265	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265]
PGEN_.00g266860	Scaffold_13	19549565	19552018	Q9ES30	C1QT3_MOUSE	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005576; GO:0005581; GO:0005615; GO:0005623; GO:0010629; GO:0032991; GO:0035356; GO:0042593; GO:0042802; GO:0045721; GO:0050715; GO:0050728; GO:0051897; GO:0070165; GO:0070206; GO:0070374; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; cellular triglyceride homeostasis [GO:0035356]; glucose homeostasis [GO:0042593]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; protein trimerization [GO:0070206]
PGEN_.00g266870	Scaffold_13	19554295	19594088	Q15648	MED1_HUMAN	Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A)	GO:0000122; GO:0000151; GO:0000785; GO:0000902; GO:0000978; GO:0001525; GO:0001889; GO:0001892; GO:0002088; GO:0002154; GO:0003222; GO:0003406; GO:0003682; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006356; GO:0006367; GO:0006590; GO:0006606; GO:0006702; GO:0007420; GO:0007595; GO:0008134; GO:0010628; GO:0010839; GO:0016020; GO:0016592; GO:0016922; GO:0019216; GO:0030216; GO:0030224; GO:0030331; GO:0030374; GO:0030375; GO:0030518; GO:0031100; GO:0031490; GO:0032993; GO:0033148; GO:0035050; GO:0035116; GO:0035162; GO:0035257; GO:0035357; GO:0035729; GO:0035855; GO:0036033; GO:0042789; GO:0042809; GO:0042974; GO:0042975; GO:0043066; GO:0045444; GO:0045618; GO:0045648; GO:0045665; GO:0045893; GO:0045944; GO:0046966; GO:0048821; GO:0048822; GO:0050693; GO:0051726; GO:0060335; GO:0060744; GO:0060745; GO:0060750; GO:0061630; GO:0070318; GO:0070371; GO:0070562; GO:0071364; GO:0071383; GO:0097067; GO:1990841; GO:2000273; GO:2000347; GO:2001141	"chromatin [GO:0000785]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; LBD domain binding [GO:0050693]; mediator complex binding [GO:0036033]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; thyroid hormone receptor coactivator activity [GO:0030375]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]; androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; ERK1 and ERK2 cascade [GO:0070371]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of lipid metabolic process [GO:0019216]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase I [GO:0006356]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
PGEN_.00g266880	Scaffold_13	19628093	19628365	NA	NA	NA	NA	NA
PGEN_.00g266890	Scaffold_13	19628416	19630021	NA	NA	NA	NA	NA
PGEN_.00g266900	Scaffold_13	19633785	19749134	Q2PC93	SSPO_CHICK	SCO-spondin	GO:0005615; GO:0007155; GO:0007399; GO:0030154	extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g266910	Scaffold_13	19759912	19760337	NA	NA	NA	NA	NA
PGEN_.00g266920	Scaffold_13	19762153	19840574	NA	NA	NA	NA	NA
PGEN_.00g266930	Scaffold_13	19886500	19959926	Q700K0	SSPO_RAT	SCO-spondin	GO:0005615; GO:0005737; GO:0007155; GO:0007399; GO:0030154	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g266940	Scaffold_13	19960242	19972746	NA	NA	NA	NA	NA
PGEN_.00g266950	Scaffold_13	19991938	20002681	NA	NA	NA	NA	NA
PGEN_.00g266960	Scaffold_13	20022185	20057690	NA	NA	NA	NA	NA
PGEN_.00g266970	Scaffold_13	20108252	20108678	NA	NA	NA	NA	NA
PGEN_.00g266980	Scaffold_13	20109322	20109636	NA	NA	NA	NA	NA
PGEN_.00g266990	Scaffold_13	20158980	20159294	NA	NA	NA	NA	NA
PGEN_.00g267000	Scaffold_13	20224783	20230153	NA	NA	NA	NA	NA
PGEN_.00g267010	Scaffold_13	20273422	20273991	NA	NA	NA	NA	NA
PGEN_.00g267020	Scaffold_13	20299105	20299500	NA	NA	NA	NA	NA
PGEN_.00g267030	Scaffold_13	20322103	20322438	NA	NA	NA	NA	NA
PGEN_.00g267040	Scaffold_13	20329247	20329531	NA	NA	NA	NA	NA
PGEN_.00g267050	Scaffold_13	20385057	20386124	Q5IS75	ACHB3_PANTR	Neuronal acetylcholine receptor subunit beta-3	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g267060	Scaffold_13	20416161	20420321	Q9BXI9	C1QT6_HUMAN	Complement C1q tumor necrosis factor-related protein 6	GO:0005581; GO:0005615; GO:0042802	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]
PGEN_.00g267070	Scaffold_13	20468360	20474267	NA	NA	NA	NA	NA
PGEN_.00g267080	Scaffold_13	20597541	20598946	NA	NA	NA	NA	NA
PGEN_.00g267090	Scaffold_13	20646464	20646811	NA	NA	NA	NA	NA
PGEN_.00g267100	Scaffold_13	20646920	20647243	NA	NA	NA	NA	NA
PGEN_.00g267110	Scaffold_13	20647399	20650480	P24557	THAS_HUMAN	Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1)	GO:0004497; GO:0004796; GO:0005506; GO:0005789; GO:0006690; GO:0016021; GO:0016705; GO:0019371; GO:0020037; GO:0036134	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; thromboxane-A synthase activity [GO:0004796]; cyclooxygenase pathway [GO:0019371]; icosanoid metabolic process [GO:0006690]"
PGEN_.00g267120	Scaffold_13	20654763	20660704	P68370	TBA1A_RAT	Tubulin alpha-1A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005881; GO:0007017; GO:0019904; GO:0031594; GO:0036464; GO:0043209; GO:0044877; GO:0045121; GO:0050807; GO:0055037	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane raft [GO:0045121]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807]
PGEN_.00g267130	Scaffold_13	20662470	20663532	NA	NA	NA	NA	NA
PGEN_.00g267140	Scaffold_13	20666793	20676455	Q9I926	FUCL6_ANGJA	Fucolectin-6	GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088	"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
PGEN_.00g267150	Scaffold_13	20676588	20685285	Q20681	BAT38_CAEEL	BTB and MATH domain-containing protein 38		
PGEN_.00g267160	Scaffold_13	20697428	20728357	NA	NA	NA	NA	NA
PGEN_.00g267170	Scaffold_13	20736628	20759467	Q9UKG9	OCTC_HUMAN	Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137)	GO:0005777; GO:0005782; GO:0005829; GO:0006091; GO:0006625; GO:0006631; GO:0006635; GO:0008458; GO:0009437; GO:0015908; GO:0015936; GO:0033540; GO:0043231; GO:0051791	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g267180	Scaffold_13	20774119	20794435	NA	NA	NA	NA	NA
PGEN_.00g267190	Scaffold_13	20799032	20805199	Q66IB8	CB076_DANRE	UPF0538 protein C2orf76 homolog		
PGEN_.00g267200	Scaffold_13	20811244	20841891	A6QLA0	NFX1_BOVIN	"Transcriptional repressor NF-X1 (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1)"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0008270; GO:0016740; GO:0045347	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g267210	Scaffold_13	20851503	20854114	NA	NA	NA	NA	NA
PGEN_.00g267220	Scaffold_13	20857381	20859696	NA	NA	NA	NA	NA
PGEN_.00g267230	Scaffold_13	20861725	20863266	NA	NA	NA	NA	NA
PGEN_.00g267240	Scaffold_13	20989262	21093413	A0A0R4IKU3	RECK_DANRE	Reversion-inducing cysteine-rich protein with Kazal motifs	GO:0001944; GO:0002040; GO:0004867; GO:0005886; GO:0008191; GO:0016055; GO:0031225; GO:0045765; GO:0060828; GO:0090049; GO:0090210; GO:0090263; GO:1904684; GO:1904928; GO:1990791; GO:1990909	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867]; dorsal root ganglion development [GO:1990791]; negative regulation of metalloendopeptidase activity [GO:1904684]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055]
PGEN_.00g267250	Scaffold_13	21101651	21101944	NA	NA	NA	NA	NA
PGEN_.00g267260	Scaffold_13	21104887	21108210	NA	NA	NA	NA	NA
PGEN_.00g267270	Scaffold_13	21108429	21109028	NA	NA	NA	NA	NA
PGEN_.00g267280	Scaffold_13	21110213	21110575	NA	NA	NA	NA	NA
PGEN_.00g267290	Scaffold_13	21120994	21124406	NA	NA	NA	NA	NA
PGEN_.00g267300	Scaffold_13	21124958	21132894	NA	NA	NA	NA	NA
PGEN_.00g267310	Scaffold_13	21139775	21140449	NA	NA	NA	NA	NA
PGEN_.00g267320	Scaffold_13	21140586	21144935	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g267330	Scaffold_13	21149789	21150355	NA	NA	NA	NA	NA
PGEN_.00g267340	Scaffold_13	21150410	21161419	NA	NA	NA	NA	NA
PGEN_.00g267350	Scaffold_13	21215749	21218594	NA	NA	NA	NA	NA
PGEN_.00g267360	Scaffold_13	21222873	21225639	Q9Z2J0	S23A1_MOUSE	Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)	GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015229; GO:0015882; GO:0016021; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g267370	Scaffold_13	21231923	21263622	Q8HXX1	MUTA_MACFA	"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)"	GO:0003924; GO:0004494; GO:0005759; GO:0031419; GO:0042802; GO:0042803; GO:0046872	mitochondrial matrix [GO:0005759]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; protein homodimerization activity [GO:0042803]
PGEN_.00g267380	Scaffold_13	21399805	21400059	NA	NA	NA	NA	NA
PGEN_.00g267390	Scaffold_13	21441432	21441917	NA	NA	NA	NA	NA
PGEN_.00g267400	Scaffold_13	21442176	21449963	NA	NA	NA	NA	NA
PGEN_.00g267410	Scaffold_13	21481752	21482138	NA	NA	NA	NA	NA
PGEN_.00g267420	Scaffold_13	21552261	21552524	NA	NA	NA	NA	NA
PGEN_.00g267430	Scaffold_13	21609008	21610543	Q25414	5HTR_LYMST	5-hydroxytryptamine receptor (5-HT receptor) (Serotonin receptor)	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g267440	Scaffold_13	21614441	21619252	NA	NA	NA	NA	NA
PGEN_.00g267450	Scaffold_13	21754400	21756951	NA	NA	NA	NA	NA
PGEN_.00g267460	Scaffold_13	21770000	21771012	NA	NA	NA	NA	NA
PGEN_.00g267470	Scaffold_13	21876421	21876672	NA	NA	NA	NA	NA
PGEN_.00g267480	Scaffold_13	21876752	21877324	NA	NA	NA	NA	NA
PGEN_.00g267490	Scaffold_13	21879907	21888603	NA	NA	NA	NA	NA
PGEN_.00g267500	Scaffold_13	21888839	21889060	NA	NA	NA	NA	NA
PGEN_.00g267510	Scaffold_13	21971896	21972531	NA	NA	NA	NA	NA
PGEN_.00g267520	Scaffold_13	22036038	22073360	NA	NA	NA	NA	NA
PGEN_.00g267530	Scaffold_13	22088633	22089295	NA	NA	NA	NA	NA
PGEN_.00g267540	Scaffold_13	22089390	22089905	NA	NA	NA	NA	NA
PGEN_.00g267550	Scaffold_13	22091973	22103612	E9Q5G3	KIF23_MOUSE	Kinesin-like protein KIF23	GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149	cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]
PGEN_.00g267560	Scaffold_13	22139536	22145852	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g267570	Scaffold_13	22145945	22149049	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g267580	Scaffold_13	22149535	22164396	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g267590	Scaffold_13	22176869	22193953	Q9CQV4	RETR3_MOUSE	Reticulophagy regulator 3	GO:0010976; GO:0016021; GO:0032991	integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; positive regulation of neuron projection development [GO:0010976]
PGEN_.00g267600	Scaffold_13	22209484	22215722	NA	NA	NA	NA	NA
PGEN_.00g267610	Scaffold_13	22254730	22255860	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g267620	Scaffold_13	22291115	22291700	NA	NA	NA	NA	NA
PGEN_.00g267630	Scaffold_13	22292814	22294537	NA	NA	NA	NA	NA
PGEN_.00g267640	Scaffold_13	22500084	22539379	Q68EK2	CALRL_DANRE	Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)	GO:0001525; GO:0001756; GO:0004948; GO:0005886; GO:0007166; GO:0016021; GO:0048844; GO:0055064	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]
PGEN_.00g267650	Scaffold_13	22547068	22548006	O94813	SLIT2_HUMAN	Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product]	GO:0001657; GO:0001933; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0005095; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0007411; GO:0008045; GO:0008201; GO:0009986; GO:0010593; GO:0010596; GO:0014912; GO:0016020; GO:0021836; GO:0021972; GO:0030308; GO:0030336; GO:0030837; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0048495; GO:0048754; GO:0048846; GO:0050772; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0060412; GO:0061364; GO:0070062; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]
PGEN_.00g267660	Scaffold_13	22561119	22562198	Q9DBB9	CPN2_MOUSE	Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit)	GO:0005615; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]
PGEN_.00g267670	Scaffold_13	22589321	22591771	NA	NA	NA	NA	NA
PGEN_.00g267680	Scaffold_13	22592655	22593530	O75093	SLIT1_HUMAN	Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4)	GO:0005509; GO:0005615; GO:0007097; GO:0007411; GO:0008045; GO:0008201; GO:0022028; GO:0031290; GO:0033563; GO:0048495; GO:0048846; GO:0048853; GO:0050919; GO:0051964	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]
PGEN_.00g267690	Scaffold_13	22610251	22610814	NA	NA	NA	NA	NA
PGEN_.00g267700	Scaffold_13	22615926	22616210	NA	NA	NA	NA	NA
PGEN_.00g267710	Scaffold_13	22622920	22627597	NA	NA	NA	NA	NA
PGEN_.00g267720	Scaffold_13	22635516	22638683	Q5TZE1	BTB6B_DANRE	BTB/POZ domain-containing protein 6-B	GO:0005634; GO:0005829; GO:0022008	cytosol [GO:0005829]; nucleus [GO:0005634]; neurogenesis [GO:0022008]
PGEN_.00g267730	Scaffold_13	22643997	22668509	A0AUR5	MINY3_DANRE	Ubiquitin carboxyl-terminal hydrolase MINDY-3 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-3) (Protein CARP)	GO:0005634; GO:0006915; GO:0016807; GO:0036459; GO:1990380	nucleus [GO:0005634]; cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; apoptotic process [GO:0006915]
PGEN_.00g267740	Scaffold_13	22680550	22680876	NA	NA	NA	NA	NA
PGEN_.00g267750	Scaffold_13	22683464	22683844	NA	NA	NA	NA	NA
PGEN_.00g267760	Scaffold_13	22687523	22692787	NA	NA	NA	NA	NA
PGEN_.00g267770	Scaffold_13	22697089	22697469	NA	NA	NA	NA	NA
PGEN_.00g267780	Scaffold_13	22697655	22698095	NA	NA	NA	NA	NA
PGEN_.00g267790	Scaffold_13	22698212	22708816	NA	NA	NA	NA	NA
PGEN_.00g267800	Scaffold_13	22708844	22710953	NA	NA	NA	NA	NA
PGEN_.00g267810	Scaffold_13	22723376	22725577	NA	NA	NA	NA	NA
PGEN_.00g267820	Scaffold_13	22728353	22728637	NA	NA	NA	NA	NA
PGEN_.00g267830	Scaffold_13	22738190	22742716	NA	NA	NA	NA	NA
PGEN_.00g267840	Scaffold_13	22829203	22875151	Q7ZXS8	CALRL_XENLA	Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)	GO:0004948; GO:0005886; GO:0007166; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g267850	Scaffold_13	22884694	22885062	NA	NA	NA	NA	NA
PGEN_.00g267860	Scaffold_13	22885309	22885641	NA	NA	NA	NA	NA
PGEN_.00g267870	Scaffold_13	23151343	23165135	P20420	ACHA5_RAT	Neuronal acetylcholine receptor subunit alpha-5	GO:0005886; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015464; GO:0022848; GO:0030054; GO:0030425; GO:0034220; GO:0035094; GO:0035095; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; protein-containing complex binding [GO:0044877]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g267880	Scaffold_13	23170471	23170704	NA	NA	NA	NA	NA
PGEN_.00g267890	Scaffold_13	23173933	23177046	NA	NA	NA	NA	NA
PGEN_.00g267900	Scaffold_13	23181325	23197785	Q05B63	TRM11_BOVIN	tRNA (guanine(10)-N2)-methyltransferase homolog (EC 2.1.1.-) (tRNA guanosine-2'-O-methyltransferase TRM11 homolog)	GO:0000049; GO:0004809; GO:0005737; GO:0008168	cytoplasm [GO:0005737]; methyltransferase activity [GO:0008168]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]
PGEN_.00g267910	Scaffold_13	23253664	23261403	NA	NA	NA	NA	NA
PGEN_.00g267920	Scaffold_13	23282109	23289994	NA	NA	NA	NA	NA
PGEN_.00g267930	Scaffold_13	23296017	23303374	NA	NA	NA	NA	NA
PGEN_.00g267940	Scaffold_13	23317679	23323932	NA	NA	NA	NA	NA
PGEN_.00g267950	Scaffold_13	23331470	23334348	Q24306	DIAP1_DROME	Death-associated inhibitor of apoptosis 1 (EC 2.3.2.27) (Apoptosis 1 inhibitor) (E3 ubiquitin-protein ligase th) (Inhibitor of apoptosis 1) (Protein thread) (RING-type E3 ubiquitin transferase Diap1)	GO:0000209; GO:0004842; GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0007275; GO:0007283; GO:0007289; GO:0007298; GO:0008270; GO:0008354; GO:0016055; GO:0022416; GO:0031398; GO:0031624; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0044390; GO:0045035; GO:0045116; GO:0046673; GO:0048800; GO:0051865; GO:0061630; GO:0061663; GO:0070936; GO:0089720; GO:0090263; GO:0097340; GO:1903688; GO:1990001; GO:1990381; GO:2001271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; NEDD8 ligase activity [GO:0061663]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; germ cell migration [GO:0008354]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g267960	Scaffold_13	23346571	23346933	NA	NA	NA	NA	NA
PGEN_.00g267970	Scaffold_13	23348714	23349076	NA	NA	NA	NA	NA
PGEN_.00g267980	Scaffold_13	23356598	23361640	H2A0L0	TYRO1_PINMG	Tyrosinase-like protein 1 (EC 1.14.18.-) (Tyrosinase 1)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g267990	Scaffold_13	23363547	23385041	Q9UJ83	HACL1_HUMAN	2-hydroxyacyl-CoA lyase 1 (EC 4.1.-.-) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2)	GO:0000287; GO:0001561; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0048037; GO:0051259	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carbon-carbon lyase activity [GO:0016830]; cofactor binding [GO:0048037]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; protein complex oligomerization [GO:0051259]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g268000	Scaffold_13	23385180	23393693	Q9I7M2	GTPBA_DROME	GTP-binding protein 10 homolog	GO:0005525; GO:0005730; GO:0042254	nucleolus [GO:0005730]; GTP binding [GO:0005525]; ribosome biogenesis [GO:0042254]
PGEN_.00g268010	Scaffold_13	23395978	23401451	NA	NA	NA	NA	NA
PGEN_.00g268020	Scaffold_13	23442605	23461514	Q64289	NDF1_RAT	Neurogenic differentiation factor 1 (NeuroD1) (Basic helix-loop-helix factor 1) (BHF-1)	GO:0000978; GO:0000981; GO:0001102; GO:0001228; GO:0003326; GO:0003329; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003713; GO:0005623; GO:0005634; GO:0005737; GO:0006913; GO:0007263; GO:0008134; GO:0009749; GO:0009952; GO:0021542; GO:0021549; GO:0023019; GO:0030073; GO:0030902; GO:0031018; GO:0035881; GO:0035883; GO:0042493; GO:0042593; GO:0043010; GO:0043065; GO:0043565; GO:0045165; GO:0045597; GO:0045664; GO:0045666; GO:0045893; GO:0045944; GO:0046426; GO:0046982; GO:0048562; GO:0048666; GO:0048839; GO:0051091; GO:0060730; GO:0070888; GO:0071156; GO:0071333; GO:0090575; GO:2000675; GO:2000679	"cell [GO:0005623]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; amacrine cell differentiation [GO:0035881]; anterior/posterior pattern specification [GO:0009952]; camera-type eye development [GO:0043010]; cell fate commitment [GO:0045165]; cellular response to glucose stimulus [GO:0071333]; cerebellum development [GO:0021549]; dentate gyrus development [GO:0021542]; embryonic organ morphogenesis [GO:0048562]; endocrine pancreas development [GO:0031018]; enteroendocrine cell differentiation [GO:0035883]; glucose homeostasis [GO:0042593]; hindbrain development [GO:0030902]; inner ear development [GO:0048839]; insulin secretion [GO:0030073]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neuron development [GO:0048666]; nitric oxide mediated signal transduction [GO:0007263]; nucleocytoplasmic transport [GO:0006913]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle arrest [GO:0071156]; regulation of intestinal epithelial structure maintenance [GO:0060730]; regulation of neuron differentiation [GO:0045664]; response to drug [GO:0042493]; response to glucose [GO:0009749]; signal transduction involved in regulation of gene expression [GO:0023019]"
PGEN_.00g268030	Scaffold_13	23474627	23475262	NA	NA	NA	NA	NA
PGEN_.00g268040	Scaffold_13	23476684	23477061	NA	NA	NA	NA	NA
PGEN_.00g268050	Scaffold_13	23481804	23512230	Q80ZA5	S4A10_RAT	Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10)	GO:0005452; GO:0005623; GO:0005886; GO:0006885; GO:0007601; GO:0008510; GO:0009416; GO:0009791; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0021860; GO:0030054; GO:0030425; GO:0030641; GO:0035264; GO:0035641; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0048854; GO:0051453; GO:0097440; GO:0097441; GO:0097442; GO:0098794; GO:1902600	apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; cell [GO:0005623]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of cellular pH [GO:0030641]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; visual perception [GO:0007601]
PGEN_.00g268060	Scaffold_13	23524919	23525272	NA	NA	NA	NA	NA
PGEN_.00g268070	Scaffold_13	23525482	23525781	NA	NA	NA	NA	NA
PGEN_.00g268080	Scaffold_13	23538203	23542111	Q5F478	ANR44_CHICK	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)		
PGEN_.00g268090	Scaffold_13	23542183	23551026	NA	NA	NA	NA	NA
PGEN_.00g268100	Scaffold_13	23553428	23555507	NA	NA	NA	NA	NA
PGEN_.00g268110	Scaffold_13	23574012	23593375	NA	NA	NA	NA	NA
PGEN_.00g268120	Scaffold_13	23596164	23597907	NA	NA	NA	NA	NA
PGEN_.00g268130	Scaffold_13	23600595	23619969	NA	NA	NA	NA	NA
PGEN_.00g268140	Scaffold_13	23638550	23640634	NA	NA	NA	NA	NA
PGEN_.00g268150	Scaffold_13	23643037	23643528	NA	NA	NA	NA	NA
PGEN_.00g268160	Scaffold_13	23643573	23655887	Q5F478	ANR44_CHICK	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)		
PGEN_.00g268170	Scaffold_13	23667188	23668270	NA	NA	NA	NA	NA
PGEN_.00g268180	Scaffold_13	23668297	23668596	NA	NA	NA	NA	NA
PGEN_.00g268190	Scaffold_13	23668806	23669159	NA	NA	NA	NA	NA
PGEN_.00g268200	Scaffold_13	23679490	23707209	Q6U841	S4A10_HUMAN	Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10)	GO:0005452; GO:0005623; GO:0005886; GO:0006821; GO:0007601; GO:0008510; GO:0009416; GO:0009791; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0021860; GO:0030054; GO:0030425; GO:0035264; GO:0035641; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0048854; GO:0051453; GO:0097440; GO:0097441; GO:0097442; GO:0098794; GO:1902600	apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; cell [GO:0005623]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; chloride transport [GO:0006821]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; visual perception [GO:0007601]
PGEN_.00g268210	Scaffold_13	23714582	23714923	NA	NA	NA	NA	NA
PGEN_.00g268220	Scaffold_13	23716345	23716980	NA	NA	NA	NA	NA
PGEN_.00g268230	Scaffold_13	23717243	23718529	NA	NA	NA	NA	NA
PGEN_.00g268240	Scaffold_13	23730097	23749063	Q60867	NDF1_MOUSE	Neurogenic differentiation factor 1 (NeuroD1) (Beta-cell E-box transcriptional activator 2) (Beta2)	GO:0000978; GO:0000981; GO:0001102; GO:0001228; GO:0003326; GO:0003329; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003713; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0006913; GO:0007263; GO:0008134; GO:0009749; GO:0009952; GO:0021542; GO:0021549; GO:0023019; GO:0030073; GO:0030902; GO:0031018; GO:0035881; GO:0035883; GO:0042493; GO:0042593; GO:0043010; GO:0043065; GO:0043565; GO:0045165; GO:0045597; GO:0045664; GO:0045666; GO:0045893; GO:0045944; GO:0046426; GO:0046982; GO:0048562; GO:0048666; GO:0048839; GO:0051091; GO:0060730; GO:0070888; GO:0071156; GO:0071333; GO:0090575; GO:2000675; GO:2000679	"cell [GO:0005623]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; amacrine cell differentiation [GO:0035881]; anterior/posterior pattern specification [GO:0009952]; camera-type eye development [GO:0043010]; cell fate commitment [GO:0045165]; cellular response to glucose stimulus [GO:0071333]; cerebellum development [GO:0021549]; dentate gyrus development [GO:0021542]; embryonic organ morphogenesis [GO:0048562]; endocrine pancreas development [GO:0031018]; enteroendocrine cell differentiation [GO:0035883]; glucose homeostasis [GO:0042593]; hindbrain development [GO:0030902]; inner ear development [GO:0048839]; insulin secretion [GO:0030073]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neuron development [GO:0048666]; nitric oxide mediated signal transduction [GO:0007263]; nucleocytoplasmic transport [GO:0006913]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle arrest [GO:0071156]; regulation of intestinal epithelial structure maintenance [GO:0060730]; regulation of neuron differentiation [GO:0045664]; response to drug [GO:0042493]; response to glucose [GO:0009749]; signal transduction involved in regulation of gene expression [GO:0023019]"
PGEN_.00g268250	Scaffold_13	23787807	23797108	NA	NA	NA	NA	NA
PGEN_.00g268260	Scaffold_13	23799432	23807862	Q9I7M2	GTPBA_DROME	GTP-binding protein 10 homolog	GO:0005525; GO:0005730; GO:0042254	nucleolus [GO:0005730]; GTP binding [GO:0005525]; ribosome biogenesis [GO:0042254]
PGEN_.00g268270	Scaffold_13	23808001	23829508	Q9UJ83	HACL1_HUMAN	2-hydroxyacyl-CoA lyase 1 (EC 4.1.-.-) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2)	GO:0000287; GO:0001561; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0048037; GO:0051259	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carbon-carbon lyase activity [GO:0016830]; cofactor binding [GO:0048037]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; protein complex oligomerization [GO:0051259]; protein targeting to peroxisome [GO:0006625]
PGEN_.00g268280	Scaffold_13	23831415	23836442	H2A0L0	TYRO1_PINMG	Tyrosinase-like protein 1 (EC 1.14.18.-) (Tyrosinase 1)	GO:0005576; GO:0016491; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g268290	Scaffold_13	23843774	23844136	NA	NA	NA	NA	NA
PGEN_.00g268300	Scaffold_13	23845917	23846279	NA	NA	NA	NA	NA
PGEN_.00g268310	Scaffold_13	23847499	23848200	NA	NA	NA	NA	NA
PGEN_.00g268320	Scaffold_13	23858465	23861349	Q24306	DIAP1_DROME	Death-associated inhibitor of apoptosis 1 (EC 2.3.2.27) (Apoptosis 1 inhibitor) (E3 ubiquitin-protein ligase th) (Inhibitor of apoptosis 1) (Protein thread) (RING-type E3 ubiquitin transferase Diap1)	GO:0000209; GO:0004842; GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0007275; GO:0007283; GO:0007289; GO:0007298; GO:0008270; GO:0008354; GO:0016055; GO:0022416; GO:0031398; GO:0031624; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0044390; GO:0045035; GO:0045116; GO:0046673; GO:0048800; GO:0051865; GO:0061630; GO:0061663; GO:0070936; GO:0089720; GO:0090263; GO:0097340; GO:1903688; GO:1990001; GO:1990381; GO:2001271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; NEDD8 ligase activity [GO:0061663]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; germ cell migration [GO:0008354]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g268330	Scaffold_13	23868881	23875133	NA	NA	NA	NA	NA
PGEN_.00g268340	Scaffold_13	23889538	23896892	NA	NA	NA	NA	NA
PGEN_.00g268350	Scaffold_13	23902936	23912259	NA	NA	NA	NA	NA
PGEN_.00g268360	Scaffold_13	23996627	24013284	Q6YJI5	TRM11_CHICK	tRNA (guanine(10)-N2)-methyltransferase homolog (EC 2.1.1.-) (tRNA guanosine-2'-O-methyltransferase TRM11 homolog)	GO:0000049; GO:0004809; GO:0005737; GO:0008168	cytoplasm [GO:0005737]; methyltransferase activity [GO:0008168]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]
PGEN_.00g268370	Scaffold_13	24016731	24019840	NA	NA	NA	NA	NA
PGEN_.00g268380	Scaffold_13	24023072	24023305	NA	NA	NA	NA	NA
PGEN_.00g268390	Scaffold_13	24028640	24042303	P20420	ACHA5_RAT	Neuronal acetylcholine receptor subunit alpha-5	GO:0005886; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015464; GO:0022848; GO:0030054; GO:0030425; GO:0034220; GO:0035094; GO:0035095; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0098691; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; protein-containing complex binding [GO:0044877]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g268400	Scaffold_13	24303795	24308113	NA	NA	NA	NA	NA
PGEN_.00g268410	Scaffold_13	24317735	24362891	Q68EK2	CALRL_DANRE	Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)	GO:0001525; GO:0001756; GO:0004948; GO:0005886; GO:0007166; GO:0016021; GO:0048844; GO:0055064	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]
PGEN_.00g268420	Scaffold_13	24448587	24453131	NA	NA	NA	NA	NA
PGEN_.00g268430	Scaffold_13	24462614	24462898	NA	NA	NA	NA	NA
PGEN_.00g268440	Scaffold_13	24465675	24467878	NA	NA	NA	NA	NA
PGEN_.00g268450	Scaffold_13	24486942	24488432	P00184	CP1A1_MOUSE	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0001666; GO:0002933; GO:0003824; GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0006778; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0008395; GO:0009308; GO:0009404; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009636; GO:0009804; GO:0009812; GO:0010041; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0016829; GO:0017143; GO:0017144; GO:0019341; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0033189; GO:0035902; GO:0042493; GO:0042572; GO:0042904; GO:0043010; GO:0043231; GO:0046483; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0055114; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0101020; GO:0101021; GO:1900087	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; maternal process involved in parturition [GO:0060137]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]"
PGEN_.00g268460	Scaffold_13	24508639	24512113	P35447	SPON1_XENLA	Spondin-1 (F-spondin)	GO:0005576; GO:0007155; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]
PGEN_.00g268470	Scaffold_13	24518453	24518818	NA	NA	NA	NA	NA
PGEN_.00g268480	Scaffold_13	24519272	24536026	NA	NA	NA	NA	NA
PGEN_.00g268490	Scaffold_13	24546060	24546988	NA	NA	NA	NA	NA
PGEN_.00g268500	Scaffold_13	24555064	24571140	Q924Z4	CERS2_MOUSE	Ceramide synthase 2 (CerS2) (EC 2.3.1.-) (LAG1 longevity assurance homolog 2) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Translocating chain-associating membrane protein homolog 3) (TRAM homolog 3)	GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0030148; GO:0046513; GO:0048681; GO:0050291; GO:1900148; GO:1905045	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g268510	Scaffold_13	24590175	24610457	Q8IU89	CERS3_HUMAN	Ceramide synthase 3 (CerS3) (EC 2.3.1.-) (Dihydroceramide synthase 3) (LAG1 longevity assurance homolog 3) (Sphingosine N-acyltransferase CERS3) (EC 2.3.1.24)	GO:0000981; GO:0003677; GO:0005783; GO:0005789; GO:0008544; GO:0016021; GO:0030148; GO:0030216; GO:0046513; GO:0050291; GO:0070268	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; cornification [GO:0070268]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; sphingolipid biosynthetic process [GO:0030148]"
PGEN_.00g268520	Scaffold_13	24621655	24655641	Q924Z4	CERS2_MOUSE	Ceramide synthase 2 (CerS2) (EC 2.3.1.-) (LAG1 longevity assurance homolog 2) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Translocating chain-associating membrane protein homolog 3) (TRAM homolog 3)	GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0030148; GO:0046513; GO:0048681; GO:0050291; GO:1900148; GO:1905045	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g268530	Scaffold_13	24681829	24692207	Q7TS68	NSUN6_MOUSE	tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 6)	GO:0000049; GO:0002946; GO:0005737; GO:0016428; GO:0030488	cytoplasm [GO:0005737]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]
PGEN_.00g268540	Scaffold_13	24692287	24693149	NA	NA	NA	NA	NA
PGEN_.00g268550	Scaffold_13	24693350	24694315	NA	NA	NA	NA	NA
PGEN_.00g268560	Scaffold_13	24694501	24700163	Q7TS68	NSUN6_MOUSE	tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 6)	GO:0000049; GO:0002946; GO:0005737; GO:0016428; GO:0030488	cytoplasm [GO:0005737]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]
PGEN_.00g268570	Scaffold_13	24700549	24701151	NA	NA	NA	NA	NA
PGEN_.00g268580	Scaffold_13	24729258	24735646	Q9PRL8	ACBP_CHICK	Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI)	GO:0000062; GO:0005783; GO:0005794; GO:0008289	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]
PGEN_.00g268590	Scaffold_13	24755147	24755452	NA	NA	NA	NA	NA
PGEN_.00g268600	Scaffold_13	24755762	24756070	NA	NA	NA	NA	NA
PGEN_.00g268610	Scaffold_13	24763306	24763614	NA	NA	NA	NA	NA
PGEN_.00g268620	Scaffold_13	24763924	24764229	NA	NA	NA	NA	NA
PGEN_.00g268630	Scaffold_13	24787648	24832035	Q7TS68	NSUN6_MOUSE	tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 6)	GO:0000049; GO:0002946; GO:0005737; GO:0016428; GO:0030488	cytoplasm [GO:0005737]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]
PGEN_.00g268640	Scaffold_13	24858432	24892330	Q924Z4	CERS2_MOUSE	Ceramide synthase 2 (CerS2) (EC 2.3.1.-) (LAG1 longevity assurance homolog 2) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Translocating chain-associating membrane protein homolog 3) (TRAM homolog 3)	GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0030148; GO:0046513; GO:0048681; GO:0050291; GO:1900148; GO:1905045	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g268650	Scaffold_13	24903589	24923925	Q3ZBF8	CERS2_BOVIN	Ceramide synthase 2 (CerS2) (EC 2.3.1.-) (LAG1 longevity assurance homolog 2) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24)	GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0046513; GO:0050291	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]
PGEN_.00g268660	Scaffold_13	24933359	24952316	NA	NA	NA	NA	NA
PGEN_.00g268670	Scaffold_13	24958929	24989955	NA	NA	NA	NA	NA
PGEN_.00g268680	Scaffold_13	24990334	24990723	NA	NA	NA	NA	NA
PGEN_.00g268690	Scaffold_13	24997063	25000542	Q9W770	SPON1_CHICK	Spondin-1 (F-spondin)	GO:0007155; GO:0031012; GO:0046872	extracellular matrix [GO:0031012]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]
PGEN_.00g268700	Scaffold_13	25023759	25025249	P00184	CP1A1_MOUSE	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0001666; GO:0002933; GO:0003824; GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0006778; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0008395; GO:0009308; GO:0009404; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009636; GO:0009804; GO:0009812; GO:0010041; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0016829; GO:0017143; GO:0017144; GO:0019341; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0033189; GO:0035902; GO:0042493; GO:0042572; GO:0042904; GO:0043010; GO:0043231; GO:0046483; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0055114; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0101020; GO:0101021; GO:1900087	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; maternal process involved in parturition [GO:0060137]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]"
PGEN_.00g268710	Scaffold_13	25037552	25046911	NA	NA	NA	NA	NA
PGEN_.00g268720	Scaffold_13	25048427	25049668	NA	NA	NA	NA	NA
PGEN_.00g268730	Scaffold_13	25077832	25108674	Q5RCS0	ATG9A_PONAB	Autophagy-related protein 9A (APG9-like 1)	GO:0000421; GO:0005794; GO:0006914; GO:0015031; GO:0016021; GO:0031902	autophagosome membrane [GO:0000421]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; autophagy [GO:0006914]; protein transport [GO:0015031]
PGEN_.00g268740	Scaffold_13	25109847	25110389	NA	NA	NA	NA	NA
PGEN_.00g268750	Scaffold_13	25110516	25114269	NA	NA	NA	NA	NA
PGEN_.00g268760	Scaffold_13	25183636	25193923	Q9EQZ6	RPGF4_MOUSE	Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-dependent Rap1 guanine-nucleotide exchange factor) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII)	GO:0001750; GO:0001917; GO:0005085; GO:0005088; GO:0005829; GO:0005886; GO:0005903; GO:0005929; GO:0007165; GO:0007264; GO:0014069; GO:0014911; GO:0016323; GO:0016324; GO:0017016; GO:0017156; GO:0017157; GO:0019933; GO:0030073; GO:0030424; GO:0030425; GO:0030426; GO:0030552; GO:0032991; GO:0043025; GO:0043197; GO:0044316; GO:0044877; GO:0050714; GO:0050773; GO:0050805; GO:0060076; GO:0098686; GO:0098693; GO:0098696; GO:0098978; GO:0099175; GO:1904457	apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cilium [GO:0005929]; cone cell pedicle [GO:0044316]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; Ras GTPase binding [GO:0017016]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; calcium-ion regulated exocytosis [GO:0017156]; cAMP-mediated signaling [GO:0019933]; insulin secretion [GO:0030073]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of protein secretion [GO:0050714]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of dendrite development [GO:0050773]; regulation of exocytosis [GO:0017157]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic vesicle cycle [GO:0098693]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g268770	Scaffold_13	25212736	25213065	NA	NA	NA	NA	NA
PGEN_.00g268780	Scaffold_13	25233763	25243442	Q8WZA2	RPGF4_HUMAN	Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII)	GO:0005085; GO:0005088; GO:0005829; GO:0005886; GO:0007186; GO:0007264; GO:0016020; GO:0017016; GO:0017156; GO:0017157; GO:0019933; GO:0030073; GO:0030552; GO:0050796; GO:0098686; GO:0098693	cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; Ras GTPase binding [GO:0017016]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; calcium-ion regulated exocytosis [GO:0017156]; cAMP-mediated signaling [GO:0019933]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; regulation of exocytosis [GO:0017157]; regulation of insulin secretion [GO:0050796]; regulation of synaptic vesicle cycle [GO:0098693]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g268790	Scaffold_13	25284780	25295641	NA	NA	NA	NA	NA
PGEN_.00g268800	Scaffold_13	25304502	25312877	NA	NA	NA	NA	NA
PGEN_.00g268810	Scaffold_13	25314762	25346565	Q95153	BRCA1_CANLF	Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1)	GO:0000724; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005694; GO:0005737; GO:0005886; GO:0006357; GO:0006633; GO:0007049; GO:0008270; GO:0009048; GO:0031436; GO:0035066; GO:0035067; GO:0043009; GO:0045717; GO:0045893; GO:0045944; GO:0051865; GO:0070063; GO:0070531; GO:0071158; GO:0085020	"BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chordate embryonic development [GO:0043009]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g268820	Scaffold_13	25347788	25350153	NA	NA	NA	NA	NA
PGEN_.00g268830	Scaffold_13	25350196	25358344	Q290X1	SWET1_DROPS	Sugar transporter SWEET1 (Protein saliva)	GO:0000139; GO:0005886; GO:0007431; GO:0016021; GO:0051119	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sugar transmembrane transporter activity [GO:0051119]; salivary gland development [GO:0007431]
PGEN_.00g268840	Scaffold_13	25366338	25375047	Q5U430	UBR3_MOUSE	E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650)	GO:0000151; GO:0001701; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016021; GO:0016567; GO:0042048; GO:0061630; GO:0071596	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; olfactory behavior [GO:0042048]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]
PGEN_.00g268850	Scaffold_13	25386026	25420087	Q5U430	UBR3_MOUSE	E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650)	GO:0000151; GO:0001701; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016021; GO:0016567; GO:0042048; GO:0061630; GO:0071596	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; olfactory behavior [GO:0042048]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]
PGEN_.00g268860	Scaffold_13	25420919	25421791	NA	NA	NA	NA	NA
PGEN_.00g268870	Scaffold_13	25427100	25431123	NA	NA	NA	NA	NA
PGEN_.00g268880	Scaffold_13	25432960	25441173	NA	NA	NA	NA	NA
PGEN_.00g268890	Scaffold_13	25450366	25469573	Q9R1S8	CAN7_MOUSE	Calpain-7 (EC 3.4.22.-) (PalB homolog) (PalBH)	GO:0004175; GO:0004198; GO:0005634; GO:0006508; GO:0010634; GO:0090541; GO:0097264	nucleus [GO:0005634]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; endopeptidase activity [GO:0004175]; MIT domain binding [GO:0090541]; positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]
PGEN_.00g268900	Scaffold_13	25509761	25510708	NA	NA	NA	NA	NA
PGEN_.00g268910	Scaffold_13	25522947	25557227	Q61851	FGFR3_MOUSE	Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Heparin-binding growth factor receptor) (CD antigen CD333)	GO:0000122; GO:0001938; GO:0002009; GO:0002089; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005634; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007267; GO:0008284; GO:0008285; GO:0008543; GO:0009898; GO:0009986; GO:0010518; GO:0010629; GO:0010712; GO:0014003; GO:0017134; GO:0018108; GO:0021762; GO:0022010; GO:0030133; GO:0030154; GO:0030278; GO:0030282; GO:0030501; GO:0030900; GO:0031398; GO:0035019; GO:0036342; GO:0038066; GO:0042531; GO:0042802; GO:0043235; GO:0043410; GO:0043525; GO:0043552; GO:0045596; GO:0045597; GO:0045670; GO:0045839; GO:0045879; GO:0046777; GO:0046850; GO:0048471; GO:0048546; GO:0048640; GO:0048678; GO:0048712; GO:0048839; GO:0050680; GO:0050731; GO:0051216; GO:0060113; GO:0060348; GO:0060349; GO:0060385; GO:0061144; GO:0061430; GO:0070307; GO:0070371; GO:0070374; GO:0070977; GO:0071864; GO:0072148; GO:0090080; GO:0090102; GO:0090263; GO:1902178	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; alveolar secondary septum development [GO:0061144]; axonogenesis involved in innervation [GO:0060385]; bone development [GO:0060348]; bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; bone trabecula morphogenesis [GO:0061430]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; central nervous system myelination [GO:0022010]; cochlea development [GO:0090102]; digestive tract morphogenesis [GO:0048546]; epithelial cell fate commitment [GO:0072148]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; lens fiber cell development [GO:0070307]; lens morphogenesis in camera-type eye [GO:0002089]; morphogenesis of an epithelium [GO:0002009]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of developmental growth [GO:0048640]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of gene expression [GO:0010629]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oligodendrocyte development [GO:0014003]; p38MAPK cascade [GO:0038066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; post-anal tail morphogenesis [GO:0036342]; protein autophosphorylation [GO:0046777]; regulation of bone remodeling [GO:0046850]; regulation of collagen metabolic process [GO:0010712]; regulation of ossification [GO:0030278]; regulation of osteoclast differentiation [GO:0045670]; response to axon injury [GO:0048678]; somatic stem cell population maintenance [GO:0035019]; substantia nigra development [GO:0021762]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g268920	Scaffold_13	25568732	25575658	Q8TC29	ENKUR_HUMAN	Enkurin	GO:0001669; GO:0005516; GO:0017124; GO:0097228	acrosomal vesicle [GO:0001669]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124]
PGEN_.00g268930	Scaffold_13	25580861	25592607	Q9JMG6	TFPT_RAT	TCF3 fusion partner homolog (Protein amida)	GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0006310; GO:0006915; GO:0008584; GO:0019901; GO:0031011; GO:0043065; GO:0044877; GO:0097190	cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; positive regulation of apoptotic process [GO:0043065]
PGEN_.00g268940	Scaffold_13	25594221	25611206	Q8NEG5	ZSWM2_HUMAN	E3 ubiquitin-protein ligase ZSWIM2 (EC 2.3.2.27) (MEKK1-related protein X) (MEX) (RING-type E3 ubiquitin transferase ZSWIM2) (ZZ-type zinc finger-containing protein 2) (Zinc finger SWIM domain-containing protein 2)	GO:0000209; GO:0006915; GO:0008270; GO:0043621; GO:0061630; GO:1902043	protein self-association [GO:0043621]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; protein polyubiquitination [GO:0000209]
PGEN_.00g268950	Scaffold_13	25624185	25632425	NA	NA	NA	NA	NA
PGEN_.00g268960	Scaffold_13	25634288	25634554	NA	NA	NA	NA	NA
PGEN_.00g268970	Scaffold_13	25662436	25724371	Q95ZJ1	GALT5_CAEEL	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g268980	Scaffold_13	25734364	25734847	Q80TC5	POGK_MOUSE	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g268990	Scaffold_13	25749914	25750378	NA	NA	NA	NA	NA
PGEN_.00g269000	Scaffold_13	25790502	25791738	NA	NA	NA	NA	NA
PGEN_.00g269010	Scaffold_13	25828377	25913057	Q8TEW0	PARD3_HUMAN	Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha)	GO:0000226; GO:0005546; GO:0005547; GO:0005623; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005913; GO:0005923; GO:0005938; GO:0006612; GO:0007049; GO:0007155; GO:0007163; GO:0007179; GO:0007205; GO:0007409; GO:0008104; GO:0008356; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032991; GO:0033269; GO:0035091; GO:0036464; GO:0042802; GO:0043025; GO:0043296; GO:0044295; GO:0045197; GO:0051660; GO:0060341; GO:0065003; GO:0070830; GO:0090162	"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell [GO:0005623]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g269020	Scaffold_13	25879235	25880334	NA	NA	NA	NA	NA
PGEN_.00g269030	Scaffold_13	25920292	25920585	NA	NA	NA	NA	NA
PGEN_.00g269040	Scaffold_13	25936171	25955105	Q5F3X4	U5S1_CHICK	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:1990904	"cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g269050	Scaffold_13	25972256	25982455	Q5F3X4	U5S1_CHICK	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:1990904	"cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g269060	Scaffold_13	26016964	26035353	Q5F3X4	U5S1_CHICK	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)"	GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:1990904	"cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g269070	Scaffold_13	26040107	26040385	NA	NA	NA	NA	NA
PGEN_.00g269080	Scaffold_13	26044364	26050051	NA	NA	NA	NA	NA
PGEN_.00g269090	Scaffold_13	26053951	26055644	NA	NA	NA	NA	NA
PGEN_.00g269100	Scaffold_13	26106383	26125016	NA	NA	NA	NA	NA
PGEN_.00g269110	Scaffold_13	26139562	26147633	O73817	PSB3_ONCMY	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0043161	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"
PGEN_.00g269120	Scaffold_13	26198613	26220666	Q9D5U8	CNBD2_MOUSE	Cyclic nucleotide-binding domain-containing protein 2 (Cyclic nucleotide receptor involved in sperm function)	GO:0005829; GO:0007283; GO:0030552	cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
PGEN_.00g269130	Scaffold_13	26230283	26249634	NA	NA	NA	NA	NA
PGEN_.00g269140	Scaffold_13	26302820	26304698	NA	NA	NA	NA	NA
PGEN_.00g269150	Scaffold_13	26314916	26317398	NA	NA	NA	NA	NA
PGEN_.00g269160	Scaffold_13	26317671	26318033	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g269170	Scaffold_13	26335914	26336687	NA	NA	NA	NA	NA
PGEN_.00g269180	Scaffold_13	26369236	26387671	Q0VA42	MINY4_XENTR	Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (EC 3.4.19.12) (Probable deubiquitinating enzyme MINDY-4)	GO:0016807; GO:0036459; GO:1990380	cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]
PGEN_.00g269190	Scaffold_13	26409047	26434581	NA	NA	NA	NA	NA
PGEN_.00g269200	Scaffold_13	26462167	26476957	E7FFT2	TMC2A_DANRE	Transmembrane channel-like protein 2-A	GO:0005886; GO:0005887; GO:0006811; GO:0048882; GO:0060119	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; inner ear receptor cell development [GO:0060119]; ion transport [GO:0006811]; lateral line development [GO:0048882]
PGEN_.00g269210	Scaffold_13	26472724	26473302	NA	NA	NA	NA	NA
PGEN_.00g269220	Scaffold_13	26513500	26514371	NA	NA	NA	NA	NA
PGEN_.00g269230	Scaffold_13	26514592	26528389	Q7Z404	TMC4_HUMAN	Transmembrane channel-like protein 4	GO:0005216; GO:0005887; GO:0008381; GO:0070062	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381]
PGEN_.00g269240	Scaffold_13	26533897	26537815	NA	NA	NA	NA	NA
PGEN_.00g269250	Scaffold_13	26552097	26588309	Q9JJK2	LANC2_MOUSE	LanC-like protein 2 (Testis-specific adriamycin sensitivity protein)	GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0009789; GO:0010314; GO:0030864; GO:0032266; GO:0045892; GO:0070273	"cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]"
PGEN_.00g269260	Scaffold_13	26625888	26641327	NA	NA	NA	NA	NA
PGEN_.00g269270	Scaffold_13	26641586	26651646	Q6AYA5	T106B_RAT	Transmembrane protein 106B	GO:0005764; GO:0005765; GO:0007040; GO:0007041; GO:0016021; GO:0031902; GO:0032418; GO:0048813; GO:1900006	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; dendrite morphogenesis [GO:0048813]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of dendrite development [GO:1900006]
PGEN_.00g269280	Scaffold_13	26663812	26664270	NA	NA	NA	NA	NA
PGEN_.00g269290	Scaffold_13	26664379	26664648	NA	NA	NA	NA	NA
PGEN_.00g269300	Scaffold_13	26664916	26665278	NA	NA	NA	NA	NA
PGEN_.00g269310	Scaffold_13	26665691	26666011	NA	NA	NA	NA	NA
PGEN_.00g269320	Scaffold_13	26666303	26667638	NA	NA	NA	NA	NA
PGEN_.00g269330	Scaffold_13	26667831	26668298	NA	NA	NA	NA	NA
PGEN_.00g269340	Scaffold_13	26670096	26670434	NA	NA	NA	NA	NA
PGEN_.00g269350	Scaffold_13	26671655	26671954	NA	NA	NA	NA	NA
PGEN_.00g269360	Scaffold_13	26672013	26672351	NA	NA	NA	NA	NA
PGEN_.00g269370	Scaffold_13	26673269	26673478	NA	NA	NA	NA	NA
PGEN_.00g269380	Scaffold_13	26681385	26681876	NA	NA	NA	NA	NA
PGEN_.00g269390	Scaffold_13	26711477	26790375	Q95M17	CHIA_BOVIN	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)	GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532]
PGEN_.00g269400	Scaffold_13	26807126	26812211	NA	NA	NA	NA	NA
PGEN_.00g269410	Scaffold_13	26832808	26833890	NA	NA	NA	NA	NA
PGEN_.00g269420	Scaffold_13	26833894	26834370	NA	NA	NA	NA	NA
PGEN_.00g269430	Scaffold_13	26834425	26840485	NA	NA	NA	NA	NA
PGEN_.00g269440	Scaffold_13	26843412	26846660	NA	NA	NA	NA	NA
PGEN_.00g269450	Scaffold_13	26849152	26854555	NA	NA	NA	NA	NA
PGEN_.00g269460	Scaffold_13	26863820	26864110	NA	NA	NA	NA	NA
PGEN_.00g269470	Scaffold_13	26874915	26875283	NA	NA	NA	NA	NA
PGEN_.00g269480	Scaffold_13	26881664	26900455	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g269490	Scaffold_13	26901176	26922419	Q8CFD1	RBM45_RAT	RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1) (RNA-binding motif protein 45)	GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0007399; GO:0030154; GO:1990904	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g269500	Scaffold_13	26939068	26971388	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g269510	Scaffold_13	27020745	27045610	NA	NA	NA	NA	NA
PGEN_.00g269520	Scaffold_13	27048737	27049276	NA	NA	NA	NA	NA
PGEN_.00g269530	Scaffold_13	27058977	27106798	NA	NA	NA	NA	NA
PGEN_.00g269540	Scaffold_13	27170154	27170546	NA	NA	NA	NA	NA
PGEN_.00g269550	Scaffold_13	27175119	27175394	NA	NA	NA	NA	NA
PGEN_.00g269560	Scaffold_13	27180560	27235126	NA	NA	NA	NA	NA
PGEN_.00g269570	Scaffold_13	27248677	27277705	D2HBV9	PORED_AILME	Polyprenol reductase (EC 1.3.1.94) (3-oxo-5-alpha-steroid 4-dehydrogenase 3) (EC 1.3.1.22) (Steroid 5-alpha-reductase 3) (S5AR 3) (SR type 3)	GO:0003865; GO:0005783; GO:0005789; GO:0006488; GO:0016021; GO:0016095; GO:0016628; GO:0019348; GO:0047751; GO:0102389	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; cholestenone 5-alpha-reductase activity [GO:0047751]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; polyprenol reductase activity [GO:0102389]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; polyprenol catabolic process [GO:0016095]"
PGEN_.00g269580	Scaffold_13	27314200	27314655	NA	NA	NA	NA	NA
PGEN_.00g269590	Scaffold_13	27314830	27317849	NA	NA	NA	NA	NA
PGEN_.00g269600	Scaffold_13	27328752	27329531	NA	NA	NA	NA	NA
PGEN_.00g269610	Scaffold_13	27452850	27516721	NA	NA	NA	NA	NA
PGEN_.00g269620	Scaffold_13	27623651	27623932	NA	NA	NA	NA	NA
PGEN_.00g269630	Scaffold_13	27645344	27655155	NA	NA	NA	NA	NA
PGEN_.00g269640	Scaffold_13	27724295	27724933	Q9WVL2	STAT2_MOUSE	Signal transducer and activator of transcription 2	GO:0000978; GO:0001228; GO:0001932; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006952; GO:0007259; GO:0019221; GO:0042127; GO:0042802; GO:0043434; GO:0044389; GO:0045944; GO:0051607; GO:0060337; GO:0090140	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-like protein ligase binding [GO:0044389]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mitochondrial fission [GO:0090140]; regulation of protein phosphorylation [GO:0001932]; response to peptide hormone [GO:0043434]; type I interferon signaling pathway [GO:0060337]"
PGEN_.00g269650	Scaffold_13	27725296	27725526	NA	NA	NA	NA	NA
PGEN_.00g269660	Scaffold_13	27738438	27738863	NA	NA	NA	NA	NA
PGEN_.00g269670	Scaffold_13	27739034	27739315	NA	NA	NA	NA	NA
PGEN_.00g269680	Scaffold_13	27792684	27793037	NA	NA	NA	NA	NA
PGEN_.00g269690	Scaffold_13	27794217	27795143	NA	NA	NA	NA	NA
PGEN_.00g269700	Scaffold_13	27821151	27821720	NA	NA	NA	NA	NA
PGEN_.00g269710	Scaffold_13	27821830	27822921	Q06852	SLAP1_HUNT2	Cell surface glycoprotein 1 (Outer layer protein B) (S-layer protein 1)	GO:0000272; GO:0005576; GO:0005618; GO:0030115; GO:0030246	cell wall [GO:0005618]; extracellular region [GO:0005576]; S-layer [GO:0030115]; carbohydrate binding [GO:0030246]; polysaccharide catabolic process [GO:0000272]
PGEN_.00g269720	Scaffold_13	27877976	27953587	O02695	PTPR2_MACNE	Receptor-type tyrosine-protein phosphatase N2 (R-PTP-N2) (EC 3.1.3.-) (EC 3.1.3.48) (M1851) [Cleaved into: IA-2beta60]	GO:0004725; GO:0005623; GO:0006629; GO:0007269; GO:0016021; GO:0030054; GO:0030667; GO:0030672; GO:0035773	cell [GO:0005623]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein tyrosine phosphatase activity [GO:0004725]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269]
PGEN_.00g269730	Scaffold_13	27941993	27943872	NA	NA	NA	NA	NA
PGEN_.00g269740	Scaffold_13	27963935	27964285	NA	NA	NA	NA	NA
PGEN_.00g269750	Scaffold_13	27973893	27975687	NA	NA	NA	NA	NA
PGEN_.00g269760	Scaffold_13	28013345	28014562	NA	NA	NA	NA	NA
PGEN_.00g269770	Scaffold_13	28015390	28015716	NA	NA	NA	NA	NA
PGEN_.00g269780	Scaffold_13	28015743	28017236	NA	NA	NA	NA	NA
PGEN_.00g269790	Scaffold_13	28030709	28030948	NA	NA	NA	NA	NA
PGEN_.00g269800	Scaffold_13	28038036	28038710	P78559	MAP1A_HUMAN	Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2]	GO:0000226; GO:0003779; GO:0005198; GO:0005623; GO:0005737; GO:0005829; GO:0005874; GO:0005875; GO:0007409; GO:0007613; GO:0008017; GO:0008093; GO:0008306; GO:0015631; GO:0016358; GO:0030424; GO:0030425; GO:0031114; GO:0032435; GO:0042995; GO:0043005; GO:0043025; GO:0043194; GO:0043198; GO:0044307; GO:0045202; GO:0048156; GO:0048167; GO:0050882; GO:0070050; GO:0099641; GO:0099642; GO:0150001; GO:1901588; GO:1902817; GO:1903829; GO:1904115; GO:1990535; GO:2000010	axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cell [GO:0005623]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic branch [GO:0044307]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; synapse [GO:0045202]; actin binding [GO:0003779]; cytoskeletal adaptor activity [GO:0008093]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; anterograde axonal protein transport [GO:0099641]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein localization to microtubule [GO:1902817]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic plasticity [GO:0048167]; retrograde axonal protein transport [GO:0099642]; voluntary musculoskeletal movement [GO:0050882]
PGEN_.00g269810	Scaffold_13	28040501	28040959	NA	NA	NA	NA	NA
PGEN_.00g269820	Scaffold_13	28041128	28041478	NA	NA	NA	NA	NA
PGEN_.00g269830	Scaffold_13	28041606	28042094	NA	NA	NA	NA	NA
PGEN_.00g269840	Scaffold_13	28042858	28043142	NA	NA	NA	NA	NA
PGEN_.00g269850	Scaffold_13	28043182	28043514	NA	NA	NA	NA	NA
PGEN_.00g269860	Scaffold_13	28105946	28106245	NA	NA	NA	NA	NA
PGEN_.00g269870	Scaffold_13	28129013	28129351	NA	NA	NA	NA	NA
PGEN_.00g269880	Scaffold_13	28131199	28133088	NA	NA	NA	NA	NA
PGEN_.00g269890	Scaffold_13	28140499	28140723	NA	NA	NA	NA	NA
PGEN_.00g269900	Scaffold_13	28161963	28162824	NA	NA	NA	NA	NA
PGEN_.00g269910	Scaffold_13	28166098	28166541	NA	NA	NA	NA	NA
PGEN_.00g269920	Scaffold_13	28175669	28177136	NA	NA	NA	NA	NA
PGEN_.00g269930	Scaffold_13	28221938	28299407	Q5RBD3	RBMS3_PONAB	"RNA-binding motif, single-stranded-interacting protein 3"	GO:0003723; GO:0005737; GO:1990904	cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]
PGEN_.00g269940	Scaffold_13	28309089	28310274	NA	NA	NA	NA	NA
PGEN_.00g269950	Scaffold_13	28320515	28321197	NA	NA	NA	NA	NA
PGEN_.00g269960	Scaffold_13	28336837	28345312	Q99973	TEP1_HUMAN	Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog)	GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]"
PGEN_.00g269970	Scaffold_13	28368889	28386545	Q54KD0	Y7407_DICDI	TPR repeat-containing protein DDB_G0287407		
PGEN_.00g269980	Scaffold_13	28399786	28421329	Q7Z5J8	ANKAR_HUMAN	Ankyrin and armadillo repeat-containing protein	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g269990	Scaffold_13	28462411	28492301	Q7Z5J8	ANKAR_HUMAN	Ankyrin and armadillo repeat-containing protein	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g270000	Scaffold_13	28496218	28505611	Q8LAN3	P4H4_ARATH	Probable prolyl 4-hydroxylase 4 (AtP4H4) (EC 1.14.11.2)	GO:0000137; GO:0004656; GO:0005506; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0009536; GO:0016021; GO:0018401; GO:0031418	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plastid [GO:0009536]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]
PGEN_.00g270010	Scaffold_13	28522995	28526712	NA	NA	NA	NA	NA
PGEN_.00g270020	Scaffold_13	28530263	28600990	Q6P1L5	F117B_HUMAN	Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein)		
PGEN_.00g270030	Scaffold_13	28643957	28650100	NA	NA	NA	NA	NA
PGEN_.00g270040	Scaffold_13	28650536	28650898	NA	NA	NA	NA	NA
PGEN_.00g270050	Scaffold_13	28656520	28665669	NA	NA	NA	NA	NA
PGEN_.00g270060	Scaffold_13	28693932	28733636	Q6A548	TERT_CANLF	Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit)	GO:0000333; GO:0000781; GO:0003720; GO:0003721; GO:0005697; GO:0005730; GO:0005737; GO:0007004; GO:0016605; GO:0042162; GO:0046872; GO:0070034	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; PML body [GO:0016605]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697]; metal ion binding [GO:0046872]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomerase RNA reverse transcriptase activity [GO:0003721]; telomeric DNA binding [GO:0042162]; telomere maintenance via telomerase [GO:0007004]"
PGEN_.00g270070	Scaffold_13	28744724	28765574	O57321	EAA1_AMBTI	Excitatory amino acid transporter 1 (SEAAT1) (Sodium-dependent glutamate/aspartate transporter) (GLAST)	GO:0005314; GO:0005887; GO:0015501; GO:0046872; GO:0070779; GO:0071805; GO:0098712; GO:0140009; GO:1902476	integral component of plasma membrane [GO:0005887]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; potassium ion transmembrane transport [GO:0071805]
PGEN_.00g270080	Scaffold_13	28795844	28815660	P48664	EAA4_HUMAN	Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6)	GO:0001504; GO:0005314; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0014047; GO:0015183; GO:0015810; GO:0015813; GO:0016020; GO:0042391; GO:0045111; GO:0046872; GO:0098712; GO:0098978; GO:0099056	glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; plasma membrane [GO:0005886]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; metal ion binding [GO:0046872]; aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter uptake [GO:0001504]; regulation of membrane potential [GO:0042391]
PGEN_.00g270090	Scaffold_13	28819117	28834051	NA	NA	NA	NA	NA
PGEN_.00g270100	Scaffold_13	28847639	28848373	NA	NA	NA	NA	NA
PGEN_.00g270110	Scaffold_13	28849482	28849796	NA	NA	NA	NA	NA
PGEN_.00g270120	Scaffold_13	28857057	28867325	NA	NA	NA	NA	NA
PGEN_.00g270130	Scaffold_13	28867999	28868292	Q5XGC9	SRFB1_XENTR	Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein)	GO:0005634; GO:0030490; GO:0030686; GO:0048471	90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; maturation of SSU-rRNA [GO:0030490]
PGEN_.00g270140	Scaffold_13	28868559	28868876	Q5XGC9	SRFB1_XENTR	Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein)	GO:0005634; GO:0030490; GO:0030686; GO:0048471	90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; maturation of SSU-rRNA [GO:0030490]
PGEN_.00g270150	Scaffold_13	28869017	28869526	Q5XGC9	SRFB1_XENTR	Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein)	GO:0005634; GO:0030490; GO:0030686; GO:0048471	90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; maturation of SSU-rRNA [GO:0030490]
PGEN_.00g270160	Scaffold_13	28869696	28872439	NA	NA	NA	NA	NA
PGEN_.00g270170	Scaffold_13	28872552	28872830	NA	NA	NA	NA	NA
PGEN_.00g270180	Scaffold_13	28872895	28873146	NA	NA	NA	NA	NA
PGEN_.00g270190	Scaffold_13	28873234	28873485	NA	NA	NA	NA	NA
PGEN_.00g270200	Scaffold_13	28874410	28874817	NA	NA	NA	NA	NA
PGEN_.00g270210	Scaffold_13	28875182	28875547	NA	NA	NA	NA	NA
PGEN_.00g270220	Scaffold_13	28877493	28889914	NA	NA	NA	NA	NA
PGEN_.00g270230	Scaffold_13	28890474	28891185	NA	NA	NA	NA	NA
PGEN_.00g270240	Scaffold_13	28916290	28978465	Q5T5U3	RHG21_HUMAN	Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21)	GO:0000139; GO:0005096; GO:0005623; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0007165; GO:0015629; GO:0030054; GO:0030659; GO:0051056; GO:0051683; GO:0051684; GO:0072384	actin cytoskeleton [GO:0015629]; cell [GO:0005623]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; establishment of Golgi localization [GO:0051683]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]
PGEN_.00g270250	Scaffold_13	28982000	28982290	NA	NA	NA	NA	NA
PGEN_.00g270260	Scaffold_13	29010892	29037584	P97435	ENTK_MOUSE	Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]	GO:0004252; GO:0005044; GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g270270	Scaffold_13	29046301	29049233	NA	NA	NA	NA	NA
PGEN_.00g270280	Scaffold_13	29054058	29054420	NA	NA	NA	NA	NA
PGEN_.00g270290	Scaffold_13	29063229	29063561	NA	NA	NA	NA	NA
PGEN_.00g270300	Scaffold_13	29063602	29065592	NA	NA	NA	NA	NA
PGEN_.00g270310	Scaffold_13	29065758	29079948	O34918	YOAJ_BACSU	Expansin-YoaJ (EXLX1)	GO:0005576; GO:0005618	cell wall [GO:0005618]; extracellular region [GO:0005576]
PGEN_.00g270320	Scaffold_13	29088775	29089062	NA	NA	NA	NA	NA
PGEN_.00g270330	Scaffold_13	29090086	29090565	NA	NA	NA	NA	NA
PGEN_.00g270340	Scaffold_13	29107179	29109218	NA	NA	NA	NA	NA
PGEN_.00g270350	Scaffold_13	29128208	29130242	NA	NA	NA	NA	NA
PGEN_.00g270360	Scaffold_13	29141026	29148426	NA	NA	NA	NA	NA
PGEN_.00g270370	Scaffold_13	29185757	29209319	NA	NA	NA	NA	NA
PGEN_.00g270380	Scaffold_13	29213690	29242225	NA	NA	NA	NA	NA
PGEN_.00g270390	Scaffold_13	29258783	29262542	NA	NA	NA	NA	NA
PGEN_.00g270400	Scaffold_13	29265594	29281067	P83888	TBG1_RAT	Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1)	GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0005819; GO:0005827; GO:0005874; GO:0005876; GO:0005881; GO:0005929; GO:0007017; GO:0007020; GO:0007052; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0045177; GO:0055037; GO:0097730	apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]
PGEN_.00g270410	Scaffold_13	29293180	29293764	NA	NA	NA	NA	NA
PGEN_.00g270420	Scaffold_13	29319827	29320312	NA	NA	NA	NA	NA
PGEN_.00g270430	Scaffold_13	29323800	29334821	NA	NA	NA	NA	NA
PGEN_.00g270440	Scaffold_13	29358650	29359486	NA	NA	NA	NA	NA
PGEN_.00g270450	Scaffold_13	29360471	29368811	Q9U221	UNG_CAEEL	Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)	GO:0004844; GO:0005634; GO:0005739; GO:0006284; GO:0097510	"mitochondrion [GO:0005739]; nucleus [GO:0005634]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]"
PGEN_.00g270460	Scaffold_13	29377343	29399818	Q04451	SYG_BOMMO	Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS)	GO:0004820; GO:0005524; GO:0005737; GO:0006426; GO:0015966; GO:0016740; GO:0046983	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]
PGEN_.00g270470	Scaffold_13	29400350	29413114	Q4V7F3	OSGP2_RAT	"Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase-like protein 1) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein Osgepl1) (tRNA threonylcarbamoyladenosine biosynthesis protein Osgepl1)"	GO:0000408; GO:0002949; GO:0004222; GO:0005739; GO:0046872; GO:0061711	EKC/KEOPS complex [GO:0000408]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]
PGEN_.00g270480	Scaffold_13	29438200	29438460	NA	NA	NA	NA	NA
PGEN_.00g270490	Scaffold_13	29443311	29443706	NA	NA	NA	NA	NA
PGEN_.00g270500	Scaffold_13	29472245	29522539	Q53SF7	COBL1_HUMAN	Cordon-bleu protein-like 1	GO:0003785; GO:0045296; GO:0070062	extracellular exosome [GO:0070062]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296]
PGEN_.00g270510	Scaffold_13	29531875	29543590	NA	NA	NA	NA	NA
PGEN_.00g270520	Scaffold_13	29550744	29556890	Q5TYS5	SCRN2_DANRE	Secernin-2	GO:0016805	dipeptidase activity [GO:0016805]
PGEN_.00g270530	Scaffold_13	29565611	29602967	Q9NGQ2	KIF1_DICDI	Kinesin-related protein 1 (Kinesin family member 1) (Kinesin-3)	GO:0003777; GO:0005524; GO:0005546; GO:0005623; GO:0005813; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0030659; GO:0042803; GO:0047496; GO:0072383; GO:0072386	"cell [GO:0005623]; centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; microtubule-based movement [GO:0007018]; plus-end-directed organelle transport along microtubule [GO:0072386]; plus-end-directed vesicle transport along microtubule [GO:0072383]; vesicle transport along microtubule [GO:0047496]"
PGEN_.00g270540	Scaffold_13	29603965	29612920	F8WLE0	KIF28_RAT	Kinesin-like protein KIF28P (Kinesin-like protein 6)	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0030705; GO:0031966; GO:0072384	kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]
PGEN_.00g270550	Scaffold_13	29628361	29631429	Q99676	ZN184_HUMAN	Zinc finger protein 184	GO:0003677; GO:0005634; GO:0006355; GO:0008270	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g270560	Scaffold_13	29636558	29640179	Q8C436	MT21D_MOUSE	Protein-lysine methyltransferase METTL21D (EC 2.1.1.-) (Methyltransferase-like protein 21D) (VCP lysine methyltransferase) (VCP-KMT) (Valosin-containing protein lysine methyltransferase)	GO:0005737; GO:0005829; GO:0016279; GO:0018022; GO:0018023; GO:0032780; GO:0032991; GO:0051117	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; protein-lysine N-methyltransferase activity [GO:0016279]; negative regulation of ATPase activity [GO:0032780]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]
PGEN_.00g270570	Scaffold_13	29642153	29663064	Q9JJZ4	UB2J1_MOUSE	Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1)	GO:0005524; GO:0005789; GO:0007286; GO:0016021; GO:0018279; GO:0030433; GO:0031625; GO:0042534; GO:0061631; GO:1904153	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of tumor necrosis factor biosynthetic process [GO:0042534]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g270580	Scaffold_13	29760910	29798521	NA	NA	NA	NA	NA
PGEN_.00g270590	Scaffold_13	29834476	29913129	NA	NA	NA	NA	NA
PGEN_.00g270600	Scaffold_13	29950324	30010007	NA	NA	NA	NA	NA
PGEN_.00g270610	Scaffold_13	30039407	30114780	B8UU59	PK1L_ACRMI	Polycystic kidney disease 1-related protein (Fragment)	GO:0001822; GO:0016021	integral component of membrane [GO:0016021]; kidney development [GO:0001822]
PGEN_.00g270620	Scaffold_13	30121904	30122392	NA	NA	NA	NA	NA
PGEN_.00g270630	Scaffold_13	30122435	30122836	NA	NA	NA	NA	NA
PGEN_.00g270640	Scaffold_13	30124160	30148040	Q2KID4	DNAL1_BOVIN	"Dynein light chain 1, axonemal"	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0036158; GO:0042995; GO:0043014; GO:0045504	cell projection [GO:0042995]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158]
PGEN_.00g270650	Scaffold_13	30131390	30131740	NA	NA	NA	NA	NA
PGEN_.00g270660	Scaffold_13	30163640	30176187	Q2EMV9	PAR14_MOUSE	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)	GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]
PGEN_.00g270670	Scaffold_13	30231477	30232532	NA	NA	NA	NA	NA
PGEN_.00g270680	Scaffold_13	30255897	30256530	Q9ERH8	S28A3_MOUSE	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (mCNT3)	GO:0001895; GO:0005337; GO:0005415; GO:0005887; GO:0015389; GO:0015390; GO:0015860; GO:0015864; GO:1901642	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; nucleoside transmembrane transport [GO:1901642]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; retina homeostasis [GO:0001895]
PGEN_.00g270690	Scaffold_13	30264014	30274552	O61598	RL37A_OSTOS	60S ribosomal protein L37a	GO:0003735; GO:0005840; GO:0006412; GO:0046872	ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g270700	Scaffold_13	30277104	30282916	Q7TM96	ZN622_RAT	Zinc finger protein 622 (Liver regeneration-related protein LRRG121)	GO:0003676; GO:0005634; GO:0005737; GO:0008270; GO:0008631; GO:0030687; GO:0033674; GO:0042273; GO:0043065; GO:0043410; GO:0046330	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]"
PGEN_.00g270710	Scaffold_13	30305457	30309333	NA	NA	NA	NA	NA
PGEN_.00g270720	Scaffold_13	30310374	30312582	Q6H236	PEG3_BOVIN	Paternally-expressed gene 3 protein	GO:0003676; GO:0003700; GO:0005634; GO:0005737; GO:0006915; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915]
PGEN_.00g270730	Scaffold_13	30314029	30317772	NA	NA	NA	NA	NA
PGEN_.00g270740	Scaffold_13	30321759	30322586	NA	NA	NA	NA	NA
PGEN_.00g270750	Scaffold_13	30327875	30335158	Q04592	PCSK5_MOUSE	Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (Subtilisin-like proprotein convertase 6) (SPC6) (Subtilisin/kexin-like protease PC5)	GO:0001822; GO:0002001; GO:0003279; GO:0004175; GO:0004252; GO:0005615; GO:0005788; GO:0005794; GO:0005797; GO:0005802; GO:0005886; GO:0006465; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030141; GO:0030173; GO:0030323; GO:0033625; GO:0035108; GO:0042089; GO:0042277; GO:0043043; GO:0043204; GO:0048566; GO:0048706; GO:0060976; GO:1904754; GO:1905609; GO:1990635; GO:2001046	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]
PGEN_.00g270760	Scaffold_13	30335713	30366937	Q15399	TLR1_HUMAN	Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281)	GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0034130; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0038123; GO:0042116; GO:0042495; GO:0042535; GO:0042802; GO:0045087; GO:0045121; GO:0045410; GO:0046982; GO:0071723; GO:0071727; GO:2000484	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; cell activation [GO:0001775]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR1:TLR2 signaling pathway [GO:0038123]
PGEN_.00g270770	Scaffold_13	30384889	30386820	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g270780	Scaffold_13	30410351	30426375	P17644	ACH2_DROME	Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2)	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g270790	Scaffold_13	30478290	30483673	NA	NA	NA	NA	NA
PGEN_.00g270800	Scaffold_13	30503307	30510824	NA	NA	NA	NA	NA
PGEN_.00g270810	Scaffold_13	30517011	30518085	O00519	FAAH1_HUMAN	Fatty-acid amide hydrolase 1 (EC 3.5.1.99) (Anandamide amidohydrolase 1) (Oleamide hydrolase 1)	GO:0004040; GO:0005789; GO:0005856; GO:0009062; GO:0016021; GO:0017064; GO:0019369; GO:0031090; GO:0047372; GO:0052651; GO:0102077; GO:0103073	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; acylglycerol lipase activity [GO:0047372]; amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]; fatty acid catabolic process [GO:0009062]; monoacylglycerol catabolic process [GO:0052651]
PGEN_.00g270820	Scaffold_13	30525714	30545378	Q90578	VDHAP_CHICK	Vitamin D3 hydroxylase-associated protein (VDHAP)	GO:0004040; GO:0005739; GO:0005743; GO:0009062; GO:0017064	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; amidase activity [GO:0004040]; fatty acid amide hydrolase activity [GO:0017064]; fatty acid catabolic process [GO:0009062]
PGEN_.00g270830	Scaffold_13	30556948	30572781	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g270840	Scaffold_13	30577557	30578888	NA	NA	NA	NA	NA
PGEN_.00g270850	Scaffold_13	30579017	30579298	NA	NA	NA	NA	NA
PGEN_.00g270860	Scaffold_13	30580818	30604396	O75095	MEGF6_HUMAN	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g270870	Scaffold_13	30600148	30600639	NA	NA	NA	NA	NA
PGEN_.00g270880	Scaffold_13	30604716	30643471	O00339	MATN2_HUMAN	Matrilin-2	GO:0001764; GO:0003429; GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007411; GO:0008347; GO:0031012; GO:0031104; GO:0048678; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; glial cell migration [GO:0008347]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]
PGEN_.00g270890	Scaffold_13	30645589	30647000	NA	NA	NA	NA	NA
PGEN_.00g270900	Scaffold_13	30698003	30699693	NA	NA	NA	NA	NA
PGEN_.00g270910	Scaffold_13	30715979	30716311	NA	NA	NA	NA	NA
PGEN_.00g270920	Scaffold_13	30721932	30722147	NA	NA	NA	NA	NA
PGEN_.00g270930	Scaffold_13	30725968	30762940	NA	NA	NA	NA	NA
PGEN_.00g270940	Scaffold_13	30794516	30812628	Q68EK2	CALRL_DANRE	Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)	GO:0001525; GO:0001756; GO:0004948; GO:0005886; GO:0007166; GO:0016021; GO:0048844; GO:0055064	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]
PGEN_.00g270950	Scaffold_13	30835864	30836307	NA	NA	NA	NA	NA
PGEN_.00g270960	Scaffold_13	30973308	30973943	NA	NA	NA	NA	NA
PGEN_.00g270970	Scaffold_13	30987450	30988298	NA	NA	NA	NA	NA
PGEN_.00g270980	Scaffold_13	30988322	30990926	NA	NA	NA	NA	NA
PGEN_.00g270990	Scaffold_13	31117999	31125685	NA	NA	NA	NA	NA
PGEN_.00g271000	Scaffold_13	31136664	31159122	Q91V92	ACLY_MOUSE	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)	GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0046872; GO:0048037	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]
PGEN_.00g271010	Scaffold_13	31159220	31180117	P53396	ACLY_HUMAN	ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme)	GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0031325; GO:0035578; GO:0043312; GO:0046872; GO:0046949; GO:0048037; GO:0070062; GO:1904813	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid biosynthetic process [GO:0008610]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]; positive regulation of cellular metabolic process [GO:0031325]
PGEN_.00g271020	Scaffold_13	31190435	31194927	NA	NA	NA	NA	NA
PGEN_.00g271030	Scaffold_13	31200657	31213185	NA	NA	NA	NA	NA
PGEN_.00g271040	Scaffold_13	31213274	31235798	Q95ZJ1	GALT5_CAEEL	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g271050	Scaffold_13	31231117	31231419	NA	NA	NA	NA	NA
PGEN_.00g271060	Scaffold_13	31238745	31252344	P25961	PTH1R_RAT	Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor)	GO:0001501; GO:0001503; GO:0001701; GO:0002062; GO:0002076; GO:0004991; GO:0005623; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006874; GO:0007166; GO:0007187; GO:0007188; GO:0007189; GO:0007200; GO:0007204; GO:0007568; GO:0008284; GO:0008285; GO:0008528; GO:0016323; GO:0016324; GO:0017046; GO:0030282; GO:0031526; GO:0042803; GO:0043235; GO:0043621; GO:0045453; GO:0048469; GO:0060732	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled peptide receptor activity [GO:0008528]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; aging [GO:0007568]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cell maturation [GO:0048469]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; chondrocyte differentiation [GO:0002062]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; in utero embryonic development [GO:0001701]; negative regulation of cell population proliferation [GO:0008285]; ossification [GO:0001503]; osteoblast development [GO:0002076]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; skeletal system development [GO:0001501]"
PGEN_.00g271070	Scaffold_13	31252401	31270746	NA	NA	NA	NA	NA
PGEN_.00g271080	Scaffold_13	31356878	31378523	NA	NA	NA	NA	NA
PGEN_.00g271090	Scaffold_13	31395820	31399280	Q5XJR6	ORML3_DANRE	ORM1-like protein 3	GO:0005623; GO:0005783; GO:0006672; GO:0016021; GO:0035339; GO:0090156; GO:1900060	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]; cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; negative regulation of ceramide biosynthetic process [GO:1900060]
PGEN_.00g271100	Scaffold_13	31412067	31457308	P11362	FGFR1_HUMAN	Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)	GO:0000122; GO:0000165; GO:0001501; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001764; GO:0002053; GO:0002062; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0007169; GO:0007605; GO:0008201; GO:0008284; GO:0008543; GO:0010518; GO:0010863; GO:0010966; GO:0010976; GO:0014068; GO:0016021; GO:0016477; GO:0017134; GO:0018108; GO:0021847; GO:0030326; GO:0030901; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043009; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0045595; GO:0045597; GO:0045666; GO:0046777; GO:0048015; GO:0048339; GO:0048378; GO:0048469; GO:0048705; GO:0048762; GO:0051897; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0070640; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1905564; GO:2000546; GO:2000830; GO:2001239	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; branching involved in salivary gland morphogenesis [GO:0060445]; cell maturation [GO:0048469]; cell migration [GO:0016477]; chondrocyte differentiation [GO:0002062]; chordate embryonic development [GO:0043009]; embryonic limb morphogenesis [GO:0030326]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung-associated mesenchyme development [GO:0060484]; MAPK cascade [GO:0000165]; mesenchymal cell differentiation [GO:0048762]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]
PGEN_.00g271110	Scaffold_13	31471095	31472089	NA	NA	NA	NA	NA
PGEN_.00g271120	Scaffold_13	31472314	31473195	NA	NA	NA	NA	NA
PGEN_.00g271130	Scaffold_13	31482215	31483861	NA	NA	NA	NA	NA
PGEN_.00g271140	Scaffold_13	31520986	31549814	Q91147	FGFR2_NOTVI	Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1)	GO:0005007; GO:0005524; GO:0005794; GO:0005886; GO:0006915; GO:0008284; GO:0016021; GO:0031410	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]
PGEN_.00g271150	Scaffold_13	31597353	31620927	NA	NA	NA	NA	NA
PGEN_.00g271160	Scaffold_13	31625503	31631178	NA	NA	NA	NA	NA
PGEN_.00g271170	Scaffold_13	31644270	31649635	NA	NA	NA	NA	NA
PGEN_.00g271180	Scaffold_13	31680505	31689129	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g271190	Scaffold_13	31695638	31696009	NA	NA	NA	NA	NA
PGEN_.00g271200	Scaffold_13	31696090	31696482	NA	NA	NA	NA	NA
PGEN_.00g271210	Scaffold_13	31696674	31696898	NA	NA	NA	NA	NA
PGEN_.00g271220	Scaffold_13	31699070	31699357	NA	NA	NA	NA	NA
PGEN_.00g271230	Scaffold_13	31700562	31701250	NA	NA	NA	NA	NA
PGEN_.00g271240	Scaffold_13	31810930	31813478	Q5DC69	CH10_SCHJA	"10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10)"	GO:0005524; GO:0005759; GO:0006457	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; protein folding [GO:0006457]
PGEN_.00g271250	Scaffold_13	31813700	31823538	Q5ZL72	CH60_CHICK	"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60)"	GO:0001530; GO:0002039; GO:0002368; GO:0002755; GO:0002842; GO:0003725; GO:0005524; GO:0005737; GO:0005759; GO:0005769; GO:0005829; GO:0005886; GO:0005905; GO:0006458; GO:0006919; GO:0006986; GO:0008035; GO:0008637; GO:0009409; GO:0009986; GO:0016853; GO:0030135; GO:0030141; GO:0031625; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0034186; GO:0042026; GO:0042100; GO:0042110; GO:0043025; GO:0043032; GO:0043066; GO:0045041; GO:0046696; GO:0048291; GO:0050821; GO:0050870; GO:0051082; GO:0051087; GO:0051702; GO:0070062; GO:0098761	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lipopolysaccharide receptor complex [GO:0046696]; mitochondrial matrix [GO:0005759]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; apolipoprotein A-I binding [GO:0034186]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell cytokine production [GO:0002368]; B cell proliferation [GO:0042100]; cellular response to interleukin-7 [GO:0098761]; interaction with symbiont [GO:0051702]; isotype switching to IgG isotypes [GO:0048291]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]
PGEN_.00g271260	Scaffold_13	31855792	31858153	NA	NA	NA	NA	NA
PGEN_.00g271270	Scaffold_13	31882873	31903268	Q5NVI6	PTTG_PONAB	Pituitary tumor-transforming gene 1 protein-interacting protein (Pituitary tumor-transforming gene protein-binding factor) (PBF) (PTTG-binding factor)	GO:0005634; GO:0005737; GO:0005886; GO:0016021	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
PGEN_.00g271280	Scaffold_13	31904774	31916763	O60662	KLH41_HUMAN	Kelch-like protein 41 (Kel-like protein 23) (Kelch repeat and BTB domain-containing protein 10) (Kelch-related protein 1) (Sarcosin)	GO:0001726; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0006941; GO:0016567; GO:0030239; GO:0031143; GO:0031275; GO:0031430; GO:0031463; GO:0033017; GO:0035914; GO:0043687; GO:0045214; GO:0045661; GO:0048741; GO:2000291; GO:2001014	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]; myofibril assembly [GO:0030239]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of lateral pseudopodium assembly [GO:0031275]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]; striated muscle contraction [GO:0006941]
PGEN_.00g271290	Scaffold_13	31928393	31939886	NA	NA	NA	NA	NA
PGEN_.00g271300	Scaffold_13	31939993	31940739	NA	NA	NA	NA	NA
PGEN_.00g271310	Scaffold_13	31940970	31941290	NA	NA	NA	NA	NA
PGEN_.00g271320	Scaffold_13	31941384	31941662	NA	NA	NA	NA	NA
PGEN_.00g271330	Scaffold_13	31941686	31993638	Q6UX71	PXDC2_HUMAN	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g271340	Scaffold_13	32023267	32031982	NA	NA	NA	NA	NA
PGEN_.00g271350	Scaffold_13	32034384	32036484	NA	NA	NA	NA	NA
PGEN_.00g271360	Scaffold_13	32039479	32087100	NA	NA	NA	NA	NA
PGEN_.00g271370	Scaffold_13	32111547	32138930	NA	NA	NA	NA	NA
PGEN_.00g271380	Scaffold_13	32206902	32227759	Q9U2C4	GALT9_CAEEL	Probable N-acetylgalactosaminyltransferase 9 (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9) (pp-GaNTase 9)	GO:0000139; GO:0005794; GO:0006486; GO:0016021; GO:0016757; GO:0030246; GO:0046872	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; protein glycosylation [GO:0006486]"
PGEN_.00g271390	Scaffold_13	32328813	32365025	A2A4P0	DHX8_MOUSE	ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8)	GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0016604; GO:0042802; GO:0071007; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex disassembly [GO:0000390]"
PGEN_.00g271400	Scaffold_13	32365065	32374584	Q5DU56	NLRC3_MOUSE	Protein NLRC3	GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0031396; GO:0032088; GO:0032496; GO:0032687; GO:0032688; GO:0032691; GO:0032695; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]
PGEN_.00g271410	Scaffold_13	32384498	32391215	NA	NA	NA	NA	NA
PGEN_.00g271420	Scaffold_13	32397816	32405993	Q5DU56	NLRC3_MOUSE	Protein NLRC3	GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0031396; GO:0032088; GO:0032496; GO:0032687; GO:0032688; GO:0032691; GO:0032695; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]
PGEN_.00g271430	Scaffold_13	32409399	32412980	NA	NA	NA	NA	NA
PGEN_.00g271440	Scaffold_13	32413113	32413991	NA	NA	NA	NA	NA
PGEN_.00g271450	Scaffold_13	32421027	32429743	NA	NA	NA	NA	NA
PGEN_.00g271460	Scaffold_13	32433565	32434557	NA	NA	NA	NA	NA
PGEN_.00g271470	Scaffold_13	32434807	32439392	NA	NA	NA	NA	NA
PGEN_.00g271480	Scaffold_13	32439892	32449372	Q96HH6	TMM19_HUMAN	Transmembrane protein 19	GO:0016020; GO:0016021	integral component of membrane [GO:0016021]; membrane [GO:0016020]
PGEN_.00g271490	Scaffold_13	32475085	32476087	Q8C262	IIGP5_MOUSE	Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1)	GO:0005525; GO:0016020; GO:0016787	membrane [GO:0016020]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]
PGEN_.00g271500	Scaffold_13	32483057	32488340	Q5U504	KLH40_XENLA	Kelch-like protein 40 (Kelch repeat and BTB domain-containing protein 5)	GO:0005737; GO:0031397; GO:0031398; GO:0031463; GO:0031672; GO:0031674; GO:0032436; GO:0048741; GO:0098528	A band [GO:0031672]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; I band [GO:0031674]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528]
PGEN_.00g271510	Scaffold_13	32624928	32655563	P34446	PAT2_CAEEL	Integrin alpha pat-2 (Paralyzed arrest at two-fold protein 2)	GO:0004888; GO:0005623; GO:0007005; GO:0007155; GO:0007229; GO:0008305; GO:0009986; GO:0031430; GO:0040017; GO:0040028; GO:0042059; GO:0046716; GO:0055120; GO:0060298; GO:0072327; GO:1901076	cell [GO:0005623]; cell surface [GO:0009986]; integrin complex [GO:0008305]; M band [GO:0031430]; striated muscle dense body [GO:0055120]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; regulation of vulval development [GO:0040028]; vulval cell fate specification [GO:0072327]
PGEN_.00g271520	Scaffold_13	32661371	32664624	NA	NA	NA	NA	NA
PGEN_.00g271530	Scaffold_13	32665985	32667740	NA	NA	NA	NA	NA
PGEN_.00g271540	Scaffold_13	32673218	32674048	Q08AN1	ZN616_HUMAN	Zinc finger protein 616	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g271550	Scaffold_13	32676258	32694098	NA	NA	NA	NA	NA
PGEN_.00g271560	Scaffold_13	32710180	32728838	NA	NA	NA	NA	NA
PGEN_.00g271570	Scaffold_13	32728894	32729765	NA	NA	NA	NA	NA
PGEN_.00g271580	Scaffold_13	32742767	32748224	P98170	XIAP_HUMAN	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0016055; GO:0030510; GO:0031398; GO:0042127; GO:0042802; GO:0043027; GO:0043066; GO:0043154; GO:0045088; GO:0046872; GO:0050727; GO:0051402; GO:0055070; GO:0061630; GO:0070424; GO:0090263; GO:1902530; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055]
PGEN_.00g271590	Scaffold_13	32759685	32765137	P98170	XIAP_HUMAN	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0016055; GO:0030510; GO:0031398; GO:0042127; GO:0042802; GO:0043027; GO:0043066; GO:0043154; GO:0045088; GO:0046872; GO:0050727; GO:0051402; GO:0055070; GO:0061630; GO:0070424; GO:0090263; GO:1902530; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055]
PGEN_.00g271600	Scaffold_13	32778197	32779069	NA	NA	NA	NA	NA
PGEN_.00g271610	Scaffold_13	32779125	32797733	NA	NA	NA	NA	NA
PGEN_.00g271620	Scaffold_13	32814246	32830545	NA	NA	NA	NA	NA
PGEN_.00g271630	Scaffold_13	32832651	32833481	Q08AN1	ZN616_HUMAN	Zinc finger protein 616	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g271640	Scaffold_13	32838933	32840691	NA	NA	NA	NA	NA
PGEN_.00g271650	Scaffold_13	32842051	32845231	NA	NA	NA	NA	NA
PGEN_.00g271660	Scaffold_13	32851023	32881726	P34446	PAT2_CAEEL	Integrin alpha pat-2 (Paralyzed arrest at two-fold protein 2)	GO:0004888; GO:0005623; GO:0007005; GO:0007155; GO:0007229; GO:0008305; GO:0009986; GO:0031430; GO:0040017; GO:0040028; GO:0042059; GO:0046716; GO:0055120; GO:0060298; GO:0072327; GO:1901076	cell [GO:0005623]; cell surface [GO:0009986]; integrin complex [GO:0008305]; M band [GO:0031430]; striated muscle dense body [GO:0055120]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; regulation of vulval development [GO:0040028]; vulval cell fate specification [GO:0072327]
PGEN_.00g271670	Scaffold_13	32917898	32926250	NA	NA	NA	NA	NA
PGEN_.00g271680	Scaffold_13	33018431	33030805	Q5U504	KLH40_XENLA	Kelch-like protein 40 (Kelch repeat and BTB domain-containing protein 5)	GO:0005737; GO:0031397; GO:0031398; GO:0031463; GO:0031672; GO:0031674; GO:0032436; GO:0048741; GO:0098528	A band [GO:0031672]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; I band [GO:0031674]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528]
PGEN_.00g271690	Scaffold_13	33051729	33056559	NA	NA	NA	NA	NA
PGEN_.00g271700	Scaffold_13	33123260	33124695	NA	NA	NA	NA	NA
PGEN_.00g271710	Scaffold_13	33128923	33137012	Q9R0I6	XIAP_RAT	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP homolog A) (Inhibitor of apoptosis protein 3) (IAP-3) (rIAP-3) (rIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	GO:0002020; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006974; GO:0016055; GO:0031398; GO:0032991; GO:0042802; GO:0043027; GO:0043066; GO:0043154; GO:0043524; GO:0046872; GO:0048471; GO:0051402; GO:0061630; GO:0090263; GO:0097110; GO:1902530; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; Wnt signaling pathway [GO:0016055]
PGEN_.00g271720	Scaffold_13	33154454	33156166	Q56R14	TRI33_XENLA	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g271730	Scaffold_13	33162392	33162652	NA	NA	NA	NA	NA
PGEN_.00g271740	Scaffold_13	33175677	33177877	NA	NA	NA	NA	NA
PGEN_.00g271750	Scaffold_13	33186824	33200739	Q16P20	CISY2_AEDAE	"Probable citrate synthase 2, mitochondrial (EC 2.3.3.16)"	GO:0004108; GO:0005759; GO:0005975; GO:0006099; GO:0006101	mitochondrial matrix [GO:0005759]; citrate (Si)-synthase activity [GO:0004108]; carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g271760	Scaffold_13	33220828	33242961	NA	NA	NA	NA	NA
PGEN_.00g271770	Scaffold_13	33248402	33248704	NA	NA	NA	NA	NA
PGEN_.00g271780	Scaffold_13	33264321	33265055	NA	NA	NA	NA	NA
PGEN_.00g271790	Scaffold_13	33265662	33269118	NA	NA	NA	NA	NA
PGEN_.00g271800	Scaffold_13	33280514	33379852	P12080	ITA2_DROME	Integrin alpha-PS2 (Position-specific antigen subunit alpha-2) (Protein inflated) [Cleaved into: Integrin alpha-PS2 heavy chain; Integrin alpha-PS2 light chain]	GO:0005886; GO:0005887; GO:0005925; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007411; GO:0007414; GO:0007419; GO:0007431; GO:0007435; GO:0007475; GO:0007476; GO:0007494; GO:0007608; GO:0008305; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016477; GO:0021551; GO:0030239; GO:0033627; GO:0034446; GO:0035099; GO:0035160; GO:0042383; GO:0045185; GO:0045214; GO:0046982; GO:0050840; GO:0051492; GO:0098609	"apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; extracellular matrix binding [GO:0050840]; protein heterodimerization activity [GO:0046982]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]"
PGEN_.00g271810	Scaffold_13	33297427	33299724	Q9ES30	C1QT3_MOUSE	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005576; GO:0005581; GO:0005615; GO:0005623; GO:0010629; GO:0032991; GO:0035356; GO:0042593; GO:0042802; GO:0045721; GO:0050715; GO:0050728; GO:0051897; GO:0070165; GO:0070206; GO:0070374; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; cellular triglyceride homeostasis [GO:0035356]; glucose homeostasis [GO:0042593]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; protein trimerization [GO:0070206]
PGEN_.00g271820	Scaffold_13	33384365	33400618	Q5R4V4	SARNP_PONAB	SAP domain-containing ribonucleoprotein (Nuclear protein Hcc-1)	GO:0000346; GO:0000978; GO:0001227; GO:0003723; GO:0006406; GO:0006417; GO:0008022; GO:0016607; GO:0036464; GO:0050733	"cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; transcription export complex [GO:0000346]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RS domain binding [GO:0050733]; mRNA export from nucleus [GO:0006406]; regulation of translation [GO:0006417]"
PGEN_.00g271830	Scaffold_13	33405112	33413748	Q92546	RGP1_HUMAN	RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog)	GO:0000139; GO:0005829; GO:0005886; GO:0016020; GO:0017112; GO:0017137; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0043547; GO:1903363	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RIC1-RGP1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g271840	Scaffold_13	33418387	33441609	B0VXE6	CFA69_CALJA	Cilia- and flagella-associated protein 69	GO:0005737; GO:0007283; GO:0007608; GO:0030154; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834	cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283]
PGEN_.00g271850	Scaffold_13	33447511	33447834	NA	NA	NA	NA	NA
PGEN_.00g271860	Scaffold_13	33448755	33458913	Q8AVQ3	143BB_XENLA	14-3-3 protein beta/alpha-B	GO:0005737; GO:0019904	cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904]
PGEN_.00g271870	Scaffold_13	33470366	33477134	Q5M856	SPC25_RAT	Kinetochore protein Spc25	GO:0000777; GO:0005634; GO:0005829; GO:0007052; GO:0007059; GO:0031262; GO:0051301	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Ndc80 complex [GO:0031262]; nucleus [GO:0005634]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic spindle organization [GO:0007052]
PGEN_.00g271880	Scaffold_13	33481198	33482893	NA	NA	NA	NA	NA
PGEN_.00g271890	Scaffold_13	33484526	33497112	Q05976	RB18A_LYMST	Ras-related protein Rab-18A	GO:0003924; GO:0005525; GO:0005886; GO:0015031	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]
PGEN_.00g271900	Scaffold_13	33512868	33513917	NA	NA	NA	NA	NA
PGEN_.00g271910	Scaffold_13	33524166	33530455	P84029	CYC2_DROME	Cytochrome c-2 (Cytochrome c-proximal)	GO:0005758; GO:0006122; GO:0006123; GO:0009055; GO:0020037; GO:0046872; GO:0055114; GO:0070469	"mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidation-reduction process [GO:0055114]"
PGEN_.00g271920	Scaffold_13	33547073	33659901	O42596	ADA22_XENLA	Disintegrin and metalloproteinase domain-containing protein 22 (ADAM 22) (MDC11.2) (Metalloprotease-disintegrin MDC11b)	GO:0004222; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]
PGEN_.00g271930	Scaffold_13	33667318	33668035	NA	NA	NA	NA	NA
PGEN_.00g271940	Scaffold_13	33668094	33668556	NA	NA	NA	NA	NA
PGEN_.00g271950	Scaffold_13	33672839	33674203	NA	NA	NA	NA	NA
PGEN_.00g271960	Scaffold_13	33675558	33679766	NA	NA	NA	NA	NA
PGEN_.00g271970	Scaffold_13	33683951	33700896	Q9NVV4	PAPD1_HUMAN	"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)"	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005739; GO:0006378; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]
PGEN_.00g271980	Scaffold_13	33703350	33718759	NA	NA	NA	NA	NA
PGEN_.00g271990	Scaffold_13	33726789	33727130	NA	NA	NA	NA	NA
PGEN_.00g272000	Scaffold_13	33734723	33734968	NA	NA	NA	NA	NA
PGEN_.00g272010	Scaffold_13	33743358	33830290	P26007	ITA6_CHICK	Integrin alpha-6 (VLA-6) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain]	GO:0005604; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009925; GO:0009986; GO:0010668; GO:0010976; GO:0022409; GO:0030056; GO:0030335; GO:0031668; GO:0031994; GO:0035878; GO:0038132; GO:0042327; GO:0043065; GO:0043547; GO:0043588; GO:0045944; GO:0046847; GO:0046872; GO:0048565; GO:0050900; GO:0072001; GO:2001237	basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; hemidesmosome [GO:0030056]; integrin complex [GO:0008305]; insulin-like growth factor I binding [GO:0031994]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]; cell-matrix adhesion [GO:0007160]; cellular response to extracellular stimulus [GO:0031668]; digestive tract development [GO:0048565]; ectodermal cell differentiation [GO:0010668]; filopodium assembly [GO:0046847]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; renal system development [GO:0072001]; skin development [GO:0043588]
PGEN_.00g272020	Scaffold_13	33830673	33836312	P78537	BL1S1_HUMAN	Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC-1 subunit 1) (GCN5-like protein 1) (Protein RT14)	GO:0005615; GO:0005758; GO:0005759; GO:0005765; GO:0005829; GO:0008089; GO:0009060; GO:0016197; GO:0018394; GO:0031083; GO:0031175; GO:0032418; GO:0032438; GO:0048490; GO:0060155; GO:0099078; GO:1904115	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394]; platelet dense granule organization [GO:0060155]
PGEN_.00g272030	Scaffold_13	33840984	33850403	Q8VCE1	DJC28_MOUSE	DnaJ homolog subfamily C member 28	GO:0006890; GO:0007030; GO:0017119; GO:0048213	"Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g272040	Scaffold_13	33853774	33859597	A6QPH1	PYM1_BOVIN	Partner of Y14 and mago (PYM homolog 1 exon junction complex-associated factor) (Protein wibg homolog)	GO:0000184; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0030054; GO:0035145; GO:0043022; GO:0045727; GO:1903259	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]"
PGEN_.00g272050	Scaffold_13	33865450	33891183	F1RBN2	SPAG1_DANRE	Sperm-associated antigen 1A	GO:0005737; GO:0070286	cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]
PGEN_.00g272060	Scaffold_13	33894362	33898191	Q07617	SPAG1_HUMAN	Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1)	GO:0005525; GO:0005737; GO:0005829; GO:0007338; GO:0016787; GO:0070286	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338]
PGEN_.00g272070	Scaffold_13	33906733	33912461	Q5RCF3	CUL2_PONAB	Cullin-2 (CUL-2)	GO:0005654; GO:0006511; GO:0016567; GO:0031462; GO:0031625	Cul2-RING ubiquitin ligase complex [GO:0031462]; nucleoplasm [GO:0005654]; ubiquitin protein ligase binding [GO:0031625]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g272080	Scaffold_13	33914724	33932389	Q9D4H8	CUL2_MOUSE	Cullin-2 (CUL-2)	GO:0005654; GO:0005730; GO:0006511; GO:0016567; GO:0019005; GO:0030163; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031625; GO:0043161; GO:0044877	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g272090	Scaffold_13	33938958	33946434	Q6AXZ2	LRC46_RAT	Leucine-rich repeat-containing protein 46		
PGEN_.00g272100	Scaffold_13	33957343	33974562	Q8BKE6	CP20A_MOUSE	Cytochrome P450 20A1 (EC 1.14.-.-)	GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037	"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g272110	Scaffold_13	34032346	34039095	Q6UW02	CP20A_HUMAN	Cytochrome P450 20A1 (EC 1.14.-.-)	GO:0004497; GO:0005506; GO:0016020; GO:0016021; GO:0016705; GO:0020037	"integral component of membrane [GO:0016021]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g272120	Scaffold_13	34046139	34049014	NA	NA	NA	NA	NA
PGEN_.00g272130	Scaffold_13	34064866	34077624	Q8BKE6	CP20A_MOUSE	Cytochrome P450 20A1 (EC 1.14.-.-)	GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037	"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g272140	Scaffold_13	34107247	34134587	NA	NA	NA	NA	NA
PGEN_.00g272150	Scaffold_13	34153174	34154391	Q6NXR0	IIGP5_HUMAN	Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1)	GO:0005525; GO:0016020; GO:0016787	membrane [GO:0016020]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]
PGEN_.00g272160	Scaffold_13	34157579	34162273	Q3T9E4	TGTP2_MOUSE	T-cell-specific guanine nucleotide triphosphate-binding protein 2 (EC 3.6.5.-) (Interferon-gamma-inducible GTPase Ifggb6 protein) (T-cell-specific guanine nucleotide triphosphate-binding protein)	GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0006952; GO:0035458; GO:0045087	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-beta [GO:0035458]; defense response [GO:0006952]; innate immune response [GO:0045087]
PGEN_.00g272170	Scaffold_13	34175393	34177258	NA	NA	NA	NA	NA
PGEN_.00g272180	Scaffold_13	34180338	34182077	Q56R14	TRI33_XENLA	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g272190	Scaffold_13	34188583	34190484	NA	NA	NA	NA	NA
PGEN_.00g272200	Scaffold_13	34199246	34206737	NA	NA	NA	NA	NA
PGEN_.00g272210	Scaffold_13	34212738	34213952	Q6NXR0	IIGP5_HUMAN	Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1)	GO:0005525; GO:0016020; GO:0016787	membrane [GO:0016020]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]
PGEN_.00g272220	Scaffold_13	34214755	34218053	NA	NA	NA	NA	NA
PGEN_.00g272230	Scaffold_13	34237727	34262026	Q9W719	HPRT_CHICK	Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8)	GO:0000166; GO:0000287; GO:0002057; GO:0002060; GO:0004422; GO:0005694; GO:0005737; GO:0006164; GO:0006166; GO:0006168; GO:0006178; GO:0032263; GO:0032264; GO:0042803; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0051289; GO:0052657	chromosome [GO:0005694]; cytoplasm [GO:0005737]; guanine binding [GO:0002057]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; purine nucleobase binding [GO:0002060]; adenine salvage [GO:0006168]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]
PGEN_.00g272240	Scaffold_13	34278355	34290679	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g272250	Scaffold_13	34297616	34297828	NA	NA	NA	NA	NA
PGEN_.00g272260	Scaffold_13	34297632	34313552	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g272270	Scaffold_13	34326336	34354424	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g272280	Scaffold_13	34365742	34377181	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g272290	Scaffold_13	34381273	34398156	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g272300	Scaffold_13	34394128	34404914	G5CTG8	AQP11_MILTA	Aquaporin-11 (AQP-11)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g272310	Scaffold_13	34412347	34429427	O88908	SOAT2_MOUSE	Sterol O-acyltransferase 2 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 2) (ACAT-2) (Cholesterol acyltransferase 2)	GO:0000062; GO:0004772; GO:0005783; GO:0005789; GO:0005903; GO:0008203; GO:0015485; GO:0016020; GO:0016021; GO:0033344; GO:0034379; GO:0034435; GO:0034736; GO:0042632	brush border [GO:0005903]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; sterol O-acyltransferase activity [GO:0004772]; cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; very-low-density lipoprotein particle assembly [GO:0034379]
PGEN_.00g272320	Scaffold_13	34481888	34484520	NA	NA	NA	NA	NA
PGEN_.00g272330	Scaffold_13	34485641	34502857	NA	NA	NA	NA	NA
PGEN_.00g272340	Scaffold_13	34530778	34532200	NA	NA	NA	NA	NA
PGEN_.00g272350	Scaffold_13	34536440	34541377	NA	NA	NA	NA	NA
PGEN_.00g272360	Scaffold_13	34547884	34548138	NA	NA	NA	NA	NA
PGEN_.00g272370	Scaffold_13	34560387	34560623	NA	NA	NA	NA	NA
PGEN_.00g272380	Scaffold_13	34592793	34601197	NA	NA	NA	NA	NA
PGEN_.00g272390	Scaffold_13	34610498	34610752	NA	NA	NA	NA	NA
PGEN_.00g272400	Scaffold_13	34648053	34648394	NA	NA	NA	NA	NA
PGEN_.00g272410	Scaffold_13	34673430	34674561	NA	NA	NA	NA	NA
PGEN_.00g272420	Scaffold_13	34676252	34719583	Q9NS40	KCNH7_HUMAN	Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (hERG-3) (Voltage-gated potassium channel subunit Kv11.3)	GO:0005249; GO:0005886; GO:0005887; GO:0034765; GO:0042391; GO:0071805	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]
PGEN_.00g272430	Scaffold_13	34757505	34758164	NA	NA	NA	NA	NA
PGEN_.00g272440	Scaffold_13	34788829	34789446	NA	NA	NA	NA	NA
PGEN_.00g272450	Scaffold_13	34797311	34836171	NA	NA	NA	NA	NA
PGEN_.00g272460	Scaffold_13	34855259	34866432	O54852	KCNH7_RAT	Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (Voltage-gated potassium channel subunit Kv11.3)	GO:0005242; GO:0005249; GO:0005267; GO:0005887; GO:0006813; GO:0007623; GO:0034765; GO:0042391; GO:0044877; GO:0071805	integral component of plasma membrane [GO:0005887]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]; circadian rhythm [GO:0007623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]
PGEN_.00g272470	Scaffold_13	34870445	34910364	Q9NS40	KCNH7_HUMAN	Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (hERG-3) (Voltage-gated potassium channel subunit Kv11.3)	GO:0005249; GO:0005886; GO:0005887; GO:0034765; GO:0042391; GO:0071805	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]
PGEN_.00g272480	Scaffold_13	34929121	34933316	B0BML7	SPRE_XENTR	Sepiapterin reductase (SPR) (EC 1.1.1.153)	GO:0004757; GO:0005737; GO:0006729	cytoplasm [GO:0005737]; sepiapterin reductase activity [GO:0004757]; tetrahydrobiopterin biosynthetic process [GO:0006729]
PGEN_.00g272490	Scaffold_13	34944729	34958516	NA	NA	NA	NA	NA
PGEN_.00g272500	Scaffold_13	35010302	35024175	Q3ZBF8	CERS2_BOVIN	Ceramide synthase 2 (CerS2) (EC 2.3.1.-) (LAG1 longevity assurance homolog 2) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24)	GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0046513; GO:0050291	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]
PGEN_.00g272510	Scaffold_13	35071692	35072534	NA	NA	NA	NA	NA
PGEN_.00g272520	Scaffold_13	35074516	35074857	NA	NA	NA	NA	NA
PGEN_.00g272530	Scaffold_13	35176803	35197702	NA	NA	NA	NA	NA
PGEN_.00g272540	Scaffold_13	35245674	35278633	Q91147	FGFR2_NOTVI	Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1)	GO:0005007; GO:0005524; GO:0005794; GO:0005886; GO:0006915; GO:0008284; GO:0016021; GO:0031410	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]
PGEN_.00g272550	Scaffold_13	35333476	35333895	Q96WV6	YHU2_SCHPO	Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02	GO:0010339; GO:0031362; GO:0098631	anchored component of external side of plasma membrane [GO:0031362]; external side of cell wall [GO:0010339]; cell adhesion mediator activity [GO:0098631]
PGEN_.00g272560	Scaffold_13	35336244	35344540	A0A0B5A8P8	INS2_CONIM	Con-Ins Im2 (Insulin 2) [Cleaved into: Con-Ins I2 B chain; Con-Ins I2 A chain]	GO:0005179; GO:0005576; GO:0006006; GO:0009405; GO:0090729	extracellular region [GO:0005576]; hormone activity [GO:0005179]; toxin activity [GO:0090729]; glucose metabolic process [GO:0006006]; pathogenesis [GO:0009405]
PGEN_.00g272570	Scaffold_13	35359299	35374847	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g272580	Scaffold_13	35398946	35408424	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g272590	Scaffold_13	35416689	35418705	NA	NA	NA	NA	NA
PGEN_.00g272600	Scaffold_13	35426017	35431678	NA	NA	NA	NA	NA
PGEN_.00g272610	Scaffold_13	35431783	35435574	NA	NA	NA	NA	NA
PGEN_.00g272620	Scaffold_13	35435712	35437296	NA	NA	NA	NA	NA
PGEN_.00g272630	Scaffold_13	35437409	35437795	NA	NA	NA	NA	NA
PGEN_.00g272640	Scaffold_13	35437905	35438765	NA	NA	NA	NA	NA
PGEN_.00g272650	Scaffold_13	35445172	35457988	Q5G265	NETR_SAGLB	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424	axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]
PGEN_.00g272660	Scaffold_13	35472048	35480104	Q13490	BIRC2_HUMAN	Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2)	GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0002756; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0010803; GO:0016579; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0035666; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043154; GO:0043161; GO:0045088; GO:0045121; GO:0045471; GO:0045595; GO:0047485; GO:0050727; GO:0051087; GO:0051291; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:1990001; GO:2000116; GO:2000377	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]
PGEN_.00g272670	Scaffold_13	35496058	35496452	NA	NA	NA	NA	NA
PGEN_.00g272680	Scaffold_13	35501080	35508960	Q99999	G3ST1_HUMAN	Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)	GO:0000139; GO:0001733; GO:0005887; GO:0006487; GO:0006682; GO:0007283; GO:0008146; GO:0016020; GO:0042552	Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; galactosylceramide biosynthetic process [GO:0006682]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]
PGEN_.00g272690	Scaffold_13	35511184	35511444	NA	NA	NA	NA	NA
PGEN_.00g272700	Scaffold_13	35515933	35516199	NA	NA	NA	NA	NA
PGEN_.00g272710	Scaffold_13	35544637	35572222	B3EWZ3	CADN_ACRMI	Coadhesin (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g272720	Scaffold_13	35575922	35594486	P05044	SORCN_CRIGR	Sorcin (22 kDa protein) (CP-22) (V19)	GO:0005509; GO:0016020; GO:0033017	membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]
PGEN_.00g272730	Scaffold_13	35598462	35630610	Q6PHS6	SNX13_MOUSE	Sorting nexin-13	GO:0005769; GO:0006886; GO:0009968; GO:0031901; GO:0032266; GO:0035091; GO:0043547	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; intracellular protein transport [GO:0006886]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]
PGEN_.00g272740	Scaffold_13	35659987	35680807	P42519	STAR_DROME	Protein Star	GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]
PGEN_.00g272750	Scaffold_13	35680887	35689430	Q502K1	EXOG_DANRE	"Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1)"	GO:0000014; GO:0000737; GO:0003676; GO:0004519; GO:0004521; GO:0005634; GO:0005739; GO:0005743; GO:0006309; GO:0008409; GO:0046872	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process, endonucleolytic [GO:0000737]"
PGEN_.00g272760	Scaffold_13	35693713	35693958	P42519	STAR_DROME	Protein Star	GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]
PGEN_.00g272770	Scaffold_13	35699003	35706871	Q9H3L0	MMAD_HUMAN	"Methylmalonic aciduria and homocystinuria type D protein, mitochondrial (CblD)"	GO:0005737; GO:0005739; GO:0005829; GO:0009108; GO:0009235	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; cobalamin metabolic process [GO:0009235]; coenzyme biosynthetic process [GO:0009108]
PGEN_.00g272780	Scaffold_13	35710049	35713132	A0JMH2	CB069_DANRE	UPF0565 protein C2orf69 homolog	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g272790	Scaffold_13	35720480	35772217	Q3UGM2	NEK10_MOUSE	Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10)	GO:0004674; GO:0005524; GO:0043406; GO:0046872; GO:1902749	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of MAP kinase activity [GO:0043406]; regulation of cell cycle G2/M phase transition [GO:1902749]
PGEN_.00g272800	Scaffold_13	35785982	35797801	O88736	DHB7_MOUSE	3-keto-steroid reductase (EC 1.1.1.270) (17-beta-hydroxysteroid dehydrogenase 7) (17-beta-HSD 7) (Estradiol 17-beta-dehydrogenase 7) (EC 1.1.1.62)	GO:0000253; GO:0004303; GO:0005148; GO:0005783; GO:0005886; GO:0006695; GO:0006703; GO:0007399; GO:0016020; GO:0016021; GO:0030154; GO:0048706	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; prolactin receptor binding [GO:0005148]; cell differentiation [GO:0030154]; cholesterol biosynthetic process [GO:0006695]; embryonic skeletal system development [GO:0048706]; estrogen biosynthetic process [GO:0006703]; nervous system development [GO:0007399]
PGEN_.00g272810	Scaffold_13	35799198	35809487	Q8T6A5	TBA1_APLCA	Tubulin alpha-1 chain	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g272820	Scaffold_13	35811781	35814846	Q9BXB1	LGR4_HUMAN	Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48)	GO:0001649; GO:0001942; GO:0004888; GO:0004930; GO:0005886; GO:0005887; GO:0007189; GO:0007190; GO:0007283; GO:0008528; GO:0009755; GO:0016500; GO:0030282; GO:0030539; GO:0032922; GO:0034122; GO:0036335; GO:0045087; GO:0045892; GO:0045893; GO:0046849; GO:0048565; GO:0050710; GO:0061290; GO:0072202; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]"
PGEN_.00g272830	Scaffold_13	35826022	35838936	Q9UA35	S28A3_EPTST	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)	GO:0005337; GO:0005887	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]
PGEN_.00g272840	Scaffold_13	35842943	35856487	Q61712	DNJC1_MOUSE	DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1)	GO:0003677; GO:0005634; GO:0005783; GO:0005788; GO:0005789; GO:0005886; GO:0006417; GO:0006457; GO:0016021; GO:0031965; GO:0043022; GO:0050708; GO:0051087	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417]
PGEN_.00g272850	Scaffold_13	35873488	35890065	P61588	RND3_MOUSE	Rho-related GTP-binding protein RhoE (Rho family GTPase 3) (Rnd3)	GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005938; GO:0007015; GO:0007266; GO:0008360; GO:0019901; GO:0030334; GO:0030950; GO:0032153; GO:0032956; GO:0043231; GO:0051017	cell cortex [GO:0005938]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]
PGEN_.00g272860	Scaffold_13	35898249	35912854	Q4R347	CNOT9_MACFA	CCR4-NOT transcription complex subunit 9 (Cell differentiation protein RQCD1 homolog) (Rcd-1)	GO:0000932; GO:0005634; GO:0006402; GO:0006417; GO:0030014; GO:0031047; GO:0033147; GO:2000327	CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; regulation of translation [GO:0006417]
PGEN_.00g272870	Scaffold_13	35914129	35915064	NA	NA	NA	NA	NA
PGEN_.00g272880	Scaffold_13	35925691	35929253	NA	NA	NA	NA	NA
PGEN_.00g272890	Scaffold_13	35981835	35982266	NA	NA	NA	NA	NA
PGEN_.00g272900	Scaffold_13	35990032	36006851	Q4KM84	MET18_RAT	Histidine protein methyltransferase 1 homolog (Methyltransferase-like protein 18) (EC 2.1.1.-)	GO:0008168; GO:0031072; GO:0032259; GO:0032991	protein-containing complex [GO:0032991]; heat shock protein binding [GO:0031072]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g272910	Scaffold_13	36007063	36020861	Q8BMQ2	TF3C4_MOUSE	General transcription factor 3C polypeptide 4 (EC 2.3.1.48) (TF3C-delta) (Transcription factor IIIC 90 kDa subunit) (TFIIIC 90 kDa subunit) (TFIIIC90) (Transcription factor IIIC subunit delta)	GO:0000127; GO:0003677; GO:0004402; GO:0005654; GO:0005739	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]
PGEN_.00g272920	Scaffold_13	36024777	36028192	NA	NA	NA	NA	NA
PGEN_.00g272930	Scaffold_13	36030484	36036146	NA	NA	NA	NA	NA
PGEN_.00g272940	Scaffold_13	36038859	36039527	NA	NA	NA	NA	NA
PGEN_.00g272950	Scaffold_13	36088476	36091497	NA	NA	NA	NA	NA
PGEN_.00g272960	Scaffold_13	36202087	36202551	NA	NA	NA	NA	NA
PGEN_.00g272970	Scaffold_13	36214740	36231685	P23811	SCTR_RAT	Secretin receptor (SCT-R)	GO:0002024; GO:0005623; GO:0005881; GO:0005886; GO:0007166; GO:0007186; GO:0007420; GO:0008528; GO:0009992; GO:0015055; GO:0016021; GO:0017046; GO:0031667; GO:0032098; GO:0042277; GO:0043950; GO:0048167; GO:0050996; GO:0070295	cell [GO:0005623]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; secretin receptor activity [GO:0015055]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cellular water homeostasis [GO:0009992]; diet induced thermogenesis [GO:0002024]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of lipid catabolic process [GO:0050996]; regulation of appetite [GO:0032098]; regulation of synaptic plasticity [GO:0048167]; renal water absorption [GO:0070295]; response to nutrient levels [GO:0031667]
PGEN_.00g272980	Scaffold_13	36241736	36285574	P25107	PTH1R_DIDVI	Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor)	GO:0004991; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0017046; GO:0042803; GO:0043621	integral component of plasma membrane [GO:0005887]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g272990	Scaffold_13	36421547	36421885	NA	NA	NA	NA	NA
PGEN_.00g273000	Scaffold_13	36561965	36562261	NA	NA	NA	NA	NA
PGEN_.00g273010	Scaffold_13	36562656	36563093	NA	NA	NA	NA	NA
PGEN_.00g273020	Scaffold_13	36569008	36577202	NA	NA	NA	NA	NA
PGEN_.00g273030	Scaffold_13	36606499	36607326	NA	NA	NA	NA	NA
PGEN_.00g273040	Scaffold_13	36621607	36633935	Q7T3S3	CHSTB_DANRE	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)	GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]
PGEN_.00g273050	Scaffold_13	36642118	36649632	P00184	CP1A1_MOUSE	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0001666; GO:0002933; GO:0003824; GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0006778; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0008395; GO:0009308; GO:0009404; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009636; GO:0009804; GO:0009812; GO:0010041; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0016829; GO:0017143; GO:0017144; GO:0019341; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0033189; GO:0035902; GO:0042493; GO:0042572; GO:0042904; GO:0043010; GO:0043231; GO:0046483; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0055114; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0101020; GO:0101021; GO:1900087	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; maternal process involved in parturition [GO:0060137]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]"
PGEN_.00g273060	Scaffold_13	36654742	36662973	NA	NA	NA	NA	NA
PGEN_.00g273070	Scaffold_13	36675770	36703003	NA	NA	NA	NA	NA
PGEN_.00g273080	Scaffold_13	36707296	36708226	NA	NA	NA	NA	NA
PGEN_.00g273090	Scaffold_13	36708269	36708852	NA	NA	NA	NA	NA
PGEN_.00g273100	Scaffold_13	36709350	36710034	NA	NA	NA	NA	NA
PGEN_.00g273110	Scaffold_13	36715516	36727652	Q9JHI9	S40A1_MOUSE	Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1) (Metal transporter protein 1) (MTP1)	GO:0002260; GO:0003158; GO:0005381; GO:0005623; GO:0005654; GO:0005829; GO:0005886; GO:0006826; GO:0006879; GO:0008021; GO:0015093; GO:0016021; GO:0016323; GO:0017046; GO:0034395; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0048536; GO:0055072; GO:0060345; GO:0060586; GO:1903988	basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen development [GO:0048536]; spleen trabecula formation [GO:0060345]
PGEN_.00g273120	Scaffold_13	36730996	36746071	O26153	IPK_METTH	Isopentenyl phosphate kinase (IPK) (EC 2.7.4.26)	GO:0005524; GO:0008299; GO:0016301; GO:0102043	ATP binding [GO:0005524]; isopentenyl phosphate kinase activity [GO:0102043]; kinase activity [GO:0016301]; isoprenoid biosynthetic process [GO:0008299]
PGEN_.00g273130	Scaffold_13	36753196	36816805	Q9NP59	S40A1_HUMAN	Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1)	GO:0002260; GO:0003158; GO:0005381; GO:0005623; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0006879; GO:0008021; GO:0015093; GO:0016021; GO:0016323; GO:0017046; GO:0034395; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0055072; GO:0060345; GO:0060586; GO:1903988	basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]
PGEN_.00g273140	Scaffold_13	36827014	36844333	Q03692	COAA1_HUMAN	Collagen alpha-1(X) chain	GO:0001501; GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]
PGEN_.00g273150	Scaffold_13	36850887	36851393	NA	NA	NA	NA	NA
PGEN_.00g273160	Scaffold_13	36851736	36852599	NA	NA	NA	NA	NA
PGEN_.00g273170	Scaffold_13	36869399	36873067	NA	NA	NA	NA	NA
PGEN_.00g273180	Scaffold_13	36876288	36879333	NA	NA	NA	NA	NA
PGEN_.00g273190	Scaffold_13	36887633	36948022	O34309	PPS_BACSU	"Putative phosphoenolpyruvate synthase (Putative PEP synthase) (Pyruvate, water dikinase)"	GO:0005524; GO:0016301	ATP binding [GO:0005524]; kinase activity [GO:0016301]
PGEN_.00g273200	Scaffold_13	36953912	36999401	E1C2U2	RIF1_CHICK	Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog)	GO:0000723; GO:0000781; GO:0005634; GO:0005737; GO:0005819; GO:0006281; GO:0006974; GO:0007049; GO:0035861; GO:0045830; GO:2000042; GO:2001034	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; telomere maintenance [GO:0000723]"
PGEN_.00g273210	Scaffold_13	37009153	37018750	Q25117	ATPB_HEMPU	"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2)"	GO:0005524; GO:0005743; GO:0015986; GO:0045261; GO:0046933	"mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]"
PGEN_.00g273220	Scaffold_13	37023884	37035391	Q4R802	AKCL2_MACFA	"1,5-anhydro-D-fructose reductase (AF reductase) (EC 1.1.1.263) (Aldo-keto reductase family 1 member C-like protein 2) (Aldo-keto reductase family 1 member E2)"	GO:0005737; GO:0050571	"cytoplasm [GO:0005737]; 1,5-anhydro-D-fructose reductase activity [GO:0050571]"
PGEN_.00g273230	Scaffold_13	37055151	37059780	Q95245	CY561_PIG	Cytochrome b561 (Cytochrome b-561)	GO:0000293; GO:0005765; GO:0016021; GO:0016491; GO:0022900; GO:0030658; GO:0046872	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; transport vesicle membrane [GO:0030658]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; electron transport chain [GO:0022900]
PGEN_.00g273240	Scaffold_13	37069843	37095100	P10155	RO60_HUMAN	60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (Ro60) (RoRNP) (Ro 60 kDa autoantigen) (Ro60 autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen) (SS-A) (TROVE domain family member 2)	GO:0002520; GO:0003723; GO:0005654; GO:0005829; GO:0006383; GO:0007224; GO:0009411; GO:0010468; GO:0030620; GO:0035457; GO:0046872; GO:0060271; GO:1990904	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cellular response to interferon-alpha [GO:0035457]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; regulation of gene expression [GO:0010468]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g273250	Scaffold_13	37110420	37167454	O34309	PPS_BACSU	"Putative phosphoenolpyruvate synthase (Putative PEP synthase) (Pyruvate, water dikinase)"	GO:0005524; GO:0016301	ATP binding [GO:0005524]; kinase activity [GO:0016301]
PGEN_.00g273260	Scaffold_13	37173002	37195270	O08914	FAAH1_MOUSE	Fatty-acid amide hydrolase 1 (EC 3.5.1.99) (Anandamide amidohydrolase 1) (Oleamide hydrolase 1)	GO:0000139; GO:0004040; GO:0005543; GO:0005789; GO:0008289; GO:0009062; GO:0016021; GO:0016788; GO:0017064; GO:0031090; GO:0042802; GO:0047372; GO:0052651; GO:0102077; GO:0103073	"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; acylglycerol lipase activity [GO:0047372]; amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; oleamide hydrolase activity [GO:0102077]; phospholipid binding [GO:0005543]; fatty acid catabolic process [GO:0009062]; monoacylglycerol catabolic process [GO:0052651]"
PGEN_.00g273270	Scaffold_13	37197460	37197708	NA	NA	NA	NA	NA
PGEN_.00g273280	Scaffold_13	37203826	37211766	P79145	CREM_CANLF	cAMP-responsive element modulator	GO:0000122; GO:0000977; GO:0003700; GO:0005634; GO:0005667; GO:0006687; GO:0007283; GO:0045944	nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]
PGEN_.00g273290	Scaffold_13	37216241	37256850	NA	NA	NA	NA	NA
PGEN_.00g273300	Scaffold_13	37265128	37273767	NA	NA	NA	NA	NA
PGEN_.00g273310	Scaffold_13	37276727	37282162	Q6P560	ZN182_MOUSE	Zinc finger protein 182 (Zinc finger protein 21)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g273320	Scaffold_13	37299751	37336352	Q9D0L6	BAMBI_MOUSE	BMP and activin membrane-bound inhibitor homolog (Putative transmembrane protein NMA)	GO:0005109; GO:0005737; GO:0005886; GO:0007179; GO:0008284; GO:0008360; GO:0010718; GO:0016020; GO:0016021; GO:0016477; GO:0030512; GO:0032092; GO:0045893; GO:0090263	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; cell migration [GO:0016477]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell shape [GO:0008360]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g273330	Scaffold_13	37355170	37355466	NA	NA	NA	NA	NA
PGEN_.00g273340	Scaffold_13	37361117	37429193	Q9Y4A5	TRRAP_HUMAN	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	GO:0000124; GO:0000125; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0016573; GO:0016578; GO:0016579; GO:0030914; GO:0033276; GO:0035267; GO:0043967; GO:0043968; GO:1904837	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; beta-catenin-TCF complex assembly [GO:1904837]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g273350	Scaffold_13	37466543	37484878	Q923L3	CSMD1_MOUSE	CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)	GO:0001964; GO:0016021; GO:0042593	integral component of membrane [GO:0016021]; glucose homeostasis [GO:0042593]; startle response [GO:0001964]
PGEN_.00g273360	Scaffold_13	37500841	37505314	NA	NA	NA	NA	NA
PGEN_.00g273370	Scaffold_13	37529332	37531105	NA	NA	NA	NA	NA
PGEN_.00g273380	Scaffold_13	37531219	37628736	P25107	PTH1R_DIDVI	Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor)	GO:0004991; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0017046; GO:0042803; GO:0043621	integral component of plasma membrane [GO:0005887]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g273390	Scaffold_13	37699563	37704610	NA	NA	NA	NA	NA
PGEN_.00g273400	Scaffold_13	37708864	37709208	NA	NA	NA	NA	NA
PGEN_.00g273410	Scaffold_13	37763055	37776604	P14650	PERT_RAT	Thyroid peroxidase (TPO) (EC 1.11.1.8)	GO:0004447; GO:0004601; GO:0005509; GO:0005615; GO:0005886; GO:0006590; GO:0009986; GO:0016021; GO:0020037; GO:0033993; GO:0035162; GO:0042446; GO:0042744; GO:0071732	cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]; cellular response to nitric oxide [GO:0071732]; embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to lipid [GO:0033993]; thyroid hormone generation [GO:0006590]
PGEN_.00g273420	Scaffold_13	37777404	37813107	NA	NA	NA	NA	NA
PGEN_.00g273430	Scaffold_13	37818798	37918142	A8XNX8	LGC4_CAEBR	Ligand-gated ion channel 4	GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g273440	Scaffold_13	37972728	37981237	D4A734	MOT12_RAT	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g273450	Scaffold_13	37995622	38001529	NA	NA	NA	NA	NA
PGEN_.00g273460	Scaffold_13	38011117	38011608	NA	NA	NA	NA	NA
PGEN_.00g273470	Scaffold_13	38023605	38026802	NA	NA	NA	NA	NA
PGEN_.00g273480	Scaffold_13	38041200	38041619	NA	NA	NA	NA	NA
PGEN_.00g273490	Scaffold_13	38042359	38063737	NA	NA	NA	NA	NA
PGEN_.00g273500	Scaffold_13	38077274	38083755	NA	NA	NA	NA	NA
PGEN_.00g273510	Scaffold_13	38087563	38087997	NA	NA	NA	NA	NA
PGEN_.00g273520	Scaffold_13	38098251	38105085	Q3SZM7	DPEP1_BOVIN	Dipeptidase 1 (EC 3.4.13.19) (Microsomal dipeptidase)	GO:0005615; GO:0005886; GO:0008239; GO:0008270; GO:0016324; GO:0016999; GO:0030336; GO:0031225; GO:0034235; GO:0035690; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070573; GO:0071277; GO:0071732; GO:0072341	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; homocysteine metabolic process [GO:0050667]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]
PGEN_.00g273530	Scaffold_13	38113228	38113521	NA	NA	NA	NA	NA
PGEN_.00g273540	Scaffold_13	38117628	38126643	O08893	CALCR_CAVPO	Calcitonin receptor (CT-R)	GO:0004948; GO:0005886; GO:0007166; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g273550	Scaffold_13	38237338	38238216	NA	NA	NA	NA	NA
PGEN_.00g273560	Scaffold_13	38242977	38255328	NA	NA	NA	NA	NA
PGEN_.00g273570	Scaffold_13	38259880	38267740	Q93YS4	AB22G_ARATH	ABC transporter G family member 22 (ABC transporter ABCG.22) (AtABCG22) (White-brown complex homolog protein 23) (AtWBC23)	GO:0005524; GO:0005886; GO:0009414; GO:0010148; GO:0016021; GO:0016887; GO:0042626; GO:0055085	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; response to water deprivation [GO:0009414]; transmembrane transport [GO:0055085]; transpiration [GO:0010148]
PGEN_.00g273580	Scaffold_13	38270817	38275304	NA	NA	NA	NA	NA
PGEN_.00g273590	Scaffold_13	38277876	38291007	Q08DA7	GTDC1_BOVIN	Glycosyltransferase-like domain-containing protein 1		
PGEN_.00g273600	Scaffold_13	38308083	38342926	O08651	SERA_RAT	D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95)	GO:0004617; GO:0006520; GO:0006541; GO:0006544; GO:0006563; GO:0006564; GO:0006566; GO:0009070; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0022008; GO:0031175; GO:0051287; GO:0070314	NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; serine family amino acid biosynthetic process [GO:0009070]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]
PGEN_.00g273610	Scaffold_13	38346209	38346523	NA	NA	NA	NA	NA
PGEN_.00g273620	Scaffold_13	38358019	38363650	NA	NA	NA	NA	NA
PGEN_.00g273630	Scaffold_13	38372755	38383554	NA	NA	NA	NA	NA
PGEN_.00g273640	Scaffold_13	38388811	38392340	Q7ZSX3	PTF1A_DANRE	Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48)	GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048699	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; pancreas development [GO:0031016]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]"
PGEN_.00g273650	Scaffold_13	38531213	38549283	NA	NA	NA	NA	NA
PGEN_.00g273660	Scaffold_13	38556515	38559519	NA	NA	NA	NA	NA
PGEN_.00g273670	Scaffold_13	38566253	38566561	NA	NA	NA	NA	NA
PGEN_.00g273680	Scaffold_13	38597484	38618559	Q922M5	CDA7L_MOUSE	Cell division cycle-associated 7-like protein (Transcription factor RAM2)	GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g273690	Scaffold_13	38620681	38627267	Q91XF0	PNPO_MOUSE	Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase)	GO:0004733; GO:0005654; GO:0005829; GO:0008615; GO:0010181; GO:0030170; GO:0042803; GO:0042823	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]
PGEN_.00g273700	Scaffold_13	38633141	38636742	Q5I0K7	ALG13_RAT	UDP-N-acetylglucosamine transferase subunit ALG13 homolog (EC 2.4.1.141) (Glycosyltransferase 28 domain-containing protein 1)	GO:0004577; GO:0005783; GO:0006488	endoplasmic reticulum [GO:0005783]; N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]
PGEN_.00g273710	Scaffold_13	38646469	38670064	Q8K1A0	METL5_MOUSE	Methyltransferase-like protein 5 (EC 2.1.1.-)	GO:0003676; GO:0008168; GO:0032259	methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; methylation [GO:0032259]
PGEN_.00g273720	Scaffold_13	38675773	38720408	Q9Y238	DLEC1_HUMAN	Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1)	GO:0005737; GO:0005829; GO:0008285	cytoplasm [GO:0005737]; cytosol [GO:0005829]; negative regulation of cell population proliferation [GO:0008285]
PGEN_.00g273730	Scaffold_13	38727381	38748515	Q99676	ZN184_HUMAN	Zinc finger protein 184	GO:0003677; GO:0005634; GO:0006355; GO:0008270	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g273740	Scaffold_13	38755061	38759794	NA	NA	NA	NA	NA
PGEN_.00g273750	Scaffold_13	38761127	38784629	Q06HQ7	PLB1_MONDO	"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]"	GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0050253; GO:0102567; GO:0102568	"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]"
PGEN_.00g273760	Scaffold_13	38791004	38792492	NA	NA	NA	NA	NA
PGEN_.00g273770	Scaffold_13	38792729	38804835	Q3TTY0	PLB1_MOUSE	"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]"	GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0042572; GO:0050253; GO:0102567; GO:0102568; GO:2000344	"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]"
PGEN_.00g273780	Scaffold_13	38806189	38807759	Q3TTY0	PLB1_MOUSE	"Phospholipase B1, membrane-associated (Phospholipase B) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]"	GO:0004622; GO:0004623; GO:0006644; GO:0016021; GO:0016042; GO:0016324; GO:0031526; GO:0042572; GO:0050253; GO:0102567; GO:0102568; GO:2000344	"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]"
PGEN_.00g273790	Scaffold_13	38816461	38836210	O88618	FTCD_RAT	Formimidoyltransferase-cyclodeaminase (58 kDa microtubule-binding protein) (Formiminotransferase-cyclodeaminase) (FTCD) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]	GO:0000139; GO:0005542; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0007010; GO:0008017; GO:0019215; GO:0019556; GO:0019557; GO:0030407; GO:0030409; GO:0030412; GO:0030868; GO:0035999	centriole [GO:0005814]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; formimidoyltransferase activity [GO:0030407]; glutamate formimidoyltransferase activity [GO:0030409]; intermediate filament binding [GO:0019215]; microtubule binding [GO:0008017]; cytoskeleton organization [GO:0007010]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]
PGEN_.00g273800	Scaffold_13	38836378	38854892	Q15326	ZMY11_HUMAN	Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Bone morphogenetic protein receptor-associated molecule 1) (Protein BS69)	GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0007049; GO:0008270; GO:0016032; GO:0034243; GO:0035064; GO:0043124; GO:0045892; GO:0046329; GO:0051607; GO:2001237	"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; viral process [GO:0016032]"
PGEN_.00g273810	Scaffold_13	38858065	38858418	NA	NA	NA	NA	NA
PGEN_.00g273820	Scaffold_13	38869265	38870648	Q3KQ77	EFCB1_XENLA	EF-hand calcium-binding domain-containing protein 1	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g273830	Scaffold_13	38874040	38879706	Q9D7Q1	CHIT1_MOUSE	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	GO:0000272; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0006032; GO:0008061; GO:0008843	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]
PGEN_.00g273840	Scaffold_13	38971294	38981765	P79782	TCF15_CHICK	Transcription factor 15 (TCF-15) (Paraxis) (Protein bHLH-EC2)	GO:0003677; GO:0005634; GO:0007275; GO:0046983	nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; multicellular organism development [GO:0007275]
PGEN_.00g273850	Scaffold_13	38992144	39025300	Q9ULI1	NWD2_HUMAN	NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)		
PGEN_.00g273860	Scaffold_13	39031325	39032987	NA	NA	NA	NA	NA
PGEN_.00g273870	Scaffold_13	39092956	39093710	NA	NA	NA	NA	NA
PGEN_.00g273880	Scaffold_13	39093876	39094154	NA	NA	NA	NA	NA
PGEN_.00g273890	Scaffold_13	39121282	39121653	NA	NA	NA	NA	NA
PGEN_.00g273900	Scaffold_13	39154301	39156322	NA	NA	NA	NA	NA
PGEN_.00g273910	Scaffold_13	39162262	39193914	Q7Z3F1	GP155_HUMAN	Integral membrane protein GPR155 (G-protein coupled receptor PGR22)	GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]
PGEN_.00g273920	Scaffold_13	39222044	39242178	Q9P6R1	VRP1_SCHPO	Verprolin	GO:0000147; GO:0003785; GO:0005634; GO:0005829; GO:0005884; GO:0006897; GO:0030048; GO:0030479; GO:0031097; GO:0035840; GO:0051015; GO:0051666; GO:2000601	actin cortical patch [GO:0030479]; actin filament [GO:0005884]; cytosol [GO:0005829]; medial cortex [GO:0031097]; nucleus [GO:0005634]; old growing cell tip [GO:0035840]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]
PGEN_.00g273930	Scaffold_13	39244673	39253625	NA	NA	NA	NA	NA
PGEN_.00g273940	Scaffold_13	39270270	39286474	Q5ZKI4	CCD93_CHICK	Coiled-coil domain-containing protein 93	GO:0005769; GO:0006893; GO:0015031	early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]
PGEN_.00g273950	Scaffold_13	39286652	39299868	Q0VD31	FBXL4_BOVIN	F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4)	GO:0005634; GO:0005758; GO:0006511; GO:0016567; GO:0019005; GO:0031146	mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g273960	Scaffold_13	39300878	39316995	NA	NA	NA	NA	NA
PGEN_.00g273970	Scaffold_13	39317057	39317620	NA	NA	NA	NA	NA
PGEN_.00g273980	Scaffold_13	39317790	39325457	Q0VD31	FBXL4_BOVIN	F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4)	GO:0005634; GO:0005758; GO:0006511; GO:0016567; GO:0019005; GO:0031146	mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g273990	Scaffold_13	39328052	39328399	NA	NA	NA	NA	NA
PGEN_.00g274000	Scaffold_13	39333394	39342756	Q5U3V9	SNF8_DANRE	Vacuolar-sorting protein SNF8 (ESCRT-II complex subunit VPS22)	GO:0000814; GO:0043328	ESCRT II complex [GO:0000814]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]
PGEN_.00g274010	Scaffold_13	39347156	39353010	NA	NA	NA	NA	NA
PGEN_.00g274020	Scaffold_13	39370904	39373253	NA	NA	NA	NA	NA
PGEN_.00g274030	Scaffold_13	39425385	39445654	Q8VIH3	S28A3_RAT	Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (rCNT3)	GO:0001895; GO:0005337; GO:0005415; GO:0005887; GO:0015389; GO:0015390; GO:0015860; GO:0015864; GO:1901642	integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; nucleoside transmembrane transport [GO:1901642]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; retina homeostasis [GO:0001895]
PGEN_.00g274040	Scaffold_13	39451236	39479514	P54277	PMS1_HUMAN	PMS1 protein homolog 1 (DNA mismatch repair protein PMS1)	GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0016887; GO:0019899; GO:0030983; GO:0032300; GO:0032389; GO:0042493	mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]; response to drug [GO:0042493]
PGEN_.00g274050	Scaffold_13	39509424	39535589	Q8BI06	CEMIP_MOUSE	Cell migration-inducing and hyaluronan-binding protein (EC 3.2.1.35) (Protein 12H19.01.T7)	GO:0004415; GO:0005540; GO:0005576; GO:0005623; GO:0005634; GO:0005737; GO:0005783; GO:0005886; GO:0005905; GO:0007605; GO:0010800; GO:0030214; GO:0030335; GO:0030665; GO:0032050; GO:0045334; GO:0046923; GO:0051281; GO:0090314; GO:1900020	cell [GO:0005623]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; ER retention sequence binding [GO:0046923]; hyaluronic acid binding [GO:0005540]; hyalurononglucosaminidase activity [GO:0004415]; hyaluronan catabolic process [GO:0030214]; positive regulation of cell migration [GO:0030335]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; sensory perception of sound [GO:0007605]
PGEN_.00g274060	Scaffold_13	39541994	39544432	NA	NA	NA	NA	NA
PGEN_.00g274070	Scaffold_13	39559087	39593604	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g274080	Scaffold_13	39602880	39621483	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g274090	Scaffold_13	39626866	39643636	Q9VCA2	ORCT_DROME	Organic cation transporter protein	GO:0006811; GO:0006915; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; apoptotic process [GO:0006915]; ion transport [GO:0006811]
PGEN_.00g274100	Scaffold_13	39731245	39732746	NA	NA	NA	NA	NA
PGEN_.00g274110	Scaffold_13	39749107	39765093	P51942	MATN1_MOUSE	Cartilage matrix protein (Matrilin-1)	GO:0002062; GO:0003429; GO:0005201; GO:0005509; GO:0005615; GO:0030500; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; chondrocyte differentiation [GO:0002062]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; regulation of bone mineralization [GO:0030500]
PGEN_.00g274120	Scaffold_13	39771653	39781668	Q0II68	ACMSD_BOVIN	2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase)	GO:0001760; GO:0005737; GO:0005829; GO:0008270; GO:0016787; GO:1904985	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; negative regulation of quinolinate biosynthetic process [GO:1904985]
PGEN_.00g274130	Scaffold_13	39785121	39794548	O42567	RXB_XENLA	Retinal homeobox protein Rx-B (Retina and anterior neural fold homeobox protein B) (Rx2A) (Xrx2)	GO:0005634; GO:0006355; GO:0007275; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g274140	Scaffold_13	39796136	39798865	Q54468	CHB_SERMA	Chitobiase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (N-acetyl-beta-glucosaminidase)	GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0042597; GO:0102148	periplasmic space [GO:0042597]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]
PGEN_.00g274150	Scaffold_13	39800330	39802566	Q20681	BAT38_CAEEL	BTB and MATH domain-containing protein 38		
PGEN_.00g274160	Scaffold_13	39804020	39807727	NA	NA	NA	NA	NA
PGEN_.00g274170	Scaffold_13	39817681	39823029	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g274180	Scaffold_13	39828406	39830758	NA	NA	NA	NA	NA
PGEN_.00g274190	Scaffold_13	39877119	39886007	NA	NA	NA	NA	NA
PGEN_.00g274200	Scaffold_13	39920441	39978785	Q99996	AKAP9_HUMAN	A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao)	GO:0000086; GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007194; GO:0007268; GO:0008076; GO:0010389; GO:0015459; GO:0031116; GO:0033138; GO:0034237; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0061337; GO:0071320; GO:0086091; GO:0097060; GO:0097711; GO:0098909; GO:0098962; GO:0098978; GO:0099147; GO:1901018; GO:1903358	centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; DNA binding [GO:0003677]; ion channel binding [GO:0044325]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; cardiac conduction [GO:0061337]; cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165]
PGEN_.00g274210	Scaffold_13	39998213	40003238	NA	NA	NA	NA	NA
PGEN_.00g274220	Scaffold_13	40034734	40059919	NA	NA	NA	NA	NA
PGEN_.00g274230	Scaffold_13	40072005	40072685	P13903	TWIST_XENLA	Twist-related protein (T18) (X-twist)	GO:0003677; GO:0005634; GO:0014029; GO:0046983	nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; neural crest formation [GO:0014029]
PGEN_.00g274240	Scaffold_13	40177935	40184649	NA	NA	NA	NA	NA
PGEN_.00g274250	Scaffold_13	40184681	40194300	NA	NA	NA	NA	NA
PGEN_.00g274260	Scaffold_13	40194976	40197757	NA	NA	NA	NA	NA
PGEN_.00g274270	Scaffold_13	40198132	40203238	NA	NA	NA	NA	NA
PGEN_.00g274280	Scaffold_13	40214658	40226488	Q9WV18	GABR1_MOUSE	Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)	GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005887; GO:0007193; GO:0007194; GO:0007214; GO:0008021; GO:0008134; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030054; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0038037; GO:0038039; GO:0042734; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043231; GO:0045121; GO:0045211; GO:0046982; GO:0050805; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099579; GO:0150099; GO:1902710; GO:1990430	axolemma [GO:0030673]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]
PGEN_.00g274290	Scaffold_13	40316632	40318361	NA	NA	NA	NA	NA
PGEN_.00g274300	Scaffold_13	40318398	40318865	NA	NA	NA	NA	NA
PGEN_.00g274310	Scaffold_13	40318929	40319541	NA	NA	NA	NA	NA
PGEN_.00g274320	Scaffold_13	40320050	40354909	NA	NA	NA	NA	NA
PGEN_.00g274330	Scaffold_13	40356445	40356687	NA	NA	NA	NA	NA
PGEN_.00g274340	Scaffold_13	40392484	40418057	Q9ESL4	M3K20_MOUSE	Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif kinase ZAK) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)	GO:0000077; GO:0000287; GO:0004674; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007010; GO:0007050; GO:0007093; GO:0007257; GO:0035556; GO:0042733; GO:0043065; GO:0051403; GO:0060173; GO:0071480	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to gamma radiation [GO:0071480]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; intracellular signal transduction [GO:0035556]; limb development [GO:0060173]; mitotic cell cycle checkpoint [GO:0007093]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403]
PGEN_.00g274350	Scaffold_13	40460675	40464493	P84080	ARF1_BOVIN	ADP-ribosylation factor 1	GO:0002090; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0014069; GO:0016192; GO:0030054; GO:0034315; GO:0043005; GO:0048471; GO:0060292; GO:0097061	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTP binding [GO:0005525]; dendritic spine organization [GO:0097061]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport [GO:0016192]
PGEN_.00g274360	Scaffold_13	40468374	40470650	P61210	ARF1_LOCMI	ADP-ribosylation factor 1 (lARF1)	GO:0005525; GO:0005794; GO:0015031; GO:0016192	Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
PGEN_.00g274370	Scaffold_13	40491109	40508108	P10076	ZFP26_MOUSE	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g274380	Scaffold_13	40551793	40557826	Q7SYI5	C1GTB_DANRE	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-B (EC 2.4.1.122) (Core 1 O-glycan T-synthase B) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1-B) (Core 1 beta1,3-galactosyltransferase 1-B) (C1GalT1-B) (Core 1 beta3-Gal-T1-B)"	GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016267; GO:0046872	"integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]"
PGEN_.00g274390	Scaffold_13	40570391	40589736	P12545	PLMN_MACMU	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
PGEN_.00g274400	Scaffold_13	40592115	40597703	NA	NA	NA	NA	NA
PGEN_.00g274410	Scaffold_13	40605683	40642918	Q7SYI5	C1GTB_DANRE	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-B (EC 2.4.1.122) (Core 1 O-glycan T-synthase B) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1-B) (Core 1 beta1,3-galactosyltransferase 1-B) (C1GalT1-B) (Core 1 beta3-Gal-T1-B)"	GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016267; GO:0046872	"integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]"
PGEN_.00g274420	Scaffold_13	40646262	40647518	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g274430	Scaffold_13	40649565	40653347	NA	NA	NA	NA	NA
PGEN_.00g274440	Scaffold_13	40653932	40655029	NA	NA	NA	NA	NA
PGEN_.00g274450	Scaffold_13	40655101	40660525	NA	NA	NA	NA	NA
PGEN_.00g274460	Scaffold_13	40663451	40664506	Q2NNR5	CLTR1_CAVPO	Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor)	GO:0002437; GO:0004974; GO:0005887; GO:0006816; GO:0006935; GO:0007166	integral component of plasma membrane [GO:0005887]; leukotriene receptor activity [GO:0004974]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; inflammatory response to antigenic stimulus [GO:0002437]
PGEN_.00g274470	Scaffold_13	40689748	40709717	NA	NA	NA	NA	NA
PGEN_.00g274480	Scaffold_13	40710268	40719414	Q4V8D7	F221A_RAT	Protein FAM221A		
PGEN_.00g274490	Scaffold_13	40732592	40735327	Q9ESN6	TRIM2_MOUSE	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (Neural activity-related RING finger protein) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017022; GO:0043161; GO:0043523; GO:0061630; GO:1990830	cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g274500	Scaffold_13	40736864	40743579	Q0VFE3	PGAP3_XENTR	Post-GPI attachment to proteins factor 3 (PER1-like domain-containing protein 1)	GO:0000139; GO:0006505; GO:0006506; GO:0016021; GO:0016788; GO:0031227	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; hydrolase activity, acting on ester bonds [GO:0016788]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]"
PGEN_.00g274510	Scaffold_13	40748214	40756190	Q0VFZ6	CC173_HUMAN	Coiled-coil domain-containing protein 173		
PGEN_.00g274520	Scaffold_13	40759189	40759977	Q66HC4	PHOP2_RAT	Pyridoxal phosphate phosphatase PHOSPHO2 (EC 3.1.3.74)	GO:0033883; GO:0046872	metal ion binding [GO:0046872]; pyridoxal phosphatase activity [GO:0033883]
PGEN_.00g274530	Scaffold_13	40767020	40771439	P06603	TBA1_DROME	Tubulin alpha-1 chain	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]
PGEN_.00g274540	Scaffold_13	40777891	40778643	Q8WQ47	TBA_LEPDS	Tubulin alpha chain (allergen Lep d ?)	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g274550	Scaffold_13	40782534	40788847	P68370	TBA1A_RAT	Tubulin alpha-1A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005881; GO:0007017; GO:0019904; GO:0031594; GO:0036464; GO:0043209; GO:0044877; GO:0045121; GO:0050807; GO:0055037	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane raft [GO:0045121]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807]
PGEN_.00g274560	Scaffold_13	40794216	40800293	P68370	TBA1A_RAT	Tubulin alpha-1A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005881; GO:0007017; GO:0019904; GO:0031594; GO:0036464; GO:0043209; GO:0044877; GO:0045121; GO:0050807; GO:0055037	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane raft [GO:0045121]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807]
PGEN_.00g274570	Scaffold_13	40807500	40829297	Q9UBS5	GABR1_HUMAN	Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)	GO:0004965; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007214; GO:0030054; GO:0030425; GO:0038039; GO:0042734; GO:0045211; GO:0098685; GO:0098982; GO:0099579; GO:0150099	cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]
PGEN_.00g274580	Scaffold_13	40836561	40857919	Q9M0X9	4CLL7_ARATH	4-coumarate--CoA ligase-like 7 (EC 6.2.1.-) (4-coumarate--CoA ligase isoform 6) (At4CL6)	GO:0004321; GO:0005524; GO:0005777; GO:0009695; GO:0016874; GO:0031408	peroxisome [GO:0005777]; ATP binding [GO:0005524]; fatty-acyl-CoA synthase activity [GO:0004321]; ligase activity [GO:0016874]; jasmonic acid biosynthetic process [GO:0009695]; oxylipin biosynthetic process [GO:0031408]
PGEN_.00g274590	Scaffold_13	40864421	40867921	P0DPH8	TBA3D_HUMAN	Tubulin alpha-3D chain (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g274600	Scaffold_13	40872642	40879102	P56695	WFS1_MOUSE	Wolframin	GO:0000122; GO:0001822; GO:0003091; GO:0005516; GO:0005783; GO:0007601; GO:0007605; GO:0030176; GO:0030285; GO:0030425; GO:0030433; GO:0030968; GO:0031016; GO:0031398; GO:0031625; GO:0032469; GO:0033613; GO:0034976; GO:0042048; GO:0042593; GO:0043069; GO:0043433; GO:0043524; GO:0045927; GO:0048306; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051726; GO:0051928; GO:0055074; GO:0070628; GO:1902236; GO:1903892; GO:2000675	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of synaptic vesicle membrane [GO:0030285]; activating transcription factor binding [GO:0033613]; ATPase binding [GO:0051117]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; proteasome binding [GO:0070628]; ubiquitin protein ligase binding [GO:0031625]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; pancreas development [GO:0031016]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; ubiquitin-dependent ERAD pathway [GO:0030433]; visual perception [GO:0007601]
PGEN_.00g274610	Scaffold_13	40887276	40890622	Q5SQN1	SNP47_HUMAN	Synaptosomal-associated protein 47 (SNAP-47) (Epididymis luminal protein 170) (Synaptosomal-associated 47 kDa protein)	GO:0005484; GO:0005886; GO:0006887; GO:0006906; GO:0014069; GO:0016082; GO:0019905; GO:0030425; GO:0030672; GO:0031201; GO:0031629; GO:0043025; GO:0048471; GO:0060291; GO:0098686; GO:0098967; GO:0098978	dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; exocytosis [GO:0006887]; long-term synaptic potentiation [GO:0060291]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]
PGEN_.00g274620	Scaffold_13	40892057	40896728	B0JZG0	S23A2_XENTR	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)	GO:0016021; GO:0019852; GO:0070890	integral component of membrane [GO:0016021]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]
PGEN_.00g274630	Scaffold_13	40900715	40901038	NA	NA	NA	NA	NA
PGEN_.00g274640	Scaffold_13	40925848	40951159	Q9H3G5	CPVL_HUMAN	"Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP)"	GO:0004185; GO:0051603; GO:0070062	extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g274650	Scaffold_13	40953138	40955003	A7MBD8	SC5AC_BOVIN	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g274660	Scaffold_13	40963586	40986256	A8WVU7	CPG1_CAEBR	Chondroitin proteoglycan 1 (Cell junction protein 1) (Cytokinesis protein cej-1)	GO:0000281; GO:0005576; GO:0006030; GO:0008061; GO:0009792	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]; embryo development ending in birth or egg hatching [GO:0009792]; mitotic cytokinesis [GO:0000281]
PGEN_.00g274670	Scaffold_13	40994678	41003927	Q0EEE2	PTHD3_MOUSE	Patched domain-containing protein 3 (RND-type protein RNDEu-3)	GO:0016021; GO:0097225	integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]
PGEN_.00g274680	Scaffold_13	41010427	41010774	NA	NA	NA	NA	NA
PGEN_.00g274690	Scaffold_13	41028246	41046709	O88871	GABR2_RAT	Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51)	GO:0004965; GO:0005737; GO:0005887; GO:0007214; GO:0016021; GO:0030054; GO:0030425; GO:0038039; GO:0043005; GO:0043204; GO:0046982; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0150099; GO:1902710	cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]
PGEN_.00g274700	Scaffold_13	41069367	41094210	Q9UI40	NCKX2_HUMAN	Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2)	GO:0005262; GO:0005623; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007601; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0034220; GO:0046983; GO:0050896; GO:0060291; GO:0060292; GO:0070588	"cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; protein dimerization activity [GO:0046983]; symporter activity [GO:0015293]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; response to stimulus [GO:0050896]; visual perception [GO:0007601]"
PGEN_.00g274710	Scaffold_13	41095790	41096134	NA	NA	NA	NA	NA
PGEN_.00g274720	Scaffold_13	41113489	41113842	NA	NA	NA	NA	NA
PGEN_.00g274730	Scaffold_13	41115768	41116046	NA	NA	NA	NA	NA
PGEN_.00g274740	Scaffold_13	41127158	41130665	NA	NA	NA	NA	NA
PGEN_.00g274750	Scaffold_13	41140728	41153475	NA	NA	NA	NA	NA
PGEN_.00g274760	Scaffold_13	41186377	41220839	NA	NA	NA	NA	NA
PGEN_.00g274770	Scaffold_13	41332983	41364709	P49883	ECR_MANSE	Ecdysone receptor (20-hydroxy-ecdysone receptor) (20E receptor) (EcRH) (Ecdysteroid receptor) (Nuclear receptor subfamily 1 group H member 1)	GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0035076; GO:0035100; GO:0043565	nucleus [GO:0005634]; ecdysone binding [GO:0035100]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076]
PGEN_.00g274780	Scaffold_13	41387296	41387748	NA	NA	NA	NA	NA
PGEN_.00g274790	Scaffold_13	41497081	41514601	NA	NA	NA	NA	NA
PGEN_.00g274800	Scaffold_13	41616755	41629512	NA	NA	NA	NA	NA
PGEN_.00g274810	Scaffold_13	41701988	41702212	NA	NA	NA	NA	NA
PGEN_.00g274820	Scaffold_13	41737190	41791126	Q96PY5	FMNL2_HUMAN	Formin-like protein 2 (Formin homology 2 domain-containing protein 2)	GO:0003779; GO:0005829; GO:0007010; GO:0008360; GO:0017048; GO:0022604; GO:0030866; GO:0032794; GO:0045296	cytosol [GO:0005829]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; GTPase activating protein binding [GO:0032794]; Rho GTPase binding [GO:0017048]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]
PGEN_.00g274830	Scaffold_13	41798755	41813972	NA	NA	NA	NA	NA
PGEN_.00g274840	Scaffold_13	41839213	41842606	Q6RFH5	WDR74_HUMAN	WD repeat-containing protein 74 (NOP seven-associated protein 1)	GO:0001825; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016070; GO:0030687; GO:0042273	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364]"
PGEN_.00g274850	Scaffold_13	41847757	41868835	Q9QZ41	DBF4A_MOUSE	Protein DBF4 homolog A (MuDBF4)	GO:0003676; GO:0004674; GO:0005634; GO:0005654; GO:0006260; GO:0007049; GO:0007089; GO:0008270; GO:0010571; GO:0016604; GO:0031431; GO:0043539; GO:1901987	Dbf4-dependent protein kinase complex [GO:0031431]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; DNA replication [GO:0006260]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987]; traversing start control point of mitotic cell cycle [GO:0007089]
PGEN_.00g274860	Scaffold_13	41881242	41883632	NA	NA	NA	NA	NA
PGEN_.00g274870	Scaffold_13	41904634	41925362	A6QL92	S35F5_BOVIN	Solute carrier family 35 member F5	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g274880	Scaffold_13	41931404	41939775	Q90WJ8	AJL2_ANGJA	Lactose-binding lectin l-2 (Ajl-2)	GO:0005576; GO:0030246; GO:0043152; GO:0050829	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; defense response to Gram-negative bacterium [GO:0050829]; induction of bacterial agglutination [GO:0043152]
PGEN_.00g274890	Scaffold_13	41941098	41949396	Q90WJ8	AJL2_ANGJA	Lactose-binding lectin l-2 (Ajl-2)	GO:0005576; GO:0030246; GO:0043152; GO:0050829	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; defense response to Gram-negative bacterium [GO:0050829]; induction of bacterial agglutination [GO:0043152]
PGEN_.00g274900	Scaffold_13	41955324	41976045	A6QL92	S35F5_BOVIN	Solute carrier family 35 member F5	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g274910	Scaffold_13	42011951	42030835	Q7ZZH7	DBF4A_XENLA	Protein DBF4 homolog A	GO:0003676; GO:0005634; GO:0007049; GO:0008270	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]
PGEN_.00g274920	Scaffold_13	42036308	42041959	Q6RFH5	WDR74_HUMAN	WD repeat-containing protein 74 (NOP seven-associated protein 1)	GO:0001825; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016070; GO:0030687; GO:0042273	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364]"
PGEN_.00g274930	Scaffold_13	42058787	42066808	Q08BN9	NXPE3_DANRE	NXPE family member 3 (Protein FAM55C)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g274940	Scaffold_13	42077389	42077694	NA	NA	NA	NA	NA
PGEN_.00g274950	Scaffold_13	42147026	42163279	A0A0E0RTV6	ZEB1_GIBZE	FAD-linked oxidoreductase ZEB1 (EC 1.-.-.-) (Zearalenone biosynthesis protein 1)	GO:0016491; GO:0071949	FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]
PGEN_.00g274960	Scaffold_13	42167946	42168719	NA	NA	NA	NA	NA
PGEN_.00g274970	Scaffold_13	42171860	42175071	Q72LL6	LYSN_THET2	2-aminoadipate transaminase (EC 2.6.1.39) (2-aminoadipate aminotransferase) (Alpha-aminoadipate aminotransferase) (AAA-AT) (AadAT)	GO:0019878; GO:0030170; GO:0047536	2-aminoadipate transaminase activity [GO:0047536]; pyridoxal phosphate binding [GO:0030170]; lysine biosynthetic process via aminoadipic acid [GO:0019878]
PGEN_.00g274980	Scaffold_13	42175356	42189247	H3ZPL1	ARAT1_THELN	Aromatic-amino-acid aminotransferase 1 (ARAT-I) (AROAT) (EC 2.6.1.57)	GO:0009058; GO:0030170; GO:0080130	L-phenylalanine:2-oxoglutarate aminotransferase activity [GO:0080130]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]
PGEN_.00g274990	Scaffold_13	42214180	42214452	NA	NA	NA	NA	NA
PGEN_.00g275000	Scaffold_13	42263024	42263446	NA	NA	NA	NA	NA
PGEN_.00g275010	Scaffold_13	42272980	42286694	Q8UUY8	ADRB2_ONCMY	Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)	GO:0004941; GO:0005886; GO:0006940; GO:0007189; GO:0007190; GO:0016021; GO:0032811; GO:0043434; GO:0071875; GO:0097746; GO:1901098; GO:1904504	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; beta2-adrenergic receptor activity [GO:0004941]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenergic receptor signaling pathway [GO:0071875]; negative regulation of epinephrine secretion [GO:0032811]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of lipophagy [GO:1904504]; regulation of blood vessel diameter [GO:0097746]; regulation of smooth muscle contraction [GO:0006940]; response to peptide hormone [GO:0043434]
PGEN_.00g275020	Scaffold_13	42297523	42297804	NA	NA	NA	NA	NA
PGEN_.00g275030	Scaffold_13	42313670	42316559	NA	NA	NA	NA	NA
PGEN_.00g275040	Scaffold_13	42330955	42351386	NA	NA	NA	NA	NA
PGEN_.00g275050	Scaffold_13	42395694	42399102	Q8BHA0	IN80C_MOUSE	INO80 complex subunit C	GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0071339	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]
PGEN_.00g275060	Scaffold_13	42401123	42418039	Q9NQR7	CC177_HUMAN	Coiled-coil domain-containing protein 177 (Myelin proteolipid protein-like protein)		
PGEN_.00g275070	Scaffold_13	42426888	42445223	NA	NA	NA	NA	NA
PGEN_.00g275080	Scaffold_13	42455843	42493552	Q92551	IP6K1_HUMAN	Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1)	GO:0000828; GO:0000832; GO:0001650; GO:0005524; GO:0005654; GO:0005829; GO:0032958; GO:0043647; GO:0046854; GO:0052723; GO:0052724; GO:0120163	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphorylation [GO:0046854]
PGEN_.00g275090	Scaffold_13	42505211	42505871	NA	NA	NA	NA	NA
PGEN_.00g275100	Scaffold_13	42506055	42521038	Q0VCF9	LSM12_BOVIN	Protein LSM12 homolog		
PGEN_.00g275110	Scaffold_13	42526915	42535250	P62407	YELL_DROSI	Protein yellow	GO:0005576; GO:0042438; GO:0060179	extracellular region [GO:0005576]; male mating behavior [GO:0060179]; melanin biosynthetic process [GO:0042438]
PGEN_.00g275120	Scaffold_13	42549011	42562895	Q68DY1	ZN626_HUMAN	Zinc finger protein 626	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g275130	Scaffold_13	42569302	42569811	NA	NA	NA	NA	NA
PGEN_.00g275140	Scaffold_13	42586626	42587168	O57321	EAA1_AMBTI	Excitatory amino acid transporter 1 (SEAAT1) (Sodium-dependent glutamate/aspartate transporter) (GLAST)	GO:0005314; GO:0005887; GO:0015501; GO:0046872; GO:0070779; GO:0071805; GO:0098712; GO:0140009; GO:1902476	integral component of plasma membrane [GO:0005887]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; potassium ion transmembrane transport [GO:0071805]
PGEN_.00g275150	Scaffold_13	42597538	42598387	NA	NA	NA	NA	NA
PGEN_.00g275160	Scaffold_13	42629486	42637901	P43003	EAA1_HUMAN	Excitatory amino acid transporter 1 (Sodium-dependent glutamate/aspartate transporter 1) (GLAST-1) (Solute carrier family 1 member 3)	GO:0001504; GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0007605; GO:0009416; GO:0009449; GO:0009611; GO:0009986; GO:0014047; GO:0015501; GO:0015813; GO:0016020; GO:0016595; GO:0021545; GO:0031223; GO:0043005; GO:0043025; GO:0045202; GO:0046677; GO:0046872; GO:0048667; GO:0050806; GO:0050885; GO:0051938; GO:0070779; GO:0071805; GO:0098712; GO:0140009; GO:1902476	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; auditory behavior [GO:0031223]; cell morphogenesis involved in neuron differentiation [GO:0048667]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cranial nerve development [GO:0021545]; D-aspartate import across plasma membrane [GO:0070779]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter uptake [GO:0001504]; positive regulation of synaptic transmission [GO:0050806]; potassium ion transmembrane transport [GO:0071805]; response to antibiotic [GO:0046677]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]
PGEN_.00g275170	Scaffold_13	42641599	42641841	NA	NA	NA	NA	NA
PGEN_.00g275180	Scaffold_13	42654609	42673341	B1H1P9	PPAL_XENLA	Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)	GO:0003993; GO:0005765; GO:0016021; GO:0043202	integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; acid phosphatase activity [GO:0003993]
PGEN_.00g275190	Scaffold_13	42681099	42684101	NA	NA	NA	NA	NA
PGEN_.00g275200	Scaffold_13	42685974	42687431	Q5F4B8	S46A3_CHICK	Solute carrier family 46 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g275210	Scaffold_13	42690272	42690694	Q5F4B8	S46A3_CHICK	Solute carrier family 46 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g275220	Scaffold_13	42754996	42765406	Q9V0D5	MDH_PYRAB	Malate dehydrogenase (EC 1.1.1.37)	GO:0005737; GO:0006099; GO:0030060	cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g275230	Scaffold_13	42765630	42767677	NA	NA	NA	NA	NA
PGEN_.00g275240	Scaffold_13	42777837	42778721	NA	NA	NA	NA	NA
PGEN_.00g275250	Scaffold_13	42783227	42800466	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g275260	Scaffold_13	42800609	42800953	NA	NA	NA	NA	NA
PGEN_.00g275270	Scaffold_13	42803862	42805922	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g275280	Scaffold_13	42838143	42842811	NA	NA	NA	NA	NA
PGEN_.00g275290	Scaffold_13	42846243	42846590	NA	NA	NA	NA	NA
PGEN_.00g275300	Scaffold_13	42875598	42884478	NA	NA	NA	NA	NA
PGEN_.00g275310	Scaffold_13	42893421	42898463	Q9Y608	LRRF2_HUMAN	Leucine-rich repeat flightless-interacting protein 2 (LRR FLII-interacting protein 2)	GO:0006355; GO:0016055; GO:0030275	"LRR domain binding [GO:0030275]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g275320	Scaffold_13	42908021	42933988	NA	NA	NA	NA	NA
PGEN_.00g275330	Scaffold_13	42937448	42950542	Q91Y80	3BP5_RAT	SH3 domain-binding protein 5 (SH3BP-5) (Vascular endothelial cell-specific protein 18)	GO:0004860; GO:0005737; GO:0005739; GO:0006469; GO:0007254; GO:0016604; GO:0017112; GO:0017124; GO:0030659; GO:0035556; GO:0061099	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; protein kinase inhibitor activity [GO:0004860]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]
PGEN_.00g275340	Scaffold_13	42950819	42951956	NA	NA	NA	NA	NA
PGEN_.00g275350	Scaffold_13	43047917	43073828	Q9GLP0	ITB1_PIG	Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29)	GO:0001968; GO:0005178; GO:0005925; GO:0007160; GO:0007229; GO:0008305; GO:0009986; GO:0010710; GO:0016020; GO:0016477; GO:0030027; GO:0030335; GO:0031623; GO:0032587; GO:0033627; GO:0038023; GO:0042470; GO:0046872; GO:0046982; GO:0055037; GO:0071404; GO:0071438; GO:0098639; GO:1903078	cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; collagen binding involved in cell-matrix adhesion [GO:0098639]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710]
PGEN_.00g275360	Scaffold_13	43080622	43113828	Q9GLP0	ITB1_PIG	Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29)	GO:0001968; GO:0005178; GO:0005925; GO:0007160; GO:0007229; GO:0008305; GO:0009986; GO:0010710; GO:0016020; GO:0016477; GO:0030027; GO:0030335; GO:0031623; GO:0032587; GO:0033627; GO:0038023; GO:0042470; GO:0046872; GO:0046982; GO:0055037; GO:0071404; GO:0071438; GO:0098639; GO:1903078	cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; collagen binding involved in cell-matrix adhesion [GO:0098639]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710]
PGEN_.00g275370	Scaffold_13	43121503	43150529	Q80U56	AVL9_MOUSE	Late secretory pathway protein AVL9 homolog	GO:0016021; GO:0016477; GO:0055037	integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; cell migration [GO:0016477]
PGEN_.00g275380	Scaffold_13	43144446	43145387	NA	NA	NA	NA	NA
PGEN_.00g275390	Scaffold_13	43145455	43146075	NA	NA	NA	NA	NA
PGEN_.00g275400	Scaffold_13	43156606	43174914	NA	NA	NA	NA	NA
PGEN_.00g275410	Scaffold_13	43180274	43180690	NA	NA	NA	NA	NA
PGEN_.00g275420	Scaffold_13	43183785	43191899	Q8N6F8	MET27_HUMAN	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)		
PGEN_.00g275430	Scaffold_13	43199255	43221222	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g275440	Scaffold_13	43307814	43383364	Q9IB86	CALRL_PAROL	Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)	GO:0004948; GO:0005886; GO:0007166; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g275450	Scaffold_13	43562057	43581220	Q9BX95	SGPP1_HUMAN	Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1) (Sphingosine-1-phosphate phosphohydrolase 1) (SPP-1)	GO:0005654; GO:0005789; GO:0005886; GO:0006668; GO:0006670; GO:0016021; GO:0030148; GO:0035621; GO:0042392; GO:0045616; GO:0045682; GO:0097191; GO:0097193	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; ER to Golgi ceramide transport [GO:0035621]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]; sphinganine-1-phosphate metabolic process [GO:0006668]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670]
PGEN_.00g275460	Scaffold_13	43596280	43623754	Q9UKI8	TLK1_HUMAN	Serine/threonine-protein kinase tousled-like 1 (EC 2.7.11.1) (PKU-beta) (Tousled-like kinase 1)	GO:0001672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006468; GO:0006886; GO:0006974; GO:0007049; GO:0007059; GO:0018105; GO:0035556	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672]
PGEN_.00g275470	Scaffold_13	43633808	43644235	NA	NA	NA	NA	NA
PGEN_.00g275480	Scaffold_13	43663287	43779572	Q68EK2	CALRL_DANRE	Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)	GO:0001525; GO:0001756; GO:0004948; GO:0005886; GO:0007166; GO:0016021; GO:0048844; GO:0055064	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell surface receptor signaling pathway [GO:0007166]; chloride ion homeostasis [GO:0055064]; somitogenesis [GO:0001756]
PGEN_.00g275490	Scaffold_13	43812095	43819008	NA	NA	NA	NA	NA
PGEN_.00g275500	Scaffold_13	43872062	43881808	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g275510	Scaffold_13	43887452	43905055	Q3ZC50	CCD47_BOVIN	Coiled-coil domain-containing protein 47	GO:0005509; GO:0005783; GO:0006983; GO:0007029; GO:0009791; GO:0016021; GO:0030433; GO:0030867; GO:0032469; GO:0036503	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum membrane [GO:0030867]; calcium ion binding [GO:0005509]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g275520	Scaffold_13	43912416	43913525	P54922	ADPRH_HUMAN	[Protein ADP-ribosylarginine] hydrolase (ADP-ribosylarginine hydrolase) (hARH1) (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme)	GO:0000287; GO:0003875; GO:0005096; GO:0005615; GO:0005829; GO:0006464; GO:0006886; GO:0017137; GO:0030955; GO:0051725; GO:0090630	cytosol [GO:0005829]; extracellular space [GO:0005615]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725]
PGEN_.00g275530	Scaffold_13	43916931	43917146	NA	NA	NA	NA	NA
PGEN_.00g275540	Scaffold_13	43929052	43941203	NA	NA	NA	NA	NA
PGEN_.00g275550	Scaffold_13	43953308	43961393	NA	NA	NA	NA	NA
PGEN_.00g275560	Scaffold_13	43977675	43979310	NA	NA	NA	NA	NA
PGEN_.00g275570	Scaffold_13	43980292	43982376	Q5AYN6	CD123_EMENI	Cell division cycle protein 123	GO:0005737; GO:0007049; GO:0051301	cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g275580	Scaffold_13	43995566	43998244	NA	NA	NA	NA	NA
PGEN_.00g275590	Scaffold_13	44010449	44032580	Q9BUL9	RPP25_HUMAN	Ribonuclease P protein subunit p25 (RNase P protein subunit p25) (EC 3.1.26.5)	GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005654; GO:0005730; GO:0006364; GO:0030681; GO:0033204; GO:0034451	centriolar satellite [GO:0034451]; multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]
PGEN_.00g275600	Scaffold_13	44044439	44056831	NA	NA	NA	NA	NA
PGEN_.00g275610	Scaffold_13	44069878	44070312	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g275620	Scaffold_13	44089917	44091565	P70345	B2CL2_MOUSE	Bcl-2-like protein 2 (Bcl2-L-2) (Apoptosis regulator Bcl-W) (c98)	GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0008630; GO:0031966; GO:0035795; GO:0042802; GO:0042803; GO:0043066; GO:0044877; GO:0046982; GO:0051400; GO:0060011; GO:0071392; GO:0090201; GO:0097136; GO:0097192; GO:0097718; GO:1904646; GO:2001243	Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; BH domain binding [GO:0051400]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; apoptotic process [GO:0006915]; cellular response to amyloid-beta [GO:1904646]; cellular response to estradiol stimulus [GO:0071392]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; Sertoli cell proliferation [GO:0060011]
PGEN_.00g275630	Scaffold_13	44106629	44107540	NA	NA	NA	NA	NA
PGEN_.00g275640	Scaffold_13	44139587	44141029	NA	NA	NA	NA	NA
PGEN_.00g275650	Scaffold_13	44157237	44160347	Q92843	B2CL2_HUMAN	Bcl-2-like protein 2 (Bcl2-L-2) (Apoptosis regulator Bcl-W)	GO:0005741; GO:0005829; GO:0007283; GO:0008630; GO:0042802; GO:0042803; GO:0043066; GO:0046982; GO:0051400; GO:0060011; GO:0071392; GO:0097136; GO:0097192; GO:0097718; GO:1904646; GO:2001243	Bcl-2 family protein complex [GO:0097136]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; BH domain binding [GO:0051400]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular response to amyloid-beta [GO:1904646]; cellular response to estradiol stimulus [GO:0071392]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; Sertoli cell proliferation [GO:0060011]; spermatogenesis [GO:0007283]
PGEN_.00g275660	Scaffold_13	44198964	44201135	NA	NA	NA	NA	NA
PGEN_.00g275670	Scaffold_13	44205438	44211569	NA	NA	NA	NA	NA
PGEN_.00g275680	Scaffold_13	44232973	44255093	Q8MU52	GST_PLAFA	Glutathione S-transferase (EC 2.5.1.18) (PfGST)	GO:0004364	glutathione transferase activity [GO:0004364]
PGEN_.00g275690	Scaffold_13	44261790	44262167	NA	NA	NA	NA	NA
PGEN_.00g275700	Scaffold_13	44262286	44271888	NA	NA	NA	NA	NA
PGEN_.00g275710	Scaffold_13	44271950	44297159	NA	NA	NA	NA	NA
PGEN_.00g275720	Scaffold_13	44302866	44310965	Q566B2	PBURS_BOMMO	Partner of bursicon (Bursicon subunit beta)	GO:0001664; GO:0005184; GO:0031395	bursicon neuropeptide hormone complex [GO:0031395]; G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]
PGEN_.00g275730	Scaffold_13	44315885	44346296	P97868	RBBP6_MOUSE	E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis)	GO:0001701; GO:0003676; GO:0004842; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006260; GO:0006275; GO:0006397; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; nucleic acid binding [GO:0003676]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g275740	Scaffold_13	44348251	44348565	NA	NA	NA	NA	NA
PGEN_.00g275750	Scaffold_13	44348867	44352049	NA	NA	NA	NA	NA
PGEN_.00g275760	Scaffold_13	44353123	44355908	O54863	TSSK2_MOUSE	Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (Serine/threonine-protein kinase 22B)	GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0006468; GO:0007275; GO:0007286; GO:0018105; GO:0035556; GO:0044877; GO:0046777	acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]
PGEN_.00g275770	Scaffold_14	46	6646	NA	NA	NA	NA	NA
PGEN_.00g275780	Scaffold_14	13198	16547	P00129	QCR7_BOVIN	Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein)	GO:0005750; GO:0006122; GO:0009060; GO:0034551	"mitochondrial respiratory chain complex III [GO:0005750]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]"
PGEN_.00g275790	Scaffold_14	16759	31643	P17041	ZNF32_HUMAN	Zinc finger protein 32 (C2H2-546) (Zinc finger protein KOX30)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g275800	Scaffold_14	33070	39741	Q8NHY6	ZFP28_HUMAN	Zinc finger protein 28 homolog (Zfp-28) (Krueppel-like zinc finger factor X6)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g275810	Scaffold_14	73483	82736	Q6PA97	TPPC9_XENLA	Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein homolog)	GO:0005783; GO:0005794; GO:0030154	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; cell differentiation [GO:0030154]
PGEN_.00g275820	Scaffold_14	82835	88063	Q54F11	HBX3_DICDI	Homeobox protein 3 (DdHbx-3)	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g275830	Scaffold_14	89085	99530	Q3U0M1	TPPC9_MOUSE	Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein)	GO:0005737; GO:0005783; GO:0005802; GO:0021987; GO:0030008; GO:0030182; GO:0051092	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; cerebral cortex development [GO:0021987]; neuron differentiation [GO:0030182]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]
PGEN_.00g275840	Scaffold_14	110205	112478	O54798	BRS3_MOUSE	Bombesin receptor subtype-3 (BRS-3)	GO:0004930; GO:0004946; GO:0005886; GO:0005887; GO:0007186; GO:0043005; GO:0043025	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; bombesin receptor activity [GO:0004946]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g275850	Scaffold_14	120847	122172	Q9GZQ6	NPFF1_HUMAN	Neuropeptide FF receptor 1 (G-protein coupled receptor 147) (RFamide-related peptide receptor OT7T022)	GO:0004930; GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0008188; GO:0032870	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g275860	Scaffold_14	125688	136507	NA	NA	NA	NA	NA
PGEN_.00g275870	Scaffold_14	137008	138240	NA	NA	NA	NA	NA
PGEN_.00g275880	Scaffold_14	151536	152738	P30551	CCKAR_RAT	Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R)	GO:0001659; GO:0001696; GO:0001764; GO:0002023; GO:0004930; GO:0004951; GO:0005623; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0005887; GO:0007186; GO:0007204; GO:0007409; GO:0007584; GO:0007631; GO:0009314; GO:0009408; GO:0016020; GO:0017046; GO:0030073; GO:0030157; GO:0030900; GO:0031016; GO:0031100; GO:0031532; GO:0032496; GO:0032870; GO:0038188; GO:0042594; GO:0042755; GO:0043195; GO:0043266; GO:0046883; GO:0048545; GO:0051384; GO:0051924; GO:0090274	cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; actin cytoskeleton reorganization [GO:0031532]; animal organ regeneration [GO:0031100]; axonogenesis [GO:0007409]; cellular response to hormone stimulus [GO:0032870]; cholecystokinin signaling pathway [GO:0038188]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric acid secretion [GO:0001696]; insulin secretion [GO:0030073]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; pancreatic juice secretion [GO:0030157]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of somatostatin secretion [GO:0090274]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of calcium ion transport [GO:0051924]; regulation of hormone secretion [GO:0046883]; regulation of potassium ion transport [GO:0043266]; response to glucocorticoid [GO:0051384]; response to heat [GO:0009408]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to radiation [GO:0009314]; response to starvation [GO:0042594]; response to steroid hormone [GO:0048545]; temperature homeostasis [GO:0001659]
PGEN_.00g275890	Scaffold_14	154707	155804	O93603	TRFR_CHICK	Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor)	GO:0004997; GO:0005886; GO:0007200; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyrotropin-releasing hormone receptor activity [GO:0004997]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]
PGEN_.00g275900	Scaffold_14	166074	172988	NA	NA	NA	NA	NA
PGEN_.00g275910	Scaffold_14	173470	177827	Q8BZ20	PAR12_MOUSE	Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)	GO:0003950; GO:0005634; GO:0046872; GO:0070213; GO:0140289; GO:1990404	nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]
PGEN_.00g275920	Scaffold_14	179860	180171	NA	NA	NA	NA	NA
PGEN_.00g275930	Scaffold_14	189435	189923	NA	NA	NA	NA	NA
PGEN_.00g275940	Scaffold_14	200673	216375	Q80TP3	UBR5_MOUSE	"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog)"	GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0031647; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:1905077; GO:2000780	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 secretion [GO:1905077]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of protein stability [GO:0031647]
PGEN_.00g275950	Scaffold_14	216450	254339	O95071	UBR5_HUMAN	"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)"	GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0016020; GO:0016032; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000780	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; viral process [GO:0016032]
PGEN_.00g275960	Scaffold_14	270643	271958	NA	NA	NA	NA	NA
PGEN_.00g275970	Scaffold_14	277394	285062	O15182	CETN3_HUMAN	Centrin-3	GO:0005509; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0007098; GO:0008017; GO:0015031; GO:0030474; GO:0044615; GO:0051028; GO:0051301; GO:0070390	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; transcription export complex 2 [GO:0070390]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; mRNA transport [GO:0051028]; protein transport [GO:0015031]; spindle pole body duplication [GO:0030474]
PGEN_.00g275980	Scaffold_14	286946	298652	NA	NA	NA	NA	NA
PGEN_.00g275990	Scaffold_14	307541	312973	NA	NA	NA	NA	NA
PGEN_.00g276000	Scaffold_14	327731	332015	NA	NA	NA	NA	NA
PGEN_.00g276010	Scaffold_14	365700	367997	NA	NA	NA	NA	NA
PGEN_.00g276020	Scaffold_14	374762	381507	NA	NA	NA	NA	NA
PGEN_.00g276030	Scaffold_14	402970	408556	NA	NA	NA	NA	NA
PGEN_.00g276040	Scaffold_14	426230	432876	NA	NA	NA	NA	NA
PGEN_.00g276050	Scaffold_14	508567	516909	NA	NA	NA	NA	NA
PGEN_.00g276060	Scaffold_14	528568	533466	NA	NA	NA	NA	NA
PGEN_.00g276070	Scaffold_14	541043	545662	NA	NA	NA	NA	NA
PGEN_.00g276080	Scaffold_14	602206	602592	NA	NA	NA	NA	NA
PGEN_.00g276090	Scaffold_14	602711	605676	NA	NA	NA	NA	NA
PGEN_.00g276100	Scaffold_14	610200	613464	NA	NA	NA	NA	NA
PGEN_.00g276110	Scaffold_14	620055	622931	NA	NA	NA	NA	NA
PGEN_.00g276120	Scaffold_14	628859	640279	Q6P2X9	MOT12_XENTR	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g276130	Scaffold_14	694621	759919	Q0P4M4	CBPC2_XENTR	Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2)	GO:0004181; GO:0005814; GO:0005829; GO:0008270; GO:0035610; GO:0036064	centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein side chain deglutamylation [GO:0035610]
PGEN_.00g276140	Scaffold_14	776419	819186	NA	NA	NA	NA	NA
PGEN_.00g276150	Scaffold_14	833064	833390	NA	NA	NA	NA	NA
PGEN_.00g276160	Scaffold_14	833999	834343	NA	NA	NA	NA	NA
PGEN_.00g276170	Scaffold_14	834400	835059	NA	NA	NA	NA	NA
PGEN_.00g276180	Scaffold_14	835249	835611	NA	NA	NA	NA	NA
PGEN_.00g276190	Scaffold_14	836198	836695	NA	NA	NA	NA	NA
PGEN_.00g276200	Scaffold_14	836756	837082	NA	NA	NA	NA	NA
PGEN_.00g276210	Scaffold_14	837506	840231	NA	NA	NA	NA	NA
PGEN_.00g276220	Scaffold_14	840297	842637	NA	NA	NA	NA	NA
PGEN_.00g276230	Scaffold_14	859274	859636	NA	NA	NA	NA	NA
PGEN_.00g276240	Scaffold_14	859894	860130	NA	NA	NA	NA	NA
PGEN_.00g276250	Scaffold_14	860471	861676	NA	NA	NA	NA	NA
PGEN_.00g276260	Scaffold_14	862484	862810	NA	NA	NA	NA	NA
PGEN_.00g276270	Scaffold_14	862871	863368	NA	NA	NA	NA	NA
PGEN_.00g276280	Scaffold_14	863955	864317	NA	NA	NA	NA	NA
PGEN_.00g276290	Scaffold_14	865156	865482	NA	NA	NA	NA	NA
PGEN_.00g276300	Scaffold_14	866091	866435	NA	NA	NA	NA	NA
PGEN_.00g276310	Scaffold_14	866492	867151	NA	NA	NA	NA	NA
PGEN_.00g276320	Scaffold_14	871652	872836	NA	NA	NA	NA	NA
PGEN_.00g276330	Scaffold_14	877724	878410	NA	NA	NA	NA	NA
PGEN_.00g276340	Scaffold_14	878565	879941	NA	NA	NA	NA	NA
PGEN_.00g276350	Scaffold_14	888488	891789	O75594	PGRP1_HUMAN	Peptidoglycan recognition protein 1 (Peptidoglycan recognition protein short) (PGRP-S)	GO:0005576; GO:0005615; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0016045; GO:0019730; GO:0031640; GO:0032689; GO:0032827; GO:0035580; GO:0042834; GO:0043312; GO:0044117; GO:0045087; GO:0050728; GO:0050830; GO:0051714; GO:0061844; GO:0070062; GO:0097013; GO:1904724	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; zinc ion binding [GO:0008270]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; growth of symbiont in host [GO:0044117]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; neutrophil degranulation [GO:0043312]; peptidoglycan catabolic process [GO:0009253]; positive regulation of cytolysis in other organism [GO:0051714]
PGEN_.00g276360	Scaffold_14	895090	912568	A1A547	PGRP3_MOUSE	Peptidoglycan recognition protein 3 (Peptidoglycan recognition protein I-alpha) (PGLYRPIalpha) (PGRP-I-alpha) (Peptidoglycan recognition protein intermediate alpha)	GO:0005615; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0016045; GO:0019730; GO:0031640; GO:0032689; GO:0032827; GO:0032991; GO:0042834; GO:0044117; GO:0045087; GO:0046982; GO:0050830; GO:0051714; GO:0061844	extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; protein heterodimerization activity [GO:0046982]; zinc ion binding [GO:0008270]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; growth of symbiont in host [GO:0044117]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253]; positive regulation of cytolysis in other organism [GO:0051714]
PGEN_.00g276370	Scaffold_14	922775	990475	Q3TLH4	PRC2C_MOUSE	Protein PRRC2C (BAT2 domain-containing protein 1) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C)	GO:0002244; GO:0005829; GO:0008022	cytosol [GO:0005829]; protein C-terminus binding [GO:0008022]; hematopoietic progenitor cell differentiation [GO:0002244]
PGEN_.00g276380	Scaffold_14	990774	999556	Q3TLH4	PRC2C_MOUSE	Protein PRRC2C (BAT2 domain-containing protein 1) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C)	GO:0002244; GO:0005829; GO:0008022	cytosol [GO:0005829]; protein C-terminus binding [GO:0008022]; hematopoietic progenitor cell differentiation [GO:0002244]
PGEN_.00g276390	Scaffold_14	1012681	1013521	NA	NA	NA	NA	NA
PGEN_.00g276400	Scaffold_14	1033893	1056968	P07207	NOTCH_DROME	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	GO:0001708; GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0005915; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007455; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035003; GO:0035153; GO:0035162; GO:0035165; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043525; GO:0043697; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048	"adherens junction [GO:0005912]; cell [GO:0005623]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
PGEN_.00g276410	Scaffold_14	1144902	1162045	NA	NA	NA	NA	NA
PGEN_.00g276420	Scaffold_14	1162205	1162513	NA	NA	NA	NA	NA
PGEN_.00g276430	Scaffold_14	1162552	1162890	NA	NA	NA	NA	NA
PGEN_.00g276440	Scaffold_14	1190825	1191181	NA	NA	NA	NA	NA
PGEN_.00g276450	Scaffold_14	1192347	1192757	NA	NA	NA	NA	NA
PGEN_.00g276460	Scaffold_14	1218172	1219078	NA	NA	NA	NA	NA
PGEN_.00g276470	Scaffold_14	1224048	1225908	NA	NA	NA	NA	NA
PGEN_.00g276480	Scaffold_14	1279549	1280163	NA	NA	NA	NA	NA
PGEN_.00g276490	Scaffold_14	1280243	1281013	NA	NA	NA	NA	NA
PGEN_.00g276500	Scaffold_14	1281542	1281970	NA	NA	NA	NA	NA
PGEN_.00g276510	Scaffold_14	1282106	1282501	NA	NA	NA	NA	NA
PGEN_.00g276520	Scaffold_14	1286779	1287057	NA	NA	NA	NA	NA
PGEN_.00g276530	Scaffold_14	1314847	1324887	NA	NA	NA	NA	NA
PGEN_.00g276540	Scaffold_14	1326807	1329050	Q6E2N3	TRI33_DANRE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]
PGEN_.00g276550	Scaffold_14	1351067	1534707	E1BPH3	TDRD5_BOVIN	Tudor domain-containing protein 5	GO:0007286; GO:0030719; GO:0033391; GO:0043046; GO:0071546	chromatoid body [GO:0033391]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; spermatid development [GO:0007286]
PGEN_.00g276560	Scaffold_14	1546749	1553206	NA	NA	NA	NA	NA
PGEN_.00g276570	Scaffold_14	1560047	1560292	NA	NA	NA	NA	NA
PGEN_.00g276580	Scaffold_14	1560417	1562631	NA	NA	NA	NA	NA
PGEN_.00g276590	Scaffold_14	1581303	1585166	Q6DKK2	TTC19_HUMAN	"Tetratricopeptide repeat protein 19, mitochondrial (TPR repeat protein 19)"	GO:0000281; GO:0005739; GO:0005743; GO:0005813; GO:0030496; GO:0034551; GO:0055114; GO:0070469	centrosome [GO:0005813]; midbody [GO:0030496]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitotic cytokinesis [GO:0000281]; oxidation-reduction process [GO:0055114]
PGEN_.00g276600	Scaffold_14	1600459	1601616	NA	NA	NA	NA	NA
PGEN_.00g276610	Scaffold_14	1603153	1608529	NA	NA	NA	NA	NA
PGEN_.00g276620	Scaffold_14	1620504	1656678	O43172	PRP4_HUMAN	U4/U6 small nuclear ribonucleoprotein Prp4 (PRP4 homolog) (hPrp4) (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)	GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0015030; GO:0016607; GO:0017070; GO:0030621; GO:0046540; GO:0071001; GO:0071005; GO:0097525	"Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"
PGEN_.00g276630	Scaffold_14	1770690	1771097	NA	NA	NA	NA	NA
PGEN_.00g276640	Scaffold_14	1771320	1771616	NA	NA	NA	NA	NA
PGEN_.00g276650	Scaffold_14	1789968	1790630	NA	NA	NA	NA	NA
PGEN_.00g276660	Scaffold_14	1790658	1790975	NA	NA	NA	NA	NA
PGEN_.00g276670	Scaffold_14	1791297	1791674	NA	NA	NA	NA	NA
PGEN_.00g276680	Scaffold_14	1791843	1792724	NA	NA	NA	NA	NA
PGEN_.00g276690	Scaffold_14	1819215	1824277	NA	NA	NA	NA	NA
PGEN_.00g276700	Scaffold_14	1830092	1830688	NA	NA	NA	NA	NA
PGEN_.00g276710	Scaffold_14	1839186	1840367	NA	NA	NA	NA	NA
PGEN_.00g276720	Scaffold_14	1909639	1910022	NA	NA	NA	NA	NA
PGEN_.00g276730	Scaffold_14	1910048	1910398	NA	NA	NA	NA	NA
PGEN_.00g276740	Scaffold_14	1918607	1918834	NA	NA	NA	NA	NA
PGEN_.00g276750	Scaffold_14	1931292	1932536	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g276760	Scaffold_14	1932533	1941091	NA	NA	NA	NA	NA
PGEN_.00g276770	Scaffold_14	1941303	1942643	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g276780	Scaffold_14	2005884	2009143	NA	NA	NA	NA	NA
PGEN_.00g276790	Scaffold_14	2009189	2009542	NA	NA	NA	NA	NA
PGEN_.00g276800	Scaffold_14	2009639	2009929	NA	NA	NA	NA	NA
PGEN_.00g276810	Scaffold_14	2010262	2011607	NA	NA	NA	NA	NA
PGEN_.00g276820	Scaffold_14	2011727	2013333	NA	NA	NA	NA	NA
PGEN_.00g276830	Scaffold_14	2013502	2013846	NA	NA	NA	NA	NA
PGEN_.00g276840	Scaffold_14	2013928	2014230	NA	NA	NA	NA	NA
PGEN_.00g276850	Scaffold_14	2014447	2016419	NA	NA	NA	NA	NA
PGEN_.00g276860	Scaffold_14	2016468	2026482	NA	NA	NA	NA	NA
PGEN_.00g276870	Scaffold_14	2037641	2038246	NA	NA	NA	NA	NA
PGEN_.00g276880	Scaffold_14	2045692	2046357	B5SNZ6	ABRA_PIG	Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling) (STARS)	GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030017; GO:0035025; GO:0045893; GO:0045944; GO:0051091	"actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]"
PGEN_.00g276890	Scaffold_14	2084044	2093400	NA	NA	NA	NA	NA
PGEN_.00g276900	Scaffold_14	2116929	2117516	NA	NA	NA	NA	NA
PGEN_.00g276910	Scaffold_14	2130524	2131132	NA	NA	NA	NA	NA
PGEN_.00g276920	Scaffold_14	2160008	2184043	Q01240	NF60_DORPE	60 kDa neurofilament protein (NF60)	GO:0005882	intermediate filament [GO:0005882]
PGEN_.00g276930	Scaffold_14	2186412	2201249	Q01241	NF70_DORPE	70 kDa neurofilament protein (NF70)	GO:0005882	intermediate filament [GO:0005882]
PGEN_.00g276940	Scaffold_14	2202607	2202900	NA	NA	NA	NA	NA
PGEN_.00g276950	Scaffold_14	2264114	2290699	Q8WPJ2	MANA_MYTED	"Mannan endo-1,4-beta-mannosidase (EC 3.2.1.78) (Beta-mannanase) (Endo-beta-1,4-mannanase) (Man5A) (ManA)"	GO:0016985; GO:0046355	"mannan endo-1,4-beta-mannosidase activity [GO:0016985]; mannan catabolic process [GO:0046355]"
PGEN_.00g276960	Scaffold_14	2333183	2361108	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g276970	Scaffold_14	2384852	2385322	NA	NA	NA	NA	NA
PGEN_.00g276980	Scaffold_14	2386447	2423151	P53611	PGTB2_HUMAN	Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta)	GO:0004663; GO:0005829; GO:0005886; GO:0005968; GO:0006464; GO:0007601; GO:0008270; GO:0017137; GO:0018342; GO:0018344; GO:0042981; GO:0043687	cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; post-translational protein modification [GO:0043687]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]; regulation of apoptotic process [GO:0042981]; visual perception [GO:0007601]
PGEN_.00g276990	Scaffold_14	2483013	2484948	O15375	MOT6_HUMAN	Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5)	GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g277000	Scaffold_14	2522358	2523134	NA	NA	NA	NA	NA
PGEN_.00g277010	Scaffold_14	2543007	2544912	NA	NA	NA	NA	NA
PGEN_.00g277020	Scaffold_14	2556613	2556846	NA	NA	NA	NA	NA
PGEN_.00g277030	Scaffold_14	2574535	2580475	P53776	LHX4_MOUSE	LIM/homeobox protein Lhx4 (LIM homeobox protein 4)	GO:0000977; GO:0000981; GO:0001890; GO:0005634; GO:0005654; GO:0008045; GO:0008327; GO:0009887; GO:0021526; GO:0030182; GO:0043066; GO:0043565; GO:0045944; GO:0046872	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g277040	Scaffold_14	2732795	2736463	NA	NA	NA	NA	NA
PGEN_.00g277050	Scaffold_14	2741454	2742021	NA	NA	NA	NA	NA
PGEN_.00g277060	Scaffold_14	2744568	2747002	NA	NA	NA	NA	NA
PGEN_.00g277070	Scaffold_14	2814395	2823833	NA	NA	NA	NA	NA
PGEN_.00g277080	Scaffold_14	2823886	2825112	NA	NA	NA	NA	NA
PGEN_.00g277090	Scaffold_14	2832638	2836480	Q864U8	B3GN5_PIG	"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase (EC 2.4.1.206) (Lactotriaosylceramide synthase) (Lc(3)Cer synthase) (Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5) (BGnT-5) (Beta-1,3-Gn-T5) (Beta-1,3-N-acetylglucosaminyltransferase 5) (Beta3Gn-T5)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006493; GO:0007417; GO:0007420; GO:0008375; GO:0008376; GO:0008378; GO:0008457; GO:0008532; GO:0016021; GO:0030311; GO:0047256	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; galactosyltransferase activity [GO:0008378]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; brain development [GO:0007420]; central nervous system development [GO:0007417]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g277100	Scaffold_14	2842592	2845387	NA	NA	NA	NA	NA
PGEN_.00g277110	Scaffold_14	2864094	2864492	NA	NA	NA	NA	NA
PGEN_.00g277120	Scaffold_14	2875563	2889499	Q5T8I3	F102B_HUMAN	Protein FAM102B		
PGEN_.00g277130	Scaffold_14	2891183	2892370	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g277140	Scaffold_14	2892404	2893138	A0A1B0GUU1	CQ113_HUMAN	Transmembrane protein C17orf113	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g277150	Scaffold_14	2900793	2907541	NA	NA	NA	NA	NA
PGEN_.00g277160	Scaffold_14	2927082	2927564	NA	NA	NA	NA	NA
PGEN_.00g277170	Scaffold_14	2928013	2928318	NA	NA	NA	NA	NA
PGEN_.00g277180	Scaffold_14	2954820	2975730	A0JPE1	DIK1B_XENTR	Divergent protein kinase domain 1B (Protein FAM69B)	GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
PGEN_.00g277190	Scaffold_14	2981602	2981925	NA	NA	NA	NA	NA
PGEN_.00g277200	Scaffold_14	2985044	2985349	NA	NA	NA	NA	NA
PGEN_.00g277210	Scaffold_14	2993637	3011741	Q9NPC3	CIP1_HUMAN	E3 ubiquitin-protein ligase CCNB1IP1 (EC 2.3.2.27) (Cyclin-B1-interacting protein 1) (Human enhancer of invasion 10) (RING-type E3 ubiquitin transferase CCNB1IP1)	GO:0000795; GO:0001825; GO:0007131; GO:0007286; GO:0046872; GO:0051026; GO:0061630	synaptonemal complex [GO:0000795]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]
PGEN_.00g277220	Scaffold_14	3019240	3035878	Q7T320	GORAB_DANRE	RAB6-interacting golgin (N-terminal kinase-like-binding protein 1) (NTKL-BP1) (NTKL-binding protein 1) (SCY1-like 1-binding protein 1) (SCYL1-BP1) (SCYL1-binding protein 1)	GO:0005794; GO:1905515	Golgi apparatus [GO:0005794]; non-motile cilium assembly [GO:1905515]
PGEN_.00g277230	Scaffold_14	3036573	3037070	NA	NA	NA	NA	NA
PGEN_.00g277240	Scaffold_14	3042902	3054461	Q6DGW9	TMCO1_DANRE	Calcium load-activated calcium channel (CLAC channel) (Transmembrane and coiled-coil domain-containing protein 1)	GO:0000139; GO:0005262; GO:0006983; GO:0030176; GO:0032469; GO:0070588	Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]
PGEN_.00g277250	Scaffold_14	3054840	3074763	Q17CQ8	ZGPAT_AEDAE	Zinc finger CCCH-type with G patch domain-containing protein	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g277260	Scaffold_14	3078995	3085867	NA	NA	NA	NA	NA
PGEN_.00g277270	Scaffold_14	3213829	3239542	Q6AY53	DHYS_RAT	Deoxyhypusine synthase (DHS) (EC 2.5.1.46)	GO:0005737; GO:0008216; GO:0008612; GO:0034038; GO:0042102; GO:0042593; GO:0042802; GO:0046203	cytoplasm [GO:0005737]; deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]; glucose homeostasis [GO:0042593]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of T cell proliferation [GO:0042102]; spermidine catabolic process [GO:0046203]; spermidine metabolic process [GO:0008216]
PGEN_.00g277280	Scaffold_14	3241495	3246989	NA	NA	NA	NA	NA
PGEN_.00g277290	Scaffold_14	3247320	3253088	Q8C4Y3	NELFB_MOUSE	Negative elongation factor B (NELF-B) (Cofactor of BRCA1)	GO:0003723; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; stem cell differentiation [GO:0048863]
PGEN_.00g277300	Scaffold_14	3296429	3298201	Q56A24	KLH24_RAT	Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1)	GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312	adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]
PGEN_.00g277310	Scaffold_14	3301997	3302269	NA	NA	NA	NA	NA
PGEN_.00g277320	Scaffold_14	3313918	3314670	NA	NA	NA	NA	NA
PGEN_.00g277330	Scaffold_14	3319585	3343014	NA	NA	NA	NA	NA
PGEN_.00g277340	Scaffold_14	3346511	3360204	NA	NA	NA	NA	NA
PGEN_.00g277350	Scaffold_14	3374323	3374763	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g277360	Scaffold_14	3377810	3378106	NA	NA	NA	NA	NA
PGEN_.00g277370	Scaffold_14	3384120	3384443	NA	NA	NA	NA	NA
PGEN_.00g277380	Scaffold_14	3386761	3387003	NA	NA	NA	NA	NA
PGEN_.00g277390	Scaffold_14	3387163	3388114	NA	NA	NA	NA	NA
PGEN_.00g277400	Scaffold_14	3391311	3397647	Q6PCJ9	PPT2A_XENLA	Lysosomal thioesterase PPT2-A (PPT-2-A) (EC 3.1.2.-)	GO:0005764; GO:0008474	lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474]
PGEN_.00g277410	Scaffold_14	3420592	3426252	O70489	PPT2_RAT	Lysosomal thioesterase PPT2 (PPT-2) (EC 3.1.2.-)	GO:0005764; GO:0008474; GO:0098599	lysosome [GO:0005764]; palmitoyl hydrolase activity [GO:0098599]; palmitoyl-(protein) hydrolase activity [GO:0008474]
PGEN_.00g277420	Scaffold_14	3438965	3442781	NA	NA	NA	NA	NA
PGEN_.00g277430	Scaffold_14	3442934	3496237	Q7Z7A1	CNTRL_HUMAN	Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110)	GO:0000086; GO:0005813; GO:0005815; GO:0005829; GO:0008092; GO:0010389; GO:0016020; GO:0051301; GO:0051493; GO:0090543; GO:0097711; GO:0120103	centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; cytoskeletal protein binding [GO:0008092]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cytoskeleton organization [GO:0051493]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]
PGEN_.00g277440	Scaffold_14	3556508	3556914	NA	NA	NA	NA	NA
PGEN_.00g277450	Scaffold_14	3560315	3583077	Q7Z7A1	CNTRL_HUMAN	Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110)	GO:0000086; GO:0005813; GO:0005815; GO:0005829; GO:0008092; GO:0010389; GO:0016020; GO:0051301; GO:0051493; GO:0090543; GO:0097711; GO:0120103	centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; cytoskeletal protein binding [GO:0008092]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cytoskeleton organization [GO:0051493]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]
PGEN_.00g277460	Scaffold_14	3593675	3595741	Q5HZL9	HDHD3_XENLA	Haloacid dehalogenase-like hydrolase domain-containing protein 3	GO:0016787	hydrolase activity [GO:0016787]
PGEN_.00g277470	Scaffold_14	3595876	3606285	NA	NA	NA	NA	NA
PGEN_.00g277480	Scaffold_14	3616380	3645141	NA	NA	NA	NA	NA
PGEN_.00g277490	Scaffold_14	3653130	3674687	Q5U3U0	PHYD1_DANRE	Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-)	GO:0046872; GO:0051213	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]
PGEN_.00g277500	Scaffold_14	3681289	3700992	Q9W0E8	ZER1_DROME	Protein zer-1 homolog (Zyg-11 homolog B-like protein)	GO:0031462	Cul2-RING ubiquitin ligase complex [GO:0031462]
PGEN_.00g277510	Scaffold_14	3709572	3720757	NA	NA	NA	NA	NA
PGEN_.00g277520	Scaffold_14	3720843	3728832	NA	NA	NA	NA	NA
PGEN_.00g277530	Scaffold_14	3731308	3733850	NA	NA	NA	NA	NA
PGEN_.00g277540	Scaffold_14	3733891	3738636	NA	NA	NA	NA	NA
PGEN_.00g277550	Scaffold_14	3747099	3749585	B0BML7	SPRE_XENTR	Sepiapterin reductase (SPR) (EC 1.1.1.153)	GO:0004757; GO:0005737; GO:0006729	cytoplasm [GO:0005737]; sepiapterin reductase activity [GO:0004757]; tetrahydrobiopterin biosynthetic process [GO:0006729]
PGEN_.00g277560	Scaffold_14	3749587	3769342	NA	NA	NA	NA	NA
PGEN_.00g277570	Scaffold_14	3781505	3816692	Q6PCJ9	PPT2A_XENLA	Lysosomal thioesterase PPT2-A (PPT-2-A) (EC 3.1.2.-)	GO:0005764; GO:0008474	lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474]
PGEN_.00g277580	Scaffold_14	3820133	3820693	NA	NA	NA	NA	NA
PGEN_.00g277590	Scaffold_14	3822549	3822833	NA	NA	NA	NA	NA
PGEN_.00g277600	Scaffold_14	3844423	3848779	NA	NA	NA	NA	NA
PGEN_.00g277610	Scaffold_14	3852190	3852837	NA	NA	NA	NA	NA
PGEN_.00g277620	Scaffold_14	3853780	3854574	NA	NA	NA	NA	NA
PGEN_.00g277630	Scaffold_14	3861728	3862381	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g277640	Scaffold_14	3868144	3897401	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g277650	Scaffold_14	3947118	3955870	NA	NA	NA	NA	NA
PGEN_.00g277660	Scaffold_14	3967976	3971647	NA	NA	NA	NA	NA
PGEN_.00g277670	Scaffold_14	3973672	3974183	Q8BR93	HARB1_MOUSE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g277680	Scaffold_14	3979552	3980615	NA	NA	NA	NA	NA
PGEN_.00g277690	Scaffold_14	3996083	3997927	NA	NA	NA	NA	NA
PGEN_.00g277700	Scaffold_14	4004597	4007359	NA	NA	NA	NA	NA
PGEN_.00g277710	Scaffold_14	4011337	4031970	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g277720	Scaffold_14	4042927	4079096	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g277730	Scaffold_14	4096178	4106508	NA	NA	NA	NA	NA
PGEN_.00g277740	Scaffold_14	4155846	4193217	Q9W332	CUBN_DROME	Cubilin homolog	GO:0005509; GO:0005886; GO:0015031; GO:0097017; GO:0097206	plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; nephrocyte filtration [GO:0097206]; protein transport [GO:0015031]; renal protein absorption [GO:0097017]
PGEN_.00g277750	Scaffold_14	4204034	4212415	Q7L0R7	RNF44_HUMAN	RING finger protein 44	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g277760	Scaffold_14	4221652	4244861	P48053	YPD1_CAEEL	Uncharacterized protein C05D11.1	GO:0004222; GO:0046872	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]
PGEN_.00g277770	Scaffold_14	4252103	4263194	P48053	YPD1_CAEEL	Uncharacterized protein C05D11.1	GO:0004222; GO:0046872	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]
PGEN_.00g277780	Scaffold_14	4270878	4272015	NA	NA	NA	NA	NA
PGEN_.00g277790	Scaffold_14	4274714	4275871	NA	NA	NA	NA	NA
PGEN_.00g277800	Scaffold_14	4281961	4307919	Q6PIJ6	FBX38_HUMAN	F-box only protein 38	GO:0002250; GO:0002842; GO:0005634; GO:0005737; GO:0005829; GO:0010976; GO:0019005; GO:0031146; GO:0070936	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g277810	Scaffold_14	4345312	4345581	Q6PIJ6	FBX38_HUMAN	F-box only protein 38	GO:0002250; GO:0002842; GO:0005634; GO:0005737; GO:0005829; GO:0010976; GO:0019005; GO:0031146; GO:0070936	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g277820	Scaffold_14	4345893	4347119	Q8BMI0	FBX38_MOUSE	F-box only protein 38 (Modulator of KLF7 activity) (MoKA)	GO:0002250; GO:0002842; GO:0005634; GO:0005737; GO:0005829; GO:0010976; GO:0031146; GO:0070936	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g277830	Scaffold_14	4355679	4356451	Q505H7	IWS1_XENTR	Protein IWS1 homolog (IWS1-like protein)	GO:0005634; GO:0006397; GO:0008380; GO:0010793; GO:0050684; GO:0051028; GO:2001253	nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]
PGEN_.00g277840	Scaffold_14	4362530	4395487	Q17938	DAF36_CAEEL	Cholesterol 7-desaturase (EC 1.14.19.21) (Cholesterol desaturase daf-36)	GO:0005737; GO:0008203; GO:0016021; GO:0016491; GO:0046872; GO:0051537	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]"
PGEN_.00g277850	Scaffold_14	4397861	4399983	NA	NA	NA	NA	NA
PGEN_.00g277860	Scaffold_14	4414404	4417976	O73917	PAX6_ORYLA	Paired box protein Pax-6	GO:0005634; GO:0006355; GO:0007275; GO:0043565	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g277870	Scaffold_14	4433922	4435369	NA	NA	NA	NA	NA
PGEN_.00g277880	Scaffold_14	4435526	4436062	NA	NA	NA	NA	NA
PGEN_.00g277890	Scaffold_14	4440546	4441043	NA	NA	NA	NA	NA
PGEN_.00g277900	Scaffold_14	4443761	4444225	NA	NA	NA	NA	NA
PGEN_.00g277910	Scaffold_14	4509691	4540589	Q61165	SL9A1_MOUSE	Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)	GO:0002026; GO:0005516; GO:0005623; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006814; GO:0006883; GO:0006885; GO:0009986; GO:0010447; GO:0010613; GO:0010882; GO:0014070; GO:0014704; GO:0015385; GO:0015386; GO:0016020; GO:0016323; GO:0016324; GO:0030307; GO:0030315; GO:0030346; GO:0032869; GO:0035794; GO:0035994; GO:0036376; GO:0042383; GO:0043065; GO:0043066; GO:0045121; GO:0045760; GO:0045944; GO:0048306; GO:0048471; GO:0051259; GO:0051453; GO:0051930; GO:0055007; GO:0070417; GO:0070886; GO:0070997; GO:0071236; GO:0071257; GO:0071456; GO:0071468; GO:0071805; GO:0071872; GO:0086003; GO:0086092; GO:0090533; GO:0098719; GO:0098735; GO:1902533; GO:1902600; GO:1903281	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular sodium ion homeostasis [GO:0006883]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; response to organic cyclic compound [GO:0014070]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]
PGEN_.00g277920	Scaffold_14	4549229	4556920	NA	NA	NA	NA	NA
PGEN_.00g277930	Scaffold_14	4565552	4578781	Q86UP6	CUZD1_HUMAN	CUB and zona pellucida-like domain-containing protein 1 (CUB and ZP domain-containing protein 1) (Transmembrane protein UO-44)	GO:0006931; GO:0007049; GO:0008283; GO:0016021; GO:0030658; GO:0032023; GO:0042589; GO:0051301	"integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; trypsinogen activation [GO:0032023]"
PGEN_.00g277940	Scaffold_14	4618432	4626192	Q4A3R3	DMBT1_PIG	Deleted in malignant brain tumors 1 protein (Hensin)	GO:0005044; GO:0007275; GO:0009897; GO:0015031; GO:0016021; GO:0019898; GO:0030154; GO:0030658; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830	external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]
PGEN_.00g277950	Scaffold_14	4645269	4666651	Q4A3R3	DMBT1_PIG	Deleted in malignant brain tumors 1 protein (Hensin)	GO:0005044; GO:0007275; GO:0009897; GO:0015031; GO:0016021; GO:0019898; GO:0030154; GO:0030658; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830	external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]
PGEN_.00g277960	Scaffold_14	4671672	4711860	O14522	PTPRT_HUMAN	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g277970	Scaffold_14	4716663	4716902	NA	NA	NA	NA	NA
PGEN_.00g277980	Scaffold_14	4718046	4768628	Q5T1B0	AXDN1_HUMAN	Axonemal dynein light chain domain-containing protein 1		
PGEN_.00g277990	Scaffold_14	4769366	4771787	NA	NA	NA	NA	NA
PGEN_.00g278000	Scaffold_14	4789306	4800608	NA	NA	NA	NA	NA
PGEN_.00g278010	Scaffold_14	4832942	4847582	NA	NA	NA	NA	NA
PGEN_.00g278020	Scaffold_14	4857521	4858024	NA	NA	NA	NA	NA
PGEN_.00g278030	Scaffold_14	4859181	4859582	NA	NA	NA	NA	NA
PGEN_.00g278040	Scaffold_14	4859676	4860011	NA	NA	NA	NA	NA
PGEN_.00g278050	Scaffold_14	4871701	4942357	NA	NA	NA	NA	NA
PGEN_.00g278060	Scaffold_14	5002298	5006666	Q8BN82	S17A5_MOUSE	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0006865; GO:0009617; GO:0015136; GO:0015293; GO:0015739; GO:0016021; GO:0030054; GO:0030672; GO:0031410	cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]
PGEN_.00g278070	Scaffold_14	5032928	5033212	NA	NA	NA	NA	NA
PGEN_.00g278080	Scaffold_14	5033260	5033493	NA	NA	NA	NA	NA
PGEN_.00g278090	Scaffold_14	5056781	5057368	NA	NA	NA	NA	NA
PGEN_.00g278100	Scaffold_14	5084048	5088447	NA	NA	NA	NA	NA
PGEN_.00g278110	Scaffold_14	5088828	5090419	NA	NA	NA	NA	NA
PGEN_.00g278120	Scaffold_14	5091904	5130859	NA	NA	NA	NA	NA
PGEN_.00g278130	Scaffold_14	5166599	5167615	NA	NA	NA	NA	NA
PGEN_.00g278140	Scaffold_14	5298479	5344343	NA	NA	NA	NA	NA
PGEN_.00g278150	Scaffold_14	5359485	5359724	NA	NA	NA	NA	NA
PGEN_.00g278160	Scaffold_14	5367495	5396206	NA	NA	NA	NA	NA
PGEN_.00g278170	Scaffold_14	5421139	5425120	Q14191	WRN_HUMAN	"Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2)"	GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0001302; GO:0003677; GO:0003678; GO:0003682; GO:0004386; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006284; GO:0006302; GO:0006310; GO:0006974; GO:0006979; GO:0007420; GO:0007568; GO:0007569; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0010259; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0042981; GO:0043005; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090656; GO:0098530; GO:1901796; GO:1902570; GO:1905773	"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replicative cell aging [GO:0001302]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"
PGEN_.00g278180	Scaffold_14	5427424	5432461	NA	NA	NA	NA	NA
PGEN_.00g278190	Scaffold_14	5438618	5438908	NA	NA	NA	NA	NA
PGEN_.00g278200	Scaffold_14	5445395	5447064	NA	NA	NA	NA	NA
PGEN_.00g278210	Scaffold_14	5451132	5451434	NA	NA	NA	NA	NA
PGEN_.00g278220	Scaffold_14	5454541	5455008	NA	NA	NA	NA	NA
PGEN_.00g278230	Scaffold_14	5469210	5475133	NA	NA	NA	NA	NA
PGEN_.00g278240	Scaffold_14	5475941	5476727	Q8BR93	HARB1_MOUSE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g278250	Scaffold_14	5477690	5486695	Q5U538	HARB1_XENLA	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g278260	Scaffold_14	5489320	5489745	NA	NA	NA	NA	NA
PGEN_.00g278270	Scaffold_14	5489949	5490863	NA	NA	NA	NA	NA
PGEN_.00g278280	Scaffold_14	5494300	5494554	NA	NA	NA	NA	NA
PGEN_.00g278290	Scaffold_14	5498691	5503233	NA	NA	NA	NA	NA
PGEN_.00g278300	Scaffold_14	5508877	5509383	NA	NA	NA	NA	NA
PGEN_.00g278310	Scaffold_14	5515276	5517946	NA	NA	NA	NA	NA
PGEN_.00g278320	Scaffold_14	5554616	5554891	NA	NA	NA	NA	NA
PGEN_.00g278330	Scaffold_14	5556974	5557207	NA	NA	NA	NA	NA
PGEN_.00g278340	Scaffold_14	5558543	5560246	NA	NA	NA	NA	NA
PGEN_.00g278350	Scaffold_14	5560475	5560792	NA	NA	NA	NA	NA
PGEN_.00g278360	Scaffold_14	5560991	5562011	NA	NA	NA	NA	NA
PGEN_.00g278370	Scaffold_14	5562066	5562997	NA	NA	NA	NA	NA
PGEN_.00g278380	Scaffold_14	5571775	5573485	NA	NA	NA	NA	NA
PGEN_.00g278390	Scaffold_14	5573974	5575082	NA	NA	NA	NA	NA
PGEN_.00g278400	Scaffold_14	5575343	5575771	NA	NA	NA	NA	NA
PGEN_.00g278410	Scaffold_14	5583433	5584586	NA	NA	NA	NA	NA
PGEN_.00g278420	Scaffold_14	5584693	5585247	NA	NA	NA	NA	NA
PGEN_.00g278430	Scaffold_14	5587776	5589550	NA	NA	NA	NA	NA
PGEN_.00g278440	Scaffold_14	5591373	5594500	NA	NA	NA	NA	NA
PGEN_.00g278450	Scaffold_14	5594721	5598899	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g278460	Scaffold_14	5623453	5633899	NA	NA	NA	NA	NA
PGEN_.00g278470	Scaffold_14	5647053	5684923	NA	NA	NA	NA	NA
PGEN_.00g278480	Scaffold_14	5715417	5720476	NA	NA	NA	NA	NA
PGEN_.00g278490	Scaffold_14	5722308	5722625	NA	NA	NA	NA	NA
PGEN_.00g278500	Scaffold_14	5796557	5798475	NA	NA	NA	NA	NA
PGEN_.00g278510	Scaffold_14	5821426	5826038	NA	NA	NA	NA	NA
PGEN_.00g278520	Scaffold_14	5828908	5829672	NA	NA	NA	NA	NA
PGEN_.00g278530	Scaffold_14	5842246	5843029	NA	NA	NA	NA	NA
PGEN_.00g278540	Scaffold_14	5845363	5846034	Q8N6D5	ANR29_HUMAN	Ankyrin repeat domain-containing protein 29		
PGEN_.00g278550	Scaffold_14	5893956	5896239	NA	NA	NA	NA	NA
PGEN_.00g278560	Scaffold_14	5910946	5911176	NA	NA	NA	NA	NA
PGEN_.00g278570	Scaffold_14	5932092	5932790	NA	NA	NA	NA	NA
PGEN_.00g278580	Scaffold_14	5933294	5952425	NA	NA	NA	NA	NA
PGEN_.00g278590	Scaffold_14	5958040	5968231	NA	NA	NA	NA	NA
PGEN_.00g278600	Scaffold_14	5982236	5985690	NA	NA	NA	NA	NA
PGEN_.00g278610	Scaffold_14	5995328	5995579	NA	NA	NA	NA	NA
PGEN_.00g278620	Scaffold_14	6014261	6046448	Q8K389	CK5P2_MOUSE	CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48)	GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0001578; GO:0005516; GO:0005623; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0008274; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0044212; GO:0044877; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0090266; GO:0097431	"cell [GO:0005623]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]"
PGEN_.00g278630	Scaffold_14	6014706	6014921	NA	NA	NA	NA	NA
PGEN_.00g278640	Scaffold_14	6058625	6083615	NA	NA	NA	NA	NA
PGEN_.00g278650	Scaffold_14	6089147	6097802	NA	NA	NA	NA	NA
PGEN_.00g278660	Scaffold_14	6101638	6106211	NA	NA	NA	NA	NA
PGEN_.00g278670	Scaffold_14	6112671	6227459	P18293	ANPRA_MOUSE	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043235; GO:0048662	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g278680	Scaffold_14	6239142	6259287	Q0VD19	ASM_BOVIN	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)	GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0043407; GO:0045121; GO:0046513; GO:0061750	"endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of protein dephosphorylation [GO:0035307]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]"
PGEN_.00g278690	Scaffold_14	6285328	6299288	NA	NA	NA	NA	NA
PGEN_.00g278700	Scaffold_14	6307537	6310962	NA	NA	NA	NA	NA
PGEN_.00g278710	Scaffold_14	6314928	6316320	NA	NA	NA	NA	NA
PGEN_.00g278720	Scaffold_14	6324325	6329056	NA	NA	NA	NA	NA
PGEN_.00g278730	Scaffold_14	6329892	6332179	NA	NA	NA	NA	NA
PGEN_.00g278740	Scaffold_14	6337891	6339900	NA	NA	NA	NA	NA
PGEN_.00g278750	Scaffold_14	6340697	6354578	Q9CYL5	GAPR1_MOUSE	Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)	GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070374	extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]
PGEN_.00g278760	Scaffold_14	6368234	6405862	NA	NA	NA	NA	NA
PGEN_.00g278770	Scaffold_14	6400798	6403091	NA	NA	NA	NA	NA
PGEN_.00g278780	Scaffold_14	6431096	6431455	NA	NA	NA	NA	NA
PGEN_.00g278790	Scaffold_14	6484217	6484582	NA	NA	NA	NA	NA
PGEN_.00g278800	Scaffold_14	6484639	6486204	P12027	PSGP_ONCMY	Polysialoglycoprotein (PSGP) (Apopolysialoglycoprotein) (apoPSGP)		
PGEN_.00g278810	Scaffold_14	6520495	6521501	Q9DAK9	PHP14_MOUSE	14 kDa phosphohistidine phosphatase (EC 3.9.1.3) (Phosphohistidine phosphatase 1) (PHPT1) (Protein histidine phosphatase) (PHP)	GO:0005829; GO:0006470; GO:0019855; GO:0035774; GO:0035971; GO:0044325; GO:0050860; GO:0051350; GO:0101006; GO:2000147; GO:2000249; GO:2000984	cytosol [GO:0005829]; calcium channel inhibitor activity [GO:0019855]; ion channel binding [GO:0044325]; protein histidine phosphatase activity [GO:0101006]; negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; protein dephosphorylation [GO:0006470]; regulation of actin cytoskeleton reorganization [GO:2000249]
PGEN_.00g278820	Scaffold_14	6530037	6533107	NA	NA	NA	NA	NA
PGEN_.00g278830	Scaffold_14	6538855	6539493	NA	NA	NA	NA	NA
PGEN_.00g278840	Scaffold_14	6540467	6541139	NA	NA	NA	NA	NA
PGEN_.00g278850	Scaffold_14	6541206	6561356	NA	NA	NA	NA	NA
PGEN_.00g278860	Scaffold_14	6564296	6566832	NA	NA	NA	NA	NA
PGEN_.00g278870	Scaffold_14	6568616	6569699	NA	NA	NA	NA	NA
PGEN_.00g278880	Scaffold_14	6572598	6578439	Q19673	TYR3_CAEEL	Putative tyrosinase-like protein tyr-3	GO:0005507; GO:0016716; GO:0042438	"copper ion binding [GO:0005507]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438]"
PGEN_.00g278890	Scaffold_14	6602965	6613745	O94760	DDAH1_HUMAN	"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)"	GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006525; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]
PGEN_.00g278900	Scaffold_14	6634727	6644105	NA	NA	NA	NA	NA
PGEN_.00g278910	Scaffold_14	6644167	6659814	NA	NA	NA	NA	NA
PGEN_.00g278920	Scaffold_14	6697287	6697874	NA	NA	NA	NA	NA
PGEN_.00g278930	Scaffold_14	6698353	6699120	NA	NA	NA	NA	NA
PGEN_.00g278940	Scaffold_14	6699431	6699826	NA	NA	NA	NA	NA
PGEN_.00g278950	Scaffold_14	6699875	6700720	NA	NA	NA	NA	NA
PGEN_.00g278960	Scaffold_14	6718669	6730197	NA	NA	NA	NA	NA
PGEN_.00g278970	Scaffold_14	6730396	6730626	NA	NA	NA	NA	NA
PGEN_.00g278980	Scaffold_14	6730653	6731078	NA	NA	NA	NA	NA
PGEN_.00g278990	Scaffold_14	6737124	6737408	NA	NA	NA	NA	NA
PGEN_.00g279000	Scaffold_14	6737436	6737672	NA	NA	NA	NA	NA
PGEN_.00g279010	Scaffold_14	6737706	6737960	NA	NA	NA	NA	NA
PGEN_.00g279020	Scaffold_14	6738042	6738512	NA	NA	NA	NA	NA
PGEN_.00g279030	Scaffold_14	6738546	6738872	NA	NA	NA	NA	NA
PGEN_.00g279040	Scaffold_14	6739578	6757631	Q03167	TGBR3_HUMAN	Transforming growth factor beta receptor type 3 (TGF-beta receptor type 3) (TGFR-3) (Betaglycan) (Transforming growth factor beta receptor III) (TGF-beta receptor type III)	GO:0001666; GO:0001837; GO:0001889; GO:0003007; GO:0003150; GO:0003151; GO:0003223; GO:0005024; GO:0005114; GO:0005160; GO:0005539; GO:0005615; GO:0005737; GO:0005887; GO:0006955; GO:0007179; GO:0007181; GO:0008201; GO:0009897; GO:0009986; GO:0015026; GO:0016477; GO:0017134; GO:0030165; GO:0030509; GO:0030511; GO:0030512; GO:0031012; GO:0031100; GO:0032354; GO:0034673; GO:0034695; GO:0034699; GO:0035556; GO:0043235; GO:0043393; GO:0046332; GO:0048185; GO:0050431; GO:0050680; GO:0051271; GO:0055010; GO:0060038; GO:0060045; GO:0060216; GO:0060317; GO:0060318; GO:0060347; GO:0060389; GO:0060412; GO:0060939; GO:0060979; GO:0061384; GO:0062009; GO:0070062; GO:0070123	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; PDZ domain binding [GO:0030165]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell migration [GO:0016477]; definitive erythrocyte differentiation [GO:0060318]; definitive hemopoiesis [GO:0060216]; epicardium-derived cardiac fibroblast cell development [GO:0060939]; epithelial to mesenchymal transition [GO:0001837]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; heart trabecula morphogenesis [GO:0061384]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; muscular septum morphogenesis [GO:0003150]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract morphogenesis [GO:0003151]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of protein binding [GO:0043393]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; secondary palate development [GO:0062009]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]"
PGEN_.00g279050	Scaffold_14	6777783	6815790	O00311	CDC7_HUMAN	Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1)	GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0070317; GO:0072686	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication [GO:0006260]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G0 to G1 transition [GO:0070317]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]
PGEN_.00g279060	Scaffold_14	6819453	6828330	Q09621	LACT2_CAEEL	Beta-lactamase domain-containing protein 2	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g279070	Scaffold_14	6848746	6856372	Q09621	LACT2_CAEEL	Beta-lactamase domain-containing protein 2	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g279080	Scaffold_14	6884640	6899126	Q09621	LACT2_CAEEL	Beta-lactamase domain-containing protein 2	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g279090	Scaffold_14	6901833	6907568	NA	NA	NA	NA	NA
PGEN_.00g279100	Scaffold_14	6909960	6915433	NA	NA	NA	NA	NA
PGEN_.00g279110	Scaffold_14	6916083	6916702	NA	NA	NA	NA	NA
PGEN_.00g279120	Scaffold_14	6920836	6932049	NA	NA	NA	NA	NA
PGEN_.00g279130	Scaffold_14	6934446	6934802	NA	NA	NA	NA	NA
PGEN_.00g279140	Scaffold_14	6934908	6946622	P50164	TRN2_HYONI	Tropinone reductase 2 (EC 1.1.1.236) (Tropinone reductase II) (TR-II)	GO:0009710; GO:0050358	tropinone reductase activity [GO:0050358]; tropane alkaloid biosynthetic process [GO:0009710]
PGEN_.00g279150	Scaffold_14	6951103	6982495	Q11D10	ASSY_CHESB	Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)	GO:0004055; GO:0005524; GO:0005737; GO:0006526	cytoplasm [GO:0005737]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]
PGEN_.00g279160	Scaffold_14	6990106	7004015	NA	NA	NA	NA	NA
PGEN_.00g279170	Scaffold_14	7069889	7072055	NA	NA	NA	NA	NA
PGEN_.00g279180	Scaffold_14	7084815	7092120	NA	NA	NA	NA	NA
PGEN_.00g279190	Scaffold_14	7093605	7095710	NA	NA	NA	NA	NA
PGEN_.00g279200	Scaffold_14	7110092	7112151	NA	NA	NA	NA	NA
PGEN_.00g279210	Scaffold_14	7128547	7151630	P81274	GPSM2_HUMAN	G-protein-signaling modulator 2 (Mosaic protein LGN)	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005623; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell [GO:0005623]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]
PGEN_.00g279220	Scaffold_14	7258900	7259643	NA	NA	NA	NA	NA
PGEN_.00g279230	Scaffold_14	7264677	7265012	NA	NA	NA	NA	NA
PGEN_.00g279240	Scaffold_14	7265039	7268065	NA	NA	NA	NA	NA
PGEN_.00g279250	Scaffold_14	7280182	7280496	NA	NA	NA	NA	NA
PGEN_.00g279260	Scaffold_14	7285038	7286668	NA	NA	NA	NA	NA
PGEN_.00g279270	Scaffold_14	7293719	7295341	NA	NA	NA	NA	NA
PGEN_.00g279280	Scaffold_14	7295393	7296914	NA	NA	NA	NA	NA
PGEN_.00g279290	Scaffold_14	7313470	7346586	Q99PK0	SYF1_RAT	Pre-mRNA-splicing factor SYF1 (Adapter protein ATH-55) (XPA-binding protein 2)	GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0021987; GO:0071007; GO:0071013; GO:0071014	"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"
PGEN_.00g279300	Scaffold_14	7369644	7385711	A0A1P8AWH8	XYN1_ARATH	"Endo-1,4-beta-xylanase 1 (AtXyn1) (Xylan endohydrolase 1) (Xylanase 1) (EC 3.2.1.8)"	GO:0005576; GO:0005618; GO:0031176; GO:0045493	"cell wall [GO:0005618]; extracellular region [GO:0005576]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g279310	Scaffold_14	7395116	7398407	NA	NA	NA	NA	NA
PGEN_.00g279320	Scaffold_14	7400801	7402902	NA	NA	NA	NA	NA
PGEN_.00g279330	Scaffold_14	7405535	7406611	NA	NA	NA	NA	NA
PGEN_.00g279340	Scaffold_14	7407129	7411589	P31722	C1QC_RAT	Complement C1q subcomponent subunit C	GO:0005576; GO:0005581; GO:0005623; GO:0006958; GO:0030853; GO:0045087; GO:0045202; GO:0045650; GO:0098794; GO:0098883	"cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; postsynapse [GO:0098794]; synapse [GO:0045202]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of macrophage differentiation [GO:0045650]; synapse pruning [GO:0098883]"
PGEN_.00g279350	Scaffold_14	7476951	7487592	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g279360	Scaffold_14	7498957	7501744	NA	NA	NA	NA	NA
PGEN_.00g279370	Scaffold_14	7565527	7567536	Q5R482	LRRN3_PONAB	Leucine-rich repeat neuronal protein 3 (Neuronal leucine-rich repeat protein 3) (NLRR-3)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g279380	Scaffold_14	7594976	7595637	NA	NA	NA	NA	NA
PGEN_.00g279390	Scaffold_14	7608851	7647621	NA	NA	NA	NA	NA
PGEN_.00g279400	Scaffold_14	7659785	7660252	NA	NA	NA	NA	NA
PGEN_.00g279410	Scaffold_14	7676447	7676914	NA	NA	NA	NA	NA
PGEN_.00g279420	Scaffold_14	7676958	7678121	NA	NA	NA	NA	NA
PGEN_.00g279430	Scaffold_14	7687420	7753254	A8Q2D1	NAS35_BRUMA	Zinc metalloproteinase dpy-31 (EC 3.4.24.-) (Nematode astacin 35) (Procollagen C-proteinase)	GO:0004222; GO:0005576; GO:0008270; GO:0042338	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]
PGEN_.00g279440	Scaffold_14	7774211	7836452	Q5ZJK0	RGPS1_CHICK	Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (RalA exchange factor RalGPS1)	GO:0005085; GO:0005737; GO:0005886; GO:0007264; GO:0032485	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of Ral protein signal transduction [GO:0032485]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g279450	Scaffold_14	7848991	7849770	NA	NA	NA	NA	NA
PGEN_.00g279460	Scaffold_14	7850002	7862389	NA	NA	NA	NA	NA
PGEN_.00g279470	Scaffold_14	7905672	7920588	Q5EAR5	TRPT1_DANRE	tRNA 2'-phosphotransferase 1 (EC 2.7.1.160)	GO:0000215; GO:0006388	"tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
PGEN_.00g279480	Scaffold_14	7950895	7957725	NA	NA	NA	NA	NA
PGEN_.00g279490	Scaffold_14	7958021	8006440	P42231	STA5A_SHEEP	Signal transducer and activator of transcription 5A (Mammary gland factor)	GO:0001553; GO:0001779; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019915; GO:0030155; GO:0030856; GO:0030879; GO:0040018; GO:0042104; GO:0043029; GO:0043066; GO:0045086; GO:0045579; GO:0045647; GO:0045931; GO:0045944; GO:0046543; GO:0050729; GO:0060397	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland development [GO:0030879]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; T cell homeostasis [GO:0043029]
PGEN_.00g279500	Scaffold_14	8033649	8089950	Q08DF4	DYN1_BOVIN	Dynamin-1 (EC 3.6.5.5)	GO:0000266; GO:0001917; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005874; GO:0005886; GO:0007032; GO:0008017; GO:0008022; GO:0014069; GO:0016020; GO:0016185; GO:0019901; GO:0030117; GO:0030424; GO:0031410; GO:0031623; GO:0042584; GO:0042802; GO:0043197; GO:0044327; GO:0045202; GO:0045211; GO:0045920; GO:0050803; GO:0050804; GO:0098684; GO:0098835; GO:0098844; GO:0098884; GO:0098978; GO:1901998	axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; endosome organization [GO:0007032]; mitochondrial fission [GO:0000266]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of exocytosis [GO:0045920]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; regulation of synapse structure or activity [GO:0050803]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998]
PGEN_.00g279510	Scaffold_14	8100537	8122813	Q19821	RHOM1_CAEEL	Rhomboid-related protein 1 (EC 3.4.21.105)	GO:0004252; GO:0016021; GO:0040026	integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; positive regulation of vulval development [GO:0040026]
PGEN_.00g279520	Scaffold_14	8134817	8137495	Q9C040	TRIM2_HUMAN	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g279530	Scaffold_14	8139701	8141881	Q9CWR2	SMYD3_MOUSE	Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1)	GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g279540	Scaffold_14	8220121	8222773	NA	NA	NA	NA	NA
PGEN_.00g279550	Scaffold_14	8224760	8225892	NA	NA	NA	NA	NA
PGEN_.00g279560	Scaffold_14	8236487	8245062	NA	NA	NA	NA	NA
PGEN_.00g279570	Scaffold_14	8255680	8262893	NA	NA	NA	NA	NA
PGEN_.00g279580	Scaffold_14	8272794	8273039	NA	NA	NA	NA	NA
PGEN_.00g279590	Scaffold_14	8273432	8283421	Q8SPI0	APOD_MACFA	Apolipoprotein D (Apo-D) (ApoD)	GO:0000302; GO:0005615; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405	cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]
PGEN_.00g279600	Scaffold_14	8289403	8295058	Q80XH4	WSCD1_MOUSE	WSC domain-containing protein 1	GO:0008146; GO:0016021	integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]
PGEN_.00g279610	Scaffold_14	8296193	8301663	NA	NA	NA	NA	NA
PGEN_.00g279620	Scaffold_14	8320149	8346464	O01812	FABP6_CAEEL	Fatty acid-binding protein homolog 6	GO:0008289	lipid binding [GO:0008289]
PGEN_.00g279630	Scaffold_14	8384362	8384625	NA	NA	NA	NA	NA
PGEN_.00g279640	Scaffold_14	8385978	8386265	NA	NA	NA	NA	NA
PGEN_.00g279650	Scaffold_14	8411900	8446281	E9PT37	RBM20_RAT	RNA-binding protein 20 (RNA-binding motif protein 20)	GO:0003723; GO:0005634; GO:0006397; GO:0007507; GO:0008270; GO:0008380; GO:0033120	nucleus [GO:0005634]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; heart development [GO:0007507]; mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; RNA splicing [GO:0008380]
PGEN_.00g279660	Scaffold_14	8446499	8471005	Q9D818	SAPC2_MOUSE	Suppressor APC domain-containing protein 2 (Protein Ang)	GO:0000132; GO:0005623; GO:0005654; GO:0005730; GO:0005829; GO:0005923; GO:0008284; GO:0016324; GO:0043296; GO:0045179; GO:0090175; GO:0098725; GO:1904777	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell [GO:0005623]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725]
PGEN_.00g279670	Scaffold_14	8486159	8487261	NA	NA	NA	NA	NA
PGEN_.00g279680	Scaffold_14	8488752	8501063	Q63413	DX39B_RAT	Spliceosome RNA helicase Ddx39b (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein Uap56)	GO:0000245; GO:0000346; GO:0000398; GO:0001889; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006406; GO:0008186; GO:0008380; GO:0010501; GO:0016363; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0032786; GO:0032991; GO:0042802; GO:0043008; GO:0044877; GO:0045727; GO:0046784; GO:0061051; GO:1904707; GO:2000002; GO:2000573	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"
PGEN_.00g279690	Scaffold_14	8510607	8527693	NA	NA	NA	NA	NA
PGEN_.00g279700	Scaffold_14	8538514	8538879	NA	NA	NA	NA	NA
PGEN_.00g279710	Scaffold_14	8544876	8566105	NA	NA	NA	NA	NA
PGEN_.00g279720	Scaffold_14	8574252	8589239	O97764	QOR_BOVIN	Zeta-crystallin	GO:0003677; GO:0003730; GO:0003960; GO:0005829; GO:0008270; GO:0042178; GO:0050661; GO:0051289; GO:0070402	cytosol [GO:0005829]; DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270]; protein homotetramerization [GO:0051289]; xenobiotic catabolic process [GO:0042178]
PGEN_.00g279730	Scaffold_14	8594867	8627802	Q5R6S0	ABHGA_PONAB	Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5 homolog) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23)	GO:0004620; GO:0006660; GO:0016021; GO:0047372; GO:0052651; GO:1905344	integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344]
PGEN_.00g279740	Scaffold_14	8644745	8688181	Q5TZ24	MOXD1_DANRE	DBH-like monooxygenase protein 1 homolog (EC 1.14.17.-)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g279750	Scaffold_14	8753411	8775138	NA	NA	NA	NA	NA
PGEN_.00g279760	Scaffold_14	8852832	8853149	NA	NA	NA	NA	NA
PGEN_.00g279770	Scaffold_14	8868311	8886624	Q9MYP6	DHB14_BOVIN	17-beta-hydroxysteroid dehydrogenase 14 (17-beta-HSD 14) (EC 1.1.1.-) (17-beta-hydroxysteroid dehydrogenase DHRS10) (Dehydrogenase/reductase SDR family member 10) (Retinal short-chain dehydrogenase/reductase retSDR3)	GO:0004303; GO:0005829; GO:0006706; GO:0042802; GO:0047045	cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706]
PGEN_.00g279780	Scaffold_14	8887125	8889057	NA	NA	NA	NA	NA
PGEN_.00g279790	Scaffold_14	8892477	8894207	Q6DE37	GXLT2_XENLA	Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4)	GO:0016021; GO:0016266; GO:0035252	integral component of membrane [GO:0016021]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]
PGEN_.00g279800	Scaffold_14	8899531	8899857	NA	NA	NA	NA	NA
PGEN_.00g279810	Scaffold_14	8914744	8914992	NA	NA	NA	NA	NA
PGEN_.00g279820	Scaffold_14	8923560	8943873	Q5I0C4	ABHEA_RAT	Protein ABHD14A (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14A) (Abhydrolase domain-containing protein 14A)	GO:0005737; GO:0016021; GO:0016787	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]
PGEN_.00g279830	Scaffold_14	8972198	8976136	NA	NA	NA	NA	NA
PGEN_.00g279840	Scaffold_14	8982220	8982519	NA	NA	NA	NA	NA
PGEN_.00g279850	Scaffold_14	9008214	9029440	Q04462	SYVC_RAT	Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS)	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006438	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]
PGEN_.00g279860	Scaffold_14	9030128	9048855	O70422	TF2H4_MOUSE	General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit)	GO:0000438; GO:0000439; GO:0001671; GO:0003690; GO:0005634; GO:0005669; GO:0005675; GO:0006289; GO:0006366; GO:0008094; GO:0008353; GO:0016251; GO:0016607; GO:0070816	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; ATPase activator activity [GO:0001671]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g279870	Scaffold_14	9058523	9112116	P00522	ABL_DROME	Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)	GO:0001764; GO:0003382; GO:0003401; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005911; GO:0005912; GO:0005927; GO:0005938; GO:0007268; GO:0007303; GO:0007370; GO:0007391; GO:0007409; GO:0007411; GO:0007417; GO:0007419; GO:0007611; GO:0008045; GO:0008064; GO:0008360; GO:0010592; GO:0010977; GO:0016199; GO:0018108; GO:0019897; GO:0021785; GO:0030424; GO:0031647; GO:0032880; GO:0045179; GO:0045202; GO:0045886; GO:0046777; GO:0046827; GO:0048749; GO:0048813; GO:0072499	"adherens junction [GO:0005912]; apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; synapse [GO:0045202]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370]"
PGEN_.00g279880	Scaffold_14	9087511	9091994	NA	NA	NA	NA	NA
PGEN_.00g279890	Scaffold_14	9131058	9131998	NA	NA	NA	NA	NA
PGEN_.00g279900	Scaffold_14	9138576	9141791	NA	NA	NA	NA	NA
PGEN_.00g279910	Scaffold_14	9152481	9185386	O95834	EMAL2_HUMAN	Echinoderm microtubule-associated protein-like 2 (EMAP-2) (HuEMAP-2)	GO:0000226; GO:0005102; GO:0005737; GO:0005819; GO:0005874; GO:0005875; GO:0007601; GO:0007605; GO:0008017; GO:0008022; GO:0010968; GO:0015631; GO:0031115	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]
PGEN_.00g279920	Scaffold_14	9210611	9226352	Q9CR83	RBM18_MOUSE	Probable RNA-binding protein 18 (RNA-binding motif protein 18)	GO:0003723	RNA binding [GO:0003723]
PGEN_.00g279930	Scaffold_14	9210642	9210890	NA	NA	NA	NA	NA
PGEN_.00g279940	Scaffold_14	9234067	9234747	P82147	L2EFL_DROME	Protein lethal(2)essential for life (Protein Efl21)	GO:0007275; GO:0009408; GO:0010998; GO:0030018; GO:0042026; GO:0045214; GO:0048471; GO:0051082; GO:0061077	perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214]
PGEN_.00g279950	Scaffold_14	9244471	9252100	Q5RKI9	RRFM_RAT	"Ribosome-recycling factor, mitochondrial (RRF) (Ribosome-releasing factor, mitochondrial)"	GO:0005739; GO:0006412; GO:0032790; GO:0043023	mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; ribosome disassembly [GO:0032790]; translation [GO:0006412]
PGEN_.00g279960	Scaffold_14	9255254	9261321	Q8TB03	CX038_HUMAN	Uncharacterized protein CXorf38		
PGEN_.00g279970	Scaffold_14	9268246	9268707	NA	NA	NA	NA	NA
PGEN_.00g279980	Scaffold_14	9269600	9270811	NA	NA	NA	NA	NA
PGEN_.00g279990	Scaffold_14	9273510	9273866	NA	NA	NA	NA	NA
PGEN_.00g280000	Scaffold_14	9274384	9279504	NA	NA	NA	NA	NA
PGEN_.00g280010	Scaffold_14	9279566	9279994	NA	NA	NA	NA	NA
PGEN_.00g280020	Scaffold_14	9285648	9286228	NA	NA	NA	NA	NA
PGEN_.00g280030	Scaffold_14	9301968	9323853	Q8TB03	CX038_HUMAN	Uncharacterized protein CXorf38		
PGEN_.00g280040	Scaffold_14	9348362	9357904	NA	NA	NA	NA	NA
PGEN_.00g280050	Scaffold_14	9366125	9368244	NA	NA	NA	NA	NA
PGEN_.00g280060	Scaffold_14	9403015	9474957	Q61554	FBN1_MOUSE	Fibrillin-1 [Cleaved into: Asprosin]	GO:0001501; GO:0001527; GO:0001656; GO:0001822; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0006006; GO:0007507; GO:0008201; GO:0010737; GO:0031012; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; kidney development [GO:0001822]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
PGEN_.00g280070	Scaffold_14	9505741	9510718	NA	NA	NA	NA	NA
PGEN_.00g280080	Scaffold_14	9515660	9522770	NA	NA	NA	NA	NA
PGEN_.00g280090	Scaffold_14	9533877	9535416	NA	NA	NA	NA	NA
PGEN_.00g280100	Scaffold_14	9536561	9548319	Q9BQ50	TREX2_HUMAN	Three prime repair exonuclease 2 (EC 3.1.11.2) (3'-5' exonuclease TREX2)	GO:0000287; GO:0003676; GO:0005634; GO:0006259; GO:0006281; GO:0008296; GO:0008853; GO:0042803	nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]
PGEN_.00g280110	Scaffold_14	9571834	9640463	P16546	SPTN1_MOUSE	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain)"	GO:0003779; GO:0005509; GO:0005516; GO:0005886; GO:0005916; GO:0015630; GO:0016020; GO:0016328; GO:0019905; GO:0030018; GO:0030507; GO:0030863; GO:0031532; GO:0032437; GO:0032991; GO:0033270; GO:0043209; GO:0043231; GO:0044877; GO:0051693	cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; fascia adherens [GO:0005916]; intracellular membrane-bounded organelle [GO:0043231]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; myelin sheath [GO:0043209]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; spectrin binding [GO:0030507]; syntaxin binding [GO:0019905]; actin cytoskeleton reorganization [GO:0031532]; actin filament capping [GO:0051693]
PGEN_.00g280120	Scaffold_14	9642795	9643052	NA	NA	NA	NA	NA
PGEN_.00g280130	Scaffold_14	9643306	9643572	NA	NA	NA	NA	NA
PGEN_.00g280140	Scaffold_14	9645945	9646388	NA	NA	NA	NA	NA
PGEN_.00g280150	Scaffold_14	9665963	9671077	Q6KAQ7	ZZZ3_MOUSE	ZZ-type zinc finger-containing protein 3	GO:0003677; GO:0005654; GO:0005671; GO:0005730; GO:0008270	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]
PGEN_.00g280160	Scaffold_14	9678103	9687053	Q00940	PEX10_PICAN	Peroxisome biogenesis factor 10 (Peroxin-10) (Peroxisomal biogenesis factor 10) (Peroxisome assembly protein 10) (Peroxisome assembly protein PER8)	GO:0005778; GO:0007031; GO:0046872	peroxisomal membrane [GO:0005778]; metal ion binding [GO:0046872]; peroxisome organization [GO:0007031]
PGEN_.00g280170	Scaffold_14	9691835	9727413	Q6PA26	BAG6B_XENLA	Large proline-rich protein bag6-B (BCL2-associated athanogene 6) (HLA-B-associated transcript 3-B)	GO:0001822; GO:0005576; GO:0005634; GO:0005829; GO:0006325; GO:0006511; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0018393; GO:0030324; GO:0030433; GO:0031593; GO:0032435; GO:0042771; GO:0043022; GO:0045861; GO:0045995; GO:0050821; GO:0061857; GO:0070059; GO:0070628; GO:0071712; GO:0071816; GO:0071818	BAT3 complex [GO:0071818]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; brain development [GO:0007420]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g280180	Scaffold_14	9759006	9759374	NA	NA	NA	NA	NA
PGEN_.00g280190	Scaffold_14	9768456	9779220	Q6GPQ6	EDF1_XENLA	Endothelial differentiation-related factor 1 homolog (EDF-1)	GO:0003677; GO:0005634	nucleus [GO:0005634]; DNA binding [GO:0003677]
PGEN_.00g280200	Scaffold_14	9785091	9790420	O35900	LSM2_MOUSE	U6 snRNA-associated Sm-like protein LSm2 (Protein G7b) (snRNP core Sm-like protein Sm-x5)	GO:0000244; GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005737; GO:0006402; GO:0017160; GO:0019901; GO:0046540; GO:0071005; GO:0071013; GO:0120115; GO:1990726	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein kinase binding [GO:0019901]; Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"
PGEN_.00g280210	Scaffold_14	9793087	9801931	O09061	PSB1_MOUSE	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"
PGEN_.00g280220	Scaffold_14	9807167	9867410	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g280230	Scaffold_14	9881804	9882070	NA	NA	NA	NA	NA
PGEN_.00g280240	Scaffold_14	9884400	9906603	Q5JXM2	MET24_HUMAN	Methyltransferase-like protein 24 (EC 2.1.1.-)	GO:0005576; GO:0008168; GO:0032259	extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g280250	Scaffold_14	9931407	9931694	NA	NA	NA	NA	NA
PGEN_.00g280260	Scaffold_14	9932454	9932702	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g280270	Scaffold_14	9945742	9946373	NA	NA	NA	NA	NA
PGEN_.00g280280	Scaffold_14	9947230	9949842	NA	NA	NA	NA	NA
PGEN_.00g280290	Scaffold_14	9950987	9951724	NA	NA	NA	NA	NA
PGEN_.00g280300	Scaffold_14	9961040	9983771	Q6UVY6	MOXD1_HUMAN	DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g280310	Scaffold_14	10000831	10014538	Q5TZ24	MOXD1_DANRE	DBH-like monooxygenase protein 1 homolog (EC 1.14.17.-)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g280320	Scaffold_14	10019446	10019739	NA	NA	NA	NA	NA
PGEN_.00g280330	Scaffold_14	10025792	10029138	Q9UUA2	PIF1_SCHPO	ATP-dependent DNA helicase pfh1 (EC 3.6.4.12) (DNA repair and recombination helicase pfh1) (PIF1 helicase homolog) (RRM3/PIF1 homolog 1)	GO:0000262; GO:0000723; GO:0000790; GO:0003723; GO:0005524; GO:0005634; GO:0005657; GO:0005724; GO:0005730; GO:0005739; GO:0006260; GO:0006310; GO:0016887; GO:0017116; GO:0031297; GO:0032508; GO:0033678; GO:0035861; GO:0043139; GO:0043504; GO:0043601; GO:0044806; GO:0045911; GO:0051880; GO:0061995; GO:0070336; GO:1902377; GO:1902983; GO:1903469; GO:1905467; GO:1990518; GO:1990814	mitochondrial chromosome [GO:0000262]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear rDNA heterochromatin [GO:1902377]; nuclear replisome [GO:0043601]; nuclear telomeric heterochromatin [GO:0005724]; nucleolus [GO:0005730]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; ATP-dependent protein-DNA complex displacement activity [GO:0061995]; ATPase activity [GO:0016887]; DNA/DNA annealing activity [GO:1990814]; flap-structured DNA binding [GO:0070336]; G-quadruplex DNA binding [GO:0051880]; RNA binding [GO:0003723]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA helicase activity [GO:0017116]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]; DNA strand elongation involved in mitotic DNA replication [GO:1902983]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial DNA repair [GO:0043504]; positive regulation of DNA recombination [GO:0045911]; positive regulation of G-quadruplex DNA unwinding [GO:1905467]; removal of RNA primer involved in mitotic DNA replication [GO:1903469]; replication fork processing [GO:0031297]; telomere maintenance [GO:0000723]
PGEN_.00g280340	Scaffold_14	10089022	10095933	Q5R662	LRP12_PONAB	Low-density lipoprotein receptor-related protein 12 (LRP-12)	GO:0001764; GO:0005887; GO:0005905; GO:0006897; GO:0031175	clathrin-coated pit [GO:0005905]; integral component of plasma membrane [GO:0005887]; endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]
PGEN_.00g280350	Scaffold_14	10112241	10113875	Q557E7	CBLA_DICDI	E3 ubiquitin-protein ligase cblA (EC 2.3.2.27) (Cbl-like protein A) (RING finger protein cblA) (RING-type E3 ubiquitin transferase cblA)	GO:0001784; GO:0005509; GO:0005634; GO:0005829; GO:0016567; GO:0016740; GO:0030587; GO:0035556	cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; transferase activity [GO:0016740]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]; sorocarp development [GO:0030587]
PGEN_.00g280360	Scaffold_14	10115665	10117294	Q9M2U3	ALPL_ARATH	Protein ALP1-like (EC 3.1.-.-)	GO:0004518; GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g280370	Scaffold_14	10123501	10162873	Q15058	KIF14_HUMAN	Kinesin-like protein KIF14	GO:0001558; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0008017; GO:0008284; GO:0008574; GO:0010389; GO:0015631; GO:0016020; GO:0016887; GO:0019901; GO:0021685; GO:0021693; GO:0021695; GO:0021766; GO:0021772; GO:0021846; GO:0021987; GO:0030155; GO:0030165; GO:0030334; GO:0030496; GO:0030705; GO:0031146; GO:0031641; GO:0032147; GO:0032467; GO:0032487; GO:0033624; GO:0034446; GO:0043066; GO:0043161; GO:0043523; GO:0043524; GO:0045184; GO:0051233; GO:0051301; GO:0090543; GO:1903429; GO:2000045	"cell [GO:0005623]; cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; cytoskeleton-dependent intracellular transport [GO:0030705]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446]"
PGEN_.00g280380	Scaffold_14	10165656	10171344	NA	NA	NA	NA	NA
PGEN_.00g280390	Scaffold_14	10172053	10176612	NA	NA	NA	NA	NA
PGEN_.00g280400	Scaffold_14	10209060	10209380	NA	NA	NA	NA	NA
PGEN_.00g280410	Scaffold_14	10209619	10209885	NA	NA	NA	NA	NA
PGEN_.00g280420	Scaffold_14	10224525	10287990	Q5T4S7	UBR4_HUMAN	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0070821; GO:0101003	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]
PGEN_.00g280430	Scaffold_14	10304048	10329726	Q2TL32	UBR4_RAT	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Zinc finger UBR1-type protein 1)	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0006511; GO:0008270; GO:0016021	centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g280440	Scaffold_14	10347916	10371646	Q5T4S7	UBR4_HUMAN	E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0070821; GO:0101003	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]
PGEN_.00g280450	Scaffold_14	10379565	10387663	Q68CI2	DOPO_CANLF	Dopamine beta-hydroxylase (EC 1.14.17.1) [Cleaved into: Soluble dopamine beta-hydroxylase]	GO:0001816; GO:0001974; GO:0001975; GO:0002443; GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005783; GO:0006589; GO:0007613; GO:0007626; GO:0008542; GO:0016021; GO:0016715; GO:0030658; GO:0030667; GO:0031418; GO:0034451; GO:0034466; GO:0034774; GO:0042127; GO:0042309; GO:0042420; GO:0042421; GO:0042584; GO:0042593; GO:0042596; GO:0042711; GO:0045907; GO:0048149; GO:0048265; GO:0050900; GO:0120162; GO:2001236	"centriolar satellite [GO:0034451]; chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; cytokine production [GO:0001816]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; response to amphetamine [GO:0001975]; response to pain [GO:0048265]; visual learning [GO:0008542]"
PGEN_.00g280460	Scaffold_14	10392576	10427842	Q08CS6	MOXD2_DANRE	DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g280470	Scaffold_14	10448693	10454135	NA	NA	NA	NA	NA
PGEN_.00g280480	Scaffold_14	10457529	10497300	A3KPQ7	CEIP2_DANRE	Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Protein frozen ventricle) (Protein wickham) (Transmembrane protein 2)	GO:0001525; GO:0001947; GO:0003143; GO:0003190; GO:0003197; GO:0003318; GO:0004415; GO:0005509; GO:0005887; GO:0016203; GO:0030214; GO:0055008; GO:0060415; GO:0060974; GO:1900748; GO:1901203; GO:1903670	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670]
PGEN_.00g280490	Scaffold_14	10497339	10518751	Q8JGT4	UN5BA_XENLA	Netrin receptor UNC5B-a (Protein Xunc-5) (Protein unc-5 homolog-a)	GO:0005042; GO:0005886; GO:0007275; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; multicellular organism development [GO:0007275]
PGEN_.00g280500	Scaffold_14	10531045	10531461	NA	NA	NA	NA	NA
PGEN_.00g280510	Scaffold_14	10536896	10580259	P19096	FAS_MOUSE	Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006084; GO:0006633; GO:0008144; GO:0008611; GO:0008659; GO:0008693; GO:0009888; GO:0016295; GO:0016296; GO:0030223; GO:0030224; GO:0030879; GO:0031177; GO:0042470; GO:0042587; GO:0042802; GO:0042803; GO:0047117; GO:0047451; GO:0048468; GO:0070402; GO:0071353; GO:0090557; GO:0102131; GO:0102132	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; drug binding [GO:0008144]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; NADPH binding [GO:0070402]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; protein homodimerization activity [GO:0042803]; acetyl-CoA metabolic process [GO:0006084]; cell development [GO:0048468]; cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; mammary gland development [GO:0030879]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; tissue development [GO:0009888]"
PGEN_.00g280520	Scaffold_14	10581898	10582359	NA	NA	NA	NA	NA
PGEN_.00g280530	Scaffold_14	10591948	10637524	P19096	FAS_MOUSE	Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006084; GO:0006633; GO:0008144; GO:0008611; GO:0008659; GO:0008693; GO:0009888; GO:0016295; GO:0016296; GO:0030223; GO:0030224; GO:0030879; GO:0031177; GO:0042470; GO:0042587; GO:0042802; GO:0042803; GO:0047117; GO:0047451; GO:0048468; GO:0070402; GO:0071353; GO:0090557; GO:0102131; GO:0102132	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; drug binding [GO:0008144]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; NADPH binding [GO:0070402]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; protein homodimerization activity [GO:0042803]; acetyl-CoA metabolic process [GO:0006084]; cell development [GO:0048468]; cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; mammary gland development [GO:0030879]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; tissue development [GO:0009888]"
PGEN_.00g280540	Scaffold_14	10654802	10664700	Q56A24	KLH24_RAT	Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1)	GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312	adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]
PGEN_.00g280550	Scaffold_14	10672807	10676750	NA	NA	NA	NA	NA
PGEN_.00g280560	Scaffold_14	10704171	10704950	NA	NA	NA	NA	NA
PGEN_.00g280570	Scaffold_14	10710796	10722724	NA	NA	NA	NA	NA
PGEN_.00g280580	Scaffold_14	10724331	10750423	R9UTQ8	PROHY_STRGD	L-proline trans-4-hydroxylase (P4H) (EC 1.14.11.57)	GO:0005506; GO:0016706; GO:0016999; GO:0017000	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]
PGEN_.00g280590	Scaffold_14	10752828	10753130	NA	NA	NA	NA	NA
PGEN_.00g280600	Scaffold_14	10762931	10763996	NA	NA	NA	NA	NA
PGEN_.00g280610	Scaffold_14	10770441	10789682	Q6GNY7	PPT2B_XENLA	Lysosomal thioesterase PPT2-B (PPT-2-B) (EC 3.1.2.-)	GO:0005764; GO:0008474	lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474]
PGEN_.00g280620	Scaffold_14	10802131	10802694	NA	NA	NA	NA	NA
PGEN_.00g280630	Scaffold_14	10803717	10804028	NA	NA	NA	NA	NA
PGEN_.00g280640	Scaffold_14	10804264	10804578	NA	NA	NA	NA	NA
PGEN_.00g280650	Scaffold_14	10806691	10807245	NA	NA	NA	NA	NA
PGEN_.00g280660	Scaffold_14	10807763	10809223	NA	NA	NA	NA	NA
PGEN_.00g280670	Scaffold_14	10819197	10824618	Q9PRC8	Y017_UREPA	Uncharacterized metal-dependent hydrolase UU017 (EC 3.1.-.-)	GO:0016888; GO:0046872	"endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"
PGEN_.00g280680	Scaffold_14	10825768	10826598	NA	NA	NA	NA	NA
PGEN_.00g280690	Scaffold_14	10833080	10833385	NA	NA	NA	NA	NA
PGEN_.00g280700	Scaffold_14	10833538	10833990	NA	NA	NA	NA	NA
PGEN_.00g280710	Scaffold_14	10835082	10837586	Q7WSH3	FADD3_COMTE	"3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl:CoA ligase (HIP:CoA ligase) (EC 6.2.1.41)"	GO:0005524; GO:0008203; GO:0016874	ATP binding [GO:0005524]; ligase activity [GO:0016874]; cholesterol metabolic process [GO:0008203]
PGEN_.00g280720	Scaffold_14	10924138	10950805	Q15113	PCOC1_HUMAN	Procollagen C-endopeptidase enhancer 1 (Procollagen COOH-terminal proteinase enhancer 1) (PCPE-1) (Procollagen C-proteinase enhancer 1) (Type 1 procollagen C-proteinase enhancer protein) (Type I procollagen COOH-terminal proteinase enhancer)	GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0007275; GO:0008201; GO:0016504; GO:0070062; GO:1990830	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; cellular response to leukemia inhibitory factor [GO:1990830]; multicellular organism development [GO:0007275]; proteolysis [GO:0006508]
PGEN_.00g280730	Scaffold_14	10958692	10959414	NA	NA	NA	NA	NA
PGEN_.00g280740	Scaffold_14	10959786	10964886	NA	NA	NA	NA	NA
PGEN_.00g280750	Scaffold_14	10971516	10972826	NA	NA	NA	NA	NA
PGEN_.00g280760	Scaffold_14	10985080	10985403	NA	NA	NA	NA	NA
PGEN_.00g280770	Scaffold_14	11001735	11002052	NA	NA	NA	NA	NA
PGEN_.00g280780	Scaffold_14	11054498	11120921	Q6XYQ8	SYT10_HUMAN	Synaptotagmin-10 (Synaptotagmin X) (SytX)	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0071277; GO:0098793	"exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g280790	Scaffold_14	11210162	11211001	NA	NA	NA	NA	NA
PGEN_.00g280800	Scaffold_14	11228135	11229972	NA	NA	NA	NA	NA
PGEN_.00g280810	Scaffold_14	11233260	11244886	NA	NA	NA	NA	NA
PGEN_.00g280820	Scaffold_14	11270906	11273634	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g280830	Scaffold_14	11273710	11277321	NA	NA	NA	NA	NA
PGEN_.00g280840	Scaffold_14	11292275	11292824	NA	NA	NA	NA	NA
PGEN_.00g280850	Scaffold_14	11293054	11294984	NA	NA	NA	NA	NA
PGEN_.00g280860	Scaffold_14	11296108	11296365	NA	NA	NA	NA	NA
PGEN_.00g280870	Scaffold_14	11323688	11324020	NA	NA	NA	NA	NA
PGEN_.00g280880	Scaffold_14	11350345	11350662	NA	NA	NA	NA	NA
PGEN_.00g280890	Scaffold_14	11357199	11376099	A0A1D3PCM3	SST_EMEND	Serine O-succinyltransferase (SST) (EC 2.3.1.-)	GO:0005739; GO:0016747; GO:0019344	"mitochondrion [GO:0005739]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; cysteine biosynthetic process [GO:0019344]"
PGEN_.00g280900	Scaffold_14	11378349	11379277	NA	NA	NA	NA	NA
PGEN_.00g280910	Scaffold_14	11379567	11380169	NA	NA	NA	NA	NA
PGEN_.00g280920	Scaffold_14	11387731	11405469	R9UTQ8	PROHY_STRGD	L-proline trans-4-hydroxylase (P4H) (EC 1.14.11.57)	GO:0005506; GO:0016706; GO:0016999; GO:0017000	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]
PGEN_.00g280930	Scaffold_14	11421609	11442550	P22735	TGM1_HUMAN	Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)	GO:0001533; GO:0003810; GO:0005829; GO:0005886; GO:0006464; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031224; GO:0043163; GO:0045787; GO:0046872; GO:0070062; GO:0070268	cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; cell envelope organization [GO:0043163]; cellular protein modification process [GO:0006464]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]
PGEN_.00g280940	Scaffold_14	11474589	11510027	P22758	TGM1_RABIT	Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)	GO:0003810; GO:0010838; GO:0016020; GO:0018149; GO:0031424; GO:0045787; GO:0046872	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]
PGEN_.00g280950	Scaffold_14	11513238	11523623	R9UTQ8	PROHY_STRGD	L-proline trans-4-hydroxylase (P4H) (EC 1.14.11.57)	GO:0005506; GO:0016706; GO:0016999; GO:0017000	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]
PGEN_.00g280960	Scaffold_14	11536839	11538910	NA	NA	NA	NA	NA
PGEN_.00g280970	Scaffold_14	11545122	11605382	NA	NA	NA	NA	NA
PGEN_.00g280980	Scaffold_14	11644440	11644727	NA	NA	NA	NA	NA
PGEN_.00g280990	Scaffold_14	11673162	11673491	NA	NA	NA	NA	NA
PGEN_.00g281000	Scaffold_14	11679852	11680181	NA	NA	NA	NA	NA
PGEN_.00g281010	Scaffold_14	11683816	11684193	P32246	CCR1_HUMAN	C-C chemokine receptor type 1 (C-C CKR-1) (CC-CKR-1) (CCR-1) (CCR1) (HM145) (LD78 receptor) (Macrophage inflammatory protein 1-alpha receptor) (MIP-1alpha-R) (RANTES-R) (CD antigen CD191)	GO:0002407; GO:0004435; GO:0004950; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0006874; GO:0006887; GO:0006935; GO:0006954; GO:0006955; GO:0007155; GO:0007166; GO:0007186; GO:0007187; GO:0007204; GO:0007267; GO:0009611; GO:0009897; GO:0010629; GO:0016493; GO:0019221; GO:0019722; GO:0019956; GO:0019957; GO:0030335; GO:0030502; GO:0035717; GO:0045672; GO:0051928; GO:0060326; GO:0070098; GO:0070374; GO:0071791; GO:0090026	"cell [GO:0005623]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine (C-C motif) ligand 5 binding [GO:0071791]; chemokine (C-C motif) ligand 7 binding [GO:0035717]; chemokine binding [GO:0019956]; chemokine receptor activity [GO:0004950]; phosphatidylinositol phospholipase C activity [GO:0004435]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell chemotaxis [GO:0002407]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of gene expression [GO:0010629]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of osteoclast differentiation [GO:0045672]; response to wounding [GO:0009611]"
PGEN_.00g281020	Scaffold_14	11874168	11880147	P30974	TLR1_DROME	Tachykinin-like peptides receptor 86C (NKD)	GO:0002121; GO:0004995; GO:0005887; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016021	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]; G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]
PGEN_.00g281030	Scaffold_14	11946768	11958850	NA	NA	NA	NA	NA
PGEN_.00g281040	Scaffold_14	11970331	11971203	NA	NA	NA	NA	NA
PGEN_.00g281050	Scaffold_14	11974955	12007892	NA	NA	NA	NA	NA
PGEN_.00g281060	Scaffold_14	12015605	12025207	P46331	YXBG_BACSU	Uncharacterized oxidoreductase YxbG (EC 1.-.-.-)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g281070	Scaffold_14	12029849	12063835	Q9EPE9	AT131_MOUSE	Manganese-transporting ATPase 13A1 (CATP) (EC 7.2.2.-)	GO:0005524; GO:0005623; GO:0005789; GO:0006812; GO:0006874; GO:0016021; GO:0016887; GO:0046872	cell [GO:0005623]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]
PGEN_.00g281080	Scaffold_14	12070040	12071769	NA	NA	NA	NA	NA
PGEN_.00g281090	Scaffold_14	12081197	12084945	NA	NA	NA	NA	NA
PGEN_.00g281100	Scaffold_14	12085290	12089012	NA	NA	NA	NA	NA
PGEN_.00g281110	Scaffold_14	12103044	12123568	Q9NX45	SOLH2_HUMAN	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2	GO:0000790; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005737; GO:0007275; GO:0007283; GO:0009994; GO:0030154; GO:0042803; GO:0046982	"cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; oocyte differentiation [GO:0009994]; spermatogenesis [GO:0007283]"
PGEN_.00g281120	Scaffold_14	12129567	12141508	NA	NA	NA	NA	NA
PGEN_.00g281130	Scaffold_14	12149330	12150869	NA	NA	NA	NA	NA
PGEN_.00g281140	Scaffold_14	12155990	12157753	NA	NA	NA	NA	NA
PGEN_.00g281150	Scaffold_14	12158430	12186520	Q1LWV4	LHX9_DANRE	LIM/homeobox protein Lhx9 (LIM homeobox protein 9)	GO:0000977; GO:0000981; GO:0003714; GO:0005634; GO:0021794; GO:0030182; GO:0045892; GO:0045944; GO:0046872; GO:0048665; GO:0097380	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; dorsal spinal cord interneuron anterior axon guidance [GO:0097380]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; thalamus development [GO:0021794]"
PGEN_.00g281160	Scaffold_14	12187281	12187706	NA	NA	NA	NA	NA
PGEN_.00g281170	Scaffold_14	12207728	12213812	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g281180	Scaffold_14	12214559	12215569	NA	NA	NA	NA	NA
PGEN_.00g281190	Scaffold_14	12234187	12242486	Q9Z0S2	LHX2_MOUSE	LIM/homeobox protein Lhx2 (Homeobox protein LH-2) (LIM homeobox protein 2)	GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001843; GO:0001942; GO:0003682; GO:0005634; GO:0005654; GO:0007399; GO:0007411; GO:0007420; GO:0007498; GO:0008134; GO:0009953; GO:0021537; GO:0021772; GO:0021978; GO:0021987; GO:0022008; GO:0030182; GO:0043565; GO:0045199; GO:0045814; GO:0045893; GO:0045944; GO:0046872; GO:0048646; GO:0048675; GO:0050768; GO:0060041; GO:2000179; GO:2000678	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; anatomical structure formation involved in morphogenesis [GO:0048646]; axon extension [GO:0048675]; axon guidance [GO:0007411]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; dorsal/ventral pattern formation [GO:0009953]; hair follicle development [GO:0001942]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm development [GO:0007498]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; olfactory bulb development [GO:0021772]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; retina development in camera-type eye [GO:0060041]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]"
PGEN_.00g281200	Scaffold_14	12268630	12271462	Q1LWV4	LHX9_DANRE	LIM/homeobox protein Lhx9 (LIM homeobox protein 9)	GO:0000977; GO:0000981; GO:0003714; GO:0005634; GO:0021794; GO:0030182; GO:0045892; GO:0045944; GO:0046872; GO:0048665; GO:0097380	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; dorsal spinal cord interneuron anterior axon guidance [GO:0097380]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; thalamus development [GO:0021794]"
PGEN_.00g281210	Scaffold_14	12288938	12300502	R9UTQ8	PROHY_STRGD	L-proline trans-4-hydroxylase (P4H) (EC 1.14.11.57)	GO:0005506; GO:0016706; GO:0016999; GO:0017000	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]
PGEN_.00g281220	Scaffold_14	12302056	12307722	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g281230	Scaffold_14	12309883	12313674	NA	NA	NA	NA	NA
PGEN_.00g281240	Scaffold_14	12314112	12317090	NA	NA	NA	NA	NA
PGEN_.00g281250	Scaffold_14	12321037	12321441	Q9PRC8	Y017_UREPA	Uncharacterized metal-dependent hydrolase UU017 (EC 3.1.-.-)	GO:0016888; GO:0046872	"endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]"
PGEN_.00g281260	Scaffold_14	12358721	12370944	R9UTQ8	PROHY_STRGD	L-proline trans-4-hydroxylase (P4H) (EC 1.14.11.57)	GO:0005506; GO:0016706; GO:0016999; GO:0017000	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]
PGEN_.00g281270	Scaffold_14	12372793	12389038	R9UTQ8	PROHY_STRGD	L-proline trans-4-hydroxylase (P4H) (EC 1.14.11.57)	GO:0005506; GO:0016706; GO:0016999; GO:0017000	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999]
PGEN_.00g281280	Scaffold_14	12401335	12408095	NA	NA	NA	NA	NA
PGEN_.00g281290	Scaffold_14	12432400	12432849	NA	NA	NA	NA	NA
PGEN_.00g281300	Scaffold_14	12438848	12439162	NA	NA	NA	NA	NA
PGEN_.00g281310	Scaffold_14	12457238	12475235	Q5TZ24	MOXD1_DANRE	DBH-like monooxygenase protein 1 homolog (EC 1.14.17.-)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g281320	Scaffold_14	12527418	12540146	NA	NA	NA	NA	NA
PGEN_.00g281330	Scaffold_14	12560731	12561168	NA	NA	NA	NA	NA
PGEN_.00g281340	Scaffold_14	12569681	12577940	NA	NA	NA	NA	NA
PGEN_.00g281350	Scaffold_14	12581258	12583499	NA	NA	NA	NA	NA
PGEN_.00g281360	Scaffold_14	12584552	12600761	Q8CF93	GLT13_MOUSE	Polypeptide N-acetylgalactosaminyltransferase 13 (EC 2.4.1.41) (Polypeptide GalNAc transferase 13) (GalNAc-T13) (pp-GaNTase 13) (Protein-UDP acetylgalactosaminyltransferase 13) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13)	GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0018242; GO:0018243; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g281370	Scaffold_14	12600936	12602679	NA	NA	NA	NA	NA
PGEN_.00g281380	Scaffold_14	12616269	12633465	Q5R7X9	RAD1_PONAB	Cell cycle checkpoint protein RAD1 (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog)	GO:0000077; GO:0005654; GO:0005694; GO:0006281; GO:0008408; GO:0008853; GO:0051598; GO:0071479	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint [GO:0051598]
PGEN_.00g281390	Scaffold_14	12646312	12646824	NA	NA	NA	NA	NA
PGEN_.00g281400	Scaffold_14	12666518	12682282	Q5R7X9	RAD1_PONAB	Cell cycle checkpoint protein RAD1 (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog)	GO:0000077; GO:0005654; GO:0005694; GO:0006281; GO:0008408; GO:0008853; GO:0051598; GO:0071479	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint [GO:0051598]
PGEN_.00g281410	Scaffold_14	12692903	12700696	NA	NA	NA	NA	NA
PGEN_.00g281420	Scaffold_14	12714534	12727337	Q9DC04	RGS3_MOUSE	Regulator of G-protein signaling 3 (RGS3) (C2PA)	GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007186; GO:0009968	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; signal transduction [GO:0007165]
PGEN_.00g281430	Scaffold_14	12739139	12739537	NA	NA	NA	NA	NA
PGEN_.00g281440	Scaffold_14	12745674	12746217	NA	NA	NA	NA	NA
PGEN_.00g281450	Scaffold_14	12902676	12917357	P70500	CDIPT_RAT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)	GO:0000139; GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]
PGEN_.00g281460	Scaffold_14	12922181	12927666	Q9R0W9	ACHA6_MOUSE	Neuronal acetylcholine receptor subunit alpha-6	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0014059; GO:0016020; GO:0022848; GO:0030054; GO:0033603; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0050877; GO:0051899; GO:0098691; GO:0099055; GO:0099056; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g281470	Scaffold_14	12935192	12947385	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g281480	Scaffold_14	12951888	12963815	P26152	ACHA5_CHICK	Neuronal acetylcholine receptor subunit alpha-5	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g281490	Scaffold_14	12994610	12994957	NA	NA	NA	NA	NA
PGEN_.00g281500	Scaffold_14	12996418	13000124	G5ECX0	LPLT2_CAEEL	Latrophilin-like protein LAT-2	GO:0004175; GO:0004930; GO:0005887; GO:0007166; GO:0007189; GO:0030246; GO:0097264	integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264]
PGEN_.00g281510	Scaffold_14	13005359	13005880	NA	NA	NA	NA	NA
PGEN_.00g281520	Scaffold_14	13007125	13007886	NA	NA	NA	NA	NA
PGEN_.00g281530	Scaffold_14	13042024	13042278	NA	NA	NA	NA	NA
PGEN_.00g281540	Scaffold_14	13047279	13054066	Q29H55	MB21L_DROPS	Protein mab-21-like		
PGEN_.00g281550	Scaffold_14	13061578	13077211	Q98ST7	MOXD1_CHICK	DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g281560	Scaffold_14	13092305	13093160	NA	NA	NA	NA	NA
PGEN_.00g281570	Scaffold_14	13094746	13095078	NA	NA	NA	NA	NA
PGEN_.00g281580	Scaffold_14	13096241	13097318	NA	NA	NA	NA	NA
PGEN_.00g281590	Scaffold_14	13097376	13097645	NA	NA	NA	NA	NA
PGEN_.00g281600	Scaffold_14	13097697	13098362	NA	NA	NA	NA	NA
PGEN_.00g281610	Scaffold_14	13100361	13101319	NA	NA	NA	NA	NA
PGEN_.00g281620	Scaffold_14	13141138	13163578	A2BFC9	CFA77_DANRE	Cilia- and flagella-associated protein 77	GO:0005929	cilium [GO:0005929]
PGEN_.00g281630	Scaffold_14	13177095	13202964	NA	NA	NA	NA	NA
PGEN_.00g281640	Scaffold_14	13210361	13237095	Q02395	MTF2_MOUSE	Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2) (Metal-response element DNA-binding protein M96) (Polycomb-like protein 2) (mPCl2) (Zinc-regulated factor 1) (ZiRF1)	GO:0000122; GO:0000977; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0006325; GO:0007379; GO:0019827; GO:0035064; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0048863; GO:0061086; GO:0061087; GO:1990830	"cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]"
PGEN_.00g281650	Scaffold_14	13243942	13244565	NA	NA	NA	NA	NA
PGEN_.00g281660	Scaffold_14	13257146	13257454	NA	NA	NA	NA	NA
PGEN_.00g281670	Scaffold_14	13258270	13258605	NA	NA	NA	NA	NA
PGEN_.00g281680	Scaffold_14	13277400	13277642	NA	NA	NA	NA	NA
PGEN_.00g281690	Scaffold_14	13285092	13286009	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g281700	Scaffold_14	13295374	13307814	Q5TZ24	MOXD1_DANRE	DBH-like monooxygenase protein 1 homolog (EC 1.14.17.-)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g281710	Scaffold_14	13323110	13349353	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g281720	Scaffold_14	13370737	13382308	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g281730	Scaffold_14	13390176	13398016	A0A1P8AWH8	XYN1_ARATH	"Endo-1,4-beta-xylanase 1 (AtXyn1) (Xylan endohydrolase 1) (Xylanase 1) (EC 3.2.1.8)"	GO:0005576; GO:0005618; GO:0031176; GO:0045493	"cell wall [GO:0005618]; extracellular region [GO:0005576]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g281740	Scaffold_14	13398114	13403199	NA	NA	NA	NA	NA
PGEN_.00g281750	Scaffold_14	13404464	13405507	Q9NUV9	GIMA4_HUMAN	GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein) (IAN-1) (hIAN1) (Immunity-associated protein 4)	GO:0005525; GO:0005829	cytosol [GO:0005829]; GTP binding [GO:0005525]
PGEN_.00g281760	Scaffold_14	13431610	13445135	NA	NA	NA	NA	NA
PGEN_.00g281770	Scaffold_14	13445935	13470597	Q95LZ5	TTC16_MACFA	Tetratricopeptide repeat protein 16 (TPR repeat protein 16)		
PGEN_.00g281780	Scaffold_14	13477030	13482688	Q8ISP0	RS18_BRABE	40S ribosomal protein S18	GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843	cytoplasm [GO:0005737]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g281790	Scaffold_14	13482798	13504588	O55166	VPS52_RAT	Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein)	GO:0000938; GO:0005794; GO:0005829; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0017137; GO:0019905; GO:0032456; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:1990745	"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g281800	Scaffold_14	13506485	13510591	NA	NA	NA	NA	NA
PGEN_.00g281810	Scaffold_14	13511613	13511978	P49894	IOD1_CANLF	Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)	GO:0004800; GO:0005789; GO:0016021; GO:0042403; GO:0042446	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]
PGEN_.00g281820	Scaffold_14	13528925	13529383	NA	NA	NA	NA	NA
PGEN_.00g281830	Scaffold_14	13570762	13571268	NA	NA	NA	NA	NA
PGEN_.00g281840	Scaffold_14	13571356	13571916	NA	NA	NA	NA	NA
PGEN_.00g281850	Scaffold_14	13572143	13578188	O60140	YNS9_SCHPO	Uncharacterized protein C18H10.09	GO:0005737; GO:0008270	cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]
PGEN_.00g281860	Scaffold_14	13584963	13597702	Q5R6L8	GPI8_PONAB	GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K)	GO:0003923; GO:0008234; GO:0016255; GO:0042765	GPI-anchor transamidase complex [GO:0042765]; cysteine-type peptidase activity [GO:0008234]; GPI-anchor transamidase activity [GO:0003923]; attachment of GPI anchor to protein [GO:0016255]
PGEN_.00g281870	Scaffold_14	13598089	13642585	A4IFD0	KAD5_BOVIN	Adenylate kinase isoenzyme 5 (AK 5) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 5)	GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0006165; GO:0009142; GO:0046034	cytoplasm [GO:0005737]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]
PGEN_.00g281880	Scaffold_14	13637701	13638360	NA	NA	NA	NA	NA
PGEN_.00g281890	Scaffold_14	13656826	13689470	P39069	KAD1_RAT	Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase)	GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005886; GO:0006165; GO:0006172; GO:0007050; GO:0007517; GO:0009142; GO:0010828; GO:0014042; GO:0014823; GO:0021549; GO:0021772; GO:0030017; GO:0030182; GO:0032355; GO:0033574; GO:0036126; GO:0042493; GO:0043005; GO:0046033; GO:0046034; GO:0046083; GO:0046103; GO:0048471	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; adenine metabolic process [GO:0046083]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cell cycle arrest [GO:0007050]; cerebellum development [GO:0021549]; inosine biosynthetic process [GO:0046103]; muscle organ development [GO:0007517]; neuron differentiation [GO:0030182]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; olfactory bulb development [GO:0021772]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of neuron maturation [GO:0014042]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to testosterone [GO:0033574]
PGEN_.00g281900	Scaffold_14	13692045	13710597	NA	NA	NA	NA	NA
PGEN_.00g281910	Scaffold_14	13711785	13719001	NA	NA	NA	NA	NA
PGEN_.00g281920	Scaffold_14	13723290	13733384	NA	NA	NA	NA	NA
PGEN_.00g281930	Scaffold_14	13750436	13750747	NA	NA	NA	NA	NA
PGEN_.00g281940	Scaffold_14	13765310	13770813	NA	NA	NA	NA	NA
PGEN_.00g281950	Scaffold_14	13777193	13812955	NA	NA	NA	NA	NA
PGEN_.00g281960	Scaffold_14	13844969	13872421	P15215	LAMC1_DROME	Laminin subunit gamma-1 (Laminin B2 chain)	GO:0005604; GO:0007435; GO:0007494; GO:0009887; GO:0009888; GO:0016477; GO:0033627; GO:0034446; GO:0061031; GO:0070831; GO:0071711; GO:0085029	basement membrane [GO:0005604]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; endodermal digestive tract morphogenesis [GO:0061031]; extracellular matrix assembly [GO:0085029]; midgut development [GO:0007494]; salivary gland morphogenesis [GO:0007435]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]
PGEN_.00g281970	Scaffold_14	13873844	13874119	NA	NA	NA	NA	NA
PGEN_.00g281980	Scaffold_14	13882667	13936365	NA	NA	NA	NA	NA
PGEN_.00g281990	Scaffold_14	13946492	13965657	Q9Y289	SC5A6_HUMAN	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	GO:0005886; GO:0005887; GO:0006768; GO:0008523; GO:0012506; GO:0015878; GO:0015887; GO:0015939; GO:0016020; GO:0031526; GO:0055085	brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; biotin metabolic process [GO:0006768]; biotin transport [GO:0015878]; pantothenate metabolic process [GO:0015939]; pantothenate transmembrane transport [GO:0015887]; transmembrane transport [GO:0055085]
PGEN_.00g282000	Scaffold_14	13986861	13987310	NA	NA	NA	NA	NA
PGEN_.00g282010	Scaffold_14	13990576	13990812	NA	NA	NA	NA	NA
PGEN_.00g282020	Scaffold_14	14045662	14046733	NA	NA	NA	NA	NA
PGEN_.00g282030	Scaffold_14	14060870	14066490	NA	NA	NA	NA	NA
PGEN_.00g282040	Scaffold_14	14066571	14119908	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g282050	Scaffold_14	14127364	14127621	NA	NA	NA	NA	NA
PGEN_.00g282060	Scaffold_14	14132657	14184574	NA	NA	NA	NA	NA
PGEN_.00g282070	Scaffold_14	14252779	14262145	NA	NA	NA	NA	NA
PGEN_.00g282080	Scaffold_14	14291377	14300567	NA	NA	NA	NA	NA
PGEN_.00g282090	Scaffold_14	14305704	14320309	NA	NA	NA	NA	NA
PGEN_.00g282100	Scaffold_14	14328997	14331132	NA	NA	NA	NA	NA
PGEN_.00g282110	Scaffold_14	14338819	14364036	Q9VRC9	NPC1B_DROME	NPC intracellular cholesterol transporter 1 homolog 1b (Niemann-Pick type protein homolog 1b)	GO:0005886; GO:0007391; GO:0007417; GO:0007422; GO:0008203; GO:0016021; GO:0030299	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; dorsal closure [GO:0007391]; intestinal cholesterol absorption [GO:0030299]; peripheral nervous system development [GO:0007422]
PGEN_.00g282120	Scaffold_14	14403766	14433673	O15118	NPC1_HUMAN	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0034383; GO:0038023; GO:0042493; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle clearance [GO:0034383]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to drug [GO:0042493]; viral entry into host cell [GO:0046718]
PGEN_.00g282130	Scaffold_14	14444875	14445618	NA	NA	NA	NA	NA
PGEN_.00g282140	Scaffold_14	14450445	14451770	Q8BUH7	RNF26_MOUSE	E3 ubiquitin-protein ligase RNF26 (EC 2.3.2.27) (RING finger protein 26)	GO:0005789; GO:0007032; GO:0016021; GO:0016567; GO:0032479; GO:0046872; GO:0050687; GO:0061630; GO:0070979; GO:1905719	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]
PGEN_.00g282150	Scaffold_14	14460006	14460653	O97237	YGCC1_PLAF7	GRIP and coiled-coil domain-containing protein PFC0235w		
PGEN_.00g282160	Scaffold_14	14518489	14523792	NA	NA	NA	NA	NA
PGEN_.00g282170	Scaffold_14	14535702	14541377	Q8BNY6	NCS1_MOUSE	Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog)	GO:0000287; GO:0005245; GO:0005509; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0010975; GO:0014069; GO:0019901; GO:0030054; GO:0030424; GO:0030425; GO:0031045; GO:0031410; GO:0043231; GO:0044305; GO:0045921; GO:0048015; GO:0048471; GO:0050806; GO:0098794; GO:0098978; GO:0099523; GO:0099524; GO:0099626; GO:2000300	axon [GO:0030424]; calyx of Held [GO:0044305]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dense core granule [GO:0031045]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of exocytosis [GO:0045921]; positive regulation of synaptic transmission [GO:0050806]; regulation of neuron projection development [GO:0010975]; regulation of synaptic vesicle exocytosis [GO:2000300]
PGEN_.00g282180	Scaffold_14	14559063	14572108	Q9V6X7	OFUT1_DROME	GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1)	GO:0005112; GO:0005783; GO:0006004; GO:0006493; GO:0007219; GO:0008417; GO:0016266; GO:0045747; GO:0045807; GO:0046922	endoplasmic reticulum [GO:0005783]; fucosyltransferase activity [GO:0008417]; Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]
PGEN_.00g282190	Scaffold_14	14590879	14593254	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g282200	Scaffold_14	14609386	14610973	Q66IT9	IER5L_XENLA	Immediate early response gene 5-like protein		
PGEN_.00g282210	Scaffold_14	14622950	14625072	E7DNB6	TMP_BPDP1	Tape measure protein (TMP)	GO:0016021; GO:0019012; GO:0033644; GO:0098003	host cell membrane [GO:0033644]; integral component of membrane [GO:0016021]; virion [GO:0019012]; viral tail assembly [GO:0098003]
PGEN_.00g282220	Scaffold_14	14641935	14642297	NA	NA	NA	NA	NA
PGEN_.00g282230	Scaffold_14	14671326	14695106	Q99PF5	FUBP2_RAT	Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (MAP2 RNA trans-acting protein 1) (MARTA1)	GO:0003677; GO:0003729; GO:0003730; GO:0005634; GO:0006355; GO:0006397; GO:0006402; GO:0008380; GO:0010494; GO:0010586; GO:0010989; GO:0030425; GO:0035925; GO:0043025; GO:0043488; GO:0045019; GO:0051028; GO:0061014; GO:0061158; GO:0071345; GO:2000628	"cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"
PGEN_.00g282240	Scaffold_14	14700817	14708683	NA	NA	NA	NA	NA
PGEN_.00g282250	Scaffold_14	14708921	14709484	NA	NA	NA	NA	NA
PGEN_.00g282260	Scaffold_14	14709509	14713401	NA	NA	NA	NA	NA
PGEN_.00g282270	Scaffold_14	14713453	14713959	NA	NA	NA	NA	NA
PGEN_.00g282280	Scaffold_14	14714004	14714390	NA	NA	NA	NA	NA
PGEN_.00g282290	Scaffold_14	14714543	14714821	NA	NA	NA	NA	NA
PGEN_.00g282300	Scaffold_14	14726953	14799906	NA	NA	NA	NA	NA
PGEN_.00g282310	Scaffold_14	14727065	14727343	NA	NA	NA	NA	NA
PGEN_.00g282320	Scaffold_14	14805044	14817134	NA	NA	NA	NA	NA
PGEN_.00g282330	Scaffold_14	14837425	14852695	NA	NA	NA	NA	NA
PGEN_.00g282340	Scaffold_14	14862252	14891511	Q108U6	MET_LOXAF	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	GO:0004714; GO:0005524; GO:0007169; GO:0016021; GO:0017154; GO:0050918; GO:0071526; GO:2001028	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; semaphorin-plexin signaling pathway [GO:0071526]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g282350	Scaffold_14	14897593	14952948	Q9I927	FUCL5_ANGJA	Fucolectin-5	GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088	"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
PGEN_.00g282360	Scaffold_14	14956325	14960512	NA	NA	NA	NA	NA
PGEN_.00g282370	Scaffold_14	14964606	14966721	NA	NA	NA	NA	NA
PGEN_.00g282380	Scaffold_14	14988548	14992298	NA	NA	NA	NA	NA
PGEN_.00g282390	Scaffold_14	14998058	15009182	NA	NA	NA	NA	NA
PGEN_.00g282400	Scaffold_14	15017636	15023793	NA	NA	NA	NA	NA
PGEN_.00g282410	Scaffold_14	15035718	15036550	NA	NA	NA	NA	NA
PGEN_.00g282420	Scaffold_14	15039140	15040723	NA	NA	NA	NA	NA
PGEN_.00g282430	Scaffold_14	15041237	15041746	NA	NA	NA	NA	NA
PGEN_.00g282440	Scaffold_14	15048018	15049369	NA	NA	NA	NA	NA
PGEN_.00g282450	Scaffold_14	15054143	15088020	NA	NA	NA	NA	NA
PGEN_.00g282460	Scaffold_14	15098169	15098651	NA	NA	NA	NA	NA
PGEN_.00g282470	Scaffold_14	15098602	15104398	NA	NA	NA	NA	NA
PGEN_.00g282480	Scaffold_14	15106036	15108080	NA	NA	NA	NA	NA
PGEN_.00g282490	Scaffold_14	15108786	15108989	NA	NA	NA	NA	NA
PGEN_.00g282500	Scaffold_14	15109032	15110213	NA	NA	NA	NA	NA
PGEN_.00g282510	Scaffold_14	15114967	15121286	NA	NA	NA	NA	NA
PGEN_.00g282520	Scaffold_14	15125881	15126147	NA	NA	NA	NA	NA
PGEN_.00g282530	Scaffold_14	15127092	15127361	NA	NA	NA	NA	NA
PGEN_.00g282540	Scaffold_14	15127410	15127673	NA	NA	NA	NA	NA
PGEN_.00g282550	Scaffold_14	15128258	15128533	NA	NA	NA	NA	NA
PGEN_.00g282560	Scaffold_14	15129268	15129645	NA	NA	NA	NA	NA
PGEN_.00g282570	Scaffold_14	15133637	15138668	NA	NA	NA	NA	NA
PGEN_.00g282580	Scaffold_14	15147615	15176783	Q6P618	KAD8_XENTR	Adenylate kinase 8 (AK 8) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 8)	GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005829; GO:0006165; GO:0009142	cytosol [GO:0005829]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]
PGEN_.00g282590	Scaffold_14	15192496	15201333	Q9VTK2	POMT1_DROME	Protein O-mannosyltransferase 1 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 1) (dPOMT1) (Protein rotated abdomen)	GO:0004169; GO:0005783; GO:0005789; GO:0007385; GO:0007517; GO:0007525; GO:0016021; GO:0016203; GO:0030259; GO:0035269; GO:0045214; GO:0060025	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; lipid glycosylation [GO:0030259]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; protein O-linked mannosylation [GO:0035269]; regulation of synaptic activity [GO:0060025]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; specification of segmental identity, abdomen [GO:0007385]"
PGEN_.00g282600	Scaffold_14	15203831	15216376	Q9W3F7	MIGA_DROME	Mitoguardin	GO:0005739; GO:0005741; GO:0008053; GO:0010635; GO:0016021; GO:0045494; GO:0070584	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; photoreceptor cell maintenance [GO:0045494]; regulation of mitochondrial fusion [GO:0010635]
PGEN_.00g282610	Scaffold_14	15226640	15230344	NA	NA	NA	NA	NA
PGEN_.00g282620	Scaffold_14	15295412	15312836	NA	NA	NA	NA	NA
PGEN_.00g282630	Scaffold_14	15320504	15324269	NA	NA	NA	NA	NA
PGEN_.00g282640	Scaffold_14	15335512	15399437	Q19958	STO2_CAEEL	Stomatin-2	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g282650	Scaffold_14	15415972	15418248	Q15399	TLR1_HUMAN	Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281)	GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0034130; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0038123; GO:0042116; GO:0042495; GO:0042535; GO:0042802; GO:0045087; GO:0045121; GO:0045410; GO:0046982; GO:0071723; GO:0071727; GO:2000484	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; cell activation [GO:0001775]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR1:TLR2 signaling pathway [GO:0038123]
PGEN_.00g282660	Scaffold_14	15446020	15514413	Q27433	MEC2_CAEEL	Mechanosensory protein 2	GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]
PGEN_.00g282670	Scaffold_14	15514927	15517600	NA	NA	NA	NA	NA
PGEN_.00g282680	Scaffold_14	15545227	15545997	NA	NA	NA	NA	NA
PGEN_.00g282690	Scaffold_14	15547062	15549740	P07271	PIF1_YEAST	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) (Petite integration frequency protein 1) (Telomere stability protein 1)	GO:0000002; GO:0000722; GO:0000723; GO:0000727; GO:0000733; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005657; GO:0005730; GO:0005739; GO:0005743; GO:0006260; GO:0006310; GO:0010521; GO:0031966; GO:0032211; GO:0032508; GO:0043139; GO:0043596; GO:0044806; GO:0051276; GO:0051880; GO:0071932	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleus [GO:0005634]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; G-quadruplex DNA binding [GO:0051880]; single-stranded DNA binding [GO:0003697]; telomerase inhibitor activity [GO:0010521]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; double-strand break repair via break-induced replication [GO:0000727]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomere maintenance via telomerase [GO:0032211]; replication fork reversal [GO:0071932]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]
PGEN_.00g282700	Scaffold_14	15559841	15561035	NA	NA	NA	NA	NA
PGEN_.00g282710	Scaffold_14	15603248	15605853	NA	NA	NA	NA	NA
PGEN_.00g282720	Scaffold_14	15617920	15618723	NA	NA	NA	NA	NA
PGEN_.00g282730	Scaffold_14	15619780	15621378	Q94521	DNAT_DROME	Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase)	GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066	"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]"
PGEN_.00g282740	Scaffold_14	15626381	15627681	NA	NA	NA	NA	NA
PGEN_.00g282750	Scaffold_14	15631796	15633776	NA	NA	NA	NA	NA
PGEN_.00g282760	Scaffold_14	15636583	15638519	NA	NA	NA	NA	NA
PGEN_.00g282770	Scaffold_14	15652145	15657437	NA	NA	NA	NA	NA
PGEN_.00g282780	Scaffold_14	15662447	15678701	P48508	GSH0_RAT	Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)	GO:0004357; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0042493; GO:0043524; GO:0044344; GO:0044752; GO:0044877; GO:0046982; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990830; GO:2001237	glutamate-cysteine ligase complex [GO:0017109]; enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]
PGEN_.00g282790	Scaffold_14	15696568	15803149	E9Q309	CE350_MOUSE	Centrosome-associated protein 350 (Cep350)	GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0008017; GO:0034453; GO:0042995	cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453]
PGEN_.00g282800	Scaffold_14	15851964	15898209	NA	NA	NA	NA	NA
PGEN_.00g282810	Scaffold_14	15903116	15914063	NA	NA	NA	NA	NA
PGEN_.00g282820	Scaffold_14	15976116	15982813	O94777	DPM2_HUMAN	Dolichol phosphate-mannose biosynthesis regulatory protein (Dolichol-phosphate mannose synthase subunit 2) (DPM synthase subunit 2)	GO:0000506; GO:0005789; GO:0006506; GO:0016254; GO:0018279; GO:0019348; GO:0030176; GO:0030234; GO:0031647; GO:0033185; GO:0035269	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of endoplasmic reticulum membrane [GO:0030176]; enzyme regulator activity [GO:0030234]; dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269]; regulation of protein stability [GO:0031647]
PGEN_.00g282830	Scaffold_14	15984894	15997701	NA	NA	NA	NA	NA
PGEN_.00g282840	Scaffold_14	15999701	16012527	Q6KAU4	MB12B_MOUSE	Multivesicular body subunit 12B (ESCRT-I complex subunit MVB12B) (Protein FAM125B)	GO:0000813; GO:0005634; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0008289; GO:0015031; GO:0019075; GO:0031902; GO:0031982; GO:0042058; GO:0046755	cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT I complex [GO:0000813]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; lipid binding [GO:0008289]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; viral budding [GO:0046755]; virus maturation [GO:0019075]
PGEN_.00g282850	Scaffold_14	16018645	16030101	Q5TJF5	DHB8_CANLF	Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)	GO:0004303; GO:0005759; GO:0006633; GO:0006703; GO:0016616; GO:0047025; GO:0047035; GO:0048038; GO:0051290; GO:0055114; GO:0070404	"mitochondrial matrix [GO:0005759]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]"
PGEN_.00g282860	Scaffold_14	16030339	16039924	Q8BW00	PTH_MOUSE	Probable peptidyl-tRNA hydrolase (PTH) (EC 3.1.1.29)	GO:0004045; GO:0005739	mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]
PGEN_.00g282870	Scaffold_14	16048431	16060704	Q0VFN8	CF157_XENTR	Cilia- and flagella-associated protein 157	GO:0005737; GO:0007288; GO:0008017; GO:0036064	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule binding [GO:0008017]; sperm axoneme assembly [GO:0007288]
PGEN_.00g282880	Scaffold_14	16060972	16068883	Q92535	PIGC_HUMAN	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C (EC 2.4.1.198) (Phosphatidylinositol-glycan biosynthesis class C protein) (PIG-C)	GO:0000506; GO:0003824; GO:0005789; GO:0006506; GO:0016021; GO:0016254; GO:0017176	endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; catalytic activity [GO:0003824]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]
PGEN_.00g282890	Scaffold_14	16073941	16074225	NA	NA	NA	NA	NA
PGEN_.00g282900	Scaffold_14	16074502	16113964	NA	NA	NA	NA	NA
PGEN_.00g282910	Scaffold_14	16117308	16170653	Q5T1M5	FKB15_HUMAN	FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP- and FKBP-like protein) (WAFL)	GO:0003755; GO:0003779; GO:0005769; GO:0005884; GO:0006897; GO:0010923; GO:0016020; GO:0030426	actin filament [GO:0005884]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]; actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; endocytosis [GO:0006897]; negative regulation of phosphatase activity [GO:0010923]
PGEN_.00g282920	Scaffold_14	16208007	16208591	NA	NA	NA	NA	NA
PGEN_.00g282930	Scaffold_14	16211946	16212167	NA	NA	NA	NA	NA
PGEN_.00g282940	Scaffold_14	16212423	16212797	NA	NA	NA	NA	NA
PGEN_.00g282950	Scaffold_14	16247021	16247884	Q12955	ANK3_HUMAN	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]"
PGEN_.00g282960	Scaffold_14	16247918	16259389	NA	NA	NA	NA	NA
PGEN_.00g282970	Scaffold_14	16304784	16310053	Q9XT77	SC5A6_RABIT	Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g282980	Scaffold_14	16310516	16329594	Q49B93	SC5AC_MOUSE	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g282990	Scaffold_14	16333081	16340111	NA	NA	NA	NA	NA
PGEN_.00g283000	Scaffold_14	16346692	16360676	Q27746	DNMT1_PARLI	DNA (cytosine-5)-methyltransferase PliMCI (EC 2.1.1.37) (DNA methyltransferase PliMCI) (DNA MTase PliMCI) (M.PliMCI) (Dnmt1) (MCMT)	GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0008270	nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]
PGEN_.00g283010	Scaffold_14	16362513	16376915	Q92072	DNMT1_CHICK	DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT)	GO:0003677; GO:0003886; GO:0005634; GO:0007265; GO:0008270; GO:0010216; GO:0010424; GO:0090309; GO:1990841	nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265]
PGEN_.00g283020	Scaffold_14	16411076	16412287	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g283030	Scaffold_14	16412323	16426369	Q12955	ANK3_HUMAN	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]"
PGEN_.00g283040	Scaffold_14	16442849	16486908	P29268	CCN2_MOUSE	CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor) (Hypertrophic chondrocyte-specific protein 24) (Protein FISP-12)	GO:0001502; GO:0001503; GO:0001525; GO:0001894; GO:0001934; GO:0001968; GO:0005178; GO:0005520; GO:0005576; GO:0005615; GO:0005801; GO:0005829; GO:0005938; GO:0007155; GO:0007160; GO:0007229; GO:0007568; GO:0008022; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0009749; GO:0010628; GO:0010629; GO:0010942; GO:0016477; GO:0030154; GO:0030324; GO:0031012; GO:0032330; GO:0032355; GO:0032967; GO:0034059; GO:0035556; GO:0035988; GO:0043200; GO:0043280; GO:0043434; GO:0045597; GO:0046330; GO:0048471; GO:0050867; GO:0051385; GO:0051496; GO:0060401; GO:0060452; GO:0060548; GO:0061448; GO:0070278; GO:0070318; GO:0070374; GO:0070542; GO:0071897; GO:0072593	cell cortex [GO:0005938]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022]; aging [GO:0007568]; angiogenesis [GO:0001525]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; connective tissue development [GO:0061448]; cytosolic calcium ion transport [GO:0060401]; DNA biosynthetic process [GO:0071897]; extracellular matrix constituent secretion [GO:0070278]; fibroblast growth factor receptor signaling pathway [GO:0008543]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; ossification [GO:0001503]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell activation [GO:0050867]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; regulation of chondrocyte differentiation [GO:0032330]; response to amino acid [GO:0043200]; response to anoxia [GO:0034059]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; tissue homeostasis [GO:0001894]
PGEN_.00g283050	Scaffold_14	16518016	16518405	NA	NA	NA	NA	NA
PGEN_.00g283060	Scaffold_14	16521952	16522197	NA	NA	NA	NA	NA
PGEN_.00g283070	Scaffold_14	16522246	16522821	NA	NA	NA	NA	NA
PGEN_.00g283080	Scaffold_14	16539753	16539971	NA	NA	NA	NA	NA
PGEN_.00g283090	Scaffold_14	16571044	16573449	Q9JLI3	MMEL1_MOUSE	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) (Neprilysin-like 1) (NL-1) (Neprilysin-like peptidase) (NEPLP) (Soluble secreted endopeptidase) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	GO:0004175; GO:0004222; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0008270; GO:0016020; GO:0016021	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g283100	Scaffold_14	16576149	16582530	Q495T6	MMEL1_HUMAN	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (Membrane metallo-endopeptidase-like 2) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0016020; GO:0016021; GO:0046872	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; proteolysis [GO:0006508]
PGEN_.00g283110	Scaffold_14	16597273	16652972	Q9WTR6	XCT_MOUSE	Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (xCT)	GO:0005791; GO:0005856; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0014070; GO:0015179; GO:0016020; GO:0016021; GO:0021591; GO:0021756; GO:0030534; GO:0031526; GO:0033029; GO:0034599; GO:0034775; GO:0035094; GO:0042127; GO:0043231; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070306; GO:0070527; GO:0071702; GO:0090461; GO:0097449; GO:0098712; GO:0140206; GO:1900407; GO:1901494; GO:1903204; GO:1903786; GO:1904717; GO:2000211	apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; L-amino acid transmembrane transporter activity [GO:0015179]; adult behavior [GO:0030534]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; organic substance transport [GO:0071702]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542]
PGEN_.00g283120	Scaffold_14	16683880	16686656	NA	NA	NA	NA	NA
PGEN_.00g283130	Scaffold_14	16704756	16705765	NA	NA	NA	NA	NA
PGEN_.00g283140	Scaffold_14	16705913	16706290	NA	NA	NA	NA	NA
PGEN_.00g283150	Scaffold_14	16760282	16760539	NA	NA	NA	NA	NA
PGEN_.00g283160	Scaffold_14	16790525	16792555	NA	NA	NA	NA	NA
PGEN_.00g283170	Scaffold_14	16827774	16828508	NA	NA	NA	NA	NA
PGEN_.00g283180	Scaffold_14	16828577	16828861	NA	NA	NA	NA	NA
PGEN_.00g283190	Scaffold_14	16834165	16853248	Q5R6Q2	STX6_PONAB	Syntaxin-6	GO:0000139; GO:0005484; GO:0006886; GO:0016021; GO:0048193	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]
PGEN_.00g283200	Scaffold_14	16859352	16859735	NA	NA	NA	NA	NA
PGEN_.00g283210	Scaffold_14	16860375	16868395	Q9JHW4	SELB_MOUSE	"Selenocysteine-specific elongation factor (Elongation factor sec) (Eukaryotic elongation factor, selenocysteine-tRNA-specific) (mSelB)"	GO:0000049; GO:0001514; GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005739; GO:0005829; GO:0006414; GO:0035368; GO:0043021; GO:1990904	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; translational elongation [GO:0006414]
PGEN_.00g283220	Scaffold_14	16900752	16906366	Q866E1	FUT1_ALOBE	"Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]
PGEN_.00g283230	Scaffold_14	16922743	16923021	NA	NA	NA	NA	NA
PGEN_.00g283240	Scaffold_14	16926884	16929169	NA	NA	NA	NA	NA
PGEN_.00g283250	Scaffold_14	16960006	16992802	Q8BYM7	RSH4A_MOUSE	Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3)	GO:0001534; GO:0003341; GO:0005654; GO:0005730; GO:0005930; GO:0035082; GO:0060294	axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]
PGEN_.00g283260	Scaffold_14	17005585	17015451	Q568K2	PP1RB_DANRE	E3 ubiquitin-protein ligase PPP1R11 (EC 2.3.2.27) (Protein phosphatase 1 regulatory subunit 11)	GO:0004865; GO:0005634; GO:0006511; GO:0008157; GO:0032515; GO:0035308; GO:0050710; GO:0050830; GO:0061630	nucleus [GO:0005634]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ubiquitin protein ligase activity [GO:0061630]; defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g283270	Scaffold_14	17025111	17025608	NA	NA	NA	NA	NA
PGEN_.00g283280	Scaffold_14	17026147	17026668	NA	NA	NA	NA	NA
PGEN_.00g283290	Scaffold_14	17034122	17080599	Q9H9B1	EHMT1_HUMAN	Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D)	GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005694; GO:0006306; GO:0006325; GO:0008168; GO:0008270; GO:0016279; GO:0016571; GO:0016604; GO:0018024; GO:0018026; GO:0018027; GO:0045892; GO:0045995; GO:0046974; GO:0046976; GO:0060992; GO:0070317; GO:0070742; GO:0120162; GO:1901796	"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to fungicide [GO:0060992]"
PGEN_.00g283300	Scaffold_14	17087740	17142910	Q28141	DHX9_BOVIN	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II)	GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0001085; GO:0003677; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005844; GO:0006260; GO:0006353; GO:0006954; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0033679; GO:0034458; GO:0035197; GO:0035549; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1902741; GO:1903608; GO:1904469; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767; GO:2000778	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"
PGEN_.00g283310	Scaffold_14	17143326	17149435	NA	NA	NA	NA	NA
PGEN_.00g283320	Scaffold_14	17159402	17202251	Q5TJG6	BRD2_CANLF	Bromodomain-containing protein 2	GO:0001843; GO:0003682; GO:0005737; GO:0006334; GO:0006357; GO:0016607; GO:0070577	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; neural tube closure [GO:0001843]; nucleosome assembly [GO:0006334]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g283330	Scaffold_14	17211201	17211935	NA	NA	NA	NA	NA
PGEN_.00g283340	Scaffold_14	17218963	17231467	P61964	WDR5_HUMAN	WD repeat-containing protein 5 (BMP2-induced 3-kb gene protein)	GO:0000123; GO:0001501; GO:0005634; GO:0005654; GO:0005671; GO:0031175; GO:0035064; GO:0035097; GO:0035948; GO:0042393; GO:0043687; GO:0043966; GO:0043981; GO:0043982; GO:0043984; GO:0044666; GO:0045652; GO:0048188; GO:0051568; GO:0071339	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; histone H3 acetylation [GO:0043966]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; neuron projection development [GO:0031175]; positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter [GO:0035948]; post-translational protein modification [GO:0043687]; regulation of megakaryocyte differentiation [GO:0045652]; skeletal system development [GO:0001501]
PGEN_.00g283350	Scaffold_14	17239593	17253962	Q5RDB9	TADA1_PONAB	Transcriptional adapter 1 (Transcriptional adapter 1-like protein)	GO:0070461	SAGA-type complex [GO:0070461]
PGEN_.00g283360	Scaffold_14	17260826	17270652	O57590	SURF4_TAKRU	Surfeit locus protein 4	GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
PGEN_.00g283370	Scaffold_14	17301497	17302862	NA	NA	NA	NA	NA
PGEN_.00g283380	Scaffold_14	17328982	17400089	Q9XTQ6	TBH1_CAEEL	Tyramine beta-hydroxylase (EC 1.14.17.-)	GO:0004500; GO:0004836; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421; GO:0045202	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; tyramine-beta hydroxylase activity [GO:0004836]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g283390	Scaffold_14	17413806	17414852	Q866E8	FUT1_SAPAP	"Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]
PGEN_.00g283400	Scaffold_14	17438532	17466778	NA	NA	NA	NA	NA
PGEN_.00g283410	Scaffold_14	17467936	17476469	NA	NA	NA	NA	NA
PGEN_.00g283420	Scaffold_14	17485123	17497547	NA	NA	NA	NA	NA
PGEN_.00g283430	Scaffold_14	17499002	17500918	NA	NA	NA	NA	NA
PGEN_.00g283440	Scaffold_14	17535287	17536186	NA	NA	NA	NA	NA
PGEN_.00g283450	Scaffold_14	17548376	17556923	NA	NA	NA	NA	NA
PGEN_.00g283460	Scaffold_14	17560493	17563983	NA	NA	NA	NA	NA
PGEN_.00g283470	Scaffold_14	17604451	17610762	NA	NA	NA	NA	NA
PGEN_.00g283480	Scaffold_14	17621937	17623388	NA	NA	NA	NA	NA
PGEN_.00g283490	Scaffold_14	17641576	17643153	NA	NA	NA	NA	NA
PGEN_.00g283500	Scaffold_14	17651892	17675927	Q5PQJ7	TBCEL_RAT	Tubulin-specific chaperone cofactor E-like protein (Leucine-rich repeat-containing protein 35)	GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]
PGEN_.00g283510	Scaffold_14	17684245	17700376	Q9D994	WDR38_MOUSE	WD repeat-containing protein 38	GO:0002244	hematopoietic progenitor cell differentiation [GO:0002244]
PGEN_.00g283520	Scaffold_14	17723510	17768147	Q6PAR5	GAPD1_MOUSE	GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6)	GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0032794; GO:0051223	cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]
PGEN_.00g283530	Scaffold_14	17786180	17788398	NA	NA	NA	NA	NA
PGEN_.00g283540	Scaffold_14	17791354	17792944	NA	NA	NA	NA	NA
PGEN_.00g283550	Scaffold_14	17805904	17814489	NA	NA	NA	NA	NA
PGEN_.00g283560	Scaffold_14	17878969	17884847	NA	NA	NA	NA	NA
PGEN_.00g283570	Scaffold_14	17898125	17899195	Q5ZIE4	CHSTA_CHICK	Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST)	GO:0000139; GO:0008146; GO:0016021; GO:0016051; GO:0030166	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166]
PGEN_.00g283580	Scaffold_14	17918240	17918577	NA	NA	NA	NA	NA
PGEN_.00g283590	Scaffold_14	17918729	17933321	NA	NA	NA	NA	NA
PGEN_.00g283600	Scaffold_14	17933391	17933633	NA	NA	NA	NA	NA
PGEN_.00g283610	Scaffold_14	17941016	17984273	Q9LGZ2	LCYD1_ORYSJ	Putative L-cysteine desulfhydrase 1 (EC 4.4.1.28) (OsL-CDes1) (L-CDes1)	GO:0016829	lyase activity [GO:0016829]
PGEN_.00g283620	Scaffold_14	17994651	18006312	Q9M1R1	LCYD1_ARATH	L-cysteine desulfhydrase (EC 4.4.1.28) (AtL-CDes1) (L-CDes1) (AtLCD)	GO:0005829; GO:0019450; GO:0080146	cytosol [GO:0005829]; L-cysteine desulfhydrase activity [GO:0080146]; L-cysteine catabolic process to pyruvate [GO:0019450]
PGEN_.00g283630	Scaffold_14	18020181	18032816	Q9LGZ2	LCYD1_ORYSJ	Putative L-cysteine desulfhydrase 1 (EC 4.4.1.28) (OsL-CDes1) (L-CDes1)	GO:0016829	lyase activity [GO:0016829]
PGEN_.00g283640	Scaffold_14	18060821	18089351	Q9FYK2	CML25_ARATH	Probable calcium-binding protein CML25 (Calmodulin-like protein 25)	GO:0005509; GO:0005634; GO:0005737; GO:0009409; GO:0048767	cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; response to cold [GO:0009409]; root hair elongation [GO:0048767]
PGEN_.00g283650	Scaffold_14	18107053	18110370	NA	NA	NA	NA	NA
PGEN_.00g283660	Scaffold_14	18121970	18127523	C3KJF2	SWI5_ANOFI	DNA repair protein SWI5 homolog (Protein SAE3 homolog)	GO:0000724; GO:0005634; GO:0032798	nucleus [GO:0005634]; Swi5-Sfr1 complex [GO:0032798]; double-strand break repair via homologous recombination [GO:0000724]
PGEN_.00g283670	Scaffold_14	18134607	18135032	NA	NA	NA	NA	NA
PGEN_.00g283680	Scaffold_14	18136454	18153351	Q8BSN3	CC151_MOUSE	Coiled-coil domain-containing protein 151	GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0036064; GO:0036158; GO:0061371; GO:1902017	axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]
PGEN_.00g283690	Scaffold_14	18169968	18198771	G3V909	ATF6A_RAT	Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha]	GO:0000976; GO:0000977; GO:0000978; GO:0001654; GO:0003700; GO:0005634; GO:0005783; GO:0005794; GO:0007601; GO:0016020; GO:0030176; GO:0030968; GO:0031625; GO:0035497; GO:0042802; GO:0043065; GO:0043565; GO:0045944; GO:0046982; GO:1903893; GO:1990440	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]; cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; endoplasmic reticulum unfolded protein response [GO:0030968]; eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; visual perception [GO:0007601]
PGEN_.00g283700	Scaffold_14	18212398	18251439	NA	NA	NA	NA	NA
PGEN_.00g283710	Scaffold_14	18281161	18333458	Q5RGJ8	GNPTA_DANRE	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein gnptab) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta]	GO:0000139; GO:0002063; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0046835; GO:0048701; GO:0048703; GO:0051216; GO:0060348	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; bone development [GO:0060348]; carbohydrate phosphorylation [GO:0046835]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]
PGEN_.00g283720	Scaffold_14	18355418	18355678	NA	NA	NA	NA	NA
PGEN_.00g283730	Scaffold_14	18360365	18360634	NA	NA	NA	NA	NA
PGEN_.00g283740	Scaffold_14	18364705	18364965	NA	NA	NA	NA	NA
PGEN_.00g283750	Scaffold_14	18365704	18366075	NA	NA	NA	NA	NA
PGEN_.00g283760	Scaffold_14	18405081	18405524	NA	NA	NA	NA	NA
PGEN_.00g283770	Scaffold_14	18407212	18407604	NA	NA	NA	NA	NA
PGEN_.00g283780	Scaffold_14	18407675	18407968	NA	NA	NA	NA	NA
PGEN_.00g283790	Scaffold_14	18490048	18495513	NA	NA	NA	NA	NA
PGEN_.00g283800	Scaffold_14	18528091	18532418	Q9P215	POGK_HUMAN	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g283810	Scaffold_14	18557119	18566782	Q8QG61	CRY1_CHICK	Cryptochrome-1	GO:0000166; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0018298; GO:0031398; GO:0042622; GO:0045721; GO:0097381	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; nucleotide binding [GO:0000166]; photoreceptor activity [GO:0009881]; circadian rhythm [GO:0007623]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; response to light stimulus [GO:0009416]
PGEN_.00g283820	Scaffold_14	18621788	18661183	NA	NA	NA	NA	NA
PGEN_.00g283830	Scaffold_14	18664549	18665427	NA	NA	NA	NA	NA
PGEN_.00g283840	Scaffold_14	18665795	18666757	NA	NA	NA	NA	NA
PGEN_.00g283850	Scaffold_14	18687569	18689348	Q5SXM8	DNLZ_HUMAN	DNL-type zinc finger protein (Hsp70-escort protein 1) (HEP1) (mtHsp70-escort protein)	GO:0005654; GO:0005739; GO:0006457; GO:0008270; GO:0030150; GO:0050821; GO:0051087	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein stabilization [GO:0050821]
PGEN_.00g283860	Scaffold_14	18689502	18701501	Q9Y3A0	COQ4_HUMAN	"Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (Coenzyme Q biosynthesis protein 4 homolog)"	GO:0005739; GO:0006744; GO:0031314; GO:0032991	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; ubiquinone biosynthetic process [GO:0006744]
PGEN_.00g283870	Scaffold_14	18712993	18782239	Q80VW7	AKNA_MOUSE	Microtubule organization protein AKNA (AT-hook-containing transcription factor)	GO:0000978; GO:0001228; GO:0001650; GO:0001837; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234	"centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]"
PGEN_.00g283880	Scaffold_14	18772442	18775487	NA	NA	NA	NA	NA
PGEN_.00g283890	Scaffold_14	18819041	18825954	NA	NA	NA	NA	NA
PGEN_.00g283900	Scaffold_14	18834644	18835000	Q5ZI27	NAIF1_CHICK	Nuclear apoptosis-inducing factor 1	GO:0000801; GO:0005634; GO:0005739; GO:0007129; GO:0007283; GO:0010705; GO:0048477; GO:1902108	central element [GO:0000801]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; oogenesis [GO:0048477]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]
PGEN_.00g283910	Scaffold_14	18835040	18837443	NA	NA	NA	NA	NA
PGEN_.00g283920	Scaffold_14	18850878	18867129	NA	NA	NA	NA	NA
PGEN_.00g283930	Scaffold_14	18878249	18900551	B8PYG1	NSMF_DANRE	NMDA receptor synaptonuclear signaling and neuronal migration factor (Nasal embryonic luteinizing hormone-releasing hormone factor) (Nasal embryonic LHRH factor)	GO:0005856; GO:0005886; GO:0005938; GO:0014069; GO:0016363; GO:0030054; GO:0030425; GO:0031965; GO:0045773; GO:0048168; GO:2001224	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; regulation of neuronal synaptic plasticity [GO:0048168]
PGEN_.00g283940	Scaffold_14	18922272	18925887	NA	NA	NA	NA	NA
PGEN_.00g283950	Scaffold_14	18934001	18934930	C7G0B5	PIF_PINFU	Protein PIF [Cleaved into: Protein Pif97; Protein Pif80 (Aragonite-binding protein)]	GO:0005576; GO:0006030; GO:0008061	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]
PGEN_.00g283960	Scaffold_14	18948278	18988598	P48760	FOLC_MOUSE	"Folylpolyglutamate synthase, mitochondrial (EC 6.3.2.17) (Folylpoly-gamma-glutamate synthetase) (FPGS) (Tetrahydrofolylpolyglutamate synthase) (Tetrahydrofolate synthase)"	GO:0004326; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006536; GO:0006730; GO:0006760; GO:0008283; GO:0009396; GO:0046872; GO:0046901	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; cell population proliferation [GO:0008283]; folic acid-containing compound biosynthetic process [GO:0009396]; folic acid-containing compound metabolic process [GO:0006760]; glutamate metabolic process [GO:0006536]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901]
PGEN_.00g283970	Scaffold_14	18990716	18991585	NA	NA	NA	NA	NA
PGEN_.00g283980	Scaffold_14	19041063	19053872	O14733	MP2K7_HUMAN	Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2)	GO:0000187; GO:0000287; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0006970; GO:0007165; GO:0007254; GO:0007257; GO:0008545; GO:0009408; GO:0009411; GO:0019899; GO:0019901; GO:0019903; GO:0023014; GO:0032147; GO:0032212; GO:0034612; GO:0038095; GO:0045893; GO:0051403; GO:0051973; GO:0070374; GO:1904355	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated MAPK cascade [GO:0051403]"
PGEN_.00g283990	Scaffold_14	19064891	19071425	P49963	SRP19_DROME	Signal recognition particle 19 kDa protein (SRP19)	GO:0005786; GO:0006617; GO:0008312	"signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]"
PGEN_.00g284000	Scaffold_14	19071551	19079033	Q8TF47	ZFP90_HUMAN	Zinc finger protein 90 homolog (Zfp-90) (Zinc finger protein 756)	GO:0000122; GO:0001227; GO:0003700; GO:0005634; GO:0043392; GO:0043565; GO:0045892; GO:0045893; GO:0046872	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g284010	Scaffold_14	19100870	19106792	NA	NA	NA	NA	NA
PGEN_.00g284020	Scaffold_14	19107485	19111137	A2I8Z7	LHX9_ASTFA	LIM/homeobox protein Lhx9 (LIM homeobox protein 9)	GO:0003714; GO:0005634; GO:0043565; GO:0045892; GO:0046872; GO:0097380	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; dorsal spinal cord interneuron anterior axon guidance [GO:0097380]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g284030	Scaffold_14	19111186	19115929	NA	NA	NA	NA	NA
PGEN_.00g284040	Scaffold_14	19122891	19128378	Q9UPM6	LHX6_HUMAN	LIM/homeobox protein Lhx6 (LIM homeobox protein 6) (LIM/homeobox protein Lhx6.1)	GO:0000790; GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0021799; GO:0021800; GO:0021853; GO:0021884; GO:0030182; GO:0045944; GO:0046872; GO:0048469	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell maturation [GO:0048469]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; forebrain neuron development [GO:0021884]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g284050	Scaffold_14	19133272	19135059	NA	NA	NA	NA	NA
PGEN_.00g284060	Scaffold_14	19147432	19154957	O14084	IMT1_SCHPO	Inositol phosphoceramide mannosyltransferase 1 (EC 2.4.-.-) (IPC mannosyltransferase 1)	GO:0000030; GO:0005537; GO:0005794; GO:0016021; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; mannose binding [GO:0005537]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g284070	Scaffold_14	19162051	19164292	NA	NA	NA	NA	NA
PGEN_.00g284080	Scaffold_14	19164984	19167683	NA	NA	NA	NA	NA
PGEN_.00g284090	Scaffold_14	19184123	19184494	NA	NA	NA	NA	NA
PGEN_.00g284100	Scaffold_14	19199428	19205118	NA	NA	NA	NA	NA
PGEN_.00g284110	Scaffold_14	19459860	19499442	NA	NA	NA	NA	NA
PGEN_.00g284120	Scaffold_14	19592473	19592907	NA	NA	NA	NA	NA
PGEN_.00g284130	Scaffold_14	19602916	19693395	C9D7C2	CAC1A_APIME	Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein)	GO:0005245; GO:0005509; GO:0005891; GO:0034765	voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g284140	Scaffold_14	19694484	19717018	NA	NA	NA	NA	NA
PGEN_.00g284150	Scaffold_14	19735181	19767631	Q9GQQ0	SPIN_DROME	Protein spinster (Protein benchwarmer) (Protein diphthong)	GO:0005765; GO:0006869; GO:0006897; GO:0007040; GO:0007619; GO:0008333; GO:0008347; GO:0008582; GO:0009267; GO:0010001; GO:0012501; GO:0016021; GO:0030514; GO:0031902; GO:0031982; GO:0035193; GO:0040011; GO:0043067; GO:0045476; GO:0045477; GO:0045924; GO:0048477; GO:0048488; GO:0051124; GO:0055085; GO:0098793	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynapse [GO:0098793]; vesicle [GO:0031982]; cellular response to starvation [GO:0009267]; courtship behavior [GO:0007619]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; glial cell differentiation [GO:0010001]; glial cell migration [GO:0008347]; larval central nervous system remodeling [GO:0035193]; lipid transport [GO:0006869]; locomotion [GO:0040011]; lysosome organization [GO:0007040]; negative regulation of BMP signaling pathway [GO:0030514]; nurse cell apoptotic process [GO:0045476]; oogenesis [GO:0048477]; programmed cell death [GO:0012501]; regulation of female receptivity [GO:0045924]; regulation of nurse cell apoptotic process [GO:0045477]; regulation of programmed cell death [GO:0043067]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic vesicle endocytosis [GO:0048488]; transmembrane transport [GO:0055085]
PGEN_.00g284160	Scaffold_14	19766058	19771561	NA	NA	NA	NA	NA
PGEN_.00g284170	Scaffold_14	19768622	19771826	NA	NA	NA	NA	NA
PGEN_.00g284180	Scaffold_14	19780648	19785626	NA	NA	NA	NA	NA
PGEN_.00g284190	Scaffold_14	19793026	19837609	Q7PMT1	EXD_ANOGA	Homeobox protein extradenticle	GO:0001654; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007422; GO:0043565	nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; eye development [GO:0001654]; peripheral nervous system development [GO:0007422]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g284200	Scaffold_14	19849768	19896298	Q7T2B0	CTL4_DANRE	Choline transporter-like protein 4 (Solute carrier family 44 member 4)	GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0032475; GO:0035675; GO:0048840; GO:0061526	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; choline transmembrane transporter activity [GO:0015220]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith development [GO:0048840]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]
PGEN_.00g284210	Scaffold_14	19865363	19866449	NA	NA	NA	NA	NA
PGEN_.00g284220	Scaffold_14	19913913	19956450	Q6IP59	CTL2_XENLA	Choline transporter-like protein 2 (Solute carrier family 44 member 2)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g284230	Scaffold_14	19960388	19962305	NA	NA	NA	NA	NA
PGEN_.00g284240	Scaffold_14	20019895	20026199	NA	NA	NA	NA	NA
PGEN_.00g284250	Scaffold_14	20029822	20049186	Q03400	SANT_PLAF7	S-antigen protein	GO:0020003	symbiont-containing vacuole [GO:0020003]
PGEN_.00g284260	Scaffold_14	20049319	20050937	NA	NA	NA	NA	NA
PGEN_.00g284270	Scaffold_14	20051120	20055332	NA	NA	NA	NA	NA
PGEN_.00g284280	Scaffold_14	20056004	20056405	NA	NA	NA	NA	NA
PGEN_.00g284290	Scaffold_14	20061023	20064403	NA	NA	NA	NA	NA
PGEN_.00g284300	Scaffold_14	20065121	20068934	NA	NA	NA	NA	NA
PGEN_.00g284310	Scaffold_14	20074341	20083691	Q6IP59	CTL2_XENLA	Choline transporter-like protein 2 (Solute carrier family 44 member 2)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g284320	Scaffold_14	20093841	20094680	NA	NA	NA	NA	NA
PGEN_.00g284330	Scaffold_14	20094792	20095121	NA	NA	NA	NA	NA
PGEN_.00g284340	Scaffold_14	20095537	20102478	NA	NA	NA	NA	NA
PGEN_.00g284350	Scaffold_14	20103856	20138903	Q7SYC9	CTL2_DANRE	Choline transporter-like protein 2 (Solute carrier family 44 member 2)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g284360	Scaffold_14	20227989	20232274	NA	NA	NA	NA	NA
PGEN_.00g284370	Scaffold_14	20232420	20233217	NA	NA	NA	NA	NA
PGEN_.00g284380	Scaffold_14	20233261	20257289	Q6IP59	CTL2_XENLA	Choline transporter-like protein 2 (Solute carrier family 44 member 2)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g284390	Scaffold_14	20272900	20278230	NA	NA	NA	NA	NA
PGEN_.00g284400	Scaffold_14	20292764	20304557	Q9I931	FUCL1_ANGJA	Fucolectin-1	GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088	"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
PGEN_.00g284410	Scaffold_14	20314916	20315815	NA	NA	NA	NA	NA
PGEN_.00g284420	Scaffold_14	20321154	20355976	Q9UHN6	CEIP2_HUMAN	Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2)	GO:0001525; GO:0004415; GO:0005509; GO:0005886; GO:0005887; GO:0016021; GO:0030214; GO:0043231; GO:0045296; GO:0070062; GO:1903670	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]
PGEN_.00g284430	Scaffold_14	20372344	20373274	NA	NA	NA	NA	NA
PGEN_.00g284440	Scaffold_14	20373873	20374223	NA	NA	NA	NA	NA
PGEN_.00g284450	Scaffold_14	20378443	20378724	NA	NA	NA	NA	NA
PGEN_.00g284460	Scaffold_14	20384876	20385247	NA	NA	NA	NA	NA
PGEN_.00g284470	Scaffold_14	20386778	20387065	NA	NA	NA	NA	NA
PGEN_.00g284480	Scaffold_14	20411362	20411616	NA	NA	NA	NA	NA
PGEN_.00g284490	Scaffold_14	20412083	20444850	Q5TZ24	MOXD1_DANRE	DBH-like monooxygenase protein 1 homolog (EC 1.14.17.-)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g284500	Scaffold_14	20454946	20468078	NA	NA	NA	NA	NA
PGEN_.00g284510	Scaffold_14	20472612	20479038	P40821	CRJ1C_TRICY	Crystallin J1C	GO:0005212	structural constituent of eye lens [GO:0005212]
PGEN_.00g284520	Scaffold_14	20495961	20499523	Q3UHJ8	RNF44_MOUSE	RING finger protein 44	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g284530	Scaffold_14	20501521	20524546	Q8R3W5	SEN15_MOUSE	tRNA-splicing endonuclease subunit Sen15 (tRNA-intron endonuclease Sen15)	GO:0003676; GO:0004518; GO:0005730; GO:0006388; GO:0006397	"nucleolus [GO:0005730]; nuclease activity [GO:0004518]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
PGEN_.00g284540	Scaffold_14	20528989	20529749	NA	NA	NA	NA	NA
PGEN_.00g284550	Scaffold_14	20538450	20558058	P16275	IFEB_HELPO	Non-neuronal cytoplasmic intermediate filament protein B (IFB)	GO:0005737; GO:0005882	cytoplasm [GO:0005737]; intermediate filament [GO:0005882]
PGEN_.00g284560	Scaffold_14	20657474	20671452	NA	NA	NA	NA	NA
PGEN_.00g284570	Scaffold_14	20681019	20681498	NA	NA	NA	NA	NA
PGEN_.00g284580	Scaffold_14	20697882	20699192	NA	NA	NA	NA	NA
PGEN_.00g284590	Scaffold_14	20699936	20718731	Q8R2T8	TF3C5_MOUSE	General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon)	GO:0000127; GO:0003677; GO:0005654; GO:0035914; GO:0070898	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; RNA polymerase III preinitiation complex assembly [GO:0070898]; skeletal muscle cell differentiation [GO:0035914]
PGEN_.00g284600	Scaffold_14	20727272	20728259	NA	NA	NA	NA	NA
PGEN_.00g284610	Scaffold_14	20734708	20735040	NA	NA	NA	NA	NA
PGEN_.00g284620	Scaffold_14	20735108	20737187	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g284630	Scaffold_14	20737622	20768357	Q8N9H8	MUT7_HUMAN	Exonuclease mut-7 homolog (EC 3.1.-.-) (Exonuclease 3'-5' domain-containing protein 3)	GO:0003676; GO:0008408; GO:0046872	3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]
PGEN_.00g284640	Scaffold_14	20793985	20801592	NA	NA	NA	NA	NA
PGEN_.00g284650	Scaffold_14	20809729	20813388	NA	NA	NA	NA	NA
PGEN_.00g284660	Scaffold_14	20820699	20830032	Q8TB03	CX038_HUMAN	Uncharacterized protein CXorf38		
PGEN_.00g284670	Scaffold_14	20837274	20846795	NA	NA	NA	NA	NA
PGEN_.00g284680	Scaffold_14	20850208	20866466	Q865C0	CAH6_CANLF	Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI)	GO:0004089; GO:0005576; GO:0006730; GO:0008270	extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]
PGEN_.00g284690	Scaffold_14	20878637	20914017	Q8K4F6	NSUN5_MOUSE	Probable 28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein homolog)	GO:0003723; GO:0005654; GO:0005730; GO:0008168; GO:0070475	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; rRNA base methylation [GO:0070475]
PGEN_.00g284700	Scaffold_14	20922501	20966852	O61491	FLOT1_DROME	Flotillin-1	GO:0005198; GO:0005737; GO:0007275; GO:0016600	cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275]
PGEN_.00g284710	Scaffold_14	20971964	20979053	NA	NA	NA	NA	NA
PGEN_.00g284720	Scaffold_14	20979277	20987808	NA	NA	NA	NA	NA
PGEN_.00g284730	Scaffold_14	20989737	20997280	Q6GLD8	CDK9_XENTR	Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9)	GO:0000307; GO:0000790; GO:0004693; GO:0005524; GO:0005634; GO:0005694; GO:0006368; GO:0006468; GO:0008024; GO:0008134; GO:0008353; GO:0030332; GO:0032968; GO:0044212; GO:0045944; GO:0070816	chromosome [GO:0005694]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g284740	Scaffold_14	21012924	21029244	Q9QZS8	SH2D3_MOUSE	SH2 domain-containing protein 3C (Cas/HEF1-associated signal transducer) (SH2 domain-containing Eph receptor-binding protein 1)	GO:0005068; GO:0005085; GO:0005737; GO:0007165; GO:0007264; GO:0016020; GO:0033138	cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g284750	Scaffold_14	21059863	21060339	NA	NA	NA	NA	NA
PGEN_.00g284760	Scaffold_14	21060477	21060854	NA	NA	NA	NA	NA
PGEN_.00g284770	Scaffold_14	21064371	21068664	NA	NA	NA	NA	NA
PGEN_.00g284780	Scaffold_14	21103586	21136085	P45448	NR5A2_MOUSE	Nuclear receptor subfamily 5 group A member 2 (Liver receptor homolog 1) (LRH-1)	GO:0000976; GO:0000978; GO:0001228; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003707; GO:0004879; GO:0005543; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008206; GO:0008270; GO:0009755; GO:0009888; GO:0030855; GO:0031018; GO:0042127; GO:0042632; GO:0043565; GO:0044212; GO:0045070; GO:0045893; GO:0045944; GO:0061113; GO:0090575; GO:0097720; GO:1990830	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; bile acid metabolic process [GO:0008206]; calcineurin-mediated signaling [GO:0097720]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; endocrine pancreas development [GO:0031018]; epithelial cell differentiation [GO:0030855]; hormone-mediated signaling pathway [GO:0009755]; pancreas morphogenesis [GO:0061113]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; tissue development [GO:0009888]"
PGEN_.00g284790	Scaffold_14	21147976	21154164	NA	NA	NA	NA	NA
PGEN_.00g284800	Scaffold_14	21192009	21197189	NA	NA	NA	NA	NA
PGEN_.00g284810	Scaffold_14	21201567	21202181	NA	NA	NA	NA	NA
PGEN_.00g284820	Scaffold_14	21208069	21221624	NA	NA	NA	NA	NA
PGEN_.00g284830	Scaffold_14	21229484	21250604	Q08CS6	MOXD2_DANRE	DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g284840	Scaffold_14	21250711	21254009	Q08CS6	MOXD2_DANRE	DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g284850	Scaffold_14	21268108	21269088	NA	NA	NA	NA	NA
PGEN_.00g284860	Scaffold_14	21279006	21313633	NA	NA	NA	NA	NA
PGEN_.00g284870	Scaffold_14	21326076	21326441	P49894	IOD1_CANLF	Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)	GO:0004800; GO:0005789; GO:0016021; GO:0042403; GO:0042446	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; thyroxine 5'-deiodinase activity [GO:0004800]; hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]
PGEN_.00g284880	Scaffold_14	21337497	21362748	Q32L65	MARH2_BOVIN	E3 ubiquitin-protein ligase MARCH2 (EC 2.3.2.27) (Membrane-associated RING finger protein 2) (Membrane-associated RING-CH protein II) (MARCH-II) (RING-type E3 ubiquitin transferase MARCH2)	GO:0004842; GO:0005765; GO:0005783; GO:0005789; GO:0006897; GO:0008270; GO:0010008; GO:0016021; GO:0016567; GO:0031410	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein ubiquitination [GO:0016567]
PGEN_.00g284890	Scaffold_14	21378031	21472741	P52735	VAV2_HUMAN	Guanine nucleotide exchange factor VAV2 (VAV-2)	GO:0001525; GO:0001784; GO:0005085; GO:0005154; GO:0005829; GO:0005886; GO:0007165; GO:0007186; GO:0007264; GO:0008361; GO:0016477; GO:0030032; GO:0030168; GO:0038095; GO:0038096; GO:0043065; GO:0043087; GO:0043552; GO:0046872; GO:0048010; GO:0048013; GO:0051056	cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]
PGEN_.00g284900	Scaffold_14	21486060	21487744	NA	NA	NA	NA	NA
PGEN_.00g284910	Scaffold_14	21488822	21493531	Q5EA50	RABEK_BOVIN	Rab9 effector protein with kelch motifs	GO:0010008	endosome membrane [GO:0010008]
PGEN_.00g284920	Scaffold_14	21500838	21501086	NA	NA	NA	NA	NA
PGEN_.00g284930	Scaffold_14	21512970	21513281	NA	NA	NA	NA	NA
PGEN_.00g284940	Scaffold_14	21513677	21538103	Q5XKL5	BTBD8_HUMAN	BTB/POZ domain-containing protein 8	GO:0005654	nucleoplasm [GO:0005654]
PGEN_.00g284950	Scaffold_14	21549924	21556253	NA	NA	NA	NA	NA
PGEN_.00g284960	Scaffold_14	21564026	21577624	NA	NA	NA	NA	NA
PGEN_.00g284970	Scaffold_14	21593228	21601187	NA	NA	NA	NA	NA
PGEN_.00g284980	Scaffold_14	21606578	21614748	NA	NA	NA	NA	NA
PGEN_.00g284990	Scaffold_14	21616174	21631195	NA	NA	NA	NA	NA
PGEN_.00g285000	Scaffold_14	21639520	21644404	NA	NA	NA	NA	NA
PGEN_.00g285010	Scaffold_14	21645245	21645751	NA	NA	NA	NA	NA
PGEN_.00g285020	Scaffold_14	21653679	21663383	Q4QQY7	TGT_XENLA	Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase)	GO:0005741; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0101030	mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030]
PGEN_.00g285030	Scaffold_14	21663487	21673999	B2KI79	DOPP1_RHIFE	Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1)	GO:0005789; GO:0006486; GO:0016021; GO:0047874	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyldiphosphatase activity [GO:0047874]; protein glycosylation [GO:0006486]
PGEN_.00g285040	Scaffold_14	21680792	21692258	NA	NA	NA	NA	NA
PGEN_.00g285050	Scaffold_14	21715429	21716496	NA	NA	NA	NA	NA
PGEN_.00g285060	Scaffold_14	21733843	21738433	Q90Z04	CDON_XENLA	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0005887; GO:0007155; GO:0007224; GO:0045663; GO:0045664; GO:0048598	integral component of plasma membrane [GO:0005887]; cell adhesion [GO:0007155]; embryonic morphogenesis [GO:0048598]; positive regulation of myoblast differentiation [GO:0045663]; regulation of neuron differentiation [GO:0045664]; smoothened signaling pathway [GO:0007224]
PGEN_.00g285070	Scaffold_14	21744907	21748499	Q86Z23	C1QL4_HUMAN	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g285080	Scaffold_14	21754694	21757865	NA	NA	NA	NA	NA
PGEN_.00g285090	Scaffold_14	21856753	21866768	A2AX52	CO6A4_MOUSE	Collagen alpha-4(VI) chain	GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; collagen binding [GO:0005518]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]
PGEN_.00g285100	Scaffold_14	21871487	21885810	NA	NA	NA	NA	NA
PGEN_.00g285110	Scaffold_14	21897819	21903936	P92204	NELFE_DROME	Negative elongation factor E	GO:0000122; GO:0003723; GO:0003729; GO:0005634; GO:0005694; GO:0006368; GO:0008023; GO:0017053; GO:0032021; GO:0032785; GO:0034244; GO:0045944	"chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptional repressor complex [GO:0017053]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription elongation from RNA polymerase II promoter [GO:0006368]"
PGEN_.00g285120	Scaffold_14	21906695	21914171	Q5ZM96	QTRT2_CHICK	Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1)	GO:0005737; GO:0005739; GO:0005741; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0101030	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030]
PGEN_.00g285130	Scaffold_14	21916355	21923144	O95295	SNAPN_HUMAN	SNARE-associated protein Snapin (Biogenesis of lysosome-related organelles complex 1 subunit 7) (BLOC-1 subunit 7) (Synaptosomal-associated protein 25-binding protein) (SNAP-associated protein)	GO:0000139; GO:0000149; GO:0005623; GO:0005765; GO:0006886; GO:0007040; GO:0007042; GO:0007269; GO:0008021; GO:0008089; GO:0008090; GO:0008333; GO:0010977; GO:0016032; GO:0016079; GO:0016188; GO:0030054; GO:0030141; GO:0030672; GO:0031083; GO:0031175; GO:0031629; GO:0032418; GO:0032438; GO:0034629; GO:0043393; GO:0045202; GO:0048471; GO:0048489; GO:0048490; GO:0051604; GO:0072553; GO:0097352; GO:0099078; GO:1902774; GO:1902824; GO:1904115; GO:2000300	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cell [GO:0005623]; cell junction [GO:0030054]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; SNARE binding [GO:0000149]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; autophagosome maturation [GO:0097352]; cellular protein-containing complex localization [GO:0034629]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; lysosomal lumen acidification [GO:0007042]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; neurotransmitter secretion [GO:0007269]; positive regulation of late endosome to lysosome transport [GO:1902824]; protein maturation [GO:0051604]; regulation of protein binding [GO:0043393]; regulation of synaptic vesicle exocytosis [GO:2000300]; retrograde axonal transport [GO:0008090]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]; viral process [GO:0016032]
PGEN_.00g285140	Scaffold_14	21948231	21958427	NA	NA	NA	NA	NA
PGEN_.00g285150	Scaffold_14	21972495	21999169	Q5EA45	FXRD1_BOVIN	FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-)	GO:0005737; GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]
PGEN_.00g285160	Scaffold_14	22025376	22043119	Q9QXW2	FBXW5_MOUSE	F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5)	GO:0005737; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; protein kinase binding [GO:0019901]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g285170	Scaffold_14	22064489	22064800	NA	NA	NA	NA	NA
PGEN_.00g285180	Scaffold_14	22066022	22066624	NA	NA	NA	NA	NA
PGEN_.00g285190	Scaffold_14	22068881	22070135	NA	NA	NA	NA	NA
PGEN_.00g285200	Scaffold_14	22072461	22073417	NA	NA	NA	NA	NA
PGEN_.00g285210	Scaffold_14	22074479	22085535	NA	NA	NA	NA	NA
PGEN_.00g285220	Scaffold_14	22089606	22089950	NA	NA	NA	NA	NA
PGEN_.00g285230	Scaffold_14	22093897	22096101	NA	NA	NA	NA	NA
PGEN_.00g285240	Scaffold_14	22105911	22117927	NA	NA	NA	NA	NA
PGEN_.00g285250	Scaffold_14	22191059	22193979	NA	NA	NA	NA	NA
PGEN_.00g285260	Scaffold_14	22210015	22213257	NA	NA	NA	NA	NA
PGEN_.00g285270	Scaffold_14	22220849	22228140	NA	NA	NA	NA	NA
PGEN_.00g285280	Scaffold_14	22231706	22239298	NA	NA	NA	NA	NA
PGEN_.00g285290	Scaffold_14	22264032	22268448	NA	NA	NA	NA	NA
PGEN_.00g285300	Scaffold_14	22291057	22348814	Q28CB1	TBD2B_XENTR	TBC1 domain family member 2B	GO:0005096; GO:0006886; GO:0017137; GO:0090630	GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]
PGEN_.00g285310	Scaffold_14	22350763	22363341	P21520	SCA_DROME	Protein scabrous	GO:0005770; GO:0007219; GO:0007399; GO:0008407; GO:0008587; GO:0016318; GO:0030154; GO:0048749; GO:0097305	late endosome [GO:0005770]; cell differentiation [GO:0030154]; chaeta morphogenesis [GO:0008407]; compound eye development [GO:0048749]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; response to alcohol [GO:0097305]
PGEN_.00g285320	Scaffold_14	22370976	22390611	Q9ESN9	JIP3_MOUSE	C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (JNK/SAPK-associated protein 1) (JSAP1) (Mitogen-activated protein kinase 8-interacting protein 3) (Sunday driver 2)	GO:0000139; GO:0001701; GO:0005078; GO:0005737; GO:0005790; GO:0005886; GO:0007254; GO:0007257; GO:0007411; GO:0007585; GO:0008104; GO:0008432; GO:0009791; GO:0010468; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0030900; GO:0031103; GO:0031410; GO:0031434; GO:0031435; GO:0043005; GO:0043507; GO:0044297; GO:0045666; GO:0046328; GO:0048286; GO:0048471; GO:0060425; GO:0061564; GO:0099641; GO:1904115; GO:2001224	axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; receptor signaling complex adaptor activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; JNK cascade [GO:0007254]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; regulation of JNK cascade [GO:0046328]; respiratory gaseous exchange by respiratory system [GO:0007585]; vesicle-mediated transport [GO:0016192]
PGEN_.00g285330	Scaffold_14	22480283	22493744	NA	NA	NA	NA	NA
PGEN_.00g285340	Scaffold_14	22493868	22525516	Q7YR37	ABCF1_PANTR	ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50)	GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0006413; GO:0008494; GO:0016887; GO:0042788; GO:0043022; GO:0045727	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
PGEN_.00g285350	Scaffold_14	22533352	22584185	NA	NA	NA	NA	NA
PGEN_.00g285360	Scaffold_14	22586611	22586991	NA	NA	NA	NA	NA
PGEN_.00g285370	Scaffold_14	22598334	22603058	NA	NA	NA	NA	NA
PGEN_.00g285380	Scaffold_14	22621708	22726702	Q5VWQ8	DAB2P_HUMAN	Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein)	GO:0000122; GO:0000165; GO:0000185; GO:0001525; GO:0001933; GO:0005096; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0007049; GO:0007252; GO:0007257; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0014067; GO:0016525; GO:0017124; GO:0019900; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030424; GO:0030425; GO:0030948; GO:0031434; GO:0031435; GO:0032088; GO:0032266; GO:0032809; GO:0034144; GO:0034260; GO:0034620; GO:0035148; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0038026; GO:0040008; GO:0042059; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043124; GO:0043184; GO:0043254; GO:0043407; GO:0043410; GO:0043497; GO:0043507; GO:0043548; GO:0043553; GO:0044257; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045296; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0046580; GO:0048147; GO:0048812; GO:0050680; GO:0051721; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071158; GO:0071222; GO:0071347; GO:0071356; GO:0071364; GO:0071889; GO:0071901; GO:0071902; GO:0072577; GO:0090090; GO:0090129; GO:1900006; GO:1900744; GO:1900747; GO:1901800; GO:1903363; GO:1903896; GO:1990032; GO:1990597; GO:2001224; GO:2001235	"AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; cadherin binding [GO:0045296]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of dendrite development [GO:1900006]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of growth [GO:0040008]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein complex assembly [GO:0043254]; regulation of protein heterodimerization activity [GO:0043497]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]"
PGEN_.00g285390	Scaffold_14	22759199	22759834	NA	NA	NA	NA	NA
PGEN_.00g285400	Scaffold_14	22759862	22760407	NA	NA	NA	NA	NA
PGEN_.00g285410	Scaffold_14	22763420	22778790	NA	NA	NA	NA	NA
PGEN_.00g285420	Scaffold_14	22790057	22790359	NA	NA	NA	NA	NA
PGEN_.00g285430	Scaffold_14	22842453	22842848	NA	NA	NA	NA	NA
PGEN_.00g285440	Scaffold_14	22861975	22874720	NA	NA	NA	NA	NA
PGEN_.00g285450	Scaffold_14	22876930	22877226	NA	NA	NA	NA	NA
PGEN_.00g285460	Scaffold_14	22877909	22878397	NA	NA	NA	NA	NA
PGEN_.00g285470	Scaffold_14	22878564	22879325	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g285480	Scaffold_14	22879856	22880089	NA	NA	NA	NA	NA
PGEN_.00g285490	Scaffold_14	22883512	22938479	Q9NQX5	NPDC1_HUMAN	Neural proliferation differentiation and control protein 1 (NPDC-1)	GO:0005886; GO:0016021; GO:0050776	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of immune response [GO:0050776]
PGEN_.00g285500	Scaffold_14	22951484	22954263	NA	NA	NA	NA	NA
PGEN_.00g285510	Scaffold_14	22991524	22997285	NA	NA	NA	NA	NA
PGEN_.00g285520	Scaffold_14	23029729	23030109	NA	NA	NA	NA	NA
PGEN_.00g285530	Scaffold_14	23030190	23039081	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g285540	Scaffold_14	23058763	23059380	NA	NA	NA	NA	NA
PGEN_.00g285550	Scaffold_14	23065349	23065807	NA	NA	NA	NA	NA
PGEN_.00g285560	Scaffold_14	23084026	23094875	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g285570	Scaffold_14	23116001	23116648	Q8TE59	ATS19_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 19 (ADAM-TS 19) (ADAM-TS19) (ADAMTS-19) (EC 3.4.24.-)	GO:0004222; GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]
PGEN_.00g285580	Scaffold_14	23134570	23134869	NA	NA	NA	NA	NA
PGEN_.00g285590	Scaffold_14	23142614	23173539	Q1EHB3	ATS7_RAT	A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) (COMPase)	GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0009986; GO:0032331; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773	cell surface [GO:0009986]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of chondrocyte differentiation [GO:0032331]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g285600	Scaffold_14	23302964	23310639	O96567	DDC_DROSI	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC)	GO:0004058; GO:0006520; GO:0030170; GO:0042423	aromatic-L-amino-acid decarboxylase activity [GO:0004058]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]
PGEN_.00g285610	Scaffold_14	23312865	23326104	Q8BZQ7	ANC2_MOUSE	Anaphase-promoting complex subunit 2 (APC2) (Cyclosome subunit 2)	GO:0005634; GO:0005680; GO:0006511; GO:0007049; GO:0010629; GO:0031625; GO:0031915; GO:0045773; GO:0050775; GO:0051301; GO:0070979; GO:0090129	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of gene expression [GO:0010629]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g285620	Scaffold_14	23326378	23334430	Q812D3	PPIL3_RAT	Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (EC 5.2.1.8) (CYP10L) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3)	GO:0000413; GO:0003755; GO:0006397; GO:0006457; GO:0008380; GO:0071013	catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]
PGEN_.00g285630	Scaffold_14	23334527	23350110	Q9S777	4CL3_ARATH	4-coumarate--CoA ligase 3 (4CL 3) (EC 6.2.1.12) (4-coumarate--CoA ligase isoform 3) (At4CL3) (4-coumaroyl-CoA synthase 3)	GO:0005524; GO:0009698; GO:0010584; GO:0016207	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]; pollen exine formation [GO:0010584]
PGEN_.00g285640	Scaffold_14	23360786	23372862	Q6ETN3	4CL3_ORYSJ	Probable 4-coumarate--CoA ligase 3 (4CL 3) (Os4CL3) (EC 6.2.1.12) (4-coumaroyl-CoA synthase 3)	GO:0005524; GO:0009698; GO:0016207	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]
PGEN_.00g285650	Scaffold_14	23379632	23383232	NA	NA	NA	NA	NA
PGEN_.00g285660	Scaffold_14	23385911	23388675	NA	NA	NA	NA	NA
PGEN_.00g285670	Scaffold_14	23394054	23394368	NA	NA	NA	NA	NA
PGEN_.00g285680	Scaffold_14	23434346	23440375	Q5XK91	FBCDB_XENLA	Fibrinogen C domain-containing protein 1-B	GO:0008061; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g285690	Scaffold_14	23440542	23441231	NA	NA	NA	NA	NA
PGEN_.00g285700	Scaffold_14	23441798	23442148	NA	NA	NA	NA	NA
PGEN_.00g285710	Scaffold_14	23442250	23443912	NA	NA	NA	NA	NA
PGEN_.00g285720	Scaffold_14	23462203	23462463	NA	NA	NA	NA	NA
PGEN_.00g285730	Scaffold_14	23464473	23487883	Q92504	S39A7_HUMAN	"Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7)"	GO:0005385; GO:0005623; GO:0005654; GO:0005783; GO:0005789; GO:0005794; GO:0006882; GO:0016020; GO:0016021; GO:0071577	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577]
PGEN_.00g285740	Scaffold_14	23489526	23491284	NA	NA	NA	NA	NA
PGEN_.00g285750	Scaffold_14	23491417	23492184	NA	NA	NA	NA	NA
PGEN_.00g285760	Scaffold_14	23596945	23600639	NA	NA	NA	NA	NA
PGEN_.00g285770	Scaffold_14	23610958	23612176	NA	NA	NA	NA	NA
PGEN_.00g285780	Scaffold_14	23613127	23631090	Q767K6	DHX16_PIG	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16)	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0071005	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g285790	Scaffold_14	23632945	23638704	Q9D2P4	URM1_MOUSE	Ubiquitin-related modifier 1	GO:0002098; GO:0005829; GO:0032447; GO:0034227; GO:0097163	cytosol [GO:0005829]; sulfur carrier activity [GO:0097163]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g285800	Scaffold_14	23641370	23661369	Q95T19	SLIMP_DROME	Serine--tRNA synthetase-like protein Slimp (Seryl-tRNA synthetase-like insect mitochondrial protein)	GO:0000049; GO:0000166; GO:0004828; GO:0005739; GO:0006434	mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; seryl-tRNA aminoacylation [GO:0006434]
PGEN_.00g285810	Scaffold_14	23661531	23661824	NA	NA	NA	NA	NA
PGEN_.00g285820	Scaffold_14	23661993	23662358	NA	NA	NA	NA	NA
PGEN_.00g285830	Scaffold_14	23662468	23662680	NA	NA	NA	NA	NA
PGEN_.00g285840	Scaffold_14	23662765	23662995	NA	NA	NA	NA	NA
PGEN_.00g285850	Scaffold_14	23663045	23663287	NA	NA	NA	NA	NA
PGEN_.00g285860	Scaffold_14	23663368	23663568	NA	NA	NA	NA	NA
PGEN_.00g285870	Scaffold_14	23668140	23668640	NA	NA	NA	NA	NA
PGEN_.00g285880	Scaffold_14	23681039	23681296	NA	NA	NA	NA	NA
PGEN_.00g285890	Scaffold_14	23681491	23698325	Q32KH7	ARSI_CANLF	Arylsulfatase I (ASI) (EC 3.1.6.-)	GO:0005576; GO:0005783; GO:0008484; GO:0046872	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484]
PGEN_.00g285900	Scaffold_14	23705545	23722726	P50429	ARSB_MOUSE	Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)	GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]
PGEN_.00g285910	Scaffold_14	23726136	23731473	NA	NA	NA	NA	NA
PGEN_.00g285920	Scaffold_14	23736783	23753602	P10079	FBP1_STRPU	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	GO:0005112; GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]
PGEN_.00g285930	Scaffold_14	23779545	23784716	Q810W9	WHRN_RAT	Whirlin (CASK-interacting protein CIP98)	GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0016020; GO:0019904; GO:0021694; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0032391; GO:0032420; GO:0032421; GO:0032426; GO:0036064; GO:0042803; GO:0043025; GO:0043198; GO:0045184; GO:0045202; GO:0046982; GO:0050910; GO:0050953; GO:0060088; GO:0060122; GO:1990075; GO:1990227; GO:1990696	actin filament [GO:0005884]; axon [GO:0030424]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]
PGEN_.00g285940	Scaffold_14	23823907	23826347	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g285950	Scaffold_14	23836529	23934833	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g285960	Scaffold_14	23943237	23947345	NA	NA	NA	NA	NA
PGEN_.00g285970	Scaffold_14	23951636	23956872	NA	NA	NA	NA	NA
PGEN_.00g285980	Scaffold_14	23968916	23989541	P97872	FMO5_MOUSE	Dimethylaniline monooxygenase [N-oxide-forming] 5 (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (FMO 5)	GO:0004497; GO:0004499; GO:0005783; GO:0005789; GO:0005829; GO:0016021; GO:0050660; GO:0050661	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
PGEN_.00g285990	Scaffold_14	23989800	23992142	Q6UXM1	LRIG3_HUMAN	Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3)	GO:0005615; GO:0005886; GO:0016021; GO:0030659; GO:0031012; GO:0032474	cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474]
PGEN_.00g286000	Scaffold_14	23998914	24014748	P29052	TF2B_DROME	Transcription initiation factor IIB (General transcription factor TFIIB)	GO:0000979; GO:0001139; GO:0001174; GO:0005634; GO:0006352; GO:0006357; GO:0006367; GO:0008134; GO:0017025; GO:0046872; GO:0051101; GO:0051123; GO:0097550	"nucleus [GO:0005634]; transcriptional preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; DNA-templated transcription, initiation [GO:0006352]; regulation of DNA binding [GO:0051101]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]"
PGEN_.00g286010	Scaffold_14	24015109	24019091	Q95NM6	NUCG_CAEEL	"Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-) (Ced-3 protease suppressor 6)"	GO:0000014; GO:0000737; GO:0004519; GO:0004520; GO:0004521; GO:0005634; GO:0005739; GO:0005743; GO:0006309; GO:0006401; GO:0006915; GO:0042803; GO:0043565; GO:0046872	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; apoptotic DNA fragmentation [GO:0006309]; apoptotic process [GO:0006915]; DNA catabolic process, endonucleolytic [GO:0000737]; RNA catabolic process [GO:0006401]"
PGEN_.00g286020	Scaffold_14	24020967	24024490	NA	NA	NA	NA	NA
PGEN_.00g286030	Scaffold_14	24028205	24041316	Q28DG7	UBAC1_XENTR	Ubiquitin-associated domain-containing protein 1 (UBA domain-containing protein 1) (E3 ubiquitin-protein ligase subunit KPC2) (Kip1 ubiquitination-promoting complex protein 2)	GO:0005737; GO:0016567	cytoplasm [GO:0005737]; protein ubiquitination [GO:0016567]
PGEN_.00g286040	Scaffold_14	24043479	24070753	P08503	ACADM_RAT	"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7)"	GO:0000062; GO:0001889; GO:0003995; GO:0005739; GO:0005759; GO:0005978; GO:0006082; GO:0006111; GO:0006635; GO:0007507; GO:0007584; GO:0009409; GO:0009437; GO:0009725; GO:0009791; GO:0016853; GO:0019254; GO:0030424; GO:0031966; GO:0033539; GO:0042493; GO:0042594; GO:0042802; GO:0045329; GO:0046688; GO:0050660; GO:0051384; GO:0051791; GO:0051793; GO:0055007; GO:0055114; GO:0070991	"axon [GO:0030424]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; cardiac muscle cell differentiation [GO:0055007]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process [GO:0009437]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; glycogen biosynthetic process [GO:0005978]; heart development [GO:0007507]; liver development [GO:0001889]; medium-chain fatty acid catabolic process [GO:0051793]; medium-chain fatty acid metabolic process [GO:0051791]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; regulation of gluconeogenesis [GO:0006111]; response to cold [GO:0009409]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]"
PGEN_.00g286050	Scaffold_14	24073777	24084540	A2RSX4	STPG3_MOUSE	Protein STPG3 (Sperm-tail PG-rich repeat-containing protein 3)		
PGEN_.00g286060	Scaffold_14	24086339	24087067	NA	NA	NA	NA	NA
PGEN_.00g286070	Scaffold_14	24106091	24118680	Q8BH27	MEGF9_MOUSE	Multiple epidermal growth factor-like domains protein 9 (Multiple EGF-like domains protein 9) (Epidermal growth factor-like protein 5) (EGF-like protein 5)	GO:0005201; GO:0005604; GO:0009887; GO:0009888; GO:0016021; GO:0016477; GO:0034446; GO:0043256; GO:0070831	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; laminin complex [GO:0043256]; extracellular matrix structural constituent [GO:0005201]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]
PGEN_.00g286080	Scaffold_14	24120924	24142993	NA	NA	NA	NA	NA
PGEN_.00g286090	Scaffold_14	24143263	24143523	NA	NA	NA	NA	NA
PGEN_.00g286100	Scaffold_14	24163288	24194302	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g286110	Scaffold_14	24210005	24218824	NA	NA	NA	NA	NA
PGEN_.00g286120	Scaffold_14	24218914	24219126	NA	NA	NA	NA	NA
PGEN_.00g286130	Scaffold_14	24219526	24220203	NA	NA	NA	NA	NA
PGEN_.00g286140	Scaffold_14	24220740	24221012	NA	NA	NA	NA	NA
PGEN_.00g286150	Scaffold_14	24221469	24222008	NA	NA	NA	NA	NA
PGEN_.00g286160	Scaffold_14	24222617	24222826	NA	NA	NA	NA	NA
PGEN_.00g286170	Scaffold_14	24222919	24223257	NA	NA	NA	NA	NA
PGEN_.00g286180	Scaffold_14	24243270	24264146	NA	NA	NA	NA	NA
PGEN_.00g286190	Scaffold_14	24264213	24264896	NA	NA	NA	NA	NA
PGEN_.00g286200	Scaffold_14	24264944	24271199	NA	NA	NA	NA	NA
PGEN_.00g286210	Scaffold_14	24287750	24291201	NA	NA	NA	NA	NA
PGEN_.00g286220	Scaffold_14	24291295	24291657	NA	NA	NA	NA	NA
PGEN_.00g286230	Scaffold_14	24291787	24293595	NA	NA	NA	NA	NA
PGEN_.00g286240	Scaffold_14	24300554	24303643	NA	NA	NA	NA	NA
PGEN_.00g286250	Scaffold_14	24314762	24315289	NA	NA	NA	NA	NA
PGEN_.00g286260	Scaffold_14	24315420	24315692	NA	NA	NA	NA	NA
PGEN_.00g286270	Scaffold_14	24316000	24316242	NA	NA	NA	NA	NA
PGEN_.00g286280	Scaffold_14	24316339	24316548	NA	NA	NA	NA	NA
PGEN_.00g286290	Scaffold_14	24317088	24317363	NA	NA	NA	NA	NA
PGEN_.00g286300	Scaffold_14	24318170	24318403	NA	NA	NA	NA	NA
PGEN_.00g286310	Scaffold_14	24319223	24319486	NA	NA	NA	NA	NA
PGEN_.00g286320	Scaffold_14	24320218	24320607	NA	NA	NA	NA	NA
PGEN_.00g286330	Scaffold_14	24320660	24321139	NA	NA	NA	NA	NA
PGEN_.00g286340	Scaffold_14	24321270	24321761	NA	NA	NA	NA	NA
PGEN_.00g286350	Scaffold_14	24322211	24322579	NA	NA	NA	NA	NA
PGEN_.00g286360	Scaffold_14	24322685	24322951	NA	NA	NA	NA	NA
PGEN_.00g286370	Scaffold_14	24343214	24343693	NA	NA	NA	NA	NA
PGEN_.00g286380	Scaffold_14	24344337	24344597	NA	NA	NA	NA	NA
PGEN_.00g286390	Scaffold_14	24348138	24348356	NA	NA	NA	NA	NA
PGEN_.00g286400	Scaffold_14	24352550	24366679	NA	NA	NA	NA	NA
PGEN_.00g286410	Scaffold_14	24368796	24369335	NA	NA	NA	NA	NA
PGEN_.00g286420	Scaffold_14	24385563	24399172	NA	NA	NA	NA	NA
PGEN_.00g286430	Scaffold_14	24400731	24413521	NA	NA	NA	NA	NA
PGEN_.00g286440	Scaffold_14	24422100	24428282	NA	NA	NA	NA	NA
PGEN_.00g286450	Scaffold_14	24436932	24457556	NA	NA	NA	NA	NA
PGEN_.00g286460	Scaffold_14	24477757	24480510	NA	NA	NA	NA	NA
PGEN_.00g286470	Scaffold_14	24494508	24513122	P41436	IAP_GVCPM	Apoptosis inhibitor IAP	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g286480	Scaffold_14	24531224	24531619	NA	NA	NA	NA	NA
PGEN_.00g286490	Scaffold_14	24533196	24533441	NA	NA	NA	NA	NA
PGEN_.00g286500	Scaffold_14	24533842	24545728	NA	NA	NA	NA	NA
PGEN_.00g286510	Scaffold_14	24558875	24564273	NA	NA	NA	NA	NA
PGEN_.00g286520	Scaffold_14	24577430	24586223	NA	NA	NA	NA	NA
PGEN_.00g286530	Scaffold_14	24672375	24674587	NA	NA	NA	NA	NA
PGEN_.00g286540	Scaffold_14	24684088	24684540	NA	NA	NA	NA	NA
PGEN_.00g286550	Scaffold_14	24686886	24707324	Q6WV19	GALT2_DROME	Polypeptide N-acetylgalactosaminyltransferase 2 (pp-GaNTase 2) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2)	GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006486; GO:0009312; GO:0016021; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]
PGEN_.00g286560	Scaffold_14	24711366	24715206	NA	NA	NA	NA	NA
PGEN_.00g286570	Scaffold_14	24729647	24752244	NA	NA	NA	NA	NA
PGEN_.00g286580	Scaffold_14	24771637	24796559	Q2T9Z7	KLHL9_BOVIN	Kelch-like protein 9	GO:0007049; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0051301	Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]
PGEN_.00g286590	Scaffold_14	24798485	24804396	Q86IC9	CAMT1_DICDI	Probable caffeoyl-CoA O-methyltransferase 1 (EC 2.1.1.104) (O-methyltransferase 5)	GO:0032259; GO:0042409; GO:0046872	caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; methylation [GO:0032259]
PGEN_.00g286600	Scaffold_14	24806125	24808556	NA	NA	NA	NA	NA
PGEN_.00g286610	Scaffold_14	24821870	24824188	NA	NA	NA	NA	NA
PGEN_.00g286620	Scaffold_14	24824261	24826637	NA	NA	NA	NA	NA
PGEN_.00g286630	Scaffold_14	24857260	24876650	Q95ZJ1	GALT5_CAEEL	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g286640	Scaffold_14	24887096	24892186	O54904	B3GT1_MOUSE	"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase-I) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g286650	Scaffold_14	24895651	24926871	Q00719	MDMC_STRMY	O-methyltransferase MdmC (EC 2.1.1.-)	GO:0008171; GO:0017000; GO:0032259; GO:0046872	metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; antibiotic biosynthetic process [GO:0017000]; methylation [GO:0032259]
PGEN_.00g286660	Scaffold_14	24931831	24939273	Q2EY14	PRTGA_DANRE	Protogenin A	GO:0016021; GO:0050768	integral component of membrane [GO:0016021]; negative regulation of neurogenesis [GO:0050768]
PGEN_.00g286670	Scaffold_14	24945609	24948363	Q9VPF0	ATK_DROME	Protein artichoke	GO:0005737; GO:0007423; GO:0031012; GO:0040011; GO:0050896; GO:0060271	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; cilium assembly [GO:0060271]; locomotion [GO:0040011]; response to stimulus [GO:0050896]; sensory organ development [GO:0007423]
PGEN_.00g286680	Scaffold_14	24952430	24975159	NA	NA	NA	NA	NA
PGEN_.00g286690	Scaffold_14	24976103	24977826	NA	NA	NA	NA	NA
PGEN_.00g286700	Scaffold_14	24988537	24991123	Q01105	SET_HUMAN	Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I)	GO:0003677; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006260; GO:0006334; GO:0006337; GO:0016032; GO:0019888; GO:0032991; GO:0035067; GO:0042393; GO:0043488; GO:0043524; GO:0045892; GO:0048471	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032]"
PGEN_.00g286710	Scaffold_14	24992850	24998179	Q8C3F7	KLH30_MOUSE	Kelch-like protein 30		
PGEN_.00g286720	Scaffold_14	25033718	25058237	NA	NA	NA	NA	NA
PGEN_.00g286730	Scaffold_14	25073167	25077353	NA	NA	NA	NA	NA
PGEN_.00g286740	Scaffold_14	25083113	25088680	NA	NA	NA	NA	NA
PGEN_.00g286750	Scaffold_14	25093551	25116850	NA	NA	NA	NA	NA
PGEN_.00g286760	Scaffold_14	25125114	25129859	Q94521	DNAT_DROME	Dopamine N-acetyltransferase (EC 2.3.1.87) (Arylalkylamine N-acetyltransferase)	GO:0004059; GO:0004060; GO:0005737; GO:0006584; GO:0008080; GO:0030187; GO:0030431; GO:0042420; GO:0042429; GO:0045187; GO:0046334; GO:0048066	"cytoplasm [GO:0005737]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; N-acetyltransferase activity [GO:0008080]; catecholamine metabolic process [GO:0006584]; developmental pigmentation [GO:0048066]; dopamine catabolic process [GO:0042420]; melatonin biosynthetic process [GO:0030187]; octopamine catabolic process [GO:0046334]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; serotonin catabolic process [GO:0042429]; sleep [GO:0030431]"
PGEN_.00g286770	Scaffold_14	25135313	25136361	NA	NA	NA	NA	NA
PGEN_.00g286780	Scaffold_14	25145051	25150323	NA	NA	NA	NA	NA
PGEN_.00g286790	Scaffold_14	25202040	25205539	NA	NA	NA	NA	NA
PGEN_.00g286800	Scaffold_14	25214455	25216356	Q99PP7	TRI33_MOUSE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0017015; GO:0030514; GO:0070410; GO:0070412	nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]
PGEN_.00g286810	Scaffold_14	25221491	25226367	NA	NA	NA	NA	NA
PGEN_.00g286820	Scaffold_14	25237418	25239319	NA	NA	NA	NA	NA
PGEN_.00g286830	Scaffold_14	25298717	25306952	NA	NA	NA	NA	NA
PGEN_.00g286840	Scaffold_14	25310965	25324031	NA	NA	NA	NA	NA
PGEN_.00g286850	Scaffold_14	25335276	25340545	NA	NA	NA	NA	NA
PGEN_.00g286860	Scaffold_14	25340988	25342263	NA	NA	NA	NA	NA
PGEN_.00g286870	Scaffold_14	25343124	25348103	NA	NA	NA	NA	NA
PGEN_.00g286880	Scaffold_14	25348258	25349397	NA	NA	NA	NA	NA
PGEN_.00g286890	Scaffold_14	25357748	25360671	NA	NA	NA	NA	NA
PGEN_.00g286900	Scaffold_14	25362528	25363046	NA	NA	NA	NA	NA
PGEN_.00g286910	Scaffold_14	25374031	25374504	NA	NA	NA	NA	NA
PGEN_.00g286920	Scaffold_14	25390736	25391140	NA	NA	NA	NA	NA
PGEN_.00g286930	Scaffold_14	25398274	25398936	NA	NA	NA	NA	NA
PGEN_.00g286940	Scaffold_14	25407544	25417530	NA	NA	NA	NA	NA
PGEN_.00g286950	Scaffold_14	25421470	25421961	P14381	YTX2_XENLA	Transposon TX1 uncharacterized 149 kDa protein (ORF 2)		
PGEN_.00g286960	Scaffold_14	25432378	25433498	NA	NA	NA	NA	NA
PGEN_.00g286970	Scaffold_14	25433544	25433846	NA	NA	NA	NA	NA
PGEN_.00g286980	Scaffold_14	25434173	25434376	NA	NA	NA	NA	NA
PGEN_.00g286990	Scaffold_14	25435213	25438918	NA	NA	NA	NA	NA
PGEN_.00g287000	Scaffold_14	25439018	25439347	NA	NA	NA	NA	NA
PGEN_.00g287010	Scaffold_14	25441462	25441833	NA	NA	NA	NA	NA
PGEN_.00g287020	Scaffold_14	25451601	25454082	NA	NA	NA	NA	NA
PGEN_.00g287030	Scaffold_14	25456519	25456827	NA	NA	NA	NA	NA
PGEN_.00g287040	Scaffold_14	25464812	25465573	NA	NA	NA	NA	NA
PGEN_.00g287050	Scaffold_14	25470750	25519782	Q9UKP5	ATS6_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)	GO:0003279; GO:0004222; GO:0005576; GO:0008237; GO:0035904; GO:0046872; GO:0060976	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]
PGEN_.00g287060	Scaffold_14	25528736	25535792	NA	NA	NA	NA	NA
PGEN_.00g287070	Scaffold_14	25576071	25583903	NA	NA	NA	NA	NA
PGEN_.00g287080	Scaffold_14	25590792	25627923	NA	NA	NA	NA	NA
PGEN_.00g287090	Scaffold_14	25630273	25635181	Q5R513	MPPA_PONAB	Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha)	GO:0004222; GO:0005743; GO:0005759; GO:0006627; GO:0046872	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627]
PGEN_.00g287100	Scaffold_14	25635211	25639019	NA	NA	NA	NA	NA
PGEN_.00g287110	Scaffold_14	25643102	25643401	NA	NA	NA	NA	NA
PGEN_.00g287120	Scaffold_14	25644914	25650375	Q8WU76	SCFD2_HUMAN	Sec1 family domain-containing protein 2 (Syntaxin-binding protein 1-like 1)	GO:0006904; GO:0015031	protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]
PGEN_.00g287130	Scaffold_14	25652341	25653207	NA	NA	NA	NA	NA
PGEN_.00g287140	Scaffold_14	25759043	25761559	NA	NA	NA	NA	NA
PGEN_.00g287150	Scaffold_14	25762363	25765170	O15226	NKRF_HUMAN	NF-kappa-B-repressing factor (NFkB-repressing factor) (Protein ITBA4) (Transcription factor NRF)	GO:0000978; GO:0001228; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0045892; GO:0045944	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g287160	Scaffold_14	25811491	25832616	A0JM59	UBP20_XENTR	Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20)	GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0006511; GO:0006897; GO:0008270; GO:0008277; GO:0016579; GO:0036459; GO:0048471; GO:0070536; GO:0071108	centrosome [GO:0005813]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g287170	Scaffold_14	25832651	25832962	NA	NA	NA	NA	NA
PGEN_.00g287180	Scaffold_14	25853309	25920427	P05560	IOVO_DRONO	Ovomucoid (OVM)	GO:0004867; GO:0005576	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]
PGEN_.00g287190	Scaffold_14	25920817	25925402	NA	NA	NA	NA	NA
PGEN_.00g287200	Scaffold_14	25928285	25942516	NA	NA	NA	NA	NA
PGEN_.00g287210	Scaffold_14	25961021	25968061	NA	NA	NA	NA	NA
PGEN_.00g287220	Scaffold_14	25973201	26007909	NA	NA	NA	NA	NA
PGEN_.00g287230	Scaffold_14	26009546	26025748	Q9WVR1	INP5E_RAT	"Phosphatidylinositol polyphosphate 5-phosphatase type IV (5-phosphatase that induces arborization) (Pharbin) (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.86)"	GO:0000139; GO:0001726; GO:0004439; GO:0004445; GO:0005737; GO:0005886; GO:0005929; GO:0005930; GO:0014067; GO:0016314; GO:0017148; GO:0032580; GO:0046488; GO:0046855; GO:0046856; GO:0106019; GO:1903565	"axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4,5-bisphosphate phosphatase activity [GO:0106019]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein localization to cilium [GO:1903565]; negative regulation of translation [GO:0017148]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]"
PGEN_.00g287240	Scaffold_14	26055982	26064274	Q1RMP0	RPA12_BOVIN	DNA-directed RNA polymerase I subunit RPA12 (Zinc ribbon domain-containing protein 1)	GO:0003676; GO:0003899; GO:0005736; GO:0006363; GO:0006379; GO:0008270	RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA cleavage [GO:0006379]; termination of RNA polymerase I transcription [GO:0006363]
PGEN_.00g287250	Scaffold_14	26064329	26069410	Q9UI30	TR112_HUMAN	Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog)	GO:0005654; GO:0005829; GO:0006415; GO:0008276; GO:0018364; GO:0030488; GO:0031167; GO:0032259; GO:0032991; GO:0046982; GO:0048471; GO:0070476; GO:2000234	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; methylation [GO:0032259]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; translational termination [GO:0006415]; tRNA methylation [GO:0030488]
PGEN_.00g287260	Scaffold_14	26072404	26095425	NA	NA	NA	NA	NA
PGEN_.00g287270	Scaffold_14	26097837	26098127	NA	NA	NA	NA	NA
PGEN_.00g287280	Scaffold_14	26105420	26118207	NA	NA	NA	NA	NA
PGEN_.00g287290	Scaffold_14	26118263	26118616	NA	NA	NA	NA	NA
PGEN_.00g287300	Scaffold_14	26129549	26130064	NA	NA	NA	NA	NA
PGEN_.00g287310	Scaffold_14	26134798	26137034	NA	NA	NA	NA	NA
PGEN_.00g287320	Scaffold_14	26151678	26155248	NA	NA	NA	NA	NA
PGEN_.00g287330	Scaffold_14	26173681	26176383	Q14B25	PRS48_MOUSE	Serine protease 48 (EC 3.4.21.-) (Epidermis-specific serine protease-like protein)	GO:0004252; GO:0005615; GO:0006508	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]
PGEN_.00g287340	Scaffold_14	26177922	26201480	Q9BYE2	TMPSD_HUMAN	Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease)	GO:0004252; GO:0005044; GO:0016021; GO:0072562	blood microparticle [GO:0072562]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]
PGEN_.00g287350	Scaffold_14	26247637	26278316	NA	NA	NA	NA	NA
PGEN_.00g287360	Scaffold_14	26282540	26290961	NA	NA	NA	NA	NA
PGEN_.00g287370	Scaffold_14	26293592	26323978	NA	NA	NA	NA	NA
PGEN_.00g287380	Scaffold_14	26352024	26354958	NA	NA	NA	NA	NA
PGEN_.00g287390	Scaffold_14	26358068	26359171	NA	NA	NA	NA	NA
PGEN_.00g287400	Scaffold_14	26359227	26360470	NA	NA	NA	NA	NA
PGEN_.00g287410	Scaffold_14	26360556	26361416	NA	NA	NA	NA	NA
PGEN_.00g287420	Scaffold_14	26361515	26361964	NA	NA	NA	NA	NA
PGEN_.00g287430	Scaffold_14	26364771	26375491	Q9W332	CUBN_DROME	Cubilin homolog	GO:0005509; GO:0005886; GO:0015031; GO:0097017; GO:0097206	plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; nephrocyte filtration [GO:0097206]; protein transport [GO:0015031]; renal protein absorption [GO:0097017]
PGEN_.00g287440	Scaffold_14	26388435	26426390	NA	NA	NA	NA	NA
PGEN_.00g287450	Scaffold_14	26433144	26445532	Q5G265	NETR_SAGLB	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424	axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]
PGEN_.00g287460	Scaffold_14	26449933	26450457	Q3S4T7	BIP_ICTTR	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)	GO:0005524; GO:0005737; GO:0005739; GO:0005788; GO:0005829; GO:0016887; GO:0030335; GO:0031204; GO:0035437; GO:0043231; GO:0090074; GO:1903895	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; positive regulation of cell migration [GO:0030335]; posttranslational protein targeting to membrane, translocation [GO:0031204]"
PGEN_.00g287470	Scaffold_14	26457945	26462792	NA	NA	NA	NA	NA
PGEN_.00g287480	Scaffold_14	26478148	26485837	Q90593	BIP_CHICK	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)	GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0006986; GO:0016020; GO:0016887; GO:0030433; GO:0030968; GO:0031072; GO:0034605; GO:0034620; GO:0034663; GO:0042026; GO:0042623; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0090074; GO:1903895	"cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein homodimerization activity [GO:0090074]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g287490	Scaffold_14	26508876	26519620	O57592	RL7A_TAKRU	60S ribosomal protein L7a (Surfeit locus protein 3)	GO:0005840; GO:0042254; GO:1990904	ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]
PGEN_.00g287500	Scaffold_14	26522778	26526088	A5WUL3	MED22_DANRE	Mediator of RNA polymerase II transcription subunit 22 (Mediator complex subunit 22) (Surfeit locus protein 5)	GO:0003712; GO:0006357; GO:0016592	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g287510	Scaffold_14	26526322	26529864	NA	NA	NA	NA	NA
PGEN_.00g287520	Scaffold_14	26533336	26566447	Q80YS9	STKL1_MOUSE	Serine/threonine kinase-like domain-containing protein STKLD1 (Serine/threonine kinase-like domain-containing protein 1) (Sugen kinase 071)	GO:0004674; GO:0005524	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g287530	Scaffold_14	26569460	26573594	Q9Y399	RT02_HUMAN	"28S ribosomal protein S2, mitochondrial (MRP-S2) (S2mt) (Mitochondrial small ribosomal subunit protein uS2m)"	GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0061668; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]
PGEN_.00g287540	Scaffold_14	26576836	26589906	Q26481	RL5_STYCL	60S ribosomal protein L5	GO:0003735; GO:0005634; GO:0005737; GO:0005840; GO:0006412; GO:0008097	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g287550	Scaffold_14	26590364	26610672	Q5T9S5	CCD18_HUMAN	Coiled-coil domain-containing protein 18 (Sarcoma antigen NY-SAR-24)		
PGEN_.00g287560	Scaffold_14	26610799	26644683	Q640L5	CCD18_MOUSE	Coiled-coil domain-containing protein 18		
PGEN_.00g287570	Scaffold_14	26651649	26702419	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g287580	Scaffold_14	26717765	26718142	NA	NA	NA	NA	NA
PGEN_.00g287590	Scaffold_14	26726295	26743224	Q7TSV3	ZMY19_RAT	Zinc finger MYND domain-containing protein 19 (Melanin-concentrating hormone receptor 1-interacting zinc finger protein) (MCH-R1-interacting zinc finger protein)	GO:0005737; GO:0005886; GO:0016020; GO:0045202; GO:0046872	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; metal ion binding [GO:0046872]
PGEN_.00g287600	Scaffold_14	26747455	26749861	NA	NA	NA	NA	NA
PGEN_.00g287610	Scaffold_14	26753624	26765995	Q9TTF0	NR2E3_BOVIN	Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor)	GO:0000122; GO:0000977; GO:0003700; GO:0003707; GO:0005634; GO:0006357; GO:0008270; GO:0030154; GO:0045944; GO:0048856	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g287620	Scaffold_14	26785396	26785737	NA	NA	NA	NA	NA
PGEN_.00g287630	Scaffold_14	26796061	26796411	NA	NA	NA	NA	NA
PGEN_.00g287640	Scaffold_14	26812319	26829006	A5A8Y8	EGFL8_PIG	Epidermal growth factor-like protein 8 (EGF-like protein 8)	GO:0005102; GO:0005509; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g287650	Scaffold_14	26842890	26847597	P74615	Y1483_SYNY3	Uncharacterized protein sll1483	GO:0005615; GO:0030288	extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]
PGEN_.00g287660	Scaffold_14	26853700	26861613	Q95LU3	FBCD1_MACFA	Fibrinogen C domain-containing protein 1	GO:0008061; GO:0016020; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g287670	Scaffold_14	26869494	26869775	NA	NA	NA	NA	NA
PGEN_.00g287680	Scaffold_14	26872633	26872986	NA	NA	NA	NA	NA
PGEN_.00g287690	Scaffold_14	26877726	26878499	NA	NA	NA	NA	NA
PGEN_.00g287700	Scaffold_14	26883762	26885425	NA	NA	NA	NA	NA
PGEN_.00g287710	Scaffold_14	26895199	26903255	P50461	CSRP3_HUMAN	"Cysteine and glycine-rich protein 3 (Cardiac LIM protein) (Cysteine-rich protein 3) (CRP3) (LIM domain protein, cardiac) (Muscle LIM protein)"	GO:0002026; GO:0003300; GO:0003779; GO:0005623; GO:0005634; GO:0005737; GO:0005856; GO:0006874; GO:0006954; GO:0007519; GO:0008286; GO:0008307; GO:0030018; GO:0030036; GO:0031433; GO:0033292; GO:0033365; GO:0035995; GO:0042593; GO:0042802; GO:0042805; GO:0045214; GO:0045662; GO:0045663; GO:0045944; GO:0046872; GO:0048738; GO:0055003; GO:0060048; GO:0060537; GO:0070528; GO:1903076; GO:1903919; GO:1903920	cell [GO:0005623]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; actinin binding [GO:0042805]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; actin cytoskeleton organization [GO:0030036]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac myofibril assembly [GO:0055003]; cellular calcium ion homeostasis [GO:0006874]; detection of muscle stretch [GO:0035995]; glucose homeostasis [GO:0042593]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; muscle tissue development [GO:0060537]; negative regulation of actin filament severing [GO:1903919]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of actin filament severing [GO:1903920]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase C signaling [GO:0070528]; protein localization to organelle [GO:0033365]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]; T-tubule organization [GO:0033292]
PGEN_.00g287720	Scaffold_14	26939045	26990495	P49796	RGS3_HUMAN	Regulator of G-protein signaling 3 (RGP3) (RGS3)	GO:0000188; GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0007186; GO:0008277	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; inactivation of MAPK activity [GO:0000188]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]
PGEN_.00g287730	Scaffold_14	26995726	26997979	NA	NA	NA	NA	NA
PGEN_.00g287740	Scaffold_14	27002757	27012520	Q5R7H4	LBR_PONAB	Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (Lamin-B receptor) (Sterol C14-reductase)	GO:0003677; GO:0005634; GO:0005637; GO:0005737; GO:0005789; GO:0006695; GO:0016021; GO:0030223; GO:0050613; GO:0070402	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; NADPH binding [GO:0070402]; cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]
PGEN_.00g287750	Scaffold_14	27016093	27018609	NA	NA	NA	NA	NA
PGEN_.00g287760	Scaffold_14	27030041	27030796	Q91XV4	DCXR_MESAU	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g287770	Scaffold_14	27091416	27094789	NA	NA	NA	NA	NA
PGEN_.00g287780	Scaffold_14	27137417	27137899	NA	NA	NA	NA	NA
PGEN_.00g287790	Scaffold_14	27151199	27151612	NA	NA	NA	NA	NA
PGEN_.00g287800	Scaffold_14	27170071	27175073	P79382	MGST1_PIG	Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I)	GO:0004364; GO:0004602; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0006749; GO:0016021; GO:0055114; GO:0070207; GO:0071449	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular response to lipid hydroperoxide [GO:0071449]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; protein homotrimerization [GO:0070207]
PGEN_.00g287810	Scaffold_14	27178670	27179713	NA	NA	NA	NA	NA
PGEN_.00g287820	Scaffold_14	27179760	27180293	NA	NA	NA	NA	NA
PGEN_.00g287830	Scaffold_14	27225553	27228016	NA	NA	NA	NA	NA
PGEN_.00g287840	Scaffold_14	27232858	27233430	NA	NA	NA	NA	NA
PGEN_.00g287850	Scaffold_14	27257473	27257733	NA	NA	NA	NA	NA
PGEN_.00g287860	Scaffold_14	27262191	27262850	NA	NA	NA	NA	NA
PGEN_.00g287870	Scaffold_14	27279699	27280349	NA	NA	NA	NA	NA
PGEN_.00g287880	Scaffold_14	27280921	27295768	Q80SU7	GVIN1_MOUSE	Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g287890	Scaffold_14	27305347	27305763	NA	NA	NA	NA	NA
PGEN_.00g287900	Scaffold_14	27325079	27326291	P31629	ZEP2_HUMAN	Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2) (HIV-EP2) (MHC-binding protein 2) (MBP-2)	GO:0003677; GO:0005654; GO:0046872	nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g287910	Scaffold_14	27326900	27328001	B4XYB8	AZIB_STREG	5-methyl-1-naphthoate synthase (EC 2.3.1.236) (Azinomycin biosynthesis protein B)	GO:0016740; GO:0017000; GO:0031177	phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740]; antibiotic biosynthetic process [GO:0017000]
PGEN_.00g287920	Scaffold_14	27328073	27328432	Q9ZGI2	PIKA4_STRVZ	"Narbonolide/10-deoxymethynolide synthase PikA4, module 6 (EC 2.3.1.239) (EC 2.3.1.240) (Narbonolide/10-deoxymethynolide synthase PikAIV) (Pikromycin polyketide synthase component PikAIV) (Pikromycin PKS component PikAIV) (Type I modular polyketide synthase PikAIV) (PKS)"	GO:0016747; GO:0016788; GO:0031177; GO:0033068	"hydrolase activity, acting on ester bonds [GO:0016788]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; macrolide biosynthetic process [GO:0033068]"
PGEN_.00g287930	Scaffold_14	27329423	27334146	NA	NA	NA	NA	NA
PGEN_.00g287940	Scaffold_14	27384066	27384745	NA	NA	NA	NA	NA
PGEN_.00g287950	Scaffold_14	27386058	27390755	NA	NA	NA	NA	NA
PGEN_.00g287960	Scaffold_14	27392324	27393289	Q80SU7	GVIN1_MOUSE	Interferon-induced very large GTPase 1 (Very large-inducible GTPase-1) (VLIG-1)	GO:0005525; GO:0005634; GO:0005829	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g287970	Scaffold_14	27393773	27394783	NA	NA	NA	NA	NA
PGEN_.00g287980	Scaffold_14	27402505	27427708	Q8WWX8	SC5AB_HUMAN	Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11)	GO:0005412; GO:0005886; GO:0006915; GO:0015166; GO:0015798; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; polyol transmembrane transporter activity [GO:0015166]; apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798]
PGEN_.00g287990	Scaffold_14	27448702	27464557	P53791	SC5A1_SHEEP	Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1)	GO:0005412; GO:0016021	integral component of membrane [GO:0016021]; glucose:sodium symporter activity [GO:0005412]
PGEN_.00g288000	Scaffold_14	27473359	27491322	G3V801	NETR_RAT	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]
PGEN_.00g288010	Scaffold_14	27512673	27534419	Q9UGM3	DMBT1_HUMAN	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0007275; GO:0008329; GO:0009897; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032]
PGEN_.00g288020	Scaffold_14	27547767	27557347	Q5Y5T3	ZDH23_MOUSE	Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (DHHC-containing protein 11) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23)	GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]
PGEN_.00g288030	Scaffold_14	27567542	27569070	P20645	MPRD_HUMAN	Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46)	GO:0004888; GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0005886; GO:0005887; GO:0006622; GO:0006898; GO:0007041; GO:0008333; GO:0016020; GO:0019904; GO:0030133; GO:0030665; GO:0032588; GO:0033299; GO:0048471; GO:0061024; GO:1905394	clathrin-coated vesicle membrane [GO:0030665]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; transmembrane signaling receptor activity [GO:0004888]; endosome to lysosome transport [GO:0008333]; lysosomal transport [GO:0007041]; membrane organization [GO:0061024]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; secretion of lysosomal enzymes [GO:0033299]
PGEN_.00g288040	Scaffold_14	27570789	27578475	P11475	ERR2_RAT	Steroid hormone receptor ERR2 (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2)	GO:0000793; GO:0000978; GO:0000981; GO:0000993; GO:0001158; GO:0001228; GO:0001701; GO:0001831; GO:0001834; GO:0001892; GO:0003700; GO:0003707; GO:0005496; GO:0005634; GO:0005737; GO:0006355; GO:0008134; GO:0008270; GO:0008283; GO:0017145; GO:0019827; GO:0043565; GO:0043697; GO:0045494; GO:0045725; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0048839; GO:0071931; GO:0090282; GO:1902459; GO:2000035; GO:2000737	"condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell division [GO:2000035]; regulation of transcription, DNA-templated [GO:0006355]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831]"
PGEN_.00g288050	Scaffold_14	27589699	27591190	Q5TZ07	PLPP6_DANRE	Phospholipid phosphatase 6 (EC 3.1.3.-) (Phosphatidic acid phosphatase type 2 domain-containing protein 2) (Presqualene diphosphate phosphatase)	GO:0016021; GO:0016787	integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]
PGEN_.00g288060	Scaffold_14	27592263	27596089	Q8C552	FA78A_MOUSE	Protein FAM78A		
PGEN_.00g288070	Scaffold_14	27601731	27604511	NA	NA	NA	NA	NA
PGEN_.00g288080	Scaffold_14	27607232	27631517	NA	NA	NA	NA	NA
PGEN_.00g288090	Scaffold_14	27652465	27687425	Q9EP53	TSC1_MOUSE	Hamartin (Tuberous sclerosis 1 protein homolog)	GO:0001822; GO:0001843; GO:0001952; GO:0002250; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005856; GO:0005884; GO:0005938; GO:0006407; GO:0006417; GO:0006813; GO:0007160; GO:0007399; GO:0008285; GO:0008344; GO:0010977; GO:0014069; GO:0016020; GO:0016239; GO:0016242; GO:0017148; GO:0021766; GO:0021987; GO:0030027; GO:0030030; GO:0030426; GO:0030544; GO:0032007; GO:0032780; GO:0032794; GO:0032868; GO:0032991; GO:0033596; GO:0034260; GO:0042030; GO:0042552; GO:0042995; GO:0043231; GO:0043379; GO:0043666; GO:0044877; GO:0045792; GO:0045859; GO:0046323; GO:0046627; GO:0047485; GO:0048471; GO:0050808; GO:0050821; GO:0051087; GO:0051291; GO:0051492; GO:0051496; GO:0051726; GO:0051879; GO:0051893; GO:0051894; GO:0055007; GO:0090630; GO:0090650; GO:0101031; GO:1901214; GO:1903204	actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; GTPase activating protein binding [GO:0032794]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; cardiac muscle cell differentiation [GO:0055007]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to oxygen-glucose deprivation [GO:0090650]; cerebral cortex development [GO:0021987]; glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATPase activity [GO:0032780]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of TOR signaling [GO:0032007]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macroautophagy [GO:0016239]; positive regulation of stress fiber assembly [GO:0051496]; potassium ion transport [GO:0006813]; protein heterooligomerization [GO:0051291]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell-matrix adhesion [GO:0001952]; regulation of focal adhesion assembly [GO:0051893]; regulation of neuron death [GO:1901214]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein kinase activity [GO:0045859]; regulation of stress fiber assembly [GO:0051492]; regulation of translation [GO:0006417]; response to insulin [GO:0032868]; rRNA export from nucleus [GO:0006407]; synapse organization [GO:0050808]
PGEN_.00g288100	Scaffold_14	27687481	27731472	Q54NA6	MYBL_DICDI	Myb-like protein L	GO:0003677; GO:0005634	nucleus [GO:0005634]; DNA binding [GO:0003677]
PGEN_.00g288110	Scaffold_14	27736781	27745020	Q767K8	RT18B_PIG	"28S ribosomal protein S18b, mitochondrial (MRP-S18-b) (Mrps18-b) (S18mt-b) (28S ribosomal protein S18-2, mitochondrial) (MRP-S18-2)"	GO:0003735; GO:0005654; GO:0005739; GO:0005763; GO:0030054; GO:0032543	cell junction [GO:0030054]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g288120	Scaffold_14	27768390	27769094	NA	NA	NA	NA	NA
PGEN_.00g288130	Scaffold_14	27793400	27796729	Q99N84	RT18B_MOUSE	"28S ribosomal protein S18b, mitochondrial (MRP-S18-b) (Mrps18-b) (S18mt-b) (28S ribosomal protein S18-2, mitochondrial) (MRP-S18-2)"	GO:0003735; GO:0005654; GO:0005739; GO:0005763; GO:0030054; GO:0032543	cell junction [GO:0030054]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g288140	Scaffold_14	27862213	27871006	Q6IND6	HMCES_XENLA	Abasic site processing protein HMCES (Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein) (ES cell-specific 5hmC-binding protein) (Peptidase HMCES) (EC 3.4.-.-) (Putative endonuclease HMCES) (EC 3.1.25.-) (SRAP domain-containing protein 1)	GO:0003697; GO:0004519; GO:0005657; GO:0006974; GO:0008233	replication fork [GO:0005657]; endonuclease activity [GO:0004519]; peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]
PGEN_.00g288150	Scaffold_14	27874295	27933560	A7MBL8	PKN2_DANRE	Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)	GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0007049; GO:0007155; GO:0017049; GO:0018105; GO:0030027; GO:0030054; GO:0030496; GO:0032154; GO:0035556; GO:0051301	cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]
PGEN_.00g288160	Scaffold_14	27879499	27881519	NA	NA	NA	NA	NA
PGEN_.00g288170	Scaffold_14	27944184	27947919	Q99622	C10_HUMAN	Protein C10	GO:0005737; GO:0009791; GO:0014819; GO:0016607; GO:0021540; GO:0021678; GO:0036343; GO:0048593; GO:0050890	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; camera-type eye morphogenesis [GO:0048593]; cognition [GO:0050890]; corpus callosum morphogenesis [GO:0021540]; post-embryonic development [GO:0009791]; psychomotor behavior [GO:0036343]; regulation of skeletal muscle contraction [GO:0014819]; third ventricle development [GO:0021678]
PGEN_.00g288180	Scaffold_14	27948161	27959514	Q6DJI8	EI3GA_XENLA	Eukaryotic translation initiation factor 3 subunit G-A (eIF3g-A) (Eukaryotic translation initiation factor 3 RNA-binding subunit A) (eIF-3 RNA-binding subunit A) (Eukaryotic translation initiation factor 3 subunit 4-A)	GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]
PGEN_.00g288190	Scaffold_14	27961987	27977548	P38004	FABG_CHLTR	3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)	GO:0004316; GO:0030497; GO:0050661; GO:0051287; GO:0102131; GO:0102132	3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497]
PGEN_.00g288200	Scaffold_14	27980045	27980290	NA	NA	NA	NA	NA
PGEN_.00g288210	Scaffold_14	27980512	27980985	NA	NA	NA	NA	NA
PGEN_.00g288220	Scaffold_14	27981037	27981468	NA	NA	NA	NA	NA
PGEN_.00g288230	Scaffold_14	27981507	27981995	NA	NA	NA	NA	NA
PGEN_.00g288240	Scaffold_14	27982113	27982940	NA	NA	NA	NA	NA
PGEN_.00g288250	Scaffold_14	27983373	27984944	A2ANX9	ZN711_MOUSE	Zinc finger protein 711	GO:0005634; GO:0043565; GO:0045893; GO:0046872	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g288260	Scaffold_14	27996336	28024143	P15622	ZN250_HUMAN	Zinc finger protein 250 (Zinc finger protein 647)	GO:0003677; GO:0005634; GO:0006355; GO:0042802; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g288270	Scaffold_14	28035647	28035976	NA	NA	NA	NA	NA
PGEN_.00g288280	Scaffold_14	28036971	28037306	NA	NA	NA	NA	NA
PGEN_.00g288290	Scaffold_14	28050682	28050954	NA	NA	NA	NA	NA
PGEN_.00g288300	Scaffold_14	28063865	28064602	NA	NA	NA	NA	NA
PGEN_.00g288310	Scaffold_14	28066818	28070616	Q580X6	PIF5_TRYB2	ATP-dependent DNA helicase PIF5 (EC 3.6.4.12) (DNA repair and recombination helicase PIF5)	GO:0000723; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005730; GO:0005737; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0032508; GO:0033567; GO:0043137; GO:0043139	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; telomere maintenance [GO:0000723]"
PGEN_.00g288320	Scaffold_14	28070660	28071025	NA	NA	NA	NA	NA
PGEN_.00g288330	Scaffold_14	28094098	28094352	NA	NA	NA	NA	NA
PGEN_.00g288340	Scaffold_14	28094580	28094927	NA	NA	NA	NA	NA
PGEN_.00g288350	Scaffold_14	28108868	28111872	NA	NA	NA	NA	NA
PGEN_.00g288360	Scaffold_14	28123920	28124378	NA	NA	NA	NA	NA
PGEN_.00g288370	Scaffold_14	28125887	28126180	NA	NA	NA	NA	NA
PGEN_.00g288380	Scaffold_14	28164421	28193991	Q5R971	HEM2_PONAB	Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)	GO:0004655; GO:0006782; GO:0006783; GO:0008270	porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]
PGEN_.00g288390	Scaffold_14	28212429	28215770	NA	NA	NA	NA	NA
PGEN_.00g288400	Scaffold_14	28228224	28244110	Q8BSN3	CC151_MOUSE	Coiled-coil domain-containing protein 151	GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0036064; GO:0036158; GO:0061371; GO:1902017	axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]
PGEN_.00g288410	Scaffold_14	28253262	28286992	Q5U3K5	RABL6_MOUSE	Rab-like protein 6 (GTP-binding protein Parf) (Rab-like protein 1) (RBEL1)	GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]
PGEN_.00g288420	Scaffold_14	28289543	28290218	NA	NA	NA	NA	NA
PGEN_.00g288430	Scaffold_14	28290736	28291065	NA	NA	NA	NA	NA
PGEN_.00g288440	Scaffold_14	28324678	28367368	Q13219	PAPP1_HUMAN	Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A)	GO:0004222; GO:0005576; GO:0005615; GO:0007565; GO:0008237; GO:0008270; GO:0032354; GO:0044267; GO:0051384	extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cellular protein metabolic process [GO:0044267]; female pregnancy [GO:0007565]; response to follicle-stimulating hormone [GO:0032354]; response to glucocorticoid [GO:0051384]
PGEN_.00g288450	Scaffold_14	28413271	28422577	P09478	ACH1_DROME	Acetylcholine receptor subunit alpha-like 1 (Nicotinic acetylcholine receptor alpha 1)	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g288460	Scaffold_14	28431740	28431979	NA	NA	NA	NA	NA
PGEN_.00g288470	Scaffold_14	28457292	28457549	NA	NA	NA	NA	NA
PGEN_.00g288480	Scaffold_14	28462293	28468165	NA	NA	NA	NA	NA
PGEN_.00g288490	Scaffold_14	28476405	28484283	NA	NA	NA	NA	NA
PGEN_.00g288500	Scaffold_14	28495250	28495669	NA	NA	NA	NA	NA
PGEN_.00g288510	Scaffold_14	28495881	28496225	NA	NA	NA	NA	NA
PGEN_.00g288520	Scaffold_14	28506204	28513588	NA	NA	NA	NA	NA
PGEN_.00g288530	Scaffold_14	28519774	28520043	NA	NA	NA	NA	NA
PGEN_.00g288540	Scaffold_14	28525582	28543104	A5PK45	GT251_BOVIN	Procollagen galactosyltransferase 1 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 1) (Glycosyltransferase 25 family member 1) (Hydroxylysine galactosyltransferase 1)	GO:0005788; GO:0050211; GO:1904028	endoplasmic reticulum lumen [GO:0005788]; procollagen galactosyltransferase activity [GO:0050211]; positive regulation of collagen fibril organization [GO:1904028]
PGEN_.00g288550	Scaffold_14	28543314	28552100	Q7Q021	GLT25_ANOGA	Glycosyltransferase 25 family member (EC 2.-.-.-)	GO:0005788; GO:0016757	"endoplasmic reticulum lumen [GO:0005788]; transferase activity, transferring glycosyl groups [GO:0016757]"
PGEN_.00g288560	Scaffold_14	28560513	28560800	NA	NA	NA	NA	NA
PGEN_.00g288570	Scaffold_14	28563243	28563524	NA	NA	NA	NA	NA
PGEN_.00g288580	Scaffold_14	28564483	28569894	C7G0B5	PIF_PINFU	Protein PIF [Cleaved into: Protein Pif97; Protein Pif80 (Aragonite-binding protein)]	GO:0005576; GO:0006030; GO:0008061	extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]
PGEN_.00g288590	Scaffold_14	28602483	28611117	NA	NA	NA	NA	NA
PGEN_.00g288600	Scaffold_14	28662580	28664802	NA	NA	NA	NA	NA
PGEN_.00g288610	Scaffold_14	28665389	28667233	NA	NA	NA	NA	NA
PGEN_.00g288620	Scaffold_14	28678584	28680750	NA	NA	NA	NA	NA
PGEN_.00g288630	Scaffold_14	28692672	28719161	Q5HZJ0	RNC_MOUSE	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III)	GO:0001530; GO:0003725; GO:0004521; GO:0004525; GO:0005634; GO:0005730; GO:0006396; GO:0010468; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]
PGEN_.00g288640	Scaffold_14	28745738	28753895	Q9NRR4	RNC_HUMAN	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)	GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0030422; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]
PGEN_.00g288650	Scaffold_14	28768838	28772850	NA	NA	NA	NA	NA
PGEN_.00g288660	Scaffold_14	28781047	28781988	NA	NA	NA	NA	NA
PGEN_.00g288670	Scaffold_14	28782815	28785282	NA	NA	NA	NA	NA
PGEN_.00g288680	Scaffold_14	28785320	28785589	NA	NA	NA	NA	NA
PGEN_.00g288690	Scaffold_14	28853602	28869395	NA	NA	NA	NA	NA
PGEN_.00g288700	Scaffold_14	28869824	28900495	Q8UVR3	LMX1B_XENLA	LIM homeobox transcription factor 1-beta.1 (LIM homeobox protein 1b) (Xlmx1b)	GO:0003700; GO:0005634; GO:0030182; GO:0039020; GO:0043565; GO:0046872; GO:0072013	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; glomus development [GO:0072013]; neuron differentiation [GO:0030182]; pronephric nephron tubule development [GO:0039020]
PGEN_.00g288710	Scaffold_14	28923765	28928645	NA	NA	NA	NA	NA
PGEN_.00g288720	Scaffold_14	28928695	28935070	NA	NA	NA	NA	NA
PGEN_.00g288730	Scaffold_14	28935341	28935808	NA	NA	NA	NA	NA
PGEN_.00g288740	Scaffold_14	28957633	28963280	NA	NA	NA	NA	NA
PGEN_.00g288750	Scaffold_14	28963493	28971585	NA	NA	NA	NA	NA
PGEN_.00g288760	Scaffold_14	28991116	29001989	NA	NA	NA	NA	NA
PGEN_.00g288770	Scaffold_14	29002502	29018612	NA	NA	NA	NA	NA
PGEN_.00g288780	Scaffold_14	29024335	29024898	NA	NA	NA	NA	NA
PGEN_.00g288790	Scaffold_14	29056978	29057178	NA	NA	NA	NA	NA
PGEN_.00g288800	Scaffold_14	29057430	29057717	NA	NA	NA	NA	NA
PGEN_.00g288810	Scaffold_14	29113467	29132549	P27105	STOM_HUMAN	Erythrocyte band 7 integral membrane protein (Protein 7.2b) (Stomatin)	GO:0005615; GO:0005739; GO:0005783; GO:0005856; GO:0005886; GO:0005887; GO:0016020; GO:0031982; GO:0035577; GO:0035579; GO:0042470; GO:0042803; GO:0043312; GO:0044829; GO:0045121; GO:0048471; GO:0051260; GO:0070062; GO:0070063; GO:0070821; GO:0072562; GO:0090314; GO:1901585	azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; regulation of acid-sensing ion channel activity [GO:1901585]
PGEN_.00g288820	Scaffold_14	29136109	29136906	NA	NA	NA	NA	NA
PGEN_.00g288830	Scaffold_14	29140065	29140871	NA	NA	NA	NA	NA
PGEN_.00g288840	Scaffold_14	29152924	29156413	NA	NA	NA	NA	NA
PGEN_.00g288850	Scaffold_14	29193837	29230220	Q27433	MEC2_CAEEL	Mechanosensory protein 2	GO:0005886; GO:0007638; GO:0009612; GO:0015485; GO:0016021; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612]
PGEN_.00g288860	Scaffold_14	29233072	29246011	Q16TM5	BND7A_AEDAE	Band 7 protein AAEL010189	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g288870	Scaffold_14	29255798	29267068	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g288880	Scaffold_14	29272549	29276624	NA	NA	NA	NA	NA
PGEN_.00g288890	Scaffold_14	29298323	29324400	Q22328	LEV9_CAEEL	Protein lev-9	GO:0005615; GO:0030054; GO:0030414; GO:0045202	cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; peptidase inhibitor activity [GO:0030414]
PGEN_.00g288900	Scaffold_14	29334655	29340409	NA	NA	NA	NA	NA
PGEN_.00g288910	Scaffold_14	29349699	29350250	NA	NA	NA	NA	NA
PGEN_.00g288920	Scaffold_14	29414242	29414565	NA	NA	NA	NA	NA
PGEN_.00g288930	Scaffold_14	29437232	29438194	NA	NA	NA	NA	NA
PGEN_.00g288940	Scaffold_14	29438541	29441125	NA	NA	NA	NA	NA
PGEN_.00g288950	Scaffold_14	29446531	29448130	NA	NA	NA	NA	NA
PGEN_.00g288960	Scaffold_14	29451259	29451480	NA	NA	NA	NA	NA
PGEN_.00g288970	Scaffold_14	29452151	29452552	NA	NA	NA	NA	NA
PGEN_.00g288980	Scaffold_14	29474912	29477765	NA	NA	NA	NA	NA
PGEN_.00g288990	Scaffold_14	29486162	29488655	NA	NA	NA	NA	NA
PGEN_.00g289000	Scaffold_14	29510470	29512256	NA	NA	NA	NA	NA
PGEN_.00g289010	Scaffold_14	29513194	29513454	NA	NA	NA	NA	NA
PGEN_.00g289020	Scaffold_14	29522854	29524741	Q26626	KIFA3_STRPU	Kinesin-associated protein 3 (SpKAP115)	GO:0007017; GO:0016939; GO:0019894	kinesin II complex [GO:0016939]; kinesin binding [GO:0019894]; microtubule-based process [GO:0007017]
PGEN_.00g289030	Scaffold_14	29546222	29548279	NA	NA	NA	NA	NA
PGEN_.00g289040	Scaffold_14	29557664	29558299	NA	NA	NA	NA	NA
PGEN_.00g289050	Scaffold_14	29598589	29600390	NA	NA	NA	NA	NA
PGEN_.00g289060	Scaffold_14	29616418	29622077	NA	NA	NA	NA	NA
PGEN_.00g289070	Scaffold_14	29630014	29630934	NA	NA	NA	NA	NA
PGEN_.00g289080	Scaffold_14	29631030	29631362	NA	NA	NA	NA	NA
PGEN_.00g289090	Scaffold_14	29650979	29662232	E9Q5G3	KIF23_MOUSE	Kinesin-like protein KIF23	GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149	cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]
PGEN_.00g289100	Scaffold_14	29669392	29682501	O35083	PLCA_MOUSE	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha)	GO:0001819; GO:0003841; GO:0005783; GO:0005789; GO:0006654; GO:0016021; GO:0016024	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of cytokine production [GO:0001819]
PGEN_.00g289110	Scaffold_14	29695864	29720046	A3DH97	RSGI6_HUNT2	"Anti-sigma-I factor RsgI6 (Endo-1,4-beta-xylanase) (EC 3.2.1.8)"	GO:0005886; GO:0016021; GO:0031176; GO:0045493	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g289120	Scaffold_14	29730269	29735847	NA	NA	NA	NA	NA
PGEN_.00g289130	Scaffold_14	29747214	29761244	P12276	FAS_CHICK	Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	GO:0003697; GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005623; GO:0006089; GO:0006633; GO:0008659; GO:0008693; GO:0016295; GO:0016296; GO:0031177; GO:0032100; GO:0047117; GO:0047451; GO:0102131; GO:0102132	"cell [GO:0005623]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; single-stranded DNA binding [GO:0003697]; fatty acid biosynthetic process [GO:0006633]; lactate metabolic process [GO:0006089]; positive regulation of appetite [GO:0032100]"
PGEN_.00g289140	Scaffold_14	29772316	29806486	P19096	FAS_MOUSE	Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006084; GO:0006633; GO:0008144; GO:0008611; GO:0008659; GO:0008693; GO:0009888; GO:0016295; GO:0016296; GO:0030223; GO:0030224; GO:0030879; GO:0031177; GO:0042470; GO:0042587; GO:0042802; GO:0042803; GO:0047117; GO:0047451; GO:0048468; GO:0070402; GO:0071353; GO:0090557; GO:0102131; GO:0102132	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; drug binding [GO:0008144]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; NADPH binding [GO:0070402]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; protein homodimerization activity [GO:0042803]; acetyl-CoA metabolic process [GO:0006084]; cell development [GO:0048468]; cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; mammary gland development [GO:0030879]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; tissue development [GO:0009888]"
PGEN_.00g289150	Scaffold_14	29814823	29819785	Q03958	PFD6_MOUSE	Prefoldin subunit 6 (Protein Ke2)	GO:0005634; GO:0005737; GO:0006457; GO:0016272; GO:0051082; GO:0051087; GO:0051131	cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457]
PGEN_.00g289160	Scaffold_14	29819999	29835877	P09925	SURF1_MOUSE	Surfeit locus protein 1	GO:0004129; GO:0005739; GO:0005743; GO:0006119; GO:0016021; GO:0033617	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; oxidative phosphorylation [GO:0006119]
PGEN_.00g289170	Scaffold_14	29847319	29857782	Q9BZX2	UCK2_HUMAN	Uridine-cytidine kinase 2 (UCK 2) (EC 2.7.1.48) (Cytidine monophosphokinase 2) (Testis-specific protein TSA903) (Uridine monophosphokinase 2)	GO:0004849; GO:0005524; GO:0005829; GO:0016301; GO:0042802; GO:0043097; GO:0044206; GO:0044211	cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]
PGEN_.00g289180	Scaffold_14	29895651	29899182	NA	NA	NA	NA	NA
PGEN_.00g289190	Scaffold_14	29924281	29924646	NA	NA	NA	NA	NA
PGEN_.00g289200	Scaffold_14	29924698	29925462	NA	NA	NA	NA	NA
PGEN_.00g289210	Scaffold_14	29946099	30003898	Q5FWI3	CEIP2_MOUSE	Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2)	GO:0001525; GO:0004415; GO:0005509; GO:0005886; GO:0005887; GO:0030214; GO:0043231; GO:1903670	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]
PGEN_.00g289220	Scaffold_14	30013953	30017315	NA	NA	NA	NA	NA
PGEN_.00g289230	Scaffold_14	30031780	30068819	Q5T5J6	SWT1_HUMAN	Transcriptional protein SWT1	GO:0005634	nucleus [GO:0005634]
PGEN_.00g289240	Scaffold_14	30069289	30082721	Q9UKM7	MA1B1_HUMAN	"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)"	GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0006491; GO:0009311; GO:0016020; GO:0016021; GO:0030433; GO:0036508; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:1903561; GO:1904380; GO:1904382	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g289250	Scaffold_14	30096649	30096906	NA	NA	NA	NA	NA
PGEN_.00g289260	Scaffold_14	30102065	30102679	NA	NA	NA	NA	NA
PGEN_.00g289270	Scaffold_14	30108395	30190536	O75445	USH2A_HUMAN	Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein)	GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0009887; GO:0009888; GO:0016021; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0060113; GO:0060171; GO:1990075; GO:1990696	apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; animal organ morphogenesis [GO:0009887]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]; visual perception [GO:0007601]
PGEN_.00g289280	Scaffold_14	30190803	30216549	Q6NZQ2	DDX31_MOUSE	Probable ATP-dependent RNA helicase DDX31 (EC 3.6.4.13) (DEAD box protein 31)	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005794; GO:0042254; GO:0043231	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ribosome biogenesis [GO:0042254]
PGEN_.00g289290	Scaffold_14	30219028	30222207	Q9QUR7	PIN1_MOUSE	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1)	GO:0001666; GO:0001932; GO:0001934; GO:0003755; GO:0003774; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0007049; GO:0008013; GO:0010468; GO:0016607; GO:0016859; GO:0030182; GO:0030496; GO:0030512; GO:0031434; GO:0031647; GO:0032091; GO:0032092; GO:0032465; GO:0032794; GO:0035307; GO:0042127; GO:0042177; GO:0043005; GO:0043524; GO:0043525; GO:0043547; GO:0045944; GO:0050808; GO:0050815; GO:0050816; GO:0050821; GO:0051219; GO:0051443; GO:0060393; GO:0061051; GO:0070373; GO:0090263; GO:0098978; GO:0099524; GO:1900180; GO:1902430; GO:2000146	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; beta-catenin binding [GO:0008013]; cis-trans isomerase activity [GO:0016859]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; motor activity [GO:0003774]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; cell cycle [GO:0007049]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein stabilization [GO:0050821]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; regulation of gene expression [GO:0010468]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]; synapse organization [GO:0050808]
PGEN_.00g289300	Scaffold_14	30230144	30258604	Q8MPM1	GELS2_LUMTE	Gelsolin-like protein 2 (Actin-modulator) (EWAM-P2)	GO:0005737; GO:0005856; GO:0051015; GO:0051693	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament capping [GO:0051693]
PGEN_.00g289310	Scaffold_14	30272414	30349357	Q5VVW2	GARL3_HUMAN	GTPase-activating Rap/Ran-GAP domain-like protein 3	GO:0005096; GO:0051056	GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g289320	Scaffold_14	30369909	30378330	O08760	OGG1_MOUSE	N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)]	GO:0000702; GO:0002526; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006285; GO:0006355; GO:0006974; GO:0006979; GO:0007568; GO:0008017; GO:0008534; GO:0009314; GO:0009416; GO:0016363; GO:0016607; GO:0019104; GO:0032355; GO:0032357; GO:0032991; GO:0033683; GO:0034039; GO:0043066; GO:0045471; GO:0051593; GO:0071276; GO:0140078; GO:1901291	"mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; microtubule binding [GO:0008017]; oxidized base lesion DNA N-glycosylase activity [GO:0000702]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair, DNA incision [GO:0033683]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]"
PGEN_.00g289330	Scaffold_14	30379386	30389690	Q91WV0	NC2B_MOUSE	Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein)	GO:0000122; GO:0001047; GO:0003714; GO:0005634; GO:0005654; GO:0005671; GO:0006338; GO:0017025; GO:0017054; GO:0043966; GO:0045898; GO:0045944; GO:0046982	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; core promoter binding [GO:0001047]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]
PGEN_.00g289340	Scaffold_14	30397962	30412201	Q68FX0	IDH3B_RAT	"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)"	GO:0000287; GO:0004449; GO:0005739; GO:0005962; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0051287	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrion [GO:0005739]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g289350	Scaffold_14	30417965	30428365	Q14DL3	LRIQ3_MOUSE	Leucine-rich repeat and IQ domain-containing protein 3 (Leucine-rich repeat-containing protein 44)		
PGEN_.00g289360	Scaffold_14	30442623	30446417	Q26065	ACT_PLAMG	"Actin, adductor muscle"	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g289370	Scaffold_14	30462031	30466364	Q26065	ACT_PLAMG	"Actin, adductor muscle"	GO:0005524; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
PGEN_.00g289380	Scaffold_14	30485899	30499464	NA	NA	NA	NA	NA
PGEN_.00g289390	Scaffold_14	30505953	30509852	P83851	IUNH_LEIMA	Inosine-uridine preferring nucleoside hydrolase (IU-NH) (IU-nucleoside hydrolase) (EC 3.2.2.2) (EC 3.2.2.3) (Non-specific nucleoside hydrolase)	GO:0005509; GO:0008477; GO:0009117; GO:0043101; GO:0045437; GO:0047724	calcium ion binding [GO:0005509]; inosine nucleosidase activity [GO:0047724]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437]; nucleotide metabolic process [GO:0009117]; purine-containing compound salvage [GO:0043101]
PGEN_.00g289400	Scaffold_14	30528992	30567289	Q61410	KGP2_MOUSE	cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)	GO:0004692; GO:0005524; GO:0005623; GO:0005886; GO:0006468; GO:0007623; GO:0016020; GO:0016324; GO:0030553; GO:0031965; GO:0032922; GO:0036289; GO:0042802; GO:0045794; GO:0071476; GO:0072659; GO:2001226	apical plasma membrane [GO:0016324]; cell [GO:0005623]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; cellular hypotonic response [GO:0071476]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cell volume [GO:0045794]; negative regulation of chloride transport [GO:2001226]; peptidyl-serine autophosphorylation [GO:0036289]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]
PGEN_.00g289410	Scaffold_14	30581923	30597229	Q9P6J4	YHD6_SCHPO	Uncharacterized protein C1683.06c	GO:0005634; GO:0005829; GO:0006152; GO:0008477; GO:0008655; GO:0019358; GO:0034356; GO:0045437; GO:0046135; GO:0070635; GO:0070636	cytosol [GO:0005829]; nucleus [GO:0005634]; nicotinamide riboside hydrolase activity [GO:0070635]; nicotinic acid riboside hydrolase activity [GO:0070636]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinate nucleotide salvage [GO:0019358]; purine nucleoside catabolic process [GO:0006152]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine-containing compound salvage [GO:0008655]
PGEN_.00g289420	Scaffold_14	30598752	30598976	NA	NA	NA	NA	NA
PGEN_.00g289430	Scaffold_14	30599145	30599465	NA	NA	NA	NA	NA
PGEN_.00g289440	Scaffold_14	30604736	30606185	NA	NA	NA	NA	NA
PGEN_.00g289450	Scaffold_14	30613351	30613557	NA	NA	NA	NA	NA
PGEN_.00g289460	Scaffold_14	30629220	30630166	NA	NA	NA	NA	NA
PGEN_.00g289470	Scaffold_14	30631585	30632996	NA	NA	NA	NA	NA
PGEN_.00g289480	Scaffold_14	30633204	30633422	NA	NA	NA	NA	NA
PGEN_.00g289490	Scaffold_14	30642135	30656067	NA	NA	NA	NA	NA
PGEN_.00g289500	Scaffold_14	30667881	30668201	NA	NA	NA	NA	NA
PGEN_.00g289510	Scaffold_14	30759140	30760518	NA	NA	NA	NA	NA
PGEN_.00g289520	Scaffold_14	30781263	30787059	NA	NA	NA	NA	NA
PGEN_.00g289530	Scaffold_14	30787187	30794621	NA	NA	NA	NA	NA
PGEN_.00g289540	Scaffold_14	30795605	30795955	NA	NA	NA	NA	NA
PGEN_.00g289550	Scaffold_14	30797893	30801443	NA	NA	NA	NA	NA
PGEN_.00g289560	Scaffold_14	30813694	30815679	NA	NA	NA	NA	NA
PGEN_.00g289570	Scaffold_14	30841807	30860163	NA	NA	NA	NA	NA
PGEN_.00g289580	Scaffold_14	30921618	30941392	NA	NA	NA	NA	NA
PGEN_.00g289590	Scaffold_14	30941527	30942174	NA	NA	NA	NA	NA
PGEN_.00g289600	Scaffold_14	30947589	30947858	NA	NA	NA	NA	NA
PGEN_.00g289610	Scaffold_14	30958239	30961127	NA	NA	NA	NA	NA
PGEN_.00g289620	Scaffold_14	30988241	30988705	NA	NA	NA	NA	NA
PGEN_.00g289630	Scaffold_14	31028950	31029312	NA	NA	NA	NA	NA
PGEN_.00g289640	Scaffold_14	31034687	31035082	NA	NA	NA	NA	NA
PGEN_.00g289650	Scaffold_14	31039099	31045357	NA	NA	NA	NA	NA
PGEN_.00g289660	Scaffold_14	31065533	31072729	NA	NA	NA	NA	NA
PGEN_.00g289670	Scaffold_14	31096576	31102663	NA	NA	NA	NA	NA
PGEN_.00g289680	Scaffold_14	31123752	31134311	Q15477	SKIV2_HUMAN	Helicase SKI2W (Ski2) (EC 3.6.4.-) (Helicase-like protein) (HLP)	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0006401; GO:0043928; GO:0055087; GO:0070478	"cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]"
PGEN_.00g289690	Scaffold_14	31137998	31160655	O15213	WDR46_HUMAN	WD repeat-containing protein 46 (WD repeat-containing protein BING4)	GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0032040	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]"
PGEN_.00g289700	Scaffold_14	31163972	31179551	Q8C8N2	SCAI_MOUSE	Protein SCAI (Suppressor of cancer cell invasion protein)	GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0016021; GO:0030336; GO:0031965; GO:0035024	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g289710	Scaffold_14	31195183	31202314	Q8N9R8	SCAI_HUMAN	Protein SCAI (Suppressor of cancer cell invasion protein)	GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0016021; GO:0030336; GO:0031965; GO:0035024	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g289720	Scaffold_14	31206279	31207898	NA	NA	NA	NA	NA
PGEN_.00g289730	Scaffold_14	31213389	31213844	NA	NA	NA	NA	NA
PGEN_.00g289740	Scaffold_14	31216691	31238235	NA	NA	NA	NA	NA
PGEN_.00g289750	Scaffold_14	31239007	31241820	Q9R186	TRPV6_RAT	Transient receptor potential cation channel subfamily V member 6 (TrpV6) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2)	GO:0005216; GO:0005227; GO:0005262; GO:0005516; GO:0005623; GO:0005886; GO:0005887; GO:0006816; GO:0016324; GO:0035898; GO:0042802; GO:0046872; GO:0051289; GO:0051592; GO:0055074; GO:0070509; GO:0070588; GO:0098703	apical plasma membrane [GO:0016324]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592]
PGEN_.00g289760	Scaffold_14	31256289	31283913	Q9JLB4	CUBN_MOUSE	Cubilin (Intrinsic factor-cobalamin receptor)	GO:0001701; GO:0005509; GO:0005623; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008144; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0045177; GO:0070062	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]
PGEN_.00g289770	Scaffold_14	31294763	31301878	O08848	RO60_MOUSE	60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (Ro60) (RoRNP) (TROVE domain family member 2)	GO:0002520; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007224; GO:0009411; GO:0010468; GO:0030620; GO:0034336; GO:0035457; GO:0046872; GO:0060271; GO:1990904	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; misfolded RNA binding [GO:0034336]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cellular response to interferon-alpha [GO:0035457]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; regulation of gene expression [GO:0010468]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]
PGEN_.00g289780	Scaffold_14	31303515	31306883	P91303	VATG_CAEEL	Probable V-type proton ATPase subunit G (V-ATPase subunit G) (Vacuolar proton pump subunit G)	GO:0006754; GO:0008553; GO:0012501; GO:0015078; GO:0016471; GO:0043068; GO:1902600	"vacuolar proton-transporting V-type ATPase complex [GO:0016471]; proton transmembrane transporter activity [GO:0015078]; proton-exporting ATPase activity, phosphorylative mechanism [GO:0008553]; ATP biosynthetic process [GO:0006754]; positive regulation of programmed cell death [GO:0043068]; programmed cell death [GO:0012501]; proton transmembrane transport [GO:1902600]"
PGEN_.00g289790	Scaffold_14	31314268	31322422	Q3T168	CYBP_BOVIN	Calcyclin-binding protein (CacyBP)	GO:0005634; GO:0005641; GO:0005654; GO:0005829; GO:0007507; GO:0015631; GO:0019005; GO:0019904; GO:0030877; GO:0031625; GO:0042803; GO:0044548; GO:1990830	beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507]
PGEN_.00g289800	Scaffold_14	31349698	31365633	Q32KT5	CF136_BOVIN	Uncharacterized protein C6orf136 homolog		
PGEN_.00g289810	Scaffold_14	31373656	31375064	NA	NA	NA	NA	NA
PGEN_.00g289820	Scaffold_14	31381729	31383210	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g289830	Scaffold_14	31384587	31388112	NA	NA	NA	NA	NA
PGEN_.00g289840	Scaffold_14	31388175	31398153	Q9D0T2	DUS12_MOUSE	Dual specificity protein phosphatase 12 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase T-DSP4) (Dual specificity phosphatase VH1)	GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008138; GO:0008270; GO:0016311; GO:0016791; GO:0019900; GO:0033133	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]; dephosphorylation [GO:0016311]; positive regulation of glucokinase activity [GO:0033133]; protein dephosphorylation [GO:0006470]
PGEN_.00g289850	Scaffold_14	31404649	31443140	A3KGV1	ODFP2_MOUSE	Outer dense fiber protein 2 (84 kDa outer dense fiber protein) (Cenexin) (Outer dense fiber of sperm tails protein 2)	GO:0000922; GO:0001520; GO:0005200; GO:0005737; GO:0005813; GO:0005814; GO:0005874; GO:0005929; GO:0007275; GO:0007286; GO:0008104; GO:0010457; GO:0017137; GO:0036064; GO:0036126; GO:0044782; GO:0097539; GO:0120103; GO:1902017	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; Rab GTPase binding [GO:0017137]; structural constituent of cytoskeleton [GO:0005200]; centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; multicellular organism development [GO:0007275]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatid development [GO:0007286]
PGEN_.00g289860	Scaffold_14	31449110	31452391	Q8BYU6	TOIP2_MOUSE	Torsin-1A-interacting protein 2	GO:0001671; GO:0005635; GO:0005783; GO:0005789; GO:0007029; GO:0016021; GO:0032781; GO:0051117; GO:0090435	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; endoplasmic reticulum organization [GO:0007029]; positive regulation of ATPase activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]
PGEN_.00g289870	Scaffold_14	31465495	31513783	Q1LXK4	M10B1_DANRE	Putative helicase mov-10-B.1 (EC 3.6.4.13)	GO:0000932; GO:0003723; GO:0005524; GO:0005829; GO:0032574; GO:0035194; GO:0035279; GO:0043186	cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; posttranscriptional gene silencing by RNA [GO:0035194]
PGEN_.00g289880	Scaffold_14	31518999	31535916	Q7ZWJ3	OSTC_DANRE	Oligosaccharyltransferase complex subunit ostc	GO:0006486; GO:0008250; GO:0016021	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]
PGEN_.00g289890	Scaffold_14	31537947	31555871	P15101	DOPO_BOVIN	Dopamine beta-hydroxylase (EC 1.14.17.1) (Dopamine beta-monooxygenase) [Cleaved into: Soluble dopamine beta-hydroxylase]	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030658; GO:0030667; GO:0031418; GO:0034466; GO:0034774; GO:0042420; GO:0042421; GO:0042584	"chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g289900	Scaffold_14	31560858	31569161	NA	NA	NA	NA	NA
PGEN_.00g289910	Scaffold_14	31569230	31570961	NA	NA	NA	NA	NA
PGEN_.00g289920	Scaffold_14	31659359	31659772	NA	NA	NA	NA	NA
PGEN_.00g289930	Scaffold_14	31663099	31665443	NA	NA	NA	NA	NA
PGEN_.00g289940	Scaffold_14	31677714	31681463	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g289950	Scaffold_14	31691782	31692675	NA	NA	NA	NA	NA
PGEN_.00g289960	Scaffold_14	31694517	31699675	NA	NA	NA	NA	NA
PGEN_.00g289970	Scaffold_14	31704048	31712309	O43543	XRCC2_HUMAN	DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2)	GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007098; GO:0008094; GO:0010165; GO:0010332; GO:0033063; GO:0035264; GO:0042148; GO:0043231; GO:0043524; GO:0050769; GO:0051321; GO:2000269	centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756]; strand invasion [GO:0042148]
PGEN_.00g289980	Scaffold_14	31722763	31733030	Q09621	LACT2_CAEEL	Beta-lactamase domain-containing protein 2	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g289990	Scaffold_14	31772343	31781974	Q19791	GON1_CAEEL	A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1)	GO:0004222; GO:0005604; GO:0005783; GO:0005794; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0048644; GO:1905607	basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]
PGEN_.00g290000	Scaffold_14	31874575	31892002	NA	NA	NA	NA	NA
PGEN_.00g290010	Scaffold_14	31892034	31926622	Q9VYY9	EVI5_DROME	Ecotropic viral integration site 5 ortholog	GO:0005096; GO:0005737; GO:0005768; GO:0005794; GO:0006886; GO:0017137; GO:0030334; GO:0031982; GO:0032880; GO:0043087; GO:0090630	cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of cell migration [GO:0030334]; regulation of GTPase activity [GO:0043087]; regulation of protein localization [GO:0032880]
PGEN_.00g290020	Scaffold_14	31911838	31915505	NA	NA	NA	NA	NA
PGEN_.00g290030	Scaffold_14	31955262	31964770	P97366	EVI5_MOUSE	Ecotropic viral integration site 5 protein (EVI-5)	GO:0005096; GO:0005634; GO:0005815; GO:0005819; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0042147; GO:0043547; GO:0051301; GO:0090630	"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular protein transport [GO:0006886]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g290040	Scaffold_14	31994718	32021098	O60447	EVI5_HUMAN	Ecotropic viral integration site 5 protein homolog (EVI-5) (Neuroblastoma stage 4S gene protein)	GO:0005096; GO:0005634; GO:0005815; GO:0005819; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0042147; GO:0043547; GO:0051301; GO:0090630	"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular protein transport [GO:0006886]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g290050	Scaffold_14	32037352	32037822	NA	NA	NA	NA	NA
PGEN_.00g290060	Scaffold_14	32038376	32040862	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g290070	Scaffold_14	32062875	32063667	NA	NA	NA	NA	NA
PGEN_.00g290080	Scaffold_14	32088946	32092915	NA	NA	NA	NA	NA
PGEN_.00g290090	Scaffold_14	32123544	32145818	NA	NA	NA	NA	NA
PGEN_.00g290100	Scaffold_14	32149423	32160913	NA	NA	NA	NA	NA
PGEN_.00g290110	Scaffold_14	32170916	32202190	Q62839	GOGA2_RAT	Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130)	GO:0000137; GO:0000139; GO:0000922; GO:0005737; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007030; GO:0007098; GO:0008017; GO:0008356; GO:0010507; GO:0015031; GO:0019901; GO:0019905; GO:0030134; GO:0032091; GO:0032580; GO:0032991; GO:0033116; GO:0042802; GO:0043025; GO:0044877; GO:0048471; GO:0050772; GO:0051225; GO:0051289; GO:0051645; GO:0060050; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307	cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]
PGEN_.00g290120	Scaffold_14	32208199	32226634	Q8BTZ4	APC5_MOUSE	Anaphase-promoting complex subunit 5 (APC5) (Cyclosome subunit 5)	GO:0005634; GO:0005680; GO:0007049; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0061630; GO:0070979	anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; ubiquitin protein ligase activity [GO:0061630]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]
PGEN_.00g290130	Scaffold_14	32239760	32279689	Q6GQB9	EDEM3_XENLA	"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)"	GO:0004571; GO:0005509; GO:0005788; GO:0006486; GO:0006986; GO:0016020; GO:1904382	"endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]"
PGEN_.00g290140	Scaffold_14	32282430	32284771	NA	NA	NA	NA	NA
PGEN_.00g290150	Scaffold_14	32311293	32342510	NA	NA	NA	NA	NA
PGEN_.00g290160	Scaffold_14	32349055	32349366	NA	NA	NA	NA	NA
PGEN_.00g290170	Scaffold_14	32368921	32396467	NA	NA	NA	NA	NA
PGEN_.00g290180	Scaffold_14	32398158	32413873	Q09621	LACT2_CAEEL	Beta-lactamase domain-containing protein 2	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g290190	Scaffold_14	32435269	32442464	Q95T12	FLOWR_DROME	Calcium channel flower (3L5)	GO:0005262; GO:0005886; GO:0006816; GO:0016192; GO:0030054; GO:0030285; GO:0035212; GO:0042802; GO:0042981; GO:0043525; GO:0044214; GO:0046530; GO:0048488; GO:0070588; GO:0099533; GO:0150007; GO:0150008	cell junction [GO:0030054]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; bulk synaptic vesicle endocytosis [GO:0150008]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell competition in a multicellular organism [GO:0035212]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; photoreceptor cell differentiation [GO:0046530]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of presynaptic cytosolic calcium concentration [GO:0099533]; regulation of apoptotic process [GO:0042981]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]
PGEN_.00g290200	Scaffold_14	32448360	32455500	NA	NA	NA	NA	NA
PGEN_.00g290210	Scaffold_14	32458123	32473415	Q9XTQ6	TBH1_CAEEL	Tyramine beta-hydroxylase (EC 1.14.17.-)	GO:0004500; GO:0004836; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421; GO:0045202	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; tyramine-beta hydroxylase activity [GO:0004836]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g290220	Scaffold_14	32481703	32524271	A3KPQ7	CEIP2_DANRE	Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Protein frozen ventricle) (Protein wickham) (Transmembrane protein 2)	GO:0001525; GO:0001947; GO:0003143; GO:0003190; GO:0003197; GO:0003318; GO:0004415; GO:0005509; GO:0005887; GO:0016203; GO:0030214; GO:0055008; GO:0060415; GO:0060974; GO:1900748; GO:1901203; GO:1903670	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670]
PGEN_.00g290230	Scaffold_14	32534973	32536067	NA	NA	NA	NA	NA
PGEN_.00g290240	Scaffold_14	32541061	32541913	NA	NA	NA	NA	NA
PGEN_.00g290250	Scaffold_14	32541998	32542384	NA	NA	NA	NA	NA
PGEN_.00g290260	Scaffold_14	32544183	32544895	NA	NA	NA	NA	NA
PGEN_.00g290270	Scaffold_14	32548031	32552392	NA	NA	NA	NA	NA
PGEN_.00g290280	Scaffold_14	32553062	32553355	NA	NA	NA	NA	NA
PGEN_.00g290290	Scaffold_14	32587246	32589468	D2GXS7	TRIM2_AILME	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	GO:0004842; GO:0005737; GO:0008270; GO:0043523	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g290300	Scaffold_14	32593238	32611384	P69478	CHSTB_RAT	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)	GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]
PGEN_.00g290310	Scaffold_14	32614139	32614390	NA	NA	NA	NA	NA
PGEN_.00g290320	Scaffold_14	32614489	32615281	NA	NA	NA	NA	NA
PGEN_.00g290330	Scaffold_14	32615031	32619956	NA	NA	NA	NA	NA
PGEN_.00g290340	Scaffold_14	32620137	32620721	Q9IR51	MREP_MDV1	Master replication protein (M-Rep) (EC 2.7.7.-) (EC 3.1.21.-) (EC 3.6.1.3)	GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0006260; GO:0016779; GO:0016888; GO:0018142; GO:0042025; GO:0046872	"host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA replication [GO:0006260]; protein-DNA covalent cross-linking [GO:0018142]"
PGEN_.00g290350	Scaffold_14	32634210	32636262	NA	NA	NA	NA	NA
PGEN_.00g290360	Scaffold_14	32641114	32641518	NA	NA	NA	NA	NA
PGEN_.00g290370	Scaffold_14	32647977	32653625	NA	NA	NA	NA	NA
PGEN_.00g290380	Scaffold_14	32655540	32658288	NA	NA	NA	NA	NA
PGEN_.00g290390	Scaffold_14	32659271	32661814	NA	NA	NA	NA	NA
PGEN_.00g290400	Scaffold_14	32684479	32694765	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g290410	Scaffold_14	32694789	32698350	Q9P2D7	DYH1_HUMAN	"Dynein heavy chain 1, axonemal (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (Heat shock regulated protein 1) (HSRF-1) (hDHC7)"	GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294	"axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288]"
PGEN_.00g290420	Scaffold_14	32716907	32717347	NA	NA	NA	NA	NA
PGEN_.00g290430	Scaffold_14	32717401	32718189	NA	NA	NA	NA	NA
PGEN_.00g290440	Scaffold_14	32730787	32752148	Q91V41	RAB14_MOUSE	Ras-related protein Rab-14	GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005769; GO:0005770; GO:0005791; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0007589; GO:0008543; GO:0016324; GO:0019003; GO:0030133; GO:0030140; GO:0030659; GO:0031489; GO:0031901; GO:0032456; GO:0032482; GO:0032880; GO:0042175; GO:0042742; GO:0043231; GO:0045176; GO:0045335; GO:0045995; GO:0048471; GO:0055037; GO:0090387; GO:0097208; GO:0098993	alveolar lamellar body [GO:0097208]; anchored component of synaptic vesicle membrane [GO:0098993]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; apical protein localization [GO:0045176]; body fluid secretion [GO:0007589]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; Rab protein signal transduction [GO:0032482]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880]
PGEN_.00g290450	Scaffold_14	32769882	32783169	Q4V7B5	CC105_RAT	Coiled-coil domain-containing protein 105		
PGEN_.00g290460	Scaffold_14	32784066	32788118	NA	NA	NA	NA	NA
PGEN_.00g290470	Scaffold_14	32831370	32841982	NA	NA	NA	NA	NA
PGEN_.00g290480	Scaffold_14	32857311	32875184	NA	NA	NA	NA	NA
PGEN_.00g290490	Scaffold_14	32879011	32879223	NA	NA	NA	NA	NA
PGEN_.00g290500	Scaffold_14	32901042	32902618	NA	NA	NA	NA	NA
PGEN_.00g290510	Scaffold_14	32902678	32944505	NA	NA	NA	NA	NA
PGEN_.00g290520	Scaffold_14	32962936	32968206	Q5UPF8	YL088_MIMIV	Putative ankyrin repeat protein L88		
PGEN_.00g290530	Scaffold_14	32974006	32979704	NA	NA	NA	NA	NA
PGEN_.00g290540	Scaffold_14	32991654	33012863	B5FYQ0	ARL3_TAEGU	ADP-ribosylation factor-like protein 3	GO:0000139; GO:0000281; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0007264; GO:0008017; GO:0015031; GO:0019003; GO:0030496; GO:0032391; GO:0042461; GO:0060271	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g290550	Scaffold_14	33013122	33045088	Q5EA43	SFXN2_BOVIN	Sideroflexin-2	GO:0005739; GO:0006865; GO:0015075; GO:0016021; GO:0031966; GO:1990542	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ion transmembrane transporter activity [GO:0015075]; amino acid transport [GO:0006865]; mitochondrial transmembrane transport [GO:1990542]
PGEN_.00g290560	Scaffold_14	33051667	33061829	P06603	TBA1_DROME	Tubulin alpha-1 chain	GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471	astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]
PGEN_.00g290570	Scaffold_14	33064198	33097178	A2AWA9	RBGP1_MOUSE	Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA)	GO:0005096; GO:0005815; GO:0005829; GO:0006886; GO:0007049; GO:0017137; GO:0043087; GO:0090630	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]
PGEN_.00g290580	Scaffold_14	33135706	33149313	NA	NA	NA	NA	NA
PGEN_.00g290590	Scaffold_14	33147042	33147590	NA	NA	NA	NA	NA
PGEN_.00g290600	Scaffold_14	33160257	33163625	NA	NA	NA	NA	NA
PGEN_.00g290610	Scaffold_14	33168702	33213754	NA	NA	NA	NA	NA
PGEN_.00g290620	Scaffold_14	33221047	33245667	Q9UBH6	XPR1_HUMAN	Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor)	GO:0000822; GO:0001618; GO:0004888; GO:0004930; GO:0005623; GO:0005794; GO:0005886; GO:0006817; GO:0007186; GO:0009615; GO:0015114; GO:0015562; GO:0016021; GO:0016036; GO:0030643; GO:0031226; GO:0035435; GO:0038023	cell [GO:0005623]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615]
PGEN_.00g290630	Scaffold_14	33251521	33261505	Q9NSG2	CA112_HUMAN	Uncharacterized protein C1orf112		
PGEN_.00g290640	Scaffold_14	33266213	33268515	NA	NA	NA	NA	NA
PGEN_.00g290650	Scaffold_14	33270203	33276595	NA	NA	NA	NA	NA
PGEN_.00g290660	Scaffold_14	33302156	33319177	Q5TYP4	CA112_DANRE	Uncharacterized protein C1orf112 homolog		
PGEN_.00g290670	Scaffold_14	33323940	33331553	NA	NA	NA	NA	NA
PGEN_.00g290680	Scaffold_14	33332314	33338570	NA	NA	NA	NA	NA
PGEN_.00g290690	Scaffold_14	33348282	33355352	B1AT66	MOT7_MOUSE	Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g290700	Scaffold_14	33361661	33366854	NA	NA	NA	NA	NA
PGEN_.00g290710	Scaffold_14	33370128	33372540	P23414	ACH1_SCHGR	Acetylcholine receptor subunit alpha-L1	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g290720	Scaffold_14	33376719	33382489	NA	NA	NA	NA	NA
PGEN_.00g290730	Scaffold_14	33382960	33383331	NA	NA	NA	NA	NA
PGEN_.00g290740	Scaffold_14	33437898	33438994	NA	NA	NA	NA	NA
PGEN_.00g290750	Scaffold_14	33444094	33449842	NA	NA	NA	NA	NA
PGEN_.00g290760	Scaffold_14	33452737	33471434	Q7Z408	CSMD2_HUMAN	CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2)	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g290770	Scaffold_14	33515660	33524735	NA	NA	NA	NA	NA
PGEN_.00g290780	Scaffold_14	33543339	33543956	NA	NA	NA	NA	NA
PGEN_.00g290790	Scaffold_14	33568563	33577224	Q9BZE3	BARH1_HUMAN	BarH-like 1 homeobox protein	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0001764; GO:0005634; GO:0006357; GO:0007399; GO:0007605; GO:0009888; GO:0030901; GO:0043524; GO:0048513	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; animal organ development [GO:0048513]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]; tissue development [GO:0009888]"
PGEN_.00g290800	Scaffold_14	33638435	33658753	Q9NY43	BARH2_HUMAN	BarH-like 2 homeobox protein	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0001709; GO:0001764; GO:0005634; GO:0006357; GO:0007399; GO:0009888; GO:0030182; GO:0030516; GO:0045727; GO:0048513	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; animal organ development [GO:0048513]; cell fate determination [GO:0001709]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; positive regulation of translation [GO:0045727]; regulation of axon extension [GO:0030516]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue development [GO:0009888]"
PGEN_.00g290810	Scaffold_14	33684910	33692715	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g290820	Scaffold_14	33706041	33707164	NA	NA	NA	NA	NA
PGEN_.00g290830	Scaffold_14	33713335	33729873	Q9CXI3	MOXD1_MOUSE	DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X)	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0005789; GO:0006589; GO:0016020; GO:0016021; GO:0016715; GO:0030667; GO:0042420; GO:0042421	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g290840	Scaffold_14	33731466	33731744	NA	NA	NA	NA	NA
PGEN_.00g290850	Scaffold_14	33735623	33736240	NA	NA	NA	NA	NA
PGEN_.00g290860	Scaffold_14	33753185	33757816	NA	NA	NA	NA	NA
PGEN_.00g290870	Scaffold_14	33792034	33804364	Q9V998	UBL5_DROME	Ubiquitin-like protein 5	GO:0000398; GO:0005634; GO:0005737; GO:0006464; GO:0031386	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein tag [GO:0031386]; cellular protein modification process [GO:0006464]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g290880	Scaffold_14	33822170	33824812	NA	NA	NA	NA	NA
PGEN_.00g290890	Scaffold_14	33860895	33874950	NA	NA	NA	NA	NA
PGEN_.00g290900	Scaffold_14	33876957	33877349	NA	NA	NA	NA	NA
PGEN_.00g290910	Scaffold_14	33881189	33896549	NA	NA	NA	NA	NA
PGEN_.00g290920	Scaffold_14	33896654	33898702	NA	NA	NA	NA	NA
PGEN_.00g290930	Scaffold_14	33905176	33910152	NA	NA	NA	NA	NA
PGEN_.00g290940	Scaffold_14	33987629	33987859	NA	NA	NA	NA	NA
PGEN_.00g290950	Scaffold_14	33988781	33991380	NA	NA	NA	NA	NA
PGEN_.00g290960	Scaffold_14	33991480	33991767	NA	NA	NA	NA	NA
PGEN_.00g290970	Scaffold_14	33993680	33994123	NA	NA	NA	NA	NA
PGEN_.00g290980	Scaffold_14	33994779	34001553	NA	NA	NA	NA	NA
PGEN_.00g290990	Scaffold_14	34009723	34009953	NA	NA	NA	NA	NA
PGEN_.00g291000	Scaffold_14	34010266	34011118	NA	NA	NA	NA	NA
PGEN_.00g291010	Scaffold_14	34070782	34073763	NA	NA	NA	NA	NA
PGEN_.00g291020	Scaffold_14	34080586	34086202	NA	NA	NA	NA	NA
PGEN_.00g291030	Scaffold_14	34086345	34087367	NA	NA	NA	NA	NA
PGEN_.00g291040	Scaffold_14	34087421	34099496	NA	NA	NA	NA	NA
PGEN_.00g291050	Scaffold_14	34118738	34118941	NA	NA	NA	NA	NA
PGEN_.00g291060	Scaffold_14	34119262	34119546	NA	NA	NA	NA	NA
PGEN_.00g291070	Scaffold_14	34119621	34119881	NA	NA	NA	NA	NA
PGEN_.00g291080	Scaffold_14	34121614	34123118	NA	NA	NA	NA	NA
PGEN_.00g291090	Scaffold_14	34149537	34163446	Q9P1Z9	CC180_HUMAN	Coiled-coil domain-containing protein 180	GO:0070062	extracellular exosome [GO:0070062]
PGEN_.00g291100	Scaffold_14	34167828	34168448	NA	NA	NA	NA	NA
PGEN_.00g291110	Scaffold_14	34176912	34203246	Q9P1Z9	CC180_HUMAN	Coiled-coil domain-containing protein 180	GO:0070062	extracellular exosome [GO:0070062]
PGEN_.00g291120	Scaffold_14	34205569	34218797	Q96AY4	TTC28_HUMAN	Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)	GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]
PGEN_.00g291130	Scaffold_14	34218823	34223488	Q80XJ3	TTC28_MOUSE	Tetratricopeptide repeat protein 28 (TPR repeat protein 28)	GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023	centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]
PGEN_.00g291140	Scaffold_14	34226546	34239684	Q9ER41	TOR1B_MOUSE	Torsin-1B (Torsin ATPase-1B) (EC 3.6.4.-) (Torsin family 1 member B)	GO:0005524; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0007029; GO:0016887; GO:0019894; GO:0031965; GO:0034504; GO:0042802; GO:0051085; GO:0071763	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum organization [GO:0007029]; nuclear membrane organization [GO:0071763]; protein localization to nucleus [GO:0034504]
PGEN_.00g291150	Scaffold_14	34299689	34312447	P67868	CSK2B_BOVIN	Casein kinase II subunit beta (CK II beta) (Phosvitin)	GO:0003682; GO:0004674; GO:0005102; GO:0005737; GO:0005886; GO:0005956; GO:0008134; GO:0010862; GO:0016055; GO:0018107; GO:0019887; GO:0019904; GO:0031519; GO:0032927; GO:0033211; GO:0042325; GO:0042802; GO:0043537; GO:0046719; GO:0046872; GO:0050792; GO:0061154	cytoplasm [GO:0005737]; PcG protein complex [GO:0031519]; plasma membrane [GO:0005886]; protein kinase CK2 complex [GO:0005956]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation by virus of viral protein levels in host cell [GO:0046719]; regulation of phosphorylation [GO:0042325]; regulation of viral process [GO:0050792]; Wnt signaling pathway [GO:0016055]
PGEN_.00g291160	Scaffold_14	34315964	34326727	Q2TBP0	PSB7_BOVIN	Proteasome subunit beta type-7 (EC 3.4.25.1)	GO:0004175; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0010499; GO:0019774; GO:0043161	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"
PGEN_.00g291170	Scaffold_14	34337006	34351452	P34121	COAA_DICDI	Coactosin (Cyclic AMP-regulated protein p16) (Cytoskeletal protein p17)	GO:0005886; GO:0009617; GO:0015629; GO:0030833; GO:0030864; GO:0045335; GO:0051015	actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617]
PGEN_.00g291180	Scaffold_14	34358820	34373918	Q80SY5	PR38B_MOUSE	Pre-mRNA-splicing factor 38B	GO:0006397; GO:0008380; GO:0071011	precatalytic spliceosome [GO:0071011]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g291190	Scaffold_14	34394380	34395747	Q9LIG0	Y3136_ARATH	Clavaminate synthase-like protein At3g21360 (EC 1.-.-.-)	GO:0005634; GO:0005829; GO:0016491; GO:0046872	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]
PGEN_.00g291200	Scaffold_14	34398342	34401549	P0CC03	ST6B1_MOUSE	Sulfotransferase 6B1 (ST6B1) (Thyroxine sulfotransferase) (EC 2.8.2.n2)	GO:0005737; GO:0008146	cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]
PGEN_.00g291210	Scaffold_14	34417950	34421184	F1QYJ6	ST6B1_DANRE	Sulfotransferase 6B1 (EC 2.8.2.-) (Thyroxine sulfotransferase) (EC 2.8.2.n2)	GO:0008146; GO:0071466	sulfotransferase activity [GO:0008146]; cellular response to xenobiotic stimulus [GO:0071466]
PGEN_.00g291220	Scaffold_14	34429520	34443983	O94919	ENDD1_HUMAN	Endonuclease domain-containing 1 protein (EC 3.1.30.-)	GO:0002576; GO:0003676; GO:0004519; GO:0005576; GO:0005829; GO:0016020; GO:0046872; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; platelet degranulation [GO:0002576]
PGEN_.00g291230	Scaffold_14	34463819	34464786	NA	NA	NA	NA	NA
PGEN_.00g291240	Scaffold_14	34475725	34483879	O00338	ST1C2_HUMAN	Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.-) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)	GO:0005737; GO:0005829; GO:0008146; GO:0009308; GO:0050427; GO:0051923	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]
PGEN_.00g291250	Scaffold_14	34486490	34504579	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g291260	Scaffold_14	34546075	34547366	NA	NA	NA	NA	NA
PGEN_.00g291270	Scaffold_14	34547511	34548036	NA	NA	NA	NA	NA
PGEN_.00g291280	Scaffold_14	34548838	34549194	NA	NA	NA	NA	NA
PGEN_.00g291290	Scaffold_14	34567114	34570524	NA	NA	NA	NA	NA
PGEN_.00g291300	Scaffold_14	34586974	34592491	NA	NA	NA	NA	NA
PGEN_.00g291310	Scaffold_14	34596281	34612929	NA	NA	NA	NA	NA
PGEN_.00g291320	Scaffold_14	34621270	34624596	A8E5W8	F166B_XENTR	Protein FAM166B		
PGEN_.00g291330	Scaffold_14	34638305	34643393	P0C7P0	CISD3_HUMAN	"CDGSH iron-sulfur domain-containing protein 3, mitochondrial (MitoNEET-related protein 2) (Miner2) (Mitochondrial inner NEET protein) (MiNT)"	GO:0005739; GO:0046872; GO:0051537; GO:0106034	"mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]"
PGEN_.00g291340	Scaffold_14	34654840	34703694	E9QAT4	SC16A_MOUSE	Protein transport protein Sec16A (SEC16 homolog A) (p250)	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0007029; GO:0007030; GO:0012507; GO:0031090; GO:0032527; GO:0034976; GO:0043000; GO:0048208; GO:0048471; GO:0050821; GO:0070863; GO:0070971; GO:0070973; GO:0072659	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g291350	Scaffold_14	34706356	34708315	NA	NA	NA	NA	NA
PGEN_.00g291360	Scaffold_14	34711170	34751528	Q9QYP0	MEGF8_RAT	Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4)	GO:0003143; GO:0005509; GO:0005576; GO:0005634; GO:0007368; GO:0009887; GO:0009888; GO:0010468; GO:0030326; GO:0030509; GO:0035108; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0071907; GO:0097094; GO:0097155	extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]
PGEN_.00g291370	Scaffold_14	34761327	34778140	Q9XSJ0	UCHL5_BOVIN	Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5)	GO:0000502; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0006511; GO:0016579; GO:0021670; GO:0030901; GO:0031011; GO:0036459; GO:0048853; GO:0070628	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g291380	Scaffold_14	34786471	34792532	B2IZD3	BDLP_NOSP7	Bacterial dynamin-like protein (BDLP) (EC 3.6.5.5)	GO:0003924; GO:0005525; GO:0005886; GO:0008289; GO:0016021; GO:0042802	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]
PGEN_.00g291390	Scaffold_14	34824301	34827744	A4IIM3	SIN1_XENTR	Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1)	GO:0005546; GO:0005737; GO:0005886; GO:0030950; GO:0031932; GO:0038203	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; TORC2 signaling [GO:0038203]"
PGEN_.00g291400	Scaffold_14	34832009	34852538	Q8N6R0	EFNMT_HUMAN	eEF1A lysine and N-terminal methyltransferase (eEF1A-KNMT) (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase (EC 2.1.1.-); eEF1A N-terminal methyltransferase (EC 2.1.1.-)]	GO:0008168; GO:0032259	methyltransferase activity [GO:0008168]; methylation [GO:0032259]
PGEN_.00g291410	Scaffold_14	34857748	34869757	Q9UHL4	DPP2_HUMAN	Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)	GO:0005576; GO:0005794; GO:0005829; GO:0006508; GO:0008236; GO:0008239; GO:0031982; GO:0035578; GO:0043231; GO:0043312; GO:0070062	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]
PGEN_.00g291420	Scaffold_14	34954985	34955197	NA	NA	NA	NA	NA
PGEN_.00g291430	Scaffold_14	34955258	34955602	NA	NA	NA	NA	NA
PGEN_.00g291440	Scaffold_14	34982249	34990921	Q9UHL4	DPP2_HUMAN	Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)	GO:0005576; GO:0005794; GO:0005829; GO:0006508; GO:0008236; GO:0008239; GO:0031982; GO:0035578; GO:0043231; GO:0043312; GO:0070062	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]
PGEN_.00g291450	Scaffold_14	34993582	34994151	NA	NA	NA	NA	NA
PGEN_.00g291460	Scaffold_14	34994397	34995888	NA	NA	NA	NA	NA
PGEN_.00g291470	Scaffold_14	34995975	34996331	NA	NA	NA	NA	NA
PGEN_.00g291480	Scaffold_14	34999334	35002820	NA	NA	NA	NA	NA
PGEN_.00g291490	Scaffold_14	35002862	35003143	NA	NA	NA	NA	NA
PGEN_.00g291500	Scaffold_14	35010189	35017397	NA	NA	NA	NA	NA
PGEN_.00g291510	Scaffold_14	35017932	35021305	NA	NA	NA	NA	NA
PGEN_.00g291520	Scaffold_14	35022796	35023089	NA	NA	NA	NA	NA
PGEN_.00g291530	Scaffold_14	35058752	35060380	NA	NA	NA	NA	NA
PGEN_.00g291540	Scaffold_14	35070193	35087497	NA	NA	NA	NA	NA
PGEN_.00g291550	Scaffold_14	35093514	35093912	NA	NA	NA	NA	NA
PGEN_.00g291560	Scaffold_14	35094136	35101126	NA	NA	NA	NA	NA
PGEN_.00g291570	Scaffold_14	35103919	35104227	NA	NA	NA	NA	NA
PGEN_.00g291580	Scaffold_14	35104257	35107220	NA	NA	NA	NA	NA
PGEN_.00g291590	Scaffold_14	35125446	35128152	NA	NA	NA	NA	NA
PGEN_.00g291600	Scaffold_14	35128313	35129873	NA	NA	NA	NA	NA
PGEN_.00g291610	Scaffold_14	35129955	35132045	NA	NA	NA	NA	NA
PGEN_.00g291620	Scaffold_14	35139761	35140081	O34748	RECQ_BACSU	Probable ATP-dependent DNA helicase RecQ (EC 3.6.4.12)	GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0009378; GO:0009432; GO:0030894; GO:0032508; GO:0043138; GO:0043590	bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]
PGEN_.00g291630	Scaffold_14	35154389	35167232	NA	NA	NA	NA	NA
PGEN_.00g291640	Scaffold_14	35167862	35175483	NA	NA	NA	NA	NA
PGEN_.00g291650	Scaffold_14	35176114	35177703	NA	NA	NA	NA	NA
PGEN_.00g291660	Scaffold_14	35177833	35181127	NA	NA	NA	NA	NA
PGEN_.00g291670	Scaffold_14	35182444	35185609	NA	NA	NA	NA	NA
PGEN_.00g291680	Scaffold_14	35188967	35191312	NA	NA	NA	NA	NA
PGEN_.00g291690	Scaffold_14	35192018	35194891	NA	NA	NA	NA	NA
PGEN_.00g291700	Scaffold_14	35195007	35195306	NA	NA	NA	NA	NA
PGEN_.00g291710	Scaffold_14	35221347	35246903	Q29496	CP3AO_SHEEP	Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)	GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]
PGEN_.00g291720	Scaffold_14	35257459	35277465	Q9JHB4	WDR31_MOUSE	WD repeat-containing protein 31 (Spermatid WD repeat-containing protein) (spWD)		
PGEN_.00g291730	Scaffold_14	35288126	35290580	Q9BYN0	SRXN1_HUMAN	Sulfiredoxin-1 (EC 1.8.98.2)	GO:0005524; GO:0005829; GO:0006979; GO:0016667; GO:0032542; GO:0034599	"cytosol [GO:0005829]; ATP binding [GO:0005524]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; sulfiredoxin activity [GO:0032542]; cellular response to oxidative stress [GO:0034599]; response to oxidative stress [GO:0006979]"
PGEN_.00g291740	Scaffold_14	35405179	35405532	NA	NA	NA	NA	NA
PGEN_.00g291750	Scaffold_14	35445892	35512241	Q16832	DDR2_HUMAN	"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)"	GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030198; GO:0030199; GO:0030500; GO:0031214; GO:0034103; GO:0035988; GO:0038062; GO:0038063; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0090091	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g291760	Scaffold_14	35539186	35547225	Q16832	DDR2_HUMAN	"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)"	GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030198; GO:0030199; GO:0030500; GO:0031214; GO:0034103; GO:0035988; GO:0038062; GO:0038063; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0090091	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g291770	Scaffold_14	35553864	35648777	Q16832	DDR2_HUMAN	"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)"	GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030198; GO:0030199; GO:0030500; GO:0031214; GO:0034103; GO:0035988; GO:0038062; GO:0038063; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0090091	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g291780	Scaffold_14	35695605	35696885	NA	NA	NA	NA	NA
PGEN_.00g291790	Scaffold_14	35697002	35698526	NA	NA	NA	NA	NA
PGEN_.00g291800	Scaffold_14	35700143	35710572	Q32L97	VAMP4_BOVIN	Vesicle-associated membrane protein 4 (VAMP-4)	GO:0000226; GO:0005794; GO:0009986; GO:0016021; GO:0035493; GO:0090161	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; Golgi ribbon formation [GO:0090161]; microtubule cytoskeleton organization [GO:0000226]; SNARE complex assembly [GO:0035493]
PGEN_.00g291810	Scaffold_14	35716420	35734120	Q2TBQ8	6PGL_BOVIN	6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)	GO:0005737; GO:0005975; GO:0009051; GO:0017057	"cytoplasm [GO:0005737]; 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt, oxidative branch [GO:0009051]"
PGEN_.00g291820	Scaffold_14	35734359	35749674	Q5ZLM0	CDC73_CHICK	Parafibromin (Cell division cycle protein 73 homolog)	GO:0000122; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005829; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0045944; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:2000134	Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g291830	Scaffold_14	35751584	35754641	Q5ZLM0	CDC73_CHICK	Parafibromin (Cell division cycle protein 73 homolog)	GO:0000122; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005829; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0045944; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:2000134	Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g291840	Scaffold_14	35756048	35761529	Q8JZM7	CDC73_MOUSE	Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein homolog)	GO:0000122; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016055; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0045944; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:2000134	Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]
PGEN_.00g291850	Scaffold_14	35768123	35782106	Q86T26	TM11B_HUMAN	Transmembrane protease serine 11B (EC 3.4.21.-) (Airway trypsin-like protease 5)	GO:0004252; GO:0005886; GO:0005887; GO:0008236; GO:0070062	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]
PGEN_.00g291860	Scaffold_14	35784445	35802303	Q8SQ75	CO2_PONPY	Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]	GO:0004252; GO:0005576; GO:0006958; GO:0045087; GO:0046872	"extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]"
PGEN_.00g291870	Scaffold_14	35867981	35869433	NA	NA	NA	NA	NA
PGEN_.00g291880	Scaffold_14	35874747	35886108	NA	NA	NA	NA	NA
PGEN_.00g291890	Scaffold_14	35886244	35886645	NA	NA	NA	NA	NA
PGEN_.00g291900	Scaffold_14	35927760	35942290	Q9Y6R7	FCGBP_HUMAN	IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP)	GO:0070062	extracellular exosome [GO:0070062]
PGEN_.00g291910	Scaffold_14	35949839	35966065	Q4PJX1	ODR4_MOUSE	Protein odr-4 homolog (mODR-4)	GO:0008104; GO:0016021	integral component of membrane [GO:0016021]; protein localization [GO:0008104]
PGEN_.00g291920	Scaffold_14	35980565	35989129	NA	NA	NA	NA	NA
PGEN_.00g291930	Scaffold_14	35994896	36000376	NA	NA	NA	NA	NA
PGEN_.00g291940	Scaffold_14	36002850	36008043	P41105	RL28_MOUSE	60S ribosomal protein L28	GO:0003735; GO:0006412; GO:0022625; GO:0030425; GO:0036464; GO:0044297	cell body [GO:0044297]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g291950	Scaffold_14	36016912	36053973	Q5TJE1	DAXX_CANLF	Death domain-associated protein 6 (Daxx)	GO:0000775; GO:0003713; GO:0003714; GO:0005634; GO:0005730; GO:0005829; GO:0006334; GO:0006915; GO:0008134; GO:0016605; GO:0031396; GO:0034605; GO:0034620; GO:0042393; GO:0042803; GO:0042981; GO:0045892; GO:0071276; GO:0071280; GO:0072738; GO:1903936	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to heat [GO:0034605]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; regulation of apoptotic process [GO:0042981]; regulation of protein ubiquitination [GO:0031396]"
PGEN_.00g291960	Scaffold_14	36081343	36086474	Q6DGX3	ANR54_DANRE	Ankyrin repeat domain-containing protein 54	GO:0005634; GO:0005737; GO:0030496	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]
PGEN_.00g291970	Scaffold_14	36086679	36094121	NA	NA	NA	NA	NA
PGEN_.00g291980	Scaffold_14	36100269	36171829	Q5U3Q6	CIP4_DANRE	Cdc42-interacting protein 4 homolog (Thyroid receptor-interacting protein 10 homolog)	GO:0005764; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0008289; GO:0030036	cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]
PGEN_.00g291990	Scaffold_14	36188864	36212289	Q7ZYD5	SCMC2_XENLA	Calcium-binding mitochondrial carrier protein SCaMC-2 (Small calcium-binding mitochondrial carrier protein 2) (Solute carrier family 25 member 25)	GO:0005509; GO:0005743; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; transmembrane transporter activity [GO:0022857]
PGEN_.00g292000	Scaffold_14	36213684	36221499	NA	NA	NA	NA	NA
PGEN_.00g292010	Scaffold_14	36231473	36243185	Q0P5A6	PSMD5_BOVIN	26S proteasome non-ATPase regulatory subunit 5	GO:0008540; GO:0022624; GO:0043248	"proteasome accessory complex [GO:0022624]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome assembly [GO:0043248]"
PGEN_.00g292020	Scaffold_14	36251364	36252323	Q99L04	DHRS1_MOUSE	Dehydrogenase/reductase SDR family member 1 (EC 1.1.-.-)	GO:0005739; GO:0005743; GO:0005783; GO:0016491	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]
PGEN_.00g292030	Scaffold_14	36268893	36271941	NA	NA	NA	NA	NA
PGEN_.00g292040	Scaffold_14	36272248	36272610	NA	NA	NA	NA	NA
PGEN_.00g292050	Scaffold_14	36273152	36273424	NA	NA	NA	NA	NA
PGEN_.00g292060	Scaffold_14	36288309	36293494	NA	NA	NA	NA	NA
PGEN_.00g292070	Scaffold_14	36295363	36301740	NA	NA	NA	NA	NA
PGEN_.00g292080	Scaffold_14	36310605	36311126	Q99L04	DHRS1_MOUSE	Dehydrogenase/reductase SDR family member 1 (EC 1.1.-.-)	GO:0005739; GO:0005743; GO:0005783; GO:0016491	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]
PGEN_.00g292090	Scaffold_14	36311246	36311563	Q99L04	DHRS1_MOUSE	Dehydrogenase/reductase SDR family member 1 (EC 1.1.-.-)	GO:0005739; GO:0005743; GO:0005783; GO:0016491	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]
PGEN_.00g292100	Scaffold_14	36337964	36372881	Q9NPB8	GPCP1_HUMAN	Glycerophosphocholine phosphodiesterase GPCPD1 (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 5)	GO:0005829; GO:0007519; GO:0046475; GO:0047389; GO:2001070	cytosol [GO:0005829]; glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]; glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g292110	Scaffold_14	36400642	36405864	NA	NA	NA	NA	NA
PGEN_.00g292120	Scaffold_14	36409291	36409608	NA	NA	NA	NA	NA
PGEN_.00g292130	Scaffold_14	36421360	36426701	A3DH97	RSGI6_HUNT2	"Anti-sigma-I factor RsgI6 (Endo-1,4-beta-xylanase) (EC 3.2.1.8)"	GO:0005886; GO:0016021; GO:0031176; GO:0045493	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g292140	Scaffold_14	36444730	36477458	A3DH97	RSGI6_HUNT2	"Anti-sigma-I factor RsgI6 (Endo-1,4-beta-xylanase) (EC 3.2.1.8)"	GO:0005886; GO:0016021; GO:0031176; GO:0045493	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g292150	Scaffold_14	36477890	36495154	A0A1P8AWH8	XYN1_ARATH	"Endo-1,4-beta-xylanase 1 (AtXyn1) (Xylan endohydrolase 1) (Xylanase 1) (EC 3.2.1.8)"	GO:0005576; GO:0005618; GO:0031176; GO:0045493	"cell wall [GO:0005618]; extracellular region [GO:0005576]; endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g292160	Scaffold_14	36497060	36511510	F4JG10	XYN3_ARATH	"Endo-1,4-beta-xylanase 3 (AtXyn3) (Xylan endohydrolase 3) (Xylanase 3) (EC 3.2.1.8)"	GO:0031176; GO:0045493	"endo-1,4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493]"
PGEN_.00g292170	Scaffold_14	36521127	36522797	NA	NA	NA	NA	NA
PGEN_.00g292180	Scaffold_14	36527428	36540949	NA	NA	NA	NA	NA
PGEN_.00g292190	Scaffold_14	36599703	36625373	NA	NA	NA	NA	NA
PGEN_.00g292200	Scaffold_14	36629433	36636187	Q6ZQH8	NU188_MOUSE	Nucleoporin NUP188 homolog	GO:0006606; GO:0017056; GO:0044611; GO:0051028	nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]
PGEN_.00g292210	Scaffold_14	36650455	36654177	NA	NA	NA	NA	NA
PGEN_.00g292220	Scaffold_14	36657192	36672030	Q6ZQH8	NU188_MOUSE	Nucleoporin NUP188 homolog	GO:0006606; GO:0017056; GO:0044611; GO:0051028	nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]
PGEN_.00g292230	Scaffold_14	36689024	36728723	Q6ZQH8	NU188_MOUSE	Nucleoporin NUP188 homolog	GO:0006606; GO:0017056; GO:0044611; GO:0051028	nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]
PGEN_.00g292240	Scaffold_14	36729113	36786140	Q5R621	HS2ST_PONAB	Heparan sulfate 2-O-sulfotransferase 1 (2-O-sulfotransferase) (2OST) (EC 2.8.2.-)	GO:0000139; GO:0008146; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]
PGEN_.00g292250	Scaffold_14	36791889	36792104	NA	NA	NA	NA	NA
PGEN_.00g292260	Scaffold_14	36818003	36818248	NA	NA	NA	NA	NA
PGEN_.00g292270	Scaffold_14	36820253	36820966	NA	NA	NA	NA	NA
PGEN_.00g292280	Scaffold_14	36821096	36821323	NA	NA	NA	NA	NA
PGEN_.00g292290	Scaffold_14	36826718	36836139	Q8R3H7	HS2ST_MOUSE	Heparan sulfate 2-O-sulfotransferase 1 (2-O-sulfotransferase) (2-OST) (2OST) (EC 2.8.2.-)	GO:0000139; GO:0004394; GO:0008146; GO:0015014; GO:0015015; GO:0016021; GO:0030202; GO:0060676	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]"
PGEN_.00g292300	Scaffold_14	36860087	36864257	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g292310	Scaffold_14	36882297	36883211	NA	NA	NA	NA	NA
PGEN_.00g292320	Scaffold_14	36886487	36888835	NA	NA	NA	NA	NA
PGEN_.00g292330	Scaffold_14	36923941	36924255	NA	NA	NA	NA	NA
PGEN_.00g292340	Scaffold_14	36924283	36924498	NA	NA	NA	NA	NA
PGEN_.00g292350	Scaffold_14	36924652	36925068	NA	NA	NA	NA	NA
PGEN_.00g292360	Scaffold_14	36958778	36970352	NA	NA	NA	NA	NA
PGEN_.00g292370	Scaffold_14	36970574	36986248	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g292380	Scaffold_14	36996745	36997330	NA	NA	NA	NA	NA
PGEN_.00g292390	Scaffold_14	36999532	37007772	NA	NA	NA	NA	NA
PGEN_.00g292400	Scaffold_14	37008621	37011074	NA	NA	NA	NA	NA
PGEN_.00g292410	Scaffold_14	37011723	37011944	NA	NA	NA	NA	NA
PGEN_.00g292420	Scaffold_14	37012083	37012325	NA	NA	NA	NA	NA
PGEN_.00g292430	Scaffold_14	37012884	37013141	NA	NA	NA	NA	NA
PGEN_.00g292440	Scaffold_14	37013220	37013761	NA	NA	NA	NA	NA
PGEN_.00g292450	Scaffold_14	37049525	37050208	NA	NA	NA	NA	NA
PGEN_.00g292460	Scaffold_14	37070396	37070713	A4II29	NRARP_XENTR	Notch-regulated ankyrin repeat-containing protein	GO:0001569; GO:0001938; GO:0002043; GO:0007219; GO:0045746; GO:0090263	blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]
PGEN_.00g292470	Scaffold_14	37119442	37130980	O15296	LX15B_HUMAN	Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-)	GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006629; GO:0006915; GO:0008285; GO:0008289; GO:0010744; GO:0016020; GO:0016165; GO:0019369; GO:0019372; GO:0019898; GO:0030336; GO:0030850; GO:0030856; GO:0035360; GO:0036403; GO:0043651; GO:0045618; GO:0045786; GO:0045926; GO:0050473; GO:0051122; GO:0070062; GO:0090197	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; arachidonate 15-lipoxygenase activity [GO:0050473]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; lipid binding [GO:0008289]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipoxygenase pathway [GO:0019372]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of chemokine secretion [GO:0090197]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostate gland development [GO:0030850]; regulation of epithelial cell differentiation [GO:0030856]
PGEN_.00g292480	Scaffold_14	37145808	37147190	NA	NA	NA	NA	NA
PGEN_.00g292490	Scaffold_14	37147921	37149462	A4QN56	MFS4B_DANRE	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g292500	Scaffold_14	37153186	37154433	Q6ZQM8	UD17C_MOUSE	UDP-glucuronosyltransferase 1-7C (UDPGT 1-7C) (UGT1*7C) (UGT1-07C) (UGT1.7C) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1A7C) (UGT1A10)	GO:0005789; GO:0006711; GO:0015020; GO:0016020; GO:0016021; GO:0019439; GO:0046226; GO:0052696; GO:0052697	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; aromatic compound catabolic process [GO:0019439]; coumarin catabolic process [GO:0046226]; estrogen catabolic process [GO:0006711]; flavonoid glucuronidation [GO:0052696]; xenobiotic glucuronidation [GO:0052697]
PGEN_.00g292510	Scaffold_14	37167038	37172558	A4QN56	MFS4B_DANRE	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g292520	Scaffold_14	37182458	37187702	B2LT65	TLR2_SHEEP	Toll-like receptor 2 (CD antigen CD282)	GO:0002755; GO:0005794; GO:0006954; GO:0016021; GO:0030670; GO:0034134; GO:0045087; GO:0045121; GO:0050707; GO:0050729; GO:0071726; GO:0071727	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]
PGEN_.00g292530	Scaffold_14	37196373	37199985	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g292540	Scaffold_14	37214258	37218483	Q9CZJ2	HS12B_MOUSE	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g292550	Scaffold_14	37237399	37238924	NA	NA	NA	NA	NA
PGEN_.00g292560	Scaffold_14	37254437	37258336	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g292570	Scaffold_14	37274734	37275207	NA	NA	NA	NA	NA
PGEN_.00g292580	Scaffold_14	37290520	37301218	Q8N531	FBXL6_HUMAN	F-box/LRR-repeat protein 6 (F-box and leucine-rich repeat protein 6) (F-box protein FBL6) (FBL6A)	GO:0004842; GO:0006508; GO:0019005; GO:0031146	SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis [GO:0006508]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g292590	Scaffold_14	37309033	37311156	A7E3N2	NCF2_RAT	Neutrophil cytosol factor 2 (NCF-2) (Neutrophil NADPH oxidase factor 2)	GO:0001669; GO:0005737; GO:0005829; GO:0006909; GO:0007568; GO:0008022; GO:0009749; GO:0014070; GO:0014823; GO:0016020; GO:0016176; GO:0032496; GO:0032570; GO:0032870; GO:0033993; GO:0034616; GO:0042493; GO:0042554; GO:0043020; GO:0043525; GO:0045730; GO:0045777; GO:0048365; GO:0055093; GO:0055114	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; protein C-terminus binding [GO:0008022]; Rac GTPase binding [GO:0048365]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; oxidation-reduction process [GO:0055114]; phagocytosis [GO:0006909]; positive regulation of blood pressure [GO:0045777]; positive regulation of neuron apoptotic process [GO:0043525]; respiratory burst [GO:0045730]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to hyperoxia [GO:0055093]; response to laminar fluid shear stress [GO:0034616]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to progesterone [GO:0032570]; superoxide anion generation [GO:0042554]
PGEN_.00g292600	Scaffold_14	37312847	37315978	NA	NA	NA	NA	NA
PGEN_.00g292610	Scaffold_14	37330165	37345881	O77775	NCF2_BOVIN	Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (Neutrophil NADPH oxidase factor 2) (p67-phox)	GO:0005829; GO:0006909; GO:0016176; GO:0042554; GO:0043020; GO:0045730; GO:0048365	cytosol [GO:0005829]; NADPH oxidase complex [GO:0043020]; Rac GTPase binding [GO:0048365]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]
PGEN_.00g292620	Scaffold_14	37346269	37348469	NA	NA	NA	NA	NA
PGEN_.00g292630	Scaffold_14	37348567	37348878	NA	NA	NA	NA	NA
PGEN_.00g292640	Scaffold_14	37356945	37387889	A4Q9F4	TTL11_MOUSE	Tubulin polyglutamylase TTLL11 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 11)	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0016874; GO:0018095; GO:0051013	cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; microtubule severing [GO:0051013]; protein polyglutamylation [GO:0018095]
PGEN_.00g292650	Scaffold_14	37392260	37410779	Q8CHT3	INT5_MOUSE	Integrator complex subunit 5 (Int5)	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]
PGEN_.00g292660	Scaffold_14	37425001	37441819	Q7TXL7	PPSD_MYCBO	Phthiocerol/phenolphthiocerol synthesis polyketide synthase type I PpsD (Beta-ketoacyl-acyl-carrier-protein synthase I) (EC 2.3.1.41)	GO:0004315; GO:0006633; GO:0016491; GO:0031177; GO:0034081; GO:0071766; GO:0097040; GO:0097041	polyketide synthase complex [GO:0034081]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040]
PGEN_.00g292670	Scaffold_14	37441871	37451664	Q0EEE2	PTHD3_MOUSE	Patched domain-containing protein 3 (RND-type protein RNDEu-3)	GO:0016021; GO:0097225	integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]
PGEN_.00g292680	Scaffold_14	37459598	37463785	Q0EEE2	PTHD3_MOUSE	Patched domain-containing protein 3 (RND-type protein RNDEu-3)	GO:0016021; GO:0097225	integral component of membrane [GO:0016021]; sperm midpiece [GO:0097225]
PGEN_.00g292690	Scaffold_14	37478382	37479728	NA	NA	NA	NA	NA
PGEN_.00g292700	Scaffold_14	37506161	37535609	Q9UKP5	ATS6_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)	GO:0003279; GO:0004222; GO:0005576; GO:0008237; GO:0035904; GO:0046872; GO:0060976	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]
PGEN_.00g292710	Scaffold_14	37543094	37548364	Q9NRF9	DPOE3_HUMAN	DNA polymerase epsilon subunit 3 (Arsenic-transactivated protein) (AsTP) (Chromatin accessibility complex 17 kDa protein) (CHRAC-17) (HuCHRAC17) (DNA polymerase II subunit 3) (DNA polymerase epsilon subunit p17)	GO:0000082; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005671; GO:0006260; GO:0006270; GO:0006974; GO:0008622; GO:0032201; GO:0034080; GO:0042766; GO:0043966; GO:0046982; GO:0070869; GO:0071480	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; heterochromatin assembly involved in chromatin silencing [GO:0070869]; histone H3 acetylation [GO:0043966]; nucleosome mobilization [GO:0042766]; telomere maintenance via semi-conservative replication [GO:0032201]
PGEN_.00g292720	Scaffold_14	37553616	37554596	NA	NA	NA	NA	NA
PGEN_.00g292730	Scaffold_14	37559853	37560740	NA	NA	NA	NA	NA
PGEN_.00g292740	Scaffold_14	37563281	37563925	NA	NA	NA	NA	NA
PGEN_.00g292750	Scaffold_14	37564239	37577103	O94967	WDR47_HUMAN	WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin)	GO:0005737; GO:0005874; GO:0007275	cytoplasm [GO:0005737]; microtubule [GO:0005874]; multicellular organism development [GO:0007275]
PGEN_.00g292760	Scaffold_14	37582832	37583692	NA	NA	NA	NA	NA
PGEN_.00g292770	Scaffold_14	37583741	37584064	NA	NA	NA	NA	NA
PGEN_.00g292780	Scaffold_14	37603971	37628801	Q5I7G2	RXR_LYMST	Retinoic acid receptor RXR (Retinoid X receptor) (LymRXR)	GO:0003700; GO:0003707; GO:0005634; GO:0005737; GO:0007275; GO:0008270; GO:0016020; GO:0016918; GO:0030426; GO:0043565	cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]
PGEN_.00g292790	Scaffold_14	37608593	37609746	NA	NA	NA	NA	NA
PGEN_.00g292800	Scaffold_14	37705229	37737623	Q92540	SMG7_HUMAN	Protein SMG7 (EST1-like protein C) (SMG-7 homolog) (hSMG-7)	GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0007004; GO:0032210; GO:0035303; GO:0042162; GO:0045111; GO:0051721; GO:0070034	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere maintenance via telomerase [GO:0007004]"
PGEN_.00g292810	Scaffold_14	37758211	37759257	NA	NA	NA	NA	NA
PGEN_.00g292820	Scaffold_14	37770033	37772513	Q64127	TIF1A_MOUSE	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005737; GO:0006468; GO:0008270; GO:0008285; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043565; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]"
PGEN_.00g292830	Scaffold_14	37785728	37786282	NA	NA	NA	NA	NA
PGEN_.00g292840	Scaffold_14	37790185	37798066	Q9W539	HR4_DROME	Hormone receptor 4 (dHR4) (Nuclear receptor subfamily 6 group A member 2)	GO:0000978; GO:0003707; GO:0004879; GO:0005634; GO:0005667; GO:0005737; GO:0008270; GO:0040018; GO:0045892; GO:0048638; GO:0071456; GO:0106023; GO:0120143	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; negative regulation of ecdysone receptor-mediated signaling pathway [GO:0120143]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of multicellular organism growth [GO:0040018]; regulation of developmental growth [GO:0048638]; regulation of pupariation [GO:0106023]"
PGEN_.00g292850	Scaffold_14	37802124	37802510	NA	NA	NA	NA	NA
PGEN_.00g292860	Scaffold_14	37802675	37803088	NA	NA	NA	NA	NA
PGEN_.00g292870	Scaffold_14	37818065	37821031	P62287	ASPM_COLGU	Abnormal spindle-like microcephaly-associated protein homolog	GO:0005516; GO:0005634; GO:0005737; GO:0005819; GO:0007051; GO:0051301	cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; cell division [GO:0051301]; spindle organization [GO:0007051]
PGEN_.00g292880	Scaffold_14	37821097	37842612	P62283	ASPM_AOTVO	Abnormal spindle-like microcephaly-associated protein homolog	GO:0005516; GO:0005634; GO:0005737; GO:0007051; GO:0051301	cytoplasm [GO:0005737]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; cell division [GO:0051301]; spindle organization [GO:0007051]
PGEN_.00g292890	Scaffold_14	37844042	37865028	NA	NA	NA	NA	NA
PGEN_.00g292900	Scaffold_14	37887697	37896351	Q4V869	ACBD6_XENLA	Acyl-CoA-binding domain-containing protein 6	GO:0000062; GO:0005737; GO:0008289	cytoplasm [GO:0005737]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]
PGEN_.00g292910	Scaffold_14	37905093	37905470	NA	NA	NA	NA	NA
PGEN_.00g292920	Scaffold_14	37906472	37943729	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g292930	Scaffold_14	37956607	37957806	NA	NA	NA	NA	NA
PGEN_.00g292940	Scaffold_14	37972055	37986722	G5EE06	FUTD_CAEEL	"Alpha-(1,3)-fucosyltransferase fut-5 (EC 2.4.1.65) (Fucosyltransferase fut-5)"	GO:0006486; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0046872; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; metal ion binding [GO:0046872]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g292950	Scaffold_14	37989702	38015242	NA	NA	NA	NA	NA
PGEN_.00g292960	Scaffold_14	38020033	38023539	NA	NA	NA	NA	NA
PGEN_.00g292970	Scaffold_14	38029142	38030236	G5EE06	FUTD_CAEEL	"Alpha-(1,3)-fucosyltransferase fut-5 (EC 2.4.1.65) (Fucosyltransferase fut-5)"	GO:0006486; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0046872; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; metal ion binding [GO:0046872]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g292980	Scaffold_14	38070294	38077189	NA	NA	NA	NA	NA
PGEN_.00g292990	Scaffold_14	38096608	38105412	C9J069	AJM1_HUMAN	Apical junction component 1 homolog	GO:0005912; GO:0005929; GO:0016324; GO:0045216	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cilium [GO:0005929]; cell-cell junction organization [GO:0045216]
PGEN_.00g293000	Scaffold_14	38116629	38116874	NA	NA	NA	NA	NA
PGEN_.00g293010	Scaffold_14	38116897	38117133	NA	NA	NA	NA	NA
PGEN_.00g293020	Scaffold_14	38117166	38126636	NA	NA	NA	NA	NA
PGEN_.00g293030	Scaffold_14	38134692	38142816	Q8BVL3	SNX17_MOUSE	Sorting nexin-17	GO:0003279; GO:0005737; GO:0005768; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0006898; GO:0007165; GO:0008022; GO:0010008; GO:0030659; GO:0031410; GO:0032456; GO:0032991; GO:0035091; GO:0035904; GO:0043231; GO:0050750; GO:0060976; GO:1990126	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"
PGEN_.00g293040	Scaffold_14	38229749	38231788	NA	NA	NA	NA	NA
PGEN_.00g293050	Scaffold_14	38243494	38257683	A8E5W8	F166B_XENTR	Protein FAM166B		
PGEN_.00g293060	Scaffold_14	38258147	38281425	Q91WD2	TRPV6_MOUSE	Transient receptor potential cation channel subfamily V member 6 (TrpV6) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2)	GO:0005216; GO:0005262; GO:0005516; GO:0005623; GO:0005886; GO:0005887; GO:0006816; GO:0016021; GO:0035898; GO:0042802; GO:0046872; GO:0051289; GO:0051592; GO:0055074; GO:0070509; GO:0070588; GO:0098703	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592]
PGEN_.00g293070	Scaffold_14	38286003	38292038	A0A1D5PXA5	TRPV4_CHICK	Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Vanilloid receptor-related osmotically activated channel) (VR-OAC)	GO:0005216; GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005623; GO:0005886; GO:0005887; GO:0005912; GO:0005929; GO:0006874; GO:0007015; GO:0007231; GO:0008289; GO:0016324; GO:0046872; GO:0071476	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell [GO:0005623]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; actin filament organization [GO:0007015]; cellular calcium ion homeostasis [GO:0006874]; cellular hypotonic response [GO:0071476]; osmosensory signaling pathway [GO:0007231]
PGEN_.00g293080	Scaffold_14	38299727	38340710	NA	NA	NA	NA	NA
PGEN_.00g293090	Scaffold_14	38359608	38391428	Q69D48	RHBGA_XENLA	Ammonium transporter Rh type B-A (Rhesus blood group family type B glycoprotein A) (Rh family type B glycoprotein A) (Rh type B glycoprotein A)	GO:0008519; GO:0016021; GO:0016323; GO:0030659	basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ammonium transmembrane transporter activity [GO:0008519]
PGEN_.00g293100	Scaffold_14	38395390	38395797	NA	NA	NA	NA	NA
PGEN_.00g293110	Scaffold_14	38469554	38477038	Q04831	GLNA_PANAR	Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)	GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542]
PGEN_.00g293120	Scaffold_14	38482738	38486016	NA	NA	NA	NA	NA
PGEN_.00g293130	Scaffold_14	38488850	38493667	Q75BT9	GLNA_ASHGO	Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase)	GO:0004356; GO:0005524; GO:0005737; GO:0006542; GO:0034399	cytoplasm [GO:0005737]; nuclear periphery [GO:0034399]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamine biosynthetic process [GO:0006542]
PGEN_.00g293140	Scaffold_14	38498853	38503760	P20478	GLNA2_DROME	Glutamine synthetase 2 cytoplasmic (EC 6.3.1.2) (Glutamate--ammonia ligase 2)	GO:0004356; GO:0005524; GO:0005737; GO:0006538; GO:0006542; GO:0007416; GO:0045213	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416]
PGEN_.00g293150	Scaffold_14	38531219	38545539	NA	NA	NA	NA	NA
PGEN_.00g293160	Scaffold_14	38549727	38551202	NA	NA	NA	NA	NA
PGEN_.00g293170	Scaffold_14	38553486	38565866	NA	NA	NA	NA	NA
PGEN_.00g293180	Scaffold_14	38575609	38599333	Q6DFU2	NS1BP_XENLA	Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog)	GO:0005634; GO:0005737; GO:0005856	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]
PGEN_.00g293190	Scaffold_14	38617008	38647642	Q6PFP6	NDOR1_DANRE	NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase)	GO:0003958; GO:0005829; GO:0008219; GO:0010181; GO:0016226; GO:0016491; GO:0036245; GO:0048471; GO:0050660; GO:0050661	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]
PGEN_.00g293200	Scaffold_14	38760131	38762943	Q69ZK9	NLGN2_MOUSE	Neuroligin-2	GO:0001966; GO:0002087; GO:0005737; GO:0005886; GO:0005887; GO:0007158; GO:0007416; GO:0007630; GO:0008284; GO:0009986; GO:0019233; GO:0030054; GO:0032024; GO:0032230; GO:0035176; GO:0035418; GO:0035641; GO:0038023; GO:0042043; GO:0042734; GO:0042802; GO:0043198; GO:0045202; GO:0045211; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0060076; GO:0060077; GO:0060999; GO:0072553; GO:0097104; GO:0097105; GO:0097116; GO:0097119; GO:0097151; GO:0097470; GO:0098690; GO:0098691; GO:0098698; GO:0098982; GO:0099055; GO:0099060; GO:1901142; GO:1902474; GO:1904034; GO:1904862; GO:1905606; GO:2000311; GO:2000463; GO:2000809	"cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dopaminergic synapse [GO:0098691]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; inhibitory synapse assembly [GO:1904862]; insulin metabolic process [GO:1901142]; jump response [GO:0007630]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of t-SNARE clustering [GO:1904034]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; regulation of AMPA receptor activity [GO:2000311]; regulation of presynapse assembly [GO:1905606]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; terminal button organization [GO:0072553]; thigmotaxis [GO:0001966]"
PGEN_.00g293210	Scaffold_14	38769585	38770637	P30122	CEL_BOVIN	Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase) (Fragment)	GO:0004771; GO:0004806; GO:0005576; GO:0005737; GO:0005887; GO:0007158; GO:0008126; GO:0009986; GO:0016042; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0097104; GO:0097105; GO:0098793	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; synapse [GO:0045202]; acetylesterase activity [GO:0008126]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]
PGEN_.00g293220	Scaffold_14	38780082	38782951	NA	NA	NA	NA	NA
PGEN_.00g293230	Scaffold_14	38794069	38798593	Q64176	EST1E_MOUSE	Carboxylesterase 1E (EC 3.1.1.1) (Egasyn) (Liver carboxylesterase 22) (Es-22) (Esterase-22)	GO:0004771; GO:0004806; GO:0005615; GO:0005788; GO:0016042; GO:0016290; GO:0052689; GO:0080030	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; palmitoyl-CoA hydrolase activity [GO:0016290]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]
PGEN_.00g293240	Scaffold_14	38863228	38895079	P63013	PRRX1_MOUSE	Paired mesoderm homeobox protein 1 (Homeobox protein K-2) (Homeobox protein mHox) (Paired-related homeobox protein 1) (PRX-1)	GO:0000122; GO:0000978; GO:0001227; GO:0002053; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0030326; GO:0042472; GO:0042474; GO:0045880; GO:0045944; GO:0048664; GO:0048701; GO:0048704; GO:0048844; GO:0051216; GO:0060021; GO:0070570; GO:0071837; GO:0097150	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; artery morphogenesis [GO:0048844]; cartilage development [GO:0051216]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; inner ear morphogenesis [GO:0042472]; middle ear morphogenesis [GO:0042474]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate determination [GO:0048664]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron projection regeneration [GO:0070570]; roof of mouth development [GO:0060021]"
PGEN_.00g293250	Scaffold_14	38901510	38910462	P82596	PLC_HALLA	Perlucin	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g293260	Scaffold_14	38916450	38924831	Q28008	CLC3A_BOVIN	C-type lectin domain family 3 member A (C-type lectin superfamily member 1) (Cartilage-derived C-type lectin)	GO:0001503; GO:0005615; GO:0030246	extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; ossification [GO:0001503]
PGEN_.00g293270	Scaffold_14	38927368	38942501	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g293280	Scaffold_14	38945665	38946808	NA	NA	NA	NA	NA
PGEN_.00g293290	Scaffold_14	38963197	38964818	NA	NA	NA	NA	NA
PGEN_.00g293300	Scaffold_14	38982767	38992866	NA	NA	NA	NA	NA
PGEN_.00g293310	Scaffold_14	38993613	39024039	NA	NA	NA	NA	NA
PGEN_.00g293320	Scaffold_14	39041847	39048665	Q8NHV1	GIMA7_HUMAN	GTPase IMAP family member 7 (Immunity-associated nucleotide 7 protein) (IAN-7)	GO:0003924; GO:0005525; GO:0005783; GO:0005794; GO:0005811; GO:0005829; GO:0042802; GO:0042803; GO:0043231; GO:0046039	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; GTP metabolic process [GO:0046039]
PGEN_.00g293330	Scaffold_14	39061337	39062473	NA	NA	NA	NA	NA
PGEN_.00g293340	Scaffold_14	39076605	39081782	Q9NUV9	GIMA4_HUMAN	GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein) (IAN-1) (hIAN1) (Immunity-associated protein 4)	GO:0005525; GO:0005829	cytosol [GO:0005829]; GTP binding [GO:0005525]
PGEN_.00g293350	Scaffold_14	39097767	39111437	NA	NA	NA	NA	NA
PGEN_.00g293360	Scaffold_14	39113555	39113860	NA	NA	NA	NA	NA
PGEN_.00g293370	Scaffold_14	39136576	39140753	NA	NA	NA	NA	NA
PGEN_.00g293380	Scaffold_14	39156698	39194669	NA	NA	NA	NA	NA
PGEN_.00g293390	Scaffold_14	39204189	39222844	P80147	GABT_PIG	"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)"	GO:0003867; GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042135; GO:0042803; GO:0046872; GO:0047298; GO:0048148; GO:0051537	"4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]"
PGEN_.00g293400	Scaffold_14	39228624	39244746	Q95ZJ1	GALT5_CAEEL	Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243]
PGEN_.00g293410	Scaffold_14	39253723	39256245	NA	NA	NA	NA	NA
PGEN_.00g293420	Scaffold_14	39256366	39257753	NA	NA	NA	NA	NA
PGEN_.00g293430	Scaffold_14	39269175	39272661	Q24306	DIAP1_DROME	Death-associated inhibitor of apoptosis 1 (EC 2.3.2.27) (Apoptosis 1 inhibitor) (E3 ubiquitin-protein ligase th) (Inhibitor of apoptosis 1) (Protein thread) (RING-type E3 ubiquitin transferase Diap1)	GO:0000209; GO:0004842; GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0007275; GO:0007283; GO:0007289; GO:0007298; GO:0008270; GO:0008354; GO:0016055; GO:0022416; GO:0031398; GO:0031624; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0044390; GO:0045035; GO:0045116; GO:0046673; GO:0048800; GO:0051865; GO:0061630; GO:0061663; GO:0070936; GO:0089720; GO:0090263; GO:0097340; GO:1903688; GO:1990001; GO:1990381; GO:2001271	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; NEDD8 ligase activity [GO:0061663]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; antennal morphogenesis [GO:0048800]; apoptotic process [GO:0006915]; border follicle cell migration [GO:0007298]; chaeta development [GO:0022416]; germ cell migration [GO:0008354]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; sensory organ precursor cell division [GO:0045035]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]
PGEN_.00g293440	Scaffold_14	39276334	39279260	NA	NA	NA	NA	NA
PGEN_.00g293450	Scaffold_14	39285574	39291671	NA	NA	NA	NA	NA
PGEN_.00g293460	Scaffold_14	39325435	39337419	Q8TDX7	NEK7_HUMAN	Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7)	GO:0000922; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0046872; GO:0051225; GO:0051973; GO:1904355	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]
PGEN_.00g293470	Scaffold_14	39410010	39411299	NA	NA	NA	NA	NA
PGEN_.00g293480	Scaffold_14	39421137	39421481	NA	NA	NA	NA	NA
PGEN_.00g293490	Scaffold_14	39426655	39426981	NA	NA	NA	NA	NA
PGEN_.00g293500	Scaffold_14	39427313	39427576	NA	NA	NA	NA	NA
PGEN_.00g293510	Scaffold_14	39438516	39455652	Q6AX23	QSOX2_XENLA	Sulfhydryl oxidase 2 (EC 1.8.3.2) (Quiescin Q6-like protein 1)	GO:0005623; GO:0016021; GO:0016971; GO:0045454	cell [GO:0005623]; integral component of membrane [GO:0016021]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; cell redox homeostasis [GO:0045454]
PGEN_.00g293520	Scaffold_14	39458189	39460922	NA	NA	NA	NA	NA
PGEN_.00g293530	Scaffold_14	39484024	39490254	NA	NA	NA	NA	NA
PGEN_.00g293540	Scaffold_14	39502247	39518699	P07207	NOTCH_DROME	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	GO:0001708; GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0005915; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007455; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035003; GO:0035153; GO:0035162; GO:0035165; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043525; GO:0043697; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048	"adherens junction [GO:0005912]; cell [GO:0005623]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
PGEN_.00g293550	Scaffold_14	39519544	39519864	P57110	ATS8_MOUSE	A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2)	GO:0004222; GO:0008201; GO:0008270; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g293560	Scaffold_14	39522872	39523669	A2AX52	CO6A4_MOUSE	Collagen alpha-4(VI) chain	GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; collagen binding [GO:0005518]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]
PGEN_.00g293570	Scaffold_14	39525229	39578377	P10040	CRB_DROME	Protein crumbs (95F)	GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007399; GO:0007424; GO:0007435; GO:0007443; GO:0008284; GO:0016021; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032435; GO:0032880; GO:0033157; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218]"
PGEN_.00g293580	Scaffold_14	39595447	39596772	NA	NA	NA	NA	NA
PGEN_.00g293590	Scaffold_14	39599187	39600590	NA	NA	NA	NA	NA
PGEN_.00g293600	Scaffold_14	39607038	39625992	NA	NA	NA	NA	NA
PGEN_.00g293610	Scaffold_14	39629274	39636951	NA	NA	NA	NA	NA
PGEN_.00g293620	Scaffold_14	39638980	39656529	NA	NA	NA	NA	NA
PGEN_.00g293630	Scaffold_14	39664982	39665311	NA	NA	NA	NA	NA
PGEN_.00g293640	Scaffold_14	39677074	39678168	P54922	ADPRH_HUMAN	[Protein ADP-ribosylarginine] hydrolase (ADP-ribosylarginine hydrolase) (hARH1) (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme)	GO:0000287; GO:0003875; GO:0005096; GO:0005615; GO:0005829; GO:0006464; GO:0006886; GO:0017137; GO:0030955; GO:0051725; GO:0090630	cytosol [GO:0005829]; extracellular space [GO:0005615]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725]
PGEN_.00g293650	Scaffold_14	39681840	39690600	NA	NA	NA	NA	NA
PGEN_.00g293660	Scaffold_14	39698377	39702410	NA	NA	NA	NA	NA
PGEN_.00g293670	Scaffold_14	39710263	39715703	NA	NA	NA	NA	NA
PGEN_.00g293680	Scaffold_14	39719991	39720704	NA	NA	NA	NA	NA
PGEN_.00g293690	Scaffold_14	39731988	39736599	NA	NA	NA	NA	NA
PGEN_.00g293700	Scaffold_14	39771709	39772053	NA	NA	NA	NA	NA
PGEN_.00g293710	Scaffold_14	39787980	39788255	NA	NA	NA	NA	NA
PGEN_.00g293720	Scaffold_14	39788307	39788816	NA	NA	NA	NA	NA
PGEN_.00g293730	Scaffold_14	39789625	39794654	NA	NA	NA	NA	NA
PGEN_.00g293740	Scaffold_14	39795197	39795586	NA	NA	NA	NA	NA
PGEN_.00g293750	Scaffold_14	39801625	39801969	NA	NA	NA	NA	NA
PGEN_.00g293760	Scaffold_14	39806216	39806527	NA	NA	NA	NA	NA
PGEN_.00g293770	Scaffold_14	39827169	39841781	NA	NA	NA	NA	NA
PGEN_.00g293780	Scaffold_14	39869041	39870807	NA	NA	NA	NA	NA
PGEN_.00g293790	Scaffold_14	39870812	39871057	NA	NA	NA	NA	NA
PGEN_.00g293800	Scaffold_14	39877870	39880095	NA	NA	NA	NA	NA
PGEN_.00g293810	Scaffold_14	39880760	39883656	NA	NA	NA	NA	NA
PGEN_.00g293820	Scaffold_14	39895479	39912830	Q8TB37	NUBPL_HUMAN	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"
PGEN_.00g293830	Scaffold_14	39913027	39918530	NA	NA	NA	NA	NA
PGEN_.00g293840	Scaffold_14	39936943	39946821	NA	NA	NA	NA	NA
PGEN_.00g293850	Scaffold_14	39948398	39955519	NA	NA	NA	NA	NA
PGEN_.00g293860	Scaffold_14	39961186	39974196	Q8TB37	NUBPL_HUMAN	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"
PGEN_.00g293870	Scaffold_14	39977230	39998336	Q571F8	GLSL_MOUSE	"Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase) (LGA)"	GO:0004359; GO:0005739; GO:0006537; GO:0006543; GO:0042981; GO:0072593	mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]
PGEN_.00g293880	Scaffold_14	40006467	40032580	NA	NA	NA	NA	NA
PGEN_.00g293890	Scaffold_14	40050304	40097587	O75052	CAPON_HUMAN	Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (C-terminal PDZ ligand of neuronal nitric oxide synthase protein) (Nitric oxide synthase 1 adaptor protein)	GO:0003062; GO:0005634; GO:0005739; GO:0005829; GO:0005901; GO:0010628; GO:0010750; GO:0030018; GO:0030315; GO:0033017; GO:0042383; GO:0045428; GO:0045429; GO:0048471; GO:0050998; GO:0050999; GO:0051000; GO:0060307; GO:0098901; GO:0098974; GO:0098978; GO:1901381; GO:1901841; GO:1902261; GO:1902514; GO:1903762; GO:2000170	caveola [GO:0005901]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018]; nitric-oxide synthase binding [GO:0050998]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate by chemical signal [GO:0003062]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]
PGEN_.00g293900	Scaffold_14	40104254	40113873	NA	NA	NA	NA	NA
PGEN_.00g293910	Scaffold_14	40115867	40132610	Q9D3A8	CAPON_MOUSE	Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (C-terminal PDZ ligand of neuronal nitric oxide synthase protein) (Nitric oxide synthase 1 adaptor protein)	GO:0002020; GO:0003062; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0030018; GO:0030165; GO:0033017; GO:0050998; GO:0060307; GO:0098793; GO:0098794; GO:0098974; GO:0098978; GO:1901215; GO:1901841; GO:2000170	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; protease binding [GO:0002020]; negative regulation of neuron death [GO:1901215]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of heart rate by chemical signal [GO:0003062]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]
PGEN_.00g293920	Scaffold_14	40142038	40178414	O08599	STXB1_MOUSE	Syntaxin-binding protein 1 (Protein unc-18 homolog 1) (Unc18-1) (Protein unc-18 homolog A) (Unc-18A)	GO:0000149; GO:0002576; GO:0003006; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006904; GO:0007269; GO:0007274; GO:0007412; GO:0010807; GO:0015031; GO:0016082; GO:0016188; GO:0017075; GO:0019901; GO:0019904; GO:0019905; GO:0030424; GO:0031091; GO:0031333; GO:0031338; GO:0031629; GO:0032229; GO:0032355; GO:0032991; GO:0035493; GO:0042802; GO:0043209; GO:0043274; GO:0043306; GO:0043524; GO:0045335; GO:0045921; GO:0045956; GO:0047485; GO:0048471; GO:0048787; GO:0050821; GO:0060292; GO:0070527; GO:0071346; GO:0072659; GO:0098793; GO:0098794; GO:0098891; GO:0098978; GO:0099525; GO:0106022; GO:1903296; GO:2000367	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of presynaptic active zone membrane [GO:0098891]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; exocytosis [GO:0006887]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of acrosomal vesicle exocytosis [GO:2000367]; regulation of synaptic vesicle priming [GO:0010807]; regulation of vesicle fusion [GO:0031338]; response to estradiol [GO:0032355]; SNARE complex assembly [GO:0035493]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904]"
PGEN_.00g293930	Scaffold_14	40183378	40258774	Q13905	RPGF1_HUMAN	Rap guanine nucleotide exchange factor 1 (CRK SH3-binding GNRP) (Guanine nucleotide-releasing factor 2) (Protein C3G)	GO:0000186; GO:0001568; GO:0005085; GO:0005737; GO:0005769; GO:0005829; GO:0007165; GO:0007169; GO:0010976; GO:0017034; GO:0017124; GO:0019221; GO:0030670; GO:0032486; GO:0032991; GO:0038180; GO:0043231; GO:0043547; GO:0046328; GO:0046579; GO:0046580; GO:0048008; GO:0048471; GO:0051898; GO:0061028; GO:0070373; GO:0070374; GO:0071320; GO:0090090; GO:0090630; GO:0098609; GO:1901888; GO:1905451; GO:1990090; GO:2000178	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; SH3 domain binding [GO:0017124]; activation of GTPase activity [GO:0090630]; activation of MAPKK activity [GO:0000186]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; cytokine-mediated signaling pathway [GO:0019221]; establishment of endothelial barrier [GO:0061028]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Ras protein signal transduction [GO:0046580]; nerve growth factor signaling pathway [GO:0038180]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g293940	Scaffold_14	40275309	40277278	NA	NA	NA	NA	NA
PGEN_.00g293950	Scaffold_14	40309022	40316363	Q866F0	FUT1_SAIBB	"Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]
PGEN_.00g293960	Scaffold_14	40325355	40327571	Q9UTI2	GLRX2_SCHPO	Glutaredoxin-2	GO:0004362; GO:0004602; GO:0005623; GO:0005634; GO:0005739; GO:0009055; GO:0015035; GO:0015038; GO:0019430; GO:0034599; GO:0045454	cell [GO:0005623]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; glutathione peroxidase activity [GO:0004602]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; removal of superoxide radicals [GO:0019430]
PGEN_.00g293970	Scaffold_14	40331055	40333408	O08547	SC22B_MOUSE	Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1) (mSec22b)	GO:0000139; GO:0005484; GO:0005783; GO:0005789; GO:0005793; GO:0006888; GO:0006890; GO:0008021; GO:0012507; GO:0015031; GO:0016021; GO:0016192; GO:0019905; GO:0030137; GO:0031201; GO:0033116; GO:0042470; GO:0045732; GO:0048280; GO:1902902	"COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of autophagosome assembly [GO:1902902]; positive regulation of protein catabolic process [GO:0045732]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g293980	Scaffold_14	40343126	40357058	Q8NCH0	CHSTE_HUMAN	Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1) (hD4ST1)	GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030208; GO:0042301; GO:0050655; GO:0070062	extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; phosphate ion binding [GO:0042301]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655]
PGEN_.00g293990	Scaffold_14	40361346	40365026	NA	NA	NA	NA	NA
PGEN_.00g294000	Scaffold_14	40383376	40390566	NA	NA	NA	NA	NA
PGEN_.00g294010	Scaffold_14	40429900	40439108	NA	NA	NA	NA	NA
PGEN_.00g294020	Scaffold_14	40444373	40452591	NA	NA	NA	NA	NA
PGEN_.00g294030	Scaffold_14	40465447	40481089	Q6DFF6	KLH20_XENLA	Kelch-like protein 20	GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]
PGEN_.00g294040	Scaffold_14	40481417	40491344	Q810N6	ANR45_MOUSE	Ankyrin repeat domain-containing protein 45		
PGEN_.00g294050	Scaffold_14	40503811	40508702	Q3UFB2	BCD1_MOUSE	Box C/D snoRNA protein 1 (Zinc finger HIT domain-containing protein 6)	GO:0000463; GO:0000492; GO:0001094; GO:0005634; GO:0019899; GO:0042802; GO:0046872; GO:0048254; GO:0051117; GO:0051259; GO:0070761	"nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; TFIID-class transcription factor complex binding [GO:0001094]; box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein complex oligomerization [GO:0051259]; snoRNA localization [GO:0048254]"
PGEN_.00g294060	Scaffold_14	40512084	40515647	NA	NA	NA	NA	NA
PGEN_.00g294070	Scaffold_14	40521505	40602304	Q9UBS5	GABR1_HUMAN	Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)	GO:0004965; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007214; GO:0030054; GO:0030425; GO:0038039; GO:0042734; GO:0045211; GO:0098685; GO:0098982; GO:0099579; GO:0150099	cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]
PGEN_.00g294080	Scaffold_14	40607412	40609503	NA	NA	NA	NA	NA
PGEN_.00g294090	Scaffold_14	40642127	40643457	NA	NA	NA	NA	NA
PGEN_.00g294100	Scaffold_14	40665427	40673757	NA	NA	NA	NA	NA
PGEN_.00g294110	Scaffold_14	40697631	40701483	Q64620	PPP6_RAT	Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) (Protein phosphatase V) (PP-V)	GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0007049; GO:0045087; GO:0046872	cytosol [GO:0005829]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]
PGEN_.00g294120	Scaffold_14	40702983	40712188	Q64620	PPP6_RAT	Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) (Protein phosphatase V) (PP-V)	GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0007049; GO:0045087; GO:0046872	cytosol [GO:0005829]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]
PGEN_.00g294130	Scaffold_14	40739055	40819294	P20909	COBA1_RAT	Collagen alpha-1(XI) chain	GO:0001502; GO:0001503; GO:0002063; GO:0003007; GO:0005201; GO:0005581; GO:0005592; GO:0005615; GO:0006029; GO:0007601; GO:0007605; GO:0008201; GO:0030198; GO:0030199; GO:0031012; GO:0035987; GO:0035989; GO:0042472; GO:0046872; GO:0048704; GO:0048705; GO:0050910; GO:0051216; GO:0055010; GO:0062023; GO:1904399	collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601]
PGEN_.00g294140	Scaffold_14	40827855	40854847	Q8BUV8	GP107_MOUSE	Protein GPR107	GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016021; GO:0030136; GO:0032050; GO:0072583	clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583]
PGEN_.00g294150	Scaffold_14	40859203	40869676	Q5TM19	IKBL1_MACMU	NF-kappa-B inhibitor-like protein 1 (Inhibitor of kappa B-like protein) (I-kappa-B-like protein) (IkappaBL) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1)	GO:0005634; GO:0007249; GO:0031665; GO:0032088; GO:0032720; GO:0034122; GO:0071222	nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]
PGEN_.00g294160	Scaffold_14	40869867	40883876	NA	NA	NA	NA	NA
PGEN_.00g294170	Scaffold_14	40893484	40906251	NA	NA	NA	NA	NA
PGEN_.00g294180	Scaffold_14	40914470	40918542	NA	NA	NA	NA	NA
PGEN_.00g294190	Scaffold_14	41031145	41065024	P61968	LMO4_HUMAN	LIM domain transcription factor LMO4 (Breast tumor autoantigen) (LIM domain only protein 4) (LMO-4)	GO:0001158; GO:0001843; GO:0003281; GO:0003700; GO:0005667; GO:0006366; GO:0008134; GO:0021514; GO:0021522; GO:0021527; GO:0030334; GO:0031252; GO:0031333; GO:0033674; GO:0042659; GO:0045944; GO:0046872; GO:0048538; GO:0050865	cell leading edge [GO:0031252]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; negative regulation of protein complex assembly [GO:0031333]; neural tube closure [GO:0001843]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell activation [GO:0050865]; regulation of cell fate specification [GO:0042659]; regulation of cell migration [GO:0030334]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron differentiation [GO:0021522]; thymus development [GO:0048538]; transcription by RNA polymerase II [GO:0006366]; ventral spinal cord interneuron differentiation [GO:0021514]; ventricular septum development [GO:0003281]
PGEN_.00g294200	Scaffold_14	41076472	41076750	NA	NA	NA	NA	NA
PGEN_.00g294210	Scaffold_14	41077428	41077919	NA	NA	NA	NA	NA
PGEN_.00g294220	Scaffold_14	41095293	41097955	P58389	PTPA_MOUSE	"Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')"	GO:0000159; GO:0003755; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0008160; GO:0016887; GO:0019888; GO:0032515; GO:0032516; GO:0034704; GO:0035307; GO:0035308; GO:0042803; GO:0043065; GO:0043666; GO:0051721	calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]; mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphoprotein phosphatase activity [GO:0043666]
PGEN_.00g294230	Scaffold_14	41119549	41133880	Q704S8	CACP_RAT	Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT)	GO:0004092; GO:0005739; GO:0005743; GO:0005777; GO:0005783; GO:0006631; GO:0019254	"endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid metabolic process [GO:0006631]"
PGEN_.00g294240	Scaffold_14	41142676	41142984	NA	NA	NA	NA	NA
PGEN_.00g294250	Scaffold_14	41147238	41147507	NA	NA	NA	NA	NA
PGEN_.00g294260	Scaffold_14	41148752	41149252	NA	NA	NA	NA	NA
PGEN_.00g294270	Scaffold_14	41149681	41150019	NA	NA	NA	NA	NA
PGEN_.00g294280	Scaffold_14	41151081	41155477	Q8C5K5	CX038_MOUSE	Uncharacterized protein CXorf38 homolog		
PGEN_.00g294290	Scaffold_14	41155500	41155944	NA	NA	NA	NA	NA
PGEN_.00g294300	Scaffold_14	41155967	41168718	NA	NA	NA	NA	NA
PGEN_.00g294310	Scaffold_14	41174891	41178920	NA	NA	NA	NA	NA
PGEN_.00g294320	Scaffold_14	41179604	41179888	NA	NA	NA	NA	NA
PGEN_.00g294330	Scaffold_14	41182978	41188009	NA	NA	NA	NA	NA
PGEN_.00g294340	Scaffold_14	41193662	41194072	NA	NA	NA	NA	NA
PGEN_.00g294350	Scaffold_14	41214708	41216799	NA	NA	NA	NA	NA
PGEN_.00g294360	Scaffold_14	41219559	41225820	NA	NA	NA	NA	NA
PGEN_.00g294370	Scaffold_14	41242183	41242449	NA	NA	NA	NA	NA
PGEN_.00g294380	Scaffold_14	41243349	41247246	NA	NA	NA	NA	NA
PGEN_.00g294390	Scaffold_14	41252322	41252798	NA	NA	NA	NA	NA
PGEN_.00g294400	Scaffold_14	41273330	41274211	NA	NA	NA	NA	NA
PGEN_.00g294410	Scaffold_14	41279474	41279899	NA	NA	NA	NA	NA
PGEN_.00g294420	Scaffold_14	41282026	41282902	NA	NA	NA	NA	NA
PGEN_.00g294430	Scaffold_14	41331805	41333289	NA	NA	NA	NA	NA
PGEN_.00g294440	Scaffold_14	41439454	41549977	Q16832	DDR2_HUMAN	"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)"	GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030198; GO:0030199; GO:0030500; GO:0031214; GO:0034103; GO:0035988; GO:0038062; GO:0038063; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0090091	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g294450	Scaffold_14	41616364	41618757	NA	NA	NA	NA	NA
PGEN_.00g294460	Scaffold_14	41629429	41629785	NA	NA	NA	NA	NA
PGEN_.00g294470	Scaffold_14	41629950	41630342	NA	NA	NA	NA	NA
PGEN_.00g294480	Scaffold_14	41630870	41631440	NA	NA	NA	NA	NA
PGEN_.00g294490	Scaffold_14	41633841	41634155	NA	NA	NA	NA	NA
PGEN_.00g294500	Scaffold_14	41649916	41651777	NA	NA	NA	NA	NA
PGEN_.00g294510	Scaffold_14	41717040	41727719	NA	NA	NA	NA	NA
PGEN_.00g294520	Scaffold_14	41748970	41749209	NA	NA	NA	NA	NA
PGEN_.00g294530	Scaffold_14	41779411	41795204	P30841	CROM_ENTDO	Omega-crystallin	GO:0005212; GO:0016620	"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; structural constituent of eye lens [GO:0005212]"
PGEN_.00g294540	Scaffold_14	41806211	41812181	NA	NA	NA	NA	NA
PGEN_.00g294550	Scaffold_14	41867987	41910872	Q9VB11	UNC80_DROME	Protein unc-80 homolog	GO:0005261; GO:0030424; GO:0034703; GO:0045475; GO:0055080	axon [GO:0030424]; cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475]
PGEN_.00g294560	Scaffold_14	42022007	42038994	Q9MYP6	DHB14_BOVIN	17-beta-hydroxysteroid dehydrogenase 14 (17-beta-HSD 14) (EC 1.1.1.-) (17-beta-hydroxysteroid dehydrogenase DHRS10) (Dehydrogenase/reductase SDR family member 10) (Retinal short-chain dehydrogenase/reductase retSDR3)	GO:0004303; GO:0005829; GO:0006706; GO:0042802; GO:0047045	cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706]
PGEN_.00g294570	Scaffold_14	42050465	42058213	NA	NA	NA	NA	NA
PGEN_.00g294580	Scaffold_14	42058539	42059207	O77486	FUT2_GORGO	"Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.344) (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g294590	Scaffold_14	42064968	42065270	NA	NA	NA	NA	NA
PGEN_.00g294600	Scaffold_14	42066846	42068637	Q0R4F1	PIF1_XENLA	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)	GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0043139	mitochondrion [GO:0005739]; nucleus [GO:0005634]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]
PGEN_.00g294610	Scaffold_14	42068742	42069782	NA	NA	NA	NA	NA
PGEN_.00g294620	Scaffold_14	42082153	42082632	Q17QS4	PI5L1_BOVIN	Phosphatidylinositol 4-phosphate 5-kinase-like protein 1 (PI(4)P 5-kinase-like protein 1) (PtdIns(4)P-5-kinase-like protein 1) (EC 2.7.1.68)	GO:0001933; GO:0005524; GO:0005829; GO:0010917; GO:0016020; GO:0016308; GO:0030336; GO:0042995; GO:0043065	cell projection [GO:0042995]; cytosol [GO:0005829]; membrane [GO:0016020]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; negative regulation of cell migration [GO:0030336]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of apoptotic process [GO:0043065]
PGEN_.00g294630	Scaffold_14	42099245	42113801	Q17QS4	PI5L1_BOVIN	Phosphatidylinositol 4-phosphate 5-kinase-like protein 1 (PI(4)P 5-kinase-like protein 1) (PtdIns(4)P-5-kinase-like protein 1) (EC 2.7.1.68)	GO:0001933; GO:0005524; GO:0005829; GO:0010917; GO:0016020; GO:0016308; GO:0030336; GO:0042995; GO:0043065	cell projection [GO:0042995]; cytosol [GO:0005829]; membrane [GO:0016020]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; negative regulation of cell migration [GO:0030336]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of apoptotic process [GO:0043065]
PGEN_.00g294640	Scaffold_14	42116857	42131807	C0IN03	HENMT_XENTR	Small RNA 2'-O-methyltransferase (EC 2.1.1.n8) (HEN1 methyltransferase homolog 1) (piRNA methyltransferase 1)	GO:0001510; GO:0003723; GO:0005634; GO:0005737; GO:0008171; GO:0008173; GO:0030422; GO:0034587; GO:0043186; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; piRNA metabolic process [GO:0034587]; production of siRNA involved in RNA interference [GO:0030422]; RNA methylation [GO:0001510]
PGEN_.00g294650	Scaffold_14	42136421	42140362	Q2TGI5	ZDH24_RAT	Probable palmitoyltransferase ZDHHC24 (EC 2.3.1.225) (Membrane-associated zinc finger protein DHHC25) (Zinc finger DHHC domain-containing protein 24) (DHHC-24)	GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612]
PGEN_.00g294660	Scaffold_14	42153072	42159139	Q9BZC7	ABCA2_HUMAN	ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2)	GO:0000166; GO:0005319; GO:0005524; GO:0005623; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006357; GO:0006629; GO:0006869; GO:0007626; GO:0010008; GO:0010872; GO:0016020; GO:0016021; GO:0016887; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042493; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0150110; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]
PGEN_.00g294670	Scaffold_14	42169844	42220795	Q9BZC7	ABCA2_HUMAN	ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2)	GO:0000166; GO:0005319; GO:0005524; GO:0005623; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006357; GO:0006629; GO:0006869; GO:0007626; GO:0010008; GO:0010872; GO:0016020; GO:0016021; GO:0016887; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042493; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0150110; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cholesterol esterification [GO:0150110]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to steroid hormone [GO:0048545]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]
PGEN_.00g294680	Scaffold_14	42226210	42233693	NA	NA	NA	NA	NA
PGEN_.00g294690	Scaffold_14	42240458	42241975	P09875	UD2B1_RAT	UDP-glucuronosyltransferase 2B1 (UDPGT 2B1) (EC 2.4.1.17) (UDPGTr-2)	GO:0005789; GO:0008194; GO:0015020; GO:0016021; GO:0017144; GO:0032496; GO:0043231; GO:0052695; GO:0070980; GO:0071361; GO:0071378; GO:0071385; GO:0071394	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to testosterone stimulus [GO:0071394]; drug metabolic process [GO:0017144]; response to lipopolysaccharide [GO:0032496]
PGEN_.00g294700	Scaffold_14	42252521	42288926	Q9NPB8	GPCP1_HUMAN	Glycerophosphocholine phosphodiesterase GPCPD1 (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 5)	GO:0005829; GO:0007519; GO:0046475; GO:0047389; GO:2001070	cytosol [GO:0005829]; glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]; glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519]
PGEN_.00g294710	Scaffold_14	42294515	42294934	NA	NA	NA	NA	NA
PGEN_.00g294720	Scaffold_14	42295899	42296366	NA	NA	NA	NA	NA
PGEN_.00g294730	Scaffold_14	42303024	42303395	NA	NA	NA	NA	NA
PGEN_.00g294740	Scaffold_14	42328854	42332781	NA	NA	NA	NA	NA
PGEN_.00g294750	Scaffold_14	42332850	42336195	NA	NA	NA	NA	NA
PGEN_.00g294760	Scaffold_14	42337180	42338337	NA	NA	NA	NA	NA
PGEN_.00g294770	Scaffold_14	42349685	42350856	NA	NA	NA	NA	NA
PGEN_.00g294780	Scaffold_14	42354015	42355592	NA	NA	NA	NA	NA
PGEN_.00g294790	Scaffold_14	42355803	42357398	NA	NA	NA	NA	NA
PGEN_.00g294800	Scaffold_14	42376150	42376646	NA	NA	NA	NA	NA
PGEN_.00g294810	Scaffold_14	42378162	42384570	NA	NA	NA	NA	NA
PGEN_.00g294820	Scaffold_14	42426136	42426417	NA	NA	NA	NA	NA
PGEN_.00g294830	Scaffold_14	42428501	42428863	NA	NA	NA	NA	NA
PGEN_.00g294840	Scaffold_14	42429391	42430098	NA	NA	NA	NA	NA
PGEN_.00g294850	Scaffold_14	42458834	42460745	NA	NA	NA	NA	NA
PGEN_.00g294860	Scaffold_14	42464175	42465515	A5A4K9	GHSR_RABIT	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GO:0001616; GO:0005886; GO:0008154; GO:0008343; GO:0009755; GO:0009986; GO:0016021; GO:0016520; GO:0030252; GO:0032094; GO:0032100; GO:0032691; GO:0032869; GO:0040018; GO:0042536; GO:0043005; GO:0043568; GO:0045121; GO:0045409; GO:0046697; GO:0050728; GO:0051963	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; decidualization [GO:0046697]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 biosynthetic process [GO:0045409]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of appetite [GO:0032100]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of synapse assembly [GO:0051963]; response to food [GO:0032094]
PGEN_.00g294870	Scaffold_14	42529536	42529871	NA	NA	NA	NA	NA
PGEN_.00g294880	Scaffold_14	42529945	42530205	NA	NA	NA	NA	NA
PGEN_.00g294890	Scaffold_14	42544121	42544768	NA	NA	NA	NA	NA
PGEN_.00g294900	Scaffold_14	42545265	42545528	NA	NA	NA	NA	NA
PGEN_.00g294910	Scaffold_14	42616092	42618102	NA	NA	NA	NA	NA
PGEN_.00g294920	Scaffold_14	42628596	42630659	NA	NA	NA	NA	NA
PGEN_.00g294930	Scaffold_14	42633256	42634044	NA	NA	NA	NA	NA
PGEN_.00g294940	Scaffold_14	42757327	42768721	O62698	PGH2_BOVIN	Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2)	GO:0000212; GO:0001516; GO:0001550; GO:0001934; GO:0004601; GO:0004666; GO:0005789; GO:0006954; GO:0006979; GO:0008217; GO:0019371; GO:0020037; GO:0040019; GO:0046872; GO:0051213; GO:0071347; GO:0150077; GO:1900195; GO:1904146	endoplasmic reticulum membrane [GO:0005789]; dioxygenase activity [GO:0051213]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; cellular response to interleukin-1 [GO:0071347]; cyclooxygenase pathway [GO:0019371]; inflammatory response [GO:0006954]; meiotic spindle organization [GO:0000212]; ovarian cumulus expansion [GO:0001550]; positive regulation of embryonic development [GO:0040019]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of protein phosphorylation [GO:0001934]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of neuroinflammatory response [GO:0150077]; response to oxidative stress [GO:0006979]
PGEN_.00g294950	Scaffold_14	42872556	42902067	P49147	PA24A_CHICK	Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]	GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0031410; GO:0046475; GO:0047498; GO:0102567; GO:0102568	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; glycerophospholipid catabolic process [GO:0046475]"
PGEN_.00g294960	Scaffold_14	42905594	42910043	NA	NA	NA	NA	NA
PGEN_.00g294970	Scaffold_14	42913851	42916759	NA	NA	NA	NA	NA
PGEN_.00g294980	Scaffold_14	42916788	42933932	Q8BWQ4	CMTR2_MOUSE	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (MTr2) (FtsJ methyltransferase domain-containing protein 1)	GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0097309; GO:0097310	cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310]
PGEN_.00g294990	Scaffold_14	42936098	42936340	NA	NA	NA	NA	NA
PGEN_.00g295000	Scaffold_14	42939867	42961992	Q71RI9	KAT3_MOUSE	Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III)	GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]
PGEN_.00g295010	Scaffold_14	42968150	42988416	Q6PCB7	S27A1_HUMAN	Long-chain fatty acid transport protein 1 (FATP-1) (Fatty acid transport protein 1) (EC 6.2.1.-) (Solute carrier family 27 member 1)	GO:0000166; GO:0001579; GO:0004467; GO:0005324; GO:0005739; GO:0005783; GO:0005886; GO:0005887; GO:0006646; GO:0006654; GO:0006655; GO:0006656; GO:0006659; GO:0006661; GO:0009409; GO:0010867; GO:0015245; GO:0015909; GO:0016020; GO:0019216; GO:0031652; GO:0031957; GO:0032049; GO:0032868; GO:0033211; GO:0042803; GO:0044539; GO:0071072; GO:0071902	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; adiponectin-activated signaling pathway [GO:0033211]; cardiolipin biosynthetic process [GO:0032049]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of lipid metabolic process [GO:0019216]; response to cold [GO:0009409]; response to insulin [GO:0032868]
PGEN_.00g295020	Scaffold_14	43030070	43034658	NA	NA	NA	NA	NA
PGEN_.00g295030	Scaffold_14	43095586	43096056	NA	NA	NA	NA	NA
PGEN_.00g295040	Scaffold_14	43119506	43130824	NA	NA	NA	NA	NA
PGEN_.00g295050	Scaffold_14	43134666	43140079	NA	NA	NA	NA	NA
PGEN_.00g295060	Scaffold_14	43169069	43180163	NA	NA	NA	NA	NA
PGEN_.00g295070	Scaffold_14	43211650	43231392	Q9NVG8	TBC13_HUMAN	TBC1 domain family member 13	GO:0005096; GO:0005829; GO:0006886; GO:0016020; GO:0017137; GO:0090630	cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]
PGEN_.00g295080	Scaffold_14	43231713	43232399	NA	NA	NA	NA	NA
PGEN_.00g295090	Scaffold_14	43237680	43238846	Q28GD4	ELAV2_XENTR	ELAV-like protein 2 (Protein ElrB)	GO:0003723; GO:0005938; GO:0007275; GO:1990904	cell cortex [GO:0005938]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]
PGEN_.00g295100	Scaffold_14	43248345	43249430	Q28GD4	ELAV2_XENTR	ELAV-like protein 2 (Protein ElrB)	GO:0003723; GO:0005938; GO:0007275; GO:1990904	cell cortex [GO:0005938]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]
PGEN_.00g295110	Scaffold_14	43249464	43255763	NA	NA	NA	NA	NA
PGEN_.00g295120	Scaffold_14	43256503	43257636	P26378	ELAV4_HUMAN	ELAV-like protein 4 (Hu-antigen D) (HuD) (Paraneoplastic encephalomyelitis antigen HuD)	GO:0003730; GO:0005737; GO:0006397; GO:0008380; GO:0030425; GO:0030426; GO:0035925; GO:0043204; GO:1990904	cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; perikaryon [GO:0043204]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g295130	Scaffold_14	43288416	43305313	Q9R1A8	COP1_MOUSE	E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2)	GO:0000139; GO:0010212; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0046872; GO:0061630	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]
PGEN_.00g295140	Scaffold_14	43309102	43314518	Q96GR4	ZDH12_HUMAN	Probable palmitoyltransferase ZDHHC12 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 12) (DHHC-12) (Zinc finger protein 400)	GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]
PGEN_.00g295150	Scaffold_14	43334425	43363123	Q9NZL6	RGL1_HUMAN	Ral guanine nucleotide dissociation stimulator-like 1 (RalGDS-like 1)	GO:0005829; GO:0007264; GO:0008321; GO:0019216	cytosol [GO:0005829]; Ral guanyl-nucleotide exchange factor activity [GO:0008321]; regulation of lipid metabolic process [GO:0019216]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g295160	Scaffold_14	43361168	43361530	NA	NA	NA	NA	NA
PGEN_.00g295170	Scaffold_14	43370415	43371300	NA	NA	NA	NA	NA
PGEN_.00g295180	Scaffold_14	43383904	43384236	NA	NA	NA	NA	NA
PGEN_.00g295190	Scaffold_14	43385169	43385531	NA	NA	NA	NA	NA
PGEN_.00g295200	Scaffold_14	43392312	43394104	NA	NA	NA	NA	NA
PGEN_.00g295210	Scaffold_14	43398047	43398328	NA	NA	NA	NA	NA
PGEN_.00g295220	Scaffold_14	43402003	43402317	NA	NA	NA	NA	NA
PGEN_.00g295230	Scaffold_14	43410597	43414147	NA	NA	NA	NA	NA
PGEN_.00g295240	Scaffold_14	43419486	43420488	NA	NA	NA	NA	NA
PGEN_.00g295250	Scaffold_14	43437390	43437686	NA	NA	NA	NA	NA
PGEN_.00g295260	Scaffold_14	43446716	43451068	NA	NA	NA	NA	NA
PGEN_.00g295270	Scaffold_14	43451098	43451526	NA	NA	NA	NA	NA
PGEN_.00g295280	Scaffold_14	43457283	43457615	NA	NA	NA	NA	NA
PGEN_.00g295290	Scaffold_14	43458983	43459450	NA	NA	NA	NA	NA
PGEN_.00g295300	Scaffold_14	43463745	43465909	NA	NA	NA	NA	NA
PGEN_.00g295310	Scaffold_14	43473836	43474111	NA	NA	NA	NA	NA
PGEN_.00g295320	Scaffold_14	43481690	43493255	NA	NA	NA	NA	NA
PGEN_.00g295330	Scaffold_14	43498556	43499070	NA	NA	NA	NA	NA
PGEN_.00g295340	Scaffold_14	43503158	43503553	NA	NA	NA	NA	NA
PGEN_.00g295350	Scaffold_14	43511515	43511985	NA	NA	NA	NA	NA
PGEN_.00g295360	Scaffold_14	43512163	43512591	NA	NA	NA	NA	NA
PGEN_.00g295370	Scaffold_14	43515612	43516983	NA	NA	NA	NA	NA
PGEN_.00g295380	Scaffold_14	43531843	43533534	NA	NA	NA	NA	NA
PGEN_.00g295390	Scaffold_14	43533624	43534706	NA	NA	NA	NA	NA
PGEN_.00g295400	Scaffold_14	43534897	43536566	NA	NA	NA	NA	NA
PGEN_.00g295410	Scaffold_14	43538368	43546653	NA	NA	NA	NA	NA
PGEN_.00g295420	Scaffold_14	43547663	43549406	NA	NA	NA	NA	NA
PGEN_.00g295430	Scaffold_14	43550567	43551282	NA	NA	NA	NA	NA
PGEN_.00g295440	Scaffold_14	43554332	43554751	NA	NA	NA	NA	NA
PGEN_.00g295450	Scaffold_14	43565179	43566593	Q94K49	ALP1_ARATH	Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 (EC 3.1.-.-)	GO:0003682; GO:0004518; GO:0005634; GO:0031936; GO:0035098; GO:0035102; GO:0046872	ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; negative regulation of chromatin silencing [GO:0031936]
PGEN_.00g295460	Scaffold_14	43574559	43575161	Q6R2W3	SCND3_HUMAN	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	GO:0003676; GO:0003700; GO:0005654; GO:0015074	nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g295470	Scaffold_14	43581471	43606551	Q9R0M3	SRPX_MOUSE	Sushi-repeat-containing protein SRPX (DRS protein)	GO:0001845; GO:0005776; GO:0005783; GO:0006914; GO:0034976; GO:0060244; GO:2001241	autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; autophagy [GO:0006914]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g295480	Scaffold_14	43606617	43620277	NA	NA	NA	NA	NA
PGEN_.00g295490	Scaffold_14	43634150	43636162	NA	NA	NA	NA	NA
PGEN_.00g295500	Scaffold_14	43636208	43636498	NA	NA	NA	NA	NA
PGEN_.00g295510	Scaffold_14	43639284	43654049	NA	NA	NA	NA	NA
PGEN_.00g295520	Scaffold_14	43667951	43674052	NA	NA	NA	NA	NA
PGEN_.00g295530	Scaffold_14	43676377	43677945	NA	NA	NA	NA	NA
PGEN_.00g295540	Scaffold_14	43678467	43679586	NA	NA	NA	NA	NA
PGEN_.00g295550	Scaffold_14	43694397	43698993	NA	NA	NA	NA	NA
PGEN_.00g295560	Scaffold_14	43703238	43719550	Q9FWW6	GSXL1_ARATH	Flavin-containing monooxygenase FMO GS-OX-like 1 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 1)	GO:0004499; GO:0009751; GO:0009753; GO:0019761; GO:0050660; GO:0050661	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; glucosinolate biosynthetic process [GO:0019761]; response to jasmonic acid [GO:0009753]; response to salicylic acid [GO:0009751]"
PGEN_.00g295570	Scaffold_14	43731571	43732466	NA	NA	NA	NA	NA
PGEN_.00g295580	Scaffold_14	43735924	43741485	Q2YDJ8	KMT5A_BOVIN	N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.-) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8)	GO:0000122; GO:0002039; GO:0003714; GO:0005654; GO:0005694; GO:0005829; GO:0007049; GO:0016279; GO:0018024; GO:0018026; GO:0043516; GO:0051301	"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"
PGEN_.00g295590	Scaffold_14	43750323	43752362	NA	NA	NA	NA	NA
PGEN_.00g295600	Scaffold_14	43760550	43761795	NA	NA	NA	NA	NA
PGEN_.00g295610	Scaffold_14	43762282	43762557	NA	NA	NA	NA	NA
PGEN_.00g295620	Scaffold_14	43762715	43764671	NA	NA	NA	NA	NA
PGEN_.00g295630	Scaffold_14	43767975	43768998	Q8TBB0	THAP6_HUMAN	THAP domain-containing protein 6	GO:0000790; GO:0000981; GO:0003677; GO:0015630; GO:0046872	"microtubule cytoskeleton [GO:0015630]; nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"
PGEN_.00g295640	Scaffold_14	43769596	43770742	NA	NA	NA	NA	NA
PGEN_.00g295650	Scaffold_14	43776867	43778280	NA	NA	NA	NA	NA
PGEN_.00g295660	Scaffold_14	43781721	43785463	NA	NA	NA	NA	NA
PGEN_.00g295670	Scaffold_14	43785637	43786308	NA	NA	NA	NA	NA
PGEN_.00g295680	Scaffold_14	43798418	43801285	NA	NA	NA	NA	NA
PGEN_.00g295690	Scaffold_14	43801735	43803502	NA	NA	NA	NA	NA
PGEN_.00g295700	Scaffold_14	43842071	43844101	NA	NA	NA	NA	NA
PGEN_.00g295710	Scaffold_14	43844132	43844479	NA	NA	NA	NA	NA
PGEN_.00g295720	Scaffold_14	43844675	43844935	NA	NA	NA	NA	NA
PGEN_.00g295730	Scaffold_14	43859924	43860379	NA	NA	NA	NA	NA
PGEN_.00g295740	Scaffold_14	43863285	43863629	NA	NA	NA	NA	NA
PGEN_.00g295750	Scaffold_14	43866587	43868803	NA	NA	NA	NA	NA
PGEN_.00g295760	Scaffold_14	43872368	43875333	NA	NA	NA	NA	NA
PGEN_.00g295770	Scaffold_14	43958972	43959247	NA	NA	NA	NA	NA
PGEN_.00g295780	Scaffold_14	43959470	43959691	NA	NA	NA	NA	NA
PGEN_.00g295790	Scaffold_14	43965839	43966228	NA	NA	NA	NA	NA
PGEN_.00g295800	Scaffold_14	43966474	43966773	NA	NA	NA	NA	NA
PGEN_.00g295810	Scaffold_14	44010095	44016474	NA	NA	NA	NA	NA
PGEN_.00g295820	Scaffold_14	44016309	44021956	NA	NA	NA	NA	NA
PGEN_.00g295830	Scaffold_14	44017474	44023269	NA	NA	NA	NA	NA
PGEN_.00g295840	Scaffold_14	44023387	44024036	NA	NA	NA	NA	NA
PGEN_.00g295850	Scaffold_14	44026876	44028882	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g295860	Scaffold_14	44034945	44039911	NA	NA	NA	NA	NA
PGEN_.00g295870	Scaffold_14	44045536	44046024	NA	NA	NA	NA	NA
PGEN_.00g295880	Scaffold_14	44045996	44048420	P03010	TRAC9_MAIZE	Putative AC9 transposase	GO:0003677; GO:0006310; GO:0032196; GO:0046983	DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; DNA recombination [GO:0006310]; transposition [GO:0032196]
PGEN_.00g295890	Scaffold_14	44057660	44057962	NA	NA	NA	NA	NA
PGEN_.00g295900	Scaffold_14	44072818	44073180	NA	NA	NA	NA	NA
PGEN_.00g295910	Scaffold_14	44075089	44077278	NA	NA	NA	NA	NA
PGEN_.00g295920	Scaffold_14	44077308	44080638	NA	NA	NA	NA	NA
PGEN_.00g295930	Scaffold_14	44082508	44082801	NA	NA	NA	NA	NA
PGEN_.00g295940	Scaffold_14	44083931	44091717	NA	NA	NA	NA	NA
PGEN_.00g295950	Scaffold_14	44091789	44092339	NA	NA	NA	NA	NA
PGEN_.00g295960	Scaffold_14	44092545	44093021	NA	NA	NA	NA	NA
PGEN_.00g295970	Scaffold_14	44102259	44140826	Q9W332	CUBN_DROME	Cubilin homolog	GO:0005509; GO:0005886; GO:0015031; GO:0097017; GO:0097206	plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; nephrocyte filtration [GO:0097206]; protein transport [GO:0015031]; renal protein absorption [GO:0097017]
PGEN_.00g295980	Scaffold_14	44151379	44151765	NA	NA	NA	NA	NA
PGEN_.00g295990	Scaffold_14	44154905	44155150	NA	NA	NA	NA	NA
PGEN_.00g296000	Scaffold_14	44168939	44171234	O43422	P52K_HUMAN	52 kDa repressor of the inhibitor of the protein kinase (p52rIPK) (58 kDa interferon-induced protein kinase-interacting protein) (p58IPK-interacting protein) (Death-associated protein 4) (THAP domain-containing protein 0) (THAP domain-containing protein 12)	GO:0000790; GO:0000981; GO:0003677; GO:0007165; GO:0008285; GO:0046872; GO:0046983	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; negative regulation of cell population proliferation [GO:0008285]; signal transduction [GO:0007165]"
PGEN_.00g296010	Scaffold_14	44197313	44197609	NA	NA	NA	NA	NA
PGEN_.00g296020	Scaffold_14	44199012	44205512	NA	NA	NA	NA	NA
PGEN_.00g296030	Scaffold_14	44205543	44208239	NA	NA	NA	NA	NA
PGEN_.00g296040	Scaffold_14	44252292	44252549	NA	NA	NA	NA	NA
PGEN_.00g296050	Scaffold_14	44253466	44253879	NA	NA	NA	NA	NA
PGEN_.00g296060	Scaffold_14	44255902	44258207	NA	NA	NA	NA	NA
PGEN_.00g296070	Scaffold_14	44270039	44271519	NA	NA	NA	NA	NA
PGEN_.00g296080	Scaffold_14	44349586	44352736	NA	NA	NA	NA	NA
PGEN_.00g296090	Scaffold_14	44352923	44353720	NA	NA	NA	NA	NA
PGEN_.00g296100	Scaffold_14	44357122	44357838	NA	NA	NA	NA	NA
PGEN_.00g296110	Scaffold_14	44357910	44358846	NA	NA	NA	NA	NA
PGEN_.00g296120	Scaffold_14	44380814	44381062	NA	NA	NA	NA	NA
PGEN_.00g296130	Scaffold_14	44381064	44386331	O96006	ZBED1_HUMAN	Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0005813; GO:0019789; GO:0031965; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983	"centrosome [GO:0005813]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g296140	Scaffold_14	44387256	44387867	NA	NA	NA	NA	NA
PGEN_.00g296150	Scaffold_14	44387890	44388873	NA	NA	NA	NA	NA
PGEN_.00g296160	Scaffold_14	44390995	44396183	NA	NA	NA	NA	NA
PGEN_.00g296170	Scaffold_14	44396997	44397368	NA	NA	NA	NA	NA
PGEN_.00g296180	Scaffold_14	44398037	44399360	NA	NA	NA	NA	NA
PGEN_.00g296190	Scaffold_14	44411165	44411503	NA	NA	NA	NA	NA
PGEN_.00g296200	Scaffold_14	44418660	44419118	NA	NA	NA	NA	NA
PGEN_.00g296210	Scaffold_14	44419182	44424167	NA	NA	NA	NA	NA
PGEN_.00g296220	Scaffold_14	44429300	44429848	NA	NA	NA	NA	NA
PGEN_.00g296230	Scaffold_14	44429905	44433798	NA	NA	NA	NA	NA
PGEN_.00g296240	Scaffold_14	44434546	44435343	NA	NA	NA	NA	NA
PGEN_.00g296250	Scaffold_14	44435471	44435743	NA	NA	NA	NA	NA
PGEN_.00g296260	Scaffold_14	44436070	44437239	NA	NA	NA	NA	NA
PGEN_.00g296270	Scaffold_14	44438218	44441811	NA	NA	NA	NA	NA
PGEN_.00g296280	Scaffold_14	44442596	44445762	NA	NA	NA	NA	NA
PGEN_.00g296290	Scaffold_14	44452449	44454931	NA	NA	NA	NA	NA
PGEN_.00g296300	Scaffold_14	44456073	44456456	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g296310	Scaffold_14	44456985	44458619	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g296320	Scaffold_14	44526585	44531451	NA	NA	NA	NA	NA
PGEN_.00g296330	Scaffold_14	44532582	44535023	NA	NA	NA	NA	NA
PGEN_.00g296340	Scaffold_14	44548930	44554092	NA	NA	NA	NA	NA
PGEN_.00g296350	Scaffold_14	44559686	44570370	Q9WIJ5	MREP_FBNY1	Master replication protein (M-Rep) (EC 2.7.7.-) (EC 3.1.21.-) (EC 3.6.1.3) (ATP-dependent helicase C2) (Replication-associated protein 2) (Rep2)	GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0006260; GO:0016779; GO:0016888; GO:0018142; GO:0042025; GO:0046872	"host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA replication [GO:0006260]; protein-DNA covalent cross-linking [GO:0018142]"
PGEN_.00g296360	Scaffold_14	44580657	44580971	NA	NA	NA	NA	NA
PGEN_.00g296370	Scaffold_14	44585031	44585252	NA	NA	NA	NA	NA
PGEN_.00g296380	Scaffold_14	44593680	44595946	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g296390	Scaffold_14	44599611	44601160	NA	NA	NA	NA	NA
PGEN_.00g296400	Scaffold_14	44609450	44610893	NA	NA	NA	NA	NA
PGEN_.00g296410	Scaffold_14	44610945	44611172	NA	NA	NA	NA	NA
PGEN_.00g296420	Scaffold_14	44618352	44623381	NA	NA	NA	NA	NA
PGEN_.00g296430	Scaffold_14	44640516	44650130	NA	NA	NA	NA	NA
PGEN_.00g296440	Scaffold_14	44650220	44651077	NA	NA	NA	NA	NA
PGEN_.00g296450	Scaffold_14	44651340	44651666	NA	NA	NA	NA	NA
PGEN_.00g296460	Scaffold_14	44666103	44666420	NA	NA	NA	NA	NA
PGEN_.00g296470	Scaffold_14	44675380	44675879	NA	NA	NA	NA	NA
PGEN_.00g296480	Scaffold_14	44675925	44676758	NA	NA	NA	NA	NA
PGEN_.00g296490	Scaffold_14	44677149	44677727	NA	NA	NA	NA	NA
PGEN_.00g296500	Scaffold_14	44678317	44679680	NA	NA	NA	NA	NA
PGEN_.00g296510	Scaffold_14	44679885	44680271	NA	NA	NA	NA	NA
PGEN_.00g296520	Scaffold_14	44686364	44686825	Q8K2R5	ZN668_MOUSE	Zinc finger protein 668	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
PGEN_.00g296530	Scaffold_14	44702631	44702984	NA	NA	NA	NA	NA
PGEN_.00g296540	Scaffold_14	44709195	44709527	NA	NA	NA	NA	NA
PGEN_.00g296550	Scaffold_14	44711002	44717179	NA	NA	NA	NA	NA
PGEN_.00g296560	Scaffold_14	44720419	44723421	NA	NA	NA	NA	NA
PGEN_.00g296570	Scaffold_14	44735552	44736883	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g296580	Scaffold_14	44743201	44743539	NA	NA	NA	NA	NA
PGEN_.00g296590	Scaffold_14	44747864	44748773	NA	NA	NA	NA	NA
PGEN_.00g296600	Scaffold_14	44779015	44780796	NA	NA	NA	NA	NA
PGEN_.00g296610	Scaffold_14	44782222	44791961	NA	NA	NA	NA	NA
PGEN_.00g296620	Scaffold_14	44793893	44794938	NA	NA	NA	NA	NA
PGEN_.00g296630	Scaffold_14	44798751	44799035	NA	NA	NA	NA	NA
PGEN_.00g296640	Scaffold_14	44799518	44800439	NA	NA	NA	NA	NA
PGEN_.00g296650	Scaffold_14	44801622	44804009	Q96DM1	PGBD4_HUMAN	PiggyBac transposable element-derived protein 4		
PGEN_.00g296660	Scaffold_14	44805718	44806714	NA	NA	NA	NA	NA
PGEN_.00g296670	Scaffold_14	44806917	44807162	NA	NA	NA	NA	NA
PGEN_.00g296680	Scaffold_14	44807428	44821064	NA	NA	NA	NA	NA
PGEN_.00g296690	Scaffold_14	44831162	44833068	NA	NA	NA	NA	NA
PGEN_.00g296700	Scaffold_14	44833448	44833669	NA	NA	NA	NA	NA
PGEN_.00g296710	Scaffold_14	44843256	44848924	NA	NA	NA	NA	NA
PGEN_.00g296720	Scaffold_14	44852128	44852946	NA	NA	NA	NA	NA
PGEN_.00g296730	Scaffold_14	44853378	44864600	NA	NA	NA	NA	NA
PGEN_.00g296740	Scaffold_14	44864859	44865323	NA	NA	NA	NA	NA
PGEN_.00g296750	Scaffold_14	44916418	44916726	NA	NA	NA	NA	NA
PGEN_.00g296760	Scaffold_14	44922123	44922913	NA	NA	NA	NA	NA
PGEN_.00g296770	Scaffold_14	44924203	44928089	NA	NA	NA	NA	NA
PGEN_.00g296780	Scaffold_14	44934738	44935669	NA	NA	NA	NA	NA
PGEN_.00g296790	Scaffold_14	44937049	44938190	NA	NA	NA	NA	NA
PGEN_.00g296800	Scaffold_14	44939045	44939401	NA	NA	NA	NA	NA
PGEN_.00g296810	Scaffold_14	44939573	44939905	NA	NA	NA	NA	NA
PGEN_.00g296820	Scaffold_14	44940372	44942900	NA	NA	NA	NA	NA
PGEN_.00g296830	Scaffold_14	44944220	44944453	NA	NA	NA	NA	NA
PGEN_.00g296840	Scaffold_14	44945618	44946199	NA	NA	NA	NA	NA
PGEN_.00g296850	Scaffold_14	44956543	44959856	Q7Z0T3	TEMPT_APLCA	Temptin	GO:0005186; GO:0005576	extracellular region [GO:0005576]; pheromone activity [GO:0005186]
PGEN_.00g296860	Scaffold_14	44960456	44963593	NA	NA	NA	NA	NA
PGEN_.00g296870	Scaffold_14	44963838	44966745	NA	NA	NA	NA	NA
PGEN_.00g296880	Scaffold_14	45091522	45093275	NA	NA	NA	NA	NA
PGEN_.00g296890	Scaffold_14	45093304	45099120	NA	NA	NA	NA	NA
PGEN_.00g296900	Scaffold_14	45110490	45116954	NA	NA	NA	NA	NA
PGEN_.00g296910	Scaffold_14	45122196	45139810	Q9H0J9	PAR12_HUMAN	Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)	GO:0003723; GO:0003950; GO:0005634; GO:0046872; GO:0070213; GO:0140289; GO:1990404	nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; RNA binding [GO:0003723]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]
PGEN_.00g296920	Scaffold_14	45160960	45161220	NA	NA	NA	NA	NA
PGEN_.00g296930	Scaffold_14	45167600	45169858	NA	NA	NA	NA	NA
PGEN_.00g296940	Scaffold_14	45171708	45173069	NA	NA	NA	NA	NA
PGEN_.00g296950	Scaffold_14	45173166	45174098	NA	NA	NA	NA	NA
PGEN_.00g296960	Scaffold_14	45196176	45196799	NA	NA	NA	NA	NA
PGEN_.00g296970	Scaffold_14	45233356	45256654	P78364	PHC1_HUMAN	Polyhomeotic-like protein 1 (hPH1) (Early development regulatory protein 1)	GO:0003677; GO:0005634; GO:0005654; GO:0007275; GO:0008270; GO:0016574; GO:0031519; GO:0035102; GO:0070317	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; histone ubiquitination [GO:0016574]; multicellular organism development [GO:0007275]; negative regulation of G0 to G1 transition [GO:0070317]
PGEN_.00g296980	Scaffold_14	45261731	45276814	Q9R088	KITM_MOUSE	"Thymidine kinase 2, mitochondrial (EC 2.7.1.21) (Mt-TK)"	GO:0004137; GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0006264; GO:0009262; GO:0019136; GO:0032042; GO:0046092; GO:0046104; GO:0071897	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; deoxynucleoside kinase activity [GO:0019136]; thymidine kinase activity [GO:0004797]; deoxycytidine metabolic process [GO:0046092]; deoxyribonucleotide metabolic process [GO:0009262]; DNA biosynthetic process [GO:0071897]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA replication [GO:0006264]; thymidine metabolic process [GO:0046104]
PGEN_.00g296990	Scaffold_14	45282674	45282964	NA	NA	NA	NA	NA
PGEN_.00g297000	Scaffold_14	45283063	45283488	NA	NA	NA	NA	NA
PGEN_.00g297010	Scaffold_14	45285904	45291153	NA	NA	NA	NA	NA
PGEN_.00g297020	Scaffold_14	45306240	45306812	NA	NA	NA	NA	NA
PGEN_.00g297030	Scaffold_14	45313061	45313633	NA	NA	NA	NA	NA
PGEN_.00g297040	Scaffold_14	45325569	45325829	NA	NA	NA	NA	NA
PGEN_.00g297050	Scaffold_14	45335012	45337081	NA	NA	NA	NA	NA
PGEN_.00g297060	Scaffold_14	45362861	45363142	NA	NA	NA	NA	NA
PGEN_.00g297070	Scaffold_14	45371141	45371422	NA	NA	NA	NA	NA
PGEN_.00g297080	Scaffold_15	3711	3965	NA	NA	NA	NA	NA
PGEN_.00g297090	Scaffold_15	22146	31610	NA	NA	NA	NA	NA
PGEN_.00g297100	Scaffold_15	31846	42316	Q6DED0	TR1L1_XENLA	Translocating chain-associated membrane protein 1-like 1	GO:0005789; GO:0006616; GO:0016021	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"
PGEN_.00g297110	Scaffold_15	50765	64379	Q63081	PDIA6_RAT	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Calcium-binding protein 1) (CaBP1) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7)	GO:0003756; GO:0004857; GO:0005509; GO:0005615; GO:0005623; GO:0005788; GO:0005790; GO:0005793; GO:0005886; GO:0006457; GO:0015037; GO:0030168; GO:0034663; GO:0042470; GO:0045454; GO:0070527; GO:1903895	cell [GO:0005623]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; enzyme inhibitor activity [GO:0004857]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]
PGEN_.00g297120	Scaffold_15	77788	88143	Q0P565	HDDC2_BOVIN	HD domain-containing protein 2	GO:0002953	5'-deoxynucleotidase activity [GO:0002953]
PGEN_.00g297130	Scaffold_15	88304	90447	Q9CY16	RT28_MOUSE	"28S ribosomal protein S28, mitochondrial (MRP-S28) (S28mt)"	GO:0005739; GO:0005763	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
PGEN_.00g297140	Scaffold_15	100649	105549	Q66KK8	HEY1_XENTR	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0000122; GO:0000977; GO:0001227; GO:0005634; GO:0007219; GO:0009952; GO:0021984; GO:0030154; GO:0033504; GO:0042803; GO:0043565; GO:0045892; GO:0046982; GO:0048793; GO:0050767; GO:0072013; GO:0072082; GO:0072359	"nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adenohypophysis development [GO:0021984]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; floor plate development [GO:0033504]; glomus development [GO:0072013]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; pronephros development [GO:0048793]; regulation of neurogenesis [GO:0050767]; specification of proximal tubule identity [GO:0072082]"
PGEN_.00g297150	Scaffold_15	133342	187790	Q86VP6	CAND1_HUMAN	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (TBP-interacting protein of 120 kDa A) (TBP-interacting protein 120A) (p120 CAND1)	GO:0000151; GO:0005576; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006879; GO:0010265; GO:0016020; GO:0016567; GO:0017025; GO:0030154; GO:0031461; GO:0034774; GO:0043086; GO:0043312; GO:0043687; GO:0045899; GO:0070062; GO:1904813	cell [GO:0005623]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; ubiquitin ligase complex [GO:0000151]; TBP-class protein binding [GO:0017025]; cell differentiation [GO:0030154]; cellular iron ion homeostasis [GO:0006879]; negative regulation of catalytic activity [GO:0043086]; neutrophil degranulation [GO:0043312]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]
PGEN_.00g297160	Scaffold_15	196569	196982	NA	NA	NA	NA	NA
PGEN_.00g297170	Scaffold_15	197215	197520	NA	NA	NA	NA	NA
PGEN_.00g297180	Scaffold_15	197562	198278	NA	NA	NA	NA	NA
PGEN_.00g297190	Scaffold_15	198390	218986	Q6DG22	ADA_DANRE	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	GO:0004000; GO:0005764; GO:0005829; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0030054; GO:0043103; GO:0046103; GO:0060205	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]
PGEN_.00g297200	Scaffold_15	218931	222599	Q7KIN0	TOLL7_DROME	Toll-like receptor 7	GO:0002752; GO:0005030; GO:0005615; GO:0007411; GO:0008329; GO:0009897; GO:0010508; GO:0016021; GO:0031012; GO:0045087; GO:0046790; GO:0050688; GO:0051607	external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neurotrophin receptor activity [GO:0005030]; signaling pattern recognition receptor activity [GO:0008329]; virion binding [GO:0046790]; axon guidance [GO:0007411]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; regulation of defense response to virus [GO:0050688]
PGEN_.00g297210	Scaffold_15	226449	237082	NA	NA	NA	NA	NA
PGEN_.00g297220	Scaffold_15	238463	238714	NA	NA	NA	NA	NA
PGEN_.00g297230	Scaffold_15	251367	323419	NA	NA	NA	NA	NA
PGEN_.00g297240	Scaffold_15	327720	328892	NA	NA	NA	NA	NA
PGEN_.00g297250	Scaffold_15	360903	373927	Q7LFX5	CHSTF_HUMAN	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]
PGEN_.00g297260	Scaffold_15	391470	392704	NA	NA	NA	NA	NA
PGEN_.00g297270	Scaffold_15	412829	419514	Q1L8L9	KAD2_DANRE	"Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)"	GO:0002244; GO:0002521; GO:0004017; GO:0005524; GO:0005758; GO:0006172; GO:0046033; GO:0046034; GO:0060218	mitochondrial intermembrane space [GO:0005758]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; leukocyte differentiation [GO:0002521]
PGEN_.00g297280	Scaffold_15	426792	475195	Q96QG7	MTMR9_HUMAN	Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9)	GO:0005737; GO:0005783; GO:0005829; GO:0006661; GO:0006897; GO:0010507; GO:0010922; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0048471; GO:0050821; GO:0060304	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903]; endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]
PGEN_.00g297290	Scaffold_15	497215	531085	NA	NA	NA	NA	NA
PGEN_.00g297300	Scaffold_15	551635	552147	NA	NA	NA	NA	NA
PGEN_.00g297310	Scaffold_15	552521	593931	NA	NA	NA	NA	NA
PGEN_.00g297320	Scaffold_15	594598	595233	NA	NA	NA	NA	NA
PGEN_.00g297330	Scaffold_15	608191	614183	P24044	CALM_PLAFA	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g297340	Scaffold_15	622617	643764	P53440	CALMF_NAEGR	"Calmodulin, flagellar (CAM-1)"	GO:0005509; GO:0019722; GO:0031514	motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g297350	Scaffold_15	646174	651112	NA	NA	NA	NA	NA
PGEN_.00g297360	Scaffold_15	651283	656277	NA	NA	NA	NA	NA
PGEN_.00g297370	Scaffold_15	658640	658963	NA	NA	NA	NA	NA
PGEN_.00g297380	Scaffold_15	661511	661987	NA	NA	NA	NA	NA
PGEN_.00g297390	Scaffold_15	674297	682374	NA	NA	NA	NA	NA
PGEN_.00g297400	Scaffold_15	687772	688320	NA	NA	NA	NA	NA
PGEN_.00g297410	Scaffold_15	693854	806702	NA	NA	NA	NA	NA
PGEN_.00g297420	Scaffold_15	828902	849099	O94964	SOGA1_HUMAN	"Protein SOGA1 (SOGA family member 1) (Suppressor of glucose by autophagy) (Suppressor of glucose, autophagy-associated protein 1) [Cleaved into: N-terminal form; C-terminal 80 kDa form (80-kDa SOGA fragment)]"	GO:0005615; GO:0008286; GO:0010506; GO:0045721; GO:0070062	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; insulin receptor signaling pathway [GO:0008286]; negative regulation of gluconeogenesis [GO:0045721]; regulation of autophagy [GO:0010506]
PGEN_.00g297430	Scaffold_15	866302	884150	Q92783	STAM1_HUMAN	Signal transducing adapter molecule 1 (STAM-1)	GO:0005070; GO:0005829; GO:0006886; GO:0007165; GO:0016197; GO:0016236; GO:0016579; GO:0031901; GO:0033565; GO:0036258; GO:0042059; GO:0044389; GO:0061024; GO:1903543; GO:1903551	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; SH3/SH2 adaptor activity [GO:0005070]; ubiquitin-like protein ligase binding [GO:0044389]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of exosomal secretion [GO:1903543]; protein deubiquitination [GO:0016579]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165]
PGEN_.00g297440	Scaffold_15	889036	912332	Q680A5	KPRS4_ARATH	Ribose-phosphate pyrophosphokinase 4 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase 4)	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006015; GO:0006164; GO:0009116; GO:0009165; GO:0009506; GO:0016301	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]
PGEN_.00g297450	Scaffold_15	912647	948499	NA	NA	NA	NA	NA
PGEN_.00g297460	Scaffold_15	951700	961414	O74761	PRI2_SCHPO	DNA primase large subunit	GO:0003677; GO:0003896; GO:0005634; GO:0005658; GO:0005737; GO:0005829; GO:0046872; GO:0051539; GO:1902981	"alpha DNA polymerase:primase complex [GO:0005658]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; synthesis of RNA primer involved in mitotic DNA replication [GO:1902981]"
PGEN_.00g297470	Scaffold_15	962152	971243	NA	NA	NA	NA	NA
PGEN_.00g297480	Scaffold_15	980454	984015	Q9LPV5	NRT25_ARATH	High affinity nitrate transporter 2.5 (AtNRT2:5)	GO:0005886; GO:0009705; GO:0015112; GO:0015706; GO:0016021; GO:0042128; GO:0071249	integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]; plasma membrane [GO:0005886]; nitrate transmembrane transporter activity [GO:0015112]; cellular response to nitrate [GO:0071249]; nitrate assimilation [GO:0042128]; nitrate transport [GO:0015706]
PGEN_.00g297490	Scaffold_15	993556	996980	NA	NA	NA	NA	NA
PGEN_.00g297500	Scaffold_15	997009	998055	NA	NA	NA	NA	NA
PGEN_.00g297510	Scaffold_15	1086554	1087303	Q63ZI0	KCNK9_XENLA	Potassium channel subfamily K member 9	GO:0005267; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]
PGEN_.00g297520	Scaffold_15	1161604	1162263	NA	NA	NA	NA	NA
PGEN_.00g297530	Scaffold_15	1283523	1299207	NA	NA	NA	NA	NA
PGEN_.00g297540	Scaffold_15	1313574	1327322	P48029	SC6A8_HUMAN	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	GO:0005308; GO:0005309; GO:0005332; GO:0005886; GO:0005887; GO:0006600; GO:0006936; GO:0015881; GO:0016021; GO:0042165; GO:0043005	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; creatine:sodium symporter activity [GO:0005309]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; creatine metabolic process [GO:0006600]; creatine transmembrane transport [GO:0015881]; muscle contraction [GO:0006936]
PGEN_.00g297550	Scaffold_15	1334147	1345897	Q9LX27	CML4_ARATH	Calmodulin-like protein 4	GO:0005509; GO:0012505	endomembrane system [GO:0012505]; calcium ion binding [GO:0005509]
PGEN_.00g297560	Scaffold_15	1364095	1382162	P48029	SC6A8_HUMAN	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	GO:0005308; GO:0005309; GO:0005332; GO:0005886; GO:0005887; GO:0006600; GO:0006936; GO:0015881; GO:0016021; GO:0042165; GO:0043005	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; creatine:sodium symporter activity [GO:0005309]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; creatine metabolic process [GO:0006600]; creatine transmembrane transport [GO:0015881]; muscle contraction [GO:0006936]
PGEN_.00g297570	Scaffold_15	1398667	1414518	NA	NA	NA	NA	NA
PGEN_.00g297580	Scaffold_15	1534515	1535174	NA	NA	NA	NA	NA
PGEN_.00g297590	Scaffold_15	1561659	1610136	Q63ZI0	KCNK9_XENLA	Potassium channel subfamily K member 9	GO:0005267; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]
PGEN_.00g297600	Scaffold_15	1698668	1699714	NA	NA	NA	NA	NA
PGEN_.00g297610	Scaffold_15	1699743	1703165	NA	NA	NA	NA	NA
PGEN_.00g297620	Scaffold_15	1712695	1716255	Q9LPV5	NRT25_ARATH	High affinity nitrate transporter 2.5 (AtNRT2:5)	GO:0005886; GO:0009705; GO:0015112; GO:0015706; GO:0016021; GO:0042128; GO:0071249	integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]; plasma membrane [GO:0005886]; nitrate transmembrane transporter activity [GO:0015112]; cellular response to nitrate [GO:0071249]; nitrate assimilation [GO:0042128]; nitrate transport [GO:0015706]
PGEN_.00g297630	Scaffold_15	1729138	1729386	NA	NA	NA	NA	NA
PGEN_.00g297640	Scaffold_15	1730125	1739826	P33610	PRI2_MOUSE	DNA primase large subunit (DNA primase 58 kDa subunit) (p58)	GO:0003677; GO:0003896; GO:0005658; GO:0046872; GO:0051539	"alpha DNA polymerase:primase complex [GO:0005658]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]"
PGEN_.00g297650	Scaffold_15	1742991	1766561	NA	NA	NA	NA	NA
PGEN_.00g297660	Scaffold_15	1767606	1768604	NA	NA	NA	NA	NA
PGEN_.00g297670	Scaffold_15	1778796	1802029	Q680A5	KPRS4_ARATH	Ribose-phosphate pyrophosphokinase 4 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase 4)	GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006015; GO:0006164; GO:0009116; GO:0009165; GO:0009506; GO:0016301	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]
PGEN_.00g297680	Scaffold_15	1805197	1823309	Q92783	STAM1_HUMAN	Signal transducing adapter molecule 1 (STAM-1)	GO:0005070; GO:0005829; GO:0006886; GO:0007165; GO:0016197; GO:0016236; GO:0016579; GO:0031901; GO:0033565; GO:0036258; GO:0042059; GO:0044389; GO:0061024; GO:1903543; GO:1903551	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; SH3/SH2 adaptor activity [GO:0005070]; ubiquitin-like protein ligase binding [GO:0044389]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of exosomal secretion [GO:1903543]; protein deubiquitination [GO:0016579]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165]
PGEN_.00g297690	Scaffold_15	1840948	1862795	O94964	SOGA1_HUMAN	"Protein SOGA1 (SOGA family member 1) (Suppressor of glucose by autophagy) (Suppressor of glucose, autophagy-associated protein 1) [Cleaved into: N-terminal form; C-terminal 80 kDa form (80-kDa SOGA fragment)]"	GO:0005615; GO:0008286; GO:0010506; GO:0045721; GO:0070062	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; insulin receptor signaling pathway [GO:0008286]; negative regulation of gluconeogenesis [GO:0045721]; regulation of autophagy [GO:0010506]
PGEN_.00g297700	Scaffold_15	1884591	1997840	NA	NA	NA	NA	NA
PGEN_.00g297710	Scaffold_15	2003367	2003915	B2RPV6	MMRN1_MOUSE	Multimerin-1	GO:0005509; GO:0007596; GO:0030023; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; blood coagulation [GO:0007596]
PGEN_.00g297720	Scaffold_15	2009355	2017437	NA	NA	NA	NA	NA
PGEN_.00g297730	Scaffold_15	2029766	2030501	NA	NA	NA	NA	NA
PGEN_.00g297740	Scaffold_15	2035634	2040666	NA	NA	NA	NA	NA
PGEN_.00g297750	Scaffold_15	2044535	2045497	NA	NA	NA	NA	NA
PGEN_.00g297760	Scaffold_15	2047899	2068746	P53440	CALMF_NAEGR	"Calmodulin, flagellar (CAM-1)"	GO:0005509; GO:0019722; GO:0031514	motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g297770	Scaffold_15	2077396	2082658	Q0JNS6	CALM1_ORYSJ	Calmodulin-1 (CaM-1)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g297780	Scaffold_15	2096463	2097098	NA	NA	NA	NA	NA
PGEN_.00g297790	Scaffold_15	2097765	2131302	NA	NA	NA	NA	NA
PGEN_.00g297800	Scaffold_15	2141878	2142657	NA	NA	NA	NA	NA
PGEN_.00g297810	Scaffold_15	2163440	2195112	NA	NA	NA	NA	NA
PGEN_.00g297820	Scaffold_15	2216727	2256466	Q96QG7	MTMR9_HUMAN	Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9)	GO:0005737; GO:0005783; GO:0005829; GO:0006661; GO:0006897; GO:0010507; GO:0010922; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0048471; GO:0050821; GO:0060304	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903]; endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]
PGEN_.00g297830	Scaffold_15	2262221	2268917	Q1L8L9	KAD2_DANRE	"Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)"	GO:0002244; GO:0002521; GO:0004017; GO:0005524; GO:0005758; GO:0006172; GO:0046033; GO:0046034; GO:0060218	mitochondrial intermembrane space [GO:0005758]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; leukocyte differentiation [GO:0002521]
PGEN_.00g297840	Scaffold_15	2291970	2293184	NA	NA	NA	NA	NA
PGEN_.00g297850	Scaffold_15	2310575	2324039	Q7LFX5	CHSTF_HUMAN	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]
PGEN_.00g297860	Scaffold_15	2359044	2360216	NA	NA	NA	NA	NA
PGEN_.00g297870	Scaffold_15	2364467	2436304	NA	NA	NA	NA	NA
PGEN_.00g297880	Scaffold_15	2449357	2449608	NA	NA	NA	NA	NA
PGEN_.00g297890	Scaffold_15	2450788	2461480	NA	NA	NA	NA	NA
PGEN_.00g297900	Scaffold_15	2467096	2470671	Q7KIN0	TOLL7_DROME	Toll-like receptor 7	GO:0002752; GO:0005030; GO:0005615; GO:0007411; GO:0008329; GO:0009897; GO:0010508; GO:0016021; GO:0031012; GO:0045087; GO:0046790; GO:0050688; GO:0051607	external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neurotrophin receptor activity [GO:0005030]; signaling pattern recognition receptor activity [GO:0008329]; virion binding [GO:0046790]; axon guidance [GO:0007411]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; regulation of defense response to virus [GO:0050688]
PGEN_.00g297910	Scaffold_15	2470709	2490336	Q6DG22	ADA_DANRE	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	GO:0004000; GO:0005764; GO:0005829; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0030054; GO:0043103; GO:0046103; GO:0060205	cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]
PGEN_.00g297920	Scaffold_15	2490926	2491363	NA	NA	NA	NA	NA
PGEN_.00g297930	Scaffold_15	2491810	2492013	NA	NA	NA	NA	NA
PGEN_.00g297940	Scaffold_15	2501110	2507875	P97536	CAND1_RAT	Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (TBP-interacting protein of 120 kDa A) (TBP-interacting protein 120A) (p120 CAND1)	GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016567; GO:0017025; GO:0030154; GO:0031461; GO:0043086; GO:0045893; GO:0045899	"cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; TBP-class protein binding [GO:0017025]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]"
PGEN_.00g297950	Scaffold_15	2585043	2589992	Q66KK8	HEY1_XENTR	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0000122; GO:0000977; GO:0001227; GO:0005634; GO:0007219; GO:0009952; GO:0021984; GO:0030154; GO:0033504; GO:0042803; GO:0043565; GO:0045892; GO:0046982; GO:0048793; GO:0050767; GO:0072013; GO:0072082; GO:0072359	"nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adenohypophysis development [GO:0021984]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; floor plate development [GO:0033504]; glomus development [GO:0072013]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; pronephros development [GO:0048793]; regulation of neurogenesis [GO:0050767]; specification of proximal tubule identity [GO:0072082]"
PGEN_.00g297960	Scaffold_15	2600529	2602673	Q9CY16	RT28_MOUSE	"28S ribosomal protein S28, mitochondrial (MRP-S28) (S28mt)"	GO:0005739; GO:0005763	mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
PGEN_.00g297970	Scaffold_15	2602834	2611909	Q0P565	HDDC2_BOVIN	HD domain-containing protein 2	GO:0002953	5'-deoxynucleotidase activity [GO:0002953]
PGEN_.00g297980	Scaffold_15	2625314	2637734	Q63081	PDIA6_RAT	Protein disulfide-isomerase A6 (EC 5.3.4.1) (Calcium-binding protein 1) (CaBP1) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7)	GO:0003756; GO:0004857; GO:0005509; GO:0005615; GO:0005623; GO:0005788; GO:0005790; GO:0005793; GO:0005886; GO:0006457; GO:0015037; GO:0030168; GO:0034663; GO:0042470; GO:0045454; GO:0070527; GO:1903895	cell [GO:0005623]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; enzyme inhibitor activity [GO:0004857]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]
PGEN_.00g297990	Scaffold_15	2645950	2656590	Q6DED0	TR1L1_XENLA	Translocating chain-associated membrane protein 1-like 1	GO:0005789; GO:0006616; GO:0016021	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"
PGEN_.00g298000	Scaffold_15	2656833	2667702	NA	NA	NA	NA	NA
PGEN_.00g298010	Scaffold_15	2684824	2719194	Q9ULU4	PKCB1_HUMAN	Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8)	GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006355; GO:0008270; GO:0019904; GO:0030336; GO:0035064; GO:0043197; GO:0043198; GO:0047485; GO:0051491; GO:0060999; GO:0070491; GO:0070577; GO:0098815; GO:1902897; GO:1902952	"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g298020	Scaffold_15	2730672	2744541	Q6PE01	SNR40_MOUSE	U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (WD repeat-containing protein 57)	GO:0005829; GO:0006397; GO:0008380; GO:0016607; GO:0071007; GO:0071013	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g298030	Scaffold_15	2747920	2753538	Q5I0X7	TTC32_HUMAN	Tetratricopeptide repeat protein 32 (TPR repeat protein 32)		
PGEN_.00g298040	Scaffold_15	2757091	2772836	NA	NA	NA	NA	NA
PGEN_.00g298050	Scaffold_15	2791092	2833815	Q5ZKL6	MBOA2_CHICK	Membrane-bound O-acyltransferase domain-containing protein 2 (O-acyltransferase domain-containing protein 2) (EC 2.3.-.-)	GO:0008654; GO:0016021; GO:0016746	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid biosynthetic process [GO:0008654]"
PGEN_.00g298060	Scaffold_15	2853788	2854303	NA	NA	NA	NA	NA
PGEN_.00g298070	Scaffold_15	2856019	2857011	O93603	TRFR_CHICK	Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor)	GO:0004997; GO:0005886; GO:0007200; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyrotropin-releasing hormone receptor activity [GO:0004997]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]
PGEN_.00g298080	Scaffold_15	2962835	2964415	NA	NA	NA	NA	NA
PGEN_.00g298090	Scaffold_15	2970594	2986469	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g298100	Scaffold_15	2992756	3046934	A0A044RE18	BLI_ONCVO	Endoprotease bli (EC 3.4.21.75) (Blisterase)	GO:0004252; GO:0005576; GO:0005634; GO:0007635; GO:0031638; GO:0040002; GO:0045887; GO:0046872; GO:0090472; GO:1902075	extracellular region [GO:0005576]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; cellular response to salt [GO:1902075]; chemosensory behavior [GO:0007635]; collagen and cuticulin-based cuticle development [GO:0040002]; dibasic protein processing [GO:0090472]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; zymogen activation [GO:0031638]
PGEN_.00g298110	Scaffold_15	3049774	3051675	Q56R14	TRI33_XENLA	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g298120	Scaffold_15	3073357	3073851	NA	NA	NA	NA	NA
PGEN_.00g298130	Scaffold_15	3142955	3143899	NA	NA	NA	NA	NA
PGEN_.00g298140	Scaffold_15	3189162	3189674	NA	NA	NA	NA	NA
PGEN_.00g298150	Scaffold_15	3189713	3189925	NA	NA	NA	NA	NA
PGEN_.00g298160	Scaffold_15	3212344	3212829	NA	NA	NA	NA	NA
PGEN_.00g298170	Scaffold_15	3225022	3230610	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g298180	Scaffold_15	3297479	3309004	Q8VDG7	PAFA2_MOUSE	"Platelet-activating factor acetylhydrolase 2, cytoplasmic (EC 3.1.1.47) (Serine-dependent phospholipase A2) (SD-PLA2)"	GO:0003847; GO:0005789; GO:0016042; GO:0043066	endoplasmic reticulum membrane [GO:0005789]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; lipid catabolic process [GO:0016042]; negative regulation of apoptotic process [GO:0043066]
PGEN_.00g298190	Scaffold_15	3314726	3326773	O14730	RIOK3_HUMAN	Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog)	GO:0004674; GO:0005524; GO:0005829; GO:0007059; GO:0030490; GO:0030688; GO:0032463; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:1990786	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]"
PGEN_.00g298200	Scaffold_15	3331932	3347077	P83205	CATB_SHEEP	Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005730; GO:0005764; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0097067	extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; viral entry into host cell [GO:0046718]
PGEN_.00g298210	Scaffold_15	3347949	3349337	NA	NA	NA	NA	NA
PGEN_.00g298220	Scaffold_15	3349405	3350094	NA	NA	NA	NA	NA
PGEN_.00g298230	Scaffold_15	3350938	3351321	NA	NA	NA	NA	NA
PGEN_.00g298240	Scaffold_15	3370265	3375744	NA	NA	NA	NA	NA
PGEN_.00g298250	Scaffold_15	3377764	3378492	NA	NA	NA	NA	NA
PGEN_.00g298260	Scaffold_15	3386796	3387752	NA	NA	NA	NA	NA
PGEN_.00g298270	Scaffold_15	3405037	3406626	NA	NA	NA	NA	NA
PGEN_.00g298280	Scaffold_15	3417959	3419172	NA	NA	NA	NA	NA
PGEN_.00g298290	Scaffold_15	3419299	3420259	NA	NA	NA	NA	NA
PGEN_.00g298300	Scaffold_15	3445630	3452962	NA	NA	NA	NA	NA
PGEN_.00g298310	Scaffold_15	3456203	3471816	NA	NA	NA	NA	NA
PGEN_.00g298320	Scaffold_15	3489441	3489881	NA	NA	NA	NA	NA
PGEN_.00g298330	Scaffold_15	3490008	3491215	NA	NA	NA	NA	NA
PGEN_.00g298340	Scaffold_15	3502590	3504179	NA	NA	NA	NA	NA
PGEN_.00g298350	Scaffold_15	3520933	3522048	NA	NA	NA	NA	NA
PGEN_.00g298360	Scaffold_15	3531377	3532105	NA	NA	NA	NA	NA
PGEN_.00g298370	Scaffold_15	3534211	3536326	NA	NA	NA	NA	NA
PGEN_.00g298380	Scaffold_15	3557325	3557708	NA	NA	NA	NA	NA
PGEN_.00g298390	Scaffold_15	3558552	3559241	NA	NA	NA	NA	NA
PGEN_.00g298400	Scaffold_15	3559309	3560697	NA	NA	NA	NA	NA
PGEN_.00g298410	Scaffold_15	3561575	3576712	P83205	CATB_SHEEP	Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]	GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005730; GO:0005764; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0097067	extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; viral entry into host cell [GO:0046718]
PGEN_.00g298420	Scaffold_15	3581947	3595364	O14730	RIOK3_HUMAN	Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog)	GO:0004674; GO:0005524; GO:0005829; GO:0007059; GO:0030490; GO:0030688; GO:0032463; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:1990786	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]"
PGEN_.00g298430	Scaffold_15	3600005	3611682	P79106	PAFA2_BOVIN	"Platelet-activating factor acetylhydrolase 2, cytoplasmic (EC 3.1.1.47) (Serine-dependent phospholipase A2) (SD-PLA2)"	GO:0003847; GO:0005789; GO:0005829; GO:0016042	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; lipid catabolic process [GO:0016042]
PGEN_.00g298440	Scaffold_15	3678317	3683975	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g298450	Scaffold_15	3696158	3696643	NA	NA	NA	NA	NA
PGEN_.00g298460	Scaffold_15	3720633	3720845	NA	NA	NA	NA	NA
PGEN_.00g298470	Scaffold_15	3721120	3721401	NA	NA	NA	NA	NA
PGEN_.00g298480	Scaffold_15	3768233	3769176	NA	NA	NA	NA	NA
PGEN_.00g298490	Scaffold_15	3837885	3838379	NA	NA	NA	NA	NA
PGEN_.00g298500	Scaffold_15	3860450	3862351	Q56R14	TRI33_XENLA	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g298510	Scaffold_15	3878635	3919516	A0A044RE18	BLI_ONCVO	Endoprotease bli (EC 3.4.21.75) (Blisterase)	GO:0004252; GO:0005576; GO:0005634; GO:0007635; GO:0031638; GO:0040002; GO:0045887; GO:0046872; GO:0090472; GO:1902075	extracellular region [GO:0005576]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; cellular response to salt [GO:1902075]; chemosensory behavior [GO:0007635]; collagen and cuticulin-based cuticle development [GO:0040002]; dibasic protein processing [GO:0090472]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; zymogen activation [GO:0031638]
PGEN_.00g298520	Scaffold_15	3925942	3941818	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g298530	Scaffold_15	3947998	3949578	NA	NA	NA	NA	NA
PGEN_.00g298540	Scaffold_15	4054060	4054344	NA	NA	NA	NA	NA
PGEN_.00g298550	Scaffold_15	4069476	4073460	Q8R3I2	MBOA2_MOUSE	Lysophospholipid acyltransferase 2 (LPLAT 2) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4) (Lyso-PC acyltransferase 4) (mLPCAT4) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2)	GO:0005783; GO:0008654; GO:0016021; GO:0047184	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; phospholipid biosynthetic process [GO:0008654]
PGEN_.00g298560	Scaffold_15	4080619	4111444	Q5ZKL6	MBOA2_CHICK	Membrane-bound O-acyltransferase domain-containing protein 2 (O-acyltransferase domain-containing protein 2) (EC 2.3.-.-)	GO:0008654; GO:0016021; GO:0016746	"integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]; phospholipid biosynthetic process [GO:0008654]"
PGEN_.00g298570	Scaffold_15	4130419	4146155	NA	NA	NA	NA	NA
PGEN_.00g298580	Scaffold_15	4149580	4155195	Q5I0X7	TTC32_HUMAN	Tetratricopeptide repeat protein 32 (TPR repeat protein 32)		
PGEN_.00g298590	Scaffold_15	4158624	4172361	Q6PE01	SNR40_MOUSE	U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (WD repeat-containing protein 57)	GO:0005829; GO:0006397; GO:0008380; GO:0016607; GO:0071007; GO:0071013	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g298600	Scaffold_15	4183385	4214062	Q9ULU4	PKCB1_HUMAN	Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8)	GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006355; GO:0008270; GO:0019904; GO:0030336; GO:0035064; GO:0043197; GO:0043198; GO:0047485; GO:0051491; GO:0060999; GO:0070491; GO:0070577; GO:0098815; GO:1902897; GO:1902952	"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g298610	Scaffold_15	4214581	4218195	NA	NA	NA	NA	NA
PGEN_.00g298620	Scaffold_15	4227352	4227771	NA	NA	NA	NA	NA
PGEN_.00g298630	Scaffold_15	4227924	4229552	NA	NA	NA	NA	NA
PGEN_.00g298640	Scaffold_15	4237339	4237614	NA	NA	NA	NA	NA
PGEN_.00g298650	Scaffold_15	4237988	4239173	NA	NA	NA	NA	NA
PGEN_.00g298660	Scaffold_15	4240120	4240575	NA	NA	NA	NA	NA
PGEN_.00g298670	Scaffold_15	4252599	4271600	NA	NA	NA	NA	NA
PGEN_.00g298680	Scaffold_15	4271822	4277319	Q91677	GATA4_XENLA	Transcription factor GATA-4 (GATA-binding factor 4) (xGATA-4)	GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0048738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; cardiac muscle tissue development [GO:0048738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g298690	Scaffold_15	4291646	4291903	NA	NA	NA	NA	NA
PGEN_.00g298700	Scaffold_15	4292110	4292322	NA	NA	NA	NA	NA
PGEN_.00g298710	Scaffold_15	4337959	4363371	P97489	GATA5_MOUSE	Transcription factor GATA-5 (GATA-binding factor 5)	GO:0000790; GO:0000978; GO:0000981; GO:0001158; GO:0003180; GO:0003274; GO:0003700; GO:0005634; GO:0006355; GO:0008270; GO:0010614; GO:0010628; GO:0010629; GO:0035481; GO:0044212; GO:0045893; GO:0045944; GO:0048738; GO:0060575; GO:0062000; GO:0071773; GO:1901228	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; aortic valve morphogenesis [GO:0003180]; cardiac muscle tissue development [GO:0048738]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion fusion [GO:0003274]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of gene expression [GO:0010629]; positive regulation of cardiac endothelial to mesenchymal transition [GO:0062000]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in heart development [GO:1901228]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g298720	Scaffold_15	4344401	4345573	NA	NA	NA	NA	NA
PGEN_.00g298730	Scaffold_15	4375752	4382345	NA	NA	NA	NA	NA
PGEN_.00g298740	Scaffold_15	4392897	4393379	NA	NA	NA	NA	NA
PGEN_.00g298750	Scaffold_15	4416144	4461051	Q7DMN9	CALM5_SOLTU	Calmodulin-5/6/7/8 (CaM-5/6/7/8)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g298760	Scaffold_15	4475687	4491447	Q63739	TP4A1_MOUSE	Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1)	GO:0004725; GO:0004727; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005783; GO:0005819; GO:0005886; GO:0007049; GO:0007275; GO:0008138; GO:0009898; GO:0030335	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell cycle [GO:0007049]; multicellular organism development [GO:0007275]; positive regulation of cell migration [GO:0030335]
PGEN_.00g298770	Scaffold_15	4483352	4485559	NA	NA	NA	NA	NA
PGEN_.00g298780	Scaffold_15	4491808	4498009	NA	NA	NA	NA	NA
PGEN_.00g298790	Scaffold_15	4519607	4520134	NA	NA	NA	NA	NA
PGEN_.00g298800	Scaffold_15	4524825	4526034	NA	NA	NA	NA	NA
PGEN_.00g298810	Scaffold_15	4528276	4535091	NA	NA	NA	NA	NA
PGEN_.00g298820	Scaffold_15	4536467	4564434	Q9V3J1	VATH_DROME	V-type proton ATPase subunit H (V-ATPase subunit H) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)	GO:0000221; GO:0008340; GO:0033181; GO:0033227; GO:0046961; GO:1902600	"plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227]; proton transmembrane transport [GO:1902600]"
PGEN_.00g298830	Scaffold_15	4569280	4575447	P22152	CRNA_EMENI	Nitrate transporter (Nitrate permease)	GO:0015112; GO:0015113; GO:0015513; GO:0015706; GO:0015707; GO:0016021; GO:0022832; GO:0042128	integral component of membrane [GO:0016021]; high-affinity secondary active nitrite transmembrane transporter activity [GO:0015513]; nitrate transmembrane transporter activity [GO:0015112]; nitrite transmembrane transporter activity [GO:0015113]; voltage-gated channel activity [GO:0022832]; nitrate assimilation [GO:0042128]; nitrate transport [GO:0015706]; nitrite transport [GO:0015707]
PGEN_.00g298840	Scaffold_15	4598879	4628273	O75339	CILP1_HUMAN	Cartilage intermediate layer protein 1 (CILP-1) (Cartilage intermediate-layer protein) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2]	GO:0005615; GO:0010629; GO:0016311; GO:0043569; GO:0060392; GO:0062023; GO:0070062; GO:0071560	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]
PGEN_.00g298850	Scaffold_15	4701818	4716022	Q5MJS3	FA20C_MOUSE	Extracellular serine/threonine protein kinase FAM20C (EC 2.7.11.1) (Dentin matrix protein 4) (DMP-4) (Golgi-enriched fraction casein kinase) (GEF-CK)	GO:0001501; GO:0004674; GO:0005509; GO:0005524; GO:0005615; GO:0005737; GO:0005794; GO:0006468; GO:0016773; GO:0030145; GO:0030501; GO:0031214; GO:0036179; GO:0040036; GO:0045669; GO:0046034; GO:0051174; GO:0070166; GO:0071895; GO:0097187	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein serine/threonine kinase activity [GO:0004674]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]; skeletal system development [GO:0001501]"
PGEN_.00g298860	Scaffold_15	4720239	4720865	NA	NA	NA	NA	NA
PGEN_.00g298870	Scaffold_15	4722459	4740222	Q6PFM1	S20AB_DANRE	Sodium-dependent phosphate transporter 1-B (Solute carrier family 20 member 1-B)	GO:0005315; GO:0005887; GO:0015319; GO:0035435	integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]; phosphate ion transmembrane transport [GO:0035435]
PGEN_.00g298880	Scaffold_15	4750327	4753685	NA	NA	NA	NA	NA
PGEN_.00g298890	Scaffold_15	4781888	4783619	NA	NA	NA	NA	NA
PGEN_.00g298900	Scaffold_15	4795405	4813045	P53440	CALMF_NAEGR	"Calmodulin, flagellar (CAM-1)"	GO:0005509; GO:0019722; GO:0031514	motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g298910	Scaffold_15	4869623	4870474	NA	NA	NA	NA	NA
PGEN_.00g298920	Scaffold_15	4905169	4905387	NA	NA	NA	NA	NA
PGEN_.00g298930	Scaffold_15	4919801	4927594	NA	NA	NA	NA	NA
PGEN_.00g298940	Scaffold_15	4937409	4940400	NA	NA	NA	NA	NA
PGEN_.00g298950	Scaffold_15	4960290	4961576	NA	NA	NA	NA	NA
PGEN_.00g298960	Scaffold_15	4971490	4971891	NA	NA	NA	NA	NA
PGEN_.00g298970	Scaffold_15	4972023	4972358	NA	NA	NA	NA	NA
PGEN_.00g298980	Scaffold_15	5066999	5074683	NA	NA	NA	NA	NA
PGEN_.00g298990	Scaffold_15	5075273	5088255	NA	NA	NA	NA	NA
PGEN_.00g299000	Scaffold_15	5115847	5179865	Q9Y6R7	FCGBP_HUMAN	IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP)	GO:0070062	extracellular exosome [GO:0070062]
PGEN_.00g299010	Scaffold_15	5187754	5193743	NA	NA	NA	NA	NA
PGEN_.00g299020	Scaffold_15	5197564	5198737	NA	NA	NA	NA	NA
PGEN_.00g299030	Scaffold_15	5201072	5204738	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g299040	Scaffold_15	5212765	5215795	NA	NA	NA	NA	NA
PGEN_.00g299050	Scaffold_15	5233015	5236098	A2VDQ7	ZN420_BOVIN	Zinc finger protein 420	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g299060	Scaffold_15	5243373	5243759	NA	NA	NA	NA	NA
PGEN_.00g299070	Scaffold_15	5256545	5261419	NA	NA	NA	NA	NA
PGEN_.00g299080	Scaffold_15	5262001	5263024	NA	NA	NA	NA	NA
PGEN_.00g299090	Scaffold_15	5296282	5296485	NA	NA	NA	NA	NA
PGEN_.00g299100	Scaffold_15	5296667	5296918	NA	NA	NA	NA	NA
PGEN_.00g299110	Scaffold_15	5375031	5375877	P24587	AKAP5_RAT	A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)	GO:0001664; GO:0001934; GO:0003779; GO:0005516; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0006605; GO:0007193; GO:0007194; GO:0008179; GO:0009898; GO:0010524; GO:0010738; GO:0014069; GO:0014850; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0021510; GO:0021766; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032991; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0043624; GO:0044877; GO:0045121; GO:0045296; GO:0045762; GO:0048471; GO:0050775; GO:0050811; GO:0051602; GO:0060076; GO:0060090; GO:0060135; GO:0070886; GO:0071417; GO:0097110; GO:0098978; GO:0099092; GO:0099149; GO:1903078	"asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; cellular protein complex disassembly [GO:0043624]; cellular response to organonitrogen compound [GO:0071417]; hippocampus development [GO:0021766]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein targeting [GO:0006605]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; response to electrical stimulus [GO:0051602]; response to muscle activity [GO:0014850]; spinal cord development [GO:0021510]"
PGEN_.00g299120	Scaffold_15	5376005	5376514	NA	NA	NA	NA	NA
PGEN_.00g299130	Scaffold_15	5376552	5378082	P35324	SPRR1_RABIT	Cornifin alpha (Small proline-rich protein I) (SPR-I)	GO:0005737; GO:0018149; GO:0031424	cytoplasm [GO:0005737]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]
PGEN_.00g299140	Scaffold_15	5491276	5521186	Q9JME2	CHSTB_MOUSE	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)	GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]
PGEN_.00g299150	Scaffold_15	5534945	5544021	NA	NA	NA	NA	NA
PGEN_.00g299160	Scaffold_15	5547974	5566541	Q0MQI6	NDUV1_PANTR	"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.99.3) (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit)"	GO:0005739; GO:0005747; GO:0006120; GO:0008137; GO:0010181; GO:0046872; GO:0051287; GO:0051539	"mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"
PGEN_.00g299170	Scaffold_15	5592105	5597921	P31729	OV16_ONCVO	OV-16 antigen		
PGEN_.00g299180	Scaffold_15	5599911	5606709	Q9H4G4	GAPR1_HUMAN	Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)	GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]
PGEN_.00g299190	Scaffold_15	5611041	5618026	P82596	PLC_HALLA	Perlucin	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g299200	Scaffold_15	5636824	5637399	NA	NA	NA	NA	NA
PGEN_.00g299210	Scaffold_15	5637754	5638029	NA	NA	NA	NA	NA
PGEN_.00g299220	Scaffold_15	5640230	5640847	NA	NA	NA	NA	NA
PGEN_.00g299230	Scaffold_15	5648209	5648553	NA	NA	NA	NA	NA
PGEN_.00g299240	Scaffold_15	5676524	5685078	NA	NA	NA	NA	NA
PGEN_.00g299250	Scaffold_15	5839233	5839466	NA	NA	NA	NA	NA
PGEN_.00g299260	Scaffold_15	5839753	5840067	NA	NA	NA	NA	NA
PGEN_.00g299270	Scaffold_15	5853571	5854185	NA	NA	NA	NA	NA
PGEN_.00g299280	Scaffold_15	5934066	5934506	NA	NA	NA	NA	NA
PGEN_.00g299290	Scaffold_15	5954664	6014678	Q9JK45	KCNQ5_MOUSE	Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5)	GO:0005249; GO:0005251; GO:0005516; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0030118; GO:0034765; GO:0071805	clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g299300	Scaffold_15	6031630	6036666	P53803	RPAB4_HUMAN	"DNA-directed RNA polymerases I, II, and III subunit RPABC4 (RNA polymerases I, II, and III subunit ABC4) (ABC10-alpha) (DNA-directed RNA polymerase II subunit K) (RNA polymerase II 7.0 kDa subunit) (RPB7.0) (RPB10alpha)"	GO:0000398; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006283; GO:0006351; GO:0006356; GO:0006361; GO:0006362; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006383; GO:0008270; GO:0008543; GO:0016070; GO:0032481; GO:0035019; GO:0042795; GO:0045815; GO:0050434; GO:0060964	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral transcription [GO:0050434]; regulation of gene silencing by miRNA [GO:0060964]; regulation of transcription by RNA polymerase I [GO:0006356]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; somatic stem cell population maintenance [GO:0035019]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"
PGEN_.00g299310	Scaffold_15	6038187	6043945	Q8AXF4	FBX43_XENLA	F-box only protein 43 (Early mitotic inhibitor 2) (Emi1-related protein 1) (F-box protein 26) (Xerp1)	GO:0016567; GO:0046872; GO:0051321	metal ion binding [GO:0046872]; meiotic cell cycle [GO:0051321]; protein ubiquitination [GO:0016567]
PGEN_.00g299320	Scaffold_15	6049055	6058280	Q9BSV6	SEN34_HUMAN	tRNA-splicing endonuclease subunit Sen34 (EC 4.6.1.16) (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34) (HsSen34)	GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005654; GO:0005730; GO:0006388; GO:0006397; GO:0016829	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]"
PGEN_.00g299330	Scaffold_15	6058750	6080496	P25205	MCM3_HUMAN	DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102)	GO:0000082; GO:0000727; GO:0000784; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005658; GO:0005813; GO:0006260; GO:0006267; GO:0006270; GO:0006271; GO:0016020; GO:0042555; GO:0048471; GO:1902975	"alpha DNA polymerase:primase complex [GO:0005658]; centrosome [GO:0005813]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]"
PGEN_.00g299340	Scaffold_15	6069374	6069943	NA	NA	NA	NA	NA
PGEN_.00g299350	Scaffold_15	6087112	6088933	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g299360	Scaffold_15	6098415	6099926	Q4V8D1	CP2U1_RAT	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g299370	Scaffold_15	6106282	6113353	NA	NA	NA	NA	NA
PGEN_.00g299380	Scaffold_15	6117129	6186123	C0HL13	LRP2_PIG	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	GO:0001702; GO:0001843; GO:0002076; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005886; GO:0005905; GO:0006898; GO:0007605; GO:0008144; GO:0008584; GO:0009897; GO:0009952; GO:0016021; GO:0016324; GO:0017124; GO:0017147; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0042632; GO:0042813; GO:0043235; GO:0045944; GO:0046849; GO:0048539; GO:0050769; GO:0051087; GO:0060068; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060982; GO:0061156; GO:0061178; GO:0061304; GO:0070447; GO:0140058; GO:1904447; GO:1905167	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; drug binding [GO:0008144]; SH3 domain binding [GO:0017124]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; gastrulation with mouth forming second [GO:0001702]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; osteoblast development [GO:0002076]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retinal blood vessel morphogenesis [GO:0061304]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]
PGEN_.00g299390	Scaffold_15	6212732	6227723	O35593	PSDE_MOUSE	26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (MAD1)	GO:0000502; GO:0000724; GO:0004175; GO:0004843; GO:0006303; GO:0008237; GO:0008541; GO:0016579; GO:0022624; GO:0031597; GO:0036459; GO:0043161; GO:0045471; GO:0046872; GO:0061133; GO:0061136; GO:0061578; GO:0070536; GO:0070628	"cytosolic proteasome complex [GO:0031597]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of proteasomal protein catabolic process [GO:0061136]; response to ethanol [GO:0045471]"
PGEN_.00g299400	Scaffold_15	6236275	6239520	P24628	DRD2A_XENLA	D(2) dopamine receptor A (D2R-A) (D2R 1)	GO:0004930; GO:0004952; GO:0005886; GO:0007195; GO:0016021; GO:0045202	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; dopamine neurotransmitter receptor activity [GO:0004952]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]
PGEN_.00g299410	Scaffold_15	6299208	6302337	NA	NA	NA	NA	NA
PGEN_.00g299420	Scaffold_15	6311957	6338500	Q2KJJ0	PRP6_BOVIN	Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)	GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005682; GO:0006403; GO:0016607; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]"
PGEN_.00g299430	Scaffold_15	6351023	6352969	NA	NA	NA	NA	NA
PGEN_.00g299440	Scaffold_15	6373906	6374880	Q504Y2	PKDCC_HUMAN	"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]
PGEN_.00g299450	Scaffold_15	6381833	6383418	NA	NA	NA	NA	NA
PGEN_.00g299460	Scaffold_15	6384316	6390973	Q75WE7	VWA5A_RAT	von Willebrand factor A domain-containing protein 5A (Loss of heterozygosity 11 chromosomal region 2 gene A protein homolog) (Mast cell surface antigen 1) (Masa-1)		
PGEN_.00g299470	Scaffold_15	6401111	6406154	NA	NA	NA	NA	NA
PGEN_.00g299480	Scaffold_15	6438057	6448181	Q7RTY1	MOT9_HUMAN	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g299490	Scaffold_15	6454854	6457666	NA	NA	NA	NA	NA
PGEN_.00g299500	Scaffold_15	6467957	6483958	Q75WE7	VWA5A_RAT	von Willebrand factor A domain-containing protein 5A (Loss of heterozygosity 11 chromosomal region 2 gene A protein homolog) (Mast cell surface antigen 1) (Masa-1)		
PGEN_.00g299510	Scaffold_15	6543904	6548797	P18714	ZG20_XENLA	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g299520	Scaffold_15	6562458	6564980	Q9NSC2	SALL1_HUMAN	Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1) (HSal1) (Sal-1)	GO:0000122; GO:0000792; GO:0000978; GO:0001227; GO:0001657; GO:0001658; GO:0001822; GO:0003281; GO:0003337; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007507; GO:0008013; GO:0008406; GO:0010369; GO:0021553; GO:0021889; GO:0021983; GO:0030177; GO:0030325; GO:0031129; GO:0035019; GO:0042473; GO:0042733; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048566; GO:0060173; GO:0061034; GO:0072073; GO:0072092	"chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; gonad development [GO:0008406]; heart development [GO:0007507]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; outer ear morphogenesis [GO:0042473]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]"
PGEN_.00g299530	Scaffold_15	6566378	6566644	P18723	ZG48_XENLA	Gastrula zinc finger protein XlCGF48.2 (Fragment)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g299540	Scaffold_15	6568212	6568538	Q9I9K0	FOG1_XENLA	Zinc finger protein ZFPM1 (Friend of GATA) (xFOG) (Friend of GATA protein 1) (FOG-1) (Fragment)	GO:0001085; GO:0003677; GO:0005634; GO:0006357; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor binding [GO:0001085]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g299550	Scaffold_15	6572413	6576933	Q6P3V2	Z585A_HUMAN	Zinc finger protein 585A	GO:0003676; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g299560	Scaffold_15	6591141	6595268	P18740	ZO14_XENLA	Oocyte zinc finger protein XlCOF14 (Fragment)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g299570	Scaffold_15	6600281	6617764	Q8BQC8	RBAK_MOUSE	RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (Zinc finger protein 769)	GO:0003676; GO:0005634; GO:0005654; GO:0006355; GO:0046872	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g299580	Scaffold_15	6675172	6675462	NA	NA	NA	NA	NA
PGEN_.00g299590	Scaffold_15	6675572	6676375	NA	NA	NA	NA	NA
PGEN_.00g299600	Scaffold_15	6686987	6692192	Q05B17	WDR48_XENTR	WD repeat-containing protein 48 (USP1-associated factor 1)	GO:0005634; GO:0005764; GO:0005770; GO:0016579; GO:0043130; GO:1903003	late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; ubiquitin binding [GO:0043130]; positive regulation of protein deubiquitination [GO:1903003]; protein deubiquitination [GO:0016579]
PGEN_.00g299610	Scaffold_15	6715908	6718164	Q17895	MNM2_CAEEL	Zinc finger protein mnm-2	GO:0003676; GO:0005634; GO:0046872; GO:1902669	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; positive regulation of axon guidance [GO:1902669]
PGEN_.00g299620	Scaffold_15	6742928	6749028	NA	NA	NA	NA	NA
PGEN_.00g299630	Scaffold_15	6763975	6765422	NA	NA	NA	NA	NA
PGEN_.00g299640	Scaffold_15	6778057	6778308	NA	NA	NA	NA	NA
PGEN_.00g299650	Scaffold_15	6816645	6838427	O75339	CILP1_HUMAN	Cartilage intermediate layer protein 1 (CILP-1) (Cartilage intermediate-layer protein) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2]	GO:0005615; GO:0010629; GO:0016311; GO:0043569; GO:0060392; GO:0062023; GO:0070062; GO:0071560	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]
PGEN_.00g299660	Scaffold_15	6838516	6840017	NA	NA	NA	NA	NA
PGEN_.00g299670	Scaffold_15	6850570	6861410	Q9UBG0	MRC2_HUMAN	C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280)	GO:0001649; GO:0004888; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0016021; GO:0030246; GO:0030574	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]
PGEN_.00g299680	Scaffold_15	6863686	6865971	NA	NA	NA	NA	NA
PGEN_.00g299690	Scaffold_15	6872729	6875759	NA	NA	NA	NA	NA
PGEN_.00g299700	Scaffold_15	6883706	6890909	NA	NA	NA	NA	NA
PGEN_.00g299710	Scaffold_15	6898542	6902367	NA	NA	NA	NA	NA
PGEN_.00g299720	Scaffold_15	6916856	6939356	Q8WUJ3	CEMIP_HUMAN	Cell migration-inducing and hyaluronan-binding protein (EC 3.2.1.35)	GO:0004415; GO:0005540; GO:0005576; GO:0005623; GO:0005634; GO:0005737; GO:0005783; GO:0005886; GO:0005905; GO:0007605; GO:0010800; GO:0030213; GO:0030214; GO:0030335; GO:0030665; GO:0032050; GO:0045334; GO:0046923; GO:0051281; GO:0090314; GO:1900020	cell [GO:0005623]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; ER retention sequence binding [GO:0046923]; hyaluronic acid binding [GO:0005540]; hyalurononglucosaminidase activity [GO:0004415]; hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; positive regulation of cell migration [GO:0030335]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; sensory perception of sound [GO:0007605]
PGEN_.00g299730	Scaffold_15	6959815	6960651	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g299740	Scaffold_15	6964636	6967727	NA	NA	NA	NA	NA
PGEN_.00g299750	Scaffold_15	6968036	6968389	NA	NA	NA	NA	NA
PGEN_.00g299760	Scaffold_15	6968599	6969231	NA	NA	NA	NA	NA
PGEN_.00g299770	Scaffold_15	6969786	6970136	NA	NA	NA	NA	NA
PGEN_.00g299780	Scaffold_15	6971697	6997589	NA	NA	NA	NA	NA
PGEN_.00g299790	Scaffold_15	7005325	7008463	NA	NA	NA	NA	NA
PGEN_.00g299800	Scaffold_15	7008671	7009195	NA	NA	NA	NA	NA
PGEN_.00g299810	Scaffold_15	7012243	7013355	NA	NA	NA	NA	NA
PGEN_.00g299820	Scaffold_15	7013399	7013686	NA	NA	NA	NA	NA
PGEN_.00g299830	Scaffold_15	7020657	7030979	NA	NA	NA	NA	NA
PGEN_.00g299840	Scaffold_15	7038040	7046342	NA	NA	NA	NA	NA
PGEN_.00g299850	Scaffold_15	7054728	7061384	NA	NA	NA	NA	NA
PGEN_.00g299860	Scaffold_15	7075540	7076711	NA	NA	NA	NA	NA
PGEN_.00g299870	Scaffold_15	7077329	7078508	NA	NA	NA	NA	NA
PGEN_.00g299880	Scaffold_15	7081992	7083044	NA	NA	NA	NA	NA
PGEN_.00g299890	Scaffold_15	7116862	7121146	NA	NA	NA	NA	NA
PGEN_.00g299900	Scaffold_15	7125758	7126042	NA	NA	NA	NA	NA
PGEN_.00g299910	Scaffold_15	7128466	7128858	NA	NA	NA	NA	NA
PGEN_.00g299920	Scaffold_15	7155609	7173049	O82811	NRT21_ARATH	High-affinity nitrate transporter 2.1 (AtNRT2:1) (Protein ACH1) (Protein LATERAL ROOT INITIATION 1)	GO:0005886; GO:0009705; GO:0010167; GO:0015112; GO:0015706; GO:0016020; GO:0016021; GO:0042128; GO:0048527; GO:0071249	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plant-type vacuole membrane [GO:0009705]; plasma membrane [GO:0005886]; nitrate transmembrane transporter activity [GO:0015112]; cellular response to nitrate [GO:0071249]; lateral root development [GO:0048527]; nitrate assimilation [GO:0042128]; nitrate transport [GO:0015706]; response to nitrate [GO:0010167]
PGEN_.00g299930	Scaffold_15	7182966	7184500	NA	NA	NA	NA	NA
PGEN_.00g299940	Scaffold_15	7223898	7240445	Q9D306	MGT4C_MOUSE	"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)"	GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0016021; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein N-linked glycosylation [GO:0006487]"
PGEN_.00g299950	Scaffold_15	7242876	7273336	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g299960	Scaffold_15	7279284	7289008	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g299970	Scaffold_15	7306468	7311373	Q00971	NPRV_VIBPR	Neutral protease (EC 3.4.24.25) (Aeromonolysin) (Vibriolysin)	GO:0004222; GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]
PGEN_.00g299980	Scaffold_15	7312789	7313103	NA	NA	NA	NA	NA
PGEN_.00g299990	Scaffold_15	7321879	7327900	Q95LU3	FBCD1_MACFA	Fibrinogen C domain-containing protein 1	GO:0008061; GO:0016020; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g300000	Scaffold_15	7340874	7348319	Q96NW4	ANR27_HUMAN	Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein)	GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0015031; GO:0016020; GO:0017137; GO:0030133; GO:0030659; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0045022; GO:0048812; GO:0050775; GO:0097422; GO:1990126	"cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]; SNARE binding [GO:0000149]; early endosome to late endosome transport [GO:0045022]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g300010	Scaffold_15	7350296	7362656	A8XZB0	ATIF2_CAEBR	"ATPase inhibitor mai-2, mitochondrial (ATP synthase F1 subunit epsilon)"	GO:0005739; GO:0006783; GO:0032780; GO:0042030; GO:0051117	mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780]
PGEN_.00g300020	Scaffold_15	7367049	7371504	Q13310	PABP4_HUMAN	Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP)	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0006412; GO:0007596; GO:0008143; GO:0008266; GO:0010494; GO:0043488; GO:0061515; GO:1990904	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412]
PGEN_.00g300030	Scaffold_15	7405126	7424878	Q9Z1N0	ACOX1_CAVPO	"Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]"	GO:0003997; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0019395; GO:0033540; GO:0071949	peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]
PGEN_.00g300040	Scaffold_15	7433365	7443247	NA	NA	NA	NA	NA
PGEN_.00g300050	Scaffold_15	7449875	7452721	NA	NA	NA	NA	NA
PGEN_.00g300060	Scaffold_15	7459230	7474370	D8VNS7	FCNV1_CERRY	Ryncolin-1	GO:0005576; GO:0009405; GO:0090729	extracellular region [GO:0005576]; toxin activity [GO:0090729]; pathogenesis [GO:0009405]
PGEN_.00g300070	Scaffold_15	7474628	7474882	NA	NA	NA	NA	NA
PGEN_.00g300080	Scaffold_15	7517454	7520246	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g300090	Scaffold_15	7521347	7554162	O55236	MCE1_MOUSE	mRNA-capping enzyme (HCE) (MCE1) [Includes: Polynucleotide 5'-triphosphatase (TPase) (mRNA 5'-triphosphatase) (EC 3.1.3.33); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)]	GO:0004484; GO:0004651; GO:0004725; GO:0005525; GO:0005634; GO:0006370; GO:0006396; GO:0008138; GO:0008192; GO:0050355	nucleus [GO:0005634]; GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA guanylyltransferase activity [GO:0008192]; triphosphatase activity [GO:0050355]; 7-methylguanosine mRNA capping [GO:0006370]; RNA processing [GO:0006396]
PGEN_.00g300100	Scaffold_15	7559190	7583802	Q8K4L0	DDX54_MOUSE	ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (DEAD box protein 54)	GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016070; GO:0030331	Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]
PGEN_.00g300110	Scaffold_15	7586331	7587946	Q7TQN8	GP119_RAT	Glucose-dependent insulinotropic receptor (G-protein coupled receptor 119)	GO:0004930; GO:0005886; GO:0016021; GO:0030073; GO:0031210; GO:0043235	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210]; insulin secretion [GO:0030073]
PGEN_.00g300120	Scaffold_15	7599617	7612883	D3Z5L6	S18B1_MOUSE	MFS-type transporter SLC18B1 (Solute carrier family 18 member B1)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g300130	Scaffold_15	7614601	7627050	A3KPN8	TTC38_DANRE	Tetratricopeptide repeat protein 38 (TPR repeat protein 38)		
PGEN_.00g300140	Scaffold_15	7630105	7633689	NA	NA	NA	NA	NA
PGEN_.00g300150	Scaffold_15	7636740	7690235	Q8K0Q5	RHG18_MOUSE	Rho GTPase-activating protein 18 (Rho-type GTPase-activating protein 18)	GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0008360; GO:0016607; GO:0030833; GO:0032956; GO:0051056; GO:2000145	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]
PGEN_.00g300160	Scaffold_15	7691200	7691451	A2VDQ7	ZN420_BOVIN	Zinc finger protein 420	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g300170	Scaffold_15	7692199	7693300	NA	NA	NA	NA	NA
PGEN_.00g300180	Scaffold_15	7693406	7693672	NA	NA	NA	NA	NA
PGEN_.00g300190	Scaffold_15	7693828	7694976	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g300200	Scaffold_15	7704700	7707901	NA	NA	NA	NA	NA
PGEN_.00g300210	Scaffold_15	7733844	7735301	Q58CW4	NMUR2_BOVIN	Neuromedin-U receptor 2 (NMU-R2)	GO:0001607; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neuromedin U receptor activity [GO:0001607]
PGEN_.00g300220	Scaffold_15	7740995	7742076	NA	NA	NA	NA	NA
PGEN_.00g300230	Scaffold_15	7743337	7751733	NA	NA	NA	NA	NA
PGEN_.00g300240	Scaffold_15	7761094	7764059	NA	NA	NA	NA	NA
PGEN_.00g300250	Scaffold_15	7787598	7801878	C3ZAH2	MTND_BRAFL	"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (EC 1.13.11.54) (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD) (Fe-ARD)"	GO:0005506; GO:0005634; GO:0005737; GO:0006555; GO:0010309; GO:0019509	cytoplasm [GO:0005737]; nucleus [GO:0005634]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]
PGEN_.00g300260	Scaffold_15	7815284	7844126	P81439	EQST_ACTEQ	Equistatin	GO:0004869; GO:0005576	extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]
PGEN_.00g300270	Scaffold_15	7854789	7859098	NA	NA	NA	NA	NA
PGEN_.00g300280	Scaffold_15	7871451	7887007	Q92519	TRIB2_HUMAN	Tribbles homolog 2 (TRB-2)	GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006469; GO:0008134; GO:0031434; GO:0031625; GO:0032436; GO:0043405; GO:0045081; GO:0045599; GO:0055106	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 biosynthetic process [GO:0045081]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]
PGEN_.00g300290	Scaffold_15	7900012	7902545	NA	NA	NA	NA	NA
PGEN_.00g300300	Scaffold_15	7902581	7903318	NA	NA	NA	NA	NA
PGEN_.00g300310	Scaffold_15	7904449	7932975	Q5F3G7	C1GLT_CHICK	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016267; GO:0046872	"integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]"
PGEN_.00g300320	Scaffold_15	7939326	7942490	Q5XJQ7	OSR1_DANRE	Protein odd-skipped-related 1 (zOsr1)	GO:0000122; GO:0000977; GO:0001655; GO:0001822; GO:0005634; GO:0033339; GO:0035775; GO:0035776; GO:0035777; GO:0035778; GO:0035779; GO:0045892; GO:0045944; GO:0046872; GO:0048382; GO:0048389; GO:0048793; GO:0072112; GO:1900107; GO:1903224	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; angioblast cell differentiation [GO:0035779]; glomerular visceral epithelial cell differentiation [GO:0072112]; intermediate mesoderm development [GO:0048389]; kidney development [GO:0001822]; mesendoderm development [GO:0048382]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pectoral fin development [GO:0033339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric distal tubule development [GO:0035777]; pronephric glomerulus morphogenesis [GO:0035775]; pronephric nephron tubule epithelial cell differentiation [GO:0035778]; pronephric proximal tubule development [GO:0035776]; pronephros development [GO:0048793]; regulation of endodermal cell differentiation [GO:1903224]; regulation of nodal signaling pathway [GO:1900107]; urogenital system development [GO:0001655]"
PGEN_.00g300330	Scaffold_15	8002355	8008044	P0DP29	CALM1_RAT	Calmodulin-1	GO:0000086; GO:0000922; GO:0001975; GO:0002027; GO:0005246; GO:0005509; GO:0005513; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005876; GO:0005886; GO:0007190; GO:0008076; GO:0008179; GO:0010856; GO:0010880; GO:0019722; GO:0019855; GO:0019901; GO:0019904; GO:0030017; GO:0030235; GO:0030426; GO:0031432; GO:0031800; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0043005; GO:0043209; GO:0043388; GO:0043548; GO:0044325; GO:0047485; GO:0048306; GO:0050998; GO:0051000; GO:0051343; GO:0051592; GO:0055117; GO:0060314; GO:0060315; GO:0060316; GO:0072542; GO:0090150; GO:0090151; GO:0097718; GO:1900242; GO:1901339; GO:1901841; GO:1902494; GO:2000300	calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium channel inhibitor activity [GO:0019855]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; ion channel binding [GO:0044325]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase activator activity [GO:0072542]; titin binding [GO:0031432]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; detection of calcium ion [GO:0005513]; establishment of protein localization to membrane [GO:0090150]; establishment of protein localization to mitochondrial membrane [GO:0090151]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of store-operated calcium channel activity [GO:1901339]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]
PGEN_.00g300340	Scaffold_15	8011454	8016054	NA	NA	NA	NA	NA
PGEN_.00g300350	Scaffold_15	8020281	8025693	NA	NA	NA	NA	NA
PGEN_.00g300360	Scaffold_15	8030605	8058122	NA	NA	NA	NA	NA
PGEN_.00g300370	Scaffold_15	8043935	8044855	NA	NA	NA	NA	NA
PGEN_.00g300380	Scaffold_15	8059012	8059302	NA	NA	NA	NA	NA
PGEN_.00g300390	Scaffold_15	8069594	8069821	NA	NA	NA	NA	NA
PGEN_.00g300400	Scaffold_15	8070655	8070999	NA	NA	NA	NA	NA
PGEN_.00g300410	Scaffold_15	8150025	8151908	NA	NA	NA	NA	NA
PGEN_.00g300420	Scaffold_15	8165628	8174470	NA	NA	NA	NA	NA
PGEN_.00g300430	Scaffold_15	8186005	8193924	A8DYP0	OBSCN_DROME	Obscurin (EC 2.7.11.1) (Muscle M-line assembly protein Unc-89)	GO:0005085; GO:0005523; GO:0005524; GO:0006468; GO:0007275; GO:0007527; GO:0016301; GO:0019901; GO:0031430; GO:0036309; GO:0045214; GO:0046872	M band [GO:0031430]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523]; adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; sarcomere organization [GO:0045214]
PGEN_.00g300440	Scaffold_15	8196795	8201303	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g300450	Scaffold_15	8201550	8201843	NA	NA	NA	NA	NA
PGEN_.00g300460	Scaffold_15	8210307	8219080	P35295	RAB20_MOUSE	Ras-related protein Rab-20	GO:0003924; GO:0005525; GO:0005623; GO:0005768; GO:0005769; GO:0005794; GO:0006886; GO:0030100; GO:0030139; GO:0030670; GO:0032482; GO:0043231; GO:0045335; GO:0071346; GO:0090383; GO:0090385	cell [GO:0005623]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; intracellular protein transport [GO:0006886]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]
PGEN_.00g300470	Scaffold_15	8283250	8283867	NA	NA	NA	NA	NA
PGEN_.00g300480	Scaffold_15	8286377	8286580	NA	NA	NA	NA	NA
PGEN_.00g300490	Scaffold_15	8299227	8300547	NA	NA	NA	NA	NA
PGEN_.00g300500	Scaffold_15	8308186	8311651	Q8BQ86	CHST8_MOUSE	Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1)	GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g300510	Scaffold_15	8317692	8322801	NA	NA	NA	NA	NA
PGEN_.00g300520	Scaffold_15	8363959	8364685	NA	NA	NA	NA	NA
PGEN_.00g300530	Scaffold_15	8375775	8383926	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g300540	Scaffold_15	8405615	8406697	NA	NA	NA	NA	NA
PGEN_.00g300550	Scaffold_15	8534828	8536765	NA	NA	NA	NA	NA
PGEN_.00g300560	Scaffold_15	8536795	8548326	NA	NA	NA	NA	NA
PGEN_.00g300570	Scaffold_15	8548377	8554782	NA	NA	NA	NA	NA
PGEN_.00g300580	Scaffold_15	8582060	8583808	NA	NA	NA	NA	NA
PGEN_.00g300590	Scaffold_15	8598620	8626699	P13611	CSPG2_HUMAN	Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M)	GO:0001501; GO:0001649; GO:0001750; GO:0005509; GO:0005539; GO:0005540; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0007155; GO:0007275; GO:0007417; GO:0008037; GO:0008347; GO:0016020; GO:0030021; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0033165; GO:0043202; GO:0043687; GO:0044267; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; interphotoreceptor matrix [GO:0033165]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; cell recognition [GO:0008037]; cellular protein metabolic process [GO:0044267]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; multicellular organism development [GO:0007275]; osteoblast differentiation [GO:0001649]; post-translational protein modification [GO:0043687]; skeletal system development [GO:0001501]
PGEN_.00g300600	Scaffold_15	8628626	8629111	NA	NA	NA	NA	NA
PGEN_.00g300610	Scaffold_15	8632683	8641547	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g300620	Scaffold_15	8646880	8653584	Q28BP9	FAF2_XENTR	FAS-associated factor 2 (UBX domain-containing protein 8)	GO:0005783; GO:0005811	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]
PGEN_.00g300630	Scaffold_15	8653640	8658174	Q28BP9	FAF2_XENTR	FAS-associated factor 2 (UBX domain-containing protein 8)	GO:0005783; GO:0005811	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]
PGEN_.00g300640	Scaffold_15	8666416	8666913	NA	NA	NA	NA	NA
PGEN_.00g300650	Scaffold_15	8667264	8672372	P18172	DHGL_DROPS	"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]"	GO:0005576; GO:0016614; GO:0050660	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
PGEN_.00g300660	Scaffold_15	8679538	8704230	P81282	CSPG2_BOVIN	Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M)	GO:0001501; GO:0001750; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0033165	extracellular matrix [GO:0031012]; interphotoreceptor matrix [GO:0033165]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g300670	Scaffold_15	8747800	8769748	NA	NA	NA	NA	NA
PGEN_.00g300680	Scaffold_15	8896448	8897530	NA	NA	NA	NA	NA
PGEN_.00g300690	Scaffold_15	8919084	8925970	Q17QR8	HARB1_BOVIN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g300700	Scaffold_15	8979731	8984839	NA	NA	NA	NA	NA
PGEN_.00g300710	Scaffold_15	8990907	8994290	Q8BQ86	CHST8_MOUSE	Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1)	GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g300720	Scaffold_15	8999586	8999906	NA	NA	NA	NA	NA
PGEN_.00g300730	Scaffold_15	9001525	9004754	NA	NA	NA	NA	NA
PGEN_.00g300740	Scaffold_15	9015495	9015698	NA	NA	NA	NA	NA
PGEN_.00g300750	Scaffold_15	9018208	9018825	NA	NA	NA	NA	NA
PGEN_.00g300760	Scaffold_15	9038262	9043466	NA	NA	NA	NA	NA
PGEN_.00g300770	Scaffold_15	9080320	9081035	NA	NA	NA	NA	NA
PGEN_.00g300780	Scaffold_15	9083239	9092009	P35295	RAB20_MOUSE	Ras-related protein Rab-20	GO:0003924; GO:0005525; GO:0005623; GO:0005768; GO:0005769; GO:0005794; GO:0006886; GO:0030100; GO:0030139; GO:0030670; GO:0032482; GO:0043231; GO:0045335; GO:0071346; GO:0090383; GO:0090385	cell [GO:0005623]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; intracellular protein transport [GO:0006886]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]
PGEN_.00g300790	Scaffold_15	9100457	9100750	NA	NA	NA	NA	NA
PGEN_.00g300800	Scaffold_15	9100997	9102014	Q98TA4	MBL_CHICK	Mannose-binding protein (MBP) (Mannan-binding protein)	GO:0001530; GO:0001867; GO:0005537; GO:0005576; GO:0005581; GO:0005615; GO:0005771; GO:0005791; GO:0006956; GO:0006958; GO:0032502; GO:0043129; GO:0048029; GO:0050766	"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791]; lipopolysaccharide binding [GO:0001530]; mannose binding [GO:0005537]; monosaccharide binding [GO:0048029]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]; developmental process [GO:0032502]; positive regulation of phagocytosis [GO:0050766]; surfactant homeostasis [GO:0043129]"
PGEN_.00g300810	Scaffold_15	9103364	9105430	NA	NA	NA	NA	NA
PGEN_.00g300820	Scaffold_15	9108372	9119919	A8DYP0	OBSCN_DROME	Obscurin (EC 2.7.11.1) (Muscle M-line assembly protein Unc-89)	GO:0005085; GO:0005523; GO:0005524; GO:0006468; GO:0007275; GO:0007527; GO:0016301; GO:0019901; GO:0031430; GO:0036309; GO:0045214; GO:0046872	M band [GO:0031430]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523]; adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; sarcomere organization [GO:0045214]
PGEN_.00g300830	Scaffold_15	9131863	9140954	NA	NA	NA	NA	NA
PGEN_.00g300840	Scaffold_15	9154772	9156655	NA	NA	NA	NA	NA
PGEN_.00g300850	Scaffold_15	9236503	9236904	NA	NA	NA	NA	NA
PGEN_.00g300860	Scaffold_15	9249113	9277257	NA	NA	NA	NA	NA
PGEN_.00g300870	Scaffold_15	9262385	9263305	NA	NA	NA	NA	NA
PGEN_.00g300880	Scaffold_15	9282188	9287528	NA	NA	NA	NA	NA
PGEN_.00g300890	Scaffold_15	9302816	9319612	Q9UBG0	MRC2_HUMAN	C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280)	GO:0001649; GO:0004888; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0016021; GO:0030246; GO:0030574	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]
PGEN_.00g300900	Scaffold_15	9325031	9328449	NA	NA	NA	NA	NA
PGEN_.00g300910	Scaffold_15	9438120	9439488	NA	NA	NA	NA	NA
PGEN_.00g300920	Scaffold_15	9493221	9494528	NA	NA	NA	NA	NA
PGEN_.00g300930	Scaffold_15	9494696	9495160	NA	NA	NA	NA	NA
PGEN_.00g300940	Scaffold_15	9539994	9540593	NA	NA	NA	NA	NA
PGEN_.00g300950	Scaffold_15	9549066	9549521	NA	NA	NA	NA	NA
PGEN_.00g300960	Scaffold_15	9557296	9557748	NA	NA	NA	NA	NA
PGEN_.00g300970	Scaffold_15	9565101	9565511	NA	NA	NA	NA	NA
PGEN_.00g300980	Scaffold_15	9579864	9590381	Q15485	FCN2_HUMAN	Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)	GO:0001867; GO:0003823; GO:0005576; GO:0005581; GO:0006956; GO:0008228; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0072562; GO:2001065	"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"
PGEN_.00g300990	Scaffold_15	9599943	9603834	O93526	FGL1L_CHICK	Fibrinogen-like protein 1-like protein (Cytidine deaminase) (CDD)	GO:0004126; GO:0047844	cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]
PGEN_.00g301000	Scaffold_15	9674173	9693643	NA	NA	NA	NA	NA
PGEN_.00g301010	Scaffold_15	9695687	9710672	Q28HU3	CENPO_XENTR	Centromere protein O (CENP-O)	GO:0000778; GO:0031511; GO:0034508	condensed nuclear chromosome kinetochore [GO:0000778]; Mis6-Sim4 complex [GO:0031511]; centromere complex assembly [GO:0034508]
PGEN_.00g301020	Scaffold_15	9734103	9739537	NA	NA	NA	NA	NA
PGEN_.00g301030	Scaffold_15	9735800	9757751	Q71MB6	SO4C1_RAT	Solute carrier organic anion transporter family member 4C1 (Solute carrier family 21 member 20)	GO:0005887; GO:0007275; GO:0007283; GO:0015347; GO:0015711; GO:0016021; GO:0016323; GO:0030154; GO:0043252	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]
PGEN_.00g301040	Scaffold_15	9763183	9764321	NA	NA	NA	NA	NA
PGEN_.00g301050	Scaffold_15	9769173	9779535	Q7LFX5	CHSTF_HUMAN	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]
PGEN_.00g301060	Scaffold_15	9791067	9792056	O42574	ADRB1_XENLA	Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR)	GO:0004940; GO:0005088; GO:0005769; GO:0005886; GO:0016021; GO:0043547; GO:0045823; GO:0071880	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; beta1-adrenergic receptor activity [GO:0004940]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart contraction [GO:0045823]
PGEN_.00g301070	Scaffold_15	9799124	9822038	Q8IWX7	UN45B_HUMAN	Protein unc-45 homolog B (Unc-45B) (SMUNC45)	GO:0002088; GO:0005829; GO:0007517; GO:0030154; GO:0051879; GO:0061077	cytosol [GO:0005829]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]
PGEN_.00g301080	Scaffold_15	9823510	9826038	NA	NA	NA	NA	NA
PGEN_.00g301090	Scaffold_15	9828527	9832896	Q9H3U1	UN45A_HUMAN	Protein unc-45 homolog A (Unc-45A) (GCUNC-45) (Smooth muscle cell-associated protein 1) (SMAP-1)	GO:0005794; GO:0005829; GO:0007517; GO:0016607; GO:0030154; GO:0045296; GO:0048471; GO:0051879; GO:0061077	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517]
PGEN_.00g301100	Scaffold_15	9844526	9845645	NA	NA	NA	NA	NA
PGEN_.00g301110	Scaffold_15	9857182	9859693	NA	NA	NA	NA	NA
PGEN_.00g301120	Scaffold_15	9861695	9862393	NA	NA	NA	NA	NA
PGEN_.00g301130	Scaffold_15	9874337	9912605	Q8CGY6	UN45B_MOUSE	Protein unc-45 homolog B (Unc-45B)	GO:0002088; GO:0005829; GO:0007517; GO:0030154; GO:0051879; GO:0061077	cytosol [GO:0005829]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]
PGEN_.00g301140	Scaffold_15	9920037	9921026	O42574	ADRB1_XENLA	Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR)	GO:0004940; GO:0005088; GO:0005769; GO:0005886; GO:0016021; GO:0043547; GO:0045823; GO:0071880	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; beta1-adrenergic receptor activity [GO:0004940]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart contraction [GO:0045823]
PGEN_.00g301150	Scaffold_15	9932409	9947919	Q8CHI9	CHSTF_RAT	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; hexose biosynthetic process [GO:0019319]
PGEN_.00g301160	Scaffold_15	9949420	9950558	NA	NA	NA	NA	NA
PGEN_.00g301170	Scaffold_15	9956010	9978080	Q71MB6	SO4C1_RAT	Solute carrier organic anion transporter family member 4C1 (Solute carrier family 21 member 20)	GO:0005887; GO:0007275; GO:0007283; GO:0015347; GO:0015711; GO:0016021; GO:0016323; GO:0030154; GO:0043252	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]
PGEN_.00g301180	Scaffold_15	10012095	10018421	Q28HU3	CENPO_XENTR	Centromere protein O (CENP-O)	GO:0000778; GO:0031511; GO:0034508	condensed nuclear chromosome kinetochore [GO:0000778]; Mis6-Sim4 complex [GO:0031511]; centromere complex assembly [GO:0034508]
PGEN_.00g301190	Scaffold_15	10020465	10039875	NA	NA	NA	NA	NA
PGEN_.00g301200	Scaffold_15	10110145	10114036	O93526	FGL1L_CHICK	Fibrinogen-like protein 1-like protein (Cytidine deaminase) (CDD)	GO:0004126; GO:0047844	cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]
PGEN_.00g301210	Scaffold_15	10123890	10134401	Q15485	FCN2_HUMAN	Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)	GO:0001867; GO:0003823; GO:0005576; GO:0005581; GO:0006956; GO:0008228; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0072562; GO:2001065	"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"
PGEN_.00g301220	Scaffold_15	10149170	10149580	NA	NA	NA	NA	NA
PGEN_.00g301230	Scaffold_15	10156938	10157390	NA	NA	NA	NA	NA
PGEN_.00g301240	Scaffold_15	10165376	10165831	NA	NA	NA	NA	NA
PGEN_.00g301250	Scaffold_15	10174830	10175429	NA	NA	NA	NA	NA
PGEN_.00g301260	Scaffold_15	10177454	10177702	NA	NA	NA	NA	NA
PGEN_.00g301270	Scaffold_15	10277493	10277717	NA	NA	NA	NA	NA
PGEN_.00g301280	Scaffold_15	10284453	10285821	NA	NA	NA	NA	NA
PGEN_.00g301290	Scaffold_15	10323357	10329366	NA	NA	NA	NA	NA
PGEN_.00g301300	Scaffold_15	10333062	10341886	NA	NA	NA	NA	NA
PGEN_.00g301310	Scaffold_15	10393824	10397262	NA	NA	NA	NA	NA
PGEN_.00g301320	Scaffold_15	10402133	10419049	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g301330	Scaffold_15	10424209	10441045	Q7TNK0	SERC1_RAT	Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2)	GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0016021; GO:0019899; GO:0030674; GO:0044091; GO:1904219; GO:1904222	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; protein binding, bridging [GO:0030674]; membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]"
PGEN_.00g301340	Scaffold_15	10447987	10463938	Q6R7G8	Y057_OSHVF	Putative transmembrane protein ORF57	GO:0016021; GO:0033644	host cell membrane [GO:0033644]; integral component of membrane [GO:0016021]
PGEN_.00g301350	Scaffold_15	10463986	10475939	NA	NA	NA	NA	NA
PGEN_.00g301360	Scaffold_15	10471561	10471770	NA	NA	NA	NA	NA
PGEN_.00g301370	Scaffold_15	10482763	10484758	NA	NA	NA	NA	NA
PGEN_.00g301380	Scaffold_15	10571192	10585245	NA	NA	NA	NA	NA
PGEN_.00g301390	Scaffold_15	10601656	10647358	NA	NA	NA	NA	NA
PGEN_.00g301400	Scaffold_15	10753698	10767170	NA	NA	NA	NA	NA
PGEN_.00g301410	Scaffold_15	10768130	10787681	P17972	KCNAW_DROME	Potassium voltage-gated channel protein Shaw (Shaw2)	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]
PGEN_.00g301420	Scaffold_15	10805747	10822230	NA	NA	NA	NA	NA
PGEN_.00g301430	Scaffold_15	10839246	10870083	Q69Z37	SAM9L_MOUSE	Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like)	GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536	cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]
PGEN_.00g301440	Scaffold_15	10886361	10928410	Q5T5Y3	CAMP1_HUMAN	Calmodulin-regulated spectrin-associated protein 1	GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0051011	cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113]
PGEN_.00g301450	Scaffold_15	10933155	10939862	NA	NA	NA	NA	NA
PGEN_.00g301460	Scaffold_15	10952575	10960664	NA	NA	NA	NA	NA
PGEN_.00g301470	Scaffold_15	10962721	10978635	NA	NA	NA	NA	NA
PGEN_.00g301480	Scaffold_15	10991213	10996756	NA	NA	NA	NA	NA
PGEN_.00g301490	Scaffold_15	11002568	11046562	Q5T5Y3	CAMP1_HUMAN	Calmodulin-regulated spectrin-associated protein 1	GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0051011	cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113]
PGEN_.00g301500	Scaffold_15	11062830	11093667	Q69Z37	SAM9L_MOUSE	Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like)	GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536	cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]
PGEN_.00g301510	Scaffold_15	11110659	11127339	NA	NA	NA	NA	NA
PGEN_.00g301520	Scaffold_15	11145445	11164376	P17972	KCNAW_DROME	Potassium voltage-gated channel protein Shaw (Shaw2)	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]
PGEN_.00g301530	Scaffold_15	11288292	11333740	NA	NA	NA	NA	NA
PGEN_.00g301540	Scaffold_15	11355308	11356255	NA	NA	NA	NA	NA
PGEN_.00g301550	Scaffold_15	11359158	11422156	Q8BI55	DYRK4_MOUSE	Dual specificity tyrosine-phosphorylation-regulated kinase 4 (EC 2.7.12.1)	GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0018105; GO:0018107; GO:0043231; GO:0046872	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]
PGEN_.00g301560	Scaffold_15	11370016	11376485	NA	NA	NA	NA	NA
PGEN_.00g301570	Scaffold_15	11439090	11458082	Q09175	KRP1_SCHPO	Dibasic-processing endoprotease (EC 3.4.21.-) (KEX2-related protease)	GO:0004175; GO:0004252; GO:0004867; GO:0005794; GO:0005802; GO:0006508; GO:0009986; GO:0016020; GO:0016485; GO:0016540; GO:0030173; GO:0070011; GO:0071432	"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity, acting on L-amino acid peptides [GO:0070011]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]; peptide mating pheromone maturation involved in positive regulation of conjugation with cellular fusion [GO:0071432]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]"
PGEN_.00g301580	Scaffold_15	11460112	11460402	NA	NA	NA	NA	NA
PGEN_.00g301590	Scaffold_15	11464347	11485316	O43909	EXTL3_HUMAN	Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3)	GO:0001888; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0015012; GO:0016021; GO:0016757; GO:0030307; GO:0036498; GO:0046872	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of cell growth [GO:0030307]; protein glycosylation [GO:0006486]"
PGEN_.00g301600	Scaffold_15	11490412	11508434	Q9NQL2	RRAGD_HUMAN	Ras-related GTP-binding protein D (Rag D) (RagD)	GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005813; GO:0005829; GO:0007050; GO:0009267; GO:0010506; GO:0016241; GO:0019003; GO:0032008; GO:0034448; GO:0034613; GO:0046982; GO:0051020; GO:0071230; GO:0071233; GO:1904263; GO:1990131; GO:1990253	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein heterodimerization activity [GO:0046982]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]
PGEN_.00g301610	Scaffold_15	11519899	11524547	NA	NA	NA	NA	NA
PGEN_.00g301620	Scaffold_15	11534772	11535980	Q8R4G9	ACHA3_MOUSE	Neuronal acetylcholine receptor subunit alpha-3	GO:0005887; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007171; GO:0007268; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0008144; GO:0014056; GO:0014069; GO:0015464; GO:0016020; GO:0022848; GO:0030054; GO:0030425; GO:0034220; GO:0035094; GO:0035095; GO:0042166; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0045211; GO:0048814; GO:0050877; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098981; GO:0099060; GO:1904315; GO:1905144; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; ion transmembrane transport [GO:0034220]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to drug [GO:0042493]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g301630	Scaffold_15	11543451	11546874	NA	NA	NA	NA	NA
PGEN_.00g301640	Scaffold_15	11596076	11621873	NA	NA	NA	NA	NA
PGEN_.00g301650	Scaffold_15	11628133	11629008	NA	NA	NA	NA	NA
PGEN_.00g301660	Scaffold_15	11632779	11635284	Q86GC8	ACES_CULPI	Acetylcholinesterase (AChE) (EC 3.1.1.7)	GO:0003990; GO:0005576; GO:0005886; GO:0030054; GO:0042135; GO:0045202	cell junction [GO:0030054]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholinesterase activity [GO:0003990]; neurotransmitter catabolic process [GO:0042135]
PGEN_.00g301670	Scaffold_15	11667835	11669502	A6NFU0	F187A_HUMAN	Ig-like V-type domain-containing protein FAM187A	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g301680	Scaffold_15	11671240	11685371	P79995	CAD10_CHICK	Cadherin-10	GO:0000902; GO:0005509; GO:0005886; GO:0005913; GO:0007043; GO:0007156; GO:0008092; GO:0009986; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0042803; GO:0044331; GO:0045296; GO:0098609	catenin complex [GO:0016342]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; protein homodimerization activity [GO:0042803]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g301690	Scaffold_15	11686959	11738759	P56941	NPC1_PIG	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]
PGEN_.00g301700	Scaffold_15	11739197	11747767	O75340	PDCD6_HUMAN	Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2)	GO:0000139; GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006919; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043280; GO:0043495; GO:0045766; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:0051898; GO:0070062; GO:0070971; GO:0097190; GO:1902527; GO:1990756	"COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein binding, bridging [GO:0030674]; protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]"
PGEN_.00g301710	Scaffold_15	11765050	11770922	Q02525	ZFP39_MOUSE	Zinc finger protein 39 (Zfp-39) (CtFIN33)	GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007283; GO:0030154; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"
PGEN_.00g301720	Scaffold_15	11772187	11779006	Q03923	ZNF85_HUMAN	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0046872	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]
PGEN_.00g301730	Scaffold_15	11795043	11813145	Q3ULM6	USPL1_MOUSE	SUMO-specific isopeptidase USPL1 (EC 3.4.22.-) (Ubiquitin-specific peptidase-like protein 1)	GO:0001825; GO:0008283; GO:0009301; GO:0015030; GO:0016926; GO:0030576; GO:0032183; GO:0070140	Cajal body [GO:0015030]; SUMO binding [GO:0032183]; SUMO-specific isopeptidase activity [GO:0070140]; blastocyst formation [GO:0001825]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; protein desumoylation [GO:0016926]; snRNA transcription [GO:0009301]
PGEN_.00g301740	Scaffold_15	11821048	11832224	P55088	AQP4_MOUSE	Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4)	GO:0005576; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006833; GO:0007605; GO:0009897; GO:0009925; GO:0009992; GO:0010008; GO:0010574; GO:0015250; GO:0015288; GO:0015670; GO:0016020; GO:0016021; GO:0016323; GO:0030104; GO:0030315; GO:0031253; GO:0032691; GO:0032715; GO:0032991; GO:0042383; GO:0042802; GO:0051289; GO:0060354; GO:0070295; GO:0071333; GO:0071346; GO:0090660; GO:0097450; GO:0098609	astrocyte end-foot [GO:0097450]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; identical protein binding [GO:0042802]; porin activity [GO:0015288]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to glucose stimulus [GO:0071333]; cellular response to interferon-gamma [GO:0071346]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid circulation [GO:0090660]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water absorption [GO:0070295]; sensory perception of sound [GO:0007605]; water homeostasis [GO:0030104]; water transport [GO:0006833]
PGEN_.00g301750	Scaffold_15	11840742	11841137	NA	NA	NA	NA	NA
PGEN_.00g301760	Scaffold_15	11964675	11966651	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g301770	Scaffold_15	11972972	11987084	NA	NA	NA	NA	NA
PGEN_.00g301780	Scaffold_15	11991586	11993454	Q56R14	TRI33_XENLA	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]
PGEN_.00g301790	Scaffold_15	12006486	12010295	NA	NA	NA	NA	NA
PGEN_.00g301800	Scaffold_15	12041201	12043658	NA	NA	NA	NA	NA
PGEN_.00g301810	Scaffold_15	12059846	12061900	NA	NA	NA	NA	NA
PGEN_.00g301820	Scaffold_15	12121380	12127202	NA	NA	NA	NA	NA
PGEN_.00g301830	Scaffold_15	12145470	12146223	NA	NA	NA	NA	NA
PGEN_.00g301840	Scaffold_15	12202265	12208352	NA	NA	NA	NA	NA
PGEN_.00g301850	Scaffold_15	12238630	12241440	Q95NT6	MTH2_DROYA	G-protein coupled receptor Mth2 (Protein methuselah-2)	GO:0004930; GO:0005886; GO:0007166; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g301860	Scaffold_15	12249416	12251877	NA	NA	NA	NA	NA
PGEN_.00g301870	Scaffold_15	12281649	12285477	Q9ULY5	CLC4E_HUMAN	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (MINCLE)	GO:0002221; GO:0002223; GO:0002292; GO:0005509; GO:0005886; GO:0016020; GO:0016021; GO:0030246; GO:0038094; GO:0038187; GO:0042742; GO:0045087; GO:0050715	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; pattern recognition receptor activity [GO:0038187]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine secretion [GO:0050715]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell differentiation involved in immune response [GO:0002292]
PGEN_.00g301880	Scaffold_15	12287538	12287873	NA	NA	NA	NA	NA
PGEN_.00g301890	Scaffold_15	12288134	12288610	NA	NA	NA	NA	NA
PGEN_.00g301900	Scaffold_15	12296205	12296534	NA	NA	NA	NA	NA
PGEN_.00g301910	Scaffold_15	12296634	12297392	NA	NA	NA	NA	NA
PGEN_.00g301920	Scaffold_15	12314933	12318205	NA	NA	NA	NA	NA
PGEN_.00g301930	Scaffold_15	12324887	12325243	NA	NA	NA	NA	NA
PGEN_.00g301940	Scaffold_15	12325378	12325869	NA	NA	NA	NA	NA
PGEN_.00g301950	Scaffold_15	12325984	12328088	NA	NA	NA	NA	NA
PGEN_.00g301960	Scaffold_15	12351028	12352544	NA	NA	NA	NA	NA
PGEN_.00g301970	Scaffold_15	12368119	12369282	NA	NA	NA	NA	NA
PGEN_.00g301980	Scaffold_15	12391370	12392615	NA	NA	NA	NA	NA
PGEN_.00g301990	Scaffold_15	12394085	12395433	NA	NA	NA	NA	NA
PGEN_.00g302000	Scaffold_15	12397094	12402192	NA	NA	NA	NA	NA
PGEN_.00g302010	Scaffold_15	12402983	12403678	NA	NA	NA	NA	NA
PGEN_.00g302020	Scaffold_15	12430748	12431086	NA	NA	NA	NA	NA
PGEN_.00g302030	Scaffold_15	12444756	12450263	NA	NA	NA	NA	NA
PGEN_.00g302040	Scaffold_15	12476175	12480941	NA	NA	NA	NA	NA
PGEN_.00g302050	Scaffold_15	12482548	12487832	Q811U4	MFN1_MOUSE	Mitofusin-1 (EC 3.6.5.-) (Transmembrane GTPase MFN1)	GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005743; GO:0008053; GO:0010636; GO:0016021; GO:0031306; GO:0031307; GO:0042802; GO:0046039; GO:0048312; GO:0051646; GO:0061003; GO:0070584; GO:0090258; GO:0098799; GO:1990613	integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fusion [GO:0008053]; mitochondrial membrane fusion [GO:1990613]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; negative regulation of mitochondrial fission [GO:0090258]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of mitochondrial fusion [GO:0010636]
PGEN_.00g302060	Scaffold_15	12495828	12498610	Q61180	SCNNA_MOUSE	Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA)	GO:0001669; GO:0003779; GO:0005737; GO:0005829; GO:0005887; GO:0006814; GO:0009897; GO:0015280; GO:0016020; GO:0016021; GO:0016324; GO:0030864; GO:0031514; GO:0034706; GO:0035725; GO:0050699; GO:0050878; GO:0050891; GO:0050896; GO:0050909; GO:0055078; GO:0060170; GO:0070062; GO:0097228	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; motile cilium [GO:0031514]; sodium channel complex [GO:0034706]; sperm principal piece [GO:0097228]; actin binding [GO:0003779]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]; multicellular organismal water homeostasis [GO:0050891]; regulation of body fluid levels [GO:0050878]; response to stimulus [GO:0050896]; sensory perception of taste [GO:0050909]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]
PGEN_.00g302070	Scaffold_15	12518982	12519212	NA	NA	NA	NA	NA
PGEN_.00g302080	Scaffold_15	12520578	12529949	K7FQW8	SCNNB_PELSI	Amiloride-sensitive sodium channel subunit beta (Beta-NaCH) (Epithelial Na(+) channel subunit beta) (Beta-ENaC) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB)	GO:0005887; GO:0009897; GO:0015280; GO:0016324; GO:0030659; GO:0034706; GO:0035725; GO:0050699; GO:0050891; GO:0055078; GO:0070062	apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; sodium channel complex [GO:0034706]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]; multicellular organismal water homeostasis [GO:0050891]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]
PGEN_.00g302090	Scaffold_15	12533926	12539861	O43704	ST1B1_HUMAN	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (Sulfotransferase 1B2) (ST1B2) (Thyroid hormone sulfotransferase)	GO:0004062; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cellular biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g302100	Scaffold_15	12546090	12549839	NA	NA	NA	NA	NA
PGEN_.00g302110	Scaffold_15	12558770	12578001	NA	NA	NA	NA	NA
PGEN_.00g302120	Scaffold_15	12581035	12584902	NA	NA	NA	NA	NA
PGEN_.00g302130	Scaffold_15	12595978	12613887	NA	NA	NA	NA	NA
PGEN_.00g302140	Scaffold_15	12622517	12626869	NA	NA	NA	NA	NA
PGEN_.00g302150	Scaffold_15	12631141	12631773	NA	NA	NA	NA	NA
PGEN_.00g302160	Scaffold_15	12641849	12642070	NA	NA	NA	NA	NA
PGEN_.00g302170	Scaffold_15	12648459	12675341	Q63504	NR1D2_RAT	Nuclear receptor subfamily 1 group D member 2 (EAR4) (Rev-erb-beta)	GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0003677; GO:0003700; GO:0003707; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007275; GO:0008134; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030374; GO:0033993; GO:0038023; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0090575; GO:0097009; GO:2001014	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor transcription coactivator activity [GO:0030374]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; multicellular organism development [GO:0007275]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]; response to lipid [GO:0033993]"
PGEN_.00g302180	Scaffold_15	12807207	12807563	NA	NA	NA	NA	NA
PGEN_.00g302190	Scaffold_15	12807613	12808463	NA	NA	NA	NA	NA
PGEN_.00g302200	Scaffold_15	12819567	12829812	NA	NA	NA	NA	NA
PGEN_.00g302210	Scaffold_15	12859531	12901650	NA	NA	NA	NA	NA
PGEN_.00g302220	Scaffold_15	12902229	12902543	NA	NA	NA	NA	NA
PGEN_.00g302230	Scaffold_15	12902637	12903578	NA	NA	NA	NA	NA
PGEN_.00g302240	Scaffold_15	12971005	13002497	NA	NA	NA	NA	NA
PGEN_.00g302250	Scaffold_15	13009376	13012863	NA	NA	NA	NA	NA
PGEN_.00g302260	Scaffold_15	13038595	13041252	NA	NA	NA	NA	NA
PGEN_.00g302270	Scaffold_15	13044878	13072431	NA	NA	NA	NA	NA
PGEN_.00g302280	Scaffold_15	13082696	13083079	NA	NA	NA	NA	NA
PGEN_.00g302290	Scaffold_15	13083102	13084214	NA	NA	NA	NA	NA
PGEN_.00g302300	Scaffold_15	13132301	13161839	Q03172	ZEP1_MOUSE	Zinc finger protein 40 (Alpha A-crystallin-binding protein 1) (Alpha A-CRYBP1) (Alpha A-crystallin-binding protein I) (Transcription factor alphaA-CRYBP1)	GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0008270; GO:0016604; GO:0030509; GO:0045892; GO:0045944; GO:0071837	"mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; HMG box domain binding [GO:0071837]; zinc ion binding [GO:0008270]; BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g302310	Scaffold_15	13172625	13190000	Q9NVV5	AIG1_HUMAN	Androgen-induced gene 1 protein (AIG-1) (Fatty acid esters of hydroxy fatty acids hydrolase AIG1) (FAHFA hydrolase AIG1) (EC 3.1.-.-)	GO:0005886; GO:0016020; GO:0016021; GO:0016787; GO:0042758	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; long-chain fatty acid catabolic process [GO:0042758]
PGEN_.00g302320	Scaffold_15	13189438	13191675	NA	NA	NA	NA	NA
PGEN_.00g302330	Scaffold_15	13201174	13213790	P68252	1433G_BOVIN	"14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed]"	GO:0005159; GO:0005737; GO:0019904; GO:0045664; GO:0048167	cytoplasm [GO:0005737]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic plasticity [GO:0048167]
PGEN_.00g302340	Scaffold_15	13221303	13232115	Q9D0I8	MRT4_MOUSE	mRNA turnover protein 4 homolog (Ribosome assembly factor Mrto4)	GO:0000027; GO:0000956; GO:0005730; GO:0005737; GO:0006364; GO:0030687; GO:0042273	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]"
PGEN_.00g302350	Scaffold_15	13247181	13247930	NA	NA	NA	NA	NA
PGEN_.00g302360	Scaffold_15	13257078	13295825	Q6P5E8	DGKQ_MOUSE	Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (Diglyceride kinase theta) (DGK-theta)	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030297; GO:0033198; GO:0033613; GO:0035556; GO:0043274; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:1900242; GO:1903432; GO:2000064; GO:2000182	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]
PGEN_.00g302370	Scaffold_15	13347306	13361108	Q8TC41	RN217_HUMAN	Probable E3 ubiquitin-protein ligase RNF217 (EC 2.3.2.31) (IBR domain-containing protein 1) (RING finger protein 217)	GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g302380	Scaffold_15	13369842	13390835	P23687	PPCE_PIG	Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)	GO:0004175; GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0070008; GO:0070012	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]
PGEN_.00g302390	Scaffold_15	13435103	13435474	NA	NA	NA	NA	NA
PGEN_.00g302400	Scaffold_15	13480412	13481053	NA	NA	NA	NA	NA
PGEN_.00g302410	Scaffold_15	13514261	13514683	NA	NA	NA	NA	NA
PGEN_.00g302420	Scaffold_15	13516224	13565895	P16581	LYAM2_HUMAN	E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E)	GO:0002092; GO:0002523; GO:0004888; GO:0005615; GO:0005886; GO:0005887; GO:0005901; GO:0005905; GO:0006954; GO:0007157; GO:0007159; GO:0007202; GO:0019722; GO:0030029; GO:0030863; GO:0032496; GO:0033691; GO:0034612; GO:0043274; GO:0045121; GO:0046872; GO:0048471; GO:0050727; GO:0050900; GO:0050901; GO:0070492; GO:0070555; GO:1903238	caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492]; phospholipase binding [GO:0043274]; sialic acid binding [GO:0033691]; transmembrane signaling receptor activity [GO:0004888]; actin filament-based process [GO:0030029]; activation of phospholipase C activity [GO:0007202]; calcium-mediated signaling [GO:0019722]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte migration involved in inflammatory response [GO:0002523]; leukocyte tethering or rolling [GO:0050901]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of receptor internalization [GO:0002092]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]
PGEN_.00g302430	Scaffold_15	13565959	13594218	NA	NA	NA	NA	NA
PGEN_.00g302440	Scaffold_15	13594801	13595823	NA	NA	NA	NA	NA
PGEN_.00g302450	Scaffold_15	13601122	13602666	NA	NA	NA	NA	NA
PGEN_.00g302460	Scaffold_15	13672892	13676989	NA	NA	NA	NA	NA
PGEN_.00g302470	Scaffold_15	13686336	13687442	NA	NA	NA	NA	NA
PGEN_.00g302480	Scaffold_15	13703933	13709065	NA	NA	NA	NA	NA
PGEN_.00g302490	Scaffold_15	13712206	13713874	NA	NA	NA	NA	NA
PGEN_.00g302500	Scaffold_15	13746340	13747992	NA	NA	NA	NA	NA
PGEN_.00g302510	Scaffold_15	13758818	13783241	NA	NA	NA	NA	NA
PGEN_.00g302520	Scaffold_15	13806031	13813938	Q98943	CASP2_CHICK	Caspase-2 (CASP-2) (EC 3.4.22.55) (ICH-1L/1S) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]	GO:0005737; GO:0006915; GO:0042981; GO:0097153; GO:0097192; GO:0097200	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981]
PGEN_.00g302530	Scaffold_15	13817679	13831102	NA	NA	NA	NA	NA
PGEN_.00g302540	Scaffold_15	13833897	13847015	NA	NA	NA	NA	NA
PGEN_.00g302550	Scaffold_15	13847080	13847526	NA	NA	NA	NA	NA
PGEN_.00g302560	Scaffold_15	13849660	13852866	NA	NA	NA	NA	NA
PGEN_.00g302570	Scaffold_15	13861728	13869753	NA	NA	NA	NA	NA
PGEN_.00g302580	Scaffold_15	13891673	13895304	NA	NA	NA	NA	NA
PGEN_.00g302590	Scaffold_15	13905577	13918031	Q9I925	FUCL7_ANGJA	Fucolectin-7	GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088	"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
PGEN_.00g302600	Scaffold_15	13975434	13976620	NA	NA	NA	NA	NA
PGEN_.00g302610	Scaffold_15	13988964	13989182	NA	NA	NA	NA	NA
PGEN_.00g302620	Scaffold_15	13990746	14001219	P97864	CASP7_MOUSE	Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]	GO:0004190; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0007507; GO:0007568; GO:0008233; GO:0008234; GO:0009411; GO:0016485; GO:0043231; GO:0051146; GO:0051402; GO:0071887; GO:0072734; GO:0097153; GO:0097194; GO:0097200	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146]
PGEN_.00g302630	Scaffold_15	14004501	14004734	NA	NA	NA	NA	NA
PGEN_.00g302640	Scaffold_15	14004789	14005085	NA	NA	NA	NA	NA
PGEN_.00g302650	Scaffold_15	14005255	14005542	NA	NA	NA	NA	NA
PGEN_.00g302660	Scaffold_15	14012326	14014280	NA	NA	NA	NA	NA
PGEN_.00g302670	Scaffold_15	14051438	14051956	NA	NA	NA	NA	NA
PGEN_.00g302680	Scaffold_15	14069649	14082341	Q3SZU0	GTSF1_BOVIN	Gametocyte-specific factor 1 (Protein FAM112B)	GO:0005737; GO:0007283; GO:0030154; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]
PGEN_.00g302690	Scaffold_15	14122917	14158267	NA	NA	NA	NA	NA
PGEN_.00g302700	Scaffold_15	14159549	14166495	NA	NA	NA	NA	NA
PGEN_.00g302710	Scaffold_15	14174536	14183000	Q8WZ42	TITIN_HUMAN	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030017; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0071688; GO:0097493	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
PGEN_.00g302720	Scaffold_15	14240147	14241706	B4XF06	GPR39_BOVIN	G-protein coupled receptor 39	GO:0004930; GO:0005886; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; metal ion binding [GO:0046872]
PGEN_.00g302730	Scaffold_15	14249175	14252498	Q9GLP1	FA5_PIG	Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]	GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091	extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; copper ion binding [GO:0005507]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]
PGEN_.00g302740	Scaffold_15	14262032	14284148	NA	NA	NA	NA	NA
PGEN_.00g302750	Scaffold_15	14303070	14315148	Q2PZL6	FAT4_MOUSE	Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
PGEN_.00g302760	Scaffold_15	14318187	14327240	Q8TDH9	BL1S5_HUMAN	Biogenesis of lysosome-related organelles complex 1 subunit 5 (BLOC-1 subunit 5) (Protein Muted homolog)	GO:0005623; GO:0008089; GO:0030133; GO:0031083; GO:0031175; GO:0032402; GO:0032438; GO:0035646; GO:0048490; GO:0050942; GO:1904115	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell [GO:0005623]; transport vesicle [GO:0030133]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosome to melanosome transport [GO:0035646]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; neuron projection development [GO:0031175]; positive regulation of pigment cell differentiation [GO:0050942]
PGEN_.00g302770	Scaffold_15	14348704	14360695	Q0PV50	TLR3_BOSTR	Toll-like receptor 3 (CD antigen CD283)	GO:0002756; GO:0003725; GO:0004888; GO:0005769; GO:0005789; GO:0006954; GO:0010008; GO:0016021; GO:0032722; GO:0034138; GO:0043330; GO:0045087; GO:0050729; GO:0051607	early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; double-stranded RNA binding [GO:0003725]; transmembrane signaling receptor activity [GO:0004888]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; positive regulation of chemokine production [GO:0032722]; positive regulation of inflammatory response [GO:0050729]; response to exogenous dsRNA [GO:0043330]; toll-like receptor 3 signaling pathway [GO:0034138]
PGEN_.00g302780	Scaffold_15	14394312	14417626	Q8BL74	TF3C2_MOUSE	General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta)	GO:0000127; GO:0005654; GO:0006383	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; transcription by RNA polymerase III [GO:0006383]
PGEN_.00g302790	Scaffold_15	14421986	14422279	NA	NA	NA	NA	NA
PGEN_.00g302800	Scaffold_15	14422347	14426797	NA	NA	NA	NA	NA
PGEN_.00g302810	Scaffold_15	14427338	14430866	Q96HR3	MED30_HUMAN	Mediator of RNA polymerase II transcription subunit 30 (Mediator complex subunit 30) (TRAP/Mediator complex component TRAP25) (Thyroid hormone receptor-associated protein 6) (Thyroid hormone receptor-associated protein complex 25 kDa component) (Trap25)	GO:0000151; GO:0003712; GO:0005634; GO:0005654; GO:0006367; GO:0016592; GO:0019827; GO:0030374; GO:0042809; GO:0045893; GO:0046966; GO:0061630	"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g302820	Scaffold_15	14437972	14445482	NA	NA	NA	NA	NA
PGEN_.00g302830	Scaffold_15	14445553	14454516	Q9BV90	SNR25_HUMAN	U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein)	GO:0000398; GO:0005634; GO:0005654; GO:0005689; GO:0005829; GO:0008380; GO:0045171	"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"
PGEN_.00g302840	Scaffold_15	14458046	14458366	Q3T058	EI2BD_BOVIN	Translation initiation factor eIF-2B subunit delta (eIF-2B GDP-GTP exchange factor subunit delta)	GO:0001541; GO:0003743; GO:0005737; GO:0005851; GO:0006413; GO:0014003; GO:0042552; GO:0050852	cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; translation initiation factor activity [GO:0003743]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]
PGEN_.00g302850	Scaffold_15	14460501	14462550	NA	NA	NA	NA	NA
PGEN_.00g302860	Scaffold_15	14475444	14494663	Q6NT16	S18B1_HUMAN	MFS-type transporter SLC18B1 (Solute carrier family 18 member B1)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g302870	Scaffold_15	14477659	14478042	NA	NA	NA	NA	NA
PGEN_.00g302880	Scaffold_15	14478247	14479008	NA	NA	NA	NA	NA
PGEN_.00g302890	Scaffold_15	14500080	14503094	NA	NA	NA	NA	NA
PGEN_.00g302900	Scaffold_15	14505239	14522668	Q6NT16	S18B1_HUMAN	MFS-type transporter SLC18B1 (Solute carrier family 18 member B1)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g302910	Scaffold_15	14523393	14524022	NA	NA	NA	NA	NA
PGEN_.00g302920	Scaffold_15	14524064	14524888	NA	NA	NA	NA	NA
PGEN_.00g302930	Scaffold_15	14531078	14532454	NA	NA	NA	NA	NA
PGEN_.00g302940	Scaffold_15	14533037	14533279	NA	NA	NA	NA	NA
PGEN_.00g302950	Scaffold_15	14538336	14555571	NA	NA	NA	NA	NA
PGEN_.00g302960	Scaffold_15	14642205	14647486	NA	NA	NA	NA	NA
PGEN_.00g302970	Scaffold_15	14707359	14711562	NA	NA	NA	NA	NA
PGEN_.00g302980	Scaffold_15	14719141	14720379	NA	NA	NA	NA	NA
PGEN_.00g302990	Scaffold_15	14743197	14743616	NA	NA	NA	NA	NA
PGEN_.00g303000	Scaffold_15	14772582	14778557	NA	NA	NA	NA	NA
PGEN_.00g303010	Scaffold_15	14782423	14787593	NA	NA	NA	NA	NA
PGEN_.00g303020	Scaffold_15	14792876	14796499	Q148M8	ABT1_BOVIN	Activator of basal transcription 1	GO:0000447; GO:0000472; GO:0000480; GO:0003677; GO:0003723; GO:0005667; GO:0005730; GO:0006357; GO:0021522; GO:0034462	"nucleolus [GO:0005730]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; regulation of transcription by RNA polymerase II [GO:0006357]; small-subunit processome assembly [GO:0034462]; spinal cord motor neuron differentiation [GO:0021522]"
PGEN_.00g303030	Scaffold_15	14803374	14803772	NA	NA	NA	NA	NA
PGEN_.00g303040	Scaffold_15	14804005	14819451	NA	NA	NA	NA	NA
PGEN_.00g303050	Scaffold_15	14820055	14831020	NA	NA	NA	NA	NA
PGEN_.00g303060	Scaffold_15	14826229	14829966	NA	NA	NA	NA	NA
PGEN_.00g303070	Scaffold_15	14836831	14852386	NA	NA	NA	NA	NA
PGEN_.00g303080	Scaffold_15	14852619	14853017	NA	NA	NA	NA	NA
PGEN_.00g303090	Scaffold_15	14868634	14870492	NA	NA	NA	NA	NA
PGEN_.00g303100	Scaffold_15	14877676	14883665	NA	NA	NA	NA	NA
PGEN_.00g303110	Scaffold_15	14891342	14892368	Q20681	BAT38_CAEEL	BTB and MATH domain-containing protein 38		
PGEN_.00g303120	Scaffold_15	14911047	14948949	P35601	RFC1_MOUSE	Replication factor C subunit 1 (A1-P145) (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (Differentiation-specific element-binding protein) (ISRE-binding protein) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit)	GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0005730; GO:0005737; GO:0006260; GO:0006281; GO:0019904; GO:0031391; GO:0032991; GO:0043565; GO:0045892; GO:0045893; GO:0061860; GO:0090618	"cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; DNA clamp unloading [GO:0090618]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g303130	Scaffold_15	14962045	14965632	NA	NA	NA	NA	NA
PGEN_.00g303140	Scaffold_15	14978104	14987040	NA	NA	NA	NA	NA
PGEN_.00g303150	Scaffold_15	14989388	14999194	Q07231	ZSC21_MOUSE	Zinc finger and SCAN domain-containing protein 21 (CtFIN51) (Transcription factor RU49) (Zinc finger protein 38) (Zfp-38)	GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0007283; GO:0045893; GO:0045944; GO:0046872; GO:0048477	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"
PGEN_.00g303160	Scaffold_15	15001374	15010712	A6NK53	ZN233_HUMAN	Zinc finger protein 233	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g303170	Scaffold_15	15015100	15018026	NA	NA	NA	NA	NA
PGEN_.00g303180	Scaffold_15	15019204	15026534	Q06730	ZN33A_HUMAN	Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g303190	Scaffold_15	15029363	15031461	Q9UJQ4	SALL4_HUMAN	Sal-like protein 4 (Zinc finger protein 797) (Zinc finger protein SALL4)	GO:0000122; GO:0000792; GO:0001833; GO:0001843; GO:0003281; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008134; GO:0030326; GO:0032991; GO:0035019; GO:0043231; GO:0045944; GO:0046872	"cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; embryonic limb morphogenesis [GO:0030326]; inner cell mass cell proliferation [GO:0001833]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; ventricular septum development [GO:0003281]"
PGEN_.00g303200	Scaffold_15	15256517	15276409	NA	NA	NA	NA	NA
PGEN_.00g303210	Scaffold_15	15279152	15328717	Q5G265	NETR_SAGLB	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005576; GO:0005886; GO:0006887; GO:0030424	axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]
PGEN_.00g303220	Scaffold_15	15332183	15339159	P0DPH7	TBA3C_HUMAN	Tubulin alpha-3C chain (Alpha-tubulin 2) (Alpha-tubulin 3C) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-3C chain]	GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g303230	Scaffold_15	15341188	15401281	NA	NA	NA	NA	NA
PGEN_.00g303240	Scaffold_15	15408399	15428557	Q66K08	CILP1_MOUSE	Cartilage intermediate layer protein 1 (CILP-1) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2]	GO:0005615; GO:0010629; GO:0043569; GO:0060392; GO:0062023; GO:0071560	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]
PGEN_.00g303250	Scaffold_15	15440486	15444009	NA	NA	NA	NA	NA
PGEN_.00g303260	Scaffold_15	15448020	15461613	Q8IUL8	CILP2_HUMAN	Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2]	GO:0016311; GO:0070062	extracellular exosome [GO:0070062]; dephosphorylation [GO:0016311]
PGEN_.00g303270	Scaffold_15	15520198	15540831	Q5XHX8	THEG_RAT	Testicular haploid expressed gene protein	GO:0005634; GO:0007275; GO:0007283; GO:0030154	nucleus [GO:0005634]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
PGEN_.00g303280	Scaffold_15	15551160	15566025	O00716	E2F3_HUMAN	Transcription factor E2F3 (E2F-3)	GO:0000122; GO:0000790; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006367; GO:0007049; GO:0008134; GO:0008284; GO:0043565; GO:0045944; GO:0046983; GO:0051726; GO:0070345; GO:0090575; GO:1905461	"nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; proximal promoter sequence-specific DNA binding [GO:0000987]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of cell cycle [GO:0051726]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
PGEN_.00g303290	Scaffold_15	15576715	15590445	Q6DEY1	SPF30_XENTR	Survival of motor neuron-related-splicing factor 30 (Survival motor neuron domain-containing protein 1)	GO:0003723; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0015030; GO:0016607	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
PGEN_.00g303300	Scaffold_15	15594099	15596225	Q96EL3	RM53_HUMAN	"39S ribosomal protein L53, mitochondrial (L53mt) (MRP-L53) (Mitochondrial large ribosomal subunit protein mL53)"	GO:0005739; GO:0005743; GO:0005762; GO:0070125; GO:0070126	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]
PGEN_.00g303310	Scaffold_15	15609166	15657415	P49760	CLK2_HUMAN	Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2)	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0032526; GO:0042802; GO:0043484; GO:0045721; GO:0046777	nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526]
PGEN_.00g303320	Scaffold_15	15661337	15661654	NA	NA	NA	NA	NA
PGEN_.00g303330	Scaffold_15	15661769	15663074	NA	NA	NA	NA	NA
PGEN_.00g303340	Scaffold_15	15675253	15696956	A0JPN2	S39A4_RAT	Zinc transporter ZIP4 (Solute carrier family 39 member 4) (Zrt- and Irt-like protein 4) (ZIP-4)	GO:0005385; GO:0005623; GO:0005768; GO:0005886; GO:0005887; GO:0006829; GO:0006882; GO:0007165; GO:0016324; GO:0031410; GO:0034224; GO:0055038; GO:0071578	apical plasma membrane [GO:0016324]; cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; zinc ion transmembrane transporter activity [GO:0005385]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829]
PGEN_.00g303350	Scaffold_15	15707279	15747260	Q6NV12	S20AA_DANRE	Sodium-dependent phosphate transporter 1-A (Solute carrier family 20 member 1-A)	GO:0005315; GO:0005887; GO:0015319; GO:0035435	integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; sodium:inorganic phosphate symporter activity [GO:0015319]; phosphate ion transmembrane transport [GO:0035435]
PGEN_.00g303360	Scaffold_15	15788464	15811402	NA	NA	NA	NA	NA
PGEN_.00g303370	Scaffold_15	15835973	15841338	NA	NA	NA	NA	NA
PGEN_.00g303380	Scaffold_15	15841445	15842059	NA	NA	NA	NA	NA
PGEN_.00g303390	Scaffold_15	15886824	15889798	NA	NA	NA	NA	NA
PGEN_.00g303400	Scaffold_15	15906339	15911141	NA	NA	NA	NA	NA
PGEN_.00g303410	Scaffold_15	15919047	15924227	NA	NA	NA	NA	NA
PGEN_.00g303420	Scaffold_15	15931201	15940322	Q26630	IDLC_STRPU	"33 kDa inner dynein arm light chain, axonemal (p33)"	GO:0003774; GO:0005737; GO:0005930; GO:0030175; GO:0030286; GO:0045504	axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]
PGEN_.00g303430	Scaffold_15	15940487	15954908	Q9CRD2	EMC2_MOUSE	ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35) (TPR repeat protein 35)	GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0072546	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
PGEN_.00g303440	Scaffold_15	15965722	15986741	A7GCK7	PSUG_CLOBL	Pseudouridine-5'-phosphate glycosidase (PsiMP glycosidase) (EC 4.2.1.70)	GO:0004730; GO:0016798; GO:0046113; GO:0046872	"hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridylate synthase activity [GO:0004730]; nucleobase catabolic process [GO:0046113]"
PGEN_.00g303450	Scaffold_15	15994381	16004310	Q90YV7	RL11_ICTPU	60S ribosomal protein L11	GO:0003735; GO:0005730; GO:0005737; GO:0005840; GO:0006412; GO:0019843; GO:0034504	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; protein localization to nucleus [GO:0034504]; translation [GO:0006412]
PGEN_.00g303460	Scaffold_15	16004442	16025265	Q96MC2	DRC1_HUMAN	Dynein regulatory complex protein 1 (Coiled-coil domain-containing protein 164)	GO:0003352; GO:0005858; GO:0005930; GO:0007368; GO:0007507; GO:0031514; GO:0060285; GO:0070286	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of cilium movement [GO:0003352]
PGEN_.00g303470	Scaffold_15	16060769	16066189	NA	NA	NA	NA	NA
PGEN_.00g303480	Scaffold_15	16094001	16102600	NA	NA	NA	NA	NA
PGEN_.00g303490	Scaffold_15	16204069	16206294	NA	NA	NA	NA	NA
PGEN_.00g303500	Scaffold_15	16210323	16215622	B2IZD3	BDLP_NOSP7	Bacterial dynamin-like protein (BDLP) (EC 3.6.5.5)	GO:0003924; GO:0005525; GO:0005886; GO:0008289; GO:0016021; GO:0042802	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]
PGEN_.00g303510	Scaffold_15	16298893	16309815	NA	NA	NA	NA	NA
PGEN_.00g303520	Scaffold_15	16368110	16368844	NA	NA	NA	NA	NA
PGEN_.00g303530	Scaffold_15	16739516	16740982	NA	NA	NA	NA	NA
PGEN_.00g303540	Scaffold_15	16787153	16788446	NA	NA	NA	NA	NA
PGEN_.00g303550	Scaffold_15	16929937	16931636	NA	NA	NA	NA	NA
PGEN_.00g303560	Scaffold_15	16947809	16949704	NA	NA	NA	NA	NA
PGEN_.00g303570	Scaffold_15	16953283	16953903	NA	NA	NA	NA	NA
PGEN_.00g303580	Scaffold_15	16953980	16954306	NA	NA	NA	NA	NA
PGEN_.00g303590	Scaffold_15	16996285	17083303	Q4H4B6	SCRIB_DANRE	Protein scribble homolog (Scribble1)	GO:0000132; GO:0001736; GO:0001764; GO:0001944; GO:0005623; GO:0005737; GO:0005886; GO:0005911; GO:0005913; GO:0008283; GO:0014021; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0030027; GO:0030054; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045202; GO:0045930; GO:0046982; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097120; GO:0097475; GO:0098609; GO:0098793; GO:0098887; GO:0098968	"basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neuron migration [GO:0001764]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; secondary neural tube formation [GO:0014021]; vasculature development [GO:0001944]"
PGEN_.00g303600	Scaffold_15	17088144	17088560	Q80TC5	POGK_MOUSE	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g303610	Scaffold_15	17088627	17089076	Q9P215	POGK_HUMAN	Pogo transposable element with KRAB domain	GO:0003677; GO:0005634; GO:0006355; GO:0007275	"nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g303620	Scaffold_15	17091291	17123036	Q14160	SCRIB_HUMAN	Protein scribble homolog (Scribble) (hScrib) (Protein LAP4)	GO:0001843; GO:0001921; GO:0005654; GO:0005886; GO:0005911; GO:0005913; GO:0008283; GO:0014069; GO:0016080; GO:0016323; GO:0016477; GO:0021747; GO:0030027; GO:0030054; GO:0034750; GO:0035089; GO:0035748; GO:0036342; GO:0039502; GO:0039563; GO:0039564; GO:0042060; GO:0043065; GO:0043113; GO:0043615; GO:0044291; GO:0045197; GO:0045202; GO:0045296; GO:0045930; GO:0048488; GO:0050918; GO:0060088; GO:0060561; GO:0060603; GO:0070062; GO:0071896; GO:0090630; GO:0097120; GO:0098609; GO:0098793; GO:0098887; GO:0098968; GO:0098978; GO:0099147; GO:0099149	"basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; myelin sheath abaxonal region [GO:0035748]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; Scrib-APC-beta-catenin complex [GO:0034750]; synapse [GO:0045202]; cadherin binding [GO:0045296]; activation of GTPase activity [GO:0090630]; apoptotic process involved in morphogenesis [GO:0060561]; astrocyte cell migration [GO:0043615]; auditory receptor cell stereocilium organization [GO:0060088]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cochlear nucleus development [GO:0021747]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube closure [GO:0001843]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; positive regulation of receptor recycling [GO:0001921]; post-anal tail morphogenesis [GO:0036342]; protein localization to adherens junction [GO:0071896]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; suppression by virus of host STAT1 activity [GO:0039563]; suppression by virus of host STAT2 activity [GO:0039564]; suppression by virus of host type I interferon-mediated signaling pathway [GO:0039502]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; wound healing [GO:0042060]"
PGEN_.00g303630	Scaffold_15	17128204	17129499	NA	NA	NA	NA	NA
PGEN_.00g303640	Scaffold_15	17130568	17138536	Q6ZSB9	ZBT49_HUMAN	Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509)	GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g303650	Scaffold_15	17147621	17169870	Q801S2	SDHAB_XENLA	"Succinate dehydrogenase [ubiquinone] flavoprotein subunit B, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II B) (Fp)"	GO:0005743; GO:0006099; GO:0008177; GO:0022900; GO:0050660	mitochondrial inner membrane [GO:0005743]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; electron transport chain [GO:0022900]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g303660	Scaffold_15	17174798	17184953	Q08AN1	ZN616_HUMAN	Zinc finger protein 616	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g303670	Scaffold_15	17195225	17199323	Q52KB5	ZBT24_DANRE	Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450)	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g303680	Scaffold_15	17224442	17227757	NA	NA	NA	NA	NA
PGEN_.00g303690	Scaffold_15	17253929	17254168	NA	NA	NA	NA	NA
PGEN_.00g303700	Scaffold_15	17260254	17266966	B2IZD3	BDLP_NOSP7	Bacterial dynamin-like protein (BDLP) (EC 3.6.5.5)	GO:0003924; GO:0005525; GO:0005886; GO:0008289; GO:0016021; GO:0042802	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]
PGEN_.00g303710	Scaffold_15	17318097	17318351	NA	NA	NA	NA	NA
PGEN_.00g303720	Scaffold_15	17323258	17331392	NA	NA	NA	NA	NA
PGEN_.00g303730	Scaffold_15	17332320	17332784	NA	NA	NA	NA	NA
PGEN_.00g303740	Scaffold_15	17332867	17334262	NA	NA	NA	NA	NA
PGEN_.00g303750	Scaffold_15	17338593	17339024	NA	NA	NA	NA	NA
PGEN_.00g303760	Scaffold_15	17348413	17349567	Q8R4G9	ACHA3_MOUSE	Neuronal acetylcholine receptor subunit alpha-3	GO:0005887; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007171; GO:0007268; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0008144; GO:0014056; GO:0014069; GO:0015464; GO:0016020; GO:0022848; GO:0030054; GO:0030425; GO:0034220; GO:0035094; GO:0035095; GO:0042166; GO:0042391; GO:0042493; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0045211; GO:0048814; GO:0050877; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098981; GO:0099060; GO:1904315; GO:1905144; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; ion transmembrane transport [GO:0034220]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to acetylcholine [GO:1905144]; response to drug [GO:0042493]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g303770	Scaffold_15	17388605	17390457	NA	NA	NA	NA	NA
PGEN_.00g303780	Scaffold_15	17398873	17402380	NA	NA	NA	NA	NA
PGEN_.00g303790	Scaffold_15	17402487	17403337	NA	NA	NA	NA	NA
PGEN_.00g303800	Scaffold_15	17462726	17463022	NA	NA	NA	NA	NA
PGEN_.00g303810	Scaffold_15	17467541	17469642	NA	NA	NA	NA	NA
PGEN_.00g303820	Scaffold_15	17495906	17515972	Q64409	CP3AH_CAVPO	Cytochrome P450 3A17 (EC 1.14.14.1) (CYPIIIA17)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g303830	Scaffold_15	17520048	17522914	O95490	AGRL2_HUMAN	Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1)	GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007420; GO:0016021; GO:0016524; GO:0030246; GO:0043005	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g303840	Scaffold_15	17534768	17546088	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g303850	Scaffold_15	17548298	17565561	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g303860	Scaffold_15	17665808	17666221	NA	NA	NA	NA	NA
PGEN_.00g303870	Scaffold_15	17702164	17703051	NA	NA	NA	NA	NA
PGEN_.00g303880	Scaffold_15	17748469	17750433	NA	NA	NA	NA	NA
PGEN_.00g303890	Scaffold_15	17779454	17781736	NA	NA	NA	NA	NA
PGEN_.00g303900	Scaffold_15	17839719	17840477	NA	NA	NA	NA	NA
PGEN_.00g303910	Scaffold_15	17840899	17841213	NA	NA	NA	NA	NA
PGEN_.00g303920	Scaffold_15	17880815	17881689	NA	NA	NA	NA	NA
PGEN_.00g303930	Scaffold_15	17883128	17883520	NA	NA	NA	NA	NA
PGEN_.00g303940	Scaffold_15	17893393	17895988	NA	NA	NA	NA	NA
PGEN_.00g303950	Scaffold_15	17899913	17904897	NA	NA	NA	NA	NA
PGEN_.00g303960	Scaffold_15	17912623	17919983	Q969G6	RIFK_HUMAN	Riboflavin kinase (EC 2.7.1.26) (ATP:riboflavin 5'-phosphotransferase) (Flavokinase)	GO:0005524; GO:0005737; GO:0005829; GO:0006771; GO:0006915; GO:0008531; GO:0009231; GO:0009398; GO:0033864; GO:0046872; GO:0072593	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531]; apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771]
PGEN_.00g303970	Scaffold_15	17928215	17933387	Q99715	COCA1_HUMAN	Collagen alpha-1(XII) chain	GO:0003429; GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0031012; GO:0035987; GO:0062023; GO:0070062; GO:1903561	collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g303980	Scaffold_15	17974031	17978762	O15232	MATN3_HUMAN	Matrilin-3	GO:0001501; GO:0003429; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0030198; GO:0031012; GO:0043687; GO:0044267; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; post-translational protein modification [GO:0043687]; skeletal system development [GO:0001501]
PGEN_.00g303990	Scaffold_15	17981127	17988757	NA	NA	NA	NA	NA
PGEN_.00g304000	Scaffold_15	17991760	17993167	NA	NA	NA	NA	NA
PGEN_.00g304010	Scaffold_15	18001928	18017927	NA	NA	NA	NA	NA
PGEN_.00g304020	Scaffold_15	18018002	18019144	P28286	5HT2B_DROME	5-hydroxytryptamine receptor 2B (5-HT receptor 2B) (5-hydroxytryptamine receptor 1B) (5-HT receptor 1B) (Serotonin receptor 1B) (Serotonin receptor 2B)	GO:0001586; GO:0004930; GO:0004993; GO:0005887; GO:0007187; GO:0007198; GO:0007208; GO:0007210; GO:0007268; GO:0008227; GO:0009649; GO:0016021; GO:0030425; GO:0030594; GO:0045202	"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; entrainment of circadian clock [GO:0009649]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; serotonin receptor signaling pathway [GO:0007210]"
PGEN_.00g304030	Scaffold_15	18025262	18026554	P28286	5HT2B_DROME	5-hydroxytryptamine receptor 2B (5-HT receptor 2B) (5-hydroxytryptamine receptor 1B) (5-HT receptor 1B) (Serotonin receptor 1B) (Serotonin receptor 2B)	GO:0001586; GO:0004930; GO:0004993; GO:0005887; GO:0007187; GO:0007198; GO:0007208; GO:0007210; GO:0007268; GO:0008227; GO:0009649; GO:0016021; GO:0030425; GO:0030594; GO:0045202	"dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; entrainment of circadian clock [GO:0009649]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; serotonin receptor signaling pathway [GO:0007210]"
PGEN_.00g304040	Scaffold_15	18044737	18048997	Q2VWH6	FEZF2_BOVIN	Fez family zinc finger protein 2 (Forebrain embryonic zinc finger-like protein 2) (Zinc finger protein 312) (Zinc finger protein Fez-like)	GO:0003677; GO:0005634; GO:0007399; GO:0030154; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g304050	Scaffold_15	18052373	18061911	Q14590	ZN235_HUMAN	Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g304060	Scaffold_15	18068323	18068736	Q6IQ21	ZN770_HUMAN	Zinc finger protein 770	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g304070	Scaffold_15	18072359	18090509	Q8TF20	ZN721_HUMAN	Zinc finger protein 721	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g304080	Scaffold_15	18091956	18092291	B0X9H6	KEN1_CULQU	Transcription factor Ken 1	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0030539; GO:0030540; GO:0045496; GO:0045497; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; female analia development [GO:0045497]; female genitalia development [GO:0030540]; male analia development [GO:0045496]; male genitalia development [GO:0030539]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g304090	Scaffold_15	18097981	18101074	Q14588	ZN234_HUMAN	Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g304100	Scaffold_15	18102336	18105156	Q6GQR8	ZN329_MOUSE	Zinc finger protein 329	GO:0003700; GO:0005634; GO:0043565; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]
PGEN_.00g304110	Scaffold_15	18110113	18111850	Q0VGE8	ZN816_HUMAN	Zinc finger protein 816	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g304120	Scaffold_15	18116600	18133970	Q5R5U3	ZN271_PONAB	Zinc finger protein 271	GO:0000976; GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]
PGEN_.00g304130	Scaffold_15	18140863	18141129	P39770	SALM_DROME	Homeotic protein spalt-major	GO:0000381; GO:0001751; GO:0003677; GO:0005634; GO:0006355; GO:0007423; GO:0007424; GO:0007427; GO:0007438; GO:0007525; GO:0007605; GO:0008584; GO:0008586; GO:0021782; GO:0030539; GO:0035155; GO:0035202; GO:0035277; GO:0035310; GO:0042659; GO:0045465; GO:0045466; GO:0046872; GO:0048098; GO:0048644	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; antennal joint development [GO:0048098]; compound eye photoreceptor cell differentiation [GO:0001751]; epithelial cell migration, open tracheal system [GO:0007427]; glial cell development [GO:0021782]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; muscle organ morphogenesis [GO:0048644]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; notum cell fate specification [GO:0035310]; oenocyte development [GO:0007438]; open tracheal system development [GO:0007424]; R7 cell differentiation [GO:0045466]; R8 cell differentiation [GO:0045465]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell fate specification [GO:0042659]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; somatic muscle development [GO:0007525]; spiracle morphogenesis, open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]"
PGEN_.00g304140	Scaffold_15	18143276	18143509	Q03923	ZNF85_HUMAN	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0046872	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]
PGEN_.00g304150	Scaffold_15	18145335	18145625	Q60636	PRDM1_MOUSE	PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1)	GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001701; GO:0001763; GO:0001892; GO:0001893; GO:0002250; GO:0003170; GO:0003279; GO:0003281; GO:0003700; GO:0005634; GO:0005737; GO:0007281; GO:0008168; GO:0009791; GO:0010628; GO:0010629; GO:0030889; GO:0031490; GO:0031665; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0045579; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990841	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]"
PGEN_.00g304160	Scaffold_15	18149307	18149657	Q14590	ZN235_HUMAN	Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g304170	Scaffold_15	18153244	18175524	Q9NSC2	SALL1_HUMAN	Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1) (HSal1) (Sal-1)	GO:0000122; GO:0000792; GO:0000978; GO:0001227; GO:0001657; GO:0001658; GO:0001822; GO:0003281; GO:0003337; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007507; GO:0008013; GO:0008406; GO:0010369; GO:0021553; GO:0021889; GO:0021983; GO:0030177; GO:0030325; GO:0031129; GO:0035019; GO:0042473; GO:0042733; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048566; GO:0060173; GO:0061034; GO:0072073; GO:0072092	"chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; gonad development [GO:0008406]; heart development [GO:0007507]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; outer ear morphogenesis [GO:0042473]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]"
PGEN_.00g304180	Scaffold_15	18234647	18238412	NA	NA	NA	NA	NA
PGEN_.00g304190	Scaffold_15	18257752	18274843	P11024	NNTM_BOVIN	"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	GO:0005739; GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]
PGEN_.00g304200	Scaffold_15	18280789	18295119	Q04467	IDHP_BOVIN	"Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)"	GO:0000287; GO:0004450; GO:0005739; GO:0005743; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0051287	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g304210	Scaffold_15	18305704	18320037	NA	NA	NA	NA	NA
PGEN_.00g304220	Scaffold_15	18321585	18322384	A7SCH8	KYNU_NEMVE	Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase)	GO:0005737; GO:0019441; GO:0019805; GO:0030170; GO:0030429; GO:0034354; GO:0043420; GO:0097053	cytoplasm [GO:0005737]; kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process to kynurenine [GO:0019441]
PGEN_.00g304230	Scaffold_15	18322399	18328696	NA	NA	NA	NA	NA
PGEN_.00g304240	Scaffold_15	18340611	18341168	NA	NA	NA	NA	NA
PGEN_.00g304250	Scaffold_15	18341336	18341860	NA	NA	NA	NA	NA
PGEN_.00g304260	Scaffold_15	18342004	18342573	NA	NA	NA	NA	NA
PGEN_.00g304270	Scaffold_15	18342718	18343317	NA	NA	NA	NA	NA
PGEN_.00g304280	Scaffold_15	18344966	18353794	NA	NA	NA	NA	NA
PGEN_.00g304290	Scaffold_15	18369462	18379778	Q96KG7	MEG10_HUMAN	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g304300	Scaffold_15	18380949	18381584	NA	NA	NA	NA	NA
PGEN_.00g304310	Scaffold_15	18382443	18382748	NA	NA	NA	NA	NA
PGEN_.00g304320	Scaffold_15	18386077	18483416	Q6DIB5	MEG10_MOUSE	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g304330	Scaffold_15	18505420	18553825	NA	NA	NA	NA	NA
PGEN_.00g304340	Scaffold_15	18581985	18582332	NA	NA	NA	NA	NA
PGEN_.00g304350	Scaffold_15	18598168	18605629	NA	NA	NA	NA	NA
PGEN_.00g304360	Scaffold_15	18613331	18620497	Q7Z408	CSMD2_HUMAN	CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2)	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g304370	Scaffold_15	18626173	18626757	NA	NA	NA	NA	NA
PGEN_.00g304380	Scaffold_15	18664526	18664960	NA	NA	NA	NA	NA
PGEN_.00g304390	Scaffold_15	18702900	18703559	Q5UP39	YR873_MIMIV	Putative ankyrin repeat protein R873		
PGEN_.00g304400	Scaffold_15	18703598	18705879	Q5UQJ2	YR863_MIMIV	Putative ankyrin repeat protein R863		
PGEN_.00g304410	Scaffold_15	18725675	18725908	NA	NA	NA	NA	NA
PGEN_.00g304420	Scaffold_15	18726133	18728663	NA	NA	NA	NA	NA
PGEN_.00g304430	Scaffold_15	18754065	18754355	NA	NA	NA	NA	NA
PGEN_.00g304440	Scaffold_15	18754402	18754758	NA	NA	NA	NA	NA
PGEN_.00g304450	Scaffold_15	18755121	18761590	NA	NA	NA	NA	NA
PGEN_.00g304460	Scaffold_15	18764870	18765868	NA	NA	NA	NA	NA
PGEN_.00g304470	Scaffold_15	18776962	18777183	NA	NA	NA	NA	NA
PGEN_.00g304480	Scaffold_15	18777385	18777678	NA	NA	NA	NA	NA
PGEN_.00g304490	Scaffold_15	18778364	18784488	NA	NA	NA	NA	NA
PGEN_.00g304500	Scaffold_15	18795138	18795434	NA	NA	NA	NA	NA
PGEN_.00g304510	Scaffold_15	18795679	18795945	NA	NA	NA	NA	NA
PGEN_.00g304520	Scaffold_15	18825166	18825528	NA	NA	NA	NA	NA
PGEN_.00g304530	Scaffold_15	18859969	18860226	NA	NA	NA	NA	NA
PGEN_.00g304540	Scaffold_15	18913220	18914813	NA	NA	NA	NA	NA
PGEN_.00g304550	Scaffold_15	18917888	18926817	Q92058	PPBT_CHICK	"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1)"	GO:0004035; GO:0005886; GO:0031225; GO:0046872; GO:0065010	anchored component of membrane [GO:0031225]; extracellular membrane-bounded organelle [GO:0065010]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]
PGEN_.00g304560	Scaffold_15	18933082	18940150	Q8IUN9	CLC10_HUMAN	C-type lectin domain family 10 member A (C-type lectin superfamily member 14) (Macrophage lectin 2) (CD antigen CD301)	GO:0002223; GO:0002250; GO:0005886; GO:0006897; GO:0016021; GO:0030246; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]
PGEN_.00g304570	Scaffold_15	18945995	18955867	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g304580	Scaffold_15	18961968	18971484	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g304590	Scaffold_15	18971546	18971881	NA	NA	NA	NA	NA
PGEN_.00g304600	Scaffold_15	18971918	18972545	NA	NA	NA	NA	NA
PGEN_.00g304610	Scaffold_15	18972669	18973022	NA	NA	NA	NA	NA
PGEN_.00g304620	Scaffold_15	18973737	18974231	NA	NA	NA	NA	NA
PGEN_.00g304630	Scaffold_15	18974295	18974645	NA	NA	NA	NA	NA
PGEN_.00g304640	Scaffold_15	18986469	18993212	P13608	PGCA_BOVIN	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g304650	Scaffold_15	18997412	18997825	NA	NA	NA	NA	NA
PGEN_.00g304660	Scaffold_15	19045660	19066261	NA	NA	NA	NA	NA
PGEN_.00g304670	Scaffold_15	19074708	19075618	NA	NA	NA	NA	NA
PGEN_.00g304680	Scaffold_15	19077932	19095127	NA	NA	NA	NA	NA
PGEN_.00g304690	Scaffold_15	19105283	19109639	NA	NA	NA	NA	NA
PGEN_.00g304700	Scaffold_15	19169183	19180521	NA	NA	NA	NA	NA
PGEN_.00g304710	Scaffold_15	19181755	19199258	NA	NA	NA	NA	NA
PGEN_.00g304720	Scaffold_15	19205506	19221657	F7E235	FAXC_XENTR	Failed axon connections homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g304730	Scaffold_15	19229369	19286968	NA	NA	NA	NA	NA
PGEN_.00g304740	Scaffold_15	19294713	19307190	Q8N8K9	K1958_HUMAN	Uncharacterized protein KIAA1958		
PGEN_.00g304750	Scaffold_15	19311546	19312340	NA	NA	NA	NA	NA
PGEN_.00g304760	Scaffold_15	19322881	19326682	NA	NA	NA	NA	NA
PGEN_.00g304770	Scaffold_15	19329302	19329628	NA	NA	NA	NA	NA
PGEN_.00g304780	Scaffold_15	19333119	19361961	Q6ZNA1	ZN836_HUMAN	Zinc finger protein 836	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g304790	Scaffold_15	19370614	19371096	Q6ZSB9	ZBT49_HUMAN	Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509)	GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g304800	Scaffold_15	19374168	19378574	Q9NPA5	NA	NA	NA	NA
PGEN_.00g304810	Scaffold_15	19397403	19419445	NA	NA	NA	NA	NA
PGEN_.00g304820	Scaffold_15	19430362	19432083	P02718	ACHD_TETCF	Acetylcholine receptor subunit delta	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g304830	Scaffold_15	19460681	19462631	NA	NA	NA	NA	NA
PGEN_.00g304840	Scaffold_15	19465487	19465762	NA	NA	NA	NA	NA
PGEN_.00g304850	Scaffold_15	19468171	19496349	Q66S37	MBL2_CHLAE	Mannose-binding protein C (MBP-C) (MBP1) (Mannan-binding protein) (Mannose-binding lectin)	GO:0001867; GO:0005537; GO:0005576; GO:0005581; GO:0006958	"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; mannose binding [GO:0005537]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]"
PGEN_.00g304860	Scaffold_15	19502679	19519156	NA	NA	NA	NA	NA
PGEN_.00g304870	Scaffold_15	19564086	19564343	NA	NA	NA	NA	NA
PGEN_.00g304880	Scaffold_15	19624840	19626027	NA	NA	NA	NA	NA
PGEN_.00g304890	Scaffold_15	19663844	19664077	NA	NA	NA	NA	NA
PGEN_.00g304900	Scaffold_15	19671152	19682524	NA	NA	NA	NA	NA
PGEN_.00g304910	Scaffold_15	19690149	19692759	NA	NA	NA	NA	NA
PGEN_.00g304920	Scaffold_15	19709067	19710275	NA	NA	NA	NA	NA
PGEN_.00g304930	Scaffold_15	19710386	19714375	NA	NA	NA	NA	NA
PGEN_.00g304940	Scaffold_15	19748509	19754594	NA	NA	NA	NA	NA
PGEN_.00g304950	Scaffold_15	19796542	19803822	NA	NA	NA	NA	NA
PGEN_.00g304960	Scaffold_15	19803988	19839080	Q9VQX4	PNCB_DROME	Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)	GO:0004514; GO:0004516; GO:0005829; GO:0006979; GO:0009435; GO:0034355; GO:0046872	cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]
PGEN_.00g304970	Scaffold_15	19841457	19849321	D2GZW6	VRTN_AILME	Vertnin	GO:0004803; GO:0006313; GO:0043565	"sequence-specific DNA binding [GO:0043565]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g304980	Scaffold_15	19850419	19865810	Q8RWM2	NPRT1_ARATH	Nicotinate phosphoribosyltransferase 1 (NAPRTase) (EC 6.3.4.21)	GO:0004514; GO:0004516; GO:0005829; GO:0009435; GO:0034355; GO:0046872	cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]
PGEN_.00g304990	Scaffold_15	19882790	19884880	NA	NA	NA	NA	NA
PGEN_.00g305000	Scaffold_15	19913458	19913967	NA	NA	NA	NA	NA
PGEN_.00g305010	Scaffold_15	19948754	19954438	Q4KLM5	ABT1_RAT	Activator of basal transcription 1	GO:0000447; GO:0000472; GO:0000480; GO:0003677; GO:0003723; GO:0005667; GO:0005730; GO:0006357; GO:0021522; GO:0034462	"nucleolus [GO:0005730]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; regulation of transcription by RNA polymerase II [GO:0006357]; small-subunit processome assembly [GO:0034462]; spinal cord motor neuron differentiation [GO:0021522]"
PGEN_.00g305020	Scaffold_15	19961124	19967087	NA	NA	NA	NA	NA
PGEN_.00g305030	Scaffold_15	19975505	20023107	NA	NA	NA	NA	NA
PGEN_.00g305040	Scaffold_15	20064010	20065428	NA	NA	NA	NA	NA
PGEN_.00g305050	Scaffold_15	20065569	20077017	NA	NA	NA	NA	NA
PGEN_.00g305060	Scaffold_15	20092819	20093019	NA	NA	NA	NA	NA
PGEN_.00g305070	Scaffold_15	20093203	20095625	NA	NA	NA	NA	NA
PGEN_.00g305080	Scaffold_15	20104887	20105570	NA	NA	NA	NA	NA
PGEN_.00g305090	Scaffold_15	20122419	20122685	NA	NA	NA	NA	NA
PGEN_.00g305100	Scaffold_15	20122753	20123100	NA	NA	NA	NA	NA
PGEN_.00g305110	Scaffold_15	20225669	20226692	NA	NA	NA	NA	NA
PGEN_.00g305120	Scaffold_15	20252610	20252957	NA	NA	NA	NA	NA
PGEN_.00g305130	Scaffold_15	20253018	20253491	NA	NA	NA	NA	NA
PGEN_.00g305140	Scaffold_15	20253816	20255036	NA	NA	NA	NA	NA
PGEN_.00g305150	Scaffold_15	20255183	20255614	NA	NA	NA	NA	NA
PGEN_.00g305160	Scaffold_15	20271092	20272661	Q7L1S5	CHST9_HUMAN	Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)	GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446	extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g305170	Scaffold_15	20302002	20352536	NA	NA	NA	NA	NA
PGEN_.00g305180	Scaffold_15	20440115	20498292	Q9Y5Q5	CORIN_HUMAN	"Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Heart-specific serine proteinase ATC2) (Pro-ANP-converting enzyme) (Transmembrane protease serine 10) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment]"	GO:0003050; GO:0004252; GO:0005576; GO:0005886; GO:0005887; GO:0007565; GO:0008217; GO:0009986; GO:0015629; GO:0016021; GO:0016486; GO:0016604; GO:0035813; GO:1903779	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]
PGEN_.00g305190	Scaffold_15	20498642	20510471	B3EWZ6	MLRP2_ACRMI	MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g305200	Scaffold_15	20520348	20527179	Q9LPV5	NRT25_ARATH	High affinity nitrate transporter 2.5 (AtNRT2:5)	GO:0005886; GO:0009705; GO:0015112; GO:0015706; GO:0016021; GO:0042128; GO:0071249	integral component of membrane [GO:0016021]; plant-type vacuole membrane [GO:0009705]; plasma membrane [GO:0005886]; nitrate transmembrane transporter activity [GO:0015112]; cellular response to nitrate [GO:0071249]; nitrate assimilation [GO:0042128]; nitrate transport [GO:0015706]
PGEN_.00g305210	Scaffold_15	20560205	20567379	P58545	BTBD3_MOUSE	BTB/POZ domain-containing protein 3	GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0048813	cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]
PGEN_.00g305220	Scaffold_15	20683212	20731935	P33450	FAT_DROME	Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]	GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016021; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0017022; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045198; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090176; GO:0090251; GO:0098609	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g305230	Scaffold_15	20747713	20766760	Q5RID7	SNX17_DANRE	Sorting nexin-17	GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0030659; GO:0031410; GO:0035091; GO:1990126	"cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165]"
PGEN_.00g305240	Scaffold_15	20769256	20774120	P18258	TBA1_PARLI	Tubulin alpha-1 chain	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g305250	Scaffold_15	20834208	20844551	NA	NA	NA	NA	NA
PGEN_.00g305260	Scaffold_15	20860833	20861354	NA	NA	NA	NA	NA
PGEN_.00g305270	Scaffold_15	20866833	20867126	NA	NA	NA	NA	NA
PGEN_.00g305280	Scaffold_15	20867253	20867714	NA	NA	NA	NA	NA
PGEN_.00g305290	Scaffold_15	20867793	20881664	NA	NA	NA	NA	NA
PGEN_.00g305300	Scaffold_15	20883767	20894227	NA	NA	NA	NA	NA
PGEN_.00g305310	Scaffold_15	20907972	20908775	NA	NA	NA	NA	NA
PGEN_.00g305320	Scaffold_15	20914590	20915768	NA	NA	NA	NA	NA
PGEN_.00g305330	Scaffold_15	20921243	20933796	Q3V188	ENDOU_MOUSE	Poly(U)-specific endoribonuclease (EC 3.1.-.-) (Placental protein 11-related protein) (PP11-related protein) (Protein endoU) (T-cell-specific protein 30) (Tcl-30) (Uridylate-specific endoribonuclease)	GO:0003723; GO:0004521; GO:0005044; GO:0005576; GO:0005737; GO:0006508; GO:0006955; GO:0007565; GO:0008236; GO:0030247; GO:0046872	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; serine-type peptidase activity [GO:0008236]; female pregnancy [GO:0007565]; immune response [GO:0006955]; proteolysis [GO:0006508]
PGEN_.00g305340	Scaffold_15	20952202	20955292	NA	NA	NA	NA	NA
PGEN_.00g305350	Scaffold_15	21012028	21047260	Q7K237	C1GLT_DROME	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	GO:0006486; GO:0007528; GO:0009247; GO:0016021; GO:0016263; GO:0016267; GO:0021551; GO:0046872; GO:0048531; GO:0051489; GO:0055001; GO:1902037	"integral component of membrane [GO:0016021]; beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; O-glycan processing, core 1 [GO:0016267]; protein glycosylation [GO:0006486]; regulation of filopodium assembly [GO:0051489]"
PGEN_.00g305360	Scaffold_15	21048461	21053343	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g305370	Scaffold_15	21060510	21065278	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g305380	Scaffold_15	21085291	21089041	NA	NA	NA	NA	NA
PGEN_.00g305390	Scaffold_15	21096923	21112329	Q5NVS6	MIC27_PONAB	MICOS complex subunit MIC27 (Apolipoprotein O-like) (Protein FAM121A)	GO:0042407; GO:0061617	MICOS complex [GO:0061617]; cristae formation [GO:0042407]
PGEN_.00g305400	Scaffold_15	21124945	21141025	Q6A4L1	S12A8_XENLA	Solute carrier family 12 member 8	GO:0006813; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; potassium ion transport [GO:0006813]
PGEN_.00g305410	Scaffold_15	21213864	21216871	NA	NA	NA	NA	NA
PGEN_.00g305420	Scaffold_15	21233419	21264266	NA	NA	NA	NA	NA
PGEN_.00g305430	Scaffold_15	21288791	21291846	P29176	FOSX_MSVFR	Transforming protein v-Fos/v-Fox	GO:0003677; GO:0003700; GO:0005667; GO:0006357; GO:0042025	host cell nucleus [GO:0042025]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g305440	Scaffold_15	21302795	21324809	Q9BUJ2	HNRL1_HUMAN	Heterogeneous nuclear ribonucleoprotein U-like protein 1 (Adenovirus early region 1B-associated protein 5) (E1B-55 kDa-associated protein 5) (E1B-AP5)	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA processing [GO:0006396]"
PGEN_.00g305450	Scaffold_15	21338775	21355796	Q9R013	CATF_MOUSE	Cathepsin F (EC 3.4.22.41)	GO:0004197; GO:0005615; GO:0005764; GO:0008234; GO:0051603	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g305460	Scaffold_15	21362061	21368068	NA	NA	NA	NA	NA
PGEN_.00g305470	Scaffold_15	21404969	21414899	P25490	TYY1_HUMAN	Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1)	GO:0000122; GO:0000400; GO:0000724; GO:0000790; GO:0000978; GO:0000987; GO:0001158; GO:0001227; GO:0003677; GO:0003700; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010467; GO:0010629; GO:0016363; GO:0016579; GO:0030154; GO:0031011; GO:0031519; GO:0032688; GO:0034644; GO:0034696; GO:0043565; GO:0044212; GO:0045944; GO:0046332; GO:0048593; GO:0051276; GO:0061052; GO:0071347; GO:1902894; GO:1990841; GO:1990904	"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; ribonucleoprotein complex [GO:1990904]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; promoter-specific chromatin binding [GO:1990841]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; gene expression [GO:0010467]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]"
PGEN_.00g305480	Scaffold_15	21415095	21432086	Q3ZBY7	DEGS1_BOVIN	Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Degenerative spermatocyte homolog 1)	GO:0005789; GO:0006633; GO:0016021; GO:0031966; GO:0042284; GO:0043217; GO:0046513	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; sphingolipid delta-4 desaturase activity [GO:0042284]; ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; myelin maintenance [GO:0043217]
PGEN_.00g305490	Scaffold_15	21442403	21443656	NA	NA	NA	NA	NA
PGEN_.00g305500	Scaffold_15	21455703	21465089	P04352	CALM_CHLRE	Calmodulin (CaM)	GO:0005509; GO:0005737; GO:0005856; GO:0019722; GO:0031514	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g305510	Scaffold_15	21477602	21477811	NA	NA	NA	NA	NA
PGEN_.00g305520	Scaffold_15	21489330	21491860	NA	NA	NA	NA	NA
PGEN_.00g305530	Scaffold_15	21493425	21494318	NA	NA	NA	NA	NA
PGEN_.00g305540	Scaffold_15	21514494	21544795	P35953	VLDLR_RABIT	Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R)	GO:0005509; GO:0005905; GO:0006869; GO:0006898; GO:0008203; GO:0016021; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038025; GO:0043235; GO:0045860; GO:0048306; GO:0048813; GO:1900006	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]
PGEN_.00g305550	Scaffold_15	21578408	21585748	Q95218	DMBT1_RABIT	Deleted in malignant brain tumors 1 protein (Hensin)	GO:0005044; GO:0005576; GO:0007275; GO:0015031; GO:0019898; GO:0030154; GO:0035375; GO:0042589; GO:0050829; GO:0050830	extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; zymogen granule membrane [GO:0042589]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]
PGEN_.00g305560	Scaffold_15	21624555	21665788	Q2VLH6	C163A_MOUSE	Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)]	GO:0005044; GO:0005576; GO:0005886; GO:0006953; GO:0009897; GO:0016021	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953]
PGEN_.00g305570	Scaffold_15	21666659	21667141	NA	NA	NA	NA	NA
PGEN_.00g305580	Scaffold_15	21669645	21680195	NA	NA	NA	NA	NA
PGEN_.00g305590	Scaffold_15	21676215	21676580	NA	NA	NA	NA	NA
PGEN_.00g305600	Scaffold_15	21682348	21690312	NA	NA	NA	NA	NA
PGEN_.00g305610	Scaffold_15	21690395	21701215	NA	NA	NA	NA	NA
PGEN_.00g305620	Scaffold_15	21713165	21715148	NA	NA	NA	NA	NA
PGEN_.00g305630	Scaffold_15	21716494	21717961	NA	NA	NA	NA	NA
PGEN_.00g305640	Scaffold_15	21730442	21754468	Q9N1E5	CD22_PANPA	B-cell receptor CD22 (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (CD antigen CD22) (Fragment)	GO:0005886; GO:0007155; GO:0030246	plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155]
PGEN_.00g305650	Scaffold_15	21761825	21766265	NA	NA	NA	NA	NA
PGEN_.00g305660	Scaffold_15	21812117	21815286	NA	NA	NA	NA	NA
PGEN_.00g305670	Scaffold_15	21822514	21851233	O60645	EXOC3_HUMAN	Exocyst complex component 3 (Exocyst complex component Sec6)	GO:0000145; GO:0000149; GO:0005794; GO:0005829; GO:0006887; GO:0015031; GO:0030426; GO:0030496; GO:0030667; GO:0042734; GO:0045296; GO:0048471; GO:0051601	cytosol [GO:0005829]; exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667]; cadherin binding [GO:0045296]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; protein transport [GO:0015031]
PGEN_.00g305680	Scaffold_15	21853239	21888214	O88873	GMEB2_RAT	Glucocorticoid modulatory element-binding protein 2 (GMEB-2)	GO:0000978; GO:0000981; GO:0001228; GO:0003713; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0046872	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g305690	Scaffold_15	21903025	21927407	NA	NA	NA	NA	NA
PGEN_.00g305700	Scaffold_15	21939292	21939798	NA	NA	NA	NA	NA
PGEN_.00g305710	Scaffold_15	21940269	21944631	NA	NA	NA	NA	NA
PGEN_.00g305720	Scaffold_15	21952205	21954623	NA	NA	NA	NA	NA
PGEN_.00g305730	Scaffold_15	21954669	21955022	NA	NA	NA	NA	NA
PGEN_.00g305740	Scaffold_15	21955087	21955641	NA	NA	NA	NA	NA
PGEN_.00g305750	Scaffold_15	21965545	21972449	NA	NA	NA	NA	NA
PGEN_.00g305760	Scaffold_15	21983654	21986487	NA	NA	NA	NA	NA
PGEN_.00g305770	Scaffold_15	22003164	22008709	NA	NA	NA	NA	NA
PGEN_.00g305780	Scaffold_15	22014825	22024756	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g305790	Scaffold_15	22059191	22071121	NA	NA	NA	NA	NA
PGEN_.00g305800	Scaffold_15	22080769	22086945	Q6P268	PDCL3_DANRE	Phosducin-like protein 3 (Viral IAP-associated factor 1 homolog)	GO:0001525; GO:0005737; GO:0005783; GO:0006915; GO:0010628; GO:0048471	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; positive regulation of gene expression [GO:0010628]
PGEN_.00g305810	Scaffold_15	22096728	22102466	Q3SZM6	COXM1_BOVIN	COX assembly mitochondrial protein homolog (Cmc1p)	GO:0005739; GO:0046872	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]
PGEN_.00g305820	Scaffold_15	22104910	22106335	NA	NA	NA	NA	NA
PGEN_.00g305830	Scaffold_15	22131863	22132111	NA	NA	NA	NA	NA
PGEN_.00g305840	Scaffold_15	22135786	22140644	NA	NA	NA	NA	NA
PGEN_.00g305850	Scaffold_15	22144997	22145698	P08021	FMRF_APLCA	FMRF-amide neuropeptides [Cleaved into: FLRF-amide; FMRF-amide]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g305860	Scaffold_15	22152245	22154626	P08953	TOLL_DROME	Protein toll	GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]
PGEN_.00g305870	Scaffold_15	22166108	22172588	NA	NA	NA	NA	NA
PGEN_.00g305880	Scaffold_15	22174402	22180730	NA	NA	NA	NA	NA
PGEN_.00g305890	Scaffold_15	22266772	22292041	Q8N323	NXPE1_HUMAN	NXPE family member 1 (Protein FAM55A)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g305900	Scaffold_15	22326833	22327045	NA	NA	NA	NA	NA
PGEN_.00g305910	Scaffold_15	22350610	22352753	P07898	PGCA_CHICK	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g305920	Scaffold_15	22361357	22372021	Q28008	CLC3A_BOVIN	C-type lectin domain family 3 member A (C-type lectin superfamily member 1) (Cartilage-derived C-type lectin)	GO:0001503; GO:0005615; GO:0030246	extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; ossification [GO:0001503]
PGEN_.00g305930	Scaffold_15	22381493	22382848	NA	NA	NA	NA	NA
PGEN_.00g305940	Scaffold_15	22386383	22403005	NA	NA	NA	NA	NA
PGEN_.00g305950	Scaffold_15	22414331	22435708	Q9UJW7	ZN229_HUMAN	Zinc finger protein 229	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g305960	Scaffold_15	22459639	22467111	Q13637	RAB32_HUMAN	Ras-related protein Rab-32	GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005769; GO:0005783; GO:0005802; GO:0005829; GO:0006886; GO:0007005; GO:0016020; GO:0016192; GO:0019882; GO:0030670; GO:0030742; GO:0032482; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0072657; GO:0090382; GO:1903232	cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192]
PGEN_.00g305970	Scaffold_15	22485979	22489865	Q8C0R9	LRRD1_MOUSE	Leucine-rich repeat and death domain-containing protein 1		
PGEN_.00g305980	Scaffold_15	22495986	22500046	Q9NQZ8	ZNF71_HUMAN	Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g305990	Scaffold_15	22519721	22520122	NA	NA	NA	NA	NA
PGEN_.00g306000	Scaffold_15	22539106	22542891	Q5RCA6	CLVS1_PONAB	Clavesin-1 (Retinaldehyde-binding protein 1-like 1)	GO:0005768; GO:0005802; GO:0007040; GO:0030136; GO:0031901; GO:0080025	"clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; lysosome organization [GO:0007040]"
PGEN_.00g306010	Scaffold_15	22546869	22557028	Q5ZIN2	SEN2_CHICK	tRNA-splicing endonuclease subunit Sen2 (EC 4.6.1.16) (tRNA-intron endonuclease Sen2)	GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0006397; GO:0016829	tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA-type intron splice site recognition and cleavage [GO:0000379]
PGEN_.00g306020	Scaffold_15	22559452	22559754	NA	NA	NA	NA	NA
PGEN_.00g306030	Scaffold_15	22570243	22604542	P62288	ASPM_FELCA	Abnormal spindle-like microcephaly-associated protein homolog (Fragment)	GO:0005516; GO:0005634; GO:0005737; GO:0005819; GO:0007051; GO:0043565; GO:0045944; GO:0051301	cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; sequence-specific DNA binding [GO:0043565]; cell division [GO:0051301]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spindle organization [GO:0007051]
PGEN_.00g306040	Scaffold_15	22604988	22605898	Q8ILR9	YPF17_PLAF7	Protein PF14_0175	GO:0003677; GO:0016021	integral component of membrane [GO:0016021]; DNA binding [GO:0003677]
PGEN_.00g306050	Scaffold_15	22628809	22629156	NA	NA	NA	NA	NA
PGEN_.00g306060	Scaffold_15	22636815	22637129	NA	NA	NA	NA	NA
PGEN_.00g306070	Scaffold_15	22652796	22653125	NA	NA	NA	NA	NA
PGEN_.00g306080	Scaffold_15	22656396	22660598	NA	NA	NA	NA	NA
PGEN_.00g306090	Scaffold_15	22666819	22667187	NA	NA	NA	NA	NA
PGEN_.00g306100	Scaffold_15	22679799	22680098	NA	NA	NA	NA	NA
PGEN_.00g306110	Scaffold_15	22700817	22702493	NA	NA	NA	NA	NA
PGEN_.00g306120	Scaffold_15	22704326	22705073	NA	NA	NA	NA	NA
PGEN_.00g306130	Scaffold_15	22720201	22723357	NA	NA	NA	NA	NA
PGEN_.00g306140	Scaffold_15	22723404	22734894	NA	NA	NA	NA	NA
PGEN_.00g306150	Scaffold_15	22782453	22783632	NA	NA	NA	NA	NA
PGEN_.00g306160	Scaffold_15	22789949	22799897	NA	NA	NA	NA	NA
PGEN_.00g306170	Scaffold_15	22809023	22816399	NA	NA	NA	NA	NA
PGEN_.00g306180	Scaffold_15	22819988	22821388	Q90WY4	ADA2A_DANRE	Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR)	GO:0004935; GO:0004938; GO:0005887; GO:0007186; GO:0007188; GO:0071880; GO:0071881	integral component of plasma membrane [GO:0005887]; adrenergic receptor activity [GO:0004935]; alpha2-adrenergic receptor activity [GO:0004938]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g306190	Scaffold_15	22833252	22834139	NA	NA	NA	NA	NA
PGEN_.00g306200	Scaffold_15	22855022	22855495	NA	NA	NA	NA	NA
PGEN_.00g306210	Scaffold_15	22859431	22875437	Q5ZLK1	DCA13_CHICK	DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)	GO:0000462; GO:0005730; GO:0016567; GO:0032040; GO:0080008	"Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]"
PGEN_.00g306220	Scaffold_15	22911713	22919678	NA	NA	NA	NA	NA
PGEN_.00g306230	Scaffold_15	22922664	22927945	NA	NA	NA	NA	NA
PGEN_.00g306240	Scaffold_15	22938805	22969148	Q5RHP9	ERIC3_HUMAN	Glutamate-rich protein 3		
PGEN_.00g306250	Scaffold_15	22980974	22988515	Q9D3B1	HACD2_MOUSE	Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B)	GO:0005783; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0042761; GO:0102158; GO:0102343; GO:0102344; GO:0102345	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]
PGEN_.00g306260	Scaffold_15	22995308	23003976	Q09221	CPNA2_CAEEL	Copine family protein 2		
PGEN_.00g306270	Scaffold_15	23023402	23041050	NA	NA	NA	NA	NA
PGEN_.00g306280	Scaffold_15	23076335	23078217	NA	NA	NA	NA	NA
PGEN_.00g306290	Scaffold_15	23078357	23085485	NA	NA	NA	NA	NA
PGEN_.00g306300	Scaffold_15	23114420	23118589	NA	NA	NA	NA	NA
PGEN_.00g306310	Scaffold_15	23135616	23138728	Q6IWZ0	OXLA_APLCA	L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (Escapin)	GO:0001716; GO:0005576; GO:0006952; GO:0031640; GO:0042742; GO:0050832; GO:0055114	extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; killing of cells of other organism [GO:0031640]; oxidation-reduction process [GO:0055114]
PGEN_.00g306320	Scaffold_15	23138719	23141323	NA	NA	NA	NA	NA
PGEN_.00g306330	Scaffold_15	23138935	23139135	NA	NA	NA	NA	NA
PGEN_.00g306340	Scaffold_15	23141862	23151274	Q17043	APLY_APLKU	Aplysianin-A	GO:0016491; GO:0042742	oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]
PGEN_.00g306350	Scaffold_15	23151746	23152366	NA	NA	NA	NA	NA
PGEN_.00g306360	Scaffold_15	23219830	23221820	NA	NA	NA	NA	NA
PGEN_.00g306370	Scaffold_15	23229112	23241419	NA	NA	NA	NA	NA
PGEN_.00g306380	Scaffold_15	23253259	23256831	NA	NA	NA	NA	NA
PGEN_.00g306390	Scaffold_15	23306199	23318283	O97578	CATC_CANLF	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain 1 (Dipeptidyl peptidase I heavy chain 1); Dipeptidyl peptidase 1 heavy chain 2 (Dipeptidyl peptidase I heavy chain 2); Dipeptidyl peptidase 1 heavy chain 3 (Dipeptidyl peptidase I heavy chain 3); Dipeptidyl peptidase 1 heavy chain 4 (Dipeptidyl peptidase I heavy chain 4); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)] (Fragment)	GO:0004197; GO:0005615; GO:0005764; GO:0051603	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g306400	Scaffold_15	23328936	23330655	NA	NA	NA	NA	NA
PGEN_.00g306410	Scaffold_15	23346654	23347928	P51993	FUT6_HUMAN	"Alpha-(1,3)-fucosyltransferase 6 (EC 2.4.1.65) (Fucosyltransferase 6) (Fucosyltransferase VI) (Fuc-TVI) (FucT-VI) (Galactoside 3-L-fucosyltransferase)"	GO:0005794; GO:0006486; GO:0006672; GO:0008417; GO:0016021; GO:0017060; GO:0032580; GO:0036065; GO:0042355; GO:0046920; GO:0070062	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; ceramide metabolic process [GO:0006672]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]
PGEN_.00g306420	Scaffold_15	23365437	23366632	NA	NA	NA	NA	NA
PGEN_.00g306430	Scaffold_15	23377257	23380091	Q76MJ5	ERN2_HUMAN	Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (hIRE2p) (Ire1-beta) (IRE1b) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]	GO:0000287; GO:0004519; GO:0004521; GO:0004672; GO:0004674; GO:0005524; GO:0005789; GO:0006397; GO:0006468; GO:0007050; GO:0007257; GO:0016021; GO:0016075; GO:0030263; GO:0030968; GO:0034976; GO:0036498; GO:0045892; GO:0051082; GO:0070059; GO:1990604	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; apoptotic chromosome condensation [GO:0030263]; cell cycle arrest [GO:0007050]; endoplasmic reticulum unfolded protein response [GO:0030968]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]"
PGEN_.00g306440	Scaffold_15	23401246	23401836	NA	NA	NA	NA	NA
PGEN_.00g306450	Scaffold_15	23442040	23453636	O08641	SH3Y1_MOUSE	SH3 domain-containing YSC84-like protein 1	GO:0006661; GO:0019902; GO:0032587; GO:0035091; GO:1900027	ruffle membrane [GO:0032587]; phosphatase binding [GO:0019902]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of ruffle assembly [GO:1900027]
PGEN_.00g306460	Scaffold_15	23461995	23468243	NA	NA	NA	NA	NA
PGEN_.00g306470	Scaffold_15	23471231	23475256	NA	NA	NA	NA	NA
PGEN_.00g306480	Scaffold_15	23484354	23523590	Q8NI77	KI18A_HUMAN	Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	"caveola [GO:0005901]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]"
PGEN_.00g306490	Scaffold_15	23536307	23543648	Q8N7B6	PACRL_HUMAN	PACRG-like protein		
PGEN_.00g306500	Scaffold_15	23571412	23579712	NA	NA	NA	NA	NA
PGEN_.00g306510	Scaffold_15	23588767	23594863	NA	NA	NA	NA	NA
PGEN_.00g306520	Scaffold_15	23601748	23623044	Q9W6I0	UQCC1_XENLA	Ubiquinol-cytochrome-c reductase complex assembly factor 1 (Basic FGF-repressed Zic-binding protein homolog) (Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog) (Zic3-binding protein)	GO:0005743; GO:0034551; GO:0070131	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of mitochondrial translation [GO:0070131]
PGEN_.00g306530	Scaffold_15	23630907	23636655	NA	NA	NA	NA	NA
PGEN_.00g306540	Scaffold_15	23637624	23643854	Q5F477	LDAH_CHICK	Lipid droplet-associated hydrolase (EC 3.1.1.-) (Lipid droplet-associated serine hydrolase)	GO:0005783; GO:0005811; GO:0016298	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; lipase activity [GO:0016298]
PGEN_.00g306550	Scaffold_15	23648683	23687165	Q00576	PTSS1_CRIGR	Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I)	GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]
PGEN_.00g306560	Scaffold_15	23707075	23722458	NA	NA	NA	NA	NA
PGEN_.00g306570	Scaffold_15	23741585	23742088	NA	NA	NA	NA	NA
PGEN_.00g306580	Scaffold_15	23769661	23769906	NA	NA	NA	NA	NA
PGEN_.00g306590	Scaffold_15	23770024	23773859	NA	NA	NA	NA	NA
PGEN_.00g306600	Scaffold_15	23797079	23797801	NA	NA	NA	NA	NA
PGEN_.00g306610	Scaffold_15	23797920	23798360	NA	NA	NA	NA	NA
PGEN_.00g306620	Scaffold_15	23798526	23800350	NA	NA	NA	NA	NA
PGEN_.00g306630	Scaffold_15	23800623	23801063	NA	NA	NA	NA	NA
PGEN_.00g306640	Scaffold_15	23801182	23801904	NA	NA	NA	NA	NA
PGEN_.00g306650	Scaffold_15	23828417	23828662	NA	NA	NA	NA	NA
PGEN_.00g306660	Scaffold_15	23848793	23856864	NA	NA	NA	NA	NA
PGEN_.00g306670	Scaffold_15	23875890	23881883	NA	NA	NA	NA	NA
PGEN_.00g306680	Scaffold_15	23893699	23898564	P82343	RENBP_MOUSE	N-acylglucosamine 2-epimerase (AGE) (EC 5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein) (RnBP)	GO:0004857; GO:0005524; GO:0006044; GO:0006051; GO:0010951; GO:0017076; GO:0019262; GO:0030414; GO:0042802; GO:0042803; GO:0043086; GO:0050121	ATP binding [GO:0005524]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]; protein homodimerization activity [GO:0042803]; purine nucleotide binding [GO:0017076]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]
PGEN_.00g306690	Scaffold_15	23912291	23949323	Q00576	PTSS1_CRIGR	Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I)	GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]
PGEN_.00g306700	Scaffold_15	23954182	23969058	Q5F477	LDAH_CHICK	Lipid droplet-associated hydrolase (EC 3.1.1.-) (Lipid droplet-associated serine hydrolase)	GO:0005783; GO:0005811; GO:0016298	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; lipase activity [GO:0016298]
PGEN_.00g306710	Scaffold_15	23974790	23980553	NA	NA	NA	NA	NA
PGEN_.00g306720	Scaffold_15	23983947	24036491	Q8CEE6	PASK_MOUSE	PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576]
PGEN_.00g306730	Scaffold_15	24042504	24053965	NA	NA	NA	NA	NA
PGEN_.00g306740	Scaffold_15	24081342	24081779	NA	NA	NA	NA	NA
PGEN_.00g306750	Scaffold_15	24083030	24083617	NA	NA	NA	NA	NA
PGEN_.00g306760	Scaffold_15	24084105	24084425	NA	NA	NA	NA	NA
PGEN_.00g306770	Scaffold_15	24084693	24085382	NA	NA	NA	NA	NA
PGEN_.00g306780	Scaffold_15	24085720	24086358	NA	NA	NA	NA	NA
PGEN_.00g306790	Scaffold_15	24108347	24123317	Q8VI24	SATB2_MOUSE	DNA-binding protein SATB2 (Special AT-rich sequence-binding protein 2)	GO:0000118; GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0001227; GO:0001764; GO:0002076; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006338; GO:0009880; GO:0010468; GO:0016363; GO:0021902; GO:0043565; GO:0045944; GO:0048704; GO:0051216; GO:0060021; GO:0071310	"histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cartilage development [GO:0051216]; cellular response to organic substance [GO:0071310]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; embryonic pattern specification [GO:0009880]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]"
PGEN_.00g306800	Scaffold_15	24129226	24210701	Q8VI24	SATB2_MOUSE	DNA-binding protein SATB2 (Special AT-rich sequence-binding protein 2)	GO:0000118; GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0001227; GO:0001764; GO:0002076; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006338; GO:0009880; GO:0010468; GO:0016363; GO:0021902; GO:0043565; GO:0045944; GO:0048704; GO:0051216; GO:0060021; GO:0071310	"histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cartilage development [GO:0051216]; cellular response to organic substance [GO:0071310]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; embryonic pattern specification [GO:0009880]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]"
PGEN_.00g306810	Scaffold_15	24211398	24238597	Q9DBU0	TM9S1_MOUSE	Transmembrane 9 superfamily member 1	GO:0000421; GO:0005765; GO:0006914; GO:0016021; GO:0031410; GO:0072657	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; protein localization to membrane [GO:0072657]
PGEN_.00g306820	Scaffold_15	24282897	24285442	NA	NA	NA	NA	NA
PGEN_.00g306830	Scaffold_15	24289214	24290901	NA	NA	NA	NA	NA
PGEN_.00g306840	Scaffold_15	24292786	24298539	NA	NA	NA	NA	NA
PGEN_.00g306850	Scaffold_15	24338447	24385099	Q9I8B3	RB24B_XENLA	RNA-binding protein 24-B (MTR-1a) (RNA-binding motif protein 24-B)	GO:0000381; GO:0003730; GO:0005634; GO:0005737; GO:0006397; GO:0006974; GO:0008380; GO:0010830; GO:0010831; GO:0030154; GO:0035925; GO:0043488; GO:0045663; GO:0048255; GO:0061157; GO:0061158; GO:0097157; GO:1902811; GO:1905870; GO:1990715; GO:1990825; GO:2000738; GO:2000766	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; sequence-specific mRNA binding [GO:1990825]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of skeletal muscle fiber differentiation [GO:1902811]; positive regulation of stem cell differentiation [GO:2000738]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA stability [GO:0043488]; regulation of myotube differentiation [GO:0010830]; RNA splicing [GO:0008380]"
PGEN_.00g306860	Scaffold_15	24432037	24432372	NA	NA	NA	NA	NA
PGEN_.00g306870	Scaffold_15	24464913	24465407	NA	NA	NA	NA	NA
PGEN_.00g306880	Scaffold_15	24488716	24490017	NA	NA	NA	NA	NA
PGEN_.00g306890	Scaffold_15	24511937	24569471	Q3SYV4	CAP1_BOVIN	Adenylyl cyclase-associated protein 1 (CAP 1)	GO:0000902; GO:0003779; GO:0005886; GO:0007163; GO:0008154; GO:0008179; GO:0030864	cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]
PGEN_.00g306900	Scaffold_15	24576876	24633063	Q8BZJ8	CH034_MOUSE	Uncharacterized protein C8orf34 homolog		
PGEN_.00g306910	Scaffold_15	24636507	24637040	NA	NA	NA	NA	NA
PGEN_.00g306920	Scaffold_15	24654426	24654632	NA	NA	NA	NA	NA
PGEN_.00g306930	Scaffold_15	24676162	24682918	NA	NA	NA	NA	NA
PGEN_.00g306940	Scaffold_15	24697303	24711556	Q90XB6	SULF1_COTCO	Extracellular sulfatase Sulf-1 (qSulf1) (EC 3.1.6.-)	GO:0001502; GO:0001822; GO:0001937; GO:0002063; GO:0004065; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005795; GO:0007155; GO:0008449; GO:0009986; GO:0014846; GO:0016525; GO:0030177; GO:0030201; GO:0030336; GO:0030513; GO:0035860; GO:0036022; GO:0040037; GO:0045121; GO:0048010; GO:0048661; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0060686; GO:0090263	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; bone development [GO:0060348]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; limb joint morphogenesis [GO:0036022]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of Wnt signaling pathway [GO:0030177]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]
PGEN_.00g306950	Scaffold_15	24721252	24743058	NA	NA	NA	NA	NA
PGEN_.00g306960	Scaffold_15	24749884	24756201	NA	NA	NA	NA	NA
PGEN_.00g306970	Scaffold_15	24772627	24773507	P37122	C76A2_SOLME	Cytochrome P450 76A2 (EC 1.14.-.-) (CYPLXXVIA2) (Cytochrome P-450EG7)	GO:0004497; GO:0005506; GO:0016705; GO:0020037	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
PGEN_.00g306980	Scaffold_15	24890445	24902905	Q5KU26	COL12_HUMAN	Collectin-12 (Collectin placenta protein 1) (CL-P1) (hCL-P1) (Nurse cell scavenger receptor 2) (Scavenger receptor class A member 4) (Scavenger receptor with C-type lectin)	GO:0005044; GO:0005534; GO:0005581; GO:0005615; GO:0005886; GO:0006898; GO:0006910; GO:0006952; GO:0008329; GO:0009756; GO:0016021; GO:0030169; GO:0030666; GO:0031012; GO:0034138; GO:0045087; GO:0046872; GO:0050776; GO:0051260; GO:0060355; GO:0071360	"collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; galactose binding [GO:0005534]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; carbohydrate mediated signaling [GO:0009756]; cellular response to exogenous dsRNA [GO:0071360]; defense response [GO:0006952]; innate immune response [GO:0045087]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; protein homooligomerization [GO:0051260]; receptor-mediated endocytosis [GO:0006898]; regulation of immune response [GO:0050776]; toll-like receptor 3 signaling pathway [GO:0034138]"
PGEN_.00g306990	Scaffold_15	24903325	24908804	NA	NA	NA	NA	NA
PGEN_.00g307000	Scaffold_15	24936522	24936920	NA	NA	NA	NA	NA
PGEN_.00g307010	Scaffold_15	24950554	24951661	Q924H0	NPFF2_MOUSE	Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408; GO:0045761; GO:2000479	actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]
PGEN_.00g307020	Scaffold_15	25012502	25016047	NA	NA	NA	NA	NA
PGEN_.00g307030	Scaffold_15	25029613	25031509	NA	NA	NA	NA	NA
PGEN_.00g307040	Scaffold_15	25042385	25042882	NA	NA	NA	NA	NA
PGEN_.00g307050	Scaffold_15	25132507	25134341	P58374	RL30_BRABE	60S ribosomal protein L30	GO:0003723; GO:0003735; GO:0022625	cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]
PGEN_.00g307060	Scaffold_15	25134598	25152313	A6N6J5	WDR35_RAT	WD repeat-containing protein 35 (Naofen)	GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1901555; GO:1905705; GO:1990830	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636]
PGEN_.00g307070	Scaffold_15	25152966	25162424	Q8BND3	WDR35_MOUSE	WD repeat-containing protein 35	GO:0005623; GO:0005737; GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0043065; GO:0043280; GO:0045019; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0090200; GO:0097421; GO:0097756; GO:1905705; GO:1990830	axoneme [GO:0005930]; cell [GO:0005623]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]
PGEN_.00g307080	Scaffold_15	25170431	25172184	NA	NA	NA	NA	NA
PGEN_.00g307090	Scaffold_15	25185658	25198922	Q91W90	TXND5_MOUSE	Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46)	GO:0005623; GO:0005788; GO:0016853; GO:0043277; GO:0045454	cell [GO:0005623]; endoplasmic reticulum lumen [GO:0005788]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454]
PGEN_.00g307100	Scaffold_15	25212119	25217045	P08570	RLA1_DROME	60S acidic ribosomal protein P1 (Acidic ribosomal protein RPA2) (RP21C)	GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0022626; GO:0030295; GO:0043021	cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414]
PGEN_.00g307110	Scaffold_15	25230741	25271937	Q8TB72	PUM2_HUMAN	Pumilio homolog 2 (Pumilio-2)	GO:0003723; GO:0003730; GO:0005829; GO:0006417; GO:0010494; GO:0010608; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051983; GO:0060964; GO:1900246; GO:2000637	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063]
PGEN_.00g307120	Scaffold_15	25280306	25307584	O96838	FYV1_DROME	Putative 1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (Type III PIP kinase) (PIPkin-III)	GO:0000285; GO:0005524; GO:0005768; GO:0008270; GO:0008333; GO:0010008; GO:0012506; GO:0016308; GO:0035556; GO:0046854; GO:0097352	endosome [GO:0005768]; endosome membrane [GO:0010008]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular signal transduction [GO:0035556]; phosphatidylinositol phosphorylation [GO:0046854]
PGEN_.00g307130	Scaffold_15	25309084	25330076	Q9Y2I7	FYV1_HUMAN	1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase)	GO:0000139; GO:0000285; GO:0005524; GO:0005829; GO:0005911; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0031901; GO:0031902; GO:0032288; GO:0034504; GO:0035556; GO:0042147; GO:0043231; GO:0043813; GO:0045121; GO:0048471; GO:1904562; GO:2000785	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g307140	Scaffold_15	25340469	25341479	A8MRX0	GSOX5_ARATH	Flavin-containing monooxygenase FMO GS-OX5 (EC 1.14.13.237) (Flavin-monooxygenase glucosinolate S-oxygenase 5)	GO:0004499; GO:0019761; GO:0050660; GO:0050661; GO:0080107	"8-methylthiopropyl glucosinolate S-oxygenase activity [GO:0080107]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; glucosinolate biosynthetic process [GO:0019761]"
PGEN_.00g307150	Scaffold_15	25354808	25356684	NA	NA	NA	NA	NA
PGEN_.00g307160	Scaffold_15	25367203	25390361	NA	NA	NA	NA	NA
PGEN_.00g307170	Scaffold_15	25398629	25399336	NA	NA	NA	NA	NA
PGEN_.00g307180	Scaffold_15	25404610	25405734	NA	NA	NA	NA	NA
PGEN_.00g307190	Scaffold_15	25405857	25407600	NA	NA	NA	NA	NA
PGEN_.00g307200	Scaffold_15	25436618	25441276	NA	NA	NA	NA	NA
PGEN_.00g307210	Scaffold_15	25446751	25447790	NA	NA	NA	NA	NA
PGEN_.00g307220	Scaffold_15	25447914	25448603	NA	NA	NA	NA	NA
PGEN_.00g307230	Scaffold_15	25468059	25469020	NA	NA	NA	NA	NA
PGEN_.00g307240	Scaffold_15	25488404	25503555	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g307250	Scaffold_15	25568293	25577868	NA	NA	NA	NA	NA
PGEN_.00g307260	Scaffold_15	25577893	25578333	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g307270	Scaffold_15	25578611	25579066	Q18297	TRPA1_CAEEL	Transient receptor potential cation channel subfamily A member 1 homolog	GO:0005216; GO:0005886; GO:0016021; GO:0043025; GO:0050896; GO:0097730	integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896]
PGEN_.00g307280	Scaffold_15	25596320	25596739	NA	NA	NA	NA	NA
PGEN_.00g307290	Scaffold_15	25669859	25671769	NA	NA	NA	NA	NA
PGEN_.00g307300	Scaffold_15	25719955	25720359	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g307310	Scaffold_15	25720411	25722033	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g307320	Scaffold_15	25722067	25722441	NA	NA	NA	NA	NA
PGEN_.00g307330	Scaffold_15	25722891	25739594	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g307340	Scaffold_15	25782877	25783386	Q9Y7S2	YQO3_SCHPO	UPF0612 protein C569.003	GO:0005829	cytosol [GO:0005829]
PGEN_.00g307350	Scaffold_15	25796192	25797325	Q20681	BAT38_CAEEL	BTB and MATH domain-containing protein 38		
PGEN_.00g307360	Scaffold_15	25816466	25817613	NA	NA	NA	NA	NA
PGEN_.00g307370	Scaffold_15	25829226	25829480	NA	NA	NA	NA	NA
PGEN_.00g307380	Scaffold_15	25829565	25829942	NA	NA	NA	NA	NA
PGEN_.00g307390	Scaffold_15	25829973	25831949	NA	NA	NA	NA	NA
PGEN_.00g307400	Scaffold_15	25844336	25844941	NA	NA	NA	NA	NA
PGEN_.00g307410	Scaffold_15	25877790	25878209	NA	NA	NA	NA	NA
PGEN_.00g307420	Scaffold_15	25882697	25883011	NA	NA	NA	NA	NA
PGEN_.00g307430	Scaffold_15	25890550	25899598	D3YVF0	AKAP5_MOUSE	A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)	GO:0001664; GO:0001934; GO:0003779; GO:0005516; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0006605; GO:0007193; GO:0007194; GO:0008179; GO:0009898; GO:0010524; GO:0010738; GO:0014069; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032991; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0043624; GO:0044877; GO:0045121; GO:0045296; GO:0045762; GO:0048471; GO:0050775; GO:0050811; GO:0060076; GO:0060090; GO:0070886; GO:0097110; GO:0098978; GO:0099092; GO:0099149; GO:1903078	"asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; cellular protein complex disassembly [GO:0043624]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein targeting [GO:0006605]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]"
PGEN_.00g307440	Scaffold_15	25901779	25902924	Q20681	BAT38_CAEEL	BTB and MATH domain-containing protein 38		
PGEN_.00g307450	Scaffold_15	25903348	25907174	Q20681	BAT38_CAEEL	BTB and MATH domain-containing protein 38		
PGEN_.00g307460	Scaffold_15	25912617	25913741	Q9XWB9	BAT36_CAEEL	BTB and MATH domain-containing protein 36		
PGEN_.00g307470	Scaffold_15	25921943	25923067	Q9XHZ8	Y1178_ARATH	BTB/POZ domain-containing protein At1g21780	GO:0016567; GO:0031463	Cul3-RING ubiquitin ligase complex [GO:0031463]; protein ubiquitination [GO:0016567]
PGEN_.00g307480	Scaffold_15	25925893	25926114	NA	NA	NA	NA	NA
PGEN_.00g307490	Scaffold_15	25939756	25940127	Q9XWB9	BAT36_CAEEL	BTB and MATH domain-containing protein 36		
PGEN_.00g307500	Scaffold_15	25940259	25940741	NA	NA	NA	NA	NA
PGEN_.00g307510	Scaffold_15	25964810	25966228	NA	NA	NA	NA	NA
PGEN_.00g307520	Scaffold_15	26010461	26019087	Q6IMM1	DJC27_CHICK	DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)	GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0032482; GO:0070374; GO:0071701	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; Rab protein signal transduction [GO:0032482]; regulation of MAPK export from nucleus [GO:0071701]
PGEN_.00g307530	Scaffold_15	26030563	26031114	NA	NA	NA	NA	NA
PGEN_.00g307540	Scaffold_15	26042318	26042869	NA	NA	NA	NA	NA
PGEN_.00g307550	Scaffold_15	26051045	26055648	NA	NA	NA	NA	NA
PGEN_.00g307560	Scaffold_15	26064665	26067166	P18238	ADT3_YEAST	"ADP,ATP carrier protein 3 (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3)"	GO:0005471; GO:0005739; GO:0005743; GO:0009061; GO:0015886; GO:0016021; GO:0042802; GO:0055085	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP:ADP antiporter activity [GO:0005471]; identical protein binding [GO:0042802]; anaerobic respiration [GO:0009061]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]
PGEN_.00g307570	Scaffold_15	26075725	26084961	Q5JVL4	EFHC1_HUMAN	EF-hand domain-containing protein 1 (Myoclonin-1)	GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005930; GO:0007052; GO:0008022; GO:0021795; GO:0043014; GO:0043025; GO:0051302; GO:0060285; GO:0072686	axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302]
PGEN_.00g307580	Scaffold_15	26085219	26104740	Q925E0	SNTG2_MOUSE	Gamma-2-syntrophin (G2SYN) (Syntrophin-5) (SYN5)	GO:0003779; GO:0005198; GO:0005737; GO:0005856; GO:0016010; GO:0030165; GO:0042383; GO:0097109	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]
PGEN_.00g307590	Scaffold_15	26105758	26112224	Q925E1	SNTG1_MOUSE	Gamma-1-syntrophin (G1SYN) (Syntrophin-4) (SYN4)	GO:0003779; GO:0005198; GO:0005634; GO:0005737; GO:0005856; GO:0008022; GO:0016010; GO:0032587	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198]
PGEN_.00g307600	Scaffold_15	26122764	26128050	NA	NA	NA	NA	NA
PGEN_.00g307610	Scaffold_15	26138317	26149371	P51589	CP2J2_HUMAN	Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070062; GO:0071614	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g307620	Scaffold_15	26150737	26157820	E7E2N8	GILT_CARAU	Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-)	GO:0005576; GO:0005764; GO:0019882; GO:0047134	extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; antigen processing and presentation [GO:0019882]
PGEN_.00g307630	Scaffold_15	26204742	26216510	Q9V730	EXT1_DROME	Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Protein tout-velu)	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006044; GO:0006486; GO:0007411; GO:0008354; GO:0008375; GO:0008589; GO:0015012; GO:0015014; GO:0015020; GO:0016021; GO:0016055; GO:0016757; GO:0030210; GO:0030513; GO:0045880; GO:0046872; GO:0050508; GO:0050509; GO:0090263	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]; axon guidance [GO:0007411]; germ cell migration [GO:0008354]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; regulation of smoothened signaling pathway [GO:0008589]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g307640	Scaffold_15	26221204	26303411	A5D7I4	EXT1_BOVIN	Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 1 homolog)	GO:0000139; GO:0001503; GO:0005794; GO:0006024; GO:0006486; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008375; GO:0015014; GO:0015020; GO:0016757; GO:0021772; GO:0030176; GO:0042803; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0072498	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity, transferring glycosyl groups [GO:0016757]; axon guidance [GO:0007411]; embryonic skeletal joint development [GO:0072498]; endoderm development [GO:0007492]; gastrulation [GO:0007369]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm development [GO:0007498]; olfactory bulb development [GO:0021772]; ossification [GO:0001503]; protein glycosylation [GO:0006486]"
PGEN_.00g307650	Scaffold_15	26308642	26312204	Q6B860	RT14_BOVIN	"28S ribosomal protein S14, mitochondrial (MRP-S14) (S14mt)"	GO:0003735; GO:0005743; GO:0005763; GO:0032543	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g307660	Scaffold_15	26325871	26336358	NA	NA	NA	NA	NA
PGEN_.00g307670	Scaffold_15	26350880	26359767	NA	NA	NA	NA	NA
PGEN_.00g307680	Scaffold_15	26370620	26373243	NA	NA	NA	NA	NA
PGEN_.00g307690	Scaffold_15	26377377	26377937	NA	NA	NA	NA	NA
PGEN_.00g307700	Scaffold_15	26387808	26389697	Q53533	SAV2_STRVL	Streptavidin-V2 (SA V2)	GO:0005576; GO:0009374	extracellular region [GO:0005576]; biotin binding [GO:0009374]
PGEN_.00g307710	Scaffold_15	26418946	26434363	Q8BXB6	SO2B1_MOUSE	Solute carrier organic anion transporter family member 2B1 (Solute carrier family 21 member 9)	GO:0005887; GO:0008514; GO:0009925; GO:0009986; GO:0015125; GO:0015347; GO:0015711; GO:0015721; GO:0016324; GO:0043252; GO:0071718	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; bile acid and bile salt transport [GO:0015721]; organic anion transport [GO:0015711]; sodium-independent icosanoid transport [GO:0071718]; sodium-independent organic anion transport [GO:0043252]
PGEN_.00g307720	Scaffold_15	26454808	26496004	Q14590	ZN235_HUMAN	Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g307730	Scaffold_15	26549335	26550342	Q8IYN0	ZN100_HUMAN	Zinc finger protein 100	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g307740	Scaffold_15	26560053	26560289	I7HJS4	ZN683_MOUSE	Tissue-resident T-cell transcription regulator protein ZNF683 (Homolog of Blimp-1 in T-cell) (Hobit) (Zinc finger protein 683)	GO:0001779; GO:0002250; GO:0003677; GO:0005634; GO:0010468; GO:0032823; GO:0032826; GO:0033082; GO:0045087; GO:0046872; GO:0051136; GO:1990841	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of natural killer cell differentiation involved in immune response [GO:0032826]; regulation of NK T cell differentiation [GO:0051136]
PGEN_.00g307750	Scaffold_15	26590865	26591804	B0BN95	HARB1_RAT	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g307760	Scaffold_15	26603774	26606265	NA	NA	NA	NA	NA
PGEN_.00g307770	Scaffold_15	26606506	26609564	NA	NA	NA	NA	NA
PGEN_.00g307780	Scaffold_15	26621120	26622059	Q96MB7	HARB1_HUMAN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g307790	Scaffold_15	26658438	26658674	I7HJS4	ZN683_MOUSE	Tissue-resident T-cell transcription regulator protein ZNF683 (Homolog of Blimp-1 in T-cell) (Hobit) (Zinc finger protein 683)	GO:0001779; GO:0002250; GO:0003677; GO:0005634; GO:0010468; GO:0032823; GO:0032826; GO:0033082; GO:0045087; GO:0046872; GO:0051136; GO:1990841	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of natural killer cell differentiation involved in immune response [GO:0032826]; regulation of NK T cell differentiation [GO:0051136]
PGEN_.00g307800	Scaffold_15	26669427	26670434	Q8IYN0	ZN100_HUMAN	Zinc finger protein 100	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g307810	Scaffold_15	26717303	26717581	Q86V71	ZN429_HUMAN	Zinc finger protein 429	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g307820	Scaffold_15	26723991	26726037	P17038	ZNF43_HUMAN	Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g307830	Scaffold_15	26740663	26765198	O75362	ZN217_HUMAN	Zinc finger protein 217	GO:0000118; GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0005739; GO:0006351; GO:0006355; GO:0016607; GO:0044212; GO:0045892; GO:0046872	"histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g307840	Scaffold_15	26786879	26800969	Q8BXB6	SO2B1_MOUSE	Solute carrier organic anion transporter family member 2B1 (Solute carrier family 21 member 9)	GO:0005887; GO:0008514; GO:0009925; GO:0009986; GO:0015125; GO:0015347; GO:0015711; GO:0015721; GO:0016324; GO:0043252; GO:0071718	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; bile acid and bile salt transport [GO:0015721]; organic anion transport [GO:0015711]; sodium-independent icosanoid transport [GO:0071718]; sodium-independent organic anion transport [GO:0043252]
PGEN_.00g307850	Scaffold_15	26830048	26831916	Q53533	SAV2_STRVL	Streptavidin-V2 (SA V2)	GO:0005576; GO:0009374	extracellular region [GO:0005576]; biotin binding [GO:0009374]
PGEN_.00g307860	Scaffold_15	26832236	26834008	NA	NA	NA	NA	NA
PGEN_.00g307870	Scaffold_15	26840661	26841221	NA	NA	NA	NA	NA
PGEN_.00g307880	Scaffold_15	26845319	26847950	NA	NA	NA	NA	NA
PGEN_.00g307890	Scaffold_15	26857675	26870337	NA	NA	NA	NA	NA
PGEN_.00g307900	Scaffold_15	26880977	26891433	NA	NA	NA	NA	NA
PGEN_.00g307910	Scaffold_15	26903428	26906991	Q6B860	RT14_BOVIN	"28S ribosomal protein S14, mitochondrial (MRP-S14) (S14mt)"	GO:0003735; GO:0005743; GO:0005763; GO:0032543	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]
PGEN_.00g307920	Scaffold_15	26912294	26993537	A5D7I4	EXT1_BOVIN	Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 1 homolog)	GO:0000139; GO:0001503; GO:0005794; GO:0006024; GO:0006486; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008375; GO:0015014; GO:0015020; GO:0016757; GO:0021772; GO:0030176; GO:0042803; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0072498	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity, transferring glycosyl groups [GO:0016757]; axon guidance [GO:0007411]; embryonic skeletal joint development [GO:0072498]; endoderm development [GO:0007492]; gastrulation [GO:0007369]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; mesoderm development [GO:0007498]; olfactory bulb development [GO:0021772]; ossification [GO:0001503]; protein glycosylation [GO:0006486]"
PGEN_.00g307930	Scaffold_15	26998231	27009965	Q9V730	EXT1_DROME	Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Protein tout-velu)	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006044; GO:0006486; GO:0007411; GO:0008354; GO:0008375; GO:0008589; GO:0015012; GO:0015014; GO:0015020; GO:0016021; GO:0016055; GO:0016757; GO:0030210; GO:0030513; GO:0045880; GO:0046872; GO:0050508; GO:0050509; GO:0090263	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; transferase activity, transferring glycosyl groups [GO:0016757]; axon guidance [GO:0007411]; germ cell migration [GO:0008354]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of smoothened signaling pathway [GO:0045880]; protein glycosylation [GO:0006486]; regulation of smoothened signaling pathway [GO:0008589]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g307940	Scaffold_15	27056829	27063954	E7E2N8	GILT_CARAU	Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-)	GO:0005576; GO:0005764; GO:0019882; GO:0047134	extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; antigen processing and presentation [GO:0019882]
PGEN_.00g307950	Scaffold_15	27065321	27076004	P51589	CP2J2_HUMAN	Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070062; GO:0071614	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g307960	Scaffold_15	27086235	27091554	NA	NA	NA	NA	NA
PGEN_.00g307970	Scaffold_15	27101922	27128515	Q9NY99	SNTG2_HUMAN	Gamma-2-syntrophin (G2SYN) (Syntrophin-5) (SYN5)	GO:0003779; GO:0005198; GO:0005737; GO:0005856; GO:0007417; GO:0016010; GO:0016013; GO:0030165; GO:0042383; GO:0097109	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; sarcolemma [GO:0042383]; syntrophin complex [GO:0016013]; actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; central nervous system development [GO:0007417]
PGEN_.00g307980	Scaffold_15	27128773	27137971	Q5JVL4	EFHC1_HUMAN	EF-hand domain-containing protein 1 (Myoclonin-1)	GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005930; GO:0007052; GO:0008022; GO:0021795; GO:0043014; GO:0043025; GO:0051302; GO:0060285; GO:0072686	axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302]
PGEN_.00g307990	Scaffold_15	27146846	27149379	P18238	ADT3_YEAST	"ADP,ATP carrier protein 3 (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3)"	GO:0005471; GO:0005739; GO:0005743; GO:0009061; GO:0015886; GO:0016021; GO:0042802; GO:0055085	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP:ADP antiporter activity [GO:0005471]; identical protein binding [GO:0042802]; anaerobic respiration [GO:0009061]; heme transport [GO:0015886]; transmembrane transport [GO:0055085]
PGEN_.00g308000	Scaffold_15	27158417	27159721	NA	NA	NA	NA	NA
PGEN_.00g308010	Scaffold_15	27171859	27172410	NA	NA	NA	NA	NA
PGEN_.00g308020	Scaffold_15	27183581	27183892	NA	NA	NA	NA	NA
PGEN_.00g308030	Scaffold_15	27191271	27191567	NA	NA	NA	NA	NA
PGEN_.00g308040	Scaffold_15	27198371	27207067	Q6IMM1	DJC27_CHICK	DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)	GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0032482; GO:0070374; GO:0071701	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; Rab protein signal transduction [GO:0032482]; regulation of MAPK export from nucleus [GO:0071701]
PGEN_.00g308050	Scaffold_15	27247782	27249941	NA	NA	NA	NA	NA
PGEN_.00g308060	Scaffold_15	27250040	27251414	NA	NA	NA	NA	NA
PGEN_.00g308070	Scaffold_15	27354949	27355257	NA	NA	NA	NA	NA
PGEN_.00g308080	Scaffold_15	27388322	27389239	O18920	ANGP1_BOVIN	Angiopoietin-1 (ANG-1)	GO:0001701; GO:0001933; GO:0002040; GO:0002092; GO:0002740; GO:0005615; GO:0005886; GO:0005902; GO:0007162; GO:0007171; GO:0014068; GO:0014842; GO:0030097; GO:0030154; GO:0030210; GO:0030971; GO:0031398; GO:0031589; GO:0032680; GO:0033138; GO:0034394; GO:0042308; GO:0043116; GO:0043122; GO:0043393; GO:0043524; GO:0043536; GO:0045121; GO:0045785; GO:0048014; GO:0050731; GO:0050918; GO:0051897; GO:0070374; GO:0072012; GO:2000352; GO:2000446	extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor tyrosine kinase binding [GO:0030971]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine secretion involved in immune response [GO:0002740]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; positive chemotaxis [GO:0050918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014]
PGEN_.00g308090	Scaffold_15	27449587	27464446	P23286	CALM_CANAX	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g308100	Scaffold_15	27476479	27482882	NA	NA	NA	NA	NA
PGEN_.00g308110	Scaffold_15	27519050	27564443	NA	NA	NA	NA	NA
PGEN_.00g308120	Scaffold_15	27570732	27571187	NA	NA	NA	NA	NA
PGEN_.00g308130	Scaffold_15	27663893	27697384	P43691	GATA4_CHICK	Transcription factor GATA-4 (GATA-binding factor 4) (Fragment)	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0008270; GO:0032526; GO:0045893; GO:0048738	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cardiac muscle tissue development [GO:0048738]; positive regulation of transcription, DNA-templated [GO:0045893]; response to retinoic acid [GO:0032526]"
PGEN_.00g308140	Scaffold_15	27704704	27705114	NA	NA	NA	NA	NA
PGEN_.00g308150	Scaffold_15	27716746	27729936	NA	NA	NA	NA	NA
PGEN_.00g308160	Scaffold_15	27747937	27750231	O35165	GOSR2_RAT	Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin)	GO:0000139; GO:0000149; GO:0005484; GO:0005789; GO:0005794; GO:0005829; GO:0006623; GO:0006888; GO:0006891; GO:0006896; GO:0012507; GO:0016021; GO:0016192; GO:0031201; GO:0031902; GO:0042147; GO:0048280	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g308170	Scaffold_15	27750998	27778568	Q499Z3	SLNL1_HUMAN	Schlafen-like protein 1	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g308180	Scaffold_15	27784294	27788941	NA	NA	NA	NA	NA
PGEN_.00g308190	Scaffold_15	27796738	27805172	Q4R3B7	SLNL1_MACFA	Schlafen-like protein 1	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g308200	Scaffold_15	27822356	27839643	Q5RFR0	TTPAL_PONAB	Alpha-tocopherol transfer protein-like		
PGEN_.00g308210	Scaffold_15	27839670	27849591	NA	NA	NA	NA	NA
PGEN_.00g308220	Scaffold_15	27859183	27860107	NA	NA	NA	NA	NA
PGEN_.00g308230	Scaffold_15	27869131	27869502	NA	NA	NA	NA	NA
PGEN_.00g308240	Scaffold_15	27893409	27894675	NA	NA	NA	NA	NA
PGEN_.00g308250	Scaffold_15	27962159	27962515	NA	NA	NA	NA	NA
PGEN_.00g308260	Scaffold_15	27962573	27963064	NA	NA	NA	NA	NA
PGEN_.00g308270	Scaffold_15	27963148	27963750	NA	NA	NA	NA	NA
PGEN_.00g308280	Scaffold_15	27972502	27972729	NA	NA	NA	NA	NA
PGEN_.00g308290	Scaffold_15	28009470	28009811	NA	NA	NA	NA	NA
PGEN_.00g308300	Scaffold_15	28009893	28010736	NA	NA	NA	NA	NA
PGEN_.00g308310	Scaffold_15	28041218	28042600	NA	NA	NA	NA	NA
PGEN_.00g308320	Scaffold_15	28042727	28043230	NA	NA	NA	NA	NA
PGEN_.00g308330	Scaffold_15	28103016	28105816	NA	NA	NA	NA	NA
PGEN_.00g308340	Scaffold_15	28113666	28116072	NA	NA	NA	NA	NA
PGEN_.00g308350	Scaffold_15	28126849	28129361	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g308360	Scaffold_15	28129407	28131176	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g308370	Scaffold_15	28131436	28133902	NA	NA	NA	NA	NA
PGEN_.00g308380	Scaffold_15	28145373	28148834	NA	NA	NA	NA	NA
PGEN_.00g308390	Scaffold_15	28148955	28149311	NA	NA	NA	NA	NA
PGEN_.00g308400	Scaffold_15	28159256	28160872	NA	NA	NA	NA	NA
PGEN_.00g308410	Scaffold_15	28405675	28406085	NA	NA	NA	NA	NA
PGEN_.00g308420	Scaffold_15	28466709	28471947	O13008	FABPH_ONCMY	"Fatty acid-binding protein, heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein) (H-FABP)"	GO:0005737; GO:0008289	cytoplasm [GO:0005737]; lipid binding [GO:0008289]
PGEN_.00g308430	Scaffold_15	28478418	28535443	O97902	ASAP1_BOVIN	"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)"	GO:0002102; GO:0005096; GO:0005737; GO:0031253; GO:0046872; GO:0060271; GO:0071803; GO:1903527	cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; podosome [GO:0002102]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803]
PGEN_.00g308440	Scaffold_15	28554073	28561596	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g308450	Scaffold_15	28594609	28596543	Q99MB1	TLR3_MOUSE	Toll-like receptor 3 (CD antigen CD283)	GO:0001774; GO:0002224; GO:0002730; GO:0002756; GO:0003725; GO:0004888; GO:0005737; GO:0005769; GO:0005789; GO:0005887; GO:0006952; GO:0006954; GO:0007252; GO:0008584; GO:0009615; GO:0009986; GO:0010008; GO:0010628; GO:0032481; GO:0032722; GO:0032728; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0034123; GO:0034138; GO:0034346; GO:0035458; GO:0035690; GO:0042802; GO:0043065; GO:0043123; GO:0043330; GO:0043331; GO:0045078; GO:0045080; GO:0045087; GO:0045356; GO:0045359; GO:0045766; GO:0045944; GO:0046330; GO:0050729; GO:0051092; GO:0051607; GO:0071260; GO:0071346; GO:0071360; GO:0097191; GO:0097527; GO:1901224	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; cellular response to drug [GO:0035690]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to mechanical stimulus [GO:0071260]; defense response [GO:0006952]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; male gonad development [GO:0008584]; microglial cell activation [GO:0001774]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic signaling pathway [GO:0097527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha biosynthetic process [GO:0045356]; positive regulation of interferon-beta biosynthetic process [GO:0045359]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma biosynthetic process [GO:0045078]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type III interferon production [GO:0034346]; regulation of dendritic cell cytokine production [GO:0002730]; response to dsRNA [GO:0043331]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g308460	Scaffold_15	28630684	28632859	NA	NA	NA	NA	NA
PGEN_.00g308470	Scaffold_15	28632922	28638970	NA	NA	NA	NA	NA
PGEN_.00g308480	Scaffold_15	28656575	28658329	Q8UUZ1	MB212_DANRE	Protein mab-21-like 2	GO:0001654; GO:0002088; GO:0005634; GO:0005737; GO:0043010; GO:0048048; GO:0048701; GO:0060041	cytoplasm [GO:0005737]; nucleus [GO:0005634]; camera-type eye development [GO:0043010]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic eye morphogenesis [GO:0048048]; eye development [GO:0001654]; lens development in camera-type eye [GO:0002088]; retina development in camera-type eye [GO:0060041]
PGEN_.00g308490	Scaffold_15	28665257	28666213	NA	NA	NA	NA	NA
PGEN_.00g308500	Scaffold_15	28670414	28674256	Q15386	UBE3C_HUMAN	Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (HectH2)	GO:0000209; GO:0000502; GO:0004842; GO:0005634; GO:0006511; GO:0061631	nucleus [GO:0005634]; proteasome complex [GO:0000502]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g308510	Scaffold_15	28706575	28733478	Q9UBF8	PI4KB_HUMAN	Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67) (NPIK) (PI4K92) (PI4KIII)	GO:0000139; GO:0004430; GO:0005524; GO:0005737; GO:0005741; GO:0005768; GO:0005829; GO:0006661; GO:0006898; GO:0007165; GO:0016020; GO:0016032; GO:0030867; GO:0046854; GO:0048015; GO:0048471; GO:0071889	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum membrane [GO:0030867]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; viral process [GO:0016032]
PGEN_.00g308520	Scaffold_15	28750202	28751458	Q96PE6	ZIM3_HUMAN	Zinc finger imprinted 3 (Zinc finger protein 657)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g308530	Scaffold_15	28776904	28788769	O18326	HUNB_BOMMO	Protein hunchback (Fragment)	GO:0000981; GO:0003677; GO:0005634; GO:0035282; GO:0040034; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of development, heterochronic [GO:0040034]; segmentation [GO:0035282]"
PGEN_.00g308540	Scaffold_15	28860857	28862092	NA	NA	NA	NA	NA
PGEN_.00g308550	Scaffold_15	28868435	28869685	NA	NA	NA	NA	NA
PGEN_.00g308560	Scaffold_15	28872872	28874351	NA	NA	NA	NA	NA
PGEN_.00g308570	Scaffold_15	28901101	28907923	Q02988	LECA_PLEWA	Lectin	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g308580	Scaffold_15	28909493	28911502	NA	NA	NA	NA	NA
PGEN_.00g308590	Scaffold_15	28974785	28976378	NA	NA	NA	NA	NA
PGEN_.00g308600	Scaffold_15	28981110	28988246	NA	NA	NA	NA	NA
PGEN_.00g308610	Scaffold_15	28991052	28997942	NA	NA	NA	NA	NA
PGEN_.00g308620	Scaffold_15	29024757	29026351	NA	NA	NA	NA	NA
PGEN_.00g308630	Scaffold_15	29108268	29120635	NA	NA	NA	NA	NA
PGEN_.00g308640	Scaffold_15	29152564	29163909	Q8C5K5	CX038_MOUSE	Uncharacterized protein CXorf38 homolog		
PGEN_.00g308650	Scaffold_15	29199687	29206270	NA	NA	NA	NA	NA
PGEN_.00g308660	Scaffold_15	29232766	29239746	Q803I2	ERGI3_DANRE	Endoplasmic reticulum-Golgi intermediate compartment protein 3	GO:0005783; GO:0006888; GO:0006890; GO:0030134; GO:0030173; GO:0030176; GO:0033116	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g308670	Scaffold_15	29240354	29245998	A4QNF3	ROMO1_XENTR	Reactive oxygen species modulator 1 (ROS modulator 1) (Protein MGR2 homolog)	GO:0001302; GO:0005739; GO:0005744; GO:0008284; GO:0016021; GO:0030150; GO:0034614; GO:0042742; GO:0045039; GO:2000379	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]
PGEN_.00g308680	Scaffold_15	29246153	29267735	Q803I2	ERGI3_DANRE	Endoplasmic reticulum-Golgi intermediate compartment protein 3	GO:0005783; GO:0006888; GO:0006890; GO:0030134; GO:0030173; GO:0030176; GO:0033116	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g308690	Scaffold_15	29283869	29307826	NA	NA	NA	NA	NA
PGEN_.00g308700	Scaffold_15	29361209	29362816	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g308710	Scaffold_15	29374030	29374572	NA	NA	NA	NA	NA
PGEN_.00g308720	Scaffold_15	29374623	29375036	NA	NA	NA	NA	NA
PGEN_.00g308730	Scaffold_15	29467647	29468384	NA	NA	NA	NA	NA
PGEN_.00g308740	Scaffold_15	29509068	29510045	NA	NA	NA	NA	NA
PGEN_.00g308750	Scaffold_15	29526252	29531523	NA	NA	NA	NA	NA
PGEN_.00g308760	Scaffold_15	29625938	29626225	NA	NA	NA	NA	NA
PGEN_.00g308770	Scaffold_15	29630370	29637810	P34927	ASGR1_MOUSE	Asialoglycoprotein receptor 1 (ASGP-R 1) (ASGPR 1) (Hepatic lectin 1) (HL-1) (mHL-1)	GO:0004873; GO:0016021; GO:0030246; GO:0031668; GO:0042803; GO:0046872	integral component of membrane [GO:0016021]; asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; cellular response to extracellular stimulus [GO:0031668]
PGEN_.00g308780	Scaffold_15	29656806	29664226	P34927	ASGR1_MOUSE	Asialoglycoprotein receptor 1 (ASGP-R 1) (ASGPR 1) (Hepatic lectin 1) (HL-1) (mHL-1)	GO:0004873; GO:0016021; GO:0030246; GO:0031668; GO:0042803; GO:0046872	integral component of membrane [GO:0016021]; asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; cellular response to extracellular stimulus [GO:0031668]
PGEN_.00g308790	Scaffold_15	29668372	29668659	NA	NA	NA	NA	NA
PGEN_.00g308800	Scaffold_15	29763385	29768657	NA	NA	NA	NA	NA
PGEN_.00g308810	Scaffold_15	29784844	29785820	NA	NA	NA	NA	NA
PGEN_.00g308820	Scaffold_15	29916896	29917201	NA	NA	NA	NA	NA
PGEN_.00g308830	Scaffold_15	29925004	29926611	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g308840	Scaffold_15	29977200	30004336	NA	NA	NA	NA	NA
PGEN_.00g308850	Scaffold_15	30020468	30037289	Q803I2	ERGI3_DANRE	Endoplasmic reticulum-Golgi intermediate compartment protein 3	GO:0005783; GO:0006888; GO:0006890; GO:0030134; GO:0030173; GO:0030176; GO:0033116	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g308860	Scaffold_15	30040461	30041247	A4QNF3	ROMO1_XENTR	Reactive oxygen species modulator 1 (ROS modulator 1) (Protein MGR2 homolog)	GO:0001302; GO:0005739; GO:0005744; GO:0008284; GO:0016021; GO:0030150; GO:0034614; GO:0042742; GO:0045039; GO:2000379	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; cellular response to reactive oxygen species [GO:0034614]; defense response to bacterium [GO:0042742]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative cell aging [GO:0001302]
PGEN_.00g308870	Scaffold_15	30044683	30052627	Q5EAE0	ERGI3_BOVIN	Endoplasmic reticulum-Golgi intermediate compartment protein 3	GO:0005783; GO:0006888; GO:0006890; GO:0030134; GO:0030173; GO:0030176; GO:0033116	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g308880	Scaffold_15	30065170	30094802	P09057	DCOR_RAT	Ornithine decarboxylase (ODC) (EC 4.1.1.17)	GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]
PGEN_.00g308890	Scaffold_15	30095532	30113780	P13010	XRCC5_HUMAN	X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining))	GO:0000723; GO:0000783; GO:0000784; GO:0002218; GO:0003677; GO:0003678; GO:0003684; GO:0003690; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007420; GO:0008022; GO:0008047; GO:0008283; GO:0016020; GO:0031625; GO:0032204; GO:0032212; GO:0032481; GO:0032991; GO:0032993; GO:0034774; GO:0042162; GO:0042493; GO:0043085; GO:0043312; GO:0043564; GO:0044212; GO:0044877; GO:0045027; GO:0045087; GO:0045860; GO:0045892; GO:0048660; GO:0050769; GO:0051973; GO:0060218; GO:0070198; GO:0070419; GO:0071398; GO:0071475; GO:0071480; GO:0071481; GO:0075713; GO:0090734; GO:1904430; GO:1990830; GO:1990904	"cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of type I interferon production [GO:0032481]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]"
PGEN_.00g308900	Scaffold_15	30115591	30135925	P27641	XRCC5_MOUSE	X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku autoantigen protein p86 homolog) (Ku80) (Nuclear factor IV)	GO:0000723; GO:0000784; GO:0002218; GO:0003678; GO:0003684; GO:0003691; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007420; GO:0008022; GO:0008283; GO:0031625; GO:0032212; GO:0032991; GO:0032993; GO:0042162; GO:0042493; GO:0043564; GO:0044212; GO:0044877; GO:0045027; GO:0045087; GO:0045860; GO:0045892; GO:0048660; GO:0050769; GO:0051575; GO:0060218; GO:0070419; GO:0071398; GO:0071475; GO:0071480; GO:0071481; GO:0090734; GO:1904430; GO:1990830; GO:1990904	"cytoplasm [GO:0005737]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded telomeric DNA binding [GO:0003691]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of smooth muscle cell proliferation [GO:0048660]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]"
PGEN_.00g308910	Scaffold_15	30154015	30185524	P48506	GSH1_HUMAN	Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)	GO:0000287; GO:0004357; GO:0005524; GO:0005623; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237	"cell [GO:0005623]; cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; coenzyme binding [GO:0050662]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel diameter [GO:0097746]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"
PGEN_.00g308920	Scaffold_15	30214226	30215584	Q5R5U3	ZN271_PONAB	Zinc finger protein 271	GO:0000976; GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]
PGEN_.00g308930	Scaffold_15	30220888	30222243	NA	NA	NA	NA	NA
PGEN_.00g308940	Scaffold_15	30230493	30233781	NA	NA	NA	NA	NA
PGEN_.00g308950	Scaffold_15	30250725	30253506	NA	NA	NA	NA	NA
PGEN_.00g308960	Scaffold_15	30253579	30255397	NA	NA	NA	NA	NA
PGEN_.00g308970	Scaffold_15	30256878	30261165	Q93075	TATD2_HUMAN	Putative deoxyribonuclease TATDN2 (EC 3.1.21.-)	GO:0005634; GO:0005654; GO:0016888; GO:0036498; GO:0046872	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]"
PGEN_.00g308980	Scaffold_15	30285277	30288371	NA	NA	NA	NA	NA
PGEN_.00g308990	Scaffold_15	30288424	30296178	Q3MIS6	ZN528_HUMAN	Zinc finger protein 528	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g309000	Scaffold_15	30318572	30324155	Q05481	ZNF91_HUMAN	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]"
PGEN_.00g309010	Scaffold_15	30340101	30340847	NA	NA	NA	NA	NA
PGEN_.00g309020	Scaffold_15	30393284	30394848	NA	NA	NA	NA	NA
PGEN_.00g309030	Scaffold_15	30403444	30487440	Q2PC93	SSPO_CHICK	SCO-spondin	GO:0005615; GO:0007155; GO:0007399; GO:0030154	extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g309040	Scaffold_15	30550782	30551270	NA	NA	NA	NA	NA
PGEN_.00g309050	Scaffold_15	30572846	30575117	NA	NA	NA	NA	NA
PGEN_.00g309060	Scaffold_15	30631784	30685976	Q2PC93	SSPO_CHICK	SCO-spondin	GO:0005615; GO:0007155; GO:0007399; GO:0030154	extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]
PGEN_.00g309070	Scaffold_15	30716045	30716263	NA	NA	NA	NA	NA
PGEN_.00g309080	Scaffold_15	30728040	30728291	NA	NA	NA	NA	NA
PGEN_.00g309090	Scaffold_15	30732685	30743486	Q96KE9	BTBD6_HUMAN	BTB/POZ domain-containing protein 6 (Lens BTB domain protein)	GO:0005829; GO:0022008; GO:0043687	cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687]
PGEN_.00g309100	Scaffold_15	30776568	30777869	NA	NA	NA	NA	NA
PGEN_.00g309110	Scaffold_15	30854318	30854572	NA	NA	NA	NA	NA
PGEN_.00g309120	Scaffold_15	30879237	30879977	Q5VV17	OTUD1_HUMAN	OTU domain-containing protein 1 (EC 3.4.19.12) (DUBA-7)	GO:0004843; GO:0070536	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K63-linked deubiquitination [GO:0070536]
PGEN_.00g309130	Scaffold_15	30906294	31017063	O15050	TRNK1_HUMAN	TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)		
PGEN_.00g309140	Scaffold_15	31030192	31053980	NA	NA	NA	NA	NA
PGEN_.00g309150	Scaffold_15	31055229	31083784	Q3UMF9	FAXC_MOUSE	Failed axon connections homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g309160	Scaffold_15	31110888	31112897	NA	NA	NA	NA	NA
PGEN_.00g309170	Scaffold_15	31113832	31114707	NA	NA	NA	NA	NA
PGEN_.00g309180	Scaffold_15	31115094	31132520	NA	NA	NA	NA	NA
PGEN_.00g309190	Scaffold_15	31117598	31122019	NA	NA	NA	NA	NA
PGEN_.00g309200	Scaffold_15	31133837	31188110	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g309210	Scaffold_15	31190376	31190714	NA	NA	NA	NA	NA
PGEN_.00g309220	Scaffold_15	31190826	31195044	NA	NA	NA	NA	NA
PGEN_.00g309230	Scaffold_15	31205231	31215035	NA	NA	NA	NA	NA
PGEN_.00g309240	Scaffold_15	31246834	31259627	A1L0T3	SRB4D_MOUSE	Scavenger receptor cysteine-rich domain-containing group B protein (Four scavenger receptor cysteine-rich domains-containing protein) (S4D-SRCRB)	GO:0005044; GO:0005576; GO:0009897	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; scavenger receptor activity [GO:0005044]
PGEN_.00g309250	Scaffold_15	31261790	31267499	NA	NA	NA	NA	NA
PGEN_.00g309260	Scaffold_15	31288306	31342851	NA	NA	NA	NA	NA
PGEN_.00g309270	Scaffold_15	31349712	31357503	NA	NA	NA	NA	NA
PGEN_.00g309280	Scaffold_15	31390201	31396888	NA	NA	NA	NA	NA
PGEN_.00g309290	Scaffold_15	31502295	31506823	Q9C509	SGPL_ARATH	Sphingosine-1-phosphate lyase (AtSPL1) (S1PL) (SP-lyase) (SPL) (EC 4.1.2.27) (Dihydrosphingosine phosphate lyase 1) (AtDPL1) (Sphingosine-1-phosphate aldolase)	GO:0005783; GO:0005789; GO:0006665; GO:0008117; GO:0016021; GO:0016831; GO:0019752; GO:0030149; GO:0030170	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]
PGEN_.00g309300	Scaffold_15	31518191	31518490	NA	NA	NA	NA	NA
PGEN_.00g309310	Scaffold_15	31518633	31519097	NA	NA	NA	NA	NA
PGEN_.00g309320	Scaffold_15	31519152	31522701	NA	NA	NA	NA	NA
PGEN_.00g309330	Scaffold_15	31521442	31529227	NA	NA	NA	NA	NA
PGEN_.00g309340	Scaffold_15	31523790	31524834	NA	NA	NA	NA	NA
PGEN_.00g309350	Scaffold_15	31540026	31551654	NA	NA	NA	NA	NA
PGEN_.00g309360	Scaffold_15	31574130	31578403	NA	NA	NA	NA	NA
PGEN_.00g309370	Scaffold_15	31579093	31579365	NA	NA	NA	NA	NA
PGEN_.00g309380	Scaffold_15	31582883	31586535	NA	NA	NA	NA	NA
PGEN_.00g309390	Scaffold_15	31588045	31588431	NA	NA	NA	NA	NA
PGEN_.00g309400	Scaffold_15	31588535	31588984	NA	NA	NA	NA	NA
PGEN_.00g309410	Scaffold_15	31590327	31590992	NA	NA	NA	NA	NA
PGEN_.00g309420	Scaffold_15	31657505	31662892	Q8WQI5	RS8_SPOFR	40S ribosomal protein S8	GO:0003735; GO:0005840; GO:0006412	ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g309430	Scaffold_15	31677017	31689743	Q5R795	MFF_PONAB	Mitochondrial fission factor	GO:0000266; GO:0005741; GO:0005777; GO:0008021; GO:0008053; GO:0016021; GO:0030054; GO:0042803; GO:0090141; GO:0090314	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]; synaptic vesicle [GO:0008021]; protein homodimerization activity [GO:0042803]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]
PGEN_.00g309440	Scaffold_15	31690888	31697124	Q9CWH4	RE114_MOUSE	Meiotic recombination protein REC114	GO:0006310; GO:0051321	DNA recombination [GO:0006310]; meiotic cell cycle [GO:0051321]
PGEN_.00g309450	Scaffold_15	31701009	31702027	NA	NA	NA	NA	NA
PGEN_.00g309460	Scaffold_15	31705991	31711448	Q9W706	FXF1A_XENLA	Forkhead box protein F1-A (FoxF1-A) (FoxF1a) (Fork head domain-related protein 13) (xFD-13)	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0008283; GO:0030154; GO:0030509; GO:0043565; GO:0045893; GO:0048566; GO:0048745	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; embryonic digestive tract development [GO:0048566]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; smooth muscle tissue development [GO:0048745]"
PGEN_.00g309470	Scaffold_15	31715425	31764687	Q9UKV8	AGO2_HUMAN	Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer)	GO:0000340; GO:0000932; GO:0000993; GO:0001047; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0007223; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016020; GO:0016442; GO:0030054; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0060964; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904	"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"
PGEN_.00g309480	Scaffold_15	31775568	31776101	NA	NA	NA	NA	NA
PGEN_.00g309490	Scaffold_15	31778950	31786663	Q8TD35	LKAM1_HUMAN	Protein LKAAEAR1 (LKAAEAR motif-containing protein 1)		
PGEN_.00g309500	Scaffold_15	31801185	31801910	NA	NA	NA	NA	NA
PGEN_.00g309510	Scaffold_15	31801934	31802227	NA	NA	NA	NA	NA
PGEN_.00g309520	Scaffold_15	31828256	31833636	O00559	RCAS1_HUMAN	Receptor-binding cancer antigen expressed on SiSo cells (Cancer-associated surface antigen RCAS1) (Estrogen receptor-binding fragment-associated gene 9 protein)	GO:0000139; GO:0001558; GO:0016021; GO:0016505; GO:0030141	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; secretory granule [GO:0030141]; peptidase activator activity involved in apoptotic process [GO:0016505]; regulation of cell growth [GO:0001558]
PGEN_.00g309530	Scaffold_15	31833765	31840073	NA	NA	NA	NA	NA
PGEN_.00g309540	Scaffold_15	31859497	31872847	Q9NS00	C1GLT_HUMAN	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)"	GO:0000139; GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016266; GO:0016267; GO:0046872; GO:0060576	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; O-glycan processing [GO:0016266]; O-glycan processing, core 1 [GO:0016267]"
PGEN_.00g309550	Scaffold_15	31877046	31880133	NA	NA	NA	NA	NA
PGEN_.00g309560	Scaffold_15	31880189	31880515	NA	NA	NA	NA	NA
PGEN_.00g309570	Scaffold_15	31898261	31953724	NA	NA	NA	NA	NA
PGEN_.00g309580	Scaffold_15	31905572	31905931	NA	NA	NA	NA	NA
PGEN_.00g309590	Scaffold_15	31940605	31941231	NA	NA	NA	NA	NA
PGEN_.00g309600	Scaffold_15	31968401	31979047	Q8L7C8	RWA1_ARATH	Protein REDUCED WALL ACETYLATION 1 (EC 2.3.1.-)	GO:0000139; GO:0005794; GO:0005975; GO:0009834; GO:0010411; GO:0016021; GO:0016407; GO:0016491; GO:0045491; GO:0045492; GO:1990937	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetyltransferase activity [GO:0016407]; oxidoreductase activity [GO:0016491]; carbohydrate metabolic process [GO:0005975]; plant-type secondary cell wall biogenesis [GO:0009834]; xylan acetylation [GO:1990937]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491]; xyloglucan metabolic process [GO:0010411]
PGEN_.00g309610	Scaffold_15	31982410	31983490	NA	NA	NA	NA	NA
PGEN_.00g309620	Scaffold_15	31983531	31983836	NA	NA	NA	NA	NA
PGEN_.00g309630	Scaffold_15	31996839	31997297	NA	NA	NA	NA	NA
PGEN_.00g309640	Scaffold_15	31997541	31997939	NA	NA	NA	NA	NA
PGEN_.00g309650	Scaffold_15	31998168	31999498	NA	NA	NA	NA	NA
PGEN_.00g309660	Scaffold_15	32048456	32049706	NA	NA	NA	NA	NA
PGEN_.00g309670	Scaffold_15	32051206	32054707	NA	NA	NA	NA	NA
PGEN_.00g309680	Scaffold_15	32103830	32104138	NA	NA	NA	NA	NA
PGEN_.00g309690	Scaffold_15	32211124	32212164	NA	NA	NA	NA	NA
PGEN_.00g309700	Scaffold_15	32211567	32211941	NA	NA	NA	NA	NA
PGEN_.00g309710	Scaffold_15	32225548	32226843	NA	NA	NA	NA	NA
PGEN_.00g309720	Scaffold_15	32247133	32247621	NA	NA	NA	NA	NA
PGEN_.00g309730	Scaffold_15	32260728	32273667	NA	NA	NA	NA	NA
PGEN_.00g309740	Scaffold_15	32286011	32286328	NA	NA	NA	NA	NA
PGEN_.00g309750	Scaffold_15	32381282	32386053	NA	NA	NA	NA	NA
PGEN_.00g309760	Scaffold_15	32400158	32415414	Q9EQW7	KI13A_MOUSE	Kinesin-like protein KIF13A	GO:0003777; GO:0005524; GO:0005623; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383	cell [GO:0005623]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]
PGEN_.00g309770	Scaffold_15	32419421	32420992	F1MT22	LGR5_BOVIN	Leucine-rich repeat-containing G-protein coupled receptor 5	GO:0004888; GO:0005887; GO:0007189; GO:0007190; GO:0008528; GO:0009755; GO:0016500; GO:0032588; GO:0090263	integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of canonical Wnt signaling pathway [GO:0090263]
PGEN_.00g309780	Scaffold_15	32425915	32426172	NA	NA	NA	NA	NA
PGEN_.00g309790	Scaffold_15	32426303	32432659	NA	NA	NA	NA	NA
PGEN_.00g309800	Scaffold_15	32438370	32567442	Q9EQW7	KI13A_MOUSE	Kinesin-like protein KIF13A	GO:0003777; GO:0005524; GO:0005623; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383	cell [GO:0005623]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]
PGEN_.00g309810	Scaffold_15	32584672	32585022	NA	NA	NA	NA	NA
PGEN_.00g309820	Scaffold_15	32585502	32585810	NA	NA	NA	NA	NA
PGEN_.00g309830	Scaffold_15	32585948	32587436	NA	NA	NA	NA	NA
PGEN_.00g309840	Scaffold_15	32587959	32589134	Q6ZMV8	ZN730_HUMAN	Putative zinc finger protein 730	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g309850	Scaffold_15	32590626	32618022	Q8MP06	SNO1_TYRJA	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	GO:0004499; GO:0005576; GO:0009820; GO:0033784; GO:0050660; GO:0050661; GO:0051289; GO:0055114	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
PGEN_.00g309860	Scaffold_15	32717407	32725064	Q8K078	SO4A1_MOUSE	Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)	GO:0005887; GO:0008514; GO:0015347; GO:0015349; GO:0015711; GO:0042403; GO:0043252	integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]
PGEN_.00g309870	Scaffold_15	32738387	32739157	NA	NA	NA	NA	NA
PGEN_.00g309880	Scaffold_15	32745029	32745265	NA	NA	NA	NA	NA
PGEN_.00g309890	Scaffold_15	32752104	32752391	NA	NA	NA	NA	NA
PGEN_.00g309900	Scaffold_15	32864634	32864957	NA	NA	NA	NA	NA
PGEN_.00g309910	Scaffold_15	32865242	32872689	NA	NA	NA	NA	NA
PGEN_.00g309920	Scaffold_15	32888425	32901720	Q8VCR2	DHB13_MOUSE	17-beta-hydroxysteroid dehydrogenase 13 (17-beta-HSD 13) (EC 1.1.-.-) (Alcohol dehydrogenase PAN1B-like) (Short-chain dehydrogenase/reductase 9)	GO:0005783; GO:0005811; GO:0016229; GO:0046889	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; steroid dehydrogenase activity [GO:0016229]; positive regulation of lipid biosynthetic process [GO:0046889]
PGEN_.00g309930	Scaffold_15	32909959	32916617	Q6ZMW2	ZN782_HUMAN	Zinc finger protein 782	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g309940	Scaffold_15	32961807	32967277	NA	NA	NA	NA	NA
PGEN_.00g309950	Scaffold_15	32996480	33000552	NA	NA	NA	NA	NA
PGEN_.00g309960	Scaffold_15	33003562	33015707	P52899	ODPA_CAEEL	"Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)"	GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]
PGEN_.00g309970	Scaffold_15	33025495	33025737	NA	NA	NA	NA	NA
PGEN_.00g309980	Scaffold_15	33025798	33026193	NA	NA	NA	NA	NA
PGEN_.00g309990	Scaffold_15	33027337	33027636	NA	NA	NA	NA	NA
PGEN_.00g310000	Scaffold_15	33028970	33029830	NA	NA	NA	NA	NA
PGEN_.00g310010	Scaffold_15	33112230	33113111	Q9NBX4	RTXE_DROME	Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)	GO:0003964; GO:0006313	"RNA-directed DNA polymerase activity [GO:0003964]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g310020	Scaffold_15	33124572	33124964	NA	NA	NA	NA	NA
PGEN_.00g310030	Scaffold_15	33164060	33168323	NA	NA	NA	NA	NA
PGEN_.00g310040	Scaffold_15	33253736	33262198	NA	NA	NA	NA	NA
PGEN_.00g310050	Scaffold_15	33296697	33297014	NA	NA	NA	NA	NA
PGEN_.00g310060	Scaffold_15	33302628	33315355	A7S7F2	BYST_NEMVE	Bystin	GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0030515; GO:0030688	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]"
PGEN_.00g310070	Scaffold_15	33320219	33320968	A7S7F2	BYST_NEMVE	Bystin	GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0030515; GO:0030688	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]"
PGEN_.00g310080	Scaffold_15	33321718	33344538	A2RT67	DEND3_MOUSE	DENN domain-containing protein 3	GO:0005737; GO:0008333; GO:0017112; GO:0044257	cytoplasm [GO:0005737]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333]
PGEN_.00g310090	Scaffold_15	33348578	33364618	A2RUS2	DEND3_HUMAN	DENN domain-containing protein 3	GO:0005829; GO:0008333; GO:0017112; GO:0044257	cytosol [GO:0005829]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333]
PGEN_.00g310100	Scaffold_15	33428744	33439708	P86789	GIGA6_CRAGI	Gigasin-6	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g310110	Scaffold_15	33530104	33530619	NA	NA	NA	NA	NA
PGEN_.00g310120	Scaffold_15	33549239	33549796	NA	NA	NA	NA	NA
PGEN_.00g310130	Scaffold_15	33562447	33573280	A8Y1P7	BRE4_CAEBR	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	GO:0005975; GO:0006486; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	"integral component of membrane [GO:0016021]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"
PGEN_.00g310140	Scaffold_15	33580738	33588404	NA	NA	NA	NA	NA
PGEN_.00g310150	Scaffold_15	33716636	33733505	D3Z7P3	GLSK_MOUSE	"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0042802; GO:0045202; GO:0051289; GO:0090461	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; identical protein binding [GO:0042802]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]
PGEN_.00g310160	Scaffold_15	33765541	33766053	NA	NA	NA	NA	NA
PGEN_.00g310170	Scaffold_15	33766103	33767228	NA	NA	NA	NA	NA
PGEN_.00g310180	Scaffold_15	33770065	33770340	NA	NA	NA	NA	NA
PGEN_.00g310190	Scaffold_15	33787762	33800894	NA	NA	NA	NA	NA
PGEN_.00g310200	Scaffold_15	33811590	33812234	NA	NA	NA	NA	NA
PGEN_.00g310210	Scaffold_15	33814699	33855441	Q66KZ9	NKAI3_XENLA	Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 3)	GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]
PGEN_.00g310220	Scaffold_15	33864218	33864478	NA	NA	NA	NA	NA
PGEN_.00g310230	Scaffold_15	33876267	33876560	NA	NA	NA	NA	NA
PGEN_.00g310240	Scaffold_15	33880044	33881951	Q17QK8	SPRE_BOVIN	Sepiapterin reductase (SPR) (EC 1.1.1.153)	GO:0004757; GO:0005737; GO:0006729	cytoplasm [GO:0005737]; sepiapterin reductase activity [GO:0004757]; tetrahydrobiopterin biosynthetic process [GO:0006729]
PGEN_.00g310250	Scaffold_15	33884691	33893471	P27120	DCOR1_XENLA	Ornithine decarboxylase 1 (ODC 1) (xODC1) (EC 4.1.1.17)	GO:0004586; GO:0005737; GO:0033387	cytoplasm [GO:0005737]; ornithine decarboxylase activity [GO:0004586]; putrescine biosynthetic process from ornithine [GO:0033387]
PGEN_.00g310260	Scaffold_15	33902351	33902857	NA	NA	NA	NA	NA
PGEN_.00g310270	Scaffold_15	33910893	33914542	NA	NA	NA	NA	NA
PGEN_.00g310280	Scaffold_15	33916256	33928406	NA	NA	NA	NA	NA
PGEN_.00g310290	Scaffold_15	34060627	34066377	Q8BSY0	ASPH_MOUSE	Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase)	GO:0004597; GO:0005509; GO:0005623; GO:0005737; GO:0005783; GO:0005886; GO:0007389; GO:0008285; GO:0010524; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033198; GO:0035108; GO:0042264; GO:0045862; GO:0045893; GO:0051480; GO:0060021; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879	"cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]"
PGEN_.00g310300	Scaffold_15	34068658	34089159	Q28056	ASPH_BOVIN	Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase)	GO:0004597; GO:0005789; GO:0005886; GO:0007389; GO:0008285; GO:0016021; GO:0031647; GO:0032541; GO:0035108; GO:0042264; GO:0046872; GO:0060021; GO:0060325; GO:0062101; GO:0097202; GO:1901879	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; activation of cysteine-type endopeptidase activity [GO:0097202]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; roof of mouth development [GO:0060021]
PGEN_.00g310310	Scaffold_15	34142276	34157424	NA	NA	NA	NA	NA
PGEN_.00g310320	Scaffold_15	34199373	34201995	NA	NA	NA	NA	NA
PGEN_.00g310330	Scaffold_15	34203049	34203399	NA	NA	NA	NA	NA
PGEN_.00g310340	Scaffold_15	34229577	34231798	NA	NA	NA	NA	NA
PGEN_.00g310350	Scaffold_15	34236527	34236850	NA	NA	NA	NA	NA
PGEN_.00g310360	Scaffold_15	34241417	34274851	NA	NA	NA	NA	NA
PGEN_.00g310370	Scaffold_15	34307109	34307582	NA	NA	NA	NA	NA
PGEN_.00g310380	Scaffold_15	34307776	34313730	NA	NA	NA	NA	NA
PGEN_.00g310390	Scaffold_15	34318853	34321883	NA	NA	NA	NA	NA
PGEN_.00g310400	Scaffold_15	34323536	34324135	NA	NA	NA	NA	NA
PGEN_.00g310410	Scaffold_15	34328151	34362896	NA	NA	NA	NA	NA
PGEN_.00g310420	Scaffold_15	34370478	34371110	NA	NA	NA	NA	NA
PGEN_.00g310430	Scaffold_15	34371395	34372244	NA	NA	NA	NA	NA
PGEN_.00g310440	Scaffold_15	34385961	34390781	NA	NA	NA	NA	NA
PGEN_.00g310450	Scaffold_15	34424286	34425937	NA	NA	NA	NA	NA
PGEN_.00g310460	Scaffold_15	34436814	34437116	NA	NA	NA	NA	NA
PGEN_.00g310470	Scaffold_15	34439613	34441063	Q9M2U3	ALPL_ARATH	Protein ALP1-like (EC 3.1.-.-)	GO:0004518; GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g310480	Scaffold_15	34473987	34498506	NA	NA	NA	NA	NA
PGEN_.00g310490	Scaffold_15	34525195	34525734	NA	NA	NA	NA	NA
PGEN_.00g310500	Scaffold_15	34547498	34551773	NA	NA	NA	NA	NA
PGEN_.00g310510	Scaffold_15	34571442	34572158	NA	NA	NA	NA	NA
PGEN_.00g310520	Scaffold_15	34581787	34614741	NA	NA	NA	NA	NA
PGEN_.00g310530	Scaffold_15	34641494	34641793	NA	NA	NA	NA	NA
PGEN_.00g310540	Scaffold_15	34667232	34750607	A0Q1R3	DNAJ_CLONN	Chaperone protein DnaJ	GO:0005524; GO:0005737; GO:0006260; GO:0006457; GO:0008270; GO:0009408; GO:0031072; GO:0051082	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; protein folding [GO:0006457]; response to heat [GO:0009408]
PGEN_.00g310550	Scaffold_15	34768586	34772751	NA	NA	NA	NA	NA
PGEN_.00g310560	Scaffold_15	34772808	34774352	NA	NA	NA	NA	NA
PGEN_.00g310570	Scaffold_15	34783734	34793620	NA	NA	NA	NA	NA
PGEN_.00g310580	Scaffold_15	34801822	34802046	NA	NA	NA	NA	NA
PGEN_.00g310590	Scaffold_15	34808487	34809876	NA	NA	NA	NA	NA
PGEN_.00g310600	Scaffold_15	34816235	34816657	NA	NA	NA	NA	NA
PGEN_.00g310610	Scaffold_15	34817151	34818790	NA	NA	NA	NA	NA
PGEN_.00g310620	Scaffold_15	34833321	34833650	NA	NA	NA	NA	NA
PGEN_.00g310630	Scaffold_15	34833771	34834040	NA	NA	NA	NA	NA
PGEN_.00g310640	Scaffold_15	34834191	34834472	NA	NA	NA	NA	NA
PGEN_.00g310650	Scaffold_15	34835915	34837351	NA	NA	NA	NA	NA
PGEN_.00g310660	Scaffold_15	34850223	34858792	NA	NA	NA	NA	NA
PGEN_.00g310670	Scaffold_15	34882791	34883183	NA	NA	NA	NA	NA
PGEN_.00g310680	Scaffold_15	34934762	34935395	NA	NA	NA	NA	NA
PGEN_.00g310690	Scaffold_15	34967572	34995347	Q9JKP8	CHRC1_MOUSE	Chromatin accessibility complex protein 1 (CHRAC-1) (DNA polymerase epsilon subunit p15) (NF-YC-like protein) (YC-like protein 1) (YCL1)	GO:0003677; GO:0003700; GO:0003887; GO:0005634; GO:0046982	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]
PGEN_.00g310700	Scaffold_15	35001113	35001961	NA	NA	NA	NA	NA
PGEN_.00g310710	Scaffold_15	35004506	35084868	NA	NA	NA	NA	NA
PGEN_.00g310720	Scaffold_15	35101306	35122598	O01802	RL7_CAEEL	60S ribosomal protein L7	GO:0000463; GO:0003723; GO:0003735; GO:0022625	"cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"
PGEN_.00g310730	Scaffold_15	35122942	35123274	Q7TQA3	RDHE2_MOUSE	Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase reductase 9) (Short-chain dehydrogenase/reductase family 16C member 5)	GO:0000122; GO:0003714; GO:0004745; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0008134; GO:0016021; GO:0017053; GO:0031065; GO:0033613; GO:0035067; GO:0042572; GO:0042574; GO:0043616	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; retinol dehydrogenase activity [GO:0004745]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]
PGEN_.00g310740	Scaffold_15	35139211	35170898	NA	NA	NA	NA	NA
PGEN_.00g310750	Scaffold_15	35173857	35178793	NA	NA	NA	NA	NA
PGEN_.00g310760	Scaffold_15	35178817	35212030	Q9DG68	RLA0_RANSY	60S acidic ribosomal protein P0 (60S ribosomal protein L10E)	GO:0005840; GO:0042254	ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]
PGEN_.00g310770	Scaffold_15	35292015	35319214	P51186	CAN3_BOVIN	Calpain-3 (EC 3.4.22.54) (Calcium-activated neutral proteinase 3) (CANP 3) (Calpain L3) (Calpain p94) (Muscle-specific calcium-activated neutral protease 3) (New calpain 1) (nCL-1)	GO:0003824; GO:0004198; GO:0005509; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0008233; GO:0008307; GO:0014718; GO:0014850; GO:0030016; GO:0030018; GO:0030239; GO:0030315; GO:0031402; GO:0031432; GO:0032991; GO:0033234; GO:0043066; GO:0043122; GO:0045214; GO:0045862; GO:0045892; GO:0045893; GO:0050790; GO:0051092; GO:0051281; GO:0051592; GO:0055103; GO:0060090; GO:0061061; GO:0065003; GO:0071277; GO:0071472; GO:0072657; GO:0097264; GO:1990092	"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; catalytic activity [GO:0003824]; ligase regulator activity [GO:0055103]; molecular adaptor activity [GO:0060090]; peptidase activity [GO:0008233]; sodium ion binding [GO:0031402]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; calcium-dependent self proteolysis [GO:1990092]; cellular response to calcium ion [GO:0071277]; cellular response to salt stress [GO:0071472]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to membrane [GO:0072657]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to calcium ion [GO:0051592]; response to muscle activity [GO:0014850]; sarcomere organization [GO:0045214]; self proteolysis [GO:0097264]"
PGEN_.00g310780	Scaffold_15	35326584	35326982	NA	NA	NA	NA	NA
PGEN_.00g310790	Scaffold_15	35336632	35353571	NA	NA	NA	NA	NA
PGEN_.00g310800	Scaffold_15	35438048	35471077	NA	NA	NA	NA	NA
PGEN_.00g310810	Scaffold_15	35475664	35476065	NA	NA	NA	NA	NA
PGEN_.00g310820	Scaffold_15	35486525	35536040	Q8BJH1	ZC21A_MOUSE	Zinc finger C2HC domain-containing protein 1A	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g310830	Scaffold_15	35556563	35561436	NA	NA	NA	NA	NA
PGEN_.00g310840	Scaffold_15	35567638	35597104	NA	NA	NA	NA	NA
PGEN_.00g310850	Scaffold_15	35597170	35600064	NA	NA	NA	NA	NA
PGEN_.00g310860	Scaffold_15	35608583	35615763	NA	NA	NA	NA	NA
PGEN_.00g310870	Scaffold_15	35615862	35616695	Q8NEP7	KLDC9_HUMAN	Kelch domain-containing protein 9 (Kelch/ankyrin repeat-containing cyclin A1-interacting protein)	GO:0030332	cyclin binding [GO:0030332]
PGEN_.00g310880	Scaffold_15	35640814	35641815	NA	NA	NA	NA	NA
PGEN_.00g310890	Scaffold_15	35642278	35655937	Q3USL1	KLDC9_MOUSE	Kelch domain-containing protein 9	GO:0030332	cyclin binding [GO:0030332]
PGEN_.00g310900	Scaffold_15	35662192	35671296	O94889	KLH18_HUMAN	Kelch-like protein 18	GO:0007049; GO:0016567; GO:0051301; GO:1901992	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]
PGEN_.00g310910	Scaffold_15	35686972	35698512	Q4V8D1	CP2U1_RAT	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g310920	Scaffold_15	35700632	35714264	NA	NA	NA	NA	NA
PGEN_.00g310930	Scaffold_15	35734319	35747731	NA	NA	NA	NA	NA
PGEN_.00g310940	Scaffold_15	35779161	35779454	NA	NA	NA	NA	NA
PGEN_.00g310950	Scaffold_15	35793124	35793459	NA	NA	NA	NA	NA
PGEN_.00g310960	Scaffold_15	35794000	35796269	NA	NA	NA	NA	NA
PGEN_.00g310970	Scaffold_15	35853138	35853401	NA	NA	NA	NA	NA
PGEN_.00g310980	Scaffold_15	35859564	35859971	NA	NA	NA	NA	NA
PGEN_.00g310990	Scaffold_15	35860155	35860613	NA	NA	NA	NA	NA
PGEN_.00g311000	Scaffold_15	35860819	35861646	NA	NA	NA	NA	NA
PGEN_.00g311010	Scaffold_15	35863361	35868893	NA	NA	NA	NA	NA
PGEN_.00g311020	Scaffold_15	35884301	35904187	Q5ZID0	NMRL1_CHICK	NmrA-like family domain-containing protein 1	GO:0005634; GO:0048471	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
PGEN_.00g311030	Scaffold_15	35950479	35959195	NA	NA	NA	NA	NA
PGEN_.00g311040	Scaffold_15	35995594	36011541	NA	NA	NA	NA	NA
PGEN_.00g311050	Scaffold_15	36025170	36050367	NA	NA	NA	NA	NA
PGEN_.00g311060	Scaffold_15	36063505	36063732	NA	NA	NA	NA	NA
PGEN_.00g311070	Scaffold_15	36068768	36088012	B3M1F2	CRBN_DROAN	Protein cereblon homolog	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g311080	Scaffold_15	36088828	36117779	Q6ZNC4	ZN704_HUMAN	Zinc finger protein 704	GO:0001158; GO:0005634; GO:0006357; GO:0046872	nucleus [GO:0005634]; enhancer sequence-specific DNA binding [GO:0001158]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g311090	Scaffold_15	36100517	36100792	NA	NA	NA	NA	NA
PGEN_.00g311100	Scaffold_15	36105311	36105586	NA	NA	NA	NA	NA
PGEN_.00g311110	Scaffold_15	36142183	36143136	NA	NA	NA	NA	NA
PGEN_.00g311120	Scaffold_15	36148611	36157584	NA	NA	NA	NA	NA
PGEN_.00g311130	Scaffold_15	36162426	36180571	Q61503	5NTD_MOUSE	5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73)	GO:0000166; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0007159; GO:0008198; GO:0008253; GO:0009986; GO:0016020; GO:0031225; GO:0046085; GO:0046086; GO:0050728; GO:0097060	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; 5'-nucleotidase activity [GO:0008253]; ferrous iron binding [GO:0008198]; nucleotide binding [GO:0000166]; adenosine biosynthetic process [GO:0046086]; adenosine metabolic process [GO:0046085]; AMP catabolic process [GO:0006196]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]
PGEN_.00g311140	Scaffold_15	36237107	36238257	NA	NA	NA	NA	NA
PGEN_.00g311150	Scaffold_15	36238712	36241275	NA	NA	NA	NA	NA
PGEN_.00g311160	Scaffold_15	36241727	36241987	NA	NA	NA	NA	NA
PGEN_.00g311170	Scaffold_15	36243042	36246758	NA	NA	NA	NA	NA
PGEN_.00g311180	Scaffold_15	36250943	36253626	NA	NA	NA	NA	NA
PGEN_.00g311190	Scaffold_15	36259441	36264805	B8NM66	USTA_ASPFN	Ribosomally synthesized cyclic peptide ustiloxin B precursosr (Ustiloxin B biosynthesis protein A) [Cleaved into: YAIG-I; YAIG-II; YAIG-III; YAIG-IV; YAIG-V; YAIG-VI; YAIG-VII; YAIG-VIII; YAIG-IX; YAIG-X; YAIG-XI; YAIG-XII; YAIG-XIII; YAIG-XIV; YAIG-XV; YAIG-XVI]		
PGEN_.00g311200	Scaffold_15	36286896	36292818	NA	NA	NA	NA	NA
PGEN_.00g311210	Scaffold_15	36341504	36344560	NA	NA	NA	NA	NA
PGEN_.00g311220	Scaffold_15	36377434	36377742	NA	NA	NA	NA	NA
PGEN_.00g311230	Scaffold_15	36382254	36382574	NA	NA	NA	NA	NA
PGEN_.00g311240	Scaffold_15	36453358	36453582	NA	NA	NA	NA	NA
PGEN_.00g311250	Scaffold_15	36456691	36476843	Q05481	ZNF91_HUMAN	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]"
PGEN_.00g311260	Scaffold_15	36477808	36478155	NA	NA	NA	NA	NA
PGEN_.00g311270	Scaffold_15	36484732	36485304	NA	NA	NA	NA	NA
PGEN_.00g311280	Scaffold_15	36492283	36504505	Q9Y575	ASB3_HUMAN	Ankyrin repeat and SOCS box protein 3 (ASB-3)	GO:0005829; GO:0016567; GO:0035556; GO:0043687	cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]
PGEN_.00g311290	Scaffold_15	36508907	36527314	A6QP15	HOT_BOVIN	"Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT) (EC 1.1.99.24) (Alcohol dehydrogenase iron-containing protein 1) (ADHFe1)"	GO:0004022; GO:0005739; GO:0006539; GO:0046872; GO:0047988	mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]
PGEN_.00g311300	Scaffold_15	36628932	36630805	NA	NA	NA	NA	NA
PGEN_.00g311310	Scaffold_15	36708824	36709222	NA	NA	NA	NA	NA
PGEN_.00g311320	Scaffold_15	36794766	36796217	Q56H79	NPSR1_MACMU	Neuropeptide S receptor (G-protein coupled receptor 154)	GO:0005000; GO:0005623; GO:0005887; GO:0007218; GO:0008188; GO:0051281	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; neuropeptide signaling pathway [GO:0007218]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]
PGEN_.00g311330	Scaffold_15	36802543	36807151	P34981	TRFR_HUMAN	Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor)	GO:0004997; GO:0005886; GO:0005887; GO:0007186; GO:0007200	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; thyrotropin-releasing hormone receptor activity [GO:0004997]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]
PGEN_.00g311340	Scaffold_15	36822843	36855626	Q9H2Y9	SO5A1_HUMAN	Solute carrier organic anion transporter family member 5A1 (Organic anion transporter polypeptide-related protein 4) (OATP-RP4) (OATPRP4) (Solute carrier family 21 member 15)	GO:0005886; GO:0005887; GO:0015347; GO:0043231; GO:0043252	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; sodium-independent organic anion transport [GO:0043252]
PGEN_.00g311350	Scaffold_15	36899122	36921342	Q9N2V2	NAS30_CAEEL	Zinc metalloproteinase nas-30 (EC 3.4.24.-) (Nematode astacin 30)	GO:0004222; GO:0008270	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g311360	Scaffold_15	36927681	36928385	NA	NA	NA	NA	NA
PGEN_.00g311370	Scaffold_15	36932962	36933372	NA	NA	NA	NA	NA
PGEN_.00g311380	Scaffold_15	36933654	36933869	NA	NA	NA	NA	NA
PGEN_.00g311390	Scaffold_15	36938062	36945125	Q9FF12	GSXL9_ARATH	Flavin-containing monooxygenase FMO GS-OX-like 9 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 9)	GO:0004499; GO:0050660; GO:0050661	"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
PGEN_.00g311400	Scaffold_15	36953271	36958148	NA	NA	NA	NA	NA
PGEN_.00g311410	Scaffold_15	36958179	36967271	Q5XEP2	HSOP2_ARATH	Hsp70-Hsp90 organizing protein 2 (AtHop2)	GO:0005634; GO:0005829; GO:0005886; GO:0046686; GO:0051131; GO:0051879; GO:0070678	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Hsp90 protein binding [GO:0051879]; preprotein binding [GO:0070678]; chaperone-mediated protein complex assembly [GO:0051131]; response to cadmium ion [GO:0046686]
PGEN_.00g311420	Scaffold_15	36978388	36981476	P71505	DLHH_METEA	Putative carboxymethylenebutenolidase (EC 3.1.1.45) (Dienelactone hydrolase) (DLH)	GO:0008806	carboxymethylenebutenolidase activity [GO:0008806]
PGEN_.00g311430	Scaffold_15	37009035	37009647	NA	NA	NA	NA	NA
PGEN_.00g311440	Scaffold_15	37015534	37016781	Q9VZW5	FMAR_DROME	FMRFamide receptor (DFR) (DrmFMRFa-R)	GO:0001653; GO:0002209; GO:0004930; GO:0005623; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
PGEN_.00g311450	Scaffold_15	37035057	37036384	NA	NA	NA	NA	NA
PGEN_.00g311460	Scaffold_15	37072962	37105111	A8G7S7	GHRB_SERP5	Glyoxylate/hydroxypyruvate reductase B (EC 1.1.1.79) (EC 1.1.1.81)	GO:0005737; GO:0005886; GO:0016618; GO:0030267; GO:0051287	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]
PGEN_.00g311470	Scaffold_15	37107461	37108285	NA	NA	NA	NA	NA
PGEN_.00g311480	Scaffold_15	37135537	37142320	NA	NA	NA	NA	NA
PGEN_.00g311490	Scaffold_15	37175363	37175848	NA	NA	NA	NA	NA
PGEN_.00g311500	Scaffold_15	37175969	37176424	NA	NA	NA	NA	NA
PGEN_.00g311510	Scaffold_15	37189978	37190454	NA	NA	NA	NA	NA
PGEN_.00g311520	Scaffold_15	37190517	37192443	NA	NA	NA	NA	NA
PGEN_.00g311530	Scaffold_15	37201880	37206986	NA	NA	NA	NA	NA
PGEN_.00g311540	Scaffold_15	37209423	37209800	NA	NA	NA	NA	NA
PGEN_.00g311550	Scaffold_15	37210113	37210901	NA	NA	NA	NA	NA
PGEN_.00g311560	Scaffold_15	37225150	37232357	NA	NA	NA	NA	NA
PGEN_.00g311570	Scaffold_15	37232704	37281346	Q9Y6Q9	NCOA3_HUMAN	Nuclear receptor coactivator 3 (NCoA-3) (EC 2.3.1.48) (ACTR) (Amplified in breast cancer 1 protein) (AIB-1) (CBP-interacting protein) (pCIP) (Class E basic helix-loop-helix protein 42) (bHLHe42) (Receptor-associated coactivator 3) (RAC-3) (Steroid receptor coactivator protein 3) (SRC-3) (Thyroid hormone receptor activator molecule 1) (TRAM-1)	GO:0000790; GO:0000981; GO:0000993; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0010628; GO:0016922; GO:0030374; GO:0030521; GO:0032870; GO:0032991; GO:0035257; GO:0035624; GO:0043697; GO:0045618; GO:0045893; GO:0045944; GO:0046966; GO:0046982; GO:0047485; GO:0050681; GO:0070062; GO:0071392; GO:0097718; GO:1902459; GO:2000035; GO:2001141	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; androgen receptor binding [GO:0050681]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; RNA polymerase II complex binding [GO:0000993]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; cell dedifferentiation [GO:0043697]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hormone stimulus [GO:0032870]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; receptor transactivation [GO:0035624]; regulation of RNA biosynthetic process [GO:2001141]; regulation of stem cell division [GO:2000035]"
PGEN_.00g311580	Scaffold_15	37317984	37318256	NA	NA	NA	NA	NA
PGEN_.00g311590	Scaffold_15	37348429	37354431	NA	NA	NA	NA	NA
PGEN_.00g311600	Scaffold_15	37372395	37372712	NA	NA	NA	NA	NA
PGEN_.00g311610	Scaffold_15	37388456	37399945	Q7TQF2	FBX10_MOUSE	F-box only protein 10	GO:0004842; GO:0005737; GO:0006511; GO:0006915; GO:0016567; GO:0042981	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g311620	Scaffold_15	37410129	37411583	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g311630	Scaffold_15	37413714	37424653	Q9UK96	FBX10_HUMAN	F-box only protein 10	GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0042981; GO:0043687	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g311640	Scaffold_15	37429727	37430459	NA	NA	NA	NA	NA
PGEN_.00g311650	Scaffold_15	37439294	37443729	Q63ZI0	KCNK9_XENLA	Potassium channel subfamily K member 9	GO:0005267; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]
PGEN_.00g311660	Scaffold_15	37447889	37448095	NA	NA	NA	NA	NA
PGEN_.00g311670	Scaffold_15	37453571	37454724	Q9BXJ2	C1QT7_HUMAN	Complement C1q tumor necrosis factor-related protein 7	GO:0005576; GO:0005581	collagen trimer [GO:0005581]; extracellular region [GO:0005576]
PGEN_.00g311680	Scaffold_15	37483130	37501518	NA	NA	NA	NA	NA
PGEN_.00g311690	Scaffold_15	37509282	37530564	Q7LFX5	CHSTF_HUMAN	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]
PGEN_.00g311700	Scaffold_15	37559351	37571229	Q80UX8	ABHDD_MOUSE	Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13)	GO:0002084; GO:0005737; GO:0008474; GO:0016021; GO:0032839	cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084]
PGEN_.00g311710	Scaffold_15	37576108	37578300	NA	NA	NA	NA	NA
PGEN_.00g311720	Scaffold_15	37581045	37645408	P80147	GABT_PIG	"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)"	GO:0003867; GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042135; GO:0042803; GO:0046872; GO:0047298; GO:0048148; GO:0051537	"4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]"
PGEN_.00g311730	Scaffold_15	37649619	37649924	NA	NA	NA	NA	NA
PGEN_.00g311740	Scaffold_15	37658333	37686625	NA	NA	NA	NA	NA
PGEN_.00g311750	Scaffold_15	37693159	37710893	NA	NA	NA	NA	NA
PGEN_.00g311760	Scaffold_15	37714854	37719543	O95801	TTC4_HUMAN	Tetratricopeptide repeat protein 4 (TPR repeat protein 4)	GO:0005634; GO:0005654; GO:0005737; GO:0045087; GO:0051607	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]
PGEN_.00g311770	Scaffold_15	37723580	37762151	Q40642	CML1_ORYSI	Calmodulin-like protein 1 (OsCaM61)	GO:0005509; GO:0016020; GO:0019722	membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g311780	Scaffold_15	37764316	37765364	NA	NA	NA	NA	NA
PGEN_.00g311790	Scaffold_15	37766245	37828483	Q5T1H1	EYS_HUMAN	Protein eyes shut homolog (Epidermal growth factor-like protein 10) (EGF-like protein 10) (Epidermal growth factor-like protein 11) (EGF-like protein 11) (Protein spacemaker homolog)	GO:0001750; GO:0005509; GO:0005737; GO:0005815; GO:0033165; GO:0043403; GO:0050908; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; interphotoreceptor matrix [GO:0033165]; microtubule organizing center [GO:0005815]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; detection of light stimulus involved in visual perception [GO:0050908]; skeletal muscle tissue regeneration [GO:0043403]
PGEN_.00g311800	Scaffold_15	37831152	37835078	P56726	SMO_MOUSE	Smoothened homolog (SMO)	GO:0000122; GO:0001503; GO:0001570; GO:0001649; GO:0001701; GO:0001708; GO:0001755; GO:0001947; GO:0002052; GO:0002053; GO:0003007; GO:0003140; GO:0003323; GO:0004930; GO:0005113; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005901; GO:0005929; GO:0007224; GO:0007228; GO:0007368; GO:0007371; GO:0007389; GO:0007417; GO:0007494; GO:0008144; GO:0008284; GO:0009952; GO:0009953; GO:0010468; GO:0010628; GO:0010629; GO:0014069; GO:0016021; GO:0021542; GO:0021696; GO:0021794; GO:0021904; GO:0021910; GO:0021938; GO:0021953; GO:0021987; GO:0030335; GO:0030425; GO:0030666; GO:0030857; GO:0031069; GO:0034504; GO:0035264; GO:0040018; GO:0042307; GO:0042475; GO:0043025; GO:0043066; GO:0043231; GO:0043392; GO:0043524; GO:0044294; GO:0044295; GO:0045880; GO:0045892; GO:0045893; GO:0045944; GO:0046622; GO:0048143; GO:0048468; GO:0048565; GO:0048568; GO:0048589; GO:0048741; GO:0048846; GO:0048853; GO:0048873; GO:0050679; GO:0050821; GO:0051451; GO:0051799; GO:0060170; GO:0060248; GO:0060413; GO:0060644; GO:0060684; GO:0061053; GO:0061113; GO:0070986; GO:0071397; GO:0071679; GO:0072285; GO:0090190; GO:1901215; GO:1904754; GO:2000036; GO:2000179; GO:2000826	"axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; patched binding [GO:0005113]; anterior/posterior pattern specification [GO:0009952]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; axon extension involved in axon guidance [GO:0048846]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; dentate gyrus development [GO:0021542]; detection of cell density by contact stimulus involved in contact inhibition [GO:0060248]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic organ development [GO:0048568]; epithelial-mesenchymal cell signaling [GO:0060684]; forebrain morphogenesis [GO:0048853]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; pattern specification process [GO:0007389]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of heart morphogenesis [GO:2000826]; regulation of stem cell population maintenance [GO:2000036]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021910]; somite development [GO:0061053]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371]"
PGEN_.00g311810	Scaffold_15	37844148	37845251	NA	NA	NA	NA	NA
PGEN_.00g311820	Scaffold_15	37857710	37858345	A0MGZ7	H6S3B_DANRE	Heparan-sulfate 6-O-sulfotransferase 3-B (HS 6-OST-3-B) (EC 2.8.2.-)	GO:0008146; GO:0015015; GO:0016021; GO:0017095; GO:0050656; GO:0070492	"integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; oligosaccharide binding [GO:0070492]; sulfotransferase activity [GO:0008146]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]"
PGEN_.00g311830	Scaffold_15	37862736	37863341	O60243	H6ST1_HUMAN	Heparan-sulfate 6-O-sulfotransferase 1 (HS6ST-1) (EC 2.8.2.-)	GO:0000139; GO:0001525; GO:0005654; GO:0005887; GO:0006024; GO:0008146; GO:0015015; GO:0016607; GO:0017095; GO:0048286; GO:0048666; GO:0060716	"Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; sulfotransferase activity [GO:0008146]; angiogenesis [GO:0001525]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; labyrinthine layer blood vessel development [GO:0060716]; lung alveolus development [GO:0048286]; neuron development [GO:0048666]"
PGEN_.00g311840	Scaffold_15	37864800	37874385	NA	NA	NA	NA	NA
PGEN_.00g311850	Scaffold_15	37886998	37899405	Q9HCD6	TANC2_HUMAN	"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)"	GO:0001701; GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0098978; GO:0099092; GO:0099519	"axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; dense core granule cytoskeletal transport [GO:0099519]; in utero embryonic development [GO:0001701]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]"
PGEN_.00g311860	Scaffold_15	37901062	37907000	P13608	PGCA_BOVIN	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g311870	Scaffold_15	37970851	37972438	NA	NA	NA	NA	NA
PGEN_.00g311880	Scaffold_15	37980105	37987347	Q5UQ88	UBC3_MIMIV	Probable ubiquitin-conjugating enzyme E2 R521 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R521) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	GO:0005524; GO:0016021; GO:0016567; GO:0016740	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567]
PGEN_.00g311890	Scaffold_15	38003559	38029732	NA	NA	NA	NA	NA
PGEN_.00g311900	Scaffold_15	38055022	38065582	Q9VPW8	PINO_DROME	Protein pinocchio	GO:0007608; GO:0042048	olfactory behavior [GO:0042048]; sensory perception of smell [GO:0007608]
PGEN_.00g311910	Scaffold_15	38066923	38075065	NA	NA	NA	NA	NA
PGEN_.00g311920	Scaffold_15	38177781	38178270	NA	NA	NA	NA	NA
PGEN_.00g311930	Scaffold_15	38179594	38199708	O01393	UNC9_CAEEL	Innexin unc-9 (Uncoordinated protein 9)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
PGEN_.00g311940	Scaffold_15	38208144	38211298	NA	NA	NA	NA	NA
PGEN_.00g311950	Scaffold_15	38223340	38232798	NA	NA	NA	NA	NA
PGEN_.00g311960	Scaffold_15	38238316	38244613	NA	NA	NA	NA	NA
PGEN_.00g311970	Scaffold_15	38302426	38303307	NA	NA	NA	NA	NA
PGEN_.00g311980	Scaffold_15	38308522	38309508	NA	NA	NA	NA	NA
PGEN_.00g311990	Scaffold_15	38331665	38338520	NA	NA	NA	NA	NA
PGEN_.00g312000	Scaffold_15	38351830	38354967	Q16706	MA2A1_HUMAN	"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062	"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]"
PGEN_.00g312010	Scaffold_15	38469676	38472408	E1BM58	PRAX_BOVIN	Periaxin	GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0030315; GO:0043484	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; regulation of RNA splicing [GO:0043484]
PGEN_.00g312020	Scaffold_15	38505859	38519514	NA	NA	NA	NA	NA
PGEN_.00g312030	Scaffold_15	38530793	38531308	NA	NA	NA	NA	NA
PGEN_.00g312040	Scaffold_15	38538370	38538747	NA	NA	NA	NA	NA
PGEN_.00g312050	Scaffold_15	38541607	38542044	NA	NA	NA	NA	NA
PGEN_.00g312060	Scaffold_15	38542564	38542806	NA	NA	NA	NA	NA
PGEN_.00g312070	Scaffold_15	38549146	38559071	NA	NA	NA	NA	NA
PGEN_.00g312080	Scaffold_15	38562274	38572003	P08478	AMDA_XENLA	Peptidyl-glycine alpha-amidating monooxygenase A (PAM-A) (Peptide C-terminal alpha-amidating enzyme I) (AE-I) (Peptidyl-glycine alpha-amidating monooxygenase I) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase A (PHM-A) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase A (EC 4.3.2.5) (Peptidylamidoglycolate lyase-A) (PAL-A)]	GO:0004504; GO:0004598; GO:0005507; GO:0006518; GO:0016021; GO:0030658	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; peptide metabolic process [GO:0006518]
PGEN_.00g312090	Scaffold_15	38574460	38591234	NA	NA	NA	NA	NA
PGEN_.00g312100	Scaffold_15	38595687	38596772	NA	NA	NA	NA	NA
PGEN_.00g312110	Scaffold_15	38606055	38612695	Q9VUL9	FUCTA_DROME	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920	"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]"
PGEN_.00g312120	Scaffold_15	38630474	38641770	NA	NA	NA	NA	NA
PGEN_.00g312130	Scaffold_15	38650010	38653707	NA	NA	NA	NA	NA
PGEN_.00g312140	Scaffold_15	38653732	38661616	O86034	BDHA_RHIME	D-beta-hydroxybutyrate dehydrogenase (BDH) (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (3-HBDH)	GO:0003858	3-hydroxybutyrate dehydrogenase activity [GO:0003858]
PGEN_.00g312150	Scaffold_15	38675619	38682634	NA	NA	NA	NA	NA
PGEN_.00g312160	Scaffold_15	38687856	38689001	Q29042	FCN1_PIG	Ficolin-1 (Ficolin-A) (Ficolin-alpha)	GO:0005576; GO:0005581; GO:0005886; GO:0030246; GO:0045087; GO:0046872	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; innate immune response [GO:0045087]
PGEN_.00g312170	Scaffold_15	38697862	38723880	Q28343	PGCA_CANLF	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g312180	Scaffold_15	38728153	38729764	NA	NA	NA	NA	NA
PGEN_.00g312190	Scaffold_15	38740228	38740668	NA	NA	NA	NA	NA
PGEN_.00g312200	Scaffold_15	38747234	38747683	NA	NA	NA	NA	NA
PGEN_.00g312210	Scaffold_15	38747708	38748526	NA	NA	NA	NA	NA
PGEN_.00g312220	Scaffold_15	38764839	38774971	NA	NA	NA	NA	NA
PGEN_.00g312230	Scaffold_15	38814734	38816787	NA	NA	NA	NA	NA
PGEN_.00g312240	Scaffold_15	38822666	38834504	NA	NA	NA	NA	NA
PGEN_.00g312250	Scaffold_15	38850324	38858953	P77735	YAJO_ECOLI	1-deoxyxylulose-5-phosphate synthase YajO (EC 1.1.-.-)	GO:0005829; GO:0006772; GO:0016491	cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772]
PGEN_.00g312260	Scaffold_15	38866273	38880298	Q5MJS3	FA20C_MOUSE	Extracellular serine/threonine protein kinase FAM20C (EC 2.7.11.1) (Dentin matrix protein 4) (DMP-4) (Golgi-enriched fraction casein kinase) (GEF-CK)	GO:0001501; GO:0004674; GO:0005509; GO:0005524; GO:0005615; GO:0005737; GO:0005794; GO:0006468; GO:0016773; GO:0030145; GO:0030501; GO:0031214; GO:0036179; GO:0040036; GO:0045669; GO:0046034; GO:0051174; GO:0070166; GO:0071895; GO:0097187	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein serine/threonine kinase activity [GO:0004674]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]; skeletal system development [GO:0001501]"
PGEN_.00g312270	Scaffold_15	38901780	38913152	NA	NA	NA	NA	NA
PGEN_.00g312280	Scaffold_15	38937664	38944007	NA	NA	NA	NA	NA
PGEN_.00g312290	Scaffold_15	38992198	39010373	Q5RBM1	RPN2_PONAB	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (Ribophorin II) (RPN-II) (Ribophorin-2)	GO:0006487; GO:0008250; GO:0016021	integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation [GO:0006487]
PGEN_.00g312300	Scaffold_15	39020553	39070876	Q9BTC0	DIDO1_HUMAN	Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1)	GO:0003723; GO:0005634; GO:0005737; GO:0005819; GO:0006351; GO:0046872; GO:0097190	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g312310	Scaffold_15	39079517	39100718	NA	NA	NA	NA	NA
PGEN_.00g312320	Scaffold_15	39137976	39145220	NA	NA	NA	NA	NA
PGEN_.00g312330	Scaffold_15	39176814	39177532	NA	NA	NA	NA	NA
PGEN_.00g312340	Scaffold_15	39182948	39187128	NA	NA	NA	NA	NA
PGEN_.00g312350	Scaffold_15	39199710	39200312	NA	NA	NA	NA	NA
PGEN_.00g312360	Scaffold_15	39202087	39202434	NA	NA	NA	NA	NA
PGEN_.00g312370	Scaffold_15	39224069	39224464	NA	NA	NA	NA	NA
PGEN_.00g312380	Scaffold_15	39227875	39228225	NA	NA	NA	NA	NA
PGEN_.00g312390	Scaffold_15	39234661	39238158	O95429	BAG4_HUMAN	BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains)	GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0010763; GO:0030838; GO:0031625; GO:0033138; GO:0033209; GO:0043066; GO:0045785; GO:0051087; GO:0051496; GO:0051897; GO:0071356; GO:0071364; GO:0072659; GO:0097178; GO:1900034; GO:1903215; GO:2001145	"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:2001145]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; regulation of cellular response to heat [GO:1900034]; ruffle assembly [GO:0097178]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"
PGEN_.00g312400	Scaffold_15	39261250	39315091	P52034	PFKA_DROME	ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase)	GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0006007; GO:0006096; GO:0009744; GO:0016208; GO:0030388; GO:0042593; GO:0042802; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070095	"6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; protein homotetramerization [GO:0051289]; response to sucrose [GO:0009744]"
PGEN_.00g312410	Scaffold_15	39316118	39322058	P84098	RL19_HUMAN	60S ribosomal protein L19 (Large ribosomal subunit protein eL19)	GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0042788; GO:0045202	"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
PGEN_.00g312420	Scaffold_15	39331617	39382427	NA	NA	NA	NA	NA
PGEN_.00g312430	Scaffold_15	39398555	39420627	Q24307	DIAP2_DROME	Death-associated inhibitor of apoptosis 2 (Apoptosis 2 inhibitor) (IAP homolog A) (IAP-like protein) (ILP) (dILP) (Inhibitor of apoptosis 2)	GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006964; GO:0008270; GO:0016567; GO:0022416; GO:0031398; GO:0031625; GO:0043027; GO:0043066; GO:0043154; GO:0043281; GO:0045087; GO:0048471; GO:0050829; GO:0061057; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1990001	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chaeta development [GO:0022416]; defense response to Gram-negative bacterium [GO:0050829]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g312440	Scaffold_15	39426630	39540564	Q4V8B0	OXR1_RAT	Oxidation resistance protein 1 (Protein C7)	GO:0005730; GO:0005739; GO:0006979; GO:0007628; GO:0016491; GO:0043524; GO:0051402; GO:0071447; GO:1900408; GO:1902083; GO:1903204	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; oxidoreductase activity [GO:0016491]; adult walking behavior [GO:0007628]; cellular response to hydroperoxide [GO:0071447]; negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuron apoptotic process [GO:0051402]; response to oxidative stress [GO:0006979]
PGEN_.00g312450	Scaffold_15	39472442	39472642	NA	NA	NA	NA	NA
PGEN_.00g312460	Scaffold_15	39551379	39573571	Q9NRA2	S17A5_HUMAN	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672	cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]
PGEN_.00g312470	Scaffold_15	39609170	39620988	Q9NRA2	S17A5_HUMAN	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672	cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]
PGEN_.00g312480	Scaffold_15	39625557	39640230	NA	NA	NA	NA	NA
PGEN_.00g312490	Scaffold_15	39680358	39696409	Q1LXE6	TT39C_DANRE	Tetratricopeptide repeat protein 39C (TPR repeat protein 39C)	GO:0032474; GO:0060271; GO:0061371	cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]
PGEN_.00g312500	Scaffold_15	39707441	39707710	Q9H840	GEMI7_HUMAN	Gem-associated protein 7 (Gemin-7) (SIP3)	GO:0000387; GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0051170; GO:0097504	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"
PGEN_.00g312510	Scaffold_15	39716231	39720722	NA	NA	NA	NA	NA
PGEN_.00g312520	Scaffold_15	39742994	39749409	NA	NA	NA	NA	NA
PGEN_.00g312530	Scaffold_15	39763845	39764213	NA	NA	NA	NA	NA
PGEN_.00g312540	Scaffold_15	39795503	39796152	NA	NA	NA	NA	NA
PGEN_.00g312550	Scaffold_15	39822183	39823899	NA	NA	NA	NA	NA
PGEN_.00g312560	Scaffold_15	39825411	39830176	NA	NA	NA	NA	NA
PGEN_.00g312570	Scaffold_15	39863323	39870425	NA	NA	NA	NA	NA
PGEN_.00g312580	Scaffold_15	39994266	39999061	NA	NA	NA	NA	NA
PGEN_.00g312590	Scaffold_15	40094355	40097315	NA	NA	NA	NA	NA
PGEN_.00g312600	Scaffold_15	40100866	40101132	NA	NA	NA	NA	NA
PGEN_.00g312610	Scaffold_15	40111922	40124015	NA	NA	NA	NA	NA
PGEN_.00g312620	Scaffold_15	40174649	40176449	NA	NA	NA	NA	NA
PGEN_.00g312630	Scaffold_15	40194893	40195144	NA	NA	NA	NA	NA
PGEN_.00g312640	Scaffold_15	40195342	40195644	NA	NA	NA	NA	NA
PGEN_.00g312650	Scaffold_15	40205821	40225957	Q09221	CPNA2_CAEEL	Copine family protein 2		
PGEN_.00g312660	Scaffold_15	40247434	40249636	NA	NA	NA	NA	NA
PGEN_.00g312670	Scaffold_15	40255490	40257418	NA	NA	NA	NA	NA
PGEN_.00g312680	Scaffold_15	40279989	40281068	NA	NA	NA	NA	NA
PGEN_.00g312690	Scaffold_15	40337744	40343589	Q6AZB8	HARB1_DANRE	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g312700	Scaffold_15	40345367	40354456	NA	NA	NA	NA	NA
PGEN_.00g312710	Scaffold_15	40447594	40449703	NA	NA	NA	NA	NA
PGEN_.00g312720	Scaffold_15	40456354	40457433	NA	NA	NA	NA	NA
PGEN_.00g312730	Scaffold_15	40495006	40495794	NA	NA	NA	NA	NA
PGEN_.00g312740	Scaffold_15	40501481	40501825	NA	NA	NA	NA	NA
PGEN_.00g312750	Scaffold_15	40509282	40518256	NA	NA	NA	NA	NA
PGEN_.00g312760	Scaffold_15	40532929	40541738	NA	NA	NA	NA	NA
PGEN_.00g312770	Scaffold_15	40543154	40549112	NA	NA	NA	NA	NA
PGEN_.00g312780	Scaffold_15	40549226	40550602	NA	NA	NA	NA	NA
PGEN_.00g312790	Scaffold_15	40550782	40552444	NA	NA	NA	NA	NA
PGEN_.00g312800	Scaffold_15	40559182	40562584	NA	NA	NA	NA	NA
PGEN_.00g312810	Scaffold_15	40578691	40579035	NA	NA	NA	NA	NA
PGEN_.00g312820	Scaffold_15	40579809	40580830	NA	NA	NA	NA	NA
PGEN_.00g312830	Scaffold_15	40610008	40615925	Q7RTY1	MOT9_HUMAN	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021; GO:0046415	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]
PGEN_.00g312840	Scaffold_15	40635635	40640809	O15375	MOT6_HUMAN	Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5)	GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g312850	Scaffold_15	40647078	40653425	Q5ZJU0	MOT9_CHICK	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g312860	Scaffold_15	40667390	40668052	NA	NA	NA	NA	NA
PGEN_.00g312870	Scaffold_15	40669665	40672345	NA	NA	NA	NA	NA
PGEN_.00g312880	Scaffold_15	40679008	40679394	NA	NA	NA	NA	NA
PGEN_.00g312890	Scaffold_15	40680787	40681086	NA	NA	NA	NA	NA
PGEN_.00g312900	Scaffold_15	40686503	40687759	Q6AX44	FBCDA_XENLA	Fibrinogen C domain-containing protein 1-A	GO:0008061; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g312910	Scaffold_15	40702039	40717831	Q23497	NPR9_CAEEL	Galanin-like G-protein coupled receptor npr-9 (Probable neuropeptide receptor 9)	GO:0004930; GO:0005887; GO:0007186; GO:0060756	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; foraging behavior [GO:0060756]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g312920	Scaffold_15	40735864	40736100	NA	NA	NA	NA	NA
PGEN_.00g312930	Scaffold_15	40802643	40810503	Q13591	SEM5A_HUMAN	Semaphorin-5A (Semaphorin-F) (Sema F)	GO:0001938; GO:0002043; GO:0005886; GO:0007155; GO:0007162; GO:0007267; GO:0007399; GO:0007413; GO:0016020; GO:0016021; GO:0021536; GO:0030215; GO:0030836; GO:0035373; GO:0043395; GO:0045545; GO:0045766; GO:0048675; GO:0048842; GO:0048843; GO:0050918; GO:0051897; GO:0060326; GO:0070062; GO:0090263; GO:0097485; GO:1990256; GO:2000352; GO:2001028	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545]; axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neuron projection guidance [GO:0097485]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; signal clustering [GO:1990256]
PGEN_.00g312940	Scaffold_15	40813707	40814746	NA	NA	NA	NA	NA
PGEN_.00g312950	Scaffold_15	40816527	40817403	NA	NA	NA	NA	NA
PGEN_.00g312960	Scaffold_15	40831486	40832571	Q3T9E4	TGTP2_MOUSE	T-cell-specific guanine nucleotide triphosphate-binding protein 2 (EC 3.6.5.-) (Interferon-gamma-inducible GTPase Ifggb6 protein) (T-cell-specific guanine nucleotide triphosphate-binding protein)	GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0006952; GO:0035458; GO:0045087	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-beta [GO:0035458]; defense response [GO:0006952]; innate immune response [GO:0045087]
PGEN_.00g312970	Scaffold_15	40876467	40879712	A4YI89	HPCD_METS5	3-hydroxypropionyl-coenzyme A dehydratase (3-hydroxypropionyl-CoA dehydratase) (EC 4.2.1.116)	GO:0006631; GO:0043956	3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; fatty acid metabolic process [GO:0006631]
PGEN_.00g312980	Scaffold_15	40880015	40894171	P28480	TCPA_RAT	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	GO:0000242; GO:0000792; GO:0001669; GO:0002199; GO:0005524; GO:0005720; GO:0005794; GO:0005813; GO:0005815; GO:0005832; GO:0005874; GO:0006457; GO:0007286; GO:0007339; GO:0031625; GO:0032212; GO:0044053; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874; GO:2000109	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; Golgi apparatus [GO:0005794]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nuclear heterochromatin [GO:0005720]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; spermatid development [GO:0007286]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]
PGEN_.00g312990	Scaffold_15	40902391	40904103	Q6E2N3	TRI33_DANRE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]
PGEN_.00g313000	Scaffold_15	40934649	40975043	Q5SZV5	K0319_MOUSE	Dyslexia-associated protein KIAA0319 homolog	GO:0001764; GO:0005769; GO:0005886; GO:0010996; GO:0016021; GO:0030517; GO:0031410; GO:0031901; GO:0033555; GO:0043231; GO:0048692; GO:0060391; GO:2000171	cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]
PGEN_.00g313010	Scaffold_15	41000349	41001992	Q3SZ85	PTRD1_BOVIN	Putative peptidyl-tRNA hydrolase PTRHD1 (EC 3.1.1.29) (Peptidyl-tRNA hydrolase domain-containing protein 1)	GO:0004045	aminoacyl-tRNA hydrolase activity [GO:0004045]
PGEN_.00g313020	Scaffold_15	41018245	41051631	Q9VCP0	ELOA1_DROME	Transcription elongation factor B polypeptide 3 (Elongin-A) (RNA polymerase II transcription factor SIII subunit A) (dEloA)	GO:0005634; GO:0006368; GO:0007474; GO:0008023; GO:0032968; GO:0070449	elongin complex [GO:0070449]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; imaginal disc-derived wing vein specification [GO:0007474]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g313030	Scaffold_15	41062773	41080463	Q9VUL9	FUCTA_DROME	"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)"	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0033932; GO:0036065; GO:0036071; GO:0046920	"Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; 1,3-alpha-L-fucosidase activity [GO:0033932]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]"
PGEN_.00g313040	Scaffold_15	41125566	41126132	NA	NA	NA	NA	NA
PGEN_.00g313050	Scaffold_15	41126609	41127328	NA	NA	NA	NA	NA
PGEN_.00g313060	Scaffold_15	41130598	41146957	O95140	MFN2_HUMAN	Mitofusin-2 (EC 3.6.5.-) (Transmembrane GTPase MFN2)	GO:0001825; GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007006; GO:0007596; GO:0008053; GO:0015630; GO:0016021; GO:0016236; GO:0031306; GO:0031625; GO:0034497; GO:0046580; GO:0048593; GO:0048662; GO:0051646; GO:0061734; GO:0120162; GO:1904707; GO:1905461	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; blood coagulation [GO:0007596]; camera-type eye morphogenesis [GO:0048593]; macroautophagy [GO:0016236]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]
PGEN_.00g313070	Scaffold_15	41149218	41157522	D3ZAT9	FAXC_RAT	Failed axon connections homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g313080	Scaffold_15	41169260	41179876	D3ZAT9	FAXC_RAT	Failed axon connections homolog	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g313090	Scaffold_15	41213587	41218355	NA	NA	NA	NA	NA
PGEN_.00g313100	Scaffold_15	41221896	41223760	NA	NA	NA	NA	NA
PGEN_.00g313110	Scaffold_15	41223827	41224078	NA	NA	NA	NA	NA
PGEN_.00g313120	Scaffold_15	41236813	41239254	NA	NA	NA	NA	NA
PGEN_.00g313130	Scaffold_15	41242911	41245304	NA	NA	NA	NA	NA
PGEN_.00g313140	Scaffold_15	41256243	41256704	NA	NA	NA	NA	NA
PGEN_.00g313150	Scaffold_15	41257816	41258091	NA	NA	NA	NA	NA
PGEN_.00g313160	Scaffold_15	41319355	41321685	NA	NA	NA	NA	NA
PGEN_.00g313170	Scaffold_15	41323073	41333937	NA	NA	NA	NA	NA
PGEN_.00g313180	Scaffold_15	41334422	41338182	NA	NA	NA	NA	NA
PGEN_.00g313190	Scaffold_15	41341308	41349803	NA	NA	NA	NA	NA
PGEN_.00g313200	Scaffold_15	41350893	41351333	NA	NA	NA	NA	NA
PGEN_.00g313210	Scaffold_15	41357912	41358790	NA	NA	NA	NA	NA
PGEN_.00g313220	Scaffold_15	41366670	41380508	Q9UBG0	MRC2_HUMAN	C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280)	GO:0001649; GO:0004888; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0016021; GO:0030246; GO:0030574	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; transmembrane signaling receptor activity [GO:0004888]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]
PGEN_.00g313230	Scaffold_15	41384672	41384986	NA	NA	NA	NA	NA
PGEN_.00g313240	Scaffold_15	41386344	41387030	NA	NA	NA	NA	NA
PGEN_.00g313250	Scaffold_15	41387057	41387431	NA	NA	NA	NA	NA
PGEN_.00g313260	Scaffold_15	41392051	41407069	NA	NA	NA	NA	NA
PGEN_.00g313270	Scaffold_15	41513536	41524630	Q8NCH0	CHSTE_HUMAN	Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1) (hD4ST1)	GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030208; GO:0042301; GO:0050655; GO:0070062	extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; phosphate ion binding [GO:0042301]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655]
PGEN_.00g313280	Scaffold_15	41573000	41573212	NA	NA	NA	NA	NA
PGEN_.00g313290	Scaffold_15	41726377	41729014	NA	NA	NA	NA	NA
PGEN_.00g313300	Scaffold_15	41769490	41772016	NA	NA	NA	NA	NA
PGEN_.00g313310	Scaffold_15	41793140	41794896	NA	NA	NA	NA	NA
PGEN_.00g313320	Scaffold_15	41795059	41795379	NA	NA	NA	NA	NA
PGEN_.00g313330	Scaffold_15	41797485	41798840	NA	NA	NA	NA	NA
PGEN_.00g313340	Scaffold_15	41805061	41806870	NA	NA	NA	NA	NA
PGEN_.00g313350	Scaffold_15	41877360	41882873	NA	NA	NA	NA	NA
PGEN_.00g313360	Scaffold_15	41882885	41885121	NA	NA	NA	NA	NA
PGEN_.00g313370	Scaffold_15	41998922	42000773	NA	NA	NA	NA	NA
PGEN_.00g313380	Scaffold_15	42028198	42029262	NA	NA	NA	NA	NA
PGEN_.00g313390	Scaffold_15	42108956	42132269	Q91XQ5	CHSTF_MOUSE	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; hexose biosynthetic process [GO:0019319]
PGEN_.00g313400	Scaffold_15	42133422	42134144	NA	NA	NA	NA	NA
PGEN_.00g313410	Scaffold_15	42135023	42135304	NA	NA	NA	NA	NA
PGEN_.00g313420	Scaffold_15	42140539	42141594	NA	NA	NA	NA	NA
PGEN_.00g313430	Scaffold_15	42170323	42170799	NA	NA	NA	NA	NA
PGEN_.00g313440	Scaffold_15	42171457	42172814	NA	NA	NA	NA	NA
PGEN_.00g313450	Scaffold_15	42173998	42174255	NA	NA	NA	NA	NA
PGEN_.00g313460	Scaffold_15	42174367	42174657	NA	NA	NA	NA	NA
PGEN_.00g313470	Scaffold_15	42281057	42349435	Q9H1P3	OSBL2_HUMAN	Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2)	GO:0005546; GO:0005811; GO:0005829; GO:0006699; GO:0007009; GO:0008289; GO:0008526; GO:0015485; GO:0015914; GO:0016020; GO:0030301; GO:0031234; GO:0032367; GO:0032934; GO:0043231; GO:0051289; GO:0120020	"cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; sterol binding [GO:0032934]; bile acid biosynthetic process [GO:0006699]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]"
PGEN_.00g313480	Scaffold_15	42353387	42357063	NA	NA	NA	NA	NA
PGEN_.00g313490	Scaffold_15	42377260	42397104	Q08882	HR3_MANSE	Probable nuclear hormone receptor HR3 (mHR3) (Nuclear receptor subfamily 1 group F member 4)	GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]
PGEN_.00g313500	Scaffold_15	42406290	42413866	Q9Y5N5	N6MT1_HUMAN	Methyltransferase N6AMT1 (HemK methyltransferase family member 2) (M.HsaHemK2P) (Methylarsonite methyltransferase N6AMT1) (EC 2.1.1.-) (N(6)-adenine-specific DNA methyltransferase 1) (EC 2.1.1.72) (Protein N(5)-glutamine methyltransferase) (EC 2.1.1.-)	GO:0003676; GO:0005634; GO:0005829; GO:0006415; GO:0008276; GO:0008757; GO:0009007; GO:0009404; GO:0018364; GO:0018872; GO:0030307; GO:0030792; GO:0032259; GO:0032775; GO:0032991; GO:0035657; GO:0036009	cytosol [GO:0005829]; eRF1 methyltransferase complex [GO:0035657]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; methylarsonite methyltransferase activity [GO:0030792]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-glutamine N-methyltransferase activity [GO:0036009]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; arsonoacetate metabolic process [GO:0018872]; DNA methylation on adenine [GO:0032775]; methylation [GO:0032259]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404]; translational termination [GO:0006415]
PGEN_.00g313510	Scaffold_15	42415599	42424558	F1QJF4	RORAB_DANRE	Nuclear receptor ROR-alpha B (Retinoid-related orphan receptor alpha 1) (Retinoid-related orphan receptor-alpha B)	GO:0003707; GO:0004879; GO:0005634; GO:0007275; GO:0008270; GO:0043565	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]
PGEN_.00g313520	Scaffold_15	42459898	42469530	Q5U3G4	RDM1_DANRE	RAD52 motif-containing protein 1	GO:0003677; GO:0003723; GO:0005730; GO:0005737	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723]
PGEN_.00g313530	Scaffold_15	42475377	42478529	NA	NA	NA	NA	NA
PGEN_.00g313540	Scaffold_15	42479232	42483560	NA	NA	NA	NA	NA
PGEN_.00g313550	Scaffold_15	42500127	42512779	NA	NA	NA	NA	NA
PGEN_.00g313560	Scaffold_15	42518311	42519939	A0JPI9	LR74A_RAT	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g313570	Scaffold_15	42534929	42536005	NA	NA	NA	NA	NA
PGEN_.00g313580	Scaffold_15	42544497	42562555	NA	NA	NA	NA	NA
PGEN_.00g313590	Scaffold_15	42568374	42568775	NA	NA	NA	NA	NA
PGEN_.00g313600	Scaffold_15	42583727	42590141	NA	NA	NA	NA	NA
PGEN_.00g313610	Scaffold_15	42590179	42591114	NA	NA	NA	NA	NA
PGEN_.00g313620	Scaffold_15	42596795	42599706	NA	NA	NA	NA	NA
PGEN_.00g313630	Scaffold_15	42625355	42701339	Q8IWA6	CCD60_HUMAN	Coiled-coil domain-containing protein 60		
PGEN_.00g313640	Scaffold_15	42717247	42717462	NA	NA	NA	NA	NA
PGEN_.00g313650	Scaffold_15	42743861	42748225	NA	NA	NA	NA	NA
PGEN_.00g313660	Scaffold_15	42748790	42754968	Q16650	TBR1_HUMAN	T-box brain protein 1 (T-brain-1) (TBR-1) (TES-56)	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001102; GO:0001228; GO:0001661; GO:0001708; GO:0001947; GO:0003700; GO:0005634; GO:0007420; GO:0010092; GO:0010975; GO:0019901; GO:0021764; GO:0021902; GO:0021987; GO:0030902; GO:0042802; GO:0045892; GO:0045944; GO:1902667	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; amygdala development [GO:0021764]; brain development [GO:0007420]; cell fate specification [GO:0001708]; cerebral cortex development [GO:0021987]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; conditioned taste aversion [GO:0001661]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axon guidance [GO:1902667]; regulation of neuron projection development [GO:0010975]; specification of animal organ identity [GO:0010092]"
PGEN_.00g313670	Scaffold_15	42771355	42786394	Q6DCQ6	VWA2_XENLA	von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen) (AMACO)	GO:0005509; GO:0005604; GO:0005615	basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]
PGEN_.00g313680	Scaffold_15	42793191	42824510	Q61391	NEP_MOUSE	Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10)	GO:0001786; GO:0001822; GO:0001890; GO:0004175; GO:0004222; GO:0005737; GO:0005769; GO:0005802; GO:0005886; GO:0005903; GO:0006508; GO:0006518; GO:0007611; GO:0008021; GO:0008233; GO:0008237; GO:0008238; GO:0008270; GO:0016020; GO:0016021; GO:0019233; GO:0030324; GO:0030424; GO:0030425; GO:0031410; GO:0042277; GO:0042803; GO:0043025; GO:0044306; GO:0045121; GO:0045202; GO:0046449; GO:0050435; GO:0050769; GO:0061837; GO:0070012; GO:0071345; GO:0071492; GO:0071493; GO:0090399; GO:0097242; GO:0098793; GO:0150094; GO:1900273; GO:1901612	axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; cardiolipin binding [GO:1901612]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; oligopeptidase activity [GO:0070012]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; cellular response to cytokine stimulus [GO:0071345]; cellular response to UV-A [GO:0071492]; cellular response to UV-B [GO:0071493]; creatinine metabolic process [GO:0046449]; kidney development [GO:0001822]; learning or memory [GO:0007611]; lung development [GO:0030324]; neuropeptide processing [GO:0061837]; peptide metabolic process [GO:0006518]; placenta development [GO:0001890]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neurogenesis [GO:0050769]; proteolysis [GO:0006508]; replicative senescence [GO:0090399]; sensory perception of pain [GO:0019233]
PGEN_.00g313690	Scaffold_15	42830309	42848955	Q2KJI2	STT3A_BOVIN	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)	GO:0004579; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872	integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]
PGEN_.00g313700	Scaffold_15	42875379	42878282	NA	NA	NA	NA	NA
PGEN_.00g313710	Scaffold_15	42904580	42914693	Q6P4T1	SNX19_MOUSE	Sorting nexin-19	GO:0002062; GO:0005737; GO:0006887; GO:0030073; GO:0030659; GO:0031901; GO:0032266; GO:1990502	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; phosphatidylinositol-3-phosphate binding [GO:0032266]; chondrocyte differentiation [GO:0002062]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]
PGEN_.00g313720	Scaffold_15	42920172	42948347	Q6PGL7	WASC2_MOUSE	WASH complex subunit 2	GO:0005546; GO:0005547; GO:0005730; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010314; GO:0015031; GO:0031901; GO:0032266; GO:0036010; GO:0042147; GO:0043231; GO:0043325; GO:0070273; GO:0071203; GO:0080025; GO:1905394	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g313730	Scaffold_15	42949208	43004630	Q641Q2	WAC2A_HUMAN	WASH complex subunit 2A	GO:0005730; GO:0005769; GO:0005829; GO:0005886; GO:0008289; GO:0015031; GO:0031901; GO:0036010; GO:0042147; GO:0043231; GO:0071203	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; lipid binding [GO:0008289]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g313740	Scaffold_15	43025563	43033849	NA	NA	NA	NA	NA
PGEN_.00g313750	Scaffold_15	43054517	43055053	NA	NA	NA	NA	NA
PGEN_.00g313760	Scaffold_15	43080136	43113523	NA	NA	NA	NA	NA
PGEN_.00g313770	Scaffold_15	43143697	43145970	NA	NA	NA	NA	NA
PGEN_.00g313780	Scaffold_15	43203324	43231684	Q9V9A8	PHTF_DROME	Putative homeodomain transcription factor	GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0046983	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g313790	Scaffold_15	43241550	43243840	Q7DMP0	CALM2_SOLTU	Calmodulin-2/4 (CaM-2/4) (Fragment)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g313800	Scaffold_15	43251366	43279744	Q95NR9	CALM_METSE	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g313810	Scaffold_15	43377399	43378372	NA	NA	NA	NA	NA
PGEN_.00g313820	Scaffold_15	43379403	43383879	NA	NA	NA	NA	NA
PGEN_.00g313830	Scaffold_15	43390268	43405052	NA	NA	NA	NA	NA
PGEN_.00g313840	Scaffold_15	43406908	43419829	P52899	ODPA_CAEEL	"Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)"	GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]
PGEN_.00g313850	Scaffold_15	43422371	43422679	NA	NA	NA	NA	NA
PGEN_.00g313860	Scaffold_15	43425531	43441439	Q03567	SL172_CAEEL	Uncharacterized transporter slc-17.2	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g313870	Scaffold_15	43452647	43472346	Q03567	SL172_CAEEL	Uncharacterized transporter slc-17.2	GO:0006814; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g313880	Scaffold_15	43493894	43499906	NA	NA	NA	NA	NA
PGEN_.00g313890	Scaffold_15	43523343	43527669	NA	NA	NA	NA	NA
PGEN_.00g313900	Scaffold_15	43531604	43542085	P14314	GLU2B_HUMAN	Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH)	GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006457; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0043687; GO:0044267; GO:0044325; GO:0051219	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein folding [GO:0006457]
PGEN_.00g313910	Scaffold_15	43570290	43581101	NA	NA	NA	NA	NA
PGEN_.00g313920	Scaffold_15	43624632	43637034	P04973	CLCA_BOVIN	Clathrin light chain A (Lca)	GO:0005198; GO:0005819; GO:0005886; GO:0006886; GO:0007049; GO:0030125; GO:0030130; GO:0030132; GO:0030672; GO:0032050; GO:0048268; GO:0051301; GO:0071439; GO:0072583; GO:0099631	clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; plasma membrane [GO:0005886]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]
PGEN_.00g313930	Scaffold_15	43637328	43652231	NA	NA	NA	NA	NA
PGEN_.00g313940	Scaffold_15	43664738	43676490	NA	NA	NA	NA	NA
PGEN_.00g313950	Scaffold_15	43711323	43760983	Q9UQ26	RIMS2_HUMAN	Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 3)	GO:0006886; GO:0010628; GO:0017137; GO:0017156; GO:0017157; GO:0019933; GO:0030054; GO:0030073; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0045202; GO:0046872; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0061669; GO:0070062; GO:0097151; GO:0098831; GO:1903861; GO:2000300; GO:2000463	cell junction [GO:0030054]; cell projection [GO:0042995]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cAMP-mediated signaling [GO:0019933]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]
PGEN_.00g313960	Scaffold_15	43764643	43765392	NA	NA	NA	NA	NA
PGEN_.00g313970	Scaffold_15	43765831	43766079	NA	NA	NA	NA	NA
PGEN_.00g313980	Scaffold_15	43767920	43768219	NA	NA	NA	NA	NA
PGEN_.00g313990	Scaffold_15	43808524	43817864	Q22366	RIM_CAEEL	Rab-3-interacting molecule unc-10 (Rim) (Uncoordinated protein 10)	GO:0006886; GO:0007271; GO:0007617; GO:0007626; GO:0008022; GO:0008104; GO:0016082; GO:0017137; GO:0030054; GO:0030421; GO:0030424; GO:0032224; GO:0040011; GO:0040018; GO:0042391; GO:0042734; GO:0043051; GO:0044325; GO:0045202; GO:0046872; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0098831; GO:1905909; GO:2000300	"axon [GO:0030424]; cell junction [GO:0030054]; cytoskeleton of presynaptic active zone [GO:0048788]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; Rab GTPase binding [GO:0017137]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; defecation [GO:0030421]; intracellular protein transport [GO:0006886]; locomotion [GO:0040011]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization [GO:0008104]; regulation of dauer entry [GO:1905909]; regulation of membrane potential [GO:0042391]; regulation of pharyngeal pumping [GO:0043051]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic transmission, cholinergic [GO:0007271]; synaptic vesicle priming [GO:0016082]"
PGEN_.00g314000	Scaffold_15	43830537	43831019	NA	NA	NA	NA	NA
PGEN_.00g314010	Scaffold_15	43831120	43831635	NA	NA	NA	NA	NA
PGEN_.00g314020	Scaffold_15	43860069	43899479	NA	NA	NA	NA	NA
PGEN_.00g314030	Scaffold_15	43932144	43935361	NA	NA	NA	NA	NA
PGEN_.00g314040	Scaffold_15	43938475	43938705	NA	NA	NA	NA	NA
PGEN_.00g314050	Scaffold_15	43964675	43976395	A3KMP2	TTC38_MOUSE	Tetratricopeptide repeat protein 38 (TPR repeat protein 38)		
PGEN_.00g314060	Scaffold_15	43994072	43994365	NA	NA	NA	NA	NA
PGEN_.00g314070	Scaffold_15	44005997	44006287	NA	NA	NA	NA	NA
PGEN_.00g314080	Scaffold_15	44020285	44021049	Q5HZI9	S2551_MOUSE	Solute carrier family 25 member 51 (Mitochondrial carrier triple repeat protein 1)	GO:0005739; GO:0005743; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
PGEN_.00g314090	Scaffold_15	44069481	44084940	A1L3G4	TM241_XENLA	Transmembrane protein 241	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g314100	Scaffold_15	44095038	44100546	Q8BNX1	CLC4G_MOUSE	C-type lectin domain family 4 member G	GO:0002710; GO:0005886; GO:0016021; GO:0030247; GO:0042130	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; polysaccharide binding [GO:0030247]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell proliferation [GO:0042130]
PGEN_.00g314110	Scaffold_15	44132462	44142086	NA	NA	NA	NA	NA
PGEN_.00g314120	Scaffold_15	44148876	44151633	NA	NA	NA	NA	NA
PGEN_.00g314130	Scaffold_15	44191792	44192247	NA	NA	NA	NA	NA
PGEN_.00g314140	Scaffold_15	44200411	44203713	NA	NA	NA	NA	NA
PGEN_.00g314150	Scaffold_15	44208981	44222761	Q53H96	P5CR3_HUMAN	Pyrroline-5-carboxylate reductase 3 (P5C reductase 3) (P5CR 3) (EC 1.5.1.2) (Pyrroline-5-carboxylate reductase-like protein)	GO:0004735; GO:0005829; GO:0008652; GO:0055129	cytosol [GO:0005829]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular amino acid biosynthetic process [GO:0008652]; L-proline biosynthetic process [GO:0055129]
PGEN_.00g314160	Scaffold_15	44234372	44253946	O93310	RAD21_XENLA	Double-strand-break repair protein rad21 homolog (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product)]	GO:0000775; GO:0000922; GO:0005829; GO:0006281; GO:0006915; GO:0007062; GO:0007275; GO:0008278; GO:0016363; GO:0051301; GO:0071168	"chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; spindle pole [GO:0000922]; apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; multicellular organism development [GO:0007275]; protein localization to chromatin [GO:0071168]; sister chromatid cohesion [GO:0007062]"
PGEN_.00g314170	Scaffold_15	44255928	44278187	NA	NA	NA	NA	NA
PGEN_.00g314180	Scaffold_15	44278690	44283222	NA	NA	NA	NA	NA
PGEN_.00g314190	Scaffold_15	44293220	44321653	Q2VJ60	RN19A_PIG	E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A)	GO:0000151; GO:0000209; GO:0005737; GO:0005815; GO:0006511; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630; GO:0098686; GO:0098794; GO:0098978; GO:0099576	"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g314200	Scaffold_15	44331775	44341107	A2ADZ8	IQCC_MOUSE	IQ domain-containing protein C		
PGEN_.00g314210	Scaffold_15	44351742	44354849	NA	NA	NA	NA	NA
PGEN_.00g314220	Scaffold_15	44386372	44388282	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g314230	Scaffold_15	44388465	44393933	NA	NA	NA	NA	NA
PGEN_.00g314240	Scaffold_15	44420926	44421498	NA	NA	NA	NA	NA
PGEN_.00g314250	Scaffold_15	44427011	44438939	Q8BNX1	CLC4G_MOUSE	C-type lectin domain family 4 member G	GO:0002710; GO:0005886; GO:0016021; GO:0030247; GO:0042130	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; polysaccharide binding [GO:0030247]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell proliferation [GO:0042130]
PGEN_.00g314260	Scaffold_15	44461323	44478381	NA	NA	NA	NA	NA
PGEN_.00g314270	Scaffold_15	44486423	44518282	NA	NA	NA	NA	NA
PGEN_.00g314280	Scaffold_15	44520567	44535399	NA	NA	NA	NA	NA
PGEN_.00g314290	Scaffold_15	44543475	44547267	NA	NA	NA	NA	NA
PGEN_.00g314300	Scaffold_15	44558319	44560469	NA	NA	NA	NA	NA
PGEN_.00g314310	Scaffold_15	44574679	44575002	NA	NA	NA	NA	NA
PGEN_.00g314320	Scaffold_15	44576915	44577166	NA	NA	NA	NA	NA
PGEN_.00g314330	Scaffold_15	44577369	44577710	NA	NA	NA	NA	NA
PGEN_.00g314340	Scaffold_15	44586139	44587497	NA	NA	NA	NA	NA
PGEN_.00g314350	Scaffold_15	44594281	44609541	G5E8K6	MOT6_MOUSE	Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5)	GO:0005887; GO:0008028; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g314360	Scaffold_15	44613345	44622054	Q8CE94	MOT13_MOUSE	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	GO:0000139; GO:0005794; GO:0005829; GO:0005886; GO:0008028; GO:0015293; GO:0016021	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g314370	Scaffold_15	44628401	44646179	P57788	MOT4_CHICK	Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3)	GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g314380	Scaffold_15	44649247	44677953	P57788	MOT4_CHICK	Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3)	GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g314390	Scaffold_15	44678272	44678544	NA	NA	NA	NA	NA
PGEN_.00g314400	Scaffold_15	44678653	44683503	Q28GF8	TM205_XENTR	Transmembrane protein 205	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g314410	Scaffold_15	44699424	44717272	A1L2F6	TM205_DANRE	Transmembrane protein 205	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g314420	Scaffold_15	44721354	44721731	NA	NA	NA	NA	NA
PGEN_.00g314430	Scaffold_15	44721832	44722299	NA	NA	NA	NA	NA
PGEN_.00g314440	Scaffold_15	44738947	44755637	Q91ZH7	ABHD3_MOUSE	Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) (Lung alpha/beta hydrolase 3) (MmLABH3)	GO:0004623; GO:0008970; GO:0016021; GO:0016298; GO:0044255; GO:0046470; GO:0047372; GO:0052739; GO:0052740; GO:0102567; GO:0102568	"integral component of membrane [GO:0016021]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; cellular lipid metabolic process [GO:0044255]; phosphatidylcholine metabolic process [GO:0046470]"
PGEN_.00g314450	Scaffold_15	44757515	44757736	NA	NA	NA	NA	NA
PGEN_.00g314460	Scaffold_15	44761981	44763946	Q09575	YRD6_CAEEL	Uncharacterized protein K02A2.6	GO:0003676; GO:0008270; GO:0015074	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]
PGEN_.00g314470	Scaffold_15	44767336	44780094	Q6P877	ADRM1_XENTR	Proteasomal ubiquitin receptor ADRM1	GO:0000502; GO:0005634; GO:0005737; GO:0006511; GO:0008541; GO:0043130; GO:0043248; GO:0061133; GO:0070628	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g314480	Scaffold_15	44790445	44813776	Q3L1C9	STAUH_APLCA	Double-stranded RNA-binding protein Staufen homolog	GO:0003729; GO:0032880; GO:0043005; GO:0043025; GO:0043204	neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; mRNA binding [GO:0003729]; regulation of protein localization [GO:0032880]
PGEN_.00g314490	Scaffold_15	44814686	44825718	Q8IX29	FBX16_HUMAN	F-box only protein 16		
PGEN_.00g314500	Scaffold_15	44825786	44835627	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g314510	Scaffold_15	44862318	44863422	NA	NA	NA	NA	NA
PGEN_.00g314520	Scaffold_15	44923279	44927265	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g314530	Scaffold_15	44931649	44935157	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g314540	Scaffold_15	44948205	44955884	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g314550	Scaffold_15	44995375	45020018	Q3ZBL5	PTH2_BOVIN	"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription)"	GO:0004045; GO:0005739; GO:0005829; GO:2000210; GO:2000811	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; negative regulation of anoikis [GO:2000811]; positive regulation of anoikis [GO:2000210]
PGEN_.00g314560	Scaffold_15	45020175	45061908	Q9ZT63	MTP1_ARATH	Metal tolerance protein 1 (AtMTP1) (ZAT1p) (Zinc transporter ZAT-1) [Cleaved into: Metal tolerance protein 1 short form]	GO:0005385; GO:0005623; GO:0005773; GO:0005774; GO:0006829; GO:0006882; GO:0016020; GO:0016021; GO:0046872; GO:0046873	cell [GO:0005623]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion transport [GO:0006829]
PGEN_.00g314570	Scaffold_15	45070143	45077357	NA	NA	NA	NA	NA
PGEN_.00g314580	Scaffold_15	45079596	45102066	NA	NA	NA	NA	NA
PGEN_.00g314590	Scaffold_15	45102325	45102708	NA	NA	NA	NA	NA
PGEN_.00g314600	Scaffold_15	45103139	45103393	NA	NA	NA	NA	NA
PGEN_.00g314610	Scaffold_15	45104045	45104368	NA	NA	NA	NA	NA
PGEN_.00g314620	Scaffold_15	45185232	45224474	Q9Y6X6	MYO16_HUMAN	Unconventional myosin-XVI (Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3) (Unconventional myosin-16)	GO:0003774; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0008285; GO:0016459; GO:0021549; GO:0048471; GO:0051015; GO:2000134	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]
PGEN_.00g314630	Scaffold_15	45200926	45201955	NA	NA	NA	NA	NA
PGEN_.00g314640	Scaffold_15	45230496	45237794	Q9YIC0	EF1A_ORYLA	Elongation factor 1-alpha (EF-1-alpha)	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]
PGEN_.00g314650	Scaffold_15	45237890	45238955	NA	NA	NA	NA	NA
PGEN_.00g314660	Scaffold_15	45250549	45277977	Q6IR80	CL066_XENLA	KICSTOR complex protein C12orf66 homolog	GO:0005765; GO:0034198; GO:0042149; GO:0061462; GO:0140007; GO:1904262	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]
PGEN_.00g314670	Scaffold_15	45290512	45321171	O43399	TPD54_HUMAN	Tumor protein D54 (hD54) (Tumor protein D52-like 2)	GO:0003723; GO:0003824; GO:0005737; GO:0042127; GO:0042803; GO:0046982; GO:0048471	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell population proliferation [GO:0042127]
PGEN_.00g314680	Scaffold_15	45337974	45351764	C0HK25	ADEL_APLDA	Lectin ADEL	GO:0005534; GO:0016936; GO:0030395; GO:0034120; GO:0048032; GO:1903777	galactose binding [GO:0005534]; galactoside binding [GO:0016936]; galacturonate binding [GO:0048032]; lactose binding [GO:0030395]; melibiose binding [GO:1903777]; positive regulation of erythrocyte aggregation [GO:0034120]
PGEN_.00g314690	Scaffold_15	45363278	45376912	Q15485	FCN2_HUMAN	Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)	GO:0001867; GO:0003823; GO:0005576; GO:0005581; GO:0006956; GO:0008228; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0072562; GO:2001065	"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; recognition of apoptotic cell [GO:0043654]"
PGEN_.00g314700	Scaffold_15	45386595	45387669	NA	NA	NA	NA	NA
PGEN_.00g314710	Scaffold_15	45389577	45391103	NA	NA	NA	NA	NA
PGEN_.00g314720	Scaffold_15	45392041	45392268	NA	NA	NA	NA	NA
PGEN_.00g314730	Scaffold_15	45409926	45449196	Q75WE7	VWA5A_RAT	von Willebrand factor A domain-containing protein 5A (Loss of heterozygosity 11 chromosomal region 2 gene A protein homolog) (Mast cell surface antigen 1) (Masa-1)		
PGEN_.00g314740	Scaffold_15	45456978	45479345	O35608	ANGP2_MOUSE	Angiopoietin-2 (ANG-2)	GO:0001525; GO:0001666; GO:0001974; GO:0005172; GO:0005615; GO:0005634; GO:0005886; GO:0007169; GO:0007281; GO:0007492; GO:0009314; GO:0009612; GO:0009749; GO:0010812; GO:0014070; GO:0014823; GO:0016525; GO:0030097; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045765; GO:0045766; GO:0046872; GO:0048014; GO:0048514; GO:0050928; GO:0060135; GO:0071363; GO:0072012	cell projection [GO:0042995]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; vascular endothelial growth factor receptor binding [GO:0005172]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; regulation of angiogenesis [GO:0045765]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g314750	Scaffold_15	45493143	45501909	NA	NA	NA	NA	NA
PGEN_.00g314760	Scaffold_15	45502210	45519138	Q6ZNA1	ZN836_HUMAN	Zinc finger protein 836	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g314770	Scaffold_15	45554817	45555260	NA	NA	NA	NA	NA
PGEN_.00g314780	Scaffold_15	45555384	45563882	NA	NA	NA	NA	NA
PGEN_.00g314790	Scaffold_15	45563938	45569175	NA	NA	NA	NA	NA
PGEN_.00g314800	Scaffold_15	45601793	45602753	NA	NA	NA	NA	NA
PGEN_.00g314810	Scaffold_15	45603351	45604939	NA	NA	NA	NA	NA
PGEN_.00g314820	Scaffold_15	45615748	45630142	NA	NA	NA	NA	NA
PGEN_.00g314830	Scaffold_15	45643217	45655695	NA	NA	NA	NA	NA
PGEN_.00g314840	Scaffold_15	45658911	45687605	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g314850	Scaffold_15	45713106	45718585	NA	NA	NA	NA	NA
PGEN_.00g314860	Scaffold_15	45737544	45737969	NA	NA	NA	NA	NA
PGEN_.00g314870	Scaffold_15	45746713	45749663	NA	NA	NA	NA	NA
PGEN_.00g314880	Scaffold_15	45756645	45764085	NA	NA	NA	NA	NA
PGEN_.00g314890	Scaffold_15	45773501	45779093	Q8NB78	KDM1B_HUMAN	Lysine-specific histone demethylase 1B (EC 1.-.-.-) (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 2)	GO:0000122; GO:0000786; GO:0000790; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006349; GO:0007275; GO:0008134; GO:0008270; GO:0016491; GO:0016579; GO:0034648; GO:0034649; GO:0034720; GO:0042393; GO:0043046; GO:0044030; GO:0045944; GO:0050660; GO:0071949	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; histone binding [GO:0042393]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; oxidoreductase activity [GO:0016491]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349]
PGEN_.00g314900	Scaffold_15	45781955	45797699	Q8NB78	KDM1B_HUMAN	Lysine-specific histone demethylase 1B (EC 1.-.-.-) (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 2)	GO:0000122; GO:0000786; GO:0000790; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006349; GO:0007275; GO:0008134; GO:0008270; GO:0016491; GO:0016579; GO:0034648; GO:0034649; GO:0034720; GO:0042393; GO:0043046; GO:0044030; GO:0045944; GO:0050660; GO:0071949	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; histone binding [GO:0042393]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; oxidoreductase activity [GO:0016491]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349]
PGEN_.00g314910	Scaffold_15	45820676	45821486	NA	NA	NA	NA	NA
PGEN_.00g314920	Scaffold_15	45846222	45862577	Q92539	LPIN2_HUMAN	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]
PGEN_.00g314930	Scaffold_15	45872022	45877077	Q32PP1	MRNIP_DANRE	MRN complex-interacting protein (MRN-interacting protein)	GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]
PGEN_.00g314940	Scaffold_15	45882170	45893857	O67802	DLHH_AQUAE	Putative carboxymethylenebutenolidase (EC 3.1.1.45) (Dienelactone hydrolase) (DLH)	GO:0008806	carboxymethylenebutenolidase activity [GO:0008806]
PGEN_.00g314950	Scaffold_15	45902030	45913226	O67802	DLHH_AQUAE	Putative carboxymethylenebutenolidase (EC 3.1.1.45) (Dienelactone hydrolase) (DLH)	GO:0008806	carboxymethylenebutenolidase activity [GO:0008806]
PGEN_.00g314960	Scaffold_15	45918653	45923744	Q32PP1	MRNIP_DANRE	MRN complex-interacting protein (MRN-interacting protein)	GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]
PGEN_.00g314970	Scaffold_15	45933203	45949393	Q99PI5	LPIN2_MOUSE	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]
PGEN_.00g314980	Scaffold_15	45997295	46013036	Q8NB78	KDM1B_HUMAN	Lysine-specific histone demethylase 1B (EC 1.-.-.-) (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 2)	GO:0000122; GO:0000786; GO:0000790; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006349; GO:0007275; GO:0008134; GO:0008270; GO:0016491; GO:0016579; GO:0034648; GO:0034649; GO:0034720; GO:0042393; GO:0043046; GO:0044030; GO:0045944; GO:0050660; GO:0071949	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; histone binding [GO:0042393]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; oxidoreductase activity [GO:0016491]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349]
PGEN_.00g314990	Scaffold_15	46015884	46022573	Q8NB78	KDM1B_HUMAN	Lysine-specific histone demethylase 1B (EC 1.-.-.-) (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 2)	GO:0000122; GO:0000786; GO:0000790; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006349; GO:0007275; GO:0008134; GO:0008270; GO:0016491; GO:0016579; GO:0034648; GO:0034649; GO:0034720; GO:0042393; GO:0043046; GO:0044030; GO:0045944; GO:0050660; GO:0071949	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; histone binding [GO:0042393]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; oxidoreductase activity [GO:0016491]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349]
PGEN_.00g315000	Scaffold_15	46032373	46039762	NA	NA	NA	NA	NA
PGEN_.00g315010	Scaffold_15	46046982	46049933	NA	NA	NA	NA	NA
PGEN_.00g315020	Scaffold_15	46058746	46059171	NA	NA	NA	NA	NA
PGEN_.00g315030	Scaffold_15	46078102	46083396	Q5IS41	NCAN_PANTR	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	GO:0001501; GO:0005509; GO:0005540; GO:0007155; GO:0007417; GO:0030246; GO:0031012	extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
PGEN_.00g315040	Scaffold_15	46108109	46119735	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g315050	Scaffold_15	46121549	46139230	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g315060	Scaffold_15	46139358	46156851	NA	NA	NA	NA	NA
PGEN_.00g315070	Scaffold_15	46162717	46176055	NA	NA	NA	NA	NA
PGEN_.00g315080	Scaffold_15	46182711	46182938	NA	NA	NA	NA	NA
PGEN_.00g315090	Scaffold_15	46183537	46183779	NA	NA	NA	NA	NA
PGEN_.00g315100	Scaffold_15	46184277	46184615	NA	NA	NA	NA	NA
PGEN_.00g315110	Scaffold_15	46218025	46222571	NA	NA	NA	NA	NA
PGEN_.00g315120	Scaffold_15	46222627	46231136	NA	NA	NA	NA	NA
PGEN_.00g315130	Scaffold_15	46231260	46231703	NA	NA	NA	NA	NA
PGEN_.00g315140	Scaffold_15	46267381	46284325	Q6ZNA1	ZN836_HUMAN	Zinc finger protein 836	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g315150	Scaffold_15	46284627	46293400	NA	NA	NA	NA	NA
PGEN_.00g315160	Scaffold_15	46308630	46330718	O35608	ANGP2_MOUSE	Angiopoietin-2 (ANG-2)	GO:0001525; GO:0001666; GO:0001974; GO:0005172; GO:0005615; GO:0005634; GO:0005886; GO:0007169; GO:0007281; GO:0007492; GO:0009314; GO:0009612; GO:0009749; GO:0010812; GO:0014070; GO:0014823; GO:0016525; GO:0030097; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045765; GO:0045766; GO:0046872; GO:0048014; GO:0048514; GO:0050928; GO:0060135; GO:0071363; GO:0072012	cell projection [GO:0042995]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; vascular endothelial growth factor receptor binding [GO:0005172]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; regulation of angiogenesis [GO:0045765]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g315170	Scaffold_15	46338626	46377887	Q75WE7	VWA5A_RAT	von Willebrand factor A domain-containing protein 5A (Loss of heterozygosity 11 chromosomal region 2 gene A protein homolog) (Mast cell surface antigen 1) (Masa-1)		
PGEN_.00g315180	Scaffold_15	46394967	46395194	NA	NA	NA	NA	NA
PGEN_.00g315190	Scaffold_15	46396282	46397055	NA	NA	NA	NA	NA
PGEN_.00g315200	Scaffold_15	46397177	46397587	NA	NA	NA	NA	NA
PGEN_.00g315210	Scaffold_15	46398027	46406533	NA	NA	NA	NA	NA
PGEN_.00g315220	Scaffold_15	46410632	46424421	P57756	FCN2_RAT	Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin)	GO:0001664; GO:0001867; GO:0002752; GO:0005576; GO:0005581; GO:0007186; GO:0008329; GO:0030246; GO:0031232; GO:0033691; GO:0034394; GO:0043654; GO:0046597; GO:0046872; GO:0097367; GO:2000484	"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; sialic acid binding [GO:0033691]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 secretion [GO:2000484]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654]"
PGEN_.00g315230	Scaffold_15	46434999	46449702	C0HK25	ADEL_APLDA	Lectin ADEL	GO:0005534; GO:0016936; GO:0030395; GO:0034120; GO:0048032; GO:1903777	galactose binding [GO:0005534]; galactoside binding [GO:0016936]; galacturonate binding [GO:0048032]; lactose binding [GO:0030395]; melibiose binding [GO:1903777]; positive regulation of erythrocyte aggregation [GO:0034120]
PGEN_.00g315240	Scaffold_15	46466474	46497241	O43399	TPD54_HUMAN	Tumor protein D54 (hD54) (Tumor protein D52-like 2)	GO:0003723; GO:0003824; GO:0005737; GO:0042127; GO:0042803; GO:0046982; GO:0048471	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell population proliferation [GO:0042127]
PGEN_.00g315250	Scaffold_15	46509780	46536073	Q6IR80	CL066_XENLA	KICSTOR complex protein C12orf66 homolog	GO:0005765; GO:0034198; GO:0042149; GO:0061462; GO:0140007; GO:1904262	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]
PGEN_.00g315260	Scaffold_15	46547654	46548705	NA	NA	NA	NA	NA
PGEN_.00g315270	Scaffold_15	46548801	46556062	Q9YIC0	EF1A_ORYLA	Elongation factor 1-alpha (EF-1-alpha)	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414]
PGEN_.00g315280	Scaffold_15	46562081	46599756	Q9Y6X6	MYO16_HUMAN	Unconventional myosin-XVI (Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3) (Unconventional myosin-16)	GO:0003774; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0008285; GO:0016459; GO:0021549; GO:0048471; GO:0051015; GO:2000134	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]
PGEN_.00g315290	Scaffold_15	46680649	46680972	NA	NA	NA	NA	NA
PGEN_.00g315300	Scaffold_15	46681624	46681878	NA	NA	NA	NA	NA
PGEN_.00g315310	Scaffold_15	46682309	46682692	NA	NA	NA	NA	NA
PGEN_.00g315320	Scaffold_15	46682951	46702038	NA	NA	NA	NA	NA
PGEN_.00g315330	Scaffold_15	46707258	46714475	NA	NA	NA	NA	NA
PGEN_.00g315340	Scaffold_15	46717855	46722407	NA	NA	NA	NA	NA
PGEN_.00g315350	Scaffold_15	46722564	46765108	Q9ZT63	MTP1_ARATH	Metal tolerance protein 1 (AtMTP1) (ZAT1p) (Zinc transporter ZAT-1) [Cleaved into: Metal tolerance protein 1 short form]	GO:0005385; GO:0005623; GO:0005773; GO:0005774; GO:0006829; GO:0006882; GO:0016020; GO:0016021; GO:0046872; GO:0046873	cell [GO:0005623]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion transport [GO:0006829]
PGEN_.00g315360	Scaffold_15	46765265	46776213	NA	NA	NA	NA	NA
PGEN_.00g315370	Scaffold_15	46782672	46795639	Q3ZBL5	PTH2_BOVIN	"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription)"	GO:0004045; GO:0005739; GO:0005829; GO:2000210; GO:2000811	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; negative regulation of anoikis [GO:2000811]; positive regulation of anoikis [GO:2000210]
PGEN_.00g315380	Scaffold_15	46829517	46837208	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g315390	Scaffold_15	46850343	46853851	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g315400	Scaffold_15	46858241	46862227	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g315410	Scaffold_15	46921815	46922192	NA	NA	NA	NA	NA
PGEN_.00g315420	Scaffold_15	46922226	46922936	NA	NA	NA	NA	NA
PGEN_.00g315430	Scaffold_15	46949547	46959402	P41366	VMO1_CHICK	Vitelline membrane outer layer protein 1 (VMO-1) (VMO-I) (VMOI)	GO:0005615; GO:0005623	cell [GO:0005623]; extracellular space [GO:0005615]
PGEN_.00g315440	Scaffold_15	46959470	46970463	Q8IX29	FBX16_HUMAN	F-box only protein 16		
PGEN_.00g315450	Scaffold_15	46970561	46992389	Q3L1C9	STAUH_APLCA	Double-stranded RNA-binding protein Staufen homolog	GO:0003729; GO:0032880; GO:0043005; GO:0043025; GO:0043204	neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; mRNA binding [GO:0003729]; regulation of protein localization [GO:0032880]
PGEN_.00g315460	Scaffold_15	46998581	47015533	Q6P877	ADRM1_XENTR	Proteasomal ubiquitin receptor ADRM1	GO:0000502; GO:0005634; GO:0005737; GO:0006511; GO:0008541; GO:0043130; GO:0043248; GO:0061133; GO:0070628	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g315470	Scaffold_15	47016929	47020126	NA	NA	NA	NA	NA
PGEN_.00g315480	Scaffold_15	47027503	47044778	Q91ZH7	ABHD3_MOUSE	Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) (Lung alpha/beta hydrolase 3) (MmLABH3)	GO:0004623; GO:0008970; GO:0016021; GO:0016298; GO:0044255; GO:0046470; GO:0047372; GO:0052739; GO:0052740; GO:0102567; GO:0102568	"integral component of membrane [GO:0016021]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; cellular lipid metabolic process [GO:0044255]; phosphatidylcholine metabolic process [GO:0046470]"
PGEN_.00g315490	Scaffold_15	47061462	47061929	NA	NA	NA	NA	NA
PGEN_.00g315500	Scaffold_15	47062030	47062407	NA	NA	NA	NA	NA
PGEN_.00g315510	Scaffold_15	47066487	47084339	A1L2F6	TM205_DANRE	Transmembrane protein 205	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g315520	Scaffold_15	47100262	47105125	Q28GF8	TM205_XENTR	Transmembrane protein 205	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g315530	Scaffold_15	47105847	47107876	NA	NA	NA	NA	NA
PGEN_.00g315540	Scaffold_15	47117703	47124024	P57788	MOT4_CHICK	Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3)	GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g315550	Scaffold_15	47137974	47155360	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g315560	Scaffold_15	47161707	47170405	Q8CE94	MOT13_MOUSE	Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13)	GO:0000139; GO:0005794; GO:0005829; GO:0005886; GO:0008028; GO:0015293; GO:0016021	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g315570	Scaffold_15	47174184	47188331	G5E8K6	MOT6_MOUSE	Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5)	GO:0005887; GO:0008028; GO:0015293; GO:0015718	integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g315580	Scaffold_15	47194894	47196168	NA	NA	NA	NA	NA
PGEN_.00g315590	Scaffold_15	47204635	47204976	NA	NA	NA	NA	NA
PGEN_.00g315600	Scaffold_15	47205179	47205430	NA	NA	NA	NA	NA
PGEN_.00g315610	Scaffold_15	47207338	47207658	NA	NA	NA	NA	NA
PGEN_.00g315620	Scaffold_15	47221919	47224069	NA	NA	NA	NA	NA
PGEN_.00g315630	Scaffold_15	47235220	47238638	NA	NA	NA	NA	NA
PGEN_.00g315640	Scaffold_15	47256730	47264348	NA	NA	NA	NA	NA
PGEN_.00g315650	Scaffold_15	47266582	47297669	NA	NA	NA	NA	NA
PGEN_.00g315660	Scaffold_15	47305727	47322762	NA	NA	NA	NA	NA
PGEN_.00g315670	Scaffold_15	47345116	47357044	Q8BNX1	CLC4G_MOUSE	C-type lectin domain family 4 member G	GO:0002710; GO:0005886; GO:0016021; GO:0030247; GO:0042130	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; polysaccharide binding [GO:0030247]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell proliferation [GO:0042130]
PGEN_.00g315680	Scaffold_15	47362557	47363129	NA	NA	NA	NA	NA
PGEN_.00g315690	Scaffold_15	47390116	47395584	NA	NA	NA	NA	NA
PGEN_.00g315700	Scaffold_15	47395767	47397677	Q4UMH6	Y381_RICFE	Putative ankyrin repeat protein RF_0381	GO:0015969	guanosine tetraphosphate metabolic process [GO:0015969]
PGEN_.00g315710	Scaffold_15	47430304	47436650	NA	NA	NA	NA	NA
PGEN_.00g315720	Scaffold_15	47443813	47452752	A2ADZ8	IQCC_MOUSE	IQ domain-containing protein C		
PGEN_.00g315730	Scaffold_15	47462791	47489210	Q2VJ60	RN19A_PIG	E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A)	GO:0000151; GO:0000209; GO:0005737; GO:0005815; GO:0006511; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630; GO:0098686; GO:0098794; GO:0098978; GO:0099576	"cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g315740	Scaffold_15	47499228	47526852	NA	NA	NA	NA	NA
PGEN_.00g315750	Scaffold_15	47528864	47548460	NA	NA	NA	NA	NA
PGEN_.00g315760	Scaffold_15	47560142	47573780	Q53H96	P5CR3_HUMAN	Pyrroline-5-carboxylate reductase 3 (P5C reductase 3) (P5CR 3) (EC 1.5.1.2) (Pyrroline-5-carboxylate reductase-like protein)	GO:0004735; GO:0005829; GO:0008652; GO:0055129	cytosol [GO:0005829]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular amino acid biosynthetic process [GO:0008652]; L-proline biosynthetic process [GO:0055129]
PGEN_.00g315770	Scaffold_15	47578979	47582231	NA	NA	NA	NA	NA
PGEN_.00g315780	Scaffold_15	47591354	47591809	NA	NA	NA	NA	NA
PGEN_.00g315790	Scaffold_15	47631988	47634745	NA	NA	NA	NA	NA
PGEN_.00g315800	Scaffold_15	47641535	47651158	NA	NA	NA	NA	NA
PGEN_.00g315810	Scaffold_15	47683139	47688853	Q8BNX1	CLC4G_MOUSE	C-type lectin domain family 4 member G	GO:0002710; GO:0005886; GO:0016021; GO:0030247; GO:0042130	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; polysaccharide binding [GO:0030247]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell proliferation [GO:0042130]
PGEN_.00g315820	Scaffold_15	47699207	47717754	A1L3G4	TM241_XENLA	Transmembrane protein 241	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g315830	Scaffold_15	47762871	47763635	Q5HZI9	S2551_MOUSE	Solute carrier family 25 member 51 (Mitochondrial carrier triple repeat protein 1)	GO:0005739; GO:0005743; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
PGEN_.00g315840	Scaffold_15	47777502	47777792	NA	NA	NA	NA	NA
PGEN_.00g315850	Scaffold_15	47789035	47789328	NA	NA	NA	NA	NA
PGEN_.00g315860	Scaffold_15	47807125	47817591	A3KMP2	TTC38_MOUSE	Tetratricopeptide repeat protein 38 (TPR repeat protein 38)		
PGEN_.00g315870	Scaffold_15	47844850	47845080	NA	NA	NA	NA	NA
PGEN_.00g315880	Scaffold_15	47851505	47854718	NA	NA	NA	NA	NA
PGEN_.00g315890	Scaffold_15	47887393	47928679	NA	NA	NA	NA	NA
PGEN_.00g315900	Scaffold_16	292	512	NA	NA	NA	NA	NA
PGEN_.00g315910	Scaffold_16	4780	13005	NA	NA	NA	NA	NA
PGEN_.00g315920	Scaffold_16	13643	14293	NA	NA	NA	NA	NA
PGEN_.00g315930	Scaffold_16	24084	25234	Q76HN1	HYAL1_RAT	Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1)	GO:0000302; GO:0004415; GO:0005615; GO:0005737; GO:0005764; GO:0005975; GO:0006954; GO:0008134; GO:0009615; GO:0010634; GO:0030212; GO:0030213; GO:0030214; GO:0030307; GO:0030308; GO:0031410; GO:0036117; GO:0036120; GO:0044344; GO:0045766; GO:0045785; GO:0045927; GO:0046677; GO:0046718; GO:0050501; GO:0050679; GO:0051216; GO:0060272; GO:0071347; GO:0071356; GO:0071467; GO:0071493; GO:1900087; GO:1900106	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; hyaluranon cable [GO:0036117]; lysosome [GO:0005764]; hyaluronan synthase activity [GO:0050501]; hyalurononglucosaminidase activity [GO:0004415]; transcription factor binding [GO:0008134]; carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to pH [GO:0071467]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; embryonic skeletal joint morphogenesis [GO:0060272]; hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of cell growth [GO:0030308]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of growth [GO:0045927]; positive regulation of hyaluranon cable assembly [GO:1900106]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615]; viral entry into host cell [GO:0046718]
PGEN_.00g315940	Scaffold_16	26088	26627	NA	NA	NA	NA	NA
PGEN_.00g315950	Scaffold_16	26650	27183	Q03650	CRAM_TRYBB	"Cysteine-rich, acidic integral membrane protein"	GO:0005886; GO:0006897; GO:0016021; GO:0020016	ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]
PGEN_.00g315960	Scaffold_16	27224	27919	NA	NA	NA	NA	NA
PGEN_.00g315970	Scaffold_16	28822	66016	J3S820	HYAL_CROAD	Hyaluronidase (EC 3.2.1.35) (Hyaluronoglucosaminidase) (Venom spreading factor)	GO:0004415; GO:0005576; GO:0005975	extracellular region [GO:0005576]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g315980	Scaffold_16	71560	89599	Q9WUA2	SYFB_MOUSE	Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)	GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0006432; GO:0009328; GO:0051290	phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]
PGEN_.00g315990	Scaffold_16	101268	101552	NA	NA	NA	NA	NA
PGEN_.00g316000	Scaffold_16	225361	230524	Q9EPS3	GLCE_MOUSE	D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin sulfate C5-epimerase) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)	GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016021; GO:0016857; GO:0030210; GO:0042803; GO:0047464; GO:0050379	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]"
PGEN_.00g316010	Scaffold_16	240684	254959	NA	NA	NA	NA	NA
PGEN_.00g316020	Scaffold_16	262711	276652	NA	NA	NA	NA	NA
PGEN_.00g316030	Scaffold_16	382074	429044	O95544	NADK_HUMAN	NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase)	GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0016310; GO:0019674; GO:0035774; GO:0046034; GO:0046872	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]
PGEN_.00g316040	Scaffold_16	438200	459444	NA	NA	NA	NA	NA
PGEN_.00g316050	Scaffold_16	459215	459469	NA	NA	NA	NA	NA
PGEN_.00g316060	Scaffold_16	468260	492645	Q1JPD8	S43A3_BOVIN	Solute carrier family 43 member 3	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g316070	Scaffold_16	521279	522328	NA	NA	NA	NA	NA
PGEN_.00g316080	Scaffold_16	548736	585812	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g316090	Scaffold_16	589364	589702	NA	NA	NA	NA	NA
PGEN_.00g316100	Scaffold_16	589989	592019	NA	NA	NA	NA	NA
PGEN_.00g316110	Scaffold_16	608990	643097	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g316120	Scaffold_16	643605	643883	NA	NA	NA	NA	NA
PGEN_.00g316130	Scaffold_16	665374	687272	Q8NBI5	S43A3_HUMAN	Solute carrier family 43 member 3 (Protein FOAP-13)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g316140	Scaffold_16	706127	715019	NA	NA	NA	NA	NA
PGEN_.00g316150	Scaffold_16	720965	721372	Q8C1B2	PARPT_MOUSE	Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (TCDD-inducible poly [ADP-ribose] polymerase)	GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0006471; GO:0006807; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0010629; GO:0030097; GO:0035326; GO:0045732; GO:0046872; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0070213; GO:0071407; GO:0140289; GO:1904612; GO:1990404	"nucleus [GO:0005634]; enhancer binding [GO:0035326]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; androgen metabolic process [GO:0008209]; cellular response to organic cyclic compound [GO:0071407]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]"
PGEN_.00g316160	Scaffold_16	721762	722379	NA	NA	NA	NA	NA
PGEN_.00g316170	Scaffold_16	790566	822937	Q5ZIJ9	MIB2_CHICK	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)	GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g316180	Scaffold_16	830367	841125	NA	NA	NA	NA	NA
PGEN_.00g316190	Scaffold_16	859328	881340	Q16WU7	WSCD_AEDAE	WSCD family member AAEL009094	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g316200	Scaffold_16	891188	960534	O00411	RPOM_HUMAN	"DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6)"	GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006390; GO:0006391; GO:0007005; GO:0032991; GO:0034245; GO:0042645; GO:0043565	mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; mitochondrial transcription [GO:0006390]; mitochondrion organization [GO:0007005]; transcription initiation from mitochondrial promoter [GO:0006391]
PGEN_.00g316210	Scaffold_16	963692	980739	Q9BWF2	TRAIP_HUMAN	E3 ubiquitin-protein ligase TRAIP (EC 2.3.2.27) (RING finger protein 206) (RING-type E3 ubiquitin transferase TRAIP) (TRAF-interacting protein)	GO:0005730; GO:0006915; GO:0007165; GO:0010804; GO:0032088; GO:0032688; GO:0046872; GO:0048471; GO:0061630	nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; signal transduction [GO:0007165]
PGEN_.00g316220	Scaffold_16	998787	999176	NA	NA	NA	NA	NA
PGEN_.00g316230	Scaffold_16	1025434	1026657	NA	NA	NA	NA	NA
PGEN_.00g316240	Scaffold_16	1155893	1217616	Q9EQJ4	ZN384_RAT	Zinc finger protein 384 (Cas-associated zinc finger protein) (Nuclear matrix transcription factor 4) (Nuclear matrix protein 4)	GO:0000978; GO:0001228; GO:0005634; GO:0005925; GO:0006913; GO:0017124; GO:0043565; GO:0045944; GO:0046872; GO:0050714	"focal adhesion [GO:0005925]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SH3 domain binding [GO:0017124]; nucleocytoplasmic transport [GO:0006913]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g316250	Scaffold_16	1239108	1249515	Q5BKF8	CCNL2_XENTR	Cyclin-L2	GO:0005634; GO:0006357; GO:0016538; GO:0016607	nuclear speck [GO:0016607]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g316260	Scaffold_16	1266277	1282993	Q5TDH0	DDI2_HUMAN	Protein DDI1 homolog 2 (EC 3.4.23.-)	GO:0004190; GO:0005654; GO:0005694; GO:0005829; GO:0010498; GO:0016485; GO:0031647; GO:0042802; GO:0043130; GO:0072711; GO:0097752	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]; cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]
PGEN_.00g316270	Scaffold_16	1292616	1297681	Q7TNS2	MIC10_MOUSE	MICOS complex subunit Mic10 (Mitochondrial inner membrane organizing system protein 1)	GO:0005739; GO:0061617	MICOS complex [GO:0061617]; mitochondrion [GO:0005739]
PGEN_.00g316280	Scaffold_16	1305787	1316203	Q9WU20	MTHR_MOUSE	Methylenetetrahydrofolate reductase (EC 1.5.1.20)	GO:0001843; GO:0004489; GO:0005829; GO:0006555; GO:0009086; GO:0031060; GO:0035999; GO:0044877; GO:0045202; GO:0046653; GO:0050660; GO:0050661; GO:0050667; GO:0070829; GO:0071949; GO:0072341	cytosol [GO:0005829]; synapse [GO:0045202]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877]; heterochromatin maintenance [GO:0070829]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; regulation of histone methylation [GO:0031060]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]
PGEN_.00g316290	Scaffold_16	1316761	1317120	NA	NA	NA	NA	NA
PGEN_.00g316300	Scaffold_16	1328137	1336055	Q9D995	CNTD1_MOUSE	Cyclin N-terminal domain-containing protein 1	GO:0007131; GO:0007283	reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]
PGEN_.00g316310	Scaffold_16	1341978	1346888	NA	NA	NA	NA	NA
PGEN_.00g316320	Scaffold_16	1354794	1402146	Q99570	PI3R4_HUMAN	Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein)	GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005930; GO:0006468; GO:0006623; GO:0006661; GO:0015630; GO:0016020; GO:0016236; GO:0030242; GO:0030670; GO:0032465; GO:0032801; GO:0034162; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561	"autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162]"
PGEN_.00g316330	Scaffold_16	1409246	1416394	Q5BKP2	UBP13_MOUSE	Ubiquitin carboxyl-terminal hydrolase 13 (EC 3.4.19.12) (Deubiquitinating enzyme 13) (Ubiquitin thioesterase 13) (Ubiquitin-specific-processing protease 13)	GO:0004197; GO:0004843; GO:0006355; GO:0006511; GO:0006914; GO:0008270; GO:0008283; GO:0010506; GO:0016579; GO:0031625; GO:0035523; GO:0036459; GO:0043130; GO:0044313; GO:0044389; GO:0050821; GO:0051087; GO:0070536; GO:0070628; GO:1904288; GO:1904294; GO:1904378; GO:1990380	"BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; positive regulation of ERAD pathway [GO:1904294]; protein deubiquitination [GO:0016579]; protein K29-linked deubiquitination [GO:0035523]; protein K6-linked deubiquitination [GO:0044313]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g316340	Scaffold_16	1418375	1427019	P56399	UBP5_MOUSE	Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)	GO:0004197; GO:0004843; GO:0006511; GO:0008270; GO:0016579; GO:0032436; GO:0043130; GO:0071108	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g316350	Scaffold_16	1472928	1516351	Q62442	VAMP1_MOUSE	Vesicle-associated membrane protein 1 (VAMP-1) (Synaptobrevin-1)	GO:0005739; GO:0009986; GO:0016082; GO:0030054; GO:0030285; GO:0031594; GO:0031630; GO:0035493; GO:0035579; GO:0043005; GO:0070821; GO:0098978	cell junction [GO:0030054]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic vesicle membrane [GO:0030285]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; SNARE complex assembly [GO:0035493]; synaptic vesicle priming [GO:0016082]
PGEN_.00g316360	Scaffold_16	1529024	1542539	Q6RFZ7	PKHG5_RAT	Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Neuronal RhoA GEF protein) (Transcript highly enriched in cortex and hippocampus)	GO:0005089; GO:0005737; GO:0005886; GO:0005911; GO:0030027; GO:0030139; GO:0035767; GO:0043542; GO:0048471; GO:0098793; GO:0099575	"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]"
PGEN_.00g316370	Scaffold_16	1588145	1663183	NA	NA	NA	NA	NA
PGEN_.00g316380	Scaffold_16	1668502	1669011	NA	NA	NA	NA	NA
PGEN_.00g316390	Scaffold_16	1669244	1669480	NA	NA	NA	NA	NA
PGEN_.00g316400	Scaffold_16	1676864	1681818	NA	NA	NA	NA	NA
PGEN_.00g316410	Scaffold_16	1787585	1788375	NA	NA	NA	NA	NA
PGEN_.00g316420	Scaffold_16	1799228	1799524	NA	NA	NA	NA	NA
PGEN_.00g316430	Scaffold_16	1807747	1819568	NA	NA	NA	NA	NA
PGEN_.00g316440	Scaffold_16	1819709	1831370	NA	NA	NA	NA	NA
PGEN_.00g316450	Scaffold_16	1843382	1846777	NA	NA	NA	NA	NA
PGEN_.00g316460	Scaffold_16	1950037	1967236	NA	NA	NA	NA	NA
PGEN_.00g316470	Scaffold_16	1967563	1967871	NA	NA	NA	NA	NA
PGEN_.00g316480	Scaffold_16	1970642	1971061	NA	NA	NA	NA	NA
PGEN_.00g316490	Scaffold_16	1971157	1971516	NA	NA	NA	NA	NA
PGEN_.00g316500	Scaffold_16	1971585	1972508	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g316510	Scaffold_16	1981286	1993101	NA	NA	NA	NA	NA
PGEN_.00g316520	Scaffold_16	2019352	2022942	NA	NA	NA	NA	NA
PGEN_.00g316530	Scaffold_16	2041129	2041935	NA	NA	NA	NA	NA
PGEN_.00g316540	Scaffold_16	2059342	2060816	NA	NA	NA	NA	NA
PGEN_.00g316550	Scaffold_16	2070559	2084150	NA	NA	NA	NA	NA
PGEN_.00g316560	Scaffold_16	2119149	2120605	NA	NA	NA	NA	NA
PGEN_.00g316570	Scaffold_16	2124465	2127141	NA	NA	NA	NA	NA
PGEN_.00g316580	Scaffold_16	2138454	2139602	NA	NA	NA	NA	NA
PGEN_.00g316590	Scaffold_16	2160879	2161226	NA	NA	NA	NA	NA
PGEN_.00g316600	Scaffold_16	2188460	2193772	Q4FZY0	EFHD2_RAT	EF-hand domain-containing protein D2 (Swiprosin-1)	GO:0005509; GO:0045121	membrane raft [GO:0045121]; calcium ion binding [GO:0005509]
PGEN_.00g316610	Scaffold_16	2215851	2244328	Q8IUN9	CLC10_HUMAN	C-type lectin domain family 10 member A (C-type lectin superfamily member 14) (Macrophage lectin 2) (CD antigen CD301)	GO:0002223; GO:0002250; GO:0005886; GO:0006897; GO:0016021; GO:0030246; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]
PGEN_.00g316620	Scaffold_16	2259881	2287874	Q8BK67	RCC2_MOUSE	Protein RCC2	GO:0005085; GO:0005634; GO:0005730; GO:0005874; GO:0005886; GO:0007049; GO:0007229; GO:0008017; GO:0010762; GO:0010971; GO:0019901; GO:0019904; GO:0030334; GO:0030496; GO:0031267; GO:0031901; GO:0034260; GO:0034506; GO:0045184; GO:0048041; GO:0048365; GO:0051301; GO:0051895; GO:0051987; GO:0072356; GO:0090630; GO:1900025; GO:1900027; GO:1990023	"chromosome, centromeric core domain [GO:0034506]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]"
PGEN_.00g316630	Scaffold_16	2328951	2359329	Q0IIC4	ZMAT3_BOVIN	Zinc finger matrin-type protein 3	GO:0003723; GO:0005654; GO:0005730; GO:0005886; GO:0006915; GO:0006974; GO:0008270; GO:0015031; GO:0040008	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; protein transport [GO:0015031]; regulation of growth [GO:0040008]
PGEN_.00g316640	Scaffold_16	2379702	2382528	NA	NA	NA	NA	NA
PGEN_.00g316650	Scaffold_16	2404443	2409967	NA	NA	NA	NA	NA
PGEN_.00g316660	Scaffold_16	2409964	2436863	P30151	EF1B_XENLA	Elongation factor 1-beta (EF-1-beta) (p30)	GO:0003746; GO:0005853	eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746]
PGEN_.00g316670	Scaffold_16	2454844	2457724	NA	NA	NA	NA	NA
PGEN_.00g316680	Scaffold_16	2490429	2496065	NA	NA	NA	NA	NA
PGEN_.00g316690	Scaffold_16	2500525	2516017	NA	NA	NA	NA	NA
PGEN_.00g316700	Scaffold_16	2546783	2571814	O15162	PLS1_HUMAN	Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (MmTRA1b)	GO:0001228; GO:0003677; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0010628; GO:0016020; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030168; GO:0033003; GO:0035456; GO:0042609; GO:0045071; GO:0045089; GO:0045121; GO:0045944; GO:0048471; GO:0051607; GO:0060368; GO:0062023; GO:0070062; GO:2000373	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]"
PGEN_.00g316710	Scaffold_16	2586771	2592234	NA	NA	NA	NA	NA
PGEN_.00g316720	Scaffold_16	2632748	2636862	P33300	SUR1_YEAST	Mannosyl phosphorylinositol ceramide synthase SUR1 (EC 2.4.-.-)	GO:0000030; GO:0000324; GO:0000329; GO:0006675; GO:0006688; GO:0016021; GO:0030148; GO:0051999	fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; glycosphingolipid biosynthetic process [GO:0006688]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]; mannosyl-inositol phosphorylceramide metabolic process [GO:0006675]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g316730	Scaffold_16	2653974	2671871	O95271	TNKS1_HUMAN	Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1)	GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g316740	Scaffold_16	2679983	2706481	P55205	GUC2G_RAT	Guanylate cyclase 2G (EC 4.6.1.2) (Guanylyl cyclase receptor G) (GC-G) (Kinase-like domain-containing soluble guanylyl cyclase) (ksGC)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005737; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0016021; GO:0035556	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g316750	Scaffold_16	2714774	2750923	O43156	TTI1_HUMAN	TELO2-interacting protein 1 homolog (Protein SMG10)	GO:0005737; GO:0031931; GO:0031932; GO:0032006; GO:0070209	ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; regulation of TOR signaling [GO:0032006]
PGEN_.00g316760	Scaffold_16	2754657	2763848	Q7ZUC2	CAB45_DANRE	45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4)	GO:0002040; GO:0005509; GO:0005783; GO:0005796; GO:0017156	endoplasmic reticulum [GO:0005783]; Golgi lumen [GO:0005796]; calcium ion binding [GO:0005509]; calcium-ion regulated exocytosis [GO:0017156]; sprouting angiogenesis [GO:0002040]
PGEN_.00g316770	Scaffold_16	2773704	2790713	Q9UGH3	S23A2_HUMAN	Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2) (hSVCT2) (Yolk sac permease-like molecule 2)	GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006979; GO:0009925; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]
PGEN_.00g316780	Scaffold_16	2803000	2860334	Q6Y7W6	GGYF2_HUMAN	GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein)	GO:0003723; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0007631; GO:0008344; GO:0009791; GO:0010494; GO:0016020; GO:0016021; GO:0016441; GO:0017148; GO:0021522; GO:0031571; GO:0032991; GO:0035264; GO:0043204; GO:0044267; GO:0045296; GO:0048009; GO:0048873; GO:0050881; GO:0050885; GO:0061157; GO:0070064; GO:1990635	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; cadherin binding [GO:0045296]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; cellular protein metabolic process [GO:0044267]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing [GO:0016441]; spinal cord motor neuron differentiation [GO:0021522]
PGEN_.00g316790	Scaffold_16	2861402	2893046	Q8BFT6	JMJD4_MOUSE	2-oxoglutarate and iron-dependent oxygenase JMJD4 (EC 1.14.11.-) (JmjC domain-containing protein 4) (Jumonji domain-containing protein 4) (Lysyl-hydroxylase JMJD4)	GO:0005737; GO:0016706; GO:0018126; GO:0045905; GO:0046872	cytoplasm [GO:0005737]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126]
PGEN_.00g316800	Scaffold_16	2899045	2909248	Q5XI32	CAPZB_RAT	F-actin-capping protein subunit beta (CapZ beta)	GO:0000902; GO:0003779; GO:0005903; GO:0007010; GO:0008290; GO:0010591; GO:0014069; GO:0014704; GO:0016020; GO:0022604; GO:0030018; GO:0030027; GO:0030030; GO:0030032; GO:0030036; GO:0030863; GO:0031115; GO:0031175; GO:0032279; GO:0043025; GO:0043197; GO:0048487; GO:0048747; GO:0051015; GO:0051016; GO:0051490; GO:0071203; GO:0090036; GO:0098685; GO:0098686	asymmetric synapse [GO:0032279]; brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; WASH complex [GO:0071203]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; muscle fiber development [GO:0048747]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]; regulation of protein kinase C signaling [GO:0090036]
PGEN_.00g316810	Scaffold_16	2914863	2926713	Q02956	KPCZ_MOUSE	Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta)	GO:0000226; GO:0001725; GO:0001954; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005623; GO:0005634; GO:0005635; GO:0005737; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0005938; GO:0006468; GO:0006954; GO:0007165; GO:0007166; GO:0007616; GO:0008284; GO:0014069; GO:0015459; GO:0016324; GO:0016363; GO:0016477; GO:0018105; GO:0019901; GO:0030010; GO:0031252; GO:0031333; GO:0031584; GO:0031982; GO:0032148; GO:0032753; GO:0032869; GO:0034613; GO:0035556; GO:0035748; GO:0043066; GO:0043203; GO:0043231; GO:0043274; GO:0044877; GO:0045121; GO:0045179; GO:0045630; GO:0046627; GO:0046628; GO:0046872; GO:0047496; GO:0048471; GO:0050732; GO:0050806; GO:0051092; GO:0051222; GO:0051291; GO:0051346; GO:0051899; GO:0060081; GO:0060291; GO:0070374; GO:0070528; GO:0071889; GO:0072659; GO:0098685; GO:0098696; GO:0098978; GO:1990138; GO:2000463; GO:2000553; GO:2000664; GO:2000667; GO:2001181	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell [GO:0005623]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; stress fiber [GO:0001725]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phospholipase binding [GO:0043274]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; activation of phospholipase D activity [GO:0031584]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cellular protein localization [GO:0034613]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 secretion [GO:2001181]; positive regulation of interleukin-13 secretion [GO:2000667]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 secretion [GO:2000664]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein transport [GO:0051222]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein heterooligomerization [GO:0051291]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; signal transduction [GO:0007165]; vesicle transport along microtubule [GO:0047496]
PGEN_.00g316820	Scaffold_16	3006100	3013929	NA	NA	NA	NA	NA
PGEN_.00g316830	Scaffold_16	3019609	3020226	NA	NA	NA	NA	NA
PGEN_.00g316840	Scaffold_16	3206825	3207328	NA	NA	NA	NA	NA
PGEN_.00g316850	Scaffold_16	3207883	3208107	NA	NA	NA	NA	NA
PGEN_.00g316860	Scaffold_16	3208530	3210352	NA	NA	NA	NA	NA
PGEN_.00g316870	Scaffold_16	3235479	3236111	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g316880	Scaffold_16	3236136	3237900	NA	NA	NA	NA	NA
PGEN_.00g316890	Scaffold_16	3248856	3250490	Q9JHG3	APJ_RAT	Apelin receptor (Angiotensin receptor-like 1) (B78) (G-protein coupled receptor APJ) (GPCR34)	GO:0001525; GO:0001568; GO:0001570; GO:0004930; GO:0005623; GO:0005886; GO:0007186; GO:0007369; GO:0007507; GO:0007512; GO:0016020; GO:0016021; GO:0042277; GO:0043951; GO:0045766; GO:0050878; GO:0051281; GO:0060182; GO:0060976; GO:1903589; GO:1904325	cell [GO:0005623]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apelin receptor activity [GO:0060182]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; adult heart development [GO:0007512]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; coronary vasculature development [GO:0060976]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; heart development [GO:0007507]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of inhibitory G protein-coupled receptor phosphorylation [GO:1904325]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]
PGEN_.00g316900	Scaffold_16	3301925	3317059	Q8K2J9	BTBD6_MOUSE	BTB/POZ domain-containing protein 6	GO:0005829; GO:0022008	cytosol [GO:0005829]; neurogenesis [GO:0022008]
PGEN_.00g316910	Scaffold_16	3359020	3359436	NA	NA	NA	NA	NA
PGEN_.00g316920	Scaffold_16	3359484	3361395	NA	NA	NA	NA	NA
PGEN_.00g316930	Scaffold_16	3449627	3466463	Q9WYP5	IOLG_THEMA	Myo-inositol 2-dehydrogenase (EC 1.1.1.18)	GO:0006020; GO:0006740; GO:0016491; GO:0050112	inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]; inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740]
PGEN_.00g316940	Scaffold_16	3469731	3471745	NA	NA	NA	NA	NA
PGEN_.00g316950	Scaffold_16	3482258	3482479	NA	NA	NA	NA	NA
PGEN_.00g316960	Scaffold_16	3489975	3506796	NA	NA	NA	NA	NA
PGEN_.00g316970	Scaffold_16	3513291	3515656	P48029	SC6A8_HUMAN	Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)	GO:0005308; GO:0005309; GO:0005332; GO:0005886; GO:0005887; GO:0006600; GO:0006936; GO:0015881; GO:0016021; GO:0042165; GO:0043005	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; creatine:sodium symporter activity [GO:0005309]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; creatine metabolic process [GO:0006600]; creatine transmembrane transport [GO:0015881]; muscle contraction [GO:0006936]
PGEN_.00g316980	Scaffold_16	3522392	3522667	P31645	SC6A4_HUMAN	Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4)	GO:0001666; GO:0005335; GO:0005886; GO:0005925; GO:0007584; GO:0007613; GO:0007623; GO:0008504; GO:0009636; GO:0010008; GO:0010628; GO:0012505; GO:0014064; GO:0015844; GO:0017075; GO:0019811; GO:0021941; GO:0032227; GO:0032355; GO:0035176; GO:0042136; GO:0042310; GO:0042493; GO:0042713; GO:0042803; GO:0043005; GO:0045121; GO:0045202; GO:0045665; GO:0045787; GO:0046621; GO:0046872; GO:0048854; GO:0050998; GO:0051015; GO:0051259; GO:0051378; GO:0051610; GO:0071300; GO:0071321; GO:0090067; GO:0099055; GO:0099056; GO:0099154	"endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonergic synapse [GO:0099154]; synapse [GO:0045202]; actin filament binding [GO:0051015]; cocaine binding [GO:0019811]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; nitric-oxide synthase binding [GO:0050998]; protein homodimerization activity [GO:0042803]; serotonin binding [GO:0051378]; serotonin:sodium symporter activity [GO:0005335]; syntaxin-1 binding [GO:0017075]; brain morphogenesis [GO:0048854]; cellular response to cGMP [GO:0071321]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; memory [GO:0007613]; monoamine transport [GO:0015844]; negative regulation of cerebellar granule cell precursor proliferation [GO:0021941]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of serotonin secretion [GO:0014064]; protein complex oligomerization [GO:0051259]; regulation of thalamus size [GO:0090067]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to toxic substance [GO:0009636]; serotonin uptake [GO:0051610]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; vasoconstriction [GO:0042310]"
PGEN_.00g316990	Scaffold_16	3537343	3557213	O35316	SC6A6_MOUSE	Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6)	GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0005887; GO:0015734; GO:0030977; GO:0042165; GO:0043005; GO:0050804; GO:0098982; GO:0099055	GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; taurine binding [GO:0030977]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369]; modulation of chemical synaptic transmission [GO:0050804]; taurine transport [GO:0015734]
PGEN_.00g317000	Scaffold_16	3559623	3570308	Q9YHT2	SDHB_CHICK	"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip)"	GO:0005743; GO:0005749; GO:0006099; GO:0008177; GO:0009055; GO:0009060; GO:0022904; GO:0031966; GO:0046872; GO:0048039; GO:0051537; GO:0051538; GO:0051539	"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]; aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099]"
PGEN_.00g317010	Scaffold_16	3573979	3577931	NA	NA	NA	NA	NA
PGEN_.00g317020	Scaffold_16	3589585	3601953	Q5XF90	AT134_MOUSE	Probable cation-transporting ATPase 13A4 (EC 7.2.2.-) (P5-ATPase isoform 4)	GO:0005388; GO:0005524; GO:0005623; GO:0005789; GO:0006874; GO:0016021; GO:0016887; GO:0046872	"cell [GO:0005623]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium transmembrane transporter activity, phosphorylative mechanism [GO:0005388]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]"
PGEN_.00g317030	Scaffold_16	3603193	3648527	Q9H7F0	AT133_HUMAN	Probable cation-transporting ATPase 13A3 (EC 7.2.2.-) (ATPase family homolog up-regulated in senescence cells 1)	GO:0005524; GO:0005623; GO:0006812; GO:0006874; GO:0016020; GO:0016021; GO:0016887; GO:0046872	cell [GO:0005623]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]
PGEN_.00g317040	Scaffold_16	3660908	3666186	NA	NA	NA	NA	NA
PGEN_.00g317050	Scaffold_16	3670955	3681629	Q4FZX7	SRPRB_RAT	Signal recognition particle receptor subunit beta (SR-beta)	GO:0005525; GO:0005737; GO:0005789; GO:0005881; GO:0016020; GO:0016021; GO:0031625	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625]
PGEN_.00g317060	Scaffold_16	3746309	3747260	NA	NA	NA	NA	NA
PGEN_.00g317070	Scaffold_16	3749574	3750588	NA	NA	NA	NA	NA
PGEN_.00g317080	Scaffold_16	3767862	3775230	NA	NA	NA	NA	NA
PGEN_.00g317090	Scaffold_16	3778404	3782530	Q90Z12	HES4A_XENLA	Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a)	GO:0000122; GO:0002088; GO:0005634; GO:0008283; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell population proliferation [GO:0008283]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501]"
PGEN_.00g317100	Scaffold_16	3951731	3952192	NA	NA	NA	NA	NA
PGEN_.00g317110	Scaffold_16	3952235	3952964	NA	NA	NA	NA	NA
PGEN_.00g317120	Scaffold_16	3973634	3975103	NA	NA	NA	NA	NA
PGEN_.00g317130	Scaffold_16	3985413	3987200	NA	NA	NA	NA	NA
PGEN_.00g317140	Scaffold_16	3987257	3989298	NA	NA	NA	NA	NA
PGEN_.00g317150	Scaffold_16	3998299	4010106	Q9I993	BCDO1_CHICK	"Beta,beta-carotene 15,15'-dioxygenase (EC 1.13.11.63) (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1)"	GO:0001523; GO:0003834; GO:0004497; GO:0004744; GO:0010436; GO:0016121; GO:0032526; GO:0042572; GO:0042574; GO:0046872; GO:1901810	"beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; retinal isomerase activity [GO:0004744]; beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; response to retinoic acid [GO:0032526]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"
PGEN_.00g317160	Scaffold_16	4010949	4033427	Q99NF1	BCDO2_MOUSE	"Beta,beta-carotene 9',10'-oxygenase (EC 1.13.11.71) (B-diox-II) (Beta-carotene dioxygenase 2)"	GO:0003834; GO:0004744; GO:0005739; GO:0010436; GO:0016116; GO:0016119; GO:0016121; GO:0016122; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0055114; GO:0102076; GO:2000377	"mitochondrion [GO:0005739]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]; carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; oxidation-reduction process [GO:0055114]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll metabolic process [GO:0016122]"
PGEN_.00g317170	Scaffold_16	4047365	4062120	Q99NF1	BCDO2_MOUSE	"Beta,beta-carotene 9',10'-oxygenase (EC 1.13.11.71) (B-diox-II) (Beta-carotene dioxygenase 2)"	GO:0003834; GO:0004744; GO:0005739; GO:0010436; GO:0016116; GO:0016119; GO:0016121; GO:0016122; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0055114; GO:0102076; GO:2000377	"mitochondrion [GO:0005739]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]; carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; oxidation-reduction process [GO:0055114]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll metabolic process [GO:0016122]"
PGEN_.00g317180	Scaffold_16	4067939	4070378	NA	NA	NA	NA	NA
PGEN_.00g317190	Scaffold_16	4175349	4178327	Q8BN82	S17A5_MOUSE	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0006865; GO:0009617; GO:0015136; GO:0015293; GO:0015739; GO:0016021; GO:0030054; GO:0030672; GO:0031410	cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; sialic acid transmembrane transporter activity [GO:0015136]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]
PGEN_.00g317200	Scaffold_16	4193866	4206302	NA	NA	NA	NA	NA
PGEN_.00g317210	Scaffold_16	4242544	4245292	NA	NA	NA	NA	NA
PGEN_.00g317220	Scaffold_16	4252000	4261700	NA	NA	NA	NA	NA
PGEN_.00g317230	Scaffold_16	4263087	4268675	NA	NA	NA	NA	NA
PGEN_.00g317240	Scaffold_16	4272657	4281380	NA	NA	NA	NA	NA
PGEN_.00g317250	Scaffold_16	4301814	4312284	NA	NA	NA	NA	NA
PGEN_.00g317260	Scaffold_16	4352604	4363159	Q95NT6	MTH2_DROYA	G-protein coupled receptor Mth2 (Protein methuselah-2)	GO:0004930; GO:0005886; GO:0007166; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g317270	Scaffold_16	4367046	4367318	NA	NA	NA	NA	NA
PGEN_.00g317280	Scaffold_16	4372113	4375350	NA	NA	NA	NA	NA
PGEN_.00g317290	Scaffold_16	4379817	4407138	NA	NA	NA	NA	NA
PGEN_.00g317300	Scaffold_16	4410480	4410866	Q9QX96	SALL2_MOUSE	Sal-like protein 2 (Spalt-like protein 2) (Zinc finger protein Spalt-2) (Sal-2) (mSal-2)	GO:0000122; GO:0000977; GO:0001228; GO:0001654; GO:0005634; GO:0006355; GO:0021915; GO:0044877; GO:0045892; GO:0045944; GO:0046872	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; eye development [GO:0001654]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g317310	Scaffold_16	4413606	4413992	Q8N859	ZN713_HUMAN	Zinc finger protein 713	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g317320	Scaffold_16	4418702	4419022	Q5R741	ZN394_PONAB	Zinc finger protein 394	GO:0003677; GO:0003700; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]
PGEN_.00g317330	Scaffold_16	4436004	4437610	NA	NA	NA	NA	NA
PGEN_.00g317340	Scaffold_16	4443843	4444175	NA	NA	NA	NA	NA
PGEN_.00g317350	Scaffold_16	4444265	4455468	Q3U288	ZN710_MOUSE	Zinc finger protein 710	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g317360	Scaffold_16	4464091	4467976	NA	NA	NA	NA	NA
PGEN_.00g317370	Scaffold_16	4482520	4483140	NA	NA	NA	NA	NA
PGEN_.00g317380	Scaffold_16	4483223	4485229	NA	NA	NA	NA	NA
PGEN_.00g317390	Scaffold_16	4487244	4523790	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g317400	Scaffold_16	4534731	4558621	Q924H0	NPFF2_MOUSE	Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408; GO:0045761; GO:2000479	actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]
PGEN_.00g317410	Scaffold_16	4558655	4559292	NA	NA	NA	NA	NA
PGEN_.00g317420	Scaffold_16	4563313	4564347	P32238	CCKAR_HUMAN	Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R)	GO:0001764; GO:0004930; GO:0004951; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007409; GO:0007631; GO:0016020; GO:0017046; GO:0030900; GO:0032870; GO:0038188; GO:0046883	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; axonogenesis [GO:0007409]; cellular response to hormone stimulus [GO:0032870]; cholecystokinin signaling pathway [GO:0038188]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of hormone secretion [GO:0046883]
PGEN_.00g317430	Scaffold_16	4597458	4598012	Q24155	TRUNK_DROME	Protein trunk	GO:0005122; GO:0005615; GO:0007362; GO:0008293; GO:0048018	extracellular space [GO:0005615]; receptor ligand activity [GO:0048018]; torso binding [GO:0005122]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]
PGEN_.00g317440	Scaffold_16	4628839	4636511	NA	NA	NA	NA	NA
PGEN_.00g317450	Scaffold_16	4664362	4682031	Q6PBE2	SPF27_XENTR	Pre-mRNA-splicing factor SPF27 (Protein BCAS2 homolog)	GO:0000398; GO:0000974; GO:0005634; GO:0071007	"nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g317460	Scaffold_16	4691340	4705431	Q8C811	S35E2_MOUSE	Solute carrier family 35 member E2A	GO:0001835; GO:0005794; GO:0015297; GO:0016021; GO:0022857	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; blastocyst hatching [GO:0001835]
PGEN_.00g317470	Scaffold_16	4711864	4712391	NA	NA	NA	NA	NA
PGEN_.00g317480	Scaffold_16	4714960	4743154	Q9ES00	UBE4B_MOUSE	Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2)	GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030433; GO:0031175; GO:0034450; GO:0034976; GO:0043161; GO:0044257; GO:0051082; GO:0051117; GO:0051865; GO:0061630	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082]; cellular protein catabolic process [GO:0044257]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222]
PGEN_.00g317490	Scaffold_16	4754179	4764680	Q567I9	CB5D1_DANRE	Cytochrome b5 domain-containing protein 1	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g317500	Scaffold_16	4764991	4776607	A2BIG9	LSMD1_DANRE	"N-alpha-acetyltransferase 38, NatC auxiliary subunit (LSM domain-containing protein 1)"	GO:0005634; GO:0005737; GO:0031417; GO:0043066	cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]
PGEN_.00g317510	Scaffold_16	4788145	4788438	NA	NA	NA	NA	NA
PGEN_.00g317520	Scaffold_16	4788647	4789039	NA	NA	NA	NA	NA
PGEN_.00g317530	Scaffold_16	4791309	4791617	NA	NA	NA	NA	NA
PGEN_.00g317540	Scaffold_16	4793799	4796072	NA	NA	NA	NA	NA
PGEN_.00g317550	Scaffold_16	4796438	4797129	NA	NA	NA	NA	NA
PGEN_.00g317560	Scaffold_16	4797223	4797870	NA	NA	NA	NA	NA
PGEN_.00g317570	Scaffold_16	4871219	4901026	NA	NA	NA	NA	NA
PGEN_.00g317580	Scaffold_16	4921822	4931579	NA	NA	NA	NA	NA
PGEN_.00g317590	Scaffold_16	4931872	4938286	NA	NA	NA	NA	NA
PGEN_.00g317600	Scaffold_16	4938339	4939259	NA	NA	NA	NA	NA
PGEN_.00g317610	Scaffold_16	4977838	4978122	NA	NA	NA	NA	NA
PGEN_.00g317620	Scaffold_16	4983231	4986904	P32320	CDD_HUMAN	Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase)	GO:0001882; GO:0004126; GO:0005576; GO:0005829; GO:0007166; GO:0008270; GO:0008655; GO:0009972; GO:0019858; GO:0030308; GO:0034774; GO:0042803; GO:0043097; GO:0043312; GO:0045980; GO:0051289; GO:1904724; GO:1904813	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytidine deaminase activity [GO:0004126]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; cytidine deamination [GO:0009972]; cytosine metabolic process [GO:0019858]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; pyrimidine-containing compound salvage [GO:0008655]
PGEN_.00g317630	Scaffold_16	5011470	5014141	NA	NA	NA	NA	NA
PGEN_.00g317640	Scaffold_16	5026550	5035089	NA	NA	NA	NA	NA
PGEN_.00g317650	Scaffold_16	5037008	5052821	NA	NA	NA	NA	NA
PGEN_.00g317660	Scaffold_16	5055460	5057989	Q5ZKS8	UBIA1_CHICK	UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-)	GO:0001885; GO:0004659; GO:0005739; GO:0005783; GO:0005789; GO:0006744; GO:0009234; GO:0016209; GO:0030173; GO:0032194; GO:0042371; GO:0072358	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of Golgi membrane [GO:0030173]; mitochondrion [GO:0005739]; antioxidant activity [GO:0016209]; prenyltransferase activity [GO:0004659]; cardiovascular system development [GO:0072358]; endothelial cell development [GO:0001885]; menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process [GO:0006744]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]; vitamin K biosynthetic process [GO:0042371]"
PGEN_.00g317670	Scaffold_16	5069574	5091190	Q9NRA2	S17A5_HUMAN	Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0030054; GO:0030672	cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]
PGEN_.00g317680	Scaffold_16	5097795	5117348	P51840	GUC2E_RAT	Retinal guanylyl cyclase 1 (RETGC-1) (EC 4.6.1.2) (Guanylate cyclase 2E) (Guanylyl cyclase GC-E)	GO:0001653; GO:0001750; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005789; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0007601; GO:0016021; GO:0016941; GO:0017046; GO:0019934; GO:0042622; GO:0042802; GO:0042803; GO:0044877	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]; visual perception [GO:0007601]
PGEN_.00g317690	Scaffold_16	5244687	5249049	NA	NA	NA	NA	NA
PGEN_.00g317700	Scaffold_16	5303396	5304333	NA	NA	NA	NA	NA
PGEN_.00g317710	Scaffold_16	5346059	5346361	NA	NA	NA	NA	NA
PGEN_.00g317720	Scaffold_16	5444261	5446008	NA	NA	NA	NA	NA
PGEN_.00g317730	Scaffold_16	5455447	5484052	O43432	IF4G3_HUMAN	Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII)	GO:0000339; GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0006446; GO:0008135; GO:0016281	"cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]"
PGEN_.00g317740	Scaffold_16	5505407	5509734	Q5UAW9	GP157_HUMAN	G-protein coupled receptor 157	GO:0004930; GO:0005623; GO:0007166; GO:0007186; GO:0016021; GO:0048512; GO:0051482; GO:0060019; GO:0060170	cell [GO:0005623]; ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; radial glial cell differentiation [GO:0060019]
PGEN_.00g317750	Scaffold_16	5513946	5516862	NA	NA	NA	NA	NA
PGEN_.00g317760	Scaffold_16	5516983	5517258	NA	NA	NA	NA	NA
PGEN_.00g317770	Scaffold_16	5517328	5518433	NA	NA	NA	NA	NA
PGEN_.00g317780	Scaffold_16	5519523	5520411	NA	NA	NA	NA	NA
PGEN_.00g317790	Scaffold_16	5520735	5537348	NA	NA	NA	NA	NA
PGEN_.00g317800	Scaffold_16	5537402	5541223	Q5UAW9	GP157_HUMAN	G-protein coupled receptor 157	GO:0004930; GO:0005623; GO:0007166; GO:0007186; GO:0016021; GO:0048512; GO:0051482; GO:0060019; GO:0060170	cell [GO:0005623]; ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; radial glial cell differentiation [GO:0060019]
PGEN_.00g317810	Scaffold_16	5554276	5572139	Q7SY23	AL4A1_DANRE	"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)"	GO:0003842; GO:0005759; GO:0010133; GO:0016620	"mitochondrial matrix [GO:0005759]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; proline catabolic process to glutamate [GO:0010133]"
PGEN_.00g317820	Scaffold_16	5599697	5601654	NA	NA	NA	NA	NA
PGEN_.00g317830	Scaffold_16	5610655	5640890	A2BFP5	S12A9_DANRE	Solute carrier family 12 member 9	GO:0005623; GO:0005886; GO:0006884; GO:0015379; GO:0016021; GO:0055064; GO:0055075; GO:1902476; GO:1990573	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]
PGEN_.00g317840	Scaffold_16	5618312	5618545	NA	NA	NA	NA	NA
PGEN_.00g317850	Scaffold_16	5618850	5619269	NA	NA	NA	NA	NA
PGEN_.00g317860	Scaffold_16	5651889	5678729	NA	NA	NA	NA	NA
PGEN_.00g317870	Scaffold_16	5685535	5705734	Q5ZK62	ACAP2_CHICK	"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)"	GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090	endosome membrane [GO:0010008]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]
PGEN_.00g317880	Scaffold_16	5710353	5715310	Q8R5M3	LRC15_RAT	Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by amyloid-beta) (rLib)	GO:0001968; GO:0005518; GO:0009986; GO:0016021; GO:0030335; GO:0043236; GO:0046813; GO:1903077	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]
PGEN_.00g317890	Scaffold_16	5716920	5745171	Q5ZK62	ACAP2_CHICK	"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)"	GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090	endosome membrane [GO:0010008]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]
PGEN_.00g317900	Scaffold_16	5755480	5782736	Q5ZIJ9	MIB2_CHICK	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)	GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g317910	Scaffold_16	5784847	5788590	NA	NA	NA	NA	NA
PGEN_.00g317920	Scaffold_16	5795994	5797331	NA	NA	NA	NA	NA
PGEN_.00g317930	Scaffold_16	5799681	5807528	NA	NA	NA	NA	NA
PGEN_.00g317940	Scaffold_16	5810751	5814046	NA	NA	NA	NA	NA
PGEN_.00g317950	Scaffold_16	5830170	5830457	NA	NA	NA	NA	NA
PGEN_.00g317960	Scaffold_16	5831117	5838743	Q5R630	NECP1_PONAB	Adaptin ear-binding coat-associated protein 1 (NECAP endocytosis-associated protein 1) (NECAP-1)	GO:0005886; GO:0006897; GO:0015031; GO:0030665	clathrin-coated vesicle membrane [GO:0030665]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; protein transport [GO:0015031]
PGEN_.00g317970	Scaffold_16	5853704	5858555	Q96AE7	TTC17_HUMAN	Tetratricopeptide repeat protein 17 (TPR repeat protein 17)	GO:0005737; GO:0005829; GO:0005886; GO:0015629; GO:0030041; GO:0044782	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]
PGEN_.00g317980	Scaffold_16	5904986	5933087	Q96AX9	MIB2_HUMAN	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (Novel zinc finger protein) (Novelzin) (Putative NF-kappa-B-activating protein 002N) (RING-type E3 ubiquitin transferase MIB2) (Skeletrophin) (Zinc finger ZZ type with ankyrin repeat domain protein 1)	GO:0000151; GO:0000209; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005829; GO:0007219; GO:0008270; GO:0016567; GO:0043123; GO:0061630	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]
PGEN_.00g317990	Scaffold_16	5937832	5941290	NA	NA	NA	NA	NA
PGEN_.00g318000	Scaffold_16	6004187	6009833	NA	NA	NA	NA	NA
PGEN_.00g318010	Scaffold_16	6043789	6045160	NA	NA	NA	NA	NA
PGEN_.00g318020	Scaffold_16	6051000	6058727	NA	NA	NA	NA	NA
PGEN_.00g318030	Scaffold_16	6343647	6352143	Q9XTA0	DOPO_HORSE	Dopamine beta-hydroxylase (EC 1.14.17.1) [Cleaved into: Soluble dopamine beta-hydroxylase]	GO:0004500; GO:0005507; GO:0005615; GO:0005737; GO:0006589; GO:0016021; GO:0016715; GO:0030658; GO:0030667; GO:0031418; GO:0034466; GO:0034774; GO:0042420; GO:0042421; GO:0042584	"chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]"
PGEN_.00g318040	Scaffold_16	6412331	6412675	NA	NA	NA	NA	NA
PGEN_.00g318050	Scaffold_16	6434309	6451007	NA	NA	NA	NA	NA
PGEN_.00g318060	Scaffold_16	6477153	6478462	NA	NA	NA	NA	NA
PGEN_.00g318070	Scaffold_16	6590126	6595210	NA	NA	NA	NA	NA
PGEN_.00g318080	Scaffold_16	6611555	6612301	NA	NA	NA	NA	NA
PGEN_.00g318090	Scaffold_16	6628659	6628976	NA	NA	NA	NA	NA
PGEN_.00g318100	Scaffold_16	6715651	6724937	Q63931	CCKAR_CAVPO	Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R)	GO:0001764; GO:0004951; GO:0005886; GO:0007409; GO:0016021; GO:0017046; GO:0030900	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cholecystokinin receptor activity [GO:0004951]; peptide hormone binding [GO:0017046]; axonogenesis [GO:0007409]; forebrain development [GO:0030900]; neuron migration [GO:0001764]
PGEN_.00g318110	Scaffold_16	6726349	6729346	NA	NA	NA	NA	NA
PGEN_.00g318120	Scaffold_16	6734656	6735153	NA	NA	NA	NA	NA
PGEN_.00g318130	Scaffold_16	6735754	6736035	NA	NA	NA	NA	NA
PGEN_.00g318140	Scaffold_16	6808752	6809069	NA	NA	NA	NA	NA
PGEN_.00g318150	Scaffold_16	6829064	6832376	NA	NA	NA	NA	NA
PGEN_.00g318160	Scaffold_16	6840463	6841248	NA	NA	NA	NA	NA
PGEN_.00g318170	Scaffold_16	6850997	6854036	NA	NA	NA	NA	NA
PGEN_.00g318180	Scaffold_16	6970043	6995463	Q9W436	NEP_DROME	Neprilysin-1 (EC 3.4.24.11)	GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]
PGEN_.00g318190	Scaffold_16	6997183	6998305	NA	NA	NA	NA	NA
PGEN_.00g318200	Scaffold_16	6999642	6999878	NA	NA	NA	NA	NA
PGEN_.00g318210	Scaffold_16	6999923	7000258	NA	NA	NA	NA	NA
PGEN_.00g318220	Scaffold_16	7000892	7001350	Q5RHD1	KDM7A_DANRE	Lysine-specific demethylase 7A (DrKDM7a) (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 1D-A)	GO:0005634; GO:0016706; GO:0030901; GO:0032454; GO:0033169; GO:0035574; GO:0035575; GO:0046872; GO:0051864; GO:0070544; GO:0071557; GO:0071558	nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; metal ion binding [GO:0046872]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]
PGEN_.00g318230	Scaffold_16	7001522	7011603	Q9JLI3	MMEL1_MOUSE	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) (Neprilysin-like 1) (NL-1) (Neprilysin-like peptidase) (NEPLP) (Soluble secreted endopeptidase) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	GO:0004175; GO:0004222; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0008270; GO:0016020; GO:0016021	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g318240	Scaffold_16	7063757	7076999	P58780	ADA2_PIG	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	GO:0004000; GO:0005615; GO:0006154; GO:0008201; GO:0008270; GO:0031685; GO:0043394; GO:0046103	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]
PGEN_.00g318250	Scaffold_16	7079324	7094636	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g318260	Scaffold_16	7084607	7084861	NA	NA	NA	NA	NA
PGEN_.00g318270	Scaffold_16	7098257	7098511	NA	NA	NA	NA	NA
PGEN_.00g318280	Scaffold_16	7098563	7099246	NA	NA	NA	NA	NA
PGEN_.00g318290	Scaffold_16	7105649	7106053	NA	NA	NA	NA	NA
PGEN_.00g318300	Scaffold_16	7111593	7112006	NA	NA	NA	NA	NA
PGEN_.00g318310	Scaffold_16	7115773	7117598	P58780	ADA2_PIG	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	GO:0004000; GO:0005615; GO:0006154; GO:0008201; GO:0008270; GO:0031685; GO:0043394; GO:0046103	extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]
PGEN_.00g318320	Scaffold_16	7188178	7200760	P02637	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)	GO:0005509	calcium ion binding [GO:0005509]
PGEN_.00g318330	Scaffold_16	7201103	7214094	Q3ZBV2	DD19A_BOVIN	ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box protein 19A)	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005643; GO:0010494; GO:0016973; GO:0031965	cytoplasmic stress granule [GO:0010494]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973]
PGEN_.00g318340	Scaffold_16	7214332	7246433	Q9Y2G8	DJC16_HUMAN	DnaJ homolog subfamily C member 16	GO:0005623; GO:0016021; GO:0045454	cell [GO:0005623]; integral component of membrane [GO:0016021]; cell redox homeostasis [GO:0045454]
PGEN_.00g318350	Scaffold_16	7247342	7249883	NA	NA	NA	NA	NA
PGEN_.00g318360	Scaffold_16	7281306	7312381	NA	NA	NA	NA	NA
PGEN_.00g318370	Scaffold_16	7312634	7312897	NA	NA	NA	NA	NA
PGEN_.00g318380	Scaffold_16	7335592	7345648	Q5KU26	COL12_HUMAN	Collectin-12 (Collectin placenta protein 1) (CL-P1) (hCL-P1) (Nurse cell scavenger receptor 2) (Scavenger receptor class A member 4) (Scavenger receptor with C-type lectin)	GO:0005044; GO:0005534; GO:0005581; GO:0005615; GO:0005886; GO:0006898; GO:0006910; GO:0006952; GO:0008329; GO:0009756; GO:0016021; GO:0030169; GO:0030666; GO:0031012; GO:0034138; GO:0045087; GO:0046872; GO:0050776; GO:0051260; GO:0060355; GO:0071360	"collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; galactose binding [GO:0005534]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; carbohydrate mediated signaling [GO:0009756]; cellular response to exogenous dsRNA [GO:0071360]; defense response [GO:0006952]; innate immune response [GO:0045087]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; protein homooligomerization [GO:0051260]; receptor-mediated endocytosis [GO:0006898]; regulation of immune response [GO:0050776]; toll-like receptor 3 signaling pathway [GO:0034138]"
PGEN_.00g318390	Scaffold_16	7350247	7352824	NA	NA	NA	NA	NA
PGEN_.00g318400	Scaffold_16	7392024	7393423	NA	NA	NA	NA	NA
PGEN_.00g318410	Scaffold_16	7406622	7420944	Q09225	NRF6_CAEEL	Nose resistant to fluoxetine protein 6 (Protein nrf-6)	GO:0006869; GO:0007275; GO:0008289; GO:0016021; GO:0016747	"integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipid transport [GO:0006869]; multicellular organism development [GO:0007275]"
PGEN_.00g318420	Scaffold_16	7422555	7427408	P55067	NCAN_RAT	Neurocan core protein (245 kDa early postnatal core glycoprotein) (Chondroitin sulfate proteoglycan 3) [Cleaved into: 150 kDa adult core glycoprotein]	GO:0001501; GO:0005509; GO:0005540; GO:0005886; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0045202; GO:0051823; GO:0072534	extracellular matrix [GO:0031012]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of synapse structural plasticity [GO:0051823]; skeletal system development [GO:0001501]
PGEN_.00g318430	Scaffold_16	7429786	7434786	NA	NA	NA	NA	NA
PGEN_.00g318440	Scaffold_16	7434890	7439035	Q96GW7	PGCB_HUMAN	Brevican core protein (Brain-enriched hyaluronan-binding protein) (BEHAB) (Chondroitin sulfate proteoglycan 7)	GO:0001501; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0021766; GO:0030198; GO:0030206; GO:0030207; GO:0030208; GO:0030246; GO:0031012; GO:0031225; GO:0043202; GO:0060074; GO:0098978	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate biosynthetic process [GO:0030208]; extracellular matrix organization [GO:0030198]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]
PGEN_.00g318450	Scaffold_16	7450443	7450664	NA	NA	NA	NA	NA
PGEN_.00g318460	Scaffold_16	7469865	7480848	A1L259	URAD_DANRE	2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (OHCU decarboxylase) (EC 4.1.1.97) (Parahox neighbor) (Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase)	GO:0005777; GO:0006144; GO:0016831; GO:0019428; GO:0019628; GO:0051997	peroxisome [GO:0005777]; 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity [GO:0051997]; carboxy-lyase activity [GO:0016831]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]
PGEN_.00g318470	Scaffold_16	7489570	7501080	NA	NA	NA	NA	NA
PGEN_.00g318480	Scaffold_16	7502835	7517774	Q9HCS2	CP4FC_HUMAN	Cytochrome P450 4F12 (EC 1.14.14.1) (CYPIVF12)	GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0005506; GO:0005737; GO:0005789; GO:0008392; GO:0016021; GO:0016324; GO:0017144; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0036101; GO:0042360; GO:0043231; GO:0050051; GO:0055078; GO:0055114; GO:0070330	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; arachidonic acid metabolic process [GO:0019369]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; oxidation-reduction process [GO:0055114]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]
PGEN_.00g318490	Scaffold_16	7523460	7524707	Q8ITC9	PK1R_DROME	Pyrokinin-1 receptor	GO:0004930; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0036401; GO:0070328; GO:0090278	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328]
PGEN_.00g318500	Scaffold_16	7533176	7538801	Q1RMI1	GP183_BOVIN	G-protein coupled receptor 183	GO:0002250; GO:0002313; GO:0002407; GO:0004930; GO:0005886; GO:0006959; GO:0007186; GO:0008142; GO:0010818; GO:0016021; GO:0030316; GO:0030595; GO:0030890; GO:0036145; GO:0061470; GO:0070374; GO:2000458	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142]; adaptive immune response [GO:0002250]; dendritic cell chemotaxis [GO:0002407]; dendritic cell homeostasis [GO:0036145]; G protein-coupled receptor signaling pathway [GO:0007186]; humoral immune response [GO:0006959]; leukocyte chemotaxis [GO:0030595]; mature B cell differentiation involved in immune response [GO:0002313]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of astrocyte chemotaxis [GO:2000458]; T cell chemotaxis [GO:0010818]; T follicular helper cell differentiation [GO:0061470]
PGEN_.00g318510	Scaffold_16	7546104	7566054	NA	NA	NA	NA	NA
PGEN_.00g318520	Scaffold_16	7569473	7580410	NA	NA	NA	NA	NA
PGEN_.00g318530	Scaffold_16	7664707	7665513	NA	NA	NA	NA	NA
PGEN_.00g318540	Scaffold_16	7703986	7719520	O75911	DHRS3_HUMAN	Short-chain dehydrogenase/reductase 3 (EC 1.1.1.300) (DD83.1) (Retinal short-chain dehydrogenase/reductase 1) (retSDR1) (Retinol dehydrogenase 17) (Short chain dehydrogenase/reductase family 16C member 1)	GO:0000166; GO:0001523; GO:0003151; GO:0004745; GO:0005789; GO:0005811; GO:0007601; GO:0009055; GO:0016021; GO:0030278; GO:0042572; GO:0042622; GO:0048385; GO:0048387; GO:0052650; GO:0060021; GO:0060349; GO:0060411	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; photoreceptor outer segment membrane [GO:0042622]; electron transfer activity [GO:0009055]; NADP-retinol dehydrogenase activity [GO:0052650]; nucleotide binding [GO:0000166]; retinol dehydrogenase activity [GO:0004745]; bone morphogenesis [GO:0060349]; cardiac septum morphogenesis [GO:0060411]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; outflow tract morphogenesis [GO:0003151]; regulation of ossification [GO:0030278]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; roof of mouth development [GO:0060021]; visual perception [GO:0007601]
PGEN_.00g318550	Scaffold_16	7734887	7786209	P16065	GCY_STRPU	Speract receptor (EC 4.6.1.2) (Guanylate cyclase)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0016021; GO:0035556	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g318560	Scaffold_16	7838838	7848742	NA	NA	NA	NA	NA
PGEN_.00g318570	Scaffold_16	7849347	7852680	NA	NA	NA	NA	NA
PGEN_.00g318580	Scaffold_16	7853314	7853577	NA	NA	NA	NA	NA
PGEN_.00g318590	Scaffold_16	7854494	7874724	Q01780	EXOSX_HUMAN	Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2)	GO:0000166; GO:0000175; GO:0000176; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000956; GO:0003723; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0009048; GO:0016020; GO:0032211; GO:0035327; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071048; GO:0071051; GO:1904872	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364]"
PGEN_.00g318600	Scaffold_16	7874982	7882687	Q645J3	SGMR1_TARGR	Sigma non-opioid intracellular receptor 1 (Sigma 1-type opioid receptor) (Sigma1-receptor) (Sigma1R)	GO:0005637; GO:0005640; GO:0005789; GO:0006869; GO:0016021; GO:0031410	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; lipid transport [GO:0006869]
PGEN_.00g318610	Scaffold_16	7886934	7894252	NA	NA	NA	NA	NA
PGEN_.00g318620	Scaffold_16	7896187	7896603	NA	NA	NA	NA	NA
PGEN_.00g318630	Scaffold_16	7906569	7907642	NA	NA	NA	NA	NA
PGEN_.00g318640	Scaffold_16	7941199	7971264	NA	NA	NA	NA	NA
PGEN_.00g318650	Scaffold_16	7981357	7988933	NA	NA	NA	NA	NA
PGEN_.00g318660	Scaffold_16	7991768	7993619	NA	NA	NA	NA	NA
PGEN_.00g318670	Scaffold_16	8003048	8056877	Q9VN14	CONT_DROME	Contactin	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]
PGEN_.00g318680	Scaffold_16	8056956	8061418	NA	NA	NA	NA	NA
PGEN_.00g318690	Scaffold_16	8089882	8097532	Q5R741	ZN394_PONAB	Zinc finger protein 394	GO:0003677; GO:0003700; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]
PGEN_.00g318700	Scaffold_16	8099452	8099691	Q9UFB7	ZBT47_HUMAN	Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651)	GO:0003677; GO:0005634; GO:0006974; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]
PGEN_.00g318710	Scaffold_16	8105046	8113154	P18714	ZG20_XENLA	Gastrula zinc finger protein xFG20-1 (XlCGF20.1)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g318720	Scaffold_16	8119104	8119457	P18740	ZO14_XENLA	Oocyte zinc finger protein XlCOF14 (Fragment)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g318730	Scaffold_16	8162703	8162978	Q6P882	ZB8AL_XENTR	Zinc finger and BTB domain-containing protein 8A.2	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g318740	Scaffold_16	8180448	8186093	NA	NA	NA	NA	NA
PGEN_.00g318750	Scaffold_16	8195695	8209790	Q5E9N4	AADAT_BOVIN	"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Kynurenine aminotransferase II) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II)"	GO:0005739; GO:0006103; GO:0006536; GO:0008483; GO:0009058; GO:0016212; GO:0030170; GO:0033512; GO:0047536; GO:0070189; GO:1901605	mitochondrion [GO:0005739]; 2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]
PGEN_.00g318760	Scaffold_16	8212930	8214824	Q90Z12	HES4A_XENLA	Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a)	GO:0000122; GO:0002088; GO:0005634; GO:0008283; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell population proliferation [GO:0008283]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501]"
PGEN_.00g318770	Scaffold_16	8226145	8240852	Q5T6V5	QSPP_HUMAN	Queuosine salvage protein	GO:0101030	tRNA-guanine transglycosylation [GO:0101030]
PGEN_.00g318780	Scaffold_16	8245147	8261244	P51869	CP4F4_RAT	Cytochrome P450 4F4 (EC 1.14.14.1) (CYPIVF4)	GO:0005506; GO:0005789; GO:0020037; GO:0070330	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]
PGEN_.00g318790	Scaffold_16	8267700	8269540	Q90VV1	HES4B_XENLA	Transcription factor HES-4-B (Hairy and enhancer of split 4-B) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2b)	GO:0000122; GO:0002088; GO:0005634; GO:0007219; GO:0007517; GO:0008283; GO:0014029; GO:0021501; GO:0033504; GO:0043066; GO:0043565; GO:0045892; GO:0046982; GO:0048642	"nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; cell population proliferation [GO:0008283]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; prechordal plate formation [GO:0021501]"
PGEN_.00g318800	Scaffold_16	8325296	8328954	O60290	ZN862_HUMAN	Zinc finger protein 862	GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g318810	Scaffold_16	8370606	8401566	Q9I7F7	ACKL_DROME	Activated Cdc42 kinase-like (EC 2.7.10.2) (Tyrosine-protein kinase PR2)	GO:0004713; GO:0004715; GO:0005524; GO:0006468; GO:0008258; GO:0031034; GO:0046664	"ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; myosin filament assembly [GO:0031034]; protein phosphorylation [GO:0006468]"
PGEN_.00g318820	Scaffold_16	8520906	8522659	NA	NA	NA	NA	NA
PGEN_.00g318830	Scaffold_16	8534984	8555850	Q9EP75	CP4FE_MOUSE	Leukotriene-B4 omega-hydroxylase 3 (EC 1.14.14.94) (Cyp4f-14) (Cytochrome P450 4F14) (Cytochrome P450-LTB-omega) (Leukotriene-B4 20-monooxygenase 3)	GO:0005506; GO:0005789; GO:0006690; GO:0008391; GO:0019369; GO:0020037; GO:0043231; GO:0050051; GO:0050544	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid binding [GO:0050544]; arachidonic acid monooxygenase activity [GO:0008391]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; arachidonic acid metabolic process [GO:0019369]; icosanoid metabolic process [GO:0006690]
PGEN_.00g318840	Scaffold_16	8571451	8623569	Q6ZUK4	TMM26_HUMAN	Transmembrane protein 26	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g318850	Scaffold_16	8658430	8670060	NA	NA	NA	NA	NA
PGEN_.00g318860	Scaffold_16	8682424	8696982	NA	NA	NA	NA	NA
PGEN_.00g318870	Scaffold_16	8703330	8703635	NA	NA	NA	NA	NA
PGEN_.00g318880	Scaffold_16	8703768	8705444	NA	NA	NA	NA	NA
PGEN_.00g318890	Scaffold_16	8708674	8716089	P24668	MPRD_MOUSE	Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46)	GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0006622; GO:0006886; GO:0007041; GO:0016021; GO:0019904; GO:0033299; GO:0048471; GO:1905394	endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299]
PGEN_.00g318900	Scaffold_16	8729501	8731566	P05434	CATR_CHLRE	Caltractin (20 kDa calcium-binding protein) (Centrin)	GO:0005509; GO:0007049; GO:0036156; GO:0045504; GO:0051301	inner dynein arm [GO:0036156]; calcium ion binding [GO:0005509]; dynein heavy chain binding [GO:0045504]; cell cycle [GO:0007049]; cell division [GO:0051301]
PGEN_.00g318910	Scaffold_16	8733611	8734590	NA	NA	NA	NA	NA
PGEN_.00g318920	Scaffold_16	8734939	8758608	P21872	PUR2_CHICK	Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]	GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006189; GO:0009113; GO:0046872	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]
PGEN_.00g318930	Scaffold_16	8784110	8784412	NA	NA	NA	NA	NA
PGEN_.00g318940	Scaffold_16	8790848	8794268	Q9NL83	ORCKA_PROCL	Orcokinin peptides type A [Cleaved into: Orcomyotropin-like peptide; Orcokinin; Orcokinin-like peptide 1; Orcokinin-like peptide 2; Orcokinin-like peptide 3; Orcokinin-like peptide 4]	GO:0005184; GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g318950	Scaffold_16	8837330	8874156	NA	NA	NA	NA	NA
PGEN_.00g318960	Scaffold_16	8925657	8964920	P08183	MDR1_HUMAN	ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)	GO:0000086; GO:0005215; GO:0005524; GO:0005886; GO:0008559; GO:0009986; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0016887; GO:0031625; GO:0042493; GO:0042626; GO:0042910; GO:0045332; GO:0047484; GO:0055085; GO:0070062; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1990962; GO:2001225	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transporter activity [GO:0005215]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic transport across blood-brain barrier [GO:1990962]
PGEN_.00g318970	Scaffold_16	8969642	8971162	Q69ZQ1	MYORG_MOUSE	Myogenesis-regulating glycosidase (EC 3.2.1.-) (Nuclear envelope transmembrane protein 37) (Uncharacterized family 31 glucosidase KIAA1161)	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"
PGEN_.00g318980	Scaffold_16	8974820	8980486	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g318990	Scaffold_16	8984994	8990686	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g319000	Scaffold_16	8995390	9021176	P31029	SPYA_CALJA	"Serine--pyruvate aminotransferase, mitochondrial (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44)"	GO:0004760; GO:0005759; GO:0005782; GO:0008453; GO:0009436; GO:0016597; GO:0019265; GO:0019448; GO:0030170; GO:0042803; GO:0042853; GO:0043621	"mitochondrial matrix [GO:0005759]; peroxisomal matrix [GO:0005782]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]"
PGEN_.00g319010	Scaffold_16	9090077	9090340	NA	NA	NA	NA	NA
PGEN_.00g319020	Scaffold_16	9098456	9101042	NA	NA	NA	NA	NA
PGEN_.00g319030	Scaffold_16	9101107	9101460	NA	NA	NA	NA	NA
PGEN_.00g319040	Scaffold_16	9158464	9208765	NA	NA	NA	NA	NA
PGEN_.00g319050	Scaffold_16	9217986	9222060	NA	NA	NA	NA	NA
PGEN_.00g319060	Scaffold_16	9243448	9244275	NA	NA	NA	NA	NA
PGEN_.00g319070	Scaffold_16	9245951	9257164	NA	NA	NA	NA	NA
PGEN_.00g319080	Scaffold_16	9280675	9303178	Q9BQQ7	RTP3_HUMAN	Receptor-transporting protein 3 (3CxxC-type zinc finger protein 3) (Transmembrane protein 7)	GO:0001580; GO:0005737; GO:0006612; GO:0016021; GO:0031849; GO:0051205	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; olfactory receptor binding [GO:0031849]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612]
PGEN_.00g319090	Scaffold_16	9319635	9320144	NA	NA	NA	NA	NA
PGEN_.00g319100	Scaffold_16	9362074	9363165	O46639	TRFR_BOVIN	Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor)	GO:0004997; GO:0005886; GO:0007200; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyrotropin-releasing hormone receptor activity [GO:0004997]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]
PGEN_.00g319110	Scaffold_16	9379397	9394413	NA	NA	NA	NA	NA
PGEN_.00g319120	Scaffold_16	9394838	9413392	Q8TC07	TBC15_HUMAN	TBC1 domain family member 15 (GTPase-activating protein RAB7) (GAP for RAB7) (Rab7-GAP)	GO:0005096; GO:0005576; GO:0005737; GO:0006886; GO:0017137; GO:0043087; GO:0090630	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087]
PGEN_.00g319130	Scaffold_16	9422359	9446245	Q8K385	FRRS1_MOUSE	Ferric-chelate reductase 1 (EC 1.-.-.-) (Stromal cell-derived receptor 2) (SDR-2)	GO:0000293; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872]
PGEN_.00g319140	Scaffold_16	9446321	9448027	NA	NA	NA	NA	NA
PGEN_.00g319150	Scaffold_16	9451383	9454177	NA	NA	NA	NA	NA
PGEN_.00g319160	Scaffold_16	9458620	9462617	NA	NA	NA	NA	NA
PGEN_.00g319170	Scaffold_16	9462728	9463891	NA	NA	NA	NA	NA
PGEN_.00g319180	Scaffold_16	9474851	9480482	NA	NA	NA	NA	NA
PGEN_.00g319190	Scaffold_16	9485061	9490604	NA	NA	NA	NA	NA
PGEN_.00g319200	Scaffold_16	9493027	9515988	P52209	6PGD_HUMAN	"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)"	GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0046177; GO:0050661; GO:0055114; GO:0070062	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate catabolic process [GO:0046177]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]"
PGEN_.00g319210	Scaffold_16	9524533	9557428	NA	NA	NA	NA	NA
PGEN_.00g319220	Scaffold_16	9613160	9636426	Q4LAL6	ALX4_BOVIN	Homeobox protein aristaless-like 4	GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0007275	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]"
PGEN_.00g319230	Scaffold_16	9646081	9652196	NA	NA	NA	NA	NA
PGEN_.00g319240	Scaffold_16	9664728	9699023	Q761V0	SC6A5_MOUSE	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	GO:0001504; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:0099056; GO:1903804	"glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission, glycinergic [GO:0060012]"
PGEN_.00g319250	Scaffold_16	9723648	9724796	NA	NA	NA	NA	NA
PGEN_.00g319260	Scaffold_16	9735141	9742112	Q3SXC5	ARL14_MOUSE	ADP-ribosylation factor-like protein 14 (ADP-ribosylation factor 7)	GO:0005525; GO:0005737; GO:0005886; GO:0006886; GO:0016192; GO:0031410	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g319270	Scaffold_16	9750207	9768884	Q8VDJ3	VIGLN_MOUSE	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)	GO:0003723; GO:0005634; GO:0005829; GO:0006869; GO:0008203; GO:0034364	cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]
PGEN_.00g319280	Scaffold_16	9781672	9822829	Q8CDI7	CC150_MOUSE	Coiled-coil domain-containing protein 150		
PGEN_.00g319290	Scaffold_16	9829634	9840244	NA	NA	NA	NA	NA
PGEN_.00g319300	Scaffold_16	9846750	9859154	Q58CP2	SUMF2_BOVIN	Inactive C-alpha-formylglycine-generating enzyme 2 (Sulfatase-modifying factor 2)	GO:0005783; GO:0005788; GO:0046872	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; metal ion binding [GO:0046872]
PGEN_.00g319310	Scaffold_16	9869107	9870599	NA	NA	NA	NA	NA
PGEN_.00g319320	Scaffold_16	9879089	9879469	NA	NA	NA	NA	NA
PGEN_.00g319330	Scaffold_16	9879505	9879894	NA	NA	NA	NA	NA
PGEN_.00g319340	Scaffold_16	9892402	9896671	A0NLY7	ISAHY_LABAI	Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b)	GO:0004061; GO:0016812; GO:0019441; GO:0030145	"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]; tryptophan catabolic process to kynurenine [GO:0019441]"
PGEN_.00g319350	Scaffold_16	9943050	9951249	NA	NA	NA	NA	NA
PGEN_.00g319360	Scaffold_16	9959149	9972511	NA	NA	NA	NA	NA
PGEN_.00g319370	Scaffold_16	9972933	9975718	NA	NA	NA	NA	NA
PGEN_.00g319380	Scaffold_16	9989282	9989737	NA	NA	NA	NA	NA
PGEN_.00g319390	Scaffold_16	9991659	9993345	NA	NA	NA	NA	NA
PGEN_.00g319400	Scaffold_16	9993449	9993829	Q93075	TATD2_HUMAN	Putative deoxyribonuclease TATDN2 (EC 3.1.21.-)	GO:0005634; GO:0005654; GO:0016888; GO:0036498; GO:0046872	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]"
PGEN_.00g319410	Scaffold_16	9995287	9996013	G5EGQ5	MBR1_CAEEL	Mblk-1-related factor 1	GO:0003677; GO:0005634; GO:0007399	nucleus [GO:0005634]; DNA binding [GO:0003677]; nervous system development [GO:0007399]
PGEN_.00g319420	Scaffold_16	10029855	10031479	NA	NA	NA	NA	NA
PGEN_.00g319430	Scaffold_16	10080145	10109935	A2ALS5	RPGP1_MOUSE	Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) (ARPP-90)	GO:0000139; GO:0005096; GO:0005769; GO:0005829; GO:0016020; GO:0017016; GO:0022409; GO:0030424; GO:0030425; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:1903697; GO:1904425; GO:1904442; GO:1990792	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]
PGEN_.00g319440	Scaffold_16	10141577	10141858	NA	NA	NA	NA	NA
PGEN_.00g319450	Scaffold_16	10148660	10149208	NA	NA	NA	NA	NA
PGEN_.00g319460	Scaffold_16	10225957	10226304	NA	NA	NA	NA	NA
PGEN_.00g319470	Scaffold_16	10252485	10253255	NA	NA	NA	NA	NA
PGEN_.00g319480	Scaffold_16	10291803	10323323	NA	NA	NA	NA	NA
PGEN_.00g319490	Scaffold_16	10347826	10371297	Q3SX07	PUS3_BOVIN	tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3)	GO:0003723; GO:0005634; GO:0005737; GO:0009982; GO:0031119; GO:0106029; GO:1990481	cytoplasm [GO:0005737]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119]
PGEN_.00g319500	Scaffold_16	10374927	10392887	NA	NA	NA	NA	NA
PGEN_.00g319510	Scaffold_16	10396952	10397539	NA	NA	NA	NA	NA
PGEN_.00g319520	Scaffold_16	10399626	10419556	Q5RDY9	F151A_PONAB	Protein FAM151A	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g319530	Scaffold_16	10420870	10425485	Q9UBQ7	GRHPR_HUMAN	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	GO:0005737; GO:0005782; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0034641; GO:0042803; GO:0043648; GO:0046487; GO:0051259; GO:0051287; GO:0055114; GO:0070062; GO:0070402	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]"
PGEN_.00g319540	Scaffold_16	10437284	10438331	NA	NA	NA	NA	NA
PGEN_.00g319550	Scaffold_16	10441020	10446559	NA	NA	NA	NA	NA
PGEN_.00g319560	Scaffold_16	10459149	10483004	NA	NA	NA	NA	NA
PGEN_.00g319570	Scaffold_16	10536890	10583449	Q14AT5	ANO7_MOUSE	Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)	GO:0005229; GO:0005634; GO:0005783; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0046983; GO:0061589; GO:0061590; GO:0061591	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transport [GO:0006821]
PGEN_.00g319580	Scaffold_16	10589471	10590189	NA	NA	NA	NA	NA
PGEN_.00g319590	Scaffold_16	10595353	10608501	NA	NA	NA	NA	NA
PGEN_.00g319600	Scaffold_16	10632633	10634029	NA	NA	NA	NA	NA
PGEN_.00g319610	Scaffold_16	10634042	10635640	NA	NA	NA	NA	NA
PGEN_.00g319620	Scaffold_16	10645754	10648557	NA	NA	NA	NA	NA
PGEN_.00g319630	Scaffold_16	10652788	10653030	NA	NA	NA	NA	NA
PGEN_.00g319640	Scaffold_16	10656191	10676706	NA	NA	NA	NA	NA
PGEN_.00g319650	Scaffold_16	10698542	10699890	NA	NA	NA	NA	NA
PGEN_.00g319660	Scaffold_16	10733758	10734276	NA	NA	NA	NA	NA
PGEN_.00g319670	Scaffold_16	10745403	10751313	NA	NA	NA	NA	NA
PGEN_.00g319680	Scaffold_16	10842975	10864010	NA	NA	NA	NA	NA
PGEN_.00g319690	Scaffold_16	10882022	10882222	NA	NA	NA	NA	NA
PGEN_.00g319700	Scaffold_16	10898991	10928378	Q5XI57	TTL10_RAT	Protein polyglycylase TTLL10 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 10)	GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0070735; GO:0070737	"axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, elongating [GO:0070737]; protein polyglycylation [GO:0018094]"
PGEN_.00g319710	Scaffold_16	10936053	10967773	Q62682	CNTN3_RAT	Contactin-3 (Brain-derived immunoglobulin superfamily protein 1) (BIG-1)	GO:0007399; GO:0046658; GO:0098609	anchored component of plasma membrane [GO:0046658]; cell-cell adhesion [GO:0098609]; nervous system development [GO:0007399]
PGEN_.00g319720	Scaffold_16	10969097	10976985	NA	NA	NA	NA	NA
PGEN_.00g319730	Scaffold_16	10977032	10977307	NA	NA	NA	NA	NA
PGEN_.00g319740	Scaffold_16	10979359	10980150	Q9GLP1	FA5_PIG	Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]	GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091	extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; copper ion binding [GO:0005507]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]
PGEN_.00g319750	Scaffold_16	10980695	10981000	NA	NA	NA	NA	NA
PGEN_.00g319760	Scaffold_16	10981313	10981728	NA	NA	NA	NA	NA
PGEN_.00g319770	Scaffold_16	10981854	10986023	NA	NA	NA	NA	NA
PGEN_.00g319780	Scaffold_16	10986293	10987503	NA	NA	NA	NA	NA
PGEN_.00g319790	Scaffold_16	10989520	11019826	A1L0Y2	NEUL4_XENTR	Neuralized-like protein 4	GO:0005737; GO:0005814; GO:0061630	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]
PGEN_.00g319800	Scaffold_16	11027814	11035242	Q09221	CPNA2_CAEEL	Copine family protein 2		
PGEN_.00g319810	Scaffold_16	11040527	11041120	NA	NA	NA	NA	NA
PGEN_.00g319820	Scaffold_16	11043095	11048267	NA	NA	NA	NA	NA
PGEN_.00g319830	Scaffold_16	11051531	11052516	NA	NA	NA	NA	NA
PGEN_.00g319840	Scaffold_16	11052592	11052816	NA	NA	NA	NA	NA
PGEN_.00g319850	Scaffold_16	11081459	11087464	NA	NA	NA	NA	NA
PGEN_.00g319860	Scaffold_16	11098944	11102886	P18730	ZG58_XENLA	Gastrula zinc finger protein XlCGF58.1 (Fragment)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g319870	Scaffold_16	11115273	11127378	A3KPP4	S2535_DANRE	Solute carrier family 25 member 35	GO:0005743; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]
PGEN_.00g319880	Scaffold_16	11132740	11138827	NA	NA	NA	NA	NA
PGEN_.00g319890	Scaffold_16	11139828	11140214	NA	NA	NA	NA	NA
PGEN_.00g319900	Scaffold_16	11140528	11140974	NA	NA	NA	NA	NA
PGEN_.00g319910	Scaffold_16	11144348	11149067	NA	NA	NA	NA	NA
PGEN_.00g319920	Scaffold_16	11156664	11157654	NA	NA	NA	NA	NA
PGEN_.00g319930	Scaffold_16	11194284	11196943	Q6IRB2	HES1A_XENLA	Transcription factor HES-1-A (Hairy and enhancer of split 1-A) (Protein hairy-1) (Xhairy-1) (Xhairy1) (Xlh1)	GO:0000122; GO:0005634; GO:0007219; GO:0007275; GO:0043425; GO:0043565; GO:0045892; GO:0046982; GO:0048635	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]"
PGEN_.00g319940	Scaffold_16	11231426	11253217	Q8AVU4	HES1B_XENLA	Transcription factor HES-1-B (Hairy and enhancer of split 1-B)	GO:0000122; GO:0003677; GO:0005634; GO:0007219; GO:0007275; GO:0043425; GO:0045892; GO:0046982; GO:0048635	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; multicellular organism development [GO:0007275]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]"
PGEN_.00g319950	Scaffold_16	11272176	11272478	NA	NA	NA	NA	NA
PGEN_.00g319960	Scaffold_16	11282975	11288985	Q5ZJP7	KCTD7_CHICK	BTB/POZ domain-containing protein KCTD7	GO:0005623; GO:0005829; GO:0005886; GO:0030007; GO:0032411; GO:0051260; GO:0060081; GO:0090461	cell [GO:0005623]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cellular potassium ion homeostasis [GO:0030007]; glutamate homeostasis [GO:0090461]; membrane hyperpolarization [GO:0060081]; positive regulation of transporter activity [GO:0032411]; protein homooligomerization [GO:0051260]
PGEN_.00g319970	Scaffold_16	11290717	11307315	Q07460	IF5A2_CHICK	Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (eIF-5A2) (Eukaryotic initiation factor 5A isoform 2) (eIF-4D)	GO:0003746; GO:0005643; GO:0005789; GO:0006452; GO:0008284; GO:0015031; GO:0043022; GO:0045901; GO:0045905; GO:0051028	endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452]
PGEN_.00g319980	Scaffold_16	11350054	11391581	Q6IVV8	PKD2_DANRE	Polycystin-2 (Curly up) (Cup) (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2)	GO:0001822; GO:0001946; GO:0001947; GO:0003143; GO:0003146; GO:0003171; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005623; GO:0005783; GO:0005856; GO:0005887; GO:0005929; GO:0007368; GO:0007507; GO:0009953; GO:0010882; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0016324; GO:0016328; GO:0030017; GO:0030659; GO:0032965; GO:0033017; GO:0034703; GO:0034765; GO:0042383; GO:0048793; GO:0050982; GO:0051209; GO:0051262; GO:0051284; GO:0051290; GO:0051371; GO:0061371; GO:0070121; GO:0070588; GO:0071277; GO:0071805; GO:0072019; GO:0072114; GO:0097704; GO:0098662; GO:0198738	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cell [GO:0005623]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell-cell signaling by wnt [GO:0198738]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; regulation of ion transmembrane transport [GO:0034765]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]
PGEN_.00g319990	Scaffold_16	11396099	11401726	P38166	SFT2_YEAST	Protein transport protein SFT2	GO:0000138; GO:0000139; GO:0005829; GO:0015031; GO:0016021; GO:0042147	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"
PGEN_.00g320000	Scaffold_16	11409581	11411479	NA	NA	NA	NA	NA
PGEN_.00g320010	Scaffold_16	11458152	11479549	NA	NA	NA	NA	NA
PGEN_.00g320020	Scaffold_16	11484774	11498476	Q9VAF5	CAD99_DROME	Cadherin-99C	GO:0002385; GO:0005509; GO:0005887; GO:0005902; GO:0007156; GO:0007304; GO:0007305; GO:0010008; GO:0016324; GO:0016339; GO:0017022; GO:0019722; GO:0031528; GO:0032529; GO:0032533; GO:0035239; GO:0044331; GO:0045176; GO:0098609; GO:2000370	apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; apical protein localization [GO:0045176]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling [GO:0019722]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; chorion-containing eggshell formation [GO:0007304]; follicle cell microvillus organization [GO:0032529]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mucosal immune response [GO:0002385]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of follicle cell microvillus length [GO:0032533]; tube morphogenesis [GO:0035239]; vitelline membrane formation involved in chorion-containing eggshell formation [GO:0007305]
PGEN_.00g320030	Scaffold_16	11501725	11502000	NA	NA	NA	NA	NA
PGEN_.00g320040	Scaffold_16	11511504	11511914	NA	NA	NA	NA	NA
PGEN_.00g320050	Scaffold_16	11512189	11520101	NA	NA	NA	NA	NA
PGEN_.00g320060	Scaffold_16	11512256	11552142	O00300	TR11B_HUMAN	Tumor necrosis factor receptor superfamily member 11B (Osteoclastogenesis inhibitory factor) (Osteoprotegerin)	GO:0001501; GO:0005125; GO:0005576; GO:0005615; GO:0005886; GO:0006915; GO:0007165; GO:0007584; GO:0030198; GO:0031012; GO:0032026; GO:0033209; GO:0038023; GO:0042489; GO:0042493; GO:0043627; GO:0045779; GO:0046685	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; signaling receptor activity [GO:0038023]; apoptotic process [GO:0006915]; extracellular matrix organization [GO:0030198]; negative regulation of bone resorption [GO:0045779]; negative regulation of odontogenesis of dentin-containing tooth [GO:0042489]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to magnesium ion [GO:0032026]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; tumor necrosis factor-mediated signaling pathway [GO:0033209]
PGEN_.00g320070	Scaffold_16	11557616	11557933	NA	NA	NA	NA	NA
PGEN_.00g320080	Scaffold_16	11560632	11561024	NA	NA	NA	NA	NA
PGEN_.00g320090	Scaffold_16	11561262	11561480	NA	NA	NA	NA	NA
PGEN_.00g320100	Scaffold_16	11578091	11590617	Q5U4Z8	RM20_XENLA	"39S ribosomal protein L20, mitochondrial (L20mt) (MRP-L20)"	GO:0003735; GO:0005762; GO:0006412; GO:0019843	mitochondrial large ribosomal subunit [GO:0005762]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
PGEN_.00g320110	Scaffold_16	11613549	11614805	NA	NA	NA	NA	NA
PGEN_.00g320120	Scaffold_16	11691561	11699295	NA	NA	NA	NA	NA
PGEN_.00g320130	Scaffold_16	11794889	11796131	NA	NA	NA	NA	NA
PGEN_.00g320140	Scaffold_16	11908508	11921325	NA	NA	NA	NA	NA
PGEN_.00g320150	Scaffold_16	11924738	11939879	P60953	CDC42_HUMAN	Cell division control protein 42 homolog (EC 3.6.5.2) (G25K GTP-binding protein)	GO:0000139; GO:0000322; GO:0002040; GO:0003161; GO:0003924; GO:0005525; GO:0005623; GO:0005737; GO:0005789; GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0006897; GO:0006911; GO:0007015; GO:0007030; GO:0007088; GO:0007097; GO:0007163; GO:0007229; GO:0007266; GO:0007596; GO:0008360; GO:0010591; GO:0010592; GO:0016020; GO:0017119; GO:0019901; GO:0021762; GO:0030031; GO:0030036; GO:0030141; GO:0030175; GO:0030225; GO:0030307; GO:0030496; GO:0030742; GO:0031256; GO:0031274; GO:0031295; GO:0031333; GO:0031435; GO:0031996; GO:0032427; GO:0032467; GO:0032488; GO:0032956; GO:0032991; GO:0034191; GO:0034329; GO:0034332; GO:0034613; GO:0035722; GO:0036336; GO:0036464; GO:0038096; GO:0038189; GO:0039694; GO:0042059; GO:0042802; GO:0042995; GO:0043005; GO:0043025; GO:0043197; GO:0043393; GO:0043525; GO:0043552; GO:0045177; GO:0045198; GO:0045335; GO:0045740; GO:0046330; GO:0046847; GO:0048010; GO:0048013; GO:0048664; GO:0051056; GO:0051149; GO:0051233; GO:0051489; GO:0051491; GO:0051492; GO:0051496; GO:0051683; GO:0051835; GO:0051988; GO:0060047; GO:0060071; GO:0060501; GO:0060661; GO:0060997; GO:0061630; GO:0070062; GO:0071346; GO:0072384; GO:0072686; GO:0090135; GO:0090316; GO:0098685; GO:0099159; GO:0099563; GO:1900026; GO:2000251	"apical part of cell [GO:0045177]; cell [GO:0005623]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]; apolipoprotein A-I receptor binding [GO:0034191]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; blood coagulation [GO:0007596]; cardiac conduction system development [GO:0003161]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cell projection assembly [GO:0030031]; cellular protein localization [GO:0034613]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; filopodium assembly [GO:0046847]; Golgi organization [GO:0007030]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; interleukin-12-mediated signaling pathway [GO:0035722]; macrophage differentiation [GO:0030225]; modification of synaptic structure [GO:0099563]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; organelle transport along microtubule [GO:0072384]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of synapse structural plasticity [GO:0051835]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; regulation of mitotic nuclear division [GO:0007088]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of protein binding [GO:0043393]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of stress fiber assembly [GO:0051492]; Rho protein signal transduction [GO:0007266]; sprouting angiogenesis [GO:0002040]; submandibular salivary gland formation [GO:0060661]; substantia nigra development [GO:0021762]; T cell costimulation [GO:0031295]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g320160	Scaffold_16	11942588	11968127	Q9JLI3	MMEL1_MOUSE	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) (Neprilysin-like 1) (NL-1) (Neprilysin-like peptidase) (NEPLP) (Soluble secreted endopeptidase) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	GO:0004175; GO:0004222; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0008270; GO:0016020; GO:0016021	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g320170	Scaffold_16	11968190	11987581	NA	NA	NA	NA	NA
PGEN_.00g320180	Scaffold_16	12000418	12003504	O01346	EGH_DROME	"Beta-1,4-mannosyltransferase egh (EC 2.4.1.-) (Protein egghead) (Protein zeste-white 4)"	GO:0001744; GO:0005737; GO:0006688; GO:0007281; GO:0007293; GO:0007298; GO:0007299; GO:0007411; GO:0008049; GO:0016021; GO:0016325; GO:0016333; GO:0019187; GO:0030707; GO:0030720; GO:0033227; GO:0042248; GO:0045165; GO:0045434; GO:0046662; GO:0048935	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; beta-1,4-mannosyltransferase activity [GO:0019187]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell fate commitment [GO:0045165]; dsRNA transport [GO:0033227]; germ cell development [GO:0007281]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; maintenance of polarity of follicular epithelium [GO:0042248]; male courtship behavior [GO:0008049]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of female receptivity, post-mating [GO:0045434]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; optic lobe placode formation [GO:0001744]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell-cell adhesion [GO:0007299]; peripheral nervous system neuron development [GO:0048935]; regulation of oviposition [GO:0046662]"
PGEN_.00g320190	Scaffold_16	12021389	12021727	NA	NA	NA	NA	NA
PGEN_.00g320200	Scaffold_16	12024031	12025608	NA	NA	NA	NA	NA
PGEN_.00g320210	Scaffold_16	12026747	12027124	NA	NA	NA	NA	NA
PGEN_.00g320220	Scaffold_16	12029140	12031075	NA	NA	NA	NA	NA
PGEN_.00g320230	Scaffold_16	12040549	12047118	Q5EBF8	ATRAP_XENTR	Type-1 angiotensin II receptor-associated protein-like	GO:0016021; GO:0038166	integral component of membrane [GO:0016021]; angiotensin-activated signaling pathway [GO:0038166]
PGEN_.00g320240	Scaffold_16	12058006	12058440	NA	NA	NA	NA	NA
PGEN_.00g320250	Scaffold_16	12059375	12060955	NA	NA	NA	NA	NA
PGEN_.00g320260	Scaffold_16	12063503	12063838	NA	NA	NA	NA	NA
PGEN_.00g320270	Scaffold_16	12069633	12069935	NA	NA	NA	NA	NA
PGEN_.00g320280	Scaffold_16	12163138	12163713	NA	NA	NA	NA	NA
PGEN_.00g320290	Scaffold_16	12186275	12191559	A4IF63	TRIM2_BOVIN	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g320300	Scaffold_16	12204731	12215898	Q9ULI1	NWD2_HUMAN	NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)		
PGEN_.00g320310	Scaffold_16	12221816	12226019	Q9CR24	NUDT8_MOUSE	Nucleoside diphosphate-linked moiety X motif 8 (Nudix motif 8) (EC 3.6.1.-)	GO:0005739; GO:0016787; GO:0046872	mitochondrion [GO:0005739]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]
PGEN_.00g320320	Scaffold_16	12232954	12233791	NA	NA	NA	NA	NA
PGEN_.00g320330	Scaffold_16	12259877	12265081	Q27955	KCAB2_BOVIN	Voltage-gated potassium channel subunit beta-2 (EC 1.1.1.-) (K(+) channel subunit beta-2) (Kv-beta-2)	GO:0004033; GO:0005249; GO:0005829; GO:0005856; GO:0015459; GO:0016020; GO:0030054; GO:0030424; GO:0031234; GO:0034705; GO:0043005; GO:0044224; GO:0045202; GO:0055114; GO:0070995; GO:1901379; GO:1990031; GO:2000008	axon [GO:0030424]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuron projection [GO:0043005]; pinceau fiber [GO:1990031]; potassium channel complex [GO:0034705]; synapse [GO:0045202]; aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]; NADPH oxidation [GO:0070995]; oxidation-reduction process [GO:0055114]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008]
PGEN_.00g320340	Scaffold_16	12267699	12268376	NA	NA	NA	NA	NA
PGEN_.00g320350	Scaffold_16	12279612	12342154	Q27955	KCAB2_BOVIN	Voltage-gated potassium channel subunit beta-2 (EC 1.1.1.-) (K(+) channel subunit beta-2) (Kv-beta-2)	GO:0004033; GO:0005249; GO:0005829; GO:0005856; GO:0015459; GO:0016020; GO:0030054; GO:0030424; GO:0031234; GO:0034705; GO:0043005; GO:0044224; GO:0045202; GO:0055114; GO:0070995; GO:1901379; GO:1990031; GO:2000008	axon [GO:0030424]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuron projection [GO:0043005]; pinceau fiber [GO:1990031]; potassium channel complex [GO:0034705]; synapse [GO:0045202]; aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]; NADPH oxidation [GO:0070995]; oxidation-reduction process [GO:0055114]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008]
PGEN_.00g320360	Scaffold_16	12342283	12354850	Q96L58	B3GT6_HUMAN	"Beta-1,3-galactosyltransferase 6 (Beta-1,3-GalTase 6) (Beta3Gal-T6) (Beta3GalT6) (EC 2.4.1.134) (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6)"	GO:0000139; GO:0005783; GO:0005794; GO:0005797; GO:0006024; GO:0006486; GO:0006493; GO:0008375; GO:0008376; GO:0008378; GO:0008499; GO:0015012; GO:0016020; GO:0016021; GO:0030203; GO:0030206; GO:0032580; GO:0035250; GO:0047220	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; galactosyltransferase activity [GO:0008378]; galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-galactosyltransferase activity [GO:0035250]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g320370	Scaffold_16	12363081	12372018	Q8N2K1	UB2J2_HUMAN	Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J2) (Non-canonical ubiquitin-conjugating enzyme 2) (NCUBE-2)	GO:0000151; GO:0000209; GO:0005524; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0016567; GO:0030433; GO:0031625; GO:0061631; GO:1903955	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]
PGEN_.00g320380	Scaffold_16	12475291	12494907	Q6P6T4	EMAL2_RAT	Echinoderm microtubule-associated protein-like 2 (EMAP-2)	GO:0000226; GO:0003824; GO:0005102; GO:0005737; GO:0005874; GO:0008017; GO:0008022; GO:0010968; GO:0015631; GO:0031115; GO:0072686	cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; catalytic activity [GO:0003824]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]
PGEN_.00g320390	Scaffold_16	12502725	12513399	Q9VUI3	EMAL_DROME	Echinoderm microtubule-associated protein-like CG42247	GO:0000226; GO:0005737; GO:0005874; GO:0007605; GO:0008017; GO:0008344; GO:0035011; GO:0035556; GO:0071683	cytoplasm [GO:0005737]; microtubule [GO:0005874]; sensory dendrite [GO:0071683]; microtubule binding [GO:0008017]; adult locomotory behavior [GO:0008344]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; microtubule cytoskeleton organization [GO:0000226]; sensory perception of sound [GO:0007605]
PGEN_.00g320400	Scaffold_16	12521767	12524430	NA	NA	NA	NA	NA
PGEN_.00g320410	Scaffold_16	12556724	12557611	NA	NA	NA	NA	NA
PGEN_.00g320420	Scaffold_16	12601272	12602519	NA	NA	NA	NA	NA
PGEN_.00g320430	Scaffold_16	12618159	12626887	Q9HAZ2	PRD16_HUMAN	Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.-) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1)	GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162	"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]"
PGEN_.00g320440	Scaffold_16	12710646	12772340	A2A935	PRD16_MOUSE	Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.-) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1)	GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0016235; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0033613; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046872; GO:0046974; GO:0048468; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162	"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; brown fat cell differentiation [GO:0050873]; cell development [GO:0048468]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872]"
PGEN_.00g320450	Scaffold_16	12792942	12794276	NA	NA	NA	NA	NA
PGEN_.00g320460	Scaffold_16	12794322	12797330	Q5UAW9	GP157_HUMAN	G-protein coupled receptor 157	GO:0004930; GO:0005623; GO:0007166; GO:0007186; GO:0016021; GO:0048512; GO:0051482; GO:0060019; GO:0060170	cell [GO:0005623]; ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; radial glial cell differentiation [GO:0060019]
PGEN_.00g320470	Scaffold_16	12802177	12826630	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g320480	Scaffold_16	12831596	12845680	Q5F464	LPP_CHICK	Lipoma-preferred partner homolog	GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]
PGEN_.00g320490	Scaffold_16	12868885	12870641	NA	NA	NA	NA	NA
PGEN_.00g320500	Scaffold_16	12892310	12899684	NA	NA	NA	NA	NA
PGEN_.00g320510	Scaffold_16	12900136	12900927	Q499N5	ACSF2_RAT	"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)"	GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]
PGEN_.00g320520	Scaffold_16	12933766	12967542	A0A0G2K344	PK3CA_RAT	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1)"	GO:0001525; GO:0001889; GO:0001932; GO:0004674; GO:0005524; GO:0005623; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006006; GO:0006909; GO:0010468; GO:0010629; GO:0014065; GO:0014870; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0030027; GO:0030295; GO:0033138; GO:0035005; GO:0036092; GO:0040014; GO:0043201; GO:0043457; GO:0043491; GO:0043524; GO:0043560; GO:0044029; GO:0046854; GO:0046934; GO:0048015; GO:0048661; GO:0052812; GO:0060612; GO:0071333; GO:0071548; GO:0097009; GO:1903544; GO:2000270; GO:2000653; GO:2000811	"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activity [GO:0004674]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; cellular response to glucose stimulus [GO:0071333]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; liver development [GO:0001889]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein kinase B signaling [GO:0043491]; regulation of cellular respiration [GO:0043457]; regulation of gene expression [GO:0010468]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]; regulation of protein phosphorylation [GO:0001932]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to leucine [GO:0043201]; response to muscle inactivity [GO:0014870]"
PGEN_.00g320530	Scaffold_16	12975523	12977800	Q7PCJ8	SAT2_BOVIN	Diamine acetyltransferase 2 (EC 2.3.1.57) (Polyamine N-acetyltransferase 2) (Spermidine/spermine N(1)-acetyltransferase 2)	GO:0004145; GO:0005737; GO:0008080; GO:0009447; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204	cytoplasm [GO:0005737]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; putrescine catabolic process [GO:0009447]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]
PGEN_.00g320540	Scaffold_16	12979762	12982437	Q7PCJ8	SAT2_BOVIN	Diamine acetyltransferase 2 (EC 2.3.1.57) (Polyamine N-acetyltransferase 2) (Spermidine/spermine N(1)-acetyltransferase 2)	GO:0004145; GO:0005737; GO:0008080; GO:0009447; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204	cytoplasm [GO:0005737]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; putrescine catabolic process [GO:0009447]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]
PGEN_.00g320550	Scaffold_16	12987838	12993282	NA	NA	NA	NA	NA
PGEN_.00g320560	Scaffold_16	13011521	13020698	NA	NA	NA	NA	NA
PGEN_.00g320570	Scaffold_16	13026326	13027537	Q20681	BAT38_CAEEL	BTB and MATH domain-containing protein 38		
PGEN_.00g320580	Scaffold_16	13028423	13034657	NA	NA	NA	NA	NA
PGEN_.00g320590	Scaffold_16	13036905	13040122	NA	NA	NA	NA	NA
PGEN_.00g320600	Scaffold_16	13040891	13044078	NA	NA	NA	NA	NA
PGEN_.00g320610	Scaffold_16	13048736	13054480	NA	NA	NA	NA	NA
PGEN_.00g320620	Scaffold_16	13073261	13088736	P42575	CASP2_HUMAN	Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12]	GO:0001554; GO:0003407; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006977; GO:0007420; GO:0007568; GO:0008630; GO:0016020; GO:0016485; GO:0019899; GO:0019904; GO:0035234; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043525; GO:0071260; GO:0097153; GO:0097190; GO:0097192; GO:0097194; GO:0097200; GO:2001235	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; regulation of apoptotic process [GO:0042981]"
PGEN_.00g320630	Scaffold_16	13091973	13154662	Q4U2R1	HERC2_MOUSE	E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)	GO:0004842; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016567; GO:0031625; GO:0032183; GO:0043161	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]
PGEN_.00g320640	Scaffold_16	13155397	13157591	NA	NA	NA	NA	NA
PGEN_.00g320650	Scaffold_16	13157641	13165345	A6X391	DEACT_OCHA4	Deacetylase Oant_2987 (EC 3.1.1.-)	GO:0016810; GO:0019213; GO:0046872; GO:0052689	"carboxylic ester hydrolase activity [GO:0052689]; deacetylase activity [GO:0019213]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; metal ion binding [GO:0046872]"
PGEN_.00g320660	Scaffold_16	13198838	13199848	NA	NA	NA	NA	NA
PGEN_.00g320670	Scaffold_16	13222385	13226324	NA	NA	NA	NA	NA
PGEN_.00g320680	Scaffold_16	13241508	13241765	NA	NA	NA	NA	NA
PGEN_.00g320690	Scaffold_16	13312784	13314933	NA	NA	NA	NA	NA
PGEN_.00g320700	Scaffold_16	13318847	13331107	O95619	YETS4_HUMAN	YEATS domain-containing protein 4 (Glioma-amplified sequence 41) (Gas41) (NuMA-binding protein 1) (NuBI-1) (NuBI1)	GO:0000278; GO:0003677; GO:0003700; GO:0005200; GO:0005654; GO:0008022; GO:0016363; GO:0031965; GO:0035267; GO:0040008; GO:0043967; GO:0043968; GO:0045893; GO:0045944	"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein C-terminus binding [GO:0008022]; structural constituent of cytoskeleton [GO:0005200]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle [GO:0000278]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]"
PGEN_.00g320710	Scaffold_16	13343864	13376552	Q9ERK0	RIPK4_MOUSE	Receptor-interacting serine/threonine-protein kinase 4 (EC 2.7.11.1) (Ankyrin repeat domain-containing protein 3) (PKC-associated protein kinase) (PKC-regulated protein kinase)	GO:0002009; GO:0004674; GO:0005524; GO:0005737; GO:0016020; GO:0051092	cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]
PGEN_.00g320720	Scaffold_16	13376762	13381671	NA	NA	NA	NA	NA
PGEN_.00g320730	Scaffold_16	13384048	13410560	NA	NA	NA	NA	NA
PGEN_.00g320740	Scaffold_16	13420284	13473652	NA	NA	NA	NA	NA
PGEN_.00g320750	Scaffold_16	13488275	13506102	O75382	TRIM3_HUMAN	Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97)	GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008022; GO:0008270; GO:0015031; GO:0030425; GO:0043161; GO:0061630	cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]
PGEN_.00g320760	Scaffold_16	13516426	13518321	O88553	ZFP37_RAT	Zinc finger protein 37 (Zfp-37)	GO:0003700; GO:0005634; GO:0008283; GO:0030154; GO:0043565; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]
PGEN_.00g320770	Scaffold_16	13524947	13526056	Q9H9B1	EHMT1_HUMAN	Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D)	GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005694; GO:0006306; GO:0006325; GO:0008168; GO:0008270; GO:0016279; GO:0016571; GO:0016604; GO:0018024; GO:0018026; GO:0018027; GO:0045892; GO:0045995; GO:0046974; GO:0046976; GO:0060992; GO:0070317; GO:0070742; GO:0120162; GO:1901796	"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to fungicide [GO:0060992]"
PGEN_.00g320780	Scaffold_16	13527299	13536228	Q92685	ALG3_HUMAN	"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein)"	GO:0000033; GO:0005789; GO:0006486; GO:0006488; GO:0030176; GO:0052925	"endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]"
PGEN_.00g320790	Scaffold_16	13536797	13551154	NA	NA	NA	NA	NA
PGEN_.00g320800	Scaffold_16	13551543	13556017	Q96MB7	HARB1_HUMAN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g320810	Scaffold_16	13572181	13572405	NA	NA	NA	NA	NA
PGEN_.00g320820	Scaffold_16	13573716	13585025	P40757	ALN_LITCT	"Allantoinase, mitochondrial (EC 3.5.2.5)"	GO:0000256; GO:0004038; GO:0005739; GO:0008270; GO:0050897	mitochondrion [GO:0005739]; allantoinase activity [GO:0004038]; cobalt ion binding [GO:0050897]; zinc ion binding [GO:0008270]; allantoin catabolic process [GO:0000256]
PGEN_.00g320830	Scaffold_16	13602821	13605365	NA	NA	NA	NA	NA
PGEN_.00g320840	Scaffold_16	13605680	13606267	NA	NA	NA	NA	NA
PGEN_.00g320850	Scaffold_16	13615074	13623148	NA	NA	NA	NA	NA
PGEN_.00g320860	Scaffold_16	13745686	13749052	NA	NA	NA	NA	NA
PGEN_.00g320870	Scaffold_16	13834709	13837173	NA	NA	NA	NA	NA
PGEN_.00g320880	Scaffold_16	13897193	13900699	D4B1Z7	A2478_ARTBC	Uncharacterized FAD-linked oxidoreductase ARB_02478 (EC 1.-.-.-)	GO:0005576; GO:0016491; GO:0071949	extracellular region [GO:0005576]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]
PGEN_.00g320890	Scaffold_16	13918909	13921911	NA	NA	NA	NA	NA
PGEN_.00g320900	Scaffold_16	13923774	13924526	NA	NA	NA	NA	NA
PGEN_.00g320910	Scaffold_16	13933764	13943173	NA	NA	NA	NA	NA
PGEN_.00g320920	Scaffold_16	13943217	13955866	Q6PDJ6	FBX42_MOUSE	F-box only protein 42		
PGEN_.00g320930	Scaffold_16	13957351	13961255	Q8VE99	CC115_MOUSE	Coiled-coil domain-containing protein 115 (Coiled-coil protein 1) (Ccp1)	GO:0005623; GO:0005764; GO:0005768; GO:0005783; GO:0005793; GO:0006879; GO:0007042; GO:0016471; GO:0030137; GO:0036295; GO:0042406; GO:0051082; GO:0070072; GO:1905146	cell [GO:0005623]; COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; lysosome [GO:0005764]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; unfolded protein binding [GO:0051082]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]
PGEN_.00g320940	Scaffold_16	14060181	14063799	NA	NA	NA	NA	NA
PGEN_.00g320950	Scaffold_16	14063949	14064254	NA	NA	NA	NA	NA
PGEN_.00g320960	Scaffold_16	14064278	14064640	NA	NA	NA	NA	NA
PGEN_.00g320970	Scaffold_16	14064670	14065342	NA	NA	NA	NA	NA
PGEN_.00g320980	Scaffold_16	14115353	14260448	P54753	EPHB3_HUMAN	Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6)	GO:0001525; GO:0001655; GO:0004714; GO:0005003; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0007413; GO:0008046; GO:0016477; GO:0021952; GO:0022038; GO:0022407; GO:0030425; GO:0031290; GO:0034446; GO:0043087; GO:0043235; GO:0046777; GO:0048013; GO:0048538; GO:0048546; GO:0050770; GO:0051965; GO:0060021; GO:0060996; GO:0060997	cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; ephrin receptor activity [GO:0005003]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; central nervous system projection neuron axonogenesis [GO:0021952]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; digestive tract morphogenesis [GO:0048546]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of axonogenesis [GO:0050770]; regulation of cell-cell adhesion [GO:0022407]; regulation of GTPase activity [GO:0043087]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; substrate adhesion-dependent cell spreading [GO:0034446]; thymus development [GO:0048538]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]
PGEN_.00g320990	Scaffold_16	14268696	14269007	NA	NA	NA	NA	NA
PGEN_.00g321000	Scaffold_16	14290777	14296969	NA	NA	NA	NA	NA
PGEN_.00g321010	Scaffold_16	14301868	14311681	NA	NA	NA	NA	NA
PGEN_.00g321020	Scaffold_16	14328330	14336156	NA	NA	NA	NA	NA
PGEN_.00g321030	Scaffold_16	14373908	14382466	NA	NA	NA	NA	NA
PGEN_.00g321040	Scaffold_16	14391067	14398485	NA	NA	NA	NA	NA
PGEN_.00g321050	Scaffold_16	14408455	14412144	NA	NA	NA	NA	NA
PGEN_.00g321060	Scaffold_16	14423245	14423640	NA	NA	NA	NA	NA
PGEN_.00g321070	Scaffold_16	14423929	14424189	NA	NA	NA	NA	NA
PGEN_.00g321080	Scaffold_16	14424454	14424945	NA	NA	NA	NA	NA
PGEN_.00g321090	Scaffold_16	14425116	14425694	NA	NA	NA	NA	NA
PGEN_.00g321100	Scaffold_16	14425783	14426235	NA	NA	NA	NA	NA
PGEN_.00g321110	Scaffold_16	14426295	14428005	NA	NA	NA	NA	NA
PGEN_.00g321120	Scaffold_16	14480718	14482959	NA	NA	NA	NA	NA
PGEN_.00g321130	Scaffold_16	14505449	14508944	NA	NA	NA	NA	NA
PGEN_.00g321140	Scaffold_16	14514250	14520904	NA	NA	NA	NA	NA
PGEN_.00g321150	Scaffold_16	14524581	14540415	Q9VUN0	TOLL6_DROME	Toll-like receptor 6	GO:0003401; GO:0005030; GO:0005886; GO:0008201; GO:0016021; GO:0048495; GO:0060026; GO:0070983	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; neurotrophin receptor activity [GO:0005030]; Roundabout binding [GO:0048495]; axis elongation [GO:0003401]; convergent extension [GO:0060026]; dendrite guidance [GO:0070983]
PGEN_.00g321160	Scaffold_16	14549227	14565431	Q02978	M2OM_HUMAN	Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (Solute carrier family 25 member 11)	GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0005887; GO:0006094; GO:0015367	integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; gluconeogenesis [GO:0006094]
PGEN_.00g321170	Scaffold_16	14588896	14643409	A6PWD2	FHAD1_MOUSE	Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1)		
PGEN_.00g321180	Scaffold_16	14655071	14708523	B0DOB4	NPHP4_XENLA	Nephrocystin-4	GO:0005737; GO:0005856; GO:0090090; GO:0097730	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; non-motile cilium [GO:0097730]; negative regulation of canonical Wnt signaling pathway [GO:0090090]
PGEN_.00g321190	Scaffold_16	14739729	14789048	Q8JZW5	SH2D5_MOUSE	SH2 domain-containing protein 5	GO:0014069; GO:0030054	cell junction [GO:0030054]; postsynaptic density [GO:0014069]
PGEN_.00g321200	Scaffold_16	14817836	14869826	Q32PJ7	TENS4_BOVIN	Tensin-4	GO:0003779; GO:0005737; GO:0005856; GO:0005925; GO:0006915	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; apoptotic process [GO:0006915]
PGEN_.00g321210	Scaffold_16	14879164	14879938	NA	NA	NA	NA	NA
PGEN_.00g321220	Scaffold_16	14884047	14907596	Q5RE69	NEP_PONAB	Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10)	GO:0001786; GO:0001822; GO:0004222; GO:0005737; GO:0005769; GO:0005802; GO:0005886; GO:0005903; GO:0006508; GO:0006518; GO:0007611; GO:0008021; GO:0008238; GO:0008270; GO:0016021; GO:0019233; GO:0030424; GO:0030425; GO:0042277; GO:0042803; GO:0043025; GO:0044306; GO:0045121; GO:0045202; GO:0046449; GO:0050435; GO:0050769; GO:0061837; GO:0071345; GO:0071492; GO:0071493; GO:0090399; GO:0150094; GO:1900273; GO:1901612	axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; cardiolipin binding [GO:1901612]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; cellular response to cytokine stimulus [GO:0071345]; cellular response to UV-A [GO:0071492]; cellular response to UV-B [GO:0071493]; creatinine metabolic process [GO:0046449]; kidney development [GO:0001822]; learning or memory [GO:0007611]; neuropeptide processing [GO:0061837]; peptide metabolic process [GO:0006518]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neurogenesis [GO:0050769]; proteolysis [GO:0006508]; replicative senescence [GO:0090399]; sensory perception of pain [GO:0019233]
PGEN_.00g321230	Scaffold_16	14908140	14932223	Q495T6	MMEL1_HUMAN	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (Membrane metallo-endopeptidase-like 2) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0016020; GO:0016021; GO:0046872	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; proteolysis [GO:0006508]
PGEN_.00g321240	Scaffold_16	14943973	14946552	NA	NA	NA	NA	NA
PGEN_.00g321250	Scaffold_16	14946575	14956975	A0NLY7	ISAHY_LABAI	Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b)	GO:0004061; GO:0016812; GO:0019441; GO:0030145	"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]; tryptophan catabolic process to kynurenine [GO:0019441]"
PGEN_.00g321260	Scaffold_16	14952931	14953287	NA	NA	NA	NA	NA
PGEN_.00g321270	Scaffold_16	14958934	14959629	Q9VGJ5	FER3_DROME	Protein Fer3 (Basic helix-loop-helix protein N-twist) (Nephew of atonal 3) (Neuronal twist)	GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0045892; GO:0046983	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g321280	Scaffold_16	14967704	14968924	NA	NA	NA	NA	NA
PGEN_.00g321290	Scaffold_16	14972160	15023803	A2A8L1	CHD5_MOUSE	Chromodomain-helicase-DNA-binding protein 5 (CHD-5) (EC 3.6.4.12) (ATP-dependent helicase CHD5)	GO:0000792; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0008285; GO:0016581; GO:0016607; GO:0021895; GO:0035093; GO:0042826; GO:0043967; GO:0045595; GO:0046872; GO:0060850; GO:0061628; GO:0098532; GO:1901798	"cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; H3K27me3 modified histone binding [GO:0061628]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; regulation of transcription involved in cell fate commitment [GO:0060850]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g321300	Scaffold_16	15034409	15034672	NA	NA	NA	NA	NA
PGEN_.00g321310	Scaffold_16	15063477	15063776	NA	NA	NA	NA	NA
PGEN_.00g321320	Scaffold_16	15073598	15116621	Q9VZZ4	PXDN_DROME	Peroxidasin (EC 1.11.1.7)	GO:0004601; GO:0005615; GO:0006909; GO:0006979; GO:0019806; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0046872; GO:0062023; GO:0070831	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bromide peroxidase activity [GO:0019806]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; phagocytosis [GO:0006909]; response to oxidative stress [GO:0006979]
PGEN_.00g321330	Scaffold_16	15123021	15129866	NA	NA	NA	NA	NA
PGEN_.00g321340	Scaffold_16	15131792	15133773	NA	NA	NA	NA	NA
PGEN_.00g321350	Scaffold_16	15133968	15134618	NA	NA	NA	NA	NA
PGEN_.00g321360	Scaffold_16	15137772	15144473	NA	NA	NA	NA	NA
PGEN_.00g321370	Scaffold_16	15147705	15171863	Q5RC70	DJC11_PONAB	DnaJ homolog subfamily C member 11	GO:0001401; GO:0042407; GO:0061617	MICOS complex [GO:0061617]; SAM complex [GO:0001401]; cristae formation [GO:0042407]
PGEN_.00g321380	Scaffold_16	15186659	15187129	NA	NA	NA	NA	NA
PGEN_.00g321390	Scaffold_16	15213172	15274063	Q9Y6Y1	CMTA1_HUMAN	Calmodulin-binding transcription activator 1	GO:0000981; GO:0005634; GO:0005730; GO:0005829; GO:0035307; GO:0043565; GO:0045944; GO:0050885; GO:0070886	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g321400	Scaffold_16	15278765	15284327	NA	NA	NA	NA	NA
PGEN_.00g321410	Scaffold_16	15294076	15297303	NA	NA	NA	NA	NA
PGEN_.00g321420	Scaffold_16	15313645	15317725	NA	NA	NA	NA	NA
PGEN_.00g321430	Scaffold_16	15323068	15336210	Q8N357	S35F6_HUMAN	Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog)	GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016021; GO:0022857; GO:0043231; GO:0070062; GO:1901029	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]
PGEN_.00g321440	Scaffold_16	15344995	15346404	NA	NA	NA	NA	NA
PGEN_.00g321450	Scaffold_16	15361917	15364804	NA	NA	NA	NA	NA
PGEN_.00g321460	Scaffold_16	15405915	15406424	NA	NA	NA	NA	NA
PGEN_.00g321470	Scaffold_16	15406669	15406983	NA	NA	NA	NA	NA
PGEN_.00g321480	Scaffold_16	15407472	15407756	NA	NA	NA	NA	NA
PGEN_.00g321490	Scaffold_16	15413455	15413733	NA	NA	NA	NA	NA
PGEN_.00g321500	Scaffold_16	15421395	15421814	NA	NA	NA	NA	NA
PGEN_.00g321510	Scaffold_16	15424960	15426329	NA	NA	NA	NA	NA
PGEN_.00g321520	Scaffold_16	15460157	15460918	NA	NA	NA	NA	NA
PGEN_.00g321530	Scaffold_16	15461292	15461738	NA	NA	NA	NA	NA
PGEN_.00g321540	Scaffold_16	15530103	15531260	NA	NA	NA	NA	NA
PGEN_.00g321550	Scaffold_16	15556531	15556800	NA	NA	NA	NA	NA
PGEN_.00g321560	Scaffold_16	15653088	15667271	Q9VI93	RN_DROME	Zinc finger protein rotund (Zinc finger protein roughened eye)	GO:0000122; GO:0000977; GO:0000981; GO:0001708; GO:0005634; GO:0007480; GO:0022416; GO:0045892; GO:0046872; GO:0048749	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg morphogenesis [GO:0007480]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g321570	Scaffold_16	15668781	15669212	NA	NA	NA	NA	NA
PGEN_.00g321580	Scaffold_16	15669900	15670268	NA	NA	NA	NA	NA
PGEN_.00g321590	Scaffold_16	15684713	15702962	NA	NA	NA	NA	NA
PGEN_.00g321600	Scaffold_16	15704066	15711421	Q9QY66	ZNHI2_MOUSE	Zinc finger HIT domain-containing protein 2 (Protein FON)	GO:0046872	metal ion binding [GO:0046872]
PGEN_.00g321610	Scaffold_16	15717126	15752095	Q8R481	PERL_MESAU	Lactoperoxidase (LPO) (EC 1.11.1.7) (Lacrimal gland peroxidase)	GO:0001580; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0020037; GO:0036393; GO:0042742; GO:0046872	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; thiocyanate peroxidase activity [GO:0036393]; defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to oxidative stress [GO:0006979]
PGEN_.00g321620	Scaffold_16	15785305	15809371	NA	NA	NA	NA	NA
PGEN_.00g321630	Scaffold_16	15809717	15827758	Q29RT6	KI20A_BOVIN	Kinesin-like protein KIF20A	GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0019901; GO:0030496; GO:0032154; GO:0032465; GO:0045171; GO:0061952	cleavage furrow [GO:0032154]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]
PGEN_.00g321640	Scaffold_16	15832865	15846431	Q5SUC9	SCO1_MOUSE	"Protein SCO1 homolog, mitochondrial"	GO:0005623; GO:0005739; GO:0006878; GO:0030016; GO:0031305; GO:0033617; GO:0045454; GO:0046872; GO:0072492; GO:1901799	cell [GO:0005623]; host cell mitochondrial intermembrane space [GO:0072492]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; metal ion binding [GO:0046872]; cell redox homeostasis [GO:0045454]; cellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; negative regulation of proteasomal protein catabolic process [GO:1901799]
PGEN_.00g321650	Scaffold_16	15852325	15867342	P17809	GTR1_MOUSE	"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (GT1)"	GO:0001666; GO:0001939; GO:0005355; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0005911; GO:0007565; GO:0009986; GO:0014704; GO:0016020; GO:0016323; GO:0016324; GO:0019900; GO:0021987; GO:0030018; GO:0030496; GO:0030864; GO:0031982; GO:0032868; GO:0033300; GO:0042149; GO:0042383; GO:0042802; GO:0042908; GO:0042910; GO:0043621; GO:0045121; GO:0055056; GO:0065003; GO:0070837; GO:0071260; GO:0071474; GO:0098793; GO:1904016; GO:1904659	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; dehydroascorbic acid transport [GO:0070837]; female pregnancy [GO:0007565]; glucose transmembrane transport [GO:1904659]; protein-containing complex assembly [GO:0065003]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]; xenobiotic transport [GO:0042908]
PGEN_.00g321660	Scaffold_16	15892438	15898140	Q6GM59	MOT12_XENLA	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0015293; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]
PGEN_.00g321670	Scaffold_16	15900700	15901047	NA	NA	NA	NA	NA
PGEN_.00g321680	Scaffold_16	15910388	15910693	NA	NA	NA	NA	NA
PGEN_.00g321690	Scaffold_16	15919164	15919463	NA	NA	NA	NA	NA
PGEN_.00g321700	Scaffold_16	15919741	15926446	NA	NA	NA	NA	NA
PGEN_.00g321710	Scaffold_16	15926523	15926981	NA	NA	NA	NA	NA
PGEN_.00g321720	Scaffold_16	15932172	15934116	NA	NA	NA	NA	NA
PGEN_.00g321730	Scaffold_16	15935672	15939820	NA	NA	NA	NA	NA
PGEN_.00g321740	Scaffold_16	15947077	15950263	NA	NA	NA	NA	NA
PGEN_.00g321750	Scaffold_16	15952336	15957331	Q6GM59	MOT12_XENLA	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0015293; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]
PGEN_.00g321760	Scaffold_16	15963744	15973224	Q6P2X9	MOT12_XENTR	Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)	GO:0005308; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g321770	Scaffold_16	15984539	15984850	NA	NA	NA	NA	NA
PGEN_.00g321780	Scaffold_16	16012018	16033974	P17244	G3P_CRIGR	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GO:0000226; GO:0004365; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006096; GO:0006417; GO:0008017; GO:0015630; GO:0035605; GO:0035606; GO:0050661; GO:0050821; GO:0051287; GO:0051402; GO:0097452	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; microtubule cytoskeleton organization [GO:0000226]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; protein stabilization [GO:0050821]; regulation of translation [GO:0006417]
PGEN_.00g321790	Scaffold_16	16039688	16043681	NA	NA	NA	NA	NA
PGEN_.00g321800	Scaffold_16	16046623	16053688	NA	NA	NA	NA	NA
PGEN_.00g321810	Scaffold_16	16057769	16066047	NA	NA	NA	NA	NA
PGEN_.00g321820	Scaffold_16	16074306	16098683	NA	NA	NA	NA	NA
PGEN_.00g321830	Scaffold_16	16099222	16099482	NA	NA	NA	NA	NA
PGEN_.00g321840	Scaffold_16	16108026	16142095	Q0IH87	PAX3B_XENLA	Paired box protein Pax-3-B (xPax3-B) (Paired-domain transcription factor Pax3-B)	GO:0005634; GO:0007399; GO:0008543; GO:0014029; GO:0014034; GO:0016055; GO:0043565; GO:0045893; GO:0048785	"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hatching gland development [GO:0048785]; nervous system development [GO:0007399]; neural crest cell fate commitment [GO:0014034]; neural crest formation [GO:0014029]; positive regulation of transcription, DNA-templated [GO:0045893]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g321850	Scaffold_16	16161929	16177507	O89110	CASP8_MOUSE	Caspase-8 (CASP-8) (EC 3.4.22.61) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]	GO:0001525; GO:0001841; GO:0004175; GO:0004197; GO:0005123; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006508; GO:0006915; GO:0006919; GO:0007507; GO:0008233; GO:0008625; GO:0030225; GO:0030690; GO:0031264; GO:0031265; GO:0031625; GO:0032731; GO:0032991; GO:0034612; GO:0035877; GO:0036462; GO:0042802; GO:0043005; GO:0043065; GO:0043123; GO:0043124; GO:0044297; GO:0044877; GO:0045121; GO:0045471; GO:0045651; GO:0045862; GO:0046982; GO:0048738; GO:0051603; GO:0060546; GO:0070243; GO:0097110; GO:0097153; GO:0097190; GO:0097191; GO:0097194; GO:0097199; GO:0097202; GO:0097264; GO:0097284; GO:0097342; GO:1901216; GO:2001233; GO:2001238	CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; Noc1p-Noc2p complex [GO:0030690]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cardiac muscle tissue development [GO:0048738]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; hepatocyte apoptotic process [GO:0097284]; macrophage differentiation [GO:0030225]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of thymocyte apoptotic process [GO:0070243]; response to ethanol [GO:0045471]; response to tumor necrosis factor [GO:0034612]; self proteolysis [GO:0097264]; TRAIL-activated apoptotic signaling pathway [GO:0036462]
PGEN_.00g321860	Scaffold_16	16183820	16209195	Q9UBZ9	REV1_HUMAN	DNA repair protein REV1 (EC 2.7.7.-) (Alpha integrin-binding protein 80) (AIBP80) (Rev1-like terminal deoxycytidyl transferase)	GO:0003684; GO:0003887; GO:0005654; GO:0006260; GO:0009411; GO:0017125; GO:0019985; GO:0042276; GO:0046872; GO:0070987	nucleoplasm [GO:0005654]; damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]
PGEN_.00g321870	Scaffold_16	16217851	16226477	O94469	DUR31_SCHPO	Probable urea active transporter 1	GO:0005886; GO:0015204; GO:0015489; GO:0015606; GO:0015840; GO:0015847; GO:0015848; GO:0016021; GO:0071918	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; putrescine transmembrane transporter activity [GO:0015489]; spermidine transmembrane transporter activity [GO:0015606]; urea transmembrane transporter activity [GO:0015204]; putrescine transport [GO:0015847]; spermidine transport [GO:0015848]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840]
PGEN_.00g321880	Scaffold_16	16240239	16253237	O54967	ACK1_MOUSE	Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2)	GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007169; GO:0007286; GO:0016310; GO:0030136; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0030659; GO:0031234; GO:0031625; GO:0038083; GO:0042127; GO:0042802; GO:0043025; GO:0046872; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:2000369	adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; cell differentiation [GO:0030154]; endocytosis [GO:0006897]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of cell population proliferation [GO:0042127]; regulation of clathrin-dependent endocytosis [GO:2000369]; spermatid development [GO:0007286]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g321890	Scaffold_16	16266841	16271235	NA	NA	NA	NA	NA
PGEN_.00g321900	Scaffold_16	16273639	16298006	Q9C0J8	WDR33_HUMAN	pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa)	GO:0000398; GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0006369; GO:0006378; GO:0006406; GO:0007283; GO:0031124	"collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]"
PGEN_.00g321910	Scaffold_16	16314452	16347263	Q5ZJQ7	SSU72_CHICK	RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16)	GO:0005737; GO:0005847; GO:0006369; GO:0006378; GO:0008420; GO:0070940	cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]
PGEN_.00g321920	Scaffold_16	16348553	16364950	Q3UM45	PP1R7_MOUSE	Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22)	GO:0005634; GO:0005694; GO:0007059; GO:0035307	chromosome [GO:0005694]; nucleus [GO:0005634]; chromosome segregation [GO:0007059]; positive regulation of protein dephosphorylation [GO:0035307]
PGEN_.00g321930	Scaffold_16	16366481	16377383	Q62901	RERE_RAT	Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-related protein)	GO:0000118; GO:0001085; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0016605; GO:0021549; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813	"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g321940	Scaffold_16	16417888	16418346	NA	NA	NA	NA	NA
PGEN_.00g321950	Scaffold_16	16429046	16433542	NA	NA	NA	NA	NA
PGEN_.00g321960	Scaffold_16	16433751	16496524	Q62901	RERE_RAT	Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-related protein)	GO:0000118; GO:0001085; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0016605; GO:0021549; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813	"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g321970	Scaffold_16	16490412	16490729	NA	NA	NA	NA	NA
PGEN_.00g321980	Scaffold_16	16492078	16492446	NA	NA	NA	NA	NA
PGEN_.00g321990	Scaffold_16	16510437	16520961	NA	NA	NA	NA	NA
PGEN_.00g322000	Scaffold_16	16572841	16583039	P0AC33	FUMA_ECOLI	"Fumarate hydratase class I, aerobic (EC 4.2.1.2) (Fumarase A) (Oxaloacetate keto--enol-isomerase) (OAAKE isomerase) (Oxaloacetate tautomerase) (EC 5.3.2.2)"	GO:0004333; GO:0005829; GO:0006099; GO:0042802; GO:0046872; GO:0050163; GO:0051539	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; fumarate hydratase activity [GO:0004333]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxaloacetate tautomerase activity [GO:0050163]; tricarboxylic acid cycle [GO:0006099]"
PGEN_.00g322010	Scaffold_16	16591302	16606919	NA	NA	NA	NA	NA
PGEN_.00g322020	Scaffold_16	16613854	16624531	NA	NA	NA	NA	NA
PGEN_.00g322030	Scaffold_16	16626416	16635515	P82596	PLC_HALLA	Perlucin	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g322040	Scaffold_16	16640617	16643662	NA	NA	NA	NA	NA
PGEN_.00g322050	Scaffold_16	16676099	16685551	NA	NA	NA	NA	NA
PGEN_.00g322060	Scaffold_16	16697704	16727957	NA	NA	NA	NA	NA
PGEN_.00g322070	Scaffold_16	16790846	16806526	O70628	PDE9A_MOUSE	"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35)"	GO:0005783; GO:0005794; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]"
PGEN_.00g322080	Scaffold_16	16817855	16823334	Q02742	GCNT1_HUMAN	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT) (Core 2 GNT)"	GO:0000139; GO:0003829; GO:0005615; GO:0005802; GO:0009101; GO:0016021; GO:0016266; GO:0031985; GO:0032868; GO:0048729; GO:0050901; GO:0060352; GO:0060993	"extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; O-glycan processing [GO:0016266]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]"
PGEN_.00g322090	Scaffold_16	16827404	16835838	Q8CH87	GCNT3_RAT	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (EC 2.4.1.102) (EC 2.4.1.148) (EC 2.4.1.150) (C2GnT-mucin type) (C2GnT-M) (dI/C2/C4GnT) (dIGnT)"	GO:0000139; GO:0002426; GO:0003829; GO:0006486; GO:0008109; GO:0016021; GO:0047225; GO:0048729; GO:0050892; GO:0060993	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0047225]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; immunoglobulin production in mucosal tissue [GO:0002426]; intestinal absorption [GO:0050892]; kidney morphogenesis [GO:0060993]; protein glycosylation [GO:0006486]; tissue morphogenesis [GO:0048729]"
PGEN_.00g322100	Scaffold_16	16836745	16837071	NA	NA	NA	NA	NA
PGEN_.00g322110	Scaffold_16	16909755	16909973	P28749	RBL1_HUMAN	Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1)	GO:0000122; GO:0000785; GO:0001012; GO:0001102; GO:0005654; GO:0005667; GO:0006325; GO:0007049; GO:0007346; GO:0008134; GO:0010629; GO:0016032; GO:0030154; GO:0043550; GO:0045944; GO:0051302; GO:1990841; GO:2000134; GO:2000773	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; viral process [GO:0016032]
PGEN_.00g322120	Scaffold_16	16910054	16910431	Q08999	RBL2_HUMAN	Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2)	GO:0000785; GO:0001012; GO:0001102; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0006325; GO:0006357; GO:0006977; GO:0007346; GO:0010629; GO:0030154; GO:0043550; GO:0051302; GO:0070062; GO:1990841; GO:2000134	"chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g322130	Scaffold_16	16910606	16912931	P28749	RBL1_HUMAN	Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1)	GO:0000122; GO:0000785; GO:0001012; GO:0001102; GO:0005654; GO:0005667; GO:0006325; GO:0007049; GO:0007346; GO:0008134; GO:0010629; GO:0016032; GO:0030154; GO:0043550; GO:0045944; GO:0051302; GO:1990841; GO:2000134; GO:2000773	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; viral process [GO:0016032]
PGEN_.00g322140	Scaffold_16	16968872	16969165	NA	NA	NA	NA	NA
PGEN_.00g322150	Scaffold_16	16977451	16993705	NA	NA	NA	NA	NA
PGEN_.00g322160	Scaffold_16	16997413	17011571	O43447	PPIH_HUMAN	Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H) (CypH) (U-snRNP-associated cyclophilin SnuCyp-20) (USA-CYP)	GO:0000398; GO:0000413; GO:0001525; GO:0003755; GO:0005654; GO:0005681; GO:0005737; GO:0006457; GO:0016018; GO:0016607; GO:0042026; GO:0043021; GO:0045070; GO:0046540; GO:0051082; GO:0065003; GO:0071001	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein-containing complex assembly [GO:0065003]"
PGEN_.00g322170	Scaffold_16	17013392	17017482	Q9UBQ7	GRHPR_HUMAN	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	GO:0005737; GO:0005782; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0034641; GO:0042803; GO:0043648; GO:0046487; GO:0051259; GO:0051287; GO:0055114; GO:0070062; GO:0070402	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]"
PGEN_.00g322180	Scaffold_16	17021342	17042694	Q9UBQ7	GRHPR_HUMAN	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	GO:0005737; GO:0005782; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0034641; GO:0042803; GO:0043648; GO:0046487; GO:0051259; GO:0051287; GO:0055114; GO:0070062; GO:0070402	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]"
PGEN_.00g322190	Scaffold_16	17046003	17050037	Q96TW9	MCH1_WICAO	Probable transporter MCH1	GO:0005774; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; transmembrane transport [GO:0055085]
PGEN_.00g322200	Scaffold_16	17053152	17056815	Q6CGU8	MCH1_YARLI	Probable transporter MCH1	GO:0005774; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; transmembrane transport [GO:0055085]
PGEN_.00g322210	Scaffold_16	17062530	17063312	NA	NA	NA	NA	NA
PGEN_.00g322220	Scaffold_16	17133374	17140011	NA	NA	NA	NA	NA
PGEN_.00g322230	Scaffold_16	17209501	17213899	NA	NA	NA	NA	NA
PGEN_.00g322240	Scaffold_16	17223129	17227190	NA	NA	NA	NA	NA
PGEN_.00g322250	Scaffold_16	17266183	17266404	NA	NA	NA	NA	NA
PGEN_.00g322260	Scaffold_16	17271889	17277730	Q9UI32	GLSL_HUMAN	"Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase)"	GO:0004359; GO:0005739; GO:0005759; GO:0006520; GO:0006537; GO:0006543; GO:0008652; GO:0014047; GO:0042981; GO:0072593	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]
PGEN_.00g322270	Scaffold_16	17288355	17291701	Q9U6D3	CALM_MYXGL	Calmodulin (CaM)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g322280	Scaffold_16	17293875	17331982	Q61116	ZN235_MOUSE	Zinc finger protein 235 (Zinc finger protein 93) (Zfp-93)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g322290	Scaffold_16	17420922	17425663	Q5ZIH0	INT11_CHICK	Integrator complex subunit 11 (Int11) (EC 3.1.27.-) (Cleavage and polyadenylation-specific factor 3-like protein) (CPSF3-like protein)	GO:0005634; GO:0016180; GO:0016787; GO:0032039	integrator complex [GO:0032039]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; snRNA processing [GO:0016180]
PGEN_.00g322300	Scaffold_16	17434287	17451500	O35125	LRC23_MOUSE	Leucine-rich repeat-containing protein 23 (Leucine-rich protein B7)	GO:0005737; GO:0005829	cytoplasm [GO:0005737]; cytosol [GO:0005829]
PGEN_.00g322310	Scaffold_16	17469239	17505876	Q9CWL2	CASZ1_MOUSE	Zinc finger protein castor homolog 1 (Castor-related protein)	GO:0003677; GO:0005654; GO:0005829; GO:0043231; GO:0045665; GO:0045893; GO:0046872; GO:0060040; GO:0060223; GO:0060226; GO:1902870	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223]"
PGEN_.00g322320	Scaffold_16	17522031	17533792	Q5ZIJ9	MIB2_CHICK	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)	GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g322330	Scaffold_16	17561067	17564160	NA	NA	NA	NA	NA
PGEN_.00g322340	Scaffold_16	17564493	17613479	B1WAP7	DVL3_XENTR	Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3)	GO:0005109; GO:0005829; GO:0008013; GO:0032053; GO:0035556; GO:0060070; GO:0060271; GO:0090179	cytosol [GO:0005829]; beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; planar cell polarity pathway involved in neural tube closure [GO:0090179]
PGEN_.00g322350	Scaffold_16	17644372	17648250	NA	NA	NA	NA	NA
PGEN_.00g322360	Scaffold_16	17758298	17760357	NA	NA	NA	NA	NA
PGEN_.00g322370	Scaffold_16	17761232	17766899	NA	NA	NA	NA	NA
PGEN_.00g322380	Scaffold_16	17784606	17786096	NA	NA	NA	NA	NA
PGEN_.00g322390	Scaffold_16	17786348	17797084	P56677	ST14_MOUSE	Suppressor of tumorigenicity 14 protein homolog (EC 3.4.21.109) (Epithin) (Serine protease 14)	GO:0001843; GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0016323; GO:0016477; GO:0019897; GO:0030216; GO:0060672	basolateral plasma membrane [GO:0016323]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; cell migration [GO:0016477]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; proteolysis [GO:0006508]
PGEN_.00g322400	Scaffold_16	17798470	17799885	NA	NA	NA	NA	NA
PGEN_.00g322410	Scaffold_16	17801508	17808518	Q7SYJ9	SPAG7_DANRE	Sperm-associated antigen 7 homolog	GO:0003676	nucleic acid binding [GO:0003676]
PGEN_.00g322420	Scaffold_16	17814226	17824136	P0DPD5	ZN723_HUMAN	Zinc finger protein 723	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g322430	Scaffold_16	17840017	17843567	NA	NA	NA	NA	NA
PGEN_.00g322440	Scaffold_16	17843628	17891698	Q91437	PYR1_SQUAC	CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]	GO:0004070; GO:0004088; GO:0004151; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006541; GO:0008270; GO:0016597; GO:0044205	cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]
PGEN_.00g322450	Scaffold_16	17900624	17913275	Q9BXM7	PINK1_HUMAN	"Serine/threonine-protein kinase PINK1, mitochondrial (EC 2.7.11.1) (BRPK) (PTEN-induced putative kinase protein 1)"	GO:0000287; GO:0000422; GO:0000785; GO:0001934; GO:0002020; GO:0002082; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0006979; GO:0007005; GO:0010310; GO:0010629; GO:0010821; GO:0010857; GO:0010952; GO:0016020; GO:0016236; GO:0016239; GO:0016242; GO:0016301; GO:0016504; GO:0016567; GO:0018105; GO:0022904; GO:0030424; GO:0030426; GO:0031307; GO:0031396; GO:0031398; GO:0031625; GO:0032148; GO:0032226; GO:0033138; GO:0033603; GO:0034599; GO:0035307; GO:0035556; GO:0036289; GO:0038203; GO:0043123; GO:0043254; GO:0043422; GO:0043524; GO:0044297; GO:0044877; GO:0045727; GO:0046329; GO:0048471; GO:0050821; GO:0051091; GO:0051443; GO:0051881; GO:0051897; GO:0055131; GO:0061136; GO:0071456; GO:0072655; GO:0072656; GO:0090141; GO:0090200; GO:0090258; GO:0097237; GO:0097413; GO:0097449; GO:0098779; GO:0099074; GO:1900407; GO:1901727; GO:1902803; GO:1902902; GO:1902958; GO:1903146; GO:1903147; GO:1903202; GO:1903204; GO:1903214; GO:1903298; GO:1903384; GO:1903751; GO:1903852; GO:1903955; GO:1904544; GO:1904783; GO:1904841; GO:1904881; GO:2000377; GO:2000378; GO:2001171; GO:2001243	"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; establishment of protein localization to mitochondrion [GO:0072655]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein complex assembly [GO:0043254]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g322460	Scaffold_16	17913946	17917192	A2VEA3	ARI1_BOVIN	E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (RING-type E3 ubiquitin transferase ARIH1)	GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0006511; GO:0008270; GO:0015030; GO:0016567; GO:0016604; GO:0019005; GO:0031462; GO:0031463; GO:0031464; GO:0031624; GO:0031625; GO:0032436; GO:0061630; GO:0097413	Cajal body [GO:0015030]; Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g322470	Scaffold_16	17917538	17917954	NA	NA	NA	NA	NA
PGEN_.00g322480	Scaffold_16	17924453	17928459	NA	NA	NA	NA	NA
PGEN_.00g322490	Scaffold_16	17929117	17941917	NA	NA	NA	NA	NA
PGEN_.00g322500	Scaffold_16	17943874	17944449	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g322510	Scaffold_16	17945339	17946092	NA	NA	NA	NA	NA
PGEN_.00g322520	Scaffold_16	17957518	17959085	NA	NA	NA	NA	NA
PGEN_.00g322530	Scaffold_16	17960064	17969679	NA	NA	NA	NA	NA
PGEN_.00g322540	Scaffold_16	17970015	17979913	Q95XZ6	LAAT1_CAEEL	Lysosomal amino acid transporter 1	GO:0005765; GO:0010508; GO:0015181; GO:0015189; GO:0015809; GO:0015819; GO:0031301; GO:0080144	integral component of organelle membrane [GO:0031301]; lysosomal membrane [GO:0005765]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; amino acid homeostasis [GO:0080144]; arginine transport [GO:0015809]; lysine transport [GO:0015819]; positive regulation of autophagy [GO:0010508]
PGEN_.00g322550	Scaffold_16	17991178	18037173	Q80XI3	IF4G3_MOUSE	Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII)	GO:0000339; GO:0001934; GO:0003729; GO:0003743; GO:0007283; GO:0016281; GO:0045727; GO:0060903	eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]
PGEN_.00g322560	Scaffold_16	18050311	18059841	Q5R4Q3	SEC62_PONAB	Translocation protein SEC62 (Translocation protein 1) (TP-1)	GO:0005791; GO:0030176; GO:0031204	"integral component of endoplasmic reticulum membrane [GO:0030176]; rough endoplasmic reticulum [GO:0005791]; posttranslational protein targeting to membrane, translocation [GO:0031204]"
PGEN_.00g322570	Scaffold_16	18060784	18061191	NA	NA	NA	NA	NA
PGEN_.00g322580	Scaffold_16	18086271	18091234	NA	NA	NA	NA	NA
PGEN_.00g322590	Scaffold_16	18164471	18167247	NA	NA	NA	NA	NA
PGEN_.00g322600	Scaffold_16	18175671	18180044	NA	NA	NA	NA	NA
PGEN_.00g322610	Scaffold_16	18193509	18211663	NA	NA	NA	NA	NA
PGEN_.00g322620	Scaffold_16	18212005	18212391	NA	NA	NA	NA	NA
PGEN_.00g322630	Scaffold_16	18215796	18234670	NA	NA	NA	NA	NA
PGEN_.00g322640	Scaffold_16	18234726	18235334	NA	NA	NA	NA	NA
PGEN_.00g322650	Scaffold_16	18248077	18261946	P22699	GUN6_DICDI	"Endoglucanase (EC 3.2.1.4) (Cellulase) (Endo-1,4-beta-glucanase) (Spore germination protein 270-6)"	GO:0005576; GO:0008810; GO:0009847; GO:0030245; GO:0030248; GO:0030435	extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]; spore germination [GO:0009847]; sporulation resulting in formation of a cellular spore [GO:0030435]
PGEN_.00g322660	Scaffold_16	18263798	18264190	NA	NA	NA	NA	NA
PGEN_.00g322670	Scaffold_16	18264315	18264590	NA	NA	NA	NA	NA
PGEN_.00g322680	Scaffold_16	18265738	18286356	P26221	GUN4_THEFU	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	GO:0008810; GO:0030245; GO:0030248	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]
PGEN_.00g322690	Scaffold_16	18295696	18299384	NA	NA	NA	NA	NA
PGEN_.00g322700	Scaffold_16	18307034	18320681	Q8AXN9	RPE65_CYNPY	Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase)	GO:0001523; GO:0001786; GO:0004744; GO:0005789; GO:0005886; GO:0007601; GO:0016020; GO:0016702; GO:0016853; GO:0031210; GO:0046872; GO:0050896; GO:0052884; GO:0052885; GO:1901612; GO:1901827	"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinal isomerase activity [GO:0004744]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]; zeaxanthin biosynthetic process [GO:1901827]"
PGEN_.00g322710	Scaffold_16	18320710	18336271	Q9YI25	RPE65_AMBTI	Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase)	GO:0001523; GO:0001786; GO:0004744; GO:0005789; GO:0005886; GO:0007601; GO:0016020; GO:0016702; GO:0016853; GO:0031210; GO:0046872; GO:0050896; GO:0052884; GO:0052885; GO:1901612; GO:1901827	"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinal isomerase activity [GO:0004744]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]; zeaxanthin biosynthetic process [GO:1901827]"
PGEN_.00g322720	Scaffold_16	18350687	18355574	NA	NA	NA	NA	NA
PGEN_.00g322730	Scaffold_16	18363324	18370542	NA	NA	NA	NA	NA
PGEN_.00g322740	Scaffold_16	18377316	18381922	NA	NA	NA	NA	NA
PGEN_.00g322750	Scaffold_16	18426695	18437001	P78348	ASIC1_HUMAN	"Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) (BNaC2)"	GO:0001662; GO:0001975; GO:0005794; GO:0005886; GO:0005887; GO:0006814; GO:0007165; GO:0007613; GO:0008306; GO:0009268; GO:0009986; GO:0010447; GO:0015280; GO:0022839; GO:0034220; GO:0035725; GO:0042391; GO:0044736; GO:0045202; GO:0046929; GO:0050915; GO:0070207; GO:0070588; GO:0071467	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acid-sensing ion channel activity [GO:0044736]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; ion transmembrane transport [GO:0034220]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; protein homotrimerization [GO:0070207]; regulation of membrane potential [GO:0042391]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; response to pH [GO:0009268]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]
PGEN_.00g322760	Scaffold_16	18440080	18442928	Q16515	ASIC2_HUMAN	"Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG)"	GO:0003026; GO:0005886; GO:0005887; GO:0007268; GO:0007417; GO:0007422; GO:0007602; GO:0007605; GO:0010447; GO:0015280; GO:0015672; GO:0019229; GO:0022839; GO:0034220; GO:0034765; GO:0035418; GO:0042391; GO:0043025; GO:0043066; GO:0043197; GO:0050915; GO:0050974; GO:0051965	dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; ion transmembrane transport [GO:0034220]; monovalent inorganic cation transport [GO:0015672]; negative regulation of apoptotic process [GO:0043066]; peripheral nervous system development [GO:0007422]; phototransduction [GO:0007602]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; response to acidic pH [GO:0010447]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]
PGEN_.00g322770	Scaffold_16	18444500	18454607	Q3SYU1	NOC2L_BOVIN	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]
PGEN_.00g322780	Scaffold_16	18488175	18488918	NA	NA	NA	NA	NA
PGEN_.00g322790	Scaffold_16	18594195	18608180	Q9WV70	NOC2L_MOUSE	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	GO:0000122; GO:0002039; GO:0002903; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031493; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal histone binding [GO:0031493]; nucleosome binding [GO:0031491]; p53 binding [GO:0002039]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]
PGEN_.00g322800	Scaffold_16	18613427	18614988	O35403	ST3A1_MOUSE	Amine sulfotransferase (EC 2.8.2.3) (SULT-X2) (Sulfotransferase 3A1) (ST3A1)	GO:0005737; GO:0008146; GO:0047685; GO:0051923	cytoplasm [GO:0005737]; amine sulfotransferase activity [GO:0047685]; sulfotransferase activity [GO:0008146]; sulfation [GO:0051923]
PGEN_.00g322810	Scaffold_16	18713833	18789293	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g322820	Scaffold_16	18797759	18822864	NA	NA	NA	NA	NA
PGEN_.00g322830	Scaffold_16	18979281	18979673	NA	NA	NA	NA	NA
PGEN_.00g322840	Scaffold_16	18979781	18980041	NA	NA	NA	NA	NA
PGEN_.00g322850	Scaffold_16	19031399	19032055	NA	NA	NA	NA	NA
PGEN_.00g322860	Scaffold_16	19234952	19235677	NA	NA	NA	NA	NA
PGEN_.00g322870	Scaffold_16	19288614	19289006	NA	NA	NA	NA	NA
PGEN_.00g322880	Scaffold_16	19440804	19462983	NA	NA	NA	NA	NA
PGEN_.00g322890	Scaffold_16	19474442	19561669	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g322900	Scaffold_16	19653146	19657827	O35403	ST3A1_MOUSE	Amine sulfotransferase (EC 2.8.2.3) (SULT-X2) (Sulfotransferase 3A1) (ST3A1)	GO:0005737; GO:0008146; GO:0047685; GO:0051923	cytoplasm [GO:0005737]; amine sulfotransferase activity [GO:0047685]; sulfotransferase activity [GO:0008146]; sulfation [GO:0051923]
PGEN_.00g322910	Scaffold_16	19660789	19675008	Q9WV70	NOC2L_MOUSE	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	GO:0000122; GO:0002039; GO:0002903; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031493; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal histone binding [GO:0031493]; nucleosome binding [GO:0031491]; p53 binding [GO:0002039]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]
PGEN_.00g322920	Scaffold_16	19749030	19755569	NA	NA	NA	NA	NA
PGEN_.00g322930	Scaffold_16	19780186	19780929	NA	NA	NA	NA	NA
PGEN_.00g322940	Scaffold_16	19814278	19825668	Q3SYU1	NOC2L_BOVIN	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243	cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]
PGEN_.00g322950	Scaffold_16	19826641	19831506	Q925H0	ASIC2_MOUSE	"Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive cation channel 1, neuronal) (Brain sodium channel 1) (BNC1) (BNaC1)"	GO:0003026; GO:0005216; GO:0005248; GO:0005261; GO:0005887; GO:0006812; GO:0006814; GO:0007602; GO:0007605; GO:0009612; GO:0010447; GO:0015280; GO:0016021; GO:0019229; GO:0022839; GO:0034220; GO:0034765; GO:0035418; GO:0035690; GO:0042391; GO:0043005; GO:0043025; GO:0043066; GO:0043197; GO:0045202; GO:0050915; GO:0050974; GO:0051965; GO:0071468; GO:2001259	dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280]; voltage-gated sodium channel activity [GO:0005248]; cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; cellular response to drug [GO:0035690]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; ion transmembrane transport [GO:0034220]; negative regulation of apoptotic process [GO:0043066]; phototransduction [GO:0007602]; positive regulation of cation channel activity [GO:2001259]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; response to acidic pH [GO:0010447]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]; sodium ion transport [GO:0006814]
PGEN_.00g322960	Scaffold_16	19835213	19845720	P78348	ASIC1_HUMAN	"Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) (BNaC2)"	GO:0001662; GO:0001975; GO:0005794; GO:0005886; GO:0005887; GO:0006814; GO:0007165; GO:0007613; GO:0008306; GO:0009268; GO:0009986; GO:0010447; GO:0015280; GO:0022839; GO:0034220; GO:0035725; GO:0042391; GO:0044736; GO:0045202; GO:0046929; GO:0050915; GO:0070207; GO:0070588; GO:0071467	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acid-sensing ion channel activity [GO:0044736]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; ion transmembrane transport [GO:0034220]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; protein homotrimerization [GO:0070207]; regulation of membrane potential [GO:0042391]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; response to pH [GO:0009268]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]
PGEN_.00g322970	Scaffold_16	19894608	19898441	NA	NA	NA	NA	NA
PGEN_.00g322980	Scaffold_16	19905461	19912654	NA	NA	NA	NA	NA
PGEN_.00g322990	Scaffold_16	19920640	19925541	NA	NA	NA	NA	NA
PGEN_.00g323000	Scaffold_16	19939930	19955936	A9C3R9	RP65B_DANRE	All-trans-retinyl ester 13-cis isomerohydrolase (13cIMH) (EC 3.1.1.90) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein homolog B) (RPE56b)	GO:0001523; GO:0004744; GO:0005789; GO:0005886; GO:0016702; GO:0042574; GO:0046872; GO:0050251; GO:0052885; GO:1901827	"endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; retinal isomerase activity [GO:0004744]; retinol isomerase activity [GO:0050251]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; zeaxanthin biosynthetic process [GO:1901827]"
PGEN_.00g323010	Scaffold_16	19955965	19957850	NA	NA	NA	NA	NA
PGEN_.00g323020	Scaffold_16	19974123	19974494	NA	NA	NA	NA	NA
PGEN_.00g323030	Scaffold_16	20040817	20050250	NA	NA	NA	NA	NA
PGEN_.00g323040	Scaffold_16	20061177	20061461	NA	NA	NA	NA	NA
PGEN_.00g323050	Scaffold_16	20085549	20101249	Q68SA9	ATS7_MOUSE	A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) (COMPase)	GO:0004222; GO:0005615; GO:0006508; GO:0008237; GO:0009986; GO:0032331; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773	cell surface [GO:0009986]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of chondrocyte differentiation [GO:0032331]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g323060	Scaffold_16	20294514	20301849	Q9TTT5	KCND3_RABIT	Potassium voltage-gated channel subfamily D member 3 (Voltage-gated potassium channel subunit Kv4.3)	GO:0005249; GO:0008076; GO:0030425; GO:0034765; GO:0042383; GO:0046872; GO:0051260	dendrite [GO:0030425]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g323070	Scaffold_16	20303652	20304821	Q92953	KCNB2_HUMAN	Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2)	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0006940; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]; regulation of smooth muscle contraction [GO:0006940]
PGEN_.00g323080	Scaffold_16	20320405	20336579	NA	NA	NA	NA	NA
PGEN_.00g323090	Scaffold_16	20348824	20370703	NA	NA	NA	NA	NA
PGEN_.00g323100	Scaffold_16	20377203	20393717	P07897	PGCA_RAT	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)	GO:0001501; GO:0001502; GO:0001503; GO:0002063; GO:0005509; GO:0005540; GO:0005604; GO:0005615; GO:0007155; GO:0007417; GO:0007507; GO:0009314; GO:0009612; GO:0009629; GO:0009749; GO:0010259; GO:0010447; GO:0014070; GO:0021510; GO:0030166; GO:0030199; GO:0030246; GO:0030336; GO:0031012; GO:0042493; GO:0043005; GO:0043025; GO:0060591; GO:0071363; GO:0072534; GO:0098966; GO:0098978; GO:0098982	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; perisynaptic extracellular matrix [GO:0098966]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; central nervous system development [GO:0007417]; chondroblast differentiation [GO:0060591]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; heart development [GO:0007507]; multicellular organism aging [GO:0010259]; negative regulation of cell migration [GO:0030336]; ossification [GO:0001503]; proteoglycan biosynthetic process [GO:0030166]; response to acidic pH [GO:0010447]; response to drug [GO:0042493]; response to glucose [GO:0009749]; response to gravity [GO:0009629]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; skeletal system development [GO:0001501]; spinal cord development [GO:0021510]
PGEN_.00g323110	Scaffold_16	20397954	20409328	Q09324	GCNT1_MOUSE	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT)"	GO:0000139; GO:0003829; GO:0005615; GO:0005802; GO:0006486; GO:0009101; GO:0016021; GO:0031985; GO:0032868; GO:0048729; GO:0050901; GO:0060352; GO:0060993	"extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; protein glycosylation [GO:0006486]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]"
PGEN_.00g323120	Scaffold_16	20437009	20454220	Q8VYS0	RD19D_ARATH	Probable cysteine protease RD19D (EC 3.4.22.-)	GO:0004197; GO:0005615; GO:0005764; GO:0051603	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g323130	Scaffold_16	20458842	20473390	NA	NA	NA	NA	NA
PGEN_.00g323140	Scaffold_16	20475729	20496118	Q4R4R0	PRS7_MACFA	26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)	GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0016887; GO:0022624; GO:0036402	cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g323150	Scaffold_16	20498872	20503432	Q9H4G4	GAPR1_HUMAN	Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)	GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]
PGEN_.00g323160	Scaffold_16	20506786	20528639	NA	NA	NA	NA	NA
PGEN_.00g323170	Scaffold_16	20540762	20540998	NA	NA	NA	NA	NA
PGEN_.00g323180	Scaffold_16	20545251	20560285	P38942	CAT2_CLOK5	4-hydroxybutyrate coenzyme A transferase (EC 2.8.3.-)	GO:0003986; GO:0006083; GO:0008775; GO:0019679	"acetate CoA-transferase activity [GO:0008775]; acetyl-CoA hydrolase activity [GO:0003986]; acetate metabolic process [GO:0006083]; propionate metabolic process, methylcitrate cycle [GO:0019679]"
PGEN_.00g323190	Scaffold_16	20560560	20577218	P38942	CAT2_CLOK5	4-hydroxybutyrate coenzyme A transferase (EC 2.8.3.-)	GO:0003986; GO:0006083; GO:0008775; GO:0019679	"acetate CoA-transferase activity [GO:0008775]; acetyl-CoA hydrolase activity [GO:0003986]; acetate metabolic process [GO:0006083]; propionate metabolic process, methylcitrate cycle [GO:0019679]"
PGEN_.00g323200	Scaffold_16	20593236	20599131	NA	NA	NA	NA	NA
PGEN_.00g323210	Scaffold_16	20598799	20599679	NA	NA	NA	NA	NA
PGEN_.00g323220	Scaffold_16	20621484	20622275	NA	NA	NA	NA	NA
PGEN_.00g323230	Scaffold_16	20627765	20650214	I6V1W0	BMBL_DANRE	Protein brambleberry	GO:0007344; GO:0016021; GO:0031965; GO:0061472	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; karyomere membrane fusion [GO:0061472]; pronuclear fusion [GO:0007344]
PGEN_.00g323240	Scaffold_16	20670536	20693753	Q5ZIJ9	MIB2_CHICK	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)	GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
PGEN_.00g323250	Scaffold_16	20715247	20730954	Q09470	KCNA1_HUMAN	Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1)	GO:0001964; GO:0005249; GO:0005251; GO:0005267; GO:0005783; GO:0005829; GO:0005886; GO:0005887; GO:0006813; GO:0006937; GO:0007268; GO:0007405; GO:0008076; GO:0009986; GO:0010644; GO:0010960; GO:0015079; GO:0016021; GO:0016324; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030424; GO:0030425; GO:0031410; GO:0033270; GO:0034613; GO:0042391; GO:0042734; GO:0043025; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0071286; GO:0071805; GO:0097718; GO:0098978; GO:0099055; GO:0099056; GO:0099508; GO:1903818; GO:1905030	apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; juxtaparanode region of axon [GO:0044224]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718]; potassium channel activity [GO:0005267]; potassium ion transmembrane transporter activity [GO:0015079]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]; cell communication by electrical coupling [GO:0010644]; cellular protein localization [GO:0034613]; cellular response to magnesium ion [GO:0071286]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964]
PGEN_.00g323260	Scaffold_16	20736615	20744075	P17658	KCNA6_HUMAN	Potassium voltage-gated channel subfamily A member 6 (Voltage-gated potassium channel HBK2) (Voltage-gated potassium channel subunit Kv1.6)	GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0034705; GO:0034765; GO:0043679; GO:0051260; GO:0071805	axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g323270	Scaffold_16	20751830	20754888	P17972	KCNAW_DROME	Potassium voltage-gated channel protein Shaw (Shaw2)	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]
PGEN_.00g323280	Scaffold_16	20763865	20817097	Q7TN88	PK1L2_MOUSE	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g323290	Scaffold_16	20842400	20844334	NA	NA	NA	NA	NA
PGEN_.00g323300	Scaffold_16	20855012	20915767	Q7TN88	PK1L2_MOUSE	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]; detection of mechanical stimulus [GO:0050982]
PGEN_.00g323310	Scaffold_16	20953826	20964966	Q5R5U4	RER1_PONAB	Protein RER1	GO:0000139; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]
PGEN_.00g323320	Scaffold_16	20969825	20987791	Q2PFV2	CASP3_MACFA	Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]	GO:0005737; GO:0006508; GO:0031647; GO:0097199; GO:1902004	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]
PGEN_.00g323330	Scaffold_16	20994954	20999477	Q0P4F7	ACSF2_DANRE	"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)"	GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]
PGEN_.00g323340	Scaffold_16	21006346	21012442	NA	NA	NA	NA	NA
PGEN_.00g323350	Scaffold_16	21075524	21081455	NA	NA	NA	NA	NA
PGEN_.00g323360	Scaffold_16	21148622	21170071	Q0VA82	MFSD8_DANRE	Major facilitator superfamily domain-containing protein 8	GO:0005765; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; transmembrane transport [GO:0055085]
PGEN_.00g323370	Scaffold_16	21182420	21182737	NA	NA	NA	NA	NA
PGEN_.00g323380	Scaffold_16	21266101	21267735	NA	NA	NA	NA	NA
PGEN_.00g323390	Scaffold_16	21268025	21269948	NA	NA	NA	NA	NA
PGEN_.00g323400	Scaffold_16	21351085	21352197	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g323410	Scaffold_16	21508926	21509237	NA	NA	NA	NA	NA
PGEN_.00g323420	Scaffold_16	21568088	21568582	NA	NA	NA	NA	NA
PGEN_.00g323430	Scaffold_16	21590117	21599289	P16112	PGCA_HUMAN	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2]	GO:0001501; GO:0001502; GO:0002063; GO:0005201; GO:0005540; GO:0005576; GO:0005604; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0007507; GO:0018146; GO:0030166; GO:0030198; GO:0030199; GO:0030246; GO:0031012; GO:0042340; GO:0043202; GO:0046872; GO:0062023; GO:0098966; GO:0098978; GO:0098982	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perisynaptic extracellular matrix [GO:0098966]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate catabolic process [GO:0042340]; proteoglycan biosynthetic process [GO:0030166]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]
PGEN_.00g323440	Scaffold_16	21610198	21617181	Q9UI32	GLSL_HUMAN	"Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase)"	GO:0004359; GO:0005739; GO:0005759; GO:0006520; GO:0006537; GO:0006543; GO:0008652; GO:0014047; GO:0042981; GO:0072593	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]
PGEN_.00g323450	Scaffold_16	21619838	21657889	P26221	GUN4_THEFU	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	GO:0008810; GO:0030245; GO:0030248	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]
PGEN_.00g323460	Scaffold_16	21673640	21675206	NA	NA	NA	NA	NA
PGEN_.00g323470	Scaffold_16	21680716	21685402	NA	NA	NA	NA	NA
PGEN_.00g323480	Scaffold_16	21685855	21690927	NA	NA	NA	NA	NA
PGEN_.00g323490	Scaffold_16	21698128	21707536	Q8R3R5	T185B_MOUSE	Transmembrane protein 185B (Erythropoietin-induced EST 3-2) (Protein FAM11B)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g323500	Scaffold_16	21724854	21732922	NA	NA	NA	NA	NA
PGEN_.00g323510	Scaffold_16	21737424	21744510	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g323520	Scaffold_16	21753140	21758754	Q9QZC7	PKHB2_MOUSE	Pleckstrin homology domain-containing family B member 2 (PH domain-containing family B member 2) (Evectin-2)	GO:0005547; GO:0016021; GO:0045595; GO:0055038	"integral component of membrane [GO:0016021]; recycling endosome membrane [GO:0055038]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; regulation of cell differentiation [GO:0045595]"
PGEN_.00g323530	Scaffold_16	21770431	21775111	A8E7I5	TTC36_DANRE	Tetratricopeptide repeat protein 36 (TPR repeat protein 36)	GO:0032474; GO:0060271; GO:0061371	cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]
PGEN_.00g323540	Scaffold_16	21775454	21792439	P46087	NOP2_HUMAN	Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)	GO:0000027; GO:0003723; GO:0005654; GO:0005730; GO:0006357; GO:0008284; GO:0009383; GO:0070475; GO:1901796	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosomal large subunit assembly [GO:0000027]; rRNA base methylation [GO:0070475]
PGEN_.00g323550	Scaffold_16	21799594	21816697	Q56H79	NPSR1_MACMU	Neuropeptide S receptor (G-protein coupled receptor 154)	GO:0005000; GO:0005623; GO:0005887; GO:0007218; GO:0008188; GO:0051281	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; neuropeptide signaling pathway [GO:0007218]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]
PGEN_.00g323560	Scaffold_16	21877528	21879351	B8NM66	USTA_ASPFN	Ribosomally synthesized cyclic peptide ustiloxin B precursosr (Ustiloxin B biosynthesis protein A) [Cleaved into: YAIG-I; YAIG-II; YAIG-III; YAIG-IV; YAIG-V; YAIG-VI; YAIG-VII; YAIG-VIII; YAIG-IX; YAIG-X; YAIG-XI; YAIG-XII; YAIG-XIII; YAIG-XIV; YAIG-XV; YAIG-XVI]		
PGEN_.00g323570	Scaffold_16	21885934	21886647	A2AVA0	SVEP1_MOUSE	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)"	GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g323580	Scaffold_16	21918325	21918681	NA	NA	NA	NA	NA
PGEN_.00g323590	Scaffold_16	21964886	21981229	P0AC33	FUMA_ECOLI	"Fumarate hydratase class I, aerobic (EC 4.2.1.2) (Fumarase A) (Oxaloacetate keto--enol-isomerase) (OAAKE isomerase) (Oxaloacetate tautomerase) (EC 5.3.2.2)"	GO:0004333; GO:0005829; GO:0006099; GO:0042802; GO:0046872; GO:0050163; GO:0051539	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; fumarate hydratase activity [GO:0004333]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxaloacetate tautomerase activity [GO:0050163]; tricarboxylic acid cycle [GO:0006099]"
PGEN_.00g323600	Scaffold_16	21987523	22014779	Q98930	SORL_CHICK	Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) (Fragment)	GO:0000139; GO:0005576; GO:0005623; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0016021; GO:0030658; GO:0031901; GO:0032585; GO:0045053; GO:0055038	cell [GO:0005623]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658]; endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]
PGEN_.00g323610	Scaffold_16	22018725	22020287	NA	NA	NA	NA	NA
PGEN_.00g323620	Scaffold_16	22034780	22045855	Q9JI18	LRP1B_MOUSE	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	GO:0001701; GO:0005041; GO:0005509; GO:0016020; GO:0016021; GO:0043235; GO:0050750	integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]; in utero embryonic development [GO:0001701]
PGEN_.00g323630	Scaffold_16	22050043	22052177	NA	NA	NA	NA	NA
PGEN_.00g323640	Scaffold_16	22052261	22053965	NA	NA	NA	NA	NA
PGEN_.00g323650	Scaffold_16	22062500	22076308	Q9R0A0	PEX14_MOUSE	Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14)	GO:0001650; GO:0003714; GO:0005102; GO:0005777; GO:0005778; GO:0007031; GO:0008017; GO:0016021; GO:0016558; GO:0016560; GO:0016561; GO:0032091; GO:0032991; GO:0034453; GO:0036250; GO:0043433; GO:0044721; GO:0045892; GO:0047485; GO:0048487; GO:0051260; GO:0065003; GO:1901094; GO:1990429	"fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; microtubule anchoring [GO:0034453]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein binding [GO:0032091]; negative regulation of protein homotetramerization [GO:1901094]; negative regulation of transcription, DNA-templated [GO:0045892]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein homooligomerization [GO:0051260]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein-containing complex assembly [GO:0065003]"
PGEN_.00g323660	Scaffold_16	22078888	22083400	O70303	CIDEB_MOUSE	Cell death activator CIDE-B (Cell death-inducing DFFA-like effector B)	GO:0005811; GO:0005829; GO:0006915; GO:0010942; GO:0042802; GO:0048471; GO:0090200; GO:0097194; GO:0097202	cytosol [GO:0005829]; lipid droplet [GO:0005811]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; execution phase of apoptosis [GO:0097194]; positive regulation of cell death [GO:0010942]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]
PGEN_.00g323670	Scaffold_16	22089443	22097796	Q9D084	CENPS_MOUSE	Centromere protein S (CENP-S) (Apoptosis-inducing TAF9-like domain-containing protein 1 homolog) (FANCM-interacting histone fold protein 1)	GO:0000712; GO:0000777; GO:0003677; GO:0003682; GO:0003690; GO:0006281; GO:0006974; GO:0031297; GO:0043240; GO:0046982; GO:0051301; GO:0051382; GO:0071821	condensed chromosome kinetochore [GO:0000777]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; kinetochore assembly [GO:0051382]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]
PGEN_.00g323680	Scaffold_16	22100064	22111531	NA	NA	NA	NA	NA
PGEN_.00g323690	Scaffold_16	22115917	22117102	NA	NA	NA	NA	NA
PGEN_.00g323700	Scaffold_16	22133843	22136013	NA	NA	NA	NA	NA
PGEN_.00g323710	Scaffold_16	22142458	22150182	NA	NA	NA	NA	NA
PGEN_.00g323720	Scaffold_16	22150251	22150580	NA	NA	NA	NA	NA
PGEN_.00g323730	Scaffold_16	22213963	22219993	Q2KI56	CSN7B_BOVIN	COP9 signalosome complex subunit 7b (SGN7b) (Signalosome subunit 7b)	GO:0005737; GO:0008180; GO:0010387	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; COP9 signalosome assembly [GO:0010387]
PGEN_.00g323740	Scaffold_16	22227905	22247641	Q5GIS3	GBB_PINFU	Guanine nucleotide-binding protein subunit beta (pfGbeta1) (G protein subunit beta-1)	GO:0005516; GO:0005737; GO:0007165	cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; signal transduction [GO:0007165]
PGEN_.00g323750	Scaffold_16	22248092	22251248	NA	NA	NA	NA	NA
PGEN_.00g323760	Scaffold_16	22308955	22312404	NA	NA	NA	NA	NA
PGEN_.00g323770	Scaffold_16	22362349	22362618	NA	NA	NA	NA	NA
PGEN_.00g323780	Scaffold_16	22390404	22419414	Q575T0	CYGB1_ORYLA	Cytoglobin-1	GO:0005344; GO:0005506; GO:0005737; GO:0019825; GO:0020037	cytoplasm [GO:0005737]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g323790	Scaffold_16	22497133	22526150	Q5F499	OPA1_CHICK	"Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1]"	GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005886; GO:0006915; GO:0008017; GO:0008053; GO:0016020; GO:0016021; GO:0031410; GO:0046039; GO:0070300; GO:0097749; GO:1901612	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; apoptotic process [GO:0006915]; GTP metabolic process [GO:0046039]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]
PGEN_.00g323800	Scaffold_16	22531997	22535576	NA	NA	NA	NA	NA
PGEN_.00g323810	Scaffold_16	22541440	22550460	NA	NA	NA	NA	NA
PGEN_.00g323820	Scaffold_16	22590935	22591270	NA	NA	NA	NA	NA
PGEN_.00g323830	Scaffold_16	22671817	22687351	Q9W436	NEP_DROME	Neprilysin-1 (EC 3.4.24.11)	GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]
PGEN_.00g323840	Scaffold_16	22748113	22786571	NA	NA	NA	NA	NA
PGEN_.00g323850	Scaffold_16	22798668	22807570	NA	NA	NA	NA	NA
PGEN_.00g323860	Scaffold_16	22833152	22833364	NA	NA	NA	NA	NA
PGEN_.00g323870	Scaffold_16	22888964	22895366	NA	NA	NA	NA	NA
PGEN_.00g323880	Scaffold_16	22921574	22926073	NA	NA	NA	NA	NA
PGEN_.00g323890	Scaffold_16	22930468	22933849	NA	NA	NA	NA	NA
PGEN_.00g323900	Scaffold_16	22937365	22939801	NA	NA	NA	NA	NA
PGEN_.00g323910	Scaffold_16	22950412	22953321	NA	NA	NA	NA	NA
PGEN_.00g323920	Scaffold_16	22987701	23058010	Q9CZR2	NALD2_MOUSE	N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)	GO:0004180; GO:0005886; GO:0006508; GO:0008233; GO:0008237; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; peptidase activity [GO:0008233]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]
PGEN_.00g323930	Scaffold_16	23058048	23059939	Q0P4F7	ACSF2_DANRE	"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)"	GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]
PGEN_.00g323940	Scaffold_16	23060228	23060806	Q8X5T5	ACSA_ECO57	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	GO:0003987; GO:0005524; GO:0006935; GO:0016208; GO:0019427; GO:0046872	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; chemotaxis [GO:0006935]
PGEN_.00g323950	Scaffold_16	23065281	23067650	Q9UKU6	TRHDE_HUMAN	Thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) (TRH-degrading ectoenzyme) (EC 3.4.19.6) (Pyroglutamyl-peptidase II) (PAP-II) (TRH-specific aminopeptidase) (Thyroliberinase)	GO:0004177; GO:0005737; GO:0005886; GO:0005887; GO:0006508; GO:0007165; GO:0007267; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; signal transduction [GO:0007165]
PGEN_.00g323960	Scaffold_16	23084404	23094179	NA	NA	NA	NA	NA
PGEN_.00g323970	Scaffold_16	23095544	23133533	O70280	WFDC1_RAT	WAP four-disulfide core domain protein 1 (Prostate stromal protein ps20) (ps20 growth inhibitor)	GO:0001558; GO:0004867; GO:0005615; GO:0032355; GO:0042493; GO:0050680; GO:0050728; GO:0061045	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of wound healing [GO:0061045]; regulation of cell growth [GO:0001558]; response to drug [GO:0042493]; response to estradiol [GO:0032355]
PGEN_.00g323980	Scaffold_16	23141961	23151788	Q6IR42	ZCPW1_MOUSE	Zinc finger CW-type PWWP domain protein 1	GO:0008270	zinc ion binding [GO:0008270]
PGEN_.00g323990	Scaffold_16	23153330	23172042	Q9H0M4	ZCPW1_HUMAN	Zinc finger CW-type PWWP domain protein 1	GO:0008270	zinc ion binding [GO:0008270]
PGEN_.00g324000	Scaffold_16	23175971	23189216	Q8K3A9	MEPCE_MOUSE	7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-)	GO:0000122; GO:0001510; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0035562; GO:0040031; GO:1900087	O-methyltransferase activity [GO:0008171]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]
PGEN_.00g324010	Scaffold_16	23224405	23224683	NA	NA	NA	NA	NA
PGEN_.00g324020	Scaffold_16	23234222	23247527	NA	NA	NA	NA	NA
PGEN_.00g324030	Scaffold_16	23284677	23284952	NA	NA	NA	NA	NA
PGEN_.00g324040	Scaffold_16	23299322	23314858	NA	NA	NA	NA	NA
PGEN_.00g324050	Scaffold_16	23323598	23323870	NA	NA	NA	NA	NA
PGEN_.00g324060	Scaffold_16	23390647	23394778	NA	NA	NA	NA	NA
PGEN_.00g324070	Scaffold_16	23395886	23396116	NA	NA	NA	NA	NA
PGEN_.00g324080	Scaffold_16	23396335	23396682	NA	NA	NA	NA	NA
PGEN_.00g324090	Scaffold_16	23396892	23397188	NA	NA	NA	NA	NA
PGEN_.00g324100	Scaffold_16	23403959	23408971	NA	NA	NA	NA	NA
PGEN_.00g324110	Scaffold_16	23425443	23434502	Q3UY96	CFA74_MOUSE	Cilia- and flagella-associated protein 74	GO:0005930; GO:0035082	axoneme [GO:0005930]; axoneme assembly [GO:0035082]
PGEN_.00g324120	Scaffold_16	23437008	23437823	NA	NA	NA	NA	NA
PGEN_.00g324130	Scaffold_16	23437880	23444705	NA	NA	NA	NA	NA
PGEN_.00g324140	Scaffold_16	23450961	23452043	NA	NA	NA	NA	NA
PGEN_.00g324150	Scaffold_16	23452289	23452906	NA	NA	NA	NA	NA
PGEN_.00g324160	Scaffold_16	23452951	23453592	NA	NA	NA	NA	NA
PGEN_.00g324170	Scaffold_16	23489471	23497688	NA	NA	NA	NA	NA
PGEN_.00g324180	Scaffold_16	23505092	23513087	Q99J27	ACATN_MOUSE	Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1)	GO:0005789; GO:0008521; GO:0015295; GO:0016021; GO:0030509; GO:0060395	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]
PGEN_.00g324190	Scaffold_16	23519456	23519782	NA	NA	NA	NA	NA
PGEN_.00g324200	Scaffold_16	23520116	23520415	NA	NA	NA	NA	NA
PGEN_.00g324210	Scaffold_16	23522644	23549463	NA	NA	NA	NA	NA
PGEN_.00g324220	Scaffold_16	23566559	23572218	Q49LS8	XKR6_TETNG	XK-related protein 6	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g324230	Scaffold_16	23591994	23601767	P30823	CTR1_RAT	High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor) (Ecotropic retrovirus receptor) (EcoR) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter)	GO:0000064; GO:0005886; GO:0015174; GO:0015181; GO:0015189; GO:0015802; GO:0015809; GO:0016021; GO:0032006; GO:0032991; GO:0097638; GO:1903352	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; arginine transmembrane transporter activity [GO:0015181]; basic amino acid transmembrane transporter activity [GO:0015174]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; arginine transport [GO:0015809]; basic amino acid transport [GO:0015802]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; regulation of TOR signaling [GO:0032006]
PGEN_.00g324240	Scaffold_16	23632946	23633158	NA	NA	NA	NA	NA
PGEN_.00g324250	Scaffold_16	23633365	23644527	Q1MTI4	TPISA_DANRE	Triosephosphate isomerase A (TIM-A) (EC 5.3.1.1) (Methylglyoxal synthase A) (EC 4.2.3.3) (Triose-phosphate isomerase A)	GO:0004807; GO:0005829; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019563; GO:0042803; GO:0046166	cytosol [GO:0005829]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]
PGEN_.00g324260	Scaffold_16	23646224	23660942	Q2YDS1	DDB2_DANRE	DNA damage-binding protein 2 (Damage-specific DNA-binding protein 2)	GO:0003684; GO:0005634; GO:0006281; GO:0009411; GO:0016567; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA repair [GO:0006281]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]
PGEN_.00g324270	Scaffold_16	23672077	23672397	NA	NA	NA	NA	NA
PGEN_.00g324280	Scaffold_16	23676391	23693516	Q96AX9	MIB2_HUMAN	E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (Novel zinc finger protein) (Novelzin) (Putative NF-kappa-B-activating protein 002N) (RING-type E3 ubiquitin transferase MIB2) (Skeletrophin) (Zinc finger ZZ type with ankyrin repeat domain protein 1)	GO:0000151; GO:0000209; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005829; GO:0007219; GO:0008270; GO:0016567; GO:0043123; GO:0061630	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]
PGEN_.00g324290	Scaffold_16	23704564	23704848	NA	NA	NA	NA	NA
PGEN_.00g324300	Scaffold_16	23739903	23839453	P30825	CTR1_HUMAN	High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter)	GO:0000064; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015181; GO:0015189; GO:0016020; GO:0032991; GO:0097638; GO:1903352	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]
PGEN_.00g324310	Scaffold_16	23965580	23970884	NA	NA	NA	NA	NA
PGEN_.00g324320	Scaffold_16	23979501	23982576	NA	NA	NA	NA	NA
PGEN_.00g324330	Scaffold_16	23996989	24023155	B3TP03	CTR2_CHICK	Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)	GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015181; GO:0015189; GO:0016021; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arginine transmembrane transporter activity [GO:0015181]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352]
PGEN_.00g324340	Scaffold_16	24024837	24046658	Q96SK2	TM209_HUMAN	Transmembrane protein 209	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g324350	Scaffold_16	24058115	24063426	NA	NA	NA	NA	NA
PGEN_.00g324360	Scaffold_16	24091231	24097266	Q7T3T8	ZAR1_DANRE	Zygote arrest protein 1 (Oocyte-specific maternal effect factor)	GO:0003729; GO:0005737; GO:0006412; GO:0007275; GO:0017148; GO:0032991; GO:1903231; GO:1905881	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; mRNA binding [GO:0003729]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; multicellular organism development [GO:0007275]; negative regulation of translation [GO:0017148]; positive regulation of oogenesis [GO:1905881]; translation [GO:0006412]
PGEN_.00g324370	Scaffold_16	24108762	24124004	NA	NA	NA	NA	NA
PGEN_.00g324380	Scaffold_16	24130567	24132547	NA	NA	NA	NA	NA
PGEN_.00g324390	Scaffold_16	24134791	24143560	NA	NA	NA	NA	NA
PGEN_.00g324400	Scaffold_16	24146874	24153954	NA	NA	NA	NA	NA
PGEN_.00g324410	Scaffold_16	24154127	24168564	Q15427	SF3B4_HUMAN	Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49)	GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1990904; GO:1990935	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"
PGEN_.00g324420	Scaffold_16	24183638	24184746	NA	NA	NA	NA	NA
PGEN_.00g324430	Scaffold_16	24186071	24186970	P41809	HKR1_YEAST	Signaling mucin HKR1 (Hansenula MRAKII killer toxin-resistant protein 1)	GO:0000282; GO:0001402; GO:0005034; GO:0005576; GO:0005886; GO:0005887; GO:0006075; GO:0006972; GO:0007232; GO:0030010; GO:0030427; GO:0031505	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; osmosensor activity [GO:0005034]; (1->3)-beta-D-glucan biosynthetic process [GO:0006075]; cellular bud site selection [GO:0000282]; establishment of cell polarity [GO:0030010]; fungal-type cell wall organization [GO:0031505]; hyperosmotic response [GO:0006972]; osmosensory signaling pathway via Sho1 osmosensor [GO:0007232]; signal transduction involved in filamentous growth [GO:0001402]
PGEN_.00g324440	Scaffold_16	24193569	24235205	Q02225	SKI_XENLA	Ski oncogene (Proto-oncogene c-Ski)	GO:0005634; GO:0006351; GO:0046332	"nucleus [GO:0005634]; SMAD binding [GO:0046332]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g324450	Scaffold_16	24246170	24246835	NA	NA	NA	NA	NA
PGEN_.00g324460	Scaffold_16	24301918	24304164	V5NAL9	TLR4_PINIB	Toll-like receptor 4 (PmTLR4)	GO:0005886; GO:0007165; GO:0016021; GO:0045087	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; signal transduction [GO:0007165]
PGEN_.00g324470	Scaffold_16	24323549	24324121	NA	NA	NA	NA	NA
PGEN_.00g324480	Scaffold_16	24324200	24325564	NA	NA	NA	NA	NA
PGEN_.00g324490	Scaffold_16	24326638	24365508	P26221	GUN4_THEFU	"Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1,4-beta-glucanase E-4)"	GO:0008810; GO:0030245; GO:0030248	cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]
PGEN_.00g324500	Scaffold_16	24375523	24377052	Q4V8D1	CP2U1_RAT	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g324510	Scaffold_16	24382237	24407675	B1AZ99	OTUD3_MOUSE	OTU domain-containing protein 3 (EC 3.4.19.12)	GO:0004843; GO:0005737; GO:0035871; GO:0044313; GO:0050821; GO:0051898; GO:0071108; GO:1990167	cytoplasm [GO:0005737]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; negative regulation of protein kinase B signaling [GO:0051898]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K48-linked deubiquitination [GO:0071108]; protein K6-linked deubiquitination [GO:0044313]; protein stabilization [GO:0050821]
PGEN_.00g324520	Scaffold_16	24408513	24411095	NA	NA	NA	NA	NA
PGEN_.00g324530	Scaffold_16	24411719	24417209	Q5TGY1	TMCO4_HUMAN	Transmembrane and coiled-coil domain-containing protein 4	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g324540	Scaffold_16	24467866	24477914	NA	NA	NA	NA	NA
PGEN_.00g324550	Scaffold_16	24469999	24470875	NA	NA	NA	NA	NA
PGEN_.00g324560	Scaffold_16	24493468	24511162	Q9H3D4	P63_HUMAN	Tumor protein 63 (p63) (Chronic ulcerative stomatitis protein) (CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L) (p40) (p51)	GO:0000122; GO:0000790; GO:0000981; GO:0001228; GO:0001302; GO:0001501; GO:0001736; GO:0002039; GO:0002064; GO:0003677; GO:0003682; GO:0003684; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005791; GO:0006338; GO:0006915; GO:0006974; GO:0007219; GO:0007283; GO:0007499; GO:0008283; GO:0009954; GO:0010259; GO:0010481; GO:0010482; GO:0010838; GO:0030216; GO:0030425; GO:0030859; GO:0031069; GO:0032991; GO:0033147; GO:0035115; GO:0035116; GO:0036342; GO:0042475; GO:0042771; GO:0042802; GO:0042981; GO:0043281; GO:0043565; GO:0043589; GO:0044212; GO:0045617; GO:0045669; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048485; GO:0048807; GO:0050699; GO:0051289; GO:0051402; GO:0060197; GO:0060513; GO:0060529; GO:0061436; GO:0097371; GO:1900740; GO:1901796; GO:1902808; GO:1904674; GO:1904888; GO:2000271; GO:2000381; GO:2000773	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]"
PGEN_.00g324570	Scaffold_16	24511530	24524138	Q9P2S5	WRP73_HUMAN	WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene)	GO:0005737; GO:0005813; GO:0005814; GO:0030030; GO:0036064; GO:0090307; GO:1902857	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cell projection organization [GO:0030030]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]
PGEN_.00g324580	Scaffold_16	24603797	24626337	Q9WVM6	TLL2_MOUSE	Tolloid-like protein 2 (EC 3.4.24.-)	GO:0004222; GO:0005509; GO:0005576; GO:0007275; GO:0008270; GO:0030154; GO:0048632	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of skeletal muscle tissue growth [GO:0048632]
PGEN_.00g324590	Scaffold_16	24643179	24644411	NA	NA	NA	NA	NA
PGEN_.00g324600	Scaffold_16	24644936	24648416	Q6DCW1	GFI1B_XENLA	Zinc finger protein Gfi-1b (Growth factor independent protein 1B)	GO:0003677; GO:0005634; GO:0006325; GO:0007275; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; multicellular organism development [GO:0007275]
PGEN_.00g324610	Scaffold_16	24657198	24670309	NA	NA	NA	NA	NA
PGEN_.00g324620	Scaffold_16	24680246	24687548	Q2M2R8	PEX5_RAT	Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1)	GO:0000038; GO:0000268; GO:0001764; GO:0005052; GO:0005737; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007005; GO:0007006; GO:0007029; GO:0007031; GO:0008022; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0019899; GO:0021795; GO:0021895; GO:0031267; GO:0032991; GO:0040018; GO:0044255; GO:0045046; GO:0047485; GO:0048468; GO:0050905; GO:0051262; GO:1901094	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome targeting sequence binding [GO:0000268]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; cell development [GO:0048468]; cellular lipid metabolic process [GO:0044255]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; negative regulation of protein homotetramerization [GO:1901094]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, translocation [GO:0016561]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; very long-chain fatty acid metabolic process [GO:0000038]"
PGEN_.00g324630	Scaffold_16	24688550	24715432	P24802	PLOD1_CHICK	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)"	GO:0005506; GO:0008475; GO:0017185; GO:0030199; GO:0030867; GO:0031418; GO:0032963; GO:0046947	rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; hydroxylysine biosynthetic process [GO:0046947]; peptidyl-lysine hydroxylation [GO:0017185]
PGEN_.00g324640	Scaffold_16	24724175	24741810	Q2TBV5	TF2H2_BOVIN	General transcription factor IIH subunit 2 (General transcription factor IIH polypeptide 2)	GO:0000438; GO:0003676; GO:0005634; GO:0005675; GO:0006289; GO:0006357; GO:0006366; GO:0006468; GO:0008270	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleus [GO:0005634]; transcription factor TFIIH holo complex [GO:0005675]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g324650	Scaffold_16	24745245	24765810	Q2TBV5	TF2H2_BOVIN	General transcription factor IIH subunit 2 (General transcription factor IIH polypeptide 2)	GO:0000438; GO:0003676; GO:0005634; GO:0005675; GO:0006289; GO:0006357; GO:0006366; GO:0006468; GO:0008270	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleus [GO:0005634]; transcription factor TFIIH holo complex [GO:0005675]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]
PGEN_.00g324660	Scaffold_16	24785188	24820012	P24802	PLOD1_CHICK	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)"	GO:0005506; GO:0008475; GO:0017185; GO:0030199; GO:0030867; GO:0031418; GO:0032963; GO:0046947	rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; hydroxylysine biosynthetic process [GO:0046947]; peptidyl-lysine hydroxylation [GO:0017185]
PGEN_.00g324670	Scaffold_16	24826737	24828939	NA	NA	NA	NA	NA
PGEN_.00g324680	Scaffold_16	24857733	24861834	NA	NA	NA	NA	NA
PGEN_.00g324690	Scaffold_16	24861876	24864926	NA	NA	NA	NA	NA
PGEN_.00g324700	Scaffold_16	24956773	24959208	NA	NA	NA	NA	NA
PGEN_.00g324710	Scaffold_16	24968727	24970304	NA	NA	NA	NA	NA
PGEN_.00g324720	Scaffold_16	25042340	25042873	NA	NA	NA	NA	NA
PGEN_.00g324730	Scaffold_16	25064658	25072959	NA	NA	NA	NA	NA
PGEN_.00g324740	Scaffold_16	25077378	25080650	NA	NA	NA	NA	NA
PGEN_.00g324750	Scaffold_16	25080811	25091629	Q2YDW7	KMT5A_MOUSE	N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.-) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8)	GO:0000122; GO:0002039; GO:0003714; GO:0005654; GO:0005694; GO:0005829; GO:0007049; GO:0016279; GO:0018024; GO:0018026; GO:0043516; GO:0045892; GO:0051301	"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]"
PGEN_.00g324760	Scaffold_16	25091665	25099275	NA	NA	NA	NA	NA
PGEN_.00g324770	Scaffold_16	25107005	25107415	Q15797	SMAD1_HUMAN	Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (JV4-1) (Mad-related protein 1) (SMAD family member 1) (SMAD 1) (Smad1) (hSMAD1) (Transforming growth factor-beta-signaling protein 1) (BSP-1)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0007165; GO:0007179; GO:0007183; GO:0009880; GO:0010628; GO:0016021; GO:0016579; GO:0017151; GO:0019901; GO:0030509; GO:0030618; GO:0031053; GO:0032991; GO:0042802; GO:0045944; GO:0046872; GO:0060395; GO:0070410; GO:0070411; GO:0070878; GO:0071141; GO:1901522; GO:1903672	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; BMP signaling pathway [GO:0030509]; embryonic pattern specification [GO:0009880]; positive regulation of gene expression [GO:0010628]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; signal transduction [GO:0007165]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g324780	Scaffold_16	25167097	25175320	NA	NA	NA	NA	NA
PGEN_.00g324790	Scaffold_16	25193944	25202166	Q9UNL2	SSRG_HUMAN	Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma)	GO:0005783; GO:0005789; GO:0006614; GO:0016021	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]
PGEN_.00g324800	Scaffold_16	25207452	25213712	O43345	ZN208_HUMAN	Zinc finger protein 208 (Zinc finger protein 91-like)	GO:0003677; GO:0005634; GO:0006355; GO:0008270	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g324810	Scaffold_16	25220820	25229916	Q0E3L5	UREF_ORYSJ	Urease accessory protein F (AtUREF)	GO:0006807; GO:0016151	nickel cation binding [GO:0016151]; nitrogen compound metabolic process [GO:0006807]
PGEN_.00g324820	Scaffold_16	25236077	25246026	NA	NA	NA	NA	NA
PGEN_.00g324830	Scaffold_16	25246348	25250774	NA	NA	NA	NA	NA
PGEN_.00g324840	Scaffold_16	25250865	25251713	NA	NA	NA	NA	NA
PGEN_.00g324850	Scaffold_16	25252003	25252212	NA	NA	NA	NA	NA
PGEN_.00g324860	Scaffold_16	25272870	25283465	Q9DAA6	EXOS1_MOUSE	Exosome complex component CSL4 (Exosome component 1)	GO:0000176; GO:0000178; GO:0003723; GO:0005730; GO:0005737; GO:0006364; GO:0006396	cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]
PGEN_.00g324870	Scaffold_16	25293235	25293501	Q8X5T5	ACSA_ECO57	Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme)	GO:0003987; GO:0005524; GO:0006935; GO:0016208; GO:0019427; GO:0046872	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; chemotaxis [GO:0006935]
PGEN_.00g324880	Scaffold_16	25293526	25296681	P38135	FADK_ECOLI	Medium-chain fatty-acid--CoA ligase (EC 6.2.1.-) (Acyl-CoA synthetase) (ACS) (Fatty acyl-CoA synthetase FadK)	GO:0005524; GO:0005886; GO:0006635; GO:0031956	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid beta-oxidation [GO:0006635]
PGEN_.00g324890	Scaffold_16	25298607	25299011	NA	NA	NA	NA	NA
PGEN_.00g324900	Scaffold_16	25302712	25304839	O31826	YNGI_BACSU	Putative acyl-CoA synthetase YngI (EC 6.2.1.-)	GO:0005524; GO:0016874	ATP binding [GO:0005524]; ligase activity [GO:0016874]
PGEN_.00g324910	Scaffold_16	25306769	25309340	Q8VCW8	ACSF2_MOUSE	"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)"	GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; fatty acid metabolic process [GO:0006631]
PGEN_.00g324920	Scaffold_16	25318911	25325720	NA	NA	NA	NA	NA
PGEN_.00g324930	Scaffold_16	25373898	25374122	NA	NA	NA	NA	NA
PGEN_.00g324940	Scaffold_16	25390854	25401552	P14821	GLB2A_ANAIN	Globin-2 A chain (Globin II A chain) (HBII-A)	GO:0005344; GO:0019825; GO:0020037; GO:0046872	heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]
PGEN_.00g324950	Scaffold_16	25427447	25428328	NA	NA	NA	NA	NA
PGEN_.00g324960	Scaffold_16	25432203	25432550	NA	NA	NA	NA	NA
PGEN_.00g324970	Scaffold_16	25441690	25447191	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g324980	Scaffold_16	25454059	25490183	P21127	CD11B_HUMAN	Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1)	GO:0000278; GO:0001558; GO:0003723; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006468; GO:0006915; GO:0050684	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g324990	Scaffold_16	25499603	25511775	Q920P0	DCXR_RAT	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase)	GO:0004090; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016614; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289; GO:0055114	"brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g325000	Scaffold_16	25517568	25517906	NA	NA	NA	NA	NA
PGEN_.00g325010	Scaffold_16	25564558	25572119	NA	NA	NA	NA	NA
PGEN_.00g325020	Scaffold_16	25582552	25582788	NA	NA	NA	NA	NA
PGEN_.00g325030	Scaffold_16	25658729	25659121	NA	NA	NA	NA	NA
PGEN_.00g325040	Scaffold_16	25802250	25802498	NA	NA	NA	NA	NA
PGEN_.00g325050	Scaffold_16	25802835	25803134	NA	NA	NA	NA	NA
PGEN_.00g325060	Scaffold_16	25809300	25826909	NA	NA	NA	NA	NA
PGEN_.00g325070	Scaffold_16	25833721	25846215	Q8JIS3	DER_CHICK	D-erythrulose reductase (EC 1.1.1.162) (Probable L-xylulose reductase) (XR) (EC 1.1.1.10)	GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0047880; GO:0050038; GO:0051289	"cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g325080	Scaffold_16	25846252	25853412	NA	NA	NA	NA	NA
PGEN_.00g325090	Scaffold_16	25855966	25875432	Q6ZS10	CL17A_HUMAN	"C-type lectin domain family 17, member A (Prolectin)"	GO:0005537; GO:0009986; GO:0016021; GO:0042806; GO:0046872	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]
PGEN_.00g325100	Scaffold_16	25880082	25886098	Q2KIP7	MD2L2_BOVIN	Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2)	GO:0001558; GO:0005634; GO:0005737; GO:0005819; GO:0006302; GO:0007049; GO:0008432; GO:0016035; GO:0033138; GO:0042177; GO:0042772; GO:0045893; GO:0051301; GO:1904667	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035]; JUN kinase binding [GO:0008432]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]"
PGEN_.00g325110	Scaffold_16	25900952	25919250	P51788	CLCN2_HUMAN	Chloride channel protein 2 (ClC-2)	GO:0005247; GO:0005886; GO:0005887; GO:0032347; GO:0034220; GO:0034707; GO:0034765; GO:0060041; GO:0060689	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated chloride channel activity [GO:0005247]; cell differentiation involved in salivary gland development [GO:0060689]; ion transmembrane transport [GO:0034220]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of ion transmembrane transport [GO:0034765]; retina development in camera-type eye [GO:0060041]
PGEN_.00g325120	Scaffold_16	25919787	25940391	Q8K0L9	ZBT20_MOUSE	Zinc finger and BTB domain-containing protein 20 (BTB/POZ domain zinc finger factor HOF) (Zinc finger protein 288)	GO:0000122; GO:0000977; GO:0001227; GO:0003677; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0010629; GO:0016604; GO:0032728; GO:0032755; GO:0032760; GO:0044212; GO:0045821; GO:0045892; GO:0046872; GO:0046889; GO:0055088; GO:0071333	"cell [GO:0005623]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of tumor necrosis factor production [GO:0032760]"
PGEN_.00g325130	Scaffold_16	25943048	25943401	NA	NA	NA	NA	NA
PGEN_.00g325140	Scaffold_16	25947169	25948452	Q7Z449	CP2U1_HUMAN	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330; GO:0097267	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g325150	Scaffold_16	25966224	25991764	Q9W436	NEP_DROME	Neprilysin-1 (EC 3.4.24.11)	GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]
PGEN_.00g325160	Scaffold_16	25993627	26024118	P25942	TNR5_HUMAN	Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40)	GO:0001934; GO:0002768; GO:0003823; GO:0005623; GO:0005737; GO:0005886; GO:0005887; GO:0006874; GO:0006954; GO:0009897; GO:0009986; GO:0019899; GO:0019904; GO:0023035; GO:0030168; GO:0030890; GO:0031625; GO:0032735; GO:0033209; GO:0033590; GO:0034341; GO:0035631; GO:0036018; GO:0038023; GO:0042100; GO:0042531; GO:0042832; GO:0043025; GO:0043123; GO:0043196; GO:0043231; GO:0043406; GO:0043491; GO:0043536; GO:0043547; GO:0045766; GO:0045944; GO:0048304; GO:0050776; GO:0051023; GO:0051092; GO:0051607; GO:0065003; GO:0070062; GO:0071222; GO:0071260; GO:0071347; GO:0090037; GO:1901652; GO:2000353	CD40 receptor complex [GO:0035631]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; varicosity [GO:0043196]; antigen binding [GO:0003823]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; cellular calcium ion homeostasis [GO:0006874]; cellular response to erythropoietin [GO:0036018]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase B signaling [GO:0043491]; protein-containing complex assembly [GO:0065003]; regulation of immune response [GO:0050776]; regulation of immunoglobulin secretion [GO:0051023]; response to cobalamin [GO:0033590]; response to interferon-gamma [GO:0034341]; response to peptide [GO:1901652]; tumor necrosis factor-mediated signaling pathway [GO:0033209]
PGEN_.00g325170	Scaffold_16	26100831	26103459	NA	NA	NA	NA	NA
PGEN_.00g325180	Scaffold_16	26193101	26201342	NA	NA	NA	NA	NA
PGEN_.00g325190	Scaffold_16	26209624	26211384	Q15935	ZNF77_HUMAN	Zinc finger protein 77 (ZNFpT1)	GO:0003700; GO:0005634; GO:0043565; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]
PGEN_.00g325200	Scaffold_16	26212960	26213412	Q95ZS2	TDC1_CAEEL	Tyrosine decarboxylase (EC 4.1.1.25)	GO:0004837; GO:0005737; GO:0006520; GO:0006589; GO:0030170; GO:0030424; GO:0043025; GO:0043204	axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837]; cellular amino acid metabolic process [GO:0006520]; octopamine biosynthetic process [GO:0006589]
PGEN_.00g325210	Scaffold_16	26226238	26235976	Q17232	OAR_BOMMO	Octopamine receptor	GO:0004989; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; octopamine receptor activity [GO:0004989]
PGEN_.00g325220	Scaffold_16	26256727	26257344	Q6DBQ8	CPTP_DANRE	Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP)	GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0008289; GO:0010008; GO:0010507; GO:0035627; GO:0050713; GO:0120009; GO:1900226; GO:1902387; GO:1902388; GO:1902389	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]
PGEN_.00g325230	Scaffold_16	26266598	26267416	NA	NA	NA	NA	NA
PGEN_.00g325240	Scaffold_16	26272667	26280865	Q05481	ZNF91_HUMAN	Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10)	GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045892; GO:0070895	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]"
PGEN_.00g325250	Scaffold_16	26305076	26306284	Q9NP94	S39A2_HUMAN	Zinc transporter ZIP2 (6A1) (Eti-1) (Solute carrier family 39 member 2) (Zrt- and Irt-like protein 2) (ZIP-2) (hZIP2)	GO:0005385; GO:0005886; GO:0005887; GO:0006829; GO:0031410; GO:0036464; GO:0071577	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]
PGEN_.00g325260	Scaffold_16	26322456	26367906	O00461	GOLI4_HUMAN	"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)"	GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0010008; GO:0016020; GO:0016021; GO:0030133; GO:0030139; GO:0032580	cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]
PGEN_.00g325270	Scaffold_16	26404732	26440953	NA	NA	NA	NA	NA
PGEN_.00g325280	Scaffold_16	26447106	26448251	Q96SQ5	ZN587_HUMAN	Zinc finger protein 587	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g325290	Scaffold_16	26466846	26487338	Q14393	GAS6_HUMAN	Growth arrest-specific protein 6 (GAS-6) (AXL receptor tyrosine kinase ligand)	GO:0001764; GO:0001786; GO:0001934; GO:0001961; GO:0002576; GO:0003104; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005623; GO:0005737; GO:0005788; GO:0005796; GO:0006468; GO:0006888; GO:0006909; GO:0007050; GO:0007155; GO:0007165; GO:0007167; GO:0008283; GO:0009267; GO:0010628; GO:0010804; GO:0010934; GO:0016477; GO:0018105; GO:0019064; GO:0019079; GO:0030168; GO:0030296; GO:0030674; GO:0030971; GO:0031093; GO:0031100; GO:0031589; GO:0032008; GO:0032148; GO:0032689; GO:0032715; GO:0032720; GO:0032825; GO:0033138; GO:0035457; GO:0035690; GO:0035754; GO:0040008; GO:0043027; GO:0043066; GO:0043154; GO:0043277; GO:0043433; GO:0043491; GO:0043687; GO:0044267; GO:0045860; GO:0045892; GO:0046718; GO:0046813; GO:0046827; GO:0048018; GO:0048146; GO:0050711; GO:0050766; GO:0050900; GO:0051897; GO:0061098; GO:0070062; GO:0070168; GO:0070374; GO:0070527; GO:0070588; GO:0071307; GO:0071333; GO:0071363; GO:0072659; GO:0085029; GO:0097028; GO:0097241; GO:1900142; GO:1900165; GO:2000270; GO:2000352; GO:2000510; GO:2000533; GO:2000669	"cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; phosphatidylserine binding [GO:0001786]; protein binding, bridging [GO:0030674]; protein tyrosine kinase activator activity [GO:0030296]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; activation of protein kinase B activity [GO:0032148]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; B cell chemotaxis [GO:0035754]; calcium ion transmembrane transport [GO:0070588]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-substrate adhesion [GO:0031589]; cellular protein metabolic process [GO:0044267]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to interferon-alpha [GO:0035457]; cellular response to starvation [GO:0009267]; cellular response to vitamin K [GO:0071307]; dendritic cell differentiation [GO:0097028]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; enzyme linked receptor protein signaling pathway [GO:0007167]; extracellular matrix assembly [GO:0085029]; fusion of virus membrane with host plasma membrane [GO:0019064]; hematopoietic stem cell migration to bone marrow [GO:0097241]; leukocyte migration [GO:0050900]; macrophage cytokine production [GO:0010934]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 secretion [GO:0050711]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of oligodendrocyte apoptotic process [GO:1900142]; negative regulation of renal albumin absorption [GO:2000533]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of TOR signaling [GO:0032008]; post-translational protein modification [GO:0043687]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]"
PGEN_.00g325300	Scaffold_16	26494118	26500127	NA	NA	NA	NA	NA
PGEN_.00g325310	Scaffold_16	26511468	26532157	Q29RU9	SOX_BOVIN	Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase)	GO:0005777; GO:0008115; GO:0033514; GO:0046653; GO:0050031	peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; tetrahydrofolate metabolic process [GO:0046653]
PGEN_.00g325320	Scaffold_16	26538094	26539752	NA	NA	NA	NA	NA
PGEN_.00g325330	Scaffold_16	26543769	26546507	NA	NA	NA	NA	NA
PGEN_.00g325340	Scaffold_16	26546552	26561432	NA	NA	NA	NA	NA
PGEN_.00g325350	Scaffold_16	26581656	26597056	P22897	MRC1_HUMAN	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g325360	Scaffold_16	26611328	26628406	Q0E908	HIL_DROME	Hillarin (D-Hillarin) (D-hil)	GO:0005938; GO:0032154; GO:0046872	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872]
PGEN_.00g325370	Scaffold_16	26636256	26646297	P20693	FCER2_MOUSE	Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23)	GO:0002925; GO:0009897; GO:0016021; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]
PGEN_.00g325380	Scaffold_16	26671989	26679627	NA	NA	NA	NA	NA
PGEN_.00g325390	Scaffold_16	26708780	26710924	O96006	ZBED1_HUMAN	Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0005813; GO:0019789; GO:0031965; GO:0042802; GO:0043565; GO:0045944; GO:0046872; GO:0046983	"centrosome [GO:0005813]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SUMO transferase activity [GO:0019789]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g325400	Scaffold_16	26711063	26716744	Q9JHG1	PIGP_MOUSE	Phosphatidylinositol N-acetylglucosaminyltransferase subunit P (EC 2.4.1.198) (Down syndrome critical region protein 5 homolog) (Phosphatidylinositol-glycan biosynthesis class P protein) (PIG-P)	GO:0000506; GO:0005783; GO:0006506; GO:0016021; GO:0017176	endoplasmic reticulum [GO:0005783]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; GPI anchor biosynthetic process [GO:0006506]
PGEN_.00g325410	Scaffold_16	26739542	26758559	NA	NA	NA	NA	NA
PGEN_.00g325420	Scaffold_16	26820840	26832929	Q6UX40	TM107_HUMAN	Transmembrane protein 107	GO:0016021; GO:0021532; GO:0035869; GO:0036038; GO:0042733; GO:0060271; GO:1904491; GO:1905515	ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]
PGEN_.00g325430	Scaffold_16	26833296	26861780	O55029	COPB2_MOUSE	Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102)	GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:1901998	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"
PGEN_.00g325440	Scaffold_16	26867225	26900313	Q9YHY6	CND1_XENLA	Condensin complex subunit 1 (Chromosome assembly protein XCAP-D2) (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (Eg7) (Non-SMC condensin I complex subunit D2)	GO:0005634; GO:0005694; GO:0005829; GO:0007076; GO:0051301	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]
PGEN_.00g325450	Scaffold_16	26906956	26926273	Q8MP06	SNO1_TYRJA	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	GO:0004499; GO:0005576; GO:0009820; GO:0033784; GO:0050660; GO:0050661; GO:0051289; GO:0055114	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
PGEN_.00g325460	Scaffold_16	26930462	26938755	O76075	DFFB_HUMAN	DNA fragmentation factor subunit beta (EC 3.-.-.-) (Caspase-activated deoxyribonuclease) (CAD) (Caspase-activated DNase) (Caspase-activated nuclease) (CPAN) (DNA fragmentation factor 40 kDa subunit) (DFF-40)	GO:0000790; GO:0004536; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006308; GO:0006309; GO:0019899; GO:0019904; GO:0030263; GO:0042802; GO:0051260; GO:0097718	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; protein homooligomerization [GO:0051260]
PGEN_.00g325470	Scaffold_16	26946710	26958031	Q8BLQ7	CTR4_MOUSE	Cationic amino acid transporter 4 (CAT-4) (CAT4) (Solute carrier family 7 member 4)	GO:0006865; GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]
PGEN_.00g325480	Scaffold_16	26965591	26977403	NA	NA	NA	NA	NA
PGEN_.00g325490	Scaffold_16	26981916	26982695	P41932	14331_CAEEL	14-3-3-like protein 1 (Partitioning defective protein 5)	GO:0000003; GO:0000132; GO:0001708; GO:0005623; GO:0005634; GO:0005737; GO:0005938; GO:0006611; GO:0007346; GO:0008340; GO:0009792; GO:0009949; GO:0010070; GO:0010286; GO:0019904; GO:0030590; GO:0035046; GO:0045167; GO:0051321	cell [GO:0005623]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; asymmetric protein localization involved in cell fate determination [GO:0045167]; cell fate specification [GO:0001708]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of mitotic spindle orientation [GO:0000132]; first cell cycle pseudocleavage [GO:0030590]; heat acclimation [GO:0010286]; meiotic cell cycle [GO:0051321]; polarity specification of anterior/posterior axis [GO:0009949]; pronuclear migration [GO:0035046]; protein export from nucleus [GO:0006611]; regulation of mitotic cell cycle [GO:0007346]; reproduction [GO:0000003]; zygote asymmetric cell division [GO:0010070]
PGEN_.00g325500	Scaffold_16	26992928	26993674	Q91X52	DCXR_MOUSE	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase)	GO:0004090; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016324; GO:0016614; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289; GO:0055114	"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; microvillus [GO:0005902]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g325510	Scaffold_16	26997171	27015087	P21783	NOTC1_XENLA	Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]
PGEN_.00g325520	Scaffold_16	27017827	27018910	NA	NA	NA	NA	NA
PGEN_.00g325530	Scaffold_16	27024377	27039970	Q25464	FP2_MYTGA	Adhesive plaque matrix protein 2 (Foot protein 2) (MGFP-2) (MGFP2)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g325540	Scaffold_16	27044858	27070401	O35516	NOTC2_MOUSE	Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]	GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005929; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0072602; GO:1990705; GO:2000249; GO:2001204	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060]
PGEN_.00g325550	Scaffold_16	27076713	27102021	NA	NA	NA	NA	NA
PGEN_.00g325560	Scaffold_16	27106682	27122718	Q8TER0	SNED1_HUMAN	"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)"	GO:0005112; GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160]
PGEN_.00g325570	Scaffold_16	27122765	27126432	NA	NA	NA	NA	NA
PGEN_.00g325580	Scaffold_16	27128705	27179338	P46530	NOTC1_DANRE	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0016021; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor-mediated endocytosis [GO:0048259]; regulation of transcription, DNA-templated [GO:0006355]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514]"
PGEN_.00g325590	Scaffold_16	27184572	27207377	Q5ZQU0	SNED1_RAT	"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)"	GO:0005112; GO:0005509; GO:0005576; GO:0007160	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160]
PGEN_.00g325600	Scaffold_16	27218998	27249055	Q99466	NOTC4_HUMAN	Neurogenic locus notch homolog protein 4 (Notch 4) (hNotch4) [Cleaved into: Notch 4 extracellular truncation; Notch 4 intracellular domain]	GO:0000139; GO:0001569; GO:0001709; GO:0001763; GO:0001886; GO:0001944; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0006367; GO:0007221; GO:0009986; GO:0030097; GO:0030154; GO:0030879; GO:0035278; GO:0038023; GO:0042060; GO:0045596; GO:0045602; GO:0045747; GO:0045893; GO:0046982	"cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; endothelial cell morphogenesis [GO:0001886]; hemopoiesis [GO:0030097]; mammary gland development [GO:0030879]; miRNA mediated inhibition of translation [GO:0035278]; morphogenesis of a branching structure [GO:0001763]; negative regulation of cell differentiation [GO:0045596]; negative regulation of endothelial cell differentiation [GO:0045602]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription initiation from RNA polymerase II promoter [GO:0006367]; vasculature development [GO:0001944]; wound healing [GO:0042060]"
PGEN_.00g325610	Scaffold_16	27264252	27281429	NA	NA	NA	NA	NA
PGEN_.00g325620	Scaffold_16	27286492	27305068	P21783	NOTC1_XENLA	Neurogenic locus notch homolog protein 1 (Notch 1) (xOTCH) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0000122; GO:0001525; GO:0005509; GO:0005654; GO:0005886; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]
PGEN_.00g325630	Scaffold_16	27305360	27320507	D3Z902	FBXW7_RAT	F-box/WD repeat-containing protein 7	GO:0001570; GO:0005623; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045741; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0051443; GO:0070374; GO:0090049; GO:0097027; GO:1901800; GO:1903026; GO:1903146; GO:1903378; GO:1903955; GO:1990452; GO:2000060; GO:2001205	"cell [GO:0005623]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein binding, bridging [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570]"
PGEN_.00g325640	Scaffold_16	27320769	27333703	Q5PQS0	PKHM1_RAT	Pleckstrin homology domain-containing family M member 1 (PH domain-containing family M member 1)	GO:0005730; GO:0005765; GO:0006914; GO:0010008; GO:0015031; GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029	endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]; protein transport [GO:0015031]
PGEN_.00g325650	Scaffold_16	27347180	27351783	Q91XV4	DCXR_MESAU	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g325660	Scaffold_16	27355579	27357112	Q91XV4	DCXR_MESAU	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g325670	Scaffold_16	27364933	27367321	Q8I7P9	POL5_DROME	Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074	"nucleus [GO:0005634]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; peptidase activity [GO:0008233]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g325680	Scaffold_16	27373888	27375409	Q91XV4	DCXR_MESAU	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)	GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289	"acrosomal vesicle [GO:0001669]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; microvillus [GO:0005902]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g325690	Scaffold_16	27393284	27401698	Q91X52	DCXR_MOUSE	L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase)	GO:0004090; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016324; GO:0016614; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0050038; GO:0051289; GO:0055114	"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; microvillus [GO:0005902]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g325700	Scaffold_16	27401873	27402154	Q8JIS3	DER_CHICK	D-erythrulose reductase (EC 1.1.1.162) (Probable L-xylulose reductase) (XR) (EC 1.1.1.10)	GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0047880; GO:0050038; GO:0051289	"cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g325710	Scaffold_16	27405448	27418283	Q8JIS3	DER_CHICK	D-erythrulose reductase (EC 1.1.1.162) (Probable L-xylulose reductase) (XR) (EC 1.1.1.10)	GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016655; GO:0042732; GO:0042802; GO:0044105; GO:0047880; GO:0050038; GO:0051289	"cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997]"
PGEN_.00g325720	Scaffold_16	27423769	27447961	Q0V9R3	DI3L2_XENTR	DIS3-like exonuclease 2 (EC 3.1.13.-)	GO:0000175; GO:0000178; GO:0000291; GO:0000932; GO:0003723; GO:0005737; GO:0007049; GO:0010587; GO:0019827; GO:0034427; GO:0046872; GO:0051301; GO:1990074	"cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827]"
PGEN_.00g325730	Scaffold_16	27460172	27471186	NA	NA	NA	NA	NA
PGEN_.00g325740	Scaffold_16	27495243	27521871	Q0IIF0	ILKAP_BOVIN	Integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP) (EC 3.1.3.16)	GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:0046872	cytosol [GO:0005829]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]
PGEN_.00g325750	Scaffold_16	27532186	27549793	NA	NA	NA	NA	NA
PGEN_.00g325760	Scaffold_16	27549900	27559506	NA	NA	NA	NA	NA
PGEN_.00g325770	Scaffold_16	27565768	27568303	Q92982	NINJ1_HUMAN	Ninjurin-1 (Nerve injury-induced protein 1)	GO:0001954; GO:0007155; GO:0007399; GO:0016021; GO:0042246; GO:1990384	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; hyaloid vascular plexus regression [GO:1990384]; nervous system development [GO:0007399]; positive regulation of cell-matrix adhesion [GO:0001954]; tissue regeneration [GO:0042246]
PGEN_.00g325780	Scaffold_16	27574742	27575866	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g325790	Scaffold_16	27596917	27602818	NA	NA	NA	NA	NA
PGEN_.00g325800	Scaffold_16	27667382	27668353	NA	NA	NA	NA	NA
PGEN_.00g325810	Scaffold_16	27673377	27687958	NA	NA	NA	NA	NA
PGEN_.00g325820	Scaffold_16	27712386	27768563	O57472	CHRD_DANRE	Chordin (Protein chordino)	GO:0001756; GO:0001947; GO:0003143; GO:0005576; GO:0007368; GO:0009948; GO:0009953; GO:0010159; GO:0030514; GO:0035143; GO:0035162; GO:0043049; GO:0048264; GO:0060030; GO:0061371; GO:0070121; GO:2000223	extracellular region [GO:0005576]; anterior/posterior axis specification [GO:0009948]; caudal fin morphogenesis [GO:0035143]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; determination of ventral identity [GO:0048264]; dorsal convergence [GO:0060030]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; embryonic hemopoiesis [GO:0035162]; heart looping [GO:0001947]; Kupffer's vesicle development [GO:0070121]; negative regulation of BMP signaling pathway [GO:0030514]; otic placode formation [GO:0043049]; regulation of BMP signaling pathway involved in heart jogging [GO:2000223]; somitogenesis [GO:0001756]; specification of animal organ position [GO:0010159]
PGEN_.00g325830	Scaffold_16	27785498	27805008	Q8ISH7	FCAP_APLCA	Feeding circuit activating peptides (FCAP) [Cleaved into: Feeding circuit activating peptide a (FCAPa); Feeding circuit activating peptide b (FCAPb); Feeding circuit activating peptide c (FCAPc); Feeding circuit activating peptide d (FCAPd); Feeding circuit activating peptide e (FCAPe); Feeding circuit activating peptide f (FCAPf); Feeding circuit activating peptide g (FCAPg); Feeding circuit activating peptide h (FCAPh)]	GO:0005184; GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g325840	Scaffold_16	27808425	27808814	NA	NA	NA	NA	NA
PGEN_.00g325850	Scaffold_16	27828500	27835726	NA	NA	NA	NA	NA
PGEN_.00g325860	Scaffold_16	27905441	27905674	NA	NA	NA	NA	NA
PGEN_.00g325870	Scaffold_16	27945164	27946504	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g325880	Scaffold_16	27951504	27953417	NA	NA	NA	NA	NA
PGEN_.00g325890	Scaffold_16	27953732	27956143	NA	NA	NA	NA	NA
PGEN_.00g325900	Scaffold_16	27999167	27999799	Q9DD78	TLR21_CHICK	Toll-like receptor 2 type-1	GO:0002224; GO:0002237; GO:0002755; GO:0005886; GO:0005887; GO:0006954; GO:0031226; GO:0034134; GO:0045087; GO:0050707; GO:0050729	integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; response to molecule of bacterial origin [GO:0002237]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g325910	Scaffold_16	28085222	28087854	P49446	PTPRE_MOUSE	Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48)	GO:0004725; GO:0005634; GO:0005737; GO:0005886; GO:0006470; GO:0007185; GO:0016021; GO:0033003; GO:0042803; GO:0046627	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]
PGEN_.00g325920	Scaffold_16	28118452	28118781	NA	NA	NA	NA	NA
PGEN_.00g325930	Scaffold_16	28122536	28143630	P29351	PTN6_MOUSE	Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (70Z-SHP) (Hematopoietic cell protein-tyrosine phosphatase) (PTPTY-42) (Protein-tyrosine phosphatase 1C) (PTP-1C) (SH-PTP1) (SHP-1)	GO:0001784; GO:0002244; GO:0002924; GO:0004725; GO:0005001; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005911; GO:0006470; GO:0008283; GO:0008284; GO:0014068; GO:0017124; GO:0018108; GO:0019221; GO:0019901; GO:0030154; GO:0030220; GO:0032715; GO:0032720; GO:0032991; GO:0033277; GO:0033630; GO:0035335; GO:0035556; GO:0035855; GO:0042105; GO:0042130; GO:0042169; GO:0042267; GO:0043407; GO:0043409; GO:0045577; GO:0046703; GO:0050732; GO:0050839; GO:0050853; GO:0050860; GO:0051279; GO:0070372; GO:0070527; GO:0140031; GO:2000045	alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cell adhesion molecule binding [GO:0050839]; natural killer cell lectin-like receptor binding [GO:0046703]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; abortive mitotic cell cycle [GO:0033277]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cytokine-mediated signaling pathway [GO:0019221]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; megakaryocyte development [GO:0035855]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein dephosphorylation [GO:0006470]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]
PGEN_.00g325940	Scaffold_16	28160269	28185870	Q8BZ20	PAR12_MOUSE	Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)	GO:0003950; GO:0005634; GO:0046872; GO:0070213; GO:0140289; GO:1990404	nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]
PGEN_.00g325950	Scaffold_16	28238844	28307730	Q06124	PTN11_HUMAN	Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3)	GO:0000077; GO:0000187; GO:0001784; GO:0004721; GO:0004725; GO:0004726; GO:0005070; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006641; GO:0007173; GO:0007229; GO:0007411; GO:0007420; GO:0007507; GO:0008543; GO:0009755; GO:0019221; GO:0019901; GO:0019904; GO:0021697; GO:0030168; GO:0030220; GO:0030971; GO:0031295; GO:0031748; GO:0032528; GO:0032728; GO:0032755; GO:0032760; GO:0032991; GO:0033277; GO:0033628; GO:0033629; GO:0035264; GO:0035265; GO:0035335; GO:0035855; GO:0036302; GO:0038127; GO:0042445; GO:0042593; GO:0043254; GO:0043274; GO:0043560; GO:0045296; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048609; GO:0048806; GO:0048839; GO:0048873; GO:0050731; GO:0050839; GO:0050900; GO:0051428; GO:0051463; GO:0051897; GO:0060020; GO:0060125; GO:0060325; GO:0060338; GO:0061582; GO:0070102; GO:0070374; GO:0071260; GO:0071345; GO:0071364; GO:1990782	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; D1 dopamine receptor binding [GO:0031748]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phospholipase binding [GO:0043274]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; SH3/SH2 adaptor activity [GO:0005070]; abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to cytokine stimulus [GO:0071345]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to mechanical stimulus [GO:0071260]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell migration [GO:0061582]; leukocyte migration [GO:0050900]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet activation [GO:0030168]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein complex assembly [GO:0043254]; regulation of protein export from nucleus [GO:0046825]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]
PGEN_.00g325960	Scaffold_16	28328733	28334440	NA	NA	NA	NA	NA
PGEN_.00g325970	Scaffold_16	28341065	28416100	P49338	WNT4_XENLA	Protein Wnt-4 (XWnt-4)	GO:0005102; GO:0005576; GO:0009880; GO:0016055; GO:0039018; GO:0039020; GO:0072013	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; embryonic pattern specification [GO:0009880]; glomus development [GO:0072013]; nephrostome development [GO:0039018]; pronephric nephron tubule development [GO:0039020]; Wnt signaling pathway [GO:0016055]
PGEN_.00g325980	Scaffold_16	28442185	28455066	A1L258	D2HDH_DANRE	"D-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.-)"	GO:0005739; GO:0016491; GO:0071949	mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]
PGEN_.00g325990	Scaffold_16	28465789	28467285	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g326000	Scaffold_16	28472496	28474931	NA	NA	NA	NA	NA
PGEN_.00g326010	Scaffold_16	28476011	28477552	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g326020	Scaffold_16	28497160	28516668	Q9JLI3	MMEL1_MOUSE	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) (Neprilysin-like 1) (NL-1) (Neprilysin-like peptidase) (NEPLP) (Soluble secreted endopeptidase) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	GO:0004175; GO:0004222; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0008270; GO:0016020; GO:0016021	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g326030	Scaffold_16	28528294	28559348	Q9W436	NEP_DROME	Neprilysin-1 (EC 3.4.24.11)	GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]
PGEN_.00g326040	Scaffold_16	28564086	28583989	P0C1T0	MMEL1_RAT	"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]"	GO:0004175; GO:0004222; GO:0005615; GO:0005783; GO:0005794; GO:0006508; GO:0008270; GO:0016020; GO:0016021	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]
PGEN_.00g326050	Scaffold_16	28586259	28590593	Q9H299	SH3L3_HUMAN	SH3 domain-binding glutamic acid-rich-like protein 3 (SH3 domain-binding protein 1) (SH3BP-1)	GO:0005623; GO:0005737; GO:0009055; GO:0015035; GO:0016604; GO:0045454; GO:0070062	cell [GO:0005623]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]
PGEN_.00g326060	Scaffold_16	28614138	28616360	NA	NA	NA	NA	NA
PGEN_.00g326070	Scaffold_16	28622353	28656089	Q5U249	ELYS_XENLA	Protein ELYS (Protein MEL-28) (xELYS)	GO:0003677; GO:0005643; GO:0005654; GO:0005737; GO:0015031; GO:0051028	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA transport [GO:0051028]; protein transport [GO:0015031]
PGEN_.00g326080	Scaffold_16	28626678	28627715	NA	NA	NA	NA	NA
PGEN_.00g326090	Scaffold_16	28630237	28630839	NA	NA	NA	NA	NA
PGEN_.00g326100	Scaffold_16	28657611	28661150	NA	NA	NA	NA	NA
PGEN_.00g326110	Scaffold_16	28672577	28690570	Q5U249	ELYS_XENLA	Protein ELYS (Protein MEL-28) (xELYS)	GO:0003677; GO:0005643; GO:0005654; GO:0005737; GO:0015031; GO:0051028	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA transport [GO:0051028]; protein transport [GO:0015031]
PGEN_.00g326120	Scaffold_16	28702385	28703143	NA	NA	NA	NA	NA
PGEN_.00g326130	Scaffold_16	28705421	28719862	Q5SXM1	ZN678_HUMAN	Zinc finger protein 678	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g326140	Scaffold_16	28806680	28808290	NA	NA	NA	NA	NA
PGEN_.00g326150	Scaffold_16	28863972	28883070	Q8MP06	SNO1_TYRJA	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	GO:0004499; GO:0005576; GO:0009820; GO:0033784; GO:0050660; GO:0050661; GO:0051289; GO:0055114	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
PGEN_.00g326160	Scaffold_16	28896776	28897027	P0CT34	TF21_SCHPO	Transposon Tf2-1 polyprotein (Retrotransposable element Tf2 155 kDa protein)	GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0015074; GO:0046872	nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]
PGEN_.00g326170	Scaffold_16	28910674	28917228	O43704	ST1B1_HUMAN	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (Sulfotransferase 1B2) (ST1B2) (Thyroid hormone sulfotransferase)	GO:0004062; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cellular biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g326180	Scaffold_16	28923007	28936885	O43704	ST1B1_HUMAN	Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (Sulfotransferase 1B2) (ST1B2) (Thyroid hormone sulfotransferase)	GO:0004062; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0008202; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cellular biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g326190	Scaffold_16	28946550	28948700	P0DMN0	ST1A4_HUMAN	Sulfotransferase 1A4 (ST1A4) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Sulfotransferase 1A3/1A4)	GO:0004062; GO:0005829; GO:0006584; GO:0008202; GO:0050427	cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]
PGEN_.00g326200	Scaffold_16	28955683	28956768	NA	NA	NA	NA	NA
PGEN_.00g326210	Scaffold_16	28962330	28967274	NA	NA	NA	NA	NA
PGEN_.00g326220	Scaffold_16	28974261	28977550	NA	NA	NA	NA	NA
PGEN_.00g326230	Scaffold_16	28987862	28990751	NA	NA	NA	NA	NA
PGEN_.00g326240	Scaffold_16	28992416	29002523	Q8NBI5	S43A3_HUMAN	Solute carrier family 43 member 3 (Protein FOAP-13)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g326250	Scaffold_16	29012177	29026845	Q8NBI5	S43A3_HUMAN	Solute carrier family 43 member 3 (Protein FOAP-13)	GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]
PGEN_.00g326260	Scaffold_16	29032136	29032402	NA	NA	NA	NA	NA
PGEN_.00g326270	Scaffold_16	29036015	29049629	NA	NA	NA	NA	NA
PGEN_.00g326280	Scaffold_16	29057382	29064061	O12947	ICMT_XENLA	Protein-S-isoprenylcysteine O-methyltransferase (EC 2.1.1.100) (Farnesyl cysteine carboxyl methyltransferase) (FCMT) (Isoprenylcysteine carboxylmethyltransferase) (Prenylated protein carboxyl methyltransferase) (PPMT) (Prenylcysteine carboxyl methyltransferase) (pcCMT)	GO:0004671; GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO:0004671]
PGEN_.00g326290	Scaffold_16	29074819	29077826	Q90Z12	HES4A_XENLA	Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a)	GO:0000122; GO:0002088; GO:0005634; GO:0008283; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell population proliferation [GO:0008283]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501]"
PGEN_.00g326300	Scaffold_16	29136289	29138693	Q90Z12	HES4A_XENLA	Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a)	GO:0000122; GO:0002088; GO:0005634; GO:0008283; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell population proliferation [GO:0008283]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501]"
PGEN_.00g326310	Scaffold_16	29179427	29180188	Q6IRB2	HES1A_XENLA	Transcription factor HES-1-A (Hairy and enhancer of split 1-A) (Protein hairy-1) (Xhairy-1) (Xhairy1) (Xlh1)	GO:0000122; GO:0005634; GO:0007219; GO:0007275; GO:0043425; GO:0043565; GO:0045892; GO:0046982; GO:0048635	"nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]"
PGEN_.00g326320	Scaffold_16	29180962	29182622	Q3ZBG4	HES1_BOVIN	Transcription factor HES-1 (Hairy and enhancer of split 1)	GO:0000122; GO:0000977; GO:0001227; GO:0001889; GO:0003143; GO:0003266; GO:0005634; GO:0005654; GO:0005737; GO:0007155; GO:0007219; GO:0007224; GO:0009952; GO:0016477; GO:0021537; GO:0021555; GO:0021557; GO:0021558; GO:0021575; GO:0021861; GO:0021984; GO:0030154; GO:0030324; GO:0030513; GO:0030901; GO:0031016; GO:0035019; GO:0035910; GO:0042102; GO:0042531; GO:0042803; GO:0042826; GO:0043388; GO:0043565; GO:0045598; GO:0045608; GO:0045665; GO:0045747; GO:0045892; GO:0045944; GO:0045977; GO:0046331; GO:0046425; GO:0046427; GO:0048469; GO:0048538; GO:0048667; GO:0048711; GO:0048715; GO:0050678; GO:0050767; GO:0051087; GO:0060122; GO:0060164; GO:0060253; GO:0060412; GO:0060675; GO:0060716; GO:0061009; GO:0061106; GO:0061309; GO:0061626; GO:0065003; GO:0070888; GO:0071820; GO:0072012; GO:0072049; GO:0072050; GO:0072141; GO:0072282; GO:0090102; GO:0090162; GO:0097084; GO:0097150; GO:1905934; GO:2000227; GO:2000737; GO:2000974; GO:2000978	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adenohypophysis development [GO:0021984]; anterior/posterior pattern specification [GO:0009952]; ascending aorta morphogenesis [GO:0035910]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cochlea development [GO:0090102]; comma-shaped body morphogenesis [GO:0072049]; common bile duct development [GO:0061009]; embryonic heart tube morphogenesis [GO:0003143]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glomerulus vasculature development [GO:0072012]; hindbrain morphogenesis [GO:0021575]; inner ear receptor cell stereocilium organization [GO:0060122]; labyrinthine layer blood vessel development [GO:0060716]; lateral inhibition [GO:0046331]; liver development [GO:0001889]; lung development [GO:0030324]; metanephric nephron tubule morphogenesis [GO:0072282]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of cell fate determination [GO:1905934]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pancreatic A cell differentiation [GO:2000227]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of stomach neuroendocrine cell differentiation [GO:0061106]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oculomotor nerve development [GO:0021557]; pancreas development [GO:0031016]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA binding [GO:0043388]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fat cell differentiation [GO:0045598]; regulation of neurogenesis [GO:0050767]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of timing of neuron differentiation [GO:0060164]; renal interstitial fibroblast development [GO:0072141]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; telencephalon development [GO:0021537]; thymus development [GO:0048538]; trochlear nerve development [GO:0021558]; ureteric bud morphogenesis [GO:0060675]; vascular smooth muscle cell development [GO:0097084]; ventricular septum morphogenesis [GO:0060412]"
PGEN_.00g326330	Scaffold_16	29194054	29195964	NA	NA	NA	NA	NA
PGEN_.00g326340	Scaffold_16	29220757	29232890	NA	NA	NA	NA	NA
PGEN_.00g326350	Scaffold_16	29285146	29290336	NA	NA	NA	NA	NA
PGEN_.00g326360	Scaffold_16	29294814	29297507	NA	NA	NA	NA	NA
PGEN_.00g326370	Scaffold_16	29305379	29305657	NA	NA	NA	NA	NA
PGEN_.00g326380	Scaffold_16	29307519	29311502	Q14D04	MELT_HUMAN	Ventricular zone-expressed PH domain-containing protein homolog 1 (Protein melted)	GO:0005886; GO:0030512; GO:0060392	plasma membrane [GO:0005886]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]
PGEN_.00g326390	Scaffold_16	29311548	29325616	Q5RF36	CIAO3_PONAB	Cytosolic iron-sulfur assembly component 3 (Cytosolic Fe-S cluster assembly factor NARFL) (Iron-only hydrogenase-like protein 1) (IOP1) (Nuclear prelamin A recognition factor-like protein)	GO:0016226; GO:0046872; GO:0051539; GO:0097361	"CIA complex [GO:0097361]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"
PGEN_.00g326400	Scaffold_16	29326129	29328185	NA	NA	NA	NA	NA
PGEN_.00g326410	Scaffold_16	29353030	29353293	Q9QUK6	TLR4_MOUSE	Toll-like receptor 4 (CD antigen CD284)	GO:0000187; GO:0001530; GO:0001726; GO:0001774; GO:0001875; GO:0001891; GO:0002218; GO:0002224; GO:0002322; GO:0002537; GO:0002730; GO:0002755; GO:0002758; GO:0005102; GO:0005737; GO:0005769; GO:0005794; GO:0005886; GO:0005887; GO:0006691; GO:0006909; GO:0006954; GO:0006979; GO:0007250; GO:0007252; GO:0009617; GO:0009897; GO:0009986; GO:0010572; GO:0010628; GO:0010838; GO:0014002; GO:0030890; GO:0031226; GO:0031663; GO:0032496; GO:0032497; GO:0032609; GO:0032689; GO:0032700; GO:0032707; GO:0032715; GO:0032720; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032732; GO:0032733; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0032874; GO:0034142; GO:0035666; GO:0042116; GO:0042535; GO:0042742; GO:0042802; GO:0043032; GO:0043065; GO:0043123; GO:0043235; GO:0043388; GO:0043548; GO:0045084; GO:0045087; GO:0045348; GO:0045359; GO:0045362; GO:0045368; GO:0045410; GO:0045416; GO:0045429; GO:0045471; GO:0045576; GO:0045944; GO:0046330; GO:0046696; GO:0046982; GO:0048471; GO:0050671; GO:0050702; GO:0050718; GO:0050727; GO:0050729; GO:0050731; GO:0050829; GO:0050965; GO:0050966; GO:0051091; GO:0051092; GO:0051770; GO:0051930; GO:0060729; GO:0060907; GO:0070373; GO:0070374; GO:0070430; GO:0070434; GO:0070542; GO:0071222; GO:0071223; GO:0071260; GO:0071346; GO:0120163; GO:0140052; GO:1900017; GO:1900227; GO:1901224; GO:1903223; GO:1903428; GO:1903974; GO:1904209; GO:1904466; GO:1904467; GO:1904646; GO:2000484; GO:2000778	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; lipopolysaccharide receptor complex [GO:0046696]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein heterodimerization activity [GO:0046982]; signaling receptor binding [GO:0005102]; activation of innate immune response [GO:0002218]; activation of MAPK activity [GO:0000187]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; astrocyte development [GO:0014002]; B cell proliferation involved in immune response [GO:0002322]; cellular response to amyloid-beta [GO:1904646]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; detection of lipopolysaccharide [GO:0032497]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response-activating signal transduction [GO:0002758]; interferon-gamma production [GO:0032609]; interleukin-1 beta secretion [GO:0050702]; intestinal epithelial structure maintenance [GO:0060729]; leukotriene metabolic process [GO:0006691]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation [GO:0042116]; mast cell activation [GO:0045576]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-23 production [GO:0032707]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide production involved in inflammatory response [GO:0002537]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular response to macrophage colony-stimulating factor stimulus [GO:1903974]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta biosynthetic process [GO:0045359]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-1 biosynthetic process [GO:0045362]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 biosynthetic process [GO:0045084]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-13 biosynthetic process [GO:0045368]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 biosynthetic process [GO:0045416]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of JNK cascade [GO:0046330]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet activation [GO:0010572]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of dendritic cell cytokine production [GO:0002730]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of tumor necrosis factor secretion [GO:1904467]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]
PGEN_.00g326420	Scaffold_16	29376044	29377519	Q8SWR3	SPR_DROME	Sex peptide receptor	GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0048042	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042]"
PGEN_.00g326430	Scaffold_16	29392847	29393065	NA	NA	NA	NA	NA
PGEN_.00g326440	Scaffold_16	29499588	29502509	NA	NA	NA	NA	NA
PGEN_.00g326450	Scaffold_16	29543086	29565945	P31422	GRM3_RAT	Metabotropic glutamate receptor 3 (mGluR3)	GO:0001641; GO:0005246; GO:0005886; GO:0005887; GO:0007216; GO:0008066; GO:0014069; GO:0019233; GO:0030424; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097449; GO:0098978; GO:0099055; GO:0099056	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]"
PGEN_.00g326460	Scaffold_16	29570264	29571309	NA	NA	NA	NA	NA
PGEN_.00g326470	Scaffold_16	29572444	29585355	NA	NA	NA	NA	NA
PGEN_.00g326480	Scaffold_16	29611067	29633827	NA	NA	NA	NA	NA
PGEN_.00g326490	Scaffold_16	29640853	29649137	O35129	PHB2_MOUSE	Prohibitin-2 (B-cell receptor-associated protein BAP37) (Repressor of estrogen receptor activity)	GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0006606; GO:0007005; GO:0007062; GO:0008022; GO:0009611; GO:0009986; GO:0014069; GO:0016363; GO:0030424; GO:0031536; GO:0032991; GO:0033147; GO:0033218; GO:0033600; GO:0043066; GO:0043433; GO:0045892; GO:0046625; GO:0047485; GO:0048786; GO:0050821; GO:0051091; GO:0060744; GO:0060749; GO:0060762; GO:0070374; GO:0071300; GO:0071456; GO:0071944; GO:0098978; GO:0098982; GO:1902808; GO:1904959	"axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; amide binding [GO:0033218]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; sphingolipid binding [GO:0046625]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cytochrome-c oxidase activity [GO:1904959]; response to wounding [GO:0009611]; sister chromatid cohesion [GO:0007062]"
PGEN_.00g326500	Scaffold_16	29651572	29658721	NA	NA	NA	NA	NA
PGEN_.00g326510	Scaffold_16	29661366	29673861	Q64674	SPEE_MOUSE	Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase)	GO:0004766; GO:0006596; GO:0008295; GO:0042802; GO:0042803; GO:1990830	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; spermidine biosynthetic process [GO:0008295]
PGEN_.00g326520	Scaffold_16	29742464	29754762	Q4R6C2	ZN383_MACFA	Zinc finger protein 383	GO:0003677; GO:0005654; GO:0005737; GO:0006355; GO:0031965; GO:0046872	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g326530	Scaffold_16	29759009	29781164	NA	NA	NA	NA	NA
PGEN_.00g326540	Scaffold_16	29823781	29866890	NA	NA	NA	NA	NA
PGEN_.00g326550	Scaffold_16	29869528	29869779	NA	NA	NA	NA	NA
PGEN_.00g326560	Scaffold_16	29883388	29884617	NA	NA	NA	NA	NA
PGEN_.00g326570	Scaffold_16	29897721	29903128	O94985	CSTN1_HUMAN	Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)]	GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005576; GO:0005634; GO:0005789; GO:0007155; GO:0007156; GO:0009986; GO:0019894; GO:0030054; GO:0042988; GO:0045211; GO:0050806; GO:0051965; GO:0090128; GO:0098845; GO:0098969; GO:0098978; GO:0098982; GO:0099003; GO:0099061; GO:0099065	cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; integral component of spine apparatus membrane [GO:0099065]; nucleus [GO:0005634]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003]
PGEN_.00g326580	Scaffold_16	29903331	29920702	O94985	CSTN1_HUMAN	Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)]	GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005576; GO:0005634; GO:0005789; GO:0007155; GO:0007156; GO:0009986; GO:0019894; GO:0030054; GO:0042988; GO:0045211; GO:0050806; GO:0051965; GO:0090128; GO:0098845; GO:0098969; GO:0098978; GO:0098982; GO:0099003; GO:0099061; GO:0099065	cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; integral component of spine apparatus membrane [GO:0099065]; nucleus [GO:0005634]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003]
PGEN_.00g326590	Scaffold_16	29964259	29966165	Q9GZX3	CHST6_HUMAN	Carbohydrate sulfotransferase 6 (EC 2.8.2.-) (Corneal N-acetylglucosamine-6-O-sulfotransferase) (C-GlcNAc6ST) (hCGn6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta) (GST4-beta) (N-acetylglucosamine 6-O-sulfotransferase 5) (GlcNAc6ST-5) (Gn6st-5)	GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0016021; GO:0018146	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g326600	Scaffold_16	29967233	29969681	NA	NA	NA	NA	NA
PGEN_.00g326610	Scaffold_16	29977910	29979265	NA	NA	NA	NA	NA
PGEN_.00g326620	Scaffold_16	30042984	30049285	P22699	GUN6_DICDI	"Endoglucanase (EC 3.2.1.4) (Cellulase) (Endo-1,4-beta-glucanase) (Spore germination protein 270-6)"	GO:0005576; GO:0008810; GO:0009847; GO:0030245; GO:0030248; GO:0030435	extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245]; spore germination [GO:0009847]; sporulation resulting in formation of a cellular spore [GO:0030435]
PGEN_.00g326630	Scaffold_16	30054631	30067950	NA	NA	NA	NA	NA
PGEN_.00g326640	Scaffold_16	30074533	30077542	NA	NA	NA	NA	NA
PGEN_.00g326650	Scaffold_16	30081258	30089225	A0NLY7	ISAHY_LABAI	Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b)	GO:0004061; GO:0016812; GO:0019441; GO:0030145	"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]; tryptophan catabolic process to kynurenine [GO:0019441]"
PGEN_.00g326660	Scaffold_16	30091021	30127198	Q5R5L7	ARRD3_PONAB	Arrestin domain-containing protein 3	GO:0005764; GO:0005769; GO:0005886	early endosome [GO:0005769]; lysosome [GO:0005764]; plasma membrane [GO:0005886]
PGEN_.00g326670	Scaffold_16	30127325	30131037	NA	NA	NA	NA	NA
PGEN_.00g326680	Scaffold_16	30155397	30217473	Q9UPW0	FOXJ3_HUMAN	Forkhead box protein J3	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0043565; GO:0045944	"nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]"
PGEN_.00g326690	Scaffold_16	30220328	30221392	NA	NA	NA	NA	NA
PGEN_.00g326700	Scaffold_16	30221435	30221728	NA	NA	NA	NA	NA
PGEN_.00g326710	Scaffold_16	30221841	30222521	NA	NA	NA	NA	NA
PGEN_.00g326720	Scaffold_16	30228373	30229765	NA	NA	NA	NA	NA
PGEN_.00g326730	Scaffold_16	30232497	30232826	NA	NA	NA	NA	NA
PGEN_.00g326740	Scaffold_16	30232863	30233219	NA	NA	NA	NA	NA
PGEN_.00g326750	Scaffold_16	30237128	30240723	NA	NA	NA	NA	NA
PGEN_.00g326760	Scaffold_16	30241448	30242383	NA	NA	NA	NA	NA
PGEN_.00g326770	Scaffold_16	30245619	30246575	NA	NA	NA	NA	NA
PGEN_.00g326780	Scaffold_16	30246816	30251730	NA	NA	NA	NA	NA
PGEN_.00g326790	Scaffold_16	30252722	30253102	NA	NA	NA	NA	NA
PGEN_.00g326800	Scaffold_16	30256576	30257055	P34456	YMD2_CAEEL	Uncharacterized protein F54H12.2	GO:0004748; GO:0005829; GO:0009263	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]"
PGEN_.00g326810	Scaffold_16	30259399	30259686	NA	NA	NA	NA	NA
PGEN_.00g326820	Scaffold_16	30259717	30260046	NA	NA	NA	NA	NA
PGEN_.00g326830	Scaffold_16	30315199	30322105	NA	NA	NA	NA	NA
PGEN_.00g326840	Scaffold_16	30331576	30331866	NA	NA	NA	NA	NA
PGEN_.00g326850	Scaffold_16	30332024	30332428	NA	NA	NA	NA	NA
PGEN_.00g326860	Scaffold_16	30344000	30344290	NA	NA	NA	NA	NA
PGEN_.00g326870	Scaffold_16	30355930	30356337	NA	NA	NA	NA	NA
PGEN_.00g326880	Scaffold_16	30367125	30497348	Q8IS64	ECE_LOCMI	Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)	GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g326890	Scaffold_16	30497544	30543566	Q8IS64	ECE_LOCMI	Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)	GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g326900	Scaffold_16	30565571	30565921	NA	NA	NA	NA	NA
PGEN_.00g326910	Scaffold_16	30566537	30585247	NA	NA	NA	NA	NA
PGEN_.00g326920	Scaffold_16	30634246	30639045	NA	NA	NA	NA	NA
PGEN_.00g326930	Scaffold_16	30662244	30662822	NA	NA	NA	NA	NA
PGEN_.00g326940	Scaffold_16	30709840	30711252	NA	NA	NA	NA	NA
PGEN_.00g326950	Scaffold_16	30725571	30725909	NA	NA	NA	NA	NA
PGEN_.00g326960	Scaffold_16	30725962	30726315	NA	NA	NA	NA	NA
PGEN_.00g326970	Scaffold_16	30747747	30891319	Q8T062	NEP4_DROME	Neprilysin-4 (EC 3.4.24.11)	GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0016529; GO:0046872	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]
PGEN_.00g326980	Scaffold_16	30904098	30904400	NA	NA	NA	NA	NA
PGEN_.00g326990	Scaffold_16	30904795	30905049	NA	NA	NA	NA	NA
PGEN_.00g327000	Scaffold_16	30910870	30911349	NA	NA	NA	NA	NA
PGEN_.00g327010	Scaffold_16	30917028	30919580	NA	NA	NA	NA	NA
PGEN_.00g327020	Scaffold_16	30920173	30928166	NA	NA	NA	NA	NA
PGEN_.00g327030	Scaffold_16	30937656	30984369	Q9W436	NEP_DROME	Neprilysin-1 (EC 3.4.24.11)	GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]
PGEN_.00g327040	Scaffold_16	30995019	30995812	NA	NA	NA	NA	NA
PGEN_.00g327050	Scaffold_16	30995989	30996243	NA	NA	NA	NA	NA
PGEN_.00g327060	Scaffold_16	30997026	30997568	NA	NA	NA	NA	NA
PGEN_.00g327070	Scaffold_16	31043431	31048775	NA	NA	NA	NA	NA
PGEN_.00g327080	Scaffold_16	31059111	31059506	NA	NA	NA	NA	NA
PGEN_.00g327090	Scaffold_16	31130032	31130370	NA	NA	NA	NA	NA
PGEN_.00g327100	Scaffold_16	31130606	31133214	NA	NA	NA	NA	NA
PGEN_.00g327110	Scaffold_16	31145448	31147083	NA	NA	NA	NA	NA
PGEN_.00g327120	Scaffold_16	31147120	31147419	NA	NA	NA	NA	NA
PGEN_.00g327130	Scaffold_16	31161603	31161944	NA	NA	NA	NA	NA
PGEN_.00g327140	Scaffold_16	31163876	31164295	NA	NA	NA	NA	NA
PGEN_.00g327150	Scaffold_16	31175437	31181690	NA	NA	NA	NA	NA
PGEN_.00g327160	Scaffold_16	31177747	31178196	NA	NA	NA	NA	NA
PGEN_.00g327170	Scaffold_16	31183919	31185390	NA	NA	NA	NA	NA
PGEN_.00g327180	Scaffold_16	31186181	31186573	NA	NA	NA	NA	NA
PGEN_.00g327190	Scaffold_16	31187545	31188366	NA	NA	NA	NA	NA
PGEN_.00g327200	Scaffold_16	31241372	31255965	Q26263	DPN_DROME	Protein deadpan	GO:0000122; GO:0000977; GO:0001227; GO:0002052; GO:0003677; GO:0003700; GO:0005634; GO:0007540; GO:0007549; GO:0008344; GO:0008345; GO:0009952; GO:0010629; GO:0014019; GO:0030154; GO:0035326; GO:0043565; GO:0045840; GO:0046983; GO:0050767; GO:1902692; GO:1990837	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enhancer binding [GO:0035326]; protein dimerization activity [GO:0046983]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; dosage compensation [GO:0007549]; larval locomotory behavior [GO:0008345]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast development [GO:0014019]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; sex determination, establishment of X:A ratio [GO:0007540]"
PGEN_.00g327210	Scaffold_16	31274295	31274696	NA	NA	NA	NA	NA
PGEN_.00g327220	Scaffold_16	31278128	31278532	NA	NA	NA	NA	NA
PGEN_.00g327230	Scaffold_16	31279287	31279730	NA	NA	NA	NA	NA
PGEN_.00g327240	Scaffold_16	31279936	31280418	NA	NA	NA	NA	NA
PGEN_.00g327250	Scaffold_16	31302771	31326754	Q8N766	EMC1_HUMAN	ER membrane protein complex subunit 1	GO:0016021; GO:0032991; GO:0072546	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]
PGEN_.00g327260	Scaffold_16	31340350	31362662	Q6NRB9	EMC1_XENLA	ER membrane protein complex subunit 1	GO:0016021; GO:0072546	ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]
PGEN_.00g327270	Scaffold_16	31369712	31379598	NA	NA	NA	NA	NA
PGEN_.00g327280	Scaffold_16	31400171	31440043	Q6NY89	LSG1_DANRE	Large subunit GTPase 1 homolog (EC 3.6.1.-)	GO:0005525; GO:0005783; GO:0005829; GO:0015030; GO:0015031; GO:0016787; GO:0051168	Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; nuclear export [GO:0051168]; protein transport [GO:0015031]
PGEN_.00g327290	Scaffold_16	31450851	31451435	NA	NA	NA	NA	NA
PGEN_.00g327300	Scaffold_16	31456827	31461029	NA	NA	NA	NA	NA
PGEN_.00g327310	Scaffold_16	31469617	31483432	A2ASQ1	AGRIN_MOUSE	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0007009; GO:0007268; GO:0007416; GO:0007528; GO:0008045; GO:0009887; GO:0009888; GO:0009986; GO:0016021; GO:0016358; GO:0030054; GO:0030548; GO:0032092; GO:0033691; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043525; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045213; GO:0045887; GO:0045944; GO:0050431; GO:0050731; GO:0050807; GO:0051290; GO:0051491; GO:0055117; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:2000541	axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; ion channel binding [GO:0044325]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; animal organ morphogenesis [GO:0009887]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; negative regulation of sodium:potassium-exchanging ATPase activity [GO:1903407]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor metabolic process [GO:0045213]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]; tissue development [GO:0009888]
PGEN_.00g327320	Scaffold_16	31592125	31592436	NA	NA	NA	NA	NA
PGEN_.00g327330	Scaffold_16	31599488	31629517	P31696	AGRIN_CHICK	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]	GO:0002162; GO:0004867; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007275; GO:0007399; GO:0007417; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0016021; GO:0030054; GO:0030154; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978; GO:1902572	axon [GO:0030424]; basal part of cell [GO:0045178]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor regulator activity [GO:0030548]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; serine-type endopeptidase inhibitor activity [GO:0004867]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; multicellular organism development [GO:0007275]; negative regulation of neuron projection development [GO:0010977]; negative regulation of serine-type peptidase activity [GO:1902572]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]
PGEN_.00g327340	Scaffold_16	31633493	31635669	NA	NA	NA	NA	NA
PGEN_.00g327350	Scaffold_16	31636784	31638151	NA	NA	NA	NA	NA
PGEN_.00g327360	Scaffold_16	31745922	31746164	NA	NA	NA	NA	NA
PGEN_.00g327370	Scaffold_16	31811427	31813099	NA	NA	NA	NA	NA
PGEN_.00g327380	Scaffold_16	31866428	31876459	B7STY1	ATRA_TAPPA	Atromentin synthetase (EC 2.3.1.-) (Atromentin biosynthesis protein A) (Nonribosomal peptide synthase atrA)	GO:0009058; GO:0016740; GO:0016788	"hydrolase activity, acting on ester bonds [GO:0016788]; transferase activity [GO:0016740]; biosynthetic process [GO:0009058]"
PGEN_.00g327390	Scaffold_16	31881958	31883886	Q9ESN6	TRIM2_MOUSE	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (Neural activity-related RING finger protein) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017022; GO:0043161; GO:0043523; GO:0061630; GO:1990830	cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g327400	Scaffold_16	31898300	31911322	O60762	DPM1_HUMAN	Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1)	GO:0004169; GO:0004582; GO:0005634; GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0018279; GO:0019348; GO:0033185; GO:0035268; GO:0035269	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269]
PGEN_.00g327410	Scaffold_16	31920350	31920658	NA	NA	NA	NA	NA
PGEN_.00g327420	Scaffold_16	31923534	31934452	O35242	FAN_MOUSE	Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation)	GO:0005123; GO:0016230; GO:0043065	death receptor binding [GO:0005123]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; positive regulation of apoptotic process [GO:0043065]
PGEN_.00g327430	Scaffold_16	31935044	31936012	NA	NA	NA	NA	NA
PGEN_.00g327440	Scaffold_16	31937656	31944097	Q54PP7	LVSF_DICDI	BEACH domain-containing protein lvsF		
PGEN_.00g327450	Scaffold_16	31950643	31965620	Q92636	FAN_HUMAN	Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation)	GO:0005737; GO:0005829; GO:0006672; GO:0007165; GO:0016230; GO:0043065; GO:2000304	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ceramide biosynthetic process [GO:2000304]; signal transduction [GO:0007165]
PGEN_.00g327460	Scaffold_16	31967876	31978177	Q54PP7	LVSF_DICDI	BEACH domain-containing protein lvsF		
PGEN_.00g327470	Scaffold_16	31979068	31979427	NA	NA	NA	NA	NA
PGEN_.00g327480	Scaffold_16	31979514	31979810	NA	NA	NA	NA	NA
PGEN_.00g327490	Scaffold_17	14520	18376	P10394	POL4_DROME	Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]	GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074	aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]
PGEN_.00g327500	Scaffold_17	35842	36177	NA	NA	NA	NA	NA
PGEN_.00g327510	Scaffold_17	56647	57282	NA	NA	NA	NA	NA
PGEN_.00g327520	Scaffold_17	58008	58484	NA	NA	NA	NA	NA
PGEN_.00g327530	Scaffold_17	60873	61628	NA	NA	NA	NA	NA
PGEN_.00g327540	Scaffold_17	62560	63075	NA	NA	NA	NA	NA
PGEN_.00g327550	Scaffold_17	63169	63501	NA	NA	NA	NA	NA
PGEN_.00g327560	Scaffold_17	64049	64393	NA	NA	NA	NA	NA
PGEN_.00g327570	Scaffold_17	64661	65086	NA	NA	NA	NA	NA
PGEN_.00g327580	Scaffold_17	65961	66645	NA	NA	NA	NA	NA
PGEN_.00g327590	Scaffold_17	66785	71761	NA	NA	NA	NA	NA
PGEN_.00g327600	Scaffold_17	84342	84883	NA	NA	NA	NA	NA
PGEN_.00g327610	Scaffold_17	86844	87194	NA	NA	NA	NA	NA
PGEN_.00g327620	Scaffold_17	104252	108076	Q5RB31	SC61B_PONAB	Protein transport protein Sec61 subunit beta	GO:0005784; GO:0016021; GO:0030433; GO:0030970; GO:0031205; GO:0048408	"endoplasmic reticulum Sec complex [GO:0031205]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; epidermal growth factor binding [GO:0048408]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g327630	Scaffold_17	115019	119078	NA	NA	NA	NA	NA
PGEN_.00g327640	Scaffold_17	127742	131821	Q5RB31	SC61B_PONAB	Protein transport protein Sec61 subunit beta	GO:0005784; GO:0016021; GO:0030433; GO:0030970; GO:0031205; GO:0048408	"endoplasmic reticulum Sec complex [GO:0031205]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; epidermal growth factor binding [GO:0048408]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g327650	Scaffold_17	131917	187272	Q8UVC3	INVS_CHICK	Inversin	GO:0005516; GO:0005737; GO:0005856; GO:0007275; GO:0016055	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]
PGEN_.00g327660	Scaffold_17	192691	201068	NA	NA	NA	NA	NA
PGEN_.00g327670	Scaffold_17	211331	213601	NA	NA	NA	NA	NA
PGEN_.00g327680	Scaffold_17	219542	229885	NA	NA	NA	NA	NA
PGEN_.00g327690	Scaffold_17	240207	253685	NA	NA	NA	NA	NA
PGEN_.00g327700	Scaffold_17	253964	277280	E9Q5F9	SETD2_MOUSE	Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.-) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2)	GO:0001525; GO:0001570; GO:0001763; GO:0001843; GO:0005634; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010452; GO:0010468; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048568; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634	"chromosome [GO:0005694]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]; vasculogenesis [GO:0001570]"
PGEN_.00g327710	Scaffold_17	291203	291640	NA	NA	NA	NA	NA
PGEN_.00g327720	Scaffold_17	303443	303814	NA	NA	NA	NA	NA
PGEN_.00g327730	Scaffold_17	334355	359137	A7MB35	ODPA_BOVIN	"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)"	GO:0004739; GO:0005739; GO:0005759; GO:0006006; GO:0006086; GO:0006099; GO:0045254	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]
PGEN_.00g327740	Scaffold_17	361013	361330	NA	NA	NA	NA	NA
PGEN_.00g327750	Scaffold_17	364218	366402	NA	NA	NA	NA	NA
PGEN_.00g327760	Scaffold_17	413406	414615	NA	NA	NA	NA	NA
PGEN_.00g327770	Scaffold_17	521185	593318	Q9QWS8	KCNH8_RAT	Potassium voltage-gated channel subfamily H member 8 (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (Voltage-gated potassium channel subunit Kv12.1)	GO:0000978; GO:0005249; GO:0005887; GO:0034765; GO:0042391; GO:0043066; GO:0071805	integral component of plasma membrane [GO:0005887]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; voltage-gated potassium channel activity [GO:0005249]; negative regulation of apoptotic process [GO:0043066]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]
PGEN_.00g327780	Scaffold_17	603310	611978	NA	NA	NA	NA	NA
PGEN_.00g327790	Scaffold_17	625371	632760	NA	NA	NA	NA	NA
PGEN_.00g327800	Scaffold_17	635551	637010	NA	NA	NA	NA	NA
PGEN_.00g327810	Scaffold_17	653705	656279	Q9GPR3	TM2D1_DICDI	TM2 domain-containing protein DDB_G0277895	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g327820	Scaffold_17	673940	679772	NA	NA	NA	NA	NA
PGEN_.00g327830	Scaffold_17	710920	756689	Q868T3	CCAPR_DROME	Cardioacceleratory peptide receptor (Crustacean cardioactive peptide receptor)	GO:0005000; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0018990	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g327840	Scaffold_17	825413	844961	Q54Z01	TBCB_DICDI	Tubulin-specific chaperone B (Tubulin-folding cofactor B)	GO:0005737; GO:0005874	cytoplasm [GO:0005737]; microtubule [GO:0005874]
PGEN_.00g327850	Scaffold_17	847047	850816	Q60648	SAP3_MOUSE	Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3)	GO:0004563; GO:0005319; GO:0005739; GO:0005764; GO:0006689; GO:0007611; GO:0008047; GO:0009313; GO:0009898; GO:0016004; GO:0016323; GO:0016324; GO:0019915; GO:0032428; GO:0050877; GO:0050885; GO:0051345	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345]
PGEN_.00g327860	Scaffold_17	853873	863064	B2DFG5	DTHAD_DELSH	D-threo-3-hydroxyaspartate dehydratase (D-THA DH) (D-THA dehydratase) (EC 4.3.1.27) (Threo-3-hydroxy-D-aspartate ammonia-lyase)	GO:0016841; GO:0030170	ammonia-lyase activity [GO:0016841]; pyridoxal phosphate binding [GO:0030170]
PGEN_.00g327870	Scaffold_17	863090	866145	NA	NA	NA	NA	NA
PGEN_.00g327880	Scaffold_17	869105	880975	Q9R1K7	TBD_MOUSE	Tubulin delta chain (Delta-tubulin)	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005874; GO:0005929; GO:0007017; GO:0007275; GO:0030030; GO:0045880	centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; cell projection organization [GO:0030030]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; multicellular organism development [GO:0007275]; positive regulation of smoothened signaling pathway [GO:0045880]
PGEN_.00g327890	Scaffold_17	976058	979842	Q7YW31	CTR1_OCTVU	Cephalotocin receptor 1 (OC/CE-R 1) (OT/VP superfamily peptide receptor 1)	GO:0005000; GO:0005886; GO:0007186; GO:0016021; GO:0016500	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g327900	Scaffold_17	1044178	1050158	A2AX52	CO6A4_MOUSE	Collagen alpha-4(VI) chain	GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; collagen binding [GO:0005518]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]
PGEN_.00g327910	Scaffold_17	1128690	1140681	NA	NA	NA	NA	NA
PGEN_.00g327920	Scaffold_17	1144547	1145080	NA	NA	NA	NA	NA
PGEN_.00g327930	Scaffold_17	1156917	1157255	NA	NA	NA	NA	NA
PGEN_.00g327940	Scaffold_17	1157321	1157572	NA	NA	NA	NA	NA
PGEN_.00g327950	Scaffold_17	1161525	1173426	NA	NA	NA	NA	NA
PGEN_.00g327960	Scaffold_17	1178801	1196592	Q92851	CASPA_HUMAN	Caspase-10 (CASP-10) (EC 3.4.22.63) (Apoptotic protease Mch-4) (FAS-associated death domain protein interleukin-1B-converting enzyme 2) (FLICE2) (ICE-like apoptotic protease 4) [Cleaved into: Caspase-10 subunit p23/17; Caspase-10 subunit p12]	GO:0004197; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0007166; GO:0031265; GO:0031625; GO:0035877; GO:0042981; GO:0043123; GO:0097153; GO:0097190; GO:0097199; GO:0097342	CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]
PGEN_.00g327970	Scaffold_17	1211131	1228738	Q0ZLH3	PJVK_HUMAN	Pejvakin (Autosomal recessive deafness type 59 protein)	GO:0007605; GO:0043025	neuronal cell body [GO:0043025]; sensory perception of sound [GO:0007605]
PGEN_.00g327980	Scaffold_17	1236272	1245698	NA	NA	NA	NA	NA
PGEN_.00g327990	Scaffold_17	1249685	1261734	NA	NA	NA	NA	NA
PGEN_.00g328000	Scaffold_17	1300180	1310556	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g328010	Scaffold_17	1314570	1325085	Q8TE56	ATS17_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 17 (ADAM-TS 17) (ADAM-TS17) (ADAMTS-17) (EC 3.4.24.-)	GO:0003676; GO:0004222; GO:0005576; GO:0046872	extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; nucleic acid binding [GO:0003676]
PGEN_.00g328020	Scaffold_17	1407812	1424778	B0VXE8	CDK14_CALJA	Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14)	GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005886; GO:0016055; GO:0051301; GO:0060828	cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]
PGEN_.00g328030	Scaffold_17	1425476	1430663	B0VXE8	CDK14_CALJA	Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14)	GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005886; GO:0016055; GO:0051301; GO:0060828	cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]
PGEN_.00g328040	Scaffold_17	1445082	1468676	NA	NA	NA	NA	NA
PGEN_.00g328050	Scaffold_17	1474613	1478504	Q9R085	UBP15_RAT	Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin carboxyl-terminal hydrolase of 109 kDa) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15)	GO:0004197; GO:0004843; GO:0005160; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0036459; GO:0042802; GO:0046332; GO:0060389; GO:0061649	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g328060	Scaffold_17	1539685	1570839	F1SRY5	UBP37_PIG	Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37)	GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0006275; GO:0006511; GO:0016579; GO:0035871; GO:0051301; GO:0071108	nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g328070	Scaffold_17	1573051	1580670	Q86T82	UBP37_HUMAN	Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37)	GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0006275; GO:0006511; GO:0016579; GO:0019901; GO:0035871; GO:0036459; GO:0051301; GO:0071108	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g328080	Scaffold_17	1582136	1582747	NA	NA	NA	NA	NA
PGEN_.00g328090	Scaffold_17	1640314	1651682	G5E8K5	ANK3_MOUSE	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g328100	Scaffold_17	1763796	1764380	NA	NA	NA	NA	NA
PGEN_.00g328110	Scaffold_17	1766345	1830146	NA	NA	NA	NA	NA
PGEN_.00g328120	Scaffold_17	1832990	1843881	NA	NA	NA	NA	NA
PGEN_.00g328130	Scaffold_17	1845177	1986168	NA	NA	NA	NA	NA
PGEN_.00g328140	Scaffold_17	2001002	2006483	P84173	PHB_CHICK	Prohibitin	GO:0005634; GO:0005743; GO:0071897	mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; DNA biosynthetic process [GO:0071897]
PGEN_.00g328150	Scaffold_17	2060417	2061728	Q9BXJ4	C1QT3_HUMAN	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]
PGEN_.00g328160	Scaffold_17	2062393	2068286	NA	NA	NA	NA	NA
PGEN_.00g328170	Scaffold_17	2069477	2069731	NA	NA	NA	NA	NA
PGEN_.00g328180	Scaffold_17	2076951	2079301	Q9ES30	C1QT3_MOUSE	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005576; GO:0005581; GO:0005615; GO:0005623; GO:0010629; GO:0032991; GO:0035356; GO:0042593; GO:0042802; GO:0045721; GO:0050715; GO:0050728; GO:0051897; GO:0070165; GO:0070206; GO:0070374; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; cellular triglyceride homeostasis [GO:0035356]; glucose homeostasis [GO:0042593]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; protein trimerization [GO:0070206]
PGEN_.00g328190	Scaffold_17	2080517	2082786	Q9ES30	C1QT3_MOUSE	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005576; GO:0005581; GO:0005615; GO:0005623; GO:0010629; GO:0032991; GO:0035356; GO:0042593; GO:0042802; GO:0045721; GO:0050715; GO:0050728; GO:0051897; GO:0070165; GO:0070206; GO:0070374; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; cellular triglyceride homeostasis [GO:0035356]; glucose homeostasis [GO:0042593]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; protein trimerization [GO:0070206]
PGEN_.00g328200	Scaffold_17	2151682	2152077	NA	NA	NA	NA	NA
PGEN_.00g328210	Scaffold_17	2221324	2221623	NA	NA	NA	NA	NA
PGEN_.00g328220	Scaffold_17	2244418	2244762	NA	NA	NA	NA	NA
PGEN_.00g328230	Scaffold_17	2284332	2284736	NA	NA	NA	NA	NA
PGEN_.00g328240	Scaffold_17	2295923	2305726	Q95116	TSP2_BOVIN	Thrombospondin-2 (Corticotropin-induced secreted protein) (CISP)	GO:0005509; GO:0007155; GO:0008201; GO:0016525; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]
PGEN_.00g328250	Scaffold_17	2337905	2341753	P35448	TSP1_XENLA	Thrombospondin-1 (Glycoprotein G)	GO:0005509; GO:0005615; GO:0005783; GO:0006954; GO:0006986; GO:0007155; GO:0008201; GO:0009986; GO:0016525; GO:0016529; GO:0031012; GO:0050840	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986]
PGEN_.00g328260	Scaffold_17	2349281	2349580	NA	NA	NA	NA	NA
PGEN_.00g328270	Scaffold_17	2357358	2361217	NA	NA	NA	NA	NA
PGEN_.00g328280	Scaffold_17	2383986	2387889	Q6NVP8	FUT8_XENTR	"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	GO:0006487; GO:0008424; GO:0016021; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046921	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]
PGEN_.00g328290	Scaffold_17	2395545	2400683	NA	NA	NA	NA	NA
PGEN_.00g328300	Scaffold_17	2400794	2401984	NA	NA	NA	NA	NA
PGEN_.00g328310	Scaffold_17	2505997	2516899	NA	NA	NA	NA	NA
PGEN_.00g328320	Scaffold_17	2520819	2528584	Q9D9P2	CC103_MOUSE	Coiled-coil domain-containing protein 103	GO:0001947; GO:0003341; GO:0003351; GO:0005576; GO:0007368; GO:0031514; GO:0036157; GO:0036158; GO:0036159; GO:0042803; GO:0070286; GO:0071907	extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; protein homodimerization activity [GO:0042803]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]
PGEN_.00g328330	Scaffold_17	2542757	2555409	Q9NPC7	MYNN_HUMAN	Myoneurin (Zinc finger and BTB domain-containing protein 31)	GO:0003677; GO:0003700; GO:0005654; GO:0006351; GO:0008270; GO:1990830	"nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; transcription, DNA-templated [GO:0006351]"
PGEN_.00g328340	Scaffold_17	2583326	2625678	F1P4W9	CFA65_CHICK	Cilia- and flagella-associated protein 65 (Coiled-coil domain-containing protein 108)	GO:0005886; GO:0016021; GO:0031514	integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]
PGEN_.00g328350	Scaffold_17	2636824	2687633	O14904	WNT9A_HUMAN	Protein Wnt-9a (Protein Wnt-14)	GO:0005109; GO:0005576; GO:0005615; GO:0007093; GO:0007267; GO:0007275; GO:0008285; GO:0016055; GO:0030182; GO:0032331; GO:0035115; GO:0043154; GO:0045165; GO:0045597; GO:0045880; GO:0048018; GO:0048704; GO:0060070; GO:0061072; GO:0061303; GO:0071300; GO:0072498	extracellular region [GO:0005576]; extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal joint development [GO:0072498]; embryonic skeletal system morphogenesis [GO:0048704]; iris morphogenesis [GO:0061072]; mitotic cell cycle checkpoint [GO:0007093]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neuron differentiation [GO:0030182]; positive regulation of cell differentiation [GO:0045597]; positive regulation of smoothened signaling pathway [GO:0045880]; Wnt signaling pathway [GO:0016055]
PGEN_.00g328360	Scaffold_17	2773008	2809143	P49340	WNT1_BOMMO	Protein Wnt-1	GO:0005102; GO:0005576; GO:0007275; GO:0016055	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]
PGEN_.00g328370	Scaffold_17	2822029	2848431	P22727	WNT6_MOUSE	Protein Wnt-6	GO:0001658; GO:0005102; GO:0005109; GO:0005615; GO:0005788; GO:0007165; GO:0007267; GO:0009798; GO:0009887; GO:0009986; GO:0010628; GO:0016055; GO:0030182; GO:0031012; GO:0042475; GO:0045165; GO:0045893; GO:0060684; GO:0070172; GO:0072079; GO:0072080	"cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule development [GO:0072080]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g328380	Scaffold_17	2892249	2897922	NA	NA	NA	NA	NA
PGEN_.00g328390	Scaffold_17	2928951	2938750	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g328400	Scaffold_17	2981915	3002863	P70701	WN10A_MOUSE	Protein Wnt-10a	GO:0001942; GO:0005102; GO:0005109; GO:0005615; GO:0007165; GO:0007267; GO:0009887; GO:0010628; GO:0014033; GO:0016055; GO:0030182; GO:0031069; GO:0042476; GO:0042487; GO:0043586; GO:0043588; GO:0045165; GO:0048018; GO:0048730; GO:0048733; GO:0060070; GO:0071560	extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; signal transduction [GO:0007165]; skin development [GO:0043588]; tongue development [GO:0043586]; Wnt signaling pathway [GO:0016055]
PGEN_.00g328410	Scaffold_17	3025144	3076168	P28572	SC6A9_RAT	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)	GO:0001504; GO:0005283; GO:0005328; GO:0005886; GO:0014069; GO:0015187; GO:0015816; GO:0030285; GO:0032279; GO:0061537; GO:0098686; GO:0098688; GO:0099055; GO:0099056	"asymmetric synapse [GO:0032279]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; amino acid:sodium symporter activity [GO:0005283]; glycine transmembrane transporter activity [GO:0015187]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine secretion, neurotransmission [GO:0061537]; glycine transport [GO:0015816]; neurotransmitter uptake [GO:0001504]"
PGEN_.00g328420	Scaffold_17	3115236	3122083	NA	NA	NA	NA	NA
PGEN_.00g328430	Scaffold_17	3341970	3369837	Q03412	UNC7_CAEEL	Innexin unc-7 (Uncoordinated protein 7)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0016264; GO:0018991; GO:0032589; GO:0034220; GO:0040011; GO:0043051; GO:0055077; GO:0072347	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; gap junction assembly [GO:0016264]; ion transmembrane transport [GO:0034220]; locomotion [GO:0040011]; oviposition [GO:0018991]; regulation of pharyngeal pumping [GO:0043051]; response to anesthetic [GO:0072347]
PGEN_.00g328440	Scaffold_17	3394330	3394626	NA	NA	NA	NA	NA
PGEN_.00g328450	Scaffold_17	3395976	3396194	NA	NA	NA	NA	NA
PGEN_.00g328460	Scaffold_17	3431478	3452465	NA	NA	NA	NA	NA
PGEN_.00g328470	Scaffold_17	3471143	3481283	P07909	ROA1_DROME	Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (PEN repeat clone P9) (hnRNP core protein A1-A)	GO:0000381; GO:0001745; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005703; GO:0007283; GO:0008266; GO:0033119; GO:0034046; GO:0036099; GO:0043565; GO:0045727; GO:0048026; GO:0048027; GO:0048477; GO:1990904	"nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell population maintenance [GO:0036099]; negative regulation of RNA splicing [GO:0033119]; oogenesis [GO:0048477]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spermatogenesis [GO:0007283]"
PGEN_.00g328480	Scaffold_17	3492996	3537442	P21369	PNCA_ECOLI	Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-)	GO:0008936; GO:0019365; GO:0046872	metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]
PGEN_.00g328490	Scaffold_17	3543750	3556497	Q5BKR2	SL9B2_MOUSE	Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2)	GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0030054; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:0097708; GO:2001206	basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]
PGEN_.00g328500	Scaffold_17	3559145	3583160	P07207	NOTCH_DROME	Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]	GO:0001708; GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0004888; GO:0005509; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0005915; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007455; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009952; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014019; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035003; GO:0035153; GO:0035162; GO:0035165; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043525; GO:0043697; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048	"adherens junction [GO:0005912]; cell [GO:0005623]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; zonula adherens [GO:0005915]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
PGEN_.00g328510	Scaffold_17	3603440	3613063	NA	NA	NA	NA	NA
PGEN_.00g328520	Scaffold_17	3621305	3650133	NA	NA	NA	NA	NA
PGEN_.00g328530	Scaffold_17	3661666	3669306	Q96JQ0	PCD16_HUMAN	Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1)	GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0007389; GO:0016020; GO:0016021; GO:0016339; GO:0021915; GO:0022008; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0048565; GO:0072137; GO:0072659; GO:0090102	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]
PGEN_.00g328540	Scaffold_17	3682052	3694355	NA	NA	NA	NA	NA
PGEN_.00g328550	Scaffold_17	3721637	3741248	Q9CX98	CP2U1_MOUSE	Cytochrome P450 2U1 (EC 1.14.14.1)	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g328560	Scaffold_17	3755894	3762590	NA	NA	NA	NA	NA
PGEN_.00g328570	Scaffold_17	3782853	3783137	NA	NA	NA	NA	NA
PGEN_.00g328580	Scaffold_17	3782960	3793233	NA	NA	NA	NA	NA
PGEN_.00g328590	Scaffold_17	3807991	3818596	Q6DE02	SOB1A_XENLA	SOSS complex subunit B1-A (Nucleic acid-binding protein 2-A) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2B-A) (Sensor of single-strand DNA complex subunit B1-A) (Sensor of ssDNA subunit B1-A) (SOSS-B1-A) (Single-stranded DNA-binding protein 1-A)	GO:0000724; GO:0003697; GO:0005634; GO:0006281; GO:0006974; GO:0007093; GO:0010212; GO:0070876	nucleus [GO:0005634]; SOSS complex [GO:0070876]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212]
PGEN_.00g328600	Scaffold_17	3821884	3844172	Q4A1L5	BECN1_PIG	Beclin-1 [Cleaved into: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa]	GO:0000045; GO:0000407; GO:0005634; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006897; GO:0006914; GO:0006915; GO:0006995; GO:0007049; GO:0010008; GO:0016236; GO:0019898; GO:0031966; GO:0032258; GO:0032465; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0045022; GO:0045324; GO:0051301; GO:0051607	"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to nitrogen starvation [GO:0006995]; cytoplasm to vacuole transport by the Cvt pathway [GO:0032258]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; regulation of cytokinesis [GO:0032465]"
PGEN_.00g328610	Scaffold_17	3912548	3912907	NA	NA	NA	NA	NA
PGEN_.00g328620	Scaffold_17	3918671	3927480	NA	NA	NA	NA	NA
PGEN_.00g328630	Scaffold_17	3955491	3960843	NA	NA	NA	NA	NA
PGEN_.00g328640	Scaffold_17	3970413	3971827	NA	NA	NA	NA	NA
PGEN_.00g328650	Scaffold_17	3989533	4043500	Q60716	P4HA2_MOUSE	"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)"	GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0016222; GO:0016702; GO:0018401; GO:0031418; GO:0043231	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; procollagen-proline 4-dioxygenase complex [GO:0016222]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"
PGEN_.00g328660	Scaffold_17	4054213	4066654	NA	NA	NA	NA	NA
PGEN_.00g328670	Scaffold_17	4086749	4087021	NA	NA	NA	NA	NA
PGEN_.00g328680	Scaffold_17	4108813	4109088	NA	NA	NA	NA	NA
PGEN_.00g328690	Scaffold_17	4150317	4187243	O95864	FADS2_HUMAN	Acyl-CoA 6-desaturase (EC 1.14.19.3) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) (Fatty acid desaturase 2)	GO:0004768; GO:0005789; GO:0005887; GO:0006636; GO:0016020; GO:0016213; GO:0036109; GO:0043651	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; linoleoyl-CoA desaturase activity [GO:0016213]; stearoyl-CoA 9-desaturase activity [GO:0004768]; alpha-linolenic acid metabolic process [GO:0036109]; linoleic acid metabolic process [GO:0043651]; unsaturated fatty acid biosynthetic process [GO:0006636]
PGEN_.00g328700	Scaffold_17	4190697	4219300	Q1ENI8	PXDN_CAEEL	Peroxidasin homolog (EC 1.11.1.7)	GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0010172; GO:0020037; GO:0042744; GO:0046872; GO:0048679	basement membrane [GO:0005604]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; embryonic body morphogenesis [GO:0010172]; hydrogen peroxide catabolic process [GO:0042744]; regulation of axon regeneration [GO:0048679]; response to oxidative stress [GO:0006979]
PGEN_.00g328710	Scaffold_17	4235199	4246607	NA	NA	NA	NA	NA
PGEN_.00g328720	Scaffold_17	4254702	4292972	P11247	PERM_MOUSE	Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase light chain; Myeloperoxidase heavy chain]	GO:0001878; GO:0002149; GO:0002679; GO:0004601; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0042582; GO:0042742; GO:0042744; GO:0043231; GO:0046872; GO:0050832; GO:0055114; GO:1990268	azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]
PGEN_.00g328730	Scaffold_17	4307651	4310516	Q8K2X3	STN1_MOUSE	CST complex subunit STN1 (Alpha-accessory factor of 44 kDa) (AAF-44) (AAF44) (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog)	GO:0000723; GO:0000724; GO:0000781; GO:0000784; GO:0001650; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006281; GO:0006289; GO:0010833; GO:0016233; GO:0032211; GO:0035861; GO:0042162; GO:0043047; GO:0043231; GO:0045111; GO:0045740; GO:1990879	"chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]"
PGEN_.00g328740	Scaffold_17	4316224	4316436	NA	NA	NA	NA	NA
PGEN_.00g328750	Scaffold_17	4328878	4342740	NA	NA	NA	NA	NA
PGEN_.00g328760	Scaffold_17	4349041	4349334	NA	NA	NA	NA	NA
PGEN_.00g328770	Scaffold_17	4349514	4350812	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g328780	Scaffold_17	4361852	4363696	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g328790	Scaffold_17	4385029	4386465	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g328800	Scaffold_17	4397267	4399168	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g328810	Scaffold_17	4414322	4416250	Q8K0U4	HS12A_MOUSE	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g328820	Scaffold_17	4420951	4421727	Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	GO:0005524	ATP binding [GO:0005524]
PGEN_.00g328830	Scaffold_17	4421802	4426335	O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	GO:0005524; GO:0005634; GO:0005737; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]
PGEN_.00g328840	Scaffold_17	4442971	4463986	Q9P2G1	AKIB1_HUMAN	Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31)	GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g328850	Scaffold_17	4465313	4476874	NA	NA	NA	NA	NA
PGEN_.00g328860	Scaffold_17	4481073	4486156	NA	NA	NA	NA	NA
PGEN_.00g328870	Scaffold_17	4502330	4505204	P48043	V1AR_SHEEP	Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor)	GO:0005000; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vasopressin receptor activity [GO:0005000]
PGEN_.00g328880	Scaffold_17	4612469	4612804	NA	NA	NA	NA	NA
PGEN_.00g328890	Scaffold_17	4665607	4678560	Q9Y2W6	TDRKH_HUMAN	Tudor and KH domain-containing protein (Tudor domain-containing protein 2)	GO:0003723; GO:0005739; GO:0007140; GO:0007283; GO:0009566; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071546; GO:0071547	mitochondrion [GO:0005739]; pi-body [GO:0071546]; piP-body [GO:0071547]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
PGEN_.00g328900	Scaffold_17	4681393	4684474	Q8WXB1	MT21A_HUMAN	Protein N-lysine methyltransferase METTL21A (EC 2.1.1.-) (HSPA lysine methyltransferase) (HSPA-KMT) (Hepatocellular carcinoma-associated antigen 557b) (Methyltransferase-like protein 21A)	GO:0005654; GO:0005737; GO:0006479; GO:0008276; GO:0016279; GO:0018022; GO:0030544; GO:0031072; GO:0032991; GO:0051117	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479]
PGEN_.00g328910	Scaffold_17	4691360	4704602	Q9WV04	KIF9_MOUSE	Kinesin-like protein KIF9	GO:0002102; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0022617; GO:0031982; GO:0046983; GO:0071801; GO:1903008	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein dimerization activity [GO:0046983]; extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of podosome assembly [GO:0071801]
PGEN_.00g328920	Scaffold_17	4732572	4732964	NA	NA	NA	NA	NA
PGEN_.00g328930	Scaffold_17	4744644	4746719	NA	NA	NA	NA	NA
PGEN_.00g328940	Scaffold_17	4753639	4755839	NA	NA	NA	NA	NA
PGEN_.00g328950	Scaffold_17	4765243	4776152	NA	NA	NA	NA	NA
PGEN_.00g328960	Scaffold_17	4818154	4836910	B3EWZ8	ECT_ACRMI	Ectin (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g328970	Scaffold_17	4839465	4841552	NA	NA	NA	NA	NA
PGEN_.00g328980	Scaffold_17	4843405	4854916	B3EWZ8	ECT_ACRMI	Ectin (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g328990	Scaffold_17	4862209	4897329	Q11011	PSA_MOUSE	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0071456	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]
PGEN_.00g329000	Scaffold_17	4903143	4929945	NA	NA	NA	NA	NA
PGEN_.00g329010	Scaffold_17	4930317	4936306	P10881	LA_BOVIN	Lupus La protein homolog (La autoantigen homolog) (La ribonucleoprotein)	GO:0000049; GO:0001682; GO:0005634; GO:0005737; GO:0006409; GO:0008266; GO:0042780; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]
PGEN_.00g329020	Scaffold_17	4942556	4974885	P70168	IMB1_MOUSE	Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG)	GO:0005623; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008536; GO:0010494; GO:0019894; GO:0019899; GO:0019904; GO:0030953; GO:0031291; GO:0031965; GO:0032991; GO:0040001; GO:0044877; GO:0045184; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307	cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; kinesin binding [GO:0019894]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; Ran GTPase binding [GO:0008536]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]
PGEN_.00g329030	Scaffold_17	4984750	4991380	Q08CI4	CCYL1_DANRE	Cyclin-Y-like protein 1	GO:0005886; GO:0016538; GO:0019901; GO:0045737	plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]
PGEN_.00g329040	Scaffold_17	5008548	5023625	Q76B49	CD63_FELCA	CD63 antigen (CD antigen CD63)	GO:0002092; GO:0005576; GO:0005765; GO:0005887; GO:0007160; GO:0009986; GO:0015031; GO:0016477; GO:0031226; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0097487; GO:1900746; GO:2001046	"cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]"
PGEN_.00g329050	Scaffold_17	5042145	5089921	B2RY50	ARMC4_MOUSE	Armadillo repeat-containing protein 4	GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546	axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591]
PGEN_.00g329060	Scaffold_17	5094817	5099543	NA	NA	NA	NA	NA
PGEN_.00g329070	Scaffold_17	5156751	5167490	NA	NA	NA	NA	NA
PGEN_.00g329080	Scaffold_17	5171548	5198109	Q6ZSM3	MOT12_HUMAN	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]
PGEN_.00g329090	Scaffold_17	5244462	5251076	NA	NA	NA	NA	NA
PGEN_.00g329100	Scaffold_17	5364584	5382463	Q80UK0	SESD1_MOUSE	SEC14 domain and spectrin repeat-containing protein 1 (Huntingtin-interacting protein-like protein)	GO:0005546; GO:0010314; GO:0032266; GO:0034704; GO:0043325; GO:0045111; GO:0070273; GO:0070300; GO:0080025; GO:1904878	"calcium channel complex [GO:0034704]; intermediate filament cytoskeleton [GO:0045111]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]"
PGEN_.00g329110	Scaffold_17	5391425	5569108	A2ASS6	TITIN_MOUSE	Titin (EC 2.7.11.1) (Connectin)	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]
PGEN_.00g329120	Scaffold_17	5571172	5673606	A2ASS6	TITIN_MOUSE	Titin (EC 2.7.11.1) (Connectin)	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]
PGEN_.00g329130	Scaffold_17	5704756	5710644	Q28824	MYLK_BOVIN	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0030027; GO:0032154; GO:0046872	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]
PGEN_.00g329140	Scaffold_17	5721144	5722439	NA	NA	NA	NA	NA
PGEN_.00g329150	Scaffold_17	5748775	5806809	Q6PDN3	MYLK_MOUSE	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	GO:0001725; GO:0003779; GO:0004672; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005911; GO:0006939; GO:0014820; GO:0015629; GO:0019899; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0035690; GO:0035865; GO:0046872; GO:0051928; GO:0060414; GO:0071277; GO:0071476; GO:0072358; GO:0090303	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cardiovascular system development [GO:0072358]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
PGEN_.00g329160	Scaffold_17	5829397	5833708	P27085	RS26_OCTVU	40S ribosomal protein S26	GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]
PGEN_.00g329170	Scaffold_17	5852312	5852566	NA	NA	NA	NA	NA
PGEN_.00g329180	Scaffold_17	5852639	5853177	NA	NA	NA	NA	NA
PGEN_.00g329190	Scaffold_17	5853588	5856695	NA	NA	NA	NA	NA
PGEN_.00g329200	Scaffold_17	5856769	5857110	NA	NA	NA	NA	NA
PGEN_.00g329210	Scaffold_17	5861509	5876126	NA	NA	NA	NA	NA
PGEN_.00g329220	Scaffold_17	5924186	5938478	Q5GFL6	VWA2_HUMAN	von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen) (AMACO) (Colon cancer secreted protein 2) (CCSP-2)	GO:0003429; GO:0005509; GO:0005604; GO:0005615; GO:0007161; GO:0031012; GO:0042802; GO:0046626; GO:0051260; GO:0062023; GO:0070062	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; calcium-independent cell-matrix adhesion [GO:0007161]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; protein homooligomerization [GO:0051260]; regulation of insulin receptor signaling pathway [GO:0046626]
PGEN_.00g329230	Scaffold_17	5974604	5994458	NA	NA	NA	NA	NA
PGEN_.00g329240	Scaffold_17	6007570	6010893	Q9UII5	ZN107_HUMAN	Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25)	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g329250	Scaffold_17	6015459	6018250	NA	NA	NA	NA	NA
PGEN_.00g329260	Scaffold_17	6036226	6041075	NA	NA	NA	NA	NA
PGEN_.00g329270	Scaffold_17	6051021	6052539	Q90ZK6	ACVR1_CHICK	Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (Type I TGF B receptor)	GO:0000082; GO:0001525; GO:0001569; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003181; GO:0003183; GO:0003203; GO:0003274; GO:0003289; GO:0004672; GO:0004674; GO:0005025; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007369; GO:0007498; GO:0007507; GO:0009968; GO:0010694; GO:0010718; GO:0010862; GO:0016020; GO:0016361; GO:0016477; GO:0018107; GO:0019838; GO:0030278; GO:0030335; GO:0030501; GO:0030509; GO:0030513; GO:0032924; GO:0032926; GO:0035556; GO:0042118; GO:0042803; GO:0043235; GO:0045177; GO:0045669; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0051145; GO:0060037; GO:0060317; GO:0060389; GO:0060412; GO:0060923; GO:0061312; GO:0061445; GO:0070724; GO:0071363; GO:0071773; GO:1905007; GO:2000017; GO:2001237	"activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; angiogenesis [GO:0001525]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell fate commitment [GO:0060923]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell activation [GO:0042118]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412]"
PGEN_.00g329280	Scaffold_17	6068773	6106439	NA	NA	NA	NA	NA
PGEN_.00g329290	Scaffold_17	6089990	6090406	NA	NA	NA	NA	NA
PGEN_.00g329300	Scaffold_17	6175015	6181326	Q9LQU4	PCR2_ARATH	Protein PLANT CADMIUM RESISTANCE 2 (AtPCR2)	GO:0005886; GO:0006979; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to oxidative stress [GO:0006979]
PGEN_.00g329310	Scaffold_17	6199177	6199449	NA	NA	NA	NA	NA
PGEN_.00g329320	Scaffold_17	6232329	6234429	NA	NA	NA	NA	NA
PGEN_.00g329330	Scaffold_17	6354176	6375875	A0JMU8	CASC3_XENLA	Protein CASC3 (Cancer susceptibility candidate gene 3 protein homolog) (Metastatic lymph node protein 51 homolog) (Protein MLN 51 homolog) (XlMLN51)	GO:0000184; GO:0000398; GO:0003723; GO:0005634; GO:0006417; GO:0010494; GO:0016607; GO:0030425; GO:0035145; GO:0048471; GO:0051028; GO:0071006	"cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]"
PGEN_.00g329340	Scaffold_17	6390680	6403037	NA	NA	NA	NA	NA
PGEN_.00g329350	Scaffold_17	6430752	6455715	NA	NA	NA	NA	NA
PGEN_.00g329360	Scaffold_17	6477177	6477515	NA	NA	NA	NA	NA
PGEN_.00g329370	Scaffold_17	6486178	6512733	NA	NA	NA	NA	NA
PGEN_.00g329380	Scaffold_17	6512955	6513458	NA	NA	NA	NA	NA
PGEN_.00g329390	Scaffold_17	6513526	6513855	NA	NA	NA	NA	NA
PGEN_.00g329400	Scaffold_17	6514224	6514580	NA	NA	NA	NA	NA
PGEN_.00g329410	Scaffold_17	6514666	6517770	NA	NA	NA	NA	NA
PGEN_.00g329420	Scaffold_17	6520223	6562195	NA	NA	NA	NA	NA
PGEN_.00g329430	Scaffold_17	6570432	6571601	NA	NA	NA	NA	NA
PGEN_.00g329440	Scaffold_17	6620714	6630068	NA	NA	NA	NA	NA
PGEN_.00g329450	Scaffold_17	6686822	6704272	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g329460	Scaffold_17	6712947	6713195	NA	NA	NA	NA	NA
PGEN_.00g329470	Scaffold_17	6728357	6740446	NA	NA	NA	NA	NA
PGEN_.00g329480	Scaffold_17	6754399	6765428	Q9H015	S22A4_HUMAN	Solute carrier family 22 member 4 (Ergothioneine transporter) (ET transporter) (Organic cation/carnitine transporter 1)	GO:0000166; GO:0005524; GO:0005739; GO:0005886; GO:0005887; GO:0006641; GO:0006814; GO:0007589; GO:0008513; GO:0009437; GO:0015226; GO:0015293; GO:0015491; GO:0015651; GO:0015695; GO:0015697; GO:0015879; GO:0016324; GO:0030165	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; nucleotide binding [GO:0000166]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; symporter activity [GO:0015293]; body fluid secretion [GO:0007589]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]
PGEN_.00g329490	Scaffold_17	6790949	6795566	NA	NA	NA	NA	NA
PGEN_.00g329500	Scaffold_17	6798467	6802607	NA	NA	NA	NA	NA
PGEN_.00g329510	Scaffold_17	6825594	6845919	Q0VAA2	LR74A_HUMAN	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)		
PGEN_.00g329520	Scaffold_17	6865031	6865741	NA	NA	NA	NA	NA
PGEN_.00g329530	Scaffold_17	6865804	6883530	NA	NA	NA	NA	NA
PGEN_.00g329540	Scaffold_17	6884129	6894239	Q6ZQY2	LR74B_HUMAN	Leucine-rich repeat-containing protein 74B		
PGEN_.00g329550	Scaffold_17	6894901	6895844	NA	NA	NA	NA	NA
PGEN_.00g329560	Scaffold_17	6901915	6906262	P27658	CO8A1_HUMAN	Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin]	GO:0001525; GO:0005201; GO:0005576; GO:0005591; GO:0005615; GO:0005788; GO:0007155; GO:0010811; GO:0030198; GO:0031012; GO:0035987; GO:0048593; GO:0050673; GO:0062023	collagen type VIII trimer [GO:0005591]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]
PGEN_.00g329570	Scaffold_17	6916704	6934162	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g329580	Scaffold_17	6939771	6950690	Q5VY43	PEAR1_HUMAN	Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12)	GO:0001891; GO:0014065; GO:0016021; GO:0038023; GO:0043491; GO:0043654; GO:0045746; GO:0070527	integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; signaling receptor activity [GO:0038023]; negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654]
PGEN_.00g329590	Scaffold_17	6956753	6963550	NA	NA	NA	NA	NA
PGEN_.00g329600	Scaffold_17	6966362	7000623	Q5U4Q0	WAC_XENTR	WW domain-containing adapter protein with coiled-coil	GO:0000993; GO:0003682; GO:0005634; GO:0006974; GO:0010390; GO:0044783; GO:0045893; GO:0071894	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]"
PGEN_.00g329610	Scaffold_17	7010055	7014821	Q08179	MDM38_YEAST	Mitochondrial distribution and morphology protein 38	GO:0005623; GO:0005739; GO:0005743; GO:0006813; GO:0016021; GO:0030007; GO:0032979; GO:0070131; GO:0097177; GO:1902600	cell [GO:0005623]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial ribosome binding [GO:0097177]; cellular potassium ion homeostasis [GO:0030007]; positive regulation of mitochondrial translation [GO:0070131]; potassium ion transport [GO:0006813]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; proton transmembrane transport [GO:1902600]
PGEN_.00g329620	Scaffold_17	7037198	7039138	NA	NA	NA	NA	NA
PGEN_.00g329630	Scaffold_17	7040915	7043331	NA	NA	NA	NA	NA
PGEN_.00g329640	Scaffold_17	7056785	7059045	NA	NA	NA	NA	NA
PGEN_.00g329650	Scaffold_17	7060137	7060541	NA	NA	NA	NA	NA
PGEN_.00g329660	Scaffold_17	7100882	7117313	NA	NA	NA	NA	NA
PGEN_.00g329670	Scaffold_17	7119550	7120029	NA	NA	NA	NA	NA
PGEN_.00g329680	Scaffold_17	7120233	7120691	NA	NA	NA	NA	NA
PGEN_.00g329690	Scaffold_17	7120717	7121106	NA	NA	NA	NA	NA
PGEN_.00g329700	Scaffold_17	7121131	7128556	NA	NA	NA	NA	NA
PGEN_.00g329710	Scaffold_17	7128836	7129120	NA	NA	NA	NA	NA
PGEN_.00g329720	Scaffold_17	7140635	7141294	NA	NA	NA	NA	NA
PGEN_.00g329730	Scaffold_17	7150922	7154574	P25145	Y432_LISMO	Uncharacterized oxidoreductase Lmo0432 (EC 1.-.-.-) (ORFA)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g329740	Scaffold_17	7155933	7162873	Q49WS9	Y1627_STAS1	Uncharacterized oxidoreductase SSP1627 (EC 1.-.-.-)	GO:0016491	oxidoreductase activity [GO:0016491]
PGEN_.00g329750	Scaffold_17	7168611	7234232	NA	NA	NA	NA	NA
PGEN_.00g329760	Scaffold_17	7206672	7206902	NA	NA	NA	NA	NA
PGEN_.00g329770	Scaffold_17	7248939	7420749	O46385	SVIL_BOVIN	Supervillin (Archvillin) (p205/p250)	GO:0002102; GO:0005737; GO:0007010; GO:0030054; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0051015; GO:0071437	cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]
PGEN_.00g329780	Scaffold_17	7464498	7465686	NA	NA	NA	NA	NA
PGEN_.00g329790	Scaffold_17	7500408	7503676	NA	NA	NA	NA	NA
PGEN_.00g329800	Scaffold_17	7506186	7508762	NA	NA	NA	NA	NA
PGEN_.00g329810	Scaffold_17	7516641	7516979	NA	NA	NA	NA	NA
PGEN_.00g329820	Scaffold_17	7533449	7560609	B3EWZ5	MLRP1_ACRMI	MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g329830	Scaffold_17	7563727	7566563	NA	NA	NA	NA	NA
PGEN_.00g329840	Scaffold_17	7613723	7614058	NA	NA	NA	NA	NA
PGEN_.00g329850	Scaffold_17	7614569	7622097	NA	NA	NA	NA	NA
PGEN_.00g329860	Scaffold_17	7626405	7633467	NA	NA	NA	NA	NA
PGEN_.00g329870	Scaffold_17	7643429	7651842	NA	NA	NA	NA	NA
PGEN_.00g329880	Scaffold_17	7675637	7682590	O01393	UNC9_CAEEL	Innexin unc-9 (Uncoordinated protein 9)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
PGEN_.00g329890	Scaffold_17	7715096	7716163	P06620	ICEN_PSESY	Ice nucleation protein	GO:0009279; GO:0050825	cell outer membrane [GO:0009279]; ice binding [GO:0050825]
PGEN_.00g329900	Scaffold_17	7843742	7844681	NA	NA	NA	NA	NA
PGEN_.00g329910	Scaffold_17	7900648	7900902	NA	NA	NA	NA	NA
PGEN_.00g329920	Scaffold_17	7983785	7995488	Q20930	MIG17_CAEEL	Metalloprotease mig-17 (EC 3.4.24.-) (Abnormal cell migration protein 17)	GO:0004222; GO:0005604; GO:0005615; GO:0008104; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354	basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]
PGEN_.00g329930	Scaffold_17	8021673	8025492	NA	NA	NA	NA	NA
PGEN_.00g329940	Scaffold_17	8027932	8034421	NA	NA	NA	NA	NA
PGEN_.00g329950	Scaffold_17	8076945	8084042	Q8TB03	CX038_HUMAN	Uncharacterized protein CXorf38		
PGEN_.00g329960	Scaffold_17	8103311	8108770	NA	NA	NA	NA	NA
PGEN_.00g329970	Scaffold_17	8116995	8129976	NA	NA	NA	NA	NA
PGEN_.00g329980	Scaffold_17	8136035	8141880	Q03350	TSP2_MOUSE	Thrombospondin-2	GO:0005509; GO:0005604; GO:0005615; GO:0007155; GO:0008201; GO:0016525; GO:0031012; GO:0031091; GO:0051965; GO:0062023	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965]
PGEN_.00g329990	Scaffold_17	8142488	8145116	NA	NA	NA	NA	NA
PGEN_.00g330000	Scaffold_17	8152259	8154341	NA	NA	NA	NA	NA
PGEN_.00g330010	Scaffold_17	8154910	8160832	NA	NA	NA	NA	NA
PGEN_.00g330020	Scaffold_17	8166509	8181797	Q66RM2	BI1_PIG	Bax inhibitor 1 (BI-1) (Testis-enhanced gene transcript protein) (Transmembrane BAX inhibitor motif-containing protein 6)	GO:0005789; GO:0006914; GO:0006915; GO:0006986; GO:0016021; GO:0043066	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; negative regulation of apoptotic process [GO:0043066]; response to unfolded protein [GO:0006986]
PGEN_.00g330030	Scaffold_17	8217469	8232108	Q3V1N1	MFHA1_MOUSE	Malignant fibrous histiocytoma-amplified sequence 1 homolog	GO:0005525; GO:0005737; GO:0006952; GO:0006954; GO:0030218; GO:0031625; GO:0034121; GO:0034136; GO:0034137; GO:0034144; GO:0035308; GO:0043030; GO:0045087; GO:0046330; GO:0050728; GO:0051721; GO:0051897; GO:0070374; GO:1900181; GO:1900745	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625]; defense response [GO:0006952]; erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]; regulation of toll-like receptor signaling pathway [GO:0034121]
PGEN_.00g330040	Scaffold_17	8232582	8236523	NA	NA	NA	NA	NA
PGEN_.00g330050	Scaffold_17	8238954	8239253	NA	NA	NA	NA	NA
PGEN_.00g330060	Scaffold_17	8240982	8241509	A6H909	TBPL2_RAT	TATA box-binding protein-like protein 2 (TBP-like protein 2) (TATA box-binding protein-related factor 3) (TBP-related factor 3)	GO:0000126; GO:0000978; GO:0000979; GO:0001016; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005669; GO:0005737; GO:0006366; GO:0007275; GO:0008134; GO:0045892; GO:0070898	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIIB complex [GO:0000126]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase III regulatory region DNA binding [GO:0001016]; transcription factor binding [GO:0008134]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA polymerase III preinitiation complex assembly [GO:0070898]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g330070	Scaffold_17	8241901	8242335	NA	NA	NA	NA	NA
PGEN_.00g330080	Scaffold_17	8242723	8243982	P34456	YMD2_CAEEL	Uncharacterized protein F54H12.2	GO:0004748; GO:0005829; GO:0009263	"cytosol [GO:0005829]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]"
PGEN_.00g330090	Scaffold_17	8244827	8245291	NA	NA	NA	NA	NA
PGEN_.00g330100	Scaffold_17	8316274	8316855	NA	NA	NA	NA	NA
PGEN_.00g330110	Scaffold_17	8334183	8334464	NA	NA	NA	NA	NA
PGEN_.00g330120	Scaffold_17	8355908	8360601	P50947	PHO23_YEAST	Transcriptional regulatory protein PHO23	GO:0000118; GO:0000122; GO:0005634; GO:0006325; GO:0010507; GO:0016479; GO:0016573; GO:0031939; GO:0033698; GO:0035064; GO:0045944; GO:0046872; GO:0061186; GO:0061188; GO:0061408; GO:0070210; GO:2000219; GO:2001159	histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; Rpd3L complex [GO:0033698]; Rpd3L-Expanded complex [GO:0070210]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; negative regulation of autophagy [GO:0010507]; negative regulation of chromatin silencing at rDNA [GO:0061188]; negative regulation of chromatin silencing at silent mating-type cassette [GO:0061186]; negative regulation of chromatin silencing at telomere [GO:0031939]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of invasive growth in response to glucose limitation [GO:2000219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; regulation of protein localization by the Cvt pathway [GO:2001159]
PGEN_.00g330130	Scaffold_17	8361116	8364455	NA	NA	NA	NA	NA
PGEN_.00g330140	Scaffold_17	8382933	8385239	NA	NA	NA	NA	NA
PGEN_.00g330150	Scaffold_17	8401718	8474909	Q14590	ZN235_HUMAN	Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g330160	Scaffold_17	8482720	8489020	NA	NA	NA	NA	NA
PGEN_.00g330170	Scaffold_17	8513824	8514387	NA	NA	NA	NA	NA
PGEN_.00g330180	Scaffold_17	8514427	8514741	NA	NA	NA	NA	NA
PGEN_.00g330190	Scaffold_17	8525756	8541793	Q8NEG2	CG057_HUMAN	Uncharacterized protein C7orf57		
PGEN_.00g330200	Scaffold_17	8548032	8551161	Q7SYN4	5NT3_DANRE	Cytosolic 5'-nucleotidase 3 (EC 3.1.3.5) (Cytosolic 5'-nucleotidase III) (cN-III)	GO:0000166; GO:0000287; GO:0005737; GO:0008253; GO:0009117; GO:0016740	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; transferase activity [GO:0016740]; nucleotide metabolic process [GO:0009117]
PGEN_.00g330210	Scaffold_17	8625083	8678941	NA	NA	NA	NA	NA
PGEN_.00g330220	Scaffold_17	8638943	8639554	NA	NA	NA	NA	NA
PGEN_.00g330230	Scaffold_17	8640720	8641046	NA	NA	NA	NA	NA
PGEN_.00g330240	Scaffold_17	8686966	8694686	B0UZC8	VWC2L_DANRE	von Willebrand factor C domain-containing protein 2-like	GO:0005615; GO:0007399; GO:0030054; GO:0030514; GO:0032281; GO:0045202	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; nervous system development [GO:0007399]
PGEN_.00g330250	Scaffold_17	8705973	8732631	NA	NA	NA	NA	NA
PGEN_.00g330260	Scaffold_17	8741898	8746355	Q6UW60	PCSK4_HUMAN	Proprotein convertase subtilisin/kexin type 4 (EC 3.4.21.-) (Proprotein convertase 4) (PC4)	GO:0001669; GO:0002080; GO:0004252; GO:0005802; GO:0007339; GO:0007340; GO:0009566; GO:0016020; GO:0016485; GO:0016486; GO:0022414; GO:0030173; GO:0048240	acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240]
PGEN_.00g330270	Scaffold_17	8752701	8769854	P23377	FURIN_RAT	Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Prohormone convertase 3)	GO:0000139; GO:0002020; GO:0004175; GO:0004252; GO:0004867; GO:0005576; GO:0005783; GO:0005789; GO:0005802; GO:0005886; GO:0006465; GO:0007568; GO:0008233; GO:0009966; GO:0009986; GO:0010008; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030140; GO:0030173; GO:0030335; GO:0030511; GO:0031638; GO:0031985; GO:0032804; GO:0032902; GO:0032911; GO:0032940; GO:0042176; GO:0042277; GO:0043043; GO:0045121; GO:0045714; GO:0046872; GO:0048406; GO:0052548; GO:0090472; GO:0097341; GO:1901394	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; nerve growth factor binding [GO:0048406]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]; aging [GO:0007568]; dibasic protein processing [GO:0090472]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of cell migration [GO:0030335]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 activation [GO:1901394]; protein processing [GO:0016485]; regulation of endopeptidase activity [GO:0052548]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]; zymogen activation [GO:0031638]; zymogen inhibition [GO:0097341]
PGEN_.00g330280	Scaffold_17	8773290	8782070	Q86JP3	RAB5A_DICDI	Ras-related protein Rab-5A	GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0010008; GO:0030139; GO:0032482	early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g330290	Scaffold_17	8790744	8796747	P35279	RAB6A_MOUSE	Ras-related protein Rab-6A (Rab-6)	GO:0000139; GO:0001671; GO:0003924; GO:0005525; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0016020; GO:0018125; GO:0019882; GO:0019904; GO:0031410; GO:0031489; GO:0032482; GO:0034067; GO:0034498; GO:0042147; GO:0051117; GO:0070381; GO:0098793	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endosome to plasma membrane transport vesicle [GO:0070381]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; antigen processing and presentation [GO:0019882]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; peptidyl-cysteine methylation [GO:0018125]; protein localization to Golgi apparatus [GO:0034067]; Rab protein signal transduction [GO:0032482]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g330300	Scaffold_17	8803175	8808276	O80501	RAH1B_ARATH	Ras-related protein RABH1b (AtRABH1b) (Ras-related protein Rab6A) (AtRab6A)	GO:0000139; GO:0001558; GO:0003924; GO:0005525; GO:0005768; GO:0005774; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006890; GO:0006891; GO:0009506; GO:0016020; GO:0032482; GO:0042147; GO:0052324	"cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; trans-Golgi network [GO:0005802]; vacuolar membrane [GO:0005774]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; exocytosis [GO:0006887]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; plant-type cell wall cellulose biosynthetic process [GO:0052324]; Rab protein signal transduction [GO:0032482]; regulation of cell growth [GO:0001558]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g330310	Scaffold_17	8824751	8930362	Q8WXX0	DYH7_HUMAN	"Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2)"	GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285	"axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]"
PGEN_.00g330320	Scaffold_17	8945788	8999981	P54288	CACB2_RABIT	Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2)	GO:0007601; GO:0008331; GO:0034765; GO:0051015; GO:0051928; GO:0070509; GO:0086056; GO:0086091; GO:0098684; GO:0098793; GO:0098912; GO:0099635; GO:1990454	L-type voltage-gated calcium channel complex [GO:1990454]; photoreceptor ribbon synapse [GO:0098684]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; calcium ion import [GO:0070509]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; positive regulation of calcium ion transport [GO:0051928]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; visual perception [GO:0007601]
PGEN_.00g330330	Scaffold_17	8996740	8998707	NA	NA	NA	NA	NA
PGEN_.00g330340	Scaffold_17	9042746	9065243	Q5CD18	TGFR1_PIG	TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I)	GO:0001938; GO:0004674; GO:0005025; GO:0005524; GO:0005623; GO:0005634; GO:0005768; GO:0005886; GO:0005923; GO:0006468; GO:0006915; GO:0007179; GO:0007399; GO:0007507; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0016020; GO:0016361; GO:0032924; GO:0035556; GO:0040008; GO:0042118; GO:0043235; GO:0045121; GO:0045893; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0060317; GO:0071363	"activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell [GO:0005623]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to growth factor stimulus [GO:0071363]; endothelial cell activation [GO:0042118]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; nervous system development [GO:0007399]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of growth [GO:0040008]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g330350	Scaffold_17	9080673	9081689	NA	NA	NA	NA	NA
PGEN_.00g330360	Scaffold_17	9087995	9092876	Q02365	NDUB3_BOVIN	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit)	GO:0005747; GO:0016021; GO:0022900; GO:0032981	integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]
PGEN_.00g330370	Scaffold_17	9093095	9096463	Q6DD06	ZC3HF_XENLA	Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1)	GO:0005634; GO:0005737; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]
PGEN_.00g330380	Scaffold_17	9212764	9363283	D3ZHV2	MACF1_RAT	Microtubule-actin cross-linking factor 1 (Actin cross-linking family 7)	GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006620; GO:0007163; GO:0008017; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]
PGEN_.00g330390	Scaffold_17	9368129	9385163	Q8K078	SO4A1_MOUSE	Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)	GO:0005887; GO:0008514; GO:0015347; GO:0015349; GO:0015711; GO:0042403; GO:0043252	integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]
PGEN_.00g330400	Scaffold_17	9393965	9409162	Q5FWL3	RNF41_XENLA	E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1)	GO:0000209; GO:0004842; GO:0046872; GO:0061630; GO:0097191	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; extrinsic apoptotic signaling pathway [GO:0097191]; protein polyubiquitination [GO:0000209]
PGEN_.00g330410	Scaffold_17	9425884	9429748	NA	NA	NA	NA	NA
PGEN_.00g330420	Scaffold_17	9445358	9467897	NA	NA	NA	NA	NA
PGEN_.00g330430	Scaffold_17	9475197	9478693	NA	NA	NA	NA	NA
PGEN_.00g330440	Scaffold_17	9489175	9491221	NA	NA	NA	NA	NA
PGEN_.00g330450	Scaffold_17	9507696	9512413	NA	NA	NA	NA	NA
PGEN_.00g330460	Scaffold_17	9516896	9522456	NA	NA	NA	NA	NA
PGEN_.00g330470	Scaffold_17	9547363	9560969	Q99JX3	GORS2_MOUSE	Golgi reassembly-stacking protein 2 (GRS2) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55)	GO:0000139; GO:0005789; GO:0005794; GO:0005797; GO:0006996; GO:0007030; GO:0007283; GO:0030154; GO:0034976; GO:0061951; GO:0070925	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]
PGEN_.00g330480	Scaffold_17	9567110	9574827	P41263	RET4_CHICK	Retinol-binding protein 4 (Plasma retinol-binding protein) (PRBP) (RBP)	GO:0001555; GO:0001654; GO:0005102; GO:0005615; GO:0006094; GO:0009615; GO:0016918; GO:0019841; GO:0019904; GO:0030136; GO:0030277; GO:0032024; GO:0032526; GO:0033189; GO:0034632; GO:0042572; GO:0042593; GO:0043627; GO:0060417; GO:0060418; GO:0065003; GO:0070062	clathrin-coated vesicle [GO:0030136]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; yolk [GO:0060417]; yolk plasma [GO:0060418]; protein domain specific binding [GO:0019904]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor binding [GO:0005102]; eye development [GO:0001654]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; maintenance of gastrointestinal epithelium [GO:0030277]; oocyte growth [GO:0001555]; positive regulation of insulin secretion [GO:0032024]; protein-containing complex assembly [GO:0065003]; response to estrogen [GO:0043627]; response to retinoic acid [GO:0032526]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; retinol metabolic process [GO:0042572]
PGEN_.00g330490	Scaffold_17	9581498	9594370	B3EWZ3	CADN_ACRMI	Coadhesin (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g330500	Scaffold_17	9602015	9616306	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g330510	Scaffold_17	9624182	9634055	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g330520	Scaffold_17	9861250	9884800	Q6NXK7	DPP10_MOUSE	Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase X) (DPP X)	GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078	membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]
PGEN_.00g330530	Scaffold_17	9886529	9895652	A5D7B7	SEPR_BOVIN	"Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) (Z-Pro-prolinal insensitive peptidase) (ZIP) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]"	GO:0001525; GO:0002020; GO:0004252; GO:0005178; GO:0005615; GO:0007155; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0016021; GO:0030054; GO:0031258; GO:0032587; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0051603; GO:0060244; GO:0071158; GO:0071438; GO:0071850; GO:0097325; GO:1900119; GO:1902362	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587]; dipeptidyl-peptidase activity [GO:0008239]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]
PGEN_.00g330540	Scaffold_17	9910867	9913367	NA	NA	NA	NA	NA
PGEN_.00g330550	Scaffold_17	9915837	9941483	Q5VV43	K0319_HUMAN	Dyslexia-associated protein KIAA0319	GO:0001764; GO:0005769; GO:0005886; GO:0010996; GO:0016021; GO:0030517; GO:0030665; GO:0031410; GO:0031901; GO:0033555; GO:0043231; GO:0048692; GO:0060391; GO:0061024; GO:2000171	clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; membrane organization [GO:0061024]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]
PGEN_.00g330560	Scaffold_17	9980671	9981249	NA	NA	NA	NA	NA
PGEN_.00g330570	Scaffold_17	9986022	9999402	A4FV48	FADS2_BOVIN	Acyl-CoA 6-desaturase (EC 1.14.19.3) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) (Fatty acid desaturase 2)	GO:0005789; GO:0006636; GO:0016021; GO:0016213	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; linoleoyl-CoA desaturase activity [GO:0016213]; unsaturated fatty acid biosynthetic process [GO:0006636]
PGEN_.00g330580	Scaffold_17	10009198	10037163	Q60848	HELLS_MOUSE	Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein)	GO:0000775; GO:0001655; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006342; GO:0006346; GO:0007049; GO:0007275; GO:0010216; GO:0030098; GO:0031508; GO:0043066; GO:0046651; GO:0051301; GO:1990830; GO:2001243	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; methylation-dependent chromatin silencing [GO:0006346]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]"
PGEN_.00g330590	Scaffold_17	10040950	10047827	O70421	FZD1_MOUSE	Frizzled-1 (Fz-1) (mFz1)	GO:0001934; GO:0003149; GO:0003150; GO:0003151; GO:0004930; GO:0005102; GO:0005109; GO:0005886; GO:0007267; GO:0009986; GO:0010976; GO:0016021; GO:0016055; GO:0017147; GO:0030165; GO:0030514; GO:0030855; GO:0035425; GO:0035567; GO:0036520; GO:0042493; GO:0042802; GO:0042803; GO:0042813; GO:0043005; GO:0044338; GO:0044339; GO:0045892; GO:0045893; GO:0046982; GO:0051091; GO:0060022; GO:0060070; GO:0060412; GO:0090090; GO:0090179; GO:1903204; GO:1905606	"cell surface [GO:0009986]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; astrocyte-dopaminergic neuron signaling [GO:0036520]; autocrine signaling [GO:0035425]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; hard palate development [GO:0060022]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of presynapse assembly [GO:1905606]; response to drug [GO:0042493]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g330600	Scaffold_17	10068635	10069009	NA	NA	NA	NA	NA
PGEN_.00g330610	Scaffold_17	10084975	10093561	Q689D1	TLR2_CANLF	Toll-like receptor 2 (CD antigen CD282)	GO:0002224; GO:0002755; GO:0005794; GO:0005887; GO:0006954; GO:0030670; GO:0031226; GO:0034134; GO:0045087; GO:0045121; GO:0050707; GO:0050729; GO:0071726; GO:0071727	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g330620	Scaffold_17	10105111	10114855	NA	NA	NA	NA	NA
PGEN_.00g330630	Scaffold_17	10127819	10138171	Q9J569	V162_FOWPN	Putative ankyrin repeat protein FPV162		
PGEN_.00g330640	Scaffold_17	10145663	10148795	NA	NA	NA	NA	NA
PGEN_.00g330650	Scaffold_17	10149830	10155601	NA	NA	NA	NA	NA
PGEN_.00g330660	Scaffold_17	10155828	10165045	Q9J569	V162_FOWPN	Putative ankyrin repeat protein FPV162		
PGEN_.00g330670	Scaffold_17	10206452	10242544	O60229	KALRN_HUMAN	Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)	GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007165; GO:0007186; GO:0007399; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0015629; GO:0016192; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043065; GO:0043547; GO:0046872; GO:0046959; GO:0048013; GO:0051056; GO:0060125; GO:0060137; GO:0061003; GO:0070062	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192]
PGEN_.00g330680	Scaffold_17	10272256	10344090	Q0KL02	TRIO_MOUSE	Triple functional domain protein (EC 2.7.11.1)	GO:0004674; GO:0005089; GO:0005524; GO:0005769; GO:0007411; GO:0007417; GO:0019899; GO:0042995; GO:0045599	cell projection [GO:0042995]; early endosome [GO:0005769]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]
PGEN_.00g330690	Scaffold_17	10379609	10451830	O60229	KALRN_HUMAN	Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)	GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007165; GO:0007186; GO:0007399; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0015629; GO:0016192; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043065; GO:0043547; GO:0046872; GO:0046959; GO:0048013; GO:0051056; GO:0060125; GO:0060137; GO:0061003; GO:0070062	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192]
PGEN_.00g330700	Scaffold_17	10495122	10495442	NA	NA	NA	NA	NA
PGEN_.00g330710	Scaffold_17	10502730	10505535	NA	NA	NA	NA	NA
PGEN_.00g330720	Scaffold_17	10511654	10526401	P17644	ACH2_DROME	Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2)	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g330730	Scaffold_17	10535160	10552248	P09628	ACHD_XENLA	Acetylcholine receptor subunit delta	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g330740	Scaffold_17	10634457	10651998	Q1JQA0	PPT2_BOVIN	Lysosomal thioesterase PPT2 (PPT-2) (EC 3.1.2.-)	GO:0005764; GO:0008474	lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474]
PGEN_.00g330750	Scaffold_17	10655873	10677129	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g330760	Scaffold_17	10687259	10695335	Q99676	ZN184_HUMAN	Zinc finger protein 184	GO:0003677; GO:0005634; GO:0006355; GO:0008270	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g330770	Scaffold_17	10701126	10702157	NA	NA	NA	NA	NA
PGEN_.00g330780	Scaffold_17	10707663	10726909	P98069	BMPH_STRPU	Bone morphogenetic protein 1 homolog (EC 3.4.24.-) (SUBMP)	GO:0004222; GO:0005509; GO:0007275; GO:0008270	calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]
PGEN_.00g330790	Scaffold_17	10744287	10744574	NA	NA	NA	NA	NA
PGEN_.00g330800	Scaffold_17	10748356	10750980	NA	NA	NA	NA	NA
PGEN_.00g330810	Scaffold_17	10759501	10765757	NA	NA	NA	NA	NA
PGEN_.00g330820	Scaffold_17	10794271	10812883	Q20930	MIG17_CAEEL	Metalloprotease mig-17 (EC 3.4.24.-) (Abnormal cell migration protein 17)	GO:0004222; GO:0005604; GO:0005615; GO:0008104; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354	basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]
PGEN_.00g330830	Scaffold_17	10828521	10873968	G5EBQ8	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063	cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]
PGEN_.00g330840	Scaffold_17	10880610	10881677	NA	NA	NA	NA	NA
PGEN_.00g330850	Scaffold_17	10883380	10896646	G5EBQ8	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063	cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]
PGEN_.00g330860	Scaffold_17	10906282	10907466	NA	NA	NA	NA	NA
PGEN_.00g330870	Scaffold_17	10914056	10927599	G5EBQ8	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063	cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]
PGEN_.00g330880	Scaffold_17	10951623	10952693	NA	NA	NA	NA	NA
PGEN_.00g330890	Scaffold_17	10955104	10962411	A0LMC1	PHNX_SYNFM	Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)	GO:0000287; GO:0019700; GO:0050194	magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700]
PGEN_.00g330900	Scaffold_17	10969520	10976468	NA	NA	NA	NA	NA
PGEN_.00g330910	Scaffold_17	10993206	10999591	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g330920	Scaffold_17	11028684	11028950	NA	NA	NA	NA	NA
PGEN_.00g330930	Scaffold_17	11109312	11141954	O13134	S4A4_AMBTI	Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4)	GO:0005452; GO:0006814; GO:0015293; GO:0016021; GO:0016323	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; inorganic anion exchanger activity [GO:0005452]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g330940	Scaffold_17	11151379	11152611	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g330950	Scaffold_17	11157077	11157970	NA	NA	NA	NA	NA
PGEN_.00g330960	Scaffold_17	11179291	11181105	NA	NA	NA	NA	NA
PGEN_.00g330970	Scaffold_17	11221438	11223739	NA	NA	NA	NA	NA
PGEN_.00g330980	Scaffold_17	11241404	11263172	Q9W6N4	THA_HIPHI	Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1)	GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565; GO:0070324	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; thyroid hormone binding [GO:0070324]; zinc ion binding [GO:0008270]
PGEN_.00g330990	Scaffold_17	11277486	11281000	NA	NA	NA	NA	NA
PGEN_.00g331000	Scaffold_17	11286758	11294581	A6QP79	COL12_BOVIN	Collectin-12 (Collectin placenta protein 1) (CL-P1)	GO:0004888; GO:0005581; GO:0006910; GO:0006955; GO:0008329; GO:0016021; GO:0030169; GO:0030246; GO:0034138; GO:0046872; GO:0060355; GO:0071360	"collagen trimer [GO:0005581]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; transmembrane signaling receptor activity [GO:0004888]; cellular response to exogenous dsRNA [GO:0071360]; immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]"
PGEN_.00g331010	Scaffold_17	11312634	11353043	Q6PB44	PTN23_MOUSE	Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48)	GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0045022; GO:0060271; GO:0061357; GO:1903387; GO:1903393; GO:2000643	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]
PGEN_.00g331020	Scaffold_17	11367948	11420414	NA	NA	NA	NA	NA
PGEN_.00g331030	Scaffold_17	11430012	11473247	Q3TN34	MILK2_MOUSE	MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2)	GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0017137; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031532; GO:0031941; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; Rab GTPase binding [GO:0017137]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; substrate adhesion-dependent cell spreading [GO:0034446]
PGEN_.00g331040	Scaffold_17	11493655	11495229	Q9ULJ8	NEB1_HUMAN	Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A)	GO:0005737; GO:0005829; GO:0007015; GO:0007568; GO:0008022; GO:0008157; GO:0014069; GO:0015629; GO:0019722; GO:0019901; GO:0019904; GO:0030054; GO:0030175; GO:0030425; GO:0030833; GO:0030864; GO:0031175; GO:0031594; GO:0042803; GO:0043025; GO:0044325; GO:0044326; GO:0045860; GO:0051015; GO:0051020; GO:0051489; GO:0051497; GO:0051823; GO:0051963; GO:0060079; GO:0060999; GO:0061001; GO:0097237; GO:0098871; GO:0098974; GO:0098978; GO:1900272; GO:1900454; GO:1904049; GO:1990761	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone lamellipodium [GO:1990761]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823]
PGEN_.00g331050	Scaffold_17	11519061	11551078	O35274	NEB2_RAT	Neurabin-2 (Neurabin-II) (Neural tissue-specific F-actin-binding protein II) (PP1bp134) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin) (p130)	GO:0001932; GO:0001975; GO:0003006; GO:0003779; GO:0004672; GO:0004864; GO:0005654; GO:0005737; GO:0005886; GO:0005912; GO:0007015; GO:0007568; GO:0007612; GO:0008022; GO:0008157; GO:0010243; GO:0014069; GO:0014070; GO:0015629; GO:0016358; GO:0016477; GO:0019722; GO:0019900; GO:0021766; GO:0021987; GO:0030027; GO:0030042; GO:0030175; GO:0030308; GO:0030425; GO:0030426; GO:0030864; GO:0031175; GO:0031749; GO:0032355; GO:0032515; GO:0032587; GO:0032591; GO:0034695; GO:0035094; GO:0035690; GO:0035902; GO:0042127; GO:0042493; GO:0043005; GO:0043025; GO:0043197; GO:0043200; GO:0044325; GO:0044326; GO:0044327; GO:0044877; GO:0046847; GO:0048545; GO:0050804; GO:0051015; GO:0060179; GO:0061458; GO:0071315; GO:0071364; GO:0071392; GO:0071407; GO:0097338; GO:1901653; GO:1903078; GO:1903119; GO:1903829; GO:1904372; GO:1904373; GO:1904386; GO:1990778; GO:1990780; GO:2000474	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of dendritic spine plasma membrane [GO:1990780]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; dendritic spine membrane [GO:0032591]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; D2 dopamine receptor binding [GO:0031749]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; protein-containing complex binding [GO:0044877]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to morphine [GO:0071315]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptide [GO:1901653]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; developmental process involved in reproduction [GO:0003006]; filopodium assembly [GO:0046847]; hippocampus development [GO:0021766]; learning [GO:0007612]; male mating behavior [GO:0060179]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; neuron projection development [GO:0031175]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of protein localization to actin cortical patch [GO:1904372]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to actin cytoskeleton [GO:1903119]; protein localization to cell periphery [GO:1990778]; regulation of cell population proliferation [GO:0042127]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of protein phosphorylation [GO:0001932]; reproductive system development [GO:0061458]; response to amino acid [GO:0043200]; response to amphetamine [GO:0001975]; response to clozapine [GO:0097338]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to kainic acid [GO:1904373]; response to L-phenylalanine derivative [GO:1904386]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to prostaglandin E [GO:0034695]; response to steroid hormone [GO:0048545]
PGEN_.00g331060	Scaffold_17	11551538	11557172	NA	NA	NA	NA	NA
PGEN_.00g331070	Scaffold_17	11552913	11556438	NA	NA	NA	NA	NA
PGEN_.00g331080	Scaffold_17	11584154	11590681	NA	NA	NA	NA	NA
PGEN_.00g331090	Scaffold_17	11594574	11612448	NA	NA	NA	NA	NA
PGEN_.00g331100	Scaffold_17	11612868	11614579	NA	NA	NA	NA	NA
PGEN_.00g331110	Scaffold_17	11631468	11652614	O35186	CATK_RAT	Cathepsin K (EC 3.4.22.38)	GO:0001957; GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0006508; GO:0008234; GO:0030574; GO:0043394; GO:0045453; GO:0051603; GO:0061037	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; intramembranous ossification [GO:0001957]; negative regulation of cartilage development [GO:0061037]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g331120	Scaffold_17	11666923	11687845	NA	NA	NA	NA	NA
PGEN_.00g331130	Scaffold_17	11788947	11790122	NA	NA	NA	NA	NA
PGEN_.00g331140	Scaffold_17	11802590	11802937	NA	NA	NA	NA	NA
PGEN_.00g331150	Scaffold_17	11809535	11815522	NA	NA	NA	NA	NA
PGEN_.00g331160	Scaffold_17	11818027	11818317	NA	NA	NA	NA	NA
PGEN_.00g331170	Scaffold_17	11830291	11833693	P42519	STAR_DROME	Protein Star	GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]
PGEN_.00g331180	Scaffold_17	11857945	11858940	Q03923	ZNF85_HUMAN	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0046872	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]
PGEN_.00g331190	Scaffold_17	11860516	11868822	A8E627	ENDUD_XENLA	Poly(U)-specific endoribonuclease-D (EC 3.1.-.-) (Protein endoU-D) (Uridylate-specific endoribonuclease-D) (XendoU-D)	GO:0003723; GO:0004521; GO:0005576; GO:0046872	extracellular region [GO:0005576]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]
PGEN_.00g331200	Scaffold_17	11884425	11885123	NA	NA	NA	NA	NA
PGEN_.00g331210	Scaffold_17	11892686	11917146	P09057	DCOR_RAT	Ornithine decarboxylase (ODC) (EC 4.1.1.17)	GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]
PGEN_.00g331220	Scaffold_17	11922169	11935802	NA	NA	NA	NA	NA
PGEN_.00g331230	Scaffold_17	11940498	11958766	Q9I8S4	AZIN2_XENLA	Antizyme inhibitor 2 (AzI2) (Ornithine decarboxylase 2) (ODC 2) (xODC2) (Ornithine decarboxylase-like protein) (ODC-like protein) (ornithine decarboxylase paralog) (ODC-p)	GO:0003824; GO:0005634; GO:0005737; GO:0005801; GO:0005802; GO:0006596; GO:0030133; GO:0030424; GO:0030425; GO:0031410; GO:0033116; GO:0042978; GO:0043085; GO:0043204; GO:0048471; GO:0098629; GO:1902269; GO:1990005	axon [GO:0030424]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; granular vesicle [GO:1990005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; catalytic activity [GO:0003824]; ornithine decarboxylase activator activity [GO:0042978]; polyamine biosynthetic process [GO:0006596]; positive regulation of catalytic activity [GO:0043085]; positive regulation of polyamine transmembrane transport [GO:1902269]; trans-Golgi network membrane organization [GO:0098629]
PGEN_.00g331240	Scaffold_17	11970122	12010341	Q3UYG8	MACD2_MOUSE	ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2) (EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2) (EC 3.2.2.-)	GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0007420; GO:0009617; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617]"
PGEN_.00g331250	Scaffold_17	12030407	12062702	Q6A0A2	LAR4B_MOUSE	La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5)	GO:0003723; GO:0005730; GO:0005829; GO:0010494; GO:0042788; GO:0045727	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727]
PGEN_.00g331260	Scaffold_17	12064989	12065363	NA	NA	NA	NA	NA
PGEN_.00g331270	Scaffold_17	12070770	12076290	NA	NA	NA	NA	NA
PGEN_.00g331280	Scaffold_17	12098736	12102717	NA	NA	NA	NA	NA
PGEN_.00g331290	Scaffold_17	12108577	12113863	NA	NA	NA	NA	NA
PGEN_.00g331300	Scaffold_17	12130024	12188092	Q8K1N4	SPAS2_MOUSE	Spermatogenesis-associated serine-rich protein 2 (Serine-rich spermatocytes and round spermatid 59 kDa protein) (p59scr)	GO:0005737; GO:0005829	cytoplasm [GO:0005737]; cytosol [GO:0005829]
PGEN_.00g331310	Scaffold_17	12237316	12244715	NA	NA	NA	NA	NA
PGEN_.00g331320	Scaffold_17	12246956	12254527	NA	NA	NA	NA	NA
PGEN_.00g331330	Scaffold_17	12290391	12300763	P16092	FGFR1_MOUSE	Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331)	GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0002053; GO:0002062; GO:0004713; GO:0004714; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008284; GO:0008543; GO:0010468; GO:0010629; GO:0010763; GO:0010863; GO:0010966; GO:0010976; GO:0017134; GO:0018108; GO:0019827; GO:0021769; GO:0021837; GO:0021847; GO:0021954; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0043583; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0050839; GO:0051174; GO:0051930; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1905564; GO:2000546; GO:2000830; GO:2001239	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of sensory perception of pain [GO:0051930]; regulation of stem cell proliferation [GO:0072091]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]
PGEN_.00g331340	Scaffold_17	12307487	12336622	Q5T2T1	MPP7_HUMAN	MAGUK p55 subfamily member 7	GO:0005654; GO:0005912; GO:0005923; GO:0019904; GO:0030010; GO:0030054; GO:0031334; GO:0035591; GO:0045296; GO:0046982; GO:0060090; GO:0070830; GO:0071896; GO:0097025	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; signaling adaptor activity [GO:0035591]; bicellular tight junction assembly [GO:0070830]; establishment of cell polarity [GO:0030010]; positive regulation of protein complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896]
PGEN_.00g331350	Scaffold_17	12377591	12380095	NA	NA	NA	NA	NA
PGEN_.00g331360	Scaffold_17	12389165	12390351	NA	NA	NA	NA	NA
PGEN_.00g331370	Scaffold_17	12412468	12451488	P28699	RARG_XENLA	Retinoic acid receptor gamma (RAR-gamma) (Nuclear receptor subfamily 1 group B member 3)	GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565; GO:0048384	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; retinoic acid receptor signaling pathway [GO:0048384]
PGEN_.00g331380	Scaffold_17	12451522	12474056	NA	NA	NA	NA	NA
PGEN_.00g331390	Scaffold_17	12531514	12533214	NA	NA	NA	NA	NA
PGEN_.00g331400	Scaffold_17	12580452	12590533	Q7M456	RNOY_CRAGI	Ribonuclease Oy (RNase Oy) (EC 3.1.27.-)	GO:0003723; GO:0005576; GO:0033897	extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]
PGEN_.00g331410	Scaffold_17	12592238	12593100	NA	NA	NA	NA	NA
PGEN_.00g331420	Scaffold_17	12632811	12638666	NA	NA	NA	NA	NA
PGEN_.00g331430	Scaffold_17	12640833	12646064	NA	NA	NA	NA	NA
PGEN_.00g331440	Scaffold_17	12648814	12651171	NA	NA	NA	NA	NA
PGEN_.00g331450	Scaffold_17	12663286	12687375	NA	NA	NA	NA	NA
PGEN_.00g331460	Scaffold_17	12709293	12709631	NA	NA	NA	NA	NA
PGEN_.00g331470	Scaffold_17	12710083	12729645	P16330	CN37_MOUSE	"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)"	GO:0000226; GO:0003723; GO:0004113; GO:0005615; GO:0005654; GO:0005737; GO:0005741; GO:0005743; GO:0005829; GO:0005874; GO:0005886; GO:0005902; GO:0007409; GO:0007568; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0030551; GO:0030900; GO:0031143; GO:0032496; GO:0035748; GO:0035749; GO:0042470; GO:0042995; GO:0043209; GO:0046902; GO:0048471; GO:0048709	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; aging [GO:0007568]; axonogenesis [GO:0007409]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; microtubule cytoskeleton organization [GO:0000226]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]"
PGEN_.00g331480	Scaffold_17	12734854	12748691	Q28DE0	FAKD1_XENTR	"FAST kinase domain-containing protein 1, mitochondrial"	GO:0004672; GO:0005739	mitochondrion [GO:0005739]; protein kinase activity [GO:0004672]
PGEN_.00g331490	Scaffold_17	12773837	12774436	NA	NA	NA	NA	NA
PGEN_.00g331500	Scaffold_17	12779554	12779841	NA	NA	NA	NA	NA
PGEN_.00g331510	Scaffold_17	12789726	12790127	NA	NA	NA	NA	NA
PGEN_.00g331520	Scaffold_17	12790856	12799197	A0NLY7	ISAHY_LABAI	Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b)	GO:0004061; GO:0016812; GO:0019441; GO:0030145	"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]; tryptophan catabolic process to kynurenine [GO:0019441]"
PGEN_.00g331530	Scaffold_17	12867072	12892650	P43144	ACHA9_RAT	Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9)	GO:0004888; GO:0005262; GO:0005623; GO:0005887; GO:0005892; GO:0006812; GO:0007165; GO:0007204; GO:0007268; GO:0007605; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0042472; GO:0043005; GO:0045202; GO:0050877; GO:0050910; GO:0070373; GO:0098981; GO:0099060; GO:1904315	acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]
PGEN_.00g331540	Scaffold_17	12894310	12904940	Q5E9Y2	STX17_BOVIN	Syntaxin-17	GO:0000149; GO:0000421; GO:0005484; GO:0005739; GO:0005776; GO:0005789; GO:0005793; GO:0005829; GO:0006886; GO:0006888; GO:0006906; GO:0007030; GO:0012505; GO:0012507; GO:0016021; GO:0016240; GO:0019903; GO:0030134; GO:0030868; GO:0030897; GO:0031201; GO:0033116; GO:0034497; GO:0044233; GO:0048278; GO:0097111; GO:0097352	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; HOPS complex [GO:0030897]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum membrane [GO:0030868]; SNARE complex [GO:0031201]; protein phosphatase binding [GO:0019903]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to phagophore assembly site [GO:0034497]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]
PGEN_.00g331550	Scaffold_17	12910186	12955663	O14513	NCKP5_HUMAN	Nck-associated protein 5 (NAP-5) (Peripheral clock protein)	GO:0001578; GO:0007019; GO:0035371	microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]
PGEN_.00g331560	Scaffold_17	12975877	12977306	NA	NA	NA	NA	NA
PGEN_.00g331570	Scaffold_17	13036910	13067385	NA	NA	NA	NA	NA
PGEN_.00g331580	Scaffold_17	13132102	13150667	P48067	SC6A9_HUMAN	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)	GO:0001504; GO:0005886; GO:0005887; GO:0014069; GO:0015375; GO:0016020; GO:0030285; GO:0061537; GO:0098686; GO:0098688; GO:0099055; GO:0099056	"hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; glycine:sodium symporter activity [GO:0015375]; glycine secretion, neurotransmission [GO:0061537]; neurotransmitter uptake [GO:0001504]"
PGEN_.00g331590	Scaffold_17	13167918	13200502	Q2KHU5	MACD1_BOVIN	ADP-ribose glycohydrolase MACROD1 (MACRO domain-containing protein 1) (O-acetyl-ADP-ribose deacetylase MACROD1) (EC 3.1.1.106) (Protein LRP16) ([Protein ADP-ribosylaspartate] hydrolase MACROD1) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD1) (EC 3.2.2.-)	GO:0005634; GO:0006974; GO:0016798; GO:0051725; GO:0140291; GO:0140293	"nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]"
PGEN_.00g331600	Scaffold_17	13211456	13219493	Q8BVT6	PP2D1_MOUSE	Protein phosphatase 2C-like domain-containing protein 1	GO:0004722; GO:0004724; GO:1990439	magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; protein serine/threonine phosphatase activity [GO:0004722]
PGEN_.00g331610	Scaffold_17	13227456	13235661	Q8CDU5	EFHB_MOUSE	EF-hand domain-containing family member B	GO:0005737; GO:0032091; GO:0061891; GO:0070884; GO:2001256	cytoplasm [GO:0005737]; calcium ion sensor activity [GO:0061891]; negative regulation of protein binding [GO:0032091]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256]
PGEN_.00g331620	Scaffold_17	13241268	13249895	Q5R7L7	RAB5C_PONAB	Ras-related protein Rab-5C	GO:0003924; GO:0005525; GO:0005811; GO:0005886; GO:0015031; GO:0019003; GO:0031901; GO:0048227	early endosome membrane [GO:0031901]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; plasma membrane to endosome transport [GO:0048227]; protein transport [GO:0015031]
PGEN_.00g331630	Scaffold_17	13286209	13290477	Q9C0F3	ZN436_HUMAN	Zinc finger protein 436	GO:0003677; GO:0005654; GO:0005829; GO:0006355; GO:0046872	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g331640	Scaffold_17	13290886	13294636	Q9UBQ7	GRHPR_HUMAN	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	GO:0005737; GO:0005782; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0034641; GO:0042803; GO:0043648; GO:0046487; GO:0051259; GO:0051287; GO:0055114; GO:0070062; GO:0070402	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]"
PGEN_.00g331650	Scaffold_17	13297391	13301754	Q9UBQ7	GRHPR_HUMAN	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	GO:0005737; GO:0005782; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0034641; GO:0042803; GO:0043648; GO:0046487; GO:0051259; GO:0051287; GO:0055114; GO:0070062; GO:0070402	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]"
PGEN_.00g331660	Scaffold_17	13303760	13325333	Q9P2E3	ZNFX1_HUMAN	NFX1-type zinc finger-containing protein 1	GO:0000775; GO:0000790; GO:0000981; GO:0003723; GO:0005634; GO:0008270; GO:0030702; GO:0031048; GO:0031380	"chromosome, centromeric region [GO:0000775]; nuclear chromatin [GO:0000790]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048]"
PGEN_.00g331670	Scaffold_17	13342558	13343019	NA	NA	NA	NA	NA
PGEN_.00g331680	Scaffold_17	13350530	13354357	NA	NA	NA	NA	NA
PGEN_.00g331690	Scaffold_17	13354640	13399499	Q7ZU45	TTC25_DANRE	Tetratricopeptide repeat protein 25 (TPR repeat protein 25)	GO:0005737; GO:0005856; GO:0032474; GO:0042995; GO:0060271; GO:0061371	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]
PGEN_.00g331700	Scaffold_17	13402659	13409519	Q28178	TSP1_BOVIN	Thrombospondin-1 (Glycoprotein G)	GO:0005509; GO:0005615; GO:0005783; GO:0006954; GO:0006986; GO:0007155; GO:0008201; GO:0009986; GO:0016525; GO:0016529; GO:0031012; GO:0034976; GO:0048266; GO:0050840; GO:0062023	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]
PGEN_.00g331710	Scaffold_17	13416691	13447658	NA	NA	NA	NA	NA
PGEN_.00g331720	Scaffold_17	13475707	13487225	NA	NA	NA	NA	NA
PGEN_.00g331730	Scaffold_17	13494947	13504771	NA	NA	NA	NA	NA
PGEN_.00g331740	Scaffold_17	13513960	13529593	O00203	AP3B1_HUMAN	AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)	GO:0005623; GO:0005765; GO:0005794; GO:0006622; GO:0006886; GO:0007596; GO:0008089; GO:0016020; GO:0016182; GO:0016192; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0032438; GO:0045202; GO:0048007; GO:0048490; GO:0051138; GO:1904115	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cell [GO:0005623]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; synapse [GO:0045202]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; positive regulation of NK T cell differentiation [GO:0051138]; protein targeting to lysosome [GO:0006622]; synaptic vesicle budding from endosome [GO:0016182]; vesicle-mediated transport [GO:0016192]"
PGEN_.00g331750	Scaffold_17	13531191	13541083	Q13367	AP3B2_HUMAN	AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain) (Neuron-specific vesicle coat protein beta-NAP)	GO:0005794; GO:0006886; GO:0008089; GO:0016192; GO:0030123; GO:0030665; GO:0048490; GO:0097708; GO:1904115	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]
PGEN_.00g331760	Scaffold_17	13550754	13551796	NA	NA	NA	NA	NA
PGEN_.00g331770	Scaffold_17	13564634	13571926	A1L2P7	EFTS_XENLA	"Elongation factor Ts, mitochondrial (EF-Ts) (EF-TsMt)"	GO:0003746; GO:0005739	mitochondrion [GO:0005739]; translation elongation factor activity [GO:0003746]
PGEN_.00g331780	Scaffold_17	13588214	13603151	Q64520	KGUA_MOUSE	Guanylate kinase (EC 2.7.4.8) (GMP kinase) (Guanylate kinase 1)	GO:0001917; GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0006185; GO:0006805; GO:0019673; GO:0034436; GO:0046034; GO:0046037; GO:0046054; GO:0046060; GO:0046711; GO:0046939	cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; nucleotide phosphorylation [GO:0046939]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805]
PGEN_.00g331790	Scaffold_17	13624131	13644896	Q4ZJM7	OTOL1_MOUSE	Otolin-1	GO:0005201; GO:0005509; GO:0005576; GO:0005581; GO:0005615; GO:0030198; GO:0031012; GO:0045299; GO:0051260	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; otolith mineralization [GO:0045299]; protein homooligomerization [GO:0051260]
PGEN_.00g331800	Scaffold_17	13649032	13651444	NA	NA	NA	NA	NA
PGEN_.00g331810	Scaffold_17	13658558	13659253	NA	NA	NA	NA	NA
PGEN_.00g331820	Scaffold_17	13669921	13676820	Q66I61	CX056_DANRE	UPF0428 protein CXorf56 homolog	GO:0005634; GO:0005737; GO:0044297	cell body [GO:0044297]; cytoplasm [GO:0005737]; nucleus [GO:0005634]
PGEN_.00g331830	Scaffold_17	13689721	13709256	Q99759	M3K3_HUMAN	Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3)	GO:0000165; GO:0001568; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0023014; GO:0032147; GO:0035556; GO:0043123; GO:0046777; GO:0046872; GO:0070498; GO:0071864; GO:0090050; GO:1900745; GO:2000773	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; blood vessel development [GO:0001568]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; signal transduction by protein phosphorylation [GO:0023014]
PGEN_.00g331840	Scaffold_17	13726488	13733595	NA	NA	NA	NA	NA
PGEN_.00g331850	Scaffold_17	13766287	13773523	Q99741	CDC6_HUMAN	Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6)	GO:0000076; GO:0000079; GO:0000082; GO:0000083; GO:0000166; GO:0000278; GO:0000922; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0019900; GO:0030071; GO:0032467; GO:0033314; GO:0045737; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:1904117; GO:1904385	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]; nucleotide binding [GO:0000166]; cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; traversing start control point of mitotic cell cycle [GO:0007089]
PGEN_.00g331860	Scaffold_17	13775128	13806057	Q5ZKA3	CWC22_CHICK	Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog)	GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0016607; GO:0071005; GO:0071006; GO:0071007; GO:0071013	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g331870	Scaffold_17	13830674	13853447	NA	NA	NA	NA	NA
PGEN_.00g331880	Scaffold_17	13861153	13893076	Q8N8U9	BMPER_HUMAN	BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2)	GO:0001657; GO:0002043; GO:0005615; GO:0010594; GO:0030514; GO:0042118; GO:0048839; GO:0060393; GO:0070374; GO:1903672	extracellular space [GO:0005615]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; ureteric bud development [GO:0001657]
PGEN_.00g331890	Scaffold_17	13974551	13990834	Q3TIU4	PDE12_MOUSE	"2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)"	GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0006397; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0060548; GO:0071346; GO:0071359; GO:0090305; GO:0090324; GO:0090503	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"
PGEN_.00g331900	Scaffold_17	13990927	13999831	Q6AXQ5	PDE12_RAT	"2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)"	GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0006397; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0060548; GO:0071346; GO:0071359; GO:0090305; GO:0090324; GO:0090503	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"
PGEN_.00g331910	Scaffold_17	14052925	14067305	A7J1T0	M313B_XENLA	Mitogen-activated protein kinase kinase kinase 13-B (EC 2.7.11.25)	GO:0004709; GO:0005524; GO:0005737; GO:0016020; GO:0046777	cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein autophosphorylation [GO:0046777]
PGEN_.00g331920	Scaffold_17	14102160	14107842	Q07954	LRP1_HUMAN	Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]	GO:0001523; GO:0001540; GO:0002020; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005623; GO:0005634; GO:0005765; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0007568; GO:0008283; GO:0010715; GO:0010875; GO:0010942; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030226; GO:0030425; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038023; GO:0038024; GO:0042157; GO:0042953; GO:0043025; GO:0043235; GO:0043277; GO:0043395; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045056; GO:0045177; GO:0045202; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051481; GO:0051895; GO:0061642; GO:0070325; GO:0070374; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905049; GO:1905167; GO:2000587	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; synapse [GO:0045202]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]
PGEN_.00g331930	Scaffold_17	14138294	14150038	Q4R6F0	LRRD1_MACFA	Leucine-rich repeat and death domain-containing protein 1	GO:0007165	signal transduction [GO:0007165]
PGEN_.00g331940	Scaffold_17	14154146	14210665	O75165	DJC13_HUMAN	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]
PGEN_.00g331950	Scaffold_17	14221720	14231051	A2RSX7	TYW5_MOUSE	tRNA wybutosine-synthesizing protein 5 (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase)	GO:0000049; GO:0005506; GO:0016706; GO:0031591; GO:0042803; GO:0102524	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524]; wybutosine biosynthetic process [GO:0031591]
PGEN_.00g331960	Scaffold_17	14260294	14261637	NA	NA	NA	NA	NA
PGEN_.00g331970	Scaffold_17	14263696	14271765	Q6P886	DBR1_XENTR	Lariat debranching enzyme (EC 3.1.-.-)	GO:0000375; GO:0000398; GO:0005634; GO:0008419	"nucleus [GO:0005634]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"
PGEN_.00g331980	Scaffold_17	14273388	14278654	Q6GPB8	DBR1A_XENLA	Lariat debranching enzyme A (EC 3.1.-.-)	GO:0000375; GO:0005634; GO:0006397; GO:0008419	"nucleus [GO:0005634]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA processing [GO:0006397]; RNA splicing, via transesterification reactions [GO:0000375]"
PGEN_.00g331990	Scaffold_17	14280744	14282821	NA	NA	NA	NA	NA
PGEN_.00g332000	Scaffold_17	14309686	14316869	A2RSX7	TYW5_MOUSE	tRNA wybutosine-synthesizing protein 5 (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase)	GO:0000049; GO:0005506; GO:0016706; GO:0031591; GO:0042803; GO:0102524	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524]; wybutosine biosynthetic process [GO:0031591]
PGEN_.00g332010	Scaffold_17	14327952	14384348	O75165	DJC13_HUMAN	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]
PGEN_.00g332020	Scaffold_17	14390404	14400895	Q4R6F0	LRRD1_MACFA	Leucine-rich repeat and death domain-containing protein 1	GO:0007165	signal transduction [GO:0007165]
PGEN_.00g332030	Scaffold_17	14430268	14435131	Q07954	LRP1_HUMAN	Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]	GO:0001523; GO:0001540; GO:0002020; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005623; GO:0005634; GO:0005765; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0007568; GO:0008283; GO:0010715; GO:0010875; GO:0010942; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030226; GO:0030425; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038023; GO:0038024; GO:0042157; GO:0042953; GO:0043025; GO:0043235; GO:0043277; GO:0043395; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045056; GO:0045177; GO:0045202; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051481; GO:0051895; GO:0061642; GO:0070325; GO:0070374; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905049; GO:1905167; GO:2000587	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; synapse [GO:0045202]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]
PGEN_.00g332040	Scaffold_17	14460928	14483997	A7J1T0	M313B_XENLA	Mitogen-activated protein kinase kinase kinase 13-B (EC 2.7.11.25)	GO:0004709; GO:0005524; GO:0005737; GO:0016020; GO:0046777	cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein autophosphorylation [GO:0046777]
PGEN_.00g332050	Scaffold_17	14565145	14568607	NA	NA	NA	NA	NA
PGEN_.00g332060	Scaffold_17	14568757	14569026	NA	NA	NA	NA	NA
PGEN_.00g332070	Scaffold_17	14579021	14582954	NA	NA	NA	NA	NA
PGEN_.00g332080	Scaffold_17	14601615	14619842	Q8WU90	ZC3HF_HUMAN	Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4)	GO:0002181; GO:0003723; GO:0005730; GO:0005829; GO:0019221; GO:0043547; GO:0045296; GO:0046872	cytosol [GO:0005829]; nucleolus [GO:0005730]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]; positive regulation of GTPase activity [GO:0043547]
PGEN_.00g332090	Scaffold_17	14624438	14645883	NA	NA	NA	NA	NA
PGEN_.00g332100	Scaffold_17	14661038	14665391	NA	NA	NA	NA	NA
PGEN_.00g332110	Scaffold_17	14668936	14674483	NA	NA	NA	NA	NA
PGEN_.00g332120	Scaffold_17	14707301	14715987	P18519	TNR16_CHICK	Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD)	GO:0005035; GO:0005516; GO:0005886; GO:0006919; GO:0007266; GO:0007399; GO:0009986; GO:0015026; GO:0016021; GO:0030054; GO:0030154; GO:0030426; GO:0031625; GO:0032922; GO:0043121; GO:0043197; GO:0043204; GO:0048406; GO:0051402; GO:1900182; GO:1902895; GO:1903588; GO:1904646	cell junction [GO:0030054]; cell surface [GO:0009986]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; circadian regulation of gene expression [GO:0032922]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein localization to nucleus [GO:1900182]; Rho protein signal transduction [GO:0007266]
PGEN_.00g332130	Scaffold_17	14743967	14792009	A0JM23	NPHP3_XENTR	Nephrocystin-3	GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095	"cilium [GO:0005929]; cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g332140	Scaffold_17	14797639	14801930	Q5KU26	COL12_HUMAN	Collectin-12 (Collectin placenta protein 1) (CL-P1) (hCL-P1) (Nurse cell scavenger receptor 2) (Scavenger receptor class A member 4) (Scavenger receptor with C-type lectin)	GO:0005044; GO:0005534; GO:0005581; GO:0005615; GO:0005886; GO:0006898; GO:0006910; GO:0006952; GO:0008329; GO:0009756; GO:0016021; GO:0030169; GO:0030666; GO:0031012; GO:0034138; GO:0045087; GO:0046872; GO:0050776; GO:0051260; GO:0060355; GO:0071360	"collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; galactose binding [GO:0005534]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; carbohydrate mediated signaling [GO:0009756]; cellular response to exogenous dsRNA [GO:0071360]; defense response [GO:0006952]; innate immune response [GO:0045087]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; protein homooligomerization [GO:0051260]; receptor-mediated endocytosis [GO:0006898]; regulation of immune response [GO:0050776]; toll-like receptor 3 signaling pathway [GO:0034138]"
PGEN_.00g332150	Scaffold_17	14822323	14881970	P09480	ACHA2_CHICK	Neuronal acetylcholine receptor subunit alpha-2	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g332160	Scaffold_17	14890253	14924784	Q8N608	DPP10_HUMAN	Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2)	GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078	membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]
PGEN_.00g332170	Scaffold_17	15024511	15036335	P00185	CP1A1_RAT	Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Cytochrome P450MT2) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B]	GO:0001666; GO:0001889; GO:0002933; GO:0003824; GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0006778; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0008395; GO:0009308; GO:0009404; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009636; GO:0009804; GO:0009812; GO:0010033; GO:0010041; GO:0014070; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0016829; GO:0017143; GO:0017144; GO:0018894; GO:0019341; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0032502; GO:0033189; GO:0035902; GO:0042493; GO:0042572; GO:0042904; GO:0043010; GO:0043231; GO:0046483; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0055114; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0101020; GO:0101021; GO:1900087	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; developmental process [GO:0032502]; dibenzo-p-dioxin catabolic process [GO:0019341]; dibenzo-p-dioxin metabolic process [GO:0018894]; digestive tract development [GO:0048565]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; liver development [GO:0001889]; maternal process involved in parturition [GO:0060137]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; toxin metabolic process [GO:0009404]"
PGEN_.00g332180	Scaffold_17	15126075	15267837	Q07954	LRP1_HUMAN	Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]	GO:0001523; GO:0001540; GO:0002020; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005623; GO:0005634; GO:0005765; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0007568; GO:0008283; GO:0010715; GO:0010875; GO:0010942; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030226; GO:0030425; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038023; GO:0038024; GO:0042157; GO:0042953; GO:0043025; GO:0043235; GO:0043277; GO:0043395; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045056; GO:0045177; GO:0045202; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051481; GO:0051895; GO:0061642; GO:0070325; GO:0070374; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905049; GO:1905167; GO:2000587	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; synapse [GO:0045202]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]
PGEN_.00g332190	Scaffold_17	15277442	15282523	P51508	ZNF81_HUMAN	Zinc finger protein 81 (HFZ20)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g332200	Scaffold_17	15285373	15370662	Q6ZQQ6	WDR87_HUMAN	WD repeat-containing protein 87 (Testis development protein NYD-SP11)		
PGEN_.00g332210	Scaffold_17	15375081	15396074	NA	NA	NA	NA	NA
PGEN_.00g332220	Scaffold_17	15396233	15396613	NA	NA	NA	NA	NA
PGEN_.00g332230	Scaffold_17	15396725	15397195	NA	NA	NA	NA	NA
PGEN_.00g332240	Scaffold_17	15397223	15410451	NA	NA	NA	NA	NA
PGEN_.00g332250	Scaffold_17	15429708	15461834	Q29261	VILI_PIG	Villin-1	GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008360; GO:0009617; GO:0010634; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392	"actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]"
PGEN_.00g332260	Scaffold_17	15547997	15556331	Q5BIM1	TRI45_BOVIN	Tripartite motif-containing protein 45	GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
PGEN_.00g332270	Scaffold_17	15559581	15571063	P97411	ICA69_MOUSE	Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69)	GO:0000139; GO:0005795; GO:0005829; GO:0006836; GO:0019904; GO:0030054; GO:0030425; GO:0030667; GO:0030672; GO:0043231; GO:0043254; GO:0046928; GO:0048471; GO:0050796	cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein complex assembly [GO:0043254]
PGEN_.00g332280	Scaffold_17	15592004	15600664	NA	NA	NA	NA	NA
PGEN_.00g332290	Scaffold_17	15711217	15713166	Q64127	TIF1A_MOUSE	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005737; GO:0006468; GO:0008270; GO:0008285; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043565; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]"
PGEN_.00g332300	Scaffold_17	15729805	15737673	P51397	DAP1_HUMAN	Death-associated protein 1 (DAP-1)	GO:0006914; GO:0006915; GO:0006919; GO:0010507; GO:0032088; GO:0034198; GO:0045892; GO:0070513; GO:0097190	"death domain binding [GO:0070513]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g332310	Scaffold_17	15738575	15749378	Q9DBF7	CWC25_MOUSE	Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25)	GO:0000398; GO:0005634; GO:0016607; GO:0071006	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g332320	Scaffold_17	15762615	15768420	Q05084	ICA69_HUMAN	Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69)	GO:0000139; GO:0005737; GO:0005829; GO:0006836; GO:0019904; GO:0030054; GO:0030667; GO:0030672; GO:0043231; GO:0050796	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]
PGEN_.00g332330	Scaffold_17	15829316	15847609	Q8NDN9	RCBT1_HUMAN	RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein) (CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1)	GO:0005634; GO:0005737; GO:0006325; GO:0007049	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]
PGEN_.00g332340	Scaffold_17	15847852	15851509	P61799	APTX_DANRE	Aprataxin (EC 3.1.11.7) (EC 3.1.12.2) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT)	GO:0000012; GO:0003697; GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0030983; GO:0033699; GO:0046872; GO:0120108; GO:1990165	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mismatched DNA binding [GO:0030983]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]
PGEN_.00g332350	Scaffold_17	15852781	15864316	NA	NA	NA	NA	NA
PGEN_.00g332360	Scaffold_17	15870616	15890442	NA	NA	NA	NA	NA
PGEN_.00g332370	Scaffold_17	15901342	15902046	NA	NA	NA	NA	NA
PGEN_.00g332380	Scaffold_17	15921369	15928770	NA	NA	NA	NA	NA
PGEN_.00g332390	Scaffold_17	15932632	15935602	NA	NA	NA	NA	NA
PGEN_.00g332400	Scaffold_17	15938502	15945365	NA	NA	NA	NA	NA
PGEN_.00g332410	Scaffold_17	15948476	15959934	Q91ZI0	CELR3_MOUSE	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0001764; GO:0001932; GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007413; GO:0016021; GO:0032880; GO:0036514; GO:0036515; GO:0060271; GO:0098609; GO:1904938	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; axonal fasciculation [GO:0007413]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]
PGEN_.00g332420	Scaffold_17	15960715	15961488	A6MFL0	OXLA_DEMVE	L-amino-acid oxidase (DvLAAO) (LAO) (EC 1.4.3.2)	GO:0001716; GO:0005576; GO:0006915; GO:0009405; GO:0042742; GO:0044179; GO:0090729	extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; toxin activity [GO:0090729]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; hemolysis in other organism [GO:0044179]; pathogenesis [GO:0009405]
PGEN_.00g332430	Scaffold_17	15967610	15968866	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g332440	Scaffold_17	16003098	16004060	O34363	YOBN_BACSU	Putative L-amino-acid oxidase YobN (EC 1.4.3.2)	GO:0001716; GO:0009063; GO:0016491	L-amino-acid oxidase activity [GO:0001716]; oxidoreductase activity [GO:0016491]; cellular amino acid catabolic process [GO:0009063]
PGEN_.00g332450	Scaffold_17	16014390	16025810	NA	NA	NA	NA	NA
PGEN_.00g332460	Scaffold_17	16022334	16022837	NA	NA	NA	NA	NA
PGEN_.00g332470	Scaffold_17	16032908	16037363	NA	NA	NA	NA	NA
PGEN_.00g332480	Scaffold_17	16037566	16040132	NA	NA	NA	NA	NA
PGEN_.00g332490	Scaffold_17	16062972	16063439	NA	NA	NA	NA	NA
PGEN_.00g332500	Scaffold_17	16070468	16070914	NA	NA	NA	NA	NA
PGEN_.00g332510	Scaffold_17	16075049	16075519	NA	NA	NA	NA	NA
PGEN_.00g332520	Scaffold_17	16080923	16081495	NA	NA	NA	NA	NA
PGEN_.00g332530	Scaffold_17	16087595	16087828	NA	NA	NA	NA	NA
PGEN_.00g332540	Scaffold_17	16087919	16088131	NA	NA	NA	NA	NA
PGEN_.00g332550	Scaffold_17	16106626	16109884	NA	NA	NA	NA	NA
PGEN_.00g332560	Scaffold_17	16111820	16124867	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g332570	Scaffold_17	16134994	16163672	B3EWZ3	CADN_ACRMI	Coadhesin (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g332580	Scaffold_17	16175405	16181543	P97353	SEC1_MOUSE	"Galactoside 2-alpha-L-fucosyltransferase 3 (EC 2.4.1.69) (Alpha(1,2)FT 3) (Fucosyltransferase 10) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 3) (Secretory blood group protein 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g332590	Scaffold_17	16193533	16213757	Q5XXP2	OPN4_PHOSU	Melanopsin (Opsin-4)	GO:0005502; GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0016021; GO:0018298; GO:0042752; GO:0048511	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601]
PGEN_.00g332600	Scaffold_17	16249005	16254617	NA	NA	NA	NA	NA
PGEN_.00g332610	Scaffold_17	16260938	16263069	NA	NA	NA	NA	NA
PGEN_.00g332620	Scaffold_17	16360712	16369502	Q6AXQ5	PDE12_RAT	"2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)"	GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0006397; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0060548; GO:0071346; GO:0071359; GO:0090305; GO:0090324; GO:0090503	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"
PGEN_.00g332630	Scaffold_17	16370496	16374506	NA	NA	NA	NA	NA
PGEN_.00g332640	Scaffold_17	16377911	16384315	Q4G055	RNPC3_RAT	RNA-binding region-containing protein 3 (RNA-binding motif protein 40) (RNA-binding protein 40)	GO:0000398; GO:0005634; GO:0005654; GO:0005689; GO:0030626; GO:0097157	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]; mRNA splicing, via spliceosome [GO:0000398]"
PGEN_.00g332650	Scaffold_17	16401630	16413307	Q1LZH1	MARC2_BOVIN	Mitochondrial amidoxime reducing component 2 (mARC2) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2) (MOSC domain-containing protein 2) (Moco sulfurase C-terminal domain-containing protein 2)	GO:0005741; GO:0005777; GO:0008940; GO:0030151; GO:0030170; GO:0042126; GO:0043546	mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; nitrate metabolic process [GO:0042126]
PGEN_.00g332660	Scaffold_17	16419550	16439185	P20664	PRI1_MOUSE	DNA primase small subunit (EC 2.7.7.-) (DNA primase 49 kDa subunit) (p49)	GO:0003697; GO:0003896; GO:0005658; GO:0006269; GO:0046872	"alpha DNA polymerase:primase complex [GO:0005658]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA replication, synthesis of RNA primer [GO:0006269]"
PGEN_.00g332670	Scaffold_17	16462707	16463351	NA	NA	NA	NA	NA
PGEN_.00g332680	Scaffold_17	16475286	16492571	Q95Q62	IP3KH_CAEEL	"Inositol-trisphosphate 3-kinase homolog (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase homolog) (IP3 3-kinase) (IP3K) (InsP 3-kinase) (let-23 fertility effector 2)"	GO:0005524; GO:0008440; GO:0032958; GO:0048815	"ATP binding [GO:0005524]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; hermaphrodite genitalia morphogenesis [GO:0048815]; inositol phosphate biosynthetic process [GO:0032958]"
PGEN_.00g332690	Scaffold_17	16509468	16541930	Q9VAC5	ADA17_DROME	ADAM 17-like protease (EC 3.4.24.-)	GO:0004222; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]
PGEN_.00g332700	Scaffold_17	16544077	16577583	O75581	LRP6_HUMAN	Low-density lipoprotein receptor-related protein 6 (LRP-6)	GO:0001702; GO:0001843; GO:0001933; GO:0003344; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005623; GO:0005783; GO:0005886; GO:0005901; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009952; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021987; GO:0030326; GO:0030901; GO:0030917; GO:0031410; GO:0031901; GO:0034185; GO:0034392; GO:0035261; GO:0042475; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0051091; GO:0060021; GO:0060026; GO:0060059; GO:0060070; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090090; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:1904886; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g332710	Scaffold_17	16585937	16590426	NA	NA	NA	NA	NA
PGEN_.00g332720	Scaffold_17	16602325	16604727	P51814	ZNF41_HUMAN	Zinc finger protein 41	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g332730	Scaffold_17	16844093	16877868	P08941	ROS1_CHICK	Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase)	GO:0001558; GO:0002066; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0006468; GO:0007169; GO:0008283; GO:0030154; GO:0032006; GO:0043235; GO:0070372	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; columnar/cuboidal epithelial cell development [GO:0002066]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of TOR signaling [GO:0032006]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g332740	Scaffold_17	16878344	16917362	Q9DBR3	ARMC8_MOUSE	Armadillo repeat-containing protein 8	GO:0000151; GO:0005634; GO:0005737; GO:0034657; GO:0043161	cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]
PGEN_.00g332750	Scaffold_17	16923284	16957337	Q0P5W1	VPS8_MOUSE	Vacuolar protein sorting-associated protein 8 homolog	GO:0005769; GO:0033263; GO:0034058; GO:0046872	CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058]
PGEN_.00g332760	Scaffold_17	16961619	16973981	P90666	TXND3_HELCR	Thioredoxin domain-containing protein 3 homolog (Intermediate chain 1) (NME/NM23 family member 8)	GO:0004550; GO:0005623; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454	cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]
PGEN_.00g332770	Scaffold_17	16975704	17016358	P90666	TXND3_HELCR	Thioredoxin domain-containing protein 3 homolog (Intermediate chain 1) (NME/NM23 family member 8)	GO:0004550; GO:0005623; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454	cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]
PGEN_.00g332780	Scaffold_17	17033382	17079889	G5EBQ8	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063	cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]
PGEN_.00g332790	Scaffold_17	17088368	17094235	Q5ZKX6	UBE2F_CHICK	NEDD8-conjugating enzyme UBE2F (EC 2.3.2.32) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F)	GO:0005524; GO:0019788; GO:0045116; GO:0061654	ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; protein neddylation [GO:0045116]
PGEN_.00g332800	Scaffold_17	17107798	17121944	P17671	E75BC_DROME	"Ecdysone-induced protein 75B, isoforms C/D (E75-A) (Nuclear receptor subfamily 1 group D member 3, isoforms C/D)"	GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0003677; GO:0003707; GO:0004879; GO:0005634; GO:0007275; GO:0007553; GO:0007591; GO:0008134; GO:0008270; GO:0009755; GO:0010468; GO:0018990; GO:0020037; GO:0030154; GO:0030374; GO:0033993; GO:0035075; GO:0038023; GO:0045944; GO:0048477; GO:0090575	"nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; ecdysis, chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle, chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]; response to lipid [GO:0033993]"
PGEN_.00g332810	Scaffold_17	17154293	17155228	NA	NA	NA	NA	NA
PGEN_.00g332820	Scaffold_17	17156190	17156540	NA	NA	NA	NA	NA
PGEN_.00g332830	Scaffold_17	17156839	17157381	NA	NA	NA	NA	NA
PGEN_.00g332840	Scaffold_17	17157565	17160033	NA	NA	NA	NA	NA
PGEN_.00g332850	Scaffold_17	17170424	17176636	Q9GV41	PGFS_TRYBB	"9,11-endoperoxide prostaglandin H2 reductase (EC 1.1.1.-) (Prostaglandin F2-alpha synthase)"	GO:0000166; GO:0001516; GO:0004033; GO:0005737; GO:0019571; GO:0045290	cytoplasm [GO:0005737]; aldo-keto reductase (NADP) activity [GO:0004033]; D-arabinose 1-dehydrogenase [NAD(P)+] activity [GO:0045290]; nucleotide binding [GO:0000166]; D-arabinose catabolic process [GO:0019571]; prostaglandin biosynthetic process [GO:0001516]
PGEN_.00g332860	Scaffold_17	17183807	17184842	Q9C1X5	YKW2_SCHPO	Uncharacterized oxidoreductase P32A8.02 (EC 1.-.-.-)	GO:0004032; GO:0005634; GO:0005737; GO:0005829; GO:0008106; GO:0016491; GO:0019568; GO:0032866; GO:0032867; GO:0042843	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; D-xylose:NADP reductase activity [GO:0032866]; L-arabinose:NADP reductase activity [GO:0032867]; oxidoreductase activity [GO:0016491]; arabinose catabolic process [GO:0019568]; D-xylose catabolic process [GO:0042843]
PGEN_.00g332870	Scaffold_17	17201302	17205845	O14088	YER5_SCHPO	Uncharacterized oxidoreductase C2F3.05c (EC 1.-.-.-)	GO:0005634; GO:0005829; GO:0019568; GO:0032866; GO:0032867; GO:0042843	cytosol [GO:0005829]; nucleus [GO:0005634]; D-xylose:NADP reductase activity [GO:0032866]; L-arabinose:NADP reductase activity [GO:0032867]; arabinose catabolic process [GO:0019568]; D-xylose catabolic process [GO:0042843]
PGEN_.00g332880	Scaffold_17	17221919	17222212	NA	NA	NA	NA	NA
PGEN_.00g332890	Scaffold_17	17226343	17226762	NA	NA	NA	NA	NA
PGEN_.00g332900	Scaffold_17	17243339	17246013	NA	NA	NA	NA	NA
PGEN_.00g332910	Scaffold_17	17359039	17390988	Q9Z218	DPP6_MOUSE	Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI)	GO:0005886; GO:0008076; GO:0008236; GO:0009986; GO:0015459; GO:0016020; GO:0016021; GO:0019228; GO:0042391; GO:0043025; GO:0043266; GO:0043268; GO:0072659; GO:1901379; GO:1901381; GO:1903078	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; neuronal action potential [GO:0019228]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transport [GO:0043266]
PGEN_.00g332920	Scaffold_17	17391344	17393096	NA	NA	NA	NA	NA
PGEN_.00g332930	Scaffold_17	17401004	17408057	NA	NA	NA	NA	NA
PGEN_.00g332940	Scaffold_17	17410608	17412114	P97353	SEC1_MOUSE	"Galactoside 2-alpha-L-fucosyltransferase 3 (EC 2.4.1.69) (Alpha(1,2)FT 3) (Fucosyltransferase 10) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 3) (Secretory blood group protein 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g332950	Scaffold_17	17417286	17429896	NA	NA	NA	NA	NA
PGEN_.00g332960	Scaffold_17	17431689	17442261	NA	NA	NA	NA	NA
PGEN_.00g332970	Scaffold_17	17454996	17468410	NA	NA	NA	NA	NA
PGEN_.00g332980	Scaffold_17	17471932	17490809	A2RUV0	NOTC1_XENTR	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0016021; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314	"integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g332990	Scaffold_17	17492727	17503517	NA	NA	NA	NA	NA
PGEN_.00g333000	Scaffold_17	17506749	17520404	NA	NA	NA	NA	NA
PGEN_.00g333010	Scaffold_17	17522301	17540656	P10040	CRB_DROME	Protein crumbs (95F)	GO:0001745; GO:0003383; GO:0005080; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0007163; GO:0007391; GO:0007399; GO:0007424; GO:0007435; GO:0007443; GO:0008284; GO:0016021; GO:0016028; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0030507; GO:0032435; GO:0032880; GO:0033157; GO:0034332; GO:0035002; GO:0035003; GO:0035088; GO:0035090; GO:0035239; GO:0035332; GO:0042051; GO:0042052; GO:0045176; GO:0045186; GO:0045218; GO:0045494; GO:0045570; GO:0045746; GO:0046621; GO:0046664; GO:0046665; GO:0048190; GO:0050821; GO:0051301; GO:0051642; GO:0060438; GO:0061024; GO:0061336; GO:0061541; GO:0098813; GO:0106036	"apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance, open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; trachea development [GO:0060438]; tube morphogenesis [GO:0035239]; wing disc dorsal/ventral pattern formation [GO:0048190]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218]"
PGEN_.00g333020	Scaffold_17	17552792	17575876	NA	NA	NA	NA	NA
PGEN_.00g333030	Scaffold_17	17599538	17607848	NA	NA	NA	NA	NA
PGEN_.00g333040	Scaffold_17	17607970	17608308	NA	NA	NA	NA	NA
PGEN_.00g333050	Scaffold_17	17623305	17624621	NA	NA	NA	NA	NA
PGEN_.00g333060	Scaffold_17	17665589	17737057	Q868T3	CCAPR_DROME	Cardioacceleratory peptide receptor (Crustacean cardioactive peptide receptor)	GO:0005000; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0018990	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g333070	Scaffold_17	17757404	17757676	NA	NA	NA	NA	NA
PGEN_.00g333080	Scaffold_17	17759885	17763855	NA	NA	NA	NA	NA
PGEN_.00g333090	Scaffold_17	17849928	17850901	NA	NA	NA	NA	NA
PGEN_.00g333100	Scaffold_17	17863319	17869105	NA	NA	NA	NA	NA
PGEN_.00g333110	Scaffold_17	17913205	17936283	Q8K370	ACD10_MOUSE	Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-)	GO:0005739; GO:0016627; GO:0016787; GO:0050660	"mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"
PGEN_.00g333120	Scaffold_17	17936452	17944065	Q6JQN1	ACD10_HUMAN	Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-)	GO:0003995; GO:0005739; GO:0005759; GO:0006635; GO:0016787; GO:0050660	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; fatty acid beta-oxidation [GO:0006635]
PGEN_.00g333130	Scaffold_17	18005359	18011278	Q6DFF4	INT9_XENLA	Integrator complex subunit 9 (Int9)	GO:0016180; GO:0032039	integrator complex [GO:0032039]; snRNA processing [GO:0016180]
PGEN_.00g333140	Scaffold_17	18014273	18057514	Q5R4M2	ULK4_PONAB	Serine/threonine-protein kinase ULK4 (EC 2.7.11.1) (Unc-51-like kinase 4)	GO:0004674; GO:0005524	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]
PGEN_.00g333150	Scaffold_17	18069850	18105664	Q01320	TOP2A_MOUSE	"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)"	GO:0000228; GO:0000287; GO:0000712; GO:0000793; GO:0000819; GO:0002244; GO:0003677; GO:0003682; GO:0003916; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008094; GO:0008144; GO:0008301; GO:0009330; GO:0019035; GO:0019899; GO:0030261; GO:0030263; GO:0032991; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0043565; GO:0044774; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:0051309; GO:1905463; GO:1990904	"centriole [GO:0005814]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; viral integration complex [GO:0019035]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; DNA-dependent ATPase activity [GO:0008094]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; sequence-specific DNA binding [GO:0043565]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic DNA integrity checkpoint [GO:0044774]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]"
PGEN_.00g333160	Scaffold_17	18109143	18116609	NA	NA	NA	NA	NA
PGEN_.00g333170	Scaffold_17	18142684	18151401	NA	NA	NA	NA	NA
PGEN_.00g333180	Scaffold_17	18197440	18197748	NA	NA	NA	NA	NA
PGEN_.00g333190	Scaffold_17	18226437	18230521	Q9BDB7	IF44L_MOUSE	Interferon-induced protein 44-like [Cleaved into: Minor histocompatibility antigen HA-28 (HLA-HA28) (IFL8)]	GO:0005737; GO:0006955; GO:0051607	cytoplasm [GO:0005737]; defense response to virus [GO:0051607]; immune response [GO:0006955]
PGEN_.00g333200	Scaffold_17	18248396	18264016	Q8BV66	IFI44_MOUSE	Interferon-induced protein 44 (Microtubule-associated protein 44)	GO:0005737; GO:0006955; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]
PGEN_.00g333210	Scaffold_17	18284606	18284887	NA	NA	NA	NA	NA
PGEN_.00g333220	Scaffold_17	18286085	18293804	Q8BV66	IFI44_MOUSE	Interferon-induced protein 44 (Microtubule-associated protein 44)	GO:0005737; GO:0006955; GO:0009617	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]
PGEN_.00g333230	Scaffold_17	18309069	18316265	NA	NA	NA	NA	NA
PGEN_.00g333240	Scaffold_17	18327650	18331593	Q6V0I7	FAT4_HUMAN	Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
PGEN_.00g333250	Scaffold_17	18345605	18346417	NA	NA	NA	NA	NA
PGEN_.00g333260	Scaffold_17	18350490	18350819	NA	NA	NA	NA	NA
PGEN_.00g333270	Scaffold_17	18357080	18362346	NA	NA	NA	NA	NA
PGEN_.00g333280	Scaffold_17	18362676	18368164	NA	NA	NA	NA	NA
PGEN_.00g333290	Scaffold_17	18370311	18388082	NA	NA	NA	NA	NA
PGEN_.00g333300	Scaffold_17	18388234	18390195	Q25434	FP1_MYTCO	Adhesive plaque matrix protein (Foot protein 1) (MCFP1)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g333310	Scaffold_17	18390397	18394828	Q8IZH2	XRN1_HUMAN	5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog)	GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0043488; GO:0045202; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:0090503; GO:1905795	"cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"
PGEN_.00g333320	Scaffold_17	18404962	18420399	Q86TI4	WDR86_HUMAN	WD repeat-containing protein 86		
PGEN_.00g333330	Scaffold_17	18434288	18456010	Q5XGT8	SP8_XENLA	Transcription factor Sp8	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g333340	Scaffold_17	18506443	18506940	NA	NA	NA	NA	NA
PGEN_.00g333350	Scaffold_17	18506974	18507429	NA	NA	NA	NA	NA
PGEN_.00g333360	Scaffold_17	18507473	18508300	NA	NA	NA	NA	NA
PGEN_.00g333370	Scaffold_17	18541066	18560694	Q6NW96	SP9_DANRE	Transcription factor Sp9	GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0030326; GO:0035118; GO:0045743; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g333380	Scaffold_17	18627551	18627838	NA	NA	NA	NA	NA
PGEN_.00g333390	Scaffold_17	18632508	18633029	NA	NA	NA	NA	NA
PGEN_.00g333400	Scaffold_17	18635214	18637072	NA	NA	NA	NA	NA
PGEN_.00g333410	Scaffold_17	18655239	18658480	NA	NA	NA	NA	NA
PGEN_.00g333420	Scaffold_17	18705665	18711433	NA	NA	NA	NA	NA
PGEN_.00g333430	Scaffold_17	18754271	18758605	NA	NA	NA	NA	NA
PGEN_.00g333440	Scaffold_17	18867846	18872179	NA	NA	NA	NA	NA
PGEN_.00g333450	Scaffold_17	18917296	18923066	NA	NA	NA	NA	NA
PGEN_.00g333460	Scaffold_17	18970377	18973713	NA	NA	NA	NA	NA
PGEN_.00g333470	Scaffold_17	18991934	18993800	NA	NA	NA	NA	NA
PGEN_.00g333480	Scaffold_17	18995985	18996506	NA	NA	NA	NA	NA
PGEN_.00g333490	Scaffold_17	19068417	19087867	Q6NW96	SP9_DANRE	Transcription factor Sp9	GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0030326; GO:0035118; GO:0045743; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g333500	Scaffold_17	19120707	19121357	NA	NA	NA	NA	NA
PGEN_.00g333510	Scaffold_17	19121716	19122126	NA	NA	NA	NA	NA
PGEN_.00g333520	Scaffold_17	19122176	19123153	NA	NA	NA	NA	NA
PGEN_.00g333530	Scaffold_17	19171608	19180943	Q5XGT8	SP8_XENLA	Transcription factor Sp8	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g333540	Scaffold_17	19207496	19252244	Q86TI4	WDR86_HUMAN	WD repeat-containing protein 86		
PGEN_.00g333550	Scaffold_17	19279458	19282105	NA	NA	NA	NA	NA
PGEN_.00g333560	Scaffold_17	19305052	19308038	NA	NA	NA	NA	NA
PGEN_.00g333570	Scaffold_17	19327828	19341195	Q0ZLH3	PJVK_HUMAN	Pejvakin (Autosomal recessive deafness type 59 protein)	GO:0007605; GO:0043025	neuronal cell body [GO:0043025]; sensory perception of sound [GO:0007605]
PGEN_.00g333580	Scaffold_17	19404156	19405016	NA	NA	NA	NA	NA
PGEN_.00g333590	Scaffold_17	19407679	19407996	NA	NA	NA	NA	NA
PGEN_.00g333600	Scaffold_17	19408101	19409362	NA	NA	NA	NA	NA
PGEN_.00g333610	Scaffold_17	19437935	19454216	Q96S96	PEBP4_HUMAN	Phosphatidylethanolamine-binding protein 4 (PEBP-4) (hPEBP4) (Protein cousin-of-RKIP 1)	GO:0005764; GO:0070062	extracellular exosome [GO:0070062]; lysosome [GO:0005764]
PGEN_.00g333620	Scaffold_17	19467228	19467611	NA	NA	NA	NA	NA
PGEN_.00g333630	Scaffold_17	19471669	19471941	NA	NA	NA	NA	NA
PGEN_.00g333640	Scaffold_17	19476485	19489907	Q9CWR2	SMYD3_MOUSE	Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1)	GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g333650	Scaffold_17	19498512	19509217	NA	NA	NA	NA	NA
PGEN_.00g333660	Scaffold_17	19509275	19537857	Q9Y5A7	NUB1_HUMAN	NEDD8 ultimate buster 1 (Negative regulator of ubiquitin-like proteins 1) (Renal carcinoma antigen NY-REN-18)	GO:0005654; GO:0005730; GO:0005829; GO:0006511; GO:0016567; GO:0032436; GO:0034341; GO:0034612; GO:0043687	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g333670	Scaffold_17	19553665	19553964	NA	NA	NA	NA	NA
PGEN_.00g333680	Scaffold_17	19562442	19567444	P58421	FZD5_XENLA	Frizzled-5 (Fz-5) (Xfz5)	GO:0000139; GO:0004930; GO:0005886; GO:0016021; GO:0016055; GO:0042127; GO:0043010; GO:0045595; GO:0048666	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; camera-type eye development [GO:0043010]; neuron development [GO:0048666]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; Wnt signaling pathway [GO:0016055]
PGEN_.00g333690	Scaffold_17	19655402	19663314	NA	NA	NA	NA	NA
PGEN_.00g333700	Scaffold_17	19681135	19686849	O34363	YOBN_BACSU	Putative L-amino-acid oxidase YobN (EC 1.4.3.2)	GO:0001716; GO:0009063; GO:0016491	L-amino-acid oxidase activity [GO:0001716]; oxidoreductase activity [GO:0016491]; cellular amino acid catabolic process [GO:0009063]
PGEN_.00g333710	Scaffold_17	19705550	19706797	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g333720	Scaffold_17	19736342	19739966	Q9VZS3	ETIF1_DROME	Eukaryotic translation initiation factor eIF1 (Protein translation factor SUI1 homolog)	GO:0001731; GO:0003723; GO:0003743; GO:0016282; GO:0043024; GO:0043614; GO:0071456	eukaryotic 43S preinitiation complex [GO:0016282]; multi-eIF complex [GO:0043614]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cellular response to hypoxia [GO:0071456]; formation of translation preinitiation complex [GO:0001731]
PGEN_.00g333730	Scaffold_17	19753371	19813455	Q7TN73	CASD1_MOUSE	N-acetylneuraminate 9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (Sialate O-acetyltransferase) (SOAT)	GO:0005794; GO:0005975; GO:0016407; GO:0030173; GO:0047186	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; acetyltransferase activity [GO:0016407]; N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]; carbohydrate metabolic process [GO:0005975]
PGEN_.00g333740	Scaffold_17	19835172	19835603	NA	NA	NA	NA	NA
PGEN_.00g333750	Scaffold_17	19841196	19842354	NA	NA	NA	NA	NA
PGEN_.00g333760	Scaffold_17	19842386	19843237	NA	NA	NA	NA	NA
PGEN_.00g333770	Scaffold_17	19854682	19856230	Q69DL0	C1QA_PIG	Complement C1q subcomponent subunit A	GO:0005576; GO:0005581; GO:0006958; GO:0045087	"collagen trimer [GO:0005581]; extracellular region [GO:0005576]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]"
PGEN_.00g333780	Scaffold_17	19862330	19865665	NA	NA	NA	NA	NA
PGEN_.00g333790	Scaffold_17	19868247	19868510	NA	NA	NA	NA	NA
PGEN_.00g333800	Scaffold_17	19873317	19875230	NA	NA	NA	NA	NA
PGEN_.00g333810	Scaffold_17	19879435	19883883	NA	NA	NA	NA	NA
PGEN_.00g333820	Scaffold_17	19888302	19888781	NA	NA	NA	NA	NA
PGEN_.00g333830	Scaffold_17	19895200	19961069	B0S6T2	S15A2_DANRE	Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2)	GO:0001878; GO:0005887; GO:0015031; GO:0015333; GO:0016021; GO:0035673; GO:0071916; GO:1904680	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide transmembrane transporter activity [GO:1904680]; peptide:proton symporter activity [GO:0015333]; protein transport [GO:0015031]; response to yeast [GO:0001878]
PGEN_.00g333840	Scaffold_17	19988568	20007509	NA	NA	NA	NA	NA
PGEN_.00g333850	Scaffold_17	20093667	20100793	Q6P121	HYCCI_DANRE	Hyccin (Protein FAM126A)	GO:0005829; GO:0005886; GO:0042552; GO:0046854; GO:0072659	cytosol [GO:0005829]; plasma membrane [GO:0005886]; myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]
PGEN_.00g333860	Scaffold_17	20102311	20118125	NA	NA	NA	NA	NA
PGEN_.00g333870	Scaffold_17	20127703	20135335	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	"endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]"
PGEN_.00g333880	Scaffold_17	20148020	20149567	NA	NA	NA	NA	NA
PGEN_.00g333890	Scaffold_17	20158754	20160146	NA	NA	NA	NA	NA
PGEN_.00g333900	Scaffold_17	20161699	20171602	NA	NA	NA	NA	NA
PGEN_.00g333910	Scaffold_17	20193210	20203647	P14248	RPB1_PLAFD	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit)	GO:0003677; GO:0003899; GO:0005665; GO:0006366; GO:0046872	"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g333920	Scaffold_17	20204385	20208836	NA	NA	NA	NA	NA
PGEN_.00g333930	Scaffold_17	20224166	20233861	NA	NA	NA	NA	NA
PGEN_.00g333940	Scaffold_17	20241750	20267037	P27120	DCOR1_XENLA	Ornithine decarboxylase 1 (ODC 1) (xODC1) (EC 4.1.1.17)	GO:0004586; GO:0005737; GO:0033387	cytoplasm [GO:0005737]; ornithine decarboxylase activity [GO:0004586]; putrescine biosynthetic process from ornithine [GO:0033387]
PGEN_.00g333950	Scaffold_17	20319367	20319876	P27118	DCOR_CHICK	Ornithine decarboxylase (ODC) (EC 4.1.1.17) (Fragment)	GO:0004586; GO:0005737; GO:0033387	cytoplasm [GO:0005737]; ornithine decarboxylase activity [GO:0004586]; putrescine biosynthetic process from ornithine [GO:0033387]
PGEN_.00g333960	Scaffold_17	20328939	20380065	Q6ZS30	NBEL1_HUMAN	Neurobeachin-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein)		
PGEN_.00g333970	Scaffold_17	20380329	20395940	P55345	ANM2_HUMAN	Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2)	GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006479; GO:0007165; GO:0008469; GO:0016274; GO:0016571; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:2000134	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone-arginine N-methyltransferase activity [GO:0008469]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]"
PGEN_.00g333980	Scaffold_17	20403964	20404296	P0CW97	PCR3_ARATH	Protein PLANT CADMIUM RESISTANCE 3 (AtPCR3)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g333990	Scaffold_17	20415710	20422396	NA	NA	NA	NA	NA
PGEN_.00g334000	Scaffold_17	20451075	20457870	D4A6L0	GP158_RAT	Probable G-protein coupled receptor 158	GO:0004930; GO:0005886; GO:0007186; GO:0016020; GO:0016021; GO:0072659	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; protein localization to plasma membrane [GO:0072659]
PGEN_.00g334010	Scaffold_17	20566453	20576793	P35224	CTNB_URECA	Catenin beta (Beta-catenin)	GO:0005737; GO:0005856; GO:0007155; GO:0045296	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]
PGEN_.00g334020	Scaffold_17	20592775	20627371	NA	NA	NA	NA	NA
PGEN_.00g334030	Scaffold_17	20676879	20699467	P49869	HR38_DROME	Probable nuclear hormone receptor HR38 (dHR38) (Nuclear receptor subfamily 4 group A member 4)	GO:0000977; GO:0000978; GO:0001047; GO:0003707; GO:0004879; GO:0005102; GO:0005634; GO:0005667; GO:0005737; GO:0008270; GO:0035259; GO:0042335; GO:0043565; GO:0045944; GO:0046982; GO:0048082; GO:0071376	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; core promoter binding [GO:0001047]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cuticle development [GO:0042335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adult chitin-containing cuticle pigmentation [GO:0048082]
PGEN_.00g334040	Scaffold_17	20700997	20709581	NA	NA	NA	NA	NA
PGEN_.00g334050	Scaffold_17	20709659	20711113	A6Q4Z6	HLDE_NITSB	Bifunctional protein HldE [Includes: D-beta-D-heptose 7-phosphate kinase (EC 2.7.1.167) (D-beta-D-heptose 7-phosphotransferase) (D-glycero-beta-D-manno-heptose-7-phosphate kinase); D-beta-D-heptose 1-phosphate adenylyltransferase (EC 2.7.7.70) (D-glycero-beta-D-manno-heptose 1-phosphate adenylyltransferase)]	GO:0005524; GO:0016773; GO:0033785; GO:0033786; GO:0097171	"ATP binding [GO:0005524]; heptose 7-phosphate kinase activity [GO:0033785]; heptose-1-phosphate adenylyltransferase activity [GO:0033786]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; ADP-L-glycero-beta-D-manno-heptose biosynthetic process [GO:0097171]"
PGEN_.00g334060	Scaffold_17	20713969	20722398	A7MAZ3	UBA5_BOVIN	Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1)	GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0032446; GO:0033146; GO:0034976; GO:0046872; GO:0050905; GO:0071566; GO:0071569; GO:1990592	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; UFM1 activating enzyme activity [GO:0071566]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]
PGEN_.00g334070	Scaffold_17	20796373	20811097	NA	NA	NA	NA	NA
PGEN_.00g334080	Scaffold_17	20824833	20853892	NA	NA	NA	NA	NA
PGEN_.00g334090	Scaffold_17	20868024	20869916	NA	NA	NA	NA	NA
PGEN_.00g334100	Scaffold_17	20874205	20874762	NA	NA	NA	NA	NA
PGEN_.00g334110	Scaffold_17	20910748	20911242	NA	NA	NA	NA	NA
PGEN_.00g334120	Scaffold_17	20911688	20912191	NA	NA	NA	NA	NA
PGEN_.00g334130	Scaffold_17	20926700	20926936	NA	NA	NA	NA	NA
PGEN_.00g334140	Scaffold_17	20934696	20937641	NA	NA	NA	NA	NA
PGEN_.00g334150	Scaffold_17	20988978	20993429	Q5WA50	CTR2_OCTVU	Cephalotocin receptor 2	GO:0005000; GO:0005886; GO:0007186; GO:0016021; GO:0016500; GO:0046887	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of hormone secretion [GO:0046887]
PGEN_.00g334160	Scaffold_17	21025053	21025631	NA	NA	NA	NA	NA
PGEN_.00g334170	Scaffold_17	21036728	21075918	Q8IZF6	AGRG4_HUMAN	Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112)	GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g334180	Scaffold_17	21108575	21111404	NA	NA	NA	NA	NA
PGEN_.00g334190	Scaffold_17	21117287	21153983	B7ZCC9	AGRG4_MOUSE	Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112)	GO:0004930; GO:0005887; GO:0007166; GO:0007189	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]
PGEN_.00g334200	Scaffold_17	21155230	21155619	NA	NA	NA	NA	NA
PGEN_.00g334210	Scaffold_17	21156463	21156762	NA	NA	NA	NA	NA
PGEN_.00g334220	Scaffold_17	21156848	21160439	NA	NA	NA	NA	NA
PGEN_.00g334230	Scaffold_17	21175872	21176210	NA	NA	NA	NA	NA
PGEN_.00g334240	Scaffold_17	21181016	21181252	NA	NA	NA	NA	NA
PGEN_.00g334250	Scaffold_17	21200375	21212229	Q6ZTW0	TPGS1_HUMAN	Tubulin polyglutamylase complex subunit 1 (PGs1)	GO:0005737; GO:0005813; GO:0005874; GO:0007268; GO:0007275; GO:0007288; GO:0008017; GO:0018095; GO:0030424; GO:0030425; GO:0030534; GO:0031514; GO:0045202; GO:0051648; GO:0070740	axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; motile cilium [GO:0031514]; synapse [GO:0045202]; microtubule binding [GO:0008017]; tubulin-glutamic acid ligase activity [GO:0070740]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648]
PGEN_.00g334260	Scaffold_17	21220726	21221055	NA	NA	NA	NA	NA
PGEN_.00g334270	Scaffold_17	21224168	21225895	Q5DRB6	PCDG4_PANTR	Protocadherin gamma-A4 (PCDH-gamma-A4)	GO:0005509; GO:0005887; GO:0007155; GO:0007156	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
PGEN_.00g334280	Scaffold_17	21228963	21233475	Q86WZ6	ZN227_HUMAN	Zinc finger protein 227	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g334290	Scaffold_17	21233714	21235101	NA	NA	NA	NA	NA
PGEN_.00g334300	Scaffold_17	21276244	21280555	A0NLY7	ISAHY_LABAI	Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b)	GO:0004061; GO:0016812; GO:0019441; GO:0030145	"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]; tryptophan catabolic process to kynurenine [GO:0019441]"
PGEN_.00g334310	Scaffold_17	21288823	21293596	NA	NA	NA	NA	NA
PGEN_.00g334320	Scaffold_17	21304108	21306186	Q9DD78	TLR21_CHICK	Toll-like receptor 2 type-1	GO:0002224; GO:0002237; GO:0002755; GO:0005886; GO:0005887; GO:0006954; GO:0031226; GO:0034134; GO:0045087; GO:0050707; GO:0050729	integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine secretion [GO:0050707]; response to molecule of bacterial origin [GO:0002237]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]
PGEN_.00g334330	Scaffold_17	21376959	21418260	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g334340	Scaffold_17	21483546	21483887	NA	NA	NA	NA	NA
PGEN_.00g334350	Scaffold_17	21505412	21505837	NA	NA	NA	NA	NA
PGEN_.00g334360	Scaffold_17	21538307	21598407	P0C7B7	ELIC_DICCH	Cys-loop ligand-gated ion channel (ELIC)	GO:0004888; GO:0005230; GO:0005886; GO:0016021; GO:0042802	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular ligand-gated ion channel activity [GO:0005230]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]
PGEN_.00g334370	Scaffold_17	21598431	21598766	NA	NA	NA	NA	NA
PGEN_.00g334380	Scaffold_17	21622312	21623062	NA	NA	NA	NA	NA
PGEN_.00g334390	Scaffold_17	21729932	21764376	P51168	SCNNB_HUMAN	Amiloride-sensitive sodium channel subunit beta (Beta-NaCH) (Epithelial Na(+) channel subunit beta) (Beta-ENaC) (ENaCB) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB)	GO:0005886; GO:0005887; GO:0006814; GO:0007588; GO:0009897; GO:0015280; GO:0016324; GO:0030659; GO:0034220; GO:0034706; GO:0035725; GO:0050699; GO:0050891; GO:0050896; GO:0050909; GO:0055078; GO:0070062	apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]; excretion [GO:0007588]; ion transmembrane transport [GO:0034220]; multicellular organismal water homeostasis [GO:0050891]; response to stimulus [GO:0050896]; sensory perception of taste [GO:0050909]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]
PGEN_.00g334400	Scaffold_17	21776739	21871098	O01761	UNC89_CAEEL	Muscle M-line assembly protein unc-89 (Obscurin) (Uncoordinated protein 89)	GO:0004672; GO:0005089; GO:0005524; GO:0010628; GO:0014722; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0034613; GO:0040017; GO:0045214; GO:0045989; GO:0060298; GO:0071688; GO:0090736; GO:1905552; GO:1905905	A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]
PGEN_.00g334410	Scaffold_17	21914142	21914492	NA	NA	NA	NA	NA
PGEN_.00g334420	Scaffold_17	21914621	21960477	NA	NA	NA	NA	NA
PGEN_.00g334430	Scaffold_17	21977058	22008513	O77245	E75_METEN	Nuclear hormone receptor E75 (Nuclear receptor subfamily 1 group D member 3)	GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]
PGEN_.00g334440	Scaffold_17	21978455	21978796	NA	NA	NA	NA	NA
PGEN_.00g334450	Scaffold_17	22009239	22011429	NA	NA	NA	NA	NA
PGEN_.00g334460	Scaffold_17	22021712	22022771	NA	NA	NA	NA	NA
PGEN_.00g334470	Scaffold_17	22134558	22162765	P15989	CO6A3_CHICK	Collagen alpha-3(VI) chain	GO:0003429; GO:0004867; GO:0005581; GO:0005615; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g334480	Scaffold_17	22163758	22266914	A6NMZ7	CO6A6_HUMAN	Collagen alpha-6(VI) chain	GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g334490	Scaffold_17	22289156	22291643	NA	NA	NA	NA	NA
PGEN_.00g334500	Scaffold_17	22296751	22297020	NA	NA	NA	NA	NA
PGEN_.00g334510	Scaffold_17	22319159	22346609	O14512	SOCS7_HUMAN	"Suppressor of cytokine signaling 7 (SOCS-7) (Nck, Ash and phospholipase C gamma-binding protein) (Nck-associated protein 4) (NAP-4)"	GO:0005634; GO:0005829; GO:0005886; GO:0005942; GO:0009968; GO:0016567; GO:0017124; GO:0035556; GO:0040008; GO:0046854; GO:0046935	cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphorylation [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]
PGEN_.00g334520	Scaffold_17	22404036	22404260	NA	NA	NA	NA	NA
PGEN_.00g334530	Scaffold_17	22415935	22418528	Q5GIG6	TNI3K_MOUSE	Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)	GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:1903779	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]; bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]
PGEN_.00g334540	Scaffold_17	22419543	22442930	NA	NA	NA	NA	NA
PGEN_.00g334550	Scaffold_17	22509836	22510297	NA	NA	NA	NA	NA
PGEN_.00g334560	Scaffold_17	22511995	22528310	NA	NA	NA	NA	NA
PGEN_.00g334570	Scaffold_17	22552268	22570892	P43143	ACHA6_RAT	Neuronal acetylcholine receptor subunit alpha-6	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0014059; GO:0016020; GO:0022848; GO:0030054; GO:0033603; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0044877; GO:0045202; GO:0050877; GO:0051899; GO:0098691; GO:0099055; GO:0099056; GO:2000300	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g334580	Scaffold_17	22572942	22573316	NA	NA	NA	NA	NA
PGEN_.00g334590	Scaffold_17	22574666	22576796	Q03400	SANT_PLAF7	S-antigen protein	GO:0020003	symbiont-containing vacuole [GO:0020003]
PGEN_.00g334600	Scaffold_17	22618387	22624139	NA	NA	NA	NA	NA
PGEN_.00g334610	Scaffold_17	22629369	22643257	P0CB15	CRIS_PROFL	Serotriflin	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g334620	Scaffold_17	22646319	22664947	B3A0P4	USP26_LOTGI	Uncharacterized shell protein 26 (BMSP-like protein) (Fragment)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g334630	Scaffold_17	22673106	22673972	NA	NA	NA	NA	NA
PGEN_.00g334640	Scaffold_17	22704949	22720148	Q28BR5	PREP_XENTR	"Presequence protease, mitochondrial (EC 3.4.24.-) (Pitrilysin metalloproteinase 1)"	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0046872	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; proteolysis [GO:0006508]
PGEN_.00g334650	Scaffold_17	22721390	22722047	NA	NA	NA	NA	NA
PGEN_.00g334660	Scaffold_17	22724172	22752983	Q7ZVZ6	PREP_DANRE	"Presequence protease, mitochondrial (EC 3.4.24.-) (Pitrilysin metalloproteinase 1)"	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0046872	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; proteolysis [GO:0006508]
PGEN_.00g334670	Scaffold_17	22799918	22801048	O46639	TRFR_BOVIN	Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor)	GO:0004997; GO:0005886; GO:0007200; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyrotropin-releasing hormone receptor activity [GO:0004997]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]
PGEN_.00g334680	Scaffold_17	22814613	22814894	NA	NA	NA	NA	NA
PGEN_.00g334690	Scaffold_17	22837350	22840373	D2GZW6	VRTN_AILME	Vertnin	GO:0004803; GO:0006313; GO:0043565	"sequence-specific DNA binding [GO:0043565]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g334700	Scaffold_17	22841611	22842480	NA	NA	NA	NA	NA
PGEN_.00g334710	Scaffold_17	22850239	22857239	NA	NA	NA	NA	NA
PGEN_.00g334720	Scaffold_17	22970486	22971817	NA	NA	NA	NA	NA
PGEN_.00g334730	Scaffold_17	22983563	23039904	P52485	UBCD2_DROME	Ubiquitin-conjugating enzyme E2-24 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)	GO:0000209; GO:0004842; GO:0005524; GO:0019915; GO:0061631	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]
PGEN_.00g334740	Scaffold_17	23058405	23132765	Q9DBS9	OSBL3_MOUSE	Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3)	GO:0005789; GO:0005829; GO:0005886; GO:0006869; GO:0008289; GO:0015485; GO:0016020; GO:0031965; GO:0032433; GO:0032934; GO:0043231; GO:0097038	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; lipid transport [GO:0006869]
PGEN_.00g334750	Scaffold_17	23079108	23079722	NA	NA	NA	NA	NA
PGEN_.00g334760	Scaffold_17	23156121	23156615	NA	NA	NA	NA	NA
PGEN_.00g334770	Scaffold_17	23229627	23230169	NA	NA	NA	NA	NA
PGEN_.00g334780	Scaffold_17	23230416	23231402	NA	NA	NA	NA	NA
PGEN_.00g334790	Scaffold_17	23236884	23258089	NA	NA	NA	NA	NA
PGEN_.00g334800	Scaffold_17	23270284	23313385	Q9Y4C0	NRX3A_HUMAN	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	GO:0005886; GO:0005887; GO:0007158; GO:0007411; GO:0007612; GO:0030534; GO:0035176; GO:0038023; GO:0046872; GO:0050839; GO:0071625; GO:0097109	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625]
PGEN_.00g334810	Scaffold_17	23320181	23322128	NA	NA	NA	NA	NA
PGEN_.00g334820	Scaffold_17	23322492	23324978	Q8TCT0	CERK1_HUMAN	Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4)	GO:0000287; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006687; GO:0016021; GO:0102773	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]
PGEN_.00g334830	Scaffold_17	23329231	23329852	NA	NA	NA	NA	NA
PGEN_.00g334840	Scaffold_17	23349593	23354075	NA	NA	NA	NA	NA
PGEN_.00g334850	Scaffold_17	23404098	23421796	B3EWZ6	MLRP2_ACRMI	MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g334860	Scaffold_17	23564283	23565585	NA	NA	NA	NA	NA
PGEN_.00g334870	Scaffold_17	23587652	23587936	NA	NA	NA	NA	NA
PGEN_.00g334880	Scaffold_17	23653710	23654207	Q04202	TCB2_CAEBR	Transposable element Tcb2 transposase	GO:0003677; GO:0005634; GO:0006313; GO:0015074	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]"
PGEN_.00g334890	Scaffold_17	23654307	23657490	NA	NA	NA	NA	NA
PGEN_.00g334900	Scaffold_17	23798163	23798573	NA	NA	NA	NA	NA
PGEN_.00g334910	Scaffold_17	23846312	23901560	P0CY46	EGFR_APIME	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1)	GO:0004714; GO:0005524; GO:0007169; GO:0007275; GO:0016021	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g334920	Scaffold_17	23860070	23866367	P13387	EGFR_CHICK	Epidermal growth factor receptor (CER) (EC 2.7.10.1) (Fragment)	GO:0000139; GO:0004713; GO:0004714; GO:0005524; GO:0005634; GO:0005789; GO:0005886; GO:0007173; GO:0007611; GO:0010008; GO:0016021; GO:0031965; GO:0071364	endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; learning or memory [GO:0007611]
PGEN_.00g334930	Scaffold_17	23922224	23932686	NA	NA	NA	NA	NA
PGEN_.00g334940	Scaffold_17	23935094	23941780	NA	NA	NA	NA	NA
PGEN_.00g334950	Scaffold_17	23961424	23962062	NA	NA	NA	NA	NA
PGEN_.00g334960	Scaffold_17	23962087	23962734	NA	NA	NA	NA	NA
PGEN_.00g334970	Scaffold_17	23962115	23962510	NA	NA	NA	NA	NA
PGEN_.00g334980	Scaffold_17	23963115	23963987	NA	NA	NA	NA	NA
PGEN_.00g334990	Scaffold_17	24049974	24050288	NA	NA	NA	NA	NA
PGEN_.00g335000	Scaffold_17	24051201	24051515	NA	NA	NA	NA	NA
PGEN_.00g335010	Scaffold_17	24103693	24119195	NA	NA	NA	NA	NA
PGEN_.00g335020	Scaffold_17	24141676	24150506	Q9TW28	MYOM_DICDI	Myosin-M heavy chain (RhoGEF domain-containing protein myoM)	GO:0000146; GO:0005524; GO:0005737; GO:0006971; GO:0006972; GO:0016461; GO:0016887; GO:0030676; GO:0031268; GO:0035020; GO:0042995; GO:0051015	cell projection [GO:0042995]; cytoplasm [GO:0005737]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microfilament motor activity [GO:0000146]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; hyperosmotic response [GO:0006972]; hypotonic response [GO:0006971]; pseudopodium organization [GO:0031268]; regulation of Rac protein signal transduction [GO:0035020]
PGEN_.00g335030	Scaffold_17	24196175	24260130	O70589	CSKP_MOUSE	Peripheral plasma membrane protein CASK (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase)	GO:0001953; GO:0004674; GO:0005516; GO:0005524; GO:0005604; GO:0005634; GO:0005652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006357; GO:0008022; GO:0010839; GO:0014069; GO:0016020; GO:0016323; GO:0016363; GO:0030165; GO:0030425; GO:0031982; GO:0032024; GO:0032991; GO:0042043; GO:0042734; GO:0043025; GO:0044877; GO:0045121; GO:0045202; GO:0045944; GO:0060170; GO:0061003; GO:0061045; GO:0070509; GO:0072659; GO:0090280; GO:0090288; GO:0097060; GO:0097440; GO:0098685; GO:0098846; GO:2000300	apical dendrite [GO:0097440]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podocyte foot [GO:0098846]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; calcium ion import [GO:0070509]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g335040	Scaffold_17	24273919	24274581	NA	NA	NA	NA	NA
PGEN_.00g335050	Scaffold_17	24305449	24305784	NA	NA	NA	NA	NA
PGEN_.00g335060	Scaffold_17	24310298	24310978	NA	NA	NA	NA	NA
PGEN_.00g335070	Scaffold_17	24311090	24311356	NA	NA	NA	NA	NA
PGEN_.00g335080	Scaffold_17	24348735	24350054	NA	NA	NA	NA	NA
PGEN_.00g335090	Scaffold_17	24350428	24350808	NA	NA	NA	NA	NA
PGEN_.00g335100	Scaffold_17	24352246	24352500	NA	NA	NA	NA	NA
PGEN_.00g335110	Scaffold_17	24353127	24353435	NA	NA	NA	NA	NA
PGEN_.00g335120	Scaffold_17	24375743	24376048	NA	NA	NA	NA	NA
PGEN_.00g335130	Scaffold_17	24376171	24377504	NA	NA	NA	NA	NA
PGEN_.00g335140	Scaffold_17	24422934	24423317	NA	NA	NA	NA	NA
PGEN_.00g335150	Scaffold_17	24425765	24440141	NA	NA	NA	NA	NA
PGEN_.00g335160	Scaffold_17	24460958	24463299	NA	NA	NA	NA	NA
PGEN_.00g335170	Scaffold_17	24463486	24463749	NA	NA	NA	NA	NA
PGEN_.00g335180	Scaffold_17	24464202	24475129	NA	NA	NA	NA	NA
PGEN_.00g335190	Scaffold_17	24483895	24485024	NA	NA	NA	NA	NA
PGEN_.00g335200	Scaffold_17	24485893	24486135	NA	NA	NA	NA	NA
PGEN_.00g335210	Scaffold_17	24486379	24491504	NA	NA	NA	NA	NA
PGEN_.00g335220	Scaffold_17	24491742	24492279	NA	NA	NA	NA	NA
PGEN_.00g335230	Scaffold_17	24501580	24559001	Q5U3N0	PKHA8_DANRE	Pleckstrin homology domain-containing family A member 8 (PH domain-containing family A member 8)	GO:0005794; GO:0005829; GO:0008289; GO:0015031; GO:0016020; GO:0035621; GO:0035627; GO:0120009; GO:1902387; GO:1902388	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; lipid binding [GO:0008289]; ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; protein transport [GO:0015031]
PGEN_.00g335240	Scaffold_17	24583006	24632373	NA	NA	NA	NA	NA
PGEN_.00g335250	Scaffold_17	24639278	24639604	NA	NA	NA	NA	NA
PGEN_.00g335260	Scaffold_17	24639929	24640318	NA	NA	NA	NA	NA
PGEN_.00g335270	Scaffold_17	24670060	24670564	NA	NA	NA	NA	NA
PGEN_.00g335280	Scaffold_17	24697665	24698096	NA	NA	NA	NA	NA
PGEN_.00g335290	Scaffold_17	24706070	24707756	NA	NA	NA	NA	NA
PGEN_.00g335300	Scaffold_17	24742873	24781040	NA	NA	NA	NA	NA
PGEN_.00g335310	Scaffold_17	24794883	24795254	NA	NA	NA	NA	NA
PGEN_.00g335320	Scaffold_17	24808256	24809232	NA	NA	NA	NA	NA
PGEN_.00g335330	Scaffold_17	24831970	24832437	NA	NA	NA	NA	NA
PGEN_.00g335340	Scaffold_17	24832490	24836626	NA	NA	NA	NA	NA
PGEN_.00g335350	Scaffold_17	24867332	24867721	NA	NA	NA	NA	NA
PGEN_.00g335360	Scaffold_17	24926025	24930809	Q5R941	FKB14_PONAB	Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (FK506-binding protein 14) (FKBP-14) (Rotamase)	GO:0003755; GO:0005509; GO:0005788	endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]
PGEN_.00g335370	Scaffold_17	24960070	24971246	NA	NA	NA	NA	NA
PGEN_.00g335380	Scaffold_17	24979463	24988525	NA	NA	NA	NA	NA
PGEN_.00g335390	Scaffold_17	24994828	24995163	NA	NA	NA	NA	NA
PGEN_.00g335400	Scaffold_17	24995344	24996066	NA	NA	NA	NA	NA
PGEN_.00g335410	Scaffold_17	25066631	25066948	NA	NA	NA	NA	NA
PGEN_.00g335420	Scaffold_17	25070484	25070900	Q59RQ0	PIF1_CANAL	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)	GO:0000002; GO:0000723; GO:0003678; GO:0005524; GO:0005634; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0008408; GO:0010521; GO:0032211; GO:0032508; GO:0043139; GO:0051880	mitochondrion [GO:0005739]; nucleus [GO:0005634]; replication fork [GO:0005657]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; G-quadruplex DNA binding [GO:0051880]; telomerase inhibitor activity [GO:0010521]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomere maintenance via telomerase [GO:0032211]; telomere maintenance [GO:0000723]
PGEN_.00g335430	Scaffold_17	25071007	25071402	NA	NA	NA	NA	NA
PGEN_.00g335440	Scaffold_17	25079280	25080408	NA	NA	NA	NA	NA
PGEN_.00g335450	Scaffold_17	25086507	25163010	O15194	CTDSL_HUMAN	CTD small phosphatase-like protein (CTDSP-like) (EC 3.1.3.16) (Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3) (NIF-like protein) (Nuclear LIM interactor-interacting factor 1) (NLI-interacting factor 1) (Protein YA22) (hYA22) (RBSP3) (Small C-terminal domain phosphatase 3) (SCP3) (Small CTD phosphatase 3)	GO:0001933; GO:0004721; GO:0005634; GO:0006357; GO:0008420; GO:0046872; GO:0070062; GO:2000134	extracellular exosome [GO:0070062]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933]; regulation of transcription by RNA polymerase II [GO:0006357]
PGEN_.00g335460	Scaffold_17	25181628	25183964	NA	NA	NA	NA	NA
PGEN_.00g335470	Scaffold_17	25212812	25213228	NA	NA	NA	NA	NA
PGEN_.00g335480	Scaffold_17	25230083	25231576	P10076	ZFP26_MOUSE	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g335490	Scaffold_17	25300637	25302641	NA	NA	NA	NA	NA
PGEN_.00g335500	Scaffold_17	25311009	25320566	Q6SJP2	B3A2_HORSE	Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (Solute carrier family 4 member 2)	GO:0005452; GO:0005623; GO:0015301; GO:0015701; GO:0016021; GO:0051453	cell [GO:0005623]; integral component of membrane [GO:0016021]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]
PGEN_.00g335510	Scaffold_17	25384048	25492755	Q9Z0S8	B3A2_CAVPO	Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (Solute carrier family 4 member 2)	GO:0005452; GO:0015301; GO:0016021	integral component of membrane [GO:0016021]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]
PGEN_.00g335520	Scaffold_17	25609412	25609954	NA	NA	NA	NA	NA
PGEN_.00g335530	Scaffold_17	25627691	25629972	NA	NA	NA	NA	NA
PGEN_.00g335540	Scaffold_17	25643535	25649842	NA	NA	NA	NA	NA
PGEN_.00g335550	Scaffold_17	25672584	25782798	P97259	MGT5A_CRIGR	"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]"	GO:0000139; GO:0004864; GO:0005576; GO:0016021; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1903614; GO:1904894	"extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279]"
PGEN_.00g335560	Scaffold_17	25679960	25680214	NA	NA	NA	NA	NA
PGEN_.00g335570	Scaffold_17	25825908	25840532	Q868T3	CCAPR_DROME	Cardioacceleratory peptide receptor (Crustacean cardioactive peptide receptor)	GO:0005000; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0018990	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]"
PGEN_.00g335580	Scaffold_17	25886805	25887095	NA	NA	NA	NA	NA
PGEN_.00g335590	Scaffold_17	25917201	25917425	NA	NA	NA	NA	NA
PGEN_.00g335600	Scaffold_17	25921956	25922294	NA	NA	NA	NA	NA
PGEN_.00g335610	Scaffold_17	26019749	26020327	O57422	OPN4B_XENLA	Melanopsin-B (Opsin-4B) (xMOP)	GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g335620	Scaffold_17	26046605	26049420	Q90214	OPSD1_ANGAN	"Rhodopsin, deep-sea form"	GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0018298	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g335630	Scaffold_17	26058155	26058773	NA	NA	NA	NA	NA
PGEN_.00g335640	Scaffold_17	26068526	26068885	NA	NA	NA	NA	NA
PGEN_.00g335650	Scaffold_17	26086068	26086550	NA	NA	NA	NA	NA
PGEN_.00g335660	Scaffold_17	26100021	26101192	NA	NA	NA	NA	NA
PGEN_.00g335670	Scaffold_17	26103938	26105121	NA	NA	NA	NA	NA
PGEN_.00g335680	Scaffold_17	26143230	26143709	NA	NA	NA	NA	NA
PGEN_.00g335690	Scaffold_17	26145322	26152845	Q8WU66	TSEAR_HUMAN	Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)	GO:0005576; GO:0007605; GO:0008593; GO:0009986; GO:0032420; GO:0034505; GO:0060170	cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; tooth mineralization [GO:0034505]
PGEN_.00g335700	Scaffold_17	26176605	26177144	NA	NA	NA	NA	NA
PGEN_.00g335710	Scaffold_17	26202586	26210709	Q6TUG0	DJB11_RAT	DnaJ homolog subfamily B member 11 (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p) (Liver regeneration-related protein LRRGT00084)	GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005788; GO:0006457; GO:0016556; GO:0032781; GO:0034663; GO:0050768; GO:0051082; GO:0051604	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]; mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; positive regulation of ATPase activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604]
PGEN_.00g335720	Scaffold_17	26228924	26240991	P27169	PON1_HUMAN	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]
PGEN_.00g335730	Scaffold_17	26266576	26269037	O01811	MEC6_CAEEL	Mechanosensory abnormality protein 6	GO:0004064; GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0009612; GO:0016021; GO:0050976; GO:1905789; GO:1905792	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; sodium channel activity [GO:0005272]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612]
PGEN_.00g335740	Scaffold_17	26276996	26281685	NA	NA	NA	NA	NA
PGEN_.00g335750	Scaffold_17	26284166	26284834	NA	NA	NA	NA	NA
PGEN_.00g335760	Scaffold_17	26284860	26285147	NA	NA	NA	NA	NA
PGEN_.00g335770	Scaffold_17	26285660	26287142	NA	NA	NA	NA	NA
PGEN_.00g335780	Scaffold_17	26287305	26287526	NA	NA	NA	NA	NA
PGEN_.00g335790	Scaffold_17	26291519	26318086	Q9VAC5	ADA17_DROME	ADAM 17-like protease (EC 3.4.24.-)	GO:0004222; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]
PGEN_.00g335800	Scaffold_17	26318799	26321708	Q9VAC5	ADA17_DROME	ADAM 17-like protease (EC 3.4.24.-)	GO:0004222; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]
PGEN_.00g335810	Scaffold_17	26330033	26330884	NA	NA	NA	NA	NA
PGEN_.00g335820	Scaffold_17	26356908	26357360	NA	NA	NA	NA	NA
PGEN_.00g335830	Scaffold_17	26393332	26393643	NA	NA	NA	NA	NA
PGEN_.00g335840	Scaffold_17	26393695	26394003	NA	NA	NA	NA	NA
PGEN_.00g335850	Scaffold_17	26394421	26394837	NA	NA	NA	NA	NA
PGEN_.00g335860	Scaffold_17	26413343	26430797	Q14BI2	GRM2_MOUSE	Metabotropic glutamate receptor 2 (mGluR2)	GO:0001641; GO:0005246; GO:0005887; GO:0007216; GO:0007268; GO:0008066; GO:0014047; GO:0030054; GO:0030424; GO:0030425; GO:0042734; GO:0043005; GO:0051966; GO:0090461; GO:0099055	"axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of synaptic transmission, glutamatergic [GO:0051966]"
PGEN_.00g335870	Scaffold_17	26443739	26446045	NA	NA	NA	NA	NA
PGEN_.00g335880	Scaffold_17	26452177	26454181	NA	NA	NA	NA	NA
PGEN_.00g335890	Scaffold_17	26457112	26459137	NA	NA	NA	NA	NA
PGEN_.00g335900	Scaffold_17	26489219	26495023	NA	NA	NA	NA	NA
PGEN_.00g335910	Scaffold_17	26523529	26523954	NA	NA	NA	NA	NA
PGEN_.00g335920	Scaffold_17	26524038	26524598	NA	NA	NA	NA	NA
PGEN_.00g335930	Scaffold_17	26524643	26524927	NA	NA	NA	NA	NA
PGEN_.00g335940	Scaffold_17	26525057	26525644	NA	NA	NA	NA	NA
PGEN_.00g335950	Scaffold_17	26532545	26532976	NA	NA	NA	NA	NA
PGEN_.00g335960	Scaffold_17	26533038	26533442	NA	NA	NA	NA	NA
PGEN_.00g335970	Scaffold_17	26534372	26534785	NA	NA	NA	NA	NA
PGEN_.00g335980	Scaffold_17	26536274	26540667	NA	NA	NA	NA	NA
PGEN_.00g335990	Scaffold_17	26614406	26614891	NA	NA	NA	NA	NA
PGEN_.00g336000	Scaffold_17	26636989	26682331	O88343	S4A4_MOUSE	Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4)	GO:0005452; GO:0005623; GO:0005887; GO:0006814; GO:0006885; GO:0008510; GO:0015701; GO:0016323; GO:0042802; GO:0051453	basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion transport [GO:0006814]
PGEN_.00g336010	Scaffold_17	26686680	26692752	Q6IMK3	DJC27_DANRE	DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)	GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0032482	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g336020	Scaffold_17	26693160	26693456	A9ULE9	DJC22_XENTR	DnaJ homolog subfamily C member 22	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g336030	Scaffold_17	26753895	26778865	O88327	CTNL1_MOUSE	Alpha-catulin (Alpha-catenin-related protein) (ACRP) (Catenin alpha-like protein 1)	GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266; GO:0045296; GO:0051015	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]
PGEN_.00g336040	Scaffold_17	26809399	26813144	NA	NA	NA	NA	NA
PGEN_.00g336050	Scaffold_17	26832964	26833266	NA	NA	NA	NA	NA
PGEN_.00g336060	Scaffold_17	26833461	26834066	NA	NA	NA	NA	NA
PGEN_.00g336070	Scaffold_17	26835280	26835549	NA	NA	NA	NA	NA
PGEN_.00g336080	Scaffold_17	26837136	26839737	P04058	ACES_TETCF	Acetylcholinesterase (AChE) (EC 3.1.1.7)	GO:0001507; GO:0003990; GO:0005886; GO:0030054; GO:0031225; GO:0043083	anchored component of membrane [GO:0031225]; cell junction [GO:0030054]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; acetylcholinesterase activity [GO:0003990]; acetylcholine catabolic process in synaptic cleft [GO:0001507]
PGEN_.00g336090	Scaffold_17	26938585	26942151	Q9D187	CIA2B_MOUSE	Cytosolic iron-sulfur assembly component 2B (Mitotic spindle-associated MMXD complex subunit MIP18)	GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007059; GO:0016226; GO:0071817; GO:0097361; GO:0097428; GO:0106035	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428]
PGEN_.00g336100	Scaffold_17	26953806	26954150	NA	NA	NA	NA	NA
PGEN_.00g336110	Scaffold_17	26959172	26959414	NA	NA	NA	NA	NA
PGEN_.00g336120	Scaffold_17	26970306	27024629	Q01064	PDE1B_HUMAN	"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B (Cam-PDE 1B) (EC 3.1.4.17) (63 kDa Cam-PDE)"	GO:0001975; GO:0004115; GO:0004117; GO:0005516; GO:0005829; GO:0006915; GO:0007186; GO:0007626; GO:0008542; GO:0030224; GO:0036006; GO:0042053; GO:0042428; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0097011	"cytosol [GO:0005829]; neuronal cell body [GO:0043025]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; monocyte differentiation [GO:0030224]; regulation of dopamine metabolic process [GO:0042053]; response to amphetamine [GO:0001975]; serotonin metabolic process [GO:0042428]; visual learning [GO:0008542]"
PGEN_.00g336130	Scaffold_17	27099377	27103742	NA	NA	NA	NA	NA
PGEN_.00g336140	Scaffold_17	27108037	27109432	NA	NA	NA	NA	NA
PGEN_.00g336150	Scaffold_17	27109650	27110218	NA	NA	NA	NA	NA
PGEN_.00g336160	Scaffold_17	27110269	27110475	NA	NA	NA	NA	NA
PGEN_.00g336170	Scaffold_17	27142116	27142436	NA	NA	NA	NA	NA
PGEN_.00g336180	Scaffold_17	27150551	27150877	NA	NA	NA	NA	NA
PGEN_.00g336190	Scaffold_17	27176845	27180353	NA	NA	NA	NA	NA
PGEN_.00g336200	Scaffold_17	27180624	27180872	NA	NA	NA	NA	NA
PGEN_.00g336210	Scaffold_17	27181273	27181881	NA	NA	NA	NA	NA
PGEN_.00g336220	Scaffold_17	27182338	27182694	NA	NA	NA	NA	NA
PGEN_.00g336230	Scaffold_17	27182734	27182955	NA	NA	NA	NA	NA
PGEN_.00g336240	Scaffold_17	27289921	27290340	NA	NA	NA	NA	NA
PGEN_.00g336250	Scaffold_17	27308568	27315423	NA	NA	NA	NA	NA
PGEN_.00g336260	Scaffold_17	27344005	27345851	NA	NA	NA	NA	NA
PGEN_.00g336270	Scaffold_17	27348167	27349402	NA	NA	NA	NA	NA
PGEN_.00g336280	Scaffold_17	27369886	27370116	NA	NA	NA	NA	NA
PGEN_.00g336290	Scaffold_17	27388173	27397002	NA	NA	NA	NA	NA
PGEN_.00g336300	Scaffold_17	27420618	27421085	NA	NA	NA	NA	NA
PGEN_.00g336310	Scaffold_17	27421577	27422179	Q8LM92	C75B4_ORYSJ	Flavonoid 3'-monooxygenase CYP75B4 (EC 1.14.14.82) (Chrysoeriol 5'-hydroxylase) (Cytochrome P450 75B4) (Flavonoid 3'-hydroxylase CYP75B4)	GO:0005506; GO:0009813; GO:0016021; GO:0016709; GO:0016711; GO:0020037	"integral component of membrane [GO:0016021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; flavonoid biosynthetic process [GO:0009813]"
PGEN_.00g336320	Scaffold_17	27422284	27422673	P00186	CP1A2_MOUSE	Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)	GO:0004497; GO:0005506; GO:0005789; GO:0006706; GO:0006725; GO:0006778; GO:0008203; GO:0008210; GO:0009403; GO:0009404; GO:0009791; GO:0009820; GO:0010468; GO:0016098; GO:0016491; GO:0016712; GO:0016829; GO:0017144; GO:0018894; GO:0019369; GO:0019899; GO:0020037; GO:0030324; GO:0032355; GO:0032451; GO:0032496; GO:0032787; GO:0034875; GO:0035902; GO:0042572; GO:0042737; GO:0042738; GO:0043231; GO:0045333; GO:0046483; GO:0050665; GO:0055114; GO:0070330; GO:0070989; GO:0071276; GO:0071280; GO:0071615; GO:0101020; GO:0101021	"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; alkaloid metabolic process [GO:0009820]; arachidonic acid metabolic process [GO:0019369]; cellular aromatic compound metabolic process [GO:0006725]; cellular respiration [GO:0045333]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cholesterol metabolic process [GO:0008203]; dibenzo-p-dioxin metabolic process [GO:0018894]; drug catabolic process [GO:0042737]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; exogenous drug catabolic process [GO:0042738]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; lung development [GO:0030324]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; oxidation-reduction process [GO:0055114]; oxidative deethylation [GO:0071615]; oxidative demethylation [GO:0070989]; porphyrin-containing compound metabolic process [GO:0006778]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; toxin biosynthetic process [GO:0009403]; toxin metabolic process [GO:0009404]"
PGEN_.00g336330	Scaffold_17	27424409	27425050	NA	NA	NA	NA	NA
PGEN_.00g336340	Scaffold_17	27450076	27469555	NA	NA	NA	NA	NA
PGEN_.00g336350	Scaffold_17	27471023	27538687	NA	NA	NA	NA	NA
PGEN_.00g336360	Scaffold_17	27549483	27550241	NA	NA	NA	NA	NA
PGEN_.00g336370	Scaffold_17	27550533	27551494	NA	NA	NA	NA	NA
PGEN_.00g336380	Scaffold_17	27558140	27559861	NA	NA	NA	NA	NA
PGEN_.00g336390	Scaffold_17	27574190	27575800	NA	NA	NA	NA	NA
PGEN_.00g336400	Scaffold_17	27587606	27592799	Q15542	TAF5_HUMAN	Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100)	GO:0000790; GO:0005634; GO:0005654; GO:0005669; GO:0006325; GO:0006352; GO:0006355; GO:0006366; GO:0006367; GO:0015629; GO:0016032; GO:0016251; GO:0016573; GO:0033276; GO:0042795; GO:0042802; GO:0044212; GO:0046983; GO:1901796	"actin cytoskeleton [GO:0015629]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; DNA-templated transcription, initiation [GO:0006352]; histone acetylation [GO:0016573]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]"
PGEN_.00g336410	Scaffold_17	27595651	27606682	Q4V8E5	MFSD3_RAT	Major facilitator superfamily domain-containing protein 3	GO:0015295; GO:0016021	integral component of membrane [GO:0016021]; solute:proton symporter activity [GO:0015295]
PGEN_.00g336420	Scaffold_17	27645291	27659488	Q20930	MIG17_CAEEL	Metalloprotease mig-17 (EC 3.4.24.-) (Abnormal cell migration protein 17)	GO:0004222; GO:0005604; GO:0005615; GO:0008104; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354	basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]
PGEN_.00g336430	Scaffold_17	27720364	27724904	NA	NA	NA	NA	NA
PGEN_.00g336440	Scaffold_17	27747365	27753613	NA	NA	NA	NA	NA
PGEN_.00g336450	Scaffold_17	27772295	27793099	Q9Y2X3	NOP58_HUMAN	Nucleolar protein 58 (Nucleolar protein 5)	GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070761	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]
PGEN_.00g336460	Scaffold_17	27800650	27801108	NA	NA	NA	NA	NA
PGEN_.00g336470	Scaffold_17	27803546	27803848	NA	NA	NA	NA	NA
PGEN_.00g336480	Scaffold_17	27816238	27819648	NA	NA	NA	NA	NA
PGEN_.00g336490	Scaffold_17	27819833	27820306	NA	NA	NA	NA	NA
PGEN_.00g336500	Scaffold_17	27918147	27941608	B9EJ80	PDZD8_MOUSE	PDZ domain-containing protein 8	GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008289; GO:0016021; GO:0022604; GO:0035556; GO:0044233; GO:0046872; GO:0051560; GO:1990456	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604]
PGEN_.00g336510	Scaffold_17	27935404	27941532	NA	NA	NA	NA	NA
PGEN_.00g336520	Scaffold_17	27959890	27962574	NA	NA	NA	NA	NA
PGEN_.00g336530	Scaffold_17	27994022	27994519	NA	NA	NA	NA	NA
PGEN_.00g336540	Scaffold_17	27996141	27998034	NA	NA	NA	NA	NA
PGEN_.00g336550	Scaffold_17	27999934	28009100	NA	NA	NA	NA	NA
PGEN_.00g336560	Scaffold_17	28033442	28112877	Q5SSZ5	TENS3_MOUSE	Tensin-3 (Tensin-like SH2 domain-containing protein 1)	GO:0005829; GO:0005925; GO:0008284; GO:0016477; GO:0048286	cytosol [GO:0005829]; focal adhesion [GO:0005925]; cell migration [GO:0016477]; lung alveolus development [GO:0048286]; positive regulation of cell population proliferation [GO:0008284]
PGEN_.00g336570	Scaffold_17	28113726	28124073	Q04205	TENS_CHICK	Tensin	GO:0003779; GO:0005737; GO:0005856; GO:0005912; GO:0009986	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]
PGEN_.00g336580	Scaffold_17	28200066	28201961	Q99PP7	TRI33_MOUSE	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0017015; GO:0030514; GO:0070410; GO:0070412	nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]
PGEN_.00g336590	Scaffold_17	28207330	28209433	NA	NA	NA	NA	NA
PGEN_.00g336600	Scaffold_17	28221981	28227190	NA	NA	NA	NA	NA
PGEN_.00g336610	Scaffold_17	28268162	28269223	NA	NA	NA	NA	NA
PGEN_.00g336620	Scaffold_17	28269758	28272255	NA	NA	NA	NA	NA
PGEN_.00g336630	Scaffold_17	28284650	28289642	Q96EH3	MASU1_HUMAN	Mitochondrial assembly of ribosomal large subunit protein 1	GO:0005739; GO:0005759; GO:0005829; GO:0017148; GO:0042273; GO:0043023; GO:0070130; GO:0090071	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273]
PGEN_.00g336640	Scaffold_17	28302059	28348731	NA	NA	NA	NA	NA
PGEN_.00g336650	Scaffold_17	28355642	28356229	NA	NA	NA	NA	NA
PGEN_.00g336660	Scaffold_17	28385423	28423069	A8T6P4	MYRIP_DANRE	Rab effector MyRIP (Exophilin-8) (Myosin VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C) (SlaC2-c) (Slp homolog lacking C2 domains c)	GO:0003779; GO:0006886; GO:0017022; GO:0017137; GO:0030133; GO:0030864; GO:0046872; GO:0048471	cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; Rab GTPase binding [GO:0017137]; intracellular protein transport [GO:0006886]
PGEN_.00g336670	Scaffold_17	28409738	28410217	NA	NA	NA	NA	NA
PGEN_.00g336680	Scaffold_17	28474608	28475060	NA	NA	NA	NA	NA
PGEN_.00g336690	Scaffold_17	28480120	28482705	NA	NA	NA	NA	NA
PGEN_.00g336700	Scaffold_17	28576031	28678769	Q32LP4	S4A10_BOVIN	Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10)	GO:0005452; GO:0005623; GO:0007601; GO:0008510; GO:0009416; GO:0009791; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0021860; GO:0030054; GO:0030425; GO:0035264; GO:0035641; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0048854; GO:0051453; GO:0097440; GO:0097441; GO:0097442; GO:0098794; GO:1902600	apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; cell [GO:0005623]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; visual perception [GO:0007601]
PGEN_.00g336710	Scaffold_17	28716380	28716842	NA	NA	NA	NA	NA
PGEN_.00g336720	Scaffold_17	28717119	28717331	NA	NA	NA	NA	NA
PGEN_.00g336730	Scaffold_17	28717839	28746181	Q8HYL6	PPARA_PHACI	Peroxisome proliferator-activated receptor alpha (PPAR-alpha) (Nuclear receptor subfamily 1 group C member 1)	GO:0003707; GO:0004879; GO:0005634; GO:0008144; GO:0008270; GO:0008289; GO:0032099; GO:0032922; GO:0042752; GO:0043565; GO:0045893	"nucleus [GO:0005634]; drug binding [GO:0008144]; lipid binding [GO:0008289]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; negative regulation of appetite [GO:0032099]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]"
PGEN_.00g336740	Scaffold_17	28766526	28768231	NA	NA	NA	NA	NA
PGEN_.00g336750	Scaffold_17	28769543	28769917	NA	NA	NA	NA	NA
PGEN_.00g336760	Scaffold_17	28780939	28782185	NA	NA	NA	NA	NA
PGEN_.00g336770	Scaffold_17	28813197	28836836	NA	NA	NA	NA	NA
PGEN_.00g336780	Scaffold_17	28839688	28840335	P49217	MTR1A_PHOSU	Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)	GO:0005886; GO:0008502; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; melatonin receptor activity [GO:0008502]
PGEN_.00g336790	Scaffold_17	28866367	28871965	Q9JHX2	SP5_MOUSE	Transcription factor Sp5	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0006357; GO:0036342; GO:0043565; GO:0046872; GO:0060349; GO:0071407	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; bone morphogenesis [GO:0060349]; cellular response to organic cyclic compound [GO:0071407]; negative regulation of transcription by RNA polymerase II [GO:0000122]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g336800	Scaffold_17	28916419	28916793	NA	NA	NA	NA	NA
PGEN_.00g336810	Scaffold_17	28917327	28918080	NA	NA	NA	NA	NA
PGEN_.00g336820	Scaffold_17	28926448	28984713	Q8MR37	KLFL_DROME	Krueppel-like factor luna	GO:0000070; GO:0000981; GO:0005634; GO:0006357; GO:0035185; GO:0043565; GO:0046872; GO:0051301	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; preblastoderm mitotic cell cycle [GO:0035185]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g336830	Scaffold_17	28998759	28999142	NA	NA	NA	NA	NA
PGEN_.00g336840	Scaffold_17	28999175	29000649	NA	NA	NA	NA	NA
PGEN_.00g336850	Scaffold_17	29036548	29036910	NA	NA	NA	NA	NA
PGEN_.00g336860	Scaffold_17	29037160	29037570	NA	NA	NA	NA	NA
PGEN_.00g336870	Scaffold_17	29037783	29038169	NA	NA	NA	NA	NA
PGEN_.00g336880	Scaffold_17	29045385	29049489	NA	NA	NA	NA	NA
PGEN_.00g336890	Scaffold_17	29058053	29074488	P91917	OLA1_CAEEL	Obg-like ATPase 1	GO:0005524; GO:0005525; GO:0005737; GO:0005783; GO:0016887; GO:0043022; GO:0043023; GO:0046872	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]
PGEN_.00g336900	Scaffold_17	29081444	29084761	G5E8K5	ANK3_MOUSE	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259	"axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
PGEN_.00g336910	Scaffold_17	29088687	29105405	NA	NA	NA	NA	NA
PGEN_.00g336920	Scaffold_17	29106155	29106442	NA	NA	NA	NA	NA
PGEN_.00g336930	Scaffold_17	29115314	29115667	NA	NA	NA	NA	NA
PGEN_.00g336940	Scaffold_17	29117379	29119111	Q4ZJM9	C1QL4_MOUSE	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]
PGEN_.00g336950	Scaffold_17	29149013	29160610	NA	NA	NA	NA	NA
PGEN_.00g336960	Scaffold_17	29172968	29204286	Q5JPF3	AN36C_HUMAN	Ankyrin repeat domain-containing protein 36C (Protein immuno-reactive with anti-PTH polyclonal antibodies)	GO:0008200	ion channel inhibitor activity [GO:0008200]
PGEN_.00g336970	Scaffold_17	29207662	29244774	NA	NA	NA	NA	NA
PGEN_.00g336980	Scaffold_17	29246178	29246462	NA	NA	NA	NA	NA
PGEN_.00g336990	Scaffold_17	29255941	29260714	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g337000	Scaffold_17	29261571	29261825	NA	NA	NA	NA	NA
PGEN_.00g337010	Scaffold_17	29279377	29286204	NA	NA	NA	NA	NA
PGEN_.00g337020	Scaffold_17	29303387	29316058	Q5ZJH7	CNPD1_CHICK	Protein CNPPD1	GO:0000079; GO:0016021; GO:0019901	integral component of membrane [GO:0016021]; protein kinase binding [GO:0019901]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]
PGEN_.00g337030	Scaffold_17	29320344	29399120	Q9W0S9	DIP2_DROME	Disco-interacting protein 2	GO:0003824; GO:0005634; GO:0007275	nucleus [GO:0005634]; catalytic activity [GO:0003824]; multicellular organism development [GO:0007275]
PGEN_.00g337040	Scaffold_17	29414352	29414651	NA	NA	NA	NA	NA
PGEN_.00g337050	Scaffold_17	29420454	29462160	Q7SXP8	GMPAB_DANRE	Mannose-1-phosphate guanyltransferase alpha-B (EC 2.7.7.13) (GDP-mannose pyrophosphorylase A-B) (GTP-mannose-1-phosphate guanylyltransferase alpha-b)	GO:0004475; GO:0005525; GO:0009298	GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]
PGEN_.00g337060	Scaffold_17	29470015	29470590	NA	NA	NA	NA	NA
PGEN_.00g337070	Scaffold_17	29478266	29478652	NA	NA	NA	NA	NA
PGEN_.00g337080	Scaffold_17	29524169	29534624	NA	NA	NA	NA	NA
PGEN_.00g337090	Scaffold_17	29538171	29539086	NA	NA	NA	NA	NA
PGEN_.00g337100	Scaffold_17	29540615	29540965	NA	NA	NA	NA	NA
PGEN_.00g337110	Scaffold_17	29544448	29567056	D3KCC4	CRNS1_CHICK	Carnosine synthase 1 (EC 6.3.2.11) (ATP-grasp domain-containing protein 1)	GO:0004459; GO:0005524; GO:0016887; GO:0019516; GO:0035499; GO:0046872; GO:0047730; GO:0102102	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; homocarnosine synthase activity [GO:0102102]; L-lactate dehydrogenase activity [GO:0004459]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; lactate oxidation [GO:0019516]
PGEN_.00g337120	Scaffold_17	29567603	29567821	NA	NA	NA	NA	NA
PGEN_.00g337130	Scaffold_17	29569827	29572117	NA	NA	NA	NA	NA
PGEN_.00g337140	Scaffold_17	29573528	29583014	Q6ZPS2	CRNS1_MOUSE	Carnosine synthase 1 (EC 6.3.2.11) (ATP-grasp domain-containing protein 1)	GO:0004459; GO:0005524; GO:0016887; GO:0019516; GO:0035499; GO:0046872; GO:0047730; GO:0102102	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; homocarnosine synthase activity [GO:0102102]; L-lactate dehydrogenase activity [GO:0004459]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; lactate oxidation [GO:0019516]
PGEN_.00g337150	Scaffold_17	29587737	29596843	P61315	G3ST3_MOUSE	"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
PGEN_.00g337160	Scaffold_17	29599541	29610572	NA	NA	NA	NA	NA
PGEN_.00g337170	Scaffold_17	29613376	29623955	NA	NA	NA	NA	NA
PGEN_.00g337180	Scaffold_17	29633742	29686528	P43304	GPDM_HUMAN	"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (mtGPD)"	GO:0004368; GO:0005509; GO:0005739; GO:0005743; GO:0006072; GO:0006094; GO:0006127; GO:0009331; GO:0019563; GO:0035264; GO:0043010; GO:0052591	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerophosphate shuttle [GO:0006127]; multicellular organism growth [GO:0035264]
PGEN_.00g337190	Scaffold_17	29777577	29794588	NA	NA	NA	NA	NA
PGEN_.00g337200	Scaffold_17	29811613	29817660	Q5RBR6	SPRY3_PONAB	SPRY domain-containing protein 3		
PGEN_.00g337210	Scaffold_17	29818380	29832825	Q5RBR6	SPRY3_PONAB	SPRY domain-containing protein 3		
PGEN_.00g337220	Scaffold_17	29858263	29873552	NA	NA	NA	NA	NA
PGEN_.00g337230	Scaffold_17	29881683	29882637	NA	NA	NA	NA	NA
PGEN_.00g337240	Scaffold_17	29882689	29882916	NA	NA	NA	NA	NA
PGEN_.00g337250	Scaffold_17	29946290	29948336	NA	NA	NA	NA	NA
PGEN_.00g337260	Scaffold_17	29966069	29994557	G5EBQ8	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063	cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]
PGEN_.00g337270	Scaffold_17	30004057	30023755	Q8TCT0	CERK1_HUMAN	Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4)	GO:0000287; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006687; GO:0016021; GO:0102773	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]
PGEN_.00g337280	Scaffold_17	30029800	30034291	P86854	PLCL_MYTGA	Perlucin-like protein	GO:0005576; GO:0030246	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
PGEN_.00g337290	Scaffold_17	30039567	30044256	NA	NA	NA	NA	NA
PGEN_.00g337300	Scaffold_17	30045893	30058605	NA	NA	NA	NA	NA
PGEN_.00g337310	Scaffold_17	30059808	30061502	Q2HJ61	PLPP2_BOVIN	Phospholipid phosphatase 2 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 2) (PAP2-gamma) (PAP2-G) (Phosphatidate phosphohydrolase type 2c) (Phosphatidic acid phosphatase 2c) (PAP-2c) (PAP2c)	GO:0005887; GO:0006644; GO:0008195; GO:0016791; GO:0042577; GO:0046839	integral component of plasma membrane [GO:0005887]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]
PGEN_.00g337320	Scaffold_17	30121076	30168927	Q8CG09	MRP1_RAT	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0009925; GO:0009986; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0016887; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042887; GO:0042908; GO:0042910; GO:0045332; GO:0050729; GO:0055085; GO:0060326; GO:0060548; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:1901215; GO:1990961	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type transmembrane transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; xenobiotic transmembrane transporter activity [GO:0042910]; cell chemotaxis [GO:0060326]; drug transmembrane transport [GO:0006855]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]
PGEN_.00g337330	Scaffold_17	30181637	30200397	NA	NA	NA	NA	NA
PGEN_.00g337340	Scaffold_17	30212543	30212803	NA	NA	NA	NA	NA
PGEN_.00g337350	Scaffold_17	30227571	30228653	NA	NA	NA	NA	NA
PGEN_.00g337360	Scaffold_17	30257872	30258210	NA	NA	NA	NA	NA
PGEN_.00g337370	Scaffold_17	30281005	30305300	Q6ZPS2	CRNS1_MOUSE	Carnosine synthase 1 (EC 6.3.2.11) (ATP-grasp domain-containing protein 1)	GO:0004459; GO:0005524; GO:0016887; GO:0019516; GO:0035499; GO:0046872; GO:0047730; GO:0102102	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; homocarnosine synthase activity [GO:0102102]; L-lactate dehydrogenase activity [GO:0004459]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; lactate oxidation [GO:0019516]
PGEN_.00g337380	Scaffold_17	30312105	30315548	Q8N0W4	NLGNX_HUMAN	"Neuroligin-4, X-linked (Neuroligin X) (HNLX)"	GO:0003360; GO:0005886; GO:0005887; GO:0007158; GO:0007612; GO:0009986; GO:0016021; GO:0021549; GO:0030054; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0071625; GO:0089717; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"
PGEN_.00g337390	Scaffold_17	30418983	30420547	Q96MB7	HARB1_HUMAN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g337400	Scaffold_17	30420834	30426173	NA	NA	NA	NA	NA
PGEN_.00g337410	Scaffold_17	30427851	30432002	NA	NA	NA	NA	NA
PGEN_.00g337420	Scaffold_17	30435084	30440159	Q5UPE2	YL063_MIMIV	Putative ankyrin repeat protein L63		
PGEN_.00g337430	Scaffold_17	30454330	30478431	NA	NA	NA	NA	NA
PGEN_.00g337440	Scaffold_17	30510544	30515041	Q9ESN6	TRIM2_MOUSE	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (Neural activity-related RING finger protein) (RING-type E3 ubiquitin transferase TRIM2)	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017022; GO:0043161; GO:0043523; GO:0061630; GO:1990830	cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]
PGEN_.00g337450	Scaffold_17	30519653	30523292	Q04310	Y4629_STRCO	Uncharacterized protein SCO4629	GO:0003677; GO:0005886	plasma membrane [GO:0005886]; DNA binding [GO:0003677]
PGEN_.00g337460	Scaffold_17	30524490	30557734	Q9D1Q6	ERP44_MOUSE	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	GO:0003756; GO:0005623; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0045454	cell [GO:0005623]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]
PGEN_.00g337470	Scaffold_17	30559854	30574330	Q9LX30	GCN2_ARATH	eIF-2-alpha kinase GCN2 (serine/threonine-protein kinase GCN2) (EC 2.7.11.1)	GO:0000049; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006412; GO:0006417; GO:0034198; GO:0070301; GO:0072755; GO:1990451	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; regulation of translation [GO:0006417]; translation [GO:0006412]
PGEN_.00g337480	Scaffold_17	30594700	30617543	P19525	E2AK2_HUMAN	"Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase)"	GO:0000186; GO:0001819; GO:0003723; GO:0003725; GO:0004672; GO:0004674; GO:0004694; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006468; GO:0008285; GO:0009615; GO:0016020; GO:0017148; GO:0019888; GO:0030683; GO:0030968; GO:0032722; GO:0032874; GO:0033689; GO:0034198; GO:0035455; GO:0042802; GO:0043066; GO:0045071; GO:0045087; GO:0046777; GO:0048471; GO:0051092; GO:0051607; GO:1900225; GO:1901224; GO:1901532; GO:1902033; GO:1902036	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribosome [GO:0005840]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; activation of MAPKK activity [GO:0000186]; cellular response to amino acid starvation [GO:0034198]; defense response to virus [GO:0051607]; endoplasmic reticulum unfolded protein response [GO:0030968]; evasion or tolerance by virus of host immune response [GO:0030683]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of NLRP3 inflammasome complex assembly [GO:1900225]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; translation [GO:0006412]
PGEN_.00g337490	Scaffold_17	30621309	30622391	NA	NA	NA	NA	NA
PGEN_.00g337500	Scaffold_17	30636472	30653101	NA	NA	NA	NA	NA
PGEN_.00g337510	Scaffold_17	30784390	30786385	NA	NA	NA	NA	NA
PGEN_.00g337520	Scaffold_17	30802169	30840166	Q9H195	MUC3B_HUMAN	Mucin-3B (MUC-3B) (Intestinal mucin-3B) (Fragments)	GO:0002223; GO:0005796; GO:0005886; GO:0016021; GO:0016266	Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]
PGEN_.00g337530	Scaffold_17	30866830	30884470	Q9H195	MUC3B_HUMAN	Mucin-3B (MUC-3B) (Intestinal mucin-3B) (Fragments)	GO:0002223; GO:0005796; GO:0005886; GO:0016021; GO:0016266	Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]
PGEN_.00g337540	Scaffold_17	30905481	30906563	NA	NA	NA	NA	NA
PGEN_.00g337550	Scaffold_17	30935814	30954841	NA	NA	NA	NA	NA
PGEN_.00g337560	Scaffold_17	31020336	31029649	NA	NA	NA	NA	NA
PGEN_.00g337570	Scaffold_17	31058067	31066961	Q86VE3	SATL1_HUMAN	Spermidine/spermine N(1)-acetyltransferase-like protein 1 (EC 2.3.1.-)	GO:0004145; GO:0005829; GO:0008080; GO:0019809; GO:0032918	cytosol [GO:0005829]; diamine N-acetyltransferase activity [GO:0004145]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; spermidine acetylation [GO:0032918]
PGEN_.00g337580	Scaffold_17	31067066	31074514	NA	NA	NA	NA	NA
PGEN_.00g337590	Scaffold_17	31102984	31112673	Q9H195	MUC3B_HUMAN	Mucin-3B (MUC-3B) (Intestinal mucin-3B) (Fragments)	GO:0002223; GO:0005796; GO:0005886; GO:0016021; GO:0016266	Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]
PGEN_.00g337600	Scaffold_17	31118692	31119078	NA	NA	NA	NA	NA
PGEN_.00g337610	Scaffold_17	31120092	31120436	NA	NA	NA	NA	NA
PGEN_.00g337620	Scaffold_17	31144034	31144234	NA	NA	NA	NA	NA
PGEN_.00g337630	Scaffold_17	31146138	31147775	NA	NA	NA	NA	NA
PGEN_.00g337640	Scaffold_17	31148574	31163081	Q02505	MUC3A_HUMAN	Mucin-3A (MUC-3A) (Intestinal mucin-3A)	GO:0002223; GO:0005201; GO:0005576; GO:0005796; GO:0005886; GO:0016021; GO:0016266; GO:0030197	"extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent, lubricant activity [GO:0030197]; extracellular matrix structural constituent [GO:0005201]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
PGEN_.00g337650	Scaffold_17	31200137	31202477	NA	NA	NA	NA	NA
PGEN_.00g337660	Scaffold_17	31220237	31222503	NA	NA	NA	NA	NA
PGEN_.00g337670	Scaffold_17	31232849	31236738	NA	NA	NA	NA	NA
PGEN_.00g337680	Scaffold_17	31255543	31263796	NA	NA	NA	NA	NA
PGEN_.00g337690	Scaffold_17	31295351	31301016	NA	NA	NA	NA	NA
PGEN_.00g337700	Scaffold_17	31325827	31327323	NA	NA	NA	NA	NA
PGEN_.00g337710	Scaffold_17	31341818	31343780	NA	NA	NA	NA	NA
PGEN_.00g337720	Scaffold_17	31348127	31353385	Q6NVP8	FUT8_XENTR	"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	GO:0006487; GO:0008424; GO:0016021; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046921	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]
PGEN_.00g337730	Scaffold_17	31378906	31384020	NA	NA	NA	NA	NA
PGEN_.00g337740	Scaffold_17	31401729	31402106	NA	NA	NA	NA	NA
PGEN_.00g337750	Scaffold_17	31402365	31402664	NA	NA	NA	NA	NA
PGEN_.00g337760	Scaffold_17	31409759	31413448	NA	NA	NA	NA	NA
PGEN_.00g337770	Scaffold_17	31419892	31420197	NA	NA	NA	NA	NA
PGEN_.00g337780	Scaffold_17	31423424	31424611	P33300	SUR1_YEAST	Mannosyl phosphorylinositol ceramide synthase SUR1 (EC 2.4.-.-)	GO:0000030; GO:0000324; GO:0000329; GO:0006675; GO:0006688; GO:0016021; GO:0030148; GO:0051999	fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; glycosphingolipid biosynthetic process [GO:0006688]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]; mannosyl-inositol phosphorylceramide metabolic process [GO:0006675]; sphingolipid biosynthetic process [GO:0030148]
PGEN_.00g337790	Scaffold_17	31441358	31454026	NA	NA	NA	NA	NA
PGEN_.00g337800	Scaffold_17	31492502	31497264	NA	NA	NA	NA	NA
PGEN_.00g337810	Scaffold_17	31520490	31520903	NA	NA	NA	NA	NA
PGEN_.00g337820	Scaffold_17	31539681	31540040	NA	NA	NA	NA	NA
PGEN_.00g337830	Scaffold_17	31545329	31552546	NA	NA	NA	NA	NA
PGEN_.00g337840	Scaffold_17	31607551	31623046	Q8BZP8	NPSR1_MOUSE	Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14)	GO:0005000; GO:0005623; GO:0005737; GO:0005887; GO:0007218; GO:0008188; GO:0042755; GO:0051281; GO:0060013; GO:0070374; GO:1903999; GO:2000293	cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; eating behavior [GO:0042755]; negative regulation of defecation [GO:2000293]; negative regulation of eating behavior [GO:1903999]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; righting reflex [GO:0060013]
PGEN_.00g337850	Scaffold_17	31636351	31656066	Q8Q0U0	Y045_METMA	Putative ankyrin repeat protein MM_0045		
PGEN_.00g337860	Scaffold_17	31660712	31667567	NA	NA	NA	NA	NA
PGEN_.00g337870	Scaffold_17	31692817	31693278	NA	NA	NA	NA	NA
PGEN_.00g337880	Scaffold_17	31697175	31698041	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g337890	Scaffold_17	31698099	31700075	Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0022604; GO:0046983	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g337900	Scaffold_17	31702399	31702896	NA	NA	NA	NA	NA
PGEN_.00g337910	Scaffold_17	31711479	31740972	Q8R0M8	MOT5_MOUSE	Monocarboxylate transporter 5 (MCT 5)	GO:0005886; GO:0008028; GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]
PGEN_.00g337920	Scaffold_17	31768912	31781272	NA	NA	NA	NA	NA
PGEN_.00g337930	Scaffold_17	31769871	31771742	NA	NA	NA	NA	NA
PGEN_.00g337940	Scaffold_17	31783684	31802918	O01393	UNC9_CAEEL	Innexin unc-9 (Uncoordinated protein 9)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
PGEN_.00g337950	Scaffold_17	31816166	31843190	Q7Z6J2	GRASP_HUMAN	General receptor for phosphoinositides 1-associated scaffold protein (GRP1-associated scaffold protein)	GO:0005886; GO:0007165; GO:0008104; GO:0014069; GO:0030054; GO:0030165; GO:0030306; GO:0042802; GO:0045211; GO:0048471; GO:0098685; GO:0098978; GO:0099152	"cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685]; ADP-ribosylation factor binding [GO:0030306]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein localization [GO:0008104]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]"
PGEN_.00g337960	Scaffold_17	31844555	31850112	NA	NA	NA	NA	NA
PGEN_.00g337970	Scaffold_17	31860029	31865934	Q7ZUZ0	CSN8_DANRE	COP9 signalosome complex subunit 8 (Signalosome subunit 8)	GO:0000338; GO:0005737; GO:0008180; GO:0010387	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]
PGEN_.00g337980	Scaffold_17	31872346	31878671	Q0DAE4	GRXC8_ORYSJ	Glutaredoxin-C8 (Glutaredoxin-C4 homolog)	GO:0004362; GO:0005623; GO:0005737; GO:0009055; GO:0015035; GO:0034599; GO:0045454	cell [GO:0005623]; cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]
PGEN_.00g337990	Scaffold_17	31887919	31895937	P36940	TNFL6_RAT	"Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]"	GO:0000122; GO:0005123; GO:0005125; GO:0005164; GO:0005615; GO:0005623; GO:0005634; GO:0005886; GO:0005901; GO:0006919; GO:0006925; GO:0008284; GO:0008625; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030644; GO:0031410; GO:0032496; GO:0043065; GO:0043123; GO:0043202; GO:0043525; GO:0045121; GO:0045742; GO:0046666; GO:0048388; GO:0048471; GO:0060205; GO:0070062; GO:0070231; GO:0070266; GO:0070848; GO:0071346; GO:0097190; GO:0097191; GO:0097527; GO:1903514; GO:2000353	caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle lumen [GO:0060205]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; death receptor binding [GO:0005123]; tumor necrosis factor receptor binding [GO:0005164]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular chloride ion homeostasis [GO:0030644]; cellular response to interferon-gamma [GO:0071346]; endosomal lumen acidification [GO:0048388]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory cell apoptotic process [GO:0006925]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron apoptotic process [GO:0043525]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; retinal cell programmed cell death [GO:0046666]; T cell apoptotic process [GO:0070231]
PGEN_.00g338000	Scaffold_17	31899521	31906131	NA	NA	NA	NA	NA
PGEN_.00g338010	Scaffold_17	31937158	31962048	NA	NA	NA	NA	NA
PGEN_.00g338020	Scaffold_17	31972196	31973785	NA	NA	NA	NA	NA
PGEN_.00g338030	Scaffold_17	32005515	32018930	Q91X17	UROM_MOUSE	"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]"	GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]
PGEN_.00g338040	Scaffold_17	32022822	32052059	Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	GO:0005102; GO:0005576; GO:0009986; GO:0048856	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]
PGEN_.00g338050	Scaffold_17	32052940	32055863	NA	NA	NA	NA	NA
PGEN_.00g338060	Scaffold_17	32070404	32073173	NA	NA	NA	NA	NA
PGEN_.00g338070	Scaffold_17	32095484	32096143	NA	NA	NA	NA	NA
PGEN_.00g338080	Scaffold_17	32147291	32160887	NA	NA	NA	NA	NA
PGEN_.00g338090	Scaffold_17	32151576	32152477	NA	NA	NA	NA	NA
PGEN_.00g338100	Scaffold_17	32164978	32165232	NA	NA	NA	NA	NA
PGEN_.00g338110	Scaffold_17	32166390	32181814	A0NLY7	ISAHY_LABAI	Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b)	GO:0004061; GO:0016812; GO:0019441; GO:0030145	"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]; tryptophan catabolic process to kynurenine [GO:0019441]"
PGEN_.00g338120	Scaffold_17	32185860	32187810	NA	NA	NA	NA	NA
PGEN_.00g338130	Scaffold_17	32193740	32193982	NA	NA	NA	NA	NA
PGEN_.00g338140	Scaffold_17	32198131	32208593	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g338150	Scaffold_17	32212041	32212532	NA	NA	NA	NA	NA
PGEN_.00g338160	Scaffold_17	32212719	32237135	Q8HXZ8	CD209_GORGO	CD209 antigen (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN1) (CD antigen CD209)	GO:0002250; GO:0005537; GO:0006897; GO:0007155; GO:0016021; GO:0045087; GO:0046872	integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; innate immune response [GO:0045087]
PGEN_.00g338170	Scaffold_17	32241786	32250799	NA	NA	NA	NA	NA
PGEN_.00g338180	Scaffold_17	32268003	32271311	NA	NA	NA	NA	NA
PGEN_.00g338190	Scaffold_17	32284682	32285289	NA	NA	NA	NA	NA
PGEN_.00g338200	Scaffold_17	32290354	32290698	NA	NA	NA	NA	NA
PGEN_.00g338210	Scaffold_17	32299126	32333863	P21803	FGFR2_MOUSE	Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332)	GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001837; GO:0002053; GO:0003148; GO:0003149; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005623; GO:0005634; GO:0005737; GO:0005794; GO:0005887; GO:0005938; GO:0006915; GO:0007169; GO:0007267; GO:0007409; GO:0007528; GO:0008201; GO:0008284; GO:0008285; GO:0008543; GO:0008589; GO:0009791; GO:0009880; GO:0009887; GO:0009986; GO:0010518; GO:0010628; GO:0016331; GO:0017134; GO:0018108; GO:0021769; GO:0021847; GO:0021860; GO:0022612; GO:0030177; GO:0030282; GO:0030324; GO:0030855; GO:0030901; GO:0030916; GO:0031069; GO:0031410; GO:0032808; GO:0035265; GO:0035602; GO:0035603; GO:0035604; GO:0035607; GO:0042127; GO:0042472; GO:0042476; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0045165; GO:0045787; GO:0045839; GO:0045944; GO:0046777; GO:0048286; GO:0048489; GO:0048557; GO:0048562; GO:0048565; GO:0048568; GO:0048608; GO:0048661; GO:0048701; GO:0048730; GO:0048755; GO:0048762; GO:0050678; GO:0050679; GO:0050680; GO:0051150; GO:0051781; GO:0055010; GO:0060045; GO:0060076; GO:0060174; GO:0060348; GO:0060349; GO:0060365; GO:0060441; GO:0060442; GO:0060445; GO:0060449; GO:0060463; GO:0060484; GO:0060501; GO:0060512; GO:0060523; GO:0060527; GO:0060529; GO:0060595; GO:0060601; GO:0060615; GO:0060664; GO:0060667; GO:0060670; GO:0060688; GO:0060915; GO:0060916; GO:0060979; GO:0061031; GO:0070307; GO:0070372; GO:0070374; GO:0090263	cell [GO:0005623]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; coronal suture morphogenesis [GO:0060365]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endodermal digestive tract morphogenesis [GO:0061031]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; lens fiber cell development [GO:0070307]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; mammary gland bud formation [GO:0060615]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of smoothened signaling pathway [GO:0008589]; reproductive structure development [GO:0048608]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; synaptic vesicle transport [GO:0048489]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]
PGEN_.00g338220	Scaffold_17	32342809	32378939	NA	NA	NA	NA	NA
PGEN_.00g338230	Scaffold_17	32384899	32389099	Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g338240	Scaffold_17	32428577	32428810	NA	NA	NA	NA	NA
PGEN_.00g338250	Scaffold_17	32437263	32451882	O14718	OPSX_HUMAN	Visual pigment-like receptor peropsin	GO:0001750; GO:0004930; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0018298; GO:0071482	integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g338260	Scaffold_17	32477444	32478022	NA	NA	NA	NA	NA
PGEN_.00g338270	Scaffold_17	32530610	32539506	O35214	OPSX_MOUSE	Visual pigment-like receptor peropsin	GO:0001750; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0018298; GO:0071482	integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]
PGEN_.00g338280	Scaffold_17	32587045	32597715	A8MUU9	YV023_HUMAN	Putative uncharacterized protein ENSP00000383309		
PGEN_.00g338290	Scaffold_17	32679508	32679855	NA	NA	NA	NA	NA
PGEN_.00g338300	Scaffold_17	32680678	32681388	NA	NA	NA	NA	NA
PGEN_.00g338310	Scaffold_17	32682479	32682769	NA	NA	NA	NA	NA
PGEN_.00g338320	Scaffold_17	32682818	32683099	NA	NA	NA	NA	NA
PGEN_.00g338330	Scaffold_17	32683672	32684337	NA	NA	NA	NA	NA
PGEN_.00g338340	Scaffold_17	32684683	32690024	NA	NA	NA	NA	NA
PGEN_.00g338350	Scaffold_17	32708924	32709520	NA	NA	NA	NA	NA
PGEN_.00g338360	Scaffold_17	32709636	32710946	NA	NA	NA	NA	NA
PGEN_.00g338370	Scaffold_17	32725546	32726847	O01393	UNC9_CAEEL	Innexin unc-9 (Uncoordinated protein 9)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
PGEN_.00g338380	Scaffold_17	32740880	32758456	O01393	UNC9_CAEEL	Innexin unc-9 (Uncoordinated protein 9)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
PGEN_.00g338390	Scaffold_17	32773236	32784206	O01393	UNC9_CAEEL	Innexin unc-9 (Uncoordinated protein 9)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
PGEN_.00g338400	Scaffold_17	32788899	32794687	O01393	UNC9_CAEEL	Innexin unc-9 (Uncoordinated protein 9)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
PGEN_.00g338410	Scaffold_17	32798920	32808573	O01393	UNC9_CAEEL	Innexin unc-9 (Uncoordinated protein 9)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
PGEN_.00g338420	Scaffold_17	32860495	32867072	NA	NA	NA	NA	NA
PGEN_.00g338430	Scaffold_17	32885131	32892680	O01393	UNC9_CAEEL	Innexin unc-9 (Uncoordinated protein 9)	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
PGEN_.00g338440	Scaffold_17	32922885	32943531	Q96EZ8	MCRS1_HUMAN	Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2)	GO:0000123; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006281; GO:0006310; GO:0006464; GO:0008266; GO:0010521; GO:0016579; GO:0030425; GO:0031011; GO:0034046; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045944; GO:0051974; GO:0071339; GO:1904357; GO:1904751	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]; G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]; cellular protein modification process [GO:0006464]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]
PGEN_.00g338450	Scaffold_17	32943579	32954885	NA	NA	NA	NA	NA
PGEN_.00g338460	Scaffold_17	32956163	32957718	NA	NA	NA	NA	NA
PGEN_.00g338470	Scaffold_17	32959683	32963070	Q6NT32	EST5A_HUMAN	Carboxylesterase 5A (EC 3.1.1.1) (Carboxylesterase-like urinary excreted protein homolog) (Cauxin)	GO:0004771; GO:0004806; GO:0005615; GO:0016042; GO:0052689; GO:0080030	extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]
PGEN_.00g338480	Scaffold_17	32966514	32969874	P14943	EST2_RABIT	Liver carboxylesterase 2 (EC 3.1.1.1)	GO:0005788; GO:0080030	endoplasmic reticulum lumen [GO:0005788]; methyl indole-3-acetate esterase activity [GO:0080030]
PGEN_.00g338490	Scaffold_17	32978553	32980436	P82596	PLC_HALLA	Perlucin	GO:0030246	carbohydrate binding [GO:0030246]
PGEN_.00g338500	Scaffold_17	32981334	32983004	NA	NA	NA	NA	NA
PGEN_.00g338510	Scaffold_17	32986262	32995332	NA	NA	NA	NA	NA
PGEN_.00g338520	Scaffold_17	33007404	33026084	NA	NA	NA	NA	NA
PGEN_.00g338530	Scaffold_17	33038876	33042924	NA	NA	NA	NA	NA
PGEN_.00g338540	Scaffold_17	33051673	33054752	NA	NA	NA	NA	NA
PGEN_.00g338550	Scaffold_17	33060401	33061456	NA	NA	NA	NA	NA
PGEN_.00g338560	Scaffold_17	33075492	33076150	NA	NA	NA	NA	NA
PGEN_.00g338570	Scaffold_17	33081173	33085700	NA	NA	NA	NA	NA
PGEN_.00g338580	Scaffold_17	33086374	33089087	NA	NA	NA	NA	NA
PGEN_.00g338590	Scaffold_17	33091349	33095548	NA	NA	NA	NA	NA
PGEN_.00g338600	Scaffold_17	33111515	33120005	Q8VC69	S22A6_MOUSE	Solute carrier family 22 member 6 (Kidney-specific transport protein) (Novel kidney transcript) (mNKT) (Organic anion transporter 1) (Renal organic anion transporter 1) (mROAT1)	GO:0005452; GO:0005886; GO:0005887; GO:0005901; GO:0006820; GO:0008514; GO:0015301; GO:0015347; GO:0015711; GO:0015742; GO:0016323; GO:0031404; GO:0031427; GO:0032991; GO:0042802; GO:0042803; GO:0043252; GO:0051260; GO:0097254	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; alpha-ketoglutarate transport [GO:0015742]; anion transport [GO:0006820]; organic anion transport [GO:0015711]; protein homooligomerization [GO:0051260]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]
PGEN_.00g338610	Scaffold_17	33124385	33141954	Q4W8A2	S22A8_MACFA	Solute carrier family 22 member 8 (Organic anion transporter 3) (mkOAT3)	GO:0006811; GO:0009636; GO:0016021; GO:0016323; GO:0022857	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]; response to toxic substance [GO:0009636]
PGEN_.00g338620	Scaffold_17	33163473	33173709	NA	NA	NA	NA	NA
PGEN_.00g338630	Scaffold_17	33196251	33201460	Q80T79	CSMD3_MOUSE	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	GO:0005886; GO:0016021; GO:0050773	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]
PGEN_.00g338640	Scaffold_17	33213032	33233895	P18708	NSF_CRIGR	Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)	GO:0000149; GO:0001921; GO:0005524; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0016887; GO:0017075; GO:0019901; GO:0030165; GO:0030496; GO:0035255; GO:0035494; GO:0042623; GO:0042802; GO:0044877; GO:0045732; GO:0046872	"cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; SNARE complex disassembly [GO:0035494]"
PGEN_.00g338650	Scaffold_17	33247092	33272284	Q8IXB1	DJC10_HUMAN	DnaJ homolog subfamily C member 10 (EC 1.8.4.-) (Endoplasmic reticulum DNA J domain-containing protein 5) (ER-resident protein ERdj5) (ERdj5) (Macrothioredoxin) (MTHr)	GO:0001671; GO:0001933; GO:0005623; GO:0005783; GO:0005788; GO:0015035; GO:0015036; GO:0016020; GO:0016671; GO:0030433; GO:0030544; GO:0032781; GO:0034663; GO:0034975; GO:0034976; GO:0045454; GO:0051087; GO:0051117; GO:0051787; GO:0070059	"cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]"
PGEN_.00g338660	Scaffold_17	33303169	33303618	NA	NA	NA	NA	NA
PGEN_.00g338670	Scaffold_17	33333694	33335215	NA	NA	NA	NA	NA
PGEN_.00g338680	Scaffold_17	33342312	33342797	NA	NA	NA	NA	NA
PGEN_.00g338690	Scaffold_17	33342848	33343198	NA	NA	NA	NA	NA
PGEN_.00g338700	Scaffold_17	33440016	33440837	NA	NA	NA	NA	NA
PGEN_.00g338710	Scaffold_17	33460303	33497657	Q9V5N8	STAN_DROME	Protocadherin-like wing polarity protein stan (Protein flamingo) (Protein starry night)	GO:0001736; GO:0001738; GO:0004888; GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007367; GO:0007409; GO:0007411; GO:0007464; GO:0016021; GO:0016318; GO:0016319; GO:0016324; GO:0016339; GO:0016358; GO:0035159; GO:0042067; GO:0045773; GO:0048057; GO:0048813; GO:0050770; GO:0050839; GO:0051963; GO:0060071; GO:0070593; GO:0090175; GO:0098609; GO:1902669	"apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of a polarized epithelium [GO:0001738]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; R3/R4 cell fate commitment [GO:0007464]; R3/R4 development [GO:0048057]; regulation of axonogenesis [GO:0050770]; regulation of establishment of planar polarity [GO:0090175]; regulation of synapse assembly [GO:0051963]; regulation of tube length, open tracheal system [GO:0035159]; segment polarity determination [GO:0007367]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
PGEN_.00g338720	Scaffold_17	33504439	33537774	P10076	ZFP26_MOUSE	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g338730	Scaffold_17	33544429	33554648	Q99999	G3ST1_HUMAN	Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)	GO:0000139; GO:0001733; GO:0005887; GO:0006487; GO:0006682; GO:0007283; GO:0008146; GO:0016020; GO:0042552	Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; galactosylceramide biosynthetic process [GO:0006682]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]
PGEN_.00g338740	Scaffold_17	33567263	33575778	O15442	MPPD1_HUMAN	Metallophosphoesterase domain-containing protein 1 (EC 3.1.-.-) (Adult brain protein 239) (239AB)	GO:0016787	hydrolase activity [GO:0016787]
PGEN_.00g338750	Scaffold_17	33580911	33587006	NA	NA	NA	NA	NA
PGEN_.00g338760	Scaffold_17	33587089	33623523	Q20930	MIG17_CAEEL	Metalloprotease mig-17 (EC 3.4.24.-) (Abnormal cell migration protein 17)	GO:0004222; GO:0005604; GO:0005615; GO:0008104; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354	basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]
PGEN_.00g338770	Scaffold_17	33626721	33640239	O15460	P4HA2_HUMAN	"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)"	GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0016702; GO:0018401; GO:0031418; GO:0043231	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"
PGEN_.00g338780	Scaffold_17	33644947	33663251	Q9D799	FMT_MOUSE	"Methionyl-tRNA formyltransferase, mitochondrial (MtFMT) (EC 2.1.2.9)"	GO:0004479; GO:0005739; GO:0071951	mitochondrion [GO:0005739]; methionyl-tRNA formyltransferase activity [GO:0004479]; conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]
PGEN_.00g338790	Scaffold_17	33667969	33686940	Q13685	AAMP_HUMAN	Angio-associated migratory cell protein	GO:0001525; GO:0005829; GO:0005886; GO:0008201; GO:0009986; GO:0010595; GO:0014909; GO:0015630; GO:0030154; GO:0045171	cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; smooth muscle cell migration [GO:0014909]
PGEN_.00g338800	Scaffold_17	33701513	33701746	NA	NA	NA	NA	NA
PGEN_.00g338810	Scaffold_17	33712300	33713442	NA	NA	NA	NA	NA
PGEN_.00g338820	Scaffold_17	33735624	33741366	NA	NA	NA	NA	NA
PGEN_.00g338830	Scaffold_17	33744652	33750453	Q96MB7	HARB1_HUMAN	Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)	GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]
PGEN_.00g338840	Scaffold_17	33752612	33752878	NA	NA	NA	NA	NA
PGEN_.00g338850	Scaffold_17	33844424	33854994	Q3U0L2	AN33B_MOUSE	Ankyrin repeat domain-containing protein 33B	GO:0003677	DNA binding [GO:0003677]
PGEN_.00g338860	Scaffold_17	33855763	33858984	NA	NA	NA	NA	NA
PGEN_.00g338870	Scaffold_17	34101829	34106122	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g338880	Scaffold_17	34161196	34166547	NA	NA	NA	NA	NA
PGEN_.00g338890	Scaffold_17	34178901	34196774	NA	NA	NA	NA	NA
PGEN_.00g338900	Scaffold_17	34208692	34221973	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g338910	Scaffold_17	34231838	34238316	NA	NA	NA	NA	NA
PGEN_.00g338920	Scaffold_17	34240267	34245877	NA	NA	NA	NA	NA
PGEN_.00g338930	Scaffold_17	34259743	34271179	NA	NA	NA	NA	NA
PGEN_.00g338940	Scaffold_17	34288238	34296320	NA	NA	NA	NA	NA
PGEN_.00g338950	Scaffold_17	34300158	34301236	NA	NA	NA	NA	NA
PGEN_.00g338960	Scaffold_17	34301535	34301879	NA	NA	NA	NA	NA
PGEN_.00g338970	Scaffold_17	34302206	34302580	NA	NA	NA	NA	NA
PGEN_.00g338980	Scaffold_17	34302623	34302886	NA	NA	NA	NA	NA
PGEN_.00g338990	Scaffold_17	34303106	34303375	NA	NA	NA	NA	NA
PGEN_.00g339000	Scaffold_17	34303543	34303896	NA	NA	NA	NA	NA
PGEN_.00g339010	Scaffold_17	34304097	34304420	NA	NA	NA	NA	NA
PGEN_.00g339020	Scaffold_17	34304477	34304680	NA	NA	NA	NA	NA
PGEN_.00g339030	Scaffold_17	34304762	34305187	NA	NA	NA	NA	NA
PGEN_.00g339040	Scaffold_17	34309394	34310488	NA	NA	NA	NA	NA
PGEN_.00g339050	Scaffold_17	34310551	34311288	NA	NA	NA	NA	NA
PGEN_.00g339060	Scaffold_17	34339571	34348910	NA	NA	NA	NA	NA
PGEN_.00g339070	Scaffold_17	34362878	34363363	P08012	PRP1_SOYBN	Repetitive proline-rich cell wall protein 1	GO:0005199; GO:0005576; GO:0005618; GO:0007275	cell wall [GO:0005618]; extracellular region [GO:0005576]; structural constituent of cell wall [GO:0005199]; multicellular organism development [GO:0007275]
PGEN_.00g339080	Scaffold_17	34364068	34364976	P08012	PRP1_SOYBN	Repetitive proline-rich cell wall protein 1	GO:0005199; GO:0005576; GO:0005618; GO:0007275	cell wall [GO:0005618]; extracellular region [GO:0005576]; structural constituent of cell wall [GO:0005199]; multicellular organism development [GO:0007275]
PGEN_.00g339090	Scaffold_17	34368866	34372539	NA	NA	NA	NA	NA
PGEN_.00g339100	Scaffold_17	34417358	34417738	NA	NA	NA	NA	NA
PGEN_.00g339110	Scaffold_17	34492722	34500840	NA	NA	NA	NA	NA
PGEN_.00g339120	Scaffold_17	34518796	34524071	NA	NA	NA	NA	NA
PGEN_.00g339130	Scaffold_17	34531250	34549373	O75208	COQ9_HUMAN	"Ubiquinone biosynthesis protein COQ9, mitochondrial"	GO:0005739; GO:0005743; GO:0006120; GO:0006744; GO:0008289; GO:0042803	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; ubiquinone biosynthetic process [GO:0006744]"
PGEN_.00g339140	Scaffold_17	34557298	34557594	NA	NA	NA	NA	NA
PGEN_.00g339150	Scaffold_17	34557883	34558269	NA	NA	NA	NA	NA
PGEN_.00g339160	Scaffold_17	34558306	34558647	NA	NA	NA	NA	NA
PGEN_.00g339170	Scaffold_17	34558949	34559230	NA	NA	NA	NA	NA
PGEN_.00g339180	Scaffold_17	34576878	34643430	O77819	ROCK1_RABIT	"Rho-associated protein kinase 1 (EC 2.7.11.1) (Corneal epithelial Rho-associated-Ser/Thr kinase 1) (HEBM1) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (cAMP-dependent protein kinase ROCK-I) (CePKA) (p160 ROCK-1) (p160ROCK)"	GO:0000139; GO:0001726; GO:0004674; GO:0005524; GO:0005814; GO:0005856; GO:0005886; GO:0006468; GO:0006915; GO:0007266; GO:0017049; GO:0030027; GO:0030036; GO:0030334; GO:0032059; GO:0046872; GO:0051451; GO:0051894; GO:0070507	bleb [GO:0032059]; centriole [GO:0005814]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; myoblast migration [GO:0051451]; positive regulation of focal adhesion assembly [GO:0051894]; protein phosphorylation [GO:0006468]; regulation of cell migration [GO:0030334]; regulation of microtubule cytoskeleton organization [GO:0070507]; Rho protein signal transduction [GO:0007266]
PGEN_.00g339190	Scaffold_17	34651394	34741873	NA	NA	NA	NA	NA
PGEN_.00g339200	Scaffold_17	34742382	34744104	NA	NA	NA	NA	NA
PGEN_.00g339210	Scaffold_17	34744727	34745506	Q9DAJ2	TEKT1_MOUSE	Tektin-1	GO:0005874; GO:0015630; GO:0060271; GO:0060294	microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]
PGEN_.00g339220	Scaffold_17	34771561	34842075	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g339230	Scaffold_17	34843639	34909448	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g339240	Scaffold_17	34913248	34922551	NA	NA	NA	NA	NA
PGEN_.00g339250	Scaffold_18	44665	88457	B7QDG3	NNRE_IXOSC	NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase)	GO:0000166; GO:0005739; GO:0046872; GO:0052856; GO:0052857	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166]
PGEN_.00g339260	Scaffold_18	108170	118082	F7FIH8	NNRE_MONDO	NAD(P)H-hydrate epimerase (EC 5.1.99.6) (Apolipoprotein A-I-binding protein) (AI-BP) (NAD(P)HX epimerase)	GO:0000166; GO:0005615; GO:0005654; GO:0005739; GO:0005829; GO:0005929; GO:0042802; GO:0044297; GO:0046496; GO:0046872; GO:0052856; GO:0052857	cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166]; nicotinamide nucleotide metabolic process [GO:0046496]
PGEN_.00g339270	Scaffold_18	199131	199415	NA	NA	NA	NA	NA
PGEN_.00g339280	Scaffold_18	285845	289869	NA	NA	NA	NA	NA
PGEN_.00g339290	Scaffold_18	358860	389461	NA	NA	NA	NA	NA
PGEN_.00g339300	Scaffold_18	403355	410351	NA	NA	NA	NA	NA
PGEN_.00g339310	Scaffold_18	413375	414137	NA	NA	NA	NA	NA
PGEN_.00g339320	Scaffold_18	420657	423979	NA	NA	NA	NA	NA
PGEN_.00g339330	Scaffold_18	430024	471770	O75182	SIN3B_HUMAN	Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)	GO:0000122; GO:0000785; GO:0000805; GO:0000806; GO:0001741; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0016575; GO:0016580; GO:0019216; GO:0030849	autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]
PGEN_.00g339340	Scaffold_18	489614	490091	NA	NA	NA	NA	NA
PGEN_.00g339350	Scaffold_18	495610	496076	NA	NA	NA	NA	NA
PGEN_.00g339360	Scaffold_18	500525	544746	NA	NA	NA	NA	NA
PGEN_.00g339370	Scaffold_18	577895	654075	Q62432	SMAD2_MOUSE	Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (Mad-related protein 2) (mMad2) (SMAD family member 2) (SMAD 2) (Smad2)	GO:0000790; GO:0000978; GO:0001228; GO:0001657; GO:0001701; GO:0001706; GO:0001707; GO:0003682; GO:0003690; GO:0003700; GO:0005160; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006468; GO:0007179; GO:0007182; GO:0007183; GO:0007352; GO:0007369; GO:0007389; GO:0007492; GO:0007507; GO:0008134; GO:0008285; GO:0009749; GO:0009791; GO:0009880; GO:0009952; GO:0010628; GO:0010629; GO:0010718; GO:0017015; GO:0019902; GO:0023019; GO:0030073; GO:0030324; GO:0030325; GO:0030513; GO:0030618; GO:0031016; GO:0031625; GO:0032444; GO:0032924; GO:0032991; GO:0033613; GO:0034713; GO:0035265; GO:0035556; GO:0038092; GO:0042060; GO:0042803; GO:0045165; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048156; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0051098; GO:0060039; GO:0060395; GO:0062009; GO:0070410; GO:0070411; GO:0070412; GO:0070723; GO:0070878; GO:0071141; GO:0071144; GO:0097718; GO:1900224	"activin responsive factor complex [GO:0032444]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anterior/posterior pattern specification [GO:0009952]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pattern specification process [GO:0007389]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]"
PGEN_.00g339380	Scaffold_18	667050	667403	NA	NA	NA	NA	NA
PGEN_.00g339390	Scaffold_18	680607	707527	Q9TYT3	SHCH1_CAEEL	SHC-transforming protein homolog 1 (Src homology 2 domain adapter homolog 1)	GO:0005159; GO:0005634; GO:0005737; GO:0005886; GO:0010038; GO:0031434; GO:0031435; GO:0033674; GO:0034976; GO:0048680	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin-like growth factor receptor binding [GO:0005159]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; positive regulation of axon regeneration [GO:0048680]; positive regulation of kinase activity [GO:0033674]; response to endoplasmic reticulum stress [GO:0034976]; response to metal ion [GO:0010038]
PGEN_.00g339400	Scaffold_18	708536	708949	NA	NA	NA	NA	NA
PGEN_.00g339410	Scaffold_18	732818	733156	NA	NA	NA	NA	NA
PGEN_.00g339420	Scaffold_18	734027	760396	NA	NA	NA	NA	NA
PGEN_.00g339430	Scaffold_18	771341	795154	NA	NA	NA	NA	NA
PGEN_.00g339440	Scaffold_18	799120	799341	NA	NA	NA	NA	NA
PGEN_.00g339450	Scaffold_18	799932	800153	NA	NA	NA	NA	NA
PGEN_.00g339460	Scaffold_18	804119	827517	NA	NA	NA	NA	NA
PGEN_.00g339470	Scaffold_18	838625	865075	NA	NA	NA	NA	NA
PGEN_.00g339480	Scaffold_18	865946	866305	NA	NA	NA	NA	NA
PGEN_.00g339490	Scaffold_18	890261	917789	Q9TYT3	SHCH1_CAEEL	SHC-transforming protein homolog 1 (Src homology 2 domain adapter homolog 1)	GO:0005159; GO:0005634; GO:0005737; GO:0005886; GO:0010038; GO:0031434; GO:0031435; GO:0033674; GO:0034976; GO:0048680	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin-like growth factor receptor binding [GO:0005159]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; positive regulation of axon regeneration [GO:0048680]; positive regulation of kinase activity [GO:0033674]; response to endoplasmic reticulum stress [GO:0034976]; response to metal ion [GO:0010038]
PGEN_.00g339500	Scaffold_18	931026	931379	NA	NA	NA	NA	NA
PGEN_.00g339510	Scaffold_18	944314	1018184	Q62432	SMAD2_MOUSE	Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (Mad-related protein 2) (mMad2) (SMAD family member 2) (SMAD 2) (Smad2)	GO:0000790; GO:0000978; GO:0001228; GO:0001657; GO:0001701; GO:0001706; GO:0001707; GO:0003682; GO:0003690; GO:0003700; GO:0005160; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006468; GO:0007179; GO:0007182; GO:0007183; GO:0007352; GO:0007369; GO:0007389; GO:0007492; GO:0007507; GO:0008134; GO:0008285; GO:0009749; GO:0009791; GO:0009880; GO:0009952; GO:0010628; GO:0010629; GO:0010718; GO:0017015; GO:0019902; GO:0023019; GO:0030073; GO:0030324; GO:0030325; GO:0030513; GO:0030618; GO:0031016; GO:0031625; GO:0032444; GO:0032924; GO:0032991; GO:0033613; GO:0034713; GO:0035265; GO:0035556; GO:0038092; GO:0042060; GO:0042803; GO:0045165; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048156; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0051098; GO:0060039; GO:0060395; GO:0062009; GO:0070410; GO:0070411; GO:0070412; GO:0070723; GO:0070878; GO:0071141; GO:0071144; GO:0097718; GO:1900224	"activin responsive factor complex [GO:0032444]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anterior/posterior pattern specification [GO:0009952]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pattern specification process [GO:0007389]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]"
PGEN_.00g339520	Scaffold_18	1042197	1042463	NA	NA	NA	NA	NA
PGEN_.00g339530	Scaffold_18	1042201	1042377	NA	NA	NA	NA	NA
PGEN_.00g339540	Scaffold_18	1050576	1094845	NA	NA	NA	NA	NA
PGEN_.00g339550	Scaffold_18	1121143	1163793	O75182	SIN3B_HUMAN	Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)	GO:0000122; GO:0000785; GO:0000805; GO:0000806; GO:0001741; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0016575; GO:0016580; GO:0019216; GO:0030849	autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]
PGEN_.00g339560	Scaffold_18	1169830	1178065	NA	NA	NA	NA	NA
PGEN_.00g339570	Scaffold_18	1181020	1188478	NA	NA	NA	NA	NA
PGEN_.00g339580	Scaffold_18	1202142	1232959	NA	NA	NA	NA	NA
PGEN_.00g339590	Scaffold_18	1299132	1303156	NA	NA	NA	NA	NA
PGEN_.00g339600	Scaffold_18	1389642	1389926	NA	NA	NA	NA	NA
PGEN_.00g339610	Scaffold_18	1392062	1392319	NA	NA	NA	NA	NA
PGEN_.00g339620	Scaffold_18	1471461	1480766	F7DL67	NNRE_XENTR	NAD(P)H-hydrate epimerase (EC 5.1.99.6) (Apolipoprotein A-I binding protein) (NAD(P)HX epimerase)	GO:0000166; GO:0005576; GO:0005739; GO:0046872; GO:0052856; GO:0052857	extracellular region [GO:0005576]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166]
PGEN_.00g339630	Scaffold_18	1500486	1542895	B7QDG3	NNRE_IXOSC	NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase)	GO:0000166; GO:0005739; GO:0046872; GO:0052856; GO:0052857	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166]
PGEN_.00g339640	Scaffold_18	1604865	1614164	NA	NA	NA	NA	NA
PGEN_.00g339650	Scaffold_18	1621864	1624772	NA	NA	NA	NA	NA
PGEN_.00g339660	Scaffold_18	1655378	1656211	NA	NA	NA	NA	NA
PGEN_.00g339670	Scaffold_18	1722523	1723778	NA	NA	NA	NA	NA
PGEN_.00g339680	Scaffold_18	1724672	1724896	NA	NA	NA	NA	NA
PGEN_.00g339690	Scaffold_18	1727350	1748540	Q8K595	MCLN2_MOUSE	Mucolipin-2 (Transient receptor potential channel mucolipin 2) (TRPML2)	GO:0002250; GO:0005623; GO:0005764; GO:0016021; GO:0032722; GO:0035926; GO:0042802; GO:0045087; GO:0055037; GO:0055038; GO:0071639; GO:0071642; GO:0071651; GO:0072345; GO:1905517; GO:1990266; GO:2000343	cell [GO:0005623]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; chemokine (C-C motif) ligand 2 secretion [GO:0035926]; innate immune response [GO:0045087]; macrophage migration [GO:1905517]; neutrophil migration [GO:1990266]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]
PGEN_.00g339700	Scaffold_18	1756531	1809209	O14672	ADA10_HUMAN	Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)	GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005102; GO:0005178; GO:0005634; GO:0005737; GO:0005788; GO:0005794; GO:0005798; GO:0005802; GO:0005886; GO:0005925; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0007229; GO:0007267; GO:0007283; GO:0008021; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010820; GO:0014069; GO:0016020; GO:0016021; GO:0016485; GO:0017124; GO:0019901; GO:0022617; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0034205; GO:0034612; GO:0035333; GO:0035579; GO:0042117; GO:0042803; GO:0042987; GO:0043025; GO:0043065; GO:0043197; GO:0043231; GO:0043312; GO:0043687; GO:0044267; GO:0045211; GO:0046872; GO:0046930; GO:0046931; GO:0051088; GO:0051089; GO:0061001; GO:0070062; GO:0070821; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0097327; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945	"axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; cell-cell signaling [GO:0007267]; cellular protein metabolic process [GO:0044267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; neutrophil degranulation [GO:0043312]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; post-translational protein modification [GO:0043687]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]"
PGEN_.00g339710	Scaffold_18	1818767	1831830	NA	NA	NA	NA	NA
PGEN_.00g339720	Scaffold_18	1839199	1859318	NA	NA	NA	NA	NA
PGEN_.00g339730	Scaffold_18	1932273	1935466	NA	NA	NA	NA	NA
PGEN_.00g339740	Scaffold_18	1937429	1953249	NA	NA	NA	NA	NA
PGEN_.00g339750	Scaffold_18	2038527	2051705	NA	NA	NA	NA	NA
PGEN_.00g339760	Scaffold_18	2056114	2058033	NA	NA	NA	NA	NA
PGEN_.00g339770	Scaffold_18	2058406	2065611	NA	NA	NA	NA	NA
PGEN_.00g339780	Scaffold_18	2068316	2078735	Q6PBA8	MNS1_DANRE	Meiosis-specific nuclear structural protein 1	GO:0005634; GO:0031514; GO:0044782; GO:0051321	motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium organization [GO:0044782]; meiotic cell cycle [GO:0051321]
PGEN_.00g339790	Scaffold_18	2079483	2124943	NA	NA	NA	NA	NA
PGEN_.00g339800	Scaffold_18	2138487	2141983	NA	NA	NA	NA	NA
PGEN_.00g339810	Scaffold_18	2215273	2222628	Q8N6F8	MET27_HUMAN	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)		
PGEN_.00g339820	Scaffold_18	2235927	2271246	Q9BXJ3	C1QT4_HUMAN	Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4)	GO:0005125; GO:0005615; GO:0032755; GO:0070105; GO:1901224; GO:1904469; GO:2000778	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469]
PGEN_.00g339830	Scaffold_18	2378072	2388007	O15975	GNAQ_MIZYE	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)	GO:0001664; GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g339840	Scaffold_18	2421987	2479928	O60331	PI51C_HUMAN	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma (PIP5K1-gamma) (PtdIns(4)P-5-kinase 1 gamma) (EC 2.7.1.68) (Phosphatidylinositol 4-phosphate 5-kinase type I gamma) (PIP5KIgamma)	GO:0001891; GO:0001931; GO:0005524; GO:0005654; GO:0005829; GO:0005925; GO:0006661; GO:0006909; GO:0010008; GO:0014066; GO:0016079; GO:0016308; GO:0030036; GO:0030593; GO:0032587; GO:0034333; GO:0048488; GO:0061024; GO:0072583; GO:0098609; GO:0098793	cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; presynapse [GO:0098793]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; cell-cell adhesion [GO:0098609]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neutrophil chemotaxis [GO:0030593]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]
PGEN_.00g339850	Scaffold_18	2502558	2503037	NA	NA	NA	NA	NA
PGEN_.00g339860	Scaffold_18	2512660	2513734	NA	NA	NA	NA	NA
PGEN_.00g339870	Scaffold_18	2517573	2525627	Q6NRT3	SMU1_XENLA	WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog)	GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0016607; GO:0071005	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"
PGEN_.00g339880	Scaffold_18	2579694	2582063	Q6P0C6	LHPL2_DANRE	LHFPL tetraspan subfamily member 2a protein	GO:0007338; GO:0016021; GO:0046545; GO:0046546; GO:1905516	integral component of membrane [GO:0016021]; development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]
PGEN_.00g339890	Scaffold_18	2598435	2641482	Q80U22	RUSC2_MOUSE	Iporin (Interacting protein of Rab1) (RUN and SH3 domain-containing protein 2)	GO:0005829; GO:0017137; GO:0031410	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Rab GTPase binding [GO:0017137]
PGEN_.00g339900	Scaffold_18	2645567	2646106	NA	NA	NA	NA	NA
PGEN_.00g339910	Scaffold_18	2668944	2692539	O60494	CUBN_HUMAN	Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]
PGEN_.00g339920	Scaffold_18	2705493	2724275	Q8CDN6	TXNL1_MOUSE	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	GO:0000502; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0015036; GO:0045454	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454]
PGEN_.00g339930	Scaffold_18	2733264	2757331	NA	NA	NA	NA	NA
PGEN_.00g339940	Scaffold_18	2760622	2803144	NA	NA	NA	NA	NA
PGEN_.00g339950	Scaffold_18	2803353	2809930	P42519	STAR_DROME	Protein Star	GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]
PGEN_.00g339960	Scaffold_18	2824455	2838922	Q4V842	GPTC4_XENLA	G patch domain-containing protein 4	GO:0003676	nucleic acid binding [GO:0003676]
PGEN_.00g339970	Scaffold_18	2843448	2852318	Q9H116	GZF1_HUMAN	GDNF-inducible zinc finger protein 1 (Zinc finger and BTB domain-containing protein 23) (Zinc finger protein 336)	GO:0000122; GO:0000978; GO:0001227; GO:0001658; GO:0005654; GO:0005730; GO:0005737; GO:0043565; GO:0045892; GO:0046872	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"
PGEN_.00g339980	Scaffold_18	3020243	3021235	NA	NA	NA	NA	NA
PGEN_.00g339990	Scaffold_18	3030483	3053438	P35280	RAB8A_RAT	Ras-related protein Rab-8A	GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0005929; GO:0006886; GO:0006904; GO:0006914; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0014069; GO:0017157; GO:0019003; GO:0019901; GO:0030140; GO:0030425; GO:0030496; GO:0030659; GO:0030670; GO:0031410; GO:0031489; GO:0032482; GO:0032869; GO:0032880; GO:0036064; GO:0042593; GO:0043025; GO:0043197; GO:0045202; GO:0045335; GO:0046326; GO:0048169; GO:0048210; GO:0051223; GO:0055037; GO:0055038; GO:0060271; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098969; GO:0098978; GO:0099003	"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; glucose homeostasis [GO:0042593]; Golgi vesicle fusion to target membrane [GO:0048210]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of glucose import [GO:0046326]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]"
PGEN_.00g340000	Scaffold_18	3063305	3067031	Q6DED9	TM267_XENLA	Transmembrane protein 267	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g340010	Scaffold_18	3073325	3089122	Q96IG2	FXL20_HUMAN	F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like)	GO:0000209; GO:0001662; GO:0005829; GO:0006511; GO:0019005; GO:0031146; GO:0043687; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g340020	Scaffold_18	3096759	3127753	Q05733	DCHS_DROME	Histidine decarboxylase (HDC) (EC 4.1.1.22)	GO:0004398; GO:0006520; GO:0030170; GO:0042423; GO:0043052	histidine decarboxylase activity [GO:0004398]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]; thermotaxis [GO:0043052]
PGEN_.00g340030	Scaffold_18	3158649	3167630	Q05733	DCHS_DROME	Histidine decarboxylase (HDC) (EC 4.1.1.22)	GO:0004398; GO:0006520; GO:0030170; GO:0042423; GO:0043052	histidine decarboxylase activity [GO:0004398]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]; thermotaxis [GO:0043052]
PGEN_.00g340040	Scaffold_18	3177470	3183809	Q0P483	S2542_DANRE	Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42)	GO:0005347; GO:0005739; GO:0005743; GO:0007006; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0016021; GO:0035349; GO:0043262; GO:0080121; GO:0080122	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; mitochondrial membrane organization [GO:0007006]
PGEN_.00g340050	Scaffold_18	3183853	3187736	NA	NA	NA	NA	NA
PGEN_.00g340060	Scaffold_18	3190105	3197074	Q91WQ9	CALL4_MOUSE	Calmodulin-like protein 4 (Calmodulin-related) (CALM-Rel)	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]
PGEN_.00g340070	Scaffold_18	3208139	3215813	NA	NA	NA	NA	NA
PGEN_.00g340080	Scaffold_18	3216219	3224951	Q61830	MRC1_MOUSE	Macrophage mannose receptor 1 (MMR) (CD antigen CD206)	GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0016021; GO:0038024; GO:0071222; GO:0071346; GO:0071353	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
PGEN_.00g340090	Scaffold_18	3229532	3233345	A6H584	CO6A5_MOUSE	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)	GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]
PGEN_.00g340100	Scaffold_18	3236275	3286164	P18910	ANPRA_RAT	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043235; GO:0048662	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g340110	Scaffold_18	3307585	3318101	NA	NA	NA	NA	NA
PGEN_.00g340120	Scaffold_18	3321941	3343002	Q6VVW5	ANPRB_MOUSE	Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)	GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]
PGEN_.00g340130	Scaffold_18	3405888	3410957	NA	NA	NA	NA	NA
PGEN_.00g340140	Scaffold_18	3426300	3441352	Q1RMI3	GABP1_BOVIN	GA-binding protein subunit beta-1 (GABP subunit beta-1) (GABPB-1) (GABP subunit beta-2) (GABPB-2)	GO:0005634; GO:0044212; GO:0045944	nucleus [GO:0005634]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944]
PGEN_.00g340150	Scaffold_18	3504614	3513932	NA	NA	NA	NA	NA
PGEN_.00g340160	Scaffold_18	3528241	3531199	NA	NA	NA	NA	NA
PGEN_.00g340170	Scaffold_18	3557977	3561558	NA	NA	NA	NA	NA
PGEN_.00g340180	Scaffold_18	3567818	3570082	NA	NA	NA	NA	NA
PGEN_.00g340190	Scaffold_18	3574213	3574746	NA	NA	NA	NA	NA
PGEN_.00g340200	Scaffold_18	3579254	3581527	NA	NA	NA	NA	NA
PGEN_.00g340210	Scaffold_18	3583362	3583643	NA	NA	NA	NA	NA
PGEN_.00g340220	Scaffold_18	3602329	3603915	Q8C4U2	TM145_MOUSE	Transmembrane protein 145	GO:0007186; GO:0016021; GO:0019236	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]
PGEN_.00g340230	Scaffold_18	3649545	3657416	NA	NA	NA	NA	NA
PGEN_.00g340240	Scaffold_18	3671313	3676383	NA	NA	NA	NA	NA
PGEN_.00g340250	Scaffold_18	3684143	3704710	NA	NA	NA	NA	NA
PGEN_.00g340260	Scaffold_18	3705842	3720875	NA	NA	NA	NA	NA
PGEN_.00g340270	Scaffold_18	3770749	3771094	NA	NA	NA	NA	NA
PGEN_.00g340280	Scaffold_18	3771218	3771715	NA	NA	NA	NA	NA
PGEN_.00g340290	Scaffold_18	3818491	3819522	NA	NA	NA	NA	NA
PGEN_.00g340300	Scaffold_18	3907998	3908288	NA	NA	NA	NA	NA
PGEN_.00g340310	Scaffold_18	3939386	4000865	NA	NA	NA	NA	NA
PGEN_.00g340320	Scaffold_18	3988963	3991050	NA	NA	NA	NA	NA
PGEN_.00g340330	Scaffold_18	4000096	4000407	NA	NA	NA	NA	NA
PGEN_.00g340340	Scaffold_18	4010065	4021678	NA	NA	NA	NA	NA
PGEN_.00g340350	Scaffold_18	4027016	4032665	NA	NA	NA	NA	NA
PGEN_.00g340360	Scaffold_18	4044375	4049691	NA	NA	NA	NA	NA
PGEN_.00g340370	Scaffold_18	4054389	4054892	NA	NA	NA	NA	NA
PGEN_.00g340380	Scaffold_18	4055793	4056311	NA	NA	NA	NA	NA
PGEN_.00g340390	Scaffold_18	4065745	4072293	NA	NA	NA	NA	NA
PGEN_.00g340400	Scaffold_18	4095289	4095717	NA	NA	NA	NA	NA
PGEN_.00g340410	Scaffold_18	4096097	4096837	NA	NA	NA	NA	NA
PGEN_.00g340420	Scaffold_18	4098210	4098980	NA	NA	NA	NA	NA
PGEN_.00g340430	Scaffold_18	4106653	4106916	NA	NA	NA	NA	NA
PGEN_.00g340440	Scaffold_18	4125775	4159305	NA	NA	NA	NA	NA
PGEN_.00g340450	Scaffold_18	4161952	4162191	NA	NA	NA	NA	NA
PGEN_.00g340460	Scaffold_18	4162274	4162525	NA	NA	NA	NA	NA
PGEN_.00g340470	Scaffold_18	4164727	4166640	NA	NA	NA	NA	NA
PGEN_.00g340480	Scaffold_18	4173035	4175581	NA	NA	NA	NA	NA
PGEN_.00g340490	Scaffold_18	4189626	4207811	NA	NA	NA	NA	NA
PGEN_.00g340500	Scaffold_18	4212790	4223863	NA	NA	NA	NA	NA
PGEN_.00g340510	Scaffold_18	4284196	4303235	NA	NA	NA	NA	NA
PGEN_.00g340520	Scaffold_18	4317590	4347130	NA	NA	NA	NA	NA
PGEN_.00g340530	Scaffold_18	4324234	4324599	NA	NA	NA	NA	NA
PGEN_.00g340540	Scaffold_18	4350656	4364471	NA	NA	NA	NA	NA
PGEN_.00g340550	Scaffold_18	4370578	4380046	NA	NA	NA	NA	NA
PGEN_.00g340560	Scaffold_18	4405240	4406779	NA	NA	NA	NA	NA
PGEN_.00g340570	Scaffold_18	4412578	4468419	NA	NA	NA	NA	NA
PGEN_.00g340580	Scaffold_18	4470167	4473249	NA	NA	NA	NA	NA
PGEN_.00g340590	Scaffold_18	4489667	4515550	NA	NA	NA	NA	NA
PGEN_.00g340600	Scaffold_18	4584794	4594501	NA	NA	NA	NA	NA
PGEN_.00g340610	Scaffold_18	4601765	4609149	Q17043	APLY_APLKU	Aplysianin-A	GO:0016491; GO:0042742	oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]
PGEN_.00g340620	Scaffold_18	4635588	4636202	NA	NA	NA	NA	NA
PGEN_.00g340630	Scaffold_18	4765716	4766060	NA	NA	NA	NA	NA
PGEN_.00g340640	Scaffold_18	4766652	4779678	Q709C8	VP13C_HUMAN	Vacuolar protein sorting-associated protein 13C	GO:0005623; GO:0005737; GO:0005741; GO:0005829; GO:0006623; GO:0006895; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1905090	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; Golgi to endosome transport [GO:0006895]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]
PGEN_.00g340650	Scaffold_18	4782641	4784584	NA	NA	NA	NA	NA
PGEN_.00g340660	Scaffold_18	4787425	4789962	Q8BX70	VP13C_MOUSE	Vacuolar protein sorting-associated protein 13C	GO:0005623; GO:0005741; GO:0005829; GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:1905090	cell [GO:0005623]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]
PGEN_.00g340670	Scaffold_18	4793909	4805839	Q14586	ZN267_HUMAN	Zinc finger protein 267 (Zinc finger protein HZF2)	GO:0003677; GO:0005634; GO:0006355; GO:0007275; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g340680	Scaffold_18	4817144	4825574	Q6PEE2	CTIF_MOUSE	CBP80/20-dependent translation initiation factor	GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0048471	"cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]"
PGEN_.00g340690	Scaffold_18	4832785	4836933	NA	NA	NA	NA	NA
PGEN_.00g340700	Scaffold_18	4841603	4844262	Q4PZA2	ECE1_MOUSE	Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)	GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0006508; GO:0006915; GO:0007507; GO:0008217; GO:0008270; GO:0009897; GO:0009986; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0030141; GO:0031410; GO:0031982; GO:0033093; GO:0034959; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0048471; GO:0060037; GO:0070372; GO:0097746	cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; endothelin maturation [GO:0034959]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to hypoxia [GO:0001666]; substance P catabolic process [GO:0010814]
PGEN_.00g340710	Scaffold_18	4846145	4859210	Q8IS64	ECE_LOCMI	Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)	GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g340720	Scaffold_18	4869864	4873553	Q9ERE8	TLRN1_MOUSE	Talin rod domain-containing protein 1 (Mesoderm development candidate 1)	GO:0003779	actin binding [GO:0003779]
PGEN_.00g340730	Scaffold_18	4876013	4876456	NA	NA	NA	NA	NA
PGEN_.00g340740	Scaffold_18	4879184	4886489	Q01484	ANK2_HUMAN	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	GO:0002027; GO:0003283; GO:0005200; GO:0005623; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]"
PGEN_.00g340750	Scaffold_18	4909068	4912920	NA	NA	NA	NA	NA
PGEN_.00g340760	Scaffold_18	4921503	4932735	NA	NA	NA	NA	NA
PGEN_.00g340770	Scaffold_18	4937680	4956253	NA	NA	NA	NA	NA
PGEN_.00g340780	Scaffold_18	4968655	4984929	NA	NA	NA	NA	NA
PGEN_.00g340790	Scaffold_18	4988732	4992647	Q8CHL0	FZD5_RAT	Frizzled-5 (Fz-5)	GO:0000139; GO:0000578; GO:0001525; GO:0001540; GO:0001944; GO:0002726; GO:0004930; GO:0005794; GO:0005886; GO:0005887; GO:0005923; GO:0008285; GO:0008289; GO:0008595; GO:0009986; GO:0016055; GO:0017147; GO:0019901; GO:0030424; GO:0030425; GO:0031076; GO:0031077; GO:0031625; GO:0032729; GO:0033077; GO:0035567; GO:0042813; GO:0043204; GO:0043507; GO:0044877; GO:0045202; GO:0045944; GO:0048469; GO:0048471; GO:0048596; GO:0050718; GO:0060061; GO:0060070; GO:0060561; GO:0060670; GO:0060715; GO:0060716; GO:0060718; GO:0071219; GO:0098978; GO:0099054; GO:1901382; GO:1904469; GO:2000810	"axon [GO:0030424]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cell maturation [GO:0048469]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye development [GO:0031076]; embryonic camera-type eye morphogenesis [GO:0048596]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; post-embryonic camera-type eye development [GO:0031077]; presynapse assembly [GO:0099054]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; Spemann organizer formation [GO:0060061]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g340800	Scaffold_18	4994932	4999860	NA	NA	NA	NA	NA
PGEN_.00g340810	Scaffold_18	5004118	5014122	NA	NA	NA	NA	NA
PGEN_.00g340820	Scaffold_18	5020651	5031574	P22129	RB11B_DIPOM	Ras-related protein Rab-11B (ORA3)	GO:0001881; GO:0003924; GO:0005525; GO:0005623; GO:0008021; GO:0019003; GO:0030054; GO:0030670; GO:0030672; GO:0032402; GO:0033572; GO:0035773; GO:0044070; GO:0045054; GO:0045055; GO:0045335; GO:0055038; GO:0071468; GO:1990126; GO:2000008; GO:2001135	"cell [GO:0005623]; cell junction [GO:0030054]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"
PGEN_.00g340830	Scaffold_18	5076505	5112831	P23508	CRCM_HUMAN	Colorectal mutant cancer protein (Protein MCC)	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0036464; GO:0038023; GO:0045184; GO:0050680; GO:0090090	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]
PGEN_.00g340840	Scaffold_18	5153174	5153998	NA	NA	NA	NA	NA
PGEN_.00g340850	Scaffold_18	5158248	5159330	NA	NA	NA	NA	NA
PGEN_.00g340860	Scaffold_18	5168875	5172456	P45961	CEX2_CAEEL	Calexcitin-2	GO:0005509; GO:0005783	endoplasmic reticulum [GO:0005783]; calcium ion binding [GO:0005509]
PGEN_.00g340870	Scaffold_18	5213397	5220059	Q8K4C0	FMO5_RAT	Dimethylaniline monooxygenase [N-oxide-forming] 5 (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (FMO 5)	GO:0004497; GO:0004499; GO:0005789; GO:0016021; GO:0050660; GO:0050661	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
PGEN_.00g340880	Scaffold_18	5253952	5254404	NA	NA	NA	NA	NA
PGEN_.00g340890	Scaffold_18	5266548	5267033	NA	NA	NA	NA	NA
PGEN_.00g340900	Scaffold_18	5282530	5283009	NA	NA	NA	NA	NA
PGEN_.00g340910	Scaffold_18	5293056	5293712	Q9GLP1	FA5_PIG	Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]	GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091	extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; copper ion binding [GO:0005507]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]
PGEN_.00g340920	Scaffold_18	5327673	5334336	Q8K4C0	FMO5_RAT	Dimethylaniline monooxygenase [N-oxide-forming] 5 (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (FMO 5)	GO:0004497; GO:0004499; GO:0005789; GO:0016021; GO:0050660; GO:0050661	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"
PGEN_.00g340930	Scaffold_18	5376139	5379719	P45961	CEX2_CAEEL	Calexcitin-2	GO:0005509; GO:0005783	endoplasmic reticulum [GO:0005783]; calcium ion binding [GO:0005509]
PGEN_.00g340940	Scaffold_18	5389225	5390307	NA	NA	NA	NA	NA
PGEN_.00g340950	Scaffold_18	5394572	5395396	NA	NA	NA	NA	NA
PGEN_.00g340960	Scaffold_18	5435740	5452554	P23508	CRCM_HUMAN	Colorectal mutant cancer protein (Protein MCC)	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0036464; GO:0038023; GO:0045184; GO:0050680; GO:0090090	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]
PGEN_.00g340970	Scaffold_18	5453897	5471182	P23508	CRCM_HUMAN	Colorectal mutant cancer protein (Protein MCC)	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0036464; GO:0038023; GO:0045184; GO:0050680; GO:0090090	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]
PGEN_.00g340980	Scaffold_18	5478335	5478556	NA	NA	NA	NA	NA
PGEN_.00g340990	Scaffold_18	5514183	5524678	P22129	RB11B_DIPOM	Ras-related protein Rab-11B (ORA3)	GO:0001881; GO:0003924; GO:0005525; GO:0005623; GO:0008021; GO:0019003; GO:0030054; GO:0030670; GO:0030672; GO:0032402; GO:0033572; GO:0035773; GO:0044070; GO:0045054; GO:0045055; GO:0045335; GO:0055038; GO:0071468; GO:1990126; GO:2000008; GO:2001135	"cell [GO:0005623]; cell junction [GO:0030054]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]"
PGEN_.00g341000	Scaffold_18	5531808	5551474	NA	NA	NA	NA	NA
PGEN_.00g341010	Scaffold_18	5553799	5558094	O93274	FZD8_XENLA	Frizzled-8 (Fz-8) (Xfz8)	GO:0004930; GO:0005886; GO:0007275; GO:0016021; GO:0051091; GO:0060070	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; canonical Wnt signaling pathway [GO:0060070]; multicellular organism development [GO:0007275]; positive regulation of DNA-binding transcription factor activity [GO:0051091]
PGEN_.00g341020	Scaffold_18	5561382	5577189	NA	NA	NA	NA	NA
PGEN_.00g341030	Scaffold_18	5589591	5608094	NA	NA	NA	NA	NA
PGEN_.00g341040	Scaffold_18	5613059	5624034	O75095	MEGF6_HUMAN	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
PGEN_.00g341050	Scaffold_18	5624124	5624531	NA	NA	NA	NA	NA
PGEN_.00g341060	Scaffold_18	5633157	5635902	NA	NA	NA	NA	NA
PGEN_.00g341070	Scaffold_18	5659576	5666882	Q01484	ANK2_HUMAN	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	GO:0002027; GO:0003283; GO:0005200; GO:0005623; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	"A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]"
PGEN_.00g341080	Scaffold_18	5668276	5668539	NA	NA	NA	NA	NA
PGEN_.00g341090	Scaffold_18	5671864	5675543	Q9ERE8	TLRN1_MOUSE	Talin rod domain-containing protein 1 (Mesoderm development candidate 1)	GO:0003779	actin binding [GO:0003779]
PGEN_.00g341100	Scaffold_18	5685506	5698018	Q8IS64	ECE_LOCMI	Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)	GO:0004175; GO:0004222; GO:0005886; GO:0008270; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
PGEN_.00g341110	Scaffold_18	5699901	5702560	Q4PZA2	ECE1_MOUSE	Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)	GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0006508; GO:0006915; GO:0007507; GO:0008217; GO:0008270; GO:0009897; GO:0009986; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0030141; GO:0031410; GO:0031982; GO:0033093; GO:0034959; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0048471; GO:0060037; GO:0070372; GO:0097746	cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; endothelin maturation [GO:0034959]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to hypoxia [GO:0001666]; substance P catabolic process [GO:0010814]
PGEN_.00g341120	Scaffold_18	5710810	5711022	NA	NA	NA	NA	NA
PGEN_.00g341130	Scaffold_18	5718216	5726335	Q6PEE2	CTIF_MOUSE	CBP80/20-dependent translation initiation factor	GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0048471	"cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]"
PGEN_.00g341140	Scaffold_18	5748417	5750010	NA	NA	NA	NA	NA
PGEN_.00g341150	Scaffold_18	5751284	5756533	Q8BX70	VP13C_MOUSE	Vacuolar protein sorting-associated protein 13C	GO:0005623; GO:0005741; GO:0005829; GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:1905090	cell [GO:0005623]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]
PGEN_.00g341160	Scaffold_18	5759369	5765197	NA	NA	NA	NA	NA
PGEN_.00g341170	Scaffold_18	5764275	5769744	Q709C8	VP13C_HUMAN	Vacuolar protein sorting-associated protein 13C	GO:0005623; GO:0005737; GO:0005741; GO:0005829; GO:0006623; GO:0006895; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1905090	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; Golgi to endosome transport [GO:0006895]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]
PGEN_.00g341180	Scaffold_18	5772955	5778221	Q709C8	VP13C_HUMAN	Vacuolar protein sorting-associated protein 13C	GO:0005623; GO:0005737; GO:0005741; GO:0005829; GO:0006623; GO:0006895; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1905090	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; Golgi to endosome transport [GO:0006895]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]
PGEN_.00g341190	Scaffold_18	5778706	5783477	Q709C8	VP13C_HUMAN	Vacuolar protein sorting-associated protein 13C	GO:0005623; GO:0005737; GO:0005741; GO:0005829; GO:0006623; GO:0006895; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1905090	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; Golgi to endosome transport [GO:0006895]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]
PGEN_.00g341200	Scaffold_18	5908297	5908911	NA	NA	NA	NA	NA
PGEN_.00g341210	Scaffold_18	5935337	5942719	Q17043	APLY_APLKU	Aplysianin-A	GO:0016491; GO:0042742	oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]
PGEN_.00g341220	Scaffold_18	5950399	5959497	NA	NA	NA	NA	NA
PGEN_.00g341230	Scaffold_18	6019479	6019958	NA	NA	NA	NA	NA
PGEN_.00g341240	Scaffold_18	6029978	6055384	NA	NA	NA	NA	NA
PGEN_.00g341250	Scaffold_18	6071825	6074958	NA	NA	NA	NA	NA
PGEN_.00g341260	Scaffold_18	6076714	6131603	NA	NA	NA	NA	NA
PGEN_.00g341270	Scaffold_18	6137442	6138981	NA	NA	NA	NA	NA
PGEN_.00g341280	Scaffold_18	6163401	6189748	NA	NA	NA	NA	NA
PGEN_.00g341290	Scaffold_18	6196407	6225896	NA	NA	NA	NA	NA
PGEN_.00g341300	Scaffold_18	6241126	6259824	NA	NA	NA	NA	NA
PGEN_.00g341310	Scaffold_18	6316320	6352257	NA	NA	NA	NA	NA
PGEN_.00g341320	Scaffold_18	6366309	6368855	NA	NA	NA	NA	NA
PGEN_.00g341330	Scaffold_18	6375250	6377163	NA	NA	NA	NA	NA
PGEN_.00g341340	Scaffold_18	6379365	6379616	NA	NA	NA	NA	NA
PGEN_.00g341350	Scaffold_18	6379699	6379938	NA	NA	NA	NA	NA
PGEN_.00g341360	Scaffold_18	6382585	6416138	NA	NA	NA	NA	NA
PGEN_.00g341370	Scaffold_18	6425787	6435149	NA	NA	NA	NA	NA
PGEN_.00g341380	Scaffold_18	6442809	6443579	NA	NA	NA	NA	NA
PGEN_.00g341390	Scaffold_18	6443922	6445650	NA	NA	NA	NA	NA
PGEN_.00g341400	Scaffold_18	6446030	6446458	NA	NA	NA	NA	NA
PGEN_.00g341410	Scaffold_18	6466224	6472739	NA	NA	NA	NA	NA
PGEN_.00g341420	Scaffold_18	6483737	6484219	NA	NA	NA	NA	NA
PGEN_.00g341430	Scaffold_18	6488959	6511743	NA	NA	NA	NA	NA
PGEN_.00g341440	Scaffold_18	6517082	6528681	NA	NA	NA	NA	NA
PGEN_.00g341450	Scaffold_18	6537261	6598491	NA	NA	NA	NA	NA
PGEN_.00g341460	Scaffold_18	6537719	6538210	NA	NA	NA	NA	NA
PGEN_.00g341470	Scaffold_18	6598528	6598932	NA	NA	NA	NA	NA
PGEN_.00g341480	Scaffold_18	6598955	6599194	NA	NA	NA	NA	NA
PGEN_.00g341490	Scaffold_18	6599491	6600995	P42565	FARX_LYMST	FMRFamide-related neuropeptides [Cleaved into: EFFPL-amide; GDPFLRF-amide 1; GDPFLRF-amide 2; GDPFLRF-amide 3; GDPFLRF-amide 4; GDPFLRF-amide 5; GDPFLRF-amide 6; GDPFLRF-amide 7; SDPFLRF-amide 1; SDPFLRF-amide 2; SDPFLRF-amide 3; SDPFLRF-amide 4; SDPFLRF-amide 5; SDPFLRF-amide 6; SDPYLRF-amide; SDPFFRF-amide; SKPYMRF-amide; SSFPRY-amide; HDYMRF-amide]	GO:0005576; GO:0007218	extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
PGEN_.00g341500	Scaffold_18	6601438	6613326	Q9U3V9	XMAS2_DROME	Protein xmas-2	GO:0003723; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0006406; GO:0007275; GO:0007283; GO:0016973; GO:0031965; GO:0034399; GO:0045944; GO:0048477; GO:0070390	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]
PGEN_.00g341510	Scaffold_18	6622245	6625612	Q6DCP6	DYM_XENLA	Dymeclin	GO:0005794	Golgi apparatus [GO:0005794]
PGEN_.00g341520	Scaffold_18	6629619	6631803	Q20065	P4HA2_CAEEL	"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)"	GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0016702; GO:0018401; GO:0031418; GO:0031545; GO:0043412; GO:0055114	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]"
PGEN_.00g341530	Scaffold_18	6632863	6647690	Q8CHY3	DYM_MOUSE	Dymeclin	GO:0005737; GO:0005794; GO:0007030; GO:0016020; GO:0019899; GO:0060348	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; enzyme binding [GO:0019899]; bone development [GO:0060348]; Golgi organization [GO:0007030]
PGEN_.00g341540	Scaffold_18	6648753	6690244	O45782	ARD17_CAEEL	Arrestin domain-containing protein 17 (Calcineurin-interacting protein 1)	GO:0007610; GO:0030346	protein phosphatase 2B binding [GO:0030346]; behavior [GO:0007610]
PGEN_.00g341550	Scaffold_18	6691900	6692739	Q7Z5P9	MUC19_HUMAN	Mucin-19 (MUC-19)	GO:0002223; GO:0005576; GO:0005796; GO:0005886; GO:0016266	extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]
PGEN_.00g341560	Scaffold_18	6712580	6776582	Q9W734	SMAD6_CHICK	Mothers against decapentaplegic homolog 6 (MAD homolog 6) (Mothers against DPP homolog 6) (SMAD family member 6) (SMAD 6) (Smad6)	GO:0003682; GO:0003700; GO:0005634; GO:0005667; GO:0005768; GO:0007179; GO:0010693; GO:0031589; GO:0032331; GO:0044212; GO:0046872; GO:0050767; GO:1902832; GO:1902844	endosome [GO:0005768]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cell-substrate adhesion [GO:0031589]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of cell proliferation in dorsal spinal cord [GO:1902832]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway [GO:1902844]; regulation of neurogenesis [GO:0050767]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g341570	Scaffold_18	6782746	6794319	Q1HE26	SMAD4_BOVIN	Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (SMAD family member 4) (SMAD 4) (Smad4)	GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0046872	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transforming growth factor beta receptor signaling pathway [GO:0007179]
PGEN_.00g341580	Scaffold_18	6810839	6815597	Q13485	SMAD4_HUMAN	Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001085; GO:0001228; GO:0001541; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0003712; GO:0005518; GO:0005623; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007411; GO:0008283; GO:0008285; GO:0010614; GO:0010718; GO:0010862; GO:0014033; GO:0016579; GO:0017015; GO:0030308; GO:0030509; GO:0030511; GO:0030513; GO:0030616; GO:0032444; GO:0032525; GO:0032909; GO:0033686; GO:0035019; GO:0035556; GO:0036302; GO:0042118; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048663; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0061614; GO:0062009; GO:0070102; GO:0070207; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071559; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:0098772; GO:1901522; GO:1905305; GO:2000617	"activin responsive factor complex [GO:0032444]; cell [GO:0005623]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molecular function regulator [GO:0098772]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sulfate binding [GO:0043199]; transcription coregulator activity [GO:0003712]; transcription regulatory region DNA binding [GO:0044212]; transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [GO:0030616]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; protein deubiquitination [GO:0016579]; protein homotrimerization [GO:0070207]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]"
PGEN_.00g341590	Scaffold_18	6816347	6816889	NA	NA	NA	NA	NA
PGEN_.00g341600	Scaffold_18	6816958	6817605	NA	NA	NA	NA	NA
PGEN_.00g341610	Scaffold_18	6827602	6852624	Q9Y6H5	SNCAP_HUMAN	Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein)	GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0044267; GO:0046928; GO:0090083	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]; cell death [GO:0008219]; cellular protein metabolic process [GO:0044267]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928]
PGEN_.00g341620	Scaffold_18	6871766	6917697	P67812	SC11A_HUMAN	Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18)	GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0008236; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type peptidase activity [GO:0008236]; signal peptide processing [GO:0006465]
PGEN_.00g341630	Scaffold_18	6883239	6883710	NA	NA	NA	NA	NA
PGEN_.00g341640	Scaffold_18	6936939	6937805	NA	NA	NA	NA	NA
PGEN_.00g341650	Scaffold_18	7102346	7109416	NA	NA	NA	NA	NA
PGEN_.00g341660	Scaffold_18	7129854	7150255	Q55E58	PATS1_DICDI	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]
PGEN_.00g341670	Scaffold_18	7151675	7151953	NA	NA	NA	NA	NA
PGEN_.00g341680	Scaffold_18	7189087	7189353	NA	NA	NA	NA	NA
PGEN_.00g341690	Scaffold_18	7220184	7243228	Q5S006	LRRK2_MOUSE	Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-)	GO:0000139; GO:0000149; GO:0000165; GO:0000186; GO:0000187; GO:0000287; GO:0001933; GO:0001934; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004708; GO:0005096; GO:0005524; GO:0005525; GO:0005623; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007283; GO:0007528; GO:0008021; GO:0008340; GO:0009267; GO:0010468; GO:0010506; GO:0010508; GO:0010738; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016020; GO:0016234; GO:0016242; GO:0016301; GO:0016310; GO:0017048; GO:0017075; GO:0018105; GO:0018107; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030054; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031398; GO:0031410; GO:0031647; GO:0031966; GO:0032091; GO:0032092; GO:0032436; GO:0032473; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034613; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036465; GO:0036479; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051770; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0070997; GO:0071287; GO:0072593; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0140058; GO:1900242; GO:1900244; GO:1901214; GO:1901215; GO:1901727; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903125; GO:1903206; GO:1903215; GO:1903351; GO:1903980; GO:1904469; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300	"amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; cell [GO:0005623]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]; actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; receptor signaling complex adaptor activity [GO:0030159]; Rho GTPase binding [GO:0017048]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; tubulin binding [GO:0015631]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation [GO:1903125]; neuromuscular junction development [GO:0007528]; neuron death [GO:0070997]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron death [GO:1901214]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]"
PGEN_.00g341700	Scaffold_18	7263119	7263415	NA	NA	NA	NA	NA
PGEN_.00g341710	Scaffold_18	7294421	7302018	NA	NA	NA	NA	NA
PGEN_.00g341720	Scaffold_18	7315162	7316508	NA	NA	NA	NA	NA
PGEN_.00g341730	Scaffold_18	7350094	7350459	NA	NA	NA	NA	NA
PGEN_.00g341740	Scaffold_18	7361687	7362805	NA	NA	NA	NA	NA
PGEN_.00g341750	Scaffold_18	7376038	7376334	NA	NA	NA	NA	NA
PGEN_.00g341760	Scaffold_18	7376371	7376661	NA	NA	NA	NA	NA
PGEN_.00g341770	Scaffold_18	7406351	7432346	P14618	KPYM_HUMAN	Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58)	GO:0000287; GO:0001666; GO:0001889; GO:0003723; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005929; GO:0006096; GO:0006754; GO:0007584; GO:0009629; GO:0012501; GO:0014870; GO:0016301; GO:0023026; GO:0030955; GO:0031100; GO:0031982; GO:0032869; GO:0034774; GO:0042802; GO:0042866; GO:0043312; GO:0043403; GO:0043531; GO:0045296; GO:0051289; GO:0061621; GO:0062023; GO:0070062; GO:0070324; GO:1902912; GO:1903561; GO:1903672; GO:1904813	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403]
PGEN_.00g341780	Scaffold_18	7455852	7456821	NA	NA	NA	NA	NA
PGEN_.00g341790	Scaffold_18	7466393	7468940	NA	NA	NA	NA	NA
PGEN_.00g341800	Scaffold_18	7486561	7521196	NA	NA	NA	NA	NA
PGEN_.00g341810	Scaffold_18	7521253	7535989	Q8IRI6	GTR1_DROME	Glucose transporter type 1	GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]
PGEN_.00g341820	Scaffold_18	7540292	7545533	Q15822	ACHA2_HUMAN	Neuronal acetylcholine receptor subunit alpha-2	GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015464; GO:0016021; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051291	"acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"
PGEN_.00g341830	Scaffold_18	7597311	7600596	NA	NA	NA	NA	NA
PGEN_.00g341840	Scaffold_18	7663999	7675542	NA	NA	NA	NA	NA
PGEN_.00g341850	Scaffold_18	7691351	7721536	NA	NA	NA	NA	NA
PGEN_.00g341860	Scaffold_18	7730969	7731223	NA	NA	NA	NA	NA
PGEN_.00g341870	Scaffold_18	7732201	7742534	NA	NA	NA	NA	NA
PGEN_.00g341880	Scaffold_18	7749678	7750736	NA	NA	NA	NA	NA
PGEN_.00g341890	Scaffold_18	7763053	7763322	NA	NA	NA	NA	NA
PGEN_.00g341900	Scaffold_18	7801756	7844722	NA	NA	NA	NA	NA
PGEN_.00g341910	Scaffold_18	7856110	7867223	Q92824	PCSK5_HUMAN	Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (hPC6) (Subtilisin/kexin-like protease PC5)	GO:0001822; GO:0002001; GO:0003279; GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005794; GO:0005796; GO:0005802; GO:0006465; GO:0007267; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030141; GO:0030173; GO:0030323; GO:0032455; GO:0035108; GO:0042089; GO:0042277; GO:0043043; GO:0048566; GO:0048706; GO:0051004; GO:0060976	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; cell-cell signaling [GO:0007267]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; nerve growth factor processing [GO:0032455]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]
PGEN_.00g341920	Scaffold_18	7923922	7950344	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g341930	Scaffold_18	7952132	7968993	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g341940	Scaffold_18	7970418	7971020	NA	NA	NA	NA	NA
PGEN_.00g341950	Scaffold_18	7971268	7971600	NA	NA	NA	NA	NA
PGEN_.00g341960	Scaffold_18	7972360	7972938	NA	NA	NA	NA	NA
PGEN_.00g341970	Scaffold_18	7973274	7973726	NA	NA	NA	NA	NA
PGEN_.00g341980	Scaffold_18	7975335	7988358	NA	NA	NA	NA	NA
PGEN_.00g341990	Scaffold_18	7992530	7993762	NA	NA	NA	NA	NA
PGEN_.00g342000	Scaffold_18	8024188	8031900	Q5RDU4	PARP6_PONAB	Protein mono-ADP-ribosyltransferase PARP6 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 17) (ARTD17) (Poly [ADP-ribose] polymerase 6) (PARP-6)	GO:0003950; GO:0070213; GO:0140289; GO:1990404	NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]
PGEN_.00g342010	Scaffold_18	8040106	8040489	NA	NA	NA	NA	NA
PGEN_.00g342020	Scaffold_18	8049345	8049665	NA	NA	NA	NA	NA
PGEN_.00g342030	Scaffold_18	8071185	8110227	Q9VR07	INE_DROME	Sodium- and chloride-dependent GABA transporter ine (Protein inebriated) (Protein receptor oscillation A)	GO:0005034; GO:0005328; GO:0005886; GO:0006836; GO:0009414; GO:0016021; GO:0016323; GO:0019226; GO:0042065; GO:0042066; GO:0047484; GO:0050891	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]; glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; transmission of nerve impulse [GO:0019226]
PGEN_.00g342040	Scaffold_18	8134547	8189617	Q03721	KCNC4_HUMAN	Potassium voltage-gated channel subfamily C member 4 (KSHIIIC) (Voltage-gated potassium channel subunit Kv3.4)	GO:0005249; GO:0005251; GO:0005267; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0016021; GO:0030424; GO:0031594; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0043679; GO:0046928; GO:0051260; GO:0071805	axon [GO:0030424]; axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; regulation of neurotransmitter secretion [GO:0046928]
PGEN_.00g342050	Scaffold_18	8190601	8190933	NA	NA	NA	NA	NA
PGEN_.00g342060	Scaffold_18	8203565	8253959	Q2VWP9	PRTG_RAT	Protogenin (Protein Shen-Dan)	GO:0005886; GO:0016021; GO:0038023; GO:0050768; GO:0051260	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of neurogenesis [GO:0050768]; protein homooligomerization [GO:0051260]
PGEN_.00g342070	Scaffold_18	8256770	8305551	Q2VWP9	PRTG_RAT	Protogenin (Protein Shen-Dan)	GO:0005886; GO:0016021; GO:0038023; GO:0050768; GO:0051260	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of neurogenesis [GO:0050768]; protein homooligomerization [GO:0051260]
PGEN_.00g342080	Scaffold_18	8311390	8311836	NA	NA	NA	NA	NA
PGEN_.00g342090	Scaffold_18	8318183	8318515	NA	NA	NA	NA	NA
PGEN_.00g342100	Scaffold_18	8319325	8377298	Q03721	KCNC4_HUMAN	Potassium voltage-gated channel subfamily C member 4 (KSHIIIC) (Voltage-gated potassium channel subunit Kv3.4)	GO:0005249; GO:0005251; GO:0005267; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0016021; GO:0030424; GO:0031594; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0043679; GO:0046928; GO:0051260; GO:0071805	axon [GO:0030424]; axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; regulation of neurotransmitter secretion [GO:0046928]
PGEN_.00g342110	Scaffold_18	8401747	8440692	Q9VR07	INE_DROME	Sodium- and chloride-dependent GABA transporter ine (Protein inebriated) (Protein receptor oscillation A)	GO:0005034; GO:0005328; GO:0005886; GO:0006836; GO:0009414; GO:0016021; GO:0016323; GO:0019226; GO:0042065; GO:0042066; GO:0047484; GO:0050891	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034]; glial cell growth [GO:0042065]; multicellular organismal water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; transmission of nerve impulse [GO:0019226]
PGEN_.00g342120	Scaffold_18	8457334	8457603	NA	NA	NA	NA	NA
PGEN_.00g342130	Scaffold_18	8457816	8458253	NA	NA	NA	NA	NA
PGEN_.00g342140	Scaffold_18	8471974	8472357	NA	NA	NA	NA	NA
PGEN_.00g342150	Scaffold_18	8484442	8492154	Q5RDU4	PARP6_PONAB	Protein mono-ADP-ribosyltransferase PARP6 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 17) (ARTD17) (Poly [ADP-ribose] polymerase 6) (PARP-6)	GO:0003950; GO:0070213; GO:0140289; GO:1990404	NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]
PGEN_.00g342160	Scaffold_18	8522489	8540866	NA	NA	NA	NA	NA
PGEN_.00g342170	Scaffold_18	8542475	8542927	NA	NA	NA	NA	NA
PGEN_.00g342180	Scaffold_18	8543263	8543841	NA	NA	NA	NA	NA
PGEN_.00g342190	Scaffold_18	8544601	8544933	NA	NA	NA	NA	NA
PGEN_.00g342200	Scaffold_18	8545181	8545783	NA	NA	NA	NA	NA
PGEN_.00g342210	Scaffold_18	8547208	8568141	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g342220	Scaffold_18	8569528	8570801	Q8WY91	THAP4_HUMAN	THAP domain-containing protein 4	GO:0000790; GO:0000981; GO:0003677; GO:0020037; GO:0042803; GO:0046872	"nuclear chromatin [GO:0000790]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"
PGEN_.00g342230	Scaffold_18	8576889	8592363	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g342240	Scaffold_18	8640163	8651811	NA	NA	NA	NA	NA
PGEN_.00g342250	Scaffold_18	8651965	8652243	NA	NA	NA	NA	NA
PGEN_.00g342260	Scaffold_18	8658211	8658531	NA	NA	NA	NA	NA
PGEN_.00g342270	Scaffold_18	8659296	8659658	NA	NA	NA	NA	NA
PGEN_.00g342280	Scaffold_18	8660013	8660324	NA	NA	NA	NA	NA
PGEN_.00g342290	Scaffold_18	8694026	8694367	NA	NA	NA	NA	NA
PGEN_.00g342300	Scaffold_18	8704095	8704340	NA	NA	NA	NA	NA
PGEN_.00g342310	Scaffold_18	8708356	8714544	NA	NA	NA	NA	NA
PGEN_.00g342320	Scaffold_18	8727686	8730108	NA	NA	NA	NA	NA
PGEN_.00g342330	Scaffold_18	8743874	8744113	NA	NA	NA	NA	NA
PGEN_.00g342340	Scaffold_18	8768629	8769162	NA	NA	NA	NA	NA
PGEN_.00g342350	Scaffold_18	8812550	8824549	NA	NA	NA	NA	NA
PGEN_.00g342360	Scaffold_18	8871155	8872132	NA	NA	NA	NA	NA
PGEN_.00g342370	Scaffold_18	8872212	8872586	NA	NA	NA	NA	NA
PGEN_.00g342380	Scaffold_18	8872795	8875392	NA	NA	NA	NA	NA
PGEN_.00g342390	Scaffold_18	8900355	8916180	NA	NA	NA	NA	NA
PGEN_.00g342400	Scaffold_18	8919832	8940993	A6H757	PPA6_BOVIN	Lysophosphatidic acid phosphatase type 6 (EC 3.1.3.2)	GO:0003993; GO:0005739; GO:0052642; GO:2001311	mitochondrion [GO:0005739]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; lysobisphosphatidic acid metabolic process [GO:2001311]
PGEN_.00g342410	Scaffold_18	8945992	8946363	NA	NA	NA	NA	NA
PGEN_.00g342420	Scaffold_18	8950141	8950590	NA	NA	NA	NA	NA
PGEN_.00g342430	Scaffold_18	8953696	8954348	NA	NA	NA	NA	NA
PGEN_.00g342440	Scaffold_18	8979721	8980197	NA	NA	NA	NA	NA
PGEN_.00g342450	Scaffold_18	9065419	9065829	NA	NA	NA	NA	NA
PGEN_.00g342460	Scaffold_18	9065848	9066189	NA	NA	NA	NA	NA
PGEN_.00g342470	Scaffold_18	9093566	9095925	NA	NA	NA	NA	NA
PGEN_.00g342480	Scaffold_18	9095997	9096302	NA	NA	NA	NA	NA
PGEN_.00g342490	Scaffold_18	9100334	9103316	NA	NA	NA	NA	NA
PGEN_.00g342500	Scaffold_18	9120981	9121322	NA	NA	NA	NA	NA
PGEN_.00g342510	Scaffold_18	9122880	9123104	NA	NA	NA	NA	NA
PGEN_.00g342520	Scaffold_18	9130305	9130778	NA	NA	NA	NA	NA
PGEN_.00g342530	Scaffold_18	9130817	9131200	NA	NA	NA	NA	NA
PGEN_.00g342540	Scaffold_18	9162712	9163344	NA	NA	NA	NA	NA
PGEN_.00g342550	Scaffold_18	9163522	9164159	NA	NA	NA	NA	NA
PGEN_.00g342560	Scaffold_18	9183015	9191675	Q01617	CPO_DROME	Protein couch potato	GO:0003729; GO:0005634; GO:0007268; GO:0007275; GO:0022611; GO:0035206; GO:0045202	nucleus [GO:0005634]; synapse [GO:0045202]; mRNA binding [GO:0003729]; chemical synaptic transmission [GO:0007268]; dormancy process [GO:0022611]; multicellular organism development [GO:0007275]; regulation of hemocyte proliferation [GO:0035206]
PGEN_.00g342570	Scaffold_18	9219078	9219623	NA	NA	NA	NA	NA
PGEN_.00g342580	Scaffold_18	9221030	9226559	O74452	SCW1_SCHPO	Cell wall integrity protein scw1 (Strong cell wall protein 1)	GO:0003723; GO:0003729; GO:0005737; GO:0032995	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of fungal-type cell wall biogenesis [GO:0032995]
PGEN_.00g342590	Scaffold_18	9253651	9254640	NA	NA	NA	NA	NA
PGEN_.00g342600	Scaffold_18	9258601	9275316	P00375	DYR_MOUSE	Dihydrofolate reductase (EC 1.5.1.3)	GO:0000900; GO:0003729; GO:0004146; GO:0005542; GO:0005737; GO:0005739; GO:0005829; GO:0006729; GO:0006730; GO:0008144; GO:0017148; GO:0031103; GO:0031427; GO:0035094; GO:0046452; GO:0046653; GO:0046654; GO:0046655; GO:0050661; GO:0051000; GO:0051870; GO:0051871; GO:0055114; GO:0070402; GO:1990825; GO:2000121	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; dihydrofolic acid binding [GO:0051871]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; methotrexate binding [GO:0051870]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; oxidation-reduction process [GO:0055114]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; response to nicotine [GO:0035094]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]"
PGEN_.00g342610	Scaffold_18	9285527	9288019	NA	NA	NA	NA	NA
PGEN_.00g342620	Scaffold_18	9298251	9305794	NA	NA	NA	NA	NA
PGEN_.00g342630	Scaffold_18	9306090	9306503	NA	NA	NA	NA	NA
PGEN_.00g342640	Scaffold_18	9338152	9344049	NA	NA	NA	NA	NA
PGEN_.00g342650	Scaffold_18	9388715	9413089	NA	NA	NA	NA	NA
PGEN_.00g342660	Scaffold_18	9434102	9447557	NA	NA	NA	NA	NA
PGEN_.00g342670	Scaffold_18	9452686	9458880	NA	NA	NA	NA	NA
PGEN_.00g342680	Scaffold_18	9459001	9459501	NA	NA	NA	NA	NA
PGEN_.00g342690	Scaffold_18	9459568	9460443	NA	NA	NA	NA	NA
PGEN_.00g342700	Scaffold_18	9460649	9460984	NA	NA	NA	NA	NA
PGEN_.00g342710	Scaffold_18	9461675	9462169	NA	NA	NA	NA	NA
PGEN_.00g342720	Scaffold_18	9462755	9463288	NA	NA	NA	NA	NA
PGEN_.00g342730	Scaffold_18	9465780	9470366	NA	NA	NA	NA	NA
PGEN_.00g342740	Scaffold_18	9470607	9471104	NA	NA	NA	NA	NA
PGEN_.00g342750	Scaffold_18	9483369	9484710	NA	NA	NA	NA	NA
PGEN_.00g342760	Scaffold_18	9501713	9533178	Q9HB55	CP343_HUMAN	Cytochrome P450 3A43 (EC 1.14.14.1)	GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0020037; GO:0050649; GO:0070330; GO:0070989; GO:0101020	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]
PGEN_.00g342770	Scaffold_18	9566491	9577642	P31689	DNJA1_HUMAN	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	GO:0001664; GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0015630; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051082; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259	"cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]"
PGEN_.00g342780	Scaffold_18	9612666	9645525	Q69CM7	MYBPP_RAT	MYCBP-associated protein (Organ of Corti membrane-associated protein of 106 kDa)	GO:0005737; GO:0007268; GO:0007275; GO:0007283; GO:0007605; GO:0019897; GO:0030154	cytoplasm [GO:0005737]; extrinsic component of plasma membrane [GO:0019897]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]
PGEN_.00g342790	Scaffold_18	9708118	9726490	Q7YRH6	PEMT_BOVIN	Phosphatidylethanolamine N-methyltransferase (PEAMT) (PEMT) (EC 2.1.1.17) (EC 2.1.1.71) (Phospholipid methyltransferase) (PLMT)	GO:0000773; GO:0004608; GO:0005789; GO:0006656; GO:0016021; GO:0031966; GO:0032259; GO:0080101	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [GO:0080101]; phosphatidyl-N-methylethanolamine N-methyltransferase activity [GO:0000773]; phosphatidylethanolamine N-methyltransferase activity [GO:0004608]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]
PGEN_.00g342800	Scaffold_18	9733194	9737262	A2RRS8	CEP78_XENTR	Centrosomal protein of 78 kDa (Cep78)	GO:0005737; GO:0005813; GO:0005814; GO:0036064; GO:0044782	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cilium organization [GO:0044782]
PGEN_.00g342810	Scaffold_18	9834941	9836143	NA	NA	NA	NA	NA
PGEN_.00g342820	Scaffold_18	9872606	9877087	A2RRS8	CEP78_XENTR	Centrosomal protein of 78 kDa (Cep78)	GO:0005737; GO:0005813; GO:0005814; GO:0036064; GO:0044782	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cilium organization [GO:0044782]
PGEN_.00g342830	Scaffold_18	9891606	9892175	NA	NA	NA	NA	NA
PGEN_.00g342840	Scaffold_18	9901713	9916203	NA	NA	NA	NA	NA
PGEN_.00g342850	Scaffold_18	9934317	9940722	Q9Y4I1	MYO5A_HUMAN	"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)"	GO:0000146; GO:0001726; GO:0001750; GO:0003723; GO:0005509; GO:0005516; GO:0005524; GO:0005623; GO:0005737; GO:0005790; GO:0005794; GO:0005829; GO:0005882; GO:0006887; GO:0006892; GO:0007268; GO:0007601; GO:0016020; GO:0016192; GO:0016461; GO:0017137; GO:0030048; GO:0030050; GO:0030073; GO:0030318; GO:0030426; GO:0031585; GO:0031987; GO:0032252; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0035371; GO:0042438; GO:0042470; GO:0042476; GO:0042552; GO:0042641; GO:0042759; GO:0042802; GO:0043005; GO:0043025; GO:0048820; GO:0050808; GO:0051015; GO:0070062; GO:0072659; GO:0097718; GO:0098794; GO:0098978; GO:0099089; GO:0099566	"actomyosin [GO:0042641]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; smooth endoplasmic reticulum [GO:0005790]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]"
PGEN_.00g342860	Scaffold_18	9942274	9942594	NA	NA	NA	NA	NA
PGEN_.00g342870	Scaffold_18	9942625	9942918	NA	NA	NA	NA	NA
PGEN_.00g342880	Scaffold_18	9953463	9959881	NA	NA	NA	NA	NA
PGEN_.00g342890	Scaffold_18	9966705	9967079	NA	NA	NA	NA	NA
PGEN_.00g342900	Scaffold_18	9967172	9967498	NA	NA	NA	NA	NA
PGEN_.00g342910	Scaffold_18	9970457	9970786	NA	NA	NA	NA	NA
PGEN_.00g342920	Scaffold_18	9971183	9971512	NA	NA	NA	NA	NA
PGEN_.00g342930	Scaffold_18	9971557	9971979	NA	NA	NA	NA	NA
PGEN_.00g342940	Scaffold_18	9972892	9978503	NA	NA	NA	NA	NA
PGEN_.00g342950	Scaffold_18	9984928	10022188	Q9ULV0	MYO5B_HUMAN	Unconventional myosin-Vb	GO:0000146; GO:0003091; GO:0005516; GO:0005524; GO:0015031; GO:0016192; GO:0016197; GO:0016459; GO:0017137; GO:0030659; GO:0032991; GO:0045179; GO:0051015; GO:0070062	apical cortex [GO:0045179]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; renal water homeostasis [GO:0003091]; vesicle-mediated transport [GO:0016192]
PGEN_.00g342960	Scaffold_18	10062017	10079192	NA	NA	NA	NA	NA
PGEN_.00g342970	Scaffold_18	10086697	10108265	NA	NA	NA	NA	NA
PGEN_.00g342980	Scaffold_18	10108303	10146367	Q7Z3K3	POGZ_HUMAN	Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635)	GO:0000790; GO:0000979; GO:0005654; GO:0005737; GO:0005829; GO:0007064; GO:0010468; GO:0046872; GO:0051301; GO:0051382	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; regulation of gene expression [GO:0010468]
PGEN_.00g342990	Scaffold_18	10157246	10157509	NA	NA	NA	NA	NA
PGEN_.00g343000	Scaffold_18	10163305	10163586	NA	NA	NA	NA	NA
PGEN_.00g343010	Scaffold_18	10163638	10169133	NA	NA	NA	NA	NA
PGEN_.00g343020	Scaffold_18	10169388	10177142	P27115	MGAT1_RABIT	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)"	GO:0000139; GO:0003827; GO:0005797; GO:0006013; GO:0006487; GO:0016021; GO:0016262; GO:0018279; GO:0030145	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"
PGEN_.00g343030	Scaffold_18	10181663	10186833	P27115	MGAT1_RABIT	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)"	GO:0000139; GO:0003827; GO:0005797; GO:0006013; GO:0006487; GO:0016021; GO:0016262; GO:0018279; GO:0030145	"Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]"
PGEN_.00g343040	Scaffold_18	10201122	10237046	NA	NA	NA	NA	NA
PGEN_.00g343050	Scaffold_18	10243169	10255092	NA	NA	NA	NA	NA
PGEN_.00g343060	Scaffold_18	10265155	10266151	P08045	XFIN_XENLA	Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)	GO:0003723; GO:0005737; GO:0006355; GO:0046872	"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g343070	Scaffold_18	10271956	10275967	NA	NA	NA	NA	NA
PGEN_.00g343080	Scaffold_18	10284353	10298808	NA	NA	NA	NA	NA
PGEN_.00g343090	Scaffold_18	10310699	10311082	NA	NA	NA	NA	NA
PGEN_.00g343100	Scaffold_18	10324588	10326095	NA	NA	NA	NA	NA
PGEN_.00g343110	Scaffold_18	10338959	10357684	Q9IBG7	KCP_XENLA	Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g343120	Scaffold_18	10358135	10359001	NA	NA	NA	NA	NA
PGEN_.00g343130	Scaffold_18	10365602	10368105	NA	NA	NA	NA	NA
PGEN_.00g343140	Scaffold_18	10377254	10387852	NA	NA	NA	NA	NA
PGEN_.00g343150	Scaffold_18	10408948	10413548	NA	NA	NA	NA	NA
PGEN_.00g343160	Scaffold_18	10420159	10428352	NA	NA	NA	NA	NA
PGEN_.00g343170	Scaffold_18	10448258	10453784	NA	NA	NA	NA	NA
PGEN_.00g343180	Scaffold_18	10457041	10457433	NA	NA	NA	NA	NA
PGEN_.00g343190	Scaffold_18	10466422	10479882	Q17043	APLY_APLKU	Aplysianin-A	GO:0016491; GO:0042742	oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]
PGEN_.00g343200	Scaffold_18	10491904	10492149	NA	NA	NA	NA	NA
PGEN_.00g343210	Scaffold_18	10497872	10498285	NA	NA	NA	NA	NA
PGEN_.00g343220	Scaffold_18	10498344	10498568	NA	NA	NA	NA	NA
PGEN_.00g343230	Scaffold_18	10525824	10532661	NA	NA	NA	NA	NA
PGEN_.00g343240	Scaffold_18	10538095	10561429	NA	NA	NA	NA	NA
PGEN_.00g343250	Scaffold_18	10569617	10569856	NA	NA	NA	NA	NA
PGEN_.00g343260	Scaffold_18	10572668	10596940	NA	NA	NA	NA	NA
PGEN_.00g343270	Scaffold_18	10715098	10810816	P54939	TLN1_CHICK	Talin-1	GO:0001726; GO:0005200; GO:0005623; GO:0005829; GO:0005925; GO:0006897; GO:0007015; GO:0007016; GO:0007155; GO:0009986; GO:0030276; GO:0030479; GO:0032051; GO:0032587; GO:0035091; GO:0035615; GO:0043231; GO:0043325; GO:0048260; GO:0048268; GO:0051015; GO:0080025	"actin cortical patch [GO:0030479]; cell [GO:0005623]; cell surface [GO:0009986]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; clathrin coat assembly [GO:0048268]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endocytosis [GO:0006897]; positive regulation of receptor-mediated endocytosis [GO:0048260]"
PGEN_.00g343280	Scaffold_18	10819559	10884512	A0JM12	MEG10_XENTR	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0005112; GO:0005886; GO:0007155; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0043277	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Notch binding [GO:0005112]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g343290	Scaffold_18	10885382	10893839	NA	NA	NA	NA	NA
PGEN_.00g343300	Scaffold_18	10912153	10914208	NA	NA	NA	NA	NA
PGEN_.00g343310	Scaffold_18	10914277	10914809	NA	NA	NA	NA	NA
PGEN_.00g343320	Scaffold_18	10919105	10922213	NA	NA	NA	NA	NA
PGEN_.00g343330	Scaffold_18	10922330	10925816	NA	NA	NA	NA	NA
PGEN_.00g343340	Scaffold_18	11012659	11013039	NA	NA	NA	NA	NA
PGEN_.00g343350	Scaffold_18	11020077	11038776	NA	NA	NA	NA	NA
PGEN_.00g343360	Scaffold_18	11041593	11056585	Q8BRK9	MA2A2_MOUSE	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0015923; GO:0016021; GO:0016799; GO:0030246; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"
PGEN_.00g343370	Scaffold_18	11056626	11096647	P49641	MA2A2_HUMAN	"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0016021; GO:0016799; GO:0030246; GO:0046872	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"
PGEN_.00g343380	Scaffold_18	11210773	11227559	D3ZTX0	TMED7_RAT	Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27)	GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0012507; GO:0016021; GO:0030134; GO:0030663; GO:0033116	COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]
PGEN_.00g343390	Scaffold_18	11214281	11214538	NA	NA	NA	NA	NA
PGEN_.00g343400	Scaffold_18	11214580	11220219	NA	NA	NA	NA	NA
PGEN_.00g343410	Scaffold_18	11231802	11232290	NA	NA	NA	NA	NA
PGEN_.00g343420	Scaffold_18	11233910	11234203	NA	NA	NA	NA	NA
PGEN_.00g343430	Scaffold_18	11285247	11305203	A4IGM4	DHI1L_XENTR	Hydroxysteroid 11-beta-dehydrogenase 1-like protein (EC 1.1.1.-) (11-beta-hydroxysteroid dehydrogenase type 3) (11-DH3) (11-beta-HSD3)	GO:0005576; GO:0016491	extracellular region [GO:0005576]; oxidoreductase activity [GO:0016491]
PGEN_.00g343440	Scaffold_18	11315343	11329398	NA	NA	NA	NA	NA
PGEN_.00g343450	Scaffold_18	11333350	11346730	NA	NA	NA	NA	NA
PGEN_.00g343460	Scaffold_18	11353216	11363480	Q96HA9	PX11C_HUMAN	Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma) (PEX11-gamma)	GO:0005777; GO:0005779; GO:0016559; GO:0031231; GO:0032991; GO:0044375	integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375]
PGEN_.00g343470	Scaffold_18	11370525	11380226	NA	NA	NA	NA	NA
PGEN_.00g343480	Scaffold_18	11380875	11385604	NA	NA	NA	NA	NA
PGEN_.00g343490	Scaffold_18	11397731	11398654	NA	NA	NA	NA	NA
PGEN_.00g343500	Scaffold_18	11448583	11522084	Q498G2	CE152_XENLA	Centrosomal protein of 152 kDa (Cep152)	GO:0000242; GO:0005737; GO:0005814; GO:0007099; GO:0030030; GO:0098535; GO:0098536	centriole [GO:0005814]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; pericentriolar material [GO:0000242]; cell projection organization [GO:0030030]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]
PGEN_.00g343510	Scaffold_18	11527356	11527718	NA	NA	NA	NA	NA
PGEN_.00g343520	Scaffold_18	11528196	11528615	NA	NA	NA	NA	NA
PGEN_.00g343530	Scaffold_18	11528779	11529928	NA	NA	NA	NA	NA
PGEN_.00g343540	Scaffold_18	11533916	11542171	NA	NA	NA	NA	NA
PGEN_.00g343550	Scaffold_18	11584930	11633097	NA	NA	NA	NA	NA
PGEN_.00g343560	Scaffold_18	11641115	11646009	A4QN56	MFS4B_DANRE	Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B)	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g343570	Scaffold_18	11653367	11664012	Q4V891	POC5_RAT	Centrosomal protein POC5 (Protein of centriole 5)	GO:0005737; GO:0005813; GO:0005814; GO:0007049; GO:0042802	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; cell cycle [GO:0007049]
PGEN_.00g343580	Scaffold_18	11730954	11759006	Q91ZR4	NEK8_MOUSE	Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8)	GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007059; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330]
PGEN_.00g343590	Scaffold_18	11759092	11768914	NA	NA	NA	NA	NA
PGEN_.00g343600	Scaffold_18	11775827	11794906	Q5ZJ85	PRPF3_CHICK	U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3)	GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0016607; GO:0046540	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"
PGEN_.00g343610	Scaffold_18	11803100	11804105	NA	NA	NA	NA	NA
PGEN_.00g343620	Scaffold_18	11827109	11835490	NA	NA	NA	NA	NA
PGEN_.00g343630	Scaffold_18	11843587	11844000	NA	NA	NA	NA	NA
PGEN_.00g343640	Scaffold_18	11844054	11844452	NA	NA	NA	NA	NA
PGEN_.00g343650	Scaffold_18	11844769	11845230	NA	NA	NA	NA	NA
PGEN_.00g343660	Scaffold_18	11869136	11922756	Q96PH1	NOX5_HUMAN	NADPH oxidase 5 (EC 1.6.3.-)	GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]
PGEN_.00g343670	Scaffold_18	11938141	11939695	Q96PP9	GBP4_HUMAN	Guanylate-binding protein 4 (EC 3.6.5.-) (GTP-binding protein 4) (GBP-4) (Guanine nucleotide-binding protein 4)	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005794; GO:0005829; GO:0005886; GO:0020005; GO:0031410; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0071346	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]
PGEN_.00g343680	Scaffold_18	11940277	11942349	NA	NA	NA	NA	NA
PGEN_.00g343690	Scaffold_18	11950407	11951069	NA	NA	NA	NA	NA
PGEN_.00g343700	Scaffold_18	11960677	11967457	NA	NA	NA	NA	NA
PGEN_.00g343710	Scaffold_18	11972432	11978058	NA	NA	NA	NA	NA
PGEN_.00g343720	Scaffold_18	11985227	11991927	NA	NA	NA	NA	NA
PGEN_.00g343730	Scaffold_18	11993698	12005329	O05389	YRBE_BACSU	Uncharacterized oxidoreductase YrbE (EC 1.-.-.-)	GO:0006740; GO:0016491	oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740]
PGEN_.00g343740	Scaffold_18	12006563	12007467	NA	NA	NA	NA	NA
PGEN_.00g343750	Scaffold_18	12008562	12026590	NA	NA	NA	NA	NA
PGEN_.00g343760	Scaffold_18	12052953	12068938	Q96EQ9	PRDM9_MOUSE	Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.-) (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-)	GO:0000785; GO:0000977; GO:0003700; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0031490; GO:0034968; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044212; GO:0044648; GO:0045893; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]"
PGEN_.00g343770	Scaffold_18	12077288	12079383	O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	"cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
PGEN_.00g343780	Scaffold_18	12149172	12151551	O88572	LRP6_MOUSE	Low-density lipoprotein receptor-related protein 6 (LRP-6)	GO:0001702; GO:0001756; GO:0001843; GO:0001933; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005623; GO:0005769; GO:0005783; GO:0005886; GO:0005901; GO:0006355; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0016020; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051091; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0061310; GO:0061324; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:2000051; GO:2000149; GO:2000151; GO:2000162; GO:2000164; GO:2000166; GO:2000168	"caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"
PGEN_.00g343790	Scaffold_18	12170809	12171811	NA	NA	NA	NA	NA
PGEN_.00g343800	Scaffold_18	12172134	12172508	NA	NA	NA	NA	NA
PGEN_.00g343810	Scaffold_18	12185899	12203146	P55210	CASP7_HUMAN	Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0008233; GO:0008234; GO:0072734; GO:0097153; GO:0097194; GO:0097200	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508]
PGEN_.00g343820	Scaffold_18	12232439	12236094	NA	NA	NA	NA	NA
PGEN_.00g343830	Scaffold_18	12243307	12244587	Q8N8K9	K1958_HUMAN	Uncharacterized protein KIAA1958		
PGEN_.00g343840	Scaffold_18	12255728	12267803	NA	NA	NA	NA	NA
PGEN_.00g343850	Scaffold_18	12290010	12290312	NA	NA	NA	NA	NA
PGEN_.00g343860	Scaffold_18	12292213	12294365	NA	NA	NA	NA	NA
PGEN_.00g343870	Scaffold_18	12311859	12323206	Q8TB03	CX038_HUMAN	Uncharacterized protein CXorf38		
PGEN_.00g343880	Scaffold_18	12323363	12326700	NA	NA	NA	NA	NA
PGEN_.00g343890	Scaffold_18	12341605	12351831	NA	NA	NA	NA	NA
PGEN_.00g343900	Scaffold_18	12371766	12372377	NA	NA	NA	NA	NA
PGEN_.00g343910	Scaffold_18	12403973	12408224	Q7T3S3	CHSTB_DANRE	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)	GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]
PGEN_.00g343920	Scaffold_18	12447784	12457124	P83088	FUCTC_DROME	"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)"	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g343930	Scaffold_18	12465762	12469522	O16374	GALT1_CAEEL	"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)"	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872	"Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]"
PGEN_.00g343940	Scaffold_18	12494604	12496021	NA	NA	NA	NA	NA
PGEN_.00g343950	Scaffold_18	12498272	12498958	NA	NA	NA	NA	NA
PGEN_.00g343960	Scaffold_18	12505065	12510950	NA	NA	NA	NA	NA
PGEN_.00g343970	Scaffold_18	12542108	12543320	NA	NA	NA	NA	NA
PGEN_.00g343980	Scaffold_18	12593040	12593312	NA	NA	NA	NA	NA
PGEN_.00g343990	Scaffold_18	12647031	12681372	P97603	NEO1_RAT	Neogenin (Fragment)	GO:0001764; GO:0005887; GO:0006355; GO:0007155; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0055072; GO:0070700; GO:0097708; GO:0098797; GO:1901215; GO:2001222	"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane protein complex [GO:0098797]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron death [GO:1901215]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g344000	Scaffold_18	12704536	12727567	Q96EQ9	PRDM9_MOUSE	Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.-) (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-)	GO:0000785; GO:0000977; GO:0003700; GO:0005634; GO:0005654; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0031490; GO:0034968; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044212; GO:0044648; GO:0045893; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]"
PGEN_.00g344010	Scaffold_18	12737354	12737989	NA	NA	NA	NA	NA
PGEN_.00g344020	Scaffold_18	12805710	12827773	Q15389	ANGP1_HUMAN	Angiopoietin-1 (ANG-1)	GO:0000165; GO:0001701; GO:0001933; GO:0001934; GO:0002040; GO:0002092; GO:0002740; GO:0005576; GO:0005615; GO:0005886; GO:0005902; GO:0007162; GO:0007171; GO:0010595; GO:0010628; GO:0014068; GO:0014842; GO:0030097; GO:0030154; GO:0030210; GO:0030971; GO:0031398; GO:0031589; GO:0032680; GO:0033138; GO:0034394; GO:0042308; GO:0043066; GO:0043116; GO:0043122; GO:0043393; GO:0043524; GO:0043536; GO:0045121; GO:0045785; GO:0048014; GO:0050731; GO:0050900; GO:0050918; GO:0051897; GO:0070062; GO:0070374; GO:0072012; GO:1905605; GO:2000352; GO:2000446	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor tyrosine kinase binding [GO:0030971]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine secretion involved in immune response [GO:0002740]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; positive chemotaxis [GO:0050918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of maintenance of permeability of blood-brain barrier [GO:1905605]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014]
PGEN_.00g344030	Scaffold_18	12863218	12879501	NA	NA	NA	NA	NA
PGEN_.00g344040	Scaffold_18	12931534	12938659	NA	NA	NA	NA	NA
PGEN_.00g344050	Scaffold_18	12998549	13005342	Q6FIF0	ZFAN6_HUMAN	AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3)	GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0031593; GO:0043066; GO:0043122; GO:0071356	cytosol [GO:0005829]; DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]
PGEN_.00g344060	Scaffold_18	13018754	13023464	Q90YG6	T2AG_ONCMY	Transcription initiation factor IIA subunit 2 (General transcription factor IIA subunit 2) (Transcription initiation factor IIA gamma chain) (TFIIA-gamma)	GO:0005672; GO:0006367	transcription factor TFIIA complex [GO:0005672]; transcription initiation from RNA polymerase II promoter [GO:0006367]
PGEN_.00g344070	Scaffold_18	13023600	13038957	Q5PQ30	LYSM1_XENLA	LysM and putative peptidoglycan-binding domain-containing protein 1		
PGEN_.00g344080	Scaffold_18	13049354	13084439	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g344090	Scaffold_18	13165225	13174269	NA	NA	NA	NA	NA
PGEN_.00g344100	Scaffold_18	13176951	13182469	NA	NA	NA	NA	NA
PGEN_.00g344110	Scaffold_18	13196419	13196781	NA	NA	NA	NA	NA
PGEN_.00g344120	Scaffold_18	13212619	13213023	NA	NA	NA	NA	NA
PGEN_.00g344130	Scaffold_18	13213107	13214329	NA	NA	NA	NA	NA
PGEN_.00g344140	Scaffold_18	13214444	13214800	NA	NA	NA	NA	NA
PGEN_.00g344150	Scaffold_18	13215573	13221263	NA	NA	NA	NA	NA
PGEN_.00g344160	Scaffold_18	13221302	13227847	NA	NA	NA	NA	NA
PGEN_.00g344170	Scaffold_18	13284826	13298256	NA	NA	NA	NA	NA
PGEN_.00g344180	Scaffold_18	13318820	13319044	NA	NA	NA	NA	NA
PGEN_.00g344190	Scaffold_18	13346225	13360857	A8Y1P7	BRE4_CAEBR	"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)"	GO:0005975; GO:0006486; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872	"integral component of membrane [GO:0016021]; beta-1,4-N-acetylgalactosaminyltransferase activity [GO:0033207]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]"
PGEN_.00g344200	Scaffold_18	13392552	13392917	NA	NA	NA	NA	NA
PGEN_.00g344210	Scaffold_18	13442235	13466553	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g344220	Scaffold_18	13466592	13467368	NA	NA	NA	NA	NA
PGEN_.00g344230	Scaffold_18	13467587	13544513	Q9C0G6	DYH6_HUMAN	"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)"	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	"cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
PGEN_.00g344240	Scaffold_18	13553461	13560062	NA	NA	NA	NA	NA
PGEN_.00g344250	Scaffold_18	13564118	13566008	Q6GZ04	PAM_TAXCA	Phenylalanine aminomutase (L-beta-phenylalanine forming) (EC 5.4.3.10) (Phenylalanine ammonia-lyase) (EC 4.3.1.24)	GO:0005737; GO:0006558; GO:0006559; GO:0009800; GO:0009821; GO:0016869; GO:0042617; GO:0045548; GO:0051289	"cytoplasm [GO:0005737]; intramolecular transferase activity, transferring amino groups [GO:0016869]; phenylalanine ammonia-lyase activity [GO:0045548]; alkaloid biosynthetic process [GO:0009821]; cinnamic acid biosynthetic process [GO:0009800]; L-phenylalanine catabolic process [GO:0006559]; L-phenylalanine metabolic process [GO:0006558]; paclitaxel biosynthetic process [GO:0042617]; protein homotetramerization [GO:0051289]"
PGEN_.00g344260	Scaffold_18	13582719	13597041	NA	NA	NA	NA	NA
PGEN_.00g344270	Scaffold_18	13601584	13602265	NA	NA	NA	NA	NA
PGEN_.00g344280	Scaffold_18	13606271	13623820	NA	NA	NA	NA	NA
PGEN_.00g344290	Scaffold_18	13635562	13636788	P17035	ZNF28_HUMAN	Zinc finger protein 28 (Zinc finger protein KOX24)	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g344300	Scaffold_18	13704765	13712099	Q7L1S5	CHST9_HUMAN	Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)	GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446	extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g344310	Scaffold_18	13783213	13784670	NA	NA	NA	NA	NA
PGEN_.00g344320	Scaffold_18	13817443	13817733	NA	NA	NA	NA	NA
PGEN_.00g344330	Scaffold_18	13820279	13831937	NA	NA	NA	NA	NA
PGEN_.00g344340	Scaffold_18	13833635	13864548	P23468	PTPRD_HUMAN	Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)	GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0007157; GO:0007185; GO:0030182; GO:0050775; GO:0050839; GO:0051965; GO:0070062; GO:0097105; GO:0098978; GO:0099151; GO:0099545; GO:0099560; GO:1905606	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]
PGEN_.00g344350	Scaffold_18	13868186	13872481	NA	NA	NA	NA	NA
PGEN_.00g344360	Scaffold_18	13882431	13889823	NA	NA	NA	NA	NA
PGEN_.00g344370	Scaffold_18	13902563	13903240	NA	NA	NA	NA	NA
PGEN_.00g344380	Scaffold_18	13927367	13927795	NA	NA	NA	NA	NA
PGEN_.00g344390	Scaffold_18	13944522	13994195	Q07157	ZO1_HUMAN	Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)	GO:0002102; GO:0005516; GO:0005737; GO:0005829; GO:0005886; GO:0005913; GO:0005921; GO:0005923; GO:0007043; GO:0016323; GO:0030054; GO:0030335; GO:0031032; GO:0032991; GO:0034334; GO:0035329; GO:0042995; GO:0043296; GO:0045177; GO:0045216; GO:0045296; GO:0051493; GO:0051497; GO:0070160; GO:0090557; GO:0150105; GO:1901350; GO:1901888; GO:1902396; GO:1903672; GO:1904696; GO:1905605; GO:2000049; GO:2000250; GO:2000810	apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; cell-cell signaling involved in cell-cell junction organization [GO:1901350]; establishment of endothelial intestinal barrier [GO:0090557]; hippo signaling [GO:0035329]; negative regulation of actin cytoskeleton reorganization [GO:2000250]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of maintenance of permeability of blood-brain barrier [GO:1905605]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell adherens junction [GO:1904696]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]
PGEN_.00g344400	Scaffold_18	14013979	14015022	NA	NA	NA	NA	NA
PGEN_.00g344410	Scaffold_18	14016918	14023109	NA	NA	NA	NA	NA
PGEN_.00g344420	Scaffold_18	14024157	14027050	NA	NA	NA	NA	NA
PGEN_.00g344430	Scaffold_18	14041001	14042113	Q8HY06	CLC4M_GORGO	C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (CD antigen CD299)	GO:0001618; GO:0002250; GO:0005537; GO:0006897; GO:0016021; GO:0045087; GO:0046872; GO:0048306	integral component of membrane [GO:0016021]; calcium-dependent protein binding [GO:0048306]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]
PGEN_.00g344440	Scaffold_18	14076636	14078078	NA	NA	NA	NA	NA
PGEN_.00g344450	Scaffold_18	14103161	14151198	Q9TTY2	FER_CANLF	Tyrosine-protein kinase Fer (EC 2.7.10.2) (Proto-oncogene c-Fer) (p94-Fer)	GO:0004715; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005856; GO:0005938; GO:0006935; GO:0007155; GO:0007169; GO:0008283; GO:0008289; GO:0016477; GO:0030054; GO:0030154; GO:0030335; GO:0031234; GO:0031532; GO:0038083; GO:0038095; GO:0042058; GO:0042127; GO:0042995; GO:0043304; GO:0051092	cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; chemotaxis [GO:0006935]; Fc-epsilon receptor signaling pathway [GO:0038095]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of cell migration [GO:0030335]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of cell population proliferation [GO:0042127]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of mast cell degranulation [GO:0043304]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g344460	Scaffold_18	14122136	14122390	NA	NA	NA	NA	NA
PGEN_.00g344470	Scaffold_18	14180044	14187779	NA	NA	NA	NA	NA
PGEN_.00g344480	Scaffold_18	14232480	14234232	NA	NA	NA	NA	NA
PGEN_.00g344490	Scaffold_18	14258848	14259390	NA	NA	NA	NA	NA
PGEN_.00g344500	Scaffold_18	14261384	14265329	NA	NA	NA	NA	NA
PGEN_.00g344510	Scaffold_18	14300122	14303543	Q4V885	COL12_RAT	Collectin-12 (Collectin placenta protein 1) (CL-P1) (Nurse cell scavenger receptor 2)	GO:0004888; GO:0005581; GO:0006910; GO:0006955; GO:0008329; GO:0016021; GO:0030169; GO:0030246; GO:0034138; GO:0046872; GO:0060355; GO:0071360	"collagen trimer [GO:0005581]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; transmembrane signaling receptor activity [GO:0004888]; cellular response to exogenous dsRNA [GO:0071360]; immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]"
PGEN_.00g344520	Scaffold_18	14303991	14304218	NA	NA	NA	NA	NA
PGEN_.00g344530	Scaffold_18	14314074	14317963	NA	NA	NA	NA	NA
PGEN_.00g344540	Scaffold_18	14320883	14350036	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g344550	Scaffold_18	14378561	14389401	NA	NA	NA	NA	NA
PGEN_.00g344560	Scaffold_18	14400509	14418279	NA	NA	NA	NA	NA
PGEN_.00g344570	Scaffold_18	14419688	14437479	NA	NA	NA	NA	NA
PGEN_.00g344580	Scaffold_18	14445112	14465056	P70701	WN10A_MOUSE	Protein Wnt-10a	GO:0001942; GO:0005102; GO:0005109; GO:0005615; GO:0007165; GO:0007267; GO:0009887; GO:0010628; GO:0014033; GO:0016055; GO:0030182; GO:0031069; GO:0042476; GO:0042487; GO:0043586; GO:0043588; GO:0045165; GO:0048018; GO:0048730; GO:0048733; GO:0060070; GO:0071560	extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; signal transduction [GO:0007165]; skin development [GO:0043588]; tongue development [GO:0043586]; Wnt signaling pathway [GO:0016055]
PGEN_.00g344590	Scaffold_18	14485961	14530144	P28571	SC6A9_MOUSE	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)	GO:0001504; GO:0005283; GO:0005328; GO:0005886; GO:0014069; GO:0015187; GO:0015816; GO:0016021; GO:0030285; GO:0032279; GO:0061537; GO:0098686; GO:0098688; GO:0099055; GO:0099056	"asymmetric synapse [GO:0032279]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; amino acid:sodium symporter activity [GO:0005283]; glycine transmembrane transporter activity [GO:0015187]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine secretion, neurotransmission [GO:0061537]; glycine transport [GO:0015816]; neurotransmitter uptake [GO:0001504]"
PGEN_.00g344600	Scaffold_18	14538178	14538378	NA	NA	NA	NA	NA
PGEN_.00g344610	Scaffold_18	14548464	14552522	NA	NA	NA	NA	NA
PGEN_.00g344620	Scaffold_18	14564174	14590582	Q9Z0E6	GBP2_MOUSE	Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (mGBP-2) (mGBP2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2)	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0009617; GO:0015629; GO:0020005; GO:0031410; GO:0034504; GO:0035458; GO:0042803; GO:0042832; GO:0044406; GO:0048471; GO:0050830; GO:0071222; GO:0071346	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; protein localization to nucleus [GO:0034504]; response to bacterium [GO:0009617]
PGEN_.00g344630	Scaffold_18	14577302	14578250	NA	NA	NA	NA	NA
PGEN_.00g344640	Scaffold_18	14644598	14645603	NA	NA	NA	NA	NA
PGEN_.00g344650	Scaffold_18	14645801	14647369	NA	NA	NA	NA	NA
PGEN_.00g344660	Scaffold_18	14653309	14660140	Q61107	GBP4_MOUSE	Guanylate-binding protein 4 (EC 3.6.5.-) (GTP-binding protein 3) (GBP-3) (GTP-binding protein 4) (GBP-4) (Guanine nucleotide-binding protein 4) (Guanylate-binding protein 3)	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005794; GO:0005829; GO:0005886; GO:0020005; GO:0031410; GO:0035458; GO:0042803; GO:0042832; GO:0044406; GO:0048471; GO:0050830; GO:0071346	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]
PGEN_.00g344670	Scaffold_18	14660287	14660508	NA	NA	NA	NA	NA
PGEN_.00g344680	Scaffold_18	14673562	14674428	NA	NA	NA	NA	NA
PGEN_.00g344690	Scaffold_18	14678690	14693291	Q63663	GBP2_RAT	Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2) (p67)	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005794; GO:0009617; GO:0020005; GO:0031410; GO:0034504; GO:0035458; GO:0042803; GO:0042832; GO:0044406; GO:0048471; GO:0050830; GO:0071222; GO:0071346; GO:0071347; GO:0071356	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; protein localization to nucleus [GO:0034504]; response to bacterium [GO:0009617]
PGEN_.00g344700	Scaffold_18	14715617	14718834	NA	NA	NA	NA	NA
PGEN_.00g344710	Scaffold_18	14731420	14752604	Q63663	GBP2_RAT	Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2) (p67)	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005794; GO:0009617; GO:0020005; GO:0031410; GO:0034504; GO:0035458; GO:0042803; GO:0042832; GO:0044406; GO:0048471; GO:0050830; GO:0071222; GO:0071346; GO:0071347; GO:0071356	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; protein localization to nucleus [GO:0034504]; response to bacterium [GO:0009617]
PGEN_.00g344720	Scaffold_18	14752709	14761600	NA	NA	NA	NA	NA
PGEN_.00g344730	Scaffold_18	14769830	14770186	NA	NA	NA	NA	NA
PGEN_.00g344740	Scaffold_18	14770408	14797481	Q00918	LTBP1_RAT	Latent-transforming growth factor beta-binding protein 1 (LTBP-1) (Transforming growth factor beta-1-binding protein 1) (TGF-beta-1-BP-1) (Transforming growth factor beta-1-masking protein large subunit)	GO:0001527; GO:0003281; GO:0005509; GO:0005737; GO:0005739; GO:0030425; GO:0031012; GO:0032967; GO:0032991; GO:0035583; GO:0035904; GO:0036120; GO:0038045; GO:0042060; GO:0043025; GO:0048471; GO:0050431; GO:0050436; GO:0060976; GO:0062023; GO:0071260; GO:0071305; GO:0071374; GO:1901388	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; large latent transforming growth factor-beta complex [GO:0038045]; microfibril [GO:0001527]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]; aorta development [GO:0035904]; cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to vitamin D [GO:0071305]; coronary vasculature development [GO:0060976]; positive regulation of collagen biosynthetic process [GO:0032967]; regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]
PGEN_.00g344750	Scaffold_18	14825343	14829673	Q9TV36	FBN1_PIG	Fibrillin-1 [Cleaved into: Asprosin]	GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0010737; GO:0031012; GO:0034199; GO:0042593	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]
PGEN_.00g344760	Scaffold_18	14841553	14855359	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g344770	Scaffold_18	14855459	14860993	NA	NA	NA	NA	NA
PGEN_.00g344780	Scaffold_18	14865702	14867056	NA	NA	NA	NA	NA
PGEN_.00g344790	Scaffold_18	14867214	14867483	NA	NA	NA	NA	NA
PGEN_.00g344800	Scaffold_18	14870735	14871121	NA	NA	NA	NA	NA
PGEN_.00g344810	Scaffold_18	14897423	14921258	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g344820	Scaffold_18	14921352	14936209	Q99102	MUC4_HUMAN	Mucin-4 (MUC-4) (Ascites sialoglycoprotein) (ASGP) (Pancreatic adenocarcinoma mucin) (Testis mucin) (Tracheobronchial mucin) [Cleaved into: Mucin-4 alpha chain (Ascites sialoglycoprotein 1) (ASGP-1); Mucin-4 beta chain (Ascites sialoglycoprotein 2) (ASGP-2)]	GO:0002223; GO:0005176; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0007160; GO:0010469; GO:0016020; GO:0016266; GO:0030197; GO:0030277; GO:0031012; GO:0031982; GO:0070062	"extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent, lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; maintenance of gastrointestinal epithelium [GO:0030277]; O-glycan processing [GO:0016266]; regulation of signaling receptor activity [GO:0010469]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
PGEN_.00g344830	Scaffold_18	14990697	15045608	P98133	FBN1_BOVIN	Fibrillin-1 (MP340) [Cleaved into: Asprosin]	GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0010737; GO:0031012; GO:0034199; GO:0042593	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]
PGEN_.00g344840	Scaffold_18	15052299	15052962	NA	NA	NA	NA	NA
PGEN_.00g344850	Scaffold_18	15057028	15062866	B3EWY9	MLP_ACRMI	Mucin-like protein (Fragment)	GO:0005509; GO:0007160; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
PGEN_.00g344860	Scaffold_18	15068276	15073766	B1WBU4	ZBT8A_RAT	Zinc finger and BTB domain-containing protein 8A	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g344870	Scaffold_18	15093885	15110980	Q9D1H9	MFAP4_MOUSE	Microfibril-associated glycoprotein 4	GO:0001527; GO:0005576; GO:0005615; GO:0007155; GO:0009650; GO:0010712; GO:0048251; GO:0062023; GO:0071493; GO:0071953; GO:0097435	collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; supramolecular fiber organization [GO:0097435]; UV protection [GO:0009650]
PGEN_.00g344880	Scaffold_18	15122564	15133653	NA	NA	NA	NA	NA
PGEN_.00g344890	Scaffold_18	15144677	15157516	P31396	HR3_DROME	Probable nuclear hormone receptor HR3 (dHR3) (Nuclear receptor subfamily 1 group F member 4)	GO:0000122; GO:0000977; GO:0003707; GO:0004879; GO:0005634; GO:0007552; GO:0008270; GO:0016319; GO:0040034; GO:0045944	"nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]"
PGEN_.00g344900	Scaffold_18	15180588	15188331	P28024	PSB4_XENLA	Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment)	GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0019774; GO:0051603	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603]"
PGEN_.00g344910	Scaffold_18	15192413	15231531	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g344920	Scaffold_18	15234545	15244556	D3YXG0	HMCN1_MOUSE	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]
PGEN_.00g344930	Scaffold_18	15264961	15277298	NA	NA	NA	NA	NA
PGEN_.00g344940	Scaffold_18	15295086	15296983	NA	NA	NA	NA	NA
PGEN_.00g344950	Scaffold_18	15302169	15313516	NA	NA	NA	NA	NA
PGEN_.00g344960	Scaffold_18	15318156	15323482	B2DFG5	DTHAD_DELSH	D-threo-3-hydroxyaspartate dehydratase (D-THA DH) (D-THA dehydratase) (EC 4.3.1.27) (Threo-3-hydroxy-D-aspartate ammonia-lyase)	GO:0016841; GO:0030170	ammonia-lyase activity [GO:0016841]; pyridoxal phosphate binding [GO:0030170]
PGEN_.00g344970	Scaffold_18	15326405	15327704	Q9US35	DSD1_SCHPO	D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase) (DSD)	GO:0005634; GO:0005829; GO:0008721; GO:0036088	cytosol [GO:0005829]; nucleus [GO:0005634]; D-serine ammonia-lyase activity [GO:0008721]; D-serine catabolic process [GO:0036088]
PGEN_.00g344980	Scaffold_18	15335212	15347027	B2DFG5	DTHAD_DELSH	D-threo-3-hydroxyaspartate dehydratase (D-THA DH) (D-THA dehydratase) (EC 4.3.1.27) (Threo-3-hydroxy-D-aspartate ammonia-lyase)	GO:0016841; GO:0030170	ammonia-lyase activity [GO:0016841]; pyridoxal phosphate binding [GO:0030170]
PGEN_.00g344990	Scaffold_18	15352069	15363093	Q5G267	NETR_MACMU	Neurotrypsin (EC 3.4.21.-) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0030424; GO:0030425; GO:0031638; GO:0043083; GO:0043195	axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; zymogen activation [GO:0031638]
PGEN_.00g345000	Scaffold_18	15368762	15375449	NA	NA	NA	NA	NA
PGEN_.00g345010	Scaffold_18	15393018	15397754	Q9NYT6	ZN226_HUMAN	Zinc finger protein 226	GO:0003677; GO:0005634; GO:0006355; GO:0046872	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g345020	Scaffold_18	15397836	15404134	O14084	IMT1_SCHPO	Inositol phosphoceramide mannosyltransferase 1 (EC 2.4.-.-) (IPC mannosyltransferase 1)	GO:0000030; GO:0005537; GO:0005794; GO:0016021; GO:0032588; GO:0033106; GO:0051999	cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; mannose binding [GO:0005537]; mannosyltransferase activity [GO:0000030]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]
PGEN_.00g345030	Scaffold_18	15407665	15416574	P85031	TLLP_PHONI	Techylectin-like protein (Fragments)	GO:0005576; GO:0030246; GO:0046872	extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]
PGEN_.00g345040	Scaffold_18	15439168	15448345	NA	NA	NA	NA	NA
PGEN_.00g345050	Scaffold_18	15533969	15534382	NA	NA	NA	NA	NA
PGEN_.00g345060	Scaffold_18	15567921	15590035	NA	NA	NA	NA	NA
PGEN_.00g345070	Scaffold_18	15590628	15592718	NA	NA	NA	NA	NA
PGEN_.00g345080	Scaffold_18	15593820	15595959	NA	NA	NA	NA	NA
PGEN_.00g345090	Scaffold_18	15601305	15614814	NA	NA	NA	NA	NA
PGEN_.00g345100	Scaffold_18	15604341	15604676	NA	NA	NA	NA	NA
PGEN_.00g345110	Scaffold_18	15618444	15628553	O54750	CP2J6_MOUSE	Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6)	GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0014070; GO:0016712; GO:0016853; GO:0019369; GO:0019373; GO:0020037; GO:0032966; GO:0035359; GO:0042738; GO:0043231; GO:0043651; GO:0055114; GO:0070330; GO:0071614; GO:1904469	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; positive regulation of tumor necrosis factor secretion [GO:1904469]; response to organic cyclic compound [GO:0014070]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]"
PGEN_.00g345120	Scaffold_18	15636177	15655619	NA	NA	NA	NA	NA
PGEN_.00g345130	Scaffold_18	15660415	15660837	NA	NA	NA	NA	NA
PGEN_.00g345140	Scaffold_18	15665344	15665634	NA	NA	NA	NA	NA
PGEN_.00g345150	Scaffold_18	15665686	15665997	NA	NA	NA	NA	NA
PGEN_.00g345160	Scaffold_18	15678032	15689281	P28271	ACOC_MOUSE	Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1)	GO:0003723; GO:0003994; GO:0005623; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0043231; GO:0046872; GO:0047780; GO:0048027; GO:0050892; GO:0051536; GO:0051538; GO:0051539	"cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron-responsive element binding [GO:0030350]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]"
PGEN_.00g345170	Scaffold_18	15689723	15720623	Q811J3	IREB2_MOUSE	Iron-responsive element-binding protein 2 (IRE-BP 2) (Iron regulatory protein 2) (IRP2)	GO:0001069; GO:0003723; GO:0003994; GO:0005623; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006782; GO:0006879; GO:0009791; GO:0010041; GO:0010468; GO:0017148; GO:0030316; GO:0030350; GO:0030371; GO:0030424; GO:0034101; GO:0043025; GO:0046872; GO:0050892; GO:0051539; GO:0055072; GO:0071283; GO:0071287; GO:0071364; GO:0072705; GO:0090650	"axon [GO:0030424]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; cellular iron ion homeostasis [GO:0006879]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to iron(III) ion [GO:0071283]; cellular response to manganese ion [GO:0071287]; cellular response to mercaptoethanol [GO:0072705]; cellular response to oxygen-glucose deprivation [GO:0090650]; citrate metabolic process [GO:0006101]; erythrocyte homeostasis [GO:0034101]; intestinal absorption [GO:0050892]; iron ion homeostasis [GO:0055072]; negative regulation of translation [GO:0017148]; osteoclast differentiation [GO:0030316]; post-embryonic development [GO:0009791]; protoporphyrinogen IX biosynthetic process [GO:0006782]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(III) ion [GO:0010041]; tricarboxylic acid cycle [GO:0006099]"
PGEN_.00g345180	Scaffold_18	15728202	15729668	NA	NA	NA	NA	NA
PGEN_.00g345190	Scaffold_18	15736239	15742912	Q60519	SEM5B_MOUSE	Semaphorin-5B (Semaphorin-G) (Sema G)	GO:0016021; GO:0030215; GO:0048675; GO:0050908; GO:0097485; GO:1990138	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]
PGEN_.00g345200	Scaffold_18	15768732	15780800	P46023	GR101_LYMST	G-protein coupled receptor GRL101	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]
PGEN_.00g345210	Scaffold_18	15802797	15848387	P98163	YL_DROME	Putative vitellogenin receptor (Protein yolkless) (YL)	GO:0005509; GO:0005886; GO:0008196; GO:0016021; GO:0030135; GO:0031410; GO:0048477	coated vesicle [GO:0030135]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; vitellogenin receptor activity [GO:0008196]; oogenesis [GO:0048477]
PGEN_.00g345220	Scaffold_18	15933419	15963258	Q8BIW1	PRUN1_MOUSE	Exopolyphosphatase PRUNE1 (EC 3.6.1.1) (PRUNEM1)	GO:0004309; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006798; GO:0015631; GO:0016791; GO:0031113; GO:0046872; GO:0050767	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]; polyphosphate catabolic process [GO:0006798]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]
PGEN_.00g345230	Scaffold_18	15997922	16010871	Q0IHU9	PRUN2_XENTR	Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1)	GO:0004309; GO:0005737; GO:0006798; GO:0006915	cytoplasm [GO:0005737]; exopolyphosphatase activity [GO:0004309]; apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798]
PGEN_.00g345240	Scaffold_18	16027680	16028645	NA	NA	NA	NA	NA
PGEN_.00g345250	Scaffold_18	16085265	16090264	NA	NA	NA	NA	NA
PGEN_.00g345260	Scaffold_18	16116830	16118557	Q03923	ZNF85_HUMAN	Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1)	GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0046872	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]
PGEN_.00g345270	Scaffold_18	16126846	16136559	NA	NA	NA	NA	NA
PGEN_.00g345280	Scaffold_18	16146311	16165322	NA	NA	NA	NA	NA
PGEN_.00g345290	Scaffold_18	16170002	16170466	NA	NA	NA	NA	NA
PGEN_.00g345300	Scaffold_18	16176103	16198836	P0C6B8	SVEP1_RAT	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
PGEN_.00g345310	Scaffold_18	16305167	16314905	P33316	DUT_HUMAN	"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial (dUTPase) (EC 3.6.1.23) (dUTP pyrophosphatase)"	GO:0000287; GO:0003723; GO:0004170; GO:0005634; GO:0005654; GO:0005739; GO:0006139; GO:0006226; GO:0006260; GO:0015949; GO:0046081; GO:0070062	extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]
PGEN_.00g345320	Scaffold_18	16315748	16328345	Q0P457	KTI12_DANRE	Protein KTI12 homolog	GO:0002098; GO:0005524; GO:0006357; GO:0033588	Elongator holoenzyme complex [GO:0033588]; ATP binding [GO:0005524]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]
PGEN_.00g345330	Scaffold_18	16330021	16348375	Q6NZK5	K1328_MOUSE	Protein hinderin		
PGEN_.00g345340	Scaffold_18	16351016	16385577	NA	NA	NA	NA	NA
PGEN_.00g345350	Scaffold_18	16385730	16397946	NA	NA	NA	NA	NA
PGEN_.00g345360	Scaffold_18	16398073	16399568	NA	NA	NA	NA	NA
PGEN_.00g345370	Scaffold_18	16399647	16400267	NA	NA	NA	NA	NA
PGEN_.00g345380	Scaffold_18	16400346	16400870	NA	NA	NA	NA	NA
PGEN_.00g345390	Scaffold_18	16401102	16401584	NA	NA	NA	NA	NA
PGEN_.00g345400	Scaffold_18	16408770	16455826	NA	NA	NA	NA	NA
PGEN_.00g345410	Scaffold_18	16460541	16500267	Q29485	PLMN_ERIEU	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
PGEN_.00g345420	Scaffold_18	16512307	16533849	NA	NA	NA	NA	NA
PGEN_.00g345430	Scaffold_18	16627812	16634502	NA	NA	NA	NA	NA
PGEN_.00g345440	Scaffold_18	16658814	16661565	NA	NA	NA	NA	NA
PGEN_.00g345450	Scaffold_18	16661774	16663632	NA	NA	NA	NA	NA
PGEN_.00g345460	Scaffold_18	16669387	16686743	NA	NA	NA	NA	NA
PGEN_.00g345470	Scaffold_18	16694920	16725049	F1NWE3	PTPRS_CHICK	Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha)	GO:0004725; GO:0005886; GO:0005887; GO:0006470; GO:0008201; GO:0030054; GO:0030285; GO:0030424; GO:0030426; GO:0030517; GO:0035335; GO:0042803; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0099061; GO:0099560	axon [GO:0030424]; cell junction [GO:0030054]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]
PGEN_.00g345480	Scaffold_18	16758076	16758429	NA	NA	NA	NA	NA
PGEN_.00g345490	Scaffold_18	16799765	16821200	P28827	PTPRM_HUMAN	Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)	GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0005913; GO:0006470; GO:0007156; GO:0007165; GO:0010596; GO:0010842; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042493; GO:0042802; GO:0045296; GO:0048471; GO:0097755	cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]
PGEN_.00g345500	Scaffold_18	16891780	16912742	P28828	PTPRM_MOUSE	Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)	GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005913; GO:0006470; GO:0007156; GO:0007165; GO:0010596; GO:0010842; GO:0016021; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042493; GO:0042802; GO:0045296; GO:0048471; GO:0097755	cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]
PGEN_.00g345510	Scaffold_18	16966403	16977710	Q9W0A0	DRPR_DROME	Protein draper	GO:0001786; GO:0001891; GO:0005737; GO:0005886; GO:0005938; GO:0006909; GO:0006911; GO:0008345; GO:0016021; GO:0016322; GO:0030054; GO:0030424; GO:0031224; GO:0035071; GO:0035212; GO:0042742; GO:0043277; GO:0043652; GO:0045211; GO:0045335; GO:0048190; GO:0048678; GO:0060100; GO:0098794; GO:1904396	"axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis, engulfment [GO:0006911]; positive regulation of phagocytosis, engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190]"
PGEN_.00g345520	Scaffold_18	17001384	17001902	NA	NA	NA	NA	NA
PGEN_.00g345530	Scaffold_18	17008772	17028006	Q66T72	PSIP1_FELCA	PC4 and SFRS1-interacting protein (LEDGF/p75) (Lens epithelium-derived growth factor) (Transcription coactivator p75)	GO:0000395; GO:0003682; GO:0003713; GO:0005654; GO:0005720; GO:0006979; GO:0009408; GO:0033613; GO:0035327; GO:0045944; GO:0097100	nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; mRNA 5'-splice site recognition [GO:0000395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]
PGEN_.00g345540	Scaffold_18	17032363	17044058	Q9GKL8	CATL1_CHLAE	Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]	GO:0004197; GO:0005764; GO:0046718	lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; viral entry into host cell [GO:0046718]
PGEN_.00g345550	Scaffold_18	17114579	17138569	B3EWZ3	CADN_ACRMI	Coadhesin (Fragment)	GO:0016021	integral component of membrane [GO:0016021]
PGEN_.00g345560	Scaffold_18	17139749	17140111	NA	NA	NA	NA	NA
PGEN_.00g345570	Scaffold_18	17142600	17145004	NA	NA	NA	NA	NA
PGEN_.00g345580	Scaffold_18	17155662	17156962	NA	NA	NA	NA	NA
PGEN_.00g345590	Scaffold_18	17163487	17163717	NA	NA	NA	NA	NA
PGEN_.00g345600	Scaffold_18	17167439	17175275	Q9Y6R7	FCGBP_HUMAN	IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP)	GO:0070062	extracellular exosome [GO:0070062]
PGEN_.00g345610	Scaffold_18	17182230	17190195	Q9GKL8	CATL1_CHLAE	Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]	GO:0004197; GO:0005764; GO:0046718	lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; viral entry into host cell [GO:0046718]
PGEN_.00g345620	Scaffold_18	17197384	17241952	Q66PG1	LARG2_DANRE	"LARGE xylosyl- and glucuronyltransferase 2 (EC 2.4.-.-) (Glycosyltransferase-like 1B) [Includes: Xylosyltransferase LARGE2 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE2 (EC 2.4.1.-)]"	GO:0000139; GO:0005794; GO:0006486; GO:0015020; GO:0016021; GO:0016757; GO:0035269; GO:0042285; GO:0046872	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]"
PGEN_.00g345630	Scaffold_18	17282370	17282939	NA	NA	NA	NA	NA
PGEN_.00g345640	Scaffold_18	17284996	17287117	NA	NA	NA	NA	NA
PGEN_.00g345650	Scaffold_18	17292325	17314943	Q02241	KIF23_HUMAN	Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1)	GO:0000022; GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0006890; GO:0007018; GO:0008017; GO:0016887; GO:0019886; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149	"cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"
PGEN_.00g345660	Scaffold_18	17352266	17368411	P17023	ZNF19_HUMAN	Zinc finger protein 19 (Zinc finger protein KOX12)	GO:0003700; GO:0005634; GO:0006355; GO:0043565; GO:0046872	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g345670	Scaffold_18	17369891	17372665	NA	NA	NA	NA	NA
PGEN_.00g345680	Scaffold_18	17385081	17405309	Q28944	CATL1_PIG	Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]	GO:0004175; GO:0004197; GO:0005615; GO:0005764; GO:0051603	extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteolysis involved in cellular protein catabolic process [GO:0051603]
PGEN_.00g345690	Scaffold_18	17407063	17407825	NA	NA	NA	NA	NA
PGEN_.00g345700	Scaffold_18	17414225	17427947	NA	NA	NA	NA	NA
PGEN_.00g345710	Scaffold_18	17422841	17426023	NA	NA	NA	NA	NA
PGEN_.00g345720	Scaffold_18	17468991	17482924	NA	NA	NA	NA	NA
PGEN_.00g345730	Scaffold_18	17486814	17487116	NA	NA	NA	NA	NA
PGEN_.00g345740	Scaffold_18	17487168	17487449	NA	NA	NA	NA	NA
PGEN_.00g345750	Scaffold_18	17495154	17500389	NA	NA	NA	NA	NA
PGEN_.00g345760	Scaffold_18	17570958	17571869	NA	NA	NA	NA	NA
PGEN_.00g345770	Scaffold_18	17590850	17591719	NA	NA	NA	NA	NA
PGEN_.00g345780	Scaffold_18	17613849	17629201	Q502K3	ANR52_DANRE	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C)		
PGEN_.00g345790	Scaffold_18	17635375	17636340	NA	NA	NA	NA	NA
PGEN_.00g345800	Scaffold_18	17659187	17660579	NA	NA	NA	NA	NA
PGEN_.00g345810	Scaffold_18	17661591	17662695	NA	NA	NA	NA	NA
PGEN_.00g345820	Scaffold_18	17662803	17663069	NA	NA	NA	NA	NA
PGEN_.00g345830	Scaffold_18	17663128	17664110	NA	NA	NA	NA	NA
PGEN_.00g345840	Scaffold_18	17690302	17702223	NA	NA	NA	NA	NA
PGEN_.00g345850	Scaffold_18	17748087	17748617	NA	NA	NA	NA	NA
PGEN_.00g345860	Scaffold_18	17748950	17749834	P34457	YMD3_CAEEL	Putative uncharacterized transposon-derived protein F54H12.3	GO:0003676; GO:0015074	nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]
PGEN_.00g345870	Scaffold_18	17771244	17783901	NA	NA	NA	NA	NA
PGEN_.00g345880	Scaffold_18	17792300	17792914	NA	NA	NA	NA	NA
PGEN_.00g345890	Scaffold_18	17815946	17821191	P62958	HINT1_BOVIN	Histidine triad nucleotide-binding protein 1 (EC 3.-.-.-) (17 kDa inhibitor of protein kinase C) (Adenosine 5'-monophosphoramidase) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1)	GO:0000118; GO:0000166; GO:0005737; GO:0006355; GO:0009154; GO:0016787; GO:0072332	"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g345900	Scaffold_18	17829953	17869243	Q58DK1	CPT1B_BOVIN	"Carnitine O-palmitoyltransferase 1, muscle isoform (CPT1-M) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, muscle isoform) (CPT I) (CPTI-M) (Carnitine palmitoyltransferase 1B)"	GO:0004095; GO:0005739; GO:0005741; GO:0006635; GO:0009437; GO:0015909; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid transport [GO:0015909]
PGEN_.00g345910	Scaffold_18	17898260	17898577	NA	NA	NA	NA	NA
PGEN_.00g345920	Scaffold_18	17901343	17905056	NA	NA	NA	NA	NA
PGEN_.00g345930	Scaffold_18	17909363	17913733	P0DPH8	TBA3D_HUMAN	Tubulin alpha-3D chain (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain]	GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
PGEN_.00g345940	Scaffold_18	17930520	17938207	NA	NA	NA	NA	NA
PGEN_.00g345950	Scaffold_18	17945341	17953909	NA	NA	NA	NA	NA
PGEN_.00g345960	Scaffold_18	17955260	17955661	NA	NA	NA	NA	NA
PGEN_.00g345970	Scaffold_18	17968831	18005389	Q32MH5	F214A_HUMAN	Protein FAM214A		
PGEN_.00g345980	Scaffold_18	18039268	18039852	NA	NA	NA	NA	NA
PGEN_.00g345990	Scaffold_18	18054920	18068777	NA	NA	NA	NA	NA
PGEN_.00g346000	Scaffold_18	18077907	18078227	NA	NA	NA	NA	NA
PGEN_.00g346010	Scaffold_18	18078263	18080778	NA	NA	NA	NA	NA
PGEN_.00g346020	Scaffold_18	18080884	18081153	NA	NA	NA	NA	NA
PGEN_.00g346030	Scaffold_18	18081463	18081690	NA	NA	NA	NA	NA
PGEN_.00g346040	Scaffold_18	18081911	18084686	NA	NA	NA	NA	NA
PGEN_.00g346050	Scaffold_18	18084754	18085110	NA	NA	NA	NA	NA
PGEN_.00g346060	Scaffold_18	18118811	18130823	NA	NA	NA	NA	NA
PGEN_.00g346070	Scaffold_18	18135375	18135626	NA	NA	NA	NA	NA
PGEN_.00g346080	Scaffold_18	18204652	18206903	NA	NA	NA	NA	NA
PGEN_.00g346090	Scaffold_18	18210872	18211084	NA	NA	NA	NA	NA
PGEN_.00g346100	Scaffold_18	18214371	18214781	NA	NA	NA	NA	NA
PGEN_.00g346110	Scaffold_18	18232242	18243578	NA	NA	NA	NA	NA
PGEN_.00g346120	Scaffold_18	18301490	18343193	NA	NA	NA	NA	NA
PGEN_.00g346130	Scaffold_18	18376584	18398582	NA	NA	NA	NA	NA
PGEN_.00g346140	Scaffold_18	18399540	18401964	NA	NA	NA	NA	NA
PGEN_.00g346150	Scaffold_18	18431843	18471558	Q60420	HTF4_MESAU	Transcription factor 12 (TCF-12) (Beta-cell E-box transcriptional activator 1) (BETA1) (DNA-binding protein HTF4) (E-box-binding protein) (Transcription factor HTF-4) (Fragment)	GO:0005634; GO:0045666; GO:0046982; GO:0070888	nucleus [GO:0005634]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; positive regulation of neuron differentiation [GO:0045666]
PGEN_.00g346160	Scaffold_18	18480917	18485752	NA	NA	NA	NA	NA
PGEN_.00g346170	Scaffold_18	18492408	18493460	NA	NA	NA	NA	NA
PGEN_.00g346180	Scaffold_18	18500080	18500577	NA	NA	NA	NA	NA
PGEN_.00g346190	Scaffold_18	18502200	18504916	NA	NA	NA	NA	NA
PGEN_.00g346200	Scaffold_18	18508891	18579038	Q6A098	SBP2L_MOUSE	Selenocysteine insertion sequence-binding protein 2-like (SECIS-binding protein 2-like)	GO:0001514; GO:0003730; GO:0035368; GO:0043021; GO:1990904	ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514]
PGEN_.00g346210	Scaffold_18	18568813	18572192	P41809	HKR1_YEAST	Signaling mucin HKR1 (Hansenula MRAKII killer toxin-resistant protein 1)	GO:0000282; GO:0001402; GO:0005034; GO:0005576; GO:0005886; GO:0005887; GO:0006075; GO:0006972; GO:0007232; GO:0030010; GO:0030427; GO:0031505	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; osmosensor activity [GO:0005034]; (1->3)-beta-D-glucan biosynthetic process [GO:0006075]; cellular bud site selection [GO:0000282]; establishment of cell polarity [GO:0030010]; fungal-type cell wall organization [GO:0031505]; hyperosmotic response [GO:0006972]; osmosensory signaling pathway via Sho1 osmosensor [GO:0007232]; signal transduction involved in filamentous growth [GO:0001402]
PGEN_.00g346220	Scaffold_18	18593513	18610959	A8WQK3	ACH1_CAEBR	Acetylcholine receptor subunit alpha-type acr-16	GO:0004888; GO:0005887; GO:0007165; GO:0007268; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]
PGEN_.00g346230	Scaffold_18	18619655	18636732	Q9QW30	NOTC2_RAT	Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]	GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0005929; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045967; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0072602; GO:1990705; GO:2000249; GO:2001204	cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]
PGEN_.00g346240	Scaffold_18	18657549	18661971	NA	NA	NA	NA	NA
PGEN_.00g346250	Scaffold_18	18682835	18683041	NA	NA	NA	NA	NA
PGEN_.00g346260	Scaffold_18	18683165	18683419	NA	NA	NA	NA	NA
PGEN_.00g346270	Scaffold_18	18683450	18683962	NA	NA	NA	NA	NA
PGEN_.00g346280	Scaffold_18	18684006	18684716	NA	NA	NA	NA	NA
PGEN_.00g346290	Scaffold_18	18684840	18694133	Q9NZ08	ERAP1_HUMAN	Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator)	GO:0001525; GO:0002250; GO:0002474; GO:0004177; GO:0005138; GO:0005151; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0006508; GO:0006509; GO:0008217; GO:0008235; GO:0008270; GO:0009617; GO:0016020; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0045088; GO:0045444; GO:0045766; GO:0070006; GO:0070062	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; aminopeptidase activity [GO:0004177]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]"
PGEN_.00g346300	Scaffold_18	18696774	18697629	NA	NA	NA	NA	NA
PGEN_.00g346310	Scaffold_18	18730662	18756454	NA	NA	NA	NA	NA
PGEN_.00g346320	Scaffold_18	18758138	18782651	NA	NA	NA	NA	NA
PGEN_.00g346330	Scaffold_18	18789752	18790462	NA	NA	NA	NA	NA
PGEN_.00g346340	Scaffold_18	18818188	18823428	Q9D0F3	LMAN1_MOUSE	Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Lectin mannose-binding 1) (p58)	GO:0000139; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0007029; GO:0007030; GO:0010638; GO:0015031; GO:0016021; GO:0030017; GO:0030134; GO:0033116; GO:0042802; GO:0043231; GO:0044220; GO:0046872; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; sarcomere [GO:0030017]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of organelle organization [GO:0010638]; protein transport [GO:0015031]
PGEN_.00g346350	Scaffold_18	18842248	18842580	NA	NA	NA	NA	NA
PGEN_.00g346360	Scaffold_18	18844012	18844623	NA	NA	NA	NA	NA
PGEN_.00g346370	Scaffold_18	18845089	18845493	NA	NA	NA	NA	NA
PGEN_.00g346380	Scaffold_18	18855556	18855768	NA	NA	NA	NA	NA
PGEN_.00g346390	Scaffold_18	18855960	18856304	NA	NA	NA	NA	NA
PGEN_.00g346400	Scaffold_18	18871754	18876779	NA	NA	NA	NA	NA
PGEN_.00g346410	Scaffold_18	18877160	18916557	NA	NA	NA	NA	NA
PGEN_.00g346420	Scaffold_18	18927443	18945533	Q96RW7	HMCN1_HUMAN	Hemicentin-1 (Fibulin-6) (FIBL-6)	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]
PGEN_.00g346430	Scaffold_18	19013013	19049609	NA	NA	NA	NA	NA
PGEN_.00g346440	Scaffold_18	19110138	19120777	P16157	ANK1_HUMAN	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]
PGEN_.00g346450	Scaffold_18	19131971	19132309	NA	NA	NA	NA	NA
PGEN_.00g346460	Scaffold_18	19132502	19136621	NA	NA	NA	NA	NA
PGEN_.00g346470	Scaffold_18	19146484	19148772	Q9Y2C9	TLR6_HUMAN	Toll-like receptor 6 (CD antigen CD286)	GO:0001540; GO:0001774; GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005102; GO:0005623; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0007250; GO:0010628; GO:0030670; GO:0034136; GO:0034150; GO:0035355; GO:0035663; GO:0035666; GO:0038023; GO:0038124; GO:0042496; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043507; GO:0045087; GO:0045121; GO:0045410; GO:0045429; GO:0046209; GO:0046982; GO:0050702; GO:0051092; GO:0071723; GO:0071726; GO:0140052; GO:1900017; GO:1900227; GO:1903223; GO:1903428; GO:1904646; GO:2000483	cell [GO:0005623]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; nitric oxide metabolic process [GO:0046209]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]
PGEN_.00g346480	Scaffold_18	19218195	19240167	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g346490	Scaffold_18	19250982	19256600	NA	NA	NA	NA	NA
PGEN_.00g346500	Scaffold_18	19366714	19367067	NA	NA	NA	NA	NA
PGEN_.00g346510	Scaffold_18	19381520	19384843	Q96P65	QRFPR_HUMAN	Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)	GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186]
PGEN_.00g346520	Scaffold_18	19507080	19507325	NA	NA	NA	NA	NA
PGEN_.00g346530	Scaffold_18	19515724	19578973	P43146	DCC_HUMAN	Netrin receptor DCC (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC)	GO:0001764; GO:0004888; GO:0005042; GO:0005829; GO:0005886; GO:0006915; GO:0007409; GO:0007411; GO:0010977; GO:0021965; GO:0030424; GO:0033563; GO:0033564; GO:0048671; GO:0097192; GO:0098685; GO:0099061; GO:0099170; GO:1901214; GO:1902842; GO:2000171	axon [GO:0030424]; cytosol [GO:0005829]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; netrin receptor activity [GO:0005042]; transmembrane signaling receptor activity [GO:0004888]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dorsal/ventral axon guidance [GO:0033563]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of netrin-activated signaling pathway [GO:1902842]; negative regulation of neuron projection development [GO:0010977]; neuron migration [GO:0001764]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of neuron death [GO:1901214]; spinal cord ventral commissure morphogenesis [GO:0021965]
PGEN_.00g346540	Scaffold_18	19584467	19585540	NA	NA	NA	NA	NA
PGEN_.00g346550	Scaffold_18	19593857	19608017	Q28XE2	AN32A_DROPS	Acidic leucine-rich nuclear phosphoprotein 32 family member A	GO:0005634; GO:0005737; GO:0005783; GO:0006913; GO:0048471	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nucleocytoplasmic transport [GO:0006913]
PGEN_.00g346560	Scaffold_18	19610984	19645314	Q6V1X1	DPP8_HUMAN	Dipeptidyl peptidase 8 (DP8) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 1) (DPRP-1) (Dipeptidyl peptidase VIII) (DPP VIII) (Prolyl dipeptidase DPP8)	GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006955; GO:0008236; GO:0008239	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; immune response [GO:0006955]; proteolysis [GO:0006508]
PGEN_.00g346570	Scaffold_18	19666886	19682639	NA	NA	NA	NA	NA
PGEN_.00g346580	Scaffold_18	19688675	19693175	NA	NA	NA	NA	NA
PGEN_.00g346590	Scaffold_18	19707524	19711889	A9JR56	C42S2_DANRE	CDC42 small effector protein 2	GO:0005737; GO:0005856; GO:0005886; GO:0008360; GO:0009966; GO:0017048; GO:0035023	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; Rho GTPase binding [GO:0017048]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of signal transduction [GO:0009966]
PGEN_.00g346600	Scaffold_18	19713609	19715879	NA	NA	NA	NA	NA
PGEN_.00g346610	Scaffold_18	19732558	19763583	Q7TMK9	HNRPQ_MOUSE	"Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68)"	GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006397; GO:0008143; GO:0008380; GO:0017148; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0097452; GO:1990904	catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; RNA splicing [GO:0008380]
PGEN_.00g346620	Scaffold_18	19781324	19787486	NA	NA	NA	NA	NA
PGEN_.00g346630	Scaffold_18	19794787	19795749	NA	NA	NA	NA	NA
PGEN_.00g346640	Scaffold_18	19796055	19796501	NA	NA	NA	NA	NA
PGEN_.00g346650	Scaffold_18	19797104	19797382	NA	NA	NA	NA	NA
PGEN_.00g346660	Scaffold_18	19797615	19798988	Q8I335	GUF1_PLAF7	"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)"	GO:0003924; GO:0005525; GO:0005743; GO:0006412	mitochondrial inner membrane [GO:0005743]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation [GO:0006412]
PGEN_.00g346670	Scaffold_18	19799403	19815638	Q6AX44	FBCDA_XENLA	Fibrinogen C domain-containing protein 1-A	GO:0008061; GO:0016021; GO:0046872	integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
PGEN_.00g346680	Scaffold_18	19824667	19825077	NA	NA	NA	NA	NA
PGEN_.00g346690	Scaffold_18	19825372	19825965	NA	NA	NA	NA	NA
PGEN_.00g346700	Scaffold_18	19826289	19827017	NA	NA	NA	NA	NA
PGEN_.00g346710	Scaffold_18	19827311	19827562	NA	NA	NA	NA	NA
PGEN_.00g346720	Scaffold_18	19831355	19837537	P24051	RS27L_RAT	40S ribosomal protein S27-like	GO:0000028; GO:0003735; GO:0005634; GO:0006412; GO:0006919; GO:0006978; GO:0008494; GO:0008656; GO:0022627; GO:0031571; GO:0042771; GO:0045727; GO:0046872	"cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation activator activity [GO:0008494]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G1 DNA damage checkpoint [GO:0031571]; positive regulation of translation [GO:0045727]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"
PGEN_.00g346730	Scaffold_18	19839437	19842188	NA	NA	NA	NA	NA
PGEN_.00g346740	Scaffold_18	19850686	19854635	Q8MYF2	RABJ_DICDI	Ras-related protein RabJ	GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0032482	plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g346750	Scaffold_18	19855702	19864992	NA	NA	NA	NA	NA
PGEN_.00g346760	Scaffold_18	19882438	19882773	NA	NA	NA	NA	NA
PGEN_.00g346770	Scaffold_18	19886904	19888848	NA	NA	NA	NA	NA
PGEN_.00g346780	Scaffold_18	19893449	19893841	NA	NA	NA	NA	NA
PGEN_.00g346790	Scaffold_18	19900741	19901220	NA	NA	NA	NA	NA
PGEN_.00g346800	Scaffold_18	19901264	19907548	NA	NA	NA	NA	NA
PGEN_.00g346810	Scaffold_18	19924339	19931104	NA	NA	NA	NA	NA
PGEN_.00g346820	Scaffold_18	19955299	19963839	NA	NA	NA	NA	NA
PGEN_.00g346830	Scaffold_18	20013750	20050790	NA	NA	NA	NA	NA
PGEN_.00g346840	Scaffold_18	20093157	20122815	Q49B93	SC5AC_MOUSE	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]
PGEN_.00g346850	Scaffold_18	20132118	20164890	Q8IV35	WDR49_HUMAN	WD repeat-containing protein 49		
PGEN_.00g346860	Scaffold_18	20242205	20250733	NA	NA	NA	NA	NA
PGEN_.00g346870	Scaffold_18	20288955	20290058	Q866F1	FUT1_SAISC	"Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]
PGEN_.00g346880	Scaffold_18	20310841	20311509	Q7LGC8	CHST3_HUMAN	Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0)	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008146; GO:0008459; GO:0016021; GO:0030206	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]
PGEN_.00g346890	Scaffold_18	20349536	20416963	NA	NA	NA	NA	NA
PGEN_.00g346900	Scaffold_18	20434141	20498651	Q9ER47	KCNH7_MOUSE	Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (Voltage-gated potassium channel subunit Kv11.3)	GO:0005242; GO:0005249; GO:0005267; GO:0005887; GO:0006813; GO:0034765; GO:0042391; GO:0044877; GO:0071805	integral component of plasma membrane [GO:0005887]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]
PGEN_.00g346910	Scaffold_18	20665256	20665785	NA	NA	NA	NA	NA
PGEN_.00g346920	Scaffold_18	20665820	20666092	NA	NA	NA	NA	NA
PGEN_.00g346930	Scaffold_18	20666270	20666539	NA	NA	NA	NA	NA
PGEN_.00g346940	Scaffold_18	20666655	20666996	NA	NA	NA	NA	NA
PGEN_.00g346950	Scaffold_18	20685133	20689811	Q5SVQ8	ZBT41_HUMAN	Zinc finger and BTB domain-containing protein 41	GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]
PGEN_.00g346960	Scaffold_18	20699756	20710158	NA	NA	NA	NA	NA
PGEN_.00g346970	Scaffold_18	20710613	20730196	Q8IWY8	ZSC29_HUMAN	Zinc finger and SCAN domain-containing protein 29 (Zinc finger protein 690)	GO:0003677; GO:0003700; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]
PGEN_.00g346980	Scaffold_18	20730308	20733181	NA	NA	NA	NA	NA
PGEN_.00g346990	Scaffold_18	20743070	20743414	NA	NA	NA	NA	NA
PGEN_.00g347000	Scaffold_18	20743485	20744480	NA	NA	NA	NA	NA
PGEN_.00g347010	Scaffold_18	20768496	20772185	NA	NA	NA	NA	NA
PGEN_.00g347020	Scaffold_18	20773250	20789855	Q589G5	PRTG_CHICK	Protogenin	GO:0007275; GO:0016021	integral component of membrane [GO:0016021]; multicellular organism development [GO:0007275]
PGEN_.00g347030	Scaffold_18	20939239	20945584	Q4V7F0	TTC23_RAT	Tetratricopeptide repeat protein 23 (TPR repeat protein 23)	GO:0005929; GO:0045880	cilium [GO:0005929]; positive regulation of smoothened signaling pathway [GO:0045880]
PGEN_.00g347040	Scaffold_18	20957623	20975489	P83095	LACTB_BOVIN	"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)"	GO:0005739; GO:0006508; GO:0006629; GO:0008233; GO:0019216	mitochondrion [GO:0005739]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]
PGEN_.00g347050	Scaffold_18	20985419	20991605	NA	NA	NA	NA	NA
PGEN_.00g347060	Scaffold_18	20998088	20999544	NA	NA	NA	NA	NA
PGEN_.00g347070	Scaffold_18	21003078	21017720	Q5F364	MRP1_CHICK	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	GO:0005524; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]
PGEN_.00g347080	Scaffold_18	21108351	21108695	NA	NA	NA	NA	NA
PGEN_.00g347090	Scaffold_18	21196848	21198251	NA	NA	NA	NA	NA
PGEN_.00g347100	Scaffold_18	21297255	21297617	NA	NA	NA	NA	NA
PGEN_.00g347110	Scaffold_18	21374374	21375063	P17342	ANPRC_HUMAN	Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C)	GO:0001501; GO:0002158; GO:0005887; GO:0007193; GO:0007194; GO:0007200; GO:0008217; GO:0008528; GO:0016941; GO:0017046; GO:0030157; GO:0031404; GO:0032991; GO:0033688; GO:0035810; GO:0042277; GO:0042562; GO:0042803; GO:0048015; GO:0048662; GO:0051000; GO:0070062; GO:0120163	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991]; chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoclast proliferation [GO:0002158]; pancreatic juice secretion [GO:0030157]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; skeletal system development [GO:0001501]
PGEN_.00g347120	Scaffold_18	21398019	21398711	NA	NA	NA	NA	NA
PGEN_.00g347130	Scaffold_18	21465612	21466340	P70180	ANPRC_MOUSE	Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C) (EF-2)	GO:0001501; GO:0002158; GO:0007193; GO:0007194; GO:0007200; GO:0008217; GO:0008528; GO:0016020; GO:0016021; GO:0016941; GO:0017046; GO:0030157; GO:0031404; GO:0032991; GO:0033688; GO:0035810; GO:0042277; GO:0042562; GO:0042802; GO:0042803; GO:0048015; GO:0048662; GO:0051000; GO:0120163	integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoclast proliferation [GO:0002158]; pancreatic juice secretion [GO:0030157]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; skeletal system development [GO:0001501]
PGEN_.00g347140	Scaffold_18	21525282	21532725	P16066	ANPRA_HUMAN	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]
PGEN_.00g347150	Scaffold_18	21569324	21578984	P16066	ANPRA_HUMAN	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]
PGEN_.00g347160	Scaffold_18	21606111	21670307	Q86GV3	GCY28_CAEEL	Receptor-type guanylate cyclase gcy-28 (EC 4.6.1.2) (GCY-X1)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006935; GO:0007165; GO:0007168; GO:0007606; GO:0016021; GO:0030424; GO:0030425; GO:0035556; GO:0042048; GO:0043005; GO:0043204; GO:0044297; GO:0046872; GO:0050893	axon [GO:0030424]; cell body [GO:0044297]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; olfactory behavior [GO:0042048]; receptor guanylyl cyclase signaling pathway [GO:0007168]; sensory perception of chemical stimulus [GO:0007606]; sensory processing [GO:0050893]; signal transduction [GO:0007165]
PGEN_.00g347170	Scaffold_18	21678191	21704069	P18293	ANPRA_MOUSE	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043235; GO:0048662	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]
PGEN_.00g347180	Scaffold_18	21788349	21789467	NA	NA	NA	NA	NA
PGEN_.00g347190	Scaffold_18	21827116	21849186	Q967R6	CPEB_APLCA	Cytoplasmic polyadenylation element-binding protein (CPE-binding protein) (CPEB)	GO:0003729; GO:0003730; GO:0008494; GO:0030054; GO:0032880; GO:0042802; GO:0043005; GO:0045182; GO:0045727; GO:0048167; GO:0071598; GO:0099154; GO:0099547	"cell junction [GO:0030054]; neuron projection [GO:0043005]; neuronal ribonucleoprotein granule [GO:0071598]; serotonergic synapse [GO:0099154]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; translation activator activity [GO:0008494]; translation regulator activity [GO:0045182]; positive regulation of translation [GO:0045727]; regulation of protein localization [GO:0032880]; regulation of synaptic plasticity [GO:0048167]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]"
PGEN_.00g347200	Scaffold_18	21854620	21862055	NA	NA	NA	NA	NA
PGEN_.00g347210	Scaffold_18	21868114	21870165	NA	NA	NA	NA	NA
PGEN_.00g347220	Scaffold_18	21871329	21876186	NA	NA	NA	NA	NA
PGEN_.00g347230	Scaffold_18	21880210	21889751	NA	NA	NA	NA	NA
PGEN_.00g347240	Scaffold_18	21897842	21898690	NA	NA	NA	NA	NA
PGEN_.00g347250	Scaffold_18	21903749	21909235	NA	NA	NA	NA	NA
PGEN_.00g347260	Scaffold_18	21912374	21938343	NA	NA	NA	NA	NA
PGEN_.00g347270	Scaffold_18	21938430	21953649	NA	NA	NA	NA	NA
PGEN_.00g347280	Scaffold_18	21967452	21982540	NA	NA	NA	NA	NA
PGEN_.00g347290	Scaffold_18	21984989	21986306	NA	NA	NA	NA	NA
PGEN_.00g347300	Scaffold_18	21989588	21993387	NA	NA	NA	NA	NA
PGEN_.00g347310	Scaffold_18	21994219	22001885	NA	NA	NA	NA	NA
PGEN_.00g347320	Scaffold_18	22008534	22019855	O55176	PJA1_MOUSE	E3 ubiquitin-protein ligase Praja-1 (Praja1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Praja-1)	GO:0005737; GO:0016567; GO:0030163; GO:0046872; GO:0061630	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]
PGEN_.00g347330	Scaffold_18	22025114	22025464	NA	NA	NA	NA	NA
PGEN_.00g347340	Scaffold_18	22034428	22035486	NA	NA	NA	NA	NA
PGEN_.00g347350	Scaffold_18	22035534	22035983	NA	NA	NA	NA	NA
PGEN_.00g347360	Scaffold_18	22046454	22046747	NA	NA	NA	NA	NA
PGEN_.00g347370	Scaffold_18	22051614	22051901	NA	NA	NA	NA	NA
PGEN_.00g347380	Scaffold_18	22060567	22061373	NA	NA	NA	NA	NA
PGEN_.00g347390	Scaffold_18	22061509	22062303	NA	NA	NA	NA	NA
PGEN_.00g347400	Scaffold_18	22084948	22096875	G5EFC3	KCNAG_CAEEL	Potassium voltage-gated channel protein egl-36 (Egg-laying defective protein 36)	GO:0005244; GO:0005249; GO:0005251; GO:0008076; GO:0016021; GO:0030424; GO:0032590; GO:0032809; GO:0034220; GO:0034765; GO:0043025; GO:0051260; GO:0071805	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]
PGEN_.00g347410	Scaffold_18	22108834	22110573	NA	NA	NA	NA	NA
PGEN_.00g347420	Scaffold_18	22203750	22209057	NA	NA	NA	NA	NA
PGEN_.00g347430	Scaffold_18	22227976	22230390	NA	NA	NA	NA	NA
PGEN_.00g347440	Scaffold_18	22240592	22240834	NA	NA	NA	NA	NA
PGEN_.00g347450	Scaffold_18	22240928	22241200	NA	NA	NA	NA	NA
PGEN_.00g347460	Scaffold_18	22257979	22258290	NA	NA	NA	NA	NA
PGEN_.00g347470	Scaffold_18	22258756	22258962	NA	NA	NA	NA	NA
PGEN_.00g347480	Scaffold_18	22269329	22290069	Q8TB03	CX038_HUMAN	Uncharacterized protein CXorf38		
PGEN_.00g347490	Scaffold_18	22305373	22305642	NA	NA	NA	NA	NA
PGEN_.00g347500	Scaffold_18	22306178	22306471	NA	NA	NA	NA	NA
PGEN_.00g347510	Scaffold_18	22306724	22306996	NA	NA	NA	NA	NA
PGEN_.00g347520	Scaffold_18	22310143	22310367	NA	NA	NA	NA	NA
PGEN_.00g347530	Scaffold_18	22321353	22326764	NA	NA	NA	NA	NA
PGEN_.00g347540	Scaffold_18	22338096	22344816	Q99676	ZN184_HUMAN	Zinc finger protein 184	GO:0003677; GO:0005634; GO:0006355; GO:0008270	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"
PGEN_.00g347550	Scaffold_18	22372281	22385406	P40818	UBP8_HUMAN	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]"
PGEN_.00g347560	Scaffold_18	22388620	22394210	Q14696	MESD_HUMAN	LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development LRP chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein) (Renal carcinoma antigen NY-REN-61)	GO:0005783; GO:0005886; GO:0006457; GO:0006909; GO:0007498; GO:0016055; GO:0034394; GO:0042802; GO:0050750; GO:1904395	endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; mesoderm development [GO:0007498]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055]
PGEN_.00g347570	Scaffold_18	22411405	22413742	P23640	RB27A_RAT	Ras-related protein Rab-27A (Rab-27) (EC 3.6.5.2) (GTP-binding protein Ram) (Ram p25)	GO:0001750; GO:0003924; GO:0005525; GO:0005623; GO:0005764; GO:0005770; GO:0005794; GO:0006605; GO:0006886; GO:0006887; GO:0007596; GO:0010628; GO:0016192; GO:0016324; GO:0019003; GO:0019882; GO:0019904; GO:0030141; GO:0030318; GO:0030425; GO:0030667; GO:0031489; GO:0032400; GO:0032402; GO:0032482; GO:0032585; GO:0033093; GO:0036257; GO:0042470; GO:0043316; GO:0043320; GO:0043473; GO:0045921; GO:0050766; GO:0051875; GO:0051904; GO:0070382; GO:0071985; GO:0097278; GO:1903307; GO:1903428; GO:1903435; GO:1990182	apical plasma membrane [GO:0016324]; cell [GO:0005623]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; Weibel-Palade body [GO:0033093]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular protein transport [GO:0006886]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; pigment granule localization [GO:0051875]; pigment granule transport [GO:0051904]; pigmentation [GO:0043473]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192]
PGEN_.00g347580	Scaffold_18	22435815	22453283	P0C6Y7	PRDM9_RAT	Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.-) (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-)	GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0006311; GO:0007129; GO:0007283; GO:0007292; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0031490; GO:0034968; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044212; GO:0044648; GO:0045893; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255	"chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; nucleosome positioning [GO:0016584]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]"
PGEN_.00g347590	Scaffold_18	22460017	22466015	NA	NA	NA	NA	NA
PGEN_.00g347600	Scaffold_18	22474032	22483886	NA	NA	NA	NA	NA
PGEN_.00g347610	Scaffold_18	22486595	22513371	G5EBQ8	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0030428; GO:0061063	cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]
PGEN_.00g347620	Scaffold_18	22630968	22634867	NA	NA	NA	NA	NA
PGEN_.00g347630	Scaffold_18	22662533	22693622	Q7TSY6	CELF4_MOUSE	CUGBP Elav-like family member 4 (CELF-4) (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4)	GO:0000380; GO:0000381; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0036002; GO:0042835; GO:0048025; GO:0048026; GO:0090394; GO:1902866; GO:1990904	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; BRE binding [GO:0042835]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; in utero embryonic development [GO:0001701]; mRNA splice site selection [GO:0006376]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of retina development in camera-type eye [GO:1902866]"
PGEN_.00g347640	Scaffold_18	22710280	22712152	B1H1X1	FXL17_XENLA	F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17)	GO:0000209; GO:0005634; GO:0005737; GO:0006515; GO:0007399; GO:0008589; GO:0014033; GO:0016567; GO:0019005; GO:0031146; GO:0043161	cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g347650	Scaffold_18	22718509	22724812	Q9QZN1	FXL17_MOUSE	F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17) (F-box only protein 13)	GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0006515; GO:0007399; GO:0008589; GO:0014033; GO:0016567; GO:0019005; GO:0031146; GO:0043161	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
PGEN_.00g347660	Scaffold_18	22740571	22744049	Q7ZWG6	PCFT_DANRE	Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)	GO:0005542; GO:0016021; GO:0055085	integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]
PGEN_.00g347670	Scaffold_18	22751595	22753734	Q9ES30	C1QT3_MOUSE	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	GO:0005576; GO:0005581; GO:0005615; GO:0005623; GO:0010629; GO:0032991; GO:0035356; GO:0042593; GO:0042802; GO:0045721; GO:0050715; GO:0050728; GO:0051897; GO:0070165; GO:0070206; GO:0070374; GO:0071638; GO:1900165; GO:1901223	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; cellular triglyceride homeostasis [GO:0035356]; glucose homeostasis [GO:0042593]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; protein trimerization [GO:0070206]
PGEN_.00g347680	Scaffold_18	22766613	22766957	NA	NA	NA	NA	NA
PGEN_.00g347690	Scaffold_18	22780768	22802518	A7RJI7	CCZ1_NEMVE	Vacuolar fusion protein CCZ1 homolog	GO:0016192; GO:0035658; GO:0043231	intracellular membrane-bounded organelle [GO:0043231]; Mon1-Ccz1 complex [GO:0035658]; vesicle-mediated transport [GO:0016192]
PGEN_.00g347700	Scaffold_18	22827462	22828821	NA	NA	NA	NA	NA
PGEN_.00g347710	Scaffold_18	22835749	22838975	NA	NA	NA	NA	NA
PGEN_.00g347720	Scaffold_18	22911452	22911751	NA	NA	NA	NA	NA
PGEN_.00g347730	Scaffold_18	22913328	22914711	NA	NA	NA	NA	NA
PGEN_.00g347740	Scaffold_18	22918150	22918455	NA	NA	NA	NA	NA
PGEN_.00g347750	Scaffold_18	22923652	22926778	NA	NA	NA	NA	NA
PGEN_.00g347760	Scaffold_18	22952578	22954824	B9UYK5	NS1_HBOC2	Initiator protein NS1 (NS1) (EC 3.1.21.-) (EC 3.6.4.12) (Non-structural protein 1) (Non-structural protein NS1)	GO:0003677; GO:0003678; GO:0004519; GO:0005524; GO:0006260; GO:0039693; GO:0042025; GO:0046872	host cell nucleus [GO:0042025]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; viral DNA genome replication [GO:0039693]
PGEN_.00g347770	Scaffold_18	22980555	22980854	NA	NA	NA	NA	NA
PGEN_.00g347780	Scaffold_18	23031546	23047175	Q6P5M2	WDR61_DANRE	WD repeat-containing protein 61	GO:0005634; GO:0005737; GO:0016593; GO:0032968; GO:0035327; GO:0045944; GO:0055087	Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]
PGEN_.00g347790	Scaffold_18	23038812	23039380	NA	NA	NA	NA	NA
PGEN_.00g347800	Scaffold_18	23093301	23101820	NA	NA	NA	NA	NA
PGEN_.00g347810	Scaffold_18	23105476	23149349	Q80V70	MEGF6_MOUSE	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	GO:0005509; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]
PGEN_.00g347820	Scaffold_18	23148534	23149392	NA	NA	NA	NA	NA
PGEN_.00g347830	Scaffold_18	23161531	23164206	NA	NA	NA	NA	NA
PGEN_.00g347840	Scaffold_18	23170960	23176449	NA	NA	NA	NA	NA
PGEN_.00g347850	Scaffold_18	23189008	23197589	B3EWZ5	MLRP1_ACRMI	MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)	GO:0005576; GO:0016020	extracellular region [GO:0005576]; membrane [GO:0016020]
PGEN_.00g347860	Scaffold_18	23200443	23201789	O93603	TRFR_CHICK	Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor)	GO:0004997; GO:0005886; GO:0007200; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyrotropin-releasing hormone receptor activity [GO:0004997]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]
PGEN_.00g347870	Scaffold_18	23236795	23245269	Q9QZ85	IIGP1_MOUSE	Interferon-inducible GTPase 1 (EC 3.6.5.-)	GO:0003924; GO:0005525; GO:0005789; GO:0006952; GO:0009617; GO:0010506; GO:0019003; GO:0019221; GO:0020005; GO:0031965; GO:0032580; GO:0035458; GO:0042802; GO:0042832; GO:0045087; GO:0050829	endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]
PGEN_.00g347880	Scaffold_18	23254628	23271150	NA	NA	NA	NA	NA
PGEN_.00g347890	Scaffold_18	23285051	23301363	Q2KHR2	RFX7_HUMAN	DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2)	GO:0000790; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357	"nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"
PGEN_.00g347900	Scaffold_18	23302157	23317099	Q9D845	TEX9_MOUSE	Testis-expressed protein 9 (Testis-specifically expressed protein 1) (Tsec-1)		
PGEN_.00g347910	Scaffold_18	23317121	23334942	NA	NA	NA	NA	NA
PGEN_.00g347920	Scaffold_18	23346084	23346503	NA	NA	NA	NA	NA
PGEN_.00g347930	Scaffold_18	23441774	23443247	Q9BXJ3	C1QT4_HUMAN	Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4)	GO:0005125; GO:0005615; GO:0032755; GO:0070105; GO:1901224; GO:1904469; GO:2000778	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469]
PGEN_.00g347940	Scaffold_18	23503187	23525836	A0A0R4IBK5	R213A_DANRE	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]
PGEN_.00g347950	Scaffold_18	23568493	23568972	NA	NA	NA	NA	NA
PGEN_.00g347960	Scaffold_18	23571295	23584415	Q25605	EAAT_ONCVO	Excitatory amino acid transporter (Sodium-dependent glutamate/ aspartate transporter)	GO:0015293; GO:0016021	integral component of membrane [GO:0016021]; symporter activity [GO:0015293]
PGEN_.00g347970	Scaffold_18	23627494	23654420	Q6ZMT9	DTHD1_HUMAN	Death domain-containing protein 1	GO:0007165	signal transduction [GO:0007165]
PGEN_.00g347980	Scaffold_18	23643906	23646272	NA	NA	NA	NA	NA
PGEN_.00g347990	Scaffold_18	23659867	23669602	Q5EA66	ANGL7_BOVIN	Angiopoietin-related protein 7 (Angiopoietin-like protein 7)	GO:0005576	extracellular region [GO:0005576]
PGEN_.00g348000	Scaffold_18	23689741	23707278	NA	NA	NA	NA	NA
PGEN_.00g348010	Scaffold_18	23726427	23735785	NA	NA	NA	NA	NA
PGEN_.00g348020	Scaffold_18	23740425	23749271	NA	NA	NA	NA	NA
PGEN_.00g348030	Scaffold_18	23755241	23766168	NA	NA	NA	NA	NA
PGEN_.00g348040	Scaffold_18	23773260	23787096	A2AJ76	HMCN2_MOUSE	Hemicentin-2	GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005938; GO:0030054; GO:0031012; GO:0032154; GO:0050896; GO:0062023	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]
PGEN_.00g348050	Scaffold_18	23834357	23836528	NA	NA	NA	NA	NA
PGEN_.00g348060	Scaffold_18	23843095	23844578	NA	NA	NA	NA	NA
PGEN_.00g348070	Scaffold_18	23858367	23860223	Q9P212	PLCE1_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Pancreas-enriched phospholipase C) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1) (PLC-epsilon-1)"	GO:0000139; GO:0000187; GO:0001558; GO:0004435; GO:0004629; GO:0005085; GO:0005623; GO:0005829; GO:0005886; GO:0006651; GO:0006940; GO:0007010; GO:0007173; GO:0007200; GO:0007204; GO:0007265; GO:0007507; GO:0008277; GO:0008283; GO:0016042; GO:0017016; GO:0019722; GO:0019899; GO:0032835; GO:0032959; GO:0043647; GO:0045859; GO:0046578; GO:0046872; GO:0048015; GO:0048016; GO:0051209	cell [GO:0005623]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; Ras GTPase binding [GO:0017016]; activation of MAPK activity [GO:0000187]; calcium-mediated signaling [GO:0019722]; cell population proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; glomerulus development [GO:0032835]; heart development [GO:0007507]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; regulation of smooth muscle contraction [GO:0006940]; release of sequestered calcium ion into cytosol [GO:0051209]
PGEN_.00g348080	Scaffold_18	23874911	23876014	NA	NA	NA	NA	NA
PGEN_.00g348090	Scaffold_18	23909243	23909455	NA	NA	NA	NA	NA
PGEN_.00g348100	Scaffold_18	23909533	23909796	NA	NA	NA	NA	NA
PGEN_.00g348110	Scaffold_18	23918721	23929110	NA	NA	NA	NA	NA
PGEN_.00g348120	Scaffold_18	23948235	23957454	NA	NA	NA	NA	NA
PGEN_.00g348130	Scaffold_18	23994118	24001019	NA	NA	NA	NA	NA
PGEN_.00g348140	Scaffold_18	24002532	24004464	NA	NA	NA	NA	NA
PGEN_.00g348150	Scaffold_18	24062383	24067755	NA	NA	NA	NA	NA
PGEN_.00g348160	Scaffold_18	24073533	24123087	Q5H8C4	VP13A_MOUSE	Vacuolar protein sorting-associated protein 13A (Chorea-acanthocytosis protein homolog) (Chorein)	GO:0005623; GO:0006623; GO:0006914; GO:0007399; GO:0007626; GO:0019898; GO:0030317; GO:0030382; GO:0031045; GO:0035176; GO:0045053; GO:0097225	cell [GO:0005623]; dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; sperm midpiece [GO:0097225]; autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382]
PGEN_.00g348170	Scaffold_18	24140824	24141138	NA	NA	NA	NA	NA
PGEN_.00g348180	Scaffold_18	24141177	24141551	NA	NA	NA	NA	NA
PGEN_.00g348190	Scaffold_18	24144677	24150863	NA	NA	NA	NA	NA
PGEN_.00g348200	Scaffold_18	24158259	24162596	A0JM12	MEG10_XENTR	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	GO:0005112; GO:0005886; GO:0007155; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0043277	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Notch binding [GO:0005112]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
PGEN_.00g348210	Scaffold_18	24178600	24183275	NA	NA	NA	NA	NA
PGEN_.00g348220	Scaffold_18	24195409	24224649	Q9ES87	PRSS8_RAT	Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]	GO:0004252; GO:0005615; GO:0005886; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0042493; GO:0043434; GO:0045121; GO:0046658; GO:0051385; GO:0070633; GO:1902307	anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; response to drug [GO:0042493]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; transepithelial transport [GO:0070633]
PGEN_.00g348230	Scaffold_18	24225067	24256241	Q5R8X6	PLMN_PONAB	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
PGEN_.00g348240	Scaffold_18	24252409	24256246	NA	NA	NA	NA	NA
PGEN_.00g348250	Scaffold_18	24270554	24277018	Q9FGK5	RAA5A_ARATH	Ras-related protein RABA5a (AtRABA5a)	GO:0003924; GO:0005525; GO:0005774; GO:0005886; GO:0006886; GO:0009536; GO:0032482	plasma membrane [GO:0005886]; plastid [GO:0009536]; vacuolar membrane [GO:0005774]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g348260	Scaffold_18	24295084	24312819	P14316	IRF2_HUMAN	Interferon regulatory factor 2 (IRF-2)	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006355; GO:0007596; GO:0008283; GO:0045944; GO:0051607; GO:0060333; GO:0060337	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; blood coagulation [GO:0007596]; cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; type I interferon signaling pathway [GO:0060337]"
PGEN_.00g348270	Scaffold_18	24321405	24321974	NA	NA	NA	NA	NA
PGEN_.00g348280	Scaffold_18	24337137	24349708	P70039	APC_XENLA	Adenomatous polyposis coli homolog (Protein APC)	GO:0000281; GO:0000776; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0007026; GO:0007050; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016477; GO:0019887; GO:0030178; GO:0030877; GO:0043065; GO:0045736; GO:0065003	beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cytokinesis [GO:0000281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055]
PGEN_.00g348290	Scaffold_18	24352693	24357563	Q9Z1K7	APCL_MOUSE	Adenomatous polyposis coli protein 2	GO:0000226; GO:0001708; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005884; GO:0007026; GO:0007389; GO:0008013; GO:0008017; GO:0015630; GO:0016055; GO:0016342; GO:0016477; GO:0030496; GO:0030877; GO:0031258; GO:0045171; GO:0045295; GO:0045595; GO:0045732; GO:0048471; GO:0090090; GO:0090630; GO:0098794	actin filament [GO:0005884]; beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; activation of GTPase activity [GO:0090630]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell differentiation [GO:0045595]; Wnt signaling pathway [GO:0016055]
PGEN_.00g348300	Scaffold_18	24373999	24374739	NA	NA	NA	NA	NA
PGEN_.00g348310	Scaffold_18	24404224	24407426	P25067	CO8A2_HUMAN	Collagen alpha-2(VIII) chain (Endothelial collagen)	GO:0001525; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0030674; GO:0031012; GO:0048593; GO:0050673; GO:0062023; GO:0098609	"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein binding, bridging [GO:0030674]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]"
PGEN_.00g348320	Scaffold_18	24416866	24417237	NA	NA	NA	NA	NA
PGEN_.00g348330	Scaffold_18	24437662	24438438	NA	NA	NA	NA	NA
PGEN_.00g348340	Scaffold_18	24453070	24453312	NA	NA	NA	NA	NA
PGEN_.00g348350	Scaffold_18	24468192	24501453	NA	NA	NA	NA	NA
PGEN_.00g348360	Scaffold_18	24508303	24508893	NA	NA	NA	NA	NA
PGEN_.00g348370	Scaffold_18	24519934	24579416	NA	NA	NA	NA	NA
PGEN_.00g348380	Scaffold_18	24583114	24610539	P05099	MATN1_CHICK	Cartilage matrix protein (Matrilin-1)	GO:0003429; GO:0005201; GO:0005509; GO:0005615; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g348390	Scaffold_18	24616033	24616347	NA	NA	NA	NA	NA
PGEN_.00g348400	Scaffold_18	24630997	24692928	P10675	FAS1_SCHAM	Fasciclin-1 (Fasciclin I) (FAS I) (FCN)	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g348410	Scaffold_18	24708032	24770271	P10675	FAS1_SCHAM	Fasciclin-1 (Fasciclin I) (FAS I) (FCN)	GO:0005886; GO:0007155; GO:0031225	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]
PGEN_.00g348420	Scaffold_18	24785210	24785906	NA	NA	NA	NA	NA
PGEN_.00g348430	Scaffold_18	24790729	24818142	P05099	MATN1_CHICK	Cartilage matrix protein (Matrilin-1)	GO:0003429; GO:0005201; GO:0005509; GO:0005615; GO:0031012; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]
PGEN_.00g348440	Scaffold_18	24821845	24871985	NA	NA	NA	NA	NA
PGEN_.00g348450	Scaffold_18	24891758	24894458	NA	NA	NA	NA	NA
PGEN_.00g348460	Scaffold_18	24899205	24932487	NA	NA	NA	NA	NA
PGEN_.00g348470	Scaffold_18	24947368	24947610	NA	NA	NA	NA	NA
PGEN_.00g348480	Scaffold_18	24962242	24963018	NA	NA	NA	NA	NA
PGEN_.00g348490	Scaffold_18	24983443	24983814	NA	NA	NA	NA	NA
PGEN_.00g348500	Scaffold_18	24993254	24996452	P25067	CO8A2_HUMAN	Collagen alpha-2(VIII) chain (Endothelial collagen)	GO:0001525; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0030674; GO:0031012; GO:0048593; GO:0050673; GO:0062023; GO:0098609	"basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein binding, bridging [GO:0030674]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]"
PGEN_.00g348510	Scaffold_18	25025569	25026309	NA	NA	NA	NA	NA
PGEN_.00g348520	Scaffold_18	25043047	25063567	P70039	APC_XENLA	Adenomatous polyposis coli homolog (Protein APC)	GO:0000281; GO:0000776; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0007026; GO:0007050; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016477; GO:0019887; GO:0030178; GO:0030877; GO:0043065; GO:0045736; GO:0065003	beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cytokinesis [GO:0000281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055]
PGEN_.00g348530	Scaffold_18	25078416	25078883	NA	NA	NA	NA	NA
PGEN_.00g348540	Scaffold_18	25087498	25105232	P14316	IRF2_HUMAN	Interferon regulatory factor 2 (IRF-2)	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006355; GO:0007596; GO:0008283; GO:0045944; GO:0051607; GO:0060333; GO:0060337	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; blood coagulation [GO:0007596]; cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; type I interferon signaling pathway [GO:0060337]"
PGEN_.00g348550	Scaffold_18	25123677	25130132	Q9FGK5	RAA5A_ARATH	Ras-related protein RABA5a (AtRABA5a)	GO:0003924; GO:0005525; GO:0005774; GO:0005886; GO:0006886; GO:0009536; GO:0032482	plasma membrane [GO:0005886]; plastid [GO:0009536]; vacuolar membrane [GO:0005774]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]
PGEN_.00g348560	Scaffold_18	25143885	25175210	Q5R8X6	PLMN_PONAB	"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]"	GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
PGEN_.00g348570	Scaffold_18	25175628	25204855	Q9ES87	PRSS8_RAT	Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]	GO:0004252; GO:0005615; GO:0005886; GO:0010765; GO:0016021; GO:0017080; GO:0019897; GO:0042493; GO:0043434; GO:0045121; GO:0046658; GO:0051385; GO:0070633; GO:1902307	anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; response to drug [GO:0042493]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; transepithelial transport [GO:0070633]
PGEN_.00g348580	Scaffold_18	25225504	25248792	B2RX12	MRP3_MOUSE	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multidrug resistance-associated protein 3)	GO:0005524; GO:0005886; GO:0005887; GO:0015722; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0042908; GO:0042910; GO:0055085; GO:0098656	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transmembrane transport [GO:0098656]; canalicular bile acid transport [GO:0015722]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g348590	Scaffold_18	25255531	25283086	Q6UR05	MRP1_CANLF	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	GO:0005524; GO:0006855; GO:0008559; GO:0015431; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042493; GO:0042626; GO:0042908; GO:0042910; GO:0050729; GO:0055085; GO:0071716; GO:0140359	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ABC-type transmembrane transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled glutathione S-conjugate transmembrane transporter activity [GO:0015431]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; glutathione transmembrane transporter activity [GO:0034634]; xenobiotic transmembrane transporter activity [GO:0042910]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; leukotriene transport [GO:0071716]; positive regulation of inflammatory response [GO:0050729]; response to drug [GO:0042493]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]
PGEN_.00g348600	Scaffold_18	25295362	25311107	Q66KM5	CTSL2_XENTR	CTD small phosphatase-like protein 2 (CTDSP-like 2) (EC 3.1.3.-)	GO:0004721	phosphoprotein phosphatase activity [GO:0004721]
PGEN_.00g348610	Scaffold_18	25321168	25365174	NA	NA	NA	NA	NA
PGEN_.00g348620	Scaffold_18	25403332	25420994	Q4N4N8	TXND_THEPA	Thioredoxin domain-containing protein (Membrane protein 23) (mp23)	GO:0005623; GO:0005789; GO:0016021; GO:0045454	cell [GO:0005623]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cell redox homeostasis [GO:0045454]
PGEN_.00g348630	Scaffold_18	25449228	25478297	O08688	CAN5_MOUSE	Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3)	GO:0004198; GO:0005737; GO:0006508; GO:0009986; GO:0045202	cell surface [GO:0009986]; cytoplasm [GO:0005737]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]
PGEN_.00g348640	Scaffold_18	25526431	25526856	NA	NA	NA	NA	NA
PGEN_.00g348650	Scaffold_18	25542029	25542436	NA	NA	NA	NA	NA
PGEN_.00g348660	Scaffold_18	25550816	25552214	NA	NA	NA	NA	NA
PGEN_.00g348670	Scaffold_18	25596745	25599695	P15145	AMPN_PIG	Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13)	GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]
PGEN_.00g348680	Scaffold_18	25598253	25599063	NA	NA	NA	NA	NA
PGEN_.00g348690	Scaffold_18	25600752	25605880	Q28C98	MESH1_XENTR	"Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase)"	GO:0008893; GO:0046872	"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"
PGEN_.00g348700	Scaffold_18	25609412	25615788	Q9UPN9	TRI33_HUMAN	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
PGEN_.00g348710	Scaffold_18	25637977	25643722	NA	NA	NA	NA	NA
PGEN_.00g348720	Scaffold_18	25644731	25645048	NA	NA	NA	NA	NA
PGEN_.00g348730	Scaffold_18	25673470	25678573	NA	NA	NA	NA	NA
PGEN_.00g348740	Scaffold_18	25681122	25684099	NA	NA	NA	NA	NA
PGEN_.00g348750	Scaffold_18	25684876	25692096	NA	NA	NA	NA	NA
PGEN_.00g348760	Scaffold_18	25736258	25736731	NA	NA	NA	NA	NA
PGEN_.00g348770	Scaffold_18	25768273	25784399	NA	NA	NA	NA	NA
PGEN_.00g348780	Scaffold_18	25798155	25798385	NA	NA	NA	NA	NA
PGEN_.00g348790	Scaffold_18	25805705	25817658	NA	NA	NA	NA	NA
PGEN_.00g348800	Scaffold_18	25817694	25818119	NA	NA	NA	NA	NA
PGEN_.00g348810	Scaffold_18	25818483	25818941	NA	NA	NA	NA	NA
PGEN_.00g348820	Scaffold_18	25820788	25821075	NA	NA	NA	NA	NA
PGEN_.00g348830	Scaffold_18	25859137	25860111	NA	NA	NA	NA	NA
PGEN_.00g348840	Scaffold_18	25860704	25870494	NA	NA	NA	NA	NA
PGEN_.00g348850	Scaffold_18	25874793	25895881	Q12913	PTPRJ_HUMAN	Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD antigen CD148)	GO:0001772; GO:0004725; GO:0005161; GO:0005886; GO:0005887; GO:0005911; GO:0006470; GO:0008013; GO:0008285; GO:0009986; GO:0010642; GO:0016791; GO:0019901; GO:0030155; GO:0030183; GO:0030308; GO:0030336; GO:0032587; GO:0032760; GO:0035335; GO:0035579; GO:0035584; GO:0042059; GO:0043116; GO:0043312; GO:0043407; GO:0043410; GO:0045295; GO:0045296; GO:0045785; GO:0048008; GO:0050731; GO:0050852; GO:0050860; GO:0050918; GO:0051019; GO:0051894; GO:0051897; GO:0051898; GO:0060242; GO:0070062; GO:0070097; GO:1905451	cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; B cell differentiation [GO:0030183]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; contact inhibition [GO:0060242]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; neutrophil degranulation [GO:0043312]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of cell adhesion [GO:0045785]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; T cell receptor signaling pathway [GO:0050852]
PGEN_.00g348860	Scaffold_18	25900195	25917615	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g348870	Scaffold_18	25926352	25945477	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g348880	Scaffold_18	26029968	26035979	NA	NA	NA	NA	NA
PGEN_.00g348890	Scaffold_18	26049634	26050428	NA	NA	NA	NA	NA
PGEN_.00g348900	Scaffold_18	26059041	26078337	NA	NA	NA	NA	NA
PGEN_.00g348910	Scaffold_18	26111962	26112363	NA	NA	NA	NA	NA
PGEN_.00g348920	Scaffold_18	26127894	26150163	NA	NA	NA	NA	NA
PGEN_.00g348930	Scaffold_18	26188024	26202221	NA	NA	NA	NA	NA
PGEN_.00g348940	Scaffold_18	26232637	26233125	NA	NA	NA	NA	NA
PGEN_.00g348950	Scaffold_18	26263070	26263894	NA	NA	NA	NA	NA
PGEN_.00g348960	Scaffold_18	26361107	26364005	NA	NA	NA	NA	NA
PGEN_.00g348970	Scaffold_18	26416567	26420426	NA	NA	NA	NA	NA
PGEN_.00g348980	Scaffold_18	26425063	26426259	Q6ZMB0	B3GN6_HUMAN	"Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.147) (Core 3 synthase) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) (BGnT-6) (Beta-1,3-Gn-T6) (Beta-1,3-N-acetylglucosaminyltransferase 6) (Beta3Gn-T6)"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006493; GO:0008375; GO:0008376; GO:0008378; GO:0008532; GO:0009101; GO:0016020; GO:0016021; GO:0016266; GO:0016269; GO:0030311; GO:0047223; GO:0047224	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047224]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; galactosyltransferase activity [GO:0008378]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; glycoprotein biosynthetic process [GO:0009101]; O-glycan processing [GO:0016266]; O-glycan processing, core 3 [GO:0016269]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]"
PGEN_.00g348990	Scaffold_18	26448470	26449573	Q9TUD6	FUT1_PANTR	"Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.344) (Alpha(1,2)FT 1) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1)"	GO:0005975; GO:0006486; GO:0008107; GO:0016021; GO:0032580; GO:0036065	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]
PGEN_.00g349000	Scaffold_18	26458587	26458952	NA	NA	NA	NA	NA
PGEN_.00g349010	Scaffold_18	26459113	26460865	NA	NA	NA	NA	NA
PGEN_.00g349020	Scaffold_18	26469115	26469405	NA	NA	NA	NA	NA
PGEN_.00g349030	Scaffold_18	26477471	26477770	NA	NA	NA	NA	NA
PGEN_.00g349040	Scaffold_18	26527604	26531526	NA	NA	NA	NA	NA
PGEN_.00g349050	Scaffold_18	26571182	26572473	NA	NA	NA	NA	NA
PGEN_.00g349060	Scaffold_18	26593096	26630918	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g349070	Scaffold_18	26659363	26660276	NA	NA	NA	NA	NA
PGEN_.00g349080	Scaffold_18	26684421	26687905	NA	NA	NA	NA	NA
PGEN_.00g349090	Scaffold_18	26688376	26688636	NA	NA	NA	NA	NA
PGEN_.00g349100	Scaffold_18	26711774	26720725	P35822	PTPRK_MOUSE	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005886; GO:0005911; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g349110	Scaffold_18	26721096	26729825	P43378	PTN9_HUMAN	Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2)	GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:0071345; GO:1903078	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]
PGEN_.00g349120	Scaffold_18	26774658	26783997	O14522	PTPRT_HUMAN	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
PGEN_.00g349130	Scaffold_18	26796877	26818617	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g349140	Scaffold_18	26824792	26825682	NA	NA	NA	NA	NA
PGEN_.00g349150	Scaffold_18	26899361	26906307	NA	NA	NA	NA	NA
PGEN_.00g349160	Scaffold_18	26919508	26924756	NA	NA	NA	NA	NA
PGEN_.00g349170	Scaffold_18	26941234	26941479	NA	NA	NA	NA	NA
PGEN_.00g349180	Scaffold_18	26942875	26943633	NA	NA	NA	NA	NA
PGEN_.00g349190	Scaffold_18	26945164	26945523	NA	NA	NA	NA	NA
PGEN_.00g349200	Scaffold_18	26951013	26952275	NA	NA	NA	NA	NA
PGEN_.00g349210	Scaffold_18	26964823	26966608	NA	NA	NA	NA	NA
PGEN_.00g349220	Scaffold_18	26981400	26984409	NA	NA	NA	NA	NA
PGEN_.00g349230	Scaffold_18	26993424	27000874	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g349240	Scaffold_18	27047068	27067259	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g349250	Scaffold_18	27079607	27085188	P35822	PTPRK_MOUSE	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005886; GO:0005911; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g349260	Scaffold_18	27090319	27098565	Q9W6V5	PTPRJ_CHICK	Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (Supporting-cell antigen)	GO:0004725; GO:0005886; GO:0005911; GO:0006470; GO:0016021; GO:0016791; GO:0032587; GO:0042059; GO:0043407; GO:0045785; GO:0048008; GO:0050860; GO:0051894; GO:0051898	cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell adhesion [GO:0045785]; positive regulation of focal adhesion assembly [GO:0051894]; protein dephosphorylation [GO:0006470]
PGEN_.00g349270	Scaffold_18	27145370	27151945	NA	NA	NA	NA	NA
PGEN_.00g349280	Scaffold_18	27158869	27167681	NA	NA	NA	NA	NA
PGEN_.00g349290	Scaffold_18	27176967	27194828	NA	NA	NA	NA	NA
PGEN_.00g349300	Scaffold_18	27218339	27236094	P28828	PTPRM_MOUSE	Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)	GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005913; GO:0006470; GO:0007156; GO:0007165; GO:0010596; GO:0010842; GO:0016021; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042493; GO:0042802; GO:0045296; GO:0048471; GO:0097755	cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]
PGEN_.00g349310	Scaffold_18	27255383	27263679	NA	NA	NA	NA	NA
PGEN_.00g349320	Scaffold_18	27328712	27348084	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g349330	Scaffold_18	27371237	27388801	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g349340	Scaffold_18	27398924	27401790	O35245	PKD2_MOUSE	Polycystin-2 (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2)	GO:0001658; GO:0001822; GO:0001889; GO:0001892; GO:0001947; GO:0002133; GO:0003127; GO:0005102; GO:0005244; GO:0005245; GO:0005248; GO:0005249; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005623; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0005929; GO:0006816; GO:0006874; GO:0007050; GO:0007204; GO:0007259; GO:0007368; GO:0007507; GO:0008092; GO:0009925; GO:0010628; GO:0015267; GO:0015271; GO:0016020; GO:0016055; GO:0021510; GO:0021915; GO:0022843; GO:0030027; GO:0030659; GO:0031514; GO:0031587; GO:0031941; GO:0034703; GO:0035502; GO:0035725; GO:0035904; GO:0036064; GO:0042127; GO:0042802; GO:0042803; GO:0042805; GO:0042994; GO:0043398; GO:0044325; GO:0044782; GO:0045180; GO:0045429; GO:0045737; GO:0045944; GO:0048763; GO:0050982; GO:0051117; GO:0051209; GO:0051219; GO:0051262; GO:0051289; GO:0051290; GO:0051371; GO:0051393; GO:0060170; GO:0060315; GO:0060674; GO:0061333; GO:0061441; GO:0070588; GO:0071158; GO:0071277; GO:0071320; GO:0071458; GO:0071464; GO:0071470; GO:0071498; GO:0071556; GO:0071805; GO:0071910; GO:0072075; GO:0072177; GO:0072208; GO:0072214; GO:0072218; GO:0072219; GO:0072235; GO:0072284; GO:0072686; GO:0090279; GO:0097730; GO:0098662; GO:0198738; GO:2000134	"basal cortex [GO:0045180]; basal plasma membrane [GO:0009925]; cation channel complex [GO:0034703]; cell [GO:0005623]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133]; actinin binding [GO:0042805]; alpha-actinin binding [GO:0051393]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; cation channel activity [GO:0005261]; channel activity [GO:0015267]; cytoskeletal protein binding [GO:0008092]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; phosphoprotein binding [GO:0051219]; potassium channel activity [GO:0005267]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; aorta development [GO:0035904]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell cycle arrest [GO:0007050]; cell-cell signaling by wnt [GO:0198738]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to osmotic stress [GO:0071470]; cilium organization [GO:0044782]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; embryonic placenta development [GO:0001892]; heart development [GO:0007507]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; liver development [GO:0001889]; mesonephric duct development [GO:0072177]; metanephric ascending thin limb development [GO:0072218]; metanephric cortex development [GO:0072214]; metanephric cortical collecting duct development [GO:0072219]; metanephric distal tubule development [GO:0072235]; metanephric mesenchyme development [GO:0072075]; metanephric part of ureteric bud development [GO:0035502]; metanephric S-shaped body morphogenesis [GO:0072284]; metanephric smooth muscle tissue development [GO:0072208]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neural tube development [GO:0021915]; placenta blood vessel development [GO:0060674]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of calcium ion import [GO:0090279]; regulation of cell population proliferation [GO:0042127]; release of sequestered calcium ion into cytosol [GO:0051209]; renal artery morphogenesis [GO:0061441]; renal tubule morphogenesis [GO:0061333]; sodium ion transmembrane transport [GO:0035725]; spinal cord development [GO:0021510]; Wnt signaling pathway [GO:0016055]"
PGEN_.00g349350	Scaffold_18	27409676	27413409	NA	NA	NA	NA	NA
PGEN_.00g349360	Scaffold_18	27429968	27442133	NA	NA	NA	NA	NA
PGEN_.00g349370	Scaffold_18	27442174	27445841	NA	NA	NA	NA	NA
PGEN_.00g349380	Scaffold_18	27473459	27494955	Q15262	PTPRK_HUMAN	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
PGEN_.00g349390	Scaffold_18	27538258	27547464	NA	NA	NA	NA	NA
PGEN_.00g349400	Scaffold_18	27560960	27568028	P62870	ELOB_RAT	Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2)	GO:0003713; GO:0005667; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0044877; GO:0045944; GO:0070449	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; transcription factor complex [GO:0005667]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]
PGEN_.00g349410	Scaffold_18	27596434	27597132	NA	NA	NA	NA	NA
PGEN_.00g349420	Scaffold_18	27616208	27641361	NA	NA	NA	NA	NA
PGEN_.00g349430	Scaffold_18	27644055	27647245	NA	NA	NA	NA	NA
PGEN_.00g349440	Scaffold_18	27686936	27710873	NA	NA	NA	NA	NA
PGEN_.00g349450	Scaffold_18	27711059	27711466	NA	NA	NA	NA	NA
PGEN_.00g349460	Scaffold_18	27713091	27719397	NA	NA	NA	NA	NA
PGEN_.00g349470	Scaffold_18	27719756	27720187	NA	NA	NA	NA	NA